<SEC-DOCUMENT>0001104659-23-077706.txt : 20230705
<SEC-HEADER>0001104659-23-077706.hdr.sgml : 20230705
<ACCEPTANCE-DATETIME>20230703182811
ACCESSION NUMBER:		0001104659-23-077706
CONFORMED SUBMISSION TYPE:	S-4/A
PUBLIC DOCUMENT COUNT:		119
FILED AS OF DATE:		20230705
DATE AS OF CHANGE:		20230703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Data Knights Acquisition Corp.
		CENTRAL INDEX KEY:			0001849380
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				862076743
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266274
		FILM NUMBER:		231066225

	BUSINESS ADDRESS:	
		STREET 1:		TRIDENT COURT, 1 OAKCROFT ROAD
		STREET 2:		CHESSINGTON
		CITY:			SURREY
		STATE:			X0
		ZIP:			KT9 1BD
		BUSINESS PHONE:		011-44-208-090-2009

	MAIL ADDRESS:	
		STREET 1:		TRIDENT COURT, 1 OAKCROFT ROAD
		STREET 2:		CHESSINGTON
		CITY:			SURREY
		STATE:			X0
		ZIP:			KT9 1BD
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4/A
<SEQUENCE>1
<FILENAME>dkdcu-20230331xs4a.htm
<DESCRIPTION>FORM S-4/A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dkdcu="http://www.dataknightsacquisitioncorp.com/20230331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="text/html" http-equiv="content-type"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" xs:nil="true" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" name="us-gaap:CommitmentsAndContingencies" id="Hidden_3qEwVNaUAEOXkCKclBiSpg"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" xs:nil="true" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" name="us-gaap:CommitmentsAndContingencies" id="Hidden_5vq8Teu4_UWE_AUrwtP8fg"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_MRX_ZdeGqE6bviB3Wa-65A">2731544</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_zgwXAYpqeUic9wcdWVt5uQ">11500000</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_h8hx7Yav9kalxT66eXT2HQ">4838792</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_vDazgkJ0EEypzusvMTfWkw">3460275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" id="Hidden_WN0ZdMDEAUyc0sklXwd2jQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" id="Hidden_DW21HBptw06l7swvsnr-FQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_hVTGu_0FbEy6zhs2-ZgI-g" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_0cQU6E49SkmrIed7ApF4pA">585275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_AfphFbe_SE-nxF-tg42oQg">585275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" id="Hidden_LaXFHryQ1EKRA0Kg9EIuMQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" id="Hidden_27iDXPTmOUGuunAZFbooDQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_waxUz0m1IEW6QjHRetjPnQ">4253517</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_sFRSisEHb0uyrZ13hj0iXw">4253517</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_N_bkTRU1XUaeJxlOVOwVeA">4253517</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden__awjW7FUnU6X-UDXcVZkog">4253517</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_Oqe_7WZuDk-uJW7b2n_V9Q">2731544</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_f4QAOOmuLkO_Ioc9BVVxwg">4838792</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_wJJYusvVpkCiZk86y5hcmg" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden__9-nOZ3Tf0ima9Px8fKAWQ">585275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_YfcwETV8Rke8WGjFqtRR8A">585275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" id="Hidden_0d94tEnIEkOK4a0q11LgXQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" id="Hidden_sR5KYKYr6UyM5gvaQmu5yg">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" id="Hidden_Irga6wd3h0KgMqeFTp1mnw">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" id="Hidden_QCO90ljSZkaitw7M44Mrkw">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" id="Hidden_Qx0YbLdM4ki2VJtXRBf4-g">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" id="Hidden_RvbG31uxZkuaQ4LC7BE17w">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" id="Hidden_wom4GW2H80aU-QiWHaxL3w">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" id="Hidden_3s5xo3tqrky61Ubyib2gZw">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_g_97mNUb4kStaMDUizkRmA" decimals="INF" name="us-gaap:CommonStockSharesIssued" id="Hidden_2Htd6WhlbkygRfO0gyxADA">585275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_ifs9AdjQcke5yZEerWtAKg" decimals="INF" name="us-gaap:CommonStockSharesIssued" id="Hidden_HcWfg_CLWUGwG6Xl75P2Hg">585275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" xs:nil="true" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" name="us-gaap:CommitmentsAndContingencies" id="Hidden_DKdOnAzLtUCI1ZhlkXnbag"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" xs:nil="true" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" name="us-gaap:CommitmentsAndContingencies" id="Hidden__WJeqUvLsU6n6vU4zmYsLQ"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_C8p4v91f6EqF3PeVT3q1HA">8667969</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_9GKVwkMtTEuRw9kheUW9eQ">8264526</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_baAZDVWKLUSHycXy1IIhbg">0.03</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_iusRv-ELz0-MplJKcZYEww">0.44</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_HTQ80Zfj90KrdrZyrohsbg">3464052</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_8BGLyMLFEUyKaHad4t72gw">3295610</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_XXUqNLWvg0qpR2rSOgLQ_A" decimals="INF" name="dkdcu:CommonStockShareOutstanding" id="Hidden_D6zPkpS9lkWf_IMzW356xQ">12085275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA" decimals="INF" name="dkdcu:CommonStockShareOutstanding" id="Hidden_WZjZE1J4WUmo3S6vFMdTQg">12085275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_o8R-ivw5E0eAlgI5XwvsAA" decimals="0" name="us-gaap:AssetsHeldInTrustNoncurrent" id="Hidden_xvojYnxUHEmC31015lSKuw">29029416</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_0kOvX431_0WNunHM_Al50g" decimals="0" name="us-gaap:AssetsHeldInTrustNoncurrent" id="Hidden_sr0HEoPf_kOjgN9eKDA_IA">29029416</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" id="Hidden_N6awHqBWSkOMkpgj69gueA">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" id="Hidden_Se6Y_IOxNUSaCbNTO65M1g">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" id="Hidden_0J-Y_1iZYEWkURAB1nKYxA">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" id="Hidden_FA7L7c8AHkm0_hoZiQd32Q">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" id="Hidden_olDCdqZL9UmfblrEUIpuTg">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" id="Hidden_RWf99jMgf0W1jlnexYZIAQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" id="Hidden_Ko7IatCJIU6AMHUF46nbqQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" id="Hidden_rWNMRiN0QUSHh15ufVHitQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" id="Hidden_uAyRdQdgYk2tUF3OWZCuUw">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" id="Hidden_3klZK77hnEiuhfDEz3gTkg">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" id="Hidden_Ke0m9uvuCE2N4AzTXFQjpg">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" id="Hidden_0EZFGJGyk0qBGi0bHucDbQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" id="Hidden_8LlqWkSsYUmTM-JHO1qetQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" id="Hidden_NJo35Z17CkaxiBzkb-i2lg">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" id="Hidden_a3V9wCTvvUG6fgodk6FUsw">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" id="Hidden_PF55ytCECEG9GfY-ENWQBA">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" id="Hidden_KK9cdvbXLU2hAfuKYlSWXA">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" id="Hidden_zTCjO-FWJEeQF0ATLCLkzw">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_N0cKDx01fE-CPoTUE87ugg" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_7-lMi5Vl10OtbuhSWUVJVg">585275</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_B7jcxCdPlUCVznHRwDYv9A">585275</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dei:EntityCentralIndexKey" id="Tc_aAwsrkrhSUuTc2tCKH7Bcg_2_1">0001849380</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dei:AmendmentFlag" id="Tc__-S_IkXC10inMqRaNub73Q_3_1">true</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dei:DocumentType" id="Hidden_XCM27r7CoUKB2qNPHJZvKg">S-4/A</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dei:EntityFilerCategory" id="Hidden_zfxpuseI_0m-v2LU_40Fcw">Non-accelerated Filer</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" xs:nil="true" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" name="us-gaap:PreferredStockValue" id="Hidden_u4VC1Bk8lEqS28vAcCMv0g"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" xs:nil="true" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" name="us-gaap:PreferredStockValue" id="Hidden_fOlcofgYgUCSYhFsYAD0Jg"></ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" sign="-" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_aMOH8UF2jkOmx4oY-W4V1w">0.01</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_UG6XxWJds0CXaH4-vLv9Ng">0.15</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" sign="-" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_U8qb5VTrkUeQ6gm1nb5pcg">0.01</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_t491--BJ_U6REG8h_KXC-w">0.15</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Hidden_3Oegvze3iUamAXcK8gfz6g">2731544</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Hidden_TC2XcqvAn0uRRhHRnkeSow">4838792</ix:nonFraction><ix:nonNumeric contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q" name="dkdcu:ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" id="Hidden_-gBu7Ivd10mlotw_rZDvrw">P6M</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ" name="dkdcu:Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" id="Hidden_pecVw-7_R0GR-O1MFLS0Dg">P20D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ" name="dkdcu:Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" id="Hidden_4KOodU4RC02gxRyhNxEksA">P60D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" id="Hidden_wWOk2hbenkiF3eCjIIPW1A">P20D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" id="Hidden_j3RPZoOibUKp_scxdjJSCw">P30D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ" name="dkdcu:NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" id="Hidden_9B-TMAVHjEWPMjdgpFxpbg">P20D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" id="Hidden_-WzpzrAyj0OzmcEU8I-ydQ">P30D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="Hidden_ZO2hDNBMi0u8zP5YIF1kNA">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="Hidden_jQL209kLek2Gbb2s5yFT1A">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" xs:nil="true" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" name="us-gaap:PreferredStockValue" id="Hidden_VDWoG3xUDkq-QnqfvPkfFQ"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" xs:nil="true" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" name="us-gaap:PreferredStockValue" id="Hidden_W_tdiYbVOUGnMuYZaFehuw"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_kKzVaGg-tkyGRoA-U4HSRg">4253517</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_bcDIwsjDIU2tiRoMVJeRRg">2875000</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" name="us-gaap:AdditionalPaidInCapital" id="Hidden_1KMWQDP80UmtJMI6pxRIgA">2242253</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DzIyCou1hkeI-WohQI5SbA" decimals="0" name="us-gaap:StockholdersEquity" id="Hidden_dGxMlHP5QkeRLf3Erq2Q8A">2242253</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" name="dkdcu:CashHeldOutsideInTrustAccount" id="Hidden_cZQeLnh3Zk29sDgjeEin2Q">30870</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_cBacU7djtUCSXr11GkPXGw">0.03</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_3Es1orTY_USJ4itNDtiZDw">0.44</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_lanKp2oqLU-qANj804gmEQ">0.03</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_5OAEfUoUY0K-bvq2FdDuFg">0.44</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA" name="dkdcu:TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" id="Hidden_bbHY3R68R0qhn-ZoycDM0g">P20D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA" name="dkdcu:TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" id="Hidden_oJtbLe8GvkWMoQVqcR68nA">P30D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" name="dkdcu:Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" id="Hidden_l9q9OYpBaE-i-c9_ByMINg">P20D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" name="dkdcu:Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" id="Hidden_O_rVnyonKkqQ7hhmRqfGSA">P60D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" id="Hidden_g1uhXZ_IzE6YLS18Pibsaw">P20D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" id="Hidden_ucp-6LYyYk2H8bhHlUU4tg">P30D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" name="dkdcu:NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" id="Hidden_Tj-gOcDc5kC5FCMl3wJLvg">P20D</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" id="Hidden_byXh1qgX90qNILMCXVSaVw">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Hidden_OyBqbq_iQkytLYvGC9d64A">1379517</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_STifUojKSEajZv3cqO8nRw">4253517</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_Vj2cJtgcg0SBI0y6E-s6Sg">2875000</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="Hidden_4REQyUAf6022aVEF9i64Ww">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" id="Hidden_-9mRpELl-Ee-JT7U3Njw7g">1855</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd"/></ix:references><ix:resources><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_FyUQPN4qe0OMnvM3JWkCvg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_OkbsNvrK3EiK9N0XIQ24yA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_3CzSjuwSC0Si51Ps-EQeBw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_pKJtyVvMnEGNV_bpgbIOwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_qRsdIQljjU-ibnyalgU8ug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HKTnd3Yg0k23m_kWDWCW4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Yt0ReKG7x0axkO27tJcJkQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KOLd2DPW60K1uO5F86SP4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_86Daq9d6j0GAwbKckEBFNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_ZMuTDpHFhkK3bBt9NctNIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_xXVChhyI6k-ndPgI-1--gQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DzIyCou1hkeI-WohQI5SbA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_tGuxzL5MjkWBTR132SmvCw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_IHG1RFSPIE2Is1YIYVb5NQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_6-yCbHCVY0uGfDrYrKv0Iw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_6Bf7HXIAMk2oElQb9ogmow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_7_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_Xe0KcyySzEqyLKiwakwyLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_7_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_n-8OnhgC0EeVoVPuKg1hVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g6Pq07wbNEa9FXfu1Ifs3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_HJQOphMcxEKTWZeeZtSgpA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_Tv60Y58O_0WnZ3tyWWSaUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_vEBEAARln0-juOH4J-Vj-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_o3_-97zDo0C3WX2zLxg1OQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_C3EiylpFM0KQmVJZCMEtQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_5_2021_iFKFTOhmqkmSj50YSfzJGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_fctU6QHKQEOu595qEl978g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_7bwDEPA2V0-iIfkW-TlPEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_goe_RVvoFUyh8ybQ7jTgQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_b2QDuXd4oUeF_buHUjKBrg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ZJf5YelKa0CSmVXNygkaMw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_AU1G1eFSN02wMgL4I9gmYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_KwfTqwNCuk64IHdfIIUfOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_THD-b4ZLeEmrlSnwTQZiEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ORH_Epj08k2OR4P3PXUF2A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_uEkHeFxWoUKCxd1wCPJN3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_P6nhobuPVE6L9qTASsfgWA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_CHYctHL-NEC04rksJieDWA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Aq0HD_XsTkKPxGsqbD7Syg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2021_To_6_1_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ylqtNA-bUEmL4qYAA8d_tw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_6IoH2prt10mKNC-IH_tP6A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_7UFsYW4z006S_tfRUh0Kjw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_z1cvmMf8N0SP-RnaUQjayA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_q8AQnXCt_EmVrk6I872x0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_OeMjnbZWu0aoMSIKBb6DzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_9p3Am8C7MEOlbQrXnk_2cg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_vJFpkC6zqk-9LH2SncbE-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_XNE4PVnPmUe5dsW-sIzGIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_yldGfAut_UOwpJfZ6m96hA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ssFfLQvrEkeHJ26-YR0QHA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_A21K0pn7TUOZCpFwGWO4nQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_cESdCtZscUO59dYHHgaZpg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_P3mtcGxGrkKUFdj5qMeMsA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_m9dIOryBAU6cFXCIBqZNRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_25_2023_To_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_isjLRKvB20-ds3dYGWYkKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-25</xbrli:startDate><xbrli:endDate>2023-04-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_17_2023_To_4_17_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_GxhdHNvlYEGHmFQK4ASs8Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-17</xbrli:startDate><xbrli:endDate>2023-04-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_S4feA0vhSU--s22UyX83mw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_Su-w_xFE4ke175Cyk-kveg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_JWpjApV5kk6mkkkuH-ZYQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_vKlhRJKu3EemIj0dy92Ntg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_x0VSehuBK02ZfQG1ov1NTw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_v4FiAYrj_UiV84PIq9aKlg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_ZP0J_NoaR0O08Cu16XJevg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_qrvljgLErEia_hKda3XtPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2023_95dncZH7m0qh7lCm80ElQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassAndClassBCommonStockNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassAndClassBCommonStockNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassAndClassBCommonStockNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassAndClassBCommonStockNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_NHlcD0Two0y88E2KkRoDFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_OlTpv8vqnUW3HCd6Lr3SsQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_FUC4KYSqtUiLtDWVMSB8ZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_w7FiqmYDb0SNPeqJvA62Hg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_QX1AgoN1i0GRrr7rqmGn3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-y3TJWpkY0KEs_22qhgoTg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_DDMbCIawE0WRTKQo8ri2HQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dkdcu:MeasurementInputProbabilityOfCompletingBusinessCombinationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_ybrEKTUYVEi2w4swS4gdww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_SAyeztzxD0CqTCyFAOQf2A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_8dkF3R4YwUqerp4U-rpgZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_g71uqyykEUaLUf1hlvHiRw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_JeEGJuHbaES_O44UyyPIfA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_bPi2WHn1CEmBrVfnbyV-yQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_8tE3iMpWckqAsmbEpESznQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dkdcu:MeasurementInputProbabilityOfCompletingBusinessCombinationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_5w37XobWakKj_h4ipX-PCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_h8eV0dNuHUC_ArrU2_om7Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_Qv7tGKJp8ESTjI2bmnNtTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_32dEYbIibku74IeSgOkApA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_MxCSmXH-QkW2v6_7S1_RpQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-7KCAAHgxkqAZ45nDl70BQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_AiXZHnfbmUaYN1Ptn1SXKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dkdcu:MeasurementInputProbabilityOfCompletingBusinessCombinationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_t_sN0AW8l0ysvEDGgawN6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_wJJYusvVpkCiZk86y5hcmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_QhH0lFLktE2HTU1zggfIyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_zc8vCgsjJ02tRG0__b_sCA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_gGMCV4IGL0WN2ukxJY-jVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_g_97mNUb4kStaMDUizkRmA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_hVTGu_0FbEy6zhs2-ZgI-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassCommonStockNotSubjectToPossibleRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_ifs9AdjQcke5yZEerWtAKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassCommonStockNotSubjectToPossibleRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_N0cKDx01fE-CPoTUE87ugg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassCommonStockNotSubjectToPossibleRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_wLPX3pqnoEGRhqgS36Atpg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_3SQJIMIvWUS9ELj-b17duQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_7_2021_xIunY2_KPEmoFeGygcAWFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_4TkL3ro1G0WNewZCXPJcSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_ePOJmFiwvU60MCXJN9p2Ug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_wiC7cqJRr0Cr05N-S5Q2Yw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_6aYBpgJYl06PCALWaa-w4w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_0kOvX431_0WNunHM_Al50g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_-SnL89jik0a1X0ZnHQTSug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_7tsBCIa7gk6SNfDSnFWCYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_o8R-ivw5E0eAlgI5XwvsAA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_aXuUNI1Ru0CZ99nEpdL7oA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_OperatingExpenseMember_Z4B4V5TZ9kOeJBQx4nhBbw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_y4Va1YH3m0eX130BeYRwng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:IntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6Bac23xTIkSPqevzW_S64Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_0L55K7OfcUakEf_TMfNGTg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6jC0xt_xPkW3XWSHKmx-Wg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_fqKCHCXgBkSvo0fCaH9NXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_0xI8gLPKx0-BmiEb0QOU0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_SGQAoQddE0emo9lL7Hd1eA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_THab5UCa2UyrRU_XTiFJiQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_23_2021_To_3_23_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_7vg13yQIHkePUv6ms7p3ng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">dkdcu:IndependentDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-23</xbrli:startDate><xbrli:endDate>2021-03-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_23_2021_To_3_23_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ThirdIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6T3pPliyHUS0duvs0F4HAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ThirdIndependentDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-23</xbrli:startDate><xbrli:endDate>2021-03-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefFinancialOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9btB9vKZLEW4K63rfAMw5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-25</xbrli:startDate><xbrli:endDate>2021-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefExecutiveOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_Mzinbo6790mIYa6MzPmccA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-25</xbrli:startDate><xbrli:endDate>2021-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_1lq6y8qH_02AAAlWFjyicg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">dkdcu:IndependentDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-25</xbrli:startDate><xbrli:endDate>2021-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefFinancialOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6znbrCXxFkGIcYmCY0iT1Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-25</xbrli:startDate><xbrli:endDate>2021-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember__hwYxA9DEkqAKdAwnBpc_w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-25</xbrli:startDate><xbrli:endDate>2021-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_TwoIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_4pqzZtHe2EG3qyNAxfbe9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:TwoIndependentDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-25</xbrli:startDate><xbrli:endDate>2021-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_okqVlM4N3EWxKtzFTl4dfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_2ZVBDaVZVk2yU4cLdp7-rQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_qQvFEWW_20uSottBNfK9TA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_ekDZPE3EmEWL2qEJTcZkQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_3_31_2024_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_JnW2PcUwp0OM1e3d0ygcIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_10_1_2023_To_12_31_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_HiR7EAU8gUSivES6ft2axA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_28_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_9U3WXH3Tuk6B4AeZ9LZceA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_UkwcjyfyIkKPsh-ZJGYHfQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-11</xbrli:startDate><xbrli:endDate>2021-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_22_2022_To_3_22_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_C-Ez8Wj92k-wMY601LQlhQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-22</xbrli:startDate><xbrli:endDate>2022-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_22_2022_To_3_22_2022_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_6BKMWuaDzEmPd9vqRg5_Nw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-22</xbrli:startDate><xbrli:endDate>2022-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:IntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-26</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-25</xbrli:startDate><xbrli:endDate>2021-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NTJiqMJD-EKRgG77t6L0wg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_C9XJ_5SJYkeABnyRWrMZ9w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_G6_zF5TSikiD8EVocXu3Mw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_5_2021_To_11_5_2021_xmuZ3mYtZE2S5AExqoqVLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-05</xbrli:startDate><xbrli:endDate>2021-11-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_11_2021_To_5_11_2021_NmXExQZglUSAztqWU0QU3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-11</xbrli:startDate><xbrli:endDate>2021-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_9qk3u5ElcEGq6oIpa2IEYQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_z_RFqAY7JE2tlCBZNXCVwQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_11_2021_To_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_Zz-LC321iEOx0QXt64XTUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-11</xbrli:startDate><xbrli:endDate>2021-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-11</xbrli:startDate><xbrli:endDate>2021-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_11_2021_To_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_y47mRrlmNUqJZIDNSj342g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-11</xbrli:startDate><xbrli:endDate>2021-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_M9ekq6WdLEucW-gPahd0mw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Cu5tn0_8kEi4cYONPPpMdw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_8_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_GfqTmPjOjEe_maJFOaIOog"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_TjM-esHGVEeoFX1cq_RpYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_6wnVrpWarEuBYWQ4-7W6Ig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_SeDSdYS9I0OQvO6F2ARe9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_gvo3MI-_1kGJuvLmpZZU2w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_ruu01iLDPE611oCSW8HUQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_QUoUswNMF02jFye3P74QXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_EF6C8NJFb0KSaqc-FbCmBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_0N5eYpz5zUyuKVAv4QYoVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_Nddpq_hUqUiHgJZLwEZXaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_hE2awbU3oU-sum3j2xFkxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember__X7tf0I7ukiYWBqvSdHF_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-10</xbrli:startDate><xbrli:endDate>2022-08-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-05</xbrli:startDate><xbrli:endDate>2022-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_aJZ8MZKwr0C2EHSlNrQl3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_IhW2rhKKn0qo7A0xhD9s0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_zKlPVPHq4kWNIVjUBUSy9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_Cfp-j1jKfkKwbJQkm0sqsA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_3RZpCGP7S0q5c4sXVDjShA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_2_8_2021_v79xWrSU2E2fOfIAgN6zrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-02-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_3sbSA6mVh0m3wtnOe9Ru3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_OOd5AilGXE2sxPflL-HxVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_9L82rWITkUe_O0x-YM5jnw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_XXUqNLWvg0qpR2rSOgLQ_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_BCoSdhDn8kSOYrKHJDYXHw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember__aKBWKKCl0y9GZbCCzx5Mg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_D81xSwKtWUK5pM73JnCYwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_g-5Z8iiekEipUKjvBBe-og"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_QaJt1ia12ECl_HVZf-OHZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_28_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Qivj15x0skm53fAZP6Gj9w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_kF1v8eLYwUqIkingtOoNMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_bWhzWPZIyUW-IA3VsLVynA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_28_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_nn_yhuYka4eAFEk-2_Tg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_19_2023_To_4_19_2023_srt_StatementScenarioAxis_dkdcu_SixthOneMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_ziSc7tDmME6Wx3vreHBoIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:SixthOneMonthExtensionToTerminationDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-19</xbrli:startDate><xbrli:endDate>2023-04-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_6_2023_To_3_6_2023_srt_StatementScenarioAxis_dkdcu_FifthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NBJMLC3FJkeQ_zMEcQPEZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:FifthMonthExtensionToTerminationDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-06</xbrli:startDate><xbrli:endDate>2023-03-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2023_To_2_8_2023_srt_StatementScenarioAxis_dkdcu_FourthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_2cSXaqbjC0G88fQ4Os87Uw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:FourthMonthExtensionToTerminationDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-08</xbrli:startDate><xbrli:endDate>2023-02-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_5_2023_To_1_5_2023_srt_StatementScenarioAxis_dkdcu_ThirdMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_zROX-Jpz0Um4wcHHn0lc3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:ThirdMonthExtensionToTerminationDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-05</xbrli:startDate><xbrli:endDate>2023-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_S7Yu6E8CZU-ri3x6GhOt_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-11</xbrli:startDate><xbrli:endDate>2022-11-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_wzq3pdLUSk-Hj-g34bsbKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-11</xbrli:startDate><xbrli:endDate>2022-11-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-11</xbrli:startDate><xbrli:endDate>2022-11-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q"><xbrli:measure>dkdcu:Vote</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw"><xbrli:measure>dkdcu:item</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_D_24WmzP3yxEKX8pNPNSJZgw"><xbrli:measure>dkdcu:D</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A"><xbrli:measure>dkdcu:Y</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:8.05pt;"><a id="_ecb04060_2ded_4909_99fb_b9d99beb7a59"></a><a id="_Hlk135152035"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:7pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">As filed with the United States Securities and Exchange Commission on July 3, 2023</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 2pt 0pt;"><b style="font-weight:bold;">Registration No.333-266274</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:right;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt 0pt 3pt 0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dei:AmendmentDescription" id="Narr_nxNU1V3DCku9BHHJINuSdQ"><b style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-weight:bold;">AMENDMENT NO. 6 </b></ix:nonNumeric><b style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-weight:bold;">TO</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:13pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">FORM&#160;</b><span style="-sec-ix-hidden:Hidden_XCM27r7CoUKB2qNPHJZvKg;"><b style="font-family:'Times New Roman','Times','serif';font-size:13pt;font-style:normal;font-weight:bold;">S-4</b></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">REGISTRATION STATEMENT UNDER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">THE SECURITIES ACT OF 1933</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:13pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dei:EntityRegistrantName" id="Narr_O-DsRzooSE2GB2YPzZwzlg"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(Exact name of registrant as specified in its charter)</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:8.75pt;"><td style="vertical-align:bottom;width:31.68%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Delaware</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:31.67%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">6770</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:32.91%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">86-2076743</b></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:31.68%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">(State or Other Jurisdiction of<br/>Incorporation or Organization)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.67%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">(Primary Standard Industrial <br/>Classification Code Number)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt 0pt 2.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">(I.R.S. Employer <br/>Identification No.)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unit G6, Frome Business Park, Manor Road</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Frome</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">United Kingdom, BA11 4FN</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">011-44 203 833 4000</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">(Address,&#160;including&#160;zip&#160;code&#160;and&#160;telephone&#160;number,&#160;including&#160;area&#160;code,&#160;of&#160;registrant&#8217;s&#160;principal&#160;executive offices)</p><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Barry Anderson</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Chief Executive Officer</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unit G6, Frome Business Park, Manor Road</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Frome</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">United Kingdom, BA11 4FN</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">011-44 203 833 4000</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">(Name,&#160;address,&#160;including&#160;zip&#160;code&#160;and&#160;telephone&#160;number,&#160;including&#160;area&#160;code,&#160;of&#160;agent&#160;for&#160;service)</p><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 5pt 0pt;"><i style="font-style:italic;">Copies to:</i></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:3.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:46.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">Andrew M. Tucker, Esq.</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Nelson Mullins Riley &amp; Scarborough LLP</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">101 Constitution Avenue, NW</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Suite 900</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Washington, DC 20001</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(202) 689-2987</b></p></td><td style="vertical-align:top;width:3.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:46.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Debbie A. Klis, Esq.</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Rimon PC</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">1990 K Street, NW</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Suite 420</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Washington, DC 20006</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(202) 935-3390</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">Approximate date of commencement of proposed sale to the public:</b> As soon as practicable after (i)&#160;this registration statement is declared effective and (ii)&#160;upon completion of the applicable transactions described in the enclosed proxy statement/prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 3pt 0pt;">If the securities being registered on this Form&#160;are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, check the following box:&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 3pt 0pt;">If this Form&#160;is filed to register additional securities for an offering pursuant to Rule&#160;462(b)&#160;under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 3pt 0pt;">If this Form&#160;is a post-effective amendment filed pursuant to Rule&#160;462(d)&#160;under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 3pt 0pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule&#160;12b-2 of the Exchange Act.</p><a id="_c32090ae_9ae9_42e4_974d_55dad25e8c27"></a><div style="padding-left:18pt;"><a id="Tc_SGErz4GDmUe0PFtoXBrJiw_2_0"></a><a id="Tc_YhjojVGBXkO1nB2hf6pAXw_2_1"></a><a id="Tc_9CnxEt0M5Uy2asrnSBxPPQ_2_2"></a><a id="Tc_TrTghHr6BUCwzmimaBTWeA_2_3"></a><a id="Tc_K-XQC1HhgEePf0yaU92Avw_4_1"></a><a id="Tc_bvsWhJygV0iyL3TjzvCLFA_4_2"></a><a id="Tc_66DQmWO-6EaQw6kMhLelaA_6_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:95%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.48%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:23.54%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:38.68%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"/></tr><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.48%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:23.54%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:38.68%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:33.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Large accelerated filer</p></td><td style="vertical-align:bottom;width:23.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:bottom;width:38.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Accelerated filer</p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';font-size:2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:38.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_zfxpuseI_0m-v2LU_40Fcw;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;">Non-accelerated</span></span></p></td><td style="vertical-align:bottom;width:23.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></p></td><td style="vertical-align:bottom;width:38.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Smaller reporting company</p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dei:EntitySmallBusiness" id="Tc_LrjCAvlHWUSu1YYxifZBJw_4_3"><span style="font-family:'Segoe UI Symbol';font-size:7pt;">&#9746;</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:33.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:38.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:38.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Emerging growth company</p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dei:EntityEmergingGrowthCompany" id="Tc_I3hwkJ9rM0WRSkz3k85sRw_6_3"><span style="font-family:'Segoe UI Symbol';font-size:7pt;">&#9746;</span></ix:nonNumeric></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 3pt 0pt;"><span style="font-size:7pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B)&#160;of the Securities Act. </span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dei:EntityExTransitionPeriod" id="Narr_JesIBITFnkSunBi9rfhiHw"><span style="font-family:'Segoe UI Symbol';font-size:7pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 3pt 0pt;">If applicable, place an X in the box to designate the appropriate rule&#160;provision relied upon in conducting this transaction:</p><div style="padding-left:18pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:95%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Exchange Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer)</p></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Exchange Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)</p></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with section 8(a)&#160;of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the SEC, acting pursuant to said section 8(a), may determine.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:4pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-indent:18pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:630.8pt;"><a id="_b4fe23da_edc7_4d5d_8a71_1ff879b5bbf1"></a><div style="height:630.04pt;left:0.29%;max-width:99.71%;position:absolute;top:0.76pt;width:51.01pt;z-index:251658240;"><div style="height:629.84pt;left:0pt;padding-bottom:0.2pt;position:relative;top:0pt;width:50.71pt;"><div style="height:629.84pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:50.71pt;"><div style="left:0pt;max-height:100%;position:relative;text-indent:0pt;top:0pt;transform:rotate(180.1deg);width:50.71pt;writing-mode:vertical-rl;-ms-writing-mode:tb-rl;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;width:100%;margin:0pt;"><b style="color:#ff0000;font-weight:bold;">The information in this preliminary proxy statement/prospectus is not complete and may be changed. Data Knights Acquisition Corp. may not issue the securities offered by this proxy statement/prospectus until the registration statement filed with the Securities and Exchange Commission, of which this proxy statement/prospectus is a part, is declared effective. This proxy statement/prospectus does not constitute an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale of these securities is not permitted.</b></p></div></div></div></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 12pt 54pt;"><b style="color:#ff0000;font-family:'Times New Roman','Times','serif';font-weight:bold;">PRELIMINARY&#160;&#8212; SUBJECT TO COMPLETION, DATED JULY 3, 2023</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0pt 54pt;"><b style="font-weight:bold;">PROXY STATEMENT OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 54pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0pt 54pt;"><b style="font-weight:bold;">PROSPECTUS FOR UP TO</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0pt 54pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; SHARES OF COMMON STOCK</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 54pt;">To the Stockholders of Data Knights Acquisition Corp.:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 54pt;">We are very pleased to provide this proxy statement/prospectus relating to the proposed merger (the &#8220;<b style="font-weight:bold;">Merger</b>&#8221;) of Data Knights Merger Sub,&#160;Inc., a Delaware corporation (&#8220;<b style="font-weight:bold;">Merger Sub</b>&#8221;) and wholly-owned subsidiary of Data Knights Acquisition Corp, a Delaware corporation (&#8220;<b style="font-weight:bold;">Data Knights</b>&#8221; or the &#8220;<b style="font-weight:bold;">Company</b>&#8221;), with and into OneMedNet Corporation, a Delaware corporation (&#8220;<b style="font-weight:bold;">OneMedNet</b>&#8221;), with OneMedNet continuing as the surviving corporation and wholly-owned subsidiary of Data Knights, as contemplated by the Agreement and Plan of Merger (the &#8220;<b style="font-weight:bold;">Merger Agreement</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 54pt;">If the Merger Agreement is adopted, all of the issued and outstanding capital stock of OneMedNet immediately prior to the effective time of the Merger (other than those properly exercising any applicable appraisal rights under Delaware law) will automatically be cancelled and shall cease to exist, in exchange for the right to receive pro rata shares of the Merger Consideration (as defined below) and Data Knights will change its name to OneMedNet Corporation at the Closing (as defined in the Merger Agreement) (collectively, the <span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-weight:bold;">Business Combination</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span>). As consideration for the Merger, the holders of OneMedNet securities collectively shall be entitled to receive from Data Knights, in the aggregate, a number of Data Knights securities with an aggregate value equal to (the <span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-weight:bold;">Merger Consideration</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span>) (a)<span style="font-family:'Times New Roman PS Std';">&#160;</span>Two Hundred Million U.S. Dollars ($200,000,000) minus (b)<span style="font-family:'Times New Roman PS Std';">&#160;</span>the amount, if any, by which the Target Net Working Capital Amount (as defined in the Merger Agreement) exceeds the Net Working Capital Amount (as defined in the Merger Agreement) (but not less than zero), minus (c)<span style="font-family:'Times New Roman PS Std';">&#160;</span>the amount of Closing Net Indebtedness (as defined in the Merger Agreement) minus (d)<span style="font-family:'Times New Roman PS Std';">&#160;</span>the amount of any Merger transaction expenses (the total portion of the Merger Consideration amount payable to all OneMedNet stockholders in accordance with the Merger Agreement is also referred to herein as the <span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-weight:bold;">Stockholder Merger Consideration</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span>). For more information, see the section entitled <span style="font-family:'Times New Roman PS Std';">&#8220;</span><i style="font-style:italic;">The Business Combination Proposal</i><i style="font-family:'Times New Roman PS Std';font-style:italic;">&#160;&#8212;</i><i style="font-style:italic;"> The Merger Agreement</i>.<span style="font-family:'Times New Roman PS Std';">&#8221;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 54pt;">Data Knights will hold a virtual special meeting of its stockholders in order to obtain the stockholder approvals necessary to complete the Business Combination. In connection with the Business Combination and the other matters described in the accompanying proxy statement, you are cordially invited to attend the special meeting of stockholders of Data Knights in lieu of the 2023 annual meeting (the <span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-weight:bold;">Special Meeting</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span>) to be held at [<span style="font-family:'Symbol';">&#183;</span>]<span style="font-family:'Times New Roman PS Std';">&#160;</span>a.m./p.m., Eastern Time on [<span style="font-family:'Symbol';">&#183;</span>], 2023. The formal meeting notice and proxy statement for the Special Meeting are attached hereto. The Special Meeting will be conducted via live webcast. You will be able to attend the Special Meeting online, vote and submit your questions during the Special Meeting by visiting <i style="font-style:italic;">https://www.cstproxy.com/dataknights/2023</i>. The virtual meeting format allows you to attend the Special Meeting from any location in the world. At the Special Meeting, Data Knights will ask its stockholders to adopt the Merger Agreement, thereby approving the Business Combination and approve the other proposals described in the accompanying proxy statement/prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 54pt;">Data Knights&#8217; Board has adopted and approved the Merger Agreement and recommends a vote &#8220;<b style="font-weight:bold;">FOR</b>&#8221; each of the Proposals to be presented at the Special Meeting.&#160;In arriving at its recommendations, Data Knights&#8217; Board carefully considered a number of factors described in the accompanying proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_452ff013_1393_47cf_bab4_8aaf7f8bf1ca"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is a blank check company incorporated as a Delaware corporation on February&#160;8, 2021, for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Data Knights&#8217; units, common stock and warrants are trading on The Nasdaq Stock Market LLC (&#8220;<b style="font-weight:bold;">Nasdaq</b>&#8221;) under the symbols &#8220;DKDCU,&#8221; &#8220;DKDCA&#8221; and &#8220;DKDCW,&#8221; respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights LLC (the &#8220;<b style="font-weight:bold;">Sponsor</b>&#8221;) and Data Knights&#8217; officers and directors (together with the Sponsor, the &#8220;<b style="font-weight:bold;">Insiders</b>&#8221;) each have agreed to (i)&#160;vote all of their shares of Data Knights Class&#160;B Common Stock in favor of the Business Combination and certain other matters, and (ii)&#160;certain restrictions on their shares of Data Knights Class&#160;B common stock (other than any shares of Data Knights Class&#160;B Common Stock received in exchange for Private Placement Warrants (as defined below))<i style="font-style:italic;">, </i>and to take other customary actions to cause the Business Combination to occur. The foregoing description of the Sponsor Support Agreement entered into in connection with the transaction is subject to and qualified in its entirety by reference to the full text of the Sponsor Support Agreement, a copy of which is included as <a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922049684/tm2213454d1_ex2-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Exhibit&#160;2.3</span></a> to Data Knights&#8217; Form&#160;8-K filed with the SEC on April&#160;25, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the Closing of the Business Combination, Data Knights&#8217; units will separate into their component shares of Class&#160;A common stock and public warrants, and the units will no longer trade separately under &#8220;DKDCU.&#8221; Data Knights has applied for the listing of the Class&#160;A common stock and public warrants on Nasdaq following the Closing of the Business Combination under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW,&#8221; respectively. Based on the capitalization of OneMedNet, as of December&#160;31, 2021, the total number of shares of Data Knights Common Stock expected to be issued in connection with the Business Combination is approximately 20,000,000, and holders of equity interests in OneMedNet as of immediately prior to the closing of the Business Combination are expected to hold, in the aggregate, approximately 57% of the issued and outstanding shares of Data Knights Common Stock immediately following the closing of the Business Combination assuming no further redemptions by Data Knights stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet is a curator of regulatory-grade Imaging Real Word Data (&#8220;<b style="font-weight:bold;">RWD</b>&#8221;), a growing emerging market. Its innovation solutions connect healthcare providers and patients by offering direct access to clinical images and associated contextual patient record. OneMedNet has proven the commercial and regulatory viability of imaging RWD by providing regulatory-grade image-centric RWD that exactly matches OneMedNet&#8217;s Life Science Partners&#8217; Case Selection Protocol. With a federated network of over 90 healthcare providers, OneMedNet has the immediate ability to quickly search and extensively curate multi-layer data from a Federated group of healthcare facilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet believes it has demonstrated its leadership in clinical imaging and curation of RWD based upon success in compiling one of the largest networks of imaging centers (comprised of hospitals, imaging centers and clinics) throughout the United States covering more than 15 million patients to date. On the global front, OneMedNet works with hospitals and life science companies around the world including Ireland, United Kingdom, Ghana, Denmark and South Korea and growing. We base these claims on our understanding of our competition in the United States and globally.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As described in the accompanying proxy statement/prospectus, certain officers, directors and equityholders of OneMedNet are parties to the Voting Agreement with Data Knights whereby such parties, among other things, have agreed to vote all of their interests in OneMedNet to approve the Merger Agreement and the Business Combination. As also described in the accompanying proxy statement/prospectus, the Sponsor is a party to the Sponsor Support Agreement with Data Knights and OneMedNet whereby the Sponsor, among other things, has agreed to vote all of its shares of Data Knights Common Stock in favor of approving the proposals described in the accompanying proxy statement/prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Pursuant to the Charter, Data Knights&#8217; public stockholders have redemption rights in connection with the Business Combination. Data Knights&#8217; public stockholders are not required to affirmatively vote for or against the Business Combination in order to redeem their shares of Class&#160;A Common Stock for cash. This means that public stockholders who hold shares of Data Knights Class&#160;A Common Stock on or before [</b><span style="font-family:'Symbol';">&#183;</span><b style="font-weight:bold;">], 2023 (two&#160;(2)&#160;business&#160;days before the Special Meeting) will be eligible&#160;to elect to have their shares of Class&#160;A common stock redeemed for cash in connection with the Special Meeting, whether or not they are holders as of the Record Date and whether or not such shares are voted at the Special Meeting.</b></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is providing this proxy statement/prospectus and accompanying proxy card to Data Knights&#8217; stockholders in connection with the solicitation of proxies to be voted at the Special Meeting and at any adjournments or postponements of the Special Meeting. <b style="font-weight:bold;">Whether or not you plan to attend the Special Meeting, Data Knights urges you to carefully read this proxy statement/prospectus (and any documents incorporated into this proxy statement/prospectus by reference). Please pay particular attention to the section titled &#8220;</b><span style="font-style:italic;font-weight:bold;">Risk Factors</span><b style="font-weight:bold;">&#8221; beginning on page&#160;</b><span style="font-weight:bold;">56</span><b style="font-weight:bold;"> of the accompanying proxy statement/prospectus.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To participate in the virtual meeting, a Data Knights stockholder of record will need the 16-digit control number included on your proxy card or instructions that accompanied your proxy materials, if applicable, or to obtain a proxy form from your broker, bank or other nominee. The Data Knights Special Meeting webcast will begin promptly at [&#9679;]&#160;a.m., Eastern Time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We strongly encourage Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> stockholders to access the Data Knights Special Meeting prior to the start time. If you encounter any difficulties accessing the virtual meeting or during the meeting time, please call the technical support number that will be posted on the virtual meeting login page.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Your vote is very important. If you are a registered stockholder of Data Knights, please vote your shares as soon as possible to ensure that your vote is counted, regardless of whether you expect to attend the Special Meeting, by completing, signing, dating, and returning the enclosed proxy card in the postage-paid envelope provided. If you hold your shares in &#8220;street name&#8221; through a bank, broker, or other nominee, you will need to follow the instructions provided to you by your bank, broker, or other nominee to ensure that your shares are represented and voted at the Special Meeting. The transactions contemplated by the Merger Agreement are conditioned on the approval of the Business Combination and satisfaction of certain other closing conditions described in the accompanying proxy statement.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On behalf of Data Knights&#8217; Board, I would like to thank you for your support and look forward to the successful completion of the Business Combination.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Chief Executive Officer</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-family:'Times New Roman PS Std';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>[&#9679;], 2023</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities to be issued under the accompanying proxy statement or determined that the accompanying proxy statement is accurate or complete. Any representation to the contrary is a criminal offense.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying proxy statement is dated [&#9679;], 2023 and is first being mailed to the stockholders of Data Knights on or about [&#9679;], 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_f5afca31_375b_40b9_bb0c_70054983b5ee"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data Knights Acquisition Corp.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unit G6, Frome Business Park, Manor Road</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Frome</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">United Kingdom, BA11 4FN</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">011-44 203 833 4000</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NOTICE OF SPECIAL MEETING OF STOCKHOLDERS OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP. IN LIEU OF ITS 2023 ANNUAL MEETING</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">TO BE HELD ON [</b><b style="font-family:'Symbol';font-weight:bold;">&#183;</b><b style="font-weight:bold;">], 2023</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">To the Stockholders of Data Knights Acquisition Corp.:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">NOTICE IS HEREBY GIVEN that a special meeting of stockholders (the &#8220;<b style="font-weight:bold;">Special Meeting</b>&#8221;) of Data Knights Acquisition Corp. (&#8220;<b style="font-weight:bold;">Data Knights</b>&#8221;), a Delaware corporation, will be held at [<span style="font-family:'Times New Roman';">&#9679;</span>]&#160;a.m. Eastern Time, on [<span style="font-family:'Times New Roman';">&#9679;</span>], 2023. The Special Meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. You will be able to attend the Special Meeting online, vote and submit your questions during the Special Meeting by visiting https://www.cstproxy.com/dataknights/2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the Special Meeting, Data Knights stockholders will be asked to consider and vote upon the following proposals (each, a &#8220;<b style="font-weight:bold;">Proposal</b>&#8221; and collectively, the &#8220;<b style="font-weight:bold;">Proposals</b>&#8221;), as more fully described in the accompanying proxy statement:</p><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(1)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">consider and vote on an amendment to the Charter (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NTA Amendment</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;), which amendment shall be effective, if adopted and implemented by Data Knights, prior to the consummation of the proposed Business Combination, to remove from the Charter the Redemption Limitation contained under Section 9.2(a) preventing Data Knights from closing a business combination if it would have less than $5,000,0001 of net tangible assets (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NTA Proposal</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;). A copy of the NTA Amendment is attached to the accompanying proxy statement/prospectus as </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Annex A</i><span style="font-family:'Times New Roman','Times','serif';">;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(2)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to adopt and approve an Agreement and Plan of Merger (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Merger Agreement</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">), by and among Data Knights, Data Knights Merger Sub,</span><span style="font-family:'Times New Roman PS Std';">&#160;</span><span style="font-family:'Times New Roman','Times','serif';">Inc., a Delaware corporation and wholly-owned subsidiary of Data Knights (</span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Merger Sub</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">), OneMedNet Corporation, a Delaware corporation (</span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">OneMedNet</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">), Data Knights, LLC, in its capacity as Purchaser Representative, and Paul Casey, in his capacity as Seller Representative, pursuant to which at the closing of the transactions contemplated by the Merger Agreement (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Closing</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">), Merger Sub will merge with and into OneMedNet (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Merger</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">), with OneMedNet changing its name to OneMedNet Solutions Corp. and continuing as the surviving corporation (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Surviving Corporation</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">) and wholly-owned subsidiary of Data Knights, which will change its name to OneMedNet Corporation at the Closing (collectively, the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Business Combination</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">). A copy of the Merger Agreement is attached to the accompanying proxy statement/prospectus as</span><span style="font-family:'Times New Roman PS Std';">&#160;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex</i><i style="font-family:'Times New Roman PS Std';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;</i><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">B</i><span style="font-family:'Times New Roman','Times','serif';">. We refer to this as the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Business Combination Proposal</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(3)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to consider and vote upon a proposal to approve, for purposes of complying with Nasdaq Listing Rules</span><span style="font-family:'Times New Roman PS Std';">&#160;</span><span style="font-family:'Times New Roman','Times','serif';">5635(a)</span><span style="font-family:'Times New Roman PS Std';">&#160;</span><span style="font-family:'Times New Roman','Times','serif';">and (b), the issuance of more than 20% of the issued and outstanding Class</span><span style="font-family:'Times New Roman PS Std';">&#160;</span><span style="font-family:'Times New Roman','Times','serif';">A common stock and the resulting change in control in connection with the Business Combination. We refer to this as the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Nasdaq Proposal</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(4)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to adopt and approve the Third Amended and Restated Certificate of Incorporation, as set out in </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex</i><i style="font-family:'Times New Roman PS Std';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;</i><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">C</i><span style="font-family:'Times New Roman','Times','serif';"> to this proxy statement/prospectus, which shall become effective upon the closing (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Closing</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">) of the Business Combination (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Charter Amendment Proposal</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">) including (i) the addition of a supermajority voting requirement to amend the Surviving Corporation</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Bylaws (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Bylaw Amendment Requirement</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">), and (ii) the addition of a supermajority voting requirement to amend Articles V (Board of Directors), VI (Stockholders), VII (Liability and Indemnification; Corporate Opportunity), VIII (Business Combinations), IX (Exclusive Forum), and Article X (Amendments) of the Third Amended and Restated Certificate of Incorporation (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Article Amendment Requirement</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">):</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(5)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to consider and vote to elect nine directors to serve staggered terms on the Data Knights Board until the 2023, 2024 and 2025 annual meeting of stockholders of Data Knights or until each such director</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s successor has been duly elected and qualified, or until each such director</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s earlier death, resignation, retirement, or removal (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Election of Directors Proposal</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">);</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(6)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to approve and adopt the 2022 Equity Incentive Plan (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Equity Incentive Plan</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">), a copy of which is attached to the accompanying proxy statement as</span><span style="font-family:'Times New Roman PS Std';">&#160;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex</i><i style="font-family:'Times New Roman PS Std';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;</i><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">D</i><span style="font-family:'Times New Roman PS Std';">&#160;</span><span style="font-family:'Times New Roman','Times','serif';">(the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Incentive Plan Proposal</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">); and</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(7)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to adopt and approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary to permit further solicitation and vote of proxies if it is determined by Data Knights that more time is necessary or appropriate to approve one or more Proposals at the Special Meeting (the </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Adjournment Proposal</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">).</span></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights&#8217; board of directors (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Board</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;) has adopted and approved the Merger Agreement and recommends a vote &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221; the NTA Proposal, &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;&#160;the Business Combination Proposal, &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;&#160;the Nasdaq Proposal, &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;&#160;the Charter Amendment Proposal (including a vote &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221; the Bylaw Amendment Requirement and &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221; the Article Amendment Requirement), &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221; the Election of Directors Proposal, &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;&#160;the Incentive Plan Proposal and &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;&#160;the Adjournment Proposal. Data Knights does not expect a vote to be taken on any other matters at the Special Meeting or any adjournment or postponement thereof.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Holders of record of Data Knights&#8217; Class&#160;A Common Stock, par value $0.0001 per share, and Data Knights&#8217; Class&#160;B Common Stock, par value $0.0001 per share (&#8221;<b style="font-weight:bold;">Founder Shares</b>,&#8221; and collectively with Data Knights&#8217; Class&#160;A Common Stock, the &#8220;<b style="font-weight:bold;">Data Knights Common Stock</b>&#8221;) at the close of business on [&#9679;], 2023 (the &#8220;<b style="font-weight:bold;">Record Date</b>&#8221;) will be entitled to notice of and to vote at the Special Meeting or any adjournment or postponement thereof. Each share of Data Knights Common Stock entitles the holder thereof to one vote. A complete list of Data Knights stockholders of record entitled to vote at the Data Knights Special Meeting will be available for 10&#160;days before the Data Knights Special Meeting at the principal executive offices of Data Knights for inspection by stockholders by appointment only during ordinary business hours for any purpose germane to the Data Knights Special Meeting. The eligible Data Knights stockholder list will also be available on the Data Knights Special Meeting website for examination by any stockholder attending the Data Knights Special Meeting webcast.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Your attention is directed to the proxy statement/prospectus accompanying this notice (including the financial statements and annexes attached thereto) for a more complete description of the proposed Business Combination and related transactions and each of our Proposals. We encourage you to read the accompanying proxy statement/prospectus carefully. If you have any questions or need assistance voting your shares, please call our proxy solicitor, Laurel Hill Advisory Group LLC at (855) 414-2266 or by email at dataknights@laurelhill.com.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">All Data Knights stockholders are cordially invited to attend the Stockholders Meeting in virtual format. Data Knights stockholders may attend, vote and examine the list of Data Knights stockholders entitled to vote at the Stockholders Meeting by visiting https://www.cstproxy.com/dataknights/2023 and using the conference ID number 0396969#. To ensure your representation at the Stockholders Meeting, you are urged to complete, sign, date and return the enclosed proxy card as soon as possible. To vote online, please have your proxy card available and visit www.cstproxyvote.com and follow the prompts to vote your shares. If your shares are held in an account at a brokerage firm or bank, you must instruct your broker or bank on how to vote your shares.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Your vote is very important regardless of the number of shares you own. Whether you plan to attend the Stockholders Meeting or not, please sign, date, and return the enclosed proxy card as soon as possible in the envelope provided. If your shares are held in &#8220;street name&#8221; or are in a margin or similar account, you should contact your broker to ensure that votes related to the shares you beneficially own are properly counted. If you sold or transferred your shares after the record date, it is still important that you vote. Each of the NTA Proposal, the Business Combination Proposal, the Charter Amendment Proposal, the Nasdaq Proposal, the Incentive Plan Proposal, and the Election of Directors Proposal is interdependent upon the others and must be approved in order for Data Knights to complete the Business Combination as contemplated by the Merger Agreement. Other than the Charter Amendment Proposal and the Election of Directors Proposal, each of the Proposals requires the affirmative vote of a majority of the issued and outstanding shares of Data Knights Common Stock cast by the stockholders represented in person (which would include presence at a virtual meeting) or by proxy at the Stockholders Meeting and entitled to vote thereon, voting as a single class. The NTA Proposal and the Charter Amendment Proposal requires the affirmative vote of a majority of the issued and outstanding shares of Data Knights Common Stock, voting as a single class. Directors are elected by a plurality of the votes cast by holders of Data Knights Common Stock present virtually or by proxy and entitled to vote thereon at the Special Meeting.</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By Order of the Board of Directors,</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;[&#9679;], 2023</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_cc62036e_b9eb_4cd6_9ed2_aec5b5aa309d"></a><a id="TOC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">TABLE OF CONTENTS</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#MARKETANDINDUSTRYDATA_312206"><span style="font-style:normal;font-weight:normal;">MARKET AND INDUSTRY DATA</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">1</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#SUMMARYTERMSHEET_472282"><span style="font-style:normal;font-weight:normal;">SUMMARY TERM SHEET</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">2</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#FREQUENTLYUSEDTERMS_367787"><span style="font-style:normal;font-weight:normal;">FREQUENTLY USED TERMS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">6</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#QUESTIONSANDANSWERSABOUTTHEPROPOSALS_437"><span style="font-style:normal;font-weight:normal;">QUESTIONS AND ANSWERS ABOUT THE PROPOSALS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">10</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#SUMMARYOFTHEPROXYSTATEMENTPROSPECTUS_964"><span style="font-style:normal;font-weight:normal;">SUMMARY OF THE PROXY STATEMENT/PROSPECTUS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">26</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#CAUTIONARYNOTEREGARDINGFORWARDLOOKINGSTA"><span style="font-style:normal;font-weight:normal;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">41</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#SELECTEDFINANCIALANDOTHERDATAOFDATAKNIGH"><span style="font-style:normal;font-weight:normal;">SELECTED FINANCIAL AND OTHER DATA OF DATA KNIGHTS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">43</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#SELECTEDFINANCIALANDOTHERDATAOFONEMEDNET"><span style="font-style:normal;font-weight:normal;">SELECTED FINANCIAL AND OTHER DATA OF ONEMEDNET</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">46</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#Unaudited"><span style="font-style:normal;font-weight:normal;">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">48</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#RISKFACTORS_551336"><span style="font-style:normal;font-weight:normal;">RISK FACTORS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">56</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#SPECIALMEETINGOFDATAKNIGHTSSTOCKHOLDERS_"><span style="font-style:normal;font-weight:normal;">SPECIAL MEETING OF DATA KNIGHTS STOCKHOLDERS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">96</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#THENTAPROPOSAL_622310"><span style="font-style:normal;font-weight:normal;">THE NTA PROPOSAL</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">102</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#THEBUSINESSCOMBINATIONPROPOSAL_239295"><span style="font-style:normal;font-weight:normal;">THE BUSINESS COMBINATION PROPOSAL</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">103</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#THENASDAQPROPOSAL_346379"><span style="font-style:normal;font-weight:normal;">THE NASDAQ PROPOSAL</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">135</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#THECHARTERAMENDMENTPROPOSAL_106350"><span style="font-style:normal;font-weight:normal;">THE CHARTER AMENDMENT PROPOSAL</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">137</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#THEDIRECTORELECTIONPROPOSAL_309989"><span style="font-style:normal;font-weight:normal;">THE DIRECTOR ELECTION PROPOSAL</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">142</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#THEEQUITYINCENTIVEPLANPROPOSAL_93419"><span style="font-style:normal;font-weight:normal;">THE EQUITY INCENTIVE PLAN PROPOSAL</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">143</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#THEADJOURNMENTPROPOSAL_592112"><span style="font-style:normal;font-weight:normal;">THE ADJOURNMENT PROPOSAL</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">148</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#INFORMATIONABOUTDATAKNIGHTS_888916"><span style="font-style:normal;font-weight:normal;">INFORMATION</span><span style="font-style:normal;font-weight:normal;"> ABOUT DATA KNIGHTS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">149</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#DATAKNIGHTSMANAGEMENT_378513"><span style="font-style:normal;font-weight:normal;">DATA KNIGHTS&#8217; MANAGEMENT</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">152</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#MANAGEMENTOFONEMEDNET_497128"><span style="font-style:normal;font-weight:normal;">MANAGEMENT OF ONEMEDNET</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">186</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#MARKETINDUSTRYOTHERDATAANDCERTAINKEYMETR"><span style="font-style:normal;font-weight:normal;">MARKET, INDUSTRY, OTHER DATA AND CERTAIN KEY METRICS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">198</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#INFORMATIONABOUTONEMEDNETCORPORATION_997"><span style="font-style:normal;font-weight:normal;">INFORMATION ABOUT ONEMEDNET CORPORATION</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">156</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#EXECUTIVECOMPENSATIONOFONEMEDNET_997034"><span style="font-style:normal;font-weight:normal;">EXECUTIVE COMPENSATION OF ONEMEDNET</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">199</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#MANAGEMENTOFTHECOMPANYFOLLOWINGTHEBUSINE"><span style="font-style:normal;font-weight:normal;">MANAGEMENT OF THE COMPANY FOLLOWING THE BUSINESS COMBINATION</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">203</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#DESCRIPTIONOFSECURITIESOFDATAKNIGHTS_883"><span style="font-style:normal;font-weight:normal;">DESCRIPTION OF SECURITIES OF DATA KNIGHTS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">214</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#DESCRIPTIONOFSECURITIESAFTERTHEBUSINESSC"><span style="font-style:normal;font-weight:normal;">DESCRIPTION OF SECURITIES AFTER THE BUSINESS COMBINATION</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">226</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#BENEFICIALOWNERSHIPOFSECURITIES_494858"><span style="font-style:normal;font-weight:normal;">BENEFICIAL OWNERSHIP OF SECURITIES</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">232</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#PRICERANGEANDDIVIDENDSOFSECURITIES_31551"><span style="font-style:normal;font-weight:normal;">PRICE RANGE AND DIVIDENDS OF SECURITIES</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">234</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#APPRAISALRIGHTS_540665"><span style="font-style:normal;font-weight:normal;">APPRAISAL RIGHTS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">235</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#HOUSEHOLDINGINFORMATION_178551"><span style="font-style:normal;font-weight:normal;">HOUSEHOLDING INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">235</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#LEGALMATTERS_628435"><span style="font-style:normal;font-weight:normal;">LEGAL MATTERS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">235</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#INDEPENDENTAUDITORS_518162"><span style="font-style:normal;font-weight:normal;">INDEPENDENT AUDITORS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">235</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#TRANSFERAGENTANDREGISTRAR_731243"><span style="font-style:normal;font-weight:normal;">TRANSFER AGENT AND REGISTRAR</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">235</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#DELIVERYOFDOCUMENTSTOSTOCKHOLDERS_532111"><span style="font-style:normal;font-weight:normal;">DELIVERY OF DOCUMENTS TO STOCKHOLDERS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">235</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#SUBMISSIONOFSTOCKHOLDERPROPOSALS_509086"><span style="font-style:normal;font-weight:normal;">SUBMISSION OF STOCKHOLDER PROPOSALS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">236</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#FUTURESTOCKHOLDERPROPOSALS_438786"><span style="font-style:normal;font-weight:normal;">FUTURE STOCKHOLDER PROPOSALS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">236</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#STOCKHOLDERCOMMUNICATIONS_371345"><span style="font-style:normal;font-weight:normal;">STOCKHOLDER COMMUNICATIONS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">236</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#WHEREYOUCANFINDMOREINFORMATION_861285"><span style="font-style:normal;font-weight:normal;">WHERE YOU CAN FIND MORE INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">236</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#INCORPORATIONBYREFERENCE_325679"><span style="font-style:normal;font-weight:normal;">INCORPORATION BY REFERENCE</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">238</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#INDEXTOFINANCIALSTATEMENTS"><span style="font-style:normal;font-weight:normal;">INDEX TO FINANCIAL STATEMENTS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-1 </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#AnnexA_191082"><span style="font-style:normal;font-weight:normal;">ANNEX A &#8211; &#8201;NTA AMENDMENT</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">A-1</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#Annex_B"><span style="font-style:normal;font-weight:normal;">ANNEX B &#8211; MERGER AGREEMENT</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-1</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#AnnexB_987067"><span style="font-style:normal;font-weight:normal;">ANNEX C &#8211; THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">C-1</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#AnnexC_319286"><span style="font-style:normal;font-weight:normal;">ANNEX D &#8211; 2022 EQUITY INCENTIVE PLAN</span></a></p></td><td style="vertical-align:bottom;width:8.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">D-1</p></td></tr><tr><td style="vertical-align:bottom;width:91.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#AnnexD_533779"><span style="font-style:normal;font-weight:normal;">ANNEX E &#8211; OPINION OF MARSHALL &amp; STEVENS</span></a></p></td><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">E-1</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_91f0005f_ca8d_472c_9e18_d0fde3dcc872"></a><a id="MARKETANDINDUSTRYDATA_312206"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">MARKET AND INDUSTRY DATA</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Information contained in this prospectus concerning the market and the industry in which OneMedNet competes, including its market position, general expectations of market opportunity and market size, is based on information from various third-party&#160;sources, on assumptions made by OneMedNet based on such sources and OneMedNet&#8217;s knowledge of the markets for its services and solutions. Any estimates provided herein involve numerous assumptions and limitations, and you are cautioned not to give undue weight to such information. Third-party&#160;sources generally state that the information contained in such source has been obtained from sources believed to be reliable but that there can be no assurance as to the accuracy or completeness of such information. The industry in which OneMedNet operates is subject to a high degree of uncertainty and risk. As a result, the estimates and market and industry information provided in this proxy statement/prospectus are subject to change based on various factors, including those described in the section entitled &#8220;<i style="font-style:italic;">Risk Factors&#160;&#8212; Risks Related to OneMedNet&#8217;s Business</i>&#8221; and elsewhere in this proxy statement/prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_2ea00f18_36cd_405a_bf4b_ff6c2643a96f"></a><a id="SUMMARYTERMSHEET_472282"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SUMMARY TERM SHEET</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">This Summary Term Sheet, together with the sections titled &#8220;</i>Questions and Answers About the Proposals<i style="font-style:italic;">&#8221; and &#8220;</i>Summary of the Proxy Statement<i style="font-style:italic;">,&#8221; summarize information contained in this proxy statement/prospectus, but do not contain all of the information that is important to you. You should read carefully this entire proxy statement, including the attached annexes, for a more complete understanding of the matters to be considered at the Special Meeting. In addition, for definitions of terms commonly used throughout this proxy statement/prospectus, including in this Summary Term Sheet, see the section titled &#8220;</i>Frequently Used Terms<i style="font-style:italic;">.&#8221;</i></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights Acquisition Corp., a Delaware corporation, which we refer to as &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; or &#8220;Data Knights,&#8221; is a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">There are currently 7,570,336 shares of Data Knights Common Stock, par value $0.0001 per share, issued and outstanding, consisting of (i)&#160;3,316,819 shares of Class&#160;A common stock (the &#8220;Class&#160;A Common Stock&#8221;), and (ii)&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">4,253,517  shares of Class&#160;B common stock (the &#8220;Class&#160;B Common Stock&#8221;), which were issued to our Sponsor prior to our IPO and to ARC Group, Ltd. under an advisory agreement. There are currently no shares of Data Knights preferred stock issued and outstanding. In addition, we issued 11,500,000 public warrants to purchase Class&#160;A Common Stock (originally sold as part of the units issued in our IPO) as part of our IPO along with 585,275 Private Placement Units, each consisting of one share of Class&#160;A Common Stock and one Private Placement Warrant, issued to our Sponsor in a private placement on the IPO closing date. Each warrant entitles its holder to purchase one share of our Class&#160;A Common Stock at an exercise price of $11.50 per share, to be exercised only for a whole number of shares of our Class&#160;A Common Stock. The warrants will become exercisable 30&#160;days after the completion of our initial business combination, and they expire five&#160;years after the completion of our initial business combination or earlier upon redemption or liquidation. Once the warrants become exercisable, the Company may redeem the outstanding warrants at a price of $0.01 per warrant, if the last sale price of the Company&#8217;s Common Stock equals or exceeds $18.00 per share for any 20 trading&#160;days within a 30-trading day period ending on the third business day before the Company sends the notice of redemption to the warrant holders. The Private Placement Warrants, however, are non-redeemable so long as they are held by our Sponsor or its permitted transferees. For more information regarding the warrants, please see the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Description of the Securities</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;.</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">On November 11, 2022, Data Knights held a virtual special meeting of its stockholders to vote on three proposals. At the special meeting, holders of Data Knights Common Stock voted on and approved, two of the three proposals presented, an extension proposal and a trust amendment proposal (the on the &#8220;Extension Amendment Proposal&#8221; and the &#8220;Trust Amendment Proposal&#8221;, respectively). In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of 8,768,456 shares of Class A Common Stock exercised their right to redeem those shares for cash. Pursuant to the Extension Amendment Proposal and the Trust Amendment Proposal, on or before each of November 11, 2022, December 11, 2022, January 11, 2023, February 11, 2023, March 11, 2023, April 11, 2023, May&#160;11,&#160;2023 and June 11, 2023, the Sponsor caused $0.045 per share of Class A Common Stock to be deposited in the Trust to secure a one-month extension of the deadline for Data Knights to complete its initial business combination, and it intends to fund a similar payment to the Trust Account on or before July 11, 2023.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Holders of Class&#160;A Common Stock and holders of Class&#160;B Common Stock are entitled to one vote for each share held on all matters to be voted on by stockholders and will vote together as a single class on all matters submitted to a vote of our stockholders except as otherwise required by law. The Class&#160;B Common Stock held by our Sponsor will automatically convert into shares of Class&#160;Common A Stock at the completion of our initial business combination. Assuming no additional shares of Class&#160;A Common Stock, or securities convertible into or exchangeable for, shares of Class&#160;A Common Stock, are issued by us in connection with or in relation to the consummation of our initial business combination, the 4,253,517 shares of Class&#160;B Common Stock will, pursuant to our Second Amended and Restated Certificate of Incorporation, automatically convert, on a one-for-one basis, into 4,253,517 shares of Class&#160;A Common Stock at the closing of our initial business combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">On April&#160;25, 2022, we, the Merger Sub and our Sponsor entered into the Merger Agreement with OneMedNet and the Seller Representative, pursuant to which </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Merger Sub will merge with and into OneMedNet, with OneMedNet continuing as the </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">surviving corporation and wholly-owned subsidiary of Data Knights, which will change its name to </span><span style="font-family:'Times New Roman PS Std';font-size:10pt;font-style:normal;font-weight:normal;">&#8220;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet Corporation</span><span style="font-family:'Times New Roman PS Std';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> at the Closing. </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A copy of the Merger Agreement is attached to this proxy statement as </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex B</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet&#8217;s innovation solutions connect healthcare providers and patients, offering direct access to clinical images and associated contextual patient record. For more information about OneMedNet, please see the sections entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Information About OneMedNet</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">,&#8221; &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">OneMedNet&#8217;s Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; and &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Management after the Business Combination</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#8221;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Subject to the terms of the Merger Agreement, the aggregate purchase price for the Business Combination and related transactions is approximately $200,000,000. The consideration to be paid to the stockholders of OneMedNet will be shares of Data Knights Class A Stock having a value equal to $200,000,000 minus (i) the amount, if any, by which the Target Net Working Capital Amount (as defined in the Merger Agreement) exceeds the Net Working Capital Amount (as defined in the Merger Agreement) (but not less than zero), minus (ii) the amount of Closing Net Indebtedness (as defined in the Merger Agreement) minus (iii) the amount of any Merger transaction expenses. </span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Pursuant to the Merger Agreement, the Company has agreed to use its reasonable commercial efforts to obtain at least $30,000,000 of additional equity capital through the sale of at least 3,000,000 shares of its Class A Common Stock at a purchase price of $10.00 per share to private investors (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">PIPE Financing</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;). There can be no assurance that the Company will be able to arrange the PIPE Financing and doing so is not a condition to Closing. </span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">As part of the potential PIPE Financing, June 28, 2023, the Company executed a Securities Purchase Agreement for PIPE Financing in the aggregate original principal amount of $1,595,744.70 and the purchase price of $1.5 million. Pursuant to the Securities Purchase Agreement, Data Knights will issue and sell to each of Thomas Kosasa, Dr. Jeffrey Yu, Aaron Green and Steve Kester (the &#8220;PIPE Investors&#8221;), a new series of senior secured convertible notes (the &#8220;PIPE Notes&#8221;), which Notes shall be convertible into shares of Common Stock at the PIPE Investors election.  The PIPE Investors&#8217; $1.5 million investment in the Notes will close and fund contemporaneous to the Closing of the Business Combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Effective June 28, 2023, EF Hutton, division of Benchmark Investments, LLC (&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">EF Hutton</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;) waived $3,025,000 of the $4,025,000 cash deferred underwriting commission, pursuant to a Satisfaction and Discharge Agreement (attached at Exhibit&#160;10.22) that would otherwise be immediately due and payable upon the Closing, accepting in lieu thereof (i) a one-time cash payment of $500,000 at the time of the Closing; (ii) a $500,000 promissory note executed by the Company on June 30, 2023 (attached at Exhibit 10.21) in which it is obligated to make six monthly payments to EF Hutton in the cash amount of $83,333.33 from October 2023 through March 2024; and (iii) 277,778 ordinary shares of the Company (the &#8220;Ordinary Shares&#8221;) at $10.89 per share, for an aggregate value of $3,025,000.</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our management and Board considered various factors in determining whether to approve the Merger Agreement and the transactions contemplated thereby, including the Business Combination, the revenue and earnings growth potential of OneMedNet, the prospects for service providers to medical-related businesses and the strength of OneMedNet&#8217;s management team, which the Board believes positions OneMedNet for future growth and profitability. For more information about our Board&#8217;s decision-making process, see the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal No.&#160;2&#8212;The Business Combination Proposal &#8212; The Board&#8217;s Reasons for Approval of the Business Combination</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#8221;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Pursuant to the Data Knights Charter, in connection with the Business Combination, holders of our Public Shares may elect to have their Class&#160;A Common Stock redeemed for cash at the applicable redemption price per share calculated in accordance with the Data Knights Charter. As of March 31, 2023 the redemption price would have been approximately $10.88 per share</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> based on funds in the Trust Account of approximately $29,725,574</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. If a holder exercises its redemption rights, then such holder will be exchanging its shares of our Class&#160;A Common Stock for cash and will no longer own shares of the post-combination company and will not participate in the future growth of the post-combination company, if any. Such a holder will be entitled to receive cash for its Public Shares only if it properly demands redemption and delivers its shares (either physically or electronically) to our transfer agent at least two business&#160;days prior to the Special Meeting. Please see the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Special Meeting of Data Knights Stockholders&#160;&#8212; Redemption Rights</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#8221;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In addition to voting on the proposal to adopt the Merger Agreement and approve the transactions contemplated thereunder, including the Business Combination, at the Special Meeting, Data Knight stockholders will be asked to vote on:</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a proposal to adopt the NTA Amendment in the form attached hereto as </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Annex A</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (the &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">NTA Proposal</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; or &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal No. 1</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;);</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a proposal to approve, for purposes of complying with applicable </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Nasdaq</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Listing Rules, the issuance of more than 20% of the Company&#8217;s issued and outstanding Common Stock in connection with the PIPE (the &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Nasdaq </i><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; or &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal No.&#160;3</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;);</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a proposal to adopt the Third Amended and Restated Certificate of Incorporation in the form attached hereto as </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex C</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (the &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Charter Amendment Proposal</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; or &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal No.&#160;4</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;);</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a proposal to elect directors to our Board to serve in a class of directors whose terms expire at the annual meeting of our stockholders to be held in 2023, 2024 and 2025 or until each such director&#8217;s successor has been duly elected and qualified, or until each such director&#8217;s earlier death, resignation, retirement, or removal (the &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Election of Directors Proposal</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; or &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal No.&#160;5</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;);</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a proposal to approve the </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Equity</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Incentive Plan, including the authorization of the initial share reserve under the </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Equity</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Incentive Plan (the &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Incentive Plan Proposal</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; or &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal No.&#160;6</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;); and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the NTA Proposal, the Business Combination Proposal, the </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Nasdaq </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal, the Charter Amendment Proposal, the Election of Directors Proposal, or the Incentive Plan Proposal (the </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">&#8220;Adjournment Proposal&#8221; </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">or</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;"> &#8220;Proposal No.&#160;7&#8221;</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">).</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 72pt;"><span style="font-family:'Times New Roman','Times','serif';">Please see the sections entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Proposal No. 1&#8201;&#8212;&#8201;NTA Proposal,&#8221; &#8220;Proposal No. 2 &#8212; Business Combination Proposal</i><span style="font-family:'Times New Roman','Times','serif';">,&#8221; &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Proposal No. 3&#8201;&#8212;&#8201;The Nasdaq Proposal</i><span style="font-family:'Times New Roman','Times','serif';">,&#8221; &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Proposal No. 4&#8201;&#8212;&#8201;The Charter Proposal</i><span style="font-family:'Times New Roman','Times','serif';">,&#8221; &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Proposal No. 5&#8201;&#8212;&#8201;Election of Directors Proposal</i><span style="font-family:'Times New Roman','Times','serif';">,&#8221; </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">&#8220;Proposal No. 6&#8201;&#8212;&#8201;Incentive Plan Proposal,&#8221;</i><span style="font-family:'Times New Roman','Times','serif';"> and &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Proposal No. 7&#8201;&#8212;&#8201;The Adjournment Proposal</i><span style="font-family:'Times New Roman','Times','serif';">.&#8221; </span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Unless waived by the parties to the Merger Agreement, the closing of the Business Combination is conditioned on the approval of the NTA Proposal, the Business Combination Proposal, the Nasdaq Proposal, the Charter Amendment Proposal, the Election of Directors Proposal, and the Incentive Plan Proposal at the Special Meeting.</b><span style="font-family:'Times New Roman','Times','serif';"> Each of the proposals at the Special Meeting, other than the Adjournment Proposal, is conditioned on the approval of the others. The Adjournment Proposal is not conditioned on the approval of any other Proposal set forth in this proxy statement.</span></p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Upon consummation of the Business Combination, we anticipate a Board of nine directors, of whom two individuals shall be designated by the Company, with the remaining seven individuals designated by OneMedNet. The nine directors shall be divided into three classes, with the first class consisting of four (4)&#160;directors with an initial term that expires in 2023, the second class consisting of two (2)&#160;directors with an initial term that expires in 2024, and the third class consisting of three (3)&#160;directors with an initial term that expires in 2025. Such directors shall serve until their respective successors are duly elected and qualified, or until their earlier resignation, removal, or death. Please see the sections entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal No.&#160;4 &#8212; Charter Amendment Proposal</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; and &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Management After the Business Combination</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; for additional information.</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unless waived by the parties to the Merger Agreement, and subject to applicable law, the closing of the Business Combination is subject to a number of conditions set forth in the Merger Agreement. For more information about the closing conditions to the Business Combination, please see the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal No.&#160;2 &#8212; The Business Combination Proposal&#160;&#8212; The Merger Agreement &#8212; Conditions to the Closing</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#8221;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Merger Agreement may be terminated at any time prior to the consummation of the Business Combination upon agreement of the parties thereto, or by certain parties in specified circumstances. For more information about the termination rights under the Merger Agreement, please see the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Proposal No.&#160;2 &#8212; The Business Combination Proposal&#160;&#8212; The Merger Agreement &#8212; Termination</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#8221;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The proposed Business Combination involves numerous risks. For more information about these risks, please see the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Risk Factors</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#8221;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Upon consummation of the Business Combination, we will enter into an Executive Employment Agreements with certain officers of OneMedNet to be effective as of the closing of the Business Combination, pursuant to which such officers will serve as our officers and the officers of OneMedNet. For more information about the Executive Employment Agreements, please see the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Management after the Business Combination &#8212; Post-Combination Company Executive Compensation &#8212; Employment Agreements</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#8221;</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">At the execution of the Merger Agreement, certain significant holders of OneMedNet shares as defined in the Merger Agreement and in the Frequently Used Terms on page </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (the &#8220;Significant Company Holders&#8221;) and certain officers and directors entered into Lock-Up Agreements with Data Knights, pursuant to which, among other things, and subject to certain exceptions, provide for the securities of Data Knights held by the Significant Company Holders to be locked-up for the earlier of (a)&#160;a period of six&#160;months from the date of the closing of the Business Combination, or (b)&#160;the date after the closing of the Business Combination on which we consummate a liquidation, merger, capital stock exchange, reorganization, or other similar transaction with an unaffiliated third party that results in all of our stockholders having the right to exchange their shares for cash, securities, or other property. The Significant Company Holders held approximately 6,353,344, or 55.7%, of the outstanding common shares, on a fully-converted basis, of OneMedNet as of the date of this Proxy Statement/Prospectus or a total of 6,398,344 shares or approximately 56.1% of OneMedNet shares including the officers and directors subject to the Lock-Up Agreement. We will be subject to certain restrictions on sale thereafter, in accordance with the terms set forth therein. We will also enter into the Registration Rights Agreement, pursuant to which, among other things, we will be obligated to file a registration statement to register the resale of certain securities of the Company, as well as provide OneMedNet with &#8220;piggy-back&#8221; registration rights, subject to certain requirements and customary conditions. Certain stockholders have also entered into Non-Competition Agreements, pursuant to which the subject parties thereto agreed to certain non-competition, non-solicitation, and confidentiality restrictions in favor of Data Knights and its affiliates.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In considering the recommendation of our Board to vote for the proposals presented at the Special Meeting, including the Business Combination Proposal, you should be aware that aside from their interests as stockholders, our Sponsor and certain members of our Board and officers may have interests in the Business Combination that are different from, or in addition to, the interests of our stockholders generally. Our Board was aware of and considered these interests, among other matters, in evaluating and negotiating the Business Combination and transaction agreements and in recommending to our stockholders that they vote in favor of the proposals presented at the Special Meeting, including the Business Combination Proposal. Stockholders should take these interests into account in deciding whether to approve the proposals presented at the Special Meeting, including the Business Combination Proposal.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_1b40bf0a_1f54_4d06_99a7_6896110f15c9"></a><a id="FREQUENTLYUSEDTERMS_367787"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">FREQUENTLY USED TERMS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Unless otherwise stated or unless the context otherwise requires, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; and &#8220;Data Knights&#8221; refer to Data Knights Acquisition Corp. As used in this proxy statement/prospectus, unless otherwise noted or the context otherwise requires:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Board&#8221;</b> shall mean the board of directors of Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Business Combination&#8221;</b> shall mean the Merger and the other transactions contemplated by the Merger Agreement whereby, among other things, Merger Sub will merge with and into OneMedNet, with OneMedNet surviving as a wholly-owned subsidiary of Data Knights, and Data Knights changing its name to OneMedNet.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Business Combination Date&#8221;</b> shall mean [&#8226;], 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Charter&#8221; </b>shall mean Data Knights&#8217; Second Amended and Restated Certificate of Incorporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Common Stock&#8221; </b>shall mean shares of Data Knights Class&#160;A Common Stock and Data Knights Class&#160;B Common Stock, collectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Closing&#8221;</b> shall mean the closing of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Closing Company Cash&#8221; </b>shall mean, as of a reference time, the aggregate cash and cash equivalents of OneMedNet and its subsidiaries on hand or in bank accounts, including deposits in transit, minus the aggregate amount of outstanding and unpaid checks issued by or on behalf of the OneMedNet and its subsidiaries of such time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Closing Date&#8221; </b>shall mean [&#8226;], 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Closing Net Indebtedness&#8221; </b>shall mean the amount by which the aggregate amount of any outstanding indebtedness of OneMedNet exceeds the cash held by OneMedNet at Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Code&#8221; </b>shall mean the Internal Revenue Code of 1986, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">&#8220;<b style="font-weight:bold;">Combined Entity&#8221; </b>shall mean Data Knights after giving effect to the Business Combination and the change of its name to OneMedNet Corporation, and which will include its direct and indirect subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Continental&#8221;</b> shall mean Continental Stock Transfer&#160;&amp; Trust Company, Data Knights&#8217; transfer agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Data Knights&#8221;</b> shall mean Data Knights Acquisition Corp., a Delaware corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Data Knights Board&#8221;</b> shall mean the board of directors of Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Data Knights Charter&#8221; </b>shall mean Data Knights&#8217; Second Amended and Restated Certificate of Incorporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Data Knights Class&#160;A Common Stock&#8221; </b>shall mean the shares of Class&#160;A common stock, par value $0.0001 per share, of Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Data Knights Class&#160;B Common Stock&#8221; </b>shall mean the shares of Class&#160;B common stock, par value $0.0001 per share, of Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Data Knights Common Stock&#8221;</b> shall mean shares of Data Knights Class&#160;A Common Stock and Data Knights Class&#160;B Common Stock, collectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Data Knights IPO&#8221;</b> shall mean Data Knights&#8217; initial public offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;DGCL&#8221;</b> shall mean the Delaware General Corporation Law, as amended.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;EF Hutton&#8221;</b> shall mean EF Hutton, division of Benchmark Investments,&#160;Inc. (formerly, Kingswood Capital Markets), who is the representative of the underwriters in the Data Knights IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Effective Time&#8221;</b> shall mean the time when the Business Combination is consummated, upon the filing of the Certificate of Merger for the merger of Merger Sub with and into Data Knights with the Delaware Secretary of State in accordance with the relevant provisions of the DGCL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Equity Incentive Plan&#8221;</b> shall mean the 2022 Equity Incentive Plan substantially in the form of Exhibit&#160;F to the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Escrow Agent&#8221;</b> shall mean Truist Bank, a North Carolina banking corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Exchange Act&#8221;</b> shall mean the Securities Exchange Act of 1934, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Extension Escrow Agreement&#8221;</b> shall mean that certain Extension Escrow Agreement dated as of April&#160;25, 2022, by and among Data Knights, OneMedNet, and Truist Bank.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Extension Units&#8221;</b> shall mean Units issued by Data Knights upon any conversion of any extension payments made by the Sponsor to the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">&#8220;<b style="font-weight:bold;">Founders</b>&#8221; shall mean Data Knights, LLC, Barry Anderson, Firdauz Edmin Bin Mokhtar, Syed Musheer Ahmed, Dr.&#160;Julianne Huh and Annie Damit Undikai, and any successors in interest thereto with respect to any Founder Shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Founder Shares&#8221;</b> shall mean shares of Data Knights Class&#160;B Common Stock, par value $0.0001 per share, purchased by the Sponsor in a private placement prior to the Data Knights IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;HSR Act&#8221;</b> shall mean the Hart-Scott-Rodino Antitrust Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Illustrative Maximum Redemptions&#8221; </b>shall mean the amount which represents the maximum number of redemptions that may occur of Data Knights Public Shares without a shortfall of cash while still satisfying the conditions to the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Insiders&#8221; </b>shall mean holders of Founder Shares prior to Data Knights IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;IPO&#8221; </b>shall mean Data Knights&#8217; initial public offering of units, consummated on May&#160;11, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Letter of Transmittal&#8221;</b> shall mean that certain letter substantially in the form of Exhibit&#160;E to the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Lock-Up Agreements&#8221;</b> shall mean those certain Lock-Up Agreements dated as of April&#160;25, 2022, entered into by Data Knights with the Significant Company Holders, substantially in the form of Exhibit&#160;C to the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Material Adverse Effect&#8221; </b>shall have the meaning assigned such term in the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Maximum Redemption Scenario&#8221; </b>shall mean an assumption that 100% of the holders of Data Knights&#8217; Public shares will exercise their right to have their Public Shares redeemed for cash, which is the maximum amount that may be redeemed without a cash shortfall, while still satisfying the conditions to the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Merger&#8221;</b> shall mean the merger of Merger Sub with and into OneMedNet, with OneMedNet continuing as the surviving corporation and wholly-owned subsidiary of Data Knights, as contemplated by the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Merger Agreement&#8221; </b>shall mean that certain Agreement and Plan of Merger dated as of April&#160;25, 2022, as it may be amended or supplemented from time to time, by and among the Company, Data Knights Merger Sub,&#160;Inc., Data Knights, LLC, Paul Casey, solely in his capacity as seller representative, and OneMedNet Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">&#8220;<b style="font-weight:bold;">Merger Consideration</b>&#8221; (a)&#160;Two Hundred Million U.S. Dollars ($200,000,000) minus (b)&#160;the amount, if any, by which the Target Net Working Capital Amount (as defined in the Merger Agreement) exceeds the Net Working Capital Amount (but not </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">less than zero) (as defined in the Merger Agreement), minus (c)&#160;the amount of Closing Net Indebtedness (as defined in the Merger Agreement) minus (d)&#160;the amount of any Merger transaction expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Merger Sub&#8221;</b> shall mean Data Knights Merger Sub,&#160;Inc., a Delaware corporation, and a wholly-owned subsidiary of Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;</b><b style="font-weight:bold;">Nasdaq</b><b style="font-weight:bold;">&#8221; </b>shall mean the Nasdaq Capital Market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Nelson Mullins&#8221;</b> shall mean Nelson Mullins Riley&#160;&amp; Scarborough LLP, counsel to Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Net Working Capital Amount&#8221; </b>shall mean, as of the Reference Time, (i)&#160;all current assets of OneMedNet and its subsidiaries (excluding, without duplication, Closing Company Cash), on a consolidated basis, minus (ii)&#160;all current liabilities of the OneMedNet and its subsidiaries (excluding, without duplication,&#160;Indebtedness and unpaid Transaction Expenses), on a consolidated basis and as determined in accordance with the Accounting Principles; provided, that, for purposes of this definition, whether or not the following is consistent with the Accounting Principles, &#8220;current assets&#8221; will exclude any receivable from a OneMedNet Stockholder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">&#8220;<b style="font-weight:bold;">New OneMedNet</b>&#8221; shall mean the Combined Entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Non-Competition Agreements&#8221; </b>shall mean those certain Non-Competition and Non-Solicitation Agreements dated as of April&#160;25, 2022, by and between Data Knights and certain significant OneMedNet stockholders, substantially in the form of Exhibit&#160;D to the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;OneMedNet&#8221;</b> shall mean OneMedNet Corporation, a Delaware corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Placement Shares&#8221; </b>shall mean the shares of Data Knights Class&#160;A common stock included within the Placement Units being purchased by our sponsor in the private placement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Placement Units&#8221; or &#8220;Private Placement Units&#8221;</b> shall mean the units purchased in a private placement in connection with the IPO, each unit consisting of one share of Data Knights Common Stock and one warrant to purchase Data Knights Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Private Placement Warrants&#8221;</b> shall mean the warrants to purchase Data Knights Common Stock underlying the private units.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#8220;Proposals&#8221;</b><span style="font-family:'Times New Roman','Times','serif';"> shall mean the NTA Proposal, the Business Combination Proposal, the Charter Amendments Proposal, the </span><span style="font-family:'Times New Roman','Times','serif';">Nasdaq </span><span style="font-family:'Times New Roman','Times','serif';">Proposal, the Director Election Proposal, the Incentive Plan Proposal, and the Adjournment Proposal.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Public Shares&#8221;</b> shall mean the Data Knights Class&#160;A Common Stock underlying the public units issued and sold in the Data Knights IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Public Units&#8221;</b> shall mean the units issued and sold in the Data Knights IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Public Warrants&#8221;</b> shall mean the warrants underlying the public units issued in the Data Knights IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Purchaser Representative&#8221;</b> shall mean Data Knights,&#160;LLC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Record Date&#8221; </b>shall mean [&#8226;], 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;redeemable&#8221;</b> shall mean, in respect of the public warrants, the ability of Data Knights to redeem such public warrants after the closing of the proposed Business Combination, provided that certain other conditions as set forth in the warrant agreement between Continental and Data Knights are met.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;redemption&#8221;</b> shall mean the right of Data Knights stockholders to have their Public Shares redeemed in accordance with the procedures set forth in this proxy statement/prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Registration Rights Agreement&#8221;</b> shall mean the Registration Rights Agreement by and among Data Knights, the Founders, and certain OneMedNet stockholders in substantially the form of Exhibit&#160;G to the Merger Agreement.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;SEC&#8221;</b> shall mean the United States Securities and Exchange Commission.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Second Amended and Restated Certificate of Incorporation</b>&#8221; shall mean Data Knights&#8217; Charter which is its Second Amended and Restated Certificate of Incorporation, dated April&#160;6, 2021, as amended to date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Securities Act&#8221;</b> shall mean the Securities Act of 1933, as amended.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#8220;Seller Representative&#8221; </b><span style="font-family:'Times New Roman','Times','serif';">shall mean Paul Casey, Chief Executive Officer of OneMedNet.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Significant Company Holders&#8221; </b>shall mean Erkan Akyuz, Jeffrey Yu, Paul Casey, Thomas Kosasa, The Baba One Irrevocable Trust dated March 26, 2021, and The Soph One Irrevocable Trust dated March 26, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Special Meeting&#8221;</b> shall mean the special meeting of the stockholders of Data Knights, to be held on [&#8226;], 2023 at [&#8226;], which will be a virtual meeting conducted via live webcast.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Sponsor&#8221;</b> shall mean Data Knights, LLC, a Delaware limited liability company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Sponsor Support Agreement&#8221;</b> shall mean that certain Sponsor Support Agreement dated as of April&#160;25, 2022, by and among Data Knights, Sponsor, and OneMedNet, whereby, among other things, Sponsor has agreed to vote its shares of Data Knights Common Stock in favor of the adoption and approval of the Merger Agreement and the transactions contemplated thereby, substantially in the form of Exhibit&#160;B to the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Trust Account&#8221;</b> shall mean the trust account of Data Knights, which holds the net proceeds of the Data Knights IPO, together with interest earned thereon, less amounts released to pay franchise and income tax obligations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Trust Agent&#8221;</b> shall mean Continental Stock Transfer&#160;&amp; Trust Company, Data Knights&#8217; transfer agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Voting Agreement&#8221;</b> shall mean that certain Voting agreement dated as of April&#160;25, 2022, by and among Data Knights, OneMedNet, and certain OneMedNet stockholders, substantially in the form of Exhibit&#160;A to the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">&#8220;Warrants&#8221; </b>shall mean Data Knights redeemable warrants, which includes the Public Warrants as well as the Private Placement Warrants and any warrants issued upon conversion of working capital loans to the extent they are no longer held by the initial holders or their permitted transferees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><b style="font-weight:bold;">&#8220;Working Capital Units&#8221; </b>shall mean Units issued by Data Knights upon any conversion of any working capital loans made by the Sponsor to Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_61b75533_aabb_4485_bbab_d7ea1f083063"></a><a id="QUESTIONSANDANSWERSABOUTTHEPROPOSALS_437"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">QUESTIONS AND ANSWERS ABOUT THE PROPOSALS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">The following questions and answers briefly address some commonly asked questions about the Proposals to be presented at the Special Meeting of Data Knights stockholders. The following questions and answers do not include all the information that is important to stockholders of Data Knights. We urge the stockholders of Data Knights to read this entire proxy statement carefully, including the annexes and other documents referred to herein.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">Why am I receiving this proxy statement/prospectus?</b></p><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights </span><span style="font-family:'Times New Roman','Times','serif';">has entered into the Merger Agreement with OneMedNet and the other parties thereto, pursuant to which OneMedNet has agreed to combine with Merger Sub that will result in OneMedNet as the surviving company and becoming a publicly-traded company on Nasdaq. A copy of the Merger Agreement is attached to this proxy statement/prospectus as </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex B</i><span style="font-family:'Times New Roman','Times','serif';">. </span><span style="font-family:'Times New Roman','Times','serif';">This proxy statement/prospectus and its annexes contain important information about the proposed Business Combination and the other matters to be acted upon at the Special Meeting. You should read this proxy statement/prospectus and its annexes carefully and in their entirety.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Your vote is important. You are encouraged to submit your proxy as soon as possible after carefully reviewing this proxy statement/prospectus and its annexes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Below are proposals on which Data Knights stockholders are being asked to vote.</p><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:21.6pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(1)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to adopt and approve the NTA Proposal;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:21.6pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(2)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to adopt and approve the Business Combination Proposal;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:21.6pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(3)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to consider and vote upon the Nasdaq Proposal;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:21.6pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(4)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to adopt and approve the Charter Amendment Proposal;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:21.6pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(5)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to consider and vote on the Election of Directors Proposal;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:21.6pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(6)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to approve and adopt the Incentive Plan Proposal; and</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:21.6pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(7)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">to adopt and approve the Adjournment Proposal.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">Are the Proposals conditioned on one another?</b></p><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:21.6pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Unless the Business Combination Proposal is approved, the NTA Proposal, Charter Amendment Proposal, the Nasdaq Proposal, the Election of Directors Proposal, and the Incentive Plan Proposal will not be presented to the stockholders of Data Knights at the Special Meeting. The Adjournment Proposal is not conditioned on the approval of any other Proposal set forth in this proxy statement/prospectus. It is important for you to note that in the event that the Business Combination Proposal does not receive the requisite vote for approval, then we will not consummate the Business Combination. If Data Knights does not consummate the Business Combination and fails to complete an initial business combination by August</span><span style="font-family:'Times New Roman PS Std';">&#160;</span><span style="font-family:'Times New Roman','Times','serif';">11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension, Data Knights will be required to dissolve and liquidate its Trust Account by returning the then remaining funds in such account to its Public Stockholders.</span></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Why is Data Knights proposing the NTA Proposal?</b></p><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:21.6pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The adoption of the NTA Amendment is being proposed in order to facilitate the consummation of the Business Combination, by permitting redemptions by public stockholders even if such redemptions result in Data Knights having net tangible assets that are less than $5,000,001 and by permitting consummation of a business combination even if it would cause Data Knights</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';"> NTA to be less than $5,000,001 either immediately prior to or upon consummation of such a business combination. The purpose of the net tangible asset test limitation was initially to ensure that the Data Knights Common Stock is not deemed to be </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><span style="font-family:'Times New Roman','Times','serif';">penny stock</span><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';"> </span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin:0pt 0pt 12pt 21.6pt;"><span style="font-family:'Times New Roman','Times','serif';">pursuant to Rule 3a51-1 under the Exchange Act. Because New OneMedNet</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Common Stock would not be deemed to be a </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><span style="font-family:'Times New Roman','Times','serif';">penny stock</span><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';"> pursuant to other applicable provisions of Rule 3a51-1 under the Exchange Act, Data Knights is presenting the NTA Proposal so that the parties may consummate the Business Combination even if Data Knights has $5,000,000 or less in net tangible assets at the Closing.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights stockholders are being asked to adopt a proposed amendment to the Charter prior to the Business Combination, which, in the judgment of the Data Knights Board, may be necessary to facilitate the Business Combination. Net tangible assts are calculated as total assets, less intangible assets and total liabilities. OneMedNet</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s financial statements reflect material intangible assets, consisting of patents, which are included in the non-current assets to OneMedNet</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Balance Sheet intangible assets, net. In addition, OneMedNet</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s financial statements reflect substantial liabilities, including pursuant to research and development. Although the calculation of net tangible assets offers limited utility to understanding the operations of a business such as OneMedNet</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s, the calculation of net tangible assets may be used by investors to determine the value of a company</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s stock. Accordingly, the removal of the net tangible asset requirement, if there are significant redemptions coupled with the lower tangible assets of OneMedNet may adversely affect the stock price of New OneMedNet following the Business Combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">As an alternative from being exempt from penny stock classification by having minimum net tangible assets of $5,000,001, a company can meet the requirements of SEC Rule 3a51-1(a)(ii), which generally require that a company (a) have either $5 million of stockholders equity or listed securities with a market value of $50 million or net income of at least $750,000 in its last fiscal year or two out of three of its most recent fiscal years, (b) either a one year operating history or listed securities with a market value of $50 million, (c) a minimum bid price of $4 per share, (d) at least 300 round lot holders of its listed securities and (e) at least one million publicly held shares with a $5 million market value. Data Knights and OneMedNet believe that New OneMedNet will meet these criteria; however, there can be no assurance to this effect.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">What will happen in the Business Combination?</b></p><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">At the Closing, Merger Sub shall be merged with and into OneMedNet, following which the separate corporate existence of Merger Sub shall cease and OneMedNet shall continue as the surviving corporation. In connection with the Business Combination, the cash held in the Trust Account will be used to fund redemptions by Data Knights stockholders, and for working capital and general corporate purposes. A copy of the Merger Agreement is attached to this proxy statement/prospectus as </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex</i><i style="font-family:'Times New Roman PS Std';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;</i><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">B</i><span style="font-family:'Times New Roman','Times','serif';">.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">How Does the Sponsor Intend to Vote on the Proposals?</b></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">The Insiders own of record and are entitled to vote an aggregate of approximately 55.9% of the outstanding shares of Data Knights Common Stock through their ownership of Founder Shares. The Insiders have agreed to vote any Founder Shares, and any Public Shares held by them as of the Record Date, in favor of the Proposals. See &#8220;Related Agreements&#160;&#8212;&#160;Support Agreements.&#8221;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">What equity stake will current stockholders of Data Knights hold after the Closing?</b></p><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">It is anticipated that, upon the completion of the Business Combination, Data Knights public stockholders will retain an ownership interest of approximately 8.3% of the outstanding capital stock of the Combined Entity, the Sponsor will retain an ownership interest of approximately 10.5% of the outstanding capital stock of the Combined Entity and the OneMedNet securityholders will own approximately 60.6% of the outstanding capital stock of the Combined Entity. The foregoing ownership percentages with respect to the Combined Entity following the Business Combination exclude any outstanding Warrants and assume that (i) there are no further redemptions of any shares by Data Knights public stockholders in connection with the Business Combination, (ii) no awards are issued under the Equity Incentive Plan and (iii) no Working Capital Units or Extension Units are issued. If the actual facts are different than these assumptions (which they are likely to be), the percentage ownership retained by Data Knights&#8217; existing stockholders in the Combined Entity will be different. </span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 18pt;">If any of the Data Knights public stockholders exercise their redemption rights, the percentage of the Combined Entity&#8217;s outstanding common stock held by Data Knights public stockholders will decrease and the percentages of the Combined Entity&#8217;s outstanding common stock held by the Sponsor and by the OneMedNet securityholders will increase, in each case relative to the percentage held if none of the Public Shares are redeemed. Upon the issuance of Combined Entity&#8217;s Common Stock in connection </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 18pt;">with the Business Combination, the percentage ownership of the Combined Entity by Data Knights&#8217; public stockholders who do not redeem their Public Shares will be diluted. Data Knights public stockholders that do not redeem their Public Shares in connection with the Business Combination will experience further dilution upon the exercise of Public Warrants that are retained after the Closing by redeeming Public Shareholders. The percentage of the total number of outstanding shares of Common Stock that will be owned by Data Knights&#8217; public stockholders as a group will vary based on the number of Public Shares for which the holders thereof request redemption in connection with the Business Combination and the number of shares of common stock issued upon conversion of the Preferred Stock. The following table illustrates varying beneficial ownership levels in the Combined Entity, as well as possible sources and extents of dilution for non-redeeming public stockholders, and assuming no further redemptions by public stockholders, and the maximum redemptions by public stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.91%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.58%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.37%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.79%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="15" style="vertical-align:bottom;width:80.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share&#160;ownership&#160;in&#160;Data&#160;Knights</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:17.57%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma&#160;Combined</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Assuming&#160;No&#160;Further</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Redemptions&#160;Scenario)</b></p></td><td style="vertical-align:bottom;width:2.86%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;width:17.51%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma&#160;Combined</b>&#160;<br/><b style="font-weight:bold;">(Assuming</b>&#160;<br/><b style="font-weight:bold;">80%&#160;Redemptions</b>&#160;<br/><b style="font-weight:bold;">Scenario)</b></p></td><td style="vertical-align:bottom;width:2.87%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;width:19.19%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma&#160;Combined</b>&#160;<br/><b style="font-weight:bold;">(Assuming</b>&#160;<br/><b style="font-weight:bold;">Maximum</b>&#160;<br/><b style="font-weight:bold;">Redemptions&#160;Scenario)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;width:2.87%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;width:17.39%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma&#160;Combined</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Assuming&#160;No&#160;Further</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Redemptions&#160;Scenario</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">and&#160;Full&#160;Exercise</b>&#160;<br/><b style="font-weight:bold;">of&#160;Options</b>&#160;<br/><b style="font-weight:bold;">and&#160;Warrants)</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">Stockholder</b></p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:10.63%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;width:1.91%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.01%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:10.58%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;width:1.77%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.15%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:11.37%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.65%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:10.63%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;width:1.79%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:4.96%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Former OneMedNet equityholders</p></td><td style="vertical-align:bottom;width:1.76%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20,000,000</p></td><td style="vertical-align:bottom;width:1.91%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">60.6</p></td><td style="vertical-align:bottom;width:2.86%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td><td style="vertical-align:bottom;width:10.58%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20,000,000</p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">61.4</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20,000,000</p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">66.4</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20,806,453</p></td><td style="vertical-align:bottom;width:1.79%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">53.8</p></td><td style="vertical-align:bottom;width:1.75%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Data Knights Public Stockholders<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(4)</sup></p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">2,731,544</p></td><td style="vertical-align:bottom;width:1.91%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">8.3</p></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td><td style="vertical-align:bottom;width:10.58%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">2,300,000</p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">7.1</p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">6,884,322</p></td><td style="vertical-align:bottom;width:1.79%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">17.8</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Data Knights Sponsor and Insiders<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;width:1.76%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">3,460,275</p></td><td style="vertical-align:bottom;width:1.91%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">10.5</p></td><td style="vertical-align:bottom;width:2.86%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.58%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">3,460,275</p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">10.6</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">3,460,275</p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">11.5</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">3,821,624</p></td><td style="vertical-align:bottom;width:1.79%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">9.9</p></td><td style="vertical-align:bottom;width:1.75%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Others</p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">6,821,967</p></td><td style="vertical-align:bottom;width:1.91%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">20.7</p></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">6,799,254</p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">20.9</p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">6,678,202</p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">22.2</p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">7,181,967</p></td><td style="vertical-align:bottom;width:1.79%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">18.6</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total Shares Outstanding</p></td><td style="vertical-align:bottom;width:1.76%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">33,013,786</p></td><td style="vertical-align:bottom;width:1.91%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;width:2.86%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.58%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">32,559,529</p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">30,138,477</p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">38,694,366</p></td><td style="vertical-align:bottom;width:1.79%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 2.9pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;width:1.75%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Assumes Illustrative Maximum Redemptions of 2,731,544 Public Shares of Data Knights Common Stock in connection with the Business Combination. For a description of the Maximum Redemption Scenario, see &#8220;<i style="font-style:italic;">Unaudited Pro Forma Condensed Combined Financial Information</i>.&#8221;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Excludes, except in the case of the last scenario, an estimated 2,731,544 shares underlying the Public Warrants beneficially held by the Data Knights Public Stockholders.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Excludes, except in the case of the last scenario, an estimated 585,275 shares underlying the placement warrants beneficially held by Sponsor.</p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(4)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On November 11, 2022, Data Knights held a virtual special meeting of its stockholders to vote on three proposals. At the special meeting, holders of Data Knights Common Stock voted on and approved, two of the three proposals presented, an extension proposal and a trust amendment proposal (the on the &#8220;Extension Amendment Proposal&#8221; and the &#8220;Trust Amendment Proposal&#8221;, respectively). In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of 8,768,456 shares of Class A Common Stock exercised their right to redeem those shares for cash. There are currently 7,570,336 shares of Data Knights Common Stock issued and outstanding, consisting of (i) 3,316,819 shares of Class A common stock, and (ii) 4,253,517 shares of Class B common stock.</span></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The &#8220;Maximum Redemption Scenario&#8221; assumes that Data Knights Public Stockholders exercise redemption rights with respect to 100% of the outstanding shares of Class&#160;A common stock. This scenario assumes that 2,731,544 shares of Class&#160;A common stock are redeemed for an aggregate payment of approximately $29.7 million from the Trust Account.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In addition, upon consummation of the Business Combination, there will be outstanding an aggregate of up to 2,731,544 Public Warrants and 585,275 Private Placement Warrants held by our Sponsor. Each of our outstanding whole warrants is exercisable commencing 30&#160;days following the Closing for one share of Data Knights Common Stock. Therefore, as of the date of this proxy statement/prospectus, if we assume that each outstanding whole warrant is exercised and one share of Data Knights Common Stock is </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">issued as a result of such exercise, with payment to Data Knights of the exercise price of $11.50 per whole warrant for one whole share, our fully-diluted share capital would increase by a total of 3,316,819 shares, with approximately $38.1 million paid to us to exercise the warrants, assuming cash exercise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The number of shares and&#160;percentage interests set forth in the above table except under the final redemption scenario do not take into account (i)&#160;potential future exercises of up to 2,731,544 Public Warrants and up to 585,275 Private Placement Warrants, which will remain outstanding immediately following the Business Combination and may be exercised thereafter at an exercise price of $11.50 (commencing 30&#160;days after the Closing of the Business Combination),&#160;(ii)&#160;806,453 shares issuable upon the exercise of outstanding options to purchase shares of OneMedNet common stock, (iii)&#160;up to 360,000 shares issuable pursuant to the Equity Incentive Plan, or (iv)&#160;warrants to purchase up to 150,000 units if the Sponsor makes a working capital loan prior to the closing of the Business Combination in an amount up to $1,500,000 ($300,000 of such loans have been made to date) and elects to convert such working capital loan into units. The exercise, issuance or vesting of any of these shares could have a dilutive effect on those of our stockholders who do not elect to redeem their shares. If all such shares were issued immediately after the Business Combination, based on the number of issued and outstanding shares of Data Knights Common Stock, non-redeeming Public Stockholders, as a group, would own:</p><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">if there are no further redemptions of Public Shares, 17.8% of the Data Knights Common Stock outstanding assuming all such shares were issued immediately after the Business Combination; or</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">if there are maximum redemptions of 100% of the outstanding Public Shares, none of the Data Knights Common Stock outstanding assuming all such shares were issued immediately after the Business Combination.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table shows the ownership of Data Knights immediately following the Business Combination giving effect to the warrants and options:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:9.24%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:4.7%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:11.79%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:10.29%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:4.82%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 55pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="11" style="vertical-align:bottom;width:56.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share&#160;ownership&#160;in&#160;Data&#160;Knights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 55pt;"><span style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;width:15.44%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro Forma Combined</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Assuming No Further</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Redemptions </b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Scenario)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:19.25%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro Forma Combined</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Assuming </b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">80% Redemptions</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Scenario)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:16.82%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro Forma Combined</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Assuming</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Maximum</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Redemptions </b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Scenario)</b><sup style="font-size:6pt;font-weight:bold;letter-spacing:-0.1pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Stockholder</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:9.24%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid transparent;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:4.7%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.79%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.5%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:10.29%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid transparent;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:4.82%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Former OMN equity holders</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">20,806,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">53.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">20,806,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">54.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">20,806,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">58.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><span style="letter-spacing:0.2pt;">OMN equity holders</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">20,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">51.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">20,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">52.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">20,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">55.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><span style="letter-spacing:0.2pt;">Holders of Outstanding Options</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">806,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">806,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">806,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Data Knights Public Stockholders</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">6,884,322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">17.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">6,452,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">16.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4,152,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">11.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><span style="letter-spacing:0.2pt;">IPO Public Shares</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2,731,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">7.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">6.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><span style="letter-spacing:0.2pt;">Public Warrants</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4,152,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">10.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4,152,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">10.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4,152,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">11.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr style="height:8.55pt;"><td style="vertical-align:bottom;width:40.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Data Knights Sponsor and Insiders</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">3,821,624</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">9.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">3,821,624</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">10.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">3,821,624</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">10.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><span style="letter-spacing:0.2pt;">Founder Shares (Converted to Class A)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2,875,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">7.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2,875,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">7.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2,875,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">8.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><span style="letter-spacing:0.2pt;">Private Placement Shares</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td><td style="vertical-align:top;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td><td style="vertical-align:top;width:10.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><span style="letter-spacing:0.2pt;">Private Placement Warrants</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">211,349</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">211,349</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">211,349</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><span style="letter-spacing:0.2pt;">Warrants for conversion of working capital loan</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Equity Incentive Plan</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">360,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">360,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">360,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 7.2pt;"><span style="letter-spacing:0.2pt;">Convertible Notes</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4,602,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">11.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td><td style="vertical-align:top;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4,602,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">12.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td><td style="vertical-align:top;width:10.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4,602,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">12.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Deferred underwriting fee</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">277,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td><td style="vertical-align:top;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">277,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td><td style="vertical-align:top;width:10.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">277,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Sponsor loans</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">291,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td><td style="vertical-align:top;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">291,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td><td style="vertical-align:top;width:10.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">291,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">ARC Group Ltd</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1,650,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1,627,976</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1,506,924</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">4.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:40.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Total</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:9.24%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">38,694,366</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.7%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:11.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">38,240,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:top;width:10.29%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">35,819,057</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The underwriting fees, including deferred fees, from Data Knights initial public offering would represent 5.5% and 27.5% of the per share offering price of the unredeemed shares in the no further redemptions and 80% redemptions scenarios.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">How much consideration will OneMedNet Stockholders receive in connection with the Business Combination?</b></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:22.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">As consideration for the Merger, the holders of OneMedNet securities collectively shall be entitled to receive from Data Knights, in the aggregate, a number of Data Knights securities with an aggregate value equal to (a)&#160;Two Hundred Million U.S. Dollars ($200,000,000) minus (b)&#160;the amount, if any, by which the Target Net Working Capital Amount exceeds the Net Working Capital Amount (but not less than zero), minus (c)&#160;the amount of Closing Net Indebtedness minus (d)&#160;the amount of any Merger transaction expenses (the total portion of the Merger Consideration amount payable to all OneMedNet Stockholders in accordance with the Merger Agreement is also referred to herein as the &#8220;<b style="font-weight:bold;">Stockholder Merger Consideration</b>&#8221;). While this amount can fluctuate, based on the Data Knights&#8217; current expectations regarding the amount of Net Working Capital Amount, Closing Net Indebtedness and Merger transaction expenses, Data Knights expects that the holders of OneMedNet securities collectively will be entitled to receive Data Knights securities with an aggregate value equal to $200,000,000. See also below &#8220;<i style="font-style:italic;">The Business Combination Proposal</i>&#160;&#8212; <i style="font-style:italic;">Merger Consideration</i>.&#8221;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">Why is Data Knights Proposing the Business Combination?</b></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">A.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Data Knights was organized to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities (collectively, a &#8220;business combination&#8221;). On May&#160;11, 2021, Data Knights completed its initial public offering, generating gross proceeds of $115,000,000. Since Data Knights&#8217; IPO, Data Knights&#8217; activity has been limited to the evaluation of business combination candidates.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">OneMedNet is an expert in clinical imaging innovation solutions that connects healthcare providers and patients and satisfies a crucial need with the life sciences. It offers direct access to clinical images and associated contextual patient record. OneMedNet proved the commercial and regulatory viability of imaging Regulatory Grade Real-World Data<b style="font-weight:bold;"> </b>(&#8220;<b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup>&#8221;), a promising emerging market, that exactly matches OneMedNet&#8217;s life science partners&#8217; case selection protocol. With a growing federated network of 90+ healthcare providers, OneMedNet has the immediate ability to quickly search and extensively curate multi-layer data from a Federated group of healthcare facilities. OneMedNet is an expert in secure data interoperability, providing fast access to curated medical images that has proved the commercial and regulatory viability of imaging RWD and covers the complete value chain in imaging RWD, validated by an increasing federated network of providers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Based on its due diligence investigation of OneMedNet and the industry in which it operates, including the financial and other information provided by OneMedNet in the course of their negotiations in connection with the Merger Agreement, Data Knights believes OneMedNet is well-positioned in its industry for growth, that its business provides a valuable service, and that it possesses a strong management team, of which the senior management intends to remain in the capacity of officers and/or directors. As a result, Data Knights believes that the Business Combination will provide Data Knights stockholders with an opportunity to participate in the ownership of a company with significant growth potential.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">What conditions must be satisfied to complete the Business Combination?</b></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Unless waived by the applicable party or parties to the Merger Agreement, and subject to applicable law, the completion of the Business Combination is subject to a number of conditions set forth in the Merger Agreement, including, among others, with respect to the obligations of all of the parties to the Merger Agreement:</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">the approval by the stockholders of each of OneMedNet and Data Knights;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">approvals of any required governmental authorities and the expiration or termination of any anti-trust waiting periods;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">receipt of specified third-party consents;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">no law or order preventing the transactions;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">no material uncured breach by the other party;</p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">the members of the post-Closing Data Knights board shall have been elected or appointed as of the Closing;</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">the Registration Statement shall have been declared effective by the SEC and shall remain effective as of the Closing, and no stop order or similar order shall be in effect with respect to the Registration Statement; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">the shares of Data Knights Common Stock issued as Merger Consideration shall have been approved for listing on Nasdaq, subject to official notice of issuance.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">In addition, unless waived by OneMedNet, the obligations of OneMedNet to consummate the Merger are subject to the satisfaction of the following Closing conditions, in addition to customary certificates and other closing deliveries: (a)&#160;the representations and warranties of Data Knights being true and correct as of the date of the Merger Agreement and as of the Closing (subject to Material Adverse Effect); (b)&#160;Data Knights having performed in all material respects the respective obligations and complied in all material respects with their respective covenants and agreements under the Merger Agreement required to be performed or complied with on or prior the date of the Closing; (c)&#160;absence of any Material Adverse Effect with respect to Data Knights since the date of the Merger Agreement which is continuing and uncured; (d)&#160;the Registration Rights Agreement being in full force and effect as of the Closing; and (e) the Minimum Cash Condition of $30 million in cash and cash equivalents held by Data Knights is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Unless waived by Data Knights, the obligations of Data Knights and Merger Sub to consummate the Merger are subject to the satisfaction of the following Closing conditions, in addition to customary certificates and other closing deliveries: (a) the representations and warranties of OneMedNet being true and correct as of the date of the Merger Agreement and as of the Closing (subject to Material Adverse Effect); (b) OneMedNet having performed in all material respects the respective obligations and complied in all material respects with its covenants and agreements under the Merger Agreement required to be performed or complied with on or prior the date of the Closing; and (c) absence of any Material Adverse Effect with respect to OneMedNet as a whole since the date of the Merger Agreement which is continuing and uncured; and (d) each Executive Employment Agreement, Lock-Up Agreement and Non-Competition Agreement being in full force and effect as of the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">For a summary of the conditions that must be satisfied or waived prior to the Closing of the Business Combination, see the section titled &#8220;<i style="font-style:italic;">The Business Combination Proposal&#160;&#8212; The Merger Agreement</i>.&#8221;</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Did the </b><b style="font-weight:bold;">Data Knights</b><b style="font-weight:bold;"> Board Obtain a Third-Party Valuation or Fairness Opinion in Determining Whether to Proceed with the Business Combination?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">A.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> board of directors did obtain a third-party fairness opinion in connection with their determination to approve the Business Combination. Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> officers, directors and advisors have substantial experience in evaluating the operating and financial merits of companies from a wide range of industries and concluded that this experience and background, together with the experience and sector expertise of Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> financial advisors, enabled them to make the necessary analyses and determinations regarding the Business Combination. In addition, Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> officers, directors and advisors have substantial experience with mergers and acquisitions. Accordingly, investors will be relying solely on the judgment of Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> board of directors and management in valuing the companies<span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="white-space:pre-wrap;"> business.  Data Knights</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span> board of directors sought a third-party fairness opinion as confirmation of their conclusions regarding the Business Combination in approving it.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Why is Data Knights providing stockholders with the opportunity to vote on the Business Combination?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Under its Charter, Data Knights must provide all holders of its Public Shares with the opportunity to have their Public Shares redeemed upon the consummation of Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> Business Combination either in conjunction with a tender offer or in conjunction with a stockholder vote. For business and other reasons, Data Knights has elected to provide its stockholders with the opportunity to have their Public Shares redeemed in connection with a stockholder vote rather than a tender offer. Therefore, Data Knights is seeking to obtain the approval of its stockholders of the Business Combination in order to allow its Public Stockholders to effectuate redemptions of their Public Shares in connection with the Closing of the Business Combination.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Are there any arrangements to help ensure that the Company will have sufficient funds, together with the proceeds in its Trust Account, to fund the Aggregate Purchase Price?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;">Yes. To the extent not utilized to consummate the Business Combination, the proceeds from the Trust Account will be used to pay any loans owed by Data Knights to its Sponsor for any Data Knights transaction expenses or other administrative expenses incurred by Data Knights, to pay all unpaid transaction expenses and any remainder will be used for general corporate purposes, </p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 12pt 18pt;">including, but not limited to, working capital for operations, capital expenditures and future acquisitions. Data Knights agrees that it (or its successor) will file with the SEC and use its commercially reasonable efforts to have the registration statement declared effective as soon as practicable.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">How many votes do I have at the Special Meeting?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Data Knights stockholders are entitled to one vote at the Special Meeting for each share of Data Knights Common Stock held of record as of [<span style="font-family:'Times New Roman PS Std';">&#9679;</span>], 2023, the record date for the Special Meeting (the <span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-weight:bold;">Record Date</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span>). As of the close of business on the Record Date, there were 2,731,544 outstanding shares of Data Knights Common Stock.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">What vote is required to approve the Proposals presented at the Special Meeting?</b></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">The approval of the Business Combination, the Nasdaq Proposal and the Incentive Plan Proposal each require the affirmative vote of the holders of a majority of the shares of Data Knights Common Stock cast by the stockholders represented in person or by proxy and entitled to vote thereon at the Special Meeting. A Data Knights stockholder&#8217;s failure to vote by proxy or to vote in person at the Special Meeting will not be counted towards the number of shares of Data Knights Common Stock required to validly establish a quorum, and if a valid quorum is otherwise established, it will have no effect on the outcome of the vote on the Nasdaq Proposal and the Incentive Plan Proposal.</p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">The approval of the NTA Proposal and the Charter Amendment Proposal require the affirmative vote of a majority of the issued and outstanding Data Knights Common Stock as of the Record Date. Accordingly, a Data Knights stockholder&#8217;s failure to vote by proxy or to vote in person at the Special Meeting or an abstention will have the same effect as a vote &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">AGAINST</b><span style="font-family:'Times New Roman','Times','serif';">&#8221; the NTA Proposal and the Charter Amendment Proposal.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">If the Business Combination is not approved, the NTA Proposal, the Nasdaq Proposal, the Charter Amendment Proposal, the Election of Directors Proposal, and the Incentive Plan Proposal will not be presented to Data Knights&#8217; stockholders for a vote. The approval of the Business Combination, the NTA Proposal, the Nasdaq Proposal, the Charter Amendment Proposal, the Election of Directors Proposal, and the Incentive Plan Proposal are preconditions to the consummation of the Business Combination.</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">May</b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#160;</b><b style="font-weight:bold;">Data Knights, the Sponsor or Data Knights</b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#8217;</b><b style="font-weight:bold;"> directors, officers, advisors, or their affiliates purchase shares in connection with the Business Combination?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">In connection with the stockholder vote to approve the Business Combination, the Sponsor, directors, officers, or advisors or their respective affiliates may privately negotiate transactions to purchase shares from stockholders who would have otherwise elected to have their shares redeemed in conjunction with a proxy solicitation pursuant to the proxy rules<span style="font-family:'Times New Roman PS Std';">&#160;</span>for a per-share pro rata portion of the Trust Account. None of Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> Sponsor, directors, officers or advisors or their respective affiliates will make any such purchases when they are in possession of any material non-public information not disclosed to the seller or during a restricted period under Regulation M under the Exchange Act. Such a purchase would include a contractual acknowledgement that such stockholder, although still the record holder of Data Knights shares, is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights. In the event that the Sponsor, directors, officers, or advisors or their affiliates purchase shares in privately negotiated transactions from Public Stockholders who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their shares. Any such privately negotiated purchases may be effected at purchase prices that are equal to or below the per-share pro rata portion of the Trust Account, none of such shares would be voted in favor of the Business Combination, and no exercise of redemption rights would be made by the purchasers with respect to such shares.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">What constitutes a quorum at the Special Meeting?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Holders of a majority in voting power of Data Knights Common Stock issued and outstanding and entitled to vote at the Special Meeting constitute a quorum. In the absence of a quorum, the chairman of the meeting has power to adjourn the Special Meeting. As of the Record Date, [<span style="font-family:'Times New Roman PS Std';">&#9679;</span>], 2023, shares of Class<span style="font-family:'Times New Roman PS Std';">&#160;</span>A Common Stock would be required to achieve a quorum.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">How will Data Knights</b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#8217;</b><b style="font-weight:bold;"> Sponsor, directors, and officers vote?</b></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">The Sponsor, as Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> initial stockholder, has agreed to vote its Founder Shares and Placement Shares (as well as any Public Shares purchased during or after the Data Knights IPO) in favor of the Business Combination. Accordingly, if Data Knights seeks stockholder approval of its initial business combination, it is more likely that the necessary stockholder approval will be received than would be the case if the Sponsor agreed to vote their Founder Shares in accordance with the majority of the votes cast by Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> Public Stockholders, and further, that means that under the DGCL no Public Shares would need to be voted in favor of the Business Combination for it to be approved.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">What interests do Data Knights</b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#8217;</b><b style="font-weight:bold;"> current officers and directors have in the Business Combination?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">The Sponsor (including certain members of the Sponsor), and certain of Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> directors and executive officers may have interests in the Business Combination that are different from or in addition to (and which may conflict with) your interests. These interests include:</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">unless Data Knights consummates an initial business combination, Data Knights&#8217; officers, directors, and the Sponsor will not receive reimbursement for any out-of-pocket expenses incurred by them to the extent that such expenses exceed the amount of available proceeds not deposited in the Trust Account;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">as a condition to the Data Knights IPO, all of the Founder Shares are subject to a lock-up and would be released only if specified conditions were met. In particular, subject to certain limited exceptions, all Founder Shares would be subject to a lock up until the earlier of (A)&#160;six&#160;months after the completion of Data Knights&#8217; Business Combination and (B)&#160;subsequent to the Business Combination, (x)&#160;if the closing price of the Class&#160;A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading&#160;days within any 30-trading day period commencing at least 150&#160;days after the Business Combination or (y)&#160;the date on which Data Knights completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of Class&#160;A Common Stock for cash, securities or other property;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Placement Units, purchased by the Sponsor will be worthless if a business combination is not consummated;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Sponsor has agreed that the Placement Units and the underlying securities, will not be sold or transferred by it until after Data Knights has completed a business combination, subject to limited exceptions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that Sponsor paid an aggregate of $25,000 for its Founder Shares and such securities will have a significantly higher value at the time of the Business Combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that Sponsor has agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if Data Knights does not complete an initial business combination by August 11, 2023, the proceeds from the sale of the Placement Units will be included in the liquidating distribution to Data Knights&#8217; Public Stockholders and the Placement Units will expire worthless; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the Trust Account is liquidated, including in the event Data Knights is unable to complete an initial business combination within the required time period, the Sponsor has agreed to indemnify Data Knights to ensure that the proceeds in the Trust Account are not reduced below $10.20 per Public Share by the claims of prospective target businesses with which Data Knights has entered into an acquisition agreement or claims of any third party for services rendered or products sold to Data Knights, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">These interests may influence Data Knights&#8217; directors in making their recommendation that you vote in favor of the approval of the Business Combination. The estimated aggregate amount invested by Sponsor and certain of Data Knights&#8217; directors and executive officers in their interests in Data Knights is $5,877,750, as detailed in the following tables:</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Assuming No Further Redemptions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,875,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,139,535</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,852,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 286,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 36,331,060</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,877,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Assuming 80% Redemptions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,875,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,133,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">6,139,535</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,852,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">286,785</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 36,331,060</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,877,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Assuming Maximum Redemptions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,875,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,139,535</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,852,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 286,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">36,331,060</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">5,877,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">To date, Data Knights&#8217; officers and directors and the Sponsor have not incurred any out-of-pocket expenses subject to reimbursement by Data Knights. The Sponsor had previously requested that the Company extend the date by which the Company has to consummate a business combination to February 11, 2023, and in connection therewith caused an aggregate of $1,150,000 (representing $0.10 per public share) to be deposited into the Company&#8217;s trust account on August 11, 2022, to extend such date to November 11, 2022, and caused an aggregate of $368,758.44 (representing $0.135 per public share) to extend such date to February 11, 2023. Under the terms of its Charter, the Company can extend the date by which it has to consummate a business combination by up to six additional one-month periods, or up to August 11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">What happens if I sell my shares of Class&#160;A Common Stock before the Special Meeting?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">The Record Date is earlier than the date of the Special Meeting. If you transfer your shares of Common Stock after the Record Date, but before the Special Meeting, unless the transferee obtains from you a proxy to vote those shares, you will retain your right to vote at the Special Meeting. However, you will not be able to seek redemption of your shares because you will no longer be able to deliver them for cancellation upon consummation of the Business Combination. If you transfer your shares of Class<span style="font-family:'Times New Roman PS Std';">&#160;</span>A Common Stock prior to the Record Date, you will have no right to vote those shares at the Special Meeting or redeem those shares for a pro rata portion of the proceeds held in our Trust Account.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">What happens if I vote against the Business Combination Proposal?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Pursuant to Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> Charter, if the Business Combination Proposal is not approved and Data Knights does not otherwise consummate an alternative business combination by August 11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension. Data Knights will be required to dissolve and liquidate its Trust Account by returning the then remaining funds in such account to the Public Stockholders.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Do I have redemption rights?</b></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to Data Knights</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';"> Charter, holders of Public Shares may elect to have their shares redeemed for cash at the applicable redemption price per share calculated in accordance with Data Knight</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Charter. As of March 31, 2023, based on funds in the Trust Account of approximately $29,725,574, this would have amounted to approximately $10.88 per share. If a holder exercises its redemption rights, then such holder will be exchanging its shares of Data Knights Common Stock for cash. Such a holder will be entitled to receive cash for its Public Shares only if it properly demands redemption and delivers its shares (either physically or electronically) to Data Knights</span><span style="font-family:'Times New Roman PS Std';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';"> Transfer Agent prior to the Special Meeting. See the section titled </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Special Meeting of Data Knights Stockholders</i><i style="font-family:'Times New Roman PS Std';font-style:italic;">&#160;&#8212;</i><i style="font-family:'Times New Roman','Times','serif';font-style:italic;"> Redemption Rights</i><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';"> for the procedures to be followed if you wish to redeem your shares for cash.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Will how I vote affect my ability to exercise redemption rights?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">No.<span style="font-family:'Times New Roman PS Std';">&#160;</span>You may exercise your redemption rights whether you vote your shares of Data Knights Common Stock <span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-weight:bold;">FOR</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span> or <span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-weight:bold;">AGAINST</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span> the Business Combination Proposal or any other Proposal described by this proxy statement/prospectus. As a result, the Merger Agreement can be approved by stockholders who will redeem their shares and no longer remain stockholders, leaving stockholders who choose not to redeem their shares holding shares in a company with a potentially less liquid trading market, fewer stockholders, potentially less cash and the potential inability to meet the listing standards of the Nasdaq Global Market.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">How do I exercise my redemption rights?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">In connection with the Business Combination, holders of Public Shares may seek to redeem their Public Shares regardless of whether such public stockholder votes <span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-weight:bold;">FOR</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span> or <span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-weight:bold;">AGAINST</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span> the Business Combination Proposal.</p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:6pt;margin:0pt 0pt 12pt 18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">To exercise your redemption rights, you must demand that the Company redeem your Public Shares.&#160;</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">In connection with tendering your shares for redemption, you must elect either to physically tender your share certificates to Continental, at Continental Stock Transfer&#160;&amp; Trust Company, One State Street Plaza, 30</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">&#160;Floor, New&#160;York, New&#160;York 10004-1561, Attn: SPAC Redemptions, at least two (2)&#160;business&#160;days prior to the Special Meeting or deliver your shares to Continental electronically using The Depository Trust Company&#8217;s DWAC (Deposit/Withdrawal At Custodian) System, which election would likely be determined based on the manner in which you hold your shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Certificates that have not been tendered in accordance with these procedures at least two (2)&#160;business&#160;days prior to the Special Meeting will not be redeemed for cash. In the event that a public stockholder tenders its shares and decides that it does not want to redeem its Public Shares, such stockholder may withdraw the tender. If you delivered your Public Shares for redemption to Continental and decide prior to the Special Meeting not to redeem your Public Shares, you may request that Continental return the shares (physically or electronically). You may make such request by contacting Continental at the address listed below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">Continental Stock Transfer&#160;&amp; Trust Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt 0pt 0pt 36pt;"><span style="font-size:10pt;">One State Street Plaza, 30</span><sup style="font-size:4.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;Floor</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">New&#160;York, New&#160;York 10004-1561</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 0pt 36pt;"><span style="font-family:'Times New Roman','Times','serif';">Attn: SPAC Redemptions</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 36pt;"><span style="font-family:'Times New Roman','Times','serif';">E-mail: spacredemptions@continentalstock.com</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Notwithstanding the foregoing, a holder of the Public Shares, together with any affiliate of his or any other person with whom he is acting in concert or as a &#8220;group&#8221; (as defined in Section&#160;13d-3 of the Exchange Act) will be restricted from seeking redemption rights with respect to an aggregate of 15% or more of the shares of Data Knights Common Stock included in the Public Units sold in the Data Knights IPO, which we refer to as the &#8220;15% threshold.&#8221; Accordingly, all Public Shares in excess of the 15% threshold beneficially owned by a Public Stockholder or group will not be redeemed for cash.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Stockholders seeking to exercise their redemption rights and opting to deliver physical certificates should allot sufficient time to obtain physical certificates from the Transfer Agent and time to effect delivery. It is Data Knights&#8217; understanding that stockholders should generally allot at least two weeks to obtain physical certificates from the Transfer Agent. However, Data Knights does not have any control over this process, and it may take longer than two weeks. Stockholders who hold their shares in street name will have to coordinate with their bank, broker or other nominee to have the shares certificated or delivered electronically.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Any demand for redemption, once made, may be withdrawn at any time until the deadline for exercising redemption requests and thereafter, with Data Knights&#8217; consent, until the vote is taken with respect to the Business Combination. If you delivered your shares for redemption to Data Knights&#8217; Transfer Agent and decide within the required timeframe not to exercise your redemption rights, you may request that Data Knights&#8217; Transfer Agent return the shares (physically or electronically). You may make such request by contacting Data Knights&#8217; Transfer Agent at the phone number or address listed under the question &#8220;<i style="font-style:italic;">Who can help answer my questions?</i>&#8221; below.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">How do redemptions of Data Knights&#8217; Public Shares impact the Closing of the Business Combination and the Minimum Cash Condition?</b></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">Substantial redemptions of Data Knights&#8217; Public Shares could adversely affect Data Knight&#8217;s satisfaction of the Minimum Cash Condition, which requires Data Knights to have at least $30 million of cash and cash equivalents at the Closing of the Business Combination if a PIPE Investment or other alternative source of funding is not achieved. The Minimum Cash Condition is a condition precedent to OneMedNet&#8217;s obligation to consummate the Business Combination. The Minimum Cash Condition is solely for the benefit of OneMedNet and is based on OneMedNet&#8217;s anticipated capital needs post-Closing during the first 12-24 months following the Closing. Based on the $29,725,574 million in the Trust Account as of March 31, 2023, together with the $1.5 million to be advanced at the time of the Business Combination under the PIPE, the Minimum Cash Condition would be satisfied. Non-redemption agreements with holders of the Public Shares would not be sufficient by themselves to ensure that Data Knights satisfied the Minimum Cash Condition. Because the Minimum Cash Condition is for OneMedNet&#8217;s benefit, it has the sole right to modify or waive the Minimum Cash Condition to ensure the Closing of the Business Combination especially when confronted by fluctuations in the PIPE market, including those resulting from rising interest rates causing a slowdown in  the PIPE Investments. OneMedNet&#8217;s anticipated capital needs following the Closing of the Business Combination is based on its pro forma expense projections which it believes are compatible with the PIPE structure to receive $1,500,000 at Closing. </span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Moreover, even if the Minimum Cash Condition was waived by OneMedNet, unless the NTA Proposal is approved by Data Knights stockholders, in no event will Data Knights redeem public shares in an amount that would cause its net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) to be less than $5,000,001. <i style="font-style:italic;">See</i> &#8220;<i style="font-style:italic;">Risk Factors</i>&#8221; and &#8220;NTA Proposal.&#8221;</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">How would the failure to complete the PIPE Investment impact Data Knights following the Closing of the Business Combination?</b></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The amount of working capital available to Data Knights after the Business Combination will depend in part on the successful completion of the PIPE Investment and/or an alternative investment. Following the redemption on November 11, 2022 of 8,768,456 shares of Class A Common Stock at an approximate price of $10.42 per share, for an aggregate of approximately $91.4 million, Data Knight&#8217;s Trust Account had a balance of approximately $28.5 million. In connection with the consummation of the Business Combination, the Public Stockholders may redeem all or a portion of the remaining shares of Class A Common Stock they hold. Accordingly, a failure to successfully complete the PIPE Investment and/or an alternative investment at a sufficient level of net proceeds could leave Data Knights undercapitalized and with inadequate working capital to fund its operations or unable to grow its operations and revenue sufficiently to achieve positive net cash flow, which could adversely affect its business, financial condition and results of operations and impair the value of the Class A Common Stock.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">What are the federal income tax consequences of exercising my redemption rights?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Data Knights stockholders who exercise their redemption rights to receive cash in exchange for their shares of Data Knights Common Stock generally will be required to treat the transaction as a sale of such shares and recognize gain or loss upon the redemption in an amount equal to the difference, if any, between the amount of cash received and the tax basis of the shares of Data Knights Common Stock redeemed. Such gain or loss should be treated as capital gain or loss if such shares were held as a capital asset on the date of the redemption. The redemption, however, may be treated as a distribution to a redeeming stockholder </p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">for U.S. federal income tax purposes if the redemption does not effect a sufficient reduction (as determined under applicable federal income tax law) in the redeeming stockholder<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s<span style="font-family:'Times New Roman PS Std';">&#160;</span>percentage ownership in us (whether such ownership is direct or through the application of certain attribution and constructive ownership rules). Any amounts treated as such a distribution will constitute a dividend to the extent not in excess of our current and accumulated earnings and profits as measured for U.S. federal income tax purposes. Any amounts treated as a distribution and that are in excess of our current and accumulated earnings and profits will reduce the redeeming stockholder<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s basis in his or her redeemed shares of our Common Stock, and any remaining amount will be treated as gain realized on the sale or other disposition of our Common Stock. These tax consequences are described in more detail in the section titled <span style="font-family:'Times New Roman PS Std';">&#8220;</span><i style="font-style:italic;">The Business Combination Proposal </i><i style="font-family:'Times New Roman PS Std';font-style:italic;">&#8212;</i><i style="font-style:italic;"> Certain Material U.S. Federal Income Tax Considerations of the Redemption.</i><span style="font-family:'Times New Roman PS Std';">&#8221;</span> We urge you to consult your tax advisor regarding the tax consequences of exercising your redemption rights.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">If I am a holder of Warrants, can I exercise redemption rights with respect to my Warrants?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">No.<span style="font-family:'Times New Roman PS Std';">&#160;</span>The holders of Warrants have no redemption rights with respect to such Warrants.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">If I am a Unit holder, can I exercise redemption rights with respect to my Units?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">No.<span style="font-family:'Times New Roman PS Std';">&#160;</span>Holders of outstanding Units must separate the underlying Public Shares and Public Warrants prior to exercising redemption rights with respect to the Public Shares.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">If you hold Units registered in your own name, you must deliver the certificate for such Units to Continental Stock Transfer&#160;&amp; Trust Company, Data Knights&#8217; Transfer Agent, with written instructions to separate such Units into Public Shares and Public Warrants. This must be completed far enough in advance to permit the mailing of the Public Share certificates back to you so that you may then exercise your redemption rights upon the separation of the Public Shares from the Units. See &#8220;<i style="font-style:italic;">How do I exercise my redemption rights?</i>&#8221; above. The address of Continental Stock Transfer&#160;&amp; Trust Company is listed under the question &#8220;<i style="font-style:italic;">Who can help answer my questions?</i>&#8221; below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">If a broker, dealer, commercial bank, trust company, or other nominee holds your units, you must instruct such nominee to separate your Units. Your nominee must send written instructions by facsimile to Continental Stock Transfer&#160;&amp; Trust Company, Data Knights&#8217; Transfer Agent. Such written instructions must include the number of Units to be split and the nominee holding such Units. Your nominee must also initiate electronically, using DTC&#8217;s deposit withdrawal at custodian (DWAC) system, a withdrawal of the relevant units and a deposit of an equal number of Public Shares, and Public Warrants. This must be completed far enough in advance to permit your nominee to exercise your redemption rights upon the separation of the Public Shares from the Units. While this is typically done electronically the same business day, you should allow at least one full business day to accomplish the separation. If you fail to cause your Public Shares to be separated in a timely manner, you will likely not be able to exercise your redemption rights.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Do I have appraisal rights if I object to the proposed Business Combination?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">No.<span style="font-family:'Times New Roman PS Std';">&#160;</span>There are no appraisal rights available to holders of Data Knights Common Stock in connection with the Business Combination.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">What happens to the funds held in the Trust Account upon consummation of the Business Combination?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">If the Business Combination is consummated, the funds held in the Trust Account will be released to pay:</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a portion of the Merger Consideration pursuant to the Merger Agreement;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights stockholders who properly exercise their redemption rights;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$500</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">,000</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> payable to EF Hutton, a division of Benchmark Investments,</span><span style="font-family:'Times New Roman PS Std';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Inc. for deferred underwriting commissions from the IPO at closing and, if funds remain, to facilitate repayment of the $500,000 balance due to EF Hutton over six months from October 2023 through March 2024 pursuant to the Promissory Note attached at Exhibit 10.21;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">certain other fees, costs, and expenses (including regulatory fees, legal fees, accounting fees, printer fees, and other professional fees) that were incurred by Data Knights or OneMedNet in connection with the transactions contemplated by the Business Combination and pursuant to the terms of the Merger Agreement;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any loans owed by Data Knights to its Sponsor for any Data Knights transaction expenses or other administrative expenses incurred by Data Knights; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for general corporate purposes including, but not limited to, working capital for operations.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">What happens if the Business Combination is not consummated?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">There are certain circumstances under which the Merger Agreement may be terminated. See the section titled <span style="font-family:'Times New Roman PS Std';">&#8220;</span><i style="font-style:italic;">The Business Combination Proposal</i><i style="font-family:'Times New Roman PS Std';font-style:italic;">&#160;&#8212;</i><i style="font-style:italic;"> The Merger Agreement</i><span style="font-family:'Times New Roman PS Std';">&#8221;</span> for information regarding the parties<span style="font-family:'Times New Roman PS Std';">&#8217;</span> specific termination rights.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">If, as a result of the termination of the Merger Agreement or otherwise, Data Knights is unable to complete the Business Combination or another initial business combination transaction by August 11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension, Data Knights&#8217; Charter provides that it will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, subject to lawfully available funds therefor, redeem 100% of the Public Shares in consideration of a per-share price, payable in cash, equal to the quotient obtained by dividing (A) the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to it to pay franchise and income taxes payable, by (B) the total number of then outstanding Public Shares, which redemption will completely extinguish rights of the Public Stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemptions, subject to the approval of Data Knights&#8217; remaining stockholders and Data Knights&#8217; Board in accordance with applicable law, dissolve and liquidate, subject (in the case of (ii) and (iii) above) to its obligations under the DGCL to provide for claims of creditors and other requirements of applicable law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Data Knights expects that the amount of any distribution its Public Stockholders will be entitled to receive upon its dissolution will be approximately the same as the amount they would have received if they had redeemed their shares in connection with the Business Combination, subject in each case to Data Knights&#8217; obligations under the DGCL to provide for claims of creditors and other requirements of applicable law. Holders of Founder Shares have waived any right to any liquidation distribution with respect to those shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">In the event of liquidation, there will be no distribution with respect to Data Knights&#8217; outstanding Warrants Accordingly, the Warrants will expire worthless.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">When is the Business Combination expected to be completed?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">The Closing is expected to take place (a)<span style="font-family:'Times New Roman PS Std';">&#160;</span>no later than the second business day following the satisfaction or waiver of the conditions described below under the section titled <span style="font-family:'Times New Roman PS Std';">&#8220;</span><i style="font-style:italic;">The Business Combination Proposal</i><i style="font-family:'Times New Roman PS Std';font-style:italic;">&#160;&#8212;</i><i style="font-style:italic;"> General Description of the Merger Agreement</i><i style="font-family:'Times New Roman PS Std';font-style:italic;">&#160;&#8212;</i><i style="font-style:italic;"> Conditions to the Closing</i><span style="font-family:'Times New Roman PS Std';">&#8221;</span> or (b)<span style="font-family:'Times New Roman PS Std';">&#160;</span>such other date as agreed to by the parties to the Merger Agreement in writing, in each case, subject to the satisfaction or waiver of the Closing conditions. The Merger Agreement may be terminated by either Data Knights or OneMedNet if the Closing has not occurred by August<span style="font-family:'Times New Roman PS Std';">&#160;</span>11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension. Neither Data Knights nor OneMedNet can assure you of when or if the Business Combination will be completed, and it is possible that factors outside of the control of Data Knights and OneMedNet could result in the Business Combination being completed at a different time or not at all. Data Knights must first obtain the approval of Data Knights stockholders for each of the Proposals set forth in this proxy statement/consent solicitation/prospectus for their approval and Data Knights and OneMedNet must also first obtain certain necessary regulatory approvals and satisfy other closing conditions. For a description of the conditions to the completion of the Business Combination, see the section titled <span style="font-family:'Times New Roman PS Std';">&#8220;</span><i style="font-style:italic;">The Business Combination Proposal </i><i style="font-family:'Times New Roman PS Std';font-style:italic;">&#8212;</i><i style="font-style:italic;"> The Merger Agreement </i><i style="font-family:'Times New Roman PS Std';font-style:italic;">&#8212;</i><i style="font-style:italic;"> Conditions to the Closing</i>.<span style="font-family:'Times New Roman PS Std';">&#8221;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">What do I need to do now?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">You are urged to read carefully and consider the information contained in this proxy statement/prospectus, including the annexes, and to consider how the Business Combination will affect you as a stockholder. You should then vote as soon as possible in accordance with the instructions provided in this proxy statement/prospectus and on the enclosed proxy card or, if you hold your shares through a brokerage firm, bank, or other nominee, on the voting instruction form provided by the broker, bank, or nominee.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">How do I vote?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">If you were a holder of record of Data Knights Common Stock on [<span style="font-family:'Symbol';">&#183;</span>], 2023, the Record Date, you may vote with respect to the Proposals virtually at the Special Meeting, or by completing, signing, dating, and returning the enclosed proxy card in the postage-paid envelope provided. If you hold your shares in <span style="font-family:'Times New Roman PS Std';">&#8220;</span>street name,<span style="font-family:'Times New Roman PS Std';">&#8221;</span> which means your shares are held of record by a broker, bank, or other nominee, you should follow the instructions provided by your broker, bank, or nominee to ensure that votes related to the shares you beneficially own are properly counted. In this regard, you must provide the record holder of your shares with instructions on how to vote your shares or, if you wish to virtually attend the Special Meeting and vote, obtain a proxy from your broker, bank, or nominee.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">What will happen if I abstain from voting or fail to vote at the Special Meeting?</b></p><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">At the Special Meeting, Data Knights will count a properly executed proxy marked </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">ABSTAIN</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';"> with respect to a particular Proposal as present for purposes of determining whether a quorum is present. Abstentions will have the same effect as a vote </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">AGAINST</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';"> the Business Combination Proposal and the Charter Amendment Proposal. Broker non-votes will not be counted as present for the purposes of establishing a quorum and will have no effect on any of the Proposals.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Q.</b></span><b style="font-weight:bold;">What will happen if I sign and return my proxy card without indicating how I wish to vote?</b></p><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Signed and dated proxies received by Data Knights without an indication of how the stockholder intends to vote on a Proposal will be voted </span><span style="font-family:'Times New Roman PS Std';">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman PS Std';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';"> each Proposal presented to the stockholders. The proxyholders may use their discretion to vote on any other matters which properly come before the Special Meeting.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">If I am not going to attend the Special Meeting, should I return my proxy card instead?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Yes. Whether you plan to attend the Special Meeting or not, please read the enclosed proxy statement carefully, and vote your shares by completing, signing, dating, and returning the enclosed proxy card in the postage-paid envelope provided.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">If my shares are held in </b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#8220;</b><b style="font-weight:bold;">street name,</b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#8221;</b><b style="font-weight:bold;"> will my broker, bank or nominee automatically vote my shares for me?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">No.<span style="font-family:'Times New Roman PS Std';">&#160;</span>Under the rules<span style="font-family:'Times New Roman PS Std';">&#160;</span>of various national and regional securities exchanges, your broker, bank, or nominee cannot vote your shares with respect to non-discretionary matters unless you provide instructions on how to vote in accordance with the information and procedures provided to you by your broker, bank, or nominee. Data Knights believes the Proposals presented to the stockholders will be considered non-discretionary and therefore your broker, bank or nominee cannot vote your shares without your instruction. Your bank, broker or other nominee can vote your shares only if you provide instructions on how to vote. You should instruct your broker to vote your shares in accordance with directions you provide.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">May</b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#160;</b><b style="font-weight:bold;">I change my vote after I have mailed my signed proxy card?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Yes. You may change your vote by sending a later-dated, signed proxy card to Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> secretary at the address listed below so that it is received by Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> secretary prior to the Special Meeting or attend the Special Meeting in person and vote. You also may revoke your proxy by sending a notice of revocation to Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> secretary, which must be received by Data Knights<span style="font-family:'Times New Roman PS Std';">&#8217;</span> secretary prior to the Special Meeting.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">What should I do if I receive more than one set of voting materials?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">You may receive more than one set of voting materials, including multiple copies of this proxy statement/prospectus and multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. If you are a holder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date and return each proxy card and voting instruction card that you receive in order to cast your vote with respect to all of your shares.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Who will solicit and pay the cost of soliciting proxies?</b></p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">A.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights will pay the cost of soliciting proxies for the Special Meeting. Data Knights has engaged Laurel Hill Advisory Group, LLC, which we refer to as </span><span style="font-family:'Times New Roman PS Std';font-size:10pt;font-style:normal;font-weight:normal;">&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Laurel Hill</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">,</span><span style="font-family:'Times New Roman PS Std';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to assist in the solicitation of proxies for the Special Meeting. Data Knights has </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">agreed to pay</span><span style="font-family:'Times New Roman PS Std';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Laurel Hill its customary fee, plus disbursements. Data Knights will reimburse Laurel Hill for reasonable out-of-pocket expenses and will indemnify Laurel Hill</span><span style="font-family:'Times New Roman PS Std';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">and its affiliates against certain claims, liabilities, losses, damages, and expenses. Data Knights will also reimburse banks, brokers and other custodians, nominees and fiduciaries representing beneficial owners of shares of Data Knights Common Stock for their expenses in forwarding soliciting materials to beneficial owners of Data Knights</span><span style="font-family:'Times New Roman PS Std';font-size:10pt;font-style:normal;font-weight:normal;">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Common Stock and in obtaining voting instructions from those owners. Data Knights</span><span style="font-family:'Times New Roman PS Std';font-size:10pt;font-style:normal;font-weight:normal;">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> directors, officers and employees may also solicit proxies by telephone, by facsimile, by mail, on the Internet or in person. They will not be paid any additional amounts for soliciting proxies.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Q.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Who can help answer my questions?</b></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">A.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">If you have questions about the Proposals or if you need additional copies of this proxy statement/prospectus or the enclosed proxy card you should contact:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">Data Knights Acquisition Corp.<br/>Unit G6, Frome Business Park, Manor Road<br/>Frome, United Kingdom, BA11 4FN<br/>Attn: Barry Anderson<br/>Telephone No.: 011-44 203 833 4000<br/>E-mail: barry@dataknightsacuk.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">You may also contact our proxy solicitor at:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">Laurel Hill Advisory Group, LLC</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">2 Robbins Lane, Suite&#160;201</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">Jericho, NY 11753</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">(855) 414-2266</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">Email: dataknights@laurelhill.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">To obtain timely delivery, Data Knights stockholders must request the materials no later than five (5)&#160;business&#160;days prior to the Special Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">You may also obtain additional information about Data Knights from documents filed with the SEC by following the instructions in the section titled &#8220;<i style="font-style:italic;">Where You Can Find More Information</i>.&#8221;</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">If you intend to seek redemption of your Public Shares, you will need to send a letter demanding redemption and deliver your stock (either physically or electronically) to Data Knights&#8217; Transfer Agent prior to the Special Meeting in accordance with the procedures detailed under the question &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">How do I exercise my redemption rights?</i><span style="font-family:'Times New Roman','Times','serif';">&#8221; If you have questions regarding the certification of your position or delivery of your stock, please contact:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">Continental Stock Transfer&#160;&amp; Trust Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt 0pt 0pt 36pt;"><span style="font-size:10pt;">One State Street Plaza, 30</span><sup style="font-size:4.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;Floor</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">New&#160;York, New&#160;York 10004-1561</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 0pt 36pt;"><span style="font-family:'Times New Roman','Times','serif';">Attn: SPAC Redemptions</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 0pt 36pt;"><span style="font-family:'Times New Roman','Times','serif';">E-mail: </span><span style="font-family:'Times New Roman','Times','serif';">spacredemptions@continentalstock.com</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><a id="_0836cd15_4876_45b6_87fa_fcd14b77e54c"></a><a id="SUMMARYOFTHEPROXYSTATEMENTPROSPECTUS_964"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SUMMARY OF THE PROXY STATEMENT/PROSPECTUS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This summary highlights selected information contained in this proxy statement and does not contain all of the information that may be important to you. You should read carefully this entire proxy statement, including the Annexes and accompanying financial statements of Data Knights and OneMedNet, to fully understand the proposed Business Combination (as described below) before voting on the Proposals to be considered at the Special Meeting (as described below). Please see the section entitled &#8220;<i style="font-style:italic;">Where You Can Find More Information</i>&#8221; beginning on page 236 of this proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise specified, all share calculations assume (i) no exercise of redemption rights by the Company&#8217;s public stockholders; and (ii) no inclusion of any shares of Class A Common Stock issuable upon the exercise of the Company&#8217;s warrants or any shares to be issued pursuant to the Equity Incentive Plan at or following the closing of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Data Knights Acquisition Corp</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is a blank check company incorporated as a Delaware corporation on February&#160;8, 2021, for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Data Knights&#8217; units, common stock and warrants are trading on Nasdaq under the symbols &#8220;DKDCU,&#8221; &#8220;DKDCA&#8221; and &#8220;DKDCW,&#8221; respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Merger Sub</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Merger Sub is a wholly-owned subsidiary of Data Knights, formed on April&#160;22, 2022, to consummate the Business Combination. At the effective time of the closing of the transactions contemplated by the Merger Agreement (the &#8220;<b style="font-weight:bold;">Closing</b>&#8221;), OneMedNet will merge with and into Merger Sub, with OneMedNet surviving the Merger as a wholly-owned subsidiary of Data Knights, which shall be renamed &#8220;OneMedNet&#8221; at the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet is a pioneer in medical image sharing and exchange technologies. OneMedNet provides curated medical image sharing, with&#160;years of experience and a multi-national footprint, including providing the technology underlying the medical image sharing services for all of the public and private hospitals in Ireland. OneMedNet is also focused on the real world data (RWD) and real world evidence (RWE) imaging markets supporting clinic trials to reduce time to market for new treatments. For more information about OneMedNet, see the sections titled &#8220;<i style="font-style:italic;">Information About OneMedNet</i>&#8221; and &#8220;<i style="font-style:italic;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of OneMedNet</i>.&#8221;</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">The NTA Proposal</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The stockholders of Data Knights will vote on a proposal relating to the amendment of the Charter. Please see the section entitled &#8220;The NTA Proposal.&#8221;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">The Business Combination Proposal</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April&#160;25, 2022, Data Knights Acquisition Corp, a Delaware corporation (&#8220;<b style="font-weight:bold;">Data Knights</b>&#8221;), entered into an Agreement and Plan of Merger (the &#8220;<b style="font-weight:bold;">Merger Agreement</b>&#8221;), by and among Data Knights, Data Knights Merger Sub,&#160;Inc., a Delaware corporation and wholly-owned subsidiary of Data Knights (&#8220;<b style="font-weight:bold;">Merger Sub</b>&#8221;), Data Knights, LLC, a Delaware limited liability company, in its capacity as Purchaser Representative (&#8220;<b style="font-weight:bold;">Sponsor</b>&#8221;), OneMedNet Corporation, a Delaware corporation (&#8220;<b style="font-weight:bold;">OneMedNet</b>&#8221;), Paul Casey, in his capacity as Seller Representative.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the Merger Agreement, at the Closing of the Business Combination, Merger Sub will merge with and into OneMedNet, with OneMedNet continuing as the surviving corporation (the &#8220;<b style="font-weight:bold;">Surviving Corporation</b>&#8221;).</p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Merger Consideration</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As consideration for the Merger, the holders of OneMedNet securities collectively shall be entitled to receive from Data Knights, in the aggregate, a number of Data Knights securities with an aggregate value equal to (the &#8220;<b style="font-weight:bold;">Merger Consideration</b>&#8221;) (a)&#160;Two Hundred Million U.S. Dollars ($200,000,000) minus (b)&#160;the amount (as defined in the Merger Agreement), if any, by which the Target Net Working Capital Amount (as defined in the Merger Agreement) exceeds the Net Working Capital Amount (but not less than zero), minus (c)&#160;the amount of Closing Net Indebtedness (as defined in the Merger Agreement) minus (d)&#160;the amount of any Merger transaction expenses (the total portion of the Merger Consideration amount payable to all OneMedNet Stockholders in accordance with the Merger Agreement is also referred to herein as the &#8220;<b style="font-weight:bold;">Stockholder Merger Consideration</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Merger Consideration is subject to adjustment after the Closing based on confirmed amounts of the Closing Net Indebtedness (as defined in the Merger Agreement) of OneMedNet as of the Closing Date. If the adjustment is a negative adjustment in favor of Data Knights, the Merger Consideration and number of shares of Data Knights Common Stock issuable to OneMedNet Stockholders shall be adjusted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Representations and Warranties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Merger Agreement contains customary representations and warranties by each of Data Knights and OneMedNet. Certain of the representations are subject to specified exceptions and qualifications contained in the Merger Agreement or in information provided pursuant to certain disclosure schedules to the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Covenants of the Parties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the Merger Agreement, each party agrees to use its commercially reasonable efforts to effect the Closing. The Merger Agreement also contains certain customary covenants by the parties during the period between the signing of the Merger Agreement and the earlier of the Closing or the termination of the Merger Agreement in accordance with its terms, including covenants regarding the conduct of their respective businesses, efforts, access, confidentiality and public announcements, the Data Knights proxy statement for the transaction (which includes the adoption of a new equity incentive plan), notice of breaches, no insider trading, indemnification of directors and officers, and other customary covenants. The parties also have agreed to the following covenants:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Each party is subject to a &#8220;no-shop&#8221; obligation between signing of the Merger Agreement and Closing and will not be allowed to solicit or discuss competing transactions with other potential parties during such time period.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Data Knights board of directors after the Closing will consist of at least nine directors, including (i)&#160;seven (7)&#160;persons designated prior to the Closing by OneMedNet, at least three (3)&#160;of whom must qualify as an independent director under Nasdaq rules; and (ii)&#160;two (2)&#160;persons designated prior to the Closing by Data Knights, at least one (1)&#160;of whom must qualify as an independent director under Nasdaq rules.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet shall use its commercially reasonable efforts to deliver audited financial statements prepared in accordance with GAAP and audited in accordance with PCAOB auditing standards for the fiscal&#160;years ended December&#160;31, 2021, and December&#160;31, 2020, to Data Knights by May&#160;15, 2022.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights also agreed in the Merger Agreement to obtain the written consent of its stockholders as promptly as practicable after the Registration Statement has become effective to approve the Merger Agreement and the Business Combination and related matters.</p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Indemnification</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The representations and warranties of OneMedNet and Data Knights contained in the Merger Agreement will not survive the Closing, and from and after the Closing, OneMedNet and Data Knights will not have any further obligations, nor shall any claim be asserted, or action be brought against OneMedNet and Data Knights or their respective representatives with respect thereto. The covenants and agreements made by OneMedNet and Data Knights in the Merger Agreement, including any rights arising out of any breach of such covenants or agreements, shall not survive the Closing, except for those covenants and agreements contained therein that by their terms apply or are to be performed in whole or in part after the Closing (which such covenants shall survive the Closing and continue until fully performed in accordance with their terms).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Conditions to Consummation of the Merger</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consummation of the Merger is subject to customary Closing conditions unless waived, including:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the approval by the stockholders of each of OneMedNet and Data Knights;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">approvals of any required governmental authorities and the expiration or termination of any anti-trust waiting periods;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">receipt of specified third-party consents;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">no law or order preventing the transactions;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">no material uncured breach by the other party;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">after giving effect to the redemption, Data Knights shall have at least $5,000,001 of net tangible assets as required by its charter;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the members of the post-Closing Data Knights board shall have been elected or appointed as of the Closing;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the Registration Statement shall have been declared effective by the SEC and shall remain effective as of the Closing, and no stop order or similar order shall be in effect with respect to the Registration Statement; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the shares of Data Knights Common Stock issued as Merger Consideration shall have been approved for listing on Nasdaq, subject to official notice of issuance.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, unless waived by OneMedNet, the obligations of OneMedNet to consummate the Merger are subject to the satisfaction of the following Closing conditions, in addition to customary certificates and other closing deliveries: (a)&#160;the representations and warranties of Data Knights being true and correct as of the date of the Merger Agreement and as of the Closing (subject to Material Adverse Effect); (b)&#160;Data Knights having performed in all material respects the respective obligations and complied in all material respects with their respective covenants and agreements under the Merger Agreement required to be performed or complied with on or prior the date of the Closing; (c)&#160;absence of any Material Adverse Effect with respect to Data Knights since the date of the Merger Agreement which is continuing and uncured; and (d)&#160;the Registration Rights Agreement being in full force and effect as of the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Unless waived by Data Knights, the obligations of Data Knights and Merger Sub to consummate the Merger are subject to the satisfaction of the following Closing conditions, in addition to customary certificates and other closing deliveries: (a)&#160;the representations and warranties of OneMedNet being true and correct as of the date of the Merger Agreement and as of the Closing (subject to Material Adverse Effect); (b)&#160;OneMedNet having performed in all material respects the respective obligations and complied in all material respects with its covenants and agreements under the Merger Agreement required to be performed or complied with on or prior the date of the Closing; and (c)&#160;absence of any Material Adverse Effect with respect to OneMedNet as a whole since the date of the Merger Agreement which is continuing and uncured; and (d)&#160;each Executive Employment Agreement, Lock-Up Agreement and Non-Competition Agreement being in full force and effect as of the Closing.</p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Termination</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by mutual agreement;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">for the other party&#8217;s uncured breach;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">if there is a government order preventing the Closing;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by either party if the Closing does not occur by August 11, 2023, as provided herein;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by Data Knights if there has been an event after the signing of the Merger Agreement that has had a Material Adverse Effect on OneMedNet that is continuing and uncured;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by Data Knights or OneMedNet if the Data Knights stockholders vote and do not approve the transactions contemplated by the Merger Agreement;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by Data Knights if it does not receive the opinion of its financial advisors that the transactions contemplated by the Merger Agreement are fair to the Company and its Stockholders; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by OneMedNet if the Data Knights Board withdraws or changes its approval or recommendation to the Data Knights stockholders in any matter that is adverse to OneMedNet.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Trust Account Waiver</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet agrees that it and is affiliates will not have any right, title, interest or claim of any kind in or to any monies in Data Knights&#8217; Trust Account held for its public shareholders, and agrees not to, and waives any right to, make any claim against the Trust Account (including any distributions therefrom).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Management</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following persons are expected to serve as executive officers and directors of OneMedNet following the Business Combination. For biographical information concerning the OneMedNet&#8217;s executive officers and OneMedNet&#8217;s designees to OneMedNet&#8217;s board of directors, see &#8220;<i style="font-style:italic;">Information about OneMedNet &#8212; Management of OneMedNet</i>.&#8221; For biographical information concerning the Data Knights designees to the OneMedNet board of directors see &#8220;<i style="font-style:italic;">Information About Data Knights &#8212; Data Knights&#8217; Management &#8212; Directors and Executive Officers</i>.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Paul Casey</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 76</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer, Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Jeffrey Yu</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 55</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chairman of the Board of Directors, Founder, Chief Medical Officer, Vice President<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aaron Green</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President</p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lisa Embree</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 51</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer, Vice President &#8212; Finance</p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Erkan Akyuz</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 53</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)(4)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eric Casaburi</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 48</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Robert Golden</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 60</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)(6)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Julianne Huh</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 53</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)(4)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Thomas Kosasa</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 77</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)(5)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:29.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">R. Scott Holbrook</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">73</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)(6)</sup></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Member of the audit committee.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Member of the compensation committee.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Member of the nominating and corporate governance committee.</p></td></tr></table></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(4)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Class&#160;I Director.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(5)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Class&#160;II Director.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(6)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Class&#160;III Director.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the Business Combination, OneMedNet will nominate one additional Class III Director, subject to the approval of Data Knights, who will qualify as an independent director as defined under the rules of the Nasdaq.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to Data Knights Charter, in connection with the Business Combination, holders of Public Shares may elect to have their shares redeemed for cash at the applicable redemption price per share calculated in accordance with the Charter. As of March 31, 2023, the pro rata portion of the $29,725,574 available in the Trust Account for the Public Shares was approximately $10.88 per share. If a holder of Public Shares exercises his, her or its redemption rights in connection with the Business Combination, such holder will be exchanging his, her or its Public Shares for cash. Such a holder will be entitled to receive cash for its Public Shares only if he, she, or it properly demands redemption and delivers its Public Shares (either physically or electronically) to Data Knights&#8217; Transfer Agent at least two (2)&#160;business&#160;days prior to the Special Meeting. Holders of Public Shares may elect to redeem their shares whether or not such shares are voted at the Special Meeting. See the section titled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Special Meeting of Data Knights Stockholders &#8212; Redemption Rights</i><span style="font-family:'Times New Roman','Times','serif';">.&#8221;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Business Combination involves numerous risks. For more information about these risks, see the section titled &#8220;<i style="font-style:italic;">Risk Factors</i>.&#8221;</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">PIPE Financing</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Securities Purchase Agreement</i></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">The Business Combination Agreement provides that Data Knights will use its reasonable commercial efforts to obtain the PIPE Financing. On June 28, 2023, the Company executed a Securities Purchase Agreement for PIPE Financing in the aggregate original principal amount of $1,595,744.70 and the purchase price of $1.5 million. Pursuant to the Securities Purchase Agreement, Data Knights will issue and sell to each of Thomas Kosasa, Dr. Jeffrey Yu, Aaron Green and Steve Kester (the &#8220;PIPE Investors&#8221;), a new series of senior secured convertible notes (the &#8220;PIPE Notes&#8221;), which Notes shall be convertible into shares of Common Stock at the PIPE Investors election.  The PIPE Investors&#8217; $1.5 million investment in the Notes will close and fund contemporaneous to the Closing of the Business Combination. At Closing of the Business Combination and funding of the PIPE, the PIPE Investors will execute additional documents including the PIPE Note in the amount corresponding to each PIPE Investor investment amount and in accordance with the terms set forth in the Securities Purchase Agreement. The aggregate purchase price for the PIPE Notes to be purchased by the PIPE Investors shall be the amount set forth in the Schedule of Buyers to the Security Purchase Agreement.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Registration Rights Agreement</i></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">At the Closing of the Securities Purchase Agreement, Data Knights has agreed to provide certain registration rights under the Securities Act of 1933 (the &#8220;1933 Act&#8221;), and applicable state securities laws. Specifically, New OneMedNet will prepare and file with the SEC an initial Registration Statement on Form S-1 covering the resale of all of the Registrable Securities (as defined in the Registration Rights Agreement). The Registration Rights Agreement requires that the initial Registration Statement register for resale, as of the date such Registration Statement is initially filed with the SEC, 100% of the maximum number of Conversion Shares (as defined in the Registration Rights Agreement) issuable upon conversion of the PIPE Notes, subject to adjustment as provided under the terms of the Registration Rights Agreement.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Form of Senior Secured Convertible Note</i></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">At the Closing of the Securities Purchase Agreement, Data-Knights will authorize a new series of Notes, in the aggregate original principal amount of $1,595,744.70 for the purchase price of $1.5 million. The PIPE Notes are convertible into shares of New OneMedNet Common Stock. The PIPE Notes will rank senior to all outstanding indebtedness  of Data Knights and its subsidiaries including New OneMedNet and OneMedNet at Closing. The PIPE Notes will be secured by the intellectual property of Data Knights and OneMedNet and a Guaranty executed by OneMedNet as Guarantor of Data Knights&#8217; obligations.</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">The Charter Amendment Proposal</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights stockholders will be asked to approve and adopt &#8212; subject to and conditional on (but with immediate effect therefrom) approval of the NTA Proposal, the Business Combination Proposal, the Nasdaq Proposal, and the Incentive Plan Proposal &#8212; an amendment and restatement of Data Knights&#8217; Charter, as set out in </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex&#160;C</i><span style="font-family:'Times New Roman','Times','serif';"> hereto (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Amended Charter</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;) to:</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(i)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">to change the name of Data Knights to <span style="font-family:'Times New Roman PS Std';">&#8220;</span>OneMedNet Corporation<span style="font-family:'Times New Roman PS Std';">&#8221;</span>;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(ii)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">to reclassify the Class<span style="font-family:'Times New Roman PS Std';">&#160;</span>A Common Stock and the Class<span style="font-family:'Times New Roman PS Std';">&#160;</span>B Common Stock as Common Stock;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(iii)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">to provide that any amendment to the Bylaws by the stockholders will require approval of the holders of 66<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>&#8725;<sub style="font-size:7.5pt;vertical-align:sub;">3</sub>% of the issued and outstanding capital stock entitled to vote generally in the election of directors;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(iv)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">to provide that any amendment to the following provisions of the Amended Charter will require approval of the holders of 66<span style="font-family:'Times New Roman PS Std';">&#8532;</span>% of the issued and outstanding capital stock entitled to vote generally in the election of directors: <span style="font-family:'Times New Roman PS Std';">&#8220;</span>Board of Directors,<span style="font-family:'Times New Roman PS Std';">&#8221;</span> <span style="font-family:'Times New Roman PS Std';">&#8220;</span>Stockholders,<span style="font-family:'Times New Roman PS Std';">&#8221;</span> <span style="font-family:'Times New Roman PS Std';">&#8220;</span>Liability and Indemnification; Corporate Opportunity,<span style="font-family:'Times New Roman PS Std';">&#8221;</span> <span style="font-family:'Times New Roman PS Std';">&#8220;</span>Business Combinations,<span style="font-family:'Times New Roman PS Std';">&#8221;</span> <span style="font-family:'Times New Roman PS Std';">&#8220;</span>Exclusive Forum,<span style="font-family:'Times New Roman PS Std';">&#8221;</span> and <span style="font-family:'Times New Roman PS Std';">&#8220;</span>Amendments<span style="font-family:'Times New Roman PS Std';">&#8221;</span>;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(v)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">to provide that the Company may not engage in certain <span style="font-family:'Times New Roman PS Std';">&#8220;</span>business combinations<span style="font-family:'Times New Roman PS Std';">&#8221;</span> with any <span style="font-family:'Times New Roman PS Std';">&#8220;</span>interested stockholder<span style="font-family:'Times New Roman PS Std';">&#8221;</span> for a three (3)<span style="font-family:'Times New Roman PS Std';">&#160;</span>year period following the time that the stockholder became an interested stockholder, unless (1)<span style="font-family:'Times New Roman PS Std';">&#160;</span>prior to the date of the transaction the Company<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s board of directors approves either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; (2)<span style="font-family:'Times New Roman PS Std';">&#160;</span>the interested stockholder owns at least 85% of the Company<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s voting stock outstanding upon consummation of the transaction, excluding for purposes of determining the number of shares outstanding (x)<span style="font-family:'Times New Roman PS Std';">&#160;</span>shares owned by persons who are directors and also officers and (y)<span style="font-family:'Times New Roman PS Std';">&#160;</span>shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether their shares held subject to the plan will be tendered in a tender or exchange offer; or (3)<span style="font-family:'Times New Roman PS Std';">&#160;</span>on or subsequent to the consummation of the transaction, the Business Combination is approved by the Company<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66<span style="font-family:'Times New Roman PS Std';">&#8532;</span>% of the Company<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s issued and outstanding voting stock which is not owned by the interested stockholder; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(vi)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">to remove from the Amended Charter the various provisions applicable only to special purpose acquisition corporations;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The material changes embodied in the Charter Amendment Proposal are (a) the addition of the supermajority voting requirement for the stockholders to amend New OneMedNet&#8217;s Bylaws (the &#8220;<b style="font-weight:bold;">Bylaw Amendment Requirement</b>&#8221;), and (b) the addition of the supermajority voting requirements enumerated in item (iv) above (the &#8220;<b style="font-weight:bold;">Article Amendment Requirement</b>&#8221;). While the adoption of each of these material changes are cross-conditioned on the adoption of the other, holders of shares of Data Knights Common Stock will be allowed to vote separately on each of them at the Special Meeting, including by virtue of the proxy solicited hereby.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Please see the section titled &#8220;<i style="font-style:italic;">The Charter Amendment Proposal</i>.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights does not currently anticipate amending or restating the Bylaws of Data Knights in connection with the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">The Nasdaq Proposal</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is proposing that its stockholders vote to approve, for purposes of complying with Nasdaq Listing Rules&#160;5635(a)&#160;and (b), the issuance of more than 20% of the issued and outstanding Class&#160;A common stock and the resulting change in control in connection with the Business Combination.</p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">The Incentive Plan Proposal</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is proposing that its stockholders approve and adopt the 2022 Equity Incentive Plan (the &#8220;<b style="font-weight:bold;">Equity Incentive Plan</b>&#8221;), which will become effective upon the Closing of the Business Combination and have the following principal features:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">provides for the creation of a Committee of at least two people, as may be appointed by the Board of Directors of OneMedNet, to administer the Equity Incentive Plan (if no such Committee is formed, then the plan will be administered by the Board of Directors of OneMedNet);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">empowers the Committee to grant, from time to time, Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Stock Bonus Awards and/or Performance Compensation Awards to Eligible Persons, as defined in the Equity Incentive Plan, subject to certain conditions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">eligibility for participation in the Equity Incentive Plan is limited to Eligible Persons who entered into an Award Agreement or who received written notification from the Committee, or in its absence, the Board of Directors of OneMedNet, or from a person designated by the same, that they have been selected to participate in the Equity Incentive Plan;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">requires that each Option, Stock Appreciation Right, Restricted Stock, and Restricted Stock Units granted under the Equity Incentive Plan be evidenced by an Award Agreement;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">specifies that all Options be Nonqualified Stock Options unless the applicable Award Agreement expressly states that the Option is intended to be an Incentive Stock Option. Incentive Stock Options shall be granted only to Eligible Persons who are employees of the Company and its Affiliates, and no Incentive Stock Option be granted to any Eligible Person who is ineligible to receive an Incentive Stock Option under the Code. The exercise price per Common Share for each Option to be no less than 100% of the Fair Market Value of such share determined as of the Date of Grant. Under the Equity Incentive Plan Options vest and become exercisable in such manner and on such date or dates determined by the Committee and expire after such period, not to exceed ten&#160;years, as may be determined by the Committee;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">notes that any Option granted under the Equity Incentive Plan may include tandem Stock Appreciation Rights, and the Committee may award Stock Appreciation Rights to Eligible Persons independent of any Option;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">stipulates that Stock Appreciation Right granted in connection with an Option shall become exercisable and shall expire according to the same vesting schedule and expiration provisions as the corresponding Option. Upon the exercise of a Stock Appreciation Right, the Company shall pay to the Participant an amount equal to the number of shares subject to the Stock Appreciation Right that are being exercised multiplied by the excess, if any, of the fair market value of one Common Share on the exercise date over the Strike Price, less an amount equal to any taxes required to be withheld or paid. The Company shall pay such amount in cash, in Data Knights Common Stock valued at fair market value, or any combination thereof, as determined by the Committee;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">authorizes the Committee to issue, in connection with Stock Bonus Awards, unrestricted Data Knights Common Stock either alone or in tandem with other awards in such amounts as the Committee may determine in its sole discretion; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">authorizes the Committee to grant Performance Compensation Awards in the shape of cash bonuses subject to certain performance criteria further set out in the Equity Incentive Plan.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Plan is set forth in the &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">The Equity Incentive Plan Proposal</i><span style="font-family:'Times New Roman','Times','serif';">&#8221; section of this proxy statement/prospectus and a complete copy of the Equity Incentive Plan is attached to this proxy statement/prospectus as </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex D</i><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">The Election of Directors Proposal</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights is proposing that its stockholders vote to elect nine directors to serve staggered terms on the New OneMedNet board of directors until the 2023, 2024 and 2025 annual meeting of stockholders of the New OneMedNet, respectively, or until their respective successors are duly elected and qualified, or until each director&#8217;s earlier death, resignation, retirement, or removal. A summary of the Election of Directors Proposal is set forth in the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Proposal No.&#160;5&#8201;&#8212;&#8201;The Election of Directors Proposal</i><span style="font-family:'Times New Roman','Times','serif';">&#8221; of this proxy statement/prospectus.</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">The Adjournment Proposal</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights stockholders will be asked to consider and vote upon a proposal to adjourn the Special Meeting to a later date or dates if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the NTA Proposal, the Business Combination Proposal, the Charter Amendment Proposal, the Nasdaq Proposal, or the Incentive Plan Proposal. Please see the section titled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Proposal No.&#160;6 &#8212; The Adjournment Proposal</i><span style="font-family:'Times New Roman','Times','serif';">.&#8221;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Interests of Data Knights&#8217; Directors and Officers and Others in the Business Combination.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The Data Knights Board has adopted and approved the Merger Agreement. In arriving at its recommendations, the Data Knights Board carefully considered a number of factors described in this proxy statement/prospectus. Please see section entitled &#8220;<i style="font-style:italic;">The Business Combination Proposal &#8212; The Board&#8217;s Reasons for Approval of the Business Combination.</i>&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">When you consider the recommendation of the Data Knights Board in favor of approval of the Proposals, you should keep in mind that the Sponsor (including certain members of the Sponsor) and certain of Data Knights&#8217; directors and executive officers may have interests in the Business Combination that are different from or in addition to (and&#160;which may conflict with) your interests as a stockholder. These interests include, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">unless Data Knights consummates an initial business combination, Data Knights&#8217; officers, directors and the Sponsor will not receive reimbursement for any out-of-pocket expenses incurred by them to the extent that such expenses exceed the amount of available proceeds not deposited in the Trust Account;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">as a condition to the Data Knights IPO, all of the Founder Shares are subject to a lock-up and would be released only if specified conditions were met. In particular, subject to certain limited exceptions, all Founder Shares would be subject to a lock up until the earlier of (A)&#160;six&#160;months after the completion of Data Knights&#8217; Business Combination and (B)&#160;subsequent to the Business Combination, (x)&#160;if the closing price of the Class&#160;A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading&#160;days within any 30-trading day period commencing at least 150&#160;days after the Business Combination or (y)&#160;the date on which Data Knights completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of Class&#160;A Common Stock for cash, securities or other property;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Placement Units, purchased by the Sponsor will be worthless if a business combination is not consummated;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Sponsor has agreed that the Placement Units and the underlying securities, will not be sold or transferred by it until after Data Knights has completed a business combination, subject to limited exceptions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that Sponsor paid an aggregate of $25,000 for its Founder Shares and such securities will have a significantly higher value at the time of the Business Combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that Sponsor has agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if Data Knights does not complete an initial business combination by August 11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension, the proceeds from the sale of the Placement Units will be included in the liquidating distribution to Data Knights&#8217; Public Stockholders and the Placement Units will expire worthless; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the Trust Account is liquidated, including in the event Data Knights is unable to complete an initial business combination within the required time period, the Sponsor has agreed to indemnify Data Knights to ensure that the proceeds in the Trust Account are not reduced below $10.20 per Public Share by the claims of prospective target businesses with which Data Knights has entered into an acquisition agreement or claims of any third party for services rendered or products sold to Data Knights, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The estimated aggregate amount invested by Sponsor and certain of Data Knights&#8217; directors and executive officers in their interests in Data Knights is $5,877,750, as detailed in the following tables:</span></td></tr></table><div style="margin-top:10pt;"></div></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Assuming No Further Redemptions</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,875,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">6,139,535</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,852,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 286,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">36,331,060</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">5,877,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assuming 80% Redemptions</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,875,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">6,139,535</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">5,852,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 286,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">36,331,060</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,877,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assuming Maximum Redemptions</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,875,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">6,139,535</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,852,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 286,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">36,331,060</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,877,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">To date, Data Knights&#8217; officers and directors and the Sponsor have not incurred any out-of-pocket expenses subject to reimbursement by Data Knights. The Sponsor had previously requested that the Company extend the date by which the Company has to consummate a business combination to February 11, 2023, and in connection therewith caused an aggregate of $1,150,000 (representing $0.10 per public share) to be deposited into the Company&#8217;s trust account on August 11, 2022, to extend such date to November 11, 2022, and caused an aggregate of $368,758.44 (representing $0.135 per public share) to extend such date to February 11, 2023. Under the terms of its Charter, the Company can extend the date by which it has to consummate a business combination by up to six additional one-month periods, or up to August 11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension. The Company has exercised the monthly extensions through July 11, 2023, and intends to exercise the next extension through August 11, 2023.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">34</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Emerging Growth Company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is currently and, following the consummation of the Business Combination, the Combined Entity will be, an &#8220;emerging growth company,&#8221; as defined in the Securities Act and as modified by the Jumpstart Our Business Startups Act (&#8220;<b style="font-weight:bold;">JOBS Act</b>&#8221;). Data Knights has taken, and the Combined Entity may continue to take, advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002 (&#8220;<b style="font-weight:bold;">Sarbanes-Oxley Act</b>&#8221;), reduced disclosure obligations regarding executive compensation in Data Knights&#8217; periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, stockholders of Data Knights and the Combined Entity may not have access to certain information they may deem important.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. Data Knights has not elected to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, Data Knights (and, following the Business Combination, the Combined Entity), as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of Data Knights&#8217; and the Combined Entity&#8217;s financial statements with certain other public companies difficult or impossible because of the potential differences in accounting standards used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights (and following the Business Combination, the Combined Entity) will remain an emerging growth company until the earliest of: (i)&#160;the last day of the fiscal&#160;year following the fifth anniversary of the closing of the Data Knights IPO, (ii)&#160;the last day of the fiscal&#160;year in which Data Knights (and following the Business Combination, the Combined Entity) has total annual gross revenue of at least $1.07 billion; (iii)&#160;the last day of the fiscal&#160;year in which Data Knights (and following the Business Combination, the Combined Entity) is deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2 under the Exchange Act, which would occur if the market value of Data Knights&#8217; (and following the Business Combination, the Combined Entity&#8217;s) Common Stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such&#160;year; or (iv)&#160;the date on which Data Knights (and following the Business Combination, the Combined Entity) has issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Risk Factors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">In evaluating the Proposals set forth in this proxy statement/prospectus, you should carefully read this proxy statement/prospectus, including the annexes, and especially consider the factors discussed in the section titled &#8220;Risk Factors.&#8221; </i><i style="font-style:italic;">The value of your investment following consummation of the Business Combination will be subject to significant risks affecting, among other things, the Combined Entity&#8217;s business, financial condition or results of operations. If any of the events described below occur, the Combined Entity&#8217;s post-Business Combination business and financial results could be adversely affected in material respects. This could result in a decline, which may be significant, in the trading price of the Combined Entity&#8217;s securities and you therefore may lose all or part of your investment. The risk factors listed below are not necessarily exhaustive and you are encouraged to perform your own investigation with respect to the businesses of Data Knights and OneMedNet. Any reference in this &#8220;Risk Factors&#8221; section to the &#8220;Surviving Entity&#8221; shall mean New OneMedNet.</i></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have a history of operating losses and may never achieve profitability in the future.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have two significant customers that represented 31%, 28% and 53%of our revenues for 2020, 2021 and 2022, respectively.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may encounter difficulties in managing our attempted growth of our business, which could negatively impact our operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our recent growth rates may not be sustainable, or indicative of future growth.</span></td></tr></table></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">35</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may be unable to execute our business objectives and growth strategies successfully or sustain our growth and, as a result, this could have a material adverse effect on our operating results.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our technology is important to our success, and our failure to protect our intellectual property rights could put us at a competitive disadvantage.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If OneMedNet is unable to protect its intellectual property, OneMedNet&#8217;s ability to maintain any technological or competitive advantage over its competitors and potential competitors would be adversely impacted, and OneMedNet&#8217;s business may be harmed.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">It is difficult and costly to protect our proprietary rights and as a result we may not be able to ensure their protection. In addition, patents have a limited lifespan and will eventually expire.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our products or processes may infringe the intellectual property rights of others, which may cause us to pay unexpected litigation costs or damages or prevent us from selling our products.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Recent patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Obtaining and maintaining patent protection depends on compliance with various procedural, documentary, fee payment, and other requirements imposed by governmental patent agencies, and patent protection could be reduced or eliminated for noncompliance with these requirements.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we are sued for infringing intellectual property rights of third parties, it will be costly and time consuming, and an unfavorable outcome in any litigation would harm our business.</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The projects and forecasts presented in the proxy statement/prospectus may not be an indication of the actual results of the transaction or OneMedNet&#8217;s future results.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may be involved in lawsuits to protect or enforce our intellectual property or the intellectual property of our licensors, which could be expensive, time consuming and unsuccessful.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may need to license certain intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may be subject to claims that our employees, independent contractors, or consultants have wrongfully used or disclosed alleged trade secrets of their former employers or other third parties.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may be unable to adequately prevent disclosure of trade secrets and other proprietary information.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We or our licensors may not be able to protect our intellectual property rights throughout the world.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we fail to comply with our obligations under technology agreements with third parties, we may be required to pay damages and we could lose license rights that are critical to our business.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Confidentiality and invention assignment agreements with our employees, advisors and consultants may not adequately prevent disclosure of trade secrets and protect other proprietary information.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Intellectual property rights do not address all potential threats to our competitive advantage.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may face difficulties with protecting our intellectual property in certain jurisdictions, which may diminish the value of our intellectual property rights in those jurisdictions.</span></td></tr></table></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">36</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If OneMedNet fails to comply with federal and state healthcare laws, including health and other information privacy and security laws, we could face substantial penalties and our business, financial condition, results of operations, and prospects could be adversely affected.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in U.S. healthcare law and implementing regulations, as well as changes in healthcare policy, may impact our business in ways that we cannot currently predict and may harm our business and results of operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our future success depends on the continuing efforts of our management team and key employees, and on our ability to attract and retain highly skilled personnel and senior management.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We are subject to many hazards and operational risks that can disrupt our business, some of which may not be insured or fully covered by insurance.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our business could be adversely affected by an accident, a safety incident or a workforce disruption.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have a several key stockholders, which may limit our ability to influence corporate matters and may give rise to conflicts of interest.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our business could be adversely affected by the military conflict in Ukraine.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may engage in merger and acquisition activities, which could require significant management attention, disrupt our business, dilute stockholder value and adversely affect our results of operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Security breaches, loss of data and other disruptions could compromise sensitive information related to our business, prevent us from accessing critical information or expose us to liability, which could adversely affect our business and our reputation.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">An active market for New OneMedNet&#8217;s securities may not develop, which would adversely affect the liquidity and price of New OneMedNet&#8217;s securities.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Nasdaq may delist New OneMedNet&#8217;s securities from trading on its exchange, which could limit investors&#8217; ability to make transactions in New OneMedNet&#8217;s securities and subject New OneMedNet to additional trading restrictions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The market price of New OneMedNet&#8217;s common stock may decline as a result of the Business Combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Because there are no current plans to pay cash dividends on the New OneMedNet common stock for the foreseeable future, you may not receive any return on investment unless you sell your New OneMedNet common stock at a price greater than what you paid for it.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">New OneMedNet stockholders may experience dilution in the future.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If securities or industry analysts do not publish research or reports about New OneMedNet&#8217;s business, if they change their recommendations regarding New OneMedNet common stock or if New OneMedNet&#8217;s operating results do not meet their expectations, the New OneMedNet common stock price and trading volume could decline.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Future sales, or the perception of future sales, by New OneMedNet or its stockholders in the public market following the Business Combination could cause the market price for New OneMedNet common stock to decline.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">New OneMedNet may redeem unexpired Public Warrants prior to their exercise at a time that is disadvantageous for Data Knights warrant holders.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Certain provisions of New OneMedNet&#8217;s amended and restated certificate of incorporation could have a material adverse effect on the rights of holders of its Common Stock.</span></td></tr></table></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">37</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights has no operating history and is subject to a mandatory liquidation and subsequent dissolution requirement. If Data Knights is unable to consummate a business combination, including the Business Combination, its public stockholders may be forced to wait until August 11, 2023 before receiving distributions from the Trust Account.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights&#8217; independent registered public accounting firm&#8217;s report contains an explanatory paragraph that expresses substantial doubt about its ability to continue as a &#8220;going concern.&#8221;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights has identified a material weakness in its internal control over financial reporting. This material weakness could continue to adversely affect its ability to report its results of operations and financial condition accurately and in a timely manner.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If Data Knights does not consummate a business combination by August 11, 2023, Data Knights will have to cease all operations except for the purpose of winding up and redeeming all of its public units for their pro rata portions of the Trust Account and liquidate or seek approval of its stockholders to extend the termination date.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights and OneMedNet are expected incur significant transaction and transition costs in connection with the Business Combination. If the parties fail to consummate the Business Combination, Data Knights may not have sufficient cash available to pay such costs.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The working capital available to Data Knights after the Business Combination will be reduced to the extent Data Knights&#8217; stockholders exercise their redemption rights in connection with the Business Combination and will also be reduced to the extent of Data Knights&#8217; and OneMedNet&#8217;s transaction expenses, which will be payable by the Combined Entity. This may adversely affect the business and future operations of Data Knights.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The unaudited pro forma financial information included in this proxy statement/prospectus may not be indicative of what the actual financial position or results of operations of the Combined Entity would have been.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">During the pendency of the Business Combination, Data Knights will not be able to enter into a business combination with another party because of restrictions in the Merger Agreement. Furthermore, certain provisions of the Merger Agreement will discourage third parties from submitting alternative takeover proposals, including proposals that may be superior to the arrangements contemplated by the Merger Agreement.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If the conditions to the Merger Agreement are not met, the Business Combination may not occur.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights may waive one or more of the conditions to the Business Combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Sponsor, directors and officers of Data Knights may have conflicts of interest in determining to pursue the Business Combination with OneMedNet, since certain of their interests, and certain interests of their affiliates and associates, are different from or in addition to (and which may conflict with) the interests of Data Knights&#8217; stockholders.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The value of the Founder Shares following completion of the Business Combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of the Data Knights Common Stock at such time is substantially less than $10.00 per share.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Because Data Knights is not conducting an underwritten offering of OneMedNet&#8217;s securities, no underwriter has conducted due diligence of OneMedNet&#8217;s business, operations or financial condition or reviewed the disclosure in this proxy statement/prospectus.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Nasdaq may delist Data Knights&#8217; securities from trading on its exchange, which could limit investors&#8217; ability to make transactions in Data Knights&#8217; securities and subject Data Knights to additional trading restrictions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Public stockholders exercising their redemption rights with respect to the public units sold in Data Knights&#8217; IPO will forfeit the portion of warrants included in the units without the payment of any additional consideration.</span></td></tr></table></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">38</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If third parties bring claims against Data Knights, the proceeds held in trust could be reduced and the per-unit redemption price received by stockholders may be less than $10.20.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights&#8217; stockholders may be held liable for claims by third parties against us to the extent of distributions received by them.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights&#8217; directors may decide not to enforce the Sponsor&#8217;s indemnification obligations, resulting in a reduction in the amount of funds in the Trust Account available for distribution to its public stockholders.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In connection with any vote to approve a business combination, Data Knights will offer each public stockholder the option to vote in favor of the Business Combination and still seek redemption of their units.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In connection with the stockholder meeting called to approve the Business Combination, Data Knights may require stockholders who wish to redeem their units in connection with the Business Combination to comply with specific requirements for redemption that may make it more difficult for them to exercise their redemption rights prior to the deadline for exercising their rights.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If, in connection with the stockholder meeting called to approve the Business Combination, Data Knights requires public stockholders who wish to redeem their units to comply with specific requirements for redemption, such redeeming stockholders may be unable to sell their securities when they wish to in the event that the proposed business combination is not approved.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If Data Knights does not file and maintain a current and effective prospectus relating to the common stock issuable upon exercise of the warrants, holders will only be able to exercise such warrants on a &#8220;cashless basis.&#8221;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights&#8217; ability to successfully effect the Business Combination and successfully operate the business thereafter will be largely dependent upon the efforts of certain key personnel, including the key personnel of OneMedNet, all of whom are expected to stay with Data Knights following the Business Combination. The loss of such key personnel could negatively impact the operations and profitability of the post-combination business.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If the Business Combination&#8217;s benefits do not meet the expectations of investors, stockholders or financial analysts, the market price of Data Knights&#8217; securities may decline.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights&#8217; public stockholders may experience dilution as a consequence of, among other transactions, the issuance of Data Knights Common Stock as consideration in the Business Combination and the assumption of debt, if convertible into equity. Having a minority share position may reduce the influence that Data Knights&#8217; current stockholders have on the management of Data Knights.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights&#8217; Sponsor, directors and officers have agreed to vote in favor of its initial business combination, regardless of how Data Knights&#8217; public stockholders vote.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Following the Closing of the Business Combination, Data Knights may be required to take write-downs or write-offs, restructuring and impairment or other charges that could adversely affect its financial condition, results of operations and stock price, which could cause you to lose some or all of your investment.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Warrants will become exercisable for Data Knights Common Stock, which would increase the number of shares eligible for future resale in the public market and result in dilution to Data Knights&#8217; stockholders.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Activities taken by affiliates of Data Knights to purchase, directly or indirectly, public units will increase the likelihood of approval of the Business Combination Proposal and other proposals and may affect the market price of Data Knights&#8217; securities during the buyback period.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Since Data Knights&#8217; Sponsor, officers, directors, and their respective affiliates will lose their entire investment in Data Knights if the Business Combination is not completed, they may have had a conflict of interest in identifying and selecting OneMedNet for Data Knights&#8217; initial business combination in order to close the Business Combination.</span></td></tr></table></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">39</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">There is no assurance that Data Knights&#8217; due diligence will reveal all material risks that may be present with regard to OneMedNet, thus, following the Business Combination, Data Knights may be required to take write- downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on its financial condition and its share price, which could cause you to lose some or all of your investment.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Since Data Knights&#8217; Sponsor, executive officers and directors will not be eligible to be reimbursed for their out-of-pocket expenses if the Business Combination is not completed, a conflict of interest may arise in determining whether OneMedNet is appropriate for Data Knights&#8217; initial business combination in order to close the Business Combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The ability to execute Data Knights&#8217; strategic plan could be negatively impacted to the extent a significant number of stockholders choose to redeem their units in connection with the Business Combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If Data Knights stockholders fail to comply with the redemption requirements specified in this proxy statement/prospectus, they will not be entitled to redeem their units for a pro rata portion of the funds held in Data Knights&#8217; Trust Account.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The ability to execute Data Knights&#8217; strategic plan could be negatively impacted to the extent a significant number of stockholders choose to redeem their units in connection with the Business Combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If Data Knights stockholders fail to comply with the redemption requirements specified in this proxy statement/prospectus, they will not be entitled to redeem their units for a pro rata portion of the funds held in Data Knights&#8217; Trust Account.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">40</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><a id="_e85a3937_e770_40dc_becf_4f79b1b014f4"></a><a id="CAUTIONARYNOTEREGARDINGFORWARDLOOKINGSTA"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">CAUTIONARY NOTE&#160;REGARDING FORWARD-LOOKING STATEMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain statements herein may constitute &#8220;forward-looking statements&#8221; for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team&#8217;s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not historical facts and are based upon estimates and assumptions that, while considered reasonable by Data Knights and its management, and OneMedNet and its management, as the case may be, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any subsequent definitive agreements with respect to the proposed business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the outcome of any legal proceedings that may be instituted against Data Knights, OneMedNet, the Combined Entity or other following the announcement of the proposed business combination and any definitive agreements with respect thereto;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the inability to complete the proposed business combination due to the failure to obtain approval of the stockholders of Data Knights, to obtain financing to complete the proposed business combination or to satisfy other conditions to closing;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the ability to meet stock exchange listing standards following the consummation of the proposed business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes to the proposed structure of the proposed business combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the proposed business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the risk that the proposed business combination disrupts current plans and operations of Data Knights or OneMedNet as a result of the announcement and consummation of the proposed business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the ability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, competition and the ability of the Combined Entity to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management, key employees, directors or partners;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">costs related to the proposed business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in applicable laws or regulations and delays in obtaining, adverse conditions contained in, or the inability to obtain regulatory approvals required to complete the proposed business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet&#8217;s ability to execute its business plans and strategy;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the inability to develop and maintain effective internal controls;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">general economic conditions and geopolitical uncertainty; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">other risks and uncertainties indicated from time to time in the final prospectus of Data Knights, including those under &#8220;Risk Factors&#8221; therein, and other documents filed or to be filed with the Securities and Exchange Commission (&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">SEC</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;) by Data Knights.</span></td></tr></table><div style="margin-top:12pt;"></div></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">41</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There may be additional risks that Data Knights presently does not know or that Data Knights currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements provide Data Knights&#8217; expectations, plans or forecasts of future events and views as of the date of this communication. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the section of this prospectus entitled &#8220;Risk Factors.&#8221; Data Knights anticipates that subsequent events and developments will cause Data Knights&#8217; assessments to change. However, while Data Knights may elect to update these forward-looking statements at some point in the future, Data Knights specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Data Knights&#8217; assessments as of any date subsequent to the date of this communication.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">42</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><a id="_88a84cb4_b03d_4d52_8967_b42eff5d57b3"></a><a id="SELECTEDFINANCIALANDOTHERDATAOFDATAKNIGH"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SELECTED FINANCIAL AND OTHER DATA OF DATA KNIGHTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Selected Historical Financial Information of Data Knights</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following tables show selected historical financial information for Data Knights and should be read in conjunction with Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of Data Knights incorporated by reference herein and the unaudited interim and audited financial statements of Data Knights, and the notes and schedules related thereto, which are included elsewhere in this proxy statement/prospectus.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">This proxy statement/prospectus contains the historical financial statements of Data Knights. The balance sheet data as of March&#160;31, 2023, and statement of operations data for the three month period ended March 31, 2023 and year ended December 31, 2022 are derived from Data Knights&#8217; audited and unaudited financial statements included elsewhere in this proxy statement/prospectus.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The historical results presented below are not necessarily indicative of the results to be expected for any future period.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">STATEMENTS OF OPERATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Period&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">ended&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">March&#160;31,&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">2023&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">ended&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">December&#160;31,&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">2022</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Audited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Formation and operating costs</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">306,303</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,103,731</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Franchise tax expenses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">47,481</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">205,560</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Loss from Operations</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(353,784)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(5,309,291)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Other Income (Expenses)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Realized and unrealized gain</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">327,399</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,371,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Change in fair value of warrant liabilities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,489,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Non-operating expense</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Net Income (loss)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(85,983)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">336,658</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Weighted average shares outstanding of Class A Common Stock subject to redemption</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;border-bottom:1px solid #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,731,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-bottom:1px solid #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-bottom:1px solid #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8,667,969</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Basic and diluted net income (loss) per common stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(0.01)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">0.03</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Weighted average shares outstanding of Class A and Class B non-redeemable common stock</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;border-bottom:1px solid #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,838,792</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-bottom:1px solid #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-bottom:1px solid #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3,464,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Basic and diluted net income (loss) per common stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(0.01)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">0.03</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">43</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">STATEMENTS OF CASH FLOWS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Period&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Ended&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">March&#160;31,&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">2023</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Ended&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">December&#160;31,&#160;</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">2022</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Audited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Cash flows from operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Net (loss) income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(85,983)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">336,658</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 11.5pt;">Adjustments to reconcile net income to net cash used in operating activities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 23.75pt;">Offering costs allocated to warrant liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 23.75pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2,825,960</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 23.75pt;">Realized and unrealized gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(327,399)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(1,371,689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 23.75pt;">Change in fair value of warrant liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(4,489,110)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 11.5pt;">Changes in operating assets and liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 23.75pt;">Prepaid expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">83,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 23.75pt;">Accrued expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">253,841</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1,553,849</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 23.75pt;">Franchise tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">47,481</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(94,042)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 23.75pt;">Income tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">59,598</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">214,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Net cash used in operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(52,462)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(940,463)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Investment of cash in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(368,760)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(2,545,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Interest withdrawn from Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">299,601</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Net cash used in investing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">(368,760)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(2,246,237)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Proceeds from working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">32,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">207,081</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Amount due to related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">(300)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">11,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Proceeds from extension loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">368,760</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2,545,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;"><b style="font-weight:bold;">Net cash provided by financing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">400,460</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">2,764,419</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Net change in cash</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">(20,762)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(422,281)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Cash at the beginning of the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">30,870</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">453,151</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Cash at the end of the period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.5%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">10,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">30,870</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Supplemental disclosure of non-cash financing activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Change in value of common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">3,359,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Redemption of Class A common stock held in Trust, including interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">91,909,483</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:68.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Re-measurement of Class A common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:12.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(583,570)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:12.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">44</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">BALANCE SHEETS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,</b><br/><b style="font-weight:bold;">2023</b><br/><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,</b><br/><b style="font-weight:bold;">2022</b><br/><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Current Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,108</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,870</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Current Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">10,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">30,870</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,725,574</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,029,416</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">29,735,682</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">29,060,286</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">LIABILITIES AND STOCKHOLDER&#8217;S DEFICIT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Accrued expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,933,661</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,679,821</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Amount due to related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">11,200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">11,500</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Income tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">274,448</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">214,850</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Franchise tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">117,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">69,966</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Current Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2,336,756</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,976,137</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Warrant liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">362,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">362,558</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Deferred underwriter fee payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,025,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,025,000</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Related Party Working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">239,081</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">207,081</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Extension loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,914,598</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,545,838</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">9,877,993</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">9,116,614</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Commitments and Contingencies</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Class&#160;A Common Stock subject to possible redemption; 2,731,544 shares at redemption value of $10.74 and $10.53 per share as of March&#160;31, 2023 and December&#160;31, 2022, respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,333,680</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">28,750,110</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stockholders&#8217; Deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at March 31, 2023 and December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Class&#160;A Common Stock, $0.0001 par value; 100,000,000 shares authorized; 585,275 shares issued and outstanding, excluding 2,731,544 shares subject to redemption as of March&#160;31, 2023 and December&#160;31, 2022, respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">59</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Class&#160;B Common Stock, par value $0.0001; 10,000,000 shares authorized; 4,253,517 issued and outstanding as of March&#160;31, 2023 and December&#160;31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">425</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">425</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Additional paid-in capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,242,253</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,242,253</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(11,718,728)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(11,632,745)</p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 14.4pt;"><b style="font-weight:bold;">Total Stockholders&#8217; Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(9,475,991)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(8,806,438)</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Liabilities, redeemable common stock and Stockholders&#8217; Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">29,735,682</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.96%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">29,060,286</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">45</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><a id="_d88e98bf_6bd7_4769_ad76_f26b93e4809a"></a><a id="SELECTEDFINANCIALANDOTHERDATAOFONEMEDNET"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SELECTED</b><b style="font-weight:bold;"> FINANCIAL AND OTHER DATA OF ONEMEDNET</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Selected Historical Consolidated Financial Information of OneMedNet</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following tables show selected historical consolidated financial information for OneMedNet&#8217;s business and should be read in conjunction with &#8220;<i style="font-style:italic;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of OneMedNet</i>&#8221; and the unaudited interim and audited consolidated financial statements of OneMedNet, and the notes and schedules related thereto, which are included elsewhere in this proxy statement/prospectus.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">This proxy statement/prospectus contains the historical consolidated financial statements of OneMedNet. The balance sheet data as of March 31, 2023, and statement of operations data for the three month period ended March 31, 2023 and the year ended December 31, 2022 are derived from OneMedNet&#8217;s audited consolidated financial statements included elsewhere in this proxy statement/prospectus.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The historical results presented below are not necessarily indicative of the results to be expected for any future period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Period Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Statement of Operation Data:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenue, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 199,614</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,152,738</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of goods sold</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (289,130)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,513,428</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross profit (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (89,516)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (360,690)</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">General and administrative.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 642,568</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,446,329</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 39,269</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 398,760</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 259,270</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 957,690</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 329,463</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 952,701</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,270,570</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,755,480</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1,360,086)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (6,116,170)</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other income (expense)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest expense, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 149,359</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 403,307</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other income (expense)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7,817</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 46,820</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income (Loss) before income tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 157,176</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 450,127</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.64%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1,517,262)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (6,566,297)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">46</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Current Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Cash and cash equivalents</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,085</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">270,859</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Accounts receivable, net of allowance (2023 $0 and 2022 $102,700)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">134,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">18,975</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Prepaid expenses and other assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">126,647</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">100,945</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">SPAC IPO Costs</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,098,369</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">900,152</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Total current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,505,021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,290,931</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Property and Equipment, Net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">76,839</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">83,097</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Total assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,581,860</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,374,028</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:0.2pt;">Liabilities and Stockholders&#8217; Equity (Deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:0.2pt;">Current Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Accounts payable &amp; accrued expenses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,404,313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,134,752</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Deferred revenues</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">156,287</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">183,683</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Convertible promissory notes</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">9,565,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8,490,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">11,125,600</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">9,808,435</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Long Term Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Convertible promissory notes</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,500,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,500,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Canada Emergency Business Loan Act</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">43,853</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">44,144</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Accrued interest, related party</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">840,131</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">690,772</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">13,509,584</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">12,043,351</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Stockholders&#8217; Equity (Deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Preferred Series A-2, par value $0.0001, 4,200,000 shares authorized and 3,853,797 shares issued and outstanding as of March 31, 2023 and December 31, 2022</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">385</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Preferred Shares A-1, par value $0.0001, 4,400,000 shares authorized and, 3,204,000 shares issued and outstanding as of March 31, 2023 and December 31, 2022</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">320</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">320</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Common Stock, par value $0.0001, 30,000,000 shares authorized, and 4,550,166</span> <span style="letter-spacing:0.2pt;">shares issued and outstanding as of March 31, 2023 and December 31, 2022</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">455</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Additional paid in capital</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">21,465,599</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">21,206,738</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Accumulated deficit</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(33,394,483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(31,877,221)</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Total stockholders&#8217; equity (deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(11,927,724)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(10,669,323)</p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">Total liabilities and stockholders&#8217; equity (deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,581,860</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,374,028</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">47</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><a id="_5f249995_dd02_4e60_a5ef_03cf58377d76"></a><a id="Unaudited"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">UNAUDITED</b><b style="font-weight:bold;"> PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Defined terms included below shall have the same meaning as terms defined and included elsewhere in this proxy statement/prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Introduction</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following unaudited pro forma condensed combined financial statements of Data Knights present the combination of the historical financial information of Data Knights and OneMedNet adjusted to give effect for the Business Combination. The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article&#160;11 of Regulation S-X.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The unaudited pro forma condensed combined balance sheet as of March 31, 2023 combines the historical balance sheet of Data Knights and the historical balance sheet of OneMedNet as of March 31, 2023, on a pro forma basis as if the Business Combination and related transactions, summarized below, had been consummated on March 31, 2023.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The unaudited pro forma condensed combined statement of operations for the three months ended March 31, 2023 and the&#160;year ended December&#160;31, 2022, combines the historical statements of operations of Data Knights and OneMedNet for such period on a pro forma basis as if the Business Combination and related transactions had been consummated on January&#160;1, 2022, the beginning of the earliest period presented.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The unaudited pro forma condensed combined financial statements have been developed from and should be read in conjunction with:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the accompanying notes to the unaudited pro forma condensed combined financial statements;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the historical unaudited financial statements of Data Knights as of and for the three months ended March 31, 2023 and the&#160;historical audited financial statements for the year ended December&#160;31, 2022, and the related notes thereto, included elsewhere in this proxy statement/prospectus;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the historical unaudited financial statements of OneMedNet as of and the three months ended March 31, 2023 and the historical audited financial statements for the&#160;year ended December&#160;31, 2022, and the related notes thereto, included elsewhere in this proxy statement/prospectus; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the sections entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of Data Knights</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; and &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of OneMedNet,</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; and other financial information relating to Data Knights and OneMedNet included elsewhere or incorporated by reference in this proxy statement/prospectus, including the Merger Agreement.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The unaudited pro forma condensed combined financial information has been presented for illustrative purposes only and does not necessarily reflect what the Combined Entity&#8217;s financial condition or results of operations would have been had the Business Combination occurred on the dates indicated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, the unaudited pro forma condensed combined financial information also may not be useful in predicting the future financial condition and results of operations of the Combined Entity. The actual financial position and results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors. The unaudited transaction accounting adjustments represent management&#8217;s estimates based on information available as of the date of this unaudited pro forma condensed combined financial information and are subject to change as additional information becomes available and analyses are performed. Assumptions and estimates underlying the unaudited pro forma adjustments set forth in the unaudited pro forma condensed combined financial statements are described in the accompanying notes. The Combined Entity believes that its assumptions and methodologies provide a reasonable basis for presenting all of the significant effects of the Business Combination based on information available to management at this time and that the transaction accounting adjustments give appropriate effect to those assumptions and are properly applied in the unaudited pro forma condensed combined financial information.</p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">48</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Description of Transaction</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April&#160;25, 2022, Data Knights, Data Knights Merger Sub,&#160;Inc., a Delaware corporation (&#8220;<b style="font-weight:bold;">Merger Sub</b>&#8221;), and Data Knights, LLC, the Company&#8217;s sponsor (the &#8220;<b style="font-weight:bold;">Sponsor</b>&#8221;), entered into a definitive Agreement and Plan of Merger (the &#8220;<b style="font-weight:bold;">Merger Agreement</b>&#8221;) with OneMedNet (together with the Company and Merger Sub, the &#8220;<b style="font-weight:bold;">Parties</b>&#8221;) and Paul Casey, as seller representative (&#8220;<b style="font-weight:bold;">Casey</b>&#8221;). Pursuant to the Merger Agreement, upon the closing (the &#8220;<b style="font-weight:bold;">Closing</b>&#8221;) of the Business Combination, the Parties will effect the merger of Merger Sub with and into OneMedNet, with OneMedNet continuing as the surviving entity (the &#8220;<b style="font-weight:bold;">Merger</b>&#8221;), as a result of which all of the issued and outstanding capital stock of OneMedNet shall be exchanged for shares of the Class&#160;A Common Stock of the Company upon the terms set forth in the Merger Agreement. Per the Merger Agreement all of the issued and outstanding capital stock of OneMedNet shall be exchanged shares of the Class&#160;A Common Stock of Data Knights. OneMedNet&#8217;s shareholders collectively shall be entitled to receive from Data Knights, in the aggregate, a number of Data Knights&#8217; securities with an aggregate value equal to $200,000,000, subject to certain adjustments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the existing Data Knights Charter, public stockholders are being offered the opportunity to redeem, upon the Closing, shares of Data Knights common stock then held by them for cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account (as of two business&#160;days prior to the Closing). The unaudited pro forma condensed combined information contained herein assumes that Data Knights stockholders approve the Business Combination. Data Knights&#8217; public stockholders may elect to redeem their common stock for cash even if they approve the Business Combination. Data Knights cannot predict how many of its stockholders will exercise their right to have their shares redeemed for cash.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">At the Closing of the Business Combination, the Combined Entity expects to have approximately $29.7 million cash proceeds from the Trust Account, assuming there are no further redemptions plus $1.5 million from the PIPE. The aggregate transaction expenses of approximately $4.2 million will be paid at closing, including the remaining deferred underwriting commission of $1,000,000, which will be paid as follows (i) $500,000 at closing and (ii) $500,000 over six payments from October 2023 through March 2024. This will result in a pro forma cash of approximately $27.5 million at Closing. If there is substantially less in the Trust Account than anticipated at the Closing of the Business Combination, then the Combined Entity expects to issue and sell Combined Entity Common Stock in connection with additional PIPE investments after Closing to pay certain of its aggregate transaction expenses at Closing and the balance of expenses over time from additional PIPE investments and from operating revenue.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For illustrative purposes, the unaudited pro forma condensed combined financial information has been prepared assuming two alternative levels of additional redemptions of Data Knights common stock:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Assuming Minimum Additional Redemptio</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ns (&#8220;Minimum Redemption&#8221;) &#8212; this scenario assumes that no additional shares of Data Knights common stock are redeemed; and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Assuming Maximum Redemptions</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (&#8220;Maximum Redemption&#8221;)&#160;&#8212; This scenario assumes the redemption of approximately 2,731,544 shares of Data Knights Common Stock at $10.88 per share, for aggregate payment of approximately $29.7 million from the Trust Account.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The public stockholder redemptions are expected to be within the parameters described by the above two scenarios. However, there can be no assurance regarding which scenario will be closest to the actual results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Business Combination between Data Knights and OneMedNet under both the minimum and maximum redemption scenarios is expected to be accounted for as a reverse recapitalization with OneMedNet as the accounting acquirer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">49</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><a id="_7a641ff5_b3b4_4314_98b5_2677bfc17ba9"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"> </b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">SHEET</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AS OF MARCH 31, 2023</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(in thousands)</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustments</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Combined</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Combined</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OneMedNet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data&#160;Knights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Current assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,726</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,381</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(29,334)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">I</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,047</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1,500</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">J</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(1,000)</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:8.1pt;"><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">135</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">135</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">135</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Prepaid expenses and other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,225</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,225</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,225</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,226</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">31,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(29,334)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,407</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Non-current assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Cash and marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,726</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (29,726)</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Property and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total non-current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,726</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (29,726)</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">77</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">77</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">TOTAL ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,582</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">29,736</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 500</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">31,818</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(29,334)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2,484</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accounts payable and accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,404</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,934</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1,000</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,338</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,338</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Amount due related party</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Income taxes payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">274</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">274</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">274</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Franchise tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">117</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">117</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">117</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Short term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">1,500</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">J</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Deferred revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">156</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">156</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">156</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Convertible promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">9,565</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(9,565)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">K</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">11,125</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,337</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(7,065)</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Non-current liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Canada Energy Business Loan Act</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">45</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">45</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">45</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued interest, related party</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">840</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(400)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">K</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Derivative liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Deferred underwriting fee payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(4,025)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Extension loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,915</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(2,915)</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">L</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">239</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">239</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">239</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Convertible promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(1,500)</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">K</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total non-current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">7,542</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(8,800)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,047</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,047</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">13,510</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">9,879</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(15,945)</b></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">7,444</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">7,444</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">COMMITMENTS AND CONTINGENCIES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Temporary equity:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Class A and Class B common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,334</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(29,334)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Stockholders&#8217; equity (deficit):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Preferred Series A-2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Preferred Series A-1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">F</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">I</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Class A common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">G</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Class B common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">G</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Additional paid-in capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">21,466</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,242</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,333</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">57,765</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(29,333)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">I</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">28,432</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(2)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">F</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(11,719)</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">H</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(1,000)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">2,915</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">L</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">11,505</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">K</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">3,025</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(33,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(11,719)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;">11,719</p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">H</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(33,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;">(33,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total shareholders&#8217; equity (deficit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(11,928)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(9,477)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">45,779</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">24,374</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(29,334)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(4,960)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS&#8217; DEFICIT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,582</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">29,736</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">500</b></p></td><td style="vertical-align:top;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">31,818</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(29,334)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">(2,484)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.36%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">50</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><a id="_561c0ee2_36d7_433f_a782_362db35378e1"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR THE THREE MONTHS ENDED MARCH 31, 2023</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(in thousands, except share and per share data)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:42.68%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:9.24%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:10.08%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:10.87%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:10.89%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.68%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;width:10.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.68%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Combined</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.68%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.68%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum&#160;and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum&#160;and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OneMedNet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data&#160;Knights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.68%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:middle;width:9.24%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:middle;width:10.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:middle;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:middle;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Cost of revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(89)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.08%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(89)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.68%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-top:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Operating costs and expenses:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">353</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.67%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">AA</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,624</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total operating costs and expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.08%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">353</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,624</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Loss from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(1,360)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(353)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(1,000)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(2,713)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.68%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Other income (expense):</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(149)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(23)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">CC</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(172)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Other income (expense)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(500)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(508)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Realized and unrealized gains on Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">327</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(327)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">BB</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total other income (expense)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(157)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">327</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(850)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(680)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Net income (loss) before income tax provision</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(1,517)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(26)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(1,850)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(3,393)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(60)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(60)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:42.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Net income (loss)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:9.24%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(1,517)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.08%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.08%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(86)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.87%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(1,850)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:10.89%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(3,453)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.44%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:59.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.51%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OneMedNet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data&#160;Knights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.51%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:59.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Weighted average shares outstanding - Common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,342,666</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:59.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted net income (loss) per share - Common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(0.33)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:59.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Weighted average shares outstanding - Class&#160;A and Class B common stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,731,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">33,013,786</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,138,477</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:59.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted net income (loss) per share - Class&#160;A and Class B common stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(0.10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(0.11)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:59.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Weighted average shares outstanding - Class A and Class&#160;B non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,838,792</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:middle;width:59.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted net income (loss) per share - Class A and Class&#160;B non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">51</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR THE YEAR ENDED DECEMBER 31, 2022</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(in thousands, except share and per share data)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:11.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma</b></p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustments</b></p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Combined</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum&#160;and</b></p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum&#160;and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OneMedNet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data&#160;Knights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,153</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.53%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,153</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Cost of revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,513</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,513</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(360)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(360)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;"><b style="font-weight:bold;">Operating costs and expenses:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-top:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;border-top:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,755</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,309</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,000</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">AA</p></td><td style="vertical-align:top;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">12,064</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Total operating costs and expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,755</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,309</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,000</p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">12,064</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Loss from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(6,115)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(5,309)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(1,000)</b></p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(12,424)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;"><b style="font-weight:bold;">Other income (expense):</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(403)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(90)</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(493)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Change in fair value of derivative liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,489</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,489</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Other income (expense)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(47)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">(47)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Realized and unrealized gains on Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(1,372)</p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">BB</p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;"><b style="font-weight:bold;">Total other income (expense)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(450)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">5,861</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(1,462)</b></p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3,949</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;"><b style="font-weight:bold;">Net income (loss) before income tax provision</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(6,565)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">552</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(2,462)</b></p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(8,475)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;">Income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(215)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(215)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 1.8pt;"><b style="font-weight:bold;">Net income (loss)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(6,565)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">337</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.37%;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(2,462)</b></p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.53%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(8,690)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.05%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:59.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.51%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OneMedNet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data&#160;Knights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.51%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Historical)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:59.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Weighted average shares outstanding - Common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,342,666</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:59.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted net income per share - Common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(0.68)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:59.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Weighted average shares outstanding - Class A and Class B common stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8,667,969</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">33,013,786</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,138,477</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:59.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted net income per share - Class A and Class B common stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(0.26)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:59.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Weighted average shares outstanding - Class A and Class B non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3,464,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.88%;background:#cceeff;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:59.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted net income per share - Class A and Class B non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.96%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.44%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:2.25pt double #000000;border-top:2.25pt double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:2.25pt double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">52</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><a id="_f602db9e_1515_4d09_98df_e36297a4b08c"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTES&#160;TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Note&#160;1&#160;&#8212; Description of the Merger</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April&#160;25, 2022, Data Knights, Data Knights Merger Sub,&#160;Inc., a Delaware corporation (&#8220;Merger Sub&#8221;), and Data Knights, LLC, the Company&#8217;s sponsor (the &#8220;Sponsor&#8221;), entered into a definitive Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with OneMedNet (together with the Company and Merger Sub, the &#8220;Parties&#8221;) and Paul Casey, as seller representative (&#8220;Casey&#8221;). Pursuant to the Merger Agreement, upon the closing (the &#8220;Closing&#8221;) of the Business Combination, the Parties will affect the merger of Merger Sub with and into OneMedNet, with OneMedNet continuing as the surviving entity (the &#8220;Merger&#8221;), as a result of which all of the issued and outstanding capital stock of OneMedNet shall be exchanged shares of the Class&#160;A Common Stock of the Company upon the terms set forth in the Merger Agreement. Per the Merger Agreement all of the issued and outstanding capital stock of OneMedNet shall be exchanged shares of the Class&#160;A Common Stock of Data Knights. OneMedNet&#8217;s shareholders collectively shall be entitled to receive from Data Knights, in the aggregate, a number of Data Knights&#8217; securities with an aggregate value equal to $200,000,000, subject to certain adjustments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Note&#160;2&#160;&#8212; Basis of Presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The unaudited pro forma condensed combined financial information was prepared in accordance with Article&#160;11 of SEC Regulation S-X as amended by the final rule, Release No.&#160;33-10786 &#8220;Amendments to Financial Disclosures about Acquired and Disposed Businesses.&#8221; The historical financial information of Data Knights and OneMedNet include transaction accounting adjustments to illustrate the estimated effect of the Business Combination and certain other adjustments to provide relevant information necessary for an understanding of the Combined Entity upon consummation of the transactions described herein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Business Combination between Data Knights and OneMedNet under both the minimum and maximum redemption scenarios is expected to be accounted for as a reverse recapitalization with OneMedNet as the accounting acquirer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The unaudited pro forma condensed combined financial information has been prepared using both the Minimum Redemption and Maximum Redemption scenarios with respect to the potential redemption of</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Public Shares into cash. The public stockholder redemptions are expected to be within the parameters described by the two scenarios. However, there can be no assurance regarding which scenario will be closest to the actual results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The unaudited pro forma condensed combined financial information does not reflect the income tax effects of the transaction accounting adjustments as any change in the deferred tax balance would be offset by an increase in the valuation allowance given the Companies&#8217; incurred losses during the historical period presented.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Note&#160;3&#160;&#8212; Transaction Accounting Adjustments to the Data Knights and OneMedNet Unaudited Pro Forma Condensed Combined Balance Sheet as of March 31, 2023</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The transaction accounting adjustments included in the unaudited pro forma condensed combined balance sheet as of March 31, 2023 are as follows:</span></p><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(A)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">Reflects the reclassification of $29.7 million of cash and cash equivalents held in the Trust Account at the balance sheet date that becomes available to fund expenses in connection with the Business Combination or future cash needs of the Company.</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(B)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">Reflects the payment of approximately $1.0 million of deferred underwriting fee and the remainder converted to stock at $10.89 per share.</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(C)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">Represents transaction costs totaling $1.0 million.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">OMN</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">DK</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Total estimated</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 2.9pt 0pt 0pt;"><span style="letter-spacing:0.2pt;">3.2 million</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 2.9pt 0pt 0pt;"><span style="letter-spacing:0.2pt;">1.8 million</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 2.9pt 0pt 0pt;"><span style="letter-spacing:0.2pt;">1.4 million</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Total incurred</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 2.9pt 0pt 0pt;"><span style="letter-spacing:0.2pt;">2.2 million</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 2.9pt 0pt 0pt;"><span style="letter-spacing:0.2pt;">1.1 million</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 2.9pt 0pt 0pt;"><span style="letter-spacing:0.2pt;">1.1 million</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Net</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 2.9pt 0pt 0pt;"><span style="letter-spacing:0.2pt;">1.0 million</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 2.9pt 0pt 0pt;"><span style="letter-spacing:0.2pt;">0.7 million</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 2.9pt 0pt 0pt;"><span style="letter-spacing:0.2pt;">0.3 million</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">53</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(D)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Reflects the reclassification of approximately $29.3 million of Class A shares subject to possible redemption to permanent equity.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">(E)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="color:#231f20;">Reflects the conversion of convertible preferred stock to common stock.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">(F)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">Represents the issuance of 20 million shares of the post-combination company&#8217;s Class&#160;A Common Stock to OneMedNet equity holders as consideration for the reverse recapitalization.</p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(G)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">Reflects the conversion of Class&#160;B </span><span style="font-family:'Times New Roman','Times','serif';">shares </span><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">held by the initial shareholders to Class&#160;A</span><span style="font-family:'Times New Roman','Times','serif';"> shares</span><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">(H)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="color:#231f20;">Reflects the reclassification of Data Knights&#8217; historical accumulated deficit.</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(I)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">Reflects the maximum redemption of 2.7 million shares for $29.3 million.</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">(J)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">$1.5 million PIPE &#8212; 12 month notes with 6% interest.</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(K)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Reflects the conversion of convertibles notes and accrued interest at a rate of $2.50 per share.</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(L)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">Reflects the conversion of Sponsor loans at a rate of $10.00 per share.</span></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Note&#160;4&#160;&#8212; Transaction Accounting Adjustments to the Data Knights and OneMedNet Unaudited Pro Forma Condensed Combined Statement of Operations for the&#160;three months ended March 31, 2023</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The transaction accounting adjustments included in the unaudited pro forma condensed combined statement of operations for the three months ended March 31, 2023 are as follows:</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">(AA) Transaction costs.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">(BB) Elimination of realized and unrealized gains in the trust.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';">(CC) Interest on short debt.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">54</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:17.6pt 4.9% 0pt 4.9%;padding:4pt 0.98% 4pt 0.98%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Note&#160;5&#160;&#8212; Loss Per Share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Net loss per share calculated using the historical weighted average shares outstanding, and the issuance of additional shares in connection with the Business Combination assuming the shares were outstanding since January&#160;1, 2021. As the Business Combination are being reflected as if they had occurred at the beginning of the periods presented, the calculation of weighted average shares outstanding for basic and diluted net loss per share assumes that the shares issuable relating to the Business Combination have been outstanding for the entire period presented. If the maximum number of shares are redeemed, this calculation is retroactively adjusted to eliminate such shares for the entire periods. Warrants have been excluded from the calculation as they are anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The unaudited pro forma condensed combined financial information has been prepared assuming five alternative levels of redemption for the three months ended March 31, 2023 and year ended December 31, 2022:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">33.33%&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">50%&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">66.67%&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OneMedNet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data&#160;Knights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Historical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Historical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Book value per diluted share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">(2.75)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">(1.25)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">(0.16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Weighted average shares outstanding&#8201;&#8211;&#8201;Common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,342,666</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">33,013,786</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">32,056,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">31,576,131</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">31,096,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,138,477</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Basic and diluted net income per share &#8211; Common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.33)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Weighted average shares outstanding - Class A and Class B common stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,731,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Basic and diluted net income per share - Class A and Class B common stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.11)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.11)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.11)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.11)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Weighted average shares outstanding - Class A and Class B non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,838,792</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Basic and diluted net income per share - Class A and Class B non-redeemable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><span style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Weighted average shares outstanding&#8201;&#8211;&#8201;Common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,342,666</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">33,013,786</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">32,056,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">31,576,131</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">31,096,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,138,477</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Basic and diluted net income per share &#8211; Common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">(0.68)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.26)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.27)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.28)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.28)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Weighted average shares outstanding - Class A and Class B common stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8,667,969</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Basic and diluted net income per share - Class A and Class B common stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:8pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Weighted average shares outstanding - Class A and Class B non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3,464,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Basic and diluted net income per share - Class A and Class B non-redeemable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div><div style="margin-left:4.9%;margin-right:4.9%;max-width:100%;padding-left:0.98%;padding-right:0.98%;position:relative;"><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">55</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.2%;border:0;margin:30pt 4.9% 30pt 4.9%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_08705e93_d996_4c6e_99d0_719edcf525c1"></a><a id="RISKFACTORS_551336"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">RISK FACTORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Stockholders should carefully consider the following risk factors, together with all of the other information included in this proxy statement/prospectus, before they decide whether to vote or instruct their vote to be cast to approve the proposals described in this proxy statement/prospectus.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">RISKS RELATED TO ONEMEDNET&#8217;S OPERATIONS AND INDUSTRY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We have a history of operating losses and may never achieve profitability in the future.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have experienced significant recurring operating losses and negative cash flows from operating activities since inception. For example, for the years ended December 31, 2020, 2021 and 2022, we had net losses of approximately $2.8 million, $2.9 million and $6.6 million, respectively. As of December 31, 2022, we had accumulated losses of approximately $31.9 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect to continue to incur significant losses in the development, marketing, sale and delivery of our services. If we do not grow our revenues or if we lose existing customers, we expect to continue to incur losses from operations for the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because of the numerous risks and uncertainties associated with the development, marketing, sale and delivery of our imaging real world data (&#8220;<b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup>&#8221;) services, we may experience larger than expected future losses and may never become profitable. Moreover, there is a substantial risk that we may not be able to successfully commercialize our <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> services, which would make it unlikely that we would ever achieving profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet believes it has demonstrated its quality and responsiveness in clinical imaging and curation of RWD based upon success in compiling one of the largest network of imaging centers (comprised of hospitals, imaging centers and clinics) throughout the United States covering more than 15 million patients to date. On the global front, OneMedNet works with hospitals and life science companies around the world including Ireland, United Kingdom, Ghana, Denmark and South Korea and growing. We base these claims on our understanding of our competition in the United States and globally. However, if we were to lose these relationships with our network of imaging centers or lose our customers or our competitors&#8217; technology surpasses ours, our competitors could claim a greater market share domestically or abroad, which could reduce our growth and our profits, which could harm our business, financial position, results of operations and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Two significant customers represented 31%, 28% and 53% of our revenues for 2020, 2021 and 2022, respectively, and is expected to continue to represent a significant portion of our forecasted revenue for 2023.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Change Healthcare and Siemens Medical Solutions USA, collectively represented 53% and 28% of our revenues in 2022 and 2021, respectively. Change Healthcare and Imaging, LLC, collectively represented 31% of our revenues in 2020. Change Healthcare is expected to continue to represent a significant portion of our forecasted revenue for 2023. If we fail to maintain and grow our relationships with Change Healthcare, we could lose a significant portion of our revenue for 2023, which would materially adversely affect our results of operations and our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Change Healthcare and OneMedNet have a seven-year relationship, which we expect to continue and to grow. Potential growth of this relationship could involve several paths potentially. The first, Change Healthcare continues as a valued customer and partner of OneMedNet in connection to which, Change Healthcare automatically renews its contract every year in March. The second relates to the sale that OneMedNet made in the Country of Ireland three years ago, and began implementation of in 2020, whereby OneMedNet has successfully installed its proprietary BEAM Image Exchange technology in all 46 public hospitals as well as the 24 private hospitals.  Thus, the entire country of Ireland is using OneMedNet&#8217;s BEAM Image Exchange technology. It is anticipated that this relationship will continue well into the future.  The subscription revenue anticipated from this relationship in Ireland is expected to generate approximately $1 million per year for the next four years at a minimum. OneMedNet believes the revenue for BEAM will continue to be flat over the next four years with the exception of volume increases from the clients increasing their image volume and adjustments for inflation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">56</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Siemens Medical Solutions USA and its affiliated entities are new clients of OneMedNet since 2021 (collectively, &#8220;Siemens&#8221;). In 2022, OneMedNet&#8217;s revenue from contracts with Siemens was more than double its revenue earned from contracts with Siemens in 2021. OneMedNet is optimistic to continue to maintain this customer&#8217;s contracts and potential grow it further in 2023 but there can be no assurance of this outcome. If OneMedNet were to lose one or more of its significant customers, its revenue may significantly decline. In addition, revenue from significant customers may vary from period to period depending on the timing of renewing existing agreements or entering into new agreements for additional OneMedNet products as well as other unforeseen risks and variables discussed in this proxy statement/prospectus. The loss of one or more of OneMedNet&#8217;s significant customers could adversely affect its business, results of operations and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">We believe Siemen&#8217;s will continue to demand the highest quality imaging services across numerous therapies, diseases, and disorders. Siemens Healthineers has a large demand for imaging studies to create artificial Intelligence driven algorithms to increase diagnosis precision and accuracy.  OneMedNet has been asked to supply Siemens numerous disease specific studies in the near future including: Chest Radiography &#8211; 4,000+ studies; Brain MRI &#8211; 400 studies; Pelvic MR Imaging &#8211; 500 studies; Training data CR &#8211; 200,000 studies, among others.  We expect the number and size of the orders to grow to fuel Siemens aggressive growth strategy however there can be no assurance of such growth. Failure to continue our relationships with Change Healthcare and Siemens would have a material adverse effect on our business, financial condition and results of operations. You should not rely on our historical relationship with these companies as an indication of our future performance.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">The projections and forecasts presented in this proxy statement/prospectus may not be an indication of the actual results of the transaction or our future results.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">This proxy statement/prospectus contains projections and forecasts prepared by OneMedNet. The projections and forecasts presented in the proxy statement/prospectus may not be an indication of the actual results of the transaction or OneMedNet&#8217;s future results. None of the projections and forecasts included in this proxy statement/prospectus have been prepared with a view toward public disclosure other than to certain parties involved in the Business Combination or toward complying with SEC guidelines or GAAP. The projections and forecasts were prepared based on numerous variables and assumptions, which are inherently uncertain and may be beyond the control of OneMedNet and Data Knights. Important factors that may affect actual results and results of OneMedNet&#8217;s operations following the Business Combination or that could lead to such projections and forecasts not being achieved include, but are not limited to, client demand for OneMedNet&#8217;s solutions and applications, the ability expand services to existing customers and to engage new customers, the timing of client orders and receipt of revenues, regulatory changes, successful management and retention of key personnel, unexpected expenses, and general economic conditions. OneMedNet derives its revenue primarily from through its BEAM(TM) Image Sharing solution and iRWD(TM) offerings and it is hard to predict when an order will be received. Delays in the timing of customer orders can have a large effect on revenues for any calendar quarter or year. While OneMedNet assumes responsibility for the accuracy and completeness of the projections and forecasts to the extent included in this proxy statement/prospectus, we caution you not to place undue reliance on the projections, as the projections may be materially different than actual results.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The projections and forecasts presented in this proxy statement/prospectus have been prepared by OneMedNet&#8217;s management. Investors and others should note that the projections and forecasts have not been independently verified or confirmed by Data Knights or any third party. In particular, none of BF Borgers CPA PC, Marcum LLP, nor any independent accountants, have audited, reviewed, examined, compiled, or applied agreed-upon procedures with respect to the projections and forecasts, and none of them have expressed an opinion or any other form of assurance with respect to the projections and forecasts.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 11pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may encounter difficulties in managing our attempted growth of our business, which could negatively impact our operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 11pt 0pt;">As we expand, market, sell and deliver our service offerings, we anticipate that we will need to increase our service development, sales and marketing and administrative headcount. Such an evolution may impact our strategic focus and our deployment and allocation of resources.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 11pt 0pt;">Our ability to manage our operations and growth effectively depends upon the continual improvement of our procedures, reporting systems and operational, financial and management controls. We may not be able to implement administrative and operational improvements in an efficient or timely manner and may discover deficiencies in existing systems and controls. If we do not meet these challenges, we may be unable to execute our business strategies and may be forced to expend more resources than anticipated addressing these issues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We may acquire additional technology and complementary businesses in the future. Acquisitions involve many risks, any of which could materially harm our business, including the diversion of management&#8217;s attention from core business concerns, failure to </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">57</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 11pt 0pt;">effectively exploit acquired technologies, failure to successfully integrate the acquired business or realize expected synergies or the loss of key employees from either our business or the acquired businesses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 11pt 0pt;">In addition, in order to continue to meet our obligations as a public listed company in both Australia and the United States and to support our anticipated long-term&#160;growth, we will need to increase our general and administrative capabilities. Our management, personnel and systems may not be adequate to support this future growth.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 11pt 0pt;">If we are unable to successfully manage our growth and the increased complexity of our operations, our business, financial position, results of operations and prospects may be harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our recent growth rates may not be sustainable, or indicative of future growth.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">Our historical revenue is extremely low in absolute dollars. While our revenues grew significantly on a&#160;percentage basis from 2020 to 2022, this rate of growth may not be sustainable or indicative of our future rate of growth. We believe that our continued revenue growth, as well as our ability to reach profitability, will depend upon, among other factors, our ability to address the challenges, risks and difficulties described elsewhere in this proxy statement/prospectus. We cannot provide assurance that we will be able to successfully manage any such challenges or risks to our future growth. Any of these factors could cause our revenue growth to decline and may adversely affect our margins and reaching profitability. Failure to continue our revenue growth or improve margins would have a material adverse effect on our business, financial condition and results of operations. You should not rely on our historical rate of revenue growth as an indication of our future performance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may be unable to execute our business objectives and growth strategies successfully or sustain our growth and, as a result, this could have a material adverse effect on our operating results.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The highly complex nature of our industry requires that we effectively execute and manage our business objectives and growth strategies, such as expanding our marketing and commercialization of our services in the U.S. and internationally, adding new customers, and increasing our service delivery capacity. However, we may not be able to execute on these strategies as effectively as anticipated. Our ability to execute on these strategies depends on a number of factors, including, without limitation:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to obtain adequate capital resources to complete execute our growth plans;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to hire, train and retain skilled managers and personnel, including quality and production personnel, and marketing and commercial specialists;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to protect our existing and new services by registering and defending our intellectual property rights; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to successfully add new customers.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the extent we are unable to execute on our growth strategies in accordance with our expectations, this could have a material adverse effect on our business, financial condition, and future results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">RISKS RELATED TO INTELLECTUAL PROPERTY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our technology is important to our success, and our failure to protect our intellectual property rights could put us at a competitive disadvantage.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We rely on the patent trademark, trade secret, and other laws of the United States to protect our proprietary rights. Although we own numerous U.S. patents and have applied for additional patent applications currently and in the past, we cannot assure you that any pending patent applications will issue, or that any patents, issued or pending, will provide us with any competitive advantage or will not be challenged, invalidated or circumvented by third parties. In addition, we rely on confidentiality agreements, governed under U.S. law, with employees, consultants, and the like and take other measures to protect our know-how and trade secrets through secured systems and protocols. The steps we have taken may not prevent unauthorized use of our technology by unauthorized parties or competitors who may copy or otherwise obtain and use these products or technology, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">58</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There is no guarantee that current and former employees, contractors and other parties will not breach their confidentiality agreements with us, misappropriate proprietary information or copy or otherwise obtain and use our information and proprietary technology without authorization or otherwise infringe on our intellectual property rights. Moreover, there can be no assurance that others will not independently develop the know-how and trade secrets or develop better technology than our own, which could reduce or eliminate any competitive advantage we have developed. Our inability to protect our proprietary technology could result in competitive harm that could adversely affect our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Moreover, if we became a party to one or more lawsuits and claims arising in the normal course of business involving intellectual property, the defense of these lawsuits may divert our management&#8217;s attention, and we could incur significant expenses in defending these lawsuits. In addition, we could be required to pay damage awards or settlements, or become subject to injunctions or other equitable remedies, that could have a material adverse effect on our financial condition and results of operations. While we do not believe that any litigation will arise, and no such litigation has arisen, however if such litigation were to arise it may have such an adverse effect.  In addition, the outcome of such litigation, including regulatory matters, is often difficult to predict, and we cannot assure that the outcome of pending or future litigation will not have a material adverse effect on our business, financial condition or results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If OneMedNet is unable to protect its intellectual property, OneMedNet&#8217;s ability to maintain any technological or competitive advantage over its competitors and potential competitors would be adversely impacted, and OneMedNet&#8217;s business may be harmed.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet relies on patent protection as well as trademark, trade secret and other intellectual property rights protection and contractual restrictions to protect OneMedNet&#8217;s proprietary technologies, all of which provide limited protection and may not adequately protect OneMedNet&#8217;s rights or permit OneMedNet to gain or keep any competitive advantage. As of March 31, 2023, OneMedNet owned 11 issued patents and 1 pending patent application. These issued patents and pending patent application (if it were to issue a patent) have expected expiration dates ranging between 2035 and 2041. If OneMedNet fails to protect its intellectual property, third parties may be able to compete more effectively against it, it may lose its technological or competitive advantage, or it may incur substantial litigation costs in its attempts to recover or restrict use of its intellectual property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet cannot assure investors that any of OneMedNet&#8217;s currently pending or future patent applications will result in granted patents, and OneMedNet cannot predict how long it will take for such patents to be granted or whether the scope of such patents, if granted, will adequately protect OneMedNet from competitors. It is possible that, for any of OneMedNet&#8217;s patents that have granted or that may be granted in the future, others will design alternatives that do not infringe upon OneMedNet&#8217;s patented technologies. Further, OneMedNet cannot assure investors that other parties will not challenge any patents granted to OneMedNet or that courts or regulatory agencies will hold OneMedNet&#8217;s patents to be valid or enforceable. OneMedNet cannot guarantee investors that it will be successful in defending challenges made against OneMedNet&#8217;s patents and patent applications. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any successful third-party challenge to OneMedNet&#8217;s patents could result in the unenforceability or invalidity of such patents, or to such patents being interpreted narrowly or otherwise in a manner adverse to OneMedNet&#8217;s interests. OneMedNet&#8217;s ability to establish or maintain a technological or competitive advantage over OneMedNet&#8217;s competitors may be diminished because of these uncertainties. For these and other reasons, OneMedNet&#8217;s intellectual property may not provide OneMedNet with any competitive advantage.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">It is difficult and costly to protect our proprietary rights and as a result we may not be able to ensure their protection. In addition, patents have a limited lifespan and will eventually expire.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Currently, the term of a new patent is 20 years from the priority date on which the application for the patent was filed in the United States. Patents offer exclusive rights to the holder for a term of 20 years from the priority date thus market exclusivity awarded by the U.S. Patent Office upon the issuance of a patent is limited in scope and duration. Moreover, during the 20-year period, the holder must protect its proprietary rights from infringement.  Thus, OneMedNet&#8217;s commercial success will depend in part on obtaining, maintaining, enforcing, and defending its patents including against third-party challenges, and maintaining our trade secret protection. We will only be able to fully protect our technologies from unauthorized use by third parties to the extent that valid and enforceable patents or trade secrets cover them.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The patent prosecution process is expensive and time consuming, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business. The patent positions of </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">59</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">technology companies can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved. No consistent policy regarding the breadth of claims allowed in technology patents has emerged to date in the United States. The patent situation outside the United States is even more uncertain. Changes in either the patent laws or in interpretations of patent laws in the United States and other countries may diminish the value of our intellectual property. Accordingly, we cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage. Moreover, the patent application process is also subject to numerous risks and uncertainties, and there can be no assurance that we or any of our future development partners will be successful in protecting our technology by obtaining and defending patents. For example:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may not have been the first to make the inventions covered by each of our pending patent applications and issued patents;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may not have been the first to file patent applications for these inventions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">others may independently develop similar or alternative technologies or duplicate any of our technologies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">it is possible that none of the pending patent applications will result in issued patents;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the issued patents may not cover commercially viable services, may not provide us with any competitive advantages, or may be successfully challenged by third parties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may not develop additional proprietary technologies that are patentable;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">patents of others may have an adverse effect on our business;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">noncompliance with governmental patent agencies requirements can result in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction, potentially allowing competitors to enter the market earlier than would otherwise have been the case;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our competitors, many of whom have substantially greater resources than we do and many of whom have made significant investments in competing technologies, may seek or may have already obtained patents that will limit, interfere with, or eliminate our ability to sell and deliver our services.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Various extensions of patent term may be available in particular countries; however, in all circumstances the life of a patent, and the protection it affords, has a limited term. If we encounter delays in obtaining regulatory approvals, the period of time during which we could market a service under patent protection could be reduced. We expect to seek extensions of patent terms where these are available in any countries where we are prosecuting patents. To the extent OneMedNet&#8217;s intellectual property offers inadequate protection, or is found to be invalid or unenforceable, OneMedNet would be exposed to a greater risk of direct competition. If OneMedNet&#8217;s intellectual property does not provide adequate coverage over OneMedNet&#8217;s product candidates and protection against OneMedNet&#8217;s competitors&#8217; product candidates, OneMedNet&#8217;s competitive position could be adversely affected, as could OneMedNet&#8217;s business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our products or processes may infringe the intellectual property rights of others, which may cause us to pay unexpected litigation costs or damages or prevent us from selling our products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We cannot be certain that our products do not and will not infringe issued patents or other intellectual property rights of third parties. We may be subject to legal proceedings and claims in the ordinary course of our business, including claims of alleged infringement of the intellectual property rights of third parties. Any such claims, whether or not meritorious, could result in litigation and divert the efforts of our personnel. If we are found liable for infringement, we may be required to enter into licensing agreements (which may not be available on acceptable terms or at all) or to pay damages and to cease making or selling certain products. We may need to redesign some of our products or processes to avoid future infringement liability. Any of the foregoing could be detrimental to our business.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">60</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Recent patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On September&#160;16, 2011, the Leahy-Smith America Invents Act, or the Leahy-Smith Act, was signed into law. The Leahy-Smith Act includes a number of significant changes to United States patent law. These include provisions that affect the way patent applications are prosecuted and may also affect patent litigation. The United States Patent Office recently developed new regulations and procedures to govern administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, and in particular, the first to file provisions, only became effective on March&#160;16, 2013. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. However, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Patent applications in the United States are maintained in confidence for at least 18&#160;months after their earliest effective filing date. In the event that a third party has also filed a U.S. patent application relating to the technology underpinning our services or a similar invention, we may have to participate in interference proceedings declared by the U.S. Patent and Trademark Office to determine priority of invention in the United States. The costs of these proceedings could be substantial, and it is possible that our efforts would be unsuccessful, resulting in a material adverse effect on our U.S. patent position. The results of these types of proceedings may reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or services and compete directly with us, without payment to us, or result in our inability to commercialize services without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future services. Such results could have a material adverse effect on our business, financial condition, results of operations, and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the patentability of claims in pending patent applications covering the technology underpinning our services can be challenged by third parties during prosecution in the U.S. Patent and Trademark Office, for example by third-party observations and derivation proceedings, and the validity of claims in issued patents can be challenged by third parties in various post-grant proceedings such as post-grant review, reexamination, and inter-parties review proceedings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Furthermore, we may not have identified all United States and foreign patents or published applications that affect our business. Even if patents issue, we cannot guarantee that the claims of those patents will be valid and enforceable or provide us with any significant protection against competitive services, or otherwise be commercially valuable to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We also rely on trade secrets to protect our technology, particularly where we do not believe patent protection is appropriate or obtainable. However, trade secrets are difficult to protect. While we use reasonable efforts to protect our trade secrets, our licensors, employees, consultants, contractors, and other advisors may unintentionally or willfully disclose our information to competitors. Enforcing a claim that a third party illegally obtained and is using our trade secrets is expensive and time consuming, and the outcome is unpredictable. In addition, courts outside the United States are sometimes less willing to protect trade secrets. Moreover, our competitors may independently develop equivalent knowledge, methods, and know-how.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Obtaining and maintaining patent protection depends on compliance with various procedural, documentary, fee payment, and other requirements imposed by governmental patent agencies, and patent protection could be reduced or eliminated for noncompliance with these requirements.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent prosecution process. Periodic maintenance fees, renewal fees, annuity fees, and various other governmental fees on patents or patent applications will be due to be paid to the USPTO and various patent agencies outside of the United States in several stages over the lifetime of the patents and applications. We have systems in place to remind us to pay these fees, and we employ and rely on reputable law firms and other professionals to effect payment of these fees to the USPTO and non-U.S. patent agencies for the patents and patent applications we own and those that we in-license. We also employ reputable law firms and other professionals to help us comply with the various documentary and other procedural requirements with respect to the patents and patent applications that we own and those that we in-license. In some cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. However, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors might be able to enter the market and this circumstance would have a material adverse effect on our business.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">61</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If we are sued for infringing intellectual property rights of third parties, it will be costly and time consuming, and an unfavorable outcome in any litigation would harm our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our ability to develop, market, sell and provide our services depends upon our ability to avoid infringing the proprietary rights of third parties, and our commercial success depends upon our ability to develop, market, and sell our services and use our proprietary technologies without infringing the proprietary rights of third parties. There is considerable intellectual property litigation in the technology industry. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the general field of image and data storage, analysis and transmission and may cover elements of our services. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future. Because of the uncertainty inherent in any patent or other litigation involving proprietary rights, we and our licensors may not be successful in defending intellectual property claims by third parties, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Regardless of the outcome of any litigation, defending the litigation may be expensive, time consuming, and distracting to management. In addition, because patent applications can take many&#160;years to issue, there may be currently pending applications, unknown to us, which may later result in issued patents that our services may infringe. There could also be existing patents of which we are not aware that our services may inadvertently infringe.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a third party claims that we infringe on their services or technology, we could face a number of issues, including:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">infringement and other intellectual property claims which, whether meritorious or not, can be expensive and time consuming to litigate and can divert management&#8217;s attention from our core business;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">substantial damages for past infringement which we may have to pay if a court decides that our services infringe on a competitor&#8217;s patent;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a court prohibiting us from selling or licensing our services unless the patent holder licenses the patent to us, which it would not be required to do;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">if a license is available from a patent holder, we may have to pay substantial royalties or grant cross licenses to our patents; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">redesigning our services and processes so they do not infringe, which may not be possible or could require substantial funds and time.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we are found to infringe a third party&#8217;s intellectual property rights, we could be required to obtain a license from such third party to continue developing and marketing our services and technology. However, we may not be able to obtain any required license on commercially reasonable terms, or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. We could be forced, including by court order, to cease commercializing the infringing technology or service. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing our services or force us to cease some of our business operations, which could materially harm our business. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business, financial condition, results of operations, and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may be involved in lawsuits to protect or enforce our intellectual property or the intellectual property of our licensors, which could be expensive, time consuming and unsuccessful.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Competitors may infringe our issued patents, our in-licensed patents, or other intellectual property that we own or in-license. Under the terms of a license agreement, if we believe a third party is infringing on the patents subject to the licenses, we may be obligated, at our own expense, to initiate suit against those third parties. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time consuming. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents. In addition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part; construe the patent&#8217;s claims narrowly; or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">62</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Most of our competitors are larger than we are and have substantially greater resources than we do. They are, therefore, likely to be able to sustain the costs of complex patent litigation longer than we could. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our clinical trials, continue our internal research programs, in-license needed technology, or enter into development partnerships that would help us bring our services to market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may need to license certain intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A third party may hold intellectual property, including patent rights that are important or necessary to the development or commercialization of our services. It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our services, in which case we would be required to obtain a license from these third parties. Such a license may not be available on commercially reasonable terms, or at all, which could materially harm our business, financial condition, results of operations, and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may be subject to claims that our employees, independent contractors, or consultants have wrongfully used or disclosed alleged trade secrets of their former employers or other third parties.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As is common in the technology industry, we employ individuals who were previously employed at other technology or companies, including our competitors or potential competitors. Although no claims against us are currently pending, we may be subject to claims that these individuals or we have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may be unable to adequately prevent disclosure of trade secrets and other proprietary information.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We rely on trade secrets to protect our proprietary technological advances and know-how, especially where we do not believe patent protection is appropriate or obtainable. However, trade secrets are difficult to protect. We rely in part on confidentiality agreements with our employees, consultants, contractors and other advisors to protect our trade secrets and other proprietary information. However, any party with whom we have executed such an agreement may breach that agreement and disclose our proprietary information, including our trade secrets. Accordingly, these agreements may not effectively prevent disclosure of confidential information and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights. In addition, others may independently discover our trade secrets and proprietary information. Failure to obtain or maintain trade secret protection could enable competitors to use our proprietary information to develop services that compete with our services or cause additional, material adverse effects upon our competitive business position and financial results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We or our licensors may not be able to protect our intellectual property rights throughout the world.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Filing, prosecuting, and defending patents on the technology that underpins our services in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling services delivered using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own services and further, may provide otherwise infringing services to territories where we have patent protection, but enforcement rights are not as strong as those in the United States. These services may compete with our services and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries do not favor the enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our or our licensors&#8217; intellectual property </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">63</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If we fail to comply with our obligations under technology agreements with third parties, we may be required to pay damages and we could lose license rights that are critical to our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the agreements under which we license intellectual property rights or technology from third parties are generally complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property rights or technology or increase what we believe to be our financial or other obligations under the relevant agreement. Any of the foregoing could have a material adverse effect on our competitive position, business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Confidentiality and invention assignment agreements with our employees, advisors and consultants may not adequately prevent disclosure of trade secrets and protect other proprietary information.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We consider proprietary trade secrets and/or confidential know-how&#160;and unpatented know-how&#160;to be important to our business. We may rely on trade secrets and/or confidential know-how&#160;to protect our technology, especially where patent protection is believed by us to be of limited value. However, trade secrets and/or confidential know-how&#160;can be difficult to maintain as confidential.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To protect this type of information against disclosure or appropriation by competitors, our policy is to require our employees, advisors and consultants to enter into confidentiality and invention assignment agreements with us. However, current or former employees, advisors and consultants may unintentionally or willfully disclose our confidential information to competitors, and confidentiality and invention assignment agreements may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. Enforcing a claim that a third party obtained illegally and is using trade secrets and/or confidential know-how&#160;is expensive, time consuming and unpredictable. The enforceability of confidentiality and invention assignment agreements may vary from jurisdiction to jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Failure to obtain or maintain trade secrets and/or confidential know-how trade protection could adversely affect our competitive position. Moreover, our competitors may independently develop substantially equivalent proprietary information and may even apply for patent protection in respect of the same. If we seek patent protection for certain technology, our competitors could limit our use of our trade secrets and/or confidential know-how.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Intellectual property rights do not address all potential threats to our competitive advantage.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business, or permit us to maintain our competitive advantage. The following examples are illustrative:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Others may be able to deliver services that are similar to ours but that are not covered by our intellectual property rights.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Others may independently develop similar or alternative technologies or otherwise circumvent any of our technologies without infringing our intellectual property rights.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We might not have been the first to conceive and reduce to practice the inventions covered by the patents or patent applications that we own, license or will own or license.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We might not have been the first to file patent applications covering certain of the patents or patent applications that we or they own or have obtained a license or will own or will have obtained a license.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">It is possible that any pending patent applications that we have filed, or will file, will not lead to issued patents.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Issued patents that we own may not provide us with any competitive advantage, or may be held invalid or unenforceable, as a result of legal challenges by our competitors.</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">64</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our competitors might conduct research and development activities in countries where we do not have patent rights, or in countries where research and development safe harbor laws exist, and then use the information learned from such activities to develop competitive products for sale in our major commercial markets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ownership of our patents or patent applications may be challenged by third parties.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The patents of third parties or pending or future applications of third parties, if issued, may have an adverse effect on our business.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may face difficulties with protecting our intellectual property in certain jurisdictions, which may diminish the value of our intellectual property rights in those jurisdictions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The laws of some jurisdictions do not protect intellectual property rights to the same extent as the laws in the United States and the European Union, and many companies have encountered significant difficulties in protecting and defending such rights in such jurisdictions. If we encounter difficulties in protecting, or are otherwise precluded from effectively protecting, the intellectual property rights important for our business in such jurisdictions, the value of these rights may be diminished, and we may face additional competition from others in those jurisdictions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Some countries in Europe and China have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we are, or any of our licensors is, forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position or commercial advantage may be impaired, and our business and results of operations may be adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">RISKS RELATED TO LEGAL AND COMPLIANCE MATTERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If OneMedNet fails to comply with federal and state healthcare laws, including health and other information privacy and security laws, we could face substantial penalties and our business, financial condition, results of operations, and prospects could be adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a health information technology company, OneMedNet is subject to many federal and state healthcare laws, including those described in the &#8220;Information about OneMedNet Corporation &#8212; Government Regulation&#8221; section of this prospectus, such as the federal Health Insurance Portability and Accountability Act of 1996 (as amended by the Health Information Technology for Economics and Clinical Health Act), and similar information privacy laws. Even though we do not and will not control referrals of healthcare services or bill directly to Medicare, Medicaid, or other third-party payors, certain federal and state healthcare laws and regulations pertaining to fraud and abuse and patients&#8217; rights are and will be applicable to our business. We would be subject to healthcare fraud and abuse and patient privacy regulation by both the federal government and the states in which we conduct our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If OneMedNet or our operations are found to be in violation of any federal or state law, or any other governmental regulations that apply to us, we may be subject to penalties, including civil, criminal, and administrative penalties, damages, fines, disgorgement, debarment from government contracts, and refusal of orders under existing contracts, exclusion from participation in U.S. federal or state health care programs, corporate integrity agreements, and the curtailment or restructuring of our operations, any of which could materially adversely affect our ability to operate our business and our financial results. If any of the customer with whom we expect to do business is found not to be in compliance with applicable laws, it may be subject to criminal, civil or administrative sanctions, including but not limited to, exclusions from participation in government healthcare programs, which could also materially affect our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although an effective compliance program can mitigate the risk of investigation and prosecution for violations of these laws, the risks cannot be entirely eliminated. Moreover, achieving and sustaining compliance with applicable federal and state privacy, security, and fraud laws may prove costly. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">65</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Changes in U.S. healthcare law and implementing regulations, as well as changes in healthcare policy, may impact our business in ways that we cannot currently predict and may harm our business and results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There have been, and likely will continue to be, several executive, legislative and regulatory changes and proposed changes regarding the healthcare system that could delay market acceptance or demand for our services. Among policy makers and payors in the United States there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access and the pharmaceutical and medical device industries have been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, collectively referred to as the Affordable Care Act, substantially changed the way healthcare is financed by both the government and private insurers, and significantly impacts the U.S. pharmaceutical and medical device industries. These changes may indirectly affect the demand for our services from our customers in these industries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect that these and other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and lower reimbursement, and put additional downward pressure on the price that we receive for any service. It is possible that additional governmental action is taken in response to the COVID-19 pandemic. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action in the United States. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, demand for our services may be affected and we may not achieve or sustain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">The Data Knights Amended Charter will designate a state or federal court located within the State of Delaware as the exclusive forum for substantially all disputes between New OneMedNet and its stockholders, and also provide that the federal district courts in Delaware will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act or the Exchange Act, each of which could limit the ability of New OneMedNet&#8217;s stockholders to choose the judicial forum for disputes with New OneMedNet or its directors, officers, or employees.</span> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Amended Charter, which will become effective upon the Closing, will provide that, unless New OneMedNet consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on its behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any of its directors, officers, or other employees to New OneMedNet or its stockholders, (iii) any action arising pursuant to any provision of the DGCL, or the certificate of incorporation or the bylaws or (iv) any other action asserting a claim that is governed by the internal affairs doctrine shall be the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware), in all cases subject to the court having jurisdiction over indispensable parties named as defendants. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Amended Charter will also provide that the federal district courts of the United States of America for the district of Delaware will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act and the Exchange Act. The exclusive forum provision will be applicable to the fullest extent permitted by applicable law, subject to certain exceptions. We note that there is uncertainty as to whether a court would enforce this provision with respect to certain claims under federal securities laws and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any person or entity purchasing or otherwise acquiring any interest in any of New OneMedNet&#8217;s securities shall be deemed to have notice of and consented to this provision. This exclusive-forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum of its choosing for disputes with New OneMedNet or its directors, officers, or other employees, which may discourage lawsuits against New OneMedNet and its directors, officers, and other employees. If a court were to find the exclusive-forum provision to be inapplicable or unenforceable in an action, New OneMedNet may incur additional costs associated with resolving the dispute in other jurisdictions, which could harm its results of operations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Delaware law and New OneMedNet&#8217;s certificate of incorporation and bylaws will contain certain provisions, including anti-takeover provisions, that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Amended Charter and New OneMedNet&#8217;s bylaws that will be in effect upon consummation of the Business Combination, and the DGCL, contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">66</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">deemed undesirable by New OneMedNet&#8217;s board of directors and therefore depress the trading price of New OneMedNet&#8217;s common stock. These provisions could also make it difficult for stockholders to take certain actions, including electing directors who are not nominated by the current members of the OneMedNet Board or taking other corporate actions, including effecting changes in the management of the Combined Entity. Among other things, the Amended Charter and New OneMedNet&#8217;s bylaws include provisions regarding: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a classified board of directors with three-year staggered terms, which could delay the ability of stockholders to change the membership of a majority of New OneMedNet&#8217;s board of directors; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the ability of New OneMedNet&#8217;s board of directors to issue shares of preferred stock, including &#8220;blank check&#8221; preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the limitation of the liability of, and the indemnification of, New OneMedNet&#8217;s directors and officers; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the exclusive right of New OneMedNet&#8217;s board of directors to elect a director to fill a vacancy created by the expansion of New OneMedNet&#8217;s board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on New OneMedNet&#8217;s board of directors; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the requirement that directors may only be removed from New OneMedNet&#8217;s board of directors for cause; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of stockholders and could delay the ability of stockholders to force consideration of a stockholder proposal or to take action, including the removal of directors; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the requirement that a special meeting of stockholders may be called only by New OneMedNet&#8217;s board of directors, the chairperson of New OneMedNet&#8217;s board of directors, New OneMedNet&#8217;s chief executive officer or New OneMedNet&#8217;s president (in the absence of a chief executive officer), which could delay the ability of stockholders to force consideration of a proposal or to take action, including the removal of directors; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the procedures for the conduct and scheduling of board of directors and stockholder meetings; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the requirement for the affirmative vote of holders of at least 2/3 of the voting power of all of the then outstanding shares of the voting stock, voting together as a single class, to amend, alter, change or repeal any provision of the Amended Charter or New OneMedNet&#8217;s bylaws, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in New OneMedNet&#8217;s board of directors and also may inhibit the ability of an acquirer to effect such amendments to facilitate an unsolicited takeover attempt; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the ability of New OneMedNet&#8217;s board of directors to amend the bylaws, which may allow New OneMedNet&#8217;s board of directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">advance notice procedures with which stockholders must comply to nominate candidates to New OneMedNet&#8217;s board of directors or to propose matters to be acted upon at a stockholders&#8217; meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in New OneMedNet&#8217;s board of directors and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of the Combined Entity.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">GENERAL RISK FACTORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our future success depends on the continuing efforts of our management team and key employees, and on our ability to attract and retain highly skilled personnel and senior management.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We depend on the talents and continued efforts of our senior management and key employees. The loss of members of our management or key employees may disrupt our business and harm our results of operations. Further, our ability to manage further </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">67</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">expansion will require us to continue to attract, motivate and retain additional qualified personnel. Competition for this type of personnel is intense, and we may not be successful in attracting, integrating and retaining the personnel required to grow and operate our business effectively. There can be no assurance that our current management team or any new members of our management team will be able to successfully execute our business and operating strategies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Resources could be wasted in researching acquisitions that are not completed (including the proposed Business Combination), which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If Data Knights has not completed its initial business combination within the required time period, its public stockholders may receive only approximately $10.20 per share, or less than such amount in certain circumstances, on the liquidation of its Trust Account and its warrants will expire worthless. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights anticipates that the investigation of each specific target business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial management time and attention and substantial costs for accountants, attorneys and others. If Data Knights decides not to complete a specific initial business combination, such as the proposed Business Combination, the costs incurred up to that point for the proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific target business, such as OneMedNet, Data Knights may fail to complete its initial business combination for any number of reasons including those beyond its control. Any such event will result in a loss to Data Knights of the related costs incurred which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If Data Knights is unable to complete our initial business combination because it does not have sufficient funds available to it, its public stockholders may receive only approximately $10.20 per share on the liquidation of its Trust Account and its Public Warrants and Private Placement Warrants will expire worthless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We are subject to many hazards and operational risks that can disrupt our business, some of which may not be insured or fully covered by insurance.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our operations are subject to many hazards and operational risks inherent to our business, including: (a)&#160;general business risks; (b)&#160;warranty liability; and (c)&#160;damage to third parties (e.g., our vendors), our infrastructure or properties caused by fires, floods and other natural disasters, power losses, telecommunications failures, terrorist attacks, riots, cyberattacks, public health crises such as the current&#160;COVID-19&#160;pandemic (and other future pandemics or epidemics), human errors and similar events. As a result of the&#160;COVID-19&#160;outbreak, or similar pandemics, we have and may in the future experience disruptions that could severely impact our business and the business of our customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our insurance coverage may be inadequate to cover our liabilities related to such hazards or operational risks. For example, we do not currently maintain cybersecurity insurance and our insurance providers may take the position that our coverage, under present circumstances, does not extend to business interruptions as they relate to the&#160;COVID-19 pandemic. In addition, we may not be able to maintain adequate insurance in the future at rates we consider reasonable and commercially justifiable, and insurance may not continue to be available on terms as favorable as our current arrangements. The occurrence of a significant uninsured claim or a claim in excess of the insurance coverage limits maintained by us could have a material adverse effect on our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our business could be adversely affected by an accident, a safety incident or a workforce disruption.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our inability to timely adapt to changing norms and requirements around maintaining a safe workplace could cause employee illness, accidents or team discontent if it is perceived that we are failing to protect the health and safety of our employees. While we maintain liability insurance, the amount of such coverage may not be adequate to cover fully all claims, and we may be forced to bear substantial losses from an accident or safety incident.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We have a several key stockholders, which may limit our ability to influence corporate matters and may give rise to conflicts of interest.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Following the consummation of the Business Combination, nine of our directors and executives are expected to beneficially own, directly or indirectly, approximately thirty-seven&#160;percent (37%) of our common stock. Accordingly, these executives exert and will continue to exert significant influence over us and any action requiring the approval of the holders of our common stock, including the election of directors and amendments to our organizational documents, such as increases in our authorized shares of common stock and approval of significant corporate transactions. This concentration of ownership may prevent or discourage unsolicited acquisition proposals or offers for our common stock. Further, the interests of these executives may not always coincide with our interests, or the </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">68</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">interests of other stockholders and these executives may act in a manner that advances its best interests and not necessarily those of other stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">OneMedNet&#8217;s business is highly competitive. Competition could present an ongoing threat to the success of OneMedNet&#8217;s business. If OneMedNet is unable to compete effectively for imaging date providers and RWD customers, OneMedNet&#8217;s business and operating results could be harmed. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">OneMedNet&#8217;s business is highly competitive. Competition could present an ongoing threat to the success of OneMedNet&#8217;s business, which competition could result from national and regional providers of imaging data, which could affect our ability to obtain and retain new customers and pricing pressures. We cannot assure you that we will be able to build our network in a timely or cost-effective manner, efficiently acquire additional customers or achieve target projected returns by penetrating the market as effectively as projected if OneMedNet is unable to compete effectively for imaging date providers and RWD customers.  As a result, OneMedNet&#8217;s business and operating results could be harmed.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In some instances, our competitors have easier access to financing, greater resources, greater operating capabilities and efficiencies of scale, stronger brand-name recognition, longstanding relationships with customers, and more customers. This provides these competitors with certain advantages in competing against us, including the ability to aggressively promote their products in markets in which we may compete. This competition may affect our ability to add and retain customers, which in turn adversely affects our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the RWD and real-world evidence (&#8220;RWE&#8221;) arena, there is a high number of service providers globally who sell electronic health records.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The competition can be organized into two groups&#8201;&#8212;&#8201;the first is RWD providers that access imaging along with electronic health records. This includes firms such as Flatiron, Aetion, ConcertAI, Life Image and Optum among many others. These groups have deep disease insights but do not focus on imaging, and, we believe, are not imaging experts. The other group includes firms such as Nuance and Truveta that provide support for research projects using RWE where imaging may be part of the deliverables but imaging is not the central focus of these companies in our opinion. We believe that anywhere imaging is required to diagnosis, assess disease progression, regression, status quo or measure the impact of a therapy, device or procedure, OneMedNet has the required radiology imaging to support these clients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">There&#8217;s a reason OneMedNet&#8217;s customer base is growing as it develops its reputation as a reliable source for regulatory-grade imaging RWD. We believe it is because it requires specialized expertise in Artificial Intelligence / Machine Learning technology, data privacy/security, as well as expertise in clinical patient condition(s) and healthcare record keeping. Having, or achieving, expertise in all essential disciplines is a challenging achievement. Our current customer base is in the United States, Canada, Ireland, Israel, Germany, Netherlands, Norway and the United Kingdom.  OneMedNet has plans to expand into Africa and Asia, we expect these expansions to be completed in 2023, however there is no assurance of that timetable. OneMedNet has a team of experienced curators with previous radiology, technical and clinical expertise.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet had a significant head start with our clinical image exchange solution which served to launch the company nearly a decade ago. Finally, OneMedNet has the most experienced and clinically trained data curators in the industry. This team appreciates the complexity and criticality of clinical data and can effectively communicate with both Provider and Life Science specialists. The chief information officer for Steinberg Diagnostic Medical Imaging, a leading US medical imaging center best summed up OneMedNet, &#8220;We have multiple data usage relationships with real world providers; however, I would put OneMedNet at the top and recommend them 100%.&#8221;&#8201;&#8212;&#8201;Angeline Cosca, SDMI Chief Information Officer. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Nevertheless, we believe that competition for users of OneMedNet&#8217;s products and services will be intense. Although OneMedNet intends to continue to develop a global platform for its OneMedNet <b style="font-weight:bold;">iRWD&#8482;</b> solution, it will face strong competition in its business. OneMedNet will compete against many companies to attract additional customers including companies which may have greater financial resources such as certain RWD and Real-World Evidence companies in the market such as Anthem Inc. , Cegedim </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Health Data, Clarivate Plc, Clinigen Group plc (U.K.), Cognizant Technologies Solutions Corporations (U.S.), Flatiron Health Inc., International Business Machines Corporation, ICON plc (Ireland), IQVIA Holdings Inc., Oracle Corporation, Paraxle International Corporation (U.S.), Thermo Fisher&#8217;s Laboratory Products and Services (formerly PPD), etc. More and more companies may seek to enter this service area to share in the growing global RWD and real-world evidence markets. </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">69</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, OneMedNet believes that its ability to compete effectively for customers depends upon many factors both within and beyond OneMedNet&#8217;s control, including: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">market acceptance of OneMedNet&#8217;s existing products and services; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the timing of OneMedNet&#8217;s new products and services; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the adoption of OneMedNet&#8217;s products and services internationally; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA&#8217;s and the medical and drug community&#8217;s continued support of real world data; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet&#8217;s reputation and brand strength relative to its competitors.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our business could be adversely affected by the military conflict in Ukraine.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In late February&#160;2022, Russian military forces invaded Ukraine. Russia&#8217;s invasion, the responses of countries and political bodies to Russia&#8217;s actions, and the potential for wider conflict may increase financial market volatility and could have adverse effects on regional and global economic markets, including the markets for certain securities and commodities. Following Russia&#8217;s actions, various countries, including the United States, Canada, the United Kingdom, Germany, and France, as well as the European Union, issued broad-ranging economic sanctions against Russia. The sanctions consist of the prohibition of trading in certain Russian securities and engaging in certain private transactions, the prohibition of doing business with certain Russian corporate entities, large financial institutions, officials and persons, and the freezing of Russian assets. The sanctions include a possible commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, commonly called &#8220;SWIFT&#8221;, the electronic network that connects banks globally, and imposed restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. A number of large corporations and U.S. states have also announced plans to curtail business dealings with certain Russian businesses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The imposition of the current sanctions (and potential imposition of further sanctions in response to continued Russian military activity) and other actions undertaken by countries and businesses may adversely impact various sectors of the Russian economy, and the military action has severe impacts on the Ukrainian economy, including its exports and food production. The duration of ongoing hostilities and corresponding sanctions and related events cannot be predicted and may result in a negative impact on the markets and thereby may negatively affect our operations and profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may engage in merger and acquisition activities, which could require significant management attention, disrupt our business, dilute stockholder value and adversely affect our results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As part of our growth, we may in the future make investments in businesses, technologies, services and other assets that complement our business. We may not be able to find suitable acquisition candidates and we may not be able to complete acquisitions on favorable terms, if at all, in the future. If we do complete acquisitions, we may not ultimately strengthen our competitive position or achieve our goals, and any acquisitions we complete could be viewed negatively by our customers or investors. Moreover, an acquisition, investment or business relationship may result in unforeseen operating difficulties and expenditures, including disrupting our ongoing operations, diverting management from their primary responsibilities, subjecting us to additional liabilities, increasing our expenses and adversely impacting our business, financial condition and results of operations. Moreover, we may be exposed to unknown liabilities and the anticipated benefits of any acquisition, investment or business relationship may not be realized, if, for example, we fail to successfully integrate such acquisitions, or the technologies associated with such acquisitions, into our company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To pay for any such acquisitions, we would have to use cash, incur debt or issue equity securities, each of which may affect our financial condition or the value of our capital stock and could result in dilution to our stockholders. If we incur more debt it would result in increased fixed obligations and could also subject us to covenants or other restrictions that would impede our ability to manage our operations. In addition, we may receive indications of interest from other parties interested in acquiring some or all of our business. The time required to evaluate such indications of interest could require significant attention from management and disrupt the ordinary functioning of our business and could have a material adverse effect on our business, financial condition and results of operations.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">70</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Security breaches, loss of data and other disruptions could compromise sensitive information related to our business, prevent us from accessing critical information or expose us to liability, which could adversely affect our business and our reputation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the ordinary course of our business, we collect and store sensitive data, including legally protected patient health information, credit card information, personally identifiable information about our employees, intellectual property, and proprietary business information. We manage and maintain our applications and data utilizing on-site systems. These applications and data encompass a wide variety of business-critical information including research and development information, commercial information and business and financial information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The secure processing, storage, maintenance and transmission of this critical information is vital to our operations and business strategy, and we devote significant resources to protecting such information. Although we take measures to protect sensitive information from unauthorized access or disclosure, our information technology and infrastructure may be vulnerable to attacks by hackers, or viruses, breaches or interruptions due to employee error, malfeasance or other disruptions, or lapses in compliance with privacy and security mandates. Any such virus, breach or interruption could compromise our networks and the information stored there could be accessed by unauthorized parties, publicly disclosed, lost or stolen. We have measures in place that are designed to prevent, and if necessary to detect and respond to such security incidents and breaches of privacy and security mandates. However, in the future, any such access, disclosure or other loss of information could result in legal claims or proceedings, liability under laws that protect the privacy of personal information, such as HIPAA and General Data Protection Regulation, or GDPR, government enforcement actions and regulatory penalties. Unauthorized access, loss or dissemination could also disrupt our operations, including our ability to process samples, provide test results, share and monitor safety data, bill payors or patients, provide customer support services, conduct research and development activities, process and prepare company financial information, manage various general and administrative aspects of our business and may damage our reputation, any of which could adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">RISKS RELATED TO DATA KNIGHTS AND DATA KNIGHTS COMMON STOCK FOLLOWING THE BUSINESS COMBINATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">An active market for New OneMedNet&#8217;s securities may not develop, which would adversely affect the liquidity and price of New OneMedNet&#8217;s securities.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The price of New OneMedNet&#8217;s securities may vary significantly due to factors specific to New OneMedNet as well as to general market or economic conditions. Furthermore, an active trading market for New OneMedNet&#8217;s securities may never develop or, if developed, it may not be sustained. You may be unable to sell your securities unless a market can be established and sustained.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Nasdaq may delist New OneMedNet&#8217;s securities from trading on its exchange, which could limit investors&#8217; ability to make transactions in New OneMedNet&#8217;s securities and subject New OneMedNet to additional trading restrictions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; securities are currently listed on Nasdaq and it is anticipated that, following the Business Combination, New OneMedNet&#8217;s securities will be listed on Nasdaq. However, Data Knights cannot assure you that New OneMedNet&#8217;s securities will continue to be listed on Nasdaq in the future. In order to continue listing its securities on Nasdaq, New OneMedNet must maintain certain financial, distribution and stock price levels. Generally, New OneMedNet must maintain a minimum number of holders of its securities (generally 400 public holders).<b style="font-weight:bold;">&#160;</b>Additionally, in connection with the Business Combination, New OneMedNet will be required to demonstrate compliance with Nasdaq&#8217;s initial listing requirements, which are more rigorous than Nasdaq&#8217;s continued listing requirements, in order to continue to maintain the listing of our securities on Nasdaq. For instance, New OneMedNet&#8217;s stock price would generally be required to be at least $4.00 per share and New OneMedNet will be required to have a minimum of 400 public&#160;holders (with at least 50% of such round lot holders holding securities with a market value of at least $2,500) in order to remain listed on the Nasdaq Global Market. Data Knights cannot assure you that New OneMedNet will be able to meet those initial listing requirements at that time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If Nasdaq delists New OneMedNet&#8217;s securities from trading on its exchange and New OneMedNet is not able to list its securities on another national securities exchange, Data Knights expects New OneMedNet&#8217;s securities could be quoted on an&#160;over-the-counter&#160;market. If this were to occur, New OneMedNet could face significant material adverse consequences, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a limited availability of market quotations for its securities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reduced liquidity for its securities;</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">71</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a determination that New OneMedNet&#8217;s common stock is a &#8220;penny stock&#8221; which will require brokers trading in the common stock to adhere to more stringent rules&#160;and possibly result in a reduced level of trading activity in the secondary trading market for New OneMedNet&#8217;s securities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a limited amount of news and analyst coverage; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decreased ability to issue additional securities or obtain additional financing in the future.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">The market price of New OneMedNet&#8217;s common stock may decline as a result of the Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The market price of New OneMedNet&#8217;s common stock may decline as a result of the Business Combination for a number of reasons including if:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">investors react negatively to the prospects of New OneMedNet&#8217;s business and the prospects of the Business Combination;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the effect of the Business Combination on New OneMedNet&#8217;s business and prospects is not consistent with the expectations of financial or industry analysts; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">New OneMedNet does not achieve the perceived benefits of the Business Combination as rapidly or to the extent anticipated by financial or industry analysts</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Because there are no current plans to pay cash dividends on the New OneMedNet common stock for the foreseeable future, you may not receive any return on investment unless you sell your New OneMedNet common stock at a price greater than what you paid for it.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">New OneMedNet intends to retain future earnings, if any, for future operations, expansion and debt repayment, and there are no current plans to pay any cash dividends for the foreseeable future. The declaration, amount and payment of any future dividends on shares of New OneMedNet common stock will be at the sole discretion of the New OneMedNet board of directors. The New OneMedNet board of directors may take into account general and economic conditions, New OneMedNet&#8217;s financial condition and results of operations, New OneMedNet&#8217;s available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax and regulatory restrictions, implications of the payment of dividends by New OneMedNet to its stockholders or by its subsidiaries to it and such other factors as the New OneMedNet board of directors may deem relevant. As a result, you may not receive any return on an investment in New OneMedNet common stock unless you sell your New OneMedNet common stock for a price greater than that which you paid for it.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">New OneMedNet stockholders may experience dilution in the future.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The&#160;percentage of shares of New OneMedNet common stock owned by current stockholders may be diluted in the future because of equity issuances for acquisitions, capital market transactions or otherwise, including, without limitation, equity awards that New OneMedNet may grant to its directors, officers and employees, exercise of the New OneMedNet warrants. Such issuances may have a dilutive effect on New OneMedNet&#8217;s earnings per share, which could adversely affect the market price of New OneMedNet common stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">New OneMedNet may issue additional New OneMedNet Common Stock or other equity securities without your approval, which would dilute your ownership interests and may depress the market price of your shares.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">New OneMedNet may issue additional shares of New OneMedNet Common Stock or other equity securities of equal or senior rank in the future in connection with, among other things, future acquisitions, repayment of outstanding indebtedness, under the Equity Incentive Plan, without stockholder approval, in a number of circumstances. The issuance of additional shares of New OneMedNet Common Stock or other equity securities of equal or senior rank could have the following effects:</span></p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">your proportionate ownership interest in New OneMedNet will decrease;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the relative voting strength of each previously outstanding share of New OneMedNet Common Stock may be diminished; or</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">72</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the market price of your Combined Entity Ordinary Shares may decline.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If securities or industry analysts do not publish research or reports about New OneMedNet&#8217;s business, if they change their recommendations regarding New OneMedNet common stock or if New OneMedNet&#8217;s operating results do not meet their expectations, the New OneMedNet common stock price and trading volume could decline.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The trading market for New OneMedNet common stock will depend in part on the research and reports that securities or industry analysts publish about New OneMedNet or its businesses. If no securities or industry analysts commence coverage of New OneMedNet, the trading price for New OneMedNet common stock could be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who cover New OneMedNet downgrade its securities or publish unfavorable research about its businesses, or if New OneMedNet&#8217;s operating results do not meet analyst expectations, the trading price of New OneMedNet common stock would likely decline. If one or more of these analysts cease coverage of New OneMedNet or fail to publish reports on New OneMedNet regularly, demand for New OneMedNet common stock could decrease, which might cause the New OneMedNet common stock price and trading volume to decline.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">The removal of the net tangible asset requirement in connection with the Business Combination may result in a depressed net tangible assets calculation for OneMedNet, which may adversely affect the share price of New OneMedNet following the Business Combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights stockholders are being asked to adopt a proposed amendment to the Charter prior to the Business Combination, which, in the judgement of the Data Knights Board, may be necessary to facilitate the Business Combination. Net tangible assts are calculated as total assets, less intangible assets and total liabilities. OneMedNet&#8217;s financial statements reflect material intangible assets, that consist of patents, which are included in the non-current assets to OneMedNet&#8217;s Balance Sheet intangible assets, net. In addition, OneMedNet&#8217;s financial statements reflect substantial liabilities, including pursuant to research and development. Although the calculation of net tangible assets offers limited utility to understanding the operations of a business such as OneMedNet&#8217;s, the calculation of net tangible assets may be used by investors to determine the value of a company&#8217;s shares. Accordingly, the removal of the net tangible asset requirement, if there are significant redemptions coupled with the lower tangible assets of OneMedNet may adversely affect the stock price of New OneMedNet following the Business Combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Although the Data Knights Class A Ordinary Shares are listed on the Nasdaq Capital Market and Data Knights and OneMedNet believe that New OneMedNet shares will be exempt from classification as a &#8220;penny stock&#8221;, if New OneMedNet does not maintain such listings, New OneMedNet shares may become subject to the &#8220;penny stock&#8221; rules in the future and the trading market in our securities would be limited, which makes transactions in our stock cumbersome and may reduce the value of an investment in our stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights believes that New OneMedNet shares will be exempt from classification as a &#8220;penny stock&#8221; upon the closing of the Business Combination with the removal of the minimum $5,000,001 net tangible assets requirement from its charter because it will be exempt under other provisions of the definition of &#8220;penny stock&#8221;; however, there can be no assurance to this effect.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As an alternative from being exempt from penny stock classification by having minimum net tangible assets of $5,000,001, a company can meet the requirements of SEC Rule 3a51-1(a)(ii), which generally require that a company (a) have either $5 million of stockholders equity or listed securities with a market value of $50 million or net income of at least $750,000 in its last fiscal year or two out of three of its most recent fiscal years, (b) either a one year operating history or listed securities with a market value of $50 million, (c) a minimum bid price of $4 per share, (d) at least 300 round lot holders of its listed securities and (e) at least one million publicly held shares with a $5 million market value. Data Knights and OneMedNet believe that New OneMedNet will meet these criteria; however, there can be no assurance to this effect, and failure to meet these criteria or some other exemption from classification as a &#8220;penny stock&#8221; could result in New OneMedNet&#8217;s securities becoming subject to the penny stock rules.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">For any transaction involving a penny stock, unless exempt, the rules require:</span></p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">that a broker or dealer approve a person&#8217;s account for transactions in penny stocks; and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">73</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">In order to approve a person&#8217;s account for transactions in penny stocks, the broker or dealer must:</span></p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtain financial information and investment experience objectives of the person; and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to the penny stock market, which:</span></p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">sets forth the basis on which the broker or dealer made the suitability determination; and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">affirms that the broker or dealer received a signed, written agreement from the investor prior to the transaction.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Generally, brokers may be less willing to execute transactions in securities subject to the &#8220;penny stock&#8221; rules. This may make it more difficult for investors to dispose of our common stock and cause a decline in the market value of our stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Stockholders should be aware that, according to SEC Release No. 34-29093, the market for &#8220;penny stocks&#8221; has suffered in recent years from patterns of fraud and abuse. Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses. Our management is aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Future sales, or the perception of future sales, by New OneMedNet or its stockholders in the public market following the Business Combination could cause the market price for New OneMedNet common stock to decline.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The sale of shares of New OneMedNet common stock in the public market, or the perception that such sales could occur, could harm the prevailing market price of shares of New OneMedNet common stock. These sales, or the possibility that these sales may occur, also might make it more difficult for New OneMedNet to sell equity securities in the future at a time and at a price that it deems appropriate.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">It is anticipated that, upon the Closing, and assuming immediate and full conversion of the Preferred Stock, Data Knights&#8217; public stockholders will retain an ownership interest of approximately 8.3% of the outstanding capital stock of the Combined Entity, the Sponsor will retain an ownership interest of approximately 10.5% of the outstanding capital stock of the Combined Entity and the OneMedNet securityholders will own approximately 60.6% of the outstanding capital stock of the Combined Entity. The foregoing ownership&#160;percentages with respect to the Combined Entity following the Business Combination exclude any outstanding Warrants and assume that (i)&#160;there are no further redemptions of any shares by Data Knights&#8217; public stockholders in connection with the Business Combination, (ii)&#160;no awards are issued under the Equity Incentive Plan and (iii)&#160;no Working Capital Units or Extension Units are issued. All shares currently held by Data Knights public stockholders and all of the shares issued in the Business Combination to existing OneMedNet securityholders will be freely tradable without registration under the Securities Act, and without restriction by persons other than New OneMedNet&#8217;s &#8220;affiliates&#8221; (as defined under Rule&#160;144 under the Securities Act, (&#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Rule&#160;144</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;)), including New OneMedNet&#8217;s directors, executive officers and other affiliates.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In connection with the Merger, certain existing OneMedNet securityholders, who are expected to own [&#160;&#160;&#160;&#160;&#160;] shares of New OneMedNet common stock following the Business Combination (based on the above assumptions and OneMedNet&#8217;s current stockholdings), have agreed with Data Knights, subject to certain exceptions, not to dispose of or hedge any of their shares of New </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">74</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">OneMedNet common stock or securities convertible into or exchangeable for shares of New OneMedNet common stock during the period from the date of the Closing continuing through the earliest of: (i)&#160;the&#160;six-month&#160;anniversary of the Closing, and (ii)&#160;the date after the Closing on which New OneMedNet consummates a liquidation, merger, capital stock exchange, reorganization or other similar transaction with an unaffiliated third party that results in all of the New OneMedNet stockholders having the right to exchange their shares of New OneMedNet common stock for cash, securities or other property. See &#8220;<i style="font-style:italic;">The Business Combination Proposal&#160;&#8212; General Description of the Merger Agreement&#160;&#8212;&#160;Related Agreements &#8212; Lock-up&#160;Agreements</i>&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the shares of New OneMedNet common stock reserved for future issuance under the Equity Incentive Plan will become eligible for sale in the public market once those shares are issued, subject to any applicable vesting requirements, lockup agreements and other restrictions imposed by law. A total number of shares representing 10% of the fully diluted, and as converted, outstanding shares of New OneMedNet common stock immediately following consummation of the Merger are expected to be reserved for future issuance under the Equity Incentive Plan. New OneMedNet is expected to file one or more registration statements on&#160;Form&#160;S-8&#160;under the Securities Act to register shares of New OneMedNet common stock or securities convertible into or exchangeable for shares of New OneMedNet common stock issued pursuant to the Equity Incentive Plan. Any such&#160;Form&#160;S-8&#160;registration statements will automatically become effective upon filing. Accordingly, shares registered under such registration statements will be available for sale in the open market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the future, New OneMedNet may also issue its securities in connection with investments or acquisitions. The amount of shares of New OneMedNet common stock issued in connection with an investment or acquisition could constitute a material portion of the then-outstanding shares of New OneMedNet common stock. Any issuance of additional securities in connection with investments or acquisitions may result in additional dilution to New OneMedNet stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights has no obligation to net cash settle the Public Warrants or Placement Warrants. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In no event will Data Knights have any obligation to net cash settle the Public Warrants or the Placement Warrants. Furthermore, there are no contractual penalties for failure to deliver securities to the holders of Public Warrants or the Placement Warrants upon consummation of an initial business combination, including the Business Combination, or exercise of the warrants. Accordingly, the warrants may expire worthless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">New OneMedNet may redeem unexpired Public Warrants prior to their exercise at a time that is disadvantageous for Data Knights warrant holders.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">New OneMedNet will have the ability to redeem outstanding Public Warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of New OneMedNet common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading&#160;days within a 30&#160;trading-day&#160;period ending on the third trading day prior to the date New OneMedNet sends the notice of redemption to the warrant holders. To date, the relevant sales price has not equaled or exceeded $18.00. If and when the Public Warrants become redeemable by New OneMedNet, New OneMedNet may exercise its redemption right if there is a current registration statement in effect with respect to the shares of New OneMedNet common stock underlying such warrants. Redemption of the outstanding Public Warrants could force you to: (i)&#160;exercise your warrants and pay the related exercise price at a time when it may be disadvantageous for you to do so; (ii)&#160;sell your warrants at the then-current market price when you might otherwise wish to hold your warrants; or (iii)&#160;accept the nominal redemption price which, at the time the outstanding Public Warrants are called for redemption, is likely to be substantially less than the market value of your warrants. None of the Placement Warrants (or if issued, any warrants underlying the Working Capital Units or Extension Units) will be redeemable by New OneMedNet for cash so long as they are held by the Sponsor or its permitted transferees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We have not registered the shares of Data Knights common stock issuable upon exercise of the Public Warrants under the Securities Act or any state securities laws at this time, and such registration may not be in place when an investor desires to exercise Public Warrants, thus precluding such investor from being able to exercise its Public Warrants except on a cashless basis and potentially causing such Public Warrants to expire worthless. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We have not registered the shares of common stock issuable upon exercise of the Public Warrants under the Securities Act or any state securities laws at this time. However, under the terms of the warrant agreement, we have agreed that as soon as practicable, but in no event later than 15 business days after the closing of our initial business combination, we will use our best efforts to file with the SEC a registration statement for the registration under the Securities Act of the shares of common stock issuable upon exercise of the warrants and thereafter will use our best efforts to cause the same to become effective within 60 business days following our initial </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">75</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">business combination and to maintain a current prospectus relating to the common stock issuable upon exercise of the Public Warrants, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We cannot assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference therein are not current or correct or the SEC issues a stop order. If the shares issuable upon exercise of the Public Warrants are not registered under the Securities Act, we will be required to permit holders to exercise their Public Warrants on a cashless basis. However, no Public Warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder or an exemption from registration is available. Notwithstanding the above, if our common stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange such that it satisfies the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of Public Warrants who exercise their Public Warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, and in the event we do not so elect, we will use our best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In no event will we be required to net cash settle any Public Warrant, or issue securities or other compensation in exchange for the Public Warrants in the event that we are unable to register or qualify the shares underlying the Public Warrants under applicable state securities laws and there is no exemption available. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the issuance of the shares of common stock upon exercise of the Public Warrants is not so registered or qualified or exempt from registration or qualification, the holder of such Public Warrant shall not be entitled to exercise such Public Warrant and such Public Warrant may have no value and expire worthless. In such event, holders who acquired their Public Warrants as part of a purchase of public units will have paid the full unit purchase price solely for the shares of common stock included in the public units. If and when the Public Warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. We will use our best efforts to register or qualify such shares of common stock under the blue sky laws of the state of residence in those states in which the warrants were offered by us in the IPO. However, there may be instances in which holders of our Public Warrants may be unable to exercise such Public Warrants but holders of our private warrants may be able to exercise such private warrants. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Future resales of New OneMedNet&#8217;s common stock after the consummation of the Business Combination may cause the market price of New OneMedNet&#8217;s securities to drop significantly, even if New OneMedNet&#8217;s business is doing well. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the Business Combination, the significant Company Holders certain of OneMedNet&#8217;s officers and directors entered into a lock-up agreement pursuant to which they will be contractually restricted from selling or transferring any of (i)their shares of New OneMedNet&#8217;s common stock held immediately following the Closing and (ii) any of their shares of New OneMedNet&#8217;s common stock that result from converting securities held immediately following the Closing. Such restrictions begin at Closing and end the earliest of: (i) the six-month anniversary of the Closing, (ii) on the date on which the closing stock price for New OneMedNet common stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period commencing at least 150 days after the Closing, and (iii) such date on which New OneMedNet completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the New OneMedNet stockholders having the right to exchange their shares of New OneMedNet common stock for cash, securities or other property. A total of 6,353,344 shares or 55.7% of OneMedNet issued and outstanding shares including the officers and directors are subject to the Lock-Up Agreement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor is subject to a lock-up pursuant to a letter agreement, entered into at the time of the IPO, among Data Knights, the Sponsor and the other parties thereto, pursuant to which the Sponsor is subject to a lock-up beginning on the Closing and end the earliest of: (i) the six-month anniversary of the Closing, (ii) on the date on which the closing stock price for New OneMedNet common stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period commencing at least 150 days after the Closing, and (iii) such date on which Data Knights completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Data Knights stockholders having the right to exchange their shares of Data Knights common stock for cash, securities or other property. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">However, following the expiration of such lock-ups, the Sponsor and the OneMedNet stockholders subject to the Lock-Up Agreement will not be restricted from selling shares of New OneMedNet&#8217;s common stock held by them, other than by applicable securities laws. </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">76</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon completion of the Business Combination, the Sponsor and the OneMedNet stockholders subject to the Lock-Up Agreement (including the shares of New OneMedNet common stock issued as awards as a result of conversion of OneMedNet common stock that were reserved for issuance pursuant to OneMedNet&#8217;s outstanding stock options and unvested restricted stock units outstanding as of immediately prior to the Closing) will collectively beneficially own approximately 32.3% of the outstanding shares of New OneMedNet common stock, assuming that no additional public stockholders redeem their public shares in connection with the Business Combination. Assuming approximately 2,731,544 million public shares are redeemed in connection with the Business Combination, in the aggregate, the ownership of the Sponsor and the OneMedNet Stockholders would rise to 35.2% of the outstanding shares of New OneMedNet common stock (including the shares of OneMedNet common stock reserved in respect of OneMedNet&#8217;s outstanding stock options and unvested restricted stock units outstanding as of immediately prior to the Closing that will be converted into awards based on New OneMedNet common stock). </p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The shares held by Sponsor and the Lock-Up Stockholders may be sold after the expiration of their applicable lock-up periods. As restrictions on resale end and registration statements (filed after the Closing to provide for the resale of such shares from time to time) are available for use, the sale or possibility of sale of these shares could have the effect of increasing the volatility in New OneMedNet&#8217;s share price or the market price of New OneMedNet common stock could decline if the holders of currently restricted shares sell them or are perceived by the market as intending to sell them.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Certain provisions of New OneMedNet&#8217;s amended and restated certificate of incorporation could have a material adverse effect on the rights of holders of its Common Stock.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">New OneMedNet will adopt the third amended and restated certificate of incorporation effective upon consummation of the Business Combination. The third amended and restated certificate of incorporation contains provisions to limit the ability of others to acquire control of New OneMedNet, including a provision that grants authority to its board of directors to issue from time to time one or more series of preferred shares without action by its stockholders and to determine, with respect to any series of preferred shares, the terms and rights of that series, and a provision establishing the Court of Chancery in the State of Delaware as the exclusive forum for many types of litigation involving New OneMedNet and its stockholders, subject to limitations under applicable federal securities law. These provisions could have the effect of depriving New OneMedNet&#8217;s stockholders of an opportunity to sell their shares at a premium over prevailing market prices by discouraging third parties from seeking to obtain control of New OneMedNet in a tender offer or similar transaction or otherwise make it more difficult for New OneMedNet&#8217;s stockholders to maximize the return on their investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">RISKS RELATING TO DATA KNIGHTS, THE BUSINESS COMBINATION AND REDEMPTION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights has no operating history and is subject to a mandatory liquidation and subsequent dissolution requirement. If Data Knights is unable to consummate a business combination, including the Business Combination, its public stockholders may be forced to wait until August 11, 2023 before receiving distributions from the Trust Account.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is a development stage blank check company, and as it has no operating history and is subject to a mandatory liquidation and subsequent dissolution requirement. Data Knights has until August 11, 2023 to complete a business combination subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension. Data Knights has no obligation to return funds to investors prior to such date unless (i) it consummates a business combination prior thereto or (ii) it seeks to amend the Data Knights Charter prior to consummation of a business combination, and only then in cases where investors have sought to redeem or sell their shares to Data Knights. Only after the expiration of this full time period will public security holders be entitled to distributions from the Trust Account if Data Knights is unable to complete a business combination. Accordingly, investors&#8217; funds may be unavailable to them until after such date and to liquidate their investment, public security holders may be forced to sell their public units or public warrants, potentially at a loss. In addition, if Data Knights fails to complete an initial business combination by the prescribed time frame, there will be no redemption rights or liquidating distributions with respect to the public warrants, which will expire worthless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights&#8217; independent registered public accounting firm&#8217;s report contains an explanatory paragraph that expresses substantial doubt about its ability to continue as a &#8220;going concern.&#8221;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023, Data Knights had $29,725,574 held in trust account, $10,108 in cash and working capital deficit of ($2,326,648). Further, Data Knights has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans, including the Business Combination. Data Knights cannot assure you that its plans to raise capital or to consummate </span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">77</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">an initial business combination, including the Business Combination, will be successful. These factors, among others, raise substantial doubt about its ability to continue as a going concern. The financial statements contained elsewhere in this proxy statement/prospectus do not include any adjustments that might result from its inability to consummate the Business Combination or its inability to continue as a going concern.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If Data Knights is required to seek additional capital, it would need to borrow funds from the Sponsor, its management team or other third parties to operate or it may be forced to liquidate. None of such persons is under any obligation to advance funds to Data Knights in such circumstances. Any such advances would be repaid only from funds held outside the Trust Account or from funds released to Data Knights from the Trust Account upon completion of the Business Combination. If Data Knights is unable to consummate the Business Combination because it does not have sufficient funds available, and if Data Knights is not able to consummate another business combination within the timeline set forth in the Data Knights Charter, Data Knights may be forced to cease operations and liquidate the Trust Account. Consequently, Data Knights&#8217; public stockholders may receive less than $10.20 per share and their warrants will expire worthless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, after consummation of the Business Combination Data Knights ability to continue as a going concern is not assured. OneMedNet is a party to convertible notes issued to fund its business which will be assumed by Data Knights in the Business Combination. Beginning on April 1, 2023, these notes may be converted into stock or repaid back in cash at the note holders&#8217; discretion. If more than 30% of these noteholders choose to be paid back in cash, Data Knights may not have sufficient cash available to meet those obligations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights has identified a material weakness in its internal control over financial reporting. This material weakness could continue to adversely affect its ability to report its results of operations and financial condition accurately and in a timely manner.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Data Knights&#8217; management is likewise required, on a quarterly basis, to evaluate the effectiveness of its internal controls and to disclose any changes and material weaknesses identified through such evaluation in those internal controls. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As described elsewhere in this proxy statement/prospectus, Data Knights identified a material weakness in its internal control over financial reporting relating to its classification of the Class&#160;A Common Stock that is subject to possible redemption in permanent equity. Specifically, its management has concluded that our control around the interpretation and accounting for complex financial instruments, such as Data Knights Class&#160;A Common Stock, was not effectively designed or maintained. This material weakness resulted in the restatement of Data Knights&#8217; audited balance sheet as of May&#160;11, 2021, which was included in Data Knights&#8217; current report on Form&#160;8-K filed on May&#160;17, 2021, and the June&#160;30, 2021 financial statements filed on Form&#160;10-Q filed on August&#160;16, 2021 (the &#8220;<b style="font-weight:bold;">Prior Financials</b>&#8221;) to reclassify 11,500,000 shares of Class&#160;A Common Stock in temporary equity. As a result of this material weakness, Data Knights&#8217; management concluded that a deficiency in internal control over financial reporting existed relating to the accounting treatment for complex financial instruments and that the failure to properly account for such instruments constituted a material weakness. This material weakness resulted in the need to restate the Prior Financials.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any failure to maintain such internal control could adversely impact our ability to report our financial position and results of operations on a timely and accurate basis. If Data Knights&#8217; financial statements are not accurate, investors may not have a complete understanding of Data Knights&#8217; operations. Likewise, if Data Knights&#8217; financial statements are not filed on a timely basis, it could be subject to sanctions or investigations by the stock exchange on which its securities are listed, the SEC or other regulatory authorities. In either case, there could result a material adverse effect on Data Knights&#8217; business. Ineffective internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of its stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights can give no assurance that any additional material weaknesses or restatements of financial results will not arise in the future due to a failure to implement and maintain adequate internal control over financial reporting or circumvention of these controls. In addition, even if Data Knights is successful in strengthening its controls and procedures, in the future those controls, and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of its financial statements.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">78</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If Data Knights does not consummate a business combination by August 11, 2023, Data Knights will have to cease all operations except for the purpose of winding up and redeeming all of its public units for their pro rata portions of the Trust Account and liquidate or seek approval of its stockholders to extend the termination date.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If Data Knights is unable to complete a business combination by August 11, 2023, Data Knights will have to (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem all public units then outstanding at a per- unit price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including any amounts representing interest earned on the Trust Account not previously released to Data Knights (net of taxes payable), divided by the number of then outstanding public units, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of its remaining stockholders and board of directors, dissolve and liquidate, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">The SEC issued proposed rules to regulate special purpose acquisition companies that, if adopted, may increase our costs and the time needed to complete our initial business combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With respect to the regulation of special purpose acquisition companies like Data Knights (&#8220;<b style="font-weight:bold;">SPACs</b>&#8221;), on March 30, 2022, the SEC issued proposed rules (the &#8220;<b style="font-weight:bold;">SPAC Rule Proposals</b>&#8221;) relating to, among other items, disclosures in business combination transactions involving SPACs and private operating companies; the condensed financial statement requirements applicable to transactions involving shell companies; the use of projections by SPACs in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business combination transactions; and to the extent to which SPACs could become subject to regulation under the Investment Company Act of 1940, as amended (the &#8220;<b style="font-weight:bold;">Investment Company Act</b>&#8221;), including a proposed rule that would provide SPACs a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a SPAC&#8217;s duration, asset composition, business purpose and activities. These rules, if adopted, whether in the form proposed or in a revised form, may increase the costs of and the time needed to negotiate and complete an initial business combination, and may constrain the circumstances under which Data Knights could complete an initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If Data Knights is deemed to be an investment company for purposes of the Investment Company Act, we would be required to institute burdensome compliance requirements and our activities would be severely restricted. As a result, in such circumstances, unless we are able to modify our activities so that we would not be deemed an investment company, we would expect to abandon our efforts to complete an initial business combination and instead to liquidate.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The SPAC Rule Proposals relate, among other matters, to the circumstances in which SPACs such as Data Knights could potentially be subject to the Investment Company Act and the regulations thereunder. The SPAC Rule Proposals would provide a safe harbor for such companies from the definition of &#8220;investment company&#8221; under Section 3(a)(1)(A) of the Investment Company Act, provided that a SPAC satisfies certain criteria, including a limited time period to announce and complete a de-SPAC transaction. Specifically, to comply with the safe harbor, the SPAC Rule Proposals would require a company to file a report on Form 8-K announcing that it has entered into an agreement with a target company for a business combination no later than 18 months after the effective date of its registration statement for its initial public offering (the &#8220;<b style="font-weight:bold;">IPO Registration Statement</b>&#8221;) and be required to complete its initial business combination no later than 24 months after the effective date of the IPO Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because the SPAC Rule Proposals have not yet been adopted, there is currently uncertainty concerning the applicability of the Investment Company Act to a SPAC, including a company like Data Knights, that may not complete its business combination within the requisite number of months after the effective date of the IPO Registration Statement. As a result, it is possible that a claim could be made that we have been operating as an unregistered investment company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If Data Knights is deemed to be an investment company under the Investment Company Act, our activities would be severely restricted. In addition, we would be subject to burdensome compliance requirements. Data Knights does not believe that our principal activities will subject us to regulation as an investment company under the Investment Company Act. However, if Data Knights is deemed to be an investment company and subject to compliance with and regulation under the Investment Company Act, we would be subject to additional regulatory burdens and expenses for which we have not allotted funds. As a result, unless we are able to modify our activities so that we would not be deemed an investment company, we would expect to abandon our efforts to complete an initial business combination and instead to liquidate.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">79</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, we may, at any time, instruct the trustee to liquidate the securities held in the Trust Account and instead to hold the funds in the Trust Account in cash until the earlier of the consummation of our initial business combination or our liquidation. As a result, following the liquidation of securities in the Trust Account, we would likely receive minimal interest, if any, on the funds held in the Trust Account, which would reduce the dollar amount our public shareholders would receive upon any redemption or liquidation of the Company.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The funds in the Trust Account have, since Data Knights&#8217; initial public offering, been held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. However, to mitigate the risk of Data Knights being deemed to be an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and thus subject to regulation under the Investment Company Act, we may, at any time, and we will, on or prior to the 24-month anniversary of the effective date of the IPO Registration Statement, instruct Continental Stock Transfer &amp; Trust Company, the trustee with respect to the Trust Account, to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash until the earlier of consummation of our initial business combination or liquidation of Data Knights. Following such liquidation, we would likely receive minimal interest, if any, on the funds held in the Trust Account. However, interest previously earned on the funds held in the Trust Account still may be released to us to pay our taxes, if any, and certain other expenses as permitted. As a result, any decision to liquidate the securities held in the Trust Account and thereafter to hold all funds in the Trust Account in cash would reduce the dollar amount our public shareholders would receive upon any redemption or liquidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, even prior to the 24-month anniversary of the effective date of the IPO Registration Statement, we may be deemed to be an investment company. The longer that the funds in the Trust Account are held in short-term U.S. government treasury obligations or in money market funds invested exclusively in such securities, even prior to the 24-month anniversary, the greater the risk that we may be considered an unregistered investment company, in which case we may be required to liquidate Data Knights. Accordingly, we may determine, in our discretion, to liquidate the securities held in the Trust Account at any time, even prior to the 24-month anniversary, and instead hold all funds in the Trust Account in cash, which would further reduce the dollar amount our public shareholders would receive upon any redemption or liquidation of Data Knights, which is consistent with the Extended Date sought hereunder to August 11, 2023 by up to nine one-month extension elections, as specifically provided herein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights and OneMedNet are expected incur significant transaction and transition costs in connection with the Business Combination. If the parties fail to consummate the Business Combination, Data Knights may not have sufficient cash available to pay such costs.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights and OneMedNet expect to incur significant, non-recurring costs in connection with consummating the Business Combination. Some of these costs are payable regardless of whether the Business Combination is completed. Data Knights&#8217; transaction expenses as a result of the Business Combination are currently estimated at approximately $2,275,000, which is comprised of (i)&#160;business combination advisory fees, fairness opinion fees and fees associated with legal, audit, and printing and mailing this proxy statement/prospectus, and (ii)&#160;</span><span style="font-family:'Times New Roman','Times','serif';">$</span><span style="font-family:'Times New Roman','Times','serif';">1,000,000</span><span style="font-family:'Times New Roman','Times','serif';"> payable to EF Hutton, a division of Benchmark Investments,</span><span style="font-family:'Times New Roman PS Std';">&#160;</span><span style="font-family:'Times New Roman','Times','serif';">Inc. for deferred underwriting commissions from the IPO</span><span style="font-family:'Times New Roman','Times','serif';">. OneMedNet estimates its Business Combination costs to be approximately $1&#160;million, which is comprised of advisory, legal, auditing, financial, insurance, investor relations fees and other operating costs. If the parties do not consummate the Business Combination, each party will be required to pay its own fees and expenses, and Data Knights likely will not have sufficient cash available to pay its fees and expenses unless and until it completes a subsequent business combination transaction.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">The working capital available to Data Knights after the Business Combination will be reduced to the extent Data Knights&#8217; stockholders exercise their redemption rights in connection with the Business Combination and will also be reduced to the extent of Data Knights&#8217; and OneMedNet&#8217;s transaction expenses, which will be payable by the Combined Entity. This may adversely affect the business and future operations of Data Knights.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The amount of working capital available to Data Knights after the Business Combination will depend in part on the extent to which Data Knights stockholders exercise their right to redeem their Public Units into cash in connection with the Business Combination. Data Knights&#8217; working capital will be reduced in proportion to such redemptions and will also be reduced to the extent of Data Knights&#8217; and OneMedNet&#8217;s transaction expenses, which will be payable by the Combined Entity. Reduced working capital may adversely affect Data Knights&#8217; business and future operations.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">80</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">The unaudited pro forma financial information included in this proxy statement/prospectus may not be indicative of what the actual financial position or results of operations of the Combined Entity would have been.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The unaudited <i style="font-style:italic;">pro forma</i> financial information in this proxy statement/prospectus is presented for illustrative purposes only and is not necessarily indicative of what the actual financial position or results of operations of the Combined Entity would have been had the Business Combination been completed on the dates indicated. See the section entitled &#8220;<i style="font-style:italic;">Unaudited Pro Forma Combined Financial Information</i>&#8221; for more information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">During the pendency of the Business Combination, Data Knights will not be able to enter into a business combination with another party because of restrictions in the Merger Agreement. Furthermore, certain provisions of the Merger Agreement will discourage third parties from submitting alternative takeover proposals, including proposals that may be superior to the arrangements contemplated by the Merger Agreement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Covenants in the Merger Agreement impede the ability of Data Knights to make acquisitions or complete other transactions that are not in the ordinary course of business pending completion of the Business Combination. As a result, Data Knights may be at a disadvantage to its competitors during that period. In addition, while the Merger Agreement is in effect, neither Data Knights nor OneMedNet may solicit, assist, facilitate the making, submission or announcement of, or intentionally encourage any alternative acquisition proposal, such as a merger, material sale of assets or equity interests or other business combination, with any third party, even though any such alternative acquisition could be more favorable to Data Knights&#8217; stockholders than the Business Combination. In addition, if the Business Combination is not completed, these provisions will make it more difficult to complete an alternative business combination following the termination of the Merger Agreement due to the passage of time during which these provisions have remained in effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If the conditions to the Merger Agreement are not met, the Business Combination may not occur.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Even if the Merger Agreement is approved by the stockholders of Data Knights, specified conditions must be satisfied or waived before the parties to the Merger Agreement are obligated to complete the Business Combination. For a list of the material closing conditions contained in the Merger Agreement, see the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Proposal 1: The Business Combination Proposal &#8212; General Description of the Merger Agreement &#8212; Conditions to the Closing</i><span style="font-family:'Times New Roman','Times','serif';">.&#8221; Data Knights and OneMedNet may not satisfy all of the closing conditions in the Merger Agreement. In particular, one of the closing conditions requires that, upon Closing, after giving effect to the completion of the Redemption and the PIPE Financing, Data Knights will have net tangible assets of at least $5,000,001 unless the NTA Proposal is adopted. See the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Unaudited Pro Forma Condensed Combined Financial Information</i><span style="font-family:'Times New Roman','Times','serif';">.&#8221; If the closing conditions are not satisfied or waived, the Business Combination will not occur or will be delayed pending later satisfaction or waiver, and such delay may cause Data Knights and OneMedNet to each lose some or all of the intended benefits of the Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights may waive one or more of the conditions to the Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights may agree to waive, in whole or in part, some of the conditions to its obligations to complete the Business Combination, to the extent permitted by the Data Knights Charter and applicable laws. For example, it is a condition to Data Knights&#8217; obligations to close the Business Combination that the representations and warranties of OneMedNet are true and correct in all respects as of the date of the Merger Agreement and as of the date of the Closing (or an earlier date to the extent that an earlier date is referenced in the representation and warranty), except, for certain of the representations and warranties, for such inaccuracies that, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect (as defined in the Merger Agreement) on OneMedNet. Under applicable law and the Data Knights Charter, Data Knights is not able to waive the condition that its stockholders approve the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">The Sponsor, directors and officers of Data Knights may have conflicts of interest in determining to pursue the Business Combination with OneMedNet, since certain of their interests, and certain interests of their affiliates and associates, are different from or in addition to (and which may conflict with) the interests of Data Knights&#8217; stockholders.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor, officers, and directors of Data Knights may have interests in and arising from the Business Combination that are different from or in addition to (and which may conflict with) the interests of Data Knights&#8217; public stockholders, which may result in a conflict of interest. These interests include, among other things:</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">81</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that if the Business Combination with OneMedNet or another business combination is not consummated by August 11, 2023 subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension, Data Knights will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding public units for cash and, subject to the approval of its remaining stockholders and the Data Knights Board, dissolving and liquidating. In such event, the founder shares held by the Sponsor and certain of Data Knights&#8217; directors, which were acquired for an aggregate purchase price of $25,000 prior to the Data Knights IPO, would be worthless because the holders are not entitled to participate in any redemption or distribution with respect to such shares. Such 2,731,544 Public Shares had an aggregate market value of $29,090,944 based upon the closing price of $10.65 per share on Nasdaq on March 21, 2023. On the other hand, if the Business Combination is consummated, each outstanding share of Data Knights Class B Common Stock will be exchanged for one share of Data Knights Class A Common Stock, subject to adjustment described herein;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that our Sponsor, officers and directors and their affiliates paid an aggregate of $5,852,750 for the Placement Units and such Placement Units had an aggregate market value of $6,233,179 based upon the closing price of $10.65 per unit on Nasdaq on March 21, 2023. The Placement Units will become worthless if Data Knights does not consummate the Business Combination by August 11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension. On the other hand, if the Business Combination is consummated, each outstanding Placement Units will become one share of Data Knights Common Stock and one warrant exercisable for one share of Data Knights Common Stock for $11.50 per share, subject to adjustment as described herein;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if Data Knights is unable to complete the Business Combination within the required time period, our Sponsor will be liable to ensure that the proceeds in the Trust Account are not reduced by the claims of target businesses or claims of vendors or other entities that are owed money by Data Knights for services rendered or contracted for or products sold to Data Knights, but only if such a vendor or target business has not executed a waiver of claims against the Trust Account and other than any claims covered by our indemnity of the underwriters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Sponsor, directors and officers will benefit from the completion of a business combination and may be incentivized to complete an acquisition of a less favorable target company or on terms less favorable to public stockholders rather than liquidate;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">based on the difference in the purchase price of $0.009 per unit that the Sponsor and certain Data Knights&#8217; directors paid for the founder shares, as compared to the purchase price of $10.00 per unit sold in the Data Knights IPO, the Sponsor and certain Data Knights&#8217; directors may earn a positive rate of return even if the share price of Data Knights after the Closing falls below the price initially paid for the public units in the Data Knights IPO and the public stockholders experience a negative rate of return following the Closing of the Business Combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that, unless Data Knights consummates the Business Combination, Data Knights&#8217; officers, directors and the Sponsor will not receive reimbursement for any out-of-pocket expenses incurred by them to the extent that such expenses exceed the amount of available proceeds not deposited in the Trust Account. As of the Record Date, the Sponsor and Data Knights&#8217; officers and directors and their affiliates had not incurred any unpaid reimbursable expenses. The Sponsor and Data Knights&#8217; officers and directors have no loans outstanding to Data Knights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that the Sponsor has agreed not to redeem any of the Founder Shares and Placement Shares in connection with a stockholder vote to approve a proposed initial business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Sponsor has agreed that the Placement Units, and all of their underlying securities, will not be sold or transferred by it until Data Knights has completed a business combination, subject to limited exceptions; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the continued indemnification of current directors and officers of Data Knights and the continuation of directors&#8217; and officers&#8217; liability insurance after the Business Combination.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These interests may influence Data Knights&#8217; directors in making their recommendation that you vote in favor of the Business Combination Proposal and the transactions contemplated thereby. The estimated aggregate amount invested by Sponsor and certain of Data Knights&#8217; directors and executive officers in their interests in Data Knights is $5,877,750.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">82</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">The value of the Founder Shares following completion of the Business Combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of the Data Knights Common Stock at such time is substantially less than $10.00 per share.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor and certain of our officers and directors have invested in us an aggregate of $5,877,750, comprised of the $25,000 purchase price for the Founder Shares and the $5,852,750 purchase price for the Placement Units apart from expenses. Assuming a trading price of $10.00 per share upon consummation of the Business Combination, the 2,875,000 Founder Shares and 585,275 Placement Shares would have an aggregate implied value of $34,602,750 (assuming no value is attributed to the Private Placement Warrants). Even if the trading price of Data Knights Common Stock was as low as approximately $1.70 per share, the value of the Founder Shares and Placement Shares would be equal to such parties&#8217; initial investment in us. As a result, such parties are likely to be able to recoup their investment in us and make a substantial profit on that investment, even if the Data Knights Common Stock loses significant value. Accordingly, the Sponsor and members of the Data Knights management team may have an economic incentive that differs from that of the Data Knights public stockholders to pursue and consummate the Business Combination, even if the Business Combination were with a riskier or less-established target business. Accordingly, you should consider the financial incentive of such parties to complete the Business Combination when evaluating whether to redeem your shares prior to or in connection with the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may be deemed a &#8220;foreign person&#8221; under U.S. foreign investment regulations which might impose conditions on the consummation of the Business Combination and our failure to obtain any required approvals within the requisite time period may require us to liquidate. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s Sponsor is Data-Knights LLC, a Delaware limited liability company. The sponsor currently beneficially owns 3,415,275 shares of our common stock (585,275 shares of Class A Common Stock and 2,830,000 shares of Class B Common Stock). The Sponsor is controlled by one or more non-U.S. persons. While we do believe that our Sponsor may constitute a &#8220;foreign person&#8221; under rules and regulations of the Committee on Foreign Investment in the United States (&#8220;CFIUS&#8221;), we do not believe the Business Combination would be subject to CFIUS review in view of the asset class of the Business Combination. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If, however, the Business Combination was deemed to fall within the scope of applicable foreign ownership restrictions, we may be unable to consummate the Business Combination so we may be required to seek other potential targets. The pool of potential targets with which we could complete an initial business combination may be limited as a result of any such regulatory restriction. Moreover, the process of any government review, whether by CFIUS or otherwise, could be lengthy, which could delay our ability to close our initial business combination within the requisite time period, which means we may be required to liquidate. We could make a mandatory filing or determine to submit a voluntary notice to CFIUS, or to proceed with the business combination without notifying CFIUS and risk CFIUS intervention, before or after closing the business combination. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Investments that involve the acquisition of, or investment in, a U.S. business by a non-U.S. investor may be subject to U.S. laws that regulate foreign investments in U.S. businesses and access by foreign persons to technology developed and produced in the United States. These laws include Section 721 of the Defense Production Act of 1950, as amended by the Foreign Investment Risk Review Modernization Act of 2018, and the regulations at 31 C.F.R. Parts 800 and 802, as amended, administered by CFIUS. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Whether CFIUS has jurisdiction to review an acquisition or investment transaction depends on, among other factors, the nature and structure of the transaction, including the level of beneficial ownership interest and the nature of any information or governance rights involved. For example, investments that result in &#8220;control&#8221; of a &#8220;U.S. business&#8221; by a &#8220;foreign person&#8221; (in each case, as such terms are defined in 31 C.F.R. Part 800) always are subject to CFIUS jurisdiction. Significant CFIUS reform legislation, which was fully implemented through regulations that became effective in 2020, expanded the scope of CFIUS&#8217;s jurisdiction to investments that do not result in control of a U.S. business by a foreign person, but afford certain foreign investors certain information or governance rights in a U.S. business that has a nexus to &#8220;critical technologies,&#8221; &#8220;covered investment critical infrastructure,&#8221; and/or &#8220;sensitive personal data&#8221; (in each case, as such terms are defined in 31 C.F.R. Part 800). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Any business combination in which we engage may be subject to notification requirements and review by CFIUS or another U.S. governmental agency, and while we do not believe that notification to CFIUS regarding the Business Combination is required, there can be no assurance that CFIUS or another U.S. governmental agency will not choose to review the Business Combination. Any review and approval of an investment or transaction by CFIUS may have outsized impacts on transaction certainty, timing, feasibility, and cost, among other things. CFIUS policies and agency practices are rapidly evolving, and, in the event that CFIUS reviews a business combination or one or more proposed or existing investment by investors, there can be no assurance that such investors will be able to maintain, or proceed with, such investments on terms acceptable to the parties to the transaction or such investors. Among </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">83</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">other things, CFIUS could seek to impose limitations or restrictions on, or prohibit, investments by such investors (including, but not limited to, limits on purchasing Data Knights common stock, limits on information sharing with such investors, requiring a voting trust, governance modifications, or forced divestiture, among other things). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If CFIUS elects to review a business combination, the time necessary to complete such review of the business combination or a decision by CFIUS to prohibit the business combination could prevent us from completing our initial business combination prior to the then applicable Extended Date. If we are not able to consummate a business combination by the applicable Extended Date, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, dissolve and liquidate, subject in each case to obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. In addition, if we fail to complete an initial business combination by the applicable Extended Date, there will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete a Business Combination with which a substantial majority of our stockholders do not agree. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights Charter does not provide a specified maximum redemption threshold, except that we will not redeem our public shares in an amount that would cause the Company&#8217;s net tangible assets to be less than $5,000,001 upon consummation of our initial business combination (such that we are not subject to the SEC&#8217;s &#8220;penny stock&#8221; rules). We are currently pursuing approval of the NTA Proposal, which would result in the removal of this limitation. See &#8220;NTA Proposal.&#8221; The Merger Agreement provides that the obligation of OneMedNet to consummate the Business Combination is not conditioned on the amount of cash or cash equivalents that we have from any source including the cash available to Data Knights from the Trust Account (after any further redemptions by the Data Knights stockholders and the payment of any deferred underwriting expenses of Data Knights not related to the Business Combination). As a result, we expect to be able to consummate our Business Combination even if a portion of our public stockholders do not agree with the transaction and have redeemed their shares or have entered into privately negotiated agreements to sell their shares. As of the date of this proxy statement/prospectus, no agreements with respect to the private purchase of public shares by the Combined Entity or the persons described above have been entered into with any such investor or holder. We will file a Current Report on Form 8-K with the SEC to disclose private arrangements entered into or significant private purchases that would affect the vote on the Business Combination Proposal or other proposals (as described in this proxy statement/prospectus) at the special meeting. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In the event of failure of the NTA Proposal and of excessive redemptions and the inability to close the PIPE to prevent the Company&#8217;s net tangible assets to be less than $5,000,001 upon consummation of our initial business combination, Data Knights may be unable to complete its initial business combination because it does not have sufficient funds available to it. In addition, excessive redemptions could result in Data Knights failing to satisfy the Minimum Cash Condition, unless waived by OneMedNet. In such event, Data Knights will be forced to cease operations and liquidate the Trust Account. Consequently, Data Knights&#8217; public stockholders may only receive an estimated $10.20 per share, or possibly less, on its redemption of its public shares, and its warrants will expire worthless. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the event the aggregate cash consideration we would be required to pay for all shares of common stock that are validly submitted for redemption exceeds the aggregate amount of cash available to us, we may not complete the Business Combination or redeem any shares, all shares of common stock submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business combination or be required to liquidate. Data Knights expects that the amount of any distribution its Public Stockholders will be entitled to receive upon its dissolution will be approximately the same as the amount they would have received if they had redeemed their shares in connection with the Business Combination, subject in each case to Data Knights&#8217; obligations under the DGCL to provide for claims of creditors and other requirements of applicable law. Holders of Founder Shares have waived any right to any liquidation distribution with respect to those shares. In the event of liquidation, there will be no distribution with respect to Data Knights&#8217; outstanding Warrants Accordingly, all Warrants will expire worthless. </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">84</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">If Data Knights is not able to close the PIPE it may not be able to meet the closing conditions of the Business Combination or it may be undercapitalized following the Business Combination. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If Data Knights is unable to close the PIPE at a sufficient level of investment, Data Knights may not have sufficient net tangible assets or sufficient cash on hand to satisfy the conditions to close the Business Combination, including the Minimum Cash Condition, unless waived by OneMedNet. Even if Data Knights can satisfy those conditions, it may not be sufficiently capitalized to execute on its post-combination business plan. Certain of the closing conditions to the Business Combination may be waived by the parties, but there can be no assurance that such a waiver will occur. If the Business Combination does not close as a result of unmet closing conditions, Data Knights may have to liquidate without completing its initial business combination. If the Business Combination is consummated, but the post-combination company is undercapitalized, Data Knights business, financial condition and results of operations may be adversely affected, reducing stockholders&#8217; return on their investment.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Because Data Knights is not conducting an underwritten offering of OneMedNet&#8217;s securities, no underwriter has conducted due diligence of OneMedNet&#8217;s business, operations or financial condition or reviewed the disclosure in this proxy statement/prospectus.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Section&#160;11 of the Securities Act (&#8220;Section&#160;11&#8221;) imposes liability on parties, including underwriters, involved in a securities offering if the registration statement contains a materially false statement or material omission. To effectively establish a due diligence defense against a cause of action brought pursuant to Section&#160;11, a defendant, including an underwriter, carries the burden of proof to demonstrate that he or she, after reasonable investigation, believed that the statements in the registration statement were true and free of material omissions. In order to meet this burden of proof, underwriters in a registered offering typically conduct extensive due diligence of the registrant and vet the registrant&#8217;s disclosure. Such due diligence may include calls with the issuer&#8217;s management, review of material agreements, and background checks on key personnel, among other investigations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because OneMedNet intends to become publicly traded through a business combination with Data Knights, a special purpose acquisition company, rather through an underwritten offering of its shares of common stock, no underwriter is involved in the transaction. As a result, no underwriter has conducted diligence on OneMedNet or Data Knights in order to establish a due diligence defense with respect to the disclosure presented in this proxy statement/prospectus. If such investigation had occurred, certain information in this proxy statement/prospectus may have been presented in a different manner or additional information may have been presented at the request of such underwriter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Nasdaq may delist Data Knights&#8217; securities from trading on its exchange, which could limit investors&#8217; ability to make transactions in Data Knights&#8217; securities and subject Data Knights to additional trading restrictions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; securities are currently listed on Nasdaq. In order to continue the listing of its securities on Nasdaq, Data Knights prior to the Business Combination, and Data Knights following the consummation of the Business Combination, must maintain certain financial, share price and distribution levels. Generally, a listed company must maintain a minimum market capitalization (generally $50,000,000) and a minimum number of holders of its securities (currently 300 public holders). Data Knights cannot assure you that Data Knights&#8217; securities will be approved for listing on Nasdaq following the Closing, or that Data Knights will be able to comply with the continued listing rules&#160;of Nasdaq. In connection with the Business Combination and as a condition to OneMedNet&#8217;s&#8217; obligations to complete the Business Combination, Data Knights will be required to demonstrate Data Knights&#8217; compliance with Nasdaq&#8217;s initial listing requirements, which are more rigorous than Nasdaq&#8217;s continued listing requirements. In addition to the listing requirements for Data Knights Common Stock, Nasdaq imposes listing standards on warrants. Data Knights cannot assure you that Data Knights will be able to meet those initial listing requirements, in which case OneMedNet will not be obligated to complete the Business Combination. Even if Data Knights Common Stock and warrants are approved for listing on Nasdaq, Data Knights may not meet Nasdaq&#8217;s continued listing requirements following the Business Combination. Data Knights&#8217; continued eligibility for listing may depend on, among other things, the number of Data Knights&#8217; units that are redeemed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If Nasdaq delists Data Knights&#8217; securities from trading on Nasdaq and Data Knights is unable to list its securities on another national securities exchange, Data Knights&#8217; securities could be quoted on an over-the-counter market. If this were to occur, Data Knights could face significant material adverse consequences, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a limited availability of market quotations for Data Knights&#8217; securities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reduced liquidity for Data Knights&#8217; securities;</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">85</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a determination that Data Knights Common Stock is a &#8220;penny stock,&#8221; which will require brokers trading in Data Knights Common Stock to adhere to more stringent rules&#160;and possibly result in a reduced level of trading activity in the secondary trading market for Data Knights&#8217; securities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a limited amount of news and analyst coverage; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decreased ability to issue additional securities or obtain additional financing in the future.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as &#8220;covered securities.&#8221; Because Data Knights&#8217; units, common stock and public warrants are listed on Nasdaq, its units, common stock and public warrants qualify as covered securities. Although the states are preempted from regulating the sale of Data Knights&#8217; securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While Data Knights is not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank check companies, other than the state of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if Data Knights&#8217; securities were no longer listed on Nasdaq, its securities would not be covered securities and Data Knights would be subject to regulation in each state in which it offers its securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Public stockholders exercising their redemption rights with respect to the public units sold in Data Knights&#8217; IPO will forfeit the portion of warrants included in the units without the payment of any additional consideration.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the Data Knights Charter, public stockholders will be entitled to redeem their public units for a portion of the Trust Account if a business combination is consummated. Accordingly, the warrants included in the public units are subject to forfeiture, without the payment of any additional consideration, if the holder elects to cause Data Knights to redeem the public unit of which the warrant forms a part. This is different than in other similarly structured blank check companies where a redeeming stockholder is able to keep any warrants he may still hold, whether included within a unit or held separately. Accordingly, investors may have a disincentive to exercise their redemption rights because they will automatically forfeit the warrant included in the unit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor, as well as Data Knights&#8217; directors, officers, advisors, and their affiliates may elect to purchase public units prior to the consummation of the Business Combination, which may influence the vote on the Business Combination and reduce the public &#8220;float&#8221; of Data Knights&#8217; common stock. Any such privately negotiated purchases may be effected at purchase prices that are equal to or below the per-share pro rata portion of the Trust Account, none of such shares would be voted in favor of the Business Combination, and no exercise of redemption rights would be made by the purchasers with respect to such shares. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">However, in the event our Sponsor, directors, officers, advisors or their affiliates were to purchase shares or warrants from public stockholders, such purchases would by structured in compliance with the requirements of Rule 14e-5 under the Exchange Act including, in pertinent part, through adherence to the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Company&#8217;s registration statement/proxy statement filed for its business combination transaction would disclose the possibility that the Company&#8217;s sponsor, directors, officers, advisors or their affiliates may purchase shares or warrants from public stockholders outside the redemption process, along with the purpose of such purchases; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the Company&#8217;s sponsor, directors, officers, advisors or their affiliates were to purchase shares or warrants from public stockholders, they would do so at a price no higher than the price offered through the Company&#8217;s redemption process; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Company&#8217;s registration statement/proxy statement filed for its business combination transaction would include a representation that any of the Company&#8217;s securities purchased by the Company&#8217;s Sponsor, directors, officers, advisors or their affiliates would not be voted in favor of approving the business combination transaction; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Company&#8217;s Sponsor, directors, officers, advisors or their affiliates would not possess any redemption rights with respect to the Company&#8217;s securities or, if they do acquire and possess redemption rights, they would waive such rights; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Company would disclose in its Form 8-K, before to the Company&#8217;s security holder meeting to approve the business combination transaction, the following material items: </span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">86</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the amount of the Company&#8217;s securities purchased outside of the redemption offer by the Company&#8217;s sponsor, directors, officers, advisors or their affiliates, along with the purchase price; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the purpose of the purchases by the Company&#8217;s sponsor, directors, officers, advisors or their affiliates; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the impact, if any, of the purchases by the Company&#8217;s sponsor, directors, officers, advisors or their affiliates on the likelihood that the business combination transaction will be approved; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the identities of Company security holders who sold to the Company&#8217;s sponsor, directors, officers, advisors or their affiliates (if not purchased on the open market) or the nature of Company security holders (e.g., 5% security holders) who sold to the Company&#8217;s sponsor, directors, officers, advisors or their affiliates; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the number of Company securities for which the Company has received redemption requests pursuant to its redemption offer.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At any time prior to the Special Meeting, during a period when they are not then aware of any material nonpublic information regarding Data Knights or its securities, Data Knights&#8217; Sponsor, directors, officers, advisors or their respective affiliates may purchase public units from investors, or they may enter into transactions with such investors and others to provide them with incentives to acquire public units or vote their shares in favor of the Business Combination Proposal. The purpose of such securities purchases and other transactions would be to increase the likelihood that the Proposals presented to stockholders for approval at the Special Meeting are approved or to provide additional equity financing. Any such share purchases and other transactions may thereby increase the likelihood of obtaining stockholder approval of the Business Combination. This may result in the completion of Data Knights&#8217; Business Combination that may not otherwise have been possible. While the exact nature of any such incentives has not been determined as of the date of this proxy statement/prospectus, they might include, without limitation, arrangements to protect such investors or holders against potential loss in value of their shares, including the granting of put options.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Entering into any such incentive arrangements may have a depressive effect on Data Knights&#8217; units. For example, as a result of these arrangements, an investor or holder may have the ability to effectively purchase units at a price lower than market and may therefore be more likely to sell the units he owns, either prior to or immediately after the Special Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If such transactions are effected, the consequence could be to cause the Business Combination to be approved in circumstances where such approval could not otherwise be obtained. Purchases of units by the persons described above would allow them to exert more influence over the approval of the Proposals to be presented at the Special Meeting and would likely increase the chances that such Proposals would be approved. In addition, if such purchases are made, the public &#8220;float&#8221; of Data Knights public units and the number of beneficial holders of Data Knights securities may be reduced, possibly making it difficult to maintain or obtain the quotation, listing, or trading of Data Knights&#8217; securities on a national securities exchange.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of the date of this proxy statement/prospectus, there have been no such discussions and no agreements to such effect have been entered into with any such investor or holder. Data Knights will file a Current Report on Form&#160;8-K to disclose any arrangements entered into or significant purchases made by any of the aforementioned persons that would affect the vote on the Proposals to be voted on at the Special Meeting. Any such report will include descriptions of any arrangements entered into or significant purchases by any of the aforementioned persons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If third parties bring claims against Data Knights, the proceeds held in trust could be reduced and the per-unit redemption price received by stockholders may be less than $10.20.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The proceeds of the Trust Account may not protect those funds from third-party claims against Data Knights. Although Data Knights has requested vendors and service providers it engages and prospective target businesses it negotiates with to execute agreements with it waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of Data Knights&#8217; public stockholders, they may not execute such agreements. Furthermore, even if such entities execute such agreements with Data Knights, they may seek recourse against the Trust Account. A court may not uphold the validity of such agreements. Accordingly, the proceeds held in trust could be subject to claims which could take priority over those of Data Knights&#8217; public stockholders. If Data Knights is unable to complete a business combination and distribute the proceeds held in trust to its public stockholders, the Sponsor has agreed (subject to certain exceptions) that it will be liable to ensure that the proceeds in the Trust Account are not reduced below $10.20 per unit by the claims of target businesses or claims of vendors or other entities that are owed money by Data Knights for services rendered or contracted for or products sold to Data Knights. However, Data Knights has not asked </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">87</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">the Sponsor to reserve for such indemnification obligations, nor has Data Knights independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor&#8217;s only assets are securities of Data Knights. Therefore, Data Knights believes it is unlikely that the Sponsor will be able to satisfy its indemnification obligations if it is required to do so. As a result, the per-unit distribution from the Trust Account may be less than $10.20, plus interest, due to such claims.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, if Data Knights is forced to file a bankruptcy case or an involuntary bankruptcy case is filed against Data Knights which is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy law and may be included in Data Knights&#8217; bankruptcy estate and subject to the claims of third parties with priority over the claims of Data Knights&#8217; stockholders. To the extent any bankruptcy claims deplete the Trust Account, Data Knights may not be able to return to its public stockholders at least $10.20.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights&#8217; stockholders may be held liable for claims by third parties against us to the extent of distributions received by them.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights Charter provides that it will continue in existence only until August 11, 2023 subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension. If Data Knights is unable to complete an initial business combination by the Business Combination Date, as the same may be extended, Data Knights will (i)&#160;cease all operations except for the purpose of winding up and (ii)&#160;as promptly as reasonably possible but not more than ten business&#160;days thereafter, redeem 100% of the outstanding public units, at a per-unit price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including any interest not previously released to Data Knights (net of taxes payable), divided by the number of then-outstanding public units, which redemption will completely extinguish public stockholders&#8217; rights as holders of units (including the right to receive further liquidation distributions, if any), subject to applicable law. Public stockholders will also forfeit the warrant included in the units being redeemed. As promptly as reasonably possible following such redemption, subject to the approval of Data Knights&#8217; remaining stockholders and its board of directors, Data Knights will dissolve and liquidate, subject to its obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Data Knights cannot assure you that it will properly assess all claims that may be potentially brought against it. As such, Data Knights&#8217; stockholders could potentially be liable for any claims to the extent of distributions received by them (but no more) and any liability of Data Knights&#8217; stockholders may extend well beyond the third anniversary of the date of distribution. Accordingly, Data Knights cannot assure you that third parties will not seek to recover from Data Knights&#8217; stockholders amounts owed to them by it.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If Data Knights is forced to file a bankruptcy case or an involuntary bankruptcy case is filed against Data Knights which is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a &#8220;preferential transfer&#8221; or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy court could seek to recover all amounts received by Data Knights&#8217; stockholders. Furthermore, because Data Knights intends to distribute the proceeds held in the Trust Account to its public stockholders promptly after expiration of the time Data Knights has to complete an initial business combination, this may be viewed or interpreted as giving preference to Data Knights&#8217; public stockholders over any potential creditors with respect to access to or distributions from its assets. Furthermore, the Data Knights Board may be viewed as having breached their fiduciary duties to its creditors and/or may have acted in bad faith, thereby exposing itself and Data Knights to claims of punitive damages, by paying public stockholders from the Trust Account prior to addressing the claims of creditors. Data Knights cannot assure you that claims will not be brought against it for these reasons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights&#8217; directors may decide not to enforce the Sponsor&#8217;s indemnification obligations, resulting in a reduction in the amount of funds in the Trust Account available for distribution to its public stockholders.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the event that the proceeds in the Trust Account are reduced below $10.20 per public unit and the Sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification obligations related to a particular claim, Data Knights&#8217; independent directors would determine whether to take legal action against the Sponsor to enforce such indemnification obligations. It is possible that Data Knights&#8217; independent directors, in exercising their business judgment, may choose not to do so in any particular instance. If Data Knights&#8217; independent directors choose not to enforce these indemnification obligations, the amount of funds in the Trust Account available for distribution to its public stockholders may be reduced below $10.20 per unit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">In connection with any vote to approve a business combination, Data Knights will offer each public stockholder the option to vote in favor of the Business Combination and still seek redemption of their units.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In connection with any vote to approve the Business Combination, Data Knights will offer each public stockholder (but not the Sponsor, officers or directors) the right to have his, her or its units redeemed for cash (subject to the limitations described elsewhere in </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">88</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">this prospectus) regardless of whether such stockholder votes for or against such proposed business combination or does not vote at all. The ability to seek redemption while voting in favor of Data Knights&#8217; proposed business combination may make it more likely that Data Knights will consummate a business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">In connection with the stockholder meeting called to approve the Business Combination, Data Knights may require stockholders who wish to redeem their units in connection with the Business Combination to comply with specific requirements for redemption that may make it more difficult for them to exercise their redemption rights prior to the deadline for exercising their rights.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the stockholder meeting called to approve the proposed Business Combination, each public stockholder will have the right, regardless of whether he or she is voting for or against such proposed business combination or does not vote at all, to demand that Data Knights redeem his or her units into a pro rata share of the Trust Account as of two business&#160;days prior to the consummation of the initial business combination. However, any stockholder redeeming its units will forfeit the warrant included in such unit, without the payment of any additional consideration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights may require public stockholders who wish to redeem their units in connection with a Business Combination to either (i)&#160;tender their certificates to our transfer agent or (ii)&#160;deliver their units to the transfer agent electronically using the Depository Trust Company&#8217;s DWAC (Deposit/Withdrawal At Custodian) System, at the holder&#8217;s option, in each case prior to a date set forth in the tender offer documents or proxy materials sent in connection with the proposal to approve the business combination. In order to obtain a physical certificate, a stockholder&#8217;s broker and/or clearing broker, DTC and our transfer agent will need to act to facilitate this request. It is Data Knights&#8217; understanding that stockholders should generally allow at least two weeks to obtain physical certificates from the transfer agent. However, because Data Knights does not have any control over this process or over the brokers or DTC, it may take significantly longer than two weeks to obtain a physical stock certificate. While Data Knights has been advised that it takes a short time to deliver units through the DWAC System, it cannot assure you of this fact. Accordingly, if it takes longer than Data Knights anticipates for stockholders to deliver their units, stockholders who wish to redeem may be unable to meet the deadline for exercising their redemption rights and thus may be unable to redeem their units.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If, in connection with the stockholder meeting called to approve the Business Combination, Data Knights requires public stockholders who wish to redeem their units to comply with specific requirements for redemption, such redeeming stockholders may be unable to sell their securities when they wish to in the event that the proposed business combination is not approved.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If Data Knights requires public stockholders who wish to redeem their units to comply with specific requirements for redemption and such proposed business combination is not consummated, Data Knights will promptly return such certificates to the tendering public stockholders. Accordingly, investors who attempted to redeem their units in such a circumstance will be unable to sell their securities after the failed acquisition until Data Knights has returned their securities to them. The market price for Data Knights&#8217; units may decline during this time and you may not be able to sell your securities when you wish to, even while other stockholders that did not seek redemption may be able to sell their securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If Data Knights does not file and maintain a current and effective prospectus relating to the common stock issuable upon exercise of the warrants, holders will only be able to exercise such warrants on a &#8220;cashless basis.&#8221;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If Data Knights does not file and maintain a current and effective prospectus relating to the common stock issuable upon exercise of the warrants at the time that holders wish to exercise such warrants, they will only be able to exercise them on a &#8220;cashless basis&#8221; provided that an exemption from registration is available. As a result, the number of shares of Data Knights Common Stock that holders will receive upon exercise of the warrants will be fewer than it would have been had such holder exercised his warrant for cash. Further, if an exemption from registration is not available, holders would not be able to exercise on a cashless basis and would only be able to exercise their warrants for cash if a current and effective prospectus relating to the Data Knights Common Stock issuable upon exercise of the warrants is available. Under the terms of the warrant agreement, Data Knights has agreed to use its best efforts to meet these conditions and to file and maintain a current and effective prospectus relating to the common stock issuable upon exercise of the warrants until the expiration of the warrants. However, Data Knights cannot assure you that it will be able to do so. If Data Knights is unable to do so, the potential &#8220;upside&#8221; of the holder&#8217;s investment in Data Knights may be reduced or the warrants may expire worthless.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">89</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights&#8217; ability to successfully effect the Business Combination and successfully operate the business thereafter will be largely dependent upon the efforts of certain key personnel, including the key personnel of OneMedNet, all of whom are expected to stay with Data Knights following the Business Combination. The loss of such key personnel could negatively impact the operations and profitability of the post-combination business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; ability to successfully effect the Business Combination and successfully operate the business of OneMedNet following the Closing is dependent upon the efforts of certain key personnel of Data Knights and the key personnel of OneMedNet Although all of such key personnel are expected to remain with Data Knights and OneMedNet following the Business Combination, it is possible that the Combined Entity will lose some key personnel, the loss of which could negatively impact the operations and profitability of the post-combination business. Furthermore, while Data Knights has scrutinized individuals it intends to engage to stay with New OneMedNet following the Business Combination, its assessment of these individuals may not prove to be correct. These individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause the Combined Entity to have to expend time and resources helping them become familiar with such requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">If the Business Combination&#8217;s benefits do not meet the expectations of investors, stockholders or financial analysts, the market price of Data Knights&#8217; securities may decline.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If the benefits of the Business Combination do not meet the expectations of investors or securities analysts, the market price of Data Knights&#8217; securities prior to the Closing of the Business Combination may decline. The market values of Data Knights&#8217; securities at the time of the Business Combination may vary significantly from their prices on the date the Merger Agreement was executed, the date of this proxy statement/prospectus, or the date on which our stockholders vote on the Business Combination. In addition, following the Business Combination, fluctuations in the price of the securities of Data Knights could contribute to the loss of all or part of your investment. Prior to the Business Combination, there has not been a public market for OneMedNet&#8217;s stock or Data Knights&#8217; stock and trading in the shares of Data Knights&#8217; common stock has not been active. Accordingly, the valuation ascribed to OneMedNet and Data Knights Common Stock in the Business Combination may not be indicative of the price that will prevail in the trading market following the Business Combination. If, following the Business Combination, an active market for Data Knights&#8217; securities develops and continues, the trading price of these securities could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond Data Knights&#8217; control. Any of the factors listed below could have a material adverse effect on your investment in our securities and Data Knights&#8217; securities may trade at prices significantly below the price you paid for them. In such circumstances, the trading price of Data Knights&#8217; securities may not recover and may experience a further decline.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Factors affecting the trading price of Data Knights&#8217; securities following the Business Combination may include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">actual or anticipated fluctuations in the quarterly financial results of Data Knights or the quarterly financial results of companies perceived to be similar to Data Knights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in the market&#8217;s expectations about Data Knights&#8217; operating results;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights&#8217; operating results failing to meet the expectation of securities analysts or investors in a particular period;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in financial estimates and recommendations by securities analysts concerning Data Knights or the pharmaceutical industry in general;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">operating and stock price performance of other companies that investors deem comparable to Data Knights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ability to obtain, maintain and enforce necessary intellectual property protections and to avoid infringing upon the intellectual property rights of others;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in laws and regulations affecting Data Knights&#8217; business;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">commencement of, or involvement in, litigation involving Data Knights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in Data Knights&#8217; capital structure, such as future issuances of securities or the incurrence of additional debt;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the volume of shares of Data Knights Common Stock available for public sale;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any major change in the board or management of Data Knights;</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">90</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">sales of substantial amounts of Data Knights&#8217; stock by its directors, executive officers or significant stockholders or the perception that such sales could occur;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">uncertain global economic conditions decreasing demand for products or causing customers and other business partners to suffer financial hardships; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">general economic and political conditions such as recessions, interest rates, fuel prices, international currency fluctuations and acts of war or terrorism.</span></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Broad market and industry factors may materially harm the market price of Data Knights&#8217; securities irrespective of its operating performance. The stock market in general has experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of Data Knights&#8217; securities, may not be predictable. A loss of investor confidence in the market for outdoor grilling-related stocks or the stocks of other companies which investors perceive to be similar to Data Knights could depress its stock price regardless of its business, prospects, financial conditions or results of operations. A decline in the market price of Data Knights&#8217; securities also could adversely affect its ability to issue additional securities and its ability to obtain additional financing in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights&#8217; public stockholders may experience dilution of their voting power as a consequence of, among other transactions, the issuance of Data Knights Common Stock as consideration in the Business Combination and the assumption of debt, if convertible into equity. Having a minority share position may reduce the influence that Data Knights&#8217; current stockholders have on the management of Data Knights.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">It is anticipated that, upon the Closing of the Business Combination, assuming no further redemptions, Data Knights&#8217; public stockholders will retain an ownership interest of approximately 8.3% in Data Knights and Data Knights&#8217; directors and the Sponsor will retain an ownership interest of approximately 10.5% in Data Knights. The ownership&#160;percentages set forth above with respect to the officers and directors of Data Knights and the Sponsor, gives effect to the transfer to 45,000 of Founder Shares owned by the Sponsor, but does not give effect to (i)&#160;any further redemption of any units by Data Knights&#8217; public stockholders; (ii)&#160;the issuance of any shares upon the exercise of warrants to purchase shares of Data Knights Common Stock that will remain outstanding following the Business Combination or any additional warrants that are issued to our Sponsor pursuant to the conversion of its working capital loans that were made to Data Knights; or (iii)&#160;the issuance of any shares under the </span><span style="font-family:'Times New Roman','Times','serif';">Equity</span><span style="font-family:'Times New Roman','Times','serif';"> Incentive Plan. If the actual facts are different than these assumptions (which they are likely to be), the&#160;percentage ownership retained by Data Knights&#8217; existing stockholders in Data Knights will be different. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">For example, if 80% of the units held by Data Knights&#8217; public stockholders are redeemed, it is anticipated that, upon the Closing of the Business Combination, assuming no further redemptions, Data Knights&#8217; public stockholders will retain an ownership interest of approximately 7.1% in Data Knights and Data Knights&#8217; directors and the Sponsor will retain an ownership interest of approximately 10.6% in Data Knights. </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">See Questions And Answers About The Proposals &#8211; What equity stake will current stockholders of Data Knights hold after the Closing?</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">To the extent that any of the outstanding warrants are exercised for shares of Data Knights Common Stock, or additional awards are issued under the Equity Incentive Plan, Data Knights&#8217; existing stockholders may experience substantial dilution. Such dilution could, among other things, limit the ability of Data Knights&#8217; current stockholders to influence Data Knights&#8217; management through the election of directors following the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Data Knights&#8217; Sponsor, directors and officers have agreed to vote in favor of its initial business combination, regardless of how Data Knights&#8217; public stockholders vote.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Unlike many other blank check companies in which the Founders agree to vote their Founder Shares in accordance with the majority of the votes cast by the public stockholders in connection with an initial business combination, Data Knights&#8217; Sponsor, directors and officers have agreed to vote their Founder Shares and Placement Shares, as well as any Public Shares underlying the units included as part of the Public</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Units purchased by them in or after the IPO, in favor of the Business Combination of Data Knights. Data Knights&#8217; Sponsor and certain of Data Knights&#8217; directors and officers currently own 3,460,275 shares of Data Knights Common Stock, representing approximately 55.9% of the issued and outstanding shares of Data Knights Common Stock. As a result, Data Knights would not need any of the 2,731,544 Public Shares to be voted in favor of the Business Combination in order to have the Business Combination approved. Accordingly, it is more likely that the necessary stockholder approval will be received than would be the case if Data </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">91</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">Knights&#8217; Sponsor, directors, and officers agreed to vote their Founder Shares and Placement Shares in accordance with the majority of the votes cast by its public stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Following the Closing of the Business Combination, Data Knights may be required to take write-downs or write-offs, restructuring and impairment or other charges that could adversely affect its financial condition, results of operations and stock price, which could cause you to lose some or all of your investment.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Although Data Knights has conducted due diligence on OneMedNet, there is no assurance that this diligence revealed all material issues that may be present in OneMedNet&#8217;s business, that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of Data Knights&#8217; and OneMedNet&#8217;s control will not later arise. As a result, Data Knights may be forced later to write down or write off assets, restructure its operations, or incur impairment or other charges following the Closing of the Business Combination that could result in losses. Even if Data Knights&#8217; due diligence successfully identifies certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and not have an immediate impact on the liquidity of Data Knights, the fact that Data Knights&#8217; reports charges of this nature could contribute to negative market perceptions about the Combined Entity or its securities. In addition, charges of this nature may cause Data Knights to be unable to obtain future financing on favorable terms or at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warrants will become exercisable for Data Knights Common Stock, which would increase the number of shares eligible for future resale in the public market and result in dilution to Data Knights&#8217; stockholders.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights issued public warrants to purchase 11,500,000 shares of Data Knights Class A Common Stock as part of the Data Knights IPO and an aggregate of 585,275 Private Placement Warrants as part of the Placement Units sold to the Sponsor. At present, the number of shares of Data Knights Class A Common Stock outstanding as part of the Data Knights IPO has been reduced to 2,731,544 following the recent redemptions contemporaneous to the Data Knights special meeting on November 11, 2022. All the OneMedNet warrants will be cancelled and exchanged for Data Knights warrants upon Closing of the Business Combination. The exercise price of the Data Knights warrants is $11.50 per share, which is above the recent trading price for the underlying Data Knights Class A Common Stock and may reduce their near term value. To the extent such warrants are exercised, additional shares of Data Knights Class A Common Stock will be issued, which will result in dilution to the then existing holders of Data Knights Class A Common Stock and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market could adversely affect the market price of Data Knights Class A Common Stock.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Activities taken by affiliates of Data Knights to purchase, directly or indirectly, public units will increase the likelihood of approval of the Business Combination Proposal and other proposals and may affect the market price of Data Knights&#8217; securities during the buyback period.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The Sponsor, directors, officers, advisors of Data Knights or their affiliates may purchase Data Knights&#8217; Public Shares in privately negotiated transactions either prior to or following the consummation of the Business Combination. No such person will make any such purchases when such persons are in possession of any material non-public information not disclosed to the seller or during a restricted period under Regulation M under the Exchange Act. Such a purchase would likely include a contractual acknowledgement that such stockholder, although still the record holder of Data Knights&#8217; units is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights. In the event that the Sponsor, directors, officers of Data Knights or their affiliates purchase units in privately negotiated transactions from public stockholders of Data Knights who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their units. There is no limit on the number of units that could be acquired by the Sponsor, directors, officers, advisors of Data Knights or their affiliates, or the price such persons may pay. Any such privately negotiated purchases may be effected at purchase prices that are equal to or below the per-share pro rata portion of the Trust Account, none of such shares would be voted in favor of the Business Combination, and no exercise of redemption rights would be made by the purchasers with respect to such shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If such transactions are affected, the consequence could be to cause the Business Combination to be approved in circumstances where such approval could not otherwise be obtained. Purchases of units by the persons described above would allow them to exert more influence over the approval of the Business Combination Proposal and other proposals and would likely increase the chances that such proposals would be approved. If the market does not view the Business Combination positively, purchases of Data Knights public units may have the effect of counteracting the market&#8217;s view, which would otherwise be reflected in a decline in the market price of Data Knights&#8217; securities. In addition, the termination of the support provided by these purchases may materially adversely affect the market price of Data Knights&#8217; securities.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">92</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, the remaining public stockholders of Data Knights following the consummation of the Business Combination will bear the economic burden of the deferred underwriting fee which will be paid from funds released to Data Knights from the Trust Account following the consummation of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">As of the date of this proxy statement/prospectus, no agreements with respect to the private purchase of public units by the persons described above have been entered into with any such investor or holder. Data Knights will file a Current Report on Form&#160;8-K with the SEC to disclose private arrangements entered into or significant private purchases made by any of the aforementioned persons that would affect the vote on the Business Combination Proposal or other proposals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Since Data Knights&#8217; Sponsor, officers, directors, and their respective affiliates will lose their entire investment in Data Knights if the Business Combination is not completed, they may have had a conflict of interest in identifying and selecting OneMedNet for Data Knights&#8217; initial business combination in order to close the Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The Sponsor and Data Knights&#8217; officers and directors currently own an aggregate of 2,875,000 Founder Shares for an aggregate purchase price of $25,000. In addition, the Sponsor purchased an aggregate of 585,275 Placement Units that occurred simultaneously with the consummation of the Data Knights IPO and upon exercise of the underwriter&#8217;s over-allotment option. All of such Founder Shares and Placement Units will be worthless if the Business Combination is not consummated. The personal and financial interests of the Sponsor, Data Knights&#8217; officers, directors and their respective affiliates may have influenced their motivation in identifying and selecting OneMedNet for its target business combination and consummating the Business Combination in order to close the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">These interests may influence Data Knights&#8217; directors in making their recommendation that you vote in favor of the approval of the Business Combination. The estimated aggregate amount invested by Sponsor and certain of Data Knights&#8217; directors and executive officers in their interests in Data Knights is $5,877,750, as detailed in the following tables:</p><a id="_Hlk131458761"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assuming No Further Redemptions</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,875,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,139,535</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,852,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 286,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 36,331,060</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,877,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assuming 80% Redemptions</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,875,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,139,535</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">5,852,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 286,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;">  0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 36,331,060</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">5,877,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,461,710</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7.26</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">93</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assuming Maximum Redemptions</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,875,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">10.49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,139,535</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">5,852,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">286,785</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">585,275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0.06</p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">36,331,060</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">5,877,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, Data Knights&#8217; officers and directors and the Sponsor have not incurred any out-of-pocket expenses subject to reimbursement by Data Knights. The Sponsor had previously requested that the Company extend the date by which the Company has to consummate a business combination to February 11, 2023, and in connection therewith caused an aggregate of $1,150,000 (representing $0.10 per public share) to be deposited into the Company&#8217;s trust account on August 11, 2022, to extend such date to November 11, 2022, and caused an aggregate of $368,758.44 (representing $0.135 per public share) to extend such date to February 11, 2023. Under the terms of its Charter, the Company can extend the date by which it has to consummate a business combination by up to six additional one-month periods, or up to August 11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">There is no assurance that Data Knights&#8217; due diligence will reveal all material risks that may be present with regard to OneMedNet, thus, following the Business Combination, Data Knights may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on its financial condition and its share price, which could cause you to lose some or all of your investment.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights cannot assure you that the due diligence Data Knights has conducted on OneMedNet will reveal all material issues that may be present with regard to OneMedNet, or that it would be possible to uncover all material issues through a customary amount of due diligence or that risks outside of Data Knights&#8217; control will not later arise. OneMedNet is aware that Data Knights must complete the Business Combination by August, 11, 2023, subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension. Consequently, OneMedNet may have obtained leverage over us in negotiating the Merger Agreement, knowing that if Data Knights does not complete the Business Combination with OneMedNet, Data Knights will not be able to complete an initial business combination with any other target business prior to such deadline. In addition, Data Knights has had limited time to conduct due diligence. OneMedNet is a privately held company and Data Knights therefore has made its decision to pursue a business combination with OneMedNet on the basis of limited information, which may result in a business combination that is not as profitable as expected, if at all. As a result of these factors, Data Knights may be forced to later write-down or write-off assets, restructure operations, or incur impairment or other charges that could result in reporting losses. Even if Data Knights&#8217; due diligence successfully identified certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and would not have an immediate impact on Data Knights&#8217; liquidity, the fact that Data Knights reports charges of this nature could contribute to negative market perceptions about Data Knights or Data Knights&#8217; securities. Accordingly, any stockholders of Data Knights who choose to remain stockholders of Data Knights following the Business Combination could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by Data Knights&#8217; officers or directors of a duty of care or other fiduciary duty owed by them to Data Knights, or if they are able to successfully bring a private claim under securities laws that the proxy statement/prospectus relating to the Business Combination contained an actionable material misstatement or material omission.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Since Data Knights&#8217; Sponsor, executive officers and directors will not be eligible to be reimbursed for their out-of-pocket expenses if the Business Combination is not completed, a conflict of interest may arise in determining whether OneMedNet is appropriate for Data Knights&#8217; initial business combination in order to close the Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">At the Closing of the Business Combination, the Sponsor, Data Knights&#8217; executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">94</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred in connection with activities on behalf of Data Knights. These financial interests of the Sponsor, executive officers and directors of Data Knights may have influenced their motivation in identifying and selecting OneMedNet for the Business Combination in order to close the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">The ability to execute Data Knights&#8217; strategic plan could be negatively impacted to the extent a significant number of stockholders choose to redeem their units in connection with the Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In the event the aggregate cash consideration Data Knights would be required to pay for all of its public units that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the Merger Agreement exceeds the aggregate amount of cash available to Data Knights, Data Knights may be required to increase the financial leverage Data Knights&#8217; business would have to support. This may negatively impact Data Knights&#8217; ability to execute on its own future strategic plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">If Data Knights stockholders fail to comply with the redemption requirements specified in this proxy statement/prospectus, they will not be entitled to redeem their units for a pro rata portion of the funds held in Data Knights&#8217; Trust Account.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Holders of public units of Data Knights will have the right, regardless of whether he or she affirmatively votes for or against the Business Combination Proposal or does not vote at all, to demand we redeem their units for a pro rata portion of the Trust Account. To exercise their redemption rights, they are required to submit a request in writing and deliver their units, which include the shares of Data Knights Common Stock underlying the units to be redeemed (either physically or electronically) to Data Knights&#8217; transfer agent at least two business&#160;days prior to the Special Meeting. Stockholders electing to redeem their units will receive their pro rata portion of the Trust Account less franchise and income taxes payable, calculated as of two business&#160;days prior to the anticipated consummation of the Business Combination. See the section entitled &#8220;<i style="font-style:italic;">Special Meeting of Data Knights Stockholders &#8212; Redemption Rights</i>&#8221; for additional information on how to exercise your redemption rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">95</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_9f66fc5e_6c44_44b9_933b_ae6e18d995cc"></a><a id="SPECIALMEETINGOFDATAKNIGHTSSTOCKHOLDERS_"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SPECIAL MEETING OF DATA KNIGHTS STOCKHOLDERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">General</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is furnishing this proxy statement/prospectus to its stockholders as part of the solicitation of proxies by the Data Knights Board for use at the Special Meeting to be held on [<span style="font-family:'Symbol';">&#183;</span>], 2023 and at any adjournment or postponement thereof. This proxy statement/prospectus provides Data Knights&#8217; stockholders with information they need to know to be able to vote or direct their vote to be cast at the Special Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Date, Time and Place</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Special Meeting will be held on [<span style="font-family:'Symbol';">&#183;</span>], 2023, at [<span style="font-family:'Symbol';">&#183;</span>], as a virtual meeting. You will be able to attend the Special Meeting online, vote and submit your questions during the Special Meeting via a live webcast available at https://www.cstproxy.com/dataknights/2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Purpose of the Stockholders Meeting</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the Stockholders Meeting, Data Knights is asking holders of its Class&#160;A Common Stock:</p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal No. 1 &#8212; NTA Proposal&#8201;&#8212;&#8201;To consider and vote upon a proposal to adopt the NTA Amendment, which is attached to this proxy statement/prospectus as </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Annex A;</i></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal No.&#160;2&#160;&#8212; Business Combination&#160;Proposal&#160;&#8212; To consider and vote upon a proposal to adopt and approve the Merger and Merger Agreement, which is attached to this proxy statement/prospectus as </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex B</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal No.&#160;3&#160;&#8212; Nasdaq Proposal&#160;&#8212; To approve, for purposes of complying with applicable Nasdaq Listing Rules, the issuance of more than 20% of the Company&#8217;s issued and outstanding Common Stock in connection with the PIPE.</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal No.&#160;4&#160;&#8212; Charter Amendment Proposal&#160;&#8212; To consider and vote upon a proposal to adopt the Third Amended and Restated Certificate of Incorporation, which is attached to this proxy statement/prospectus as </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex C</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">,</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> including: </span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal 4A&#8201;&#8212;&#8201;the Bylaw Amendment Requirement; and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal 4B&#8201;&#8212;&#8201;the Article Amendment Requirement;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal No.&#160;5&#160;&#8212; Election of Directors Proposal&#160;&#8212; To consider and vote to elect nine directors to serve staggered terms on Data Knights&#8217; board of directors until the 2024, 2025 and 2026 annual meetings of stockholders of Data Knights, respectively, and until their respective successors are duly elected and qualified;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal No.&#160;6&#160;&#8212; Incentive Plan Proposal&#160;&#8212; To consider and vote upon a proposal to approve the Equity Incentive Plan, including the authorization of the initial share reserve under the Equity Incentive Plan, which is attached to this proxy statement/prospectus as </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex D</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Proposal No.&#160;7&#160;&#8212; Adjournment Proposal&#160;&#8212; To consider and vote upon a proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the NTA Proposal, the Business Combination Proposal, the Nasdaq Proposal, Charter Amendment Proposal, the Election of Directors Proposal, or the Incentive Plan Proposal. This proposal will only be presented at the Special Meeting if there are not sufficient votes to approve the NTA Proposal, the Business Combination Proposal, the Nasdaq Proposal, Charter Amendment Proposal, the Election of Directors Proposal, or the Incentive Plan Proposal.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">96</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recommendation of the Data Knights Board</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; Board has unanimously determined that each of the Proposals is fair to and in the best interests of Data Knights and its stockholders, and has unanimously approved such Proposals. The Board unanimously recommends that stockholders:</p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">vote &#8220;FOR&#8221; the Proposal No. 1&#8201;&#8212;&#8201;NTA Proposal;</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">vote &#8220;FOR&#8221; the Proposal No.&#160;2&#160;&#8212; Business Combination&#160;Proposal;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">vote &#8220;FOR&#8221; the Proposal No.&#160;3&#160;&#8212; Nasdaq Proposal;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">vote &#8220;FOR&#8221; the Proposal No.&#160;4&#160;&#8212; Charter Amendment Proposal, including:</span></p></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">vote &#8220;FOR&#8221; the Proposal 4A&#8201;&#8212;&#8201;the Bylaw Amendment Requirement; and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">vote &#8220;FOR&#8221; the Proposal 4B&#8201;&#8212;&#8201;the Article Amendment Requirement;</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">vote &#8220;FOR&#8221; the Proposal No.&#160;5&#160;&#8212; Election of Directors Proposal;</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">vote &#8220;FOR&#8221; the Proposal No.&#160;6&#160;&#8212; Incentive Plan Proposal; and</span></p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">vote &#8220;FOR&#8221; the Proposal No.&#160;7&#160;&#8212; Adjournment Proposal, if presented at the Stockholders Meeting.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">When you consider the recommendation of the Data Knights Board in favor of approval of the Proposals, you should keep in mind that the Sponsor (including certain members of the Sponsor), and certain of Data Knights&#8217; directors and executive officers may have interests in the Business Combination that are different from or in addition to (or which may conflict with) your interests as a stockholder. These interests include, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">unless Data Knights consummates an initial business combination, Data Knights&#8217; officers, directors and the Sponsor will not receive reimbursement for any out-of-pocket expenses incurred by them to the extent that such expenses exceed the amount of available proceeds not deposited in the Trust Account;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">as a condition to the Data Knights IPO, all of the Founder Shares are subject to a lock-up and would be released only if specified conditions were met. In particular, subject to certain limited exceptions, all Founder Shares would be subject to a lock up until the earlier of (A)&#160;six&#160;months after the completion of Data Knights&#8217; Business Combination and (B)&#160;subsequent to the Business Combination, (x)&#160;if the closing price of the Class&#160;A Common Stock equals or exceeds $12.00 per unit (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading&#160;days within any 30-trading day period commencing at least 150&#160;days after the Business Combination or (y)&#160;the date on which Data Knights completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of Class&#160;A Common Stock for cash, securities or other property;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Placement Units, purchased by the Sponsor will be worthless if a business combination is not consummated;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Sponsor has agreed that the Placement Units and the underlying securities, will not be sold or transferred by it until after Data Knights has completed a business combination, subject to limited exceptions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that Sponsor paid an aggregate of $25,000 for its Founder Shares and such securities will have a significantly higher value at the time of the Business Combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that Sponsor has agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination;</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">97</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if Data Knights does not complete an initial business combination by August 11, 2023, the proceeds from the sale of the Placement Units will be included in a liquidating distribution to Data Knights&#8217; Public Stockholders, and the Placement Units will expire worthless; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the Trust Account is liquidated, including in the event Data Knights is unable to complete an initial business combination within the required time period, the Sponsor has agreed to indemnify Data Knights to ensure that the proceeds in the Trust Account are not reduced below $10.20 per Public Share by the claims of prospective target businesses with which Data Knights has entered into an acquisition agreement or claims of any third party for services rendered or products sold to Data Knights, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The estimated aggregate amount invested by Sponsor and certain of Data Knights&#8217; directors and executive officers in their interests in Data Knights is $5,877,750.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Voting Power; Record Date</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">You will be entitled to vote or direct votes to be cast at the Special Meeting if you owned shares of Data Knights Common Stock at the close of business on [</span><span style="font-family:'Symbol';">&#183;</span><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">], 2023 which is the Record Date. You are entitled to one vote for each share of Data Knights Common Stock that you owned as of the close of business on the Record Date. If your shares are held in &#8220;street name&#8221; or are in a margin or similar account, you should contact your broker, bank or other nominee to ensure that votes related to the shares you beneficially own are properly counted. On the Record Date, there were 7,570,336 shares of Data Knights Common Stock issued and outstanding, consisting of  (i) 3,316,819 shares of Class A common stock, and (ii) 4,253,517 shares of Class B common stock.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Vote of the Sponsor, Directors and Officers</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the Data Knights IPO, Data Knights entered into agreements with each of its Sponsor, directors and officers pursuant to which each agreed to vote any shares of Common Stock owned by it in favor of the Business Combination and for all other Proposals presented at the Special Meeting. These agreements apply to the Sponsor as it relates to the Founder Shares and any Placement Shares and the requirement to vote such shares in favor of the Business Combination and for all other Proposals presented to Data Knights stockholders in this proxy statement/prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; Sponsor, directors and officers and Sponsor have waived any redemption rights, including with respect to shares of Class&#160;A Common Stock issued or purchased in the Data Knights IPO or in the aftermarket, in connection with Business Combination. The Founder Shares have no redemption rights upon Data Knights&#8217; liquidation and will be worthless if no business combination is effected by Data Knights by August&#160;11, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quorum and Required Vote for Proposals</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A quorum of Data Knights stockholders is necessary to hold a valid meeting. A quorum will be present at the Special Meeting if a majority of the Common Stock outstanding and entitled to vote at the Special Meeting is represented in person or by proxy at the Special Meeting.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The approval of the NTA Proposal, the Business Combination Proposal, the Nasdaq Proposal, the Equity Incentive Plan Proposal and the Adjournment Proposal each require the affirmative vote of the holders of a majority of the shares of Data Knights Common Stock cast by the stockholders represented in person or by proxy and entitled to vote thereon at the Special Meeting. The approval of the Charter Amendment Proposal requires the affirmative vote of a majority of the issued and outstanding Data Knights Common Stock as of the Record Date for the Special Meeting.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If the Business Combination is not approved, the NTA Proposal, the Nasdaq Proposal, the Charter Amendment Proposal and the Incentive Plan Proposal will not be presented to the Data Knights stockholders for a vote. The approval of the NTA Proposal, the Charter Amendment Proposal, the Business Combination Proposal, the Nasdaq Proposal, the Charter Amendment Proposal and the Incentive Plan Proposal are preconditions to the consummation of the Business Combination. The Nasdaq Proposal, the Charter Amendment Proposal and the Incentive Plan Proposal are conditioned on the approval of the Business Combination (and the Business Combination is conditioned on the approval of the Charter Amendment Proposal, the Nasdaq Proposal, and the Incentive Plan Proposal.</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">98</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">It is important for you to note that in the event the Business Combination does not receive the requisite vote for approval, then Data Knights will not consummate the Business Combination. If Data Knights does not consummate the Business Combination by August&#160;11, 2023, Data Knights will be required to dissolve and liquidate its Trust Account by returning the then remaining funds in such account to the Public Stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Abstentions and Broker Non-Votes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Abstentions will be counted in connection with the determination of whether a valid quorum is established and will have the same effect as a vote &#8220;AGAINST&#8221; the Proposals. Accordingly, a failure to vote by proxy or to vote in person or an abstention from voting with regard to the Proposals will have the same effect as a vote &#8220;AGAINST&#8221; the Business Combination and the Charter Amendment Proposal and if a valid quorum is otherwise established, it will have no effect on the outcome of the vote on the Nasdaq Proposal and the Incentive Plan Proposal. Broker non-votes will not be counted as present for the purposes of establishing a quorum and will have no effect on any of the Proposals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Voting Your Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Each Data Knights Common Stock that you own in your name entitles you to one vote. If you are a record owner of your shares, there are two ways to vote your shares of Data Knights Common Stock at the Special Meeting:</p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">You Can Vote By Signing and Returning the Enclosed Proxy Card</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. &#160;&#160;If you vote by proxy card, your &#8220;proxy,&#8221; whose name is listed on the proxy card, will vote your shares as you instruct on the proxy card. If you sign and return the proxy card but do not give instructions on how to vote your shares, your shares will be voted as recommended by Data Knights&#8217; Board &#8220;FOR&#8221; the NTA Proposal, the Business Combination Proposal, the Article Amendment Proposal (including the Bylaw Amendment Requirement and the Charter Amendment Requirement), the Nasdaq Proposal and the Equity Incentive Plan. Votes received after a matter has been voted upon at the Special Meeting will not be counted.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">You Can Attend the Meeting and Vote in Person or Electronically</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. You can attend the Meeting in person and vote on the ballot you will receive when you arrive, or you can attend the Meeting via the virtual meeting platform and vote during the Meeting by following the instructions on your proxy card. You can access the Meeting by visiting the website </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">https://www</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.cstproxy.com/dataknights/2023. You will need your control number for access. If you do not have a control number, please contact Continental Stock Transfer &amp; Trust Company. Instructions on how to attend and participate at the Meeting are available at </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">https://www</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.cstproxy.com/dataknights/2023.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If your shares are held in &#8220;street name&#8221; or are in a margin or similar account, you should contact your broker to ensure that votes related to the shares you beneficially own are properly counted. If you wish to attend the meeting and vote in person and your shares are held in &#8220;street name,&#8221; you must obtain a legal proxy from your broker, bank or nominee. That is the only way Data Knights can be sure that the broker, bank or nominee has not already voted your shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Revoking Your Proxy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If you are a record owner of your shares and you give a proxy, you may change or revoke it at any time before it is exercised by doing any one of the following:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">you may send another proxy card with a later date; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">you may notify Data Knights&#8217; secretary in writing before the Special Meeting that you have revoked your proxy.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If your shares are held in &#8220;street name&#8221; or are in a margin or similar account, you should contact your broker for information on how to change or revoke your voting instructions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Who Can Answer Your Questions About Voting Your Shares?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If you are a stockholder and have any questions about how to vote or direct a vote in respect of your Data Knights Common Stock, you may call Laurel Hill Advisory Group LLC, Data Knights&#8217; proxy solicitor, at (855) 414-2266 or by email at dataknights@laurelhill.com.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">99</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">No Additional Matters May&#160;Be Presented at the Special Meeting</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Special Meeting has been called only to consider the approval of the NTA Proposal, the Charter Amendment Proposal, the Business Combination Proposal, the Nasdaq Proposal, and the Incentive Plan Proposal. Under Data Knights&#8217; bylaws, other than procedural matters incident to the conduct of the Special Meeting, no other matters may be considered at the Special Meeting if they are not included in this proxy statement/prospectus, which serves as the notice of the Special Meeting.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Redemption Rights</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to Data Knights&#8217; Charter, any holders of Public Shares may demand that such shares be redeemed in exchange for a pro rata share of the aggregate amount on deposit in the Trust Account, less franchise and income taxes payable, calculated as of two (2)&#160;business&#160;days prior to the consummation of the Business Combination. If demand is properly made and the Business Combination is consummated, these shares, immediately prior to the Business Combination, will cease to be outstanding and will represent only the right to receive a pro rata share of the aggregate amount on deposit in the Trust Account which holds the proceeds of the Data Knights IPO (calculated as of two (2)&#160;business&#160;days prior to the consummation of the Business Combination, including interest earned on the funds held in the Trust Account and not previously released to it to pay the Company&#8217;s franchise and income taxes). For illustrative purposes, based on funds in the Trust Account of approximately $29,725,572 on March 31, 2023, the estimated per share redemption price would have been approximately $10.88.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to exercise your redemption rights, you must:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">affirmatively vote either for or against the Business Combination Proposal;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">check the box on the enclosed proxy card to elect redemption;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">check the box on the enclosed proxy card marked &#8220;Stockholder Certification&#8221; if you are not acting in concert or as a &#8220;group&#8221; (as defined in Section&#160;13d-3 of the Exchange Act) with any other stockholder with respect to shares of Common Stock;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">prior to 5:00 PM Eastern time on [</span><span style="font-family:'Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#183;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">], 2023 (two (2)&#160;business&#160;days before the Special Meeting), tender your shares physically or electronically and submit a request in writing that we redeem your Public Shares for cash to Continental Stock Transfer&#160;&amp; Trust Company, Data Knights&#8217; Transfer Agent, at the following address:</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Continental Stock Transfer&#160;&amp; Trust Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:10pt;">One State Street Plaza, 30</span><sup style="font-size:4.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;"> Floor</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">New&#160;York, New&#160;York 10004</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Attn: SPAC Redemptions</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">E-mail: spacredemptions@continentalstock.com</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">and</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">deliver your Public Shares either physically or electronically through DTC to Data Knights&#8217; Transfer Agent at least two (2)&#160;business&#160;days before the Special Meeting. Stockholders seeking to exercise their redemption rights and opting to deliver physical certificates should allot sufficient time to obtain physical certificates from the Transfer Agent and time to effect delivery. It is Data Knights&#8217; understanding that stockholders should generally allot at least two weeks to obtain physical certificates from the Transfer Agent. However, Data Knights does not have any control over this process, and it may take longer than two weeks. Stockholders who hold their shares in street name will have to coordinate with their bank, broker or other nominee to have the shares certificated or delivered electronically. If you do not submit a written request and deliver your Public Shares as described above, your shares will not be redeemed.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Any demand for redemption, once made, may be withdrawn at any time until the deadline for exercising redemption requests (and submitting shares to the Transfer Agent) and thereafter, with Data Knights&#8217; consent, until the vote is taken with respect to the Business Combination. If you delivered your shares for redemption to Data Knights&#8217; Transfer Agent and decide within the required timeframe not to exercise your redemption rights, you may request that Data Knights&#8217; Transfer Agent return the shares (physically or electronically). You may make such request by contacting Data Knights&#8217; Transfer Agent at the email or mailing address listed above.</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">100</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prior to exercising redemption rights, stockholders should verify the market price of Data Knights Common Stock as they may receive higher proceeds from the sale of their Common Stock in the public market than from exercising their redemption rights if the market price per share is higher than the redemption price. We cannot assure you that you will be able to sell your shares of Data Knights Common Stock in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in Data Knights Common Stock when you wish to sell your shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If you exercise your redemption rights, your shares of Data Knights Common Stock will cease to be outstanding immediately prior to the Business Combination and will only represent the right to receive a pro rata share of the aggregate amount on deposit in the Trust Account. You will no longer own those shares and will have no right to participate in, or have any interest in, the future growth of OneMedNet, if any. You will be entitled to receive cash for these shares only if you properly and timely demand redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the Business Combination is not approved and Data Knights does not consummate an initial business combination by February&#160;11, 2023 (which Data Knights can extend to as late as August 11, 2023 by depositing additional funds into its Trust Account), Data Knights will be required to dissolve and liquidate its Trust Account by returning the then remaining funds in such account to the Public Stockholders and Warrants will expire worthless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Appraisal Rights</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights stockholders do not have appraisal rights in connection with the Business Combination or the other Proposals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Proxy Solicitation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is soliciting proxies on behalf of its Board. This solicitation is being made by mail but also may be made by telephone or in person. Data Knights and its directors, officers and employees may also solicit proxies in person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights has hired Laurel Hill Advisory Group, LLC to assist in the proxy solicitation process. Data Knights will pay Laurel Hill its customary fee plus disbursements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Data Knights will ask banks, brokers and other institutions, nominees and fiduciaries to forward the proxy materials to their principals and to obtain their authority to execute proxies and voting instructions. Data Knights will reimburse them for their reasonable expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">101</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_79d94808_7b05_45a9_99c4_5ce643083d93"></a><a id="THENTAPROPOSAL_622310"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">THE NTA PROPOSAL</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">General</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">As discussed elsewhere in this proxy statement/prospectus, Data Knights is asking its stockholders to approve the NTA Proposal. The NTA Proposal is conditioned upon the approval of the Business Combination Proposal. Therefore, if the Business Combination Proposal is not approved, then the NTA Proposal will have no effect, even if approved by Data Knights stockholders. If the NTA Proposal and the Business Combination Proposal are approved at the Special Meeting, the following amendment (the &#8220;NTA Amendment&#8221;) will be made to the Charter, which shall be effective, if adopted and implemented by Data Knights, immediately prior to the consummation of the proposed Business Combination:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">Section 9.2(a) of the Charter will amended and restated in its entirety to read as follows:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(a)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Prior to the consummation of the initial Business Combination, the Corporation shall provide all holders of Offering Shares with the opportunity to have their Offering Shares redeemed upon the consummation of the initial Business Combination pursuant to, and subject to the limitations of, Sections 9.2(b) and 9.2(c) (such rights of such holders to have their Offering Shares redeemed pursuant to such Sections, the &#8220;Redemption Rights&#8221;) hereof for cash equal to the applicable redemption price per share determined in accordance with Section 9.2(b) hereof (the &#8220;Redemption Price&#8221;). Notwithstanding anything to the contrary contained in this Amended and Restated Certificate, there shall be no Redemption Rights or liquidating distributions with respect to any warrant issued pursuant to the Offering.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">A copy of the NTA Amendment to the Charter is attached to this proxy statement/prospectus as Annex A.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Reasons for the Amendments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights stockholders are being asked to adopt the proposed amendments to the Charter prior to the Closing, which, in the judgment of our Board, could facilitate the consummation of the Business Combination if Data Knights&#8217; net tangible assets would be below $5,000,001 immediately prior to and following the Closing. The Charter limits Data Knights&#8217; ability to consummate an initial business combination, or to redeem shares of Data Knights Common Stock in connection with an initial business combination, if it would cause Data Knights to have less than $5,000,001 in net tangible assets. The purpose of such limitation was initially to ensure that Data Knights Common Stock would not be deemed a &#8220;penny stock&#8221; pursuant to Rule 3a51-1 under the Exchange Act. Because the Data Knights Common Stock and the New OneMedNet Common Stock would not be deemed to be a &#8220;penny stock&#8221; pursuant to other applicable provisions of Rule 3a51-1 under the Exchange Act, Data Knights is presenting the NTA Proposal to facilitate the consummation of the Business Combination. If the NTA Proposal is not approved and there are significant requests for redemption such that Data Knights&#8217; net tangible assets would be less than $5,000,001 immediately prior to and upon the consummation of the Business Combination, the Charter would prevent Data Knights from being able to consummate the Business Combination even if all other conditions to Closing are met. If the Business Combination is consummated, then the Charter, as amended by the NTA Amendment, will be replaced in its entirety by the Amended Charter upon the Closing of the Business Combination and all of the references in this proxy statement/prospectus to the &#8220;Charter&#8221; shall be deemed to mean the Charter as amended by amendments contained in this NTA Proposal.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Vote Required for Approval</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The NTA Proposal will be approved and adopted only if the holders of at least a majority of the outstanding shares of Data Knights Common Stock vote &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221; for the NTA Amendment. Failure to vote by proxy or to vote virtually at the Special Meeting or an abstention from voting will have the same effect as a vote &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">AGAINST</b><span style="font-family:'Times New Roman','Times','serif';">&#8221; the NTA Proposal. In addition, because they are cross-conditioned on each other, the NTA Proposal will be approved and adopted only if each of the Proposals is approved at the Special</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">Meeting by the affirmative vote of a majority of the issued and outstanding shares of Data Knights Common Stock cast on each such proposal at the Special Meeting.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Recommendation of Data Knights&#8217; Board</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DATA KNIGHTS&#8217; BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT ITS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE NTA PROPOSAL.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">102</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_0867c9d5_20b0_43f0_81b1_e43d639a69da"></a><a id="THEBUSINESSCOMBINATIONPROPOSAL_239295"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">THE BUSINESS COMBINATION PROPOSAL</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">General</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Holders of Data Knights Common Stock are being asked to approve and adopt the Merger Agreement and the transactions contemplated thereby, including the Business Combination. Data Knights stockholders should read this proxy statement/prospectus carefully and in its entirety for more detailed information concerning the Merger Agreement. The Merger Agreement is attached as</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> Annex&#160;B</i><span style="font-family:'Times New Roman','Times','serif';"> to this proxy statement/prospectus. Please see the section entitled &#8220;&#8212; </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">The Merger Agreement</i><span style="font-family:'Times New Roman','Times','serif';">&#8221; below for additional information and a summary of certain terms of the Merger Agreement. You are also urged to read the Merger Agreement carefully and in its entirety, as amended, before voting on this proposal.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights may consummate the Business Combination only if all Proposals are approved by the respective required vote of the holders of the shares of Data Knights Common Stock cast by the stockholders represented in person or by proxy and entitled to vote thereon at the Special Meeting.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">The Merger Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The subsections that follow this subsection describe the material provisions of the Merger Agreement, but do not purport to describe all of the terms of the Merger Agreement. The following summary is qualified in its entirety by reference to the complete text of the Merger Agreement, a copy of which is attached as </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex&#160;B</i><span style="font-family:'Times New Roman','Times','serif';"> hereto, respectively, which is incorporated herein by reference. Stockholders and other interested parties are urged to read the Merger Agreement carefully and in its entirety (and, if appropriate, with the advice of financial and legal counsel), because it is the primary legal document that governs the Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">The Merger Agreement contains representations, warranties and covenants that the respective parties made to each other as of the date of the Merger Agreement or other specific dates, which may be updated prior to the Closing of the Business Combination. The assertions embodied in those representations, warranties and covenants were made for purposes of the contract among the respective parties and are subject to important qualifications and limitations agreed to by the parties in connection with negotiating the Merger Agreement. The representations, warranties and covenants in the Merger Agreement are also modified in important part by the disclosure schedules attached thereto which are not filed publicly and which are subject to a contractual standard of materiality different from that generally applicable to stockholders. The disclosure schedules were used for the purpose of allocating risk among the parties rather than establishing matters as facts. We do not believe that the disclosure schedules contain information that is material to an investment decision.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">General Description of the Merger Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April&#160;25, 2022, Data Knights Acquisition Corp, a Delaware corporation (&#8220;<b style="font-weight:bold;">Data Knights</b>&#8221;), entered into an Agreement and Plan of Merger (the &#8220;<b style="font-weight:bold;">Merger Agreement</b>&#8221;), by and among Data Knights, Data Knights Merger Sub,&#160;Inc., a Delaware corporation and wholly-owned subsidiary of Data Knights (&#8220;<b style="font-weight:bold;">Merger Sub</b>&#8221;), Data Knights, LLC, a Delaware limited liability company, in its capacity as Purchaser Representative (&#8220;<b style="font-weight:bold;">Sponsor</b>&#8221;), OneMedNet Corporation, a Delaware corporation (&#8220;<b style="font-weight:bold;">OneMedNet</b>&#8221;), and Paul Casey, in his capacity as Seller Representative.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the Merger Agreement, at the closing of the transactions contemplated by the Merger Agreement (the &#8220;<b style="font-weight:bold;">Closing</b>&#8221;), Merger Sub will merge with and into OneMedNet, with OneMedNet changing its name to OneMedNet Solutions Corp and continuing as the surviving corporation (the &#8220;<b style="font-weight:bold;">Surviving Corporation</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Merger Consideration</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As consideration for the Merger, the holders of OneMedNet securities collectively shall be entitled to receive from Data Knights, in the aggregate, a number of Data Knights securities with an aggregate value equal to (the &#8220;<b style="font-weight:bold;">Merger Consideration</b>&#8221;) (a)&#160;Two Hundred Million U.S. Dollars ($200,000,000) minus (b)&#160;the amount, if any, by which the Target Net Working Capital Amount exceeds the Net Working Capital Amount (but not less than zero), minus (c)&#160;the amount of Closing Net Indebtedness (as each term is defined in the Merger Agreement) minus (d)&#160;the amount of any Transaction Expenses, provided that the Merger Consideration otherwise payable to the OneMedNet&#8217;s shareholders is subject to adjustment after the Closing in accordance with Section&#160;1.15 of the Merger Agreement, with each OneMedNet stockholder receiving, for each share of OneMedNet common stock held, a number of shares of Data Knights Common Stock equal to (i)&#160;the Per Share Consideration, divided by (ii)&#160;the Redemption Price (the total portion of the Merger Consideration amount payable to all OneMedNet stockholders in accordance with the Merger Agreement is also </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">103</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">referred to herein as the &#8220;<b style="font-weight:bold;">Stockholder Merger Consideration</b>&#8221;). The Merger Consideration is subject to adjustment after the Closing based on confirmed amounts of the Closing Net Indebtedness of OneMedNet as of the Closing Date.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Post-Business Combination Ownership of OneMedNet</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The ownership of Data Knights immediately following the Business Combination will be as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:10.63%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.91%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:5.01%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:10.58%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:11.37%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:10.63%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.79%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:4.96%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="15" style="vertical-align:bottom;width:80.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share&#160;ownership&#160;in&#160;Data&#160;Knights</b></p></td><td style="vertical-align:bottom;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:17.57%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma&#160;Combined</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Assuming&#160;No&#160;Further</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Redemptions&#160;Scenario)</b></p></td><td style="vertical-align:bottom;width:2.86%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;width:17.51%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma&#160;Combined</b>&#160;<br/><b style="font-weight:bold;">(Assuming</b>&#160;<br/><b style="font-weight:bold;">80%&#160;Redemptions</b>&#160;<br/><b style="font-weight:bold;">Scenario)</b></p></td><td style="vertical-align:bottom;width:2.87%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;width:19.19%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma&#160;Combined</b>&#160;<br/><b style="font-weight:bold;">(Assuming</b>&#160;<br/><b style="font-weight:bold;">Maximum</b>&#160;<br/><b style="font-weight:bold;">Redemptions&#160;Scenario)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;width:2.87%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;width:17.39%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro&#160;Forma&#160;Combined</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(Assuming&#160;No&#160;Further</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Redemptions&#160;Scenario</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">and&#160;Full&#160;Exercise</b>&#160;<br/><b style="font-weight:bold;">of&#160;Options</b>&#160;<br/><b style="font-weight:bold;">and&#160;Warrants)</b></p></td><td style="vertical-align:bottom;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">Stockholder</b></p></td><td style="vertical-align:bottom;width:1.76%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:10.63%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;width:1.91%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.01%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;width:2.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:10.58%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;width:1.77%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.15%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;width:2.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:11.37%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;width:2.15%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.65%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;width:2.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:10.63%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;width:1.79%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:4.96%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.25;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Former OneMedNet equityholders</p></td><td style="vertical-align:bottom;width:1.76%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20,000,000</p></td><td style="vertical-align:bottom;width:1.91%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">60.6</p></td><td style="vertical-align:bottom;width:2.86%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td><td style="vertical-align:bottom;width:10.58%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20,000,000</p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">61.4</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20,000,000</p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">66.4</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20,806,453</p></td><td style="vertical-align:bottom;width:1.79%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">53.8</p></td><td style="vertical-align:bottom;width:1.75%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Data Knights Public Stockholders<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(4)</sup></p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">2,731,544</p></td><td style="vertical-align:bottom;width:1.91%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">8.3</p></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td><td style="vertical-align:bottom;width:10.58%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">2,300,000</p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">7.1</p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;width:2.87%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">6,884,322</p></td><td style="vertical-align:bottom;width:1.79%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">17.8</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Data Knights Sponsor and Insiders<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;width:1.76%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">3,460,275</p></td><td style="vertical-align:bottom;width:1.91%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">10.54</p></td><td style="vertical-align:bottom;width:2.86%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.58%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">3,460,275</p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">10.6</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">3,460,275</p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">11.5</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">3,821,624</p></td><td style="vertical-align:bottom;width:1.79%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">9.9</p></td><td style="vertical-align:bottom;width:1.75%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Others</p></td><td style="vertical-align:bottom;width:1.76%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">6,821,967</p></td><td style="vertical-align:bottom;width:1.91%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20.7</p></td><td style="vertical-align:bottom;width:2.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">6,799,254</p></td><td style="vertical-align:bottom;width:1.77%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">20.9</p></td><td style="vertical-align:bottom;width:2.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">6,678,202</p></td><td style="vertical-align:bottom;width:2.15%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">22.2</p></td><td style="vertical-align:bottom;width:2.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">7,181,967</p></td><td style="vertical-align:bottom;width:1.79%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">18.6</p></td><td style="vertical-align:bottom;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:16.16%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total Shares Outstanding</p></td><td style="vertical-align:bottom;width:1.76%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">33,013,786</p></td><td style="vertical-align:bottom;width:1.91%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.01%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;width:2.86%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.58%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">32,599,529</p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.37%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">30,138,477</p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;width:2.87%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.63%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">38,694,366</p></td><td style="vertical-align:bottom;width:1.79%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.96%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;text-align:right;margin:0pt 3pt 0pt 0pt;">100.0</p></td><td style="vertical-align:bottom;width:1.75%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;margin:0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Assumes Illustrative Maximum Redemptions of 2,731,544 Public Shares of Data Knights Common Stock in connection with the Business Combination. For a description of the Maximum Redemption Scenario, see &#8220;<i style="font-style:italic;">Unaudited Pro Forma Condensed Combined Financial Information</i>.&#8221;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Excludes, except in the case of the last scenario, an estimated 2,731,544 shares underlying the Public Warrants beneficially held by the Data Knights Public Stockholders.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Excludes, except in the case of the last scenario, an estimated 585,275 shares underlying the placement warrants beneficially held by Sponsor.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(4)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">On November 11, 2022, Data Knights held a virtual special meeting of its stockholders to vote on three proposals. At the special meeting, holders of Data Knights Common Stock voted on and approved, two of the three proposals presented, an extension proposal and a trust amendment proposal (the on the &#8220;Extension Amendment Proposal&#8221; and the &#8220;Trust Amendment Proposal&#8221;, respectively). In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of 8,768,456 shares of Class A Common Stock exercised their right to redeem those shares for cash. There are currently 7,570,336 shares of Data Knights Common Stock issued and outstanding, consisting of (i) 3,316,819 shares of Class A common stock, and (ii) 4,253,517 shares of Class B common stock.</p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The &#8220;Maximum Redemption Scenario&#8221; assumes that Data Knights Public Stockholders exercise redemption rights with respect to 100% of the outstanding shares of Class&#160;A common stock. This scenario assumes that 2,731,544 shares of Class&#160;A common stock are redeemed for an aggregate payment of approximately $29.7 million from the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">In addition, upon consummation of the Business Combination, there will be outstanding an aggregate of up to 2,731,544 Public Warrants and 585,275 placement warrants held by our Sponsor. Each of our outstanding whole warrants is exercisable commencing 30&#160;days following the Closing for one share of Data Knights Common Stock. Therefore, as of the date of this proxy statement/prospectus, if we assume that each outstanding whole warrant is exercised and one share of Data Knights Common Stock is issued as a result of such exercise, with payment to Data Knights of the exercise price of $11.50 per whole warrant for one whole share, our fully-diluted share capital would increase by a total of&#160;3,316,819 shares, with approximately $38,143,418.50 paid to us to exercise the warrants, assuming cash exercise.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The numbers of shares and&#160;percentage interests set forth in the above table under either redemption scenario do not take into account potential future exercises of up to 2,731,544 Public Warrants and up to 585,275 placement warrants, which will remain outstanding immediately following the Business Combination and may be exercised thereafter at an exercise price of $11.50 </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">104</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(commencing 30&#160;days after the Closing of the Business Combination). The exercise, issuance or vesting of any of these shares could have a dilutive effect on those of our stockholders who do not elect to redeem their shares. If all such shares were issued immediately after the Business Combination, based on the number of issued and outstanding shares of Data Knights Common Stock, non-redeeming Public Stockholders, as a group, would own:</p><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">if there are no further redemptions of Public Shares, 9.9% of the Data Knights&#8217; common stock outstanding assuming all such shares were issued immediately after the Business Combination; or</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">if there are maximum redemptions of 100% of the outstanding Public Shares, none of the Data Knights&#8217; common stock outstanding.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the actual facts are different than the assumptions set forth above, the share numbers set forth above will be different. For more information, please see the section entitled &#8220;<i style="font-style:italic;">Unaudited Pro Forma Condensed Combined Financial Information</i>.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Representations and Warranties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Merger Agreement contains customary representations and warranties by each of Data Knights and OneMedNet. Certain of the representations are subject to specified exceptions and qualifications contained in the Merger Agreement or in information provided pursuant to certain disclosure schedules to the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Covenants of the Parties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the Merger Agreement, each party agrees to use its commercially reasonable efforts to effect the Closing. The Merger Agreement also contains certain customary covenants by the parties during the period between the signing of the Merger Agreement and the earlier of the Closing or the termination of the Merger Agreement in accordance with its terms, including covenants regarding the conduct of their respective businesses, efforts, access, confidentiality and public announcements, the Data Knights proxy statement for the transaction (which includes the adoption of a new equity incentive plan with a number of awards thereunder equal to 15% of the issued and outstanding shares of Data Knights immediately after the Closing), notice of breaches, no insider trading, indemnification of directors and officers, and other customary covenants. The parties also have agreed to the following covenants:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Each party is subject to a &#8220;no-shop&#8221; obligation between signing of the Merger Agreement and Closing and will not be allowed to solicit or discuss competing transactions with other potential parties during such time period.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Data Knights board of directors after the Closing will consist of at least nine directors, including (i)&#160;seven (7)&#160;persons designated prior to the Closing by OneMedNet, at least three (3)&#160;of whom must qualify as an independent director under Nasdaq rules; and (ii)&#160;two (2)&#160;persons designated prior to the Closing by Data Knights, at least one (1)&#160;of whom must qualify as an independent director under Nasdaq rules.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet shall use its commercially reasonable efforts to deliver audited financial statements prepared in accordance with GAAP and audited in accordance with PCAOB auditing standards for the fiscal&#160;years ended December&#160;31, 2021 and December&#160;31, 2020 to Data Knights by May&#160;15, 2022.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights also agreed in the Merger Agreement to obtain the written consent of its stockholders as promptly as practicable after the Registration Statement has become effective to approve the Merger Agreement and the Business Combination and related matters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Conditions to the Closing</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consummation of the Merger is subject to customary closing conditions unless waived, including among other conditions:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the approval by the stockholders of each of OneMedNet and Data Knights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approvals of any required governmental authorities and the expiration or termination of any anti-trust waiting periods;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">receipt of specified third-party consents;</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">105</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">no law or order preventing the transactions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">no material uncured breach by the other party;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">after giving effect to the redemption, Data Knights shall have at least $5,000,001 of net tangible assets as required by its charter;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the members of the post-Closing Data Knights board shall have been elected or appointed as of the Closing;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Registration Statement shall have been declared effective by the SEC and shall remain effective as of the Closing, and no stop order or similar order shall be in effect with respect to the Registration Statement; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the shares of Data Knights Common Stock issued as Merger Consideration shall have been approved for listing on Nasdaq, subject to official notice of issuance.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, unless waived by OneMedNet, the obligations of OneMedNet to consummate the Merger are subject to the satisfaction of the following Closing conditions, in addition to customary certificates and other closing deliveries: (a)&#160;the representations and warranties of Data Knights being true and correct as of the date of the Merger Agreement and as of the Closing (subject to Material Adverse Effect); (b)&#160;Data Knights having performed in all material respects the respective obligations and complied with in all material respects with their respective covenants and agreements under the Merger Agreement required to be performed or complied with on or prior the date of the Closing; (c)&#160;absence of any Material Adverse Effect with respect to Data Knights since the date of the Merger Agreement which is continuing and uncured; (d)&#160;the Registration Rights Agreement being in full force and effect as of the Closing; and (e) the Minimum Cash Condition of $30 million in cash and cash equivalents held by Data Knights is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Unless waived by Data Knights, the obligations of Data Knights and Merger Sub to consummate the Merger are subject to the satisfaction of the following Closing conditions, in addition to customary certificates and other closing deliveries: (a)&#160;the representations and warranties of OneMedNet being true and correct as of the date of the Merger Agreement and as of the Closing (subject to Material Adverse Effect); (b)&#160;OneMedNet having performed in all material respects the respective obligations and complied in all material respects with its covenants and agreements under the Merger Agreement required to be performed or complied with on or prior the date of the Closing; and (c)&#160;absence of any Material Adverse Effect with respect to OneMedNet as a whole since the date of the Merger Agreement which is continuing and uncured; and (d)&#160;each Executive Employment Agreement, Lock-Up Agreement and Non-Competition Agreement being in full force and effect as of the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Termination</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by mutual agreement;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">for the other party&#8217;s uncured breach;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">if there is a government order preventing the Closing;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by either party if the Closing does not occur by August 11, 2023, for completing its initial business combination under the terms of the Data Knights IPO;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by Data Knights if there has been an event after the signing of the Merger Agreement that has had a Material Adverse Effect on OneMedNet that is continuing and uncured;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by Data Knights or OneMedNet if the Data Knights stockholders vote and do not approve the transactions contemplated by the Merger Agreement;</p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">106</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by Data Knights if it does not receive the opinion of its financial advisors that the transactions contemplated by the Merger Agreement are fair to the Company and its Stockholders; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">by OneMedNet if the Data Knights board withdraws or changes its approval or recommendation to the Data Knights stockholders in any matter that is adverse to OneMedNet.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Governing Law and Dispute Resolution</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Merger Agreement is governed in accordance with the laws of the State of Delaware and, subject to certain exceptions, all actions arising out of or relating to the Merger Agreement shall be heard and determined exclusively in any state or federal court located in Delaware (or in any appellate court thereof).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Related Agreements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Lock-Up Agreements</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Significant Company Holders and certain officers and directors of OneMedNet have entered into lock-up agreements (the &#8220;<b style="font-weight:bold;">Lock-up Agreements</b>&#8221;) providing for a lock-up period commencing on the Closing Date and ending on the earlier of (x)&#160;six&#160;months from the Closing and (y)&#160;the date Data Knights consummates a liquidation, merger, share exchange or other similar transaction with an unaffiliated third party that results in all of Data Knights&#8217; stockholders having the right to exchange their shares of Data Knights Common Stock for cash, securities or other property. A total of 6,353,344 shares or 55.7% of OneMedNet issued and outstanding shares including the officers and directors are subject to the Lock-Up Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Non-Competition and Non-Solicitation Agreements</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain significant stockholders of OneMedNet have entered into non-competition and non-solicitation agreements (the &#8220;<b style="font-weight:bold;">Non-Competition Agreements</b>&#8221;), pursuant to which they agreed not to compete with Data Knights, OneMedNet and their respective subsidiaries during the five-year period following the Closing and, during such five-year restricted period, not to solicit employees or customers or clients of such entities. The agreements also contain customary non-disparagement and confidentiality provisions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Registration Rights Agreement</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the Closing, certain significant stockholders of OneMedNet will enter into a registration rights agreement (&#8220;<b style="font-weight:bold;">Registration Rights Agreement</b>&#8221;) with Data Knights providing for the right to three (3)&#160;demand registrations, unlimited piggy-back registrations and shelf registrations on a continuous basis, with respect to the Merger Consideration shares and Founder Shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Support Agreements</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the execution of the Merger Agreement,(i)&#160;Data Knights and Data Knights, LLC and entered into a sponsor support agreement (the &#8220;<b style="font-weight:bold;">Support Agreement</b>&#8221;) in favor of Data Knights and OneMedNet and their present and future successors and subsidiaries, and (ii)&#160;certain significant stockholders of OneMedNet entered into a Voting Agreement with Data Knights and OneMedNet (the &#8220;<b style="font-weight:bold;">Voting Agreement</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the Support Agreement and Voting Agreement, the parties agreed to vote all of their Data Knights and OneMedNet stock in favor of the Merger Agreement and related transactions and to take certain other actions in support of the Merger Agreement and related transactions. The Support Agreement and Voting Agreement also prevent these stockholders from transferring their voting rights with respect to their stock or otherwise transferring their stock prior to the approval of the Merger Agreement and related transactions, except for certain permitted transfers.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">107</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Board of Directors and Management Following the Business Combination</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following persons are expected to serve as executive officers and directors of OneMedNet following the Business Combination. For biographical information concerning the OneMedNet executive officers and OneMedNet designees to OneMedNet&#8217;s board of directors, see &#8220;<i style="font-style:italic;">Information about OneMedNet&#160;&#8212; Executive Officers and Directors</i>. For biographical information concerning the Data Knights designees to OneMedNet&#8217;s board of directors see &#8220;<i style="font-style:italic;">Information About Data Knights&#160;&#8212; Management&#160;&#8212; Directors and Executive Officers</i>.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:47.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Paul Casey</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.74%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer, Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td></tr><tr><td style="vertical-align:top;width:42.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Dr. Jeffrey Yu</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">55</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chairman of the Board of Directors, Founder, Chief Medical Officer, Vice President<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:42.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Aaron Green</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President</p></td></tr><tr><td style="vertical-align:bottom;width:42.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Lisa Embree</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer, Vice President &#8212; Finance</p></td></tr><tr><td style="vertical-align:bottom;width:42.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Erkan Akyuz</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)(4)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:42.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Eric Casaburi</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)(5)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:42.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Robert Golden</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)(4)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:42.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Dr. Julianne Huh</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)(5)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:42.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Dr. Thomas Kosasa</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)(5)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:42.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">R. Scott Holbrook</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">73</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)(6)</sup></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:23.75pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Member of the audit committee.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:23.75pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Member of the compensation committee.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:23.75pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Member of the nominating and corporate governance committee.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:23.75pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(4)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Class<span style="font-family:'Times New Roman PS Std';">&#160;</span>I Director.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:23.75pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(5)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Class<span style="font-family:'Times New Roman PS Std';">&#160;</span>II Director.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:23.75pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(6)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Class<span style="font-family:'Times New Roman PS Std';">&#160;</span>III Director.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the Business Combination, OneMedNet will nominate one additional Class III Director, subject to the approval of Data Knights, who will qualify as an independent director as defined under the rules of the Nasdaq.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Classified Board of Directors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s board of directors will consist of at least nine directors upon the Closing of the Business Combination. In accordance with the Amended Charter to be filed immediately following consummation of the Business Combination, OneMedNet&#8217;s board of directors will be divided into three (3)&#160;classes. OneMedNet&#8217;s directors will elected at each annual general meeting of stockholders, and the successors to directors whose terms then expire will be elected to serve from the time of election and qualification until the third annual meeting following the election. The directors will be divided among the three (3)&#160;classes as follows:</p><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">the Class&#160;I directors will be Erkan Akyuz, Paul Casey, R. Scott Holbrook and Robert Golden, and their terms will expire at the annual meeting of stockholders to be held in 2024;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the Class&#160;II directors will be Eric Casaburi, Dr.&#160;Julianne Huh and Dr.&#160;Thomas Kosasa, and their terms will expire at the annual meeting of stockholders to be held in 2025; and</p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">the Class&#160;III directors will be Dr.&#160;Jeffrey Yu and R. Scott Holbrook, and their terms will expire at the annual meeting of stockholders to be held in 2026.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet expects that any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. The division of OneMedNet&#8217;s board of directors into three (3)&#160;classes with staggered three-year terms may delay or prevent a change of our management or a change in control.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">108</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Interests of Data Knights&#8217; Directors and Officers and Others in the Business Combination</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">When you consider the recommendation of Data Knights&#8217; Board in favor of approval of the Business Combination and the other Proposals, you should keep in mind that the Sponsor (including certain members of the Sponsor), and Data Knights&#8217; directors and executive officers, may have interests in the Proposals that are different from, or in addition to, your interests as a stockholder. These interests include, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">unless Data Knights consummates an initial business combination, Data Knights&#8217; officers, directors and the Sponsor will not receive reimbursement for any out-of-pocket expenses incurred by them to the extent that such expenses exceed the amount of available proceeds not deposited in the Trust Account;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">as a condition to the Data Knights IPO, all of the Founder Shares are subject to a lock-up and would be released only if specified conditions were met. In particular, subject to certain limited exceptions, all Founder Shares would be subject to a lock up until the earlier of (A)&#160;six&#160;months after the completion of Data Knights&#8217; Business Combination and (B)&#160;subsequent to the Business Combination, (x)&#160;if the closing price of the Class&#160;A Common Stock equals or exceeds $12.00 per unit (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading&#160;days within any 30-trading day period commencing at least 150&#160;days after the Business Combination or (y)&#160;the date on which Data Knights completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of Class&#160;A Common Stock for cash, securities or other property;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Placement Units, purchased by the Sponsor will be worthless if a business combination is not consummated;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Sponsor has agreed that the Placement Units and the underlying securities, will not be sold or transferred by it until after Data Knights has completed a business combination, subject to limited exceptions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that Sponsor paid an aggregate of $25,000 for its Founder Shares and such securities will have a significantly higher value at the time of the Business Combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the fact that Sponsor has agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if Data Knights does not complete an initial business combination by August 11, 2023, the proceeds from the sale of the Placement Units will be included in the liquidating distribution to Data Knights&#8217; Public Stockholders and the Placement Units will expire worthless; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the Trust Account is liquidated, including in the event Data Knights is unable to complete an initial business combination within the required time period, the Sponsor has agreed to indemnify Data Knights to ensure that the proceeds in the Trust Account are not reduced below $10.10 per Public Share by the claims of prospective target businesses with which Data Knights has entered into an acquisition agreement or claims of any third party for services rendered or products sold to Data Knights, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The estimated aggregate amount invested by Sponsor and certain of Data Knights&#8217; directors and executive officers in their interests in Data Knights is $5,877,750, as detailed in the following tables:</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">109</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_Hlk131461146"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assuming No Further Redemptions</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,875,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,137,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,510,135</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,852,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 257,385</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">9,359</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,075,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 35,701,660</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,877,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,433,269</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.47</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assuming 80% Redemptions</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,875,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,139,535</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,852,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 286,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 36,331,060</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,877,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assuming Maximum Redemptions</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;Per</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit&#160;Per</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Security</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Founder Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,875,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,158,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,133,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.48</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Placement Units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,139,535</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,852,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 286,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 585,275</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Warrants for conversion of working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.06</span></p></td></tr><tr><td style="vertical-align:bottom;width:30.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total/Weighted Average</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,195,550</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 36,331,060</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,877,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">30,461,710</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">7.26</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">To date, Data Knights&#8217; officers and directors and the Sponsor have not incurred any out-of-pocket expenses subject to reimbursement by Data Knights. The Sponsor had previously requested that the Company extend the date by which the Company has to consummate a business combination to February 11, 2023, and in connection therewith caused an aggregate of $1,150,000 (representing $0.10 per public share) to be deposited into the Company&#8217;s trust account on August 11, 2022, to extend such date to November 11, 2022, and caused an aggregate of $368,758.44 (representing $0.135 per public share) to extend such date to February 11, 2023. Under the terms of its Charter, the Company can extend the date by which it has to consummate a business combination by up to six additional one-month periods, or up to August 11, 2023 , subject to monthly extension payments of $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account in connection with the exercise of each monthly extension.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Name; </b><b style="font-weight:bold;">Headquarters</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The name of the Combined Entity of OneMedNet and Data Knights will be OneMedNet Corporation and its headquarters will be located at <span style="color:#202124;">6385 Old Shady Oak Rd #250, Eden Prairie, MN 55344</span>.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">110</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Background of the Business Combination</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is a blank check company incorporated as a Delaware corporation on February&#160;8, 2021, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more target businesses. Prior to the consummation of Data Knight&#8217;s initial public offering, neither Data Knights, nor anyone on its behalf, contacted any prospective target business or had any substantive discussions, formal or otherwise, with respect to such a transaction with any prospective business combination target. Promptly following its initial public offering that closed on May&#160;11, 2021, Data Knights expended extensive efforts into identifying a prospective business combination target.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Through Data Knights&#8217; Sponsor, Data Knights, LLC, Data Knights is affiliated with ARC Group Limited (&#8220;<b style="font-weight:bold;">ARC Group</b>&#8221;), a consulting firm, which Data Knights has agreed to pay a total of $10,000 per month for office space, utilities and secretarial and administrative support until the completion of an initial business combination or liquidation pursuant to a Sponsor Support Agreement executed contemporaneous with Data Knights&#8217; IPO. In addition, Data Knights has utilized ARC Group&#8217;s network of relationships and administrative resources to identify, process, and analyze potential acquisition opportunities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; management team, supported by ARC Group, sought out potential business combination targets through their network of relationships across different industries. Data Knights also responded to inquiries from investment bankers who represented companies that were potential business combination targets, and received a number of unsolicited requests from potential targets. During the search process, Data Knights reviewed the materials of and/or had discussions with representatives of more than fifteen potential business combination targets in a wide range of data-focused industries. Data Knights management updated the Board as to the progress of the foregoing on both a formal and informal basis. Data Knights then discussed preliminary parameters for proposals to those targets that it determined were strong candidates for a potential business combination. If a potential business combination target was deemed compelling enough for Data Knights to pursue a potential business combination with, based on the assessment by Data Knights&#8217; management team of the preliminary business, industry, market position, management and financial information available, an initial non-binding letter of intent (&#8220;<b style="font-weight:bold;">LOI</b>&#8221;) to pursue a proposed business combination was prepared.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition to the foregoing assistance, ARC provided consulting advice to Data Knights and the Sponsor regarding the business aspects of potential business combinations and completion of Data Knights transition to a post-initial business combination public company. Data Knights has agreed to pay ARC fees aggregating $[&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;] for ARC&#8217;s services. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June 22, 2021 Data Knights exchanged a non-binding letter of intent with a company which manufactured devices that allow for the tracking of statistics associated with athlete performance. The technology and algorithms associated with the device were considered by the Data Knights management team to be significant and unique. The company had substantial existing contracts and partnerships with a pipeline for future growth. The introduction of this company was made through ARC Group. Although Data Knights&#8217; team was encouraged by the prospects of this potential merger, Data Knights did not proceed to entering into a business combination agreement or advanced stages of a transaction with the company due to the fact that the company&#8217;s audit was not complete and did not have a timeline for completing them that would align with Data Knight&#8217;s timing for a merger. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On January 12, 2022 Data Knights sent an initial draft non-binding letter of intent to an electric vehicle producer based. The introduction to this company was made through Data Knight&#8217;s underwriter. In discussion and negotiations, Data Knights and the target company could not agree on final terms for the deal including a final valuation and a cash on closing requirement. Due to the gaps in negotiations over these terms, Data Knights did not proceed to entering into a business combination agreement or advanced stages of a potential transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">On February 20, 2022 Paul Chong of ARC introduced OMN to Data Knights as a potential source of capital.  Paul Casey, Chief Executive Officer of OneMedNet, was acquainted with Mr. Chong from prior dealings when he was Chief Executive Officer of another company and Mr. Chong was working with a financial institution in Southeast Asia.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On March 4, 2022, Data Knights and OneMedNet exchanged an initial draft of a non-binding letter of intent regarding a potential business combination, the terms of which included, among others, transaction consideration for OneMedNet of $200 million in the form of the issuance of shares of common stock of Data Knights. The valuation was determined by Data Knights and presented to OneMedNet via the non-binding letter of intent. Data Knights, with the assistance from ARC Group, used comparable analysis to companies that were similar in industry or services to determine a range of $150 million to $200 million valuation. The draft letter of intent proposed entry into a forty-five day exclusivity period, whereby the parties would negotiate the terms of a definitive transaction agreement. The draft letter of intent provided that each of Data Knights and OneMedNet would be obligated to pay their respective </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">111</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">expenses incurred in connection with the business combination. Data Knights proposed the transaction consideration amount based on preliminary financial and business information shared by OneMedNet.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 6, 2022, Data Knights held a Board meeting call to discuss the status of Data Knights&#8217; search for a suitable business combination candidate, including discussions with OneMedNet and the potential timeline for a business combination. The Board also discussed the plan for Data Knights&#8217; due diligence efforts, audit-related matters, post-transaction leadership and governance matters, as well as discussions regarding the framework of a transaction. The board expressed their support for the OneMedNet deal and proceeding with exclusivity based on the current and future performance of the company, the good fit with their original mandate to find a data-based company, and the agreeable terms of the transaction (including a $200 million valuation subject to further diligence through a third-party opinion). No other valuation amount was considered by the board. The valuation was made with an assumption of no PIPE funding given the uncertainty in the amount that would be raised and the deemed minimal amount of capital needed to execute to OneMedNet&#8217;s business plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 8, 2022, OneMedNet sent Data Knights an updated draft non-binding letter of intent, including clarification of the net working capital target for OneMedNet at closing of the acquisition and the mechanism for OneMedNet&#8217;s funding of Data Knights&#8217; extension payments, clarifying that the transaction lockup period would apply to OneMedNet stockholders with greater than 1% ownership, and adding provisions requiring Data Knights to seek to secure a PIPE transaction of at least $10 million and to engage a mutually agreeable investment bank to assist in the PIPE transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 10, 2022, after negotiations between the parties, Data Knights determined to pursue discussions solely with OneMedNet, and Data Knights and OneMedNet executed the non-binding letter of intent. The non-binding letter of intent included a forty-five day exclusivity period and contemplated a valuation for OneMedNet of $200 million to be paid in the form of the issuance of shares of common stock of Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 11, 2022, Data Knights submitted a due diligence request list to OneMedNet.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 14, 2022, Nelson Mullins, as legal counsel to Data Knights, distributed an initial draft of the Merger Agreement to OneMedNet through its legal counsel, Rimon PC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">On March 26, 2022, Rimon distributed initial comments to the draft Merger Agreement to Nelson Mullins and Data Knights, which included proposed revisions to OneMedNet&#8217;s representations and warranties in the draft to reflect OneMedNet&#8217;s business and proposed revisions to the draft to clarify the treatment of options and warrants issued by OneMedNet, but indicated general agreement on a number of the proposed terms of transaction, including the formula to determine the amount of the merger consideration, the closing conditions, the no-shop provision, the governance of the post-combination company and the termination provisions, as they were consistent with the non-binding letter of intent.  The representations and warranties and provisions governing the treatment of options and warrants, together with those relating to the Minimum Cash Condition and the PIPE financing, were the material terms negotiated in the Merger Agreement. In particular, the parties negotiated materiality and knowledge qualifiers to provisions in the representations regarding financial statements, compliance with laws, litigation, intellectual property, taxes and employment matters, as well as the scope of representations regarding environmental matters and the completeness of the representations. The parties also negotiated provisions to address the required exercise or forfeiture of the outstanding options and warrants of OneMedNet, to characterize the PIPE financing obligation as a reasonable business efforts obligation of Data Knights, and to establish the minimum required cash and cash equivalents level of the Minimum Cash Condition at $30 million based on OneMedNet&#8217;s anticipated capital needs post-closing during the first 12-24 months following the closing of the Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 29, 2022, Nelson Mullins distributed a revised draft of the Merger Agreement to Rimon and OneMedNet accepting many of the revisions proposed in the comments previously distributed by Rimon and clarify others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From April 1, 2022 until April 24, 2022, Data Knights, Nelson Mullins and its other advisors conducted a due diligence review of the business, assets and operations of OneMedNet.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">On April 6, 2022, Rimon distributed comments to the revised draft Merger Agreement to Nelson Mullins and Data Knights proposing further revisions to OneMedNet&#8217;s representations and warranties in the draft to reflect OneMedNet&#8217;s business and proposed revisions to the draft to clarify the terms of the proposed PIPE Financing and the minimum cash condition to provide up to $30 million of post-closing cash.  OneMedNet proposed the minimum cash condition based on its anticipated capital needs during the first 12-24 months following the Closing of the Business Combination.</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">112</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April 10, 2022, Nelson Mullins distributed a revised draft of the Merger Agreement to Rimon and OneMedNet proposing clarifications to OneMedNet&#8217;s representations and warranties in the draft, along with drafts of the forms of ancillary documents to the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April 18, 2022, the Board of Directors of Data Knights met to discuss the proposed transaction, the Merger Agreement and ancillary documents. At the meeting, the Board approved the execution and delivery of the Merger Agreement and ancillary documents subject to finalizing the wording of several outstanding provisions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April 19, 2022, Rimon distributed drafts of OneMedNet&#8217;s disclosure schedule to the Merger Agreement to Nelson Mullins and Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April 21, 2022, Nelson Mullins distributed drafts of Data Knights&#8217; disclosure schedule to the Merger Agreement to Rimon and OneMedNet.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From April 22, 2022, to April 24, 2022, Nelson Mullins and Rimon exchanged revised drafts of the Merger Agreement, ancillary documents and disclosure schedules to finalize the documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April 25, 2022, Data Knights and OneMedNet executed and delivered the Merger Agreement and, together with the relevant counterparties, the Sponsor Support Agreement, the Voting Agreement, the Lock-Up Agreements, the Non-Competition and Non-Solicitation Agreements and the Extension Escrow Agreement.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On May 20, 2022, Data Knights entered into a placement agent agreement with EF Hutton to assist with the raising of PIPE funds for the transaction. To date, term sheets with multiple investors have been shared. Pursuant to the Securities Purchase Agreement, Data Knights will issue and sell to each PIPE Investor, a Senior Secured Convertible Note (each a &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">PIPE Note</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;) for an aggregate principal amount of $1.5 million, as part of a private placement. The PIPE Notes are convertible into shares of the Combined Entity&#8217;s Common Stock at any time after the funding and rank senior to all outstanding indebtedness of Data Knights and its subsidiaries.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On June 28, 2023, EF Hutton waived $3,025,000 of $4,025,000 cash deferred underwriting commission, pursuant to a Satisfaction and Discharge Agreement (attached at Exhibit 10.22) that would otherwise be immediately due and payable upon the Closing, accepting in lieu thereof (i) a one-time cash payment of $500,000 at the time of the Closing; (ii) a $500,000 promissory note executed by the Company on June 30, 2023 (attached at Exhibit 10.21) in which it is obligated to make monthly payments to EF Hutton in the cash amount of $83,333.33 from October 2023 through March 2024; and (iii) 277,778 ordinary shares of the Company (the &#8220;Ordinary Shares&#8221;) at $10.89 per share, for an aggregate value of $3,025,000.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Satisfaction of 80% Test</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">It is a requirement under Nasdaq listing rules&#160;that any business that Data Knights acquires have a fair market value equal to at least 80% of the balance of the funds in the Trust Account at the time of the execution of a definitive agreement for the Business Combination. The balance of the funds in the Trust Account as of the Record Date, [&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;], 2023 was $[</span><span style="font-family:'Times New Roman';">&#9679;</span><span style="font-family:'Times New Roman','Times','serif';">] (including $4,025,000 of the cash portion of the deferred underwriting commissions, however only $500,000 of which is due at Closing, effective June 28, 2023, when EF Hutton, waived $3,025,000 of the $4,025,000 cash deferred underwriting commission, pursuant to a Satisfaction and Discharge Agreement (attached at Exhibit 10.22) that would otherwise be immediately due and payable upon the Closing, accepting in lieu thereof (i) a one-time cash payment of $500,000 at the time of the Closing; (ii) a $500,000 promissory note executed by the Company on June 30, 2023 (attached at Exhibit 10.21) in which it is obligated to make six monthly payments to EF Hutton in the cash amount of $83,333.33 from October 2023 through March 2024; and (iii) 277,778 ordinary shares of the Company (the &#8220;Ordinary Shares&#8221;) at $10.89 per share, for an aggregate value of $3,025,000) and 80% thereof represents $[&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;]. In reaching its conclusion that the Business Combination satisfied the 80% asset test, the Board of Directors looked at the enterprise value of OneMedNet of approximately $200 million. In determining whether the enterprise value described above represents the fair market value of OneMedNet, our Board of Directors considered all of the factors described in this section, and the fact that the purchase price for OneMedNet was the result of an arm&#8217;s length negotiation with OneMedNet management, among other reasons. As a result, our Board of Directors concluded that the fair market value of the businesses acquired was significantly in excess of 80% of the assets held in the Trust Account. In light of the financial background and experience of the members of Data Knights&#8217; management team and the Board of Directors, Data Knights&#8217; Board of Directors believes that the members of Data Knights&#8217; management team and the Board of Directors are qualified to determine whether the Business Combination satisfies the 80% asset test. Data Knights&#8217; Board of Directors has not obtained an opinion of an outside fairness or valuation advisor as to whether the 80% asset test has been satisfied.</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">113</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Anticipated Accounting Treatment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the legal form of the Business Combination pursuant to the Merger Agreement, the Business Combination is expected to be accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, Data Knights will be treated as the acquired company and OneMedNet will be treated as the survivor for financial statement reporting purposes. OneMedNet has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet existing securityholders will have the greatest voting interest in the Combined Entity under the no further redemptions and maximum redemptions scenarios with more than 54.5% and 81.2% voting interest, respectively (excluding any outstanding Warrants and assuming that (i)&#160;there are no further redemptions of any shares by Data Knights&#8217; public stockholders in connection with the Business Combination, and (ii)&#160;no awards are issued under the Equity Incentive Plan;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the largest individual minority stockholder of the Combined Entity is an existing stockholder of OneMedNet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet&#8217;s directors will represent seven out of nine board seats for the Combined Entity&#8217;s board of directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet&#8217;s existing stockholders will have the ability to control decisions regarding election and removal of directors and officers of the Combined Entity&#8217;s executive board of directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet&#8217;s senior management will be the senior management of the Combined Entity; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet operations will be the only continuing operations of the Combined Entity.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Potential Purchases of Public Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the stockholder vote to approve the proposed Business Combination, the Sponsor, directors, officers, or advisors or their respective affiliates may privately negotiate transactions to purchase shares from stockholders who would have otherwise elected to have their shares redeemed in conjunction with a proxy solicitation pursuant to the proxy rules&#160;for a per-share pro rata portion of the Trust Account. None of Data Knights&#8217; directors, officers or advisors or their respective affiliates will make any such purchases when they are in possession of any material non-public information not disclosed to the seller. Such a purchase would include a contractual acknowledgement that such stockholder, although still the record holder of Data Knights&#8217; shares is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights, and would include a contractual provision that directs such stockholder to vote such shares in a manner directed by the purchaser. In the event that the Sponsor, directors, officers or advisors or their affiliates purchase shares in privately negotiated transactions from public stockholders who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their shares. Any such privately negotiated purchases may be effected at purchase prices that are equal to or below the per-share pro rata portion of the Trust Account, none of such shares would be voted in favor of the Business Combination, and no exercise of redemption rights would be made by the purchasers with respect to such shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The purpose of such purchases would be to increase the likelihood of obtaining stockholder approval of the Business Combination or, where the purchases are made by the Sponsor, directors, officers or advisors or their respective affiliates, to satisfy a closing condition in an agreement related to the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">The Board&#8217;s Reasons for Approval of the Business Combination</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights Board, in evaluating the Business Combination, consulted with Data Knights&#8217; management and its financial and legal advisors. Data Knights Board obtained a third-party fairness opinion prior to closing the Business Combination. Data Knights&#8217; officers, directors and advisors have substantial experience in evaluating the operating and financial merits of companies from a wide range of industries but concluded that a third-party fairness opinion coupled with Data Knights&#8217; officers, directors and advisors experience and backgrounds, together with the experience and sector expertise of Data Knights&#8217; financial advisors, enabled them to make the necessary analyses and determinations regarding the Business Combination. In addition, Data Knights&#8217; officers, directors and advisors have substantial experience with mergers and acquisitions. Accordingly, investors will be relying solely on the judgment of Data Knights&#8217; board of directors and management in valuing the Companies&#8217; business</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">114</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In reaching its unanimous resolution (i)&#160;that the Merger Agreement and the transactions contemplated thereby, including the Business Combination and the issuance of shares of Data Knights Common Stock in connection therewith, are advisable and in the best interests of Data Knights, and (ii)&#160;to recommend that the Data Knights stockholders adopt the Merger Agreement and approve the Business Combination and the other transactions contemplated by the Merger Agreement, the Data Knights Board considered a range of factors, including, but not limited to, the factors discussed below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In light of the number and wide variety of factors considered in connection with its evaluation of the Business Combination, the Data Knights Board did not consider it practicable to, and did not attempt to, quantify or otherwise assign relative weights to the specific factors that it considered in reaching its determination and supporting its decision. The Data Knights Board viewed its decision as being based on any and all of the information available and the factors presented to and considered by it. In addition, individual directors may have given different weight to different factors. This explanation of Data Knights&#8217; reasons for the Business Combination and all other information presented in this section may be forward-looking in nature and, therefore, should be read in light of the factors discussed under &#8220;<i style="font-style:italic;">Cautionary Statement Regarding Forward-Looking Statements</i>.&#8221; Many factors were considered by Data Knights, and the factors outlined herein may or may not have been considered by any particular directors, member of management, or advisor of Data Knights. Notwithstanding whether any of these factors were considered by any individual board member, the Board voted unanimously to proceed with the transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The officers and directors of Data Knights have substantial experience in evaluating the operating and financial merits of companies from a wide range of industries and concluded that their experience and background, together with experience and sector expertise of Data Knights&#8217; advisors, enabled them to make the necessary analyses and determinations regarding the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights Board considered a number of factors pertaining to the Business Combination as generally supporting its decision to enter into the Merger Agreement and the transactions contemplated thereby, including, but not limited to, the following material factors:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Growth Prospects</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. With the well-documented growing need for evidence generated from Real-World Data, the increasing importance of epidemiological data in decision making, and a shift from volume to value-based care, there has been an increased focus on patient registries, a rise in the adoption of electronic medical records in hospitals, and exponential growth in mobile health data and social media which have resulted in the generation of huge amounts of medical data with the market size of this segment projected to reach $1,792.0 million by 2028 from $1,038.3 million in 2021, at a CAGR of 8.1% during the forecast period according to Meticulous Research&#174; Analysis.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Purchase Price. </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;Data Knights&#8217; board considered the valuation of OneMedNet implied by the terms of the Merger Agreement to reflect an attractive valuation of OneMedNet, while offering substantial potential upside after consummating the Business Combination relative to current valuations of other private and publicly traded comparable medical, data and cloud services companies for which Data Knights&#8217; management could obtain data. These companies aligned with the list of public companies that were ultimately included in the guideline public company analysis used by Marshall &amp; Stevens in preparing its opinion. See </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Opinion of Marshall &amp; Stevens&#8201;&#8212;&#8201;Guideline Public Company Analysis</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> below. The following table summarizes the enterprise value of the companies considered by Data Knights&#8217; board as a multiple of projected 2023 and 2024 revenue, compared to the multiples for OneMedNet at its enterprise value implied by the Merger Consideration:</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Company</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">EV/Revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">EV/Revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.25%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">MongoDB</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">15.17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">11.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Snowflake</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">18.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">13.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Datadog</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">20.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">14.33</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Doximity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">14.64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;">&#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Cloudflare</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">26.33</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">20.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">NextDC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">15.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">12.90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">4DMedical</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">30.14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">11.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">OneMedNet</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">23.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;">10.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">Based on the favorable long-term comparison of OneMedNet to the referenced companies, Data Knights&#8217; board considered the Merger Agreement to offer an attractive value proposition for Data Knights&#8217; stockholders.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">115</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is a table including details regarding the industry, size, and profitability along with further detail regarding revenue forecasts and the specific multiples considered for each comparison company:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:14.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:7.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:7.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:6.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:7.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:7.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:6.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:4.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:0.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:14.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Comparison&#160;Companies</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:8.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">MongoDB,&#160;Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:8.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Snowflake&#160;Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Datadog,</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Doximity,</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:7.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cloudflare,</b><br/><b style="font-weight:bold;">Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:7.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NEXTDC</b><br/><b style="font-weight:bold;">Limited</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">4DMedical</b><br/><b style="font-weight:bold;">Limited</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:4.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Median</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">25</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">th</sup><br/><b style="font-weight:bold;">Percentile</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">75</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">th</sup><br/><b style="font-weight:bold;">Percentile</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.32%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:top;width:14.29%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Industry</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.64%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:8%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;">&#8199;Internet Services and Infrastructure</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.64%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:7.75%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;">&#8199;Internet Services and Infrastructure</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.64%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:7.23%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">Application Software</p></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.64%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.19%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">Health Care Technology</p></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.64%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:7.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;">&#8199;Internet Services and Infrastructure</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.64%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:7.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;">&#8199;Internet Services and Infrastructure</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.64%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.19%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">Health Care Technology</p></td><td style="vertical-align:top;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.25%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.54%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.54%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:14.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 5.75pt;">Enterprise Value (in millions)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">24,105.37</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">53,086.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">38,678.74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:6.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8,622.40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">19,363.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,666.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:6.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">47.45</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:14.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Profitability&#8201;&#8211;&#8201;LTM EBITDA Percentage</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">-29.22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">-47.39</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">33.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">-11.39</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">52.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">-4979.43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:14.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Projected Revenue (in</b> <b style="font-weight:bold;">millions)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:14.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Calendar Year + 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,193.52</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,025.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,618.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:6.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">414.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">958.61</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">221.86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:6.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2.73</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:14.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Calendar Year + 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,562.64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3,110.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,226.06</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:6.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">547.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,309.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">265.77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:6.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:15.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:6.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:15.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Selected Guideline</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Public Companies</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:9.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">MongoDB,&#160;Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:9.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Snowflake&#160;Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Datadog,</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Doximity,</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:7.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cloudflare</b><br/><b style="font-weight:bold;">Inc.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NEXTDC</b><br/><b style="font-weight:bold;">Limited</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">4DMedical</b><br/><b style="font-weight:bold;">Limited</b></p></td><td style="vertical-align:bottom;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Median</b></p></td><td style="vertical-align:bottom;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">25</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">th</sup><br/><b style="font-weight:bold;">Percentile</b></p></td><td style="vertical-align:bottom;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">75</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">th</sup><br/><b style="font-weight:bold;">Percentile</b></p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Calendar Year + 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.86%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:8.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,055.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:8.58%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,559.39</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.75%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3,101.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.44%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">705.94</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:6.41%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,795.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">344.83</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.94%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.87%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Calendar Year + 4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,663.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6,923.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,332.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">866.63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:6.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,776.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">448.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Multiple Analysis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Enterprise Value / Total Revenue&#8201;&#8211;&#8201; Size Adjusted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Calendar Year + 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">9.2x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">9.2x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">9.9x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">9.4x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">9.1x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">10.4x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">5.7x</p></td><td style="vertical-align:bottom;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">9.2x</p></td><td style="vertical-align:bottom;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">9.1x</p></td><td style="vertical-align:bottom;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">9.7x</p></td><td style="vertical-align:top;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Calendar Year + 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7.8x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7.3x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">8.1x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">8.0x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7.4x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">8.8x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7.9x</p></td><td style="vertical-align:bottom;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7.5x</p></td><td style="vertical-align:bottom;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">8.1x</p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Calendar Year + 4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">6.5x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">5.5x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">6.4x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7.0x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">5.4x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7.4x</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">6.5x</p></td><td style="vertical-align:bottom;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">5.8x</p></td><td style="vertical-align:bottom;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">6.9x</p></td><td style="vertical-align:top;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Due Diligence.&#160;</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Due diligence examinations of OneMedNet and discussions with OneMedNet&#8217;s management team and Data Knights&#8217; legal advisors concerning Data Knights&#8217; due diligence examination of OneMedNet have led Data Knights to deem that OneMedNet has assembled the foundation to grow OneMedNet to a potentially very successful clinical imaging and Real-World Data company;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Stockholder Liquidity</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The obligation in the Merger Agreement to have Data Knights Common Stock issued as merger consideration listed on the Nasdaq, a major U.S. stock exchange, which the Data Knights Board believes has the potential to offer its existing stockholders enhanced liquidity as result of higher trading volume and additional analyst interest;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Financial Information and Comparable Company Analysis</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The Data Knights Board also considered factors related to OneMedNet&#8217;s financial outlook. In connection with Data Knights&#8217; review of the Business Combination, OneMedNet provided Data Knights&#8217; management with its internal financial analysis model. See </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Opinion of Marshall &amp; Stevens</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> for information regarding this model. Although Data Knights&#8217; board received certain financial projections included in OneMedNet&#8217;s financial model, it did not rely on these financial projections as a determinative factor in its decision to enter into the Merger Agreement but did find their content informative of OneMedNet&#8217;s financial outlook. Evaluating real world growth and financial projections related to a rapid growth company in a competitive industry can be challenging; the Board recognized that a properly capitalized technology company in the Real-World Data space should instead have a primary focus of user acquisition during its initial growth stages. This may initially hamper EBITDA and even topline revenues. However, the Board believes that if management of OneMedNet is successful in the user acquisition phase, this will ultimately drive the key performance indicators that are directly correlated to the cash flow and income statements. </span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; management also reviewed the financial projection assumptions and revenue projections for OneMedNet&#8217;s second product, OneMedNet <b style="font-weight:bold;">iRWD&#8482;</b> solution, including projections and potential pricing models. See<i style="font-style:italic;"> Opinion of Marshall &amp; Stevens &#8211; Financial Projections</i> <i style="font-style:italic;">and Information about OneMedNet Corporation &#8211; Material Customer Agreements.</i></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Experienced Management Team</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. OneMedNet has a strong management team with significant experience.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Lock-Up. </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Key stockholders of OneMedNet (including certain of its directors and executive officers) agreed to be subject to a six-month lockup in respect of their Data Knights Common Stock, subject to certain customary exceptions, which would provide important stability to the leadership and governance of OneMedNet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Other Alternatives</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The Data Knights Board believes, after a thorough review of other business combination opportunities reasonably available to Data Knights, that the proposed Business Combination represents the best potential business combination for Data Knights and the most attractive opportunity based upon the process utilized to evaluate and assess other </span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">116</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">potential acquisition targets. Given the potential number of customers for </span><span style="color:#747474;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet </span><b style="color:#747474;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">iRWD&#8482;</b><span style="color:#747474;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> solution</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, the Data Knights Board believes OneMedNet offers its shareholders the most potential value when compared to other target candidates.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Negotiated Transaction</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The financial and other terms of the Merger Agreement and the fact that such terms and conditions are reasonable and were the product of arm&#8217;s length negotiations between Data Knights and OneMedNet.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights Board also considered a variety of uncertainties and risks and other potentially negative factors concerning the Business Combination including, but not limited to, the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Macroeconomic Risks.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;Macroeconomic uncertainty, including the potential impact of the&#160;COVID-19&#160;pandemic, and the effects it could have on OneMedNet&#8217;s revenues post-closing;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Business Plan and Projections May&#160;Not Be Achieved.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;The risk that OneMedNet may not be able to execute on the business plan or realize the financial performance, as set forth in the financial projections, in each case, presented to Data Knights&#8217; management team and board of directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Redemption Risk</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The potential that a significant number of Data Knights stockholders elect to redeem their shares prior to the consummation of the Business Combination and pursuant to Data Knights Charter, which would potentially make the Business Combination more difficult or impossible to complete;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Stockholder Vote.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;The risk that Data Knights&#8217; stockholders may fail to provide the respective votes necessary to affect the Business Combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Closing Conditions</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The fact that the completion of the Business Combination is conditioned on the satisfaction of certain closing conditions that are not within Data Knights&#8217; control;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Litigation.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;The possibility of litigation challenging the Business Combination or that an adverse judgment granting permanent injunctive relief could indefinitely enjoin consummation of the Business Combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Listing Risks.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;The challenges associated with preparing OneMedNet, a private entity, for the applicable disclosure and listing requirements to which OneMedNet will be subject as a publicly traded company on the Nasdaq;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Benefits May&#160;Not Be Achieved.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;The risks that the potential benefits of the Business Combination may not be fully achieved or may not be achieved within the expected timeframe;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Liquidation of Data Knights.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;The risks and costs to Data Knights if the Business Combination is not completed, including the risk of diverting management focus and resources from other business combination opportunities, which could result in Data Knights being unable to effect a business combination by the Outside Date;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Growth Initiatives May&#160;Not be Achieved</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The risk that OneMedNet&#8217;s growth initiatives may not be fully achieved or may not be achieved within the expected timeframe;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Board and Independent Committees</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The risk that OneMedNet&#8217;s board of directors post-Closing and independent committees do not possess adequate skills set within the context of OneMedNet operating as a public company;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Data Knights Stockholders Receiving a Minority Position in OneMedNet</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The risk that Data Knights stockholders will hold a minority position in OneMedNet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Differing Interests of Data Knights Public Stockholders and its Directors, Executive Officers and Sponsor.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> The risk that the differing interests of Data Knights directors, executive officers and sponsor might have influenced the proposed investment in OneMedNet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Fees and Expenses</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The fees and expenses associated with completing the Business Combination; and</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">117</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Other Risk Factors.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;Various other risk factors associated with the business of OneMedNet, as described in the section entitled &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Risk Factors</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221; appearing elsewhere in this proxy statement/prospectus.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The above discussion of the material factors considered by the Data Knights Board is not intended to be exhaustive, but does set forth the principal factors considered by the Data Knights Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Board concluded that the potential benefits expected to be achieved by Data Knights and its stockholders resulting from the Business Combination outweighed the potentially negative factors associated with the Business Combination. Accordingly, the Board determined that the Business Combination was advisable, fair to, and in the best interests of, Data Knights and its shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Opinion of Marshall&#160;&amp; Stevens</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On May 6, 2022, Data Knights engaged Marshall &amp; Stevens Transaction Advisory Services LLC (&#8220;Marshall &amp; Stevens&#8221;) to evaluate the fairness, from a financial point of view, to Data Knights of the consideration to be received by Data Knights in consideration of the issuance of its equity securities to the equity holders of OneMedNet in connection with the anticipated acquisition by Data Knights of one hundred percent of the equity and equity equivalents (&#8220;<b style="font-weight:bold;">equity</b>&#8221;) and/or all or substantially all of the assets and business (the &#8220;<b style="font-weight:bold;">business</b>&#8221;) of OneMedNet (the &#8220;<b style="font-weight:bold;">Acquired Business</b>&#8221;), allowing Data Knights&#8217; board of directors to confirm its judgment in approving the Merger Agreement. On June 23, 2022, Data Knights&#8217; board of directors met to review the proposed merger. During this meeting, Marshall &amp; Stevens reviewed with Data Knights&#8217; board of directors certain financial analyses as described below and rendered its oral opinion to Data Knights&#8217; board of directors, which opinion was confirmed by delivery of a written opinion, dated June 23, 2022, to the effect that, as of that date and based on and subject to the matters described in its opinion, the purchase price being paid by Data Knights for OneMedNet in the transaction was fair, from a financial point of view, to Data Knights.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The full text of Marshall&#160;&amp; Stevens&#8217; written opinion, dated June&#160;23, 2022, to Data Knights&#8217; board of directors, which sets forth, among other things, the assumptions made, matters considered and limitations on the scope of review undertaken by Marshall&#160;&amp; Stevens in rendering its opinion, is attached as </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex E</i><span style="font-family:'Times New Roman','Times','serif';"> and is incorporated into this proxy statement by reference in its entirety. Holders of the Class&#160;A Common Stock are encouraged to read this opinion carefully in its entirety. Marshall&#160;&amp; Stevens&#8217; opinion was provided to Data Knights&#8217; board of directors for their information in connection with their evaluation of the consideration to be received by Data Knights in consideration of the issuance of its equity securities to the equity holders of OneMedNet in the merger and relates only to the fairness, from a financial point of view, of such consideration, does not address any other aspect of the merger and does not constitute a recommendation to any stockholder as to how such stockholder should vote or act with respect to any matters relating to the merger. Pursuant to the terms of Data Knights&#8217; engagement of Marshall &amp; Stevens, the opinion was provided to Data Knights&#8217; board of directors and may be relied upon only by the board, although stockholders may by virtue of the DGCL and other applicable law indirectly receive the benefit thereof. The summary of Marshall&#160;&amp; Stevens&#8217; opinion in this proxy statement is qualified in its entirety by reference to the full text of the opinion.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In arriving at its opinion, Marshall&#160;&amp; Stevens, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewed the Merger Agreement dated April&#160;25, 2022;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewed certain operating and financial information relating to OneMedNet&#8217;s business and prospects, including financial statements for the three years ended December 31, 2019 through 2021, internal financial records for the three-month periods ended March 31, 2021 and March 31, 2022, and projections for the years ending December 31, 2022 through December 31, 2032, all as prepared and provided to it by OneMedNet&#8217;s management;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">spoke with certain members of OneMedNet&#8217;s management regarding OneMedNet&#8217;s operations, financial condition, future prospects and projected operations and performance and regarding the merger;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">participated in discussions with the board and its counsel regarding OneMedNet&#8217;s projected financials results, among other matters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewed certain business, financial and other information regarding OneMedNet that was furnished to it by OneMedNet through its management;</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">118</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewed certain other publicly available financial data for certain companies that Marshal&#160;&amp; Stevens deemed relevant for purposes of its analysis and publicly available transaction prices and premiums paid in other transactions that it deemed relevant for purposes of its analysis;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">performed a discounted cash flow analysis based on the projected financial information provided by OneMedNet&#8217;s management; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">conducted such other financial studies, analyses and inquiries as it deemed appropriate.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with its review, Marshall&#160;&amp; Stevens relied upon and assumed, without independent verification, the accuracy and completeness of all data, material and other information furnished or otherwise made available to it, discussed with or reviewed by it, or publicly available, and did not assume any responsibility with respect to such data, material and other information. In addition, OneMedNet&#8217;s management advised Marshall&#160;&amp; Stevens, and Marshall&#160;&amp; Stevens assumed, that OneMedNet&#8217;s projected financial information provided to Marshall&#160;<span style="white-space:pre-wrap;">&amp; Stevens was reasonably prepared on bases reflecting the best currently available estimates and judgments of OneMedNet&#8217;s future financial results and condition. In evaluating fairness, Marshall &amp; Stevens assumed a fair market value for Data Knights shares of $10.32 per share (the then estimated redemption value of such shares).  This value was used, with the consent of Data Knights&#8217; board of directors, due to the fact that Data Knights is a special purpose acquisition company with only limited trading history and no material operations or assets other than cash or cash equivalent and an as yet to be approved merger agreement.  Accordingly, Marshall &amp; Stevens did not perform an independent analysis regarding the fair market value of the common stock to be issued pursuant to the Merger Agreement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marshall&#160;&amp; Stevens expressed no opinion with respect to such forecasts and projections or the assumptions on which they are based. Marshall&#160;&amp; Stevens also relied upon and assumed, without independent verification, that there has been no material change in OneMedNet&#8217;s assets, liabilities, financial condition, results of operations, business or prospects since the date of the most recent financial statements provided to Marshall&#160;&amp; Stevens, and that there is no information or facts that would make the information reviewed by Marshall&#160;&amp; Stevens incomplete or misleading. Marshall&#160;&amp; Stevens also assumed that OneMedNet is not party to any material pending transaction, including, without limitation, any external financing (other than in connection with the merger), recapitalization, acquisition or merger, divestiture or spin-off (other than the merger or other publicly disclosed transactions).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marshall&#160;&amp; Stevens relied upon and assumed, without independent verification, that (a)&#160;the representations and warranties of all parties to the agreements identified in the Merger Agreement and all other related documents and instruments that are referred to therein are true and correct, (b)&#160;each party to each such agreement, document or instrument will perform all of the covenants and agreements required to be performed by such party, (c)&#160;all conditions to the completion of the merger will be satisfied without waiver thereof and (d)&#160;the merger will be completed in a timely manner in accordance with the terms described in the agreements provided to Marshall&#160;&amp; Stevens, without any amendments or modifications thereto or any adjustment to the aggregate consideration (through offset, reduction, indemnity claims, post-closing purchase price adjustments or otherwise). Marshall&#160;&amp; Stevens also relied upon and assumed, without independent verification, that all governmental, regulatory and other consents and approvals necessary for the completion of the merger will be obtained and that no delay, limitations, restrictions or conditions will be imposed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marshall&#160;&amp; Stevens was not requested to make, and did not make, any physical inspection or independent appraisal or evaluation of any of the assets, properties or liabilities (contingent or otherwise) of OneMedNet, Data Knights or any other party. Furthermore, Marshall&#160;&amp; Stevens did not undertake independent analysis of any potential or actual litigation, governmental investigation, regulatory action, possible unasserted claims or other contingent liabilities to which OneMedNet or Data Knights is a party or may be subject.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marshall&#160;&amp; Stevens&#8217; opinion addressed only the fairness, from a financial point of view, of the consideration to be received by Data Knights in consideration of the issuance of its equity securities to the equity holders of OneMedNet in the merger and did not address any other aspect or implication of the merger or any other agreement, arrangement or understanding entered into in connection with the merger or otherwise. Marshall&#160;&amp; Stevens&#8217; opinion was necessarily based upon information made available to it as of the date of the opinion and financial, economic, market and other conditions as they existed and could be evaluated on the date of the opinion. Marshall&#160;&amp; Stevens&#8217; opinion did not address the relative merits of the merger as compared to alternative transactions or strategies that might be available to Data Knights, nor did it address Data Knights&#8217; underlying business decision to proceed with the merger. Except as described herein, Data Knights&#8217; board of directors imposed no other limitations on Marshall&#160;&amp; Stevens with respect to the investigations made or procedures followed in rendering the opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In preparing its opinion to Data Knights&#8217; board of directors, Marshall&#160;&amp; Stevens performed a variety of financial and comparative analyses, including those described below that were the material financial analyses reviewed with Data Knights&#8217; board of directors in </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">119</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">connection with Marshall&#160;&amp; Stevens&#8217; opinion. The summary of Marshall&#160;&amp; Stevens&#8217; analyses described below is not a complete description of such analyses underlying Marshall&#160;&amp; Stevens&#8217; opinion. The preparation of a fairness opinion is a complex process involving various determinations as to the most appropriate and relevant methods of financial analysis and the application of those methods to the particular circumstances and, therefore, a fairness opinion is not readily susceptible to partial analysis or summary description. Marshall&#160;&amp; Stevens arrived at its ultimate opinion based on the results of all analyses undertaken by it and assessed as a whole and did not draw, in isolation, conclusions from or with regard to any one factor or method of analysis. Accordingly, Marshall&#160;&amp; Stevens believes that its analyses must be considered as a whole and that selecting portions of its analyses and factors or focusing on information presented in tabular format, without considering all analyses and factors or the narrative description of the analyses, could create a misleading or incomplete view of the processes underlying its analyses and opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In its analyses, Marshall&#160;&amp; Stevens considered industry performance, general business, economic, market and financial conditions and other matters, many of which are beyond OneMedNet&#8217;s control. No company, transaction or business used in Marshall&#160;&amp; Stevens&#8217; analyses as a comparison is identical to OneMedNet or the proposed merger, and an evaluation of the results of those analyses is not entirely mathematical. Rather, the analyses involve complex considerations and judgments concerning financial and operating characteristics and other factors that could affect the acquisition, public trading or other values of the companies, business segments or transactions analyzed. The estimates contained in Marshall&#160;&amp; Stevens&#8217; analyses and the ranges of valuations resulting from any particular analysis are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable than those suggested by the analyses. In addition, analyses relating to the value of businesses or securities do not purport to be appraisals or to reflect the prices at which businesses or securities actually may be sold. Accordingly, the estimates used in, and the results derived from, Marshall&#160;&amp; Stevens&#8217; analyses are inherently subject to substantial uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marshall&#160;&amp; Stevens was not requested to, and it did not, recommend the specific consideration payable in the merger, which consideration was determined between Data Knights and OneMedNet, and the decision to enter into the merger was solely that of Data Knights&#8217; board of directors. Marshall&#160;&amp; Stevens&#8217; opinion and financial analyses were only one of many factors considered by Data Knights&#8217; board of directors in its evaluation of the merger and should not be viewed as determinative of the views of Data Knights&#8217; board of directors or Data Knights&#8217; management with respect to the merger or the merger consideration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is a summary of the material financial analyses reviewed with Data Knights&#8217; board of directors in connection with Marshall&#160;&amp; Stevens&#8217; opinion. The financial analyses summarized below include information presented in tabular format. In order to fully understand Marshall&#160;&amp; Stevens&#8217; financial analyses, the tables must be read together with the text of each summary. The tables alone do not constitute a complete description of the financial analyses. Considering the data in the tables below without considering the full narrative description of the financial analyses, including the methodologies and assumptions underlying the analyses, could create a misleading or incomplete view of Marshall&#160;&amp; Stevens&#8217; financial analyses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Fees Paid to Marshall &amp; Stevens</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fee to be paid to Marshall &amp; Stevens is a fixed fee and not contingent upon the completion of the transaction. Marshall &amp; Stevens provided no additional services associated with the transaction and has provided no other services for the Sponsor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Financial Projections</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Using financial projections provided by OneMedNet&#8217;s management, Marshall&#160;&amp; Stevens calculated the net present value of the unlevered, after-tax free cash flows that OneMedNet&#8217;s business is forecasted to generate for the financial&#160;years 2022 through 2032, plus the present value of the terminal value of OneMedNet&#8217;s business in year 2032.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Given the early stage of OneMedNet, the projections provided anticipated a steeper growth rate in revenues and profits than historically observed.  OneMedNet advised that the major assumptions implemented by its management in developing the projections were as follows.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the years prior to 2021, OneMedNet&#8217;s primary focus was on its BEAM Image Exchange technology (&#8220;BEAM<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup>&#8221;) market segment. OneMedNet&#8217;s BEAM<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> revenue accounted for 90% of its revenue for those fiscal years. The BEAM<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> technology is a Software as a Service (&#8220;SaaS&#8221;) subscription-based model with recurring revenue annually from its customers. From 2019 to 2020 the BEAM<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> Image Exchange business flattened due to the saturation of the market with many competitors fighting for market share. While OneMedNet has retained its existing customer base, it does not expect the BEAM<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> product line to demonstrate continued growth.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">120</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2019, OneMedNet&#8217;s management team recognized an emerging market in the Real-World Data (&#8220;RWD&#8221;) space, specifically in Imaging which has been the area of expertise of OneMedNet. Subsequently, OneMedNet entered the Real-World Data market and launched its Imaging Real World Data (iRWD<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup>) product line in 2020.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">OneMedNet&#8217;s 10-year growth forecast is based on the recent emergence and growth rate of the Real-World Data market, and on the market acceptance of its iRWD</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup><span style="font-family:'Times New Roman','Times','serif';"> product. Since the launch of the iRWD</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup><span style="font-family:'Times New Roman','Times','serif';"> product, OneMedNet has experienced significant year-over-year growth due to the demand for the product. In addition, since 2020 OneMedNet&#8217;s customers have frequently disclosed significant year-over-year increases in their budgets for OneMedNet&#8217;s iRWD</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup><span style="font-family:'Times New Roman','Times','serif';"> product. At the same time iRWD</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup><span style="font-family:'Times New Roman','Times','serif';"> has been adopted by a larger and more diverse group of customers, including customers in the pharmaceutical and healthcare payer sectors.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe there is a reason OneMedNet&#8217;s customer base is growing as it develops its reputation as a reliable source for regulatory-grade imaging RWD. We believe it is because it requires specialized expertise in Artificial Intelligence / Machine Learning technology, data privacy/security, as well as expertise in clinical patient condition(s) and healthcare record keeping. Having, or achieving, expertise in all essential disciplines is a challenging achievement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Our current customer base is in the United States, Canada, Ireland, Israel, Germany, Netherlands, Norway and the United Kingdom.  OneMedNet has plans to expand into Africa and Asia, we expect these expansions to be completed in 2023, however there is no assurance of that timetable. OneMedNet has a team of experienced curators with previous radiology, technical and clinical expertise.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s projections for market and revenue growth to build on its momentum in iRWD rely upon the following assumptions:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">OneMedNet maintains its expertise in radiology and imaging</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">OneMedNet transitions from a transactional-based customer selling model (single data set purchases) to a longitudinal selling model (access to long-term data studies), generating multi-year revenue</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">OneMedNet&#8217;s longitudinal selling model will be driven by the pharmaceutical, artificial intelligence and clinical study customer bases as end users use iRWD<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> to support clinical trials and track long term efficacy of diagnosis and treatments</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">The Food and Drug Administration (the &#8220;FDA&#8221;) continues its trend of increasingly using and accepting Real-World Data to monitor post-market safety and adverse events and to make regulatory decisions</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">The health care community continues its trend of increasingly using Real-World Data to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From 2021 to 2022, OneMedNet&#8217;s iRWD<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> customer bookings doubled, confirming its assumptions about increasing market demand. OneMedNet believes that its continued build out of its platform will result in customer acceptance of its SAAS-based model, allowing it to capture the market share of long-term pharmaceutical, medical device, and artificial intelligence customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The largest accelerator for Real World Data Bookings and Revenues is the FDA and their guidance for rapid adoption of Real World Data to support drug development. The 21<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">st</sup> Century Cures Act is intended to accelerate medical product development and bring innovations faster and more efficiently to the patients who need them. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Among other provisions: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">FDA created a framework for a program (RWE Program) to evaluate the potential use of RWE in regulatory decision-making. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Enhanced FDA&#8217;s understanding of the scope and use of RWD and RWE submitted to support. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Representative examples of study designs that may be included in regulatory submissions are: </span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:46.8pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Randomized clinical trials that use RWD to capture clinical outcomes related to safety or effectiveness; </span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">121</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:46.8pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Single-arm trials that use RWD in an external control arm; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:46.8pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Observational studies, such as observational cohort and case-control studies, that generate RWE intended to help support an efficacy supplement; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:46.8pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Clinical trials or observational studies that use RWD or RWE to fulfill a post-marketing requirement (PMR) or post-marketing commitment. </span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FDA&#8217;s support of RWD and RWE has increased since year after year since 2016 and OneMedNet believes it is reasonable to expect this trend to continue and such trend will have a materially favorable effect on revenues from continuing operations. However, if this trend were to change, OneMedNet&#8217;s projections could be materially impacted in an adverse manner.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">The following table summarizes OneMedNet&#8217;s revenue projections:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="font-style:italic;font-weight:bold;">OneMedNet Revenue Projections</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:9.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:4.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:4.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:4.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:9.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">AOP</b></p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:5.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:5.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:5.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:5.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:5.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2025</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:5.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2026</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:5.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">2027</b></p></td><td style="vertical-align:top;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">2028</b></p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">2029</b></p></td><td style="vertical-align:bottom;width:1.82%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">2030</b></p></td><td style="vertical-align:bottom;width:1.82%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">2031</b></p></td><td style="vertical-align:bottom;width:1.82%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:6.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">2032</b></p></td><td style="vertical-align:bottom;width:1.13%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.04%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Bookings</b></p></td><td style="vertical-align:top;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:4.47%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">1,346.4</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">4,612.0</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">11,409.8</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">23,811.5</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">44,274.4</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">61,554.1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:4.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">85,745.7</b></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">120,043.9</b></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">168,061.5</b></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">235,286.1</b></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">329,400.6</b></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">461,160.8</b></p></td><td style="vertical-align:bottom;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">YoY Growth Assumptions</p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">29</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">243</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">147</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">109</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">86</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">39</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">39</i></p></td><td style="vertical-align:bottom;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">40</i></p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">40</i></p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">40</i></p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">40</i></p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">40</i></p></td><td style="vertical-align:bottom;width:1.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td></tr><tr><td style="vertical-align:bottom;width:9.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Revenue</b></p></td><td style="vertical-align:top;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,091.8</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">3,799.0</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">8,620.9</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">18,610.8</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">35,693.2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">57,745.1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:4.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">88,177.2</b></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">126,066.6</b></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">167,938.7</b></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">207,151.7</b></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">233,941.6</b></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">240,229.0</b></p></td><td style="vertical-align:bottom;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt 0pt 0pt 7.2pt;">YoY Revenue Growth Assumptions</p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">32</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">248</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">127</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">116</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">92</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">62</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">53</i></p></td><td style="vertical-align:bottom;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">43</i></p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">33</i></p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">23</i></p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">13</i></p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">3</i></p></td><td style="vertical-align:bottom;width:1.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td></tr><tr><td style="vertical-align:bottom;width:9.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt 0pt 0pt 7.2pt;">% of Bookings turned to Revenue</p></td><td style="vertical-align:top;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">81</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">82</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">76</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">78</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">81</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">94</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">103</i></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">105</i></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">100</i></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">88</i></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">71</i></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">52</i></p></td><td style="vertical-align:bottom;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td></tr><tr><td style="vertical-align:bottom;width:9.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt 0pt 0pt 7.2pt;">Cost of Sales</p></td><td style="vertical-align:top;width:0.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">1,205.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,638.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,352.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">6,547.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">11,791.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">16,796.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">25,648.2</p></td><td style="vertical-align:bottom;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">36,417.0</p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">48,030.5</p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">58,623.9</p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">64,333.9</p></td><td style="vertical-align:bottom;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;">64,861.8</p></td><td style="vertical-align:bottom;width:1.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt 0pt 0pt 7.2pt;">Cost of sales as % of Revenue</p></td><td style="vertical-align:top;width:0.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">110</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">69</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">39</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">35</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">33</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">29</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">29</i></p></td><td style="vertical-align:bottom;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">29</i></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">29</i></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">28</i></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">27</i></p></td><td style="vertical-align:bottom;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;width:0.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><i style="font-style:italic;">27</i></p></td><td style="vertical-align:bottom;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;line-height:1.27;margin:0pt;"><i style="font-style:italic;">%</i></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Note: 2021 data is historical.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s revenue projections contained herein are based on assumptions that are quantitative and some that are qualitative and not quantifiable. The qualitative assumptions are based on OneMedNet&#8217;s key personnel in production, sales, procurement and operations to arrive at forecasts. Moreover, the projections are based on OneMedNet&#8217;s historical operations plus the projection that OneMedNet would retain current customers, would grow current customers through offering additional products and attract new customers was based on such OneMedNet&#8217;s key personnel&#8217;s qualitative assumptions. Where we used quantifiable assumptions, they related primarily to either the historical performance of OneMedNet&#8217;s customer contracts and actual increases in revenue from those contracts plus assumptions to support projected growth. There can be no certainty or assurances that such projected growth will be achieved. </p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">OneMedNet&#8217;s revenue projections also reflects its evolution from a point-in-time analysis (e.g., single data set transactional sale) to a longitudinal selling model (e.g., multi-year agreements with long-term data requirements) whereby (A) the average selling price for a single data transactional sale is approximately $40,000 for a single point in time deliverable; and (B) the average selling price for a longitudinal data deliverable is approximately $360,000 per year with anticipated 2&#8201;&#8211;&#8201;3 year requirement. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Historically, OneMedNet&#8217;s single data transactional sale buyers were artificial intelligence companies. Presently, OneMedNet&#8217;s commercial focus is increasingly on large medical device, imaging and biopharmaceutical organizations where its key executives believe here is significant demand for the next generation of RWD such as that provided by OneMedNet. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In OneMedNet&#8217;s experience, RWD is generally purchased on a multi-year longitudinal basis by its customers because it is usually more cost effective to do so. Moreover, longitudinal contracts enable the most current data to be embedded into workflows and studies according to OneMedNet&#8217;s experience with clients such as GlaxoSmithKline, Janssen, Siemens, Depuy, Janssen and Optum. For 2023, OneMedNet has set a goal of approximately 40&#8201;&#8211;&#8201;45% of its RWD sales to be from longitudinal data sales. For 2024, OneMedNet has set a goal of securing 60&#8201;&#8211;&#8201;75% of the forecast with longitudinal data sales. Both years&#8217; goals are based on past trends which OneMedNet&#8217;s key executives used to extrapolate future goals and forecasts. There can be no certainty or assurances that such goals or projected growth will be achieved. </p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights and its Board are aware of and are continuously updated regarding the performance of OneMedNet, including OneMedNet&#8217;s FY2022 actualized revenue of $1.53M compared to the projected$3.8M and continues to feel confident in the agreed </span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">122</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">upon deal structure and consideration given to OneMedNet. The Board believes the near-term performance is not an indicator of any fundamental issues which would prevent OneMedNet from achieving the expected growth in the future, but rather that the estimated delayed revenue is in large part due to the limited marketing that has occurred up to this point of OMN services and technologies. These technologies continue to be developed on time and are fundamental to their business. The Board&#8217;s best estimate is that the revenue is delayed but will still be achieved. The management teams of both organizations expect that the growth will be realized through 2023 </span><span style="font-family:'Times New Roman','Times','serif';">and 2024.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">No material changes to the future projections are being made at this time. As discussed, the Board acknowledges that revenues may continue to be offset or delayed compared to original projections. Any changes to the estimated revenues occurring later than anticipated (but still being realized) would not change the Board&#8217;s view of the OneMedNet&#8217;s value. The understanding of the Board is that access to capital markets is necessary to fund the marketing that enables the expected growth. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet anticipates a decrease in operating costs to produce RWD under its customer contracts as it moves to longitudinal sales with greater opportunity to increase efficiencies. One example of greater operating efficiencies is through sales of specific images that support a disease-specific initiative, like Non-Small Cell Lung cancer, to multiple clients. By finding such new and additional uses for its previously curated real world imaging data to support similar projects for customers, OneMedNet believes it may also improve its customer service by delivering products to customers quicker to facilitate their goals and deadlines. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet is encouraged by the ever-increasing support of RWD by the FDA since the 2016 passage of the 21<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">st</sup> Century Cures Act that places additional focus on the use of these types of data to support regulatory decision making, including approval of new indications for approved drugs and devices. Congress defined RWE as data regarding the usage, or the potential benefits or risks, of a drug derived from sources other than traditional clinical trials. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Regarding how the FDA and the healthcare community will continue the trend of increasingly using and accepting RWD, OneMedNet is optimistic about the FDA&#8217;s and the healthcare communities&#8217; increased used and support of RWD. The FDA has expanded is guidance regarding RWD every year since 2016 with the latest guidance published on September 8, 2022 titled, &#8220;Submitting Documents Using Real-World Data and Real-World Evidence to FDA for Drug and Biological Products.&#8221; The draft version of the guidance was published in 2019 and was meant to help clarify the agency&#8217;s thinking on how sponsors should summarize their RWD in product applications. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">123</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FDA&#8217;s September 8, 2022 guidance is the result of the agency&#8217;s mandate under the 21<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">st</sup> Century Cures Act to develop an RWD program to evaluate the use of RWE in regulatory decision-making. &#8220;The availability of RWD and evolving analytic techniques to generate RWE have created interest within the research and medical communities in the use of RWD to enhance clinical research and support regulatory decision-making,&#8221; the FDA noted.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Regarding the healthcare communities&#8217; increasing trend toward using and accepting RWD, at present, pharmaceutical, biotechnology, and medical device companies; healthcare payers; healthcare providers; and other end users (e.g., academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies) utilize RWD to add value at every stage of the medical and drug development lifecycles from understanding unmet healthcare needs and defining the patient journey to supporting regulatory submissions and post-market studies, offering value to payers, and defining market strategies according to a new market research report. An article titled, &#8220;Real-world Data Market by Source (EMR, Claims, Pharmacy, Disease Registries), Application [Market Access, Drug Development &amp; Approvals (Oncology, Neurology), Post-market Surveillance], and End User (Pharma, Payers)&#8201;&#8212;&#8201;Global Forecast to 2029&#8221;, published on June 21, 2022,<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup> supports the support of RWD by healthcare community and regulators stating that this market is driven by key factors such as rapidly growing big data in healthcare, shift from volume to value-based care, growing adoption of AI in RWD studies, and rising focus on personalized healthcare. The article estimates that the RWD market is expected to grow at a CAGR of 8.2% from 2022 to 2029, to reach $2 billion by 2029. Nevertheless, there can be no assurance that the healthcare communities and regulators such as the FDA will continue to use, accept and support RWD. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Customer Bookings</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">OneMedNet&#8217;s customer bookings support its bookings forecast increase of 243% from 2021 to 2022:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">iRWD</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> &#8211; As of June 30, 2022, OneMedNet had $2,321,800 of identified revenue in its sales pipeline, including $1,035,100 to be generated from its existing customer base committed to close during the third quarter of 2022 and $822,340 committed to close in during the fourth quarter of 2022.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">BEAM Image Exchange Technology</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> &#8211; OneMedNet anticipates finalizing a partnership in 2022 resulting in an additional $2,000,000 in booking revenue and anticipates an additional $800,000 in revenue from existing customer subscriptions.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s bookings forecast for years after 2022 focus on iRWD<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> product growth as it sees its existing customer base migrate to its subscription model and it moves into the pharmaceutical, medical device, and artificial intelligence market segments. This product line growth supports the projected 147% bookings increase from 2022 to 2023.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">1</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">https://www.raps.org/news-and-articles/news-articles/2022/9/fda-finalizes-guidance-submitting-rwdrwe-in-applic</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">2</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">https://www.globenewswire.com/en/news-release/2022/06/22/2466709/0/en/Real-world-Data-Market-Worth-2-Billion-by-2029-Exclusive-Report-by-Meticulous-Research.html</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">124</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Revenue and Subscription Model</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Historically OneMedNet has recognized an average of 80% of its bookings as revenue during recent fiscal years, and this rate is reflected in the model. OneMedNet expects this rate to increase in future years, and to experience a shortening of the time from booking to recognition of the related revenue. As OneMedNet&#8217;s client facing technology moves to a subscription-based model beginning in early 2023, OneMedNet expects its annual recurring revenue to significantly increase.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">OneMedNet&#8217;s subscription model is expected to provide it with a steady volume of recurring revenue, which will help OneMedNet&#8217;s management plan further into the future with a higher level of confidence. The subscription model will generate data to gauge customer interest in new product offerings and new price models.  By allowing customers greater control over the types and amounts of services they use, the flexibility to alter their service plans as needed, a wide variety of options from which to choose and lower upfront expense and costs spread in periodic payments, the subscription model should accelerate customer adoption and growth in use.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Cost of Sales</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Project cost is projected to drop from 69% of revenue in 2022 to an average of 35% of revenue in subsequent years, driven by:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Increased efficiency and lower labor costs as OneMedNet develops additional functionality in its iRWD<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> platform.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">A larger library of stored images and clinical data which will allow OneMedNet to fulfill new orders without incurring the cost of human intervention to curate the data.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">A decrease in OneMedNet&#8217;s contractor costs from the levels experienced in 2021 and 2022 as the platform is further automated.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:21.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:21.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2025</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2026</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2027</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2028</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2029</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2030</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2031</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2032</b></p></td><td style="vertical-align:top;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">SG&amp;A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,801.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,131.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,359.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7,635.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,468.3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 11,189.8</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 17,086.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,213.3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 33,587.7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 43,087.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 49,595.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 50,688.3</span></p></td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">YoY Revenue Growth Assumptions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 18</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 151</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 42</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 24</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 18</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 53</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 48</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 33</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 28</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 15</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 2</i></p></td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td></tr><tr><td style="vertical-align:bottom;width:21.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">R&amp;D, Ops</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 795.226</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,496.7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,301.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,700.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,102.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,451.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,270.3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,933.7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,236.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10,357.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 11,697.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 12,011.5</span></p></td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:6pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">YoY Revenue Growth Assumptions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 88</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 54</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 17</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 15</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 11</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 53</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 32</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 33</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 12</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 13</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 3</i></p></td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt 2.25pt 0pt 0pt;"><i style="font-style:italic;">%&#160;&#160;</i></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because of OneMedNet&#8217;s confidence in demand for its Real-World Data products, it grew its team from 10 employees in 2021 to 20 through August 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Sales, General and Administrative Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet expanded its executive leadership team with the addition of a chief executive officer, chief financial officer and chief commercial officer in 2022. OneMedNet added two new salespersons in 2022 and anticipates hiring four additional salespersons in 2023, reaching a total of 8.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Research and Development, Operations Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet expanded its operations team with the addition of a chief technology officer, chief operations officer, and directors of engineering, technology, and innovation in 2022. OneMedNet anticipates additional support staff hiring in the first two quarters of 2023 to support the expansion of its iRWD<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> platform.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Marshall &amp; Stevens was not involved in the development of any of the above OneMedNet assumptions, and did not independently review, confirm or verify any of such assumptions, the reasonableness thereof or the extent to which such assumptions were relied upon by OneMedNet in preparing their projections and forecasts.  Only a limited number of these assumptions were discussed with OneMedNet and/or the Board.</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">125</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Discounted Cash Flow Analysis</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The major inputs and assumptions used in Marshall &amp; Stevens&#8217;s discounted cash flow method were as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OneMedNet provided a forecast through 2032 as the basis for the Discounted Cash Flow analysis. The duration of the projection provided assumes a time period by which OneMedNet believes it would achieve a stabilized long term growth rate.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A weighted average cost of capital (WACC) was used as the discount rate in Marshall &amp; Stevens&#8217;s analysis and applied to debt free, after-tax cash flows. The WACC was calculated to be 20% and was determined based upon a cost of equity of approximately 20.7% and an after-tax cost of debt of 3.8%.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A cost of equity was determined using a 20-year U.S. Treasury Rate (3.45%), Equity Risk Premium of 6.22% (Kroll Cost of Capital Navigator 2022 (&#8220;KCOC&#8221;)), Re-levered Equity beta of 1.12 based upon the Guideline Companies discussed below, a size premium of 4.8% based upon KCOC data for the 10</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> decile, and a company specific risk premium of 5.5% based upon anticipated forecast risk. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">After-tax cost of debt was determined using BBB rated bond yields and a tax rate of 29%.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The debt-to-capital ratio was estimated at 5% and the equity-to-capital ratio was estimated at 95% using input from the Guideline Companies discussed below. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Estimated income tax expense of 29% of pre-tax income;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Capital expenditures of $500,000 per year based upon OneMedNet management estimates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Working capital requirements were estimated to be </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">de minimis</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> as the company has historically operated at negative debt-free, cash free working capital levels and was expected to continue doing so going forward;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A terminal year multiple of 6.25x was calculated using the Gordon Growth Model and based upon a WACC of 20% and terminal growth rate of 4%.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marshall &amp; Stevens performed sensitivity analyses, including varying the terminal growth rate, the WACC rate, and the revenue growth rate. The Enterprise Value for OneMedNet was estimated to be between $164,000,000 and $207,000,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Guideline Public Company Analysis</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marshall&#160;&amp; Stevens reviewed and analyzed selected historical and projected information about OneMedNet provided by OneMedNet&#8217;s management and compared this information to certain financial information of seven publicly traded companies that Marshall&#160;&amp; Stevens deemed to be reasonably comparable to OneMedNet (each a &#8220;Guideline Company&#8221; and, collectively, the &#8220;Guideline Companies&#8221;). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Business descriptions and financial information are provided below for the selected Guideline Companies. The descriptions of these companies and the financial information for such companies set out below are derived from publicly available information and are summary in nature. Shareholders are referred to, and these summaries are qualified in full by reference to, the public reports filed by these companies with the SEC. Marshall &amp; Stevens has conducted no due diligence as to the truthfulness, accuracy or completeness of this information and makes no representation or warranty as to any such matter.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">MongoDB, Inc. (NasdaqGM: MDB)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;">MongoDB, Inc. provides general purpose database platform worldwide. The company offers MongoDB Enterprise Advanced, a commercial database server for enterprise customers to run in the cloud, on-premise, or in a hybrid environment; MongoDB Atlas, a hosted multi-cloud database-as-a-service solution; and Community Server, a free-to-download version of its database, which includes the functionality that developers need to get started with MongoDB. It also provides professional </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">126</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">services comprising consulting and training. The company was formerly known as 10gen, Inc. and changed its name to MongoDB, Inc. in August 2013. MongoDB, Inc. was incorporated in 2007 and is headquartered in New York, New York.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Snowflake, Inc. (NYSE: SNOW)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">Snowflake Inc. provides a cloud-based data platform in the United States and internationally. The company&#8217;s platform offers Data Cloud, which enables customers to consolidate data into a single source of truth to drive meaningful business insights, build data-driven applications, and share data. Its platform is used by various organizations of sizes in a range of industries. The company was formerly known as Snowflake Computing, Inc. and changed its name to Snowflake Inc. in April 2019. Snowflake Inc. was incorporated in 2012 and is based in Bozeman, Montana.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Datadog, Inc. (NasdaqGS: DDOG)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">Datadog, Inc. provides monitoring and analytics platform for developers, information technology operations teams, and business users in the cloud in North America and internationally. The company&#8217;s SaaS platform integrates and automates infrastructure monitoring, application performance monitoring, log management, and security monitoring to provide real-time observability of its customers technology stack. Its platform also provides user experience monitoring, network performance monitoring, cloud security, developer-focused observability, and incident management, as well as a range of shared features, such as dashboards, analytics, collaboration tools, and alerting capabilities. The company was incorporated in 2010 and is headquartered in New York, New York.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Doximity, Inc. (NYSE: DOCS)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company&#8217;s platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Cloudflare, Inc. (NYSE: NET)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">CloudFlare, Inc. operates as a cloud services provider that delivers a range of services to businesses worldwide. The company offers an integrated cloud-based security solution to secure a range of combination of platforms, including public cloud, private cloud, on-premise, software-as-a-service applications, and IoT devices. Its security products comprise cloud firewall, bot management, distributed denial of service, IoT, SSL/TLS, secure origin connection, and rate limiting products. The company also offers performance solutions, which include content delivery and intelligent routing, as well as content, mobile, and image optimization solutions. In addition, it provides reliability solutions comprising load balancing, anycast network, virtual backbone, DNS, DNS resolver, online, and virtual waiting room solutions. Further, the company offers Cloudflare internal infrastructure solutions, including on-ramps, which connect users, devices, or locations to its network; and filters, which are the products that protect, inspect, and privilege data. Additionally, it provides developer-based solutions, such as serverless computing/programmable network, website development, domain registration, Cloudflare apps, analytics, and data localization management; Consumer DNS Resolver, a consumer app to browse the Internet; and Consumer VPN for consumers to secure and accelerate traffic on mobile devices. The company serves customers in the technology, healthcare, financial services, consumer and retail, and non-profit industries, as well as government. CloudFlare, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">NEXTDC Limited (ASX: NXT)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;">NEXTDC Limited, a technology company, provides data center outsourcing solutions, connectivity services, and infrastructure management software in Australia. The company offers connectivity solutions, such as interconnection and intercapital services, data centre interconnect, and cross connect; data center-as-a-service solutions; cloud solutions; and industry solutions. It also provides technical assistance on-the-ground; and professional services for the infrastructure life cycle, including planning, project management, and migration stages. In addition, the company provides data center colocation solutions comprising rack packages for single or multiple racks; Rack Blocks to share the total power allocation across various racks; and Quarter Racks for smaller footprints. Further, it offers security systems and protocols that include multi-layered access systems </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">127</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">with biometric fingerprint technology and ID access cards. Additionally, the company provides ONEDC, a data center infrastructure management tool, which delivers real-time intelligence across entire NEXTDC data center footprint to manage infrastructure; disaster recovery solutions; and AXON interconnectivity platform. NEXTDC Limited was incorporated in 2010 and is headquartered in Brisbane, Australia.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">4DMedical Limited (ASX: 4DX)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following is a table including details regarding the industry, size, and profitability along with further detail regarding revenue forecasts and the specific multiples considered for each Guideline Company:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:8.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:4.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:5.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Selected Guideline</b></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">NEXTDC</b></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">4DMedical</b></p></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:4.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">25</b><sup style="font-size:4.87pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">th</sup><b style="font-size:6.5pt;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">75</b><sup style="font-size:4.87pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">th</sup><b style="font-size:6.5pt;font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Public Companies</b></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:8.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">MongoDB,&#160;Inc.</b></p></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Snowflake&#160;Inc.</b></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:7.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Datadog, Inc.</b></p></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Doximity,&#160;Inc.</b></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Cloudflare,&#160;Inc.</b></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Limited</b></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Limited</b></p></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Median</b></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Percentile</b></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Percentile</b></p></td></tr><tr><td style="vertical-align:top;width:9.14%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Industry</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:8.29%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;">Internet Services and Infrastructure</span></p></td><td style="vertical-align:bottom;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:8.75%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;">Internet Services and Infrastructure</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:7.74%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;">Application Software</span></p></td><td style="vertical-align:bottom;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:7.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;">Health Care Technology</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;">Internet Services and Infrastructure</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.02%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;">Internet Services and Infrastructure</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:7.92%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;">Health Care Technology</span></p></td><td style="vertical-align:bottom;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.42%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.7%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Enterprise Value (in millions)</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 24,105.37</span></p></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 53,086.08</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 38,678.74</span></p></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 8,622.40</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 19,363.24</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:8.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 4,666.18</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 47.45</span></p></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Profitability - LTM EBITDA Percentage</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> -29.22</span></p></td><td style="vertical-align:bottom;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">%&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> -47.39</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">%&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 2.20</span></p></td><td style="vertical-align:bottom;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">%&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 33.50</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">%&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> -11.39</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">%&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 52.76</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">%&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:0.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> -4979.43</span></p></td><td style="vertical-align:bottom;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">%&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Projected Revenue (in millions)</b></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:8.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Calendar Year + 1</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 1,193.52</span></p></td><td style="vertical-align:bottom;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 2,025.65</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 1,618.67</span></p></td><td style="vertical-align:bottom;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 414.60</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 958.61</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 221.86</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 2.73</span></p></td><td style="vertical-align:bottom;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Calendar Year + 2 </span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 1,562.64</span></p></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 3,110.71</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 2,226.06</span></p></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 547.13</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 1,309.25</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:8.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 265.77</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 8.26</span></p></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Calendar Year + 3</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 2,055.21</span></p></td><td style="vertical-align:bottom;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 4,559.39</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 3,101.71</span></p></td><td style="vertical-align:bottom;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 705.94</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 1,795.65</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 344.83</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">N/A</span></p></td><td style="vertical-align:bottom;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Calendar Year + 4</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 2,663.71</span></p></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 6,923.30</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 4,332.01</span></p></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:6.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 866.63</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 2,776.56</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">$</span></p></td><td style="vertical-align:bottom;width:8.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;white-space:pre-wrap;"> 448.71</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">N/A</span></p></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-size:6.5pt;font-weight:bold;">Multiple Analysis</b></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Enterprise Value / Total</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:8.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Revenue - Size Adjusted</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt;"><span style="font-size:6.5pt;">&#160;&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Calendar Year + 2 </span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">9.2x</span></p></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">9.2x</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">9.9x</span></p></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">9.4x</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">9.1x</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:8.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">10.4x</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">5.7x</span></p></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">9.2x</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">9.1x</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">9.7x</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Calendar Year + 3</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">7.8x</span></p></td><td style="vertical-align:bottom;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">7.3x</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">8.1x</span></p></td><td style="vertical-align:bottom;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">8.0x</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">7.4x</span></p></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">8.8x</span></p></td><td style="vertical-align:bottom;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">N/A</span></p></td><td style="vertical-align:bottom;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">7.9x</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">7.5x</span></p></td><td style="vertical-align:bottom;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">8.1x</span></p></td></tr><tr><td style="vertical-align:top;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">Calendar Year + 4</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">6.5x</span></p></td><td style="vertical-align:bottom;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">5.5x</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">6.4x</span></p></td><td style="vertical-align:bottom;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:6.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">7.0x</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">5.4x</span></p></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:8.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">7.4x</span></p></td><td style="vertical-align:bottom;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:7.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">N/A</span></p></td><td style="vertical-align:bottom;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:4.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">6.5x</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">5.8x</span></p></td><td style="vertical-align:bottom;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-size:6.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:6.5pt;">6.9x</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marshall &amp; Stevens reviewed, among other things, the Guideline Companies&#8217; enterprise value as a multiple of revenue for the first, second, third and fourth year forecast for each Guideline Company. The non-size adjusted multiples of enterprise value to revenue for the Guideline Companies ranged from 17.4x to 26.2x. The multiples were size adjusted based on a comparison to the respective deciles, and the respective equity risk premium, to which each Guideline Company was classified compared to the 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> decile utilized for OneMedNet. The base value multiples selected were based upon the median multiple, the low value was based on the 25<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> percentile multiple and the high value was based on the 75<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> percentile multiple. Given the expected growth profile of OneMedNet, the second, third and fourth year forecasted value indications were weighted equally 1/3 each to arrive at the final range of value. The selected multiples were as follows:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Second Year: 9.1x to 9.7x</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Third Year: 7.5x to 8.1x</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Fourth Year: 5.8x to 6.9x</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The overall range of Enterprise Value for the guideline public company approach was $196,000,000 to $221,000,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Reconciled Conclusion of Value</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">Marshall &amp; Stevens considered the discounted cash flow method, the guideline public company method and the guideline transaction method. The guideline transaction method was given no weight due to a lack of available data for comparable transactions.  Given the anticipated growth of OneMedNet and the detailed forecast provided by OneMedNet management for the discounted cash </span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">128</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">flow method, more weight was placed on the discounted cash flow method than the guideline public company method for their final reconciliation of value. Marshall &amp; Stevens concluded to a final enterprise value range of $172,000,000 to $211,000,000.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Certain Material U.S. Federal Tax Considerations</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Certain Material U.S. Federal Income Tax Considerations of the Redemption</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is a discussion of certain potential U.S. federal income tax considerations for holders of our shares of Class A Common Stock that elect to have their Class A Common Stock redeemed for cash if the Business Combination is completed. Class A Common Stockholders are urged to consult their own tax advisors regarding these matters. This discussion applies only to Class A Common Stock that is held as a capital asset for U.S. federal income tax purposes, and is limited to U.S. federal income tax considerations, and does not address estate or any gift tax considerations or considerations arising under the tax laws of any state, local or non-U.S. jurisdiction. This discussion does not describe all of the U.S. federal income tax consequences that may be relevant to you in light of your particular circumstances, including the alternative minimum tax, the Medicare tax on certain investment income and the different consequences that may apply if you are subject to special rules that apply to certain types of investors, such as:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">financial institutions or financial services entities;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">broker dealers;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">insurance companies;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">dealers or traders in securities subject to a mark-to-market method of accounting with respect to shares of Class&#160;A Common Stock;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">persons holding Class&#160;A Common Stock as part of a &#8220;straddle,&#8221; hedge, integrated transaction or similar transaction;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">U.S. holders (as defined below) whose functional currency is not the U.S. dollar;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman PS Std';">&#8220;</span>specified foreign corporations<span style="font-family:'Times New Roman PS Std';">&#8221;</span> (including <span style="font-family:'Times New Roman PS Std';">&#8220;</span>controlled foreign corporations<span style="font-family:'Times New Roman PS Std';">&#8221;</span>), <span style="font-family:'Times New Roman PS Std';">&#8220;</span>passive foreign investment companies<span style="font-family:'Times New Roman PS Std';">&#8221;</span> and corporations that accumulate earnings to avoid U.S. federal income tax;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">U.S. expatriates or former long-term residents of the U.S.;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">governments or agencies or instrumentalities thereof;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">regulated investment companies (RICs) or real estate investment trusts (REITs);</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">persons subject to the alternative minimum tax provisions of the Code;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">persons who received their shares of Class&#160;A Common Stock as compensation;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">partnerships or other pass-through entities for U.S. federal income tax purposes; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">tax-exempt entities.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If you are a partnership (or other pass-through entity) for U.S. federal income tax purposes, the U.S. federal income tax treatment of your partners (or other owners) will generally depend on the status of the partners and your activities. Partnerships and their partners (or other owners) should consult their tax advisors with respect to the consequences to them of electing to have their Class&#160;A Common Stock redeemed for cash if the Business Combination is completed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">This discussion is based on the Code and administrative pronouncements, judicial decisions and final, temporary and proposed Treasury regulations as of the date hereof, changes to any of which subsequent to the date of this proxy statement/prospectus may affect the tax consequences described herein. No assurance can be given that the IRS would not assert, or that a court would not </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">129</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">sustain, a contrary position. This discussion does not address any aspect of state, local or non-U.S. taxation, or any U.S. federal taxes other than income taxes (such as gift and estate taxes). You are urged to consult your tax advisor with respect to the application of U.S. federal tax laws to your particular situation, as well as any tax consequences arising under the laws of any state, local or foreign jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Redemption of Class&#160;A Common Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the event that a holder&#8217;s shares of Class&#160;A Common Stock are redeemed pursuant to the redemption provisions described in this proxy statement/prospectus under the section entitled &#8220;<i style="font-style:italic;">Special Meeting of Data Knights Stockholders&#160;&#8212; Redemption Rights</i>,&#8221; the treatment of the redemption for U.S. federal income tax purposes will depend on whether the redemption qualifies as a sale or other exchange of shares of Class&#160;A Common Stock under Section&#160;302 of the Code. If the redemption qualifies as a sale of shares of Class&#160;A Common Stock, a U.S. holder will be treated as described below under the section entitled &#8220;&#8212;&#160;<i style="font-style:italic;">U.S. Holders&#160;&#8212;&#160;Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Class&#160;A Common Stock</i>,&#8221; and a Non-U.S. holder will be treated as described under the section entitled &#8220;&#8212;&#160;<i style="font-style:italic;">Non-U.S. Holders&#160;&#8212;&#160;Gain on Sale, Taxable Exchange or Other Taxable Disposition of Class&#160;A Common Stock</i>.&#8221; If the redemption does not qualify as a sale of shares of Class&#160;A Common Stock, a holder will be treated as receiving a corporate distribution with the tax consequences to a U.S. holder described below under the section entitled &#8220;&#8212;&#160;<i style="font-style:italic;">U.S. Holders&#160;&#8212;&#160;Taxation of Distributions</i>,&#8221; and the tax consequences to a Non-U.S. holder described below under the section entitled &#8220;&#8212;&#160;<i style="font-style:italic;">Non-U.S. Holder&#160;&#8212;&#160;Taxation of Distributions</i>.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Whether a redemption of shares of Class&#160;A Common Stock qualifies for sale treatment will depend largely on the total number of shares of our stock treated as held by the redeemed holder before and after the redemption (including any stock constructively owned by the holder as a result of owning private placement warrants or public warrants and any of our stock that a holder would directly or indirectly acquire pursuant to the Business Combination) relative to all of our shares outstanding both before and after the redemption. The redemption of Class&#160;A Common Stock generally will be treated as a sale of Class&#160;A Common Stock (rather than as a corporate distribution) if the redemption (1)&#160;is &#8220;substantially disproportionate&#8221; with respect to the holder, (2)&#160;results in a &#8220;complete termination&#8221; of the holder&#8217;s interest in us or (3)&#160;is &#8220;not essentially equivalent to a dividend&#8221; with respect to the holder. These tests are explained more fully below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In determining whether any of the foregoing tests result in a redemption qualifying for sale treatment, a holder takes into account not only shares of our stock actually owned by the holder, but also shares of our stock that are constructively owned by it. A holder may constructively own, in addition to stock owned directly, stock owned by certain related individuals and entities in which the holder has an interest or that have an interest in such holder, as well as any stock that the holder has a right to acquire by exercise of an option, which would generally include Class&#160;A Common Stock which could be acquired pursuant to the exercise of the private placement warrants or the public warrants. Moreover, any of our stock that a holder directly or constructively acquires pursuant to the Business Combination generally should be included in determining the U.S. federal income tax treatment of the redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to meet the substantially disproportionate test, the&#160;percentage of our outstanding voting stock actually and constructively owned by the holder immediately following the redemption of shares of Class&#160;A Common Stock must, among other requirements, be less than eighty&#160;percent (80%) of the&#160;percentage of our outstanding voting stock actually and constructively owned by the holder immediately before the redemption (taking into account both redemptions by other holders of Class&#160;A Common Stock and the Class&#160;A Common Stock to be issued pursuant to the Business Combination). There will be a complete termination of a holder&#8217;s interest if either (1)&#160;all of the shares of our stock actually and constructively owned by the holder are redeemed or (2)&#160;all of the shares of our stock actually owned by the holder are redeemed and the holder is eligible to waive, and effectively waives in accordance with specific rules, the attribution of stock owned by certain family members and the holder does not constructively own any other stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The redemption of Class&#160;A Common Stock will not be essentially equivalent to a dividend if the redemption results in a &#8220;meaningful reduction&#8221; of the holder&#8217;s proportionate interest in us. Whether the redemption will result in a meaningful reduction in a holder&#8217;s proportionate interest in us will depend on the particular facts and circumstances. However, the IRS has indicated in a published ruling that even a small reduction in the proportionate interest of a small minority stockholder in a publicly held corporation where such stockholder exercises no control over corporate affairs may constitute such a &#8220;meaningful reduction.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">If none of the foregoing tests is satisfied, then the redemption of shares of Class&#160;A Common Stock will be treated as a corporate distribution to the redeemed holder and the tax effects to such a U.S. holder will be as described below under the section entitled &#8220;<i style="font-style:italic;">U.S. Holders&#160;&#8212; Taxation of Distributions</i>,&#8221; and the tax effects to such a Non-U.S. holder will be as described below under the section entitled &#8220;<i style="font-style:italic;">Non-U.S. Holders&#160;&#8212; Taxation of Distributions</i>.&#8221; After the application of those rules, any remaining tax basis of the holder in the redeemed Class&#160;A Common Stock will be added to the holder&#8217;s adjusted tax basis in its remaining stock, or, if it has none, to the </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">130</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">holder&#8217;s adjusted tax basis in its warrants or possibly in other stock constructively owned by it. A holder should consult with its own tax advisors as to the tax consequences of a redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">U.S. Holders</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This section applies to you if you are a &#8220;U.S. holder.&#8221; A U.S. holder is a beneficial owner of our shares of Class&#160;A Common Stock who or that is, for U.S. federal income tax purposes:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an individual who is a citizen or resident of the United&#160;States;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized in or under the laws of the United&#160;States, any state thereof or the District of Columbia;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an estate the income of which is subject to U.S. federal income taxation purposes regardless of its source; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an entity treated as a trust for U.S. federal income tax purposes if (i)&#160;a court within the United&#160;States is able to exercise primary supervision over the administration of such trust, and one or more such U.S. persons have the authority to control all substantial decisions of such trust or (ii)&#160;it has a valid election in effect under Treasury regulations to be treated as a U.S. person.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Taxation of Distributions. &#160;&#160;</i>If our redemption of a U.S. holder&#8217;s shares of Class&#160;A Common Stock is treated as a corporate distribution, as discussed above under the section entitled &#8220;&#8212; <i style="font-style:italic;">Redemption of Class&#160;A Common Stock,</i>&#8221; such distribution generally will constitute a dividend for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the U.S. holder&#8217;s adjusted tax basis in our Class&#160;A Common Stock. Any remaining excess will be treated as gain realized on the sale or other disposition of the Class&#160;A Common Stock and will be treated as described below under the section entitled &#8220;&#8212;&#160;<i style="font-style:italic;">Redemption of Class&#160;A Common Stock&#160;&#8212;&#160;U.S. Holders&#160;&#8212; Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Class&#160;A Common Stock.</i>&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dividends we pay to a U.S. holder that is a taxable corporation generally will qualify for the dividends received deduction if the requisite holding period is satisfied. With certain exceptions (including, but not limited to, dividends treated as investment income for purposes of investment interest deduction limitations), and provided certain holding period requirements are met, dividends we pay to a non-corporate U.S. holder generally will constitute &#8220;qualified dividends&#8221; that will be subject to tax at the maximum tax rate accorded to long-term capital gains. It is unclear whether the redemption rights with respect to the Class&#160;A Common Stock described in this proxy statement/prospectus may prevent a U.S. holder from satisfying the applicable holding period requirements with respect to the dividends received deduction or the preferential tax rate on qualified dividend income, as the case may be.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Class&#160;A Common Stock</i>. &#160;&#160;If our redemption of a U.S. holder&#8217;s shares of Class&#160;A Common Stock is treated as a sale, taxable exchange or other taxable disposition, as discussed above under the section entitled &#8220;&#8212; <i style="font-style:italic;">Redemption of Class&#160;A Common Stock</i>,&#8221; a U.S. holder generally will recognize capital gain or loss in an amount equal to the difference between the amount of cash and the U.S. holder&#8217;s adjusted tax basis in the shares of Class&#160;A Common Stock redeemed. A U.S. holder&#8217;s adjusted tax basis in its Class&#160;A Common Stock generally will equal the U.S. holder&#8217;s acquisition cost less any prior distributions paid to such U.S. holder with respect to its shares of Class&#160;A Common Stock treated as a return of capital. Any such capital gain or loss generally will be long-term capital gain or loss if the U.S. holder&#8217;s holding period for the Class&#160;A Common Stock so disposed of exceeds one&#160;year. Long-term capital gains recognized by noncorporate U.S. holders will be eligible to be taxed at reduced rates. The deductibility of capital losses is subject to limitations. U.S. holders who hold different blocks of Class&#160;A Common Stock (shares of Class&#160;A Common Stock purchased or acquired on different dates or at different prices) should consult their tax advisors to determine how the above rules&#160;apply to them.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Non-U.S. Holders</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This section applies to you if you are a &#8220;Non-U.S. holder.&#8221; A Non-U.S. holder is a beneficial owner of our Class&#160;A Common Stock who, or that is, for U.S. federal income tax purposes:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a non-resident alien individual, other than certain former citizens and residents of the United&#160;States subject to U.S. tax as expatriates;</p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">131</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a foreign corporation; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">an estate or trust that is not a U.S. holder.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Taxation of Distributions</i>. &#160;&#160;If our redemption of a Non-U.S. holder&#8217;s shares of Class&#160;A Common Stock is treated as a corporate distribution, as discussed above under the section entitled &#8220;&#8212; <i style="font-style:italic;">Redemption of Class&#160;A Common Stock</i>,&#8221; to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles), such distribution will constitute a dividend for U.S. federal income tax purposes and, provided such dividend is not effectively connected with the Non-U.S. holder&#8217;s conduct of a trade or business within the United&#160;States, we will be required to withhold tax from the gross amount of the dividend at a rate of 30&#160;percent (30%), unless such Non-U.S. holder is eligible for a reduced rate of withholding tax under an applicable income tax treaty and provides proper certification of its eligibility for such reduced rate (usually on an IRS Form&#160;W-8BEN or W-8BEN-E). Any distribution not constituting a dividend will be treated first as reducing (but not below zero) the Non-U.S. holder&#8217;s adjusted tax basis in its shares of our Class&#160;A Common Stock and, to the extent such distribution exceeds the Non-U.S. holder&#8217;s adjusted tax basis, as gain realized from the sale or other disposition of the Class&#160;A Common Stock, which will be treated as described below under the section entitled &#8220;&#8212; <i style="font-style:italic;">Redemption of Class&#160;A Common Stock&#160;&#8212; Non-U.S. Holders&#160;&#8212; Gain on Sale, Taxable Exchange or Other Taxable Disposition of Class&#160;A Common Stock</i>.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The withholding tax described in the preceding paragraph does not apply to dividends paid to a Non-U.S. holder who provides an IRS Form&#160;W-8ECI certifying that the dividends are effectively connected with the Non-U.S. holder&#8217;s conduct of a trade or business within the United&#160;States. Instead, the effectively connected dividends will be subject to regular U.S. federal income tax as if the Non-U.S. holder were a U.S. resident, subject to an applicable income tax treaty providing otherwise. A Non-U.S. holder that is a corporation for U.S. federal income tax purposes and is receiving effectively connected dividends may also be subject to an additional &#8220;branch profits tax&#8221; imposed at a rate of 30&#160;percent (30%) (or a lower applicable income tax treaty rate).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Gain on Sale, Taxable Exchange or Other Taxable Disposition of Class&#160;A Common Stock</i>. &#160;&#160;If our redemption of a U.S. holder&#8217;s shares of Class&#160;A Common Stock is treated as a sale or other taxable disposition, as discussed above under the section entitled &#8220;&#8212; <i style="font-style:italic;">Redemption of Class&#160;A Common Stock</i>,&#8221; a Non-U.S. holder generally will not be subject to U.S. federal income or withholding tax in respect of the redemption, unless:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the gain is effectively connected with the conduct of a trade or business by the Non-U.S. holder within the United&#160;States (and, under certain income tax treaties, is attributable to a United&#160;States permanent establishment or fixed base maintained by the Non-U.S. holder);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">such Non-U.S. holder is an individual who is present in the United&#160;States for 183&#160;days or more during the taxable&#160;year in which the disposition takes place and certain other conditions are met; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we are or have been a &#8220;United&#160;States real property holding corporation&#8221; for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the period that the Non-U.S. holder held our Class&#160;A common stock and, in the circumstance in which shares of our Class&#160;A Common Stock are regularly traded on an established securities market, the Non- U.S. holder has owned, directly or constructively, more than 5% of our Class&#160;A Common Stock at any time within the shorter of the five-year period preceding the redemption or such Non-U.S. holder&#8217;s holding period for the shares of our Class&#160;A Common Stock. There can be no assurance that our Class&#160;A Common Stock will be treated as regularly traded on an established securities market for this purpose.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Unless an applicable treaty provides otherwise, gain described in the first bullet point above will be subject to tax at generally applicable U.S. federal income tax rates as if the Non-U.S. holder were a U.S. resident. Any gains described in the first bullet point above of a Non-U.S. holder that is a corporation for U.S. federal income tax purposes may also be subject to an additional &#8220;branch profits tax&#8221; at a 30&#160;percent (30%) rate (or lower income tax treaty rate). If the second bullet point applies to a Non-U.S. holder, such Non-U.S. holder will be subject to U.S. tax on such Non-U.S. holder&#8217;s net capital gain for such&#160;year (including any gain realized in connection with the redemption) at a tax rate of 30&#160;percent (30%).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the third bullet point above applies to a Non-U.S. holder, gain recognized by such holder in the redemption will be subject to tax at generally applicable U.S. federal income tax rates. In addition, we may be required to withhold U.S. federal income tax at a rate of fifteen&#160;percent (15%) of the amount realized upon such redemption. We believe that we are not, and have not been at any time since our formation, a United&#160;States real property holding corporation and we do not expect to be a United&#160;States real property holding corporation immediately after the Business Combination is completed.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">132</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Information Reporting and Backup Withholding</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dividend payments with respect to our Class&#160;A Common Stock and proceeds from the sale, taxable exchange or taxable redemption of our Class&#160;A Common Stock may be subject to information reporting to the IRS and possible United&#160;States backup withholding. Backup withholding will not apply, however, to a U.S. holder who furnishes a correct taxpayer identification number and makes other required certifications, or who is otherwise exempt from backup withholding and establishes such exempt status.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Amounts treated as dividends that are paid to a Non-U.S. holder are generally subject to reporting on IRS Form&#160;1042-S even if the payments are exempt from withholding. A Non-U.S. holder generally will eliminate any other requirement for information reporting and backup withholding by providing certification of its foreign status, under penalties of perjury, on a duly executed applicable IRS Form&#160;W-8 or by otherwise establishing an exemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Backup withholding is not an additional tax. Amounts withheld as backup withholding may be credited against a holder&#8217;s United&#160;States federal income tax liability, and a holder generally may obtain a refund of any excess amounts withheld under the backup withholding rules&#160;by timely filing the appropriate claim for refund with the IRS and furnishing any required information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">FATCA Withholding Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Provisions commonly referred to as &#8220;FATCA&#8221; impose withholding of 30&#160;percent (30%) on payments of dividends (including amounts treated as dividends received pursuant to a redemption of stock) on our Class&#160;A Common Stock. Previously, withholding with respect to the gross proceeds of a disposition of any stock, debt instrument, or other property that can produce U.S.-source dividends or interest was scheduled to begin on January&#160;1, 2019; however, such withholding has been eliminated under proposed U.S. Treasury regulations, which can be relied on until final regulations become effective. In general, no such withholding will be required with respect to a U.S. holder or an individual Non-U.S. holder that timely provides the certifications required on a valid IRS Form&#160;W-9 or W-8, respectively. Holders potentially subject to withholding include &#8220;foreign financial institutions&#8221; (which is broadly defined for this purpose and in general includes investment vehicles) and certain other non-U.S. entities unless various U.S. information reporting and due diligence requirements (generally relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied, or an exemption applies (typically certified as to by the delivery of a properly completed IRS Form&#160;W-8BEN-E). If FATCA withholding is imposed, a beneficial owner that is not a foreign financial institution generally will be entitled to a refund of any amounts withheld by filing a U.S. federal income tax return (which may entail significant administrative burden). Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United&#160;States governing FATCA may be subject to different rules. Non-U.S. holders should consult their tax advisers regarding the effects of FATCA on a redemption of Class&#160;A Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Tax Consequences to OneMedNet Stockholders</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Merger will qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a)&#160;of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). Accordingly, a U.S. holder of OneMedNet&#8217;s common stock will not recognize any gain or loss for U.S. federal income tax purposes on the exchange of shares of OneMedNet&#8217;s common stock for shares of Data Knights Common Stock in the Merger. If any of the tax opinion representations and assumptions is incorrect, incomplete or inaccurate or is violated, the accuracy of the opinions described above may be affected and the U.S. federal income tax consequences of the merger could differ from those described in this proxy statement/prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Net Investment Income Tax</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Certain non-corporate OneMedNet Stockholders that are U.S. holders with taxable incomes over certain threshold amounts, including individuals and certain estates and trusts, may be subject to an additional 3.8% tax on all or a portion of their &#8220;net investment income.&#8221; This tax amounts to an additional 3.8% tax on the lesser of (i)&#160;the U.S. holder&#8217;s &#8220;net investment income&#8221; for the relevant taxable&#160;year and (ii)&#160;the excess of the U.S. holder&#8217;s modified adjusted gross income for the taxable&#160;year over a certain threshold (which, in the case of an individual, will be between $125,000 and $250,000, depending on the individual&#8217;s circumstances). Net investment income generally includes dividends such as the qualified dividend resulting from the distribution of the Merger Consideration Shares to the OneMedNet Stockholders. OneMedNet Stockholders are urged to consult their own tax advisors regarding the potential applicability of the net income tax to them and the implications of the net investment income tax.</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">133</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Vote Required for Approval</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Business Combination (and consequently, the Merger Agreement and the transactions contemplated thereby, including the Business Combination) will be approved and adopted only if the holders of at least a majority of the outstanding shares of Data Knights&#8217; Common Stock represented in person or by proxy and entitled to vote thereon at the Special Meeting and voting thereon vote &#8220;FOR&#8221; the NTA Proposal, the Business Combination, the Nasdaq Proposal and the Incentive Plan Proposal, and only if the holders of at least a majority of the outstanding shares of Data Knights&#8217; Common Stock vote &#8220;FOR&#8221; the Charter Amendment Proposal (including the Bylaw Amendment Requirement and the Article Amendment Requirement). Accordingly, failure to vote by proxy or to vote in person at the Special Meeting or an abstention from voting will have the same effect as a vote &#8220;AGAINST&#8221; the Business Combination Proposal.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The NTA Proposal, the Charter Amendment Proposal, the Nasdaq Proposal and the Incentive Plan Proposal are conditioned on the approval of the Business Combination at the Special Meeting.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of the Record Date, Data Knights&#8217; Sponsor, directors and officers have agreed to vote any shares of Common Stock owned by them in favor of the Business Combination. As of the date hereof, the Sponsor, directors and officers have not purchased any Public Shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recommendation of Data Knights&#8217; Board</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS&#8217; BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT ITS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE BUSINESS COMBINATION PROPOSAL.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">134</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_90f9c2bc_28e1_4d48_bd95_ffc3ceb85c7c"></a><a id="THENASDAQPROPOSAL_346379"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">THE NASDAQ PROPOSAL</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Overview</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In connection with the Business Combination, we intend to effect (subject to customary terms and conditions, including the Closing) the issuance of up to 5,000,000 shares of Data Knights Common Stock, subject to adjustment, in connection with the PIPE.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Why Data Knights Needs Stockholder Approval</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are seeking stockholder approval in order to comply with Nasdaq Listing Rule&#160;5635(a), (b)&#160;and (d).</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Under Nasdaq Listing Rule&#160;5635(a), stockholder approval is required prior to the issuance of common stock, or of securities convertible into or exercisable for common stock, in connection with the acquisition of another company if such securities are not issued in a public offering for cash and: (i)&#160;the common stock has or will have upon issuance, voting power equal to or in excess of 20% of the voting power outstanding before the issuance of such common stock (or securities convertible into or exercisable for common stock); or (ii)&#160;the number of shares of common stock to be issued is or will be equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the common stock or securities.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under Nasdaq Listing Rule&#160;5635(b), stockholder approval is required prior to the issuance of securities when the issuance or potential issuance will result in a &#8220;change of control&#8221; of the registrant. Although Nasdaq has not adopted any rule&#160;on what constitutes a &#8220;change of control&#8221; for purposes of Rule&#160;5635(b), Nasdaq has previously indicated that the acquisition of, or right to acquire, by a single investor or affiliated investor group, as little as 20% of the common stock (or securities convertible into or exercisable for common stock) or voting power of an issuer could constitute a change of control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under Nasdaq Listing Rule&#160;5635(d), stockholder approval is required for a transaction other than a public offering involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) at a price that is less than the greater of book or market value of the stock if the number of shares of common stock to be issued is or may be equal to 20% or more of the common stock, or 20% or more of the voting power, outstanding before the issuance.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As described above, Data Knights will issue shares of Data Knights Common Stock to PIPE Investors, as set forth in the Subscription Agreements.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stockholder approval of the Nasdaq Proposal is also a condition to the closing under the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Effect of Proposal on Current Stockholders</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the Nasdaq Proposal is adopted, we will issue 3,600,000 shares of Data Knights Common Stock upon the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The issuances of the shares of Data Knights Common Stock described above would result in significant dilution to Data Knights stockholders and result in Data Knights stockholders having a smaller&#160;percentage interest in the voting power, liquidation value and aggregate book value of Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, the receipt of earn-out shares in the future upon satisfaction of the conditions to receive such shares may result in further dilution to Data Knights stockholders in the future.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">135</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Vote Required for Approval</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Approval of the Nasdaq Proposal requires the affirmative vote in person (which would include presence at a virtual meeting) or by proxy of holders of a majority of the outstanding shares of Data Knights Common Stock and Class&#160;B common stock entitled to vote and actually cast thereon at the Stockholders Meeting. Failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Stockholders Meeting and broker non-votes will have no effect on the Nasdaq Proposal. Abstentions will have the same effect as a vote &#8220;AGAINST&#8221; the Nasdaq Proposal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Nasdaq Proposal is conditioned on the approval of the Business Combination Proposal at the Stockholders Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recommendation of the Data Knights Board</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">THE DATA KNIGHTS BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL THE NASDAQ PROPOSAL.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">136</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_4cd591eb_3b63_4c4c_aedc_8513d686d5cb"></a><a id="THECHARTERAMENDMENTPROPOSAL_106350"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">THE CHARTER AMENDMENT PROPOSAL</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Overview</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If the Business Combination is to be consummated, Data Knights Acquisition Corp. will replace its certificate of incorporation with the Amended Charter in the form attached to this proxy statement/prospectus as </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex C</i><span style="font-family:'Times New Roman','Times','serif';">, which, in the judgment of the Data Knights Board, is necessary to adequately address the needs of the Combined Entity following the Closing. Data Knights does not currently anticipate amending or restating the Bylaws of Data Knights in connection with the Business Combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table sets forth a summary of the principal changes proposed to be made between the Charter and the proposed Amended Charter. This summary is qualified by reference to the complete text of the proposed Amended Charter, a copy of which is attached to this proxy statement/prospectus as</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> Annex&#160;C</i><span style="font-family:'Times New Roman','Times','serif';">. All stockholders are encouraged to read the proposed Amended Charter in its entirety for a more complete description of its terms.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_Hlk108172562"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charter</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:39.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Proposed&#160;Amended&#160;Charter</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:40%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:39.98%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Name Change</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Data Knights Acquisition Corp.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">OneMedNet Corporation</p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Purpose</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Data Knights Charter provides that the purpose of Data Knights Acquisition Corp. is to engage in any lawful act or activity for which corporations may be organized under the DGCL. In addition to the powers and privileges conferred upon the Corporation by law and those incidental thereto, the Corporation shall possess and may exercise all the powers and privileges that are necessary or convenient to the conduct, promotion or attainment of the business or purposes of the Corporation, including, but not limited to, effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, involving the Corporation and one or more businesses.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Proposed Amended Charter provides that the purpose of OneMedNet Corporation is to engage in any lawful act or activity for which a corporation may be organized under the General Corporation Law of the State of Delaware.</p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Capitalization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Data Knights Charter authorized 111,000,000 shares, consisting of 100,000,000 shares of Class A Common Stock, 10,000,000 shares of Class B Common Stock, and 1,000,000 shares of preferred stock, each with a par value of $0.0001.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Proposed Amended Charter eliminates the Class B common stock, so that the total number of shares of all classes of capital stock is 111,000,000 shares, consisting of 110,000,000 shares of common stock and 1,000,000 shares of preferred stock, each with a par value of $0.0001.</p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Reclassification of Class A and Class B Common Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Data Knights Charter authorized Class A common stock and Class B common stock.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Proposed Amended Charter eliminates the Class A common stock and Class B common stock in place of common stock</p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Composition of the Board</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Data Knights Charter provides that the number of directors of the Corporation, other than those who may be elected by the holders of </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Proposed Amended Charter provides that number of directors of the Corporation shall be nine, which number may be increased or decreased by one or more</p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">137</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charter</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:39.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Proposed&#160;Amended&#160;Charter</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:40%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:39.98%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">one or more series of the preferred stock voting separately by class or series, shall be fixed from time to time exclusively by the Board pursuant to a resolution adopted by a majority of the Board. The Board of Directors is classified, with respect to the term for which the directors hold office, into three equal or nearly equal classes, with each class serving for staggered three year terms. At each annual meeting of stockholders, directors elected to succeed those directors whose terms expire shall be elected for a term of office to expire at the third succeeding annual meeting of stockholders after their election.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">adopted from time to time by the Board of Directors. The Board of Directors shall be classified, with respect to the term for which the directors hold office, into three classes, one class serving for a term expiring at the annual meeting of stockholders to be held in 2024, the second class serving for a term expiring at the annual meeting of stockholders to be held in 2025, and the third class serving for a term expiring at the annual meeting of stockholders to be held in 2026. At each annual meeting of stockholders, directors elected to succeed those directors whose terms expire shall be elected for a term of office to expire at the third succeeding annual meeting of stockholders after their election. Notwithstanding the foregoing, the directors elected to each class shall hold office until their successors are duly elected and qualified or until their earlier resignation, death, or removal. If the number of directors is hereafter changed, any newly created directorship or decrease in directorships shall be so apportioned among the classes as to make all classes as nearly equal in number as is practicable, provided that no decrease in the number of directors constituting the entire Board shall shorten the term of any incumbent director. No reduction in the number of directors shall cause the removal of any director from office prior to the expiration of his or her term. This classification of the Board may have the effect of delaying or preventing changes in New OneMedNet&#8217;s control or management by requiring, in most circumstances, a person to successfully engaging in a proxy contest at two or more annual meetings in order to gain control of the Board.</p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">138</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charter</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:39.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Proposed&#160;Amended&#160;Charter</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:40%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:39.98%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amendment of By-Laws</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Data Knights Charter provides that the affirmative vote of a majority of the Board shall be required to adopt, amend, alter or repeal the By-Laws. The By-Laws also may be adopted, amended, altered or repealed by the stockholders; provided, however, that in addition to any vote of the holders of any class or series of capital stock of the Corporation required by law or by this Amended and Restated Certificate (including any Preferred Stock Designation), the affirmative vote of the holders of at least a majority of the voting power of all then outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required for the stockholders to adopt, amend, alter or repeal the By-Laws; and provided further, however, that no By-Laws hereafter adopted by the stockholders shall invalidate any prior act of the Board that would have been valid if such By-Laws had not been adopted.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Proposed Amended Charter provides that the Board of Directors is expressly authorized to adopt, amend, alter, or repeal the Bylaws of the Corporation. In addition to any vote of the holders of any class or series of stock of the Corporation required by applicable law or by this Third Amended and Restated Certificate (including any Certificate of Designation in respect of one or more classes or series of Preferred Stock), the adoption, amendment or repeal of the Bylaws of the Corporation by the stockholders of the Corporation shall require the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2/3%) of the voting power of all the then-outstanding shares of the Voting Stock, voting together as a single class; provided that no Bylaws hereafter adopted by the stockholders of the Corporation shall invalidate any prior act of the Board of Directors that would have been valid if such Bylaws had not been adopted. This higher approval requirement may have the effect of delaying or preventing changes in New OneMedNet&#8217;s Bylaws, and may have the effect of delaying or preventing changes in New OneMedNet&#8217;s control or management.</p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Charter Amendment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Data Knights Charter provides that the Corporation reserves the right at any time and from time to time to amend, alter, change or repeal any provision contained therein, and other provisions authorized by the laws of the State of Delaware at the time in force that may be added or inserted, in the manner now or hereafter prescribed by the Data Knights Acquisition Corp. Charter and the DGCL; and, except as set forth in Article VIII therein, all rights, preferences and privileges of whatever nature conferred upon stockholders, directors or any other persons by and pursuant to the Data Knights Acquisition Corp. are granted subject to the right reserved in Article XI (Corporate Opportunity); provided, however, that Article IX (Business Combination Requirements; Existence) may be amended only as provided therein.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Proposed Amended Charter provides that the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2/3%) of the voting power of all of the then-outstanding shares of the Voting Stock, voting together as a single class, shall be required to alter, amend, or repeal Articles V (Board of Directors), VI (Stockholders), VII (Liability and Indemnification; Corporate Opportunity), VIII (Business Combinations), IX (Exclusive Forum), and Article X (Amendments). This higher approval requirement may have the effect of delaying or preventing changes in these provisions of New OneMedNet&#8217;s Charter, and thereby have the effect of delaying or preventing changes in New OneMedNet&#8217;s control or management.</p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Provisions Specific to a Blank Check Company</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Data Knights Charter sets forth various provisions related to our operations as a blank check company prior to the consummation of an initial business combination.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Proposed Amended Charter deletes these provisions previously included in the Data Knights Acquisition Corp. Charter in their entirety because, upon consummation of the Business Combination, Data Knights Acquisition Corp. will cease to be a blank check company. In addition, the provisions requiring that the proceeds from the Offering be held in a Trust Account until a business combination or liquidation of Data Knights Acquisition Corp. and the terms governing consummation of a proposed business combination will not be applicable following consummation of the Business Combination and thus will be deleted.</p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">139</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charter</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:39.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Proposed&#160;Amended&#160;Charter</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:40%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:39.98%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Duration of Existence</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Data Knights Charter provides that if Data Knights does not consummate the Business Combination and fails to complete an initial business combination within 12 months from the closing of the IPO or during any extension period (subject to the requirements of law), it will be required to dissolve and liquidate its Trust Account by returning the then-remaining funds in such account to the Public Stockholders, subject to the ability of the Data Knights Sponsor to extend the duration in certain circumstances.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Proposed Amended Charter deletes the liquidation provision in the Data Knights Charter and retains the default of perpetual existence under the DGCL</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reasons for the Proposed Amendments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Board&#8217;s reasons for proposing each of these amendments to the certificate of incorporation are set forth below:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Name Change</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: Currently, the Company&#8217;s name is Data Knights Acquisition Corp. The Board believes the name of the post-combination company should more closely align with the name of the post-Business Combination operating business and therefore has proposed the name change.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purpose</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The elimination of certain provisions related to the Company&#8217;s purpose is desirable because these provisions will not be necessary following the Business Combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Capitalization</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: The elimination of the authorized shares of Class B Common Stock must occur following the Business Combination pursuant to the terms of the Data Knights Charter.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassification of Class&#160;A and Class&#160;B Common Stock</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: The reclassification of Class&#160;A and Class&#160;B Common Stock must occur following the Business Combination pursuant to the terms of the Data Knights Charter.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Composition of the Board</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: The Board believes that an amendment to the composition of the Board is necessary to reflect the changes undergone by the Company in terms of governance as a consequence of the Business Combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment of By-Laws and Charter</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: The Board believes that amendments to the By-Laws and the Charter are necessary to both reflect the changes undergone by the Company as a consequence of the Business Combination and to adequately address the needs of OneMedNet Corporation following the Closing.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Provisions Specific to a Blank Check Company</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The elimination of certain provisions related to Data Knights&#8217; status as a blank check company is desirable because these provisions will serve no purpose following the Business Combination.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Duration of Existence</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Perpetual existence is the usual period of existence for corporations and the Data Knights Board believes it is the most appropriate period following the Business Combination.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Material Elements of the Charter Amendment Proposal; Vote Required for Approval</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The material changes embodied in the Charter Amendment Proposal are (i) the addition of the supermajority voting requirement to amend New OneMedNet&#8217;s Bylaws (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Bylaw Amendment Requirement</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;), and (ii) the addition of the supermajority voting requirement to amend Articles V (Board of Directors), VI (Stockholders), VII (Liability and Indemnification; Corporate Opportunity), VIII (Business Combinations), IX (Exclusive Forum), and Article X (Amendments) of the Amended Charter (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Article Amendment Requirement</b><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">&#8221;).  While the adoption of each of these material changes are cross-conditioned on the adoption of the other, holders of shares of Data Knights Common Stock will be allowed to vote separately on each of them at the Special Meeting, including by virtue of the proxy solicited hereby. The Charter Amendment Proposal will be approved and adopted only if the holders of at least a majority of the outstanding shares of Data Knights Common Stock vote &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR</b><span style="font-family:'Times New Roman','Times','serif';">&#8221; each of the Bylaw Amendment Requirement and the Article Amendment Requirement. Failure to vote by proxy or to vote virtually at the Special Meeting or an abstention from voting will have the same effect as a vote &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">AGAINST</b><span style="font-family:'Times New Roman','Times','serif';">&#8221; the Charter Amendment Proposal. In addition, because they </span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">140</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">are cross-conditioned on each other, the Charter Amendment Proposal will be approved and adopted only if each of the NTA Proposal, the Business Combination Proposal, the NASDAQ Proposal, and the Incentive Plan Proposal is approved at the Special Meeting by the affirmative vote of a majority of the issued and outstanding shares of Data Knights Common Stock cast on each such proposal at the Special Meeting.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recommendation of the Board</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS&#8217; BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT OUR</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;"> STOCKHOLDERS VOTE &#8220;FOR&#8221; APPROVAL OF THE CHARTER AMENDMENT </b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">PROPOSAL AND EACH OF THE BYLAW AMENDMENT REQUIREMENT </b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">AND THE ARTICLE AMENDMENT REQUIREMENT.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">141</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_4b450413_6819_4513_8477_2a2e93705225"></a><a id="THEDIRECTORELECTIONPROPOSAL_309989"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">THE DIRECTOR ELECTION PROPOSAL</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Board is currently divided into three classes with only one class of directors being elected in each&#160;year and each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a three-year term.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the Governance Approval Proposal is approved, Data Knights&#8217; Charter will keep the classification of our Board and our Board will consist of three classes of directors, with only one class of directors being elected in each&#160;year at the annual meeting of our stockholders commencing in 2024, and each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a three-year term whose term will continue to the first annual meeting of stockholders following the date of the closing of the business combination.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Our board of directors has nominated Erkan Akyuz, Eric Casaburi, and Robert Golden to serve in a class of directors whose terms expire at the annual meeting of stockholders to be held in 2024 or until each such director&#8217;s successor has been duly elected and qualified, or until each such director&#8217;s earlier death, resignation, retirement or removal. Our board of directors has nominated Paul Casey, Dr.&#160;Julianne Huh, Scott Holbrook and Dr.&#160;Thomas Kosasa to serve in a class of directors whose terms expire at the annual meeting of stockholders to be held in 2025 or until each such director&#8217;s successor has been duly elected and qualified, or until each such director&#8217;s earlier death, resignation, retirement or removal. Our board of directors has nominated Dr. Jeffrey Yu and R. Scott Holbrook to serve in a class of directors whose terms expire at the annual meeting of stockholders to be held in 2026 or until each such director&#8217;s successor has been duly elected and qualified, or until each such director&#8217;s earlier death, resignation, retirement or removal.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Vote Required for Approval</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Directors are elected by a plurality of the votes cast by holders of Data Knights Common Stock present virtually or by proxy and entitled to vote thereon at the Special Meeting. This means that the two director nominees who receive the most affirmative votes will be elected. Votes marked&#160;<i style="font-style:italic;">&#8220;FOR&#8221;</i>&#160;a nominee will be counted in favor of that nominee. Stockholders may not cumulate their votes with respect to the election of directors. Accordingly, assuming a valid quorum is established, a Company stockholder&#8217;s failure to vote by proxy or to vote virtually at the Special Meeting, as well as an abstention from voting or broker non-vote, will have no effect on the outcome of the Director Election Proposal.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">This Director Election Proposal is conditioned on the approval of the NTA Proposal, the Business Combination Proposal, the Nasdaq Proposal, the Charter Amendment Proposal, and the Incentive Plan Proposal. If each of the NTA Proposal, the Business Combination Proposal, the Nasdaq Proposal, the Charter Amendment Proposal, and the Incentive Plan Proposal is not approved, this Director Election Proposal will have no effect, even if approved by our stockholders.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS&#8217; BOARD UNANIMOUSLY RECOMMENDS THAT DATA KNIGHTS&#8217; PUBLIC STOCKHOLDERS VOTE &#8220;FOR&#8221; THE DIRECTOR ELECTION PROPOSAL.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">142</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_8c130767_1cb3_41ad_a9ff_9597e380ad77"></a><a id="THEEQUITYINCENTIVEPLANPROPOSAL_93419"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">THE EQUITY INCENTIVE PLAN PROPOSAL</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The holders of Data Knights&#8217; Public Shares are being asked to approve the OneMedNet 2022 Equity Incentive Plan (the &#8220;<b style="font-weight:bold;">2022 Equity Incentive Plan&#8221;)</b>. Data Knights&#8217; board intends to adopt the 2022 Equity Incentive Plan, subject to approval from the holders of Data Knights&#8217; Public Shares. If approved, the 2022 Equity Incentive Plan will become effective upon the Closing of the Business Combination and will be used by OneMedNet following the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; Board believes that the Company must offer a competitive equity incentive program if it is to successfully attract and retain the best possible candidates for positions of substantial responsibility within the Company. Data Knights&#8217; Board expects that the 2022 Equity Incentive Plan will be an important factor in attracting, retaining and rewarding high caliber employees who are essential to the Company&#8217;s success and in providing incentive to these individuals to promote the success of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Summary of the 2022 Equity Incentive Plan</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following summary is not a complete statement of the 2022 Equity Incentive Plan and is qualified in its entirety by reference to the complete text of the 2022 Equity Incentive Plan, a copy of which is attached hereto as </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex&#160;D</i><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">General</span><b style="font-weight:bold;">. </b>&#160;&#160;The purposes of the 2022 Equity Incentive Plan are to recognize contributions made to the Company and its affiliates by its employees, directors, consultants and advisors, to provide such persons with additional incentive to devote themselves to the future success of the Company and to improve the ability of the Company to attract, retain and motivate individuals upon whom the Company&#8217;s sustained growth and financial success depend. These incentives are provided through the grant of stock options, stock appreciation rights, restricted stock, restricted stock units and dividend equivalent rights. Any of these awards may, but need not, be made as performance incentives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Authorized Shares</span><b style="font-weight:bold;">. </b>&#160;&#160;A total number of shares of the Company&#8217;s common stock equal to 10% of issued and outstanding shares of the Company&#8217;s Common Stock immediately after the Closing of the Business Combination, which using the assumptions described under the section entitled &#8220;<i style="font-style:italic;">Total Company Shares to be Issued in the Business Combination</i>&#8221; would be 3,496,027 shares of the Company&#8217;s Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If shares covered by an award are not purchased or are forfeited or expire, or otherwise terminate without delivery of any shares subject thereto, then such shares will, to the extent of any such forfeiture, termination, cash-settlement or expiration, be available for future grant under the 2022 Equity Incentive Plan. If any options or stock appreciation rights terminate or expire without being fully exercised or are canceled, forfeited or cash-settled, the shares for which the option or stock appreciation right was not exercised may granted again under the 2022 Equity Incentive Plan; <i style="font-style:italic;">provided</i>, that to the extent any shares subject to an option or stock-settled stock appreciation right are withheld for payment of the purchase or exercise price or for payment of taxes, such withheld shares will be treated as granted and will not again be available for future grants. If any full-value award is canceled, forfeited or cash-settled, the shares for which such award was canceled, forfeited or cash-settled may be granted again under the 2022 Equity Incentive Plan; provided that to the extent shares subject to a full-value award are not actually issued at the time of exercise or settlement, including shares withheld for taxes, such withheld shares will not again be available for future grants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Adjustments to Shares Subject to the 2022 Equity Incentive Plan</span><b style="font-weight:bold;">. </b>&#160;&#160;In the event of a stock dividend, extraordinary cash dividend, stock split, recapitalization or other change in the number or class of issued or outstanding securities resulting from a subdivision or consolidation of the Company&#8217;s Common Stock and/or other outstanding equity securities or a recapitalization or other capital adjustment affecting the Company&#8217;s Common Stock, the administrator (as defined below) has the authority to make appropriate adjustments to the aggregate number of shares and class of shares as to which awards may be granted, the limitations as to grants to non-employee directors, the number of shares covered by each outstanding award and the option price for each related outstanding option and stock appreciation right.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Administration</span><b style="font-weight:bold;">. </b>&#160;&#160;The compensation committee of the Company Board will administer the 2022 Equity Incentive Plan (referred to as the &#8220;<b style="font-weight:bold;">administrator</b>&#8221;); provided that such committee consist of at least two members of the Company Board, each of whom qualifies as a non-employee director under Rule&#160;16b-3 of the Securities Exchange Act of 1934, as amended (the &#8220;<b style="font-weight:bold;">Exchange Act</b>&#8221;) and as an independent director under the rules&#160;of the stock exchange for so long as the Company is a publicly traded corporation. The Company Board may establish one or more committees to administer the 2022 Equity Incentive Plan with respect to separate classes of grantees (other than officers subject to Section&#160;16 of the Exchange Act) and the Company Board will act as the administrator with respect to awards made to non-employee directors. Subject to the provisions of the 2022 Equity Incentive Plan, the administrator has the power to administer the 2022 Equity Incentive Plan, including but not limited to, the authority to (i)&#160;direct the Company to grant </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">143</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">awards pursuant to the 2022 Equity Incentive Plan, (ii)&#160;determine the grantees to whom and the times at which awards will be granted, (iii)&#160;determine the price at which options are granted, (iv)&#160;determine the type of option to be awarded and the number of shares subject to such option, (v)&#160;determine the number of shares granted pursuant to each award and (vi)&#160;approve the form and terms and conditions of the award documents and of each award. The administrator&#8217;s interpretation and construction of any provisions of the 2022 Equity Incentive Plan or any award are final, binding and conclusive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Eligibility</span><b style="font-weight:bold;">. </b>&#160;&#160;Awards may be granted to employees, directors, consultants and advisors of the Company and any parent or subsidiary corporation of the Company. Incentive stock options may be granted only to employees who, as of the time of grant, are employees of the Company or any parent or subsidiary corporation of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock Options</span><b style="font-weight:bold;">. </b>&#160;&#160;Stock options in the form of non-statutory stock options or incentive stock options may be granted under the 2022 Equity Incentive Plan. The administrator determines the number of shares subject to each option. The administrator determines the exercise price of options granted under the 2022 Equity Incentive Plan; provided that the exercise price must at least be equal to the fair market value of the Company&#8217;s Common Stock on the date of grant. The term of a stock option may not exceed ten&#160;years, except that with respect to any participant who owns more than 10% of the voting power of all classes of the Company&#8217;s outstanding stock, the term of an incentive stock option must not exceed five&#160;years and the exercise price must equal at least 110% of the fair market value on the grant date. The grantee may pay the exercise price of an option (i)&#160;in cash, (ii)&#160;by certified check or (iii)&#160;by such method as the administrator approves, including payment through a broker. After the termination of service of a grantee other than due to death or disability, his or her option will remain exercisable for ninety (90)&#160;days except as otherwise provided in the award agreement. After the termination of service of a grantee due to death or disability, the option will remain exercisable for 12&#160;months unless otherwise provided in the award agreement. Upon a termination for cause, all options cease to be exercisable immediately on the date of termination and the grantee automatically forfeits all shares for which the Company has not yet delivered the share certificates. An option may not be exercised later than the expiration of its term. Subject to the provisions of the 2022 Equity Incentive Plan, the administrator determines the other terms of options.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock Appreciation Rights</span><b style="font-weight:bold;">. </b>&#160;&#160;Stock appreciation rights may be granted under the 2022 Equity Incentive Plan. Stock appreciation rights allow the recipient to receive the appreciation in the fair market value of the Company&#8217;s Common Stock between the exercise date and the date of grant. Stock appreciation rights may not have a term exceeding ten&#160;years. Unless otherwise provided in an award agreement, in the event that a grantee&#8217;s services terminate for any reason other than due to death or disability, any stock appreciation right is forfeited and reacquired by the Company. In the event of a termination due to death or disability, all remaining restrictions with respect to stock appreciation rights immediately lapse unless otherwise provided in an award agreement. The grant price for a stock appreciation right may not be less than 100% of the fair market value per share on the date of grant. Subject to the provisions of the 2022 Equity Incentive Plan, the administrator determines the other terms of stock appreciation rights, including when such rights become exercisable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Restricted Stock Awards</span><b style="font-weight:bold;">. </b>&#160;&#160;Restricted stock may be granted under the 2022 Equity Incentive Plan. Restricted stock awards are grants of shares of the Company&#8217;s Common Stock that vest in accordance with terms and conditions established by the administrator. The administrator will determine the number of shares of restricted stock granted to any employee, director, consultant or advisor and, subject to the provisions of the 2022 Equity Incentive Plan, will determine the terms and conditions of such awards. The administrator may impose whatever conditions to vesting it determines to be appropriate (for example, the administrator may set restrictions based on the achievement of specific performance goals or continued service to the Company); provided, however, that the administrator, in its sole discretion, may accelerate the time at which any restrictions will lapse or be removed. Recipients of restricted stock awards generally will have voting rights with respect to such shares upon grant unless the administrator provides otherwise. Recipients of restricted stock awards are not entitled to receive any dividends with respect to such shares until the shares become vested. The administrator may provide that any dividends paid on restricted stock awards must be reinvested in shares of Common Stock, which is subject to the same vesting conditions applicable to the restricted stock awards. Unless otherwise provided in an award agreement, upon a termination of service for any reason other than due to death or disability any unvested restricted stock awards are forfeited and upon a termination due to death or disability all restrictions with respect to any restricted stock awards immediately lapse.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Restricted Stock Units. </span>&#160;&#160;Restricted stock units may be granted under the 2022 Equity Incentive Plan. Restricted stock units are bookkeeping entries representing an amount equal to the fair market value of one share of the Company&#8217;s Common Stock. Subject to the provisions of the 2022 Equity Incentive Plan, the administrator determines the terms and conditions of restricted stock units, including the vesting criteria (which may include accomplishing specified performance criteria or continued service to the Company) and the form and timing of payment. Holders of restricted stock units do not have any rights as stockholders but the administrator may provide in an award agreement that such holders are entitled to receive cash payments equal to the per-share dividend paid on </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">144</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Common Stock which will be distributed upon vesting of the restricted stock unit. Restricted stock units are subject the same treatment upon terminations of service as restricted stock awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Dividend Equivalent Rights. &#160;&#160;</span>Dividend equivalent rights may be granted under the 2022 Equity Incentive Plan. Dividend equivalent rights are entitlements to receive credits based on cash distributions that would have been paid on the shares of Common Stock subject to an equity-based award granted to an individual as though such shares had been issued to and held by the grantee. Dividend equivalent rights may not be granted in connection with stock options or stock appreciation rights. Subject to the terms of the 2022 Equity Incentive Plan, the administrator determines the terms and conditions of dividend equivalent rights. Except as otherwise provided in an award agreement, all dividend equivalent rights automatically terminate on the grantee&#8217;s termination of service for any reason.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Transferability of Awards. </span><span style="font-family:'Times New Roman PS Std';">&#160;&#160;</span>The 2022 Equity Incentive Plan allows for the transfer of awards (other than incentive stock options) for no consideration to the grantee&#8217;s immediate family or any trust or partnership in which all of the beneficiaries or partners or members, as applicable, are such grantee or his or her immediate family.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Grants to Non-Employee Directors. </span>&#160;&#160;Grants made to non-employee directors may be in any form other than incentive stock options. The fair value of any awards granted to a non-employee director, including cash compensation in respect of such director&#8217;s service, may not exceed $750,000 in any one calendar&#160;year.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Parachute Limitations. </span><span style="font-family:'Times New Roman','Times','serif';">&#160;&#160;To the extent that a grantee is a &#8220;disqualified individual&#8221; under Section&#160;280G(c)&#160;of the Internal Revenue Code of 1986 (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Code</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;), any award held by such grantee and any right to receive any payment or other benefit under the 2022 Equity Incentive Plan will not become exercisable</span><span style="font-family:'Times New Roman','Times','serif';"> or vested to the extent such exercise or vesting would cause any payment or benefit to such grantee to be subject to excise tax under Section</span><span style="font-family:'Times New Roman PS Std';">&#160;</span><span style="font-family:'Times New Roman','Times','serif';">4999 of the Code; provided that such limitations are only applicable to the extent that the imposition of such limitation is beneficial to the grantee on a net after tax basis.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Change in Control. </span>&#160;&#160;The 2022 Equity Incentive Plan provides that in the event of a change of control, as defined under the 2022 Equity Incentive Plan, each outstanding award will be treated as the administrator determines, including accelerating the expiration or termination date or the date of exercisability of an award, settling any award by means of a cash payment, or removing any restrictions from or imposing any additional restrictions on any outstanding awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Amendment; Termination. </span>&#160;&#160;The Company Board has the authority to amend the 2022 Equity Incentive Plan from time to time; provided that stockholder consent is require to: (i)&#160;increase the maximum number of shares as to which awards may be granted, except for adjustments in connection with certain events specified in the 2022 Equity Incentive Plan, (ii)&#160;materially expand the eligible participants or (iii)&#160;adopt any amendment constituting a change requiring stockholder approval under applicable laws or applicable listing requirements. Additionally, no amendment may materially adversely affect any outstanding award without consent of the impacted grantee. The 2022 Equity Incentive Plan automatically will terminate in 2030.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Summary of U.S. Federal Income Tax Consequences of the 2022 Equity Incentive Plan</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following summary is intended only as a general guide to the material U.S. federal income tax consequences of participation in the 2022 Equity Incentive Plan. The summary is based on existing U.S. laws and regulations, and there can be no assurance that those laws and regulations will not change in the future. The summary does not purport to be complete and does not discuss the tax consequences upon a participant&#8217;s death, or the provisions of the income tax laws of any municipality, state or foreign country in which the participant may reside. As a result, tax consequences for any particular participant may vary based on individual circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Incentive Stock Options. </span>&#160;&#160;An optionee recognizes no taxable income for regular income tax purposes as a result of the grant or exercise of an incentive stock option qualifying under Section&#160;422 of the Code. Optionees who neither dispose of their shares within two&#160;years following the date the option was granted nor within one&#160;year following the exercise of the option normally will recognize a capital gain or loss equal to the difference, if any, between the sale price and the purchase price of the shares. If an optionee satisfies such holding periods upon a sale of the shares, the Company will not be entitled to any deduction for federal income tax purposes. If an optionee disposes of shares within two&#160;years after the date of grant or within one&#160;year after the date of exercise (a &#8220;<b style="font-weight:bold;">disqualifying disposition</b>&#8221;), the difference between the fair market value of the shares on the exercise date and the option exercise price (not to exceed the gain realized on the sale if the disposition is a transaction with respect to which a loss, if sustained, would be recognized) will be taxed as ordinary income at the time of disposition. Any gain in excess of that amount will be a capital gain. If a loss is recognized, there will be no ordinary income, and such loss will be a capital loss. Any ordinary income recognized by the optionee </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">145</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">upon the disqualifying disposition of the shares generally should be deductible by the Company for federal income tax purposes, except to the extent such deduction is limited by applicable provisions of the Code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The difference between the option exercise price and the fair market value of the shares on the exercise date is treated as an adjustment in computing the optionee&#8217;s alternative minimum taxable income and may be subject to an alternative minimum tax which is paid if such tax exceeds the regular tax for the&#160;year. General rules&#160;may apply with respect to certain subsequent sales of the shares in a disqualifying disposition, certain basis adjustments for purposes of computing the alternative minimum taxable income on a subsequent sale of the shares and certain tax credits which may arise with respect to optionees subject to the alternative minimum tax.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Nonstatutory Stock Options. </span><b style="font-weight:bold;">&#160;&#160;</b>Options not designated or qualifying as incentive stock options will be nonstatutory stock options having no special U.S. tax status. An optionee generally recognizes no taxable income as the result of the grant of such an option. Upon exercise of a nonstatutory stock option, the optionee normally recognizes ordinary income equal to the amount that the fair market value of the shares on such date exceeds the exercise price. If the optionee is an employee, such ordinary income generally is subject to withholding of income and employment taxes. Upon the sale of stock acquired by the exercise of a nonstatutory stock option, any gain or loss, based on the difference between the sale price and the fair market value on the exercise date, will be taxed as capital gain or loss. No tax deduction is available to the Company with respect to the grant of a nonstatutory stock option or the sale of the stock acquired pursuant to such grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock Appreciation Rights. </span><b style="font-weight:bold;">&#160;&#160;</b>In general, no taxable income is reportable when a stock appreciation right is granted to a participant. Upon exercise, the participant generally will recognize ordinary income in an amount equal to the fair market value of any shares of Company Common Stock received. Any additional gain or loss recognized upon any later disposition of the shares would be capital gain or loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Restricted Stock Awards. </span><b style="font-weight:bold;">&#160;&#160;</b>A participant acquiring restricted stock generally will recognize ordinary income equal to the fair market value of the shares on the vesting date. If the participant is an employee, such ordinary income generally is subject to withholding of income and employment taxes. The participant may elect, pursuant to Section&#160;83(b)&#160;of the Code, to accelerate the ordinary income tax event to the date of acquisition by filing an election with the Internal Revenue Service no later than thirty (30)&#160;days after the date the shares are acquired. Upon the sale of shares acquired pursuant to a restricted stock award, any gain or loss, based on the difference between the sale price and the fair market value on the date the ordinary income tax event occurs, will be taxed as capital gain or loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Restricted Stock Unit Awards. </span><b style="font-weight:bold;">&#160;&#160;</b>There are no immediate tax consequences of receiving an award of restricted stock units. A participant who is awarded restricted stock units generally will be required to recognize ordinary income in an amount equal to the fair market value of shares issued to such participant at the end of the applicable vesting period or, if later, the settlement date elected by the administrator or a participant. Any additional gain or loss recognized upon any later disposition of any shares received would be capital gain or loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Section&#160;409A. </span>&#160;&#160;Section&#160;409A of the Code provides certain requirements for non-qualified deferred compensation arrangements with respect to an individual&#8217;s deferral and distribution elections and permissible distribution events. If an award is subject to and fails to satisfy the requirements of Section&#160;409A of the Code, the recipient of that award may recognize ordinary income on the amounts deferred under the award, to the extent vested, which may be prior to when the compensation is actually or constructively received. Also, if an award that is subject to Section&#160;409A fails to comply with Section&#160;409A&#8217;s provisions, Section&#160;409A imposes an additional 20% federal income tax on compensation recognized as ordinary income, as well as interest on such deferred compensation. Certain states have enacted laws similar to Section&#160;409A which impose additional taxes, interest and penalties on non-qualified deferred compensation arrangements. The Company will also have withholding and reporting requirements with respect to such amounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Tax Effect for the Company</span><b style="font-weight:bold;">. </b>&#160;&#160;The Company generally will be entitled to a tax deduction in connection with an award under the 2022 Equity Incentive Plan in an amount equal to the ordinary income realized by a participant and at the time the participant recognizes such income (for example, the exercise of a nonstatutory stock option). General rules&#160;limit the deductibility of compensation paid to the Company&#8217;s chief executive officer and other &#8220;covered employees&#8221; as determined under Section&#160;162(m)&#160;and applicable guidance.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">146</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">THE FOREGOING IS ONLY A SUMMARY OF THE EFFECT OF THE U.S. FEDERAL INCOME TAXATION UPON PARTICIPANTS AND THE COMPANY UNDER THE 2022 EQUITY INCENTIVE PLAN. IT DOES NOT PURPORT TO BE COMPLETE AND DOES NOT DISCUSS THE TAX CONSEQUENCES OF A PARTICIPANT&#8217;S DEATH OR THE PROVISIONS OF THE INCOME TAX LAWS OF ANY MUNICIPALITY, STATE, OR FOREIGN COUNTRY IN WHICH THE PARTICIPANT MAY&#160;RESIDE.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Number of Awards Granted to Employees, Consultants, and Directors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of the date hereof, no awards have been granted under the 2022 Equity Incentive Plan. It is currently expected that no awards will be granted under the 2022 Equity Incentive Plan prior to Closing of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Vote Required</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The approval of this proposal to adopt the 2022 Equity Incentive Plan requires the affirmative vote of the holders of a majority of the shares of Data Knights&#8217; Common Stock cast by the stockholders represented &#8220;in person&#8221; or by proxy and entitled to vote thereon at the Special Meeting, assuming that a quorum is present. Abstentions will have no effect on the Incentive Plan Proposal. Broker non-votes will have no effect with respect to the approval of Incentive Plan Proposal.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Incentive Plan Proposal is conditioned on the approval of the NTA Proposal, the Business Combination, the Charter Amendment Proposal and the Nasdaq Proposal.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recommendation of the Board</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS&#8217; BOARD UNANIMOUSLY RECOMMENDS THAT DATA KNIGHTS&#8217; PUBLIC STOCKHOLDERS VOTE &#8220;FOR&#8221; THE INCENTIVE PLAN PROPOSAL.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">147</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_779a3b50_1ddc_436d_acdd_9c6132bb2c15"></a><a id="THEADJOURNMENTPROPOSAL_592112"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">THE ADJOURNMENT PROPOSAL</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Overview</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Adjournment Proposal, if adopted, will allow Data Knights&#8217; Board to adjourn the Special Meeting to a later date or dates to permit further solicitation of proxies. The Adjournment Proposal will only be presented to Data Knights&#8217; stockholders in the event that based upon the tabulated vote at the time of the Special Meeting there are insufficient votes for, or otherwise in connection with, the approval of the NTA Proposal, the Business Combination Proposal, the Nasdaq Proposal, the Charter Amendment Proposal, the Director Election Proposal, or the Incentive Plan Proposal. In no event will Data Knights&#8217; Board adjourn the Special Meeting or consummate the Business Combination beyond the date by which it may properly do so under its amended and restated certificate of incorporation and Delaware law.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Consequences if the Adjournment Proposal is Not Approved</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the Adjournment Proposal is not approved by Data Knights&#8217; stockholders, Data Knights&#8217; Board may not be able to adjourn the Special Meeting to a later date in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Business Combination Proposal or any other proposal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Vote Required for Approval</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The approval of the Adjournment Proposal requires the affirmative vote of a majority of the votes cast by Data Knights&#8217; Public Stockholders represented &#8220;in person&#8221; or by proxy and entitled to vote thereon at the Special Meeting, assuming that a quorum is present. Abstentions will have no effect on the Adjournment Proposal. Broker non-votes will have no effect with respect to the approval of the Adjournment Proposal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recommendation of the Board</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS&#8217; BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT ITS STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE ADJOURNMENT PROPOSAL.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">148</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_f2b954b3_3c8a_40d7_a018_4aea23536bdf"></a><a id="INFORMATIONABOUTDATAKNIGHTS_888916"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">INFORMATION</b><b style="font-weight:bold;"> ABOUT DATA KNIGHTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Overview</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is a blank check company incorporated as a Delaware corporation on February&#160;8, 2021 and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business transaction with one or more operating businesses or assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Significant Activities Since Inception</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The registration statement for Data Knights&#8217; Initial Public Offering was declared effective on May&#160;6, 2021. On May&#160;11, 2021, Data Knights consummated its Initial Public Offering of 10,000,000 units (the &#8220;<b style="font-weight:bold;">Units</b>&#8221; and, with respect to the Class&#160;A common stock included in the Units being offered, the &#8220;<b style="font-weight:bold;">Public Shares</b>&#8221;), at $10.00 per Unit, generating gross proceeds of $100,000,000 (the &#8220;<b style="font-weight:bold;">Initial Public Offering</b>&#8221;). Data Knights granted the underwriter a 45-day option to purchase up to an additional 1,500,000 Units at the Initial Public Offering price to cover over-allotments, if any.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Simultaneously with the consummation of the closing of the Offering, Data Knights consummated the private placement of an aggregate of 585,275 units (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Placement Units</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;) to the Sponsor at a price of $10.00 per Placement Unit, generating total gross proceeds of $5,852,750 (the &#8220;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Private Placement</b><span style="font-family:'Times New Roman','Times','serif';">&#8221;).</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Also on May&#160;11, 2021, the underwriters exercised the over-allotment option in full, and the closing of the issuance and sale of the additional Units occurred (the &#8220;<b style="font-weight:bold;">Over-allotment Option Units</b>&#8221;). The total aggregate issuance by Data Knights of 1,500,000 units at a price of $10.00 per unit resulted in total gross proceeds of $15,000,000. On May&#160;11, 2021, simultaneously with the sale of the Over-allotment Option Units, Data Knights consummated the private sale of an additional 60,000 Placement Units, generating gross proceeds of $600,000. The Placement Units were issued pursuant to Section&#160;4(a)(2)&#160;of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">A total of $117,300,000, comprised of the proceeds from the Offering and the proceeds of private placements that closed on May&#160;11, 2021, net of the underwriting commissions, discounts, and offering expenses, was deposited in a trust account established for the benefit of Data Knights&#8217; public stockholders. As of March&#160;31, 2023, Data Knights had $29,725,574 held in trust account, $10,108 in cash and working capital deficit of $2,326,648.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June&#160;22, 2021, the Class&#160;A Common Stock and Public Warrants included in the Units began separate trading.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Effecting a Business Combination</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is not presently engaged in, and will not engage in, any operations until after the business combination. Data Knights intends to effect the business combination using cash held in the Trust Account and, if needed, funds from any additional private equity financings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Selection of a Target Business and Structuring of the Initial Business Combination</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the Nasdaq rules, an initial business combination must occur with one or more target businesses that together have a fair market value of at least 80% of Data Knights&#8217; assets held in the Trust Account (excluding taxes payable on the income earned on the Trust Account count) at the time of the agreement to enter into the initial business combination. The fair market value of the target or targets will be determined by Data Knights&#8217; Board based upon one or more standards generally accepted by the financial community, such as discounted cash flow valuation or value of comparable businesses. Subject to this requirement, Data Knights&#8217; management has had virtually unrestricted flexibility in identifying and selecting one or more prospective target businesses, although Data Knights was not permitted to effectuate an initial business combination with another blank check company or a similar company with nominal operations. In any case, Data Knights determined that it would only complete an initial business combination in which we acquired 50% or more of the outstanding voting securities of the target or were otherwise not required to register as an investment company under the Investment Company Act.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">149</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Redemption Rights for Holders of Public Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights will provide public stockholders with the opportunity to redeem all or a portion of their Class&#160;A Common Stock upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business&#160;days prior to the completion of the initial business combination, including interest earned on the funds held in the trust account and not previously released to us to pay Data Knights&#8217; taxes, if any, divided by the number of then outstanding Public Shares, subject to the limitations described herein. The amount in the trust account is initially $10.20 per public share. The per-share amount Data Knights will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions Data Knights will pay to the underwriters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. Data Knights&#8217; Sponsor, directors and each member of Data Knights&#8217; management have entered into a letter agreement with Data Knights, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and any Public Shares held by them in connection with (i)&#160;the completion of Data Knights&#8217; initial business combination and (ii)&#160;a stockholder vote to approve an amendment to Data Knights&#8217; third amended and restated certificate of incorporation that would affect the substance or timing of Data Knights&#8217; obligation to allow redemption in connection with Data Knights&#8217; initial business combination or to redeem 100% of Data Knights&#8217; Public Shares if Data Knights has not completed an initial business combination within the period to consummate the initial business combination. However, Data Knights will only redeem the Public Shares so long as (after such redemption) Data Knights&#8217; net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our initial business combination and after payment of deferred underwriters&#8217; fees and commissions (so that Data Knights is not subject to the SEC&#8217;s &#8220;penny stock&#8221; rules). If this optional redemption right is exercised with respect to an excessive number of Public Shares such that Data Knights cannot satisfy the net tangible asset requirement (described above), Data Knights would not proceed with the amendment or the related redemption of Data Knights&#8217; Public Shares at such time. There will be no redemption rights or liquidating distributions with respect to Data Knights&#8217; warrants, which will expire worthless if Data Knights fail to complete the Business Combination within the 18-month time period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">All costs and expenses associated with implementing Data Knights&#8217; plan of dissolution, as well as payments to any creditors, will be funded from amounts remaining out of the approximately $600,000 of proceeds held outside the trust account, although Data Knights cannot assure that there will be sufficient funds for such purpose. Data Knights will depend on sufficient interest being earned on the proceeds held in the trust account to pay any tax obligations Data Knights may owe. However, if those funds are not sufficient to cover the costs and expenses associated with implementing Data Knights&#8217; plan of dissolution, to the extent that there is any interest accrued in the trust account not required to pay taxes on interest income earned on the trust account balance, Data Knights may request the trustee to release to Data Knights an additional amount of up to $100,000 of such accrued interest to pay taxes, and these costs and expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Submission of Data Knights&#8217; Initial Business Combination to a Stockholder Vote</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is providing its public stockholders with redemption rights upon consummation of the business combination. Public stockholders electing to exercise their redemption rights will be entitled to receive the cash amount specified above for its Public Shares only if it properly demands redemption and delivers its Public Shares (either physically or electronically) to Data Knights&#8217; transfer agent prior to the Special Meeting. Public stockholders must follow the specific procedures for redemption set forth in this proxy statement/prospectus relating to the stockholder vote on a business combination. Unlike many other blank check companies, Data Knights&#8217; public stockholders are not required to vote against the business combination in order to exercise their redemption rights. If the business combination is not completed, then public stockholders electing to exercise their redemption rights will not be entitled to receive such payments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The holders of the Founder Shares and shares of Class&#160;A Common Stock underlying the Placement Units have agreed to vote such Common Stock owned by them in favor of the business combination. In addition, the Sponsor and Data Knights&#8217; officers and directors have agreed to waive their redemption rights with respect to any capital stock they may hold in connection with the consummation of the business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Limitation on Redemption Rights</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the foregoing, Data Knights&#8217; Charter provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as&#160;defined under Section&#160;13 of the Exchange Act), will be restricted from seeking redemptions with respect to more than 15% of the shares sold in the Data Knights IPO.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">150</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Employees</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights currently has two executive officers. These individuals are not obligated to devote any specific number of hours to Data Knights&#8217; matters, but they intend to devote as much of their time as they deem necessary to Data Knights&#8217; affairs until Data Knights has completed the initial business combination. Data Knights does not intend to have any full-time employees prior to the completion of the initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Facilities</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights maintains its principal executive offices at Unit G6, Frome Business Park, Manor Road, Frome, United Kingdom, BA11 4FN. The cost for this space is included in the $10,000&#160;monthly charge to the Sponsor, which includes certain administrative and support services, which commenced on May&#160;7, 2021 pursuant to a letter agreement between Data Knights and the Sponsor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Legal Proceedings</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the knowledge of Data Knights&#8217; management, there are no legal proceedings pending against Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">151</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_2653fb40_63eb_4990_a9dc_e73dde16e3e9"></a><a id="DATAKNIGHTSMANAGEMENT_378513"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">DATA KNIGHTS&#8217; MANAGEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">Unless otherwise indicated or the context otherwise requires, references in this section to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and other similar terms refer to Data Knights and its subsidiaries before the Business Combination.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Directors and Executive Officers</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The directors and executive officers of Data Knights are as follows as of the date of this proxy statement/prospectus:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:42.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:42.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.59%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 45</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:42.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chairman, Chief Executive Officer and Director</p></td></tr><tr><td style="vertical-align:bottom;width:42.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Firdauz Edmin Bin Mokhtar</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:42.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer and Secretary</p></td></tr><tr><td style="vertical-align:bottom;width:42.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Syed Musheer Ahmed</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 38</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:42.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;width:42.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Julianne Huh</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 53</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:42.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;width:42.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Annie Damit Undikai</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 60</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:42.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Barry Anderson</span> has served as our chairman and Chief Executive Officer since our inception. Mr.&#160;Anderson has been serving as the Chief Executive Officer of Present D&#8217;Lloyd Technologies Ltd since September&#160;2019, where he has conceptualized and implemented the business development strategy that has yielded significant results in raising the company profile. From October&#160;2011 to September&#160;2019, Mr.&#160;Anderson served as the Managing Director of Serba Dinamik International Ltd, where he provided leadership and vision to the organization by assisting the board of directors with the development of long range and annual strategies and planning. From July&#160;2013 to September&#160;2019, Mr.&#160;Anderson served as the Non-Executive Director of Quantum Offshore Ltd, where he was assisting and identifying new areas for development and providing guidance on capital raising activities. Mr.&#160;Anderson currently sits on the board of directors and contributes his&#160;years of experience to develop new areas for growth by creating meaningful and lasting relationships with key customers for future business. From January&#160;2007 to August&#160;2011, Mr.&#160;Anderson served as the Business Development Manager of Serba Dinamik Sdn Bhd, where he developed and managed a sales team to promote nitrogen generation, turbine, and compressor services. Mr.&#160;Anderson effectively implemented sales strategies to achieve targets, and generated key accounts and term contracts with clients globally. From January&#160;2007 to September&#160;2008, Mr.&#160;Anderson served as the Business Development Manager of RAM Global Ltd, where he was responsible for the sales and marketing of advanced polymer products. In 1998, Mr.&#160;Anderson received his Bachelor of Arts Degree in Asian Studies at Manchester University.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Firdauz Edmin Bin Mokhtar</span> has served as our Chief Financial Officer and secretary since inception<span style="color:#333333;"> on February&#160;8, 2021</span>. Mr.&#160;Mokhtar has been serving as the Senior Vice President, Special Project of Group CEO Office, of Serba Dinamik Holdings Berhad since November&#160;2019. In May&#160;2012, Mr.&#160;Mokhtar joined PBJV Group Sdn. Bhd. (PBJV) as the Chief Financial Officer with the primary task to list the group in Bursa Malaysia. PBJV was successfully listed in Bursa Malaysia in November&#160;2013 under a new investment holding company, Barakah Offshore Petroleum Berhad (Barakah). Mr.&#160;Mokhtar was also transferred from PBJV to Barakah as group Chief Financial Officer. Prior to joining PBJV, Mr.&#160;Mokhtar was employed by TidalMarine Engineering Sdn Bhd (TidalMarine) as Director of Corporate Affairs and Finance since May&#160;2007. TidalMarine is one of the leading marine engineering companies in Malaysia specializing in marine and infrastructure services. In October&#160;2005, Mr.&#160;Mokhtar joined PECD Berhad as a Manager in its Investment Division, where he was primarily responsible for evaluating and acquiring concession type assets in the water, infrastructure, power, oil and gas sectors. Subsequently in October&#160;2006, he was promoted to Head of Corporate Affairs (Group CEO Office). In May&#160;2003, Mr.&#160;Mokhtar joined Ranhill Berhad (RB) as the Senior Manager of Corporate Planning, where he was instrumental in the acquisition and debt restructuring of Ranhill Power Berhad (formerly known as EPE Power Corporation Berhad) and Ranhill Utilities Berhad. Upon receiving his Bachelor&#8217;s Degree (Honours) in Accountancy in July&#160;1997 from International Islamic University Malaysia, Mr.&#160;Mokhtar started his career at PwC Malaysia in the Corporate Finance/Recovery Department before he moved to the Corporate Finance Department at Alliance Investment Banks in July&#160;1999. Mr.&#160;Mokhtar is also a Certified Public Accountant registered with the Malaysian Institute of Accountants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Syed Musheer Ahmed</span> was appointed to our Board in May&#160;2021. Mr.&#160;Ahmed co-founded FinStep Asia based in Hong Kong and has been serving as its Managing Director since October&#160;2019. FinStep Asia is a venture builder where Mr.&#160;Ahmed facilitated fintech partnerships across Asia, Europe and the U.S. for a Singaporean e-commerce Unicorn, and provided market entry strategy and growth advisory services to fintech firms across Asia, with a focus on Hong Kong, India and Singapore. From October&#160;2017 to October&#160;2019, Mr.&#160;Ahmed co-founded the Fintech Association based in Hong Kong and has been serving as its General Manager. The Fintech Association of Hong Kong is the representative body for Hong Kong&#8217;s Fintech Industry, where Mr.&#160;Ahmed developed strategic, digital and policy frameworks for the financial services and fintech industry in Hong Kong. From January&#160;2016 to July&#160;2017, Mr.&#160;Ahmed served as the Senior Consultant and Co-head of Risk and Regulations at GreySpark Partners based in Hong Kong. GreySpark is a global management consulting firm with a focus on financial services technology. From July&#160;2005 to June&#160;2014, </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">152</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Mr.&#160;Ahmed served as the Country Head of Hertshten Group and its subsidiaries. Hertshten Group is one of the world&#8217;s largest firms in fixed income and commodities futures trading. In August&#160;2015, Mr.&#160;Ahmed received his MBA degree with a focus on Finance and Strategy, from the London Business School and the University of Hong Kong. In June&#160;2005, Mr.&#160;Ahmed received his Bachelor of Engineering degree from R.V.C.E. in India. We believe Mr.&#160;Ahmed is well-qualified to serve as a member of our board of directors due to his experience in fintech and the financial services industry, and his network of contacts and relationships.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Dr.&#160;Julianne Huh</span> was appointed to our Board in May&#160;2021. Since October&#160;2017, Dr.&#160;Huh has been serving as the Director of S&amp;I F&amp;B Management Sdn, Bhd based in Kuala Lumpur, Malaysia, where she manages the overall business, operations and marketing of 2 Ox French Bistro. From June&#160;2016 to August&#160;2017, Dr.&#160;Huh served as the Vice President of The Mall of Korea based in Bangkok, Thailand, where she managed projects for business set-up, construction of department stores and nine restaurants. Dr.&#160;Huh also managed the overall business, operations and marketing while serving as the Vice President during this time. From November&#160;2013 to June&#160;2016, Dr.&#160;Huh served as the Director of Business Development of Juna International Ltd based in Shanghai, China and Seoul, Korea, where she oversaw China Business Development in the entertainment and music industry. From August&#160;2006 to June&#160;2016, Dr.&#160;Huh founded the Wonderful World of Learning (WWL) and served as its General Manager based in Shanghai, where she managed the overall business and operations of the preschool, curriculum development and teacher training. From October&#160;2011 to May&#160;2014, Dr.&#160;Huh served as the Managing Partner as well as Vice President of Pronovias Korea based in Seoul, Korea, where she launched the wedding dress brand &#8220;Pronovias&#8221; of the Spain flagship store as the sole franchise for the Korean market. Dr.&#160;Huh also oversaw and managed operations, marketing, PR and bi-annual buying and merchandising. From September&#160;2009 to September&#160;2019, Dr.&#160;Huh founded Only Natural Organic Bath Products based in Shanghai, China, where she was in charge of brand development and sales for charity purposes. In May&#160;2005, Dr.&#160;Huh received her Doctor of Education (Ed.D) degree at the University of Massachusetts in the U.S. In May&#160;1995, Dr.&#160;Huh received her Master of Education (M.Ed.) degree from the University of Massachusetts in the U.S. In June&#160;1993, Dr.&#160;Huh completed two semesters of courses at the MBA program at the Yonsei University in Seoul, Korea. In February&#160;1991, Dr.&#160;Huh received her Bachelor of Arts degree in English Language and Literature from Ewha Women&#8217;s University in Seoul, Korea. We believe Dr.&#160;Huh is well-qualified to serve as a member of our board of directors due to her experience in global finance, as well as her network of contacts and relationships.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Annie Damit Undikai</span> was appointed to our Board in May&#160;2021. Since August&#160;2005, Ms.&#160;Undikai has been serving as a Director of Brighton Management Limited, an underwriting and insurance management firm. Since November&#160;2007, Ms.&#160;Undikai has been serving as a Director of Brighton International Management SDN BHD, an affiliate of Brighton Management Limited providing management and support services. Since September&#160;2010, Ms.&#160;Undikai has been serving as a Director of Brighton International Group Limited, an affiliate of Brighton Management Limited. Since August&#160;2013, Ms.&#160;Undikai has been serving as a Director of Brighton Management Singapore PTE&#160;Ltd., an affiliate of Brighton Management Limited providing management and support services. Since December&#160;2019, Ms.&#160;Undikai has also been serving as a Director of Park Lane PCC Limited, a captive insurance company. In July&#160;1983, Ms.&#160;Undikai received her Bachelor of Arts with Honors in Accounting and Computing from the University of Kent at Canterbury in the United Kingdom. Ms.&#160;Undikai is a Fellow Member of the Association of Chartered Certified Accountants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Number and Terms of Office of Officers and Directors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have four directors. Our board of directors is divided into three classes with only one class of directors being elected in each&#160;year and each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a three-year term. In accordance with Nasdaq corporate governance requirements, we are not required to hold an annual meeting until one&#160;year after our first fiscal&#160;year end following our listing on Nasdaq. The term of office of the first class of directors, consisting of Mr.&#160;Ahmed will expire at our first annual meeting of stockholders. The term of office of the second class of directors, consisting of Dr.&#160;Huh, will expire at the second annual meeting of stockholders. The term of office of the third class of directors, consisting of Mr.&#160;Anderson and Ms.&#160;Undikai, will expire at the third annual meeting of stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our bylaws as it deems appropriate. Our bylaws provide that our officers may consist of a Chairman of the Board, Chief Executive Officer, Chief Financial Officer, President, Vice Presidents, Secretary, Treasurer, Assistant Secretaries and such other offices as may be determined by the board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Committees of the Board of Directors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our board of directors has two standing committees: an audit committee and a compensation committee. Subject to phase-in rules&#160;and a limited exception, Nasdaq rules&#160;and Rule&#160;10A-3 of the Exchange Act require that the audit committee of a listed company </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">153</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">be comprised solely of independent directors, and Nasdaq rules&#160;require that the compensation committee of a listed company be comprised solely of independent directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Audit Committee</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have established an audit committee of the board of directors. Dr.&#160;Huh, Mr.&#160;Ahmed, and Ms.&#160;Undikai serve as members of our audit committee, and Ms.&#160;Undikai chairs the audit committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least three members of the audit committee, all of whom must be independent. Each of Messrs.&#160;Dr.&#160;Huh, Mr.&#160;Ahmed, and Ms.&#160;Undikai meet the independent director standard under Nasdaq listing standards and under Rule&#160;10-A-3(b)(1)&#160;of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Each member of the audit committee is financially literate and our board of directors has determined that that Ms.&#160;Undikai qualifies as an &#8220;audit committee financial expert&#8221; as defined in applicable SEC rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have adopted an audit committee charter, which details the principal functions of the audit committee, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm engaged by us;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">pre-approving all audit and permitted non-audit services to be provided by the independent registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">setting clear hiring policies for employees or former employees of the independent registered public accounting firm, including but not limited to, as required by applicable laws and regulations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">setting clear policies for audit partner rotation in compliance with applicable laws and regulations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (i)&#160;the independent registered public accounting firm&#8217;s internal quality-control procedures, (ii)&#160;any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five&#160;years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues and (iii)&#160;all relationships between the independent registered public accounting firm and us to assess the independent registered public accounting firm&#8217;s independence;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving any related party transaction required to be disclosed pursuant to Item&#160;404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules&#160;promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Compensation Committee</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have established a compensation committee of the board of directors. Dr.&#160;Huh, Mr.&#160;Ahmed, and Ms.&#160;Undikai serve as members of our compensation committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least two members of the compensation committee, all of whom must be independent. Each of Dr.&#160;Huh, Mr.&#160;Ahmed, and Ms.&#160;Undikai are independent and Dr.&#160;Huh chairs the compensation committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer&#8217;s compensation, if any is paid by us, evaluating our Chief Executive Officer&#8217;s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">154</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving on an annual basis the compensation, if any is paid by us, of all of our other officers;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing on an annual basis our executive compensation policies and plans;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">implementing and administering our incentive compensation equity-based remuneration plans;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">assisting management in complying with our proxy statement and annual report disclosure requirements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if required, producing a report on executive compensation to be included in our annual proxy statement; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the foregoing, as indicated above, other than the payment to ARC Group of $10,000 per&#160;month for office space, utilities and secretarial and administrative support and reimbursement of expenses, no compensation of any kind, including finders, consulting or other similar fees, will be paid to any of our existing stockholders, officers, directors or any of their respective affiliates, prior to, or for any services they render in order to effectuate the consummation of an initial business combination. Accordingly, it is likely that prior to the consummation of an initial business combination, the compensation committee will only be responsible for the review and recommendation of any compensation arrangements to be entered into in connection with such initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Director Nominations</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We do not have a standing nominating committee though we intend to form a corporate governance and nominating committee as and when required to do so by law or Nasdaq rules. In accordance with Rule&#160;5605 of the Nasdaq rules, a majority of the independent directors may recommend a director nominee for selection by the board of directors. The board of directors believes that the independent directors can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee. Our independent directors will participate in the consideration and recommendation of director nominees. In accordance with Rule&#160;5605 of the Nasdaq rules, all such directors are independent. As there is no standing nominating committee, we do not have a nominating committee charter in place.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The board of directors will also consider director candidates recommended for nomination by our stockholders during such times as they are seeking proposed nominees to stand for election at the next annual meeting of stockholders (or, if applicable, a special meeting of stockholders). Our stockholders that wish to nominate a director for election to our board of directors should follow the procedures set forth in our bylaws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Code of Ethics</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have adopted a Code of Ethics applicable to our directors, officers and employees. We have filed a copy of our Code of Ethics and our audit and compensation committee charters with the SEC and copies are available on our website. You are able to review these documents by accessing our public filings at the SEC&#8217;s web site at www.sec.gov. In addition, a copy of the Code of Ethics will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form&#160;8-K.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">155</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:156.75pt;"><a id="_d18936df_ac00_46ee_9620_39a7ad1d53bf"></a><a id="INFORMATIONABOUTONEMEDNETCORPORATION_997"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">INFORMATION ABOUT ONEMEDNET CORPORATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Unless the context otherwise requires, all references in this section to &#8220;OneMedNet,&#8221; &#8220;OMN,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refer to OneMedNet Corporation and its subsidiaries prior to the consummation of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Company Overview</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">OneMedNet is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup><span style="font-family:'Times New Roman','Times','serif';"> or </span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">iRWD</b><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup><span style="font-family:'Times New Roman','Times','serif';">. OneMedNet&#8217;s innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record. OneMedNet&#8217;s innovative technology proved the commercial and regulatory viability of imaging Real-World Data, an emerging market, and provides regulatory-grade image-centric </span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">iRWD</b><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup><span style="font-family:'Times New Roman','Times','serif';"> that exactly matches OMN&#8217;s Life Science partners Case Selection Protocols and paves the way for Real World Evidence.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet was founded in 2006 to solve a deficiency in how clinical images were shared between healthcare providers. This resulted in OMN&#8217;s initial product <b style="font-weight:bold;">BEAM</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> image exchange that enabled the successful sharing of images for more than a decade with OMN&#8217;s largest customer being the Country of Ireland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet continued to innovate by responding to the demand for and utilization of Real-World Data and Real-World Evidence, specifically data that focused on clinical images with its associated contextual clinical record. We were able to leverage internal technological competencies along with OneMedNet&#8217;s formidable healthcare provider installed base from its first product with <b style="font-weight:bold;">BEAM</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> to become the first RWD solution for Life Science companies with its launch of <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> in 2019.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet provides innovative solutions that unlock the significant value contained within clinical image archives. With a growing federated network of 95+ healthcare facilities, OneMedNet has the immediate ability to quickly search and extensively curate multi-layer data from a Federated group of healthcare facilities. The term &#8220;healthcare facilities&#8221; refers specifically to the hospitals, integrated delivery networks (&#8220;IDNs&#8221;) and imaging centers that provide imaging to OneMedNet, which represent the core source of our data. At present, OneMedNet works with more than 95 facilities who provide regulatory grade imaging to us. OneMedNet has access to these more than 95 facilities because these 95+ contracted facilities have more than 200 locations among them including offices and clinics, which in total generates regulatory grade imaging from more than 200 customers. Among these customers, all are data providers and some are data purchasers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet is ahead of the curve when it comes to providing fast and secure access to curated medical images. Initially, it was all about solving the diverse access needs of patient care providers. This focus systematically evolved to addressing the rapidly growing needs of image analysis and researchers, clinicians, regulators, scientists and more.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="dkdcu-20230331xs4a014.jpg" alt="Graphic" style="display:inline-block;height:156.74pt;width:306.04pt;"/></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Real-world data is any data that is collected in the context of the routine delivery of care, in contrast to data collected within a clinical trial where study design controls variability in ways that are not representative of real-world care and outcomes.</p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">156</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">A key component driving its mission is that OneMedNet believes we have a unique opportunity to affect a material positive impact on the lives of tens of millions of people while improving our customers&#8217; business productivity. First and foremost, OneMedNet<span style="direction:rtl;">&#8217;</span>s <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offering plays a significant role in enabling Life Science companies to bring safer and more effective patient care to market sooner. Using our highly curated de-identified clinical data in our <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offering in Life Science product development, validation, and regulatory approval processes, they contribute to patient care advancements in more meaningful ways. Moreover, Life Sciences improve their product development and validation processes, which benefits all parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Significant documentation exists that shows that Real-World Data can provide expanded insights across broader and more representative patient populations.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup> For this reason, the Food and Drug Administration (<span style="direction:rtl;">&#8220;</span>FDA&#8221;) has instituted Real-World Data guidelines for regulatory approvals. Utilization of highly reliable and quality Real-World Data that strictly adheres to all of the very specific data stratification requirements can supplement or supplant clinical trials.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet covers the complete value chain in imaging Real-World Data; it begins with our 10+&#160;year federated network of providers and is supported by a multi-faceted data curation process managed by an expert in-house clinical team. Additionally, we work hand-in-hand with our Life Science partners regarding the Case Selection Protocol and when required producing Case Report Forms for regulatory clearance. We are focused on delivering value by supporting Life Science Advancements with OneMedNet<span style="direction:rtl;">&#8217;</span>s <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM </sup>which holds the key to unlocking boundless patient care advances. We unleash the power of research-grade image-centric <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> that is highly curated to painstakingly meet every cohort requirement and stand up to all of the rigors of prospective clinical trials.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Today, life science companies, including pharmaceutical companies, artificial intelligence (AI) developers, medical device businesses, and clinical research organizations share the same widespread challenge in obtaining insight-rich, high-quality patient data that explicitly matches their precise cohort specifications. A substantial portion of patient diagnosis involves clinical imaging and approximately 90% of healthcare data, by size, is associated with imaging. Historically, much of imaging value has been derived from its initial review and further gains from the image archives have been very limited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We help providers to <span style="direction:rtl;">&#8220;</span>Unlock the Value in Imaging Archives&#8221;.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM </sup>By utilizing OneMedNet<span style="direction:rtl;">&#8217;</span>s <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM </sup>offering, providers can greatly improve their research efforts with streamlined data access. Health care providers such as hospitals, clinics, and imaging centers can also accelerate life science patient care innovations by sharing de-identified data in a well-defined and de-identified and secure manner. In return for doing so, income is generated and applied to critical and possibly unfunded provider projects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Industry Background</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A 2016 analysis published in the Journal of Health Economics and authored by the Tufts Center for the Study of Drug Development placed the cost of bringing a drug to market, including post-approval research and development, at a staggering $2.87 billion.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5</sup> Meanwhile, a 2018 study from the Tufts Center noted that the timeline for new drug development ranged from 12.8&#160;years for the average drug to 17.2&#160;years for ultra-orphan drugs that only affect several hundred patients.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">6</sup> This places the onus on life science organizations to find ways to deliver treatments to patients faster&#160;&#8212; especially those who cannot wait 17&#160;years for a potentially life-saving treatment. Knowing how a medicinal product is actually used by patients can help stakeholders across the&#160;healthcare&#160;ecosystem make important and potentially life-saving real-time decisions.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup><span style="display:inline-block;width:14.75pt;"></span><i style="font-style:italic;">See</i> https://www.fda.gov/media/120060/download.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5</sup><span style="display:inline-block;width:14.75pt;"></span>https://www.outsourcing-pharma.com/Article/2016/03/14/Tufts-examines-2.87bn-drug-development-cost</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">6</sup><span style="display:inline-block;width:14.75pt;"></span>https://www.hcplive.com/view/new-data-reinforces-difficulty-orphan-drug-development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">157</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Real-World Data is observational data typically gathered when an approved medical product is on the market and used by &#8220;real&#8221; patients in real life, as opposed to clinical trials or real world images for real patients. The FDA cites several potential sources of Real-World Data, including electronic health records (&#8220;EHRs&#8221;), claims, disease and product registries, there are multiple types of data including structured and unstructured data, clinical and billing data, transactional and claims data, patient-generated data, and data gathered from additional sources that can shed light on a patient&#8217;s health status and more. As reliance on healthcare data grows exponentially, OneMedNet has observed that the reliance on information has increased coming from multiple additional sources including EHRs, claims, registries, clinical trials, patient and provider surveys, wearable devices and more. These additional sources include the internet of things (&#8220;IoT&#8221;), social media forums and blogs. Real-World Data has the potential to break down inefficiencies and fill gaps in information silos among stakeholders throughout the healthcare ecosystem of providers, payers, manufacturers, government entities and patients. This information sharing, in turn, enables all parties to derive new insights, support value-based care and deliver better health outcomes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">Commercializing a drug requires its developer to harness various sources of Real-World Data to identify patient populations and refine sales and marketing strategies for those populations among many other undertakings. Historically, this practice involved purchasing large amounts of data from data aggregators or data platforms, if not directly from the source itself, sometimes without much knowledge about the quality of the data. Preparing this data for analysis is both expensive and time-consuming thus many organizations would outsource the process to consultants or third-party vendors; moreover, the process of preparing this data for analysis by untrained consultants can yield a static analysis that is difficult to modify or rerun in response to follow-up questions or potential discrepancies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Definitions of Real-World Data and Real-World Evidence</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Real-World Data has become a powerful tool in the life sciences industry. After decades of relying on clinical data as the gold standard for decision making, industry leaders now recognize how data collected in the real world adds valuable context and insight to their efforts. From identifying unmet medical needs and defining the patient journey, to supporting regulatory submissions, proving value to payers, and shaping market strategies, Real-World Data adds value at every stage of the drug development lifecycle. Real-World Data also sets the foundation for Real World Evidence, and while the terms are often used interchangeably, they are distinct and they are changing healthcare. Here<span style="direction:rtl;">&#8217;</span>s how it happens:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">1.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">First, Real-World Data are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources. Real-World Data is aggregated and transformed such as through OneMedNet&#8217;s robust analytics. Real-World Data are the data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources. There are many different types, sources and uses of Real-World Data, for example:</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Clinical Data</i><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">&#160;&#8212; </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">For example, clinical data from EHRs and case report forms (&#8220;eCRF&#8221;) including biopsies and other pathology tests, diagnostic imaging, social determinants of health, cancer organoids, that provide patient demographics, family history, comorbidities, procedure and treatment history, and outcomes.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Patient Generated Data&#160;&#8212;</i><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"> </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">For example, patient-generated data from patient-reported outcome surveys, which data provide insights directly from the patient, and they help researchers understand what happens outside of clinic visits, procedures, and hospital stays.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Cost and Utilization Data (Qualitative Studies)</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;&#8212; For example, cost and utilization data from claims and public datasets, which data provides information regarding healthcare services utilization, population coverage, and prescribing patterns.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Public Health Data</i><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">&#160;&#8211; </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">For example, public health data from various government data sources. These add critical information to enable stakeholders to best serve the needs of the populations they serve.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The availability of medical imaging in Real-World Data such as that provided by OneMedNet is facilitated by the development of digital image analysis to increase the accuracy of diagnostics&#160;and conduct passive screening on large databases of medical images using artificial-intelligence (<span style="direction:rtl;">&#8220;</span>AI&#8221;) algorithms such as those applied by OneMedNet. Algorithms can also help identify additional diagnostic tests of value from medical images with pathology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Real-World Evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of Real-World Data, as defined by the Food and Drug Administration. Real-World Evidence can be generated by different study designs or analyses, including but not limited to, randomized trials, including large simple trials, pragmatic trials, and </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">158</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">observational studies (prospective and/or retrospective). The difference in Real World Evidence and Real World Data focuses on the end use case. Real World Data can take the form of claims, electronic health records, labs, data etc. Often this insight is used to better understand a patient&#8217;s journey or a natural history of a disorder (how does a disease progress if left untreated.)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Real World Evidence in contrast builds upon many of these data sets and prepares them for submission, as part of regulatory review such as to the Food and Drug Administration or the European Medicines Agency, for example, in support of a customer&#8217;s clinical trial application. When data and in particular imaging data is submitted to the FDA the agency requires the following:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Guard against biased &#8212; evidence must align with the patient population being study &#8211; expectations focus on the similar patient demographics, comorbidities, disease severity, etc.; </p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Traceability &#8212; confirm the chain of custody, the source of the data is known and can be validated if required; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Go forward basis &#8212; regulatory agencies seek evidence that aligns with the trials timeframe and when possible collect evidence that mirrors the clinical trials timeline.</p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">One area where Real World Evidence has been relief on heavily relates to oncology approvals. Food and Drug Administration&#8217;s Oncology Center of Excellence actually presented an analysis of this at American Society of Clinical Oncology in 2021, looking at oncology applications containing Real-World Data and Real-World Evidence. That analysis looked at 94 applications that were submitted from 2011-2020, and showed that inclusion of Real-World Data to support regulatory decision-making has increased dramatically over that period. In 2020 alone, there were 28 submissions for oncology products that contained Real-World Data. Outside of the oncology context, probably the most notable recent example of an approval relying on Real World Evidence is the July 2021 approval of a new indication for Astellas&#8217; drug Prograf (or tacrolimus) for the prevention of organ rejection in lung transplant patients. The approval there was based on a non-interventional study providing Real-World Evidence of effectiveness.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">7</sup><span style="font-family:'Times New Roman','Times','serif';"> FDA&#8217;s press release announcing the approval noted that the approval was &#8220;significant because it reflects how a well-designed, non-interventional study relying on fit-for-purpose real-world data, when compared to a suitable control, can be considered adequate and well-controlled under FDA regulations.&#8221;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">An additional recent approval of note was the December 2021 approval of the supplemental BLA for Orencia to prevent graft versus host disease.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">8</sup> The application included data from a randomized clinical trial, with additional evidence of effectiveness provided by a registry-based clinical study that was conducted using real-world data from the Center for International Blood and Marrow Transplant Research.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">9</sup> And that registry study analyzed outcomes of 54 patients treated with Orencia for the prevention of graft versus host disease, in combination with standard immunosuppressive drugs, versus 162 patients treated with the standard immunosuppressive drugs alone, and showed efficacy in that indication.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">AI is employed in Real-World Data to enhance data anomaly detection, standardization, and quality checking at the pre-processing stage. AI is expected to offer pharma and biotech companies the ability to increase meaningful Real World Evidence output, decrease time to insights, and make the most of the available vast data sources. A Real World Evidence technology platform that delivers smart data processing, analysis, and outcomes offers an unparalleled opportunity to capitalize on these computing advancements. When used as part of an overall comprehensive Real World Evidence strategy, AI innovations can enhance drug development, improve patient treatment and access, and drive valuable new business opportunities.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">7</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><i style="font-style:italic;">See</i> https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-new-use-transplant-drug-based-real-world-evidence</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">8</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><i style="font-style:italic;">See</i> https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-prevent-graft-versus-host-disease</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">9</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><i style="font-style:italic;">See</i> https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-orencia-abatacept-prophylaxis-acute-graft-versus-host-disease</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">159</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In post-marketing studies, adverse events reporting is an area where AI is used, creating greater automation and efficiency in historical data sets. Techniques like natural language processing (&#8220;NLP&#8221;) enable AI to scan tens of thousands of records and quickly find adverse event details. AI integrated analytics and automation provide access to crucial insights from historical clinical trial Real-World Data and Real World Evidence, expanding end-to-end clinical trial capabilities:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data ingestion&#160;&#8212; publicly/historical available Real-World Data</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Text extraction&#160;&#8212; NLP used to extract key entities from clinical trial documents</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data transformation&#160;&amp; standardization&#160;&#8212; data standardization using pre-built models</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">AI model deployment&#160;&#8212; predicting trial design impacts on costs, feasibility, cycle times, and quality risk</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">AI is driving ground-breaking leaps in protein structure identification, and advances in regulations are providing healthcare research organizations with access to real-world data to accelerate clinical trial processes. We believe that </span><span style="font-family:'Times New Roman','Times','serif';">AI-enabled technologies have unparalleled potential to offer innovative trial design and collection, organizing, and analyzing the increasing amount of data generated by clinical trials. AI has many applications in clinical trials, both short and long-term. AI technologies make possible innovations crucial for transforming clinical trials, such as seamlessly combining Phases I and II, developing novel patient-centered endpoints, and collecting and analyzing Real-World Data. OneMedNet believes that AI tools also have wider benefits for hospitals and health systems. Professor Alexander Wong, University of Waterloo Canada Research Chair in AI and Medical Imaging, points out that AI benefits include the potential to ease the burden on radiology departments in terms of assessing scans and predicting upcoming demand for general hospital and intensive care beds, and demand for equipment such as respirators and ventilators, medicines, masks, and ventilator mouthpieces, as well as aiding workforce planning.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">10</sup><span style="font-family:'Times New Roman','Times','serif';"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Across a diverse set of imaging modalities, digital images typically include metadata and/or annotations that may include protected health information (<i style="font-style:italic;">e.g.,</i> patient name, date of birth). Although diagnostic images generally do not warrant the same level of privacy concerns as genomic data, researchers must also remove facial characteristics or other features that could identify a patient.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Digital image analysis can be used to support research and development by analyzing large volumes of tissue specimens or other medical images to run molecular screens that model biomarkers and treatment responses by transplanting a portion of a patient<span style="direction:rtl;">&#8217;</span>s tumor into humanized mice&#160;or 3D tissue cultures derived from stem cells that resemble miniature organs.&#160;These models allow researchers to conduct controlled laboratory experiments that can inform treatment approaches and link predicted treatment response to actual clinical outcomes by linking this data to EHR, claims, and other sources of Real-World Data. Similarly, preclinical studies can be informed by safety assessments conducted in animal models or studies of animal molecular biomarkers or anatomic abnormalities to minimize the burden on human study participants.&#160;Findings can also inform clinical trial optimization by stratifying participants according to predicted response and determining appropriate eligibility criteria.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">2.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Second, Real-World Evidence is the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of Real-World Data. Real World Evidence provides clinically-rich insights into what actually happens in everyday practice and why. The FD&amp;C Act defines Real-World Evidence as &#8220;<i style="font-style:italic;">data regarding the usage, or the potential benefits or risks, of a drug derived from sources other than traditional clinical trials.</i>&#8221;<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">11</sup> In developing its Real-World Evidence program, FDA believes it is helpful to distinguish between the sources of Real-World Data and the evidence derived from that data.</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">10</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">See</i> https://www.eurekalert.org/news-releases/936861</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">11</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">See</i> 21 U.S.C. 355(g)(b).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">160</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Evaluating Real-World Evidence in the context of regulatory decision-making depends not only on the evaluation of the methodologies used to generate the evidence but also on the reliability and relevance of the underlying Real-World Data; these constructs may raise different types of considerations. Real-World Evidence refers to evidence about the risks and benefits of a product derived from analysis of the Real-World Data. For example, the FDA has used Real-World Data and Real-World Evidence, derived from its Sentinel system for monitoring the safety of regulated products, in place of post-marketing studies. It has carried this out for nine potential safety issues involving five products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Real-World Evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of Real-World Data.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">12</sup> Real World Evidence can be generated by different study designs or analysis, including but not limited to, randomized trials, including large simple trials, pragmatic trials, and observational studies (prospective and/or retrospective).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">Unlike traditional clinical trials, where necessary data elements can be curated and collection mandated, the creation of Real World Evidence requires assessing, validating and aggregating various, often disparate, sources of data available through routine clinical practice. Real-world evidence is used by different stakeholders in many different ways.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">It gives life sciences companies insight into how their drugs are being used.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">It helps providers improve the delivery of care.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">It enables regulatory authorities to monitor post-market safety and adverse events.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">It helps payers assess outcomes from treatments.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">12</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">See</i> https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">161</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:168.68pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">From Real-World Data to Real World Evidence</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="dkdcu-20230331xs4a020.jpg" alt="Graphic" style="display:inline-block;height:168.68pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:467.99pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The creation of Real World Evidence requires a combination of high-powered analytics, a validated approach and a robust knowledge of available Real-World Data sources (<i style="font-style:italic;">e.g.,</i> what data is captured within existing quality registries, what data can be captured through electronic health records and case report forms or claims, which patient organizations capture data on relevant patient cohorts). This process includes several steps, which are summarized here:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">1.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Defining a study protocol answering relevant clinical questions.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">2.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Defining which data elements can be collected from which Real-World Data sources.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">3.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Establishing data capture arrangements and protocols with existing Real-World Data sources.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">4.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Blending disparate data sources through probabilistic record matching algorithms.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Validating and supplementing blended data through editable eCRFs.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">6.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Defining and calculating clinically relevant outcomes and measures.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">7.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Appropriately assessing and controlling for variability in data quality, availability and confounding patient factors affecting measured outcomes.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">8.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Real World Evidence can provide a holistic view of patients that in many cases cannot be studied through traditional clinical trials.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Real World Evidence has been proven to fill a gap between research (what we learn) and everyday practice (what we do) in healthcare, and it creates a difference between what is expected to happen and what really happens. Driving measurable improvements in healthcare requires us all to be rooted in the reality of what actually happens before, during, and after clinical procedures, interventions, and office visits. Real World Evidence fill those gaps and documents the truth by establishing definitively what really happens when doctors treat a wide range of patients that do not look like the homogeneous patient groups in a clinical trial. Because of this, Real World Evidence serves many uses and provides many benefits across the healthcare ecosystem.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As more countries battle to contain healthcare costs, and as the population ages and the number of patients with chronic diseases increases, the need to remove inefficiencies and upgrade the delivery of coordinated care that improves outcomes is more pressing. At the same time, life sciences companies are facing tumultuous times. Industry globalization, the end of the blockbuster era, and an increasingly complex regulatory environment all add to the difficulty of bringing products to market. And across the board, companies are moving toward a&#160;patient-centric and outcome-focused model. In this environment, Real World Evidence can be transformative for the industry when Real-World Data is combined with the right technology framework and the regulatory intelligence to make sense of it. As data is consumed across life sciences in different ways and by different stakeholders, it can provide valuable insights and &#8220;evidence&#8221; across the product life cycle.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">162</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:229.55pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Third, stakeholders across the healthcare ecosystem use this new knowledge to support decision-making and improve safety and effectiveness, and ultimately, patient outcomes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Uses of Real World Evidence in Life Sciences, Among Regulators, Clinicians, Researchers and Healthcare Systems</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">According to repeated studies by Deloitte,<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">13</sup> the importance of Real World Evidence continues to rise as it promises to accelerate regulatory decision-making and support the approval of new indications for drugs already on the market. Life Sciences, pharmaceutical and medical device companies are significant consumers of Real World Evidence because it can provide value across the entire product lifecycle from pre-trial design to clinical studies and trials to post-market surveillance. Medical product developers are using Real World Evidence to support clinical trial designs (<i style="font-style:italic;">e.g.,</i> large simple trials, pragmatic clinical trials) and observational studies to generate innovative, new treatment approaches.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contrast between Randomized Clinical Trial (RCT), Observational Studies and RWD</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="dkdcu-20230331xs4a021.jpg" alt="Graphic" style="display:inline-block;height:229.49pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:461.67pt;"/></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">13</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">See</i> https://www2.deloitte.com/content/dam/insights/us/articles/4354_Real-World-Evidence/DI_Real-World-Evidence.pdf</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">163</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Real World Evidence can be used to make clinical trials more effective and efficient, for example in patient recruitment or label extension, Real World Evidence gathered from other studies or from currently marketed products in a similar category, for example, can have a positive effect on the product portfolio by exposing positive side effects as new potential indications. The most famous example is Viagra, which was initially studied as a drug to lower blood pressure, but an unexpected side effect led to the drug ultimately being approved for erectile dysfunction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The benefits of Real World Evidence derived from Real-World Data are increasingly being recognized by regulatory authorities. The FDA released a framework for using Real World Evidence to support&#160;the process of drug regulation and submission. This is a major step toward recognizing that clinical trials, while still relevant, are not the only way to assess the efficacy and safety of a product. Indeed, the FDA is soon expected to conduct its first full post-market safety approval using only Real World Evidence.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Real World Evidence is now accepted as a reliable source of information for regulatory decision making in certain circumstances. A primary rationale for the FDA to use Real World Evidence E is to help support the approval of a new or extended use for a drug approved under the FD&amp;C Act and to help support or satisfy post-approval study requirements always with the condition that the data quality is up to the standard required. In a recent statement, the FDA even noted how new tools for capturing data in the post-market period, including more sophisticated use of Real-World Data and Real-World Evidence are providing new approaches to address important questions about the safety and benefits of new drugs in real world settings and that these approaches have the potential to do to so more rapidly and with greater efficiency than traditional methods.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">14</sup></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The AI-enabled patient enrichment and recruitment process can improve suitable cohorts and increase clinical trial effectiveness, data management, analysis, and interpretation of multiple Real-World Data sources, including EHRs and medical imaging data. This presents a unique opportunity for NLP to perform the sophisticated analysis necessary to combine genomic data with electronic medical records (&#8220;EMRs&#8221;) and other patient data, present in various locations, owners, and formats&#160;&#8212; from handwritten paper copies to digital medical images&#160;&#8212; to surface biomarkers that lead to endpoints that can be more efficiently measured, and thereby identify and characterize appropriate patient subpopulations. AI-enabled systems can help to improve patient cohort composition and aid with patient recruitment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AI technologies can help biopharma companies identify target locations, qualified investigators, and priority candidates and collect and collate evidence to satisfy regulators that the trial process complies with good clinical practice (&#8220;GMP&#8221;) requirements. One of the most important elements of a clinical trial is a selection of high-functioning investigator sites. Site qualities such as resource availability, administrative procedures, and experienced clinicians with in-depth knowledge and understanding of the disease can shape study timelines and data quality, accuracy, completeness, and consistency.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AI integrated clinical trial programs can help monitor and manage patients by automating real-world data capture, sharing data across systems, and digitalizing standard clinical assessments. AI technologies and wearable technologies can help enable continuous patient monitoring and generate real-time insights into the safety and effectiveness of treatment while predicting the possible risk of dropouts, thereby enhancing patient engagement and retention. To comply with trial adherence criteria, patients must keep detailed records of their medication intake and other data points related to their bodily functions, response to medication, and daily protocols. This can be an overwhelming and tedious task, leading to 40% of patients becoming non-adherent after 150&#160;days into a clinical trial. Wearable devices/sensors and video monitoring are used to collect patient data automatically and continuously, thereby relieving the patient of this task. In combination with wearable technology, AI techniques offer new approaches to developing real-time, power-efficient, mobile, and personalized patient monitoring systems.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">14</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">See</i> https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">164</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Among regulators, clinicians, academic researchers and healthcare systems, the reliance on curated Real World Evidence has grown significantly because of the value it can provide, which is unique relative to each parties</span><span style="direction:rtl;font-family:'Times New Roman','Times','serif';">&#8217; </span><span style="font-family:'Times New Roman','Times','serif';">objectives and mandates. It also helps that the FDA has also sharpened its focus on Real-World Data and Real World Evidence. For example, late last&#160;year, the FDA published proposed guidance related to&#160;data standards for product submissions with Real-World Data and also weighed in on&#160;the use of Real-World Data and Real World Evidence to support&#160;regulatory decision-making for drugs and biological products&#160;with specific&#160;advice for data from electronic health records and medical claims.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">15</sup><span style="font-family:'Times New Roman','Times','serif';"> In addition, the FDA uses Real-World Data and Real World Evidence to monitor post-market safety and adverse events and to make regulatory decisions. The health care community is using these data to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">A OneMedNet Case Study</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The demand for high-quality imaging of Real-World Data and Real World Evidence is growing rapidly among imaging core lab services, AI developers, pharmaceutical companies, and medical device organizations. As the importance of RWE continues to rise, the answers for biopharma companies seem to lie in enterprise-wide technology solutions, new operating models to support end-to-end evidence management, and external partnerships such as those formed with OneMedNet. However, few RWD partners can meet this increasing need due to adjoining complexities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In one instance, a Life Science company came to OneMedNet in need of more than 1,000 mammography images for a cancer research and detection. Obtaining the actual number of mammography images was less of a challenge, rather it was all of the surrounding data requirements as part of the case selection protocol, which made it very difficult for this company to achieve their goal. The case had to represent the natural occurring diverse population with respect to race, ethnicity, age, etc. The requirements specified a mix of technology vendors; metadata for all biopsy, cytology or histology of the specimen (within 12&#160;months of the specimen) had to be provided. Moreover, once all of the data was sourced, it needed to be provided in a specific format to match their utilization needs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A case such as the foregoing was truly one where we excel. OneMedNet is unique in its capacity to handle all of a Life Science company<span style="direction:rtl;">&#8217;</span>s or health care provider<span style="direction:rtl;">&#8217;</span>s needs fully, efficient and promptly. Our data curation process involves both cutting-edge proprietary technology and clinical expert intervention, which process includes in part:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Converting unstructured data into structured data;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Reconciling longitudinal (chronological data) and disparate patient data and information; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Harmonizing site dependent and&#160;year-to-year data formatting inconsistencies.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The result is a highly-accurate cohort population that requires no sifting by the life science company, as we have handled that as part of our expert intervention. The raw data we receive remains native to our data providers during our de-identification, search, and curation process&#160;&#8212; which they prefer, and importantly, it affords us with ongoing access to the highest fidelity data. Those details often include ethnicity, age, image system vendor, time spans, and precise clinical attributes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Real World Evidence plays an important role for research across the product lifecycle for both pharmaceutical and device companies. It can inform pre-trial study design by helping researchers identify potential patients and create proper inclusion criteria for clinical trials. Racial and ethnic diversity among clinical trial participants is important to support science-driven strategies aimed at understanding the needs of those affected by the disease or condition being investigated.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">15</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><i style="font-style:italic;">See</i> https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-real-world-data-and-real-world-evidence-support-regulatory-decision-making-drug</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">165</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For Life Science companies, much of medical innovation is driven by traditional clinical trials and studies, where new pharmaceuticals and devices are studied and tracked before they can be sold and widely distributed. Real-World Data and Real World Evidence can highlight failure points and inadequacies in clinical trials or if a drug demonstrates unique efficacy or a safety improvement. All sorts of things may be part of the calculus about why a program is promising for patients, but real-world data is in every one of the steps. Although clinical trials are essential to determine the safety and efficacy of new technologies, when compared Real World Evidence, clinical trials do have some limitations such as they can have strict inclusion criteria that makes it challenging for providers to accurately extrapolate the results of a clinical trial to a broader population; and clinical trial participation is often limited by who the study administrators are able to recruit, and various demographics are often not able to participate. This again challenges the generalizability of clinical trial results across patient populations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Real World Evidence can help overcome the limitations of clinical trials by providing information about a broader cross-section of society. Overcoming these impediments can help clinicians, researchers, and industry partners better understand their products and how they work.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Requirements</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;&#8212; Real-World Data and Real World Evidence can expand an indication profile for a product thus assisting Life Science companies. Since companies can use the same predictive-modeling approach for many aspects of the treatment journey, models can be scaled up to scan for drivers across decision points and across the entire patient population for a particular indication. This approach helps generate detailed evidence on the potential drivers of decisions for various treatments, not just a company&#8217;s own therapies. For instance, while it may not be feasible to perform a full clinical trial for a product that is commonly used for off-label indications, by collecting Real-World Data from disease or product registries, companies may be able to study safety and outcomes data for their product or device, which can then be used to supplement a submission to the FDA or European Medicines Agency (EMA). In addition, the FDA has indicated that for certain products, a promise of Real World Evidence analysis in the post-market period can be used as part of a regulatory approval. For example, it might not be feasible to run a clinical trial on a product that is to be implanted for a long period of time. In a case like this, post-market Real World Evidence can help provide that missing long-term data.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Regulators and Post-Market Approvals</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;&#8212; Regulatory bodies like the U.S. FDA and the EMA are increasingly using real-world evidence, and in some cases requiring it, to satisfy post-market approvals. The U.S. FDA has provided a framework that provides insight and instruction on how to utilize RWE to support a new drug or device regulatory filing.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">16</sup><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> The FDA specifically notes a few use cases where Real-World Data and Real World Evidence can be utilized:</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Expanded label indications for a product or device.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Post-market surveillance studies.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Post-approval device surveillance as a condition of approval.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Control groups for certain clinical studies.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Supplementary data to help understand clinical trial data.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Objective performance criteria and performance goals.</span></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">16</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">See</i> https://www.fda.gov/media/120060/download</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">166</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:246.52pt;"><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Clinicians and Researchers</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;&#8212; Through advanced analytics, Real-World Data and Real World Evidence can provide individualized decision support tools that can facilitate shared decision-making between a patient and physician. For example, Real World Evidence is used to determine, based on individual characteristics, how a patient might respond to different types of surgery. Moreover, through comparing outcomes for different treatment options, it might become evident that particular drugs or dosages are better optimized for different individuals, and treatment guidelines can be refined and optimized accordingly. With large real-world datasets, researchers can perform observational, retrospective, and prospective studies that help academia advance its understanding of current therapies and technologies.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Healthcare Systems Quality Measurement, Benchmarking, and Improvement</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;&#8211; Real-World Data and Real World Evidence can track outcome and quality measures across organizations. For administrators, RWE can provide information about how their entire health system is performing relative to others, and how their individual physicians are benchmarking relative to peers. This information can help inform coverage discussions with payers, and refine quality-based reimbursement strategies that reward solid outcomes.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="dkdcu-20230331xs4a026.jpg" alt="Graphic" style="display:inline-block;height:246.52pt;width:468pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Market Opportunity</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A recent report by Deloitte, <span style="direction:rtl;">&#8220;</span>Measuring the Return from Pharmaceutical Innovation 2020,&#8221; revealed that there is a pressing need to optimize processes and fundamentally change the drug development paradigm through the use of digital and transformative approaches.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">17</sup> The COVID-19 pandemic spurred on need for greater innovation in fact, according to Deloitte<span style="direction:rtl;">&#8217;</span>s report, as of 2020, 70% of the biopharma interviewees noted a lack of research-grade data as hindering their efforts to incorporate Real World Evidence in their research and development (<span style="direction:rtl;">&#8220;</span>R&amp;D&#8221;). Moreover, 80% of the biopharma interviewees reported that they are presently entering, or seeking to enter, strategic partnerships to access new sources of Real-World Data because obtaining this data would accelerate their time to market substantially.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">17</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><i style="font-style:italic;">See</i> https://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/measuring-return-from-pharmaceutical-innovation.html</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">167</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:305.23pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Excerpts from </span><b style="font-weight:bold;">Deloitte, </b><b style="direction:rtl;font-weight:bold;">&#8220;</b><b style="font-weight:bold;">Measuring the Return from Pharmaceutical Innovation 2020&#8221; Article</b><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Longer cycle times remain a challenge for biopharma R&amp;D</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">This year&#8217;s analysis suggests the trend towards longer cycle times has continued. Despite the small uptick in 2020, we have seen an overall decline in IRR, which highlights a need to optimize existing processes and fundamentally change the development paradigm. This &#8216;need for speed&#8217; is perhaps the most vital factor for improving productivity, recognizing that many of the underlying costs are hard to control. From protocol design to study execution, companies are attempting to integrate AI and other digital technologies into their existing development processes. While the use of transformative approaches to drug development such as master protocols, adaptive trial design, enhanced segmentation of patients and diseases, and use of real-world evidence (RWE) are beginning to gain momentum; upscaling their use will be essential if companies are to reduce cycle times.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="dkdcu-20230331xs4a028.jpg" alt="Graphic" style="display:inline-block;height:305.23pt;width:467.24pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In particular, according to the Deloitte report, the Real-World Data sought must meet the biopharma companies<span style="direction:rtl;">&#8217; </span>respective clinical attributes sought; it must represent large populations diversity, such as geographical dispersion and ethnicity variance. We can uniquely meet the stringent cohort demands using advance technologies, searching across a federated network that is de-identified, indexed, and immediately searchable. In-house clinical experts bring multiple bring multi-step step data inspection protocols to ensure that all facets of the cohort specification are met. Our meticulous and multi-step data curation process behind OneMedNet <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> is unmatched in the industry. This process enables our life science customers to receive, and employ, data that stands up to all of the rigors of prospective clinical trials. Moreover, we can even assist our life science customers with the related regulatory requirements such as Case Report Forms.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">Id.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">168</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Biopharma and medical device companies require insight-rich, high-quality patient data to fuel their development of novel therapeutics and devices. OneMedNet addresses and delivers on multiple aspects of these requirements, playing at the nexus of three market opportunities:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Clinical Trials</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Scientific studies of the safety and efficacy of a new medical drug or other treatment conducted on human volunteers.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Leverage Real-World Evidence to evaluate the effects of these therapies on health related biomedical or behavioral outcomes</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Real World Evidence</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Clinical evidence about the usage and potential benefits/risks of products derived from Real-World Data analysis</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Real-World Data</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">RWD harmonizes siloed data by ingesting large quantities of structured and unstructured data and creating a comprehensive, longitudinal view or &#8220;sole source of truth</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Our Technological Advantages</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet has the knowledge, tools, and experience to access and harmonize complete patient profiles across fragmented data silos. We use robust real-world datasets to&#160;offer customized consulting services to generate fit-for-purpose data and insights for their stakeholders instead of providing terabytes of data. We curate information to the most stringent multi-level stratified requirements while providing unmatched data accuracy and ensuring the security and privacy of protected health information. Moreover, we deliver this curated data quickly and efficiently to address the rapidly growing needs of life science researchers and to speed life science product development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Numerous factors have accelerated the adoption of Real World Evidence, including an industry-wide shift from volume- to value-based payment models, personalized medicine, and the need to adapt clinical trials during the pandemic. These factors have influenced regulatory bodies globally and fuel interest in using Real World Evidence to &#8220;understand and demonstrate the value of pharmaceutical and medical device innovations.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The bipartisan 21st Century Cures Act, signed by President Obama in late 2016, charged the FDA with evaluating the expanded use of Real World Evidence including its potential to support the approval of new indications for previously approved drugs. The 21st Century Cures Act (<span style="direction:rtl;">&#8220;</span>Cures Act&#8221;),<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">19</sup> signed into law on December&#160;13, 2016, was designed to accelerate medical product development and bring new innovations and advances faster and more efficiently to the patients who need them. Among other provisions, the Cures Act added section 505F to the Federal Food, Drug, and Cosmetic Act, as amended (<span style="direction:rtl;">&#8220;</span>FD&amp;C Act&#8221;). Pursuant to section 505F, the Food and Drug Administration (<span style="direction:rtl;">&#8220;</span>FDA&#8221;) created a framework to evaluate the potential use of Real World Evidence to support the approval of a new indication for a drug already approved under section 505(c)&#160;of the FD&amp;C Act or to help support or satisfy drug post-approval study requirements. In addition to drug and biological products approved under section 505(c), this framework is also intended for application to biological products licensed under the Public Health Service Act. The FD&amp;C Act established a Real World Evidence program within the FDA to support several objectives:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Generating hypotheses for testing in randomized controlled trials</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Identifying drug development tools, including biomarker identification</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">19</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">See</i> https://www.congress.gov/bill/114th-congress/house-bill/34/</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">169</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Assessing trial feasibility by examining the impact of planned inclusion/exclusion criteria in the relevant population, both within a geographical area or at a particular trial site</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Informing prior probability distributions in Bayesian statistical models</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Identifying prognostic indicators or patient baseline characteristics for enrichment or stratification</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Assembling geographically distributed research cohorts as in drug development for rare diseases or targeted therapeutics</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">According to the FDA, generating hypotheses trials are crucial to understanding newly-approved products in real-world settings, providing clinical evidence on long-term safety and drug efficacy.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">20</sup> Real World Evidence trials in 2021 reached the highest number to date.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">21</sup> We believe that ultimately, Real-World Data leading to Real World Evidence could revolutionize every clinical research stage, from trial design to outcomes measurement. High-quality information could be used to determine which treatments should be approved, reimbursed, and prescribed. Real World Evidence could also drive new standards for new sources of high-validity and quality evidence to be adopted by regulators, payers, and providers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Market Size</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The global Real World Evidence solutions market size was valued at $37.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2021 to 2028 according to Grand View Research.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">22</sup> The drug development and approvals segment accounted for the highest revenue share of around 28.9% in 2020. Real-world evidence solutions services allow pharmaceutical companies and healthcare providers as well as payers for efficient management of operations and accelerate the process of drug development and its approval, which fuels market growth. Support from regulatory bodies for using Real World Evidence solutions and an increase in research and development spending are anticipated to boost the market growth.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With the growing need for evidence generated from Real-World Data, the increasing importance of epidemiological data in decision making, and a shift from volume to value-based care, there has been an increased focus on patient registries, a rise in the adoption of EMR in hospitals, and exponential growth in mobile health data and social media which have resulted in the generation of huge amounts of medical data. In 2021, the real-world datasets segment is estimated to account for the larger share of 51.2% of the global real-world evidence solutions market. The market size of this segment is projected to reach $1,792.0 million by 2028 from $1,038.3 million in 2021, at a CAGR of 8.1% during the forecast period according to Meticulous Research&#174; Analysis.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">23</sup></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Based on end user, the global Real World Evidence solutions market is segmented into pharmaceutical, biotechnology, and medical device companies; healthcare payers; healthcare providers; and other end-users (academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies). In 2021, the pharmaceutical, biotechnology, and medical device companies segment is estimated to account for the largest share of 36.5% of the global real-world evidence solutions market. The market size of this segment is projected to reach $2,025.7 million by 2028 from $739.7 million in 2021, at a CAGR of 15.5% during the forecast period according to Meticulous Research&#174; Analysis. The large share of this segment is primarily attributed to the increasing importance of Real World Evidence studies in drug development and approvals and the growing need to avoid costly drug recalls and assess drug performance in real-world settings.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">20</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><i style="font-style:italic;">See</i> https://www.fda.gov/media/120060/download</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">21</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><i style="font-style:italic;">See</i> https://sdlcpartners.com/insights/real-world-evidence-trends/#:~:text=RWE % 20and %2 0 the % 20FDA&amp;text=RWE %20trials %20in %202021 %20reached,regulatory %20decision %2Dmaking %20in %20MedTech.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">22</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><i style="font-style:italic;">See</i> https://www.grandviewresearch.com/industry-analysis/real-world-evidence-solutions-market-report</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">23</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Meticulous Research&#174; Analysis, which derived its analysis after a detailed assessment of various quantitative and qualitative factors, such as the historical revenue growth trends of leading players, major market growth drivers, restraints, and challenges, along with their impacts over the forecast period and relevant macroeconomic and microeconomic indicators.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">170</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:184.54pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Global Real-World Evidence Solutions Market Size, By End User, 2021&#8211;2028 (USD Million)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="dkdcu-20230331xs4a032.jpg" alt="Graphic" style="display:inline-block;height:184.44pt;left:0%;padding-bottom:0.1pt;position:relative;top:0pt;width:432pt;"/></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Because of the demand for Real World Evidence, healthcare providers are now able to monetize one of their largest assets, their data, which has the potential to be converted into improved insights, services, and financial advantages. For healthcare, this means the chance to revolutionize healthcare delivery into a more personalized approach. This also means that healthcare companies and patients alike sit on an ever-growing mountain of valuable resources and the trend of healthcare data monetization is likely to continue to grow.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">24</sup></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The impacts of various competitive strategic developments, such as new product launches and approvals, partnerships, collaborations, expansions, and acquisitions, have also been considered in the growth forecast provided in this study. The Real World Evidence solutions market is mainly segmented on the basis of component (datasets and consulting services), application (market access and reimbursement/coverage decisions, drug development and approvals, post market surveillance, medical device development and approvals, and other applications), end user (pharmaceutical, biotechnology, and medical device companies, healthcare payers, healthcare providers, and other end users), and geography.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">According to the International Federation of Pharmaceutical Manufacturers and Associations, the cost of developing a new drug was more than $2,600 million in in 2020 compared to $802 million in 2003, which increase reflects various technical, regulatory, and economic challenges pharmaceutical research and development pipelines face. Even in times of economic turmoil, the research-based pharmaceutical industry has consistently invested more in R&amp;D as compared to other industries. The annual spending by the pharmaceutical industry is almost 5.5 times greater than that of the aerospace&#160;&amp;defense industry and around 1.8 times more than that of the software and computer services industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The global R&amp;D spending in 2021 surged by 7.0% ($212 billion) compared to 2020. As a&#160;percentage of total prescription sales, average R&amp;D spending moderately increased to 22.0%% in 2020. The report also indicates that overall, R&amp;D spending is expected to grow by 4.2% each&#160;year, reaching roughly $254 billion by 2026. However, developing a drug is very expensive, results in decreased productivity of the pharmaceutical industry, and makes overhauling of the R&amp;D model more important than ever.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">24</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Businesswire (2021). Global Data Monetization report. <i style="font-style:italic;">See</i> https://www.businesswire.com/news/home/ 20210617005487/en/Global-Data-Monetization-Market-2021-to-2026&#8201;&#8212;&#8201;Growth-Trends-COVID-19-Impact-and-Forecasts&#8201;&#8212;&#8201;ResearchAndMarkets.com</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">171</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:203.04pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Pharmaceutical R&amp;D Spending, 2012&#8211;2026 (USD Billion)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="dkdcu-20230331xs4a034.jpg" alt="Graphic" style="display:inline-block;height:203.04pt;width:468pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The pharmaceutical, biotech, and medical device industries are facing a list of unprecedented challenges led by the global economic crisis, coronavirus pandemic, and concerns about escalating healthcare costs. A series of well-publicized recalls, and regulatory settlements have left policymakers and consumers questioning the safety of medical products and their trust in manufacturers. The pressures are more significant in the oncological department, where high-cost agents with similar effects compete in the market. With rising challenges, healthcare payers are increasingly focused on evidence of clinical value for making market access and reimbursement/coverage decisions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Historically, payers infrequently used Real World Evidence, or information on how treatments work in the real world, to guide their medication coverage and reimbursement decisions. The enhancements in data management and data integration provide improvements to both the speed and quality of drug discovery and clinical trial processes. Real World Evidence helps and provides a means for demonstrating value, ranging from confirming randomized trial benefits in real-world populations to a fuller characterization of resource impacts. In 2021, the market access and reimbursement as well as coverage decisions segment accounted for a share of 52.2% of the real-world evidence solutions market. The market size of this segment is projected to reach $2,485.9 million by 2028 from $1,060.1 million in 2021, at a CAGR of 12.9% during the forecast period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Moreover, OneMedNet believes that the innovative technology advancements of AI, machine learning, and natural language processing offer pharmaceutical, biotechnology, and medical device companies the power to generate enhanced Real World Evidence output, decrease time to insights, and make the most out of the vast real-world data sources available. Companies operating in the real-world evidence oncology solutions market have also adopted various strategies to align themselves with the changing dynamics of the real-world solutions space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The growing adoption of AI to process large data sets to generate Real World Evidence offer pharmaceutical and biotechnology companies the tool to increase meaningful Real World Evidence output, decrease time to insights, minimize product failure, and make the most of the vast data sources available.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">25</sup> An AI integrated Real World Evidence technology platform delivers smart data processing, analysis, and outcomes that offer unparalleled computing advancements that can further enhance drug development, improve patient treatment and access, and drive valuable new business opportunities</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">25</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">See</i> https://www.iconplc.com/insights/blog/2019/07/05/five-applications-of-artificial-intelligence-to-enhance-rwe-generation/</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">172</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:201.26pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Based on geography, the Real-World Evidence solutions market is segmented into five regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East&#160;&amp; Africa. In 2021, North America is estimated to account for the largest share of 48.9% of the real-world evidence solutions market. This region&#8217;s market size is projected to reach $2,283.7 million by 2028 from $992.2 million in 2021, at a CAGR of 12.6% during that period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Global Real-World Evidence Solutions Market, By Component, 2021 vs. 2028 (USD Million)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="dkdcu-20230331xs4a036.jpg" alt="Graphic" style="display:inline-block;height:201.26pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:467.99pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With the growing need for evidence generated from Real-World Data, the increasing importance of epidemiological data in decision making, and a shift from volume to value-based care, there has been an increased focus on patient registries, a rise in the adoption of EMR in hospitals, and exponential growth in mobile health data and social media which have resulted in the generation of huge amounts of medical data. In 2021, the real-world datasets segment accounted for the larger share of 51.2% of the global Real-World Evidence solutions market according to Meticulous Research&#174; Analysis&#8217; <i style="font-style:italic;">Global Forecast to 2028 Report</i>. The market size of this segment is projected to reach $1,792.0 million by 2028 from $1,038.3 million in 2021, at a CAGR of 8.1% during that period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Why OneMedNet is Positioned to Win</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Industry Experts on Management</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">OneMedNet has assembled a team focused on leaders in software engineering, systems engineering, health care innovation, medicine, business and finance. OneMedNet</span><span style="direction:rtl;font-family:'Times New Roman','Times','serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s current leadership and their summary biographies are set forth herein as are the biographies of the Executives and the Board of the Combined Entity expected after the Closing of the Business Combination, including for example, President Aaron Green, is a healthcare IT business transformation leader with more than 20 years of leadership experience in healthcare management, sales, strategic planning, M&amp;A, product development, customer support and services operations. Chief Executive Officer and Director, Paul J. Casey, was the former President and Chief Executive Officer of Hawaiian Airlines, Inc. (NASDAQ:HA). Under Mr. Casey&#8217;s marketing and sales-oriented leadership. Hawaiian Airlines increased annual revenues by nearly 60 percent through operational growth and innovative marketing, improved its cash reserves from $37.2 million in 1996 to $102.9 million in 2001, increased its workforce by 800 to 3,200 employees, among other success. R. Scott Holbrook brings 50 years of experience to OneMedNet in the healthcare technology space as both a vendor and with healthcare provider organizations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our Culture</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet<span style="direction:rtl;">&#8217;</span>s values guide our work and culture and support our ability to deliver our mission. They set the tone for the way we operate, they define who we are and how we do things, and they guide us when we face difficult situations. We believe that our corporate culture fosters innovation, creativity and teamwork. OneMedNet&#8217;s values are:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Operate with integrity</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#160;We do the right thing. Our success depends on being trustworthy. Our task is to build and earn trust with everything that we do;</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">173</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Focus</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#160;We are solving one of the most challenging problems of our generation &#8212; and we&#8217;ll get there by fostering a culture of depth, focus, and rigorous engineering;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Be collaborative</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#160;We solve hard technical problems through discussion and collaboration. We assume the best intent in people and trust we are all working towards the common goal;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Be reasonable</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#160;We expect each other to use good judgment and always have the best interest of the company and our partners in mind;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Set outrageous goals</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#160;We set ambitious goals and move with urgency to deliver our best work; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Win together</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#160;We are building a technology and a company that will serve people and communities around the world. Our team&#8217;s diverse perspective and experience makes us stronger, and better reflects the world in which we live.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We intend to continue to develop and implement the right processes and tools to manage our changing enterprise and maintain our culture, our ability to compete successfully and achieve our business objectives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Competition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Though massive amounts of medical images and associated reports are generated daily, researchers have historically found it difficult to efficiently tap into imaging because of limited access and/or complexities surrounding marrying it with other clinical data. OneMedNet has its proprietary solution in its<b style="font-weight:bold;"> iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offering thus its medical imaging&#8217;s contribution to drug development is being recognized. While OneMedNet competitors may state they offer imaging real world data, they are challenged to provide datasets on-demand that meet regulatory standards foundational to influencing regulatory decision making. Moreover, OneMedNet believes that, among its competitors in the medical-imaging real world data space, the companies with the most similar response time; data quality, quantity, diversity and breadth; and access to relevant imaging data with expert curation capability required to meet regulatory standards includes NTT DATA, Segmed, COTA Inc. and Hoppr, which are discussed here:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">NTT DATA&#8201;</span>&#8212;&#8201;NTT DATA is a $33 billion public company headquartered in Tokyo that is part of NTT Group, one of the world&#8217;s largest technology services companies, and partner to 80% of the Fortune Global 100, with more than 300,000 employees operating in 70+ countries. NTT DATA has many divisions of the company outside of the Real World Data market, specific to the Imaging Real World Data market, which competes with OneMedNet. NTT DATA is new to this space with a very small division in the United States with less than 25 employees dedicated to providing Imaging Real World Data, in some cases OneMedNet has provided imaging data to NTT DATA as they are limited to the number of companies they have contracted with that can provide imaging data. Although NTT DATA does not break out the revenue by specific divisions, we estimated the revenue in the Imaging Real World Data space to be approximately $2 million to $4 million annually.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">SEGMED&#8201;</span>&#8212;&#8201;Segmed is a privately held, venture capital-backed company in Stanford, California, founded in 2019 with an estimated 28 employees and estimated revenue of $1 million to $2 million annually. Segmed is a cloud-based platform where users can access real world imaging data for medical AI training and validation. It is estimated by OneMedNet that Segmed&#8217;s curated data is sourced from within California and two other states, which means that Segmed has limitations in data quality, diversity, and breadth of data required by organizations providing clinical research data and that Segmed has insufficient access to relevant non-imaging data along with expert curation capability to meet regulatory standards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">COTA INC.&#8201;</span>&#8212;&#8201;COTA Inc. is a private New York based company founded in 2011 by doctors, engineers, and data scientists that has raised more than $100 million in venture capital with oncology expertise in the real world data space. COTA has the largest inventory in hematologic oncology diseases whose regulatory-grade data has been successfully used in FDA and EMA filings. COTA&#8217;s standard-level curation includes the most medically relevant data elements and its curated data augments clinical trials with external or hybrid control and comparator arms. COTA is led by elite researchers and data scientists. COTA&#8217;s full service analytics platform can help life sciences and oncology practices make sense of fragmented and often incomplete healthcare data. Users can easily access clinically relevant metrics and reporting needed to understand treatments and outcomes within their patient population. OneMedNet considers COTA a significant competitor in particular with respect to the area of hematologic oncology diseases real world data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">HOPPR</span>&#8201;&#8212;&#8201;Hoppr is a privately-held San Francisco-based SaaS start-up founded in 2019 estimated to have approximately 10 employees, which generates an estimated revenue of approximately $1 million annually. Hoppr provides a developed solution that </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">174</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:183.05pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">appears to be customized to each organization that requires a high level of support to acquire data. Hoppr appears to have limitations in breadth, diversity and data quality which limits the number of clinical research organizations to which it can market and has limited availability of non-imaging data due to the custom development requirements of the solution. Additionally, the limitation of employee resources and data sources, Hoppr&#8217;s ability to deliver data timely is a challenge for the company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet curation experience question: OneMedNet has 3 full-time and 10 part-time contractors with years of experience in the curation of imaging and clinical data, this provides us the opportunity to deliver data quality, diversity and breadth of data to research organizations in a timely manner.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Today, especially in the United States, client trials are overwhelmingly conducted in three states: California, New York and Massachusetts and are over indexed on white/Caucasian patients. We believe there is a significant need to increase the diversity of patients participating in clinical trials both in terms of geographic representation and ethnicity. OneMedNet&#8217;s relationship with its global life science partners allows it to cull the imaging data necessary to address this critical need.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="dkdcu-20230331xs4a037.jpg" alt="Graphic" style="display:inline-block;height:182.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:467.69pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Intellectual Property</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our success and competitive advantage depend in part upon our ability to develop and protect our core technology and intellectual property. We own a portfolio of intellectual property, including patents and registered trademarks, along with confidential technical information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have filed patent and trademark applications in order to further secure these rights and strengthen our ability to defend against third parties who may infringe on our rights. We also rely on trade secrets, design and&#160;manufacturing&#160;know-how,&#160;continuing&#160;technological innovations, and licensing and exclusivity opportunities to maintain and improve our competitive position. Additionally, we protect our proprietary rights through agreements with our commercial partners, supply-chain vendors, employees, and consultants, as well as close monitoring of the developments and products in the industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December&#160;31, 2022, we own 11 patents and one pending applications, including U.S. and foreign. In addition, we have six registered U.S. trademarks and three pending trademark applications. Our patents and patent applications cover a broad range of technology relevant to our <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> and <b style="font-weight:bold;">BEAM</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offerings. The following table summarizes the patents:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:13.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:11.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:16.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:52.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:13.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">Patent Number</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Jurisdiction</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:16.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Anticipated</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Expiration&#160;Date</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:52.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Brief&#160;Description</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">8065166</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">02/21/2030</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods, computer systems, and computer-readable storage for electronically transferring medical files from a source medical facility to a destination medical facility</span></p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">175</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:13.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:11.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:16.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:52.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:13.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">Patent Number</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Jurisdiction</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:16.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Anticipated</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Expiration&#160;Date</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:52.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Brief&#160;Description</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">8090596</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">09/12/2028</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods, computer systems, and computer-readable storage for electronically transferring medical files from a source computing system to a destination computing system, or from a first medical facility to a second medical facility</span></p></td></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">8099307</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">09/12/2028</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods, computer systems, and computer-readable storage for electronically transferring medical files from a source facility computing system to a destination facility computing system</span></p></td></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">8108228</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">09/12/2028</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods, computer systems, and computer-readable storage for electronically transferring medical files from at least one of a radiology information system, a hospital information system, a picture archiving and communication system, an image server, and other medical system of the medical facility to a storage facility, storage computing system, or a destination facility</span></p></td></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">8121870</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">09/12/2028</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods, computer systems, and computer-readable storage for verifying and approving a government required release form</span></p></td></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">8131569</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">09/12/2028</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods, computer systems, and computer-readable storage for electronically transferring medical files from a source computing system to a destination facility or destination computing system</span></p></td></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">8195483</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">09/12/2028</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods, computer systems, and computer-readable storage for controlling a permission-based workflow process for transferring medical files from a source facility to a destination facility</span></p></td></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">8386278</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">09/12/2028</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods, computer systems, and computer-readable storage for electronically transferring medical files from a source medical facility to a destination medical facility</span></p></td></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">9171344</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">03/11/2033</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods for accessing one or more electronic medical data sources in response to inputs received from a user via an interactive user interface in order to transfer one or more medical files from a source facility to a destination facility over a computer network</span></p></td></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">9760677</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">USA</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">04/23/2030</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Electronic methods and processes for medical informatics device component tracking for providing access to one or more electronic medical data sources in response to instructions received via an interactive user interface in order to transfer and route medical data</span></p></td></tr><tr><td style="vertical-align:top;width:13.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">2008318772</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">AUS</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="letter-spacing:0.2pt;">10/29/2028</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:52.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;">Computer-implemented methods, computer systems, and computer-readable storage for electronically transferring medical files from a source computing system to a destination computing system</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Material Customer Agreements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">To date, OneMedNet has entered into numerous material agreements with customers around the world. We have two main types of agreements with our customers &#8212; our Data Exchange Master Reseller Agreement and our Data License Agreement which includes </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">176</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Real World Data Clinical Trial Agreements.  OneMedNet&#8217;s Data Exchange Master Reseller Agreement and our Data License Agreement are described generally, as follows.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Data Exchange Master Reseller Agreement is our data license agreement that provides our customers with a non-exclusive, non-transferable limited license to use and market our BEAMTM offerings for the secure transmission of medical studies and information, including the related documentation. Under the terms of this agreement, we do not provide our customers with any rights to the data or to OneMedNet IP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Through our Data Exchange Master Reseller Agreements, OneMedNet owns, distributes and supports an image exchange solution. Our Data Exchange Master Reseller Agreements with Change Healthcare include a business partnership to resell the software solution to its current and prospective customers. Change Healthcare through its license grant with OneMedNet and in connection with the Change Healthcare products, are marketed and distributed as interfaced products, to current and prospective customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Change Healthcare markets to Hospitals, Health Systems and Imaging Centers worldwide, a Picture Archiving and Communications System (PACS) which is a medical imaging technology that provides, management, retrieval, storage and presentation of medical images. OneMedNet Markets an Image Exchange Solution (BEAM) to Hospitals, Healthy Systems and imaging centers worldwide that allows the ability to transfer seamlessly images from one Hospital, Imaging Center or IDN to another. Change Healthcare and OneMedNet have integrated the PACS and BEAM solution so that Change Healthcare under a Reseller license, markets and sells the integrated solution to its current and prospective customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s BEAMTM pricing in our Data Exchange Master Reseller Agreements is derived from the cumulative annual gross study volume of the participating Change Healthcare customer sites. Cumulative gross study volume is used as an indication of customer size to set the OneMedNet&#8217;s BEAMTM Annual Subscription for the term of the agreement and the System Set-up Cost.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Annual Subscription (Recurring):</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">Fixed annual SW license for BEAM Solution for the term of the agreement inclusive of:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unlimited transfers and transactions via BEAM Unlimited BEAM locations and user accounts Telephone support including 24/7 emergency response Software upgrades delivered remotely</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Paid annually in advance (including year 1)</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Provides initial remote system configuration, testing, deployment, and initial remote training for administrators and end-users.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">System Set-Up Cost (one-time):</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">One (1) HL7 reports interface is installed &amp; configured for customers that perform 250,000+ gross annual studies. Additional HL7 reports interfaces, or customers performing less than 250,000 gross studies can optionally purchase HL7 reports interface(s).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Onsite support is optional &#8212; travel expenses and additional professional services on request.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">On-site training is optional at an additional fee.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Set-up Cost is 20% of the first year subscription. Note:</span></td></tr></table><div style="margin-top:8pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 10pt 36pt;">&#8226; ** Minimum service fee of $2,000 includes maximum of up to 8 hours for one time set up fee.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Transfer Pricing:</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s BEAMTM is priced under the Data Exchange Master Reseller Agreements using a unit basis. One (1) unit is defined as 10,000 cumulative annual gross studies of the participating Change Healthcare customer sites. The Annual Subscription for BEAM is calculated by multiplying the number of units by the unit subscription price.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">177</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Volume discounts for the unit subscription price are applied for every 25 unit increment (which is equal to 250,000 gross annual studies). Once the Annual Subscription is determined, the System Set-Up Cost is assessed at 20% of one year of the Annual Subscription. Examples are set forth in the following table from an actual 2021 Data Exchange Master Reseller Agreement:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:35.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Unit Tiers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;width:28.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reseller&#160;Transfer&#160;Fee</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:31.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Annual&#160;Studies&#160;Volume</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Unit</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Tier</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.96%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Min</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:11.96%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Max</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;width:13.13%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unit&#160;Fee</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;width:13.12%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Set-up&#160;Fee</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:14.96%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Min</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Volume</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:14.97%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Max</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Volume</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">714</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,571</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">250,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">696</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">6,964</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">500,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">10,179</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">510,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">661</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">13,214</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">760,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">1,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">101</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">125</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">643</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">16,071</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">1,010,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">1,250,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">150</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">625</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">18,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">1,260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="letter-spacing:0.2pt;">1,500,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="letter-spacing:0.2pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">151</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">175</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">607</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">21,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">1,510,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">1,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">8</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">176</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">589</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">23,571</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">1,760,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">201</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">225</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;">S71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">25,714</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,010,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,250,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">10</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">226</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">27,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,500,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">11</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">275</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">536</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">29,464</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,510,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">12</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">276</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">300</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">518</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">31,071</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,760,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">13</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">301</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">325</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,010,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,250,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">14</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">326</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">350</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">482</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">33,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,500,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">15</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">351</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">375</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">464</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">34,821</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,510,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">16</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">376</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">446</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">35,714</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">3,760,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">17</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">401</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">425</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">36,429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,010,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,250,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">18</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">426</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">450</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">411</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">36,964</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,500,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">19</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">451</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">475</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">393</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">37,321</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,510,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">20</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">375</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">37,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,760,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:14.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">5,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under a Data License Agreement, we perform medical queries for our customers who seek data for clinical trials, and provide them with the data resulting from such queries. Our customer retains the rights to this data and grants us a perpetual, non-exclusive non-transferable license to use the data. For clinical research, our Data License Agreement include a real world data clinical trial form of Data License Agreement, which is a business associate agreement, under which we provide our customers with retrospective imaging studies along with corresponding radiology and pathology reports typically for our clinical research organization clients that need clinical research data for a clinical trial.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Through the Data License Agreements, we provide our clients with global coverage of imaging data, most major radiology modalities and real-world data regarding many diseases and disorders. The Data License Agreement establishes a true partnership between the life science provider and OneMedNet as we cull, curate and provide data that meets the search parameters set forth therein. OneMedNet generates revenue under the Data License Agreements by executing and delivering on the search parameters. OneMedNet charges its customers per study, as shown in the following snapshot of a September 2021 Data License Agreement with Siemens.</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">The following table breaks down and summarizes revenue generated from OneMedNet&#8217;s Data Exchange Master Reseller Agreements versus its Data License Agreements:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.03%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:39.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three&#160;Months&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:57.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:19.58%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.59%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Data Exchange</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:19.58%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.59%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Data License Agreement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">79,519</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">79,298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Master Reseller Agreement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">87,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">90,422</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.24%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">166,829</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">169,720</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">With reference to the Siemens Data License Agreement, there are no material differences between the standard OneMedNet Data license Agreement and the Siemens Data License Agreement. One minor difference between the two agreements is how &#8220;Protected Health Information&#8221; is defined for non-United States patient data because of different applicable regulatory regimes. OneMedNet has employed the General Data Protection Regulations (&#8220;GDPR&#8221;) Compliance Guidelines for the European Union Countries with respect to the protection of patient data. In principal part, the GDPR guidelines are very similar to the HIPAA guidelines required in the </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">178</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:339.35pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">United States, all of the contractual language has been reviewed and approved by the OneMedNet contracted legal firm that has expertise in European Union contracting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may also enter into a Data Exchange Business Associate Agreement with our customers, which governs our use or disclosure of protected health information while performing services on behalf of our customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="dkdcu-20230331xs4a038.jpg" alt="Graphic" style="display:inline-block;height:339.35pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:431.94pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Our customers fall into two product lines (i) Real World Data, and (ii) Data Exchange. Within the Real World Data (</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">i.e.,</i><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> iRWD) product line, OneMedNet&#8217;s customers falls into three categories: (i) AI, (ii) Imaging, and (iii) Medical Device.  With the Data Exchange (i.e., Beam) product line, OneMedNet&#8217;s customers fall into one category, which is Hospitals and Health Systems. OneMedNet&#8217;s 2022 revenue and its revenue for 2023 through the three months ended March 31, 2023 derived from its two product lines and customer categories this is summarized in the following table:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:23.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:45.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three&#160;Months&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:51.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:24.46%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.96%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Real World Data (iRWD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:24.46%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">AI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:23.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,785</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">27,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Imaging</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:23.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">36,495</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:23.12%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">32,785</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.62%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">64,246</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:23.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Data Exchange (Beam)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:23.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Hospitals &amp; Health Systems</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:23.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">166,829</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">169,720</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Total Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:23.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">199,614</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">233,966</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.63%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">179</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">With reference to the &#8220;Data Exchange Master Reseller Agreement&#8221; OneMedNet has &#8220;Direct Contracted Sales Customers&#8221; contracted customers as well as one agreement under the Reseller Agreement which is with Change Healthcare.  The corresponding revenue breakdown per agreement type is set forth above.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The following discussion lists and summarizes ten of OneMedNet&#8217;s material customer agreements including noting their counterparties. OneMedNet selected these ten customer agreements because they are the top revenue producers at this particularly point in time and we have a very strong partnership with these organizations.  These customer agreements demonstrate OneMedNet&#8217;s ability to provide our customers with critical insight required to support observational clinical trials and post-marketing surveillance data. These customers demonstrate the length of our customer relationships and how we partner with customers to advance our product portfolio in pharmaceutical and device development.  These selected customer agreements also showcase OneMedNet&#8217;s ability to provide customers with critical insight required to support observational clinical trials as well as post-marketing surveillance data. OneMedNet anticipates that our business and partners will focus on these type of customers, long-term relationship clients who partner with OneMedNet to advance the product portfolio both pharmaceutical and device.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">All of the following material agreements remain in effect as of the date hereof. Further, each of these material agreements contain evergreen provisions that provide for automatic renewal unless terminated. Each project requires an updated work order that clearly identifies the current project or projects, objective of the study, the radiology modality required, the required number of patients and the specific patient cohort and so forth.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">1.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Change Healthcare Technologies, LLC</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On May&#160;22, 2015, OneMedNet entered into a Data Exchange Master Reseller Agreement with Change Healthcare Technologies, LLC for a term of three&#160;years, with the option to renew automatically for successive terms of one&#160;year, which has been so amended through 2023. Pursuant to the Agreement, we granted McKesson Technologies,&#160;Inc., which became Change HC, the right and license to use and market the <b style="font-weight:bold;">BEAM</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offerings and related documentation. Through our Data Exchange Master Reseller Agreements, OneMedNet owns, distributes and supports an image exchange solution. Our Data Exchange Master Reseller Agreements with Change Healthcare include a business partnership to resell the software solution to its current and prospective customers. Change Healthcare through its license grant with OneMedNet and in connection with the Change Healthcare products, are marketed and distributed as interfaced products, to current and prospective customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s BEAM<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> pricing in our Data Exchange Master Reseller Agreements is derived from the cumulative annual gross study volume of the participating Change Healthcare customer sites. Cumulative gross study volume is used as an indication of customer size to set the OneMedNet&#8217;s BEAM<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup> Annual Subscription for the term of the agreement and the System Set-up Cost.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">2.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Change Healthcare Ireland</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December&#160;17, 2017, OneMedNet entered into a Data Exchange Master Reseller Agreement with Change Healthcare Ireland for an unlimited term with regards to OneMedNet&#8217;s <b style="font-weight:bold;">BEAM</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offerings. OneMedNet&#8217;s Data Exchange Master Reseller Agreement with Change Healthcare Ireland automatically renews until either party terminates the agreement.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">3.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Gleamer, a French Med-Tech Company</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February&#160;5, 2020, OneMedNet entered into a Real-World Data Order Form&#160;Agreement with Gleamer pursuant to which we provided certain medical search information. Thereafter, OneMedNet entered into additional Real-World Data Order Form&#160;Agreements with Gleamer for fracture X-ray information on September&#160;8, 2020.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">4.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Hawaii Health Systems Corporation</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On July&#160;23, 2015, OneMedNet entered into a Data Exchange Agreement for Non-Bid Purchase of Goods and Services with Hawaii Health Systems Corporation whereby OneMedNet agreed to provide Hawaii Health Systems Corporation with our <b style="font-weight:bold;">BEAM</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offerings for the secure transmission of medical studies and information. The Agreement was extended on November&#160;30, 2015, July&#160;19, 2016 and May&#160;11, 2017, respectively through the execution of supplemental agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June&#160;26, 2018, OneMedNet entered into a subsequent Agreement for Non-Bid Purchase of Goods and Services with Hawaii Health Systems Corporation whereby OneMedNet agreed to provide Hawaii Health Systems Corporation with OneMedNet BEAM service for the secure transmission of medical studies and information.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">180</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Intrinsic Imaging, LLC</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February&#160;6, 2020, OneMedNet entered into a Real-World Data Clinical Trial Agreement with Intrinsic Imaging, LLC, pursuant to which OneMedNet provides Intrinsic Imaging, which is acting on behalf of a sponsor, with retrospective subject cases, including chest CT scans along with corresponding radiology and pathology reports. On June&#160;1, 2021, OneMedNet entered into a subsequent Real-World Data Clinical Trial Agreement with Intrinsic Imaging, LLC, pursuant to which OneMedNet provides Intrinsic Imaging, which is acting on behalf of a sponsor, with retrospective mammograms imaging studies along with corresponding radiology and pathology reports.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June&#160;29, 2021, OneMedNet entered into a subsequent Real-World Data Clinical Trial Agreement with Intrinsic Imaging, LLC, pursuant to which OneMedNet provides Intrinsic Imaging, which is acting on behalf of a sponsor, with retrospective prostate MR imaging studies along with corresponding radiology and pathology reports. On February&#160;2, 2022, OneMedNet entered into a subsequent Real-World Data Clinical Trial Agreement with Intrinsic Imaging, LLC, pursuant to which OneMedNet provides Intrinsic Imaging, which is acting on behalf of a sponsor, with retrospective Liver CT imaging studies along with corresponding radiology and pathology reports.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">6.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Whiterabbit AI&#160;Inc.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February&#160;5, 2020, OneMedNet entered into a Real-World Data Order Form&#160;with Whiterabbit AI&#160;Inc., which specializes in detecting late-stage diseases with artificial intelligence, and a Data License Agreement pursuant to which OneMedNet agreed to perform certain medical queries and provide Whiterabbit AI&#160;Inc. with the data resulting from the queries.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">7.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Kheiron Medical Technologies&#160;Inc.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On September&#160;26, 2020, OneMedNet entered into a Real-World Data Order Form&#160;with Kheiron Medical Technologies&#160;Inc. and a Data License Agreement pursuant to which OneMedNet agreed to perform certain medical queries and provide Kheiron Medical Technologies&#160;Inc. with the data resulting from the queries. Kheiron Medical Technologies&#160;Inc. is a United Kingdom-based company transforming cancer diagnostics through the power of deep learning.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">8.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Queens Medical Center</span></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On January&#160;10, 2011, OneMedNet entered into a Data Exchange Business Associate Addendum with The Queen</span><span style="direction:rtl;font-family:'Times New Roman','Times','serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Medical Center pursuant to which The Queen</span><span style="direction:rtl;font-family:'Times New Roman','Times','serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Medical Center disclosed certain protected health information including electronic protected health information to OneMedNet. The term of the Agreement shall continue until such time as the underlying Agreement is expired and when all of the protected health information is returned to The Queen</span><span style="direction:rtl;font-family:'Times New Roman','Times','serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Medical Center. On July&#160;1, 2017, we entered into an Amended and Restated Subscription and License Agreement with The Queen</span><span style="direction:rtl;font-family:'Times New Roman','Times','serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Medical Center pursuant to which OneMedNet shared and exchanged medical imaging studies and related data including the BEAM software. The amended Agreement shall continue for a term of three&#160;years.</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">9.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Siemens Medical Solutions USA,&#160;Inc.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 9pt 0pt;">On August&#160;8, 2021, OneMedNet entered into a Real-World Data Order Form&#160;with Siemens Medical Solutions USA,&#160;Inc. and a Data License Agreement pursuant to which we agreed to perform certain medical queries and provide Siemens Medical Solutions USA,&#160;Inc. with the data resulting from the queries. On September&#160;21, 2021, OneMedNet entered into an Order Form&#160;with Siemens Medical Solutions USA,&#160;Inc. and a Data License Agreement pursuant to which OneMedNet agreed to perform certain medical queries and provide Siemens Medical Solutions USA,&#160;Inc. with the data resulting from the queries. Through the Data License Agreements, we provide Siemens with global coverage of imaging data, most major radiology modalities and real-world data regarding many diseases and disorders. The Data License Agreement establishes a true partnership between the life science provider and OneMedNet as we cull, curate and provide data that meets the search parameters set forth therein. OneMedNet generates revenue under the Data License Agreements by executing and delivering on the search parameters.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:9pt;margin-top:0pt;">10.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:9pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">University of Kentucky</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 9pt 0pt;">On January&#160;15, 2019, OneMedNet entered into a Data Exchange Business Associate Agreement with the University of Kentucky pursuant to which OneMedNet uses or discloses protected health information while performing services on behalf of the University of Kentucky.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">181</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 9pt 0pt;"><span style="font-style:italic;font-weight:bold;">Corporate Social Responsibilities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 9pt 0pt;">Achieving our mission &#8212; delivering the benefits of <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup>&#160;&#8212; is how OneMedNet aims to make a positive impact in communities. We strive to revolutionize access fast and secure access to curated medical images with our strategic thinking, successful market entry and execution to continue to open new possibilities for providing clinical imaging evidence. While <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> has the potential to be leveraged successfully across various healthcare use-cases, the following are areas in which it will be especially valuable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 9pt 0pt;"><i style="font-style:italic;">Early stage discovery and exploratory analytics</i>.&#160;Cancer drug development, as one therapeutic area, needs to be precise with targeted interventions, and with narrower and nuanced clinical indications influenced by genomic biomarkers. Increasing use of imaging linked to genomic and clinical data assets de-risks the variability generally existing in early discovery processes by identifying high respondent cohorts meeting the trial criteria.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 9pt 0pt;"><i style="font-style:italic;">Targeted feasibility studies</i>.&#160;Targeted use of multi-modal data assets representing imaging, genomics, EMR, patient reported outcomes, social data sets, CT data and more enables the optimization of target protocols earlier in the product lifecycle. For example, a new monoclonal antibody therapy for Multiple Sclerosis can track long-term impact by quantifying imaging plaques in a 10-year image set to demonstrate effectiveness of imaging based end-points. Similarly, in nonalcoholic fatty liver disease (NASH), viewing the disease journey by longitudinal liver images leads to stratification of strong responders to new drugs based on genetic and radiographic profiles. This leads to integrated pharmacogenomic and radiology decision support for treatment qualification. These examples are a testament to how and where the need for imaging using Real World Evidence such as what OneMedNet provides is increasingly shifting investment priorities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Moreover, while claims and EMR Real-World Data are fairly accessible, imaging and pathology data are not widely available, even though these sources provide some of the highest quality data in terms of material clinical utility. Medical imaging data in particular has emerged to offer a powerful and broad-based capability to shape and inform the shift to value-based, personalized healthcare in the oncology, cardiology and neurology spaces.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">26</sup> Though massive amounts of medical images and associated reports are generated daily, researchers have historically found it difficult to efficiently tap into imaging because of limited access and/or complexities surrounding marrying it with other clinical data. OneMedNet has its proprietary solution in its<b style="font-weight:bold;"> iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offering thus its medical imaging&#8217;s contribution to drug development is being recognized.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">26</sup><span style="display:inline-block;width:11.5pt;"></span>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325854/</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">182</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Diversity and Inclusion</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are committed to diversity and inclusion. We celebrate the diversity of the people, experiences, and backgrounds that make up OneMedNet, and we encourage each other to speak up and share perspectives, respectfully and thoughtfully. We are building technology that will impact all people, so we strive to foster and embrace diversity throughout our business and our teams to bring us closer to those we serve.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Government Regulation </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Many aspects of our businesses are regulated by federal and state laws, rules and regulations. Accordingly, we maintain a robust compliance program aimed at ensuring we operate our business in compliance with all existing legal requirements material to the operation of our businesses. There are, however, occasionally uncertainties involving the application of various legal requirements, the violation of which could result in, among other things, fines or other sanctions. <i style="font-style:italic;">See</i> &#8220;Risk Factors&#8221; for additional detail. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Regulation of Patient Information.</span> Our information management services relate to the processing of information regarding patient diagnosis and treatment of disease and are, therefore, subject to substantial governmental regulation. In addition, the confidentiality of patient-specific information and the circumstances under which such patient-specific records may be released for inclusion in our databases or used in other aspects of our business is heavily regulated. Federal, state and foreign governments are contemplating or have proposed or adopted additional legislation governing the possession, use and dissemination of personal data, such as personal health information and personal financial data, as well as security breach notification rules for loss or theft of such data. Additional legislation or regulation of this type might, among other things, require us to implement additional security measures and processes or bring within the legislation or regulation deidentified health or other data, each of which may require substantial expenditures or limit our ability to offer some of our services. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In particular, personal health information is recognized as a special, sensitive category of personal information, subject to additional mandatory protections. Violations of data protection regulations are subject to administrative penalties, civil money penalties and criminal prosecution, including corporate fines and personal liability. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Data Privacy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 5pt 0pt;">Patient health information is among the most sensitive of personal information, and it is critically important that information about an individual&#8217;s healthcare is properly protected from inappropriate access, use and disclosure. Real world evidence &#8212; information that allows us to examine actual practices and outcomes &#8212; is essential to increase access to care, improve outcomes, and lower costs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">183</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. We employ a wide variety of methods to manage privacy requirements, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">governance, frameworks, models and training to promote good decision making and accountability;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a layered approach to privacy and security management to avoid a single point of failure; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ongoing evaluation of privacy and security practices to promote continuous improvement; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">use of technical, administrative, physical and organizational safeguards and controls; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">collaboration with data suppliers and trusted third parties for our syndicated market research and analytics offerings to remove identifiable information or employ effective encryption or other techniques to render information non-identified before data is delivered to us; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">work with leading researchers, policy makers, thought leaders and others in a variety of fields relevant to the application of effective privacy and security practices, including statistical, epidemiological and cryptographic sciences, legal, information security and compliance, and privacy. </span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have relied on expertise in the industry with de-identifying data. Our capabilities allow us to render data non-identified while still maintaining data utility, thus protecting privacy while still advancing innovation. Not only do we make use of de-identification techniques with respect to the data we hold, but we also share our expertise in this area with policymakers, regulators and others to help them understand de-identification methodologies and practical considerations to avoid re-identification risk. We operate in more than 100 countries around the world, many of which have data protection and privacy laws and regulations based on similar core principles (<i style="font-style:italic;">e.g.,</i> openness, accountability, security safeguards, etc.). We apply those principles globally and augment our practices to address local laws, contractual obligations and other data privacy requirements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Compliance team, led by our Chief Compliance Officer, is comprised of privacy professionals and privacy law experts who drive our strategy and develop and manage our policies and standards. The Compliance team provides subject matter expertise related to the proper management of all data types. In addition, our Compliance team liaises with our Legal, IT, Information Security and other teams so that privacy requirements are addressed in technology, contracting, offerings and other business activities. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The OneMedNet Privacy Policy (the &#8220;<b style="font-weight:bold;">Privacy Policy</b>&#8221;) is our foundational privacy policy. It explains how, when applicable, we collect, hold, use and disclose personal information, including that of our personnel, consumers, healthcare professionals, patients, medical research subjects, clinical investigators, customers, suppliers, vendors, business partners and investors. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cybersecurity</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We employ an array of data security technologies, processes, and methods across our infrastructure to protect systems and sensitive information from unauthorized access. OneMedNet maintains comprehensive identity and access management practices (<i style="font-style:italic;">e.g.,</i> roles and access privileges for each user; multi-factor authentication, privileged user accounts, single sign-on, user lifecycle management) and employs a variety of security information and event management tools. We developed, maintain and utilize a global integrated information security framework to guide our practices, based on relevant industry frameworks and laws, including, but not limited to NIST, GxP, HITRUST, the ISO 27000 family, COBIT, GDPR, and HIPAA. </p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The framework consists of policies, standards, procedures, work Instructions and documentation. Information is classified into four categories to help individuals apply the right level of controls and safeguards to information, applications and systems. Our cybersecurity program focuses on all areas of our business, including cloud-based environments, data centers, devices used by employees and contractors, facilities, networks, applications, vendors, disaster recovery / business continuity and controls and safeguards enabled through business processes and tools. We continuously monitor for threats and unauthorized access. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We draw on the knowledge and insight of external cybersecurity experts and vendors, and internally employ dedicated, certified, cybersecurity staff, such as but not limited to, CISSP, CISM, CISA, CSSP or other equivalent certifications, that leverage an array of third-party tools to secure OneMedNet information infrastructure and protect systems and information from unauthorized access. Non-</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">184</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">technical safeguards also play an important role in our cybersecurity program. We provide various training programs and tools to employees so they can avoid risky practices and help us promptly identify potential or actual issues. We also have global incident response procedures, global service tools to log incidents and issues for investigation, and an ethics line to report concerns and follow-up on matters already reported. The Compliance team, led by our Chief Compliance Officer, develops and implements our strategy, as well as monitors systems and devices for risks and threats. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Regulatory Quality Compliance (FDA 21 CFR Part 11)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet provides high-quality, de-identified, regulatory-grade imaging and clinical data; as such OneMedNet adheres to all applicable local and Federal regulatory quality requirements, including but not limited to FDA 21 CFR Part 11.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">OneMedNet maintains a rigorous and ongoing internal quality management system to enable the organization to produce the highest quality regulatory compliant clinical data for our clients and consumers.  This program includes:</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ongoing internal audits, policy reviews, and procedure testing to ensure validation, audit trails, legacy systems, and record handling and retention adhere to the latest regulatory guidelines and best practices.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Regular third-party or client initiated external audits to assess the compliance of OneMedNet to ensure operations are in accordance with, but not limited to the applicable regulations, standards, policies, and standard operation procedures</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Employees</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">We currently have four officers: Paul Casey, as Chief Executive Officer and Director; Dr.&#160;Jeffrey Yu, as Chairman of the Board and Chief Medical Officer; Aaron Green, as President; and Lisa Embree, Vice President&#160;&#8211; Finance and Chief Financial Officer; two executives, Brad Overby and Doug Arent; and one director of marketing, Del Coufal. We have 18 employees. None of our employees are represented by a labor union, and we consider our employee relations to be in good standing. To date, we have not experienced any work stoppages.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Facilities</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We currently maintain our executive offices at 6385 Old Shady Oak Road, Suite&#160;250, Eden Prairie, MN 55344 and our telephone number is (800)&#160;918-7189. We consider our current office space adequate for our current operations and needs and that, should it be needed, suitable additional or alternative space will be available to accommodate our operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Legal Proceedings</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">185</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_7a8e8cbb_4196_4071_b3d3_a5724693d5cb"></a><a id="MANAGEMENTOFONEMEDNET_497128"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">MANAGEMENT OF ONEMEDNET</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table sets forth certain information regarding OneMedNet&#8217;s executive officers and directors as of the filing of this proxy statement/prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:62.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:62.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position(s)</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Paul Casey</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 76</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:62.63%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer, Director</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Jeffrey Yu</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 55</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Founder, Chief Medical Officer, Vice President, Chairman of the Board of Directors</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lisa Embree</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 51</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Vice President &#8212; Finance, Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Paul Casey, Chief Executive Officer</b>&#160;&#8212; Paul Casey is a seasoned executive and operator, bringing more than 40&#160;years of senior management experience in both the public and private sectors across a variety of industries, including airlines, tourism, software, and medical devices and technology.&#160;Mr.&#160;Casey is widely respected for his confluence of strategic vision, finance, operations, marketing, and commercialization expertise supplementing his strong track record of building and maintaining shareholder value. Previously Mr.&#160;Casey was on the board of TZ Limited, a global leader in electronic locking devices (Australian listed company) and concurrently on the board of a Chicago based subsidiary PDT Limited, a leading industrial design firm focused on consumer military and medical devices. Throughout his career, Mr.&#160;Casey has leveraged his multi-functional expertise to drive business value creation and expansion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">He took over Hawaiian Airlines (then AMEX Global listed) right after the company emerged from bankruptcy and successfully refocused the company on revenue creation while changing the culture from top down to bottom up, in addition to replacing an aging fleet with more modern aircrafts and renegotiated six union contracts. Prior to his tenure at Hawaiian Airlines, Mr.&#160;Casey ran a tourism focused software company in Bangkok (Galaxy Systems), working with Macquarie Bank in Hong Kong to pursue M&amp;A opportunities in the tourism sector. Mr.&#160;Casey has been an angel investor in a number of startup companies and been a mentor and advisor to many founders. Additionally, Mr.&#160;Casey was an investor in a collection of boutique hotels in California and Oregon under the umbrella of Greystone Hotels.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Dr.&#160;Jeffrey Yu,&#160;Founder, Chief Medical Officer, Vice President, Chairman of the Board</b>&#160;&#8212;<b style="font-weight:bold;">&#160;</b>OneMedNet was founded in&#160;2006 by Dr.&#160;Jeffrey Yu who applies his 28&#160;years of sophisticated healthcare IT experience to the company every day. Dr.&#160;Jeffrey Yu is a board-certified Radiologist and is also fellowship-trained and board-certified in Nuclear Medicine. In 2006, he was part of a small group that recognized there was a need to develop electronic sharing technology to help imaging specialists move patient imaging studies quickly, securely, and cost-effectively. Dr.&#160;Yu<span style="direction:rtl;">&#8217;</span>s early research and development led to the BEAM solution which helped improve care and outcomes for stroke and trauma patients. In 2009, he started OneMedNet Corporation to commercialize the BEAM product. Since that time, Dr.&#160;Yu has remained an integral part of the strategic decision-making within OneMedNet. Dr.&#160;Yu received his BS at U.C.&#160;Berkeley, MD&#160;at Wake Forest University, conducted MRI research at Stanford University, and completed his Radiology residency and Nuclear Medicine fellowship at the Mallinckrodt Institute at Washington University.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Aaron Green, President</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"> &#8212; </b><span style="font-family:'Times New Roman','Times','serif';">Mr. Green is a healthcare IT business transformation leader with more than 20 years of leadership experience in healthcare management, sales, strategic planning, M&amp;A, product development, customer support and services operations. Prior to joining OneMedNet, Mr. Green served in a variety of healthcare technology roles including most recently at Optum, a United Health Group company (NYSE: UHG), a leading healthcare technology company, as Vice President Cloud Solutions. At Optum, Mr. Green was responsible for developing and attaining the P&amp;L, Bookings, Revenue and EBIDTA targets of its Cloud Solution lines. Before Optum, Mr. Green worked nearly six years with Change Health Care, most recently as Vice President Cloud Solutions. Previously, Mr. Green worked for more than 15 years with McKesson growing to Division Vice President, Sales where he led an organization of 50+ executives, salespersons and staff, across the US, Canada, and the US government territories. He holds a Bachelor of Science in Biochemistry from the University of Victoria, British Columbia, a Systems Analyst Diploma from Royal Roads University, British Columbia, and an Executive MBA from the Wharton School.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Lisa Embree, </b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vice President&#160;&#8212; Finance, Chief Financial Officer</b><span style="font-family:'Times New Roman','Times','serif';">&#160;&#8212; Ms.&#160;Embree is a Certified Professional Accountant with 18&#160;years of senior-level business experience. During this time, she has gained very strong and impactful business competencies within administrative&#160;&amp; financial management, financial accountability, and communication&#160;&amp; strategic partnerships. Previous to OneMedNet, she was the Director of Finance for Equicare Health, and an Accounting Manager with Haemonetics Corporation (NYSE: HAE). Lisa has a Bachelor of Science (BSc) from Simon Fraser University, Business Administration (BA) from British Columbia Institute of Technology, and is a member of the Certified Public Accountants of Canada.</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">186</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Non-Executive Officers</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Brad Overby</b><b style="font-weight:bold;">, </b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vice President, Operations</b>&#160;&#8212; Mr.&#160;Brad Overby has been thriving within the healthcare marketplace for over 28&#160;years. He has in-depth knowledge of the Health Information Exchange (HIE) and is well-recognized as an HIE industry expert. Prior to joining OneMedNet, he held several senior positions with Medicity Inc, including VP Sales, from its inception to its acquisition by Aetna. He championed many of Medicity<span style="direction:rtl;">&#8217;</span>s early sales successes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Earlier, Brad was Senior Vice President, Sales for Professional Healthcare Systems,&#160;Inc., where he managed sales, marketing and client services for hospital information systems nationwide, serving a number of top tier academic institutions. Brad also serves as a strategic advisor and investor to a number of early stage healthcare companies. Brad received a BA from the University of Minnesota&#160;&#8212; Twin Cities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Doug Arent</b>, <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vice President, Sales</b>&#160;&#8212; Mr.&#160;Doug Arent brings more than 20&#160;years of experience in driving multi-million dollar revenue growth within highly competitive markets. His strong business acumen, technical expertise, and leadership ability have enabled him to build, grow, and retain top-performing sales teams. Importantly, Mr.&#160;Arent has a broad base of corporate involvement which includes product development, product management, implementation and support, sales and marketing, and business development. This diverse background has helped Doug excel in forging invaluable relationships across all levels of business partners. He began his career at McKesson (formerly HBO&#160;&amp; Co.), and more recently has held leadership roles at Teradata, Datica, QPID Health, and Medicity. Doug holds a BS in Industrial Engineering from University of Massachusetts at Amherst.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Family Relationships</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There are no family relationships among any of New OneMedNet&#8217;s directors or executive officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">187</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">The following discussion and analysis of the financial condition and results of operations of OneMedNet should be read together with OneMedNet&#8217;s audited financial statements for the&#160;years ended December&#160;31, 2022 and 2021, in each case together with related notes (Notes 1-11) thereto, included elsewhere in this proxy statement/prospectus. The discussion and analysis should also be read together with the section entitled &#8220;Information about OneMedNet&#8221;. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside of OneMedNet&#8217;s control. OneMedNet Corporation&#8217;s actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause future results to differ materially from those projected in the forward-looking statements include, but are not limited to, those discussed in the sections entitled &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; included elsewhere herein.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Percentage amounts included in this prospectus have not in all cases been calculated on the basis of such rounded figures, but on the basis of such amounts prior to rounding. For this reason,&#160;percentage amounts in this prospectus may vary from those obtained by performing the same calculations using the figures in our consolidated financial statements included elsewhere in this prospectus. Certain other amounts that appear in this prospectus may not sum due to rounding.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Unless otherwise indicated or the context otherwise requires, references in this OneMedNet Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section to &#8220;OneMedNet,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to OneMedNet prior to the Business Combination and to OneMedNet Corporation and its consolidated subsidiaries after giving effect to the Business Combination.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Overview</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet Corporation (&#8220;OneMedNet&#8221; or &#8220;OMN&#8221;) is a provider of leader in clinical imaging innovation and experienced curator of regulatory-grade Imaging Real-World Data<sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> or <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup>. Our innovation solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and associated contextual patient record. Our innovative technology proved the commercial and regulatory viability of imaging Real-World Data, a promising emerging market, and provides regulatory-grade image-centric <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> that exactly matches our Life Science partners&#8217; Case Selection Protocol.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet was founded in 2006 to solve a deficiency in how clinical images were shared between healthcare providers. This resulted in our initial product <b style="font-weight:bold;">BEAM</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> image exchange that enabled the successful sharing of images for more than a decade. OneMedNet continued to innovate which responded to the demand for and utilization of Real-World Data, specifically data that focused on clinical images. We were able to leverage internal technological competencies along with a formidable healthcare provider installed database from our first product with <b style="font-weight:bold;">BEAM</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> to become the first RWD solution for Life Science companies with our launch of <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> in 2019.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet provides innovative solutions that unlock the significant value contained within clinical image archives. With a growing federated network of 90+ healthcare providers, OneMedNet has the immediate ability to quickly search and extensively curate multi-layer data from a Federated group of healthcare facilities. OneMedNet is ahead of the curve when it comes to providing fast and secure access to curated medical images. Initially, it was all about solving the diverse access needs of patient care providers. This focus systematically evolved to addressing the rapidly growing needs of image analysis and researchers, clinicians, regulators, scientists and more.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Beyond the economic opportunity, we believe we have a unique opportunity to affect a material positive impact on the lives of tens of millions of people, while also improving business productivity. First and foremost, OneMedNet&#8217;s <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offering plays a significant role in enabling Life Science companies to bring safer and more effective patient care to market sooner. Using our highly curated de-identified clinical data in our <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> offering in healthcare providers&#8217; product development, validation, and regulatory approval processes, they contribute to patient care advancements in more meaningful ways. Moreover, healthcare providers improve their product development and validation processes, which benefits all parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">188</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Significant documentation exists that shows that Real-World Data can provide expanded insights across broader and more representative patient populations.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">27</sup> For this reason, the Food and Drug Administration (&#8220;FDA&#8221;) is instituting Real-World Data usage guidelines for regulatory approvals, which can supplement or supplant clinical trials that would be premised on the utilization of highly reliable and quality Real-World Data that strictly adheres to all of the very specific data stratification requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet covers the complete value chain in imaging Real-World Data; it begins with our 10+&#160;year federated network of providers and is supported by a multi-faceted data curation process managed by an expert in-house clinical team. Additionally, we work hand-in-hand with our Life Science partners regarding the Case Selection Protocol and when required producing Case Report Forms for regulatory clearance. We are focused on delivering value in by supporting Life Science Advancements with OneMedNet&#8217;s <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM </sup>that holds the key to unlocking boundless patient care advances. We unleash the power of research-grade image-centric <b style="font-weight:bold;">iRWD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM</sup> that is highly curated to painstakingly meet every cohort requirement and stand up to all of the rigors of prospective clinical trials.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Today, life science companies, typically pharmaceutical companies, artificially intelligence (AI) developers, medical device businesses, and clinical research organizations share the same widespread challenge in obtaining insight-rich, high-quality patient data that explicitly matches their precise cohort specifications. A substantial portion of patient care diagnosis involves clinical imaging and approximately 90% of healthcare data, by size, is associated with imaging. Historically, much of imaging value has been derived from its initial review and further gains from the image archives have been very limited.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">We help providers to &#8220;Unlock the Value in Imaging Archives&#8221;.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM </sup><span style="font-family:'Times New Roman','Times','serif';">By utilizing OneMedNet&#8217;s </span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">iRWD</b><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">TM </sup><span style="font-family:'Times New Roman','Times','serif';">offering, providers can greatly improve their research efforts with streamlined data access. Health care providers can also accelerate life science patient care innovations by sharing de-identified data in a well-defined and de-identified and secure manner. In return for doing so, income is generated and applied to critical and possibly unfunded provider projects. OneMedNet believes that access to high quality data with advanced analytics and AI companions enable healthcare providers to make smarter decisions:</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Longitudinal patient and cohort data from imaging, laboratory and genomics can help to improve clinical decisions in single interventions, along patient pathways or across whole populations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Enterprise-wide, real-time, operational data is needed for better operational decisions targeting single asset and fleets, workflows and workforce or the overall enterprise performance.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consumer decision-making benefits from self-scheduling, health informatics or even predictive wellness coaches.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Our Business Model</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical images remain one of the most important tools used in delivering and improving patient care. For healthcare providers, timely access&#160;&#8212; no matter the source, directly impacts patient lives. OneMedNet first responded to this need with the <b style="font-weight:bold;">BEAM&#8482;</b> Image Exchange solution offering a unique combination of simplicity, security, and low cost. Pharmaceutical companies, Imaging AI developers, Device organizations, Clinical Research Organizations, and Core Labs are all challenged to find the volume and specificity of imaging real world data to fulfill their respective needs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s innovative technology which&#160;<i style="font-style:italic;">Unlocks the Value in Imaging Data</i>&#174; for both providers and aforementioned industry members in our <b style="font-weight:bold;">iRWD&#8482;</b> solution goes far beyond simply sourcing de-identified images. Frankly, other organizations can do that. OneMedNet has the clinical expertise to understand and anticipate the nuances and depth of the most stringent and specific imaging cohort request. &#160;By quickly tapping into our large federated healthcare provider network, we are able to adeptly move from request to fulfillment&#160;&#8212; with comprehensive regulatory-grade patient data. &#160;And if additional patient insights are required, OneMedNet is setup and ready to support progressive needs.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">27</sup><span style="display:inline-block;width:11.5pt;"></span><i style="font-style:italic;">See</i> https://www.fda.gov/media/120060/download.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">189</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Significant Events and Transactions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April&#160;27, 2022, OneMedNet entered into the Merger Agreement with Data Knights. Pursuant to the Merger Agreement, and assuming a favorable vote of Data Knights&#8217; shareholders and OneMedNet Stockholders and that all other closing conditions are satisfied or waived, Merger Sub, a newly formed subsidiary of Data Knights, will merge with and into OneMedNet, with OneMedNet surviving as a wholly owned subsidiary of Data Knights, which will be renamed OneMedNet Corporation,&#160;Inc. (the &#8220;Business Combination&#8221;). OneMedNet will be deemed the accounting predecessor and the post-combination company will be the successor SEC registrant, which means that OneMedNet&#8217;s financial statements for previous periods will be disclosed in the Company&#8217;s future periodic reports filed with the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Business Combination is anticipated to be accounted for as a reverse recapitalization. Under this method of accounting, Data Knights will be treated as the acquired company for financial statement reporting purposes. Under the terms of the Business Combination, Merger Sub will merge with and into OneMedNet, with OneMedNet surviving as a wholly owned subsidiary of OneMedNet Corporation. The Business Combination is expected to close during the second half of 2022 and remains subject to customary closing conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a consequence of the Business Combination, OneMedNet Corporation will be required to hire additional personnel and implement procedures and processes to address public company regulatory requirements and customary practices. OneMedNet Corporation expects to incur additional annual expenses as a public company for, among other things, directors&#8217; and officers&#8217; liability insurance, director fees and additional internal and external accounting and legal and administrative resources, including increased audit and legal fees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For accounting purposes, OneMedNet will be deemed to be the accounting acquirer in the transaction and, consequently, the transaction will be treated as a recapitalization of OneMedNet (i.e., a capital transaction involving the issuance of stock by Data Knights for the stock of OneMedNet). Accordingly, the consolidated assets, liabilities and results of operations of OneMedNet will become the historical financial statements of New OneMedNet, and Data Knights&#8217; assets, liabilities and results of operations will be consolidated with OneMedNet&#8217;s beginning on the acquisition date. Operations prior to the Business Combination will be presented as those of OneMedNet in future reports. The net assets of Data Knights will be recognized at historical cost (which is expected to be consistent with carrying value), with no goodwill or other intangible assets recorded.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recent Developments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet accomplished the following major milestones since the signing of the Business Combination Agreement:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">1.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Strengthened the Company&#8217;s leadership team and announced post-closing&#160;of the Business Combination Board of Directors:</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">a.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Named Robert (Bob) L. Golden to its board following the recent signing of the Merger Agreement with Data Knights. Bob Golden is a Member of California Society of Certified Public Accountants, the Managing Partner of Cohen, Bender&#160;&amp; Golden LLP and a Member of The American Institute of Certified Public Accountants.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">b.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Named Eric Casaburi to its board following the signing of the Merger Agreement with Data Knights. Eric Casaburi is currently the Chief Executive Officer and Founder of Serotonin Centers, health and anti-aging wellness centers, the leader and founder of Lifespan Capital and leads a group at Tiger 21 Orlando as Chair, and was the Founder and CEO, and is a current board member of RetroFitness.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">c.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Named R. Scott Holbrook, a 50-year healthcare technology veteran in both vendor and healthcare provider organizations to its board. Most recently, Mr. Holbrook served as a founder and principal of Mountain Summit Advisors and sits on several boards or advisory boards including KLAS Enterprises (Pleasant Grove), Azova Health (Alpine) and Cerberus Sentinel (Scottsdale, AZ). He served as a Strategic Advisor to Health Catalyst as they launched and was instrumental in setting up their marketing and sales strategies and was the Executive Vice President of Medicity, a provider of healthcare technology products to RHIOs, IDNS, large laboratories, payors, hospitals and clinics, which grew and was sold to Aetna for $500 million.</p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">190</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border:0;border-collapse:collapse;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">2.</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Strengthened the Company&#8217;s leadership team and announced, pre-closing&#160;of the Business Combination, new executive officers:</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">a.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Appointed industry accounting and financial expert, Lisa Embree as Interim Chief Financial Officer and Vice President&#160;<span style="white-space:pre-wrap;">&#8212; Finance on June 15, 2022, who was subsequently promoted to the permanent role of Chief Financial Officer and Vice President&#8201;-&#8201;Finance on November 11, 2022. Ms. Embree previously held the role of Controller with OneMedNet and nearly 20 years of executive finance roles with both public and private companies.  Ms. Embree holds a Bachelor of Science from Simon Fraser University, a Bachelor of Arts in Business Administration from British Columbia Institute of Technology and is a member of the Certified Public Accountants of Canada.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">b.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Named Joe Walsh to its executive team as Chief Commercial Officer, effective on July 18, 2022. Mr. Walsh is an accomplished industry veteran with significant business experience leading healthcare technology commercial teams in high growth mode with the demonstrated ability to deliver business critical results. Mr. Walsh is a proven sales and marketing professional with an exceptional record of exceeding sales and revenue targets including at Komodo Health, an advanced platform for healthcare intelligence, where he played a critical role in growing revenue 18x over four years resulting in a valuation of $3.3 billion. Most recently, Mr. Walsh served as Head of Sales at AllStripes, a healthcare technology company.</p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">c.</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">Named Aaron Green, a healthcare IT business transformation leader with more than 20 years of leadership experience in healthcare management, sales, strategic planning, M&amp;A, product development, customer support and services operations, as President.  Prior to joining OneMedNet, Mr. Green served in a variety of healthcare technology roles including most recently at Optum, a United Health Group company (NYSE: UHG), a leading healthcare technology company, as Vice President Cloud Solutions. At Optum, Mr. Green was responsible for developing and attaining the P&amp;L, Bookings, Revenue and EBIDTA targets of its Cloud Solution lines. Before Optum, Mr. Green worked nearly six years with Change Health Care, most recently as Vice President Cloud Solutions. Previously, Mr. Green worked for more than 15 years with McKesson growing to Division Vice President.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">3.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Related party notes payable and notes payable will be assumed</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">a.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">OneMedNet&#8217;s related party notes payable and notes payable will be assumed at the consummation of the Business Combination (approximately $6,850,000 million plus interest).</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">4.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Joint Venture opportunities:</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">a.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">On May&#160;16, 2022, OneMedNet announced a referral partnership with Flywheel to provide state-of-the-art healthcare imaging data and data management solutions. The referral agreement creates a unique partnership in the healthcare data space, offering pharmaceutical companies, Imaging AI developers, device organizations, Clinical Research Organizations, and core labs access to OneMedNet&#8217;s de-identified clinical images and associated patient data, and Flywheel&#8217;s comprehensive research data management solutions.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">New Business Lines</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">a.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="white-space:pre-wrap;">On March 14, 2023, OneMedNet announced that it has built one of the largest and most diverse dataset of breast cancer screenings, a vital tool in early detection of breast cancer. OneMedNet&#8217;s Breast Imaging Dataset collects insight from more than one million US patients with emphasis on gathering screenings from a diverse patient population.  OneMedNet believes that the breast cancer screening dataset is an invaluable tool for AI, imaging and pharma companies looking to bring novel treatments and detection programs to patients faster.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Liquidity and Capital Resources</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s ability to meet its short term and long-term cash flow requirements are dependent on the following key variables:</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">191</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1)</span></span>achieve our forecasted numbers in terms of customer agreements which drive our revenue and cash inflow in connection to which we have made the following assumptions:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Assumed that 40 &#8211; 45% of our sales forecast will be moved from single data set purchases to multi- year longitudinal sales</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ability to add pharmaceutical companies in addition to our current customer base in AI, Device and Imaging</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Achieve our move to a subscription based model from a single transaction based model </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ability to develop a platform that can provide large volumes of data to provide for a steady volume of recurring revenue</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Assumption that the FDA 21st Century Act guidance to use data to support regulatory decision making and approvals of drugs and devices will continue to drive our Customers need for Real World Data</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Ability to maintain or shorten our sales cycle which varies from customer to customer because of various factors including the discretionary nature of customers&#8217; purchasing and budget decisions, and the purchasing approval processes of potential customers.</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If our sales cycle lengthens, as we have experienced in 2022, or we invest substantial resources pursuing unsuccessful sales opportunities</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the announcement or planned introduction of applications or services by us or our competitors</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Remaining competitive in our market by continuing to innovate and provide services that are useful and needed</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our business may not grow at similar rates, or at all </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our market opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates which may not prove to be accurate</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Any failure to maintain high-quality professional services, or a market perception that we do not maintain high-quality professional services, could harm our reputation, adversely affect our ability to sell our Solution to existing and prospective customers</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The inaccuracy of any of the above assumptions or inability to achieve, will impact our results of operations and growth. This would result in the ability to meet our revenue and cash forecasted in the short and long term.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Funding to be received as upon completion of our SPAC.</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anything greater than 90% redemption will result in no funding available for use in growing and maintaining our business and cash needs for the first half of 2023</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">4)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Ability to raise capital in the public market.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">The principal purpose of the Business Combination is to increase our capitalization and financial flexibility, create a public market for our stock and thereby enable access to the public equity markets by our employees and stockholders, obtain additional capital, and strengthen our position in the data analytics market. We plan to use of proceeds received from the public market for working capital and continued development of our subscription based data platform.</p><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">5)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">We have used Convertible Note offering proceeds since 2019 to maintain and grow our business. Our management has broad discretion over the specific use of these proceeds. To date we have received $11.07M in notes plus interest. At June 30, 2023, </span></p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">192</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Times New Roman','Times','serif';">these notes may be converted into stock or repaid back in cash at the note holders discretion. If more than 30% of these noteholders choose to be paid back in cash, we may not be able to meet the cash requirements to meet this obligation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Components of OneMedNet&#8217;s Results of Operations</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Key Factors Affecting Our Results</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s performance and future success depend on several factors that present significant opportunities but also pose risks and challenges, including those discussed below and in the Proxy/Prospectus section titled &#8220;Risk Factors.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Development of Our Technology</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Since our inception, we have focused on attracting and retaining&#160;best-in-class&#160;talent to&#160;provide innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing our proven OneMedNet <b style="font-weight:bold;">iRWD&#8482;</b> solution, we securely de-identify data, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with cutting-edge proprietary technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous Real-World Data Life Science requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We continue to invest in employee recruitment and retention to advance our technology. Additionally, our team has made purposeful and foundational technological investments in hardware and software. We believe these early investments in our technology will enable us to move toward additional technical innovation more safely and quickly than would otherwise be possible. When we have deemed it to be beneficial, we have entered into strategic partnerships to expand and accelerate our technology development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe that our developmental approach provides us with meaningful technological advantages in areas such as our fusion of artificial intelligence and imaging with our proprietary curation and innovation approaches. The successful execution of these details of clinical imaging is what we believe will allow us to continue to differentiate ourselves through our proven OneMedNet <b style="font-weight:bold;">iRWD&#8482;</b> solution. While we believe we are best positioned to address advanced imaging solutions, potential competition may exist from other imaging providers using other approaches. Future success will be dependent on our ability to continue to execute innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Commercialization and Strategic Partnerships</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet set forth on a corporate journey to create safer and more intelligent care solutions for patients, providers and hospitals. The company has been solely focused on creating innovative solutions that enable healthcare providers to gain increased value from medical imaging data. Whether requesting or transferring an image, the process must be straightforward and streamlined on both ends. OneMedNet&#8217;s <b style="font-weight:bold;">BEAM&#8482; </b>Image Sharing solution has been exceeding customer expectations for more than a decade with customer renewal rates exceeding 96%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">However, as important as the initial (or secondary) read may be to patient care, the value and impact of imaging goes well beyond an individual image. It&#8217;s about the entire patient population archive utility and the potential data mining benefits for improving care. Research institutions often have difficulty gathering cohort data&#160;&#8212; even from their own internal center(s). It&#8217;s not only cumbersome but very time consuming. And community hospitals increasingly leverage data for self-analysis and patient care advancement. Using our OneMedNet <b style="font-weight:bold;">iRWD&#8482;</b>, we can de-identify, index, and curate an archive resulting in fast, yet detailed search capabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Providers can also advance healthcare on a much broader basis by sharing de-identified imaging data with external researchers. OneMedNet continually receives patient cohort requests from &#8220;Data Users&#8221; (<i style="font-style:italic;">e.g</i>., Pharma, CRO&#8217;s, Core Labs, AI, Medical Devices). If a cohort match is found at one of our networked providers, OneMedNet will present that provider with a potential monetizing agreement. If agreement is reached, only then will the de-identified data be shared externally.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Production and Operations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">OneMedNet expects to incur significant operating costs that will impact its future profitability, including research and development expenses as it continues to introduce new offerings and upgrades its existing <b style="font-weight:bold;">iRWD&#8482; </b>offering plus additional operating </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">193</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">costs and expenses as it scales its operations; interest expense from debt financing activities; and selling and distribution expenses as it builds its brand and markets its <b style="font-weight:bold;">iRWD&#8482;</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Revenues</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">For the period January 1, 2022 to March 31, 2022, the company generated revenue totaling $233,966 and for the period January 1, 2023 to March 31, 2023 the company generated revenue totaling $199,614. The decrease is attributable to an iRWD revenue delivery being delayed to May of 2023.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Cost of Revenues</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In the second half of 2022, the company hired an employee to curate and deliver data resulting in an increase to compensation costs of $31,966. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The company disaggregates Cost of Revenues as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 67pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:34.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 67pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid transparent;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Salaries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">200,379</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">168,413</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Hosting</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">84,281</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">94,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,471</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">330</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:right;text-indent:-7.2pt;margin:0pt 0pt 0pt 67pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">289,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">263,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Research and Development</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Research and development costs are expensed as incurred. Research and development costs consist of payroll, hardware and electrical engineering prototyping, cloud computing, data labeling, and third-party development services, as well as costs associated curating and testing. These costs are included within research and development within the statement of operations. We expect our research and development expenses to increase in absolute dollars as we increase our investment in scaling our proprietary technologies.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Research and development increased by $173,000 in the first quarter of 2023 with the addition of an employee in the second half of 2022. In 2023, the company started allocating hosting costs specific to research and development work, resulting in a $28,102 cost for the first three months of 2023.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The company disaggregates Research and Development as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 67pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:34.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.47%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:62.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 67pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid transparent;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.47%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Salaries and consultants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">301,361</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">156,610</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Hosting</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">28,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.47%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:right;text-indent:-7.2pt;margin:0pt 0pt 0pt 67pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">329,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">156,610</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.47%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Selling, Operations, General and Administrative</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Selling, general and administrative costs consist primarily of personnel-related expenses such as salaries, wages and benefits as well as equity compensation. Selling, general and administrative also includes professional service fees, marketing and other general corporate expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the completion of this offering, we expect to incur additional selling, general and administrative expenses as a result of operating as a public company, including expenses related to compliance with the rules&#160;and regulations of the SEC and stock exchange listing standards, additional insurance expenses, investor relations activities, and other administrative and professional services. We also expect to increase the size of our selling, general and administrative function to support the growth of our business. As a result, we expect that our selling, general and administrative expenses will increase in absolute dollars.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">194</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In the first quarter of 2023, the Company had additional expenses of $278,152 in general and administrative expense. An increase of $236,500 in warrant expense; $105,000 in recruitment fees, a bad debt reversal of $102,700 and an increase in audit fees of $82,988.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The company disaggregates General and Administrative expense as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:44.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three&#160;Months&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;border-bottom:1px solid transparent;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Salaries and consultants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">193,432</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">220,005</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Bad Debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">(102,700)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Depreciation and Amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">6,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,435</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Insurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">5,328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">4,675</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Professional fees (legal and audit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">110,705</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">189,713</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Recruitment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">105,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Rent, Telecom and Office</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">55,093</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">29,660</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Stock Compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">22,361</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">10,281</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Travel</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">10,591</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">8,347</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Warrant issuance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">236,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.34%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">642,568</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.74%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">467,116</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The company disaggregates Operations expense as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 67pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:34.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:62.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 67pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid transparent;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Salaries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">39,269</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">29,543</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Sales and marketing increased in the first quarter of 2023 by $83,000 with the addition of a Chief Commercial Officer and a sales representative compared to the same quarter in 2022.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The company disaggregates Sales and Marketing expense as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 67pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:34.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 67pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid transparent;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Salaries and consultants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">236,404</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">116,134</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Tradeshows</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">20,616</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">60,148</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">2,249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;padding-left:7.2pt;text-align:right;text-indent:-7.2pt;margin:0pt 0pt 0pt 67pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.95%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">259,270</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 3pt 0pt 0pt;">176,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Income Tax Expense (Benefit)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Provision for income taxes consists of U.S. federal and state income taxes and income taxes. Since inception, we have incurred operating losses. We have a valuation allowance for net deferred tax assets, including federal and state net operating loss carryforwards and research and development credit carryforwards. We expect to maintain this valuation allowance until it becomes more likely than not that the benefit of our federal and state deferred tax assets will be realized by way of expected future taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Critical Accounting Policies and Significant Accounting Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet&#8217;s management&#8217;s discussion and analysis of its financial condition and results of operations is based on its financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States, or GAAP. The preparation of these financial statements requires OneMedNet to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements as well as the reported expenses during the reporting periods. The accounting estimates that require the most significant, difficult, and subjective judgments have an impact on revenue recognition, the determination of share-based compensation, and financial instruments. The estimates and judgments are evaluated on an ongoing basis. Actual results may differ materially from these estimates under different assumptions or conditions.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">195</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Income Taxes.&#160;</i>OneMedNet intends to account for income taxes under ASC 740 &#8220;Income Taxes&#8221; which codified SFAS 109, &#8220;Accounting for Income Taxes&#8221; and FIN 48 &#8220;Accounting for Uncertainty in Income Taxes&#160;&#8212; an Interpretation of FASB Statement No.&#160;109,&#8221; under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the company will not realize tax assets through future operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates.&#160;</i>The preparation of financial statements in accordance with U.S. GAAP requires OneMedNet to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, assumptions used in the fair value of equity instruments, the valuation allowance against deferred tax assets, and the estimates of fair value of derivative liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Off-balance&#160;Sheet Arrangements.&#160;</i>OneMedNet has no&#160;off-balance&#160;sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Net Sales.&#160;</i>OneMedNet has not generated significant revenues to date. OneMedNet expects to continue to generate revenue primarily through its <b style="font-weight:bold;">BEAM&#8482; </b>Image Sharing solution and <b style="font-weight:bold;">iRWD&#8482; </b>offering. The Company records revenue in accordance with ASC 606. The Company determines the amount of revenue to be recognized through application of the following steps&#160;&#8212; Identification of the contract, or contracts with a customer;&#160;&#8212; Identification of the performance obligations in the contract;&#160;&#8212; Determination of the transaction price;&#160;&#8212; Allocation of the transaction price to the performance obligations in the contract; and&#160;&#8212; Recognition of revenue when or as the Company satisfies the performance obligations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Cost of revenue.&#160;</i>Cost of revenue consists of costs related to technology development, which is comprised of costs associated with delivering OneMedNet&#8217;s <b style="font-weight:bold;">BEAM&#8482; </b>Image Sharing solution and <b style="font-weight:bold;">iRWD&#8482; </b>offering. These costs consist primarily of payroll, payroll-related expense, stock-based compensation, property and equipment, and allocated overhead incurred as the Company performs the underlying services related to satisfying the performance obligations under the Real-World Data and data-exchange agreements for example. Costs related to services provided are recognized in the period incurred, unless criteria for capitalization of costs are met. Cost of revenue consist of direct labor, hosting environment and data extraction costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Research and development.&#160;</i>Research and development expenses consist primarily of personnel-related costs, including salaries, benefits and stock-based compensation, for our engineers and other employees engaged in the research and development of our products and services. In addition, research and development expenses include amortization of acquired intangible assets, allocated facilities costs, and other supporting overhead costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Marketing and sales.&#160;</i>Sales and marketing expenses consist primarily of personnel-related costs, including salaries, commissions, benefits and stock-based compensation for our employees engaged in sales, sales support, business development and media, marketing, corporate communications and customer service functions. In addition, marketing and sales-related expenses also include advertising costs, market research, trade shows, branding, marketing, public relations costs, amortization of acquired intangible assets, allocated facilities costs, and other supporting overhead costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">196</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">General and administrative.&#160;</i><span style="font-family:'Times New Roman','Times','serif';">General and administrative expenses consist primarily of personnel-related costs, including salaries, benefits and stock-based compensation, for our executive, finance, legal, information technology, human resources and other administrative employees. In addition, general and administrative expenses include fees and costs for professional services, including consulting, third-party legal and accounting services and facilities costs and other supporting overhead costs that are not allocated to other departments</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Interest Expense.&#160;</i>Interest expense consists of accreted interest expense on outstanding convertible promissory note obligations, amortization of deferred financing costs and other related financing expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Other Income (Expense).&#160;</i>Other income or (expense) reflects&#160;non-recurring&#160;and extraordinary&#160;non-operating&#160;expenses, cost associated with discontinued operations and gains or losses, including the costs and related accumulated depreciation recapture, resulting from the disposal of an asset, upon the sale or retirement of such asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Emerging Growth Company Status</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet qualifies as an &#8220;emerging growth company&#8221; under the JOBS Act. As a result, we are permitted to, and intend to, rely on exemptions from certain disclosure requirements. For so long as OneMedNet is an emerging growth company, we will not be required to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">have an auditor report on our internal controls over financial reporting pursuant to Section&#160;404(b)&#160;of the Sarbanes-Oxley Act;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">submit certain executive compensation matters to shareholder advisory votes, such as&#160;&#8220;say-on-pay,&#8221; &#8220;say-on-frequency&#8221; and pay ratio; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the CEO&#8217;s compensation to median employee compensation.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In addition, Section&#160;107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section&#160;7(a)(2)(B)&#160;of the Securities Act for complying with new or revised accounting standards. As a result, OneMedNet may adopt new or revised accounting standard by the date private companies are required to comply. OneMedNet will continue to be an emerging growth company for five fiscal&#160;years unless total annual gross revenues exceed $1.07&#160;billion, OneMedNet issues more than $1&#160;billion in debt in a three&#160;year period or it becomes a large accelerated filer, as defined in the Exchange Act Rule&#160;12b-2. Large, accelerated filers have a number of criteria to meet, with a significant criterion of having aggregate worldwide common equity held by&#160;non-affiliates of greater than $700&#160;million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">197</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_c4d71409_3f32_49ed_8bec_bcc238a1c65e"></a><a id="MARKETINDUSTRYOTHERDATAANDCERTAINKEYMETR"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">MARKET, INDUSTRY, OTHER DATA AND CERTAIN KEY METRICS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">This proxy statement/prospectus contains estimates, projections and other information concerning our industry, our business and the markets for our products, some of which are based on industry publications and studies conducted by third parties and some of which are based on OneMedNet&#8217;s management&#8217;s estimates and calculations. These industry publications and third-party studies generally state that the information they contain has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. While we and OneMedNet believe that each of these publications and third-party studies is reliable, neither we nor OneMedNet has have not independently verified the market and industry data obtained from these third-party sources.&#160;Forecasts and other forward-looking information obtained from these sources are subject to the same qualifications and uncertainties as the other forward-looking statements contained in this proxy statement/prospectus. These forecasts and forward-looking information are subject to uncertainty and risk due to a variety of factors, including those described in &#8220;Risk Factors.&#8221;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">These and other factors could cause results to differ materially from those expressed in our forecasts or estimates or those of independent third parties. While we and OneMedNet believe OneMedNet&#8217;s internal research is reliable and the definitions of OneMedNet&#8217;s market and industry are appropriate, neither such research nor these definitions have been verified by any independent source.&#160;Forecasts and other forward-looking information obtained from these sources are subject to the same qualifications and uncertainties as the other forward-looking statements contained in this proxy statement/prospectus. These forecasts and forward-looking information are subject to uncertainty and risk due to a variety of factors, including those described in &#8220;Risk&#160;Factors.&#8221; These and other factors could cause results to differ materially from those expressed in our forecasts or estimates or those of independent third parties.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">198</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_f2f84726_6081_4dd1_816c_48fe1a6f788e"></a><a id="EXECUTIVECOMPENSATIONOFONEMEDNET_997034"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXECUTIVE COMPENSATION OF ONEMEDNET</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following sets forth information about the compensation paid to or accrued by OneMedNet&#8217;s principal executive officer and its two other most highly compensated persons serving as executive officers as of the periods indicated for services rendered for such periods. These executives are referred to as OneMedNet&#8217;s &#8220;named executive officers.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Summary Compensation Table</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">Name and Principal</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">Position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:4.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:1.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;letter-spacing:-0.15pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">Salary</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:11.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">Contract</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">RSUs</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">Stock</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">Options</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">Bonus</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:10%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">All Other</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">Compensation</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">Total</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;letter-spacing:-0.15pt;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Paul Casey</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">84,545</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">60,000(1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">585,545</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">441,000(1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">585,545</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Doug Arent</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">161,200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">46,473</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">217,673</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">155,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">165,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">109,792</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">209,792</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Saurabh Mathur</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">218,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">323,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Joseph Walsh</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">137,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">225,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">362,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">David Gascoigne</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">110,445</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">132,267</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">242,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Lisa Embree</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">106,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(7)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">27,231(8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">163,481</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Debra Reinhart</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">163,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(9)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">54,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">246,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">134,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(9)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">25,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">159,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">122,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(9)</sup><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">15,050(10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">50,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">187,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:17.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">109,130(10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">109,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Represents fees under a consulting agreement with OneMedNet effective March 28, 2022 through June 1, 2022 to provide services to the Company in his position of Chief Executive Officer.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Represents Mr. Casey&#8217;s pro rata base salary for the period from June 1, 2022 through December 31, 2022 pursuant to an Executive Employment Agreement that provides for an annual base salary of $144,000.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Represents Mr. Arent&#8217;s base salary for the period from January 1, 2022 through December 31, 2022, January 1, 2021 through December 31, 2021 and January 1, 2020 through December 31, 2020, respectively.</p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(4)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Represents Mr. Mathur&#8217;s base salary for the period from January 17, 2022 through December 31, 2022. Mr. Mathur is no longer employed at OMN.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(5)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Represents Mr. Walsh&#8217;s base salary for the period from July 16, 2022 through December 31, 2022.</p></td></tr></table><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(6)</span></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:6pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Represents Mr. Gascoigne&#8217;s base salary for the period from September 12, 2022 through December 31, 2022. Mr. Gascoigne is no longer employed at OMN.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(7)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Represents Ms. Embree&#8217;s base salary for the period from April 16, 2022 through December 31, 2022.</p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">199</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(8)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Represents fees under a consulting agreement with OneMedNet effective March 28, 2022 through June 1, 2022 to provide accounting and financial services to the Company.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(9)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Represents Ms. Reinhart&#8217;s base salary for the period from January 1, 2022 through December 31, 2022, January 1, 2021 through December 31, 2021 and February 3, 2020 through December 31, 2020, respectively.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(10)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Represents fees under a consulting agreement with OneMedNet effective November 14, 2018 through February 3, 2020 to provide services to the Company as Director of Product &amp; Clinical.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Executive Employment Agreements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet currently has the following Employment Agreements in place:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Paul Casey</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Mr.&#160;Casey entered into a consulting agreement with OneMedNet on March&#160;28, 2022 to provide services to the Company in his position of Chief Executive Officer. The consulting agreement provided Mr.&#160;Casey with warrants to purchase 294,000 shares of OneMedNet Common Stock under the Company&#8217;s 2020 Equity Incentive plan, at a strike price of $1.00 per share, plus 147,000 shares of OneMedNet Common Stock will be awarded with a successful fundraising of greater than $20,000,000 in the company upon the closing of the Merger. Mr.&#160;Casey became a full-time employee of OneMedNet on June&#160;1, 2022 pursuant to an Executive Employment Agreement however the warrants and common share awards survive. </p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Executive Employment Agreement provides for an annual base salary of $144,000 with an eligibility to participate in the annual bonus plan and be entitled to participate in such health, group insurance, welfare, pension, and other employee benefit plans, programs, and arrangements as are made generally available to other employees and shall be eligible for up to 20 days of Annual Leave per calendar year. As Chief Executive Officer, Mr. Casey will report to the New OneMedNet Board of Directors and be responsible for the management, direction, and coordination of all organizational operations and related activities for the purpose of attaining the goals and objectives as set forth by the Board of Directors and to recommend, develop, implement and update strategic long-and short-range plans within the limits of his authority, as set forth by the policies and directives established by the Board of Directors.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Aaron Green</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">Mr. Green entered in an Executive Employment Agreement with OneMedNet as President effective May 23, 2023 that  provides for an annual base salary of $350,000 with an eligibility to receive an annual cash performance bonus of $175,000 upon the achievement of the performance goals set by the  Company&#8217;s CEO and Board of Directors.  Mr. Green will be responsible for (i) communicating with shareholders, government entities, and the public; (ii) leading the development of New OneMedNet&#8217;s short- and long-term strategy; (iii) creating and implementing New OneMedNet&#8217;s vision and mission; (iv) evaluating the work of other executive leaders within New OneMedNet; (v) maintaining awareness of the competitive market landscape, expansion opportunities, industry developments; (vi) ensuring that New OneMedNet maintains high social responsibility wherever it does business; (vii) assessing risks to New OneMedNet and ensuring they are monitored and minimized; and (viii) setting strategic, goals and making sure they are measurable and describable. Mr. Green agreed to devote all of his professional time and attention to the business and affairs of New OneMedNet.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">In exchange for these services, Mr. Green shall also be eligible to participate in New OneMedNet&#8217;s incentive plan, on terms and conditions as determined by the Compensation Committee and be entitled to participate in such health, group insurance, welfare, pension, and other employee benefit plans, programs, and arrangements as are made generally available to other employees.  The Employment Agreement may be terminated by New OneMedNet and by Mr. Green subject to at least 60 days&#8217; written notice of intent to terminate employment. Mr. Green will be subject to restrictions on the disclosure of confidential information relating to New OneMedNet. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Dr. Jeffrey Yu</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Dr. Yu will enter in an Executive Employment Agreement with New OneMedNet, as Chief Medical Officer effective at Closing. Dr. Yu will report directly to the Chief Executive Officer and his primary role of the will be to provide leadership and direction for New OneMedNet&#8217;s pipeline of Real-World Data development programs and will be responsible for the strategy, direction and execution of the company&#8217;s strategic development plans as a key member of the senior executive team.</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">200</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">In exchange for these services, Dr. Yu shall receive an annual base salary of $300,000 and will be eligible to participate in New OneMedNet&#8217;s incentive plan, on terms and conditions as determined by the Compensation Committee and be entitled to participate in such health, group insurance, welfare, pension, and other employee benefit plans, programs, and arrangements as are made generally available to other employees and shall be eligible for up to 15 days of Annual Leave per calendar year.  The Employment Agreement may be terminated by New OneMedNet and by Dr. Yu subject to at least 60 days&#8217; written notice of intent to terminate employment. Dr. Yu will be subject to restrictions on the disclosure of confidential information relating to New OneMedNet. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Lisa Embree</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Lisa Embree entered in an Executive Employment Agreement with New OneMedNet, as Controller and was then promoted to Chief Financial Officer. Ms. Embree reports directly to the Chief Executive Officer and her primary is to provide manage the company&#8217;s financial planning, accounting, risk management, investment supervision, controller and to plan and implement the Company&#8217;s investment strategies as a key member of the senior executive team.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In exchange for these services, Ms. Embree shall receive an annual base salary of $150,000 and will be eligible to participate in New OneMedNet&#8217;s incentive plan, on terms and conditions as determined by the Compensation Committee and be entitled to participate in such health, group insurance, welfare, pension, and other employee benefit plans, programs, and arrangements as are made generally available to other employees and shall be eligible for Annual Leave per calendar year in accordance with the Company&#8217;s policy. Ms. Embree is subject to 12 months non-competition and non-solicitation after she terminates her employment with the Company. The Employment Agreement may be terminated by New OneMedNet and by Ms. Embree subject to advance written notice of intent to terminate employment. Ms. Embree is subject to restrictions on the disclosure of confidential information relating to OneMedNet.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Doug Arent</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">Mr. Arent entered into an Executive Employment Agreement with OneMedNet effective April 15, 2020. The Executive Employment Agreement provides for an annual base salary of $155,000 with eligibility to earn commission based upon data broker sales revenue at the rate of 6.25% up to $2,000,000 in sales and 7.5% in additional sales subject to a to be determined cap, and an initial stock option grant of 100,000 shares of OneMedNet Common Stock that will vest over four years, as more fully described in the employment agreement, and will be eligible to participate in New OneMedNet&#8217;s incentive plan, on terms and conditions as determined by the Compensation Committee and be entitled to participate in such health, group insurance, welfare, pension, and other employee benefit plans, programs, and arrangements as are made generally available to other employee. Mr. Arent is entitled to annual vacation leave of three (3) weeks.  Mr. Arent is an at-will employee without severance rights and is subject to restrictions on the disclosure of confidential information relating to OneMedNet.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Quantification of Potential Payments and Benefits to the Executive Officer of OneMedNet in Connection with the Business Combination</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The information set forth in the table below is intended to comply with Item&#160;402(t)&#160;of the SEC&#8217;s Regulation S-K, which requires disclosure of information about certain compensation for executives of OneMedNet that is based on, or otherwise relates to, the transactions contemplated by the Business Combination, which is referred to as the purchase-related compensation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:normal;width:38.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:6.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:3.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:2.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:38.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:6.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension/</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Perquisites/</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Tax</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:3.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:2.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cash&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:6.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NQDC</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Benefits</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reimbursements</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Other</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:5.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:6.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:4.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.35%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Paul Casey</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 144,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:5.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:6.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.72%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:12.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:3.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:2.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aaron Green</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 250,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:6.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:3.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:2.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Jeffrey Yu</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 300,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:5.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:6.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:3.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:2.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lisa Embree</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 150,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:6.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:3.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:2.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Doug Arent</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 155,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:5.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:6.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:3.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:normal;width:2.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18.75pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">In connection with the business combination, no outstanding Company options or warrants (whether vested or unvested) were assumed, continued or replaced by the surviving company; OneMedNet terminated all outstanding Company options and warrants at the effective time of the business combination.</p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">201</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Non-Competition Agreements</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Mr. Casey is not subject to a non-competition agreement. Mr. Green and Dr. Yu are not subject to non-competition during the course of their employment. Mr. Arent and Ms. Embree are subject to non-competition and non-solicitation restrictions during their employment with OneMedNet and for a period of 12 months following termination of employment.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Benefits and Perquisites</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet provides benefits to its named executive officers on the same basis as provided to all of its employees, including health, dental and vision insurance; life insurance; accidental death and dismemberment insurance; and short-and long-term disability insurance; and a tax-qualified Section 401(k) plan. OneMedNet does not offer any executive-specific benefit or perquisite programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Severance Agreements</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Mr.&#160;Casey is eligible for severance in the event of a termination by the Company without cause or for good reason in the amount of accrued obligations plus an amount equal to four weeks of his base salary. Mr. Green is eligible for three-months severance in the event of a termination by the Company without cause before 12 months but after six months, and six months severance in the event of a termination by the Company without cause on or after 12 months. Mr.&#160;Arent is not eligible for severance and may be terminated without notice. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Equity Grants at Closing</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet has no equity awards anticipated at the Closing of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Outstanding Equity Awards</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">OneMedNet has $604,000 of outstanding equity awards  in the form of stock options arising from $150,000 in grants in 2020, $35,000 in grants in 2021, and $419,000 in grants in 2022. OneMedNet issued $487,473 of warrants in 2022.</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Securities</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Underlying</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Unexercised</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Options (#)</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Exercisable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Securities</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Underlying</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Unexercised</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Options (#)</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Unexercisable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Incentive</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Plan</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Awards:</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Number of</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Securities</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Underlying</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Unexercised</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Unearned</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Options (#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:7.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Exercise</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Price ($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Expiration</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">of Shares</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">or Units</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">of Stock</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">that</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Have Not</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Vested</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Market</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Value of</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Shares</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">or Units</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">of Stock</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">that</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Have Not</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Vested</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Incentive</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Plan</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Awards:</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Number of</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Unearned</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Shares,</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Units or</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Other</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Rights that</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Have Not</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Vested</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Incentive</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Plan: Market</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">or Payout</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Value of</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Unearned</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Shares, Units</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">or Other</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Rights that</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Have Not</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Vested ($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:10.62%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Paul Casey</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Doug Arent</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,208</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,208</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">01/01/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Doug Arent</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">01/01/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Doug Arent</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">37,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">37,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">06/15/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Joseph Walsh</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">225,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">225,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">225,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">07/16/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Lisa Embree</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">30,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">03/15/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Debra Reinhart</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">50,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">18,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">18,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">06/03/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Debra Reinhart</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">25,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">16,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">16,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">08/31/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Debra Reinhart</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">50,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">50,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">50,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">04/01/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Director Compensation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">For fiscal&#160;year 2021, OneMedNet did not provide director compensation to its directors. However, all of the directors are reimbursed for their reasonable out-of-pocket expenses related to their services as a member of the OneMedNet board of directors. In connection with the Business Combination, we intend to approve and implement a non-employee director compensation policy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">202</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_b7b3f14b_c159_4163_9b6b_0e9edba3f013"></a><a id="MANAGEMENTOFTHECOMPANYFOLLOWINGTHEBUSINE"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">MANAGEMENT OF THE COMPANY FOLLOWING THE BUSINESS COMBINATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Executive Officers and Directors After the Business Combination</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the consummation of the Business Combination, the business and affairs of Data Knights will be managed by or under the direction of the Data Knights Board. Data Knights&#8217; Proposed Certificate of Incorporation provides for a staggered, or classified, Board consisting of three classes of directors, each serving a staggered three-year term and with one class being elected at each&#160;year&#8217;s annual meeting of stockholders, as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Class&#160;I will serve for a term expiring at the first annual meeting of stockholders to be held after the consummation of the Business Combination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Class&#160;II will serve for a term expiring at the second annual meeting of stockholders to be held after the consummation of the Business Combination; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Class&#160;III will serve for a term expiring at the third annual meeting of stockholders to be held after the consummation of the Business Combination.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At each annual meeting of stockholders to be held after the initial classification, directors for that class will be elected for a three-year term at the annual meeting of stockholders in the&#160;year in which the term expires. Each director&#8217;s term is subject to the election and qualification of his or her successor, or his or her earlier death, disqualification, resignation or removal. Subject to any rights applicable to any then outstanding preferred stock, any vacancies on the Data Knights Board may be filled only by the affirmative vote of a majority of the directors then in office. Any increase or decrease in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. This classification of the Data Knights Board may have the effect of delaying or preventing changes in Data Knights&#8217; control or management. Data Knights&#8217; directors may be removed for cause by the affirmative vote of the holders of at least&#160;two-thirds&#160;of Data Knights&#8217; voting securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table sets forth the name, age and position of each of the expected directors and executive officers of Data Knights upon consummation of the Business Combination:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:45.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:45.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.36%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Paul Casey</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:45.36%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer, Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td></tr><tr><td style="vertical-align:top;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Jeffrey Yu</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:5.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">55</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chairman of the Board of Directors, Founder, Chief Medical Officer, Vice President<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup></p></td></tr><tr><td style="vertical-align:top;width:45.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aaron Green</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President</p></td></tr><tr><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lisa Embree</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer, Vice President &#8212;&#8201; Finance</p></td></tr><tr><td style="vertical-align:bottom;width:45.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Erkan Akyuz</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:45.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)(4)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eric Casaburi</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)(5)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:45.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Robert Golden</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:45.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)(4)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Julianne Huh</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)(5)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:45.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Thomas Kosasa</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:45.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(5)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">R. Scott Holbrook</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">73</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)(6)</sup></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Member of the audit committee.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Member of the compensation committee.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Member of the nominating and corporate governance committee.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(4)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Class&#160;I Director.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(5)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Class&#160;II Director.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">(6)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;">Class&#160;III Director.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In connection with the Business Combination, OneMedNet will nominate one additional Class III Director, subject to the approval of Data Knights, who will qualify as an independent director as defined under the rules of the Nasdaq. Each director will </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">203</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">hold office until his or her term expires at the next annual meeting of stockholders for such director&#8217;s class or until his or her death, resignation, removal or the earlier termination of his or her term of office.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Paul Casey, Chief Executive Officer</b>&#160;&#8212; Paul Casey is a seasoned executive and operator, bringing more than 40&#160;years of senior management experience in both the public and private sectors across a variety of industries, including airlines, tourism, software, and medical devices and technology.&#160;Mr.&#160;Casey is widely respected for his confluence of strategic vision, finance, operations, marketing, and commercialization expertise supplementing his strong track record of building and maintaining shareholder value. Previously Mr.&#160;Casey was on the board of TZ Limited, a global leader in electronic locking devices (Australian listed company) and concurrently on the board of a Chicago based subsidiary PDT Limited, a leading industrial design firm focused on consumer military and medical devices. Throughout his career, Mr.&#160;Casey has leveraged his multi-functional expertise to drive business value creation and expansion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">He took over Hawaiian Airlines (then AMEX Global listed) right after the company emerged from bankruptcy and successfully refocused the company on revenue creation while changing the culture from top down to bottom up, in addition to replacing an aging fleet with more modern aircrafts and renegotiated six union contracts. Prior to his tenure at Hawaiian Airlines, Mr.&#160;Casey ran a tourism focused software company in Bangkok (Galaxy Systems), working with Macquarie Bank in Hong Kong to pursue M&amp;A opportunities in the tourism sector. Mr.&#160;Casey has been an angel investor in a number of startup companies and been a mentor and advisor to many founders. Additionally, Mr.&#160;Casey was an investor in a collection of boutique hotels in California and Oregon under the umbrella of Greystone Hotels.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Jeffrey Yu,&#160;Founder, Chief Medical Officer, Vice President, Chairman of the Board</b><span style="font-family:'Times New Roman','Times','serif';">&#160;&#8212;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;</b><span style="font-family:'Times New Roman','Times','serif';">OneMedNet was founded in&#160;2006 by Dr.&#160;Jeffrey Yu who applies his 28&#160;years of sophisticated healthcare IT experience to the company every day. Dr.&#160;Jeffrey Yu is a board-certified Radiologist and is also fellowship-trained and board-certified in Nuclear Medicine. In 2006, he was part of a small group that recognized there was a need to develop electronic sharing technology to help imaging specialists move patient imaging studies quickly, securely, and cost-effectively. Dr.&#160;Yu</span><span style="direction:rtl;font-family:'Times New Roman','Times','serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s early research and development led to the BEAM solution which helped improve care and outcomes for stroke and trauma patients. In 2009, he started OneMedNet Corporation to commercialize the BEAM product. Since that time, Dr.&#160;Yu has remained an integral part of the strategic decision-making within OneMedNet. Dr.&#160;Yu received his BS at U.C.&#160;Berkeley, MD&#160;at Wake Forest University, conducted MRI research at Stanford University, and completed his Radiology residency and Nuclear Medicine fellowship at the Mallinckrodt Institute at Washington University.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Aaron Green, President</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"> &#8212; </b><span style="font-family:'Times New Roman','Times','serif';">Mr. Green is a healthcare IT business transformation leader with more than 20 years of leadership experience in healthcare management, sales, strategic planning, M&amp;A, product development, customer support and services operations. Prior to joining OneMedNet, Mr. Green served in a variety of healthcare technology roles including most recently at Optum, a United Health Group company (NYSE: UHG), a leading healthcare technology company, as Vice President Cloud Solutions. At Optum, Mr. Green was responsible for developing and attaining the P&amp;L, Bookings, Revenue and EBIDTA targets of its Cloud Solution lines. Before Optum, Mr. Green worked nearly six years with Change Health Care, most recently as Vice President Cloud Solutions. Previously, Mr. Green worked for more than 15 years with McKesson growing to Division Vice President, Sales where he led an organization of 50+ executives, salespersons and staff, across the US, Canada, and the US government territories. He holds a Bachelor of Science in Biochemistry from the University of Victoria, British Columbia, a Systems Analyst Diploma from Royal Roads University, British Columbia, and an Executive MBA from the Wharton School.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Lisa Embree, </b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vice President&#160;&#8212; Finance, Chief Financial Officer</b><span style="font-family:'Times New Roman','Times','serif';">&#160;&#8212; Ms.&#160;Embree is a Certified Professional Accountant with 18&#160;years of senior-level business experience. During this time, she has gained very strong and impactful business competencies within administrative&#160;&amp; financial management, financial accountability, and communication&#160;&amp; strategic partnerships. Previous to OneMedNet, she was the Director of Finance for Equicare Health, and an Accounting Manager with Haemonetics Corporation (NYSE: HAE). Lisa has a Bachelor of Science (BSc) from Simon Fraser University, Business Administration (BA) from British Columbia Institute of Technology, and is a member of the Certified Public Accountants of Canada.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Erkan Akyuz</b><b style="font-weight:bold;">, </b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Director</b>&#160;&#8212; Mr.&#160;Akyuz presently serves as&#160;President and Chief Executive Officer of Lyniate where under his leadership, since carving out Rhapsody from Orion Health in 2018, Lyniate has been on a steadfast mission to cover the crucial corners in healthcare interoperability. In 2019 it merged with Corepoint Health, and this&#160;year it has released two new versions of Rhapsody and another version of Lyniate Corepoint, as well as new products that were not in its portfolio prior to 2021. One of the new products is Lyniate Rapid, which is an API gateway and management tool that helps healthcare systems as well as healthcare IT vendors manage and secure API communications in FHIR and non-FHIR formats. Before taking on this position, Mr.&#160;Akyuz was President of Medical Imaging, Workflow, and Care Solutions for McKesson Technology Solutions/Change Healthcare and before joining the McKesson IWS team in 2014, he was President and Chief Executive Officer at Vital Images&#160;Inc. and Executive Vice President and Chief Technology Officer at Agfa Healthcare, with oversight of the Medical Imaging Informatics business. Mr.&#160;brings </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">204</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">more than 20&#160;years of healthcare IT experience to OneMedNet. Mr.&#160;Akyuz earned an Executive MBA INSEAD (2007), a Master&#8217;s in Computer Science from the Navy Postgraduate School (1997) and a Bachelor&#8217;s Degree in Electrical, Electronics and Communications Engineering (1991) from the Naval Academy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Eric Casaburi</b>, <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Director</b>&#160;&#8212; Eric Casaburi is an experienced entrepreneur and chief executive officer with a successfully demonstrated history of explosive growth in the franchising, health and wellness, food services, and real estate industries including founding and leading RetroFitness from a start-up single-gym business to a $150 Million per&#160;year in sales operation while expanding its national footprint. Mr.&#160;Casaburi has founded and held positions as chief executive officer for multiple franchise brands each having successful exits with impressive returns for investors and private equity partners. Since 2021, Mr.&#160;Casaburi has served as founder and Chief Executive Officer of Serotonin Enterprises LLC, a cutting edge Anti-Aging Health Optimization Franchise that offers a vast service menu covering all aspects of optimal health, appearance and performance. Serotonin Centers have been featured in the Franchise Times as the first franchise of its kind in the United States. Since 2019, Mr.&#160;Casaburi has served as the Chair of TIGER 21 Orlando, a group of men and woman who have achieved both success and significance in their lives that helps members build the skill set to successfully transition from focused entrepreneurs to disciplined managers of wealth.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Since 2020, Mr.&#160;Casaburi has founded and operated Longevity Brands and since 2016, Mr.&#160;Casaburi founded and owns CEVD Holdings, a commercial real estate investment and management company. From 2005 to 2019, Mr.&#160;Casaburi founded and ran Fierce Brands (RetroFitness) as Chief Executive Officer and continues as a Board Member, which is a highly successful fitness center business and expanded into a sought-after fitness franchise with annual sales of more than $153 million and more than 150 locations in the first 10&#160;years. Developed all sales, operations, and marketing systems for both the fitness centers and the franchise. Designed and implemented a diversified reoccurring revenue model to improve business health and value. Mr.&#160;Casaburi also founded and served as the Chief Executive Officer of Fierce Brands (Lets YO! Yogurt) from 2012&#8211;2015, self-serve yogurt and treats restaurant popularized through social media savvy, in which he franchised the business model and opened 24 restaurants in the first&#160;year and led to a successful exit to an industry private equity firm.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Robert Golden</b>, <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Director</b><b style="font-weight:bold;">&#160;&#8212; </b>Mr.&#160;Robert (Bob) Golden is an accomplished Certified Public Accountant (&#8220;CPA&#8221;) with more than 30&#160;years of experience. Mr.&#160;Golden is currently the Managing Partner of Cohen, Bender&#160;&amp; Golden LLP, where he provides consulting, accounting and tax services to middle market businesses and owners since September&#160;2015. Prior to that, from January&#160;2013 to August&#160;2015, Mr.&#160;Golden worked at Fenton&#160;&amp; Ross Accountancy Corporation and, from September&#160;2004 to December&#160;2012, at Saffer&#160;&amp; Flint Accountancy Corporation. From December&#160;1989 to June&#160;2004, Mr.&#160;Golden was at Good Swartz Brown&#160;&amp; Berns LLP (&#8220;GSBB&#8221; now CohnReznick), where he served as a partner from 1994 onwards. There, Mr.&#160;Golden performed administrative duties, including overseeing the company&#8217;s merger negotiations in 2000 and performed financial statement audits, reviews and income tax planning for middle market businesses and owners. While at GSBB and continuing today, Mr.&#160;Golden consults&#160;with his&#160;business clients&#160;to assist their entrepreneurial owners to better understand&#160;the financial performance of their businesses and to help them&#160;improve operational efficiencies and profitability by acting as their outside CFO. Bob also&#160;assists with structuring and negotiating financing, compensation planning, investment opportunity review, as well as&#160;merger&#160;and acquisition activities and works with wealthy families acting in a CFO-type role for their family office activities. After leaving GSBB in&#160;2004, in addition to continuing to provide&#160;consulting services to middle-market companies, Bob was the owner and CEO of several companies in the construction and engineering field, coffee and baked goods industries and also&#160;syndicated&#160;commercial real estate acquisitions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From September&#160;1984 to December&#160;1989, Mr.&#160;Golden was a CPA at Ernst&#160;&amp; Young in Los Angeles. Apart from his experience as a CPA, Mr.&#160;Golden is currently the Chief Financial Officer of Promo Shop,&#160;Inc.&#160;&amp; Subsidiaries, a specialty advertising promotional products multi-office distributor based in Los Angeles. Mr.&#160;Golden establishes the company&#8217;s annual budget among other duties and has been in this role since January&#160;2008. Mr.&#160;Golden is also currently the Chief Financial Officer at iKahan Media,&#160;Inc., an out of home media company specializing in digital and traditional billboards and advertisement, where he has served since September&#160;2014. Mr.&#160;Golden is a member of the Board of Directors of Talon International,&#160;Inc. (OTCMKTS: TALN), the world&#8217;s oldest and largest zipper manufacturer.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In 1984, Mr.&#160;Golden received his Bachelor of Science degree in Business Administration from the University of Southern California. Mr.&#160;Golden also holds a Certified Public Accountant certification from the California Board of Accountancy, is an Investment Advisor Representative with the SEC and is a Licensed Engineering Contractor with the California Contractors State License Board. We believe Mr.&#160;Golden is well-qualified to serve as a member of our board of directors due to his extensive experience as a Certified Public Accountant at numerous firms as well as his experience as an executive officer at multiple companies.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Dr.&#160;Julianne Huh</b>, <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Director</b>&#160;&#8212; Dr.&#160;Julianne Huh has served as an Independent Director, and a Member of the Audit Committee and Compensation Committee of Data Knights Acquisition Corp since its IPO on May&#160;11, 2021. Since October&#160;2017, Dr.&#160;Huh has </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">205</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">been serving as the Director of S&amp;I F&amp;B Management Sdn., Bhd. based in Kuala Lumpur, Malaysia, where she manages the overall business, operations and marketing of 2 Ox French Bistro. From June&#160;2016 to August&#160;2017, Dr.&#160;Huh served as the Vice President of The Mall of Korea based in Bangkok, Thailand, where she managed projects for business set-up, construction of department stores and nine restaurants. Dr.&#160;Huh also managed the overall business, operations and marketing while serving as the Vice President during this time. From November&#160;2013 to June&#160;2016, Dr.&#160;Huh served as the Director of Business Development of Juna International Ltd based in Shanghai, China and Seoul, Korea, where she oversaw China Business Development in the entertainment and music industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From August&#160;2006 to June&#160;2016, Dr.&#160;Huh founded the Wonderful World of Learning (WWL) and served as its General Manager based in Shanghai, where she managed the overall business and operations of the preschool, curriculum development and teacher training. From October&#160;2011 to May&#160;2014, Dr.&#160;Huh served as the Managing Partner as well as Vice President of Pronovias Korea based in Seoul, Korea, where she launched the wedding dress brand &#8220;Pronovias&#8221; of the Spain flagship store as the sole franchise for the Korean market. Dr.&#160;Huh also oversaw and managed operations, marketing, PR and bi-annual buying and merchandising. From September&#160;2009 to September&#160;2019, Dr.&#160;Huh founded Only Natural Organic Bath Products based in Shanghai, China, where she was in charge of brand development and sales for charity purposes. In May&#160;2005, Dr.&#160;Huh received her Doctor of Education (Ed. D) degree at the University of Massachusetts in the U.S. In May&#160;1995, Dr.&#160;Huh received her Master of Education (M. Ed) degree from the University of Massachusetts in the U.S. In June&#160;1993, Dr.&#160;Huh completed two semesters of courses at the MBA program at the Yonsei University in Seoul, Korea. In February&#160;1991, Dr.&#160;Huh received her Bachelor of Arts degree in English Language and Literature from Ewha Women&#8217;s University in Seoul, Korea. We believe Dr.&#160;Huh is well-qualified to serve as a member of our board of directors due to her experience in global finance, as well as her network of contacts and relationships.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Dr.&#160;Thomas Kosasa</b><b style="font-weight:bold;">, </b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Director</b>&#160;&#8212; Dr.&#160;Thomas Kosasa is a renowned Ob/Gyn/Fertility specialist at the Pacific In Vitro Fertilization Institute, and serves on the Board of Trustees of Pan Pacific Surgical and as a professor of reproductive endocrinology at the University of Hawaii, John A. Burns School of Medicine.&#160;Dr.&#160;Kosasa is a consultant for Maternal and Reproductive Health for the Food and Drug Administration and a past member for the Hawaii State Board of Medical Examiners and the Food and Drug Administration. Dr.&#160;Kosasa is a retired Major in the United States Army and was the Chief of Gyn-Surgical Service and the Director of the Infertility Division at Martin Army Hospital in Fort Benning, GA. Dr.&#160;Kosasa graduated from Dartmouth College and earned his medical degree at the McGill University School of Medicine. He completed his residency in obstetrics and gynecology and fellowship in reproductive endocrinology at Harvard Medical School in the Boston Hospital for Women, and completed a Reproductive Endocrinology Fellowship at the Peter Bent Brigham Hospital, Harvard Medical School. Dr.&#160;Kosasa<span style="direction:rtl;">&#8217;</span>s Professional Societies include American College of Obstetricians and Gynecologists, American Fertility Society, Board of Trustees, Pan Pacific Surgical Association, Hawaii Medical Association and Pacific Coast Obstetrical and Gynecological Society.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">R. Scott Holbrook, Director</b>&#8201;-&#8201;R. Scott Holbrook is a 50-year healthcare technology veteran in both vendor and healthcare provider organizations, most recently serving as a founder and principal of Mountain Summit Advisors that consults with sellers of care businesses. Mr. Holbrook sits on several boards or advisory boards including KLAS Enterprises (Pleasant Grove), Azova Health (Alpine) and Cerberus Sentinel (Scottsdale, AZ and served as a Strategic Advisor to Health Catalyst when they launched. Mr. Holbrook established their marketing and sales strategies and sold 25% of their initial business that helped them more into the marketplace.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Mr. Holbrook was the Executive Vice President of Medicity, a provider of healthcare technology products to RHIOs, IDNS, large laboratories, payors, hospitals and clinics. The company grew and was sold to Aetna for $500M. He is one of the founders and owners of KLAS that has grown to more than 250 people and is the market leader in evaluating healthcare IT products and services. He has served in executive positions at IHC, GTE, Sunquest Information Systems, Integrated Medical Networks (IMN), and a founder of Park City Solutions. Scott was the Intermountain Healthcare (IHC) executive over information systems, which sold to GTE in 1988. After two years with GTE, Mr. Holbrook moved to Sunquest Information Systems and helped to increase its annual revenue from $35 million to $100 million and to complete its initial public offering with a market cap of $389M.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Mr. Holbrook assisted in a turnaround of Integrated Medical Networks, a near bankrupt company in 1997-1998 and sold it to Compucare for $50 million In 1999, GTCR funded Park City Solutions to do IT Services and Health Care Web services. This company was sold in 2005 to Medicity and became the basis for their future products. From 1977-88, Mr. Holbrook served as a Vice President of IT Services (before CIO titles were around) for Intermountain Health Care for their 26-hospitals. During this tenure at IHC, Mr. Holbrook and his staff developed the Medseries4 product that is currently owned by Siemens and has 450 hospitals who continue to use the product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Known as an industry innovator, client advocate and champion, Mr. Holbrook is very active in the healthcare industry associations and is a HIMSS Fellow. He served on the National/International HIMSS Board for four years; HIMSS Analytics Board </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">206</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">for seven years, Chair of the HIMSS Finance Committee for two years and as Vice Chair of HIMSS (2013). Scott successful set up healthcare IT international businesses as he managed IHC, GTE, Sunquest Information Systems, Medicity, and KLAS. Mr. Holbrook holds a Master of Science, from Utah State University, a Bachelor of Science from Brigham Young University and is a Six Sigma Black Belt.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Executive Officers and Directors of OneMedNet Before the Business Combination</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Currently, OneMedNet&#8217;s management team is comprised of the following three executives and directors who will remain with OneMedNet following the Business Combination:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:47.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.33%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Paul Casey</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.74%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer, Director</p></td></tr><tr><td style="vertical-align:top;width:43.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Dr. Jeffrey Yu</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:5.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">55</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chairman of the Board of Directors, Founder, Chief Medical Officer, Vice President</p></td></tr><tr><td style="vertical-align:bottom;width:43.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Lisa Embree</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:47.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer, Vice President &#8212; Finance</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The current officers and directors of the OneMedNet and the additional members of the OneMedNet Board following the Business Combination are well qualified as leaders. In their prior positions they have gained substantial business, finance, medical, data, accounting, and public company experience as well as core management skills, such as strategic and financial planning, financial reporting, compliance, risk management, and leadership development. OneMedNet&#8217;s officers and directors following the Business Combination also have experience serving on boards of directors and board committees of other public companies and private companies, and have an understanding of corporate governance practices and trends, which provides an understanding of different business processes, challenges, and strategies. Further, certain officers and directors have other experience that makes them valuable, such as prior experience in mergers and acquisitions, in financial services, managing and investing in assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights believes that the above-mentioned attributes, along with the leadership skills and other experiences of the officers and board members described below, will provide OneMedNet with a diverse range of perspectives and judgment necessary to facilitate the goals of the Company and be good stewards of capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Corporate Governance Guidelines and Code of Business Conduct</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The OneMedNet Board will adopt Corporate Governance Guidelines that address items such as the qualifications and responsibilities of its directors and director candidates and corporate governance policies and standards applicable. In addition, the OneMedNet Board will adopt a Code of Business Conduct and Ethics that applies to all of its employees, officers and directors, including its Chief Executive Officer, Chief Financial Officer and other executive and senior financial officers. The full text of OneMedNet&#8217;s Corporate Governance Guidelines and its Code of Business Conduct and Ethics will be posted on the Corporate Governance portion of the OneMedNet&#8217;s website. OneMedNet will post amendments to its Code of Business Conduct and Ethics or waivers of its Code of Business Conduct and Ethics for directors and officers on the same website.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Board Composition</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the consummation of the Business Combination, the Data Knights Board will be comprised of nine directors, of which seven directors will be nominated by OneMedNet, and two directors will be nominated by Data Knights. Dr.&#160;Jeffrey Yu will serve as Chair of the Data Knights Board. The primary responsibilities of the Data Knights Board will be to provide oversight, strategic guidance, counseling and direction to OneMedNet&#8217;s management. The Data Knights Board will meet on a regular basis and additionally as required.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">After the closing of the merger, the number of directors will be fixed by New OneMedNet&#8217;s board of directors, subject to the terms of New OneMedNet&#8217;s second amended and restated certificate of incorporation that will become effective at the effective time. Each of New OneMedNet&#8217;s directors will continue to serve as a director until the election and qualification of his or her successor, or until his or her earlier death, resignation or removal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Director Independence</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Upon the consummation of the Business Combination, the Data Knights Board is expected to determine that Erkan Akyuz, Eric Casaburi, Robert Golden, Dr.&#160;</span><span style="font-family:'Times New Roman','Times','serif';">Julianne Huh, Dr.&#160;</span><span style="font-family:'Times New Roman','Times','serif';">Thomas Kosasa, and R. Scott Holbrook will qualify as independent directors, as </span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">207</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">defined under the listing rules&#160;of Nasdaq, and the Data Knights Board will consist of a majority of &#8220;independent directors,&#8221; as defined under the rules&#160;of the SEC and Nasdaq relating to director independence requirements. In addition, Data Knights will be subject to the rules&#160;of the SEC and Nasdaq relating to the membership, qualifications, and operations of the audit committee, as discussed below. Prior to the completion of the merger, the parties undertook a review of the independence of the individuals named above and determined that each of the director nominees, other than Paul Casey and Dr.&#160;Jeffrey Yu, will qualify as independent directors, as defined under the rules&#160;of the Nasdaq, and the New OneMedNet board of directors will consist of a majority of &#8220;independent directors,&#8221; as defined under the rules&#160;of the SEC and the Nasdaq relating to director independence requirements. In addition, New OneMedNet will be subject to the rules&#160;of the SEC and the Nasdaq relating to the membership, qualifications, and operations of the audit committee, as discussed below.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Role of the Data Knights Board in Risk Oversight/Risk Committee</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the consummation of the Business Combination, one of the key functions of the Data Knights Board will be informed oversight of Data Knights&#8217; risk management process. The Data Knights Board does not anticipate having a standing risk management committee, but rather anticipates administering this oversight function directly through the Data Knights Board as a whole, as well as through various standing committees of the Data Knights Board that address risks inherent in their respective areas of oversight. In particular, the Data Knights Board will be responsible for monitoring and assessing strategic risk exposure and Data Knights&#8217; audit committee will have the responsibility of considering and discussing Data Knights&#8217; major financial risk exposures and the steps its management will take to monitor and control such exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The audit committee will also monitor compliance with legal and regulatory requirements. Data Knights&#8217; compensation committee will also assess and monitor whether Data Knights&#8217; compensation plans, policies and programs comply with applicable legal and regulatory requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Board Committees</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Effective upon the consummation of the Business Combination, the Data Knights Board will have three standing committees &#8212; an audit committee, a compensation committee, and a nominating and corporate governance committee. The Data Knights Board will adopt a charter for each of these committees, which will comply with the applicable requirements of current Nasdaq rules. Data Knights intends to comply with future requirements to the extent they will be applicable to Data Knights. Following the consummation of the Business Combination, copies of the charters for each committee will be available on the investor relations portion of Data Knights&#8217; website. Information contained on or accessible through New OneMedNet&#8217;s website is not a part of this proxy statement/prospectus, and the inclusion of New OneMedNet&#8217;s website address in this proxy statement/prospectus is an inactive textual reference only.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Audit Committee</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights&#8217; audit committee will consist of Robert Golden, Erkan Akyuz and R. Scott Holbrook. The Data Knights Board will determine that each of the members of the audit committee will satisfy the independence requirements of the Nasdaq and&#160;Rule&#160;10A-3&#160;under the Exchange Act and be able to read and understand fundamental financial statements in accordance with the Nasdaq audit committee requirements. In arriving at this determination, the Data Knights Board will examine each audit committee member&#8217;s scope of experience and the nature of their prior and/or current employment.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Robert Golden&#160;will serve as the chair of the audit committee. The Data Knights Board determined that Robert Golden qualifies as an audit committee financial expert within the meaning of SEC regulations and meet the financial sophistication requirements of the Nasdaq rules. In making this determination, the Data Knights Board considered Robert Golden&#8217;s formal education, licensure and certifications, and previous experience in financial roles. Both Data Knights&#8217; independent registered public accounting firm and management will periodically meet privately with Data Knights&#8217; audit committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The functions of this committee are expected to include, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">evaluating the performance, independence and qualifications of Data Knights&#8217; independent auditors and determining whether to retain Data Knights&#8217; existing independent auditors or engage new independent auditors;</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">208</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">monitoring the integrity of Data Knights&#8217; financial statements and Data Knights&#8217; compliance with legal and regulatory requirements as they relate to financial statements or accounting matters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing the integrity, adequacy and effectiveness of Data Knights&#8217; internal control policies and procedures;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">preparing the audit committee report required by the SEC to be included in Data Knights&#8217; annual proxy statement;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">discussing the scope and results of the audit with Data Knights&#8217; independent auditors, and reviewing with management and Data Knights&#8217; independent auditors Data Knights&#8217; interim and&#160;year-end operating results;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establishing and overseeing procedures for employees to submit concerns anonymously about questionable accounting or auditing matters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing Data Knights&#8217; guidelines and policies on risk assessment and risk management;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving related party transactions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining and reviewing a report by Data Knights&#8217; independent auditors at least annually that describes Data Knights&#8217; independent auditors internal quality control procedures, any material issues raised by review under such procedures, and any steps taken to deal with such issues when required by applicable law; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approving (or, as permitted, pre-approving) all audit and non-audit services to be performed by Data Knights&#8217; independent auditors.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The composition and function of the audit committee will comply with all applicable requirements of the Sarbanes-Oxley Act, SEC rules&#160;and regulations and Nasdaq listing rules. Data Knights will comply with future requirements to the extent they become applicable to Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Compensation Committee</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights&#8217; compensation committee will consist of Erkan Akyuz, Robert Golden and R. Scott Holbrook. Erkan Akyuz will serve as the chair of the compensation committee. The Data Knights Board will determine that each of the members of the compensation committee will be a&#160;non-employee&#160;director, as defined in&#160;Rule&#160;16b-3&#160;promulgated under the Exchange Act and will satisfy the independence requirements of Nasdaq. The functions of the committee are expected to include, among other things:</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approving the retention of compensation consultants and outside service providers and advisors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving, or recommending that the Data Knights Board approve, the compensation of Data Knights&#8217; executive officers, including annual base salary, annual incentive bonuses, specific performance goals relevant to their compensation, equity compensation and employment;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and recommending to the Data Knights Board the compensation of Data Knights&#8217; directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">administering and determining any award grants under Data Knights&#8217; equity and non-equity incentive plans;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and evaluating succession plans for the executive officers;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">preparing the compensation committee report required by the SEC to be included in Data Knights&#8217; annual proxy statement; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically reviewing Data Knights&#8217; practices and policies of employee compensation as they relate to risk management and risk-taking incentives.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">209</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The composition and function of its compensation committee will comply with all applicable requirements of the Sarbanes-Oxley Act and all applicable SEC rules&#160;and regulations and Nasdaq listing rules. Data Knights will comply with future requirements to the extent they become applicable to Data Knights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Nominating and Corporate Governance Committee</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights&#8217; nominating and corporate governance committee will consist of Dr.&#160;Julianne Huh, Dr. Thomas Kosasa and Eric Casaburi. The Data Knights Board will determine that each of the members of Data Knights&#8217; nominating and corporate governance committee will satisfy the independence requirements of the Nasdaq.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dr.&#160;Julianne Huh will serve as the chair of Data Knights&#8217; nominating and corporate governance committee. The functions of this committee are expected to include, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">identifying, evaluating, and recommending individuals qualified to become members of the Data Knights Board and its committees;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">evaluating the performance of the Data Knights Board and of individual directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing the Company&#8217;s environmental and social responsibility policies and practices;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developing and recommending corporate governance guidelines to the Data Knights Board; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overseeing an annual evaluation of the Data Knights Board and management.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The composition and function of the nominating and corporate governance committee will comply with all applicable requirements of the Sarbanes-Oxley Act and all applicable SEC rules&#160;and regulations and Nasdaq listing rules. Data Knights will comply with future requirements to the extent they become applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Compensation Committee Interlocks and Insider Participation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">None of the intended members of Data Knights&#8217; compensation committee has ever been an executive officer or employee of Data Knights. None of Data Knights&#8217; intended executive officers currently serves, or has served during the last completed fiscal&#160;year, on the compensation committee or board of directors of any other entity that has one or more executive officers that will serve as a member of the Data Knights Board or compensation committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Limitation on Liability and Indemnification of Directors and Officers</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Proposed Certificate of Incorporation which will be effective upon Closing limits Data Knights&#8217; directors&#8217; liability to the fullest extent permitted under the DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for any transaction from which the director derives an improper personal benefit;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for any unlawful payment of dividends or redemption of shares; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for any breach of a director&#8217;s duty of loyalty to the corporation or its stockholders.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of Data Knights&#8217; directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. The DGCL and the Data Knights Bylaws provide that Data Knights will, in certain situations, indemnify Data Knights&#8217; directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct payment, or reimbursement of reasonable expenses (including attorneys&#8217; fees and disbursements) in advance of the final disposition of the proceeding.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">210</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, Data Knights will enter into separate indemnification agreements with Data Knights&#8217; directors and officers. These agreements, among other things, require Data Knights to indemnify its directors and officers for certain expenses, including attorneys&#8217; fees, judgments, fines, and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as one of Data Knights&#8217; directors or officers or any other company or enterprise to which the person provides services at Data Knights&#8217; request.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights plans to maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which Data Knights&#8217; directors and officers are insured against liability for actions taken in their capacities as directors and officers. Data Knights believes these provisions in the Proposed Certificate of Incorporation and the Data Knights Bylaws and these indemnification agreements are necessary to attract and retain qualified persons as directors and officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, or control persons, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Code of Conduct and Ethics for Employees, Executive Officers and Directors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights Board will adopt a code of business conduct and ethics, or the Code of Conduct, applicable to all of Data Knights&#8217; employees, executive officers and directors. The Code of Conduct will be available on Data Knights&#8217; website. Information contained on or accessible through Data Knights&#8217; website is not a part of this proxy statement/prospectus/information statement, and the inclusion of Data Knights&#8217; website address in this proxy statement/prospectus/information statement is an inactive textual reference only. The nominating and corporate governance committee of the Data Knights Board will be responsible for overseeing the Code of Conduct and must approve any waivers of the Code of Conduct for employees, executive officers and directors. Data Knights expects that any amendments to the Code of Conduct, or any waivers of its requirements, will be disclosed on its website.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Board Diversity</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of this merger, the New OneMedNet nominating and corporate governance committee will be responsible for reviewing with the OneMedNet board of directors, on an annual basis, the appropriate characteristics, skills and experience required for the board of directors as a whole and its individual members. In evaluating the suitability of individual candidates (both new candidates and current members), the New OneMedNet nominating and corporate governance committee, in recommending candidates for election, and the new OneMedNet board of directors, in approving (and, in the case of vacancies, appointing) such candidates, may take into account many factors, including but not limited to the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">personal and professional integrity;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ethics and values;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">experience in corporate management, such as serving as an officer or former officer of a publicly held company;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">professional and academic experience relevant to New OneMedNet&#8217;s industry;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">experience as a board member of another publicly held company;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">strength of leadership skills;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">experience in finance and accounting and/or executive compensation practices;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ability to devote the time required for preparation, participation and attendance at board of directors&#8217; meetings and committee meetings, if applicable;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">background, gender, age and ethnicity;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">conflicts of interest; and</span></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">211</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ability to make mature business judgments.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the merger, the New OneMedNet board of directors will evaluate each individual in the context of the board of directors as a whole, with the objective of ensuring that the board of directors, as a whole, has the necessary tools to perform its oversight function effectively in light of New OneMedNet&#8217;s business and structure.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Non-Employee&#160;Director Compensation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the consummation of the Business Combination, Data Knights intends to propose for adoption by our Board a compensation program for our non-employee directors that is designed to align compensation with New OneMedNet&#8217;s business objectives and the creation of stockholder value, while enabling New OneMedNet to attract, retain, incentivize and reward directors who contribute to the long-term success of New OneMedNet. The New OneMedNet board of directors expects to review director compensation periodically to ensure that director compensation remains competitive such that New OneMedNet is able to recruit and retain qualified directors. Following the closing of the merger, New OneMedNet intends to develop a&#160;non-employee&#160;director compensation program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Role of Board in Risk Oversight</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the merger, risk assessment and oversight will be an integral part of New OneMedNet&#8217;s governance and management processes. The New OneMedNet board of directors will encourage management to promote a culture that incorporates risk management into its corporate strategy and&#160;day-to-day&#160;business operations. Management will discuss strategic and operational risks at regular management meetings, and conduct specific strategic planning and review sessions during the&#160;year that include a focused discussion and analysis of the risks facing New OneMedNet. Throughout the&#160;year, senior management will review these risks with the New OneMedNet board of directors at regular board meetings as part of management presentations that focus on particular business functions, operations or strategies, and present the steps taken by management to mitigate or eliminate such risks.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the merger, the New OneMedNet board of directors will not have a standing risk management committee, but rather will administer this oversight function directly through the New OneMedNet board of directors as a whole, as well as through various standing committees of the New OneMedNet board of directors that address the risks inherent in their respective areas of oversight.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">While the New OneMedNet board of directors will be responsible for monitoring strategic risk exposure, the New OneMedNet audit committee will oversee management of financial reporting, compliance and litigation risks, as well as the steps management has taken to monitor and control such exposures. The New OneMedNet nominating and corporate governance committee will manage risks associated with the independence of the New OneMedNet board of directors, potential conflicts of interest and the effectiveness of the New OneMedNet board of directors. The New OneMedNet compensation committee will be responsible for overseeing the management of risks relating to New OneMedNet&#8217;s executive compensation policies, plans and arrangements and the extent to which those policies or practices increase or decrease risks for New OneMedNet.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Limitation on Liability and Indemnification Matters</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">New OneMedNet&#8217;s third amended and restated certificate of incorporation which will become effective at the effective time, will limit New OneMedNet&#8217;s directors&#8217; liability and may indemnify New OneMedNet&#8217;s directors and officers to the fullest extent permitted under the Delaware General Corporation Law, or DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability for:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any breach of the director&#8217;s duty of loyalty to New OneMedNet or its stockholders;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any unlawful payment of dividends or unlawful stock repurchases or redemptions as provided in Section&#160;174 of the DGCL; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any transaction from which the director derived an improper benefit.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">212</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The DGCL and New OneMedNet&#8217;s amended and restated bylaws provide that New OneMedNet will, in certain situations, indemnify New OneMedNet&#8217;s directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. New OneMedNet expects to enter into indemnification agreements with each of New OneMedNet&#8217;s directors and officers. These indemnification agreements may require New OneMedNet, among other things, to indemnify New OneMedNet&#8217;s directors and officers for some expenses, including attorneys&#8217; fees, judgments, penalties, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of his or her service as one of New OneMedNet&#8217;s directors or officers, or any of its subsidiaries or any other company or enterprise to which the person provides services at New OneMedNet&#8217;s request. Subject to certain limitations, New OneMedNet&#8217;s indemnification agreements will also require New OneMedNet to advance expenses incurred by New OneMedNet&#8217;s directors or officers for the defense of any action for which indemnification is required or permitted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">New OneMedNet will maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which New OneMedNet&#8217;s directors and officers will be insured against liability for actions taken in their capacities as directors and officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The limitation of liability and indemnification provisions in New OneMedNet&#8217;s second amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against New OneMedNet&#8217;s directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against New OneMedNet&#8217;s directors and officers, even though an action, if successful, might benefit New OneMedNet and its stockholders. Further, a stockholder&#8217;s investment may be adversely affected to the extent that New OneMedNet pay the costs of settlement and damage awards against directors and officers as required by these indemnification provisions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or control persons, in the opinion of the SEC, such indemnification is against public policy, as expressed in the Securities Act and is therefore unenforceable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Code of Business Conduct and Ethics for Employees, Executive Officers, and Directors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">New OneMedNet will adopt a code of business conduct and ethics (the &#8220;Code of Conduct&#8221;), applicable to all of New OneMedNet&#8217;s employees, executive officers and directors. The Code of Conduct will be available on New OneMedNet&#8217;s website. The audit committee of the New OneMedNet board of directors will be responsible for overseeing the Code of Conduct and must approve any waivers of the Code of Conduct for employees, executive officers and directors. Any amendments to the Code of Conduct, or any waivers of its requirements, will be disclosed on its website.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">213</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_4aa52ed0_105e_40e5_b4b6_ed85ecea8daf"></a><a id="DESCRIPTIONOFSECURITIESOFDATAKNIGHTS_883"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">DESCRIPTION OF SECURITIES OF DATA KNIGHTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following summary of the material terms of Data Knights&#8217; securities prior to the Business Combination is not intended to be a complete summary of the rights and preferences of such securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is a Delaware corporation, and Data Knights&#8217; affairs are governed by Data Knights&#8217; second amended and restated certificate of incorporation and the DGCL. Pursuant to Data Knights&#8217; amended and restated certificate of incorporation, Data Knights is authorized to issue 100,000,000 shares of Class&#160;A common stock, $0.0001 par value, 10,000,000 shares of Class&#160;B common stock, $0.0001 par value, and 1,000,000 shares of undesignated preferred stock, $0.0001 par value. The following description summarizes certain terms of Data Knights&#8217; capital stock as set out more particularly in Data Knights&#8217; amended and restated certificate of incorporation. Because it is only a summary, it may not contain all the information that is important to you.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Units</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Each unit has an offering price of $10.00 and consists of one share of Class&#160;A common stock and one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class&#160;A common stock at a price of $11.50 per share, subject to adjustment as described in this prospectus. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June&#160;22, 2021, the Class&#160;A Common Stock and Public Warrants included in the Units began separate trading.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Placement Units</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Private Placement Units are identical to the Public Units sold in the offering except that (a)&#160;the Placement Units and their component securities will not be transferable, assignable or salable until 30&#160;days after the consummation of Data Knights&#8217; initial business combination except to permitted transferees, (b)&#160;the Private Placement Shares and Placement Warrants, so long as they are held by Data Knights&#8217; sponsor or its permitted transferees, (i)&#160;will not be redeemable by Data Knights, (ii)&#160;may be exercised by the holders on a cashless basis, and (iii)&#160;will be entitled to registration rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Common Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prior to February&#160;25, 2021, there were 2,875,000 shares of Data Knights&#8217; Founder Shares issued and outstanding, all of which were held of record by Data Knights initial stockholders. Data Knights&#8217; sponsor transferred a total of 45,000 Founder Shares among Data Knights&#8217; Chief Executive Officer, Chief Financial Officer and three independent director nominees pursuant to executed securities assignment agreements, effective as of February&#160;25, 2021 with respect to each of them except one independent director, as to whom the transfer was effective March&#160;23, 2021. The Founder Shares held by Data Knights initial stockholders represent 46.4% of Data Knights&#8217; outstanding shares of Data Knight Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of [<span style="font-family:'Times New Roman';">&#9679;</span>], 2023, 2,731,544 shares of Class&#160;A Common Stock outstanding are subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stockholders of record are entitled to one vote for each share held (on an as-converted to Class&#160;A Common Stock basis) on all matters to be voted on by stockholders. Prior to the Closing of Data Knights&#8217; Business Combination, only holders of Data Knights&#8217; Founder Shares will have the right to vote on the appointment of directors. In addition, prior to the completion of the Business Combination, holders of a majority of Data Knights&#8217; Founder Shares may remove a member of the board of directors for any reason. These provisions of Data Knights&#8217; Charter may be amended only by approval of 90% of the shares of common stock voting in an annual meeting. With respect to any other matter submitted to a vote of Data Knights stockholders, including any vote in connection with Data Knights&#8217; initial business combination, except as required by law, holders of Data Knights&#8217; Founder Shares and holders of Data Knights&#8217; Public Shares will vote together as a single class, with each share entitling the holder to one vote for each share held (on an as-converted to Class&#160;A Common Stock basis).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Unless specified in Data Knights&#8217; amended and restated certificate of incorporation, or as required by applicable provisions of the DGCL or applicable stock exchange rules, the affirmative vote of a majority of our shares of Data Knight Common Stock that are voted is required to approve any such matter voted on by Data Knights stockholders. Data Knights&#8217; board of directors is divided into three classes, each of which will generally serve for a term of three&#160;years with only one class of directors being elected in each&#160;year. There is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the shares </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">214</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">voted for the election of directors can elect all of the directors. Data Knights stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; board of directors is divided into three classes with only one class of directors being elected in each&#160;year and each class (except for those directors appointed prior to Data Knights&#8217; first annual meeting of stockholders) serving a three-year term. In accordance with the Nasdaq corporate governance requirements, Data Knights is not required to hold an annual meeting until one&#160;year after Data Knights&#8217; first fiscal&#160;year end following Data Knights&#8217; listing on Nasdaq. Under Section&#160;211(b)&#160;of the DGCL, Data Knights is, however, required to hold annual meetings of stockholders for the purpose of electing directors in accordance with Data Knights&#8217; bylaws, unless such election is made by written consent in lieu of such a meeting. Data Knights may not hold an annual meeting of stockholders to elect new directors prior to the completion of Data Knights&#8217; Business Combination, and thus Data Knights may not be in compliance with Section&#160;211(b)&#160;of the DGCL, which requires an annual meeting. Therefore, if Data Knights stockholders would like to hold an annual meeting prior to the completion of an initial business combination, they may attempt to force Data Knights to hold one by submitting an application to the Delaware Court of Chancery in accordance with Section&#160;211(c)&#160;of the DGCL. Prior to the completion of an initial business combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of Data Knights&#8217; Founder Shares. In addition, prior to the completion of an initial business combination, holders of a majority of Data Knights&#8217; Founder Shares may remove a member of the board of directors for any reason.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights will provide their public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the Closing of Data Knights&#8217; the Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business&#160;days prior to the completion of Data Knights&#8217; Business Combination, including interest earned on the funds held in the trust account and not previously released to us to pay Data Knights&#8217; taxes, divided by the number of the then outstanding Public Shares, subject to the limitations described herein. The amount in the trust account is currently anticipated to be $10.32 per Public Share. The per-share amount Data Knights will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions Data Knights will pay to the underwriters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The redemption rights will include the requirement that a beneficial owner must identify itself in order to validly redeem its shares. Data Knights&#8217; sponsor, directors and each member of Data Knights&#8217; management team have entered into a letter agreement with Data Knights, pursuant to which they have agreed to waive their redemption rights with respect to their Founder Shares and any Public Shares held by them in connection with (i)&#160;the completion of Data Knights&#8217; Business Combination and (ii)&#160;a stockholder vote to approve an amendment to Data Knights&#8217; amended and restated certificate of incorporation that would affect the substance or timing of Data Knights&#8217; obligation to allow redemption in connection with Data Knights&#8217; Business Combination or to redeem 100% of Data Knights&#8217; Public Shares if Data Knights has not completed an initial business combination within the period to consummate the initial business combination. Unlike many blank check companies that hold stockholder votes and conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of Public Shares for cash upon completion of such initial business combinations even when a vote is not required by law, if a stockholder vote is not required by applicable law or stock exchange rule&#160;and Data Knights does not decide to hold a stockholder vote for business or other reasons, Data Knights will, pursuant to Data Knights&#8217; amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules&#160;of the SEC and file tender offer documents with the SEC prior to completing the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; Charter requires these tender offer documents to contain substantially the same financial and other information about the Business Combination and the redemption rights as is required under the SEC&#8217;s proxy rules. If, however, a stockholder approval of the transaction is required by applicable law or stock exchange rule, or Data Knights decides to obtain stockholder approval for business or other reasons, Data Knights will, like many blank check companies, offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules&#160;and not pursuant to the tender offer rules. If Data Knights seeks stockholder approval, Data Knights will complete its Business Combination only if a majority of the shares of Data Knights Common Stock voted are voted in favor of its initial business combination. However, the participation of Data Knights&#8217; sponsor, officers, directors, advisors or their respective affiliates in privately-negotiated transactions, if any, could result in the approval of Data Knights&#8217; Business Combination even if a majority of Data Knights public stockholders&#8217; vote, or indicate their intention to vote, against the Business Combination. For purposes of seeking approval of the majority of Data Knights outstanding Common Stock, non-votes will have no effect on the approval of its Business Combination once a quorum is obtained.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">If Data Knights seeks stockholder approval of the Business Combination and Data Knights does not conduct redemptions in connection with the Business Combination pursuant to the tender offer rules, Data Knights&#8217; Charter provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section&#160;13 of the Exchange Act), will be restricted from redeeming in the aggregate, his, her or its Public Shares, in excess of 15% of the Public Shares (the &#8220;Excess Shares&#8221;), without the prior written consent of Data Knights. However, Data Knights </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">215</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">would not be restricting its stockholders&#8217; ability to vote all of their shares (including Excess Shares) for or against its initial business combination. Data Knights stockholders&#8217; inability to redeem the Excess Shares will reduce their influence over its ability to complete our initial business combination, and such stockholders could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such stockholders will not receive redemption distributions with respect to the Excess Shares if Data Knights completes its initial business combination. And, as a result, such stockholders will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares would be required to sell their shares in open market transactions, potentially at a loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If Data Knights seeks stockholder approval in connection with its initial business combination, pursuant to the terms of a letter agreement entered into with Data Knights and the Founders, Data Knights&#8217; sponsor, directors and each member of Data Knights&#8217; management team have agreed to vote their Founder Shares and any Public Shares purchased during or after this offering, in favor of its initial business combination. As a result, in addition to Data Knights initial stockholders&#8217; Founder Shares and Placement Shares Data Knights would not need any Public Shares to be voted in favor of an initial business combination in order to have its initial business combination approved. Additionally, each public stockholder may elect to redeem its Public Shares irrespective of whether they vote for or against the proposed transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to Data Knights&#8217; amended and restated certificate of incorporation, if Data Knights has not completed an initial business combination within the period to consummate the initial business combination, Data Knights will (i)&#160;cease all operations except for the purpose of winding up; (ii)&#160;as promptly as reasonably possible but no more than ten business&#160;days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to Data Knights to pay taxes, divided by the number of the then outstanding Public Shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of Data Knights&#8217; remaining stockholders and Data Knights&#8217; board of directors, liquidate and dissolve, subject in each case to Data Knights&#8217; obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Data Knights&#8217; sponsor and members of Data Knights&#8217; management team have entered into letter agreements with Data Knights, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if Data Knights does not complete an initial business combination within the period to consummate the initial business combination. However, if Data Knights&#8217; sponsor or members of Data Knights&#8217; management team acquire Public Shares in or after this offering, they will be entitled to liquidating distributions from the trust account with respect to such Public Shares if Data Knights does not complete our initial business combination within the prescribed time period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the event of a liquidation, dissolution or winding up of the company after a business combination, Data Knights stockholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of shares, if any, having preference over the common stock. Data Knights stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the common stock, except that we will provide our public stockholders with the opportunity to redeem their Public Shares for cash at a per unit price equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to Data Knights to pay taxes, divided by the number of the then outstanding Public Shares, upon the completion of Data Knights&#8217; initial business combination, subject to the limitations described herein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Founder Shares and Placement Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The founder shares and placement shares are identical to the shares of Class&#160;A common stock included in the units sold in the offering, and holders of founder shares and placement shares have the same stockholder rights as public stockholders, except that (i)&#160;the founder shares and placement shares are subject to certain transfer restrictions, as described in more detail below, (ii)&#160;Data Knights&#8217; sponsor, officers and directors have entered into a letter agreement with Data Knights, pursuant to which they have agreed (A)&#160;to waive their redemption rights with respect to any founder shares, placement shares and any Public Shares held by them in connection with the completion of Data Knights&#8217; initial business combination, (B)&#160;to waive their redemption rights with respect to their founder shares, placement shares, and Public Shares in connection with a stockholder vote to approve an amendment to Data Knights&#8217; amended and restated certificate of incorporation to (i)&#160;modify the substance or timing of Data Knights&#8217; obligation to provide for the redemption of Data Knights&#8217; Public Shares in connection with an initial business combination or to redeem 100% of Data Knights&#8217; Public Shares if Data Knights does not complete its initial business combination within 18&#160;months from the closing of this offering or (ii)&#160;with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity, and (C)&#160;to waive their rights to liquidating distributions from the trust account with respect to any founder shares or </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">216</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">placement shares held by them if Data Knights fails to complete its initial business combination within 18&#160;months from the closing of the offering, although they will be entitled to liquidating distributions from the trust account with respect to any Public Shares they hold if Data Knights fails to complete its initial business combination within such time period, (iii)&#160;the founder shares are shares of Data Knights&#8217; founder shares that will automatically convert into shares of Class&#160;A common stock at the time of Data Knights&#8217; initial business combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights as described herein and (iv)&#160;are entitled to registration rights. If Data Knights submits its initial business combination to Data Knights public stockholders for a vote, Data Knights&#8217; sponsor, officers and directors have agreed (and its permitted transferees will agree) pursuant to the letter agreement to vote any founder shares held by them and any Public Shares purchased during or after this offering (including in open market and privately-negotiated transactions) in favor of its initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the case that additional shares of Class&#160;A common stock or equity-linked securities are issued or deemed issued in connection with Data Knights&#8217; initial business combination, the number of shares of Class&#160;A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, approximately 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the offering (without giving effect to the private placement and assuming they do not purchase any units in this offering), plus the total number of shares of Class&#160;A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class&#160;A common stock or equity-linked securities exercisable for or convertible into shares of Class&#160;A common stock issued, or to be issued, to any seller in the initial business combination and any private placement-equivalent units issued to Data Knights&#8217; sponsor, officers or directors upon conversion of working capital loans; provided that such conversion of founder shares will never occur on a less than one for one basis. Data Knights cannot determine at this time whether a majority of the holders of our founder shares at the time of any future issuance would agree to waive such adjustment to the conversion ratio.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prior to its initial business combination, only holders of Data Knights&#8217; founder shares will have the right to vote on the appointment of directors. Holders of Data Knights Public Shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion of an initial business combination, holders of a majority of Data Knights&#8217; founder shares may remove a member of the board of directors for any reason. These provisions of Data Knights&#8217; amended and restated certificate of incorporation may only be amended by approval of a majority of at least 90% of Data Knights&#8217; founder shares voting in an annual meeting. With respect to any other matter submitted to a vote of Data Knights stockholders, including any vote in connection with our initial business combination, except as required by law, holders of Data Knights&#8217; founder shares and holders of Data Knights Public Shares will vote together as a single class, with each share entitling the holder to one vote.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Preferred Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; amended and restated certificate of incorporation authorizes 1,000,000 shares of preferred stock and provides that shares of preferred stock may be issued from time to time in one or more series. Data Knights&#8217; board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Data Knights&#8217; board of directors will be able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of Data Knights&#8217; board of directors to issue shares of preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of Data Knights or the removal of existing management. Data Knights has no shares of preferred stock issued and outstanding at the date hereof. Although Data Knights does not currently intend to issue any shares of preferred stock, Data Knights cannot assure you that we will not do so in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Public Stockholders&#8217; Warrants</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Each whole warrant entitles the registered holder to purchase one share of Data Knights Class&#160;A common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of 12&#160;months from the closing of the offering (which has expired as of the date hereof) and 30&#160;days after the completion of Data Knights&#8217; initial business combination. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class&#160;A common stock. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants were issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least two units, you will not be able to receive or trade a whole warrant.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">217</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The warrants will expire five&#160;years after the completion of Data Knights&#8217; initial business combination, at 5:00&#160;p.m., New York City time, or earlier upon redemption or liquidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights will not be obligated to deliver any shares of Class&#160;A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class&#160;A common stock and warrants underlying the warrants is then effective and a current prospectus relating thereto is current, subject to Data Knights satisfying its obligations described below with respect to registration. No warrant will be exercisable, and Data Knights will not be obligated to issue shares of Class&#160;A common stock upon exercise of a warrant unless Class&#160;A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will Data Knights be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant, if not cash settled, will have paid the full purchase price for the unit solely for the share of Class&#160;A common stock and warrants underlying such unit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights did not register the shares of Class&#160;A common stock issuable upon exercise of the warrants at the time of the offering. However, Data Knights has agreed that as soon as practicable, but in no event later than 15 business&#160;days after the closing of its initial business combination, Data Knights will use its best efforts to file with the SEC a registration statement registering the issuance of the shares of Class&#160;A common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class&#160;A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class&#160;A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of Data Knights&#8217; initial business combination or within a specified period following the consummation of Data Knights&#8217; initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when Data Knights has failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; pursuant to the exemption provided by Section&#160;3(a)(9)&#160;of the Securities Act; provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. Once the warrants become exercisable, Data Knights may call the warrants for redemption:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of $0.01 per warrant;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than 30&#160;days&#8217; prior written notice of redemption given after the warrants become exercisable (the &#8220;30-day redemption period&#8221;) to each warrant holder; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported last sale price of the Class&#160;A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading&#160;days within a 30-trading day period commencing once the warrants become exercisable and ending three business&#160;days before we send the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If and when the warrants become redeemable by Data Knights, Data Knights may not exercise its redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or Data Knights is unable to effect such registration or qualification. Data Knights will use its best efforts to register or qualify such shares of common stock under the blue-sky laws of the state of residence in those states in which the warrants were offered by Data Knights in its offering. Data Knights has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and Data Knights issues a notice of redemption of the warrants, each warrant holder will be entitled to exercise its warrant prior to the scheduled redemption date. However, the price of the Class&#160;A common stock may fall below the $18.00 redemption trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 warrant exercise price after the redemption notice is issued.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">If Data Knights calls the warrants for redemption as described above, Data Knights&#8217; management will have the option to require any holder that wishes to exercise its warrant to do so on a &#8220;cashless basis.&#8221; In determining whether to require all holders to exercise their warrants on a &#8220;cashless basis,&#8221; Data Knights&#8217; management will consider, among other factors, Data Knights&#8217; cash position, the number of warrants that are outstanding and the dilutive effect on Data Knights stockholders of issuing the maximum number of shares of Class&#160;A common stock issuable upon the exercise of our warrants. If Data Knights&#8217; management takes advantage of this </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">218</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Class&#160;A common stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of Class&#160;A common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The &#8220;fair market value&#8221; for this purpose shall mean the average reported last sale price of the Class&#160;A common stock for the 10 trading&#160;days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If Data Knights&#8217; management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Class&#160;A common stock to be received upon exercise of the warrants, including the &#8220;fair market value&#8221; in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. Data Knights believes this feature is an attractive option to Data Knights if it does not need the cash from the exercise of the warrants after its initial business combination. If Data Knights calls its warrants for redemption and Data Knights&#8217; management does not take advantage of this option, Data Knights&#8217; sponsor and its permitted transferees would still be entitled to exercise their placement warrants for cash or on a cashless basis using the same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise their warrants on a cashless basis, as described in more detail below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A holder of a warrant may notify Data Knights in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person&#8217;s affiliates), to the warrant agent&#8217;s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the shares of Class&#160;A common stock outstanding immediately after giving effect to such exercise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the number of outstanding shares of Class&#160;A common stock is increased by a stock dividend payable in shares of Class&#160;A common stock, or by a split-up of shares of Class&#160;A common stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Class&#160;A common stock issuable on exercise of each whole warrant will be increased in proportion to such increase in the outstanding shares of Class&#160;A common stock. A rights offering to holders of Class&#160;A common stock entitling holders to purchase shares of Class&#160;A common stock at a price less than the fair market value will be deemed a stock dividend of a number of shares of Class&#160;A common stock equal to the product of (i)&#160;the number of shares of Class&#160;A common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class&#160;A common stock) and (ii)&#160;one (1)&#160;minus the quotient of (x)&#160;the price per share of Class&#160;A common stock paid in such rights offering divided by (y)&#160;the fair market value. For these purposes (i)&#160;if the rights offering is for securities convertible into or exercisable for Class&#160;A common stock, in determining the price payable for Class&#160;A common stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii)&#160;fair market value means the volume weighted average price of Class&#160;A common stock as reported during the ten (10)&#160;trading day period ending on the trading day prior to the first date on which the shares of Class&#160;A common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, if Data Knights, at any time while the warrants are outstanding and unexpired, pays a dividend or makes a distribution in cash, securities or other assets to the holders of Class&#160;A common stock on account of such shares of Class&#160;A common stock (or other shares of our capital stock into which the warrants are convertible), other than (a)&#160;as described above, (b)&#160;certain ordinary cash dividends, (c)&#160;to satisfy the redemption rights of the holders of Class&#160;A common stock in connection with a proposed initial business combination, (d)&#160;to satisfy the redemption rights of the holders of Class&#160;A common stock in connection with a stockholder vote to amend Data Knights&#8217; amended and restated certificate of incorporation (i)&#160;to modify the substance or timing of Data Knights&#8217; obligation to allow redemption in connection with its initial business combination or certain amendments to our charter prior thereto or to redeem 100% of Data Knights&#8217; Class&#160;A common stock if Data Knights does not complete its initial business combination within 18&#160;months from the closing of the offering or (ii)&#160;with respect to any other provision relating to stockholders&#8217; rights or pre-initial business combination activity, or (e)&#160;in connection with the redemption of our Public Shares upon Data Knights&#8217; failure to complete its initial business combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of Class&#160;A common stock in respect of such event.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the number of outstanding shares of our Class&#160;A common stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Class&#160;A common stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Class&#160;A common stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding shares of Class&#160;A common stock.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">219</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Whenever the number of shares of Class&#160;A common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x)&#160;the numerator of which will be the number of shares of Class&#160;A common stock purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y)&#160;the denominator of which will be the number of shares of Class&#160;A common stock so purchasable immediately thereafter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In case of any reclassification or reorganization of the outstanding shares of Class&#160;A common stock (other than those described above or that solely affects the par value of such shares of Class&#160;A common stock), or in the case of any merger or consolidation of Data Knights with or into another corporation (other than a consolidation or merger in which Data Knights is the continuing corporation and that does not result in any reclassification or reorganization of Data Knights&#8217; outstanding shares of Class&#160;A common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of Data Knights as an entirety or substantially as an entirety in connection with which Data Knights is dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the shares of Data Knights Class&#160;A common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">However, if less than 70% of the consideration receivable by the holders of Class&#160;A common stock in such a transaction is payable in the form of Class&#160;A common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty&#160;days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants in order to determine and realize the option value component of the warrant. This formula is to compensate the warrant holder for the loss of the option value portion of the warrant due to the requirement that the warrant holder exercise the warrant within 30&#160;days of the event. The Black-Scholes model is an accepted pricing model for estimating fair market value where no quoted market price for an instrument is available.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The warrants will be issued in registered form under a warrant agreement between Continental Stock Transfer&#160;&amp; Trust Company, as warrant agent, and Data Knights. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in this prospectus, or defective provision, but requires the approval by the holders of at least a majority of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, if (x)&#160;Data Knights issues additional shares of Class&#160;A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at a Newly Issued Price of less than $9.20 per share of Class&#160;A common stock (with such issue price or effective issue price to be determined in good faith by Data Knights&#8217; board of directors and, in the case of any such issuance to Data Knights&#8217; sponsor or its affiliates, without taking into account any founder shares held by Data Knights&#8217; sponsor or such affiliates, as applicable, prior to such issuance), (y)&#160;the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of Data Knights&#8217; initial business combination on the date of the consummation of its initial business combination (net of redemptions), and (z)&#160;the Market Value is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of Class&#160;A common stock and any voting rights until they exercise their warrants and receive shares of Class&#160;A common stock. After the issuance of shares of Class&#160;A common stock upon exercise of the warrants, each holder will be entitled to one (1)&#160;vote for each share held of record on all matters to be voted on by stockholders.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">220</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, Data Knights will, upon exercise, round down to the nearest whole number of shares of Class&#160;A common stock to be issued to the warrant holder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights has agreed that, subject to applicable law, any action, proceeding or claim against Data Knights arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and Data Knights irrevocably submits to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive forum.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Placement Warrants</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Except as described below, the placement warrants have terms and provisions that are identical to those of the warrants sold as part of the units in the offering, including as to exercise price, exercisability and exercise period. The placement warrants (including the Class&#160;A common stock issuable upon exercise of the placement warrants) will not be transferable, assignable or salable until 30&#160;days after the completion of Data Knights&#8217; initial business combination. The placement warrants will also be exercisable on a cashless basis and will not be redeemable by Data Knights so long as they are held by Data Knights&#8217; sponsor or its permitted transferees. Data Knights&#8217; sponsor or its permitted transferees have the option to exercise the placement warrants on a cashless basis. If the placement warrants are held by holders other than the sponsor or its permitted transferees, the placement warrants will be redeemable by Data Knights and exercisable by the holders on the same basis as the warrants included in the units being sold in this offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If holders of the placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering their warrants for that number of shares of Class&#160;A common stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of Class&#160;A common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value. The &#8220;fair market value&#8221; for this purpose shall mean the average reported last sale price of the Class&#160;A common stock for the 10 trading&#160;days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. The reason Data Knights agreed that these warrants will be exercisable on a cashless basis so long as they are held by the sponsor or its permitted transferees is because it is not known at this time whether they will be affiliated with Data Knights following an initial business combination. If they remain affiliated with Data Knights, their ability to sell Data Knights&#8217; securities in the open market will be significantly limited. Data Knights expects to have policies in place that prohibit insiders from selling Data Knights&#8217; securities except during specific periods of time. Even during such periods of time when insiders will be permitted to sell Data Knights&#8217; securities, an insider cannot trade in Data Knights&#8217; securities if he or she is in possession of material non-public information. Accordingly, unlike public stockholders who typically could sell the shares of Class&#160;A common stock issuable upon exercise of the warrants freely in the open market, the insiders could be significantly restricted from doing so. As a result, Data Knights believes that allowing the holders to exercise such warrants on a cashless basis is appropriate. In addition, holders of Data Knights&#8217; placement warrants are entitled to certain registration rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to finance transaction costs in connection with an intended initial business combination, Data Knights&#8217; sponsor or an affiliate of Data Knights&#8217; sponsor or certain of Data Knights&#8217; officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into units, at a price of $10.00 per unit at the option of the lender, upon consummation of our initial business combination. The units would be identical to the placement units. However, as the units would not be issued until consummation of Data Knights&#8217; initial business combination, any warrants underlying such units would not be able to be voted on an amendment to the warrant agreement in connection with such business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Accounting Treatment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Due to certain provisions contained in Data Knights&#8217; warrant agreement, both the public warrants and the placement warrants are expected to be treated as a derivative liability, and, as such, Data Knights is required to record the fair value of each warrant as a liability in accordance with the guidance contained in ASC 815-40. As a result, each quarter, Data Knights is required to determine the fair value of each warrant and record the change on the value of the warrants from the prior quarter as a gain or a loss on Data Knights&#8217; income statement, which will change the value of the liability for the warrants on its balance sheet.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">221</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Dividends</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights has not paid any cash dividends on Data Knights Common Stock to date and does not intend to pay cash dividends prior to the completion of a business combination. The payment of cash dividends in the future will be dependent upon Data Knights&#8217; revenues and earnings, if any, capital requirements and general financial conditions subsequent to completion of a business combination. The payment of any cash dividends subsequent to a business combination will be within the discretion of Data Knights&#8217; board of directors at such time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Our Transfer Agent</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The transfer agent for Data Knights&#8217; common stock is Continental Stock Transfer&#160;&amp; Trust Company. Data Knights has agreed to indemnify Continental Stock Transfer&#160;&amp; Trust Company in its role as transfer agent, its agents and each of its stockholders, directors, officers and employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any claims and losses due to any gross negligence or intentional misconduct of the indemnified person or entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Certain Anti-Takeover Provisions of Delaware Law and Data Knights&#8217; Charter and Bylaws</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights is subject to the provisions of Section&#160;203 of the DGCL regulating corporate takeovers. This statute prevents certain Delaware corporations, under certain circumstances, from engaging in a &#8220;business combination&#8221; with:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an &#8220;interested stockholder&#8221;);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an affiliate of an interested stockholder; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an associate of an interested stockholder, for three&#160;years following the date that the stockholder became an interested stockholder.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A &#8220;business combination&#8221; includes a merger or sale of more than 10% of Data Knights&#8217; assets. However, the above provisions of Section&#160;203 do not apply if:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Data Knights&#8217; board of directors approves the transaction that made the stockholder an &#8220;interested stockholder,&#8221; prior to the date of the transaction;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">after the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at least 85% of Data Knights&#8217; voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">on or subsequent to the date of the transaction, the initial business combination is approved by Data Knights&#8217; board of directors and authorized at a meeting of Data Knights stockholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; amended and restated certificate of incorporation provides that Data Knights&#8217; board of directors will be classified into three classes of directors. As a result, in most circumstances, a person can gain control of Data Knights&#8217; board of directors only by successfully engaging in a proxy contest at two or more annual meetings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; authorized but unissued common stock and preferred stock will be available for future issuances without stockholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more difficult or discourage an attempt to obtain control of Data Knights by means of a proxy contest, tender offer, merger or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Exclusive forum for certain lawsuits</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Data Knights&#8217; amended and restated certificate of incorporation will require, to the fullest extent permitted by law, that derivative actions brought in Data Knights&#8217; name, actions against directors, officers and employees for breach of fiduciary duty and certain other actions may be brought only in the Court of Chancery in the State of Delaware, except any action (A)&#160;as to which the Court of </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">222</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Chancery in the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten&#160;days following such determination), (B)&#160;which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery or (C)&#160;for which the Court of Chancery does not have subject matter jurisdiction. Data Knights&#8217; amended and restated certificate of incorporation will provide that actions under the Securities Act or the Exchange Act be brought exclusively in the federal district court for the district of Delaware. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder&#8217;s counsel. Although Data Knights believes this provision benefits it by providing increased consistency in the application of law in the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits against Data Knights&#8217; directors and officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; amended and restated certificate of incorporation will provide that the exclusive forum provision will be applicable to the fullest extent permitted by applicable law, subject to certain exceptions. There is uncertainty as to whether a court would enforce this provision with respect to certain claims under federal securities laws, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Special meeting of stockholders</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; bylaws provide that special meetings of Data Knights&#8217; stockholders may be called only by a majority vote of our board of directors, by our Chief Executive Officer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Advance notice requirements for stockholder proposals and director nominations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; bylaws provide that stockholders seeking to bring business before Data Knights&#8217; annual meeting of stockholders, or to nominate candidates for election as directors at Data Knights&#8217; annual meeting of stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder&#8217;s notice will need to be received by the company secretary at Data Knights&#8217; principal executive offices not later than the close of business on the 90th day nor earlier than the opening of business on the 120th day prior to the anniversary date of the immediately preceding annual meeting of stockholders. Pursuant to Rule&#160;14a-8 of the Exchange Act, proposals seeking inclusion in Data Knights&#8217; annual proxy statement must comply with the notice periods contained therein. Data Knights&#8217; bylaws also specify certain requirements as to the form and content of a stockholders&#8217; meeting. These provisions may preclude Data Knights stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at Data Knights&#8217; annual meeting of stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Action by written consent</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Subsequent to the consummation of the offering, any action required or permitted to be taken by Data Knights common stockholders must be effected by a duly called annual or special meetings of such stockholders and may not be effected by written consent of the stockholders other than with respect to Data Knights&#8217; founder shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Classified board of directors</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; board of directors will initially be divided into three classes, Class&#160;I, Class&#160;II and Class&#160;III, with members of each class serving staggered three-year terms. Data Knights&#8217; amended and restated certificate of incorporation provides that the authorized number of directors may be changed only by resolution of the board of directors. Subject to the terms of any preferred stock, any or all of the directors may be removed from office at any time, but only for cause and only by the affirmative vote of holders of a majority of the voting power of all then outstanding shares of Data Knights Acquisition stock entitled to vote generally in the election of directors, voting together as a single class. Any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of Data Knights&#8217; directors then in office.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Class&#160;B Common Stock Consent Right</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">For so long as any shares of Data Knights&#8217; founder shares remain outstanding, Data Knights may not, without the prior vote or voting separately as a single class, amend, alter or repeal any provision of Data Knights&#8217; amended and restated certificate of incorporation, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal would alter or change the </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">223</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">powers, preferences or relative, participating, optional or other or special rights of the founder shares. Any action required or permitted to be taken at any meeting of the holders of Data Knights&#8217; founder shares may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of the outstanding founder shares having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares of Data Knights&#8217; founder shares were present and voted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Rule&#160;144</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to Rule&#160;144, a person who has beneficially owned restricted shares for at least six&#160;months would be entitled to sell their securities provided that (i)&#160;such person is not deemed to have been one of Data Knights&#8217; affiliates at the time of, or at any time during the three&#160;months preceding, a sale and (ii)&#160;Data Knights is subject to the Exchange Act periodic reporting requirements for at least three&#160;months before the sale and have filed all required reports under Section&#160;13 or 15(d)&#160;of the Exchange Act during the 12&#160;months (or such shorter period as we were required to file reports) preceding the sale.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Persons who have beneficially owned restricted shares for at least six&#160;months but who are Data Knights affiliates at the time of, or at any time during the three&#160;months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1% of the total number of shares of common stock then outstanding, which will equal 100,000 shares immediately after this offering (or 115,000 if the underwriters exercise their over-allotment option in full); or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the average weekly reported trading volume of shares of Data Knights Class&#160;A common stock during the four calendar weeks preceding the filing of a notice on Form&#160;144 with respect to the sale.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Sales by our affiliates under Rule&#160;144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information about us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Restrictions on the Use of Rule&#160;144 by Shell Companies or Former Shell Companies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Rule&#160;144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell companies) or issuers that have been at any time previously a shell company. However, Rule&#160;144 also includes an important exception to this prohibition if the following conditions are met:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the issuer of the securities that was formerly a shell company has ceased to be a shell company;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the issuer of the securities is subject to the reporting requirements of Section&#160;13 or 15(d)&#160;of the Exchange Act; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12&#160;months (or such shorter period that the issuer was required to file such reports and materials), other than Form&#160;8-K reports; and at least one&#160;year has elapsed from the time that the issuer filed current Form&#160;10 type information with the SEC reflecting its status as an entity that is not a shell company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a result, Data Knights&#8217; initial stockholders will be able to sell their founder shares and placement units (including component securities contained therein), as applicable, pursuant to Rule&#160;144 without registration one&#160;year after Data Knights has completed its initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Registration Rights</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The holders of the founder shares and placement units (including securities contained therein) and units (including securities contained therein) that may be issued upon conversion of working capital loans, and any shares of Class&#160;A common stock issuable upon the exercise of the placement warrants and any shares of Class&#160;A common stock and warrants (and underlying Class&#160;A common stock) that may be issued upon conversion of the units issued as part of the working capital loans and Class&#160;A common stock issuable upon conversion of the founder shares, are entitled to registration rights pursuant to a registration rights agreement that was signed prior to the effective date of this offering, requiring Data Knights to register such securities for resale (in the case of the founder shares, only after conversion to Data Knights Class&#160;A common stock). The holders of these securities are entitled to make up to two demands, excluding short form demands, that Data Knights register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; </p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">224</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">registration rights with respect to registration statements filed subsequent to Data Knights&#8217; completion of its initial business combination and rights to require Data Knights to register for resale such securities pursuant to Rule&#160;415 under the Securities Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">However, the registration rights agreement provides that Data Knights will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i)&#160;in the case of the founder shares, as described in the following paragraph, and (ii)&#160;in the case of the placement warrants, on the later of 12&#160;months from the closing of Data Knights&#8217; offering (which has expired as of the date hereof) and 30&#160;days after the Closing of the Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering our securities. Data Knights will bear the expenses incurred in connection with the filing of any such registration statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Except as described herein, Data Knights&#8217; Sponsor, officers and directors have agreed not to transfer, assign or sell any of their founder shares and placement units until the earlier to occur of: (A)&#160;six&#160;months after the Closing of the Business Combination or (B)&#160;subsequent to Data Knights&#8217; initial business combination, (x)&#160;if the last sale price of Data Knights&#8217; Class&#160;A Common Stock equals or exceeds $12.00 per unit (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading&#160;days within any 30-trading day period commencing at least 150&#160;days after Data Knights&#8217; initial business combination, or (y)&#160;the date on which Data Knights completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of Data Knights&#8217; stockholders having the right to exchange their shares of common stock for cash, securities or other property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Concurrently with the Closing, Data Knights will amend and restate its registration rights agreement, dated April&#160;25, 2022, pursuant to which the existing OneMedNet Stockholders will become party thereto and New OneMedNet will agree that, within 30 calendar&#160;days after the Closing of the Business Combination, New OneMedNet will file with the SEC a resale registration statement (a &#8220;Resale Registration Statement&#8221;), and New OneMedNet will use its commercially reasonable efforts to have the Resale Registration Statement declared effective as soon as reasonably practicable after the filing thereof. In certain circumstances, the holders party thereto can demand New OneMedNet&#8217;s assistance with underwritten offerings and block trades. Such holders will be entitled to customary piggyback registration rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Lock-Up</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Simultaneously with the execution of the Merger Agreement, the Significant Company Holders and certain directors and officers of OneMedNet entered into lock-up agreements providing for a lock-up period commencing on the Closing Date and ending on the earlier of (x) six months from the Closing and (y) the date Data Knights consummates a liquidation, merger, share exchange or other similar transaction with an unaffiliated third party that results in all of Data Knights&#8217; stockholders having the right to exchange their shares of Data Knights Common Stock for cash, securities or other property. A total of 6,353,344 shares or 55.7% of OneMedNet issued and outstanding shares including the officers and directors are subject to the Lock-Up Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">225</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_a799833f_00ae_42c0_8f0c_75e2f8768ded"></a><a id="DESCRIPTIONOFSECURITIESAFTERTHEBUSINESSC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">DESCRIPTION OF SECURITIES AFTER THE BUSINESS COMBINATION</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following summary of the material terms of Data Knights&#8217; securities following the Business Combination is not intended to be a complete summary of the rights and preferences of such securities. We urge you to read the proposed A/R Charter in its entirety for a complete description of the rights and preferences of Data Knights&#8217; securities following the Business Combination. The proposed A/R Charter is described in &#8220;</span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">The Charter Amendment Proposal</i><span style="font-family:'Times New Roman','Times','serif';">,&#8221; and the full text of the proposed A/R Charter is attached as Form&#160;of Third Amended and Restated Certificate of Incorporation (included as </span><i style="font-family:'Times New Roman','Times','serif';font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex&#160;C</i><span style="font-family:'Times New Roman','Times','serif';"> to the proxy statement/prospectus). Data Knights does not currently anticipate amending or restating the Bylaws of Data Knights in connection with the Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the Data Knights Charter, Data Knights&#8217; authorized capital stock consists of 111,000,000 shares of common stock, $0.0001 par value including (i)&#160;100,000,000 shares of Class&#160;A Common Stock (the &#8220;Class&#160;A Common Stock&#8221;), and (ii)&#160;10,000,000 shares of Class&#160;B Common Stock (the &#8220;Class&#160;B Common Stock&#8221;), and (b)&#160;1,000,000 shares of preferred stock (the &#8220;Preferred Stock&#8221;). Following the Business Combination, pursuant to the Data Knights A/R Charter, the authorized capital stock of Data Knights will consist of 100,000,000 shares of common stock, $0.0001 par value, and 1,000,000 shares of undesignated preferred stock, $0.0001 par value. The following description summarizes the material terms of the capital stock of Data Knights after the Business Combination. Because it is only a summary, it may not contain all the information that is important to you.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Common Stock</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">It is anticipated that, immediately after the Closing of the Business Combination, Data Knights will have a total of 33,013,786 shares of Data Knights Common Stock issued and outstanding. The foregoing excludes any outstanding warrants and assumes that (i)&#160;there are no further redemptions of any shares by Data Knights&#8217; public stockholders in connection with the Business Combination; (ii)&#160;no awards are issued under the </span><span style="font-family:'Times New Roman','Times','serif';">Equity</span><span style="font-family:'Times New Roman','Times','serif';"> Incentive Plan; and (iii)&#160;Data Knights does not engage in any kind of additional equity financing prior to the Closing. If the actual facts are different than these assumptions (which they are likely to be), the&#160;percentage ownership retained by the Data Knights&#8217; existing stockholders and the other parties described above in Data Knights will be different.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Unless specified in the Data Knights A/R Charter or Data Knights Bylaws, or as required by applicable provisions of the DGCL or applicable stock exchange rules, the affirmative vote of a majority of our shares of Data Knights Common Stock that are voted is required to approve any such matter voted on by our stockholders.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Data Knights Board will consist of nine members upon the closing of the Business Combination. In accordance with the Data Knights A/R Charter to be filed immediately prior to the Closing of the Business Combination, the Data Knights Board will be divided into three classes of directors, with (a)&#160;one class of directors, the Class&#160;I Directors, initially serving a one (1)-year term, such term effective from the Closing (but any subsequent Class&#160;I Directors serving a three (3)-year term), (b)&#160;a second class of directors, the Class&#160;II Directors, initially serving a two (2)-year term, such term effective from the Closing (but any subsequent Class&#160;II Directors serving a three (3)-year term), and (c)&#160;a third class of directors, the Class&#160;III Directors, serving a three (3)-year term, such term effective from the Closing. Directors will not be able to be removed during their term except for cause and only by the affirmative vote of the holders of at least sixty-six and two-thirds&#160;percent (66-2/3%) of the total voting power of the outstanding shares of capital stock entitled to vote in the election of directors, voting together as a single class. There is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the election of directors can elect all of the directors. Our stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">All of the outstanding shares of Data Knights Common Stock will convert into shares of Data Knights Common Stock at the Closing of the Business Combination. With certain limited exceptions, the founder shares are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with our initial stockholders, each of whom will be subject to the same transfer restrictions) until the earlier of (A)&#160;the six-month anniversary of the Closing or (B)&#160;subsequent to our initial business combination, (x)&#160;if the last reported sale price of Data Knights Common Stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading&#160;days within any 30-trading day period following our initial business combination, or (y)&#160;the date on which we complete a liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">226</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Preferred Stock</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights A/R Charter provides that shares of preferred stock may be issued from time to time in one or more series. The Data Knights Board will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The Data Knights Board will be able to, without stockholder approval, issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of the Data Knights Board to issue preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of Data Knights or the removal of existing management. Although Data Knights will not have any preferred stock outstanding at or prior to the date of the Closing of the Business Combination and does not currently intend to issue any shares of preferred stock in connection with the Business Combination, Data Knights cannot assure you that it will not do so in the future. No shares of preferred stock are being issued or registered in the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warrants</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Each Data Knights warrant entitles the registered holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30&#160;days after the completion of the Business Combination. However, no warrants will be exercisable for cash unless Data Knights has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective within a specified period following the consummation of our initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when Data Knights shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section&#160;3(a)(9)&#160;of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value. The &#8220;fair market value&#8221; for this purpose will mean the average reported last sale price of the shares of common stock for the five trading&#160;days ending on the trading day prior to the date of exercise. The warrants will expire on the fifth anniversary of the completion of the Business Combination, at 5:00&#160;p.m., New York City time, or earlier upon redemption or liquidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant,</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at any time after the warrants become exercisable,</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than 30&#160;days&#8217; prior written notice of redemption to each warrant holder,</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20&#160;trading&#160;days within a 30-trading-day period commencing after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The right to exercise will be forfeited unless the warrants are exercised prior to the date specified in the notice of redemption. On and after the redemption date, a record holder of a warrant will have no further rights except to receive the redemption price for such holder&#8217;s warrant upon surrender of such warrant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The redemption criteria for the warrants have been established at a price which is intended to provide warrant holders a reasonable premium to the initial exercise price and provide a sufficient differential between the then-prevailing&#160;share price and the warrant exercise price so that if the share price declines as a result of our redemption call, the redemption will not cause the share price to drop below the exercise price of the warrants.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">227</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we call the warrants for redemption as described above, Data Knights management will have the option to require all holders that wish to exercise warrants to do so on a &#8220;cashless basis.&#8221; In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value. The &#8220;fair market value&#8221; for this purpose shall mean the average reported last sale price of the shares of common stock for the five&#160;trading&#160;days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The warrants will be issued in registered form under a warrant agreement between <span style="color:#333333;">Continental Stock Transfer&#160;&amp; Trust Company</span>, as warrant agent, and Data Knights. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision but requires the approval, by written consent or vote, of the holders of at least 50% of the then-outstanding public warrants in order to make any change that adversely affects the interests of the registered holders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The exercise price and number of shares of common stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise prices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price, by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of shares of common stock and any voting rights until they exercise their warrants and receive shares of common stock. After the issuance of shares of common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Warrant holders may elect to be subject to a restriction on the exercise of their warrants such that an electing warrant holder would not be able to exercise their warrants to the extent that, after giving effect to such exercise, such holder would beneficially own in excess of 9.8% of the shares of common stock outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, Data Knights will, upon exercise, round up to the nearest whole number the number of shares of common stock to be issued to the warrant holder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Warrant Agreement provides that, subject to applicable law, any action, proceeding or claim against Data Knights, as the successor or assignor of Data Knights, arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State of New York or the United&#160;States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding, or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive forum. Data Knights&#8217; Amended Charter also contains provisions regarding the exclusive forum for certain actions involving Data Knights&#8217;. See &#8220;<i style="font-style:italic;">Exclusive Forum for Certain Lawsuits</i>&#8221; below and &#8220;<i style="font-style:italic;">Risk Factors&#8201;&#8212;&#8201;Risks Related to Legal and Compliance Matters&#8201;&#8212;&#8201;The Data Knights Amended Charter will designate a state or federal court located within the State of Delaware as the exclusive forum for substantially all disputes between New OneMedNet and its stockholders, and also provide that the federal district courts in Delaware will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act or the Exchange Act, each of which could limit the ability of New OneMedNet&#8217;s stockholders to choose the judicial forum for disputes with New OneMedNet or its directors, officers, or employees.&#8221;</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Dividends</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights does not intend to pay cash dividends on its common stock. The payment of cash dividends will be dependent upon Data Knights&#8217; revenues and earnings, if any, capital requirements and general financial conditions. The payment of any cash dividends will be within the discretion of the Data Knights Board at such time. Further, Data Knights&#8217; ability to declare dividends may be limited by restrictive covenants contained in the agreements governing Data Knights&#8217; indebtedness.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">228</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our Transfer Agent and Warrant Agent</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The transfer agent for Data Knights Common Stock and warrant agent for Data Knights warrants will be Continental Stock Transfer&#160;&amp; Trust Company. Data Knights has agreed to indemnify Continental Stock Transfer&#160;&amp; Trust Company in its roles as transfer agent and warrant agent, its agents and each of its stockholders, directors, officers and employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any liability due to any gross negligence, willful misconduct or bad faith of the indemnified person or entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Certain Anti-Takeover Provisions of Delaware Law and the Data Knights A/R Charter and the Data Knights Bylaws</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights will be subject to the provisions of Section&#160;203 of the DGCL regulating corporate takeovers. This statute prevents certain Delaware corporations, under certain circumstances, from engaging in a &#8220;business combination&#8221; with:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a stockholder who owns 15% or more of Data Knights&#8217; outstanding voting stock (otherwise known as an &#8220;interested stockholder&#8221;);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an affiliate of an interested stockholder; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an associate of an interested stockholder for three&#160;years following the date that the stockholder became an interested stockholder.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A &#8220;business combination&#8221; includes a merger or sale of Data Knights&#8217; assets with a market value of 10% or more of its aggregate market value of all of its assets or of all of its outstanding stock. However, the above provisions of Section&#160;203 do not apply if:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Data Knights Board approves the transaction that made the stockholder an &#8220;interested stockholder&#8221; prior to the date of the transaction;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">after the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at least 85% of Data Knights&#8217; voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">on or subsequent to the date of the transaction, the initial business combination is approved by the Data Knights Board and authorized at a meeting of Data Knights&#8217; stockholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under certain circumstances, Section&#160;203 of the DGCL will make it more difficult for a person who would be an &#8220;interested stockholder&#8221; to effect various business combinations with Data Knights for a three-year period. This provision may encourage companies interested in acquiring Data Knights to negotiate in advance with the Data Knights Board because the stockholder approval requirement would be avoided if the Data Knights Board approves either the business combination or the transaction which results in the stockholder becoming an interested stockholder. Section&#160;203 of the DGCL also may have the effect of preventing changes in the Data Knights Board and may make it more difficult to accomplish transactions which stockholders may otherwise deem to be in their best interests.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights A/R Charter provides that the Data Knights Board is classified into three classes of directors. As a result, in most circumstances, a person can gain control of the Data Knights Board only by successfully engaging in a proxy contest at two or more annual meetings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights A/R Charter provides that the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>&#8725;<sub style="font-size:7.5pt;vertical-align:sub;">3</sub>)% of the voting power of all of the then-outstanding shares of the Voting Stock (as defined in the A/R Charter), voting together as a single class, shall be required to alter, amend, or repeal Articles V (Board of Directors), VI (Stockholders), VII (Liability and Indemnification; Corporate Opportunity), VIII (Business Combinations), IX (Exclusive Forum), and Article X (Amendments) of the A/R Charter. This higher approval requirement may have the effect of delaying or preventing changes in these provisions of the A/R Charter, and thereby have the effect of delaying or preventing changes in OneMedNet&#8217;s control or management.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">229</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Authorized But Unissued Shares</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; authorized but unissued common stock and preferred stock are available for future issuances without stockholder approval (including a specified future issuance) and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions, and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more difficult or discourage an attempt to obtain control of Data Knights by means of a proxy contest, tender offer, merger, or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Exclusive Forum for Certain Lawsuits</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; amended and restated certificate of incorporation will require, to the fullest extent permitted by law, that derivative actions brought in Data Knights&#8217; name, actions against directors, officers and employees for breach of fiduciary duty and certain other actions may be brought only in the Court of Chancery in the State of Delaware, except any action (A) as to which the Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery or (C) for which the Court of Chancery does not have subject matter jurisdiction. Data Knights&#8217; amended and restated certificate of incorporation will provide that actions under the Securities Act or the Exchange Act be brought exclusively in the federal district court for the district of Delaware. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder&#8217;s counsel. Although Data Knights believes this provision benefits it by providing increased consistency in the application of law in the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits against Data Knights&#8217; directors and officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights&#8217; amended and restated certificate of incorporation will provide that the exclusive forum provision will be applicable to the fullest extent permitted by applicable law, subject to certain exceptions. There is uncertainty as to whether a court would enforce this provision with respect to certain claims under federal securities laws, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Special Meeting of Stockholders</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights Bylaws provide that special meetings of our stockholders may be called only by a resolution adopted by the Data Knights Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Advance Notice Requirements for Stockholder Proposals and Director Nominations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Data Knights Bylaws provide that stockholders seeking to bring business before Data Knights&#8217; annual meeting of stockholders, or to nominate candidates for election as directors at Data Knights&#8217; annual meeting of stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder&#8217;s notice will need to be received by the company secretary at Data Knights&#8217; principal executive offices not later than the close of business on the 90th day nor earlier than the opening of business on the 120th day prior to the anniversary date of the immediately preceding annual meeting of stockholders. Pursuant to Rule&#160;14A-8 of the Exchange Act, proposals seeking inclusion in Data Knights&#8217; annual proxy statement must comply with the notice periods contained therein. The Data Knights Bylaws also specify certain requirements as to the form and content of a stockholders&#8217; meeting. These provisions may preclude Data Knights&#8217; stockholders from bringing matters before Data Knights&#8217; annual meeting of stockholders or from making nominations for directors at Data Knights&#8217; annual meeting of stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Action by Written Consent</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Subsequent to the consummation of the IPO, any action required or permitted to be taken at any annual and special meetings of stockholders may be taken only upon the vote of stockholders at an annual or special meeting duly noticed and called in accordance with the DGCL and may not be taken by written consent of the stockholders without a meeting.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">230</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Classified Board of Directors</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 12pt 0pt;">The Data Knights Board will be divided into three classes, Class&#160;I, Class&#160;II and Class&#160;III, with members of each class serving staggered three-year terms. As a result, in most circumstances, a person can gain control of the Data Knights Board only by successfully engaging in a proxy contest at two or more annual meetings. The Data Knights A/R Charter and the Data Knights Bylaws provide that the authorized number of directors may be changed only by resolution of the board of directors. Subject to the terms of any preferred stock, any or all of the directors may be removed from office at any time, but only for cause and only by the affirmative vote of holders of at least 66<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>/<sub style="font-size:7.5pt;vertical-align:sub;">3</sub>% of the voting power of all then outstanding shares of Data Knights capital stock entitled to vote generally in the election of directors, voting together as a single class. Any vacancy on the Data Knights Board, including a vacancy resulting from an enlargement of the Data Knights Board, may be filled only by vote of a majority of Data Knights&#8217; directors then in office.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Listing of Data Knights Securities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">It is anticipated that Data Knights&#8217; common stock and warrants will be traded on The Nasdaq Stock Market LLC under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW,&#8221; respectively, following the closing of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">231</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_a49e8ce6_479f_42b3_80ed_1b2765bd5267"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="BENEFICIALOWNERSHIPOFSECURITIES_494858"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:center;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">BENEFICIAL OWNERSHIP OF SECURITIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 12pt 0pt;">The following table sets forth information regarding (i)&#160;the actual beneficial ownership of Data Knights Common Stock as of [<span style="font-family:'Symbol';">&#183;</span>], 2023, the record date, and (ii)&#160;expected beneficial ownership of the Post-Combination Company common stock immediately following the Closing, assuming that no Public Shares are redeemed, and alternatively that all 2,731,544 of the Public Shares are redeemed, by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt 0pt 12pt 0pt;">&#9679;</td><td style="padding:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each person who is, or is expected to be, the beneficial owner of more than 5% of issued and outstanding shares of Data Knights Common Stock or of the Post-Combination Company common stock;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt 0pt 12pt 0pt;">&#9679;</td><td style="padding:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each of our current executive officers and directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt 0pt 12pt 0pt;">&#9679;</td><td style="padding:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each person who will become an executive officer or director of the Post-Combination Company post-Business Combination; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all executive officers and directors of Data Knights as a group pre-Business Combination and all executive officers and directors of the Post-Combination Company post-Business Combination.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 12pt 0pt;">Beneficial ownership is determined according to the rules&#160;of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60&#160;days. Unless otherwise indicated, Data Knights believes that all persons named in the table have sole voting and investment power with respect to all shares of Data Knights Common Stock beneficially owned by them.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The beneficial ownership of shares of Data Knights Common Stock pre-Business Combination is based on 7,570,336 shares of Data Knights Common Stock (including 2,731,544 Public Shares, 585,275 Placement Shares, 2,875,000 Founder Shares, and 1,378,517 shares held by ARC Group) issued and outstanding as of April&#160;1, 2023.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The beneficial ownership information below excludes the shares underlying the Public Warrants and the Private Placement Warrants because those securities are not exercisable within 60&#160;days of this proxy statement/prospectus and are contingent upon the consummation of the Business Combination. The beneficial ownership information below excludes the shares expected to be issued or reserved under the 2022 Equity Incentive Plan, as well as shares underlying unvested stock options.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The expected beneficial ownership of shares of the Post-Combination Company common stock post-Business Combination assuming none of the Public Shares are redeemed has been determined based upon the following: (i)&#160;that no Public Stockholders exercise their redemption rights (no further redemptions scenario), (ii)&#160;that none of the investors set forth in the table below has purchased or purchases shares of Data Knights Common Stock (pre-Business Combination) or Data Knights Common Stock (post-Business Combination), (iii)&#160;that 20,000,000 shares of Data Knights Common Stock are issued in the Business Combination, and (iv)&#160;there will be an aggregate of 33,013,786 shares of the Data Knights Common Stock issued and outstanding at Closing.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The expected beneficial ownership of shares of Data Knights Common Stock post-Business Combination assuming the maximum number of Public Shares have been redeemed has been determined based on the following: (i)&#160;that holders of all 2,731,544 of the Public Shares exercise their redemption rights (maximum redemption scenario), (ii)&#160;that none of the investors set forth in the table below has purchased or purchases shares of Data Knights Common Stock (pre-Business Combination) or the Post-Combination Company common stock (post-Business Combination), (iii)&#160;that 20,000,000 shares of the Post-Combination Company common stock are issued in the Business Combination, and (iv)&#160;there will be an aggregate of 35,819,057&#160;shares of the Post-Combination Company common stock issued and outstanding at Closing.</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">232</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares beneficially owned by them.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:normal;width:48.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:normal;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:normal;width:32.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">After the Business Combination</b></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:normal;width:15.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:normal;width:15.18%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming</b></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:normal;width:15.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Before the Business</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:normal;width:15.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assuming No</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:normal;width:15.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maximum</b></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:normal;width:15.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Combination</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:normal;width:15.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Further Redemptions</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:normal;width:15.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redemptions</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">shares of</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">shares of</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">shares of</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:normal;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data Knights</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data Knights</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data Knights</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Common</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Common</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Common</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Name and Address of Beneficial Owner</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock</b></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">%</b></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Directors and Executive Officers</span> <span style="font-style:italic;font-weight:bold;">Pre-Business Combination</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Barry Anderson</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">15,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">15,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">15,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Firdauz Edmin bin Mokhtar</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">15,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">15,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">15,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Syed Musheer Ahmed</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Dr. Julianne Huh</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Annie Damit Undikai</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><i style="font-style:italic;">All pre-Business Combination directors</i> <i style="font-style:italic;">and executive officers as a group (5 individuals)</i></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Directors and Executive Officers Post-Business</span> <span style="font-style:italic;font-weight:bold;">Combination</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Julianne Huh</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Paul Casey</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">599,172</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">11.9%</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">599,172</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2.6%</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Jeffrey Yu</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">3,713,753</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10.6%</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">3,713,753</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15.8%</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lisa Embree</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Erkan Akyuz</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eric Casaburi</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Robert Golden</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Thomas Kosasa<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4,952,409</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">14.2%</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> 4,952,409</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">21.0%</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">R. Scott Holbrook</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> 45,000</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><i style="font-style:italic;">All post-Business Combination directors and executive officers as a group (10 individuals)</i></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;">5,000</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">*</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">9,535,334</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">27.3%</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">9,535,334</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">40.6%</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Five Percent Holders:</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Data Knights, LLC<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(3)</sup></p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,415,275</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">22.8%</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">3,415,275</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9.8%</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">3,415,275</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">14.6%</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Jerry Hiatt</p></td><td style="vertical-align:bottom;white-space:normal;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">1,329,058</p></td><td style="vertical-align:bottom;white-space:normal;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:5.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3.8%</p></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">1,329,058</p></td><td style="vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">5.7%</p></td><td style="vertical-align:bottom;white-space:normal;width:0.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">*</span></span>Less than 1%</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">Excludes 32,656 shares held jointly with a trust in a tenants in common relationship as to which Dr. Kosasa disclaims any beneficial ownership.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">Data Knights, LLC, our sponsor, is the record holder of 585,275 shares of Class A Common Stock and 2,830,000 shares of Class B Common Stock reported herein. Barry Anderson, our Chairman and Chief Executive Officer, is a manager of our sponsor. Firdauz Edmin Bin Mokhtar, our Chief Financial Officer, is a manager and equity holder of our sponsor. By virtue of this relationship, Mr. Anderson and Mr. Mokhtar may be deemed to share beneficial ownership of the securities held of record by our sponsor. Mr. Anderson and Mr. Mokhtar each disclaims any such beneficial ownership except to the extent of his respective pecuniary interest. The business address of each of these entities and individuals is Unit G6, Frome Business Park, Manor Road, Frome, United Kingdom, BA11 4FN.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;">Includers shares of Class B Common Stock convertible into shares of Class A Common Stock on a one-for-one basis, subject to adjustment.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">233</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_e90ac3ec_892e_47a2_8c68_019a5c522493"></a><a id="PRICERANGEANDDIVIDENDSOFSECURITIES_31551"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PRICE RANGE AND DIVIDENDS OF SECURITIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Data Knights</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Price Range of Data Knights Securities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights Units, Class&#160;A Common Stock and Warrants are currently listed on the Nasdaq under the symbols &#8220;DKDCU,&#8221; &#8220;DKDCA,&#8221; and &#8220;DKDCW,&#8221; respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Units commenced public trading on May&#160;7, 2021. The Class&#160;A Common Stock, and Warrants each commenced separate public trading on June&#160;22, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The closing price of the Data Knights Common Stock, Data Knights Warrants and Data Knights Units on April&#160;22, 2022, the last trading day before announcement of the execution of the Merger Agreement, was $10.20, $0.15 and $10.42, respectively. As of [<span style="font-family:'Times New Roman';">&#9679;</span>], 2023, the record date for the Stockholders Meeting, the closing price for the Data Knights Common Stock, Data Knights Warrants and Data Knights Units was $ [<span style="font-family:'Times New Roman';">&#9679;</span>], $ [<span style="font-family:'Times New Roman';">&#9679;</span>] and $ [<span style="font-family:'Times New Roman';">&#9679;</span>], respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Holders of Data Knights</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of the Record Date, there were [<span style="font-family:'Times New Roman';">&#9679;</span>] holders of record of Data Knights Common Stock&#160;and [<span style="font-family:'Times New Roman';">&#9679;</span>] holders of&#160;record of Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Dividend Policy of Data Knights</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights has not paid any cash dividends on its common stock to date and do not intend to pay cash dividends prior to the completion of its initial business combination. The payment of cash dividends in the future will be dependent upon Data Knights&#8217; revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of its initial business combination. The payment of any cash dividends subsequent to Data Knights&#8217; initial business combination will be within the discretion of its board of directors at such time. In addition, Data Knights&#8217; board of directors is not currently contemplating and does not anticipate declaring any stock dividends in the foreseeable future. Further, if Data Knights incurs any indebtedness in connection with its business combination, its ability to declare dividends may be limited by restrictive covenants Data Knights may agree to in connection therewith.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Dividend Policy of OneMedNet</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet has not paid any cash dividends on its stock to date and does not intend to pay cash dividends prior to the completion of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Dividend Policy of the Combined Entity Following the Business Combination</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Combined Entity intends to retain future earnings, if any, for future operations and expansion and there are no current plans to pay any cash dividends for the foreseeable future. The declaration, amount and payment of any cash dividends in the future will be at the sole discretion of the Combined Entity&#8217;s board of directors, and will depend upon the Combined Entity&#8217;s revenue earnings, if any, available cash, current and anticipated cash needs, capital requirements, contractual, legal, tax and regulatory restrictions, general financial condition subsequent to completion of the Business Combination and such other factors as the Combined Entity&#8217;s board of directors may deem relevant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">234</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_aeede3c6_0ef5_45c8_94b9_bcd9d9b7893b"></a><a id="APPRAISALRIGHTS_540665"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">APPRAISAL RIGHTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Data Knights&#8217; stockholders do not have appraisal rights in connection with the Business Combination under Delaware law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_2225013e_2d91_4140_98a1_baa6b04dbb46"></a><a id="HOUSEHOLDINGINFORMATION_178551"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">HOUSEHOLDING INFORMATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Unless we have received contrary instructions, we may send a single copy of this proxy statement to any household at which two or more stockholders reside if we believe the stockholders are members of the same family. This process, known as &#8220;householding,&#8221; reduces the volume of duplicate information received at any one household and helps to reduce our expenses. However, if stockholders prefer to receive multiple sets of our disclosure documents at the same address this&#160;year or in future&#160;years, the stockholders should follow the instructions described below. Similarly, if an address is shared with another stockholder and together both of the stockholders would like to receive only a single set of our disclosure documents, the stockholders should follow these instructions:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">If the shares are registered in the name of the stockholder, the stockholder should contact our proxy solicitor at Laurel Hill Advisory Group, LLC, 2 Robbins Lane, Suite&#160;201, Jericho, NY 11753 or by telephone at (855) 414-2266, to inform us of his or her request; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman';">&#9679;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;">If a bank, broker or other nominee holds the shares, the stockholder should contact the bank, broker or other nominee directly</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_bc66700f_3632_4f23_a67e_2ec04cc425fe"></a><a id="LEGALMATTERS_628435"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">LEGAL MATTERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Certain legal matters relating to the validity of the Class&#160;A Common Stock to be issued hereunder and certain other legal matters related to this proxy statement/prospectus will be passed upon for Data Knights by Nelson Mullins Riley&#160;&amp; Scarborough&#160;LLP. Rim&#244;n P.C. has acted as counsel for OneMedNet.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_f348d55a_2a6f_4102_a7b8_c653e7b8886e"></a><a id="INDEPENDENTAUDITORS_518162"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">INDEPENDENT AUDITORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The financial statements of Data Knights Acquisition Corp. as of December 31, 2022 and 2021 and for the year ended December 31, 2022 and the period from February 8, 2021 (inception) to December 31, 2021 included in this prospectus have been audited by Marcum LLP, independent registered public accounting firm, as set forth in their report, thereon (which contains an explanatory paragraph relating to substantial doubt about the ability of Data Knights Acquisition Corp. to continue as a going concern as described in Note 1 to the financial statements), appearing elsewhere in this prospectus, and are included in reliance on the report of such firm given upon their authority as experts in accounting and auditing.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The financial statements of OneMedNet Corporation for as of December 31, 2022 and December&#160;31, 2021, included in this proxy statement/prospectus have been so included in reliance on the report of BF Borgers CPA PC, an independent registered public accounting firm, appearing elsewhere herein (which report contains an explanatory paragraph relating to substantial doubt about the ability of OneMedNet Corporation to continue as a going concern as described in Note 2 to the financial statements), given on the authority of said firm as experts in auditing and accounting.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_d573c8c5_6f95_460a_81ed_1fbf11c89b96"></a><a id="TRANSFERAGENTANDREGISTRAR_731243"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">TRANSFER AGENT AND REGISTRAR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Transfer Agent for Data Knights&#8217; securities is Continental Stock Transfer&#160;&amp; Trust Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_20e4b7c7_438a_4a2d_bdb9_af1327bf39dd"></a><a id="DELIVERYOFDOCUMENTSTOSTOCKHOLDERS_532111"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">DELIVERY OF DOCUMENTS TO STOCKHOLDERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Pursuant to the rules&#160;of the SEC, Data Knights and servicers that it employs to deliver communications to Data Knights&#8217; stockholders are permitted to deliver to two or more stockholders sharing the same address a single copy of this proxy statement/prospectus. Upon written or oral request, Data Knights will deliver a separate copy of this proxy statement/prospectus to any stockholder at a shared address to which a single copy of this proxy statement/prospectus was delivered and who wishes to receive separate copies in the future. Stockholders receiving multiple copies of this proxy statement/prospectus may likewise request that Data Knights deliver single copies of Data Knights&#8217; proxy statement in the future. Stockholders may notify Data Knights of their requests by calling or writing Data Knights at its proxy solicitor&#8217;s offices at Laurel Hill Advisory Group, LLC, 2 Robbins Lane, Suite&#160;201, Jericho, NY 11753.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">235</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_414de91b_87f1_4e6d_97ce_815978e69e75"></a><a id="SUBMISSIONOFSTOCKHOLDERPROPOSALS_509086"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SUBMISSION OF STOCKHOLDER PROPOSALS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Data Knights&#8217; board of directors is aware of no other matter that may be brought before the Special Meeting. Under Delaware law, only business that is specified in the notice of Special Meeting to stockholders may be transacted at the Special Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_26be91e9_5058_45a6_9617_5e7910483156"></a><a id="FUTURESTOCKHOLDERPROPOSALS_438786"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">FUTURE STOCKHOLDER PROPOSALS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the Business Combination is completed, you will be entitled to attend and participate in OneMedNet&#8217;s annual meetings of stockholders. If we hold a 2024 annual meeting of stockholders, we will provide notice of or otherwise publicly disclose the date on which the 2024 annual meeting will be held. If the 2023 annual meeting of stockholders is held, stockholder proposals will be eligible for consideration by the directors for inclusion in the proxy statement for the Company&#8217;s 2024 annual meeting of stockholders in accordance with Rule&#160;14a-8 under the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">Stockholder proposals, other than director nominations, for the 2025 annual meeting must be received by our secretary at our principal executive offices not later than the close of business on the 90</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day nor earlier than the close of business on the 120</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day before the anniversary date of our 2024 annual meeting. However, in the event that our 2024 annual meeting is more than 30&#160;days before or more than 60&#160;days after the anniversary date of our 2024 annual meeting, to be timely a stockholder&#8217;s notice must be received by our secretary at our principal executive office not earlier than the close of business on the 120</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day before the 2025 annual meeting and not later than the later of (1)&#160;the close of business on the 90</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day before the 2025 annual meeting or (2)&#160;the close of business on the 10</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day following the day on which public announcement of the date of the 2025 annual meeting is first made by us.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">Director nominations for the 2025 annual meeting must be received by our secretary at our principal executive offices not later than the close of business on the 90</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day nor earlier than the close of business on the 120</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day before the anniversary date of our 2024 annual meeting. However, in the event that our 2025 annual meeting is more than 30&#160;days before or more than 60&#160;days after the anniversary date of our 2024 annual meeting, to be timely a stockholder&#8217;s notice must be received by our secretary at our principal executive office not earlier than the close of business on the 120</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day before the 2025 annual meeting and not later than the later of (1)&#160;the close of business on the 90</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day before the 2025 annual meeting or (2)&#160;the close of business on the 10</span><sup style="font-size:6.37pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-size:10pt;">&#160;day following the day on which public announcement of the date of the 2025 annual meeting is first made by us.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In addition to the above, a stockholder proposal must otherwise comply with applicable SEC rules&#160;to be considered for inclusion in our proxy materials relating to our 2025 annual meeting. You may contact our Chief Executive Officer at our principal executive offices for a copy of the relevant bylaw provisions regarding the requirements for making stockholder proposals and nominating director candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_e3439bb7_0b0f_4b1f_88f7_7f7636940b29"></a><a id="STOCKHOLDERCOMMUNICATIONS_371345"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">STOCKHOLDER COMMUNICATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Stockholders and interested parties may communicate with Data Knights Board, any committee chairperson or the&#160;non-management&#160;directors as a group by writing to the board or committee chairperson in care of Barry Anderson, Chief Executive Officer, Data Knights Acquisition Corp., Unit G6, Frome Business Park, Manor Road, Frome, United Kingdom, BA11 4FN. Following the Business Combination, such communications should be sent to OneMedNet Corporation, 6385 Old Shady Oak Road, Suite&#160;250, Eden Prairie, MN 55344. Each communication will be forwarded, depending on the subject matter, to the board of directors, the appropriate committee chairperson or all&#160;non-management&#160;directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_e881b1dd_c688_41d2_90b7_5109c98ba339"></a><a id="WHEREYOUCANFINDMOREINFORMATION_861285"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHERE YOU CAN FIND MORE INFORMATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights has filed a registration statement on&#160;Form&#160;S-4&#160;to register the issuance of securities described elsewhere in this proxy statement/prospectus. This proxy statement/prospectus is a part of that registration statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We file reports, proxy statements and other information with the SEC as required by the Exchange Act. You can read Data Knights&#8217; SEC filings, including this proxy statement/prospectus, over the Internet at the SEC&#8217;s website at&#160;<i style="font-style:italic;">http://www.sec.gov</i>.&#160;You may also read and copy any document Data Knights files with the SEC at the SEC public reference room located at 100 F Street, N.E., Room&#160;1580 Washington, D.C., 20549. You may obtain information on the operation of the Public Reference Room&#160;by calling the SEC at 1-800-SEC-0330. You may also obtain copies of the materials described above at prescribed rates by writing to the SEC, Public Reference Section, 100&#160;F Street, N.E., Washington, D.C. 20549.</p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">236</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If you would like additional copies of this proxy statement/prospectus or if you have questions about the Business Combination or the proposals to be presented at the Special Meeting, you should contact Data Knights by telephone or in writing:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Data Knights Acquisition Corp.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Unit G6, Frome Business Park, Manor Road</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Frome</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">United Kingdom, BA11 4FN</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Attn: Barry Anderson</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Telephone No.:  011-44 203 833 4000</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">You may also obtain these documents by requesting them in writing or by telephone from Data Knights&#8217; proxy solicitation agent at the following address and telephone number:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Laurel Hill Advisory Group, LLC</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">2 Robbins Lane, Suite&#160;201</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Jericho, NY 11753</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(855) 414-2266</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">Email: dataknights@laurelhill.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If you are a stockholder of Data Knights and would like to request documents, please do so by [<span style="font-family:'Symbol';">&#183;</span>], 2023, in order to receive them before the Special Meeting. If you request any documents from Data Knights, Data Knights will mail them to you by first class mail, or another equally prompt means.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">All information contained or incorporated by reference in this proxy statement/prospectus relating to Data Knights has been supplied by Data Knights, and all such information relating to OneMedNet has been supplied by OneMedNet. Information provided by either Data Knights or OneMedNet does not constitute any representation, estimate or projection of any other party.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">This document is a proxy statement of Data Knights for the Special Meeting. Neither Data Knights nor OneMedNet has authorized anyone to give any information or make any representation about the Business Combination, Data Knights or OneMedNet that is different from, or in addition to, that contained in this proxy statement/prospectus. Therefore, if anyone does give you information of this sort, you should not rely on it. The information contained in this proxy statement/prospectus speaks only as of the date of this proxy statement/prospectus, unless the information specifically indicates that another date applies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">237</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_4ba5928b_b3ae_43ed_a89f_2052675702a6"></a><a id="INCORPORATIONBYREFERENCE_325679"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">INCORPORATION BY REFERENCE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The SEC allows us to &#8220;incorporate by reference&#8221; information into this proxy statement, which means that we can disclose important information to you by referring you to another document filed separately by it with the SEC. The information incorporated by reference is deemed to be a part of this proxy statement, except for any information superseded by any information contained directly in this proxy statement or incorporated by reference subsequent to the date of this proxy statement as described below. This document incorporates by reference the following documents that have previously been filed with the SEC.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000141057823000553/dkdcu-20221231x10k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, filed on March 31, 2023;</span></a></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000141057822003493/dkdcu-20220930x10q.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022, filed on November 18, 2022</span></a><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465922118850/tm2230525d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Current Report on Form 8-K filed on November 11, 2022</span></a><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465922115814/tm2230017d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Current Report on Form 8-K filed on November 8, 2022</span></a><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465922115049/tm2229853d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Current Report on Form 8-K filed on November 7, 2022</span></a><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000141057822002552/dkdcu-20220630x10q.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022, filed on August 15, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465922089380/tm2223196d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Current Report on Form 8-K filed on August 11, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465922082037/tm2221662d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Current Report on Form 8-K filed on July 22, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465922063400/tm2216110d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Current Report on Form&#160;8-K filed on May&#160;20, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000141057822001631/dkdcu-20220331x10q.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Quarterly Report on Form&#160;10-Q for the quarterly period ended March&#160;31, 2022, filed on May&#160;16, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465922059473/tm2215402d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Current Report on Form&#160;8-K filed on May&#160;12, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465922056612/tm2214688d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Current Report on Form&#160;8-K filed on May&#160;6, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465922049684/tm2213454d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Current Report on Form&#160;8-K filed on April&#160;25, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000141057822000812/dkdcu-20211231x10k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Annual Report on Form&#160;10-K for the&#160;year ended December&#160;31, 2021, filed on April&#160;1, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922041170/tm223852d1_nt10k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Report on Form&#160;NT 10-K filed on March&#160;31, 2022;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465921139304/dkdcu-20210930x10q.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Quarterly Report on Form&#160;10-Q for the quarterly period ended September&#160;30, 2021, filed on November&#160;15, 2021;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1849380/000110465921106132/dkdcu-20210630x10q.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Quarterly Report on Form&#160;10-Q for the quarterly period ended June&#160;30, 2021, filed on August&#160;16, 2021;</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921093828/tm2120205d2_10qa.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Quarterly Report on Form&#160;10-Q/A for the quarterly period ended March&#160;31, 2021, filed on July&#160;20, 2021; and</span></a></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921083392/tm2120205d1_10q.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">The Company&#8217;s Quarterly Report on Form&#160;10-Q for the quarterly period ended March&#160;31, 2021, filed on June&#160;21, 2021.</span></a></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">238</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_89376008_d295_409e_b871_e31811580eff"></a><a id="INDEXTOFINANCIALSTATEMENTS"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INDEX TO FINANCIAL STATEMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Page No</b><span style="font-size:10pt;">.</span></p></td></tr><tr><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Unaudited Financial Statements of Data Knights Acquisition Corp.</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Financial Statements:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#BALANCE_SHEET1"><span style="font-style:normal;font-weight:normal;">Condensed Consolidated Balance Sheets as of March 31, 2023 (unaudited) and December 31, 2022</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-2</p></td></tr><tr><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#STATEMENTSOFOPERA_1"><span style="font-style:normal;font-weight:normal;">Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2023 and 2022</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-3</p></td></tr><tr><td style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#STOCKHOLDERS_DE_1"><span style="font-style:normal;font-weight:normal;">Unaudited Consolidated Statements of Changes in Stockholders&#8217; Deficit for the Three Months Ended March&#160;31, 2023 and 2022</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-4</p></td></tr><tr><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#STATEMENTSOFCASHFLOWS_1"><span style="font-style:normal;font-weight:normal;">Unaudited Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2023 and 2022</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-5</p></td></tr><tr><td style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#NOTESTOCONDENSED_1"><span style="font-style:normal;font-weight:normal;">Unaudited Notes to the Consolidated Financial Statements </span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-6</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Audited Financial Statements of Data Knights Acquisition Corp.</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#REPORT_OF_INDEPENDENT2"><span style="font-style:normal;font-weight:normal;">Report of Independent Registered Public Accounting Firm</span></a> (PCAOB ID #688)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-22</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td colspan="2" style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#BALANCE_SHEET2"><span style="font-style:normal;font-weight:normal;">Consolidated Balance Sheets as of December 31, 2022 and 2021</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-23</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#STATEMENTSOFOPERATIONS2"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Operations for the year ended December 31, 2022, and for the period from February 8, 2021 (inception) through December 31, 2021</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-24</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#STOCKHOLDERS_2"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Changes in Stockholders&#8217; Deficit for the year ended December 31, 2022, and for the period from February 8, 2021 (inception) through December 31, 2021</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-25</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#CASHFLOW_2"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Cash Flows for the year ended December 31, 2022, and for the period from February 8, 2021 (inception) through December 31, 2021</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-26</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#NOTES_2"><span style="font-style:normal;font-weight:normal;">Notes to the Consolidated Financial Statements</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-27</p></td></tr><tr><td colspan="2" style="vertical-align:top;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Audited Consolidated Financial Statements of OneMedNet Corporation</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:89.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Report of Independent Registered Accounting Firm</p></td><td colspan="3" style="vertical-align:top;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:89.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Financial Statements</p></td><td colspan="3" style="vertical-align:top;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:89.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ConsolidatedBalanceSheets_260616"><span style="font-style:normal;font-weight:normal;">Consolidated Balance Sheets</span></a></p></td><td colspan="3" style="vertical-align:top;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-44</p></td></tr><tr><td style="vertical-align:bottom;width:89.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ConsolidatedStatementsofOperations_74253"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Operations</span></a></p></td><td colspan="3" style="vertical-align:top;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-45</p></td></tr><tr><td style="vertical-align:bottom;width:89.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ConsolidatedStatementsofStockholdersEqui"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Stockholders&#8217; Equity (Deficit)</span></a></p></td><td colspan="3" style="vertical-align:top;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-46</p></td></tr><tr><td style="vertical-align:bottom;width:89.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ConsolidatedStatementsofCashFlows_31429"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Cash Flows</span></a></p></td><td colspan="3" style="vertical-align:top;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-47</p></td></tr><tr><td style="vertical-align:bottom;width:89.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#SummaryofSignificantAccountingPolicies_6"><span style="font-style:normal;font-weight:normal;">Notes to the Consolidated Financial Statements</span></a></p></td><td colspan="3" style="vertical-align:top;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-48</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#Report_3"><span style="font-style:normal;font-weight:normal;">Report of Independent Registered Public Accounting Firm</span></a> (PCAOB ID #5041)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-57</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#BALANCESHEETS3"><span style="font-style:normal;font-weight:normal;">Consolidated Balance Sheets as of December 31, 2022 and December 31, 2021</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-58</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#STATEMENTSOFOPERATIONS3"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Operations for the Years Ended December 31, 2022 and 2021</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-59</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#EQUITY3"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Changes in Shareholder&#8217;s Equity for the Years Ended December 31, 2022 and 2021</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-60</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#CASHFLOWS3"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Cash Flows for the Years Ended December 31, 2022 and 2021</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-61</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#NOTES3"><span style="font-style:normal;font-weight:normal;">Notes to Consolidated Financial Statements</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">F-62</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_ace248d6_dbe4_4e70_9ad8_9b055f42e8e8"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><a id="BALANCE_SHEET1"></a><a id="_48698"></a><a id="CONDENSEDBALANCESHEET_673575"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;font-weight:bold;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEET</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">S</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_3c68b537_3aa2_4ee9_85d8_a5869547635c"></a><a id="Tc_4pNnJV7uWkuqtVBXpHzC4A_1_2"></a><a id="Tc_xQLrLzVukk2_QoVVuDjjJg_1_5"></a><a id="Tc_rGTbPtD9oUa7jTQgLoWfQg_2_2"></a><a id="Tc_ZWHnIfDfp0KzJS4G_WwqUg_2_5"></a><a id="Tc_zwQwhLPuyE-G8rEEKPXI7w_3_2"></a><a id="Tc_WgK-gjSZjUC-IN6sXTilpA_3_6"></a><a id="Tc_I3VZcM22Q0ifF9Ol18w4rw_4_0"></a><a id="Tc_zqrNEqo5jUaJvN5alraqfw_5_0"></a><a id="Tc_VWOP3Xtc7EqVTIu4m_kaFw_6_0"></a><a id="Tc_-zr67myGxEirOQCcV3Hu1Q_6_2"></a><a id="Tc_hvYz-YLIg06qMWCIHz1cnA_6_5"></a><a id="Tc_Q8hZZOeeJUSru2NHYyDDKw_7_0"></a><a id="Tc_-eG3bggG9UqEqALdU3-IOQ_9_0"></a><a id="Tc_YxAjJ1E7OUWiUUOAOh2ZyA_10_0"></a><a id="Tc_aXlcdWfnpEO1_IOtOrEqCg_10_2"></a><a id="Tc_kOdKCYUQ_USJOPVGSmbCKw_10_5"></a><a id="Tc_dqW1Kk8eVUiaVEeKWp5FAA_12_0"></a><a id="Tc_ywKZyzWSuEWcTNknr86aWA_13_0"></a><a id="Tc_Z2mKaxRczEehftxJtiyK1A_14_0"></a><a id="Tc_pT9QJkmnzUi36iGf62BCLw_14_2"></a><a id="Tc_mb_UEinKtEqBNOW0r1cl7Q_14_5"></a><a id="Tc_8mZy7Ql0uU-LPpYHLjGgHw_15_0"></a><a id="Tc_A1-0apnxHkq-YXyiFN8UiQ_16_0"></a><a id="Tc_qpLAIASA3k-Px7RlGfcH8Q_17_0"></a><a id="Tc_tXDozGwnp0Ka4meaegT5fg_18_0"></a><a id="Tc_ndOpDau_2EeBrjySuLiaBQ_20_0"></a><a id="Tc_kBFEsOPbYkKweuktieFAww_21_0"></a><a id="Tc_Qz8JJwfNfky6zhvVLP2ADw_22_0"></a><a id="Tc_QWocqRpe5EW31FaCDC5YHA_23_0"></a><a id="Tc_GtGWXB23qkSJ_6lNWUKREg_24_0"></a><a id="Tc_3FGqVxGJYUuOJwRRNEgE3Q_26_0"></a><a id="Tc_MfGTWmWqK0CfJUve6dXoqA_27_0"></a><a id="Tc_LzgaemOQ606QFsTReDxGpA_29_0"></a><a id="Tc_EzTeQHuK6kGQC_y0eI9q1A_30_0"></a><a id="_470e89cc_7e11_44c4_bc19_d7bf438559d2"></a><a id="_470e89cc_7e11_44c4_bc19_d7bf438559d2_2"></a><a id="_470e89cc_7e11_44c4_bc19_d7bf438559d2_3"></a><a id="Tc_fevo4GLj-UWfRbIeze9ilg_31_0"></a><a id="_963d8df4_4958_459b_9da5_98d49fb2b2df"></a><a id="_963d8df4_4958_459b_9da5_98d49fb2b2df_2"></a><a id="_963d8df4_4958_459b_9da5_98d49fb2b2df_3"></a><a id="Tc_pIoHso2uVkuTksuuRiOBpA_32_0"></a><a id="_e5eff8ed_cbcc_4dbe_b8c6_640af2a3673a"></a><a id="_e5eff8ed_cbcc_4dbe_b8c6_640af2a3673a_2"></a><a id="_e5eff8ed_cbcc_4dbe_b8c6_640af2a3673a_3"></a><a id="Tc_iTZpbErMpkGcq4O5zEtegw_33_0"></a><a id="Tc_hjUmEsaFXEiCHb2R1jvftA_34_0"></a><a id="Tc_EzeCEDSyT06EIXmxFGxouA_35_0"></a><a id="Tc_JzIBcGp7QEW9HGTL6n3ndA_36_0"></a><a id="Tc_le_BudwbS0-wmCG_v2EDhA_36_2"></a><a id="Tc_YT8RnAKtP0qx7TTaYb0RZQ_36_5"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="Tc_eYp4eg20kEW93Cvcu0joAQ_6_3">10,108</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="Tc_fe6Qec6DUkKSJNjQck5BaA_6_6">30,870</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total Current Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="Tc_pflWTnVrdEmGjKURs3Vatw_7_3">10,108</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="Tc_jzvL3PaCUES1x4Kw9o-hWw_7_6">30,870</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Tc_jmTk0uGilkGtDHI21Vv5Hw_9_3">29,725,574</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Tc_X4ihOY-uNU-ipA_tBuS4RQ_9_6">29,029,416</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="Tc_jU0f0945-02NZ5PJ61mytA_10_3">29,735,682</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="Tc_uxSSOjHxukasFAqFL59aVw_10_6">29,060,286</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">LIABILITIES AND STOCKHOLDER&#8217;S EQUITY</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Current Liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent" scale="0" id="Tc_364sXAXUMkqCAG-WuZOAJw_14_3">1,933,661</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent" scale="0" id="Tc_wi7ndgIXyUyOUl7bb4Ng6A_14_6">1,679,821</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Amount due to related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesCurrent" scale="0" id="Tc_SBl7yBkD2EiG_NivAQuRqw_15_3">11,200</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesCurrent" scale="0" id="Tc_WML-d-UaKEK0Y569SEHdTQ_15_6">11,500</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Income tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="0" id="Tc_1s0d2Q4NxU6vBJfp5K36eQ_16_3">274,448</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="0" id="Tc_S-xNwBwwOEunpEDAvrDnXw_16_6">214,850</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Franchise tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="0" id="Tc_6nWR4M7_a0eKl-V2rdC3Jw_17_3">117,447</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="0" id="Tc_M4l3fXfUjEyikJzrfQV84g_17_6">69,966</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Current Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="Tc_E_nIuNNIc0S71-rBaKik5A_18_3">2,336,756</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="Tc_iHcqT-CUz0u0M_LRkWeiNQ_18_6">1,976,137</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Warrant liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WarrantLiabilityNonCurrent" scale="0" id="Tc_aJ7_U46cC0y34y-3vTQIyA_20_3">362,558</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WarrantLiabilityNonCurrent" scale="0" id="Tc_DD4kXQP5oUqRnlZADXNokw_20_6">362,558</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Deferred underwriter fee payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:DeferredOfferingCostsNonCurrent" scale="0" id="Tc_N5J0W_AgMkmKbqVmAT_wJA_21_3">4,025,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:DeferredOfferingCostsNonCurrent" scale="0" id="Tc_spT7e17PQ0iYiUrIEXA83g_21_6">4,025,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesNoncurrent" scale="0" id="Tc_fwxG_phlG0-zowJymr-b2w_22_3">239,081</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesNoncurrent" scale="0" id="Tc_QeYUx8nuh0KJPS9k1p6TKg_22_6">207,081</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Extension loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ExtensionLoansNonCurrent" scale="0" id="Tc_S7SGYSjLS0ut7-5VSEXF6A_23_3">2,914,598</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ExtensionLoansNonCurrent" scale="0" id="Tc_czE3q62NgEuGwPX4X1Cx6Q_23_6">2,545,838</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" id="Tc_Iu0T8dXkRUeqP0_N8UcCSg_24_3">9,877,993</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" id="Tc_RJ6hs_r2yEK7Y0LqvvUU9A_24_6">9,116,614</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Commitments and Contingencies</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Class A Common Stock subject to possible redemption; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_62RSk0fIZUChrAPBGoxlEQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_lLJNC-Jw5UWKys-IP9vUHw">2,731,544</ix:nonFraction></ix:nonFraction> shares at redemption value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w" decimals="2" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="Narr_4sqodA-j-kyD8KVnfOql_A">10.74</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="Narr_8nOmFSy6LkanLcIaDnlePA">10.53</ix:nonFraction> per share as of March&#160;31,&#160;2023 and December&#160;31,&#160;2022, respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_d_u4YKzNO02_GfvFOCkfPQ_27_3">29,333,680</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_Me57LgP_gkKAGtvIYx6vKg_27_6">28,750,110</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Stockholders&#8217; Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Preferred shares, $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_yMy9cIFsCkW_IqM0PW00eA"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_JtTuCEm_B0-DBuKscTPprA">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_IlL-QA136EOdqLSPvKwtBw"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_RAC7vCX7wUmqzxJDgkcZsg">1,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_YdtJhDbB-EOnqmq_-HQURg"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_KDMVFsSpS0mXF3hg213h8g">none</ix:nonFraction></ix:nonFraction> issued and outstanding </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_u4VC1Bk8lEqS28vAcCMv0g;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">&#8212;</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_fOlcofgYgUCSYhFsYAD0Jg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">&#8212;</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Class A Common Stock, $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_-cP9_7cpz0ynJ6niuWye5A"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_iM1J0yuOsESz-NJIrCvXQQ">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_5t4dUt6HOU2AxGp_k5LpoQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_PT1qJvxICUiQv2CdD5BUQw">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_hVTGu_0FbEy6zhs2-ZgI-g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_nakMLoLc5k6bJvtV6wPtWw"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_2pDRRScxUECo-1nqi1Brdw">585,275</ix:nonFraction></ix:nonFraction> issued and outstanding, excluding <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_scKBAVP6q0ySjT7i0lnPLw"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_9IFi35-JfUeUK3dPSqZd2g">2,731,544</ix:nonFraction></ix:nonFraction> shares subject to redemption as of March 31, 2023 and December 31, 2022, respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_meEFrlS_zECT-F3yvlmZXw_31_3">59</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_fn4vBE8COEq9-NptSEq5cQ_31_6">59</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Class B Common Stock, par value $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_SE5YcZ3TyEamPaOy0OU5Dw"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_7DGbjZH4h0Ce0TiS7ugkbw">0.0001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_0dSNZaFkNkq_yIQV_P8-gg"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_37ZGvz6X9UK7usLxbx4Mog">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_p69fYo4uwk2gd80_0ih9wQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_TW4N6WMmF0-PC1DurO6ljw">4,253,517</ix:nonFraction></ix:nonFraction> issued<span style="white-space:pre-wrap;"> and outstanding  as of March 31, 2023 and December 31, 2022, respectively</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_yNYiz0PUREuFGvM_VIV8Dw_32_3">425</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_xxAMnWfKnUmCFTlOQf_vWQ_32_6">425</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Additional paid-in capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="0" id="Tc_xrt4_Zeu9UOrMpDi8QoWCQ_33_3">2,242,253</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="0" id="Tc_QFQml17PYECM5vO0FYCS_w_33_6">2,242,253</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" sign="-" scale="0" id="Tc_nAu0u7OWM06PwEbhv-j7Jw_34_3">11,718,728</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" sign="-" scale="0" id="Tc_OnnO60uynEa0DSx8i611sA_34_6">11,632,745</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Stockholders&#8217; Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_0llmDO0IXEmY3xGzwOvyWQ_35_3">9,475,991</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_xPj4hFILp06QWG9Bsayhkw_35_6">8,806,438</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Liabilities and Stockholders&#8217; Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="Tc_-6iZ9z8Nw0-TzTP8E5avHQ_36_3">29,735,682</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="Tc_G4JjXn4tT0iKLdNfTd9VgA_36_6">29,060,286</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">The accompanying notes are an integral part of the consolidated financial statements.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_287048c0_a0c2_4102_a4b8_671b8b11589f"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><a id="STATEMENTSOFOPERA_1"></a><a id="_862950"></a><a id="STATEMENTOFOPERATIONS_466869"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;font-weight:bold;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(UNAUDITED)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_67b8a6da_1fea_48e6_9f59_6e4ff13d6ba0"></a><a id="Tc_mpxO10__CUWxo8mkaj5l4w_1_2"></a><a id="Tc_Eg-BNLI5oEKNjoW4Dgr1SA_2_2"></a><a id="Tc_7DF4osKGjkaa9mk3qKCUXw_3_2"></a><a id="Tc_HGxW6jawX0CdcvREWQSqHw_4_2"></a><a id="Tc_9mqPZfXWI0KnSQQ4xgczfA_4_5"></a><a id="Tc_ZWZBue36WUO7buAx6_IwcA_5_0"></a><a id="Tc_0g4x8AP97kOnIWk-yFv_gA_5_2"></a><a id="Tc_vScpVReQckKgtZU3aUs2Jw_5_5"></a><a id="Tc_YNW67t0GFUe3ANoBPD-OYA_6_0"></a><a id="Tc_sPFl0H2zbkOHy110Z1-8BQ_7_0"></a><a id="Tc_nLAJFclyRk2WNCssg-DKLA_9_0"></a><a id="Tc__VAga3ju40OFBkqnGSEY4Q_10_0"></a><a id="Tc_kfsAZ-9l-kiP67yRL1hz7A_11_0"></a><a id="Tc_Rzfh3q_-b0GlD7YN-A2NwQ_11_3"></a><a id="Tc_wa3UvIYSN0KQPTPzrukpGw_12_0"></a><a id="Tc_OlmJH7dTGUuivlV37KyiNw_12_2"></a><a id="Tc_2hBxi7JqQ0W_rHHE9A6IZQ_12_5"></a><a id="Tc_mvSk5uAFcEKeviGzMsHRzQ_13_0"></a><a id="Tc_LNXZ99EUBU6DrJvntQn9hg_13_6"></a><a id="Tc_r0JsdkRrq0u4xKwpULXtbA_14_0"></a><a id="Tc_BTiDHAfU2kKvZFSrrJQRjA_14_2"></a><a id="Tc_2DQh0tq7ikCxTc5GHGy10w_14_5"></a><a id="Tc_QFKYtG0BeEWE2-hk-KwEGw_16_0"></a><a id="Tc_ApJsQXJBIE2WjGU7n0ju3g_17_0"></a><a id="Tc_zzG9F8LGNkaRwLVx-45lbA_19_0"></a><a id="Tc_tBJU4MQy00iklldswTyUCg_20_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Formation and operating costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" id="Tc_i_g9I0whZ02BuGSbCKv0Yw_5_3">306,303</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" id="Tc_fffWaDCeoEOoS-Lk1QAtfw_5_6">560,185</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Franchise tax expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FranchiseTaxExpense" scale="0" id="Tc_H7xFPMcyp0mGWUjYZMTNBg_6_3">47,481</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FranchiseTaxExpense" scale="0" id="Tc_YFVzhbXQA0SWVQdTiaVB-Q_6_6">50,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Loss from operation costs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="0" id="Tc_Q2NkY_xQakyCA5CUAA3CzA_7_3">353,784</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="0" id="Tc_LmQWM8nArE2SFdvqtkvU3A_7_6">610,185</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Other income (expense):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Dividends, realized and unrealized gain in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_RtxhY1n7eU-13eRWG7q53Q_10_3">327,399</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_Y4yFPKklK0OEEG8A-e9_pQ_10_6">43,053</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value of warrant liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" sign="-" scale="0" id="Tc_2z5Ryc4YEE6XiwNoVEqPUw_11_6">2,762,640</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net income (loss) before provision for income taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" sign="-" scale="0" id="Tc_c8l-Dam0VEWICZsVfdeaaA_12_3">26,385</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" id="Tc_bpazGDnkf0CpeTR2820_rw_12_6">2,195,508</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Provision for income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="Tc_KWoRlTeMX0GLs9bVq3WA2g_13_3">59,598</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net income (loss)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_BmgEdHb_8Uurpr2djOlnpg_14_3">85,983</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_xhEsEmSA40uGiHpe8kksLA_14_6">2,195,508</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average shares outstanding of Class A Common Stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_1xQ0GefAS0KdX7lJI72MRQ_16_3">2,731,544</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_tGgjM0D6Gkad8Qc07KmoSA_16_6">11,500,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Basic and diluted net income (loss) per common stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_aMOH8UF2jkOmx4oY-W4V1w;"><b style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:bold;">$</b></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_dbh28USOAkmgcx1TDH81OQ_17_3">0.01</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_UG6XxWJds0CXaH4-vLv9Ng;"><b style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:bold;">$</b></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_iIRpX7-h4k6WQHwe5Cxu2Q_17_6">0.15</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average shares outstanding of Class A and Class B non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_pIh9wyPIMEOOsLvbK1n1fw_19_3">4,838,792</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_OWLMoCvzlUq1z2D8BT4p5w_19_6">3,460,275</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Basic and diluted net income (loss) per common stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_U8qb5VTrkUeQ6gm1nb5pcg;"><b style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:bold;">$</b></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_LoMbAnc1EkmTfvCjL8YaeA_20_3">0.01</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_t491--BJ_U6REG8h_KXC-w;"><b style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:bold;">$</b></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_0o1fOUeiX0K7m73EK5xNkQ_20_6">0.15</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">The accompanying notes are an integral part of the consolidated financial statements.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:4.55%;padding-right:4.55%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_5d782b03_c23a_4dc8_a950_4ca10fc738bf"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><a id="STOCKHOLDERS_DE_1"></a><a id="_803524"></a><a id="CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDE"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;font-weight:bold;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">CONSOLIDATED STATEMENTS OF CHANGES IN </b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">STOCKHOLDERS&#8217; DEFICI</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">T</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR THE THREE MONTHS ENDED MARCH 31, 2023</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(UNAUDITED)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_4a5e53c6_e395_4ffe_a9f0_c877f1f3e2d8"></a><a id="Tc_DR_i7FuvwEeOdsK4U_kYEA_1_2"></a><a id="Tc_ukywZOgYg0agRIY-_hDQsQ_1_7"></a><a id="Tc_ELMcYVI60EWArYYIyIAlLQ_1_12"></a><a id="Tc_1fHxYyU6SkOpbT4QQy0knw_1_18"></a><a id="Tc_d0odNvq4fkCDBzW8SmFnww_2_2"></a><a id="Tc_gWlqskRXlU6GteFnh_MClg_2_7"></a><a id="Tc_GXG9mnbw7kCdY-M6-hac_g_2_12"></a><a id="Tc_wIy3aGjdjECylC91UoCbYA_2_15"></a><a id="Tc_hOJ01B0XlkGkmrNN1tj1Ow_2_18"></a><a id="Tc_mSvphOEqQ0ODNHvLQH28jg_3_2"></a><a id="Tc_ugOn3K-ur0K0GevgcC31ZA_3_4"></a><a id="Tc_Zk25n36n9kaGy1-K6W8-vw_3_7"></a><a id="Tc_LZKnooJT6UizLqsBMkBuIA_3_9"></a><a id="Tc_rSzKYN35IUq2FFFUKA7nJQ_3_12"></a><a id="Tc_sMc08cUQhUi45yvOzDdKVQ_3_15"></a><a id="Tc_HgXEyQu-NUy-UE3yeKQREA_3_18"></a><a id="Tc_CYbWMRo00ku2pFWXlhk2SQ_4_0"></a><a id="Tc_x0GYSQtOuEOpsyCBTsqslA_4_4"></a><a id="Tc_6Wan9RdUbEmM1Pj0Z5vSZQ_4_9"></a><a id="Tc_OJv9ZUDh-kqp7gunU7ghow_4_12"></a><a id="Tc_np-yKiRJ7k-Y50mICQ9f3g_4_15"></a><a id="Tc_aRtQSdH9_0ObH86LnahI9Q_4_18"></a><a id="Tc_H8bmgASxJUeBmGTs0WjLQw_5_0"></a><a id="Tc_lgcnt6G6C0WtVrQbsKFGCQ_6_0"></a><a id="Tc_FHHtI8myB0OI8VWXkgk_Pg_7_0"></a><a id="Tc_5i_HRClQ20aJgOoDsOZIMw_7_4"></a><a id="Tc_HK7hBShcUkujwNzWov8lYA_7_9"></a><a id="Tc_XW8IL6ck-k668LbKtKM9Lw_7_12"></a><a id="Tc_g-eIEHPCokSNzcEFX1VibA_7_15"></a><a id="Tc_i96Jg8mOzE6lNu3p4pabpQ_7_18"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:25.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class&#160;A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class&#160;B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additional</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paid in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholders&#8217;</b></p></td></tr><tr><td style="vertical-align:bottom;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deficit</b></p></td></tr><tr><td style="vertical-align:top;width:25.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance &#8212; January 1, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc__Hufem0fbUG3PVak7pLY4w_4_2">585,275</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> </span><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_q6zO0F2z0UCl1t_pbk2mtQ_4_5">59</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_OUp9gTvqvUi8RrJcWh2Tew_4_7">4,253,517</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_XMKEYNJdBEC3Wy0lss4Eyw_4_10">425</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DzIyCou1hkeI-WohQI5SbA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_1Qxj0O3JpEKE9D1ilryQIQ_4_13">2,242,253</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_xXVChhyI6k-ndPgI-1--gQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_qzWE9SUOVUGk0eN7_c2Qrg_4_16">11,632,745</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_nSfUtdDeXkqOfRV583Co2w_4_19">8,806,438</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:top;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Re-measurement of Class A Common Stock Subject to Possible Redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q" decimals="INF" format="ixt:zerodash" name="dkdcu:CommonStockSubjectToPossibleRedemptionShares" scale="0" id="Tc_826RBxjKY0mEkXX-a2L-5A_5_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q" decimals="0" format="ixt:zerodash" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_4yZdSg9440uxsyJR3dYgUw_5_5">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ" decimals="INF" format="ixt:zerodash" name="dkdcu:CommonStockSubjectToPossibleRedemptionShares" scale="0" id="Tc_kZmDeiSoyEuVumtbF6ETFw_5_7">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ" decimals="0" format="ixt:zerodash" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_oMyGZB-d_0u7M-sP5as9oA_5_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_OOd5AilGXE2sxPflL-HxVw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_5fR89A1NzU--iipqDJ7G3g_5_13">583,570</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_3sbSA6mVh0m3wtnOe9Ru3Q" decimals="0" format="ixt:zerodash" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_xCppH6lQmkmiODL98Ob_bA_5_16">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_XviSAHLeUkCa9-aorgyLHQ_5_19">583,570</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;width:25.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q" decimals="INF" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_c_aIsQM1l0S4p60WgLIcbg_6_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_sfqmbH4Q0EqWPjR14Ty2PA_6_5">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ" decimals="INF" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_plk5jFuXcEidHNsozqefXg_6_7">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_5Hg6WgEZhEiieOUhM-rnZw_6_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_OOd5AilGXE2sxPflL-HxVw" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_gqRp6JPiCkeJwkAr2IGSIA_6_13">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_3sbSA6mVh0m3wtnOe9Ru3Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_P7bFqG6QV0CcYZPGd76h4A_6_16">85,983</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_TQ_3vyhPGkOwmv3TPtYoXw_6_19">85,983</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance &#8212; March 31, 2023 (unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_goe_RVvoFUyh8ybQ7jTgQw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_ulIoRXylNU2EYi0ZIILlyA_7_2">585,275</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_goe_RVvoFUyh8ybQ7jTgQw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_EUKuvkJA-EeHHtYr425pZQ_7_5">59</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_7bwDEPA2V0-iIfkW-TlPEg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_zvqvJqracEy-HdXOK3nLdg_7_7">4,253,517</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_7bwDEPA2V0-iIfkW-TlPEg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_JYvsSzLYlU6nK8bYv5Z_TA_7_10">425</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_ZMuTDpHFhkK3bBt9NctNIA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_zKCmGXJlWEutOllgM6ddiw_7_13">2,242,253</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_86Daq9d6j0GAwbKckEBFNA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_z9_I2jYZaEK6wSnEAxroyw_7_16">11,718,728</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_AN2PuMpvBEGVH39jO_vqTQ_7_19">9,475,991</ix:nonFraction>)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FOR THE THREE MONTHS ENDED MARCH 31, 2022</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(UNAUDITED)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_8a49166c_8d21_4757_a95b_7501d61ad02d"></a><a id="Tc_jx2L5ldOKE6O7G8diMWmCA_1_2"></a><a id="Tc_XgeJa7wsYUSb5ozWydv44A_1_7"></a><a id="Tc_rjIN13wfz0OndVMwW3U1pw_1_12"></a><a id="Tc_k-v8pmK6DkKM2pPtPFXGPw_1_18"></a><a id="Tc_gH115B2nwkmOAcs8nlfrcw_2_2"></a><a id="Tc_4JU20YCDrUa9hNxXz1Sgaw_2_7"></a><a id="Tc_wBBVFHfoF06EMj1U74Qoow_2_12"></a><a id="Tc_U4YkRskFJ0yfoLytSfjFTA_2_15"></a><a id="Tc_8ApMWW_XFEaQNtru3ZhxrA_2_18"></a><a id="Tc_Jq1749dMhkacTr2ooMouMQ_3_2"></a><a id="Tc_CQ01eGFY8U6cLWx6zsEqUw_3_4"></a><a id="Tc_fme--EJxEE6y1NW5IAut6w_3_7"></a><a id="Tc_LUPMLsytBEqChSZi-6ZaKg_3_9"></a><a id="Tc_MznG4MMq70ax1R3PmwROig_3_12"></a><a id="Tc_W-H9YhJ8Lkm6O9M73oKPsw_3_15"></a><a id="Tc_cpOWJJqPZk2dOTJeJXqTvw_3_18"></a><a id="Tc_TGGdkmLAJUSyDyHAe2EcEw_4_0"></a><a id="Tc_3_1sWFdsXEGbq3wNlW68VA_4_4"></a><a id="Tc_m9TUPz0ZiEK5DN3B5ndhdg_4_9"></a><a id="Tc_M1E2hakcEkSEskY7T4TQbQ_4_12"></a><a id="Tc_W0-oB9sCck6Inih25P-RKw_4_15"></a><a id="Tc_IMosvMWI0US75ezun2tBAw_4_18"></a><a id="Tc_6dFMc6bChU6BLA6c0QaGJA_5_0"></a><a id="Tc_QN1UmafbFk2UKlY1VgrqdA_6_0"></a><a id="Tc_0KY1UyezbECUcdMO-NXVCA_6_4"></a><a id="Tc_O5GrgeYG_U-imtRqwIfn1Q_6_9"></a><a id="Tc_Nk8X2thmWk-b_9iRt0ahog_6_12"></a><a id="Tc_G2G3uzrvNk6mXkOT62eALg_6_15"></a><a id="Tc_I8pxGPAtWEWwbUBz0o-7Wg_6_18"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:25.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class&#160;A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class&#160;B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additional</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paid in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholders&#8217;</b></p></td></tr><tr><td style="vertical-align:bottom;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deficit</b></p></td></tr><tr><td style="vertical-align:top;width:25.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance &#8212; January 1, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_fzVo9h8xG0un0KxaxlZybw_4_2">585,275</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_iUkX8JSPkUW4cFu0ISP5Fw_4_5">59</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_yG9Kz8qPJ0SSXm9ZSJF6pA_4_7">2,875,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_MxNflieEXEK89ggZIHX08Q_4_10">288</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_6Bf7HXIAMk2oElQb9ogmow" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="Tc_XXGAyFbF6Umcl83DTUXD6A_4_13">&#8212;</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_6-yCbHCVY0uGfDrYrKv0Iw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_lVJUn-9Vtk6goL-9l-RTsA_4_16">8,609,810</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_Ydf5t4ijP0Kqc0XqdazNbw_4_19">8,609,463</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:top;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_cESdCtZscUO59dYHHgaZpg" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_XnQS1xUb-EGmpDDv2emyCg_5_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_cESdCtZscUO59dYHHgaZpg" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_2JgnZAcsHUOOFA0pN-ooEA_5_5">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_A21K0pn7TUOZCpFwGWO4nQ" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_WCm3Xu3QCE6Ec7-2-K0I9w_5_7">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_A21K0pn7TUOZCpFwGWO4nQ" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_Km4tZzr1DUSp5l4RmsXPcQ_5_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_m9dIOryBAU6cFXCIBqZNRQ" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_qsk6Ivd_tEWNcsnWzpWtmA_5_13">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_P3mtcGxGrkKUFdj5qMeMsA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_XEy9IvSqw0m5vMf353ev0A_5_16">2,195,508</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_5OHV7LoGYEe03fL4cAc_3A_5_19">2,195,508</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:25.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance &#8212; March 31, 2022 (unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ZJf5YelKa0CSmVXNygkaMw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_uqKjwucVrUqELeoSlax7cQ_6_2">585,275</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ZJf5YelKa0CSmVXNygkaMw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_bC_WEfos0EqV2YqULIU5yA_6_5">59</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_b2QDuXd4oUeF_buHUjKBrg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_U0AJmsryyka-9TEie0as1w_6_7">2,875,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_b2QDuXd4oUeF_buHUjKBrg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_npNdexUIWkub15-vMZBSDw_6_10">288</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_IHG1RFSPIE2Is1YIYVb5NQ" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="Tc_sWh7JsnoEU2vZbk9squKtA_6_13">&#8212;</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_tGuxzL5MjkWBTR132SmvCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_4wuy-cPI70SURv-2a0bimA_6_16">6,414,302</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_uLnFCcX6pEWeDUoEJSDLng_6_19">6,413,955</ix:nonFraction>)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">The accompanying notes are an integral part of the consolidated financial statements.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.91%;border:0;margin:30pt 4.55% 30pt 4.55%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_6860edae_36d1_47a3_b1ee_481dcfbb555e"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><a id="STATEMENTSOFCASHFLOWS_1"></a><a id="_676047"></a><a id="STATEMENTOFCASHFLOWS_875585"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;font-weight:bold;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">CONSOLIDATED </b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">STATEMENTS OF CASH FLOWS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(UNAUDITED)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_065ce1a5_62e3_42f9_a2d1_d9064e5b5e97"></a><a id="Tc_4S0IcntIOUm9FACaS_p78g_1_2"></a><a id="Tc_BTfTBwXZ60Kmklgl9QsSHQ_2_2"></a><a id="Tc_cUduDnfQL0G10MsYoSN1kw_3_2"></a><a id="Tc_UeoMchfsSkKhqW_j0A6Dfg_4_2"></a><a id="Tc_kf2_0HFiKk2DY4Xv9EOLaw_4_5"></a><a id="Tc_BiVbIcE7EUe32gAR1a4GrA_5_0"></a><a id="Tc_WzeeJuixGEK7k8wj5HTC1w_6_0"></a><a id="Tc_qr0N8Y9huUOGDL96WRn4RQ_6_2"></a><a id="Tc_l4gR7uIEikeJU3AkMiow4Q_6_5"></a><a id="Tc_qGUqG_LuIkGUbPnCnEDFWw_7_0"></a><a id="Tc_83qjoUsTAEmespkyryG0Jw_8_0"></a><a id="Tc_6c5isUIb1EigwCWcwhZJkg_9_0"></a><a id="Tc_5gDpTjWlWk-v2roNFZKCpA_9_3"></a><a id="Tc_sHQbFxHEOkK7zcg0orVSgg_10_0"></a><a id="Tc_JGrGsDh-lkKJFOWSDcYHrQ_11_0"></a><a id="Tc_flR04XS70kSVRsW96u_u0A_11_3"></a><a id="Tc_itvzm4ht9kOWy_njuei3Gw_12_0"></a><a id="Tc_FnkrAPqdrkyghG6XN3wGcg_13_0"></a><a id="Tc_FJr90etQtEq845rz5-IQqA_14_0"></a><a id="Tc_tpP1pZKBAE-WqccppHYg7Q_15_0"></a><a id="Tc_Xu2XEFP7eE-jzCp9rhBLsQ_17_0"></a><a id="Tc_9T2GeqFU_UWi7BRobkaomA_18_0"></a><a id="Tc_SPXVrN3Pg0W_iis0wBLy5w_18_6"></a><a id="Tc_yHjD9xh-WUup3_5cPLDEAg_19_0"></a><a id="Tc_Qm6EwUT0wki8zbbITjNsHg_19_6"></a><a id="Tc_2tcxCL7QQ0yqy3-PEGNOuw_21_0"></a><a id="Tc_ynXxIW6PXkmL_IkEw4f3FA_22_0"></a><a id="Tc_saQ6iEokfUGPFaMTpv-FDw_22_6"></a><a id="Tc_N40WHQzLBEqLY8F18-mtKQ_23_0"></a><a id="Tc_StuoedpN30apjrL-r3Q7uA_23_6"></a><a id="Tc_TYzg2TSmVk-uCSc3BtTeUQ_24_0"></a><a id="Tc_UQhJL_DMyky-RrVpdS6sYw_24_6"></a><a id="Tc_O7oNts628kicABcYGSnbmA_25_0"></a><a id="Tc_mnwJXbKkxEmZfoIWTjMGUA_25_6"></a><a id="Tc_3jAUjqQ4akeYmooKOfiZEQ_27_0"></a><a id="Tc_iVc_OgPSIE23ro3FfC4_xA_28_0"></a><a id="Tc_wnQRftLHdEyUkMX7f_xlRg_29_0"></a><a id="Tc_FR0JxegtFEehAJjOuBptEw_29_2"></a><a id="Tc_oTRIaYpZQUSZMwA7iaojCw_29_5"></a><a id="Tc_9bEBQSTO5UaAifbRjN5Gfg_31_0"></a><a id="Tc_FPFemV4SMU2Z93p5zkyL2A_32_0"></a><a id="Tc_lPyfdJRpaEi7OR-2E-1tMA_32_2"></a><a id="Tc_xtS0ZMsZU0iYXxQt5eFHIA_32_5"></a><a id="Tc_ILMul59R7kihRjrqOaZxSQ_32_6"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from operating activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" scale="0" id="Tc_Icd4WNlFlkid6BsMN24uLw_6_3">85,983</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="Tc_roeJIkRjAkGdCvMuOwARNg_6_6">2,195,508</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Adjustments to reconcile net income to net cash used in operating activities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Dividends, realized and unrealized gain in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_TuH3Ln0vVkqCnYjzo15UUg_8_3">327,399</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_oFFmmwx4AkawooO2xjQokg_8_6">43,053</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Change in fair value of warrant liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" sign="-" scale="0" id="Tc_jjP4jYZLRUWAl6XPN0vA-w_9_6">2,762,640</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Changes in operating assets and liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Prepaid expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" sign="-" scale="0" id="Tc__J092Zc1K0qkL1vOp_i64g_11_6">39,739</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="0" id="Tc_6YBDwhpUT02B_I1D0cnPBw_12_3">253,841</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="0" id="Tc_KfQCJZNFeEmDQ5r_1LbRpw_12_6">390,436</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Franchise tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:IncreaseDecreaseFranchiseTaxPayable" scale="0" id="Tc_prCMYYd_UUiIT6Cek5kE-A_13_3">47,481</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:IncreaseDecreaseFranchiseTaxPayable" sign="-" scale="0" id="Tc_3ZL8jQprS0OSq5Rj4idqRg_13_6">114,008</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Income tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" id="Tc_VS6b17GO_02rA4gkZs7Z9A_14_3">59,598</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net cash used in operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" sign="-" scale="0" id="Tc_fKpqeAI6IEGYUYraSWukUg_15_3">52,462</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" sign="-" scale="0" id="Tc_W08N_kL4VUKWBrTZfQoCsQ_15_6">294,018</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from investing activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Investment of cash in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Tc_v2HG3lYcvUOxAL3pxBOf8A_18_3">368,760</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Net cash used in investing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="0" id="Tc_EMLKytGbCkGc0Py4Fr06ag_19_3">368,760</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from financing activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Advances from related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AdvancesFromRelatedParties" sign="-" scale="0" id="Tc_KPof7OtRwUKQjIlCRhR4qA_22_3">300</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="white-space:pre-wrap;">Proceeds  from working capital loan</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromWorkingCapitalLoan" scale="0" id="Tc_RHAjvl7A20OB5hiszVrXUQ_23_3">32,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from extension loans </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromExtensionLoan" scale="0" id="Tc_hZgN_wus2kWCmJo4uhaTrA_24_3">368,760</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net cash provided by financing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="Tc_Y9YJaLW_WkSDdPlZ5aA3cQ_25_3">400,460</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">&#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net change in cash</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" sign="-" scale="0" id="Tc_Jy3QDbx0xkemYQRvGkShLw_27_3">20,762</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" sign="-" scale="0" id="Tc_pVFVvAJhN0-F62_O23DpYg_27_6">294,018</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash at the beginning of the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_Z8Yv2pzhS026ofI6jxknAw_28_3">30,870</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_fjbWwMiSukqfr6i4bCtcqw_28_6">453,151</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash at the end of the period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_7E1nCj4MVEuFb9BzzoKhCA_29_3">10,108</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_DIBFdwa3HUmLaFHzLcMuRQ_29_6">159,133</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Supplemental disclosure of non-cash financing activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Re-measurement of Class A common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption" sign="-" scale="0" id="Tc_1kcDF7UKA02bo5lx2bPjxA_32_3">583,570</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">The accompanying notes are an integral part of the consolidated financial statements.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_2be1d70c_e776_480b_9cc9_7d8d4405ea88"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DATA KNIGHTS ACQUISITION CAPITAL CORP.</b></p><a id="NOTESTOCONDENSED_1"></a><a id="NOTESTOCONDENSEDFINANCIALSTATEMENTS_7458"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL </b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-transform:uppercase;">STATEMENTS</b></p><a id="_300573"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:NatureOfOperations" id="Tb_1OzVSi66rUSynMQdMg13LQ" continuedAt="Tb_1OzVSi66rUSynMQdMg13LQ_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights Acquisition Corp. (the &#8220;Company&#8221;) is a blank check company incorporated in Delaware on February 8, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_2_8_2021_To_2_8_2021_v79xWrSU2E2fOfIAgN6zrQ" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" scale="0" id="Narr_m_9SprT5mECuLy0YjwxRqQ">one</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> or more businesses (the &#8220;Business Combination&#8221;). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023, the Company had not yet commenced any operations. All activity for the period February 8, 2021 (inception) through March 31, 2023, relates to the Company&#8217;s formation and the initial public offering (the &#8220;Initial Public Offering&#8221;), and, since the closing of the initial public offering, the Company has entered into a merger agreement (as described below), and continued a search for a Business Combination candidate. The Company has selected December 31 as its fiscal year end.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The registration statement for the Company&#8217;s Initial Public Offering was declared effective on May 6, 2021. On May 11, 2021, the Company consummated the Initial Public Offering of </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_8lHByssoi0mEGyKP5OcowQ">11,500,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> units (&#8220;Units&#8221; and, with respect to the shares of Class&#160;A Common Stock included in the Units offered, the &#8220;Public Shares&#8221;), generating gross proceeds of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromSaleOfUnits" scale="0" id="Narr_uJtSc1X9zEKqB-eB_QMQuw">115,000,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, which is described in Note&#160;3.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:NumberOfWarrantsIssued" scale="0" id="Narr_tABF-dmeVkiyaGtbubc-lg">585,275</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> private placement units (the &#8220;Private Placement Units&#8221;) at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_D81xSwKtWUK5pM73JnCYwA" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="Narr_u0zWzpBV9EGoKOLWMQLIoA">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per unit in a private placement to the Sponsor, generating gross proceeds of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" id="Narr_wmHQkh5y_0GQzufhuW3cCg">5,852,750</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, which is described in Note&#160;4.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Following the closing of the Initial Public Offering on May 11, 2021, an amount of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_5_11_2021_To_5_11_2021_NmXExQZglUSAztqWU0QU3w" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Narr_Ror1kOiz10GuXDjEMke_WA">117,300,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> (</span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_QpdQ9UBuGk-ab2g7OpHNPg">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (&#8220;Trust Account&#8221;) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company&#8217;s stockholders, as described below.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Transaction costs of the Initial Public Offering amounted to </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:TransactionCosts" scale="0" id="Narr_vf_hMcc25k2RI2d3LMPNTA">6,771,112</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, of which </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SaleOfStockUnderwritingFees" scale="0" id="Narr_KAHZ_ilQ_ESqZEpOWI6B-Q">2,300,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> was for underwriting fees paid at the time of the IPO, </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." scale="0" id="Narr_H0G3qZ4PBEKKl5XPBt4AIw">4,025,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> was for deferred underwriting commissions, and </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SaleOfStockOtherOfferingCosts" scale="0" id="Narr_Xa8e_7aE4kOgicRq9kkCgA">446,112</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> was for other offering costs. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Following the closing of the Initial Public Offering </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_C9XJ_5SJYkeABnyRWrMZ9w" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Narr_JaySfmnHmkO9FJH9elkSfg">959,560</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> of cash was held outside of the Trust Account available for working capital purposes. As of March 31, 2023, the Company has </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="0" id="Narr_RaEG9UDGRUGWS3olkkUHSg">10,108</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> of cash and a working capital deficit of $</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WorkingCapitalDeficit" scale="0" id="Narr_jf1hrEpciU-4FMfvMYO6JQ">2,326,648</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" scale="-2" id="Narr_guZxS1OltUavgW__zZSAbA">80</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" scale="-2" id="Narr_67SHys486EiCwM2r3dcLlQ">50</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully affect a Business Combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 25, 2022, the Company, Data Knights Merger Sub, Inc., a Delaware corporation (&#8220;Merger Sub&#8221;), and Data Knights, LLC, the Company&#8217;s sponsor (the &#8220;Sponsor&#8221;), entered into a definitive Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with OneMedNet Corporation, Inc., a Delaware corporation (the &#8220;Target&#8221;, and together with the Company and Merger Sub, the &#8220;Parties&#8221;) and Paul Casey, as seller representative (&#8220;Casey&#8221;). Pursuant to the Merger Agreement, upon the closing (the &#8220;Closing&#8221;) of the Business Combination, the Parties will effect the merger of Merger Sub with and into the Target, with the Target continuing as the </span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_1OzVSi66rUSynMQdMg13LQ_cont1" continuedAt="Tb_1OzVSi66rUSynMQdMg13LQ_cont2"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">surviving entity (the &#8220;Merger&#8221;), as a result of which all of the issued and outstanding capital stock of the Target shall be exchanged shares of the Class A Common Stock of the Company upon the terms set forth in the Merger Agreement.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On May 5, 2022, the Company extended the date by which the Company has to consummate a business combination from May 11, 2022 to August 11, 2022 (the &#8220;First Extension&#8221;). The First Extension was the first of </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_PRACNMXpjkGdmYKKlUrEnA">two</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> </span><ix:nonNumeric contextRef="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_lTbclWfaWky18zKDYENEEg"><span style="font-family:'Times New Roman','Times','serif';">three-month</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> extensions permitted under the Company&#8217;s governing documents.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On August 10, 2022, the Company extended the date by which the Company has to consummate a business combination from August 11, 2022 to November 11, 2022 (the &#8220;Second Extension&#8221;). The Second Extension was the second of </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_kTw6EvwyzUyWOXI8bOIjYg">two</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> </span><ix:nonNumeric contextRef="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_8DgAK-nZ-EGY188kvf-N-A"><span style="font-family:'Times New Roman','Times','serif';">three-month</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> extensions permitted under the Company&#8217;s governing documents.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On October 27, 2022, the Company filed a definitive proxy statement with the SEC in connection with the Company&#8217;s solicitation of proxies for the vote by the stockholders of the Company at a special meeting of the Company&#8217;s stockholders to be held on November 11, 2022 (the &#8220;Special Meeting&#8221;).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On November 11, 2022, at 10:00 a.m. ET, the Company held a virtual special meeting of its stockholders. At the special meeting, Company stockholders entitle to vote at the special meeting cast their votes and approved the Trust Amendment Proposal, pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO if the Company has not completed its initial business combination, from November 11, 2022 to August 11, 2023 (or such earlier date after November 11, 2022, as determined by the Data Knights Board). As a part of Special Meeting, the Company&#8217;s stockholders approved amendments to its second amended and restated certificate of incorporation (the &#8220;Extension Amendment&#8221;) and the investment management trust agreement (the &#8220;Trust Agreement&#8221;) between Continental Stock Transfer &amp; Trust Company, as trustee (&#8220;Continental&#8221;), and the Company governing the trust account (the &#8220;Trust Account&#8221;) established in connection with the Company&#8217;s initial public offering dated May 11, 2021 (the &#8220;Trust Amendment&#8221;), which together allow the Company to extend the deadline by which it must complete its initial business combination by up to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_gajh3oUhKUamVnWnHovbNQ">nine</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> </span><ix:nonNumeric contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_i--tghQml0y1qPf3Y3lQQg"><span style="font-family:'Times New Roman','Times','serif';">one-month</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> periods. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, shall cause </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_S7Yu6E8CZU-ri3x6GhOt_A" decimals="3" format="ixt:numdotdecimal" name="dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" scale="0" id="Narr_DnyaJGje7kCx0Yt86Mb6wA">0.045</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per outstanding share of the Company&#8217;s Class A Common Stock, or approximately </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" scale="0" id="Narr_XiTkHm9srE6EsrtKJo1ANw">122,920</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, to be deposited in the Trust Account. As of March 31, 2023, the Company has executed </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfOneMonthExtensionsExecuted" scale="0" id="Narr_ydYeLziJtk-hHCd63x5Odw">five</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" id="Narr_vcUEw5FSekq9QsZZi604Gg"><span style="font-family:'Times New Roman','Times','serif';">one-month</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> extensions, out of the </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_wtw9Zzj88UWy34yzWDgT2Q">nine</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, resulting in deposits of approximately </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" scale="0" id="Narr_epi1RrA40E2xrVlLp0kUxg">614,600</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> into the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In connection with the proposed Business Combination with the Target, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Stock upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the proposed Business Combination with the Target is not consummated, in connection with an alternative proposed initial business combination, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:MinimumNetTangibleAssetUponConsummationOfBusinessCombination" scale="0" id="Narr_BmilkgGuLE-rkc3iIK0S_Q">5,000,001</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" scale="0" id="Narr_L_mUhTJbf02m-fRf0F5z8A">8,768,456</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="Narr_zcmm8ZqFekK-6WDpfV7XMw">10.42</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share, for an aggregate of approximately </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="6" id="Narr_PBU5lVXlk02H0o_g1qEUQA">91.4</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> million. Following the payment of the redemptions, the Trust Account had a balance of approximately </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrust" scale="6" id="Narr_Qc0a40hkyEuYN7gjeJg9qg">28.5</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> million.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Based on the above, the Company will have until August 11, 2023 to consummate a Business Combination. If the Company is unable to complete a Business Combination on August 11, 2023 at the election of the Company subject to satisfaction of certain conditions, including the deposit of up </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_Cfp-j1jKfkKwbJQkm0sqsA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" scale="0" id="Narr_cFac52VTXE2Wj-m7Ld_EGQ">2,300,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> since the underwriters&#8217; over-allotment option is exercised in full (</span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_Cfp-j1jKfkKwbJQkm0sqsA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_bLF2mp6ankSpHevvmvUs6g">0.10</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per unit), into the Trust Account, or as extended by the Company&#8217;s stockholders in accordance with the Company&#8217;s amended and restated certificate of incorporation) (the &#8220;Combination Period&#8221;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:MaximumNetInterestToPayDissolutionExpenses" scale="0" id="Narr_rPDunkUQPEmrUI_T5Kr_uA">100,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#8217;s </span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_1OzVSi66rUSynMQdMg13LQ_cont2" continuedAt="Tb_1OzVSi66rUSynMQdMg13LQ_cont3"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit (</span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_aW_BWTfQF0mtQBlsdr1PCw">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the shares of Class A Common Stock and the warrants that are included as components of the Private Placement Units. Such warrants will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_vg1VwnqTEEWqnRazLisXEw">10.20</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_Y9saIerki0Wz7UfmGn2jDg">10.20</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Going Concern, Liquidity and Capital Resources</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and December 31, 2022, the Company had cash held outside of the Trust Account of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CashHeldOutsideInTrustAccount" scale="0" id="Narr_BJ3DnDm8TkeSfCvmAEl7yw">10,108</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> and $</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CashHeldOutsideInTrustAccount" scale="0" id="Narr_FnV-Y_OAtkmuvRST-K706g">30,870</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial business combination. As of March 31, 2023 and December 31,2022, the Company had working capital deficit of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WorkingCapitalDeficit" scale="0" id="Narr_Pn2EJ29ZL02meVIHbiNUAQ">2,326,648</ix:nonFraction> </span><span style="font-family:'Times New Roman','Times','serif';">and </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WorkingCapitalDeficit" sign="-" scale="0" id="Narr_piGUOOehSEOOWoMZkUHW6g">1,945,267</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company&#8217;s liquidity needs prior to the consummation of its IPO were satisfied through the proceeds of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_3CzSjuwSC0Si51Ps-EQeBw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Narr_rzT9mqj9hEyFe09066Uvhg">25,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> from the sale of the Founder Shares and proceed from the promissory note from sponsor of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_q8AQnXCt_EmVrk6I872x0w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" id="Narr_ElAsSvaE6k-kWqQCFaYHdg">78,925</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, which was repaid upon closure of the IPO. Subsequent to the IPO, the Company&#8217;s liquidity will be satisfied through a portion of the net proceeds from IPO held outside of the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and December 31, 2022, we had investments of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Narr_IElnOJruS0S4v6zfo7Lt2Q">29,725,574</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Narr_KdcIJskPJUWKHnbe-BoNUA">29,029,416</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> held in the Trust Account, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes. For the three months ended March 31, 2023, we did not withdraw any of interest earned on the Trust Account. During the period ended December 31, 2022, we withdraw </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount" scale="0" id="Narr_jvTG3B1YhUiLbefBiZDQ8Q">299,601</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> interest earned on the Trust Account to pay Delaware Franchise Tax. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed. The Company will have until August 23, 2023 to consummate a Business Combination. If our initial business combination is not consummated by </span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_1OzVSi66rUSynMQdMg13LQ_cont3"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">August 23, 2023, less than one year after the date the financial statements are issued, then our existence will terminate, and we will distribute all amounts in the trust account. The Company intends to complete a business combination before the liquidation date and no adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after such date. There can be no assurance that the Company will be able to consummate an initial business combination by August 23, 2023 and/or have sufficient working capital and borrowing capacity to meet its needs. Based upon the above analysis, management determined that these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Accounts to repay such loaned amounts but no proceeds from our Trust Accounts would be used for such repayment. Up to </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet" scale="0" id="Narr_tcMc55tqSUy6FD4DpET6Yw">1,500,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> of such loans may be convertible into units identical to the Placement Units, at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="Narr_OTvEBXgTD0aaSwdtJHHIPQ">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per unit at the option of the lender.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Risks and Uncertainties</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into law. The IR Act provides for, among other measures, a new 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom the shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased. For purposes of calculating the excise tax, however, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#8220;Treasury Department&#8221;) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Any redemption or other repurchase effected by us that occurs after December 31, 2022, in connection with a Business Combination or otherwise, may be subject to this excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the nature and amount of any PIPE financing or other equity issuances in connection with the Business Combination (or any other equity issuances within the same taxable year of the Business Combination) and (iii) the content of any regulations and other guidance issued by the Treasury Department and/or the Internal Revenue Service. In addition, because the excise tax would be payable by us and not by the redeeming holder, it could cause a reduction in the value of our stock. The foregoing could cause a reduction in the cash available on hand to complete a business Combination in the required time and redeem </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfPublicSharesToBeRedeemed." scale="-2" id="Narr_iI4QKgVYWEWqMjlrP45ODQ">100</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> of our public shares in accordance with our amended and restated certificate of incorporation) could be subject to the excise tax, in which case the amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="Tb_2YicMT5uLEWIw6u8C06rdA" continuedAt="Tb_2YicMT5uLEWIw6u8C06rdA_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Tb_U_v_ZoFRsU6v9G6EOvUWQA" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Basis of presentation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:ConsolidationPolicyTextBlock" id="Tb_9FHENoiLP0ibnVssHj1gsQ" continuedAt="Tb_9FHENoiLP0ibnVssHj1gsQ_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</span></p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_2YicMT5uLEWIw6u8C06rdA_cont1" continuedAt="Tb_2YicMT5uLEWIw6u8C06rdA_cont2"><ix:continuation id="Tb_9FHENoiLP0ibnVssHj1gsQ_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dkdcu:EmergingGrowthCompanyPolicyPolicyTextBlock" id="Tb_rDZb14pOmk27qNKRlKF_XQ" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Emerging growth company</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:UseOfEstimates" id="Tb_bpBCB3tNF0GClCVtJ32WcQ" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Use of estimates</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="Tb_OXRlmbl5r0ml1TgPRSzeHw" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="0" id="Narr_zykdW-W9IkiRXgrwqmLG_w">10,108</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="0" id="Narr_TbugI8XLg0Ocb0KHDmiTyA">30,870</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> in cash and </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CashEquivalentsAtCarryingValue" scale="0" id="Narr_orxXGH17B0-lXHJEAtAQSA"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CashEquivalentsAtCarryingValue" scale="0" id="Narr_i4lla8oStEe4K8ThFOXI6g">no</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> cash equivalents as of March 31, 2023 and December 31, 2022, respectively.</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dkdcu:AssetsHeldInTrustAccountPolicyPolicyTextBlock" id="Tb_D4L2l9BiD0udu4d7OcD2Ig" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Trust Account</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Upon the closing of the Initial Public Offering and the Private Placement, </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_5_11_2021_To_5_11_2021_NmXExQZglUSAztqWU0QU3w" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Narr_v7heVJWJYEGu_bcoM2MuBg">117,300,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> (</span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_fb1Dl4_cvUeiHd7t1-fG3w">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:DeferredChargesPolicyTextBlock" id="Tb_BmlEAvdVt0a9GFD3AApgdg" continuedAt="Tb_BmlEAvdVt0a9GFD3AApgdg_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</span></p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_OuK825JRCUuDwq6kuYmJVg_1_2"></a><a id="Tc_q4qpyHpDGk2I1pRTjOLBRg_2_2"></a><a id="Tc_-ist8DkB4USA0cG--a3tJQ_3_2"></a><a id="Tc_Y97SCw5XXkiOYdtu4R-o9Q_4_2"></a><a id="Tc_ICIR5LCNyUymQwRg3kgVvg_4_5"></a><a id="Tc_gssHTOO2DU6jSXu4lNQv1Q_5_0"></a><a id="Tc_il66x9LoNESr4hNLNmz4ow_5_2"></a><a id="Tc_7mKYzt1sGUinePsPv--oFQ_5_5"></a><a id="Tc_WTWGilpy8UmqCkQYrwFMLg_6_0"></a><a id="Tc_dR3ApJM1OkCWztFAQZcBKg_7_0"></a><a id="Tc_Q7vdWJ0sT06xLLksiJdbEQ_8_0"></a><ix:continuation id="Tb_2YicMT5uLEWIw6u8C06rdA_cont2" continuedAt="Tb_2YicMT5uLEWIw6u8C06rdA_cont3"><ix:continuation id="Tb_BmlEAvdVt0a9GFD3AApgdg_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dkdcu:TemporaryEquityPolicyPolicyTextBlock" id="Group_yhrTbBWKOkWeeAS5_glvyA" continuedAt="Group_yhrTbBWKOkWeeAS5_glvyA_2" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</span><span style="font-family:'Times New Roman','Times','serif';"> Accordingly, as of March 31, 2023, there were </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_cOTdt3PUa0WDE3rWjvoZtA">3,316,819</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, excluding </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_o7l_WPT6NEC9VpKZrTtWEA">2,731,544</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 31, 2023, there are </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_hVTGu_0FbEy6zhs2-ZgI-g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_mdrn_LXYdUiNWa_2mj26Ig">585,275</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_fZfPUHrGL0ynP8qvs-yiKQ">4,838,792</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, which are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</span></p></ix:nonNumeric><ix:continuation id="Group_yhrTbBWKOkWeeAS5_glvyA_2"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and 2022, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:TemporaryEquityTableTextBlock" id="Tb_ZqiR4o5I5EKTGPKwxSbcqA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock &#8211; </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_x8noT7HZ8Ea8eJawCxiguQ_5_3">28,750,110</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_3enq_4DgOEaXJn81x6Td1w_5_6">117,300,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="0" id="Tc_TB_nSYwuvkiGyG3PJ5jamg_7_3">583,570</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="0" format="ixt:zerodash" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="0" id="Tc_9QWE8CqyxEeR1SOkrfWpKw_7_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock - </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_FyUQPN4qe0OMnvM3JWkCvg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_9sT6cpi0qE-E1p5DCnZ39Q_8_3">29,333,680</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_OkbsNvrK3EiK9N0XIQ24yA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_5msqLNiWGUCfYw3A2apaHQ_8_6">117,300,000</ix:nonFraction></p></td></tr></table></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:EarningsPerSharePolicyTextBlock" id="Tb_4iXzCCIpqUqQT1mLzDafFA" continuedAt="Tb_4iXzCCIpqUqQT1mLzDafFA_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Net income (loss) per share</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net income (loss) between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantExercisable" scale="0" id="Narr_MVbGu3SNG0yaamCYA1A4Qw">12,085,275</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of common stock in the aggregate.</span></p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_bb5af42b_dacd_4539_b478_4210ed96f867"></a><a id="_61ca6ddb_2bc8_4d10_8002_b274ab389c33"></a><a id="Tc_l8h_xDkV0Eqw0C6AsuwTGQ_1_2"></a><a id="Tc_yRDGaXQMB0ye7XV3K_1dVw_2_2"></a><a id="Tc_9egffzOIXUit8XKhiy794g_3_2"></a><a id="Tc_7rrrIMYPJ0KzXx8kNKKw1A_3_5"></a><a id="Tc_vd3iIXfcrEOC6AJMFhDOHQ_4_0"></a><a id="Tc_Oa1EsrO-p0iwnmkT3lBFzw_5_0"></a><a id="Tc_MVQXx_hoHU-T-SmRjobhFw_6_0"></a><a id="Tc_8rYZyy1vnUaLl8ZdXG565Q_6_2"></a><a id="Tc_X0QExLR_DUSyNbq9cHLZww_6_5"></a><a id="Tc_idiksSFK0Uu4gn7-xCNcTg_8_0"></a><a id="Tc_pfYI9RSzmUu5WJtpRaw1Bg_9_0"></a><a id="Tc_p7MAcRaodkm8zGqR1hOxOw_9_2"></a><a id="Tc_18qIYHOpjEq6kqn6o7etBg_9_5"></a><a id="Tc_0rFqAZvt4kq5yoMwWti02Q_11_0"></a><a id="Tc_nyjxVy6b-0-2HNMhIiin0A_12_0"></a><a id="Tc_Dw-EyD_DnkmrOXSBxPv25A_13_0"></a><a id="Tc_4ckyyRalCEinFEH2PyITtg_13_2"></a><a id="Tc_-EzptlNtgkqAz4cgyhUJRw_13_5"></a><a id="Tc_c-uFRI-my0GTwc7Lvj8vuA_15_0"></a><a id="Tc_mbvdyS8vSEm4V2_oA47nOw_16_0"></a><a id="Tc_T9rUMwZxgUCT6yAtdCAfjA_16_2"></a><a id="Tc_t_wQvrvgLEydqNSqEjY_2g_16_5"></a><ix:continuation id="Tb_2YicMT5uLEWIw6u8C06rdA_cont3" continuedAt="Tb_2YicMT5uLEWIw6u8C06rdA_cont4"><ix:continuation id="Tb_4iXzCCIpqUqQT1mLzDafFA_cont1"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table reflects the calculation of basic and diluted net income (loss) per common share:</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="Tb_0xOQiY3GskqY6yidCJuYjw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_uSz1gBOQhUCZPBdUGGDuOA_6_3">54,958</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_iyzxHTksMkWaeqzYPzTijw_6_6">1,687,692</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"><span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 4,838,792</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_jt4E-ST-gkCSIXu_ndXVzg_8_6"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_jt4E-ST-gkCSIXu_ndXVzg_8_6_2">11,500,000</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_CDGcuiBnnkymsuW5u8gYJA_9_3"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" sign="-" scale="0" id="Tc_CDGcuiBnnkymsuW5u8gYJA_9_3_2">0.01</ix:nonFraction></ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_etoGQPBR9kWBZyuBtAsjBg_9_6"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_etoGQPBR9kWBZyuBtAsjBg_9_6_2">0.15</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_qUUWJeJQ3EyAiwS2nD90Pw_13_3">31,025</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_I_nky-jpQEegLeFkJlmVqQ_13_6">507,816</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"><span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 2,731,544</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_7wj1HLYCqEeOB5byl6qJaw_15_6"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_7wj1HLYCqEeOB5byl6qJaw_15_6_2">3,460,275</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_qnOsdnjebES_TrbZXM8-iw_16_3"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" sign="-" scale="0" id="Tc_qnOsdnjebES_TrbZXM8-iw_16_3_2">0.01</ix:nonFraction></ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_xASg6hKpxUSSOGNOwz7xjg_16_6"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_xASg6hKpxUSSOGNOwz7xjg_16_6_2">0.15</ix:nonFraction></ix:nonFraction></p></td></tr></table></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:ConcentrationRiskCreditRisk" id="Tb_r5Igr6sroEuilSyZANnCzQ" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At March 31, 2023 and 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="Tb_YIzHszrorEyCVtVBkbDQ4w" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dkdcu:DerivativeFinancialInstrumentsPolicyPolicyTextBlock" id="Tb_hv2OFglg8EmqFQrEv_x8Yw" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:IncomeTaxPolicyTextBlock" id="Tb_Qez7QJkZ50SkuT0Fu8AIxw" continuedAt="Tb_Qez7QJkZ50SkuT0Fu8AIxw_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Income Taxes </b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="Narr_I2d3r-ynM0Cl9r28SUIvzg"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="Narr_LZpG7WrMjki4bz2V2pIWPg">no</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> unrecognized tax benefits and </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" id="Narr_XljdfjTZR0-h52uO4jLSbg"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" id="Narr_ez8G0ImBv0ODksKCNw5LmQ">no</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> amounts accrued for interest and penalties </span></p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_2YicMT5uLEWIw6u8C06rdA_cont4"><ix:continuation id="Tb_Qez7QJkZ50SkuT0Fu8AIxw_cont1"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">as of March 31, 2023 and 2022, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Our effective tax rate was </span><span style="font-family:'Times New Roman','Times','serif';">(<ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="4" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" sign="-" scale="-2" id="Narr_EC_xFfGhKUe3iib63Vi-9g">225.88</ix:nonFraction>%)</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw" decimals="4" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="Narr_TwHLx9HitUGR9G7_Pzj4VQ">0</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_3_31_2023_95dncZH7m0qh7lCm80ElQQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Narr_lTKF1i5WbUK0_tzl39vSjA">21</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, due to transaction costs and the valuation allowance on the deferred tax assets.</span></p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Tb_j_ZSZ3QWRkCEeYtYvYfdkQ" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within those fiscal years.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</span></p></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dkdcu:InitialPublicOfferingDisclosureTextBlock" id="Tb_Gj_KkWriWUGW41GcjHXPwA" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 3. INITIAL PUBLIC OFFERING</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to the Initial Public Offering, the Company sold </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_GoAOXUaqi0GldBA65yTdgQ">11,500,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> Units at a purchase price of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_fctU6QHKQEOu595qEl978g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_eB3jg7dLZUy1knOl0fcCPQ">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per Unit. Each Unit consists of </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_y47mRrlmNUqJZIDNSj342g" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfSharesIssuedPerUnit" scale="0" id="Narr_DiCrFsE9R0KGnBPidD1wGA">one</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> share of the Company&#8217;s Class A Common Stock, </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_sZt_rwB1jU6Hd66CQV3JCw">0.0001</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> par value, and </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_Zz-LC321iEOx0QXt64XTUw" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfWarrantsIssuedPerUnit" scale="0" id="Narr_yYd-YRzu1U-aXpm90W_coQ">one</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" id="Narr_1AlXl3yW7ECXplBChafC4Q">one</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> share of Class A Common Stock at an exercise price of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_3SQJIMIvWUS9ELj-b17duQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="Narr_3VnTsoXNuE2WwCBcp7vWaQ">11.50</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">&#160;per whole share (see Note&#160;9).</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dkdcu:PrivatePlacementTextBlock" id="Tb_aZ6cs-hIkkSyq9gurkc1sg" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 4. PRIVATE PLACEMENT</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_BCoSdhDn8kSOYrKHJDYXHw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="Narr_GiY_e7eIwU-hJL_yoGIWiQ">585,275</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> Private Placement Units at a price of $</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_BCoSdhDn8kSOYrKHJDYXHw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="Narr_Pm5wubpzx0mUFmy8lHzFGA">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per Private Placement Unit for an aggregate purchase price of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_9p3Am8C7MEOlbQrXnk_2cg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" id="Narr_P77Nsqz4q0aLfm8SL-ieLA">5,852,750</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Private Placement Units are identical to the Units, except that (a) the Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of the Company&#8217;s initial business combination except to permitted transferees and (b) the Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) may be exercised by the holders on a cashless basis and (ii) will be entitled to registration rights.</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="Tb_7rwS5Y0HLEaNnqCwbwvmPA" continuedAt="Tb_7rwS5Y0HLEaNnqCwbwvmPA_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 5. RELATED PARTY TRANSACTIONS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Introducing Advisor Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On June 26, 2021, the Company entered into an introducing advisor agreement (the &#8220;Introducing Advisor Agreement&#8221;) with ARC Group Limited, the Company&#8217;s financial advisor (&#8220;ARC&#8221;), pursuant to which ARC will make strategic introductions to the Company of potential target companies and/or their subsidiaries, affiliates, or representatives (each an &#8220;Advisor Target&#8221;) who may be interested in potential business combinations with the Company. In consideration for ARC&#8217;s services under the Introducing Advisor Agreement, we agreed to (i) pay to ARC (a) a retainer of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RetainerFeeUponExecutionOfAgreement" scale="0" id="Narr_hHk_4BRMBE-3KDM6TJ_n4A">50,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> upon execution of the Introducing Advisor Agreement and (b) a success fee of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SuccessFeeUponClosingOfInitialBusinessCombination" scale="0" id="Narr_2pEKpDN_ykWPEDjBzTpAsg">100,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> upon the closing our initial business combination, and (ii) cause to be issued to ARC equity interests in the post-combination company representing a five-percent (</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfOwnershipAsConsiderationForService" scale="-2" id="Narr_eUNDVAl2jEmX_odjgwWdrw">5</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';">) ownership interest in the post-combination company, if at any time prior to June 25, 2022 (the &#8220;Termination Date&#8221;), or within six (</span><span style="-sec-ix-hidden:Hidden_-gBu7Ivd10mlotw_rZDvrw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6</span></span><span style="font-family:'Times New Roman','Times','serif';">) months after the consummation of an initial business combination or any financing with any Advisor Target or any affiliate of an Advisor Target (the &#8220;Equity Issuance&#8221;).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_6BKMWuaDzEmPd9vqRg5_Nw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing" scale="-2" id="Narr_B2U9d-5duUSXmZBAZSgfOQ">5</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';">) on any PIPE </span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_7rwS5Y0HLEaNnqCwbwvmPA_cont1" continuedAt="Tb_7rwS5Y0HLEaNnqCwbwvmPA_cont2"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">that was brought by ARC in connection with the Company&#8217;s initial business combination upon the closing of the Company&#8217;s initial business combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_DbPO6wJFG0miuXZLNaYvBg">1,378,517</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of the Company&#8217;s Class B Common Stock, up to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" scale="0" id="Narr_sQvbQ2U9x0yHCiuxuZtCPQ">143,766</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Founder Shares</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On February 25, 2021, the Company issued an aggregate of </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_R_BRyHuFHEGSYLA18M9u6Q">2,875,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B Common Stock (the &#8220;Founder Shares&#8221;) to the Sponsor for an aggregate purchase price of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Narr_d3p9KIVWdUuoPJGGARqK0A">25,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">. On February 25, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember__hwYxA9DEkqAKdAwnBpc_w" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_XIkFpV7x-UelbjdtCvwpPA">15,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Executive Officer, </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefFinancialOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6znbrCXxFkGIcYmCY0iT1Q" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr__AmFIwgXEkKZgZfKN_4Vvw">15,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Financial Officer and </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_TwoIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_4pqzZtHe2EG3qyNAxfbe9A" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_kCwRjMLQ9E62mcX6GgXj0g">5,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_3_23_2021_To_3_23_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ThirdIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6T3pPliyHUS0duvs0F4HAw" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_1-7VIRaVVU2guxZUeZDr_g">5,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares to such independent director. The Founder Shares which the Sponsor and its permitted transferees will collectively own, on an as-converted basis, represent </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" scale="-2" id="Narr_Pi4mkjnwV0W1dUfRmTK1JQ">20</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. In connection with the Introducing Advisors Agreement, on December 31, 2022, ARC was granted </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_IhW2rhKKn0qo7A0xhD9s0w" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:ExtensionLoansNonCurrent" scale="0" id="Narr_J56PJgAycU2ZZLyBw_GWig">1,378,517</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B common stock, </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_IhW2rhKKn0qo7A0xhD9s0w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_ZRuG4HBsIUSvrW11U-G1lA">0.0001</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> par value per share, up to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" scale="0" id="Narr_kqUI5-G-C0OtlK9s-s8S-A">143,766</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> of which are subject to forfeiture by ARC if the Company&#8217;s public shareholders exercise redemption rights with respect to any of outstanding shares of Class A common stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;</span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw" format="ixt-sec:durwordsen" name="dkdcu:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" id="Narr_knboR-y4_E-ttCtdzsKr1A"><span style="font-family:'Times New Roman','Times','serif';">six months</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company&#8217;s Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" scale="0" id="Narr_V_vRXZ2cBEuUBs3QTnn4hQ">12.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_D_24WmzP3yxEKX8pNPNSJZgw" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" scale="0" id="Narr_QhgKmc059UCauYTl586NgQ">20</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> trading&#160;days within any </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_D_24WmzP3yxEKX8pNPNSJZgw" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" scale="0" id="Narr_rEFNRfk9kkKZb8BefjMqBg">30</ix:nonFraction>-</span><span style="font-family:'Times New Roman','Times','serif';">trading day period commencing at least </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw" format="ixt-sec:durwordsen" name="dkdcu:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" id="Narr_03TFcGNrPkCPAGNL42TULQ"><span style="font-family:'Times New Roman','Times','serif';">150 days</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> after the Business Combination, the Founder Shares will be released from the lock-up.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Promissory Note&#160;&#8212; Related Party</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On February 8, 2021, the Sponsor committed to loan the Company an aggregate of up to </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_2_8_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_GfqTmPjOjEe_maJFOaIOog" decimals="0" format="ixt:numdotdecimal" name="dkdcu:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" scale="0" id="Narr_9nraSoqBJ0aId_641UDOjA">300,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#8220;Note&#8221;). The Note was non-interest bearing and was payable on the earlier of July 31, 2021 or the completion of the Initial Public Offering. On June 1, 2021, the </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_6_1_2021_To_6_1_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ylqtNA-bUEmL4qYAA8d_tw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" id="Narr_diY9jlFjwU2Gjzw_83_amQ">78,925</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> outstanding under the promissory note was repaid in full. On March 31, 2023 and December 31, 2022, there is </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_XNE4PVnPmUe5dsW-sIzGIQ" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent" scale="0" id="Narr_evChlAHR1kyJA84fMctrxQ"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_yldGfAut_UOwpJfZ6m96hA" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent" scale="0" id="Narr_2hGoCyE_ZEmsi67nuslfnA">no</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> amount outstanding under the promissory note.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Related Party Loans</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In order to finance transaction costs in connection with a Business Combination, the Company&#8217;s Sponsor, an affiliate of the Sponsor, or the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the &#8220;Working Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_UkwcjyfyIkKPsh-ZJGYHfQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" scale="0" id="Narr_H1OjJo3gZ0m9Drjgsy76Fg">1,500,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> of notes may be converted upon consummation of a Business Combination into units at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_aJZ8MZKwr0C2EHSlNrQl3w" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="Narr_yG0x8Ampw0OkmndPu7XuSg">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per unit. The Units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On March 31, 2023 and December 31, 2022, there is </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_t_sN0AW8l0ysvEDGgawN6g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_KUJtHdrUKkeLlw7Cs6PJ6Q">239,081</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_QhH0lFLktE2HTU1zggfIyA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_6ZHBtFS0X0qPyvnkoXudkQ">207,081</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> outstanding under the Working Capital Loans, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company&#8217;s second amended and restated certificate of incorporation provides that, if the Company anticipates that it may not be able to consummate a Business Combination within </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" format="ixt-sec:durwordsen" name="dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" id="Narr_f4GL3Qm4IUqhuU1vfIJnFg"><span style="font-family:'Times New Roman','Times','serif';">12 months</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> from the closing of the Company&#8217;s initial public offering, the Company may, by resolution of the Company&#8217;s board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_PbNPt_yapkSBHj3BAe6I9g">two</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> times, each by an additional </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_rVGz1DSwEEq-KOUxag_OpQ"><span style="font-family:'Times New Roman','Times','serif';">three months</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> (for a total of up to </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" format="ixt-sec:durwordsen" name="dkdcu:AggregatePeriodToConsummateInitialBusinessCombination" id="Narr_YQ0KGlguqkixneAHo31r-A"><span style="font-family:'Times New Roman','Times','serif';">18 months</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account as set out below. Pursuant to the terms of the </span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_7rwS5Y0HLEaNnqCwbwvmPA_cont2"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Company&#8217;s second amended and restated certificate of incorporation and the trust agreement entered into between the Company and Continental Stock Transfer &amp; Trust Company, in order for the time available for the Company to consummate the initial Business Combination to be extended, the Sponsor or its affiliates or designees, upon </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" scale="0" id="Narr_yux4JMy-qUqno3WX7gqVwQ">five</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> business days advance notice prior to the applicable deadline, must deposit into the Trust Account </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_kF1v8eLYwUqIkingtOoNMA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SecuritiesDepositHeldInTrustAccount" scale="0" id="Narr_HD5yUwVZiE-RSTKuU1Xt9w">1,150,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> since the underwriters&#8217; over-allotment option is exercised in full (</span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_P6nhobuPVE6L9qTASsfgWA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="Narr_o8uhUDzuRk2Jrjr12gVrCw">0.10</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per unit), on or prior to the date of the applicable deadline, for each of the available </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_cGkdbrLM_k-ZycWOafyRbA"><span style="font-family:'Times New Roman','Times','serif';">three month</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> extensions, providing a total possible Business Combination period of </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" format="ixt-sec:durwordsen" name="dkdcu:AggregatePeriodToConsummateInitialBusinessCombination" id="Narr_IyKpfzEit0ijDhGQNUl4xw"><span style="font-family:'Times New Roman','Times','serif';">18 months</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> at a total payment value of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_kF1v8eLYwUqIkingtOoNMA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:BusinessCombinationTotalPayments" scale="0" id="Narr_xgT4brqN-kWVfXlKBQudbg">2,300,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> since the underwriters&#8217; over-allotment option is exercised in full (</span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_P6nhobuPVE6L9qTASsfgWA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="Narr_85ULlj3h8U-cBXAqdU2Kdw">0.10</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per unit) (the &#8220;Extension Loans&#8221;). Any such payments would be made in the form of non-interest-bearing loans. If the Company completes its initial Business Combination, the Company will, at the option of the Sponsor, repay the Extension Loans out of the proceeds of the Trust Account released to the Company or convert a portion or all of the total loan amount into units at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_aJZ8MZKwr0C2EHSlNrQl3w" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="Narr_w6k4PhN0PkCmvn-4f7nMTQ">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">&#160;per unit, which units will be identical to the Private Placement Units. If the Company does not complete a Business Combination, the Company will repay such loans only from funds held outside of the Trust Account. Furthermore, the letter agreement among the Company and the Company&#8217;s officers, directors, and the Sponsor contains a provision pursuant to which the Sponsor will agree to waive its right to be repaid for such loans to the extent there is insufficient funds held outside of the Trust Account in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination. The public stockholders will not be afforded an opportunity to vote on the extension of time to consummate an initial Business Combination from </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" format="ixt-sec:durwordsen" name="dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" id="Narr_CFK4nGkSJEe0kLnRaL6EjA"><span style="font-family:'Times New Roman','Times','serif';">12 months</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> to </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" format="ixt-sec:durwordsen" name="dkdcu:AggregatePeriodToConsummateInitialBusinessCombination" id="Narr_YHyZTQZ4_Ua-5Rsx11LQWw"><span style="font-family:'Times New Roman','Times','serif';">18 months</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> described above or redeem their shares in connection with such extensions. Pursuant to the foregoing, on May 5, 2022, the Company extended the date by which the Company had to consummate a business combination from May 11, 2022 to August 11, 2022. On August 10, 2022, the Company extended the date by which the Company had to consummate a business combination from August 11, 2022 to November 11, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As described in Note 1, on November 11, 2022, the Stockholders of the Company approved the Extension Amendment and the Trust Amendment to allow the Company to extend the deadline by which it must complete its initial business combination by up to nine </span><ix:nonNumeric contextRef="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_wzq3pdLUSk-Hj-g34bsbKA" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_pQTfxQX_KUyciOArSX60_w"><span style="font-family:'Times New Roman','Times','serif';">one-month</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> periods from November 11, 2022. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, caused </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_wzq3pdLUSk-Hj-g34bsbKA" decimals="3" format="ixt:numdotdecimal" name="dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" scale="0" id="Narr_IsNfwHB8kUy601g_626elA">0.045</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per outstanding share of the Company&#8217;s Class A Common Stock, or approximately </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_wzq3pdLUSk-Hj-g34bsbKA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" scale="0" id="Narr_cgsHplyH50i7HayJZF6IQg">122,920</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, deposited in the Trust Account in connection with the exercise of the monthly extension. In connection with each such extension, the Company will have until April 11, 2023 to consummate a Business Combination(see Note 11). On March 31, 2023 and December 31, 2022, there is </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_aJZ8MZKwr0C2EHSlNrQl3w" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ExtensionLoansNonCurrent" scale="0" id="Narr_P5OjVCVLqEOCdCPZzXpnYw">2,914,598</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_zKlPVPHq4kWNIVjUBUSy9g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ExtensionLoansNonCurrent" scale="0" id="Narr_6VXdtLMUEUSm1ugwTTxW3w">2,545,838</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> outstanding under the Extension Loan, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Administrative Services Arrangement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Commencing on the date of the prospectus and until completion of the Company&#8217;s Business Combination or liquidation, the Company may reimburse ARC Group Ltd., an affiliate of the Sponsor, up to an amount of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_2ZVBDaVZVk2yU4cLdp7-rQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" scale="0" id="Narr_PsliPgJ9Lka-a-dGgrhRQQ">10,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per month for office space, secretarial and administrative support. For the three months ended March 31, 2023 and 2022, we have incurred </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_7UFsYW4z006S_tfRUh0Kjw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="Narr__AicVxTEO0ijyz8ZJedorw"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_6IoH2prt10mKNC-IH_tP6A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="Narr_G09xTlH_2ki6W584tPQAWQ">30,000</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> in fees under this agreement, respectively.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Tb_HMPOOhticUawTcAaUlmg6Q" continuedAt="Tb_HMPOOhticUawTcAaUlmg6Q_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 6. COMMITMENTS AND CONTINGENCIES</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Registration Rights</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to a registration rights agreement entered into on May 6, 2021, the holders of the Founder Shares, Private Placement Units (including the securities contained therein), the units (including the securities contained therein) that may be issued upon conversion of the Working Capital Loans, and any shares of Class A Common Stock issuable upon the exercise of the Placement Warrants and any shares of Class A Common Stock, warrants (and underlying Class A Common Stock) that may be issued upon conversion of the units issued as part of the working capital loans and Class A Common Stock issuable upon conversion of the founder shares are entitled to registration rights. The holders of a majority of these securities are entitled to make up to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:MaximumNumberOfDemandsForRegistrationOfSecurities" scale="0" id="Narr_s-yOCNOCH0q9czdLoW7fIg">three</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_HMPOOhticUawTcAaUlmg6Q_cont1"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Underwriters Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company granted the underwriter a </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_9qk3u5ElcEGq6oIpa2IEYQ" format="ixt-sec:durday" name="dkdcu:OverAllotmentOptionPeriod" id="Narr_7l3PQh_ItUWjYJY_jNvg7w"><span style="font-family:'Times New Roman','Times','serif';">45</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';">-day option to purchase up to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_9qk3u5ElcEGq6oIpa2IEYQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_6dAdKGn5yUu_j-WMhri_wA">1,500,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The aforementioned option was exercised on May 11, 2021.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The underwriter was paid a cash underwriting discount of two percent (</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="4" format="ixt:numdotdecimal" name="dkdcu:UnderwritingDiscountPercentage" scale="-2" id="Narr_4HDZkRXV3kO86IyYSD0xgw">2.00</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';">) of the gross proceeds of the Initial Public Offering, or </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:UnderwritingDiscountPaid" scale="0" id="Narr_rLz8nRREqEyiYaFUw9Z9qg">2,300,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">. In addition, the underwriter is entitled to a deferred fee of three and a half percent (</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="4" format="ixt:numdotdecimal" name="dkdcu:DeferredUnderwritingFeesPercentage" scale="-2" id="Narr_shP2kHG-hUu-OimqLWsXGw">3.50</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';">) of the gross proceeds of the Initial Public Offering, or </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." scale="0" id="Narr_VvbF9qaNwEihbB_Xfu7Zxw">4,025,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Right of First Refusal</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">For a period beginning on May 7, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">First Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_C-Ez8Wj92k-wMY601LQlhQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing" scale="-2" id="Narr_HfayEQIsh0aHQ7jD-2BexQ">5</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">%) on any PIPE that was brought by ARC in connection with an initial business combination upon the closing of an initial business combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Second Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_uEkHeFxWoUKCxd1wCPJN3g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_w4pUxgqqNUWtvp4hn2Z0uw">1,378,517</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of the Company&#8217;s Class B Common Stock, up to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_M9ekq6WdLEucW-gPahd0mw" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" scale="0" id="Narr_EFB6fDxHo0SpTmiuKjoQzA">143,766</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="dkdcu:WarrantLiabilityTextBlock" id="Tb_glm-dHpVjk2Uh24z1yPlqg" continuedAt="Tb_glm-dHpVjk2Uh24z1yPlqg_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 7. WARRANT LIABILITY</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ" format="ixt-sec:durwordsen" name="dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" id="Narr_GaVrNZDX_kSILRGuEo7ETQ"><span style="font-family:'Times New Roman','Times','serif';">30 days</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination and will expire </span><ix:nonNumeric contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_6wnVrpWarEuBYWQ4-7W6Ig" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Narr_PVA_5Ze79U6z1Yq44x0N4g"><span style="font-family:'Times New Roman','Times','serif';">five years</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination or earlier upon redemption or liquidation.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company has agreed that as soon as practicable, but in no event later than </span><span style="-sec-ix-hidden:Hidden_pecVw-7_R0GR-O1MFLS0Dg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';"> business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants is not effective by the </span><span style="-sec-ix-hidden:Hidden_4KOodU4RC02gxRyhNxEksA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">60</span></span><span style="font-family:'Times New Roman','Times','serif';">th business day after the closing of the Company&#8217;s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants </span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_glm-dHpVjk2Uh24z1yPlqg_cont1" continuedAt="Tb_glm-dHpVjk2Uh24z1yPlqg_cont2"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company&#8217;s shares of Class A Common Stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Redemption of warrants when the price per Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="Narr_8wg35HZj6karahb0WX4gPw">18.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">. Once the warrants become exercisable, the Company may redeem the Public Warrants:</span></p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" scale="0" id="Narr_m2h-J9gK5U-XGwzgEMu7Ew">0.01</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per Public Warrant;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw" format="ixt-sec:durwordsen" name="dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" id="Narr_6KwLP-AtZUu_40hl3Vdg3w"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 days</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8217; prior written notice of redemption to each warrant holder; and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="Narr_9bBTvnJJ9kWCy11etKm31g">18.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any </span><span style="-sec-ix-hidden:Hidden_wWOk2hbenkiF3eCjIIPW1A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="-sec-ix-hidden:Hidden_j3RPZoOibUKp_scxdjJSCw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Placement Warrants were identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw" format="ixt-sec:durwordsen" name="dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" id="Narr_GmDb5xUV6kOfChkAK48ymw"><span style="font-family:'Times New Roman','Times','serif';">30 days</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">In addition, if (x) the Company issues additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_THD-b4ZLeEmrlSnwTQZiEA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_ikxpa1WbKUuSbkoEN3T98g">9.20</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfGrossProceedsOnTotalEquityProceed" scale="-2" id="Narr_tho6qIBp0UaZxrrUd4mw-A">60</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> of the total equity proceeds, and interest thereon, available for the funding of the Company&#8217;s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s common stock during the </span><span style="-sec-ix-hidden:Hidden_9B-TMAVHjEWPMjdgpFxpbg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';"> trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_6wnVrpWarEuBYWQ4-7W6Ig" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_q4S1euaBJk2UbCS2u-xoLw">9.20</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice" scale="-2" id="Narr_xa1wNLDMzkWbiS2PE0_lEw">115</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> of the higher of the Market Value and the Newly Issued Price, the </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="Narr_eH08CD25gEK0Ua8LjxMzoA">18.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_g-5Z8iiekEipUKjvBBe-og" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice" scale="-2" id="Narr_0MdGgQ_lS0WGZ8r9e7B6xg">180</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> of the greater of the Market Value and the Newly Issued Price and the </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_g-5Z8iiekEipUKjvBBe-og" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="Narr_WmbK6QOHREW9B0vQ3D4sdA">10.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per </span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_glm-dHpVjk2Uh24z1yPlqg_cont2"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until </span><span style="-sec-ix-hidden:Hidden_-WzpzrAyj0OzmcEU8I-ydQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';"> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">At March 31, 2022 and December 31, 2022, the Company accounted for the aggregate </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6Bac23xTIkSPqevzW_S64Q" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_LproTjpq9U-REDlRUPO_PA"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6jC0xt_xPkW3XWSHKmx-Wg" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_iRRBC1ybzUOYQ7svywDC8Q">12,085,275</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> warrants issued in connection with the Initial Public Offering (the </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_diIvEq3-20mlMWv_eEGTGg"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_MOVzISFFMEm8Oo5O-HJejw">11,500,000</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> Public Warrants and the </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_0L55K7OfcUakEf_TMfNGTg" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_Wax-0QQsJ0S4fJunqmh6AQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_fqKCHCXgBkSvo0fCaH9NXQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr__ghx70nlD0SEEQe6c4AINw">585,275</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company&#8217;s statement of operations.</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_2573097d_b20f_43a4_91f5_bd9945529ca3"></a><a id="_2573097d_b20f_43a4_91f5_bd9945529ca3_2"></a><a id="_2573097d_b20f_43a4_91f5_bd9945529ca3_3"></a><a id="_189912fb_43fb_4097_9942_5fa1cf0d8930"></a><a id="_189912fb_43fb_4097_9942_5fa1cf0d8930_2"></a><a id="_189912fb_43fb_4097_9942_5fa1cf0d8930_3"></a><a id="Narr_easACGA81UaClunAk4xIDQ"></a><a id="Narr_euslF1DgC0COuVQsk_ic7A"></a><a id="_42ecd34e_5b2b_4f0c_bcea_79a1506345f9"></a><a id="_42ecd34e_5b2b_4f0c_bcea_79a1506345f9_2"></a><a id="_42ecd34e_5b2b_4f0c_bcea_79a1506345f9_3"></a><a id="_d1857c93_5e76_422c_ad96_7671e6cc55f5"></a><a id="_d1857c93_5e76_422c_ad96_7671e6cc55f5_2"></a><a id="_d1857c93_5e76_422c_ad96_7671e6cc55f5_3"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Tb_MrlXHVPqFUmF4Z5KV3ChhQ" continuedAt="Tb_MrlXHVPqFUmF4Z5KV3ChhQ_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 8. STOCKHOLDER&#8217;S EQUITY</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Preferred Shares </span><span style="font-family:'Times New Roman','Times','serif';">&#8212; The Company is authorized to issue </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_lymSmJJccUaQMjRUqg6D_w"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_VNcLEjHJAUaCZMpvLtPMBw">1,000,000</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> preferred shares with a par value of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_0zwXuWfsJk-WLdb4Mxs8Lw"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_rujtr7-eDEq0guKGPaoEJw">0.0001</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s Board of Directors. At March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_kGul5tmO2kajLU8WHKYYvQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_jCXnvA7QJkSqAjWV1YJDCQ">no</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> preferred shares issued or </span><span style="font-family:'Times New Roman','Times','serif';">outstanding</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Class A Common Stock </span><span style="font-family:'Times New Roman','Times','serif';">&#8212; The Company is authorized to issue </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_zR4KSQbS00-gfMcsraHsOA"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_ZI7NYbJw_UKt5FWeLvsVVA">100,000,000</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock with a par value of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_-b4w_g-LhUupNJBFvInc3Q"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_gYtQY-AWokCTvPfFY1avgw">0.0001</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share. Holders of the Company&#8217;s Class A Common Stock are entitled to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:CommonStockNumberOfVotesPerShare" scale="0" id="Narr_z_vhAtkgDk2hROuvxEZ2gw"><ix:nonFraction unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:CommonStockNumberOfVotesPerShare" scale="0" id="Narr_yIU_d30Ds0uQ4t592whBiw">one</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> vote for each share. At March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_g_97mNUb4kStaMDUizkRmA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_F7CLokEFx0mc814jc5yqKQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_ifs9AdjQcke5yZEerWtAKg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_K-JHUitIqESKj2wNunysgw">585,275</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of non-redeemable Class A Common Stock </span><span style="font-family:'Times New Roman','Times','serif';">issued</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">outstanding</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">in connection with the private placement (Note 4), excluding </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_KetYLL_kO06m9-uBo1B9Xg"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_iI2s35hgV02FDS15mw-ZHw">2,731,544</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock subject to possible redemption as of March 31, 2023 and December 31, 2022, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Class B Common Stock &#8212; </span><span style="font-family:'Times New Roman','Times','serif';">The Company is authorized to issue up to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_fnb72YxZ1EqfvjmOPvizsA"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_Ppl02wE0R0S2cScmDhKMlQ">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B Common Stock with a par value of </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_m_6fo_OOf0qgrEBUL41gbg"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_f7uuNTqgakC6IP6bv3ujFA">0.0001</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share. Holders of the Company&#8217;s Class B Common Stock are entitled to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:CommonStockNumberOfVotesPerShare" scale="0" id="Narr_kDkzxHTQ8UmmJcvQGe18GA"><ix:nonFraction unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:CommonStockNumberOfVotesPerShare" scale="0" id="Narr_B4qjzgvGM0WgW7x3n4jqjg">one</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> vote for each share. On February 25, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefExecutiveOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_Mzinbo6790mIYa6MzPmccA" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_GsbVVKXzTUWeJ3viogOTZw">15,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Executive Officer, </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefFinancialOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9btB9vKZLEW4K63rfAMw5Q" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_qR5eff72IES0-NOwk75iLQ">15,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Financial Officer and </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_1lq6y8qH_02AAAlWFjyicg" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_jHIWHC8EqEK1ZbyapAFd4A">5,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_3_23_2021_To_3_23_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_7vg13yQIHkePUv6ms7p3ng" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_lbzU2T1Rb0msrIw3ykhBYw">5,000</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares to such independent director.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On December 31, 2022, ARC Group Limited, the Company&#8217;s Financial Advisor, was granted </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_k4XnqCxapUm0XkP2LUlKAQ">1,379,517</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B common stock with a par value of $</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_wLPX3pqnoEGRhqgS36Atpg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_O_kGZPrXlkChie9aqq0Cvw">0.0001</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share, up to </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" scale="0" id="Narr_P5OBOYf4wEqQvd8nnRx06Q">143,766</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> of which are subject to forfeiture if the Company&#8217;s public stockholders exercise redemption rights with respect to any of the Company&#8217;s remaining outstanding shares of Class A common stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">At March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_wlejDTuRR020duFRPk6Zsg"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_d2eueHj7iE6gG20J5Xnzmg">4,253,517</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B Common Stock issued and </span><span style="font-family:'Times New Roman','Times','serif';">outstanding</span><span style="font-family:'Times New Roman','Times','serif';">, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Holders of Class A Common Stock and Class B Common Stock will vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Business Combination on a </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KOLd2DPW60K1uO5F86SP4A" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="Narr_FFQxn5GibkqpTgLSS_-2Cw">one</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A Common Stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B Common Stock shall convert into shares of Class A Common Stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B Common Stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A Common Stock issuable upon conversion of all shares of Class B Common Stock will equal, in the aggregate, on an as converted basis, </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA" decimals="2" format="ixt:numdotdecimal" name="dkdcu:Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" scale="-2" id="Narr_LiPTQdN-sEmoQPEsK4m9BA">20</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';"> of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A Common Stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be </span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_MrlXHVPqFUmF4Z5KV3ChhQ_cont1"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">issued, to any seller in a Business Combination, and any private placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_f72dade5_83ef_4ee9_8458_4c33cdbd5ac2"></a><a id="Tc_flvFkrs2BEqoEp39iRk9sw_1_2"></a><a id="Tc_lO4EMMWLwES92P1ZcJWWFg_2_2"></a><a id="Tc_PNBt9JHT3UG3-dzel8RsDQ_2_5"></a><a id="Tc_lx3AFoGlQU6NErj5Jx2FUg_2_8"></a><a id="Tc_Xzk68lGlVkmYu8em-Ncp3A_3_2"></a><a id="Tc_siWkSF6hJkG2aoCxaz3esQ_3_5"></a><a id="Tc_CI4ghpcMtEq2nuJlmPXsgA_3_8"></a><a id="Tc_Hu0kocBMo0CKOcWa2mSgGg_4_0"></a><a id="Tc_4JpSoTgwUUq5h6Vvw9mmqQ_4_2"></a><a id="Tc_8Iao0w3Vh0u-3iVn1ChcNA_4_5"></a><a id="Tc_1ILe5g14xE2OSkZI3zPAmQ_4_8"></a><a id="Tc_V4JLKRYEfkqpinmIbslnjQ_5_0"></a><a id="Tc_dAkpPSYseEOjs0ZO0AwmSA_6_0"></a><a id="Tc_UEYyM8gXRkedKTYaxdgDZg_6_2"></a><a id="Tc_0fPbyjocGUOcKlhF4iOCkA_6_5"></a><a id="Tc_xGieQ-6-s0GLMAwtEW12oQ_6_6"></a><a id="Tc_dZT2u0NnrkmVBid0_jkh6w_6_8"></a><a id="Tc_eeQRnFG5LEet7_6D8xzPNQ_6_9"></a><a id="Tc_6vAmigkEnUqPEhLsNstawg_8_0"></a><a id="Tc_YBWSzBllVEW6ChYGAG8IAg_9_0"></a><a id="Tc_RmEA5etROE6NN--uaTfipw_9_2"></a><a id="Tc_aRvUSJi9VEKsIoJyoASKRg_9_5"></a><a id="Tc_K7XoscrsZEenP0-IzYVF2A_9_6"></a><a id="Tc_IHMcWNFKKk-THiYoBJbuLA_9_8"></a><a id="Tc_j1fBmBEBTU-C0x5KDpLgIA_9_9"></a><a id="Tc_ylCurFDghU-AVhVhjTgHaQ_10_0"></a><a id="Tc_hzaZo75pZUuP__mrxy7Dgw_10_2"></a><a id="Tc_cweHltyZpECZOV-mWt4J9w_10_3"></a><a id="Tc_wisuZXydZU60BWEG4YShrw_10_5"></a><a id="Tc_7ECJDjemUUqtzQ5xoZrC0A_10_6"></a><a id="Tc_EG8wI_4q20Oo6ht5gNWd1Q_10_8"></a><a id="_509193e9_0d32_4715_a314_0bc76a12da59"></a><a id="Tc_3qNn1fIx3EyDMSNwR7jyiA_1_2"></a><a id="Tc_vOGVddw82EC6gwd6atl3dw_2_2"></a><a id="Tc_uJ1z1n2YUEa9rYlcPP5AdQ_2_5"></a><a id="Tc_BMvy0LOBq0qcUGwuHxrg4A_2_8"></a><a id="Tc_8vOrQd4PpUiSKIr89YTEMA_3_2"></a><a id="Tc_wowOw8yjWEeGz74WfSliyA_3_5"></a><a id="Tc_li2XD3meBk687dWdD9j2jA_3_8"></a><a id="Tc_tPAJozXZ80aXu9wEx4Qseg_4_0"></a><a id="Tc_IXN7NEBADEiHojE5Hk0a3w_4_2"></a><a id="Tc_JrGCNuYjrkaQU20uMutCqw_4_5"></a><a id="Tc_hejBV7mF-Uu1q6okLg5i3w_4_8"></a><a id="Tc_yLIyk8NriUmD2wU5G1DODQ_5_0"></a><a id="Tc_-St0gOs2FECItqwmu6lIKg_6_0"></a><a id="Tc_kBaDDejeYkuFjeRnDQQ0kA_6_2"></a><a id="Tc_8IWrAnwgNkSgYzLAd8Edog_6_5"></a><a id="Tc__dO-aeFJt0uwZEda3JSiOg_6_6"></a><a id="Tc_9tjiM58mBUKP_h3K3vXVWQ_6_8"></a><a id="Tc_ojbjxC7gCkejMrucoDyHhA_6_9"></a><a id="Tc_GfvHUALYwEyzvuZxWwUN5g_8_0"></a><a id="Tc_jYdLSWr7IEuqsC0KordIjQ_9_0"></a><a id="Tc_csdL0evF9kaefU3nv5nJMw_9_2"></a><a id="Tc_b98h5tTlv0ep4Cv4izahSw_9_5"></a><a id="Tc_4ekzV63NGUeBpigvDz-JeQ_9_6"></a><a id="Tc_XZIpJ_hzw0icbbv_kVWh-g_9_8"></a><a id="Tc_HyqwTS4g1EGga54AGJKmlQ_9_9"></a><a id="Tc_eWw3zjg_-ECu9yM4f8SISQ_10_0"></a><a id="Tc_GumOgBRqS0e1OnFqSH_wyg_10_2"></a><a id="Tc_NJVR50p0QUGqMChihiFiFA_10_3"></a><a id="Tc_W0BF3USeu0-WdIXEi7p0sA_10_5"></a><a id="Tc_wCDW5lduDUWrzsY3dRZnkQ_10_6"></a><a id="Tc_FSBwR5ZDwUOcIQk1uR8XQQ_10_8"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:FairValueDisclosuresTextBlock" id="Tb_N82u0-JigEy2Mmr1RU2RvQ" continuedAt="Tb_N82u0-JigEy2Mmr1RU2RvQ_cont1" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 9. FAIR VALUE MEASUREMENTS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table presents information about the Company&#8217;s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="Tb_3K3A-o2QEkC95aKbfl_Iyw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_4TkL3ro1G0WNewZCXPJcSw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Tc_KeHiXirZFkCy9q4YBGiKAA_6_3">29,725,574</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g6Pq07wbNEa9FXfu1Ifs3Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" scale="0" id="Tc_OVPKtHJYkkevLi8_RjgdmQ_9_3">345,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_HJQOphMcxEKTWZeeZtSgpA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" scale="0" id="Tc_dmPW1IGvZkaIlVTvBMhnYw_10_9">17,558</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_6aYBpgJYl06PCALWaa-w4w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Tc_XDiIopO91k-2ZmTeSoad3A_6_3">29,029,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_Tv60Y58O_0WnZ3tyWWSaUA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" scale="0" id="Tc_JdNMDlHkKE6zGwB6HcBpeg_9_3">345,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_vEBEAARln0-juOH4J-Vj-A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" scale="0" id="Tc_28wBwEQ0YUyqEzGBDdPrPQ_10_9">17,558</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Warrants are measured at fair value on a recurring basis. The Public Warrants were valued initially and at each reporting period that the warrants were not actively traded, using a Monte Carlo simulation. As of March 31, 2023 and December 31, 2022, the Public Warrants were valued using the instrument&#8217;s publicly listed trading price, which is considered to be a Level 1 measurement due to the use of an observable market quote in an active market. Private Placement Warrants were valued using a Monte Carlo valuation model using level 3 inputs at initial valuation and as of March 31, 2023 and December 31, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">At March 31, 2023 and December 31, 2022, assets held in the Trust Account were invested solely in BlackRock US Treasury mutual fund of $</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_ePOJmFiwvU60MCXJN9p2Ug" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Narr_BY2JcUMGCE-RBfNsWWwPWw">29,725,574</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_0kOvX431_0WNunHM_Al50g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Narr_uzpfzLO6nkmgkNsRxkv5AA">29,029,416</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, respectively. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments and are considered Level 1 assets.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statement of operations.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_a1b02e3c_a89c_4d60_9147_17629b639403"></a><a id="_a1b02e3c_a89c_4d60_9147_17629b639403_2"></a><a id="_a1b02e3c_a89c_4d60_9147_17629b639403_3"></a><a id="_01de8fc7_ee85_42f5_a766_f4ec69aacf7c"></a><a id="_01de8fc7_ee85_42f5_a766_f4ec69aacf7c_2"></a><a id="_01de8fc7_ee85_42f5_a766_f4ec69aacf7c_3"></a><a id="_b5aee876_4f62_48f8_a64a_f81deb530239"></a><a id="_b5aee876_4f62_48f8_a64a_f81deb530239_2"></a><a id="_b5aee876_4f62_48f8_a64a_f81deb530239_3"></a><a id="_1ca72b11_3cc3_4ae5_b67f_659f0733a700"></a><a id="_1ca72b11_3cc3_4ae5_b67f_659f0733a700_2"></a><a id="_1ca72b11_3cc3_4ae5_b67f_659f0733a700_3"></a><a id="_10376463_eefb_4fe5_b090_7dfe329ec848"></a><a id="Tc_7TeoIBZQhkSlMjerKNn3mQ_1_2"></a><a id="Tc_1FGD38czGkecYDHkKHgiNw_1_5"></a><a id="Tc_RhBIvl3XukeYbllSJOae-w_2_2"></a><a id="Tc_pFU_Mstr7Em6Wc6rf7lboA_2_5"></a><a id="Tc_XXTMeOQyp0eNW4H9Ub-Zww_3_0"></a><a id="Tc_UfhUjO4N5U-nJaIImbryGw_3_2"></a><a id="Tc_p-CoEWnUKEKPfEpj5yA8eA_3_5"></a><a id="Tc_U17nWORnzUeDpF-s4UwQCg_4_0"></a><a id="Tc_Ua1UFlb5W0eGft1jNGGpMQ_4_2"></a><a id="Tc_Lb0wU39Sv0a92DazcxbYzA_4_5"></a><a id="Tc_0X79xjiGU0yAaBF0Usnq_Q_5_0"></a><a id="Tc_Ck4NXgGzMkeJVhvG7HCw3A_6_0"></a><a id="Tc_h1aS-93zFUODQKwrmE9rMg_6_4"></a><a id="Tc_PFm_zQNwyUOizcxQ2r0baw_6_7"></a><a id="Tc_AXTefE8eoU6rUt-i-pfkvQ_7_0"></a><a id="Tc_c-LnTl95LUyJJBjx155znA_7_4"></a><a id="Tc_nVBb31sIt0S27zIqs87O-A_7_7"></a><a id="Tc_jOn-wxlCnE2SOUjUAB7Sdg_8_0"></a><a id="Tc_cAFwVsRwmkWLN-nvHZderg_8_4"></a><a id="Tc_HYtHyDfIL0We1q7UGH4zYw_8_7"></a><a id="Tc_6byhaB2hTkasez3nlpqggQ_9_0"></a><a id="Tc_gmWIcDXk0ECBGgYlygHWRQ_9_2"></a><a id="Tc_gyMV_D8dpUKG0JQRxXpBSA_9_5"></a><a id="_09d83757_1a20_4225_9462_5e079a556119"></a><a id="Tc_UCekpZAqiUSdGqdONie9dg_1_2"></a><a id="Tc_xdQdC2suBEOoq3m4VTJeLg_1_5"></a><a id="Tc_3RBlwEJhgEa3Hz25i-adaw_1_8"></a><a id="Tc_F9ZkTLy6yU6KKoequ4yyeg_2_0"></a><a id="Tc_1ygB1gpaKEy5t4iYv7CM4w_2_2"></a><a id="Tc_xJiEftf4WUWH4gb0iyhtkA_2_5"></a><a id="Tc_G5ROa41kXkOPXhskrCSinA_2_8"></a><a id="_ee43be19_b7b5_48ee_acfb_120496c19ccc"></a><a id="Tc_DFi47ykRSUWWOz2Mugnu4w_3_3"></a><a id="Tc_wGbw3rNADkiSjjcEXiqo7g_3_6"></a><a id="Tc_9UeVLpBG70e-BqAh4LzS7Q_3_9"></a><a id="Tc_xixXkOTFAkS0vImyzKNqQQ_4_0"></a><a id="Tc_tXa3RiCAN0KkCJxYBZM-Ig_4_2"></a><a id="Tc_CnnIAkCt_keyQ_jEhoB5cg_4_5"></a><a id="Tc_tgeMJUZDGUSSiHzBfPjGYg_4_8"></a><a id="_3bef4d2e_ee8a_48fe_b50e_d47f4df1a402"></a><a id="Tc_Bniw_LnQ5E2GhDg7wuk7dg_1_2"></a><a id="Tc_QriLdkVUREKQpFpiA83qjQ_1_5"></a><a id="Tc_gpXbqFhTO06AxUJGZtAbXQ_1_8"></a><a id="Tc_RMoYbC4EZUiV-B7ajJ5-pg_2_0"></a><a id="Tc_wL5V8EM9lEuwsHEyuCpkeg_2_2"></a><a id="Tc_VAg527e3JkmwTyAh57zxWA_2_5"></a><a id="Tc_zgzOY1TYikSHAl9kpe4r6g_2_8"></a><a id="Tc_-ndu7CIjj0SULrZhlJTaBg_4_0"></a><a id="Tc_QyEa9F2gCUqnPyTeZA7Q1A_4_2"></a><a id="Tc_rbdi7YZjvkanyybM-rMPMg_4_5"></a><a id="Tc_ykS5-sXjzEakPURE3dUD6g_4_8"></a><ix:continuation id="Tb_N82u0-JigEy2Mmr1RU2RvQ_cont1"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company utilized a Monte Carlo simulation to estimate the fair value of the Public warrants at each reporting period for its warrants that are not actively traded. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. On June 22, 2021, the Public Warrants surpassed the threshold waiting period to be publicly traded. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of March 31, 2023 and December 31, 2022, the Company classified the Public Warrants as Level 1.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s common stock that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_QX1AgoN1i0GRrr7rqmGn3w" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Narr_porlIwgUP06nm7_faGzA2A">zero</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Transfers</span><span style="font-family:'Times New Roman','Times','serif';"> to/</span><span style="font-family:'Times New Roman','Times','serif';">from</span><span style="font-family:'Times New Roman','Times','serif';"> Levels 1, 2 and 3 are </span><span style="font-family:'Times New Roman','Times','serif';">recognized</span><span style="font-family:'Times New Roman','Times','serif';"> at the end of the reporting period in which a change in </span><span style="font-family:'Times New Roman','Times','serif';">valuation</span><span style="font-family:'Times New Roman','Times','serif';"> technique or methodology occurs. For the three months ended March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" decimals="0" format="ixt-sec:numwordsen" name="dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" scale="0" id="Narr_eSxiiTqij06FQEi0ZAHlDQ"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt-sec:numwordsen" name="dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" scale="0" id="Narr_NdNR_c781kipcgZYjZ03YA">no</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> transfers between levels</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: </span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="Tb_8CgPTPdHOUGRRzBsWTHJ_A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-y3TJWpkY0KEs_22qhgoTg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_uwAW-ZDRR0GT3wH0-Mfm6A_3_3">11.50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_bPi2WHn1CEmBrVfnbyV-yQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_s8ZtEF3KWEuQKcCX_8VwbQ_3_6">11.50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_NHlcD0Two0y88E2KkRoDFA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_Lz9Ow2Pik06fpNfjCsMoRA_4_3">10.69</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_ybrEKTUYVEi2w4swS4gdww" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_TeLSLN6uGEaNzPG71a-27w_4_6">10.44</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_w7FiqmYDb0SNPeqJvA62Hg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_v_JmWYX3EkyqzWZW6fEIaQ_5_3">5.18</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_g71uqyykEUaLUf1hlvHiRw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_bGUnv0GRCUyUQcWSWygwZA_5_6">5.12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_DDMbCIawE0WRTKQo8ri2HQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_42xfd6X7mEWIKo63rJ37tg_6_3">2.65</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_8tE3iMpWckqAsmbEpESznQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_lIGn4KeP60azMPa6zufkmQ_6_6">2.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_FUC4KYSqtUiLtDWVMSB8ZA" decimals="3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_iwLQFg70P0W0ZCtpjzl9-Q_7_3">3.2</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_8dkF3R4YwUqerp4U-rpgZQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_MLaQAwJ2YEK3VsBZdZW5xw_7_6">4.2</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_OlTpv8vqnUW3HCd6Lr3SsQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_aEZOxDMVQk6D_ZHDQydakA_8_3">3.53</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_SAyeztzxD0CqTCyFAOQf2A" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_6EPsw7DdyU2qotpBP02UiQ_8_6">3.91</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_QX1AgoN1i0GRrr7rqmGn3w" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_XopkTyFrPkC0x5MDpueQ9w_9_3">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_JeEGJuHbaES_O44UyyPIfA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_8Z-ov8Ph3EW23g1SdTi_4g_9_6">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The change in the fair value of the derivative warrant liabilities for the three months ended March 31, 2023 and 2022 is as follows:</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="Tb_zdULv7_43kem04eQX7oiDg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_ruu01iLDPE611oCSW8HUQw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_p-1QmXjSF02Nh58W3mlsqA_2_3">17,558</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_zH5qiDPjEkemrIOi-ojQnA_2_6">345,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_gvo3MI-_1kGJuvLmpZZU2w" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc__jKmYL1Ns0u2mSJ5kK2ySw_2_9">362,558</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_ZO2hDNBMi0u8zP5YIF1kNA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_SeDSdYS9I0OQvO6F2ARe9A" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_I00c7BPZAk-1VzkVyS6cbA_4_3">17,558</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_6wnVrpWarEuBYWQ4-7W6Ig" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_1o4sdKnnNkq_zKwA1u8wHA_4_6">345,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_TjM-esHGVEeoFX1cq_RpYg" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_jZwWnSZtwEeBPWEYfRjdOw_4_9">362,558</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember__X7tf0I7ukiYWBqvSdHF_A" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_EVcU-H5HuEieiUEcvrYGlw_2_3">251,668</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_hE2awbU3oU-sum3j2xFkxg" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_VVQSoDpbj0Ghn9OW8R3ukA_2_6">4,600,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_Nddpq_hUqUiHgJZLwEZXaw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_m88JGQBBKE6WEYWBi5ML6A_2_9">4,851,668</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_jQL209kLek2Gbb2s5yFT1A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_x0VSehuBK02ZfQG1ov1NTw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" sign="-" scale="0" id="Tc_JavFyKOh4kyj3mKICDANAA_3_3">117,640</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_vKlhRJKu3EemIj0dy92Ntg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" sign="-" scale="0" id="Tc_-vuHKvdMhEKihD0wLukt_w_3_6">2,645,000</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_JWpjApV5kk6mkkkuH-ZYQg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" sign="-" scale="0" id="Tc_qo2sFylQO0mIyakzyMefrg_3_9">2,762,640</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_0N5eYpz5zUyuKVAv4QYoVw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_pXIphiM_LUWFbRLZ_HIjfg_4_3">134,028</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_EF6C8NJFb0KSaqc-FbCmBg" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_wdl0_X_1zUus9igtleCBPQ_4_6">1,955,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_QUoUswNMF02jFye3P74QXQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_L-AWW6EJ5kumkL5vpEXeMQ_4_9">2,089,028</ix:nonFraction></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border:0pt;border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g" name="us-gaap:SubsequentEventsTextBlock" id="Tb_9A3Ss4wVdUqMSRaizVhi3A" escape="true"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 10. SUBSEQUENT EVENTS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In accordance with ASC Topic 855, &#8220;Subsequent Events&#8221;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identified any subsequent events that would have required adjustment or disclosure in the financial statements other than as described below.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 17, 2023, the Company withdrew $</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_4_17_2023_To_4_17_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_GxhdHNvlYEGHmFQK4ASs8Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="Narr_W2hoNMOWP0i4rzg_JVEcNA">214,850</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> interest earned on the Trust account to pay 2022&#8217;s income tax payment. The income tax was paid on April 18, 2023.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 19, 2023, the Company elected to exercise its sixth-month extension to the Termination Date, which extended its deadline to complete its initial business combination to May 11, 2023, by depositing </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_4_19_2023_To_4_19_2023_srt_StatementScenarioAxis_dkdcu_SixthOneMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_ziSc7tDmME6Wx3vreHBoIw" decimals="3" format="ixt:numdotdecimal" name="dkdcu:AmountDepositedPerEachPublicShareOutstanding" scale="0" id="Narr_AgsswMByr0CHyV1n4hpqgQ">0.045</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately </span><span style="font-family:'Times New Roman','Times','serif';">$<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_4_19_2023_To_4_19_2023_srt_StatementScenarioAxis_dkdcu_SixthOneMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_ziSc7tDmME6Wx3vreHBoIw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AggregateAmountDepositedInTrustAccount" scale="0" id="Narr__bwetUT6pESjCQAk_9oaQg">122,920</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';">, was deposited in the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 25, 2023, the Company withdrew $</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_4_25_2023_To_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_isjLRKvB20-ds3dYGWYkKg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="Narr_uQLn7T5xl0Sos6dZEN1Gdw">73,846</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> interest earned on the Trust account to pay 2022&#8217;s remaining balance and 2023 Q1 prepayment of Delaware Franchise tax. $</span><span style="font-family:'Times New Roman','Times','serif';"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NTJiqMJD-EKRgG77t6L0wg" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsOfFranchiseTax" scale="0" id="Narr_awgA6ZwaA0-jBK1N9z6hUg">73,846</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';"> was paid to the State of Delaware on May 2, 2023.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June 28, 2023, EF Hutton waived $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_6_28_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Qivj15x0skm53fAZP6Gj9w" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CashWaivedDeferredUnderwritingCommission" scale="0" id="Narr_l07fYU7PzE-OHu-M775lgw">3,025,000</ix:nonFraction> of the $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_6_28_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Qivj15x0skm53fAZP6Gj9w" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CashDeferredUnderwritingCommissions" scale="0" id="Narr_7TwPSBzUn0Cl6anM23N74w">4,025,000</ix:nonFraction> cash deferred underwriting commission, pursuant to a Satisfaction and Discharge Agreement (attached at Exhibit 10.22) that would otherwise be immediately due and payable upon the Closing, accepting in lieu thereof (i) a one-time cash payment of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_6_28_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_9U3WXH3Tuk6B4AeZ9LZceA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RelatedPartyPayment" scale="0" id="Narr_TZhifrol_Emdw15a5ubA1g">500,000</ix:nonFraction> at the time of the Closing; (ii) a $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_6_28_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_9U3WXH3Tuk6B4AeZ9LZceA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RelatedPartyPromissoryNoteExecuted" scale="0" id="Narr_0IJcacSG-kuvlzpHQMLLlQ">500,000</ix:nonFraction> promissory note executed by the Company on June 30, 2023 (attached at Exhibit 10.21) in which it is obligated to make six monthly payments to EF Hutton in the cash amount of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_10_1_2023_To_12_31_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_HiR7EAU8gUSivES6ft2axA" decimals="2" format="ixt:numdotdecimal" name="dkdcu:RelatedPartyPromissoryNoteExecutedPerMonth" scale="0" id="Narr_S6obIYsaq0-8-qW0BQt9qg"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2024_To_3_31_2024_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_JnW2PcUwp0OM1e3d0ygcIQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:RelatedPartyPromissoryNoteExecutedPerMonth" scale="0" id="Narr_94sjogzlfESNParGU-RC3g">83,333.33</ix:nonFraction></ix:nonFraction> from October 2023 through March 2024; and (iii) <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_6_28_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_nn_yhuYka4eAFEk-2_Tg" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:AggregateNumberOfSharesOwned" scale="0" id="Narr_Ag-S5CSFo0GSlaYHMJ4zbA">277,778</ix:nonFraction> ordinary shares of the Company (the &#8220;Ordinary Shares&#8221;) at $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_6_28_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_nn_yhuYka4eAFEk-2_Tg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_Fw2iecscSkesFyBqsOVAmA">10.89</ix:nonFraction> per share, for an aggregate value of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_6_28_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_nn_yhuYka4eAFEk-2_Tg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="Narr_iyZo0YNkoka9Bi7hLNjYbA">3,025,000</ix:nonFraction>.</p></ix:nonNumeric><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_5e268a1d_4da0_4b0d_b967_d28198c85f44"></a><a id="REPORT_OF_INDEPENDENT2"></a><a id="REPORTOFINDEPENDENTREGISTEREDPUBLICACCOU"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">REPORT OF INDEPENDENT</b><b style="font-weight:bold;"> REGISTERED PUBLIC ACCOUNTING FIRM</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">To the Shareholders and Board of Directors of</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Data Knights Acquisition Corp.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Opinion on the Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have audited the accompanying consolidated balance sheets of Data Knights Acquisition Corp. (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, the related consolidated statements of operations, changes in stockholders&#8217; deficit and cash flows for the year ended December 31, 2022 and for the period from February 8, 2021 (inception) to December 31, 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the year ended December 31, 2022 and for the period from February 8, 2021 (inception) to December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Explanatory Paragraph &#8211; Going Concern</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1 to the financial statements, the Company has until August 11, 2023 to complete a business combination or the Company will cease all operations except for the purpose of liquidating. Further, the Company&#8217;s cash and working capital as of December 31, 2022 are not sufficient to complete its planned activities for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Basis for Opinion</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">/s/ Marcum LLP</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Marcum LLP</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">We have served as the Company&#8217;s auditor since 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Boston, MA</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">March 31, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_31624512_c1b2_4c09_bc90_773625b5aaa5"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><a id="BALANCE_SHEET2"></a><a id="_48698_0"></a><a id="CONDENSEDBALANCESHEETS_343968"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED </b><b style="font-weight:bold;">BALANCE SHEET</b><b style="font-weight:bold;">S</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_cf058ce8_b128_416c_90c5_651e5782e45d"></a><a id="Tc_77BnIhgwBUictouq4i-3CA_1_2"></a><a id="Tc_JgcxOqNnPkCVBpdFkOn-mg_1_5"></a><a id="Tc_kjHRm9Yw6ECUSYIiNYP-iw_2_2"></a><a id="Tc_srkqRkL7T0CnBP758fEzfw_2_5"></a><a id="Tc_8IUaBAtRwESfD25HxBwf4w_3_0"></a><a id="Tc_Ccch9AGdEEOYVNDueHcOlw_4_0"></a><a id="Tc_fWqY-Vi0fU2VSJDgOpRhQw_5_0"></a><a id="Tc_4Ymx_nxrxUO-ypu32-WDHg_5_2"></a><a id="Tc_y-h94PhHI0G6HK7fZOXQag_5_5"></a><a id="Tc_C98D0mtBS0if9RNREMqatQ_6_0"></a><a id="Tc_GcIcAy4dtU-AyaGCJ3GjZw_6_3"></a><a id="Tc_AW0Y3_jTUUGB6woe_mapvg_7_0"></a><a id="Tc_5HNV3UJN5k2bg7_3jyjC2A_7_3"></a><a id="Tc_sZPz6B9rXE2kjTgpaDOIQQ_8_0"></a><a id="Tc_2PyRD9kz9kKQkNMwDJs1KA_9_0"></a><a id="Tc_Joxpqe3Fbk69GxvPSW13uA_10_0"></a><a id="Tc_vvNdKGURe0y5NpgJLY5SBQ_10_2"></a><a id="Tc_rYZJ1VtKuEOZStMWWm34Eg_10_5"></a><a id="Tc_EhFcLuGoR0SoeT_FD5CnsA_11_0"></a><a id="Tc_FBF6odlKEE-OBhWxEBLd2Q_12_0"></a><a id="Tc_mfq_d9Fab0maTag0QzOyhA_13_0"></a><a id="Tc_DvO9-6G55kSnYL-G0VAhWA_13_2"></a><a id="Tc_Bh6c8V5uB0yxcTJx5psC9A_13_5"></a><a id="Tc_f9YlwCIG7U2XweiBboSQlw_14_0"></a><a id="Tc_1NPcyYkIKkGN7EHggCe13A_14_6"></a><a id="Tc_knO4IIlLc02ECoa5fuZ8XQ_15_0"></a><a id="Tc_hzx6_J_gA0i-K3cU7FNBgA_15_6"></a><a id="Tc_Nf_IFk2YqEi3mlDR8XMGdg_16_0"></a><a id="Tc_YAKkHkbs90Oy9XQjTc9oKA_17_0"></a><a id="Tc_eO9nyQoBAUKULxMTI9RrYA_18_0"></a><a id="Tc_C_CTAFYlRUehpOBiINsEIA_19_0"></a><a id="Tc__4MNLC4e70CRExbvj3fhAA_20_0"></a><a id="Tc_4PMm7kdJL0SsKTCqzPPV8A_20_6"></a><a id="Tc_FUPueYv5IUOnZRujGpbTYw_21_0"></a><a id="Tc_jyozxTOOgEquJ8OWfBnNuQ_21_6"></a><a id="Tc_QwkNbkTUOUWnPICpHC3CEw_22_0"></a><a id="Tc_rcTAebIGH06ma48jQDWMXg_23_0"></a><a id="Tc_-MfKkmr9JUCzQnLz0ea5Qg_24_0"></a><a id="Tc_g8FvCtwgwkqjDErDKQ34xA_25_0"></a><a id="Tc_iS_bf6c22Um4hI5pyGbpTQ_26_0"></a><a id="_7a6d6062_788b_4466_89fd_f3064fb11920"></a><a id="_7a6d6062_788b_4466_89fd_f3064fb11920_2"></a><a id="_7a6d6062_788b_4466_89fd_f3064fb11920_3"></a><a id="Tc_XsaZ8HS6qEiP8osB8YmiVw_27_0"></a><a id="_ed2e138a_8a12_47fc_a4de_8418bdc213b5"></a><a id="_ed2e138a_8a12_47fc_a4de_8418bdc213b5_2"></a><a id="_ed2e138a_8a12_47fc_a4de_8418bdc213b5_3"></a><a id="Tc_QnAiac0Ay0uAzJ_Z0jQgtw_28_0"></a><a id="Tc_3DfxGJel2kGi85HDESEu3A_29_0"></a><a id="Tc_sK3xN0poA0C9yOphw75SLg_29_6"></a><a id="Tc_8FDyKYTXWUyO85WZjpJNYA_30_0"></a><a id="Tc_L4XQAJ8Ff0iSRF3ZX5lGPQ_31_0"></a><a id="Tc_wRlXSFt4Y0KNZh91lQCl9w_32_0"></a><a id="Tc_Jf2p17k3g02xYiiHccjIoQ_32_2"></a><a id="Tc_lW3q7DLvwUmXt4aFVWPxvA_32_5"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="Tc_RblwZP-9DUmBX91KIsti1g_5_3">30,870</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="Tc_TinpKNxpWk6iLP1TSlKhjQ_5_6">453,151</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Prepaid expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="0" id="Tc_gTGSUCThr0GIjcCR3PNm-Q_6_6">21,215</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Prepaid insurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PrepaidInsuranceCurrent" scale="0" id="Tc_dAnonmc6Pk-l1177LdmNjQ_7_6">61,846</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total Current Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="Tc_Dgb0pOqxD0azO7Tnb4AcMQ_8_3">30,870</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="Tc_YGwAkJu5cEqiz15gPuEllA_8_6">536,212</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Tc_wLbf1d1ch0ysdt5QDctNxw_9_3">29,029,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Tc_YEJd7vXA8EOukQbH_db1aA_9_6">117,320,973</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="Tc_eR4N2KDywU2vo2I9gx-ixQ_10_3">29,060,286</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="Tc_SaLcpEWsOUmtlddG2EYlpw_10_6">117,857,185</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">LIABILITIES AND STOCKHOLDER&#8217;S EQUITY</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Current Liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent" scale="0" id="Tc_1maUdy4iQkin4NeIK4S6Zw_13_3">1,679,821</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent" scale="0" id="Tc_6DYygbATw02ya4_fzSm3mg_13_6">125,972</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Amount due to related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesCurrent" scale="0" id="Tc_vTgoY0qjIEuwebG_E0FD7g_14_3">11,500</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Income tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="0" id="Tc_PzV8-Y5dsEqK5mATgpnc6g_15_3">214,850</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Franchise tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="0" id="Tc_uNghmCXt7U6jabH0eJmF2A_16_3">69,966</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="0" id="Tc_0NGig1FRU0iXGP1c3bolZg_16_6">164,008</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Current Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="Tc_dIjsFsPkqUSCh0sR-9qDpg_17_3">1,976,137</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="Tc_xyq-UPyaAEiHK5HWZAkmtg_17_6">289,980</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Warrant liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WarrantLiabilityNonCurrent" scale="0" id="Tc_gTfgpfrXW0yGT_Z5RZt4xA_18_3">362,558</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WarrantLiabilityNonCurrent" scale="0" id="Tc_s0CO9WMYy06ZMIAqR6xsDQ_18_6">4,851,668</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Deferred underwriter fee payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:DeferredOfferingCostsNonCurrent" scale="0" id="Tc_WP0w9kh9aEyeg59VBrRpoA_19_3">4,025,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:DeferredOfferingCostsNonCurrent" scale="0" id="Tc_K_g9yazeDkS9u_3Ls39LUA_19_6">4,025,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesNoncurrent" scale="0" id="Tc_tzsqnMP1J0meUTeAdPpNeQ_20_3">207,081</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Extension loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ExtensionLoansNonCurrent" scale="0" id="Tc_o-CaXKXN20idq_x_vzujmw_21_3">2,545,838</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" id="Tc_oXrt7B9Qs0G-L-L0RDtH4g_22_3">9,116,614</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" id="Tc_gFZuR0llCkKJLTrBnoCsow_22_6">9,166,648</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Commitments and Contingencies </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Class A Common Stock subject to possible redemption; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_QYYqobg4zkWQJtd3XV9Xeg">2,731,544</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_6KuFasZCyUO3DLsVOdobbA">11,500,000</ix:nonFraction> shares at redemption value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="Narr_nLcWdmB5gEu5NMAI2NF0Bw">10.53</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="Narr_7uZ9iul740OMiN9Mn6ABRw">10.20</ix:nonFraction> per share as of December 31, 2022 and 2021, respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_UvGJfpJNmUyvoFE9oEcFBQ_24_3">28,750,110</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_Rl5YKMk2PUun7cwXeFnNAQ_24_6">117,300,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Stockholders&#8217; Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Preferred shares, $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_oheOXmZ0p0u1r_JOSLECaQ"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_eEFIX1jSKU-h_Z9KBZqzCw">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_qq0X0guaKE2336klirWFkQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_MZFz9FbY0EmJ2jsqMQqTSA">1,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_JbnHqbpN-EmrBKA4nKihhA"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_Qh3qqcozbUO5fHUQdjovdA">none</ix:nonFraction></ix:nonFraction> issued and outstanding </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_VDWoG3xUDkq-QnqfvPkfFQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_W_tdiYbVOUGnMuYZaFehuw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Class A Common Stock, $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_5FNxDAzHT023E7BEuc0lpA"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_uJ5G-27WbkiBG1Ht6tC7Qw">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_pXdEQZEfIUmX1bNG_XEc_w"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr__e91UKg9UU-mbdGUu4uXlQ">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_N0cKDx01fE-CPoTUE87ugg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_I2ufn8-mOEivvhlH7sBw3A"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_cCUyR3aweUuSHX25RF6xQg">585,275</ix:nonFraction></ix:nonFraction> issued and outstanding, excluding <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_pembWoKvTkaEQ5tDdouM_w">2,731,544</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_R-burb9PiEm0cQHh8pQU0Q">11,500,000</ix:nonFraction> shares subject to redemption as of December 31, 2022 and 2021, respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_3dSh_es03kSLXioMqsZV9Q_27_3">59</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_N0cKDx01fE-CPoTUE87ugg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_Ix2nIO7zq0OaGuiRFip8gA_27_6">59</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Class B Common Stock, par value $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_VglCnL2pR0Kykbqqs6EDxw"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_nQWK5s3J40mPCspcJoSfyQ">0.0001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_e8F49ISoxUm2nESFgVrq3Q"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_wKsG4cbEtkmazsxgpC3cAw">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_fJvOPVKVlUmDx-I3IRl8Vg">4,253,517</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_dYD8Xe_pJk-NWNCIdLbyig">2,875,000</ix:nonFraction> <span style="-sec-ix-hidden:Hidden_kKzVaGg-tkyGRoA-U4HSRg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">issued</span></span> and <span style="-sec-ix-hidden:Hidden_bcDIwsjDIU2tiRoMVJeRRg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span> as of December 31, 2022 and 2021, respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_hl82ZCGImkqKS3SBs2BDXg_28_3">425</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_a2jQC42mtEaQhAhlOBioqQ_28_6">288</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Additional paid-in capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_1KMWQDP80UmtJMI6pxRIgA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2,825,823</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" sign="-" scale="0" id="Tc__QFh_K3wv0CRZN5e6jMnTA_30_3">11,632,745</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" sign="-" scale="0" id="Tc_s6DAPQFgxUOolQ2w_01Jeg_30_6">8,609,810</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Stockholders&#8217; Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_GgWdoKdVcE6bweAVa7uyGQ_31_3">8,806,438</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_MBHCFG1GJE-iw91iJLBnWQ_31_6">8,609,463</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total Liabilities and Stockholders&#8217; Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="Tc_r2Fqj5zNPEKpEXicF9QfUQ_32_3">29,060,286</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="Tc_f1kMBAfK8U28r06O97MfsA_32_6">117,857,185</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">The accompanying notes are an integral part of the consolidated financial statements.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ee3dbb3d_ec19_46ec_9b37_9111577a8757"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><a id="STATEMENTSOFOPERATIONS2"></a><a id="_862950_0"></a><a id="STATEMENTOFOPERATIONS_466869_0"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED </b><b style="font-weight:bold;">STATEMENTS OF OPERATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_82cf14ca_e0eb_44b8_9bbb_f6374ee3c9e2"></a><a id="_6ab28faf_abee_4408_b527_0fd93a190ec8"></a><a id="Tc_plErbRd-ckKYWxHySjlgdQ_1_5"></a><a id="Tc_KeHLKC0YTUi-nSbghGry0A_2_5"></a><a id="Tc_Ywkzq5hgUkGLAM6DCQNddQ_3_5"></a><a id="Tc_bfeTgKFRCE-AEDTjkSxC9w_4_2"></a><a id="Tc_G2jhlac_hEmw4gjYfehNSA_4_5"></a><a id="Tc_hMjnjXZXBEGluPmAhC6kzA_5_2"></a><a id="Tc_MT9qiUrTP0CjxkgI2UsTEg_5_5"></a><a id="Tc_ebL0DKo8dkKUrhwDPLVPyA_6_2"></a><a id="Tc_GpUmjQLdbkqgSGGZcYVEpA_6_5"></a><a id="Tc_OxHlkNQhOUyxSRmaHbJcOg_7_2"></a><a id="Tc_6kyqqnbJLEKZaKC7wne-Tw_7_5"></a><a id="Tc_kUbJTcUVhk-Zjop4ZL5xvw_8_5"></a><a id="Tc_-EwSnlbM2UyNrKLzPEAP8Q_9_0"></a><a id="Tc_aaY4CG5FEUiVts4jyXRfnw_9_2"></a><a id="Tc_9uc66zzTw0a3WOpAJR1epg_9_5"></a><a id="Tc_WSwtjNhBQ0moP5DDPwIYZg_10_0"></a><a id="Tc_D5Yq9fVG6kC3TK1QonDn3g_11_0"></a><a id="Tc_HIUORR76yUqUnekQ_sRLaw_13_0"></a><a id="Tc_IKRAiVll3ESOraE52RRTMA_14_0"></a><a id="Tc_Tu1VUcytX0eJnKjYm-a4mg_14_3"></a><a id="Tc_1NDUPYnvx0iH7cUyWedMgA_15_0"></a><a id="Tc_HxQs4jeZ7E2Jy6hvQuJWcA_16_0"></a><a id="Tc_NZOeUBydGEKwcEJDleO84Q_17_0"></a><a id="Tc_LwcUZ8_YwUqyPqyERu1mZg_17_3"></a><a id="Tc__NbRJAL-T0q-1AaMtk7WFg_18_0"></a><a id="Tc_wzxrfQpDTE6_wC4xatwG8Q_18_2"></a><a id="Tc_UYRQWN4Sk0CpZg899mkWdQ_18_5"></a><a id="Tc_vGwlvBZkOEuXuyBzM7R2Ng_19_0"></a><a id="Tc_xdsySk7UNUy-VNnYh169Gg_19_6"></a><a id="Tc_pB_LePKyL0S3l4p5yazHGQ_20_0"></a><a id="Tc_rEIYuMBf7ky3cmtM5quDqA_20_2"></a><a id="Tc_1CbV-MVEbkWtW0M7FoQcGg_20_5"></a><a id="Tc_yNqb2eOTdEO_OG59APR2vg_22_0"></a><a id="Tc_C_y8N-0FTU2xIG8mhDR57w_23_0"></a><a id="Tc_G0H6r2NqKEGwF_XBeVNNxQ_23_2"></a><a id="Tc_TBaonXdohU2k5U1igwvFUA_23_5"></a><a id="Tc_PAn5RAcRc0-IJ8wkXKoD8w_25_0"></a><a id="Tc_tnPJFdRe70eyM-7mHjnrpw_26_0"></a><a id="Tc_QiqmA5kOXkG9GI2xiAkU3w_26_2"></a><a id="Tc_Nh6xLh2uxEWPsMtyPNKNRQ_26_5"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Period </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> from</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Formation and operating costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" id="Tc_7a0jMzEekEKs1V4V7jj3oA_9_3">5,103,731</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" id="Tc_bJmNEKXLmE-HX103jsP-FQ_9_6">421,397</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Franchise tax expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FranchiseTaxExpense" scale="0" id="Tc_-2KGvG69DUWHAeL-neVE9w_10_3">205,560</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FranchiseTaxExpense" scale="0" id="Tc_A9WEL222mkqc9wriY5gp7A_10_6">164,008</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Loss from operation costs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="0" id="Tc_UuvVKwhMuUSLw2LxCMyMHw_11_3">5,309,291</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="0" id="Tc_z2QFA8C9DEmzJjsoi7GmBw_11_6">585,405</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other income (expense):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest earned on marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" scale="0" id="Tc_IKYAxZm6VEy-sdWMQtylrg_14_6">1,876</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividends, realized and unrealized gain in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_3OGTjmSjh0iWBpgwWz7hpQ_15_3">1,371,689</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_AZ_DUXjLzESWxSmy9dny-g_15_6">19,097</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value of warrant liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" sign="-" scale="0" id="Tc_Wb3LNrwpWECk4clUmrzDKQ_16_3">4,489,110</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" sign="-" scale="0" id="Tc_qVT0ySmpC0eRpeh3A-zs0Q_16_6">6,325,281</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-operating expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" sign="-" scale="0" id="Tc_rMDXvPeGnUqya2vLx_Hsmg_17_6">625,059</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net income before provision for income taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" id="Tc_a2EjBv4U9ESObXndSp1SNg_18_3">551,508</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" id="Tc_eLsndga8xUmAjiNuUDojWA_18_6">5,135,790</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="Tc_FmoCHqEHiku1jyrlebFgZA_19_3">214,850</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_LkpzeFrA9Uuy72gap5vwDw_20_3">336,658</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_yQAj7YB7i0u6xwS9Y9bgJg_20_6">5,135,790</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average shares outstanding of Class A Common Stock subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_jj5teGH2YUaZrjAV6BBK5w_22_3"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_jj5teGH2YUaZrjAV6BBK5w_22_3_2">8,667,969</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_5jhAXktUhU-uNKS_k6KwUQ_22_6"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_5jhAXktUhU-uNKS_k6KwUQ_22_6_2">8,264,526</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Basic and diluted net income per common stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_N76YRM4310qHClVHwYtZ0w_23_3"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_N76YRM4310qHClVHwYtZ0w_23_3_2">0.03</ix:nonFraction></ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_R-IZ3jhcKkqXbIOvia9a4A_23_6"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_R-IZ3jhcKkqXbIOvia9a4A_23_6_2">0.44</ix:nonFraction></ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average shares outstanding of Class A and Class B non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_NfYhucN-Q0Gqc9PRngNPtA_25_3"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_NfYhucN-Q0Gqc9PRngNPtA_25_3_2">3,464,052</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_8tGc-h5KI0a4F4XbQSDobA_25_6"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_8tGc-h5KI0a4F4XbQSDobA_25_6_2">3,295,610</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Basic and diluted net income per common stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_6JU_UBc40Eus4qZMpbGGWg_26_3"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_6JU_UBc40Eus4qZMpbGGWg_26_3_2">0.03</ix:nonFraction></ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_S6g0s3JgA0SbIruOEsDD9g_26_6"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_S6g0s3JgA0SbIruOEsDD9g_26_6_2">0.44</ix:nonFraction></ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">The accompanying notes are an integral part of the consolidated financial statements.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:4.55%;padding-right:4.55%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_e9c1d2fa_669c_4b8b_b64f_3bc9c6f51aa5"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_803524_0"></a><a id="CHANGESINSTOCKHOLDERSEQUITY_196601"></a><a id="STOCKHOLDERS_2"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED STATEMENTS OF CHANGES IN </b><b style="font-weight:bold;">STOCKHOLDERS</b><b style="font-weight:bold;">&#8217; DEFICIT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">FOR THE YEAR ENDED DECEMBER 31, 2022</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_05ae478f_39f1_48c9_88b0_0f1e89d4d123"></a><a id="Tc_jdWzFGQx90W-Z4N7BDqmwg_1_2"></a><a id="Tc_3X8U4SXtq06XJnC-nkeqTA_1_7"></a><a id="Tc_aYA4P3tVYkSbhWwrL_Mgxw_1_12"></a><a id="Tc_jIfei1SMQEyFVoyl21a6sw_1_19"></a><a id="Tc_KruM0s8UQkSQtIWfedluSw_2_2"></a><a id="Tc_9QvJuy49kk6qZus4Fu2gtA_2_7"></a><a id="Tc_bLjyGaZTqkGOo0vkILqKZQ_2_12"></a><a id="Tc_xDTlYHU58k-s3p5VuRNBZg_2_15"></a><a id="Tc_bJrFw-XyDUq1-oHbFV_czw_2_19"></a><a id="Tc_9PJKCDe_TEGi9fZTq96MtQ_3_2"></a><a id="Tc_j9uSXmRyBkqHb7qu1x_6vQ_3_4"></a><a id="Tc_7VdbDyVD80GSM-Z33C7zRQ_3_7"></a><a id="Tc_srh4FLOwsEKmZJOe1Och-g_3_9"></a><a id="Tc_GMBW4yGI70eSMEEq1G10FQ_3_12"></a><a id="Tc_4fe7NooS9UKvdje3GgFDIg_3_15"></a><a id="Tc_XfpbWll7BEeGl3EK3tlmxw_3_19"></a><a id="Tc_gVbnBKPkQkyjWSRqMmHC_g_4_0"></a><a id="Tc_Yz4VOzYdxkyq41lS4t-s_Q_4_4"></a><a id="Tc_QE6OA-oUEkalLdq1ZSvytA_4_9"></a><a id="Tc_5HSvfJM2YUaNHAkOJSLgKQ_4_12"></a><a id="Tc_jXjSVrcmqkOHdBQ8gE7HdQ_4_13"></a><a id="Tc_upvmI7N3ik2uqAFus2b0VQ_4_15"></a><a id="Tc_rFCvGXPiY0SlcslEuTORTA_4_18"></a><a id="Tc_FRhhtMaTOkmAyW8SvR7a8g_5_0"></a><a id="Tc_7wzU3USIwUWwpaukeTqK0Q_5_2"></a><a id="Tc__bdHazJLzEmakXr0E7llHQ_5_5"></a><a id="Tc_fSMUJp1h-kyG0gGjsD95ug_5_7"></a><a id="Tc_Hujf5gMPWEesOs_ffij_9Q_5_10"></a><a id="Tc_CFgd0Kd0fUma-Uh9ILiG7Q_5_13"></a><a id="Tc_Akv4xSu8qUmqM5yTyKSknQ_6_0"></a><a id="Tc_l5kLQBrQQ0S8DLsqTnoSxA_6_2"></a><a id="Tc_gXbF5sXvrUKEspu126bS_A_6_5"></a><a id="Tc_7WmVcSWKU06-YXLHrUi0Og_6_16"></a><a id="Tc_mQybjUXE9EqxUlNdDkeTkg_7_0"></a><a id="Tc_gxqoJVyka0SFqg7J2jnA5A_7_2"></a><a id="Tc_fhqP1mJJd0SOkCvYnRSkwQ_7_5"></a><a id="Tc_hTncGvkHs06_U6kYHKyZRg_7_7"></a><a id="Tc_REiuYnVPA0SVBfxkLC189w_7_10"></a><a id="Tc_4ux6zt4oR0qY7Uu1DZ0dCQ_7_13"></a><a id="Tc_V5qqjWbkQUiwzMiLWkoVLQ_8_0"></a><a id="Tc_FZAsaEp7d06O4Owhw2OHUA_8_4"></a><a id="Tc_53DvJBYY3EW2Eh2T_dLXqw_8_9"></a><a id="Tc_7cvBZI-OWUOS7kyMW-7bqQ_8_12"></a><a id="Tc_TdheomKDwUKUfCXkO200pQ_8_15"></a><a id="Tc_YfBYuRmbj0O9K5Vv8cBKEg_8_18"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:16.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class&#160;A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:16.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class&#160;B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additional</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:36.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:16.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:16.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paid in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholders&#8217;</b></p></td></tr><tr><td style="vertical-align:bottom;width:36.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deficit</b></p></td></tr><tr><td style="vertical-align:bottom;width:36.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;&#8212; January 1, 2022 &#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_iEMTTAoujkKdYzAB7uGGkw_4_2">585,275</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.97%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_HCt3US7J0k-ocmWyMYFfyQ_4_5">59</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_C2wqknDZnUmabdGIpenp-Q_4_7">2,875,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_TZTAecaPXECXDXP_9q7avA_4_10">288</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_6-yCbHCVY0uGfDrYrKv0Iw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_p6yaYkUTIkiF3J9exUqU6w_4_16">8,609,810</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_E7Fe11iZVEyX14jFJ8iIhQ_4_19">8,609,463</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:36.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Re-measurement of Class A Common Stock Subject to Possible Redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_9L82rWITkUe_O0x-YM5jnw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_LGy24TTzsUeJIyGPUu-HqQ_5_16">3,359,593</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_t4-7XrbpjEqnMqvXlx6D_Q_5_19">3,359,593</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:36.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Issuance of Class B Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HKTnd3Yg0k23m_kWDWCW4g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="Tc_z7eU8OsEzUWSwUKtqIlB_A_6_7">1,378,517</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HKTnd3Yg0k23m_kWDWCW4g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc__GRyhGQt30WfHzBjwE7kfg_6_10">137</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_qRsdIQljjU-ibnyalgU8ug" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc_aM3RGlTOC0mHMNm8ThvEGw_6_13">2,825,823</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc_UDsiUqpwkEqGG2Ky3ArOpw_6_19">2,825,960</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:36.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_9L82rWITkUe_O0x-YM5jnw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_rgWOIUXb9kidm2HSNh9KmQ_7_16">336,658</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_DFJfhTIxf0CGJv9qpndIrA_7_19">336,658</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:36.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;&#8212; December 31, 2022 </b></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;white-space:nowrap;width:6.93%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_OuGtR_tW6ESdip0kXPgSyg_8_2">585,275</ix:nonFraction></b></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;white-space:nowrap;width:0.88%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:top;white-space:nowrap;width:6.97%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_bSUKSJ3pbUGl4j52bQtsMg_8_5">59</ix:nonFraction></b></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;white-space:nowrap;width:6.93%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_xu08xK7-BkW1daWlZqbZUQ_8_7">4,253,517</ix:nonFraction></b></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;white-space:nowrap;width:0.88%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:top;white-space:nowrap;width:6.95%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_QRGRHL8GiEyVyunVfoUDYw_8_10">425</ix:nonFraction></b></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;white-space:nowrap;width:0.88%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:top;white-space:nowrap;width:7.25%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_dGxMlHP5QkeRLf3Erq2Q8A;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2,825,823</b></span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;white-space:nowrap;width:0.88%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:top;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_xXVChhyI6k-ndPgI-1--gQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_Eni_E4ooMUeuVNq5riIlnA_8_16">11,632,745</ix:nonFraction>)</b></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;white-space:nowrap;width:0.9%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:top;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc__H4b_7OmWUe_zB4x4BAhYA_8_19">8,806,438</ix:nonFraction>)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FOR THE PERIOD FROM FEBRUARY 8, 2021 (INCEPTION) THROUGH DECEMBER 31, 2021</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_cd5f7e3c_674d_45c7_841f_3e459170bc16"></a><a id="Tc_FlDi7vj0vEaVOaqW-gQd4w_1_2"></a><a id="Tc_UoZ4PC0AA0GWMAKxd5_T-Q_1_7"></a><a id="Tc_7bjBiG5KXkGH_5V30nAtCg_1_12"></a><a id="Tc_BA4iYpefeUqmtrxpbR6SJg_1_18"></a><a id="Tc_OLM4vqK4GUGAMNCdKrG-dQ_2_2"></a><a id="Tc_aei0wHblYUai095XA3VCYQ_2_7"></a><a id="Tc_Eb3gnUe5J0KX08jm8Z-4rQ_2_12"></a><a id="Tc_AcH3bqk_ZEqLKVdsEyWCww_2_15"></a><a id="Tc_RNS1jw6oFke-x5s3PpL7iw_2_18"></a><a id="Tc_mnKSZyKYaUy-6lYScEKnQg_3_2"></a><a id="Tc_07xCrZfIBkegwOLQ7kfHYg_3_4"></a><a id="Tc_xhutsnyIWU-JbC0Eorc8og_3_7"></a><a id="Tc_yX7DIs_V5kmrQwcHZljcsg_3_9"></a><a id="Tc_6AC_8GK-IkeKjY7H58UnyQ_3_12"></a><a id="Tc_If6I_22-tE-cayCjrF7Wlw_3_15"></a><a id="Tc_JZfDiUCz-E6xXz7Dcfcl2Q_3_18"></a><a id="Tc_cSisfYkMZEmtylvdBM9-9Q_4_0"></a><a id="Tc_3C7FnuK9VUGCQGTsasoKzg_4_4"></a><a id="Tc_QLtdTLr31EO909F8JY1jEQ_4_9"></a><a id="Tc_jw6KKj2Hoki2XsOWTKVfCQ_4_12"></a><a id="Tc_vMWQIUPLKUiKn84f_OsREA_4_15"></a><a id="Tc__BQTP4t-v0KAPxOkeXODLA_4_18"></a><a id="Tc_-60iJGF8AECwDTmAl2-R7A_5_0"></a><a id="Tc_JcW7dT_dEU6kHqJLBBxbYA_5_2"></a><a id="Tc_Pm9XFzFcHEaXmOae8ziYPw_5_5"></a><a id="Tc_XE68aHHHG0S3c4sJuXtXHw_6_0"></a><a id="Tc__tVNNgkxIkq6If06XHvHPA_6_7"></a><a id="Tc_2byPqKAXvkWODKUNq22cTg_6_10"></a><a id="Tc_YoN2XSEBMku3CYtnXAMuHg_7_0"></a><a id="Tc_gYPQJX18OUmIz2CesVhwEA_7_2"></a><a id="Tc_MXZth3XWVEqc8Tgl5-cz9A_7_5"></a><a id="Tc_RMuj_5TkCUehz46DMkM3NA_7_7"></a><a id="Tc_83kREmBavkyC3OOoD35HGw_7_10"></a><a id="Tc_scfhJFcDWkacAmyMUV9xOQ_8_0"></a><a id="Tc_Vjtxq0amI0GDCvdvogNp2Q_8_2"></a><a id="Tc_s6rV7woRqkasOXKG6bXf7A_8_5"></a><a id="Tc_o-JHlUPWmkCWAEttfvKcyA_8_7"></a><a id="Tc_bh9GbxLth0aHGM8GEwhepw_8_10"></a><a id="Tc_bl8nqWhLUUGB1I3l9zJlyw_9_0"></a><a id="Tc_e1K0x0BJVkK0Rvi5hvDPPw_9_4"></a><a id="Tc_3xEos2Q5tkSL3Y-fJv-uIg_9_9"></a><a id="Tc_6h5cl6ijJk20lrlaFWvg2w_9_12"></a><a id="Tc_BD6ZrisGZ0WJPnOCATF0jg_9_15"></a><a id="Tc_FZPawte2i0-hNw4NyNDeYQ_9_18"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:35.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class&#160;A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:16.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class&#160;B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additional</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:16.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paid in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholders&#8217;</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deficit</b></p></td></tr><tr><td style="vertical-align:top;width:35.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;&#8212; February 8, 2021 (inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_KwfTqwNCuk64IHdfIIUfOQ" decimals="INF" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="Tc_2a2nI-gLR0aqw_B0k1GQVw_4_2">&#8212;</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_KwfTqwNCuk64IHdfIIUfOQ" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="Tc_3qvRXL9zSkuIitzWUxt4jw_4_5">&#8212;</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_AU1G1eFSN02wMgL4I9gmYA" decimals="INF" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="Tc_RM4VnUr7NUGqVBdofGuN5Q_4_7">&#8212;</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_AU1G1eFSN02wMgL4I9gmYA" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="Tc_Dd_na0KteEGlEpIUFy6hZA_4_10">&#8212;</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_2_7_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_n-8OnhgC0EeVoVPuKg1hVw" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="Tc_Fbl6JxYQtEyGEddvK2sL1g_4_13">&#8212;</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_2_7_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_Xe0KcyySzEqyLKiwakwyLQ" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="Tc_tXCM97l03E2q2v2kMy7fUQ_4_16">&#8212;</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_2_7_2021_xIunY2_KPEmoFeGygcAWFQ" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="Tc_G4Z0FPSzTkKMU5cXz3PfUg_4_19">&#8212;</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:top;width:35.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Issuance of Class B Common Stock to Sponsor</p></td><td style="vertical-align:top;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Yt0ReKG7x0axkO27tJcJkQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="Tc_lgruwMQnkk-9J1dWT_dMxw_5_7">2,875,000</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Yt0ReKG7x0axkO27tJcJkQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc_BokN7KMBFkuFgL2XGjgSMg_5_10">288</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc_B96Q65Lupka4frvuczhfSA_5_13">24,712</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg" decimals="0" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc_GjCRfs-eNkaHa3tbRFFpwQ_5_16">&#8212;</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc_yF5anY6KoUygBpTklfYedA_5_19">25,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:35.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Sale of non-redeemable private placement units to Sponsor</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_okqVlM4N3EWxKtzFTl4dfw" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" scale="0" id="Tc_afC7aJ5Py0epZb91uZsT5w_6_2">585,275</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_okqVlM4N3EWxKtzFTl4dfw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" scale="0" id="Tc_SO9irq-JCUKAtEkHM_JVMQ_6_5">59</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" scale="0" id="Tc_1Lq_k8pktU2TIjtqpSpqkg_6_13">5,290,242</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg" decimals="0" format="ixt:zerodash" name="dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" scale="0" id="Tc_kR2MfgfF5UOszX1e5rBWog_6_16">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" scale="0" id="Tc_qZTKhob_j02QAd8crLvrSg_6_19">5,290,301</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:35.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Re-measurement of Class A Common Stock Subject to Possible Redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;">  &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_qQSyEOYfskqbJpXhyYxfBA_7_13">5,314,954</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_ZPwVgxckHES7v7ewEP50dg_7_16">13,745,600</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CommonStockSubjectToPossibleRedemptionValue" scale="0" id="Tc_XEcsoItXZ0u6LurDmMr2iA_7_19">19,060,554</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;width:35.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_Um-rNMYkHE67NGxX8PwqMg_8_13">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_Js9ZlM5A5kanwEVGICGzTQ_8_16">5,135,790</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_ZEYH7bijPkmxUnr77X2KGA_8_19">5,135,790</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:35.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;&#8212; December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_mAdhZ-CUz06VojbkOv1YRw_9_2">585,275</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_up4snfkxskeyIHz56U-g4w_9_5">59</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="Tc_FiOl0WhuOUOtIFj4K8fH4Q_9_7">2,875,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_GNmORRbOs06LaJpUKloI4A_9_10">288</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_6Bf7HXIAMk2oElQb9ogmow" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="Tc_S8Q-C9M3OEWr8nFUe-vRfA_9_13">&#8212;</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_6-yCbHCVY0uGfDrYrKv0Iw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_I2VOn1CmRkmuo2tgVV87dA_9_16">8,609,810</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_3cc1DTKvoEy55vr8w-4k4g_9_19">8,609,463</ix:nonFraction>)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">The accompanying notes are an integral part of the consolidated financial statements.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:90.91%;border:0;margin:30pt 4.55% 30pt 4.55%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_7ed3f2b0_a9f1_401a_b3d3_9a25c2062756"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="CASHFLOW_2"></a><a id="_676047_0"></a><a id="STATEMENTOFCASHFLOWS_875585_0"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED STATEMENTS OF </b><b style="font-weight:bold;">CASH FLOW</b><b style="font-weight:bold;">S</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_bf349d01_fd45_4915_bad4_4145110cef43"></a><a id="_1ae0717b_f783_4126_ae60_899b2825e0de"></a><a id="Tc_p3vuy9ygsECMXvx6jjXKyw_0_5"></a><a id="Tc_eNHNY_yFq06uhJ9KOXrRFQ_1_2"></a><a id="Tc_1ZimS7edT0yf83qVHjQZ0g_1_5"></a><a id="Tc_kJjvTtA5eUOhzVzOkZiDZQ_2_2"></a><a id="Tc_522YtOMbPECyp5Us0qd_oA_2_5"></a><a id="Tc_0zU-muDkD0ydScQHsrW6iA_3_2"></a><a id="Tc_bzDTusmSC0Gwp0MH3gqwVA_3_5"></a><a id="Tc_V6NuYHOeHkqCv0hy9pv_7A_4_5"></a><a id="Tc_Qpgdl58oiEatnud0Doyjew_5_0"></a><a id="Tc_Uzitd5xIk0-tYehzMLItFw_6_0"></a><a id="Tc_OKThoDMG-0WKi8PBc2FaOQ_6_2"></a><a id="Tc_hftVu7LusUG7aNrwvXLahw_6_5"></a><a id="Tc_NTNGdkT0CUOZT17yav4QjA_7_0"></a><a id="Tc_y0kIvIU0YE27a3YHMXetFQ_8_0"></a><a id="Tc_eBZRO5wnl0OYtzMtr6ejMw_8_3"></a><a id="Tc_x9px-7McwU2ZpNfuRn3GsQ_9_0"></a><a id="Tc_W8aZ2RfWGE-WPDsWgRrjRA_10_0"></a><a id="Tc_BdtgUrTCME63XF5KhKIjww_11_0"></a><a id="Tc_E_gUDtdZ_kuFkOT3HXXV8w_11_3"></a><a id="Tc_OU9Tn8YaRkmpUGTvB9G0wA_12_0"></a><a id="Tc_tDlbPj3to0WUQCx4oAqK6g_13_0"></a><a id="Tc_jwlRaHCMXkCiXvhtcOrQQw_14_0"></a><a id="Tc_rpjYe1odE0m0q1CD5PppuQ_15_0"></a><a id="Tc_QZ1La0OLTkSQzku0Y5p4BQ_16_0"></a><a id="Tc_pJbwh74PaUWsI9VDAH60FA_17_0"></a><a id="Tc_50Ej8iSYMkuhAqv4uZqhXQ_18_0"></a><a id="Tc_hCaSeD_AgU-39Xkf4Pu0ug_19_0"></a><a id="Tc_kSCrq2LOEE-mnxI1xaIOag_20_0"></a><a id="Tc_j5Ha3ADha0mTtAHUGrJLZw_21_0"></a><a id="Tc_CD8ljwHwiUqJf5Bk-R_HPg_22_0"></a><a id="Tc_zhWXC1HfLUmFAHjLXylEKQ_23_0"></a><a id="Tc_JZdZbFo-Jk-zjypczE5uXg_24_0"></a><a id="Tc_p57v3lJa5Eu0n7IHcfCC-A_24_3"></a><a id="Tc_g5fvo0SPkkW3CQsLRreXuQ_25_0"></a><a id="Tc_7VWYKYull0CFIVMwAlzrnw_25_3"></a><a id="Tc_s-5YKth7u0OY0FnWQ9ytgg_26_0"></a><a id="Tc_6teOQC5M-02QR_dLYAhRUQ_26_3"></a><a id="Tc_L7PEM5s0hEC-BFZYfTd0sQ_27_0"></a><a id="Tc_ifIdnwlg4EWn-SuLk14Rog_27_3"></a><a id="Tc_UUl_zFFn9U6xGNeJHcSEqw_28_0"></a><a id="Tc_i4O0ycNNnkKn27suPX28-Q_28_3"></a><a id="Tc_W_FW04JulEWpVk50EJz0cA_29_0"></a><a id="Tc_omsPCerkN0GrllrEzxSm8Q_29_3"></a><a id="Tc_0eqIA5YM0U29oCPOenEg-A_30_0"></a><a id="Tc_S89gM1aV302bgrgOeYIPrQ_31_0"></a><a id="Tc_UAOpQAyKNEe7PLwfsI4ENA_32_0"></a><a id="Tc_dsumo7z-E0q_mIwUGkJZFA_33_0"></a><a id="Tc_MCynQyW-F0mPvPM8Z8tNUQ_34_0"></a><a id="Tc_NaKCPmvF4kSgKP7KNtmygg_35_0"></a><a id="Tc_CQ3tjyh3s0i-ikIkiTX7OQ_36_0"></a><a id="Tc_Tr3kT0YdhEuMNK6ZHaTzng_36_2"></a><a id="Tc_4MXi6WLZckOFGnXuKKdPoQ_36_5"></a><a id="Tc_UXlflAxrvUekqS-CCe2ipw_37_0"></a><a id="Tc_THth4wYkmkejZb8_o1fWGg_38_0"></a><a id="Tc_IZEji3rZxEG6VoVDz42BfA_38_2"></a><a id="Tc_H4gZmKjVDE2BnEADPxwjnw_38_5"></a><a id="Tc_AcjjlLR6C02FU6PSNgQKxA_39_0"></a><a id="Tc_NmcjKD-OiUCYWStrRbAaWg_39_2"></a><a id="Tc_BkXmBzpoHE21iWSscGXQCw_39_5"></a><a id="Tc_jPw-1K_fnkiL1_dS_-6Tsg_40_0"></a><a id="Tc_H5mRpqCj_Uu3GGp_7SPHMQ_40_2"></a><a id="Tc_sjF40GGLx0K8zaJKqgA9Wg_40_3"></a><a id="Tc_xWNTJ3EYAkS3xwL24y6XyQ_40_5"></a><a id="Tc_CRNBmIVaYUe7kNaAv0-7QQ_41_0"></a><a id="Tc_t5Zb-eu1RUKzf9puaz3rNw_41_2"></a><a id="Tc_zjOptAmq9katYkUuQb_HEg_41_3"></a><a id="Tc_RD1YTg7O5kufxX2XMl2vZA_41_5"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Period from</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Year</b></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Inception ) Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:16.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from operating activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="Tc_zjgHLyPgw0eOSb7A-12baQ_6_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="Tc_zjgHLyPgw0eOSb7A-12baQ_6_3_2">336,658</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="Tc_hV9NS9Ma1Eqs4jz_Ft9wLg_6_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="Tc_hV9NS9Ma1Eqs4jz_Ft9wLg_6_6_2">5,135,790</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 11.5pt;">Adjustments to reconcile net income to net cash used in operating activities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 17.3pt;">Offering costs allocated to warrant liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:OfferingCostsAllocatedToWarrantLiability" scale="0" id="Tc_ZkRUOog4GkyLESGpgcs_kA_8_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:OfferingCostsAllocatedToWarrantLiability" scale="0" id="Tc_ZkRUOog4GkyLESGpgcs_kA_8_6_2">625,059</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 17.3pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="0" id="Tc_iW1PHTAkWkW9VgZkxHpOhQ_9_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="0" id="Tc_iW1PHTAkWkW9VgZkxHpOhQ_9_3_2">2,825,960</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:zerodash" name="us-gaap:ShareBasedCompensation" scale="0" id="Tc_xsSaeFLFbkG8avTtcyzyaQ_9_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 17.3pt;">Dividends, realized and unrealized gain in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_E_LFdyqZ20Gkx8F_xsRvBA_10_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_E_LFdyqZ20Gkx8F_xsRvBA_10_3_2">1,371,689</ix:nonFraction></ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_sVjN5C7O1k2Q3AmjgAFGdw_10_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RealizedAndUnrealizedGainLoss" scale="0" id="Tc_sVjN5C7O1k2Q3AmjgAFGdw_10_6_2">19,097</ix:nonFraction></ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 17.3pt;">Interest earned on securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" scale="0" id="Tc_Qko-MgehTEumMM2cQkNS5A_11_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" scale="0" id="Tc_Qko-MgehTEumMM2cQkNS5A_11_6_2">1,876</ix:nonFraction></ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 17.3pt;">Change in fair value of warrant liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" sign="-" scale="0" id="Tc_WhUX6B1OqE6vtN4lGiQY4g_12_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" sign="-" scale="0" id="Tc_WhUX6B1OqE6vtN4lGiQY4g_12_3_2">4,489,110</ix:nonFraction></ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" sign="-" scale="0" id="Tc_EMISAq5iKUmeYtZTjeW_WQ_12_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" sign="-" scale="0" id="Tc_EMISAq5iKUmeYtZTjeW_WQ_12_6_2">6,325,281</ix:nonFraction></ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 11.5pt;">Changes in operating assets and liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 17.3pt;">Prepaid expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" sign="-" scale="0" id="Tc_R_XJX136Y0a6_vx0dQEwgg_14_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" sign="-" scale="0" id="Tc_R_XJX136Y0a6_vx0dQEwgg_14_3_2">83,061</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="0" id="Tc_aDeus0i4HEu1O9m_NZhfhw_14_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="0" id="Tc_aDeus0i4HEu1O9m_NZhfhw_14_6_2">83,061</ix:nonFraction></ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 17.3pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="0" id="Tc_6qU4Fc6gH0iDyZVcETQyUQ_15_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="0" id="Tc_6qU4Fc6gH0iDyZVcETQyUQ_15_3_2">1,553,849</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="0" id="Tc_oOWpjfmQ0kq1zCNH2ZmFSw_15_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="0" id="Tc_oOWpjfmQ0kq1zCNH2ZmFSw_15_6_2">125,972</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 17.3pt;">Franchise tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:IncreaseDecreaseFranchiseTaxPayable" sign="-" scale="0" id="Tc_FvrFo1ixPUaAyAXhMpxEFg_16_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:IncreaseDecreaseFranchiseTaxPayable" sign="-" scale="0" id="Tc_FvrFo1ixPUaAyAXhMpxEFg_16_3_2">94,042</ix:nonFraction></ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:IncreaseDecreaseFranchiseTaxPayable" scale="0" id="Tc_VMB2wRY-yUWgPNAbrccIPg_16_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:IncreaseDecreaseFranchiseTaxPayable" scale="0" id="Tc_VMB2wRY-yUWgPNAbrccIPg_16_6_2">164,008</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 17.3pt;">Income tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;">  <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" id="Tc_7husQuxNrUO9aAFRL6HfZg_17_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" id="Tc_7husQuxNrUO9aAFRL6HfZg_17_3_2">214,850</ix:nonFraction></ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" id="Tc_wC1gewjkv0iZXiOdRocsYg_17_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net cash used in operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" sign="-" scale="0" id="Tc_Uz4ftD4JqESRfZLsXafrVg_18_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" sign="-" scale="0" id="Tc_Uz4ftD4JqESRfZLsXafrVg_18_3_2">940,463</ix:nonFraction></ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" sign="-" scale="0" id="Tc_uCqYC6B3UE2m_pluVGnsrw_18_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" sign="-" scale="0" id="Tc_uCqYC6B3UE2m_pluVGnsrw_18_6_2">378,487</ix:nonFraction></ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from investing activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 5.75pt;">Investment of cash in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Tc_h42ifOCPxk61aBdBfw-m4w_20_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Tc_h42ifOCPxk61aBdBfw-m4w_20_3_2">2,545,838</ix:nonFraction></ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Tc_cROB-VOYcEa0y0MMZtet3Q_20_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Tc_cROB-VOYcEa0y0MMZtet3Q_20_6_2">117,300,000</ix:nonFraction></ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 5.75pt;">Interest withdrawn from Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount" scale="0" id="Tc_TjM7aAtTV0i3-zt3DNdSzQ_21_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount" scale="0" id="Tc_TjM7aAtTV0i3-zt3DNdSzQ_21_3_2">299,601</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:zerodash" name="dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount" scale="0" id="Tc_8IB8HLi4eUWgyPOrh1l6Og_21_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net cash used in investing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="0" id="Tc_0VbxG7-eSU2TtscRvFeLxA_22_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="0" id="Tc_0VbxG7-eSU2TtscRvFeLxA_22_3_2">2,246,237</ix:nonFraction></ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="0" id="Tc_YF7pB75HSECavwwyaf1FRg_22_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="0" id="Tc_YF7pB75HSECavwwyaf1FRg_22_6_2">117,300,000</ix:nonFraction></ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from financing activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from issuance of Class B common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" id="Tc_9ohKa6mWB0W_39viFqKu5w_24_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" id="Tc_9ohKa6mWB0W_39viFqKu5w_24_6_2">25,000</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from sale of Units, net of underwriting discount paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:NetProceedsFromInitialPublicOffering" scale="0" id="Tc_mn9wUvM0oEeVdHL4riM7wA_25_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:NetProceedsFromInitialPublicOffering" scale="0" id="Tc_mn9wUvM0oEeVdHL4riM7wA_25_6_2">112,700,000</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from sale of Private units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromSaleOfPrivateUnits" scale="0" id="Tc_vVUPnxqyH02tyYoaRqYu5A_26_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromSaleOfPrivateUnits" scale="0" id="Tc_vVUPnxqyH02tyYoaRqYu5A_26_6_2">5,852,750</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Payment of offering costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" id="Tc_TyJb6LnOJU2QPf2jH-EThA_27_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" id="Tc_TyJb6LnOJU2QPf2jH-EThA_27_6_2">446,112</ix:nonFraction></ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from promissory note</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" id="Tc_gDXSxvgg0k-NDZH_C9PeIg_28_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" id="Tc_gDXSxvgg0k-NDZH_C9PeIg_28_6_2">78,925</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Repayment of promissory note</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" id="Tc_78BoQwImLEumlHXozRq_Bw_29_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" id="Tc_78BoQwImLEumlHXozRq_Bw_29_6_2">78,925</ix:nonFraction></ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Advances from related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AdvancesFromRelatedParties" scale="0" id="Tc_AOO-h08NBUuUwLxVsbHJfg_30_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AdvancesFromRelatedParties" scale="0" id="Tc_AOO-h08NBUuUwLxVsbHJfg_30_3_2">11,500</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:zerodash" name="dkdcu:AdvancesFromRelatedParties" scale="0" id="Tc_8KnhIxR_-EiCJto0bYLM2g_30_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from working capital loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromWorkingCapitalLoan" scale="0" id="Tc_7vakT5DyqUKuxHvUYVaDTA_31_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromWorkingCapitalLoan" scale="0" id="Tc_7vakT5DyqUKuxHvUYVaDTA_31_3_2">207,081</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:zerodash" name="dkdcu:ProceedsFromWorkingCapitalLoan" scale="0" id="Tc_P2Awxn_fVkOO8lqRyQmsDw_31_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from extension loans </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromExtensionLoan" scale="0" id="Tc_AOCMRQNcfU2IYiIG_Fu0Pw_32_3">2,545,838</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:zerodash" name="dkdcu:ProceedsFromExtensionLoan" scale="0" id="Tc_y1RW-yE3Ok6CYSBLAjLYdw_32_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net cash provided by financing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="Tc_dIT0rpLVvU60VmtK3IpZTw_33_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="Tc_dIT0rpLVvU60VmtK3IpZTw_33_3_2">2,764,419</ix:nonFraction></ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="Tc_9E5WbvCq0E6PWRmqCmRiOQ_33_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="Tc_9E5WbvCq0E6PWRmqCmRiOQ_33_6_2">118,131,638</ix:nonFraction></ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net change in cash</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" sign="-" scale="0" id="Tc_Qzto0ukTtEqcu901Kn2Ypg_34_3">422,281</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" id="Tc_0mkDc3Yc6kq5P1RMFXui7w_34_6">453,151</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash at the beginning of the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_5oAXKrfNyUqh1g9NfQDh0Q_35_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_5oAXKrfNyUqh1g9NfQDh0Q_35_3_2">453,151</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_2_7_2021_xIunY2_KPEmoFeGygcAWFQ" decimals="0" format="ixt:zerodash" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_mcTc7Q73-Ueopyj9h2nNdg_35_6">&#8212;</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash at the end of the period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_do3t2Fgmikyif-krl3AINg_36_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_do3t2Fgmikyif-krl3AINg_36_3_2">30,870</ix:nonFraction></ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_cg_2i8hhiUWiMBSd6vaMRg_36_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_cg_2i8hhiUWiMBSd6vaMRg_36_6_2">453,151</ix:nonFraction></ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Supplemental disclosure of non-cash financing activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Re-measurement of Class A common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption" scale="0" id="Tc_8oVCHZYctkCr0h6JpU_8HQ_38_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption" scale="0" id="Tc_8oVCHZYctkCr0h6JpU_8HQ_38_3_2">3,359,593</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:zerodash" name="dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption" scale="0" id="Tc_tp9YxPlCWUONEzoUOYkUWw_38_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Redemption of Class A common stock held in Trust, including interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RedemptionOfClassCommonStockHeldInTrustIncludingInterest" scale="0" id="Tc_c09xa1uUfkq2bOpFzZr3Hw_39_3"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RedemptionOfClassCommonStockHeldInTrustIncludingInterest" scale="0" id="Tc_c09xa1uUfkq2bOpFzZr3Hw_39_3_2">91,909,483</ix:nonFraction></ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:zerodash" name="dkdcu:RedemptionOfClassCommonStockHeldInTrustIncludingInterest" scale="0" id="Tc_mQeGvpeARUSdtETqdlRSHQ_39_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred underwriting fee payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:DeferredUnderwritingFeePayable" scale="0" id="Tc_xAs1Vd84WU6u73I_WZD_tw_40_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:DeferredUnderwritingFeePayable" scale="0" id="Tc_xAs1Vd84WU6u73I_WZD_tw_40_6_2">4,025,000</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Initial classification of warrant liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.84%;background:#cceeff;border-bottom:3px double #000000;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:InitialFairValueOfWarrantLiabilities" scale="0" id="Tc_CDPUhW1RTESc8weoTExWpQ_41_6"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:InitialFairValueOfWarrantLiabilities" scale="0" id="Tc_CDPUhW1RTESc8weoTExWpQ_41_6_2">11,176,949</ix:nonFraction></ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">The accompanying notes are an integral part of the consolidated financial statements.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_c6d8cc7f_5325_4cc8_bb95_969e4e129e46"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CAPITAL CORP.</b></p><a id="NOTES_2"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTES </b><b style="font-weight:bold;">TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><a id="_300573_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:NatureOfOperations" id="Tb_HyzlKk_iaUWwtVzM6B2cqg" continuedAt="Tb_HyzlKk_iaUWwtVzM6B2cqg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights Acquisition Corp. (the &#8220;Company&#8221;) is a blank check company incorporated in Delaware on February 8, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with <ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_2_8_2021_To_2_8_2021_v79xWrSU2E2fOfIAgN6zrQ" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" scale="0" id="Narr_oE_OWcuCPUaLmnL38KQSrw">one</ix:nonFraction> or more businesses (the &#8220;Business Combination&#8221;). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, the Company had not yet commenced any operations. All activity for the period February 8, 2021 (inception) through December 31, 2022, relates to the Company&#8217;s formation and the initial public offering (the &#8220;Initial Public Offering&#8221;), and, since the closing of the initial public offering, the Company has entered into a merger agreement (as described below), and continued a search for a Business Combination candidate. The Company has selected December 31 as its fiscal year end.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The registration statement for the Company&#8217;s Initial Public Offering was declared effective on May 6, 2021. On May 11, 2021, the Company consummated the Initial Public Offering of <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr__8_nz8rGLECkdnr493XVSQ">11,500,000</ix:nonFraction> units (&#8220;Units&#8221; and, with respect to the shares of Class&#160;A Common Stock included in the Units offered, the &#8220;Public Shares&#8221;), generating gross proceeds of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromSaleOfUnits" scale="0" id="Narr_tWdmwVA6V0SLwKgT5GthCw">115,000,000</ix:nonFraction>, which is described in Note&#160;3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:NumberOfWarrantsIssued" scale="0" id="Narr_UF2lpy25kUuEYpwbpwNIsg">585,275</ix:nonFraction> private placement units (the &#8220;Private Placement Units&#8221;) at a price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_D81xSwKtWUK5pM73JnCYwA" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="Narr_HSiFOGQ2YEKHYHHusJnLdg">10.00</ix:nonFraction> per unit in a private placement to the Sponsor, generating gross proceeds of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" id="Narr_xU0RxFoTL0Sg3fyrGcbNxg">5,852,750</ix:nonFraction>, which is described in Note&#160;4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering on May 11, 2021, an amount of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_5_11_2021_To_5_11_2021_NmXExQZglUSAztqWU0QU3w" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Narr__tNjnF7S6kmxsywxa37bXQ">117,300,000</ix:nonFraction> ($<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_wTwtt_v4j0eOv2yEWMOeRg">10.00</ix:nonFraction> per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (&#8220;Trust Account&#8221;) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company&#8217;s stockholders, as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Transaction costs of the Initial Public Offering amounted to $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:TransactionCosts" scale="0" id="Narr_yTVi61axkECET7o1MYi38w">6,771,112</ix:nonFraction>, of which $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SaleOfStockUnderwritingFees" scale="0" id="Narr_S7ecLtdJw0WRI0ZSt2Yg6w">2,300,000</ix:nonFraction> was for underwriting fees paid at the time of the IPO, $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." scale="0" id="Narr_rMDs8keZ3kuAtje9BsPE9A">4,025,000</ix:nonFraction> was for deferred underwriting commissions, and $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SaleOfStockOtherOfferingCosts" scale="0" id="Narr_hTu786zymEWWzq77KN14Qg">446,112</ix:nonFraction> was for other offering costs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_G6_zF5TSikiD8EVocXu3Mw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Narr_7XoOkugdMku9XhN6_tm2Cg">959,560</ix:nonFraction> of cash was held outside of the Trust Account available for working capital purposes. As of December 31, 2022, the Company has $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="0" id="Narr_kngHyduLjECXIRlSQ7Oc-Q">30,870</ix:nonFraction> of cash and a working capital deficit of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WorkingCapitalDeficit" sign="-" scale="0" id="Narr_1MOFRzVGBUC2C_VeocwLew">1,945,267</ix:nonFraction>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" scale="-2" id="Narr_xje7TZ--V06qAmC5CAOW9A">80</ix:nonFraction>% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" scale="-2" id="Narr_pUIG3lyVK0-6zXkxygmXpA">50</ix:nonFraction>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On April 25, 2022, the Company, Data Knights Merger Sub, Inc., a Delaware corporation (&#8220;Merger Sub&#8221;), and Data Knights, LLC, the Company&#8217;s sponsor (the &#8220;Sponsor&#8221;), entered into a definitive Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with OneMedNet Corporation, Inc., a Delaware corporation (the &#8220;Target&#8221;, and together with the Company and Merger Sub, the &#8220;Parties&#8221;) and Paul Casey, as seller representative (&#8220;Casey&#8221;). Pursuant to the Merger Agreement, upon the closing (the &#8220;Closing&#8221;) of the Business Combination, the Parties will effect the merger of Merger Sub with and into the Target, with the Target continuing as the </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_HyzlKk_iaUWwtVzM6B2cqg_cont1" continuedAt="Tb_HyzlKk_iaUWwtVzM6B2cqg_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">surviving entity (the &#8220;Merger&#8221;), as a result of which all of the issued and outstanding capital stock of the Target shall be exchanged shares of the Class A Common Stock of the Company upon the terms set forth in the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On May 5, 2022, the Company extended the date by which the Company has to consummate a business combination from May 11, 2022 to August 11, 2022 (the &#8220;First Extension&#8221;). The First Extension was the first of <ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_8cqxnvyhy020OvypatfoPQ">two</ix:nonFraction> <ix:nonNumeric contextRef="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_-tQ8VUNdA0WHSEPFZpIdLg">three-month</ix:nonNumeric> extensions permitted under the Company&#8217;s governing documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On August 10, 2022, the Company extended the date by which the Company has to consummate a business combination from August 11, 2022 to November 11, 2022 (the &#8220;Second Extension&#8221;). The Second Extension was the second of <ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_y35jDHIREUSwSobfVvrFCw">two</ix:nonFraction> <ix:nonNumeric contextRef="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_qWzYbfxVnk2S7FCcPigDdg">three-month</ix:nonNumeric> extensions permitted under the Company&#8217;s governing documents. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On October 27, 2022, the Company filed a definitive proxy statement with the SEC in connection with the Company&#8217;s solicitation of proxies for the vote by the stockholders of the Company at a special meeting of the Company&#8217;s stockholders to be held on November 11, 2022 (the &#8220;Special Meeting&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On November 11, 2022, at 10:00 a.m. ET, the Company held a virtual special meeting of its stockholders. At the special meeting, Company stockholders entitle to vote at the special meeting cast their votes and approved the Trust Amendment Proposal, pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO if the Company has not completed its initial business combination, from November 11, 2022 to August 11, 2023 (or such earlier date after November 11, 2022, as determined by the Data Knights Board). As a part of Special Meeting, the Company&#8217;s stockholders approved amendments to its second amended and restated certificate of incorporation (the &#8220;Extension Amendment&#8221;) and the investment management trust agreement (the &#8220;Trust Agreement&#8221;) between Continental Stock Transfer &amp; Trust Company, as trustee (&#8220;Continental&#8221;), and the Company governing the trust account (the &#8220;Trust Account&#8221;) established in connection with the Company&#8217;s initial public offering dated May 11, 2021 (the &#8220;Trust Amendment&#8221;), which together allow the Company to extend the deadline by which it must complete its initial business combination by up to <ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_49_sTkmA5UCOFs1bp6Xrug">nine</ix:nonFraction> <ix:nonNumeric contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_jzlacAGIqUWLS_palteGWg">one-month</ix:nonNumeric> periods. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, shall cause $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" decimals="3" format="ixt:numdotdecimal" name="dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" scale="0" id="Narr_aKjpcztF_0CnxlJokrH4UQ">0.045</ix:nonFraction> per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" scale="0" id="Narr_wlYUEWs8uE2Y9k3zaKqAfA">122,920</ix:nonFraction>, to be deposited in the Trust Account. As of December 31, 2022, the Company has executed <ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfOneMonthExtensionsExecuted" scale="0" id="Narr_4nDMqq5l_0yY-LxR8hboJA">two</ix:nonFraction> <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" id="Narr_pK2GJrQeDkWELF-ioNkE_A">one-month</ix:nonNumeric> extensions, out of the <ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_W_ENoM0f6UOKk7eE_DQLsw">nine</ix:nonFraction>, resulting in deposits of approximately $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" scale="0" id="Narr_TRS5w4Q8s0SLjeap6FGOlA">245,840</ix:nonFraction> into the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the proposed Business Combination with the Target, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Stock upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the proposed Business Combination with the Target is not consummated, in connection with an alternative proposed initial business combination, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:MinimumNetTangibleAssetUponConsummationOfBusinessCombination" scale="0" id="Narr_sEfn5Pjs0UuvvrUMrbOByQ">5,000,001</ix:nonFraction> either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" scale="0" id="Narr_z0A1rqPCiEWoISvBjBIs0w">8,768,456</ix:nonFraction> shares of Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="Narr_-671-RQgrUKJQgI8RwaeXQ">10.42</ix:nonFraction> per share, for an aggregate of approximately $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="6" id="Narr_KGusdaueakmSGYN4MQzsFg">91.4</ix:nonFraction> million. Following the payment of the redemptions, the Trust Account had a balance of approximately $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrust" scale="6" id="Narr_McxjfwU8Fku0UXOQcTzCWA">28.5</ix:nonFraction> million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Based on the above, the Company will have until August 11, 2023 to consummate a Business Combination. If the Company is unable to complete a Business Combination on August 11, 2023 at the election of the Company subject to satisfaction of certain conditions, including the deposit of up $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_3RZpCGP7S0q5c4sXVDjShA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" scale="0" id="Narr_pOETQbE67EqX8R3pkFKe0g">2,300,000</ix:nonFraction> since the underwriters&#8217; over-allotment option is exercised in full ($<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_3RZpCGP7S0q5c4sXVDjShA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_wFgekSbZO0uN0A_NX2dyUg">0.10</ix:nonFraction> per unit), into the Trust Account, or as extended by the Company&#8217;s stockholders in accordance with the Company&#8217;s amended and restated certificate of incorporation) (the &#8220;Combination Period&#8221;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:MaximumNetInterestToPayDissolutionExpenses" scale="0" id="Narr_XJ3m7FyRKkyW45xO3bBZww">100,000</ix:nonFraction> of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#8217;s </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_HyzlKk_iaUWwtVzM6B2cqg_cont2" continuedAt="Tb_HyzlKk_iaUWwtVzM6B2cqg_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_N1zvwemyLkWMmiK69kjNUg">10.00</ix:nonFraction>). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the shares of Class A Common Stock and the warrants that are included as components of the Private Placement Units. Such warrants will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="Narr_V2Pd_lOgN0CbHIatzyaEyw">10.20</ix:nonFraction> per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="Narr_bXGvsuTWqUq02h0XxGm4RA">10.20</ix:nonFraction> per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Going Concern, Liquidity and Capital Resources</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, the Company had cash held outside of the Trust Account of <span style="-sec-ix-hidden:Hidden_cZQeLnh3Zk29sDgjeEin2Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$30,780</span></span> and $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CashHeldOutsideInTrustAccount" scale="0" id="Narr__apPkERyc0mwx9l8pn-k2g">453,151</ix:nonFraction>, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial business combination. As of December 31, 2022 and 2021, the Company had working capital surplus (deficit) of $(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WorkingCapitalDeficit" sign="-" scale="0" id="Narr_18xg_LQoCkK-ro_1hnq7TA">1,945,267</ix:nonFraction>) and $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WorkingCapitalDeficit" scale="0" id="Narr_c-6tMLhZTEy3GLiLLRc4hg">246,232</ix:nonFraction>, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s liquidity needs prior to the consummation of its IPO were satisfied through the proceeds of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_pKJtyVvMnEGNV_bpgbIOwA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Narr_pYD1ff7bKUqbJoNt84sKYA">25,000</ix:nonFraction> from the sale of the Founder Shares and proceed from the promissory note from sponsor of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2021_To_12_31_2021_OeMjnbZWu0aoMSIKBb6DzQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" id="Narr_WHuNGf0oMUq1hZbBBWuKxg">78,925</ix:nonFraction>, which was repaid upon closure of the IPO. Subsequent to the IPO, the Company&#8217;s liquidity will be satisfied through a portion of the net proceeds from IPO held outside of the Trust Account. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, we had investments of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Narr_UpV77KJyIU-07f1u3Q4tmg">29,029,416</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Narr_H0fzAwDYskybeeQXXT7nlw">117,320,973</ix:nonFraction> held in the Trust Account, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes. During the period ended December 31, 2022, we withdraw $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount" scale="0" id="Narr_e9Hgb5P-JU6T6StJJxpxoQ">299,601</ix:nonFraction> of interest earned on the Trust Account to pay Delaware Franchise Tax. During the period ended December 31, 2021, we did not withdraw any interest earned on the Trust Account. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed. The Company will have until August 23, 2023 to consummate a Business Combination. If our initial business combination is not consummated by </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_HyzlKk_iaUWwtVzM6B2cqg_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">August 23, 2023, less than one year after the date the financial statements are issued, then our existence will terminate, and we will distribute all amounts in the trust account. The Company intends to complete a business combination before the liquidation date and no adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after such date. There can be no assurance that the Company will be able to consummate an initial business combination by August 23, 2023 and/or have sufficient working capital and borrowing capacity to meet its needs. Based upon the above analysis, management determined that these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Accounts to repay such loaned amounts but no proceeds from our Trust Accounts would be used for such repayment. Up to $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet" scale="0" id="Narr_OButbJAtxkC-77YeVUuNXw">1,500,000</ix:nonFraction> of such loans may be convertible into units identical to the Placement Units, at a price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="Narr_yNz8DbOEtE20y0jAeXCZDw">10.00</ix:nonFraction> per unit at the option of the lender.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Risks and Uncertainties</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into law. The IR Act provides for, among other measures, a new 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom the shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased. For purposes of calculating the excise tax, however, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#8220;Treasury Department&#8221;) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Any redemption or other repurchase effected by us that occurs after December 31, 2022, in connection with a Business Combination or otherwise, may be subject to this excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the nature and amount of any PIPE financing or other equity issuances in connection with the Business Combination (or any other equity issuances within the same taxable year of the Business Combination) and (iii) the content of any regulations and other guidance issued by the Treasury Department and/or the Internal Revenue Service. In addition, because the excise tax would be payable by us and not by the redeeming holder, it could cause a reduction in the value of our stock. The foregoing could cause a reduction in the cash available on hand to complete a business Combination in the required time and redeem <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfPublicSharesToBeRedeemed." scale="-2" id="Narr_Ao-1jPJ4ykulUHNpCdLaRg">100</ix:nonFraction>% of our public shares in accordance with our amended and restated certificate of incorporation) could be subject to the excise tax, in which case the amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="Tb_Fmbr_UvpKEO8ROQAWUmADg" continuedAt="Tb_Fmbr_UvpKEO8ROQAWUmADg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Tb_DlWpaf7ZyE--w8e7B3E5wQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Basis of presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:ConsolidationPolicyTextBlock" id="Tb_ugwMMdIIlUilrCizxrHJqw" continuedAt="Tb_ugwMMdIIlUilrCizxrHJqw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_Fmbr_UvpKEO8ROQAWUmADg_cont1" continuedAt="Tb_Fmbr_UvpKEO8ROQAWUmADg_cont2"><ix:continuation id="Tb_ugwMMdIIlUilrCizxrHJqw_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="dkdcu:EmergingGrowthCompanyPolicyPolicyTextBlock" id="Tb_Xmp_r3Y7GE-wGJCJ3ysNVA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Emerging growth company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:UseOfEstimates" id="Tb_IT7QZiP--EKb5n5lhah_sw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="Tb_ROMBo4d-KEW-ljrwMWqSCQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="0" id="Narr_aFhNK60vWUyM40TvYP4Jxg">30,870</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="0" id="Narr_wAqj3Rl03k-F24G_VNmY8g">453,151</ix:nonFraction> in cash and <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:CashEquivalentsAtCarryingValue" scale="0" id="Narr_GQfTdcJPhEmq8ND7gDkPqw"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:CashEquivalentsAtCarryingValue" scale="0" id="Narr_Ewp3Nd4fvESktwiAcSB8Pw">no</ix:nonFraction></ix:nonFraction> cash equivalents as of December 31, 2022 and 2021.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="dkdcu:AssetsHeldInTrustAccountPolicyPolicyTextBlock" id="Tb_qNI8HejdsEuRoqgwRWStog" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Trust Account</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the Initial Public Offering and the Private Placement, $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_11_5_2021_To_11_5_2021_xmuZ3mYtZE2S5AExqoqVLQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:PaymentsForInvestmentOfCashInTrustAccount" scale="0" id="Narr_7gw0SoXvB0e-lv8OGY3q8Q">117,300,000</ix:nonFraction> ($<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_11_5_2021_iFKFTOhmqkmSj50YSfzJGg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_dvq_QmBwZEqo7JE0U0zV1Q">10.00</ix:nonFraction> per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:DeferredChargesPolicyTextBlock" id="Tb_Xq1KrZHdeE248eAM7HFs2A" continuedAt="Tb_Xq1KrZHdeE248eAM7HFs2A_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_YytX21PCVEasYqxi9NbuCg_1_2"></a><a id="Tc_0txYa6NsUkmYdfeTKbn8-w_1_5"></a><a id="Tc_Q-c2g9Z1J06kBZLZqYM-7Q_2_0"></a><a id="Tc_BzIklZ41g0OXRAW8PZba6Q_2_2"></a><a id="Tc_3VLL40wyF0yh5Prx-_QX_Q_2_5"></a><a id="Tc_PFNsjlLBTUK_N1a6GVnnUA_2_6"></a><a id="Tc__CqlUP72CE2XsYeXH7uNIA_3_0"></a><a id="Tc_E-4cqwrsAUOc96yTfMMPNA_3_3"></a><a id="Tc_On7_pO77fUW5JozI48Ij1g_4_0"></a><a id="Tc_yqAriiNc90KdlItiKxNqew_5_0"></a><a id="Tc_41dKHBewkUymTmUQL6jwkg_5_3"></a><a id="Tc_hc75W17JVU6Ev41oFzMXwg_6_0"></a><a id="Tc_CxlGstFD0U2w8SAjr2N6wA_6_3"></a><a id="Tc_YYEaWzyiu0euE1o3P1eH3Q_7_0"></a><a id="Tc_DPFA_IgeQ0WN59tnq5xHKA_7_6"></a><a id="Tc_owG2QAFEwEG2ijb1fGddAg_8_0"></a><a id="Tc_saeY41paM0aj3xNEooEXlA_9_0"></a><a id="Tc_jLvrt_T3GkK1OdUBB9XOGQ_10_0"></a><ix:continuation id="Tb_Fmbr_UvpKEO8ROQAWUmADg_cont2" continuedAt="Tb_Fmbr_UvpKEO8ROQAWUmADg_cont3"><ix:continuation id="Tb_Xq1KrZHdeE248eAM7HFs2A_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="dkdcu:TemporaryEquityPolicyPolicyTextBlock" id="Tb_fhm7Siq6Kk6yL0KKl0lkkA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, there are <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_cPiNE1TrwEiEkVSRwpcLnQ">585,275</ix:nonFraction> shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_frsXccNzG0yI5MyFhPNehQ">11,500,000</ix:nonFraction> shares of Class A Common Stock outstanding, which are subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December 31, 2022 and 2021, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:TemporaryEquityTableTextBlock" id="Tb_Wuho8W7ZJU-0VOstRdeQHw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_Owl-jrRR2U2S4GooWzVmIQ_2_3">117,300,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross Proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ProceedsFromIssuanceOfTemporaryEquity" scale="0" id="Tc_ugrhOpYiB02wpnycWhpiIg_3_6">115,000,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to public warrants and private warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="0" format="ixt:numdotdecimal" name="dkdcu:TemporaryEquityProceedsAllocatedToWarrants" sign="-" scale="0" id="Tc_KG7SY-lmbkiCx80KpdiE3g_5_6">10,614,500</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issuance costs related to Class A Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="0" format="ixt:numdotdecimal" name="dkdcu:TemporaryEquityIssuanceCosts" sign="-" scale="0" id="Tc_SVsoJGvMhEmy2UKs9zpMjw_6_6">6,146,054</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Redemption of Class A Common Stock, including interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" sign="-" scale="0" id="Tc_y5Ke43J370W8TysT17lJ3Q_7_3">91,909,483</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="0" id="Tc_fwJP14Cx0EaSQA4NNJ4axA_9_3">3,359,593</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="0" id="Tc_M8wChOYki0-6ANI576v2gg_9_6">19,060,554</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_agTOGxeanUGVHEin3jaHeg_10_3">28,750,110</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_qZhYHy-w9UGTjxHb8kC3kQ_10_6">117,300,000</ix:nonFraction></p></td></tr></table></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:EarningsPerSharePolicyTextBlock" id="Tb_lP7EwBfRMkuryqN2zMOOGQ" continuedAt="Tb_lP7EwBfRMkuryqN2zMOOGQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Net income per share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net income per share is computed by dividing net income by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:WarrantExercisable" scale="0" id="Narr_r5J3dAQkWU2hwkIohrUo8A">12,085,275</ix:nonFraction> shares of common stock in the aggregate.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_32a289f7_13cc_4c56_a655_5a034bb47683"></a><a id="_78687399_4b7d_4afd_a73a_2f133657d665"></a><a id="Tc_0THEBdBiEEKOmhnNT52OgQ_1_5"></a><a id="Tc_eLgRTIVbmkiAlKwe0TGBPg_2_5"></a><a id="Tc_IY8ptxjE8ECA5Geoh-cnbA_3_2"></a><a id="Tc_qnlaNcU_KUyiq02uXUKcQA_3_5"></a><a id="Tc_uW4dQKES5U2yDp-hNEuC3A_4_2"></a><a id="Tc_7_DA19SMwkmCQHLm7c0zpg_4_5"></a><a id="Tc_ylR5pmqLiEmg_hwZ0Yqd0g_5_2"></a><a id="Tc_8yj00REc8Ui9PC72F9NsHA_5_5"></a><a id="Tc_caZXy379TUqGqCmKMXBp8Q_6_0"></a><a id="Tc_y_lKmdV7hEaQ_aKzdu23xA_7_0"></a><a id="Tc_qbaEGddpf0KvNVN7c9Oeiw_8_0"></a><a id="Tc_z0ki3OgfYUuo-9e6dsJhAg_8_2"></a><a id="Tc_2OhreEKQ2USecNVAPQmMFA_8_5"></a><a id="Tc_DRwpi2-jjkmlGUZB5ZMUBQ_9_0"></a><a id="Tc_qr1PFVbtAEa52gPVKbx9RA_10_0"></a><a id="Tc_0JPZX4_kB0-QS_E-5Xaf9Q_11_0"></a><a id="Tc_Yql4TPu3m0-gidRavZElag_12_0"></a><a id="Tc_NfJkolETlUqLVkuD-7q6Hw_13_0"></a><a id="Tc_OswIAICI5EOWbxF7EXsK8w_13_2"></a><a id="Tc_WRVMQnHSCUqMjrLtmZaxzA_13_5"></a><a id="Tc_EoqZV50QZkW1zBIB-VPiuQ_14_0"></a><a id="Tc_GARaF2SdykqMglTWvir8IQ_15_0"></a><ix:continuation id="Tb_Fmbr_UvpKEO8ROQAWUmADg_cont3" continuedAt="Tb_Fmbr_UvpKEO8ROQAWUmADg_cont4"><ix:continuation id="Tb_lP7EwBfRMkuryqN2zMOOGQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The following table reflects the calculation of basic and diluted net income per common share:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="Tb_M0A8YHO8sESBPelt9J_G1g" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period of</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_LwQNralN4UGht9eTS0ZT5A_8_3">240,532</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_gEWU1elYlUW7VAUU4ySyiA_8_6">3,671,658</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_xl2JldvbmE2eP3HmUc0PsA_9_3">8,667,969</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_wYnX5Bf8OEKrycvCvzu1xg_9_6">8,264,526</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_umm3y3TxGUe8oDpbTgLDSg_10_3">0.03</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_IgTUMVIjLEKXzfPykspgZw_10_6">0.44</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_huW10Xjlx0OOyA8T62T6Ww_13_3">96,126</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="Tc_Es17RgWfdkyDNa4nklQINQ_13_6">1,464,132</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_CAs8Cp3Z-0eKMtB1XMrfAQ_14_3">3,464,052</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_GYzORes69EGUH69oeWmG4g_14_6">3,295,610</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_-MDOx1K3WUOuvyr3xEec7w_15_3">0.03</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_UKrDuNA7IkyEBz8_cUgsIQ_15_6">0.44</ix:nonFraction></p></td></tr></table></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="Tb_h4yJF8FDZk2g0vs7BZRZ5w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation Expense</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for stock-based compensation expense in accordance with ASC Topic 718, &#8220;Compensation &#8211; Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. The fair value of equity awards has been estimated using a market approach. Forfeitures are recognized as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Company determined that it was not probable that ARC would meet the performance condition as defined in the Introducing Advisor Agreement (See Note 5), and therefore, <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_y4Va1YH3m0eX130BeYRwng" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_x7nJySX5ikyH2cXbVWfMyA">no</ix:nonFraction> stock-based compensation expense was recognized. At December 31, 2022, upon amendment of the Introducing Advisor Agreement, which amended ARC&#8217;s performance condition that was concurrently deemed to have been met, ARC was granted <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_uEkHeFxWoUKCxd1wCPJN3g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_OA-Ut2LqP0KzGuQB8jv0xg">1,378,517</ix:nonFraction> shares of the Company&#8217;s Class B common stock at a fair value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_wLPX3pqnoEGRhqgS36Atpg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_sEZbhWytk0ehXX7IOEZ3TQ">2.05</ix:nonFraction> per share. The Company recorded the resulting $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_OperatingExpenseMember_Z4B4V5TZ9kOeJBQx4nhBbw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_nKBUPrORhkacJoq_m6c3QQ">2,825,960</ix:nonFraction><span style="white-space:pre-wrap;"> of stock based compensation expense on December 31, 2022, which is included in formation and operating costs in the consolidated statement of operations.  The fair value of the Class B common stock was determined by applying a discount to the actively traded Class A shares, which have an observable market price. The discount was calculated as the average discount of the Class B share price (derived) compared to the Class A share price (observable) for SPACs that have actively traded &#8220;Rights&#8221;.</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:ConcentrationRiskCreditRisk" id="Tb_ElqC65m54USTkS6HPLUfVQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="Tb_87TI69vu30mklENRA-KHLw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="dkdcu:DerivativeFinancialInstrumentsPolicyPolicyTextBlock" id="Tb_SjwqaCNNq0WKmzJ7EfB0qQ" continuedAt="Tb_SjwqaCNNq0WKmzJ7EfB0qQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. </p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_Fmbr_UvpKEO8ROQAWUmADg_cont4"><ix:continuation id="Tb_SjwqaCNNq0WKmzJ7EfB0qQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:IncomeTaxPolicyTextBlock" id="Tb_UhFl38eawUCe6vgQVRybuQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="Narr_OLnwJGjZAUCvnpcNgWqH3Q"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="Narr_GiDSppUEOUOn_J-4d59OLA">no</ix:nonFraction></ix:nonFraction> unrecognized tax benefits and <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" id="Narr_PqvEgFeJLk-bWOX6gCqTJA"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" id="Narr_ZWNqevjSVUy5GpOy3i7GnA">no</ix:nonFraction></ix:nonFraction> amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Tb_t7MJSQCImESFDyDol0GcSQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</p></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="dkdcu:InitialPublicOfferingDisclosureTextBlock" id="Tb_zAK-jRFJFE6Gjh9I53n7Mg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 3. INITIAL PUBLIC OFFERING</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Pursuant to the Initial Public Offering, the Company sold <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_TbTarYU-HECHA2cHsjn7Zw">11,500,000</ix:nonFraction> Units at a purchase price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_fctU6QHKQEOu595qEl978g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_PjjqBn-9rEma33YcvfOa1Q">10.00</ix:nonFraction> per Unit. Each Unit consists of <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_y47mRrlmNUqJZIDNSj342g" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfSharesIssuedPerUnit" scale="0" id="Narr_fEiTAohav0ag775u_hXWMQ">one</ix:nonFraction> share of the Company&#8217;s Class A Common Stock, $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_oWRM9rxdbEupqt4TEM7oAg">0.0001</ix:nonFraction> par value, and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_Zz-LC321iEOx0QXt64XTUw" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfWarrantsIssuedPerUnit" scale="0" id="Narr_sx0udbdfE0KgxZRYRmJPIg">one</ix:nonFraction> redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" id="Narr_PE_SqZykFUWlHUxqnsxaJg">one</ix:nonFraction> share of Class A Common Stock at an exercise price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_3SQJIMIvWUS9ELj-b17duQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="Narr__OpYJAPqF066jV5Yq9luxg">11.50</ix:nonFraction>&#160;per whole share (see Note&#160;9).</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="dkdcu:PrivatePlacementTextBlock" id="Tb_nOcF53VKfE-75HprFEZSIQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 4. PRIVATE PLACEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember__aKBWKKCl0y9GZbCCzx5Mg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="Narr_sxh6lL1vKk67vr-0k4gHLA">585,275</ix:nonFraction> Private Placement Units at a price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember__aKBWKKCl0y9GZbCCzx5Mg" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="Narr_H69MDnu600yQskM-C-s8aA">10.00</ix:nonFraction> per Private Placement Unit for an aggregate purchase price of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_vJFpkC6zqk-9LH2SncbE-Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" id="Narr_OeOYL6u_GkqS-Zb_3brTlQ">5,852,750</ix:nonFraction>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Private Placement Units are identical to the Units, except that (a) the Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of the Company&#8217;s initial business combination except to permitted transferees and (b) the Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) may be exercised by the holders on a cashless basis and (ii) will be entitled to registration rights.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-34</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="Tb_DLLd0hUY8kCh2q3KBhUSWA" continuedAt="Tb_DLLd0hUY8kCh2q3KBhUSWA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 5. RELATED PARTY TRANSACTIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Introducing Advisor Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June 26, 2021, the Company entered into an introducing advisor agreement (the &#8220;Introducing Advisor Agreement&#8221;) with ARC Group Limited, the Company&#8217;s financial advisor (&#8220;ARC&#8221;), pursuant to which ARC will make strategic introductions to the Company of potential target companies and/or their subsidiaries, affiliates, or representatives (each an &#8220;Advisor Target&#8221;) who may be interested in potential business combinations with the Company. In consideration for ARC&#8217;s services under the Introducing Advisor Agreement, we agreed to (i) pay to ARC (a) a retainer of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RetainerFeeUponExecutionOfAgreement" scale="0" id="Narr_mrbQNAAB5E6LOwLNPUWr0A">50,000</ix:nonFraction> upon execution of the Introducing Advisor Agreement and (b) a success fee of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SuccessFeeUponClosingOfInitialBusinessCombination" scale="0" id="Narr_Qkl2ZtwZs0afuMY1dwvWBg">100,000</ix:nonFraction> upon the closing our initial business combination, and (ii) cause to be issued to ARC equity interests in the post-combination company representing a five-percent (<ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfOwnershipAsConsiderationForService" scale="-2" id="Narr_GYKnCLXfXUC64MpH7sslUQ">5</ix:nonFraction>%) ownership interest in the post-combination company, if at any time prior to June 25, 2022 (the &#8220;Termination Date&#8221;), or within six (<ix:nonNumeric contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q" format="ixt-sec:durmonth" name="dkdcu:ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" id="Narr_3PrGREL50U2DQuNSmViyfg">6</ix:nonNumeric>) months after the consummation of an initial business combination or any financing with any Advisor Target or any affiliate of an Advisor Target (the &#8220;Equity Issuance&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (<ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_6BKMWuaDzEmPd9vqRg5_Nw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing" scale="-2" id="Narr_J2y7c8dROU2qaFdaryr4mw">5</ix:nonFraction>%) on any PIPE that was brought by ARC in connection with the Company&#8217;s initial business combination upon the closing of the Company&#8217;s initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_nI7vSrnZ6Eq4A4LeU2TrUg">1,378,517</ix:nonFraction> shares of the Company&#8217;s Class B Common Stock, up to <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" scale="0" id="Narr_DHdPXfOb00i0um3MvnjBRQ">143,766</ix:nonFraction> shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Founder Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 25, 2021, the Company issued an aggregate of <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_k8KGHo5KLECVjcD67BcJxg">2,875,000</ix:nonFraction> shares of Class B Common Stock (the &#8220;Founder Shares&#8221;) to the Sponsor for an aggregate purchase price of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Narr_KW8kAgr5cUS8vVlcyQWnOg">25,000</ix:nonFraction>. On February 25, 2021, the Sponsor transferred <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember__hwYxA9DEkqAKdAwnBpc_w" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_avyBpwJ0n0OVxMMMihuZiA">15,000</ix:nonFraction> shares to the Company&#8217;s Chief Executive Officer, <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefFinancialOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6znbrCXxFkGIcYmCY0iT1Q" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_iPtXHT5osUq9d48NXyx1Iw">15,000</ix:nonFraction> shares to the Company&#8217;s Chief Financial Officer and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_TwoIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_4pqzZtHe2EG3qyNAxfbe9A" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_AG6FacGPM0-TOe71GlkbZQ">5,000</ix:nonFraction> shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_3_23_2021_To_3_23_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ThirdIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6T3pPliyHUS0duvs0F4HAw" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_sa6D2QB3e02ZFDkA2mwa7w">5,000</ix:nonFraction> shares to such independent director. The Founder Shares which the Sponsor and its permitted transferees will collectively own, on an as-converted basis, represent <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" scale="-2" id="Narr_f4X2BmaCTkOavtWXHjxBxQ">20</ix:nonFraction>% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. In connection with the Introducing Advisors Agreement, on December 31, 2022, ARC was granted <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_Qow3lGdI1U20mOTx1OTCeg">1,378,517</ix:nonFraction> shares of Class B common stock, $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_IhW2rhKKn0qo7A0xhD9s0w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_iRgyoihwK0CqBRk_ZIxqRA">0.0001</ix:nonFraction> par value per share, up to <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" scale="0" id="Narr_oSFHTy6CMkOpybxBidvDRw">143,766</ix:nonFraction> of which are subject to forfeiture by ARC if the Company&#8217;s public shareholders exercise redemption rights with respect to any of outstanding shares of Class A common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;<ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA" format="ixt-sec:durwordsen" name="dkdcu:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" id="Narr_FNbZTqL060KCYNw4G-Jxew">six months</ix:nonNumeric> after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company&#8217;s Class A Common Stock equals or exceeds $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA" decimals="2" format="ixt:numdotdecimal" name="dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" scale="0" id="Narr_NltVwj7ZO0WI1HGNmYTLiA">12.00</ix:nonFraction> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any <span style="-sec-ix-hidden:Hidden_bbHY3R68R0qhn-ZoycDM0g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> trading&#160;days within any <span style="-sec-ix-hidden:Hidden_oJtbLe8GvkWMoQVqcR68nA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span>-trading day period commencing at least <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA" format="ixt-sec:durwordsen" name="dkdcu:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" id="Narr_hLGbcdM-Jke7zEOLQt35yA">150 days</ix:nonNumeric> after the Business Combination, the Founder Shares will be released from the lock-up.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Promissory Note&#160;&#8212; Related Party</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 8, 2021, the Sponsor committed to loan the Company an aggregate of up to $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_2_8_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_GfqTmPjOjEe_maJFOaIOog" decimals="0" format="ixt:numdotdecimal" name="dkdcu:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" scale="0" id="Narr_Puiefft-Q0avyLEKLOWH2A">300,000</ix:nonFraction> to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#8220;Note&#8221;). The Note was non-interest bearing and was payable on the earlier of July 31, 2021 or the completion of the Initial Public Offering. On June 1, 2021, the $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_6_1_2021_To_6_1_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ylqtNA-bUEmL4qYAA8d_tw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" id="Narr_GSEOj7vz7UWCPEdSdTBHsg">78,925</ix:nonFraction> outstanding under the promissory note was repaid in full. On December 31, 2022 and 2021, there is <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ssFfLQvrEkeHJ26-YR0QHA" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent" scale="0" id="Narr_OAWZh2zsLk2TWpKPvYi99g"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_yldGfAut_UOwpJfZ6m96hA" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent" scale="0" id="Narr_xPuHOe4lxEGvsZXwQ62h4A">no</ix:nonFraction></ix:nonFraction> amount outstanding under the promissory note.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-35</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_DLLd0hUY8kCh2q3KBhUSWA_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Related Party Loans</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to finance transaction costs in connection with a Business Combination, the Company&#8217;s Sponsor, an affiliate of the Sponsor, or the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the &#8220;Working Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Cu5tn0_8kEi4cYONPPpMdw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:MaximumLoansConvertibleUptoConsummation" scale="0" id="Narr_yTHmrmXA2U685MqbQm6kug">1,500,000</ix:nonFraction> of notes may be converted upon consummation of a Business Combination into units at a price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Aq0HD_XsTkKPxGsqbD7Syg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="Narr_hmEV-g36_EuNWa9e7hFvLw">10.00</ix:nonFraction> per unit. The Units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On December 31, 2022 and 2021, there is $<ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_zc8vCgsjJ02tRG0__b_sCA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_WCVtcwYkTketwgk7W_ue9g">207,081</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_gGMCV4IGL0WN2ukxJY-jVw" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_6XoEIRWYp02W7B85fJLdoQ">nil</ix:nonFraction> outstanding under the Working Capital Loans, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s second amended and restated certificate of incorporation provides that, if the Company anticipates that it may not be able to consummate a Business Combination within <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" format="ixt-sec:durmonth" name="dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" id="Narr_Oedgnq_WnkWs9HHJjrhing">12</ix:nonNumeric> months from the closing of the Company&#8217;s initial public offering, the Company may, by resolution of the Company&#8217;s board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to <ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" scale="0" id="Narr_v7xaDD6JcUyK0_HT-OI7Dg">two</ix:nonFraction> times, each by an additional <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_PFDuO8PwMESAedg0WLwnjA">three months</ix:nonNumeric> (for a total of up to <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" format="ixt-sec:durmonth" name="dkdcu:AggregatePeriodToConsummateInitialBusinessCombination" id="Narr_FmC0atJ4V0Ogoc0vlhCgnA">18</ix:nonNumeric> months to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account as set out below. Pursuant to the terms of the Company&#8217;s second amended and restated certificate of incorporation and the trust agreement entered into between the Company and Continental Stock Transfer &amp; Trust Company, in order for the time available for the Company to consummate the initial Business Combination to be extended, the Sponsor or its affiliates or designees, upon <ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" scale="0" id="Narr_BL9uxVqsQUyucWxJmGWLIg">five</ix:nonFraction> business days advance notice prior to the applicable deadline, must deposit into the Trust Account $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_bWhzWPZIyUW-IA3VsLVynA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:SecuritiesDepositHeldInTrustAccount" scale="0" id="Narr_MF9i2faL2kG0axJTj7Rqnw">1,150,000</ix:nonFraction> since the underwriters&#8217; over-allotment option is exercised in full ($<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_CHYctHL-NEC04rksJieDWA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="Narr_CrU3d1QQwU2zxZWPDo8GYg">0.10</ix:nonFraction> per unit), on or prior to the date of the applicable deadline, for each of the available <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_HnO2OS65iEexOwD5oFP7Ig">three month</ix:nonNumeric> extensions, providing a total possible Business Combination period of <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" format="ixt-sec:durmonth" name="dkdcu:AggregatePeriodToConsummateInitialBusinessCombination" id="Narr_neVKXw7i1kuYenpxwqp5WA">18</ix:nonNumeric> months at a total payment value of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_bWhzWPZIyUW-IA3VsLVynA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:BusinessCombinationTotalPayments" scale="0" id="Narr__MKOierm8kusZgKq6-m8vQ">2,300,000</ix:nonFraction> since the underwriters&#8217; over-allotment option is exercised in full ($<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_CHYctHL-NEC04rksJieDWA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="Narr_sniTBJt1RkypzP4R_Brp8g">0.10</ix:nonFraction> per unit) (the &#8220;Extension Loans&#8221;). Any such payments would be made in the form of non-interest-bearing loans. If the Company completes its initial Business Combination, the Company will, at the option of the Sponsor, repay the Extension Loans out of the proceeds of the Trust Account released to the Company or convert a portion or all of the total loan amount into units at a price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Aq0HD_XsTkKPxGsqbD7Syg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="Narr_0eKCil74GESWdX59eoIjhQ">10.00</ix:nonFraction>&#160;per unit, which units will be identical to the Private Placement Units. If the Company does not complete a Business Combination, the Company will repay such loans only from funds held outside of the Trust Account. Furthermore, the letter agreement among the Company and the Company&#8217;s officers, directors, and the Sponsor contains a provision pursuant to which the Sponsor will agree to waive its right to be repaid for such loans to the extent there is insufficient funds held outside of the Trust Account in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination. The public stockholders will not be afforded an opportunity to vote on the extension of time to consummate an initial Business Combination from <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" format="ixt-sec:durmonth" name="dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" id="Narr_ALldqhi0PkCjNEwqwoVbwA">12</ix:nonNumeric> months to <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" format="ixt-sec:durmonth" name="dkdcu:AggregatePeriodToConsummateInitialBusinessCombination" id="Narr_Eqa-mlNy0U-4pk8FN8EvTw">18</ix:nonNumeric> months described above or redeem their shares in connection with such extensions. Pursuant to the foregoing, on May 5, 2022, the Company extended the date by which the Company had to consummate a business combination from May 11, 2022 to August 11, 2022. On August 10, 2022, the Company extended the date by which the Company had to consummate a business combination from August 11, 2022 to November 11, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As described in Note 1, on November 11, 2022, the Stockholders of the Company approved the Extension Amendment and the Trust Amendment to allow the Company to extend the deadline by which it must complete its initial business combination by up to nine <ix:nonNumeric contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" format="ixt-sec:durwordsen" name="dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination" id="Narr_UoPdwn7IbEu1eOxKYQKBqg">one-month</ix:nonNumeric> periods from November 11, 2022. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, caused $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" decimals="3" format="ixt:numdotdecimal" name="dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" scale="0" id="Narr_eJ-tIfGqIkiWYzqTt3ZHhg">0.045</ix:nonFraction> per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" scale="0" id="Narr_h29T-mLByk-oGxxPF4KCfw">122,920</ix:nonFraction>, deposited in the Trust Account in connection with the exercise of the monthly extension. In connection with each such extension, the Company will have until April 11, 2023 to consummate a Business Combination (see Note 11). On December 31, 2022 and 2021, there is $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:ExtensionLoansNonCurrent" scale="0" id="Narr__6Cu0fsLEkqS9HmTXhm9FA">2,545,838</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt-sec:numwordsen" name="dkdcu:ExtensionLoansNonCurrent" scale="0" id="Narr_hYQnUbQR3UeSAmKfEPl_oA">nil</ix:nonFraction> outstanding under the Extension Loan, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Administrative Services Arrangement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Commencing on the date of the prospectus and until completion of the Company&#8217;s Business Combination or liquidation, the Company may reimburse ARC Group Ltd., an affiliate of the Sponsor, up to an amount of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_ekDZPE3EmEWL2qEJTcZkQw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" scale="0" id="Narr_pTNnnN4AWEqGH625jXKBeA">10,000</ix:nonFraction> per month for office space, secretarial and administrative support. For the year ended December 31, 2022, we have incurred $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_qQvFEWW_20uSottBNfK9TA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" scale="0" id="Narr_ngU72Ne5lEKvVHnhBVVSXA">120,000</ix:nonFraction> in fees under this agreement. From February 8, 2021(inception) to December 31, 2021, the Company incurred $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_z1cvmMf8N0SP-RnaUQjayA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="Narr_e0t4M5UNPEqvS1usa_5EBA">80,000</ix:nonFraction> in fees under this agreement.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-36</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Tb_xn5_m0FBSkWYWtd2fN5XJQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 6. COMMITMENTS AND CONTINGENCIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Registration Rights</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to a registration rights agreement entered into on May 6, 2021, the holders of the Founder Shares, Private Placement Units (including the securities contained therein), the units (including the securities contained therein) that may be issued upon conversion of the Working Capital Loans, and any shares of Class A Common Stock issuable upon the exercise of the Placement Warrants and any shares of Class A Common Stock, warrants (and underlying Class A Common Stock) that may be issued upon conversion of the units issued as part of the working capital loans and Class A Common Stock issuable upon conversion of the founder shares are entitled to registration rights. The holders of a majority of these securities are entitled to make up to <ix:nonFraction unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:MaximumNumberOfDemandsForRegistrationOfSecurities" scale="0" id="Narr_zi5bI1FyRkmU32Yjk6CwzQ">three</ix:nonFraction> demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Underwriters Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company granted the underwriter a <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_z_RFqAY7JE2tlCBZNXCVwQ" format="ixt-sec:durday" name="dkdcu:OverAllotmentOptionPeriod" id="Narr_ilURQURQXUuHxn7fx51aMA">45</ix:nonNumeric>-day option to purchase up to <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_z_RFqAY7JE2tlCBZNXCVwQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_tKvkDNOVBUqUNJn6lGtHIQ">1,500,000</ix:nonFraction> additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The aforementioned option was exercised on May 11, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The underwriter was paid a cash underwriting discount of two percent (<ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="4" format="ixt:numdotdecimal" name="dkdcu:UnderwritingDiscountPercentage" scale="-2" id="Narr_HYa4dDbjMEK7hhwP5Tg2Ag">2.00</ix:nonFraction>%) of the gross proceeds of the Initial Public Offering, or $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:UnderwritingDiscountPaid" scale="0" id="Narr_6wM63ogJ9UaqE6HFS9guRg">2,300,000</ix:nonFraction>. In addition, the underwriter is entitled to a deferred fee of three and a half percent (<ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="4" format="ixt:numdotdecimal" name="dkdcu:DeferredUnderwritingFeesPercentage" scale="-2" id="Narr_AOYmAI5tPEW5_VVmWkd4Iw">3.50</ix:nonFraction>%) of the gross proceeds of the Initial Public Offering, or $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." scale="0" id="Narr_eOC5nP-epEaOJ7v0nhKthA">4,025,000</ix:nonFraction>. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Right of First Refusal</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a period beginning on May 7, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">First Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_C-Ez8Wj92k-wMY601LQlhQ" decimals="2" format="ixt-sec:numwordsen" name="dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing" scale="-2" id="Narr_ugdPTYOjcUGlMrP2sVx3Fg">five</ix:nonFraction> percent (<ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_6BKMWuaDzEmPd9vqRg5_Nw" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing" scale="-2" id="Narr_gepflZ17K060awfYKq2OYg">5</ix:nonFraction>%) on any PIPE that was brought by ARC in connection with an initial business combination upon the closing of an initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Second Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_uEkHeFxWoUKCxd1wCPJN3g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_w1ZCF3FtwEulPpTB98azOg">1,378,517</ix:nonFraction> shares of the Company&#8217;s Class B Common Stock, up to <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" scale="0" id="Narr_Dv0I9Pqum0WopSPhK9qXDQ">143,766</ix:nonFraction> shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-37</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="dkdcu:WarrantLiabilityTextBlock" id="Tb_oyCgTeo_q0yvO0Iczq6I3w" continuedAt="Tb_oyCgTeo_q0yvO0Iczq6I3w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 7. WARRANT LIABILITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" format="ixt-sec:durwordsen" name="dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" id="Narr_RQMC260SIU6mWAUVDZb_zA">30 days</ix:nonNumeric> after the completion of a Business Combination and will expire <ix:nonNumeric contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Narr_C5HW7rpxDUO-GRg852iZ4w">five years</ix:nonNumeric> after the completion of a Business Combination or earlier upon redemption or liquidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has agreed that as soon as practicable, but in no event later than <span style="-sec-ix-hidden:Hidden_l9q9OYpBaE-i-c9_ByMINg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class&#160;A Common Stock issuable upon exercise of the warrants is not effective by the <span style="-sec-ix-hidden:Hidden_O_rVnyonKkqQ7hhmRqfGSA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">60</span></span>th business day after the closing of the Company&#8217;s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company&#8217;s shares of Class A Common Stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Redemption of warrants when the price per Class A Common Stock equals or exceeds $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="Narr_ufgDjCpnv0CUIBSn9S_M5Q">18.00</ix:nonFraction>. Once the warrants become exercisable, the Company may redeem the Public Warrants:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" scale="0" id="Narr_Xhg8xVu8AE-IqUfobJAqPA">0.01</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per Public Warrant;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg" format="ixt-sec:durwordsen" name="dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" id="Narr_V0ty8V4pLUm4vtDdh7rjbQ"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 days</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8217; prior written notice of redemption to each warrant holder; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="Narr_LKQ6x4zj10mRWosgS3efTw">18.00</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any </span><span style="-sec-ix-hidden:Hidden_g1uhXZ_IzE6YLS18Pibsaw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="-sec-ix-hidden:Hidden_ucp-6LYyYk2H8bhHlUU4tg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-38</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_oyCgTeo_q0yvO0Iczq6I3w_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.The Placement Warrants were identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg" format="ixt-sec:durwordsen" name="dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" id="Narr_5Tt_ngskXky6x4dpewbOEw">30 days</ix:nonNumeric> after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, if (x) the Company issues additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ORH_Epj08k2OR4P3PXUF2A" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_jalzeqU90Eyx89peyP-59g">9.20</ix:nonFraction> per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:PercentageOfGrossProceedsOnTotalEquityProceed" scale="-2" id="Narr_0-GUWt8-vUyFQjmfKMXrSA">60</ix:nonFraction>% of the total equity proceeds, and interest thereon, available for the funding of the Company&#8217;s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s common stock during the <span style="-sec-ix-hidden:Hidden_Tj-gOcDc5kC5FCMl3wJLvg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_0b-KlvCTa02Nw2vOsKQKdg">9.20</ix:nonFraction> per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice" scale="-2" id="Narr_6GmjFY8rzkyG7euNDPdUUw">115</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price, the $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="Narr_3e423EMiEUC_HmpwkmTHlA">18.00</ix:nonFraction> per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_QaJt1ia12ECl_HVZf-OHZA" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice" scale="-2" id="Narr_7Hin2Nzr7UWfVLa9ElUdmQ">180</ix:nonFraction>% of the greater of the Market Value and the Newly Issued Price and the $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_QaJt1ia12ECl_HVZf-OHZA" decimals="2" format="ixt:numdotdecimal" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="Narr_z1KNqT9yEkSma7MIUvmMLQ">10.00</ix:nonFraction> per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg" format="ixt-sec:durwordsen" name="dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" id="Narr_7rbzSKLOfUGjg--44Z01aQ">30 days</ix:nonNumeric> after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">At December 31, 2022 and 2021, the Company accounted for the aggregate <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_0xI8gLPKx0-BmiEb0QOU0g" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_AsbJ04R3dUmWNPu0_KdPow"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6jC0xt_xPkW3XWSHKmx-Wg" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_pcps90HwCESHFDbjeWS89Q">12,085,275</ix:nonFraction></ix:nonFraction> warrants issued in connection with the Initial Public Offering (the <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_SGQAoQddE0emo9lL7Hd1eA" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_ybxk6Pz-NEa2uWpV1irOOg"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_hU3yJ8PS-kGw_3nqHUEEig">11,500,000</ix:nonFraction></ix:nonFraction> Public Warrants and the <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_THab5UCa2UyrRU_XTiFJiQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_ZiWpukcpWEGWbvDPTeOcbg"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_fqKCHCXgBkSvo0fCaH9NXQ" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:WarrantsOrRightsIssued" scale="0" id="Narr_wmtPBvitT0ypPiHeGU18KQ">585,275</ix:nonFraction></ix:nonFraction> Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company&#8217;s statement of operations.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_7bb10240_75a8_458c_b95b_0bc6c3a91f4b"></a><a id="_7bb10240_75a8_458c_b95b_0bc6c3a91f4b_2"></a><a id="_7bb10240_75a8_458c_b95b_0bc6c3a91f4b_3"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Tb_mIldiqkdaEmwbKCa6-q1OA" continuedAt="Tb_mIldiqkdaEmwbKCa6-q1OA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 8. STOCKHOLDER&#8217;S EQUITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Preferred Shares </span><b style="font-weight:bold;">&#8212;</b> The Company is authorized to issue <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_KmljgCkYskWvTG2oKfEsyg">1,000,000</ix:nonFraction> preferred shares with a par value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_g3LKGWp-b0GkDjXdxl28XA">0.0001</ix:nonFraction> per share with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s Board of Directors. At December&#160;31,&#160;2022 and 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_F9PAgPp1vEaGhvf1_iolBQ">no</ix:nonFraction> preferred shares issued or <span style="-sec-ix-hidden:Hidden_byXh1qgX90qNILMCXVSaVw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Class A Common Stock </span><b style="font-weight:bold;">&#8212;</b> The Company is authorized to issue <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_0uupdqVcnka8WRjpWmePKQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_Tz3pCCoj40-2Tr79l94EWw">100,000,000</ix:nonFraction></ix:nonFraction> shares of Class A Common Stock with a par value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_15-hJZM8zUe_SqrRzJYoiA"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_mz0w46oPeUGHziUhhCdodg">0.0001</ix:nonFraction></ix:nonFraction> per share. Holders of the Company&#8217;s Class A Common Stock are entitled to <ix:nonFraction unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:CommonStockNumberOfVotesPerShare" scale="0" id="Narr_tLQPl1hgREmIn3XLge_isQ">one</ix:nonFraction> vote for each share. At December 31, 2022 and 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_XXUqNLWvg0qpR2rSOgLQ_A" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:CommonStockShareIssued" scale="0" id="Narr_4KMHuHstl0Se5GwqhIOnKA"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:CommonStockShareIssued" scale="0" id="Narr_CrKAoQai9k-gMh9u4RQCXQ">12,085,275</ix:nonFraction></ix:nonFraction> shares of Class A Common Stock issued and outstanding, including <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_XXUqNLWvg0qpR2rSOgLQ_A" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_TklTzClYlU2B4r2oAAZIxQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_NPUMAZN2FUeUAV-V9LCkOw">585,275</ix:nonFraction></ix:nonFraction> shares of non-redeemable Class A Common Stock issued in connection with the private placement (Note 4), and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_3Ts8KQurpky1IrokmqkvsQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_QfQqu3IHOUC3S03AV1eP0Q">11,500,000</ix:nonFraction></ix:nonFraction> shares of Class A Common Stock subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Class B Common Stock</span> <b style="font-weight:bold;">&#8212;</b> The Company is authorized to issue up to <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_kaifN0wG9UehIvgGIZUugQ"><ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_KmsgC0a3F0-uXP4t2Bubpg">10,000,000</ix:nonFraction></ix:nonFraction> shares of Class B Common Stock with a par value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_Wwe7FNNFdUqr4A4ZVgXccA"><ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_xJ1KygLMYUKF0Vuao2aDFw">0.0001</ix:nonFraction></ix:nonFraction> per share. Holders of the Company&#8217;s Class B Common Stock are entitled to <ix:nonFraction unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt-sec:numwordsen" name="dkdcu:CommonStockNumberOfVotesPerShare" scale="0" id="Narr_XsORvS1ZTkafBUZWNJZljA">one</ix:nonFraction> vote for each share. On February 25, 2021, the Sponsor transferred <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefExecutiveOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_Mzinbo6790mIYa6MzPmccA" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_0sMBx09SjU6IUV3_TFeI-A">15,000</ix:nonFraction> shares to the Company&#8217;s Chief Executive Officer, <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefFinancialOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9btB9vKZLEW4K63rfAMw5Q" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_HY3GQOfQjUuLyTGDsgYI-A">15,000</ix:nonFraction> shares to the Company&#8217;s Chief Financial Officer and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_1lq6y8qH_02AAAlWFjyicg" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_cmepE5IO0ES9jdkdCB2e1w">5,000</ix:nonFraction> shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_3_23_2021_To_3_23_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_7vg13yQIHkePUv6ms7p3ng" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:StockTransferredToOthersDuringPeriodShare" scale="0" id="Narr_wAo8OlIBJUyqcek_SSsB6Q">5,000</ix:nonFraction> shares to such independent director. </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-39</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_mIldiqkdaEmwbKCa6-q1OA_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, ARC Group Limited, the Company&#8217;s Financial Advisor, was granted <span style="-sec-ix-hidden:Hidden_OyBqbq_iQkytLYvGC9d64A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1,378,517</span></span> shares of Class B common stock with a par value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_wLPX3pqnoEGRhqgS36Atpg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_w30VTyt8qUCgiJkJmVXfPg">0.0001</ix:nonFraction> per share, up to <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw" decimals="INF" format="ixt:numdotdecimal" name="dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" scale="0" id="Narr_amTWJPWxyEKzCi6TIE1-Lg">143,766</ix:nonFraction> of which are subject to forfeiture if the Company&#8217;s public stockholders exercise redemption rights with respect to any of the Company&#8217;s remaining outstanding shares of Class A common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December 31, 2022 and 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_BWlx-K-fpU2ZNITTzwtArQ">4,253,517</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg" contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_uwaTb8pRLkCOkgSIt8Cznw">2,875,000</ix:nonFraction> shares of Class B Common Stock <span style="-sec-ix-hidden:Hidden_STifUojKSEajZv3cqO8nRw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">issued</span></span> and <span style="-sec-ix-hidden:Hidden_Vj2cJtgcg0SBI0y6E-s6Sg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span>, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Holders of Class A Common Stock and Class B Common Stock will vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A Common Stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class&#160;B Common Stock shall convert into shares of Class A Common Stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B Common Stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A Common Stock issuable upon conversion of all shares of Class B Common Stock will equal, in the aggregate, on an as converted basis, <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA" decimals="2" format="ixt:numdotdecimal" name="dkdcu:Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" scale="-2" id="Narr_HUNVNaXF3k6N7VQNzPayOA">20</ix:nonFraction>% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A Common Stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_885a25e1_3351_43b1_9a9f_454e015b7c72"></a><a id="Tc_NppRXCcFP0WXNDkcU4LFpw_1_2"></a><a id="Tc_67zkRQt010Khb-tX5makKg_2_2"></a><a id="Tc_sEr6BB_QQEuWs0IMnTVOFA_2_5"></a><a id="Tc_r5zXSFZchkS7CXA4QwAxRg_2_9"></a><a id="Tc_aiUIS7k220meEC-9Me75BQ_3_2"></a><a id="Tc_G7aAuXHN9E-6xEDV3vGlCg_3_5"></a><a id="Tc_1vt5DiSEXEG3WvlojZRlQg_3_9"></a><a id="Tc_u5RNtFZlPUWd75KK--vBsg_4_0"></a><a id="Tc_CUuK5P448kW9kX6yfGD7pg_4_2"></a><a id="Tc_VEXyAU4mjkSrqTx3d0xEPA_4_5"></a><a id="Tc_LjAuC9HuPUefbLX_gpg1Pw_4_9"></a><a id="Tc_n_PYhUd4dUCrelc3nWHmug_5_0"></a><a id="Tc_DIBwofImKEOLhHTlaL4yAw_6_0"></a><a id="Tc_US3g-kvL1UqH6h-V8HTNQQ_6_2"></a><a id="Tc_T832rCJ2tEihwjzQ3D-Kog_6_5"></a><a id="Tc_bGekc8sBdEimCIaubA5MZA_6_6"></a><a id="Tc_1DU4GAIG0kGtkK-D2cb10Q_6_8"></a><a id="Tc_oQ3Zt9e2WEunfH-hWAXQnQ_6_9"></a><a id="Tc_Zaakt_Eg7EmZ0Kfq8hkuqA_8_0"></a><a id="Tc_iTnNluad3EKB82Pom1F3_A_9_0"></a><a id="Tc__UCXdBBr9USNjQezAp8CAw_9_2"></a><a id="Tc_k47Xincs2kyw1D9DtdGIdA_9_5"></a><a id="Tc_O4nTSlLSKUCXv6qKIe0XoA_9_6"></a><a id="Tc_RiJ6tsDzGUasTLBMQp30rw_9_8"></a><a id="Tc_dWC0pYZ7XkuA1LBTPm7HJg_9_9"></a><a id="Tc_u0uTKEdCRkCLmBDpX1g5fg_10_0"></a><a id="Tc_o6Cxm2zL10GJJy2SjAN-qA_10_2"></a><a id="Tc_A4xYX7KCA0iKqYC9WHYXfQ_10_3"></a><a id="Tc_uEUU1rRNQk-TStyhDdsnlA_10_5"></a><a id="Tc_i5IOt9-xKUmrJsDSXlbNSQ_10_6"></a><a id="Tc_n2qQQPC40EivufY-Nk5Evg_10_8"></a><a id="_2e3bbe26_7592_4789_b879_6dc80429873c"></a><a id="Tc_-0RSB2x7zkq5TPlY5KA_FA_1_2"></a><a id="Tc_jZ_I1R5CyEC8HgMJzUzIcg_2_2"></a><a id="Tc_MshEv5wn_UmETtKF0e66kA_2_5"></a><a id="Tc_c303vVikDUKVre850SjbEQ_2_8"></a><a id="Tc_gcQgsdKMW0-bgIMBqZwpjg_3_2"></a><a id="Tc_irRXuI7SaEi7Mhl6GUgUgA_3_5"></a><a id="Tc_HEXb2uAl2U-nKtI5Zw8gOg_3_8"></a><a id="Tc_U4TqadTl0EulnFildAmqjA_4_0"></a><a id="Tc_ZATVYyxdCUyR_2Nrc_5R5w_4_2"></a><a id="Tc_hIoD18IMGUaOn4KzoaLkFg_4_5"></a><a id="Tc_L-HkDP1DC0m0Q3vxJekyVA_4_8"></a><a id="Tc__GqNUkrRf0mkHVJC0eXaew_5_0"></a><a id="Tc_JGJChrOJkE-V5GkNJbR50A_6_0"></a><a id="Tc_pR8CWDTvC02fWI84epk1Xw_6_2"></a><a id="Tc_p3GJZ1ciOUCJYet0viNTbA_6_5"></a><a id="Tc_Oy4kpSIaVUOl_T2TXqtqQA_6_6"></a><a id="Tc_TJUJYQ86XkCaV0XBmK1u4Q_6_8"></a><a id="Tc_fireUnIIX0WJfLo1iI4vNw_6_9"></a><a id="Tc_edMmdImDwkmeHjkHtq3T3Q_8_0"></a><a id="Tc_jaMBDfzSAkW8rVUzmrhKJQ_9_0"></a><a id="Tc_c6IUo8sr9E6bLNGyYdk1Hw_9_2"></a><a id="Tc_wFiyzxs3kE-bMPBymKTOtA_9_5"></a><a id="Tc_36A8ewaqCUajnPiP1NS8aQ_9_6"></a><a id="Tc_w4S8rKGjQEW6JCau8ITb8Q_9_8"></a><a id="Tc_47veKtd1yEKiI5X1DEmEfA_9_9"></a><a id="Tc__wj5HY3asU66Yt9LvxxjYg_10_0"></a><a id="Tc_vZ5V1JpFpEWWLRb-ahiXXg_10_2"></a><a id="Tc_x-SBYI7J7U2CyNaAgLOz6g_10_3"></a><a id="Tc_lREClxPTjUCl1saJt-v5Lw_10_5"></a><a id="Tc_vV8M4BGnIE25Mnd8gCDfKQ_10_6"></a><a id="Tc_TEwYCNX-FkePTwq2KvajWQ_10_8"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:FairValueDisclosuresTextBlock" id="Tb_X9w2RdnlvkGLhJbxenfTBA" continuedAt="Tb_X9w2RdnlvkGLhJbxenfTBA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 9. FAIR VALUE MEASUREMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table presents information about the Company&#8217;s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="Tb_iEqHdvARiUWMMj8pi17Naw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments&#160; held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_wiC7cqJRr0Cr05N-S5Q2Yw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Tc_6rpLeKAIsEe_vMtDEZIbcA_6_3">29,029,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_Tv60Y58O_0WnZ3tyWWSaUA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" scale="0" id="Tc_zrlVE5rymEev1Qu5dY8oAg_9_3">345,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_vEBEAARln0-juOH4J-Vj-A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" scale="0" id="Tc_359YL2u8Vkqhm44PuYrIUQ_10_9">17,558</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_7tsBCIa7gk6SNfDSnFWCYg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Tc_qz8juPY2vkypugwqcH4rOw_6_3">117,320,973</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_o3_-97zDo0C3WX2zLxg1OQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" scale="0" id="Tc_uA1zl37RpUerJmeaFTpRgQ_9_3">4,600,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_C3EiylpFM0KQmVJZCMEtQA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" scale="0" id="Tc_ER42PrHD60CSqBXKPtXRRg_10_9">251,668</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Warrants are measured at fair value on a recurring basis. The Public Warrants were valued initially and at each reporting period that the warrants were not actively traded, using a Monte Carlo simulation. As of December 31, 2022 and 2021, the Public Warrants were valued using the instrument&#8217;s publicly listed trading price, which is considered to be a Level 1 measurement due to the </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-40</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_cc8881bf_31bb_494a_b761_b068636937ac"></a><a id="_cc8881bf_31bb_494a_b761_b068636937ac_2"></a><a id="_cc8881bf_31bb_494a_b761_b068636937ac_3"></a><a id="_c0ca940b_cc82_48e7_a706_3b9fb97f0a9f"></a><a id="_c0ca940b_cc82_48e7_a706_3b9fb97f0a9f_2"></a><a id="_c0ca940b_cc82_48e7_a706_3b9fb97f0a9f_3"></a><a id="_c0ca940b_cc82_48e7_a706_3b9fb97f0a9f_4"></a><a id="_c0ca940b_cc82_48e7_a706_3b9fb97f0a9f_5"></a><a id="_841565f5_c9d0_4ffc_bdd3_91eacc942219"></a><a id="_841565f5_c9d0_4ffc_bdd3_91eacc942219_2"></a><a id="_841565f5_c9d0_4ffc_bdd3_91eacc942219_3"></a><a id="_841565f5_c9d0_4ffc_bdd3_91eacc942219_4"></a><a id="_841565f5_c9d0_4ffc_bdd3_91eacc942219_5"></a><a id="_1d204f80_bbb0_495a_9954_23523ba42c7c"></a><a id="_1d204f80_bbb0_495a_9954_23523ba42c7c_2"></a><a id="_1d204f80_bbb0_495a_9954_23523ba42c7c_3"></a><a id="_1d204f80_bbb0_495a_9954_23523ba42c7c_4"></a><a id="_1d204f80_bbb0_495a_9954_23523ba42c7c_5"></a><a id="_d01e29ee_8850_450c_a7ee_d774eb5f7274"></a><a id="_d01e29ee_8850_450c_a7ee_d774eb5f7274_2"></a><a id="_d01e29ee_8850_450c_a7ee_d774eb5f7274_3"></a><a id="_d01e29ee_8850_450c_a7ee_d774eb5f7274_4"></a><a id="_d01e29ee_8850_450c_a7ee_d774eb5f7274_5"></a><a id="_028e5baf_63c8_4a3d_ade2_c219c4184d65"></a><a id="Tc_shfptk2yOkueg21YEP80hw_1_2"></a><a id="Tc_y0o32IP0JkaFSPNN7K784Q_1_5"></a><a id="Tc_PlMZt9yqAkiLGqsk_p-Bdg_2_2"></a><a id="Tc_rKTV--p13EqpkR2OWqPwig_2_5"></a><a id="Tc_9rAvZ3FsEk62yIpAkiUOJw_3_0"></a><a id="Tc_BQtaTC3ibUCjuogmYwAiBA_3_2"></a><a id="Tc_pxMFuNmVpE6bxxski3cM2w_3_5"></a><a id="Tc_QfO7UEiZV0Sqemf0VHJXzA_4_0"></a><a id="Tc_zz-fJu_LaUC_U9Np_W29NA_4_2"></a><a id="Tc_5lttKzJH2k-0T_Be-ugTDw_4_5"></a><a id="Tc_gB499Z3I0UCfv3iaS5JXsA_5_0"></a><a id="Tc_q5f6UAHRKUeoYaP_Ge9I0g_6_0"></a><a id="Tc_VzhjW1iMG0ixhen5qkUfew_6_4"></a><a id="Tc_bNA_dN0inkKDu1xoWjMpRg_6_7"></a><a id="Tc_M1dnUeonc0SPCwPNVzE5Zg_7_0"></a><a id="Tc_EvejggB4dEySRBZZDimqeA_7_4"></a><a id="Tc_zbyEDK9N80ikoo_0zcDY2A_7_7"></a><a id="Tc_fWUU_H2NyU-qhYoRNRtMzg_8_0"></a><a id="Tc_ykCZliccqEGiTvLrt48esg_8_4"></a><a id="Tc_B2r-id3dNE-XV4T2Ac08Dg_8_7"></a><a id="Tc_2n2eGaHteEKTOh7n0CbulA_9_0"></a><a id="Tc_9XOmt493JkCgqdJhcGzxKQ_9_2"></a><a id="Tc__bqV1XSgo0mnKXQVaXoIpQ_9_5"></a><ix:continuation id="Tb_X9w2RdnlvkGLhJbxenfTBA_cont1" continuedAt="Tb_X9w2RdnlvkGLhJbxenfTBA_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">use of an observable market quote in an active market. Private Placement Warrants were valued using a Monte Carlo valuation model using level 3 inputs at initial valuation and as of December 31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December 31, 2022 and 2021, assets held in the Trust Account were comprised of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_aXuUNI1Ru0CZ99nEpdL7oA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Narr_k-slNGlb70CKVNblUtrgSw"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_-SnL89jik0a1X0ZnHQTSug" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" id="Narr_fzlPJZNZeEqb-saob5A19g">29,029,416</ix:nonFraction></ix:nonFraction> in money market mutual fund and $117,320,973 in U.S. Treasury Securities, respectively. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments and are considered Level 1 assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company utilized a Monte Carlo simulation to estimate the fair value of the Public warrants at each reporting period for its warrants that are not actively traded. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. On June 22, 2021, the Public Warrants surpassed the threshold waiting period to be publicly traded. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of December 31, 2022 and 2021, the Company classified the Public Warrants as Level 1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s common stock that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. During the year ended December 31, 2022 and for the period from February 8, 2021 (inception) through December&#160;31,&#160;2021 there were <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw" decimals="0" format="ixt-sec:numwordsen" name="dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" scale="0" id="Narr_Z05OBs6xvkmOn5t-HaJFPw"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g" decimals="0" format="ixt-sec:numwordsen" name="dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" scale="0" id="Narr_gRq2w659xUaBzh1RFAalUg"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw" decimals="0" format="ixt-sec:numwordsen" name="dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" scale="0" id="Narr_15-ZR14pr0yQVdK_5sBEVg"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt-sec:numwordsen" name="dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" scale="0" id="Narr_pNqSxT7Ha0eP4SnbeyY7xQ">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> transfers between levels.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: </p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="Tb_3xdCWzNjKkGTcWh0bpyLhQ" continuedAt="Tb_3xdCWzNjKkGTcWh0bpyLhQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_bPi2WHn1CEmBrVfnbyV-yQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_rFwb_kI3AUCONxCusWin8A_3_3">11.50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-7KCAAHgxkqAZ45nDl70BQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_TOzHTgEHvUm0axqQhMm1Wg_3_6">11.50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_ybrEKTUYVEi2w4swS4gdww" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_3n4JO0yceEuqHmn70aHI8g_4_3">10.44</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_5w37XobWakKj_h4ipX-PCQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_XC-GzgRSBEeNNPiCURqvHw_4_6">10.10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_g71uqyykEUaLUf1hlvHiRw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_Cu8em76UFU6Nlzhlr-naiw_5_3">5.12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_32dEYbIibku74IeSgOkApA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="Tc_MVwKbBMhXkSTH7oJzGRGwA_5_6">5.36</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_8tE3iMpWckqAsmbEpESznQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_Rl1cLw_tnUqFXzLrqD53wQ_6_3">2.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_AiXZHnfbmUaYN1Ptn1SXKA" decimals="3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_P_-GWAFgv02192iOYQ0PDQ_6_6">100.0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_8dkF3R4YwUqerp4U-rpgZQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_5yzFoRLX_kKcgxa4vRo0cw_7_3">4.2</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_Qv7tGKJp8ESTjI2bmnNtTA" decimals="3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_6mCz9yJ9pEKS_T3XL7K1kw_7_6">7.4</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_SAyeztzxD0CqTCyFAOQf2A" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_I8fhbu1ow0SIPIAs7yaCzw_8_3">3.91</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_h8eV0dNuHUC_ArrU2_om7Q" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_qABxfnz3qEG9rfOWyYtxtA_8_6">1.28</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_JeEGJuHbaES_O44UyyPIfA" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_QnRD0lXYbUGIBXFoco0XMg_9_3">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_MxCSmXH-QkW2v6_7S1_RpQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="Tc_EM_nf1ZGVESOzphMmRXsXA_9_6">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-41</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_25453fbc_2d97_40e6_b5bc_b8e11a0ffccf"></a><a id="Tc_PBNztVgFxkqwx1UnrbnKvA_1_2"></a><a id="Tc_mKGkTLP-GUirgiUKOvi55g_1_5"></a><a id="Tc_S1KD6yNaQ0ezZN-f9UQytg_1_8"></a><a id="Tc_J2b48CFgP0GEoU1mZ1hD9Q_2_0"></a><a id="Tc_niSrFAlAVE6k97AfhpAqFA_2_2"></a><a id="Tc_QktDE__wREGsm-Kgjy6Wpw_2_3"></a><a id="Tc_m7ngqKq4LESzYT_hCdOKyA_2_5"></a><a id="Tc_EuTQYKcQuE-jR5C4qfPIEw_2_6"></a><a id="Tc_muKw5-t2A0KT5Hc1pVWp-A_2_8"></a><a id="Tc_O-_OA18vfUmsHMbwneo23A_2_9"></a><a id="Tc_spPrJlgQw0q5Mi44dz9vow_3_0"></a><a id="Tc_9Zmsn3wguE2o4hH2q5X47g_4_0"></a><a id="_99a4faa0_2c97_4393_98d1_61221b89ae42"></a><a id="Tc_EecTFxLlO06gq1o1pZtb5g_6_0"></a><a id="Tc_o9f-a7PCVU-MaVP76vSOmA_6_2"></a><a id="Tc_F9_kv97jskuotqjqCQUu-w_6_5"></a><a id="Tc_E4aV2W5qlU6WHz5pmYOZcA_6_8"></a><ix:continuation id="Tb_X9w2RdnlvkGLhJbxenfTBA_cont2"><ix:continuation id="Tb_3xdCWzNjKkGTcWh0bpyLhQ_cont1"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The change in the fair value of the derivative warrant liabilities for the year ended December 31, 2022 and for the period from February 8, 2021(inception) to December 31, 2021 is as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="Group_43qTDkf5rE-4V60Yt3vBAw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of February 8, 2021(inception)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_qrvljgLErEia_hKda3XtPw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="0" id="Tc_Y5hgmQv0L0-aMd3eBOEXKA_3_3">251,668</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_ZP0J_NoaR0O08Cu16XJevg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="0" id="Tc_zK_JLC5IEE2CSJkAVwX-wQ_3_6">4,600,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_v4FiAYrj_UiV84PIq9aKlg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="0" id="Tc_uex-NeMRuUGMyxgtYO8Ukw_3_9">4,851,668</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember__X7tf0I7ukiYWBqvSdHF_A" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc__eIyFQwNbESbuFdByZGDPQ_4_3">251,668</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_hE2awbU3oU-sum3j2xFkxg" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_JXo3bdf3r0CwrNNPp0ezKw_4_6">4,600,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_Nddpq_hUqUiHgJZLwEZXaw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_JYm4Ych8QU-Jsv8f7JV1fA_4_9">4,851,668</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_4REQyUAf6022aVEF9i64Ww;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_Su-w_xFE4ke175Cyk-kveg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" sign="-" scale="0" id="Tc_NrVXkvjwwUWSU8YDcgCMOA_5_3">234,110</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" sign="-" scale="0" id="Tc_4ddffYNfTEGm5J2pXbavPw_5_6">4,255,000</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_S4feA0vhSU--s22UyX83mw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" sign="-" scale="0" id="Tc_1KO289HitkG8kfO45ZCeTA_5_9">4,489,110</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_ruu01iLDPE611oCSW8HUQw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_L7xQbDjSMk20U71KEGyzBQ_6_3">17,558</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_i3YcttQtE0qD_bVp81S3_Q_6_6">345,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_gvo3MI-_1kGJuvLmpZZU2w" decimals="0" format="ixt:numdotdecimal" name="dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" scale="0" id="Tc_SRWH9u22CECKmX2n8DlWzw_6_9">362,558</ix:nonFraction></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="Tc_8-JVMXNysESxRlOI2E89rw_1_5"></a><a id="Tc_HJT0ebzvgUiXpwUh21Eckw_2_5"></a><a id="Tc_4zEBALfz8kOu0kmtogJI9g_3_5"></a><a id="Tc_tlks64H3uUayMw0mXajVfg_4_2"></a><a id="Tc_bFUVI6Sbj0iJURM0QoD4iQ_4_5"></a><a id="Tc_7MgJRHTIpE2G8_yME7uD5A_5_2"></a><a id="Tc_xVEuYQk9PkSlRA8EuIR-2g_5_5"></a><a id="Tc_GbJnsvCCzUizSmWdMMABxw_6_2"></a><a id="Tc_OhDht3nsyUK-mscTwnMTFg_6_5"></a><a id="Tc_E5oKP61m_Uyg6cyLUuSiCw_7_0"></a><a id="Tc_lIE73FArbk-XgskmgBfs5Q_8_0"></a><a id="Tc_khURYza7XEiVHwrBfAlFlg_8_2"></a><a id="Tc_OMUwSzPFfECTLorXoGaD2Q_8_5"></a><a id="Tc_odu2NvjbgkOcr9Vbc-yzOA_8_6"></a><a id="Tc_mYoBwBVK40WejYwXrKk34g_9_0"></a><a id="Tc_-FfTALhJOEmWpmhCARx_lw_10_0"></a><a id="Tc_uVN43zl3TUaKuWiDSRLzTg_11_0"></a><a id="Tc_XGVe-S8WZE-XydDX7RRC5w_11_2"></a><a id="Tc_FM2twDwXMkifa6id9cca3g_11_3"></a><a id="Tc_ejsNIRt7GEeTiTa1IstajA_11_5"></a><a id="Tc_xyyck14gZ0OLshz58ldA6g_11_6"></a><a id="Tc_D777xIkZj0OV7nL7YPNGng_12_0"></a><a id="Tc__AZGlikR60OFUly5OgHeMQ_12_3"></a><a id="Tc_lKlJ4EsMP0636COBUOe_kg_12_6"></a><a id="Tc_LQoQIrMuIUGw9GXKy0c_7w_13_0"></a><a id="Tc_EtGFr_CyekKoRwiFglmIeQ_14_0"></a><a id="Tc_p9eEcoMGeUKdq4zrNI_N_A_14_2"></a><a id="Tc_KaHO9BDbKECn4FX74Zpw6Q_14_5"></a><a id="Tc_pSVv9gWj9kOEyhf-yUflsA_14_6"></a><a id="Tc_R-JUsgtri02k7ht_EFc7Eg_0_5"></a><a id="Tc_UVkV39hi-ECjvCH03UJyAQ_1_5"></a><a id="Tc_dXFkz3HBGkqp-rxDnQajaQ_2_5"></a><a id="Tc_gmEq7ehy4EOM7Lnf1UbLuQ_3_2"></a><a id="Tc_AT_UzoMvKkK2llJSFjyhRw_3_5"></a><a id="Tc_gkMx_i9iMk2aQgPQ6Fjlsg_4_2"></a><a id="Tc_Pc-pDVp0KUe_eZY3LRmOFA_4_5"></a><a id="Tc_47r3uYMsOUibvK4gQeL8Rw_5_2"></a><a id="Tc_7DoCiZ-lgUiIiXRnftMjAw_5_5"></a><a id="Tc_lFlVGmbl10OgXcVMHmYhUg_6_0"></a><a id="Tc_jrJNg0GfiE6EOwOYoJUjiw_7_0"></a><a id="Tc_DtVp1tHbN0SkGkSKVNalYA_7_2"></a><a id="Tc_KLVhhVlBzEiOfRUEwcjERg_7_3"></a><a id="Tc_XX1ANSNqpEqEDRAOlU6Zpw_7_5"></a><a id="Tc_-jYHasjr-02lZwyzpnbI6w_8_0"></a><a id="Tc_wzJH-xTm4E-j20QhwtFGSw_9_0"></a><a id="Tc_SBvxO-SqF0SCSVeT-cgRiQ_10_0"></a><a id="Tc_G8JsuF8NNECBtLIc3qrU5Q_10_3"></a><a id="Tc_zh5_qArYykqIV3BzrMKLlg_10_6"></a><a id="Tc_3ls_ohCiwk2LchPTcl1pLQ_11_0"></a><a id="Tc_56FLIVGmaUCA1uCqBA2sXw_11_3"></a><a id="Tc_XE5kHohXL0iQ7CNQGiFsCw_12_0"></a><a id="Tc_e6s0DBjAgEuczVyts-N66A_13_0"></a><a id="Tc_E1bWNMiRpUeKn1xMnVK2ng_14_0"></a><a id="Tc_b-yfMJ1LAUK3-eTcZxZIDA_14_2"></a><a id="Tc_XaRfSyGihUO4WNQu0mI3ew_14_3"></a><a id="Tc_k4NHi_6UZkC2xZzWkOimbg_14_5"></a><a id="Tc_AMXok3ip4kqZtnakac82Og_14_6"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:IncomeTaxDisclosureTextBlock" id="Tb_9qVB0HwvVku_skTkgnP2Bw" continuedAt="Tb_9qVB0HwvVku_skTkgnP2Bw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 10. INCOME TAX</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The income tax provision consists of the following:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="Tb_g1X2tb3t30KJq-7pJuCNTA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the period from</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(inception)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="0" id="Tc_uG8jZmuNyEKffzX1PXYanA_8_3">214,850</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Deferred</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" sign="-" scale="0" id="Tc_whJsxHl-hUuPHgDvotY_eA_9_3">715,345</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" sign="-" scale="0" id="Tc_CFCq_ljBIUe2B1c9HyMnXw_9_6">118,531</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State and Local</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Deferred</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" id="Tc_T-kCnilt6E2Lt2zG3dJcWQ_13_3">715,345</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" id="Tc_Tr4wBrc7mkyE1ZRXYDCu5Q_13_6">118,531</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="Tc_z6gLIr_jt0G4lHcOvGq4Cg_14_3">214,850</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s net deferred tax assets are as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="Tb_bRGJisxduUu53rijGnv34A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period from</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Net Operating Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" id="Tc_TehFiJWTmUykGRks2Dn9Nw_7_6">31,893</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Sec. 195 Start-up Costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="dkdcu:StartUpCosts" scale="0" id="Tc_K2ij3Cu7mUiMRFhjKcaaMA_8_3">833,875</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:StartUpCosts" scale="0" id="Tc_OQXMXOwmqkOGqeU0MJ5IJA_8_6">88,493</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" id="Tc_FT6_5z5icEmgc_adzva2Jg_9_3">833,875</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" id="Tc_XTwAaufuYUuVcmCPekKNQg_9_6">120,386</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Tax Liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Unrealized gain on Investment in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:UnrealizedGainOnInvestmentInTrustAccount" scale="0" id="Tc_2yGnS8B260OmrK6Vy-qiug_11_6">1,855</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="0" id="Tc_nUMcV31DVUeRJ1EwmbKIkQ_12_3">833,875</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_-9mRpELl-Ee-JT7U3Njw7g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (1,855)</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" id="Tc_o1Pae4HZOkaCN7ZSHU7sLg_13_3">833,875</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" id="Tc_MN0Ose-VtEupDz55QQPdaQ_13_6">118,531</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Tax Assets, net of allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:12pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, the Company had <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt-sec:numwordsen" name="dkdcu:U.s.FederalAndStateNetOperatingLoss" scale="0" id="Narr_iLj_tRAFxUiJp1DOgzbIxg">zero</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:U.s.FederalAndStateNetOperatingLoss" scale="0" id="Narr_uWnF4pq_ek2R0bBHeJk7Cw">162,132</ix:nonFraction> of U.S. federal and state net operating loss carryovers available to offset future taxable income. The federal net operating losses can be carried forward indefinitely, subject to a limitation in utilization against <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="2" format="ixt:numdotdecimal" name="dkdcu:LimitationOnAnnualTaxableIncome" scale="-2" id="Narr_sTHlCVH0Lkqa_IYT91j40w">80</ix:nonFraction>% of annual taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-42</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_ukUt1uxZO0mFRL27FUFyvQ_1_4"></a><a id="Tc_F1DwGVtas0yAQ7rrX_wgtA_2_4"></a><a id="Tc_7eqj7QQtmEi8pIiXH4gMRA_3_4"></a><a id="Tc_n-rzd_L5o06mjVOln49s5A_4_2"></a><a id="Tc_iy1ru3Shu0yfrdFw0Vq66A_4_4"></a><a id="Tc_TXyNS2AvP02oFGCRHeU1VA_5_2"></a><a id="Tc_zZES-u_OF0KmPa5zNOB_5Q_5_4"></a><a id="Tc_O0z3DfpNg0O4at0m-dq41w_6_2"></a><a id="Tc_UOy_bvpdOkWTELg2oRiv1w_6_4"></a><a id="Tc_68ylRJQkFU6v3qVH5SDIfw_7_0"></a><a id="Tc_2QPGKAuvJ0qTKycnT9HuFA_7_3"></a><a id="Tc_qLoxEcwJbkCCPoEsPk8_Yw_7_5"></a><a id="Tc__1EdsLnUh0Wbsy9GC-WVDA_8_0"></a><a id="Tc_UQsP2Mg5JUKpvhws95z5Lg_8_2"></a><a id="Tc_o4KIm0U9JUW2LiMD6hJzYw_8_3"></a><a id="Tc_6K7ngukFbkWhY7b_agMJvw_8_4"></a><a id="Tc_MASry1j1q0SKZnCptedChQ_8_5"></a><a id="Tc_dkERuWAcs0OONAaGHbafWg_9_0"></a><a id="Tc_CGSJSuzIck2uYFGsiup2Qw_9_3"></a><a id="Tc_8F2qTQYZdECIHHG47fcPBQ_9_5"></a><a id="Tc_IrsOPxiW5kamziTyQWWQoA_10_0"></a><a id="Tc_hKBRAgOkVkuw6cy4y4rdPg_10_3"></a><a id="Tc_fqwMHj3YAk2UjWnut_n3Bg_10_4"></a><a id="Tc_ocsVCuoTcU-ASa67BhOAKw_10_5"></a><a id="Tc_8U92AoqAgECdgsa2LrMgIA_11_0"></a><a id="Tc_r494d2RaVUagZIeNqoMgKQ_11_2"></a><a id="Tc_ovUAVU7igECO1ezk1j3pYg_11_3"></a><a id="Tc_t_7CJjgzG0K4-0NzevGNUA_11_5"></a><a id="Tc_n2ugWDpjxUKE6OhfC6vCbw_12_0"></a><a id="Tc_afhWVD-aEUuyMRTOE8oYSA_12_3"></a><a id="Tc_Qztcql2qZ0ysea1ssTkLkg_12_5"></a><a id="Tc__hXDaoYzMEK0yWtcl6tetA_13_0"></a><a id="Tc_nsGVdtLSUEC8DrlkeTasFA_13_3"></a><a id="Tc__zRRJNqqw0aMexYwR-mP1Q_13_4"></a><a id="Tc_N2ZZLVidmkuZISV08sphzA_13_5"></a><ix:continuation id="Tb_9qVB0HwvVku_skTkgnP2Bw_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of deferred tax assets and therefore established a full valuation allowance of $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" id="Narr_BkFxwnZaqECztpOt6TLmWQ">833,875</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" id="Narr_ItBa2oGjxUe5CCywlhkDPQ">118,531</ix:nonFraction> as of December&#160;31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate is as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="Tb_4uXv6UBS1UebaK0dE_4xxA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period from</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Statutory federal income tax rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="4" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Tc_-zGVQQ535UiYsjnjLbC07w_7_2">21.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="4" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Tc_maRTpByffEGoWqMs5_D6hQ_7_4">21.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">State taxes, net of federal tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value of derivative liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="4" format="ixt:numdotdecimal" name="dkdcu:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities" sign="-" scale="-2" id="Tc_lhEkvifUSkOxhpRPBC19BA_9_2">170.93</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="4" format="ixt:numdotdecimal" name="dkdcu:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities" sign="-" scale="-2" id="Tc_yUl-VGx6T026JqAsyIloJg_9_4">25.89</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="4" format="ixt:numdotdecimal" name="dkdcu:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" scale="-2" id="Tc_D0t5sKW3p06bDXu6FL5cGA_10_2">59.18</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs allocated to warrant issuance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="4" format="ixt:numdotdecimal" name="dkdcu:EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance" scale="-2" id="Tc_Rk17eR19rEiCQWbycxTnkA_11_4">2.57</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="4" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="Tc_3SPhwU2teUiXb54VFUP4Gg_12_2">129.71</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw" decimals="4" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="Tc_RNTbpJL3MkCxxBwQr42ENQ_12_4">2.32</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w" contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" decimals="4" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" sign="-" scale="-2" id="Tc_nY29vdizJ0qms1VMLHOMGg_13_2">38.96</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s effective tax rates for the periods presented differ from the expected (statutory) rates due to the recording of full valuation allowances on deferred tax assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company&#8217;s tax returns since inception remain open to examination by the taxing authorities. There were <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="Narr_3ngPvdPM2E2PL6wMCG1flA">no</ix:nonFraction> unrecognized tax benefits as of December 31, 2022 and 2021. <ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" id="Narr_RO_dLhTdgUmPnPPmjBc2Qw">No</ix:nonFraction> amounts were accrued for the payment of interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="noteend"></a><a id="_416851_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw" name="us-gaap:SubsequentEventsTextBlock" id="Tb_CYc_H8dyEUSGp17szbPU8w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 11. SUBSEQUENT EVENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with ASC Topic 855, &#8220;Subsequent Events&#8221;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identified any subsequent events that would have required adjustment or disclosure in the financial statements other than as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On January 5, 2023, the Company elected to exercise its third-month extension to the Termination Date, which extended its deadline to complete its initial business combination from January 11, 2023 to February 11, 2023, by depositing $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_1_5_2023_To_1_5_2023_srt_StatementScenarioAxis_dkdcu_ThirdMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_zROX-Jpz0Um4wcHHn0lc3g" decimals="3" format="ixt:numdotdecimal" name="dkdcu:AmountDepositedPerEachPublicShareOutstanding" scale="0" id="Narr_LHuPZ3QTUEmYuWnqsL94LA">0.045</ix:nonFraction> per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_1_5_2023_To_1_5_2023_srt_StatementScenarioAxis_dkdcu_ThirdMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_zROX-Jpz0Um4wcHHn0lc3g" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AggregateAmountDepositedInTrustAccount" scale="0" id="Narr_Grr3_YeLBkiGx-LCm9IMRQ">122,920</ix:nonFraction>, was deposited in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 8, 2023, the Company elected to exercise its fourth-month extension to the Termination Date, which extended its deadline to complete its initial business combination from February 11, 2023 to March 11, 2023, by depositing $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_2_8_2023_To_2_8_2023_srt_StatementScenarioAxis_dkdcu_FourthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_2cSXaqbjC0G88fQ4Os87Uw" decimals="3" format="ixt:numdotdecimal" name="dkdcu:AmountDepositedPerEachPublicShareOutstanding" scale="0" id="Narr_n4MrObnATUSbd3E7GRyUeQ">0.045</ix:nonFraction> per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_2_8_2023_To_2_8_2023_srt_StatementScenarioAxis_dkdcu_FourthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_2cSXaqbjC0G88fQ4Os87Uw" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AggregateAmountDepositedInTrustAccount" scale="0" id="Narr_WvlcW5DBNUO95wwR1TQ9VA">122,920</ix:nonFraction>, was deposited in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">On March 6, 2023, the Company elected to exercise its fifth-month extension to the Termination Date, which extended its deadline to complete its initial business combination from March 11, 2023 to April 11, 2023, by depositing $<ix:nonFraction unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ" contextRef="Duration_3_6_2023_To_3_6_2023_srt_StatementScenarioAxis_dkdcu_FifthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NBJMLC3FJkeQ_zMEcQPEZA" decimals="3" format="ixt:numdotdecimal" name="dkdcu:AmountDepositedPerEachPublicShareOutstanding" scale="0" id="Narr_QrV5i_BCG0WuZeSM9SpnSw">0.045</ix:nonFraction> per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $<ix:nonFraction unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA" contextRef="Duration_3_6_2023_To_3_6_2023_srt_StatementScenarioAxis_dkdcu_FifthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NBJMLC3FJkeQ_zMEcQPEZA" decimals="0" format="ixt:numdotdecimal" name="dkdcu:AggregateAmountDepositedInTrustAccount" scale="0" id="Narr_mP7-VNWDqEW3akmei32NdA">122,920</ix:nonFraction>, was deposited in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-43</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 32.15pt;"><span style="font-size:1pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_6c8bd045_5c70_4a87_b4dd_a21e036eece0"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">OneMedNet Corporation</b></p><a id="ConsolidatedBalanceSheets_260616"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Consolidated Balance Sheets</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">March 31, 2023 and December 31, 2022</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Current Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,085</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">270,859</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accounts receivable, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">134,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">18,975</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">(2023 $0 and 2022 $102,700)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Prepaid expenses and other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">126,647</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">100,945</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">SPAC IPO Costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,098,369</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">900,152</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,505,021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,290,931</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Property and Equipment, Net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">76,839</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">83,097</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;"><b style="font-weight:bold;">Total assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,581,860</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,374,028</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Liabilities and Stockholders&#8217; Equity (Deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Current Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accounts payable &amp; accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,404,313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,134,752</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Deferred revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">156,287</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">183,683</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Convertible promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">9,565,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8,490,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">11,125,600</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">9,808,435</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Long Term Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Convertible promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,500,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,500,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Canada Emergency Business Loan Act</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">43,853</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">44,144</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued interest, related party</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">840,131</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">690,772</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">13,509,584</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">12,043,351</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Stockholders&#8217; Equity (Deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Preferred Series A-2, par value $0.0001, 4,200,000 shares authorized and 3,853,797 shares issued and outstanding as of March 31, 2023 and December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">385</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Preferred Shares A-1, par value $0.0001, 4,400,000 shares authorized and, 3,204,000 shares issued and outstanding as of March 31, 2023 and December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">320</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">320</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Common Stock, par value $0.0001, 30,000,000 shares authorized, and 4,550,166 shares issued and outstanding as of March 31, 2023 and December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">455</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Additional paid in capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">21,465,599</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">21,206,738</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(33,394,483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(31,877,221)</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total stockholders&#8217; equity (deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(11,927,724)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(10,669,323)</p></td></tr><tr><td style="vertical-align:bottom;width:76.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities and stockholders&#8217; equity (deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,581,860</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.92%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,374,028</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">See notes to financial statements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br/></i><span style="font-size:1pt;visibility:hidden;">&#8203;</span><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-44</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_625c6dc9_115b_493a_9418_49d1d34e1927"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">OneMedNet Corporation</b></p><a id="ConsolidatedStatementsofOperations_74253"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Consolidated Statements of Operations</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Quarter End March 31, 2023 and 2022</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"/><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Revenue </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">199,614</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">233,966</p></td></tr><tr><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Cost of Revenue </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">289,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">263,453</p></td></tr><tr><td style="vertical-align:bottom;width:74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Gross Margin </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(89,516)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(29,487)</p></td></tr><tr><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Operating Expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">General and administrative </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">642,568</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">467,116</p></td></tr><tr><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Operations </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">39,269</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">29,543</p></td></tr><tr><td style="vertical-align:bottom;width:74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Sales &amp; Marketing </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">259,270</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">176,282</p></td></tr><tr><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Research and development </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">329,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">156,610</p></td></tr><tr><td style="vertical-align:bottom;width:74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total Operating Expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,270,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">829,551</p></td></tr><tr><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Operating loss </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(1,360,086)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(859,038)</p></td></tr><tr><td style="vertical-align:bottom;width:74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Other Expense (income) </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Interest expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">149,359</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">74,712</p></td></tr><tr><td style="vertical-align:bottom;width:74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Other expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">7,817</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,043</p></td></tr><tr><td style="vertical-align:bottom;width:74%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">157,176</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">79,755</p></td></tr><tr><td style="vertical-align:bottom;width:74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Net loss </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(1,517,262)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:1%;background:#cceeff;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10%;background:#cceeff;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(938,793)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:9pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Earnings per Share March 31, 2023 -$0.33 and 2022 -$0.22</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:9pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Diluted Earnings per Share March 31, 2023 -$0.10 and 2022 -$0.07</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">See notes to financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="font-size:9pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-45</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_25c340e7_4d5a_48a9_8411_20e731536514"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">OneMedNet Corporation</b></p><a id="ConsolidatedStatementsofStockholdersEqui"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Consolidated Statements of Stockholders</b><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">&#8217;</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"> Equity (Deficit)</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Quarter End March 31, 2023 and Year Ended December 31, 2022</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:26.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:26.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:14.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Series&#160;A-2</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Preferred&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:14.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Series&#160;A-1</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Preferred&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Additional</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.38%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:26.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.56%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Paid-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stockholders&#8217;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:26.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">in&#160;Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b></p></td></tr><tr><td style="vertical-align:bottom;width:26.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Balances, December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">3,853,797</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">385</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">3,204,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">320</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">4,342,666</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">434</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">19,607,173</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(25,310,924)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(5,702,612)</b></p></td></tr><tr><td style="vertical-align:bottom;width:26.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Issuance of common shares in exchange for services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">200,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">199,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;">200,000</p></td></tr><tr><td style="vertical-align:bottom;width:26.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Issuance of common shares in exchange for cash at $1.00 per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:7pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:7pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:7pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:7pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">0.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">7,500</p></td></tr><tr><td style="vertical-align:bottom;width:26.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:7pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:7pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">1,392,086</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">1,392,086</p></td></tr><tr><td style="vertical-align:bottom;width:26.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">2022 net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">(6,566,297)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">(6,566,297)</p></td></tr><tr><td style="vertical-align:bottom;width:26.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Balances, December 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">3,853,797</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">385</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">3,204,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">320</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">4,550,166</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">455</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">21,206,738</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(31,877,221)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(10,669,323)</b></p></td></tr><tr><td style="vertical-align:bottom;width:26.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:7pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-size:7pt;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">258,861</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">258,861</p></td></tr><tr><td style="vertical-align:bottom;width:26.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Q1 2023 net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">(1,517,262)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">(1,517,262)</p></td></tr><tr><td style="vertical-align:bottom;width:26.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:7pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Balances, March 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.97%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">3,853,797</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">385</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.78%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">3,204,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.76%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.64%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">320</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">4,550,166</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.66%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">455</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.34%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">21,465,599</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(33,394,483)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.71%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">(11,927,724)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">See notes to financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-46</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_d4980059_6ebd_4a1d_ab24_70544eea3d87"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">OneMedNet Corporation</b></p><a id="ConsolidatedStatementsofCashFlows_31429"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Consolidated Statements of Cash Flows</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Quarter Ended March 31, 2023 and 2022</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from Operating Activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Net Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(1,517,262)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(938,793)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Adjustments to reconcile net loss to</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">net cash flows from operating activities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 14.4pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4,370</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 14.4pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">258,861</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,277</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 14.4pt;">Changes in assets and liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 14.4pt;">Accounts Receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(115,945)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">12,927</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 14.4pt;">Other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(223,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(47,266)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 14.4pt;">Accounts payable &amp; accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">269,561</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(198,147)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 14.4pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(27,396)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">25,417</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net cash flows from operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(1,349,842)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(1,131,215)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash used for Investing Activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Purchase of property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(16,971)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from Financing Activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Proceeds from Canada Emergency Business Loan Act</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(291)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">662</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Proceeds from issuance of convertible promissory note</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,224,359</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,074,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net cash flows from financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,224,068</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,075,374</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net change in cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(125,774)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(72,812)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents, Beginning</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">270,859</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">699,320</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents, Ending</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.23%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,085</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.25%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">626,508</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.53%;background:#cceeff;border-bottom:3px double transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:9pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">See notes to financial statements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-47</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quarter Ended March 31, 2023 and Year Ended December 31, 2022</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_195f2718_cf0b_430b_b194_3b678307014d"></a><a id="SummaryofSignificantAccountingPolicies_6"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">1.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Summary of Significant Accounting Policies</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Nature of Operations</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">OneMedNet Corporation (the </span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8220;</span><span style="font-family:'Times New Roman','Times','serif';">Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">) is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. The Company was incorporated in Delaware on September 20, 2006. The Company has been solely focused on creating solutions that simplify digital medical image management, exchange, and sharing. The Company has one wholly- owned subsidiary, OneMedNet Technologies (Canada) Inc., incorporated on October 16, 2015 under the provisions of the Business Corporations Act of British Columbia whose functional currency is the Canadian dollar.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Basis of Presentation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The consolidated financial statements of the Company have been prepared on the basis of generally accepted accounting principles in the United States of America (US GAAP).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Use of Estimates</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Cash and cash equivalents consist of highly liquid, short-term investments with a maturity of three months or less when purchased. Cash equivalents consist of money market funds and are carried at cost, which approximates fair value. The balances, at times, may exceed FDIC Insured limits.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Accounts Receivable</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Accounts receivable are unsecured, recorded at net realizable value, and do not bear interest. Accounts receivable are considered past due if not paid within the terms established between the Company and the customer. Amounts are only written off after all attempts at collections have been exhausted. The Company determines the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. As of December 31, 2022 the Company established allowances of $102,700. The net receivable balances outstanding are fully collectible.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Property and Equipment</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Property and equipment are recorded at cost. The straight-line method is used for computing depreciation and amortization. Assets are depreciated over their estimated useful lives ranging from three to five years. Cost of maintenance and repairs are charged to expense when incurred.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Impairment of Long-Lived Assets</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of an asset may not be fully recoverable. An impairment loss would be recognized when the estimated future cash flows from the use of the asset are less than the carrying amount of that asset. There have been no losses during the quarter ended March 31, 2023 and the year ended December 31, 2022.</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-48</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quarter Ended March 31, 2023 and Year Ended December 31, 2022</b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Revenue Recognition</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Revenue from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to a customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account under topic 606. A contract</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s transaction price is allocated to each distinct performance obligation in proportion to the standalone selling price for each and recognized as revenue when, or as, the performance obligation is satisfied.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The steps the company uses to determine revenue recognition are as follows: identification of the contract with a customer, identification of the performance obligations, determining the transaction price, allocation of the transaction price to the performance obligation and recognition of revenue when the Company satisfies the performance obligation.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Individual promised goods and services in a contract are considered a performance obligation and accounted for separately if the good or service is distinct. A good or service is considered distinct if the customer can benefit from the good or service on its own or with other resources that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company generates revenue from two streams: (1) iRWD (imaging Real World Data) which provides regulatory grade imaging and clinical data in the Pharmaceutical, Device Manufacturing, CRO&#8217;s and AI markets and (2) BEAM which is a Medical Imaging Exchange platform between Hospital/Healthcare Systems, Imaging Centers, Physicians and Patients.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">iRWD is sold on a fixed fee basis based on the number of data units and the cost per data unit committed to in the customer contract. Revenue is recognized when the data is delivered to the customer.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Beam revenue is subscription-based revenue which is recognized ratably over the subscription period committed to by the customer. The company invoices its Beam customers quarterly or annually in advance with the customer contracts automatically renewing unless the customer issues a cancellation notice.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company excludes from revenue taxes collected from a customer that are assessed by a governmental authority and imposed on and concurrent with a specific revenue-producing transaction.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The transaction price for the products is the invoiced amount. Advanced billings from contracts are deferred and recognized as revenue when earned.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Deferred revenue consists of payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. The Company receives payments from customers based upon contractual billing schedules. Accounts receivable is recorded when the right to consideration becomes unconditional. Payment terms on invoiced amounts typically range from zero to 90 days, with typical terms of 30 days.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Income Taxes</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial statement carrying amount and the tax basis of assets and liabilities. The Company provides for deferred taxes at the enacted tax rate that is expected to apply when the temporary differences reverse. The Company has recorded a full valuation allowance against the net deferred tax asset due to the uncertainty of realizing the related benefits.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Patents and Trademarks</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Costs associated with the submission of a patent application are expensed as incurred given the uncertainty of the patents resulting in probable future economic benefits to the Company and are included in research and development expenses on the consolidated statements of operations.</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-49</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quarter Ended March 31, 2023 and Year Ended December 31, 2022</b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Research and Development</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Research and development expenditures were charged to operating expense as incurred for the</span><span style="font-family:'Times New Roman','Times','serif';"> periods ended March 31, 2023 and December 31, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Stock-based Compensation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company has a stock-based compensation plan, which is described in more detail in Note 8. The fair value of stock option and warrant grants are determined on the date of grant using the Black Scholes valuation model. Forfeitures of stock based awards are recorded as the actual forfeitures occur. Stock based compensation expense is recognized over the service period, net of estimated forfeitures, using the straight-line method.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:45.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2025</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Equivalent Common Shares, 2009 Equity Plan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">383,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">383,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">383,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">383,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Equivalent Common Shares, 2020 Equity Plan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">184,581</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">400,581</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">549,512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">648,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">567,581</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">783,581</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">932,512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,031,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Recent Accounting </b><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Pronouncements</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. The ASU also provides updated guidance regarding the impairment of available-for-sale debt securities and includes additional disclosure requirements. The new guidance is effective for fiscal periods beginning after December 15, 2022. Early adoption is permitted. The Company is currently assessing the effect that ASU No. 2016- 13 will have on its consolidated financial statements and related disclosures.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company has issued convertible promissory notes with related party investors. In order to simplify, and provide less confusion, on accounting for debt with conversion options, FASB release ASU 2020-06 in August 2020. ASU 2020-06 simplifies the accounting for convertible instruments. The embedded conversion features are no longer separated from the debt with conversion features that are not required to be accounted for as derivatives under or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost and therefore will be accounted for as a single equity instrument measured at its historical cost. The Company has early adopted ASU 2020-06 and therefore a derivative liability has not been recorded.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_8c559b9b_7d3c_4a27_8240_292803611b9e"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">2.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Going Concern</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The Company does not have adequate liquidity to fund its operations through at least twelve months from the date these financial statements were available for issuance. The Company has an accumulated deficit of $33,394,483 (2022 - $31,877,221) and has had negative cash flows from operating activities for the quarter ended March 31, 2023 and year ended December 31, 2022. These conditions raise substantial doubt about the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s ability to continue as a going concern.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">To continue in existence and expand its operations, the Company will be required to, and management plans to, raise additional working capital through an equity or debt offering and ultimately attain profitable operations. If the Company is not able to raise additional working capital, it would have a material adverse effect on the operations of the Company and continuing research and development of its product.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s continuation as a going concern is dependent upon its ability to continue receiving working capital cash payments and generating cash flow from operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-50</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quarter Ended March 31, 2023 and Year Ended December 31, 2022</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_018187d9_4841_4eb3_9fab_b445a80d8c0d"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">3.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Property and Equipment</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Property and equipment are summarized as of December 31:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr><td style="vertical-align:bottom;width:64.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.6%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.37%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.37%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Computers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">259,208</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">259,206</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Furniture and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3,785</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3,785</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.6%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Total Property and Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">262,993</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">262,991</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: accumulated depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(186,153)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(179,895)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.6%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Net Property and Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">76,839</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.59%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.77%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">83,097</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Depreciation and amortization expense was $6,258 for the quarter ended March 31, 2023 and $24,807 for the year ended December 31, 2022.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_c78481e3_6e1e_4384_96c7_ba18ff8f4de3"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">4.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Income Taxes</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company has generated both federal and state net operating losses (NOL) of approximately $21 million and $23 million, respectively, which if not used, will begin to expire in 2030. The Company believes that its ability to fully utilize the existing NOL carryforwards could be restricted on a portion of the NOL by changes in control that may have occurred or may occur in the future and by its ability to generate net income. The Company has not yet conducted a formal study of whether, or to what extent, past changes in control of the Company impairs its NOL carryforwards because such NOL carryforwards cannot be utilized until the Company achieves profitability.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Components of deferred income taxes are as follows as of December 31:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr><td style="vertical-align:bottom;width:67.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.62%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.28%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.17%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Net operating loss carry forward</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6,973,587</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,604,237</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Stock Compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">481,144</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">467,925</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.2pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">53,268</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">51,617</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.62%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">7,507,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.17%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.13%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6,123,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.62%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.28%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(7,507,999)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.17%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.13%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(6,123,778)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.62%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.17%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.13%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.62%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The change in the valuation allowance was $1,384,220 and $764,878 for the years ended December 31, 2022 and 2021, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The effective tax rate for the years ended December 31, 2022 and 2021 differs from the federal and state statutory rates due to the full valuation allowance.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statement is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The tax years from inception through December 31, 2022 remain subject to examination by all major taxing authorities due to the net operating loss carryovers. The Company is not currently under examination by any taxing jurisdiction. The Company did not incur any interest or penalties during the years ended December 31, 2022 or 2021.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_63fa206d_f00e_4210_8235_8119e3a72ce9"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">5.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Convertible Promissory Notes held by Related Party</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">During the first quarter of 2023, the Company entered into various Convertible Promissory Notes (</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8220;</span><span style="font-family:'Times New Roman','Times','serif';">Note</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">) with related party investors totaling $600,000 (2022 - $4,700,000) and unrelated party investors of $475,000 (2022 - $440,000). The Notes issued are unsecured and bear an interest rate of six percent annually from the date of issuance until the outstanding principal is paid or </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-51</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quarter Ended March 31, 2023 and Year Ended December 31, 2022</b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">converted. On November 11, 2022 the Convertible note agreement was amended and restated in order to (i) provide for the sale and issuance to Purchasers from the effective date of January 1, 2022 and after the date of this Agreement of up to an additional $3,000,000 aggregate principal amount of Notes and warrants to purchase shares of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s capital stock, (ii) provide for the sale and issuance to Purchasers who purchased Notes under the Prior Agreement between the Effective Date and the date of this Agreement of warrants to purchase shares of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s common stock at an exercise price of $1.00 per share; (iii) extend the maturity date of all outstanding Notes from December 31, 2022 to May 31, 2023.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The principal and unpaid accrued interest on each Note will convert; (i) automatically, upon the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s issuance of equity securities (the </span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8220;</span><span style="font-family:'Times New Roman','Times','serif';">Next Equity Financing</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">) in a single transaction, or series of related transactions, with aggregate gross proceeds to the Company of at least $5,000,000, into shares of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s capital stock issued to investors in the Next Equity Financing, at a conversion price equal to the lesser of (A) a 20% discount to the lowest price per share of shares sold in the Next Equity Financing, or (B) $2.50 per share; (ii) at the noteholder</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s option, in the event of a defined Corporate Transaction while such Note remains outstanding, into shares of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Series A-2 Preferred Stock at a conversion price equal to $2.50 per share; and (iii) at the noteholder</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s option, on or after the Maturity Date while such Note remains outstanding, into shares of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Series A-2 Preferred Stock at a conversion price equal to $2.50 per share.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If a Corporate Transaction occurs before the repayment or conversion of the Notes, the Company will pay at the closing of the Corporate Transaction to each noteholder that elects not to convert its Notes in connection with such Corporate Transaction an amount equal to the outstanding principal amount of such noteholder</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s Note plus a 20% premium. </span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8220;</span><span style="font-family:'Times New Roman','Times','serif';">Corporate Transaction</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';"> means (a) a sale by the Company of all or substantially all of its assets, (b) a merger of the Company with or into another entity (if after such merger the holders of a majority of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s voting securities immediately prior to the transaction do not hold a majority of the voting securities of the successor entity) or (c) the transfer of more than 50% of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s voting securities to a person or group.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">During November 2019, the Company entered into a Convertible Promissory Note (</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8220;</span><span style="font-family:'Times New Roman','Times','serif';">Note</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">) agreement with a related party investor. The total amount of the Note is $1,500,000. The Note is unsecured and bears interest at a rate of four percent annually from the date of issuance until the outstanding principal is paid or converted. The Note matures on January 1, 2025. The Note shall automatically convert into the next offering of preferred stock upon closing of such next equity financing. The number of shares of preferred stock to be issued upon conversion shall be equal to the number obtained by dividing the outstanding principal and unpaid accrued interest owed on the date of conversion, by the conversion price. The conversion price is 100 percent of the lowest price per share paid for the next equity preferred stock by other investors in the next equity financing. In the event that prior to the conversion or repayment of amounts owed, the Company completes a financing transaction in which the Company sells equity securities but such transaction does not qualify as next equity financing (i.e. an </span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8220;</span><span style="font-family:'Times New Roman','Times','serif';">alternative financing</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8221;</span><span style="font-family:'Times New Roman','Times','serif';">), then the principal and unpaid accrued interest may (upon written election of the purchaser holding the Note) convert into the securities issued by the Company in the alternative financing. The number of alternative financing equity securities to be issued upon such conversion shall be equal to the number obtained by dividing the outstanding principal and unpaid accrued interest owed by an amount equal to 100 percent multiplied by the lowest price per share at which the alternative financing equity securities are sold and issued for cash in the alternative financing.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 $11,065,000 and as of December 31, 2022 there was $9,990,000 in outstanding principal balance on the Notes, respectively, and $840,131 and $690,771 in accrued interest, respectively, all included in long-term liabilities on the balance sheet. There have been no payments of principal or interest to date. In connection with the $1,075,000 in convertible notes issued in the first quarter of 2023 (2022 - $5,140,000), 430,000 (2022 - 2,056,000) in warrants were issued.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_204c9f2b_696e_4f4a_9251_1fa3a4d42e3e"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">6.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Canadian Emergency Business Loan Act (CEBA)</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">During December 2020, the Company applied for and received a $43,853 USD CEBA loan. The loan was provided by the Government of Canada to provide capital to organizations to see them through the current challenges and better position them to return to providing services and creating employment. The loan is unsecured. The loan is interest free to December 31, 2023. If the loan is paid back by December 31, 2023,</span><span style="font-family:'Times New Roman','Times','serif';"> $14,617 of the loan will be forgiven. If the loan is not paid back by December 31, 2023, the full $43,853 loan will be converted to loan repayable over three years with a 5% interest rate.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company accounted for the loan as debt in accordance with FASB Accounting Standards Codification 470 Debt and accrued interest in accordance with the interest method under FASB ASC 835-30. Full or partial loan forgiveness with legal release reduces the liability by the amount forgiven and record a gain on extinguishment in the statement of operations.</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-52</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quarter Ended March 31, 2023 and Year Ended December 31, 2022</b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_0ab72b23_b4b0_428d_a2b0_895de13c3b53"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">7.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Shareholders</b><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">&#8217;</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"> Equity Series A-2 Preferred Stock</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Series A-2 preferred stock includes a $0.15 per share annual noncumulative dividend when and if declared by the board of directors. No dividends have been declared as of March 31, 2023 and December 31, 2022. The Series A-2 preferred stock also includes a liquidation preference of 1.25 times the original issue price plus any declared but unpaid dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and have a preference upon liquidation over Series A-1 preferred stock and common stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Each share of Series A-2 preferred stock may be converted into equal shares of common stock at the option of the holder at any time. In addition, the Series A-2 preferred stock shares are automatically convertible into common shares upon the sale of shares of common stock to the public at the then applicable conversion price in a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $20 million in proceeds, net of underwriting discounts and commissions. Each share of Series A-2 preferred stock has voting rights equal to the number of shares of common stock then issuable upon conversion of such share of preferred stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company is obligated to redeem shares of Series A-2 Preferred Stock in the occurrence of a Deemed Liquidation Event unless a majority of the holders of Series A-2 Preferred Stock and a majority of the Series A-1 Preferred Stock consent otherwise.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Series A-1 Preferred Stock</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Series A-1 preferred stock includes a $0.15 per share annual noncumulative dividend when and if declared by the board of directors. No dividends have been declared as of March 31, 2023 and December 31, 2022. The Series A-1 preferred stock also includes a liquidation preference of 1.25 times the original issue price plus any declared but unpaid dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and have a preference upon liquidation over common stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Each share of Series A-1 preferred stock may be converted into equal shares of common stock at the option of the holder at any time. In addition, the Series A-1 preferred stock shares are automatically convertible into common shares upon the sale of shares of common stock to the public at the then applicable conversion price in a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $20 million in proceeds, net of underwriting discounts and commissions. Each share of Series A-1 preferred stock has voting rights equal to the number of shares of common stock then issuable upon conversion of such share of preferred stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company is obligated to redeem shares of Series A-1 Preferred Stock in the occurrence of a Deemed Liquidation Event unless a majority of the holders of Series A-1 Preferred Stock consent otherwise.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Common Stock</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">In 2022, in connection with services performed by the Board of Directors common shares of 100,000 for 2021 and 100,000 for 2022 were issued at $1.00 per share. These were expensed as general and administrative expenses in the statement of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_7898d4d8_edaf_42b0_936f_c0aeabd9fbde"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">8.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Stock Options</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">During 2020, the Company adopted a new equity incentive plan (the Plan), which provides for the granting of incentive and nonqualified stock options to employees, directors, and consultants. As of December 31, 2020, the Company has reserved 3,000,000 shares of common stock under the Plan. The Company believes that such awards better align the interests of its employees with those of its stockholders. Option awards are generally granted with an exercise price equal to the fair market value of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s stock at the date of grant; those option awards generally vest with a range of one to four years of continuous service and have ten-year contractual terms. As there is no public data available for the share price valuation, the Company considers the Fair Market Value of $1 to be on the conservative side and similar to the exercise price. Certain option awards provide for accelerated vesting if there is a change in control, as defined in the Plan. The Plan also permits the granting of restricted stock and other stock-based awards. Unexercised options are cancelled upon termination of employment and become available under the Plan.</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-53</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quarter Ended March 31, 2023 and Year Ended December 31, 2022</b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Information with respect to options outstanding is summarized as follows:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:56.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted-</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Average</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Exercise&#160;Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Intrinsic&#160;Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Outstanding as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">947,184</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.62%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">947,184</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Granted - under the Plan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">577,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(7,500)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Cancelled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(485,684)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 2.9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.03%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Outstanding as of December 31, 2022 and March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,031,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,031,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Options exercisable as of March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">607,674</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">1.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">607,674</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and December 31, 2022, there were 1,031,000 common stock options outstanding with a weighted average remaining contractual life of 6.86 and 7.11 years, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and December 31, 2022, there were 607,674 and 567,581 common stock options exercisable at a weighted average remaining contractual life of 5.49 and 5.56 years, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Black Scholes Assumptions</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The determination of the fair value of stock options using an option valuation model is affected by the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s stock price valuation, as well as assumptions regarding a number of complex and subjective variables. The volatility assumption is based on volatilities of similar companies over a period of time equal to the expected term of the stock options. The volatilities of similar companies are used in conjunction with the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s historical volatility because of the lack of sufficient relevant history for the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s</span><span style="font-family:'Times New Roman','Times','serif';"> common stock equal to the expected term. The expected term of the employee stock options represents the weighted average period for which the stock options are expected to remain outstanding. The expected term assumption is estimated based primarily on the options</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';"> vesting terms and remaining contractual life and employees</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';"> expected exercise and post- vesting employment termination behavior. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield assumption is based on the expectation of no future dividend payouts by the Company.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The fair value of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s stock options was estimated assuming no expected dividends and the following weighted average assumptions:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2011</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:63.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected life in years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">5.89</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">6.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.55</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:63.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:63.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The total expense recognized for share-based payments was $22,361 for the quarter ending March 31, 2023 and $45,584 for the year ended December 31, 2022. These costs are included in the statements of operations. As of March 31, 2023 there was $57,261 and as of December 31, 2022, there was $75,987 of unrecognized compensation costs related to stock option grants which will be recognized over the next four years.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_0b0f83b2_bcc8_44d8_af54_31006e21fefe"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Stock Warrants</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In 2021, there were 174,102 outstanding common stock warrants issued for service at a weighted average exercise price of $0.10. The weighted average remaining contractual life was 4.21 years as of March 31, 2023.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In 2022 for the exercise price of $1.00, the company issued 145,746 warrants for 2021 service and 294,000 warrants for 2022 service, 2,056,000 in warrants were issued attached to convertible notes. The weighted average remaining contractual life of the warrants issued in 2022 is 4.24 years.</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-54</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quarter Ended March 31, 2023 and Year Ended December 31, 2022</b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In the first quarter of 2023, the company issued 430,000 warrants attached to convertible notes. The weighted average remaining contractual life of these warrants is 4.93 years.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">All warrants vested immediately upon grant issuance. The Company expensed $236,500 for the period ended March 31, 2023 and $1,346,288 in 2022 in relation to the issuance of the Warrants.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:52.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2025</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2026</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equivalent Common Shares, 2020 Grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equivalent Common Shares, 2021 Grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,746</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,746</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,746</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,746</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equivalent Common Shares, 2022 Grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,629,848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,629,848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,629,848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,629,848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,484,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Black Scholes Assumptions</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The determination of the fair value of common stock warrants using an option valuation model is affected by the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s stock price valuation, as well as assumptions regarding a number of complex and subjective variables. The volatility assumption is based on volatilities of similar companies over a period of time equal to the expected term of the common stock warrants. The volatilities of similar companies are used in conjunction with the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s historical volatility because of the lack of sufficient relevant history for the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s common stock equal to the expected term. The expected term of the common stock warrants represents the weighted average period for which the common stock warrants are expected to remain outstanding. The expected term assumption is estimated based primarily on the options</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';"> vesting terms and remaining contractual life. The risk-free rate for periods within the contractual life of the common stock warrant is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield assumption is based on the expectation of no future dividend payouts by the Company.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The fair value of the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s common stock warrants was estimated assuming no expected dividends and the following weighted average assumptions:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected life in years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">5.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">3.88</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:84.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:84.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="_7eab2a20_7e99_47e0_b2ed_13b764a3ebd0"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">10.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Commitments, Contingencies, and Concentrations Operating lease</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company has a month-to-month lease for a suite at a cost of $575 per month. As well, as part of an employment agreement with the Chief Commercial Officer, rent of $450 a month is reimbursed for the lease this individual personally has for office space.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company incurred $1,850 for the period ended March 31, 2023 and $7,694 for the year ended December 31, 2022 of rent expense.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_23f2416e_0ffd_4254_bdad_6f32fb4b59f6"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">11.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Receivable from SPAC for IPO Related Costs</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">During 2022, the company entered a Business Combination Agreement with SPAC Data Knights. $1,098,369 of SPAC related expenses are on the Balance Sheet as receivable to be received at close of the merger.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-55</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quarter Ended March 31, 2023 and Year Ended December 31, 2022</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_e39990cb_aca2_48e4_8bff_0277f513aa22"></a><table style="border:0;border-collapse:collapse;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">12.</b></p></td><td style="padding:0pt;"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Subsequent Events</b></p></td></tr></table><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company has evaluated subsequent events occurring through May 10, 2023, the date the financial statements were available for issuance, for events requiring recording or disclosure in the Company</span><span style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="font-family:'Times New Roman','Times','serif';">s financial statements.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">From the period April 1, 2023 to the date of this report, the Company issued $500,000 of additional convertible promissory notes to investors in exchange for cash. These promissory notes are unsecured and contain an interest rate of 6% per annum. The notes mature on May 31, 2023. The notes provide for automatic conversion of the principal and interest of the notes into shares of the next preferred stock financing round upon the subsequent receipt of proceeds from the sale of stock in excess of $5 million as defined in the bridge loan agreements.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-56</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_4f49ad50_fad1_4bd6_ac7c_c1fe62da7ffd"></a><a id="Report_3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">To the shareholders and the board of directors of OneMedNet Corporation:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Opinion on the Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have audited the accompanying consolidated balance sheets of OneMedNet Corporation as of December&#160;31, 2022 and 2021, the related statements of operations, stockholders&#8217; equity (deficit), and cash flows for the&#160;years then ended, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2022 and 2021, and the results of its operations and its cash flows for the&#160;years then ended, in conformity with accounting principles generally accepted in the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Substantial Doubt about the Company&#8217;s Ability to Continue as a Going Concern</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note&#160;2 to the financial statements, the Company has suffered recurring losses from operations and has a significant accumulated deficit. In addition, the Company continues to experience negative cash flows from operations. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note&#160;2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Basis for Opinion</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules&#160;and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">/S/ BF Borgers CPA PC</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">BF Borgers CPA PC (PCAOB ID 5041)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">We have served as the Company&#8217;s auditor since 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Lakewood, CO</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">March 23, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-57</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_0f89535d_d3b5_4967_a085_04df717d9dfd"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">ONEMEDNET CORPORATION</b></p><a id="BALANCESHEETS3"></a><a id="CONSOLIDATEDBALANCESHEETS_3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED </b><b style="font-weight:bold;">BALANCE SHEETS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;December&#160;31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.71%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Current Assets:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">270,859</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 699,320</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Accounts receivable, net of allowance (2022&#8201;&#8211;&#8201;$102,700 &amp; 2021&#8201;&#8211;&#8201;$22,533)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">18,975</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 91,742</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Prepaid expenses and other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">100,945</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 42,231</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Receivable from SPAC for IPO Related Costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">900,152</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,290,931</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 833,293</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Non-Current assets:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Property and Equipment, Net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">83,097</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 49,767</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,374,028</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 883,060</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Liabilities and Stockholders&#8217; Equity (Deficit)</b></p></td><td style="vertical-align:bottom;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.53%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.17%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.53%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.1%;background:#cceeff;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Current Liabilities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Accounts payable &amp; accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,134,752</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 758,815</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Deferred revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">183,683</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 642,350</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Convertible promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8,490,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,350,000</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">9,808,435</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,751,165</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Long Term Liabilities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Convertible promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,500,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,500,000</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Canada Emergency Business Loan Act</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">44,144</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 46,897</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Accrued interest, related party</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">690,772</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 287,610</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">12,043,351</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 6,585,672</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Stockholders&#8217; Equity (Deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;"><span style="white-space:pre-wrap;">Preferred Series A-2, par value $0.0001, 4,200,000 shares authorized and  3,853,797 shares issued and outstanding as of December 31, 2022 and 2021</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 385</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 385</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Preferred Shares A-1, par value $0.0001, 4,400,000 shares authorized and, 3,024,000 shares issued and outstanding as of December 31, 2022 and 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 320</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 320</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Common Stock, par value $0.0001, 30,000,000 shares authorized and 4,550,166 shares issued and outstanding as of December 31, 2022 and 4,342,666 as of December 31, 2021 respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 434</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Additional paid in capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">21,206,738</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 19,607,173</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (31,877,221)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (25,310,924)</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total stockholders&#8217; equity (deficit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (10,669,323)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (5,702,612)</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities and stockholders&#8217; equity (deficit)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">1,374,028</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 883,060</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-58</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_137ccd83_ded4_41c5_8d3f_875a45183189"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">ONEMEDNET CORPORATION</b></p><a id="STATEMENTSOFOPERATIONS3"></a><a id="CONSOLIDATEDSTATEMENTSOFOPERATIONS_3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED </b><b style="font-weight:bold;">STATEMENTS OF OPERATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:24.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.55%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.55%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,152,738</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,091,777</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cost of Revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,513,428</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,205,184</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross Margin</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (360,690)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (113,407)</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating Expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">3,446,329</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,196,712</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 398,760</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 152,461</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sales &amp; Marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">957,690</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 605,235</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">952,701</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 642,765</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Operating Expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,755,480</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,597,173</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Operating loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (6,161,170)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (2,710,580)</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other Expense (income)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 403,307</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (195,381)</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Other expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">46,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 34,908</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 450,127</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 230,289</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (6,566,297)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (2,940,869)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Earnings per Share December 31, 2022&#8201;&#8211;&#8201;$1.44 and 2021&#8201;&#8211;&#8201;$0.68</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Diluted Earnings per Share December 31, 2022&#8201;&#8211;&#8201;$0.44 and 2021&#8201;&#8211;&#8201;$0.23</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-59</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ecbfe082_bfef_4612_94f8_083ab409c830"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">ONEMEDNET CORPORATION</b></p><a id="EQUITY3"></a><a id="EQUITY_3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">CONSOLIDATED STATEMENTS OF CHANGES IN </b><b style="font-weight:bold;">EQUITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:19.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:14.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Series A-2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:14.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Series A-1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:14.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Preferred Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:14.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Preferred Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:13.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Common Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Additional&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stockholders&#8217;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Paid-in&#160;Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Balances, December 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,853,797</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">385</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,204,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 320</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">3,834,666</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;"><b style="font-weight:bold;">383</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,905,353</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (22,370,058)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (2,859,617)</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Issuance of common shares in exchange for services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">508,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">50,749</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">50,800</p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">47,071</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">47,071</p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">2021 net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (2,940,866)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (2,940,866)</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Balances, at December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,853,797</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 385</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,204,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 320</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">4,342,666</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">434</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,607,173</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (25,310,924)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (5,702,612)</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Issuance of common shares in exchange for services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">200,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">199,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">200,000</p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Issuance of common shares in exchange for cash at $1.00 per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">7,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">0.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">7,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">7,500</p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,392,086</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,392,086</p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">2022 net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 2.9pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (6,566,297)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (6,566,297)</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Balances, December 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,853,797</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 385</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,204,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 320</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">4,550,166</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">455</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">21,206,738</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (31,877,221)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (10,669,323)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-60</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_13adb30b_717a_4f79_84a8_7b676a8bc770"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">ONEMEDNET CORPORATION</b></p><a id="CASHFLOWS3"></a><a id="CASHFLOWS_3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">CONSOLIDATED STATEMENTS OF </b><b style="font-weight:bold;">CASH FLOWS</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Cash Flows From Operating Activities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (6,566,297)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (2,940,866)</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Adjustments to reconcile net loss to net cash flows from operating activities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.7pt;text-indent:-0.7pt;margin:0pt 0pt 0pt 12.25pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 24,807</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 14,466</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.7pt;text-indent:-0.7pt;margin:0pt 0pt 0pt 12.25pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,599,586</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 97,871</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.7pt;text-indent:-0.7pt;margin:0pt 0pt 0pt 12.25pt;">Changes in assets and liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 12pt;">Accounts Receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> (52,466)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 81,092</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 12pt;">Allowance Bad Debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 125,233</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 22,533</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 12pt;">Other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (958,865)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (23,164)</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 12pt;">Accounts payable &amp; accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 375,937</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 367,696</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 12pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">(458,667)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 535,977</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net cash flows used in operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(5,910,732)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1,844,395)</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash used for Investing Activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Purchase of property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(58,137)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(29,936)</p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from Financing Activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Proceeds from Canada Emergency Business Loan Act</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> (2,754)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 47</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Proceeds from issuance of convertible promissory note payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,543,162</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,494,421</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Net cash flows from financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5,540,408</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,494,468</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 7.2pt;">Net change in cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(428,462)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (620,137)</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents, Beginning</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 699,320</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 79,183</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents, Ending</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 270,859</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 699,320</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-61</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_9b43bdbe_fe8e_401b_bfca_243e1c7d7c24"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ONEMEDNET CORPORATION</b></p><a id="NOTES3"></a><a id="NOTES_3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">1.&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies Nature of Operations</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">OneMedNet Corporation (the &#8220;Company&#8221;) is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. The Company was incorporated in Delaware on September&#160;20, 2006. The Company has been solely focused on creating solutions that simplify digital medical image management, exchange, and sharing. The Company has one wholly- owned subsidiary, OneMedNet Technologies (Canada)&#160;Inc., incorporated on October&#160;16, 2015 under the provisions of the Business Corporations Act of British Columbia whose functional currency is the Canadian dollar.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Basis of Presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements of the Company have been prepared on the basis of generally accepted accounting principles in the United States of America (US GAAP).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents consist of highly liquid, short-term investments with a maturity of three&#160;months or less when purchased. Cash equivalents consist of money market funds and are carried at cost, which approximates fair value. The balances, at times, may exceed FDIC Insured limits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Accounts Receivable</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Accounts receivable are unsecured, recorded at net realizable value, and do not bear interest. Accounts receivable are considered past due if not paid within the terms established between the Company and the customer. Amounts are only written off after all attempts at collections have been exhausted. The Company determines the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. As of December&#160;31, 2022 and 2021, the Company established allowances of $102,700 and $22,533 respectively. The net receivable balances outstanding are fully collectible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Property and Equipment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Property and equipment are recorded at cost. The straight-line method is used for computing depreciation and amortization. Assets are depreciated over their estimated useful lives ranging from three to five&#160;years. Cost of maintenance and repairs are charged to expense when incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Impairment of Long-Lived Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of an asset may not be fully recoverable. An impairment loss would be recognized when the estimated future cash flows from the use of the asset are less than the carrying amount of that asset. There have been no losses during the&#160;year ended December&#160;31, 2022 or 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Revenue Recognition</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Revenue from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to a customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-62</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">the unit of account under topic 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation in proportion to the standalone selling price for each and recognized as revenue when, or as, the performance obligation is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The steps the company uses to determine revenue recognition are as follows: identification of the contract with a customer, identification of the performance obligations, determining the transaction price, allocation of the transaction price to the performance obligation and recognition of revenue when the Company satisfies the performance obligation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Individual promised goods and services in a contract are considered a performance obligation and accounted for separately if the good or service is distinct. A good or service is considered distinct if the customer can benefit from the good or service on its own or with other resources that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company generates revenue from two streams: (1) iRWD (imaging Real World Data) which provides regulatory grade imaging and clinical data in the Pharmaceutical, Device Manufacturing, CRO&#8217;s and AI markets, and (2)&#160;BEAM which is a Medical Imaging Exchange platform between Hospital/Healthcare Systems, Imaging Centers, Physicians and Patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">iRWD is sold on a fixed fee basis based on the number of data units and the cost per data unit committed to in the customer contract. Revenue is recognized when the data is delivered to the customer. BEAM revenue is subscription-based revenue which is recognized ratably over the subscription period committed to by the customer. The company invoices its BEAM customers quarterly or annually in advance with the customer contracts automatically renewing unless the customer issues a cancellation notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company excludes from revenue taxes collected from a customer that are assessed by a governmental authority and imposed on and concurrent with a specific revenue-producing transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The transaction price for the products is the invoiced amount. Advanced billings from contracts are deferred and recognized as revenue when earned.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred revenue consists of payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. The Company receives payments from customers based upon contractual billing schedules. Accounts receivable is recorded when the right to consideration becomes unconditional. Payment terms on invoiced amounts typically range from zero to 90 days, with typical terms of 30 days.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial statement carrying amount and the tax basis of assets and liabilities. The Company provides for deferred taxes at the enacted tax rate that is expected to apply when the temporary differences reverse. The Company has recorded a full valuation allowance against the net deferred tax asset due to the uncertainty of realizing the related benefits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Patents and Trademarks</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Costs associated with the submission of a patent application are expensed as incurred given the uncertainty of the patents resulting in probable future economic benefits to the Company and are included in research and development expenses on the consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Research and Development</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Research and development expenditures were charged to operating expense as incurred for the&#160;years ended December&#160;31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-63</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Stock-based Compensation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has a stock-based compensation plan, which is described in more detail in Note&#160;8. The fair value of stock option and warrant grants are determined on the date of grant using the Black Scholes valuation model. Forfeitures of stock based awards are recorded as the actual forfeitures occur. Stock based compensation expense is recognized over the service period, net of estimated forfeitures, using the straight-line method.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">2025</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Equivalent Common Shares, 2009 Equity Plan</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">383,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">383,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">383,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">383,000</p></td></tr><tr><td style="vertical-align:bottom;width:51.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Equivalent Common Shares, 2020 Equity Plan</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">184,581</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">400,581</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">549,512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">648,000</p></td></tr><tr><td style="vertical-align:bottom;width:51.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">567,581</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">783,581</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">932,512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.27%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,031,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recent Accounting Pronouncements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June&#160;2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. The ASU also provides updated guidance regarding the impairment of available-for-sale debt securities and includes additional disclosure requirements. The new guidance is effective for fiscal periods beginning after December&#160;15, 2022. Early adoption is permitted. The Company is currently assessing the effect that ASU No.&#160;2016- 13 will have on its consolidated financial statements and related disclosures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company has issued convertible promissory notes with related party investors. In order to simplify, and provide less confusion, on accounting for debt with conversion options, FASB release ASU 2020-06 in August 2020. ASU 2020-06 simplifies the accounting for convertible instruments. The embedded conversion features are no longer separated from the debt with conversion features that are not required to be accounted for as derivatives under or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost and therefore will be accounted for as a single equity instrument measured at its historical cost. The Company has early adopted ASU 2020-06 and therefore a derivative liability has not been recorded.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_e0d55991_cb92_4240_bb71_bc93a26e56e0"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">2.&#160;&#160;&#160;&#160;Going Concern</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The Company does not have adequate liquidity to fund its operations through at least twelve&#160;months from the date these financial statements were available for issuance. The Company has an accumulated deficit of $31,877,221 (2021-$25,310,924) and has had negative cash flows from operating activities for the&#160;year ended December&#160;31, 2022. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To continue in existence and expand its operations, the Company will be required to, and management plans to, raise additional working capital through an equity or debt offering and ultimately attain profitable operations. If the Company is not able to raise additional working capital, it would have a material adverse effect on the operations of the Company and continuing research and development of its product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The Company&#8217;s continuation as a going concern is dependent upon its ability to continue receiving working capital cash payments and generating cash flow from operations.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-64</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_339617e8_bfb8_48bc_ac19_ea7a0cc5f9eb"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">3.&#160;&#160;&#160;&#160;Property and Equipment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Property and equipment are summarized as of December&#160;31:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Computers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 259,206</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 202,777</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Furniture and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,785</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,785</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 12.25pt;">Total Property and Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 262,991</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 206,562</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Less: accumulated depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (179,895)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (156,794)</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 12.25pt;">Net Property and Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 83,097</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 49,767</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Depreciation and amortization expense was $24,807 and $14,466 for the&#160;years ended December&#160;31, 2022 and 2021, respectively.</p><a id="_aa04ee48_6770_41ba_bc42_68896cec93ed"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">4.&#160;&#160;&#160;&#160;Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has generated both federal and state net operating losses (NOL) of approximately $21 million and $23 million, respectively, which if not used, will begin to expire in 2030. The Company believes that its ability to fully utilize the existing NOL carryforwards could be restricted on a portion of the NOL by changes in control that may have occurred or may occur in the future and by its ability to generate net income. The Company has not yet conducted a formal study of whether, or to what extent, past changes in control of the Company impairs its NOL carryforwards because such NOL carryforwards cannot be utilized until the Company achieves profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Components of deferred income taxes are as follows as of December&#160;31:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Net operating loss carry forward</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6,973,587</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,604,237</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Stock Compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">481,144</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 467,925</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">53,268</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 51,617</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Gross deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">7,507,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,123,778</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Less valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (7,507,999)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (6,123,778)</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The change in the valuation allowance was $1,384,220 and $764,878 for the years ended December 31, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effective tax rate for the&#160;years ended December&#160;31, 2022 and 2021 differs from the federal and state statutory rates due to the full valuation allowance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statement is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The tax&#160;years from inception through December&#160;31, 2022 remain subject to examination by all major taxing authorities due to the net operating loss carryovers. The Company is not currently under examination by any taxing jurisdiction. The Company did not incur any interest or penalties during the&#160;years ended December&#160;31, 2022 or 2021.</p><a id="_8cfb29ca_369b_499f_90be_799c103e8744"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">5.&#160;&#160;&#160;&#160;Convertible Promissory Notes&#160;held by Related Party</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">During 2022, the Company entered into various Convertible Promissory Notes (&#8220;Note&#8221;) with related party investors totaling $4,700,000 (2020&#8201;&#8212;&#8201;$2,300,000) and unrelated party investors of $440,000. The Notes issued are unsecured and bear an interest rate of six percent annually from the date of issuance until the outstanding principal is paid or converted. On November 11, 2022 the Convertible note agreement was amended and restated in order to (i) provide for the sale and issuance to Purchasers from the effective date of January 1, 2022 and after the date of this Agreement of up to an additional $3,000,000 aggregate principal amount of Notes and warrants to purchase shares of the Company&#8217;s capital stock, (ii) provide for the sale and issuance to Purchasers who purchased Notes under the Prior Agreement between the Effective Date and the date of this Agreement of warrants to purchase shares of the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-65</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Company&#8217;s common stock at an exercise price of $1.00 per share; (iii) extend the maturity date of all outstanding Notes from December 31, 2022 to March 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The principal and unpaid accrued interest on each Note will convert; (i) automatically, upon the Company&#8217;s issuance of equity securities (the &#8220;Next Equity Financing&#8221;) in a single transaction, or series of related transactions, with aggregate gross proceeds to the Company of at least $5,000,000, into shares of the Company&#8217;s capital stock issued to investors in the Next Equity Financing, at a conversion price equal to the lesser of (A) a 20% discount to the lowest price per share of shares sold in the Next Equity Financing, or (B) $2.50 per share; (ii) at the noteholder&#8217;s option, in the event of a defined Corporate Transaction while such Note remains outstanding, into shares of the Company&#8217;s Series A-2 Preferred Stock at a conversion price equal to $2.50 per share; and (iii) at the noteholder&#8217;s option, on or after the Maturity Date while such Note remains outstanding, into shares of the Company&#8217;s Series A-2 Preferred Stock at a conversion price equal to $2.50 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a Corporate Transaction occurs before the repayment or conversion of the Notes, the Company will pay at the closing of the Corporate Transaction to each noteholder that elects not to convert its Notes&#160;in connection with such Corporate Transaction an amount equal to the outstanding principal amount of such noteholder&#8217;s Note&#160;plus a 20% premium. &#8220;Corporate Transaction&#8221; means (a)&#160;a sale by the Company of all or substantially all of its assets, (b)&#160;a merger of the Company with or into another entity (if after such merger the holders of a majority of the Company&#8217;s voting securities immediately prior to the transaction do not hold a majority of the voting securities of the successor entity) or (c)&#160;the transfer of more than 50% of the Company&#8217;s voting securities to a person or group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During November&#160;2019, the Company entered into a Convertible Promissory Note&#160;(&#8220;Note&#8221;) agreement with a related party investor. The total amount of the Note&#160;is $1,500,000. The Note&#160;is unsecured and bears interest at a rate of four&#160;percent annually from the date of issuance until the outstanding principal is paid or converted. The Note&#160;matures on January&#160;1, 2025. The Note&#160;shall automatically convert into the next offering of preferred stock upon closing of such next equity financing. The number of shares of preferred stock to be issued upon conversion shall be equal to the number obtained by dividing the outstanding principal and unpaid accrued interest owed on the date of conversion, by the conversion price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The conversion price is 100&#160;percent of the lowest price per share paid for the next equity preferred stock by other investors in the next equity financing. In the event that prior to the conversion or repayment of amounts owed, the Company completes a financing transaction in which the Company sells equity securities but such transaction does not qualify as next equity financing (i.e., an &#8220;alternative financing&#8221;), then the principal and unpaid accrued interest may (upon written election of the purchaser holding the Note) convert into the securities issued by the Company in the alternative financing. The number of alternative financing equity securities to be issued upon such conversion shall be equal to the number obtained by dividing the outstanding principal and unpaid accrued interest owed by an amount equal to 100&#160;percent multiplied by the lowest price per share at which the alternative financing equity securities are sold and issued for cash in the alternative financing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and December 31, 2021, there was $9,990 000 and $4,850,000 in outstanding principal balance on the Notes, respectively, and $690,771 and $287,609 in accrued interest, respectively, all included in long-term liabilities on the balance sheet. There were no payments of principal or interest during 2022. In connection with the $5,140,000 in convertible notes issued in 2022, 2,056,000 in warrants were issued.</p><a id="_ffe93840_0b3e_4e8a_b021_99ee2267f086"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">6.&#160;&#160;&#160;&#160;Canadian Emergency Business Loan Act (CEBA)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During December&#160;2020, the Company applied for and received a $46,850 USD CEBA loan. The loan was provided by the Government of Canada to provide capital to organizations to see them through the current challenges and better position them to return to providing services and creating employment. The loan is unsecured. The loan is interest free to December&#160;31, 2023. If the loan is paid back by December&#160;31, 2023, $15,617 of the loan will be forgiven. If the loan is not paid back by December&#160;31, 2023, the full $46,850 loan will be converted to loan repayable over three&#160;years with a 5% interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounted for the loan as debt in accordance with FASB Accounting Standards Codification 470 Debt and accrued interest in accordance with the interest method under FASB ASC 835-30. Full or partial loan forgiveness with legal release reduces the liability by the amount forgiven and record a gain on extinguishment in the statement of operations.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-66</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ed109321_8809_4537_b253_9bd0b0b228bc"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">7.&#160;&#160;&#160;&#160;Shareholders&#8217; Equity Series&#160;A-2 Preferred Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Series&#160;A-2 preferred stock includes a $0.15 per share annual noncumulative dividend when and if declared by the board of directors. No dividends have been declared as of both December&#160;31, 2022 or 2021. The Series&#160;A-2 preferred stock also includes a liquidation preference of 1.25 times the original issue price plus any declared but unpaid dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and have a preference upon liquidation over Series&#160;A-1 preferred stock and common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Each share of Series&#160;A-2 preferred stock may be converted into equal shares of common stock at the option of the holder at any time. In addition, the Series&#160;A-2 preferred stock shares are automatically convertible into common shares upon the sale of shares of common stock to the public at the then applicable conversion price in a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $20 million in proceeds, net of underwriting discounts and commissions. Each share of Series&#160;A-2 preferred stock has voting rights equal to the number of shares of common stock then issuable upon conversion of such share of preferred stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is obligated to redeem shares of Series&#160;A-2 Preferred Stock in the occurrence of a Deemed Liquidation Event unless a majority of the holders of Series&#160;A-2 Preferred Stock and a majority of the Series&#160;A-1 Preferred Stock consent otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Series&#160;A-1 Preferred Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Series&#160;A-1 preferred stock includes a $0.15 per share annual noncumulative dividend when and if declared by the board of directors. No dividends have been declared as of both December&#160;31, 2022 or 2021. The Series&#160;A-1 preferred stock also includes a liquidation preference of 1.25 times the original issue price plus any declared but unpaid dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and have a preference upon liquidation over common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Each share of Series&#160;A-1 preferred stock may be converted into equal shares of common stock at the option of the holder at any time. In addition, the Series&#160;A-1 preferred stock shares are automatically convertible into common shares upon the sale of shares of common stock to the public at the then applicable conversion price in a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $20 million in proceeds, net of underwriting discounts and commissions. Each share of Series&#160;A-1 preferred stock has voting rights equal to the number of shares of common stock then issuable upon conversion of such share of preferred stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is obligated to redeem shares of Series&#160;A-1 Preferred Stock in the occurrence of a Deemed Liquidation Event unless a majority of the holders of Series&#160;A-1 Preferred Stock consent otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Common Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2022, in connection with services performed by the Board of Directors common shares of 100,000 for 2021 and 100,000 for 2022 were issued at $1.00 per share. These were expensed as general and administrative expenses in the statement of operations.</p><a id="_8007c482_969d_4fd3_b80b_e0444b3dd545"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">8.&#160;&#160;&#160;&#160;&#160;Stock Options</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During 2020, the Company adopted a new equity incentive plan (the Plan), which provides for the granting of incentive and nonqualified stock options to employees, directors, and consultants. As of December&#160;31, 2020, the Company has reserved 3,000,000 shares of common stock under the Plan. The Company believes that such awards better align the interests of its employees with those of its stockholders. Option awards are generally granted with an exercise price equal to the fair market value of the Company&#8217;s stock at the date of grant; those option awards generally vest with a range of one to four&#160;years of continuous service and have ten-year contractual terms. As there is no public data available for the share price valuation, the Company considers the Fair Market Value of $1 to be on the conservative side and similar to the exercise price. Certain option awards provide for accelerated vesting if there is a change in control, as defined in the Plan. The Plan also permits the granting of restricted stock and other stock-based awards. Unexercised options are cancelled upon termination of employment and become available under the Plan.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-67</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Information with respect to options outstanding is summarized as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise&#160;Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic&#160;Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Outstanding as of December 31, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,995,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,995,000</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Granted &#8211; under the Plan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">25,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Cancelled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1,072,816)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Outstanding as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 947,184</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 947,184</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Granted &#8211; under the Plan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 577,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> (7,500)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Cancelled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (485,684)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Outstanding as of December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,031,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Options exercisable as of December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 567,581</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 567,581</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, there were 1,031,000 and 947,184 common stock options outstanding with a weighted average remaining contractual life of 7.11 years and 6.01 years, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, there were 567,581 and 723,431 common stock options exercisable at a weighted average remaining contractual life of 5.56 years and 5.27 years, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Black Scholes Assumptions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The determination of the fair value of stock options using an option valuation model is affected by the Company&#8217;s stock price valuation, as well as assumptions regarding a number of complex and subjective variables. The volatility assumption is based on volatilities of similar companies over a period of time equal to the expected term of the stock options. The volatilities of similar companies are used in conjunction with the Company&#8217;s historical volatility because of the lack of sufficient relevant history for the Company&#8217;s common stock equal to the expected term. The expected term of the employee stock options represents the weighted average period for which the stock options are expected to remain outstanding. The expected term assumption is estimated based primarily on the options&#8217; vesting terms and remaining contractual life and employees&#8217; expected exercise and post- vesting employment termination behavior. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield assumption is based on the expectation of no future dividend payouts by the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The fair value of the Company&#8217;s stock options was estimated assuming no expected dividends and the following weighted average assumptions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2011</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected life in years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5.89</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6.08</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.55</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 60</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The total expense recognized for share-based payments was $45,584 and $47,071 for the years ended December 31, 2022 and 2021, respectively. These costs are included in the statements of operations. As of December 31, 2022, there was $75,987 of unrecognized compensation costs related to stock option grants which will be recognized over the next four years.</p><a id="_c924c774_6a1c_40fe_bf92_27815593c70d"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">9.&#160;&#160;&#160;&#160;&#160;Stock Warrants</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2021, there were 174,102 outstanding common stock warrants issued for service at a weighted average exercise price of $0.10. The weighted average remaining contractual life was 4.46 years as of December 31, 2022.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-68</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2022 for the exercise price of $1.00, the company issued 145,746 warrants for 2021 service and 294,000 warrants for 2022 service, 2,056,000 in warrants were issued attached to convertible notes. The weighted average remaining contractual life of the warrants issued in 2022 is 4.49 years. All warrants vested immediately upon grant issuance. The Company expensed $1,346,288 in 2022 in relation to the issuance of the Warrants.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:10.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">2025</b></p></td><td style="vertical-align:top;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.15pt;">2026</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Equivalent Common Shares, 2020 Grants</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.54%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td><td style="vertical-align:top;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:10.65%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">174,102</p></td></tr><tr><td style="vertical-align:bottom;width:44.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Equivalent Common Shares, 2021 Grants</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,746</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,746</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,746</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">145,746</p></td><td style="vertical-align:top;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:44.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:0.2pt;">Equivalent Common Shares, 2022 Grants</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td><td style="vertical-align:top;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:10.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,310,000</p></td></tr><tr><td style="vertical-align:bottom;width:44.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.54%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,629,848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,629,848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,629,848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,629,848</p></td><td style="vertical-align:top;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:10.65%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2,484,102</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Black Scholes Assumptions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The determination of the fair value of common stock warrants using an option valuation model is affected by the Company&#8217;s stock price valuation, as well as assumptions regarding a number of complex and subjective variables. The volatility assumption is based on volatilities of similar companies over a period of time equal to the expected term of the common stock warrants. The volatilities of similar companies are used in conjunction with the Company&#8217;s historical volatility because of the lack of sufficient relevant history for the Company&#8217;s common stock equal to the expected term. The expected term of the common stock warrants represents the weighted average period for which the common stock warrants are expected to remain outstanding. The expected term assumption is estimated based primarily on the options&#8217; vesting terms and remaining contractual life. The risk-free rate for periods within the contractual life of the common stock warrant is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield assumption is based on the expectation of no future dividend payouts by the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The fair value of the Company&#8217;s common stock warrants was estimated assuming no expected dividends and the following weighted average assumptions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected life in years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">3.88</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected Dividend Yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 60</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_57a01ec9_6eb7_4b55_8f65_298711f7aa79"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">10.&#160;&#160;&#160;&#160;&#160;Commitments, Contingencies, and Concentrations Operating lease</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has a month-to-month lease for a suite at a cost of $575 per month. As well, as part of an employment agreement with the Chief Commercial Officer, rent of $450 a month is reimbursed for the lease this individual personally has for office space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company incurred $7,694 and $6,660 of rent expense, including common tenant costs and cancellation costs, during the years ended December 31, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_51b4edd7_8a97_4bf3_a084_b26fecad5c39"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">11.&#160;&#160;&#160;&#160;&#160;Receivable from SPAC for IPO Related Costs</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During 2022, the company entered a Business Combination Agreement with SPAC Data Knights. $900,152 of SPAC related expenses are on the Balance Sheet as receivable to be received at close of the merger.</p><a id="_c75cca5d_fc52_483e_a5c1_eb8ca450d5b7"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">12.&#160;&#160;&#160;&#160;&#160;Subsequent Events</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has evaluated subsequent events occurring through March 20, 2023, the date the financial statements were available for issuance, for events requiring recording or disclosure in the Company&#8217;s financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">During 2023 to the date of this report, the Company issued $750,000 of additional convertible promissory notes to investors in exchange for cash. These promissory notes are unsecured and contain an interest rate of 6% per annum. The notes mature on March 31, 2023. The notes provide for automatic conversion of the principal and interest of the notes into shares of the next preferred stock financing round upon the subsequent receipt of proceeds from the sale of stock in excess of $5,000,000, as defined in the bridge loan agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-69</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_74fc6bc3_eca4_471c_9e86_c8016c7ad8ac"></a><a id="AnnexA_191082"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:right;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Annex A</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FIRST AMENDMENT TO THE</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">SECOND AMENDED AND RESTATED</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">CERTIFICATE OF INCORPORATION OF</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">[</b><span style="font-family:'Symbol';">&#183;</span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">], 2023</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:20pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the &#8220;</span><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Corporation</span><span style="font-family:'Times New Roman','Times','serif';">&#8221;), DOES HEREBY CERTIFY AS FOLLOWS:</span></p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The name of the Corporation is &#8220;Data Knights Acquisition Corp.&#8221; The original certificate of incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on February&#160;8, 2021, was amended and restated on March&#160;8, 2021 by the First Amended and Restated Certificate, and was amended and restated on April&#160;6, 2021 by the Second Amended and Restated Certificate (the &#8220;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Certificate</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;).</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">This First Amendment to the Certificate, which restates and amends the provisions of the Certificate, was duly adopted in accordance with Sections&#160;228, 242 and 245 of the General Corporation Law of the State of Delaware, as amended from time to time (the &#8220;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">DGCL</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;)</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">This First Amendment to the Certificate shall become effective on the date of filing with the Secretary of State of Delaware.</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Section&#160;9.2(a) of the Certificate is hereby amended and restated in its entirety to read as follows:</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Prior to the consummation of the initial Business Combination, the Corporation shall provide all holders of Offering Shares with the opportunity to have their Offering Shares redeemed upon the consummation of the initial Business Combination pursuant to, and subject to the limitations of, Sections&#160;9.2(b) and 9.2(c) (such rights of such holders to have their Offering Shares redeemed pursuant to such Sections, the &#8220;Redemption Rights&#8221;) hereof for cash equal to the applicable redemption price per share determined in accordance with Section&#160;9.2(b) hereof (the &#8220;Redemption Price&#8221;). Notwithstanding anything to the contrary contained in this Amended and Restated Certificate, there shall be no Redemption Rights or liquidating distributions with respect to any warrant issued pursuant to the Offering.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:20pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">IN WITNESS WHEREOF, Data Knights Acquisition Corp. has caused this First Amendment to the Certificate to be duly executed and acknowledged in its name and on its behalf by an authorized officer as of the date first set forth above.</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:39.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:39.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:6.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:39.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:39.72%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td></tr><tr><td style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:39.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">A-1</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_d3c4b558_615a_461f_aadd_df627da9bb91"></a><a id="Annex_B"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Annex B</b></p><a id="AGREEMENTANDPLANOFMERGER_839005"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">AGREEMENT AND PLAN OF MERGER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">by and among</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data Knights Acquisition Corp.</b>,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">as the Purchaser,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data Knights Merger Sub, Inc.</b>,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">as Merger Sub,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data Knights, LLC</b>,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">in the capacity as the Purchaser Representative,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Paul Casey</b>,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">solely in his capacity as the Seller Representative,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b>,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">as the Company,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Dated as of April 25, 2022</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_c4e9c252_4aa4_450c_a367_e82a967e255e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.44pt 0pt;"><b style="font-weight:bold;">TABLE OF CONTENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:6.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Page</b></p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEI_873180"><span style="font-style:normal;font-weight:normal;">ARTICLE I. MERGER</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-2</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a11Merger_416295"><span style="font-style:normal;font-weight:normal;">1.1.&#160;&#160;&#160;&#160;&#160;Merger</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-2</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a12EffectiveTime_660503"><span style="font-style:normal;font-weight:normal;">1.2.&#160;&#160;&#160;&#160;&#160;Transaction Effective Time</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-2</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a13EffectoftheMerger_527930"><span style="font-style:normal;font-weight:normal;">1.3.&#160;&#160;&#160;&#160;&#160;Effect of the Merger</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-2</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a14TaxTreatment_820943"><span style="font-style:normal;font-weight:normal;">1.4.&#160;&#160;&#160;&#160;&#160;Tax Treatment</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-2</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a15CertificateofIncorporationandBylaws_3"><span style="font-style:normal;font-weight:normal;">1.5.&#160;&#160;&#160;&#160;&#160;Certificate of Incorporation and Bylaws</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-2</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a16DirectorsandOfficersoftheSurvivingCor"><span style="font-style:normal;font-weight:normal;">1.6.&#160;&#160;&#160;&#160;&#160;Directors and Officers of the Transaction Surviving Corporation</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-2</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a17MergerConsideration_432684"><span style="font-style:normal;font-weight:normal;">1.7.&#160;&#160;&#160;&#160;&#160;Merger Consideration</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-3</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a18ConversionofCompanyStock_629356"><span style="font-style:normal;font-weight:normal;">1.8.&#160;&#160;&#160;&#160;&#160;Conversion of Company Stock</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-3</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a19TreasuryStock_415363"><span style="font-style:normal;font-weight:normal;">1.9.&#160;&#160;&#160;&#160;&#160;Treasury Stock</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-3</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a110RightsCeasetoExist_601425"><span style="font-style:normal;font-weight:normal;">1.10.&#160;&#160;&#160;Rights Cease to Exist</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-3</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a111DissentingShares_646707"><span style="font-style:normal;font-weight:normal;">1.11.&#160;&#160;&#160;Dissenting Shares</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-4</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a112SurrenderofCompanySecuritiesandDisbu"><span style="font-style:normal;font-weight:normal;">1.12.&#160;&#160;&#160;Surrender of Company Securities and Disbursement of Merger Consideration</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-4</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a113EffectofTransactiononMergerSubStock_"><span style="font-style:normal;font-weight:normal;">1.13.&#160;&#160;&#160;Effect of Transaction on Merger Sub Stock</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-5</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a114ClosingCalculations_188103"><span style="font-style:normal;font-weight:normal;">1.14.&#160;&#160;&#160;Closing Calculations</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-5</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a115MergerConsiderationAdjustment_391877"><span style="font-style:normal;font-weight:normal;">1.15.&#160;&#160;&#160;Merger Consideration Adjustment</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-5</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a116TakingofNecessaryActionFurtherAction"><span style="font-style:normal;font-weight:normal;">1.16.&#160;&#160;&#160;Taking of Necessary Action; Further Action</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-6</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a117AppraisalandDissentersRights_313402"><span style="font-style:normal;font-weight:normal;">1.17.&#160;&#160;&#160;Appraisal and Dissenter&#8217;s Rights</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-7</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a118AmendedPurchaserCertificateofIncorpo"><span style="font-style:normal;font-weight:normal;">1.18.&#160;&#160;&#160;Amended Purchaser Certificate of Incorporation</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-7</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEII_863125"><span style="font-style:normal;font-weight:normal;">ARTICLE II. CLOSING</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-7</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a21Closing_869010"><span style="font-style:normal;font-weight:normal;">2.1.&#160;&#160;&#160;&#160;&#160;Closing</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-7</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEIII_29927"><span style="font-style:normal;font-weight:normal;">ARTICLE III. REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-7</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a31OrganizationandStanding_64614"><span style="font-style:normal;font-weight:normal;">3.1.&#160;&#160;&#160;&#160;&#160;Organization and Standing</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-7</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a32AuthorizationBindingAgreement_42023"><span style="font-style:normal;font-weight:normal;">3.2.&#160;&#160;&#160;&#160;&#160;Authorization; Binding Agreement</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-8</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a33GovernmentalApprovals_265283"><span style="font-style:normal;font-weight:normal;">3.3.&#160;&#160;&#160;&#160;&#160;Governmental Approvals</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-8</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a34NonContravention_494735"><span style="font-style:normal;font-weight:normal;">3.4.&#160;&#160;&#160;&#160;&#160;Non-Contravention</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-8</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a35Capitalization_78611"><span style="font-style:normal;font-weight:normal;">3.5.&#160;&#160;&#160;&#160;&#160;Capitalization</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-8</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a36SECFilingsandPurchaserFinancials_8483"><span style="font-style:normal;font-weight:normal;">3.6.&#160;&#160;&#160;&#160;&#160;SEC Filings and Purchaser Financials</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-9</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a37AbsenceofCertainChanges_872106"><span style="font-style:normal;font-weight:normal;">3.7.&#160;&#160;&#160;&#160;&#160;Absence of Certain Changes</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-10</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a38CompliancewithLaws_341668"><span style="font-style:normal;font-weight:normal;">3.8.&#160;&#160;&#160;&#160;&#160;Compliance with Laws</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-10</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a39ActionsOrdersPermits_616973"><span style="font-style:normal;font-weight:normal;">3.9.&#160;&#160;&#160;&#160;&#160;Actions; Orders; Permits</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-10</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a310TaxesandReturns_572126"><span style="font-style:normal;font-weight:normal;">3.10.&#160;&#160;&#160;Taxes and Returns</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-10</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a311EmployeesandEmployeeBenefitPlans_918"><span style="font-style:normal;font-weight:normal;">3.11.&#160;&#160;&#160;Employees and Employee Benefit Plans</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-11</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a312Properties_108604"><span style="font-style:normal;font-weight:normal;">3.12.&#160;&#160;&#160;Properties</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-11</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a313MaterialContracts_50633"><span style="font-style:normal;font-weight:normal;">3.13.&#160;&#160;&#160;Material Contracts</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-11</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a314TransactionswithAffiliates_961912"><span style="font-style:normal;font-weight:normal;">3.14.&#160;&#160;&#160;Transactions with Affiliates</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-11</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a315MergerSubActivities_751587"><span style="font-style:normal;font-weight:normal;">3.15.&#160;&#160;&#160;Merger Sub Activities</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-11</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a316InvestmentCompanyAct_844247"><span style="font-style:normal;font-weight:normal;">3.16.&#160;&#160;&#160;Investment Company Act</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-11</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a317FindersandBrokers_718030"><span style="font-style:normal;font-weight:normal;">3.17.&#160;&#160;&#160;Finders and Brokers</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-12</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a318OwnershipofStockholderMergerConsider"><span style="font-style:normal;font-weight:normal;">3.18.&#160;&#160;&#160;Ownership of Stockholder Merger Consideration</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-12</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a319CertainBusinessPractices_308628"><span style="font-style:normal;font-weight:normal;">3.19.&#160;&#160;&#160;Certain Business Practices</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-12</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a320Insurance_491699"><span style="font-style:normal;font-weight:normal;">3.20.&#160;&#160;&#160;Insurance</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-12</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a321PurchaserTrustAccount_359034"><span style="font-style:normal;font-weight:normal;">3.21.&#160;&#160;&#160;Purchaser Trust Account</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-12</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a322IndependentInvestigation_322138"><span style="font-style:normal;font-weight:normal;">3.22.&#160;&#160;&#160;Independent Investigation</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-13</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEIV_124659"><span style="font-style:normal;font-weight:normal;">ARTICLE IV. REPRESENTATIONS AND WARRANTIES OF THE COMPANY</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-13</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a41OrganizationandStanding_161585"><span style="font-style:normal;font-weight:normal;">4.1.&#160;&#160;&#160;&#160;&#160;Organization and Standing</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-13</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a42AuthorizationBindingAgreement_469814"><span style="font-style:normal;font-weight:normal;">4.2.&#160;&#160;&#160;&#160;&#160;Authorization; Binding Agreement</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-13</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a43Capitalization_440268"><span style="font-style:normal;font-weight:normal;">4.3.&#160;&#160;&#160;&#160;&#160;Capitalization</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-14</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.44pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-i</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_65b7c21b_6803_42b3_8172_8b1e8521387f"></a><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;margin:0pt;"><span style="white-space:pre-wrap;">                                       </span><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:6.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Page</b></p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a44Subsidiaries_960415"><span style="font-style:normal;font-weight:normal;">4.4.&#160;&#160;&#160;&#160;&#160;Subsidiaries</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-14</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a45GovernmentalApprovals_614722"><span style="font-style:normal;font-weight:normal;">4.5.&#160;&#160;&#160;&#160;&#160;Governmental Approvals</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-15</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a46NonContravention_795918"><span style="font-style:normal;font-weight:normal;">4.6.&#160;&#160;&#160;&#160;&#160;Non-Contravention</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-15</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a47FinancialStatements_812557"><span style="font-style:normal;font-weight:normal;">4.7.&#160;&#160;&#160;&#160;&#160;Financial Statements</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-15</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a48AbsenceofCertainChanges_820578"><span style="font-style:normal;font-weight:normal;">4.8.&#160;&#160;&#160;&#160;&#160;Absence of Certain Changes</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-16</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a49CompliancewithLaws_264470"><span style="font-style:normal;font-weight:normal;">4.9.&#160;&#160;&#160;&#160;&#160;Compliance with Laws</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-16</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a410CompanyPermits_772776"><span style="font-style:normal;font-weight:normal;">4.10.&#160;&#160;&#160;Company Permits</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-17</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a411Litigation_353313"><span style="font-style:normal;font-weight:normal;">4.11.&#160;&#160;&#160;Litigation</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-17</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a412MaterialContracts_115393"><span style="font-style:normal;font-weight:normal;">4.12.&#160;&#160;&#160;Material Contracts</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-17</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a413IntellectualProperty_48027"><span style="font-style:normal;font-weight:normal;">4.13.&#160;&#160;&#160;Intellectual Property</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-18</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a414TaxesandReturns_889224"><span style="font-style:normal;font-weight:normal;">4.14.&#160;&#160;&#160;Taxes and Returns</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-20</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a415RealProperty_461502"><span style="font-style:normal;font-weight:normal;">4.15.&#160;&#160;&#160;Real Property</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-21</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a416PersonalProperty_569101"><span style="font-style:normal;font-weight:normal;">4.16.&#160;&#160;&#160;Personal Property</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-21</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a417TitletoandSufficiencyofAssets_577619"><span style="font-style:normal;font-weight:normal;">4.17.&#160;&#160;&#160;Title to and Sufficiency of Assets</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-22</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a418EmployeeMatters_820038"><span style="font-style:normal;font-weight:normal;">4.18.&#160;&#160;&#160;Employee Matters</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-22</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a419BenefitPlans_169045"><span style="font-style:normal;font-weight:normal;">4.19.&#160;&#160;&#160;Benefit Plans</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-23</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a420EnvironmentalMatters_640656"><span style="font-style:normal;font-weight:normal;">4.20.&#160;&#160;&#160;Environmental Matters</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-24</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a421TransactionswithRelatedPersons_42368"><span style="font-style:normal;font-weight:normal;">4.21.&#160;&#160;&#160;Transactions with Related Persons</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-24</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a422Insurance_206926"><span style="font-style:normal;font-weight:normal;">4.22.&#160;&#160;&#160;Insurance</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-24</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a423BooksandRecords_27928"><span style="font-style:normal;font-weight:normal;">4.23.&#160;&#160;&#160;Books and Records</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-25</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a424TopCustomersandSuppliers_741680"><span style="font-style:normal;font-weight:normal;">4.24.&#160;&#160;&#160;Top Customers and Suppliers</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-25</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a425CertainBusinessPractices_743948"><span style="font-style:normal;font-weight:normal;">4.25 &#160;&#160;&#160;Certain Business Practices</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-25</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a426CompliancewithPrivacyLawsPrivacyPoli"><span style="font-style:normal;font-weight:normal;">4.26.&#160;&#160;&#160;Compliance with Privacy Laws, Privacy Policies and Certain Contracts</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-26</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a427InvestmentCompanyAct_995641"><span style="font-style:normal;font-weight:normal;">4.27.&#160;&#160;&#160;Investment Company Act</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-26</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a428FindersandBrokers_854976"><span style="font-style:normal;font-weight:normal;">4.28.&#160;&#160;&#160;Finders and Brokers</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-26</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a429IndependentInvestigation_791588"><span style="font-style:normal;font-weight:normal;">4.29.&#160;&#160;&#160;Independent Investigation</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-26</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a430InformationSupplied_159928"><span style="font-style:normal;font-weight:normal;">4.30.&#160;&#160;&#160;Information Supplied</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-26</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a431Disclosure_13559"><span style="font-style:normal;font-weight:normal;">4.31.&#160;&#160;&#160;Disclosure</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-27</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEV_959013"><span style="font-style:normal;font-weight:normal;">ARTICLE V. COVENANTS</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-27</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a51AccessandInformation_659606"><span style="font-style:normal;font-weight:normal;">5.1.&#160;&#160;&#160;&#160;&#160;Access and Information</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-27</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a52ConductofBusinessoftheCompany_77329"><span style="font-style:normal;font-weight:normal;">5.2.&#160;&#160;&#160;&#160;&#160;Conduct of Business of the Company</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-28</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a53ConductofBusinessofthePurchaser_57672"><span style="font-style:normal;font-weight:normal;">5.3.&#160;&#160;&#160;&#160;&#160;Conduct of Business of the Purchaser</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-30</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a54AnnualandInterimFinancialStatements_6"><span style="font-style:normal;font-weight:normal;">5.4.&#160;&#160;&#160;&#160;&#160;Annual and Interim Financial Statements</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-32</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a55PurchaserPublicFilings_827478"><span style="font-style:normal;font-weight:normal;">5.5.&#160;&#160;&#160;&#160;&#160;Purchaser Public Filings</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-32</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a56NoSolicitation_492644"><span style="font-style:normal;font-weight:normal;">5.6.&#160;&#160;&#160;&#160;&#160;No Solicitation</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-32</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a57NoTrading_392133"><span style="font-style:normal;font-weight:normal;">5.7.&#160;&#160;&#160;&#160;&#160;No Trading</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-33</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a58NotificationofCertainMatters_494615"><span style="font-style:normal;font-weight:normal;">5.8.&#160;&#160;&#160;&#160;&#160;Notification of Certain Matters</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-33</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a59Efforts_892936"><span style="font-style:normal;font-weight:normal;">5.9.&#160;&#160;&#160;&#160;&#160;Efforts</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-33</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a510TaxMatters_60719"><span style="font-style:normal;font-weight:normal;">5.10.&#160;&#160;&#160;Tax Matters</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-34</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a511FurtherAssurances_143385"><span style="font-style:normal;font-weight:normal;">5.11.&#160;&#160;&#160;Further Assurances</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-35</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a512TheRegistrationStatement_106156"><span style="font-style:normal;font-weight:normal;">5.12.&#160;&#160;&#160;The Registration Statement</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-35</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a513CompanyStockholderApproval_654474"><span style="font-style:normal;font-weight:normal;">5.13.&#160;&#160;&#160;Company Stockholder Meeting</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-36</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a514PublicAnnouncements_553037"><span style="font-style:normal;font-weight:normal;">5.14.&#160;&#160;&#160;Public Announcements</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-36</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a515ConfidentialInformation_574282"><span style="font-style:normal;font-weight:normal;">5.15.&#160;&#160;&#160;Confidential Information</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-37</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a516DocumentsandInformation_17856"><span style="font-style:normal;font-weight:normal;">5.16.&#160;&#160;&#160;Documents and Information</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-38</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a517PostClosingBoardofDirectorsandExecut"><span style="font-style:normal;font-weight:normal;">5.17.&#160;&#160;&#160;Post-Closing Board of Directors and Executive Officers</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-38</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a518IndemnificationofDirectorsandOfficer"><span style="font-style:normal;font-weight:normal;">5.18.&#160;&#160;&#160;Indemnification of Officers and Directors; Tail Insurance</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-38</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a519TrustAccountProceedsExpenses_134501"><span style="font-style:normal;font-weight:normal;">5.19.&#160;&#160;&#160;Trust Account Proceeds</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-39</p></td></tr><tr><td style="vertical-align:bottom;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a520PIPEInvestment_714350"><span style="font-style:normal;font-weight:normal;">5.20.&#160;&#160;&#160;PIPE Investment</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-39</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-ii</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:6.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Page</b></p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEVI_21984"><span style="font-style:normal;font-weight:normal;">ARTICLE VI. SURVIVAL AND INDEMNIFICATION</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-40</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a61NoSurvival_770255"><span style="font-style:normal;font-weight:normal;">6.1. &#160;&#160;&#160;&#160;Survival</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-40</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEVII_407690"><span style="font-style:normal;font-weight:normal;">ARTICLE VII. CLOSING CONDITIONS</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-40</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a71ConditionstoEachPartysObligations_232"><span style="font-style:normal;font-weight:normal;">7.1. &#160;&#160;&#160;&#160;Conditions of Each Party&#8217;s Obligations</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-40</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a72ConditionstoObligationsoftheCompany_6"><span style="font-style:normal;font-weight:normal;">7.2. &#160;&#160;&#160;&#160;Conditions to Obligations of the Company</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-41</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a73ConditionstoObligationsofthePurchaser"><span style="font-style:normal;font-weight:normal;">7.3. &#160;&#160;&#160;&#160;Conditions to Obligations of the Purchaser</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-42</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a74FrustrationofConditions_246877"><span style="font-style:normal;font-weight:normal;">7.4. &#160;&#160;&#160;&#160;Frustration of Conditions</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-43</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEVIII_524256"><span style="font-style:normal;font-weight:normal;">ARTICLE VIII. TERMINATION AND EXPENSES</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-43</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a81Termination_394572"><span style="font-style:normal;font-weight:normal;">8.1. &#160;&#160;&#160;&#160;Termination</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-43</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a82EffectofTermination_645381"><span style="font-style:normal;font-weight:normal;">8.2. &#160;&#160;&#160;&#160;Effect of Termination</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-44</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a83FeesandExpenses_202919"><span style="font-style:normal;font-weight:normal;">8.3. &#160;&#160;&#160;&#160;Fees and Expenses</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-44 </p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEIX_637818"><span style="font-style:normal;font-weight:normal;">ARTICLE IX. WAIVERS AND RELEASES</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-45</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a91WaiverofClaimsAgainstTrust_484382"><span style="font-style:normal;font-weight:normal;">9.1. &#160;&#160;&#160;&#160;Waiver of Claims Against Trust</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-45</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEX_755374"><span style="font-style:normal;font-weight:normal;">ARTICLE X. MISCELLANEOUS</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-45</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a101Notices_293594"><span style="font-style:normal;font-weight:normal;">10.1. &#160;&#160;&#160;&#160;Notices</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-45</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a102BindingEffectAssignment_659465"><span style="font-style:normal;font-weight:normal;">10.2. &#160;&#160;&#160;&#160;Binding Effect; Assignment</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-47</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a103ThirdParties_195519"><span style="font-style:normal;font-weight:normal;">10.3. &#160;&#160;&#160;&#160;Third Parties</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-47</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a104Arbitration_743713"><span style="font-style:normal;font-weight:normal;">10.4. &#160;&#160;&#160;&#160;Arbitration</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-47</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a105GoverningLawJurisdiction_453486"><span style="font-style:normal;font-weight:normal;">10.5. &#160;&#160;&#160;&#160;Governing Law; Jurisdiction</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-48</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a106WAIVEROFJURYTRIAL_943780"><span style="font-style:normal;font-weight:normal;">10.6. &#160;&#160;&#160;&#160;WAIVER OF JURY TRIAL</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-48</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a107SpecificPerformance_427382"><span style="font-style:normal;font-weight:normal;">10.7. &#160;&#160;&#160;&#160;Specific Performance</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-48</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a108Severability_296646"><span style="font-style:normal;font-weight:normal;">10.8. &#160;&#160;&#160;&#160;Severability</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-48</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a109Amendment_65500"><span style="font-style:normal;font-weight:normal;">10.9. &#160;&#160;&#160;&#160;Amendment</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-49</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a1010Waiver_591213"><span style="font-style:normal;font-weight:normal;">10.10. &#160;&#160;Waiver</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-49</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a1011EntireAgreement_193351"><span style="font-style:normal;font-weight:normal;">10.11. &#160;&#160;Entire Agreement</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-49</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a1012Interpretation_303791"><span style="font-style:normal;font-weight:normal;">10.12. &#160;&#160;Interpretation</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-49</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a1013Counterparts_49665"><span style="font-style:normal;font-weight:normal;">10.13. &#160;&#160;Counterparts</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-50</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a1014PurchaserRepresentative_777239"><span style="font-style:normal;font-weight:normal;">10.14. &#160;&#160;Purchaser Representative</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-50</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a1015SellerRepresentative_702611"><span style="font-style:normal;font-weight:normal;">10.15. &#160;&#160;Seller Representative</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-51</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a1016LegalRepresentation_295025"><span style="font-style:normal;font-weight:normal;">10.16. &#160;&#160;Legal Representation</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-52</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ARTICLEXI_860860"><span style="font-style:normal;font-weight:normal;">ARTICLE XI. DEFINITIONS</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-52</p></td></tr><tr><td style="vertical-align:top;width:91.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a111CertainDefinitions_763607"><span style="font-style:normal;font-weight:normal;">11.1.&#160;&#160;&#160;&#160;&#160;Certain Definitions</span></a></p></td><td style="vertical-align:top;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-52</p></td></tr><tr><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a112SectionReferences_974920"><span style="font-style:normal;font-weight:normal;">11.2.&#160;&#160;&#160;&#160;&#160;Section References</span></a></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">B-61</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-iii</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_dbf89ee9_cbef_4818_8b01_6be60f238d77"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.44pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">INDEX OF EXHIBITS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Exhibit</b></p></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:88.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit A</p></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Form of Voting Agreement</p></td></tr><tr><td style="vertical-align:bottom;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit B</p></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Form of Sponsor Support Agreement </p></td></tr><tr><td style="vertical-align:bottom;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit C</p></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Form of Lock-Up Agreement</p></td></tr><tr><td style="vertical-align:bottom;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit D</p></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Form of Non-Competition and Non-Solicitation Agreement </p></td></tr><tr><td style="vertical-align:bottom;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit E</p></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Form of Letter of Transmittal</p></td></tr><tr><td style="vertical-align:bottom;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit F</p></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Form of Equity Incentive Plan</p></td></tr><tr><td style="vertical-align:bottom;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit G</p></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Form of Registration Rights Agreement </p></td></tr><tr><td style="vertical-align:bottom;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit H</p></td><td style="vertical-align:top;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Extension Escrow Agreement</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-iv</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_618944f8_e952_402b_a9f1_757cfe354050"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AGREEMENT AND PLAN OF MERGER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Agreement and Plan of Merger (this &#8220;<span style="font-style:italic;font-weight:bold;">Agreement</span>&#8221;) is made and entered into as of April 25, 2022 (the &#8220;<span style="font-style:italic;font-weight:bold;">Effective Date</span>&#8221;) by and among (i) <b style="font-weight:bold;">Data Knights Acquisition Corp.</b>, a company incorporated in Delaware (together with its successors, the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser</span>&#8221;), (ii) Data Knights Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Purchaser (&#8220;<span style="font-style:italic;font-weight:bold;">Merger Sub</span>&#8221;<i style="font-style:italic;">)</i>, (iii) Data Knights, LLC, a Delaware limited liability company in the capacity as the representative from and after the Effective Time (as defined below) for the stockholders of the Purchaser (other than the Company Security Holders (as defined below) as of immediately prior to the Effective Time and their successors and assignees) in accordance with the terms and conditions of this Agreement (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Representative</span>&#8221;), (iv) Paul Casey, solely in his capacity as the representative from and after the Effective Time for the Company Stockholders (as defined below) as of immediately prior to the Effective Time in accordance with the terms and conditions of this Agreement (the &#8220;<span style="font-style:italic;font-weight:bold;">Seller Representative</span>&#8221;), and (v) <b style="font-weight:bold;">OneMedNet Corporation</b>, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;). The Purchaser, Merger Sub, the Purchaser Representative, the Seller Representative and the Company are sometimes referred to herein individually as a &#8220;<span style="font-style:italic;font-weight:bold;">Party</span>&#8221; and, collectively, as the &#8220;<span style="font-style:italic;font-weight:bold;">Parties.</span>&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">RECITALS:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A.</span></span>The Company, directly and indirectly through its subsidiaries, develops healthcare imaging solutions that provide regulatory-grade real world data for use in discovery, development, regulatory approval, and post-market surveillance in the life sciences industry;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">B.</span></span>The Purchaser owns all of the issued and outstanding capital stock of Merger Sub, which was formed for the sole purpose of the Merger (as defined below);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">C.</span></span>The Parties intend to effect the merger of Merger Sub with and into the Company, with the Company continuing as the surviving entity (the &#8220;<span style="font-style:italic;font-weight:bold;">Merger</span>&#8221;), as a result of which all of the issued and outstanding capital stock of the Company immediately prior to the Effective Time, shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, and shall be exchanged for the right for each Company Stockholder to receive its Pro Rata Share (as defined herein) of the Stockholder Merger Consideration (as defined herein), all upon the terms and subject to the conditions set forth in this Agreement and in accordance with the applicable provisions of the DGCL, all in accordance with the terms of this Agreement;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">D.</span></span>The boards of directors of the Company, the Purchaser and Merger Sub have each (i) determined that the Merger is fair, advisable and in the best interests of their respective companies and stockholders, (ii) approved this Agreement and the transactions contemplated hereby, including the Merger, upon the terms and subject to the conditions set forth herein, and (iii) determined to recommend to their respective stockholders the approval and adoption of this Agreement and the transactions contemplated hereby, including the Merger;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">E.</span></span>The Purchaser has received voting and support agreements in the form attached as <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</span> hereto (collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Voting Agreements</span>&#8221;) signed by the Company, its executive officers and directors, and the Significant Company Holders (as defined herein) sufficient to approve the Merger and the other transactions contemplated by this Agreement;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">F.</span></span>Contemporaneously with the execution of, and as a condition and an inducement to the Purchaser and the Company entering into this Agreement, specified stockholders of Purchaser are entering into and delivering Support Agreements, substantially in the form attached hereto as <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit B</span> (each, a &#8220;<span style="font-style:italic;font-weight:bold;">Sponsor Support Agreement</span>&#8221;), pursuant to which each such Purchaser stockholder has agreed (x) not to transfer or redeem any shares of Purchaser Common Stock held by such Purchaser stockholder in accordance with the Insider Letter, (y) to vote in favor of this Agreement and the Merger at the Purchaser Special Meeting in accordance with the Insider Letter and (z) to waive any adjustment to the conversion ratio set forth in the Purchaser Certificate of Incorporation or any other anti-dilution or similar protection with respect to the Purchaser Class B Common Stock (whether resulting from the transactions contemplated hereby, by the Ancillary Documents or by any other transaction consummated in connection with the transactions contemplated hereby);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">G.</span></span>Simultaneously with the execution and delivery of this Agreement, (a) the Significant Company Holders have each entered into a Lock- Up Agreement with Purchaser and the Purchaser Representative, the form of which is attached as <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit C</span> hereto (each, a &#8220;<span style="font-style:italic;font-weight:bold;">Lock-Up Agreement</span>&#8221;) and (b) Key Management shall have each entered into a Non-Competition and Non-Solicitation Agreement in favor of Purchaser and the Company, the form of which is attached as <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit D</span> hereto (each, a &#8220;<span style="font-style:italic;font-weight:bold;">Non-Competition Agreement</span>&#8221;), each of which agreements described in clauses (a) and (b) above will become effective as of the Closing;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">H.</span></span>In connection with the execution and delivery of this Agreement, Purchaser will use its reasonable commercial efforts to enter into subscription agreements (the &#8220;<span style="font-style:italic;font-weight:bold;">Subscription Agreements</span>&#8221;) with certain investors (the &#8220;<span style="font-style:italic;font-weight:bold;">PIPE Investors</span>&#8221;) pursuant to which such PIPE Investors, upon the terms and subject to the conditions set forth therein, will purchase at least 3,000,000 shares of Purchaser Common Stock at a purchase price of ten dollars ($10.00) per share, for an aggregate purchase price of at least $30,000,000, in a private placement or placements (the &#8220;<span style="font-style:italic;font-weight:bold;">Private Placement</span>&#8221;) to be consummated immediately prior to the consummation of the Merger (collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">PIPE Investment</span>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">I.</span></span>Concurrently with the execution and delivery of this Agreement, the Company has deposited $1,150,000 (the &#8220;<span style="font-style:italic;font-weight:bold;">Extension Escrow Amount</span>&#8221;) with the Escrow Agent (as defined below) pursuant to an Extension Escrow Agreement, the form of which is attached as Exhibit H hereto (the &#8220;<span style="font-style:italic;font-weight:bold;">Escrow Extension Agreement</span>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">J.</span></span>The Parties intend that the Merger will qualify as a tax-free &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code (as defined herein); and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">K.</span></span>Certain capitalized terms used herein are defined in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article XI</span> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">NOW, THEREFORE</b>, in consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and the representations, warranties, covenants and agreements contained in this Agreement, and intending to be legally bound hereby, the Parties hereto agree as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_5096acf4_078c_4960_8bbf_57f6e2bb2f1c"></a><a id="ARTICLEI_873180"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ARTICLE I</b></p><a id="MERGER_638846"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">MERGER</b></p><a id="a11Merger_416295"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger</span>. At the Effective Time, and subject to and upon the terms and conditions of this Agreement, and in accordance with the applicable provisions of the DGCL, Merger Sub and the Company shall consummate the Merger, pursuant to which Merger Sub shall be merged with and into the Company, following which the separate corporate existence of Merger Sub shall cease and the Company shall continue as the surviving corporation. The Company, as the surviving corporation after the Merger, is hereinafter sometimes referred to as the &#8220;<span style="font-style:italic;font-weight:bold;">Surviving Corporation</span>&#8221; (provided, that references to the Company for periods after the Effective Time shall include the Surviving Corporation).</p><a id="a12EffectiveTime_660503"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effective Time</span>. The Parties hereto shall cause the Merger to be consummated by filing the Certificate of Merger for the merger of Merger Sub with and into the Company (the &#8220;<span style="font-style:italic;font-weight:bold;">Certificate of Merger</span>&#8221;) with the Secretary of State of the State of Delaware in accordance with the relevant provisions of the DGCL (the time of such filing, or such later time as may be specified in the Certificate of Merger, being the &#8220;<span style="font-style:italic;font-weight:bold;">Effective Time</span>&#8221;).</p><a id="a13EffectoftheMerger_527930"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effect of the Merger</span>. At the Effective Time, the effect of the Merger shall be as provided in this Agreement, the Certificate of Merger and the applicable provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, all the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of Merger Sub and the Company shall become the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of the Surviving Corporation, which shall include the assumption by the Surviving Corporation of any and all agreements, covenants, duties and obligations of Merger Sub and the Company set forth in this Agreement to be performed after the Effective Time.</p><a id="a14TaxTreatment_820943"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Tax Treatment</span>. For federal income tax purposes, the Merger is intended to constitute a &#8220;reorganization&#8221; within the meaning of Section 368 of the Code. The Parties adopt this Agreement as a &#8220;plan of reorganization&#8221; within the meaning of Sections 1.368-2(g) and 1.368-3(a) of the United States Treasury Regulations.</p><a id="a15CertificateofIncorporationandBylaws_3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.5</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certificate of Incorporation and Bylaws</span>. At the Effective Time, the Company Charter and Bylaws of the Company, each as in effect immediately prior to the Effective Time, shall automatically be amended and restated in their entirety to read identically to the Certificate of Incorporation and Bylaws of Merger Sub, as in effect immediately prior to the Effective Time, and such amended and restated Certificate of Incorporation and Bylaws shall become the respective Certificate of Incorporation and Bylaws of the Surviving Corporation, except that the name of the Surviving Corporation in such Certificate of Incorporation and Bylaws shall be amended to be &#8220;OneMedNet Corporation&#8221;.</p><a id="a16DirectorsandOfficersoftheSurvivingCor"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.6</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Directors and Officers of the Surviving Corporation</span>. At the Effective Time, the board of directors and executive officers of the Surviving Corporation shall be the board of directors and executive officers of the Purchaser, after giving effect to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.17</span>, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">each to hold office in accordance with the Certificate of Incorporation and Bylaws of the Surviving Corporation until their respective successors are duly elected or appointed and qualified or their earlier death, resignation or removal.</p><a id="a17MergerConsideration_432684"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.7</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger Consideration</span>. As consideration for the Merger, the Company Security Holders collectively shall be entitled to receive from the Purchaser, in the aggregate, a number of Purchaser Securities with an aggregate value equal to (a) Two Hundred Million U.S. Dollars ($200,000,000) minus (b) the amount, if any, by which the Target Net Working Capital Amount exceeds the Net Working Capital Amount (but not less than zero), minus (c) the amount of Closing Net Indebtedness minus (d) the amount of any Transaction Expenses (the total portion of the Merger Consideration amount payable to all Company Stockholders in accordance with this Agreement is also referred to herein as the &#8220;<span style="font-style:italic;font-weight:bold;">Stockholder Merger Consideration</span>&#8221;); <i style="font-style:italic;">provided, </i>that the Merger Consideration otherwise payable to Company Stockholders is subject to adjustment after the Closing in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.15</span>.</p><a id="a18ConversionofCompanyStock_629356"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.8</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conversion of Company Stock</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Company shall take all actions necessary to cause each issued and outstanding share of Company Preferred Stock to be automatically converted immediately prior to and contingent upon the occurrence of the Effective Time into a number of shares of Common Stock set forth in the Allocation Schedule (as defined below). Each issued share of Company Stock outstanding immediately prior to the Effective Time (other than shares to be canceled in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.12</span> or Dissenting Shares) shall, subject to the terms and conditions of this Agreement, be automatically converted (the &#8220;<span style="font-style:italic;font-weight:bold;">Conversion</span>&#8221;) into the right to receive a number of shares of Purchaser Common Stock equal to: (i) the Per Share Consideration divided by (ii) the Redemption Price, as set forth on the Allocation Schedule.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company Options</span>. No outstanding Company Options (whether vested or unvested) shall be assumed by, continued in effect or replaced by Purchaser or the Surviving Company pursuant to or in connection with the Merger. The Company shall take all actions necessary so that, at the Effective Time, each Company Option (whether vested or unvested) that is unexpired, unexercised and outstanding immediately prior to the Effective Time shall terminate and be cancelled as of the Effective Time. Subject to any applicable backup or other withholding requirements, each holder of a vested Company Option immediately prior to the Effective Time shall, by virtue of the Merger and pursuant to the terms of the Company Stock Option Plan, have a period of no less than ten (10) days before the Effective Date to exercise said vested Company Option through a net share exercise method by which the holder of said vested Company Option shall receive a number of Purchaser Common Stock equal to (i) the difference between the Per Share Consideration and the exercise price of such vested Company Option divided by (ii) the Per Share Consideration, as set forth on the Allocation Schedule. No fractional Shares shall be issuable upon exercise of the vested Company Option and the number of Shares to be issued shall be rounded down to the nearest whole Share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company Warrants</span>. At the Effective Time, each Company Warrant that is at such time outstanding and unexercised shall, by virtue of the Merger pursuant to the terms of the relevant Warrant Instrument, and without any action on the part of Purchaser, Merger Sub, the Company, the holder of such Warrant or any other Person, be cancelled in consideration for (and each holder of such Company Warrant shall cease to have any rights with respect thereto) other than the right to receive a portion of the Merger Consideration equal to such amounts as the holder of such Company Warrant would have received in respect of the shares of Company Common Stock into which such Company Warrant is exercisable, if they were to have fully exercised such Company Warrant immediately prior to the Effective Time, <i style="font-style:italic;">less </i>the aggregate exercise price of such Company Warrant per underlying share, in each case as shown in the Allocation Schedule.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company Promissory Notes</span>. At the Effective Time, each Company Promissory Note that is at such time outstanding shall, by virtue of the Merger pursuant to the terms of each Company Promissory Note, and without any action on the part of Purchaser, Merger Sub, the Company, the holder of such Company Promissory Note or any other Person, be assumed by the Surviving Corporation.</p><a id="a19TreasuryStock_415363"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.9</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Treasury Stock</span>. At the Effective Time, if there are any Company Securities that are owned by the Company as treasury shares or any Company Securities owned by any direct or indirect Subsidiary of the Company immediately prior to the Effective Time, such Company Securities shall be canceled and shall cease to exist without any conversion thereof or payment therefor.</p><a id="a110RightsCeasetoExist_601425"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">1.10&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Rights Cease to Exist</span>. As of the Effective Time, all shares of Company Stock shall no longer be outstanding, shall automatically be canceled and shall cease to exist and each holder of shares of Company Stock shall cease to have any rights with respect thereto, except the rights set forth in this Agreement.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a111DissentingShares_646707"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">1.11&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Dissenting Shares</span>. Each of the Dissenting Shares issued and outstanding immediately prior to the Effective Time shall be cancelled and cease to exist in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.17</span> and shall thereafter represent only the right to receive the applicable payments set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.17</span>.</p><a id="a112SurrenderofCompanySecuritiesandDisbu"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">1.12&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Surrender of Company Securities and Disbursement of Merger Consideration</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Prior to the Effective Time, the Purchaser shall appoint its transfer agent, Continental Stock Transfer &amp; Trust Company, or another agent reasonably acceptable to the Company (the &#8220;<span style="font-style:italic;font-weight:bold;">Exchange Agent</span>&#8221;), for the purpose of disbursing the Stockholder Merger Consideration. At or prior to the Effective Time, the Purchaser shall deposit, or cause to be deposited, with the Exchange Agent the Stockholder Merger Consideration. At or prior to the Effective Time, the Purchaser shall send, or shall cause the Exchange Agent to send, to each Company Stockholder, a letter of transmittal for use in such exchange, in the form attached hereto as Exhibit E (a &#8220;<span style="font-style:italic;font-weight:bold;">Letter of Transmittal</span>&#8221;) (which shall specify that the delivery of Company Stock in respect of the Stockholder Merger Consideration shall be effected, and risk of loss and title shall pass, only upon proper delivery of a properly completed and duly executed Letter of Transmittal and Company Certificates, if any (or a Lost Certificate Affidavit)), to the Exchange Agent for use in such exchange.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Each Company Stockholder shall be entitled to receive its Pro Rata Share of the Stockholder Merger Consideration in respect of the Company Stock tendered for exchange (excluding any Dissenting Shares), as soon as reasonably practicable after the Effective Time, but subject to the delivery to the Exchange Agent of the following items prior thereto (collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Transmittal Documents</span>&#8221;): (i) the Company Certificate(s), if any, for its Company Stock (or a Lost Certificate Affidavit), and/or a properly completed and duly executed Letter of Transmittal and (ii) such other documents as may be reasonably requested by the Exchange Agent or the Purchaser. Until so surrendered, each Company Certificate shall represent after the Effective Time for all purposes only the right to receive such portion of the Stockholder Merger Consideration (as it may be adjusted after the Closing pursuant to<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> Section 1.15</span>) attributable to such Company Certificate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>If any portion of the Stockholder Merger Consideration is to be delivered or issued to a Person other than the Person in whose name the surrendered Company Certificate is registered immediately prior to the Effective Time, it shall be a condition to such delivery that (i) the transfer of such Company Stock shall have been permitted in accordance with the terms of the Company&#8217;s Organizational Documents and any stockholders agreement with respect to the Company, each as in effect immediately prior to the Effective Time, (ii) such Company Certificate shall be properly endorsed or shall otherwise be in proper form for transfer, (iii) the recipient of such portion of the Stockholder Merger Consideration, or the Person in whose name such portion of the Stockholder Merger Consideration is delivered or issued, shall have already executed and delivered, if a Significant Company Holder, counterparts to a Lock-Up Agreement and Non-Competition Agreement, and such other Transmittal Documents as are reasonably deemed necessary by the Exchange Agent or the Purchaser, and (iv) the Person requesting such delivery shall pay to the Exchange Agent any transfer or other Taxes required as a result of such delivery to a Person other than the registered holder of such Company Certificate or establish to the satisfaction of the Exchange Agent that such Tax has been paid or is not payable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>Notwithstanding anything to the contrary contained herein, in the event that any Company Certificate shall have been lost, stolen or destroyed, in lieu of delivery of a Company Certificate to the Exchange Agent, the Company Stockholder may instead deliver to the Exchange Agent an affidavit of lost certificate and indemnity of loss in form and substance reasonably acceptable to the Purchaser (a &#8220;<span style="font-style:italic;font-weight:bold;">Lost Certificate Affidavit</span>&#8221;), which at the reasonable discretion of the Purchaser may include a requirement that the owner of such lost, stolen or destroyed Company Certificate deliver a bond in such sum as it may reasonably direct as indemnity against any claim that may be made against the Purchaser or the Surviving Corporation with respect to the shares of Company Stock represented by the Company Certificates alleged to have been lost, stolen or destroyed. Any Lost Certificate Affidavit properly delivered in accordance with this Section 1.12(d) shall be treated as a Company Certificate for all purposes of this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>After the Effective Time, there shall be no further registration of transfers of Company Stock. If, after the Effective Time, the Transmittal Documents are presented to the Surviving Corporation, the Purchaser or the Exchange Agent, the Company Stock and any Company Certificates representing such Company Stock shall be canceled and exchanged for the applicable portion of the Stockholder Merger Consideration provided for, and in accordance with, the procedures set forth in this Section 1.12.&#160;No dividends or other distributions declared or made after the date of this Agreement with respect to Purchaser Common Stock with a record date after the Effective Time will be paid to the holders of any Company Stock that has not yet been surrendered with respect to the Purchaser Common Stock to be issued upon surrender thereof until the holders of record of such Company Stock shall surrender the Company Certificates, if any (or provide a Lost Certificate Affidavit), and/or provide the other </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Transmittal Documents. Subject to applicable Law, following surrender of any such Company Certificates, if any (or delivery of a Lost Certificate Affidavit), and/or delivery of the other Transmittal Documents, Purchaser shall promptly deliver to the record holders thereof, without interest, the certificates representing the Purchaser Common Stock issued in exchange therefor and the amount of any such dividends or other distributions with a record date after the Effective Time theretofore paid with respect to such Purchaser Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>All securities issued upon the surrender of Company Securities in accordance with the terms hereof shall be deemed to have been issued in full satisfaction of all rights pertaining to such Company Securities. Any portion of the Stockholder Merger Consideration made available to the Exchange Agent pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.12(a</span>) that remains unclaimed by Company Stockholders two (2) years after the Effective Time shall be returned to the Purchaser, upon demand, and any such Company Stockholder who has not exchanged its Company Stock for the applicable portion of the Stockholder Merger Consideration in accordance with this Section 1.12 prior to that time shall thereafter look only to the Purchaser for payment of the portion of the Stockholder Merger Consideration in respect of such shares of Company Stock without any interest thereon (but with any dividends paid with respect thereto). Notwithstanding the foregoing, none of the Surviving Corporation, the Purchaser or any Party hereto shall be liable to any Person for any amount properly paid to a public official pursuant to any applicable abandoned property, escheat or similar law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>Notwithstanding anything to the contrary contained herein, no fraction of a share of Purchaser Common Stock will be issued by virtue of the Merger or the transactions contemplated hereby, and each Person who would otherwise be entitled to a fraction of a share of Purchaser Common Stock (after aggregating all fractional shares of Purchaser Common Stock that otherwise would be received by such holder) shall instead have the number of shares of Purchaser Common Stock issued to such Person rounded down in the aggregate to the nearest whole share of Purchaser Common Stock.</p><a id="a113EffectofTransactiononMergerSubStock_"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">1.13&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effect of Transaction on Merger Sub Stock</span>. At the Effective Time, by virtue of the Merger and without any action on the part of any Party or the holders of any Company Securities or the holders of any shares of capital stock of the Purchaser or Merger Sub, each share of Merger Sub Common Stock outstanding immediately prior to the Effective Time shall be converted into an equal number of shares of common stock of the Surviving Corporation, with the same rights, powers and privileges as the shares so converted and shall constitute the only outstanding shares of capital stock of the Surviving Corporation.</p><a id="a114ClosingCalculations_188103"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.14</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Closing Calculations</span>. At least three (3) Business Days prior to the Closing Date, the Company shall deliver to the Purchaser (i) an allocation schedule (the &#8220;<span style="font-style:italic;font-weight:bold;">Allocation Schedule</span>&#8221;) setting forth (a) the number of Company Shares held by each Company Stockholder, and (b) the portion of the Merger Consideration allocated to each Company Stockholder, and (ii) a statement certified by the Company&#8217;s chief executive officer (the &#8220;<span style="font-style:italic;font-weight:bold;">Estimated Closing Statement</span>&#8221;) setting forth a good faith calculation of the Company&#8217;s estimate of the Closing Net Indebtedness, Net Working Capital and Transaction Expenses, in each case, as of the Reference Time, and the resulting Merger Consideration based on such estimates, in reasonable detail including for each component thereof, along with the amount owed to each creditor of any of the Target Companies, and bank statements and other evidence reasonably necessary to confirm such calculations. Promptly upon delivering the Estimated Closing Statement to the Purchaser, if requested by the Purchaser, the Company will meet with the Purchaser to review and discuss the Estimated Closing Statement and the Company will consider in good faith the Purchaser&#8217;s comments to the Estimated Closing Statement and make any appropriate adjustments to the Estimated Closing Statement prior to the Closing, which adjusted Estimated Closing Statement, as mutually approved by the Company and the Purchaser both acting reasonably and in good faith, shall thereafter become the Estimated Closing Statement for all purposes of this Agreement. The Estimated Closing Statement and the determinations contained therein shall be prepared in accordance with the Accounting Principles and otherwise in accordance with this Agreement.</p><a id="a115MergerConsiderationAdjustment_391877"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.15</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger Consideration Adjustment</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Within ninety (90) days after the Closing Date, Purchaser&#8217;s Chief Financial Officer (the &#8220;<span style="font-style:italic;font-weight:bold;">CFO</span>&#8221;) shall deliver to the Purchaser Representative and the Seller Representative a statement (the &#8220;<span style="font-style:italic;font-weight:bold;">Closing Statement</span>&#8221;) setting forth (i) a consolidated balance sheet of the Target Companies as of the Reference Time and (ii) a good faith calculation of the Closing Net Indebtedness, Net Working Capital and Transaction Expenses, in each case, as of the Reference Time, and the resulting Merger Consideration using the formula in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.7</span>. The Closing Statement shall be prepared, and the Closing Net Indebtedness, Net Working Capital, and Transaction Expenses and the resulting Merger Consideration and shares shall be determined in accordance with the Accounting Principles and otherwise in accordance with this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>After delivery of the Closing Statement, each of the Seller Representative and the Purchaser Representative, and their respective Representatives on their behalves, shall be permitted reasonable access to the books, records, working papers, files, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">facilities and personnel of the Target Companies relating to the preparation of the Closing Statement. The Seller Representative and the Purchaser Representative, and their respective Representatives on their behalves, may make inquiries of the CFO and related Purchaser and Target Company personnel and advisors regarding questions concerning or disagreements with the Closing Statement arising in the course of their review thereof, and Purchaser and the Company shall provide reasonable cooperation in connection therewith. If either the Seller Representative or the Purchaser Representative (each, a &#8220;<span style="font-style:italic;font-weight:bold;">Representative Party</span>&#8221;) has any objections to the Closing Statement, such Representative Party shall deliver to the CFO and the other Representative Party a statement setting forth its objections thereto (in reasonable detail) (an &#8220;<span style="font-style:italic;font-weight:bold;">Objection Statement</span>&#8221;). If an Objection Statement is not delivered by a Representative Party within thirty (30) days following the date of delivery of the Closing Statement, then such Representative Party will have waived its right to contest the Closing Statement, all determinations and calculations set forth therein, and the resulting Merger Consideration set forth therein. If an Objection Statement is delivered within such thirty (30) day period, then the Seller Representative and the Purchaser Representative shall negotiate in good faith to resolve any such objections for a period of twenty (20) days thereafter. If the Seller Representative and the Purchaser Representative do not reach a final resolution within such twenty (20) day period, then upon the written request of either Representative Party (the date of receipt of such notice by the other Party, the &#8220;<span style="font-style:italic;font-weight:bold;">Independent Expert Notice Date</span>&#8221;), the Representative Parties will refer the dispute to the Independent Expert for final resolution of the dispute in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.15(c</span>). For purposes hereof, the &#8220;<span style="font-style:italic;font-weight:bold;">Independent Expert</span>&#8221; shall mean a mutually acceptable independent (i.e., no prior material business relationship with any party) accounting firm appointed by the Purchaser Representative and the Seller Representative, which appointment will be made no later than ten (10) days after the Independent Expert Notice Date; provided, that if the Independent Expert does not accept its appointment or if the Purchaser Representative and the Seller Representative cannot agree on the Independent Expert, in either case within twenty (20) days after the Independent Expert Notice Date, either Representative Party may require, by written notice to the other Representative Party, that the Independent Expert be selected by the New York City Regional Office of the AAA in accordance with the AAA&#8217;s procedures. The parties agree that the Independent Expert will be deemed to be independent even though a Party or its Affiliates may, in the future, designate the Independent Expert to resolve disputes of the types described in this Section 1.15. The Parties acknowledge that any information provided pursuant to this Section 1.15 will be subject to the confidentiality obligations of Section 5.15.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>If a dispute with respect to the Closing Statement is submitted in accordance with this Section 1.15 to the Independent Expert for final resolution, the Parties will follow the procedures set forth in this Section 1.15(c). Each of the Seller Representative and the Purchaser Representative agrees to execute, if requested by the Independent Expert, a reasonable engagement letter with respect to the determination to be made by the Independent Expert. All fees and expenses of the Independent Expert will be borne by the Purchaser. Except as provided in the preceding sentence, all other costs and expenses incurred by the Seller Representative in connection with resolving any dispute hereunder before the Independent Expert will be borne by the Company Stockholders, and all other costs and expenses incurred by the Purchaser Representative in connection with resolving any dispute hereunder before the Independent Expert will be borne by the Purchaser. The Independent Expert will determine only those issues still in dispute as of the Independent Expert Notice Date and the Independent Expert&#8217;s determination will be based solely upon and consistent with the terms and conditions of this Agreement. The determination by the Independent Expert will be based solely on presentations with respect to such disputed items by the Purchaser Representative and the Seller Representative to the Independent Expert and not on the Independent Expert&#8217;s independent review; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, that such presentations will be deemed to include any work papers, records, accounts or similar materials delivered to the Independent Expert by a Representative Party in connection with such presentations and any materials delivered to the Independent Expert in response to requests by the Independent Expert. Each of the Seller Representative and the Purchaser Representative will use their reasonable efforts to make their respective presentations as promptly as practicable following submission to the Independent Expert of the disputed items, and each such Representative Party will be entitled, as part of its presentation, to respond to the presentation of the other Representative Party and any questions and requests of the Independent Expert. In deciding any matter, the Independent Expert will be bound by the provisions of this Agreement, including this Section 1.15. It is the intent of the parties hereto that the activities of the Independent Expert in connection herewith are not (and should not be considered to be or treated as) an arbitration proceeding or similar arbitral process and that no formal arbitration rules should be followed (including rules with respect to procedures and discovery). The Seller Representative and the Purchaser Representative will request that the Independent Expert&#8217;s determination be made within forty-five (45) days after its engagement, or as soon thereafter as possible, will be set forth in a written statement delivered to the Purchaser Representative and the Seller Representative and will be final, conclusive, non-appealable and binding for all purposes hereunder (other than for fraud or manifest error).</p><a id="a116TakingofNecessaryActionFurtherAction"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.16</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Taking of Necessary Action; Further Action</span>. If, at any time after the Effective Time, any further action is necessary or desirable to carry out the purposes of this Agreement and to vest the Surviving Corporation with full right, title and possession to all assets, property, rights, privileges, powers and franchises of the Company and Merger Sub, the officers and directors of the Company and Merger Sub are fully authorized in the name of their respective corporations or otherwise to take, and will take, all such lawful and necessary action, so long as such action is not inconsistent with this Agreement.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a117AppraisalandDissentersRights_313402"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.17</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Appraisal and Dissenter&#8217;s Rights</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;">Dissenting Shares</i>. Notwithstanding anything in this Agreement to the contrary, any Dissenting Shares shall not be converted into or represent a right to receive the applicable consideration for Company Stock set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.7</span>, but instead the holder thereof shall only be entitled to such rights as are provided by the DGCL. In the event that a holder properly perfects such holder&#8217;s appraisal, dissenters&#8217; or similar rights by demanding and not effectively withdrawing or losing such holder&#8217;s appraisal, dissenters&#8217; or similar rights for any shares of Company Stock, the Exchange Agent shall deliver to Purchaser such holder&#8217;s portion of the Stockholder Merger Consideration that is attributable to such shares at the time such portion of such Stockholder Merger Consideration is determined and such rights are perfected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;">Withdrawal or Loss of Rights</i>. Notwithstanding the provisions of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.17(a)</span>, if any holder of Dissenting Shares effectively withdraws or loses (through failure to perfect or otherwise) such holder&#8217;s appraisal or dissenters&#8217; rights with respect to such shares under the DGCL, then, as of the later of the Effective Time and the occurrence of such event, (i) such holder&#8217;s shares shall automatically convert into and represent only the right to receive the consideration for Company Stock, as applicable, set forth in and subject to the provisions of this Agreement, upon surrender of the certificate(s) formerly representing such shares (if any), and (ii) Purchaser (to the extent the following amounts have been previously delivered by the Exchange Agent to Purchaser pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.17(a)</span> and not returned to the Exchange Agent) or the Exchange Agent shall deliver to such holder such holder&#8217;s portion of the Stockholder Merger Consideration that is attributable to such shares at the time such rights are withdrawn or lost.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;">Demands for Appraisal</i>. The Company shall give Purchaser (i) prompt notice of any written demand for appraisal received by the Company pursuant to the applicable provisions of the DGCL, and (ii) the opportunity to participate in all negotiations and proceedings with respect to such demands. The Company shall not, except with the prior written consent of Purchaser, make any payment with respect to any such demands or offer to settle or settle any such demands.</p><a id="a118AmendedPurchaserCertificateofIncorpo"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">1.18&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amended Purchaser Certificate of Incorporation</span>. Upon the Effective Time, the Purchaser shall amend and restate its Amended and Restated Certificate of Incorporation in a form to be mutually agreed between the Purchaser and the Company (the &#8220;<span style="font-style:italic;font-weight:bold;">Amended Purchaser Certificate of Incorporation</span>&#8221;) which shall, among other matters, amend the Purchaser&#8217;s Certificate of Incorporation to (i) provide that the name of the Purchaser shall be changed to &#8220;OneMedNet Corporation&#8221; or such other name as mutually agreed to by the Parties, (ii) provide for size and structure of the Post-Closing Purchaser Board in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.17</span>, and (iii) remove and change certain provisions in the Certificate of Incorporation related to the Purchaser&#8217;s status as a blank check company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_d7ec6f39_8298_4907_b97d_d59c5511d617"></a><a id="ARTICLEII_863125"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ARTICLE II</b></p><a id="CLOSING_321051"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">CLOSING</b></p><a id="a21Closing_869010"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Closing</span>. Subject to the satisfaction or waiver of the conditions set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article VII</span>, the consummation of the transactions contemplated by this Agreement (the &#8220;<span style="font-style:italic;font-weight:bold;">Closing</span>&#8221;) shall take place electronically via exchange of documents and signatures, on a date and at a time to be agreed upon by Purchaser and the Company, which date shall be no later than the second (2nd) Business Day after all the Closing conditions to this Agreement have been satisfied or waived, or at such other date, time or place (including remotely) as the Purchaser and the Company may agree (the date and time at which the Closing is actually held being the &#8220;<span style="font-style:italic;font-weight:bold;">Closing Date</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_3df6ddef_fe81_4886_862f_b6e515c87aab"></a><a id="ARTICLEIII_29927"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.6pt 0pt;"><b style="font-weight:bold;">ARTICLE III</b></p><a id="REPRESENTATIONSANDWARRANTIESOFTHEPURCHAS"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Except as set forth in (i) the disclosure schedules delivered by the Purchaser to the Company on the date hereof (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Disclosure Schedules</span>&#8221;), the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they refer, or (ii) the SEC Reports that are available on the SEC&#8217;s website through EDGAR, the Purchaser represents and warrants to the Company as of the date of this Agreement and as of the Closing Date, as follows:</p><a id="a31OrganizationandStanding_64614"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Organization and Standing</span>. The Purchaser is a corporation duly incorporated, validly existing and in good standing under the Laws of Delaware. The Purchaser has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. The Purchaser is duly qualified or licensed and in good standing to do business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except where the failure to be so qualified or licensed or in good standing can be cured without material cost or expense. The Purchaser has heretofore made available to the Company accurate and complete copies of its </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Organizational Documents, as currently in effect. The Purchaser is not in violation of any provision of its Organizational Documents in any material respect.</p><a id="a32AuthorizationBindingAgreement_42023"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Authorization; Binding Agreement</span>. The Purchaser has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is a party, to perform the Purchaser&#8217;s obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby, subject to obtaining the Required Purchaser Stockholder Approval. The execution and delivery of this Agreement and each Ancillary Document to which it is a party and the consummation of the transactions contemplated hereby and thereby (a) have been duly and validly authorized by the board of directors of the Purchaser, and (b) other than the Required Purchaser Stockholder Approval, no other corporate proceedings, other than as set forth elsewhere in the Agreement, on the part of the Purchaser are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary Document to which the Purchaser is a party shall be when delivered, duly and validly executed and delivered by the Purchaser and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except to the extent that enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization and moratorium laws and other laws of general application affecting the enforcement of creditors&#8217; rights generally or by any applicable statute of limitation or by any valid defense of set-off or counterclaim, and the fact that equitable remedies or relief (including the remedy of specific performance) are subject to the discretion of the court from which such relief may be sought (collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Enforceability Exceptions</span>&#8221;). The Purchaser&#8217;s board of directors, by resolutions duly adopted at a meeting duly called and held (i) determined that this Agreement and the Merger and the other transactions contemplated hereby are advisable, fair to, and in the best interests of, the Purchaser and its stockholders, (ii) approved this Agreement and the Merger and the other transactions contemplated by this Agreement in accordance with the DGCL, (iii) directed that this Agreement be submitted to the Purchaser&#8217;s stockholders for adoption and (iv) resolved to recommend that the Purchaser&#8217;s stockholders adopt this Agreement.</p><a id="a33GovernmentalApprovals_265283"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governmental Approvals</span>. Except as otherwise described in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.3</span>, no Consent of or with any Governmental Authority, on the part of the Purchaser is required to be obtained or made in connection with the execution, delivery or performance by the Purchaser of this Agreement and each Ancillary Document to which it is a party or the consummation by the Purchaser of the transactions contemplated hereby and thereby, other than (a) pursuant to Antitrust Laws, (b) such filings as contemplated by this Agreement, (c) any filings required with Nasdaq or the SEC with respect to the transactions contemplated by this Agreement, (d) applicable requirements, if any, of the Securities Act, the Exchange Act, and/ or any state &#8220;blue sky&#8221; securities Laws, and the rules and regulations thereunder, and (e) where the failure to obtain or make such Consents or to make such filings or notifications, would not reasonably be expected to have a Material Adverse Effect on the Purchaser.</p><a id="a34NonContravention_494735"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Contravention</span>. Except as otherwise described in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.4</span>, the execution and delivery by the Purchaser of this Agreement and each Ancillary Document to which it is a party, the consummation by the Purchaser of the transactions contemplated hereby and thereby, and compliance by the Purchaser with any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of the Purchaser&#8217;s Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 3.3</span> hereof, and the waiting periods referred to therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable to the Purchaser, Merger Sub, or any of their properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by the Purchaser under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of the Purchaser under, (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of, any Purchaser Material Contract, except for any deviations from any of the foregoing clauses (a), (b) or (c) that would not reasonably be expected to have a Material Adverse Effect on the Purchaser.</p><a id="a35Capitalization_78611"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.5</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Capitalization</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Purchaser is authorized to issue 110,000,000 shares of common stock, including 100,000,000 shares of Purchaser Class A Common Stock and 10,000,000 shares of Purchaser Class B Common Stock, par value $0.0001 per share; and is authorized to issue 1,000,000 shares of Purchaser Preferred Shares. The issued and outstanding Purchaser Securities as of the date of this </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Agreement are set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.5(a)</span>. There are no issued or outstanding shares of Purchaser Preferred Shares. All outstanding shares of Purchaser Common Stock are duly authorized, validly issued, fully paid and non-assessable and are not subject to or issued in violation of any purchase option, right of first refusal, preemptive right, subscription right or any similar right under any provision of the Delaware General Corporation Law (as amended, the &#8220;<span style="font-style:italic;font-weight:bold;">DGCL</span>&#8221;), Purchaser&#8217;s Organizational Documents or any Contract to which Purchaser is a party. None of the outstanding Purchaser Securities has been issued in violation of any applicable securities Laws</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Prior to giving effect to the Merger, Merger Sub is authorized to issue 1,000 shares of Merger Sub Common Stock, of which 1,000 shares are issued and outstanding, and all of which are owned by the Purchaser. Prior to giving effect to the transactions contemplated by this Agreement, other than Merger Sub, Purchaser does not have any Subsidiaries or own any equity interests in any other Person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.5(a)</span> or <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.5(c)</span> there are no (i) outstanding options, warrants, puts, calls, convertible securities, preemptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general voting rights or that are convertible or exchangeable into securities having such rights or (iii) subscriptions or other rights, agreements, arrangements, Contracts or commitments of any character (other than this Agreement and the Ancillary Documents), (A) relating to the issued or unissued shares of Purchaser or (B) obligating Purchaser to issue, transfer, deliver or sell or cause to be issued, transferred, delivered, sold or repurchased any options or shares or securities convertible into or exchangeable for such shares, or (C) obligating Purchaser to grant, extend or enter into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment for such capital shares. Other than the Redemption or as expressly set forth in this Agreement, there are no outstanding obligations of Purchaser to repurchase, redeem or otherwise acquire any shares of Purchaser or to provide funds to make any investment (in the form of a loan, capital contribution or otherwise) in any Person. Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.5(c)</span>, there are no stockholders agreements, voting trusts or other agreements or understandings to which Purchaser is a party with respect to the voting of any shares of Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>All Indebtedness of Purchaser as of the date of this Agreement is disclosed on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.5(d)</span>. No Indebtedness of Purchaser contains any restriction upon (i) the prepayment of any of such Indebtedness, (ii) the incurrence of Indebtedness by Purchaser or (iii) the ability of Purchaser to grant any Lien on its properties or assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>Since the date of formation of Purchaser, and except as contemplated by this Agreement, Purchaser has not declared or paid any distribution or dividend in respect of its shares and has not repurchased, redeemed or otherwise acquired any of its shares, and Purchaser&#8217;s board of directors has not authorized any of the foregoing.</p><a id="a36SECFilingsandPurchaserFinancials_8483"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.6</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SEC Filings and Purchaser Financials</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Purchaser, since the IPO, has filed all forms, reports, schedules, statements, registration statements, prospectuses and other documents required to be filed or furnished by the Purchaser with the SEC under the Securities Act and/or the Exchange Act, together with any amendments, restatements or supplements thereto, and will file all such forms, reports, schedules, statements and other documents required to be filed subsequent to the date of this Agreement. Except to the extent available on the SEC&#8217;s web site through EDGAR, the Purchaser has delivered to the Company copies in the form filed with the SEC of all of the following: (i) the Purchaser&#8217;s annual reports on Form 10-K for each fiscal year of the Purchaser beginning with the first year the Purchaser was required to file such a form, (ii) the Purchaser&#8217;s quarterly reports on Form 10-Q for each fiscal quarter that the Purchaser filed such reports to disclose its quarterly financial results in each of the fiscal years of the Purchaser referred to in clause (i) above, (iii) all other forms, reports, registration statements, prospectuses and other documents (other than preliminary materials) filed by the Purchaser with the SEC since the beginning of the first fiscal year referred to in clause (i) above (the forms, reports, registration statements, prospectuses and other documents referred to in clauses (i), (ii) and (iii) above, whether or not available through EDGAR, are, collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">SEC Reports</span>&#8221;) and (iv) all certifications and statements required by (A) Rules 13a-14 or 15d-14 under the Exchange Act, and (B) 18 U.S.C. &#167;1350 (Section 906 of SOX) with respect to any report referred to in clause (i) above (collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Public Certifications</span>&#8221;). The SEC Reports (x) were prepared in all material respects in accordance with the requirements of the Securities Act and the Exchange Act, as the case may be, and the rules and regulations thereunder and (y) did not, as of their respective effective dates (in the case of SEC Reports that are registration statements filed pursuant to the requirements of the Securities Act) and at the time they were filed with the SEC (in the case of all other SEC Reports) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received from the SEC with respect to any SEC Reports. None of the SEC Reports filed on or prior to the date of this Agreement is subject to ongoing SEC </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">review or investigation as of the date of this Agreement. The Public Certifications are each true as of their respective dates of filing. As used in this Section 3.6, the term &#8220;file&#8221; shall be broadly construed to include any manner permitted by SEC rules and regulations in which a document or information is furnished, supplied or otherwise made available to the SEC. As of the date of this Agreement, (A) the Purchaser Public Units, the Purchaser Common Stock and the Purchaser Public Warrants are listed on Nasdaq, (B) the Purchaser has not received any written deficiency notice from Nasdaq relating to the continued listing requirements of such Purchaser Securities, (C) there are no Actions pending or, to the Knowledge of the Purchaser, threatened against the Purchaser by the Financial Industry Regulatory Authority with respect to any intention by such entity to suspend, prohibit or terminate the quoting of such Purchaser Securities on Nasdaq and (D) such Purchaser Securities are in compliance with all of the applicable corporate governance rules of Nasdaq.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The financial statements and notes of the Purchaser contained or incorporated by reference in the SEC Reports (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Financials</span>&#8221;), fairly present in all material respects the financial position and the results of operations, changes in stockholders&#8217; equity, and cash flows of the Purchaser at the respective dates of and for the periods referred to in such financial statements, all in accordance with (i) GAAP methodologies applied on a consistent basis throughout the periods involved and (ii) Regulation S-X or Regulation S-K, as applicable (except as may be indicated in the notes thereto and for the omission of notes and audit adjustments in the case of unaudited quarterly financial statements to the extent permitted by Regulation S-X or Regulation S-K, as applicable).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>Except as and to the extent reflected or reserved against in the Purchaser Financials, the Purchaser has not incurred any Liabilities or obligations of the type required to be reflected on a balance sheet in accordance with GAAP that are not adequately reflected or reserved on or provided for in the Purchaser Financials, other than Liabilities of the type required to be reflected on a balance sheet in accordance with GAAP that have been incurred since the Purchaser&#8217;s formation in the ordinary course of business. All debts and Liabilities, fixed or contingent, which should be included under U.S. GAAP on a balance sheet are included in all material respects in the Purchaser Financials as of the date of such Purchaser Financial.</p><a id="a37AbsenceofCertainChanges_872106"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.7</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Absence of Certain Changes</span>. As of the date of this Agreement, except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.7</span>, the Purchaser has, (a) since its formation, conducted no business other than its formation, the public offering of its securities (and the related private offerings), public reporting and its search for an initial Business Combination as described in the IPO Prospectus (including the investigation of the Target Companies and the negotiation and execution of this Agreement) and related activities and (b) since May 6, 2021, not been subject to a Material Adverse Effect on the Purchaser.</p><a id="a38CompliancewithLaws_341668"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.8</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Laws</span>. The Purchaser is, and has since its formation been, in compliance with all Laws applicable to it and the conduct of its business except for such noncompliance which would not reasonably be expected to have a Material Adverse Effect on the Purchaser, and the Purchaser has not received written notice alleging any violation of applicable Law in any material respect by the Purchaser. Purchaser is not under investigation with respect to any violation or alleged violation of, any law, or judgment, order or decree entered by any court, arbitrator, or Governmental Authority, domestic or foreign, and the Purchaser has not previously received any subpoenas from any Governmental Authority.</p><a id="a39ActionsOrdersPermits_616973"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.9</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Actions; Orders; Permits</span>. There is no pending or, to the Knowledge of the Purchaser, threatened material Action to which the Purchaser is subject which would reasonably be expected to have a Material Adverse Effect on the Purchaser. There is no material Action that the Purchaser has pending against any other Person. The Purchaser is not subject to any material Orders of any Governmental Authority, nor are any such Orders pending. The Purchaser holds all material Permits necessary to lawfully conduct its business as presently conducted, and to own, lease and operate its assets and properties, all of which are in full force and effect.</p><a id="a310TaxesandReturns_572126"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.10</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Taxes and Returns</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Purchaser has timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it, which such Tax Returns are accurate and complete in all material respects, and has paid, collected, or withheld, or caused to be paid, collected, or withheld, all material Taxes required to be paid, collected, or withheld, other than such Taxes for which adequate reserves in the Purchaser Financials have been established in accordance with GAAP. The Purchaser has complied with all applicable Laws relating to Taxes. <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.10(a)</span> sets forth each jurisdiction where the Purchaser files or is required to file a Tax Return. There are no audits, examinations, investigations, or other proceedings pending against the Purchaser in respect of any Tax, and the Purchaser has not been notified in writing of any proposed Tax claims or assessments against the Purchaser (other than, in each case, claims or assessments for which adequate reserves in the Purchaser Financials have been established in accordance with GAAP or are immaterial in amount). There are no Liens with respect to any Taxes upon any of the Purchaser&#8217;s assets, other than Permitted Liens. The Purchaser has no outstanding waivers or extensions of any applicable statute of limitations </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">to assess any material amount of Taxes. There are no outstanding requests by the Purchaser for any extension of time within which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Since the date of its formation, the Purchaser has not (i) changed any Tax accounting methods, policies, or procedures except as required by a change in Law, (ii) made, revoked, or amended any material Tax election, (iii) filed any amended Tax Returns or claim for refund or (iv) entered into any closing agreement affecting or otherwise settled or compromised any material Tax liability or refund.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>To the Knowledge of the Purchaser, there are no facts or circumstances that would reasonably be expected to prevent the Merger from qualifying as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code.</p><a id="a311EmployeesandEmployeeBenefitPlans_918"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.11</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employees and Employee Benefit Plans</span>. The Purchaser does not (a) have any paid employees or (b) maintain, sponsor, contribute to or otherwise have any Liability under, any Benefit Plans.</p><a id="a312Properties_108604"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">3.12&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Properties</span>. The Purchaser does not own, license, or otherwise have any right, title, or interest in or to any material Intellectual Property. The Purchaser does not own or lease any material real property or material Personal Property.</p><a id="a313MaterialContracts_50633"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">3.13&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Material Contracts</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.13(a)</span>, other than this Agreement and the Ancillary Documents, there are no Contracts to which the Purchaser is a party or by which any of its properties or assets may be bound, subject or affected, which (i) creates or imposes a Liability greater than $50,000, (ii) may not be cancelled by the Purchaser on less than sixty (60) days&#8217; prior notice without payment of a material penalty or termination fee or (iii) prohibits, prevents, restricts or impairs in any material respect any business practice of the Purchaser as its business is currently conducted, any acquisition of material property by the Purchaser, or restricts in any material respect the ability of the Purchaser to engage in business as currently conducted by it or compete with any other Person (each, a &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Material Contract</span>&#8221;). All Purchaser Material Contracts have been made available to the Company other than those that are exhibits to the SEC Reports.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>With respect to each Purchaser Material Contract: (i) the Purchaser Material Contract was entered into at arms&#8217; length and in the ordinary course of business; (ii) the Purchaser Material Contract is legal, valid, binding and enforceable in all material respects against the Purchaser and, to the Knowledge of the Purchaser, the other parties thereto, and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions); (iii) the Purchaser is not in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute such a breach or default in any material respect by the Purchaser, or permit termination or acceleration by the other party, under such Purchaser Material Contract; and (iv) to the Knowledge of the Purchaser, no other party to any Purchaser Material Contract is in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute such a breach or default by such other party, or permit termination or acceleration by the Purchaser under any Purchaser Material Contract.</p><a id="a314TransactionswithAffiliates_961912"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.14</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transactions with Affiliates</span>. <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.14</span> sets forth a true, correct and complete list of the Contracts and arrangements that are in existence as of the date of this Agreement under which there are any existing or future Liabilities or obligations between the Purchaser and any (a) present or former director, officer or employee or Affiliate of the Purchaser, or any immediate family member of any of the foregoing, or (b) record or beneficial owner of more than five percent (5%) of the Purchaser&#8217;s outstanding capital stock as of the date hereof.</p><a id="a315MergerSubActivities_751587"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.15</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger Sub Activities</span>. Since its formation, Merger Sub has not engaged in any business activities other than as contemplated by this Agreement, does not own directly or indirectly any ownership, equity, profits or voting interest in any Person and has no assets or Liabilities except those incurred in connection with this Agreement and the Ancillary Documents to which it is a party and the Merger, and, other than this Agreement and the Ancillary Documents to which it is a party, Merger Sub is not party to or bound by any Contract.</p><a id="a316InvestmentCompanyAct_844247"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.16</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investment Company Act</span>. The Purchaser is not an &#8220;investment company&#8221; or a Person directly or indirectly &#8220;controlled&#8221; by or acting on behalf of an &#8220;investment company,&#8221; or required to register as an &#8220;investment company,&#8221; in each case within the meaning of the Investment Company Act of 1940, as amended.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a317FindersandBrokers_718030"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.17</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Finders and Brokers</span>. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.17</span>, no broker, finder or investment banker is entitled to any brokerage, finder&#8217;s or other fee or commission from the Purchaser, the Target Companies or any of their respective Affiliates in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of the Purchaser.</p><a id="a318OwnershipofStockholderMergerConsider"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">3.18&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Ownership of Stockholder Merger Consideration</span>. All shares of Purchaser Common Stock to be issued and delivered to the Company Stockholders as Stockholder Merger Consideration in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article I</span> shall be, upon issuance and delivery of such Purchaser Common Stock, fully paid and non-assessable, free and clear of all Liens, other than restrictions arising from applicable securities Laws, any applicable Lock-Up Agreement, and any Liens incurred by any Company Stockholder, and the issuance and sale of such Purchaser Common Stock pursuant hereto will not be subject to or give rise to any preemptive rights or rights of first refusal.</p><a id="a319CertainBusinessPractices_308628"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">3.19&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certain Business Practices</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Neither the Purchaser, nor any of its Representatives acting on its behalf, has (i) used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign Corrupt Practices Act of 1977 or any other local or foreign anti-corruption or bribery Law, (iii) made any other unlawful payment or (iv) since the formation of the Purchaser, directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount to any customer, supplier, governmental employee or other Person who is or may be in a position to help or hinder the Purchaser or assist it in connection with any actual or proposed transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The operations of the Purchaser are and have been conducted at all times in material compliance with money laundering statutes in all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations, or guidelines, issued, administered, or enforced by any Governmental Authority, and no Action involving the Purchaser with respect to any of the foregoing is pending or, to the Knowledge of the Purchaser, threatened.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>None of the Purchaser or any of its directors or officers, or, to the Knowledge of the Purchaser, any other Representative acting on behalf of the Purchaser is currently identified on the specially designated nationals or other blocked person list or otherwise currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<span style="font-style:italic;font-weight:bold;">OFAC</span>&#8221;), and the Purchaser has not, in the last five (5) fiscal years, directly or indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in any other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to, or otherwise in violation of, any U.S. sanctions administered by OFAC.</p><a id="a320Insurance_491699"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.20</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Insurance</span>. <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 3.20</span> lists all insurance policies (by policy number, insurer, coverage period, coverage amount, annual premium and type of policy) held by the Purchaser relating to the Purchaser or its business, properties, assets, directors, officers and employees, copies of which have been provided to the Company. All premiums due and payable under all such insurance policies have been timely paid and the Purchaser is otherwise in material compliance with the terms of such insurance policies. All such insurance policies are in full force and effect, and to the Knowledge of the Purchaser, there is no threatened termination of, or material premium increase with respect to, any of such insurance policies. There have been no insurance claims made by the Purchaser. The Purchaser has each reported to its insurers all claims and pending circumstances that would reasonably be expected to result in a claim, except where such failure to report such a claim would not be reasonably likely to have a Material Adverse Effect on the Purchaser.</p><a id="a321PurchaserTrustAccount_359034"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.21</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchaser Trust Account</span>. As of December 31, 2021, the Trust Account has a balance of no less than $117,300,000. Such monies are invested solely in United States &#8220;government securities&#8221; within the meaning of Section 2(a)(16) of the Investment Company Act or money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, and held in trust by Continental Stock Transfer &amp; Trust Company pursuant to the Trust Agreement. The Trust Agreement is valid and in full force and effect and enforceable in accordance with its terms (subject to the Enforceability Exceptions) and has not been amended or modified. The Purchaser has performed all material obligations required to be performed by it to date under, and is not in material default or delinquent in performance or any other respect (claimed or actual) in connection with the Trust Agreement, and, to the knowledge of the Purchaser, no event has occurred which, with due notice or lapse of time or both, would constitute such a material default thereunder. As of the date of this Agreement, there are no claims or proceedings pending with respect to the Trust Account. There are no separate agreements, side letters or other agreements that would cause the description of the Trust Agreement in the SEC Reports to be inaccurate in any material respect and/or that would entitle any Person (other than the underwriters of the IPO, Public Stockholders who shall have elected to redeem their Purchaser Common Stock pursuant to the Purchaser Certificate of Incorporation (or in connection with an extension of Purchaser&#8217;s deadline to consummate a Business Combination) or Governmental </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Authorities for Taxes) to any portion of the proceeds in the Trust Account. Prior to the Closing, none of the funds held in the Trust Account may be released except as described in the Trust Agreement. Upon the consummation of the transactions contemplated hereby, including the distribution of assets from the Trust Account, the Trust Agreement shall terminate in accordance with its terms.</p><a id="a322IndependentInvestigation_322138"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.22</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Independent Investigation</span>. The Purchaser has conducted its own independent investigation, review and analysis of the business, results of operations, prospects, condition (financial or otherwise) or assets of the Target Companies, and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of the Target Companies for such purpose. The Purchaser acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of the Company set forth in this Agreement (including the related portions of the Company Disclosure Schedules) and in any certificate delivered to Purchaser pursuant hereto, and the information provided by or on behalf of the Company for the Registration Statement; and (b) none of the Company nor its respective Representatives have made any representation or warranty as to the Target Companies, or this Agreement, except as expressly set forth in this Agreement (including the related portions of the Company Disclosure Schedules) or in any certificate delivered to Purchaser pursuant hereto, or with respect to the information provided by or on behalf of the Company for the Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:31.05pt;margin:0pt 0pt 0pt 7.65pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_cb3f7258_6e46_4b02_accb_b3674a66d378"></a><a id="_Hlk109262542"></a><a id="ARTICLEIV_124659"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.6pt 0pt;"><b style="font-weight:bold;">ARTICLE IV</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Except as set forth in the disclosure schedules delivered by the Company to the Purchaser on the date hereof (the &#8220;<span style="font-style:italic;font-weight:bold;">Company Disclosure Schedules</span>&#8221;), the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they refer, the Company hereby represents and warrants to the Purchaser, as of the date hereof and as of the Closing, as follows:</p><a id="a41OrganizationandStanding_161585"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Organization and Standing</span>. The Company is a corporation duly incorporated, validly existing and in good standing under the DGCL and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Each Subsidiary of the Company is a corporation or other entity duly formed, validly existing and in good standing under the Laws of its jurisdiction of organization and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Each Target Company is duly qualified or licensed and in good standing in the jurisdiction in which it is incorporated or registered and in each other jurisdiction where it does business or operates to the extent that the character of the property owned, or leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary. <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.1</span> lists all jurisdictions in which any Target Company is qualified to conduct business and all names other than its legal name under which any Target Company does business. The Company has provided to the Purchaser accurate and complete copies of its Organizational Documents and the Organizational Documents of each of its Subsidiaries, each as amended to date and as currently in effect. No Target Company is in violation of any provision of its Organizational Documents.</p><a id="a42AuthorizationBindingAgreement_469814"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Authorization; Binding Agreement</span>. The Company has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is or is required to be a party, to perform the Company&#8217;s obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby, subject to obtaining the Required Company Stockholder Approval. The execution and delivery of this Agreement and each Ancillary Document to which the Company is or is required to be a party and the consummation of the transactions contemplated hereby and thereby, (a) have been duly and validly authorized by the Company&#8217;s board of directors in accordance with the Company&#8217;s Organizational Documents, the DGCL, any other applicable Law or any Contract to which the Company or any of its stockholders is a party or by which it or its securities are bound and (b) other than the Required Company Stockholder Approval, no other corporate proceedings on the part of the Company are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary Document to which the Company is or is required to be a party shall be when delivered, duly and validly executed and delivered by the Company and assuming the due authorization, execution and delivery of this Agreement and any such Ancillary Document by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions. The Company&#8217;s board of directors, by resolutions duly adopted at a meeting duly called and held or by action by unanimous written consent in accordance with the Company&#8217;s Organizational Documents (i) determined that this Agreement and the Merger and the other transactions contemplated hereby are advisable, fair to, and in the best interests of, the Company and its stockholders, (ii) approved this Agreement and the Merger and the other transactions contemplated by this Agreement in accordance with the DGCL, (iii) directed that this Agreement be submitted to the Company&#8217;s stockholders for adoption and (iv) resolved to recommend that the Company stockholders adopt this Agreement. The Voting Agreements delivered by the Company include holders of Company Stock representing at least the Required </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Company Stockholder Approval, and such Voting Agreements constitute, the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</p><a id="a43Capitalization_440268"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Capitalization</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>As of the Effective Date, the Company is authorized to issue (i) 30,000,000 shares of Company Common Stock, of which 4,342,666 shares are issued and outstanding, and (ii) 13,600,000 shares of Company Preferred Stock, of which 4,400,000 shares are designated as Series A-1 Preferred Stock, 3,204,000 of which are issued and outstanding, 4,200,000 shares are designated as Series A-2 Preferred Stock, 3,853,797 of which are issued and outstanding, and 5,000,000 shares are undesignated. As of the Effective Date, all of the issued and outstanding Company Stock and other equity interests of the Company are set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.3(a)</span>, along with the beneficial and record owners thereof, all of which shares and other equity interests are owned free and clear of any Liens other than those imposed under the Company Charter. All of the outstanding shares and other equity interests of the Company have been duly authorized, are fully paid and non-assessable and not in violation of any purchase option, right of first refusal, preemptive right, subscription right or any similar right under any provision of the DGCL, any other applicable Law, the Company Charter or any Contract to which the Company is a party or by which it or its securities are bound. The Company holds no shares or other equity interests of the Company in its treasury. None of the outstanding shares or other equity interests of the Company were issued in violation of any applicable securities Laws. The rights, privileges and preferences of the Company Preferred Stock are as stated in the Company Charter and as provided by the DGCL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The Company has reserved (i) 1,500,000 shares of Company Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to the Company&#8217;s 2009 Equity Incentive Plan (the &#8220;<span style="font-style:italic;font-weight:bold;">2009 Plan</span>&#8221;), and (ii) 2,597,000 shares of Company Common Stock 2020 Stock Incentive Plan (the &#8220;<span style="font-style:italic;font-weight:bold;">2020 Plan</span>&#8221; and together with the 2009 Plan, the &#8220;<span style="font-style:italic;font-weight:bold;">Company Equity Plans</span>&#8221;), both of which Company Equity Plans were duly adopted by the Company&#8217;s board of directors and approved by the Company&#8217;s stockholders. Of such shares of Company Common Stock reserved for issuance under the 2009 Plan, (x) 403,000 options are currently issued and outstanding, and (y) no shares remain available for future awards permitted under the 2009 Plan. Of such shares of Company Common Stock reserved for issuance under the 2020 Plan, (x) 834,187 options are currently issued and outstanding, and (y) 1,762,813 shares remain available for future awards permitted under the 2020 Plan. The Company has furnished to the Purchaser complete and accurate copies of the Company Equity Plans and forms of agreements used thereunder. The Company has reserved 319,848 shares of Company Common Stock for issuance upon the exercise of outstanding Common Stock Warrants, and has issued Company Promissory Notes convertible into shares of Company Preferred Stock, with an aggregate outstanding principal amount of $4,450,000. Other than as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.3(b)</span>, there are no Company Convertible Securities, or preemptive rights or rights of first refusal or first offer, nor are there any Contracts, commitments, arrangements or restrictions to which the Company or, to the Knowledge of the Company, any of its stockholders is a party or bound relating to any equity securities of the Company, whether or not outstanding. There are no outstanding or authorized equity appreciation, phantom equity or similar rights with respect to the Company. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.3(b)</span>, there are no voting trusts, proxies, stockholder agreements or any other agreements or understandings with respect to the voting of the Company&#8217;s equity interests. Except as set forth in the Company Charter, there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any equity interests or securities of the Company, nor has the Company granted any registration rights to any Person with respect to the Company&#8217;s equity securities. All of the Company&#8217;s securities have been granted, offered, sold and issued in compliance with all applicable securities Laws. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.3(b)</span>, as a result of the consummation of the transactions contemplated by this Agreement, no equity interests of the Company are issuable, and no rights in connection with any interests, warrants, rights, options or other securities of the Company accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or otherwise).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>Except as disclosed in the Company Financials, since January 1, 2022, the Company has not declared or paid any distribution or dividend in respect of its equity interests and has not repurchased, redeemed or otherwise acquired any equity interests of the Company, and the board of directors of the Company has not authorized any of the foregoing.</p><a id="a44Subsidiaries_960415"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Subsidiaries</span>. <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.4</span> sets forth the name of each Subsidiary of the Company, and with respect to each Subsidiary (a) its jurisdiction of organization, (b) its authorized shares or other equity interests (if applicable), (c) the number of issued and outstanding shares or other equity interests and the record holders and beneficial owners thereof and (d) its Tax election to be treated as a corporate or a disregarded entity under the Code and any state or applicable non-U.S. Tax laws, if any. All of the outstanding equity securities of each Subsidiary of the Company are duly authorized and validly issued, fully paid and non-assessable (if applicable), and were offered, sold and delivered in compliance with all applicable securities Laws, and owned by one or more of the Company or its Subsidiaries free and clear of all Liens (other than those, if any, imposed by such Subsidiary&#8217;s Organizational Documents). There are no Contracts to which the Company or any of its Affiliates is a party or bound with respect to the voting (including voting trusts or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">proxies) of the equity interests of any Subsidiary of the Company other than the Organizational Documents of any such Subsidiary. There are no outstanding or authorized options, warrants, rights, agreements, subscriptions, convertible securities or commitments to which any Subsidiary of the Company is a party or which are binding upon any Subsidiary of the Company providing for the issuance or redemption of any equity interests of any Subsidiary of the Company. There are no outstanding equity appreciation, phantom equity, profit participation or similar rights granted by any Subsidiary of the Company. No Subsidiary of the Company has any limitation, whether by Contract, Order or applicable Law, on its ability to make any distributions or dividends to its equity holders or repay any debt owed to another Target Company. Except for the equity interests of the Subsidiaries listed on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.4</span>, the Company does not own or have any rights to acquire, directly or indirectly, any equity interests of, or otherwise Control, any Person. None of the Company or its Subsidiaries is a participant in any joint venture, partnership or similar arrangement. There are no outstanding contractual obligations of the Company or its Subsidiaries to provide funds to, or make any investment (in the form of a loan, capital contribution or otherwise) in, any other Person.</p><a id="a45GovernmentalApprovals_614722"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.5</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governmental Approvals</span>. Except as otherwise described in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.5</span>, no Consent of or with any Governmental Authority on the part of any Target Company is required to be obtained or made in connection with the execution, delivery or performance by the Company of this Agreement or any Ancillary Documents or the consummation by the Company of the transactions contemplated hereby or thereby other than (a) such filings as are expressly contemplated by this Agreement, (b) pursuant to Antitrust Laws, (c) the filing with the SEC of (A) the Registration Statement/Proxy Statement and the declaration of the effectiveness thereof by the SEC and (B) such reports under Section 13(a) or 15(d) of the Exchange Act as may be required in connection with this Agreement, the Transaction Documents or the transactions contemplated hereby or thereby, (d) filing of the Certificate of Merger or (e) any other consents, approvals, authorizations, designations, declarations, waivers or filings, the absence of which would not have a Company Material Adverse Effect.</p><a id="a46NonContravention_795918"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.6</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Contravention</span>. Except as otherwise described in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.6</span>, the execution and delivery by the Company (or any other Target Company, as applicable) of this Agreement and each Ancillary Document to which any Target Company is or is required to be a party or otherwise bound, and the consummation by any Target Company of the transactions contemplated hereby and thereby and compliance by any Target Company with any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of any Target Company&#8217;s Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 4.5</span> hereof, the waiting periods referred to therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable to any Target Company or any of its material properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by any Target Company under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of any Target Company under (other than Permitted Liens), (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of any Company Material Contract, except in the cases of clauses (b) and (c), as has not been and would not reasonably be expected to have a Company Material Adverse Effect on any Target Company or its ability to consummate the transactions contemplated by this Agreement or the Ancillary Documents or to perform such Target Company&#8217;s obligations hereunder or thereunder.</p><a id="a47FinancialStatements_812557"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.7</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Financial Statements</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>As used herein, the term &#8220;<span style="font-style:italic;font-weight:bold;">Company Financials</span>&#8221; means the (i) audited consolidated financial statements of the Target Companies on a consolidated basis (including, in each case, any related notes thereto), consisting of the consolidated balance sheets of the Target Companies as of December 31, 2021 and December 31, 2020, and the related consolidated audited income statements, changes in stockholder equity and statements of cash flows for the fiscal years then ended, each audited by a PCAOB qualified auditor in accordance with GAAP and PCAOB standards (the &#8220;<span style="font-style:italic;font-weight:bold;">Audited Company Financials</span>&#8221;), and (ii) the Company prepared and auditor reviewed financial statements, consisting of the consolidated balance sheet of the Target Companies on a consolidated basis as of February 28, 2022 (the &#8220;<span style="font-style:italic;font-weight:bold;">Interim Balance Sheet Date</span>&#8221;) and the related consolidated income statement, changes in stockholder equity and statement of cash flows for the two (2) months then ended. True and correct copies of the Company Financials have been provided to the Purchaser. The Company Financials (i) accurately reflect the books and records of the Target Companies on a consolidated basis as of the times and for the periods referred to therein, (ii) were prepared in accordance with GAAP, consistently applied throughout and among the periods involved (except that the unaudited statements exclude the footnote disclosures and other presentation items required for GAAP and exclude year-end adjustments which will not be material in amount), (iii) comply in all material respects with all applicable accounting requirements under the Securities </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Act and the rules and regulations of the SEC thereunder, and (iv) fairly present in all material respects the consolidated financial position of the Target Companies on a consolidated basis as of the respective dates thereof and the consolidated results of the operations and cash flows of the Target Companies for the periods indicated. No Target Company has ever been subject to the reporting requirements of Sections 13(a) and 15(d) of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Each Target Company maintains accurate books and records reflecting its assets and Liabilities in all material respects, and maintains internal accounting controls that provide reasonable assurance that (i) such Target Company does not maintain any off-the-book accounts and that such Target Company&#8217;s assets are used only in accordance with such Target Company&#8217;s management policies and directives, (ii) transactions are executed with management&#8217;s authorization, (iii) transactions are recorded as necessary to permit preparation of the financial statements of such Target Company and to maintain accountability for such Target Company&#8217;s assets. All of the financial books and records of the Target Companies are complete and accurate in all material respects and have been maintained in the ordinary course consistent with past practice and in accordance with applicable Laws. No Target Company has been subject to or involved in any material fraud that involves management or other employees who have a significant role in the internal controls over financial reporting of any Target Company. In the past five (5) years, no Target Company or its Representatives has received any written complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies or methods of any Target Company or its internal accounting controls, including any material written complaint, allegation, assertion or claim that any Target Company has engaged in questionable accounting or auditing practices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>The Target Companies do not have any Indebtedness other than the Indebtedness set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.7(c)</span>, which schedule sets for the amounts (including principal and any accrued but unpaid interest or other obligations) with respect to such Indebtedness. Except as disclosed on<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> Schedule 4.7(c)</span>, no Indebtedness of any Target Company contains any restriction upon (i) the prepayment of any of such Indebtedness, (ii) the incurrence of Indebtedness by any Target Company, or (iii) the ability of the Target Companies to grant any Lien on their respective properties or assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.7(d)</span>, no Target Company is subject to any Liabilities or obligations (whether or not required to be reflected on a balance sheet prepared in accordance with GAAP), except for those that are either (i) adequately reflected or reserved on or provided for in the consolidated balance sheet of the Company and its Subsidiaries as of the Interim Balance Sheet Date contained in the Company Financials or (ii) not material and that were incurred after the Interim Balance Sheet Date in the ordinary course of business consistent with past practice (other than Liabilities for breach of any Contract or violation of any Law).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>All financial projections with respect to the Target Companies that were delivered by or on behalf of the Company to the Purchaser or its Representatives were prepared in good faith using assumptions that the Company believes to be reasonable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>All accounts, notes and other receivables, whether or not accrued, and whether or not billed, of the Target Companies (the &#8220;<span style="font-style:italic;font-weight:bold;">Accounts Receivable</span>&#8221;) arose from sales actually made or services actually performed in the ordinary course of business and represent valid obligations to a Target Company arising from its business. None of the Accounts Receivable are subject to any right of recourse, defense, deduction, return of goods, counterclaim, offset, or set off on the part of the obligor in excess of any amounts reserved therefore on the Company Financials. All of the Accounts Receivable are, to the Knowledge of the Company, fully collectible according to their terms in amounts not less than the aggregate amounts thereof carried on the books of the Target Companies (net of reserves) within ninety (90) days.</p><a id="a48AbsenceofCertainChanges_820578"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.8</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Absence of Certain Changes</span>. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.8</span>, since January 1, 2022, each Target Company has (a) conducted its business only in the ordinary course of business consistent with past practice, (b) not been subject to a Material Adverse Effect and (c) has not taken any action or committed or agreed to take any action that would be prohibited by <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.2(b)</span> (without giving effect to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 5.2)</span> if such action were taken on or after the date hereof without the consent of the Purchaser.</p><a id="a49CompliancewithLaws_264470"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.9</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Laws</span>. Since January 1, 2019, no Target Company is or has been in material conflict or material non-compliance with, or in material default or violation of, nor has any Target Company received, since January 1, 2019, any written or, to the actual Knowledge of the Company without inquiry, oral notice of any material conflict or non-compliance with, or material default or violation of, any applicable Laws by which it or any of its properties, assets, employees, business, products or operations are or were bound or affected. For purposes of this Section 4.9, &#8220;material&#8221; shall mean material to the Company and its Subsidiaries taken as a whole.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a410CompanyPermits_772776"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.10</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company Permits</span>. Each Target Company holds all Permits necessary to lawfully conduct in all material respects its business as presently conducted; to own, lease and operate its assets and properties; and to conduct its business as currently conducted (collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Company Permits</span>&#8221;). The Company has made available to the Purchaser true, correct and complete copies of all material Company Permits. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.10</span>, all of the Company Permits are in full force and effect, and no suspension or cancellation of any of the Company Permits is pending or, to the Company&#8217;s knowledge, threatened. No Target Company is in violation in any material respect of the terms of any Company Permit, and no Target Company has received any written notice of any Actions relating to the revocation or modification of any Company Permit.</p><a id="a411Litigation_353313"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.11</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Litigation</span>. Except as described on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.11</span>, there is no (a) Action of any nature currently pending or, to the Company&#8217;s Knowledge, threatened in writing, and no such Action has been brought by the Company in the past five (5) years; or (b) Order now, to the Company&#8217;s knowledge, pending, or outstanding or that was rendered by a Governmental Authority in the past five (5) years, in either case of (a) or (b) by or against any Target Company, or to the Company&#8217;s knowledge, by or against its current or former directors, officers or equity holders (provided, that any litigation involving the directors, officers or equity holders of a Target Company must be directly related to their service as a director, officer or equity holder of the Target Company, its business, equity securities or assets). The items listed on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.11</span>, if finally determined adversely to the Target Companies, will not have, either individually or in the aggregate, a Material Adverse Effect upon any Target Company. In the past five (5) years, to the Company&#8217;s Knowledge, none of the current or former officers or directors of any Target Company has been charged with, indicted for, arrested for, or convicted of any felony or any crime involving fraud.</p><a id="a412MaterialContracts_115393"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.12</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Material Contracts</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.12(a)</span> sets forth a true, correct and complete list of, and the Company has made available to the Purchaser true, correct and complete copies of, each Contract to which any Target Company is a party or by which any Target Company, or any of its properties or assets are bound or affected (each Contract required to be set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.12(a)</span>, other than a Company Benefit Plan, a &#8220;<span style="font-style:italic;font-weight:bold;">Company Material Contract</span>&#8221;) that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>contains covenants that materially limit the ability of any Target Company (A) to compete in any line of business or with any Person or in any geographic area or to sell, or provide any service or product or solicit any Person, including any non-competition covenants, employee and customer non-solicit covenants, exclusivity restrictions, rights of first refusal or most-favored pricing clauses or (B) to purchase or acquire an interest in any other Person;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>involves any joint venture, profit-sharing, partnership, limited liability company or other similar agreement or arrangement relating to the formation, creation, operation, management or control of any partnership or joint venture;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>involves any exchange traded, over the counter or other swap, cap, floor, collar, futures contract, forward contract, option or other derivative financial instrument or Contract, based on any commodity, security, instrument, asset, rate or index of any kind or nature whatsoever, whether tangible or intangible, including currencies, interest rates, foreign currency and indices;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>evidences Indebtedness (whether incurred, assumed, guaranteed or secured by any asset) of any Target Company having an outstanding principal amount in excess of $25,000;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span>involves the acquisition or disposition, directly or indirectly (by merger or otherwise), of assets with an aggregate value in excess of $250,000 (other than in the ordinary course of business consistent with past practice) or shares or other equity interests of any Target Company or another Person;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vi)</span></span>relates to any merger, consolidation or other business combination with any other Person or the acquisition or disposition of any other entity or its business or material assets or the sale of any Target Company, its business or material assets;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(vii)&#160;&#160;by its terms, individually or with all related Contracts, calls for aggregate payments or receipts by the Target Companies under such Contract or Contracts of at least $25,000 per year or $100,000 in the aggregate;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(viii)&#160;&#160;is with any Top Customer or Top Supplier;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ix)</span></span>obligates the Target Companies to provide continuing indemnification or a guarantee of obligations of a third party after the date hereof in excess of $25,000;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(x)</span></span>is between any Target Company and any directors, officers or employees of a Target Company (other than at-will employment arrangements with employees entered into in the ordinary course of business consistent with past practice), including all non-competition, severance and indemnification agreements, or any Related Person;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xi)</span></span>obligates the Target Companies to make any capital commitment or expenditure in excess of $25,000 (including pursuant to any joint venture);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xii)</span></span>relates to a material settlement entered into within two (2) years prior to the date of this Agreement or under which any Target Company has outstanding obligations (other than customary confidentiality obligations);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xiii)&#160;&#160;provides another Person (other than another Target Company or any manager, director or officer of any Target Company) with a power of attorney;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xiv)&#160;&#160;relates to the development, ownership, licensing or use of any Intellectual Property by, to or from any Target Company, other than (A) Off-the-Shelf Software, (B) employee or consultant invention assignment agreements entered into on a Target Company&#8217;s standard form of such agreement, (C) confidentiality agreements entered into in the ordinary course of business, (D) non-exclusive licenses from customers or distributors to any Target Company entered into in the ordinary course of business or (E) feedback and ordinary course trade name or logo rights that are not material to any Target Company;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xv)</span></span>that will be required to be filed with the Registration Statement under applicable SEC requirements or would otherwise be required to be filed by the Company as an exhibit for a Form S-1 pursuant to Items 601(b)(1), (2), (4), (9) or (10) of Regulation S-K under the Securities Act as if the Company was the registrant; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xvi)&#160;&#160;is otherwise material to the Company and its Subsidiaries taken as a whole and not described in clauses (i) through (xv) above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Except as disclosed in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.12(b)</span>, with respect to each Company Material Contract: (i) such Company Material Contract is valid and binding and enforceable in all respects against the Target Company party thereto and, to the Knowledge of the Company, each other party thereto, and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions); (ii) the consummation of the transactions contemplated by this Agreement will not affect the validity or enforceability of any Company Material Contract; (iii) no Target Company is in breach or default in any material respect, and, to the Knowledge of the Company, no event has occurred that with the passage of time or giving of notice or both would constitute a material breach or default by any Target Company, or permit termination or acceleration by the other party thereto, under such Company Material Contract; (iv) to the Knowledge of the Company, no other party to such Company Material Contract is in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute such a material breach or default by such other party, or permit termination or acceleration by any Target Company, under such Company Material Contract; (v) no Target Company has received written or, to the Company&#8217;s Knowledge, notice of an intention by any party to any such Company Material Contract that provides for a continuing obligation by any party thereto to terminate such Company Material Contract or amend the terms thereof, other than modifications in the ordinary course of business that do not adversely affect any Target Company in any material respect; and (vi) no Target Company has waived any material rights under any such Company Material Contract.</p><a id="a413IntellectualProperty_48027"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">4.13&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Intellectual Property</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.13(a)(i)</span> sets forth: (i) all U.S. and foreign registered Patents, Trademarks, Copyrights and Internet Assets and applications owned or licensed by a Target Company or otherwise used or held for use by a Target Company in which a Target Company is the owner, applicant or assignee (&#8220;<span style="font-style:italic;font-weight:bold;">Company Registered IP</span>&#8221;), specifying as to each item, as applicable: (A) the nature of the item, including the title, (B) the owner of the item, (C) the jurisdictions in which the item is issued or registered or in which an application for issuance or registration has been filed and (D) the issuance, registration or application numbers and dates; and (ii) all material unregistered Intellectual Property owned or purported to be owned by a Target Company. <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.13(a)(ii)</span> sets forth all Intellectual Property licenses, sublicenses and other agreements or permissions (&#8220;<span style="font-style:italic;font-weight:bold;">Company IP Licenses</span>&#8221;) (other than &#8220;shrink wrap,&#8221; &#8220;click wrap,&#8221; and &#8220;off the shelf&#8221; software agreements and other agreements for Software commercially </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">available on reasonable terms to the public generally with license, maintenance, support and other fees of less than $20,000 per year (collectively, &#8220;<span style="font-style:italic;font-weight:bold;">Off-the-Shelf Software</span>&#8221;), which are not required to be listed, although such licenses are &#8220;Company IP Licenses&#8221; as that term is used herein), under which a Target Company is a licensee or otherwise is authorized to use or practice any Intellectual Property, and describes (A) the applicable Intellectual Property licensed, sublicensed or used and (B) any royalties, license fees or other compensation due from a Target Company, if any. Each Target Company owns, free and clear of all Liens (other than Permitted Liens), has valid and enforceable rights in, and has the unrestricted right to use, sell, license, transfer or assign, all Intellectual Property currently used, licensed or held for use by such Target Company, and previously used or licensed by such Target Company, except for the Intellectual Property that is the subject of the Company IP Licenses. No item of Company Registered IP that consists of a pending Patent application fails to identify all pertinent inventors, and for each Patent and Patent application in the Company Registered IP, the Target Companies have obtained valid assignments of inventions from each inventor. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.13(a)(iii)</span>, all Company Registered IP is owned exclusively by the applicable Target Company without obligation to pay royalties, licensing fees or other fees, or otherwise account to any third party with respect to such Company Registered IP, and such Target Company has recorded assignments of all Company Registered IP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Each Target Company has a valid and enforceable license to use all Intellectual Property that is the subject of the Company IP Licenses applicable to such Target Company. The Company IP Licenses include all of the licenses, sublicenses and other agreements or permissions necessary to operate the Target Companies as presently conducted. Each Target Company has performed all obligations imposed on it in the Company IP Licenses, has made all payments required to date, and such Target Company is not, nor, to the Knowledge of the Company, is any other party thereto, in breach or default thereunder, nor has any event occurred that with notice or lapse of time or both would constitute a default thereunder. The continued use by the Target Companies of the Intellectual Property that is the subject of the Company IP Licenses in the same manner that it is currently being used is not restricted by any applicable license of any Target Company. All registrations for Copyrights, Patents, Trademarks and Internet Assets that are owned by or exclusively licensed to any Target Company are valid, in force and in good standing, with all required fees and maintenance fees having been paid with no Actions pending, and all applications to register any Copyrights, Patents and Trademarks are pending and in good standing, all without challenge of any kind. No Target Company is party to any Contract that requires a Target Company to assign to any Person all of its rights in any Intellectual Property developed by a Target Company under such Contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.13(c)</span> sets forth all licenses, sublicenses and other agreements or permissions under which a Target Company is the licensor (each, an &#8220;<span style="font-style:italic;font-weight:bold;">Outbound IP License</span>&#8221;), and for each such Outbound IP License, describes (i) the applicable Intellectual Property licensed, (ii) the licensee under such Outbound IP License, and (iii) any royalties, license fees or other compensation due to a Target Company, if any. Each Target Company has performed all obligations imposed on it in the Outbound IP Licenses, and such Target Company is not, nor, to the Knowledge of the Company, is any other party thereto, in breach or default thereunder, nor has any event occurred that with notice or lapse of time or both would constitute a default thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>No Action is pending or, to the Company&#8217;s Knowledge, threatened against a Target Company that challenges the validity, enforceability, ownership, or right to use, sell, license or sublicense, or that otherwise relates to, any Intellectual Property currently owned, licensed, used or held for use by the Target Companies, nor, to the Knowledge of the Company, is there any reasonable basis for any such Action. No Target Company has received any written or, to the Knowledge of the Company, oral notice or claim asserting or suggesting that any infringement, misappropriation, violation, dilution or unauthorized use of the Intellectual Property of any other Person is or may be occurring or has or may have occurred, as a consequence of the business activities of any Target Company, nor to the Knowledge of the Company is there a reasonable basis therefor. There are no Orders to which any Target Company is a party or its otherwise bound that (i) restrict the rights of a Target Company to use, transfer, license or enforce any Intellectual Property owned by a Target Company, (ii) restrict the conduct of the business of a Target Company in order to accommodate a third Person&#8217;s Intellectual Property, or (iii) other than the Outbound IP Licenses, grant any third Person any right with respect to any Intellectual Property owned by a Target Company. No Target Company is currently infringing, or has, in the past, infringed, misappropriated or violated any Intellectual Property of any other Person in any material respect in connection with the ownership, use or license of any Intellectual Property owned or purported to be owned by a Target Company or, to the Knowledge of the Company, otherwise in connection with the conduct of the respective businesses of the Target Companies. To the Company&#8217;s Knowledge, no third party is currently, or in the past five (5) years has been, infringing upon, misappropriating or otherwise violating any Intellectual Property owned, licensed by, licensed to, or otherwise used or held for use by any Target Company (&#8220;<span style="font-style:italic;font-weight:bold;">Company IP</span>&#8221;) in any material respect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>All officers, directors, employees and independent contractors (to the extent any such independent contractor had access to Intellectual Property of a Target Company) of a Target Company (and each of their respective Affiliates) have assigned to the Target Companies all Intellectual Property arising from the services performed for a Target Company by such Persons and all </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">such assignments of Company Registered IP have been recorded. No current or former officers, employees or independent contractors of a Target Company have claimed any ownership interest in any Intellectual Property owned by a Target Company. To the Knowledge of the Company, there has been no violation of a Target Company&#8217;s policies or practices related to protection of Company IP or any confidentiality or nondisclosure Contract relating to the Intellectual Property owned by a Target Company. The Company has made available to the Purchaser true and complete copies of all written Contracts referenced in subsections under which employees and independent contractors assigned their Intellectual Property to a Target Company. To the Company&#8217;s Knowledge, none of the employees of any Target Company is obligated under any Contract, or subject to any Order, that would materially interfere with the use of such employee&#8217;s best efforts to promote the interests of the Target Companies, or that would materially conflict with the business of any Target Company as presently conducted or contemplated to be conducted. Each Target Company has taken reasonable security measures in order to protect the secrecy, confidentiality and value of the material Company IP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>To the Knowledge of the Company, no Person has obtained unauthorized access to third party information and data (including personally identifiable information or information that can be used to identify a natural person (&#8220;personal information&#8221;)) in the possession of a Target Company, nor has there been any other material compromise of the security, confidentiality or integrity of such information or data, and no written or, to the Knowledge of the Company, oral complaint relating to an improper use or disclosure of, or a breach in the security of, any such information or data has been received by a Target Company. Each Target Company has complied in all material respects with all applicable Laws and Contract requirements relating to privacy, personal information protection, and the collection, processing and use of personal information and its own privacy policies and guidelines, if any, each with respect to the Target Companies&#8217; collection, processing and use of personal information. To the Knowledge of the Company, the operation of the business of the Target Companies has not and does not violate any right to privacy or publicity of any third person, or constitute unfair competition or trade practices under applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>The consummation of any of the transactions contemplated by this Agreement will not result in the material breach, material modification, cancellation, termination, suspension of, or acceleration of any payments with respect to, or release of source code because of, (i) any Contract providing for the license or other use of Intellectual Property owned by a Target Company, or (ii) any Company IP License. Following the Closing, the Company shall be permitted to exercise, directly or indirectly through its Subsidiaries, all of the Target Companies&#8217; rights under such Contracts or Company IP Licenses to the same extent that the Target Companies would have been able to exercise had the transactions contemplated by this Agreement not occurred, without the payment of any additional amounts or consideration other than ongoing fees, royalties or payments which the Target Companies would otherwise be required to pay in the absence of such transactions.</p><a id="a414TaxesandReturns_889224"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.14</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Taxes and Returns</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Each Target Company has or will have timely filed, or caused to be timely filed, all federal, state, local and foreign Tax Returns required to be filed by it (taking into account all available extensions), which Tax Returns are true, accurate, correct and complete in all material respects, and has paid, collected or withheld, or caused to be paid, collected or withheld, all Taxes required to be paid, collected or withheld, other than such Taxes for which adequate reserves in the Company Financials have been established. Each Target Company has complied in all material respects with all applicable Laws relating to Tax.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>There is no Action currently pending or, to the Knowledge of the Company, threatened in writing against a Target Company by a Governmental Authority in a jurisdiction where the Target Company does not file Tax Returns that it is or may be subject to taxation by that jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>No Target Company is being audited by any Governmental Authority or has been notified in writing by any Governmental Authority that any such audit is contemplated or pending. There are no claims, assessments, audits, examinations, investigations or other Actions pending against a Target Company in respect of any Tax, and no Target Company has been notified in writing of any proposed Tax claims or assessments against it (other than, in each case, claims or assessments for which adequate reserves in the Company Financials have been established).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>There are no Liens with respect to any Taxes upon any Target Company&#8217;s assets, other than Permitted Liens.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>No Target Company has any outstanding waivers or extensions of any applicable statute of limitations to assess any amount of Taxes. There are no outstanding requests by a Target Company for any extension of time within which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>No Target Company has made any change in accounting method (except as required by a change in Law) or received a ruling from, or signed an agreement with, any Governmental Authority that would reasonably be expected to have a material impact on its Taxes following the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>No Target Company has engaged in any &#8220;listed transaction,&#8221; as defined in U.S. Treasury Regulation section 1.6011-4(b)(2).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span>No Target Company has any Liability for the Taxes of another Person (other than another Target Company) that are not adequately reflected in the Company Financials (i) under any applicable Tax Law, (ii) as a transferee or successor, or (iii) by contract or indemnity (excluding commercial agreements entered into in the ordinary course of business the primary purpose of which is not the sharing of Taxes). No Target Company is a party to or bound by any Tax indemnity agreement, Tax sharing agreement or Tax allocation agreement or similar agreement, arrangement or practice (excluding commercial agreements, arrangements or practices entered into in the ordinary course of business the primary purpose of which is not the sharing of Taxes) with respect to Taxes (including advance pricing agreement, closing agreement or other agreement relating to Taxes with any Governmental Authority) that will be binding on any Target Company with respect to any period following the Closing Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>No Target Company has requested, or is it the subject of or bound by any private letter ruling, technical advice memorandum, closing agreement or similar ruling, memorandum or agreement with any Governmental Authority with respect to any Taxes, nor is any such request outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span>No Target Company: (i) has constituted either a &#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of securities (to any Person or entity that is not a member of the consolidated group of which the Company is the common parent corporation) qualifying for, or intended to qualify for, Tax-free treatment under Section 355 of the Code (A) within the two- year period ending on the date hereof or (B) in a distribution which could otherwise constitute part of a &#8220;plan&#8221; or &#8220;series of related transactions&#8221; (within the meaning of Section 355(e) of the Code) in conjunction with the transactions contemplated by this Agreement; or (ii) is or has ever been (A) a U.S. real property holding corporation within the meaning of Section 897(c)(2) of the Code, or (B) a member of any consolidated, combined, unitary or affiliated group of corporations for any Tax purposes other than a group of which the Company is or was the common parent corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span>To the Knowledge of the Company, no Target Company is aware of any fact or circumstance that would reasonably be expected to prevent the Merger from qualifying as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code.</p><a id="a415RealProperty_461502"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">4.15&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Real Property</span>. <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.15</span> contains a complete and accurate list of all premises currently leased or subleased or otherwise used or occupied by a Target Company for the operation of the business of a Target Company, and of all current leases, lease guarantees, agreements and documents related thereto, including all amendments, terminations and modifications thereof or waivers thereto (collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Company Real Property Leases</span>&#8221;), as well as the current annual rent and term under each Company Real Property Lease. The Company has provided to the Purchaser a true and complete copy of each of the Company Real Property Leases. The Company Real Property Leases are valid, binding and enforceable in accordance with their terms and are in full force and effect, subject to Enforceability Exceptions. To the Knowledge of the Company, no event has occurred which (whether with or without notice, lapse of time or both or the happening or occurrence of any other event) would constitute a default on the part of a Target Company or any other party under any of the Company Real Property Leases, and no Target Company has received notice of any such condition. No Target Company owns or has ever owned any real property or any interest in real property (other than the leasehold interests in the Company Real Property Leases).</p><a id="a416PersonalProperty_569101"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.16</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Personal Property</span>. Each item of Personal Property which is currently owned, used or leased by a Target Company with a book value or fair market value of greater than Fifty Thousand Dollars ($50,000) is set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.16</span>, along with, to the extent applicable, a list of lease agreements, lease guarantees, security agreements and other agreements related thereto, including all amendments, terminations and modifications thereof or waivers thereto (&#8220;<span style="font-style:italic;font-weight:bold;">Company Personal Property Leases</span>&#8221;). Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.16</span>, all such items of Personal Property are in good operating condition and repair (reasonable wear and tear excepted consistent with the age of such items) and are suitable for their intended use in the business of the Target Companies. The operation of each Target Company&#8217;s business as it is now conducted is not in any material respect dependent upon the right to use the Personal Property of Persons other than a Target Company, except for such Personal Property that is owned, leased or licensed by or otherwise contracted to a Target Company. The Company has provided to the Purchaser a true and complete copy of each of the Company Personal Property Leases. The Company Personal Property Leases are valid, binding and enforceable in accordance with their terms and are in full force and effect. To the Knowledge of the Company, no event has occurred which (whether with or without notice, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">lapse of time or both or the happening or occurrence of any other event) would constitute a default on the part of a Target Company or any other party under any of the Company Personal Property Leases, and no Target Company has received notice of any such condition.</p><a id="a417TitletoandSufficiencyofAssets_577619"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">4.17&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Title to and Sufficiency of Assets</span>. Each Target Company has good and marketable title to, or a valid leasehold interest in or right to use, all of its assets, free and clear of all Liens other than (a) Permitted Liens, (b) the rights of lessors under leasehold interests, (c) Liens specifically identified on the consolidated balance sheet of the Target Companies as of the Interim Balance Sheet Date and (d) Liens set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.17</span>. The assets (including Intellectual Property rights and contractual rights) of the Target Companies constitute all of the assets, rights and properties that are used in the operation of the businesses of the Target Companies as it is now conducted or that are used or held by the Target Companies for use in the operation of the businesses of the Target Companies, and taken together, are adequate and sufficient for the operation of the businesses of the Target Companies as currently conducted.</p><a id="a418EmployeeMatters_820038"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.18</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employee Matters</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(a)</span>, no Target Company is a party to any collective bargaining agreement or other Contract covering any group of employees, labor organization or other representative of any of the employees of any Target Company, and the Company has no Knowledge of any activities or proceedings of any labor union or other party to organize or represent such employees. There has not occurred or been threatened in writing any strike, slow-down, picketing, work-stoppage, or other similar labor activity with respect to any such employees. <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(a)</span> sets forth all unresolved labor controversies (including unresolved grievances and age or other discrimination claims other than any workers&#8217; compensation or unemployment claims), if any, that are pending or threatened in writing between any Target Company and Persons employed by or providing services as independent contractors to a Target Company. No current officer or employee of a Target Company has provided any Target Company written or, to the Knowledge of the Company, oral notice of his or her plan to terminate his or her employment with any Target Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(b)</span>, each Target Company (i) is and has been in compliance in all material respects with all applicable Laws respecting employment and employment practices, terms and conditions of employment, health and safety and wages and hours, and other Laws relating to discrimination, disability, labor relations, hours of work, payment of wages and overtime wages, pay equity, immigration, workers compensation, working conditions, employee scheduling, occupational safety and health, family and medical leave, and employee terminations, and has not received written notice that there is any pending Action involving unfair labor practices against a Target Company, (ii) is not liable for any material past due arrears of wages or any material penalty for failure to comply with any of the foregoing, and (iii) is not liable for any material payment to any Governmental Authority with respect to unemployment compensation benefits, social security or other benefits or obligations for employees, independent contractors or consultants (other than routine payments to be made in the ordinary course of business and consistent with past practice). Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(b)</span>, there are no Actions pending or threatened in writing against a Target Company brought by or on behalf of any applicant for employment, any current or former employee, any Person alleging to be a current or former employee, or any Governmental Authority, relating to any such Law or regulation, or alleging breach of any express or implied contract of employment, wrongful termination of employment, or alleging any other discriminatory, wrongful or tortious conduct in connection with the employment relationship.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(c)</span> hereto sets forth a complete and accurate list as of the date hereof of all employees of the Target Companies showing for each as of such date (i) the employee&#8217;s name, job title or description, employer, location, salary or hourly rate; and (ii) wages, bonus, commission or other compensation paid during the fiscal year ending December 31, 2021. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(c)</span>, (A) no employee is a party to a written employment Contract with a Target Company that is not terminable &#8220;at will,&#8221; and (B) the Target Companies have paid in full to all their employees all wages, salaries, commission, bonuses and other compensation due to their employees, including overtime compensation, and, except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(c)</span>, no Target Company has any obligation or Liability (whether or not contingent) with respect to severance payments to any such employees under the terms of any written agreement, or commitment or any applicable Law, custom, trade or practice. Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(c)</span>, each Target Company employee has entered into the Company&#8217;s standard form of employee non-disclosure, inventions and restrictive covenants agreement with a Target Company (whether pursuant to a separate agreement or incorporated as part of such employee&#8217;s overall employment agreement), a copy of which has been made available to the Purchaser by the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(d)</span> contains a list of all independent contractors (including consultants) currently engaged by any Target Company, along with a description of the general nature of the work performed, date of retention and rate of remuneration, most recent increase (or decrease) in remuneration and amount thereof, for each such Person. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(d)</span>, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">all of such independent contractors are a party to a written Contract with a Target Company. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(d)</span>, each such independent contractor has entered into customary covenants regarding confidentiality and assignment of inventions and copyrights in such Person&#8217;s agreement with a Target Company, a copy of which has been provided to the Purchaser by the Company. To the Company&#8217;s knowledge, no material Company liability exists related to the classification of any individual as an independent contractor who is currently, or within the last six (6) years has been, engaged by a Target Company. Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.18(d)</span>, each independent contractor is terminable on fewer than thirty (30) days&#8217; notice, without any obligation of any Target Company to pay severance or a termination fee.</p><a id="a419BenefitPlans_169045"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.19</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Benefit Plans</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.19(a)</span> is a true and complete list of each Benefit Plan of a Target Company (each, a &#8220;<span style="font-style:italic;font-weight:bold;">Company Benefit Plan</span>&#8221;). With respect to each Company Benefit Plan, there are no funded benefit obligations for which contributions have not been made or properly accrued and there are no unfunded benefit obligations that have not been accounted for by reserves, or otherwise properly footnoted in accordance with GAAP on the Company Financials. No Target Company is or has in the past been a member of a &#8220;controlled group&#8221; for purposes of Section 414(b), (c), (m) or (o) of the Code, nor does any Target Company have any Liability with respect to any collectively-bargained for plans, whether or not subject to the provisions of ERISA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Each Company Benefit Plan is and has been operated at all times in compliance with all applicable Laws in all material respects, including ERISA and the Code. Each Company Benefit Plan which is intended to be &#8220;qualified&#8221; within the meaning of Section 401(a) of the Code (i) has been determined by the IRS to be so qualified (or is based on a prototype plan which has received a favorable opinion letter) during the period from its adoption to the date of this Agreement and (ii) its related trust has been determined to be exempt from taxation under Section 501(a) of the Code or the Target Companies have requested an initial favorable IRS determination of qualification and/or exemption within the period permitted by applicable Law. To the Company&#8217;s Knowledge, no fact exists which could adversely affect the qualified status of such Company Benefit Plans or the exempt status of such trusts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>With respect to each Company Benefit Plan which covers any current or former officer, director, consultant or employee (or beneficiary thereof) of a Target Company, the Company has provided to Purchaser accurate and complete copies, if applicable, of: (i) all Company Benefit Plan documents and agreements and related trust agreements or annuity Contracts (including any amendments, modifications or supplements thereto); (ii) all summary plan descriptions and summary of material modifications thereto; (iii) the three (3) most recent Forms 5500, if applicable, and annual report, including all schedules thereto; (iv) the most recent annual and periodic accounting of plan assets; (v) the three (3) most recent nondiscrimination testing reports; (vi) the most recent determination letter received from the IRS, if any; (vii) the most recent actuarial valuation; and (viii) all material communications with any Governmental Authority within the last three (3) years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>With respect to each Company Benefit Plan: (i) such Company Benefit Plan has been administered and enforced in all material respects in accordance with its terms, the Code and ERISA; (ii) no breach of fiduciary duty has occurred; (iii) no Action is pending or threatened in writing (other than routine claims for benefits arising in the ordinary course of administration); (iv) no prohibited transaction, as defined in Section 406 of ERISA or Section 4975 of the Code, has occurred, excluding transactions effected pursuant to a statutory or administration exemption; and (v) all contributions and premiums due through the Closing Date have been made in all material respects as required under ERISA or have been fully accrued in all material respects on the Company Financials.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>No Company Benefit Plan is a &#8220;defined benefit plan&#8221; (as defined in Section 414(j) of the Code), a &#8220;multiemployer plan&#8221; (as defined in Section 3(37) of ERISA) or a &#8220;multiple employer plan&#8221; (as described in Section 413(c) of the Code) or is otherwise subject to Title IV of ERISA or Section 412 of the Code, and no Target Company has incurred any Liability or otherwise could have any Liability, contingent or otherwise, under Title IV of ERISA and no condition presently exists that is expected to cause such Liability to be incurred. No Company Benefit Plan will become a multiple employer plan with respect to any Target Company immediately after the Closing Date. No Target Company currently maintains or has ever maintained, or is required currently or has ever been required to contribute to or otherwise participate in, a multiple employer welfare arrangement or voluntary employees&#8217; beneficiary association as defined in Section 501(c)(9) of the Code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>No arrangement exists pursuant to which a Target Company will be required to &#8220;gross up&#8221; or otherwise compensate any person because of the imposition of any excise tax on a payment to such person.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>With respect to each Company Benefit Plan which is a &#8220;welfare plan&#8221; (as described in Section 3(1) of ERISA): (i) no such plan provides medical or death benefits with respect to current or former employees of a Target Company beyond their termination of employment (other than coverage mandated by Law, which is paid solely by such employees); and (ii) there are no reserves, assets, surplus or prepaid premiums under any such plan. Each Target Company has complied in all material respects with the provisions of Section 601 et seq. of ERISA and Section 4980B of the Code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span>Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.19(h)</span>, the consummation of the transactions contemplated by this Agreement and the Ancillary Documents will not: (i) entitle any individual to severance pay, unemployment compensation or other benefits or compensation (except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.19(a))</span>; (ii) accelerate the time of payment or vesting, or increase the amount of any compensation due, or in respect of, any individual; or (iii) result in or satisfy a condition to the payment of compensation that would, in combination with any other payment, result in an &#8220;excess parachute payment&#8221; within the meaning of Section 280G of the Code. No Target Company has incurred any Liability for any Tax imposed under Chapter 43 of the Code or civil liability under Section 502(i) or (l) of ERISA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>All Company Benefit Plans can be terminated at any time prior to the Closing Date without resulting in any Liability to the Surviving Corporation or Purchaser or their respective Affiliates for any additional contributions, penalties, premiums, fees, fines, excise taxes or any other charges or liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span>Each Company Benefit Plan that is subject to Section 409A of the Code (each, a &#8220;<span style="font-style:italic;font-weight:bold;">Section 409A Plan</span>&#8221;) as of the Closing Date is indicated as such on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.19(j)</span>. No options or other equity-based awards have been issued or granted by the Company that are, or are subject to, a Section 409A Plan. Each Section 409A Plan has been administered in compliance, and is in documentary compliance, in all material respects, with the applicable provisions of Section 409A of the Code, the regulations thereunder and other official guidance issued thereunder. No Target Company has any obligation to any employee or other service provider with respect to any Section 409A Plan that may be subject to any Tax under Section 409A of the Code. No payment to be made under any Section 409A Plan is, or to the Knowledge of the Company will be, subject to the penalties of Section 409A(a)(1) of the Code. There is no Contract or plan to which any Target Company is a party or by which it is bound to compensate any employee, consultant or director for penalty taxes paid pursuant to Section 409A of the Code.</p><a id="a420EnvironmentalMatters_640656"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">4.20&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Environmental Matters</span>. Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.20</span>, each Target Company is and has been in compliance in all material respects with all applicable Environmental Laws. No Target Company has manufactured, treated, stored, disposed of, arranged for or permitted the disposal of, generated, handled or released any Hazardous Material, or operated any property or facility in a manner that has given or would reasonably be expected to give rise to any material Liability or obligation under applicable Environmental Laws. To the actual knowledge of the Company without inquiry, there is not located at any commercial office space leased by a Target Company any (i) underground storage tanks, (ii) asbestos-containing material, or (iii) equipment containing polychlorinated biphenyls.</p><a id="a421TransactionswithRelatedPersons_42368"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">4.21&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transactions with Related Persons</span>. Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.21</span>, no Target Company nor any of its Affiliates, nor any officer, director, manager, employee, trustee or beneficiary of a Target Company or any of its Affiliates, nor any immediate family member of any of the foregoing (whether directly or indirectly through an Affiliate of such Person) (each of the foregoing, a &#8220;<span style="font-style:italic;font-weight:bold;">Related Person</span>&#8221;) is presently, or in the past two (2) years, has been, a party to any transaction with a Target Company, including any Contract or other arrangement (a) providing for the furnishing of services by (other than as officers, directors or employees of the Target Company), (b) providing for the rental of real property or Personal Property from or (c) otherwise requiring payments to (other than for services or expenses as directors, officers or employees of the Target Company in the ordinary course of business consistent with past practice) any Related Person or any Person in which any Related Person has an interest as an owner, officer, manager, director, trustee or partner or in which any Related Person has any direct or indirect interest (other than the ownership of securities representing no more than two percent (2%) of the outstanding voting power or economic interest of a publicly traded company). Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.21</span>, no Target Company has outstanding any Contract or other arrangement or commitment with any Related Person, and no Related Person owns any real property or Personal Property, or right, tangible or intangible (including Intellectual Property) which is used in the business of any Target Company. The assets of the Target Companies do not include any material receivable or other obligation from a Related Person, and the liabilities of the Target Companies do not include any material payable or other obligation or commitment to any Related Person.</p><a id="a422Insurance_206926"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.22</span></span>&#160;Insurance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.22(a)</span> lists all insurance policies (by policy number, insurer, coverage period, coverage amount, annual premium and type of policy) held by a Target Company relating to a Target Company or its business, properties, assets, directors, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">officers and employees, copies of which have been provided to the Purchaser. All premiums due and payable under all such insurance policies have been timely paid and the Target Companies are otherwise in material compliance with the terms of such insurance policies. Each such insurance policy (i) is legal, valid, binding, enforceable and in full force and effect and (ii) will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the Closing. No Target Company has any self-insurance or co-insurance programs. In the past five (5) years, no Target Company has received any written notice from, or on behalf of, any insurance carrier relating to or involving any adverse change or any change other than in the ordinary course of business, in the conditions of insurance, any refusal to issue an insurance policy or non-renewal of a policy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.22(b)</span> identifies each individual insurance claim in excess of $50,000 made by a Target Company in the past five (5) years. Each Target Company has reported to its insurers all claims and pending circumstances that would reasonably be expected to result in a claim, except where such failure to report such a claim would not be reasonably likely to have a material adverse effect on the Target Companies as a whole. To the Knowledge of the Company, no event has occurred, and no condition or circumstance exists, that would reasonably be expected to (with or without notice or lapse of time) give rise to or serve as a basis for the denial of any such insurance claim. In the three (3) years preceding the date hereof, no Target Company has made any claim against an insurance policy as to which the insurer is denying coverage.</p><a id="a423BooksandRecords_27928"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.23</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Books and Records</span>. All of the financial books and records of the Target Companies are complete and accurate in all material respects and have been maintained in the ordinary course of business consistent with past practice and in accordance with applicable Laws.</p><a id="a424TopCustomersandSuppliers_741680"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.24</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Top Customers and Suppliers. Schedule 4.24</span> lists, by dollar volume received or paid, as applicable, for each of (a) the twelve (12) months ended on December 31, 2021 and (b) the period from January 1, 2022 through the Interim Balance Sheet Date, the ten (10) largest customers of the Target Companies (the &#8220;<span style="font-style:italic;font-weight:bold;">Top Customers</span>&#8221;) and the ten largest suppliers of goods or services to the Target Companies (the &#8220;<span style="font-style:italic;font-weight:bold;">Top Suppliers</span>&#8221;), along with the amounts of such dollar volumes. The relationships of each Target Company with such suppliers and customers are good commercial working relationships and (i) no Top Supplier or Top Customer within the last twelve (12) months has cancelled or otherwise terminated, or, to the Company&#8217;s Knowledge, intends to cancel or otherwise terminate, any material relationships of such Person with a Target Company, (ii) no Top Supplier or Top Customer has during the last twelve (12) months decreased materially or threatened in writing to stop, decrease or limit materially, or intends to modify materially its material relationships with a Target Company or stop, decrease or limit materially its products or services to any Target Company or its usage or purchase of the products or services of any Target Company, (iii) no Top Supplier or Top Customer has threatened in writing to refuse to pay any amount due to any Target Company or seek to exercise any remedy against any Target Company, and (iv) no Target Company has within the past two (2) years been engaged in any material dispute with any Top Supplier or Top Customer.</p><a id="a425CertainBusinessPractices_743948"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">4.25&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certain Business Practices</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>No Target Company, nor any of their respective Representatives acting on their behalf has (i) used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign Corrupt Practices Act of 1977 or any other local or foreign anti-corruption or bribery Law or (iii) made any other unlawful payment. No Target Company, nor to the Knowledge of the Company, any of their respective Representatives acting on the Target Company&#8217;s behalf has directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount to any customer, supplier, governmental employee or other Person who is or may be in a position to help or hinder any Target Company or assist any Target Company in connection with any actual or proposed transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The operations of each Target Company are and have been conducted at all times in compliance with money laundering statutes in all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority, and no Action involving a Target Company with respect to any of the foregoing is pending or threatened in writing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>No Target Company or any of their respective directors or officers, or, to the Knowledge of the Company, any other Representative acting on behalf of a Target Company is currently identified on the specially designated nationals or other blocked person list or otherwise currently subject to any U.S. sanctions administered by OFAC, and no Target Company has in the last five (5) fiscal years, directly or indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">or any other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to, or otherwise in violation of, any U.S. sanctions administered by OFAC.</p><a id="a426CompliancewithPrivacyLawsPrivacyPoli"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">4.26&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Privacy Laws, Privacy Policies and Certain Contracts</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Except as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.26(a)</span>:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Neither the Company, nor, the Knowledge of the Company, its officers, directors, managers, employees, agents, subcontractors and vendors to whom Company has given access to Personal Data or Protected Health Information, are and have been at all times, in compliance in all material respects with all applicable Privacy Laws;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Except as would not, individually or in the aggregate, have a Material Adverse Effect, to the Knowledge of the Company, the Company has not experienced any loss, damage or unauthorized access, use, disclosure or modification, or breach of security of Personal Data or Protected Health Information maintained by or on behalf of the Company (including, to the Knowledge of the Company, by any agent, subcontractor or vendor of the Company);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>Except as would not, individually or in the aggregate, have a Material Adverse Effect, to the Knowledge of the Company, (i) no Person, including any Governmental Authority, has made any written claim or commenced any Proceeding with respect to any violation of any Privacy Law by the Company (ii) the Company has not been given written notice of any criminal, civil or administrative violation of any Privacy Law, in any case including any claim or action with respect to any loss, damage or unauthorized access, use, disclosure, modification, or breach of security, of Personal Data or Protected Health Information maintained by or on behalf of the Company (including by any agent, subcontractor or vendor of the Company); and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>Neither the Company nor, to the Knowledge of the Company, any subcontractor agent or vendor of the Company, has incurred any breach of &#8220;unsecured protected health information&#8221; (as defined in 45 C.F.R. Part 164, Subpart D) requiring reporting to any Governmental Authority.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>To the Knowledge of the Company, all activities conducted by the Company with respect to any Protected Health Information or Personal Data are permitted under the Contracts relating to Personal Data or Protected Health Information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>To the Knowledge of the Company, each Contract between the Company and a customer of the Company contains all the terms and conditions that the Company is required to include therein under the Company&#8217;s Contracts with its vendors and suppliers.</p><a id="a427InvestmentCompanyAct_995641"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.27</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investment Company Act</span>. No Target Company is an &#8220;investment company&#8221; or a Person directly or indirectly &#8220;controlled&#8221; by or acting on behalf of an &#8220;investment company,&#8221; or required to register as an &#8220;investment company,&#8221; in each case within the meaning of the Investment Company Act of 1940, as amended.</p><a id="a428FindersandBrokers_854976"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">4.28&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Finders and Brokers</span>. Except as set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 4.28</span>, no Target Company has incurred or will incur any Liability for any brokerage, finder&#8217;s or other fee or commission in connection with the transactions contemplated hereby.</p><a id="a429IndependentInvestigation_791588"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">4.29&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Independent Investigation</span>. The Company has conducted its own independent investigation, review and analysis of the business, results of operations, prospects, condition (financial or otherwise) or assets of the Purchaser, and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of the Purchaser for such purpose. The Company acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of the Purchaser set forth in Agreement (including the related portions of the Purchaser Disclosure Schedules) and in any certificate delivered to the Company pursuant hereto; and (b) neither the Purchaser nor any of its Representatives have made any representation or warranty as to the Purchaser or this Agreement, except as expressly set forth in this Agreement (including the related portions of the Purchaser Disclosure Schedules) or in any certificate delivered to the Company pursuant hereto.</p><a id="a430InformationSupplied_159928"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.30</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Information Supplied</span>. None of the information supplied or to be supplied by the Company expressly for inclusion or incorporation by reference in the Registration Statement/Proxy Statement will, when filed, declared effective or first mailed or distributed to the Purchaser&#8217;s Stockholders, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">misleading. None of the information supplied or to be supplied by the Company expressly for inclusion or incorporation by reference in any of the Signing Press Release, the Signing Filing, the Closing Press Release and the Closing Filing will, when filed or distributed, as applicable, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, the Company makes no representation, warranty or covenant with respect to any information supplied by or on behalf of the Purchaser or its Affiliates, or any information provided by the Company and modified in any material respect by Purchaser or any of its Affiliates without the Company&#8217;s prior written approval.</p><a id="a431Disclosure_13559"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">4.31&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disclosure</span>. No representations or warranties by the Company in this Agreement (as modified by the Company Disclosure Schedules) or the Ancillary Documents, (a) contains or will contain any untrue statement of a material fact, or (b) omits or will omit to state, when read in conjunction with all of the information contained in this Agreement, the Company Disclosure Schedules and the Ancillary Documents, any fact necessary to make the statements or facts contained therein not materially misleading. Except for the representations and warranties expressly made by the Company in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article IV</span> (as modified by the Company Disclosure Schedules) or as expressly set forth in an Ancillary Document, no Target Company nor any other Person on its behalf makes any express or implied representation or warranty with respect to any of the Target Companies, the Company Security Holders, the Company Stock, the business of the Target Companies, or the transactions contemplated by this Agreement or any of the other Ancillary Documents, and the Company hereby expressly disclaims any other representations or warranties, whether implied or made by any Target Company or any of its Representatives. Except for the representations and warranties expressly made by the Company in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article IV</span> (as modified by the Company Disclosure Schedules) or in an Ancillary Document, the Company hereby expressly disclaims all liability and responsibility for any representation, warranty, projection, forecast, statement or information made, communicated or furnished in writing to the Purchaser, the Purchaser Representative or any of their respective Representatives (including any opinion, information, projection or advice that may have been or may be provided to the Purchaser, the Purchaser Representative or any of their respective Representatives by any Representative of the Company), including any representations or warranties regarding the probable success or profitability of the businesses of the Target Companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_a355b653_8a73_4a8f_872e_ab7facb69438"></a><a id="ARTICLEV_959013"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ARTICLE V</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">COVENANTS</b></p><a id="a51AccessandInformation_659606"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Access and Information</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>During the period from the date of this Agreement and continuing until the earlier of the termination of this Agreement in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8.1</span> or the Closing (the &#8220;<span style="font-style:italic;font-weight:bold;">Interim Period</span>&#8221;), subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.15</span>, the Company shall give, and shall cause its Representatives to give, the Purchaser and its Representatives, at reasonable times during normal business hours and upon reasonable intervals and notice, reasonable access to all offices and other facilities and to all employees, properties, Contracts, agreements, commitments, books and records, financial and operating data and other information (including Tax Returns and Contracts), of or pertaining to the Target Companies, as the Purchaser or its Representatives may reasonably request regarding the Target Companies and their respective businesses, assets, Liabilities, financial condition, prospects, operations, management, employees and other aspects (including unaudited quarterly financial statements, including a consolidated quarterly balance sheet and income statement, a copy of each material report, schedule and other document filed with or received by a Governmental Authority pursuant to the requirements of applicable securities Laws, and independent public accountants&#8217; work papers (subject to the consent or any other conditions required by such accountants, if any)) and cause each of the Company&#8217;s Representatives to reasonably cooperate with the Purchaser and its Representatives in their investigation; <i style="font-style:italic;">provided, however, </i>that the Purchaser and its Representatives shall conduct any such activities in such a manner as not to unreasonably interfere with the business or operations of the Target Companies; and provided further, the Company shall not be required to provide, or cause to be provided to, the Purchaser or any of its Representatives any information (i) if and to the extent doing so would (A) violate any Law to which any Target Company is subject, (B) result in the disclosure of any trade secrets of third parties in breach of any Contract with such third party, (C) violate any legally-binding obligation of any Target Company with respect to confidentiality, non-disclosure or privacy or (D) jeopardize protections afforded to any Target Company under the attorney-client privilege or the attorney work product doctrine; provided that in each case the Target Company shall cooperate with the Purchaser to effect disclosure of such information in a manner which does not result in such a breach, violation or jeopardization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>During the Interim Period, subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.15</span>, the Purchaser shall give, and shall cause its Representatives to give, the Company and its Representatives, at reasonable times during normal business hours and upon reasonable intervals and notice, reasonable access to all offices and other facilities and to all employees, properties, Contracts, agreements, commitments, books and records, financial and operating data and other information (including Tax Returns, internal working papers, client files, client Contracts and director service agreements), of or pertaining to the Purchaser or its Subsidiaries, as the Company or its </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Representatives may reasonably request regarding the Purchaser, its Subsidiaries and their respective businesses, assets, Liabilities, financial condition, prospects, operations, management, employees and other aspects (including unaudited quarterly financial statements, including a consolidated quarterly balance sheet and income statement, a copy of each material report, schedule and other document filed with or received by a Governmental Authority pursuant to the requirements of applicable securities Laws, and independent public accountants&#8217; work papers (subject to the consent or any other conditions required by such accountants, if any)) and cause each of the Purchaser&#8217;s Representatives to reasonably cooperate with the Company and its Representatives in their investigation<i style="font-style:italic;">; provided, however, </i>that the Company and its Representatives shall conduct any such activities in such a manner as not to unreasonably interfere with the business or operations of the Purchaser or any of its Subsidiaries.</p><a id="a52ConductofBusinessoftheCompany_77329"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conduct of Business of the Company</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Unless the Purchaser shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period, except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 5.2</span>, the Company shall, and shall cause its Subsidiaries to, (i) conduct their respective businesses, in all material respects, in the ordinary course of business consistent with past practice, (ii) comply with all Laws applicable to the Target Companies and their respective businesses, assets and employees, and (iii) take all commercially reasonable measures necessary or appropriate to preserve intact, in all material respects, their respective business organizations, to keep available the services of their respective managers, directors, officers, employees and consultants, and to preserve the possession, control and condition of their respective material assets, all as consistent with past practice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Without limiting the generality of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.2(a)</span> and except as contemplated by the terms of this Agreement or the Ancillary Documents as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 5.2</span>, during the Interim Period, without the prior written consent of the Purchaser (such consent not to be unreasonably withheld, conditioned or delayed), the Company shall not, and shall cause its Subsidiaries to not, except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 5.2(b)</span>:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span>amend, waive or otherwise change, in any respect, its Organizational Documents, except as required by applicable Law and to effect the transactions contemplated by this Agreement and the Ancillary Documents;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vi)</span></span>authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities, or other securities, including any securities convertible into or exchangeable for any of its shares or other equity securities or securities of any class and any other equity-based awards, other than the issuance of Company Stock upon the exercise of Company Warrants or Company Options or conversion of Company Promissory Notes outstanding as of the date hereof in accordance with their existing terms or pursuant to amendments necessary to effect the transactions contemplated by this Agreement, or engage in any hedging transaction with a third Person with respect to such securities;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vii)</span></span>split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities (except for the repurchase of Company Common Stock from former employees, non-employee directors and consultants in accordance with agreements as in effect on the date hereof providing for the repurchase of shares in connection with any termination of service);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(viii)&#160;incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $25,000 individually or $100,000 in the aggregate, make a loan or advance to or investment in any third party (other than advancement or reimbursement of expenses to employees in the ordinary course of business), or guarantee or endorse any Indebtedness, Liability or obligation of any Person in excess of $25,000 individually or $100,000 in the aggregate;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ix)</span></span>increase the wages, salaries or compensation of its employees other than in the ordinary course of business, consistent with past practice, and in any event not in the aggregate by more than five percent (5%), or make or commit to make any bonus payment (whether in cash, property or securities) other than in the ordinary course of business consistent with past practice, to any employee, or materially increase other benefits of employees generally other than in the ordinary course of business consistent with past practice, or enter into, establish, materially amend or terminate any Company Benefit Plan with, for or in respect of any current consultant, officer, manager director or employee, in each case other than as </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">required by applicable Law, pursuant to the terms of any Company Benefit Plans, pursuant to the terms of this Agreement or the Ancillary Documents, in the ordinary course of business consistent with past practice, or as required to consummate the transactions contemplated by this Agreement or the Ancillary Documents;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(x)</span></span>make or rescind any material election relating to Taxes, settle any material claim, action, suit, litigation, proceeding, arbitration, investigation, audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting or Tax policies or procedures, in each case except as required by applicable Law or in compliance with GAAP;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xi)</span></span>transfer or license to any Person or otherwise extend, materially amend or modify, permit to lapse or fail to preserve any material Company Registered IP, Company IP Licenses or other Company IP (excluding non-exclusive licenses of Company IP to Target Company customers in the ordinary course of business consistent with past practice), or disclose to any Person who has not entered into a confidentiality agreement any Trade Secrets;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xii)</span></span>&#160;terminate, or waive or assign any material right under, any Company Material Contract or enter into any Contract that would be a Company Material Contract, in any case outside of the ordinary course of business consistent with past practice, other than any termination at the end of the term of such Company Material Contract pursuant to the terms thereof, or as required to consummate the transactions contemplated by this Agreement or the Ancillary Documents;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xiii)&#160;fail to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xiv)&#160;establish any Subsidiary or enter into any new line of business;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xv)</span></span>fail to use commercially reasonable efforts to keep in force material insurance policies or replacement or revised policies providing insurance coverage with respect to its assets, operations and activities in such amount and scope of coverage substantially similar to that which is currently in effect;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xvi)&#160;revalue any of its material assets or make any material change in accounting methods, principles or practices, except to the extent required to comply with GAAP and after consulting with the Company&#8217;s outside auditors;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xvii)&#160;waive, release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by, a Target Company or its Affiliates) not in excess of $25,000 individually or $100,000 in the aggregate, or otherwise pay, discharge or satisfy any Actions, Liabilities or obligations, unless such amount has been reserved in the Company Financials;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xviii)&#160;close or materially reduce its activities, or effect any layoff or other personnel reduction or change, at any of its facilities;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xix)&#160;acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets outside the ordinary course of business consistent with past practice;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xx)&#160;make capital expenditures in excess of $25,000 (individually for any project or set of related projects) or $100,000 in the aggregate other than pursuant to the terms of a Company Material Contract;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xxi)&#160;adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xxii)&#160;voluntarily incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $25,000 individually or $100,000 in the aggregate other than pursuant to the terms of a Company Material Contract or Company Benefit Plan;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xxiii)&#160;sell, lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise dispose of any material portion of its properties, assets or rights;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xxiv)&#160;enter into any agreement, understanding or arrangement with respect to the voting of equity securities of the Company;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xxv)&#160;take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental Authority to be obtained in connection with this Agreement;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xxvi)&#160;accelerate the collection of any trade receivables or delay the payment of trade payables or any other liabilities other than in the ordinary course of business consistent with past practice;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xxvii)&#160;enter into, amend, waive or terminate (other than terminations in accordance with their terms) any transaction with any Related Person (other than compensation and benefits and advancement of expenses, in each case, provided in the ordinary course of business consistent with past practice); or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xxviii)&#160;authorize or agree to do any of the foregoing actions;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">provided, that any actions reasonably taken in good faith by the Company or its Subsidiaries to the extent reasonably believed to be necessary to comply with Laws (including orders of Governmental Authorities) related to COVID-19 shall be deemed not to constitute a breach of the requirements set forth under this Section 5.2. The Company shall notify the Purchaser in writing of any such actions taken in accordance with the foregoing proviso and shall use reasonable best efforts to mitigate any negative effects of such actions on the business of the Target Companies, in consultation with the Purchaser whenever practicable.</p><a id="a53ConductofBusinessofthePurchaser_57672"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conduct of Business of the Purchaser.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Unless the Company shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period, except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 5.3</span>, the Purchaser shall, and shall cause its Subsidiaries to, (i) conduct their respective businesses, in all material respects, in the ordinary course of business consistent with past practice, (ii) comply with all Laws applicable to the Purchaser and its Subsidiaries and their respective businesses, assets and employees, and (iii) take all commercially reasonable measures necessary or appropriate to preserve intact, in all material respects, their respective business organizations, to keep available the services of their respective managers, directors, officers, employees and consultants, and to preserve the possession, control and condition of their respective material assets, all as consistent with past practice. Notwithstanding anything to the contrary in this Section 5.3, nothing in this Agreement shall prohibit or restrict Purchaser from extending, in accordance with Purchaser&#8217;s Organizational Documents and the IPO Prospectus, the deadline by which it must complete its Business Combination (each, an &#8220;<span style="font-style:italic;font-weight:bold;">Extension</span>&#8221;), including securing the release of all or a portion of the Extension Escrow Amount pursuant to the Extension Escrow Agreement for deposit into the Trust Account in order to secure such extension, and no consent of any other Party shall be required in connection therewith.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Without limiting the generality of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.3(a)</span> and except as contemplated by the terms of this Agreement or the Ancillary Documents (including as contemplated by any PIPE Investment consented to by the Company in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.20)</span> or as set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 5.3</span>, during the Interim Period, without the prior written consent of the Company (such consent not to be unreasonably withheld, conditioned or delayed), the Purchaser shall not, and shall cause its Subsidiaries to not:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>amend, waive or otherwise change, in any respect, its Organizational Documents except as required by applicable Law;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities, or other securities, including any securities convertible into or exchangeable for any of its equity securities or other security interests of any class and any other equity-based awards, other than the issuance of Purchaser securities issuable upon conversion or exchange of outstanding Purchaser securities in accordance with their terms, or engage in any hedging transaction with a third Person with respect to such securities;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its shares or other equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $25,000 individually or $100,000 in the aggregate, make a loan or advance to or investment in any third party, or guarantee or endorse any Indebtedness, Liability or obligation of any Person (provided, that this Section 5.3(b)(iv) shall not prevent the Purchaser from borrowing funds necessary to finance its ordinary course administrative costs and expenses and Expenses incurred in connection with the consummation of the Merger and the other transactions contemplated by this Agreement (including any PIPE Investment and the reasonable costs and expenses necessary for one or more Extensions up to an aggregate of $2,500,000 (such expenses, &#8220;<span style="font-style:italic;font-weight:bold;">Extension Expenses</span>&#8221;)), up to aggregate additional Indebtedness during the Interim Period of $3,000,000);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span>make or rescind any material election relating to Taxes, settle any claim, action, suit, litigation, proceeding, arbitration, investigation, audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting or Tax policies or procedures, in each case except as required by applicable Law or in compliance with GAAP;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vi)</span></span>amend, waive or otherwise change the Trust Agreement in any manner adverse to the Purchaser;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vii)</span></span>terminate, waive or assign any material right under any Purchaser Material Contract or enter into any Contract that would be a Purchaser Material Contract;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(viii)&#160;fail to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ix)</span></span>establish any Subsidiary or enter into any new line of business;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(x)&#160;fail to use commercially reasonable efforts to keep in force insurance policies or replacement or revised policies providing insurance coverage with respect to its assets, operations and activities in such amount and scope of coverage substantially similar to that which is currently in effect;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xi)</span></span>revalue any of its material assets or make any material change in accounting methods, principles or practices, except to the extent required to comply with GAAP and after consulting the Purchaser&#8217;s outside auditors;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xii)</span></span>&#160;waive, release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by, the Purchaser or its Subsidiary) not in excess of $25,000 individually or $100,000 in the aggregate, or otherwise pay, discharge or satisfy any Actions, Liabilities or obligations, unless such amount has been reserved in the Purchaser Financials;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xiii)&#160;acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets outside the ordinary course of business;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xiv)&#160;make capital expenditures in excess of $25,000 individually for any project (or set of related projects) or $100,000 in the aggregate (excluding for the avoidance of doubt, incurring any Expenses);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xv)&#160;adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization (other than with respect to the Merger);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;">(xvi)&#160;voluntarily incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $25,000 individually or $100,000 in the aggregate (excluding the incurrence of any Expenses) other than pursuant to the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">terms of a Contract in existence as of the date of this Agreement or entered into in the ordinary course of business or in accordance with the terms of this Section 5.3 during the Interim Period;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xvii)&#160;sell, lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise dispose of any material portion of its properties, assets or rights;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xviii)&#160;enter into any agreement, understanding or arrangement with respect to the voting of Purchaser Securities;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xix)&#160;take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental Authority to be obtained in connection with this Agreement; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(xx)&#160;authorize or agree to do any of the foregoing actions;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">provided, that any actions reasonably taken in good faith by the Purchaser or its Subsidiaries to the extent reasonably believed to be necessary to comply with Laws (including orders of Governmental Authorities) related to COVID-19 shall be deemed not to constitute a breach of the requirements set forth under this Section 5.3. The Purchaser shall notify the Company in writing of any such actions taken in accordance with the foregoing proviso and shall use reasonable best efforts to mitigate any negative effects of such actions on the Purchaser and its Subsidiaries.</p><a id="a54AnnualandInterimFinancialStatements_6"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annual and Interim Financial Statements</span>. During the Interim Period, within thirty (30) calendar days following the end of each three- month quarterly period and each fiscal year, the Company shall deliver to the Purchaser an unaudited consolidated income statement and an unaudited consolidated balance sheet of the Target Companies for the period from the Interim Balance Sheet Date through the end of such calendar month, quarterly period or fiscal year and the applicable comparative period in the preceding fiscal year, in each case accompanied by a certificate of the Chief Financial Officer of the Company to the effect that all such financial statements fairly present the consolidated financial position and results of operations of the Target Companies as of the date or for the periods indicated, in accordance with GAAP, subject to year-end audit adjustments and excluding footnotes. From the date hereof through the Closing Date, the Company will also promptly deliver to the Purchaser copies of any audited consolidated financial statements of the Target Companies that the Target Companies&#8217; certified public accountants may issue. The Company shall use commercially reasonable efforts to deliver the Audited Company Financials for the year ended December 31, 2021 to the Purchaser by June 1, 2022.</p><a id="a55PurchaserPublicFilings_827478"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.5</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchaser Public Filings</span>. During the Interim Period, the Purchaser will keep current and timely file all of its public filings with the SEC and otherwise comply in all material respects with applicable securities Laws and shall use its reasonable best efforts prior to the Closing to maintain the listing of the Purchaser Public Units, the Purchaser Common Stock and the Purchaser Public Warrants on Nasdaq; <i style="font-style:italic;">provided, </i>that the Parties acknowledge and agree that from and after the Closing, the Parties intend to list on Nasdaq only the Purchaser Common Stock and the Purchaser Public Warrants. The Purchaser shall cause the ticker under which the Purchaser Common Stock and Purchaser Public Warrants are listed for trading on Nasdaq to be changed to &#8220;ONMD&#8221; and have the Purchaser Common Stock and Purchaser Public Warrants listed for trading with such trading ticker.</p><a id="a56NoSolicitation_492644"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.6</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Solicitation</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>For purposes of this Agreement, (i) an &#8220;<span style="font-style:italic;font-weight:bold;">Acquisition Proposal</span>&#8221; means any inquiry, proposal or offer, or any indication of interest in making an offer or proposal, from any Person or group at any time relating to an Alternative Transaction, and (ii) an &#8220;<span style="font-style:italic;font-weight:bold;">Alternative Transaction</span>&#8221; means (A) with respect to the Company and its Affiliates, a transaction (other than the transactions contemplated by this Agreement) concerning the sale of (x) all or any material part of the business or assets of the Target Companies (other than in the ordinary course of business consistent with past practice) or (y) any of the shares or other equity interests or profits of the Target Companies, in any case, whether such transaction takes the form of a sale of shares or other equity interests, assets, merger, consolidation, issuance of debt securities, management Contract, joint venture or partnership, or otherwise and (B) with respect to the Purchaser and its Affiliates, a transaction (other than the transactions contemplated by this Agreement) concerning a Business Combination involving Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>During the Interim Period, in order to induce the other Parties to continue to commit to expend management time and financial resources in furtherance of the transactions contemplated hereby, each Party shall not, and shall cause its Representatives to not, without the prior written consent of the Company and the Purchaser, directly or indirectly, (i) solicit, assist, initiate or facilitate the making, submission or announcement of, or intentionally encourage, any Acquisition Proposal, (ii) furnish any non-public information regarding such Party or its Affiliates or their respective businesses, operations, assets, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Liabilities, financial condition, prospects or employees to any Person or group (other than a Party to this Agreement or their respective Representatives) in connection with or in response to an Acquisition Proposal, (iii) engage or participate in discussions or negotiations with any Person or group with respect to, or that could reasonably be expected to lead to, an Acquisition Proposal, (iv) approve, endorse or recommend, or publicly propose to approve, endorse or recommend, any Acquisition Proposal, (v) negotiate or enter into any letter of intent, agreement in principle, acquisition agreement or other similar agreement related to any Acquisition Proposal, or (vi) release any third Person from, or waive any provision of, any confidentiality agreement to which such Party is a party.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>Each Party shall notify the others as promptly as practicable (and in any event within 48 hours) in writing of the receipt by such Party or any of its Representatives of (i) any bona fide inquiries, proposals or offers, requests for information or requests for discussions or negotiations regarding or constituting any Acquisition Proposal or any bona fide inquiries, proposals or offers, requests for information or requests for discussions or negotiations that could reasonably be expected to result in an Acquisition Proposal, and (ii) any request for non-public information relating to such Party or its Affiliates in connection with any Acquisition Proposal, specifying in each case, the material terms and conditions thereof and the identity of the party making such inquiry, proposal, offer or request for information. Each Party shall keep the others promptly informed of the status of any such inquiries, proposals, offers or requests for information. During the Interim Period, each Party shall, and shall cause its Representatives to, immediately cease and cause to be terminated any solicitations, discussions or negotiations with any Person with respect to any Acquisition Proposal and shall, and shall direct its Representatives to, cease and terminate any such solicitations, discussions or negotiations.</p><a id="a57NoTrading_392133"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.7</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Trading</span>. The Company acknowledges and agrees that it is aware, and that the Company&#8217;s Affiliates are aware (and each of their respective Representatives is aware or, upon receipt of any material nonpublic information of the Purchaser, will be advised) of the restrictions imposed by U.S. federal securities laws and the rules and regulations of the SEC and Nasdaq promulgated thereunder or otherwise (the &#8220;<span style="font-style:italic;font-weight:bold;">Federal Securities Laws</span>&#8221;) and other applicable foreign and domestic Laws on a Person possessing material nonpublic information about a publicly traded company. The Company hereby agrees that, while it is in possession of such material nonpublic information, it shall not purchase or sell any securities of the Purchaser (other than to engage in the Merger in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article I)</span>, communicate such information to any third party, take any other action with respect to the Purchaser in violation of such Laws, or cause or encourage any third party to do any of the foregoing.</p><a id="a58NotificationofCertainMatters_494615"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.8</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notification of Certain Matters</span>. During the Interim Period, each Party shall give prompt notice to the other Parties if such Party or its Affiliates: (a) fails to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it or its Affiliates hereunder in any material respect; (b) receives any notice or other communication in writing from any third party (including any Governmental Authority) alleging (i) that the Consent of such third party is or may be required in connection with the transactions contemplated by this Agreement or (ii) any non-compliance with any Law by such Party or its Affiliates; (c) receives any notice or other communication from any Governmental Authority in connection with the transactions contemplated by this Agreement; (d) discovers any fact or circumstance that, or becomes aware of the occurrence or non-occurrence of any event the occurrence or non-occurrence of which, would reasonably be expected to cause or result in any of the conditions to the Closing set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article VII</span> not being satisfied or the satisfaction of those conditions being materially delayed; or (e) becomes aware of the commencement or threat, in writing, of any Action against such Party or any of its Affiliates, or any of their respective properties or assets, or, to the Knowledge of such Party, any officer, director, partner, member or manager, in his, her or its capacity as such, of such Party or of its Affiliates with respect to the consummation of the transactions contemplated by this Agreement. No such notice shall constitute an acknowledgement or admission by the Party providing the notice regarding whether or not any of the conditions to the Closing have been satisfied or in determining whether or not any of the representations, warranties or covenants contained in this Agreement have been breached.</p><a id="a59Efforts_892936"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.9</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Efforts</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Subject to the terms and conditions of this Agreement, each Party shall use its commercially reasonable efforts, and shall cooperate fully with the other Parties, to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper or advisable under applicable Laws and regulations to consummate the transactions contemplated by this Agreement (including the receipt of all applicable Consents of Governmental Authorities) and to comply as promptly as practicable with all requirements of Governmental Authorities applicable to the transactions contemplated by this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>In furtherance and not in limitation of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.9(a)</span>, to the extent required under any Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade (&#8220;<span style="font-style:italic;font-weight:bold;">Antitrust Laws</span>&#8221;), each Party hereto agrees to make any required filing or application under Antitrust Laws, as applicable, at such Party&#8217;s sole cost and expense, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">with respect to the transactions contemplated hereby as promptly as practicable, to supply as promptly as reasonably practicable any additional information and documentary material that may be reasonably requested pursuant to Antitrust Laws and to take all other actions reasonably necessary, proper or advisable to cause the expiration or termination of the applicable waiting periods under Antitrust Laws as soon as practicable, including by requesting early termination of the waiting period provided for under the Antitrust Laws. Each Party shall, in connection with its efforts to obtain all requisite approvals and authorizations for the transactions contemplated by this Agreement under any Antitrust Law, use its commercially reasonable efforts to: (i) cooperate in all respects with each other Party or its Affiliates in connection with any filing or submission and in connection with any investigation or other inquiry, including any proceeding initiated by a private Person; (ii) keep the other Parties reasonably informed of any communication received by such Party or its Representatives from, or given by such Party or its Representatives to, any Governmental Authority and of any communication received or given in connection with any proceeding by a private Person, in each case regarding any of the transactions contemplated by this Agreement; (iii) permit a Representative of the other Parties and their respective outside counsel to review any communication given by it to, and consult with each other in advance of any meeting or conference with, any Governmental Authority or, in connection with any proceeding by a private Person, with any other Person, and to the extent permitted by such Governmental Authority or other Person, give a Representative or Representatives of the other Parties the opportunity to attend and participate in such meetings and conferences; (iv) in the event a Party&#8217;s Representative is prohibited from participating in or attending any meetings or conferences, the other Parties shall keep such Party promptly and reasonably apprised with respect thereto; and (v) use commercially reasonable efforts to cooperate in the filing of any memoranda, white papers, filings, correspondence or other written communications explaining or defending the transactions contemplated hereby, articulating any regulatory or competitive argument, and/or responding to requests or objections made by any Governmental Authority.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>As soon as reasonably practicable following the date of this Agreement, the Parties shall reasonably cooperate with each other and use (and shall cause their respective Affiliates to use) their respective commercially reasonable efforts to prepare and file with Governmental Authorities requests for approval of the transactions contemplated by this Agreement and shall use all commercially reasonable efforts to have such Governmental Authorities approve the transactions contemplated by this Agreement. Each Party shall give prompt written notice to the other Parties if such Party or any of its Representatives receives any notice from such Governmental Authorities in connection with the transactions contemplated by this Agreement, and shall promptly furnish the other Parties with a copy of such Governmental Authority notice. If any Governmental Authority requires that a hearing or meeting be held in connection with its approval of the transactions contemplated hereby, whether prior to the Closing or after the Closing, each Party shall arrange for Representatives of such Party to be present for such hearing or meeting. If any objections are asserted with respect to the transactions contemplated by this Agreement under any applicable Law or if any Action is instituted (or threatened to be instituted) by any applicable Governmental Authority or any private Person challenging any of the transactions contemplated by this Agreement or any Ancillary Document as violative of any applicable Law or which would otherwise prevent, materially impede or materially delay the consummation of the transactions contemplated hereby or thereby, the Parties shall use their commercially reasonable efforts to resolve any such objections or Actions so as to timely permit consummation of the transactions contemplated by this Agreement and the Ancillary Documents, including in order to resolve such objections or Actions which, in any case if not resolved, could reasonably be expected to prevent, materially impede or materially delay the consummation of the transactions contemplated hereby or thereby. In the event any Action is instituted (or threatened to be instituted) by a Governmental Authority or private Person challenging the transactions contemplated by this Agreement, or any Ancillary Document, the Parties shall, and shall cause their respective Representatives to, reasonably cooperate with each other and use their respective commercially reasonable efforts to contest and resist any such Action and to have vacated, lifted, reversed or overturned any Order, whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the transactions contemplated by this Agreement or the Ancillary Documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>Prior to the Closing, each Party shall use its commercially reasonable efforts to obtain any Consents of Governmental Authorities or other third Persons as may be necessary for the consummation by such Party or its Affiliates of the transactions contemplated by this Agreement or required as a result of the execution or performance of, or consummation of the transactions contemplated by, this Agreement by such Party or its Affiliates, and the other Parties shall provide reasonable cooperation in connection with such efforts.</p><a id="a510TaxMatters_60719"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">5.10&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Tax Matters</span>. Each of the Parties shall use its reasonable best efforts to cause the Merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. None of the Parties shall (and each of the Parties shall cause its respective Subsidiaries not to) take any action, or fail to take any action, that could reasonably be expected to cause the Merger to fail to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. The Parties intend to report and, except to the extent otherwise required by Law, shall report, for federal income tax purposes, the Merger as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-34</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a511FurtherAssurances_143385"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">5.11&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Further Assurances</span>. The Parties hereto shall further cooperate with each other and use their respective commercially reasonable efforts to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on their part under this Agreement and applicable Laws to consummate the transactions contemplated by this Agreement as soon as reasonably practicable, including preparing and filing as soon as practicable all documentation to effect all necessary notices, reports and other filings.</p><a id="a512TheRegistrationStatement_106156"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">5.12&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Registration Statement</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>As promptly as practicable after the date hereof, the Purchaser shall prepare with the reasonable assistance of the Company, and file with the SEC a registration statement on Form S-4 (as amended or supplemented from time to time, and including the Proxy Statement contained therein, the &#8220;<span style="font-style:italic;font-weight:bold;">Registration Statement</span>&#8221;) in connection with the registration under the Securities Act of the Purchaser Common Stock to be issued under this Agreement as the Merger Consideration, which Registration Statement will also contain a proxy statement (as amended, the &#8220;<span style="font-style:italic;font-weight:bold;">Proxy Statement</span>&#8221;) for the purpose of soliciting proxies from Purchaser stockholders for the matters to be acted upon at the Purchaser Special Meeting and providing the Public Stockholders an opportunity in accordance with the Purchaser&#8217;s Organizational Documents and the IPO Prospectus to have their Purchaser Common Stock redeemed (the &#8220;<span style="font-style:italic;font-weight:bold;">Redemption</span>&#8221;) in conjunction with the stockholder vote on the Purchaser Stockholder Approval Matters. The Proxy Statement shall include proxy materials for the purpose of soliciting proxies from Purchaser stockholders to vote, at a special meeting of Purchaser stockholders to be called and held for such purpose (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Special Meeting</span>&#8221;), in favor of resolutions approving (i) the adoption and approval of this Agreement and the transactions contemplated hereby or referred to herein, including the Merger (and, to the extent required, the issuance of any shares in connection with the PIPE Investment), by the holders of Purchaser Common Stock in accordance with the Purchaser&#8217;s Organizational Documents and IPO Prospectus, the Securities Act, the DGCL and the rules and regulations of the SEC and Nasdaq, (ii) the adoption and approval of the Amended Purchaser Certificate of Incorporation, including the change of name of the Purchaser, (iii) adoption and approval of a new equity incentive plan in substantially the form attached as Exhibit F hereto (the &#8220;<span style="font-style:italic;font-weight:bold;">Incentive Plan</span>&#8221;), and which will provide for awards for a number of shares of Purchaser Common Stock equal to ten percent (10%) of the aggregate number of shares of Purchaser Common Stock issued and outstanding immediately after the Closing (giving effect to the Redemption), (iv) the appointment of the members of the Post-Closing Purchaser Board in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.17</span> hereof, (v) such other matters as the Company and Purchaser shall hereafter mutually determine to be necessary or appropriate in order to effect the Merger and the other transactions contemplated by this Agreement (the approvals described in foregoing clauses (i) through (v), collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Stockholder Approval Matters</span>&#8221;), and (vi) the adjournment of the Purchaser Special Meeting, if necessary or desirable in the reasonable determination of Purchaser. If on the date for which the Purchaser Special Meeting is scheduled, Purchaser has not received proxies representing a sufficient number of shares to obtain the Required Purchaser Stockholder Approval, whether or not a quorum is present, Purchaser may make one or more successive postponements or adjournments of the Purchaser Special Meeting. In connection with the Registration Statement, Purchaser will file with the SEC financial and other information about the transactions contemplated by this Agreement in accordance with applicable Law and applicable proxy solicitation and registration statement rules set forth in the Purchaser&#8217;s Organizational Documents, the Securities Act, the DGCL and the rules and regulations of the SEC and Nasdaq. Purchaser shall cooperate and provide the Company (and its counsel) with a reasonable opportunity to review and comment on the Registration Statement and any amendment or supplement thereto prior to filing the same with the SEC, and Purchaser shall consider any such comments timely made in good faith. The Company shall provide Purchaser with such information concerning the Target Companies and their stockholders, officers, directors, employees, assets, Liabilities, condition (financial or otherwise), business and operations that may be required or appropriate for inclusion in the Registration Statement, or in any amendments or supplements thereto, which information provided by the Company shall be true and correct and not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not materially misleading. Any filing fees (or similar fees) with respect to any regulatory or governmental approval shall be borne by SPAC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Purchaser shall take any and all reasonable and necessary actions required to satisfy the requirements of the Securities Act, the Exchange Act and other applicable Laws in connection with the Registration Statement, the Purchaser Special Meeting and the Redemption. Each of Purchaser and the Company shall, and shall cause each of its Subsidiaries to, make their respective directors, officers and employees, upon reasonable advance notice, available to the Company, Purchaser and, after the Closing, the Purchaser Representative, and their respective Representatives in connection with the drafting of the public filings with respect to the transactions contemplated by this Agreement, including the Registration Statement, and responding in a timely manner to comments from the SEC. Each Party shall promptly correct any information provided by it for use in the Registration Statement (and other related materials) if and to the extent that such information is determined to have become false or misleading in any material respect or as otherwise required by applicable Laws. Purchaser shall amend or supplement the Registration Statement and cause the Registration Statement, as so amended or supplemented, to be filed with the SEC and to be disseminated </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-35</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">to Purchaser stockholders, in each case as and to the extent required by applicable Laws and subject to the terms and conditions of this Agreement and the Purchaser&#8217;s Organizational Documents; provided, however, that the Purchaser shall not amend or supplement the Registration Statement without prior consultation with the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>Purchaser, with the assistance of the other Parties, shall promptly respond to any SEC comments on the Registration Statement and shall otherwise use its commercially reasonable efforts to cause the Registration Statement to &#8220;clear&#8221; comments from the SEC and become effective. Purchaser shall provide the Company with copies of any written comments, and shall inform the Company of any material oral comments, that Purchaser or its Representatives receive from the SEC or its staff with respect to the Registration Statement, the Purchaser Special Meeting and the Redemption promptly after the receipt of such comments and shall give the Company and its counsel a reasonable opportunity to review and comment on any proposed written or material oral responses to such comments, including, to the extent permitted by the SEC, participation by the Company or its counsel in any discussions or meetings with the SEC, and the Purchaser shall consider any such comments timely made in good faith under the circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>As soon as practicable following the Registration Statement &#8220;clearing&#8221; comments from the SEC and becoming effective, Purchaser shall distribute the Registration Statement to Purchaser&#8217;s stockholders and the Company Stockholders, and, pursuant thereto, shall call the Purchaser Special Meeting in accordance with the Securities Act for a date no later than thirty (30) days following the effectiveness of the Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>Purchaser shall comply with all applicable Laws, any applicable rules and regulations of Nasdaq, Purchaser&#8217;s Organizational Documents and this Agreement in the preparation, filing and distribution of the Registration Statement, any solicitation of proxies thereunder, the calling and holding of the Purchaser Special Meeting and the Redemption. Purchaser shall apply for, and shall take commercially reasonable actions to cause, the Purchaser Common Stock to be issued in connection with the Merger to be approved for listing on Nasdaq as of the Closing.</p><a id="a513CompanyStockholderApproval_654474"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">5.13&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company Stockholder Approval</span>. As promptly as practicable after the Registration Statement has become effective, the Company will call a meeting of its stockholders or otherwise solicit written consents in order to obtain the Required Company Stockholder Approval (the &#8220;<span style="font-style:italic;font-weight:bold;">Company Special Meeting</span>&#8221;), and the Company shall use its commercially reasonable efforts to solicit from the Company Stockholders proxies in favor of the Required Company Stockholder Approval prior to such Company Special Meeting, and to take all other actions necessary or advisable to secure the Required Company Stockholder Approval, including enforcing the Voting Agreements.</p><a id="a514PublicAnnouncements_553037"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.14</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Public Announcements</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Parties agree that during the Interim Period no public release, filing or announcement concerning this Agreement or the Ancillary Documents or the transactions contemplated hereby or thereby shall be issued by any Party or any of their Affiliates without the prior written consent of the Purchaser and the Company (which consent shall not be unreasonably withheld, conditioned or delayed), except as such release or announcement may be required by applicable Law or the rules or regulations of any securities exchange, in which case the applicable Party shall use commercially reasonable efforts to allow the other Parties reasonable time to comment on, and arrange for any required filing with respect to, such release or announcement in advance of such issuance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The Parties shall mutually agree upon and, as promptly as practicable after the execution of this Agreement (but in any event within four (4) Business Days thereafter), issue a press release announcing the execution of this Agreement (the &#8220;<span style="font-style:italic;font-weight:bold;">Signing Press Release</span>&#8221;). Promptly after the issuance of the Signing Press Release, the Purchaser shall file a current report on Form 8-K (the &#8220;<span style="font-style:italic;font-weight:bold;">Signing Filing</span>&#8221;) with the Signing Press Release and a description of this Agreement as required by Federal Securities Laws, which the Company shall review, comment upon and approve (which approval shall not be unreasonably withheld, conditioned or delayed) prior to filing (with the Company reviewing, commenting upon and approving such Signing Filing in any event no later than the third (3rd) Business Day after the execution of this Agreement); provided that the Purchaser provides the Company with a reasonable amount of time to complete such review, comment and approval prior to the third (3rd) Business Day after the date thereof. The Parties shall mutually agree upon and, as promptly as practicable after the Closing (but in any event within four (4) Business Days thereafter), issue a press release announcing the consummation of the transactions contemplated by this Agreement (the &#8220;<span style="font-style:italic;font-weight:bold;">Closing Press Release</span>&#8221;). Promptly after the issuance of the Closing Press Release, the Purchaser shall file a current report on Form 8-K (the &#8220;<span style="font-style:italic;font-weight:bold;">Closing Filing</span>&#8221;) with the Closing Press Release and a description of the Closing as required by Federal Securities Laws which the Seller Representative and the Purchaser Representative shall review, comment upon and approve (which approval shall not be unreasonably withheld, conditioned or delayed) prior to filing. In connection with the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-36</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">preparation of the Signing Press Release, the Signing Filing, the Closing Filing, the Closing Press Release, or any other report, statement, filing notice or application made by or on behalf of a Party to any Governmental Authority or other third party in connection with the transactions contemplated hereby, each Party shall, upon request by any other Party, furnish the Parties with all information concerning themselves, their respective directors, officers and equity holders, and such other matters as may be reasonably necessary or advisable in connection with the transactions contemplated hereby, or any other report, statement, filing, notice or application made by or on behalf of a Party to any third party and/ or any Governmental Authority in connection with the transactions contemplated hereby.</p><a id="a515ConfidentialInformation_574282"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">5.15&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidential Information</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Company and the Seller Representative hereby agrees that during the Interim Period and, in the event that this Agreement is terminated in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article VIII</span>, for a period of two (2) years after such termination, they shall, and shall cause their respective Representatives to: (i) treat and hold in strict confidence any Purchaser Confidential Information, and will not use for any purpose (except in connection with the consummation of the transactions contemplated by this Agreement or the Ancillary Documents, performing their obligations hereunder or thereunder, enforcing their rights hereunder or thereunder, or in furtherance of their authorized duties on behalf of the Purchaser or its Subsidiaries), nor directly or indirectly disclose, distribute, publish, disseminate or otherwise make available to any third party any of the Purchaser Confidential Information without the Purchaser&#8217;s prior written consent; and (ii) in the event that the Company, the Seller Representative or any of their respective Representatives, during the Interim Period or, in the event that this Agreement is terminated in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article VIII</span>, for a period of two (2) years after such termination, becomes legally compelled to disclose any Purchaser Confidential Information, (A) provide the Purchaser to the extent legally permitted with prompt written notice of such requirement so that the Purchaser or an Affiliate thereof may seek, at Purchaser&#8217;s cost, a protective Order or other remedy or waive compliance with this Section 5.15(a), and (B) in the event that such protective Order or other remedy is not obtained, or the Purchaser waives compliance with this Section 5.15(a), furnish only that portion of such Purchaser Confidential Information which is legally required to be provided as advised in writing by outside counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential treatment will be accorded such Purchaser Confidential Information. In the event that this Agreement is terminated and the transactions contemplated hereby are not consummated, the Company and the Seller Representative shall, and shall cause their respective Representatives to, promptly deliver to the Purchaser or destroy (at Purchaser&#8217;s election) any and all copies (in whatever form or medium) of Purchaser Confidential Information and destroy all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based thereon; provided, however, that the Company and the Seller Representative and their respective Representatives shall be entitled to keep any records required by applicable Law or bona fide record retention policies; and provided, further, that any Purchaser Confidential Information that is not returned or destroyed shall remain subject to the confidentiality obligations set forth in this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The Purchaser hereby agrees that during the Interim Period and, in the event that this Agreement is terminated in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article VIII</span>, for a period of two (2) years after such termination, it shall, and shall cause its Representatives to: (i) treat and hold in strict confidence any Company Confidential Information, and will not use for any purpose (except in connection with the consummation of the transactions contemplated by this Agreement or the Ancillary Documents, performing its obligations hereunder or thereunder or enforcing its rights hereunder or thereunder), nor directly or indirectly disclose, distribute, publish, disseminate or otherwise make available to any third party any of the Company Confidential Information without the Company&#8217;s prior written consent; and (ii) in the event that the Purchaser or any of its Representatives, during the Interim Period or, in the event that this Agreement is terminated in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article VIII</span>, for a period of two (2) years after such termination, becomes legally compelled to disclose any Company Confidential Information, (A) provide the Company to the extent legally permitted with prompt written notice of such requirement so that the Company may seek, at the Company&#8217;s sole expense, a protective Order or other remedy or waive compliance with this Section 5.15(b) and (B) in the event that such protective Order or other remedy is not obtained, or the Company waives compliance with this Section 5.15(b), furnish only that portion of such Company Confidential Information which is legally required to be provided as advised in writing by outside counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential treatment will be accorded such Company Confidential Information. In the event that this Agreement is terminated and the transactions contemplated hereby are not consummated, the Purchaser shall, and shall cause its Representatives to, promptly deliver to the Company or destroy (at the Purchaser&#8217;s election) any and all copies (in whatever form or medium) of Company Confidential Information and destroy all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based thereon; provided, however, that the Purchaser and its Representatives shall be entitled to keep any records required by applicable Law or bona fide record retention policies; and provided, further, that any Company Confidential Information that is not returned or destroyed shall remain subject to the confidentiality obligations set forth in this Agreement.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-37</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a516DocumentsandInformation_17856"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.16</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Documents and Information</span>. After the Closing Date, the Purchaser and the Company shall, and shall cause their respective Subsidiaries to, until the seventh (7th) anniversary of the Closing Date, retain all books, records and other documents pertaining to the business of the Target Companies in existence on the Closing Date and make the same available for inspection and copying by the Purchaser Representative during normal business hours of the Company and its Subsidiaries, as applicable, upon reasonable request and upon reasonable notice. No such books, records or documents shall be destroyed after the seventh (7th) anniversary of the Closing Date by the Purchaser or its Subsidiaries (including any Target Company) without first advising the Purchaser Representative in writing and giving the Purchaser Representative a reasonable opportunity to obtain possession thereof.</p><a id="a517PostClosingBoardofDirectorsandExecut"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">5.17&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Post-Closing Board of Directors and Executive Officers</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Parties shall take all necessary action, including causing the directors of the Purchaser to resign, so that effective as of the Closing, the Purchaser&#8217;s board of directors (the &#8220;<span style="font-style:italic;font-weight:bold;">Post-Closing Purchaser Board</span>&#8221;) will consist of nine (9) individuals. Immediately after the Closing, the Parties shall take all necessary action to designate and appoint to the Post-Closing Purchaser Board, two (2) persons that are designated by the Purchaser prior to the Closing, at least one (1) of whom shall be required to qualify as an independent director under Nasdaq rules (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Director</span>&#8221;), and seven (7) persons that are designated by the Company prior to the Closing (the &#8220;<span style="font-style:italic;font-weight:bold;">Company Directors</span>&#8221;), at least three (3) of whom shall be required to qualify as an independent director under Nasdaq rules. At or prior to the Closing, the Purchaser will provide each director of Purchaser with a customary director indemnification agreement, in form and substance reasonably acceptable to such director of Purchaser. Prior to the mailing of the Proxy Statement, the Purchaser and the Company shall mutually agree to each director that will serve on the compensation committee, the audit committee and the nominating committee of the <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchaser&#8217;s</span> Board immediately after the Effective Time, based on the qualifications of each director, subject to applicable listing rules of Nasdaq and applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The Parties shall take all action necessary, including causing the executive officers of Purchaser to resign, so that the individuals serving as the chief executive officer and chief financial officer, respectively, of Purchaser immediately after the Closing will be the same individuals (in the same office) as that of the Company immediately prior to the Closing (unless, at its sole discretion, the Company desires to appoint another qualified person to either such role, in which case, such other person identified by the Company shall serve in such role).</p><a id="a518IndemnificationofDirectorsandOfficer"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.18</span></span>&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnification of Directors and Officers; Tail Insurance</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Parties agree that all rights to exculpation, indemnification and advancement of expenses existing in favor of the current or former directors and officers of the Purchaser or Merger Sub and each Person who served as a director, officer, member, trustee or fiduciary of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise at the request of the Purchaser or Merger Sub (the &#8220;<span style="font-style:italic;font-weight:bold;">D&amp;O Indemnified Persons</span>&#8221;) as provided in their respective Organizational Documents or under any indemnification, employment or other similar agreements between any D&amp;O Indemnified Person and the Purchaser or Merger Sub, in each case as in effect on the date of this Agreement, shall survive the Closing and continue in full force and effect in accordance with their respective terms to the extent permitted by applicable Law. For a period of six (6) years after the Effective Time, the Purchaser shall cause the Organizational Documents of the Purchaser and the Surviving Corporation to contain provisions no less favorable with respect to exculpation and indemnification of and advancement of expenses to D&amp;O Indemnified Persons than are set forth as of the date of this Agreement in the Organizational Documents of the Purchaser and Merger Sub to the extent permitted by applicable Law. The provisions of this Section 5.18 shall survive the consummation of the Merger and are intended to be for the benefit of, and shall be enforceable by, each of the D&amp;O Indemnified Persons and their respective heirs and representatives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>For the benefit of the Purchaser&#8217;s and Merger Sub&#8217;s directors and officers, the Purchaser shall be permitted prior to the Effective Time to obtain and fully pay the premium for a &#8220;tail&#8221; insurance policy that provides coverage for up to a six-year period from and after the Effective Time for events occurring prior to the Effective Time (the &#8220;<span style="font-style:italic;font-weight:bold;">D&amp;O Tail Insurance</span>&#8221;) that is substantially equivalent to and in any event not less favorable in the aggregate than the Purchaser&#8217;s existing policy or, if substantially equivalent insurance coverage is unavailable, the best available coverage. If obtained, the Purchaser shall maintain the D&amp;O Tail Insurance in full force and effect, and continue to honor the obligations thereunder, and the Purchaser shall timely pay or caused to be paid all premiums with respect to the D&amp;O Tail Insurance.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-38</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a519TrustAccountProceedsExpenses_134501"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">5.19&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Trust Account Proceeds; Expenses</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>At least three (3) Business Days prior to the contemplated Closing Date, the Purchaser and Company shall exchange written statements setting forth complete and accurate schedules of their good faith estimates of all unpaid Expenses and Transaction Expenses, respectively, as of the Closing Date (the &#8220;<span style="font-style:italic;font-weight:bold;">Expense Statements</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Upon satisfaction or, to the extent permitted by applicable Law, waiver of the conditions set forth in Article 7 and provision of notice thereof to the Trustee, (a) at the Closing, the Purchaser shall (i) cause the documents, certificates and notices required to be delivered to the Trustee pursuant to the Trust Agreement to be so delivered, and (ii) make all appropriate arrangements to cause the Trustee to pay (A) as and when due all amounts, if any, payable pursuant to the Redemption, (B) the amounts due to the underwriters of Purchaser&#8217;s IPO for their deferred underwriting commissions as set forth in the Trust Agreement, and (C) immediately thereafter, pay all remaining amounts then available in the Trust Account to Purchaser in accordance with the Trust Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>Thereafter, the Trust Account shall terminate, except as otherwise provided therein. Any remaining cash will be used (i) first, to pay Transaction Expenses, and then (ii) for working capital and general corporate purposes of the Purchaser and the Surviving Corporation.</p><a id="a520PIPEInvestment_714350"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">5.20&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">PIPE Investment</span>. Without limiting anything to the contrary contained herein, during the Interim Period, Purchaser shall use its reasonable commercial efforts to enter into and consummate Subscription Agreements with investors relating to a private equity investment in Purchaser to purchase at least 3,000,000 shares of Purchaser Common Stock at a purchase price of ten dollars ($10.00) per share, for an aggregate purchase price of at least $30,000,000 in connection with a private placement, and/or enter into backstop arrangements with potential investors, in either case on terms mutually agreeable to the Company and Purchaser, acting reasonably (a &#8220;<span style="font-style:italic;font-weight:bold;">PIPE Investment</span>&#8221;), and Purchaser and the Company shall, and shall cause their respective Representatives to, cooperate with each other and their respective Representatives in connection with such PIPE Investment and use their respective commercially reasonable efforts to cause such PIPE Investment to occur (including having the Company&#8217;s senior management participate in any investor meetings and roadshows as reasonably requested by Purchaser). The Purchaser shall use its reasonable best efforts to satisfy the conditions of the PIPE Investors&#8217; closing obligations contained in the Subscription Agreements and consummate the transactions contemplated thereby. The Purchaser shall not terminate, or amend or waive in any manner materially adverse to the Purchaser, any Subscription Agreement without the Company&#8217;s prior written consent (not to be unreasonably withheld, delayed or conditioned), other than (i) as expressly provided for by the terms of the Subscription Agreements or (ii) to reflect any permitted assignments or transfers of the Subscription Agreements by the applicable PIPE Investors pursuant to the Subscription Agreements. Each of the Purchaser and, as applicable, the Company, shall, and shall cause its Affiliates to, use commercially reasonable efforts to avoid being in breach or default under the Subscription Agreements. Additionally, during the Interim Period, the Purchaser may, but shall not be required to, enter into and consummate additional Subscription Agreements with additional PIPE Investors, including in the event that there is an actual or threatened material breach or default by a PIPE Investor under a Subscription Agreement, or the Purchaser reasonably believes in good faith that such PIPE Investor otherwise is not willing or able to consummate the transactions contemplated thereby upon the satisfaction of the conditions of such PIPE Investor&#8217;s closing obligations thereunder, which additional Subscription Agreements shall become part of the PIPE Investment hereunder; provided, that the terms of such additional Subscription Agreements shall not, without the Company&#8217;s prior written consent (not to be unreasonably withheld, delayed or conditioned), be on materially less favorable terms to the Purchaser or the Company than those set forth in existing Subscription Agreements. If the Purchaser elects to seek such additional Subscription Agreements (with, solely with respect to any additional Subscription Agreements containing terms that are substantially different from the terms of Subscription Agreements then in effect, the Company&#8217;s prior written consent, not to be unreasonably withheld, delayed or conditioned), the Purchaser and the Company shall, and shall cause their respective Representatives to, cooperate with each other and their respective Representatives in connection with such additional Subscription Agreements and use their respective reasonable efforts to cause such additional Subscription Agreements to be executed and the transactions contemplated thereby to occur (including having the Company&#8217;s senior management participate in any investor meetings and roadshows as reasonably requested by the Purchaser). The Purchaser will deliver to the Company true, correct and complete copies of each Subscription Agreement entered into by the Purchaser and any other Contracts between the Purchaser and PIPE Investors that could affect the obligation of such PIPE Investors to contribute to the Purchaser their applicable portion of the aggregate gross proceeds of the PIPE Investment as set forth in the Subscription Agreement of such PIPE Investor. The Company shall not enter into any Contract with a PIPE Investor during the Interim Period without the prior written consent of the Purchaser, not to be unreasonably withheld, delayed or conditioned.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">5.21&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Incentive Equity Plan</span>. Prior to the Closing Date, the Purchaser shall approve and adopt the Incentive Equity Plan in the form attached hereto as Exhibit F (with such changes as may be agreed by Purchaser and the Company). Within 30 days after the Closing, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-39</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">the Purchaser shall file a registration statement on Form S-8 (or other applicable form) with respect to the Shares issuable under the Incentive Equity Plan, and Purchaser shall use reasonable efforts to maintain the effectiveness of such registration statement (and maintain the current status of the prospectus contained therein) for so long as awards granted pursuant to the Incentive Equity Plan remain outstanding.</p><a id="_1a804e66_33d2_4ead_a61a_6af2524058f9"></a><a id="ARTICLEVI_21984"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ARTICLE VI</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">NO SURVIVAL</b></p><a id="a61NoSurvival_770255"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Survival</span>. Representations and warranties of the Company and the Purchaser contained in this Agreement or in any certificate or instrument delivered by or on behalf of the Company or the Purchaser pursuant to this Agreement shall not survive the Closing, and from and after the Closing, the Company and the Purchaser and their respective Representatives shall not have any further obligations, nor shall any claim be asserted or action be brought against the Company or the Purchaser or their respective Representatives with respect thereto. The covenants and agreements made by the Company and the Purchaser in this Agreement or in any certificate or instrument delivered pursuant to this Agreement, including any rights arising out of any breach of such covenants or agreements, shall not survive the Closing, except for those covenants and agreements contained herein and therein that by their terms apply or are to be performed in whole or in part after the Closing (which such covenants shall survive the Closing and continue until fully performed in accordance with their terms).</p><a id="_bad678a0_5888_4630_8493_1aba8ea166ea"></a><a id="ARTICLEVII_407690"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ARTICLE VII</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">CLOSING CONDITIONS</b></p><a id="a71ConditionstoEachPartysObligations_232"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conditions to Each Party&#8217;s Obligations</span>. The obligations of each Party to consummate the Merger and the other transactions described herein shall be subject to the satisfaction or written waiver (where permissible) by the Company and the Purchaser of the following conditions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;">Required Purchaser Stockholder Approval</i>. The Purchaser Stockholder Approval Matters that are submitted to the vote of the stockholders of the Purchaser at the Purchaser Special Meeting in accordance with the Proxy Statement shall have been approved by the requisite vote of the stockholders of the Purchaser at the Purchaser Special Meeting in accordance with the Purchaser&#8217;s Organizational Documents, applicable Law and the Proxy Statement (the &#8220;<span style="font-style:italic;font-weight:bold;">Required Purchaser Stockholder Approval</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;">Required Company Stockholder Approval</i>. Written consents representing the requisite vote of the Company Stockholders (including any separate class or series vote that is required, whether pursuant to the Company&#8217;s Organizational Documents, any stockholder agreement or otherwise) shall have been obtained, as necessary, to authorize, approve and consent to, the execution, delivery and performance of this Agreement and each of the Ancillary Documents to which the Company is or is required to be a party or bound, and the consummation of the transactions contemplated hereby and thereby, including the Merger (the &#8220;<span style="font-style:italic;font-weight:bold;">Required Company Stockholder Approval</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;">Antitrust Laws. </i>Any waiting period (and any extension thereof) applicable to the consummation of this Agreement under any Antitrust Laws shall have expired or been terminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;">Requisite Regulatory Approvals</i>. All Consents required to be obtained from or made with any Governmental Authority in order to consummate the transactions contemplated by this Agreement shall have been obtained or made.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;">Requisite Consents</i>. The Consents required to be obtained from or made with any third Person (other than a Governmental Authority) in order to consummate the transactions contemplated by this Agreement that are set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 7.1(e)</span> shall have each been obtained or made.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span><i style="font-style:italic;">No Adverse Law or Order</i>. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent) or Order that is then in effect and which has the effect of making the transactions or agreements contemplated by this Agreement illegal or which otherwise prevents or prohibits consummation of the transactions contemplated by this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span><i style="font-style:italic;">Net Tangible Assets Test. </i>Upon the Closing, after giving effect to the Redemption and any PIPE Investment, the Purchaser shall have net tangible assets of at least $5,000,001.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-40</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span><i style="font-style:italic;">Minimum Cash Condition</i>. Upon the Closing, the Purchaser shall have cash and cash equivalents, including funds remaining in the Trust Account (after giving effect to the completion and payment of the Redemption) and the proceeds of any PIPE Investment, after giving effect to the payment of the Purchaser&#8217;s Expenses and the Company&#8217;s Transaction Expenses pursuant to the terms of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.19</span> hereof, at least equal to Thirty Million U.S. Dollars ($30,00,000).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span><i style="font-style:italic;">Appointment to the Board</i>. The members of the Post-Closing Purchaser Board shall have been elected or appointed as of the Closing consistent with the requirements of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.17</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span><i style="font-style:italic;">Registration Statement. </i>The Registration Statement shall have been declared effective by the SEC and shall remain effective as of the Closing, and no stop order or similar order shall be in effect with respect to the Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span><i style="font-style:italic;">Nasdaq Listing</i>. The shares of Purchaser Common Stock issued as Merger Consideration shall have been approved for listing on Nasdaq, subject to official notice of issuance.</p><a id="a72ConditionstoObligationsoftheCompany_6"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conditions to Obligations of the Company</span>. In addition to the conditions specified in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7.1</span>, the obligations of the Company to consummate the Merger and the other transactions contemplated by this Agreement are subject to the satisfaction or written waiver (by the Company) of the following conditions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;">Representations and Warranties</i>. All of the representations and warranties of the Purchaser set forth in this Agreement and in any certificate delivered by or on behalf of the Purchaser pursuant hereto shall be true and correct on and as of the date of this Agreement and on and as of the Closing Date as if made on the Closing Date, except for (i) those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been accurate as of such date), and (ii) any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect), individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on, or with respect to, the Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;">Agreements and Covenants</i>. The Purchaser shall have performed in all material respects all of the Purchaser&#8217;s obligations and complied in all material respects with all of the Purchaser&#8217;s agreements and covenants under this Agreement to be performed or complied with by it on or prior to the Closing Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;">No Purchaser Material Adverse Effect</i>. No Material Adverse Effect shall have occurred with respect to the Purchaser since the date of this Agreement which is continuing and uncured.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;">Closing Deliveries.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>OFFICER CERTIFICATE. The Purchaser shall have delivered to the Company a certificate, dated the Closing Date, signed by an executive officer of the Purchaser in such capacity, certifying as to the satisfaction of the conditions specified in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 7.2(a)</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">7.2(b)</span> and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">7.2(c)</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>SECRETARY CERTIFICATE. The Purchaser shall have delivered to the Company a certificate from its secretary or other executive officer certifying as to, and attaching, (A) copies of the Purchaser&#8217;s Organizational Documents as in effect as of the Closing Date (after giving effect to the Conversion), (B) the resolutions of the Purchaser&#8217;s board of directors authorizing and approving the execution, delivery and performance of this Agreement and each of the Ancillary Documents to which it is a party or by which it is bound, and the consummation of the transactions contemplated hereby and thereby, (C) evidence that the Required Purchaser Stockholder Approval has been obtained and (D) the incumbency of officers authorized to execute this Agreement or any Ancillary Document to which the Purchaser is or is required to be a party or otherwise bound.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>GOOD STANDING. The Purchaser shall have delivered to the Company a good standing certificate (or similar documents applicable for such jurisdictions) for the Purchaser certified as of a date no earlier than thirty (30) days prior to the Closing Date from the proper Governmental Authority of the Purchaser&#8217;s jurisdiction of organization and from each other jurisdiction in which the Purchaser is qualified to do business as a foreign entity as of the Closing, in each case to the extent that good standing certificates or similar documents are generally available in such jurisdictions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>REGISTRATION RIGHTS AGREEMENT. The Company shall have received a copy of the Registration Rights Agreement, duly executed by the Purchaser.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-41</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span>REPRESENTATION AND WARRANTY INSURANCE. The Purchaser shall have received representation and warranty insurance in an amount customary of a transaction of this size.</p><a id="a73ConditionstoObligationsofthePurchaser"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conditions to Obligations of the Purchaser</span>. In addition to the conditions specified in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7.1</span>, the obligations of the Purchaser and Merger Sub to consummate the Merger and the other transactions contemplated by this Agreement are subject to the satisfaction or written waiver (by the Purchaser) of the following conditions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;">Representations and Warranties</i>. All of the representations and warranties of the Company set forth in this Agreement and in any certificate delivered by or on behalf of the Company pursuant hereto shall be true and correct on and as of the date of this Agreement and on and as of the Closing Date as if made on the Closing Date, except for (i) those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been accurate as of such date), and (ii) any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect), individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on, or with respect to, the Target Companies, taken as a whole.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;">Agreements and Covenants</i>. The Company shall have performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under this Agreement to be performed or complied with by it on or prior to the Closing Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;">No Material Adverse Effect</i>. No Material Adverse Effect shall have occurred with respect to the Target Companies taken as a whole since the date of this Agreement which is continuing and uncured.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;">Certain Ancillary Documents. </i>Each Lock-Up Agreement and Non-Competition Agreement shall be in full force and effect in accordance with the terms thereof as of the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;">Closing Deliveries.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>OFFICER CERTIFICATE. The Purchaser shall have received a certificate from the Company, dated as the Closing Date, signed by an executive officer of the Company in such capacity, certifying as to the satisfaction of the conditions specified in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 7.3(a)</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">7.3(b)</span> and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">7.3(c)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>SECRETARY CERTIFICATE. The Company shall have delivered to the Purchaser a certificate executed by the Company&#8217;s secretary certifying as to the validity and effectiveness of, and attaching, (A) copies of the Company&#8217;s Organizational Documents as in effect as of the Closing Date (immediately prior to the Effective Time), (B) the requisite resolutions of the Company&#8217;s board of directors authorizing and approving the execution, delivery and performance of this Agreement and each Ancillary Document to which the Company is or is required to be a party or bound, and the consummation of the Merger and the other transactions contemplated hereby and thereby, and the adoption of the Surviving Corporation Organizational Documents, and recommending the approval and adoption of the same by the Company Stockholders at a duly called meeting of stockholders, (C) evidence that the Required Company Stockholder Approval has been obtained and (D) the incumbency of officers of the Company authorized to execute this Agreement or any Ancillary Document to which the Company is or is required to be a party or otherwise bound.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>GOOD STANDING. The Company shall have delivered to the Purchaser good standing certificates (or similar documents applicable for such jurisdictions) for each Target Company certified as of a date no earlier than thirty (30) days prior to the Closing Date from the proper Governmental Authority of the Target Company&#8217;s jurisdiction of organization and from each other jurisdiction in which the Target Company is qualified to do business as a foreign corporation or other entity as of the Closing, in each case to the extent that good standing certificates or similar documents are generally available in such jurisdictions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>CERTIFIED CHARTER. The Company shall have delivered to the Purchaser a copy of the Company Charter, as in effect as of immediately prior to the Effective Time, certified by the Secretary of State of the State of Delaware as of a date no more than ten (10) Business Days prior to the Closing Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span>EMPLOYMENT AGREEMENTS. The Purchaser shall have received employment agreements, in each case effective as of the Closing, in form and substance reasonably acceptable to the Company and the Purchaser, between each of </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-42</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">the persons set forth <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 7.3(e)(v)</span> hereto and the applicable Target Company or the Purchaser, as noted in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 7.3(e)(v)</span>, each such employment agreement duly executed by the parties thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vi)</span></span>The Company shall have delivered to the Purchaser copies of the Lock-up Agreement duly executed by the Significant Company Holders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vii)</span></span>The Company shall have delivered to the Purchaser copies of the Non-Competition Agreements duly executed by each of the Key Management members.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(viii)&#160;TRANSMITTAL DOCUMENTS. The Exchange Agent shall have received from each Company Stockholder the Transmittal Documents, each in form reasonably acceptable for transfer on the books of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ix)</span></span>The Purchaser shall have received evidence reasonably acceptable to the Purchaser that the Company shall have terminated, extinguished and cancelled in full any outstanding unvested Stock Options, unexercised Warrants or commitments therefor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(x)</span></span>RESIGNATIONS. Subject to the requirements of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.17(b)</span>, the Purchaser shall have received written resignations, effective as of the Closing, of each of the directors and officers of the Company listed on Schedule 7.3(e)(x) prior to the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xi)</span></span>TERMINATION OF CERTAIN CONTRACTS. The Purchaser shall have received evidence reasonably acceptable to the Purchaser that the Contracts involving the Target Companies and/or Company Security Holders or other Related Persons set forth on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule 7.3(e)(xi)</span> shall have been terminated with no further obligation or Liability of the Target Companies thereunder.</p><a id="a74FrustrationofConditions_246877"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Frustration of Conditions</span>. Notwithstanding anything contained herein to the contrary, no Party may rely on the failure of any condition set forth in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article VII</span> to be satisfied if such failure was caused by the failure of such Party or its Affiliates (or with respect to the Company, any Target Company or Company Stockholder) failure to comply with or perform any of its covenants or obligations set forth in this Agreement.</p><a id="_7cee9cb9_6b20_412f_8363_efc0400a0034"></a><a id="ARTICLEVIII_524256"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ARTICLE VIII</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">TERMINATION AND EXPENSES</b></p><a id="a81Termination_394572"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination</span>. This Agreement may be terminated and the transactions contemplated hereby may be abandoned at any time prior to the Closing as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>by mutual written consent of the Purchaser and the Company;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>by written notice by the Purchaser or the Company if any of the conditions to the Closing set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Article VII</span> have not been satisfied or waived by June 30, 2022 (the &#8220;<span style="font-style:italic;font-weight:bold;">Outside Date</span>&#8221;) (provided, that if Purchaser seeks and obtains one or more Extensions, Purchaser shall have the right with respect to each extension, by providing written notice thereof to the Company, to extend the Outside Date for an additional period equal to the shortest of (i) three (3) additional months, (ii) the period ending on the last date for Purchaser to consummate its Business Combination pursuant to such Extension and (iii) such period as determined by Purchaser); <i style="font-style:italic;">provided, however</i>, the right to terminate this Agreement under this Section 8.1(b) shall not be available to a Party if the breach or violation by such Party or its Affiliates of any representation, warranty, covenant or obligation under this Agreement was the proximate cause of the failure of the Closing to occur on or before the Outside Date;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>by written notice by either the Purchaser or the Company if a Governmental Authority of competent jurisdiction shall have issued an Order or taken any other action permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement, and such Order or other action has become final and non-appealable; <i style="font-style:italic;">provided, however, </i>that the right to terminate this Agreement pursuant to this Section 8.1(c) shall not be available to a Party if the failure by such Party or its Affiliates to comply with any provision of this Agreement has been a substantial cause of such action by such Governmental Authority;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>by written notice by the Company to Purchaser, if (i) there has been a material breach by the Purchaser of any of its representations, warranties, covenants or agreements contained in this Agreement, or if any representation or warranty of the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-43</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Purchaser shall have become untrue or inaccurate, in any case, which would result in a failure of a condition set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7.2(a)</span> or <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7.2(b)</span> to be satisfied (treating the Closing Date for such purposes as the date of this Agreement or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) twenty (20) days after written notice of such breach or inaccuracy is provided to the Purchaser or (B) the Outside Date; provided, that the Company shall not have the right to terminate this Agreement pursuant to this Section 8.1(d) if at such time the Company is in material uncured breach of this Agreement;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>by written notice by the Purchaser to the Company, if (i) there has been a material breach by the Company of any of its representations, warranties, covenants or agreements contained in this Agreement, or if any representation or warranty of such Parties shall have become untrue or inaccurate, in any case, which would result in a failure of a condition set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7.3(a)</span> or <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7.3(b)</span> to be satisfied (treating the Closing Date for such purposes as the date of this Agreement or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) twenty (20) days after written notice of such breach or inaccuracy is provided to the Company or (B) the Outside Date; provided, that the Purchaser shall not have the right to terminate this Agreement pursuant to this Section 8.1(e) if at such time the Purchaser is in material uncured breach of this Agreement;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>by written notice by the Purchaser to the Company, if there shall have been a Material Adverse Effect on the Target Companies taken as a whole following the date of this Agreement which is uncured for at least twenty (20) days after written notice of such Material Adverse Effect is provided by the Purchaser to the Company;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>by written notice by either the Purchaser or the Company to the other, if the Purchaser Special Meeting is held (including any adjournment or postponement thereof) and has concluded, the Purchaser&#8217;s stockholders have duly voted, and the Required Purchaser Stockholder Approval was not obtained;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span>by written notice by the Purchaser to the Company, if the Purchaser has not received the opinion of its financial advisor that the Merger and the other transactions contemplated hereby are fair to the Company and its stockholders from a financial point of view within 30 days after the date of this Agreement; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>by written notice by the Purchaser to the Company, if the Company shall fail to deliver the Audited Company Financials for the year ended December 31, 2021 to the Purchaser by May 15, 2022.</p><a id="a82EffectofTermination_645381"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effect of Termination</span>. This Agreement may only be terminated in the circumstances described in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8.1</span> and pursuant to a written notice delivered by the applicable Party to the other applicable Parties, which sets forth the basis for such termination, including the provision of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8.1</span> under which such termination is made. In the event of the valid termination of this Agreement pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8.1</span>, this Agreement shall forthwith become void, and there shall be no Liability on the part of any Party or any of their respective Representatives, and all rights and obligations of each Party shall cease, except: (i) <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 5.14</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">5.15</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">8.3</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">8.4</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">9.1</span>, Article XI and this Section 8.2 shall survive the termination of this Agreement, and (ii) nothing herein shall relieve any Party from Liability for any willful breach of any representation, warranty, covenant or obligation under this Agreement or any Fraud Claim against such Party, in either case, prior to termination of this Agreement (in each case of clauses (i) and (ii) above, subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9.1)</span>. Without limiting the foregoing, and except as provided in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 8.3</span> and this Section 8.2 (but subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9.1)</span> and subject to the right to seek injunctions, specific performance or other equitable relief in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 10.7</span>, the Parties&#8217; sole right prior to the Closing with respect to any breach of any representation, warranty, covenant or other agreement contained in this Agreement by another Party or with respect to the transactions contemplated by this Agreement shall be the right, if applicable, to terminate this Agreement pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8.1</span>. Upon the termination of this Agreement for any reason, the Extension Escrow Amount shall be distributed as provided in the Extension Escrow Agreement.</p><a id="a83FeesandExpenses_202919"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Fees and Expenses</span>. Subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 5.3</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">8.4</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">9.1</span>, and Article XI all Expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the Party incurring such expenses. As used in this Agreement, &#8220;<span style="font-style:italic;font-weight:bold;">Expenses</span>&#8221; shall include all out-of-pocket expenses (including all fees and expenses of counsel, accountants, investment bankers, financial advisors, financing sources, experts and consultants to a Party hereto or any of its Affiliates) incurred by a Party or on its behalf in connection with or related to the authorization, preparation, negotiation, execution or performance of this Agreement or any Ancillary Document related hereto and all other matters related to the consummation of this Agreement. With respect to the Purchaser, Expenses shall include any and all expenses, filing fees, costs and deferred expenses (including fees or commissions payable to the underwriters and any legal fees) of the IPO upon consummation of a Business Combination and any Extension Expenses.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-44</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ca1be0a3_235a_4498_90b4_999e7b4eeca4"></a><a id="ARTICLEIX_637818"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ARTICLE IX</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">WAIVERS AND RELEASES</b></p><a id="a91WaiverofClaimsAgainstTrust_484382"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">9.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Waiver of Claims Against Trust</span>. Reference is made to the IPO Prospectus. The Company and the Seller Representative each hereby represents and warrants that it has read the IPO Prospectus and understands that Purchaser has established the Trust Account containing the proceeds of the IPO and the overallotment shares acquired by Purchaser&#8217;s underwriters and from certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of Purchaser&#8217;s public stockholders (including overallotment shares acquired by Purchaser&#8217;s underwriters) (the &#8220;<span style="font-style:italic;font-weight:bold;">Public Stockholders</span>&#8221;) and that, except as otherwise described in the IPO Prospectus, Purchaser may disburse monies from the Trust Account only: (a) to the Public Stockholders in the event they elect to redeem their Purchaser Common Stock in connection with the consummation of its initial business combination (as such term is used in the IPO Prospectus) (&#8220;<span style="font-style:italic;font-weight:bold;">Business Combination</span>&#8221;) or in connection with an amendment to Purchaser&#8217;s Organizational Documents to extend Purchaser&#8217;s deadline to consummate a Business Combination, (b) to the Public Stockholders if the Purchaser fails to consummate a Business Combination within twelve (12) months after the closing of the IPO, subject to extension, (c) with respect to any interest earned on the amounts held in the Trust Account, amounts necessary to pay for any taxes, and (d) to Purchaser after or concurrently with the consummation of a Business Combination. For and in consideration of Purchaser entering into this Agreement and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each of the Company and the Seller Representative hereby agrees on behalf of itself and its Affiliates that, notwithstanding anything to the contrary in this Agreement, none of the Company or the Seller Representative nor any of their respective Affiliates do now or shall at any time hereafter have any right, title, interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any claim against the Trust Account (including any distributions therefrom), regardless of whether such claim arises as a result of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship between Purchaser or any of its Representatives, on the one hand, and the Company, the Seller Representative or any of their respective Representatives, on the other hand, or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Released Claims</span>&#8221;). Each of the Company and the Seller Representative on behalf of itself and its Affiliates hereby irrevocably waives any Released Claims that any such Party or any of its Affiliates may have against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, any negotiations, contracts or agreements with Purchaser or its Representatives and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with Purchaser or its Affiliates). The Company and the Seller Representative each agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically relied upon by Purchaser and its Affiliates to induce Purchaser to enter in this Agreement, and each of the Company and the Seller Representative further intends and understands such waiver to be valid, binding and enforceable against such Party and each of its Affiliates under applicable Law. To the extent that the Company or the Seller Representative or any of their respective Affiliates commences any Action based upon, in connection with, relating to or arising out of any matter relating to Purchaser or its Representatives, which proceeding seeks, in whole or in part, monetary relief against Purchaser or its Representatives, each of the Company and the Seller Representative hereby acknowledges and agrees that its and its Affiliates&#8217; sole remedy shall be against funds held outside of the Trust Account and that such claim shall not permit such Party or any of its Affiliates (or any Person claiming on any of their behalves or in lieu of them) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein. In the event that the Company or the Seller Representative or any of their respective Affiliates commences Action based upon, in connection with, relating to or arising out of any matter relating to Purchaser or its Representatives which proceeding seeks, in whole or in part, relief against the Trust Account (including any distributions therefrom) or the Public Stockholders, whether in the form of money damages or injunctive relief, Purchaser and its Representatives, as applicable, shall be entitled to recover from the Company, the Seller Representative (on behalf of the Company Stockholders) and their respective Affiliates, as applicable, the associated legal fees and costs in connection with any such Action, in the event Purchaser or its Representatives, as applicable, prevails in such Action. This Section 9.1 shall survive termination of this Agreement for any reason and continue indefinitely.</p><a id="_96467145_2d16_43d1_b5c5_c7d6be165832"></a><a id="ARTICLEX_755374"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ARTICLE X</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">MISCELLANEOUS</b></p><a id="a101Notices_293594"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.1</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</span>. All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in person, (ii) by facsimile or other electronic means (including e-mail), with affirmative confirmation of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-45</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(iv) three (3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">If to the Purchaser or Merger Sub at or prior to the Closing, to:</i></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Data Knights Acquisition Corp.</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nelson Mullins Riley &amp; Scarborough LLP</p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unit G6, Frome Business Park,</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101 Constitution Avenue, NW, Suite 900</p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Manor Road, Frome, BA11 4FN</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, DC 20001</p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Kingdom</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Andrew M. Tucker, Esq.</p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Barry Anderson</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facsimile No.: (202) 689-2860</p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: 44 203 833 4000</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: (202) 689-2987</p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: barry@dataknightsacuk.com</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: andy.tucker@nelsonmullins.com</p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">If to the Purchaser Representative, to:</i></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Data Knights, LLC</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nelson Mullins Riley &amp; Scarborough LLP</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">c/o Data Knights Acquisition Corp.</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101 Constitution Avenue, NW, Suite 900</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unit G6, Frome Business Park,</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, DC 20001</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Manor Road, Frome, BA11 4FN</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Andrew M. Tucker, Esq.</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Kingdom</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facsimile No.: (202) 689-2860</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Barry Anderson</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: (202) 689-2987</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: 44 203 833 4000</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: andy.tucker@nelsonmullins.com</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: barry@dataknightsacuk.com</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">If to the Company or the Surviving Corporation, to:</i></p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">OneMedNet Corporation</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rimon, P.C.</p></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">6385 Old Shady Oak Road</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1990 K Street, NW Suite 420</p></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Suite 250</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, D.C. 20006</p></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eden Prairie, Minnesota 55344</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Debbie Klis; Debra Vernon</p></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Paul Casey</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: 202-971-9494</p></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: 800-918-7189</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: debbie.klis@rimonlaw.com; </p></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: paul.casey@onemednet.com</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;debra.vernon@rimonlaw.com</p></td></tr><tr><td style="vertical-align:top;width:48.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-46</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">If to the Seller Representative to:</i></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Paul Casey</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rimon, P.C.</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">c/o OneMedNet Corporation</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1990 K Street, NW Suite 420</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">6385 Old Shady Oak Road</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, D.C. 20006</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Suite 250</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Debbie Klis; Debra Vernon</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eden Prairie, Minnesota 55344</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: 202-971-9494</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: 800-918-7189</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: debbie.klis@rimonlaw.com; </p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: paul.casey@onemednet.com</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;debra.vernon@rimonlaw.com</p></td></tr><tr><td style="vertical-align:top;width:48.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">If to the Purchaser after the Closing, to:</i></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">OneMedNet Corporation</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rimon, P.C.</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">6385 Old Shady Oak Road</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1990 K Street, NW Suite 420</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Suite 250</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, D.C. 20006</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eden Prairie, Minnesota 55344</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Debbie Klis; Debra Vernon</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Paul Casey</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: 202-971-9494</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: 800-918-7189</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: debbie.klis@rimonlaw.com; </p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: paul.casey@onemednet.com</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;debra.vernon@rimonlaw.com</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">and</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">and</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">the Purchaser Representative</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nelson Mullins Riley &amp; Scarborough LLP</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101 Constitution Avenue, NW, Suite 900</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, DC 20001</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Andrew M. Tucker, Esq.</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facsimile No.: (202) 689-2860</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: (202) 689-2987</p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail: andy.tucker@nelsonmullins.com</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="a102BindingEffectAssignment_659465"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.2</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Binding Effect; Assignment</span>. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and permitted assigns. This Agreement shall not be assigned by operation of Law or otherwise without the prior written consent of the Purchaser and the Company (and after the Closing, the Purchaser Representative and the Seller Representative), and any assignment without such consent shall be null and void; <i style="font-style:italic;">provided </i>that no such assignment shall relieve the assigning Party of its obligations hereunder.</p><a id="a103ThirdParties_195519"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.3</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Third Parties</span>. Except for the rights of the D&amp;O Indemnified Persons set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5.18</span>, which the Parties acknowledge and agree are express third party beneficiaries of this Agreement, nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any Person that is not a Party hereto or thereto or a successor or permitted assign of such a Party.</p><a id="a104Arbitration_743713"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.4</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Arbitration</span>. Any and all disputes, controversies and claims (other than applications for a temporary restraining order, preliminary injunction, permanent injunction or other equitable relief or application for enforcement of a resolution under this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 10.4</span>, and any dispute to be determined by the Independent Expert in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.15)</span> arising out of, related to, or in connection with this Agreement or the transactions contemplated hereby (a &#8220;<span style="font-style:italic;font-weight:bold;">Dispute</span>&#8221;) shall be governed by this Section 10.4. A party must, in the first instance, provide written notice of any Disputes to the other parties subject to such Dispute, which notice must provide a reasonably detailed description of the matters subject to the Dispute. The parties involved in such Dispute shall seek to resolve the Dispute on an amicable basis within twenty (20) Business Days of the notice of such Dispute being received by such other parties subject to such Dispute (the &#8220;<span style="font-style:italic;font-weight:bold;">Resolution Period</span>&#8221;); <i style="font-style:italic;">provided</i>, that if any Dispute would reasonably be expected to have become moot or otherwise irrelevant if not decided within sixty (60) days after the occurrence of such Dispute, then there shall be no Resolution Period with respect to such Dispute. Any Dispute that is not resolved during the Resolution Period may immediately be referred to and finally resolved by arbitration pursuant to the then-existing Expedited Procedures (as defined in the AAA Procedures) of the Commercial Arbitration Rules (the &#8220;<span style="font-style:italic;font-weight:bold;">AAA Procedures</span>&#8221;) of the AAA. Any party involved in such Dispute may submit the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-47</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Dispute to the AAA to commence the proceedings after the Resolution Period. To the extent that the AAA Procedures and this Agreement are in conflict, the terms of this Agreement shall control. The arbitration shall be conducted by one arbitrator nominated by the AAA and reasonably acceptable to each party subject to the Dispute, which arbitrator shall be a commercial lawyer with substantial experience arbitrating disputes under acquisition agreements. The arbitrator shall accept his or her appointment and begin the arbitration process promptly after his or her nomination and acceptance by the parties subject to the Dispute. The proceedings shall be streamlined and efficient. The arbitrator shall decide the Dispute in accordance with the substantive law of the state of Delaware. Time is of the essence. Each party subject to the Dispute shall submit a proposal for resolution of the Dispute to the arbitrator within twenty (20) business days after confirmation of the appointment of the arbitrator. The arbitrator shall have the power to order any party to do, or to refrain from doing, anything consistent with this Agreement, the Ancillary Documents and applicable Law, including to perform its contractual obligation(s); <i style="font-style:italic;">provided, </i>that the arbitrator shall be limited to ordering pursuant to the foregoing power (and, for the avoidance of doubt, shall order) the relevant party (or parties, as applicable) to comply with only one or the other of the proposals. The arbitrator&#8217;s award shall be in writing and shall include a reasonable explanation of the arbitrator&#8217;s reason(s) for selecting one or the other proposal. The seat of arbitration shall be in Delaware. The language of the arbitration shall be English.</p><a id="a105GoverningLawJurisdiction_453486"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.5</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law; Jurisdiction</span>. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of Delaware without regard to the conflict of laws principles thereof. Subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 1.15</span> and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">10.4</span>, all Actions arising out of or relating to this Agreement shall be heard and determined exclusively in the Chancery Court of the State of Delaware (or if the Chancery Court of the State of Delaware declines to accept jurisdiction, any state or federal court within the State of Delaware or in any appellate court thereof) (the &#8220;<span style="font-style:italic;font-weight:bold;">Specified Courts</span>&#8221;). Subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 1.15</span> and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">10.4</span>, each Party hereto hereby (a) submits to the exclusive jurisdiction of the Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any Party hereto and (b) irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by the Specified Court. Each Party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each Party irrevocably consents to the service of the summons and complaint and any other process in any other Action relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such Party at the applicable address set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 10.1</span>. Nothing in this Section 10.5 shall affect the right of any Party to serve legal process in any other manner permitted by Law.</p><a id="a106WAIVEROFJURYTRIAL_943780"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.6</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">WAIVER OF JURY TRIAL</span>. EACH PARTY HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 10.6.</p><a id="a107SpecificPerformance_427382"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.7</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Specific Performance</span>. Each Party acknowledges that the rights of each Party to consummate the transactions contemplated hereby are unique, recognizes and affirms that in the event of a breach of this Agreement by any Party, money damages may be inadequate and the non-breaching Parties may have not adequate remedy at law, and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed by an applicable Party in accordance with their specific terms or were otherwise breached. Accordingly, each Party shall be entitled to seek an injunction or restraining order to prevent breaches of this Agreement and to seek to enforce specifically the terms and provisions hereof, without the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition to any other right or remedy to which such Party may be entitled under this Agreement, at law or in equity.</p><a id="a108Severability_296646"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.8</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</span>. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-48</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a109Amendment_65500"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.9</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment</span>. This Agreement may be amended, supplemented or modified only by execution of a written instrument signed by the Purchaser, the Company, the Purchaser Representative and the Seller Representative.</p><a id="a1010Waiver_591213"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.10</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Waiver</span>. The Purchaser on behalf of itself and its Affiliates, the Company on behalf of itself and its Affiliates, and the Seller Representative on behalf of itself and the Company Stockholders, may in its sole discretion (i) extend the time for the performance of any obligation or other act of any other non-Affiliated Party hereto, (ii) waive any inaccuracy in the representations and warranties by such other non-Affiliated Party contained herein or in any document delivered pursuant hereto and (iii) waive compliance by such other non-Affiliated Party with any covenant or condition contained herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the Party or Parties to be bound thereby (including by the Purchaser Representative or the Seller Representative in lieu of such Party to the extent provided in this Agreement). Notwithstanding the foregoing, no failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder. Notwithstanding the foregoing, any waiver of any provision of this Agreement after the Closing shall also require the prior written consent of the Purchaser Representative.</p><a id="a1011EntireAgreement_193351"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.11</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Entire Agreement</span>. This Agreement and the documents or instruments referred to herein, including any exhibits and schedules attached hereto, which exhibits and schedules are incorporated herein by reference, together with the Ancillary Documents, embody the entire agreement and understanding of the Parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, representations, warranties, covenants or undertakings, other than those expressly set forth or referred to herein or the documents or instruments referred to herein, which collectively supersede all prior agreements and the understandings among the Parties with respect to the subject matter contained herein.</p><a id="a1012Interpretation_303791"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.12</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Interpretation</span>. The table of contents and the Article and Section headings contained in this Agreement are solely for the purpose of reference, are not part of the agreement of the Parties and shall not in any way affect the meaning or interpretation of this Agreement. In this Agreement, unless the context otherwise requires: (a) any pronoun used shall include the corresponding masculine, feminine or neuter forms, and words in the singular, including any defined terms, include the plural and vice versa; (b) reference to any Person includes such Person&#8217;s successors and assigns but, if applicable, only if such successors and assigns are permitted by this Agreement, and reference to a Person in a particular capacity excludes such Person in any other capacity; (c) any accounting term used and not otherwise defined in this Agreement or any Ancillary Document has the meaning assigned to such term in accordance with GAAP; (d) &#8220;including&#8221; (and with correlative meaning &#8220;include&#8221;) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words &#8220;without limitation&#8221;; (e) the words &#8220;herein,&#8221; &#8220;hereto,&#8221; and &#8220;hereby&#8221; and other words of similar import shall be deemed in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement; (f) the word &#8220;if&#8221; and other words of similar import when used herein shall be deemed in each case to be followed by the phrase &#8220;and only if&#8221;; (g) the term &#8220;or&#8221; means &#8220;and/or&#8221;; (h) any reference to the term &#8220;ordinary course&#8221; or &#8220;ordinary course of business&#8221; shall be deemed in each case to be followed by the words &#8220;consistent with past practice&#8221;; (i) any agreement, instrument, insurance policy, Law or Order defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument, insurance policy, Law or Order as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes, regulations, rules or orders) by succession of comparable successor statutes, regulations, rules or orders and references to all attachments thereto and instruments incorporated therein; (j) except as otherwise indicated, all references in this Agreement to the words &#8220;Section,&#8221; &#8220;Article,&#8221; &#8220;Schedule&#8221; and &#8220;Exhibit&#8221; are intended to refer to Sections, Articles, Schedules and Exhibits to this Agreement; and (k) the term &#8220;Dollars&#8221; or &#8220;$&#8221; means United States dollars. Any reference in this Agreement to a Person&#8217;s directors shall include any member of such Person&#8217;s governing body and any reference in this Agreement to a Person&#8217;s officers shall include any Person filling a substantially similar position for such Person. Any reference in this Agreement or any Ancillary Document to a Person&#8217;s shareholders or stockholders shall include any applicable owners of the equity interests of such Person, in whatever form, including with respect to the Purchaser its stockholders under the DGCL, as then applicable, or its Organizational Documents. The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement. To the extent that any Contract, document, certificate or instrument is represented and warranted to by the Company to be given, delivered, provided or made available by the Company, in order for such Contract, document, certificate or instrument to have been deemed to have been given, delivered, provided and made available to the Purchaser or its Representatives, such Contract, document, certificate or instrument shall have been posted to the electronic data site maintained on behalf of the Company for the benefit of the Purchaser and its Representatives and the Purchaser and its Representatives have been given access to the electronic folders containing such information.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-49</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a1013Counterparts_49665"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.13</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts</span>. This Agreement and each Ancillary Document may be executed and delivered (including by facsimile or other electronic transmission) in one or more counterparts, and by the different Parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.</p><a id="a1014PurchaserRepresentative_777239"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.14</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchaser Representative</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Purchaser, on behalf of itself and its Subsidiaries, successors and assigns, by execution and delivery of this Agreement, hereby irrevocably appoints Data Knights, LLC, in the capacity as the Purchaser Representative, as each such Person&#8217;s agent, attorney-in-fact and representative, with full power of substitution to act in the name, place and stead of such Person, to act on behalf of such Person from and after the Closing in connection with: (i) controlling and making any determinations with respect to the post-Closing Merger Consideration adjustments under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.15</span>; (ii) acting on behalf of such Person under the Extension Escrow Agreement; (iii) terminating, amending or waiving on behalf of such Person any provision of this Agreement or any Ancillary Documents to which the Purchaser Representative is a party or otherwise has rights in such capacity (together with this Agreement, the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Representative Documents</span>&#8221;); (iv) signing on behalf of such Person any releases or other documents with respect to any dispute or remedy arising under any Purchaser Representative Documents; (v) employing and obtaining the advice of legal counsel, accountants and other professional advisors as the Purchaser Representative, in its reasonable discretion, deems necessary or advisable in the performance of its duties as the Purchaser Representative and to rely on their advice and counsel; (vi) incurring and paying reasonable out-of-pocket costs and expenses, including fees of brokers, attorneys and accountants incurred pursuant to the transactions contemplated hereby, and any other reasonable out-of-pocket fees and expenses allocable or in any way relating to such transaction or any indemnification claim; and (vii) otherwise enforcing the rights and obligations of any such Persons under any Purchaser Representative Documents, including giving and receiving all notices and communications hereunder or thereunder on behalf of such Person; <i style="font-style:italic;">provided, </i>that the Parties acknowledge that the Purchaser Representative is specifically authorized and directed to act on behalf of, and for the benefit of, the holders of Purchaser Securities (other than the Company Security Holders immediately prior to the Effective Time and their respective successors and assigns). All decisions and actions by the Purchaser Representative shall be binding upon the Purchaser and its Subsidiaries, successors and assigns, and neither they nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The provisions of this Section 10.14 are irrevocable and coupled with an interest. The Purchaser Representative hereby accepts its appointment and authorization as the Purchaser Representative under this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The Purchaser Representative shall not be liable for any act done or omitted under any Purchaser Representative Document as the Purchaser Representative while acting in good faith and without willful misconduct or gross negligence, and any act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith. The Purchaser shall indemnify, defend and hold harmless the Purchaser Representative from and against any and all losses incurred without gross negligence, bad faith or willful misconduct on the part of the Purchaser Representative (in its capacity as such) and arising out of or in connection with the acceptance or administration of the Purchaser Representative&#8217;s duties under any Purchaser Representative Document, including the reasonable fees and expenses of any legal counsel retained by the Purchaser Representative. In no event shall the Purchaser Representative in such capacity be liable hereunder or in connection herewith for any indirect, punitive, special or consequential damages. The Purchaser Representative shall be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be genuine, including facsimiles or copies thereof, and no Person shall have any Liability for relying on the Purchaser Representative in the foregoing manner. In connection with the performance of its rights and obligations hereunder, the Purchaser Representative shall have the right at any time and from time to time to select and engage, at the cost and expense of the Purchaser, attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance, maintain such records and incur other out-of-pocket expenses, as the Purchaser Representative may deem necessary or appropriate from time to time. All of the indemnities, immunities, releases and powers granted to the Purchaser Representative under this Section 10.14 shall survive the Closing and continue indefinitely.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>The Person serving as the Purchaser Representative may resign upon ten (10) days&#8217; prior written notice to the Purchaser and the Seller Representative, provided, that the Purchaser Representative appoints in writing a replacement Purchaser Representative. Each successor Purchaser Representative shall have all of the power, authority, rights and privileges conferred by this Agreement upon the original Purchaser Representative, and the term &#8220;Purchaser Representative&#8221; as used herein shall be deemed to include any such successor Purchaser Representatives.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-50</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a1015SellerRepresentative_702611"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.15</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Seller Representative</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Each Company Stockholder, by delivery of a Letter of Transmittal, on behalf of itself and its successors and assigns, hereby irrevocably constitutes and appoints Paul Casey, in his capacity as the Seller Representative, as the true and lawful agent and attorney-in-fact of such Persons with full powers of substitution to act in the name, place and stead of thereof with respect to the performance on behalf of such Person under the terms and provisions of this Agreement and the Ancillary Documents to which the Seller Representative is a party or otherwise has rights in such capacity (together with this Agreement, the &#8220;<span style="font-style:italic;font-weight:bold;">Seller Representative Documents</span>&#8221;), as the same may be from time to time amended, and to do or refrain from doing all such further acts and things, and to execute all such documents on behalf of such Person, if any, as the Seller Representative will deem necessary or appropriate in connection with any of the transactions contemplated under the Seller Representative Documents, including: (i) controlling and making any determinations with respect to the post-Closing Merger Consideration adjustments under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.15</span>; (ii) acting on behalf of such Person under the Extension Escrow Agreement; (iii) terminating, amending or waiving on behalf of such Person any provision of any Seller Representative Document (provided, that any such action, if material to the rights and obligations of the Company Stockholders in the reasonable judgment of the Seller Representative, will be taken in the same manner with respect to all Company Stockholders unless otherwise agreed by each Company Stockholder who is subject to any disparate treatment of a potentially material and adverse nature); (iv) signing on behalf of such Person any releases or other documents with respect to any dispute or remedy arising under any Seller Representative Document; (v) employing and obtaining the advice of legal counsel, accountants and other professional advisors as the Seller Representative, in its reasonable discretion, deems necessary or advisable in the performance of its duties as the Seller Representative and to rely on their advice and counsel; (vi) incurring and paying reasonable costs and expenses, including fees of brokers, attorneys and accountants incurred pursuant to the transactions contemplated hereby, and any other reasonable fees and expenses allocable or in any way relating to such transaction or any indemnification claim, whether incurred prior or subsequent to Closing; (vii) receiving all or any portion of the consideration provided to the Company Stockholders under this Agreement and to distribute the same to the Company Stockholders in accordance with their Pro Rata Share; and (viii) otherwise enforcing the rights and obligations of any such Persons under any Seller Representative Document, including giving and receiving all notices and communications hereunder or thereunder on behalf of such Person. All decisions and actions by the Seller Representative shall be binding upon each Company Stockholder and their respective successors and assigns, and neither they nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The provisions of this Section 10.15 are irrevocable and coupled with an interest. The Seller Representative hereby accepts its appointment and authorization as the Seller Representative under this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Any other Person, including the Purchaser Representative, the Purchaser and the Company may conclusively and absolutely rely, without inquiry, upon any actions of the Seller Representative as the acts of the Company Stockholders under any Seller Representative Documents. The Purchaser Representative, the Purchaser and the Company shall be entitled to rely conclusively on the instructions and decisions of the Seller Representative as to (i) any payment instructions provided by the Seller Representative or (ii) any other actions required or permitted to be taken by the Seller Representative hereunder, and no Company Stockholder shall have any cause of action against the Purchaser Representative, the Purchaser or the Company for any action taken by any of them in reliance upon the instructions or decisions of the Seller Representative. The Purchaser Representative, the Purchaser and the Company shall not have any Liability to any Company Stockholder for any allocation or distribution among the Company Stockholders by the Seller Representative of payments made to or at the direction of the Seller Representative. All notices or other communications required to be made or delivered to a Company Stockholder under any Seller Representative Document shall be made to the Seller Representative for the benefit of such Company Stockholder, and any notices so made shall discharge in full all notice requirements of the other parties hereto or thereto to such Company Stockholder with respect thereto. All notices or other communications required to be made or delivered by a Company Stockholder shall be made by the Seller Representative (except for a notice under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 10.15(d)</span> of the replacement of the Seller Representative).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>The Seller Representative will act for the Company Stockholders on all of the matters set forth in this Agreement in the manner the Seller Representative believes to be in the best interest of the Company Stockholders, but the Seller Representative will not be responsible to the Company Stockholders for any losses that any Company Stockholder may suffer by reason of the performance by the Seller Representative of the Seller Representative&#8217;s duties under this Agreement, other than losses arising from the bad faith, gross negligence or willful misconduct by the Seller Representative in the performance of its duties under this Agreement. From and after the Closing, the Company Stockholders shall jointly and severally indemnify, defend and hold the Seller Representative harmless from and against any and all losses reasonably incurred without gross negligence, bad faith or willful misconduct on the part of the Seller Representative (in its capacity as such) and arising out of or in connection with the acceptance or administration of the Seller Representative&#8217;s duties under any Seller Representative Document, including the reasonable fees and expenses of any legal counsel retained by the Seller Representative. In no event shall the Seller Representative in such capacity be liable hereunder or in connection herewith for any indirect, punitive, special or consequential </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-51</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">damages. The Seller Representative shall not be liable for any act done or omitted under any Seller Representative Document as the Seller Representative while acting in good faith and without willful misconduct or gross negligence, and any act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith. The Seller Representative shall be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be genuine, including facsimiles or copies thereof, and no Person shall have any Liability for relying on the Seller Representative in the foregoing manner. In connection with the performance of its rights and obligations hereunder, the Seller Representative shall have the right at any time and from time to time to select and engage, at the reasonable cost and expense of the Company Stockholders, attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance, maintain such records and incur other reasonable out-of-pocket expenses, as the Seller Representative may reasonably deem necessary or appropriate from time to time. All of the indemnities, immunities, releases and powers granted to the Seller Representative under this Section 10.15 shall survive the Closing and continue indefinitely.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>If the Seller Representative shall die, become disabled, dissolve, resign or otherwise be unable or unwilling to fulfill its responsibilities as representative and agent of Company Stockholders, then the Company Stockholders shall, within ten (10) days after such death, disability, dissolution, resignation or other event, appoint a successor Seller Representative (by vote or written consent of the Company Stockholders holding in the aggregate a Pro Rata Share in excess of fifty percent (50%)), and promptly thereafter (but in any event within five (5) Business Days after such appointment) notify the Purchaser Representative and the Purchaser in writing of the identity of such successor. Any such successor so appointed shall become the &#8220;Seller Representative&#8221; for purposes of this Agreement.</p><a id="a1016LegalRepresentation_295025"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.16</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Legal Representation</span>. The Parties agree that, notwithstanding the fact that Nelson Mullins may have, prior to Closing, jointly represented the Purchaser, Merger Sub, the Purchaser Representative and/or Data Knights, LLC in connection with this Agreement, the Ancillary Documents and the transactions contemplated hereby and thereby, and has also represented the Purchaser and/or its Affiliates in connection with matters other than the transaction that is the subject of this Agreement, Nelson Mullins will be permitted in the future, after Closing, to represent Data Knights, LLC, the Purchaser Representative or their respective Affiliates in connection with matters in which such Persons are adverse to the Purchaser or any of its Affiliates, including any disputes arising out of, or related to, this Agreement. The Company and the Seller Representative, who are or have the right to be represented by independent counsel in connection with the transactions contemplated by this Agreement, hereby agree, in advance, to waive (and to cause their Affiliates to waive) any actual or potential conflict of interest that may hereafter arise in connection with Nelson Mullins&#8217;s future representation of one or more of Data Knights, LLC, the Purchaser Representative or their respective Affiliates in which the interests of such Person are adverse to the interests of the Purchaser, the Company and/or the Seller Representative or any of their respective Affiliates, including any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation by Nelson Mullins of the Purchaser, Merger Sub, Data Knights, LLC, the Purchaser Representative or any of their respective Affiliates. The Parties acknowledge and agree that, for the purposes of the attorney-client privilege, Data Knights, LLC and the Purchaser Representative shall be deemed the clients of Nelson Mullins with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents. All such communications shall remain privileged after the Closing and the privilege and the expectation of client confidence relating thereto shall belong solely to Data Knights, LLC and the Purchaser Representative, shall be controlled by Data Knights, LLC and the Purchaser Representative and shall not pass to or be claimed by Purchaser or the Surviving Corporation; <i style="font-style:italic;">provided, further, </i>that nothing contained herein shall be deemed to be a waiver by the Purchaser or any of its Affiliates (including, after the Effective Time, the Surviving Corporation and its Affiliates) of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications to any third party.</p><a id="ARTICLEXI_860860"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ARTICLE XI</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">DEFINITIONS</b></p><a id="a111CertainDefinitions_763607"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">11.1&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certain Definitions</span>. For purpose of this Agreement, the following capitalized terms have the following meanings:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">AAA</span>&#8221; means the American Arbitration Association or any successor entity conducting arbitrations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Accounting Principles</span>&#8221; means in accordance with GAAP as in effect at the date of the financial statement to which it refers or if there is no such financial statement, then as of the Closing Date, using and applying the same accounting principles, practices, procedures, policies and methods (with consistent classifications, judgments, elections, inclusions, exclusions and valuation and estimation methodologies) used and applied by the Target Companies in the preparation of the latest audited Company Financials.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-52</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Action</span>&#8221; means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint, stipulation, assessment or arbitration, or any request (including any request for information), inquiry, hearing, proceeding or investigation, by or before any Governmental Authority.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Affiliate</span>&#8221; means, with respect to any Person, any other Person directly or indirectly Controlling, Controlled by, or under common Control with such Person. For the avoidance of doubt, Data Knights, LLC shall be deemed to be an Affiliate or the Purchaser prior to the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Ancillary Documents</span>&#8221; means each agreement, instrument or document attached hereto as an Exhibit, and the other agreements, certificates and instruments to be executed or delivered by any of the Parties hereto in connection with or pursuant to this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Benefit Plans</span>&#8221; of any Person means any and all deferred compensation, executive compensation, incentive compensation, equity purchase or other equity-based compensation plan, severance or termination pay, holiday, vacation or other bonus plan or practice, hospitalization or other medical, life or other insurance, supplemental unemployment benefits, profit sharing, pension, or retirement plan, program, agreement, commitment or arrangement, and each other employee benefit plan, program, agreement or arrangement, including each &#8220;employee benefit plan&#8221; as such term is defined under Section 3(3) of ERISA, maintained or contributed to or required to be contributed to by a Person for the benefit of any employee or terminated employee of such Person, or with respect to which such Person has any Liability, whether direct or indirect, actual or contingent, whether formal or informal, and whether legally binding or not.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Business Day</span>&#8221; means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New York are authorized to close for business, excluding as a result of &#8220;stay at home,&#8221; &#8220;shelter-in-place,&#8221; &#8220;non-essential employee&#8221; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems, including for wire transfers, of commercially banking institutions in New York, New York are generally open for use by customers on such day.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Closing Company Cash</span>&#8221; means, as of the Reference Time, the aggregate cash and cash equivalents of the Target Companies on hand or in bank accounts, including deposits in transit, minus the aggregate amount of outstanding and unpaid checks issued by or on behalf of the Target Companies as of such time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Closing Net Indebtedness</span>&#8221; means, as of the Reference Time, (i) the aggregate amount of all Indebtedness of the Target Companies, less (ii) the Closing Company Cash, in each case of clauses (i) and (ii), on a consolidated basis and as determined in accordance with the Accounting Principles.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Code</span>&#8221; means the Internal Revenue Code of 1986, as amended, and any successor statute thereto, as amended. Reference to a specific section of the Code shall include such section and any valid Treasury Regulation promulgated thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Common Consideration</span>&#8221; means the aggregate amount that would be paid in respect of the aggregate number of shares of Company Common Stock that are issued and outstanding as of immediately prior to the Effective Time (other than shares to be cancelled in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.12)</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Charter</span>&#8221; means the Certificate of Incorporation of the Company, as amended and effective under the DGCL, prior to the Effective Time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">&#8220;</i><span style="font-style:italic;font-weight:bold;">Company Common Stock</span><i style="font-style:italic;">&#8221; </i>means the common stock, par value $0.0005 per share, of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Confidential Information</span>&#8221; means all confidential or proprietary documents and information concerning the Target Companies or any of their respective Representatives, furnished in connection with this Agreement or the transactions contemplated hereby; <i style="font-style:italic;">provided, however</i>, that Company Confidential Information shall not include any information which, (i) at the time of disclosure by the Purchaser or its Representatives, is generally available publicly and was not disclosed in breach of this Agreement or (ii) at the time of the disclosure by the Company or its Representatives to the Purchaser or its Representatives was previously known by such receiving party without violation of Law or any confidentiality obligation by the Person receiving such Company Confidential Information.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-53</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Convertible Securities</span>&#8221; means, collectively, any warrants, convertible promissory notes or other rights to subscribe for or purchase any capital stock of the Company or securities convertible into or exchangeable for, or that otherwise confer on the holder any right to acquire any capital stock of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Equity Plans</span>&#8221; shall have the meaning set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 4.3(b)</span> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Option</span>&#8221; means each option to purchase shares of Company Common Stock granted to any current or former director, officer, employee or other service provider of the Company or any of its Subsidiaries that is outstanding and unexercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Preferred Stock</span>&#8221; means the Series A-1 Preferred Stock and Series A-2 Preferred Stock, par value $0.0001 per share, of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Securities</span>&#8221; means, collectively, the Company Stock and any Company Convertible Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Security Holders</span>&#8221; means, collectively, the holders of Company Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Stock</span>&#8221; means any shares of the Company Common Stock and the Company Preferred Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Stockholders</span>&#8221; means, collectively, the holders of Company Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Unvested Option</span>&#8221; means each Company Option outstanding as of immediately prior to the Effective Time that is not a Vested Company Option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Vested Option</span>&#8221; means each Company Option outstanding as of immediately prior to the Effective Time that is vested as of such time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Company Warrants</span>&#8221; means, collectively, warrants issued by the Company to purchase Company Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Consent</span>&#8221; means any consent, approval, waiver, authorization or Permit of, or notice to or declaration or filing with any Governmental Authority or any other Person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Contracts</span>&#8221; means all contracts, agreements, binding arrangements, bonds, notes, indentures, mortgages, debt instruments, purchase order, licenses (and all other contracts, agreements or binding arrangements concerning Intellectual Property), franchises, leases and other instruments or obligations of any kind, written or oral (including any amendments and other modifications thereto).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Control</span>&#8221; of a Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract, or otherwise. &#8220;Controlled,&#8221; &#8220;Controlling&#8221; and &#8220;under common Control with&#8221; have correlative meanings. Without limiting the foregoing a Person (the &#8220;<span style="font-style:italic;font-weight:bold;">Controlled Person</span>&#8221;) shall be deemed Controlled by (a) any other Person (i) owning beneficially, as meant in Rule 13d-3 under the Exchange Act, securities entitling such Person to cast ten percent (10%) or more of the votes for election of directors or equivalent governing authority of the Controlled Person or (ii) entitled to be allocated or receive ten percent (10%) or more of the profits, losses, or distributions of the Controlled Person; (b) an officer, director, general partner, partner (other than a limited partner), manager, or member (other than a member having no management authority that is not a Person described in clause (a) above) of the Controlled Person; or (c) a spouse, parent, lineal descendant, sibling, aunt, uncle, niece, nephew, mother-in-law, father-in-law, sister-in-law, or brother-in-law of an Affiliate of the Controlled Person or a trust for the benefit of an Affiliate of the Controlled Person or of which an Affiliate of the Controlled Person is a trustee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Copyrights</span>&#8221; means any works of authorship, mask works and all copyrights therein, including all renewals and extensions, copyright registrations and applications for registration and renewal, and non-registered copyrights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Dissenting Shares</span>&#8221; means any shares of Company Stock for which a Company Stockholder has exercised appraisal rights pursuant to Section 262 of the DGCL.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-54</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Environmental Law</span>&#8221; means any Law in any way relating to (a) the protection of human health and safety, (b) the protection, preservation or restoration of the environment and natural resources (including air, water vapor, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource), or (c) the exposure to, or the use, storage, recycling, treatment, generation, transportation, processing, handling, labeling, production, release or disposal of Hazardous Materials, including the Comprehensive Environmental Response, Compensation and Liability Act, 42 USC. Section 9601 et. seq., the Resource Conservation and Recovery Act, 42 USC. Section 6901 et. seq., the Toxic Substances Control Act, 15 USC. Section 2601 et. seq., the Federal Water Pollution Control Act, 33 USC. Section 1151 et seq., the Clean Air Act, 42 USC. Section 7401 et seq., the Federal Insecticide, Fungicide and Rodenticide Act, 7 USC. Section 111 et. seq., Occupational Safety and Health Act, 29 USC. Section 651 et. seq. (to the extent it relates to exposure to Hazardous Substances), the Asbestos Hazard Emergency Response Act, 15 USC. Section 2601 et. seq., the Safe Drinking Water Act, 42 USC. Section 300f et. seq., the Oil Pollution Act of 1990 and analogous state acts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">ERISA</span>&#8221; means the U.S. Employee Retirement Income Security Act of 1974, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Exchange Act</span>&#8221; means the U.S. Securities Exchange Act of 1934, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Fraud Claim</span>&#8221; means any claim based in whole or in part upon fraud, willful misconduct or intentional misrepresentation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">GAAP</span>&#8221; means generally accepted accounting principles as in effect in the United States of America.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Governmental Authority</span>&#8221; means any federal, state, local, foreign or other governmental, quasi-governmental or administrative body, instrumentality, department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute-resolving panel or body.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Hazardous Material</span>&#8221; means any waste, gas, liquid or other substance or material that is defined, listed or designated as a &#8220;hazardous substance,&#8221; &#8220;pollutant,&#8221; &#8220;contaminant,&#8221; &#8220;hazardous waste,&#8221; &#8220;regulated substance,&#8221; &#8220;hazardous chemical,&#8221; or &#8220;toxic chemical&#8221; (or by any similar term) under any Environmental Law, or any other material regulated, or that could result in the imposition of Liability or responsibility, under any Environmental Law, including petroleum and its by-products, asbestos, polychlorinated biphenyls, radon, mold, and urea formaldehyde insulation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Indebtedness</span>&#8221; of any Person means, without duplication, (a) all indebtedness of such Person for borrowed money (including the outstanding principal and accrued but unpaid interest), (b) all obligations for the deferred purchase price of property or services (other than trade payables incurred in the ordinary course of business), (c) any other indebtedness of such Person that is evidenced by a note, bond, debenture, credit agreement or similar instrument, (d) all obligations of such Person under leases that should be classified as capital leases in accordance with GAAP, (e) all obligations of such Person for the reimbursement of any obligor on any line or letter of credit, banker&#8217;s acceptance, guarantee or similar credit transaction, in each case, that has been drawn or claimed against, (f) all obligations of such Person in respect of acceptances issued or created, (g) all interest rate and currency swaps, caps, collars and similar agreements or hedging devices under which payments are obligated to be made by such Person, whether periodically or upon the happening of a contingency, (h) all obligations secured by an Lien on any property of such Person, (i) any premiums, prepayment fees or other penalties, fees, costs or expenses associated with payment of any Indebtedness of such Person and (j) all obligation described in clauses (a) through (i) above of any other Person which is directly or indirectly guaranteed by such Person or which such Person has agreed (contingently or otherwise) to purchase or otherwise acquire or in respect of which it has otherwise assured a creditor against loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">&#8220;Insider Letter&#8221; </span>means the letter dated May 6, 2021 to the Purchaser from the Purchaser Representative and other parties, as filed as Exhibit 10.1 to the Current Report on Form 8-K filed by the Purchaser with the SEC on May 11, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Intellectual Property</span>&#8221; means all of the following as they exist in any jurisdiction throughout the world: Patents, Trademarks, Copyrights, Trade Secrets, Internet Assets, Software and other intellectual property, and all licenses, sublicenses and other agreements or permissions related to the preceding property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Internet Assets</span>&#8221; means any and all domain name registrations, web sites and web addresses and related rights, items and documentation related thereto, and applications for registration therefor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">IPO</span>&#8221; means the initial public offering of Purchaser Public Units pursuant to the IPO Prospectus.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-55</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">IPO Prospectus</span>&#8221; means the final prospectus of the Purchaser, dated as of May 6, 2021, and filed with the SEC on May 10, 2021 (File No. 333-254029).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">IPO Underwriter</span>&#8221; means EF Hutton, a division of Benchmark Investments, LLC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">IRS</span>&#8221; means the U.S. Internal Revenue Service (or any successor Governmental Authority).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Key Management</span>&#8221; means Saurabh Mathur, Debra Reinhart, Brad Overby, Paul Casey, Douglas Arent and Dr. Jeffrey Yu.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Knowledge</span>&#8221; means, with respect to (i) the Company, the actual knowledge of Key Management, after reasonable inquiry, or (ii) any other Party, (A) if an entity, the actual knowledge of its directors and executive officers, after reasonable inquiry, or (B) if a natural person, the actual knowledge of such Party after reasonable inquiry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Law</span>&#8221; means any federal, state, local, municipal, foreign or other law, statute, legislation, principle of common law, ordinance, code, edict, decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Order or Consent that is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the authority of any Governmental Authority.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Liabilities</span>&#8221; means any and all liabilities, Indebtedness, Actions or obligations of any nature (whether absolute, accrued, contingent or otherwise, whether known or unknown, whether direct or indirect, whether matured or unmatured, whether due or to become due and whether or not required to be recorded or reflected on a balance sheet under GAAP or other applicable accounting standards), including Tax liabilities due or to become due.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Lien</span>&#8221; means any mortgage, pledge, security interest, attachment, right of first refusal, option, proxy, voting trust, encumbrance, lien or charge of any kind (including any conditional sale or other title retention agreement or lease in the nature thereof), restriction (whether on voting, sale, transfer, disposition or otherwise), any subordination arrangement in favor of another Person, or any filing or agreement to file a financing statement as debtor under the Uniform Commercial Code or any similar Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Material Adverse Effect</span>&#8221; means, with respect to any specified Person, any fact, event, occurrence, change or effect that has had, or would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (a) the business, assets, Liabilities, results of operations, prospects or condition (financial or otherwise) of such Person and its Subsidiaries, taken as a whole, or (b) the ability of such Person or any of its Subsidiaries on a timely basis to consummate the transactions contemplated by this Agreement or the Ancillary Documents to which it is a party or bound or to perform its obligations hereunder or thereunder; <i style="font-style:italic;">provided, however</i>, that for purposes of clause (a) above, any changes or effects directly or indirectly attributable to, resulting from, relating to or arising out of the following (by themselves or when aggregated with any other, changes or effects) shall not be deemed to be, constitute, or be taken into account when determining whether there has or may, would or could have occurred a Material Adverse Effect: (i) general changes in the financial or securities markets or general economic or political conditions in the country or region in which such Person or any of its Subsidiaries do business; (ii) changes, conditions or effects that generally affect the industries in which such Person or any of its Subsidiaries principally operate; (iii) changes in GAAP or other applicable accounting principles or mandatory changes in the regulatory accounting requirements applicable to any industry in which such Person and its Subsidiaries principally operate; (iv) conditions caused by acts of God, terrorism, pandemic, war (whether or not declared) or natural disaster; (v) any failure in and of itself by such Person and its Subsidiaries to meet any internal or published budgets, projections, forecasts or predictions of financial performance for any period (provided that the underlying cause of any such failure may be considered in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur to the extent not excluded by another exception herein) and (vi) with respect to the Purchaser, the consummation and effects of the Redemption (or any redemption in connection with the Extension); <i style="font-style:italic;">provided further, however</i>, that any event, occurrence, fact, condition, or change referred to in clauses (i) &#8211; (iv) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event, occurrence, fact, condition, or change has a disproportionate effect on such Person or any of its Subsidiaries compared to other participants in the industries in which such Person or any of its Subsidiaries primarily conducts its businesses. Notwithstanding the foregoing, with respect to the Purchaser, the amount of the Redemption (or any redemption in connection with the Extension, if any) or the failure to obtain the Required Purchaser Stockholder Approval shall not be deemed to be a Material Adverse Effect on or with respect to the Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Merger Sub Common Stock</span>&#8221; means the shares of common stock, par value $0.0001 per share, of Merger Sub.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-56</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Nasdaq</span>&#8221; means the Nasdaq Global Market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Net Working Capital</span>&#8221; means, as of the Reference Time, (i) all current assets of the Target Companies (excluding, without duplication, Closing Company Cash), on a consolidated basis, minus (ii) all current liabilities of the Target Companies (excluding, without duplication, Indebtedness and unpaid Transaction Expenses), on a consolidated basis and as determined in accordance with the Accounting Principles; provided, that, for purposes of this definition, whether or not the following is consistent with the Accounting Principles, &#8220;current assets&#8221; will exclude any receivable from a Company Stockholder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Order</span>&#8221; means any order, decree, ruling, judgment, injunction, writ, determination, binding decision, verdict, judicial award or other action that is or has been made, entered, rendered, or otherwise put into effect by or under the authority of any Governmental Authority.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Organizational Documents</span>&#8221; means, with respect to any Person that is an entity, its certificate of incorporation or formation, bylaws, operating agreement, memorandum and articles of association or similar organizational documents, in each case, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Patents</span>&#8221; means any patents, patent applications and the inventions, designs and improvements described and claimed therein, patentable inventions, and other patent rights (including any divisionals, provisionals, continuations, continuations-in-part, substitutions, or reissues thereof, whether or not patents are issued on any such applications and whether or not any such applications are amended, modified, withdrawn, or refiled).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">PCAOB</span>&#8221; means the U.S. Public Company Accounting Oversight Board (or any successor thereto).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Per Share Consideration</span>&#8221; means the quotient of (i) the Common Consideration divided by (ii) the sum, without duplication, of the aggregate number of shares of Company Common Stock that are issued and outstanding immediately prior to the Effective Time (other than shares to be cancelled in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1.12)</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Permits</span>&#8221; means all federal, state, local or foreign or other third-party permits, grants, easements, consents, approvals, authorizations, exemptions, licenses, franchises, concessions, ratifications, permissions, clearances, confirmations, endorsements, waivers, certifications, designations, ratings, registrations, qualifications or orders of any Governmental Authority or any other Person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Permitted Liens</span>&#8221; means (a) Liens for Taxes or assessments and similar governmental charges or levies, which either are (i) not delinquent or (ii) being contested in good faith and by appropriate proceedings, and adequate reserves have been established with respect thereto, (b) other Liens imposed by operation of Law arising in the ordinary course of business for amounts which are not due and payable and as would not in the aggregate materially adversely affect the value of, or materially adversely interfere with the use of, the property subject thereto, (c) Liens incurred or deposits made in the ordinary course of business in connection with social security, (d) Liens on goods in transit incurred pursuant to documentary letters of credit, in each case arising in the ordinary course of business, or (e) Liens arising under this Agreement or any Ancillary Document.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Person</span>&#8221; means an individual, corporation, partnership (including a general partnership, limited partnership or limited liability partnership), limited liability company, association, trust or other entity or organization, including a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Personal Data</span>&#8221; means, with respect to any natural Person, such Person&#8217;s name, street address, telephone number, e-mail address, photograph, social security number, tax identification number, driver&#8217;s license number, passport number, credit card number, bank account number and other financial information, customer or account numbers, account access codes and passwords, any other information that allows the identification of such Person or enables access to such Person&#8217;s financial information or that is defined as &#8220;personal data,&#8221; &#8220;personally identifiable information,&#8221; &#8220;personal information,&#8221; &#8220;protected health information&#8221; or similar term under any applicable Privacy Laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Personal Property</span>&#8221; means any machinery, equipment, tools, vehicles, furniture, leasehold improvements, office equipment, plant, parts and other tangible personal property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">PIPE Investment</span>&#8221; shall have the meaning set forth in the Recitals.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-57</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">PIPE Investor</span>&#8221; shall have the meaning set forth in the Recitals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Privacy Laws</span>&#8221; means all applicable United States state and federal Laws, and the laws of applicable jurisdictions, relating to privacy and protection of Personal Data and/or Protected Health Information, including the General Data Protection Regulation, the Health Insurance Portability and Accountability Act of 1996 (&#8220;<span style="font-style:italic;font-weight:bold;">HIPAA</span>&#8221;); the Health Information Technology for Economic and Clinical Health Act; and any and all similar state and federal Laws relating to privacy, security, data protection, data availability and destruction and data breach, including security incident notification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Pro Rata Share</span>&#8221; means with respect to each Company Stockholder, a fraction expressed a percentage equal to (i) the portion of the Stockholder Merger Consideration payable by the Purchaser to such Company Stockholder in accordance with the terms of this Agreement, divided by (ii) the total Stockholder Merger Consideration payable by the Purchaser to all Company Stockholders in accordance with the terms of this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Proceeding</span>&#8221; means any action, suit, proceeding, complaint, claim, charge, hearing, labor dispute, inquiry or investigation before or by a Governmental Authority or an arbitrator.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Protected Health Information</span>&#8221; has the meaning given to such term under HIPAA, including all such information in electronic form.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Certificate of Incorporation</span>&#8221; means Second Amended and Restated Certificate of Incorporation of the Purchaser dated as of April 6, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Class A Common Stock</span>&#8221; means the shares of Class A common stock, par value $0.0001 per share, of the Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Class B Common Stock</span>&#8221; means the shares of Class B common stock, par value $0.0001 per share, of the Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Common Stock</span>&#8221; means the shares of Purchaser Class A Common Stock and Purchaser Class B Common Stock, collectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Confidential Information</span>&#8221; means all confidential or proprietary documents and information concerning the Purchaser or any of its Representatives; <i style="font-style:italic;">provided, however</i>, that Purchaser Confidential Information shall not include any information which, (i) at the time of disclosure by the Company, the Seller Representative or any of their respective Representatives, is generally available publicly and was not disclosed in breach of this Agreement or (ii) at the time of the disclosure by the Purchaser or its Representatives to the Company, the Seller Representative or any of their respective Representatives, was previously known by such receiving party without violation of Law or any confidentiality obligation by the Person receiving such Purchaser Confidential Information. For the avoidance of doubt, from and after the Closing, Purchaser Confidential Information will include the confidential or proprietary information of the Target Companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Preferred Shares</span>&#8221; means preferred shares, par value $0.0001 per share, of Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Private Units</span>&#8221; means the units issued by Purchaser in a private placement to Data Knights, LLC at the time of the consummation of the IPO consisting of one (1) share of Purchaser Class A Common Stock and one Purchaser Private Warrant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Private Warrants</span>&#8221; means one whole warrant that was included in as part of each Purchaser Private Unit, entitling the holder thereof to purchase one (1) share of Purchaser Class A Common Stock at a purchase price of $11.50 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Public Units</span>&#8221; means the units issued in the IPO (including overallotment units acquired by Purchaser&#8217;s underwriter) consisting of one (1) share of Purchaser Class A Common Stock and one Purchaser Public Warrant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Public Warrants</span>&#8221; means one whole warrant that was included in as part of each Purchaser Public Unit, entitling the holder thereof to purchase one (1) share of Purchaser Class A Common Stock at a purchase price of $11.50 per share.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-58</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Securities</span>&#8221; means the Purchaser Units, the Purchaser Common Stock, the Purchaser Preferred Shares and the Purchaser Warrants, collectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Units</span>&#8221; means Purchaser Private Units and Purchaser Public Units, collectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Warrants</span>&#8221; means Purchaser Private Warrants and Purchaser Public Warrants, collectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">&#8220;Purchaser&#8217;s Organizational Documents</span>&#8221; means the Organizational Documents of the Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Redemption Price</span>&#8221; means an amount equal to the price at which each share of Purchaser Common Stock is redeemed or converted pursuant to the Redemption (as equitably adjusted for stock splits, stock dividends, combinations, recapitalizations and the like after the Closing).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Registration Rights Agreement</span>&#8221; means the Registration Rights Agreement in the form of Exhibit G hereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Reference Time</span>&#8221; means the close of business of the Company on the Closing Date (but without giving effect to the transactions contemplated by this Agreement, including any payments by Purchaser hereunder to occur at the Closing, but treating any obligations in respect of Indebtedness, Transaction Expenses or other liabilities that are contingent upon the consummation of the Closing as currently due and owing without contingency as of the Reference Time).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Release</span>&#8221; means any release, spill, emission, leaking, pumping, injection, deposit, disposal, discharge, dispersal, or leaching into the indoor or outdoor environment, or into or out of any property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Representatives</span>&#8221; means, as to any Person, such Person&#8217;s Affiliates and the respective managers, directors, officers, employees, independent contractors, consultants, advisors (including financial advisors, counsel and accountants), agents and other legal representatives of such Person or its Affiliates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">SEC</span>&#8221; means the U.S. Securities and Exchange Commission (or any successor Governmental Authority). &#8220;<span style="font-style:italic;font-weight:bold;">Securities Act</span>&#8221; means the Securities Act of 1933, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Significant Company Holder</span>&#8221; means any Company Stockholder who (i) is an executive officer or director of the Company or (ii) owns more than five percent (5%) of the issued and outstanding shares of the Company (treating any Company Preferred Stock on an as-converted to Company Common Stock basis).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Software</span>&#8221; means any computer software programs, including all source code, object code, and documentation related thereto and all software modules, tools and databases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">SOX</span>&#8221; means the U.S. Sarbanes-Oxley Act of 2002, as amended. &#8220;<span style="font-style:italic;font-weight:bold;">Sponsor</span>&#8221; means Data Knights, LLC, a Delaware limited liability company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Subscription Agreement</span>&#8221; shall have the meaning set forth in the Recitals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Subsidiary</span>&#8221; means, with respect to any Person, any corporation, partnership, association or other business entity of which (i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (ii) if a partnership, association or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated a majority of partnership, association or other business entity gains or losses or will be or control the managing director, managing member, general partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person will also include any variable interest entity which is consolidated with such Person under applicable accounting rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Target Company</span>&#8221; means each of the Company and its direct and indirect Subsidiaries.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-59</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Target Net Working Capital Amount</span>&#8221; means an amount equal to $500,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Tax Return</span>&#8221; means any return, declaration, report, claim for refund, information return or other documents (including any related or supporting schedules, statements or information) filed or required to be filed in connection with the determination, assessment or collection of any Taxes or the administration of any Laws or administrative requirements relating to any Taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Taxes</span>&#8221; means (a) all direct or indirect federal, state, local, foreign and other net income, gross income, gross receipts, sales, use, value- added, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, social security and related contributions due in relation to the payment of compensation to employees, excise, severance, stamp, occupation, premium, property, windfall profits, alternative minimum, estimated, customs, duties or other taxes, fees, assessments or charges of any kind whatsoever, together with any interest and any penalties, additions to tax or additional amounts with respect thereto, (b) any Liability for payment of amounts described in clause (a) whether as a result of being a member of an affiliated, consolidated, combined or unitary group for any period or otherwise through operation of law and (c) any Liability for the payment of amounts described in clauses (a) or (b) as a result of any tax sharing, tax group, tax indemnity or tax allocation agreement (excluding commercial agreements entered into in the ordinary course of business the primary purpose of which is not the sharing of Taxes) with, or any other express or implied agreement to indemnify, any other Person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Trade Secrets</span>&#8221; means any trade secrets, confidential business information, concepts, ideas, designs, research or development information, processes, procedures, techniques, technical information, specifications, operating and maintenance manuals, engineering drawings, methods, know-how, data, mask works, discoveries, inventions, modifications, extensions, improvements, and other proprietary rights (whether or not patentable or subject to copyright, trademark, or trade secret protection).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Trademarks</span>&#8221; means any trademarks, service marks, trade dress, trade names, brand names, internet domain names, designs, logos, or corporate names (including, in each case, the goodwill associated therewith), whether registered or unregistered, and all registrations and applications for registration and renewal thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Transaction Expenses</span>&#8221; means all fees and expenses of any of the Target Companies incurred or payable as of the Closing and not paid prior to the Closing (i) in connection with the consummation of the transactions contemplated hereby, including any amounts payable to professionals (including investment bankers, brokers, finders, attorneys, accountants and other consultants and advisors) retained by or on behalf of any Target Company, (ii) any change in control bonus, transaction bonus, retention bonus, termination or severance payment or payment relating to terminated options, warrants or other equity appreciation, phantom equity, profit participation or similar rights, in any case, to be made to any current or former employee, independent contractor, director or officer of any Target Company at or after the Closing pursuant to any agreement to which any Target Company is a party prior to the Closing which become payable (including if subject to continued employment) as a result of the execution of this Agreement or the consummation of the transactions contemplated hereby and (iii) any sales, use, real property transfer, stamp, stock transfer or other similar transfer Taxes imposed on Purchaser, Merger Sub or any Target Company in connection with the Mergers or the other transactions contemplated by this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Trust Account</span>&#8221; means the trust account established by Purchaser with the proceeds from the IPO pursuant to the Trust Agreement in accordance with the IPO Prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Trust Agreement</span>&#8221; means that certain Investment Management Trust Agreement, dated as of May 6, 2021, as it may be amended, by and between the Purchaser and the Trustee, as well as any other agreements entered into related to or governing the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">&#8220;<span style="font-style:italic;font-weight:bold;">Trustee</span>&#8221; means Continental Stock Transfer and Trust Company, in its capacity as trustee under the Trust Agreement.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-60</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a112SectionReferences_974920"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">11.2</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section References</span>. The following capitalized terms, as used in this Agreement, have the respective meanings given to them in the Section as set forth below adjacent to such terms:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:top;width:84.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Term</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Section</b></p></th></tr><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:top;width:84.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:12.98%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accounts Receivable</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.7(f)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Acquisition Proposal</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.6(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Agreement</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preamble</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Alternative Transaction</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.6(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amended Purchaser Certificate of Incorporation</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.19</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Antitrust Laws</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.9(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Audited Company Financials</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.7(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Business Combination</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.1</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Certificate of Merger</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.2</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CFO</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.15(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Closing</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.1</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Closing Date</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.1</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Closing Filing</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.14(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Closing Press Release</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.14(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Closing Statement</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.15(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preamble</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Benefit Plan</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.19(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Certificates</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Directors</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.17(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Disclosure Schedules</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Article IV</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Financials</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.7(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company IP</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.13(d)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company IP Licenses</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.13(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Material Contracts</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Permits</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.10</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Personal Property Leases</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.16</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Real Property Leases</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.15</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Registered IP</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.13(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Company Special Meeting</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.13</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Controlled Person</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Article XI</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Conversion</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.8</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">D&amp;O Indemnified Persons</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.18(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">D&amp;O Tail Insurance</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.18(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">DGCL</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.2</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effective Time</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.2</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Enforceability Exceptions</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.2</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Environmental Permits</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.20(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Estimated Closing Statement</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.14</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exchange Agent</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expenses</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">8.3</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Extension</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.3(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Extension Expenses</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.3(a)(iv)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Federal Securities Laws</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.7</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Incentive Plan</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Independent Expert</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.15(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Independent Expert Notice Date</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.15(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interim Balance Sheet Date</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.7(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interim Period</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.1(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Letter of Transmittal</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lock-Up Agreement</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recitals</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lost Certificate Affidavit</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.12(d)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Merger</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recitals</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Merger Consideration</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.7</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-61</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:top;width:84.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Term</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Section</b></p></th></tr><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:top;width:84.96%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:12.98%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Merger Sub</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preamble</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nelson Mullins</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.1</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Non-Competition Agreement</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recitals</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Objection Statement</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.15(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">OFAC</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.19(c)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Off-the-Shelf Software</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.13(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outbound IP License</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.13(c)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outside Date</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">8.1(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Party(ies)</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preamble</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">PIPE Investment</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.20</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Post-Closing Purchaser Board</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.17(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Proxy Statement</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Certifications</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.6(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Stockholders</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.1</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preamble</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Director</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.17(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Disclosure Schedules</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Article III</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Financials</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.6(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Material Contract</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.13(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Representative</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preamble</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Stockholder Approval Matters</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Special Meeting</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Termination Fee</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">8.4</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Redemption</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Registration Statement</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.12(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Related Person</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.21</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Released Claims</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.1</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Representative Party</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.15(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Required Company Stockholder Approval</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.1(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Required Purchaser Stockholder Approval</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.1(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">SEC Reports</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.6(a)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Section 409A Plan</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.19(j)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Seller Representative</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preamble</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Signing Filing</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.14(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Signing Press Release</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.14(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sponsor Support Agreement</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recitals</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stockholder Merger Consideration</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.7</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Surviving Corporation</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.1</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Top Customers</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.24</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Top Suppliers</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.24</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Transmittal Documents</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.12(b)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:84.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Voting Agreements</p></td><td style="vertical-align:top;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recitals</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">{REMAINDER OF PAGE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS}</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">B-62</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_1dd5399b_d114_4454_b0bb_90c71b26317e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">IN WITNESS WHEREOF, each Party hereto has caused this Agreement and Plan of Merger to be signed and delivered as of the date first written above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:2.65pt;"><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><div style="height:2.65pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><div style="height:2.65pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><div style="height:2.65pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Purchaser</i><i style="font-style:italic;">:</i></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Data Knights Acquisition Corp.</b></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="3" style="vertical-align:top;width:50.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Barry Anderson</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.75%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td colspan="2" style="vertical-align:top;width:45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: </p></td><td colspan="2" style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Purchaser Representative</i><i style="font-style:italic;">:</i></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Data Knights, LLC, </b>solely in the capacity as the Purchaser Representative hereunder</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="3" style="vertical-align:top;width:50.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Firdauz Edmin Bin Mokhtar</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:6.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:44.15%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Firdauz Edmin Bin Mokhtar</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:6.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:44.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger Sub</i><i style="font-style:italic;">:</i></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Data Knights Merger Sub, Inc.</b></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="3" style="vertical-align:top;width:50.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Barry Anderson</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:6.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:44.15%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:6.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: </p></td><td style="vertical-align:top;width:44.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Compan</i><i style="font-style:italic;">y:</i></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="3" style="vertical-align:top;width:50.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Paul Casey</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:6.6%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: </p></td><td style="vertical-align:top;width:44.15%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Paul Casey</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:6.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: </p></td><td style="vertical-align:top;width:44.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Seller Representative</i><i style="font-style:italic;">:</i></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:53.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Paul Casey, </b>solely in the capacity as the Seller Representative hereunder</p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:46.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="3" style="vertical-align:top;width:50.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Paul Casey</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">[Signature Page to Merger Agreement]</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_3320c053_4e6b_4556_ab19_312345295159"></a><a id="ExhibitA_572102"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Exhibit A</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">FORM OF VOTING AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This VOTING AGREEMENT, dated as of April 25, 2022 (this &#8220;<span style="font-style:italic;font-weight:bold;">Agreement</span>&#8221;), by and among the Data Knights Acquisition Corp., a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser</span>&#8221;), OneMedNet Corporation, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;), and each of the stockholders of the Company whose names appear on the signature pages of this Agreement (each, a &#8220;<span style="font-style:italic;font-weight:bold;">Company Stockholder</span>&#8221; and, collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Company Stockholders</span>&#8221;). Capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined herein).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, simultaneously herewith, the Purchaser, Data Knights Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Purchaser (&#8220;<span style="font-style:italic;font-weight:bold;">Merger Sub</span>&#8221;<i style="font-style:italic;">)</i>, Data Knights, LLC, a Delaware limited liability company (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Representative</span>&#8221;), Paul Casey (the &#8220;<span style="font-style:italic;font-weight:bold;">Seller Representative</span>&#8221;), and (v) <b style="font-weight:bold;">OneMedNet Corporation</b>, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;) have entered into that certain Agreement and Plan of Merger (as amended from time to time in accordance with the terms thereof, the &#8220;<span style="font-style:italic;font-weight:bold;">Merger Agreement</span>&#8221;), a copy of which has been made available to each Company Stockholders, pursuant to which the parties thereto intend to effect the merger of Merger Sub with and into the Company, with the Company continuing as the surviving entity (the &#8220;<span style="font-style:italic;font-weight:bold;">Merger</span>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, as of the date hereof, each Company Stockholder owns of record the number of equity securities of the Company as set forth opposite such Company Stockholder&#8217;s name on <span style="font-style:italic;font-weight:bold;">Exhibit A </span>hereto (all such securities and any underlying securities of the Company of which ownership of record or the power to vote is hereafter acquired by the Company Stockholders prior to the termination of this Agreement being referred to herein as the &#8220;<span style="font-style:italic;font-weight:bold;">Securities</span>&#8221;); and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, in order to induce the Purchaser, Merger Sub, and the Company to enter into the Merger Agreement, the Company Stockholders are executing and delivering this Agreement to the Purchaser and the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOW, THEREFORE</b>, in consideration of the foregoing and of the mutual covenants and agreements contained herein, and intending to be legally bound hereby, each of the Company Stockholders (severally and not jointly), the Purchaser and the Company hereby agrees as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Agreement to Vote</span>. Each Company Stockholder, by this Agreement, with respect to its Securities, severally and not jointly, hereby agrees (and agrees to execute such documents and certificates evidencing such agreement as the Purchaser may reasonably request in connection therewith), if (and only if) the Approval Condition (as defined below) shall have been satisfied, to vote, at any meeting of the members of the Company, and in any action by written consent of the members of the Company, all of such Company Stockholder&#8217;s Securities (a) in favor of the approval and adoption of the Merger Agreement, the transactions contemplated by the Merger Agreement and this Agreement, (b) in favor of any other matter reasonably necessary to the consummation of the transactions contemplated by the Merger Agreement and considered and voted upon by the stockholders of the Company, (c) in favor of the approval and adoption of the Incentive Plan (as defined in the Merger Agreement) and (d) against any action, agreement or transaction (other than the Merger Agreement or the transactions contemplated thereby) or proposal that would result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company under the Merger Agreement or that would reasonably be expected to result in the failure of the transactions contemplated by the Merger Agreement from being consummated. Each Company Stockholder acknowledges receipt and review of a copy of the Merger Agreement. For purposes of this Agreement, &#8220;<span style="font-style:italic;font-weight:bold;">Approval Condition</span>&#8221; shall mean that the Merger Agreement shall not have been amended or modified to change the Merger Consideration payable under the Merger Agreement to the Company Stockholders. For the purpose of clarification, any adjustment to the Merger Consideration pursuant to <span style="font-style:italic;font-weight:bold;">Section 1.15 </span>of the Merger Agreement shall not constitute an amendment or modification to the Merger Consideration for purposes of the immediately preceding sentence.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transfer of Securities</span>. Except as may be required by or permitted in the Merger Agreement, each Company Stockholder, severally and not jointly, agrees that it shall not, directly or indirectly, (a) sell, assign, transfer (including by operation of law), lien, pledge, dispose of or otherwise encumber any of the Securities or otherwise agree to do any of the foregoing (unless the transferee agrees to be bound by this Agreement), (b) deposit any Securities into a voting trust or enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto that is inconsistent with this Agreement, (c) enter into any contract, option or other arrangement or undertaking with respect to the direct or indirect acquisition or sale, assignment, transfer (including by operation of law) or other disposition of any Securities (unless the transferee agrees to be bound by this Agreement), or (d) take any action that would have the effect of preventing or disabling the Company Stockholder from performing its obligations hereunder.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Representations and Warranties</span>. Each Company Stockholder, severally and not jointly, represents and warrants for and on behalf of itself to the Purchaser as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:25.5pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The execution, delivery and performance by such Company Stockholder of this Agreement and the consummation by such Company Stockholder of the transactions contemplated hereby do not and will not (i) conflict with or violate any Law or other Order applicable to such Company Stockholder, (ii) require any consent, approval or authorization of, declaration, filing or registration with, or notice to, any person or entity, (iii) result in the creation of any Lien on any Securities (other than pursuant to this Agreement, the Merger Agreement or transfer restrictions under applicable securities laws or the Organizational Documents of the Company or such Company Stockholder) or (iv) conflict with or result in a breach of or constitute a default under any provision of such Company Stockholder&#8217;s Organizational Documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:26pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Such Company Stockholder owns of record and has good, valid and marketable title to the Securities set forth opposite the Company Stockholder&#8217;s name on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</span> free and clear of any Lien (other than pursuant to this Agreement or transfer restrictions under applicable securities Laws or the Organizational Documents of such Company Stockholder) and has the sole power (as currently in effect) to vote and the full right, power and authority to sell, transfer and deliver such Securities, and such Company Stockholder does not own, directly or indirectly, any other Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:25.5pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>Such Company Stockholder has the power, authority and capacity to execute, deliver and perform this Agreement, and that this Agreement has been duly authorized, executed and delivered by such Company Stockholder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination</span>. This Agreement and the obligations of the Company Stockholders under this Agreement shall automatically terminate upon the earliest of (a) the Effective Time; (b) the termination of the Merger Agreement in accordance with its terms; or (c) the mutual written agreement of the Purchaser and the Company. Upon termination or expiration of this Agreement, no party shall have any further obligations or liabilities under this Agreement; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, such termination or expiration shall not relieve any party from liability for any willful breach of this Agreement occurring prior to such termination of this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:25.5pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Except as otherwise provided herein, in the Merger Agreement or in any Ancillary Document, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses, whether or not the transactions contemplated hereby are consummated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:26pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by telecopy or e-mail, or by registered or certified mail (postage prepaid, return receipt requested) to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this <span style="font-style:italic;font-weight:bold;">Section 5(b)</span>):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If to the Purchaser, to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Data Knights Acquisition Corp.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Unit G6, Frome Business Park,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Manor Road, Frome, BA11 4FN,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">United Kingdom</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Tel: +44 203 833 4000</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Email: barry@dataknightsacuk.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">with a copy to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Nelson Mullins Riley &amp; Scarborough LLP</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">101 Constitution Ave NW, Suite 900</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Washington, DC 20001</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Attention: Andy Tucker</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Telephone: (202) 689-2987</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">E-mail: andy.tucker@nelsonmullins.com</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If to the Company, to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">OneMedNet Corporation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">6385 Old Shady Oak Road</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Suite 250</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Eden Prairie, Minnesota 55344</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Attn: Paul Casey</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Telephone No.: (808) 228-5998</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">E-mail: paul.casey@onemednet.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">with a copy to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Rimon, P.C.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">1990 K Street, NW Suite 420</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Washington, D.C. 20006</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Attn: Debbie Klis; Debra Vernon</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Telephone No.: (202) 971-9494</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">E-mail: debbie.klis@rimonlaw.com; debra.vernon@rimonlaw.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If to a Company Stockholder, to the address set forth for such Company Stockholder on the signature page hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>This Agreement, the Merger Agreement and the Ancillary Documents constitute the entire agreement among the parties with respect to the subject matter hereof and thereof, and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof and thereof. This Agreement shall not be assigned (whether pursuant to a merger, by operation of law or otherwise) without the prior written consent of the parties, and any attempt to do so without such consent shall be void ab initio.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. No Company Stockholder shall be liable for the breach of this Agreement by any other Company Stockholder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>The parties hereto agree that irreparable damage may occur in the event any provision of this Agreement is not performed in accordance with the terms hereof and that the parties shall be entitled to seek specific performance of the terms hereof, in addition to any other remedy at law or in equity. Each of the parties agrees that it shall not oppose the granting of an injunction, specific performance or other equitable relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate remedy at law or that an award of specific performance is not an appropriate remedy for any reason at law or equity. Any party seeking an injunction or injunctions to prevent breaches or threatened breaches of, or to enforce compliance with, this Agreement, when expressly available pursuant to the terms of this Agreement, shall not be required to provide any bond or other security in connection with any such Order.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed in and to be performed in that State without giving effect to principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction. All actions, suits or proceedings (each an &#8220;<span style="font-style:italic;font-weight:bold;">Action</span>&#8221;, and, collectively, &#8220;<span style="font-style:italic;font-weight:bold;">Actions</span>&#8221;), arising out of or relating to this Agreement shall be heard and determined exclusively in any federal or state court having jurisdiction within the State of Delaware. The parties hereto hereby (i) submit to the exclusive jurisdiction of federal or state courts within the State of Delaware for the purpose of any Action arising out of or relating to this Agreement brought by any party hereto, and (ii) irrevocably waive, and agree not to assert by way of motion, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">defense, or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereunder may not be enforced in or by any of the above-named courts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span>This Agreement may be executed and delivered (including by facsimile or portable document format (pdf) transmission) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Without further consideration, each party shall use commercially reasonable efforts to execute and deliver or cause to be executed and delivered such additional documents and instruments and take all such further action as may be reasonably necessary or desirable to consummate the transactions contemplated by this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span>This Agreement shall not be effective or binding upon any Company Stockholder until such time as the Merger Agreement is executed by each of the parties thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span>If, and as often as, there are any changes in the Company or the Company Stockholder&#8217;s Securities by way of equity split, dividend, combination or reclassification, or through merger, consolidation, reorganization, recapitalization or business combination, or by any other means, equitable adjustment shall be made to the provisions of this Agreement as may be required so that the rights, privileges, duties and obligations hereunder shall continue with respect to the Company Stockholder and its Securities as so changed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(l)</span></span>Each of the parties hereto hereby waives to the fullest extent permitted by applicable law any right it may have to a trial by jury with respect to any litigation directly or indirectly arising out of, under or in connection with this Agreement. Each of the parties hereto (i) certifies that no representative, agent or attorney of any other party has represented, expressly or otherwise, that such other party would not, in the event of litigation, seek to enforce that foregoing waiver and (ii) acknowledges that it and the other parties hereto have been induced to enter into this Agreement and the transactions contemplated hereby, as applicable, by, among other things, the mutual waivers and certifications in this Paragraph (l).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">[Signature pages follow.]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_4d09a2da_749b_423b_b2d4_70ffff3f0242"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, the parties have executed this Agreement as of the date first written above.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td colspan="2" style="vertical-align:top;width:47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:41.65%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:41.65%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">ONEMEDNET CORPORATION</b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:41.65%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:41.65%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><i style="font-style:italic;">[Signature Page to Voting Agreement]</i></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, the parties have executed this Agreement as of the date first written above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">COMPANY STOCKHOLDERS</b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Baba One Irrevocable Trust dated March 26, 2021</b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Bradley Overby</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: Trustee</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Soph One Irrevocable Trust dated March 26, 2021</b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Bradley Overby</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:Trustee</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Jeffrey Yu</b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Revocable Trust of Jerry M. Hiatt dated March 17, 1997, as amended</b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:Jerry M. Hiatt</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:Trustee</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Paul Casey</b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Thomas Kosasa</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><i style="font-style:italic;">[Signature Page to Voting Agreement]</i></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:44.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:50.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Revocable Trust of Jerry M. Hiatt dated March 17, 1997, as amended, as tenants in common</b></p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:44.75%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:Thomas Kosasa</p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:Trustee</p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:44.75%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:Jerry M. Hiatt</p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:Trustee</p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:44.75%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Erkan Akyuz</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><i style="font-style:italic;">[Signature Page to Voting Agreement]</i></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_e8fa3c4a_1e9b_45bc_8a4e_d05403d7c934"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">COMPANY STOCKHOLDERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Company Stockholder</b></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Company Securities</b></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1.0pt solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1.0pt solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1.0pt solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1.0pt solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:50%;border-bottom:1.0pt solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1.0pt solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_897a4fd0_b978_4bfc_9191_a52e4fd49882"></a><a id="ExhibitB_559211"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Exhibit B</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SPONSOR SUPPORT AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This SPONSOR SUPPORT AGREEMENT, dated as of April 25, 2022 (this &#8220;<span style="font-style:italic;font-weight:bold;">Agreement</span>&#8221;), by and among Data Knights, LLC, a Delaware limited liability company (&#8220;<span style="font-style:italic;font-weight:bold;">Sponsor</span>&#8221;), Data Knights Acquisition Corp., a Delaware corporation (&#8220;<span style="font-style:italic;font-weight:bold;">Purchaser</span>&#8221;), and OneMedNet Corporation, a Delaware limited liability company (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;). Terms used but not defined in this Agreement shall have the meanings ascribed to them in the Merger Agreement (as defined below).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, contemporaneously herewith, the Purchaser, Data Knights Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Purchaser (<i style="font-style:italic;">&#8220;</i><span style="font-style:italic;font-weight:bold;">Merger Sub</span><i style="font-style:italic;">&#8221;), </i>Data Knights, LLC, a Delaware limited liability company (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Representative</span>&#8221;), Paul Casey (the &#8220;<span style="font-style:italic;font-weight:bold;">Seller Representative</span>&#8221;), and <b style="font-weight:bold;">OneMedNet Corporation</b>, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;), entered into that certain Agreement and Plan of Merger (the &#8220;<span style="font-style:italic;font-weight:bold;">Merger Agreement</span>&#8221;), pursuant to which Merger Sub will merge with and into the Company, with the Company continuing as the surviving entity (the &#8220;<span style="font-style:italic;font-weight:bold;">Merger</span>&#8221;), and as a result of which the stockholders of the Company will receive shares of the Purchaser&#8217;s Common Stock;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, as of the date hereof, Sponsor owns 3,415,275 shares of Purchaser Common Stock (all such shares of Purchaser Common Stock and any shares of Purchaser Common Stock of which ownership of record or the power to vote is hereafter acquired by Sponsor prior to the termination of this Agreement being referred to herein as the &#8220;<span style="font-style:italic;font-weight:bold;">Shares</span>&#8221;); and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, in order to induce the Company and Purchaser to enter into the Merger Agreement, Sponsor is executing and delivering this Agreement to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements contained herein, and intending to be legally bound hereby, Sponsor, the Company, and Purchaser hereby agree as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Agreement to Vote</span>. Sponsor, with respect to the Shares, hereby agrees (and agrees to execute such documents or certificates evidencing such agreement as Purchaser and/or the Company may reasonably request in connection therewith) to vote at any meeting of the stockholders of Purchaser, and in any action by written consent of the stockholders of Purchaser, to approve the Merger Agreement, all of the Shares (a) in favor of the approval and adoption of the Merger Agreement, the transactions contemplated by the Merger Agreement and this Agreement, (b) in favor of any other matter reasonably necessary to the consummation of the transactions contemplated by the Merger Agreement and considered and voted upon by the stockholders of Purchaser (including the Purchaser Stockholder Approval Matters), (c) in favor of the approval and adoption of the Incentive Plan, (d) for the appointment, and designation of classes, of the members of the Post-Closing Purchaser Board and (e) against any action, agreement or transaction (other than the Merger Agreement or the transactions contemplated thereby) or proposal that would result in a breach of any covenant, representation or warranty or any other obligation or agreement of Purchaser or Merger Sub under the Merger Agreement or that would reasonably be expected to result in the failure of the transactions contemplated by the Merger Agreement from being consummated. Sponsor acknowledges receipt and review of a copy of the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transfer of Shares</span>. Sponsor agrees that it shall not, directly or indirectly, except as otherwise contemplated pursuant to the Merger Agreement, (a) sell, assign, transfer (including by operation of law), redeem, lien, pledge, distribute, dispose of or otherwise encumber any of the Shares or otherwise agree to do any of the foregoing (unless the transferee agrees to be bound by this Agreement), (b) deposit any Shares into a voting trust, enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto that is inconsistent with this Agreement, (c) enter into any contract, option or other arrangement or undertaking with respect to the direct or indirect acquisition or sale, assignment, transfer (including by operation of law), redemption or other disposition of any Shares (unless the transferee agrees to be bound by this Agreement) or (d) take any action that would have the effect of preventing or disabling Sponsor from performing its obligations hereunder. From time to time, at the request of Purchaser, Sponsor shall take all such further actions as may be necessary or appropriate to effect the purposes of this Agreement, and execute customary documents incident to the consummation of the Merger.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Representations and Warranties</span>. Sponsor represents and warrants for and on behalf of itself to Purchaser and the Company as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The execution, delivery and performance by Sponsor of this Agreement and the consummation by Sponsor of the transactions contemplated hereby do not and will not (i) conflict with or violate any Law or Order applicable to Sponsor, (ii) require any consent, approval or authorization of, declaration, filing or registration with, or notice to, any person or entity, (iii) result in the creation of any Lien on any Shares (other than pursuant to this Agreement or transfer restrictions under applicable </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">securities laws or the Organizational Documents of Sponsor) or (iv) conflict with or result in a breach of or constitute a default under any provision of Sponsor&#8217;s Organizational Documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Sponsor owns of record and has good, valid and marketable title to the Shares free and clear of any Lien (other than pursuant to this Agreement or transfer restrictions under applicable securities Laws or the Organizational Documents of Sponsor) and has the sole power (as currently in effect) to vote and has the full right, power and authority to sell, transfer and deliver such Shares. Sponsor does not own, directly or indirectly, any other shares of Purchaser capital stock other than the Shares, or any options, warrants or other rights to acquire any additional shares of the capital stock of Purchase or any security exercisable for or convertible into the capital stock of Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>Sponsor has the power, authority and capacity to execute, deliver and perform this Agreement, and this Agreement has been duly authorized, executed and delivered by Sponsor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><span style="color:#202020;">There is no Action pending, or, to the knowledge of Sponsor, threatened, against Sponsor that would reasonably be expected to materially impair or materially adversely affect the ability of Sponsor to perform its obligations hereunder or to consummate the transactions contemplated by this Agreement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Covenants and Agreements</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>At the Effective Time, Sponsor will deliver to Purchaser a duly executed copy of the Lock-Up Agreement and the Registration Rights Agreement in substantially the forms attached as Exhibits C and G to the Merger Agreement<span style="color:#4d4d4d;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Sponsor agrees to and shall be bound by and subject to Section 5.15 (Confidential Information) and Section 5.16 (Public Announcements), Section 5.6. (No Solicitation), and Section 9.1 (Waiver of Claims Against Trust) of the Merger Agreement to the same extent as such provisions apply to the parties to the Merger Agreement, as if Sponsor is directly party thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>Sponsor hereby waives, and agrees not to assert or perfect, any rights of appraisal or rights to dissent from the Merger that Sponsor may have by virtue of ownership of the Shares and agrees not to commence or participate in any claim, derivative or otherwise, against Purchaser relating to the negotiation, execution or delivery of this Agreement or the Merger Agreement or the consummation of the Merger.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination</span>. This Agreement and the obligations of Sponsor under this Agreement shall automatically terminate upon the earliest of: (a) the Effective Time; (b) the termination of the Merger Agreement in accordance with its terms; or (c) the mutual written agreement of the Company and Purchaser. Upon termination or expiration of this Agreement, no party shall have any further obligations or liabilities under this Agreement; provided, however, such termination or expiration shall not relieve any party from liability for any willful breach of this Agreement occurring prior to its termination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>Except as otherwise provided herein or in the Merger Agreement or any Ancillary Document, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses, whether or not the transactions contemplated hereby are consummated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by telecopy or e-mail or by registered or certified mail (postage prepaid, return receipt requested) to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5(b</span>)):</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If to the Purchaser, to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Data Knights Acquisition Corp.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Unit G6, Frome Business Park,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Manor Road, Frome, BA11 4FN,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">United Kingdom</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Tel: +44 203 833 4000</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Email: barry@dataknightsacuk.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">with a copy to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Nelson Mullins Riley &amp; Scarborough LLP</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">101 Constitution Ave NW, Suite 900</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Washington, DC 20001</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Attention: Andy Tucker</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Telephone: (202) 689-2987</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">E-mail: andy.tucker@nelsonmullins.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If to the Sponsor, to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Data Knights, LLC</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Unit G6, Frome Business Park,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Manor Road, Frome, BA11 4FN,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">United Kingdom</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Tel: +44 203 833 4000</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Email: barry@dataknightsacuk.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">with a copy to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Nelson Mullins Riley &amp; Scarborough LLP</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">101 Constitution Ave NW, Suite 900</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Washington, DC 20001</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Attention: Andy Tucker</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Telephone: (202) 689-2987</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">E-mail: andy.tucker@nelsonmullins.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If to the Company, to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">OneMedNet Corporation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">6385 Old Shady Oak Road</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Suite 250</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Eden Prairie, MN 55344</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Attn: Paul Casey</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Telephone No.: (808) 228-5998</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">E-mail: paul.casey@onemednet.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">with a copy to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Rim&#244;n, P.C.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">1990 K Street NW, Suite 420</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Washington, DC 20006</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Attn: Debbie Klis; Debra Vernon</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Telephone: (202) 971-9494; (650) 292-5910</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">E-mail: debbie.klis@rimonlaw.com; debra.vernon@rimonlaw.com</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>This Agreement, the Merger Agreement and the Ancillary Documents constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof. This Agreement shall not be assigned (whether pursuant to a merger, by operation of law or otherwise).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>The parties hereto agree that irreparable damage may occur in the event any provision of this Agreement was not performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy at law or in equity. Each of the parties agrees that it shall not oppose the granting of an injunction, specific performance and other equitable relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity. Any party seeking an injunction or injunctions to prevent breaches or threatened breaches of, or to enforce compliance with this Agreement when expressly available pursuant to the terms of this Agreement shall not be required to provide any bond or other security in connection with any such Order.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed in and to be performed in that State without giving effect to principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction. All actions, suits or proceedings (collectively, &#8220;<span style="font-style:italic;font-weight:bold;">Action</span>&#8221;) arising out of or relating to this Agreement shall be heard and determined exclusively in any federal or state court having jurisdiction within the State of Delaware. The parties hereto hereby (i) submit to the exclusive jurisdiction of federal or state courts within the State of Delaware for the purpose of any Action arising out of or relating to this Agreement brought by any party hereto, and (ii) irrevocably waive, and agree not to assert by way of motion, defense, or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereunder may not be enforced in or by any of the above-named courts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span>This Agreement may be executed and delivered (including by facsimile or portable document format (pdf) transmission) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Without further consideration, each party shall use commercially reasonable efforts to execute and deliver or cause to be executed and delivered such additional documents and instruments and take all such further action as may be reasonably necessary or desirable to consummate the transactions contemplated by this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span>This Agreement shall not be effective or binding upon Sponsor until such time as the Merger Agreement is executed by each of the parties thereto.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span>If, and as often as, there are any changes in Purchaser or the Purchaser Common Stock by way of stock split, stock dividend, combination or reclassification, or through merger, consolidation, reorganization, recapitalization or business combination, or by any other means, equitable adjustment shall be made to the provisions of this Agreement as may be required so that the rights, privileges, duties and obligations hereunder shall continue with respect to Purchaser, Sponsor and the Shares as so changed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(l)</span></span>Each of the parties hereto hereby waives to the fullest extent permitted by applicable law any right it may have to a trial by jury with respect to any litigation directly or indirectly arising out of, under or in connection with this Agreement. Each of the parties hereto (i) certifies that no representative, agent or attorney of any other party has represented, expressly or otherwise, that such other party would not, in the event of litigation, seek to enforce that foregoing waiver and (ii) acknowledges that it and the other parties hereto have been induced to enter into this Agreement and the transactions contemplated hereby, as applicable, by, among other things, the mutual waivers and certifications in this Paragraph (l).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">[Signature pages follow]</p><a id="_Hlk109267359_0_0_0"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_cd913c9d_1ea6_4fec_b178_c65202e991ac"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;">IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:bottom;width:46.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: </p></td><td style="vertical-align:bottom;width:41.65%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS, LLC</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:bottom;width:46.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:41.65%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 2pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">ONEMEDNET CORPORATION</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:bottom;width:46.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:41.65%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><i style="font-style:italic;">[Signature Page to Sponsor Support Agreement]</i></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_1f4995fa_25b9_4517_ac66_9a431222e0f6"></a><a id="ExhibitC_693181"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.44pt 0pt;"><span style="font-style:italic;font-weight:bold;">Exhibit C</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.75pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FORM OF LOCK-UP AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">THIS LOCK-UP AGREEMENT (this &#8220;<span style="font-style:italic;font-weight:bold;">Agreement</span>&#8221;) is made and entered into as of the Closing Date (as defined in the Merger Agreement, as defined below) by and between (i) <b style="font-weight:bold;">Data Knights Acquisition Corp.</b>, a Delaware corporation (including any successor entity thereto, the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser</span>&#8221;), and (ii) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (the &#8220;<span style="font-style:italic;font-weight:bold;">Subject Party</span>&#8221;). Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, on April 25, 2022, (i) the Purchaser, (ii) Data Knights Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Purchaser (&#8220;<span style="font-style:italic;font-weight:bold;">Merger Sub</span>&#8221;<i style="font-style:italic;">)</i>, (iii) Data Knights, LLC, a Delaware limited liability company (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Representative</span>&#8221;), (iv) Paul Casey (the &#8220;<span style="font-style:italic;font-weight:bold;">Seller Representative</span>&#8221;), and (v) <b style="font-weight:bold;">OneMedNet Corporation</b>, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;) entered into that certain Agreement and Plan of Merger (as amended from time to time in accordance with the terms thereof, the &#8220;<span style="font-style:italic;font-weight:bold;">Merger Agreement</span>&#8221;), pursuant to which the parties thereto intend to effect the merger of Merger Sub with and into the Company, with the Company continuing as the surviving entity (the &#8220;<span style="font-style:italic;font-weight:bold;">Merger</span>&#8221;), as a result of which all of the issued and outstanding capital stock of the Company immediately prior to the Effective Time shall be exchanged for the Stockholder Merger Consideration, all upon the terms and subject to the conditions set forth in this Agreement;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, pursuant to the Merger Agreement, and in view of the valuable consideration to be received by the Subject Party thereunder, the parties desire to enter into this Agreement, pursuant to which the Purchaser Common Stock received by the Subject Party in the Merger (all such securities, together with any securities paid as dividends or distributions with respect to such securities or into which such securities are exchanged or converted, the <i style="font-style:italic;">&#8220;</i><span style="font-style:italic;font-weight:bold;">Restricted Securities</span><i style="font-style:italic;">&#8221;</i>) shall become subject to limitations on disposition as set forth herein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOW, THEREFORE</b>, in consideration of the premises set forth above, which are incorporated into this Agreement as if fully set forth below, and intending to be legally bound hereby, the parties hereby agree as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Lock-Up Provisions</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Subject Party hereby agrees not to, during the period commencing from the Closing and ending on the earliest of (x) six (6) months after the date of the Closing and (y) the date after the Closing on which the Purchaser consummates a liquidation, merger, capital stock exchange, reorganization, or other similar transaction with an unaffiliated third party that results in all of the Purchaser&#8217;s stockholders having the right to exchange their shares of the Purchaser Common Stock for cash, securities, or other property (the &#8220;<span style="font-style:italic;font-weight:bold;">Lock-Up Period</span>&#8221;): (i) lend, offer, pledge, hypothecate, encumber, donate, assign, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any Restricted Securities, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Restricted Securities, or (iii) publicly disclose the intention to do any of the foregoing, whether any such transaction described in clauses (i), (ii), or (iii) above is to be settled by delivery of Restricted Securities or other securities, in cash or otherwise (any of the foregoing described in clauses (i), (ii), or (iii), a &#8220;<span style="font-style:italic;font-weight:bold;">Prohibited Transfer</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The foregoing shall not apply to the transfer of any or all of the Restricted Securities (I) to any Permitted Transferee or (II) pursuant to a court order or settlement agreement related to the distribution of assets in connection with the dissolution of marriage or civil union; provided, however, that in either of cases (I) or (II), it shall be a condition to such transfer that such transfer complies with the Securities Act of 1933, as amended, and other applicable law, and that the transferee executes and delivers to the Purchaser an agreement stating that the transferee is receiving and holding the Restricted Securities subject to the provisions of this Agreement applicable to the Subject Party, and there shall be no further transfer of such Restricted Securities except in accordance with this Agreement. As used in this Agreement, the term &#8220;<span style="font-style:italic;font-weight:bold;">Permitted Transferee</span>&#8221; shall mean: (1) the members of the Subject Party&#8217;s immediate family (for purposes of this Agreement, &#8220;immediate family&#8221; shall mean with respect to any natural person, any of the following: such person&#8217;s spouse or domestic partner, the siblings of such person and his or her spouse or domestic partner, and the direct descendants and ascendants (including adopted and step children and parents) of such person and his or her spouses or domestic partners and siblings), (2) any trust for the direct or indirect benefit of the Subject Party or the immediate family of the Subject Party, (3) if the Subject Party is a trust, to the trustor or beneficiary of such trust or to the estate of a beneficiary of such trust, (4) in the case of an entity, officers, directors, general partners, limited partners, members, or stockholders of such entity that receive such transfer as a distribution, or related investment funds or vehicles controlled or managed by such persons or their respective affiliates, (5) to any affiliate of the Subject Party, and (6) any transferee whereby there is no change in beneficial ownership. The Subject Party further agrees to execute such agreements as may be reasonably requested by the Purchaser that are consistent with the foregoing or that are necessary to give further effect thereto.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>If any Prohibited Transfer is made or attempted contrary to the provisions of this Agreement, such purported Prohibited Transfer shall be null and void ab initio, and the Purchaser shall refuse to recognize any such purported transferee of the Restricted Securities as one of its equity holders for any purpose, and shall refuse to record any such purported transfer of the Restricted Securities in the books of the Company. In order to enforce this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 1</span>, the Purchaser may impose stop-transfer instructions with respect to the Restricted Securities of the Subject Party (and Permitted Transferees and assigns thereof) until the end of the Lock-Up Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>During the Lock-Up Period, each certificate evidencing any Restricted Securities shall be stamped or otherwise imprinted with a legend in substantially the following form, in addition to any other applicable legends:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 54pt;">&#8220;THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A LOCK-UP AGREEMENT, DATED AS OF [<span style="font-family:'Times New Roman';">&#9679;</span>], 2022, BY AND AMONG THE ISSUER OF SUCH SECURITIES (THE &#8220;ISSUER&#8221;) AND THE ISSUER&#8217;S SECURITY HOLDER NAMED THEREIN, AS AMENDED. A COPY OF SUCH LOCK-UP AGREEMENT WILL BE FURNISHED WITHOUT CHARGE BY THE ISSUER TO THE HOLDER HEREOF UPON WRITTEN REQUEST.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>For the avoidance of any doubt, the Subject Party shall retain all of its rights as a stockholder of the Purchaser during the Lock-Up Period, including the right to vote any Restricted Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>The foregoing notwithstanding, to the extent any Subject Party is granted a release or waiver from the restrictions contained in this Section 1 prior to the expiration of the Lock-Up Period, then all Subject Parties shall be automatically granted a release or waiver from the restrictions contained in this Section to the same extent, on substantially the same terms as and on a pro rata basis with, the Subject Party to which such release or waiver is granted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous; No Third-Party Beneficiaries</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Binding Effect; Assignment</span>. This Agreement and all of the provisions herein shall be binding upon and inure to the benefit of the parties hereto and their respective permitted successors and assigns. This Agreement and all rights and obligations of a party are personal and may not be transferred or delegated at any time. Notwithstanding the foregoing, the Purchaser may freely assign any or all of its rights under this Agreement, in whole or in part, to any successor entity (whether by merger, consolidation, equity sale, asset sale, or otherwise) without obtaining the consent or approval of the Subject Party. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision herein be enforced by, any other person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Third Parties</span>. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person or entity that is not a party hereto or thereto or a successor or permitted assign of such a party.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law; Jurisdiction</span>. This Agreement and any dispute or controversy arising out of or relating to this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflict of law principles thereof. All Actions arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court located in Wilmington, Delaware (or in any appellate courts thereof) (the &#8220;<span style="font-style:italic;font-weight:bold;">Specified Courts</span>&#8221;). Each party hereto hereby (i) submits to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any party hereto and (ii) irrevocably waives, and agrees not to assert by way of motion, defense, or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court. Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such party at the applicable address set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 2</span>(f). Nothing in this Section shall affect the right of any party to serve legal process in any other manner permitted by applicable law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">WAIVER OF JURY TRIAL</span>. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Interpretation</span>. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (ii) &#8220;including&#8221; (and with correlative meaning &#8220;include&#8221;) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words &#8220;without limitation&#8221;; (iii) the words &#8220;herein,&#8221; &#8220;hereto,&#8221; and &#8220;hereby&#8221; and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement; and (iv) the term &#8220;or&#8221; means &#8220;and/or&#8221;. The parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</span>. All notices, consents, waivers, and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in person, (ii) by facsimile or other electronic means, with affirmative confirmation of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service, or (iv) three (3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable party at the following addresses (or at such other address for a party as shall be specified by like notice):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:62.15pt;margin:0pt 0pt 0pt 7.65pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><i style="font-style:italic;">If to the Purchaser before the Closing, to:</i></p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with copies to (which shall not constitute notice):</i></p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Data Knights Acquisition Corp. </p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nelson Mullins Riley &amp; Scarborough LLP </p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Unit G6, Frome Business Park,</p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101 Constitution Avenue, NW, Suite 900</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Manor Road, Frome, BA11 4FN, </p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, D.C. 20001</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">United Kingdom</p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Andrew M. Tucker, Esq.</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Tel: +44 203 833 4000</p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facsimile No.: (202) 689-2860</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Email: barry@dataknightsacuk.com</p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: (202) 689-2987</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email: andy.tucker@nelsonmullins.com</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><i style="font-style:italic;">If to the Company (or to the Purchaser after the Closing), to:</i></p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with copies to (which shall not constitute notice):</i></p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">OneMedNet Corporation </p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rim&#244;n, P.C.</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">6385 Old Shady Oak Road</p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1990 K Street NW, Suite 420</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Suite 250</p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, D.C. 20006</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Eden Prairie, Minnesota 55344 </p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Debbie Klis; Debra Vernon</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Attn: Paul Casey</p></td><td colspan="2" style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone: (202) 971-9494; (650) 292-5910</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Telephone No.: (808) 228-5998</p></td><td style="vertical-align:bottom;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail:</p></td><td style="vertical-align:bottom;width:38.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">debbie.klis@rimonlaw.com;</p></td></tr><tr><td style="vertical-align:bottom;width:55.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">E-mail: paul.casey@onemednet.com</p></td><td style="vertical-align:bottom;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:38.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">debra.vernon@rimonlaw.com</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">If to the Subject Party, to</i>: the address set forth below the Subject Party&#8217;s name on the signature page to this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendments and Waivers</span>. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Purchaser and the Subject Party. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Authorization on Behalf of the Purchaser</span>. The parties acknowledge and agree that notwithstanding anything to the contrary contained in this Agreement, any and all determinations, actions, or other authorizations under this Agreement on behalf </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">of the Purchaser, including enforcing the Purchaser&#8217;s rights and remedies under this Agreement, or providing any waivers with respect to the provisions hereof, shall solely be made, taken, and authorized by majority of the disinterested independent directors of the Purchaser&#8217;s board of directors. In the event that the Purchaser at any time does not have any disinterested directors, so long as the Subject Party has any remaining obligations under this Agreement, the Purchaser will promptly appoint one in connection with this Agreement. Without limiting the foregoing, in the event that an affiliate of a Subject Party serves as a director, officer, employee, or other authorized agent of the Purchaser or any of its current or future affiliates, neither the Subject Party nor its affiliate shall have authority, express or implied, to act or make any determination on behalf of the Purchaser or any of its current or future affiliates in connection with this Agreement or any dispute or Action with respect hereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</span>. In case any provision in this Agreement shall be held invalid, illegal, or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal, and enforceable, and the validity, legality, and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality, or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal, or incapable of being enforced, the parties will substitute for any invalid, illegal, or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal, and enforceable, the intent and purpose of such invalid, illegal, or unenforceable provision.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Specific Performance</span>. Each party acknowledges that its obligations under this Agreement are unique, recognizes and affirms that, in the event of a breach of this Agreement, money damages will be inadequate and there will be no adequate remedy at law, and agrees that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, the adversely affected party or parties shall be entitled to an injunction or restraining order to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, without the requirement to post any bond or other security, this being in addition to any other right or remedy available under this Agreement, at law or in equity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Entire Agreement</span>. This Agreement constitutes the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled; p<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">rovided</span>, that, for the avoidance of doubt, the foregoing shall not affect the rights and obligations of the parties under the Merger Agreement or any Ancillary Document. Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights or remedies or any of the obligations of the parties hereto under any other agreement between a Subject Party and the Purchaser or any certificate or instrument delivered in connection with the Purchase, and nothing in any other agreement, certificate, or instrument shall limit any of the rights or remedies or any of the obligations under this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(l)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Further Assurances</span>. From time to time, at another party&#8217;s request and without further consideration (but at the requesting party&#8217;s reasonable cost and expense), each party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(m)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts; Facsimile</span>. This Agreement may also be executed and delivered by facsimile signature or by email in portable document format in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-style:italic;font-weight:bold;">[Remainder of Page Intentionally Left Blank; Signature Pages Follow]</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_2b04d949_0c9a_4a00_9ef4_efe80847df06"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.44pt 0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, the parties have executed this Lock-Up Agreement as of the date first written above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Purchaser</span><span style="font-style:italic;font-weight:bold;">:</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:7.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:42.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:50.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:7.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:42.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:bottom;width:47.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:42.8%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:42.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.75pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-style:italic;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-style:italic;font-weight:bold;">{Additional Signatures on the Following Pages}</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_09b0d82c_9617_49f1_9a7e_8529a876d17b"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td colspan="4" style="vertical-align:bottom;width:49.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Baba One Irrevocable Trust dated March 26, 2021</b></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="4" style="vertical-align:bottom;width:49.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:49.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Bradley Overby </p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:49.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: Trustee</p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Number of Shares and Type of Purchaser Common Stock:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Common Stock:</p></td><td style="vertical-align:bottom;width:32.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Address for Notice:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address:</p></td><td colspan="3" style="vertical-align:bottom;width:44.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:44.34%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td colspan="3" style="vertical-align:bottom;width:44.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="3" style="vertical-align:bottom;width:44.34%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:40.22%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: </p></td><td colspan="2" style="vertical-align:bottom;width:40.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.:</p></td><td colspan="2" style="vertical-align:bottom;width:40.22%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="2" style="vertical-align:bottom;width:40.22%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td colspan="4" style="vertical-align:bottom;width:49.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Soph One Irrevocable Trust dated March 26, 2021</b></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="4" style="vertical-align:bottom;width:49.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:49.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Bradley Overby </p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:49.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: Trustee</p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Number of Shares and Type of Purchaser Common Stock:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Common Stock:</p></td><td style="vertical-align:bottom;width:32.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Address for Notice:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address:</p></td><td colspan="3" style="vertical-align:bottom;width:44.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:44.34%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td colspan="3" style="vertical-align:bottom;width:44.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="3" style="vertical-align:bottom;width:44.34%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:40.22%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: </p></td><td colspan="2" style="vertical-align:bottom;width:40.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.:</p></td><td colspan="2" style="vertical-align:bottom;width:40.22%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="2" style="vertical-align:bottom;width:40.22%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:32.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Jeffrey Yu</b></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Number of Shares and Type of Purchaser Common Stock:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Common Stock:</p></td><td style="vertical-align:bottom;width:32.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Address for Notice:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: </p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td colspan="4" style="vertical-align:bottom;width:56.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Revocable Trust of Jerry M. Hiatt dated March 17, 1997, as amended</b></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="4" style="vertical-align:bottom;width:56.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:56.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Jerry M. Hiatt</p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:56.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: Trustee</p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Number of Shares and Type of Purchaser Common Stock:</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Common Stock:</p></td><td style="vertical-align:bottom;width:39.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Address for Notice:</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address:</p></td><td colspan="3" style="vertical-align:bottom;width:51.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:51.16%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td colspan="3" style="vertical-align:bottom;width:51.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="3" style="vertical-align:bottom;width:51.16%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:59.4%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:47.04%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: </p></td><td colspan="2" style="vertical-align:bottom;width:47.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.:</p></td><td colspan="2" style="vertical-align:bottom;width:47.04%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="2" style="vertical-align:bottom;width:47.04%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.59%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.65pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:32.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Paul Casey</b></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Number of Shares and Type of Purchaser Common Stock:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Common Stock:</p></td><td style="vertical-align:bottom;width:32.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Address for Notice:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: </p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:32.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Thomas Kosasa</b></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Number of Shares and Type of Purchaser Common Stock:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Common Stock:</p></td><td style="vertical-align:bottom;width:32.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Address for Notice:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: </p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:3.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td colspan="6" style="vertical-align:bottom;width:47.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Revocable Trust of Jerry M. Hiatt dated March 17, 1997, as amended, as Tenants in Common</b></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="6" style="vertical-align:bottom;width:47.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:6.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: </p></td><td colspan="3" style="vertical-align:bottom;width:40.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Thomas Kosasa</p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:6.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: </p></td><td colspan="3" style="vertical-align:bottom;width:40.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trustee</p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="6" style="vertical-align:bottom;width:47.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:5.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: </p></td><td colspan="4" style="vertical-align:bottom;width:41.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Jerry M. Hiatt</p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:5.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: </p></td><td colspan="4" style="vertical-align:bottom;width:41.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trustee</p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Number of Shares and Type of Purchaser Common Stock:</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="6" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Common Stock:</p></td><td style="vertical-align:bottom;width:30.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Address for Notice:</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address:</p></td><td colspan="5" style="vertical-align:bottom;width:42.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;width:42.09%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td colspan="5" style="vertical-align:bottom;width:42.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="5" style="vertical-align:bottom;width:42.09%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:50.33%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:12.36%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:37.97%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: </p></td><td colspan="2" style="vertical-align:bottom;width:37.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.:</p></td><td colspan="2" style="vertical-align:bottom;width:37.97%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="2" style="vertical-align:bottom;width:37.97%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:32.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.5pt 0pt;"><b style="font-weight:bold;">Erkan Akyuz</b></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Number of Shares and Type of Purchaser Common Stock:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Common Stock:</p></td><td style="vertical-align:bottom;width:32.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Address for Notice:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: </p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:32.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Lisa Embree</b></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Number of Shares and Type of Purchaser Common Stock:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:19.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchaser Common Stock:</p></td><td style="vertical-align:bottom;width:32.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Address for Notice:</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="3" style="vertical-align:bottom;width:44.33%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with a copy (which will not constitute notice) to:</i></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:52.58%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: </p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email:</p></td><td colspan="2" style="vertical-align:bottom;width:40.21%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.41%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ed5763c4_b335_424d_8861_68eb732c783c"></a><a id="ExhibitD_882944"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.44pt 0pt;"><span style="font-style:italic;font-weight:bold;">Exhibit D</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.75pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">NON-COMPETITION AND NON-SOLICITATION AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">THIS NON-COMPETITION AND NON-SOLICITATION AGREEMENT (this &#8220;<span style="font-style:italic;font-weight:bold;">Agreement</span>&#8221;) has been executed, and is effective as of the Closing Date, by [&#160;&#160;&#160;&#160;&#160;], a [&#160;&#160;&#160;&#160;&#160;&#160;] and stockholder of the Company (defined below) (the &#8220;<span style="font-style:italic;font-weight:bold;">Subject Party</span>&#8221;), in favor of and for the benefit of <b style="font-weight:bold;">Data Knights Acquisition Corp.</b>, a Delaware corporation (including any successor entity thereto, the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser</span>&#8221;), and each of the Purchaser&#8217;s Affiliates (as defined in the Merger Agreement (as defined below)), successors, and direct and indirect Subsidiaries (as defined in the Merger Agreement) (collectively with the Purchaser, the &#8220;<span style="font-style:italic;font-weight:bold;">Covered Parties</span>&#8221;). Any capitalized term used, but not defined in this Agreement will have the meaning ascribed to such term in the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, on April 25, 2021, (i) the Purchaser, (ii) Data Knights Merger Sub, Inc., Delaware corporation and a wholly-owned subsidiary of the Purchaser (&#8220;<span style="font-style:italic;font-weight:bold;">Merger Sub</span>&#8221;<i style="font-style:italic;">)</i>, (iii) Data Knights, LLC, a Delaware limited liability company (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Representative</span>&#8221;), (iv) Paul Casey (the &#8220;<span style="font-style:italic;font-weight:bold;">Seller Representative</span>&#8221;), and (v) <b style="font-weight:bold;">OneMedNet Corporation</b>, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;) entered into that certain Agreement and Plan of Merger (as amended from time to time in accordance with the terms thereof, the &#8220;<span style="font-style:italic;font-weight:bold;">Merger Agreement</span>&#8221;), pursuant to which the parties thereto intend to effect the merger of Merger Sub with and into the Company, with the Company continuing as the surviving entity (the &#8220;<span style="font-style:italic;font-weight:bold;">Merger</span>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, as of the Closing Date, the Company provides healthcare imaging solutions that provide regulatory-grade real world data for use in discovery, development, regulatory approval, and post-market surveillance in the life sciences industry (the &#8220;<span style="font-style:italic;font-weight:bold;">Business</span>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, in connection with, and as a condition to the consummation of the Merger and the other transactions contemplated thereby (the &#8220;<span style="font-style:italic;font-weight:bold;">Transactions</span>&#8221;), and to enable the Purchaser to secure more fully the benefits of the Transactions, including the protection and maintenance of the goodwill and confidential information of the Company, the Purchaser has required that the Subject Party enter into this Agreement;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, the Subject Party is entering into this Agreement in order to induce the Purchaser to consummate the Transactions, pursuant to which the Subject Party will directly or indirectly receive a material benefit; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, the Subject Party, as a former stockholder of the Company, has contributed to the value of the Company and has obtained extensive and valuable knowledge and confidential information concerning the business of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOW, THEREFORE</b>, in order to induce the Purchaser to consummate the Transactions, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Subject Party hereby agrees as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span><b style="font-weight:bold;">Restriction on Competition.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restriction</span>. The Subject Party hereby agrees that during the period from the Closing until the five (5) year anniversary of the Closing Date (the &#8220;<span style="font-style:italic;font-weight:bold;">Termination Date</span>,&#8221; and such period from the Closing until the Termination Date, the &#8220;<span style="font-style:italic;font-weight:bold;">Restricted Period</span>&#8221;), the Subject Party will not, and will cause its Affiliates not to, without the prior written consent of the Purchaser (which may be withheld in its sole discretion), (i) anywhere in the United States and (ii) in any other jurisdictions in which the Covered Parties are engaged, or are actively contemplating to become engaged, in the Business as of the Closing Date or during the Restricted Period (clauses (i) and (ii), collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Territory</span>&#8221;), directly or indirectly engage in the Business (other than through a Covered Party) or own, manage, finance, or control, or participate in the ownership, management, financing, or control of, or become engaged or serve as an officer, director, member, partner, employee, agent, consultant, advisor, or representative of, a business or entity (other than a Covered Party) that engages in the Business (a &#8220;<span style="font-style:italic;font-weight:bold;">Competitor</span>&#8221;). Notwithstanding the foregoing, the Subject Party and its Affiliates may own passive investments of no more than two percent (2%) of any class of outstanding equity interests in a Competitor that is publicly traded, so long as the Subject Party and its Affiliates and immediate family members are not involved in the management or control of such Competitor (&#8220;<span style="font-style:italic;font-weight:bold;">Permitted Ownership</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Acknowledgment</span>. The Subject Party acknowledges and agrees, that (i) the Subject Party possesses knowledge of confidential information of the Company and the Business, (ii) the Subject Party&#8217;s execution of this Agreement is a material inducement to the Purchaser to consummate the Transactions and to realize the goodwill of the Company, for which the Subject Party and/or its Affiliates will receive a substantial direct or indirect financial benefit, and that the Purchaser would not have entered into the Merger Agreement or consummated the Transactions but for the Subject Party&#8217;s agreements set forth in this Agreement, (iii) it would substantially impair the goodwill of the Company and materially reduce the value of the assets of the Company and cause serious and irreparable injury if the Subject Party were to use its ability and knowledge by engaging in the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Business in competition with a Covered Party, and/or to otherwise breach the obligations contained herein and that the Covered Parties would not have an adequate remedy at law because of the unique nature of the Business, (iv) the Subject Party and its Affiliates have no intention of engaging in the Business (other than through the Covered Parties) during the Restricted Period other than through Permitted Ownership, (v) the relevant public policy aspects of restrictive covenants, covenants not to compete, and non-solicitation provisions have been discussed, and every effort has been made to limit the restrictions placed upon the Subject Party to those that are reasonable and necessary to protect the Covered Parties&#8217; legitimate interests, (vi) the Covered Parties conduct and intend to conduct the Business everywhere in the Territory and compete with other businesses that are or could be located in any part of the Territory, (vii) the foregoing restrictions on competition are fair and reasonable in type of prohibited activity, geographic area covered, scope, and duration, (viii) the consideration provided to the Subject Party under this Agreement and the Merger Agreement is not illusory, and (ix) such provisions do not impose a greater restraint than is necessary to protect the goodwill or other business interests of the Covered Parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.</b></span><b style="font-weight:bold;">No Solicitation; No Disparagement.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Solicitation of Employees and Consultants</span>. The Subject Party agrees that, during the Restricted Period, the Subject Party will not, and will not permit its Affiliates to, without the prior written consent of the Purchaser (which may be withheld in its sole discretion), either on its own behalf or on behalf of any other Person (other than, if applicable, a Covered Party in the performance of the Subject Party&#8217;s duties on behalf of the Covered Parties), directly or indirectly: (i) hire or engage as an employee, independent contractor, consultant, or otherwise any Covered Personnel (as defined below); (ii) solicit, induce, encourage, or otherwise knowingly cause (or attempt to do any of the foregoing) any Covered Personnel to leave the service (whether as an employee, consultant, or independent contractor) of any Covered Party; or (iii) in any way interfere with or attempt to interfere with the relationship between any Covered Personnel and any Covered Party; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, the Subject Party and its Affiliates will not be deemed to have violated this Section 2(a) if any Covered Personnel voluntarily and independently solicits an offer of employment from the Subject Party or any of its Affiliates by responding to a general advertisement or solicitation program conducted by or on behalf of the Subject Party or any of its Affiliates (or such other Person whom any of them is acting on behalf of) that is not targeted at such Covered Personnel or Covered Personnel generally, so long as such Covered Personnel are not hired. For purposes of this Agreement, &#8220;<span style="font-style:italic;font-weight:bold;">Covered Personnel</span>&#8221; shall mean any Person who is or was an employee, consultant, or independent contractor of the Covered Parties, as of the Closing Date, at any time during the Restricted Period, or as of the relevant time of determination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Solicitation of Customers and Suppliers</span>. The Subject Party agrees that, during the Restricted Period, the Subject Party and its Affiliates will not, without the prior written consent of the Purchaser (which may be withheld in its sole discretion), individually or on behalf of any other Person (other than, if applicable, a Covered Party in the performance of the Subject Party&#8217;s duties on behalf of the Covered Parties), knowingly and for a purpose competitive with a Covered Party as it related to the Business: (i) solicit, induce, encourage, or otherwise knowingly cause (or attempt to do any of the foregoing) any Covered Customer (as defined below) to (A) cease being, or not become, a client or customer of any Covered Party with respect to the Business or (B) reduce the amount of business of such Covered Customer with any Covered Party, or otherwise alter such business relationship in a manner adverse to any Covered Party, in either case, with respect to or relating to the Business; (ii) interfere with or disrupt (or attempt to interfere with or disrupt) the contractual relationship between any Covered Party and any Covered Customer; (iii) divert any business with any Covered Customer relating to the Business from a Covered Party; (iv) solicit for business, provide services to, engage in or do business with, any Covered Customer for products or services that are part of the Business; or (v) interfere with or disrupt (or attempt to interfere with or disrupt), any Person that was a vendor, supplier, distributor, agent, or other service provider of a Covered Party at the time of such interference or disruption. For purposes of this Agreement, a &#8220;<span style="font-style:italic;font-weight:bold;">Covered Customer</span>&#8221; shall mean (x) any Person who is or was an actual customer or client (or prospective customer or client with whom a Covered Party actively marketed or made or taken specific action to make a proposal) of a Covered Party, as of the Closing Date, at any time during the Restricted Period, or as of the relevant time of determination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mutual Non-Disparagement</span>. The Subject Party and the Covered Parties each agrees that from and after the Closing until the fifth (5th) anniversary of the end of the Restricted Period, neither will, and each will cause its respective Affiliates not to, directly or indirectly engage in any conduct that involves the making or publishing (including through electronic mail distribution or online social media) of any written or oral statements or remarks (including the repetition or distribution of derogatory rumors, allegations, negative reports, or comments) that are disparaging, deleterious, or damaging to the integrity, reputation, or good will of the other or their respective management, officers, employees, independent contractors, or consultants. Notwithstanding the foregoing, subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 3</span> below, the provisions of this Section 2(c) shall not restrict the Subject Party or the Covered Parties from providing truthful testimony or information in response to a subpoena or investigation by a Governmental Authority or in </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">connection with any legal action under this Agreement, the Merger Agreement, or any other Ancillary Document that is asserted in good faith.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">3.</b></span><b style="font-weight:bold;">Confidentiality. </b>From and after the Closing Date, the Subject Party will, and will cause its Representatives (as defined in the Merger Agreement) to, keep confidential and not (except, if applicable, in the performance of the Subject Party&#8217;s duties on behalf of the Covered Parties) directly or indirectly use, disclose, reveal, publish, transfer, or provide access to, any and all Covered Party Information without the prior written consent of the Purchaser (which may be withheld in its sole discretion). As used in this Agreement, &#8220;<span style="font-style:italic;font-weight:bold;">Covered Party Information</span>&#8221; means all material and information relating to the Business, including material and information that concerns or relates to such Covered Party&#8217;s bidding and proposal, technical, computer hardware or software, administrative, management, operational, data processing, financial, marketing, sales, human resources, business development, planning, and/or other business activities, regardless of whether such material and information is maintained in physical, electronic, or other form, that is: (A) gathered, compiled, generated, produced, or maintained by such Covered Party through its Representatives, or provided to such Covered Party by its suppliers, service providers, or customers; and (B) intended and maintained by such Covered Party or its Representatives, suppliers, service providers, or customers to be kept in confidence. The obligations set forth in this Section 3 will not apply to any Covered Party Information where the Subject Party can prove that such material or information: (i) is known or available through other lawful sources not bound by a confidentiality agreement with, or other confidentiality obligation to, any Covered Party; (ii) is or becomes publicly known through no violation of this Agreement or other non-disclosure obligation of the Subject Party or any of its Representatives; (iii) is already in the possession of the Subject Party at the time of disclosure through lawful sources not bound by a confidentiality agreement or other confidentiality obligation as evidenced by the Subject Party&#8217;s documents and records; or (iv) is required to be disclosed pursuant to an order of any administrative body or court of competent jurisdiction (<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that (A) the applicable Covered Party is given reasonable prior written notice, (B) the Subject Party cooperates (and causes its Representatives to cooperate) with any reasonable request of any Covered Party to seek to prevent or narrow such disclosure and (C) if after compliance with clauses (A) and (B) such disclosure is still required, the Subject Party and its Representatives only disclose such portion of the Covered Party Information that is expressly required by such order, as it may be subsequently narrowed).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">4.</b></span><b style="font-weight:bold;">Representations and Warranties</b>. The Subject Party hereby represents and warrants, to and for the benefit of the Covered Parties as of the date of this Agreement and as of the Closing Date, that: (a) the Subject Party has full power and capacity to execute and deliver, and to perform all of the Subject Party&#8217;s obligations under, this Agreement; and (b) neither the execution and delivery of this Agreement nor the performance of the Subject Party&#8217;s obligations hereunder will result directly or indirectly in a violation or breach of any agreement or obligation by which the Subject Party is a party or otherwise bound. By entering into this Agreement, the Subject Party certifies and acknowledges that the Subject Party has carefully read all of the provisions of this Agreement, and that the Subject Party voluntarily and knowingly enters into this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">5.</b></span><b style="font-weight:bold;">Remedies. </b>The covenants and undertakings contained in this Agreement relate to matters which are of a special, unique, and extraordinary character and a violation of any of the terms of this Agreement may cause irreparable injury, the amount of which may be impossible to estimate or determine and which cannot be adequately compensated. In the event of any breach or threatened breach of any covenant or obligation contained in this Agreement, the adversely affected party or parties will be entitled to seek the following remedies (in addition to, and not in lieu of, any other remedy at law or in equity or pursuant to the Merger Agreement or the other Ancillary Documents that may be available, including monetary damages), and a court of competent jurisdiction may award: (i) an injunction, restraining order, or other equitable relief restraining or preventing such breach or threatened breach, without the necessity of posting bond or security, which each party expressly waives; and (ii) recovery of attorneys&#8217; fees and costs incurred in enforcing the party&#8217;s rights under this Agreement. The Subject Party hereby acknowledges and agrees that in the event of any breach of this Agreement, any value attributed or allocated to this Agreement (or any other non-competition agreement with the Subject Party) under or in connection with the Merger Agreement shall not be considered a measure of, or a limit on, the damages of the Covered Parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">6.</b></span><b style="font-weight:bold;">Survival of Obligations. </b>The expiration of the Restricted Period will not relieve the Subject Party of any obligation or liability arising from any breach by the Subject Party of this Agreement during the Restricted Period. The Subject Party further agrees that the time periods during which the covenants contained in this Agreement will be effective will be computed by excluding from such computation any time during which the Subject Party is in violation of any provision of such Sections.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">7.</b></span><b style="font-weight:bold;">Miscellaneous.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</span>. All notices, consents, waivers, and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in person, (ii) by facsimile or other electronic means, with affirmative confirmation of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">(3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable party at the following addresses (or at such other address for a party as shall be specified by like notice):</p><div style="padding-left:18pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:96%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:50.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><i style="font-style:italic;">If to the Purchaser after the Closing, to:</i></p></td><td style="vertical-align:bottom;width:50.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">with copies to (which shall not constitute notice):</i></p></td></tr><tr><td style="vertical-align:bottom;width:49.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:50.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Data Knights Acquisition Corp. </p></td><td style="vertical-align:bottom;width:50.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nelson Mullins Riley &amp; Scarborough LLP </p></td></tr><tr><td style="vertical-align:bottom;width:49.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Unit G6, Frome Business Park,</p></td><td style="vertical-align:bottom;width:50.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101 Constitution Avenue, NW, Suite 900</p></td></tr><tr><td style="vertical-align:bottom;width:49.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Manor Road, Frome, BA11 4FN,</p></td><td style="vertical-align:bottom;width:50.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, D.C. 20001</p></td></tr><tr><td style="vertical-align:bottom;width:49.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">United Kingdom</p></td><td style="vertical-align:bottom;width:50.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Andrew M. Tucker, Esq.</p></td></tr><tr><td style="vertical-align:bottom;width:49.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Tel: +44 203 833 4000</p></td><td style="vertical-align:bottom;width:50.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: (202) 689-2987</p></td></tr><tr><td style="vertical-align:bottom;width:49.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Email: barry@dataknightsacuk.com</p></td><td style="vertical-align:bottom;width:50.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email: andy.tucker@nelsonmullins.com</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">If to the Subject Party, to: </i>the address set forth below the Subject Party&#8217;s name on the signature page to this Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Integration and Non-Exclusivity</span>. This Agreement, the Merger Agreement, and the other Ancillary Documents contain the entire agreement between the Subject Party and the Covered Parties concerning the subject matter hereof. Notwithstanding the foregoing, the rights and remedies of the Covered Parties under this Agreement are not exclusive of or limited by any other rights or remedies which they may have, whether at law, in equity, by contract or otherwise, all of which will be cumulative (and not alternative). Without limiting the generality of the foregoing, the rights, remedies, obligations, and liabilities of the parties under this Agreement are in addition to their respective rights, remedies, obligations, and liabilities (i) under the laws of unfair competition, misappropriation of trade secrets, or other requirements of statutory or common law, or any applicable rules and regulations and (ii) otherwise conferred by contract, including the Merger Agreement and any other written agreement between the Subject Party or its Affiliates and any of the Covered Parties. Nothing in the Merger Agreement will limit any of the obligations, liabilities, rights, or remedies of the Subject Party or the Covered Parties under this Agreement, nor will any breach of the Merger Agreement or any other agreement between the Subject Party or its Affiliates and any of the Covered Parties limit or otherwise affect any right or remedy under this Agreement. If any covenant set forth in any other agreement between the Subject Party or its Affiliates and any of the Covered Parties conflicts or is inconsistent with the terms and conditions of this Agreement, the more restrictive terms will control as to the Subject Party or its Affiliate, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability; Reformation</span>. Each provision of this Agreement is separable from every other provision of this Agreement. If any provision of this Agreement is found or held to be invalid, illegal, or unenforceable, in whole or in part, by a court of competent jurisdiction, then (i) such provision will be deemed amended to conform to applicable laws so as to be valid, legal, and enforceable to the fullest possible extent, (ii) the invalidity, illegality, or unenforceability of such provision will not affect the validity, legality, or enforceability of such provision under any other circumstances or in any other jurisdiction, and (iii) the invalidity, illegality, or unenforceability of such provision will not affect the validity, legality, or enforceability of the remainder of such provision or the validity, legality, or enforceability of any other provision of this Agreement. The Subject Party and the Covered Parties will substitute for any invalid, illegal, or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal, and enforceable, the intent and purpose of such invalid, illegal, or unenforceable provision. Without limiting the foregoing, if any court of competent jurisdiction determines that any part hereof is unenforceable because of the duration, geographic area covered, scope of such provision, or otherwise, such court will have the power to reduce the duration, geographic area covered, or scope of such provision, as the case may be, and, in its reduced form, such provision will then be enforceable. The Subject Party will, at a Covered Party&#8217;s request, join such Covered Party in requesting that such court take such action.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment; Waiver</span>. This Agreement may not be amended or modified in any respect, except by a written agreement executed by the Subject Party, the Purchaser, and a majority of the disinterested independent directors of the Purchaser&#8217;s board of directors (or their respective permitted successors or assigns). No waiver will be effective unless it is expressly set forth in a written instrument executed by the waiving party (and if such waiving party is a Covered Party, by a majority of the disinterested independent directors of the Purchaser&#8217;s board of directors) and any such waiver will have no effect except in the specific instance in which it is given. Any delay or omission by a party in exercising its rights under this Agreement, or failure to insist upon strict compliance with any term, covenant, or condition of this Agreement will not be deemed a waiver of such term, covenant, condition, or right, nor will any waiver or relinquishment of any right or power under this Agreement at any time or times be deemed a waiver or relinquishment of such right or power at any other time or times.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Dispute Resolution</span>. Any dispute, difference, controversy, or claim arising in connection with or related or incidental to, or question occurring under, this Agreement or the subject matter hereof (other than applications for a temporary restraining order, preliminary injunction, permanent injunction or other equitable relief or application for enforcement of a resolution under this Section </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7(e)) (a &#8220;<span style="font-style:italic;font-weight:bold;">Dispute</span>&#8221;) shall be governed by this Section 7(e). A party must, in the first instance, provide written notice of any Disputes to the other parties subject to such Dispute, which notice must provide a reasonably detailed description of the matters subject to the Dispute. Any Dispute that is not resolved within fifteen business days (the &#8220;<span style="font-style:italic;font-weight:bold;">Resolution Period</span>&#8221;) after the delivery of such notice may immediately be referred to and finally resolved by arbitration pursuant to the then-existing Expedited Procedures of the Commercial Arbitration Rules (the &#8220;<span style="font-style:italic;font-weight:bold;">AAA Procedures</span>&#8221;) of the American Arbitration Association (the &#8220;<span style="font-style:italic;font-weight:bold;">AAA</span>&#8221;). Any party involved in such Dispute may submit the Dispute to the AAA to commence the proceedings after the Resolution Period. To the extent that the AAA Procedures and this Agreement are in conflict, the terms of this Agreement shall control. The arbitration shall be conducted by one arbitrator nominated by the AAA promptly (but in any event within five (5) Business Days) after the submission of the Dispute to the AAA and reasonably acceptable to each party subject to the Dispute, which arbitrator shall be a commercial lawyer with substantial experience arbitrating disputes under acquisition agreements. The arbitrator shall accept his or her appointment and begin the arbitration process promptly (but in any event within five (5) Business Days) after his or her nomination and acceptance by the parties subject to the Dispute. The proceedings shall be streamlined and efficient. The arbitrator shall decide the Dispute in accordance with the substantive law of the State of Delaware. Time is of the essence. Each party shall submit a proposal for resolution of the Dispute to the arbitrator within twenty (20) days after confirmation of the appointment of the arbitrator. The arbitrator shall have the power to order any party to do, or to refrain from doing, anything consistent with this Agreement, the Ancillary Documents and applicable Law, including to perform its contractual obligation(s); p<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">rovided</span>, that the arbitrator shall be limited to ordering pursuant to the foregoing power (and, for the avoidance of doubt, shall order) the relevant party (or parties, as applicable) to comply with only one or the other of the proposals. The arbitrator&#8217;s award shall be in writing and shall include a reasonable explanation of the arbitrator&#8217;s reason(s) for selecting one or the other proposal. The seat of arbitration shall be in Wilmington, Delaware. The language of the arbitration shall be English.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law; Jurisdiction</span>. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of Delaware without regard to the conflict of laws principles thereof. Subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7(e)</span>, all Actions arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court located in Wilmington, Delaware (or in any appellate courts thereof) (the &#8220;<span style="font-style:italic;font-weight:bold;">Specified Courts</span>&#8221;). Subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7(e)</span>, each party hereto hereby (a) submits to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any party hereto, (b) irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court and (c) waives any bond, surety or other security that might be required of any other party with respect thereto. Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law or in equity. Each party irrevocably consents to the service of the summons and complaint and any other process in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such party at the applicable address set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7(a)</span>. Nothing in this Section 7(f) shall affect the right of any party to serve legal process in any other manner permitted by Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">WAIVER OF JURY TRIAL</span>. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 7(g). ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 7(g) WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Successors and Assigns; Third Party Beneficiaries</span>. This Agreement will be binding upon, and will inure to the benefit of the parties, and their respective successors and assigns. No Covered Party may assign any or all of its rights under this Agreement, at any time, in whole or in part, to any Person without first obtaining the consent or approval of the Subject Party (which consent shall not be unreasonably withheld, conditioned or delayed). The Subject Party agrees that the obligations of the Subject Party under this Agreement are specific to each of them and will not be assigned by the Subject Party.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disinterested Director Majority Authorized to Act on Behalf of Covered Parties</span>. The parties acknowledge and agree that the majority of the disinterested independent directors of the Purchaser&#8217;s board of directors is authorized and shall have the sole right to act on behalf of Purchaser and the other Covered Parties under this Agreement, including the right to enforce the Purchaser&#8217;s rights </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">and remedies under this Agreement. Without limiting the foregoing, in the event that the Subject Party or Affiliate thereof serves as a director, officer, employee, or other authorized agent of a Covered Party, the Subject Party shall have no authority, express or implied, to act or make any determination on behalf of a Covered Party in connection with this Agreement or any dispute or Action with respect hereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Construction</span>. The Subject Party acknowledges that the Subject Party has been represented by counsel, or had the opportunity to be represented by counsel of the Subject Party&#8217;s choice. Any rule of construction to the effect that ambiguities are to be resolved against the drafting party will not be applied in the construction or interpretation of this Agreement. Neither the drafting history nor the negotiating history of this Agreement will be used or referred to in connection with the construction or interpretation of this Agreement. The headings and subheadings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. In this Agreement: (i) the words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; when used herein shall be deemed in each case to be followed by the words &#8220;without limitation&#8221;; (ii) the definitions contained herein are applicable to the singular as well as the plural forms of such terms; (iii) whenever required by the context, any pronoun shall include the corresponding masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (iv) the words &#8220;herein,&#8221; &#8220;hereto,&#8221; and &#8220;hereby&#8221; and other words of similar import shall be deemed in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement; (v) the word &#8220;if&#8221; and other words of similar import when used herein shall be deemed in each case to be followed by the phrase &#8220;and only if&#8221;; (vi) the term &#8220;or&#8221; means &#8220;and/or&#8221;; and (vii) any agreement or instrument defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement or instrument as from time to time amended, modified, or supplemented, including by waiver or consent and references to all attachments thereto and instruments incorporated therein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts</span>. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. A photocopy, faxed, scanned, and/or emailed copy of this Agreement or any signature page to this Agreement, shall have the same validity and enforceability as an originally signed copy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(l)</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effectiveness</span>. This Agreement shall be binding upon the Subject Party upon the Subject Party&#8217;s execution and delivery of this Agreement, but this Agreement shall only become effective upon the consummation of the Transactions. In the event that the Merger Agreement is validly terminated in accordance with its terms prior to the consummation of the Transactions, this Agreement shall automatically terminate and become null and void, and the parties shall have no obligations hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-style:italic;font-weight:bold;">[Remainder of Page Intentionally Left Blank; Signature Pages Follows]</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_d5a534c6_2f2e_49bd_8161_53f2957adb3e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, the undersigned has duly executed and delivered this Non-Competition and Non-Solicitation Agreement as of the date first written above.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:6.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:36.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:top;width:46.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Subject Party</span><span style="font-style:italic;font-weight:bold;">:</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:42.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="3" style="vertical-align:top;width:42.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:6.36%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:36.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td colspan="2" style="vertical-align:bottom;width:36.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><i style="font-style:italic;">[Signature Page to the Non-Competition Agreement]</i></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100.97%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:5.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:43.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:50.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Acknowledged and accepted as of the date first written above:</span></p></td><td style="vertical-align:bottom;width:50.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:50.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Purchaser:</span></p></td><td style="vertical-align:bottom;width:50.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:50.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p></td><td style="vertical-align:bottom;width:50.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:50.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By: </p></td><td style="vertical-align:bottom;width:43.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:50.48%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:50.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:50.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><i style="font-style:italic;">[Signature Page to the Non-Competition Agreement]</i></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b6d794f9_692e_4aae_892c_9058b1446e09"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.4pt 0pt;"><span style="font-style:italic;font-weight:bold;">Exhibit E</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Form Letter of Transmittal</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">for Securities of</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">OneMedNet Corporation</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Surrendered for Payment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pursuant to the Agreement and Plan of Merger</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">By and Among</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Data Knights Acquisition Corp.,</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Data Knights Merger Sub, Inc.,</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Data Knights, LLC,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paul Casey,</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">and</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">THE INSTRUCTIONS ACCOMPANYING THIS LETTER OF TRANSMITTAL SHOULD BE READ CAREFULLY, BEFORE THIS <i style="font-style:italic;">LETTER OF TRANSMITTAL </i>IS COMPLETED. IF SECURITIES ARE REGISTERED IN MORE THAN ONE NAME, A SEPARATE LETTER OF TRANSMITTAL MUST BE SUBMITTED FOR EACH SEPARATE REGISTERED HOLDER OF SUCH SECURITIES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">BY SIGNING THIS LETTER OF TRANSMITTAL, YOU AGREE TO THE PROVISIONS CONTAINED HEREIN AND MAKE THE ACKNOWLEDGEMENTS AND REPRESENTATIONS PROVIDED HEREIN.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Ladies and Gentlemen:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Letter of Transmittal is being sent to you because you are a OneMedNet Corporation Security Holder in connection with that certain Agreement and Plan of Merger (as amended from time to time in accordance with the terms thereof, the &#8220;<span style="font-style:italic;font-weight:bold;">Merger Agreement</span>&#8221;), by and among (i) <b style="font-weight:bold;">Data Knights Acquisition Corp.</b>, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser</span>&#8221;), (ii) Data Knights Merger Sub, Inc., Delaware corporation and a wholly-owned subsidiary of the Purchaser (&#8220;<span style="font-style:italic;font-weight:bold;">Merger Sub</span>&#8221;), (iii) <b style="font-weight:bold;">Data Knights, LLC</b>, a Delaware limited liability company (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Representative</span>&#8221;), (iv) Paul Casey (the &#8220;<span style="font-style:italic;font-weight:bold;">Seller Representative</span>&#8221;), and (v) <b style="font-weight:bold;">OneMedNet Corporation</b>, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;, and collectively with the foregoing, referred to herein as the &#8220;<span style="font-style:italic;font-weight:bold;">Parties</span>&#8221;). C<i style="font-style:italic;">apitalized terms used herein without definition shall have the meanings specified in the Merger Agreement</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">You have received this Letter of Transmittal because the Company&#8217;s records indicate that you own shares of Company Stock of the Company and unexercised options to purchase Common Stock (&#8220;<span style="font-style:italic;font-weight:bold;">Options</span>&#8221;), and/or warrants to purchase shares of Common Stock (&#8220;<span style="font-style:italic;font-weight:bold;">Warrants</span>&#8221;). In order to receive payment for your shares of Company Stock, Options or Warrants you must (a) complete and sign this Letter of Transmittal and Consent (&#8220;<span style="font-style:italic;font-weight:bold;">Letter of Transmittal</span>&#8221;) in the space provided below and (b) mail or deliver the completed Letter of Transmittal evidencing your surrender and delivery of your shares of Company Stock, the option agreements (&#8220;<span style="font-style:italic;font-weight:bold;">Option Agreements</span>&#8221;) evidencing your Options and/or the warrant agreements (&#8220;<span style="font-style:italic;font-weight:bold;">Warrant Agreements</span>&#8221;) evidencing your Warrants (collectively, the &#8220;<span style="font-style:italic;font-weight:bold;">Surrendered Securities</span>&#8221;) to Continental Stock Transfer &amp; Trust Company. We have set forth on the signature page to this Letter of Transmittal the number of shares of Company Stock and/or the number of Options and/or Warrants that our records indicate are held by you.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">You must complete, sign and return this Letter of Transmittal, the Form W-9 and, as applicable, your Option Agreements to the Exchange Agent at the following address:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.6pt 0pt;"><b style="font-weight:bold;">Continental Stock Transfer &amp; Trust Company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1 State Street, 30th Floor | New York, NY 10004-1561<br/>212.509.4000 | cstmail@continentalstock.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PLEASE READ AND FOLLOW THE ACCOMPANYING INSTRUCTIONS CAREFULLY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with the Merger Agreement, by and among the Parties, the undersigned (the &#8220;<span style="font-style:italic;font-weight:bold;">Holder</span>&#8221;) hereby delivers this Letter of Transmittal and surrenders to the Exchange Agent all shares of Company Stock owned by the undersigned, any Option Agreements evidencing Options and any Warrant Agreements evidencing Warrants, in each case, in exchange for the right to receive the shares of Purchaser Common Stock payable to such Holder pursuant to and in accordance with the terms set forth in the Merger Agreement (the &#8220;<span style="font-style:italic;font-weight:bold;">Holder&#8217;s Payment</span>&#8221;). Unless otherwise defined in this Letter of Transmittal, capitalized terms contained in this Letter of Transmittal will have the meanings set forth in the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger Consideration.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the Merger Agreement, the Parties intend to effect a business combination through, among other transactions, the merger of the Merger Sub with and into the Company, with the Company continuing as the surviving company and wholly owned subsidiary of Data Knights Acquisition Corp. after which the Merger Sub will no longer exist. <i style="font-style:italic;">See Art. I, Merger </i>of <i style="font-style:italic;">the Merger Agreement</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the Effective Time, by virtue of the Merger and without any further action on the part of the Parties, any Company Security Holder or any other Person, subject to any applicable withholding pursuant to the Merger Agreement, each share of Company Stock issued and outstanding immediately prior to the Effective Time (other than Dissenting Shares) shall be automatically converted into the right to receive, upon delivery of this properly completed and duly executed Letter of Transmittal (together with duly executed IRS Form(s) W-8 (and any attachments thereto) and/or W-9, as applicable) its allocable share of the Stockholder Merger Consideration (the &#8220;<span style="font-style:italic;font-weight:bold;">Merger Consideration</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The undersigned hereby acknowledges and agrees that all descriptions of the payment of the Merger Consideration and other matters related to the Merger and the other transactions contemplated by the Merger Agreement are set forth in summary form in this Letter of Transmittal for the undersigned&#8217;s convenience only and are qualified in their entirety by the terms of the Merger Agreement. For the avoidance of doubt, the undersigned hereby acknowledges and agrees that his, her or its agreements, acknowledgements and covenants herein are supplemental to and are not intended to call into doubt the existing validity or effectiveness of any of the matters set forth herein by virtue of the prior adoption of the Merger Agreement and approval of the Merger and the other transactions contemplated by the Merger Agreement by the requisite stockholders of the Company and other actions and operation of applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Without limitation to the matters set forth in this Letter of Transmittal or the Merger Agreement, the undersigned hereby acknowledges and agrees that (i) the undersigned has received a copy of the Merger Agreement and has reviewed and understands the matters set forth therein, and (ii) the undersigned has been urged to and has been given the opportunity to consult with the undersigned&#8217;s legal and tax advisors regarding the legal and tax consequences of the transactions contemplated by the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the avoidance of doubt and without limitation of the foregoing, the undersigned hereby acknowledges and agrees that any payments made to the undersigned pursuant to the Merger Agreement shall be final and in no event shall Purchaser or the Surviving Corporation or any of their respective Affiliates have any liability to the undersigned for payment or disbursement by any Person (including Purchaser and the Surviving Corporation and their respective Affiliates and representatives (including the Exchange Agent) in accordance with the Merger Agreement. For the avoidance of doubt, the undersigned hereby acknowledges and agrees that the undersigned shall bear liability for any stock transfer taxes applicable to the delivery of the portion of the Merger Consideration due and payable to the undersigned pursuant to the Merger Agreement in exchange for the Surrendered Securities (defined below).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The undersigned acknowledges that the Exchange Agent or Purchaser, as applicable, may not deliver the applicable portion of the Merger Consideration otherwise due and payable to the undersigned pursuant to the Merger Agreement unless the undersigned delivers to the Exchange Agent: (i) this Letter of Transmittal, completed in full, (ii) (a) original share certificates or instruments for the Surrendered Securities or (b) a completed Affidavit and Indemnification Concerning Lost Certificate(s) relating to the Surrendered Securities, and (iii) a completed W-9 or W-8, as applicable.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notice of Action by Stockholders and Appraisal Rights; Affirmation of Consent</b><b style="font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the Delaware General Corporation Law (the &#8220;<span style="font-style:italic;font-weight:bold;">DGCL</span>&#8221;), the Merger and the Merger Agreement must be approved by the board of directors of the Company (the &#8220;<span style="font-style:italic;font-weight:bold;">Board of Directors</span>&#8221;) and the requisite vote of the stockholders of the Company under the Company&#8217;s Organization Documents (in each case, the &#8220;<span style="font-style:italic;font-weight:bold;">Majority Holders</span>&#8221;). If the Majority Holders approve the Merger Agreement and Merger by written consent, but not all stockholders sign the written consent, then the DGCL requires that notice of such action be given to the stockholders that did not sign the written consent. The Board of Directors and holders of a majority of the outstanding shares of the voting Company Stock have approved the Merger Agreement and the Merger pursuant to a written consent. A copy of the written consent of the Company&#8217;s stockholders is attached hereto as <b style="font-weight:bold;">Exhibit A</b>. The undersigned has reviewed the written consent and hereby affirms its consent to the matters set forth therein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Letter of Transmittal constitutes notice to the undersigned of the approval of the <i style="font-style:italic;">Merger </i>and the Merger Agreement by written consent of the Company&#8217;s stockholders in accordance with Section 228 of the DGCL. In addition, pursuant to the DGCL, holders of capital stock of a corporation engaged in a transaction such as the Merger are entitled to exercise appraisal rights pursuant to Section 262 of the DGCL. This Letter of Transmittal also provides the undersigned with information regarding appraisal rights pursuant to DGCL, 8 Del. C. &#167; 262, Appraisal Rights, a copy of which is attached hereto as <b style="font-weight:bold;">Exhibit B</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Acknowledgments and Agreements of the Undersigned with Respect to the Merger</b><b style="font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Consent to Merger Agreement and Other Documents</i>. The undersigned hereby (a) consents to and approves the execution and performance of the Merger Agreement and all of the documents related thereto by the Exchange Agent and the Company and the completion of the transactions contemplated thereby, (b) forever waives, to the extent not otherwise waived, all appraisal rights or dissenter&#8217;s rights which might otherwise be available to the undersigned pursuant to Section 262 of the DGCL, and (c) agrees that other than the undersigned&#8217;s right to receive the Holder&#8217;s Payment for its stock, warrants, and options, the undersigned shall have no further rights arising out of any stock, warrants or options that it owns, and upon the completion of the Merger such stock, warrants or options shall be automatically cancelled and of no further force or effect without any further action required on the part of the undersigned.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Termination of Options and Warrants</i>. If the undersigned is an optionholder or warrantholder, the undersigned understands and, by execution of this Letter of Transmittal, agrees that, effective as of the Closing, each of (i) the Options and Warrants issued by the Company in favor of the undersigned and (ii)<span style="display:inline-block;width:16.66pt;"></span>the Option Agreements and Warrant Agreements by and between the Company and the undersigned, shall automatically terminate and the Company shall not have any further or continuing obligation or responsibility to the undersigned pursuant to the Option(s), Warrant(s), Option Agreements and/or Warrant Agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Incorporation of Merger Agreement</i>. The undersigned understands and, by execution of this Letter of Transmittal agrees, that this Letter of Transmittal and all Payment payable to the undersigned as a Company Security Holder as a result of the Merger are subject to, and governed by, the terms and conditions of the Merger Agreement and the documents related thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Exchange</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Agreements with Respect to Exchange of Shares and Option Agreements and Warrant Agreements. </i>The undersigned understands that the surrender of Company Stock, Option Agreements and/or Warrant Agreements will not be deemed to be in acceptable form until the Exchange Agent has received this Letter of Transmittal properly completed and signed, together with all required documents, in form satisfactory to the Exchange Agent. The undersigned understands that (i) unless and until the undersigned surrenders this Letter of Transmittal properly completed and signed, and all other required documents to the Exchange Agent at its address set forth on the cover of this Letter of Transmittal, no Payment pursuant to the Merger Agreement shall be paid to the undersigned and (ii) no interest will accrue on any Payment due. All questions as to the documents, validity, form, eligibility and acceptance for Payment of any shares of Company Stock, Option Agreements and/or Warrant Agreements surrendered pursuant to any of the procedures described in this Letter of Transmittal will be determined by the Exchange Agent, and such determination will be final and binding. Delivery and surrender of Company Stock, Option Agreements and/or Warrant Agreements will be effected, and risk of loss and title to such shares of Company Stock, Option Agreements and/or Warrant Agreements will pass only upon proper delivery of this Letter of Transmittal to the Exchange Agent and, with respect to the Company Stock, surrender of the certificates evidencing ownership thereof. The undersigned has duly and validly executed and delivered this Letter of Transmittal, and it constitutes the undersigned&#8217;s legal, valid and binding obligation, enforceable against the undersigned in accordance with its terms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Attorney-in-Fact</i>. The undersigned hereby irrevocably appoints and constitutes the Exchange Agent, or its designee or appointee, as the undersigned&#8217;s true and lawful agent and attorney-in-fact with respect to the Company Stock, options, warrants, option agreements and/or warrant agreements surrendered herewith, to take all actions contemplated by the Merger Agreement including, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">without limitation, delivering this Letter of Transmittal and the undersigned&#8217;s Company Stock, option agreements and/or warrant agreements together with all accompanying evidences of authority, in the Exchange Agent&#8217;s sole discretion, to the Purchaser in connection with the completion of the Closing. This power is irrevocable and coupled with an interest, and shall not be affected by the undersigned&#8217;s death, incapacity, illness, dissolution or other inability to act. See also the section below entitled &#8220;<i style="font-style:italic;">The Exchange Agent</i>&#8221; for additional information regarding the Exchange Agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Representations of the Undersigned</i>. The name and address of the registered holder(s) of the Company Stock, Options and/or Warrants set forth on the signature page hereto are as they appear on the stock ledger with respect to Company Stock, Option Agreements with respect to Options, and/or Warrant Agreements with respect to Warrants. The undersigned represents and warrants to the Purchaser, the Company, the Exchange Agent and the other Company Security Holders that the undersigned (a) is the sole record and beneficial owner of each share of each class of Company Stock, each Option and/or each Warrant identified on the signature page to this Letter of Transmittal and the Company Stock, Option Agreements and/or Warrant Agreements surrendered herewith, (b) has good title to such shares of Company Stock, (c) has full right, power, legal capacity and authority to execute this Letter of Transmittal and sell, assign, transfer and surrender such Company Stock, Options and/or Warrants, (d) needs no consent or approval of, and need not give notice to, any third party in order to validly sell, assign, transfer and surrender such Company Stock, Warrants and/or Options, (e) holds such shares of Company Stock, Warrants and/or Options free and clear of all liens, claims and encumbrances and such shares are not subject to any adverse claim or any limitation or restriction on sale, transfer or delivery, and (f) is not party to any voting trusts, stockholder agreements, proxies or other agreements or understandings in effect with respect to the voting or transfer of any of the capital stock or other equity securities of the Company. The undersigned further represents and acknowledges that the undersigned (a) has read the Merger Agreement and this Letter of Transmittal; (b) agrees to be bound by this Letter of Transmittal freely, voluntarily and without coercion, with full knowledge of its significance and the legal consequences thereof; (c) has had an adequate opportunity to review and consider the terms of the Merger Agreement and this Letter of Transmittal; (d) has fully informed itself of the terms, contents, conditions and effects of the Merger Agreement and this Letter of Transmittal; and (e) has relied solely and completely upon its own judgment in executing this Letter of Transmittal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Additional Documents</i>. The undersigned shall, upon request, execute and deliver any additional documents deemed appropriate or necessary by the Exchange Agent in connection with the surrender of the Company Stock, the Options and the Option Agreements, and/or the Warrants and the Warrant Agreements. All authority conferred in this Letter of Transmittal shall not be affected by, and shall survive, the death or incapacity of the undersigned and any obligation of the undersigned will be binding upon the successors, assigns, heirs, executors, administrators and legal representatives of the undersigned.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Survival of Representations, Warranties and Agreements</i>. The representations, warranties, covenants, agreements, confirmations, appointments and releases made herein by the undersigned shall survive the execution and delivery hereof and the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">The Exchange Agent</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Appointment of Exchange Agent</i>. The undersigned hereby irrevocably appoints the Exchange Agent as the undersigned&#8217;s true and lawful agent and attorney-in-fact, with full power and authority to act for and on behalf of the undersigned for all purposes of the Merger Agreement and the documents related thereto and agrees to be bound by the provisions of the Letter of Transmittal and such documents, pursuant to which, among other matters, the undersigned agrees to indemnify and hold the Exchange Agent harmless from any losses, claims, damages and expenses the Exchange Agent may suffer or incur in connection with any action taken by the Exchange Agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Authority of Exchange Agent</i>. The undersigned hereby acknowledges and agrees that all decisions and actions by the Exchange Agent are binding upon all Company Security Holders, and no Company Security Holder has the right to object, dissent, protest or otherwise contest the same. The undersigned further acknowledges and agrees that the Exchange Agent, pursuant to the Merger Agreement and this Letter of Transmittal, has the exclusive authority to act on the undersigned&#8217;s behalf in connection with the Merger Agreement and the documents related thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Consent and Release</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Release by the Undersigned</i>. Effective as of the Closing, the undersigned (a) hereby completely and irrevocably releases and forever discharges the Seller Representative and its directors, officers, managers, members, partners, stockholders, principals, employees, agents, representatives, predecessors, successors and assigns from any and all claims, damages, losses, demands, actions, causes of action, promises and/or liabilities whatsoever, including, but not limited to, any claims arising out of or in any way related, directly or indirectly, with the undersigned having been an equityholder, optionholder, warrantholder and/or employee of the Company or any of its Subsidiaries, (b) completely and irrevocably releases and forever discharges the Company and its Affiliates and Subsidiaries, and their respective directors, officers, managers, members, stockholders, principals, employees, agents, representatives, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">predecessors, successors and assigns from any and all claims, damages, losses, demands, actions, causes of action, promises and/or liabilities arising out of or in any way related, directly or indirectly, with the undersigned having been an equityholder, warrantholder or optionholder of the Company or any of its Subsidiaries, and (c) waives any and all claims the undersigned may have to any additional shares of stock, warrants or options of the Company or any of its Subsidiaries; provided, however, that such release shall not extend to the undersigned&#8217;s rights (i) expressly set forth in the Merger Agreement or the exhibits thereto, and if the undersigned is an employee of the Company or any of its Subsidiaries, under any Contract or agreement between the undersigned and the Company or any of its Subsidiaries, (ii) under any contract of insurance or other indemnification obligations covering or otherwise in favor of the managers, directors or officers of the Company or any of its Subsidiaries prior to the Closing, or (iii) to receive accrued but unpaid compensation (including pursuant to any employment agreement or other arrangement) or health, disability or life insurance benefits to which the undersigned is entitled, if any.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidentiality</b><b style="font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Except as may be required by Law or the rules of any stock exchange, or as otherwise permitted or expressly contemplated herein, the undersigned and his, her or its agents and representatives shall not disclose to any third party the existence of this agreement, the Merger Agreement or the subject matter or terms hereof and thereof; provided, however, that the undersigned shall be permitted to (a) disclose such information to his, her or its attorneys, advisors, representatives, directors, members, or investors, and (b) disclose and use such information in connection with enforcing their rights and fulfilling their obligations under this agreement or any other agreement entered into in connection with this agreement or the Merger Agreement. Notwithstanding the foregoing, nothing in this agreement shall restrict the ability of any of Exchange Agent from providing (i) the financial results achieved by any of the Exchange Agent entities with respect to their beneficial interest in the Purchaser and its subsidiaries, (ii) a description of the Purchaser and its subsidiaries (including their financial performance, and the Exchange Agent&#8217;s investment and role therein), or (iii) such other information as the Exchange Agent provide to such third parties in the ordinary course of its business to the current or prospective limited partners, financing sources or other business associates of the Exchange Agent and their respective advisors in the ordinary course of business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">INSTRUCTIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</span></span><b style="font-weight:bold;">Delivery of Letter of Transmittal and Certificates</b>. Certificate(s) representing shares of stock of the undersigned, as applicable, as well as a properly completed and duly executed Letter of Transmittal and any other documents required by this Letter of Transmittal, must be delivered to the Exchange Agent at its address set forth on the cover of this Letter of Transmittal. Please do not send the Option Agreements directly to the Company or the Purchaser. The surrender of Company Stock, Option Agreements and/or Warrant Agreements will be deemed made only when this Letter of Transmittal and any other documents are received by the Exchange Agent. The method of delivery of the documents is at the election and risk of the undersigned. If such delivery is by mail, registered mail with return receipt requested, properly insured, is recommended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</span></span><b style="font-weight:bold;">Signature on Letter of Transmittal, Stock Powers and Endorsements. </b>This Letter of Transmittal should be signed by the registered holder of Company Stock, Warrants and/or Options surrendered hereby without any correction or change in the name of the registered holder, the signature must correspond exactly with the name as written on the stock ledger for the Company Stock and/or on the face of the Option Agreements and/or Warrant Agreements without any change whatsoever. In the event the name of the registered holder(s) needs to be corrected or has changed (by marriage or otherwise), please print such correction or change on the form itself and provide evidence of such change or correction as requested by the Exchange Agent, in its sole discretion. If (a) the surrendered Company Stock is registered in the name of a person other than the signer of this Letter of Transmittal, (b) the wire transfer of a Holder&#8217;s Payment is to be made to a person other than the signer of this Letter of Transmittal, or (c) the wire transfer of a Holder&#8217;s Payment is to be made to a person other than the registered owner(s) of the Company Stock surrendered hereby, then the surrendered Company Stock must be accompanied by duly executed stock or other power(s), signed exactly as the name(s) of the registered owner(s) appears on the Company&#8217;s stock ledger as registered or stock or other power(s), with the signatures on the stock or other power(s) guaranteed by a firm that is a bank, broker, dealer, credit union, savings association or other entity which is a member in good standing of the Securities Transfer Agents&#8217; Medallion Program. If any of the Securities surrendered hereby are held of record by two or more joint owners, all such owners must sign this Letter of Transmittal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">3.</b></span><b style="font-weight:bold;">Payment and Delivery Instructions. </b>The undersigned understands that delivery of a wire transfer or check representing the Holder&#8217;s Payment will be made after the Closing and after the surrender of the Certificate(s), Option Agreements and/or Warrant Agreements is made and this Letter of Transmittal and any other necessary documents are completed in acceptable form. The form of delivery (either wire or check) will be determined in the sole discretion of the Exchange Agent. The undersigned understands that with respect to Options, such amount representing the Holder&#8217;s Payment shall be made via the Company&#8217;s next regularly scheduled payroll following the Closing Date. The undersigned understands that the amount of any wire transfer or check representing any portion of the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Holder&#8217;s Payment will be reduced by any applicable withholding taxes. No interest shall accrue on any cash payments to be delivered hereunder except as provided in the Escrow Agreement, if at all<b style="font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">4.</b></span><b style="font-weight:bold;">Lost, Stolen or Destroyed Stock Certificate. </b>In the event that the undersigned is unable to deliver any certificate(s) representing his, her or its Company Stock due to the loss or destruction of such certificate(s), such fact should be indicated on the face of this Letter of Transmittal. In such case, the holder should also contact the Exchange Agent to report the lost, stolen or destroyed certificate(s). An Affidavit of Lost Certificate must be completed in order to effectively surrender such lost, stolen or destroyed certificate(s). Surrenders hereunder regarding such lost certificate(s) will be processed only after such Affidavit of Lost Certificate has been submitted to and approved by the Exchange Agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">5.</b></span><b style="font-weight:bold;">IRS Form W-9 or IRS Form W-8. </b>Under U.S. federal income tax laws, the Exchange Agent may be required to &#8220;<i style="font-style:italic;">backup withhold</i>&#8221; a portion of the amount of any payments made to certain Company Security Holders, as applicable. To avoid such backup withholding, each Company Security Holder that is a United States person (for U.S. federal income tax purposes), must provide the Exchange Agent with such Company Security Holder&#8217;s correct taxpayer identification number (&#8220;<span style="font-style:italic;font-weight:bold;">TIN</span>&#8221;) and certify that such Company Security Holder is not subject to such backup withholding by completing the attached IRS Form W-9. In general, if a Company Security Holder is an individual, the TIN is the Social Security number of such individual. If the Exchange Agent is not provided with the correct TIN, the Company Security Holder may be subject to a penalty imposed by the IRS. For further information concerning backup withholding and instructions for completing the IRS Form W-9 (including how to obtain a TIN if you do not have one and how to complete the IRS Form W-9 if the Stock Certificates are held in more than one name), consult the enclosed IRS Form W-9 and the instructions thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a.</span></span>Certain Company Security Holders (including, among others, certain corporations, non-resident foreign individuals and foreign entities) are not subject to these backup withholding and reporting requirements, but such Company Security Holders should certify their exemption by completing either the IRS Form W-9 or the appropriate IRS Form W-8, as applicable. A Company Security Holder who is a foreign individual or a foreign entity should complete, sign and submit to the Exchange Agent the appropriate IRS Form W-8. An IRS Form W-8BEN or W- 8BEN-E or other applicable IRS Form W-8 may be obtained from the Exchange Agent or downloaded from the IRS&#8217;s website at the following address: http://wwwirs.gov. Failure to complete the IRS Form W-9 or applicable IRS Form W-8 may require the Exchange Agent to withhold a portion of the amount of any payments made to a Company Security Holder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">b.</span></span>If backup withholding applies under Applicable Law, the Exchange Agent is required to withhold a portion of any payments of the purchase price made to the Company Security Holder. Backup withholding is not an additional tax. Rather, the tax liability of persons subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, a refund or credit may be obtained from the IRS provided that the required information is furnished to the IRS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Please consult your accountant or tax advisor for further guidance regarding the completion of the IRS Form W-9 or the appropriate IRS Form W-8, as applicable, to claim exemption from backup withholding or contact the Exchange Agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.</span></span><b style="font-weight:bold;">Miscellaneous. </b>The Exchange Agency anticipates that it will provide notification of any defects in the deposit and surrender of any Company Stock, Option Agreements or Warrant Agreements, but neither the Purchaser nor the Exchange Agent shall incur any liability for failure to give such notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7.</span></span><b style="font-weight:bold;">Stock Transfer Taxes. </b>If payment for surrendered securities is to be made by wire transfer to any person(s) other than the registered holder(s) of the surrendered securities, it shall be a condition of such payment that the amount of any transfer taxes (whether imposed on the registered holder(s) or such other person(s)) payable on account of the transfer (or transfers) of the surrendered securities shall be delivered to the Purchaser or deducted from such payment if satisfactory evidence of the payment of such taxes or nonapplicability thereof is not submitted to the Purchaser or the Exchange Agent before such payment is made.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.6pt 0pt;"><b style="font-weight:bold;">ALL STOCKHOLDERS AND HOLDERS OF OPTIONS MUST SIGN HERE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Also Complete the Form W-9)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The undersigned acknowledges that the undersigned has thoroughly read this Letter of Transmittal and agrees to be bound by the terms and conditions set forth herein and in the accompanying materials.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The wire transfer or check representing the Holder&#8217;s Payment will be issued only in the name of the person submitting this Letter of Transmittal and will be mailed to the address set forth below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:1pt;text-align:center;border-top:1px solid #000000;margin:0pt;">Signature of Holder</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dated: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.44pt 0pt;">(Must be signed by registered holder exactly as the name appears on the stock ledger or option agreement. If signature is by an officer of a corporation, attorney-in-fact, executor, administrator, trustee, guardian or other person(s) acting in a fiduciary or representative capacity, then please set forth full title.)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:86.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name of Holder:</p></td><td style="vertical-align:bottom;width:86.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.44pt 0pt;">(Please print)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:17.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:51.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:30.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax Identification or Social Security No.:</p></td><td style="vertical-align:bottom;width:17.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Address of Holder:</p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Area Code and Tel. No.:</p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Number and Class of Shares of Company Stock to be Delivered:</p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">[Attach sheet for additional entries]</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Number of Options:</p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date of Option Agreement: </p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise Price Per Share:</p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Number of Warrants:</p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date of Warrant Agreement:</p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise Price Per Warrant:</p></td><td style="vertical-align:bottom;width:51.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">[SIGNATURE PAGE TO LETTER OF TRANSMITTAL]</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Wire instructions:</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:37.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account Name:</p></td><td style="vertical-align:bottom;width:37.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account Number:</p></td><td style="vertical-align:bottom;width:37.5%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bank Name:</p></td><td style="vertical-align:bottom;width:37.5%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ABA Number:</p></td><td style="vertical-align:bottom;width:37.5%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Lost Certificates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18.6pt;"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></span>I have lost my Certificate(s) that represented shares of Company Stock (class: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) of the Company. I have completed the Affidavit and Indemnification Concerning Lost Certificate(s) attached hereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7.65pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">AFFIDAVIT AND INDEMNIFICATION CONCERNING LOST CERTIFICATE(S</span>)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Re: Certificate(s) representing shares of Company Stock</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:32.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Class of Stock</p></td><td style="vertical-align:top;width:32.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Certificate Number(s)</p></td><td style="vertical-align:top;width:32.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(the &#8220;<b style="font-weight:bold;">Certificate(s)</b>&#8221;),</p></td></tr><tr><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Number of Shares</p></td><td style="vertical-align:top;width:32.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(the &#8220;<b style="font-weight:bold;">Shares</b>&#8221;),</p></td></tr><tr><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Stockholder Name</p></td><td style="vertical-align:top;width:32.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">, being duly sworn, affirms the following:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</span></span>My name is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. I am the legal and beneficial owner of the Certificate(s) and the Shares evidenced thereby and am entitled to the possession of the Certificate(s). This Affidavit is executed by me in such capacities. I am of lawful age and have personal knowledge of the facts and circumstances hereinafter set out.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</span></span>This Affidavit is made in connection with the redemption of the Certificate(s) referenced above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.</span></span>I have made, or caused to be made, a diligent search for the Certificate(s) and have been unable to locate such Certificate(s). None of the Certificate(s), the Shares or any interest in the Certificate(s) or Shares has been sold, assigned, endorsed, transferred, deposited under any agreement, hypothecated, pledged, canceled or disposed of in any manner by me. No person, entity, or governmental authority, other than me, has or has asserted any right, title, claim, equity, or interest in, to, or respecting the Certificate(s) or the Shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.</span></span>In the event that the original Certificate(s) comes into my possession, I will deliver it or cause it to be delivered to Exchange Agent, or its successor, in order that the same may be canceled.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.</span></span>I hereby agree to indemnify and defend the Data Knights Acquisition Corp. and its successors and assigns, to hold each harmless from and against any and all cost, claim, liability, loss, or damage whatsoever which each may suffer or incur as a result of my inability to locate the Certificate(s), including but not limited to that which may result from any claim of ownership of the Certificate(s), the Shares, or any interest in the Certificate(s) or the Shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">IN WITNESS WHEREOF, the undersigned has executed this Affidavit and Indemnification Concerning Lost Certificate(s) as of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;day of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">OWNER:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Printed Name:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">IMPORTANT TAX INFORMATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18.2pt;margin:0pt 0pt 12pt 0pt;">Under the federal tax law, a holder who transmits Certificate(s) and/or Option Agreements hereby is required by law to provide the Representative with such holder&#8217;s correct TIN on the Form W-9 below. If such holder is an individual, then the TIN is his or her social security number. If the Exchange Agent is not provided with the correct TIN, then the holder or other payee may be subject to a $50 penalty imposed by the Internal Revenue Service. In addition, payments that are made to such holder or other payee with respect to Certificates and/or Option Agreements may be subject to backup withholding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Payments subject to regular wage withholding and reporting (such as payments to employees on payroll) are not also subject to backup withholding. Notwithstanding the foregoing, a holder who transmits an Option Agreement receiving such a payment still must provide its TIN on the attached Form W-9.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain persons (including, among others, all foreign corporations and certain foreign individuals) are not subject to these backup withholding and reporting requirements. A foreign corporation or individual may qualify as an exempt recipient or other payee by submitting to the Exchange Agent a properly completed IRS Form W-8BEN, W-8BEN-E, W-8ECI or other applicable IRS Form W-8, signed under penalty of perjury attesting to such holder&#8217;s exempt status. IRS Forms W-8 may be obtained at www.irs.gov.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If backup withholding applies, then the Exchange Agent is required to withhold 24% of any payments made to the holder or other payee. Backup withholding is not an additional tax. Rather, the federal income tax liability of persons subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, then a refund may be obtained from the Internal Revenue Service.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Purpose of Form W-9</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To prevent backup withholding on payments made to a holder or other payee with respect to Certificates and/or Option Agreements, the holder is required to notify the Exchange Agent of the holder&#8217;s correct TIN by completing the form below, certifying that the TIN provided on the Form W-9 is correct (or that such holder is awaiting a TIN) and that (1) the holder has not been notified by the Internal Revenue Service that the holder is subject to backup withholding as a result of failure to report all interest or dividends, or (2) the Internal Revenue Service has notified the holder that the holder is no longer subject to backup withholding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">What Number to Give the Exchange Agent</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The holder is required to give the Exchange Agent the TIN (e.g., social security number or employer identification number) of the record owner of Certificates, Option Agreements and/or Warrant Agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE: Failure to complete and return the Form W-9 may result in backup withholding of 24% of any payments made to you pursuant to the Merger. Please review the enclosed guidelines for certification of taxpayer identification number on the Form W-9 for additional details.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">FOR ADDITIONAL INFORMATION, CONTACT YOUR TAX ADVISOR OR THE INTERNAL REVENUE SERVICE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">W-9</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">W-8</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ACTION BY WRITTEN CONSENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">OF THE STOCKHOLDERS OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ONEMEDNET CORPORATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">[Insert]</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT B</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">APPRAISAL RIGHTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.6pt 0pt;">8 Del. C. &#167; 262, Appraisal Rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.6pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">[insert]</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_cc22f59c_6e3e_43c6_b0d5_8ce23b92acc8"></a><a id="ExhibitF_862814"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Exhibit F</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3.54pt 0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup><b style="font-weight:bold;"> 2022 EQUITY INCENTIVE PLAN</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purpose</i>. The purpose of the Data Knights Acquisition Corp. 2022 Equity Incentive Plan (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Plan</span>&#8221;) is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby Directors, officers, Employees, and Consultants (and prospective Directors, officers, Employees, and Consultants) of the Company and its Affiliates can acquire and maintain an equity interest in the Company, or be paid incentive compensation, which may (but need not) be measured by reference to the value of Common Shares, thereby strengthening their commitment to the welfare of the Company and its Affiliates and aligning their interests with those of the Company&#8217;s stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Definitions</i>. The following definitions shall be applicable throughout the Plan:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Affiliate</i>&#8221; means (i) any person or entity that directly or indirectly controls, is controlled by or is under common control with the Company and/or (ii) to the extent provided by the Committee, any person or entity in which the Company has a significant interest. The term &#8220;control&#8221; (including, with correlative meaning, the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;), as applied to any person or entity, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such person or entity, whether through the ownership of voting or other securities, by contract or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><span style="color:#010000;">&#8220;</span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Award</i>&#8221; means, individually or collectively, any Incentive Stock Option, Nonqualified Stock Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Stock Bonus Award, and Performance Compensation Award granted under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;">&#8220;Award Agreement&#8221; </i>means a written or electronic agreement between the Company and a Participant setting forth the terms, conditions and restrictions of the Award granted to the Participant</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Board</i>&#8221; means the Board of Directors of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Business Combination</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cause</i>&#8221; means, in the case of a particular Award, unless the applicable Award Agreement or the Participant&#8217;s employment agreement with the Company states otherwise, the Company&#8217;s termination of the Participant&#8217;s employment with the Company as a result of: (i) fraud, embezzlement or other willful act of material dishonesty by the Participant in connection with or relating to the Participant&#8217;s employment with the Company; (ii) theft or misappropriation of property, information or other assets by the Participant in connection with the Participant&#8217;s employment with the Company which results in or could reasonably be expected to result in material loss, damage or injury to the Company, its goodwill, business or reputation; (iii) the Participant&#8217;s commission, guilty plea, no contest plea or similar plea for any felony or crime involving moral turpitude; (iv) the Participant&#8217;s use of alcohol or drugs while working that materially interferes with the Participant&#8217;s duties under this Agreement; (v) material breach of a material Company policy, or material breach of a Company policy that results in or could reasonably be expected to result in material loss, damage or injury to the Company, its goodwill, business or reputation; (vi) the Participant&#8217;s material breach of any of Participant&#8217;s obligations under this Agreement; or (vii) the Participant&#8217;s repeated insubordination, or refusal (other than as a result of a Disability or physical or mental illness) to carry out or follow specific reasonable and lawful instructions, duties or assignments given by the Board which are consistent with the Participant&#8217;s position with the Company. Additionally, in the event that the basis for Cause is, in the reasonable good faith determination of the Company not reasonably subject to cure, then such thirty (30) days&#8217; prior notice of termination for Cause shall not be required, and such termination shall be effective on the date the Company delivers notice of such termination for Cause.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1.5pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup><span style="display:inline-block;width:10.2pt;"></span>Company name to be changed to OneMedNet Corporation upon stockholder approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:5.8pt;text-indent:-5.8pt;margin:0pt 0pt 0pt 7.59pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.44pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Change in Control</i>&#8221; shall, in the case of a particular Award, unless the applicable Award Agreement states otherwise or contains a different definition of &#8220;Change in Control,&#8221; be deemed to occur upon:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.6pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Any sale, lease, exchange or other transfer (in one or a series of related transactions) of all or substantially all of the assets of the Company;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Any &#8220;Person&#8221; as such term is used in Section 13(d) and Section 14(d) of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Act</span>&#8221;) becomes, directly or indirectly, the &#8220;beneficial owner&#8221; as defined in Rule 13d-3 under the Exchange Act of securities of the Company that represent more than 50% of the combined voting power of the Company&#8217;s then outstanding voting securities (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Outstanding Company Voting Securities</span>&#8221;); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that for purposes of this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 2(f)(ii)</span>, the following acquisitions shall not constitute a Change in Control: (I) any acquisition directly from the Company principally for bona fide equity financing purposes, (II) any acquisition by the Company, (III) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Affiliate, (IV) any acquisition by any corporation pursuant to a transaction that complies with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 2(f)(iv)(A)</span> and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">2(f)(iv)(B)</span>, and (V) any acquisition involving beneficial ownership of less than 50% of the then- outstanding Common Shares (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Outstanding Company Common Shares</span>&#8221;) or the Outstanding Company Voting Securities that is determined by the Board, based on review of public disclosure by the acquiring Person with respect to its passive investment intent, not to have a purpose or effect of changing or influencing the control of the Company; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided, however</span>, that for purposes of this clause (V), any such acquisition in connection with (x) an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents or (y) any &#8220;Business Combination&#8221; (as defined below) shall be presumed to be for the purpose or with the effect of changing or influencing the control of the Company;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>During any period of not more than two (2) consecutive years, individuals who constitute the Board as of the beginning of the period (the &#8220;Incumbent Directors&#8221;) cease for any reason to constitute at least a majority of the Board, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided that</span> any person becoming a director subsequent to the beginning of such period, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) will be an Incumbent Director; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board will be deemed to be an Incumbent Director;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>Consummation of a merger, amalgamation or consolidation (a &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Business Combination</span>&#8221;) of the Company with any other corporation, unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Shares and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company&#8217;s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Shares and the Outstanding Company Voting Securities, as the case may be, and (B) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were Incumbent Directors at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span>Stockholder approval of a plan of complete liquidation of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vi)</span></span>A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transactions. In addition, if any Person (as defined above) is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered to cause a Change in Control. If required for compliance with Code Section 409A, in no event will a Change in Control be deemed to have occurred if such transaction is not also a &#8220;change in the ownership or effective control of&#8221; the Company or &#8220;a change in the ownership of a substantial portion of the assets of&#8221; the Company as determined under Treasury Regulation Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:54pt;margin:0pt 0pt 0.1pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Code</i>&#8221; means the Internal Revenue Code of 1986, as amended, and any successor thereto. Reference in the Plan to any section of the Code shall be deemed to include any regulations or other interpretative guidance under such section, and any amendments or successor provisions to such section, regulations or guidance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Committee</i>&#8221; means a committee of at least two people as the Board may appoint to administer the Plan or, if no such committee has been appointed by the Board, the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Common Shares</i>&#8221; means shares of the Company&#8217;s Class A common stock (and any stock or other securities into which such ordinary shares may be converted or into which they may be exchanged).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</i>&#8221; means Data Knights Acquisition Corp.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>, a Delaware corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(l)</span></span><span style="color:#010000;">&#8220;</span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Consultant</i>&#8221; means any person, including an advisor, consultant or agent, engaged by the Company or a Parent or Subsidiary to render services to such entity or who renders, or has rendered, services to the Company, or any Parent, Subsidiary or affiliate and is compensated for such services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(m)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Date of Grant</i>&#8221; means the date on which the granting of an Award is authorized, or such other date as may be specified in such authorization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(n)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Director</i>&#8221; means a member of the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(o)</span></span>&#8220;<i style="color:#010000;font-style:italic;text-decoration-color:#010000;text-decoration-line:underline;text-decoration-style:solid;">Disability</i><span style="color:#010000;">&#8221; </span>means, for the purpose of Incentive Stock Options, total and permanent disability as defined in Code Section 22(e)(3); and for the purpose of Awards other than Incentive Stock Options, means the inability of the Participant to perform the Participant&#8217;s material duties hereunder with a reasonable accommodation due to a physical or mental injury, infirmity or incapacity for one hundred and twenty (120) days (including weekends and holidays) in any three hundred sixty-five (365) day period. The Participant shall reasonably cooperate with the Company if a question arises as to whether the Participant has become disabled (including, without limitation, submitting to reasonable examinations by one or more medical doctors and other health care specialists reasonably selected by the Company and authorizing such medical doctors and other health care specialists to discuss the Participant&#8217;s condition with the Company).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(p)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effective Date</i>&#8221; means the date means the date on which the Plan is approved by the stockholders of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(q)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Eligible Director</i>&#8221; means a person who is a &#8220;non-employee director&#8221; within the meaning of Rule 16b-3 under the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(r)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Eligible Person</i>&#8221; with respect to an Award denominated in Common Shares, means any (i) Employee; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that no such employee covered by a collective bargaining agreement shall be an Eligible Person unless and to the extent that such eligibility is set forth in such collective bargaining agreement which includes rules regarding equity entitlement or in an agreement or instrument relating thereto; (ii) Director of the Company or an Affiliate; (iii) Consultant to the Company or an Affiliate; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that if the Securities Act applies such persons must be eligible to be offered securities registrable on Form S-8 under the Securities Act; or (iv) prospective employees, directors, officers, consultants or advisors who have accepted offers of employment or consultancy from the Company or its Affiliates (and would satisfy the provisions of clauses (i) through (iii) above once he or she begins employment with or begins providing services to the Company or its Affiliates).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:54pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1.5pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup><span style="display:inline-block;width:10.2pt;"></span>Company named to be changed to OneMedNet Corporation upon stockholder approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(s)</span></span>&#8220;<i style="color:#010000;font-style:italic;text-decoration-color:#010000;text-decoration-line:underline;text-decoration-style:solid;">Employee</i>&#8221; means any person, including officers and Directors, employed by the Company or any Affiliate or Subsidiary of the Company. Neither service as a Director nor payment of a director&#8217;s fee by the Company will be sufficient to constitute &#8220;employment&#8221; by the Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(t)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Act</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control,&#8221; and any reference in the Plan to any section of (or rule promulgated under) the Exchange Act shall be deemed to include any rules, regulations or other interpretative guidance under such section or rule, and any amendments or successor provisions to such section, rules, regulations or guidance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(u)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Program</i>&#8221; means a program under which outstanding Awards are amended to provide for a lower Exercise Price or surrendered or cancelled in exchange for (i) Awards with a lower Exercise Price, (ii) a different type of Award or awards under a different equity incentive plan, (iii) cash, or (iv) a combination of (i), (ii) and/or (iii). Notwithstanding the preceding, the term Exchange Program does not include (A) any action taken in connection with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> or with a Change in Control transaction nor (B) any transfer or other disposition permitted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 15(c</span>). For the purpose of clarity, each of the actions described in the prior sentence, none of which constitute an Exchange Program, may be undertaken (or authorized) by the Committee in its sole discretion without approval by the Company&#8217;s stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exercise Price</i>&#8221; has the meaning given such term in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7(b)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(w)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Fair Market Value</i>&#8221; means, as of any date, the value of Common Shares determined as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>If the Common Shares are listed on any established stock exchange or a national market system will be the closing sales price for such shares (or the closing bid, if no sales were reported) as quoted on such exchange or system on the day of determination, as reported in <i style="font-style:italic;">The Wall Street Journal </i>or such other source as the Committee deems reliable;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>If the Common Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Common Share will be the mean between the high bid and low asked prices for the Common Shares on the day of determination, as reported in <i style="font-style:italic;">The Wall Street Journal </i>or such other source as the Committee deems reliable; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>In the absence of an established market for the Common Shares, the Fair Market Value will be determined in good faith by the Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(x)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Good Reason</i>&#8221; means, in the case of a particular Award, unless the applicable Award Agreement or the Participant&#8217;s employment agreement with the Company states otherwise, the occurrence of any of the following events, without the express written consent of the Participant: (i) the Company&#8217;s material breach of any of its obligations under the Participant&#8217;s employment agreement with the Company or this Agreement, (ii) reduction in the Participant&#8217;s total annual cash compensation opportunity (i.e., base salary and target annual bonus) as described in the Participant&#8217;s employment agreement with the Company, (iii) a material relocation of the Participant&#8217;s principal place of employment to a location more than fifty (50) miles from the current principal place of employment approved by the Company, or (iv) the failure of a successor to the Company to assume the Company&#8217;s obligations under the Participant&#8217;s employment agreement with the Company or this Agreement, p<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">rovided</span>, that, for (i) &#8211; (iv) above, the Participant has given written notice to the Company of the condition giving rise to Good Reason within ninety (90) days after its initial occurrence and the Company fails to cure such condition within thirty (30) days following the receipt of such written notification by the Participant to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(y)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Immediate Family Members</i>&#8221; shall have the meaning set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 16(b)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(z)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Incentive Stock Option</i>&#8221; means an Option that is designated by the Committee as an incentive stock option as described in Code Section 422 and otherwise meets the requirements set forth in the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(aa)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnifiable Person</i>&#8221; shall have the meaning set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 4(e)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(bb)</span></span><i style="font-style:italic;">&#8220;</i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mature Shares</i>&#8221; means Common Shares owned by a Participant that are not subject to any pledge or security interest and that have been either previously acquired by the Participant on the open market or meet such other requirements, if any, as the Committee may determine are necessary in order to avoid an accounting earnings charge on account of the use of such shares to pay the Exercise Price or satisfy a tax or deduction obligation of the Participant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(cc)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nonqualified Stock Option</i>&#8221; means an Option that is not designated by the Committee as an Incentive Stock Option.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(dd)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Option</i>&#8221; means an Award granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ee)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Option Period</i>&#8221; has the meaning given such term in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7(c)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ff)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Cash-Based Award</i>&#8221; shall mean a right or other interest granted to a Participant pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 11</span> of the Plan other than an Other Stock-Based Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(gg)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Stock-Based Award</i>&#8221; shall mean a right or other interest granted to a Participant, valued in whole or in part by reference to, or otherwise based on, or related to, Common Stock pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 11</span> of the Plan including but not limited to (i) unrestricted Common Stock awarded as a bonus or upon the attainment of performance goals or otherwise as permitted under the Plan, and (ii) a right granted to a Participant to acquire Common Stock from the Company containing terms and conditions prescribed by the Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(hh)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Outstanding Company Common Shares</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Outstanding Company Voting Securities</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(jj)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Participant</i>&#8221; means an Eligible Person who has been selected by the Committee to participate in the Plan and to receive an Award pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 6</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(kk)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Compensation Award</i>&#8221; shall mean any Award designated by the Committee as a Performance Compensation Award pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 11</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ll)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Criteria</i>&#8221; shall mean the criterion or criteria that the Committee shall select for purposes of establishing the Performance Goal(s) for a Performance Period with respect to any Performance Compensation Award under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(mm)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Formula</i>&#8221; shall mean, for a Performance Period, the one or more formulae applied against the relevant Performance Goal to determine, with regard to the Performance Compensation Award of a particular Participant, whether all, some portion but less than all, or none of the Performance Compensation Award has been earned for the Performance Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(nn)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Goals</i>&#8221; shall mean, for a Performance Period, the one or more goals established by the Committee for the Performance Period based upon the Performance Criteria.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(oo)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Period</i>&#8221; shall mean the one or more periods of time, as the Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to, and the payment of, a Performance Compensation Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(pp)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Permitted Transferee</i>&#8221; shall have the meaning set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 16(b)</span> of the Plan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(qq)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Person</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(rr)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Plan</i>&#8221; means this Data Knights Acquisition Corp.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup> 2022 Equity Incentive Plan, as amended from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:54pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:5.75pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Company name to be changed to OneMedNet Corporation upon stockholder approval.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ss)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Qualifying Termination</i>&#8221; means, except as otherwise provided by the Committee as set forth in the Award, the occurrence of either a termination of a Participant&#8217;s employment by the Company without Cause or for Good Reason, in either case, occurring on or within the 12-month period (or such other period specified in the applicable Award Agreement) following the consummation of a Change in Control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(tt)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Period</i>&#8221; means the period of time determined by the Committee during which an Award is subject to restrictions or, as applicable, the period of time within which performance is measured for purposes of determining whether an Award has been earned.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(uu)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Stock Unit</i>&#8221; means an unfunded and unsecured promise to deliver Common Shares, cash, other securities or other property, subject to certain performance or time-based restrictions (including, without limitation, a requirement that the Participant remain continuously employed or provide continuous services for a specified period of time), granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vv)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Stock</i>&#8221; means Common Shares, subject to certain specified performance or time-based restrictions (including, without limitation, a requirement that the Participant remain continuously employed or provide continuous services for a specified period of time), granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ww)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Retirement</i>&#8221; means, in the case of a particular Award, the definition set forth in the applicable Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xx)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SAR Period</i>&#8221; has the meaning given such term in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8(b</span>) of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(yy)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Securities Act</i>&#8221; means the Securities Act of 1933, as amended, and any successor thereto. Reference in the Plan to any section of the Securities Act shall be deemed to include any rules, regulations or other interpretative guidance under such section, and any amendments or successor provisions to such section, rules, regulations or guidance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(zz)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Appreciation Right</i>&#8221; or <i style="font-style:italic;">&#8220;</i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SAR</i><i style="font-style:italic;">&#8221; </i>means an Award granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;">(aaa)&#160;&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Bonus Award</i>&#8221; means an Award granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 10</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;">(bbb)&#160;&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Strike Price</i>&#8221; means, except as otherwise provided by the Committee in the case of Substitute Awards, (i) in the case of a SAR granted in tandem with an Option, the Exercise Price of the related Option, or (ii) in the case of a SAR granted independent of an Option, the Fair Market Value on the Date of Grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;">(ccc)&#160;&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Subsidiary</i><i style="font-style:italic;">&#8221; means, with respect to any specified Person:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>any corporation, association or other business entity of which more than 50% of the total voting power of shares (without regard to the occurrence of any contingency and after giving effect to any voting agreement or stockholders&#8217; agreement that effectively transfers voting power) is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person (or a combination thereof); and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>any partnership (or any comparable foreign entity (a) the sole general partner (or functional equivalent thereof) or the managing general partner of which is such Person or Subsidiary of such Person or (b) the only general partners (or functional equivalents thereof) of which are that Person or one or more Subsidiaries of that Person (or any combination thereof).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Substitute Award</i>&#8221; has the meaning given such term in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5(e)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effective Date; Duration</i>. The Plan shall be effective as of the Effective Date. The expiration date of the Plan, on and after which date no Awards may be granted hereunder, shall be the tenth anniversary of the Effective Date; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that such expiration shall not affect Awards then outstanding, and the terms and conditions of the Plan shall continue to apply to such Awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Administration</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Committee shall administer the Plan. To the extent required to comply with the applicable provisions of Rule 16b-3 promulgated under the Exchange Act (if the Board is not acting as the Committee under the Plan), it is intended that each member of the Committee shall, at the time he or she takes any action with respect to an Award under the Plan, be an Eligible Director. However, the fact that a Committee member shall fail to qualify as an Eligible Director shall not invalidate any Award granted by the Committee that is otherwise validly granted under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Subject to the provisions of the Plan and applicable law, the Committee shall have the sole and plenary authority, in addition to other express powers and authorizations conferred on the Committee by the Plan or by the Board, to: (i) designate Participants; (ii) determine the type or types of Awards to be granted to a Participant; (iii) determine the number of Common Shares to be covered by, or with respect to which payments, rights, or other matters are to be calculated in connection with, Awards; (iv) determine the form of Award Agreement and the terms and conditions of any Award; (v) determine whether, to what extent, and under what circumstances Awards may be settled or exercised in cash, Common Shares, other securities, other Awards or other property, or canceled, forfeited, or suspended and the method or methods by which Awards may be settled, exercised, canceled, forfeited, or suspended; (vi) determine whether, to what extent, and under what circumstances the delivery of cash, Common Shares, other securities, other Awards or other property and other amounts payable with respect to an Award shall be deferred either automatically or at the election of the Participant or of the Committee; (vii) interpret, administer, reconcile any inconsistency in, correct any defect in and/or supply any omission in the Plan and any instrument or agreement relating to, or Award granted under, the Plan; (viii) establish, amend, suspend, or waive any rules and regulations and appoint such agents as the Committee shall deem appropriate for the proper administration of the Plan; (ix) accelerate the vesting or exercisability of, payment for or lapse of restrictions on, Awards, including, but not limited to, upon a Qualifying Termination; (x) to institute and determine the terms and conditions of an Exchange Program; provided, however, that the Committee shall not implement an Exchange Program without the approval of the holders of a majority of the Shares that are present in person or by proxy and entitled to vote at any annual or special meeting of Company&#8217;s stockholders; and (xi) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>The Committee may delegate to one or more officers of the Company or any Affiliate the authority to act on behalf of the Committee with respect to any matter, right, obligation, or election that is the responsibility of or that is allocated to the Committee herein, and that may be so delegated as a matter of law, except for grants of Awards to persons subject to Section 16 of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>Unless otherwise expressly provided in the Plan, all designations, determinations, interpretations, and other decisions under or with respect to the Plan or any Award or any documents evidencing Awards granted pursuant to the Plan shall be within the sole discretion of the Committee, may be made at any time and shall be final, conclusive and binding upon all persons or entities, including, without limitation, the Company, any Affiliate, any Participant, any holder or beneficiary of any Award, and any stockholder of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>No member of the Board, the Committee, delegate of the Committee or any employee or agent of the Company (each such person, an &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnifiable Person</span>&#8221;) shall be liable for any action taken or omitted to be taken or any determination made in good faith with respect to the Plan or any Award hereunder. Each Indemnifiable Person shall be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense (including attorneys&#8217; fees) that may be imposed upon or incurred by such Indemnifiable Person in connection with or resulting from any action, suit or proceeding to which such Indemnifiable Person may be a party or in which such Indemnifiable Person may be involved by reason of any action taken or omitted to be taken under the Plan or any Award Agreement and against and from any and all amounts paid by such Indemnifiable Person with the Company&#8217;s approval, in settlement thereof, or paid by such Indemnifiable Person in satisfaction of any judgment in any such action, suit or proceeding against such Indemnifiable Person, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that the Company shall have the right, at its own expense, to assume and defend any such action, suit or proceeding and once the Company gives notice of its intent to assume the defense, the Company shall have sole control over such defense with counsel of the Company&#8217;s choice. The foregoing right of indemnification shall not be available to an Indemnifiable Person to the extent that a final judgment or other final adjudication (in either case not subject to further appeal) binding upon such Indemnifiable Person determines that the acts or omissions of such Indemnifiable Person giving rise to the indemnification claim resulted from such Indemnifiable Person&#8217;s bad faith, fraud or willful criminal act or omission or that such right of indemnification is otherwise prohibited by law or by the Company&#8217;s Articles of Incorporation or Bylaws. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such Indemnifiable Persons may be entitled under the Company&#8217;s Articles of Incorporation or Bylaws, as a matter of law, or otherwise, or any other power that the Company may have to indemnify such Indemnifiable Persons or hold them harmless.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>Notwithstanding anything to the contrary contained in the Plan, the Board may, in its sole discretion, at any time and from time to time, grant Awards and administer the Plan with respect to such Awards. In any such case, the Board shall have all the authority granted to the Committee under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Grant of Awards; Shares Subject to the Plan; Limitations</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Committee may, from time to time, grant Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Stock Bonus Awards and/or Performance Compensation Awards to one or more Eligible Persons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> of the Plan, Awards granted under the Plan shall be subject to the following limitations: (i) the Committee is authorized to deliver under the Plan an aggregate of [&#160;&#160;]<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup> Common Shares; provided, that total number of Common Shares that will be reserved, and that may be issued, under the Plan will automatically increase on the first trading day of each calendar year, beginning with calendar year 2023, by a number of Common Shares equal to five percent (5%) of the total outstanding Common Shares on the last day of the prior calendar year (subject to a maximum annual increase of 1,000,000 Common Shares), (ii) in no event shall the maximum aggregate number of Common Shares that may be issued under the Plan pursuant to Incentive Stock Options exceed the aggregate number of Common Shares set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5(b)(i)</span> of the Plan plus, to the extent allowable under Code Section 422 and the regulations promulgated thereunder, any Common Shares that again become available for issuance pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5(c)</span> of the Plan and (iii) the maximum number of Common Shares that may be granted under the Plan during any single fiscal year to any Participant who is a non-employee director, when taken together with any cash fees paid to such non-employee director during such year in respect of his or her service as a non-employee director (including service as a member or chair of any committee of the Board), shall not exceed $750,000 in total value (calculating the value of any such Awards based on the grant date fair value of such Awards for financial reporting purposes); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that the non-employee directors who are considered independent (under the rules of The NASDAQ Stock Market or other securities exchange on which the Common Shares are traded) may make exceptions to this limit for a non-executive chair of the Board, if any, in which case the non-employee Director receiving such additional compensation may not participate in the decision to award such compensation. Notwithstanding the automatic annual increase set forth in (i) above, the Board may act prior to January 1st of a given year to provide that there will be no such increase in the share reserve for such year or that the increase in the share reserve for such year will be a lesser number of Common Shares than would otherwise occur pursuant to the stipulated percentage.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>In the event that (i) any Option or other Award granted hereunder is exercised through the tendering of Common Shares (either actually or by attestation) or by the withholding of Common Shares by the Company, or (ii) tax or deduction liabilities arising from such Option or other Award are satisfied by the tendering of Common Shares (either actually or by attestation) or by the withholding of Common Shares by the Company, then in each such case the Common Shares so tendered or withheld shall be added to the Common Shares available for grant under the Plan on a one-for-one basis. Shares underlying Awards under this Plan that are forfeited, cancelled, expire unexercised, or are settled in cash are available again for Awards under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>Common Shares delivered by the Company in settlement of Awards may be authorized and unissued shares, shares held in the treasury of the Company, shares purchased on the open market or by private purchase, or a combination of the foregoing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>Awards may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding awards previously granted by an entity acquired by the Company or with which the Company combines (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Substitute Awards</span>&#8221;). The number of Common Shares underlying any Substitute Awards shall not be counted against the aggregate number of Common Shares available for Awards under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:30.95pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Eligibility</i>. Participation shall be limited to Eligible Persons who have entered into an Award Agreement or who have received written notification from the Committee, or from a person designated by the Committee, that they have been selected to participate in the Plan.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup><span style="display:inline-block;width:10.05pt;"></span>To equal 10% of basic Class A shares outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Options</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Generally</i>. Each Option granted under the Plan shall be evidenced by an Award Agreement (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)). Each Option so granted shall be subject to the conditions set forth in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7</span>, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. All Options granted under the Plan shall be Nonqualified Stock Options unless the applicable Award Agreement expressly states that the Option is intended to be an Incentive Stock Option. Incentive Stock Options shall be granted only to Eligible Persons who are employees of the Company and its Affiliates, and no Incentive Stock Option shall be granted to any Eligible Person who is ineligible to receive an Incentive Stock Option under the Code. No Option shall be treated as an Incentive Stock Option unless the Plan has been approved by the stockholders of the Company in a manner intended to comply with the stockholder approval requirements of Code Section 422(b)(1); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that any Option intended to be an Incentive Stock Option shall not fail to be effective solely on account of a failure to obtain such approval, but rather such Option shall be treated as a Nonqualified Stock Option unless and until such approval is obtained. In the case of an Incentive Stock Option, the terms and conditions of such grant shall be subject to and comply with such rules as may be prescribed by Code Section 422. If for any reason an Option intended to be an Incentive Stock Option (or any portion thereof) shall not qualify as an Incentive Stock Option, then, to the extent of such non-qualification, such Option or portion thereof shall be regarded as a Nonqualified Stock Option appropriately granted under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exercise Price</i>. Except with respect to Substitute Awards, the exercise price (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exercise Price</span>&#8221;) per Common Share for each Option shall not be less than 100% of the Fair Market Value of such share determined as of the Date of Grant; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that in the case of an Incentive Stock Option granted to an employee who, at the time of the grant of such Option, owns shares representing more than 10% of the total combined voting power of all classes of shares of the Company or any related corporation (as determined in accordance with Treasury Regulation Section 1.422-2(f)), the Exercise Price per share shall not be less than 110% of the Fair Market Value per share on the Date of Grant and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided further</span>, that, notwithstanding any provision herein to the contrary, the Exercise Price shall not be less than the par value per Common Share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vestin</i><i style="font-style:italic;">g </i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">and Expiration</i>. Options shall vest and become exercisable in such manner and on such date or dates determined by the Committee and shall expire after such period, not to exceed ten years, as may be determined by the Committee (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Option Period</span>&#8221;); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that the Option Period shall not exceed five years from the Date of Grant in the case of an Incentive Stock Option granted to a Participant who on the Date of Grant owns shares representing more than 10% of the total combined voting power of all classes of shares of the Company or any related corporation (as determined in accordance with Treasury Regulation Section 1.422-2(f)); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">further</span>, that notwithstanding any vesting dates set by the Committee, the Committee may, in its sole discretion, accelerate the exercisability of any Option, which acceleration shall not affect the terms and conditions of such Option other than with respect to exercisability. Unless otherwise provided by the Committee in an Award Agreement: (i) the unvested portion of an Option shall expire upon termination of employment or service of the Participant granted the Option, and the vested portion of such Option shall remain exercisable for (A) one year following termination of employment or service by reason of such Participant&#8217;s death or disability (as determined by the Committee), but not later than the expiration of the Option Period or (B) ninety (90) days following termination of employment or service for any reason other than such Participant&#8217;s death or disability, and other than such Participant&#8217;s termination of employment or service for Cause, but not later than the expiration of the Option Period; and (ii) both the unvested and the vested portion of an Option shall expire upon the termination of the Participant&#8217;s employment or service by the Company for Cause. If the Option would expire at a time when the exercise of the Option would violate applicable securities laws, the expiration date applicable to the Option will be automatically extended to a date that is thirty (30) calendar days following the date such exercise would no longer violate applicable securities laws (so long as such extension shall not violate Code Section 409A); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, that in no event shall such expiration date be extended beyond the expiration of the Option Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Method of Exercise and Form of Payment</i>. No Common Shares shall be delivered pursuant to any exercise of an Option until payment in full of the Exercise Price therefor is received by the Company and the Participant has paid to the Company an amount equal to any taxes required to be withheld or paid. Options that have become exercisable may be exercised by delivery of written or electronic notice of exercise to the Company in accordance with the terms of the Option accompanied by payment of the Exercise Price. The Exercise Price shall be payable (i) in cash, check, cash equivalent and/or Common Shares valued at the fair market value at the time the Option is exercised (including, pursuant to procedures approved by the Committee, by means of attestation of ownership of a sufficient number of Common Shares in lieu of actual delivery of such shares to the Company); provided that such Common Shares are not subject to any pledge or other security interest and are Mature Shares and; (ii) by such other method as the Committee may permit in accordance with applicable law, in its sole discretion, on a case by case basis, including without limitation: (A) in other property having a fair market value on the date of exercise equal to the Exercise Price or (B) if there is a public market for the Common Shares at such time, by means of a broker-assisted &#8220;cashless exercise&#8221; pursuant to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">which the Company is delivered a copy of irrevocable instructions to a stockbroker to sell the Common Shares otherwise deliverable upon the exercise of the Option and to deliver promptly to the Company an amount equal to the Exercise Price or (C) by a &#8220;net exercise&#8221; method whereby the Company withholds from the delivery of the Common Shares for which the Option was exercised that number of Common Shares having a fair market value equal to the aggregate Exercise Price for the Common Shares for which the Option was exercised. No fractional Common Shares shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall determine whether cash, other securities or other property shall be paid or transferred in lieu of any fractional Common Shares, or whether such fractional Common Shares or any rights thereto shall be canceled, terminated or otherwise eliminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notification upon Disqualifying Disposition of an Incentive Stock Option</i>. Each Participant awarded an Incentive Stock Option under the Plan shall notify the Company in writing immediately after the date he makes a disqualifying disposition of any Common Shares acquired pursuant to the exercise of such Incentive Stock Option. A disqualifying disposition is any disposition (including, without limitation, any sale) of such Common Shares before the later of (A) two (2) years after the Date of Grant of the Incentive Stock Option or (B) one (1) year after the date of exercise of the Incentive Stock Option. The Company may, if determined by the Committee and in accordance with procedures established by the Committee, retain possession of any Common Shares acquired pursuant to the exercise of an Incentive Stock Option as agent for the applicable Participant until the end of the period described in the preceding sentence.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Laws, etc</i>. Notwithstanding the foregoing, in no event shall a Participant be permitted to exercise an Option in a manner that the Committee determines would violate the Sarbanes-Oxley Act of 2002, if applicable, or any other applicable law or the applicable rules and regulations of the Securities and Exchange Commission or the applicable rules and regulations of any securities exchange or inter-dealer quotation system on which the securities of the Company are listed or traded.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Appreciation Rights</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Generally</i>. Each SAR granted under the Plan shall be evidenced by an Award Agreement (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)). Each SAR so granted shall be subject to the conditions set forth in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8</span>, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. Any Option granted under the Plan may include tandem SARs. The Committee also may award SARs to Eligible Persons independent of any Option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exercise Price</i>. The Exercise Price per Common Share for each SAR shall not be less than 100% of the Fair Market Value of such share determined as of the Date of Grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vesting and Expiration</i>. A SAR granted in connection with an Option shall become exercisable and shall expire according to the same vesting schedule and expiration provisions as the corresponding Option. A SAR granted independent of an Option shall vest and become exercisable and shall expire in such manner and on such date or dates determined by the Committee and shall expire after such period, not to exceed ten years, as may be determined by the Committee (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SAR Period</span>&#8221;); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that notwithstanding any vesting dates set by the Committee, the Committee may, in its sole discretion, accelerate the exercisability of any SAR, which acceleration shall not affect the terms and conditions of such SAR other than with respect to exercisability. Unless otherwise provided by the Committee in an Award Agreement: (i) the unvested portion of a SAR shall expire upon termination of employment or service of the Participant granted the SAR, and the vested portion of such SAR shall remain exercisable for (A) one year following termination of employment or service by reason of such Participant&#8217;s death or disability (as determined by the Committee), but not later than the expiration of the SAR Period or (B) 90 days following termination of employment or service for any reason other than such Participant&#8217;s death or disability, and other than such Participant&#8217;s termination of employment or service for Cause, but not later than the expiration of the SAR Period; and (ii) both the unvested and the vested portion of a SAR shall expire upon the termination of the Participant&#8217;s employment or service by the Company for Cause. If the SAR would expire at a time when the exercise of the SAR would violate applicable securities laws, the expiration date applicable to the SAR will be automatically extended to a date that is thirty (30) calendar days following the date such exercise would no longer violate applicable securities laws (so long as such extension shall not violate Code Section 409A); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, that in no event shall such expiration date be extended beyond the expiration of the SAR Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Method of Exercise</i>. SARs that have become exercisable may be exercised by delivery of written or electronic notice of exercise to the Company in accordance with the terms of the Award, specifying the number of SARs to be exercised and the date on which such SARs were awarded. Notwithstanding the foregoing, if on the last day of the Option Period (or in the case of a SAR independent of an option, the SAR Period), the fair market value exceeds the Strike Price, the Participant has not exercised </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">the SAR or the corresponding Option (if applicable), and neither the SAR nor the corresponding Option (if applicable) has expired, such SAR shall be deemed to have been exercised by the Participant on such last day and the Company shall make the appropriate payment therefor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payment</i>. Upon the exercise of a SAR, the Company shall pay to the Participant an amount equal to the number of shares subject to the SAR that are being exercised multiplied by the excess, if any, of the fair market value of one Common Share on the exercise date over the Strike Price, less an amount equal to any taxes required to be withheld or paid. The Company shall pay such amount in cash, in Common Shares valued at fair market value, or any combination thereof, as determined by the Committee. No fractional Common Shares shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall determine whether cash, other securities or other property shall be paid or transferred in lieu of any fractional Common Shares, or whether such fractional Common Shares or any rights thereto shall be canceled, terminated or otherwise eliminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">9.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Stock and Restricted Stock Units</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Generally</i>. Each grant of Restricted Stock and Restricted Stock Units shall be evidenced by an Award Agreement (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)). Each such grant shall be subject to the conditions set forth in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span>, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Accounts; Escrow or Similar Arrangement</i>. Upon the grant of Restricted Stock, a book entry in a restricted account shall be established in the Participant&#8217;s name at the Company&#8217;s transfer agent and, if the Committee determines that the Restricted Stock shall be held by the Company or in escrow rather than held in such restricted account pending the release of the applicable restrictions, the Committee may require the Participant to additionally execute and deliver to the Company (i) an escrow agreement satisfactory to the Committee, if applicable, and (ii) the appropriate share power (endorsed in blank) with respect to the Restricted Stock covered by such agreement. If a Participant shall fail to execute an agreement evidencing an Award of Restricted Stock and, if applicable, an escrow agreement and blank share power within the amount of time specified by the Committee, the Award shall be null and void. Subject to the restrictions set forth in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span> and the applicable Award Agreement, the Participant generally shall have the rights and privileges of a stockholder as to such Restricted Stock, including without limitation the right to vote such Restricted Stock and the right to receive dividends, if applicable. To the extent shares of Restricted Stock are forfeited, any share certificates issued to the Participant evidencing such shares shall be returned to the Company, and all rights of the Participant to such shares and as a stockholder with respect thereto shall terminate without further obligation on the part of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vesting; Acceleration of Lapse of Restrictions</i>. Unless otherwise provided by the Committee in an Award Agreement the unvested portion of Restricted Stock and Restricted Stock Units shall terminate and be forfeited upon termination of employment or service of the Participant granted the applicable Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Delivery of Restricted Stock and Settlement of Restricted Stock Units</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Upon the expiration of the Restricted Period with respect to any shares of Restricted Stock, the restrictions set forth in the applicable Award Agreement shall be of no further force or effect with respect to such shares, except as set forth in the applicable Award Agreement. If an escrow arrangement is used, upon such expiration, the Company shall deliver to the Participant, or his beneficiary, without charge, the share certificate evidencing the shares of Restricted Stock that have not then been forfeited and with respect to which the Restricted Period has expired (rounded down to the nearest full share). Dividends, if any, that may have been withheld by the Committee and attributable to any particular share of Restricted Stock shall be distributed to the Committee and attributable to any particular share of Restricted Stock shall be distributed to the Participant in cash or, at the sole discretion of the Committee, in Common Shares having a fair market value equal to the amount of such dividends, upon the release of restrictions on such share and, if such share is forfeited, the Participant shall have no right to such dividends (except as otherwise set forth by the Committee in the applicable Award Agreement).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Unless otherwise provided by the Committee in an Award Agreement, upon the expiration of the Restricted Period with respect to any outstanding Restricted Stock Units, the Company shall deliver to the Participant, or his beneficiary, without charge, one Common Share for each such outstanding Restricted Stock Unit; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that the Committee may, in its sole discretion, elect to (i) pay cash or part cash and part Common Share in lieu of delivering only Common Shares in respect of such Restricted Stock Units or (ii) defer the delivery of Common Shares (or cash or part Common Shares and part cash, as the case may be) beyond the expiration of the Restricted Period if such delivery would result in a violation of applicable law until such time as is no longer the case. If a cash payment is made in lieu of delivering Common Shares, the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">amount of such payment shall be equal to the fair market value of the Common Shares as of the date on which the Restricted Period lapsed with respect to such Restricted Stock Units, less an amount equal to any taxes required to be withheld or paid.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Bonus Awards</i>. The Committee may issue unrestricted Common Shares, or other Awards denominated in Common Shares, under the Plan to Eligible Persons, either alone or in tandem with other awards, in such amounts as the Committee shall from time to time in its sole discretion determine. Each Stock Bonus Award granted under the Plan shall be evidenced by an Award Agreement (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)). Each Stock Bonus Award so granted shall be subject to such conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">11.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Compensation Awards</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Generally</i>. The Committee shall have the authority, at the time of grant of any Award described in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 7</span> through <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">10</span> of the Plan, to designate such Award as a Performance Compensation Award. The Committee shall have the authority to make an award of a cash bonus to any Participant and designate such Award as a Performance Compensation Award. Unless otherwise determined by the Committee, all Performance Compensation Awards shall be evidenced by an Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Discretion of Committee with Respect to Performance Compensation Awards</i>. The Committee shall have the discretion to establish the terms, conditions and restrictions of any Performance Compensation Award. With regard to a particular Performance Period, the Committee shall have sole discretion to select the length of such Performance Period, the type(s) of Performance Compensation Awards to be issued, the Performance Criteria that will be used to establish the Performance Goal (s), the kind(s) and/or level(s) of the Performance Goals(s) that is (are) to apply and the Performance Formula.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 3.59pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Criteria</i>. The Committee may establish Performance Criteria that will be used to establish the Performance Goal(s) for Performance Compensation Awards which may be based on the attainment of specific levels of performance of the Company (and/or one or more Affiliates, divisions, business segments or operational units, or any combination of the foregoing) and may include, without limitation, any of the following: (i) net earnings or net income (before or after taxes); (ii) basic or diluted earnings per share (before or after taxes); (iii) revenue or revenue growth (measured on a net or gross basis); (iv) gross profit or gross profit growth; (v) operating profit (before or after taxes); (vi) return measures (including, but not limited to, return on assets, capital, invested capital, equity, or sales); (vii) cash flow (including, but not limited to, operating cash flow, free cash flow, net cash provided by operations and cash flow return on capital); (viii) financing and other capital raising transactions (including, but not limited to, sales of the Company&#8217;s equity or debt securities); (ix) earnings before or after taxes, interest, depreciation and/or amortization; (x) gross or operating margins; (xi) productivity ratios; (xii) share price (including, but not limited to, growth measures and total stockholder return); (xiii) expense targets; (xiv) margins; (xv) productivity and operating efficiencies; (xvi) customer satisfaction; (xvii) customer growth; (xviii) working capital targets; (xix) measures of economic value added; (xx) inventory control; (xxi) enterprise value; (xxii) sales; (xxiii) debt levels and net debt; (xxiv) combined ratio; (xxv) timely launch of new facilities; (xxvi) client retention; (xxvii) employee retention; (xxviii) timely completion of rollouts of new products and services; (xxix) cost targets; (xxx) reductions and savings; (xxxi) productivity and efficiencies; (xxxii) strategic partnerships or transactions; and (xxxiii) personal targets, goals or completion of projects. Any one or more of the Performance Criteria may be used on an absolute or relative basis to measure the performance of the Company and/or one or more Affiliates as a whole or any business unit(s) of the Company and/or one or more Affiliates or any combination thereof, as the Committee may deem appropriate, or any of the above Performance Criteria may be compared to the performance of a selected group of comparison or peer companies, or a published or special index that the Committee, in its sole discretion, deems appropriate, or as compared to various stock market indices. The Committee also has the authority to provide for accelerated vesting of any Award based on the achievement of Performance Goals pursuant to the Performance Criteria specified in this paragraph. Any Performance Criteria that are financial metrics, may be determined in accordance with United States Generally Accepted Accounting Principles (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">GAAP</span>&#8221;) or may be adjusted when established to include or exclude any items otherwise includable or excludable under GAAP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Modification of Performance Goal(s)</i>. The Committee is authorized at any time to adjust or modify the calculation of a Performance Goal for such Performance Period, based on and in order to appropriately reflect any specified circumstance or event that occurs during a Performance Period, including but not limited to the following: (i) asset write-downs; (ii) litigation or claim judgments or settlements; (iii) the effect of changes in tax laws, accounting principles, or other laws or regulatory rules affecting reported results; (iv) any reorganization and restructuring programs; (v) unusual and/or infrequently occurring items as described in Accounting Principles Board Opinion No. 30 (or any successor pronouncement thereto) and/or in management&#8217;s discussion and analysis of financial condition and results of operations appearing in the Company&#8217;s annual report to stockholders for the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">applicable year; (vi) acquisitions or divestitures; (vii) discontinued operations; (viii) any other specific unusual or infrequently occurring or non-recurring events, or objectively determinable category thereof; (ix) foreign exchange gains and losses; and (x) a change in the Company&#8217;s fiscal year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Terms and Conditions to Receipt of Payment</i>. Unless otherwise provided in the applicable Award Agreement, a Participant must be employed by the Company on the last day of a Performance Period to be eligible for payment in respect of a Performance Compensation Award for such Performance Period. A Participant shall be eligible to receive payment in respect of a Performance Compensation Award only to the extent that: (A) the Performance Goals for such period are achieved; and (B) all or some of the portion of such Participant&#8217;s Performance Compensation Award has been earned for the Performance Period based on the application of the Performance Formula to such achieved Performance Goals. Following the completion of a Performance Period, the Committee shall determine whether, and to what extent, the Performance Goals for the Performance Period have been achieved and, if so, calculate the amount of the Performance Compensation Awards earned for the period based upon the Performance Formula. The Committee shall then determine the amount of each Participant&#8217;s Performance Compensation Award actually payable for the Performance Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 3.59pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Timing of Award Payments</i>. Except as provided in an Award Agreement, Performance Compensation Awards granted for a Performance Period shall be paid to Participants as soon as administratively practicable following the Committee&#8217;s determination in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 11(e</span>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">12.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Stock-or Cash-Based Awards</i>. The Committee is authorized to grant Awards to Participants in the form of Other Stock-Based Awards or Other Cash-Based Awards, as deemed by the Committee to be consistent with the purposes of the Plan. To the extent necessary to satisfy the short-term deferral exception to Code Section 409A, unless the Committee shall determine otherwise, the Awards shall provide that payment shall be made within 2 &#189; months after the end of the year in which the Participant has a legally binding vested right to such Award. The Committee may establish such other rules applicable to the Other Stock- or Cash-Based Awards as it deems appropriate, to the extent not inconsistent with the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">13.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Changes in Capital Structure and Similar Events</i>. In the event of (i) any dividend (other than ordinary cash dividends) or other distribution (whether in the form of cash, Common Shares, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, amalgamation, consolidation, spin-off, split-up, split-off, combination, repurchase or exchange of Common Shares or other securities of the Company, issuance of warrants or other rights to acquire Common Shares or other securities of the Company, or other similar corporate transaction or event (including, without limitation, a Change in Control) that affects the Common Shares, or (ii) unusual or infrequently occurring events (including, without limitation, a Change in Control) affecting the Company, any Affiliate, or the financial statements of the Company or any Affiliate, or changes in applicable rules, rulings, regulations or other requirements of any governmental body or securities exchange or inter-dealer quotation system, accounting principles or law, such that in either case an adjustment is determined by the Committee in its sole discretion to be necessary or appropriate, then the Committee shall make any such adjustments in such manner as it may deem equitable, including without limitation any or all of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>adjusting any or all of (A) the number of Common Shares or other securities of the Company (or number and kind of other securities or other property) that may be delivered in respect of Awards or with respect to which Awards may be granted under the Plan (including, without limitation, adjusting any or all of the limitations under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5</span> of the Plan) and (B) the terms of any outstanding Award, including, without limitation, (1) the number of Common Shares or other securities of the Company (or number and kind of other securities or other property) subject to outstanding Awards or to which outstanding Awards relate, (2) the Exercise Price or Strike Price with respect to any Award or (3) any applicable performance measures (including, without limitation, Performance Criteria and Performance Goals);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>providing for a substitution or assumption of Awards in a manner that substantially preserves the applicable terms of such Awards;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>accelerating the exercisability or vesting of, lapse of restrictions on, or termination of, Awards or providing for a period of time for exercise prior to the occurrence of such event;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>modifying the terms of Awards to add events, conditions or circumstances (including termination of employment within a specified period after a Change in Control) upon which the exercisability or vesting of or lapse of restrictions thereon will accelerate;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>deeming any performance measures (including, without limitation, Performance Criteria and Performance Goals) satisfied at target, maximum or actual performance through closing or such other level determined by the Committee in its sole discretion, or providing for the performance measures to continue (as is or as adjusted by the Committee) after closing;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>providing that for a period prior to the Change in Control determined by the Committee in its sole discretion, any Options or SARs that would not otherwise become exercisable prior to the Change in Control will be exercisable as to all Common Shares subject thereto (but any such exercise will be contingent upon and subject to the occurrence of the Change in Control and if the Change in Control does not take place after giving such notice for any reason whatsoever, the exercise will be null and void) and that any Options or SARs not exercised prior to the consummation of the Change in Control will terminate and be of no further force and effect as of the consummation of the Change in Control; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>canceling any one or more outstanding Awards and causing to be paid to the holders thereof, in cash, Common Shares, other securities or other property, or any combination thereof, the value of such Awards, if any, as determined by the Committee (which if applicable may be based upon the price per Common Share received or to be received by other stockholders of the Company in such event), including without limitation, in the case of an outstanding Option or SAR, a cash payment in an amount equal to the excess, if any, of the fair market value (as of a date specified by the Committee) of the Common Shares subject to such Option or SAR over the aggregate Exercise Price or Strike Price of such Option or SAR, respectively (it being understood that, in such event, any Option or SAR having a per share Exercise Price or Strike Price equal to, or in excess of, the fair market value of a Common Share subject thereto may be canceled and terminated without any payment or consideration therefor); provided, however, that in the case of any &#8220;equity restructuring&#8221; (within the meaning of the Financial Accounting Standards Board Accounting Standards Codification Topic 718), the Committee shall make an equitable or proportionate adjustment to outstanding Awards to reflect such equity restructuring. The Company shall give each Participant notice of an adjustment hereunder and, upon notice, such adjustment shall be conclusive and binding for all purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">14.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendments and Termination</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment and Termination of the Plan</i>. The Board may amend, alter, suspend, discontinue, or terminate the Plan or any portion thereof at any time; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that (i) no amendment to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 14(b)</span> (to the extent required by the proviso in such <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 14(b))</span> shall be made without stockholder approval and (ii) no such amendment, alteration, suspension, discontinuation or termination shall be made without stockholder approval if such approval is necessary to comply with any tax or regulatory requirement applicable to the Plan (including, without limitation, as necessary to comply with any rules or requirements of any securities exchange or inter-dealer quotation system on which the Common Shares may be listed or quoted); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">further</span>, that any such amendment, alteration, suspension, discontinuance or termination that would materially and adversely affect the rights of any Participant or any holder or beneficiary of any Award theretofore granted shall not to that extent be effective without the consent of the affected Participant, holder or beneficiary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment of Award Agreements</i>. The Committee may, to the extent consistent with the terms of any applicable Award Agreement, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any Award theretofore granted or the associated Award Agreement, prospectively or retroactively; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would materially and adversely affect the rights of any Participant with respect to any Award theretofore granted shall not to that extent be effective without the consent of the affected Participant; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">further</span>, that without stockholder approval, except as otherwise permitted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> of the Plan, (i) no amendment or modification may reduce the Exercise Price of any Option or the Strike Price of any SAR, (ii) the Committee may not cancel any outstanding Option or SAR where the Fair Market Value of the Common Shares underlying such Option or SAR is less than its Exercise Price and replace it with a new Option or SAR, another Award or cash and (iii) the Committee may not take any other action that is considered a &#8220;repricing&#8221; for purposes of the stockholder approval rules of the applicable securities exchange or inter-dealer quotation system on which the Common Shares are listed or quoted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">15.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Award Agreements</i>. Each Award under the Plan shall be evidenced by an Award Agreement, which shall be delivered to the Participant (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)) and shall specify the terms and conditions of the Award and any rules applicable thereto, including without limitation, the effect on such Award of the death, disability or termination of employment or service of a Participant, or of such other events as may be determined by the Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nontransferability</i><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Each Award shall be exercisable only by a Participant during the Participant&#8217;s lifetime, or, if permissible under applicable law, by the Participant&#8217;s legal guardian or representative. No Award may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a Participant other than by will or by the laws of descent and distribution and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or an Affiliate; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Notwithstanding the foregoing, the Committee may, in its sole discretion, permit Awards (other than Incentive Stock Options) to be transferred by a Participant, without consideration, subject to such rules as the Committee may adopt consistent with any applicable Award Agreement to preserve the purposes of the Plan, to: (A) any person who is a &#8220;family member&#8221; of the Participant, as such term is used in the instructions to Form S-8 under the Securities Act (collectively, the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Immediate Family</span> <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Members</span>&#8221;); (B) a trust solely for the benefit of the Participant and his or her Immediate Family Members; (C) a partnership or limited liability company whose only partners or stockholders are the Participant and his or her Immediate Family Members; or (D) any other transferee as may be approved either (I) by the Board or the Committee in its sole discretion, or (II) as provided in the applicable Award Agreement (each transferee described in clauses (A), (B), (C) and (D) above is hereinafter referred to as a &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Permitted Transferee</span>&#8221;); <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that the Participant gives the Committee advance written notice describing the terms and conditions of the proposed transfer and the Committee notifies the Participant in writing that such a transfer would comply with the requirements of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>The terms of any Award transferred in accordance with the immediately preceding sentence shall apply to the Permitted Transferee and any reference in the Plan, or in any applicable Award Agreement, to a Participant shall be deemed to refer to the Permitted Transferee, except that (A) Permitted Transferees shall not be entitled to transfer any Award, other than by will or the laws of descent and distribution; (B) Permitted Transferees shall not be entitled to exercise any transferred Option unless there shall be in effect a registration statement on an appropriate form covering the Common Shares to be acquired pursuant to the exercise of such Option if the Committee determines, consistent with any applicable Award Agreement, that such a registration statement is necessary or appropriate; (C) the Committee or the Company shall not be required to provide any notice to a Permitted Transferee, whether or not such notice is or would otherwise have been required to be given to the Participant under the Plan or otherwise; and (D) the consequences of the termination of the Participant&#8217;s employment by, or services to, the Company or an Affiliate under the terms of the Plan and the applicable Award Agreement shall continue to be applied with respect to the Participant, including, without limitation, that an Option shall be exercisable by the Permitted Transferee only to the extent, and for the periods, specified in the Plan and the applicable Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Tax Withholding and Deductions</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>A Participant shall be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right and is hereby authorized to deduct and withhold, from any cash, Common Shares, other securities or other property deliverable under any Award or from any compensation or other amounts owing to a Participant, the amount (in cash, Common Shares, other securities or other property) of any required taxes (up to the maximum statutory rate under applicable law as in effect from time to time as determined by the Committee) and deduction in respect of an Award, its grant, vesting or exercise, or any payment or transfer under an Award or under the Plan and to take such other action as may be necessary in the opinion of the Committee or the Company to satisfy all obligations for the payment of such taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Without limiting the generality of clause (i) above, the Committee may, in its sole discretion, determined on a case by case basis, permit a Participant to satisfy, in whole or in part, the foregoing tax and deduction liability by (A) the delivery of Common Shares (which are not subject to any pledge or other security interest and are Mature Shares, except as otherwise determined by the Committee) owned by the Participant having a fair market value equal to such liability or (B) having the Company withhold from the number of Common Shares otherwise issuable or deliverable pursuant to the exercise or settlement of the Award a number of shares with a fair market value equal to such liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Claim to Awards; No Rights to Continued Employment; Waiver</i>. No employee of the Company or an Affiliate, or other person, shall have any claim or right to be granted an Award under the Plan or, having been selected for the grant of an Award, to be selected for a grant of any other Award. There is no obligation for uniformity of treatment of Participants or holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee&#8217;s determinations and interpretations with respect thereto need not be the same with respect to each Participant and may be made selectively among Participants, whether or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.1pt 18pt;">not such Participants are similarly situated. Neither the Plan nor any action taken hereunder shall be construed as giving any Participant any right to be retained in the employ or service of the Company or an Affiliate, nor shall it be construed as giving any Participant any rights to continued service on the Board. The Company or any of its Affiliates may at any time dismiss a Participant from employment or discontinue any consulting relationship, free from any liability or any claim under the Plan, unless otherwise expressly provided in the Plan or any Award Agreement. By accepting an Award under the Plan, a Participant shall thereby be deemed to have waived any claim to continued exercise or vesting of an Award or to damages or severance entitlement related to non-continuation of the Award beyond the period provided under the Plan or any Award Agreement, notwithstanding any provision to the contrary in any written employment contract or other agreement between the Company and its Affiliates and the Participant, whether any such agreement is executed before, on or after the Date of Grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Addenda/International Participants</i>. The Committee may adopt such addenda to the Plan as it may consider necessary or appropriate for the purpose of granting Awards, which Awards may contain such terms and conditions as the Committee deems necessary or appropriate to accommodate differences in local law, tax policy or custom, which may deviate from the terms and conditions set forth in this Plan The terms of any such addenda shall supersede the terms of the Plan to the extent necessary to accommodate such differences but shall not otherwise affect the terms of the Plan as in effect for any other purpose. With respect to Participants who reside or work outside of the United States of America, the Committee may in its sole discretion amend the terms of the Plan or outstanding Awards with respect to such Participants in order to conform such terms with the requirements of local law or to obtain more favorable tax or other treatment for a Participant, the Company or its Affiliates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Designation and Change of Beneficiary</i>. Each Participant may file with the Committee a written designation of one or more persons as the beneficiary(ies) who shall be entitled to receive the amounts payable with respect to an Award, if any, due under the Plan upon his death. A Participant may, from time to time, revoke or change his beneficiary designation without the consent of any prior beneficiary by filing a new designation with the Committee. The last such designation received by the Committee shall be controlling; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that no designation, or change or revocation thereof, shall be effective unless received by the Committee prior to the Participant&#8217;s death, and in no event shall it be effective as of a date prior to such receipt. If no beneficiary designation is filed by a Participant, the beneficiary shall be deemed to be his or her spouse or, if the Participant is unmarried at the time of death, his or her estate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination of Employment/Service</i>. Unless determined otherwise by the Committee at any point following such event: (i) neither a temporary absence from employment or service due to illness, vacation or leave of absence nor a transfer from employment or service with the Company to employment or service with an Affiliate (or vice-versa) shall be considered a termination of employment or service with the Company or an Affiliate; and (ii) if a Participant&#8217;s employment with the Company and its Affiliates terminates, but such Participant continues to provide services to the Company and its Affiliates in a non-employee capacity (or vice-versa), such change in status shall not be considered a termination of employment with the Company or an Affiliate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.15pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Leaves of Absence/Transfer Between Locations</i>. The Committee shall have the discretion to determine at any time whether and to what extent the vesting of Awards shall be suspended during any leave of absence; provided, however, that in the absence of such determination, vesting of Awards shall continue during any paid leave and during any unpaid leave (unless otherwise required by applicable Laws). A Participant will not cease to be an Employee in the case of (a) any leave of absence approved by the Participant&#8217;s employer or (b) transfers between locations of the Company or between the Company or any Subsidiary. If an Employee is holding an Incentive Stock Option and such leave exceeds three (3) months then, for purposes of Incentive Stock Option status only, such Employee&#8217;s service as an Employee shall be deemed terminated on the first (1st) day following such three (3) month period and the Incentive Stock Option shall thereafter automatically treated for tax purposes as a Nonstatutory Stock Option in accordance with applicable laws, unless reemployment upon the expiration of such leave is guaranteed by contract or statute, or unless provided otherwise pursuant to a written Company policy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Rights as a Stockholder</i>. Except as otherwise specifically provided in the Plan or any Award Agreement, no person shall be entitled to the privileges of ownership in respect of Common Shares or other securities that are subject to Awards hereunder until such shares have been issued or delivered to that person<i style="font-style:italic;">.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Government and Other Re</i><i style="font-style:italic;">g</i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ulations</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>The obligation of the Company to settle Awards in Common Shares or other consideration shall be subject to all applicable laws, rules, and regulations, and to such approvals by governmental agencies as may be required. Notwithstanding any terms or conditions of any Award to the contrary, the Company shall be under no obligation to offer to sell or to sell, and shall be prohibited from offering to sell or selling, any Common Shares or other securities pursuant to an Award unless such </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.15pt 36pt;">shares have been properly registered for sale pursuant to the Securities Act with the Securities and Exchange Commission or unless the Company has received an opinion of counsel, satisfactory to the Company, that such shares may be offered or sold without such registration pursuant to an available exemption therefrom and the terms and conditions of such exemption have been fully complied with. The Company shall be under no obligation to register for sale under the Securities Act any of the Common Shares or other securities to be offered or sold under the Plan. The Committee shall have the authority to provide that all certificates for Common Shares or other securities of the Company or any Affiliate delivered under the Plan shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan, the applicable Award Agreement, the federal securities laws, or the rules, regulations and other requirements of the Securities and Exchange Commission, any securities exchange or inter-dealer quotation system upon which such shares or other securities are then listed or quoted and any other applicable federal, state, local or non-U.S. laws, and, without limiting the generality of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span> of the Plan, the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. Notwithstanding any provision in the Plan to the contrary, the Committee reserves the right to add any additional terms or provisions to any Award granted under the Plan that it in its sole discretion deems necessary or advisable in order that such Award complies with the legal requirements of any governmental entity to whose jurisdiction the Award is subject.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>The Committee may cancel an Award or any portion thereof if it determines, in its sole discretion, that legal or contractual restrictions and/or blockage and/or other market considerations would make the Company&#8217;s acquisition of Common Shares from the public markets, the Company&#8217;s issuance of Common Shares or other securities to the Participant, the Participant&#8217;s acquisition of Common Shares or other securities from the Company and/or the Participant&#8217;s sale of Common Shares to the public markets, illegal, impracticable or inadvisable. If the Committee determines to cancel all or any portion of an Award denominated in Common Shares in accordance with the foregoing, the Company shall pay to the Participant an amount equal to the excess of (A) the aggregate fair market value of the Common Shares subject to such Award or portion thereof canceled (determined as of the applicable exercise date, or the date that the shares would have been vested or delivered, as applicable), over (B) the aggregate Exercise Price or Strike Price (in the case of an Option or SAR, respectively) or any amount payable as a condition of delivery of Common Shares (in the case of any other Award). Such amount shall be delivered to the Participant as soon as practicable following the cancellation of such Award or portion thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payments to Persons Other Than Participants</i>. If the Committee shall find that any person to whom any amount is payable under the Plan is unable to care for his affairs because of illness or accident, or is a minor, or has died, then any payment due to such person or his estate (unless a prior claim therefor has been made by a duly appointed legal representative) may, if the Committee so directs the Company, be paid to his spouse, child, relative, an institution maintaining or having custody of such person, or any other person deemed by the Committee to be a proper recipient on behalf of such person otherwise entitled to payment. Any such payment shall be a complete discharge of the liability of the Committee and the Company therefor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(l)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nonexclusivity of the Plan</i>. Neither the adoption of this Plan by the Board nor the submission of this Plan to the stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of stock options or other equity-based awards otherwise than under this Plan, and such arrangements may be either applicable generally or only in specific cases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(m)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Trust or Fund Created</i>. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate, on the one hand, and a Participant or other person or entity, on the other hand. No provision of the Plan or any Award shall require the Company, for the purpose of satisfying any obligations under the Plan, to purchase assets or place any assets in a trust or other entity to which contributions are made or otherwise to segregate any assets, nor shall the Company maintain separate bank accounts, books, records or other evidence of the existence of a segregated or separately maintained or administered fund for such purposes. Participants shall have no rights under the Plan other than as unsecured general creditors of the Company, except that insofar as they may have become entitled to payment of additional compensation by performance of services, they shall have the same rights as other employees under general law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(n)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reliance on Reports</i>. Each member of the Committee and each member of the Board shall be fully justified in acting or failing to act, as the case may be, and shall not be liable for having so acted or failed to act in good faith, in reliance upon any report made by the independent public accountant of the Company and its Affiliates and/or any other information furnished in connection with the Plan by any agent of the Company or the Committee or the Board, other than himself.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(o)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Relationship to Other Benefits</i>. No payment under the Plan shall be taken into account in determining any benefits under any pension, retirement, profit sharing, group insurance or other benefit plan of the Company except as otherwise specifically provided in such other plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(p)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law</i>. The Plan shall be governed by and construed in accordance with the internal laws of the State of Delaware applicable to contracts made and performed wholly within the State of Delaware, without giving effect to the conflict of laws provisions thereof. Each party hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the state and federal courts seated in Wilmington, Delaware (and any appellate courts thereof) in any action or proceeding arising out of or relating to this Plan, and each of the parties hereby irrevocably and unconditionally (a) agrees not to commence any such action or proceeding except in such courts, (b) agrees that any claim in respect of any such action or proceeding may be heard and determined in such court, (c) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such action or proceeding in any such court, and (d) waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. Each party agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Each party hereby knowingly, voluntarily and intentionally irrevocably waives the right to a trial by jury in respect to any litigation, dispute, claim, legal action or other legal proceeding based hereon, or arising out of, under, or in connection with, this Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(q)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</i>. If any provision of the Plan or any Award or Award Agreement is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any person or entity or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to the applicable laws, or if it cannot be construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be construed or deemed stricken as to such jurisdiction, person or entity or Award and the remainder of the Plan and any such Award shall remain in full force and effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(r)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Obligations Binding on Successors</i>. The obligations of the Company under the Plan shall be binding upon any successor corporation or organization resulting from the merger, amalgamation, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(s)</span></span><i style="font-style:italic;">Status under ERISA. </i>It is the intent of the Company that the Plan shall not constitute an &#8220;employee benefit plan&#8221; for purposes of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(t)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Code Section 409A</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Notwithstanding any provision of this Plan to the contrary, all Awards made under this Plan are intended to be exempt from or, in the alternative, comply with Code Section 409A and the interpretive guidance thereunder, including the exceptions for stock rights and short-term deferrals. The Plan shall be construed and interpreted in accordance with such intent. Each payment under an Award shall be treated as a separate payment for purposes of Code Section 409A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>If a Participant is a &#8220;specified employee&#8221; (as such term is defined for purposes of Code Section 409A) at the time of his or her termination of service, no amount that is nonqualified deferred compensation subject to Code Section 409A and that becomes payable by reason of such termination of service shall be paid to the Participant (or in the event of the Participant&#8217;s death, the Participant&#8217;s representative or estate) before the earlier of (x) the first business day after the date that is six months following the date of the Participant&#8217;s termination of service, and (y) within 30 days following the date of the Participant&#8217;s death. For purposes of Code Section 409A, a termination of service shall be deemed to occur only if it is a &#8220;separation from service&#8221; within the meaning of Code Section 409A, and references in the Plan and any Award Agreement to &#8220;termination of service&#8221; or similar terms shall mean a &#8220;separation from service.&#8221; If any Award is or becomes subject to Code Section 409A, unless the applicable Award Agreement provides otherwise, such Award shall be payable upon the Participant&#8217;s &#8220;separation from service&#8221; within the meaning of Code Section 409A. If any Award is or becomes subject to Code Section 409A and if payment of such Award would be accelerated or otherwise triggered under a Change in Control, then the definition of Change in Control shall be deemed modified, only to the extent necessary to avoid the imposition of an excise tax under Code Section 409A, to mean a &#8220;change in control event&#8221; as such term is defined for purposes of Code Section 409A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>Any adjustments made pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> to Awards that are subject to Code Section 409A shall be made in compliance with the requirements of Code Section 409A, and any adjustments made pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> to Awards that </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">are not subject to Code Section 409A shall be made in such a manner as to ensure that after such adjustment, the Awards either (x) continue not to be subject to Code Section 409A or (y) comply with the requirements of Code Section 409A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(u)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Expenses; Gender; Titles and Headings</i>. The expenses of administering the Plan shall be borne by the Company and its Affiliates. Masculine pronouns and other words of masculine gender shall refer to both men and women. The titles and headings of the sections in the Plan are for convenience of reference only, and in the event of any conflict, the text of the Plan, rather than such titles or headings shall control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Agreements</i>. Notwithstanding the above, the Committee may require, as a condition to the grant of and/or the receipt of Common Shares or other securities under an Award, that the Participant execute lock-up, stockholder or other agreements, as it may determine in its sole and absolute discretion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(w)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payments</i><i style="font-style:italic;">. </i>Participants shall be required to pay, to the extent required by applicable law, any amounts required to receive Common Shares or other securities under any Award made under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(x)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Erroneously Awarded Compensation</i>. All Awards shall be subject (including on a retroactive basis) to (i) any clawback, forfeiture or similar incentive compensation recoupment policy established from time to time by the Company, including, without limitation, any such policy established to comply with the Dodd-Frank Wall Street Reform and Consumer Protection Act, (ii) applicable law (including, without limitation, Section 304 of the Sarbanes-Oxley Act and Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act), and/or (iii) the rules and regulations of the applicable securities exchange or inter-dealer quotation system on which the Common Shares or other securities are listed or quoted, and such requirements shall be deemed incorporated by reference into all outstanding Award Agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(y)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investment Representations</i>. As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(z)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Corporate Records Control</i>. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">[Signature page follows]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_2e1e4fa5_3ff3_4470_9571_a3e77d8697d9"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, this Data Knights Acquisition Corp.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5</sup> 2022 Equity Incentive Plan has been duly approved and adopted by the Company and the stockholders as of the dates set forth below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Adopted by consent of the Board: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022 </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Stockholder Approved:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022 </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">6</sup></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:45.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:45.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Date:</p></td><td style="vertical-align:bottom;width:45.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">[Signature page to Data Knights Acquisition Corp. 2022 Equity Incentive Plan]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:5.8pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5</sup></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Company name to be changed to OneMedNet Corporation upon stockholder approval.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:5.8pt;text-indent:-5.8pt;margin:0pt 0pt 0pt 7.59pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 8pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_665a71f2_0c35_470c_aa33_595440159ab5"></a><a id="_Hlk114354792"></a><a id="ExhibitG_395489"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.44pt 0pt;"><i style="font-style:italic;">Exhibit G</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">REGISTRATION RIGHTS AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">THIS REGISTRATION RIGHTS AGREEMENT </b>(this &#8220;<span style="font-style:italic;font-weight:bold;">Agreement</span>&#8221;) is made and entered into as of [<span style="font-family:'Symbol';">&#183;</span>], 2022 (the &#8220;<span style="font-style:italic;font-weight:bold;">Effective Date</span>&#8221;) by and among (i) Data Knights Acquisition Corp., a Delaware corporation (including its successors, the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser</span>&#8221;), and (ii) and the undersigned parties listed on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</span> hereto (each such party, together with any person or entity who hereafter becomes a party to this Agreement pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 6.2</span> of this Agreement, a &#8220;<span style="font-style:italic;font-weight:bold;">Holder</span>&#8221; and collectively the &#8220;<span style="font-style:italic;font-weight:bold;">Holders</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">WHEREAS</b>, on April 25, 2022, Purchaser, Data Knights Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Purchaser (&#8220;<span style="font-style:italic;font-weight:bold;">Merger Sub</span>&#8221;), Data Knights, LLC, a Delaware limited liability company (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Representative</span>&#8221;), Paul Casey (the &#8220;<span style="font-style:italic;font-weight:bold;">Seller Representative</span>&#8221;), and (v) OneMedNet Corporation, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;), entered into that certain Agreement and Plan of Merger (as amended from time to time in accordance with the terms thereof, the &#8220;<span style="font-style:italic;font-weight:bold;">Merger Agreement</span>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">WHEREAS</b>, pursuant to the Merger Agreement, subject to the terms and conditions thereof, upon the consummation of the transactions contemplated thereby (the &#8220;<span style="font-style:italic;font-weight:bold;">Closing</span>&#8221;), among other matters, Merger Sub will merge with and into the Company, with the Company continuing as the surviving entity and a wholly-owned subsidiary of the Purchaser, and with the Holders, as stockholders of the Purchaser, receiving shares of the Purchaser&#8217;s Class A common stock (the &#8220;<span style="font-style:italic;font-weight:bold;">Merger Shares</span>&#8221;), all upon the terms and subject to the conditions set forth in the Merger Agreement and in accordance with the provisions of applicable law;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">WHEREAS</b>, the Company is a party to that certain Investors&#8217; Rights Agreement dated as of December 31, 2009, entered into with certain investors listed therein (the &#8220;<span style="font-style:italic;font-weight:bold;">Company Investors</span>&#8221;) holding shares of Company capital stock to be exchanged into shares of Purchaser&#8217;s Class A common stock in the Merger (the &#8220;<span style="font-style:italic;font-weight:bold;">Prior Agreement</span>&#8221;), and that certain Founders Registration Rights Agreement with the Founders with regard to the Founder Securities (each as such term is defined below) (together with the Prior Agreement, the &#8220;<span style="font-style:italic;font-weight:bold;">Existing Agreements</span>&#8221;); and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">WHEREAS</b>, the parties desire to enter into this Agreement, and terminate the Existing Agreements, to provide the Holders and Founders with certain rights relating to the registration of the Merger Shares and Founder Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">NOW, THEREFORE</b>, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="color:#010000;">1.</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">DEFINITIONS</span>. The following capitalized terms used herein have the following meanings:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Affiliate</b>&#8221; means, with respect to any specified Person, any Person that, directly or indirectly through one or more entities, controls or is controlled by, or is under common control with, such specified Person. The term &#8220;control&#8221; (including the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by Contract or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">A</b><b style="font-weight:bold;">g</b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">reement</b>&#8221; means this Agreement, as amended, restated, supplemented, or otherwise modified from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Business Combination</b>&#8221; means the acquisition of direct or indirect ownership through a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar type of transaction, of one or more businesses or entities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Commission</b>&#8221; means the Securities and Exchange Commission, or any other Federal agency then administering the Securities Act or the Exchange</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Common Stock</b>&#8221; means the Class A common stock, par value $0.000001 per share, of the Purchaser and the Class B common stock, par value $0.000001 per share of the Purchaser, along with any equity securities paid as dividends or distributions after the Closing with respect to such shares or into which such shares are exchanged or converted after the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</b>&#8221; is defined in the preamble to this Agreement. &#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Demand Registration</b>&#8221; is defined in Section 2.2.1. &#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Demanding Holder</b>&#8221; is defined in Section 2.2.1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effectiveness Date</b><b style="font-weight:bold;">&#8221; </b>means, with respect to the Initial Registration Statement, the 90th calendar day following the Filing Date (or in the event the Registration Statement receives a &#8220;full review&#8221; by the Commission, the 120th day following the Filing Date) and with respect to any additional Registration Statements which may be required pursuant to Sections 2.2 and 2.3, the 90th calendar day </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">following the date on which an additional Registration Statement is required to be filed hereunder; provided, however, that in the event the Purchaser is notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Business Day following the date on which the Purchaser is so notified if such date precedes the dates otherwise required above; provided, further, that, if the Effectiveness Date falls on a Saturday, Sunday or any other day which shall be a legal holiday or a day on which the Commission is authorized or required by law or other government actions to close, the Effectiveness Date shall be the following Business Day.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effectiveness Period</b>&#8221; shall have the meaning set forth in Section 2.1.1</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Act</b>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder, all as the same shall be in effect at the time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Filing Date</b>&#8221; means, with respect to the Initial Registration Statement required hereunder, the 30th calendar day following the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Sections 2.2 and 2.3, the earliest practical date on which the Purchaser is permitted by Commission Guidance to file such additional Registration Statement related to the Registrable Securities; provided, however, that, if the Filing Date falls on a Saturday, Sunday or any other day which shall be a legal holiday or a day on which the Commission is authorized or required by law or other government actions to close, the Filing Date shall be the following Business Day.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Form S-3</b>&#8221; is defined in Section 2.4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Founder Registration Rights Agreement</b>&#8221; means that certain Registration Rights Agreement, dated as of May 6, 2021, by and among Purchaser, Data Knights, LLC and certain directors of Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Founder Securities</b>&#8221; means all shares of Common Stock, and all securities convertible into or exercisable for shares of Common Stock, held by the Founders as of the Effective Date of this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Founders</b>&#8221; means Data Knights, LLC, Barry Anderson, Firdauz Edmin Bin Mokhtar, Syed Musheer Ahmed, Julianne Huh and Annie Damit Undikai, and any successors in interest thereto with respect to any Founder Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Holder</b>&#8221; is defined in the preamble to this Agreement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnified Party</b>&#8221; is defined in Section 4.3. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnifying Party</b>&#8221; is defined in Section 4.3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Initial Registration Statement</b>&#8221; means the Registration Statement required to be filed pursuant to Section 2.1. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Holder Indemnified Party</b>&#8221; is defined in Section 4.1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Maximum Number of Shares</b>&#8221; is defined in Section 2.2.4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger Shares</b>&#8221; means the shares of Common Stock of the Purchaser issued or issuable to the Holders pursuant to the terms of the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</b>&#8221; is defined in Section 6.3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Piggy-Back Registration</b>&#8221; is defined in Section 2.3.1. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Pro Rata</b>&#8221; is defined in Section 2.2.4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchaser</b>&#8221; is defined in the preamble to this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Register</b>,&#8221; &#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registered</b>&#8221; and &#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration</b>&#8221; mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registrable Securities</b>&#8221; means (i) the Shares and any shares of Common Stock held by the Holders and Founders immediately following the closing of the Business Combination, and (ii) any warrants, shares of capital stock or other securities of the Purchaser acquired by a Holder or Founder after the Closing, or issued as a dividend or other distribution with respect to or in exchange for or in replacement of such Shares. As to any particular Registrable Securities, such securities shall cease to be Registrable Securities when: (a) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (b) such securities shall have been otherwise transferred, new certificates for them not bearing a legend restricting further transfer shall have been delivered by the Purchaser and subsequent public distribution of them shall not require registration under the Securities Act; (c) such securities shall have ceased to be outstanding; or (d) the Registrable Securities are freely saleable under Rule 144 without volume limitations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Statement</b>&#8221; means a registration statement filed by the Purchaser with the Commission in compliance with the Securities Act and the rules and regulations promulgated thereunder for a public offering and sale of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities (other than a registration statement on Form S-4 or Form S-8, or their successors, or any registration statement covering only securities proposed to be issued in exchange for securities or assets of another entity).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Securities Act</b>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder, all as the same shall be in effect at the time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Shares</b>&#8221; means the Merger Shares and the Founder Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">&#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Underwriter</b>&#8221; means, solely for the purposes of this Agreement, a securities dealer who purchases any Registrable Securities as principal in an underwritten offering and not as part of such dealer&#8217;s market-making activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">REGISTRATION RIGHTS</span>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Shelf Registration.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.1.1</span></span>On or prior to each Filing Date, the Purchaser shall prepare and file with the Commission a Registration Statement covering the resale of all or such maximum portion of the Registrable Securities as permitted by SEC Guidance (provided that, the Purchaser shall use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, the Manual of Publicly Available Telephone Interpretations D.29) that are not then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-1 (except if the Purchaser is then eligible to register for resale the Registrable Securities on Form S-3, such registration shall be on Form S-3 in accordance herewith). Subject to the terms of this Agreement, the Purchaser shall use its commercially reasonable efforts to cause a Registration Statement to be declared effective under the Securities Act as promptly as practicable after the filing thereof, but in any event prior to the applicable Effectiveness Date, and shall use its commercially reasonable efforts to keep such Registration Statement continuously effective under the Securities Act until all Registrable Securities covered by such Registration Statement have been sold, or may be sold without volume or manner-of-sale restrictions pursuant to Rule 144, without the requirement for the Purchaser to be in compliance with the current public information requirement under Rule 144, as determined by the counsel to the Purchaser pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &#8220;<span style="font-style:italic;font-weight:bold;">Effectiveness Period</span>&#8221;). The Purchaser shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. New York City time on a Business Day. The Purchaser shall promptly notify the Holders by e-mail of the effectiveness of a Registration Statement on the same Business Day that the Purchaser telephonically confirms effectiveness with the Commission. The Purchaser shall, no later than the second Business Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.1.2</span></span>Notwithstanding any other provision of this Agreement, if any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement (and notwithstanding that the Purchaser used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), the number of Registrable Securities to be registered shall be reduced on a on a pro rata basis based on the total number of Registrable Securities held by such Holders (such proportion is referred to herein as &#8220;<span style="font-style:italic;font-weight:bold;">Pro Rata</span>&#8221;). In the event of a reduction hereunder, the Purchaser shall give the Holder and Founders, as applicable, at least five (5) Business Days prior written notice along with the calculations as to such Holder&#8217;s or Founder&#8217;s allotment. Promptly after such SEC Guidance is no longer applicable </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">with respect to some or all of the remaining unregistered Registrable Securities, the Purchaser shall file an additional Registration Statement in accordance with this Section 2 to with respect to such shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.1.3</span></span>Each Holder agrees to furnish to the Purchaser a completed Selling Stockholder Questionnaire within five (5) Business Days following the date of this Agreement. Each Holder further acknowledges and agrees that it shall not be entitled to be named as a selling security holder in the Registration Statement or use the Prospectus for offers and resales of Registrable Securities at any time unless such Holder has returned to the Purchaser a completed and signed Selling Stockholder Questionnaire. If a Holder of Registrable Securities returns a Selling Stockholder Questionnaire after the deadline specified in the previous sentence, the Purchaser shall use its commercially reasonable efforts to take such actions as are required to name such Holder as a selling security holder in the Registration Statement or any pre-effective or post-effective amendment thereto and to include (to the extent not theretofore included) in the Registration Statement the Registrable Securities identified in such late Selling Stockholder Questionnaire; provided that the Purchaser shall not be required to file an additional Registration Statement solely for such shares. Each Holder acknowledges and agrees that the information in the Selling Stockholder Questionnaire will be used by the Purchaser in the preparation of the Registration Statement and hereby consents to the inclusion of such information in the Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Demand Registration</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.2.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Request for Registration</span>. At any time and from time to time on or after the date of this Agreement, the Holders of twenty-five percent (25%) of the Registrable Securities may make a written demand for registration under the Securities Act of all or part of their Registrable Securities, as the case may be (a &#8220;<span style="font-style:italic;font-weight:bold;">Demand Registration</span>&#8221;). Any demand for a Demand Registration shall specify the number of shares of Registrable Securities proposed to be sold and the intended method(s) of distribution thereof. The Purchaser will within twenty (20) days of the Purchaser&#8217;s receipt of the Demand Registration notify all holders of Registrable Securities of the demand, and each holder of Registrable Securities who wishes to include all or a portion of such holder&#8217;s Registrable Securities in the Demand Registration (each such holder including shares of Registrable Securities in such registration, a &#8220;<span style="font-style:italic;font-weight:bold;">Demanding Holder</span>&#8221;) shall so notify the Purchaser within ten (10) days after the receipt by the holder of the notice from the Purchaser. Upon any such request, the Demanding Holders shall be entitled to have their Registrable Securities included in the Demand Registration, subject to Section 2.1.4 and the provisos set forth in Section 3.1.1. The Purchaser shall not be obligated to effect no more than an aggregate of three (3) Demand Registrations under this Section 2.1.1 in respect of all Registrable Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.2.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effective Registration</span>. A registration will not count as a Demand Registration until the Registration Statement filed with the Commission with respect to such Demand Registration has been declared effective and the Purchaser has complied with all of its obligations under this Agreement with respect thereto; provided, however, that if, after such Registration Statement has been declared effective, the offering of Registrable Securities pursuant to a Demand Registration is interfered with by any stop order or injunction of the Commission or any other governmental agency or court, the Registration Statement with respect to such Demand Registration will be deemed not to have been declared effective, unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of the Demanding Holders thereafter elect to continue the offering; provided, further, that the Purchaser shall not be obligated to file a second Registration Statement until a Registration Statement that has been filed is counted as a Demand Registration or is terminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.2.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Underwritten Offering</span>. If a majority-in-interest of the Demanding Holders so elect and such holders so advise the Purchaser as part of their written demand for a Demand Registration, the offering of such Registrable Securities pursuant to such Demand Registration shall be in the form of an underwritten offering; provided that the total offering price is reasonably expected to exceed, in the aggregate, $50 million. In such event, the right of any holder to include its Registrable Securities in such registration shall be conditioned upon such holder&#8217;s participation in such underwriting and the inclusion of such holder&#8217;s Registrable Securities in the underwriting to the extent provided herein. All Demanding Holders proposing to distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the Underwriter or Underwriters selected for such underwriting by a majority-in-interest of the holders initiating the Demand Registration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.2.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reduction of Offering</span>. If the managing Underwriter or Underwriters for a Demand Registration that is to be an underwritten offering, in good faith, advises the Purchaser and the Demanding Holders in writing that the dollar amount or number of shares of Registrable Securities which the Demanding Holders desire to sell, taken together with all other shares of Common Stock or other securities which the Purchaser desires to sell and the shares of Common Stock, if any, as to which registration has been requested pursuant to written contractual piggy-back registration rights held by other shareholders of the Purchaser who desire to sell, exceeds the maximum dollar amount or maximum number of shares that can be sold in such offering </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of shares, as applicable, the &#8220;<span style="font-style:italic;font-weight:bold;">Maximum Number of Shares</span>&#8221; ), then the Purchaser shall include in such registration: (i) first, the Registrable Securities as to which Demand Registration has been requested by the Demanding Holders (Pro Rata in accordance with the number of shares that each such Person has requested be included in such registration, regardless of the number of shares held by each such Person) that can be sold without exceeding the Maximum Number of Shares; (ii) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (i), the Registrable Securities of Holders exercising their rights to register their Registrable Securities that can be sold without exceeding the Maximum Number of Shares; and (iii) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (i) and (ii), shares of Common Stock or other securities that the Purchaser desires to sell that can be sold without exceeding the Maximum Number of Shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.2.5</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Withdrawal</span>. If, prior to filing of the applicable &#8220;red herring prospectus&#8221; or prospectus supplement used for marketing such registration, a majority-in-interest of the Demanding Holders disapprove of the terms of any underwriting or are not entitled to include all of their Registrable Securities in any offering, such majority-in-interest of the Demanding Holders may elect to withdraw from such offering by giving written notice to the Purchaser and the Underwriter or Underwriters of their request to withdraw prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Demand Registration. If the majority-in-interest of the Demanding Holders withdraws from a proposed offering relating to a Demand Registration, then such registration shall not count as a Demand Registration provided for in Section 2.1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Piggy-Back Registration</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.3.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Piggy-Back Rights</span>. If at any time on or after the date of this Agreement the Purchaser proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities, by the Purchaser for its own account or for shareholders of the Purchaser for their account (or by the Purchaser and by shareholders of the Purchaser including, without limitation, pursuant to Section 2.1), other than a Registration Statement (i) filed in connection with any employee stock option or other benefit plan, (ii) for an exchange offer or offering of securities solely to the Purchaser&#8217;s existing shareholders, (iii) for an offering of debt that is convertible into equity securities of the Purchaser or (iv) for a dividend reinvestment plan, then the Purchaser shall (x) give written notice of such proposed filing to the holders of Registrable Securities as soon as practicable but in no event less than twenty (20) days before the anticipated filing date, which notice shall describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, of the offering, and (y) offer to the holders of Registrable Securities in such notice the opportunity to register the sale of such number of shares of Registrable Securities as such holders may request in writing within ten (10) days following receipt of such notice (a &#8220;<span style="font-style:italic;font-weight:bold;">Piggy-Back Registration</span>&#8221; ). The Purchaser shall, in good faith, cause such Registrable Securities to be included in such registration and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed underwritten offering to permit the Registrable Securities requested to be included in a Piggy-Back Registration on the same terms and conditions as any similar securities of the Purchaser and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All holders of Registrable Securities proposing to distribute their securities through a Piggy-Back Registration that involves an Underwriter or Underwriters shall enter into an underwriting agreement in customary form with the Underwriter or Underwriters selected for such Piggy-Back Registration. Notwithstanding the provisions set forth in the immediately preceding sentences, the right to a Piggy-Back Registration set forth under this Section 2.2.1 with respect to the Registrable Securities shall terminate on the seventh anniversary of the Effective Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.3.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reduction of Offering</span>. If the managing Underwriter or Underwriters for a Piggy-Back Registration that is to be an underwritten offering advises the Purchaser and the holders of Registrable Securities in writing that the dollar amount or number of shares of Common Stock which the Purchaser desires to sell, taken together with the shares of Common Stock, if any, as to which registration has been demanded pursuant to written contractual arrangements with persons other than the holders of Registrable Securities hereunder, the Registrable Securities as to which registration has been requested under this Section 2.2, and the shares of Common Stock, if any, as to which registration has been requested pursuant to the terms hereof exceeds the Maximum Number of Shares, then the Purchaser shall include in any such registration:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a)</span></span>If the registration is undertaken for the Purchaser&#8217;s account: (A) first, the shares of Common Stock or other securities that the Purchaser desires to sell that can be sold without exceeding the Maximum Number of Shares; and (B) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (A), the shares of Common Stock or other securities, if any, comprised of Registrable Securities as to which registration has been requested pursuant to the terms hereof, Pro Rata, that can be sold without exceeding the Maximum Number of Shares; and (C) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A) and (B), the shares of </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">Common Stock or other securities for the account of other persons that the Purchaser is obligated to register pursuant to written contractual piggy-back registration rights with such persons and that can be sold without exceeding the Maximum Number of Shares;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">b)</span></span>If the registration is a &#8220;demand&#8221; registration undertaken at the demand of persons other than the holders of Registrable Securities, (A) first, the shares of Common Stock or other securities for the account of the demanding persons that can be sold without exceeding the Maximum Number of Shares; (B) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (A), the shares of Common Stock or other securities comprised of Registrable Securities, Pro Rata, as to which registration has been requested pursuant to the terms hereof, that can be sold without exceeding the Maximum Number of Shares; and (C) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A) and (B), the shares of Common Stock or other securities that the Purchaser desires to sell that can be sold without exceeding the Maximum Number of Shares; and (D) fourth, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A), (B) and (C), the shares of Common Stock or other securities for the account of other persons that the Purchaser is obligated to register pursuant to written contractual arrangements with such persons, that can be sold without exceeding the Maximum Number of Shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:51.2pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.3.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Withdrawal</span>. Any holder of Registrable Securities may elect to withdraw such holder&#8217;s request for inclusion of Registrable Securities in any Piggy-Back Registration by giving written notice to the Purchaser of such request to withdraw prior to the effectiveness of the Registration Statement. The Purchaser (whether on its own determination or as the result of a withdrawal by persons making a demand pursuant to written contractual obligations) may withdraw a Registration Statement at any time prior to the effectiveness of such Registration Statement. Notwithstanding any such withdrawal, the Purchaser shall pay all expenses incurred by the holders of Registrable Securities in connection with such Piggy-Back Registration as provided in Section 3.3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:51.2pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.3.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Unlimited Piggy-Back Registration Rights</span>. For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1 hereof. The Holders shall have unlimited Piggy-Back Registration Rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:51.2pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.3.5</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registrations on Form S-3</span>. The holders of Registrable Securities may at any time and from time to time, request in writing that the Purchaser register the resale of any or all of such Registrable Securities on Form S-3 or any similar short-form registration which may be available at such time (&#8220;<span style="font-style:italic;font-weight:bold;">Form S-3</span>&#8221;); provided, however, that the Purchaser shall not be obligated to effect such request through an underwritten offering. Upon receipt of such written request, the Purchaser will promptly give written notice of the proposed registration to all other holders of Registrable Securities, and, as soon as practicable thereafter, effect the registration of all or such portion of such holder&#8217;s or holders&#8217; Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities or other securities of the Purchaser, if any, of any other holder or holders joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice from the Purchaser; provided, however, that the Purchaser shall not be obligated to effect any such registration pursuant to this Section 2.3: (i) if Form S-3 is not available for such offering; or (ii) if the holders of the Registrable Securities, together with the holders of any other securities of the Purchaser entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at any aggregate price to the public of less than $500,000. Registrations effected pursuant to this Section 2.3 shall not be counted as Demand Registrations effected pursuant to Section 2.1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Block Trades; Other Coordinated Offerings</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.4.1</span></span>Notwithstanding any other provision of this Section 2,4, at any time and from time to time when an effective Shelf Registration is on file with the Commission, if a Demanding Holder wishes to engage in (a) an underwritten registered offering (whether firm commitment or otherwise) not involving a &#8220;road show&#8221; or other substantial marketing efforts prior to pricing (commonly referred to as a &#8220;Block Trade&#8221;) or (b) an otherwise coordinated &#8220;at the market&#8221; or similar registered offering through a broker, sales agent or distribution agent, whether as agent or principal (an &#8220;<span style="font-style:italic;font-weight:bold;">Other Coordinated Offering</span>&#8221;), in each case, with a total offering price reasonably expected to exceed, in the aggregate, either (x) $10 million or (y) all remaining Registrable Securities held by the Demanding Holder, then such Demanding Holder shall notify the Purchaser of the Block Trade or Other Coordinated Offering at least five (5) business days prior to the day such offering is expected to commence, and the Purchaser shall as expeditiously as possible use its commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding Holders representing a majority of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall use commercially reasonable efforts to work with the Purchaser and any Underwriters, brokers, sales agents or placement agents prior to making such request in order to facilitate preparation of the registration statement, prospectus and other offering documentation related to the Block Trade or Other Coordinated Offering.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.4.2</span></span>The Purchaser may facilitate a Block Trade or Other Coordinated Offering if it determines that sufficient shares shall be traded by any Holder or Holders that would be more efficiently traded as a block trade.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.4.3</span></span>Prior to the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement used in connection with a Block Trade or Other Coordinated Offering, a majority-in-interest of the Demanding Holders initiating such Block Trade or Other Coordinated Offering shall have the right to submit a notice to the Purchaser and the Underwriter(s) if any, of their intention to withdraw from such Block Trade or Other Coordinated Offering. Notwithstanding anything to the contrary in this Agreement, the Purchaser shall be responsible for the Registration Expenses incurred in connection with a block trade prior to its withdrawal under this Section 2.4.3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.4.4</span></span>Notwithstanding anything to the contrary in this Agreement, Section 2.3 shall not apply to a Block Trade or Other Coordinated Offering initiated by a Demanding Holder pursuant to this Section 2.4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.4.5</span></span>The Purchaser shall have the right to select the Underwriters, and brokers, sale agents or placement agents (if any) for such Block Trade or Other Coordinated Offering, in each case, which shall consist of one or more reputable nationally recognized investment bank.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.4.6</span></span>A Holder in the aggregate may demand no more than two (2) Block Trades or Other Coordinated Offerings pursuant to this Section 2.4 in any twelve (12) month period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">REGISTRATION PROCEDURES</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Filings; Information</span>. Whenever the Purchaser is required to effect the registration of any Registrable Securities pursuant to Section 2, the Purchaser shall use its best efforts to effect the registration and sale of such Registrable Securities in accordance with the intended method(s) of distribution thereof as expeditiously as practicable, and in connection with any such request:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Filing Registration Statement</span>. The Purchaser shall use its best efforts to, as expeditiously as possible after receipt of a request for a Demand Registration pursuant to Section 2.1, prepare and file with the Commission a Registration Statement on any form for which the Purchaser then qualifies or which counsel for the Purchaser shall deem appropriate and which form shall be available for the sale of all Registrable Securities to be registered thereunder in accordance with the intended method(s) of distribution thereof, and shall use its best efforts to cause such Registration Statement to become effective and use its best efforts to keep it effective for the period required by Section 3.1.3; provided, however, that the Purchaser shall have the right to defer any Demand Registration for up to ninety (90) days, and any Piggy-Back Registration for such period as may be applicable to deferment of any demand registration to which such Piggy-Back Registration relates, in each case if the Purchaser shall furnish to the holders a certificate signed by Chief Executive Officer or Chairman of the Purchaser stating that, in the good faith judgment of the Board of Directors of the Purchaser, it would be materially detrimental to the Purchaser and its shareholders for such Registration Statement to be effected at such time; provided further, however, that the Purchaser shall not have the right to exercise the right set forth in this provision more than once in any 365-day period in respect of a Demand Registration hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Copies</span>. The Purchaser shall, prior to filing a Registration Statement or prospectus, or any amendment or supplement thereto, furnish without charge to the holders of Registrable Securities included in such registration, and such holders&#8217; legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the prospectus included in such Registration Statement (including each preliminary prospectus), and such other documents as the holders of Registrable Securities included in such registration or legal counsel for any such holders may request in order to facilitate the disposition of the Registrable Securities owned by such holders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendments and Supplements</span>. The Purchaser shall prepare and file with the Commission such amendments, including post- effective amendments, and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary to keep such Registration Statement effective and in compliance with the provisions of the Securities Act until all Registrable Securities and other securities covered by such Registration Statement have been disposed of in accordance with the intended method(s) of distribution set forth in such Registration Statement or such securities have been withdrawn.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notification</span>. After the filing of a Registration Statement, the Purchaser shall promptly, and in no event more than two (2) business days after such filing, notify the holders of Registrable Securities included in such Registration Statement of </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">such filing, and shall further notify such holders promptly and confirm such advice in writing in all events within two (2) business days of the occurrence of any of the following: (i) when such Registration Statement becomes effective; (ii) when any post-effective amendment to such Registration Statement becomes effective; (iii) the issuance or threatened issuance by the Commission of any stop order (and the Purchaser shall take all actions required to prevent the entry of such stop order or to remove it if entered); and (iv) any request by the Commission for any amendment or supplement to such Registration Statement or any prospectus relating thereto or for additional information or of the occurrence of an event requiring the preparation of a supplement or amendment to such prospectus so that, as thereafter delivered to the purchasers of the securities covered by such Registration Statement, such prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and promptly make available to the holders of Registrable Securities included in such Registration Statement any such supplement or amendment; except that before filing with the Commission a Registration Statement or prospectus or any amendment or supplement thereto, including documents incorporated by reference, the Purchaser shall furnish to the holders of Registrable Securities included in such Registration Statement and to the legal counsel for any such holders, copies of all such documents proposed to be filed sufficiently in advance of filing to provide such holders and legal counsel with a reasonable opportunity to review such documents and comment thereon, and the Purchaser shall not file any Registration Statement or prospectus or amendment or supplement thereto, including documents incorporated by reference, to which such holders or their legal counsel shall object.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.5</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">State Securities Laws Compliance</span>. The Purchaser shall use its best efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under such securities or &#8220;blue sky&#8221; laws of such jurisdictions in the United States as the holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Purchaser and do any and all other acts and things that may be necessary or advisable to enable the holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Purchaser shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this paragraph or subject itself to taxation in any such jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.6</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Agreements for Disposition</span>. The Purchaser shall enter into customary agreements (including, if applicable, an underwriting agreement in customary form) and take such other actions as are reasonably required in order to expedite or facilitate the disposition of such Registrable Securities. The representations, warranties and covenants of the Purchaser in any underwriting agreement which are made to or for the benefit of any Underwriters, to the extent applicable, shall also be made to and for the benefit of the holders of Registrable Securities included in such registration statement. No holder of Registrable Securities included in such registration statement shall be required to make any representations or warranties in the underwriting agreement except, if applicable, with respect to such holder&#8217;s organization, good standing, authority, title to Registrable Securities, lack of conflict of such sale with such holder&#8217;s material agreements and organizational documents, and with respect to written information relating to such holder that such holder has furnished in writing expressly for inclusion in such Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.7</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cooperation</span>. The principal executive officer of the Purchaser, the principal financial officer of the Purchaser, the principal accounting officer of the Purchaser and all other officers and members of the management of the Purchaser shall cooperate fully in any offering of Registrable Securities hereunder, which cooperation shall include, without limitation, the preparation of the Registration Statement with respect to such offering and all other offering materials and related documents, and participation in meetings with Underwriters, attorneys, accountants and potential Holders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.8</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Records</span>. The Purchaser shall make available for inspection by the holders of Registrable Securities included in such Registration Statement, any Underwriter participating in any disposition pursuant to such registration statement and any attorney, accountant or other professional retained by any holder of Registrable Securities included in such Registration Statement or any Underwriter, all financial and other records, pertinent corporate documents and properties of the Purchaser, as shall be necessary to enable them to exercise their due diligence responsibility, and cause the Purchaser&#8217;s officers, directors and employees to supply all information requested by any of them in connection with such Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:51.2pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.9</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Opinions and Comfort Letters</span>. Upon request, the Purchaser shall furnish to each holder of Registrable Securities included in any Registration Statement a signed counterpart, addressed to such holder, of (i) any opinion of counsel to the Purchaser delivered to any Underwriter and (ii) any comfort letter from the Purchaser&#8217;s independent public accountants delivered to any Underwriter. In the event no legal opinion is delivered to any Underwriter, the Purchaser shall furnish to each holder of Registrable Securities included in such Registration Statement, at any time that such holder elects to use a prospectus, an opinion </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">of counsel to the Purchaser to the effect that the Registration Statement containing such prospectus has been declared effective and that no stop order is in effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.10</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Earnings Statement</span>. The Purchaser shall comply with all applicable rules and regulations of the Commission and the Securities Act, and make available to its shareholders, as soon as practicable, an earnings statement covering a period of twelve (12) months, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.11</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Listing</span>. The Purchaser shall use its best efforts to cause all Registrable Securities included in any registration to be listed on such exchanges or otherwise designated for trading in the same manner as similar securities issued by the Purchaser are then listed or designated or, if no such similar securities are then listed or designated, in a manner satisfactory to the holders of a majority of the Registrable Securities included in such registration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.12</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Road Show</span>. If the registration involves the registration of Registrable Securities involving gross proceeds in excess of $50,000,000, the Purchaser shall use its reasonable efforts to make available senior executives of the Purchaser to participate in customary &#8220;road show&#8221; presentations that may be reasonably requested by the Underwriter in any underwritten offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Obligation to Suspend Distribution</span>. Upon receipt of any notice from the Purchaser of the happening of any event of the kind described in Section 3.1.4(iv), or, in the case of a resale registration on Form S-3 pursuant to Section 2.3 hereof, upon any suspension by the Purchaser, pursuant to a written insider trading compliance program adopted by the Purchaser&#8217;s Board of Directors, of the ability of all &#8220;insiders&#8221; covered by such program to transact in the Purchaser&#8217;s securities because of the existence of material non-public information, each holder of Registrable Securities included in any registration shall immediately discontinue disposition of such Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until such holder receives the supplemented or amended prospectus contemplated by Section 3.1.4(iv) or the restriction on the ability of &#8220;insiders&#8221; to transact in the Purchaser&#8217;s securities is removed, as applicable, and, if so directed by the Purchaser, each such holder will deliver to the Purchaser all copies, other than permanent file copies then in such holder&#8217;s possession, of the most recent prospectus covering such Registrable Securities at the time of receipt of such notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3.59pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Expenses</span>. The Purchaser shall bear all costs and expenses incurred in connection with any Demand Registration pursuant to Section 2.2, any Piggy-Back Registration pursuant to Section 2.3, and any registration on Form S-3 effected pursuant to Section 2.4, and all expenses incurred in performing or complying with its other obligations under this Agreement, whether or not the Registration Statement becomes effective, including, without limitation: (i) all registration and filing fees; (ii) fees and expenses of compliance with securities or &#8220;blue sky&#8221; laws (including fees and disbursements of counsel in connection with blue sky qualifications of the Registrable Securities); (iii) printing expenses; (iv) the fees and expenses incurred in connection with the listing of the Registrable Securities as required by Section 3.1.11; (v) Financial Industry Regulatory Authority fees; (vi) fees and disbursements of counsel for the Purchaser and fees and expenses for independent certified public accountants retained by the Purchaser (including the expenses or costs associated with the delivery of any opinions or comfort letters requested pursuant to Section 3.1.9); and (viii) the reasonable fees and expenses of any special experts retained by the Purchaser in connection with such registration. The Purchaser shall have no obligation to pay (i) any underwriting discounts or selling commissions attributable to the Registrable Securities being sold by the holders thereof, which underwriting discounts or selling commissions shall be borne by such holders, or (ii) the fees and expenses of any legal counsel representing any Holders. Additionally, in an underwritten offering, all selling shareholders and the Purchaser shall bear the expenses of the Underwriter pro rata in proportion to the respective amount of shares each is selling in such offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Information</span>. The holders of Registrable Securities shall provide such information as may reasonably be requested by the Purchaser, or the managing Underwriter, if any, in connection with the preparation of any Registration Statement, including amendments and supplements thereto, in order to effect the registration of any Registrable Securities under the Securities Act pursuant to Section 2 and in connection with the Purchaser&#8217;s obligation to comply with Federal and applicable state securities laws. In addition, the holders of Registrable Securities shall comply with all prospectus delivery requirements under the Securities Act and applicable SEC regulations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.5</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Legend Removal Obligations</span>. In connection with the written request of any Holder, the Purchaser shall remove any restrictive legend included on the certificates (or, in the case of book-entry shares, any other instrument or record) representing such Holder&#8217;s and/or its affiliates&#8217; or permitted transferee&#8217;s ownership of Registrable Securities, and promptly issue a certificate (or evidence of the issuance of securities in book-entry form) without such restrictive legend or any other restrictive legend to the holder of the applicable shares of Registrable Securities upon which it is stamped, if (i) such Registrable Securities are registered for resale under the Securities Act and such Registration Statement for such Registrable Securities has not been suspended under the Securities Act, the Exchange Act or the rules and regulations of the Commission promulgated thereunder, (ii) such Registrable Securities are </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">sold or transferred pursuant to Rule 144, or (iii) such Registrable Securities are eligible for sale pursuant to Section 4(a)(1) of the Securities Act or Rule 144 without volume or manner-of-sale restrictions. Following the earlier of (A) the effective date of a Registration Statement registering such Registrable Securities or (B) Rule 144 becoming available for the resale of such Registrable Securities without volume or manner-of-sale restrictions, the Purchaser upon the written request of the Holder or its permitted transferee, shall instruct the Purchaser&#8217;s transfer agent to remove the legend from such Registrable Securities (in whatever form) and shall cause the Purchaser&#8217;s counsel to issue any legend removal opinion required by the transfer agent. Any reasonable and documented fees (with respect to the transfer agent, the Purchaser&#8217;s counsel, or otherwise) associated with the removal of such legend shall be borne by the Purchaser. If a legend is no longer required pursuant to the foregoing, the Purchaser will, as soon as practicable following the delivery by any Holder or its permitted transferee to the Purchaser or the transfer agent (with notice to the Purchaser) of a legended certificate (if applicable) representing such Registrable Securities and, to the extent such sale is not pursuant to an effective registration statement, such other documentation as reasonably requested by the Purchaser, deliver or cause to be delivered to the holder of such Registrable Securities a certificate representing such Registrable Securities (or evidence of the issuance of such Registrable Securities in book-entry form) that is free from all restrictive legends; provided that, notwithstanding the foregoing, the Purchaser will not be required to deliver any opinion, authorization, certificate or direction to remove the restrictive legend pursuant to this Section 3.5 if (x) removal of the legend would result in or facilitate transfer of securities in violation of applicable law or (y) following receipt of instruction from the Purchaser, the transfer agent refuses to remove the legend.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">INDEMNIFICATION AND CONTRIBUTION</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.1</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnification by the Purchaser</span>. The Purchaser agrees to indemnify and hold harmless each Holder and each other holder of Registrable Securities, and each of their respective officers, employees, affiliates, directors, partners, members, attorneys and agents, and each person, if any, who controls an Holder and each other holder of Registrable Securities (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) (each, an &#8220;<span style="font-style:italic;font-weight:bold;">Holder Indemnified Party</span>&#8221; ), from and against any expenses, losses, judgments, claims, damages or liabilities, whether joint or several, arising out of or based upon any untrue statement (or allegedly untrue statement) of a material fact contained in any Registration Statement under which the sale of such Registrable Securities was registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained in the Registration Statement, or any amendment or supplement to such Registration Statement, or arising out of or based upon any omission (or alleged omission) to state a material fact required to be stated therein or necessary to make the statements therein not misleading, or any violation by the Purchaser of the Securities Act or any rule or regulation promulgated thereunder applicable to the Purchaser and relating to action or inaction required of the Purchaser in connection with any such registration; and the Purchaser shall promptly reimburse the Holder Indemnified Party for any legal and any other expenses reasonably incurred by such Holder Indemnified Party in connection with investigating and defending any such expense, loss, judgment, claim, damage, liability or action; provided, however, that the Purchaser will not be liable in any such case to the extent that any such expense, loss, claim, damage or liability arises out of or is based upon any untrue statement or allegedly untrue statement or omission or alleged omission made in such Registration Statement, preliminary prospectus, final prospectus, or summary prospectus, or any such amendment or supplement, in reliance upon and in conformity with information furnished to the Purchaser, in writing, by such selling Holder expressly for use therein. The Purchaser also shall indemnify any Underwriter of the Registrable Securities, their officers, affiliates, directors, partners, members and agents and each person who controls such Underwriter on substantially the same basis as that of the indemnification provided above in this Section 4.1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.2</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnification by Holders of Registrable Securities</span>. Each selling Holder will, in the event that any registration is being effected under the Securities Act pursuant to this Agreement of any Registrable Securities held by such selling Holder, indemnify and hold harmless the Purchaser, each of its directors and officers and each Underwriter (if any), and each other selling Holder and each other person, if any, who controls another selling Holder or such Underwriter within the meaning of the Securities Act, against any losses, claims, judgments, damages or liabilities, whether joint or several, insofar as such losses, claims, judgments, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or allegedly untrue statement of a material fact contained in any Registration Statement under which the sale of such Registrable Securities was registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained in the Registration Statement, or any amendment or supplement to the Registration Statement, or arise out of or are based upon any omission or the alleged omission to state a material fact required to be stated therein or necessary to make the statement therein not misleading, if the statement or omission was made in reliance upon and in conformity with information furnished in writing to the Purchaser by such selling Holder expressly for use therein, and shall reimburse the Purchaser, its directors and officers, and each other selling holder or controlling person for any legal or other expenses reasonably incurred by any of them in connection with investigation or defending any such loss, claim, damage, liability or action. Each selling Holder&#8217;s indemnification obligations hereunder shall be several and not joint and shall be limited to the amount of any net proceeds actually received by such selling Holder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.3</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conduct of Indemnification Proceedings</span>. Promptly after receipt by any person of any notice of any loss, claim, damage or liability or any action in respect of which indemnity may be sought pursuant to Section 4.1 or 4.2, such person (the &#8220;<span style="font-style:italic;font-weight:bold;">Indemnified Party</span>&#8221;) shall, if a claim in respect thereof is to be made against any other person for indemnification hereunder, notify such other person (the &#8220;<span style="font-style:italic;font-weight:bold;">Indemnifying Party</span>&#8221; ) in writing of the loss, claim, judgment, damage, liability or action; provided, however, that the failure by the Indemnified Party to notify the Indemnifying Party shall not relieve the Indemnifying Party from any liability which the Indemnifying Party may have to such Indemnified Party hereunder, except and solely to the extent the Indemnifying Party is actually prejudiced by such failure. If the Indemnified Party is seeking indemnification with respect to any claim or action brought against the Indemnified Party, then the Indemnifying Party shall be entitled to participate in such claim or action, and, to the extent that it wishes, jointly with all other Indemnifying Parties, to assume control of the defense thereof with counsel satisfactory to the Indemnified Party. After notice from the Indemnifying Party to the Indemnified Party of its election to assume control of the defense of such claim or action, the Indemnifying Party shall not be liable to the Indemnified Party for any legal or other expenses subsequently incurred by the Indemnified Party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that in any action in which both the Indemnified Party and the Indemnifying Party are named as defendants, the Indemnified Party shall have the right to employ separate counsel (but no more than one such separate counsel) to represent the Indemnified Party and its controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the Indemnified Party against the Indemnifying Party, with the fees and expenses of such counsel to be paid by such Indemnifying Party if, based upon the written opinion of counsel of such Indemnified Party, representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, consent to entry of judgment or effect any settlement of any claim or pending or threatened proceeding in respect of which the Indemnified Party is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such judgment or settlement includes an unconditional release of such Indemnified Party from all liability arising out of such claim or proceeding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Contribution</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.4.1</span></span>If the indemnification provided for in the foregoing Sections 4.1, 4.2 and 4.3 is unavailable to any Indemnified Party in respect of any loss, claim, damage, liability or action referred to herein, then each such Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such loss, claim, damage, liability or action in such proportion as is appropriate to reflect the relative fault of the Indemnified Parties and the Indemnifying Parties in connection with the actions or omissions which resulted in such loss, claim, damage, liability or action, as well as any other relevant equitable considerations. The relative fault of any Indemnified Party and any Indemnifying Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by such Indemnified Party or such Indemnifying Party and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.4.2</span></span>The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 4.4 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately preceding Section 4.4.1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.4.3</span></span>The amount paid or payable by an Indemnified Party as a result of any loss, claim, damage, liability or action referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 4.4, no holder of Registrable Securities shall be required to contribute any amount in excess of the dollar amount of the net proceeds (after payment of any underwriting fees, discounts, commissions or taxes) actually received by such holder from the sale of Registrable Securities which gave rise to such contribution obligation. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#010000;">4.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Survival</span>. The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Party or any officer, director or controlling person of such Indemnified Party and shall survive the transfer of securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#010000;">5. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">RULE 144</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#010000;">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Rule 144</span>. The Purchaser covenants that it shall file any reports required to be filed by it under the Securities Act and the Exchange Act and shall take such further action as the holders of Registrable Securities may reasonably request, all to the extent </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">required from time to time to enable such holders to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 under the Securities Act, as such Rules may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#010000;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">MISCELLANEOUS</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#010000;">6.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Registration Rights</span>. The Purchaser represents and warrants that no person, other than the holders of the Registrable Securities, has any right to require the Purchaser to register any shares of the Purchaser&#8217;s capital stock for sale or to include shares of the Purchaser&#8217;s capital stock in any registration filed by the Purchaser for the sale of shares of capital stock for its own account or for the account of any other person. Further, the Purchaser represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#010000;">6.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Assignment; No Third Party Beneficiaries</span>. This Agreement and the rights, duties and obligations of the Purchaser hereunder may not be assigned or delegated by the Purchaser in whole or in part. This Agreement and the rights, duties and obligations of the holders of Registrable Securities hereunder may be freely assigned or delegated by such holder of Registrable Securities in conjunction with and to the extent of any transfer of Registrable Securities by any such holder. This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties, to the permitted assigns of the Holders or holder of Registrable Securities or of any assignee of the Holders or holder of Registrable Securities. This Agreement is not intended to confer any rights or benefits on any persons that are not party hereto other than as expressly set forth in Article 4 and this Section 6.2.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="color:#010000;">6.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</span>. All notices, demands, requests, consents, approvals or other communications (collectively, &#8220;<span style="font-style:italic;font-weight:bold;">Notices</span>&#8221; ) required or permitted to be given hereunder or which are given with respect to this Agreement shall be in writing and shall be personally served, delivered by reputable air courier service with charges prepaid, or transmitted by hand delivery, telegram, telex or facsimile, addressed as set forth below, or to such other address as such party shall have specified most recently by written notice. Notice shall be deemed given on the date of service or transmission if personally served or transmitted by telegram, telex or facsimile; provided, that if such service or transmission is not on a business day or is after normal business hours, then such notice shall be deemed given on the next business day. Notice otherwise sent as provided herein shall be deemed given on the next business day following timely delivery of such notice to a reputable air courier service with an order for next-day delivery.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">To the Purchaser before the Closing:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">Data Knights Acquisition Corp </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">Unit G6, Frome Business Park, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">Manor Road, Frome, BA11 4FN, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">United Kingdom</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.6pt 18pt;">Tel: +44 203 833 4000</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;">Email: barry@dataknightsacuk.com </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;">with a copy to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">Nelson Mullins Riley &amp; Scarborough LLP </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">101 Constitution Avenue, NW, Suite 900</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.6pt 18pt;">Washington, DC 20001</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Attn: Andrew M. Tucker, Esq. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Facsimile No.: (202) 689-2860</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.6pt 18pt;">Telephone No.: (202) 689-2987</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;">E-mail: andy.tucker@nelsonmullins.com </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;">To the Purchaser after the Closing:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">OneMedNet Corporation </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">6385 Old Shady Oak Road </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">Suite 250</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Eden Prairie, Minnesota 55344 </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Attn: Paul Casey</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.6pt 18pt;">Telephone No.: (808) 228-5998</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;">E-mail: paul.casey@onemednet.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;">with a copy to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.6pt 18pt;">Rim&#244;n, P.C.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.6pt 18pt;">1990 K Street NW, Suite 420</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.6pt 18pt;">Washington, D.C. 20006</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Attn: Debbie Klis; Debra Vernon</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Telephone: (202) 971-9494; (650) 292-5910</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">E-mail: debbie.klis@rimonlaw.com; debra.vernon@rimonlaw.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">To a Holder, to the address set forth below such Holder&#8217;s name on <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</span> hereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.4</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</span>. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible that is valid and enforceable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.5</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts</span>. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, and all of which taken together shall constitute one and the same instrument.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.6</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Entire Agreement</span>. This Agreement (including all agreements entered into pursuant hereto and all certificates and instruments delivered pursuant hereto and thereto) constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all prior and contemporaneous agreements, representations, understandings, negotiations and discussions between the parties, whether oral or written, including but not limited to the Existing Agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.7</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Modifications and Amendments; Termination</span>. No amendment, modification or termination of this Agreement shall be binding upon the Purchaser unless executed in writing by the Purchaser. No amendment, modification or termination of this Agreement shall be binding upon the holders of the Registrable Securities unless executed in writing by the holders of the majority Registrable Securities. This Agreement shall terminate with respect to any Holder on the date that such Holder no longer holds any Registrable Securities. The provisions of Article IV shall survive any termination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.8</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Titles and Headings</span>. Titles and headings of sections of this Agreement are for convenience only and shall not affect the construction of any provision of this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.9</span></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Waivers and Extensions</span>. Any party to this Agreement may waive any right, breach or default which such party has the right to waive, provided that such waiver will not be effective against the waiving party unless it is in writing, is signed by such party, and specifically refers to this Agreement. Waivers may be made in advance or after the right waived has arisen or the breach or default waived has occurred. Any waiver may be conditional. No waiver of any breach of any agreement or provision herein contained shall be deemed a waiver of any preceding or succeeding breach thereof nor of any other agreement or provision herein contained. No waiver or extension of time for performance of any obligations or acts shall be deemed a waiver or extension of the time for performance of any other obligations or acts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.10</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law</span>. This Agreement shall be governed by, interpreted under, and construed in accordance with the internal laws of the State of Delaware applicable to agreements made and to be performed within the State of Delaware, without giving effect to any choice-of-law provisions thereof that would compel the application of the substantive laws of any other jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.11</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Waiver of Trial by Jury</span>. Each party hereby irrevocably and unconditionally waives the right to a trial by jury in any action, suit, counterclaim or other proceeding (whether based on contract, tort or otherwise) arising out of, connected with or relating to this Agreement, the transactions contemplated hereby, or the actions of the Holder in the negotiation, administration, performance or enforcement hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.12</span></span><span style="display:inline-block;width:18pt;"></span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination of Existing Agreements</span>. The Existing Agreements are hereby terminated in their entirety.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_79b653ca_c9e0_476b_9498_6b836e68f2c8"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">PURCHASER:</b></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">DATA KNIGHTS ACQUISITION CORP.</p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:45%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: </p></td><td style="vertical-align:bottom;width:45%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">HOLDERS:</p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">[<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>]</p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 8pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_bd9263e2_d97b_43a9_bfb8_61245388f555"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule of Holders</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 8pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_a4dcb079_4db9_4e53_8427_fb5798e739b7"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Exhibit H</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXTENSION ESCROW AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">THIS EXTENSION ESCROW AGREEMENT (this &#8220;<span style="font-style:italic;font-weight:bold;">Escrow Agreement</span>&#8221;) is entered into and effective the 25th day of April 2022, by and among Data Knights Acquisition Corp., a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser</span>&#8221;), OneMedNet Corporation, a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221; and together with Purchaser, the &#8220;<span style="font-style:italic;font-weight:bold;">Parties</span>&#8221;, and each, individually, a &#8220;<span style="font-style:italic;font-weight:bold;">Party</span>&#8221;) and Truist Bank, a North Carolina banking corporation, as escrow agent (&#8220;<span style="font-style:italic;font-weight:bold;">Escrow Agent</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, pursuant to that certain Agreement and Plan of Merger, dated as of April 25, 2022, by and among Purchaser, Data Knights Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Purchaser (&#8220;<span style="font-style:italic;font-weight:bold;">Merger Sub</span>&#8221;<i style="font-style:italic;">)</i>, Data Knights, LLC, a Delaware limited liability company (the &#8220;<span style="font-style:italic;font-weight:bold;">Purchaser Representative</span>&#8221;), Paul Casey, an individual, solely in his capacity as the seller representative from and after the effective date of this Escrow Agreement on behalf of the Company&#8217;s stockholders, (the &#8220;<span style="font-style:italic;font-weight:bold;">Seller Representative</span>&#8221;), and the Company (as amended from time to time in accordance with the terms thereof, the &#8220;<span style="font-style:italic;font-weight:bold;">Merger Agreement</span>&#8221;), pursuant to which the parties thereto intend to effect the merger of Merger Sub with and into the Company, with the Company continuing as the surviving entity (the &#8220;<span style="font-style:italic;font-weight:bold;">Merger</span>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, the Parties desire for the Escrow Agent to open an account (the &#8220;<span style="font-style:italic;font-weight:bold;">Escrow Account</span>&#8221;) into which the Company will deposit funds to be held, disbursed and invested by the Escrow Agent in accordance with this Escrow Agreement; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, the Parties acknowledge that the Escrow Agent is not a party to, and has no duties or obligations under, the Merger Agreement, that all references in this Escrow Agreement to the Merger Agreement are for convenience only, and that the Escrow Agent shall have no implied duties beyond the express duties set forth in this Escrow Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">NOW, THEREFORE, in consideration of the premises herein, the Parties and the Escrow Agent agree as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">I.</b></span><b style="font-weight:bold;">Terms and Conditions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.1.</span></span>The Parties hereby appoint the Escrow Agent as their escrow agent for the purposes set forth herein, and the Escrow Agent hereby accepts such appointment under the terms and conditions set forth herein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.2.</span></span>The Company shall remit $1,150,000 (the &#8220;<span style="font-style:italic;font-weight:bold;">Escrow Fund</span>&#8221;) to the Escrow Agent, using the wire instructions set forth below, to be held by the Escrow Agent and invested and disbursed as provided in this Escrow Agreement.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:10.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td colspan="2" style="vertical-align:bottom;width:40.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:49.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:50.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Truist Bank ABA: 061000104</p></td><td style="vertical-align:bottom;width:49.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:50.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Account: 9443001321</p></td><td style="vertical-align:bottom;width:49.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:50.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Account Name: Escrow Services</p></td><td style="vertical-align:bottom;width:49.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Reference:</p></td><td style="vertical-align:bottom;width:22.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.78%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:50.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Attention: Charles.Henderson@truist.com</p></td><td style="vertical-align:bottom;width:49.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.3.</span></span>Within two Business Days of receipt of (a) an Extension Notice (as defined below), (b) joint written instructions (&#8220;<span style="font-style:italic;font-weight:bold;">Joint Instructions</span>&#8221;), signed by an authorized representative of the each of the Parties set forth on such Party&#8217;s Certificate of Incumbency provided to the Escrow Agent pursuant to Section 4.13<b style="font-weight:bold;">, </b>or (c) a Final Decision (as defined below), in each case specifying the amount of the disbursement and containing instructions for payment of the disbursement, the Escrow Agent shall disburse funds as provided in the Extension Notice, Joint Instructions or Final Decision, as the case may be, but only to the extent that funds are collected and available. For purposes of this Escrow Agreement, &#8220;<span style="font-style:italic;font-weight:bold;">Business Day</span>&#8221; shall mean any day other than a Saturday, Sunday or any other day on which the Escrow Agent located at the notice address set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 4.5</span> is authorized or required by law or executive order to remain closed. For purposes of this Escrow Agreement, &#8220;<span style="font-style:italic;font-weight:bold;">Final Decision</span>&#8221; shall mean a written final order of a court of competent jurisdiction delivered by a Party to the Escrow Agent and accompanied by a written opinion from legal counsel for such Party to the effect that such order is final and not subject to further proceedings or appeal and a written instruction from such Party to the Escrow Agent to effectuate such order. The Escrow Agent shall be entitled conclusively to rely upon any such opinion and instruction and shall have no responsibility to make any determination as to whether such order is from a court of competent jurisdiction or is a final order.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">If the Purchaser elects to extend the Applicable Deadline, as defined in that certain Investment Management Trust Agreement dated as of May 6, 2021 (the &#8220;<span style="font-style:italic;font-weight:bold;">Trust Agreement</span>&#8221;), by and between the Purchaser and Continental Stock Transfer &amp; Trust Company, LLC (the &#8220;<span style="font-style:italic;font-weight:bold;">Trustee</span>&#8221;), pursuant to the terms of the Trust Agreement, Purchaser may deliver to the Escrow Agent an extension notice substantially in the form attached hereto as <span style="font-style:italic;font-weight:bold;">Exhibit D </span>(each, an &#8220;<span style="font-style:italic;font-weight:bold;">Extension Notice</span>&#8221;) directing the Escrow Agent to disburse to the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.1pt 0pt;">Trustee the amount of $1,150,000 with respect to the related Extension (as defined in the Trust Agreement) and attaching a copy of the Extension Letter (as defined in the Trust Agreement). If the Purchaser does not elect to extend the first Applicable Deadline by its due date of May 10, 2022, the Escrow Agent shall return the Escrow Funds to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.4.</span></span>Upon the distribution of any portion of the Escrow Funds by the Escrow Agent pursuant to the first Extension Notice, Purchaser shall use commercially reasonable efforts to replenish the Escrow Funds to fund the second Extension. In the event Purchaser is unable to replenish the Escrow Funds, Purchaser shall give written notice to the Company to replenish the Escrow Funds so that the balance of the Escrow Funds is at least $1,150,000. The Company shall only be obligated to so replenish the Escrow Funds only one time after the first Extension and not after the second or any subsequent Extension. If the Purchaser does not elect to extend the second Applicable Deadline by its due date of August 10, 2022, the Escrow Agent shall return the Escrow Funds to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.5.</span></span>On the date that is two Business Days following the earlier of either the date of termination of the Merger Agreement in accordance with its terms or the Effective Date (as defined in the Merger Agreement) (such earlier date being the &#8220;<span style="font-style:italic;font-weight:bold;">Expiration Date</span>&#8221;), the Escrow Agent shall distribute to the Company the balance (if any) of the Escrow Fund. The Parties shall cooperate to certify the Expiration Date to the Escrow Agent, including but not limited to providing Joint Instructions relating to the distribution of the balance of the Escrow Fund upon such Expiration Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.6.</span></span>Purchaser hereby acknowledges and agrees that any and all Escrow Funds paid by the Company under this Escrow Agreement to facilitate Purchaser&#8217;s ability to exercise one or both Extension Notices are deemed a loan to Purchaser. Accordingly, Purchaser further covenants and agrees that in the event of the termination of the Merger Agreement in accordance with its terms, Purchaser shall repay all Escrow Funds paid by the Company under this Escrow Agreement within thirty (30) days of the event of the termination of the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">II.</b></span><b style="font-weight:bold;">Provisions as to Escrow Agent</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.1.</span></span>This Escrow Agreement expressly and exclusively sets forth the duties of the Escrow Agent with respect to any and all matters pertinent hereto, which duties shall be deemed purely ministerial in nature, and no implied duties or obligations shall be read into this Escrow Agreement against the Escrow Agent. The Escrow Agent shall in no event be deemed to be a fiduciary to any Party or any other person or entity under this Escrow Agreement. The permissive rights of the Escrow Agent to do things enumerated in this Escrow Agreement shall not be construed as duties. In performing its duties under this Escrow Agreement, or upon the claimed failure to perform its duties, the Escrow Agent shall not be liable for any damages, losses or expenses other than damages, losses or expenses which have been finally adjudicated by a court of competent jurisdiction to have directly resulted from the Escrow Agent&#8217;s willful misconduct or gross negligence. In no event shall the Escrow Agent be liable for incidental, indirect, special, consequential or punitive damages of any kind whatsoever (including but not limited to lost profits), even if the Escrow Agent has been advised of the likelihood of such loss or damage and regardless of the form of action. The Escrow Agent shall not be responsible or liable for the failure of any Party to take any action in accordance with this Escrow Agreement. Any wire transfers of funds made by the Escrow Agent pursuant to this Escrow Agreement will be made subject to and in accordance with the Escrow Agent&#8217;s usual and ordinary wire transfer procedures in effect from time to time as provided in <span style="font-style:italic;font-weight:bold;">Exhibit C</span>, the Truist Wealth Management Addendum for Wire Transfers, for which the Parties shall execute on or before the release of any wire transfer of funds. The Escrow Agent shall have no liability with respect to the transfer or distribution of any funds effected by the Escrow Agent pursuant to wiring or transfer instructions provided to the Escrow Agent in accordance with the provisions of this Escrow Agreement. The Escrow Agent shall not be obligated to take any legal action or to commence any proceedings in connection with this Escrow Agreement or any property held hereunder or to appear in, prosecute or defend in any such legal action or proceedings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.2.</span></span>The Parties acknowledge and agree that the Escrow Agent acts hereunder as a depository only, and is not responsible or liable in any manner whatsoever for the sufficiency, correctness, genuineness or validity of the subject matter of this Escrow Agreement or any part thereof, or of any person executing or depositing such subject matter. No provision of this Escrow Agreement shall require the Escrow Agent to risk or advance its own funds or otherwise incur any financial liability or potential financial liability in the performance of its duties or the exercise of its rights under this Escrow Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.3.</span></span>This Escrow Agreement constitutes the entire agreement between the Escrow Agent and the Parties in connection with the subject matter of this Escrow Agreement, and no other agreement entered into between the Parties, or any of them, including, without limitation, the Unit Purchase Agreement, shall be considered as adopted or binding, in whole or in part, upon the Escrow Agent notwithstanding that any such other agreement may be deposited with the Escrow Agent or the Escrow Agent may have knowledge thereof.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.4.</span></span>The Escrow Agent shall in no way be responsible for nor shall it be its duty to notify any Party or any other person or entity interested in this Escrow Agreement of any payment required or maturity occurring under this Escrow Agreement or under the terms of any instrument deposited herewith unless such notice is explicitly provided for in this Escrow Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.5.</span></span>The Escrow Agent shall be protected in acting upon any written instruction, notice, request, waiver, consent, certificate, receipt, authorization, power of attorney, or other paper or document which the Escrow Agent in good faith believes to be genuine and what it purports to be, including, but not limited to, items directing investment or non-investment of funds, items requesting or authorizing release, disbursement or retainage of the subject matter of this Escrow Agreement and items amending the terms of this Escrow Agreement. The Escrow Agent shall be under no duty or obligation to inquire into or investigate the validity, accuracy or content of any such notice, request, waiver, consent, certificate, receipt, authorization, power of attorney, or other paper or document. The Escrow Agent shall have no duty or obligation to make any formulaic calculations of any kind hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.6.</span></span>The Escrow Agent may execute any of its powers and perform any of its duties hereunder directly or through affiliates or agents. The Escrow Agent shall be entitled to seek the advice of legal counsel with respect to any matter arising under this Escrow Agreement and the Escrow Agent shall have no liability and shall be fully protected with respect to any action taken or omitted pursuant to the advice of such legal counsel. The Parties shall be jointly and severally liable for and shall promptly pay upon demand by the Escrow Agent the reasonable and documented fees and expenses of any such legal counsel.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.7.</span></span>In the event of any disagreement between any of the Parties, or between any of them and any other person or entity, resulting in adverse claims or demands being made in connection with the matters covered by this Escrow Agreement, or in the event that the Escrow Agent, in good faith, is in doubt as to what action it should take hereunder, the Escrow Agent may, at its option, refuse to comply with any claims or demands on it, or refuse to take any other action hereunder, so long as such disagreement continues or such doubt exists, and in any such event, the Escrow Agent shall not be or become liable in any way or to any Party or other person or entity for its failure or refusal to act, and the Escrow Agent shall be entitled to continue to refrain from acting until (i) the rights of the Parties and all other interested persons and entities shall have been fully and finally adjudicated by a court of competent jurisdiction, or (ii) all differences shall have been settled and all doubt resolved by agreement among all of the Parties and all other interested persons and entities, and the Escrow Agent shall have been notified thereof in writing signed by the Parties and all such persons and entities. Notwithstanding the preceding, the Escrow Agent may in its discretion obey the order, judgment, decree or levy of any court, whether with or without jurisdiction, or of an agency of the United States or any political subdivision thereof, or of any agency of any State of the United States or of any political subdivision of any thereof, and the Escrow Agent is hereby authorized in its sole discretion to comply with and obey any such orders, judgments, decrees or levies. The rights of the Escrow Agent under this sub-paragraph are cumulative of all other rights which it may have by law or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">In the event of any disagreement or doubt, as described above, the Escrow Agent shall have the right, in addition to the rights described above and at the election of the Escrow Agent, to tender into the registry or custody of any court having jurisdiction, all funds and property held under this Escrow Agreement, and the Escrow Agent shall have the right to take such other legal action as may be appropriate or necessary, in the sole discretion of the Escrow Agent. Upon such tender, the Parties agree that the Escrow Agent shall be discharged from all further duties under this Escrow Agreement; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, however, that any such action of the Escrow Agent shall not deprive the Escrow Agent of its compensation and right to reimbursement of expenses hereunder arising prior to such action and discharge of the Escrow Agent of its duties hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.8.</span></span>The Parties jointly and severally agree to indemnify, defend and hold harmless the Escrow Agent and each of the Escrow Agent&#8217;s officers, directors, agents and employees (the &#8220;<span style="font-style:italic;font-weight:bold;">Indemnified Parties</span>&#8221;) from and against any and all losses, liabilities, claims made by any Party or any other person or entity, damages, expenses and costs (including, without limitation, attorneys&#8217; fees and expenses) of every nature whatsoever (collectively, &#8220;<span style="font-style:italic;font-weight:bold;">Losses</span>&#8221;) which any such Indemnified Party may incur and which arise directly or indirectly from this Escrow Agreement or which arise directly or indirectly by virtue of the Escrow Agent&#8217;s undertaking to serve as Escrow Agent hereunder; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, however, that no Indemnified Party shall be entitled to indemnity with respect to Losses that have been finally adjudicated by a court of competent jurisdiction to have been directly caused by such Indemnified Party&#8217;s gross negligence or willful misconduct. The provisions of this section shall survive the termination of this Escrow Agreement and any resignation or removal of the Escrow Agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.9.</span></span>Any entity into which the Escrow Agent may be merged or converted or with which it may be consolidated, or any entity to which all or substantially all the escrow business of the Escrow Agent may be transferred, shall be the Escrow Agent under this Escrow Agreement without further act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;">2.10.&#160;The Escrow Agent may resign at any time from its obligations under this Escrow Agreement by providing written notice to the Parties. Such resignation shall be effective on the date set forth in such written notice, which shall be no earlier than thirty (30) days after such written notice has been furnished. In such event, the Parties shall promptly appoint a successor escrow agent. In the event no successor escrow agent has been appointed on or prior to the date such resignation is to become effective, the Escrow Agent shall be entitled to tender into the custody of any court of competent jurisdiction all funds and other property then held by the Escrow Agent hereunder and the Escrow Agent shall thereupon be relieved of all further duties and obligations under this Escrow Agreement; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, however, that any such action of the Escrow Agent shall not deprive the Escrow Agent of its compensation and right to reimbursement of expenses hereunder arising prior to such action and discharge of the Escrow Agent of its duties hereunder. The Escrow Agent shall have no responsibility for the appointment of a successor escrow agent hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;">2.11.&#160;The Escrow Agent and any director, officer or employee of the Escrow Agent may become financially interested in any transaction in which any of the Parties may be interested and may contract with and lend money to any Party and otherwise act as fully and freely as though it were not escrow agent under this Escrow Agreement. Nothing herein shall preclude the Escrow Agent from acting in any other capacity for any Party.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">III.</b></span><b style="font-weight:bold;">Compensation of Escrow Agent</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.1.</span></span>The Parties jointly and severally agree to pay to the Escrow Agent compensation, and to reimburse the Escrow Agent for costs and expenses, all in accordance with the provisions of <span style="font-style:italic;font-weight:bold;">Exhibit B </span>hereto, which is incorporated herein by reference and made a part hereof. The fees agreed upon for the services rendered hereunder are intended as full compensation for the Escrow Agent&#8217;s services as contemplated by this Escrow Agreement; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, however, that in the event that the conditions for the disbursement of funds are not fulfilled, or the Escrow Agent renders any service not contemplated in this Escrow Agreement, or there is any assignment of interest in the subject matter of this Escrow Agreement or any material modification hereof, or if any dispute or controversy arises hereunder, or the Escrow Agent is made a party to any litigation pertaining to this Escrow Agreement or the subject matter hereof, then the Parties jointly and severally agree to compensate the Escrow Agent for such extraordinary services and reimburse the Escrow Agent for all costs and expenses, including reasonable attorneys&#8217; fees and expenses, occasioned by any such event. In the event the Escrow Agent is authorized to make a distribution of funds to any Party (or at the direction of any Party) pursuant to the terms of this Escrow Agreement, and fees or expenses are then due and payable to the Escrow Agent pursuant to the terms of this Escrow Agreement (including, without limitation, amounts owed under this Section 3.1 and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 2.8</span>) by the Party receiving or directing such distribution, the Escrow Agent is authorized to offset and deduct such amounts due and payable to it from such distribution. The Escrow Agent shall have, and is hereby granted, a prior lien upon and first priority security interest in the Escrow Fund (and the earnings and interest accrued thereon) with respect to its unpaid fees, non-reimbursed expenses and unsatisfied indemnification rights, superior to the interests of any other persons or entities and without judicial action to foreclose such lien and security interest, and the Escrow Agent shall have and is hereby granted the right to set off and deduct any unpaid fees, non-reimbursed expenses and unsatisfied indemnification rights from the Escrow Fund (and the earnings and interest accrued thereon). The provisions of this section shall survive the termination of this Escrow Agreement and any resignation or removal of the Escrow Agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">IV.</b></span><b style="font-weight:bold;">Miscellaneous</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.1.</span></span>Escrow Agent shall make no disbursement, investment or other use of funds until and unless it has collected funds. The Escrow Agent shall not be liable for collection items until the proceeds of the same in actual cash have been received or the Federal Reserve has given the Escrow Agent credit for such funds.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.2.</span></span>The Escrow Agent shall invest all funds held pursuant to this Escrow Agreement in the Truist Bank Deposit Option. The investments in the Truist Bank Deposit Option are insured, subject to the applicable rules and regulations of the Federal Deposit Insurance Corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">FDIC</span>&#8221;), in the standard FDIC insurance amount of $250,000, including principal and accrued interest, and are not secured. The Truist Bank Deposit Option is more fully described in materials which have been furnished to the Parties by the Escrow Agent, and the Parties acknowledge receipt of such materials from the Escrow Agent. Instructions to make any other investment must be in writing and signed by each of the Parties. The Parties recognize and agree that the Escrow Agent will not provide supervision, recommendations or advice relating to the investment of moneys held hereunder or the purchase, sale, retention or other disposition of any investment, and the Escrow Agent shall not be liable to any Party or any other person or entity for any loss incurred in connection with any such investment. The Escrow Agent is hereby authorized to execute purchases and sales of investments through the facilities of its own trading or capital markets operations or those of any affiliated entity. The Escrow Agent or any of its affiliates may receive compensation with respect to any investment directed hereunder including without limitation charging any applicable agency fee in connection with each transaction. The Escrow Agent shall use its best efforts to invest funds on a timely basis upon receipt of such funds; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, however, that the Escrow Agent shall in no event be liable for compensation to any Party or other person or entity related to funds which are held un-invested or funds which are not invested timely. The Escrow Agent is authorized and directed to sell or redeem any investments as it deems necessary to make any payments or distributions required under this Escrow Agreement. Any investment earnings and income on the Escrow Fund shall become part of the Escrow Fund and shall be disbursed in accordance with this Escrow Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.3.</span></span>The Escrow Agent shall provide monthly reports of transactions and holdings to the Parties as of the end of each month, at the addresses provided by the Parties in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 4.5</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.4.</span></span>The Parties agree that all interest and income from the investment of the funds shall be reported as having been earned by the Company, as of the end of each calendar year whether or not such income was disbursed during such calendar year and to the extent required by the Internal Revenue Service. On or before the execution and delivery of this Escrow Agreement, each of the Parties shall provide to the Escrow Agent a correct, duly completed, dated and executed current United States Internal Revenue Service Form W-9 or Form W-8, whichever is appropriate, or any successor forms thereto, in a form and substance satisfactory to the Escrow Agent including appropriate supporting documentation and/or any other form, document, and/or certificate required or reasonably requested by the Escrow Agent to validate the form provided. Notwithstanding anything to the contrary herein provided, except for the delivery and filing of tax information reporting forms required pursuant to the Internal Revenue Code of 1986, as amended, to be delivered and filed with the Internal Revenue Service by the Escrow Agent, as escrow agent hereunder, the Escrow Agent shall have no duty to prepare or file any Federal or state tax report or return with respect to any funds held pursuant to this Escrow Agreement or any income earned thereon. With respect to the preparation, delivery and filing of such required tax information reporting forms and all matters pertaining to the reporting of earnings on funds held under this Escrow Agreement, the Escrow Agent shall be entitled to request and receive written instructions from Purchaser, and the Escrow Agent shall be entitled to rely conclusively and without further inquiry on such written instructions. The Parties jointly and severally agree to indemnify, defend and hold the Escrow Agent harmless from and against any tax, late payment, interest, penalty or other cost or expense that may be assessed against the Escrow Agent on or with respect to the Escrow Fund or any earnings or interest thereon unless such tax, late payment, interest, penalty or other cost or expense was finally adjudicated by a court of competent jurisdiction to have been directly caused by the gross negligence of willful misconduct of the Escrow Agent. The indemnification provided in this section is in addition to the indemnification provided to the Escrow Agent elsewhere in this Escrow Agreement and shall survive the resignation or removal of the Escrow Agent and the termination of this Escrow Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.5.</span></span>Any notice, request for consent, report, or any other communication required or permitted in this Escrow Agreement shall be in writing and shall be deemed to have been given when delivered (i) personally, (ii) by facsimile transmission with written confirmation of receipt, (iii) by electronic mail to the e-mail address given below, and written confirmation of receipt is obtained promptly after completion of the transmission, (iv) by overnight delivery by a reputable national overnight delivery service, or (v) by United States mail, postage prepaid, or by certified mail, return receipt requested and postage prepaid, in each case to the appropriate address set forth below or at such other address as any party hereto may have furnished to the other parties hereto in writing :</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><div style="padding-left:18pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:95%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td colspan="3" style="vertical-align:bottom;width:16.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:23.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">If to Escrow Agent:</p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Truist Bank</span></p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Escrow Services</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">919 East Main Street, 2nd Floor</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Richmond, Virginia 23219</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Client Manager: Charles Henderson</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone: (804) 782-7087</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email: Charles.Henderson@Truist.com</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">If to the Purchaser:</p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Data Knights Acquisition Corp.</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unit G6, Frome Business Park,</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Manor Road, Frome, BA11 4FN,</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Kingdom</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tel: +44 203 833 4000</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email: barry@dataknightsacuk.com</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:16.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax identification #:</p></td><td style="vertical-align:bottom;width:23.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">If to the Company:</p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">OneMedNet Corporation</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">6385 Old Shady Oak Road</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Suite 250</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eden Prairie, Minnesota 55344</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attn: Paul Casey</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facsimile No.:</p></td><td colspan="2" style="vertical-align:bottom;width:27.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;width:40.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Telephone No.: (800) 918-7189</p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">E-mail:</p></td><td colspan="3" style="vertical-align:bottom;width:34.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:22.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;width:16.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax identification #:</p></td><td style="vertical-align:bottom;width:23.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:37.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;">Any party hereto may unilaterally designate a different address by giving notice of each change in the manner specified above to each other party hereto. Notwithstanding anything to the contrary herein provided, the Escrow Agent shall not be deemed to have received any notice, request, report or other communication hereunder prior to the Escrow Agent&#8217;s actual receipt thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.6.</span></span>This Escrow Agreement is being made in and is intended to be construed according to the laws of the State of North Carolina. Except as permitted in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 2.9</span>, neither this Escrow Agreement nor any rights or obligations hereunder may be assigned by any party hereto without the express written consent of each of the other Parties hereto. This Escrow Agreement shall inure to and be binding upon the Parties and the Escrow Agent and their respective successors, heirs and permitted assigns.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.7.</span></span>The terms of this Escrow Agreement may be altered, amended, modified or revoked only by an instrument in writing signed by all the Parties and the Escrow Agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.8.</span></span>This Escrow Agreement is for the sole benefit of the Indemnified Parties, the Parties and the Escrow Agent, and their respective successors and permitted assigns, and nothing herein, express or implied, is intended to nor shall confer upon any other person or entity any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Escrow Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.9.</span></span>No party to this Escrow Agreement shall be liable to any other party hereto for losses due to, or if it is unable to perform its obligations under the terms of this Escrow Agreement because of, acts of God, fire, war, terrorism, floods, strikes, electrical outages, equipment or transmission failure, or other causes reasonably beyond its control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;">4.10.<span style="color:#010000;">&#160;</span>This Escrow Agreement shall terminate on the first to occur of either (i) the date on which all of the funds and property held by the Escrow Agent under this Escrow Agreement have been disbursed or (ii) January 1, 2023 at which time the Escrow Agent is authorized and directed to disburse all of the remaining funds and property held hereunder in accordance with the Joint Instructions of the Parties. Upon the termination of this Escrow Agreement and the disbursement of all of the funds and property held hereunder, this Escrow Agreement shall be of no further effect except that the provisions of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 2.8</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">3.1</span> and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">4.4</span> shall survive such termination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;">4.11.<span style="color:#010000;">&#160;</span>All titles and headings in this Escrow Agreement are intended solely for convenience of reference and shall in no way limit or otherwise affect the interpretation of any of the provisions hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;">4.12.&#160;This Escrow Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 3.54pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.1pt 18pt;">4.13.&#160;Contemporaneously with the execution and delivery of this Escrow Agreement and, if necessary, from time to time thereafter, each of the Parties shall execute and deliver to the Escrow Agent a Certificate of Incumbency substantially in the form of <span style="font-style:italic;font-weight:bold;">Exhibits A-1 </span>and <span style="font-style:italic;font-weight:bold;">A-2 </span>hereto, as applicable (a &#8220;<span style="font-style:italic;font-weight:bold;">Certificate of Incumbency</span>&#8221;), for the purpose of establishing the identity and authority of persons entitled to issue notices, instructions or directions to the Escrow Agent on behalf of each such party. Until such time as the Escrow Agent shall receive an amended Certificate of Incumbency replacing any Certificate of Incumbency theretofore delivered to the Escrow Agent, the Escrow Agent shall be fully protected in relying, without further inquiry, on the most recent Certificate of Incumbency furnished to the Escrow Agent. Whenever this Escrow Agreement provides for joint written notices, joint written instructions or other joint actions to be delivered to the Escrow Agent, the Escrow Agent shall be fully protected in relying, without further inquiry, on any joint written notice, instructions or action executed by persons named in such Certificate of Incumbency.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 18pt;">4.14.&#160;Each Party to this Escrow Agreement represents and warrants that it has the full power and authority to enter into this Escrow Agreement and to carry out the transactions contemplated by it and that it has taken all action necessary to authorize the execution, delivery, and performance of this Escrow Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">[Signatures on following page]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-style:italic;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_7f45288d_536e_445f_ba9c_484c2bb88fc5"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.05pt 0pt;">IN WITNESS WHEREOF, the Parties hereto have caused this Escrow Agreement to be executed as of the date first above written.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:40.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Purchaser:</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><b style="font-weight:bold;">Data Knights Acquisition Corp.</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">By:</p></td><td style="vertical-align:bottom;width:40.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Name:</p></td><td style="vertical-align:bottom;width:40.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Title:</p></td><td style="vertical-align:bottom;width:40.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Company:</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><b style="font-weight:bold;">OneMedNet Corporation</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">By:</p></td><td style="vertical-align:bottom;width:40.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Name:</p></td><td style="vertical-align:bottom;width:40.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Title:</p></td><td style="vertical-align:bottom;width:40.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Escrow Agent:</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><b style="font-weight:bold;">Truist Bank, as Escrow Agent</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">By: </p></td><td style="vertical-align:bottom;width:40.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Name:</p></td><td style="vertical-align:bottom;width:40.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Title:</p></td><td style="vertical-align:bottom;width:40.84%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 8pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_9daaceb5_d150_4f60_acc8_176aad02c467"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXHIBIT B-1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">TRUIST BANK &#8211; CORPORATE TRUST AND ESCROW SERVICES </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INCUMBENCY CERTIFICATE AND CLIENT NOTICE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">INDIVIDUAL(S) AUTHORIZED TO DIRECT TRUIST BANK AND SIGN DOCUMENTS ON BEHALF OF [CLIENT&#160;NAME] (&#8220;CLIENT&#8221;) WITH REGARD TO [ACCOUNT NUMBER/NAME]</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sign:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fax:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account View Access (Y/N):</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes: 1</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sign:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fax:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account View Access (Y/N):</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes: 1</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sign:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fax:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account View Access (Y/N):</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes: 1</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">INDIVIDUAL(S) AUTHORIZED TO RECEIVE ONLINE ACCESS<span style="letter-spacing:0.2pt;"> &#8201;&#8212;&#8201;</span> ONLY</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sign:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fax:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account View Access (Y/N):</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:5.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:92.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:5.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NOTE</b></p></td><td style="vertical-align:top;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:92.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SPECIAL INSTRUCTIONS (e.g., Limitations of Authority)</b></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:5.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></td><td style="vertical-align:top;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 4.8pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:92.5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 4.8pt;">Authorized to perform all Client actions contemplated under the governing documents.</p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:5.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2</p></td><td style="vertical-align:top;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:92.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:5.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:top;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:92.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The below undersigned individual hereby certifies: (i) to possess familiarity with documents and records that govern the above-referenced account and the operation and management of Client, (ii) to have the power and authority on behalf of Client to execute this Incumbency Certificate, and (iii) that the afore- referenced individuals (along with the undersigned, as noted) are duly authorized to instruct Truist Bank Corporate Trust on behalf of Client, and/or authorized to view bank statements regarding the above-referenced account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:4.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:23.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:34.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:0.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:4.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Date:</p></td><td style="vertical-align:bottom;width:23.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:34.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.13%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Signature</p></td><td style="vertical-align:top;width:0.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Truist Bank shall be entitled to rely upon any instructions from the individuals listed herein until notified in writing otherwise, or until termination of the above-referenced account. Client&#8217;s failure to submit an updated Incumbency Certificate shall deem the Certificate of Incumbency (or similar signatory and/or Notices disclosure) on file as its Evergreen Incumbency Certificate and all current trust accounting access as approved. All current trust accounting access, including paper statements, online statements and online transaction review access, shall be approved, as applicable. Client shall promptly advise Truist Bank Corporate Trust and Escrow Services of any changes affecting this Incumbency Certificate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 3.55pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3.54pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_55444138_48c2_45e7_9b97_2126408a19a9"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXHIBIT B-2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">TRUIST BANK &#8211; CORPORATE TRUST AND ESCROW SERVICES </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">INCUMBENCY CERTIFICATE AND CLIENT NOTICE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.2pt 0pt;">INDIVIDUAL(S) AUTHORIZED TO DIRECT TRUIST BANK AND SIGN DOCUMENTS ON BEHALF OF [CLIENT NAME] (&#8220;CLIENT&#8221;) WITH REGARD TO [ACCOUNT NUMBER/NAME]</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sign:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fax:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account View Access (Y/N):</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes: 1</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sign:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fax:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account View Access (Y/N):</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes: 1</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sign:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fax:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account View Access (Y/N):</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes: 1</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.2pt 0pt;">INDIVIDUAL(S) AUTHORIZED TO RECEIVE ONLINE ACCESS<span style="letter-spacing:0.2pt;"> &#8201;&#8212;&#8201;</span> ONLY</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phone #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #1:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Email #2:</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sign:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fax:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Account View Access (Y/N):</p></td></tr><tr style="height:14.15pt;"><td style="vertical-align:top;width:34.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:33.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td><td style="vertical-align:top;width:32.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:10.25pt;"><td style="vertical-align:top;width:5.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NOTE</b></p></td><td style="vertical-align:top;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:91.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SPECIAL INSTRUCTIONS (e.g., Limitations of Authority)</b></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:5.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></td><td style="vertical-align:top;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 4.8pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.65%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 4.8pt;">Authorized to perform all Client actions contemplated under the governing documents.</p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:5.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2</p></td><td style="vertical-align:top;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:10.25pt;"><td style="vertical-align:top;width:5.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:top;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.44pt 0pt;">The below undersigned individual hereby certifies: (i) to possess familiarity with documents and records that govern the above-referenced account and the operation and management of Client, (ii) to have the power and authority on behalf of Client to execute this Incumbency Certificate, and (iii) that the afore- referenced individuals (along with the undersigned, as noted) are duly authorized to instruct Truist Bank Corporate Trust on behalf of Client, and/or authorized to view bank statements regarding the above-referenced account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:4.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:26.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:4.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:34.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:27.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:4.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Date:</p></td><td style="vertical-align:top;width:26.66%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.26%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:34.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:27.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:26.66%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.17%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Signature</p></td><td style="vertical-align:top;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:27.5%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Truist Bank shall be entitled to rely upon any instructions from the individuals listed herein until notified in writing otherwise, or until termination of the above-referenced account. Client&#8217;s failure to submit an updated Incumbency Certificate shall deem the Certificate of Incumbency (or similar signatory and/or Notices disclosure) on file as its Evergreen Incumbency Certificate and all current trust accounting access as approved. All current trust accounting access, including paper statements, online statements and online transaction review access, shall be approved, as applicable. Client shall promptly advise Truist Bank Corporate Trust and Escrow Services of any changes affecting this Incumbency Certificate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_864b7e13_1435_4927_a48d_c0aa14a98bf6"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">EXHIBIT B</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Truist Bank, as Escrow Agent</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.44pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Schedule of Fees &amp; Expenses</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Acceptance Fee:</b><span style="display:inline-block;width:2.32pt;"></span><b style="font-weight:bold;">$1,000.00 &#8211;</b> one time only payable at the time of signing the Escrow Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.4pt 0pt;">The Acceptance Fee includes review of all related documents and accepting the appointment of Escrow Agent on behalf of Truist Bank. The fee also includes setting up the required account(s) and accounting records, document filing, and coordinating the receipt of funds/assets for deposit to the Escrow Account. This is a one-time fee payable upon execution of the Escrow Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.44pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Legal Review Fee:</b><span style="display:inline-block;width:11.7pt;"></span><b style="font-weight:bold;">$1,000.00 &#8211;</b> one time only payable at the time of signing the Escrow Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 4.75pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.4pt 0pt;">(Fee is waived if no legal review is needed)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.4pt 0pt;">The Legal Review Fee includes review of all related documents on behalf of Truist Bank as Escrow Agent. <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As soon as Truist Bank&#8217;s attorney begins to review the Escrow Agreement, the Legal Review Fee is subject to payment regardless if the Parties decide to appoint a different escrow agent or a decision is made that the Escrow Agreement is not needed.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.75pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.44pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Administration Fee:</b><span style="display:inline-block;width:3.62pt;"></span><b style="font-weight:bold;">$2,500.00 &#8211;</b> payable at the time of signing the Escrow Agreement and on the anniversary date thereafter, if applicable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.4pt 0pt;">The Administration Fee includes providing routine and standard services of an Escrow Agent. The fee includes administering the escrow account, performing investment transactions, processing cash transactions (including wires and check processing), disbursing funds in accordance with the Agreement (note any pricing considerations below), and providing trust account statements to the Parties for a twelve (12) month period. If the account remains open beyond the twelve (12) month term, the Parties will be invoiced each year on the anniversary date of the execution of the Escrow Agreement. Extraordinary expenses, including legal counsel fees, will be billed as out-of-pocket. The Administration Fee is due upon execution of the Escrow Agreement. The fees shall be deemed earned in full upon receipt by the Escrow Agent, and no portion shall be refundable for any reason, including without limitation, termination of the agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.75pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.44pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Out-of-Pocket Expenses:</b><span style="display:inline-block;width:2.18pt;"></span><b style="font-weight:bold;">At Cost</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.4pt 0pt;">Out-of-pocket expenses such as, but not limited to, postage, courier, overnight mail, wire transfer, travel, legal (out-of-pocket to counsel) or accounting, will be billed at cost.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.4pt 0pt;"><b style="font-weight:bold;">Note: This fee schedule is based on the assumption that the escrowed funds will be invested in the Truist Non-Interest Deposit Option. If any other investment options are chosen, this fee schedule will become subject to change.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deborah Spitale</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Senior Vice President</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">404-844-7533</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Deb.Sptiale@truist.com</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3.54pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_373b3976_8c3b_42f7_9eac_b47ed63b9796"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXHIBIT C</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Addendum for Wire Transfers</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3.59pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_858e2996_2c2d_441e_bf42_50da724209f7"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXHIBIT D</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Form of Extension Notice</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_940fb17d_e93b_430e_af69_f2cd8fd98b85"></a><a id="AnnexB_987067"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Annex C</span></p><a id="THIRDAMENDEDANDRESTATED_236185"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:12pt 0pt 0pt 0pt;"><b style="font-weight:bold;">THIRD AMENDED AND RESTATED</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATE OF INCORPORATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">[&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;], 2023</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the &#8220;<span style="font-style:italic;font-weight:bold;">Corporation</span>&#8221;), DOES HEREBY CERTIFY AS FOLLOWS:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</span></span>The name of the Corporation is &#8220;Data Knights Acquisition Corp.&#8221; The original certificate of incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on February 8, 2021, was amended and restated on March 8, 2021 by the First Amended and Restated Certificate, and was amended and restated on April 6, 2021 by the Second Amended and Restated Certificate (the &#8220;<span style="font-style:italic;font-weight:bold;">Certificate</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</span></span>This Third Amended and Restated Certificate of Incorporation (this &#8220;<span style="font-style:italic;font-weight:bold;">Third Amended and Restated Certificate</span>&#8221;), which both restates and amends the provisions of the Certificate, was duly adopted in accordance with Sections 228, 242 and 245 of the General Corporation Law of the State of Delaware, as amended from time to time (the &#8220;<span style="font-style:italic;font-weight:bold;">DGCL</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.</span></span>This Third Amended and Restated Certificate shall become effective on the date of filing with Secretary of State of Delaware.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.</span></span>The texts of the Certificate, as amended to the date hereof, is hereby restated and amended in their entirety to read as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE I</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NAME</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The name of the corporation is OneMedNet Corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Corporation</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE II</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PURPOSE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the General Corporation Law of the State of Delaware (the &#8220;<span style="font-style:italic;font-weight:bold;">DGCL</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE III</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">REGISTERED OFFICE AND AGENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The address of the Corporation&#8217;s registered office in the State of Delaware is 1209 Orange Street, Corporation Trust Center, City of Wilmington, County of New Castle, 19801. The name of its registered agent at that address is The Corporation Trust Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE IV</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">CAPITAL STOCK</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 4.1 </b>The total number of shares of all classes of capital stock, each with a par value of $0.0001 per share, which the Corporation is authorized to issue is 101,000,000 shares, consisting of (a) 100,000,000 shares of common stock (the &#8220;<span style="font-style:italic;font-weight:bold;">Common Stock</span>&#8221;), (b) 1,000,000 shares of preferred stock (the &#8220;<span style="font-style:italic;font-weight:bold;">Preferred Stock</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Section 4.2 </b>Shares of Preferred Stock may be issued from time to time in one or more classes or series. The Board of Directors of the Corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Board of Directors</span>&#8221;) is hereby authorized to provide from time to time by resolution or resolutions for the creation and issuance, out of the authorized and unissued shares of Preferred Stock, of one or more classes or series of Preferred Stock by filing a certificate (a &#8220;<span style="font-style:italic;font-weight:bold;">Certificate of Designation</span>&#8221;) pursuant to the DGCL, setting forth such resolution and, with respect to each such series, establishing the designation of such class or series and the number of shares to be included in such class or series and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">C-1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">fixing the voting powers (full or limited, or no voting power), preferences and relative, participating, optional or other special rights, and the qualifications, limitations and restrictions thereof, of the shares of each such class or series. Without limiting the generality of the foregoing, the resolution or resolutions providing for the establishment of any class or series of Preferred Stock may, to the extent permitted by law, provide that such class or series shall be superior to, rank equally with or be junior to the Preferred Stock of any other class or series. The powers, preferences and relative, participating, optional and other special rights of each class or series of Preferred Stock, and the qualifications, limitations, or restrictions thereof, if any, may be different from those of any and all other classes or series at any time outstanding. Except as otherwise expressly provided in the resolution or resolutions providing for the establishment of any class or series of Preferred Stock, no vote of the holders of shares of Preferred Stock or Common Stock shall be a prerequisite to the issuance of any shares of any class or series of the Preferred Stock so authorized in accordance with this Third Amended and Restated Certificate. Unless otherwise provided in the Certificate of Designation establishing a class or series of Preferred Stock, the Board of Directors may, by resolution or resolutions, increase or decrease (but not below the number of shares of such class or series then outstanding) the number of shares of such class or series and, if the number of shares of such class or series shall be so decreased, the shares constituting such decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such class or series.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 4.3 </b>The Corporation has the authority to create and issue rights, warrants, and options entitling the holders thereof to purchase shares of any class or series of the Corporation&#8217;s capital stock or other securities of the Corporation, and such rights, warrants and options shall be evidenced by or in instrument(s) approved by the Board of Directors. The Board of Directors is empowered to set the exercise price, duration, times for exercise and other terms and conditions of such rights, warrants or options; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that the consideration to be received for any shares of capital stock subject thereto may not be less than the par value thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 4.4</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(a) Except as otherwise required by law or this Third Amended and Restated Certificate (or any Certificate of Designation made hereunder), the holders of Common Stock shall exclusively possess all voting power with respect to the Corporation. The holders of shares of Common Stock shall be entitled to one vote for each such share on each matter properly submitted to the stockholders on which the holders of the Common Stock are entitled to vote. The holders of shares of the Common Stock shall at all times vote together as one class on all matters submitted to a vote of the stockholders of the Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(b) Except as otherwise required by law or this Third Amended and Restated Certificate (or any Certificate of Designation made hereunder), at any annual or special meetings of the stockholders of the Corporation, the holders of the Common Stock shall have the exclusive right to vote for the election of directors and on all other matters properly submitted to a vote of the stockholders. Notwithstanding the foregoing, except as otherwise required by law or this Third Amended and Restated Certificate (or any Certificate of Designation made hereunder), the holders of the Common Stock shall not be entitled to vote on any amendment to this Third Amended and Restated Certificate (or any Certificate of Designation made hereunder) that relates solely to the terms of one or more outstanding class or series of the Preferred Stock if the holders of such affected class or series of Preferred Stock are entitled, either separately or together with the holders of one or more other such class or series, to vote thereon pursuant to this Third Amended and Restated Certificate (or any Certificate of Designation made hereunder) or the DGCL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(c) Subject to applicable law and the rights, if any, of the holders of any outstanding class or series of the Preferred Stock, the holders of the shares of the Common Stock shall be entitled to receive such dividends and other distributions (payable in cash, property or capital stock of the Corporation) when, as and if declared thereon by the Board from time to time out of any assets or funds of the Corporation legally available therefor, and shall share equally on a per share basis in such dividends and distributions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(d) Subject to applicable law and the rights, if any, of the holders of any outstanding class or series of the Preferred Stock, in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the Corporation, after payment or provision for payment of the debts and other liabilities of the Corporation, the holders of the shares of the Common Stock shall be entitled to receive all the remaining assets of the Corporation available for distribution to its stockholders, ratably in proportion to the number of shares of the Common Stock held by them.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">C-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE V</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">BOARD OF DIRECTORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the management of the business and for the conduct of the affairs of the Corporation it is further provided that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 5.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(a) The management of the business and the conduct of the affairs of the Corporation shall be vested in the Board of Directors. The number of directors of the Corporation shall be nine (9), which number may be increased or decreased by one or more resolutions adopted from time to time by the Board of Directors, subject to Sections 5.1(c) and 5.1(d). The Board of Directors shall be classified, with respect to the term for which the directors hold office, into three classes, one class serving for a term expiring at the annual meeting of stockholders to be held in 2023, the second class serving for a term expiring at the annual meeting of stockholders to be held in 2024, and the third class serving for a term expiring at the annual meeting of stockholders to be held in 2025. At each annual meeting of stockholders, directors elected to succeed those directors whose terms expire shall be elected for a term of office to expire at the third succeeding annual meeting of stockholders after their election. Notwithstanding the foregoing, the directors elected to each class shall hold office until their successors are duly elected and qualified or until their earlier resignation, death, or removal. If the number of directors is hereafter changed, any newly created directorships or decrease in directorships shall be so apportioned among the classes as to make all classes as nearly equal in number as is practicable, provided that no decrease in the number of directors constituting the entire Board shall shorten the term of any incumbent director. No reduction in the number of directors shall cause the removal of any director from office prior to the expiration of his or her term.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(b) Except as may otherwise be provided in the terms of any Preferred Stock issued by the Corporation, the Board of Directors or any individual director may be removed from office at any time but only by the affirmative vote of the holders of at least a majority of the voting power of all of the then outstanding shares of voting stock of the Corporation with the power to vote at an election of directors (the &#8220;<span style="font-style:italic;font-weight:bold;">Voting Stock</span>&#8221;) and, in addition to and without limitation of the foregoing only for cause.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(c) Except as may otherwise be provided in the terms of any Preferred Stock issued by the Corporation and subject to Section 5.1(d) below, any vacancies on the Board of Directors resulting from death, resignation, disqualification, retirement, removal or other causes and any newly created directorships resulting from any increase in the number of directors shall, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by the stockholders, and except as otherwise provided by law, be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum, or by a sole remaining director, and shall not be filled by the stockholders. Any director appointed in accordance with the preceding sentence shall hold office for a term that shall coincide with the remaining term of the vacancy to which the director shall have been appointed and until such director&#8217;s successor shall have been elected and qualified or until his or her earlier death, resignation, disqualification, retirement, or removal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(d) Effective as of the date of filing of this Third Amended and Restated Certificate, the Board of Directors of the Corporation shall consist of nine (9) members, constituted as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(i) in the director class whose term expires at the annual meeting held in 2023, three&#160;(3) directors nominated by OneMedNet [Technologies] Corporation, f/k/a OneMedNet Corporation, a Delaware corporation (&#8220;OneMedNet [Technologies]&#8221;), one of whom shall qualify as an independent director under the rules of The Nasdaq Stock Market (an &#8220;<span style="font-style:italic;font-weight:bold;">Independent Director</span>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(ii) in the director class whose term expires at the annual meeting held in 2024, (A)&#160;two (2) directors designated by OneMedNet [Technologies], one (1) of whom shall be an Independent Director, and (B) one (1) director designated by Data Knights, LLC, a Delaware limited liability company and the Corporation&#8217;s sponsor (the &#8220;<span style="font-style:italic;font-weight:bold;">Sponsor</span>&#8221;), who shall be an Independent Director; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(iii) in the director class whose term expires at the annual meeting held in 2025, (A)&#160;two (2) directors designated by OneMedNet [Technologies], one (1) of whom shall be an Independent Director, and (B) one (1) director designated by the Sponsor.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">C-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 5.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(a) In furtherance and not in limitation of the powers conferred by statute, the Board of Directors is expressly authorized to adopt, amend, alter, or repeal the Bylaws of the Corporation. In addition to any vote of the holders of any class or series of stock of the Corporation required by applicable law or by this Third Amended and Restated Certificate (including any Certificate of Designation in respect of one or more classes or series of Preferred Stock), the adoption, amendment or repeal of the Bylaws of the Corporation by the stockholders of the Corporation shall require the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2/3%) of the voting power of all the then-outstanding shares of the Voting Stock, voting together as a single class; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that no Bylaws hereafter adopted by the stockholders of the Corporation shall invalidate any prior act of the Board of Directors that would have been valid if such Bylaws had not been adopted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(b) The directors of the Corporation need not be elected by written ballot unless the Bylaws so provide.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE VI</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">STOCKHOLDERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 6.1 </b>Subject to the special rights of the holders of one or more classes or series of Preferred Stock, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meetings of the stockholders of the Corporation, and the taking of any action by written consent of the stockholders in lieu of a meeting of the stockholders is specifically denied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 6.2 </b>Subject to the special rights of the holders of one or more classes or series of Preferred Stock, special meetings of the stockholders of the Corporation may be called, for any purpose or purposes as is a proper matter for stockholder action under the DGCL, by (i) the Chairperson of the Board of Directors, (ii) the Chief Executive Officer, or (iii) the Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directors (whether or not there exist any vacancies in previously authorized directorships at the time any such resolution is presented to the Board of Directors for adoption). Such special meetings may not be called by stockholders or any other person or persons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 6.3 </b>Advance notice of stockholder nominations for the election of directors and of other business proposed to be brought by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE VII</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">LIABILITY AND INDEMNIFICATION; CORPORATE OPPORTUNITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 7.1 </b>To the fullest extent permitted by the DGCL, as the same exists or as may hereafter be amended, a director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director. If the DGCL is amended after approval by the stockholders of this Article VII to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL as so amended, automatically and without further action, upon the date of such amendment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 7.2 </b>The Corporation, to the fullest extent permitted by law, shall indemnify and advance expenses to any person made or threatened to be made a party to an action, suit or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that he or she, or his or her testator or intestate, is or was a director or officer of the Corporation or any predecessor of the Corporation, or serves or served at any other enterprise as a director or officer at the request of the Corporation or any predecessor to the Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 7.3 </b>The Corporation, to the fullest extent permitted by law, may indemnify and advance expenses to any person made or threatened to be made a party to an action, suit or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that he or she, or his or her testator or intestate, is or was an employee or agent of the Corporation or any predecessor of the Corporation, or serves or served at any other enterprise as an employee or agent at the request of the Corporation or any predecessor to the Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Section 7.4 </b>Neither any amendment nor repeal of this Article VII, nor the adoption by amendment of this Third Amended and Restated Certificate of any provision inconsistent with this Article VII, shall eliminate or reduce the effect of this Article VII in </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">C-4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">respect of any matter occurring, or any action or proceeding accruing or arising (or that, but for this Article VII, would accrue or arise) prior to such amendment or repeal or adoption of an inconsistent provision.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE VIII</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">BUSINESS COMBINATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 8.1 </b>The Corporation will be subject to Section 203 of the DGCL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 8.2 </b>Notwithstanding Section 8.1, the Corporation shall not engage in any business combination (as defined below), at any point in time at which the Corporation&#8217;s common stock is registered under Section 12(b) or 12(g) of the Exchange Act, with any interested stockholder (as defined below) for a period of three years following the time that such stockholder of the Corporation became an interested stockholder, unless:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(a) prior to such time, the Board approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder, or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(b) upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock (as defined below) of the Corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned by (i) persons who are directors and also officers of the Corporation or (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer, or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(c) at or subsequent to such time, the business combination is approved by the Board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2/3</sup>% of the outstanding voting stock of the Corporation which is not owned by the interested stockholder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 8.3 </b>For the purposes of this Article VIII:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(a) &#8220;affiliate&#8221; means a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, another person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(b) &#8220;associate,&#8221; when used to indicate a relationship with any person, means: (i) any corporation, partnership, unincorporated association or other entity of which such person is a director, officer or partner or is, directly or indirectly, the owner of 20% or more of any class of voting stock; (ii) any trust or other estate in which such person has at least a 20% beneficial interest or as to which such person serves as trustee or in a similar fiduciary capacity; and (iii) any relative or spouse of such person, or any relative of such spouse, who has the same residence as such person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(c) &#8220;business combination,&#8221; when used in reference to the Corporation and any interested stockholder, means:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(i) any merger or consolidation of the Corporation or any direct or indirect majority-owned subsidiary of the Corporation (A) with the interested stockholder, or (B) with any other corporation, partnership, unincorporated association or other entity if the merger or consolidation is caused by the interested stockholder and as a result of such merger or consolidation Article XI is not applicable to the surviving entity;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(ii) any sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of transactions), except proportionately as a stockholder of the Corporation, to or with the interested stockholder, whether as part of a dissolution or otherwise, of assets of the Corporation or of any direct or indirect majority-owned subsidiary of the Corporation which assets have an aggregate market value equal to 10% or more of either the aggregate market value of all the assets of the Corporation determined on a consolidated basis or the aggregate market value of all the outstanding stock of the Corporation;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;">(iii) any transaction which results in the issuance or transfer by the Corporation or by any direct or indirect majority-owned subsidiary of the Corporation of any stock of the Corporation or of such subsidiary to the interested stockholder, except: (A) pursuant to the exercise, exchange or conversion of securities exercisable for, exchangeable for or convertible into stock of the Corporation or any such subsidiary which securities were outstanding prior to the time that the interested </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">C-5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">stockholder became such; (B) pursuant to a merger under Section 251(g) of the DGCL; (C) pursuant to a dividend or distribution paid or made, or the exercise, exchange or conversion of securities exercisable for, exchangeable for or convertible into stock of the Corporation or any such subsidiary which security is distributed, pro rata to all holders of a class or series of stock of the Corporation subsequent to the time the interested stockholder became such; (D) pursuant to an exchange offer by the Corporation to purchase stock made on the same terms to all holders of said stock; or (E) any issuance or transfer of stock by the Corporation; provided, however, that in no case under items (C)-(E) of this subsection (iii) shall there be an increase in the interested stockholder&#8217;s proportionate share of the stock of any class or series of the Corporation or of the voting stock of the Corporation (except as a result of immaterial changes due to fractional share adjustments);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(iv) any transaction involving the Corporation or any direct or indirect majority-owned subsidiary of the Corporation which has the effect, directly or indirectly, of increasing the proportionate share of the stock of any class or series, or securities convertible into the stock of any class or series, of the Corporation or of any such subsidiary which is owned by the interested stockholder, except as a result of immaterial changes due to fractional share adjustments or as a result of any purchase or redemption of any shares of stock not caused, directly or indirectly, by the interested stockholder; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(v) any receipt by the interested stockholder of the benefit, directly or indirectly (except proportionately as a stockholder of the Corporation), of any loans, advances, guarantees or pledges (other than those expressly permitted in subsections (i)-(iv) above) provided by or through the Corporation or any direct or indirect majority-owned subsidiary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(d) &#8220;control,&#8221; including the terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and &#8220;under common control with,&#8221; means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a person, whether through the ownership of voting stock, by contract, or otherwise. A person who is the owner of 20% or more of the outstanding voting stock of the Corporation, partnership, unincorporated association or other entity shall be presumed to have control of such entity, in the absence of proof by a preponderance of the evidence to the contrary. Notwithstanding the foregoing, a presumption of control shall not apply where such person holds voting stock, in good faith and not for the purpose of circumventing this Article VIII, as an agent, bank, broker, nominee, custodian or trustee for one or more owners who do not individually or as a group have control of such entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(e) &#8220;interested stockholder&#8221; means any person (other than the Corporation or any direct or indirect majority-owned subsidiary of the Corporation) that (i) is the owner of 15% or more of the outstanding voting stock of the Corporation, or (ii) is an affiliate or associate of the Corporation and was the owner of 15% or more of the outstanding voting stock of the Corporation at any time within the three year period immediately prior to the date on which it is sought to be determined whether such person is an interested stockholder, and the affiliates and associates of such person; provided, however, that the term &#8220;interested stockholder&#8221; shall not include (A) the Principal Stockholder or Principal Stockholder Transferees or any &#8220;group&#8221; (within the meaning of Rule 13d-5 of the Exchange Act) that includes any Principal Stockholder or Principal Stockholder Transferee or (B) any person whose ownership of shares in excess of the 15% limitation set forth herein is the result of any action taken solely by the Corporation; provided that such person specified in this clause (B) shall be an interested stockholder if thereafter such person acquires additional shares of voting stock of the Corporation, except as a result of further corporate action not caused, directly or indirectly, by such person. For the purpose of determining whether a person is an interested stockholder, the voting stock of the Corporation deemed to be outstanding shall include stock deemed to be owned by the person through application of the definition of &#8220;owner&#8221; below but shall not include any other unissued stock of the Corporation which may be issuable pursuant to any agreement, arrangement or understanding, or upon exercise of conversion rights, warrants or options, or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(f) &#8220;owner,&#8221; including the terms &#8220;own&#8221; and &#8220;owned,&#8221; when used with respect to any stock, means a person that individually or with or through any of its affiliates or associates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(i) beneficially owns such stock, directly or indirectly; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(ii) has (A) the right to acquire such stock (whether such right is exercisable immediately or only after the passage of time) pursuant to any agreement, arrangement or understanding, or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise; provided, however, that a person shall not be deemed the owner of stock tendered pursuant to a tender or exchange offer made by such person or any of such person&#8217;s affiliates or associates until such tendered stock is accepted for purchase or exchange; or (B) the right to vote such stock pursuant to any agreement, arrangement or understanding; provided, however, that a person shall not be deemed the owner of any stock because of such person&#8217;s right to vote such stock if the agreement, arrangement or understanding to vote such stock arises solely from a revocable proxy or consent given in response to a proxy or consent solicitation made to ten or more persons; or</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">C-6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;">(iii) has any agreement, arrangement or understanding for the purpose of acquiring, holding, voting (except voting pursuant to a revocable proxy or consent as described in item (B) of subsection (ii) above), or disposing of such stock with any other person that beneficially owns, or whose affiliates or associates beneficially own, directly or indirectly, such stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(g) &#8220;person&#8221; means any individual, corporation, partnership, unincorporated association or other entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(h) &#8220;stock&#8221; means, with respect to any corporation, capital stock and, with respect to any other entity, any equity interest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(i) &#8220;Principal Stockholder&#8221; means, collectively, (i) the Sponsor and (ii) any affiliate or successor of a person referenced in clauses (i) and (ii) of this definition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(j) &#8220;Principal Stockholder Transferee&#8221; means any Person who acquires voting stock of the Corporation from the Principal Stockholder (other than in connection with a public offering) and who is designated in writing by the Principal Stockholder as a &#8220;Principal Stockholder Transferee.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(k) &#8220;voting stock&#8221; means stock of any class or series entitled to vote generally in matters submitted for stockholders&#8217; approval other than the election of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE IX</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXCLUSIVE FORUM</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 9.1 </b>Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for (a) any derivative action or proceeding brought on behalf of the Corporation, (b) any action asserting a claim of breach of fiduciary duty owed by any director, officer, employee, agent or stockholder of the Corporation to the Corporation or the Corporation&#8217;s stockholders, creditors or other constituents, (c) any action asserting a claim arising pursuant to any provision of the DGCL or this Third Amended and Restated Certificate or the Bylaws of the Corporation, or (d) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein; <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span> that suits brought to enforce any liability or duty created by the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts have exclusive jurisdiction, shall be brought in the federal district court for the district of Delaware; and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided further</span> that, if and only if the Court of Chancery of the State of Delaware dismisses any such action for lack of subject matter jurisdiction, such action may be brought in another state or federal court sitting in the State of Delaware. To the fullest extent permitted by applicable law, any person or entity purchasing or otherwise acquiring or holding any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article VIII. Notwithstanding any other provisions of law, this Third Amended and Restated Certificate or the Bylaws of the Corporation, and notwithstanding the fact that a lesser percentage may be specified by law, the affirmative vote of the holders of at least two-thirds in voting power of the outstanding shares of capital stock of the Corporation entitled to vote thereon shall be required to amend or repeal, or to adopt any provision inconsistent with, this Article VIII. If any provision or provisions of this Article VIII shall be held to be invalid, illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Article VIII (including, without limitation, each portion of any sentence of this Article VIII containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Section 9.2 </b>If any action the subject matter of which is within the scope of Section 9.1 is filed in a court other than within the State of Delaware (a &#8220;<span style="font-style:italic;font-weight:bold;">Foreign Action</span>&#8221;) in the name of any stockholder, such stockholder shall be deemed to have consented to (i) the personal jurisdiction of the state and federal courts of the State of Delaware in connection with any action brought in any such court to enforce Section 9.1 (an &#8220;<span style="font-style:italic;font-weight:bold;">FSC Enforcement Action</span>&#8221;) and (ii) having service of process made upon such stockholder in any such FSC Enforcement Action by service upon such stockholder&#8217;s counsel in the Foreign Action as agent for such stockholder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Section 9.3 </b>If any provision or provisions of this Article VIII shall be held to be invalid, illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Article VIII (including, without limitation, each portion of any sentence of this Article VIII containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby. Any person or entity purchasing or otherwise acquiring any </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">C-7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article VIII.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ARTICLE X</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">AMENDMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Notwithstanding any other provisions of this Third Amended and Restated Certificate or any provision of law which might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the Voting Stock required by law or by this Third Amended and Restated Certificate (including any Certificate of Designation in respect of one or more series of Preferred Stock), the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2/3%) of the voting power of all of the then-outstanding shares of the Voting Stock, voting together as a single class, shall be required to alter, amend or repeal Articles V, VI, VII, VIII, IX and this Article X.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">C-8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_a31d65fe_9976_44ce_bf78_a1d71ca9f073"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">IN WITNESS WHEREOF, Data Knights Acquisition Corp. has caused this Amended and Restated Certificate to be duly executed and acknowledged in its name and on its behalf by an authorized officer as of the date first set forth above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:98%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:5.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:40.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:49.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:49.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:49.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:45.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.51%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:40.47%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:40.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_b417528b_dfc5_4a17_8bcd_489acb8fabe1"></a><a id="AnnexC_319286"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:right;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Annex D</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="DATAKNIGHTSACQUISITIONCORP12022EQUITYINC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup><b style="font-weight:bold;"> 2022 EQUITY INCENTIVE PLAN</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purpose</i>. The purpose of the Data Knights Acquisition Corp. 2022 Equity Incentive Plan (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Plan</span>&#8221;) is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby Directors, officers, Employees, and Consultants (and prospective Directors, officers, Employees, and Consultants) of the Company and its Affiliates can acquire and maintain an equity interest in the Company, or be paid incentive compensation, which may (but need not) be measured by reference to the value of Common Shares, thereby strengthening their commitment to the welfare of the Company and its Affiliates and aligning their interests with those of the Company&#8217;s stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Definitions</i>. The following definitions shall be applicable throughout the Plan:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Affiliate</i>&#8221; means (i) any person or entity that directly or indirectly controls, is controlled by or is under common control with the Company and/or (ii) to the extent provided by the Committee, any person or entity in which the Company has a significant interest. The term &#8220;control&#8221; (including, with correlative meaning, the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;), as applied to any person or entity, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such person or entity, whether through the ownership of voting or other securities, by contract or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Award</i>&#8221; means, individually or collectively, any Incentive Stock Option, Nonqualified Stock Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Stock Bonus Award, and Performance Compensation Award granted under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;">&#8220;Award Agreement&#8221;</i> means a written or electronic agreement between the Company and a Participant setting forth the terms, conditions and restrictions of the Award granted to the Participant</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Board</i>&#8221; means the Board of Directors of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Business Combination</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cause</i>&#8221; means, in the case of a particular Award, unless the applicable Award Agreement or the Participant&#8217;s employment agreement with the Company states otherwise, the Company&#8217;s termination of the Participant&#8217;s employment with the Company as a result of: (i) fraud, embezzlement or other willful act of material dishonesty by the Participant in connection with or relating to the Participant&#8217;s employment with the Company; (ii) theft or misappropriation of property, information or other assets by the Participant in connection with the Participant&#8217;s employment with the Company which results in or could reasonably be expected to result in material loss, damage or injury to the Company, its goodwill, business or reputation; (iii) the Participant&#8217;s commission, guilty plea, no contest plea or similar plea for any felony or crime involving moral turpitude; (iv) the Participant&#8217;s use of alcohol or drugs while working that materially interferes with the Participant&#8217;s duties under this Agreement; (v) material breach of a material Company policy, or material breach of a Company policy that results in or could reasonably be expected to result in material loss, damage or injury to the Company, its goodwill, business or reputation; (vi) the Participant&#8217;s material breach of any of Participant&#8217;s obligations under this Agreement; or (vii) the Participant&#8217;s repeated insubordination, or refusal (other than as a result of a Disability or physical or mental illness) to carry out or follow specific reasonable and lawful instructions, duties or assignments given by the Board which are consistent with the Participant&#8217;s position with the Company. Additionally, in the event that the basis for Cause is, in the reasonable good faith determination of the Company not reasonably subject to cure, then such thirty (30) days&#8217; prior notice of termination for Cause shall not be required, and such termination shall be effective on the date the Company delivers notice of such termination for Cause.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup><span style="display:inline-block;width:14.75pt;"></span>Company name to be changed to OneMedNet Corporation upon stockholder approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Change in Control</i>&#8221; shall, in the case of a particular Award, unless the applicable Award Agreement states otherwise or contains a different definition of &#8220;Change in Control,&#8221; be deemed to occur upon:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Any sale, lease, exchange or other transfer (in one or a series of related transactions) of all or substantially all of the assets of the Company;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Any &#8220;Person&#8221; as such term is used in Section 13(d) and Section 14(d) of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Act</span>&#8221;) becomes, directly or indirectly, the &#8220;beneficial owner&#8221; as defined in Rule 13d-3 under the Exchange Act of securities of the Company that represent more than 50% of the combined voting power of the Company&#8217;s then outstanding voting securities (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Outstanding Company Voting Securities</span>&#8221;);&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that for purposes of this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 2(f)(ii)</span>, the following acquisitions shall not constitute a Change in Control: (I) any acquisition directly from the Company principally for bona fide equity financing purposes, (II) any acquisition by the Company, (III) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Affiliate, (IV) any acquisition by any corporation pursuant to a transaction that complies with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 2(f)(iv)(A)</span> and <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">2(f)(iv)(B)</span>, and (V) any acquisition involving beneficial ownership of less than 50% of the then-outstanding Common Shares (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Outstanding Company Common Shares</span>&#8221;) or the Outstanding Company Voting Securities that is determined by the Board, based on review of public disclosure by the acquiring Person with respect to its passive investment intent, not to have a purpose or effect of changing or influencing the control of the Company;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that for purposes of this clause (V), any such acquisition in connection with (x) an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents or (y) any &#8220;Business Combination&#8221; (as defined below) shall be presumed to be for the purpose or with the effect of changing or influencing the control of the Company;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>During any period of not more than two (2) consecutive years, individuals who constitute the Board as of the beginning of the period (the &#8220;Incumbent Directors&#8221;) cease for any reason to constitute at least a majority of the Board,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided that</span>&#160;any person becoming a director subsequent to the beginning of such period, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) will be an Incumbent Director;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board will be deemed to be an Incumbent Director;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>Consummation of a merger, amalgamation or consolidation (a &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Business Combination</span>&#8221;) of the Company with any other corporation, unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Shares and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company&#8217;s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Shares and the Outstanding Company Voting Securities, as the case may be, and (B) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were Incumbent Directors at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span>Stockholder approval of a plan of complete liquidation of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vi)</span></span>A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transactions. In addition, if any Person (as defined above) is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered to cause a Change in Control. If required for compliance with Code Section&#160;409A, in no event will a Change in Control be deemed to have occurred if such transaction is not also a &#8220;change in the ownership or effective control of&#8221; the Company or &#8220;a change in the ownership of a substantial portion of the assets of&#8221; the Company as determined under Treasury Regulation&#160;Section&#160;1.409A-3(i)(5)&#160;(without regard to any alternative definition thereunder).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Code</i>&#8221; means the Internal Revenue Code of 1986, as amended, and any successor thereto. Reference in the Plan to any section of the Code shall be deemed to include any regulations or other interpretative guidance under such section, and any amendments or successor provisions to such section, regulations or guidance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Committee</i>&#8221; means a committee of at least two people as the Board may appoint to administer the Plan or, if no such committee has been appointed by the Board, the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Common Shares</i>&#8221; means shares of the Company&#8217;s Class A common stock (and any stock or other securities into which such ordinary shares may be converted or into which they may be exchanged).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</i>&#8221; means Data Knights Acquisition Corp.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>, a Delaware corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(l)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Consultant</i>&#8221; means any person, including an advisor, consultant or agent, engaged by the Company or a Parent or Subsidiary to render services to such entity or who renders, or has rendered, services to the Company, or any Parent, Subsidiary or affiliate and is compensated for such services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(m)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Date of Grant</i>&#8221; means the date on which the granting of an Award is authorized, or such other date as may be specified in such authorization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(n)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Director</i>&#8221; means a member of the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(o)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disability</i>&#8221; means, for the purpose of Incentive Stock Options, total and permanent disability as defined in Code Section&#160;22(e)(3); and for the purpose of Awards other than Incentive Stock Options, means the inability of the Participant to perform the Participant&#8217;s material duties hereunder with a reasonable accommodation due to a physical or mental injury, infirmity or incapacity for one hundred and twenty (120) days (including weekends and holidays) in any three hundred sixty-five (365) day period. The Participant shall reasonably cooperate with the Company if a question arises as to whether the Participant has become disabled (including, without limitation, submitting to reasonable examinations by one or more medical doctors and other health care specialists reasonably selected by the Company and authorizing such medical doctors and other health care specialists to discuss the Participant&#8217;s condition with the Company).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(p)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effective Date</i>&#8221; means the date means the date on which the Plan is approved by the stockholders of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(q)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Eligible Director</i>&#8221; means a person who is a &#8220;non-employee director&#8221; within the meaning of Rule 16b-3 under the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(r)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Eligible Person</i>&#8221; with respect to an Award denominated in Common Shares, means any (i) Employee;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that no such employee covered by a collective bargaining agreement shall be an Eligible Person unless and to the extent that such eligibility is set forth in such collective bargaining agreement which includes rules regarding equity entitlement or in an agreement or instrument relating thereto; (ii) Director of the Company or an Affiliate; (iii) Consultant to the Company or an Affiliate;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>&#160;that if the Securities Act applies such persons must be eligible to be offered securities registrable on Form S-8 under the Securities Act; or (iv) prospective employees, directors, officers, consultants or advisors who have accepted offers of employment or consultancy from the Company or its Affiliates (and would satisfy the provisions of clauses (i) through (iii) above once he or she begins employment with or begins providing services to the Company or its Affiliates).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(s)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employee</i>&#8221; means any person, including officers and Directors, employed by the Company or any Affiliate or Subsidiary of the Company. Neither service as a Director nor payment of a director&#8217;s fee by the Company will be sufficient to constitute &#8220;employment&#8221; by the Company</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup><span style="display:inline-block;width:14.75pt;"></span>Company named to be changed to OneMedNet Corporation upon stockholder approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(t)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Act</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control,&#8221; and any reference in the Plan to any section of (or rule promulgated under) the Exchange Act shall be deemed to include any rules, regulations or other interpretative guidance under such section or rule, and any amendments or successor provisions to such section, rules, regulations or guidance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(u)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Program</i>&#8221; means a program under which outstanding Awards are amended to provide for a lower Exercise Price or surrendered or cancelled in exchange for (i)&#160;Awards with a lower Exercise Price, (ii)&#160;a different type of Award or awards under a different equity incentive plan, (iii)&#160;cash, or (iv)&#160;a combination of (i), (ii)&#160;and/or (iii). Notwithstanding the preceding, the term Exchange Program does not include (A)&#160;any action taken in connection with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> or with a Change in Control transaction nor (B)&#160;any transfer or other disposition permitted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section&#160;15(c)</span>. For the purpose of clarity, each of the actions described in the prior sentence, none of which constitute an Exchange Program, may be undertaken (or authorized) by the Committee in its sole discretion without approval by the Company&#8217;s stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exercise Price</i>&#8221; has the meaning given such term in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7(b)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(w)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Fair Market Value</i>&#8221; means, as of any date, the value of Common Shares determined as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>If the Common Shares are listed on any established stock exchange or a national market system will be the closing sales price for such shares (or the closing bid, if no sales were reported) as quoted on such exchange or system on the day of determination, as reported in&#160;<i style="font-style:italic;">The Wall Street Journal&#160;</i>or such other source as the Committee deems reliable;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>If the Common Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Common Share will be the mean between the high bid and low asked prices for the Common Shares on the day of determination, as reported in&#160;<i style="font-style:italic;">The Wall Street Journal&#160;</i>or such other source as the Committee deems reliable; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>In the absence of an established market for the Common Shares, the Fair Market Value will be determined in good faith by the Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(x)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Good Reason</i>&#8221; means, in the case of a particular Award, unless the applicable Award Agreement or the Participant&#8217;s employment agreement with the Company states otherwise, the occurrence of any of the following events, without the express written consent of the Participant: (i) the Company&#8217;s material breach of any of its obligations under the Participant&#8217;s employment agreement with the Company or this Agreement, (ii) reduction in the Participant&#8217;s total annual cash compensation opportunity (i.e., base salary and target annual bonus) as described in the Participant&#8217;s employment agreement with the Company, (iii) a material relocation of the Participant&#8217;s principal place of employment to a location more than fifty (50) miles from the current principal place of employment approved by the Company, or (iv) the failure of a successor to the Company to assume the Company&#8217;s obligations under the Participant&#8217;s employment agreement with the Company or this Agreement, <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, that, for (i) &#8211; (iv) above, the Participant has given written notice to the Company of the condition giving rise to Good Reason within ninety (90) days after its initial occurrence and the Company fails to cure such condition within thirty (30) days following the receipt of such written notification by the Participant to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(y)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Immediate Family Members</i>&#8221; shall have the meaning set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 16(b)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(z)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Incentive Stock Option</i>&#8221; means an Option that is designated by the Committee as an incentive stock option as described in Code Section 422 and otherwise meets the requirements set forth in the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(aa)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnifiable Person</i>&#8221; shall have the meaning set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 4(e)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(bb)</span></span><i style="font-style:italic;">&#8220;</i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mature Shares</i>&#8221; means Common Shares owned by a Participant that are not subject to any pledge or security interest and that have been either previously acquired by the Participant on the open market or meet such other requirements, if any, as the Committee may determine are necessary in order to avoid an accounting earnings charge on account of the use of such shares to pay the Exercise Price or satisfy a tax or deduction obligation of the Participant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(cc)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nonqualified Stock Option</i>&#8221; means an Option that is not designated by the Committee as an Incentive Stock Option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(dd)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Option</i>&#8221; means an Award granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7</span> of the Plan.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ee)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Option Period</i>&#8221; has the meaning given such term in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7(c)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ff)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Cash-Based Award</i>&#8221; shall mean a right or other interest granted to a Participant pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section&#160;11</span> of the Plan other than an Other Stock-Based Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(gg)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Stock-Based Award</i>&#8221; shall mean a right or other interest granted to a Participant, valued in whole or in part by reference to, or otherwise based on, or related to, Common Stock pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section&#160;11</span> of the Plan including but not limited to (i)&#160;unrestricted Common Stock awarded as a bonus or upon the attainment of performance goals or otherwise as permitted under the Plan, and (ii)&#160;a right granted to a Participant to acquire Common Stock from the Company containing terms and conditions prescribed by the Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(hh)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Outstanding Company Common Shares</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Outstanding Company Voting Securities</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(jj)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Participant</i>&#8221; means an Eligible Person who has been selected by the Committee to participate in the Plan and to receive an Award pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 6</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(kk)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Compensation Award</i>&#8221; shall mean any Award designated by the Committee as a Performance Compensation Award pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 11</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ll)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Criteria</i>&#8221; shall mean the criterion or criteria that the Committee shall select for purposes of establishing the Performance Goal(s) for a Performance Period with respect to any Performance Compensation Award under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(mm)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Formula</i>&#8221; shall mean, for a Performance Period, the one or more formulae applied against the relevant Performance Goal to determine, with regard to the Performance Compensation Award of a particular Participant, whether all, some portion but less than all, or none of the Performance Compensation Award has been earned for the Performance Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(nn)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Goals</i>&#8221; shall mean, for a Performance Period, the one or more goals established by the Committee for the Performance Period based upon the Performance Criteria.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(oo)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Period</i>&#8221; shall mean the one or more periods of time, as the Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to, and the payment of, a Performance Compensation Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(pp)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Permitted Transferee</i>&#8221; shall have the meaning set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 16(b)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(qq)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Person</i>&#8221; has the meaning given such term in the definition of &#8220;Change in Control.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(rr)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Plan</i>&#8221; means this Data Knights Acquisition Corp.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup> 2022 Equity Incentive Plan, as amended from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ss)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Qualifying Termination</i>&#8221; means, except as otherwise provided by the Committee as set forth in the Award, the occurrence of either a termination of a Participant&#8217;s employment by the Company without Cause or for Good Reason, in either case, occurring on or within the 12-month period (or such other period specified in the applicable Award Agreement) following the consummation of a Change in Control.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup><span style="display:inline-block;width:14.75pt;"></span>Company name to be changed to OneMedNet Corporation upon stockholder approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(tt)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Period</i>&#8221; means the period of time determined by the Committee during which an Award is subject to restrictions or, as applicable, the period of time within which performance is measured for purposes of determining whether an Award has been earned.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(uu)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Stock Unit</i>&#8221; means an unfunded and unsecured promise to deliver Common Shares, cash, other securities or other property, subject to certain performance or time-based restrictions (including, without limitation, a requirement that the Participant remain continuously employed or provide continuous services for a specified period of time), granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vv)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Stock</i>&#8221; means Common Shares, subject to certain specified performance or time-based restrictions (including, without limitation, a requirement that the Participant remain continuously employed or provide continuous services for a specified period of time), granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(ww)&#160;&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Retirement</i>&#8221; means, in the case of a particular Award, the definition set forth in the applicable Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(xx)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SAR Period</i>&#8221; has the meaning given such term in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8(b)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(yy)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Securities Act</i>&#8221; means the Securities Act of 1933, as amended, and any successor thereto. Reference in the Plan to any section of the Securities Act shall be deemed to include any rules, regulations or other interpretative guidance under such section, and any amendments or successor provisions to such section, rules, regulations or guidance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(zz)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Appreciation Right</i>&#8221; or&#160;<i style="font-style:italic;">&#8220;</i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SAR</i><i style="font-style:italic;">&#8221;&#160;</i>means an Award granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(aaa)&#160;&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Bonus Award</i>&#8221; means an Award granted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 10</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(bbb)&#160;&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Strike Price</i>&#8221; means, except as otherwise provided by the Committee in the case of Substitute Awards, (i)&#160;in the case of a SAR granted in tandem with an Option, the Exercise Price of the related Option, or (ii) in the case of a SAR granted independent of an Option, the Fair Market Value on the Date of Grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;">(ccc)&#160;&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Subsidiary</i>&#8221; means, with respect to any specified Person:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>any corporation, association or other business entity of which more than 50% of the total voting power of shares (without regard to the occurrence of any contingency and after giving effect to any voting agreement or stockholders&#8217; agreement that effectively transfers voting power) is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person (or a combination thereof); and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>any partnership (or any comparable foreign entity (a) the sole general partner (or functional equivalent thereof) or the managing general partner of which is such Person or Subsidiary of such Person or (b) the only general partners (or functional equivalents thereof) of which are that Person or one or more Subsidiaries of that Person (or any combination thereof).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>&#8220;<i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Substitute Award</i>&#8221; has the meaning given such term in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5(e)</span> of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effective Date; Duration</i>. The Plan shall be effective as of the Effective Date. The expiration date of the Plan, on and after which date no Awards may be granted hereunder, shall be the tenth anniversary of the Effective Date;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that such expiration shall not affect Awards then outstanding, and the terms and conditions of the Plan shall continue to apply to such Awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Administration</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Committee shall administer the Plan. To the extent required to comply with the applicable provisions of Rule 16b-3 promulgated under the Exchange Act (if the Board is not acting as the Committee under the Plan), it is intended that each member of the Committee shall, at the time he or she takes any action with respect to an Award under the Plan, be an Eligible Director. However, the fact that a Committee member shall fail to qualify as an Eligible Director shall not invalidate any Award granted by the Committee that is otherwise validly granted under the Plan.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Subject to the provisions of the Plan and applicable law, the Committee shall have the sole and plenary authority, in addition to other express powers and authorizations conferred on the Committee by the Plan or by the Board, to: (i) designate Participants; (ii) determine the type or types of Awards to be granted to a Participant; (iii) determine the number of Common Shares to be covered by, or with respect to which payments, rights, or other matters are to be calculated in connection with, Awards; (iv) determine the form of Award Agreement and the terms and conditions of any Award; (v) determine whether, to what extent, and under what circumstances Awards may be settled or exercised in cash, Common Shares, other securities, other Awards or other property, or canceled, forfeited, or suspended and the method or methods by which Awards may be settled, exercised, canceled, forfeited, or suspended; (vi) determine whether, to what extent, and under what circumstances the delivery of cash, Common Shares, other securities, other Awards or other property and other amounts payable with respect to an Award shall be deferred either automatically or at the election of the Participant or of the Committee; (vii) interpret, administer, reconcile any inconsistency in, correct any defect in and/or supply any omission in the Plan and any instrument or agreement relating to, or Award granted under, the Plan; (viii) establish, amend, suspend, or waive any rules and regulations and appoint such agents as the Committee shall deem appropriate for the proper administration of the Plan; (ix) accelerate the vesting or exercisability of, payment for or lapse of restrictions on, Awards, including, but not limited to, upon a Qualifying Termination; (x) to institute and determine the terms and conditions of an Exchange Program; provided, however, that the Committee shall not implement an Exchange Program without the approval of the holders of a majority of the Shares that are present in person or by proxy and entitled to vote at any annual or special meeting of Company&#8217;s stockholders; and (xi) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>The Committee may delegate to one or more officers of the Company or any Affiliate the authority to act on behalf of the Committee with respect to any matter, right, obligation, or election that is the responsibility of or that is allocated to the Committee herein, and that may be so delegated as a matter of law, except for grants of Awards to persons subject to Section 16 of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>Unless otherwise expressly provided in the Plan, all designations, determinations, interpretations, and other decisions under or with respect to the Plan or any Award or any documents evidencing Awards granted pursuant to the Plan shall be within the sole discretion of the Committee, may be made at any time and shall be final, conclusive and binding upon all persons or entities, including, without limitation, the Company, any Affiliate, any Participant, any holder or beneficiary of any Award, and any stockholder of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>No member of the Board, the Committee, delegate of the Committee or any employee or agent of the Company (each such person, an &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnifiable Person</span>&#8221;) shall be liable for any action taken or omitted to be taken or any determination made in good faith with respect to the Plan or any Award hereunder. Each Indemnifiable Person shall be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense (including attorneys&#8217; fees) that may be imposed upon or incurred by such Indemnifiable Person in connection with or resulting from any action, suit or proceeding to which such Indemnifiable Person may be a party or in which such Indemnifiable Person may be involved by reason of any action taken or omitted to be taken under the Plan or any Award Agreement and against and from any and all amounts paid by such Indemnifiable Person with the Company&#8217;s approval, in settlement thereof, or paid by such Indemnifiable Person in satisfaction of any judgment in any such action, suit or proceeding against such Indemnifiable Person,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided&#160;</span>that the Company shall have the right, at its own expense, to assume and defend any such action, suit or proceeding and once the Company gives notice of its intent to assume the defense, the Company shall have sole control over such defense with counsel of the Company&#8217;s choice. The foregoing right of indemnification shall not be available to an Indemnifiable Person to the extent that a final judgment or other final adjudication (in either case not subject to further appeal) binding upon such Indemnifiable Person determines that the acts or omissions of such Indemnifiable Person giving rise to the indemnification claim resulted from such Indemnifiable Person&#8217;s bad faith, fraud or willful criminal act or omission or that such right of indemnification is otherwise prohibited by law or by the Company&#8217;s Articles of Incorporation or Bylaws. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such Indemnifiable Persons may be entitled under the Company&#8217;s Articles of Incorporation or Bylaws, as a matter of law, or otherwise, or any other power that the Company may have to indemnify such Indemnifiable Persons or hold them harmless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>Notwithstanding anything to the contrary contained in the Plan, the Board may, in its sole discretion, at any time and from time to time, grant Awards and administer the Plan with respect to such Awards. In any such case, the Board shall have all the authority granted to the Committee under the Plan.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Grant of Awards; Shares Subject to the Plan; Limitations</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>The Committee may, from time to time, grant Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Stock Bonus Awards and/or Performance Compensation Awards to one or more Eligible Persons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>Subject to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> of the Plan, Awards granted under the Plan shall be subject to the following limitations: (i) the Committee is authorized to deliver under the Plan an aggregate of [&#160;&#160;&#160;]<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4 </sup>Common Shares; provided, that total number of Common Shares that will be reserved, and that may be issued, under the Plan will automatically increase on the first trading day of each calendar year, beginning with calendar year 2023, by a number of Common Shares equal to five percent (5%) of the total outstanding Common Shares on the last day of the prior calendar year (subject to a maximum annual increase of 1,000,000 Common Shares), (ii) in no event shall the maximum aggregate number of Common Shares that may be issued under the Plan pursuant to Incentive Stock Options exceed the aggregate number of Common Shares set forth in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5(b)(i)</span> of the Plan plus, to the extent allowable under Code Section&#160;422 and the regulations promulgated thereunder, any Common Shares that again become available for issuance pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5(c)</span> of the Plan and (iii) the maximum number of Common Shares that may be granted under the Plan during any single fiscal year to any Participant who is a non-employee director, when taken together with any cash fees paid to such non-employee director during such year in respect of his or her service as a non-employee director (including service as a member or chair of any committee of the Board), shall not exceed $750,000 in total value (calculating the value of any such Awards based on the grant date fair value of such Awards for financial reporting purposes);&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>&#160;that the non-employee directors who are considered independent (under the rules of The NASDAQ Stock Market or other securities exchange on which the Common Shares are traded) may make exceptions to this limit for a non-executive chair of the Board, if any, in which case the non-employee Director receiving such additional compensation may not participate in the decision to award such compensation. Notwithstanding the automatic annual increase set forth in (i) above, the Board may act prior to January 1st of a given year to provide that there will be no such increase in the share reserve for such year or that the increase in the share reserve for such year will be a lesser number of Common Shares than would otherwise occur pursuant to the stipulated percentage.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>In the event that (i) any Option or other Award granted hereunder is exercised through the tendering of Common Shares (either actually or by attestation) or by the withholding of Common Shares by the Company, or (ii) tax or deduction liabilities arising from such Option or other Award are satisfied by the tendering of Common Shares (either actually or by attestation) or by the withholding of Common Shares by the Company, then in each such case the Common Shares so tendered or withheld shall be added to the Common Shares available for grant under the Plan on a one-for-one basis. Shares underlying Awards under this Plan that are forfeited, cancelled, expire unexercised, or are settled in cash are available again for Awards under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>Common Shares delivered by the Company in settlement of Awards may be authorized and unissued shares, shares held in the treasury of the Company, shares purchased on the open market or by private purchase, or a combination of the foregoing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>Awards may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding awards previously granted by an entity acquired by the Company or with which the Company combines (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Substitute Awards</span>&#8221;). The number of Common Shares underlying any Substitute Awards shall not be counted against the aggregate number of Common Shares available for Awards under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Eligibility</i>. Participation shall be limited to Eligible Persons who have entered into an Award Agreement or who have received written notification from the Committee, or from a person designated by the Committee, that they have been selected to participate in the Plan.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup><span style="display:inline-block;width:14.75pt;"></span>To equal 10% of basic Class A shares outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Options</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Generally</i>. Each Option granted under the Plan shall be evidenced by an Award Agreement (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)). Each Option so granted shall be subject to the conditions set forth in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 7</span>, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. All Options granted under the Plan shall be Nonqualified Stock Options unless the applicable Award Agreement expressly states that the Option is intended to be an Incentive Stock Option. Incentive Stock Options shall be granted only to Eligible Persons who are employees of the Company and its Affiliates, and no Incentive Stock Option shall be granted to any Eligible Person who is ineligible to receive an Incentive Stock Option under the Code. No Option shall be treated as an Incentive Stock Option unless the Plan has been approved by the stockholders of the Company in a manner intended to comply with the stockholder approval requirements of Code Section 422(b)(1);&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>&#160;that any Option intended to be an Incentive Stock Option shall not fail to be effective solely on account of a failure to obtain such approval, but rather such Option shall be treated as a Nonqualified Stock Option unless and until such approval is obtained. In the case of an Incentive Stock Option, the terms and conditions of such grant shall be subject to and comply with such rules as may be prescribed by Code Section 422. If for any reason an Option intended to be an Incentive Stock Option (or any portion thereof) shall not qualify as an Incentive Stock Option, then, to the extent of such non-qualification, such Option or portion thereof shall be regarded as a Nonqualified Stock Option appropriately granted under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exercise Price</i>. Except with respect to Substitute Awards, the exercise price (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exercise Price</span>&#8221;) per Common Share for each Option shall not be less than 100% of the Fair Market Value of such share determined as of the Date of Grant;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that in the case of an Incentive Stock Option granted to an employee who, at the time of the grant of such Option, owns shares representing more than 10% of the total combined voting power of all classes of shares of the Company or any related corporation (as determined in accordance with Treasury Regulation Section 1.422-2(f)), the Exercise Price per share shall not be less than 110% of the Fair Market Value per share on the Date of Grant and&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided further</span>, that, notwithstanding any provision herein to the contrary, the Exercise Price shall not be less than the par value per Common Share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vesting and Expiration</i>. Options shall vest and become exercisable in such manner and on such date or dates determined by the Committee and shall expire after such period, not to exceed ten years, as may be determined by the Committee (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Option Period</span>&#8221;);&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that the Option Period shall not exceed five years from the Date of Grant in the case of an Incentive Stock Option granted to a Participant who on the Date of Grant owns shares representing more than 10% of the total combined voting power of all classes of shares of the Company or any related corporation (as determined in accordance with Treasury Regulation Section 1.422-2(f));&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">further</span>, that notwithstanding any vesting dates set by the Committee, the Committee may, in its sole discretion, accelerate the exercisability of any Option, which acceleration shall not affect the terms and conditions of such Option other than with respect to exercisability. Unless otherwise provided by the Committee in an Award Agreement: (i) the unvested portion of an Option shall expire upon termination of employment or service of the Participant granted the Option, and the vested portion of such Option shall remain exercisable for (A) one year following termination of employment or service by reason of such Participant&#8217;s death or disability (as determined by the Committee), but not later than the expiration of the Option Period or (B) ninety (90) days following termination of employment or service for any reason other than such Participant&#8217;s death or disability, and other than such Participant&#8217;s termination of employment or service for Cause, but not later than the expiration of the Option Period; and (ii) both the unvested and the vested portion of an Option shall expire upon the termination of the Participant&#8217;s employment or service by the Company for Cause. If the Option would expire at a time when the exercise of the Option would violate applicable securities laws, the expiration date applicable to the Option will be automatically extended to a date that is thirty (30) calendar days following the date such exercise would no longer violate applicable securities laws (so long as such extension shall not violate Code Section 409A);&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, that in no event shall such expiration date be extended beyond the expiration of the Option Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Method of Exercise and Form of Payment</i>. No Common Shares shall be delivered pursuant to any exercise of an Option until payment in full of the Exercise Price therefor is received by the Company and the Participant has paid to the Company an amount equal to any taxes required to be withheld or paid. Options that have become exercisable may be exercised by delivery of written or electronic notice of exercise to the Company in accordance with the terms of the Option accompanied by payment of the Exercise Price. The Exercise Price shall be payable (i) in cash, check, cash equivalent and/or Common Shares valued at the fair market value at the time the Option is exercised (including, pursuant to procedures approved by the Committee, by means of attestation of ownership of a sufficient number of Common Shares in lieu of actual delivery of such shares to the Company); provided that such Common Shares are not subject to any pledge or other security interest and are Mature Shares and; (ii) by such other method as the Committee may permit in accordance with applicable law, in its sole discretion, on a case by case basis, including without limitation: (A) in other property having a fair market value on the date of exercise equal to the Exercise Price or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">(B) if there is a public market for the Common Shares at such time, by means of a broker-assisted &#8220;cashless exercise&#8221; pursuant to which the Company is delivered a copy of irrevocable instructions to a stockbroker to sell the Common Shares otherwise deliverable upon the exercise of the Option and to deliver promptly to the Company an amount equal to the Exercise Price or (C) by a &#8220;net exercise&#8221; method whereby the Company withholds from the delivery of the Common Shares for which the Option was exercised that number of Common Shares having a fair market value equal to the aggregate Exercise Price for the Common Shares for which the Option was exercised. No fractional Common Shares shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall determine whether cash, other securities or other property shall be paid or transferred in lieu of any fractional Common Shares, or whether such fractional Common Shares or any rights thereto shall be canceled, terminated or otherwise eliminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notification upon Disqualifying Disposition of an Incentive Stock Option</i>. Each Participant awarded an Incentive Stock Option under the Plan shall notify the Company in writing immediately after the date he makes a disqualifying disposition of any Common Shares acquired pursuant to the exercise of such Incentive Stock Option. A disqualifying disposition is any disposition (including, without limitation, any sale) of such Common Shares before the later of (A) two (2) years after the Date of Grant of the Incentive Stock Option or (B) one (1) year after the date of exercise of the Incentive Stock Option. The Company may, if determined by the Committee and in accordance with procedures established by the Committee, retain possession of any Common Shares acquired pursuant to the exercise of an Incentive Stock Option as agent for the applicable Participant until the end of the period described in the preceding sentence.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Laws, etc</i>. Notwithstanding the foregoing, in no event shall a Participant be permitted to exercise an Option in a manner that the Committee determines would violate the Sarbanes-Oxley Act of 2002, if applicable, or any other applicable law or the applicable rules and regulations of the Securities and Exchange Commission or the applicable rules and regulations of any securities exchange or inter-dealer quotation system on which the securities of the Company are listed or traded.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Appreciation Rights</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Generally</i>. Each SAR granted under the Plan shall be evidenced by an Award Agreement (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)). Each SAR so granted shall be subject to the conditions set forth in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8</span>, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. Any Option granted under the Plan may include tandem SARs. The Committee also may award SARs to Eligible Persons independent of any Option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exercise Price</i>. The Exercise Price per Common Share for each SAR shall not be less than 100% of the Fair Market Value of such share determined as of the Date of Grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vesting and Expiration</i>. A SAR granted in connection with an Option shall become exercisable and shall expire according to the same vesting schedule and expiration provisions as the corresponding Option. A SAR granted independent of an Option shall vest and become exercisable and shall expire in such manner and on such date or dates determined by the Committee and shall expire after such period, not to exceed ten years, as may be determined by the Committee (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SAR Period</span>&#8221;);&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that notwithstanding any vesting dates set by the Committee, the Committee may, in its sole discretion, accelerate the exercisability of any SAR, which acceleration shall not affect the terms and conditions of such SAR other than with respect to exercisability. Unless otherwise provided by the Committee in an Award Agreement: (i) the unvested portion of a SAR shall expire upon termination of employment or service of the Participant granted the SAR, and the vested portion of such SAR shall remain exercisable for (A) one year following termination of employment or service by reason of such Participant&#8217;s death or disability (as determined by the Committee), but not later than the expiration of the SAR Period or (B) 90 days following termination of employment or service for any reason other than such Participant&#8217;s death or disability, and other than such Participant&#8217;s termination of employment or service for Cause, but not later than the expiration of the SAR Period; and (ii) both the unvested and the vested portion of a SAR shall expire upon the termination of the Participant&#8217;s employment or service by the Company for Cause. If the SAR would expire at a time when the exercise of the SAR would violate applicable securities laws, the expiration date applicable to the SAR will be automatically extended to a date that is thirty (30) calendar days following the date such exercise would no longer violate applicable securities laws (so long as such extension shall not violate Code Section 409A);&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>, that in no event shall such expiration date be extended beyond the expiration of the SAR Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Method of Exercise</i>. SARs that have become exercisable may be exercised by delivery of written or electronic notice of exercise to the Company in accordance with the terms of the Award, specifying the number of SARs to be exercised and the date </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">on which such SARs were awarded. Notwithstanding the foregoing, if on the last day of the Option Period (or in the case of a SAR independent of an option, the SAR Period), the fair market value exceeds the Strike Price, the Participant has not exercised the SAR or the corresponding Option (if applicable), and neither the SAR nor the corresponding Option (if applicable) has expired, such SAR shall be deemed to have been exercised by the Participant on such last day and the Company shall make the appropriate payment therefor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payment</i>. Upon the exercise of a SAR, the Company shall pay to the Participant an amount equal to the number of shares subject to the SAR that are being exercised multiplied by the excess, if any, of the fair market value of one Common Share on the exercise date over the Strike Price, less an amount equal to any taxes required to be withheld or paid. The Company shall pay such amount in cash, in Common Shares valued at fair market value, or any combination thereof, as determined by the Committee. No fractional Common Shares shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall determine whether cash, other securities or other property shall be paid or transferred in lieu of any fractional Common Shares, or whether such fractional Common Shares or any rights thereto shall be canceled, terminated or otherwise eliminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">9.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Stock and Restricted Stock Units</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Generally</i>. Each grant of Restricted Stock and Restricted Stock Units shall be evidenced by an Award Agreement (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)). Each such grant shall be subject to the conditions set forth in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span>, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Accounts; Escrow or Similar Arrangement</i>. Upon the grant of Restricted Stock, a book entry in a restricted account shall be established in the Participant&#8217;s name at the Company&#8217;s transfer agent and, if the Committee determines that the Restricted Stock shall be held by the Company or in escrow rather than held in such restricted account pending the release of the applicable restrictions, the Committee may require the Participant to additionally execute and deliver to the Company (i) an escrow agreement satisfactory to the Committee, if applicable, and (ii) the appropriate share power (endorsed in blank) with respect to the Restricted Stock covered by such agreement. If a Participant shall fail to execute an agreement evidencing an Award of Restricted Stock and, if applicable, an escrow agreement and blank share power within the amount of time specified by the Committee, the Award shall be null and void. Subject to the restrictions set forth in this <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span> and the applicable Award Agreement, the Participant generally shall have the rights and privileges of a stockholder as to such Restricted Stock, including without limitation the right to vote such Restricted Stock and the right to receive dividends, if applicable. To the extent shares of Restricted Stock are forfeited, any share certificates issued to the Participant evidencing such shares shall be returned to the Company, and all rights of the Participant to such shares and as a stockholder with respect thereto shall terminate without further obligation on the part of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vesting; Acceleration of Lapse of Restrictions</i>. Unless otherwise provided by the Committee in an Award Agreement the unvested portion of Restricted Stock and Restricted Stock Units shall terminate and be forfeited upon termination of employment or service of the Participant granted the applicable Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Delivery of Restricted Stock and Settlement of Restricted Stock Units</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Upon the expiration of the Restricted Period with respect to any shares of Restricted Stock, the restrictions set forth in the applicable Award Agreement shall be of no further force or effect with respect to such shares, except as set forth in the applicable Award Agreement. If an escrow arrangement is used, upon such expiration, the Company shall deliver to the Participant, or his beneficiary, without charge, the share certificate evidencing the shares of Restricted Stock that have not then been forfeited and with respect to which the Restricted Period has expired (rounded down to the nearest full share). Dividends, if any, that may have been withheld by the Committee and attributable to any particular share of Restricted Stock shall be distributed to the Committee and attributable to any particular share of Restricted Stock shall be distributed to the Participant in cash or, at the sole discretion of the Committee, in Common Shares having a fair market value equal to the amount of such dividends, upon the release of restrictions on such share and, if such share is forfeited, the Participant shall have no right to such dividends (except as otherwise set forth by the Committee in the applicable Award Agreement).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Unless otherwise provided by the Committee in an Award Agreement, upon the expiration of the Restricted Period with respect to any outstanding Restricted Stock Units, the Company shall deliver to the Participant, or his beneficiary, without charge, one Common Share for each such outstanding Restricted Stock Unit;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that the Committee may, in its sole discretion, elect to (i) pay cash or part cash and part Common Share in lieu of delivering only Common </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">Shares in respect of such Restricted Stock Units or (ii) defer the delivery of Common Shares (or cash or part Common Shares and part cash, as the case may be) beyond the expiration of the Restricted Period if such delivery would result in a violation of applicable law until such time as is no longer the case. If a cash payment is made in lieu of delivering Common Shares, the amount of such payment shall be equal to the fair market value of the Common Shares as of the date on which the Restricted Period lapsed with respect to such Restricted Stock Units, less an amount equal to any taxes required to be withheld or paid.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Bonus Awards</i>. The Committee may issue unrestricted Common Shares, or other Awards denominated in Common Shares, under the Plan to Eligible Persons, either alone or in tandem with other awards, in such amounts as the Committee shall from time to time in its sole discretion determine. Each Stock Bonus Award granted under the Plan shall be evidenced by an Award Agreement (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)). Each Stock Bonus Award so granted shall be subject to such conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">11.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Compensation Awards</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Generally</i>. The Committee shall have the authority, at the time of grant of any Award described in <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections 7</span> through <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">10</span> of the Plan, to designate such Award as a Performance Compensation Award. The Committee shall have the authority to make an award of a cash bonus to any Participant and designate such Award as a Performance Compensation Award. Unless otherwise determined by the Committee, all Performance Compensation Awards shall be evidenced by an Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Discretion of Committee with Respect to Performance Compensation Awards</i>. The Committee shall have the discretion to establish the terms, conditions and restrictions of any Performance Compensation Award. With regard to a particular Performance Period, the Committee shall have sole discretion to select the length of such Performance Period, the type(s) of Performance Compensation Awards to be issued, the Performance Criteria that will be used to establish the Performance Goal (s), the kind(s) and/or level(s) of the Performance Goals(s) that is (are) to apply and the Performance Formula.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Criteria</i>. The Committee may establish Performance Criteria that will be used to establish the Performance Goal(s) for Performance Compensation Awards which may be based on the attainment of specific levels of performance of the Company (and/or one or more Affiliates, divisions, business segments or operational units, or any combination of the foregoing) and may include, without limitation, any of the following: (i)&#160;net earnings or net income (before or after taxes); (ii)&#160;basic or diluted earnings per share (before or after taxes); (iii)&#160; revenue or revenue growth (measured on a net or gross basis); (iv)&#160;gross profit or gross profit growth; (v)&#160;operating profit (before or after taxes); (vi)&#160;return measures (including, but not limited to, return on assets, capital, invested capital, equity, or sales); (vii)&#160;cash flow (including, but not limited to, operating cash flow, free cash flow, net cash provided by operations and cash flow return on capital); (viii)&#160;financing and other capital raising transactions (including, but not limited to, sales of the Company&#8217;s equity or debt securities); (ix)&#160;earnings before or after taxes, interest, depreciation and/or amortization; (x)&#160;gross or operating margins; (xi)&#160;productivity ratios; (xii)&#160;share price (including, but not limited to, growth measures and total stockholder return); (xiii)&#160;expense targets; (xiv)&#160;margins; (xv)&#160;productivity and operating efficiencies; (xvi)&#160; customer satisfaction; (xvii)&#160;customer growth; (xviii)&#160;working capital targets; (xix)&#160;measures of economic value added; (xx)&#160;inventory control; (xxi)&#160;enterprise value; (xxii)&#160;sales; (xxiii)&#160;debt levels and net debt; (xxiv)&#160;combined ratio; (xxv)&#160;timely launch of new facilities; (xxvi)&#160;client retention; (xxvii)&#160;employee retention; (xxviii)&#160;timely completion of rollouts of new products and services; (xxix)&#160;cost targets; (xxx)&#160;reductions and savings; (xxxi)&#160;productivity and efficiencies; (xxxii)&#160;strategic partnerships or transactions; and (xxxiii)&#160;personal targets, goals or completion of projects. Any one or more of the Performance Criteria may be used on an absolute or relative basis to measure the performance of the Company and/or one or more Affiliates as a whole or any business unit(s) of the Company and/or one or more Affiliates or any combination thereof, as the Committee may deem appropriate, or any of the above Performance Criteria may be compared to the performance of a selected group of comparison or peer companies, or a published or special index that the Committee, in its sole discretion, deems appropriate, or as compared to various stock market indices. The Committee also has the authority to provide for accelerated vesting of any Award based on the achievement of Performance Goals pursuant to the Performance Criteria specified in this paragraph. Any Performance Criteria that are financial metrics, may be determined in accordance with United States Generally Accepted Accounting Principles (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">GAAP</span>&#8221;) or may be adjusted when established to include or exclude any items otherwise includable or excludable under GAAP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Modification of Performance Goal(s)</i>. The Committee is authorized at any time to adjust or modify the calculation of a Performance Goal for such Performance Period, based on and in order to appropriately reflect any specified circumstance or event that occurs during a Performance Period, including but not limited to the following: (i) asset write-downs; (ii) litigation or claim judgments or settlements; (iii) the effect of changes in tax laws, accounting principles, or other laws or regulatory rules affecting </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">reported results; (iv) any reorganization and restructuring programs; (v) unusual and/or infrequently occurring items as described in Accounting Principles Board Opinion No. 30 (or any successor pronouncement thereto) and/or in management&#8217;s discussion and analysis of financial condition and results of operations appearing in the Company&#8217;s annual report to stockholders for the applicable year; (vi) acquisitions or divestitures; (vii) discontinued operations; (viii) any other specific unusual or infrequently occurring or non-recurring events, or objectively determinable category thereof; (ix) foreign exchange gains and losses; and (x) a change in the Company&#8217;s fiscal year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Terms and Conditions to Receipt of Payment</i>. Unless otherwise provided in the applicable Award Agreement, a Participant must be employed by the Company on the last day of a Performance Period to be eligible for payment in respect of a Performance Compensation Award for such Performance Period. A Participant shall be eligible to receive payment in respect of a Performance Compensation Award only to the extent that: (A) the Performance Goals for such period are achieved; and (B) all or some of the portion of such Participant&#8217;s Performance Compensation Award has been earned for the Performance Period based on the application of the Performance Formula to such achieved Performance Goals. Following the completion of a Performance Period, the Committee shall determine whether, and to what extent, the Performance Goals for the Performance Period have been achieved and, if so, calculate the amount of the Performance Compensation Awards earned for the period based upon the Performance Formula. The Committee shall then determine the amount of each Participant&#8217;s Performance Compensation Award actually payable for the Performance Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Timing of Award Payments</i>. Except as provided in an Award Agreement, Performance Compensation Awards granted for a Performance Period shall be paid to Participants as soon as administratively practicable following the Committee&#8217;s determination in accordance with <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 11(e)</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">12.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other&#160;Stock-or&#160;Cash-Based Awards</i>. The Committee is authorized to grant Awards to Participants in the form of Other Stock-Based Awards or Other Cash-Based Awards, as deemed by the Committee to be consistent with the purposes of the Plan. To the extent necessary to satisfy the short-term deferral exception to Code Section&#160;409A, unless the Committee shall determine otherwise, the Awards shall provide that payment shall be made within 2 &#189; months after the end of the year in which the Participant has a legally binding vested right to such Award. The Committee may establish such other rules applicable to the Other Stock- or Cash-Based Awards as it deems appropriate, to the extent not inconsistent with the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">13.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Changes in Capital Structure and Similar Events</i>. In the event of (i) any dividend (other than ordinary cash dividends) or other distribution (whether in the form of cash, Common Shares, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, amalgamation, consolidation, spin-off, split-up, split-off, combination, repurchase or exchange of Common Shares or other securities of the Company, issuance of warrants or other rights to acquire Common Shares or other securities of the Company, or other similar corporate transaction or event (including, without limitation, a Change in Control) that affects the Common Shares, or (ii) unusual or infrequently occurring events (including, without limitation, a Change in Control) affecting the Company, any Affiliate, or the financial statements of the Company or any Affiliate, or changes in applicable rules, rulings, regulations or other requirements of any governmental body or securities exchange or inter-dealer quotation system, accounting principles or law, such that in either case an adjustment is determined by the Committee in its sole discretion to be necessary or appropriate, then the Committee shall make any such adjustments in such manner as it may deem equitable, including without limitation any or all of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span>adjusting any or all of (A)&#160;the number of Common Shares or other securities of the Company (or number and kind of other securities or other property) that may be delivered in respect of Awards or with respect to which Awards may be granted under the Plan (including, without limitation, adjusting any or all of the limitations under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 5</span> of the Plan) and (B)&#160;the terms of any outstanding Award, including, without limitation, (1)&#160;the number of Common Shares or other securities of the Company (or number and kind of other securities or other property) subject to outstanding Awards or to which outstanding Awards relate, (2)&#160;the Exercise Price or Strike Price with respect to any Award or (3)&#160;any applicable performance measures (including, without limitation, Performance Criteria and Performance Goals);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>providing for a substitution or assumption of Awards in a manner that substantially preserves the applicable terms of such Awards;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span>accelerating the exercisability or vesting of, lapse of restrictions on, or termination of, Awards or providing for a period of time for exercise prior to the occurrence of such event;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>modifying the terms of Awards to add events, conditions or circumstances (including termination of employment within a specified period after a Change in Control) upon which the exercisability or vesting of or lapse of restrictions thereon will accelerate;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>deeming any performance measures (including, without limitation, Performance Criteria and Performance Goals) satisfied at target, maximum or actual performance through closing or such other level determined by the Committee in its sole discretion, or providing for the performance measures to continue (as is or as adjusted by the Committee) after closing;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span>providing that for a period prior to the Change in Control determined by the Committee in its sole discretion, any Options or SARs that would not otherwise become exercisable prior to the Change in Control will be exercisable as to all Common Shares subject thereto (but any such exercise will be contingent upon and subject to the occurrence of the Change in Control and if the Change in Control does not take place after giving such notice for any reason whatsoever, the exercise will be null and void) and that any Options or SARs not exercised prior to the consummation of the Change in Control will terminate and be of no further force and effect as of the consummation of the Change in Control; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span>canceling any one or more outstanding Awards and causing to be paid to the holders thereof, in cash, Common Shares, other securities or other property, or any combination thereof, the value of such Awards, if any, as determined by the Committee (which if applicable may be based upon the price per Common Share received or to be received by other stockholders of the Company in such event), including without limitation, in the case of an outstanding Option or SAR, a cash payment in an amount equal to the excess, if any, of the fair market value (as of a date specified by the Committee) of the Common Shares subject to such Option or SAR over the aggregate Exercise Price or Strike Price of such Option or SAR, respectively (it being understood that, in such event, any Option or SAR having a per share Exercise Price or Strike Price equal to, or in excess of, the fair market value of a Common Share subject thereto may be canceled and terminated without any payment or consideration therefor); provided, however, that in the case of any &#8220;equity restructuring&#8221; (within the meaning of the Financial Accounting Standards Board Accounting Standards Codification Topic 718), the Committee shall make an equitable or proportionate adjustment to outstanding Awards to reflect such equity restructuring. The Company shall give each Participant notice of an adjustment hereunder and, upon notice, such adjustment shall be conclusive and binding for all purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">14.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendments and Termination</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment and Termination of the Plan</i>. The Board may amend, alter, suspend, discontinue, or terminate the Plan or any portion thereof at any time;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>&#160;that (i) no amendment to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 14(b)</span> (to the extent required by the proviso in such <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 14(b)</span>) shall be made without stockholder approval and (ii) no such amendment, alteration, suspension, discontinuation or termination shall be made without stockholder approval if such approval is necessary to comply with any tax or regulatory requirement applicable to the Plan (including, without limitation, as necessary to comply with any rules or requirements of any securities exchange or inter-dealer quotation system on which the Common Shares may be listed or quoted);&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">further</span>, that any such amendment, alteration, suspension, discontinuance or termination that would materially and adversely affect the rights of any Participant or any holder or beneficiary of any Award theretofore granted shall not to that extent be effective without the consent of the affected Participant, holder or beneficiary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment of Award Agreements</i>. The Committee may, to the extent consistent with the terms of any applicable Award Agreement, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any Award theretofore granted or the associated Award Agreement, prospectively or retroactively;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>&#160;that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would materially and adversely affect the rights of any Participant with respect to any Award theretofore granted shall not to that extent be effective without the consent of the affected Participant;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">further</span>, that without stockholder approval, except as otherwise permitted under <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> of the Plan, (i) no amendment or modification may reduce the Exercise Price of any Option or the Strike Price of any SAR, (ii) the Committee may not cancel any outstanding Option or SAR where the Fair Market Value of the Common Shares underlying such Option or SAR is less than its Exercise Price and replace it with a new Option or SAR, another Award or cash and (iii) the Committee may not take any other action that is considered a &#8220;repricing&#8221; for purposes of the stockholder approval rules of the applicable securities exchange or inter-dealer quotation system on which the Common Shares are listed or quoted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">15.</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Award Agreements</i>. Each Award under the Plan shall be evidenced by an Award Agreement, which shall be delivered to the Participant (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">or a third party under contract with the Company)) and shall specify the terms and conditions of the Award and any rules applicable thereto, including without limitation, the effect on such Award of the death, disability or termination of employment or service of a Participant, or of such other events as may be determined by the Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nontransferability</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Each Award shall be exercisable only by a Participant during the Participant&#8217;s lifetime, or, if permissible under applicable law, by the Participant&#8217;s legal guardian or representative. No Award may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a Participant other than by will or by the laws of descent and distribution and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or an Affiliate;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>&#160;that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Notwithstanding the foregoing, the Committee may, in its sole discretion, permit Awards (other than Incentive Stock Options) to be transferred by a Participant, without consideration, subject to such rules as the Committee may adopt consistent with any applicable Award Agreement to preserve the purposes of the Plan, to: (A)&#160;any person who is a &#8220;family member&#8221; of the Participant, as such term is used in the instructions to Form S-8 under the Securities Act (collectively, the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Immediate Family Members</span>&#8221;); (B)&#160;a trust solely for the benefit of the Participant and his or her Immediate Family Members; (C)&#160;a partnership or limited liability company whose only partners or stockholders are the Participant and his or her Immediate Family Members; or (D)&#160;any other transferee as may be approved either (I)&#160;by the Board or the Committee in its sole discretion, or (II)&#160;as provided in the applicable Award Agreement (each transferee described in clauses&#160;(A), (B), (C) and (D) above is hereinafter referred to as a &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Permitted Transferee</span>&#8221;);&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>&#160;that the Participant gives the Committee advance written notice describing the terms and conditions of the proposed transfer and the Committee notifies the Participant in writing that such a transfer would comply with the requirements of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>The terms of any Award transferred in accordance with the immediately preceding sentence shall apply to the Permitted Transferee and any reference in the Plan, or in any applicable Award Agreement, to a Participant shall be deemed to refer to the Permitted Transferee, except that (A) Permitted Transferees shall not be entitled to transfer any Award, other than by will or the laws of descent and distribution; (B) Permitted Transferees shall not be entitled to exercise any transferred Option unless there shall be in effect a registration statement on an appropriate form covering the Common Shares to be acquired pursuant to the exercise of such Option if the Committee determines, consistent with any applicable Award Agreement, that such a registration statement is necessary or appropriate; (C) the Committee or the Company shall not be required to provide any notice to a Permitted Transferee, whether or not such notice is or would otherwise have been required to be given to the Participant under the Plan or otherwise; and (D) the consequences of the termination of the Participant&#8217;s employment by, or services to, the Company or an Affiliate under the terms of the Plan and the applicable Award Agreement shall continue to be applied with respect to the Participant, including, without limitation, that an Option shall be exercisable by the Permitted Transferee only to the extent, and for the periods, specified in the Plan and the applicable Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Tax Withholding and Deductions</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>A Participant shall be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right and is hereby authorized to deduct and withhold, from any cash, Common Shares, other securities or other property deliverable under any Award or from any compensation or other amounts owing to a Participant, the amount (in cash, Common Shares, other securities or other property) of any required taxes (up to the maximum statutory rate under applicable law as in effect from time to time as determined by the Committee) and deduction in respect of an Award, its grant, vesting or exercise, or any payment or transfer under an Award or under the Plan and to take such other action as may be necessary in the opinion of the Committee or the Company to satisfy all obligations for the payment of such taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Without limiting the generality of clause (i) above, the Committee may, in its sole discretion, determined on a case by case basis, permit a Participant to satisfy, in whole or in part, the foregoing tax and deduction liability by (A) the delivery of Common Shares (which are not subject to any pledge or other security interest and are Mature Shares, except as otherwise determined by the Committee) owned by the Participant having a fair market value equal to such liability or (B) having the Company withhold from the number of Common Shares otherwise issuable or deliverable pursuant to the exercise or settlement of the Award a number of shares with a fair market value equal to such liability.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Claim to Awards; No Rights to Continued Employment; Waiver</i>. No employee of the Company or an Affiliate, or other person, shall have any claim or right to be granted an Award under the Plan or, having been selected for the grant of an Award, to be selected for a grant of any other Award. There is no obligation for uniformity of treatment of Participants or holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee&#8217;s determinations and interpretations with respect thereto need not be the same with respect to each Participant and may be made selectively among Participants, whether or not such Participants are similarly situated. Neither the Plan nor any action taken hereunder shall be construed as giving any Participant any right to be retained in the employ or service of the Company or an Affiliate, nor shall it be construed as giving any Participant any rights to continued service on the Board. The Company or any of its Affiliates may at any time dismiss a Participant from employment or discontinue any consulting relationship, free from any liability or any claim under the Plan, unless otherwise expressly provided in the Plan or any Award Agreement. By accepting an Award under the Plan, a Participant shall thereby be deemed to have waived any claim to continued exercise or vesting of an Award or to damages or severance entitlement related to non-continuation of the Award beyond the period provided under the Plan or any Award Agreement, notwithstanding any provision to the contrary in any written employment contract or other agreement between the Company and its Affiliates and the Participant, whether any such agreement is executed before, on or after the Date of Grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Addenda/International Participants</i>. The Committee may adopt such addenda to the Plan as it may consider necessary or appropriate for the purpose of granting Awards, which Awards may contain such terms and conditions as the Committee deems necessary or appropriate to accommodate differences in local law, tax policy or custom, which may deviate from the terms and conditions set forth in this Plan The terms of any such addenda shall supersede the terms of the Plan to the extent necessary to accommodate such differences but shall not otherwise affect the terms of the Plan as in effect for any other purpose. With respect to Participants who reside or work outside of the United States of America, the Committee may in its sole discretion amend the terms of the Plan or outstanding Awards with respect to such Participants in order to conform such terms with the requirements of local law or to obtain more favorable tax or other treatment for a Participant, the Company or its Affiliates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Designation and Change of Beneficiary</i>. Each Participant may file with the Committee a written designation of one or more persons as the beneficiary(ies) who shall be entitled to receive the amounts payable with respect to an Award, if any, due under the Plan upon his death. A Participant may, from time to time, revoke or change his beneficiary designation without the consent of any prior beneficiary by filing a new designation with the Committee. The last such designation received by the Committee shall be controlling;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that no designation, or change or revocation thereof, shall be effective unless received by the Committee prior to the Participant&#8217;s death, and in no event shall it be effective as of a date prior to such receipt. If no beneficiary designation is filed by a Participant, the beneficiary shall be deemed to be his or her spouse or, if the Participant is unmarried at the time of death, his or her estate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination of Employment/Service</i>. Unless determined otherwise by the Committee at any point following such event: (i) neither a temporary absence from employment or service due to illness, vacation or leave of absence nor a transfer from employment or service with the Company to employment or service with an Affiliate (or vice-versa) shall be considered a termination of employment or service with the Company or an Affiliate; and (ii) if a Participant&#8217;s employment with the Company and its Affiliates terminates, but such Participant continues to provide services to the Company and its Affiliates in a non-employee capacity (or vice-versa), such change in status shall not be considered a termination of employment with the Company or an Affiliate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Leaves of Absence/Transfer Between Locations</i>. The Committee shall have the discretion to determine at any time whether and to what extent the vesting of Awards shall be suspended during any leave of absence; provided, however, that in the absence of such determination, vesting of Awards shall continue during any paid leave and during any unpaid leave (unless otherwise required by applicable Laws). A Participant will not cease to be an Employee in the case of (a)&#160;any leave of absence approved by the Participant&#8217;s employer or (b)&#160;transfers between locations of the Company or between the Company or any Subsidiary. If an Employee is holding an Incentive Stock Option and such leave exceeds three (3)&#160;months then, for purposes of Incentive Stock Option status only, such Employee&#8217;s service as an Employee shall be deemed terminated on the first (1<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">st</sup>) day following such three (3)&#160;month period and the Incentive Stock Option shall thereafter automatically treated for tax purposes as a Nonstatutory Stock Option in accordance with applicable laws, unless reemployment upon the expiration of such leave is guaranteed by contract or statute, or unless provided otherwise pursuant to a written Company policy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">(i)</i></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Rights as a Stockholder</i>. Except as otherwise specifically provided in the Plan or any Award Agreement, no person shall be entitled to the privileges of ownership in respect of Common Shares or other securities that are subject to Awards hereunder until such shares have been issued or delivered to that person<i style="font-style:italic;">.</i></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Government and Other Regulations</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>The obligation of the Company to settle Awards in Common Shares or other consideration shall be subject to all applicable laws, rules, and regulations, and to such approvals by governmental agencies as may be required. Notwithstanding any terms or conditions of any Award to the contrary, the Company shall be under no obligation to offer to sell or to sell, and shall be prohibited from offering to sell or selling, any Common Shares or other securities pursuant to an Award unless such shares have been properly registered for sale pursuant to the Securities Act with the Securities and Exchange Commission or unless the Company has received an opinion of counsel, satisfactory to the Company, that such shares may be offered or sold without such registration pursuant to an available exemption therefrom and the terms and conditions of such exemption have been fully complied with. The Company shall be under no obligation to register for sale under the Securities Act any of the Common Shares or other securities to be offered or sold under the Plan. The Committee shall have the authority to provide that all certificates for Common Shares or other securities of the Company or any Affiliate delivered under the Plan shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan, the applicable Award Agreement, the federal securities laws, or the rules, regulations and other requirements of the Securities and Exchange Commission, any securities exchange or inter-dealer quotation system upon which such shares or other securities are then listed or quoted and any other applicable federal, state, local or non-U.S. laws, and, without limiting the generality of <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 9</span> of the Plan, the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. Notwithstanding any provision in the Plan to the contrary, the Committee reserves the right to add any additional terms or provisions to any Award granted under the Plan that it in its sole discretion deems necessary or advisable in order that such Award complies with the legal requirements of any governmental entity to whose jurisdiction the Award is subject.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>The Committee may cancel an Award or any portion thereof if it determines, in its sole discretion, that legal or contractual restrictions and/or blockage and/or other market considerations would make the Company&#8217;s acquisition of Common Shares from the public markets, the Company&#8217;s issuance of Common Shares or other securities to the Participant, the Participant&#8217;s acquisition of Common Shares or other securities from the Company and/or the Participant&#8217;s sale of Common Shares to the public markets, illegal, impracticable or inadvisable. If the Committee determines to cancel all or any portion of an Award denominated in Common Shares in accordance with the foregoing, the Company shall pay to the Participant an amount equal to the excess of (A) the aggregate fair market value of the Common Shares subject to such Award or portion thereof canceled (determined as of the applicable exercise date, or the date that the shares would have been vested or delivered, as applicable), over (B) the aggregate Exercise Price or Strike Price (in the case of an Option or SAR, respectively) or any amount payable as a condition of delivery of Common Shares (in the case of any other Award). Such amount shall be delivered to the Participant as soon as practicable following the cancellation of such Award or portion thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payments to Persons Other Than Participants</i>. If the Committee shall find that any person to whom any amount is payable under the Plan is unable to care for his affairs because of illness or accident, or is a minor, or has died, then any payment due to such person or his estate (unless a prior claim therefor has been made by a duly appointed legal representative) may, if the Committee so directs the Company, be paid to his spouse, child, relative, an institution maintaining or having custody of such person, or any other person deemed by the Committee to be a proper recipient on behalf of such person otherwise entitled to payment. Any such payment shall be a complete discharge of the liability of the Committee and the Company therefor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(l)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nonexclusivity of the Plan</i>. Neither the adoption of this Plan by the Board nor the submission of this Plan to the stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of stock options or other equity-based awards otherwise than under this Plan, and such arrangements may be either applicable generally or only in specific cases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(m)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Trust or Fund Created</i>. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate, on the one hand, and a Participant or other person or entity, on the other hand. No provision of the Plan or any Award shall require the Company, for the purpose of satisfying any obligations under the Plan, to purchase assets or place any assets in a trust or other entity to which contributions are made or otherwise to segregate any assets, nor shall the Company maintain separate bank accounts, books, records or other evidence of the existence of a segregated or separately maintained or administered fund for such purposes. Participants shall have no rights under the Plan other than as unsecured general creditors of the Company, except that insofar as they may have become entitled to payment of additional compensation by performance of services, they shall have the same rights as other employees under general law.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(n)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reliance on Reports</i>. Each member of the Committee and each member of the Board shall be fully justified in acting or failing to act, as the case may be, and shall not be liable for having so acted or failed to act in good faith, in reliance upon any report made by the independent public accountant of the Company and its Affiliates and/or any other information furnished in connection with the Plan by any agent of the Company or the Committee or the Board, other than himself.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(o)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Relationship to Other Benefits</i>. No payment under the Plan shall be taken into account in determining any benefits under any pension, retirement, profit sharing, group insurance or other benefit plan of the Company except as otherwise specifically provided in such other plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(p)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law</i>. The Plan shall be governed by and construed in accordance with the internal laws of the State of Delaware applicable to contracts made and performed wholly within the State of Delaware, without giving effect to the conflict of laws provisions thereof. Each party hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the state and federal courts seated in Wilmington, Delaware (and any appellate courts thereof) in any action or proceeding arising out of or relating to this Plan, and each of the parties hereby irrevocably and unconditionally (a) agrees not to commence any such action or proceeding except in such courts, (b) agrees that any claim in respect of any such action or proceeding may be heard and determined in such court, (c) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such action or proceeding in any such court, and (d) waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. Each party agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Each party hereby knowingly, voluntarily and intentionally irrevocably waives the right to a trial by jury in respect to any litigation, dispute, claim, legal action or other legal proceeding based hereon, or arising out of, under, or in connection with, this Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(q)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</i>. If any provision of the Plan or any Award or Award Agreement is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any person or entity or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to the applicable laws, or if it cannot be construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be construed or deemed stricken as to such jurisdiction, person or entity or Award and the remainder of the Plan and any such Award shall remain in full force and effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(r)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Obligations Binding on Successors</i>. The obligations of the Company under the Plan shall be binding upon any successor corporation or organization resulting from the merger, amalgamation, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(s)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Status under ERISA</i>. It is the intent of the Company that the Plan shall not constitute an &#8220;employee benefit plan&#8221; for purposes of Section&#160;3(3) of the Employee Retirement Income Security Act of 1974, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(t)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Code Section 409A</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Notwithstanding any provision of this Plan to the contrary, all Awards made under this Plan are intended to be exempt from or, in the alternative, comply with Code Section 409A and the interpretive guidance thereunder, including the exceptions for stock rights and short-term deferrals. The Plan shall be construed and interpreted in accordance with such intent. Each payment under an Award shall be treated as a separate payment for purposes of Code Section 409A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>If a Participant is a &#8220;specified employee&#8221; (as such term is defined for purposes of Code Section 409A) at the time of his or her termination of service, no amount that is nonqualified deferred compensation subject to Code Section 409A and that becomes payable by reason of such termination of service shall be paid to the Participant (or in the event of the Participant&#8217;s death, the Participant&#8217;s representative or estate) before the earlier of (x) the first business day after the date that is six months following the date of the Participant&#8217;s termination of service, and (y) within 30 days following the date of the Participant&#8217;s death. For purposes of Code Section 409A, a termination of service shall be deemed to occur only if it is a &#8220;separation from service&#8221; within the meaning of Code Section 409A, and references in the Plan and any Award Agreement to &#8220;termination of service&#8221; or similar terms shall mean a &#8220;separation from service.&#8221; If any Award is or becomes subject to Code Section 409A, unless the applicable Award Agreement provides otherwise, such Award shall be payable upon the Participant&#8217;s &#8220;separation from service&#8221; within the meaning of Code Section 409A. If any Award is or becomes subject to Code Section 409A and if payment of such Award would be accelerated or otherwise triggered under a Change in Control, then the definition of Change in Control shall be deemed modified, only to the extent necessary to avoid the imposition of an excise tax under Code Section 409A, to mean a &#8220;change in control event&#8221; as such term is defined for purposes of Code Section 409A.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>Any adjustments made pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> to Awards that are subject to Code Section 409A shall be made in compliance with the requirements of Code Section 409A, and any adjustments made pursuant to <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 13</span> to Awards that are not subject to Code Section 409A shall be made in such a manner as to ensure that after such adjustment, the Awards either (x) continue not to be subject to Code Section 409A or (y) comply with the requirements of Code Section 409A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(u)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Expenses; Gender; Titles and Headings</i>. The expenses of administering the Plan shall be borne by the Company and its Affiliates. Masculine pronouns and other words of masculine gender shall refer to both men and women. The titles and headings of the sections in the Plan are for convenience of reference only, and in the event of any conflict, the text of the Plan, rather than such titles or headings shall control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Agreements</i>. Notwithstanding the above, the Committee may require, as a condition to the grant of and/or the receipt of Common Shares or other securities under an Award, that the Participant execute lock-up, stockholder or other agreements, as it may determine in its sole and absolute discretion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(w)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payments</i>.&#160;Participants shall be required to pay, to the extent required by applicable law, any amounts required to receive Common Shares or other securities under any Award made under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(x)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Erroneously Awarded Compensation</i>. All Awards shall be subject (including on a retroactive basis) to (i) any clawback, forfeiture or similar incentive compensation recoupment policy established from time to time by the Company, including, without limitation, any such policy established to comply with the Dodd-Frank Wall Street Reform and Consumer Protection Act, (ii) applicable law (including, without limitation, Section 304 of the Sarbanes-Oxley Act and Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act), and/or (iii) the rules and regulations of the applicable securities exchange or inter-dealer quotation system on which the Common Shares or other securities are listed or quoted, and such requirements shall be deemed incorporated by reference into all outstanding Award Agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(y)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investment Representations</i>. As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(z)</span></span><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Corporate Records Control</i>. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">[Signature page follows]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-align:center;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">D-19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_8cde7b5a_332f_4037_9cde_78a108b3e1ca"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, this Data Knights Acquisition Corp.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5</sup> 2022 Equity Incentive Plan has been duly approved and adopted by the Company and the stockholders as of the dates set forth below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:44.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adopted by consent of the Board: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022</p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stockholder Approved: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022</p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:44.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">6</sup></p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:49.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:44.94%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.85%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:44.94%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:44.94%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.85%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:44.94%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date:</p></td><td style="vertical-align:top;width:44.94%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.85%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:44.94%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">[Signature page to Data Knights Acquisition Corp. 2022 Equity Incentive Plan]</i></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5 </sup>Company name to be changed to OneMedNet Corporation upon stockholder approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:70.53pt;"><a id="_99e24b09_2e81_430b_a0e2_3afc5f4b366b"></a><a id="AnnexD_533779"></a><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:right;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Annex E</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><img src="dkdcu-20230331xs4a057.jpg" alt="Graphic" style="display:inline-block;height:70.28pt;left:0%;padding-bottom:0.25pt;position:relative;top:0pt;width:182.22pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:99.9%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">June 23, 2022</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">File Reference: 34-36-63301</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt;">Mr. Barry Anderson</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Chairman and Chief Executive Officer</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt;">Data Knights Acquisition Corp.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt;">Unit G6, Frome Business Park</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt;">Manor Road, Frome,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt;">Somerset, BA11 4FN</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt;">United Kingdom</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt;">To the Board of Directors:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Marshall &amp; Stevens Transaction Advisory Services LLC (referred to herein as &#8220;Marshall &amp; Stevens&#8221; or &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) has been engaged by Data Knights Acquisition Corp. (&#8220;Data Knights&#8221; or the &#8220;SPAC&#8221;) for the benefit of and to advise the board of directors (the &#8220;Board&#8221;) in connection with the consideration by the Board of a possible acquisition of OneMedNet Corporation (&#8220;OneMedNet&#8221;). We have been engaged to perform a fairness analysis and issue our opinion as to the fairness to Data Knights, from a financial point of view, of the consideration to be received by Data Knights in consideration of the issuance of its equity securities to the equity holders of OneMedNet in connection with the anticipated acquisition by Data Knights of one hundred percent of the equity and equity equivalents (&#8220;equity&#8221;) and/or all or substantially all of the assets and business (the &#8220;business&#8221;) of OneMedNet (the &#8220;Acquired Business). This opinion (our &#8220;Opinion&#8221;) is being delivered pursuant to our Engagement Letter dated May 6, 2022 and the General Contractual Conditions thereto (collectively, the &#8220;Engagement Agreement&#8221;). All assumptions and limitations stated below are either as provided in the Engagement Agreement or made with the consent or approval of the Board, as specifically set out below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We are advised, and have relied upon such advice with your approval, that the Transaction will be consummated as set forth in the Agreement and Plan of Merger by and among Data Knights, Data Knights Merger Sub, Inc., Data Knights LLC, Paul Casey and OneMedNet (the &#8220;Merger Agreement&#8221;) provided to us by the Company and dated April 25, 2022. We understand that the Transaction is expected to close on or about October 15, 2022 (the &#8220;Transaction Date&#8221;). We are further advised, and have relied upon such advice with your approval, that the Transaction consists of a business combination between OneMedNet and the Company pursuant to which the Company will acquire the Acquired Business in consideration of the issuance by the Company to the equity holders of OneMedNet of approximately 20,000,000 shares of its authorized but unissued common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;) with an aggregate stated value as per the Merger Agreement of $200,000,000 (referred to in the Merger Agreement after certain adjustments for working capital balances and transaction costs as the &#8220;Merger Consideration&#8221;) to be issued at the closing of the Transaction (the &#8220;Closing&#8221;), such shares of Common Stock to be valued at the &#8220;Redemption Price&#8221; for such shares (as defined in the Merger Agreement). We have assumed for purposes of our analysis and Option that the Redemption Price will be $10.32 per share of Common Stock and, as the Company is a special purpose acquisition company with only a limited trading history and no material operations or assets other than cash or cash equivalents and the yet to be approved Merger Agreement, we have also assumed that this $10.32 per share of Common Stock Redemption Price represents the fair market value of such shares of Common Stock for purposes of this fairness analysis and Opinion. Accordingly, we have not performed an independent analysis regarding the fair market value of the Common Stock to be issued in the Transaction at the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">350 Fifth Avenue, Suite 4100, New York, NY 10118</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;">212.425.4300  &#8226;  212.344.9731 fax  &#8226;  www.marshall-stevens.com</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:99.9%;"><tr><td style="vertical-align:top;width:14.28%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chicago </p></td><td style="vertical-align:top;width:14.28%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:14.28%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Los Angeles</p></td><td style="vertical-align:top;width:14.28%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:14.29%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">New York</p></td><td style="vertical-align:top;width:14.29%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:14.29%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tampa</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:57.43pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As used herein, the term &#8220;Purchase Price&#8221; means, and is limited to, the fair market value of the Common Stock to be issued at the Closing (valued at the Redemption Price). The Purchase Price assumes that, at the Closing, the Acquired Business on a consolidated basis has no debt after deducting any excess cash on the balance sheet (&#8220;Net Debt&#8221;) and a normalized level of net working capital. We understand that the Merger Agreement provides for an adjustment up or down of the Purchase Price, if these assumptions are not satisfied at the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As stated above, we have been retained only to advise the Board as to the fairness, from a financial point of view, to the Company of the Purchase Price to be paid by the Company in the Transaction. We have not been engaged to render any opinion with respect to the fairness of the Purchase Price to any other person or entity or as to any other aspect of the Transaction, and we specifically render no such opinion. We have not been engaged to serve as the financial advisor to the Board; we were not involved in the negotiation or structuring of the Transaction; we have not been engaged to do, and have not done, any legal or contract review or (except as is customary in engagements of this type) any other due diligence review of the Transaction, OneMedNet and/or the Acquired Business or any projections related thereto; and we have not been asked to consider any non-financial elements of the Transaction or any other alternatives that might be available to the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In valuing the Acquired Business for purposes of our Opinion, we have looked solely at the enterprise value of Acquired Business as a going concern and on a standalone basis immediately prior to the Transaction Date and have not considered any impact on value (positive or negative) of the consummation of the Transaction on the value of the Acquired Business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We understand that incident to the Transaction, certain employees of OneMedNet may enter into employment agreements with the surviving entity, and that certain equity of the Company will be reserved for issuance pursuant to stock bonus arrangements to be entered into as a part of the Transaction. Our Opinion does not address the fairness of such agreements or stock bonus arrangements. We further understand that, in conjunction with the Transaction, the Company is making certain commitments with respect to the future financing or funding of the Acquired Business. Our Opinion has assigned no value to such future financing or funding commitments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In connection with this opinion, we have made such reviews, analysis and inquiry as we, in the exercise of our professional judgment, have deemed necessary and appropriate under the circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">With your consent, we have i) relied upon the accuracy and completeness of the financial and supplemental information (a) provided by or on behalf of the Board, the Company or OneMedNet or (b) which we have otherwise obtained from public sources or from private sources and which we believe, in the exercise of our professional judgment, to be reasonably dependable, ii) not assumed responsibility for independent verification of such information, iii) not conducted any independent valuation or appraisal of any specific assets of the Company or OneMedNet or any appraisal or estimate of any specific liabilities of the Company or OneMedNet, and iv) assumed that there are no contingent or off-balance sheet assets or liabilities of the Company or OneMedNet that have not been disclosed in writing to us. With respect to the financial forecasts relating to OneMedNet, with your consent, we have assumed that such forecasts have been reasonably prepared on the basis of and reflect the best currently available estimates and judgments of the management of OneMedNet as to the future financial performance of that company and, accordingly, take no responsibility for, and express no view as to, such financial forecasts or the assumptions on which they are based. With the Board&#8217;s approval, we have assumed that the management of OneMedNet executes on its business plan in accordance with its projections, and that all documents related to the Transaction filed with the Securities and Exchange Commission comply with all applicable laws and regulations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;text-indent:18pt;margin:0pt;"><img src="dkdcu-20230331xs4a058.jpg" alt="Graphic" style="display:inline-block;height:57.43pt;width:148.9pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">E-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:36.03pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Except as otherwise provide herein, our Opinion is based upon economic, market and other conditions as they exist and can reasonably be evaluated on the date hereof and does not address the fairness of the Transaction as of any other date. Likewise, our Opinion, is based on the factual circumstances, agreements and terms, as they exist and are known to us at the date of our Opinion. It is understood that financial markets are subject to volatility, and our opinion does not purport to address potential developments in applicable financial markets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our Opinion expressed herein has been prepared for the Board in connection with its consideration of the Transaction and may not be relied upon by any other person or entity or for any other purpose. Our Opinion does not constitute a recommendation to the Board or the shareholders of the Company, the equity holders of OneMedNet or any other person or entity as to any action the Board, the shareholders of Company, the equity holders of OneMedNet or any other person or entity should take, or omit to take, in connection with the Transaction or any aspect thereof. Our opinion does not address the merits of the Transaction or the underlying decision by the Board to engage in the Transaction or the relative merits of any alternatives that may be available to Company. Our Opinion addresses only certain financial aspects of the Transaction and does not address any other aspect of the Transaction. Our Opinion does not represent any advice as to the fairness of any matters of management compensation or of any fees paid or expenses incurred. Furthermore, our Opinion is not to be construed or deemed to be a solvency opinion or provide any advice as to legal, accounting or tax matters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Subject to the foregoing, it is our opinion that, as of the date hereof, the Purchase Price to be paid by the Company to the equity holders of OneMedNet in the Transaction for the Acquired Business as provided in the Merger Agreement is fair to the Company from a financial point of view.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.7pt;text-indent:-0.7pt;margin:0pt;">Sincerely,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt 0pt 0.25pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt 0pt 0.25pt 0pt;"><img src="dkdcu-20230331xs4a059.jpg" alt="Graphic" style="display:inline-block;height:35.93pt;left:0%;padding-bottom:0.1pt;position:relative;top:0pt;width:185.29pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt 0pt 0.25pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.7pt;text-indent:-0.7pt;margin:0pt;"><b style="font-weight:bold;">Marshall &amp; Stevens Transaction Advisory Services LLC</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.7pt;text-indent:-0.7pt;margin:0pt;"><b style="font-weight:bold;">File No. 34-36-63301</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt 0pt 0.75pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">E-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_46a2a36e_88ea_482d_a0d3_67fd103e8366"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PART&#160;II</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">INFORMATION NOT REQUIRED IN PROSPECTUS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item&#160;20. &#160;&#160;&#160;Indemnification of Directors and Officers.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our amended and restated certificate of incorporation will provide that all of our directors, officers, employees and agents shall be entitled to be indemnified by us to the fullest extent permitted by Section&#160;145 of the Delaware General Corporation Law (&#8220;DGCL&#8221;). Section&#160;145 of the Delaware General Corporation Law concerning indemnification of officers, directors, employees and agents is set forth below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Section&#160;145. Indemnification of officers, directors, employees and agents; insurance.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(a)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys<span style="font-family:'Times New Roman PS Std';">&#8217;</span> fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the person<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s conduct was unlawful.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(b)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys<span style="font-family:'Times New Roman PS Std';">&#8217;</span> fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(c)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">To the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a)<span style="font-family:'Times New Roman PS Std';">&#160;</span>and (b)<span style="font-family:'Times New Roman PS Std';">&#160;</span>of this section, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys<span style="font-family:'Times New Roman PS Std';">&#8217;</span> fees) actually and reasonably incurred by such person in connection therewith.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(d)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Any indemnification under subsections (a)<span style="font-family:'Times New Roman PS Std';">&#160;</span>and (b)<span style="font-family:'Times New Roman PS Std';">&#160;</span>of this section (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in subsections (a)<span style="font-family:'Times New Roman PS Std';">&#160;</span>and (b)<span style="font-family:'Times New Roman PS Std';">&#160;</span>of this section. Such determination shall be made, with respect to a person who is a director or officer at the time of such determination, (1)<span style="font-family:'Times New Roman PS Std';">&#160;</span>by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, or (2)<span style="font-family:'Times New Roman PS Std';">&#160;</span>by a committee of such directors designated by majority vote of such directors, even though less than a quorum, or (3)<span style="font-family:'Times New Roman PS Std';">&#160;</span>if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or (4)<span style="font-family:'Times New Roman PS Std';">&#160;</span>by the stockholders.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">II-1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(e)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Expenses (including attorneys<span style="font-family:'Times New Roman PS Std';">&#8217;</span> fees) incurred by an officer or director in defending any civil, criminal, administrative or investigative action, suit or proceeding may be paid by the corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the corporation as authorized in this section. Such expenses (including attorneys<span style="font-family:'Times New Roman PS Std';">&#8217;</span> fees) incurred by former officers and directors or other employees and agents may be so paid upon such terms and conditions, if any, as the corporation deems appropriate.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(f)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">The indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this section shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s official capacity and as to action in another capacity while holding such office. A right to indemnification or to advancement of expenses arising under a provision of the certificate of incorporation or a bylaw shall not be eliminated or impaired by an amendment to such provision after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or omission explicitly authorizes such elimination or impairment after such action or omission has occurred.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(g)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">A corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s status as such, whether or not the corporation would have the power to indemnify such person against such liability under this section.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(h)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">For purposes of this section, references to <span style="font-family:'Times New Roman PS Std';">&#8220;</span>the corporation<span style="font-family:'Times New Roman PS Std';">&#8221;</span> shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under this section with respect to the resulting or surviving corporation as such person would have with respect to such constituent corporation if its separate existence had continued.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(i)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">For purposes of this section, references to <span style="font-family:'Times New Roman PS Std';">&#8220;</span>other enterprises<span style="font-family:'Times New Roman PS Std';">&#8221;</span> shall include employee benefit plans; references to <span style="font-family:'Times New Roman PS Std';">&#8220;</span>fines<span style="font-family:'Times New Roman PS Std';">&#8221;</span> shall include any excise taxes assessed on a person with respect to any employee benefit plan; and references to <span style="font-family:'Times New Roman PS Std';">&#8220;</span>serving at the request of the corporation<span style="font-family:'Times New Roman PS Std';">&#8221;</span> shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner <span style="font-family:'Times New Roman PS Std';">&#8220;</span>not opposed to the best interests of the corporation<span style="font-family:'Times New Roman PS Std';">&#8221;</span> as referred to in this section.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(j)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">The indemnification and advancement of expenses provided by, or granted pursuant to, this section shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(k)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">The Court of Chancery is hereby vested with exclusive jurisdiction to hear and determine all actions for advancement of expenses or indemnification brought under this section or under any by law, agreement, vote of stockholders or disinterested directors, or otherwise. The Court of Chancery may summarily determine a corporation<span style="font-family:'Times New Roman PS Std';">&#8217;</span>s obligation to advance expenses (including attorneys<span style="font-family:'Times New Roman PS Std';">&#8217;</span> fees).</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment of expenses incurred or paid by a director, officer or controlling person </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">II-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">in a successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to the court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with Section&#160;102(b)(7)&#160;of the DGCL, our amended and restated certificate of incorporation, will provide that no director shall be personally liable to us or any of our stockholders for monetary damages resulting from breaches of their fiduciary duty as directors, except to the extent such limitation on or exemption from liability is not permitted under the DGCL. The effect of this provision of our amended and restated certificate of incorporation is to eliminate our rights and those of our stockholders (through stockholders&#8217; derivative suits on our behalf) to recover monetary damages against a director for breach of the fiduciary duty of care as a director, including breaches resulting from negligent or grossly negligent behavior, except, as restricted by Section&#160;102(b)(7)&#160;of the DGCL. However, this provision does not limit or eliminate our rights or the rights of any stockholder to seek non-monetary relief, such as an injunction or rescission, in the event of a breach of a director&#8217;s duty of care.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the DGCL is amended to authorize corporate action further eliminating or limiting the liability of directors, then, in accordance with our amended and restated certificate of incorporation, the liability of our directors to us or our stockholders will be eliminated or limited to the fullest extent authorized by the DGCL, as so amended. Any repeal or amendment of provisions of our amended and restated certificate of incorporation limiting or eliminating the liability of directors, whether by our stockholders or by changes in law, or the adoption of any other provisions inconsistent therewith, will (unless otherwise required by law) be prospective only, except to the extent such amendment or change in law permits us to further limit or eliminate the liability of directors on a retroactive basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our amended and restated certificate of incorporation will also provide that we will, to the fullest extent authorized or permitted by the DGCL and Data Knights&#8217; bylaws, indemnify our current and former officers and directors, as well as those persons who, while directors or officers of our corporation, are or were serving as directors, officers, employees or agents of another entity, trust or other enterprise, including service with respect to an employee benefit plan, in connection with any threatened, pending or completed proceeding, whether civil, criminal, administrative or investigative, against all expense, liability and loss (including, without limitation, attorney&#8217;s fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred or suffered by any such person in connection with any such proceeding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the foregoing, a person eligible for indemnification pursuant to our amended and restated certificate of incorporation will be indemnified by us in connection with a proceeding initiated by such person only if such proceeding was authorized by our board of directors, except for proceedings to enforce rights to indemnification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The right to indemnification which will be conferred by our amended and restated certificate of incorporation is a contract right that includes the right to be paid by us the expenses incurred in defending or otherwise participating in any proceeding referenced above in advance of its final disposition, provided, however, that if the DGCL requires, an advancement of expenses incurred by our officer or director (solely in the capacity as an officer or director of our corporation) will be made only upon delivery to us of an undertaking, by or on behalf of such officer or director, to repay all amounts so advanced if it is ultimately determined that such person is not entitled to be indemnified for such expenses under our amended and restated certificate of incorporation or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The rights to indemnification and advancement of expenses will not be deemed exclusive of any other rights which any person covered by our amended and restated certificate of incorporation may have or hereafter acquire under law, our amended and restated certificate of incorporation, our bylaws, an agreement, vote of stockholders or disinterested directors, or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any repeal or amendment of provisions of our amended and restated certificate of incorporation affecting indemnification rights, whether by our stockholders or by changes in law, or the adoption of any other provisions inconsistent therewith, will (unless otherwise required by law) be prospective only, except to the extent such amendment or change in law permits us to provide broader indemnification rights on a retroactive basis, and will not in any way diminish or adversely affect any right or protection existing at the time of such repeal or amendment or adoption of such inconsistent provision with respect to any act or omission occurring prior to such repeal or amendment or adoption of such inconsistent provision. Our amended and restated certificate of incorporation will also permit us, to the extent and in the manner authorized or permitted by law, to indemnify and to advance expenses to persons other that those specifically covered by our amended and restated certificate of incorporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our bylaws, which we intend to adopt immediately prior to the closing of this offering, include the provisions relating to advancement of expenses and indemnification rights consistent with those which will be set forth in our amended and restated certificate of incorporation. In addition, our bylaws provide for a right of indemnity to bring a suit in the event a claim for </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">II-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">indemnification or advancement of expenses is not paid in full by us within a specified period of time. Our bylaws also permit us to purchase and maintain insurance, at our expense, to protect us and/or any director, officer, employee or agent of our corporation or another entity, trust or other enterprise against any expense, liability or loss, whether or not we would have the power to indemnify such person against such expense, liability or loss under the DGCL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any repeal or amendment of provisions of our bylaws affecting indemnification rights, whether by our board of directors, stockholders or by changes in applicable law, or the adoption of any other provisions inconsistent therewith, will (unless otherwise required by law) be prospective only, except to the extent such amendment or change in law permits us to provide broader indemnification rights on a retroactive basis, and will not in any way diminish or adversely affect any right or protection existing thereunder with respect to any act or omission occurring prior to such repeal or amendment or adoption of such inconsistent provision.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We will enter into indemnification agreements with each of our officers and directors a form of which is to be filed as an exhibit to this Registration Statement. These agreements will require us to indemnify these individuals to the fullest extent permitted under Delaware law against liabilities that may arise by reason of their service to us, and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In addition, effective upon the consummation of the Business Combination, as defined in Part&#160;I of this registration statement, Data Knights has entered or will enter into indemnification agreements with directors, officers, and some employees containing provisions which are in some respects broader than the specific indemnification provisions contained in the DGCL. The indemnification agreements will require Data Knights, among other things, to indemnify its directors against certain liabilities that may arise by reason of their status or service as directors and to advance their expenses incurred as a result of any proceeding against them as to which they could be indemnified.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">II-4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_d0ab4366_b890_4dc1_ad7e_39237efba79d"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Item&#160;21. &#160;&#160;&#160;Exhibits and Financial Statement Schedules.</b></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:10pt;margin-top:0pt;">(a)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:10pt;margin-top:0pt;">The following exhibits are filed as part of this Registration Statement:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">EXHIBIT&#160;INDEX</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:9.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:9.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exhibit</b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#160;</b><b style="font-weight:bold;">No.</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:88.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></th></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">2.1</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922049684/tm2213454d1_ex2-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Agreement and Plan of Merger, dated April&#160;25, 2022, by and among Data Knights, Merger Sub, Sponsor, OneMedNet, and Paul Casey.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">3.1</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921047461/tm218584d2_ex3-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Amended and Restated Certificate of Incorporation.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">3.2</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#AnnexB_987067"><span style="font-style:normal;font-weight:normal;">Form</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-style:normal;font-weight:normal;">of Third Amended and Restated Certificate of Incorporation (included as </span><i style="font-style:italic;font-weight:normal;">Annex</i><i style="font-family:'Times New Roman PS Std';font-style:italic;font-weight:normal;">&#160;</i><i style="font-style:italic;font-weight:normal;">C</i><span style="font-style:normal;font-weight:normal;"> to the proxy statement/prospectus).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">3.3</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921047461/tm218584d2_ex3-2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Bylaws.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">3.4</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="dkdcu-20230331xex3d4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">of Certificate of Merger</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">4.1</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921047461/tm218584d2_ex4-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Specimen Unit Certificate.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">4.2</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921047461/tm218584d2_ex4-2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Specimen Class</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">A Common Stock Certificate.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(5)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">4.3</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921047461/tm218584d2_ex4-3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Specimen Warrant Certificate.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(6)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">4.4</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921047461/tm218584d2_ex4-4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Warrant Agreement, dated May</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">6, 2021, by and between Continental Stock Transfer</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">&amp; Trust Company and the Company.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(7)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">5.1*</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xex5d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Opinion of Nelson Mullins Riley</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">&amp; Scarborough</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">LLP.</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">8.1*</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922117224/tm2220656d11_ex8-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Opinion of Nelson Mullins Riley &amp; Scarborough regarding certain tax matters.</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.1</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921064666/tm218584d10_ex10-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Letter Agreement, dated May</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">6, 2021, by and between the Company, the initial security holders and the officers and directors of the Company.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(8)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.2</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921064666/tm218584d10_ex10-2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Investment Management Trust Account Agreement, dated May</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">6, 2021, by and between Continental Stock Transfer</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">&amp; Trust Company and the Company.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(9)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.3</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921064666/tm218584d10_ex10-3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Registration Rights Agreement, dated May</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">6, 2021, by and among the Company and the initial security holders.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(10)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.4</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921064666/tm218584d10_ex10-4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Placement Unit Purchase Agreement, dated May</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">6, 2021, between the Registrant and Data Knights, LLC</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(11)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.5</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921047461/tm218584d2_ex10-7.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">of Indemnification Agreement.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(12)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.6</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921064666/tm218584d10_ex10-6.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Administrative Support Agreement, dated May</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">7, 2021, by and among the Company and Data Knights,</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">LLC.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(13)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.7</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921064666/tm218584d10_ex1-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Underwriting Agreement, dated May</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">6, 2021, by and between the Company and EF Hutton, division of Benchmark Investments LLC, as representatives of the several underwriters.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(14)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.8</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xs4.htm#AnnexC_319286"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">of 2022 Equity Incentive Plan (included as Annex</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">D to the proxy statement/prospectus).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.9</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xs4.htm#ExhibitA_572102"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">of Voting Agreement(included as Exhibit</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">A to Annex B to the proxy statement/prospectus).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.10</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xs4.htm#ExhibitB_559211"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Sponsor Support Agreement (included as Exhibit B to Annex B to the proxy statement/prospectus).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.11</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xs4.htm#ExhibitC_693181"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Lock-Up Agreement (included as Exhibit C to Annex B to the proxy statement/prospectus).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.12</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xs4.htm#ExhibitD_882944"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Non-Competition and Non-Solicitation Agreement (included as Exhibit D to Annex B to the proxy statement/prospectus).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.13</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xs4.htm#ExhibitG_395489"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Registration Rights Agreement (included as Exhibit G to Annex B to the proxy statement/prospectus).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.14</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xs4.htm#ExhibitF_862814"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Extension Escrow Agreement (included as Exhibit F to Annex B to the proxy statement/prospectus).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.15</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="dkdcu-20230331xex10d15.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Executive Employment Agreement with Paul Casey</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.16</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="dkdcu-20230331xex10d16.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Employment Agreement with </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Doug Arent</span></a> </p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.17</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="dkdcu-20230331xex10d17.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Employment Agreement with Aaron Green</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.18*</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465923043708/dkdcu-20221231xex10d18.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Data License Agreement dated September 16, 2021</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.19*</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465923043708/dkdcu-20221231xex10d19.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Master Reseller Agreement dated May 22, 2015</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.20<span style="font-family:'Times New Roman PS Std';">&#8224;&#8224;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="dkdcu-20230331xex10d20.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Securities Purchase Agreement dated June 28, 2023</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.21</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="dkdcu-20230331xex10d21.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Promissory Note dated June 30, 2023</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">10.22</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="dkdcu-20230331xex10d22.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Satisfaction and Discharge Agreement dated June 28, 2023</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">14.1</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921047461/tm218584d2_ex14-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Code of Ethics.</span><sup style="font-family:'Times New Roman','Times','serif';font-size:4.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(15)</sup></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">21.1*</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xex21d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">List of Subsidiaries.</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">23.1</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="dkdcu-20230331xex23d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of Marcum LLP</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">23.2*</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xex5d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of Nelson Mullins Riley</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">&amp; Scarborough LLP (included as part of Exhibit</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">5.1).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">23.3</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="dkdcu-20230331xex23d3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of BF Borgers CPA PC</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">23.4</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="dkdcu-20230331xex23d4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of Marshall &amp; Stevens Transaction Advisory Services LLC</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">24.1*</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xs4.htm#SIGNATURES_79383"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Power of Attorney (contained on the signature page</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">to this registration statement).</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">99.1*</p></td><td style="vertical-align:top;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465923010532/tm2220656d17_ex99-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">of Proxy Card for Stockholders.</span></a></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">II-5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:12pt;"><td style="vertical-align:bottom;width:9.65%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;"><b style="font-weight:bold;">Exhibit</b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#160;</b><b style="font-weight:bold;">No.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:88.48%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">99.2*</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922104260/dkdcu-20211231xex99d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Erkan Akyuz to be named as a director.</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">99.3*</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922104260/dkdcu-20211231xex99d3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Eric Casaburi to be named as a director.</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">99.4*</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922104260/dkdcu-20211231xex99d4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Robert Golden to be named as a director.</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">99.5*</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922104260/dkdcu-20211231xex99d5.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of Dr.</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Julianne Huh </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">to be named as a director</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">99.6*</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922104260/dkdcu-20211231xex99d6.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of Dr.</span><span style="font-family:'Times New Roman PS Std';font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Thomas Kosasa to be named as a director</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">99.7*</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922104260/dkdcu-20211231xex99d7.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">R. Scott Holbrook to be named as a director</span></a></p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">101.SCH</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">XBRL Taxonomy Extension Schema Document.</p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">101.CAL</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">XBRL Taxonomy Extension Calculation Linkbase Document.</p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">101.DEF</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">XBRL Taxonomy Extension Definition Linkbase Document.</p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">101.LAB</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">XBRL Taxonomy Extension Label Linkbase Document.</p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">101.PRE</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">XBRL Taxonomy Extension Presentation Linkbase Document.</p></td></tr><tr style="height:12pt;"><td style="vertical-align:top;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;">107*</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922081691/dkdcu-20211231xexfilingfees.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Filing Fee Table</span></a></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Previously filed.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">**</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">To be filed by amendment.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#8224;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Certain of the exhibits and schedules to this Exhibit&#160;have been omitted in accordance with Regulation S-K Item&#160;601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8224;&#8224;</span></span>Certain portions of this Exhibit have been omitted in accordance with Item 601(b)(10)(iv) of Regulation S-K.<br/><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Form 8-K, filed with the SEC on April 25, 2022.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Form S-1/A, filed with the SEC on April 7, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 3.2 to the Company&#8217;s Form S-1/A, filed with the SEC on April 7, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(4)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Form S-1/A, filed with the SEC on April 7, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(5)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form S-1/A, filed with the SEC on April 7, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(6)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 4.3 to the Company&#8217;s Form S-1/A, filed with the SEC on April 7, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(7)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 4.4 to the Company&#8217;s Form S-1/A, filed with the SEC on April 7, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(8)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Form 8-K, filed with the SEC on May 11, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(9)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Form 8-K, filed with the SEC on May 11, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(10)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Form 8-K, filed with the SEC on May 11, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(11)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Form 8-K, filed with the SEC on May 11, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(12)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Form 8-K, filed with the SEC on May 11, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(13)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 10.6 to the Company&#8217;s Form 8-K, filed with the SEC on May 11, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(14)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Incorporated by reference to Exhibit 1.1 to the Company&#8217;s Form 8-K, filed with the SEC on May 11, 2021.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">(15)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Incorporated by reference to Exhibit 14.1 to the Company&#8217;s Form S-1/A, filed with the SEC on April 7, 2021.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">II-6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_4e3c7a42_7abf_4699_8833_d4d8d8095865"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item&#160;22. &#160;&#160;&#160;Undertakings.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b)</span></span>The undersigned registrant hereby undertakes as follows:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">i.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">To include any prospectus required by Section<span style="font-family:'Times New Roman PS Std';">&#160;</span>10(a)(3)<span style="font-family:'Times New Roman PS Std';">&#160;</span>of the Securities Act of 1933;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">ii.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule<span style="font-family:'Times New Roman PS Std';">&#160;</span>424(b)<span style="font-family:'Times New Roman PS Std';">&#160;</span>if, in the aggregate, the changes in volume and price represent no more than 20<span style="font-family:'Times New Roman PS Std';">&#160;</span>percent change in the maximum aggregate offering price set forth in the <span style="font-family:'Times New Roman PS Std';">&#8220;</span>Calculation of Registration Fee<span style="font-family:'Times New Roman PS Std';">&#8221;</span> table in the effective registration statement;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">iii.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial<span style="font-family:'Times New Roman PS Std';">&#160;</span><i style="font-style:italic;">bona fide</i><span style="font-family:'Times New Roman PS Std';">&#160;</span>offering thereof.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(4)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule<span style="font-family:'Times New Roman PS Std';">&#160;</span>424(b)<span style="font-family:'Times New Roman PS Std';">&#160;</span>as part of a registration statement relating to an offering, other than registration statements relying on Rule<span style="font-family:'Times New Roman PS Std';">&#160;</span>430B or other than prospectuses filed in reliance on Rule<span style="font-family:'Times New Roman PS Std';">&#160;</span>430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(5)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">That, for the purpose of determining any liability under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">i.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule<span style="font-family:'Times New Roman PS Std';">&#160;</span>424;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">ii.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">iii.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">II-7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">iv.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(6)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">That prior to any public reoffering of the securities registered hereunder through use of a prospectus which is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule<span style="font-family:'Times New Roman PS Std';">&#160;</span>145(c), the issuer undertakes that such reoffering prospectus will contain the information called for by the applicable registration form with respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(7)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">That every prospectus: (i)<span style="font-family:'Times New Roman PS Std';">&#160;</span>that is filed pursuant to the immediately preceding paragraph, or (ii)<span style="font-family:'Times New Roman PS Std';">&#160;</span>that purports to meet the requirements of Section<span style="font-family:'Times New Roman PS Std';">&#160;</span>10(a)(3)<span style="font-family:'Times New Roman PS Std';">&#160;</span>of the Act and is used in connection with an offering of securities subject to Rule<span style="font-family:'Times New Roman PS Std';">&#160;</span>415, will be filed as a part of an amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial<span style="font-family:'Times New Roman PS Std';">&#160;</span><i style="font-style:italic;">bona fide</i><span style="font-family:'Times New Roman PS Std';">&#160;</span>offering thereof.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">(8)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin-bottom:12pt;margin-top:0pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the undersigned pursuant to the foregoing provisions, or otherwise, the undersigned has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the undersigned of expenses incurred or paid by a director, officer or controlling person of the undersigned in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the undersigned will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(c)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">The undersigned registrant hereby undertakes to respond to requests for information that is incorporated by reference into the prospectus pursuant to Item<span style="font-family:'Times New Roman PS Std';">&#160;</span>4, 10(b), 11, or 13 of this form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to the effective date of the registration statement through the date of responding to the request.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(d)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">The undersigned registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein, that was not the subject of and included in the registration statement when it became effective.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">II-8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_d920b417_1152_4ed1_abd4_45fa06188317"></a><a id="SIGNATURES_79383"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Frome, United Kingdom, on the 3rd day of July&#160;2023.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:3.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:4.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:42.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:12pt;"><td style="vertical-align:bottom;width:48.75%;margin:0pt;padding:0pt;"/><td colspan="3" style="vertical-align:bottom;width:51.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION</b><b style="font-family:'Times New Roman PS Std';font-weight:bold;">&#160;</b><b style="font-weight:bold;">CORP.</b></p></td></tr><tr style="height:12pt;"><td style="vertical-align:bottom;width:48.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:8.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:42.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td style="vertical-align:bottom;width:48.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:bottom;width:47.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Barry Anderson</p></td></tr><tr style="height:12pt;"><td style="vertical-align:bottom;width:48.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:42.93%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td></tr><tr style="height:12pt;"><td style="vertical-align:bottom;width:48.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:42.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer and Director</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:43.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:22.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Date</b></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;margin:8pt 0pt 0pt 0pt;">/s/<span style="font-size:10pt;"> Barry Anderson</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:8pt 0pt 0pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:8pt 0pt 0pt 0pt;">Chief Executive Officer, Director </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:8pt 0pt 0pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:8pt 0pt 0pt 0pt;">July 3, 2023</p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(Principal Executive Officer)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Firdauz Edmin Bin Mokhtar</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">July 3, 2023</p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Firdauz Edmin Bin Mokhtar</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(Principal Financial and Accounting Officer)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Julianne Huh*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">July 3, 2023</p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Julianne Huh</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/<span style="color:#333333;"> Syed Musheer Ahmed*</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">July 3, 2023</p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Syed Musheer Ahmed</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#333333;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ <span style="color:#333333;">Annie Damit Undikai*</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">July 3, 2023</p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#333333;">Annie Damit Undikai</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#333333;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td colspan="2" style="vertical-align:bottom;width:30.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#333333;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td style="vertical-align:bottom;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">*By: </p></td><td style="vertical-align:bottom;width:26.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Barry Anderson</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.87%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:22.24%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td style="vertical-align:bottom;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:26.55%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Barry Anderson</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td style="vertical-align:bottom;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:26.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attorney-in-fact</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:22.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>2
<FILENAME>dkdcu-20230331xex3d4.htm
<DESCRIPTION>EXHIBIT 3.4
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:19 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Exhibit 3.4</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">FORM OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">STATE OF DELAWARE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">CERTIFICATE OF MERGER OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">DOMESTIC CORPORATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Pursuant to Tile 8, Section 251(c) of the Delaware General Corporation Law (&#8220;DGCL&#8221;), the undersigned corporation executed the following Certificate of Merger as of ____________, 2023:</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">FIRST:</b></p></td><td style="vertical-align:top;width:90%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">Data Knights Merger Sub, Inc., a Delaware corporation (the &#8220;Merged Corporation&#8221;) is merging with and into OneMedNet Corporation, a Delaware corporation (the &#8220;Surviving Corporation&#8221;).</p></td></tr><tr><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">SECOND:</b></p></td><td style="vertical-align:top;width:90%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">An Agreement and Plan of Merger has been approved, adopted, executed and acknowledged by the board of directors and the stockholders of both the Merged Corporation and the Surviving Corporation in accordance with Section 251 of the DGCL.</p></td></tr><tr><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">THIRD: </b></p></td><td style="vertical-align:top;width:90%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">OneMedNet Corporation, shall be the surviving corporation.</p></td></tr><tr><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">FOURTH: </b></p></td><td style="vertical-align:top;width:90%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">The Certificate of Incorporation of the Surviving Corporation as currently in effect shall be the Certificate of Incorporation of the Surviving Corporation.</p></td></tr><tr><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">FIFTH:</b></p></td><td style="vertical-align:top;width:90%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">An executed copy of the Agreement and Plan of Merger is on file at the principal office of the Surviving Corporation at ____________, the place of business of the Surviving Corporation, and a copy of such executed Agreement and Plan of Merger will be furnished by the Surviving Corporation, on request and without cost, to any stockholder of either the Surviving Corporation or the Merged Corporation.</p></td></tr><tr><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">SIXTH:</b></p></td><td style="vertical-align:top;width:90%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">The merger herein provided for shall become effective in the State of Delaware upon filing.</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;">[<i style="font-style:italic;">Signature Page Follows</i>]</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Surviving Corporation and the Merged Corporation have each caused this certificate to be signed by an authorized officer of each entity on the date first set forth above.</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">ONEMEDNET CORPORATION</b></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:44%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:44%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS MERGER SUB, INC.</b></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:44%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:44%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>3
<FILENAME>dkdcu-20230331xex10d15.htm
<DESCRIPTION>EXHIBIT 10.15
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:19 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 10.15</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><img src="dkdcu-20230331xex10d15001.jpg" alt="Graphic" style="display:inline-block;height:55.49pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:92.23pt;"></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.34pt 0pt;">OneMedNet Corporation<br>Suite 250, 6385 Old Shady Oak Road<br>Eden Prairie, MN 55344 USA<br>Tel: 1-800-918-7189<br><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">www.onemednet.com</u></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.3pt 7pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;" align="center"><tr><td style="vertical-align:bottom;width:31.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">June 1, 2022 </p></td><td style="vertical-align:bottom;width:68.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:68.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention:</p></td><td style="vertical-align:bottom;width:68.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Paul Casey</b></p></td><td style="vertical-align:bottom;width:68.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1010 Wilder Ave, Apt 804</p></td><td style="vertical-align:bottom;width:68.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Honolulu, HI 96822</p></td><td style="vertical-align:bottom;width:68.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2.65pt 0pt;">Dear Paul Casey,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On behalf of OneMedNet Corporation (the &#8220;Company&#8221;), I am pleased to make you an offer of employment to join our team. This letter sets forth the terms and conditions of your employment with the Company. Once you accept these terms as outlined below, this letter will constitute your Employment Agreement with the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">This terms and conditions of employment with the Company are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Role and Duties</u></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">1.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You will be employed in the position of CEO reporting to the Board of Directors.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">2.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You represent that you are legally eligible to work in the jurisdiction in which the Company has offered you employment.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">3.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Your employment will start effective June 1, 2022 (the &#8220;Start Date&#8221;) and will continue until your employment is terminated in accordance with this Employment Agreement.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">4.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">In recognition of your service as a contractor with OneMedNet you will not be subject to a probationary period.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">During your employment you agree that you will conduct yourself at all times in a professional and honest manner. You further agree that you will not work, directly or indirectly, on your own behalf or for any other individual, corporation, partnership, unincorporated organization, governmental agency or other entity which, in the reasonable opinion of the Company, may give rise to a conflict of interest between you and the Company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compensation and Benefits (US Dollars unless otherwise indicated)</u></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">6.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Effective on the Start Date, your base salary will be $144,000.00 per annum and will be reviewed from time to time by the Company starting with the first anniversary of your Start Date. Any increases in salary over the course of your employment will be at the Company&#8217;s discretion.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">7.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Your position is not eligible for overtime pay. Your base salary, stock options and various incentive and benefits programs described herein will be your compensation for all hours worked during your employment.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">8.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You will be eligible to participate in employee bonus programs subject to the approval of the Board of Directors based on the Company&#8217;s achievement of revenues and profitability over time. The Board and the management team will work together to construct these incentive plans for the Company.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">9.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You will be eligible for standard benefits coverage under the Company&#8217;s Benefit Plan provided to all salaried employees in accordance with the terms of such plan, as amended by the Company or the insurer from time to time.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">10.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You will be entitled to annual vacation leave as provided under the Company&#8217;s vacation policy.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">11.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You will be entitled for reimbursement of all reasonable business-related expenses, subject to the submission of expense reports and receipts for all expenses incurred.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination</u></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">12.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><i style="font-style:italic;">Termination Without Cause: </i>The Company may terminate your employment at any time without cause by providing you with working notice or, at the Company&#8217;s option, pay in lieu of such notice or a combination of working notice and pay in lieu of such notice in accordance with the following provisions:</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">(a)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Without any notice if, at the date notice is given, the length of your employment measured from the Start Date is less than 60 days;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">(b)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Four weeks of notice if, at the date notice is given, the length of your employment measured from your Start Date is between 60 days and two (2) years; or</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">(c)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Four weeks of notice after two (2) consecutive years of employment measured from your Start Date plus two (2) additional weeks of notice for each additional full year of employment to a maximum of 26 weeks of notice. In the event the Company elects to provide payment in lieu of working notice of termination under this paragraph, the Company shall continue to provide only those benefits that it is permitted or able to provide under the applicable rules of the relevant plans to the end of what would have been the working notice period under this paragraph.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 72pt;">Unless the terms and conditions of any applicable bonus or stock options plans or agreements provide otherwise, you will not be entitled to continue to participate in or to receive payment in lieu of such participation, in any of the Company&#8217;s bonus or stock option programs made available to any of its employees after the period of notice specified in this paragraph has expired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 72pt;">You agree that, where permitted by law, the Company may elect to make any pay in lieu of working notice payments to you as required under this paragraph on a regular basis in accordance with normal payroll practices. If the Company makes such election or if you are given working notice of termination, you shall have a</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page 2</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 72pt;">duty to mitigate by seeking out and obtaining new employment. If you obtain new employment you must immediately notify the Company and all payments to you will cease immediately.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">13.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><i style="font-style:italic;">Termination With Cause: </i>In the event of your termination for cause, you will be immediately relieved of your duties at the Company and shall receive no working notice or pay in lieu of notice from the Company. For the purposes of this Employment Agreement, &#8220;cause&#8221; has the meaning commonly ascribed to the phrase &#8220;cause&#8221; or &#8220;just cause&#8221; for termination&#8221; in the Courts of the State of Delaware.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">14.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><i style="font-style:italic;">No Additional Payments: </i>You acknowledge and agree that unless otherwise expressly agreed in writing between you and the Company, you will not be entitled, by reason of your employment with the Company or by reason of any termination of such employment, howsoever arising, to any remuneration, compensation or other benefits other than those expressly provided for in this Employment Agreement. You further acknowledge and agree that any amounts paid to you pursuant to this Employment Agreement are inclusive of any amounts that may be payable under any statute of the State of Delaware in respect of compensation for length of service, notice of termination or severance pay.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidential Information</u></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">15.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">The term &#8220;Confidential Information&#8221; as used in this Employment Agreement means all trade secrets, proprietary information and other data or information (and any tangible evidence, record or representation thereof) whether prepared, conceived or developed by an employee or agent of the Company (including by you) or received by the Company from an outside source which is maintained in confidence by the Company or any of its customers. Without limiting the generality of the foregoing, Confidential Information, includes information of the Company pertaining to:</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">(a)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">research and development plans or projects, data and reports; computer materials such as programs, instructions, source and object code, and printouts; formulas, inventions, developments and discoveries; product information, including testing information; business improvements and processes; marketing and selling plans; business opportunities, plans (whether pursued or not) and budgets; unpublished financial statements; licenses; pricing, pricing strategy and cost data; information regarding the skills and compensation of employees; the identities of clients and potential clients, customers and potential customers (collectively, &#8220;Customers&#8221;); the identities of contact persons at Customers; the preferences and needs of Customers; customer contact persons; information regarding sales calls, timing, sales terms, service plans, methods, practices, strategies, forecasts, know-how, and other marketing techniques; the identities of key accounts, potential key accounts; the identities of suppliers and contractors, and all information about those supplier and contractor relationships such as contact person(s), pricing and other terms;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">(b)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">any information relating to the relationship of the Company with any personnel, suppliers, principals, investors, contacts or prospects of the Company and any information relating to the requirements, specifications, proposals, orders, contracts or transactions of or with any such persons; and</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 0pt 43pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page 3</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 0pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</font></font>financial information, including the Company&#8217;s costs,<font style="display:inline-block;width:0.21pt;"></font>financing or debt arrangements, income, profits, salaries or wages.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">16.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You acknowledge that during your employment you will have access to the Confidential Information which is a valuable and unique asset of the Company and that the Confidential Information is and will remain the exclusive property of the Company. You agree to maintain securely and hold in strict confidence all Confidential Information received, acquired or developed by you or disclosed to you as a result of or in connection with his employment with the Company.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">17.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You agree that, both during your employment and after the termination of your employment with the Company, you will not use or disclose any Confidential Information to any person, other than as required to perform your duties hereunder, without the prior written authorization of the Company&#8217;s President and Chief Executive Officer. The obligation of confidentiality imposed by this Employment Agreement shall not apply to information that appears in issued patents or printed publications, that otherwise becomes generally known in the industry through no act on your part in breach of this Employment Agreement, or that is required to be disclosed by court order or applicable law.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">18.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You understand that the Company has from time to time in its possession information belonging to third parties or which is claimed by third parties to be confidential or proprietary, including health information about patients and which the Company has agreed to keep confidential. You agree that all such information shall be Confidential Information for the purposes of this Employment Agreement.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disclosure of Discoveries, Ideas and Inventions</u></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">19.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You acknowledge that all Confidential Information (as hereinafter defined) and all discoveries, know-how, inventions, ideas, concepts, processes, products, protocols, treatments, methods, tests and improvements, computer programs, or parts thereof, conceived, developed, reduced to practice or otherwise made or developed by you either alone or with others, during the course of employment with the Company pursuant to this Employment Agreement or any previous employment agreements or arrangements between you and the Company, whether or not conceived, developed, reduced to practice or made during your regular working hours or on the premises of the Company (collectively &#8220;Inventions&#8221;), and any and all services and products which embody, emulate or employ any such Inventions will be the sole property of the Company and all copyrights, patents, patent rights, trademarks, service marks and reproduction rights to, and other proprietary rights in, each such Invention, whether or not patentable or copyrightable, will belong exclusively to the Company.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">20.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You represent and warrant that you do not claim rights in, or otherwise exclude from this Employment Agreement, any Invention except as listed on Exhibit &#8220;A&#8221; hereto.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">21.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You hereby assign and agree to assign all your rights, title and interest in the Inventions, to the Company or its nominee. For purposes of the copyright laws of the United States of America, to the extent, if any, that such laws are applicable to any Confidential Information, Invention or any such service or product, it will be considered a work made for hire and the Company will be considered the author thereof. You hereby waive for the</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page 4</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">benefit of the Company and its successors and assigns any and all moral rights in respect of any Inventions.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">22.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You agree that you shall disclose promptly to the Company, its successors or assigns, any Inventions. Whenever requested to do so by the Company, you shall execute any and all applications, assignments or other instruments which the Company shall deem necessary to apply for and obtain patents or copyrights of Canada, the United States or any foreign country or to otherwise protect the Company&#8217;s interest in the Inventions and shall assist the Company in every proper way (entirely at the Company&#8217;s expense, including reimbursement to you for all expense and loss of income) to obtain such patents and copyrights and to enforce them.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Post-Employment Restrictions</u></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">23.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><i style="font-style:italic;">Non-Competition</i>: During your employment with the Company and for a period of 12 months following the termination of your employment from the Company for any reason, you agree that you shall not, anywhere in the United States of America, directly or indirectly, own, manage, operate, finance, join, control or participate in the ownership, management, operation, financing or control of, or be connected as an officer, director, employee, partner, principal, agent, representative, consultant, or use or permit your name to be used in connection with, any business or enterprise which competes with the Company in the business of researching, developing and producing medical image sharing and exchange software solutions.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">24.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><i style="font-style:italic;">Non-Solicitation</i>: During your employment with the Company and for a period of 12 months following the termination of your employment from the Company for any reason, you agree that you shall not (unless acting as an employee under this Employment Agreement or with the prior written consent of the Company&#8217;s President and Chief Executive Officer): (i) call on, solicit, or endeavor to entice away, either directly or indirectly, any Customers of the Company that the Employee or his subordinates solicited or serviced for the Company; or (ii) directly or indirectly, solicit or attempt to solicit, any employee, independent contractor or consultant of the Company to terminate his or her relationship with the Company in order to become an employee, consultant or independent contractor for any person or entity other than the Company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General</u></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">25.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">For the purposes of paragraphs 18 through 27 of this Employment Agreement the &#8220;Company&#8221; includes the Company&#8217;s subsidiaries, affiliates and otherwise related companies.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">26.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You acknowledge that the terms contained in paragraphs 18 through 27 survive the termination of this Agreement and are reasonable and necessary to protect the legitimate interests of the Company such that any violated of these paragraphs by you could result in irreparable injury to the Company. You agree that, in the event you violate any of these terms the Company shall be entitled to preliminary and permanent injunctive relief and any other remedies in law or in equity which the court deems fit.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page 5</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">27.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You agree that documents, copies, records and other property or materials made or received by you that pertain to the business and affairs of the Company, including all Confidential Information or Inventions in your possession or under your control are the property of the Company and that you will return same and any copies of same to the Company immediately upon termination of your employment or at any time upon the request of the Company.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">28.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">The Company may modify your duties, title, salary and/or benefits from time to time. You agree that any minor modifications to your duties, salary and/or benefits do not constitute a breach of the terms of this Employment Agreement or a termination of your employment and that all other aspects of this letter shall continue in full force and effect.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">29.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You agree to be bound by the terms and conditions of employment which are set out in the Company<font style="font-family:'Arial','Helvetica','sans-serif';">&#8217;</font>s Employment Handbook.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">30.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">This Employment Agreement constitutes the entire employment agreement between you and the Company and supersedes and replaces any prior oral and written agreements, understandings, commitments and practices between you and the Company relating to your employment. You also agree that the terms and conditions of this Employment Agreement are contractual.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">31.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">You acknowledge that this Employment Agreement has been prepared by the Company and acknowledge that you have had sufficient time to review this document thoroughly, including enough time to obtain independent legal advice concerning the interpretation and effect of it prior to its execution. By signing this document, you represent and warrant that you have read and understood it and that you execute it of your own free will and act.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">32.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">This letter and your employment will be governed by and construed in accordance with the laws of the State of Delaware and the federal laws of the United States applicable therein, which shall be deemed to be the proper law hereof. You and the Company hereby submit to the exclusive jurisdiction of the courts of the State of Delaware.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Section Intentionally Left Blank)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page 6</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Kindly signify your acceptance of the terms and conditions under which the Company is offering you employment by signing and dating the duplicate copy of this letter and returning same to me prior to that date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 7pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Yours truly,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">ONEMEDNET CORPORATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 7pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;" align="center"><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">/s/ Jeffrey Yu</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Jeffrey Yu, Founder</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">I HEREBY ACCEPT EMPLOYMENT ON THE TERMS AND CONDITIONS OUTLINED HEREIN</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">THIS 1st DAY OF JUNE, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;" align="center"><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">/s/ Paul Casey</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Paul Casey</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page 7</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exhibit </b><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">&#8220;</b><b style="font-weight:bold;">A</b><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">&#8221;</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">List of Excluded Inventions, Patents and Other Intellectual Properties</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6.69pt 0pt;">None <font style="font-family:'MS Gothic';">&#9744;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">See List Below</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 7pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;" align="center"><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Employee Initials</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page 8</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>4
<FILENAME>dkdcu-20230331xex10d16.htm
<DESCRIPTION>EXHIBIT 10.16
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:19 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exhibit&#160;10.16</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:99.9%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><img src="dkdcu-20230331xex10d16001.jpg" alt="Graphic" style="display:inline-block;height:55.49pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:92.23pt;"></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;text-indent:41pt;margin:0pt 0pt 0pt 8pt;">OneMedNet<br>Corporation Suite 250, 6385 Old<br>Shady Oak Road Eden Prairie,<br>MN 55344 USA</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">Tel: 1-800-918-7189</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">www.onemednet.com</u></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">April 14, 2020</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2.15pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.2pt 0pt;">Attention: Doug Arent 33175<br>Timber Ridge Rd Evergreen, CO<br>80439</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2.29pt 0pt;">Dear Doug:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On behalf of OneMedNet Corporation (the &#8220;Company&#8221;), I am pleased to make you an offer of employment to join our team. This letter sets forth the terms and conditions of your employment with the Company. Once you accept the terms as outlined below by signing and returning a copy of this letter to me, this letter will constitute your Employment Agreement with the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">This terms and conditions of your employment with the Company are as follows: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Role and Duties</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">1.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You will be employed in the position of VP of Sales working under the direction and supervision of myself, or any other such person as the Company may designate from time to time. The current job responsibilities for your position is appended as Exhibit B and incorporated herein by this reference and that may be modified from time to time at the sole discretion of the Company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">2.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You represent that you are legally eligible to work in the jurisdiction in which the Company has offered you employment.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">3.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">Your employment is estimated to be April 15<sup style="font-size:7.5pt;font-weight:bold;vertical-align:top;">th</sup><b style="font-weight:bold;">, </b>2020 (the &#8220;Start Date&#8221;) and will continue until your employment is terminated in accordance with this Employment Agreement.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">4.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You will be subject to a probationary period of 60 days measured from the Start Date, during which time you will be assessed for ongoing suitability as a regular employee of the Company. If, during your probationary period, either you or the Company believes that employment should not continue for any reason, you or the Company may terminate the employment relationship effective immediately without any notice.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">During your employment you agree that you will conduct yourself at all times in a professional and honest manner. You further agree that you will not work, directly or indirectly, on your own behalf or for any other individual, corporation,</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">partnership, unincorporated organization, governmental agency or other entity which, in the reasonable opinion of the Company, may give rise to a conflict of interest between you and the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.75pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.25pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compensation and Benefits (US Dollars unless otherwise indicated)</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.59pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">6.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">Effective on the Start Date, your base salary will be <b style="font-weight:bold;">$155,000 </b>per annum and will be reviewed from time to time by the Company starting with the first anniversary of your Start Date. Any increases in salary over the course of your employment will be at the Company&#8217;s discretion.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">7.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">Your position is not eligible for overtime pay. Your base salary, stock options and various incentive and benefits programs described herein will be your compensation for all hours worked during your employment.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">8.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You will be eligible for variable compensation based on Data Broker Sales Revenue. The commission rate on 1st year Sales is 6.25% up to $2MM of Sales, and 7.5% thereafter with a cap to be determined in the company&#8217;s sole discretion. Commissions are paid based on revenue (cash received). After the 6 months, this variable plan will be revisited and updated based on the financial plan and status of the Company at that time.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">9.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">Upon completion of your probationary period and Subject to Board of Director approval and pursuant to the terms and requirements of the Company&#8217;s revised and Board approved employee stock option plan (&#8220;RSOP&#8221;) (which is in the process of being revised by Company&#8217;s counsel), you will be granted an <b style="font-weight:bold;">option to purchase 100,000 stock shares</b>. The option grant to you is presently intended to provide that your options will vest 25% after the first full year of service (one-year cliff) and the remaining 75% will vest monthly at the rate of 1/36th per month thereafter over the next 3 years of service. Stock option grants will be presented for approval at the first Board meeting which occurs after the SOP has been revised and implemented after your employment begins. Subject to these conditions vesting will be credited and begin upon the first day of your full-time employment with the Company. Vesting, strike price and other option grant details are subject to approval by the Board of Directors. The option grant shall not be binding on the Company until issued in a separate document signed by the Company and yourself. If not exercised earlier then all vested options must be exercised by payment in full to the Company within 90 days following your end of employment with the Company, or they will automatically lapse and be of no further force or effect.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">10.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You will be eligible for standard benefits coverage under the Company&#8217;s Trinet Benefits Plan provided to all salaried employees in accordance with the terms of such plan, as amended by the Company or the insurer from time to time. Benefits include a 401k plan.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 0pt 8pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page&#160;2</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3.79pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">11.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You will be entitled to annual vacation leave of <b style="font-weight:bold;">three (3) weeks </b>as provided under the Company&#8217;s vacation policy.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">12.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You will be entitled to reimbursement from the Company of all reasonable and necessary business-related expenses, within 30 days following your submission and Company approval of written expense reports and copies of receipts for all expenses incurred.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.59pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">13.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">At will employment: Your employment is &#8220;at will&#8221;, meaning that the Company can terminate that employment at any time, with, or without, cause and that you may also terminate your employment at any time. In the event of your termination, you will be immediately relieved of your duties at the Company and shall receive no working notice (&#8221;WN&#8221;) or pay in lieu of notice from the Company. For the purposes of this Employment Agreement, &#8220;cause&#8221; has the meaning commonly ascribed to the phrase &#8220;cause&#8221; or &#8220;just cause for termination&#8221; in the State of Delaware. Any termination during a quarter shall entitle you to the pro rata share of the options for that quarter up to the date of the termination</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">14.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><i style="font-style:italic;">No Additional Payments: </i>You acknowledge and agree that, unless otherwise expressly agreed in writing between you and the Company and thereafter approved in writing by the Board of the Company, you will not be entitled, by reason of your employment with the Company or by reason of any termination of such employment, howsoever arising, to any remuneration, compensation or other benefits other than those expressly provided for in this Employment Agreement. You further acknowledge and agree that any amounts paid to you pursuant to this Employment Agreement are inclusive of any amounts that may be payable under any statute of the State of Delaware in respect of compensation for length of service, notice of termination or severance pay.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidential Information</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.59pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">15.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">The term &#8220;Confidential Information&#8221; as used in this Employment Agreement means all trade secrets, proprietary information and other data or information (and any tangible evidence, record or representation thereof) whether prepared, conceived or developed by an employee or agent of the Company (including by you) or received by the Company from an outside source which is maintained in confidence by the Company or any of its customers. Without limiting the generality of the foregoing, Confidential Information, includes information of the Company pertaining to:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">(a)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">research and development plans or projects, data and reports; computer materials such as programs, instructions, source and object code, and printouts; formulas, inventions, developments and discoveries; product</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 0pt 44pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page&#160;3</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 72pt;">information, including testing information; business improvements and processes; marketing and selling plans; business opportunities, plans (whether pursued or not) and budgets; unpublished financial statements; licenses; pricing, pricing strategy and cost data; information regarding the skills and compensation of employees; the identities of clients and potential clients, customers and potential customers (collectively, &#8220;Customers&#8221;); the identities of contact persons at Customers; the preferences and needs of Customers; customer contact persons; information regarding sales calls, timing, sales terms, service plans, methods, practices, strategies, forecasts, know-how, and other marketing techniques; the identities of key accounts, potential key accounts; the identities of suppliers and contractors, and all information about those supplier and contractor relationships such as contact person(s), pricing and other terms;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">(b)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">any information relating to the relationship of the Company with any personnel, suppliers, principals, investors, contacts or prospects of the Company and any information relating to the requirements, specifications, proposals, orders, contracts or transactions of or with any such persons; and</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">(c)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">financial information, including the Company&#8217;s costs, financing or debt arrangements, income, profits, salaries or wages.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">16.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You acknowledge that during your employment you will have access to the Confidential Information which is a valuable and unique asset of the Company and that the Confidential Information is and will remain the exclusive property of the Company. You agree to maintain securely and hold in strict confidence all Confidential Information received, acquired or developed by you or disclosed to you as a result of or in connection with his employment with the Company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">17.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You agree that, both during your employment and after the termination of your employment with the Company, you will not use or disclose any Confidential Information to any person, other than as required to perform your duties hereunder, without the prior written authorization of the Company&#8217;s President and Chief Executive Officer. The obligation of confidentiality imposed by this Employment Agreement shall not apply to information that appears in issued patents or printed publications, that otherwise becomes generally known in the industry through no act on your part in breach of this Employment Agreement, or that is required to be disclosed by court order or applicable law.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">18.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You understand that the Company has from time to time in its possession information belonging to third parties or which is claimed by third parties to be confidential or proprietary, including health information about patients and which the Company has agreed to keep confidential. You agree that all such information shall be Confidential Information for the purposes of this Employment Agreement.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 0pt 8pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page&#160;4</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disclosure of Discoveries, Ideas and Inventions</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">19.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You acknowledge that all Confidential Information (as hereinafter defined) and all discoveries, know-how, inventions, ideas, concepts, processes, products, protocols, treatments, methods, tests and improvements, computer programs, or parts thereof, conceived, developed, reduced to practice or otherwise made or developed by you either alone or with others, during the course of employment with the Company pursuant to this Employment Agreement or any previous employment agreements or arrangements between you and the Company, whether or not conceived, developed, reduced to practice or made during your regular working hours or on the premises of the Company (collectively &#8220;Inventions&#8221;), and any and all services and products which embody, emulate or employ any such Inventions will be the sole property of the Company and all copyrights, patents, patent rights, trademarks, service marks and reproduction rights to, and other proprietary rights in, each such Invention, whether or not patentable or copyrightable, will belong exclusively to the Company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">20.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You represent and warrant that you do not claim rights in, or otherwise exclude from this Employment Agreement, any Invention except as listed on Exhibit &#8220;A&#8221; hereto.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">21.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You hereby assign and agree to assign all your rights, title and interest in the Inventions, to the Company or its nominee. For purposes of the copyright laws of the United States of America, to the extent, if any, that such laws are applicable to any Confidential Information, Invention or any such service or product, it will be considered a work made for hire and the Company will be considered the author thereof. You hereby waive for the benefit of the Company and its successors and assigns any and all moral rights in respect of any Inventions.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">22.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You agree that you shall disclose promptly to the Company, its successors or assigns, any Inventions. Whenever requested to do so by the Company, you shall execute any and all applications, assignments or other instruments which the Company shall deem necessary to apply for and obtain patents or copyrights of Canada, the United States or any foreign country or to otherwise protect the Company&#8217;s interest in the Inventions and shall assist the Company in every proper way (entirely at the Company&#8217;s expense, including reimbursement to you for all expense) to obtain such patents and copyrights and to enforce them.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Post-Employment Restrictions</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">23.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><i style="font-style:italic;">Non-Competition</i>: Following successful completion of the 60 day probationary period, during your employment with the Company and for a period of 12 months following the termination of your employment from the Company for any reason, you agree that you shall not, anywhere in the United States of America, directly or indirectly, own, manage, operate, finance, join, control or participate in the</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 0pt 8pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page&#160;5</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">ownership, management, operation, financing or control of, or be connected as an officer, director, employee, partner, principal, agent, representative, consultant, or use or permit your name to be used in connection with, any business or enterprise whose products or services compete with products or services the company is providing, or has proposed to design, sell or provide, during the twelve (12) Month period prior to the termination date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">24.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><i style="font-style:italic;">Non-Solicitation</i>: During your employment with the Company and for a period of 12 months following the termination of your employment from the Company for any reason, you agree that you shall not (unless acting as an employee under this Employment Agreement or with the prior written consent of the Company&#8217;s President and Chief Executive Officer): (i) call on, solicit, or endeavor to entice away, either directly or indirectly, any Customers of the Company that the Employee or his subordinates solicited or serviced for the Company; or (ii) directly or indirectly, solicit or attempt to solicit, any employee, independent contractor or consultant of the Company to terminate his or her relationship with the Company in order to become an employee, consultant or independent contractor for any person or entity other than the Company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">25.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">For the purposes of paragraphs 16 through 26 of this Employment Agreement the &#8220;Company&#8221; includes the Company&#8217;s subsidiaries, affiliates and otherwise related companies.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">26.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You acknowledge that the terms contained in paragraphs 16 through 26 survive the termination of this Agreement and are reasonable and necessary to protect the legitimate interests of the Company such that any violated of these paragraphs by you could result in irreparable injury to the Company. You agree that, in the event you violate any of these terms the Company shall be entitled to preliminary and permanent injunctive relief and any other remedies in law or in equity which the court deems fit.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">27.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You agree that documents, copies, records and other property or materials made or received by you that pertain to the business and affairs of the Company, including all Confidential Information or Inventions in your possession or under your control are the property of the Company and that you will return same and any copies of same to the Company immediately upon termination of your employment or at any time upon the request of the Company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">28.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">The Company may modify your duties, title, salary and/or benefits from time to time. You agree that any modifications to your duties, or salary and/or benefits reductions of 10% or less do not constitute a breach of the terms of this Employment Agreement, or a termination of your employment and that all other aspects of this letter shall continue in full force and effect.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 0pt 8pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page&#160;6</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">29.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You agree to be bound by the terms and conditions of employment which are set out in the Company&#8217;s Employment Handbook.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">30.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">This Employment Agreement constitutes the entire employment agreement between you and the Company and supersedes and replaces any prior oral and written agreements, understandings, commitments and practices between you and the Company relating to your employment. You also agree that the terms and conditions of this Employment Agreement are contractual.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">31.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">You acknowledge that this Employment Agreement has been prepared by the Company and acknowledge that you have had sufficient time to review this document thoroughly, including enough time to obtain independent legal advice concerning the interpretation and effect of it prior to its execution. By signing this document, you represent and warrant that you have read and understood it and that you execute it of your own free will and act.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">32.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">This letter and your employment will be governed by and construed in accordance with the laws of the State of Delaware and the federal laws of the United States applicable therein, which shall be deemed to be the law applicable to this Agreement. You and the Company hereby submit to the exclusive jurisdiction of the courts of the State of Delaware solely as to any dispute regarding injunctive or equitable relief. If any other dispute whatsoever arises hereunder the parties agree that it shall be subject to binding arbitration under the Commercial Rules then in effect of the American Arbitration Association (&quot;AAA&quot;). The Arbitration shall be held in San Francisco before a single neutral arbitrator chosen from a list of 15 qualified arbitrators provided by the AAA and shall be selected by the alternative strike off method. The first strike shall be given to the winner of a coin tossed by the AAA administrator. The prevailing party shall be entitled to recover their reasonable attorneys&#39; fees, costs and arbitration expenses, including the compensation of the arbitrator. You and the Company hereby submit to the exclusive jurisdiction of the AAA for the purpose of resolving any such dispute.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 0pt 8pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Section Intentionally Left Blank)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page&#160;7</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2.5pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">This offer is available for your acceptance on or prior to April 14, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 8pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Kindly signify your acceptance of the terms and conditions under which the Company is offering you employment by signing and dating the duplicate copy of this letter and returning same to me prior to that date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 8pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Yours truly,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.4pt 0pt;"><b style="font-weight:bold;">ONEMEDNET CORPORATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.4pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.4pt 0pt;"><img src="dkdcu-20230331xex10d16002.jpg" alt="Graphic" style="display:inline-block;height:65.24pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:158.98pt;"></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0.4pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Mike LaChance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">President, CEO</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 8pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">I HEREBY ACCEPT EMPLOYMENT ON THE TERMS AND CONDITIONS OUTLINED HEREIN</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 8pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.55pt 0pt;">THIS _14th&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>&#160;DAY OF April&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><img src="dkdcu-20230331xex10d16004.jpg" alt="Graphic" style="display:inline-block;height:34.49pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:118.48pt;"></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page&#160;8</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exhibit &#8220;A&#8221;</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">List of Excluded Inventions, Patents and Other Intellectual Properties</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">None&#160;<font style="font-family:'Segoe UI Symbol';">&#9746;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">See List Below</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:99.9%;"><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="text-decoration-line:line-through;text-decoration-style:solid;">foSure</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><img src="dkdcu-20230331xex10d16004.jpg" alt="Graphic" style="display:inline-block;height:34.49pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:118.48pt;"></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page&#160;9</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Exhibit &#8220;B&#8221;</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Job Responsibilities</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Title: VP of Sales Location</b>:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.34pt 0pt;">Remote</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.2pt 0pt;"><b style="font-weight:bold;">Primary Responsibilities</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-weight:bold;">Grow Data Broker Sales </b>&#8211; OneMedNet&#8217;s Data Broker business has just entered the initial sales stage of a high-growth, new business in an emerging market. Sales traction is fundamental to driving business growth, consequently sales growth is a priority for the company. As OneMedNet&#8217;s first dedicated Data Broker Sales resource, it is expected that you will place the highest priority on growing sales while you build a sales strategy, process, and team.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-weight:bold;">Develop OneMedNet&#8217;s Data Broker Sales Strategy </b>&#8211; Working with leadership, lead development of OneMedNet&#8217;s Data Broker Sales Strategy, including staffing, selling process, sales reporting, and collaboration with Product and Marketing.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;"><b style="font-weight:bold;">Execute OneMedNet&#8217;s Data Broker Sales Strategy </b>&#8211; Successfully lead OneMedNet&#8217;s Data Broker Strategy execution including achieving revenue targets.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0.25pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0.25pt;margin-top:0pt;"><b style="font-weight:bold;">Participate as a Core Member of OneMedNet Leadership Team </b>&#8211; Although you lead Sales, as a member of the leadership team you are expected to meaningfully participate in business-wide strategies, prioritization, and initiatives.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;">Page&#160;10</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>5
<FILENAME>dkdcu-20230331xex10d17.htm
<DESCRIPTION>EXHIBIT 10.17
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:19 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Exhibit 10.17</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;"><img src="dkdcu-20230331xex10d17001.jpg" alt="Graphic" style="display:inline-block;height:63.44pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:170.85pt;"></font></p></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">OneMedNet <font style="letter-spacing:-0.1pt;">Corporation</font><font style="letter-spacing:-0.1pt;"><br></font>6385<font style="letter-spacing:-0.3pt;"> </font>Old<font style="letter-spacing:-0.35pt;"> </font>Shady<font style="letter-spacing:-0.3pt;"> </font>Oak<font style="letter-spacing:-0.35pt;"> </font>Road<font style="letter-spacing:-0.3pt;"> </font>Suite<font style="letter-spacing:-0.3pt;"> </font>250<br>Eden Prairie, MN 55344</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">January 13, <font style="letter-spacing:-0.2pt;">2022</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.15pt 0pt;"><font style="font-size:11pt;">Saurabh Mathur</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:11pt;">5045 Shiloh Crossing Way </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:11pt;">Cumming, Georgia 30040</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.1pt 0pt;"><font style="font-size:11pt;">(770) 298-7875</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.55pt 0pt;"><u style="font-size:11pt;text-decoration-line:underline;text-decoration-style:solid;">forsaurabhmather@gmail.com</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.55pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 2.65pt 0pt;"><font style="font-size:12pt;">Delivered via Email </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 2.65pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 2.65pt 0pt;"><font style="font-size:12pt;">Dear Saurabh,</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 2.65pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;">When executed by you and the company this will constitute a letter agreement (&#8220;Agreement&#8221;) confirming the terms and conditions under which OneMedNet Corporation, a Delaware corporation (&#8220;Company&#8221;), is prepared to offer full time employment to you (&#8220;you&#8221; or &#8220;Employee&#8221;), commencing on or before January 17, 2022. Employee&#8217;s employment terms are as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">1.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employment Document</u><font style="font-size:12pt;">. This Agreement together with the exhibits and any other documents referenced herein will be the entire documentation which establishes the terms of your employment.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">2.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General Understandings</u><font style="font-size:12pt;">. Employee acknowledges and agrees that the Company is an early stage, high technology, start-up Company. The Employee agrees that he shall, at all times, work as efficiently as reasonably possible.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.15pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">3.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Title</u><font style="font-size:12pt;">. Employee&#8217;s title shall be Vice President of Technology and Innovation. the Employee shall work under the direction and supervision of the CEO and Board of Directors of the Company (the &#8220;Board&#8221;) under the leadership of the Chairman of the Board. Employee&#8217;s Job duties are set forth in Exhibit 1 hereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">4.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Base Salary and Bonus.</u><font style="font-size:12pt;"> Employee&#8217;s base salary shall be $250,000 per annum, payable bi-weekly in arrears, less all required withholdings. Employee&#8217;s salary may be eligible for annual adjustment consistent with the Company policy, if, when or as approved by the Board. In addition, Employee shall be eligible for an annual bonus, up to a maximum of twenty percent (20%) of annual salary if Employee achieves Employee&#8217;s goals and business objectives. The primary goals for the first twelve (12)-month period and the allocable bonus amounts for each such goal and when such bonus shall be due and payable are set forth in Exhibit 2 hereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">1</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.15pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">5.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Options From The Company</u><font style="font-size:12pt;">. Employee shall be awarded an option to purchase (the &#8220;Options&#8221;) 100,000 shares of common stock of the Company under the Company&#8217;s 2020 Equity Incentive Plan, at a strike price of $1.00 per share, (being at or above fair market value), which Options shall vest over a four-year term at calendar quarter ends, subject to a one-year cliff vesting provision. If not exercised by written notice and payment in full of the exercised price, then any and all such non-exercised options shall terminate on the earlier of 5 years from date of issue or 90 days after the last day of Employee&#8217;s employment. From time to time the Company, at its discretion, may offer Employee incentives, including in the form of Options.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">6.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exempt Employee</u><font style="font-size:12pt;">. Employee agrees that Employee is accepting a salaried, exempt position. Employee&#8217;s hours in this position may fluctuate, and each monthly portion of Employee&#8217;s annual salary shall compensate Employee for all hours Employee worked during that month. Employee shall devote substantially all of his productive working time to the Company and shall not be employed in any capacity (whether part-time, full-time. as a consultant, or otherwise) for any other organization unless that is specifically agreed to in writing by the Company prior to the start of the new employment or other relationship.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.15pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">7.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Travel, Home Base, Response Times</u><font style="font-size:12pt;">. Company and Employee agree that travel may be necessary by Employee to perform his duties hereunder and Employee is willing and able to do so. Employee understands that the Company has development personnel in Vancouver, Canada and Employee will travel there as needed. To the extent the Company does not need Employee to be in Vancouver, Employee shall be allowed to work remotely from his principal residence but is encouraged to set up an office in Atlanta, Georgia, provided, that Employee secures the prior written approval of the CEO for the budget for such office. Such written approval shall be in the sole discretion of the Company. Employee shall normally respond to any inquiry from any board member within two (2) business days, unless circumstances prevent that, in which case he shall respond as soon as reasonably possible.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.5pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">8.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Probationary Period and At-Will Employment</u><font style="font-size:12pt;">. Employee understands that his employment is subject to a 90-day probationary period, which commences on the first day of his employment, during which time Employee will be assessed for ongoing suitability as a regular employee of the Company. Employee recognizes that he retains the option, as does OneMedNet, of ending his employment with OneMedNet at any time, during the probationary period, or otherwise, with or without notice and with, or without cause. As such, Employee&#8217;s employment with OneMedNet is at-will. Neither this letter, nor any other oral or written representation may be considered a contract for employment for any specific period of time. In executing Employee&#39;s job duties, he agrees that he will work closely, cooperatively and in a collegial fashion with existing personnel, management, the Company&#39;s Board, and the Company&#39;s customers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">9.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employee Benefits</u><font style="font-size:12pt;">. &#160;Employee will be eligible for standard benefit coverage under the current health and welfare insurance plans covering all salaried employees, in accordance with the terms of any such adopted plan, as amended by the Company, or the insurer, from time to time. Employee shall have access to a list of such benefits on the PEO platform, and PEO will make additional information available to Employee and may require Employee to execute and deliver additional documents regarding Employee&#8217;s compensation and benefits under the Agreement. Company may assist in the Employee&#8217;s development in the form of training, certifications and further education that pertains to the current roles and responsibilities.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0pt 5.05pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.15pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">10.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Expenses</u><font style="font-size:12pt;">. Employee will be entitled to reimbursement from the Company of any actual and necessary business-related expenses if the expenses claimed are approved by the Company following Employee&#8217;s submittal of written expense reports, with receipts attached, showing the date and reason for the expense claimed.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.44pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">11.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Background Check</u><font style="font-size:12pt;">. Employee&#8217;s employment is contingent upon his successful completion of a background and reference check to include Employee&#8217;s last employer.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">12.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Legal Residency</u><font style="font-size:12pt;">. Employee understands that in accordance with the Immigration Reform Control Act of 1986, all employees are required to produce documents that establish identify and employment eligibility in the United States. A list of acceptable documents which establish such identity is available on page 5 of the I-9 Form. Employee will supply sufficient documents from this list to establish identity and employment eligibility within his first three days of employment, along with the completed I-9 Form. Employee represents and warrants to Company that he is legally eligible to work in the United States.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.3pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">13.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severance</u><font style="font-size:12pt;">. The Company reserves the right to terminate your employment at any time for any reason. Should you be terminated for cause, then you will not be entitled to any advance notice of termination or severance pay for base salary in lieu thereof. Should you be terminated for reasons other than cause, then you will be entitled to advance notice of your termination, or severance pay in lieu thereof, or any combination of advance notice and severance pay, in accordance with the following formula:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 0.2pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(i)</font></font><font style="font-size:12pt;">upon completion of probation but less than one year&#8217;s employment &#8211; one month advance notice or severance pay in lieu thereof;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 0.2pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(ii)</font></font><font style="font-size:12pt;">after one year of continuous employment - one-month advance notice for each additional full year of employment or severance pay in lieu thereof, up to a maximum of eight months.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt 0pt 4.65pt 0pt;"><font style="font-size:6.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 0.4pt 0pt;"><font style="font-size:12pt;">Any severance payments made in accordance with this formula can be paid on a regular periodic basis, as opposed to a lump-sum basis, and are subject to the Employees duty to mitigate by seeking other reasonably comparable employment.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">14.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disclosure of Discoveries, Ideas and Inventions</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">14.1.</font></font><font style="font-size:12pt;">Employee agrees that all new technologies, knowledge, information or other ideas which are related to the business of the Company or its affiliates or subsidiaries (together &#8220;Affiliates&#8221;), and all discoveries, know-how, inventions, concepts, processes, products, protocols, treatments, methods, tests, improvements, computer programs, or parts thereof, conceived, developed, reduced to practice or otherwise made by him, either alone or with others (together &#8220;Inventions&#8221;), during the course of his employment with the Company, whether or not the Inventions are conceived, developed, reduced to practice or made during the Employee&#8217;s regular working hours or on the premises of the Company, together with any and all services and products which embody, emulate or employ any such Inventions, shall all be the sole property of the Company. In addition, copyrights, patents, patent rights, trademarks, service marks and</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 0pt 5.05pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">reproduction rights to, and other proprietary rights in such Invention whether or not patentable or copyrightable, shall belong exclusively to the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">14.2.</font></font><font style="font-size:12pt;">The Employee shall promptly disclose to the Company, its successors or assigns, any Inventions.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">14.3.</font></font><font style="font-size:12pt;">The Employee hereby assigns and agrees to assign all his rights, title and interest in the Inventions, to the Company or its nominee. Employee shall never assert ownership or control of any such Inventions. For purposes of the copyright laws of the United States of America, to the extent, if any, that such laws are applicable to any such Invention or any such service or product, any such Invention will be considered a work made for hire for the Company and the Company shall be considered the author thereof.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">14.4.</font></font><font style="font-size:12pt;">Whenever requested to do so by the Company, the Employee shall execute any and all applications, assignments or other instruments which the Company shall deem necessary to apply for and obtain any patents or copyrights from the United States, Canada and/or any other foreign country or to otherwise protect the Company&#8217;s interest in the Inventions. The Employee shall assist the Company in every proper way (entirely at the Company&#8217;s expense) to obtain such patents and copyrights and to enforce them as to any such Invention.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">14.5.</font></font><font style="font-size:12pt;">For the benefit of the Company and its successors and assigns, the Employee hereby waives any and all moral rights in respect to any such Inventions.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">14.6.</font></font><font style="font-size:12pt;">The Employee represents and warrants that he does not claim rights in, or otherwise exclude from this Agreement, any Invention except those specifically listed on Exhibit &#8220;3&#8221; hereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">14.7.</font></font><font style="font-size:12pt;">Each of the Employee&#8217;s obligations in this section shall survive the Employee&#8217;s termination of employment from the Company and shall be binding upon the Employee&#8217;s assigns, executors, administrators, assigns and other legal representatives.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidential Information</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.1.</font></font><font style="font-size:12pt;">The term &#8220;Confidential Information&#8221; as used in this Agreement shall mean and include all trade secrets, proprietary information and other data or information (and any tangible evidence, record, or representation thereof) whether prepared, conceived or developed by an employee or agent of the Company (including the Employee) or received by the Company from an outside source which is considered to be confidential by the Company or any of its customers. Without limiting the generality of the foregoing, Confidential Information, includes information of the Company and its Affiliates pertaining to:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:108pt;margin:0pt;"><font style="font-size:12pt;">(i)</font><font style="display:inline-block;width:24.67pt;"></font><font style="font-size:12pt;">research and development plans or projects, data and reports; computer materials such as programs, instructions, source and object code, and printouts; formulas, inventions, developments and discoveries; product information, including testing information; business improvements and processes; marketing and sales plans; business opportunities (whether pursued or not), budgets; unpublished financial statements, licenses; pricing, pricing strategy, cost data, information regarding the skills and compensation of employees; the identities of clients and potential clients, customers and potential customers (collectively, &#8220;Customers&#8221;); the identities of</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:108pt;margin:0pt 0pt 0pt 5.05pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;">contact persons at Customers; the preferences and needs of Customers; information regarding sales calls, timing, sales terms, service plans, methods, practices, strategies, forecasts, know-how, and other marketing techniques; the identities of key accounts, potential key accounts;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:108pt;margin:0pt;"><font style="font-size:12pt;">(ii)</font><font style="display:inline-block;width:21.34pt;"></font><font style="font-size:12pt;">any information relating to the relationship of the Company with any personnel, suppliers, principals, investors, contacts or prospects of the Company and any information relating to the requirements, specifications, proposals, orders, contracts or transactions of or with any such persons;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:11.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:108pt;margin:0pt;"><font style="font-size:12pt;">(iii)</font><font style="display:inline-block;width:18pt;"></font><font style="font-size:12pt;">financial information, including the Company&#8217;s costs, financing or debt arrangements, income, profits, salaries, or wages; and</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:11.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:108pt;margin:0pt;"><font style="font-size:12pt;">(iv)</font><font style="display:inline-block;width:18.67pt;"></font><font style="font-size:12pt;">any and all health care records of patients.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:108pt;margin:0pt;"><font style="font-size:12pt;">(v)</font><font style="display:inline-block;width:22.01pt;"></font><font style="font-size:12pt;">Confidential Information shall not include information that appears in issued patents or publications available to the general public, or that otherwise becomes generally known in the industry through no act of the Employee in breach of this Agreement, or that is required to be disclosed by court order or applicable law.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:108pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.2.</font></font><font style="font-size:12pt;">The Employee acknowledges that, by reason of his employment with the Company, he will have access to Confidential Information, and various other information of the Company and its Affiliates, that the Company and its Affiliates have spent time, effort and money to develop and acquire.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.3.</font></font><font style="font-size:12pt;">The Employee acknowledges that the Confidential Information is a valuable and unique asset of the Company and that the Confidential Information is and will remain the exclusive property of the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.4.</font></font><font style="font-size:12pt;">The Employee agrees to maintain securely and hold in strict confidence all Confidential Information. The Employee agrees that, both during his employment and after the termination of his employment with the Company, he will not use or disclose any Confidential Information to any person, other than as required to perform his duties hereunder, without the prior written authorization of the Company&#8217;s President and Chief Executive Officer.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.5.</font></font><font style="font-size:12pt;">The Employee represents and warrants that he has not brought and will not bring with him to the Company, and that he has not used and will not use, while performing his duties for the Company, any materials or documents of a former employer which he is under a duty not to disclose. The Employee understands that, while employed by the Company, the Employee shall not breach any obligation or confidence or duty the Company may have to a former employer and the Employee agrees that the Employee will fulfill all such obligations during the Employee&#8217;s employment with the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.6.</font></font><font style="font-size:12pt;">The Employee represents and warrants that the Employee will not, to the best of the Employee&#8217;s knowledge and belief, use or cause to be incorporated in any of the Employee&#8217;s work product for the Company any data software, information, designs, techniques or know-how which the Employee or the Company does not have the right to use.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:71.95pt;margin:0pt 0pt 0pt 5.1pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.19pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.7.</font></font><font style="font-size:12pt;">The Employee agrees that documents, copies, records and other property or materials made or received by the Employee that pertain to the business and affairs of the Company or its Affiliates, including all Confidential Information which is in the Employee&#8217;s possession, or under the Employee&#8217;s control are the property of the Company and that the Employee will return the same together with any copies of same to the Company immediately upon termination of the Employee&#8217;s employment with the Company, or at any other time if requested by the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.8.</font></font><font style="font-size:12pt;">All of the Employee&#8217;s obligations in this section shall continue beyond the Employee&#8217;s termination of employment.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 4.84pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">16.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidential Information</u><font style="font-size:12pt;">. During his employment with the Company and for a period of 24 months following the Employee&#8217;s termination of employment from the Company for any reason, the Employee shall not, at any place in the world, directly or indirectly, own, manage, operate, finance, join, control or participate in the ownership, management, operation, financing or control of, or be connected as an officer, director, employee, partner, principal, agent, representative, consultant, or use or permit his name to be used in connection with, any business or enterprise whose products or services compete with products or services which the Company is providing, or has proposed to design, sell or provide, during the twelve (12) month period prior to the Termination Date and as to which Executive was made aware prior to Executive&#8217;s termination of employment, together the &#8220;Restricted Areas&#8221;. This restriction does not, and is not intended to, apply to businesses which deal in other aspects of medical imaging that are not within the Restricted Areas. This restriction has been discussed and is mutually agreed to be reasonable and fully enforceable, particularly in light of the Company&#8217;s early leadership position in the Restricted Areas and the severe harm that such competition would create for the Company given its investment in the Restricted Areas. If doubt arises about the scope of this restriction, then the Employee and the Company agree that they will discuss the issues and try to resolve that dispute in good faith within 7 days of receipt of written notice of the issue arising. The parties agree that any remaining dispute may be resolved in an expedited arbitration proceeding under paragraph 27 of this Agreement, which proceeding shall be completed (including issuance of the award)within 120 days of the selection of the arbitrator. Both parties shall be entitled to expedited discovery and to any other relevant procedures deemed reasonable by the arbitrator if needed to meet this deadline.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.4pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">17.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Solicitation</u><font style="font-size:12pt;">. During his employment with the Company and for a period of 24 months following the Employee&#8217;s termination of employment from the Company for any reason, the Employee shall not (unless acting as an employee under this Agreement, or with the prior written consent of the Company&#8217;s Board and its Chief Executive Officer): (i) call on, solicit, or endeavor to entice away, either directly or indirectly, any Customers (as defined above) of the Company or its Affiliates; or (ii) directly or indirectly, solicit or attempt to solicit, any employee, independent contractor, or consultant of the Company or its Affiliates to terminate his, her or its relationship with the Company or its Affiliates in order to become an employee, consultant or independent contractor for any person or entity other than the Company or its Affiliates.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:35.95pt;margin:0pt 0pt 0pt 5.05pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">18.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Equitable Relief</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 0.1pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">18.1.</font></font><font style="font-size:12pt;">The Employee acknowledges that the restrictions contained herein are, in view of the nature of the business of the Company, reasonable and necessary to protect the legitimate interests of the Company, that the Company would not have entered into this Agreement in the absence of such restrictions, that the business of the Company is international in scope and that any violation of any provision of those Sections could result in irreparable injury to the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 4.5pt 0pt;"><font style="font-size:5.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 0.1pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:41.05pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">18.2.</font></font><font style="font-size:12pt;">The Employee agrees that, in the event he violates any of the restrictions referred to herein, the Company shall be entitled to preliminary and permanent injunctive relief and any other remedies in law or in equity which the court deems fit.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.44pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">19.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reasonable Best Efforts</u><font style="font-size:12pt;">. Employee shall use his reasonable best efforts during his employment to reach the goals articulated herein and thereafter from time to time.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">20.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Jurisdiction</u><font style="font-size:12pt;">. Company and Employee hereby irrevocably consents and submits to the jurisdiction of the U S District Court for the District of State of Hawaii, in connection with any equitable relief sought, any suit, action or other proceeding concerning the interpretation and enforcement of this Agreement, or its arbitration clause. Employee waives and agrees not to assert any defense that the court lacks jurisdiction, venue is improper, the forum is inconvenient or otherwise. Employee agrees to accept service of process by certified mail at Employee&#8217;s current home address, which is set forth in the address line above.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.05pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">21.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Dispute Resolution</u><font style="font-size:12pt;">. Employee agrees to resolve any and all disputes with the Company its officers or employees by binding arbitration before a single, neutral arbitrator in Honolulu, Hawaii at the offices of Dispute Prevention &amp; Resolution, Inc. (&#8220;DPR&#8221;) according to rules established by DPR at the time of the dispute. In any such action, the prevailing party shall be entitled to recover all of its costs and attorneys&#8217; fees and all fees and costs of the arbitrator.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0.3pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:37.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">22.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Entire Agreement</u><font style="font-size:12pt;">. This Agreement sets forth the entire agreement and understanding of the Company and Employee to the subject matter hereof, and supersedes all prior agreements, arrangements and understandings, written or oral, relating to the subject matter hereof. No party shall be deemed the drafter of this Agreement and the rule of construction against the drafter shall not apply to the interpretation or enforcement of this agreement The Employee is advised of his right to seek independent counsel concerning the terms of the Agreement and encouraged to do so. No representations, promise or inducement has been made by either party that is not embodied in this Agreement, and neither party shall be bound by or liable for any alleged representation, promise or inducement not set forth herein.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;">If you accept the terms and conditions set forth above under which the Company is offering you employment, please sign and date this letter and return it to me. This Agreement may be signed electronically, by facsimile and/or or in counterparts and any such signatures shall be sufficient proof of the Agreement so long as all required signatures are present.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0pt 5.05pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.19pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Yours truly,</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">ONEMEDNET CORP.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Dr. Jeffrey Yu</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Chairman of the Board of Directors</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">I HEREBY ACCEPT EMPLOYMENT ON THE TERMS AND CONDITIONS SET FORTH HEREIN ON THIS 13th DAY OF JANUARY 2022.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:auto;width:100%;"><tr style="height:37.35pt;"><td style="vertical-align:top;width:51.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;"><img src="dkdcu-20230331xex10d17002.jpg" alt="Graphic" style="display:inline-block;height:35.77pt;width:104.28pt;"></font></p></td><td style="vertical-align:top;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">&#160;&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:top;width:45.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:51.66%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Saurabh Mathur</font></p></td><td style="vertical-align:top;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:45.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:51.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:45.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">EXHIBIT 1: JOB DUTIES</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#494949;font-size:11pt;">The Vice President of Technology and Innovation will oversee the company&#8217;s science, engineering, and technology efforts.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#494949;font-size:12pt;">Duties and responsibilities include:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:13pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Present reports on the company&#8217;s technology status, goals and or progress</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Develop technical aspects of the company&#8217;s strategy to ensure alignment with its business goals</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Align the company&#8217;s technology resources with the organization&#8217;s short- and long-term goals</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Discover and implement new technologies that yield competitive advantage</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Serve on the executive team to align technology goals to other departmental and organizational objectives</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Identify what technologies can be used to improve the company&#8217;s products and services</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Create and oversee high-level KPIs for IT department</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Assist in recruiting, onboarding, and training IT managers</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Manage the department&#8217;s budget</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Discover and implement new technologies that yield competitive advantage</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11.5pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Help departments use technology profitably</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Supervise system infrastructure to ensure functionality and efficiency</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Build quality assurance and data protection processes</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Use stakeholders&#8217; feedback to inform necessary improvements and adjustments to technology</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">Communicate technology strategy to partners and investors</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">On an annual basis, Employee and CEO shall conduct a performance review and refine the subsequent years job description criteria.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 5.05pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 4.5pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">EXHIBIT 2</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.1pt 0pt;"><font style="font-size:11pt;">1H&#8217;22</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0.55pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0.55pt;margin-top:0pt;"><font style="font-size:11pt;">Actively and effectively participate as a core team member in the development of OneMedNet Solution Roadmap $5k</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:11pt;">Lead development and publish OneMedNet Technical Product Roadmap $10k</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 23.05pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:11pt;">Lead development of and publish OneMedNet R&amp;D Staffing and Technology Partner Plan $10k</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0.44pt 23.05pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:11pt;">Total $25K</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.25pt 5.05pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.25pt 0pt;"><font style="font-size:11pt;">2H&#8217;22</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 0.25pt 5.05pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:11pt;">Execute OneMedNet R&amp;D Staffing and Technology Partner Plan to the milestones of the Plan $10k</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:11pt;">Execute and Deliver OneMedNet Technical Product Roadmap to the milestones of the Plan $10k</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:11pt;">Actively and effectively participate as team member on the OneMedNet Executive Team $5K</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:11pt;">Total $25K</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">EXHIBIT 3: PRIOR INVENTIONS</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:13pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">THE LIST OF EXCLUDED INVENTIONS IS AS FOLLOWS, OR, IF NONE, EMPLOYEE SHALL SO STATE:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 5.05pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:auto;width:100%;"><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;width:51.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:45.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr style="height:37.35pt;"><td style="vertical-align:top;width:25.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;"><img src="dkdcu-20230331xex10d17002.jpg" alt="Graphic" style="display:inline-block;height:35.77pt;width:104.28pt;"></font></p></td><td style="vertical-align:top;width:25.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">&#160;&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;width:45.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">13-Jan-2022</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:51.68%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Saurabh Mathur</font></p></td><td style="vertical-align:top;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:45.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">Dated</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:51.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:45.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>6
<FILENAME>dkdcu-20230331xex10d20.htm
<DESCRIPTION>EXHIBIT 10.20
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:36 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Exhibit 10.20</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:15pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#ff1418;font-size:15pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#ff1418;font-size:15pt;font-weight:bold;">REDACTED COPY</b></p></td></tr><tr><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#ff1418;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#ff1418;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#ff1418;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="color:#ff1418;font-size:11pt;font-weight:bold;">Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private and confidential.</b></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">SECURITIES PURCHASE AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">This SECURITIES PURCHASE AGREEMENT (the &#8220;Agreement&#8221;), dated as of this 28</font><sup style="font-size:8.25pt;vertical-align:top;">th</sup><font style="font-size:11pt;"> day of June 2023, is by and among Data Knights Acquisition Corp, a Delaware corporation with offices located at Unit G6, Frome Business Park, Manor Road, Frome, United Kingdom, BA11 4FN (the &#8220;Company&#8221;), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a &#8220;Buyer&#8221; and collectively, the &#8220;Buyers&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">RECITALS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">A. The Company and each Buyer is executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;1933 Act&#8221;), and Rule 506(b) of Regulation D (&#8220;Regulation D&#8221;) as promulgated by the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) under the 1933 Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">B. The Company has authorized a new series of senior secured convertible notes of the Company, in the aggregate original principal amount of $1,595,744.70, substantially in the form attached hereto as </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;"> (the &#8220;Notes&#8221;), which Notes shall be convertible into shares of Common Stock (as defined below) (the shares of Common Stock issuable pursuant to the terms of the Notes, including, without limitation, upon conversion, as Pre-Delivery Shares (as defined in the Notes) or otherwise, collectively, the &#8220;Conversion Shares&#8221;), in accordance with the terms of the Notes. Each Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, a Note in the aggregate original principal amount set forth opposite such Buyer&#8217;s name in column (2) on the Schedule of Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">C. The Company has authorized a new series of Common Stock purchase warrants of the Company, substantially in the form attached hereto as </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit B</u><font style="font-size:11pt;"> (the &#8220;Warrants&#8221;), which Warrants shall be exercisable for up to 95,744.70 shares of Common Stock (as defined below) in the aggregate (the shares of Common Stock issuable pursuant to the terms of the Warrants, collectively, the &#8220;Warrant Shares&#8221;), in accordance with the terms of the Warrants. Each Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, the number of Warrants set forth opposite such Buyer&#8217;s name in column (3) on the Schedule of Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">D. At the Closing, the parties hereto shall execute and deliver a Registration Rights Agreement, in the form attached hereto as </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit C</u><font style="font-size:11pt;"> (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Company has agreed to provide certain registration rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement), under the 1933 Act and the rules and regulations promulgated thereunder, and applicable state securities laws.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">E. The Notes, the Warrants, the Warrant Shares and the Conversion Shares are collectively referred to herein as the &#8220;Securities.&#8221;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">F. The Notes will be secured by a security interest in the existing intellectual property assets of the Company, as evidenced by a security agreement in the form attached hereto as </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit D</u><font style="font-size:11pt;"> (the &#8220;Security Agreement&#8221; and the other security documents and agreements entered into in connection with this Agreement, as each may be amended or modified from time to time, collectively, the &#8220;Security Documents&#8221;), executed by OneMedNet Solutions Corporation, a Delaware corporation and its subsidiary (the &#8220;OneMedNet&#8221;), which are prospective subsidiaries of the Company upon the closing of the Business Combination Agreement (as defined below).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and each Buyer hereby agree as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">1.</font></font><font style="font-size:11pt;">PURCHASE AND SALE OF NOTES AND WARRANTS.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(a)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchase of Notes</u><font style="font-size:11pt;">. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 6 and 7 below, the Company shall issue and sell to each Buyer, and each Buyer severally, but not jointly, agrees to purchase from the Company on the applicable Closing Date (as defined below) a Note in the original principal amount as is set forth opposite such Buyer&#8217;s name in column (2) on the Schedule of Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(b)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchase of Warrants</u><font style="font-size:11pt;">. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 6 and 7 below, the Company shall issue and sell to each Buyer, and each Buyer severally, but not jointly, agrees to purchase from the Company on the applicable Closing Date (as defined below) the number of Warrants as is set forth opposite such Buyer&#8217;s name in column (3) on the Schedule of Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(c)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Closing</u><font style="font-size:11pt;">. Following the execution of this Agreement, the closing and payment (the &#8220;Closing&#8221;) of the Purchase Price (as defined below) of the Notes and Warrants by the Buyers shall occur at the offices of Rimon P.C., 1990 K. Street, NW, Suite 420, Washington, DC 20006. The date and time of the Closing (the &#8220;Closing Date&#8221;) shall occur at 10:00 a.m., EST, on the closing date of the Business Combination Agreement (or such other date, time or place (including remotely) as is mutually agreed to by the Company and each Buyer). As used herein &#8220;Business Day&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;">, </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u><font style="font-size:11pt;">, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(d)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchase Price</u><font style="font-size:11pt;">. The aggregate purchase price for the Notes and Warrants to be purchased by each Buyer (the &#8220;Purchase Price&#8221;) shall be the amount set forth opposite such Buyer&#8217;s name in column (4) on the Schedule of Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(e)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payment</u><font style="font-size:11pt;">. On the Closing Date, (i) each Buyer shall pay its respective Purchase Price to the Company for the Notes and Warrants to be issued and sold to such Buyer at such Closing, by wire transfer of immediately available funds, and (ii) the Company shall deliver to each Buyer (1) a Note in the aggregate original principal amount as is set forth opposite such Buyer&#8217;s name in column (2) of the Schedule of Buyers, duly executed on behalf of the Company and registered in the name of such Buyer or its designee and (2) a Warrant in the amount as is set forth opposite such Buyer&#8217;s name in column (3) of the Schedule of Buyers, duly executed on behalf of the Company and registered in the name of such Buyer or its designee.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">2.</font></font><font style="font-size:11pt;">BUYER&#8217;S REPRESENTATIONS AND WARRANTIES.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">Each Buyer, severally and not jointly, represents and warrants to the Company with respect to only itself that, as of the date hereof and as of the Closing Date:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(a)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Organization; Authority</u><font style="font-size:11pt;">. Such Buyer, if an entity and thus applicable, is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(b)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Public Sale or Distribution</u><font style="font-size:11pt;">. Such Buyer (i) is acquiring its Note and its Warrant, and (ii) upon conversion of its Note will acquire the Conversion Shares, and upon exercise of its Warrant will acquire the Warrant Shares, in each case, for its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof in violation of applicable securities laws, except pursuant to sales registered or exempted under the 1933 Act; provided, however, by making the representations herein, such Buyer does not agree, or make any representation or warranty, to hold any of the Securities for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration statement or an exemption from registration under the 1933 Act. Such Buyer does not presently have any agreement or understanding, directly or indirectly, with any Person to distribute any of the Securities in violation of applicable securities laws. For purposes of this Agreement, &#8220;Person&#8221; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and any Governmental Entity or any department or agency thereof.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(c)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Accredited Investor Status</u><font style="font-size:11pt;">. Such Buyer is an &#8220;accredited investor&#8221; as that term is defined in Rule 501(a) of Regulation D.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(d)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reliance on Exemptions</u><font style="font-size:11pt;">. Such Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and such Buyer&#8217;s compliance with, the representations, warranties, agreements, acknowledgments and understandings of such Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of such Buyer to acquire the Securities.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(e)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Information</u><font style="font-size:11pt;">. Such Buyer and its advisors, if any, have been furnished with all materials relating to the business, finances and operations of the Company and its Subsidiaries and potential Subsidiaries and materials relating to the offer and sale of the Securities that have been requested by such Buyer and its Subsidiaries and potential Subsidiaries. Such Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company and its Subsidiaries and potential Subsidiaries. Neither such inquiries nor any other due diligence investigations conducted by such Buyer or its advisors, if any, or its representatives shall modify, amend or affect such Buyer&#8217;s right to rely on the Company&#8217;s representations and warranties contained herein. Such Buyer understands that its investment in the Securities involves a high degree of risk. Such Buyer has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(f)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Governmental Review</u><font style="font-size:11pt;">. Such Buyer understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(g)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transfer or Resale</u><font style="font-size:11pt;">. Such Buyer understands that except as provided in the Registration Rights Agreement: (i) the Securities have not been and are not being registered under the 1933 Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) such Buyer shall have delivered to the Company (if requested by the Company) an opinion of counsel, in a form reasonably acceptable to the Company, to the effect that such Securities to be sold, assigned or transferred may be sold, assigned or transferred pursuant to an exemption from such</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">registration, or (C) such Buyer provides the Company with reasonable assurance that such Securities can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A promulgated under the 1933 Act (or a successor rule thereto) (collectively, &#8220;Rule 144&#8221;); (ii) any sale of the Securities made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144, and further, if Rule 144 is not applicable, any resale of the Securities under circumstances in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC promulgated thereunder; and (iii) neither the Company nor any other Person is under any obligation to register the Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder. Notwithstanding the foregoing, the Securities may be pledged in connection with a bona fide margin account or other loan or financing arrangement secured by the Securities and such pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities hereunder, and no Buyer effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction Document (as defined in Section 3(b)), including, without limitation, this Section 2(g).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(h)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Validity; Enforcement</u><font style="font-size:11pt;">. This Agreement and the Registration Rights Agreement have been duly and validly authorized, executed and delivered on behalf of such Buyer and shall constitute the legal, valid and binding obligations of such Buyer enforceable against such Buyer in accordance with their respective terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors&#8217; rights and remedies.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Conflicts</u><font style="font-size:11pt;">. The execution, delivery and performance by such Buyer of this Agreement and the Registration Rights Agreement and the consummation by such Buyer of the transactions contemplated hereby and thereby will not, where applicable, (i) result in a violation of the organizational documents of such Buyer, or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such Buyer is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to such Buyer, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which could not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of such Buyer to perform its obligations hereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">3.</font></font><font style="font-size:11pt;">REPRESENTATIONS AND WARRANTIES OF THE COMPANY.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">The Company represents and warrants to each of the Buyers that, as of the date hereof and as of the Closing Date:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(a)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Organization and Qualification</u><font style="font-size:11pt;">. The Company is an entity duly organized and validly existing and in good standing under the laws of the jurisdiction in which it is formed, and has the requisite power and authority to own its properties and to carry on its business as now being conducted and as presently proposed to be conducted. The Company is duly qualified as a foreign entity to do business and is in good standing in every jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing would not reasonably be expected to have a Material Adverse Effect (as defined below). As used in this Agreement, &#8220;Material Adverse Effect&#8221; means any material adverse effect on (i) the business, properties, assets, liabilities, operations (including results thereof), condition (financial or otherwise) or prospects of the Company or any Subsidiary, individually or taken as a whole, (ii) the transactions contemplated hereby or in any of the other Transaction Documents or any other agreements or instruments to be entered into in connection herewith or therewith or (iii) the authority or ability of the</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">Company or any of its Subsidiaries to perform any of their respective obligations under any of the Transaction Documents.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(b)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Authorization; Enforcement; Validity</u><font style="font-size:11pt;">. The Company has the requisite power and authority to enter into and perform its obligations under this Agreement and the other Transaction Documents and to issue the Securities in accordance with the terms hereof and thereof. Each Subsidiary has the requisite power and authority to enter into and perform its obligations under the Transaction Documents to which it is a party. The execution and delivery of this Agreement and the other Transaction Documents by the Company and its Subsidiaries, and the consummation by the Company and its Subsidiaries of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Notes and Warrants, respectively, and the reservation for the Conversion Shares issuable upon conversion of the Notes and the Warrant Shares issuable upon exercise of the Warrants, respectively) have been duly authorized by the Company&#8217;s board of directors and each of its Subsidiaries&#8217; board of directors or other governing body, as applicable, and (other than the filing with the SEC of one or more Registration Statements in accordance with the requirements of the Registration Rights Agreement, a Form D with the SEC and any other filings as may be required by any state securities agencies) no further filing, consent or authorization is required by the Company, its Subsidiaries, their respective boards of directors or their stockholders or other governing body. This Agreement has been, and the other Transaction Documents to which it is a party will be prior to the Closing, duly executed and delivered by the Company, and each constitutes the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with its respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors&#8217; rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities law. Prior to the Closing, the Transaction Documents to which each Subsidiary is a party will be duly executed and delivered by each such Subsidiary, and shall constitute the legal, valid and binding obligations of each such Subsidiary, enforceable against each such Subsidiary in accordance with their respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors&#8217; rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities law. &#8220;Transaction Documents&#8221; means, collectively, this Agreement, the Notes, the Warrants, the Registration Rights Agreement, and the Guaranty, and each of the other agreements and instruments entered into or delivered by any of the parties hereto in connection with the transactions contemplated hereby and thereby, as may be amended from time to time.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(c)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Issuance of Securities</u><font style="font-size:11pt;">. The issuance of the Notes and Warrants are duly authorized and upon issuance in accordance with the terms of the Transaction Documents shall be validly issued, fully paid and non-assessable and free from all preemptive or similar rights, mortgages, defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances (collectively &#8220;Liens&#8221;) with respect to the issuance thereof. As of the Closing, the Company shall have reserved from its duly authorized capital stock not less than 200% of the maximum number of Conversion Shares issuable upon conversion of the Notes (assuming for purposes hereof that (x) the Notes are convertible at the Alternate Conversion Price (as defined in the Notes) assuming an Alternate Conversion Date (as defined in the Note) as of the date hereof, (y) interest on the Notes shall accrue through the first anniversary of the Closing Date and will be converted in shares of Common Stock at a conversion price equal to the Alternate Conversion Price assuming an Alternate Conversion Date as of the date hereof and (z) any such conversion shall not take into account any limitations on the conversion of the Notes set forth in the Notes) and Warrant Shares issuable upon exercise of the Warrants (assuming for purposes hereof that any such exercise shall not take into account any limitations on the exercise of the Warrants set forth in the Warrants). Upon issuance or conversion in accordance with the Notes, the Conversion Shares, when issued, will be validly issued, fully paid and nonassessable and free from all preemptive or similar rights or Liens with respect to</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock. Upon exercise in accordance with the Warrants, the Warrant Shares, when issued, will be validly issued, fully paid and nonassessable and free from all preemptive or similar rights or Liens with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock. Subject to the accuracy of the representations and warranties of the Buyers in this Agreement, the offer and issuance by the Company of the Securities is exempt from registration under the 1933 Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(d)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Conflicts</u><font style="font-size:11pt;">. The execution, delivery and performance of the Transaction Documents by the Company and its Subsidiaries and the consummation by the Company and its Subsidiaries of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Notes and the Conversion Shares, the issuance of the Warrants and the Warrant Shares, and the reservation for issuance of the Conversion Shares and Warrant Shares, will not (i) result in a violation of the Certificate of Incorporation (as defined below) (including, without limitation, any certificate of designation contained therein), Bylaws (as defined below), certificate of formation, memorandum of association, articles of association, bylaws or other organizational documents of the Company or any of its Subsidiaries, or any capital stock or other securities of the Company or any of its Subsidiaries, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) in any respect under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including, without limitation, foreign, federal and state securities laws and regulations and the rules and regulations of the Nasdaq Capital Market (the &#8220;Principal Market&#8221;) and including all applicable foreign, federal and state laws, rules and regulations) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(e)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Consents</u><font style="font-size:11pt;">. Neither the Company nor any Subsidiary is required to obtain any consent from, authorization or order of, or make any filing or registration with (other than the filing with the SEC of one or more Registration Statements in accordance with the requirements of the Registration Rights Agreement, a Form D with the SEC and any other filings as may be required by any state securities agencies), any Governmental Entity (as defined below) or any regulatory or self-regulatory agency or any other Person in order for it to execute, deliver or perform any of its respective obligations under or contemplated by the Transaction Documents, in each case, in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and registrations which the Company or any Subsidiary is required to obtain pursuant to the preceding sentence have been or will be obtained or effected on or prior to the Closing Date, and neither the Company nor any of its Subsidiaries are aware of any facts or circumstances which might prevent the Company or any of its Subsidiaries from obtaining or effecting any of the registration, application or filings contemplated by the Transaction Documents. The Company is not in violation of the requirements of the Principal Market and has no knowledge of any facts or circumstances which could reasonably lead to delisting or suspension of the Common Stock in the foreseeable future.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(f)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Acknowledgment Regarding Buyer&#8217;s Purchase of Securities</u><font style="font-size:11pt;">. The Company acknowledges and agrees that each Buyer is acting solely in the capacity of an arm&#8217;s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby and that no Buyer is (i) an officer or director of the Company or any of its Subsidiaries, (ii) an &#8220;affiliate&#8221; (as defined in Rule 144) of the Company or any of its Subsidiaries or (iii) to its knowledge, a &#8220;beneficial owner&#8221; of more than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the &#8220;1934 Act&#8221;)). The Company further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby, and any advice given by a Buyer or any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to such Buyer&#8217;s purchase of the</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">Securities. The Company further represents to each Buyer that the Company&#8217;s and each Subsidiary&#8217;s decision to enter into the Transaction Documents to which it is a party has been based solely on the independent evaluation by the Company, each Subsidiary and their respective representatives.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(g)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No General Solicitation; Placement Agent&#8217;s Fees</u><font style="font-size:11pt;">. Neither the Company, nor any of its Subsidiaries or affiliates, nor any Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Securities. The Company shall be responsible for the payment of any placement agent&#8217;s fees, financial advisory fees, or brokers&#8217; commissions (other than for Persons engaged by any Buyer or its investment advisor) relating to or arising out of the transactions contemplated hereby. The Company shall pay, and hold each Buyer harmless against, any liability, loss or expense (including, without limitation, attorney&#8217;s fees and out-of-pocket expenses) arising in connection with any such claim. The Company acknowledges that neither the Company nor any of its Subsidiaries has engaged any placement agent or other agent in connection with the offer or sale of the Securities.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(h)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Integrated Offering</u><font style="font-size:11pt;">. None of the Company, its Subsidiaries or any of their affiliates, nor any Person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would require registration of the issuance of any of the Securities under the 1933 Act, whether through integration with prior offerings or otherwise, or cause this offering of the Securities to require approval of stockholders of the Company for purposes of the 1933 Act or under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on which any of the securities of the Company are listed or designated for quotation. None of the Company, its Subsidiaries, their affiliates nor any Person acting on their behalf will take any action or steps that would require registration of the issuance of any of the Securities under the 1933 Act or cause the offering of any of the Securities to be integrated with other offerings of securities of the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Dilutive Effect</u><font style="font-size:11pt;">. The Company understands and acknowledges that the number of Conversion Shares and Warrant Shares will increase in certain circumstances. The Company further acknowledges that its obligation to issue the Conversion Shares pursuant to the terms of the Notes and its obligation to issue the Warrant Shares pursuant to the terms of the Warrants in accordance with this Agreement is, in each case, absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of other stockholders of the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(j)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Application of Takeover Protections; Rights Agreement</u><font style="font-size:11pt;">. The Company and its board of directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, interested stockholder, business combination, poison pill (including, without limitation, any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover provision under the Certificate of Incorporation, Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation or otherwise which is or could become applicable to any Buyer as a result of the transactions contemplated by this Agreement, including, without limitation, the Company&#8217;s issuance of the Securities and any Buyer&#8217;s ownership of the Securities. The Company and its board of directors have taken all necessary action, if any, in order to render inapplicable any stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership of shares of Common Stock or a change in control of the Company or any of its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(k)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SEC Documents; Financial Statements</u><font style="font-size:11pt;">. During the twelve (12) months prior to the date hereof, the Company has timely filed all reports, schedules, forms, proxy statements, statements and other documents pursuant to the reporting requirements of the 1934 Act (all of the foregoing filed prior to the date hereof and all exhibits and appendices included therein and financial statements, notes and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the &#8220;SEC</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">Documents&#8221;). The Company has delivered or has made available to the Buyers or their respective representatives true, correct and complete copies of each of the SEC Documents not available on the EDGAR system. As of their respective dates, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. As of their respective dates, the financial statements of the Company included in the SEC Documents complied in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto as in effect as of the time of filing. Such financial statements have been prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;), consistently applied, during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments which will not be material, either individually or in the aggregate). No information provided by or on behalf of the Company to any of the Buyers which is not included in the SEC Documents contains any untrue statement of a material fact or omits to state any material fact necessary in order to make the statements therein not misleading, in the light of the circumstance under which they are or were made. The Company is not currently contemplating to amend or restate any of the financial statements (including, without limitation, any notes or any letter of the independent accountants of the Company with respect thereto) included in the SEC Documents (the &#8220;Financial Statements&#8221;), nor is the Company currently aware of facts or circumstances which would require the Company to amend or restate any of the Financial Statements, in each case, in order for any of the Financials Statements to be in compliance with GAAP and the rules and regulations of the SEC. The Company has not been informed by its independent accountants that they recommend that the Company amend or restate any of the Financial Statements or that there is any need for the Company to amend or restate any of the Financial Statements.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(l)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Absence of Certain Changes</u><font style="font-size:11pt;">. Since the date of the Company&#8217;s most recent audited financial statements contained in a Form 10-K, there has been no material adverse change and no material adverse development in the business, assets, liabilities, properties, operations (including results thereof), condition (financial or otherwise) or prospects of the Company or any of its Subsidiaries. Since the date of the Company&#8217;s most recent audited financial statements contained in a Form 10-K, neither the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any assets, individually or in the aggregate, outside of the ordinary course of business or (iii) made any capital expenditures, individually or in the aggregate, outside of the ordinary course of business. Neither the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant to any law or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up, nor does the Company or any Subsidiary have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so. The Company and its Subsidiaries, individually and on a consolidated basis, are not as of the date hereof, and after giving effect to the transactions contemplated hereby to occur at the Closing, will not be Insolvent which means, (i) with respect to the Company and its Subsidiaries, on a consolidated basis, (A) the present fair saleable value of the Company&#8217;s and its Subsidiaries&#8217; assets is less than the amount required to pay the Company&#8217;s and its Subsidiaries&#8217; total Indebtedness (as defined below), (B) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured or (C) the Company and its Subsidiaries intend to incur or believe that they will incur debts that would be beyond their ability to pay as such debts mature; and (ii) with respect to the Company and each Subsidiary, individually, (A) the present fair saleable value of the Company&#8217;s or such Subsidiary&#8217;s (as the case may be) assets is less than the amount required to pay its</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">respective total Indebtedness, (B) the Company or such Subsidiary (as the case may be) is unable to pay its respective debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured or (C) the Company or such Subsidiary (as the case may be) intends to incur or believes that it will incur debts that would be beyond its respective ability to pay as such debts mature.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(m)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Undisclosed Events, Liabilities, Developments or Circumstances</u><font style="font-size:11pt;">. No event, liability, development or circumstance has occurred or exists, or is reasonably expected to exist or occur with respect to the Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (i) would be required to be disclosed by the Company under applicable securities laws on a registration statement on Form S-1 filed with the SEC relating to an issuance and sale by the Company of its Common Stock and which has not been publicly announced, (ii) could have a material adverse effect on any Buyer&#8217;s investment hereunder or (iii) could have a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(n)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conduct of Business; Regulatory Permits</u><font style="font-size:11pt;">. Neither the Company nor any of its Subsidiaries is in violation of any term of or in default under its Certificate of Incorporation, any certificate of designation, preferences or rights of any other outstanding series of preferred stock of the Company or any of its Subsidiaries or Bylaws or their organizational charter, certificate of formation, memorandum of association, articles of association, Certificate of Incorporation or certificate of incorporation or bylaws, respectively. Neither the Company nor any of its Subsidiaries is in violation of any judgment, decree or order or any statute, ordinance, rule or regulation applicable to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct its business in violation of any of the foregoing, except in all cases for possible violations which could not, individually or in the aggregate, have a Material Adverse Effect. Without limiting the generality of the foregoing, the Company is not in violation of any of the rules, regulations or requirements of the Principal Market and has no knowledge of any facts or circumstances that could reasonably lead to delisting or suspension of the Common Stock by the Principal Market in the foreseeable future. As applicable, during the two years prior to the date hereof, (i) the Common Stock has been listed or designated for quotation on the Principal Market, (ii) trading in the Common Stock has not been suspended by the SEC or the Principal Market and (iii) the Company has received no communication, written or oral, from the SEC or the Principal Market regarding the suspension or delisting of the Common Stock from the Principal Market. The Company and each of its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such certificates, authorizations or permits would not have, individually or in the aggregate, a Material Adverse Effect, and neither the Company nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit. There is no agreement, commitment, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the Company or any of its Subsidiaries is a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries as currently conducted other than such effects, individually or in the aggregate, which have not had and would not reasonably be expected to have a Material Adverse Effect on the Company or any of its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(o)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Foreign Corrupt Practices</u><font style="font-size:11pt;">. Neither the Company, the Company&#8217;s subsidiary or any director, officer, agent, employee, nor any other person acting for or on behalf of the foregoing (individually and collectively, a &#8220;Company Affiliate&#8221;) have violated the U.S. Foreign Corrupt Practices Act (the &#8220;FCPA&#8221;) or any other applicable anti-bribery or anti-corruption laws, nor has any Company Affiliate offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised to give, or authorized the giving of anything of value, to any officer, employee or any other person acting in an official capacity for any Governmental Entity to any political party or official thereof or to any candidate</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">for political office (individually and collectively, a &#8220;Government Official&#8221;) or to any person under circumstances where such Company Affiliate knew or was aware of a high probability that all or a portion of such money or thing of value would be offered, given or promised, directly or indirectly, to any Government Official, for the purpose of:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><font style="font-size:11pt;">(A) influencing any act or decision of such Government Official in his/her official capacity, (B) inducing such Government Official to do or omit to do any act in violation of his/her lawful duty, (C) securing any improper advantage, or (D) inducing such Government Official to influence or affect any act or decision of any Governmental Entity, or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ii)</font></font><font style="font-size:11pt;">assisting the Company or its Subsidiaries in obtaining or retaining business for or with, or directing business to, the Company or its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(p)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sarbanes-Oxley Act</u><font style="font-size:11pt;">. The Company and each Subsidiary is in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, and any and all applicable rules and regulations promulgated by the SEC thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(q)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Equity Capitalization</u><font style="font-size:11pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Definitions</u><font style="font-size:11pt;">:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:11pt;">(A)</font><font style="display:inline-block;width:20.73pt;"></font><font style="font-size:11pt;">&#8220;Common Stock&#8221; means (x) the Company&#8217;s shares of Class A common stock, $0.0001 par value per share, and (y) any capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:11pt;">(B)</font><font style="display:inline-block;width:21.34pt;"></font><font style="font-size:11pt;">&#8220;Preferred Stock&#8221; means (x) the Company&#8217;s blank check preferred stock, $0.0001 par value per share, the terms of which may be designated by the board of directors of the Company in a certificate of designations and (y) any capital stock into which such preferred stock shall have been changed or any share capital resulting from a reclassification of such preferred stock (other than a conversion of such preferred stock into Common Stock in accordance with the terms of such certificate of designations).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ii)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Authorized and Outstanding Capital Stock</u><font style="font-size:11pt;">. As of the date hereof, the authorized capital stock of the Company consists of (A) 100,000,000 shares of Common Stock, of which, 3,316,819 shares of Class A Common Stock and 4,253,517 shares of Class B Common Stock are issued and outstanding and 1,908,080 shares are reserved for issuance pursuant to Convertible Securities exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 1,000,000 shares of Preferred Stock, none of which are issued and outstanding. &#8220;Convertible Securities&#8221; means any capital stock or other security of the Company or any of its Subsidiaries that is directly or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital stock or other security of the Company (including, without limitation, Common Stock) or any of its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iii)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Valid Issuance</u><font style="font-size:11pt;">. All of such outstanding shares are duly authorized and have been, or upon issuance will be, validly issued and are fully paid and nonassessable.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iv)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Existing Securities; Obligations</u><font style="font-size:11pt;">. Except as disclosed in the SEC Documents: (A) none of the Company&#8217;s or any Subsidiary&#8217;s shares, interests or capital stock is subject to preemptive rights or any other similar rights or Liens suffered or permitted by the Company or any Subsidiary; (B) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="font-size:11pt;">of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares, interests or capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares, interests or capital stock of the Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares, interests or capital stock of the Company or any of its Subsidiaries; (C) there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities under the 1933 Act (except pursuant to the Registration Rights Agreement); (D) there are no outstanding securities or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries; (E) there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Securities; and (F) neither the Company nor any Subsidiary has any stock appreciation rights or &#8220;phantom stock&#8221; plans or agreements or any similar plan or agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(v)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Organizational Documents</u><font style="font-size:11pt;">. The Company has furnished to the Buyers true, correct and complete copies of the Company&#8217;s Certificate of Incorporation, as amended and as in effect on the date hereof (the &#8220;Certificate of Incorporation&#8221;), and the Company&#8217;s bylaws, as amended and as in effect on the date hereof (the &#8220;Bylaws&#8221;), and the terms of all Convertible Securities and the material rights of the holders thereof in respect thereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(r)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indebtedness and Other Contracts</u><font style="font-size:11pt;">. Neither the Company nor any of its Subsidiaries, (i) is a party to any contract, agreement or instrument, the violation of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be expected to result in a Material Adverse Effect, (ii) has any financing statements securing obligations in any amounts filed in connection with the Company or any of its Subsidiaries; (iii) is in violation of any term of, or in default under, any contract, agreement or instrument relating to any Indebtedness, except where such violations and defaults would not result, individually or in the aggregate, in a Material Adverse Effect, or (iv) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance of which, in the judgment of the Company&#8217;s officers, has or is expected to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries have any liabilities or obligations required to be disclosed in the SEC Documents which are not so disclosed in the SEC Documents, other than those incurred in the ordinary course of the Company&#8217;s or its Subsidiaries&#8217; respective businesses and which, individually or in the aggregate, do not or could not have a Material Adverse Effect. For purposes of this Agreement: (x) &#8220;Indebtedness&#8221; of any Person means, without duplication all indebtedness for borrowed money.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(s)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Litigation</u><font style="font-size:11pt;">. There is no action, suit, arbitration, proceeding, inquiry or investigation before or by the Principal Market, any court, public board, other Governmental Entity, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries, the Common Stock or any of the Company&#8217;s or its Subsidiaries&#8217; officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such. No director, officer or employee of the Company or any of its subsidiaries has willfully violated 18 U.S.C. &#167;1519 or engaged in spoliation in reasonable anticipation of litigation. Without limitation of the foregoing, there has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries or any current or former director or officer of the Company or any of its Subsidiaries. The SEC has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company under the 1933 Act or the 1934 Act. After reasonable inquiry of its employees, the Company is not aware of any fact which might result in or form the basis for</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">any such action, suit, arbitration, investigation, inquiry or other proceeding. Neither the Company nor any of its Subsidiaries is subject to any order, writ, judgment, injunction, decree, determination or award of any Governmental Entity.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(t)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Insurance</u><font style="font-size:11pt;">. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance coverage sought or applied for, and neither the Company nor any such Subsidiary has any reason to believe that it will be unable to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(u)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employee Relations</u><font style="font-size:11pt;">. Neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement or employs any member of a union. The Company and its Subsidiaries believe that their relations with their employees are good. No executive officer (as defined in Rule 501(f) promulgated under the 1933 Act) or other key employee of the Company or any of its Subsidiaries has notified the Company or any such Subsidiary that such officer intends to leave the Company or any such Subsidiary or otherwise terminate such officer&#8217;s employment with the Company or any such Subsidiary. No current (or former) executive officer or other key employee of the Company or any of its Subsidiaries is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement, non-competition agreement, or any other contract or agreement or any restrictive covenant, and the continued employment of each such executive officer or other key employee (as the case may be) does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all federal, state, local and foreign laws and regulations respecting labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except where failure to be in compliance would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(v)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Title</u><font style="font-size:11pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Real Property</u><font style="font-size:11pt;">. Each of the Company and its Subsidiaries holds good title to all real property, leases in real property, facilities or other interests in real property owned or held by the Company or any of its Subsidiaries (the &#8220;Real Property&#8221;) owned by the Company or any of its Subsidiaries (as applicable). The Real Property is free and clear of all Liens and is not subject to any rights of way, building use restrictions, exceptions, variances, reservations, or limitations of any nature except for (a) Liens for current taxes not yet due and (b) zoning laws and other land use restrictions that do not impair the present or anticipated use of the property subject thereto. Any Real Property held under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company or any of its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ii)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Fixtures and Equipment</u><font style="font-size:11pt;">. Each of the Company and its Subsidiaries (as applicable) has good title to, or a valid leasehold interest in, the tangible personal property, equipment, improvements, fixtures, and other personal property and appurtenances that are used by the Company or its Subsidiary in connection with the conduct of its business (the &#8220;Fixtures and Equipment&#8221;). The Fixtures and Equipment are structurally sound, are in good operating condition and repair, are adequate for the uses to which they are being put, are not in need of maintenance or repairs except for ordinary, routine maintenance and repairs and are sufficient for the conduct of</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="font-size:11pt;">the Company&#8217;s and/or its Subsidiaries&#8217; businesses (as applicable) in the manner as conducted prior to the Closing. Each of the Company and its Subsidiaries owns all of its Fixtures and Equipment free and clear of all Liens except for (a) liens for current taxes not yet due and (b) zoning laws and other land use restrictions that do not impair the present or anticipated use of the property subject thereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(w)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Intellectual Property Rights</u><font style="font-size:11pt;">. The Company and its Subsidiaries own or possess adequate rights or licenses to use all trademarks, trade names, service marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications and registrations therefor (&#8220;Intellectual Property Rights&#8221;) necessary to conduct their respective businesses as now conducted and presently proposed to be conducted. None of the Company&#8217;s Intellectual Property Rights have expired or terminated or have been abandoned or are expected to expire or terminate or are expected to be abandoned, within three years from the date of this Agreement. The Company does not have any knowledge of any infringement by the Company or its Subsidiaries of Intellectual Property Rights of others. There is no claim, action or proceeding being made or brought, or to the knowledge of the Company or any of its Subsidiaries, being threatened, against the Company or any of its Subsidiaries regarding its Intellectual Property Rights. Neither the Company nor any of its Subsidiaries is aware of any facts or circumstances which might give rise to any of the foregoing infringements or claims, actions or proceedings. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their Intellectual Property Rights.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(x)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Environmental Laws</u><font style="font-size:11pt;">. (i) The Company and its Subsidiaries (A) are in compliance with any and all Environmental Laws (as defined below), (B) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (C) are in compliance with all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses (A), (B) and (C), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. The term &#8220;Environmental Laws&#8221; means all federal, state, local or foreign laws relating to pollution or protection of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &#8220;Hazardous Materials&#8221;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Hazardous Materials</u><font style="font-size:11pt;">:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:11pt;">(A)</font><font style="display:inline-block;width:20.73pt;"></font><font style="font-size:11pt;">have been disposed of or otherwise released from any Real Property of the Company or any of its Subsidiaries in violation of any Environmental Laws; or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:11pt;">(B)</font><font style="display:inline-block;width:21.34pt;"></font><font style="font-size:11pt;">are present on, over, beneath, in or upon any Real Property or any portion thereof in quantities that would constitute a violation of any Environmental Laws. No prior use by the Company or any of its Subsidiaries of any Real Property has occurred that violates any Environmental Laws, which violation would have a material adverse effect on the business of the Company or any of its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ii)</font></font><font style="font-size:11pt;">Neither the Company nor any of its Subsidiaries knows of any other person who or entity which has stored, treated, recycled, disposed of or otherwise located on any Real Property any Hazardous Materials, including, without limitation, such substances as asbestos and</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="font-size:11pt;">polychlorinated biphenyls.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iii)</font></font><font style="font-size:11pt;">None of the Real Properties are on any federal or state &#8220;Superfund&#8221; list or Liability Information System (&#8220;CERCLIS&#8221;) list or any state environmental agency list of sites under consideration for CERCLIS, nor subject to any environmental related Liens.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(y)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Subsidiary Rights</u><font style="font-size:11pt;">. The Company or one of its Subsidiaries has the unrestricted right to vote, and (subject to limitations imposed by applicable law) to receive dividends and distributions on, all capital securities of its Subsidiaries as owned by the Company or such Subsidiary.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(z)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Tax Status</u><font style="font-size:11pt;">. The Company and each of its Subsidiaries (i) has timely made or filed all foreign, federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, and (ii) has timely paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company and its Subsidiaries know of no basis for any such claim. The Company is not operated in such a manner as to qualify as a passive foreign investment company, as defined in Section 1297 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). The net operating loss carryforwards (&#8220;NOLs&#8221;) for United States federal income tax purposes of the consolidated group of which the Company is the common parent, if any, shall not be adversely effected by the transactions contemplated hereby. The transactions contemplated hereby do not constitute an &#8220;ownership change&#8221; within the meaning of Section 382 of the Code, thereby preserving the Company&#8217;s ability to utilize such NOLs.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(aa)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Internal Accounting and Disclosure Controls</u><font style="font-size:11pt;">. The Company and each of its Subsidiaries maintains internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934 Act) that is effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, including that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance with management&#8217;s general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the 1934 Act) that are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the SEC, including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is accumulated and communicated to the Company&#8217;s management, including its principal executive officer or officers and its principal financial officer or officers, as appropriate, to allow timely decisions regarding required disclosure. Neither the Company nor any of its Subsidiaries has received any notice or correspondence from any accountant, Governmental Entity or other Person relating to any potential material weakness or significant deficiency in any part of the internal controls over financial reporting of the Company or any of its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(bb)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Off Balance Sheet Arrangements</u><font style="font-size:11pt;">. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(cc)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investment Company Status</u><font style="font-size:11pt;">. The Company is not, and upon consummation of the sale of the Securities will not be, an &#8220;investment company,&#8221; an affiliate of an &#8220;investment company,&#8221; a company controlled by an &#8220;investment company&#8221; or an &#8220;affiliated person&#8221; of, or &#8220;promoter&#8221; or &#8220;principal underwriter&#8221; for, an &#8220;investment company&#8221; as such terms are defined in the Investment Company Act of 1940, as amended.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(dd)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Acknowledgement Regarding Buyers&#8217; Trading Activity</u><font style="font-size:11pt;">. It is understood and acknowledged by the Company that (i) following the public disclosure of the transactions contemplated by the Transaction Documents, in accordance with the terms thereof, none of the Buyers have been asked by the Company or any of its Subsidiaries to agree, nor has any Buyer agreed with the Company or any of its Subsidiaries, to desist from effecting any transactions in or with respect to (including, without limitation, purchasing or selling, long and/or short) any securities of the Company, or &#8220;derivative&#8221; securities based on securities issued by the Company or to hold any of the Securities for any specified term; (ii) any Buyer, and counterparties in &#8220;derivative&#8221; transactions to which any such Buyer is a party, directly or indirectly, presently may have a &#8220;short&#8221; position in the Common Stock which was established prior to such Buyer&#8217;s knowledge of the transactions contemplated by the Transaction Documents; (iii) each Buyer shall not be deemed to have any affiliation with or control over any arm&#8217;s length counterparty in any &#8220;derivative&#8221; transaction; and (iv) each Buyer may rely on the Company&#8217;s obligation to timely deliver shares of Common Stock upon conversion or exchange, as applicable, of the Securities as and when required pursuant to the Transaction Documents for purposes of effecting trading in the Common Stock of the Company. The Company further understands and acknowledges that following the public disclosure of the transactions contemplated by the Transaction Documents pursuant to the Press Release (as defined below) one or more Buyers may engage in hedging and/or trading activities (including, without limitation, the location and/or reservation of borrowable shares of Common Stock) at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value and/or number of the Conversion Shares and Warrant Shares deliverable with respect to the Securities are being determined and such hedging and/or trading activities (including, without limitation, the location and/or reservation of borrowable shares of Common Stock), if any, can reduce the value of the existing stockholders&#8217; equity interest in the Company both at and after the time the hedging and/or trading activities are being conducted. The Company acknowledges that such aforementioned hedging and/or trading activities do not constitute a breach of this Agreement, the Notes, the Warrants, or any other Transaction Document or any of the documents executed in connection herewith or therewith.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ee)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Manipulation of Price</u><font style="font-size:11pt;">. Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company, no Person acting on their behalf has, directly or indirectly, (i) taken any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company or any of its Subsidiaries to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities (other than the Placement Agent), (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company or any of its Subsidiaries or (iv) paid or agreed to pay any Person for research services with respect to any securities of the Company or any of its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ff)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">U.S. Real Property Holding Corporation</u><font style="font-size:11pt;">. Neither the Company nor any of its Subsidiaries is, or has ever been, and so long as any of the Securities are held by any of the Buyers, shall become, a U.S. real property holding corporation within the meaning of Section 897 of the Code, and the Company and each Subsidiary shall so certify upon any Buyer&#8217;s request.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(gg)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Eligibility</u><font style="font-size:11pt;">. The Company is currently eligible to register the Registrable Securities (defined in the Registration Rights Agreement) for resale by the Buyers using Form S-1 promulgated under the 1933 Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(hh)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transfer Taxes</u><font style="font-size:11pt;">. On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required to be paid in connection with the issuance, sale and transfer of the Securities to be sold to each Buyer hereunder will be, or will have been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been complied with.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ii)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Bank Holding Company Act</u><font style="font-size:11pt;">. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;BHCA&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;Federal Reserve&#8221;). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(jj)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Shell Company Status</u><font style="font-size:11pt;">. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(kk)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Illegal or Unauthorized Payments; Political Contributions</u><font style="font-size:11pt;">. Neither the Company nor any of its Subsidiaries nor, to the best of the Company&#8217;s knowledge (after reasonable inquiry of its officers and directors), any of the officers, directors, employees, agents or other representatives of the Company or any of its Subsidiaries or any other business entity or enterprise with which the Company or any Subsidiary is or has been affiliated or associated, has, directly or indirectly, made or authorized any payment, contribution or gift of money, property, or services, whether or not in contravention of applicable law, (i) as a kickback or bribe to any Person or (ii) to any political organization, or the holder of or any aspirant to any elective or appointive public office except for personal political contributions not involving the direct or indirect use of funds of the Company or any of its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ll)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Money Laundering</u><font style="font-size:11pt;">. The Company and its Subsidiaries are in compliance with, and have not previously violated, the USA Patriot Act of 2001 and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, without limitation, the laws, regulations and Executive Orders and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, but not limited, to (i) Executive Order 13224 of September 23, 2001 entitled, &#8220;Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism&#8221; (66 Fed. Reg. 49079 (2001)); and (ii) any regulations contained in 31 CFR, Subtitle B, Chapter V.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(mm)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Management</u><font style="font-size:11pt;">. During the past five year period, no current or former officer or director or, to the knowledge of the Company, no current ten percent (10%) or greater stockholder of the Company or any of its Subsidiaries has been the subject of:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><font style="font-size:11pt;">a petition under bankruptcy laws or any other insolvency or moratorium law or the appointment by a court of a receiver, fiscal agent or similar officer for such Person, or any partnership in which such person was a general partner at or within two years before the filing of such petition or such appointment, or any corporation or business association of which such person was an executive officer at or within two years before the time of the filing of such petition or such appointment;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ii)</font></font><font style="font-size:11pt;">a conviction in a criminal proceeding or a named subject of a pending criminal proceeding (excluding traffic violations that do not relate to driving while intoxicated or driving under the influence);</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iii)</font></font><font style="font-size:11pt;">any order, judgment or decree, not subsequently reversed, suspended or vacated,</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="font-size:11pt;">of any court of competent jurisdiction, permanently or temporarily enjoining any such person from, or otherwise limiting, the following activities:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:11pt;">(A)</font><font style="display:inline-block;width:20.73pt;"></font><font style="font-size:11pt;">Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the United States Commodity Futures Trading Commission or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:11pt;">(B)</font><font style="display:inline-block;width:21.34pt;"></font><font style="font-size:11pt;">Engaging in any particular type of business practice; or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:11pt;">(C)</font><font style="display:inline-block;width:21.34pt;"></font><font style="font-size:11pt;">Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of securities laws or commodities laws;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iv)</font></font><font style="font-size:11pt;">any order, judgment or decree, not subsequently reversed, suspended or vacated, of any authority barring, suspending or otherwise limiting for more than sixty (60) days the right of any such person to engage in any activity described in the preceding sub paragraph, or to be associated with persons engaged in any such activity;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(v)</font></font><font style="font-size:11pt;">a finding by a court of competent jurisdiction in a civil action or by the SEC or other authority to have violated any securities law, regulation or decree and the judgment in such civil action or finding by the SEC or any other authority has not been subsequently reversed, suspended or vacated; or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(vi)</font></font><font style="font-size:11pt;">a finding by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any federal commodities law, and the judgment in such civil action or finding has not been subsequently reversed, suspended or vacated.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(nn)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Option Plans</u><font style="font-size:11pt;">. Each stock option granted by the Company was granted (i) in accordance with the terms of the applicable stock option plan of the Company and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&#8217;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(oo)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Disagreements with Accountants and Lawyers</u><font style="font-size:11pt;">. There are no material disagreements of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company&#8217;s ability to perform any of its obligations under any of the Transaction Documents. In addition, on or prior to the date hereof, the Company had discussions with its accountants about its financial statements previously filed with the SEC. Based on those discussions, the Company has no reason to believe that it will need to restate any such financial statements or any part thereof.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(pp)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Disqualification Events</u><font style="font-size:11pt;">. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b) under the 1933 Act (&#8220;Regulation D Securities&#8221;), none of the Company, any of its</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of the Company&#8217;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at the time of sale (each, an &#8220;Issuer Covered Person&#8221; and, together, &#8220;Issuer Covered Persons&#8221;) is subject to any of the &#8220;Bad Actor&#8221; disqualifications described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a &#8220;Disqualification Event&#8221;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Buyers a copy of any disclosures provided thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(qq)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Covered Persons</u><font style="font-size:11pt;">. The Company is not aware of any Person (other than the Placement Agent) that has been or will be paid (directly or indirectly) remuneration for solicitation of Buyers or potential purchasers in connection with the sale of any Regulation D Securities.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(rr)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Additional Agreements</u><font style="font-size:11pt;">. The Company does not have any agreement or understanding with any Buyer with respect to the transactions contemplated by the Transaction Documents other than as specified in the Transaction Documents.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ss)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Public Utility Holding Act</u><font style="font-size:11pt;">. None of the Company nor any of its Subsidiaries is a &#8220;holding company,&#8221; or an &#8220;affiliate&#8221; of a &#8220;holding company,&#8221; as such terms are defined in the Public Utility Holding Act of 2005.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(tt)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Federal Power Act</u><font style="font-size:11pt;">. None of the Company nor any of its Subsidiaries is subject to regulation as a &#8220;public utility&#8221; under the Federal Power Act, as amended.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(uu)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Ranking of Notes</u><font style="font-size:11pt;">. No Indebtedness of the Company, at the Closing, will be senior to the Notes in right of payment, whether with respect to payment or redemptions, interest, damages, upon liquidation or dissolution or otherwise, unless waived by the Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(vv)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cybersecurity</u><font style="font-size:11pt;">. The Company and its Subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#8220;IT Systems&#8221;) are adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants that would reasonably be expected to have a Material Adverse Effect on the Company&#8217;s business. The Company and its Subsidiaries have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data, including &#8220;Personal Data,&#8221; used in connection with their businesses. &#8220;Personal Data&#8221; means (i) a natural person&#8217;s name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver&#8217;s license number, passport number, credit card number, bank information, or customer or account number; (ii) any information which would qualify as &#8220;personally identifying information&#8221; under the Federal Trade Commission Act, as amended; (iii) &#8220;personal data&#8221; as defined by the European Union General Data Protection Regulation (&#8220;GDPR&#8221;) (EU 2016/679); (iv) any information which would qualify as &#8220;protected health information&#8221; under the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, &#8220;HIPAA&#8221;); and (v) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis of any data related to an identified person&#8217;s health or sexual orientation. There have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">material cost or liability or the duty to notify any other person or such, nor any incidents under internal review or investigations relating to the same except in each case, where such would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. The Company and its Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification except in each case, where such would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ww)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Data Privacy Laws</u><font style="font-size:11pt;">. The Company and its Subsidiaries are, and at all prior times were, in compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company and its Subsidiaries have taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, have been and currently are in compliance with, the GDPR (EU 2016/679) (collectively, the &#8220;Privacy Laws&#8221;) except in each case, where such would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. To ensure compliance with the Privacy Laws, the Company and its Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure compliance in all material respects with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the &#8220;Policies&#8221;). The Company and its Subsidiaries have at all times made all disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further certifies that neither it nor any Subsidiary: (i) has received notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement that imposes any obligation or liability under any Privacy Law.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(xx)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disclosure</u><font style="font-size:11pt;">. The Company confirms that neither it nor any other Person acting on its behalf has provided any of the Buyers or their agents or counsel with any information that constitutes or could reasonably be expected to constitute material, non-public information concerning the Company or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the other Transaction Documents. The Company understands and confirms that each of the Buyers will rely on the foregoing representations in effecting transactions in securities of the Company. All disclosure provided to the Buyers regarding the Company and its Subsidiaries, their businesses and the transactions contemplated hereby, including the schedules to this Agreement, furnished by or on behalf of the Company or any of its Subsidiaries is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">4.</font></font><font style="font-size:11pt;">COVENANTS.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(a)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Best Efforts</u><font style="font-size:11pt;">. Each Buyer shall use its best efforts to timely satisfy each of the covenants hereunder and conditions to be satisfied by it as provided in Section 6 of this Agreement. The Company shall use its best efforts to timely satisfy each of the covenants hereunder and conditions to be satisfied by it as provided in Section 7 of this Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(b)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Form D and Blue Sky</u><font style="font-size:11pt;">. The Company shall file a Form D with respect to the Securities as</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">required under Regulation D and to provide a copy thereof to each Buyer promptly after such filing. The Company shall, on or before the Closing Date, take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to, qualify the Securities for sale to the Buyers at the Closing pursuant to this Agreement under applicable securities or &#8220;Blue Sky&#8221; laws of the states of the United States (or to obtain an exemption from such qualification), and shall provide evidence of any such action so taken to the Buyers on or prior to the Closing Date. Without limiting any other obligation of the Company under this Agreement, the Company shall timely make all filings and reports relating to the offer and sale of the Securities required under all applicable securities laws (including, without limitation, all applicable federal securities laws and all applicable &#8220;Blue Sky&#8221; laws), and the Company shall comply with all applicable foreign, federal, state and local laws, statutes, rules, regulations and the like relating to the offering and sale of the Securities to the Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(c)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reporting Status</u><font style="font-size:11pt;">. Until the date on which the Buyers shall have sold all of the Registrable Securities (the &#8220;Reporting Period&#8221;), the Company shall timely file all reports required to be filed with the SEC pursuant to the 1934 Act, and the Company shall not terminate its status as an issuer required to file reports under the 1934 Act even if the 1934 Act or the rules and regulations thereunder would no longer require or otherwise permit such termination. From the time Form S-3 is available to the Company for the registration of the Registrable Securities, the Company shall take all actions necessary to maintain its eligibility to register the Registrable Securities for resale by the Buyers on Form S-3.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(d)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Proceeds</u><font style="font-size:11pt;">. The Company will use the proceeds from the sale of the Securities for working capital, but not, directly or indirectly, for the redemption or repurchase of any securities of the Company or any of its Subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(e)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Financial Information</u><font style="font-size:11pt;">. The Company agrees to send the following to each Investor (as defined in the Registration Rights Agreement) during the Reporting Period (i) unless the following are filed with the SEC through EDGAR and are available to the public through the EDGAR system, within one (1) Business Day after the filing thereof with the SEC, a copy of its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, any interim reports or any consolidated balance sheets, income statements, stockholders&#8217; equity statements and/or cash flow statements for any period other than annual, any Current Reports on Form 8-K and any registration statements (other than on Form S-8) or amendments filed pursuant to the 1933 Act, (ii) unless the following are either filed with the SEC through EDGAR or are otherwise widely disseminated via a recognized news release service (such as PR Newswire), on the same day as the release thereof, e-mail copies of all press releases issued by the Company or any of its Subsidiaries and (iii) unless the following are filed with the SEC through EDGAR, copies of any notices and other information made available or given to the stockholders of the Company generally, contemporaneously with the making available or giving thereof to the stockholders.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(f)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Listing</u><font style="font-size:11pt;">. The Company shall promptly secure the listing or designation for quotation (as the case may be) of all of the Registrable Securities upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed or designated for quotation (as the case may be) (subject to official notice of issuance) and shall maintain such listing or designation for quotation (as the case may be) of all Registrable Securities from time to time issuable under the terms of the Transaction Documents on such national securities exchange or automated quotation system. The Company shall maintain the Common Stock&#8217;s listing or authorization for quotation (as the case may be) on the Principal Market, The New York Stock Exchange, the NYSE American, the Nasdaq Global Market or the Nasdaq Global Select Market (each, an &#8220;Eligible Market&#8221;). Neither the Company nor any of its Subsidiaries shall take any action which could be reasonably expected to result in the delisting or suspension of the Common Stock on an Eligible Market. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section 4(f).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(g)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Additional Registration Statements</u><font style="font-size:11pt;">. Until the Applicable Date (as defined below) and at any time</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(h)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Dilutive Issuances</u><font style="font-size:11pt;">. For so long as any Notes and Warrants remain outstanding, the Company shall not, in any manner, enter into or affect any Dilutive Issuance (as defined in the Notes) if the effect of such Dilutive Issuance is to cause the Company to be required to issue upon conversion of any Notes or exercise of any Warrants any shares of Common Stock in excess of that number of shares of Common Stock which the Company may issue upon conversion of the Notes or exercise of the Warrants without breaching the Company&#8217;s obligations under the rules or regulations of the Principal Market.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Passive Foreign Investment Company</u><font style="font-size:11pt;">. The Company shall conduct its business, and shall cause its Subsidiaries to conduct their respective businesses, in such a manner as will ensure that the Company will not be deemed to constitute a passive foreign investment company within the meaning of Section 1297 of the Code.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(j)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restriction on Redemption and Cash Dividends</u><font style="font-size:11pt;">. So long as any Notes and Warrants are outstanding, the Company shall not, directly or indirectly, redeem, or declare or pay any cash dividend or distribution on, any securities of the Company without the prior express written consent of the Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(k)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Corporate Existence</u><font style="font-size:11pt;">. So long as any Buyer beneficially owns any Notes or Warrants, the Company shall not be party to any Fundamental Transaction (as defined in the Notes) unless the Company is in compliance with the applicable provisions governing Fundamental Transactions set forth in the Notes and Warrants.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(l)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Splits</u><font style="font-size:11pt;">. Until the Notes and Warrants are no longer outstanding, the Company shall not effect any stock combination, reverse stock split or other similar transaction (or make any public announcement or disclosure with respect to any of the foregoing) without the prior written consent of a majority of the Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(m)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conversion Procedures</u><font style="font-size:11pt;">. Each of the form of Conversion Notice and Exercise Notice (as defined in the Notes and Warrants, respectively) included in the Notes and Warrants set forth the totality of the procedures required of the Buyers in order to convert the Notes and exercise the Warrants. Except as provided in Section 5(d), no additional legal opinion, other information or instructions shall be required of the Buyers to convert their Notes or exercise their Warrants. The Company shall honor conversions of the Notes and exercises of the Warrants and shall deliver the Conversion Shares and Warrant Shares in accordance with the terms, conditions and time periods set forth in the Notes and Warrants.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(n)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Regulation M</u><font style="font-size:11pt;">. The Company will not take any action prohibited by Regulation M under the 1934 Act, in connection with the distribution of the Securities contemplated hereby.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(o)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General Solicitation</u><font style="font-size:11pt;">. None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act) or any person acting on behalf of the Company or such affiliate will solicit any offer to buy or offer or sell the Securities by means of any form of general solicitation or general advertising within the meaning of Regulation D, including: (i) any advertisement, article, notice or other communication published in any newspaper, magazine or similar medium or broadcast over television or radio; and (ii) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(p)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Integration</u><font style="font-size:11pt;">. None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act), or any person acting on behalf of the Company or such affiliate will sell, offer for sale, or solicit offers to buy or otherwise negotiate in respect of any security (as defined in the 1933 Act) which will be</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">integrated with the sale of the Securities in a manner which would require the registration of the Securities under the 1933 Act or require stockholder approval under the rules and regulations of the Principal Market and the Company will take all action that is appropriate or necessary to assure that its offerings of other securities will not be integrated for purposes of the 1933 Act or the rules and regulations of the Principal Market, with the issuance of Securities contemplated hereby.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(q)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notice of Disqualification Events</u><font style="font-size:11pt;">. The Company will notify the Buyers in writing, prior to the Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer Covered Person.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(r)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stockholder Approval</u><font style="font-size:11pt;">. The Company shall either (x) if the Company shall have obtained the prior written consent of the requisite stockholders (the &#8220;Stockholder Consent&#8221;) to obtain the Stockholder Approval (as defined below), inform the stockholders of the Company of the receipt of the Stockholder Consent by preparing and filing with the SEC, as promptly as practicable after the date hereof.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(s)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Sales of Pre-Delivery Shares; Return of Pre-Delivery Shares</u><font style="font-size:11pt;">. Each Buyer, severally, hereby covenants and agrees (i) not to sell any Pre-Delivery Shares issued to such Buyer until such time as such Pre-Delivery Shares shall become Delivery Shares (as defined in the Notes) and (ii) that if such Buyer holds any Pre-Delivery Shares after such date that no Notes are then held by such Buyer (whether following the conversion or redemption, as applicable, of all Notes then held by such Buyer, but after any applicable Delivery Share Applications (as defined in the Notes) related thereto), such remaining Pre-Delivery Shares shall be promptly returned by such Buyer to the Company for cancellation.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(t)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Holding Period</u><font style="font-size:11pt;">. For the purposes of Rule 144, the Company acknowledges that the holding period of the Pre-Delivery Shares may be tacked onto the holding period of the Notes and shall, consequently, be deemed to have been issued as of the Closing Date for purposes of Rule 144 and the Company agrees not to take a position contrary to this Section 4(dd).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(u)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Closing Documents</u><font style="font-size:11pt;">. On or prior to fourteen (14) calendar days after the Closing Date, the Company agrees to deliver, or cause to be delivered, to each Buyer and Rimon P.C., a complete closing set of the executed Transaction Documents, Securities and any other document required to be delivered to any party pursuant to Section 7 hereof or otherwise.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">5.</font></font><font style="font-size:11pt;">REGISTER; TRANSFER AGENT INSTRUCTIONS; LEGEND.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(a)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Register</u><font style="font-size:11pt;">. The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice to each holder of Securities), a register for the Notes and Warrants in which the Company shall record the name and address of the Person in whose name the Notes and Warrants have been issued (including the name and address of each transferee), the principal amount of the Notes and Warrants held by such Person and the number of Conversion Shares issuable pursuant to the terms of the Notes and the number of Warrant Shares exercisable pursuant to the terms of the Warrants. The Company shall keep the register open and available at all times during business hours for inspection of any Buyer or its legal representatives.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(b)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transfer Agent Instructions</u><font style="font-size:11pt;">. The Company shall issue irrevocable instructions to its transfer agent and any subsequent transfer agent (as applicable, the &#8220;Transfer Agent&#8221;) in a form acceptable to each of the Buyers (the &#8220;Irrevocable Transfer Agent Instructions&#8221;) to issue certificates or credit shares to the applicable balance accounts at The Depository Trust Company (&#8220;DTC&#8221;), registered in the name of each Buyer or its respective nominee(s), for the Conversion Shares and Warrant Shares in such amounts as specified from time to time by each Buyer to the Company upon conversion of the Notes and exercise of</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">the Warrants. The Company represents and warrants that no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5(b), and stop transfer instructions to give effect to Section 2(g) hereof, will be given by the Company to its transfer agent with respect to the Securities, and that the Securities shall otherwise be freely transferable on the books and records of the Company, as applicable, to the extent provided in this Agreement and the other Transaction Documents. If a Buyer effects a sale, assignment or transfer of the Securities in accordance with Section 2(g), the Company shall permit the transfer and shall promptly instruct its transfer agent to issue one or more certificates or credit shares to the applicable balance accounts at DTC in such name and in such denominations as specified by such Buyer to effect such sale, transfer or assignment. In the event that such sale, assignment or transfer involves Conversion Shares or Warrant Shares sold, assigned or transferred pursuant to an effective registration statement or in compliance with Rule 144, the transfer agent shall issue such shares to such Buyer, assignee or transferee (as the case may be) without any restrictive legend in accordance with Section 5(d) below. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to a Buyer. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Section 5(b) will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Section 5(b), that a Buyer shall be entitled, in addition to all other available remedies, to an order and/or injunction restraining any breach and requiring immediate issuance and transfer, without the necessity of showing economic loss and without any bond or other security being required. The Company shall cause its counsel to issue the legal opinion referred to in the Irrevocable Transfer Agent Instructions to the Company&#8217;s transfer agent on each Effective Date (as defined in the Registration Rights Agreement). Any fees (with respect to the transfer agent, counsel to the Company or otherwise) associated with the issuance of such opinion or the removal of any legends on any of the Securities shall be borne by the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(c)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Legends</u><font style="font-size:11pt;">. Each Buyer understands that the Securities have been issued (or will be issued in the case of the Conversion Shares or Warrant Shares) pursuant to an exemption from registration or qualification under the 1933 Act and applicable state securities laws, and except as set forth below, the Securities shall bear any legend as required by the &#8220;blue sky&#8221; laws of any state and a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of such stock certificates):</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="font-size:11pt;">[NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN][THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(d)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Removal of Legends</u><font style="font-size:11pt;">. Certificates evidencing Securities shall not be required to contain the legend set forth in Section 5(c) above or any other legend (i) while a registration statement (including a Registration Statement) covering the resale of such Securities is effective under the 1933 Act, (ii) following</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">any sale of such Securities pursuant to Rule 144 (assuming the transferor is not an affiliate of the Company), (iii) if such Securities are eligible to be sold, assigned or transferred under Rule 144 (provided that a Buyer provides the Company with reasonable assurances that such Securities are eligible for sale, assignment or transfer under Rule 144 which shall not include an opinion of Buyer&#8217;s counsel), (iv) in connection with a sale, assignment or other transfer (other than under Rule 144), provided that such Buyer provides the Company with an opinion of counsel to such Buyer, in a generally acceptable form, to the effect that such sale, assignment or transfer of the Securities may be made without registration under the applicable requirements of the 1933 Act or (v) if such legend is not required under applicable requirements of the 1933 Act (including, without limitation, controlling judicial interpretations and pronouncements issued by the SEC). If a legend is not required pursuant to the foregoing, the Company shall no later than two (2) Trading Days (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a trade initiated on the date such Buyer delivers such legended certificate representing such Securities to the Company) following the delivery by a Buyer to the Company or the Transfer Agent (with notice to the Company) of a legended certificate representing such Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer, if applicable), together with any other deliveries from such Buyer as may be required above in this Section 5(d), as directed by such Buyer, either: (A) provided that the Company&#8217;s Transfer Agent is participating in the DTC Fast Automated Securities Transfer Program (&#8220;FAST&#8221;) and such Securities are Conversion Shares or Warrant Shares, credit the aggregate number of shares of Common Stock to which such Buyer shall be entitled to such Buyer&#8217;s or its designee&#8217;s balance account with DTC through its Deposit/Withdrawal at Custodian system or (B) if the Company&#8217;s Transfer Agent is not participating in FAST, issue and deliver (via reputable overnight courier) to such Buyer, a certificate representing such Securities that is free from all restrictive and other legends, registered in the name of such Buyer or its designee (the date by which such credit is so required to be made to the balance account of such Buyer&#8217;s or such Buyer&#8217;s designee with DTC or such certificate is required to be delivered to such Buyer pursuant to the foregoing is referred to herein as the &#8220;Required Delivery Date&#8221;, and the date such shares of Common Stock are actually delivered without restrictive legend to such Buyer or such Buyer&#8217;s designee with DTC, as applicable, the &#8220;Share Delivery Date&#8221;). The Company shall be responsible for any Transfer Agent fees or DTC fees with respect to any issuance of Securities or the removal of any legends with respect to any Securities in accordance herewith.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">6.</font></font><font style="font-size:11pt;">CONDITIONS TO THE COMPANY&#8217;S OBLIGATION TO SELL.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:11pt;">The obligation of the Company hereunder to issue and sell the Notes and Warrants to each Buyer at the Closing is subject to the satisfaction, at or before the Closing Date, of each of the following conditions, provided that these conditions are for the Company&#8217;s sole benefit and may be waived by the Company at any time in its sole discretion by providing each Buyer with prior written notice thereof:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><font style="font-size:11pt;">Such Buyer shall have executed each of the Transaction Documents to which it is a party and delivered the same to the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ii)</font></font><font style="font-size:11pt;">Such Buyer and each other Buyer shall have delivered to the Company the Purchase Price for the Note and Warrant being purchased by such Buyer at the Closing by wire transfer of immediately available funds.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iii)</font></font><font style="font-size:11pt;">The representations and warranties of such Buyer shall be true and correct in all material respects as of the date when made and as of the Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true and correct as of such specific date), and such Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Buyer at or prior to the Closing</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="font-size:11pt;">Date.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">7.</font></font><font style="font-size:11pt;">CONDITIONS TO EACH BUYER&#8217;S OBLIGATION TO PURCHASE.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:11pt;">The obligation of each Buyer hereunder to purchase its Note and Warrant at the Closing is subject to the satisfaction, at or before the Closing Date, of each of the following conditions, provided that these conditions are for each Buyer&#8217;s sole benefit and may be waived by such Buyer at any time in its sole discretion by providing the Company with prior written notice thereof:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><font style="font-size:11pt;">The Company shall have duly executed and delivered to such Buyer each of the Transaction Documents to which it is a party, and the Company shall have duly executed and delivered to such Buyer a Note in such original principal amount as is set forth across from such Buyer&#8217;s name in column (2) of the Schedule of Buyers as being purchased by such Buyer at the Closing pursuant to this Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ii)</font></font><font style="font-size:11pt;">The Company shall have duly executed and delivered to such Buyer each of the Transaction Documents to which it is a party, and the Company shall have duly executed and delivered to such Buyer a Warrant for such number of Warrant Shares as is set forth across from such Buyer&#8217;s name in column (3) of the Schedule of Buyers as being purchased by such Buyer at the Closing pursuant to this Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iii)</font></font><font style="font-size:11pt;">Such Buyer shall have received the opinion of Nelson Mullins, the Company&#8217;s counsel, dated as of the Closing Date, in the form acceptable to such Buyer.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iv)</font></font><font style="font-size:11pt;">The Company shall have delivered to such Buyer a certificate evidencing the formation and good standing of the Company in such entity&#8217;s jurisdiction of formation issued by the Secretary of State (or comparable office) of such jurisdiction of formation as of a date within ten (10) days of the Closing Date.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(v)</font></font><font style="font-size:11pt;">The Company shall have delivered to such Buyer a certified copy of the Certificate of Incorporation as certified by the Delaware Secretary of State within ten (10) days of the Closing Date.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(vi)</font></font><font style="font-size:11pt;">Each and every representation and warranty of the Company shall be true and correct as of the date when made and as of the Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true and correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects with the covenants, agreements and conditions required to be performed, satisfied or complied with by the Company at or prior to the Closing Date. Such Buyer shall have received a certificate, duly executed by the Chief Executive Officer of the Company, dated as of the Closing Date, to the foregoing effect and as to such other matters as may be reasonably requested by such Buyer in the form acceptable to such Buyer.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(vii)</font></font><font style="font-size:11pt;">The Company shall have delivered to such Buyer a letter from the Company&#8217;s Transfer Agent certifying the number of shares of Common Stock outstanding on the Closing Date immediately prior to the Closing.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(viii)</font></font><font style="font-size:11pt;">The Common Stock (A) shall be designated for quotation or listed (as applicable) on the Principal Market and (B) shall not have been suspended, as of the Closing Date, by the SEC or the Principal Market from trading on the Principal Market nor shall suspension by the SEC or the Principal Market have been threatened, as of the Closing Date, either (I) in writing by the SEC</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="font-size:11pt;">or the Principal Market or (II) by falling below the minimum maintenance requirements of the Principal Market.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ix)</font></font><font style="font-size:11pt;">The Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale of the Securities, including without limitation, those required by the Principal Market, if any.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(x)</font></font><font style="font-size:11pt;">No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(xi)</font></font><font style="font-size:11pt;">Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably would have or result in a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(xii)</font></font><font style="font-size:11pt;">Pursuant to an executed Business Combination Agreement (the &#8220;Business Combination Agreement&#8221;), the Company has consummated the merger of Data Knights Merger Sub, Inc., a Delaware corporation, a wholly-owned subsidiary of the Company, with and into OneMedNet Corporation, a Delaware corporation (&#8220;OneMedNet&#8221;), with OneMedNet continuing as the surviving corporation and wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">8.</font></font><font style="font-size:11pt;">TERMINATION.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">In the event that the Closing shall not have occurred with respect to a Buyer by October 1, 2023, then such Buyer shall have the right to terminate its obligations under this Agreement with respect to itself at any time on or after the close of business on such date without liability of such Buyer to any other party; provided, however, (i) the right to terminate this Agreement under this Section 8 shall not be available to such Buyer if the failure of the transactions contemplated by this Agreement to have been consummated by such date is the result of such Buyer&#8217;s breach of this Agreement and (ii) the abandonment of the sale and purchase of the Notes and Warrants shall be applicable only to such Buyer providing such written notice, provided further that no such termination shall affect any obligation of the Company under this Agreement to reimburse such Buyer for the expenses described in Section 4(g) above. Nothing contained in this Section 8 shall be deemed to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or the other Transaction Documents or to impair the right of any party to compel specific performance by any other party of its obligations under this Agreement or the other Transaction Documents.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">9.</font></font><font style="font-size:11pt;">MISCELLANEOUS.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(a)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law; Jurisdiction; Jury Trial</u><font style="font-size:11pt;">. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of Wilmington, Delaware, for the adjudication of any dispute hereunder or in connection herewith or under any of the other Transaction Documents or with any transaction contemplated hereby or thereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude any Buyer from bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company&#8217;s obligations to such Buyer or to enforce a judgment or other court ruling in favor of such Buyer. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(b)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts</u><font style="font-size:11pt;">. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(c)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Headings; Gender</u><font style="font-size:11pt;">. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms &#8220;including,&#8221; &#8220;includes,&#8221; &#8220;include&#8221; and words of like import shall be construed broadly as if followed by the words &#8220;without limitation.&#8221; The terms &#8220;herein,&#8221; &#8220;hereunder,&#8221; &#8220;hereof&#8221; and words of like import refer to this entire Agreement instead of just the provision in which they are found.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(d)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability; Maximum Payment Amounts</u><font style="font-size:11pt;">. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s). Notwithstanding anything to the contrary contained in this Agreement or any other Transaction Document (and without implication that the following is required or applicable), it is the intention of the parties that in no event shall amounts and value paid by the Company and/or any of its Subsidiaries (as the case may be), or payable to or received by any of the Buyers, under the Transaction Documents (including without limitation, any amounts that would be characterized as &#8220;interest&#8221; under applicable law) exceed amounts permitted under any applicable law. Accordingly, if any obligation to pay, payment made to any Buyer, or collection by any Buyer pursuant the Transaction Documents is finally judicially determined to be contrary to any such applicable law, such obligation to pay, payment or collection shall be deemed to have been made by mutual mistake of such Buyer, the Company and its Subsidiaries and such amount shall be deemed to have been adjusted with retroactive effect to the maximum amount or rate of interest, as the case may be, as would not be so prohibited by the applicable law. Such adjustment shall be effected, to the extent necessary, by reducing or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">refunding, at the option of such Buyer, the amount of interest or any other amounts which would constitute unlawful amounts required to be paid or actually paid to such Buyer under the Transaction Documents. For greater certainty, to the extent that any interest, charges, fees, expenses or other amounts required to be paid to or received by such Buyer under any of the Transaction Documents or related thereto are held to be within the meaning of &#8220;interest&#8221; or another applicable term to otherwise be violative of applicable law, such amounts shall be pro-rated over the period of time to which they relate.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(e)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Entire Agreement; Amendments</u><font style="font-size:11pt;">. This Agreement, the other Transaction Documents and the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein supersede all other prior oral or written agreements between the Buyers, the Company, its Subsidiaries, their affiliates and Persons acting on their behalf, including, without limitation, any transactions by any Buyer with respect to Common Stock or the Securities, and the other matters contained herein and therein, and this Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein contain the entire understanding of the parties solely with respect to the matters covered herein and therein; provided, however, nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect on any agreements any Buyer has entered into with, or any instruments any Buyer has received from, the Company or any of its Subsidiaries prior to the date hereof with respect to any prior investment made by such Buyer in the Company or (ii) waive, alter, modify or amend in any respect any obligations of the Company or any of its Subsidiaries, or any rights of or benefits to any Buyer or any other Person, in any agreement entered into prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Buyer, or any instruments any Buyer received from the Company and/or any of its Subsidiaries prior to the date hereof, and all such agreements and instruments shall continue in full force and effect. Except as specifically set forth herein or therein, neither the Company nor any Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party. No consideration (other than reimbursement of reasonable legal fees) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration also is offered to all of the parties to the Transaction Documents, all holders of the Notes and Warrants. Without limiting the foregoing, the Company confirms that, except as set forth in this Agreement, no Buyer has made any commitment or promise or has any other obligation to provide any financing to the Company, any Subsidiary or otherwise.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(f)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</u><font style="font-size:11pt;">. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party does not receive an automatically generated message from the recipient&#8217;s email server that such e-mail could not be delivered to such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:76.01%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">If to the Company:</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Data Knights Acquisition Corp</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Unit G6, Frome Business Park</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Manor Road Frome</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">United Kingdom, BA11 4FN</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Telephone: 011-44 203 833 4000</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;white-space:pre-wrap;">Attention:  Barry Anderson</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Email: barryanderson8@gmail.com</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">28</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td colspan="2" style="vertical-align:top;width:9.17%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:66.84%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:76.01%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">With a copy (for informational purposes only) to:</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Nelson Mullins Riley&#160;&amp; Scarborough LLP</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">101 Constitution Avenue, NW, Suite 900</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Washington, DC 20001</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Telephone: (202) 689-2987</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;white-space:pre-wrap;">Attention:  Andy Tucker</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Email: andy.tucker@nelsonmullins.com</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:76.01%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:76.01%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td colspan="3" style="vertical-align:top;width:76.01%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">If to OneMedNet Corporation:</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">OneMedNet Corporation</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">6385 Old Shady Oak Road, Suite 250</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Eden Prairie, Minnesota 55344</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Telephone: (808) 228-5998</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Attention: Paul Casey</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">E-Mail: paul.casey@onemednet.com</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td colspan="3" style="vertical-align:top;width:76.01%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">With a copy (for informational purposes only) to:</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Rimon PC</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">1990 K. Street, NW, Suite 420</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Washington DC 20006</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Telephone: 202-935-3390</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Attention: Debbie A. Klis</font></p></td></tr><tr><td style="vertical-align:top;width:23.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:8.51%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:67.5%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">E-Mail: debbie.klis@rimonlaw.com</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">If to a Buyer, to its mailing address and e-mail address set forth on the Schedule of Buyers, with copies to such Buyer&#8217;s representatives as set forth on the Schedule of Buyers, or to such other mailing address and/or e-mail address and/or to the attention of such other Person as the recipient party has specified by written notice given. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender&#8217;s e-mail containing the time, date and recipient&#8217;s e-mail or (C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by e-mail or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(g)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Successors and Assigns</u><font style="font-size:11pt;">. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns, including any purchasers of any of the Notes and Warrants. A Buyer may assign some or all of its rights hereunder in connection with any transfer of any of its Securities without the consent of the Company, in which event such assignee shall be deemed to be a Buyer hereunder with respect to such assigned rights.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(h)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Third Party Beneficiaries</u><font style="font-size:11pt;">. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than the Indemnitees referred to herein.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Survival</u><font style="font-size:11pt;">. The representations, warranties, agreements and covenants shall survive the Closings. Each Buyer shall be responsible only for its own representations, warranties, agreements and covenants hereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(j)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Further Assurances</u><font style="font-size:11pt;">. Each party shall do and perform, or cause to be done and performed,</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">29</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(k)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnification</u><font style="font-size:11pt;">. In consideration of each Buyer&#8217;s execution and delivery of the Transaction Documents and acquiring the Securities thereunder and in addition to all of the Company&#8217;s other obligations under the Transaction Documents, the Company shall defend, protect, indemnify and hold harmless each Buyer and each holder of any Securities and all of their stockholders, partners, members, officers, directors, employees and direct or indirect investors and any of the foregoing Persons&#8217; agents or other representatives (including, without limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the &#8220;Indemnitees&#8221;) from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable attorneys&#8217; fees and disbursements (the &#8220;Indemnified Liabilities&#8221;), incurred by any Indemnitee as a result of, or arising out of, or relating to (i) any misrepresentation or breach of any representation or warranty made by the Company or any Subsidiary in any of the Transaction Documents, (ii) any breach of any covenant, agreement or obligation of the Company or any Subsidiary contained in any of the Transaction Documents or (iii) any cause of action, suit, proceeding or claim brought or made against such Indemnitee by a third party (including for these purposes a derivative action brought on behalf of the Company or any Subsidiary) or which otherwise involves such Indemnitee that arises out of or results from (A) the execution, delivery, performance or enforcement of any of the Transaction Documents, (B) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities, (C) any disclosure properly made by such Buyer, or (D) the status of such Buyer or holder of the Securities either as an investor in the Company pursuant to the transactions contemplated by the Transaction Documents or as a party to this Agreement (including, without limitation, as a party in interest or otherwise in any action or proceeding for injunctive or other equitable relief). To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law. Except as otherwise set forth herein, the mechanics and procedures with respect to the rights and obligations under this Section 9(k) shall be the same as those set forth in Section 6 of the Registration Rights Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(l)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Construction</u><font style="font-size:11pt;">. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. No specific representation or warranty shall limit the generality or applicability of a more general representation or warranty. Each and every reference to share prices, shares of Common Stock and any other numbers in this Agreement that relate to the Common Stock shall be automatically adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions that occur with respect to the Common Stock after the date of this Agreement. Notwithstanding anything in this Agreement to the contrary, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty against, or a prohibition of, any actions with respect to the borrowing of, arrangement to borrow, identification of the availability of, and/or securing of, securities of the Company in order for such Buyer (or its broker or other financial representative) to effect short sales or similar transactions in the future.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(m)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Remedies</u><font style="font-size:11pt;">. Each Buyer and in the event of assignment by Buyer of its rights and obligations hereunder, each holder of Securities, shall have all rights and remedies set forth in the Transaction Documents and all rights and remedies which such holders have been granted at any time under any other agreement or contract and all of the rights which such holders have under any law. Any Person having any rights under any provision of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security), to recover damages by reason of any breach of any provision of this</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">30</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">Agreement and to exercise all other rights granted by law. Furthermore, the Company recognizes that in the event that it or any Subsidiary fails to perform, observe, or discharge any or all of its or such Subsidiary&#8217;s (as the case may be) obligations under the Transaction Documents, any remedy at law would inadequate relief to the Buyers. The Company therefore agrees that the Buyers shall be entitled to specific performance and/or temporary, preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and without posting a bond or other security. The remedies provided in this Agreement and the other Transaction Documents shall be cumulative and in addition to all other remedies available under this Agreement and the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(n)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Withdrawal Right</u><font style="font-size:11pt;">. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction Documents, whenever any Buyer exercises a right, election, demand or option under a Transaction Document and the Company or any Subsidiary does not timely perform its related obligations within the periods therein provided, then such Buyer may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company or such Subsidiary (as the case may be), any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:40.5pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:31.5pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(o)</font></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Independent Nature of Buyers&#8217; Obligations and Rights</u><font style="font-size:11pt;">. The obligations of each Buyer under the Transaction Documents are several and not joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance of the obligations of any other Buyer under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company acknowledges that the Buyers do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Buyers are in any way acting in concert or as a group or entity, and the Company shall not assert any such claim with respect to such obligations or the transactions contemplated by the Transaction Documents or any matters, and the Company acknowledges that the Buyers are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Buyer acknowledges that no other Buyer has acted as agent for such Buyer in connection with such Buyer making its investment hereunder and that no other Buyer will be acting as agent of such Buyer in connection with monitoring such Buyer&#8217;s investment in the Securities or enforcing its rights under the Transaction Documents. The Company and each Buyer confirms that each Buyer has independently participated with the Company and its Subsidiaries in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Buyer shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary for any other Buyer to be joined as an additional party in any proceeding for such purpose. The use of a single agreement to effectuate the purchase and sale of the Securities contemplated hereby was solely in the control of the Company, not the action or decision of any Buyer, and was done solely for the convenience of the Company and its Subsidiaries and not because it was required or requested to do so by any Buyer. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company, each Subsidiary and a Buyer, solely, and not between the Company, its Subsidiaries and the Buyers collectively and not between and among the Buyers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">[</font><i style="font-size:11pt;font-style:italic;">signature pages follow</i><font style="font-size:11pt;">]</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">31</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:44.74%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:50.26%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">COMPANY:</font></p></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:50.26%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;white-space:pre-wrap;">DATA KNIGHTS ACQUISITION  CORP</font></p></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:50.26%;margin:0pt;padding:0.25pt;"></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">By:</font></p></td><td style="vertical-align:top;width:44.74%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Name:</font></p></td><td style="vertical-align:top;width:44.74%;border-top:1px solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Barry Anderson</font></p></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Title:</font></p></td><td style="vertical-align:top;width:44.74%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Chief Executive Officer</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:50.26%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">BUYER:</font></p></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">By:</font></p></td><td style="vertical-align:top;width:44.74%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Name:</font></p></td><td style="vertical-align:top;width:44.74%;border-top:1px solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Thomas Kosasa</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:44.74%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:middle;width:49.73%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:50.26%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">BUYER:</font></p></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">By:</font></p></td><td style="vertical-align:top;width:44.74%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Name:</font></p></td><td style="vertical-align:top;width:44.74%;border-top:1px solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Dr. </font><font style="font-size:11pt;">Jeffrey Yu</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:50.26%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">BUYER:</font></p></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">By:</font></p></td><td style="vertical-align:top;width:44.74%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Name:</font></p></td><td style="vertical-align:top;width:44.74%;border-top:1px solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Aaron Green</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:44.74%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:middle;width:49.73%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:top;width:50.26%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">BUYER:</font></p></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">By:</font></p></td><td style="vertical-align:top;width:44.74%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.75pt 0.25pt;"></td></tr><tr><td style="vertical-align:top;width:49.73%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:5.52%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Name:</font></p></td><td style="vertical-align:top;width:44.74%;border-top:1px solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Steve Kester</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Schedule of Buyers</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Closing</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#ff0000;font-size:30pt;">Omitted</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Exhibit A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Note</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-size:11pt;font-style:italic;">(Attached)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Exhibit B</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Warrant</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-size:11pt;font-style:italic;">(Attached)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Exhibit C</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Registration Rights Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-size:11pt;font-style:italic;">(Attached)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Exhibit D</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Security Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-size:11pt;font-style:italic;">(Attached)</i></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>7
<FILENAME>dkdcu-20230331xex10d21.htm
<DESCRIPTION>EXHIBIT 10.21
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:39 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Exhibit 10.21</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">PROMISSORY NOTE</b></p><div style="margin-left:0pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">$500,000</font></p></td><td style="vertical-align:top;width:16.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">June 30, 2023</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">FOR VALUE RECEIVED, Data Knights Acquisition Corp., a Delaware corporation, (herein called the &#8220;Company&#8221;), hereby promises to pay to EF Hutton, division of Benchmark Investments, LLC (herein called the &#8220;Holder&#8221;), the principal sum of five hundred thousand dollars ($500,000). &#160;In the case of an event of default, this note shall bear interest at a rate of 12.5% per annum until such event of default is cured. &#160;The principal amount of this Note and any accrued interest shall be payable (the &#8220;Maturity Date&#8221;) as follows: (i) $83,333.33 on each of October 1, 2023, November 1, 2023, December 1, 2023, January 1, 2023; and (ii) $83,333.34 on each of February 1, 2024, and March 1, 2024.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">Payments hereunder shall be made at such place as the holder hereof shall designate to the undersigned, in writing, in lawful money of the United States of America. &#160;Any payment which becomes due on a Saturday, Sunday or legal holiday shall be payable on the next business day.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">This Note shall, (i) upon declaration by the Holder or (ii) automatically upon acceleration pursuant to clause (b) below, become immediately due and payable upon the occurrence of any of the following specified events of default:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:11pt;">If the Company shall default in any of the due and punctual payments of the principal amount of this Note when and as the same shall become due and payable, whether at maturity or by acceleration; or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:11pt;">If the Company shall commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of it or any substantial part of its property, or shall consent to any such relief or to the appointment of or taking of possession by any such official in an involuntary case or other proceeding commenced against it, or shall make a general assignment for the benefit of creditors, or shall take any corporate action to authorize any of the foregoing; or an involuntary case or other proceeding shall be commenced against the Company seeking liquidation, reorganization or other relief with respect to it or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of it or any substantial part of its property, and such involuntary case or other proceeding shall remain undismissed or unstayed for a period of 60 consecutive days.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">Declaration of this Note being immediately due and payable by the Holder may only be made by written notice to the Company declaring the unpaid balance of the principal amount of this Note to be due. &#160;The Company agrees that a declaration of default via email from the Holder to the undersigned at __________@________.com, with a copy to ______@_____.com, is acceptable written notice. &#160;Such declaration shall be deemed given upon the occurrence of any event specified in clause (b) above. &#160;In the event of a default, all expenses and costs incurred by Holder in connection with enforcement of the Note and collection of any judgment on the Note, including reasonable attorneys&#8217; fees, shall be paid by the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">This Note may be prepaid by the Company in whole or in part at any time or from time to time without penalty or premium. &#160;The obligations of the Company and the Holder set forth herein shall be</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">binding upon the successors and assigns of each such party, whether or not such successors or assigns are permitted by the terms hereof.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">The Company for itself and its successors and assigns hereby waives presentment, demand, notice, protest and all other demands and notices in connection with the delivery, acceptance, performance or endorsement of this Note, and agrees that this Note shall be deemed to have been made under, and shall be interpreted and governed by reference to, the laws of the State of New York. &#160;The Company for itself and its successors hereby expressly and irrevocably agrees that any suit or proceeding arising directly and/or indirectly pursuant to or under this Promissory Note shall be brought solely in a federal or state court located in the City, County and State of New York. &#160;By its execution hereof, the parties hereto covenant and irrevocably submit to the in personam jurisdiction of the federal and state courts located in the City, County and State of New York and agree that any process in any such action may be served upon any of them personally or by certified mail or registered mail upon them or their agent, return receipt requested, with the same full force and effect as if personally served upon them in New York, New York. &#160;The Company for itself and its successors expressly and irrevocably waive any claim or defense that any such jurisdiction in New York, New York is not a convenient forum for any such suit or proceeding.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">Except as expressly agreed in writing by the Holder, no extension of time for payment of this Note, or any installment hereof, and no alteration, amendment or waiver of any provision of this Note shall release, discharge, modify, change or affect the liability of the Company under this Note.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">All of the covenants, stipulations, promises and agreements made by or contained in this Note on behalf of the undersigned shall bind its successors, whether so expressed or not.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">No failure on the part of the Holder to exercise, and no delay in exercising, any right under this Note shall operate as a waiver thereof, nor shall any single or partial exercise of such rights preclude any other or further exercise thereof or the exercise of any other right.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">THE COMPANY ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL TRANSACTION, AND TO THE EXTENT ALLOWED BY APPLICABLE LAW, HEREBY WAIVES ITS RIGHT TO NOTICE AND HEARING WITH RESPECT TO ANY PREJUDGMENT REMEDY WHICH THE HOLDER OR ITS SUCCESSORS OR ASSIGNS MAY DESIRE TO USE.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">It is the intention of the Company and the Holder that all payments due hereunder will be treated for accounting and tax purposes as indebtedness of the Company to the Holder. &#160;Each of the Company and the Holder agrees to report such payments due hereunder for the purposes of all taxes in a manner consistent with such intended characterization.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">If any term or provision of this Note shall be held invalid, illegal or unenforceable, the validity of all other terms and provisions herein shall in no way be affected thereby.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-size:11pt;font-style:italic;">[signature page of Note follows]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;">IN WITNESS WHEREOF, the Company has caused this Note to be signed in its corporate name by a duly authorized officer as of the date hereinabove set forth.</font></p><div style="margin-left:0pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Data Knights Acquisition Corp.</b></p></td></tr><tr><td style="vertical-align:top;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">By:</font></p></td><td style="vertical-align:top;width:44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Name:</font></p></td><td style="vertical-align:top;width:44%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Title: </font></p></td><td style="vertical-align:top;width:44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Chief Executive Officer</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>8
<FILENAME>dkdcu-20230331xex10d22.htm
<DESCRIPTION>EXHIBIT 10.22
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:40 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="color:#262626;font-size:12pt;font-weight:bold;">Exhibit 10.22</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#262626;font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#262626;font-size:12pt;font-weight:bold;">SATISFACTION AND DISCHARGE OF INDEBTEDNESS PURSUANT TO UNDERWRITING AGREEMENT DATED MAY 6, 2021</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#262626;font-size:12pt;font-weight:bold;">JUNE </b><b style="color:#262626;font-size:12pt;font-weight:bold;">28, 2023</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#262626;font-size:12pt;">This Satisfaction and Discharge of Indebtedness (the &#8220;Satisfaction and Discharge&#8221;) is made and entered into to be effective as of June 28, 2023, by and between Data Knights Acquisition Corp., </font><font style="font-size:12pt;">a Delaware corporation </font><font style="color:#262626;font-size:12pt;">(the &#8220;Company&#8221;), OneMedNet Corporation, a Delaware Corporation, and EF Hutton, division of Benchmark Investments, LLC (&#8220;EF Hutton&#8221;) (f/k/a Kingswood Capital Markets, division of Benchmark Investments, Inc.). &#160;Capitalized terms used but not defined herein shall have the meanings assigned to them in the Underwriting Agreement (as defined below).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><u style="color:#262626;font-size:12pt;text-decoration-color:#262626;text-decoration-line:underline;text-decoration-style:solid;">RECITALS</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#262626;font-size:12pt;">WHEREAS, the Company and EF Hutton are parties to an Underwriting Agreement dated May 6, 2021 (the &#8220;Underwriting Agreement&#8221;);</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#262626;font-size:12pt;">WHEREAS, the Sections 1.3 and 3.16 of Underwriting Agreement provide the principal sum of $4,025,000 (the &#8220;Deferred Underwriting Commission&#8221;) shall be payable to EF Hutton upon the consummation of the Company&#8217;s initial business combination, and the Company agreed that it will cause the Trustee to pay the Deferred Underwriting Commission directly from the Trust Account to EF Hutton.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#262626;font-size:12pt;">WHEREAS, on April 25, 2022, the Company and OneMedNet Corporation (&#8220;OneMedNet&#8221;) announced that they signed a definitive business combination agreement that will result at the closing of the business combination in the Company changing its name to OneMedNet Corporation (the &#8220;Business Combination&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#262626;font-size:12pt;">WHEREAS, the Business Combination is scheduled to close on or about July __, 2023, at which time, the Deferred Underwriting Commission to EF Hutton would be immediately due and payable.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><font style="color:#262626;font-size:12pt;">WHEREAS, the Company and OneMedNet have requested of EF Hutton that in lieu of the Company tendering the full amount of the Deferred Underwriting Commission ($4,025,000) in cash, EF Hutton accept cash and ordinary shares of the Company as satisfaction of the Deferred Underwriting Commission.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><font style="color:#262626;font-size:12pt;">WHEREAS, in lieu of collecting the full amount of the Deferred Underwriting Commission in cash at the time of the closing of the Business Combination, EF Hutton&#160;hereby agrees to&#160;accept&#160;as full&#160;satisfaction of&#160;the Deferred Underwriting Commission,&#160;the specific allocated payments of (1) $500,000 in cash at the time of the closing of the Business Combination; (2) a $500,000 promissory note executed by the Company in which it is obligated to pay EF Hutton $83,333.33 in cash on October 1, 2023, November 1, 2023, December 1, 2023; January 1, 2024, February 1, 2024 and March 1, 2024 and (3) 277,778 of newly issued ordinary shares of the Company (the &#8220;Ordinary Shares&#8221;), which when multiplied by the Market Share Price (as defined below) as of the date of this Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">1</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><font style="color:#262626;font-size:12pt;">equals the &#8220;Original Aggregate Share Value&#8221;, shall be issued and delivered to EF Hutton upon execution of this Agreement (the &#8220;Effective Date&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#262626;font-size:12pt;">For clarity, this Agreement is not&#160;intended&#160;to, and shall not serve to,&#160;affect, modify or amend the Underwriting Agreement and the Deferred Underwriting Commission unless or until&#160;the amounts specified in subsection (a) and (b) below are&#160;timely&#160;paid in full.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#262626;font-size:12pt;">ARTICLE I</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><u style="color:#262626;font-size:12pt;text-decoration-color:#262626;text-decoration-line:underline;text-decoration-style:solid;">CONDITIONS TO SATISFACTION AND DISCHARGE</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">1.1</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">EF Hutton shall only acknowledge the satisfaction and discharge of the Deferred Underwriting Commission and will only acknowledge that the Company&#8217;s obligations to pay in cash the Deferred Underwriting Commission under the Underwriting Agreement have been satisfied and discharged, if the below conditions occur:</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">A.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">On the closing date of the Business Combination, the Company wires $500,000 to the bank account of EF Hutton;</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 54pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">B.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">The Company satisfies the full amount of the $500,000 promissory note due EF Hutton; and</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 54pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">C.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">The Company transfers to EF Hutton (or its designees) 277,778 Ordinary Shares, which is equal to the Original Aggregate Share Value as of the Effective Date.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">1.2</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">After the conditions above are satisfied, EF Hutton shall acknowledge the satisfaction and discharge of the Deferred Underwriting Commission, except (i) with respect to those obligations that the Promissory Note provides shall survive the satisfaction and discharge thereof; and (ii) with respect to Article II below.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#262626;font-size:12pt;">ARTICLE II</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><u style="color:#262626;font-size:12pt;text-decoration-color:#262626;text-decoration-line:underline;text-decoration-style:solid;">POST-SATISFACTION COMPANY COVENANTS</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">2.1</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">After EF Hutton has acknowledged the satisfaction and discharge of the Deferred Underwriting Compensation, the Company irrevocably covenants to perform the following after execution of this Agreement:</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">A.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#333333;font-size:12pt;">Within fifteen (15) days from Effective Date, the Company shall cause to be registered under the Securities Act all of the Ordinary Shares that EF Hutton has requested to be registered.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 90pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 72pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="color:#262626;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">i.</font></font><font style="color:#262626;font-size:12pt;">Furthermore, if the aggregate VWAP value of the 277,778 Ordinary Shares that EF Hutton holds as a result of this Satisfaction and Discharge, as of the Registration Confirmation Date is lower than the Original Aggregate Share Value (the difference between the VWAP value on any given date and the Original</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 72pt;"><font style="color:#262626;font-size:12pt;">Aggregate Share Value, the &#8220;Difference in Amount&#8221;), then the Company shall compensate EF Hutton either in cash or issuing additional Ordinary Shares at a new value of Ordinary Shares, the (&#8220;New Share Price&#8221;) in an amount equal to the Difference in Amount on the Registration Confirmation Date. If the Company decides to compensate EF Hutton for the Difference in Amount in issuing additional Ordinary Shares, then the New Share Price shall equal </font><font style="font-size:12pt;">an amount that is the lowest of the VWAP for a period of five (5) trading days immediately prior to the Registration Confirmation Date</font><font style="color:#262626;font-size:12pt;">. The Company will nevertheless proceed to register all or any of the Ordinary Shares EF Hutton has requested to be registered.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 90pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">B.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">Alternatively, if after six (6) months from the Effective Date (the &#8220;Six-month Period Date&#8221;), the Company has not registered any of EF Hutton&#8217;s Ordinary Shares on an effective Registration Statement, then the Company will confirm in writing that such Ordinary Shares are freely sellable under Rule 144. No later than the Six-month Period Date, the Company shall provide EF Hutton a valid legal opinion that its Ordinary Shares are eligible for resale pursuant to Rule 144.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 54pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 72pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="color:#262626;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">i.</font></font><font style="color:#262626;font-size:12pt;">Furthermore, if five (5) trading days prior to the Six-month Period Date, the aggregate VWAP value of the 277,778 Ordinary Shares that EF Hutton holds as a result of this Satisfaction and Discharge, is lower than the Original Aggregate Share Value, then the Company shall compensate EF Hutton either in cash or issuing additional Ordinary Shares at a New Share Price in an amount equal to the Difference in Amount on such date. If the Company decides to compensate EF Hutton for the Difference in Amount in issuing additional Ordinary Shares, then the New Share Price of such additional Ordinary Shares shall equal an amount that is the lowest of the VWAP for a period of five (5) trading days immediately prior to the five (5) trading days before the Six-month Period Date.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 72pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#262626;font-size:12pt;">ARTICLE II</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><u style="color:#262626;font-size:12pt;text-decoration-color:#262626;text-decoration-line:underline;text-decoration-style:solid;">MISCELLANEOUS PROVISIONS</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#262626;font-size:12pt;">3.1 This Satisfaction and Discharge shall be governed by and construed in accordance with the laws of the State of New York.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#262626;font-size:12pt;">3.2 This Satisfaction and Discharge may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all of which shall together constitute but one and the same instrument.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">3.3</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">The Company hereby acknowledges and agrees that EF Hutton shall be entitled to all of their rights, protections, indemnities and immunities in connection with their execution of this Satisfaction and Discharge and the performance of any obligations hereunder or in connection herewith.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="color:#262626;font-size:12pt;">3.4</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">For purposes of this Agreement, the following terms shall have the following meanings:</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;">&#8220;Market Price Per Share&#8221; or &#8220;Market Share Price&#8221; means the most recent previous close price of a single Ordinary Share of the Company as listed on the Principal Market.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;">&#8220;Principal Market&#8221; means the Nasdaq Global Market.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;">&#8220;VWAP&#8221; means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the Principal Market is not the principal trading market for such security, then on the principal securities exchange or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg through its &#8220;VAP&#8221; function (set to 09:30 start time and 16:00 end time) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such security on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="color:#262626;font-size:12pt;">IN WITNESS WHEREOF, EF Hutton and the Company have caused their corporate names to be hereunto affixed, and this instrument to be signed by their respective authorized officers, all as of the day and year first above written.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">EF HUTTON,</b></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DIVISION OF BENCHMARK INVESTMENTS, LLC</b></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:45.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Sam Fleischman</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: Supervisory Principal</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">DATA KNIGHTS ACQUISITION CORP.</b></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:45.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Barry Anderson</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: Chief Executive Officer</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">ONEMEDNET CORPORATION</b></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By: </p></td><td style="vertical-align:bottom;width:45.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: Chief Executive Officer</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>9
<FILENAME>dkdcu-20230331xex23d1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:39 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Exhibit 23.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&#8217;S CONSENT</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;">We consent to the inclusion in this Registration Statement of Data Knights Acquisition Corp. on Amendment No. 6 to Form S-4 of our report dated March 31, 2023, which includes an explanatory paragraph as to the Company&#8217;s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of Data Knights Acquisition Corp. as of December 31, 2022 and 2021 and for the year ended December 31, 2022 and for the period from February 8, 2021 (inception) through December 31, 2021, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading &#8220;Experts&#8221; in such Prospectus.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">/s/ Marcum LLP</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Marcum LLP</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Boston, MA</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">July 3, 2023</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>10
<FILENAME>dkdcu-20230331xex23d3.htm
<DESCRIPTION>EXHIBIT 23.3
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:54 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Exhibit 23.3</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We hereby consent to the incorporation in this Form S-4-A6 of our report dated March 23, 2023, relating to the financial statements of OneMedNet Corporation as of December 31, 2022 and to all references to our firm included in this registration statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.34pt 0pt;">/s/ BF Borgers CPA PC</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">BF Borgers CPA PC</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Certified Public Accountants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Lakewood, CO</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">June 30, 2023</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>11
<FILENAME>dkdcu-20230331xex23d4.htm
<DESCRIPTION>EXHIBIT 23.4
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/3/2023 10:18:55 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 23.4</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt 0pt 0.05pt 0pt;">Consent of Marshall &amp; Stevens Transaction Advisory Services LLC</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt 0pt 0.05pt 0pt;"><font style="white-space:pre-wrap;">We hereby consent to the quotation and summarization of our opinion letter to the board of directors of Data Knights Acquisition Corp. (the &#8220;Company&#8221;) in the proxy statement/prospectus contained in the Company&#8217;s registration statement on Form S-4 relating to the proposed acquisition of OneMedNet Corporation (the &#8220;Registration Statement&#8221;), as well as to the references to our firm and such opinion letter contained therein.  In giving this consent, we do not admit, and we understand that the Company not contend, that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we thereby admit that we are experts with respect to any part of such Registration Statement within the meaning of the term &#8220;experts&#8221; as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission.  It is understood that we will not be held out by the Company in the Registration Statement or in any other disclosure document, filing or communication as such an &#8220;expert.&#8221;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt 0pt 0.05pt 0pt;">/s/ Marshall &amp; Stevens Transaction Advisory Services LLC</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt 0pt 0.05pt 0pt;">New York, New York</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:0.5pt;text-indent:-0.5pt;margin:0pt 0pt 0.05pt 0pt;">June 13, 2023</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>dkdcu-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.3.0.9 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/3/2023 10:19:27 PM-->
<!--Modified on: 7/3/2023 10:19:27 PM-->
<xsd:schema xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:srt-roles="http://fasb.org/srt-roles/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xs="http://www.w3.org/2001/XMLSchema" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dataknightsacquisitioncorp.com/20230331" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dkdcu="http://www.dataknightsacquisitioncorp.com/20230331">
  <xsd:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets" id="StatementCondensedConsolidatedBalanceSheets">
        <link:definition>100100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" id="StatementCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>100400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>200100 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" id="StatementConsolidatedStatementsOfOperations">
        <link:definition>200200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>200400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails" id="DisclosureIncomeTaxIncomeTaxProvisionDetails">
        <link:definition>241001 - Disclosure - INCOME TAX - Income tax provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails" id="DisclosureIncomeTaxesFederalIncomeTaxRateDetails">
        <link:definition>241003 - Disclosure - INCOME TAXES - Federal income tax rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>100090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" id="StatementCondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>100105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations" id="StatementCondensedConsolidatedStatementsOfOperations">
        <link:definition>100200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit" id="StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit">
        <link:definition>100300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" id="DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails">
        <link:definition>140101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesDetails">
        <link:definition>140201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails">
        <link:definition>140202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails">
        <link:definition>140203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" id="DisclosureInitialPublicOfferingDetails">
        <link:definition>140301 - Disclosure - INITIAL PUBLIC OFFERING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" id="DisclosurePrivatePlacementDetails">
        <link:definition>140401 - Disclosure - PRIVATE PLACEMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" id="DisclosureRelatedPartyTransactionsFounderSharesDetails">
        <link:definition>140501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" id="DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>140502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails" id="DisclosureCommitmentsAndContingenciesDetails">
        <link:definition>140601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails" id="DisclosureWarrantLiabilityDetails">
        <link:definition>140701 - Disclosure - WARRANT LIABILITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails" id="DisclosureStockholderSEquityCommonStockDetails">
        <link:definition>140802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" id="DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>140901 - Disclosure - FAIR VALUE MEASUREMENTS - Assets and derivative warrant liabilities measured at fair value on recurring basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails" id="DisclosureFairValueMeasurementsDetails">
        <link:definition>140902 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" id="DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails">
        <link:definition>140903 - Disclosure - FAIR VALUE MEASUREMENTS - Quantitative information regarding Level 3 fair value measurements inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" id="DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails">
        <link:definition>140904 - Disclosure - FAIR VALUE MEASUREMENTS - Change in fair value of derivative warrant liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" id="DisclosureSubsequentEventsDetails">
        <link:definition>141001 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" id="StatementConsolidatedBalanceSheetParenthetical">
        <link:definition>200105 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" id="StatementConsolidatedStatementsOfChangesInStockholdersDeficit">
        <link:definition>200300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss" id="DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss">
        <link:definition>240101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss" id="DisclosureSummaryOfSignificantAccountingPoliciesDetailss">
        <link:definition>240201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss" id="DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss">
        <link:definition>240202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss" id="DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss">
        <link:definition>240203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss" id="DisclosureInitialPublicOfferingDetailss">
        <link:definition>240301 - Disclosure - INITIAL PUBLIC OFFERING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss" id="DisclosurePrivatePlacementDetailss">
        <link:definition>240401 - Disclosure - PRIVATE PLACEMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss" id="DisclosureRelatedPartyTransactionsFounderSharesDetailss">
        <link:definition>240501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss" id="DisclosureRelatedPartyTransactionsAdditionalInformationDetailss">
        <link:definition>240502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss" id="DisclosureCommitmentsAndContingenciesDetailss">
        <link:definition>240601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss" id="DisclosureWarrantLiabilityDetailss">
        <link:definition>240701 - Disclosure - WARRANT LIABILITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails" id="DisclosureStockholderSEquityCommonStockSharesDetails">
        <link:definition>240802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss" id="DisclosureFairValueMeasurementsDetailss">
        <link:definition>240901 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" id="DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails">
        <link:definition>240902 - Disclosure - FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" id="DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails">
        <link:definition>240903 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails" id="DisclosureIncomeTaxesNetDeferredTaxAssetsDetails">
        <link:definition>241002 - Disclosure - INCOME TAXES - Net deferred tax assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss" id="DisclosureSubsequentEventsDetailss">
        <link:definition>241101 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations" id="DisclosureDescriptionOfOrganizationAndBusinessOperations">
        <link:definition>110101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies" id="DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>110201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOffering" id="DisclosureInitialPublicOffering">
        <link:definition>110301 - Disclosure - INITIAL PUBLIC OFFERING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacement" id="DisclosurePrivatePlacement">
        <link:definition>110401 - Disclosure - PRIVATE PLACEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactions" id="DisclosureRelatedPartyTransactions">
        <link:definition>110501 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>110601 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiability" id="DisclosureWarrantLiability">
        <link:definition>110701 - Disclosure - WARRANT LIABILITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquity" id="DisclosureStockholderSEquity">
        <link:definition>110801 - Disclosure - STOCKHOLDER'S EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>110901 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>111001 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>120202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>130203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>130903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredSharesDetails" id="DisclosureStockholderSEquityPreferredSharesDetails">
        <link:definition>140801 - Disclosure - STOCKHOLDER'S EQUITY - Preferred Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationss" id="DisclosureDescriptionOfOrganizationAndBusinessOperationss">
        <link:definition>210101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciess" id="DisclosureSummaryOfSignificantAccountingPoliciess">
        <link:definition>210201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferings" id="DisclosureInitialPublicOfferings">
        <link:definition>210301 - Disclosure - INITIAL PUBLIC OFFERING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacements" id="DisclosurePrivatePlacements">
        <link:definition>210401 - Disclosure - PRIVATE PLACEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionss" id="DisclosureRelatedPartyTransactionss">
        <link:definition>210501 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciess" id="DisclosureCommitmentsAndContingenciess">
        <link:definition>210601 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilitys" id="DisclosureWarrantLiabilitys">
        <link:definition>210701 - Disclosure - WARRANT LIABILITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquitys" id="DisclosureStockholderSEquitys">
        <link:definition>210801 - Disclosure - STOCKHOLDER'S EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementss" id="DisclosureFairValueMeasurementss">
        <link:definition>210901 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>211001 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventss" id="DisclosureSubsequentEventss">
        <link:definition>211101 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess" id="DisclosureSummaryOfSignificantAccountingPoliciesPoliciess">
        <link:definition>220202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTabless" id="DisclosureSummaryOfSignificantAccountingPoliciesTabless">
        <link:definition>230203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTabless" id="DisclosureFairValueMeasurementsTabless">
        <link:definition>230903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>231003 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredStockSharesDetails" id="DisclosureStockholderSEquityPreferredStockSharesDetails">
        <link:definition>240801 - Disclosure - STOCKHOLDER'S EQUITY - Preferred Stock Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails" id="DisclosureIncomeTaxesDetails">
        <link:definition>241004 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="dkdcu-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="dkdcu-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="dkdcu-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="dkdcu-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xbrli:periodType="duration" name="UnitsIssuedDuringPeriodSharesNewIssues" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_SaleOfStockUnderwritingFees" xbrli:periodType="instant" xbrli:balance="credit" name="SaleOfStockUnderwritingFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_SaleOfStockOtherOfferingCosts" xbrli:periodType="instant" xbrli:balance="credit" name="SaleOfStockOtherOfferingCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" xbrli:periodType="duration" name="ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" xbrli:periodType="duration" name="ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_InitialPublicOfferingAbstract" xbrli:periodType="duration" abstract="true" name="InitialPublicOfferingAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element id="dkdcu_NumberOfSharesIssuedPerUnit" xbrli:periodType="duration" name="NumberOfSharesIssuedPerUnit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_NumberOfWarrantsIssuedPerUnit" xbrli:periodType="duration" name="NumberOfWarrantsIssuedPerUnit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_PrivatePlacementAbstract" xbrli:periodType="duration" abstract="true" name="PrivatePlacementAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element id="dkdcu_PrivatePlacementTextBlock" xbrli:periodType="duration" name="PrivatePlacementTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" />
  <xsd:element id="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xbrli:periodType="instant" name="ClassOfWarrantOrRightPriceOfWarrantsOrRights" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" />
  <xsd:element id="dkdcu_SponsorMember" xbrli:periodType="duration" abstract="true" name="SponsorMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xbrli:periodType="duration" name="PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xbrli:periodType="duration" name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" />
  <xsd:element id="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xbrli:periodType="duration" name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element id="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xbrli:periodType="duration" name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element id="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xbrli:periodType="duration" name="ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_PromissoryNoteWithRelatedPartyMember" xbrli:periodType="duration" abstract="true" name="PromissoryNoteWithRelatedPartyMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_RelatedPartyLoansMember" xbrli:periodType="duration" abstract="true" name="RelatedPartyLoansMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xbrli:periodType="duration" xbrli:balance="debit" name="RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_CommonStockNumberOfVotesPerShare" xbrli:periodType="instant" name="CommonStockNumberOfVotesPerShare" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element id="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xbrli:periodType="duration" abstract="true" name="RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xbrli:periodType="duration" abstract="true" name="RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xbrli:periodType="duration" name="ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" />
  <xsd:element id="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xbrli:periodType="duration" name="ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xbrli:periodType="duration" name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xbrli:periodType="duration" name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xbrli:periodType="instant" xbrli:balance="credit" name="MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_TransactionCosts" xbrli:periodType="instant" xbrli:balance="credit" name="TransactionCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" xbrli:periodType="instant" name="MaximumNumberOfDemandsForRegistrationOfSecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element id="dkdcu_AdministrativeSupportAgreementMember" xbrli:periodType="duration" abstract="true" name="AdministrativeSupportAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_AggregateNumberOfSharesOwned" xbrli:periodType="instant" name="AggregateNumberOfSharesOwned" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock" xbrli:periodType="duration" name="AssetsHeldInTrustAccountPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" />
  <xsd:element id="dkdcu_TemporaryEquityPolicyPolicyTextBlock" xbrli:periodType="duration" name="TemporaryEquityPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" />
  <xsd:element id="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xbrli:periodType="duration" xbrli:balance="credit" name="PaymentsForInvestmentOfCashInTrustAccount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_NetProceedsFromInitialPublicOffering" xbrli:periodType="duration" xbrli:balance="debit" name="NetProceedsFromInitialPublicOffering" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_DeferredUnderwritingFeePayable" xbrli:periodType="duration" xbrli:balance="credit" name="DeferredUnderwritingFeePayable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_CommonStockSubjectToPossibleRedemptionValue" xbrli:periodType="duration" xbrli:balance="debit" name="CommonStockSubjectToPossibleRedemptionValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_CommonStockSubjectToPossibleRedemptionShares" xbrli:periodType="duration" name="CommonStockSubjectToPossibleRedemptionShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_PublicWarrantsMember" xbrli:periodType="duration" abstract="true" name="PublicWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_PrivatePlacementWarrantsMember" xbrli:periodType="duration" abstract="true" name="PrivatePlacementWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xbrli:periodType="duration" name="ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element id="dkdcu_CommonClassaSubjectToRedemptionMember" xbrli:periodType="duration" abstract="true" name="CommonClassaSubjectToRedemptionMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_CommonClassaNotSubjectToRedemptionMember" xbrli:periodType="duration" abstract="true" name="CommonClassaNotSubjectToRedemptionMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_IncreaseDecreaseFranchiseTaxPayable" xbrli:periodType="duration" xbrli:balance="debit" name="IncreaseDecreaseFranchiseTaxPayable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_WorkingCapitalLoansWarrantMember" xbrli:periodType="duration" abstract="true" name="WorkingCapitalLoansWarrantMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xbrli:periodType="instant" xbrli:balance="debit" name="ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xbrli:periodType="duration" name="RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_FranchiseTaxExpense" xbrli:periodType="duration" xbrli:balance="debit" name="FranchiseTaxExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_InitialFairValueOfWarrantLiabilities" xbrli:periodType="duration" xbrli:balance="debit" name="InitialFairValueOfWarrantLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" xbrli:periodType="duration" abstract="true" name="MeasurementInputProbabilityOfCompletingBusinessCombinationMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xbrli:periodType="instant" xbrli:balance="credit" name="AccruedLiabilitiesExcludingOfferingCostsCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ProceedsFromSaleOfUnits" xbrli:periodType="duration" xbrli:balance="debit" name="ProceedsFromSaleOfUnits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_NumberOfWarrantsIssued" xbrli:periodType="duration" name="NumberOfWarrantsIssued" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" xbrli:periodType="instant" name="Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_WarrantLiabilityAbstract" xbrli:periodType="duration" abstract="true" name="WarrantLiabilityAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element id="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" xbrli:periodType="duration" name="Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" xbrli:periodType="duration" name="Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_FounderSharesMember" xbrli:periodType="duration" abstract="true" name="FounderSharesMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_TwoIndependentDirectorMember" xbrli:periodType="duration" abstract="true" name="TwoIndependentDirectorMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_ThirdIndependentDirectorMember" xbrli:periodType="duration" abstract="true" name="ThirdIndependentDirectorMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_IndependentDirectorsMember" xbrli:periodType="duration" abstract="true" name="IndependentDirectorsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_PlacementWarrantsMember" xbrli:periodType="duration" abstract="true" name="PlacementWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_WarrantsOrRightsIssued" xbrli:periodType="duration" name="WarrantsOrRightsIssued" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_WorkingCapitalDeficit" xbrli:periodType="instant" xbrli:balance="credit" name="WorkingCapitalDeficit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_DeferredOfferingCostsNonCurrent" xbrli:periodType="instant" xbrli:balance="credit" name="DeferredOfferingCostsNonCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_MaximumNetInterestToPayDissolutionExpenses" xbrli:periodType="duration" xbrli:balance="credit" name="MaximumNetInterestToPayDissolutionExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_MaximumLoansConvertibleUptoConsummation" xbrli:periodType="duration" xbrli:balance="debit" name="MaximumLoansConvertibleUptoConsummation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_SecuritiesDepositHeldInTrustAccount" xbrli:periodType="duration" xbrli:balance="debit" name="SecuritiesDepositHeldInTrustAccount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_BusinessCombinationTotalPayments" xbrli:periodType="duration" xbrli:balance="debit" name="BusinessCombinationTotalPayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xbrli:periodType="duration" name="NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" xbrli:periodType="duration" name="ClassOfWarrantOrRightAdjustmentOfExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xbrli:periodType="duration" name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" />
  <xsd:element id="dkdcu_UnderwritingDiscountPercentage" xbrli:periodType="duration" name="UnderwritingDiscountPercentage" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_OverAllotmentOptionPeriod" xbrli:periodType="duration" name="OverAllotmentOptionPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_UnderwritingDiscountPaid" xbrli:periodType="duration" xbrli:balance="credit" name="UnderwritingDiscountPaid" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_DeferredUnderwritingFeesPercentage" xbrli:periodType="duration" name="DeferredUnderwritingFeesPercentage" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xbrli:periodType="instant" xbrli:balance="credit" name="CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_CommonClassSubjectToRedemptionMember" xbrli:periodType="duration" abstract="true" name="CommonClassSubjectToRedemptionMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_WarrantLiabilityMember" xbrli:periodType="duration" abstract="true" name="WarrantLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_WarrantLiabilityNonCurrent" xbrli:periodType="instant" xbrli:balance="credit" name="WarrantLiabilityNonCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xbrli:periodType="duration" xbrli:balance="credit" name="InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" xbrli:periodType="duration" name="PercentageOfGrossProceedsOnTotalEquityProceed" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xbrli:periodType="duration" abstract="true" name="ClassAndClassBCommonStockNotSubjectToRedemptionMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_OfferingCostsAllocatedToWarrantLiability" xbrli:periodType="duration" xbrli:balance="debit" name="OfferingCostsAllocatedToWarrantLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ProceedsFromIssuanceOfTemporaryEquity" xbrli:periodType="duration" xbrli:balance="credit" name="ProceedsFromIssuanceOfTemporaryEquity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_TemporaryEquityProceedsAllocatedToWarrants" xbrli:periodType="duration" xbrli:balance="debit" name="TemporaryEquityProceedsAllocatedToWarrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_TemporaryEquityIssuanceCosts" xbrli:periodType="duration" xbrli:balance="debit" name="TemporaryEquityIssuanceCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_WarrantExercisable" xbrli:periodType="duration" name="WarrantExercisable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_PrepaidInsuranceCurrent" xbrli:periodType="instant" xbrli:balance="debit" name="PrepaidInsuranceCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_WarrantLiabilityTextBlock" xbrli:periodType="duration" name="WarrantLiabilityTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" />
  <xsd:element id="dkdcu_StockTransferredToOthersDuringPeriodShare" xbrli:periodType="duration" name="StockTransferredToOthersDuringPeriodShare" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" xbrli:periodType="instant" xbrli:balance="debit" name="MinimumNetTangibleAssetUponConsummationOfBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_PrivateWarrantMember" xbrli:periodType="duration" abstract="true" name="PrivateWarrantMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_RealizedAndUnrealizedGainLoss" xbrli:periodType="duration" xbrli:balance="credit" name="RealizedAndUnrealizedGainLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" xbrli:periodType="duration" xbrli:balance="credit" name="SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" xbrli:periodType="duration" name="SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_CommonStockShareIssued" xbrli:periodType="instant" name="CommonStockShareIssued" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_CommonStockShareOutstanding" xbrli:periodType="instant" name="CommonStockShareOutstanding" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xbrli:periodType="instant" xbrli:balance="credit" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ExtensionLoansNonCurrent" xbrli:periodType="instant" xbrli:balance="credit" name="ExtensionLoansNonCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ProceedsFromExtensionLoan" xbrli:periodType="duration" xbrli:balance="debit" name="ProceedsFromExtensionLoan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ProceedsFromSaleOfPrivateUnits" xbrli:periodType="duration" xbrli:balance="debit" name="ProceedsFromSaleOfPrivateUnits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xbrli:periodType="duration" abstract="true" name="ClassCommonStockNotSubjectToPossibleRedemptionMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xbrli:periodType="duration" name="NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element id="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xbrli:periodType="duration" name="ExtensionPeriodForConsummatingInitialBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xbrli:periodType="duration" name="NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element id="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xbrli:periodType="duration" name="AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" />
  <xsd:element id="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock" xbrli:periodType="duration" name="EmergingGrowthCompanyPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" />
  <xsd:element id="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock" xbrli:periodType="duration" name="DerivativeFinancialInstrumentsPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" />
  <xsd:element id="dkdcu_AccountingPoliciesTable" xbrli:periodType="duration" abstract="true" name="AccountingPoliciesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element id="dkdcu_AccountingPoliciesLineItems" xbrli:periodType="duration" abstract="true" name="AccountingPoliciesLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element id="dkdcu_PrivatePlacementTable" xbrli:periodType="duration" abstract="true" name="PrivatePlacementTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element id="dkdcu_PrivatePlacementLineItems" xbrli:periodType="duration" abstract="true" name="PrivatePlacementLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element id="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" xbrli:periodType="duration" name="AggregatePeriodToConsummateInitialBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" xbrli:periodType="duration" name="NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element id="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" xbrli:periodType="duration" xbrli:balance="debit" name="RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" xbrli:periodType="duration" name="PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xbrli:periodType="duration" xbrli:balance="debit" name="AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" xbrli:periodType="duration" name="CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xbrli:periodType="duration" xbrli:balance="debit" name="ProceedsFromInterestWithdrawnFromTrustAccount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_AdvancesFromRelatedParties" xbrli:periodType="duration" xbrli:balance="debit" name="AdvancesFromRelatedParties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ProceedsFromWorkingCapitalLoan" xbrli:periodType="duration" xbrli:balance="debit" name="ProceedsFromWorkingCapitalLoan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption" xbrli:periodType="duration" xbrli:balance="credit" name="RemeasurementOfClassCommonStockSubjectToPossibleRedemption" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest" xbrli:periodType="duration" xbrli:balance="credit" name="RedemptionOfClassCommonStockHeldInTrustIncludingInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_NumberOfOneMonthExtensionsExecuted" xbrli:periodType="instant" name="NumberOfOneMonthExtensionsExecuted" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element id="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" xbrli:periodType="duration" name="ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" xbrli:periodType="duration" xbrli:balance="credit" name="AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" xbrli:periodType="duration" xbrli:balance="debit" name="RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ArcGroupLimitedMember" xbrli:periodType="duration" abstract="true" name="ArcGroupLimitedMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xbrli:periodType="duration" abstract="true" name="IntroducingAdvisorAgreementWithArcGroupLimitedMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xbrli:periodType="duration" abstract="true" name="SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xbrli:periodType="duration" abstract="true" name="FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xbrli:periodType="duration" name="MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element id="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xbrli:periodType="duration" name="PercentageOfSuccessFeeOnAnyPipeFinancing" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_PercentageOfOwnershipAsConsiderationForService" xbrli:periodType="duration" name="PercentageOfOwnershipAsConsiderationForService" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" xbrli:periodType="duration" name="ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_PercentageOfPublicSharesToBeRedeemed." xbrli:periodType="instant" name="PercentageOfPublicSharesToBeRedeemed." nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xbrli:periodType="duration" name="TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xbrli:periodType="duration" name="TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element id="dkdcu_CashHeldOutsideInTrustAccount" xbrli:periodType="instant" xbrli:balance="debit" name="CashHeldOutsideInTrustAccount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_RetainerFeeUponExecutionOfAgreement" xbrli:periodType="duration" xbrli:balance="debit" name="RetainerFeeUponExecutionOfAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" xbrli:periodType="duration" xbrli:balance="debit" name="SuccessFeeUponClosingOfInitialBusinessCombination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_ThirdMonthExtensionToTerminationDateMember" xbrli:periodType="duration" abstract="true" name="ThirdMonthExtensionToTerminationDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_FourthMonthExtensionToTerminationDateMember" xbrli:periodType="duration" abstract="true" name="FourthMonthExtensionToTerminationDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_FifthMonthExtensionToTerminationDateMember" xbrli:periodType="duration" abstract="true" name="FifthMonthExtensionToTerminationDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_AmountDepositedPerEachPublicShareOutstanding" xbrli:periodType="duration" name="AmountDepositedPerEachPublicShareOutstanding" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" />
  <xsd:element id="dkdcu_AggregateAmountDepositedInTrustAccount" xbrli:periodType="duration" xbrli:balance="debit" name="AggregateAmountDepositedInTrustAccount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" xbrli:periodType="duration" xbrli:balance="debit" name="FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_PaymentsOfFranchiseTax" xbrli:periodType="instant" xbrli:balance="credit" name="PaymentsOfFranchiseTax" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_InitialPublicOfferingDisclosureTextBlock" xbrli:periodType="duration" name="InitialPublicOfferingDisclosureTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" />
  <xsd:element id="dkdcu_SixthOneMonthExtensionToTerminationDateMember" xbrli:periodType="duration" abstract="true" name="SixthOneMonthExtensionToTerminationDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" />
  <xsd:element id="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities" xbrli:periodType="duration" name="EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance" xbrli:periodType="duration" name="EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_StartUpCosts" xbrli:periodType="instant" xbrli:balance="debit" name="StartUpCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_UnrealizedGainOnInvestmentInTrustAccount" xbrli:periodType="instant" xbrli:balance="credit" name="UnrealizedGainOnInvestmentInTrustAccount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_U.s.FederalAndStateNetOperatingLoss" xbrli:periodType="instant" xbrli:balance="debit" name="U.s.FederalAndStateNetOperatingLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element id="dkdcu_LimitationOnAnnualTaxableIncome" xbrli:periodType="instant" name="LimitationOnAnnualTaxableIncome" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element id="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xbrli:periodType="duration" name="EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" />
  <xsd:element name="CashDeferredUnderwritingCommissions" id="dkdcu_CashDeferredUnderwritingCommissions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="CashWaivedDeferredUnderwritingCommission" id="dkdcu_CashWaivedDeferredUnderwritingCommission" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="RelatedPartyPromissoryNoteExecuted" id="dkdcu_RelatedPartyPromissoryNoteExecuted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="RelatedPartyPromissoryNoteExecutedPerMonth" id="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="RelatedPartyPayment" id="dkdcu_RelatedPartyPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>dkdcu-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.3.0.9 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/3/2023 10:19:27 PM-->
<!--Modified on: 7/3/2023 10:19:28 PM-->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedStatementsOfOperations" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureIncomeTaxIncomeTaxProvisionDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureIncomeTaxesFederalIncomeTaxRateDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails" />
  <link:roleRef roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" xlink:href="dkdcu-20230331.xsd#DisclosureSubsequentEventsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss" xlink:href="dkdcu-20230331.xsd#DisclosureSubsequentEventsDetailss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails" xlink:href="dkdcu-20230331.xsd#DisclosureIncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="simple" />
  <calculationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="extended" xlink:title="100100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_638240195654244253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets_1" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_638240195654244253" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638240195654254251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets_1" xlink:to="us-gaap_AssetsCurrent_638240195654254251" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638240195654254251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638240195654254251" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638240195654254251" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent_638240195654254251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638240195654254251" xlink:to="us-gaap_PrepaidExpenseCurrent_638240195654254251" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrepaidInsuranceCurrent" xlink:label="dkdcu_PrepaidInsuranceCurrent_638240195654254251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638240195654254251" xlink:to="dkdcu_PrepaidInsuranceCurrent_638240195654254251" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638240195654254251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:to="us-gaap_StockholdersEquity_638240195654254251" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638240195654254251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638240195654254251" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638240195654254251" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_638240195654254251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638240195654254251" xlink:to="us-gaap_AdditionalPaidInCapital_638240195654254251" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638240195654254251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638240195654254251" xlink:to="us-gaap_CommonStockValue_638240195654254251" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_638240195654254251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638240195654254251" xlink:to="us-gaap_PreferredStockValue_638240195654254251" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195654264255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195654264255" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638240195654264255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:to="us-gaap_CommitmentsAndContingencies_638240195654264255" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_638240195654264255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:to="us-gaap_Liabilities_638240195654264255" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent_638240195654264255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654264255" xlink:to="dkdcu_ExtensionLoansNonCurrent_638240195654264255" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_638240195654264255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654264255" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent_638240195654264255" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredOfferingCostsNonCurrent" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent_638240195654264255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654264255" xlink:to="dkdcu_DeferredOfferingCostsNonCurrent_638240195654264255" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityNonCurrent" xlink:label="dkdcu_WarrantLiabilityNonCurrent_638240195654264255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654264255" xlink:to="dkdcu_WarrantLiabilityNonCurrent_638240195654264255" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638240195654264255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654264255" xlink:to="us-gaap_LiabilitiesCurrent_638240195654264255" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_638240195654274252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638240195654264255" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_638240195654274252" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_638240195654274252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638240195654264255" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_638240195654274252" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent_638240195654274252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638240195654264255" xlink:to="us-gaap_DueToRelatedPartiesCurrent_638240195654274252" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_638240195654274252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638240195654264255" xlink:to="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_638240195654274252" order="4" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="100400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654274252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654274252" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromExtensionLoan" xlink:label="dkdcu_ProceedsFromExtensionLoan_638240195654274252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654274252" xlink:to="dkdcu_ProceedsFromExtensionLoan_638240195654274252" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromWorkingCapitalLoan" xlink:label="dkdcu_ProceedsFromWorkingCapitalLoan_638240195654284255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654274252" xlink:to="dkdcu_ProceedsFromWorkingCapitalLoan_638240195654284255" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdvancesFromRelatedParties" xlink:label="dkdcu_AdvancesFromRelatedParties_638240195654284255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654274252" xlink:to="dkdcu_AdvancesFromRelatedParties_638240195654284255" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_638240195654284255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654274252" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_638240195654284255" order="4" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfPrivateUnits" xlink:label="dkdcu_ProceedsFromSaleOfPrivateUnits_638240195654284255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654274252" xlink:to="dkdcu_ProceedsFromSaleOfPrivateUnits_638240195654284255" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NetProceedsFromInitialPublicOffering" xlink:label="dkdcu_NetProceedsFromInitialPublicOffering_638240195654284255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654274252" xlink:to="dkdcu_NetProceedsFromInitialPublicOffering_638240195654284255" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638240195654284255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654274252" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638240195654284255" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195654284255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195654284255" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195654284255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195654284255" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195654284255" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638240195654294286" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638240195654294286" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IncreaseDecreaseFranchiseTaxPayable" xlink:label="dkdcu_IncreaseDecreaseFranchiseTaxPayable_638240195654294286" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="dkdcu_IncreaseDecreaseFranchiseTaxPayable_638240195654294286" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_638240195654294286" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_638240195654294286" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_638240195654294286" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_638240195654294286" order="4" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_638240195654294286" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_638240195654294286" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195654294286" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195654294286" order="6" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_638240195654294286" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss_638240195654294286" order="7" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638240195654294286" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="us-gaap_ShareBasedCompensation_638240195654294286" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OfferingCostsAllocatedToWarrantLiability" xlink:label="dkdcu_OfferingCostsAllocatedToWarrantLiability_638240195654304277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="dkdcu_OfferingCostsAllocatedToWarrantLiability_638240195654304277" order="9" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_638240195654304277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654284255" xlink:to="us-gaap_ProfitLoss_638240195654304277" order="10" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="200100 - Statement - CONSOLIDATED BALANCE SHEETS">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_638240195654304277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_638240195654304277" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638240195654304277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent_638240195654304277" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638240195654304277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638240195654304277" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638240195654304277" order="1" use="optional" weight="1" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent_638240195654304277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638240195654304277" xlink:to="us-gaap_PrepaidExpenseCurrent_638240195654304277" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrepaidInsuranceCurrent" xlink:label="dkdcu_PrepaidInsuranceCurrent_638240195654304277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638240195654304277" xlink:to="dkdcu_PrepaidInsuranceCurrent_638240195654304277" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_638240195654314277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities_638240195654314277" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638240195654314277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654314277" xlink:to="us-gaap_LiabilitiesCurrent_638240195654314277" order="1" use="optional" weight="1" priority="4" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_638240195654314277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638240195654314277" xlink:to="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_638240195654314277" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_638240195654314277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638240195654314277" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_638240195654314277" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent_638240195654314277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638240195654314277" xlink:to="us-gaap_DueToRelatedPartiesCurrent_638240195654314277" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_638240195654314277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638240195654314277" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_638240195654314277" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityNonCurrent" xlink:label="dkdcu_WarrantLiabilityNonCurrent_638240195654314277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654314277" xlink:to="dkdcu_WarrantLiabilityNonCurrent_638240195654314277" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredOfferingCostsNonCurrent" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent_638240195654314277" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654314277" xlink:to="dkdcu_DeferredOfferingCostsNonCurrent_638240195654314277" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_638240195654324281" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654314277" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent_638240195654324281" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent_638240195654324281" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638240195654314277" xlink:to="dkdcu_ExtensionLoansNonCurrent_638240195654324281" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638240195654324281" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity_638240195654324281" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638240195654324281" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638240195654324281" xlink:to="us-gaap_CommonStockValue_638240195654324281" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_638240195654324281" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638240195654324281" xlink:to="us-gaap_PreferredStockValue_638240195654324281" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_638240195654324281" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638240195654324281" xlink:to="us-gaap_AdditionalPaidInCapital_638240195654324281" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638240195654324281" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638240195654324281" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638240195654324281" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195654334252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195654334252" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638240195654334252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies_638240195654334252" order="4" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" xlink:type="extended" xlink:title="200200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638240195654334252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638240195654334252" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195654334252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195654334252" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195654334252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195654334252" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195654334252" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_638240195654334252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195654334252" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss_638240195654334252" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_638240195654334252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195654334252" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_638240195654334252" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638240195654334252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195654334252" xlink:to="us-gaap_NonoperatingIncomeExpense_638240195654334252" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638240195654344429" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195654334252" xlink:to="us-gaap_OperatingIncomeLoss_638240195654344429" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses_638240195654344429" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638240195654344429" xlink:to="us-gaap_OperatingCostsAndExpenses_638240195654344429" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FranchiseTaxExpense" xlink:label="dkdcu_FranchiseTaxExpense_638240195654344429" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638240195654344429" xlink:to="dkdcu_FranchiseTaxExpense_638240195654344429" order="2" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="200400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_638240195654344429" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="us-gaap_ProfitLoss_638240195654344429" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OfferingCostsAllocatedToWarrantLiability" xlink:label="dkdcu_OfferingCostsAllocatedToWarrantLiability_638240195654344429" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="dkdcu_OfferingCostsAllocatedToWarrantLiability_638240195654344429" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638240195654344429" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="us-gaap_ShareBasedCompensation_638240195654344429" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_638240195654354253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss_638240195654354253" order="4" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195654354253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195654354253" order="5" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_638240195654354253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_638240195654354253" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_638240195654354253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_638240195654354253" order="7" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_638240195654354253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_638240195654354253" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IncreaseDecreaseFranchiseTaxPayable" xlink:label="dkdcu_IncreaseDecreaseFranchiseTaxPayable_638240195654354253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="dkdcu_IncreaseDecreaseFranchiseTaxPayable_638240195654354253" order="9" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638240195654354253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195654344429" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638240195654354253" order="10" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195654354253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195654354253" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195654354253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195654354253" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195654354253" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_638240195654364249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195654354253" xlink:to="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_638240195654364249" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638240195654364249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638240195654364249" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_638240195654364249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_638240195654364249" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_638240195654364249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_638240195654364249" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NetProceedsFromInitialPublicOffering" xlink:label="dkdcu_NetProceedsFromInitialPublicOffering_638240195654364249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" xlink:to="dkdcu_NetProceedsFromInitialPublicOffering_638240195654364249" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfPrivateUnits" xlink:label="dkdcu_ProceedsFromSaleOfPrivateUnits_638240195654364249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" xlink:to="dkdcu_ProceedsFromSaleOfPrivateUnits_638240195654364249" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_638240195654364249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_638240195654364249" order="6" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromWorkingCapitalLoan" xlink:label="dkdcu_ProceedsFromWorkingCapitalLoan_638240195654374245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" xlink:to="dkdcu_ProceedsFromWorkingCapitalLoan_638240195654374245" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdvancesFromRelatedParties" xlink:label="dkdcu_AdvancesFromRelatedParties_638240195654374245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" xlink:to="dkdcu_AdvancesFromRelatedParties_638240195654374245" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromExtensionLoan" xlink:label="dkdcu_ProceedsFromExtensionLoan_638240195654374245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195654364249" xlink:to="dkdcu_ProceedsFromExtensionLoan_638240195654374245" order="9" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails" xlink:type="extended" xlink:title="241001 - Disclosure - INCOME TAX - Income tax provision (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_638240195654374245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit_1" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_638240195654374245" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_638240195654374245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit_1" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_638240195654374245" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638240195654374245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit_1" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638240195654374245" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails" xlink:type="extended" xlink:title="241003 - Disclosure - INCOME TAXES - Federal income tax rate (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_638240195654384245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_638240195654384245" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_638240195654384245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_638240195654384245" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance_638240195654384245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance_638240195654384245" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities_638240195654384245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities_638240195654384245" order="4" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638240195654384245" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638240195654384245" order="5" use="optional" weight="-1" />
  </calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>dkdcu-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.3.0.9 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/3/2023 10:19:27 PM-->
<!--Modified on: 7/3/2023 10:19:28 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedStatementsOfOperations" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureInitialPublicOfferingDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosurePrivatePlacementDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactionsFounderSharesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureCommitmentsAndContingenciesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureWarrantLiabilityDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureStockholderSEquityCommonStockDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSubsequentEventsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedBalanceSheetParenthetical" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedStatementsOfOperations" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedStatementsOfChangesInStockholdersDeficit" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureInitialPublicOfferingDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosurePrivatePlacementDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactionsFounderSharesDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactionsAdditionalInformationDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureCommitmentsAndContingenciesDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureWarrantLiabilityDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureStockholderSEquityCommonStockSharesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSubsequentEventsDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:href="dkdcu-20230331.xsd#DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureStandardAndCustomAxisDomainDefaults">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_1" xlink:title="us-gaap_StatementClassOfStockAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1" xlink:title="us-gaap_ClassOfStockDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementClassOfStockAxis_1" xlink:to="us-gaap_ClassOfStockDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementClassOfStockAxis_1 To us-gaap_ClassOfStockDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_1" xlink:title="us-gaap_SubsidiarySaleOfStockAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:title="us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_1" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_SubsidiarySaleOfStockAxis_1 To us-gaap_SaleOfStockNameOfTransactionDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_1" xlink:title="us-gaap_StatementEquityComponentsAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_1" xlink:title="us-gaap_EquityComponentDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementEquityComponentsAxis_1" xlink:to="us-gaap_EquityComponentDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementEquityComponentsAxis_1 To us-gaap_EquityComponentDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_1" xlink:title="us-gaap_ClassOfWarrantOrRightAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_1" xlink:title="us-gaap_ClassOfWarrantOrRightDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_ClassOfWarrantOrRightAxis_1 To us-gaap_ClassOfWarrantOrRightDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_1" xlink:title="us-gaap_SubsequentEventTypeAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_1" xlink:title="us-gaap_SubsequentEventTypeDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_SubsequentEventTypeAxis_1" xlink:to="us-gaap_SubsequentEventTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_SubsequentEventTypeAxis_1 To us-gaap_SubsequentEventTypeDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1 To us-gaap_AntidilutiveSecuritiesNameDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_1" xlink:title="us-gaap_RelatedPartyTransactionAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_1" xlink:title="us-gaap_RelatedPartyTransactionDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_RelatedPartyTransactionAxis_1" xlink:to="us-gaap_RelatedPartyTransactionDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_RelatedPartyTransactionAxis_1 To us-gaap_RelatedPartyTransactionDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_1" xlink:title="us-gaap_RelatedPartyDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="us-gaap_RelatedPartyDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1 To us-gaap_RelatedPartyDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_1" xlink:title="srt_StatementScenarioAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_1" xlink:title="srt_ScenarioUnspecifiedDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_StatementScenarioAxis_1" xlink:to="srt_ScenarioUnspecifiedDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_StatementScenarioAxis_1 To srt_ScenarioUnspecifiedDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_1" xlink:title="srt_TitleOfIndividualAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_1" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_TitleOfIndividualAxis_1" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_TitleOfIndividualAxis_1 To srt_TitleOfIndividualWithRelationshipToEntityDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_FairValueByFairValueHierarchyLevelAxis_1 To us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis_1" xlink:title="us-gaap_FinancialInstrumentAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:title="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_FinancialInstrumentAxis_1" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_FinancialInstrumentAxis_1 To us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_1" xlink:title="us-gaap_FairValueByMeasurementFrequencyAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_1" xlink:title="us-gaap_FairValueMeasurementFrequencyDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis_1" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_FairValueByMeasurementFrequencyAxis_1 To us-gaap_FairValueMeasurementFrequencyDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_1" xlink:title="us-gaap_MeasurementInputTypeAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_1" xlink:title="us-gaap_MeasurementInputTypeDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_MeasurementInputTypeAxis_1" xlink:to="us-gaap_MeasurementInputTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_MeasurementInputTypeAxis_1 To us-gaap_MeasurementInputTypeDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis_1" xlink:title="us-gaap_IncomeTaxAuthorityAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_1" xlink:title="us-gaap_IncomeTaxAuthorityDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_IncomeTaxAuthorityAxis_1" xlink:to="us-gaap_IncomeTaxAuthorityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_IncomeTaxAuthorityAxis_1 To us-gaap_IncomeTaxAuthorityDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis_1" xlink:title="srt_RestatementAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain_1" xlink:title="srt_RestatementDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_RestatementAxis_1" xlink:to="srt_RestatementDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_RestatementAxis_1 To srt_RestatementDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_1" xlink:title="srt_RangeAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_1" xlink:title="srt_RangeMember_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_RangeAxis_1" xlink:to="srt_RangeMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_RangeAxis_1 To srt_RangeMember_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis_1" xlink:title="us-gaap_FairValueByAssetClassAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" xlink:title="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_FairValueByAssetClassAxis_1" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_FairValueByAssetClassAxis_1 To us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_1" xlink:title="us-gaap_TypeOfArrangementAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:title="us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_TypeOfArrangementAxis_1" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_TypeOfArrangementAxis_1 To us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" order="1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_1" xlink:title="us-gaap_IncomeStatementLocationAxis_1" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_1" xlink:title="us-gaap_IncomeStatementLocationDomain_1" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_IncomeStatementLocationAxis_1" xlink:to="us-gaap_IncomeStatementLocationDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_IncomeStatementLocationAxis_1 To us-gaap_IncomeStatementLocationDomain_1" order="1" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:title="us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:title="us-gaap_FairValueAdjustmentOfWarrants" xlink:type="locator" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_IncomeStatementAbstract To us-gaap_FairValueAdjustmentOfWarrants" order="1" priority="0" />
  </link:definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="extended" xlink:title="100100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrepaidInsuranceCurrent" xlink:label="dkdcu_PrepaidInsuranceCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="dkdcu_PrepaidInsuranceCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityNonCurrent" xlink:label="dkdcu_WarrantLiabilityNonCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="dkdcu_WarrantLiabilityNonCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredOfferingCostsNonCurrent" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="dkdcu_DeferredOfferingCostsNonCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="dkdcu_ExtensionLoansNonCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="100105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations" xlink:type="extended" xlink:title="100200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FranchiseTaxExpense" xlink:label="dkdcu_FranchiseTaxExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="dkdcu_FranchiseTaxExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:type="extended" xlink:title="100300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_SharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionValue" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionShares" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" xlink:type="extended" xlink:title="140101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_SponsorMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:label="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfUnits" xlink:label="dkdcu_ProceedsFromSaleOfUnits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ProceedsFromSaleOfUnits" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssued" xlink:label="dkdcu_NumberOfWarrantsIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfWarrantsIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransactionCosts" xlink:label="dkdcu_TransactionCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_TransactionCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockUnderwritingFees" xlink:label="dkdcu_SaleOfStockUnderwritingFees" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dkdcu_TransactionCosts" xlink:to="dkdcu_SaleOfStockUnderwritingFees" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dkdcu_TransactionCosts" xlink:to="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeePayable" xlink:label="dkdcu_DeferredUnderwritingFeePayable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dkdcu_TransactionCosts" xlink:to="dkdcu_DeferredUnderwritingFeePayable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockOtherOfferingCosts" xlink:label="dkdcu_SaleOfStockOtherOfferingCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dkdcu_TransactionCosts" xlink:to="dkdcu_SaleOfStockOtherOfferingCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashHeldOutsideInTrustAccount" xlink:label="dkdcu_CashHeldOutsideInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_CashHeldOutsideInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalDeficit" xlink:label="dkdcu_WorkingCapitalDeficit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_WorkingCapitalDeficit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" xlink:label="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" xlink:label="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" xlink:label="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsExecuted" xlink:label="dkdcu_NumberOfOneMonthExtensionsExecuted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfOneMonthExtensionsExecuted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" xlink:label="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" xlink:label="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="25" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="26" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_AssetsHeldInTrust" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="27" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNetInterestToPayDissolutionExpenses" xlink:label="dkdcu_MaximumNetInterestToPayDissolutionExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="28" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_MaximumNetInterestToPayDissolutionExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="29" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="30" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="31" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="32" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="33" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="34" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="35" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_Cash" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="36" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfPublicSharesToBeRedeemed." xlink:label="dkdcu_PercentageOfPublicSharesToBeRedeemed." />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="37" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_PercentageOfPublicSharesToBeRedeemed." priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:label="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="38" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" xlink:type="extended" xlink:title="140201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesTable" xlink:label="dkdcu_AccountingPoliciesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember" xlink:label="us-gaap_OperatingExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OperatingExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_ArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesLineItems" xlink:label="dkdcu_AccountingPoliciesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_AccountingPoliciesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_Cash" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantExercisable" xlink:label="dkdcu_WarrantExercisable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_WarrantExercisable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails" xlink:type="extended" xlink:title="140202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesTable" xlink:label="dkdcu_AccountingPoliciesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesLineItems" xlink:label="dkdcu_AccountingPoliciesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_AccountingPoliciesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromIssuanceOfTemporaryEquity" xlink:label="dkdcu_ProceedsFromIssuanceOfTemporaryEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_ProceedsFromIssuanceOfTemporaryEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityProceedsAllocatedToWarrants" xlink:label="dkdcu_TemporaryEquityProceedsAllocatedToWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_TemporaryEquityProceedsAllocatedToWarrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityIssuanceCosts" xlink:label="dkdcu_TemporaryEquityIssuanceCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_TemporaryEquityIssuanceCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" xlink:label="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails" xlink:type="extended" xlink:title="140203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" xlink:type="extended" xlink:title="140301 - Disclosure - INITIAL PUBLIC OFFERING (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PublicWarrantsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSharesIssuedPerUnit" xlink:label="dkdcu_NumberOfSharesIssuedPerUnit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfSharesIssuedPerUnit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssuedPerUnit" xlink:label="dkdcu_NumberOfWarrantsIssuedPerUnit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfWarrantsIssuedPerUnit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" xlink:type="extended" xlink:title="140401 - Disclosure - PRIVATE PLACEMENT (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementTable" xlink:label="dkdcu_PrivatePlacementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dkdcu_PrivatePlacementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementLineItems" xlink:label="dkdcu_PrivatePlacementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dkdcu_PrivatePlacementLineItems" xlink:to="dkdcu_PrivatePlacementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dkdcu_PrivatePlacementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dkdcu_PrivatePlacementLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dkdcu_PrivatePlacementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" xlink:type="extended" xlink:title="140501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_SponsorMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_ChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_ChiefFinancialOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TwoIndependentDirectorMember" xlink:label="dkdcu_TwoIndependentDirectorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_TwoIndependentDirectorMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdIndependentDirectorMember" xlink:label="dkdcu_ThirdIndependentDirectorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_ThirdIndependentDirectorMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_AffiliatedEntityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_StockTransferredToOthersDuringPeriodShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_ExtensionLoansNonCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:label="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended" xlink:title="140502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PromissoryNoteWithRelatedPartyMember" xlink:label="dkdcu_PromissoryNoteWithRelatedPartyMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_PromissoryNoteWithRelatedPartyMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdministrativeSupportAgreementMember" xlink:label="dkdcu_AdministrativeSupportAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_AdministrativeSupportAgreementMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyLoansMember" xlink:label="dkdcu_RelatedPartyLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_RelatedPartyLoansMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalLoansWarrantMember" xlink:label="dkdcu_WorkingCapitalLoansWarrantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_WorkingCapitalLoansWarrantMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_AffiliatedEntityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RetainerFeeUponExecutionOfAgreement" xlink:label="dkdcu_RetainerFeeUponExecutionOfAgreement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_RetainerFeeUponExecutionOfAgreement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" xlink:label="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfOwnershipAsConsiderationForService" xlink:label="dkdcu_PercentageOfOwnershipAsConsiderationForService" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_PercentageOfOwnershipAsConsiderationForService" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" xlink:label="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumLoansConvertibleUptoConsummation" xlink:label="dkdcu_MaximumLoansConvertibleUptoConsummation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_MaximumLoansConvertibleUptoConsummation" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" xlink:label="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" xlink:label="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecuritiesDepositHeldInTrustAccount" xlink:label="dkdcu_SecuritiesDepositHeldInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_SecuritiesDepositHeldInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" xlink:label="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" xlink:label="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_BusinessCombinationTotalPayments" xlink:label="dkdcu_BusinessCombinationTotalPayments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_BusinessCombinationTotalPayments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_ExtensionLoansNonCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="25" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="26" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="27" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="extended" xlink:title="140601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_ArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OverAllotmentOptionPeriod" xlink:label="dkdcu_OverAllotmentOptionPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_OverAllotmentOptionPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPercentage" xlink:label="dkdcu_UnderwritingDiscountPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_UnderwritingDiscountPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPaid" xlink:label="dkdcu_UnderwritingDiscountPaid" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_UnderwritingDiscountPaid" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeesPercentage" xlink:label="dkdcu_DeferredUnderwritingFeesPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_DeferredUnderwritingFeesPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails" xlink:type="extended" xlink:title="140701 - Disclosure - WARRANT LIABILITY (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PlacementWarrantsMember" xlink:label="dkdcu_PlacementWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_WarrantMember" xlink:to="dkdcu_PlacementWarrantsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_WarrantMember" xlink:to="dkdcu_PublicWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:label="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_SharePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:label="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:label="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" xlink:label="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantsOrRightsIssued" xlink:label="dkdcu_WarrantsOrRightsIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_WarrantsOrRightsIssued" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails" xlink:type="extended" xlink:title="140802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_CommonClassAMember" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaNotSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaNotSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_CommonClassAMember" xlink:to="dkdcu_CommonClassaNotSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_SponsorMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_ArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_TitleOfIndividualAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IndependentDirectorsMember" xlink:label="dkdcu_IndependentDirectorsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="dkdcu_IndependentDirectorsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_StockTransferredToOthersDuringPeriodShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockNumberOfVotesPerShare" xlink:label="dkdcu_CommonStockNumberOfVotesPerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_CommonStockNumberOfVotesPerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareIssued" xlink:label="dkdcu_CommonStockShareIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_CommonStockShareIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareOutstanding" xlink:label="dkdcu_CommonStockShareOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_CommonStockShareOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" xlink:label="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="extended" xlink:title="140901 - Disclosure - FAIR VALUE MEASUREMENTS - Assets and derivative warrant liabilities measured at fair value on recurring basis (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementWarrantsMember" xlink:label="dkdcu_PrivatePlacementWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PrivatePlacementWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PublicWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="extended" xlink:title="140902 - Disclosure - FAIR VALUE MEASUREMENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" xlink:label="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" xlink:type="extended" xlink:title="140903 - Disclosure - FAIR VALUE MEASUREMENTS - Quantitative information regarding Level 3 fair value measurements inputs (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivateWarrantMember" xlink:label="dkdcu_PrivateWarrantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PrivateWarrantMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_MeasurementInputTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExercisePriceMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputSharePriceMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" xlink:label="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:type="extended" xlink:title="140904 - Disclosure - FAIR VALUE MEASUREMENTS - Change in fair value of derivative warrant liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PublicWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivateWarrantMember" xlink:label="dkdcu_PrivateWarrantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PrivateWarrantMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityMember" xlink:label="dkdcu_WarrantLiabilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_WarrantLiabilityMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="141001 - Disclosure - SUBSEQUENT EVENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdMonthExtensionToTerminationDateMember" xlink:label="dkdcu_ThirdMonthExtensionToTerminationDateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_ThirdMonthExtensionToTerminationDateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FourthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FourthMonthExtensionToTerminationDateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_FourthMonthExtensionToTerminationDateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FifthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FifthMonthExtensionToTerminationDateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_FifthMonthExtensionToTerminationDateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SixthOneMonthExtensionToTerminationDateMember" xlink:label="dkdcu_SixthOneMonthExtensionToTerminationDateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_SixthOneMonthExtensionToTerminationDateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedPerEachPublicShareOutstanding" xlink:label="dkdcu_AmountDepositedPerEachPublicShareOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_AmountDepositedPerEachPublicShareOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregateAmountDepositedInTrustAccount" xlink:label="dkdcu_AggregateAmountDepositedInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_AggregateAmountDepositedInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsOfFranchiseTax" xlink:label="dkdcu_PaymentsOfFranchiseTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_PaymentsOfFranchiseTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashWaivedDeferredUnderwritingCommission" xlink:label="dkdcu_CashWaivedDeferredUnderwritingCommission" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_CashWaivedDeferredUnderwritingCommission" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashDeferredUnderwritingCommissions" xlink:label="dkdcu_CashDeferredUnderwritingCommissions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_CashDeferredUnderwritingCommissions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyPayment" xlink:label="dkdcu_RelatedPartyPayment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_RelatedPartyPayment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyPromissoryNoteExecuted" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecuted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_RelatedPartyPromissoryNoteExecuted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregateNumberOfSharesOwned" xlink:label="dkdcu_AggregateNumberOfSharesOwned" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_AggregateNumberOfSharesOwned" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SharePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="200100 - Statement - CONSOLIDATED BALANCE SHEETS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrepaidInsuranceCurrent" xlink:label="dkdcu_PrepaidInsuranceCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="dkdcu_PrepaidInsuranceCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityNonCurrent" xlink:label="dkdcu_WarrantLiabilityNonCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="dkdcu_WarrantLiabilityNonCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredOfferingCostsNonCurrent" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="dkdcu_DeferredOfferingCostsNonCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="dkdcu_ExtensionLoansNonCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" xlink:type="extended" xlink:title="200105 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" xlink:type="extended" xlink:title="200200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FranchiseTaxExpense" xlink:label="dkdcu_FranchiseTaxExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="dkdcu_FranchiseTaxExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:type="extended" xlink:title="200300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_SharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionValue" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionShares" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss" xlink:type="extended" xlink:title="240101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_WarrantMember" xlink:to="dkdcu_PublicWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_SponsorMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:label="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfUnits" xlink:label="dkdcu_ProceedsFromSaleOfUnits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ProceedsFromSaleOfUnits" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssued" xlink:label="dkdcu_NumberOfWarrantsIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfWarrantsIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransactionCosts" xlink:label="dkdcu_TransactionCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_TransactionCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockUnderwritingFees" xlink:label="dkdcu_SaleOfStockUnderwritingFees" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dkdcu_TransactionCosts" xlink:to="dkdcu_SaleOfStockUnderwritingFees" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dkdcu_TransactionCosts" xlink:to="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeePayable" xlink:label="dkdcu_DeferredUnderwritingFeePayable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dkdcu_TransactionCosts" xlink:to="dkdcu_DeferredUnderwritingFeePayable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockOtherOfferingCosts" xlink:label="dkdcu_SaleOfStockOtherOfferingCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dkdcu_TransactionCosts" xlink:to="dkdcu_SaleOfStockOtherOfferingCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashHeldOutsideInTrustAccount" xlink:label="dkdcu_CashHeldOutsideInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_CashHeldOutsideInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalDeficit" xlink:label="dkdcu_WorkingCapitalDeficit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_WorkingCapitalDeficit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" xlink:label="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" xlink:label="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" xlink:label="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsExecuted" xlink:label="dkdcu_NumberOfOneMonthExtensionsExecuted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfOneMonthExtensionsExecuted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" xlink:label="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" xlink:label="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="25" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="26" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_AssetsHeldInTrust" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="27" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNetInterestToPayDissolutionExpenses" xlink:label="dkdcu_MaximumNetInterestToPayDissolutionExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="28" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_MaximumNetInterestToPayDissolutionExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="29" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="30" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="31" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="32" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="33" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="34" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="35" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_Cash" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="36" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfPublicSharesToBeRedeemed." xlink:label="dkdcu_PercentageOfPublicSharesToBeRedeemed." />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="37" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_PercentageOfPublicSharesToBeRedeemed." priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:label="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="38" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss" xlink:type="extended" xlink:title="240201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesTable" xlink:label="dkdcu_AccountingPoliciesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember" xlink:label="us-gaap_OperatingExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OperatingExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_ArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesLineItems" xlink:label="dkdcu_AccountingPoliciesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_AccountingPoliciesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_Cash" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantExercisable" xlink:label="dkdcu_WarrantExercisable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_WarrantExercisable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_SharePrice" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss" xlink:type="extended" xlink:title="240202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesTable" xlink:label="dkdcu_AccountingPoliciesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesLineItems" xlink:label="dkdcu_AccountingPoliciesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_AccountingPoliciesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromIssuanceOfTemporaryEquity" xlink:label="dkdcu_ProceedsFromIssuanceOfTemporaryEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_ProceedsFromIssuanceOfTemporaryEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityProceedsAllocatedToWarrants" xlink:label="dkdcu_TemporaryEquityProceedsAllocatedToWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_TemporaryEquityProceedsAllocatedToWarrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityIssuanceCosts" xlink:label="dkdcu_TemporaryEquityIssuanceCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_TemporaryEquityIssuanceCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" xlink:label="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss" xlink:type="extended" xlink:title="240203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss" xlink:type="extended" xlink:title="240301 - Disclosure - INITIAL PUBLIC OFFERING (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PublicWarrantsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSharesIssuedPerUnit" xlink:label="dkdcu_NumberOfSharesIssuedPerUnit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfSharesIssuedPerUnit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssuedPerUnit" xlink:label="dkdcu_NumberOfWarrantsIssuedPerUnit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dkdcu_NumberOfWarrantsIssuedPerUnit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss" xlink:type="extended" xlink:title="240401 - Disclosure - PRIVATE PLACEMENT (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementTable" xlink:label="dkdcu_PrivatePlacementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dkdcu_PrivatePlacementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementLineItems" xlink:label="dkdcu_PrivatePlacementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dkdcu_PrivatePlacementLineItems" xlink:to="dkdcu_PrivatePlacementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dkdcu_PrivatePlacementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dkdcu_PrivatePlacementLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dkdcu_PrivatePlacementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss" xlink:type="extended" xlink:title="240501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_SponsorMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_ChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_ChiefFinancialOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TwoIndependentDirectorMember" xlink:label="dkdcu_TwoIndependentDirectorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_TwoIndependentDirectorMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdIndependentDirectorMember" xlink:label="dkdcu_ThirdIndependentDirectorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_ThirdIndependentDirectorMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_AffiliatedEntityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_StockTransferredToOthersDuringPeriodShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RetainerFeeUponExecutionOfAgreement" xlink:label="dkdcu_RetainerFeeUponExecutionOfAgreement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_RetainerFeeUponExecutionOfAgreement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" xlink:label="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:label="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" xlink:label="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" xlink:label="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" xlink:label="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_ExtensionLoansNonCurrent" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss" xlink:type="extended" xlink:title="240502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PromissoryNoteWithRelatedPartyMember" xlink:label="dkdcu_PromissoryNoteWithRelatedPartyMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_PromissoryNoteWithRelatedPartyMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdministrativeSupportAgreementMember" xlink:label="dkdcu_AdministrativeSupportAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_AdministrativeSupportAgreementMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyLoansMember" xlink:label="dkdcu_RelatedPartyLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_RelatedPartyLoansMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalLoansWarrantMember" xlink:label="dkdcu_WorkingCapitalLoansWarrantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_WorkingCapitalLoansWarrantMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_AffiliatedEntityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumLoansConvertibleUptoConsummation" xlink:label="dkdcu_MaximumLoansConvertibleUptoConsummation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_MaximumLoansConvertibleUptoConsummation" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecuritiesDepositHeldInTrustAccount" xlink:label="dkdcu_SecuritiesDepositHeldInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_SecuritiesDepositHeldInTrustAccount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_BusinessCombinationTotalPayments" xlink:label="dkdcu_BusinessCombinationTotalPayments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_BusinessCombinationTotalPayments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfOwnershipAsConsiderationForService" xlink:label="dkdcu_PercentageOfOwnershipAsConsiderationForService" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_PercentageOfOwnershipAsConsiderationForService" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" xlink:label="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss" xlink:type="extended" xlink:title="240601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_ArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OverAllotmentOptionPeriod" xlink:label="dkdcu_OverAllotmentOptionPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_OverAllotmentOptionPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPercentage" xlink:label="dkdcu_UnderwritingDiscountPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_UnderwritingDiscountPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPaid" xlink:label="dkdcu_UnderwritingDiscountPaid" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_UnderwritingDiscountPaid" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeesPercentage" xlink:label="dkdcu_DeferredUnderwritingFeesPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_DeferredUnderwritingFeesPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss" xlink:type="extended" xlink:title="240701 - Disclosure - WARRANT LIABILITY (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PlacementWarrantsMember" xlink:label="dkdcu_PlacementWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_WarrantMember" xlink:to="dkdcu_PlacementWarrantsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_WarrantMember" xlink:to="dkdcu_PublicWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:label="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_SharePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:label="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:label="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" xlink:label="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantsOrRightsIssued" xlink:label="dkdcu_WarrantsOrRightsIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dkdcu_WarrantsOrRightsIssued" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails" xlink:type="extended" xlink:title="240802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_CommonClassAMember" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaNotSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaNotSubjectToRedemptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_CommonClassAMember" xlink:to="dkdcu_CommonClassaNotSubjectToRedemptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_SponsorMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="dkdcu_ArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="dkdcu_FounderSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_TitleOfIndividualAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IndependentDirectorsMember" xlink:label="dkdcu_IndependentDirectorsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="dkdcu_IndependentDirectorsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockNumberOfVotesPerShare" xlink:label="dkdcu_CommonStockNumberOfVotesPerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_CommonStockNumberOfVotesPerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_StockTransferredToOthersDuringPeriodShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareIssued" xlink:label="dkdcu_CommonStockShareIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_CommonStockShareIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareOutstanding" xlink:label="dkdcu_CommonStockShareOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_CommonStockShareOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" xlink:label="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss" xlink:type="extended" xlink:title="240901 - Disclosure - FAIR VALUE MEASUREMENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementWarrantsMember" xlink:label="dkdcu_PrivatePlacementWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PrivatePlacementWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PublicWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" xlink:label="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" xlink:type="extended" xlink:title="240902 - Disclosure - FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivateWarrantMember" xlink:label="dkdcu_PrivateWarrantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PrivateWarrantMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_MeasurementInputTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExercisePriceMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputSharePriceMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" xlink:label="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" xlink:type="extended" xlink:title="240903 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PublicWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivateWarrantMember" xlink:label="dkdcu_PrivateWarrantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_PrivateWarrantMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityMember" xlink:label="dkdcu_WarrantLiabilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dkdcu_WarrantLiabilityMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss" xlink:type="extended" xlink:title="241101 - Disclosure - SUBSEQUENT EVENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdMonthExtensionToTerminationDateMember" xlink:label="dkdcu_ThirdMonthExtensionToTerminationDateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_ThirdMonthExtensionToTerminationDateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FourthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FourthMonthExtensionToTerminationDateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_FourthMonthExtensionToTerminationDateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FifthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FifthMonthExtensionToTerminationDateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="dkdcu_FifthMonthExtensionToTerminationDateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedPerEachPublicShareOutstanding" xlink:label="dkdcu_AmountDepositedPerEachPublicShareOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_AmountDepositedPerEachPublicShareOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregateAmountDepositedInTrustAccount" xlink:label="dkdcu_AggregateAmountDepositedInTrustAccount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="dkdcu_AggregateAmountDepositedInTrustAccount" priority="1" use="optional" />
  </definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>dkdcu-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.3.0.9 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/3/2023 10:19:27 PM-->
<!--Modified on: 7/3/2023 10:19:28 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Information [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Information [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Small Business</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Ex Transition Period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Description</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CONDENSED CONSOLIDATED BALANCE SHEETS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A common stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CommonClassSubjectToRedemptionMember" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classification of common stock representing ownership interest in a corporation that is subject to redemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A common stock subject to redemption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock subject to possible redemption</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:to="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Class A common stock not subject to possible redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock Not Subject To Possible Redemption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock not subject to possible redemption</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class B common stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class B Common Stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ASSETS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash held outside the Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid Expense, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expense</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrepaidInsuranceCurrent" xlink:label="dkdcu_PrepaidInsuranceCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PrepaidInsuranceCurrent" xlink:to="dkdcu_PrepaidInsuranceCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PrepaidInsuranceCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of prepaid insurance current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PrepaidInsuranceCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid Insurance Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PrepaidInsuranceCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid insurance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Current Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable securities held in Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investments held in Trust Account</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">LIABILITIES AND STOCKHOLDER'S EQUITY</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Liabilities</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:to="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered, excluding offering costs (due within one year or within the normal operating cycle if longer).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Liabilities Excluding Offering Costs, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Due to Related Parties, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount due to related parties</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Income Taxes, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrual for Taxes Other than Income Taxes, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Franchise tax payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Current Liabilities</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityNonCurrent" xlink:label="dkdcu_WarrantLiabilityNonCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_WarrantLiabilityNonCurrent" xlink:to="dkdcu_WarrantLiabilityNonCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_WarrantLiabilityNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of warrant liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_WarrantLiabilityNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant Liability, Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_WarrantLiabilityNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant liabilities</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredOfferingCostsNonCurrent" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_DeferredOfferingCostsNonCurrent" xlink:to="dkdcu_DeferredOfferingCostsNonCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Offering Costs Non current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred underwriter fee payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Due to Related Parties, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Working capital loan</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ExtensionLoansNonCurrent" xlink:to="dkdcu_ExtensionLoansNonCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ExtensionLoansNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of extension loans outstanding, non-current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ExtensionLoansNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Extension Loans, Non-current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ExtensionLoansNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Extension loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_ExtensionLoansNonCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount outstanding under the extension loan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Carrying Amount, Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingently redeemable Class A Common Stock - Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingently redeemable Class A Common Stock - Opening Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock subject to possible redemption; 4,838,792 shares at redemption value of $10.74 and $10.53 per share as of March 31, 2023 and December 31, 2022, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock subject to possible redemption; 2,731,544 and 11,500,000 shares at redemption value of $10.53 and $10.20 per share as of December 31, 2022 and 2021, respectively</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Attributable to Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Deficit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid in Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional paid-in capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained Earnings (Accumulated Deficit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated deficit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at the end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at the beginning</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Stockholders' Deficit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Liabilities and Stockholders' Deficit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred shares, par value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred shares, shares authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred shares authorized</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred shares, shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred shares issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred shares, shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred shares outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, par value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, shares authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, shares authorized</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, shares issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, shares outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Redemption Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common share at redemption value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption price per share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, subject to possible redemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, subject to possible redemption</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CommonClassaSubjectToRedemptionMember" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classification of common stock representing ownership interest in a corporation that is subject to redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock Subject to Redemption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock Subject to Redemption</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:to="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classification of common stock A and B representing ownership interest in a corporation that is not subject to redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A and Class B Common Stock Not Subject to Redemption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A and Class B non-redeemable common stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Formation and operating costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Formation and operating costs</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FranchiseTaxExpense" xlink:label="dkdcu_FranchiseTaxExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_FranchiseTaxExpense" xlink:to="dkdcu_FranchiseTaxExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_FranchiseTaxExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of franchise tax expense incurred during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_FranchiseTaxExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Franchise Tax Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_FranchiseTaxExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Franchise tax expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss from operation costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nonoperating Income (Expense) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other income (expense):</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest earned on marketable securities held in Trust Account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Earned On Marketable Securities Held In Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest earned on securities held in Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest earned on securities held in Trust Account</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RealizedAndUnrealizedGainLoss" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of realized and unrealized gain (loss) on investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Realized and Unrealized Gain Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dividends, realized and unrealized gain in Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dividends, realized and unrealized gain in Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Realized and unrealized gain</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Adjustment of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in fair value of warrant liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in fair value of warrant liability</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nonoperating Income (Expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-operating expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income (loss) before provision for income taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Provision for income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax provision</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Income (Loss) Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income (loss) allocable to common stock not subject to redemption</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Number of Shares Outstanding, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average shares outstanding, Basic</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average shares outstanding, Diluted</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic net income (loss) per common stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic net income per common stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted net income (loss) per common stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted net income per common stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Components [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Component [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ordinary shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid-in Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid in Capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained Earnings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Deficit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Stockholders' Equity [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase Decrease In Stockholders Equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at the end (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at the beginning (in shares)</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of Sale of non-redeemable private placement units to Sponsor.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale Of Non-Redeemable Private Placement Units To Sponsor</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of non-redeemable private placement units to Sponsor</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents of Sale Of Non-Redeemable Private Placement Units To Sponsor in Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale Of Non-Redeemable Private Placement Units To Sponsor In Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of non-redeemable private placement units to Sponsor(in shares)</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionValue" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CommonStockSubjectToPossibleRedemptionValue" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity impact of the value of common stock subject to possible redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock Subject To Possible Redemption, Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Re-measurement of Class A Common Stock Subject to Possible Redemption</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionShares" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CommonStockSubjectToPossibleRedemptionShares" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of the shares of common stock subject to possible redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock Subject To Possible Redemption, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Re-measurement of Class A Common Stock Subject to Possible Redemption (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flows from Operating Activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flow from operating activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to reconcile net income to net cash used in operating activities:</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OfferingCostsAllocatedToWarrantLiability" xlink:label="dkdcu_OfferingCostsAllocatedToWarrantLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_OfferingCostsAllocatedToWarrantLiability" xlink:to="dkdcu_OfferingCostsAllocatedToWarrantLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_OfferingCostsAllocatedToWarrantLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of Offering costs allocated to warrant liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_OfferingCostsAllocatedToWarrantLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Offering Costs Allocated To Warrant Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_OfferingCostsAllocatedToWarrantLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Offering costs allocated to warrant liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-Based Payment Arrangement, Noncash Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Operating Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in operating assets and liabilities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Prepaid Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accrued Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IncreaseDecreaseFranchiseTaxPayable" xlink:label="dkdcu_IncreaseDecreaseFranchiseTaxPayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_IncreaseDecreaseFranchiseTaxPayable" xlink:to="dkdcu_IncreaseDecreaseFranchiseTaxPayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_IncreaseDecreaseFranchiseTaxPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) during the reporting period of franchise tax payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_IncreaseDecreaseFranchiseTaxPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase Decrease In Franchise Tax Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_IncreaseDecreaseFranchiseTaxPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Franchise tax payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Income Taxes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash used in operating activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flow from investing activities:</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of cash outflow for investment of cash in trust account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments For Investment Of Cash In Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment of cash in Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for investment of cash in trust account</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash used in investing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flows from Financing Activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flow from financing activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of Class B common stock</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NetProceedsFromInitialPublicOffering" xlink:label="dkdcu_NetProceedsFromInitialPublicOffering" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_NetProceedsFromInitialPublicOffering" xlink:to="dkdcu_NetProceedsFromInitialPublicOffering_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_NetProceedsFromInitialPublicOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow associated with the amount received from entity's first offering of stock to the public, net of underwriting discounts paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_NetProceedsFromInitialPublicOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Proceeds From Initial Public Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_NetProceedsFromInitialPublicOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of Units, net of underwriting discount paid</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfPrivateUnits" xlink:label="dkdcu_ProceedsFromSaleOfPrivateUnits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ProceedsFromSaleOfPrivateUnits" xlink:to="dkdcu_ProceedsFromSaleOfPrivateUnits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ProceedsFromSaleOfPrivateUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow from sale of private units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ProceedsFromSaleOfPrivateUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds From Sale Of Private Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ProceedsFromSaleOfPrivateUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of Private units</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments of Stock Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment of offering costs</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdvancesFromRelatedParties" xlink:label="dkdcu_AdvancesFromRelatedParties" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AdvancesFromRelatedParties" xlink:to="dkdcu_AdvancesFromRelatedParties_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AdvancesFromRelatedParties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow associated with advances from related parties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AdvancesFromRelatedParties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Advances from Related Parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AdvancesFromRelatedParties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Advances from related parties</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromWorkingCapitalLoan" xlink:label="dkdcu_ProceedsFromWorkingCapitalLoan" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ProceedsFromWorkingCapitalLoan" xlink:to="dkdcu_ProceedsFromWorkingCapitalLoan_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ProceedsFromWorkingCapitalLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow associated with proceeds from working capital loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ProceedsFromWorkingCapitalLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Working Capital Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ProceedsFromWorkingCapitalLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from working capital loan</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromExtensionLoan" xlink:label="dkdcu_ProceedsFromExtensionLoan" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ProceedsFromExtensionLoan" xlink:to="dkdcu_ProceedsFromExtensionLoan_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ProceedsFromExtensionLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow associated with proceeds from extension loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ProceedsFromExtensionLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Extension Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ProceedsFromExtensionLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from extension loans</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash provided by financing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net change in cash</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash at the beginning of the period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental disclosure of non-cash financing activities:</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption" xlink:label="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption" xlink:to="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of remeasurement of Class A common stock subject to possible redemption, classified as non-cash financing activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remeasurement of Class A Common Stock Subject to Possible Redemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Re-measurement of Class A common stock subject to possible redemption</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest" xlink:label="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest" xlink:to="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of redemption of Class A common stock held in Trust, including interest, classified as non-cash financing activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption of Class A Common Stock Held in Trust, Including Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption of Class A common stock held in Trust, including interest</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeePayable" xlink:label="dkdcu_DeferredUnderwritingFeePayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_DeferredUnderwritingFeePayable" xlink:to="dkdcu_DeferredUnderwritingFeePayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_DeferredUnderwritingFeePayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_DeferredUnderwritingFeePayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Underwriting Fee Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_DeferredUnderwritingFeePayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred underwriting fee payable</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialFairValueOfWarrantLiabilities" xlink:label="dkdcu_InitialFairValueOfWarrantLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_InitialFairValueOfWarrantLiabilities" xlink:to="dkdcu_InitialFairValueOfWarrantLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_InitialFairValueOfWarrantLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The initial fair value classification of warrant liabilities disclosed in the supplemental non-cash cash flow activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_InitialFairValueOfWarrantLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Initial Fair Value Of Warrant Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_InitialFairValueOfWarrantLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Initial classification of warrant liability</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nature of Operations [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [TEXT BLOCK]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialPublicOfferingAbstract" xlink:label="dkdcu_InitialPublicOfferingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_InitialPublicOfferingAbstract" xlink:to="dkdcu_InitialPublicOfferingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_InitialPublicOfferingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_InitialPublicOfferingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">INITIAL PUBLIC OFFERING</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialPublicOfferingDisclosureTextBlock" xlink:label="dkdcu_InitialPublicOfferingDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_InitialPublicOfferingDisclosureTextBlock" xlink:to="dkdcu_InitialPublicOfferingDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_InitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure on information about initial public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_InitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Initial Public Offering Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_InitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">INITIAL PUBLIC OFFERING</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementAbstract" xlink:label="dkdcu_PrivatePlacementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PrivatePlacementAbstract" xlink:to="dkdcu_PrivatePlacementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PrivatePlacementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PrivatePlacementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">PRIVATE PLACEMENT</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementTextBlock" xlink:label="dkdcu_PrivatePlacementTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PrivatePlacementTextBlock" xlink:to="dkdcu_PrivatePlacementTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PrivatePlacementTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure on information about private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PrivatePlacementTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Private Placement [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_PrivatePlacementTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">PRIVATE PLACEMENT</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RELATED PARTY TRANSACTIONS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transactions Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RELATED PARTY TRANSACTIONS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">COMMITMENTS AND CONTINGENCIES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">COMMITMENTS AND CONTINGENCIES</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityAbstract" xlink:label="dkdcu_WarrantLiabilityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_WarrantLiabilityAbstract" xlink:to="dkdcu_WarrantLiabilityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_WarrantLiabilityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_WarrantLiabilityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">WARRANT LIABILITY</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityTextBlock" xlink:label="dkdcu_WarrantLiabilityTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_WarrantLiabilityTextBlock" xlink:to="dkdcu_WarrantLiabilityTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_WarrantLiabilityTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure of warrant liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_WarrantLiabilityTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant Liability [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_WarrantLiabilityTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">WARRANT LIABILITY</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">STOCKHOLDER'S EQUITY</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Note Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">STOCKHOLDER'S EQUITY</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">FAIR VALUE MEASUREMENTS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Disclosures [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">FAIR VALUE MEASUREMENTS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUBSEQUENT EVENTS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Events [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUBSEQUENT EVENTS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Accounting, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Presentation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidation, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principles of Consolidation</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:label="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:to="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of accounting policy on emerging growth company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Emerging Growth Company Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Emerging growth company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Use of Estimates, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Use of estimates</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock" xlink:label="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock" xlink:to="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of accounting policy for assets held in trust.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets Held In Trust Account, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trust Account</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Charges, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Offering Costs Associated with the Initial Public Offering</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityPolicyPolicyTextBlock" xlink:label="dkdcu_TemporaryEquityPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TemporaryEquityPolicyPolicyTextBlock" xlink:to="dkdcu_TemporaryEquityPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TemporaryEquityPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of accounting policy for temporary equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TemporaryEquityPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TemporaryEquityPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock Subject to Possible Redemption</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income (loss) per share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-Based Payment Arrangement [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-Based Compensation Expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration of credit risk</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of financial instruments</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock" xlink:label="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock" xlink:to="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of accounting policy on derivative financial instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Financial Instruments Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Financial Instruments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Recently Issued Accounting Standards</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Class A Common Stock reflected on the balance sheet are reconciled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Class A Common Stock reflected on the condensed consolidated balance sheet are reconciled</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of Net Loss per Common Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of basic and diluted net income (loss) per common share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of basic and diluted net income per common share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Company's assets that are measured at fair value on a recurring basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of assets and derivative warrant liabilities measured at fair value on recurring basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of company's assets and derivative warrant liabilities that are measured at fair value on a recurring basis</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of quantitative information regarding Level 3 fair value measurements inputs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of change in fair value of derivative warrant liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of change in the fair value of the warrant liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPO</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Private Placement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Private Placement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Over-Allotment Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Over-Allotment Option</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction [Domain]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_FounderSharesMember" xlink:to="dkdcu_FounderSharesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_FounderSharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for founder shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_FounderSharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Founder Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_FounderSharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Founder Shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party [Domain]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_SponsorMember" xlink:to="dkdcu_SponsorMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_SponsorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for sponsor.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_SponsorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sponsor [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_SponsorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sponsor</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsidiary, Sale of Stock [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">INITIAL PUBLIC OFFERING</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:label="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:to="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condition For Future Business Combination Number Of Businesses Minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condition for future business combination number of businesses minimum</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of new units issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Units Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of units in Initial Public Offering, net of offering costs (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of units issued</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfUnits" xlink:label="dkdcu_ProceedsFromSaleOfUnits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ProceedsFromSaleOfUnits" xlink:to="dkdcu_ProceedsFromSaleOfUnits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ProceedsFromSaleOfUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This represents Proceeds from Sale of Units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ProceedsFromSaleOfUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds From Sale Of Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ProceedsFromSaleOfUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of units</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssued" xlink:label="dkdcu_NumberOfWarrantsIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_NumberOfWarrantsIssued" xlink:to="dkdcu_NumberOfWarrantsIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_NumberOfWarrantsIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the number of warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_NumberOfWarrantsIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Warrants Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_NumberOfWarrantsIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of warrants issued</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:to="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Price per share or per unit of warrants or rights outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Price of Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Price of warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Price of warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of Private units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate purchase price</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares Issued, Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Price per unit</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransactionCosts" xlink:label="dkdcu_TransactionCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TransactionCosts" xlink:to="dkdcu_TransactionCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the amount of transaction costs incurred.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockUnderwritingFees" xlink:label="dkdcu_SaleOfStockUnderwritingFees" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_SaleOfStockUnderwritingFees" xlink:to="dkdcu_SaleOfStockUnderwritingFees_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_SaleOfStockUnderwritingFees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the amount of offering fees incurred and paid for underwriters.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_SaleOfStockUnderwritingFees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock, Underwriting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_SaleOfStockUnderwritingFees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Underwriting fees</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:to="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Underwriting Commissions Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred underwriting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred underwriting commissions</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockOtherOfferingCosts" xlink:label="dkdcu_SaleOfStockOtherOfferingCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_SaleOfStockOtherOfferingCosts" xlink:to="dkdcu_SaleOfStockOtherOfferingCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_SaleOfStockOtherOfferingCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the amount of other offering costs incurred.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_SaleOfStockOtherOfferingCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock, Other Offering Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_SaleOfStockOtherOfferingCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other offering costs</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashHeldOutsideInTrustAccount" xlink:label="dkdcu_CashHeldOutsideInTrustAccount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CashHeldOutsideInTrustAccount" xlink:to="dkdcu_CashHeldOutsideInTrustAccount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CashHeldOutsideInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of cash held outside the trust account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CashHeldOutsideInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Held Outside In The Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CashHeldOutsideInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash held outside the Trust Account</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalDeficit" xlink:label="dkdcu_WorkingCapitalDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_WorkingCapitalDeficit" xlink:to="dkdcu_WorkingCapitalDeficit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_WorkingCapitalDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of working capital deficit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_WorkingCapitalDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Working Capital Deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_WorkingCapitalDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Working capital deficit</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" xlink:label="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" xlink:to="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" xlink:label="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" xlink:to="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:to="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of three-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Three-Month Extensions Permitted For Consummating Initial Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of three-month extensions for consummation of initial business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:to="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Extension period for consummating initial business combination as permitted under the Company's governing documents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Extension Period For Consummating Initial Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Extension period for consummating initial business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:to="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of one-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of One-Month Extensions Permitted For Consummating Initial Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum number of one-month extension periods for consummation of Initial Business Combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:to="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional amount per unit sold in the company's initial public offering required to be deposited in trust account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Amount Per Unit Required To Be Deposited In Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional amount per unit required to be deposited in trust account</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" xlink:label="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" xlink:to="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount deposited into the Trust Account on execution of two one-month extensions out of the nine.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount Deposited Into the Trust Account on Execution of Two One-Month Extensions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount deposited into the Trust Account on execution of two one-month extensions</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsExecuted" xlink:label="dkdcu_NumberOfOneMonthExtensionsExecuted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_NumberOfOneMonthExtensionsExecuted" xlink:to="dkdcu_NumberOfOneMonthExtensionsExecuted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_NumberOfOneMonthExtensionsExecuted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the number of one-month extensions executed by the Company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_NumberOfOneMonthExtensionsExecuted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of One Month Extensions Executed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_NumberOfOneMonthExtensionsExecuted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of one-month extensions executed</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" xlink:to="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The extension period each time for the Company to consummate initial business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Extension Period Each Time for the Company to Consummate Initial Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Extension period each time for the Company to consummate initial business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" xlink:label="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" xlink:to="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the minimum net tangible assets upon consummation of the Business Combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum net tangible asset upon consummation of business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum net tangible asset upon consummation of business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" xlink:label="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" xlink:to="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares for which Common Stock exercised their right to redeem those shares for cash.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock Holders Exercised Their Right to Redeem Shares for Cash , Number of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares for which share holders exercised their right to redeem</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Aggregate Amount of Redemption Requirement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate amount of shares redeemed</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrust" xlink:to="us-gaap_AssetsHeldInTrust_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrust_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets Held-in-trust</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrust_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trust account balance</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:to="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount to be deposited in the trust account in connection with the exercise of the first monthly extension.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount to be Deposited in Trust Account in Connection With The Exercise of First Monthly Extension</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount to be deposited in trust account in connection with the exercise of the first monthly extension</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNetInterestToPayDissolutionExpenses" xlink:label="dkdcu_MaximumNetInterestToPayDissolutionExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_MaximumNetInterestToPayDissolutionExpenses" xlink:to="dkdcu_MaximumNetInterestToPayDissolutionExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_MaximumNetInterestToPayDissolutionExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_MaximumNetInterestToPayDissolutionExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum Net Interest To Pay Dissolution Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_MaximumNetInterestToPayDissolutionExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum net interest to pay dissolution expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of Class B Common Stock to Sponsor</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of founder shares</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xlink:to="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow associated with interest withdrawn from Trust Account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Interest Withdrawn from Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest withdrawn from Trust Account</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" xlink:to="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Increase (Decrease), Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible loans</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Convertible, Conversion Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Units per price</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Public share price considered</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Related Party Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from promissory note</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfPublicSharesToBeRedeemed." xlink:label="dkdcu_PercentageOfPublicSharesToBeRedeemed." xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PercentageOfPublicSharesToBeRedeemed." xlink:to="dkdcu_PercentageOfPublicSharesToBeRedeemed._lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PercentageOfPublicSharesToBeRedeemed._lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of public shares redeemed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PercentageOfPublicSharesToBeRedeemed._lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage Of Public Shares To Be Redeemed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PercentageOfPublicSharesToBeRedeemed._lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of public shares redeemed</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:label="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:to="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condition for future business combination threshold Net Tangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condition For Future Business Combination Threshold Net Tangible Assets</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesTable" xlink:label="dkdcu_AccountingPoliciesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AccountingPoliciesTable" xlink:to="dkdcu_AccountingPoliciesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AccountingPoliciesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule detailing information related to accounting policies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AccountingPoliciesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting Policies [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember" xlink:label="us-gaap_OperatingExpenseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenseMember" xlink:to="us-gaap_OperatingExpenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Expense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Formation and operating costs</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ArcGroupLimitedMember" xlink:to="dkdcu_ArcGroupLimitedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to ARC Group Limited, the Company's financial advisor ("ARC").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ARC Group Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ARC</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to introducing advisor agreement with ARC Group Limited, the Company's financial advisor ("ARC").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Introducing Advisor Agreement with ARC Group Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Introducing Advisor Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Introducing Advisor Agreement with ARC Group Ltd</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesLineItems" xlink:label="dkdcu_AccountingPoliciesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AccountingPoliciesLineItems" xlink:to="dkdcu_AccountingPoliciesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AccountingPoliciesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent to accounting policies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AccountingPoliciesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AccountingPoliciesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Equivalents, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash equivalents</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantExercisable" xlink:label="dkdcu_WarrantExercisable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_WarrantExercisable" xlink:to="dkdcu_WarrantExercisable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_WarrantExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares of  warrant exercisable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_WarrantExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_WarrantExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant exercisable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-Based Payment Arrangement, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized tax benefits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized tax benefits accrued for interest and penalties</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective tax rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statutory tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statutory federal income tax rate</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromIssuanceOfTemporaryEquity" xlink:label="dkdcu_ProceedsFromIssuanceOfTemporaryEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ProceedsFromIssuanceOfTemporaryEquity" xlink:to="dkdcu_ProceedsFromIssuanceOfTemporaryEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ProceedsFromIssuanceOfTemporaryEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow from issuance of temporary equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ProceedsFromIssuanceOfTemporaryEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds From Issuance Of Temporary Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ProceedsFromIssuanceOfTemporaryEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Proceeds</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityProceedsAllocatedToWarrants" xlink:label="dkdcu_TemporaryEquityProceedsAllocatedToWarrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TemporaryEquityProceedsAllocatedToWarrants" xlink:to="dkdcu_TemporaryEquityProceedsAllocatedToWarrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TemporaryEquityProceedsAllocatedToWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of gross proceeds allocated from temporary equity to warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TemporaryEquityProceedsAllocatedToWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity Proceeds Allocated To Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TemporaryEquityProceedsAllocatedToWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds allocated to public warrants and private warrants</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityIssuanceCosts" xlink:label="dkdcu_TemporaryEquityIssuanceCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TemporaryEquityIssuanceCosts" xlink:to="dkdcu_TemporaryEquityIssuanceCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TemporaryEquityIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of issuance costs related to temporary equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TemporaryEquityIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TemporaryEquityIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance costs related to Class A Common Stock</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" xlink:label="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" xlink:to="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of redemption of Class A Common Stock subject to possible redemption, including interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption of Class A Common Stock Subject to Possible Redemption, Including Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption of Class A Common Stock, including interest</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Accretion to Redemption Value, Adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Re-measurement of carrying value to redemption value</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Domain]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PublicWarrantsMember" xlink:to="dkdcu_PublicWarrantsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PublicWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PublicWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Public Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PublicWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Public Warrants</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSharesIssuedPerUnit" xlink:label="dkdcu_NumberOfSharesIssuedPerUnit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_NumberOfSharesIssuedPerUnit" xlink:to="dkdcu_NumberOfSharesIssuedPerUnit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_NumberOfSharesIssuedPerUnit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the number of shares in a unit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_NumberOfSharesIssuedPerUnit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Shares Issued Per Unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_NumberOfSharesIssuedPerUnit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares in a unit</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssuedPerUnit" xlink:label="dkdcu_NumberOfWarrantsIssuedPerUnit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_NumberOfWarrantsIssuedPerUnit" xlink:to="dkdcu_NumberOfWarrantsIssuedPerUnit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_NumberOfWarrantsIssuedPerUnit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the number of warrants in a unit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_NumberOfWarrantsIssuedPerUnit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Warrants Issued Per Unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_NumberOfWarrantsIssuedPerUnit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of warrants in a unit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issuable per warrant</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price of warrants</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementTable" xlink:label="dkdcu_PrivatePlacementTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PrivatePlacementTable" xlink:to="dkdcu_PrivatePlacementTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PrivatePlacementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule reflecting a private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PrivatePlacementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Private Placement [Table]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementLineItems" xlink:label="dkdcu_PrivatePlacementLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PrivatePlacementLineItems" xlink:to="dkdcu_PrivatePlacementLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PrivatePlacementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PrivatePlacementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Private Placement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PrivatePlacementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">PRIVATE PLACEMENT</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of warrants to purchase shares issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to second amendment to the introducing advisor agreement with ARC Group Limited, the Company's financial advisor ("ARC").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Second Amendment to the Introducing Advisor Agreement with ARC Group Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Second Amendment to the Introducing Advisor Agreement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Chief Executive Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Chief Executive Officer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Chief Financial Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Chief Financial Officer</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TwoIndependentDirectorMember" xlink:label="dkdcu_TwoIndependentDirectorMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TwoIndependentDirectorMember" xlink:to="dkdcu_TwoIndependentDirectorMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TwoIndependentDirectorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to two independent director member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TwoIndependentDirectorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Two Independent Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TwoIndependentDirectorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Two Independent Director</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdIndependentDirectorMember" xlink:label="dkdcu_ThirdIndependentDirectorMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ThirdIndependentDirectorMember" xlink:to="dkdcu_ThirdIndependentDirectorMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ThirdIndependentDirectorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to third independent director member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ThirdIndependentDirectorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Third Independent Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ThirdIndependentDirectorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Third Independent Director</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AffiliatedEntityMember" xlink:to="srt_AffiliatedEntityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AffiliatedEntityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ARC Group Ltd</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_AffiliatedEntityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ARC Group Ltd</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RELATED PARTY TRANSACTIONS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of Class B Common Stock to Sponsor (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:to="dkdcu_StockTransferredToOthersDuringPeriodShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares transferred to others during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Transferred to Others During Period Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares transferred</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:to="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The expected ownership percentage by the founders after completion of the proposed public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents maximum number of shares subject to forfeiture.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum Number of Shares Subject to Forfeiture if Public Stockholders Exercise Redemption Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:to="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period of time after completion of a business combination during which the shares or warrant may not be transferred.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restrictions On Transfer Period Of Time After Business Combination Completion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restrictions on transfer period of time after business combination completion</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:to="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The transfer assign or sell any shares or warrants after completion of initial business combination threshold trading days business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Consecutive Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:to="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The transfer assign or sell any shares or warrants after completion of initial business combination threshold trading days business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer Assign Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:label="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:to="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PromissoryNoteWithRelatedPartyMember" xlink:label="dkdcu_PromissoryNoteWithRelatedPartyMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PromissoryNoteWithRelatedPartyMember" xlink:to="dkdcu_PromissoryNoteWithRelatedPartyMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PromissoryNoteWithRelatedPartyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for promissory note with related party.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PromissoryNoteWithRelatedPartyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Promissory Note with Related Party [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PromissoryNoteWithRelatedPartyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Promissory Note with Related Party</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdministrativeSupportAgreementMember" xlink:label="dkdcu_AdministrativeSupportAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AdministrativeSupportAgreementMember" xlink:to="dkdcu_AdministrativeSupportAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AdministrativeSupportAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for administrative support agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AdministrativeSupportAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Administrative Support Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AdministrativeSupportAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Administrative Support Agreement</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyLoansMember" xlink:label="dkdcu_RelatedPartyLoansMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RelatedPartyLoansMember" xlink:to="dkdcu_RelatedPartyLoansMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RelatedPartyLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for related party loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RelatedPartyLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Loans [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RelatedPartyLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Loans</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:to="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to first amendment to the introducing advisor agreement with ARC Group Limited, the company's financial advisor ("ARC").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First Amendment to the Introducing Advisor Agreement with ARC Group Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First Amendment to the Introducing Advisor Agreement</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalLoansWarrantMember" xlink:label="dkdcu_WorkingCapitalLoansWarrantMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_WorkingCapitalLoansWarrantMember" xlink:to="dkdcu_WorkingCapitalLoansWarrantMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_WorkingCapitalLoansWarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for working capital loans warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_WorkingCapitalLoansWarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Working Capital Loans Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_WorkingCapitalLoansWarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Working capital loans warrant</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RetainerFeeUponExecutionOfAgreement" xlink:label="dkdcu_RetainerFeeUponExecutionOfAgreement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RetainerFeeUponExecutionOfAgreement" xlink:to="dkdcu_RetainerFeeUponExecutionOfAgreement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RetainerFeeUponExecutionOfAgreement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of retainer fee upon execution of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RetainerFeeUponExecutionOfAgreement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retainer Fee Upon Execution Of Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RetainerFeeUponExecutionOfAgreement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retainer fee</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" xlink:label="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" xlink:to="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of success fee upon closing of business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Success Fee Upon Closing Of Initial Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Success fee</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfOwnershipAsConsiderationForService" xlink:label="dkdcu_PercentageOfOwnershipAsConsiderationForService" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PercentageOfOwnershipAsConsiderationForService" xlink:to="dkdcu_PercentageOfOwnershipAsConsiderationForService_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PercentageOfOwnershipAsConsiderationForService_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the percentage of ownership as consideration for service.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PercentageOfOwnershipAsConsiderationForService_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of Ownership as Consideration for Service</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PercentageOfOwnershipAsConsiderationForService_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of ownership as consideration for service</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" xlink:label="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" xlink:to="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the threshold period for consideration payable after the closes on business combination or any financing with any Advisor Target or any affiliate of an Advisor Target.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold Period for Consideration Payable After the Closes on Business Combination or Any Financing with Any Advisor Target or Any Affiliate of an Advisor Target</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold period for consideration payable after the closes on business combination or any financing with any Advisor Target or any affiliate of an Advisor Target</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:to="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of success fee on any PIPE that was brought by ARC.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of Success Fee on Any PIPE Financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of success fee on any PIPE that was brought by ARC</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares granted</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:to="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of maximum borrowing capacity of related party promissory note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum Borrowing Capacity of Related Party Promissory Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum borrowing capacity of related party promissory note</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumLoansConvertibleUptoConsummation" xlink:label="dkdcu_MaximumLoansConvertibleUptoConsummation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_MaximumLoansConvertibleUptoConsummation" xlink:to="dkdcu_MaximumLoansConvertibleUptoConsummation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_MaximumLoansConvertibleUptoConsummation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of maximum loans convertible up to consummation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_MaximumLoansConvertibleUptoConsummation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum Loans Convertible Up to Consummation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_MaximumLoansConvertibleUptoConsummation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related party loans convertible up to consummation of a business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" xlink:label="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" xlink:to="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period from the closing of the Company's initial public offering during which the company is required to consummate Initial Business Combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period from the closing of the Company initial public offering to consummate Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period from the closing of the company's initial public offering to consummate business combination</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Notes Payable, Related Parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding balance of related party note</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayments of Related Party Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayment of promissory note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding of promissory note - related party</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" xlink:label="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" xlink:to="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of maximum loans convertible up to consummation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Loans Convertible Up To Consummation Of Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related party loans convertible up to consummation of a Business Combination</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock, Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of stock, price per share</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecuritiesDepositHeldInTrustAccount" xlink:label="dkdcu_SecuritiesDepositHeldInTrustAccount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_SecuritiesDepositHeldInTrustAccount" xlink:to="dkdcu_SecuritiesDepositHeldInTrustAccount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_SecuritiesDepositHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of securities or Deposits held in the trust account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_SecuritiesDepositHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Securities Deposit Held In Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_SecuritiesDepositHeldInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deposit held in trust account</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" xlink:label="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" xlink:to="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of business days prior to the applicable deadline during which a notice of extension is to be given for deposit to be made in trust account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Business Days For Advance Notice Of Extension To Be Given</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of business days for advance notice of extension to be given</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" xlink:label="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" xlink:to="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate period including extension period during which the company is required to consummate Initial Business Combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate Period To Consummate Initial Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate period to consummate business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_BusinessCombinationTotalPayments" xlink:label="dkdcu_BusinessCombinationTotalPayments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_BusinessCombinationTotalPayments" xlink:to="dkdcu_BusinessCombinationTotalPayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_BusinessCombinationTotalPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of payment in business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_BusinessCombinationTotalPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Total Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_BusinessCombinationTotalPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business combination, total payments</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:to="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The contractual monthly amount to be paid for support services.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction, Expenses from Transactions with Related Party Per Month</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses per month</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction, Expenses from Transactions with Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related party transaction expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss Contingencies [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss Contingencies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">COMMITMENTS AND CONTINGENCIES</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:to="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the maximum number of demands for registration of securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum Number Of Demands For Registration Of Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum number of demands for registration of securities</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OverAllotmentOptionPeriod" xlink:label="dkdcu_OverAllotmentOptionPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_OverAllotmentOptionPeriod" xlink:to="dkdcu_OverAllotmentOptionPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_OverAllotmentOptionPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period of the over-allotment option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_OverAllotmentOptionPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Over Allotment Option Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_OverAllotmentOptionPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Overallotment option period</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPercentage" xlink:label="dkdcu_UnderwritingDiscountPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_UnderwritingDiscountPercentage" xlink:to="dkdcu_UnderwritingDiscountPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_UnderwritingDiscountPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of per Unit offering price paid as discount to underwriter.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_UnderwritingDiscountPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Underwriting Discount Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_UnderwritingDiscountPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Underwriting discount (as a percent)</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPaid" xlink:label="dkdcu_UnderwritingDiscountPaid" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_UnderwritingDiscountPaid" xlink:to="dkdcu_UnderwritingDiscountPaid_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_UnderwritingDiscountPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of underwriting discount paid by the company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_UnderwritingDiscountPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Underwriting Discount Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_UnderwritingDiscountPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Underwriting discount paid</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeesPercentage" xlink:label="dkdcu_DeferredUnderwritingFeesPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_DeferredUnderwritingFeesPercentage" xlink:to="dkdcu_DeferredUnderwritingFeesPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_DeferredUnderwritingFeesPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of deferred underwriting commissions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_DeferredUnderwritingFeesPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Underwriting Fees Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_DeferredUnderwritingFeesPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred underwriting fees (as a percent)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redeemable warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PlacementWarrantsMember" xlink:label="dkdcu_PlacementWarrantsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PlacementWarrantsMember" xlink:to="dkdcu_PlacementWarrantsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PlacementWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to placement warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PlacementWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Placement Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PlacementWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Placement Warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Domain]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 18.00 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 10.00 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">WARRANT LIABILITY</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:label="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:to="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum threshold written notice period for redemption of public warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants and Rights Outstanding, Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Public Warrants expiration term</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" xlink:to="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum threshold period for registration statement to become effective after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">MaximumThresHoldPeriodForFilingRegistrationStatementAfterBusinessCombination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum threshold period for registration statement to become effective after business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" xlink:to="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum threshold period for registration statement to become effective after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">MaximumThresholdPeriodForRegistrationStatementToBecomeEffectiveAfterBusinessCombination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum threshold period for registration statement to become effective after business combination</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock price trigger for redemption of public warrants (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption price per share or per unit of warrants or rights outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redemption price per public warrant (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold trading days for redemption of public warrants</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold consecutive trading days for redemption of public warrants</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:label="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:to="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the percentage of gross proceeds on total equity proceeds.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of Gross Proceeds on Total Equity Proceed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of gross proceeds on total equity proceed</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:label="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:to="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The threshold number of specified trading period determining volume weighted average trading price , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Specified Trading Days Determining Volume Weighted Average Trading Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading days determining volume weighted average price</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" xlink:label="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" xlink:to="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage represents the class of warrant or right Adjustment of exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class Of Warrant Or Right Adjustment Of Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustment of exercise price of warrants based on market value (as a percent)</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantsOrRightsIssued" xlink:label="dkdcu_WarrantsOrRightsIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_WarrantsOrRightsIssued" xlink:to="dkdcu_WarrantsOrRightsIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_WarrantsOrRightsIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The Value of issued derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_WarrantsOrRightsIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants Or Rights Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_WarrantsOrRightsIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Stock by Class [Table]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaNotSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaNotSubjectToRedemptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CommonClassaNotSubjectToRedemptionMember" xlink:to="dkdcu_CommonClassaNotSubjectToRedemptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CommonClassaNotSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classification of common stock representing ownership interest in a corporation that is not subject to redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CommonClassaNotSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Class a Not Subject To Redemption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CommonClassaNotSubjectToRedemptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class A Common Stock Not Subject to Redemption</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of Individual [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of Individual [Domain]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IndependentDirectorsMember" xlink:label="dkdcu_IndependentDirectorsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_IndependentDirectorsMember" xlink:to="dkdcu_IndependentDirectorsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_IndependentDirectorsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to independent directors.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_IndependentDirectorsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Independent Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_IndependentDirectorsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Independent Directors</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">STOCKHOLDER'S EQUITY</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockNumberOfVotesPerShare" xlink:label="dkdcu_CommonStockNumberOfVotesPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CommonStockNumberOfVotesPerShare" xlink:to="dkdcu_CommonStockNumberOfVotesPerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CommonStockNumberOfVotesPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of votes that each common share is entitled.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CommonStockNumberOfVotesPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Number of Votes Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CommonStockNumberOfVotesPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, votes per share</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareIssued" xlink:label="dkdcu_CommonStockShareIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CommonStockShareIssued" xlink:to="dkdcu_CommonStockShareIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CommonStockShareIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents of Common Stock Share Issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CommonStockShareIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock Share Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CommonStockShareIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares, shares issued</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareOutstanding" xlink:label="dkdcu_CommonStockShareOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CommonStockShareOutstanding" xlink:to="dkdcu_CommonStockShareOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CommonStockShareOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents of Common Stock Share Outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CommonStockShareOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock Share Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CommonStockShareOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares, shares outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Note, Stock Split, Conversion Ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, conversion ratio</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" xlink:label="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" xlink:to="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of outstanding stock after stock conversion issuable pursuant to initial business combination transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Initial Business Combination Shares Issuable as percent of Outstanding Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issuable as percent of outstanding shares on Initial Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Initial business combination shares issuable as percent of outstanding share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Recurring and Nonrecurring [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Hierarchy and NAV [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Hierarchy and NAV [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Inputs, Level 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Level 1</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Inputs, Level 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Level 3</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Frequency [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Frequency [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Recurring [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Recurring basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Recurring</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementWarrantsMember" xlink:label="dkdcu_PrivatePlacementWarrantsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PrivatePlacementWarrantsMember" xlink:to="dkdcu_PrivatePlacementWarrantsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Private Placement Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Private Placement Warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">FAIR VALUE MEASUREMENTS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Instrument [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Instruments [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Money Market Funds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Money market mutual fund</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">US Treasury Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">U.S. Treasury Securities</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" xlink:label="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" xlink:to="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of transfers of assets and liabilities measured on a recurring basis between level 1 and level 2.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Assets and Liabilities, Transfers Between Level 1 to Level 2, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer of assets and liabilities between level 1 and level 2</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer of assets into level 3</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer of assets out of level 3</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer of liabilities into level 3</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfer of liabilities out of level 3</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivateWarrantMember" xlink:label="dkdcu_PrivateWarrantMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PrivateWarrantMember" xlink:to="dkdcu_PrivateWarrantMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PrivateWarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to private warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PrivateWarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Private Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PrivateWarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Private Warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input, Exercise Price [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input, Share Price [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Price</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input, Expected Term [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected term (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected term (years)</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" xlink:label="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" xlink:to="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement input using probability of acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Probability of Acquisition [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Probability of Acquisition</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input, Price Volatility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Volatility</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input, Risk Free Interest Rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk-free rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input, Expected Dividend Rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dividend yield (per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Liability, Measurement Input</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value measurements input</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative liability, measurement input</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityMember" xlink:label="dkdcu_WarrantLiabilityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_WarrantLiabilityMember" xlink:to="dkdcu_WarrantLiabilityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_WarrantLiabilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to warrant liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_WarrantLiabilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_WarrantLiabilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant Liability</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">FAIR VALUE MEASUREMENTS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in fair value of derivative warrant liabilities</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xlink:to="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of liability, fair value measurement with unobservable inputs, reconciliation recurring basis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value, beginning balance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in valuation inputs or other assumption</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Events.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent event</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdMonthExtensionToTerminationDateMember" xlink:label="dkdcu_ThirdMonthExtensionToTerminationDateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_ThirdMonthExtensionToTerminationDateMember" xlink:to="dkdcu_ThirdMonthExtensionToTerminationDateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_ThirdMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to third month extension to termination date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_ThirdMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Third Month Extension to Termination Date [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_ThirdMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Third-month extension to the Termination Date</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FourthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FourthMonthExtensionToTerminationDateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_FourthMonthExtensionToTerminationDateMember" xlink:to="dkdcu_FourthMonthExtensionToTerminationDateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_FourthMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to fourth month extension to termination date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_FourthMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fourth Month Extension to Termination Date [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_FourthMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fourth-month extension to the Termination Date</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FifthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FifthMonthExtensionToTerminationDateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_FifthMonthExtensionToTerminationDateMember" xlink:to="dkdcu_FifthMonthExtensionToTerminationDateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_FifthMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to fifth month extension to termination date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_FifthMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fifth Month Extension to Termination Date [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_FifthMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fifth-month extension to the Termination Date</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SixthOneMonthExtensionToTerminationDateMember" xlink:label="dkdcu_SixthOneMonthExtensionToTerminationDateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_SixthOneMonthExtensionToTerminationDateMember" xlink:to="dkdcu_SixthOneMonthExtensionToTerminationDateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_SixthOneMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to six one month extension to termination date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_SixthOneMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sixth One Month Extension To Termination Date [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_SixthOneMonthExtensionToTerminationDateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sixth one-month extension to the Termination Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forecast [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forecast</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUBSEQUENT EVENTS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment Income, Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest earned</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedPerEachPublicShareOutstanding" xlink:label="dkdcu_AmountDepositedPerEachPublicShareOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AmountDepositedPerEachPublicShareOutstanding" xlink:to="dkdcu_AmountDepositedPerEachPublicShareOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AmountDepositedPerEachPublicShareOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount per each outstanding public share deposited in trust account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AmountDepositedPerEachPublicShareOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount Deposited Per Each Public Share Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AmountDepositedPerEachPublicShareOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount deposited per each public share outstanding</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregateAmountDepositedInTrustAccount" xlink:label="dkdcu_AggregateAmountDepositedInTrustAccount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AggregateAmountDepositedInTrustAccount" xlink:to="dkdcu_AggregateAmountDepositedInTrustAccount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AggregateAmountDepositedInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount deposited in trust account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AggregateAmountDepositedInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate Amount Deposited in Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AggregateAmountDepositedInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate amount deposited</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsOfFranchiseTax" xlink:label="dkdcu_PaymentsOfFranchiseTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_PaymentsOfFranchiseTax" xlink:to="dkdcu_PaymentsOfFranchiseTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_PaymentsOfFranchiseTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of payment of franchise tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_PaymentsOfFranchiseTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments of franchise tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_PaymentsOfFranchiseTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments of franchise tax</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashWaivedDeferredUnderwritingCommission" xlink:label="dkdcu_CashWaivedDeferredUnderwritingCommission" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CashWaivedDeferredUnderwritingCommission" xlink:to="dkdcu_CashWaivedDeferredUnderwritingCommission_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CashWaivedDeferredUnderwritingCommission_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of cash waived deferred underwriting commissions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CashWaivedDeferredUnderwritingCommission_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Waived Deferred Underwriting Commission</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CashWaivedDeferredUnderwritingCommission_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Waived amount</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashDeferredUnderwritingCommissions" xlink:label="dkdcu_CashDeferredUnderwritingCommissions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_CashDeferredUnderwritingCommissions" xlink:to="dkdcu_CashDeferredUnderwritingCommissions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_CashDeferredUnderwritingCommissions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_CashDeferredUnderwritingCommissions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Deferred Underwriting Commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_CashDeferredUnderwritingCommissions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash deferred underwriting commission</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyPayment" xlink:label="dkdcu_RelatedPartyPayment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RelatedPartyPayment" xlink:to="dkdcu_RelatedPartyPayment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RelatedPartyPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of related party payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RelatedPartyPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RelatedPartyPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash payment</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyPromissoryNoteExecuted" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecuted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RelatedPartyPromissoryNoteExecuted" xlink:to="dkdcu_RelatedPartyPromissoryNoteExecuted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecuted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of related party promissory note executed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecuted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Promissory Note Executed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecuted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Promissory note executed</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth" xlink:to="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of related party promissory note executed per month.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Promissory Note Executed Per Month</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Executed per month</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregateNumberOfSharesOwned" xlink:label="dkdcu_AggregateNumberOfSharesOwned" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_AggregateNumberOfSharesOwned" xlink:to="dkdcu_AggregateNumberOfSharesOwned_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_AggregateNumberOfSharesOwned_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of shares owned by the founders after the impact of the stock dividend.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_AggregateNumberOfSharesOwned_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate Number Of Shares Owned</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_AggregateNumberOfSharesOwned_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate number of shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Face Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate value</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">INCOME TAX</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">INCOME TAX</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of income tax provision</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of significant components of the Company's deferred tax assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Federal.</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Federal Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Federal Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in valuation allowance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Loss Carryforwards [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Loss Carryforwards [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Loss Carryforwards</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax assets:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Operating Loss</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StartUpCosts" xlink:label="dkdcu_StartUpCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_StartUpCosts" xlink:to="dkdcu_StartUpCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_StartUpCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of Sec. 195 Start-up Costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_StartUpCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Start-up Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_StartUpCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sec. 195 Start-up Costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Deferred Tax Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Net [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liability</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnrealizedGainOnInvestmentInTrustAccount" xlink:label="dkdcu_UnrealizedGainOnInvestmentInTrustAccount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_UnrealizedGainOnInvestmentInTrustAccount" xlink:to="dkdcu_UnrealizedGainOnInvestmentInTrustAccount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_UnrealizedGainOnInvestmentInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of Unrealized gain on Investment in Trust Account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_UnrealizedGainOnInvestmentInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrealized gain on Investment in Trust Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="dkdcu_UnrealizedGainOnInvestmentInTrustAccount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrealized gain on Investment in Trust Account</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Deferred Tax Liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less: Valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Valuation allowance</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities" xlink:to="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to change in fair value of derivative liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Change in Fair Value of Derivative Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in fair value of derivative liabilities</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance" xlink:to="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs allocated to warrant issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Transaction Costs Allocated to Warrant Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs allocated to warrant issuance</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:to="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Transaction Costs, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in valuation allowance</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_U.s.FederalAndStateNetOperatingLoss" xlink:label="dkdcu_U.s.FederalAndStateNetOperatingLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_U.s.FederalAndStateNetOperatingLoss" xlink:to="dkdcu_U.s.FederalAndStateNetOperatingLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_U.s.FederalAndStateNetOperatingLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of U.S. federal and state net operating loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_U.s.FederalAndStateNetOperatingLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">U.S. Federal and State Net Operating Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dkdcu_U.s.FederalAndStateNetOperatingLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">U.S. federal and state net operating loss</label>
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_LimitationOnAnnualTaxableIncome" xlink:label="dkdcu_LimitationOnAnnualTaxableIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dkdcu_LimitationOnAnnualTaxableIncome" xlink:to="dkdcu_LimitationOnAnnualTaxableIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="dkdcu_LimitationOnAnnualTaxableIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents of Limitation On Annual Taxable Income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dkdcu_LimitationOnAnnualTaxableIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Limitation on Annual Taxable Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dkdcu_LimitationOnAnnualTaxableIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Limitation on annual taxable income</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>dkdcu-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.3.0.9 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/3/2023 10:19:27 PM-->
<!--Modified on: 7/3/2023 10:19:27 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedStatementsOfOperations" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureDescriptionOfOrganizationAndBusinessOperations" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPolicies" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureInitialPublicOffering" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOffering" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosurePrivatePlacement" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacement" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactions" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureCommitmentsAndContingencies" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureWarrantLiability" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureStockholderSEquity" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurements" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurements" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSubsequentEvents" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEvents" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsTables" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureInitialPublicOfferingDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosurePrivatePlacementDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactionsFounderSharesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureCommitmentsAndContingenciesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureWarrantLiabilityDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureStockholderSEquityPreferredSharesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredSharesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureStockholderSEquityCommonStockDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSubsequentEventsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedBalanceSheetParenthetical" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedStatementsOfOperations" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedStatementsOfChangesInStockholdersDeficit" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureDescriptionOfOrganizationAndBusinessOperationss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciess" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciess" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureInitialPublicOfferings" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferings" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosurePrivatePlacements" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacements" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactionss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureCommitmentsAndContingenciess" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciess" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureWarrantLiabilitys" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilitys" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureStockholderSEquitys" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquitys" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureIncomeTaxes" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSubsequentEventss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPoliciess" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTabless" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTabless" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsTabless" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTabless" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureIncomeTaxesTables" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureInitialPublicOfferingDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosurePrivatePlacementDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactionsFounderSharesDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureRelatedPartyTransactionsAdditionalInformationDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureCommitmentsAndContingenciesDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureWarrantLiabilityDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureStockholderSEquityPreferredStockSharesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredStockSharesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureStockholderSEquityCommonStockSharesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureIncomeTaxIncomeTaxProvisionDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureIncomeTaxesNetDeferredTaxAssetsDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureIncomeTaxesFederalIncomeTaxRateDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureIncomeTaxesDetails" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="dkdcu-20230331.xsd#DisclosureSubsequentEventsDetailss" roleURI="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="100090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638240195656224694" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638240195656224694" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638240195656224694" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638240195656224694" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFilerCategory_638240195656234201" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntitySmallBusiness_638240195656234201" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638240195656234201" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityExTransitionPeriod_638240195656234201" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638240195656234201" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638240195656234201" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentDescription_638240195656234201" order="9" use="optional" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="extended" xlink:title="100100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_637309996491150416" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637309996491150416" xlink:to="us-gaap_StatementTable_638240195656234201" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656234201" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656234201" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656234201" xlink:to="us-gaap_ClassOfStockDomain_638240195656234201" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656234201" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656234201" xlink:to="us-gaap_CommonClassAMember_638240195656234201" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656234201" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember_638240195656244199" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656234201" xlink:to="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_638240195656244199" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656234201" xlink:to="us-gaap_CommonClassBMember_638240195656244199" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656234201" xlink:to="us-gaap_StatementLineItems_638240195656244199" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656244199" xlink:to="us-gaap_AssetsAbstract_638240195656244199" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638240195656244199" xlink:to="us-gaap_AssetsCurrentAbstract_638240195656244199" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638240195656244199" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638240195656244199" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638240195656244199" xlink:to="us-gaap_PrepaidExpenseCurrent_638240195656244199" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrepaidInsuranceCurrent" xlink:label="dkdcu_PrepaidInsuranceCurrent_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638240195656244199" xlink:to="dkdcu_PrepaidInsuranceCurrent_638240195656244199" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638240195656244199" xlink:to="us-gaap_AssetsCurrent_638240195656244199" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_638240195656244199" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638240195656244199" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_638240195656244199" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_638240195656254222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638240195656244199" xlink:to="us-gaap_Assets_638240195656254222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656244199" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_638240195656254222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="us-gaap_LiabilitiesCurrentAbstract_638240195656254222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_638240195656254222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656254222" xlink:to="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_638240195656254222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent_638240195656254222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656254222" xlink:to="us-gaap_DueToRelatedPartiesCurrent_638240195656254222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_638240195656254222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656254222" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_638240195656254222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_638240195656254222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656254222" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_638240195656254222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638240195656254222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656254222" xlink:to="us-gaap_LiabilitiesCurrent_638240195656254222" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityNonCurrent" xlink:label="dkdcu_WarrantLiabilityNonCurrent_638240195656254222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="dkdcu_WarrantLiabilityNonCurrent_638240195656254222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredOfferingCostsNonCurrent" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent_638240195656264204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="dkdcu_DeferredOfferingCostsNonCurrent_638240195656264204" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_638240195656264204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent_638240195656264204" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent_638240195656264204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="dkdcu_ExtensionLoansNonCurrent_638240195656264204" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_638240195656264204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="us-gaap_Liabilities_638240195656264204" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638240195656264204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="us-gaap_CommitmentsAndContingencies_638240195656264204" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195656264204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195656264204" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_638240195656264204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="us-gaap_StockholdersEquityAbstract_638240195656264204" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_638240195656264204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656264204" xlink:to="us-gaap_PreferredStockValue_638240195656264204" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638240195656274235" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656264204" xlink:to="us-gaap_CommonStockValue_638240195656274235" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_638240195656274235" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656264204" xlink:to="us-gaap_AdditionalPaidInCapital_638240195656274235" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638240195656274235" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656264204" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638240195656274235" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638240195656274235" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656264204" xlink:to="us-gaap_StockholdersEquity_638240195656274235" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_638240195656274235" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656254222" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_638240195656274235" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="100105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_637309996491800131" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638240195656274235" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637309996491800131" xlink:to="us-gaap_StatementTable_638240195656274235" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656274235" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656284181" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656284181" xlink:to="us-gaap_ClassOfStockDomain_638240195656284181" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656284181" xlink:to="us-gaap_CommonClassAMember_638240195656284181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656284181" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember_638240195656284181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656284181" xlink:to="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_638240195656284181" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656284181" xlink:to="us-gaap_CommonClassBMember_638240195656284181" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656274235" xlink:to="us-gaap_StatementLineItems_638240195656284181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_638240195656284181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_PreferredStockSharesAuthorized_638240195656284181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_PreferredStockSharesIssued_638240195656284181" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_PreferredStockSharesOutstanding_638240195656284181" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638240195656284181" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_638240195656284181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_CommonStockSharesAuthorized_638240195656284181" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_638240195656294176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_CommonStockSharesIssued_638240195656294176" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638240195656294176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_CommonStockSharesOutstanding_638240195656294176" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_638240195656294176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_638240195656294176" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_638240195656294176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656284181" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_638240195656294176" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations" xlink:type="extended" xlink:title="100200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638240195656294176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable_638240195656294176" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656294176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656294176" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656294176" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656294176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656294176" xlink:to="us-gaap_ClassOfStockDomain_638240195656294176" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656294176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656294176" xlink:to="us-gaap_CommonClassAMember_638240195656294176" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656294176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656294176" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656294176" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656294176" xlink:to="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_638240195656304175" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656294176" xlink:to="us-gaap_StatementLineItems_638240195656304175" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_OperatingCostsAndExpenses_638240195656304175" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FranchiseTaxExpense" xlink:label="dkdcu_FranchiseTaxExpense_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="dkdcu_FranchiseTaxExpense_638240195656304175" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_OperatingIncomeLoss_638240195656304175" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656304175" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656304175" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195656304175" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656304175" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss_638240195656304175" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656304175" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_638240195656304175" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656304175" xlink:to="us-gaap_NonoperatingIncomeExpense_638240195656304175" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195656304175" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638240195656304175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638240195656304175" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638240195656314204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_NetIncomeLoss_638240195656314204" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638240195656314204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638240195656314204" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638240195656314204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638240195656314204" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638240195656314204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_EarningsPerShareBasic_638240195656314204" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638240195656314204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656304175" xlink:to="us-gaap_EarningsPerShareDiluted_638240195656314204" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:type="extended" xlink:title="100300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_637309996491800131" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638240195656314204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract_637309996491800131" xlink:to="us-gaap_StatementTable_638240195656314204" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656314204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656314204" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656314204" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656314204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656314204" xlink:to="us-gaap_CommonClassAMember_638240195656314204" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656314204" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656314204" xlink:to="us-gaap_CommonClassBMember_638240195656314204" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656314204" xlink:to="us-gaap_ClassOfStockDomain_638240195656324214" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656314204" xlink:to="us-gaap_StatementEquityComponentsAxis_638240195656324214" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638240195656324214" xlink:to="us-gaap_CommonStockMember_638240195656324214" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638240195656324214" xlink:to="us-gaap_AdditionalPaidInCapitalMember_638240195656324214" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638240195656324214" xlink:to="us-gaap_RetainedEarningsMember_638240195656324214" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638240195656324214" xlink:to="us-gaap_EquityComponentDomain_638240195656324214" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656314204" xlink:to="us-gaap_StatementLineItems_638240195656324214" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656324214" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" xlink:to="us-gaap_StockholdersEquity_638240195656324214" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" xlink:to="us-gaap_SharesIssued_638240195656324214" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor_638240195656324214" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor_638240195656324214" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares_638240195656334182" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares_638240195656334182" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionValue" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionValue_638240195656334182" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionValue_638240195656334182" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionShares" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionShares_638240195656334182" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionShares_638240195656334182" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638240195656334182" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" xlink:to="us-gaap_NetIncomeLoss_638240195656334182" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638240195656334182" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" xlink:to="us-gaap_StockholdersEquity_638240195656334182" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_638240195656334182" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656324214" xlink:to="us-gaap_SharesIssued_638240195656334182" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="100400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_638240195656334182" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" xlink:to="us-gaap_ProfitLoss_638240195656334182" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OfferingCostsAllocatedToWarrantLiability" xlink:label="dkdcu_OfferingCostsAllocatedToWarrantLiability_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" xlink:to="dkdcu_OfferingCostsAllocatedToWarrantLiability_638240195656344178" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" xlink:to="us-gaap_ShareBasedCompensation_638240195656344178" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss_638240195656344178" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195656344178" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_638240195656344178" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195656344178" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195656344178" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_638240195656344178" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195656344178" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_638240195656344178" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IncreaseDecreaseFranchiseTaxPayable" xlink:label="dkdcu_IncreaseDecreaseFranchiseTaxPayable_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195656344178" xlink:to="dkdcu_IncreaseDecreaseFranchiseTaxPayable_638240195656344178" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195656344178" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638240195656344178" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195656334182" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195656344178" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638240195656344178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638240195656344178" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195656354197" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638240195656344178" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195656354197" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195656354197" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638240195656344178" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195656354197" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638240195656354197" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638240195656354197" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NetProceedsFromInitialPublicOffering" xlink:label="dkdcu_NetProceedsFromInitialPublicOffering_638240195656354197" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" xlink:to="dkdcu_NetProceedsFromInitialPublicOffering_638240195656354197" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfPrivateUnits" xlink:label="dkdcu_ProceedsFromSaleOfPrivateUnits_638240195656354197" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" xlink:to="dkdcu_ProceedsFromSaleOfPrivateUnits_638240195656354197" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_638240195656354197" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_638240195656354197" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdvancesFromRelatedParties" xlink:label="dkdcu_AdvancesFromRelatedParties_638240195656354197" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" xlink:to="dkdcu_AdvancesFromRelatedParties_638240195656354197" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromWorkingCapitalLoan" xlink:label="dkdcu_ProceedsFromWorkingCapitalLoan_638240195656354197" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" xlink:to="dkdcu_ProceedsFromWorkingCapitalLoan_638240195656354197" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromExtensionLoan" xlink:label="dkdcu_ProceedsFromExtensionLoan_638240195656364178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" xlink:to="dkdcu_ProceedsFromExtensionLoan_638240195656364178" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195656364178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195656354197" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195656364178" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638240195656364178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638240195656364178" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638240195656364178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638240195656364178" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6382401956563641781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6382401956563641781" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195656364178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195656364178" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption" xlink:label="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption_638240195656364178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195656364178" xlink:to="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption_638240195656364178" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest" xlink:label="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest_638240195656364178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195656364178" xlink:to="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest_638240195656364178" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeePayable" xlink:label="dkdcu_DeferredUnderwritingFeePayable_638240195656374203" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195656364178" xlink:to="dkdcu_DeferredUnderwritingFeePayable_638240195656374203" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialFairValueOfWarrantLiabilities" xlink:label="dkdcu_InitialFairValueOfWarrantLiabilities_638240195656374203" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195656364178" xlink:to="dkdcu_InitialFairValueOfWarrantLiabilities_638240195656374203" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations" xlink:type="extended" xlink:title="110101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations_638240195656374203" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations_638240195656374203" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="extended" xlink:title="110201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_638240195656374203" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_638240195656374203" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOffering" xlink:type="extended" xlink:title="110301 - Disclosure - INITIAL PUBLIC OFFERING" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialPublicOfferingAbstract" xlink:label="dkdcu_InitialPublicOfferingAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialPublicOfferingDisclosureTextBlock" xlink:label="dkdcu_InitialPublicOfferingDisclosureTextBlock_638240195656384178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_InitialPublicOfferingAbstract" xlink:to="dkdcu_InitialPublicOfferingDisclosureTextBlock_638240195656384178" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacement" xlink:type="extended" xlink:title="110401 - Disclosure - PRIVATE PLACEMENT" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementAbstract" xlink:label="dkdcu_PrivatePlacementAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementTextBlock" xlink:label="dkdcu_PrivatePlacementTextBlock_638240195656384178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementAbstract" xlink:to="dkdcu_PrivatePlacementTextBlock_638240195656384178" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactions" xlink:type="extended" xlink:title="110501 - Disclosure - RELATED PARTY TRANSACTIONS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_638240195656384178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_638240195656384178" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingencies" xlink:type="extended" xlink:title="110601 - Disclosure - COMMITMENTS AND CONTINGENCIES" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638240195656384178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638240195656384178" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiability" xlink:type="extended" xlink:title="110701 - Disclosure - WARRANT LIABILITY" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityAbstract" xlink:label="dkdcu_WarrantLiabilityAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityTextBlock" xlink:label="dkdcu_WarrantLiabilityTextBlock_638240195656394345" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_WarrantLiabilityAbstract" xlink:to="dkdcu_WarrantLiabilityTextBlock_638240195656394345" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquity" xlink:type="extended" xlink:title="110801 - Disclosure - STOCKHOLDER'S EQUITY" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_638240195656394345" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_638240195656394345" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurements" xlink:type="extended" xlink:title="110901 - Disclosure - FAIR VALUE MEASUREMENTS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock_638240195656394345" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock_638240195656394345" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEvents" xlink:type="extended" xlink:title="111001 - Disclosure - SUBSEQUENT EVENTS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock_638240195656394345" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock_638240195656394345" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" xlink:title="120202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_638240195656404193" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock_638240195656404193" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:label="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock_638240195656404193" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates_638240195656404193" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638240195656404193" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock" xlink:label="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock_638240195656404193" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_638240195656404193" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityPolicyPolicyTextBlock" xlink:label="dkdcu_TemporaryEquityPolicyPolicyTextBlock_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_TemporaryEquityPolicyPolicyTextBlock_638240195656404193" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_638240195656404193" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638240195656404193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638240195656404193" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk_638240195656414177" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk_638240195656414177" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_638240195656414177" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_638240195656414177" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock" xlink:label="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock_638240195656414177" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock_638240195656414177" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_638240195656414177" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_638240195656414177" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638240195656414177" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638240195656414177" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" xlink:title="130203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock_638240195656414177" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TemporaryEquityTableTextBlock_638240195656414177" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638240195656414177" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638240195656414177" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" xlink:type="extended" xlink:title="130903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_638240195656424173" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_638240195656424173" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_638240195656424173" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" xlink:type="extended" xlink:title="140101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_637326625217147953" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_637326625217147953" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656424173" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656424173" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195656424173" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195656424173" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656424173" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656424173" xlink:to="us-gaap_IPOMember_638240195656424173" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656424173" xlink:to="us-gaap_PrivatePlacementMember_638240195656424173" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656424173" xlink:to="us-gaap_OverAllotmentOptionMember_638240195656424173" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656424173" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195656424173" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195656424173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195656424173" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195656424173" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195656424173" xlink:to="dkdcu_FounderSharesMember_638240195656434174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656424173" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656434174" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656434174" xlink:to="us-gaap_RelatedPartyDomain_638240195656434174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656434174" xlink:to="dkdcu_SponsorMember_638240195656434174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656424173" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:label="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_638240195656434174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195656434174" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfUnits" xlink:label="dkdcu_ProceedsFromSaleOfUnits_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_ProceedsFromSaleOfUnits_638240195656434174" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssued" xlink:label="dkdcu_NumberOfWarrantsIssued_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_NumberOfWarrantsIssued_638240195656434174" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_638240195656434174" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_638240195656434174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_638240195656434174" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195656444171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195656444171" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_638240195656444171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_SharesIssuedPricePerShare_638240195656444171" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransactionCosts" xlink:label="dkdcu_TransactionCosts_638240195656444171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_TransactionCosts_638240195656444171" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockUnderwritingFees" xlink:label="dkdcu_SaleOfStockUnderwritingFees_638240195656444171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_TransactionCosts_638240195656444171" xlink:to="dkdcu_SaleOfStockUnderwritingFees_638240195656444171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._638240195656444171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_TransactionCosts_638240195656444171" xlink:to="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._638240195656444171" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeePayable" xlink:label="dkdcu_DeferredUnderwritingFeePayable_638240195656444171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_TransactionCosts_638240195656444171" xlink:to="dkdcu_DeferredUnderwritingFeePayable_638240195656444171" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockOtherOfferingCosts" xlink:label="dkdcu_SaleOfStockOtherOfferingCosts_638240195656444171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_TransactionCosts_638240195656444171" xlink:to="dkdcu_SaleOfStockOtherOfferingCosts_638240195656444171" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashHeldOutsideInTrustAccount" xlink:label="dkdcu_CashHeldOutsideInTrustAccount_638240195656444171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_CashHeldOutsideInTrustAccount_638240195656444171" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalDeficit" xlink:label="dkdcu_WorkingCapitalDeficit_638240195656444171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_WorkingCapitalDeficit_638240195656444171" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" xlink:label="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount_638240195656454194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount_638240195656454194" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" xlink:label="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination_638240195656454194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination_638240195656454194" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195656454194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195656454194" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_638240195656454194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_638240195656454194" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195656454194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195656454194" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_638240195656454194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_638240195656454194" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" xlink:label="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions_638240195656454194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions_638240195656454194" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsExecuted" xlink:label="dkdcu_NumberOfOneMonthExtensionsExecuted_638240195656464178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_NumberOfOneMonthExtensionsExecuted_638240195656464178" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination_638240195656464178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination_638240195656464178" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" xlink:label="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination_638240195656464178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination_638240195656464178" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" xlink:label="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares_638240195656464178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares_638240195656464178" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_638240195656464178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_638240195656464178" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_638240195656464178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_638240195656464178" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust_638240195656464178" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_AssetsHeldInTrust_638240195656464178" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_638240195656474176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_638240195656474176" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNetInterestToPayDissolutionExpenses" xlink:label="dkdcu_MaximumNetInterestToPayDissolutionExpenses_638240195656474176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_MaximumNetInterestToPayDissolutionExpenses_638240195656474176" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195656474176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195656474176" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_638240195656474176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_638240195656474176" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_638240195656474176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_638240195656474176" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet_638240195656474176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet_638240195656474176" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_638240195656484172" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_638240195656484172" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_638240195656484172" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_SharePrice_638240195656484172" order="33" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_638240195656484172" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_Cash_638240195656484172" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_638240195656524172" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_638240195656524172" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfPublicSharesToBeRedeemed." xlink:label="dkdcu_PercentageOfPublicSharesToBeRedeemed._638240195656534176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_PercentageOfPublicSharesToBeRedeemed._638240195656534176" order="36" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:label="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_638240195656534176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656434174" xlink:to="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_638240195656534176" order="37" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" xlink:type="extended" xlink:title="140201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesTable" xlink:label="dkdcu_AccountingPoliciesTable_638240195656534176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_AccountingPoliciesTable_638240195656534176" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656534176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195656534176" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656534176" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656534176" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656534176" xlink:to="us-gaap_ClassOfStockDomain_638240195656534176" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656534176" xlink:to="us-gaap_CommonClassAMember_638240195656544171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656534176" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember_638240195656544171" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656534176" xlink:to="us-gaap_CommonClassBMember_638240195656544171" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195656534176" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195656544171" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195656544171" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195656544171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195656544171" xlink:to="dkdcu_FounderSharesMember_638240195656544171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195656534176" xlink:to="us-gaap_IncomeStatementLocationAxis_638240195656544171" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_638240195656544171" xlink:to="us-gaap_IncomeStatementLocationDomain_638240195656544171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember" xlink:label="us-gaap_OperatingExpenseMember_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638240195656544171" xlink:to="us-gaap_OperatingExpenseMember_638240195656544171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195656534176" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656544171" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656544171" xlink:to="us-gaap_RelatedPartyDomain_638240195656544171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember_638240195656544171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656544171" xlink:to="dkdcu_ArcGroupLimitedMember_638240195656544171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195656534176" xlink:to="us-gaap_TypeOfArrangementAxis_638240195656554207" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195656554207" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656554207" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656554207" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656554207" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesLineItems" xlink:label="dkdcu_AccountingPoliciesLineItems_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195656534176" xlink:to="dkdcu_AccountingPoliciesLineItems_638240195656554207" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_Cash_638240195656554207" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_638240195656554207" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195656554207" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_SharesIssuedPricePerShare_638240195656554207" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_CommonStockSharesOutstanding_638240195656554207" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_638240195656554207" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_638240195656554207" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantExercisable" xlink:label="dkdcu_WarrantExercisable_638240195656564180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="dkdcu_WarrantExercisable_638240195656564180" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638240195656564180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638240195656564180" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_638240195656564180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_UnrecognizedTaxBenefits_638240195656564180" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_638240195656564180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_638240195656564180" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_638240195656564180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_638240195656564180" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638240195656564180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656554207" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638240195656564180" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails" xlink:type="extended" xlink:title="140202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesTable" xlink:label="dkdcu_AccountingPoliciesTable_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_1" xlink:to="dkdcu_AccountingPoliciesTable_638240195656574173" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195656574173" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656574173" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656574173" xlink:to="us-gaap_ClassOfStockDomain_638240195656574173" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656574173" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656574173" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesLineItems" xlink:label="dkdcu_AccountingPoliciesLineItems_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195656574173" xlink:to="dkdcu_AccountingPoliciesLineItems_638240195656574173" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656574173" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195656574173" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromIssuanceOfTemporaryEquity" xlink:label="dkdcu_ProceedsFromIssuanceOfTemporaryEquity_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656574173" xlink:to="dkdcu_ProceedsFromIssuanceOfTemporaryEquity_638240195656574173" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityProceedsAllocatedToWarrants" xlink:label="dkdcu_TemporaryEquityProceedsAllocatedToWarrants_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656574173" xlink:to="dkdcu_TemporaryEquityProceedsAllocatedToWarrants_638240195656574173" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityIssuanceCosts" xlink:label="dkdcu_TemporaryEquityIssuanceCosts_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656574173" xlink:to="dkdcu_TemporaryEquityIssuanceCosts_638240195656574173" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" xlink:label="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656574173" xlink:to="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest_638240195656574173" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_638240195656574173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656574173" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_638240195656574173" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6382401956565741731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195656574173" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6382401956565741731" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails" xlink:type="extended" xlink:title="140203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638240195656584171" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638240195656584171" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656584171" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656584171" xlink:to="us-gaap_ClassOfStockDomain_638240195656584171" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656584171" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656584171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656584171" xlink:to="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_638240195656584171" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638240195656584171" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195656584171" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195656584171" xlink:to="us-gaap_NetIncomeLoss_638240195656584171" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195656584171" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638240195656584171" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195656584171" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638240195656584171" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195656584171" xlink:to="us-gaap_EarningsPerShareBasic_638240195656584171" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638240195656584171" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195656584171" xlink:to="us-gaap_EarningsPerShareDiluted_638240195656584171" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" xlink:type="extended" xlink:title="140301 - Disclosure - INITIAL PUBLIC OFFERING (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialPublicOfferingAbstract" xlink:label="dkdcu_InitialPublicOfferingAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_InitialPublicOfferingAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656594170" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656594170" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195656594170" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195656594170" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656594170" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656594170" xlink:to="us-gaap_IPOMember_638240195656594170" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656594170" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195656594170" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195656594170" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195656594170" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195656594170" xlink:to="dkdcu_PublicWarrantsMember_638240195656594170" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656594170" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656594170" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656594170" xlink:to="us-gaap_ClassOfStockDomain_638240195656594170" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656594170" xlink:to="us-gaap_CommonClassAMember_638240195656594170" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195656594170" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_638240195656594170" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656594170" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195656594170" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_638240195656594170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656594170" xlink:to="us-gaap_SharesIssuedPricePerShare_638240195656594170" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSharesIssuedPerUnit" xlink:label="dkdcu_NumberOfSharesIssuedPerUnit_638240195656604168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656594170" xlink:to="dkdcu_NumberOfSharesIssuedPerUnit_638240195656604168" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638240195656604168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656594170" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638240195656604168" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssuedPerUnit" xlink:label="dkdcu_NumberOfWarrantsIssuedPerUnit_638240195656604168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656594170" xlink:to="dkdcu_NumberOfWarrantsIssuedPerUnit_638240195656604168" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_638240195656604168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656594170" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_638240195656604168" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638240195656604168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195656594170" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638240195656604168" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" xlink:type="extended" xlink:title="140401 - Disclosure - PRIVATE PLACEMENT (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementAbstract" xlink:label="dkdcu_PrivatePlacementAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementTable" xlink:label="dkdcu_PrivatePlacementTable_638240195656604168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementAbstract" xlink:to="dkdcu_PrivatePlacementTable_638240195656604168" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195656604168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementTable_638240195656604168" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195656604168" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656604168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195656604168" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656604168" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember_638240195656604168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656604168" xlink:to="us-gaap_PrivatePlacementMember_638240195656604168" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementLineItems" xlink:label="dkdcu_PrivatePlacementLineItems_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementTable_638240195656604168" xlink:to="dkdcu_PrivatePlacementLineItems_638240195656614212" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementLineItems_638240195656614212" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638240195656614212" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementLineItems_638240195656614212" xlink:to="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_638240195656614212" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementLineItems_638240195656614212" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_638240195656614212" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" xlink:type="extended" xlink:title="140501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656614212" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656614212" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195656614212" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195656614212" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195656614212" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195656614212" xlink:to="dkdcu_FounderSharesMember_638240195656614212" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656614212" xlink:to="us-gaap_TypeOfArrangementAxis_638240195656614212" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195656614212" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656614212" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656614212" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656614212" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656614212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656614212" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656614212" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656614212" xlink:to="us-gaap_RelatedPartyDomain_638240195656624198" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656624198" xlink:to="dkdcu_SponsorMember_638240195656624198" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656624198" xlink:to="srt_ChiefExecutiveOfficerMember_638240195656624198" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656624198" xlink:to="srt_ChiefFinancialOfficerMember_638240195656624198" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TwoIndependentDirectorMember" xlink:label="dkdcu_TwoIndependentDirectorMember_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656624198" xlink:to="dkdcu_TwoIndependentDirectorMember_638240195656624198" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdIndependentDirectorMember" xlink:label="dkdcu_ThirdIndependentDirectorMember_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656624198" xlink:to="dkdcu_ThirdIndependentDirectorMember_638240195656624198" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656624198" xlink:to="srt_AffiliatedEntityMember_638240195656624198" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656614212" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656624198" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656624198" xlink:to="us-gaap_ClassOfStockDomain_638240195656624198" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656624198" xlink:to="us-gaap_CommonClassBMember_638240195656624198" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656614212" xlink:to="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638240195656634983" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638240195656634983" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195656634983" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195656634983" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare_638240195656634983" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_StockTransferredToOthersDuringPeriodShare_638240195656634983" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_638240195656634983" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_638240195656634983" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent_638240195656634983" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_ExtensionLoansNonCurrent_638240195656634983" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638240195656634983" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638240195656634983" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195656634983" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195656634983" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_638240195656634983" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_638240195656634983" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_638240195656634983" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_638240195656634983" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_638240195656644208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_638240195656644208" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_638240195656644208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_638240195656644208" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_638240195656644208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_638240195656644208" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_638240195656644208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_638240195656644208" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:label="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_638240195656644208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656624198" xlink:to="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_638240195656644208" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended" xlink:title="140502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656644208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656644208" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656644208" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195656654642" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195656654642" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195656654642" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PromissoryNoteWithRelatedPartyMember" xlink:label="dkdcu_PromissoryNoteWithRelatedPartyMember_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195656654642" xlink:to="dkdcu_PromissoryNoteWithRelatedPartyMember_638240195656654642" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdministrativeSupportAgreementMember" xlink:label="dkdcu_AdministrativeSupportAgreementMember_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195656654642" xlink:to="dkdcu_AdministrativeSupportAgreementMember_638240195656654642" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyLoansMember" xlink:label="dkdcu_RelatedPartyLoansMember_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195656654642" xlink:to="dkdcu_RelatedPartyLoansMember_638240195656654642" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195656654642" xlink:to="dkdcu_FounderSharesMember_638240195656654642" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656644208" xlink:to="us-gaap_TypeOfArrangementAxis_638240195656654642" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195656654642" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656654642" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656654642" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656654642" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656654642" xlink:to="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656654642" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656654642" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656654642" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656654642" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656644208" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656654642" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656654642" xlink:to="us-gaap_ClassOfStockDomain_638240195656664180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656664180" xlink:to="us-gaap_CommonClassBMember_638240195656664180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656644208" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195656664180" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195656664180" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656664180" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656664180" xlink:to="us-gaap_OverAllotmentOptionMember_638240195656664180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656644208" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195656664180" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195656664180" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195656664180" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalLoansWarrantMember" xlink:label="dkdcu_WorkingCapitalLoansWarrantMember_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195656664180" xlink:to="dkdcu_WorkingCapitalLoansWarrantMember_638240195656664180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656644208" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656664180" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195656664180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656664180" xlink:to="us-gaap_RelatedPartyDomain_638240195656664180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember_638240195656674188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656664180" xlink:to="srt_AffiliatedEntityMember_638240195656674188" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195656644208" xlink:to="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RetainerFeeUponExecutionOfAgreement" xlink:label="dkdcu_RetainerFeeUponExecutionOfAgreement_638240195656674188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_RetainerFeeUponExecutionOfAgreement_638240195656674188" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" xlink:label="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination_638240195656674188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination_638240195656674188" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfOwnershipAsConsiderationForService" xlink:label="dkdcu_PercentageOfOwnershipAsConsiderationForService_638240195656674188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_PercentageOfOwnershipAsConsiderationForService_638240195656674188" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" xlink:label="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget_638240195656674188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget_638240195656674188" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_638240195656674188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_638240195656674188" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195656674188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195656674188" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195656674188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195656674188" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_638240195656684211" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_638240195656684211" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumLoansConvertibleUptoConsummation" xlink:label="dkdcu_MaximumLoansConvertibleUptoConsummation_638240195656684211" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_MaximumLoansConvertibleUptoConsummation_638240195656684211" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" xlink:label="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination_638240195656684211" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination_638240195656684211" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_638240195656684211" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_638240195656684211" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_638240195656684211" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_638240195656684211" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination" xlink:label="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination_638240195656684211" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination_638240195656684211" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_638240195656684211" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="us-gaap_SaleOfStockPricePerShare_638240195656684211" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecuritiesDepositHeldInTrustAccount" xlink:label="dkdcu_SecuritiesDepositHeldInTrustAccount_638240195656694212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_SecuritiesDepositHeldInTrustAccount_638240195656694212" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_638240195656694212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_638240195656694212" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" xlink:label="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven_638240195656694212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven_638240195656694212" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195656694212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195656694212" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" xlink:label="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination_638240195656694212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination_638240195656694212" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_BusinessCombinationTotalPayments" xlink:label="dkdcu_BusinessCombinationTotalPayments_638240195656694212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_BusinessCombinationTotalPayments_638240195656694212" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_638240195656694212" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_638240195656694212" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_638240195656704170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_638240195656704170" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent_638240195656704170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_ExtensionLoansNonCurrent_638240195656704170" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_638240195656704170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_638240195656704170" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_638240195656704170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_638240195656704170" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638240195656704170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195656674188" xlink:to="us-gaap_CommonStockSharesOutstanding_638240195656704170" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="extended" xlink:title="140601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable_638240195656714859" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable_638240195656714859" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195656714859" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195656714859" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195656714859" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656714859" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195656714859" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656714859" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_638240195656714859" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656714859" xlink:to="us-gaap_OverAllotmentOptionMember_638240195656714859" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195656714859" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195656714859" xlink:to="us-gaap_TypeOfArrangementAxis_638240195656714859" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656714859" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195656714859" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656714859" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656714859" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656714859" xlink:to="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656714859" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656714859" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656714859" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656714859" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656714859" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195656714859" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656714859" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656714859" xlink:to="us-gaap_RelatedPartyDomain_638240195656724168" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656724168" xlink:to="dkdcu_ArcGroupLimitedMember_638240195656724168" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195656714859" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195656724168" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195656724168" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195656724168" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195656724168" xlink:to="dkdcu_FounderSharesMember_638240195656724168" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195656714859" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656724168" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656724168" xlink:to="us-gaap_ClassOfStockDomain_638240195656724168" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656724168" xlink:to="us-gaap_CommonClassBMember_638240195656724168" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195656714859" xlink:to="us-gaap_LossContingenciesLineItems_638240195656724168" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities_638240195656724168" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OverAllotmentOptionPeriod" xlink:label="dkdcu_OverAllotmentOptionPeriod_638240195656724168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="dkdcu_OverAllotmentOptionPeriod_638240195656724168" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195656734162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195656734162" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPercentage" xlink:label="dkdcu_UnderwritingDiscountPercentage_638240195656734162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="dkdcu_UnderwritingDiscountPercentage_638240195656734162" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPaid" xlink:label="dkdcu_UnderwritingDiscountPaid_638240195656734162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="dkdcu_UnderwritingDiscountPaid_638240195656734162" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeesPercentage" xlink:label="dkdcu_DeferredUnderwritingFeesPercentage_638240195656734162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="dkdcu_DeferredUnderwritingFeesPercentage_638240195656734162" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._638240195656734162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._638240195656734162" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_638240195656734162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_638240195656734162" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195656734162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195656734162" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195656734162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195656724168" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195656734162" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails" xlink:type="extended" xlink:title="140701 - Disclosure - WARRANT LIABILITY (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityAbstract" xlink:label="dkdcu_WarrantLiabilityAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_WarrantLiabilityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable_638240195656744181" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638240195656744181" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195656744181" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195656744181" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195656744181" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195656744181" xlink:to="us-gaap_WarrantMember_638240195656744181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PlacementWarrantsMember" xlink:label="dkdcu_PlacementWarrantsMember_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantMember_638240195656744181" xlink:to="dkdcu_PlacementWarrantsMember_638240195656744181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantMember_638240195656744181" xlink:to="dkdcu_PublicWarrantsMember_638240195656744181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638240195656744181" xlink:to="srt_StatementScenarioAxis_638240195656744181" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_638240195656744181" xlink:to="srt_ScenarioUnspecifiedDomain_638240195656744181" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195656744181" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_638240195656744181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195656744181" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_638240195656744181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656744181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638240195656744181" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656744181" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656744181" xlink:to="us-gaap_ClassOfStockDomain_638240195656754191" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656754191" xlink:to="us-gaap_CommonClassAMember_638240195656754191" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656754191" xlink:to="us-gaap_CommonClassBMember_638240195656754191" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638240195656744181" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:label="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_638240195656754191" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_638240195656754191" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination_638240195656754191" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination_638240195656754191" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_638240195656754191" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_638240195656754191" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_638240195656754191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_638240195656754191" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_638240195656764164" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_638240195656764164" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_638240195656764164" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="us-gaap_SharePrice_638240195656764164" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:label="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed_638240195656764164" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed_638240195656764164" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:label="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_638240195656764164" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_638240195656764164" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" xlink:label="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice_638240195656764164" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice_638240195656764164" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantsOrRightsIssued" xlink:label="dkdcu_WarrantsOrRightsIssued_638240195656764164" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195656754191" xlink:to="dkdcu_WarrantsOrRightsIssued_638240195656764164" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredSharesDetails" xlink:type="extended" xlink:title="140801 - Disclosure - STOCKHOLDER'S EQUITY - Preferred Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized_638240195656774162" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_638240195656774162" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockSharesIssued_638240195656774162" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding_638240195656774162" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails" xlink:type="extended" xlink:title="140802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable_638240195656774162" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195656774162" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656774162" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656774162" xlink:to="us-gaap_ClassOfStockDomain_638240195656774162" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656774162" xlink:to="us-gaap_CommonClassAMember_638240195656774162" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonClassAMember_638240195656774162" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656774162" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaNotSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaNotSubjectToRedemptionMember_638240195656774162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonClassAMember_638240195656774162" xlink:to="dkdcu_CommonClassaNotSubjectToRedemptionMember_638240195656774162" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656774162" xlink:to="us-gaap_CommonClassBMember_638240195656784200" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195656774162" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656784200" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195656784200" xlink:to="us-gaap_RelatedPartyDomain_638240195656784200" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656784200" xlink:to="dkdcu_SponsorMember_638240195656784200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195656784200" xlink:to="dkdcu_ArcGroupLimitedMember_638240195656784200" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195656774162" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195656784200" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195656784200" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195656784200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195656784200" xlink:to="dkdcu_FounderSharesMember_638240195656784200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195656774162" xlink:to="srt_TitleOfIndividualAxis_638240195656784200" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis_638240195656784200" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195656784200" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195656784200" xlink:to="srt_ChiefExecutiveOfficerMember_638240195656784200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember_638240195656784200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195656784200" xlink:to="srt_ChiefFinancialOfficerMember_638240195656784200" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IndependentDirectorsMember" xlink:label="dkdcu_IndependentDirectorsMember_638240195656794163" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195656784200" xlink:to="dkdcu_IndependentDirectorsMember_638240195656794163" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195656794163" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195656774162" xlink:to="us-gaap_TypeOfArrangementAxis_638240195656794163" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656794163" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195656794163" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656794163" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656794163" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195656794163" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195656794163" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195656794163" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195656774162" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195656794163" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656794163" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195656794163" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656794163" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember_638240195656794163" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195656794163" xlink:to="us-gaap_PrivatePlacementMember_638240195656794163" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_638240195656794163" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195656774162" xlink:to="us-gaap_ClassOfStockLineItems_638240195656794163" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_638240195656794163" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="us-gaap_CommonStockSharesAuthorized_638240195656794163" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare_638240195656804159" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="dkdcu_StockTransferredToOthersDuringPeriodShare_638240195656804159" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638240195656804159" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638240195656804159" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockNumberOfVotesPerShare" xlink:label="dkdcu_CommonStockNumberOfVotesPerShare_638240195656804159" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="dkdcu_CommonStockNumberOfVotesPerShare_638240195656804159" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_638240195656804159" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="us-gaap_CommonStockSharesIssued_638240195656804159" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638240195656804159" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="us-gaap_CommonStockSharesOutstanding_638240195656804159" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_638240195656804159" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_638240195656804159" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195656804159" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195656804159" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareIssued" xlink:label="dkdcu_CommonStockShareIssued_638240195656804159" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="dkdcu_CommonStockShareIssued_638240195656804159" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareOutstanding" xlink:label="dkdcu_CommonStockShareOutstanding_638240195656814158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="dkdcu_CommonStockShareOutstanding_638240195656814158" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_638240195656814158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_638240195656814158" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" xlink:label="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare_638240195656814158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare_638240195656814158" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195656814158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195656794163" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195656814158" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="extended" xlink:title="140901 - Disclosure - FAIR VALUE MEASUREMENTS - Assets and derivative warrant liabilities measured at fair value on recurring basis (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656814158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656814158" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656814158" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195656824188" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195656824188" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195656824188" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195656824188" xlink:to="us-gaap_FairValueInputsLevel1Member_638240195656824188" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195656824188" xlink:to="us-gaap_FairValueInputsLevel3Member_638240195656824188" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656814158" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_638240195656824188" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis_638240195656824188" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_638240195656824188" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain_638240195656824188" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_638240195656824188" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656814158" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195656824188" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195656824188" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195656824188" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195656824188" xlink:to="dkdcu_PublicWarrantsMember_638240195656824188" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementWarrantsMember" xlink:label="dkdcu_PrivatePlacementWarrantsMember_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195656824188" xlink:to="dkdcu_PrivatePlacementWarrantsMember_638240195656824188" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656814158" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656824188" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_638240195656824188" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656824188" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_638240195656824188" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656824188" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_638240195656834175" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="extended" xlink:title="140902 - Disclosure - FAIR VALUE MEASUREMENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_2" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656834175" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656834175" xlink:to="us-gaap_FinancialInstrumentAxis_638240195656834175" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis_638240195656834175" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638240195656834175" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638240195656834175" xlink:to="us-gaap_MoneyMarketFundsMember_638240195656834175" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638240195656834175" xlink:to="us-gaap_USTreasurySecuritiesMember_638240195656834175" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656834175" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656834175" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656834175" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_638240195656834175" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" xlink:label="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656834175" xlink:to="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount_638240195656834175" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_638240195656834175" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656834175" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_638240195656834175" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656834175" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_638240195656844161" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656834175" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_638240195656844161" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656834175" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_638240195656844161" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" xlink:type="extended" xlink:title="140903 - Disclosure - FAIR VALUE MEASUREMENTS - Quantitative information regarding Level 3 fair value measurements inputs (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_637552778634131650" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_637552778634131650" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656844161" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656844161" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195656844161" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195656844161" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195656844161" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivateWarrantMember" xlink:label="dkdcu_PrivateWarrantMember_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195656844161" xlink:to="dkdcu_PrivateWarrantMember_638240195656844161" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656844161" xlink:to="us-gaap_MeasurementInputTypeAxis_638240195656844161" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis_638240195656844161" xlink:to="us-gaap_MeasurementInputTypeDomain_638240195656844161" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195656844161" xlink:to="us-gaap_MeasurementInputExercisePriceMember_638240195656844161" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember_638240195656844161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195656844161" xlink:to="us-gaap_MeasurementInputSharePriceMember_638240195656844161" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195656844161" xlink:to="us-gaap_MeasurementInputExpectedTermMember_638240195656854202" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" xlink:label="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195656844161" xlink:to="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_638240195656854202" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195656844161" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_638240195656854202" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195656844161" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_638240195656854202" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195656844161" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_638240195656854202" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656844161" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195656854202" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195656854202" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195656854202" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195656854202" xlink:to="us-gaap_FairValueInputsLevel3Member_638240195656854202" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656844161" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_638240195656854202" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis_638240195656854202" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_638240195656854202" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_638240195656854202" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain_638240195656854202" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_638240195656854202" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656864208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195656844161" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656864208" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_638240195656864208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195656864208" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput_638240195656864208" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:type="extended" xlink:title="140904 - Disclosure - FAIR VALUE MEASUREMENTS - Change in fair value of derivative warrant liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638240195656864208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638240195656864208" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195656864208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638240195656864208" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195656864208" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195656864208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195656864208" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195656864208" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivateWarrantMember" xlink:label="dkdcu_PrivateWarrantMember_638240195656864208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195656864208" xlink:to="dkdcu_PrivateWarrantMember_638240195656864208" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember_638240195656864208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195656864208" xlink:to="dkdcu_PublicWarrantsMember_638240195656864208" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityMember" xlink:label="dkdcu_WarrantLiabilityMember_638240195656864208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195656864208" xlink:to="dkdcu_WarrantLiabilityMember_638240195656864208" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_638240195656864208" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638240195656864208" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_638240195656864208" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195656874200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_638240195656864208" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195656874200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_638240195656874200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195656874200" xlink:to="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_638240195656874200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_638240195656874200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195656874200" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_638240195656874200" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_6382401956568742001" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195656874200" xlink:to="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_6382401956568742001" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_638240195656874200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195656874200" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_638240195656874200" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="141001 - Disclosure - SUBSEQUENT EVENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable_638240195656874200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract_1" xlink:to="us-gaap_SubsequentEventTable_638240195656874200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_638240195656874200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638240195656874200" xlink:to="us-gaap_SubsequentEventTypeAxis_638240195656874200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_638240195656874200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis_638240195656874200" xlink:to="us-gaap_SubsequentEventTypeDomain_638240195656874200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember_638240195656874200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain_638240195656874200" xlink:to="us-gaap_SubsequentEventMember_638240195656874200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656874200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638240195656874200" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656874200" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656874200" xlink:to="us-gaap_ClassOfStockDomain_638240195656884200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656884200" xlink:to="us-gaap_CommonStockMember_638240195656884200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638240195656874200" xlink:to="srt_StatementScenarioAxis_638240195656884200" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_638240195656884200" xlink:to="srt_ScenarioUnspecifiedDomain_638240195656884200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdMonthExtensionToTerminationDateMember" xlink:label="dkdcu_ThirdMonthExtensionToTerminationDateMember_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195656884200" xlink:to="dkdcu_ThirdMonthExtensionToTerminationDateMember_638240195656884200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FourthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FourthMonthExtensionToTerminationDateMember_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195656884200" xlink:to="dkdcu_FourthMonthExtensionToTerminationDateMember_638240195656884200" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FifthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FifthMonthExtensionToTerminationDateMember_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195656884200" xlink:to="dkdcu_FifthMonthExtensionToTerminationDateMember_638240195656884200" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SixthOneMonthExtensionToTerminationDateMember" xlink:label="dkdcu_SixthOneMonthExtensionToTerminationDateMember_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195656884200" xlink:to="dkdcu_SixthOneMonthExtensionToTerminationDateMember_638240195656884200" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195656884200" xlink:to="srt_ScenarioForecastMember_638240195656884200" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638240195656874200" xlink:to="us-gaap_SubsequentEventLineItems_638240195656884200" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="us-gaap_InvestmentIncomeInterest_638240195656884200" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedPerEachPublicShareOutstanding" xlink:label="dkdcu_AmountDepositedPerEachPublicShareOutstanding_638240195656884200" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="dkdcu_AmountDepositedPerEachPublicShareOutstanding_638240195656884200" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregateAmountDepositedInTrustAccount" xlink:label="dkdcu_AggregateAmountDepositedInTrustAccount_638240195656894174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="dkdcu_AggregateAmountDepositedInTrustAccount_638240195656894174" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsOfFranchiseTax" xlink:label="dkdcu_PaymentsOfFranchiseTax_638240195656894174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="dkdcu_PaymentsOfFranchiseTax_638240195656894174" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashWaivedDeferredUnderwritingCommission" xlink:label="dkdcu_CashWaivedDeferredUnderwritingCommission_638240195656894174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="dkdcu_CashWaivedDeferredUnderwritingCommission_638240195656894174" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashDeferredUnderwritingCommissions" xlink:label="dkdcu_CashDeferredUnderwritingCommissions_638240195656894174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="dkdcu_CashDeferredUnderwritingCommissions_638240195656894174" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyPayment" xlink:label="dkdcu_RelatedPartyPayment_638240195656894174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="dkdcu_RelatedPartyPayment_638240195656894174" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyPromissoryNoteExecuted" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecuted_638240195656894174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="dkdcu_RelatedPartyPromissoryNoteExecuted_638240195656894174" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth" xlink:label="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth_638240195656894174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth_638240195656894174" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregateNumberOfSharesOwned" xlink:label="dkdcu_AggregateNumberOfSharesOwned_638240195656894174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="dkdcu_AggregateNumberOfSharesOwned_638240195656894174" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_638240195656894174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="us-gaap_SharePrice_638240195656894174" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_638240195656904160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195656884200" xlink:to="us-gaap_DebtInstrumentFaceAmount_638240195656904160" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="200100 - Statement - CONSOLIDATED BALANCE SHEETS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_637309996491150416" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638240195656904160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637309996491150416" xlink:to="us-gaap_StatementTable_638240195656904160" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656904160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656904160" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656904160" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656904160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656904160" xlink:to="us-gaap_ClassOfStockDomain_638240195656904160" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656904160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656904160" xlink:to="us-gaap_CommonClassAMember_638240195656904160" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember_638240195656904160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656904160" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember_638240195656904160" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_638240195656904160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656904160" xlink:to="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_638240195656904160" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656904160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656904160" xlink:to="us-gaap_CommonClassBMember_638240195656904160" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656904160" xlink:to="us-gaap_StatementLineItems_638240195656914185" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656914185" xlink:to="us-gaap_AssetsAbstract_638240195656914185" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638240195656914185" xlink:to="us-gaap_AssetsCurrentAbstract_638240195656914185" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638240195656914185" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638240195656914185" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638240195656914185" xlink:to="us-gaap_PrepaidExpenseCurrent_638240195656914185" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrepaidInsuranceCurrent" xlink:label="dkdcu_PrepaidInsuranceCurrent_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638240195656914185" xlink:to="dkdcu_PrepaidInsuranceCurrent_638240195656914185" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638240195656914185" xlink:to="us-gaap_AssetsCurrent_638240195656914185" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638240195656914185" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_638240195656914185" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638240195656914185" xlink:to="us-gaap_Assets_638240195656914185" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656914185" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_638240195656914185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="us-gaap_LiabilitiesCurrentAbstract_638240195656914185" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_638240195656924213" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656914185" xlink:to="dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent_638240195656924213" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent_638240195656924213" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656914185" xlink:to="us-gaap_DueToRelatedPartiesCurrent_638240195656924213" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_638240195656924213" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656914185" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_638240195656924213" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_638240195656924213" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656914185" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_638240195656924213" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638240195656924213" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638240195656914185" xlink:to="us-gaap_LiabilitiesCurrent_638240195656924213" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityNonCurrent" xlink:label="dkdcu_WarrantLiabilityNonCurrent_638240195656924213" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="dkdcu_WarrantLiabilityNonCurrent_638240195656924213" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredOfferingCostsNonCurrent" xlink:label="dkdcu_DeferredOfferingCostsNonCurrent_638240195656924213" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="dkdcu_DeferredOfferingCostsNonCurrent_638240195656924213" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_638240195656924213" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent_638240195656924213" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent_638240195656934185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="dkdcu_ExtensionLoansNonCurrent_638240195656934185" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_638240195656934185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="us-gaap_Liabilities_638240195656934185" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638240195656934185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="us-gaap_CommitmentsAndContingencies_638240195656934185" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195656934185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195656934185" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_638240195656934185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="us-gaap_StockholdersEquityAbstract_638240195656934185" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_638240195656934185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656934185" xlink:to="us-gaap_PreferredStockValue_638240195656934185" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638240195656934185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656934185" xlink:to="us-gaap_CommonStockValue_638240195656934185" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_638240195656934185" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656934185" xlink:to="us-gaap_AdditionalPaidInCapital_638240195656934185" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656934185" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638240195656944174" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638240195656934185" xlink:to="us-gaap_StockholdersEquity_638240195656944174" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638240195656914185" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_638240195656944174" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" xlink:type="extended" xlink:title="200105 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_637309996491800131" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637309996491800131" xlink:to="us-gaap_StatementTable_638240195656944174" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656944174" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656944174" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656944174" xlink:to="us-gaap_ClassOfStockDomain_638240195656944174" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656944174" xlink:to="us-gaap_CommonClassAMember_638240195656944174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656944174" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember_638240195656944174" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember" xlink:label="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656944174" xlink:to="dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_638240195656944174" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656944174" xlink:to="us-gaap_CommonClassBMember_638240195656944174" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656944174" xlink:to="us-gaap_StatementLineItems_638240195656944174" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_638240195656944174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_PreferredStockSharesAuthorized_638240195656944174" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_PreferredStockSharesIssued_638240195656944174" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_PreferredStockSharesOutstanding_638240195656944174" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638240195656944174" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_CommonStockSharesAuthorized_638240195656944174" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_CommonStockSharesIssued_638240195656944174" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_CommonStockSharesOutstanding_638240195656944174" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_638240195656944174" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656944174" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_638240195656944174" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" xlink:type="extended" xlink:title="200200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable_638240195656944174" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656944174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656944174" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656944174" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656972231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656944174" xlink:to="us-gaap_ClassOfStockDomain_638240195656972231" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656972231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656972231" xlink:to="us-gaap_CommonClassAMember_638240195656972231" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656972231" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember_638240195656974158" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195656972231" xlink:to="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_638240195656974158" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656944174" xlink:to="us-gaap_StatementLineItems_638240195656974158" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_OperatingCostsAndExpenses_638240195656974158" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FranchiseTaxExpense" xlink:label="dkdcu_FranchiseTaxExpense_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="dkdcu_FranchiseTaxExpense_638240195656974158" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_OperatingIncomeLoss_638240195656974158" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656974158" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656974158" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195656974158" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656974158" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss_638240195656974158" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656974158" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_638240195656974158" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638240195656974158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638240195656974158" xlink:to="us-gaap_NonoperatingIncomeExpense_638240195656974158" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195656984158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638240195656984158" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638240195656984158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638240195656984158" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638240195656984158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_NetIncomeLoss_638240195656984158" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638240195656984158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638240195656984158" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638240195656984158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638240195656984158" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638240195656984158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_EarningsPerShareBasic_638240195656984158" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638240195656984158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656974158" xlink:to="us-gaap_EarningsPerShareDiluted_638240195656984158" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:type="extended" xlink:title="200300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_637309996491800131" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract_637309996491800131" xlink:to="us-gaap_StatementTable_638240195656994215" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656994215" xlink:to="us-gaap_StatementClassOfStockAxis_638240195656994215" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656994215" xlink:to="us-gaap_CommonClassAMember_638240195656994215" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656994215" xlink:to="us-gaap_CommonClassBMember_638240195656994215" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195656994215" xlink:to="us-gaap_ClassOfStockDomain_638240195656994215" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656994215" xlink:to="us-gaap_StatementEquityComponentsAxis_638240195656994215" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638240195656994215" xlink:to="us-gaap_CommonStockMember_638240195656994215" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638240195656994215" xlink:to="us-gaap_AdditionalPaidInCapitalMember_638240195656994215" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638240195656994215" xlink:to="us-gaap_RetainedEarningsMember_638240195656994215" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638240195656994215" xlink:to="us-gaap_EquityComponentDomain_638240195656994215" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638240195656994215" xlink:to="us-gaap_StatementLineItems_638240195656994215" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638240195656994215" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638240195657004156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="us-gaap_StockholdersEquity_638240195657004156" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_638240195657004156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="us-gaap_SharesIssued_638240195657004156" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195657004156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195657004156" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638240195657004156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638240195657004156" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor_638240195657004156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor_638240195657004156" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares" xlink:label="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares_638240195657004156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares_638240195657004156" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionValue" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionValue_638240195657004156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionValue_638240195657004156" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockSubjectToPossibleRedemptionShares" xlink:label="dkdcu_CommonStockSubjectToPossibleRedemptionShares_638240195657064362" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="dkdcu_CommonStockSubjectToPossibleRedemptionShares_638240195657064362" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638240195657064362" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="us-gaap_NetIncomeLoss_638240195657064362" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638240195657064362" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="us-gaap_StockholdersEquity_638240195657064362" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_638240195657064362" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638240195656994215" xlink:to="us-gaap_SharesIssued_638240195657064362" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="200400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_638240195657064362" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" xlink:to="us-gaap_ProfitLoss_638240195657064362" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OfferingCostsAllocatedToWarrantLiability" xlink:label="dkdcu_OfferingCostsAllocatedToWarrantLiability_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" xlink:to="dkdcu_OfferingCostsAllocatedToWarrantLiability_638240195657074161" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" xlink:to="us-gaap_ShareBasedCompensation_638240195657074161" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RealizedAndUnrealizedGainLoss" xlink:label="dkdcu_RealizedAndUnrealizedGainLoss_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" xlink:to="dkdcu_RealizedAndUnrealizedGainLoss_638240195657074161" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" xlink:to="dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount_638240195657074161" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_638240195657074161" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195657074161" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195657074161" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_638240195657074161" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195657074161" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_638240195657074161" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IncreaseDecreaseFranchiseTaxPayable" xlink:label="dkdcu_IncreaseDecreaseFranchiseTaxPayable_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195657074161" xlink:to="dkdcu_IncreaseDecreaseFranchiseTaxPayable_638240195657074161" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638240195657074161" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638240195657074161" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638240195657064362" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638240195657074161" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638240195657074161" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638240195657074161" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638240195657074161" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195657084173" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638240195657074161" xlink:to="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_638240195657084173" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638240195657074161" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638240195657084173" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638240195657084173" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NetProceedsFromInitialPublicOffering" xlink:label="dkdcu_NetProceedsFromInitialPublicOffering_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="dkdcu_NetProceedsFromInitialPublicOffering_638240195657084173" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfPrivateUnits" xlink:label="dkdcu_ProceedsFromSaleOfPrivateUnits_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="dkdcu_ProceedsFromSaleOfPrivateUnits_638240195657084173" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_638240195657084173" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_638240195657084173" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_638240195657084173" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_638240195657084173" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdvancesFromRelatedParties" xlink:label="dkdcu_AdvancesFromRelatedParties_638240195657094169" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="dkdcu_AdvancesFromRelatedParties_638240195657094169" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromWorkingCapitalLoan" xlink:label="dkdcu_ProceedsFromWorkingCapitalLoan_638240195657094169" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="dkdcu_ProceedsFromWorkingCapitalLoan_638240195657094169" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromExtensionLoan" xlink:label="dkdcu_ProceedsFromExtensionLoan_638240195657094169" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="dkdcu_ProceedsFromExtensionLoan_638240195657094169" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195657094169" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638240195657084173" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638240195657094169" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638240195657094169" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638240195657094169" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638240195657094169" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638240195657094169" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6382401956570941691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6382401956570941691" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195657094169" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195657094169" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption" xlink:label="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption_638240195657104151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195657094169" xlink:to="dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption_638240195657104151" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest" xlink:label="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest_638240195657104151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195657094169" xlink:to="dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest_638240195657104151" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeePayable" xlink:label="dkdcu_DeferredUnderwritingFeePayable_638240195657104151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195657094169" xlink:to="dkdcu_DeferredUnderwritingFeePayable_638240195657104151" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialFairValueOfWarrantLiabilities" xlink:label="dkdcu_InitialFairValueOfWarrantLiabilities_638240195657104151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638240195657094169" xlink:to="dkdcu_InitialFairValueOfWarrantLiabilities_638240195657104151" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationss" xlink:type="extended" xlink:title="210101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations_638240195657114174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations_638240195657114174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciess" xlink:type="extended" xlink:title="210201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_638240195657114174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_638240195657114174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferings" xlink:type="extended" xlink:title="210301 - Disclosure - INITIAL PUBLIC OFFERING" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialPublicOfferingAbstract" xlink:label="dkdcu_InitialPublicOfferingAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialPublicOfferingDisclosureTextBlock" xlink:label="dkdcu_InitialPublicOfferingDisclosureTextBlock_638240195657114174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_InitialPublicOfferingAbstract" xlink:to="dkdcu_InitialPublicOfferingDisclosureTextBlock_638240195657114174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacements" xlink:type="extended" xlink:title="210401 - Disclosure - PRIVATE PLACEMENT" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementAbstract" xlink:label="dkdcu_PrivatePlacementAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementTextBlock" xlink:label="dkdcu_PrivatePlacementTextBlock_638240195657114174" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementAbstract" xlink:to="dkdcu_PrivatePlacementTextBlock_638240195657114174" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionss" xlink:type="extended" xlink:title="210501 - Disclosure - RELATED PARTY TRANSACTIONS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_638240195657124377" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_638240195657124377" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciess" xlink:type="extended" xlink:title="210601 - Disclosure - COMMITMENTS AND CONTINGENCIES" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638240195657124377" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638240195657124377" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilitys" xlink:type="extended" xlink:title="210701 - Disclosure - WARRANT LIABILITY" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityAbstract" xlink:label="dkdcu_WarrantLiabilityAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityTextBlock" xlink:label="dkdcu_WarrantLiabilityTextBlock_638240195657124377" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_WarrantLiabilityAbstract" xlink:to="dkdcu_WarrantLiabilityTextBlock_638240195657124377" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquitys" xlink:type="extended" xlink:title="210801 - Disclosure - STOCKHOLDER'S EQUITY" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_638240195657134162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_638240195657134162" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementss" xlink:type="extended" xlink:title="210901 - Disclosure - FAIR VALUE MEASUREMENTS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock_638240195657134162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock_638240195657134162" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="211001 - Disclosure - INCOME TAXES" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_637514469402508513" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_638240195657134162" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637514469402508513" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_638240195657134162" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventss" xlink:type="extended" xlink:title="211101 - Disclosure - SUBSEQUENT EVENTS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock_638240195657144158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock_638240195657144158" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess" xlink:type="extended" xlink:title="220202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_638240195657144158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_638240195657144158" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock_638240195657144158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock_638240195657144158" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:label="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock_638240195657144158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock_638240195657144158" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_638240195657144158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates_638240195657144158" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638240195657144158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638240195657144158" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock" xlink:label="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock_638240195657144158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock_638240195657144158" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_638240195657144158" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_638240195657144158" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityPolicyPolicyTextBlock" xlink:label="dkdcu_TemporaryEquityPolicyPolicyTextBlock_638240195657154194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_TemporaryEquityPolicyPolicyTextBlock_638240195657154194" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_638240195657154194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_638240195657154194" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638240195657154194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638240195657154194" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk_638240195657154194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk_638240195657154194" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_638240195657154194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_638240195657154194" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock" xlink:label="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock_638240195657154194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock_638240195657154194" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_638240195657154194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_638240195657154194" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638240195657154194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638240195657154194" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTabless" xlink:type="extended" xlink:title="230203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock_638240195657164193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TemporaryEquityTableTextBlock_638240195657164193" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638240195657164193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638240195657164193" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTabless" xlink:type="extended" xlink:title="230903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_638240195657164193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_638240195657164193" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_638240195657164193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_638240195657164193" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_638240195657164193" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_638240195657164193" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesTables" xlink:type="extended" xlink:title="231003 - Disclosure - INCOME TAXES (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_638240195657174155" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_638240195657174155" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_638240195657174155" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss" xlink:type="extended" xlink:title="240101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_637326625217147953" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_637326625217147953" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657174155" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657174155" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195657174155" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195657174155" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657174155" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657174155" xlink:to="us-gaap_IPOMember_638240195657174155" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657174155" xlink:to="us-gaap_PrivatePlacementMember_638240195657174155" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657174155" xlink:to="us-gaap_OverAllotmentOptionMember_638240195657174155" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657174155" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195657174155" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195657174155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195657174155" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195657174155" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657174155" xlink:to="us-gaap_WarrantMember_638240195657184194" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantMember_638240195657184194" xlink:to="dkdcu_PublicWarrantsMember_638240195657184194" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657174155" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195657184194" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195657184194" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195657184194" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195657184194" xlink:to="dkdcu_FounderSharesMember_638240195657184194" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657174155" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657184194" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657184194" xlink:to="us-gaap_RelatedPartyDomain_638240195657184194" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657184194" xlink:to="dkdcu_SponsorMember_638240195657184194" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657174155" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:label="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_638240195657184194" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195657184194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195657184194" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromSaleOfUnits" xlink:label="dkdcu_ProceedsFromSaleOfUnits_638240195657194151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_ProceedsFromSaleOfUnits_638240195657194151" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssued" xlink:label="dkdcu_NumberOfWarrantsIssued_638240195657194151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_NumberOfWarrantsIssued_638240195657194151" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_638240195657194151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_638240195657194151" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_638240195657194151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_638240195657194151" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195657194151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195657194151" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_638240195657194151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_SharesIssuedPricePerShare_638240195657194151" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransactionCosts" xlink:label="dkdcu_TransactionCosts_638240195657194151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_TransactionCosts_638240195657194151" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockUnderwritingFees" xlink:label="dkdcu_SaleOfStockUnderwritingFees_638240195657194151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_TransactionCosts_638240195657194151" xlink:to="dkdcu_SaleOfStockUnderwritingFees_638240195657194151" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._638240195657194151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_TransactionCosts_638240195657194151" xlink:to="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._638240195657194151" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeePayable" xlink:label="dkdcu_DeferredUnderwritingFeePayable_638240195657204146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_TransactionCosts_638240195657194151" xlink:to="dkdcu_DeferredUnderwritingFeePayable_638240195657204146" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SaleOfStockOtherOfferingCosts" xlink:label="dkdcu_SaleOfStockOtherOfferingCosts_638240195657204146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_TransactionCosts_638240195657194151" xlink:to="dkdcu_SaleOfStockOtherOfferingCosts_638240195657204146" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CashHeldOutsideInTrustAccount" xlink:label="dkdcu_CashHeldOutsideInTrustAccount_638240195657204146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_CashHeldOutsideInTrustAccount_638240195657204146" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalDeficit" xlink:label="dkdcu_WorkingCapitalDeficit_638240195657204146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_WorkingCapitalDeficit_638240195657204146" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount" xlink:label="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount_638240195657204146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount_638240195657204146" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination" xlink:label="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination_638240195657204146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination_638240195657204146" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195657204146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195657204146" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_638240195657204146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_638240195657204146" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195657214147" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195657214147" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_638240195657214147" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_638240195657214147" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions" xlink:label="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions_638240195657214147" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions_638240195657214147" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfOneMonthExtensionsExecuted" xlink:label="dkdcu_NumberOfOneMonthExtensionsExecuted_638240195657214147" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_NumberOfOneMonthExtensionsExecuted_638240195657214147" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination_638240195657214147" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination_638240195657214147" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination" xlink:label="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination_638240195657214147" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination_638240195657214147" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares" xlink:label="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares_638240195657214147" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares_638240195657214147" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_638240195657224170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_638240195657224170" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_638240195657224170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_638240195657224170" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust_638240195657224170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_AssetsHeldInTrust_638240195657224170" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_638240195657224170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_638240195657224170" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNetInterestToPayDissolutionExpenses" xlink:label="dkdcu_MaximumNetInterestToPayDissolutionExpenses_638240195657224170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_MaximumNetInterestToPayDissolutionExpenses_638240195657224170" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195657224170" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195657224170" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_638240195657234144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_638240195657234144" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount" xlink:label="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_638240195657234144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount_638240195657234144" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet_638240195657234144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet_638240195657234144" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_638240195657234144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_638240195657234144" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_638240195657234144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_SharePrice_638240195657234144" order="33" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_638240195657244146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_Cash_638240195657244146" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_638240195657244146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_638240195657244146" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfPublicSharesToBeRedeemed." xlink:label="dkdcu_PercentageOfPublicSharesToBeRedeemed._638240195657244146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_PercentageOfPublicSharesToBeRedeemed._638240195657244146" order="36" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:label="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_638240195657244146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657184194" xlink:to="dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_638240195657244146" order="37" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss" xlink:type="extended" xlink:title="240201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesTable" xlink:label="dkdcu_AccountingPoliciesTable_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="dkdcu_AccountingPoliciesTable_638240195657254148" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195657254148" xlink:to="us-gaap_StatementClassOfStockAxis_638240195657254148" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195657254148" xlink:to="us-gaap_ClassOfStockDomain_638240195657254148" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassSubjectToRedemptionMember_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657254148" xlink:to="dkdcu_CommonClassSubjectToRedemptionMember_638240195657254148" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657254148" xlink:to="us-gaap_CommonClassBMember_638240195657254148" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195657254148" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195657254148" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195657254148" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195657254148" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195657254148" xlink:to="dkdcu_FounderSharesMember_638240195657254148" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195657254148" xlink:to="us-gaap_IncomeStatementLocationAxis_638240195657254148" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638240195657254148" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_638240195657254148" xlink:to="us-gaap_IncomeStatementLocationDomain_638240195657254148" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember" xlink:label="us-gaap_OperatingExpenseMember_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638240195657254148" xlink:to="us-gaap_OperatingExpenseMember_638240195657264180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195657254148" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657264180" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657264180" xlink:to="us-gaap_RelatedPartyDomain_638240195657264180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657264180" xlink:to="dkdcu_ArcGroupLimitedMember_638240195657264180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195657254148" xlink:to="us-gaap_TypeOfArrangementAxis_638240195657264180" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195657264180" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657264180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657264180" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657264180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657264180" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657264180" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesLineItems" xlink:label="dkdcu_AccountingPoliciesLineItems_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195657254148" xlink:to="dkdcu_AccountingPoliciesLineItems_638240195657264180" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="us-gaap_Cash_638240195657264180" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_638240195657264180" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_638240195657264180" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195657274146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="dkdcu_PaymentsForInvestmentOfCashInTrustAccount_638240195657274146" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_638240195657274146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="us-gaap_SharesIssuedPricePerShare_638240195657274146" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_638240195657274146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_638240195657274146" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantExercisable" xlink:label="dkdcu_WarrantExercisable_638240195657274146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="dkdcu_WarrantExercisable_638240195657274146" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638240195657274146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638240195657274146" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_638240195657274146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="us-gaap_UnrecognizedTaxBenefits_638240195657274146" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_638240195657274146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_638240195657274146" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657274146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657274146" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_638240195657274146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657264180" xlink:to="us-gaap_SharePrice_638240195657274146" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss" xlink:type="extended" xlink:title="240202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_1" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesTable" xlink:label="dkdcu_AccountingPoliciesTable_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_1" xlink:to="dkdcu_AccountingPoliciesTable_638240195657284144" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195657284144" xlink:to="us-gaap_StatementClassOfStockAxis_638240195657284144" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195657284144" xlink:to="us-gaap_ClassOfStockDomain_638240195657284144" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657284144" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember_638240195657284144" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AccountingPoliciesLineItems" xlink:label="dkdcu_AccountingPoliciesLineItems_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesTable_638240195657284144" xlink:to="dkdcu_AccountingPoliciesLineItems_638240195657284144" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657284144" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195657284144" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ProceedsFromIssuanceOfTemporaryEquity" xlink:label="dkdcu_ProceedsFromIssuanceOfTemporaryEquity_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657284144" xlink:to="dkdcu_ProceedsFromIssuanceOfTemporaryEquity_638240195657284144" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityProceedsAllocatedToWarrants" xlink:label="dkdcu_TemporaryEquityProceedsAllocatedToWarrants_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657284144" xlink:to="dkdcu_TemporaryEquityProceedsAllocatedToWarrants_638240195657284144" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TemporaryEquityIssuanceCosts" xlink:label="dkdcu_TemporaryEquityIssuanceCosts_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657284144" xlink:to="dkdcu_TemporaryEquityIssuanceCosts_638240195657284144" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest" xlink:label="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest_638240195657284144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657284144" xlink:to="dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest_638240195657284144" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657284144" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_638240195657294154" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_AccountingPoliciesLineItems_638240195657284144" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_638240195657294154" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss" xlink:type="extended" xlink:title="240203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638240195657294154" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638240195657294154" xlink:to="us-gaap_StatementClassOfStockAxis_638240195657294154" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195657294154" xlink:to="us-gaap_ClassOfStockDomain_638240195657294154" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657294154" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember_638240195657294154" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember" xlink:label="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657294154" xlink:to="dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_638240195657294154" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638240195657294154" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195657294154" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195657294154" xlink:to="us-gaap_NetIncomeLoss_638240195657294154" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638240195657294154" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195657294154" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638240195657294154" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195657294154" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638240195657304142" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195657294154" xlink:to="us-gaap_EarningsPerShareBasic_638240195657304142" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638240195657294154" xlink:to="us-gaap_EarningsPerShareDiluted_638240195657304142" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss" xlink:type="extended" xlink:title="240301 - Disclosure - INITIAL PUBLIC OFFERING (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_InitialPublicOfferingAbstract" xlink:label="dkdcu_InitialPublicOfferingAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_InitialPublicOfferingAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657304142" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657304142" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195657304142" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195657304142" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657304142" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657304142" xlink:to="us-gaap_IPOMember_638240195657304142" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657304142" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195657304142" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195657304142" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195657304142" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember_638240195657304142" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657304142" xlink:to="dkdcu_PublicWarrantsMember_638240195657304142" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657304142" xlink:to="us-gaap_StatementClassOfStockAxis_638240195657314141" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195657314141" xlink:to="us-gaap_ClassOfStockDomain_638240195657314141" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657314141" xlink:to="us-gaap_CommonClassAMember_638240195657314141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_638240195657304142" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_638240195657314141" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657314141" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195657314141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657314141" xlink:to="us-gaap_SharesIssuedPricePerShare_638240195657314141" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSharesIssuedPerUnit" xlink:label="dkdcu_NumberOfSharesIssuedPerUnit_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657314141" xlink:to="dkdcu_NumberOfSharesIssuedPerUnit_638240195657314141" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657314141" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638240195657314141" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfWarrantsIssuedPerUnit" xlink:label="dkdcu_NumberOfWarrantsIssuedPerUnit_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657314141" xlink:to="dkdcu_NumberOfWarrantsIssuedPerUnit_638240195657314141" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657314141" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_638240195657314141" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638240195657314141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_638240195657314141" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638240195657314141" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss" xlink:type="extended" xlink:title="240401 - Disclosure - PRIVATE PLACEMENT (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementAbstract" xlink:label="dkdcu_PrivatePlacementAbstract" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementTable" xlink:label="dkdcu_PrivatePlacementTable_638240195657324145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementAbstract" xlink:to="dkdcu_PrivatePlacementTable_638240195657324145" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195657324145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementTable_638240195657324145" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195657324145" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657324145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195657324145" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657324145" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember_638240195657324145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657324145" xlink:to="us-gaap_PrivatePlacementMember_638240195657324145" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementLineItems" xlink:label="dkdcu_PrivatePlacementLineItems_638240195657324145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementTable_638240195657324145" xlink:to="dkdcu_PrivatePlacementLineItems_638240195657324145" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638240195657324145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementLineItems_638240195657324145" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638240195657324145" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_638240195657324145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementLineItems_638240195657324145" xlink:to="dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights_638240195657324145" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_638240195657324145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_PrivatePlacementLineItems_638240195657324145" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_638240195657324145" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss" xlink:type="extended" xlink:title="240501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657334165" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657334165" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195657334165" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195657334165" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195657334165" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195657334165" xlink:to="dkdcu_FounderSharesMember_638240195657334165" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657334165" xlink:to="us-gaap_TypeOfArrangementAxis_638240195657334165" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195657334165" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657334165" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657334165" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657334165" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657334165" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657334165" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657334165" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657334165" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657334165" xlink:to="us-gaap_RelatedPartyDomain_638240195657334165" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657334165" xlink:to="dkdcu_SponsorMember_638240195657334165" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657334165" xlink:to="srt_ChiefExecutiveOfficerMember_638240195657334165" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember_638240195657334165" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657334165" xlink:to="srt_ChiefFinancialOfficerMember_638240195657334165" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TwoIndependentDirectorMember" xlink:label="dkdcu_TwoIndependentDirectorMember_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657334165" xlink:to="dkdcu_TwoIndependentDirectorMember_638240195657344196" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdIndependentDirectorMember" xlink:label="dkdcu_ThirdIndependentDirectorMember_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657334165" xlink:to="dkdcu_ThirdIndependentDirectorMember_638240195657344196" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657334165" xlink:to="srt_AffiliatedEntityMember_638240195657344196" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657334165" xlink:to="us-gaap_StatementClassOfStockAxis_638240195657344196" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195657344196" xlink:to="us-gaap_ClassOfStockDomain_638240195657344196" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657344196" xlink:to="us-gaap_CommonClassBMember_638240195657344196" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657334165" xlink:to="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638240195657344196" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_638240195657344196" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare_638240195657344196" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_StockTransferredToOthersDuringPeriodShare_638240195657344196" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RetainerFeeUponExecutionOfAgreement" xlink:label="dkdcu_RetainerFeeUponExecutionOfAgreement_638240195657354155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_RetainerFeeUponExecutionOfAgreement_638240195657354155" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination" xlink:label="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination_638240195657354155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination_638240195657354155" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_638240195657354155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_638240195657354155" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_638240195657354155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_638240195657354155" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_638240195657354155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_638240195657354155" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_638240195657354155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_638240195657354155" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_638240195657354155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_638240195657354155" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:label="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_638240195657354155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_638240195657354155" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657364168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657364168" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638240195657364168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638240195657364168" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195657364168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195657364168" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination" xlink:label="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination_638240195657364168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination_638240195657364168" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination" xlink:label="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195657364168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination_638240195657364168" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregatePeriodToConsummateInitialBusinessCombination" xlink:label="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination_638240195657364168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_AggregatePeriodToConsummateInitialBusinessCombination_638240195657364168" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven" xlink:label="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven_638240195657364168" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven_638240195657364168" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination" xlink:label="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_638240195657374150" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination_638240195657374150" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount" xlink:label="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_638240195657374150" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount_638240195657374150" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension" xlink:label="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_638240195657374150" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension_638240195657374150" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ExtensionLoansNonCurrent" xlink:label="dkdcu_ExtensionLoansNonCurrent_638240195657374150" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657344196" xlink:to="dkdcu_ExtensionLoansNonCurrent_638240195657374150" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss" xlink:type="extended" xlink:title="240502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657374150" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657374150" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657374150" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195657384145" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195657384145" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195657384145" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PromissoryNoteWithRelatedPartyMember" xlink:label="dkdcu_PromissoryNoteWithRelatedPartyMember_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195657384145" xlink:to="dkdcu_PromissoryNoteWithRelatedPartyMember_638240195657384145" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AdministrativeSupportAgreementMember" xlink:label="dkdcu_AdministrativeSupportAgreementMember_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195657384145" xlink:to="dkdcu_AdministrativeSupportAgreementMember_638240195657384145" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyLoansMember" xlink:label="dkdcu_RelatedPartyLoansMember_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195657384145" xlink:to="dkdcu_RelatedPartyLoansMember_638240195657384145" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195657384145" xlink:to="dkdcu_FounderSharesMember_638240195657384145" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657374150" xlink:to="us-gaap_TypeOfArrangementAxis_638240195657384145" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195657384145" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657384145" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657384145" xlink:to="dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657384145" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657384145" xlink:to="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657384145" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657384145" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657384145" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657374150" xlink:to="us-gaap_StatementClassOfStockAxis_638240195657384145" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195657384145" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195657384145" xlink:to="us-gaap_ClassOfStockDomain_638240195657384145" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657384145" xlink:to="us-gaap_CommonClassBMember_638240195657394144" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657374150" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195657394144" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195657394144" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657394144" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657394144" xlink:to="us-gaap_OverAllotmentOptionMember_638240195657394144" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657374150" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195657394144" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195657394144" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195657394144" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WorkingCapitalLoansWarrantMember" xlink:label="dkdcu_WorkingCapitalLoansWarrantMember_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657394144" xlink:to="dkdcu_WorkingCapitalLoansWarrantMember_638240195657394144" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657374150" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657394144" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657394144" xlink:to="us-gaap_RelatedPartyDomain_638240195657394144" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember_638240195657394144" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657394144" xlink:to="srt_AffiliatedEntityMember_638240195657394144" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_638240195657374150" xlink:to="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_638240195657404160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_638240195657404160" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumLoansConvertibleUptoConsummation" xlink:label="dkdcu_MaximumLoansConvertibleUptoConsummation_638240195657404160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="dkdcu_MaximumLoansConvertibleUptoConsummation_638240195657404160" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_638240195657404160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_638240195657404160" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_638240195657404160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_638240195657404160" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_638240195657404160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="us-gaap_SaleOfStockPricePerShare_638240195657404160" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecuritiesDepositHeldInTrustAccount" xlink:label="dkdcu_SecuritiesDepositHeldInTrustAccount_638240195657404160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="dkdcu_SecuritiesDepositHeldInTrustAccount_638240195657404160" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_BusinessCombinationTotalPayments" xlink:label="dkdcu_BusinessCombinationTotalPayments_638240195657404160" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="dkdcu_BusinessCombinationTotalPayments_638240195657404160" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_638240195657414156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_638240195657414156" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_638240195657414156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_638240195657414156" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638240195657414156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="us-gaap_CommonStockSharesOutstanding_638240195657414156" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfOwnershipAsConsiderationForService" xlink:label="dkdcu_PercentageOfOwnershipAsConsiderationForService_638240195657414156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="dkdcu_PercentageOfOwnershipAsConsiderationForService_638240195657414156" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget" xlink:label="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget_638240195657414156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget_638240195657414156" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_638240195657414156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_638240195657414156" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657414156" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657414156" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195657424143" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_638240195657404160" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195657424143" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss" xlink:type="extended" xlink:title="240601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable_638240195657424143" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable_638240195657424143" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638240195657424143" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195657424143" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638240195657424143" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657424143" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638240195657424143" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657424143" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_638240195657424143" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638240195657424143" xlink:to="us-gaap_OverAllotmentOptionMember_638240195657424143" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195657424143" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195657424143" xlink:to="us-gaap_TypeOfArrangementAxis_638240195657424143" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657424143" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195657424143" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657424143" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657424143" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657424143" xlink:to="dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657424143" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657424143" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657434141" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195657424143" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657434141" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657434141" xlink:to="us-gaap_RelatedPartyDomain_638240195657434141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657434141" xlink:to="dkdcu_ArcGroupLimitedMember_638240195657434141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195657424143" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195657434141" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195657434141" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195657434141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195657434141" xlink:to="dkdcu_FounderSharesMember_638240195657434141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195657424143" xlink:to="us-gaap_StatementClassOfStockAxis_638240195657434141" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195657434141" xlink:to="us-gaap_ClassOfStockDomain_638240195657434141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657434141" xlink:to="us-gaap_CommonClassBMember_638240195657434141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems_638240195657434141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638240195657424143" xlink:to="us-gaap_LossContingenciesLineItems_638240195657434141" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_OverAllotmentOptionPeriod" xlink:label="dkdcu_OverAllotmentOptionPeriod_638240195657444141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="dkdcu_OverAllotmentOptionPeriod_638240195657444141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities_638240195657444141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities_638240195657444141" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195657444141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="dkdcu_UnitsIssuedDuringPeriodSharesNewIssues_638240195657444141" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPercentage" xlink:label="dkdcu_UnderwritingDiscountPercentage_638240195657444141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="dkdcu_UnderwritingDiscountPercentage_638240195657444141" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnderwritingDiscountPaid" xlink:label="dkdcu_UnderwritingDiscountPaid_638240195657444141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="dkdcu_UnderwritingDiscountPaid_638240195657444141" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_DeferredUnderwritingFeesPercentage" xlink:label="dkdcu_DeferredUnderwritingFeesPercentage_638240195657444141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="dkdcu_DeferredUnderwritingFeesPercentage_638240195657444141" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger." xlink:label="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._638240195657444141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger._638240195657444141" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing" xlink:label="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_638240195657444141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing_638240195657444141" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657444141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657444141" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195657454141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638240195657434141" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195657454141" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss" xlink:type="extended" xlink:title="240701 - Disclosure - WARRANT LIABILITY (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityAbstract" xlink:label="dkdcu_WarrantLiabilityAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable_638240195657454141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dkdcu_WarrantLiabilityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable_638240195657454141" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195657454141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638240195657454141" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195657454141" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195657454141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195657454141" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195657454141" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_638240195657454141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657454141" xlink:to="us-gaap_WarrantMember_638240195657454141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PlacementWarrantsMember" xlink:label="dkdcu_PlacementWarrantsMember_638240195657454141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantMember_638240195657454141" xlink:to="dkdcu_PlacementWarrantsMember_638240195657454141" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember_638240195657454141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantMember_638240195657454141" xlink:to="dkdcu_PublicWarrantsMember_638240195657454141" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_638240195657454141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638240195657454141" xlink:to="srt_StatementScenarioAxis_638240195657454141" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_638240195657454141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_638240195657454141" xlink:to="srt_ScenarioUnspecifiedDomain_638240195657454141" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195657454141" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_638240195657464189" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195657454141" xlink:to="dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_638240195657464189" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638240195657454141" xlink:to="us-gaap_StatementClassOfStockAxis_638240195657464189" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195657464189" xlink:to="us-gaap_ClassOfStockDomain_638240195657464189" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657464189" xlink:to="us-gaap_CommonClassAMember_638240195657464189" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657464189" xlink:to="us-gaap_CommonClassBMember_638240195657464189" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638240195657454141" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:label="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_638240195657464189" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_638240195657464189" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination_638240195657464189" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination" xlink:label="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination_638240195657464189" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination_638240195657464189" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_638240195657474146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_638240195657474146" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_638240195657474146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_638240195657474146" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_638240195657474146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_638240195657474146" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_638240195657474146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_638240195657474146" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_638240195657474146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="us-gaap_SharePrice_638240195657474146" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:label="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed_638240195657474146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed_638240195657474146" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:label="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_638240195657474146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_638240195657474146" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice" xlink:label="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice_638240195657474146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice_638240195657474146" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantsOrRightsIssued" xlink:label="dkdcu_WarrantsOrRightsIssued_638240195657474146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638240195657464189" xlink:to="dkdcu_WarrantsOrRightsIssued_638240195657474146" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredStockSharesDetails" xlink:type="extended" xlink:title="240801 - Disclosure - STOCKHOLDER'S EQUITY - Preferred Stock Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_638240195657484139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized_638240195657484139" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_638240195657484139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_638240195657484139" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_638240195657484139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockSharesIssued_638240195657484139" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_638240195657484139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding_638240195657484139" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails" xlink:type="extended" xlink:title="240802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable_638240195657484139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable_638240195657484139" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195657484139" xlink:to="us-gaap_StatementClassOfStockAxis_638240195657494138" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638240195657494138" xlink:to="us-gaap_ClassOfStockDomain_638240195657494138" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657494138" xlink:to="us-gaap_CommonClassAMember_638240195657494138" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaSubjectToRedemptionMember_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonClassAMember_638240195657494138" xlink:to="dkdcu_CommonClassaSubjectToRedemptionMember_638240195657494138" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonClassaNotSubjectToRedemptionMember" xlink:label="dkdcu_CommonClassaNotSubjectToRedemptionMember_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonClassAMember_638240195657494138" xlink:to="dkdcu_CommonClassaNotSubjectToRedemptionMember_638240195657494138" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638240195657494138" xlink:to="us-gaap_CommonClassBMember_638240195657494138" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195657484139" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657494138" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638240195657494138" xlink:to="us-gaap_RelatedPartyDomain_638240195657494138" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SponsorMember" xlink:label="dkdcu_SponsorMember_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657494138" xlink:to="dkdcu_SponsorMember_638240195657494138" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ArcGroupLimitedMember" xlink:label="dkdcu_ArcGroupLimitedMember_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638240195657494138" xlink:to="dkdcu_ArcGroupLimitedMember_638240195657494138" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195657484139" xlink:to="us-gaap_RelatedPartyTransactionAxis_638240195657494138" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_638240195657494138" xlink:to="us-gaap_RelatedPartyTransactionDomain_638240195657494138" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FounderSharesMember" xlink:label="dkdcu_FounderSharesMember_638240195657494138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_638240195657494138" xlink:to="dkdcu_FounderSharesMember_638240195657494138" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_638240195657504187" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195657484139" xlink:to="srt_TitleOfIndividualAxis_638240195657504187" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195657504187" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis_638240195657504187" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195657504187" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember_638240195657504187" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195657504187" xlink:to="srt_ChiefExecutiveOfficerMember_638240195657504187" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember_638240195657504187" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195657504187" xlink:to="srt_ChiefFinancialOfficerMember_638240195657504187" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_IndependentDirectorsMember" xlink:label="dkdcu_IndependentDirectorsMember_638240195657504187" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_638240195657504187" xlink:to="dkdcu_IndependentDirectorsMember_638240195657504187" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638240195657504187" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195657484139" xlink:to="us-gaap_TypeOfArrangementAxis_638240195657504187" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657504187" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638240195657504187" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657504187" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember" xlink:label="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657504187" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638240195657504187" xlink:to="dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_638240195657504187" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_638240195657504187" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_638240195657484139" xlink:to="us-gaap_ClassOfStockLineItems_638240195657504187" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_638240195657514146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="us-gaap_CommonStockSharesAuthorized_638240195657514146" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638240195657514146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638240195657514146" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockNumberOfVotesPerShare" xlink:label="dkdcu_CommonStockNumberOfVotesPerShare_638240195657514146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="dkdcu_CommonStockNumberOfVotesPerShare_638240195657514146" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StockTransferredToOthersDuringPeriodShare" xlink:label="dkdcu_StockTransferredToOthersDuringPeriodShare_638240195657514146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="dkdcu_StockTransferredToOthersDuringPeriodShare_638240195657514146" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_638240195657514146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="us-gaap_CommonStockSharesIssued_638240195657514146" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638240195657514146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="us-gaap_CommonStockSharesOutstanding_638240195657514146" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_638240195657514146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_638240195657514146" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657514146" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638240195657514146" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights" xlink:label="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195657524139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights_638240195657524139" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareIssued" xlink:label="dkdcu_CommonStockShareIssued_638240195657524139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="dkdcu_CommonStockShareIssued_638240195657524139" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_CommonStockShareOutstanding" xlink:label="dkdcu_CommonStockShareOutstanding_638240195657524139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="dkdcu_CommonStockShareOutstanding_638240195657524139" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare" xlink:label="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare_638240195657524139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_638240195657504187" xlink:to="dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare_638240195657524139" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss" xlink:type="extended" xlink:title="240901 - Disclosure - FAIR VALUE MEASUREMENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657524139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657524139" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657524139" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195657534139" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195657534139" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195657534139" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195657534139" xlink:to="us-gaap_FairValueInputsLevel1Member_638240195657534139" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195657534139" xlink:to="us-gaap_FairValueInputsLevel3Member_638240195657534139" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657524139" xlink:to="us-gaap_FinancialInstrumentAxis_638240195657534139" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis_638240195657534139" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638240195657534139" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638240195657534139" xlink:to="us-gaap_USTreasurySecuritiesMember_638240195657534139" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638240195657534139" xlink:to="us-gaap_MoneyMarketFundsMember_638240195657534139" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657524139" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_638240195657534139" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis_638240195657534139" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_638240195657534139" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_638240195657534139" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain_638240195657534139" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_638240195657534139" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195657544138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657524139" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195657544138" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195657544138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195657544138" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195657544138" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember_638240195657544138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657544138" xlink:to="dkdcu_PublicWarrantsMember_638240195657544138" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivatePlacementWarrantsMember" xlink:label="dkdcu_PrivatePlacementWarrantsMember_638240195657544138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657544138" xlink:to="dkdcu_PrivatePlacementWarrantsMember_638240195657544138" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657544138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657524139" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657544138" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_638240195657544138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657544138" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_638240195657544138" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_638240195657544138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657544138" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_638240195657544138" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount" xlink:label="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount_638240195657594155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657544138" xlink:to="dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount_638240195657594155" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_638240195657594155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657544138" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_638240195657594155" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_638240195657594155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657544138" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_638240195657594155" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_638240195657594155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657544138" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_638240195657594155" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_638240195657594155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657544138" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_638240195657594155" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" xlink:type="extended" xlink:title="240902 - Disclosure - FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_637552778634131650" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657604134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_637552778634131650" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657604134" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195657604134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657604134" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195657604134" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195657604134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195657604134" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195657604134" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivateWarrantMember" xlink:label="dkdcu_PrivateWarrantMember_638240195657604134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657604134" xlink:to="dkdcu_PrivateWarrantMember_638240195657604134" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_638240195657604134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657604134" xlink:to="us-gaap_MeasurementInputTypeAxis_638240195657604134" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_638240195657604134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis_638240195657604134" xlink:to="us-gaap_MeasurementInputTypeDomain_638240195657604134" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember_638240195657604134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195657604134" xlink:to="us-gaap_MeasurementInputExercisePriceMember_638240195657604134" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember_638240195657604134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195657604134" xlink:to="us-gaap_MeasurementInputSharePriceMember_638240195657604134" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember_638240195657604134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195657604134" xlink:to="us-gaap_MeasurementInputExpectedTermMember_638240195657604134" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember" xlink:label="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195657604134" xlink:to="dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_638240195657614134" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195657604134" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_638240195657614134" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195657604134" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_638240195657614134" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638240195657604134" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_638240195657614134" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657604134" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195657614134" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_638240195657614134" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195657614134" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638240195657614134" xlink:to="us-gaap_FairValueInputsLevel3Member_638240195657614134" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657604134" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_638240195657614134" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis_638240195657614134" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_638240195657614134" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain_638240195657614134" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_638240195657614134" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657614134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638240195657604134" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657614134" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_638240195657624131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638240195657614134" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput_638240195657624131" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" xlink:type="extended" xlink:title="240903 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638240195657624131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638240195657624131" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638240195657624131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638240195657624131" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638240195657624131" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638240195657624131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638240195657624131" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638240195657624131" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PublicWarrantsMember" xlink:label="dkdcu_PublicWarrantsMember_638240195657624131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657624131" xlink:to="dkdcu_PublicWarrantsMember_638240195657624131" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_PrivateWarrantMember" xlink:label="dkdcu_PrivateWarrantMember_638240195657624131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657624131" xlink:to="dkdcu_PrivateWarrantMember_638240195657624131" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_WarrantLiabilityMember" xlink:label="dkdcu_WarrantLiabilityMember_638240195657624131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638240195657624131" xlink:to="dkdcu_WarrantLiabilityMember_638240195657624131" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_638240195657624131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638240195657624131" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_638240195657624131" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195657624131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_638240195657624131" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195657624131" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_638240195657634131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195657624131" xlink:to="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_638240195657634131" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_638240195657634131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195657624131" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_638240195657634131" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue" xlink:label="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_6382401956576341311" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195657624131" xlink:to="dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue_6382401956576341311" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_638240195657634131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638240195657624131" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_638240195657634131" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails" xlink:type="extended" xlink:title="241001 - Disclosure - INCOME TAX - Income tax provision (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_638240195657634131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_1" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_638240195657634131" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_638240195657634131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_638240195657634131" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_638240195657634131" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638240195657634131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_638240195657634131" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638240195657634131" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_638240195657634131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_1" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_638240195657634131" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638240195657634131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_1" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638240195657634131" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="extended" xlink:title="241002 - Disclosure - INCOME TAXES - Net deferred tax assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_637514476478691693" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_638240195657644136" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637514476478691693" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_638240195657644136" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638240195657644136" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_638240195657644136" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638240195657644136" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_StartUpCosts" xlink:label="dkdcu_StartUpCosts_638240195657644136" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_638240195657644136" xlink:to="dkdcu_StartUpCosts_638240195657644136" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross_638240195657644136" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_638240195657644136" xlink:to="us-gaap_DeferredTaxAssetsGross_638240195657644136" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_638240195657644136" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637514476478691693" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_638240195657644136" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_UnrealizedGainOnInvestmentInTrustAccount" xlink:label="dkdcu_UnrealizedGainOnInvestmentInTrustAccount_638240195657644136" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract_638240195657644136" xlink:to="dkdcu_UnrealizedGainOnInvestmentInTrustAccount_638240195657644136" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_638240195657644136" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract_638240195657644136" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_638240195657644136" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_638240195657644136" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract_638240195657644136" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_638240195657644136" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails" xlink:type="extended" xlink:title="241003 - Disclosure - INCOME TAXES - Federal income tax rate (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_637514470597206961" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638240195657644136" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637514470597206961" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638240195657644136" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637514470597206961" xlink:to="dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities_638240195657654134" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637514470597206961" xlink:to="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance_638240195657654134" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:label="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637514470597206961" xlink:to="dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_638240195657654134" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637514470597206961" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_638240195657654134" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637514470597206961" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_638240195657654134" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails" xlink:type="extended" xlink:title="241004 - Disclosure - INCOME TAXES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_2" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_U.s.FederalAndStateNetOperatingLoss" xlink:label="dkdcu_U.s.FederalAndStateNetOperatingLoss_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_2" xlink:to="dkdcu_U.s.FederalAndStateNetOperatingLoss_638240195657654134" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_LimitationOnAnnualTaxableIncome" xlink:label="dkdcu_LimitationOnAnnualTaxableIncome_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_2" xlink:to="dkdcu_LimitationOnAnnualTaxableIncome_638240195657654134" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_2" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_638240195657654134" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_2" xlink:to="us-gaap_UnrecognizedTaxBenefits_638240195657654134" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_638240195657654134" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_2" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_638240195657654134" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss" xlink:type="extended" xlink:title="241101 - Disclosure - SUBSEQUENT EVENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract_1" xlink:to="us-gaap_SubsequentEventTable_638240195657664191" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638240195657664191" xlink:to="us-gaap_SubsequentEventTypeAxis_638240195657664191" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis_638240195657664191" xlink:to="us-gaap_SubsequentEventTypeDomain_638240195657664191" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain_638240195657664191" xlink:to="us-gaap_SubsequentEventMember_638240195657664191" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638240195657664191" xlink:to="srt_StatementScenarioAxis_638240195657664191" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_638240195657664191" xlink:to="srt_ScenarioUnspecifiedDomain_638240195657664191" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_ThirdMonthExtensionToTerminationDateMember" xlink:label="dkdcu_ThirdMonthExtensionToTerminationDateMember_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195657664191" xlink:to="dkdcu_ThirdMonthExtensionToTerminationDateMember_638240195657664191" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FourthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FourthMonthExtensionToTerminationDateMember_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195657664191" xlink:to="dkdcu_FourthMonthExtensionToTerminationDateMember_638240195657664191" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_FifthMonthExtensionToTerminationDateMember" xlink:label="dkdcu_FifthMonthExtensionToTerminationDateMember_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638240195657664191" xlink:to="dkdcu_FifthMonthExtensionToTerminationDateMember_638240195657664191" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems_638240195657664191" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638240195657664191" xlink:to="us-gaap_SubsequentEventLineItems_638240195657664191" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AmountDepositedPerEachPublicShareOutstanding" xlink:label="dkdcu_AmountDepositedPerEachPublicShareOutstanding_638240195657674153" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195657664191" xlink:to="dkdcu_AmountDepositedPerEachPublicShareOutstanding_638240195657674153" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="dkdcu-20230331.xsd#dkdcu_AggregateAmountDepositedInTrustAccount" xlink:label="dkdcu_AggregateAmountDepositedInTrustAccount_638240195657674153" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638240195657664191" xlink:to="dkdcu_AggregateAmountDepositedInTrustAccount_638240195657674153" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>dkdcu-20230331xex10d15001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xex10d15001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !* 'L# 2(  A$! Q$!_\0
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M5?MM#^*][Y8&HPZ>&)^2&W;<G88!&,X/_P!?K6!:?$KXG:H8X['3$LHVQA3
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M!"3]G\M?+X(Q\N,56^)NB:<VB:1,;"U,T96-)#"NY5"'"@XX ]* ,&XO]?\
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78^%/+MH([>/[0YV1(%&<#G KLZ /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>dkdcu-20230331xex10d16001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xex10d16001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !* 'L# 2(  A$! Q$!_\0
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M/1?#R64E_=K;B\C22/?G&&Z'IG_/X5H:]XGT_P /6,5U>S-%#)(D:LJ$DEB
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B4X5%Z#G-<G\)K."Q\*>7;01V\?VASLB0*,X'.!79T ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>dkdcu-20230331xex10d16002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xex10d16002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !7 -0# 2(  A$! Q$!_\0
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M4\!66E_!W4O$.F?LGV?PCTIKJWM(O$NIZRB7REGW*([&.0 ,RH5;<'P&;TR
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MQ]')<*UCX7^'VGBTTF>+DDW#1[. V0,<@#.[C%?2WPW\%_$+PQ"L?P9_8_\
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MGKFKW26.E:;;27EW<RG"Q11J6=C[  F@#XS_ &Q+ZQ^-_P"TI\,?@Q>3Q_\
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M>#Z@ ]0^/O[2F@? VTT^P6UN/%7CK6G,&A>$-(Q)?:A+@D':,^7$,$M*PVJ
M>IXKF/@G^SWK<OC0?%OXPW5OKWQ0N(FCL+"W._3O#%LV?]&LP>LF#B2;JQR
M<9+=+\"/V9?#WP2DO]:FOKWQEX_U;G5_&6O/YM_=G.=BDY$,0X"Q)@ *N=Q
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@E];*C$R130VS03*PQP,JC Y/WSZ5ZY110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>dkdcu-20230331xex10d16004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xex10d16004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  N )X# 2(  A$! Q$!_\0
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MM/\ "'C'XN:U87%U?_;=8MM(FU+4&,EUJ,UE;A;BZF?HS-<37"X4!5$850%
M !GT-1110(**X[Q7\2K7POX^\$>$OL4][J7BB6[\MHB EK!;0&66>3/\.YH8
MP!_%,M=C0 4444 >=?%KXHW?@V72?#GAG3H]>\?^(/-72-,F9DMXUC"^;=W4
MB@F.VBWIN(^9BR(@+.*3X7_!:Q\ WUWXAU2^F\5^/=23;J7B?4$'G.N<^1;I
MR+>W4_=A3C@%B[98Q?#+X::IH/COQYXS\3W<&H^(->O1:V36^?*LM(@+?9+=
M W(8EY))#_%)(>RKCTN@9S?CKQQ:> =.TV^OHF>UN]4L]+:16 $3W,RPQL<]
MO,=!_P "KH+FYALK::XN)8[>WA0R22RL%1% R68G@ #DDUXS^V5(UI^SCXIO
MU_YALVGZFQS@A+>_MYV(/8[8S@^M<GXF\8Z3\<;:[\0^*-6L/#_[/.D2EFNM
M2G6&/Q5/&_WG9CC^SU9?E7_EY8 \Q8$H!M^&Q+^T]XJTOQ==V[0_"G0;M;WP
MY:SQLDFOWJ9"ZC*C8Q;1G)MU(S(W[XX"Q9][KYJLOVL/$GB+6=,@\)?".^?P
MQJ5K=76EZ]XDU6+1H;RWMC'OECA*22)&5D1T,BIN4,< #G2^%/[5R>)]*T6^
M\;Z59^#3XCTRZ\2:5:V]ZUX;71((T9KZ_D,:+;JY==G4$.HSD,  ?0=>??'O
MXQ:;\!_A5KGC'4(S=RVD7EV&G)GS=0O7^6WMHP 26D<J. 2!DXP#7A?A[_@H
MYX(\1?$#2]+'A_6-'\&ZA:7=Y!XPUO9:030P1-(9H[<DS-"Y 17*KN=E4 DX
MKB/%7QXU+7/C9'XF\8>#KZ[M/#OV6'P%\.H$5M5O]9O(F<7%PI.Q)8;0"1LD
MK;I<@L?,Z 'J_P"RK\ M=TG4K[XO?%8"^^+OB2'#QR2&1-"M&.Y;* $D)C/S
M;<= O.&9_I6O!;']K_PW?Z7=6MOIMSJ/C>WU!-"7PMI5S#=276J_9HY[BV@F
M#!72W$F)IV"HFQB>@!]#^$GQ%F^(W@;^WK^RM=*ECOKVQE6UO?M5LS6US) S
MQ3%$WH3$2"5']2 =O575=4M-#TN\U+4+A+2PLX7N+BXE.$BC12S,3Z  G\*3
M3]7L=65VL;VWO APQMY5DVGWP3CH?RKYS_;6\:7C>&;3P/HE]96E[=1C7]:D
MOXVE@BT>UN(?-69$=6V32/'$1N&4\_G@T =1\-;[[#X0\6?&WQ?%-;W.L6+Z
MG#:7<8632M$@C:2VML?PLR!IY >?,F93PBXZ#]F7PKJG@_X%^$[3726\07<#
MZMJA8DL+R[E>ZG4D\G;),RY/]T5XU\<OA3XJ\9ZAX3^'.K?%SQ%>ZIXSN97U
M6TL+"RM]/CTNUVRW#1Q&"1X_G-M$"\K[C-AMPR*V?^&HKSX5?"NVN_$]AJ_C
MGQ#!>ZTDZV<-M;7"V-CJ#VWGSC<D7F$&!%2,9EDD 1>3@ ^FZ\7NOVAM?_M.
M;3;#X'_$:]O(Y'C\QX-.M[5BI(W":2\"E3@$$=B/<5W&M?&#P3X<UW4-&U;Q
M1IFF:KIVF#6+RTN[A8WM[/?L\Y\_=7<0.><D>HK#US]H/PG8_"BR\>Z5=2:]
MIVKLEOH5K:Q.MQJ]U(YCA@AC90Q9W!Y(PJAG.%4D 'SOX6^)'QC^+O[4_B5]
M'\">&O".H^"-!M](O(/$NNM>FU-_(+DL%M(RKR%+:'*>8  !ESNP/>F^'_Q8
MUD9U3XL6FD!@=T?ACPS#"5SV#W4EQGCH=H^G:O*OV19I+?XR_$[2=5C>+QO8
MZ7I9\6L8#''<:I+=:E.9HC_' 8I8A$W41HBD J17U?0!Y3I?[/ZVUT9]3^(W
MQ!UYR/NW.OM:IG.<[;5(178^&/AYH_A"YEN-/DU9Y95V,=0UF\O1C(/ FE<#
MIU !_.NEHH ***9-$L\3QOG8ZE3@X.#QUH$?&/[2VM?$#]KJ+7?AA\';6RF\
M$6HGL_$GBZ^O#;VES>(A*Z? RJS2*K[#*R*5)Q&64;PWH_B+]BOP[X\\!ZCI
M?C'6[[Q5XHNM/:RMO$&H0Q%-)RH ^PV2@06Z# !5%#,N0SG.:]K\!> ] ^&'
M@[2O"OA?3(='T#2X1!:64&2L:Y)/))+$DEBQ)))))))K?H&>6^$/@E-;:M-K
MGCGQ-<>.]?DL)=+C:2U2RL+.UE(,L=O:QDA"^Q SNSN0B@,%&*X;6?V)_@MI
MOAS49-<M=4;1(]*2UU-]0\1WODRV=LNZ$3YF *6ZKE ?E3&<9&:^BZY3XK?#
MG3OB[\./$/@S5KBZM=.UNT>SGFLI-DJ*W<$@@].58%6&0002* /DK]F7X5^'
M/B=^T%XE\:_\(7%I'A?P<\*>'X]1,D^H76HW,*327U])*S2-.L!M_+CD)\E9
M@ %<-CZ3\:?LT_#+X@^(+K7];\(V<WB&Y9&FUJUDDM+]PL1A"_:(62388B4*
M!MK+P0:Z+X8?#G3OA5X-M/#^G3W-\(WEN+G4+]P]S?7,KF2:XF8  N[LQ.
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&1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>dkdcu-20230331xex10d17001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xex10d17001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !R 3,# 2(  A$! Q$!_\0
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MGBO_ (),_M3RZ/J$MYK'P7\4S!Q*59M]MNP)   OVF , X ^=<=-R[0#MO\
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M_@K]_P E]^ W_;3_ -*H:_52@ HHHH **** "BBB@ IKHLBE74,IZ@C(IU%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>dkdcu-20230331xex10d17002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xex10d17002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !( -$# 2(  A$! Q$!_\0
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ML0 /K7#W_P"T-X!M_A%J?Q-L?$%MKW@[3H9)YK_2'6X!"?>4 '[PX^4X/(H
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MX[I7!0Q>49<ANFTY!S0!]245G:#XBTKQ5ID>HZ+J5IJ^GR%E2ZL9UFB8J<,
MRD@X((-:- 'E'[1W[1?AO]F[P*^NZY(LVH7):#2=+RROJ%SC(A5@K!2<]3Q6
MG^S_ /&&#X[_  JT7QC%ILNC2WJLEQITS[WM9D8J\9; S@CK@5\7?\% 7'Q+
M_:Q^"'@""07$=I=1WEU;]?+>27$9(]2%->H_L\?$%OA_^QUX\U]/^/G1M6UJ
M.$+R?.$[+&,=SN9>* /L2BOF_P#X)]^)_%OC#]F?1=4\;:A=:GKTUW=>9/>2
M,\FWS#A<MS@<C';&*]@\<?&'P/\ #2^TRR\5^+-(\/7FIRB&RM]1O$BDG8G
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MEWWC*/0;71=:NX'NC9?VQ!#$]HLP&2K*)?. '0N8M@/!:O1Z "BBB@ HHHH
M**** "BBB@ HHHH Q/&/@K0?B#H-QHOB32;36M*G'SVMY$'7." P[JPR<,,$
M=B*\:B_8I\%:?&L&C^(?&V@6"9$=AIOB2X2",>BABQ'YT45T4\16HKEIR:1A
M4H4JKYIQ38[_ (8V\.X_Y'OXB_\ A3S?X5I>'/V4M"\->(-.U>'QGX[NYK&X
M2X2"]\12RP2%6!"NA&&4XY'<445H\9B&K.;,UA*"=U!'EVI?LV^,M2\6ZJ(O
M#>E6AG\5C7K7Q9_PE%TLEM&)TD&+!83&SX0K@M@D\D5U6G? [QS;(GAJ6/1O
M^$8T>\UG4].U)+V0W5X]\MUMAD@,6V(1F[DRXD;.Q<*,G!17%;W>7H=E]>8R
M?AS\$_&VC^ 9?"LG@S3O"E])X>;23XBM_&-U?XE$(0.+9H5"AF'\+94'C-1^
M'OV=?$VC:)K3VWP^\ 6=I.^G;/!%U=R7^G7)MBPDF\Z2W'E2NI4*WE,<H"Q)
MZ%%5?J38N:%\"_'W@..'6/#FD^&%O[R#4+*?PVNH2V]CI<%T\3@6\H@.\(T(
M8KY: F1\8XRLO[)_BG2M9\(ZCI?CIYVTZXTP75O<V412.&U0*1"Q!8 G<VWN
M3R>!1126C3[ U>_F<UX9_9F\<V>OZ<G]@Z7HTEEXFFUG_A*8O$UU,[V[7#R&
M(6'E"/+HVP@MCDFIKK]E?QCJD^N&>"PLX;6UU"+2;>+Q!=W-O.]R6X6*5/\
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D;=CD_+CO113V5B>MSH*6BB@84444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>dkdcu-20230331xs4a014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $Z F4# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#](]9U$+D
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M>K*-F@"?><T;Z9G-% B0'BESFHJ* )<BC/O45% $N:,^]144 2YI<U#3@YH
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MIN<=*1FP*8& H&2 YH+8J/?1OH 5VJ!SFG%L5&S4"9&W45%(,G%2N:CVDG-
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MF:-89K^SBN7C0Y52Z@D#\ZX<5E^(P24JRM?S+A4C/X3HI'JI/)@&OGC]K?\
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MA:S\;^%=3T'4/,%EJ$#6\OEMM;:P[&M0+@]:D7[O6OD8R<6I+='=NCXCM?\
M@F7IIU.X>Y\97"V'F$PI%; R;/1B3C/TK1U;_@FCX8ELR-/\5ZC;W0'#30HR
M$^XSQ7V66].:86KUWG&.;O[3\%_D8>PI]C\??C%\&/%'[.7C.V@NYRK9\ZRU
M*U)4/@]0>Q'I7Z&_L@?&VX^,WPM2?4Y!)KFF2?9;Q_\ GIQE'_$?J#7E/_!2
MB6S_ .$'\,))M^W&]<Q_WMFWYOPZ5D?\$S(91I?CF4Y$!EME'H6Q)FO?QD_K
M^5+$U5[Z>_SL<T%[.MRK8C_X*6G-EX0_ZZR?RK8_8Y\'V_C[]E[Q#H%TH:*^
MFFB&X?=;'RG\#BL;_@I8<V/A#_KK+_*N\_X)Z'/P6N0?^?\ D_D*QG)PR6G*
M.ZE^K&E>NSXN^#?BN[^!7QZTZYO%:$6-ZUG>Q],QDE&_0Y_"OU/\=>,[3P?X
M"U/Q%+(OV>VM&N%;/#?+E<?7BOSS_;W^&Y\'?%Y=>MHMEEKL0G! P!,@"N/Y
M'\:D^*7[2I\7?LQ^%/"\=UG5RYMK\ _-Y40 4G_>R/R-=N+PJS3ZOB8?:TE^
M?^:,X3]ES19Q7P'\+77QV_:$M9KU3+'->-J-XS<_(&W8/Z"O7?\ @I%&L/C#
MPG&HPJV+J![;J]!_X)W?#,:5X2U/QA=0[;F_D\BV9A_RR7J1]37 ?\%*#_Q6
MOA7_ *\I/_0ZTCB%5SB-*/PP37X:ARVH-]6>Y?\ !/[G]GZ#_L(W'_LM>&_M
M5?!?XG^+?C'JNI>'=)U.YTN1$$<EO,50D#G S7N'[ +!?V?83_U$KC_V6OH>
MYN0F>:^>JXR>!S"M5@DW=K7U.B,%4I),_)GQ!\"?BWH6C7E]JNCZK#I]O&7G
M>6<E0@ZY&ZN)\">#_$OC35IK/PQ;7-U?)$9'2V?:P0$ DG(XR17ZD?M"7N[X
M.>+USUT^7^5?%7[!;;/BOJO_ &"W_P#1B5]+A<UJUL'5Q#BDX_<<LZ*C4C&^
MYPI^ GQ>')T;5O\ O^?_ (JON/X#Z3JWASX5:'I^LQ2P:C#&1*DS98'/<UZ0
MYSGFHR@(KY+'9K4QU-4YQ2L[Z'93HJF[ID7F$T4I3'>BO%.C0];)Q32<BF%L
M>N:;F@8;N<U\$?M_?L^7QUT_$C0[1KBUN$6+58HERT3J,++@=BH )[$"OO>H
MKJVAO+:2">))H9%*O&ZY5@>H(->A@<9/ UE6AKW7=&52"J1LS\Z/V>?V[YOA
MEX9M_#?BW2[G6=-M%V6MW9,OVB-.R$.P# =N16Y\:?\ @H5'XJ\+WFB^"M%O
M=,DO(S#+J&I%1)&AX.Q48C)'<FO;_'?["7PT\8:A)>VUO=:#-(=S)82 1D^R
MD''X5E^&?^"?OPWT.^2XO9-1UD(<^3<2A4/U"C/ZU]$\5D\JGUB4'S;V\_OL
M<O)62Y;GS5^Q'\#[_P >_$FT\6WUO)'H&B2_:!-(,">X'W%7/7!^8_05]6?M
MD?%/Q%\(_!&BZYX<NQ;7:ZBJ.KIOCE3:Q*L.X->XZ)H.G>&M,@TW2;.'3["!
M=L=O FU5%4?&'@O1/'>DOI>OZ;!JEB_)BG7(!]0>H/N*\JOF2Q6,C7JQO!=/
M(VC2Y(.*>I\>^$?^"DT MT3Q/X1E\X#YIM)F!4_1)#_[-6OKW_!2/PS'8N=&
M\*:M/>8.P7SQ11@^Y5F)KJM?_8"^&VK7#26;ZGI>XY\N&8,H]AD5GZ?_ ,$\
MO %M<![G4]6NXP?]675 ?R%>C[3(Y/FY9+RU_P S.U=:7/C+Q1XF\9_M._$U
M+F2W:^U6[80V]I:H?*MH\\*.N%&223[FOTY^!GPQB^$7PWTKPZC+)<0ION95
MZ/*W+$>W;\*F^'/P<\(?"BT,/AK1H;&1AB2Y/S32?5CS^ XKN%ZUP9EF:Q<8
MT*,>6G'9%TJ7(^:3NS\^_P#@H\?^+@^&O^P>?_0S7TE^PX<_LX^'O^NMQ_Z-
M:M_XN_LU^$?C9JMGJ'B);PW%K#Y,?V:;8-N<\\'UKM/AI\.M*^%?A"S\.:*)
M1I]L69//;<V68DY/U-/$8ZE4RZGA8WYHO7MU_P PC3DJKFSP3]O_ .&G_"5_
M"R'Q%;Q[[W0Y=YP.3$W#?EP:_/GX=^$+CQ]XXT7P];!C+J%TD.5ZJI/S'\!D
MU^S'B/P_9>*M"OM(U&+SK*\B:&5/52*\H^&7[(O@'X4^+(?$6CPWCZA"K+&;
MF;>J9X) QUQ79EV<1PF%E1G?F5^7^O4BI1<YJ2/6_#6@VWA;P[IVCV:".ULK
M=+>)1V55 '\J_.?_ (**?\ELL?\ L&)_Z&U?I4,&O'OBU^ROX+^,_B.+6_$
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M 8YS3OX:C8&E!H <.*"V!TI10_ H CR",FJ-ZZ;3P*FNIQ&IYKG-2U0#(!H
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MQ6N\U#QB%SB3I7Y_6J3HXN=2F[-2?YGH12E!)F?\+O@EX*^#.BQV'A_1X(V
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M4/U_*NO(W[2AB**W:_1HG$:2C(_0*SG-O(I!(P:[ZR\5"W\,:IYCX M9._\
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MA: &2-A:IN>:M2U4>@!JG-/'(J->]/6@:&-4+#!J9JB/2@0+TI#UI1TI#UH
M*BD6I1]TTQZ ("O!JNPJR>]0/U- $!&*A<5/43]Z"D57X-(*<_6FT$D<BA@<
MU0N8L5H'O56XZ4#Z&5(N#4#]:MSU5DIB(&/K4=.?K3:: C8=Z81NYI[=*;WI
M,8PKFHF'YU.>M1-]XT(1'BBE;K2=Z0T%!&:**"@IK'-.I@[T"!A@4H;BAON4
MV/J:!(FM+M[>X##M7J_@7Q65,<;O^M>0_P ==)X:8K=QX)'TH"Q]0Z1J"72
MALUINV,5PO@YB8DR2>G>NWD_AIB8]T$BFL>]LP<D#-;$?2JLW0T CEIH3&3Q
445:-[]XUFG[PI%)BE<T4^B@9_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>dkdcu-20230331xs4a020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %2 Z@# 2(  A$! Q$!_\0
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M?V_J/_/[-_WU1_;^H_\ /Y+_ -]&L^B@#0_M_4?^?R7_ +Z-']OZC_S^2_\
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ML@[\\8KO?"G@AI/BU?3:OIQN8X;*-8YIX]R%QUP?6O<]NX=!_C00/08/:GS
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M5+_PO2[_ .@9&?\ @5>6KTY]:4FM+ >H?\+UN_\ H&Q_]]4G_"]KO_H'1_\
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M *!D?YTG_"];O_H'1_\ ?5>8$D=J,MGIBBP'J'_"]+O_ *!T?_?5(?CI>?\
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M-K*)X$D4Y5AD&IJXSX.Z\WB7X;Z%J#G=)+;(6/OBNSH$%%%% !1110 4444
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M$LD.&^9<BO*F*EGV@A<\ ]:V8O&.K0SR2)=',B"-LC(*^E8Y9IG+D?,3GY:
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MRKLLU^.8F_MY^K/CJCO-Z"-TKO/ M_YMD\!/*'-<(1FMSP=>_9-71?X9!MK
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M .^!1_PU%\1_^@^__? _PI+*LQ_Y_?BQ_5,1_.?:G_#,?PX_Z%R(_P# J/\
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M?$%I;6&K7$%HY>!6^5B,&L[/-22S2SR-)(QD<\EF/)J,\]>* %QQ2'@4M(:
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M+EI[W+<I=CPF\^'.H:;I]])<JR7EK<"W-L%)))JE<^!M?M+JWMI-*N$GN/\
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M@?\ /\/RHU$>/?\ "L?$!_Y=#^='_"L/$!_Y<S^=>P_\++T#_G^'Y4?\++T
M?\OP_*C4#SKP5X!UG2O$=M<7%MLB4\G->J>+;";4-!NH($WRLF%%5K+Q]HVJ
M726]M=!Y6Z#%;-]?Q:=:O<3L$C09)]JGJ!\_'X9^(/\ GS_6@?##Q ?^7,_G
M7L ^)OA_'_']^E*/B;X?'_+]^E4!X]_PK#7_ /GT_6E_X5AX@_Y]#^=>P?\
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M^&8OK,_^?;/SX&C7X_Y<9_\ OV:0:)J(/_'E/_W[-?H/_P -$?"7_GYL<?\
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ME)9P/XB?6@#PB?QW>Z!H<<-G<R"[1RS+MW9&>YILVJZSKL>K22ZL\(>WC(@
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M")'NM]_>-?6*<P1D\ >_K6?XROAXKD2PLI2\,:^:[KTX[5J6GC"#2/"5G=S
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MR<'O0!:G^)2SW%S(;=OWT2QXSTQ3S\28YFG2:U9H)8!"54\\=Z'^&T[6,$,
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M- XZT .XI"!W-&>.M)UH =QVKL_A&?\ BKT'^P:XO.:[3X2+GQ<GNAI/8#Z
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M3MK_ -UORHP_]QORH ;C]:7.ZEVO_</Y48?^XWY4 !)' I*7:_\ <;\J,/\
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MKC/I3^R-+_Y]K7_OD4?V1I?_ #[VO_?(KYL_MZ__ .?R;_OJC^WM0_Y_)O\
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MQ%9 K(>"&Z&O / &L7MQXHM$DNI'0GE2>M>R>-IFA\-7CQL4<(<$=J6PR_\
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MM0_Y_)O^^J.5A<^E3I.EG_EVM?\ OD4ATG2Q_P NUK_WRM?-?]O:A_S^3?\
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MDW_?5']O:A_S]S?]]468CZ5.DZ5_S[6O_?*TATK2_P#GVM?^^5KYK_M[4/\
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M_P J7=[4=QZ4M '2?#K_ )&RSQQS7M?CS_D5[S_<->*?#L_\599_6O:_'?\
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MF.I^&Y=.MM,-Q;74UFT!\Q$8EO,([U0T'3]1T'2UDFT^XD@6U8+ 02=Q/&:
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MMTRR*",/75W-M'>020R*'1Q@@UP,6KW?A'69-*MXY-4MA\^V,?-"#VH V/\
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MK5PTT8M5M'2VPO&[C%><W?AW4;*]-I-:2K<8SLVY-4)(I(9&CE5D<'#*1@T
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M,4ZB@!NP>E+M'I2T4 -V '..:*=10!Y/KW_(7N?]\UX#\;"!XAMLG_EE7O\
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M_"E-(_YZS?\ ?5%Q'B70]>*,<5[;_P *5TC_ )ZS?]]4O_"E-'_YZS?]]T7
M\1 XXI>E>V?\*5TC/^MF_P"^J/\ A2ND?\]9O^^J5QGB7%&17MO_  I72/\
MGK-_WU1_PI72/^>LW_?5%Q'B7%'>O;O^%*Z1_P ]9O\ OJC_ (4II'_/6;_O
MJG<#Q#&#2]Z]N_X4II'_ #UF_P"^J/\ A2FD'_EI-_WU2N,\1[]?PH/UQ7MW
M_"E-(_YZS?\ ?5'_  I/1_\ GM-_WW1<#Q+Z4G2O;A\$](Q_K9O^^J/^%*:/
M_P ]IO\ OJG<#Q$].M=M\(<'Q<@!S\AKN#\%-'S_ *V;_OJM7PW\--/\-Z@M
MY;O(TH&/F-)L1YW^V;_R0W4?4W$/_H8K\^,9137ZG?$[X=:?\4?"L^@ZD\B6
MTCJY:(D'*G/]*\8'["_@]< WM]TZ>97V.4YGA\'A^2J];GLX3$TZ,.61\+C[
MI'>E(^Z>F*^Y_P#AA?P</^7V^_[^4O\ PPQX//\ R^WW_?PU[?\ ;N#[L[?K
MU%'Q5>^+=;U"Q6QN=4NIK-5"K"TAV@#H,4MIXHUFTL1:0:G<Q6RY B60@<]:
M^U/^&%_!_P#S^WW_ '\H'[#/@\?\OU[_ -_*C^V< O\ AA?7*#/B>'Q-J]G'
M;Q0:C<11VQ)A57("?3TJ/4M;U'6 GV^]FN]GW/,8G%?;A_88\'GG[;??]_*/
M^&&/!Q_Y?;[_ +^&C^VL"GI^0?7:%[GQ,?$NK_819'4)S:+C;#O.T4Q]?U-F
ME8WTQ:7:'.XY;'3-?;G_  PQX/(_X_;[_OY2?\,+^#S_ ,OM[_W\H6=8#;]
M^O43XD;7=2^W27AO9_M<H(>;<=S#T)J4>(]4@LA9K?W'V8'<(]YV@^M?:_\
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M@#I**S=*UNSUA&>SN([@*<'8P.*T0><4 +1110!Y/KG&L7/^^:\K^(GQ$O\
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M@/0_^%V:Q_S[P_G0/C9K/_/O#^=>?$X-&3WHL!Z"?C9K/_/O#^='_"[-9/\
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M\0I=.L+OQ3J&I/-J,\"P3%$2-L59N_!\486*YUFX"R' 5W^\?2D!U-C+YMG
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M-W%+>Z9<L7%J1M9N6 /;/M76?7CTKE_#QSXJUS)(&Y>/7BNJ3!FCXP-P_G0
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MJ"WE\;L9KQ4\8&?TH#=AD?05JL#%1E%R>KN6HKJSZ8\7_$'PYXIC\6Z?>7T
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MTMX8%>)RW!)ZTEYX;\,GQ0OA^&RDCFE@#"Y>3(WD<#&*\]E\2ZK+:BW>_G:
M#:$+\8]*JOJ-U-=K=-/(;A<8DSR,=* /6].^'.@1W<]K>$O<6, := ?O,?\
M"J5EX T'7[V^L=.9S/$5E#2\83^(5YM'K>H1WCW:7<JW+?>D#'<:U]$\:2Z*
M;RYVM-J4Z%/M#L> ?:@#LAX2\/ZCIFK-IMH[W$#,$\V3:NU>,@XYZ5Y21M8C
M&"#C%7(]<U""S>T2[D6W?EHPW!JGG/%  1BC(SP,4 >M)MH 7%'4T8-'0]J
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M*\NEBJ/.JKCKT/8PE!U874FC]&/^$;^"6/\ CVT$_P# C1_PCGP2'/V70?\
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M "[:#_WT:0^'/@D /]&T'_OHU^=!9@/OMGZT .Q^^P'UH_L:7_/^7WA]3?\
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M[.8]LJC@YZ@FJEMI.@7/BR\TR/2MJPKM24-N4GU->3C4+LQB/[3-Y8.0OF'
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M/NAJ]G:$2 A@"/0\TJP[>  !0!Y;XG^&.I>+MT]Y+%;3M&!LB;Y=P]ZM^"O
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MGK_A3NO?W8Z7_A3NO?W4KZ#_ +/N_P#GUE_[X-)]@NO^?:7_ +X-%V!\^_\
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M?^L&+[(/[1J]C\\/^&,OB#_SQ@_[Z'^-'_#&7Q!_YXP?]]?_ %Z_0[^SKO\
MY]9?^^31_9UW_P ^TO\ WR:/]8,5V0?VC5['YX_\,9?$'_GC!_WT/\:/^&,O
MB%_SQ@_[ZK]#O[.N_P#GVE_[Y-+_ &?=G_EVE_[Y-+_6#%=D']HU?Y3\[_\
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L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>dkdcu-20230331xs4a021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '+ YP# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**0G%
M"TF:XKXJ_$.Q^&'@75O$>H2K';V4+/R<;FQP*^5_V(?VSIOC?X@UW0M>G5+_
M .T/+9 \9BR<+^5*X'V]135;Y1FG4P"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M072C:3(!NZ9- %NBJRW*N,K(I'?!SBD6Z5V*K(K-Z9SB@"U1587*ERGF*6]
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MC]:_Z])/_037Q?\ \$P_^0=X^]]8F_\ 0S0P/NVBBBF 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 (1D8-&T8Q2T4 -V 4NT4M%
M&#X[)3P7KC*2K"SE((/(^0UYW^RE+)=?!C199I&ED._+N<D\FO1/'I_XHK7/
M^O*;_P! -><?LE?\D3T7_@?_ *%0!['L&* @':G44 )M%%+10 4444 %%%%
M!33&I[4ZB@"+R$]*7R5/8U)10 @&!BD*@TZB@! H%)L'XTZB@"-HU^8\Y(ZU
MX#^S"H_X2WXICM_;S_RKZ ;H:\ _9CX\7?%3_L/R?RH ]^,8)Z4>6OI3@<TM
M #1&![_6@(HZ#BG44 (5!I-@]*=10 W9_G- 4#M3J* &[12X%+10 TJ",4",
M"G44 -V#-+M%+10 WRQ1L%.HH ;L%&P9IU% ";12T44 %%%% !1110 4444
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MI@%%%% !1110 4444 %%%% !112$XH 6BD!S2T %%%% !1110 4444 %%%%
M!1110 44A. :0-TH PO'O_(E:Y_UY2_^@&O.?V2?^2):(?\ ?_\ 0J]'\>_\
MB5KO_7E+_P"@&O./V2?^2):)_P #_P#0J /9:*** "BBB@ HHHH **:6Q]/6
MJE_J<5C&2[#?V% %F258E)=@H'<UB7_B2.$E8/G?U[5B:AJT]^6!)">@JD!B
MM%'N2V6+J^GO&W2.3[ \5!CV%%+6A @&!1S110 49/J:*.G7@>M ",,CK7BG
M[.@_XG_Q,_[#\G3Z5[4Y(#>Q_*O%OV<_^0]\3.<?\5!)_(5+^) >UXQ1115@
M!-%%%(!<TA&:** )K:_N+1P8Y"/8GBN@L?$R2D)./+;^\*YG]1Z4A&1CM2<;
MCN>B12+*@96# ]Q3A7"V&K36+KARR#J#75Z=JT5_&&! 8]5-9.-B[FA12 YI
M:D84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1/*
M5)XI'E*LW' KYB_;*_:ZT[]GWPVUK9NMSXDNT(AMPWW/]HTF[ >H?&+]HSP7
M\$-*>]\3ZS!:L!E+9&W32?1.IKX=^(G_  5WG6YFB\&^%8GA!*I<:D6RWOM!
M%?G_ /$#XC>(/BAXBN=9\0ZA-?74S%OWC9" ]@*YQ%QTZUC*?8AL^I]<_P""
MC7Q-UGQQIWB9H--BOK!&CA1(3LPP(.<GT->J^"?^"N7C"QF6/Q+X8TZ_MR1N
MDM-RR ?]]8KX$(%)@<]Z2D3S,_;[X&?M[_#CXUO%9Q7RZ)J[X'V2_8(6/HI.
M :^D[:Y%Q'N5E8'D%3Q7\V5K=W%A<QW%M*\$\9#(Z'!4U^D7[ O[<]W?7UKX
M"\<7OFM(PCL;^9N2>R,?Y5HI%*5S[5^/7AJ_U/\ X1S6]+MGN[K1[T2F&/EB
MC##''?%<5XD^ NKZ[+K>I6=[#_Q,=4@U,6-RK"*552,&.4#!(^4\5]$Q;+I
MXY'4'UIYMU/3BK+/FRP_9MUFV\.^)K9;G3=.O-7N([E$LH2D,!7L!Z5JW?P)
MU[QQ.\GC"^LV2&P:QMDL4;G(QO;.?3IT]J^@!" ?:D, ]:+#/!?!WP4U71-,
MN]+N=+\-Q1"S:VAU"TM=ER^00"Q_P%=OH_PS6+X52>$+^4.DUL]M))#D<,,9
M ->B^4,8S2>2,8HL!X5\//A)KG@@K"ND^&,6<#QVNH0V>VZ8_P )8CC/KCK5
M3PO^S[J_A?6I]8@UGSK_ %=)%UGS!E9F;HR^F*^@/)''.<4"$ $$YS19 ?.5
MQ^SUK6I>$;'2KV72YYM%NC<:<7B+QRJ2>)5/!Z]JV3\&-3U72+"*>QT'1)[>
M]2Z==(MS&L@'KZFO<OLX]:7R0#G/.,9HM81X[XK^"<_BC6_%5V]ZL4&L:1_9
MR@#YD;^\:S5^#6N^(4\,C7[FR0Z3:7-DWV0-\\;B/:>3U&TYKW00#&,T@MU!
MSWSFF!X#I_P,\326&D>&]3U&R?PSI4HDA>)&^T2!?NACT_(5J-\$KX^ -:T%
M;R$27M^;I'*G"KNS@U[9Y0P:00 #'XTK#/!O'7P>U[Q1?Z<L<.D6L5F(\:I$
MKI>J%'0,#SGT(K3^#GA74H_'?BCQ+J<4L7VD16$ EX:2.(<.?J6/Y5[,8 3G
M)H6 *00<<YHL(D'2EHHI@%%%% !1110 4444 %%%% 'B_P"T[HOA_6/AG.WB
M+4#IVGVDZ7/G8W;F4\*!WS7R[\#- T_4/BWHFO:=XECC\.SWKO96CP>7,\G1
ME)]/:OI;]K+2M/UGX43P7VH?V:1<1M!<%=RB7^'</3->*?LZ?LT^,=,\7:7K
M?BK7K.[T>RF-W:P6D>W>[<ANOZ5# ^P/&QSX-UG_ *])/_037QG_ ,$PO^0;
MX_\ ^PO-_P"AFOLSQL-O@[6O^O23_P!!-?&7_!,(YT[Q]_V&)O\ T,U3 ^[*
M***8!1110 4444 %%%% !1110 5%-)LQ4M131!QD]10!\)?M$?\ !2&[^"'Q
M3U7PG%X92_6S*CSS)C=D9KS1O^"OFH 9_P"$-C_[_5\Z?\%!EQ^U#XH'NG_H
M(KYNS\P'J:P<V9MRZ'Z.?\/?-0[>#8S_ -MJ/^'OVH=O!D9'_7:O)+[X ?"_
MPG\*?#NMZU%K5SJFK:>UT#:#,:,!T/'O69X-^"'PILO@1H'CCQE>ZA;R:Q>S
MVL7V=AM38[*"?P IIR%>1[<?^"OFH_\ 0FQ\?]-J!_P5]U$_\R9'_P!_J^4/
MB]^SE+X'\:>';#0[UM5T?Q"$>PN"/F(8]#[C-=9^TW^S;X>^%G@_3=8\,7LU
M\\,HL]5$ASY4VT$@>G)H3D.[/H/_ (>^:@?^9,C_ ._U'_#W[4,X_P"$-C_[
M_5^<ASBOK+X,?L[>!->^ MCXZ\20:O>7-S>RVODZ<,[=I.">.G%)2DR>9O8]
MI/\ P5]U #/_  AD?_?ZC_A[[J!_YDR/_O\ 5XM\'OV7_"7Q5\"^/M8CN+NT
MN],NI(--ADX+;4# -[\UG_LO_LLZ3\5--\57OBBYGLETY98K5(^#)*@)(_(4
M[R'>1[S_ ,/?=0_Z$R/_ +_4I_X*^ZACCP9'_P!_J^5_V<_@?HGQ*\:^(%\2
M74MEX9TC<)KB/@YW849KC?CO\-4^%7Q"OM(MW>73\^9:ROU:,]#1S207D?='
MA_\ X*U7VN>(--TUO"$<8N[F. OYOW=S 9_6OT=TC4/[2T^TN2NWSHEDQZ9&
M:_G4\ X/CSPX>QU&W_\ 1BU^_$OQ(\.^ O"^CRZWJEO8B2"-465P&8X' %5&
M5]RHNYTOCUL>"==_Z\I?_0#7G'[)7_)$]$_X'_.O1=:'_"2^%;R"W(Q?6K+&
MQZ89>#^HKF_@CX)O/AO\/=.T*]D6>XM]VYD&!R:T+/1:*B\X#K0)N,F@"6BH
M3-TQCFCS^>E $U(3BHC<!1DX ]37/ZUX@/,-N?JWI32N!=U?78[-6CC^>7V[
M5RUQ</=.7<[B?4U"\I=CN.YNYI!+R16T4C-L=CGVI:3?^M&[&?6JN(6BFER.
MU+NQGT%(!:*:7YH+$=J '4'D4T-Q1NQS^E '$?&3QY>?#7P1?Z_9Z5)K+VB>
M8]M$<,5[GWKY&_9#_:LN/&?Q,U_0;'PW*S:WJ#W\DV[BW3H0:^Z+RVAOH)8)
MXUFC=2A1AD$'KFO'_@;^S1X>^".M^)M3TR,//JUR98R1S#'_ '1^=0T^;0#V
MA6)Y[4ZF!L<GOZ4N_/2K =12;L].M-+D8XZT /HIH<]<<4;Z '&@#BDW<T;^
M,@9%.X 1G%20RO X>-BI%1%\?3-!?I[T@N=3I7B%)BL<YVOT!K=5PW3FO.=V
M#QU]JV=)\0/:[8YCN3. 3VK-Q[%IG7T55@OEG0,F#]*F$H-9E$E%1&4@]*03
M]>,>] $U%0^?@@'K1Y^>W- $U%1&;C@ TAF([9H FHJ+S>!P/SI#.!0!-14)
MFQVR*///H,=Z )J*A\[Z4"<DXQ0!-14!G^;@ BCS\-@CB@">BH3-@]*#-QG
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M:9/@S6<G_ET?_P!!-?&?_!,+C3?'W_87F_\ 0S5 ?==%(.:6@ HHHH ****
M"BBB@ HHHH *;)]PTZHIGV_+CKWH _#W_@H/G_AJ+Q1]4_\ 017S=CYE/H:^
M_/VQ_P!CKXH?$[X]:]X@\/:"UYIESL\N4-C.%'M7B1_X)\_&L_\ ,K-_WW_]
M:N=IW,7=,[3XN_M+W/ACX0^ /#GAJ[TV_CDTEH;Y&57>)B ,'T/6M#PKX8\*
M_%_]DGP1X>OO'FB>&+W2]2N;JZBU&?#E&D8_*H!R<&O._P#AWQ\;/^A7./\
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MU"WO%/>%PU:(<9/'2OPE\%_&GQK\/+Z*ZT3Q#>V[(<[&E+(1Z8/%??7[,O\
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M?&/_  3"_P"0=X^_["\W_H9JF(^[****8!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 5[R,2Q,C<*PP37(?#7X;:+\.8]2BT7S-E]=27<V]]W[Q
MV);^==9J>?L4NWAMIP17A7[).IZWJ6F^,#K4MS*\>N720_:<\1B0[0,]L8H
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M]<?V'-9EUG]G?P_YI)-MF 9/8 '^M?D#XR\27/C3Q1J^MW/-UJ-P]PP]V/\
M]>OV._8U\-MX9_9Z\+Q2*4DN8?M)!Z\X']*NE\1+/;Z***[6 4445(!1110
M4444 %%%% !1110 4444 %%%+0 E!&:** +5EJ4VGN"C%E]#TKJM-UF&^0<[
M9/[I-<7VI59HW#(VTCI4M7&G8TOB?X!_X63X-U'P])>2V,-ZGEO+#C<%[UY9
MKO[%_@?4O".@Z/8VJZ3=Z1/#<0ZE;1@3,\; \GWQ7L&E>(\!8[CC'&^NCCE2
M50R,&![BL;&AX'X=_9(T?P_;^-8UU2ZG;Q3C[4[  H0,9%<W/^PCX?">%C:Z
M[J%G/H=A_9OFQ;<SPXP0?0^]?46<4M*P'S;'^QKX?L/"&BZ%'J-W]DTB^-_$
MW!9VSG::\YU'X-WGQ>_:DT;Q'/X=NM'T/P^F)9[H86ZD7A"!WK[39"Q/2HS
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M:$8_U8].O-?2*<+@C@<#VKLI1Y=1CATHHZ45L@"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *,9HHH #FK=EJD]A("A+)_=-5>E(!19,=SK]/UZ
M&ZPCGRY#V-:P.0*\ZQSD<'UK1T_7Y[(A'8O'[UFX]AIG:9I:HV6J07R@HV&]
M#5W-9EBT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:.0.<_6;_A*]'_Z"=M_W\%'_  E>C_\ 03MO^_@K\FO^$MU?_H)W/_?PT?\
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M/VU-3LDCCUS2H[D#AI(6*G'TYKRJF4UJ>L-3BJ8*<?AU/L:BO%/#O[6/@C7
M@GNWTV0]KA>*],T/QQH?B.-7T[4[>Y#=-L@KRYX>K3^.+1Q2HSCNC?HIJ$'I
MS[TN<]^*Y_0Q%HHSQ1GFCU&%%%&!VH]!V"BEI*!!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%+BDH **** "BBB@1=T7_ )"MO_O5W-<-HO\
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M1N+8KTV.<5Y-3)HO^'+[SBEE\7K$_4L.#T.1ZTI//'-? 7@_]J3QCX9*I<W
MU*$?P2U[#X;_ &U-)NRB:MISVQSRZGY:\JKEF(ALKG#/!U(['TX1QQ^-'<UY
M[X9^._@_Q0J_9M6A20_\LY&P:[JWOX+R,20RI*IZ%6R*\R=.=/22L<DJ<H[H
ML&BFY.?:G"LS,**,T=:!A11WHH$%%%+0,2BBB@ HHHH **** "BBB@ HHHH
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M'<E:\JIDK6M*9Q3P'6+/TP'3FD#>M?%_A;]L_6[$(NK64=ZHX+ ;37K?A?\
M:T\(ZT42^D;3Y6QQ(.*\JI@,12WC='%/#5([(]VS1FN?T3QUH7B&)9+#4[><
M'IMD&:W@P905.1UR#Q7!*+C\2.9QE'XD.HH%%22%%%% !1110 4444 %%%%
M!1110 4444"+NB_\A6W_ -X5W-</HO\ R%+?_>'\Z[BLI;FBV"BBBH*"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#!\<G_BD=8_Z])/_ $$U\8?\$Q&VZ=X^SQG5YO\
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MHHNQ";1Z4;1Z49YI:+L!N >U&T4N:,8HNP$P/2@ >E.HI\S[CNR&X4>6>*H
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M*JZ$7Z*S_P"WM/\ ^?R'_OL4?V_I_P#S^0_]]BCFB!?Q1FJ']OZ?_P _</\
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M )@^NU_YB7[$/[U+]B']ZH_[?TXC_C\A_P"^Q2?V]IW_ #^0_P#?8H_M2O\
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MC%?%^I_\$N?!.I:K=7IU6ZC:XE:5@I[DYK[>VCTHP/2E8-SX9/\ P2N\$?\
M08O?S-'_  ZN\$?]!B]_,_XU]ST4Q61\,_\ #JSP1C_D,7OYG_&C_AU;X)_Z
M#-Y^9K[EQ1B@+(^&O^'5W@C_ *#%[^9H'_!*WP0?^8Q>_F:^Y<4M 61\,'_@
ME=X(!_Y#%[^9_P :/^'5W@C_ *#%[^9_QK[GHH"R/AC_ (=7>"/^@Q>_F:/^
M'5W@C_H,7OYG_&ON>B@+(^&/^'5W@C_H,7OYG_&E'_!*[P1_T&+T?B:^YJ*
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M LCX8_X=7>"/^@Q>_F:/^'5W@C_H,7OYFON>B@+(^&!_P2M\$_\ 08O/S/\
MC0?^"5W@C_H,7OYG_&ON>B@+(^&/^'5O@D_\QB\'XG_&C_AU=X('_,8O3^)_
MQK[FI: LCX8_X=7>"/\ H,7OYG_&C_AU=X(_Z#%[^9_QK[GHH"R/AD?\$K?!
M'_08O?S-'_#JWP1_T&;S\S_C7W-24!9'PP?^"5W@C_H,7I^A-*/^"5O@D]-8
MO?S-?<])B@+(^&?^'5O@G_H,7OYG_&C_ (=7>"!_S&+T_B:^YL4M 61\,?\
M#J_P0?\ F+WOYFC_ (=6^"/^@Q>?F?\ &ON>B@+(^&/^'5W@G_H,7GYG_&E'
M_!*WP0?^8Q>_F:^YJ*!61\,G_@E;X('_ #&+W\S2?\.KO!'_ $&+W\S_ (U]
MST4#LCX8_P"'5W@C_H,7GYG_ !H_X=7>"/\ H,7GYG_&ON>B@+(^&/\ AU;X
M(_Z#-Y^9I?\ AU;X)_Z#%[^9K[EQ2T!9'PR?^"5O@C_H,7N?J?\ &D_X=6^"
M?^@Q>?F:^YZ* LCX8_X=6^"/^@Q>?F?\:/\ AU=X(/\ S&+W\S7W/10%D?#
M_P""5W@@'G6+W\S2'_@E=X('36;S\S_C7W/@4FT9J6KA9'PT?^"5_@G&?[9O
M/SI/^'5O@D]=8O ?K7W/@48![5?,UU*OI8^&?^'5G@G_ *#%Y^=(?^"5W@C'
M_(8O/SK[GQ[T8%/FEW$?# _X)7>"?^@Q>4?\.KO!'?6;S\Z^Y^E& >U+FEW
M^%S_ ,$KO!/;6+P_C2G_ ()6^"3C_B<W?YU]S[1Z4FVCFEW ^&1_P2M\$?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLK=K9PO29"Q)#?BQ_.J$O[-.FRK#;G5;O^SH+HW45IGY$8G->S'H*0D[\4K
M>2^(?V>=.UJ751;ZE<Z?;:I#Y-W!"<+(-NW/Y58M/V?= @34HIFDGAOM.ATV
M1'_N1%BI^N6KU,'F@=318#S;0?A%/H<!@3Q!>20+$8HE;'R<8!_"N6UKX&W&
MGZ;K=QIEW)?:WJL(M9)YL+MB)^;]":]R'6H'YW>PS18#,\%>'X?"OA?3=)@_
MU=G D()[[0!6Y44'W3]:EI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
-44 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>dkdcu-20230331xs4a026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a026.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'N Z@# 2(  A$! Q$!_\0
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MRP:M=CDS'\*_4WP;XS\$?MC?"J:RO88I+DIMN;1SB2WEQ@,O?\:_/O\ : ^
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MN99=P)4 <]A7,LQPS3=G]V^MM/F3[:*/$9X-:ATV+4I+>XCTZ5MJ73(0C-Z
M]ZI_VI=@']\QS7TG\7X_#H_93\+_ /"+W=Q=Z5_:G[M[M=LJC!X88KY?&1GT
MKIPE;ZQ!S<;:M?<73DYEL:M>$<2M1_:MX/\ ELU502%X%'7L:[;+L:V+7]K7
MG_/5J/[5O/\ GLU5>?2C)]*.5=A61;_M6\_Y[-7J?P#_ &C==^"?B:.Y1S=Z
M/,X^U6C=U[D>XKR'?VQ33DD9Z5E5H4ZT'3FKID3A&2LS]2_B/X"\*?M=?#F'
M6M U!1J:1%[:X1AN1L?<<=N:_-_QMX=\2?#WQ#=:-KD$UE?0.1M=2 X_O*>X
MKK_@!^T%K/P*\31W-M*]QHT[!;NS)RI7/4#L:^Z?B=\-/!W[8?PW@US0KB$:
ML(LVUXO#QOU\MQ_C7R\)3R>I[.KK2>S['FQ<L)/E?PO\#\Q_[7O#_P M6IW]
MJW@X,K5H^-O!>K?#KQ+>:)K=J]K?6SE3O'#CLRGN#6&S;SS7U<7&:4H[,]./
M+)71;&J71ZS-FD_M>Z_YZM5:-'DD6.*%I97.%5 23] *T=1\,ZUI, GO]'O[
M&!A\LMQ;LBG\2*&X)V=KA=7Y65QJEV!GSF^E']KW1ZS-54,,XP/KUH)XSCGT
MJ^5=BM"V-6N?^>K4AUBZQ_KF%5=X],4$@>WUI<J[!IW+0U6Z YF8THUBY_Y[
M-54N/2DSG) %'*NP[KN6SJ]R>DSTBZI='CSFJHIVGD?AFE9P"._THY5V#0M?
MVI=*<><QI3J=V>DS8]*J#YSD9QZUJ+X7U4^'SK@L93I(D\HW6WY-WIFD^5;B
MNKE4ZM=XP)6IR:I=@$F9L52W[<\?I6Y'X-UJ7PXNO+I\ITEI?(%SCY2_I2ER
M1^(3:,X:M>#/[UN:&U6\('[UJM^(?#&J^%)X8-6L9;&2:,2QK*,%E/0BLG<3
MWHCRR5T/0MG5[SC]\U._M:\P?WIQBJ?+=!THY(!*G;T!QP:JR["T+7]JW:X_
M?-2_VO=\CSFJWK?A75O#MK97&I6$MI#>1^9;O(N!(OJ*R4&_G(^E)<LE=:@F
MD6O[5NQ_RV:E&K78_P"6S538A3SFE0 G'%.R*T>A:;5[L_\ +9A2_P!J7CH1
MYS5591C'>D#[0<T<J["LK'UC^R7^U[<>!=1MO"_BV42Z#)B.WNCUMSG@'VK]
M']-U&VU2S@NK29+B"50Z21L&!!Z$8K\+L[CQP>M?6G[(G[7=Q\/+NV\*^*[E
M[C0IG$=M=2')MB>@)_N_RKY#-LHY[U\.M>J_R/(QF%YO?AN?I8#M!HJCIVI0
M:I90W=K.D]M*H>-XSN# ]\T5\&UK:QX-NY^%\;%05]>*[[X Q@_&SP8C\K_:
M4/\ Z$*X!C\U=!X#\5#P1XUT;7S UT-.N4N/)!P7*D'&:_9JT7*G*,=VF?:2
M3:T/N[QZ+_PE#\4==\3^(K3Q%X7>-[:VT:!-[VDIZ;O[M>'?#G]GC1W^%F@^
M*]3T2Y\0W.MR\6\-XENMI%DC.6^\:XG2/VC'L_'?C#5;S2&O?#WB?<+S1VD&
M.>A!]14WAC]H;3;+P;!X2\2>%VU_0+&9I-.C%R8I;=220A8$9 S7S$,'BZ$'
M&FM[-]-+;?(X(TZD5HSNM _9R\"6WQEUG0-2U<WMC%9"ZT^Q6Y57G<KD1;^F
M0>*R5_9^TCQ;\;](\)VF@:MX4M&MWN;N*]E60R*O:-AQ7GNE_$[PA;^,K[5+
M[P,MUIDR*MO9)=LKV^!U5]V<_C73:]^U?K%SXZ\/Z[H^FIIMCHL+6\%E+(9&
M>-AA@[DDG.!WKI=+'<_NMWY=WM>WKN:6J]#J_B5^SSX>@\":_J>GZ;/X<U'2
M)B+>*:^2<WT><< =&K>^%O[-WA3QOI%EI^H^#]<T>]N;(R_VI<7D87S,<$1X
MW8Z5Y+XV^-GAC789+G1O _\ 9&M33K</>27CR(&#;CM3=CD^U=LG[9=M%XCT
MOQ"O@X'7+>W6VGN6NF*N@&,(F<*??%8.GCW325[^NWXZHF2K6T*/PJ^"?@R_
M\"^/-7\7RW@'AS4/)\ZU8!G16(*@$=3BET/P!\,/^$'USXE7NG:K)X92Y%II
MVEK,HD8@@$LV/>N*L/CF+'P-XX\/?V6['Q+>?:Q-Y@Q#\Q."._6F_##XWVO@
M[P9?^#O$GAV/Q1X:NI/-^RO)L:-^#D'/M73*CC'SSN]UI?II>QIRU-3UK]EJ
M?PCJGC[QP^B6=YIGAUM&/F0W$@DE7KNP17)^+?AI\/O$_P $=2\:>#;34-+N
M],N_)ECO90_G L1D8'%<YX1^.VD^"/$OB*_T7PH-/T_5+ V,=E%-_JO]HD]:
MH>$?C5;^&OA?J/@ZYT=[R*]NX[EYA( ,*VXKCWZ4OJ^(C4=6":UCUZ=;D<DU
M+F1VFO0+\,?@IX-\/#$.J^)+R+4;L8^98PXVJ?8@5Z!\;?B[XI\$_'+PYI>F
MZ@W]E26ENLFG.NZ&0-P<K7SG\3OBE-\1O&UIKC6OV2ULDABM;,MGRHX\84'\
M*]3U[]J;PIK.M67B%_AQ%<^)K.%8H;VZN-R+MZ';FIGA:MXSE3YF^:^V[_R!
MP=TVCT/5/A9HB?M#^([6S,^G02Z%)?M#82>7L<ID@\=/:N.^#_P1\$^)OAM)
MK4]C>^+O$'VF59]*L+I8Y8$#$!@&')QS7GGA3]HG5=+\>ZYXKUJV;5KS4[66
MU*(X01AQ@8]AZ59^&'QR\-?#ZWM[B;P2;SQ!;2O+'J<%VT6XELC>H(SBE/#X
MN%-QC=NT=GVO<'&I%:;G0>!?@_X/_L3QKXR\36.J)H.C7'DV^CAU2<G/1V(Z
MBF?#CX;^ /BCX@U_7;:RU+2_".AV!NKBQ:96GE;T#8X'X5F>'_VGIX[_ ,61
M>)= @U[0_$<WGW.G[]FQL\;6JEX;^/VG^!_%=]<>'_"D%GX9O[;[)=Z+)(6$
MR>I;/6M94\8U/?FLK:Z6TNO7?4JT[-G4ZK\-?AWK_@2R\?>'K/4+'2+74%M-
M1T^[F5BR;@-RL!QQ6LW[-_A^T^*^KRSI-_P@EMI7]I1/OY(*_*N['K7G'Q#^
M.EIX@\$IX0\+^&XO"WA]IC<3P+)YC2N>Y.36OJO[3]_JGP3B\#?V84OP@AEU
M;>,R1 Y"8ZU/L<;RKE;U=M]4N_J3:KH=CX(_9ZT&?P'8^*;K1;K71K%VRP6L
M-ZD MH<\$EA\QQ5G2/V8_!__  LSQ1H][?S-HMII:ZA#+%*'>#/56(&"1BO.
M?!'[05II?@>#PGXM\.?\)+I-JV^U"7!ADB/U!'%1>%_CQ8>$O$/B6^TWPVUK
M9ZM8FRCM%N"WDCU)8G-9NCCN::3?EKY^OZ!:K=ZG6>$_!/PJ^)UWXAT7PW8:
MA;7]M9/)8S7<PW32KU^4#OBN5\>?"_2/A]\%M O[Z&5?%VJ3.Q5GP$B!Q]W'
MM4'[-&@>(+[XIZ=K.B0J+>QFWW<TCA5CB/WLYZ\9JQ^U7\1X?B%\6+T6,BMI
M.G@6T B^X<=2/QKIC&I'%JC&;<5J]?P^>Y7O*=NAXVF?6GTGRYP,TM>^=@=Z
M;C!)I3TH0A<YH#;40\\GI6AX?\1:AX6U>WU32;J2ROK=@\<L;$$'TK/;YCG&
M*ZSX9_#+6OBMXJMM#T*W,L\I'F2G[L2]R36524(P;J;=2)62;>Q^C7[-?[0&
MD?M(>"KG0->M%;5[>$1W<3KN24$8W#-?(W[7'[,#_!O6I-:T;]YX:NY,A"1N
M@8_P_2OM'P1X(\%?L@_#"6_NVA2X6+?=7; >9/(!]T5^??[0O[0NM?'7Q/+/
M-*]MHL+D6MB#A0.S,/6OC<LC*>,G4PFE+K?KZ'D892E5<J?PGDJ-M=&[!@3^
M=>L?&SXRP?$N+P]#IB7EI%I]BEM*DKX#L!@D 'I7E!7Y@HY).*]IM?V0_B#<
MZ;:7L2:61=Q":&%K]5D=2,C"D=:^JKNA"<*E:5FKV/4ERWO(Q_ 'Q9T_PI\)
M_%WA6YM+B6\UAD,4L>-BX_O9YK0^!_QXM?ASH6K^&M;L[NY\/ZFV]VT^7RKB
M)O56/%>7>(] U'PIJ]QIFK6DEC?0-LDA<<@UF]>,,">@(P34RPM&K"2>JEK_
M ,,)PA+<]1^(GQ,TR[U.PG\$7'B#3_LRG_2-1O?,ER?3 XKSW5/$.I:[JB7^
MJ7LVHW:D$R7+;F(!Z9JCDYV@'=Z8YI0$P<!M_< 9Q6].C3I144MOO'RQCU/J
MZS_:^\,VQ\,7S:)JZ:GI<*V\D$-TJ6A4<%MG<_6N%O/C_I%WH/Q'L!878D\2
MS^;;-E<1C.?F_P#K5YU\+OAE>_%36;O3K&[BM7M[=KAGE!((';]*Y6YMFM;J
M6W8[FC<J2O?!Q7G0P.%4W&.ZLWKYW1G&G3N['KT_QUM+?X2^"_#=C:7":MX?
MO/M33OCRG^;(QWKT&S_:=^'L7CF#QHWA/4O^$EEMC!=2"=?*!VXW*N.OU-?+
M;,!D [B>O%"D9&>!ZL.*VG@*$]_/KWW'[*#-;4-?>3Q5<:U9@PR&Z-S%GJ#N
MR*]P\0_&WX9_%""TU+QOX5U5_$EO L+SZ9<(D<^T8!;()KYW8G>1@]..#2YS
M'QR._'2MZN'IU.5NZ:V:=B^6+MY'L$?QCT2V^#=_X.MM.NX99M3%Y$Q92JQ@
M\ GUKJ9OVE=%D^*G@WQ/_9]Y]DT73OL<L7R[V;9MROM7SLK9X4$G_9&30 C,
M1R3Z 'CZUD\#1=_._7OHQ.G#J>U>!?CII7A;6OB%>SV5U*OB.*2.W6/;F,MG
M[V?KVI=1_: @C\%> -.TNSF75/#=RUP[RD;),]ACFO$W"@#)(]R,9K5NO#&K
M:?HEEK,]E+'IMVQ2"X*\.1UQ0\)A^92>[\_*WY"Y(+4]B^)/Q8^&7C.^D\20
M^%=3A\6S21S2[YT^S;U(+'&,\XKT2W_;)\*V_B'2-=CT/64OH+86LUJMTHMD
M7&"40#D_6OD4 DELT%A63RVA.*C*[2\_P!T(R5F>SS?''2Y/A5XN\,+8W(N]
M8U(WD4IV[54G.&]Z\9SNYI-_MQ3L[N:[J-"%"_)UU-8P4-@HHHKH+"D-+10
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M/_'/_BJ7_AE7XL_]"5J/_CG_ ,51];P__/Q?>@]I#^9'E+?-S2!2!R17J_\
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MW:ZF5249;-'?:[X-\.^-_CYX;M=:\B6_LM'6>[@?#;Y@HP''4GVKC/B'XO\
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MO?[)\,WOD7LAEGMIT1XG8G).TM4J^#_VB%\53^(!X4N4U*:W-L=D*!!&1@@
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M:0[GE[@$C'6D!RVW'!KU'_AE_P"*_P#T(^I_DG_Q5'_#+OQ7)_Y$C4Q^"?\
MQ5'UK#_\_%]Z'[2'<\P8;1@4U7 (W#->HM^R]\5U_P"9(U,_@G_Q5-_X9?\
MBN3_ ,B/J?Y)_P#%4?6L/_S\7WH?M(?S(\Q."6(&*"YQM'2O4/\ AE_XK_\
M0CZG^2?_ !5'_#+_ ,5_^A'U/\D_^*H^M8?_ )^+[T+VD.YY?C(R*7?V(YKT
M_P#X9?\ BO\ ]"/J?Y)_\52?\,N_%;MX'U/\D_\ BJ/K6'_Y^+[T'M(]9'EY
M)%"MD'->H?\ #+WQ7_Z$C4_R3_XJE'[+WQ6_Z$?4_P D_P#BJ/K6'_Y^+[T/
MVD.Z/+2.>.E*/EZ5Z@?V7_BQ_P!"/J?Y)_\ %4O_  R[\5R/^1'U/\D_^*H^
MM8?_ )^+[T+VD.Z/,% ;T!I"NU<YKU#_ (9=^*X_YDC4_P  G_Q5)_PR[\5_
M^A'U/\D_^*H^M8?_ )^+[T'M(?S'E^X@?6@J,5ZA_P ,O?%<?\R1J?Y)_P#%
M4G_#,'Q7_P"A(U3\D_\ BJ/K6'_Y^+[T'M(=T>7YQ3MVVO3Q^R]\5^O_  @^
MI_DG_P 52_\ #+_Q7_Z$?4_R3_XJCZUA_P#GXOO0_:0[GEYXHS7I_P#PR_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%-;UIU-:@"O;7BW32A1CRVVG-61TJE96IMWG.03(^[CM5T=* %HHHH ****
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M-5_X/UB7QG\*IWT/6HLR3:9&<6]X.I4KT!-8)T*^C7)+\/\ @&?[NIHU9GU
MDBL2 <T\&O'/@'\=[/XJZ?-9WD?]F^)M//E7^FR@AXV'&0/0U["C9.*XJE.=
M*;A)'/.#@[,?1114$!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)_%:R:V\0:1!=L!^[N -LL9]0PP17C<7[.7Q-^&LA;X??$*=]/!^73=67S5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD1LJ17YV^ /AEH/B+X8?%?6=2TN.[U&WNI_)EF3+1X)P5ST_"OJ_]E.XE?X
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MXBLHG['9G/\ .N?#:4JK\OU1STO@GZ'T)X;\%Z+X4LTM]%TRUTN!0 $M8@G
MZ>];(@  &22.].C^Z*?7 CE$5=HP*6BBF 4444 %%%% !1110 4444 %%%%
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MG==ZCM0!/&254^PJ6HT.X*>GM4E !28YZT,<#-0-<$#G ^M*P$^.*,5"LQ#
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MT444P"BBFL=JDT .HJ S-UZ#UQ7+>+?BIX9\#V[2ZWK-I98_Y9L^9#]%')H
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MKC64D;6Y(W%R..:^?_ 7[+_CKX7^'/#'C?0=/ED\96-RRW^DSRAA+;ECPHZ
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MZ,=3U;X#?&^T^-WA<ZK;6DFGSQ2-#<6DQRT3@X(KT?4;IK2T>4#<1@8-?/\
M^R-\.M>^'^G>)(M<L38R76I2S1*S [D+$@C%?0=\D+6S"8_N^,\UY&(A3A6:
MI;'GUE%3:CL3H20I/>I*CC  7!R,<5)7.8C6 (P:C$*@X_.I6Z5G2:'%-(SF
M:<%NN)"* +GD+V)^F:/*0GT^E4/[ A_Y[W/_ ']-']@0#_EM<_C*:6H%_P I
M >Q^M+L3US6?_8$/_/:X_P"_IH_L"'_GK<?]_: - (@&  /I0(EQSS6?_8$/
M_/:X_P"_II?[ A_Y[7'_ ']- %_RE]>*#$K#V]JH?V!#_P ]KG\)31_8$/\
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MD':GJ,  =*S_ .P(/^>UQ_W]-6K2Q6R4JCNP)_C;)H LT444 %%%% !1110
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MN6D/R^>RG:#[X(K2.!C/%RH)OEC>]M["CAU*LX+8^X=-O++6;&"]LY5N;69
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MVE#E0<Y]Z/+7'3'TI0 .E85*DZLN>H[LRG-S=V+1114$!1110 4444 %%%%
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MVL\&?R5WG\<4\:]%_P \+C_OV:/[>A_YXW'_ '[- $L>B6$7E;;.!?)),>U
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MFC^7IV.B-6RY9:HX7P+\;_!'Q$LTGT3Q%8W+L 6B\Y5=3Z%2<YKO8YTE4%)
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M>GS?:+6.3&W<N<>E %FBBB@ HKB_BI\5-!^$7AU=9\173VUD\JP*8TWL78\
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M7;-+MK4WT N0.8C(N[\LYH UJ*X_PU\2M!\7ZCJ=EI6J17-SITQM[B-6'RN
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M "BBB@ HHHH **** &;\'D&G9I&/\JYOQ9XQTSP1H=UK&MWT5C86Z;I)96P
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MZ]Z!GQ]H>FZ1X0L/CB?#MG;6/C9+N:2S6+*W/E-$A)0=<<GI5K3(_!^A^)/
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MYX7VKK/!OPETCPCX9U/0D9[RRU&622=9AUW]179?V]IX_P"7E/UI/[=TX_\
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MJFGFSN+RV5I[*3YO+)'*GUKYV\(>&)/VE/B?IOQ%ELDTCPSHSD::P0">^/\
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M+^*O%-OX6TYNNEZ$I=ROHTK!2#]*Z[P7^S[X)\'W(OK?2%O=4ZMJ%^3+,W_
MC7I^T>@HP/2@"*&)(UVHH11V XJ3:/04ZB@!  .PI:** "BBB@ IK4ZFMUH
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MVR/+JZ"1EA4%^>_'/XU%^TQJ?B#0_&?P\T;PAJ7_  CS:BAC?[.H1.>"Q5<
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MN#@J: /!?VB?BMXD\#RP0>&-6TFWN(X6GGM[M7EF8 9 "(IP#@\UP]I^T?\
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M /<OLT7_ #S7\J/LT?\ <7\J\BG^+-[\,?#%O-\29[9=7N)?+@M]&C:5I_\
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M2[@T^RM;Y/H=,\/>5[&U%?W_ (7^&'C/Q;KD36NO^-)Q%86+<2A7RL:[?7#
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MX%:/?V&JW4MQ=Z\(95N'$@4>8W0'IFM+6K_QMXC@^)>N1^-]0TR+PY*6L+.
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M_E^0?]LQ0!J8HZ5E"TU$_P#+\G_?L4OV34?^?Y/^^!0!J"BLO['J1_Y?E/\
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M%% !1110 4UC^E.IK<4 9VERO(]UN.<2$"M)>E5+.XBG,XC3;M?#>YJVO2@
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M@34] LK"!RY($T(4G(],K0,]!\$?&N34=4T71_$>D2:+JFHZ?]MB=FS$X'4
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M5#Y,#DML0D]3B@"L-<L/^?A/UI?[<L!_R\+^M6#! .L: ?04OV:W)QY:'\*
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M)?6N;I)A-&@)()7[IP.AH ]K^P69'%O%_P!\4"QLR,^1%_WR*^=M$_:[EO\
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M^?.Y_P"_=)_;:_\ /G<_]^J '0:+;V^GPV"PH;2*,1")@"NT#'2D.@VF_?\
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M1\4?M">%)] ^+]A#)<:9X>\)#2GAL3>Z:UU;)(2-P !&UL9Y-5-3\&Z+X?\
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ML=2_Y_D_[]__ %Z ('\(:5) (7TVR:,/O\LP+MW>N,5JVMLEK$L<:)&BC 5
M !]!5'[#J7_/\O\ W[_^O2?8-1_Y_E_[]_\ UZ -4T5E?8-1_P"?Y?\ OW_]
M>E^P:E_S_K_W[_\ KT :A.* <UE_8=2_Y_E_[]__ %Z0V&I?\_Z_]^__ *]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.@_W: +E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% "'H:J:A$D]HZ2G:AZFKE9NN<:;+^'\Z +R=% Z 5)4<(
MPB?2I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>dkdcu-20230331xs4a028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a028.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" )C Z<# 2(  A$! Q$!_\0
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M&>_I6BE@JJ@IV32CWU]UW3^=E?SZD2AF%!U'3NU)RTTT]Z-FM^CD[>5M#?\
M#O[45KKEIX<NGT:2VM-2U!],GG$P9+>9>G(X*G/!J+6OVJK'2?[=9-(:6*RU
M$:5:RO<+''<S?Q98\*J\Y)I-/_9BEMOA/K'A*35H6O+G4&U"VOHX2@@<D$?+
MVQCM3K_]ER*?X8Z/H$5];MK&G71OS>7,'F13SDY;>AZ@],4)99SWZ7MUVWO^
MGXB;S?DLM^6_3?5<OY2O\CK_ (/?&>+XG3ZM8RVD5IJ>F,HF6VN5N(75NC)(
MO!K$^*OQ]N_AEK4D4^B6MQID6PO,VI1).X/79$?F.*Z7X5> =3\(1WCZG;^'
M[>:? 4:%IRVHP/[Q'WJ\M\5_LJZKK_B3Q5=1ZOIAM-;E6;S[RS\VZ@(Q\J.?
MNCCM6%*.">*ESM*"2[[Z7L]^[-ZLLQ6"C[--U&WKHFEK:Z>G9=.Y[%XS^(T'
MA3X=2>+%M'NK=;=+@0!MI(8 _P!:\]\/?M)7%YXDTRRUSPO/H=CJEJUU9W3S
MK(651D[@.E=QXQ^&MQXG^%7_  B:7D<$QM8[?[2R$KE0!G'X5R^I? .;5-7\
M'W,NI1&WT2R:TFC"',P*[20>U8T?J:A)5-[NSUVMI^/<Z:_UYSA*D[)*-UI9
MN^M[Z[7V.;TO]KRPO]:MEDTN*/1[JZ:UBG2]C>X!!^\T(^8*<5(?VH;ZXO+!
M[3PPLNEZAJ+:=:S->!92X."63' J#P]^S_J_PXDEDM8O#>JZ5:R/=1M/I*/?
MD<D()/7T->+>#[V?2_%D.MZ9;:3J/B*[U)BVE3Z7,;RW#-@G?PBX'<"O:IX7
M UW)T8W27=_CV\WL?/U<9F6'C%8B5FWV73MW\EN^Y]!^/OVA[OX>Z]]GO]#M
M3IRS1PM(NIQ&X.X@;EB^]@$U5MOC1XKU3XS:KX=LO#YN-%MK.*5L3(DD:MSY
MV>_!^[7-7G[)VL:I-K0?5=+6#4KQ;_[5-9;[Q6R#Y?F9X7Z5W4WP=\2Z3\37
M\3:%J]C#;WME%97T%U SL50 90@C&<=ZX[8"$+1:<N5_S6OI;Y[H[[YG.HVU
M)0YEMRWM=W^5N5G+_#7XXQ:)8Z'#<6VHW.G:QK5UIYU'4+SSFMY0WRJ2?X3S
M@=L&M?6/VI['3--UZ_&DL]M9:HND64C3JBW<_))R>%4 9)-.7]FR>3X0:CX1
MEU:+[?+J+ZE:WZ1D""0ON4XZ\<C\:-3_ &9(;[X2:1X52^A_M33[L:B+V: 2
M1S7'.XNAZJ=QXHE++ISYI?S6Z[;\WZ?B$8YK"GR0_EOT^*S7+]]I7^6QTGP?
M^-D7Q/O]6TN6TAM-4TP(\BVMTES"Z-T*R+P?<5ZLO05YK\*/A]JG@\WTFJ6W
MAZ":8*J?V%IJVO Z[R/O9XX[5Z4HP!FO'Q?LO:OV'PZ?UJ>]@?;^P7UA^]KT
MMUTV%IDIQ&WTI]-D!9"!U(KC.\_/?X@?%_4I/VF_$WAS6OC;JOP[TBU:$6%E
M:6 N4G9NJ\*2/J37HK?M"67PO\;_ !)O[ZXU[7DT:RM2(9KH&"5G "F-.D9)
MY)KUCP5\ 9?#/QF\7^-[N[M;^'6TC6*T,.6A*]R3Q^5>'_M._"K4/AWI?Q,\
M7F9=0M?%T=O8&**U,@L5R 99.#E1[#-8IN%.*>]OQ?\ 7H=&DZC[:?\ !-Z+
M]MS6K.X\1V^K> EM)-$TQ=5F\K4EDW1MC8!A>IS7=R_M20)??#*V.ARG_A-+
M?[0C></]&^7=@\<U\L?L_>$6\5R>(_AGHR:#J&@:UI)2[\2Z-I]Q$T$@ V*[
MS,2W/8'%>T>#?V._'EGXE\!:EXC\<Z=J=IX01K>TM+:Q:/=%MP,L6.6KI25U
M?;3_ -NO^GYF&EO/7\E;]3:\&?MH2^+X-<U4^!-2M/"V@BY&I:Y),ABC:+.%
M1<@L6P.W>F?"']MJT^)?CG0=!O/#RZ3'X@1WTR>+48KESM!.)40YC)'/-=1\
M./V7!X7^$7B_P)K.IKJ%MX@N+J9I[9"GE++TX/4BN:^ _P"R=K?PC\1Z3)>C
MP/>Z;I2LL-]9^&XH=4DX(4M< 9S@\GJ:SANE+LOOMK^-K%3M9V[O[NG_  2Q
M^VWXN^)_@KX;WNJ>!;NTT;3;* SW^JLP:Y7Y@%CC0C'.>O:N/^)GQ!\=>+[_
M ."_@70/%ESX8O?$VBQZCJ.M01*\S;8$8X!XRS-DXKZ&^/?PPN_C#\*-?\(V
M]Y'I\VIPB);F52RQX8') Y/2O-_B+^S'KVMZ?\/=1\*^([;1?%_@^QCL8;VY
MMS+!.@B6-P5!!YVY%0E:Z>UU^3_)V*NM+;V?Z?\ !+O[&7Q+\0>/? VN6/BF
M_P#[4UKP[J]QI,VH%0IN50_*[ <9ZUI?M??$[4/AU\+)!H5X;/Q%JD\=AI\L
M>-R2N<;AGTZUB?"7]G7QC\']*TBSTKQ=:S-<:I-J?B*::TR;YY.HCY^4"KWQ
MY_9A7]H#QEX9E\0WL4_@W2F:2XT;YU>YD(P#O4C JIIR44_*_P!RN_GJ3%QC
M)OIJU][LCR_X0_M(^*? _P '_&2>+UG\6^*?!M_Y=\QD5));=L%9.!C@9KM/
M$/[:.A:/K6G6\&ES7UB^B_VW=WD<HQ;1D952.Y/2H_!W[$VB_#?QYKEWX5:'
M3/!FM:6UA>:$YDE)<YQ('=C[<>U9/PP_85M_"7A'QIH^N:V-8FUV'[';W21$
M-:6P)*)R><$T-R:OUM^-FK?-V8TH)_/\'9_AJON'_#[]N2T\6ZY%I^H>'5T_
M[?9RWNGO;ZE%<F144MLD5#F-B!T-;WPC_:HUOXOZ9?:OIOP\O[;0[2"5CJ%U
M=1QQS3(?]6A)Z?[1XK#^%G[(>N^!=UG=_P#"#R6<-G+:P7^G^'(H-0;<I56>
M8#.1GG'6MNR_9/O[;]FJ[^%[>(46ZF>1QJ$,;!/F;=@KG)'8T2T3:[:?>_T"
M/*[7[ZF%X6_;EM9_$FMZ)XC\-C3;RPTZ34T_L[48;Y9$3JA:,G:WL:C\/_MJ
M:E?>)]'L=3\$IIFFZII\FK0WG]I+(5M5R2S*!PW'2N U?]E;6_@EIE_X]N+G
M2=1FT_09=-.EZ#I @5PPP)".=Y[DD&O,OV<-%CA\9:5X;T:#P_XHMO$5G+:Z
MO=:?I]REWIT3+GYI9257D_=4 <=*%=MQ6]OQ]ZWZ:[!:*5WM_P -?]3Z,^'G
M[=FG>-/&N@:7/X>%AI?B&Y:TTZ]348II=X.%\V%3N0-VS7IOQX^/Q^$5QX<T
M73=!N?%/BGQ%<-!I^EVTBQ[]H^9F9N !D?G7F?P=_8ZU?X5>)M+Y\$ZAHFFW
M!FAO'\-Q?VJPSE1]HQD,/[W7BN__ &A/@%K7Q-UOPCXI\+:[!X?\6>&KAY;2
M>Z@,T#JX 964$'L/UIR^S;:^O>PE:[]-.US)TO\ :@U/2O'N@^%O'7@R;P=<
MZOI]Q=P337:3(7BR3'E>,D#(Y[BN97]MY]1\-Z'<Z1X+O=4UOQ'J,UCHNEQW
M"J;F.,X,Q8\*M>8_MB:?JNN^%/!7@35M8;7?C)_:275I+HUA)%&EO(2C\\@+
MCKDYR!7L/B_]DK4)O#WPTG\$ZW;^'?$_@F():SW5OYT$N5 D#J"#R<TEJN9[
M7MIVW;7IM]_4;LM.K5_T7W[G)>)OBKXMD_:,^$TGB"TU#P=!/:7\E_H8OO,B
M<(F0S!#M;U&>E7_#7[?FDZ[XLTR"7P_]F\.:GJ)TVVU%=1A>8/NVAW@!WJA/
M>NIN?V:?%GB[Q[X,\5>,/%%CJ=[HUO=V]VEI:-$LPF7: @R<8]ZY;X;?L5:G
M\-O$UHD'_"#ZGX=M[XW2W%]X:BDU0)NW;!.1G([-VJH:-*6VOY_Y;$S:LW'>
MR_+_ #.M_:]^./BOX+:)X>;POI2WUUJ>HQ6QFD9=H!/*8/=AQGM7.P_&+4;3
MXXQ?VYI^LZ3J47AR:_FT8:BKV8V@GE1P6XZUZ3^TM\#-1^-WA+3K+2=4AT?5
M=-OH[ZUGN(C)%O0\!E!SBN2C_9H\6:QX]_X2[Q#XCTZZU.70IM(G6TM6C1G<
M$!P"3P,]*R]Y)VWN_P#TG3\2WRZ>B_\ 2O\ (X2U_;]U*6U\/:BWPLU0:3K\
MAM["=+N,M-/_ '0O89[FNITO]MFQL_!WC#5/%?A>[\.ZIX;F6&?33.DC2LWW
M K#CFEM?V/=3MO"7PST?_A(+8OX0O_MDLHA;%P,_=49X_&D\4_L6_P#"9GXB
MIJ6M1^3XHFCN+?RX<FV=.FX'AA[5<NJ7G^EOU$N6Z;\OUO\ H4?"_P"W?IVH
M6FN?VQX<>SOM/T_^THK>POHKP3Q?W=R$[6'<&O0?V=_C[J7QVT^;4I/#D.E:
M;L#P7-OJ<5UNS_ ZIRC#N#7)_#;]F7Q=X#TW48T/@&TU$V?V6SO=,\,102$]
M-TS#!<$=1WJ[^SI^RUJOP@\=:_XIU/4-*6XU5 C:?H%HUK:@@Y+["2,GVK16
MN^UOQU_X!D_ATWO_ )?\$PO$OQ-US7=?^,5Z^J7]KX;\+V!M(K73Y!$[2[2S
M2!\9##M6=X8_:PO?#GASX?>'M&\*:QXQUC7-'%W;&XO4,QP.?-D;KQWK9?X2
M:W+XZ^+GA4Q26NE>,+;[1::F8RT4<C+M96QW[UI?#_\ 92U+P9XK\ ZO+KEM
M<IX:T=M,DC2%@9B?X@<\"LH7LK[-+\I7_&QM-QUMY_\ MMOPN=G^S_\ 'H?'
M+PCJFI#1)]$U32[N6QN]-GD#E)DZ@,.HKSJ;]MFSM_"%[=R^&KA/$UOKW]@'
M0O/'F-*6P&#8Z=Z]"^ OP2NO@E;^,'O-2AU$:SJ\^JKY497RE?G:<]2/6OF_
MP/X%T7XV_MK:EXQ\-BXN?"6E!;B\:6W:*&34%4I\H8#)  YJHWE.*[I7\K6;
M_5>K1+M&,GV>GGNE^C^3.R\2?\%!-'T'Q+JEJGATW&B:+>)8:C?'4(DF68G#
M>5 3ND53P2*['XY?M77/P>DM;Q/#5OJN@O9QWS7CZM#!*Z-VCA8[V('/3O7(
M7?[#]]HWQ"\0ZOH#^#K_ $C7+[[?-%XG\/17]S;.QRXAD8< \\'I57XE?L):
MMXV\;^+]5M-=T2&P\16L4!%_I0GN+'8@4+;L3B-3C^'I47ERQ[]?NV^_8JT.
M=ZZ?\'?[MSL/$W[84EKXK\,^'_#7@G4O%-]XATB/5K*.WE2/",>0^XX  R2?
M:H-*_:_OO$_Q>O? FD^#'DNM.DC@O6N-2A@G5F&6:.-N75<\D5N>!/V8[_PA
M\2O!?B>368+F+P_X=71'MUB(:5@"/,!)X'M7+_$_]D_Q3\3_ (HZ?XCU76M!
MMK+3KU;JVNK'36BU(1J<B%I0WS#ZUIHIKM=_=?3\/ZN0[<KMO9??;7\3K?@O
MXZ\0Q?&OX@^ /$.I2ZJMD8]2TV>8#>MO)P8R0!G:W2O1OBOX>\1^)O"%Q8^&
M/% \(7[D%M3\D2F-/XL \9QWKYVLM#^)4GQ3\<>/O#^BO;W=Y<VNB6"W\?6U
M1OWLQ4D<=<5[?\>?AKXM^*'PUN?#OASQ'%X:O[K:D]XT;,&3^)0%.1GV-9[T
MH]_ZM^%KENRJ/M_5_P ;V/D'2OCM\2/ ND?%&SM?&ESXXT?2S%::=XENK9%*
M73L%95QPV,GUZ5W'PO\ 'OQ2\ _%Z3P!J'B=_'L^K:#_ &KI\FJ(L)AGVY*D
MJ/N\UU/AO]DKQNGPTO\ P%X@\4: _AUK?;91Z1I;0/#.#D2,2QW<]>YKHO@M
M^S'XE\)?$IO'7CGQ1;>(];@L!IMDME:F".*(#&3DG+8%6E[VKTM^C^YWL_3J
M2VG';6_ZK\+7.'_9D^+?CE?B!\5K7XF^(DOH]!5)?+C55@MNY5. 2.W-8GPE
M_:!\;^,/VJKB'7=5_LOP3=Z7)>V6F2E%C2('"R.Q&02.>M>M:+^R9;MXQ^)5
M_P"(;]=2TCQ@R$V=L6ADA"]BPZ_A7'Z+_P $]?"^A?&&#Q-%=W%SX:AM#;_V
M/>74LKNQXY<MRF/X>E$&[P<NUOG9_K8<N6TDN_ZK_@GI'QICU7XA>$DOO!GQ
M4M?".CV.^34=2T](KIBH&<!\X4U\K6_QX^*VK>!? WA6'Q3<07OB779K&U\5
M-;H)Y;-"!Y@4C&3GK[5[]\9?V1K[Q)X4LO"WPTU#2? 7AWSS<ZCIPM'>.];C
M ?:P.WCD9YK*U_\ 9.\>>*O">@1ZGXOT:#Q/X9O%N-#O-,TPPVT"  >6\>[)
M''8U*6M^EUI\U?\ X;M<=]$NMG^3M_7H8OPJ\0_$OXH>!/&'@X?$-M&U[PMK
M#6=QXF>S1YIK8<DX/"M[^U>57/[0_P 3O"7PK\06-EXOF\0K=>)8="T7Q;=0
M(LC*V?-8 #!QC /O7LUQ^QWXW@^%>L>'])\>V]AXB\1:@U[KNJ&U;9<JPYB0
M Y5?7FEN/V//&7B7X4'P7XB\5Z)'%ILL-SH,NBZ8UNMG-&3\S@L=^[OWZU77
M7^[?SVO;[FEMNR=.GG;RWM^C]$;7[*WCKQ;:_$CQ[\-?%OB&;Q5/X?\ (N;;
M5KF-8Y'CD7)5@..">*]_NOB/X4L;Q[.X\2:3!=HVUH)+V-7!]""V<UY7^S[^
MS_K/PRUSQ/XF\5:Y!XB\5^(&C%S=6L/E1)'&,*JJ23]:Z+6/V8OA?X@UN?6=
M2\!:'>ZK-)YLEY-:*TCOUW$^M6_LKRU,_P"9_<0?M$?M :;\"?#&G:A+83ZW
MJ6J7266G:=:, ]Q,W(&X\ 8'6O/O%/[5GB+P3HFAV^N_#:]M_&FO7IL]-T"*
M]B<S<9WE\X4=JZW]I+]G:3XX>&=$@TS51H&MZ%>I?Z==M'OC211@!E'48/:N
M*\7_ +,_Q&\?V7AO7-8\;Z8GQ \.WQN]/U"VT\K:A2,%'CW9.<9SFLXWOKW_
M  TV\]S3HO3\==_+8J:S^VZGA?P%XCU/7?!M[IOB+P]>P6=]H?VA&8>:P"LC
MC@CFLZ']MKQ/<:_<^'[;X2ZJ^MFR&IVMLU]$H>UQN\QS_#QSBDUW]B?Q'XP\
M'>*$U[Q;97'B[Q%?VMW=7T-HR6Z)"P(14SGG'7->B67[.%_:?%K_ (3 ZO T
M'_"/#1?LHB(;<$V[\^GM2UL[[_\ VO\ GH/W=/ZZ_P"5SP+XE?M1ZMX^L?A-
MXK\,66L64EQKDEI=Z#;76QIY$&#&Q!"L,^M=-\1_VIY_$'PT\766MZ)KG@OQ
M%H=U EQ::??JDVUV&UEE';UJ:V_88\2Z=X5\-V&F^,[2SU/1-;GUB*\^R,ZD
MORJ[<]N]7-0_8K\4^+/#?BY_$OB^RO?%7B*XA>2\AM&2WBCC;(4)G/ZU;[+:
M]_\ TG_@@N52N_3\]_P-+Q'^UUJ?A?6CX8T+P-J'B>^LM'AU*6?[6B_NB@+%
MRW4X_.C4/VZM(E\$>%=4TC1&GU?7BZI87U[':QP[/O[Y7.VNGTW]F+4+'QSK
M.OG6;=X[_04T981$<HP3;O)ST]J\X/[!-]9^#/"UK;:MH>HZ[H4\SK_;.EB[
ML9TD.=KQ/W'K0W=O^NK_ $L)<ME_71?K<V+7]O'3]7\+63Z/X5NM4\67.HG3
M%T2&ZC(\T=2)1\I7WJO^R7\0?%'C;XV?%-/$0U33_L\D/EZ-?W1E6S.#D)@E
M0/I5O4/V/O$=SH6BWFG:EX5\-^+])O\ [9;S:'H:VED1C&UXDP6/O7<? ?\
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M0@,9HL'&[UK.EEDZT(34E[WKM=K]#7$9O3P]2<)0?NW[:M)/:_9GVMYJT&4
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M,UR>I^/9M+U*WM)M%NPL\X@CF!4JQ/?KG%=9(H.*YF?2)[[Q7'=SQ@6=I%B
M$YW.>I_*A;@]B?Q!XL?0(VF?3I[BVC3S)9H\81>Y_"M^&43Q)(OW6 (K@/%%
MUJ^KSP6/]CW']EMS<,CKNDY^Y]#WKO;4YMX_D,?RCY3V]J.@=26BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(KZ+ 11@8%&Q,DX&:-]/ZZ_YB4MO(\&CE_MN3P)I]MX?NX[K2;Q'NI)+?8L
M",I.[ODFNP^(H.G^+?"6J/9S7%I ]Q%*\$7F&,O& I(],BO2@JC. *"%;@X-
M#U^^_P"0K_E;\_\ ,^?KF.:+P3K'A%]$NYM<N[J7RIA!^[<O)N64R=L CZ8K
MWG38VBLXDD.Z1$56;U(')JQL7.<#/KBE Q0M$#=_Z[BT444Q!1110 4444 %
M-*@G-.HH :8U;J!2@8I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM2Y^&3S^%]9TA;P+_:%T+@2&/[@#*V,9Y^[2U_KY?\$OW;_UYG)^.O'.M?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVT#5G37GAG2]1>Y:YL8)VN8O)F,D8)D3^ZW'(]JH>'/A[X?\)-*VCZ;#8-*
M&:)<$@=!GT]JYOX4>.]3\>Z')K<]W9RVDS$P6UM92PO",\!W=SO..X516%I7
MQ=\3C3=(UG5-%TP:'J5TEJKV=\[7,)=RJ%HVB"L,XSALCT-"T=OZ_K4+-W\O
MZ_0[)_AW8/XFU34Y");75($AO+"6,/%*R'Y7YZ$#CISQ72IHUFE])>K @NY$
M$;SA1O91T!/IR:\W\*_&S3-3CGCU6ZBM;Q-1GLB8H7\I=LS(@9N0&( ZGJ>U
M=/J_Q)T70M56PO;MH)BR)N>%O+4N<*"^,<GWH70;O=IDTOPQ\+S:\=:?1;1M
M3+B3[08ANWC^+_>]^M:+>$](>"^A.GVYBOG\RY0QC$S8 RPQR< #GTK'3XEZ
M++K3:5'=/+=I)Y+F.W=D63 .TL!M!Y]:;'\4?#[ZT=,&I*;GS?L^?+;R_-_N
M;\;<^V:%LDA._4Z+^Q++[;'>?9XQ=1IY:S!1N5?0'TK.OO >@ZGJZZI=:;#-
MJ C,7GLHW%#_  GU'UJKXF\82Z!JVB6:P+,-0N#"7+8V<$YZ<]*Y_3?BG>:K
M!I!AT^(3ZC-=0JC2G:IB9E'..^W\,TKK<=G_ %_7D=NWAO37BM(VLX3':$&W
M78,18&!M]/PK)/PP\+_VV=7&CVRZB7\PSJ@!+?WCV)]Z9X1\<+XF\.-JDL?V
M%H&DBNHG.?)D0X89[COGTJK;_%CPY=Z?/?Q:FKV4) -P(VV,2< *<?,?IFJZ
MBUV-/Q+\//#WC!H6UC3(;]X<B-I1RH/49]#Z4RY^&_AN[BTZ*32+;R]..;15
MC"^3_NXZ=*KV?Q*T6_TRYU""\:2WMG\N91"_F1MV!3&[]*;;_$W0KG2;G4EU
M!8[6U?RIC*C(Z.>BE2,Y.1@8YS1L%FQ]O\*/"5KJ3ZA'H-D+QW\TRF($A\YW
M#T.><UNVNA6%E;RP6]M'##*S/(B* '9N6)]2:X'Q'\9K/2ET.ZMY +"\OOLE
MP]Q;R*ZCRV8;%X))('8]:WK3XG:#=:1>:B-26.VLW"7'FHR/&QY *D Y.1@8
MYS2Z#UT?<U_#_@_2/"MH]KI-G'8VSR&4Q0C"[CU..U9\/PP\+6VN_P!LQ:)9
MQZD',@N%B&X.>K#W]^M0Z?\ $O0[_3-0OTU%([>P -T9T:-H0>065@#R.GK6
M/IGQ:M_$'C[3M"TR5)()M.N+N;S8'CE4H\2H1NQ\I$C=CT%-;^8M;'=6>CV=
M@\[6UO' T[^9*8U WMTW'U/%7 ,#%-B+-&"W6GT""BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-2TZ[N(@]S8N\ML^XC8S(R,<=_E9ASZUH"1%3<S!0.I)H2LT^UOPM_D-R?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=RA&P"5';VJ26)9%VLH89S@BG*,#IBFMK$MW=QU%%% @HHHH **** "BBB@
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M)=MRGS1\W!^4^O$EIXW\3:+'X:U'7Y--GL=:VH\%G;O$]H[1EUP[.V\9&T\
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M)HOPVN[3Q39:]JGB&[UB[LK>2U@C:*.*-4<KN)"CEOD'-=W5]$O7\R6%%%%
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M6R,$ [B2>0<]#3/%5HNK^#?$=E<O</:1^%+61(DGD10^P\C:16=VU]WXIO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%0SW"P122.0J("22:FKR;]HGQZ?!G@F6"V?&H:@?(A53SSU-=6%P\L56C1AO
M)G#CL7# X:>)J;15SS?PU9M\:?CK=ZO,"^D:,VR//()!X'YU]/)&$ QP!VKS
M+X >!QX+\!VOFK_IM[_I,['J2>@KU"N_-:\:M?V5/X(+E7RZ_-GDY#A)T,+[
M:M_$JOGE\]E\D%%%%>,?2!1110 4444 %%%% &'?^"- U345O[S1K*ZO5  G
MF@5GXZ<D<XJ\VAZ>Z.C65NRO&(G4Q+AD'13QR/:N"T[XSV5Q=>+5N[#4;&T\
M.O+]HNY;1Q&5C0.Q#8P3@\#N*M6GQ+BUJ31Y;475E:WUT(H6N[5E^U*49@4S
MT&!G)_K26NW]7&TUO_5CM7TBRDE,C6L+2&/RBQ09*?W<^GM6?JG@C0-;2W2_
MT>RO%MP!")H%;RP.R\<#VK&?XE6L.MIIES8ZC8O-(T$%S<VK)#*X!X5CZXX/
M>N>\-?%YCX?TTW]O>:GJ]V]TWD:=;&0B..XD0,0.G"K^-&@69V]_X"\.:K<P
MW%YHEA=30J$C>6W5BJCH.1T]JO'P]IAA>(V%L8GB\ED\I<&/^Z1CI[51TCQ5
M;ZM=M:QI<PW*PK.T5Q"R%5;H#GO[5F^)_B);>%KP1W=CJ1MEV^9>16K-!'DX
M&7Z?X4!J9GB'X;G4IM-TRT-G8>&;:03RV,4&&=U.1@] /PKNI=.M[FV\B:%)
M82 #&XRI'T-<+JOQ@TC3]5O[&.VU+4);!$DO&M+1Y$@5EW E@,=.:FU/XL:7
M8S106T=[J<SVPNREA;-*8HCT=\=.]%[*X[,ZW4_#VF:S8FSO[&"\M#C]S/&'
M3CIP:I#P)X=72?[+&BV0T[=YGV;R%V;O[V,=??K7-?#WQQ=>)_AG!X@N9U\Q
M[>24R",@ #."5Z\8Z567XQ6-M-;:>L6H:QJ;6,=\\>GV3MB)RP#GTY4\4W[K
MLQ69UTO@/P[/?K?2Z)82WBJ$$[VZEL 8')'8<"KXT+3@Q;[#;EBZ2Y,2YWJ
M%;IU  P>V*Y.X^+.E)8:7/:QWFI2:G$TUM;65NTDIC7&YBH^Z 2!SW(%<MXS
M^+L]RW@^#P^;\1ZW=2(]S!ISSM&L<;LR%>S;DP0>@R:/(+7/5[C1;"[EDDGL
MX)I)$$;M)$K%E!)"G(Y ))Q[T[^R[,"?%M$!/S+A!^\.,?-Z\>M>->#?B=JV
MLW]S=7U]=65HFL_V5%;W6F/&LF)-@P_]X[3GTS79Q?$^VU2YN8;"VU"6WA9X
MVU%;1C;*Z@Y&_H0,=12Z7_KH_P!4.SO;^OZT.<UWX27T^MZG+8/HLEA?;0T>
MI6'G20 *%VQGHJX' ]:Z35/AQ#?> (/"T<X\F-(X_,E7<&"D'!'H?2JK?%.P
ML;/34=;O5KV[MOM6S3[5G;RQU=E_A'UIUS\8M%BFTZ"TBOM3NM0@:ZM[>SM6
M=S&IPQ(_AP3@YH6FG]:#UO<ZG3/!6A:-%<1V6D65JER,3+# JB0>AP.1[4FG
M>!_#^D1NEEHUC:JX(816Z+N!Z@\=/:N-G^-UB=2T*VMM-U6[74VE0F*S=FA:
M,9*L .#_ /KKJ/$GC*U\,:?%=77GNTSK%#;PQEY97/154<DT>9-GL:]YH6GZ
MCISV%U9PW%BZ[6MY$#1D=AMZ5';>&M*L[9K>#3[:.!H_*9%B&&3IM/'(]JX#
MP_\ %6?6?$OB& V=^MOIMO$_V)K1A<AFZ@+U/X4NN?'"STG1;J[&EZJUW;7$
M,$MDUHPE7S'"AMN.G-&_S'9G7V/@K0=$#1Z?H]C9JS"0B*!0"PZ'IU';TK%\
M)_"G1M$:6ZN]/L;[46O)KI+MK==Z;Y&8#)&<C.,U9U?QZFFZ?;7;:/K%PLL9
MD9(K)RT0'7>.Q]NM:"^+M.E\+KKZW0326M_M7VAN (\9SCZ47MKV_K]!:M6[
M_P!?J2W'@7P]>ZBVH7&BV,]\R[6GDMU9V&,<DCGCBM1=-M4,S+;QAIO]:0@S
M)QCYO7CCFN5TOX@C5+.YNETC6888H_-7S;%U:9?]A<9)]NM43\8-'M-*UF^U
M)+W2QI*)+=0W=LRR(CGY6 [@X[>AH>FC!7>QU<_A'1;FYM;B72[1Y[5/+@D,
M*YB7^ZO' ]NE0:-X#\.^'KM[K3-%L;"Y;(,MO J-@]0"!P/:N3N/C5IUO9W<
MLNGZI;3Q6CWD%O/9NCW,:C)*#'/;CM6IX7^)=GXBM-',EM>Z?=:G%YD,-W;-
M&3A YZCI@\'O36_]?UT"QU4^CV5S(SS6L,KLNUF>,$D9S@Y'3-2?8+?SHY3#
M&98P0DA4;E!Z@'M7&Z_\6-$\.BX6YEN&EANUL3'# SLTS*&"J .<@BF:E\5;
M/3$MTDL=3DO983<O9PVK/+!&#@LX'W12NAV9TVM^$=%\2>5_:FF6M^8CE#<1
M!ROT)Z5/'H&FPJ%2PMT (8;8E'(& >G84:#K%MK^DVVH6DOG6UP@='QC(K0I
MVZ$WN4_[(L?L[0?9(1 QW&+RQM)ZY(Z9J&X\.:7=VL]M/86TMO.<RQ/$I60^
MK#'/XUI44K <X?AUX8;3DL#H.GFS1_,6$VZE0_\ >''6M*T\/:98K$MMI]M
M(F+1B.%5V$C!(P."16C13 :JA>@Q3J** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CDE\L,S$!0,Y]*^7[\-\
M;_CREL,RZ)HI^;^Z2#S^M>P_&_QRG@7P-?70;%U,ODP*.I8\5SW[-O@5O"_@
M_P#M.[R=0U5O/D9NH4]!_6OHL#_L>%J8U_$_=CZO=_)'QV:+^TL?1RQ?!'WY
M^B^%?-GK\-ND$:HBA54 *!V%2T@I:^=/L0HHHH **** "BBB@ HHHH \7U;P
MOKDME\3M&BTIY%UV*>:RNPZ^6[/;B,(>X.X5T_B3PU?WC^$#:0K_ ,2VX$DN
M3@(!"R_CR17?>8GJ*/,3U%)*WX?@4W?7U_&W^1\^V'@OQ;J^K^';G4;&_-]9
MWWGW]S=7:F CYA^Z0=N1BKI\':EIGA33+.30-0EU>W>[>*_TRX5&A+SR.H.3
MR"&!->VC4[,OL%S%N\SRL;QG?C.WZX[5.70#((I6TL/F=[G#?#_6=;NXCIFL
M6A6ZLK>+SKK/$DC9R!VX &<=Z\]^(/A'Q?XFO/$%FUI?W0FE7^SWCNECM4B&
M"=R]2W!KWI70<\#-$MQ#",R2*@)QECBGUN2G;8\UT3P=J5E!XQ$ENJMJ,$<<
M!# [B(-AS^-87AS0O$?@/4WN%T1]42\TZ"!A#(H,,J+MP<_PG@Y^M>T^8@[C
MFC>A[BAJ^_\ 6EAWTL>;> _"VK:1\(UT:]MTAU(VLJ-"C94,P; S^-1_#[P=
MJ6@ZW/=7D"HCZ-9V88,#^\C:4L/_ !Y?SKTXLH[BDWICJ!3E[S;[_P!?J*[M
M8^>H/ACKFC/X>U&2VU&4P:?+8W%OI=RL<D9,V]6Y!# Y.?H*Z_2/ D]E/X(D
MLK&XM;>QO[J[NX[R8/*GF02KDD=26<=/6O5O,3'WA09$'.1]:%I_7G<;?,[_
M -=CR$^ M8.FPP&!58>*7U,X<<0&9FW?D1Q4_A&TU[0] D\+W.A3,L?G)%J$
M<B^4Z,258]P><8KU.VN[>[A6:"5)8FZ.C9!_&I/,3U%*VCCW_P DOT#F=[_U
MNW^I\_O\,]:TC5=-U![;4[B)]*CL;B'2[I8WB=&8C((Y!W?I78^$O LVA^)M
M,N[>REM;"'3)8"MQ('E21I%;!(Z]#7I_F(#C(HWIZBA:?C^-_P#,3=_Z]/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQF:U@G1I8O\ >4'(_&O*O#?Q(>\T;7]+77]+U615\C2K_38Q%'<R%"?+0*S
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MX.\ -ZD]*]7AEM["*.,M'"K-LC7A03V 'X59\Q0,DBK=F[DZVL>.6W@S7YM
M70Y=.$7V36HKY+EIE*31"<2$@=00 >#70^+=+UJR\::7X@TS3/[6CAM9;6:!
M)5C<;BI# MP1E<&O0A(N,YI6&5./2DE9*W]:6'S,^:]4T+Q+]OTS3OLZV?B6
M:_GU1!:WHA:.W(VE1+@@DYY&#3;Z^EUF'2O#NC:=)IWB.RU!Y6D74!N.!F1E
MGY!)SR"#]*]YUOP?H_BB)(M:T:PU:-#E$OK9)E4^H# X-5;KX>>'+S3(M,G\
M.:5-IT1W1VCV,30H?4(5P/RI)65AWUO_ %U_S/-_"^F3ZZ;&PMM-^Q7>C:L)
M[]I+S[1YA,;9;?W.6''&*W/"/@#5M'UG0[JYCB$=G!/'(0X)R[Y&/PKT+0M!
ML/#UJ+73;"VTVT7[L%I"L2#Z*H K2P*=M;_UV%=VL?/'B_PWK%IX@BL;%/+U
MF[U:74K:6"Z$#B#8%8!R",DXRI!Z5WWPKOHYM*U72UT]K&]L;AH[HM<_:/-E
M8;BYD[DYY':NP\1>%-(\4QI%K&D6.KPH<K'?6R3*I]0&!J32-"L=!LUL]-T^
MVT^U7[L%K"L4:_15  H2TL_ZV&W?^OZ[GD^C^$O$VF^&?"J#1E.H>&91'Y!N
M%VWD10HS(W8XP1N]Q77>#-'U:;Q5K7B/5;(:8;R*&V@LO,$CJD>XEG(XR2W3
MMBN_ X'&*6CS$W?^O.YY3;_#_5H]:%R4B\K_ (2-]3_U@SY)A1 ?KD'BEU3P
M%JUUI?Q @C2/S-:(-IE\9_=[?F].:]4I'&5.!DTN71+^MDOT'S.]_P"NYX5H
MTGB/2O&GC*SL-%35$DM;.+<LZQ^7)Y;CYL]1]/2ND\ ?#O4O"^K6TMQY;11Z
M4+1Y$;GS3)O8 >G)KTBUTZWMKF>XCMXHIY\>;*B -)CIN/4XR>M6Z=NO];6_
M45^B_K^K'B2^#_%.G^&[WPA!I44UG/<R.FJFX4*L3OO.4^]N&2*N2?"W4SXU
MA",O_"+LBW$T>_#_ &E5V@[?0]2?6O8:*5NX^9GA'A'X52:%=6NG:GH&I:A%
M;7)DCO1K]RUKC<2K&W:7:",]-N*[_P 9>%[W7->\-W5LJ&"PFD>8LV" 8V48
M'?DBNXHJGKN3?6YX_I.@ZI:_#\Z#J_A#^V%MI-@B%S&!*NXD2(3]TC@]CGI7
M2_"C2-;T?3[^/5OM45NUP6LK:]NS=300X'RM*<EN<XR20"!FN[HHZM]P;N%%
M%% @HHHH *1N0:6B@"G::?;VLTDD5O'$\AR[H@!8^I]:MTM% !1110 4444
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M[QPQQNWWF5 "WU-6:* &I&D>=JA<G)P,9IU%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?+OC&728]<^(1O_  F=7N)K
M^&V@U)XU5+=WB14)EZIAB#D=*O?$FVU."\T:SAL(_%VH:1HZ6VKR74>^.$.H
M!N O5G)5C@<D9KVL_#S2I8M?AGC:YM];;=>12G*M\FS &..!6*WPB^SRPSZ;
MXDU;3;P6L5G<7*F*5[I(QA6?>A&\9/S #J:A+2WI^3_SU[_(TYE>_K^:.(UW
M4-%UCX?:+H-G=_VW9V$^G6\L\B[TF!*@;CT)(&2.V:V=<\-:9X%\<>&+KP]:
M1:7)J-R;6[MK1=D=Q'M)RRC@D$=<9K3L_@)HNF:'=:7I^H:G80W%REZ[Q3(S
MBX!W&4;T898\D8V^@%;FB_#6VTS5EU6]U/4-=U-$,<5SJ3H3"IZA%C1$&?7;
MGWK3=W?>_P"");TLNUC#\:ZUX@_X3G0/#^C7MKIT%]#-+/<S0>:Z[!D;1N _
M.N;;QQXMFOH_#L%W8C4XM5-A/J36QVM'LW!Q'NX;MC.*Z+QQX#U#Q%\0_#VH
M6MU=Z;%96\X-]:%,QLPX!# @@_2MS1_A?IFEBSF^T7-U>0W37CW<[J7GE88+
M/@ =.P %2ME?^M?\@;7]>ASCW?BO5_$.J:-I^N6UG_8T$1EN);(2&ZE==PR-
MX"KCTS65X=\?>(?B'?Z?INFWEOHLRV'VN[N&MO.WMO9 JJ6&!E2>]=SXA^&R
MZQJ\VI6>LZAHES<Q"&Y-B4Q.@Z9#JV"!QD8-59?A'8V_V"32-0O-"NK.#[,M
MQ:%&:2+.=KAU8'G)SCJ:2\_ZW_X [KI_6W_!."^#_B#5=/N++2[IK>1[S4M2
M-RZ(0"R2<%>>.M;VK?$/5C/JNG6;6\=V=:CTNUFDC++$K1*[,PR-Q'S>G:M:
MW^"FGZ9IMG;Z7JNHV%U:7$MS'?!TDEWR'+AMRD$'TQ4EO\%]+@TF_M'U'49[
MJ\O1J+ZA)*OGI<  !TPH4?='&,>V*>M]?ZV_1,+KI_6__ .?\=6WB[3+;PU;
M0^*XO/N-8CBDN/[/QN0J2%*B0<9'XY'IS!<>+]2\.ZUXEN$ALGMM.U2QAU">
M*W*22P/;Q[Y&.[JI8$=>%Q[UV-W\-)M2T:*TOO$FHW5Y!=+=V^H%85DA=>@
M";2.N<@]35R#X=6"0:XD\T]T^M!!>O*1\Y6(1@@ #'"C\:6JOZW_ "_R87B[
M7[6_%_YG#ZCXOOM7U^WD6&RFTE=?BTZS>6'>X98W,DJG/!#?*/H?6LGPKXA\
M6Z/X/US6[K58=92UU>93;FS*LL*S8<*V\_P]!CBO2M-^&.E:5H>AZ7"TYM]'
MG6Y@=W!=W 89<XYSN.:Q;SPF?!%AKC6"ZAK5OJ+NXTE51E220Y9@< XSZDXH
M^%.W];?G9CNI-?UU?Z-&GX8\3S^)?$>JBW>%]%M$BCBE4'=)*PW,0<] "O:N
MV'05Y_\ #OX<R>&/"FA6GVR>TFMG-Q<Q1,I$S,#E')!R!D=,?=%>@#@55K:&
M>XM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4%U<QVMO)+(P2-%+
M,QZ "IF^Z:\._:9^($NBZ#;^&],8G5M7;RPJ'YEC[_GTKLP>&EC*\:,.OX+J
MSS<QQM/+L+/$U-HK;N^B^;.+\.6TWQ[^-UQJMPID\.:(VV)3]UB#\H_$Y)^E
M?4448B&  ![5POP7\ 1?#[P59V.Q1=R#S;E\<LY_PZ5WU=>9XF->JJ=+^'!<
ML?1=?GN>?D>!GA<.ZN(UJU7S2]7LO1+0*0BEHKR#Z(XCXE?"?1?B9IC0:C $
MN4&8;N/B2,_7N/8UX9I'B_Q=^SMK$>C^(DDU;PLS[8;H GRU]C_[*:^JJR]?
M\.6'B;3)[#4K:.ZM)@0T<@S^5>SA,P]E#ZOB(\])].J\XOHSYO,,G]O4^N8.
M7LZZ^TMGY275?BAGAOQ5IGBO3(;_ $RZ2ZMI1D,ASCV([&M7<,X[U\M:[X#\
M5_L^ZS)KOA.:34O#I;=/8MEMJ^A'MZBO9_AA\7]%^)5@)+200WR#]]:2'YT/
M?'J/>GB\O5.'UC#2YZ3Z]5Y270G+\X]M4^IXV/LZZZ=)><7U7ENCT"BFJX;I
M3J\4^F"BBB@ HHHH **** "BBB@ II< T,^T]*\^^*WQ>TCX9Z?NN7$]_*#Y
M-FA^=S_05O1H5,1-4Z4;MG-B<31P=*5:O)1BMVSH_&7C;2O ^C3:CJMPL$*#
M(!/S.?0#N:^<DN_%?[36N>2!+HW@V&3+%1CS/J?XC[=!5KPG\./$GQSUR+Q)
MXV>2VT53NMM/^[N7L .P]^IKZ6TS2+31[*&TLH([:VB 5(HUPH%?0.='*%RT
M[3K]]U'T[OS/CXT\3Q%)3JWIX7I':53S?:/ENS(\%> ](\!:5'8:1:);Q ?,
MV,O(?5CW-=)117S<YRJR<YN[9]I2I4Z$%3I12BMDM@HHHJ#4**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@!C(&-.5=HQ2T4 %%%% !1110 4
M444 %120"0YZ&I:* $5=HP*6BB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLIMS<):PM+(ZI&HRS,< "OGGXF_'#4?%&J_\(I\/T:\OI28YKZ,96,=#M/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN^_G_7ZLFUK>7]?H/HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $8X%>%?M,^/
M9;#1K;PMIC%]5U9A&43[PC)P?SZ5[/KFJV^B:5<WUS((H($,C,3C@"OG#X+:
M/<_%CXEZMXZU2,O96TACLE<< C[H'T'/U->]E=*$'+&5E[M/7UET7ZGRF>UZ
ME2,,MP[_ 'E;1OM'[3^[1'LWP?\  ,'P]\$V6FJH-R0);A^[2$<_ETKMP,4V
M,8!I]>/6JSKU)59N[;N?1X?#T\+1C0I*T8JR"BBBL3H"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH 0L!UHW#UJ.;'&3BN>L_$%YJ6JSP6MG"UE;
MOY<EQ).5<L.NU IR!ZDB@#I-X]0/K2@YKEO%&O:IH4$UY#ID%Y8V\1EF=[LQ
MN !D[5V$$X]2*Z6VE$\$<@& ZAL&@"6D;[IHZ5A>-?%=KX/\,W^KW+#RK:(O
MC^\>P'U-7"$JDE"*NV9U*D:,)5)NR2N_0\/_ &E?%=WKFI:5X#T=V>[OI%:Y
M$9Y52> ?Y_A7MG@+PI:^"?"]AI%J@1+>,!B!]Y_XF/U->(_LW^&;KQAKFJ_$
M/6E+W5U*R6V[H.Q(SV P!7T:@(SFO>S.<</"&7TWI#67G)[_ ';'R>1TY8NI
M4S>LM:FD%V@MO_ MV/HHHKYX^P"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH 2EHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BF.Y7MFLF+Q-;SZB]G#'-,\9VR2)&2B'
MT+>M &S17/:SXUL-$N6@F6>5TC\V3R8RPC3^\WH*W8)DN(4E1@R. P(Z$4 2
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#B:Z[%(YP* U.2_P"%J>'_ /GO/_X#2?\ Q-+_ ,+4\/\ _/>?_P !I/\
MXFNF:?:<;AGTI/M'S;=XSZ=Z-!ZG,_\ "U/#_P#SWG_\!9/_ (FC_A:GA_\
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M . TG_Q-=4[%2>PIAN!SA@<>AHT#4YC_ (6IX>_Y[W'_ ("R?_$T?\+4\/\
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MZG&:5\0M2?55MI[<WX"/\]DF$E"G&]<G@?C73W?CZSM--M;_ ,B9[.90QE
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>dkdcu-20230331xs4a032.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a032.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %Q V # 2(  A$! Q$!_\0
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MCDJ%X#<Y%:GQ=^ .M?$KQSH'BC3?'^I^%[G1;>2*TMK>Q@N8DD?[TP$@.'(
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M@9.Z?=C=YA!Y[5%\)/@:_P --4U+5M1\1ZAXLUN[MX;%;Z^BCB,5I$,1PJJ
M#CJ6/)/-=#:=:<^C_+WM/+5J7_!1-OW<8]O_ +77[E)?/LSUKM6!#XOTQ]52
MP\V5+F20QH)(&568 D@,1@\ UOCI7->+O^0EX:_["0_]%25)1THI:** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA'8*:[A!DTZH;@ J.W/6LRSSSXE_M!^#/A-J-K8^(+N[6ZFB-P\=E8S71MH
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ME"2 $HPY5AP:^?%C>Z_8:U#P3 ^?%W_"'37@T@ _:1"[N5;9C.".,5T7P/\
M$&E>.OCUJ^O>';N'4]%MO"&G6$UW:,'B%QNW^46'&]5ZCJO?%=-OWTX=%_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPH/45FR?M6^*O$6EZ#8>%/#6F3^,YXM0GU.QU*[>.UMUL7\NX$;JI9BS\)D
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ML-=L=34-:W<4V>RL,_E7VYZ9HT4PL13J %HHHH **** "BBB@ HHHH ****
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MW1LX]:YZJC)QB_ZT_P""E\^AI%M7:_K^M_D>M_LE?#?Q!X$D\52^+M;T._\
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MXVJ.<\FM_P#:2UW5M.\/^&-#T75+G1;GQ+X@MM&DU"S8">"%P[R&,D':Q5"
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M*];HKRZN682M76)G"\U^GEL82HTY2YVM1JC&:=117J&X4444 %%%% !1110
MC<@\9KD_$RY\3^%E(!'VF3J/^F35UM<IXF(_X2GPO_U\R?\ HIJ .B$)5>%
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M,A1110 49P#10>E 'W5\.!GX?^'/^P?!_P"@"ND'6N;^&_\ R3_PY_V#X/\
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M^_9_^*H'QEUT_P#+*S_[]M_\57"#I2UYG^M^??\ 09/[SH_LK _\^E]QW/\
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M^ K_ .2#_5O&]X_>_P#(]XHKPC_A;OB+_GM;_P#?D4A^+WB(?\M;?_OR*/\
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M^$_^A8UG_OY'1_P\:\)YQ_PC&L<_]-(J_/\ I1P:/[ P/\K^]A_K;FO\Z_\
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M3=.=35.ST?3Y'WI17P7_ ,/(]=_Z$K3O_ Z3_P"(I/\ AY'KV?\ D2]._P#
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MK_L)#_T5)735S/BW_D)>&?\ L)#_ -%24 =-1110 V3[IK\FOVIO^3A/'/\
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M"EQQ0!3J &@\5](>!>?".E?]<17SB>E?1W@7_D4=*_ZXBOVWPJ_Y&.(_P?\
MMR/B^*/]WI_XOT-VBBBOZ:/S@**** "FN!@G'-.IK_=H _)']I/_ )+IXQ_Z
M_FKS2O2OVD_^2Z>,O^OYJ\UK]IPO^[T_1?D?S-F'^^5O\4OS"BBBNHX HHHH
M 5>M?=/PX_Y$'P]_UX1?^@U\++UK[J^'/_(A>'?^O"'_ -!K^8/'G_D3X/\
MZ^/_ -)9^^>$/_(PQ7^!?^E'1@9I=M-HK^)#^IQVVC;24E(!X&*911WI@?1O
M@#_D3])_ZX#^9KH:Y[P#_P B?I/_ %P'\S70U_=^3?\ (LPW^"'_ *2C\/QG
M^\U/\3_,3&:Y?Q,H_P"$H\+_ /7Q)_Z*:NIKEO$W_(T>%_\ KXD_]%-7L'(=
M'-A8\A<UX_\ &+X$W7Q9USP]J<'C35?#,FB2-/;Q65M;S1M*<8D994;YEYQZ
M9KV&;F/WKRWXM_'33?A//I]G+HNK^(-3O4>9;'18DDE2",9DF;<P 101GO42
MLK-]_P"OZ^923::1+-\(I]9T2YTCQ+XLU;Q+I]WIIT^Z@NDAC65BQ)G(1!A\
M'''''2LKX?\ [/MKX.BUJ74_$FK^)K_4[----[>%(9(;1!A(T\M5QCNW4XKL
M3\2] 7X>_P#":?;0- -G]N^U8_Y9XST]>V/6O-M*_:QT74M U.[E\,^(M-U.
MQ\EDT.]MXTN[J.8XB>,!RI5O<C'>B7+&4E+?K\V_\W\KK8(ZI2CMT_#_ "7S
MMU-CPU^SIHOA3QY;>(=/U"\BLK5=UOHVV/R8YO*\HR[\;S\@QM)QGFO8X#F(
M=ZXKP%\4=#^(EC'-I4[BX\A)Y[.5,2VX8D!7QQG*L.">E=K <QBM+65B-'J2
M4444AA1110 4444 %%%% !1110 4444 %(>G%+10!Q.H^'?%$_Q L]6@\5_9
M?#4,12?P_P#V<KF=^?G^T;\KVX"GI7:KT%+10M%8.MQ&SCBO.?%FG^(O[6T'
M&LV2HVH_N5.FDF/]V^,GS?FXSZ5Z/7,^+O\ D)>&?^PD/_14E #?[)\6?]#%
MI_\ X*3_ /'Z/[)\6?\ 0Q:?_P""D_\ Q^NHHH Y9]'\5E3_ ,5%8'V_L@__
M !ZO /''["NG?$7Q=JOB/4_%MY%?ZC-YTR6]DBQAL ?*"Y..!WKZHHKHH8BK
MAI.5&5F^QQXK!T,;!0Q$%)+74^-;G_@G9X7L@#<>-[V$'@&2WC7/YM3'_P""
M>7A..>"%_'5XLT^?)C:"(-)@9.T;N<#TK3_;CM]*OO'?P8M-=\.:CXOT>75;
MS[1H>F1O+-= 6QP BL"V#SU[5Y[HWA#QYX=U?P):Z%%_PA,LNK:U<Z#9>)XF
MO)--L?LRE49 ^<Y#84M\N:Z%F^-LVZLK:_A;\>OHF>=_8.6725"/W>O^7XH[
M?_AW#X=_Z'+4?_ 6/_XJC_AW#X>[>,=1_P# 6/\ ^*K-\:?M6>,]/^&/A77K
M"\TFSU6;2;G4KZQM]+N-0GNC [*V(X^+> ["3*Q^4G':K^M_M"_$G4+SQKK6
MC76B6'A_P_X:T_5EL+BR:6XEGNH2P'F9 "*1Z$FJ>;8SWOWKT_X/^3!9#EEU
M'ZO&[\O3_->0\?\ !.'P]_T..H_^ J?_ !5!_P""</AX?\SCJ/\ X"Q__%5B
MZW\=_C1X/D\2RZEK/A:_M_#%C8:Y=-!I,D;7D%R0/LRYD(C*_P#/3DGT%=+\
M2_VH/$G@OXLV%G:W&GWWAXW]G87.EVFF3S/&+@??FO,".&0$@K%SD?6J_M3&
M\RC[5W;M_7ST_P"!J3_8>5ZVH1VOM_737_@Z'HVC?LYS:%I-EIUOXI#6]K$L
M,;2:>"Q51@9/F=>*O_\ "A+W_H:%_P#!:/\ X[7GGAKXW?$>\T34?B)<PZ+?
M>!2FIR)I4<9AN[);;?Y3&0M^],A3# *-N>*\]\,?MA>.]3\+ZYJ+QPWX2TLK
MR&\?0;FPBMGFG5'MOWW$N%8$..O-? U.%\DQ=9U*F%BYS=VVM;R;W\W9OM\V
MD?91S+%X>FH1J-1CHEY1LM/31=_EJ?0O_"A;P?\ ,T+_ ."X?_'::GP*NI2P
M7Q7&Q4[6 T]>#Z'][7C'QQ^(WC[7I]=L=%UVUT*WT3QAIE@I%H7>6*4(V"0P
MXW$YZY'%6=+^*7B*Q\8>*_"GA>/2M(U[7/'=QIB:I<6[S1(L=E%,\KQ[N7(X
M R!7-#A/()JZP</N_P '_P FC6>:8Z#2=9_US?\ R)[!_P *%O/^AH3_ ,%P
M_P#CM01?!-Y[N:UC\7P27,(!DA6Q4N@/0LOFY&?>O+_C%\=/B5\-?!^CI=7F
MAV/B1(;VXNX;'3IM3DOUMV&UDABSY$; Y=W;Y"0*Z;]G+Q0WC;XQ^-?$,D"V
M\FJ:#HEXT:<A2\!8@>P)K2/".03;MA(67EZ_Y/S5M>AG+-\=&R=5W_X*3_->
M1V/_  H.^7_F9T_\%H_^.UU^B^$O$NA:;!96_B.R,,0POF:42>N><35VH8-T
M.:6O2P&19;E=1U<%0C"35KI=.WX&-?&XC$Q4:TW)>9R_]D^+/^ABT_\ \%)_
M^/T?V3XK_P"ABT__ ,%)_P#C]=117NG"<#JS>+--U#3+8:YI\@O9S"6_LHC9
MA"V?]=STK6_LGQ9_T,6G_P#@I/\ \?I?%7_(>\,?]?K?^BGKIZ!G,?V1XK_Z
M&+3_ /P4G_X_36TCQ65.?$5AC'_0(/\ \?KJ:*!'RGXQ_8,TOQYXJU7Q#J/B
MV]COM2N&N)E@LT5 Q_N@L<#CU-8__#M_P_\ ]#CJ7_@+'_\ %5]B45Z<<RQD
M4HQJNR/$GDN75).<J$6WY'QW_P .W_#W_0X:C_X")_\ %4O_  [?\/?]#AJ7
M_@+'_P#%5]AT4_[4QO\ S]9/]A99_P ^(_<?'9_X)O\ A_\ Z''4O_ 6/_XJ
MC_AV_P"'A_S.&I?^ B?_ !5?8E%']J8W_GZP_L++/^?$?N/CK_AW%X?!_P"1
MOU+_ ,!$_P#BJ]2T+]FR;0-'M-.MO%!,%M&(T,FG L0/4^97N=%>'FV'I9[3
MC1S./M8Q=TI:V>U_N/6RZA2RF<JF!BJ;DK.VET>-_P#"@[W_ *&=3_W#1_\
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MI!TI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/L[?7;R^U_S?(MX-+D9[<Q.$E%P.L6PMSNZ8K8^'W[1/A7XD^*)]$TJ/58Y
M)FM;R\L)(;6^6)]DI@E(PX5N#^E>7?!SX":OX&\7>$]5C\/VOAO3[72M0AN;
M$ZL^H213SR(R[I7&9"0I+-ZT[X"_"CQ[X.^+FI7]]I-GX9\-O'<FZAL-4-S:
MZE.\FY)H;8C_ $4XSN .">U:0U:4O[WX-V_!+O>^W58R;2;7E^2O_6RL?3X.
M:6F(,#K3Z985RWBS_D.>&O\ K]/_ * U=37+^+/^0YX:_P"OP_\ H!H Z<=*
M6D'2EH \P_:%\?WWPO\ A+XD\4::(&O=.@$L8N1F/[P!W#TYKA++]IO3=9^+
MGA#P_I6N:+J>B7FA7>I:M-9W"S/;2Q+&P!*D[1\S<'TKM_VB_ 6H_$OX/>)O
M#.CQ0SZEJ$'EQ1W#[(R=X)!)! X%>8^(?V8O/^(7AJ^T'1M%T'3$\+W^D:E/
M80102&XFC14.U%&\ AN3T_&L6Y*[6N]O_ 96_&WS-+)J*OZ_?']+G=Z+^U5X
M'UVSU2<G6+"&TLSJ$;7VF31&]MMVT2VX(S*I. ,<G(]:XWQ;^TLNJV7AVX\,
M+JFF72^)K/3-6TK5--,5XL,N3M\IQD;U'!'->7?#O]E;QCX,\&Z]9:9X930/
M%-MI(TRTUV3Q5/>_;@&&X11OD6JNH(X^Z3QTJ;X;_LP^-M(U5K^;P]9^'[:;
MQ/I.L?83K;ZA)'# &$I::3+,V2#C.#GC%6]9I)Z>[K_V^K_+EW7K=)6,7?V<
MGUM+3_MW_P"2V?XW-K_ALW5=4B\+ZO'X?UG2[%_%EYHE[IT&E//<WL42R;%C
M0C=ORHW!>AX)KUVY_:Q\$V_A[0M4MH=;U275TEDATVPTR26\C2(XF:2,<H(S
M][->;>$?@/XXTSQ#H<=W864>GZ1XTU#7!=K> F>UN!(RD)C(8%P"N?>J&B?!
M3XD_#.^T#Q+H6B:9XAU:U.J6<VF3:D($6*YGWQS!RI!V_P 2XS0F^5+OK\^5
M:?.7I;78MKWF_7_TJ7Y*WKH>N:U^UEX"T9M,D$NJW]A>6\%T^I66FRRVMI%,
M=L3SR8PFXG&#S4G_  U1X,%YXIB\K6C#X<D,%Y=KIDC0/-D!88G _>.Q885>
M:^>OC9^S?\5_B+/%;W.G:9KZ-I]DD$]MJSZ=::7<QN&GVVJ864/C"[L@8Z5W
M7B']F[Q'XA^#_CSP_/%;F_U+7QJ]E EZT0G12C"-I4 ,9;:1D=.M*[UOY_\
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MY9^;@D'I7%>*_P!F#QQXM\.1:OJOAZWN-7@\3W.MMX>L/$+V;20S0"/:MY&
M4=3D],''O6<6]7MT]-8?>_BUZ6^^I)II?TW:7W*_+ZW^[WJ']K+P/=ZCH-E:
M+K-Y/K$#W,8@TV1A;QHVV0S_ //+80<[JW/AC^T)X7^*^K3Z?I$6JV\ZPFZ@
M;4;"2WCO+?=M\^!F&'0GO7EGPG^ NM>"O$6EW]MHEAX?L(O#US9-8OJ+ZAY=
MS)+O 9W&Z0'N:G_9J^%WCWP'XVU:?6=+MO#/AM[8Q_V5:ZH;V"YNM^3<P(PS
M;1D9_=YQDUI#>TNS_-V_!+[^VJF6UX^7Y*_YO[OD_IJBBBF,Y3QC_P AKPQ_
MU_\ _LC5U0Z5ROC'_D->&/\ K_\ _9&KJATH 6BBB@!#T-?/_P 2/B%X]UCX
MF:CX0\ W&CZ4^BZ<NJ7][K%L]P)RQ.R!%5UVYP<OSCL*^@#TKYZ^)?@[X@>%
MOBEJ?B_P+H>G^*4UW34TR\LK_4/L;6K(25F5BI#KACE>#64^:ZMY_?9V_&WE
MWT*6S^7W75_POY]M3D=+_;)O/$DGAW3[7PU?6UUJ^BWE[)J$=N\EM;W$&X$(
MQ&&0,AR3TR*Z+X)_M7Z#XH\"VLOB2;4[#6;/1UU6]N;_ $M[:*ZC'#R0<8<!
ML#Y1U/%<W9_LY>*_!H\!6NF06>J0V.C:EI^I3&Y$/E37.Y]Z@@EU#-M_6L[5
MOV6O%7B/PYINCW)M+;R_!#Z'*ZW.<77FHX4$#.T[2-PZ4Y.2<K?U;VCT_P#)
M5YW74E+X?Z_D7_R3\M3U&^_;"\#V'ANYU2\LO$=G)#<V]K_9L^D2K>N9S^X=
M(3RROC@BJ?[1?QDUKP+\./#6M^';JT\/7&LZC;6K3^(K4E;..7.3)'N7!'<$
MBO*/!'[,7B*RTFPD3P9%X8U.#7-,NKDW7BB;59+B"W?+N'D^XO=4'K7KW[5O
MPWU[XC^#M#A\.:'8>)+K3M8M]0ETS4[A(89XT)W*2ZLO.>A%:225O\2_\!]V
M_P";^X4&VW_A?WZ_+HK%+3_V@X/AMX7T>Y\7^(H/B%>ZU=30:=-X&TAY%F*)
MN9 BR/D@ \YJ7XA?M9^%]/\ A[:ZGH0UC4M1U;3KB\L8+#2I+B6W$8PTDZ ?
M(J-@-FL>R^'7C/Q1K7P]U.\\"Z)X$@T&^O'GTS2[Z.6)8Y+=D5UV1J,ECR,>
M]<-!\ ?B7X)T73)M%T33-<O[C2=0T6^MIM3$"VRS2EXYE<J0P&>5 !K&IS--
M?UL[?>[:]/Q-(64HO[__  +7[ETZGI6I_&?Q%H?[,WA#QKOM[S7-1335N))H
MMJ,9I$5SM7&#ACBMOQ+\=8_ WQ*UVPUZ6*V\,Z7H2:F\R1L\QD:0)M '7.<
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MZC1/B[X1U_1O#NI1:]8VL>OP+<:=#>W"0S7"D=%1B"2.AHY54CIM_P %6_\
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MN1\(?":W>@#PQ.-/CW:0&9A:^B#=\V/0'D9Q7HM<LOC&16R/#FM9_P"O<?\
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M^ Z__%4?\)K-_P!"[K/_ (#K_P#%4 =/17,?\)K-_P!"YK7_ (#K_P#%4?\
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ML_\ @.O_ ,50!U%%<Q_PFLW_ $+NM?\ @.O_ ,51_P )K-_T+NM?^ Z__%4
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M /&JZFB@#S3Q)-XK_MGP]YMIHP?[6WE[;F<@MY3=?W? QFNB\_QGC_CST/\
M\"Y__C5/\5?\AWPQ_P!?K?\ HIZZ:@#EO.\9_P#/GH7_ (%S_P#QJCSO&?\
MSYZ%_P"!<_\ \:KJ:* .6\[QG_SYZ%_X%S__ !JCSO&7_/GH?_@7/_\ &JZF
MB@#EO.\9_P#/GH7_ (%S_P#QJCSO&?\ SYZ%_P"!<_\ \:KJ:* .5:X\9#K9
MZ%S_ -/<_P#\:I//\8C_ )<]!Q_U]S__ !JLCXY:9K&I_#O5UT3Q%=>&;N&W
MDG:]LHT>8HB,Q12X(4G ^;&1VKF_@S<Z[XG_ &:O"\MOJS)XAO="3R]3O/WI
M6=H^)7SRV"03ZU-W:32VM\[W_P AZ)Q3ZW_"W^9W?VCQB.MGH0^MW/\ _&J4
MW'C'_GST+)_Z>Y__ (U7SI\*/"&NZ7\1_%OASP[X[UW4+6'1$BU;6KVY-]'#
MK#/EF@$N51@N28^BY Q7&:9XL\3+^S/J3:GXHUJYMT\93:=J^O\ GL+R'3UG
M"NX=!E,  94# )Q2YK[>7IK)1^[6]^VM@:M?^OL\WWZ6MWT/KWS_ !E_SYZ#
M_P"!<X_]I4HN/&/_ #YZ'_X%S_\ QJO(_P!DGQC#XB\'>*+.QUFZ\0:%HVMS
MV6E:C>S/--+:A49<R/\ ,^-Q 8\D5YU\#?C-J'B#XQ7&J^+K+Q1;PZYJU[HF
M@WDEY&-'Q"[!8DMU<L'*H2977DY JUK)1757^^UOGKL3>T7)]';\[_+1ZGU%
MYWC/_GST/_P+G_\ C5'G>,_^?/0O_ N?_P"-5TZ<J*=0,Y;SO&7_ #YZ'_X%
MS_\ QJCS_&7_ #YZ'_X%S_\ QJNIHH Y;SO&7_/GH?\ X%S_ /QJCSO&?_/G
MH7_@7/\ _&JZFB@#EO.\9_\ /GH7_@7/_P#&JYWQ-+XL.KZ!YMIHHD^UGR]E
MU,03L/7]W7I=<MXM_P"0YX:_Z_3_ .@-0 U)O&84#['H6/\ K[G_ /C5.\[Q
MG_SYZ'_X%S__ !JNH'2EH Y;SO&?_/GH7_@7/_\ &J/.\9?\^>A_^!<__P :
MKJ:* .6\[QE_SYZ'_P"!<_\ \:H\[QG_ ,^>A?\ @7/_ /&JZFB@#EO.\9?\
M^>A_^!<__P :I#/XR YL]"'UNY__ (U755%<#,9[4 <S]H\8YXL]"/\ V]S_
M /QJC[1XPZ_8]"/_ &]S_P#QJOEWXH_&34[/]HG4X=3T[Q5/X'\')9232Z!>
M1V]K%+.2/,NE+AYE' V*"!R33_'WQEU/Q7^T_P" +#0O$$-EX2T[4Y-/N5BN
M0/MUT\#,=ZYY2/"CGJS>U1&7,HV6_P"7=^MU;U7G8>CDNRO^%[?);_U?Z?\
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M-&#_ &W]WLN9B"VQNO[OI71I-XR _P"//0__  +G_P#C5)XQ_P"0UX8_Z_\
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MQ)S7._!?XAW$'QP\/07'BC5[WQ;K5]J5MXCT&^N97@M$CW&#9$WR18P,%?O
MFE3?/9=[_A_6KZ>FH37)?^M-?\M#Z\$_C#_GST(_]O<__P :I1/XQ[6>A?\
M@7/_ /&J^<OVFOB/KEO\6M$\+V6G>)]0\.V.FOK>JQ^%[R*TE*JX ,DCNI*#
M#$HF2W3%?3?@OQ!9>*_#.FZSILAET^^MTG@=NK(PXS[TX/GCS+;_ (+7YIV]
M!2]V7+_7?\FOO*7G>,_^?/0O_ N?_P"-4>=XS_Y\]"_\"Y__ (U74T50'+>?
MXR_Y\]#_ / N?_XU1YWC+_GST/\ \"Y__C5=310!RWG>,_\ GST+_P "Y_\
MXU1YWC/_ )\]"_\  N?_ .-5U-% '*M-XSP?]#T+_P "Y_\ XU6->/KK>+_#
M/]JP:=%%Y\FTV<TCMGRFZ[E'%>AUROB;_D:?"_\ U\R_^BFH ZD=!2T@Z4M
M!1110 4444 %%%% !1110 4444 ,D^XW;BO.="\(P>,/ASH%M/<R6ZQ R!H@
M"2<L._UKT:7_ %;?2O-_ /AG4+OPEIDT?B34;6-XR5AC6(J@W'@97-<F+PE#
M'T)8;$QYH2W7?[C:E5G0FJE-V:$_X4?I_P#T$[O_ +Y3_"C_ (4=IW_03NO^
M^4_PKH3X1U,#/_"6:I_WQ#_\12#PGJ1_YFS5/^^(?_B*^2_U(X>_Z!%]\O\
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MFJ?]\0__ !% SJ<T9%<M_P (?JG_ $-FJ?\ ?$/_ ,11_P (?J?_ $-FJ?\
M?$/_ ,10!U.11FN6_P"$/U/_ *&S5/\ OB'_ .(H'@_4_P#H;-4_[XA_^(H
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M '4YHR/6N6_X0_4_^ALU3_OB'_XBC_A#]4_Z&S5/^^(?_B* .IR*,CUKEO\
MA#]4_P"ALU3_ +XA_P#B*/\ A#]4_P"ALU3_ +XA_P#B* .GD 9&&1R*\/\
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M_P"^(?\ XB@9U.1ZT9'K7+?\(?JG_0V:I_WQ#_\ $4?\(=JG_0V:I_WQ#_\
M$4 =3FC(]:Y;_A#]4_Z&S5/^^(?_ (BC_A#]3_Z&S5/^^(?_ (B@#J2P'>N5
M\2D'Q3X7Q_S\R_\ HIJ7_A#]3_Z&S5/^^(?_ (BL>[T2\TOQ?X:>YUF\U)6G
ME 2X" +^Z;D;5% 'H(Z4M(.@I: "BBB@ HHHH **** "BBB@ HHHH :_*-]*
MX3PAJ5YIG@#0Y+/3Y-19HR&1&V[1N/-=W)]QOI7*_#.5!X'T@%E'[H]Q_>-
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M?WA^8H ^98/"Z^&OVUK*:/4M3O9-4\.WES*M_>/+'&?/C"I&A.U% X  K@O
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M<7*UNC3^YW*3LGZ/\CSS]D>&2Z^ =M937=S#+'=7ELT.YO,T_$K 6X8YYC&
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M7XF?^"B/_P".T?\ #4>I_P#1%?B9_P""B/\ ^.T >K?\*[\-?] 6T_[]T?\
M"N_#7_0%M/\ OW7E7_#46I_]$5^)G_@HC_\ CM)_PU'J?_1%?B9_X*(__CM
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M?] 6S_[]T?\ "N_#7_0%L_\ OW7E'_#4>I_]$5^)G_@HC_\ CM'_  U'J?\
MT17XF?\ @HC_ /CM 'J__"N_#7_0%M/^_=)_PKOPU_T!;3_OW7E/_#4>I_\
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M[2?\-1ZG_P!$5^)G_@HC_P#CM 'JW_"N_#7_ $!;3_OW2_\ "N_#7_0%L_\
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MU'J?_1%?B9_X*(__ ([0!ZO_ ,*[\-?] 6T_[]T?\*[\-?\ 0%M/^_=>4?\
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M_AJ+4_\ HBOQ,_\ !1'_ /':3_AJ/4_^B*_$S_P41_\ QV@#U?\ X5WX:_Z
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M&O\ H"VG_?NO*/\ AJ/4_P#HBOQ,_P#!1'_\=I?^&HM3_P"B*_$S_P %$?\
M\=H ]5_X5WX:_P"@+:?]^Z/^%=^&O^@+:?\ ?NO*?^&H]3_Z(K\3/_!1'_\
M':/^&H]3_P"B*_$S_P %$?\ \=H ]7_X5WX:[:+:#_MG4^G>"]#TF[2ZM-,M
MH+A,[9$C&Y<\<'M7D7_#46I_]$5^)G_@HC_^.T?\-1ZG_P!$5^)G_@HC_P#C
MM 'O%%>#_P##46I_]$5^)G_@HC_^.TG_  U'J?\ T17XF?\ @HC_ /CM 'O-
M%>#?\-1ZG_T17XF?^"B/_P".T?\ #4>I_P#1%?B9_P""B/\ ^.T >\T5X/\
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M*MM%9QDW&\OZT37YV?;J5)6E9>7^3_)NW7H?< UFT,,4INH!%,P6*3>-KD]
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MH13+@Z4M%%(04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
H% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>dkdcu-20230331xs4a034.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a034.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &7 Z@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^*O@%-8Z!X<&HZ+J'B%+NQT"ZF\I/L@?[N2>%([#M3EE\.7GP^L? FG>#(?
M1_X3&ST[Q#H=K,TD4NY=XP^?F5@HS35WI:SNDEZ\JU]'*VE]41>WIKKZ<ST]
M5&Y]RV&K6FK6PN+*YCNX6Z2PR!E/XBM1/N#O7S5^S78VWA+XG?$WPKI4'V/0
M[&[BDM;.,GRH=R D*.PS7TJG*BJ5G&,EU28]4W%]#ES_ ,E)S_U#_P#V:NJK
MEL9^(_\ VX?^S5U- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 444AX% "T5 )%W;2W/IF@.N\+NY],T 3T4A8"@'-
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MJ<7MV\UW.:S51I_/R?;\;_-G9454WD<Y/TJ<-GH:S-"2BDI: "BBB@ HHHH
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MPKPN,O\ D08O_#^J.W*/]^I>IXL.E(>M*.E(>M?Q6?L@#M7TMX3_ .1=L/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCX[B;_=8?XOT9T]%%%?U$?FIPOQ@_P"13;_KLM>&=*]R^,/_ "*;?]=EKP[
MK^4/$S_D>_\ ;D?U/U'AO_<OF_T$Q24_-)M%?DQ]4?1W@7_D5--_ZXK_ "K>
MK!\#?\BKIO\ UQ7^5;U?WCE'_(NP_P#@C^2/P[%?[Q4]7^85YY\:?^1>M_\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHICD@C% #)I"K
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MQKL:_N+AK_D383_!'\C\5S'_ 'RK_B?YA7&_%?\ Y%"X_P!Y?YUV5<;\5_\
MD4+C_>7^=+B;_D2XO_!+\@R[_?*7^)?F>"CI01Q2@8H-?PZ?M0WI7T+\-_\
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MK]T4M(OW12U)04444 %%%% '*G_DI/\ W#__ &:NJKE3_P E(_[</_9JZJ@
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MW_I+/ S_ /Y%\_E^:/4****_L(_)3/\ $'_("U#_ *X/_P"@FOF+O7T]K_\
MR [_ /ZX/_Z":^83]X_6OYP\5_\ >,)_AE^:/T+A?^'5]4+@4IZ4W)HS7X,?
M<GL?P2.=*O\ _KJO\C7I5>:_!+_D%7__ %U7^1KTJO[/X(_Y)[">C_\ 2F?C
MV<_[_5]?T05C^,/^18U/_K@_\JV*Q_&'_(L:G_UP?^5?3YE_N-?_  2_)GFX
M?^-#U7YGS5GBC-&.*2OX*1^Y"Y->S_!/_D!WO_78?RKQ>O:/@G_R [W_ *[#
M^5?I_AQ_R4%/_#+\CYOB'_<)>J_,]&HHHK^N#\I,/QM_R*VH_P#7(U\W9^8_
M6OI'QM_R*VH_]<C7S<?O'ZU_,OBI_P C'#_X/U9^C<,?P*GK^@9_.ES3:=_#
M7XB?:GM_P<Y\,O\ ]=37>UP7P<_Y%E_^NIKO:_MKA+_D183_  (_&<U_WZKZ
MA7-?$/\ Y%.^_P!VNEKFOB'_ ,BG>_[M>EGO_(KQ7^"7Y,Y\%_O5/_$OS/GG
M%%%-)K^$S]N%SCK7N_PC_P"11C_WVKP<],U[Q\)/^11B_P!\U^N>&/\ R.Y?
MX)?FCY3B3_<UZH[6BBBOZL/R\Y#XI?\ (GW?^\M>!8)%>^_%'_D3[K_>7^=>
M YXK^6/%#_D<P_Z]K\Y'Z;PU_NDO\7Z(7 %*#FF@^M*!7X\?7'OGPK_Y%&V^
MIKL*X[X5?\BC;?4_SKL:_N/AK_D383_!'\C\5S'_ 'RK_B85QOQ7_P"10N/]
MY?YUV5<;\5_^10N/]Y?YTN)O^1+B_P#!+\@R[_?*7^)?F>"CI1C YI,'%'6O
MX=/VH7M7T+\-_P#D4-/_ -ROGKH*^A?AO_R*&G_[E?LWA;_R-JW^!_\ I2/C
MN)O]UA_B_1G3T445_41^:G"_&#_D4V_Z[+7AF,=:]R^,'_(IG_KLM>&FOY/\
M3/\ D>_]N1_4_4>&_P#<OF_T#.: ,T;:=7Y0?5'T;X&_Y%73?^N*_P JWJP?
M W_(JZ;_ -<5_E6]7]XY1_R+L/\ X(_DC\.Q7^\5/5_F%>>?&G_D7K?_ *["
MO0Z\\^-/_(O6_P#UV%>%QE_R(,7_ (?U1VY1_OU+U/%<<49.**2OXL/V04=<
MU]+>$_\ D7;#_KBO\J^:1UKZ6\)_\B[8?]<5_E7[EX5?[[B?\*_,^)XH_@T_
M5FO1117]*'YT(:\ _;*N?%,7P;O3X5DU."43)]LDT0XO%M\_.8O]K%>_FO ?
MVQ]:\5:%\'[J[\*F^BG$\8NY],B\RYBM]WSLB]SBL*WP?-?GU\N_D:TOB_KM
M^?;S/E+]DOX@^*O$7C/P?X:\/1^-C8Z5JE_<:I>^(A(D<UG(!Y2R;CAW!''I
MVK[W^)'@^Y\;>&;G2['5[C0[MP&CN[<!L,.S*00R^H-?)'PZ^.M[\2OC;\/[
M;P"?$KZ9:6;V?B"/5-.:"W=5!VS,Q _>%N*^Z!$N,XKIG%3@D_/\':_IIH<\
M':3?]:W;3\[M_*Q\@WW@S]HCP[=?9M,\+_"KQ-;*<)J%]926LI]&9$?!/TQ7
MJ/PR\&?%&?6;;5_'_BBPACMT(C\/>&[<P68)[NS,S/CL"<5[:858<BD^S)G.
M.:E:>?\ 7W?@4U?^OZ8]/NBJNI:3::O93VEY ES;3J4EBD&5=3U!'I5L# I:
M35]&/;8Y;5?AAX5UOPC_ ,(O?:#8W.@!/+&GR0J8@OH%Q@52LO@MX(T_P-)X
M.M_#.FQ>&9 0^F"W7R7SU)7')]Z[:BAJ][]=_,%I:W38YOP5\.?#?PZT2/2/
M#>CVNC:<AR(+2,(N?4XZFNC P,4M%4VWJQ));'*G_DI/_</_ /9JZJN5/_)2
M?^X?_P"S5U)I#(VB5CDC)I1"G'%>+^-/&VLZ9XCN[>WNS'$AX6L7_A8NO_\
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MTR3[K?2GTR3[K?2OK7L>4?/VO>+-;@UF\CCU6\2-92%59V  _.J'_"::\/\
MF,7O_@0W^-5_$O\ R'K[_KJW\ZS<U_#6.S/'K%54J\[<TOM/OZG[71PU!THM
MP6RZ(V#XSU[_ *#-]_W_ &_QKL_A7X@U/4_$+Q7FH7-S&(R=DLI89_$UYH!F
MN\^#PQXF?_KD:]WA7,<;5SO"PJ5I-.2NG)M?F<.:8>C#!57&"3MV1[C1117]
MDGY$,E^X?I7S/XD_Y#]_S_RV;^=?3$OW#]*^9_$O_(?O_P#KLW\Z_"/%;_=<
M+_B?Y'V_"_\ %J>B,X?G00:0 THK^;C]$/0O@QSKER/^F=>TKTKQ?X,\:W<_
M]<Q7M K^N/#C_D00_P 4OS/RGB'_ '^7HOR%J*Y/[B3_ '34M17(_<2?[I_E
M7Z;/X'Z'SD=T?,FK?\A2[_ZZM_.J9&:MZK_R$[K_ *ZM_.J9ZU_ >)_CS]7^
M9^Z4O@CZ( .:].^"/_'[?_[HKS$\5Z=\$3_IM_\ [HK[/@;_ )*'"^K_ /26
M>/G?^X5/E^:/7Z***_LP_(2KJ?\ QX3_ .X?Y5\PW7_'W-_OG^=?3VI_\>$_
M^X?Y5\PW7_'W-_OG^=?SSXK_ !83_M[]#[[A;:K\OU(\<T$4$XI,_G7\^GWI
MZE\#O^/C4_\ =7^M>MUY)\#O^/C4_P#=7^M>MU_87A]_R3M#UE_Z4S\DS[_D
M85/E^2"J^H?\>%S_ -<V_E5BJ^H_\>%S_P!<V_E7Z!6_A2]&>%#XD?+L_P#K
MI/\ >-, S3Y?]=)_O'^=-/'2O\_Y?$S]V6R$(Q7KOP/_ ./34_\ >3^1KR(\
MXKUWX'_\>FI_[R?R-?HGA]_R46'_ .WO_26>!G__ "+Y_+\T>H4445_81^2F
M?X@_Y >H?]<'_P#037S%WKZ=\0?\@+4/^N#_ /H)KYB/6OYP\5_]XPG^&7YH
M_0N%_P"'5]4+CFD(HR:,U^#V/N3V+X(_\@J__P"NJ_R->EUYK\$O^05?_P#7
M1?Y&O2J_L[@C_DGL)Z/_ -*9^/9S_O\ 5]?T05C^,/\ D6-3_P"N#_RK8K'\
M8?\ (L:G_P!<'_E7T^9?[C7_ ,$OR9YN'_C0]5^9\UGI3:<>E)C-?P4C]R"O
M:/@K_P @.\_Z[#^5>+D8KV?X)_\ (#O?^NP_E7Z?X<?\E!3_ ,,OR/F^(?\
M<)>J_,]&HHHK^N#\I,/QM_R*VH_]<C7S=U8_6OI'QM_R*VH_]<C7S?QN/UK^
M9?%7_D88?_!^K/T?A?\ @5/7] QQUI,TX]*:1@5^)'VA[A\'/^19?_KJ:[VN
M"^#G_(LO_P!=37>U_;/"/_(BPG^!'XSFO^_5?4*YOXA_\BE??[M=)7-?$/\
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M7]!:#S2?Q4M?B)]H>W?!SCPR_P#UU-=[7!_!W_D67_ZZFN\K^VN$?^1%A/\
M C\9S7_?JOJ%<U\0_P#D4[W_ ':Z6N:^(G_(I7W^[7I9[_R*L5_@E^3.?!?[
MU3_Q+\SYX(R:6DZ<4E?PI8_;AQZ5[M\(_P#D48_]]J\(W5[O\)/^11B_WS7Z
MWX8_\CN7^"7YH^4XD_W->J.UHHHK^K#\O.0^*0_XH^Z_WE_G7@=>^_%+CP==
M?[RUX%GC-?ROXH?\CF'_ %[7YR/TWAK_ '27^)_DAIZT9HHK\@/KCWWX6?\
M(HVWX_SKL*X[X5?\BC;?C_.NQK^XN&O^1+A/\$?R/Q7,?]\J_P")A7&_%?\
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MI ,FDHK^9['Z0=S\(?\ D:#_ -<S7N@XKPOX0?\ (T?]LS7NM?U?X9_\B/\
M[?E^A^6\1_[[\D%,D^ZWTI],D^ZWT-?J[V/ET?-/B4?\3^^/_35JRSP:T_$G
M_(?OC_TU:LP]:_@?'_[W6_Q2_-G[G0_A0]%^0=37=_!T?\5-)_UR-<*.:[KX
M.\>)I/\ KD:^@X1_Y'V$_P ://S;_<:OH>Y4445_;)^-C)?N'Z5\T>)>-?U#
M_KLW\Z^EY?N-]#7S/XE_Y#]__P!=F_G7X/XK?[KA?\3_ "/M^%_XM3T1G@YI
M#UH7I2'DU_.!^B'HGP7/_$\N?^N?]:]H7I7B_P &.-<N?^N=>T#O7];^''_(
M@A_BE^9^4\0_[_+T7Y"U%<_\>\O^Z?Y5+45S_P >\O\ NG^5?IL_@?H?.1W1
M\PZM_P A2[_ZZM_.JH&:MZM_R%+O_KJW\ZJCK7\"8K^//U?YG[I2^"/HA#7I
MWP2_X_;_ /W17F)->G?!+_C]O_\ =%?9<#?\E#A?5_\ I+/'SO\ W"I\OS1Z
M_1117]F'Y"5M2_X\+C_</\J^8;G_ (^I_P#?/\Z^G=2_X\+C_</\J^8+O_CZ
MF_WS_.OYY\5_BPG_ &]_[:??<+;5?E^HQJ2@=:",5_/VA]Z>I? _BXU/_=7^
MM>MUY)\#^;G4_P#=7^M>MU_8/A]_R3M#UE_Z4S\DS[_D85/E^2"JVH_\>%S_
M -<V_E5FJ^H_\>%S_P!<V_E7Z!6_AR]&>%#XD?+LH_?/_O&F$8%22C]\_P#O
M&F-TK^ )?$S]V6R!:];^!_\ QZZG_O)_(UY(M>N? _\ X]-3_P!Y/ZU^A^'_
M /R4>'])?^DL\#/_ /D7S^7YH]0HHHK^PC\E,_Q!_P @+4/^N#_^@FOF(]:^
MG?$'_("U#_K@_P#Z":^8N]?SAXK_ .\83_#+\T?H7"_\.KZH.]./%)BE/2OP
M8^Y/8?@D<Z5J'_71?Y&O2J\U^"7_ ""K_P#ZZ+_(UZ57]G\$?\D]A/1_^E,_
M'LY_W^KZ_H@K'\8?\BQJ?_7!_P"5;%8_C#_D6-3_ .N#_P J^GS+_<:_^"7Y
M,\W#_P :'JOS/FI>M&,DTH%&*_@D_<A"<U[/\$_^0'>_]=A_*O&",5[/\$_^
M0'>_]=A_*OU#PX_Y*"G_ (9?D?-\0_[A+U7YGHU%%%?UP?E)A^-?^17U'_KD
M:^;R,DU](>-O^16U'_KD:^;B>3]:_F7Q5_Y&.'_P?JS]'X8_@5/7] Z&E!S2
M8XH')K\1/M#W'X._\BR__74UWE<%\'>/#+_]=37>U_;7"/\ R(L)_@1^,YK_
M +]5]0KFOB)_R*5]_NUTM<W\1/\ D4K[_=KTL\_Y%>*_P2_)G/@O]YI_XE^9
M\[XP*3%'4T$8Q7\*'[<)7O/PD_Y%&+_?->$%:]W^$?\ R*,?^^U?K?AC_P C
MN7^"7YH^4XD_W->J.UHHHK^K#\O.0^*7/@ZZ_P!Y:\!Z\5[]\4?^1/NO]Y?Y
MUX%U%?ROXH?\CF'_ %[7YR/TWAK_ '27^)_D@VT;:,TM?CY]<>]_"L8\(VWX
M_P Z["N.^%C?\4C;?4_SKL:_N/AK_D2X3_!'\C\5S'_?*O\ B85QOQ6'_%(7
M'^\O\Z[*N-^*_P#R*%Q_O+_.EQ-_R)<7_@E^09=_OE+_ !+\SP2BDI<<5_#[
M/VH0]*^AOAO_ ,BAI_\ N5\\U]#?#?\ Y%#3_P#<K]E\+?\ D:UO\'_MR/C^
M)O\ =8?XOT9U%%%%?U"?FAPOQAX\)M_UV6O#,5[G\8.?";?]=EKPNOY0\3/^
M1[_VY']3]1X;_P!R^;_06DHIV!7Y.?5'T=X&_P"15TW_ *XK_*MZL'P-_P B
MKIO_ %Q7^5;U?WAE'_(NP_\ @C^2/P[%?[Q4]7^85YY\:!_Q3T'_ %V%>AUY
MY\:?^1>M_P#KL*\/C+_D08O_  _JCMRC_?J7J>+ 9% &*;17\5G[(._BKZ5\
M)_\ (NV'_7%?Y5\TCDBOI;PG_P B[8?]<5_E7[GX5?[[B?\ "OS/B>*/X-/U
M9KT445_2A^="&OG?]L7QWIWAWX5W,'_"-6?C2^GN8H(=)N+I8%$K-\K,Y/RC
M..:^B#TK\S?VN?@9X>^(_P >M9MO"_PTT_Q%XBAMEOM7O]4U2>!2O9417 SC
MO6%5ZQB]M_NU?X=>AK#1.7]:Z?FSH_@+X+\>7_[0^E^*O$GP-\,>'#,&$VK6
M7BBWNGA^3&]8%D.6. "0*_0]>E?$W[&_[,GP4N-&\-_$[PWX2;0?$T9D0Q'4
M991#*I*. &;!&0>U?;(Z5V37(E3['-%\S<^XM%%%9&@5P?QA;'PS\4@#K8S8
MP?\ 9-=Y4+6R.3D9!ZBLZD>>#AW+A+DDI=CXNU>_C\)?"GX+^*]0!BT71KI)
M+^Y*DB!""-S<< >M<<;E9M%\1?%&!7F\(R>/;35%O AVFTCB$;S#OL#$\^@K
M[_?3X)8C$T:M$1@H5&"/I0-.MQ!Y(B00XV^7M&T#TQ5N[G*HMV[K_P "C+\X
MK[V81@E",'T5OPDO_;G]R/F_]F74K;QK\0_B1XSTB4W?A_4[N)+.\4?N[@*@
M#,A[C/%?2Z?<%00:?!;1+%#&L,:C"HBA5'T JP!@8IZ)**V22-+MMRENSEC_
M ,E)_P"X?_[-74FN6/\ R4G_ +A__LU=2>E SYW^(G_(VWQ_VJYQ>E='\0_^
M1MO?]X5SG0XK^$\\_P"1GB?\<OS9^VX+_=:?^%?D-KL?A5_R-<7^Z:Y BNP^
M%7_(UP_[IKKX9?\ PLX3_''\S+,O]SJ^C/>QTI:0=*6O[A/Q81ONFOF[QK_R
M-&H?]=#7TBWW37S?XU'_ !5&H?\ 70U^(>*G^X8?_'^A]GPQ_O%3T_4P^M*
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M;1C%&>/>EK\1/M#V_P"#O_(LO_UU-=Y7!_!W_D67_P"NIKO*_MKA'_D183_
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M4#I1T%?PZ?M0$=Z^A/AO_P BAI_^Y7ST3D5]"_#?_D4-/_W*_9_"W_D:U?\
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M_DH*?^&7Y'S?$/\ N$O5?F>C4445_7!^4F'XV_Y%;4?^N1KYO(^8U](>-O\
MD5M1_P"N1KYN)^8_6OYE\5/^1CA_\'ZL_1^&/X%3U_0=C%%(30"2:_$3[0]P
M^#O_ "++_P#74UWE<'\'?^19?_KJ:[RO[:X1_P"1%A/\"/QG-?\ ?JOJ%<W\
M0_\ D4K_ /W:Z2N;^(?_ "*5_P#[M>EGG_(KQ/\ @E^3.?!?[S3_ ,2_,^=:
M4=:*4^U?PH?MP$#%>[_"3_D48O\ ?->#Y->\?"/_ )%&/_?:OUOPQ_Y'<O\
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MU>M/E&9I/]X_SIG0U_ $OB9^[+9"XZUZY\#_ /CTU/\ WD_K7D6XUZ[\#_\
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MWC;L[>MI6_&RL_(]X_9^\=>)=5UGQ;X4\6:C%K.K>'[E(QJ,<*PF=&4,"44
M \]J]S3[@^E?/7[.6CZKJ/BKQQXVU/1[O1(M>N8VM+2^0QS>6JA=S*>1DBOH
M5/NCZ5MKRQYM[*_K8C2[Y=KG+G_DI/\ W#__ &:NJKE3_P E)_[A_P#[-754
MAGSK\0_^1NOO]ZN<R:Z/XA_\C;??[U<W7\)YW_R-,3_CE^;/V[!?[K3_ ,*_
M(4#(KL/A5_R-<7^Z:X\'BNP^%?\ R-</^Z:ZN&?^1UA?\<?S,LR_W.KZ,]\'
M2EI!TI:_N(_%A&^Z:^;_ !I_R-&H?]=#7T@WW37S?XT_Y&C4/^NAK\0\5/\
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M!/\ Y =[_P!=A_*OU#PX_P"2@I_X9?D?-\0_[A+U7YGHU%%%?UP?E)A^-O\
MD5M1_P"N1KYN)Y-?2/C;_D5M1_ZY&OF[HQ^M?S+XJ?\ (QP_^#]6?H_"_P#
MJ>OZ"YR,4A&!1UI<<8K\1/M#V_X.?\BR_P#UU-=[7!?!SCPR_P#UU-=[7]M<
M)?\ (BPG^!'XSFO^_5?4*YKXB?\ (I7W^[72US7Q#_Y%.]_W:]+/?^17BO\
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M]]Q/^%?F?$\4?P:?JS7HHHK^E#\Z"BBB@ HHHH **** "BBB@ HHHH ****
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MUU/_ 'T_D:\;_M"V'_+>/_OJO4O@WXDTK3K;41=:C;6Y9DV^9*%SU]:^_P"
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M@N[RU4NZ/&\091U9&=0'4>JDBIT;L/97.T_X1K23_P PZV_[]"C_ (1K2?\
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M#X#\>:U>Z5H>OPWM]9@M+&4>,;1U9690&7W4D466WS^0KG9_\(UI7_0.MO\
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M_P"V8H_X1K2?^@=;?]^A61X[^)OAWX::.=4\1ZBFG6>X(K%&=W;^ZJ*"S'Z
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MJ,<4G97OTT^?8%K:W74[ ^&M*_Z!UM_WZ%*/#>E@?\@^V_[]BN:MOC3X+NO
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MIC$ETUY+9-?*8)78Y.X;,D?C6M:?LH^$K3Q^OB@7&I.%N?MJ:2]P#9I<?\]
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M)?Q&M[8Z;HNH6T=AIT2KM,UNC &1A[]O:NY^'L,-E^T5X.338T2WD\*KYWE
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M_)=47_:0^',;HC>*;%7==P4R<XQFM2\^-7@NPT*SUF?7[2/3KMML$Q?AS[4
M0_\ ".?$;_H=]$_\)M__ )+H_P"$<^(W_0[Z)_X3<G_R77;V-[#J-I#=6TBS
M6\RAXY$.0RGH14]&P;G _P#".?$;_H=]$_\ ";D_^2Z/^$<^(W_0[Z)_X3<G
M_P EUWU% ' _\(Y\1O\ H=]$_P#";D_^2Z/^$<^(W_0[Z)_X3<G_ ,EUWU%
M' _\(Y\1O^AWT3_PFW_^2Z7_ (1SXC?]#MHG_A-O_P#)==[10!P/_".?$;_H
M=]$_\)N3_P"2Z/\ A'/B-_T.^B?^$W)_\EUWU% ' _\ ".?$;_H=]$_\)N3_
M .2Z/^$<^(W_ $.^B?\ A-R?_)==]10!P7_".?$;_H=]$_\ ";?_ .2Z/^$<
M^(W_ $.VB?\ A-O_ /)==[10!P/_  CGQ&_Z'?1/_";?_P"2Z/\ A'/B-_T.
M^B?^$W)_\EUWU% ' _\ ".?$;_H=]$_\)N3_ .2Z/^$<^(W_ $.^B?\ A-R?
M_)==]10!P/\ PCGQ&_Z'?1/_  FY/_DNC_A'/B-_T.^B?^$W)_\ )==]10!P
M/_".?$;_ *'?1/\ PFY/_DNC_A'/B-_T.^B?^$W)_P#)==]10!P/_".?$;_H
M=]$_\)N3_P"2Z/\ A'/B-_T.^B?^$W)_\EUWU% ' _\ ".?$;_H=]$_\)N3_
M .2Z/^$<^(W_ $.^B?\ A-O_ /)==]10!P/_  CGQ&_Z'?1/_";?_P"2Z/\
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M*.4UKX2:MXQM?A]'H.@W/A?2&FGM]6M-1O8YYX;9AEAO65]Q;&/E)Q7*ZO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>dkdcu-20230331xs4a036.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a036.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &3 Z@# 2(  A$! Q$!_\0
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M=+\0:?K32K974=PT0!<(?NYZ9_(UHUSVF+M\8ZOS_P NUO\ SDKH:@H****
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MZ"MI_P!_11_PENB_]!6T_P"_HKYH[4=:/^(K8W_H%A][#_5>C_S\?W(^E_\
MA+M$_P"@K:?]_11_PEVB?]!6T_[^BOFBCK1_Q%;&_P#0+#[V'^J]'_GX_N1]
M+_\ "7:)_P!!6T_[^BC_ (2W1?\ H*VG_?T5\TX-&.*7_$5L;_T"P^]A_JO1
M_P"?C^Y'TM_PEVB_]!6T_P"_HH_X2W1?^@K:?]_17S1THI_\16QO_0+'[V'^
MJ]'_ )^/[D?2_P#PEVB?]!6T_P"_HH_X2[1?^@K:?]_17S12X':C_B*V-_Z!
M8?>P_P!5Z/\ S\?W(^EO^$MT7_H*VG_?T5J12I/&LD;!T8!E93D$'O7RI7TW
MX:X\/Z;_ ->T?_H(K]"X/XOK\2UJU*M24.1)Z-N]WYG@9OE,,MA"49-\S-.B
MBBOU(^9"BBB@ HHHH YSQI,D-G8O(ZHBZA:DLQP /-6MRUOK>]#&WGCF"GG8
MP.*P?&ELEQ:622HLD;ZA:@JPR"/-7J*V;'2[;3BWV:"*W5NHB0+G\J!F=XOL
M]5U'1+NVT?4CI%](F(KT0B8Q'NP1N"<=,\5X?\(/BEJ'A[]FV7Q-XFU:XUS4
M[:\U&W6YN=HENY$O)8HD 4 9.%4 "OHN0%HV ZD8KQ+P_P#LS:7<_"BU\%^+
M9/[4BM]5N=4CDLI9(-KR7,DR8((.5\P#ZBLFFV[=?\_\BDU97[_H_P#@%3]D
MW7?$^JZ%XOB\7ZJ^I:Q:Z[*C;FRL*M'&_E)_LKO*CZ5YU\0/$OB;^T/&_C2V
M\2:E:3>&M<MK"STV&?%F\!*B0/'C#%MW4\C'%>A_#G]GG5?@];^*&\*ZI +O
M5]66[1M1EFG1+8! 4.XD[^&^;W'I5#Q=^SOXEU[Q)K%K9ZU86_A#7-0@U+4(
M)(W-T)(\$K&1\NUBHZU6K<&NR^_W;_J9QT3YM=7]VO\ P#DKWQ;\0_!GCZ2:
MXNKB#^UY)(8Y=1N U@J%E:.2-,_*(XP^[@9. <YKZOT^ZCO+.&:*9+B-U#+)
M&058>H(KQ_XN_ :3QZ\5_;WD+7]HMNMG:WREK4+'('=' Y(?"@\=A7;_  E\
M$S_#[P#I.@W-REU/:(V^2,$)EG9]J@_PC=@>P%5!6C9]/R!_%?N=E1113&%%
M%% !7CW[56FIJWP=UFUET#5O$J.$_P");HDYANI?F_@8=*]AKRG]IO4+72/@
MKXIU"]CU::UM+0SR1Z'/Y-VP4@XC?!P?P-95;*#;-*=^96/SE_X5OI^/^2 _
M%T_]QM_\:_1[]F?3TTOX,^';:/1=3\/(D) TW6)C+=0_,>'8]37Y=#XI>%?C
MSXGO]5T/PO\ &:^O;ALR66C>*H%"$#'$7E[ATK]0OV8;-M/^"OARW?3]<TMD
MA.;3Q).)K^/YC_K7  )_"NA7Y'?R,7;FT/5:***@H\0_:7^*9^'^CV6G6C36
MFJ:W(;6+4EM))X[&/CS)6V*QR!]T=SBJG@SQGX$T;P3H_@OP_)<ZM]LTZZ-I
M;K;R0R78B7,Q)=5(9BW4CDFO=I8(YA\Z*YQQN&:PQX+TIO$MOX@DL(&UBWMV
MM(KK'S)$S!F4>F2!GZ5'+=-/K_EI^)5[--=/\]?P/BJQ\&:;J<.J:3\+=+U:
MQT2?PK.FJZ==+,%BNAM\J-O,',H^8';5[Q#%=_%73K^[T'3KV9-*\(P6EPLE
MK)&?M"R(S1*& W, AZ5]P16L<6[;&J%CDX&,TB6B1[@B(NX\X'6AIOK_ ,/K
M_P#)?@2M+>O_ ,C_ /(_F?-/P[\:V%]\1=?\;B*\C\.:=X>L[*:Y:RF#&8,S
M.BIMW,5R < USGQ=U'_A'_%OQ3,MG=S_ /"9>&K.+1##:R/]IF43JT7"_*P\
MQ#AL<&OKF.SCC0J(T"MU '!H:T21U9XU;:<C(Z?2B4>:R>VOXWO^8XMPNUOI
M^%K?D8'PUTFXT'P)X?TZZ7;<VNGP0R#T98U!'YUN7T4UQ"Z0S- YZ.H!(_.K
M5+6LI<S<NY,5RI(Y/PY:SVGBW6%GNGNV-O;G<Z@$<R>E=96!I_\ R.6K_P#7
MM;_SDK?J1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1132X!(]* '4F:BFNX;>,O+(L:#JS$ 5SM_P"/]*MY
M/+@>2]FZ!+="V?QH Z?</6D9U52S,%4=R:XX:IXEUC M-/BT^%NDMRV6Q]/_
M *U/7P+/?D/JVJSW?<Q1G8E &CJ/C32].)5[I9'[1Q#<3^59Q\5ZMJORZ7I+
MJIZ3W/R@?A6SI_AC3]+ ^SVD2-_?(RWYUJJNW/3\* ./'AK6M4_Y">J&*,]8
MK88'YUHZ;X*TJQ??]G$TG]^4[C70T4 1QP)$H5%"@=A3PH%+10 4444 %%%%
M !1110 5Q7Q<_P"1/F_ZZ+_.NUKBOBY_R)\W_71?YU\QQ1_R),9_U[E^1Z66
M_P"^4O\ $OS/".,<TVG$9 H ]:_A\_:1.]*2*3!I0,4@$..U ZT8- Y^M, X
MS0?:@ T8- "@^M!-!%(!SS2 !R>:7 H.!]:4=* $P*3H:7/-+B@!#TKZ9\-?
M\B_IO_7M'_Z"*^9FZ5],^&O^1?TW_KVC_P#017[OX4?[UBO\,?S9\/Q3_"I>
MK-.BBBOZ1/SP**** "BBB@#G_%__ ![Z?_V$;7_T:M;_ *U@>+_^/?3_ /L(
MVO\ Z-6M_P!: %HI"<"HA<KDCD?48H E(!I @!S0DBR#*FHS<H"1SQ0!*5#=
M: ,5&EPKCC/Y5(#N (H 6BBB@ HHHH *X;XQ^(M;\)_#S7=6\-Z/_P )!KMK
M:M)::9@G[0_9>*[FN7^(OC+3_A[X2U7Q)JA86&FV[7$VP98J.P]ZB?PO6Q4?
MB6ES\L_'B_%WXY3^=X\^"NIZ(/,#?\4?H$$%X0.YNY69P?<**_2']F73SI7P
M6\-V;:=K6E-#!L-KXAG\^^3#'B5\#)_I7A@_:W^+=S"->M?@/J4O@TQ?:A=-
M?(+IH,9WB/IG;SBOIGX5^/=,^*'@?2O%.CES8:E L\:R##IGJK#U!R#6D5RQ
M<4K?UU,V[R3;.MHHHI%!1110 4444 %%%% !1110!S^G'_BL]7_Z]K?^<E=!
M6!I__(Y:O_U[6_\ .2M^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HI"P%)YB@$DX'J: '45D:EXGTS3 ?/NT#?W5.6_*L1_&=S
M?G;I6F3W!/\ RTE&U10!V.:I7NL6NGHSW$\<2C^\U<X-'\1ZN/\ 3+]+*(]8
M[<?-^=6K/P#IMO()9D>[F_O3ONH AG^(-O(YBT^UN+Z7ML3"_G43?\)1K Z6
M^EPGO]YZZRWM8[9-L<:1J.@08J7 H Y&V\ 6LT@DU"ZN+^3J?,?"_E71V>D6
M>GJ%M[>.$=/D4"K=+0 Q8PISBGT44 %%%% !1110 4444 %%%% !1110 444
M4 %<5\7/^1/F_P"NB_SKM:XKXN?\B?-_UT7^=?,<4?\ (DQG_7N7Y'I9;_OE
M+_$OS/!P32G/:D]/6G5_#Q^TB#/>ACBC(I: $'(H Q]: 12YH :210":=2<4
MP FDR:#R:4CBD AI1TIO2ESFF $\TH/K2"C&30 $U]->&O\ D7]-_P"O:/\
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M,$FMU>TOE^O]>M[:&'6*]?T_KTM<]0HHHJ2RK<WR6FYI62-!_$[8%(MV74$
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MJ"02HCNBEVVJ&;!8^@]:^>_@MH%IX ^,.J^']%4V>DW/A^SOWM%8[//+,K2
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MK$[?M N)<X$< +$U03P&UX^_5-2NKX]?+W;$_*MS3?#UAI@_<6<41]0N3^=
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M?YW&X9X;&.*]KHH:3M?I_7Z@M-%_7]612T?28-$TZVL;50EM;Q+#&@'W548
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M)?F>$9P*!0?NTG(K^'S]I%VTM)NHSCK2 ;C)I=OTI2*3FF H&!2$YHYH'6@
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M\7_$#1M:?PGK/C_P9!9M"VA:)JWV*5)]V0Y&0'&.*X?]G+X.>(],^-'AG6]
M^'GB/X5Z';-)_:<7B'7!<_;E*G:BQ GD'G-31Z+S?YO?]+=+(JH]_3].G_!Z
MGZ)44458@I#T-+7->._&UC\/O#MWKFI_:#86BAI1:V[3R<G'"J"3U]*3:6K
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M'_79?YU].+7]$^%=2=3#XKGDWK'=^3/@.)XQC4I<JMH_T'4445^ZGQ(4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<5\7/\ D3YO^NB_SKM:XKXN?\B?-_UT7^=?,<4?\B3&?]>Y?D>EEO\
MOE+_ !+\SP@&D(Q2@YH(S7\/'[2&Z@C-(.M*U,!0,4A.*%I&ZT@%W4;J!THV
MTP#/&:4<TTC%)0 K#O24J]:#UH0"@TI&:1::>M "XP*^FO#7_(OZ;_U[1_\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<5\7/\
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M )]1^Y"_MC,?^@B?_@3/>_\ AN'XN_\ 0>MO_ "'_P")H'[</Q<_Z#UM_P"
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MQH__ '__ /K4A_:5^&'_ $/&C_\ ?_\ ^M7Y(XI,"E_JUA_^?DOP#_7;%?\
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M/.*/XE+T?YCJ***_>3X<**** "BBB@ HHHH **** "BBB@ HHHH _,#]N/\
MY.(UK_KWMO\ T6*\#KWW]N/_ ).(UK_KWMO_ $6*\"K]BR[_ '.E_A7Y'\W9
MQ_R,<1_CE^84445Z)Y 4444 &**** "BBB@ HHHH **** "O6?V9Q_Q<4_\
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MQ12LK6#K<R_#WARP\+:9#IVEVD-C8P+MBMK= B(/0 5J444]P"BBB@ HHHH
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M.@_\"1_A2_U(XA_Z!']\?\P_MG ?\_5^/^1S-.S@"ND_X5?XL_Z!T'_@2/\
M"C_A6'BP?\PZ#_P)'^%'^I/$/_0(_OC_ )A_;. _Y^K\?\CFVI*Z7_A67BS_
M *!UN?\ MY'^%)_PK#Q9_P! V#_P)'^%'^I'$/\ T"O[X_YA_;. _P"?J_'_
M ".;W9HKI/\ A6?BH_\ ,.@_\"1_A2CX9>+,?\@ZW_\  D?X4?ZD<0_] K^^
M/^8?VS@/^?J_'_(YM>E(3S72CX9^*R?^0=;_ /@2/\*#\,/%A_YAT'_@2/\
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M?_7O;?\ HL5X%7V[^T#^RMXY^,'Q.O\ Q-90V=E!<11((9I\L-J@'D"O.?\
MA@3XB_\ /33C_P!MC_A7Z;@LUP5+#4X3J6:23W[>A^'YGD&95\;6JTZ3<92;
M6JV;]3YHHKZ8_P"&!/B+_P ]-._[_'_"C_A@/XB_\]-._P"_Q_PKL_MC ?\
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M]\?\Q?VUE_\ S]7X_P"1S@Z&@"NE'PR\6'_F'6__ ($C_"@_#'Q9C_D'6_\
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M2#4+*WEM(T9K=[>8@M&\9VLI(ZX(ZUV%;-6(3N%%%%(84444 %%%% !1110
M4444 %%%% !1110 F :-H]*6B@ I",TM% '/Z<,>,M7_ .O:W_G)705@:?\
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M .3D==%10!SO]M:__P!"[_Y.1T?VUK__ $+O_DY'7144 <[_ &UK_P#T+O\
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M"V/_  ,CKI:* .:_M77?^A;'_@9'0=5UT]?#G_DY'72T4 <U_:NN_P#0N?\
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M-9_Z%^;_ ,"8O_BJ .AHKGO[7UG_ *%^;_P)B_\ BJ/[8UK_ *%^7_P)B_\
MBJ .AHKGO[8UK_H7Y?\ P)B_^*H_MC6O^A?E_P# F+_XJ@#H:*Y[^U]9_P"A
M?F_\"8O_ (JC^V-:_P"A?E_\"8O_ (J@#H:*Y[^V-:_Z%^7_ ,"8O_BJ/[8U
MG_H7YO\ P)B_^*H Z&BN>_M?6?\ H 3?^!,7_P 51_;.L_\ 0 E_\"8O_BJ
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M#UQ<V[SS1]$DC=W$7N0Q!KTK^U]9_P"A?E_\"8O_ (JC^U]9/7P_-_X$Q?\
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M1A H*QCH!G@5O>'_  I\4()]>\62Z#96GB.WT*+2=,T_[8&2:53S(S8^49Y
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MN*,4 8?]O:F?^9<O/_ BW_\ CE']O:F/^9=O/_ BW_\ CE;F*,4 88U[4_\
MH7+S_P "+?\ ^.4?V]J?_0N7G_@1;_\ QRMS%&* ,!];U*1<-X=O,?\ 7Q;_
M /QRHFU"]< -X;NV .1F>W.#_P!_*Z3%<;\6?&DOP^\$:IKL%M]KFM(MR0EM
MH9N@R>P]:3=E<:+YU/4#_P R[>_^!%O_ /'*!J>H Y_X1Z]_\"+?_P".5Y[\
M&/BAX@\9ZOJND>((=,-Y:0PW*7.DRL\+)(,A3N_B%6/B'\3O$G@[X@>%M'@\
M.I+H>K7L=G+JTUT%*NP)VI&,DXQU.!36K2770AR2BY/9'>?VGJ./^1=O0/\
MKXM__CE-&IZ@!C_A';W_ ,"+?_XY7D?B3]H&]\+_ !(OM*O+>W&DVS>2(48_
M:F;86#^FTGBO;-!OGU*PM[F2&2W::-9##*063(S@X[TD[JZ+>CL5$UK4T7 \
M.WA^MQ;_ /QRE_M[4_\ H7;S_P "+?\ ^.5NXHQ3$87]O:G_ -"[>?\ @1;_
M /QRC^WM3_Z%V\_\"+?_ ..5NXHQ0!AC7=4/_,N7G_@1;_\ QRC^WM3_ .A=
MO/\ P(M__CE;F*,4 8?]O:G_ -"[>?\ @1;_ /QRD_M[4_\ H7+S_P "+?\
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M ,<H_MW4Q_S+EY_X$6__ ,<K<Q1B@##.O:G_ -"Y>?\ @1;_ /QRD_M[4_\
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M_H7K_P#.'_XN@ZU==?\ A'K_ /.'_P"+J]>;F>_]/\165N7H?*/C/X1>,O\
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M/^@!J'_?4/\ \70!MT5B?\)!>?\ 0 U#_OJ'_P"+H_X2"\_Z &H?]]0__%T
M;=%8G_"07G_0 U#_ +ZA_P#BZ/\ A(+S_H :A_WU#_\ %T ;=%8G_"07G_0
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M_:0_Z)]X8_\ !P*/^$R_:0_Z)]X8_P#!P*!V/HBBOG;_ (3+]I#/_)/O#/\
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M_"9?M(?]$^\,?^#@4 ?1%%?.W_"9?M(9_P"2>^&?_!P*7_A,OVD/^B?>&/\
MP<"@#Z(HKYW_ .$R_:0_Z)]X8_\ !P*1O&?[1X_YI_X9'_<8% 'T317SO_PF
M7[2'_1/O#'_@X%'_  F7[2'_ $3WPQ_X.10%CZ(HKYV/C+]I#_HGOAG_ ,'
MI?\ A,OVD/\ HGWAC_P<"@1]$45\[_\ "9?M(?\ 1/O#'_@X%'_"9?M(?]$^
M\,?^#D4#L?1%%?.__"9?M(?]$^\,?^#@4?\ "9_M(?\ 1/?#'_@Y% CZ(HKY
MW_X3+]I#_HGWAC_P<"C_ (3+]I#_ *)]X8_\' H'8^B**^=_^$R_:0_Z)]X8
M_P#!P*/^$R_:0_Z)]X8_\' H ^B**^=AXR_:0_Z)]X9_\' I?^$R_:0_Z)]X
M8_\ !P* /HBBOG?_ (3+]I#_ *)]X8_\' H_X3+]I#_HGWAC_P ' H"Q]$45
M\[_\)E^TA_T3[PQ_X.!0?&7[1^/^2?>&1_W&10!]$45\[_\ "9?M(?\ 1/O#
M'_@X%(?&7[2'_1/O#/\ X.!0(^B:*^=AXR_:0Q_R3[PQ_P"#@4O_  F7[2&?
M^2?>&/\ P<"@#Z(HKYV/C+]I ?\ -/O#'_@X%*/&7[2'_1/?#'_@Y% 'T117
MSO\ \)E^TA_T3[PQ_P"#@4?\)E^TA_T3[PQ_X.!0.Q]$45\[_P#"9_M(?]$^
M\,?^#@4A\9?M(?\ 1/?#/_@X% CZ)HKYW_X3+]I#_HGWAC_P<"C_ (3+]I#_
M *)]X8_\' H'8^B**^=CXR_:0Q_R3[PQ_P"#@4#QE^TA_P!$^\,?^#@4"/HF
MBOG?_A,OVD/^B?>&/_!P*/\ A,OVD/\ HGWAC_P<"@=CZ(HKYW_X3+]I#_HG
MWAC_ ,' H_X3+]I#_HGWAC_P<"@+'T117SO_ ,)E^TA_T3[PQ_X.!1_PF7[2
M'_1/O#'_ (.10!]$45\[_P#"9?M(?]$^\,?^#@4?\)E^TA_T3[PQ_P"#D4"/
MHBBOG?\ X3+]I#_HGWAC_P ' H_X3+]I#_HGWAC_ ,' H&?1%%?._P#PF7[2
M'_1/O#'_ (.!2?\ "9?M(?\ 1/O#'_@X% 6/HFBOG8>,_P!I#_HGWAG_ ,'
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M/+48PH';I2>1$JE1&H4G.,<444 !AC<;612,YP12F&,N&**6'?'-%%  T,;
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>dkdcu-20230331xs4a037.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a037.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %N Z@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Y,HHII&*_
M<#Y\=0#FDSGM2@8H **** $(S2CBBB@ HHHH :!FG444 (U"TIYI,8H&+10*
M*!!2$=Z6B@ '2BBB@ HHHH ****  G%!IN*7;0,4#%%%% @HHHH *,<YH- Z
M4 %%%&: "C-%)MH 6@#%%% P(YHHHH$!XI <TN:* #'.:*#10  <T444 %%%
M&:  G%- I2,T#CO0,6BB@\B@044@&*6@ HI,\XI: "BC&#1F@  Q11FB@ HH
M(S10 449HH **0C-+CC% PHH'2B@0 <T444!8**** "@#%%% !1110 4444
M%(12T4  Z449H YH ***"<4 %%%% !03S110 4444 %%&:* "BBB@ HHHH *
M*,T4 %%%% "'[U+2$9I1QWH&%%!Y% XH$% '-!Y%% !111F@ HHH Q0 4444
M %&.<T49YH **** #&:*** "B@"B@  Q12'- Z4 +1110 4444 %%%% !111
M0 48S110 44$\T$\T %%%% !1110 4444 !&:3I2T$9H **** "BBB@ HHHH
M :>M.'2C'-%  1FDP*4T8R* "BBB@ H(S110 8Q1110 FVEZ44'I0![[^R_^
MRR/VCK7Q'-_;YT4Z0J-@6_F^9N#?[0Q]VO#=9L/[)U>^L=_F_9IY(-^,;MK$
M9Q^%?>'_  2]_P"09\1O^N4/\GKX:\8G'C#7?^O^?_T8U>/AJ]2IC*]*3]V-
MK?-&\XI0BT>]?LP_L@)^T3X6UC69/$_]A)I]R("AMO,!&T-NSN&.M=1X^_8C
M\*^#/!^JZU;_ !9TO4Y[*%I5M(A%NE(_A&)"<_A7KW_!-FT2_P#@YXZMI9?(
MBFNVC>0]$!A )_#K7B7QA_95\#> _ FLZ]I7Q4L]>U"U4O'I\0CW2G/3AR?T
MKRGBZLL;.BZKBDTDE&_X]#H4(JFG8YKXI?LG'P)\%-#^(^F>(/[;T_4 C20_
M9]GDAAZACG!XKC?V<?@/>?M!_$ >';>].FV\<#7$][Y?F",#@#&1U-?5?[*.
MHK\:_P!E#QG\.KUA->:9'(]J&Y.TC<F/HP/YTS]BK1U^#GP,^)7Q)U",1301
MS0P%QC/E @ ?5R!5RQ]>E1K4Y.]2,K+Y[$JG&4HM;'D?PY_8UL?B/\8_&?@B
MQ\8XA\.*N[4/L>1,^<,NW=Q@]\]J[76O^"?_ (5T:UO7?XP:5]HM4=FMV6)6
MW*"=N/,SGC%:/_!,^_FUGXE^/;VZ<R7%W:":60\DLTI+'\R:/C+^R9X"EU3Q
M;XB/Q8LDU(O-=?V9B/<'Y/E_?SG/'2L*N+KPQ3H3K.*26T;W=M>FA:A%PYE$
M\A_9A_9-7]HVX\3H/$?]C+HTD:!A;^:)0V[G[PQ]W]:]+UG_ ()O75UIMW<>
M$/'^E^)+FW!W6P0+\P_AW*S8/U%=C_P2RC_=?$5 <C=:J#^$E=O\#OV?)?V7
M=?\ %7Q#\6>++4Z08Y<P6S,4PSY^;W[8J,7F%>EB:L(U;<MK*U[W6P0IQ<4[
M'YJ:[HMYX<UB\TO4(6M[VTE:&:)NJL#@BOKCX2?\$\[GXC_#'3/%%YXH.DWN
MH0-/#I_V4/E?X?FW#KQV[UXIJH'[0'[2,@TF!A#KVKCRTQR(RW+'_@()K[N^
M*WC[5?A?\>OA'X;T:PNY/#VFP_9[XP0L8BDP$?.!CY<!OPKOS#%XB*ITZ+Y9
MM.3^2V^;,Z4(W;EJC\Q-=T:X\/:W?Z9=J4N;.=X)%/9E)!_E7OWP"_8G\4_&
MS1DU^YO8?#?AMLE+VZ0LT@'4JN1Q[DBMC]NSX4Q>#OVB$O8(?+TSQ*4NQ@<>
M86"RC\^?^!5[U^W/XFO?AQ\!?!7A/P](=-T^_2."7R#MS&J#Y>.Q)R:=;'U*
MM.A'#NTJG7M;<4:23DY=#R_Q!^P3X3BT'5;W0OB]I=_<Z;;R7%Q$XC8!44LV
M=CDCH>QKQ;]F+]GC_AHOQ;J6B_VU_8HL[0W7G"#S=_S 8QD>M>P:5_P3@\:7
MVF)?6WBS2@DT D94=\[67.#@5>_X)HV;6'QE\6VKD,T&G/$2.Y60#^E8O%RA
MA:TZ=?GE&W2UBE!.<4XV/%?AW^SF/'?Q[OOAN=:-I]FDEC^W^1NW;/\ 9SW^
MM;?[4'[(6I_LY6^EWZZH=>TB])C:Z$'E>5(/X2,GJ*]-_9X/_&>>N>OVF[KZ
M%M?$NF?M'7/Q2^#?B=T;4=.O)O[/G. WEYS&X]T;CZ5&(S#$4,1%WO!13DO7
M2XXTXRBUU/B+X(?LO#XQ?#'Q;XN_M\Z8=!5F^RBWW^;A"W7<,=*\W^%/PG\1
M?&3Q7!H'ART^T73C=)(QQ'"G=F/85]M_LL>%-0\ ?!3XX>&]5B,.HZ;)-!*A
M'I$V"/8CD?6H?^"=EE;Z!\)?'GBB&)6U.)6VN1D@(A8#\ZTJ9C4IJO.+O9Q4
M>VJ)5)-Q3.8'_!.WPUH,4%KXI^+.G:3K,R@K:E(T&?;>X)'OQ7S3\?O@\GP.
M\?-X:77;;Q !;I<"YMEV@*V=H89/.!G@GJ*]&^&?[/7B[]K34/$7BAO$MK#>
M1W[12?VA(Q=F/(VX[<XKAOVB?@-K7P!\4Z=I&N:E!JES>6GVE)8"Q"J&*X.?
MI75A*DXU_95<1S2MK&UM?4F:7+=1LCRFOJK]F[]AN?X[> 3XGO?$;>'X9;AH
M;:+[,)/-"]6R6'?/Y5\O:9IL^L:E:V-JADN;F588T'=F. /UK]*/C+J>K_L]
M?#_X->'/#5C=7#Z=?07EZ+2)F#(@Q(K8'\6]JO-,15IJ%&A*TY/\$A481=Y2
M6B/SU^)G@2[^&7CW6O#%Z2\^FW#0F3;C>!T;'N,&N8-?9_\ P4H^'45AXR\/
M^.[*$I:ZY:B*X;;C]Z@RI/N5Q_WS7Q@>*[<%B/K6'A5ZM:^O4SJ1Y)M'T/\
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M3M(&W&1ZU]$?\$P_$U_+XG\4^'9)WDTJ2U6X\EB2BOG!(';(JU^QWI-MX?\
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M@ HHHH ****  9HHHH 0YS2T44 &:*3!S2\Y]J "D).:#F@<')H 6BC.:*
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MZ*** "BCO10 F.:6C.:"<4#"B@G H!S0(**** "B@'-% !1110 'I2 <TM%
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MHEW<>'[*01SWJ1DHK?U [GM7J_[*G[*FK_'SQ'%>7D,MEX0M) ;N](QYN/\
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MLDDL-W+"GFKM*H'.!6M#%RK5?9\MM-=>I;I)4^>_;]?\CA**,45Z1S!0:**
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M11S 2;J-P]*CHI\P$F_%+YGO45+GBGS"L2AR>]+O.*AW4;JI3%RHG$@I=XJ
M&EWT^87*B<$&EJ#?3E8^M5S(GE9+24P28[4X,#3N)IH=FC)I,T4R3Z*_92.8
M]:]<I7L7B?P#H?BR)EU'3XIF(_U@7#C\:\7_ &4R?-UI>G"5]%5_&W'.(K87
MB?$5</-QDN75.S^%=C]^X;I4Z^34H58IK71^K/G'QC^R_/$[W'A^\$L?7[-<
M<,/H:\=\0^"M:\*S%-2T^:#T<KE3^-?>%5+[2[;5(&@NX(YXF&"DBY%>SDWB
M?FF!M3QR5:"ZO27WK?YKYG#F'!V#Q%Y89^SE]Z^X_/\ HKZL\8?LVZ#KA:;3
M7?2KD_PIS&?P[?A7BWC'X%^)_"B//]F_M"T7DS6WS$#W7K7[GD_'629Q:$*O
MLYO[,]'\GL_O/S?'\-YC@+RE#FBNL=?^">>4 YI65D8JRD,.H(I*_04T]4?+
MA2#FEH Q3 *".:** "BBD/!S0 M% YHH **** "K-KJ5Y8P7$-M=S6\-RNR>
M.*0JLJYSM8 \C/8U6H)HM<"\=<U$P64/]H77DV+%[6/SFVV[$Y)C&<*20#D=
MZG;Q9KCWVH7C:SJ#7>H!EO+AKIS)<AOO"1LY<'OG.:RLT5/+'L.[.BL?B-XL
MTO16T>S\4:S::2RLK6$&H2I 0WW@8PVW![\513Q5K<=_97R:SJ"WEBBQVMP+
MIQ);J!@+&V<J!V Q3]6\)ZOH>EZ9J5_8R6UCJ2&2TF?&)E!P2/QK(J(JG*[B
MD.[+5MJE[9:@E_;W<\%\DGFK=12,LH?.=P8'.<]ZT],\>>)M%FOI=/\ $6K6
M,M_G[6]M>RQM<9Z^80PWYR>N:PJ*IQB]&A)M:HN:9K%_HFIPZCIU]<V&H0OO
MCN[:9HY4;U#J00?<&MA_B5XOEUJ+6'\5:V^KQ(8X[]M1F,Z*1@J)-VX#VS7-
MT4.$):M!=FS-XU\17&JW&J2Z]J<FI7$9BFO&O)#-*A&"K/NR01Q@G%0+XEUA
M+6PMAJMZ+>PE,UI"+A]EO(2"6C&<*20#D8/%9M%')%= YF=!I?Q#\5:'J%[?
MZ;XFUC3[Z^8O=W-K?RQR7#$Y)D96!8Y).3GFIK+XG^,M-DNY+3Q;KEK)=L7N
M&AU*9#,QZER&^8^YKF:*3IP>\4/F?<D^T2B?SA*XFW;_ #-QW;LYSGKFNBN/
MBAXSO-2M-1N/%VNSZA:*5MKN74IFEA!QD(Y;*@X&<'M7,TA--PC+="N:&MZ]
MJGB;4'OM7U*[U6]< -<WL[32,!TRS$FN\U7X[Z_-\/\ PWX5T?4-4T.TTRWG
MM[D6=_)''>"1R3O12!C!*X.:\T!S3X8GN)5CB1I)&X"(,D_A42HTY6YEMJOR
M*4I)Z,LG6=0.E'3#?7)TTR_:#9^<WD^9C&_9G&['&<9K1B\>>)H-!.AQ>(M5
MCT5AAM.2]E%N1U_U>[;^E8; HQ5A@@X(/:DJW"+W1-VBU'JEY#836,=W.EE,
MRO+;+*1'(R]&9>A(R<$U8/B;6#'IR'5;TIIN?L2_:'Q:Y.X^6,_)SS\N.:S:
M*?+'L*_0Z34_B5XOUME;4?%6M7[*ZR W.H32$.IRK?,QY!Z'M6==>)]9O;6Z
MM;G5[ZXMKN?[5<0RW+LDTV,"1U)PS8)&X\UF4#)P ,D]JE4X+9(KFEW.P\*_
M$*\TK7H=3U/4]>GGM[7[+;7-AJCP7%N@&%5)#DA1D_*..:T_BU\7KGXG0:#:
M%;P6FD6YA274;LW-S.Y.6DD<XR>WT%>?S0R6\ACE1HW'57&"/PIE9^PIN:J6
MU6P*3C=+^MO\B\VNZF^G6VGMJ-VUC;2&:"U,[>5$YZLJYPI.!R.:U]3^)WC'
M64*ZAXLUR^4JJE;G49I 0"& Y8]" ?J :H?\(KJW_",#Q%]AD_L4W/V3[9QL
M\W&[;]<<UDU?+3F]D[!=K8W]8^(?BGQ&+0ZMXEU?4_LC[[?[9?2S>2WJFYCM
M/N*J^(/%FM^+KB.XUS6=0UJ>-=B2ZA=/.RK_ '07)('M65CC% XJE"$;60<S
M[A11CG-%62%%&>** $Z4H.:",T4 %%% - !1110 'BD')S2XYS10 4444 %%
M!I <F@ SFEI-M+0,****!'MG[&'_ "<KX*_Z^C_Z":_9D]*_&;]C'_DY3P5_
MU]'_ -!-?LSUK\ZXCUQ,?\/ZL]3"_ S\L?\ @I9S\<[/_L')_,U\C[J^M_\
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M@Y/S?^5CR/3?V9/"5F5-P;R\8=0\NU3^ %=3IWP<\&Z8!Y6@VCL!C=,ID/\
MX]FNSHKY3$\1YQB_XV+F_P#MYI?<K(]NCE& H?PZ$5\E^I3T_1K'28]EE:06
MB]Q#&$!_(5<%%&:^?E.4Y.4G=GJQC&"M%60X#I01FDQQ0#4E 1Q364-@'&/0
MTX\]J <&D!QGBWX1^&?&*L;S3HXKDCBXMQY;@^^.OXUXKXO_ &8]2T]9)]"N
MEU", GR)?ED^@[&OI+4=3MM*MWN+N>.W@099Y&P!7SK\4/VB9[J2;3O#;&&
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M04X\R;VLOT/:]8T#P)\,3X-TG5[32KC2-2T&._O[F:"22]EEE#?-$X7 "D
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M9<$;@L2* 3N.<=>^:XRO1PM&5%2YNKO^"_R(G+FMY?YM_J%%!I,UVF0M%%%
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M_->/.0D.\-L5%'!X]<U#9_"E/B-I7@G39=4O8H-8\5:C!/$)-T44<?S,R(>
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M2C?3-0IQ;Y4]2M4>R?L8?\G*^"O^OH_^@FOV;/2OQB_8N;_C)?P5_P!?1_\
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M&#CSZ?UJ:O5'J7[%S#_AI;P2!_S]'_T U^SQZ5^+O[%AQ^TQX)/_ $]'_P!
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MOB50QPY&-VTYQ7:>"/@[IWCJ7P!;^++JQLM/O?#ES>VBZ5:M',XC9AF9^=S
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MVFF^,I()K:6-%>2!HW5@&7(R#CL:[*SJU5"=*]K:]_BC^ERZ?+&H^?;3]?\
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MM5]8AAX[N2W\]-O^"**BY+FV)]._9SN;F;1M*N]>L[#Q3K%B-0LM'DC<L\3
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MHPO)KJ32KBTDE$=K&F]I<D! Q4]\=?6N4^(=HMIXLO41I,-M?;-C>N0#M;
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M6EVLB6DI(^60C[OH#TS5C]HWP3I/P]\<W>A:1_9YMK1E13;SF2?_ %:DF4=
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ME\&_ _AOXAWM[I]^+Z"XM-.N+YI867:YC0L  ?7%<)XK\.GPIKUUI9O[/4S
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MTM[<1L/++22,C9]1P*\\\/>/O$GA2XFGTC6[ZPEFC,,CPSL"R'J#S76^ ?C
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MJS10YYI:"<45H(****!!1110 4A'I2YYHH 0D@4HHQFDYH 6BBB@ HI-PI:
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M@DD4F.14P2C:0>U*Q=T/&X?Q5 R98U/R>U)LSUJK7)6A&I91C.!2D[^O-/V
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MTX$$WFR,[+.N<%BV0,\XQQ7@^F?$2ZT3P+JOAJPM(;9-5=#?7H),LR(25C]
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M_+;O\A*DM7?K;\[?>?/.I>$YM,\/:5J[75M-'J&_;!%(&ECVG'SKVS6*T;H
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MUH)& (A"IE\>G!KY@VBO6OAY^S_/XY^'=YXQN=?L-$TFVOOL+-=[LF3:&&,
M_P!ZO-K8:A3AK[J;7WFT9-GN_C7]H>1M/^,B6/B9 S:A"=%$;+\J<;C%QQ[X
MJ_J/BCPIXC\;:]XBM?$<4?B+^PM/2$)??9(YY/E\\NX') &<=Z^2+CX9Z^UQ
M$+#3[C4K2YN6MK2ZMHRT=PRG^$T^P^$OC'4K>_N+7P]?S06+,EQ(D1VQE?O
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M^,W[&/\ R<MX*_Z^3_Z :_9D]*_.^(_]YC_A_5GJ87X&?+O[1ZC_ (3B(_\
M3N/YUY1T&:]7_:0_Y'>+_KW6O)]PQBOY&S[_ )&=?_$S^@<D_P"1=1]!=U0W
M5Y%9023SR+%%&"S.YP /K5?5M8M-#L)KR\F6"")2S,QKY4^+'QJN_&T\ECIY
M:UTE6QC.&E]S[>U>OPSPMC.)<1R45RTU\4GLO3N_(QSC.L/E%+FJ:S>T>_\
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MVI:EJ<=^UW!IRV2PA,D$@*NYR3R?UJ)4,1&25[Z^>GO7[6V_X E*$K_UT?\
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M6^O:3X@WSRC[TUF\A#D_[N*\LE^-GC&7^Q\:HL*Z/<&ZL$@MHHUMY",$JJJ
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M^/W_  P7\8?^A>'_ '^3_&@_L%_&#_H71_W_ %_QK]@<"C H_P!8,5V7W?\
M!#ZK _'W_A@OXP?]"ZO_ '_7_&F_\,&?&#_H7!_W^7_&OV$P*,#TH_U@Q79?
MU\P^K0/Q[_X8+^,'_0NC_O\ +_C1_P ,%?&#_H75_P"_Z_XU^PE&!Z4O]8,5
MV7]?,/JT.Y^/?_#!7QA_Z%T?]_E_QH_X8*^,)_YEP?\ ?Y?\:_86BG_K!BNR
M_KYC^K0[GX]#]@KXP?\ 0N+_ -_E_P :7_A@SXP?]"XO_?\ 7_&OV$I,#TI?
MZP8KLOZ^8?5H=S\?/^&"_C!_T+B_]_U_QI#^P7\81_S+@_[_ *?XU^PF!Z4M
M/_6#%=E_7S%]6AW/Q['[!7Q@_P"A<'_?]?\ &E_X8*^,'_0N@?\ ;=/\:_8+
M HP*/]8,5V7]?,/JT#\?O^&"_C"/^9='_?\ 3_&C_A@SXPX_Y%T?]_U_QK]@
M<"C H_U@Q79?=_P1?58'X_?\,&?&'_H71_W_ %_QI/\ A@WXP_\ 0NC_ +_K
M_C7[!8%&!1_K#BNR_KYA]5@?C[_PP=\8<X_X1T?]_E_QH_X8-^,7_0NC_O\
M+_C7[!8I:/\ 6#%?RK\?\Q_5H'X^?\,&_&+_ *%T?]_E_P :/^&#?C#_ -"Z
M/^_R_P"-?L'13_UAQ7\J_'_,/JT#\??^&#/C#_T+H_[_ *_XT?\ #!GQ@[^'
M1_W^7_&OV"HI?ZP8KLOZ^8OJL#\??^&#?C!_T+@_[_K_ (T?\,'?&'_H70/^
MVR_XU^P5)M%'^L&*[+\?\Q_58'X_?\,'?&$?\RZ/^_R_XT?\,'?&$]/#H_[_
M *_XU^P5%/\ UAQ79?<_\P^K0/Q^'[!WQA_Z%T?]_P!?\:/^&#OC#_T+H_[_
M "_XU^P-%'^L6+[+\?\ ,/JL#\?O^&#OC#_T+H_[_I_C1_PP=\8?^A<'_?\
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M8MN)P0HYQQ1]2P#5_9K[@YZG<]__ .'C7Q8_OZ;_ -^#_C1_P\:^+']_3/\
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MGU*/^"C?Q8/5],_\!S_C1_P\;^+'][3/^_!_QKY:HH_LS!_\^D'MJG<^I?\
MAXW\6/[VF?\ ?@_XTG_#QKXL?W],_P"_!_QKY;H)Q1_9F#_Y](/;5.Y]2?\
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M%%% !11G-!.*  \4=:,YHH **** #-&<4#&:,9H * <T4@&* %HHHH ****
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94$\T %%!.*0GI0.PM%'6B@044'BB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>dkdcu-20230331xs4a038.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a038.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *G V # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]GM+5F7R&&0X)QD8J7Q1XZM/[!NO[,DNKFY?3S>QR6,89HXRN5<[O7CCD^U
M':45YUX5^(J6OPZT/4=3-UJ-X=+BO;Q[>-695*@M(PR._8<^U2>,_B-9R>$-
M2GT.XN;FX&FF^CN+!%<PHRY1R&]?3!/M0!Z#16%X#OI]4\#^'KRZD,UU<:=;
MS2R'&7=HE+$X]236[0(*X'Q-X9URX^)6A^(]/M[2YMK"RGM7BFN#&[F0J<CY
M#TV_K7?5RVN>/8]&\6:?X>72[R^OKZ"2YB,!C";$(#9+.,'YA0,Q_&'A[Q-X
MOT(V\D%C;2IJ5G=10BX9E$<,R2-EMG+-MQTXK#\6?#/7]=TCXA6D LT?Q#-
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MB3R<@8XJYG- A:*0$'I2T %%%% '$_$'PSJVO:EX=N=-BMI%TZ\%S*)YBA8
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M'4L&BGCSAD7:0K=AM..<GV2H4L[>.=ID@B69N&D5 &/U-34( HHHIB"BBB@
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MW$ G<YR"9I80!@Y59.FTD '=_P#" >'/^@/:_P#?%'_" >'/^@/:_P#?%/\
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MH** .?\ ^$ \.?\ 0'M?^^*/^$ \.?\ 0'M?^^*Z"B@#G_\ A /#G_0'M?\
MOBC_ (0#PY_T![7_ +XKH** .?\ ^$ \.?\ 0'M?^^*X#5/"ND1?';PYIJ:?
M"MA-X>U&XDMPOR-(EQ9JK$>H#L!_O&O7Z\UUC_DXOPM_V+&J?^E5C0!U7_"
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M!80Q6UU/<">)5PL@$1(SZX->@_\ " >'?^@/:_\ ?%<G\0O^2J_#G_KXN?\
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M>7-_\:?#'B?1;BWT7Q+JTNH6^K,T?V9XI+>"-0IW[_,#(Q^[@;>N2,_0*J%
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MW= 'SYI'@[Q#I7QH74=#@U:TTB[U6>;6-+U2(266/+(6[M9?X68A04!SRV5
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MD, @W$^4.A&-WMR )^U'\5I$^$/Q(M_#D6L->Z#:[+C5=+F2%;.<@,%)WJS
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>:ZQ_R<7X6_[%C5/_2JQKTJO-=8_P"3B_"W_8L:I_Z56- 'I5%%% !1
M110 4444 %%%% !7GGPG_P"0]\3/^QH;_P!(+*O0Z\\^$_\ R'OB9_V-#?\
MI!94 >AT444 %%%% !1110 4444 %%%% 'F?Q"_Y*K\.?^OBY_\ 1+5Z97F?
MQ"_Y*K\.?^OBY_\ 1+5Z90 4444 %%%% !1110 4444 %%%% !6!X]\8VO@#
MP=J_B&\BDN(=/MVF%O ,R3OT2)!W=V*J!W+"M^O*?B'=7_B_Q]H?A?1KZUL)
M]-/]L7,FH:=+=0.RY6%,+)%D@DO]_@JIQ0!VOP_\;:=\1O!&A^*-)?S-.U:T
MCNX<GE0RYVGW!R#[@UK0WMEJ:3)%/!=HA,<JHZN >ZL/Z&OCW3(_&'@3X?\
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MM[*WM-WD010[CEO+0+D^^*\>^ D/A?5-;U_Q+X6O==O(-4AMQ<G4;=+6W61
MPPD*Q1XDP1N..>/2O:*!!1110 4444 %>9_%W_D;OA+_ -C2W_ILOZ],KS/X
MN_\ (W?"7_L:6_\ 39?T >F4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>:ZQ_R<
M7X6_[%C5/_2JQKTJO-=8_P"3B_"W_8L:I_Z56- 'I5%%% !1110 4444 %%%
M% !7GGPG_P"0]\3/^QH;_P!(+*O0Z\\^$_\ R'OB9_V-#?\ I!94 >AT444
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MHFQ-:JVTRQ\?,H/''J*\O\(?##QEH=I\(4?28(I_#5GJ%O?,;J-EC>:+9&0
M?F&[!..U9WAKX9^/8O&.F^(-2T)/M7_"*7FBWK'44;==/)&ZM&OW4C.P@*N
M,C(ZF@#U.P^/?@[4I=+6"^G*:G/#;64S6LBQSR2IO15<C!) /?L17::?KEKJ
M=]?VD!=I;)Q'-E"%#$9 ![\&O'M9\'V\'[-FE^%_$]W;>'-;L-,A^R3&X0M!
M>VJJ\<L1!RQ#HIPO)!([UZ1\-=(O]*\(63ZN(_[<O!]LU$QK@?:'Y8 >@X7_
M (#0!U-%%% !7G?Q4_Y&GX7_ /8RM_Z;KVO1*\[^*G_(T_"__L96_P#3=>T
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M[O-9E3A1Q'CG).[/;/)GPYX@7XN^+M<&D!M*O_#]IIMM-]ICW22PRW+G*YR
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M K<H **** "BBB@ KSW5/^2^>&_^Q=U+_P!*+*O0J\]U3_DOGAO_ +%W4O\
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M)-,DO=.B\0^&%M9X+G2964?O7 V2_-P<#(]LY[4 85M\2?$FLZSX.\+W3?\
M"/ZOK%A<W\]W%"C$+$V$"J^Y5+@JQ!!QDCWKJ/@E\1;CXE>#[F\O8XTU'3M1
MNM*NVA7;')+!(4+J,G 88..Q)KG;3X57%A\,M"T"ZTF#7]:TX2K97M_+N^Q*
MTCF/,F=S;(V52!UV^E=I\*_AU9?"SP38^'[-O.,1>:XN2H4SSNQ:1R!P,DG
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M(F%XVY(VYYQU)ZUZ17F^@>$-4U;XG+XSUBT&F26^F?V?#:"42$LS!I&R.V0
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MG(X/!KH-9\766B7FCVTR3S2:M.;:T:W3>KN(WEQG/'R1N<^U> _#+PS;ZO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD@/(!!)'UKZQT&">VTBTCNKK[9<",;YR@0OWZ"@#0HKPSX__ !+\0>#$UQ]
MU"+S]*T*;5190VXED#(>'F+$!8B 1@'<3TZ51L?&7CGQQ\3#H^G>(+31=+_X
M1^QUO8+ 2N&D8^9'N+="!P>U 'T#17RK\+/B-XIL?A_X'TI]8.IZOXFUG5X%
MO;S:CH(;NY) .""Q"C'& !@#%:NH^+/BSI^N>#/"^HZYHVGZGJ^H:A9R7=G;
MBYQ#'%YD$C [0LN"-RXQW[T ?0-CXGTO4M;U#1[:\CFU+3UC>ZMESNB#YV$\
M8YP?RJ'Q?XST3P%HLNK^(-3M])TV(A6N+E]J@DX ]R3V%>*7_P 3?%F@:G\0
M-*OO$&G";1K;3!:7L]D57S)B5?\ =H279B/E4=R!7%_%3QQKGB7X._&S1M:$
MI319;6.T-S&B3^7(J/B0(2N0<XQV- SZX!R,TM(#Q7@7C/Q'\1-9^)GC+P[X
M:\1V&D1:5I$&I6GGV E+2L7&QR6'RG8,GJ,T"/?J*^:_A?\ ''Q+\<K1(K"X
MC\+W\/AFTUAP;<2B2>;=CAC_ *L%#P.3N'-4/ WQ>\?_ !AOO!\6GZK:>%UU
MCPZ^ISJU@)S'/%<")MN6&4;!(SV(H ^HZQ/$?C70_",NF1:QJ=OI\NIW<=C9
M1S/AKB=V"I&HZDDD5\]?#[Q?XFT[POK4UQXH-S=W?C:YTQ!+;![B2-6 \N!1
MQO*J ,X50"2>":R-8\<ZOX\\%>$)]< ^W:;\4['30Q15=HX[R/87"DKNPV#@
MXXH ^MZ*\\^/.K>*?#?PVU37/"$B'5-+47CVKPB7[1"A!EC4=F*!L>^*XCQ'
M\<+P:!9^(-#O+>YT?6]0T[2M,FG0(BO<%=TK-[!P #QGKWH ]ZHKYM\;^-/B
MKX"L["*]U+1T-]XHT[3[215$\S6EQ*J.)0 H# DX8=15.7XX^*O#.KZCX8U#
M4;:]OI?%UCX>M=6:V$8ACN$#EF0'!8 ,J\]2,T#/IZBOEWXA?&SQGX$G\;Z/
M%>0W=SH-QI4UKJ$ML,2P75PL3Q. <;@-Q!'J.*Z7Q-\3?'-OXH^).DZ%:IK,
MNB+ILUG9PHJSM'*_[\(6(#/L#; <9; H ]]I"0 2> *\\^"/CZ'XA>%[J^34
M9[V2&\D@DAO;,VEU:$8_<S1GHX]>ASQ57XI?$.\T/QMX#\'Z;*+*\\47<\;7
M[H'$$4,+2N%!XWMM"C/3)/:@1VOAWQAHOBTW_P#8VI0:B+&X-K<F!MPBE'5"
M?49IGB'QOH7A2]TFSU?5+>PN]6N5L[&&5L/<3'HB#J37S/X+\9:UX*U[7M"M
MKJ&XU/Q!XXETX:A<!8@H%H9>."-[>6$''5JN?$J?Q8LOPMMO&$VG7&HVWQ"L
MUAEL9=Q,!20IYHP-KX/..O6@9]3TM?/,/Q5\4R?$+PS!#J=MJ&C:MKUYHTLE
MO;#[,@2VFDC$;D[FD5HL,<%>2 :E\(?%'Q7J.K7?@G4-1@/C6PUIA=/';*%&
MF >:)O+W9PR8C#?WV% CZ!K#UOQMH?AS5=,TS4M3@M-0U-VBLK5V_>3L%+$*
MHY. "?PKQ;2_B7X]U>UTWQE9S:,WA9;ZXM]2LKBY56$2L\:^40N?.WJORD_-
MNQP<5S)\3ZO\1+KX!>,KO45:TUCQ!).FFK"H$&;.ZV -U)"@@YZD]L4 ?4.F
MZI::Q9I=65Q'<V[YVR1MD''!'U!X([5:KQSX9:I<V?QW^)_AU9$.E11V.I00
MK_RREF5UD^FXQJWU)/>O8Z "O-=8_P"3B_"W_8L:I_Z56->E5YKK'_)Q?A;_
M +%C5/\ TJL: /2J*** "BBB@ KGH?B#X;N=>_L6+6[*35"[1"V$PW,ZC+(/
M5@.2HY Y(K<N8VEMY$5MK,I 8=CCK7QGXF\/^-/"'@3P;\/);!F\7-XN%UIN
MMQRK,)XQ<-</,!RZ$1EE8L !ZG.* /K5O'&@+KPT0ZO:#52P3[*91OWD;@G^
M]MYV]<<XQ1/XWT"VUX:))J]FFK$J/LAE&\%L[ 1V+8. >3@XSBOD^YGFMOV9
MQJ-Y(;/Q'-XU,UR\+E9/M8U'8H)'.=JQC'H!4LD\ES\ ?BO>1S&[UZ/QI=O$
M9G+,ERDD*Q*I//"K'@?2@9]CUYY\)_\ D/?$S_L:&_\ 2"RKNM,:=].M6N1M
MN3$AE'H^!G]<UPOPG_Y#WQ,_[&AO_2"RH$>AT444 %8/BCQUH'@Q8#K>JVVG
M&<D1I,^&?'4A>I [GH.];U>&_'CPKXHL_$>F^.?!MQ;W^HZ;;FTO= NCA;VW
M>17PK_\ +-\Q\'H>AH ]HTS5+/6K""^T^ZAOK*=0\5Q;R"2.13T*L."/I5JN
M/^$?BG3/&GP]TC6M(L9=,LKM9&%G.NUX)!(RR(1ZAPX_"NPH RM<\5:/X9%L
M=7U2TTT7,JP0?:IUC\V1C@(N3\S'T%.UWQ/I'AB"&;5]3M-,BFD6&)[N=8A)
M(QPJ+N(R2>@%>6_M/01R>%?#CLBLR^(=/*LR@D?OEZ5:_::ACD^',3LBLR:G
M9%21DC]^G2@#U2ZO8+&TENKF9(+:%#))+(P544#)))Z#%,TS4K76=.M;^QGC
MNK*ZB6:">)MR2(PRK ]P00:\/_:+\<I9V$GAR\T'Q->Z1-I\EQ=76D:'=7L$
MF 0L+21(RJ">6R>@]ZZ[]FWQ!#XB^!_@R6WL[^R2WTJUMBFH64EJS%(4!95D
M4%D/9AP>QH /B%_R57X<_P#7Q<_^B6KTRO,_B%_R57X<_P#7Q<_^B6KTR@"M
MJ.I6FCV,U[?7,5G:0J7EGG<(B*.I)/ %8G@_XC>&_'T<[:#K%KJ+0,RRQ1/^
M\CPQ7+(?F )4X)&#CBL[XP^!1\1O E[H:ZH='NI622VO!@^7,C!D)!X8;@,C
MO7EG[+WC"]N[N]\.>*-%2R\6Z>MTPU6V.;?4;<WD@=T'5,29^4]..: /=(/%
M.CW.NSZ+#JEG-K%O&)IK".=6FC0G 9D!R ?4U7?QOH*:^-$;5K0:L<#[(91Y
MF2,@8]2 3CK@5YQ:1)#^U#J#1(JNWAL$D#!8^>.M>#B[U1OV>O$.I!I6\5?\
M+"E*.1^]\T7J(@'?B,*![8H ^K7^+G@J/QF/"+>*M(7Q01D:0;R/[3TSC9G.
M<<XZUUI.!FO'?B)\/=*\8:IX>T+3[*&&?3]5BUR[O%4;[<J^_.[KO<C;]/85
M'^U1JVJVOP]L-)TFZ.GRZ]JMKI,UXI(\F*60*YR.1D<9]Z!GIMIXST2^MKZY
MM]4M9K2Q+"YN4D!AB*_>#2?=!&.1GCO1H_C/0_$&G7%_IVJVMU:6_,TR2C;&
M,9RV>@QSD]N:^5/B]XHUG2-+O?AK=V5G:Z'I5YI+)=:;&8HC8R3JAB=<G&,
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MX;P^%X_$>BM!!>^&-7N)[S[-.-X4S\S1,I&&1B6/_ B*TO\ A)KK^ZGY4?\
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M1[,[0 22,#/)]36#H'[.O@CPUJ6B7]C8W:7>B1SPZ=(]_,QMHYMN]%RWW,(
M%Z#GC/-='_PDUU_=3\J/^$FNO[J?E18#*A^!_A.#1]'TQ+:[6VTB_;4K%DO9
M4D@F8.K$.K!MK"20%<X(8UL^$?A[HO@B[URYTF&6&76KPW]Z9)6<23E0I?D\
M?*JC XX%1_\ "377]U/RH_X2:Z_NI^5%@&:O\,-"USQQH_BZ\BN)-=T>.6*Q
MG%PP6!)0%E 3.WY@JYR.P]*N>(O ^F^*-3T>_OC<_:=)G-S9M#.T8CD*-&6P
M."=CNO/9C5;_ (2:Z_NI^5'_  DUU_=3\J+ 8-Q^S_X-NY;*:6SNVNK*^GU"
MWN5OI4FBEG!$^UU8,%DS\RYP?2G:;\ _"&BZ1:Z9IUO>V-E;I<Q+%%?2D-'<
M,K31L&8Y5BB\=L<8R<[G_"377]U/RH_X2:Z_NI^5%@.?UC]G?P)K/B+3];;2
M9+._L[9+(-I]W+;)/;I]R*98V E0>C9_*NM\3^#M,\6Z1#IM\DB6\$T5Q";:
M4PM%)&P:-E*XQ@@52_X2:Z_NI^5'_"377]U/RHL!E77P.\(7UG9P7&GR2/:Z
MH=:6Y%PZ3->%=K3,ZD%B5.T@\;<#& *S-6_9J\ ZU>:C/=:7/Y6H:A%JL]I%
M>RQV[7:%2)A&K!0YV)EAR=M=1_PDUU_=3\J/^$FNO[J?E18#FM4_9R\#:KJ.
MK7<EA=P#5IDNKVUM;^:&WGG7&)FC5@/,^5<L.3@$Y/-.TSPAK/B/X@VFK>)=
M%TRSL/#<DZZ)-#<-<W$XD4()'+*-GR;LKDY8@Y^7GH_^$FNO[J?E1_PDUU_=
M3\J+ 3^/_!MKX_\ "6H:'=.T,=R@VS1_>B<$,CCW# '\*\M\1_"[Q-XK^,?P
M^U^_A\FRT32K^RO;VRO?+D,LWE!61<9*D1G(/3=WQFO2_P#A)KK^ZGY4?\)-
M=?W4_*BP%6W^$7AFSO?#US:V<EH^@+(NGK!.ZK%YF?,)&?F+9.2V2<D]ZSV^
M ?@H^/KGQ@FFRPZO=NDMTD-U*EM<RJ,))+ &V.X &"0>GK6U_P )-=?W4_*C
M_A)KK^ZGY46 U/%'A;2O&GA^^T/6[*+4=*O8C#<6TPRKJ>W_ ->N0TSX">#M
M-\(W?ALV=W?Z=<E"[:A?37,XV',865V+($/W0I&.W>MO_A)KK^ZGY4?\)-=?
MW4_*BP&7J/P1\+:SHFI:9J-O<W\>I");RXGNG,\ZQ',:E\Y"J<D 8&23U)I=
M3^"7A/6K_6+R_LI;R?5].32KTRW#D2VR9*IC/&"Q.1SDFM/_ (2:Z_NI^5'_
M  DUU_=3\J+ 5M(^$WA_1-;M-6MDO&OK6R.GI)/>2RY@)W%6W,=V6YR>:PM%
M_9M\!>'Y-/>QTNYA&GR326<?V^<I;B7.]$7?A4)8G:!BNF_X2:Z_NI^5'_"3
M77]U/RHL!EGX(^%)]-N[&]M)]2M[BP.F'[;</*\=J<9B5B<@9 .<YX'/%-TK
MX2V>A^-M+URRNKV./3]/:P$4U]--YRDYRX=B"0>=QY_ 5K?\)-=?W4_*C_A)
MKK^ZGY46 S/&7P2\(^/M6N-2UG3Y9KJYL6TZX,-U+"L]NV3LD5& 8 DD9Z$U
M8\,_"+PWX0UM-6TR"YBO4L(]-#RW4DH^SIRJ$,3G!R<GGFK?_"377]U/RH_X
M2:Z_NI^5%@.:U#]F_P !:EX=N-$ETJ9;&6_;4X_+O9E>UN&<N7@8-F+YF8X3
M R36G:_!7PM9W/AZYCMKHW.A2/-9SR7DLDGF.-KO(S,3(S#@EB>/H*TO^$FN
MO[J?E1_PDUU_=3\J+ 9/B#X%^$/%-QKL^I64]Q+K0A%XWVJ123$=T3)@C85/
M(*XJG<?L[>"+NPURSEL+N2'7!$-1WW\[-<^7]TL2Y.>!D]3C'2NB_P"$FNO[
MJ?E1_P )-=?W4_*BP%;0OAU#HGCW4O$D=W<L]Y:16CPR7,DBML/#E2=H/;@#
MWKB)_A'?:_\ &_Q/KFJV\\/A[4=)@T]7MKXQM-M9BZNB\[2&Z@YZ]*] _P"$
MFNO[J?E1_P )-=?W4_*BP%/4O@_X8U"_L[V.SDTRZM+/^SXY--F:V)ML "$[
M",J,#'<=B*FT_P"%/AO2?$6F:U8V36=YIMC_ &;:+!(RQ16W'[L(.,<#MGBI
MO^$FNO[J?E1_PDUU_=3\J+ 8%]^SUX(OY+F1M.N899]2&K>9;WTT;177>2/:
MPV$\YVXSGFB+]GOP3;VBVL&GW,,"ZJFMJBWLQVWBD%91ECSD ^YY.:W_ /A)
MKK^ZGY4?\)-=?W4_*BP'3/$LD+1.-R,NT@]Q7&W?P:\&WWPZ?P)-H=NWA5D*
M?V<,A%&_?E2#D$,<@@Y!Q5S_ (2:Z_NI^5'_  DUU_=3\J+ 8$'[/O@^#0;'
M26@O[BWL[V+4(Y;G4)I9S/$08G:1F+'80, G QTJQJ'P*\':M'KB7NGR77]L
MSQW5VTEP^[SH\>7(A!RC+@8*XZ5K_P#"377]U/RH_P"$FNO[J?E18"AJ'P9\
M+:QX;U?1-2LY=1MM6V&]FN9V:>4IC8WF9R"I (QC!&:H6OP \'V<NH7$5O?B
M]O\ [,;B\.HSF9V@</$Y8O\ >5@#G\.G%;W_  DUU_=3\J/^$FNO[J?E18#G
M-7^!VDW>HZ%=V4UW8W.G:JNK2W<=W(LMQ(,;A( 0KA@-I##&TG KH_'OPUT#
MXE6%G:ZY:O*;*X6[M+FWF:&>VF7H\<B$,IY/0]Z/^$FNO[J?E1_PDUU_=3\J
M+ <O=_LT_#_4-"U32;O29[J#4KQ-0GEFOIWF%RH 69)"^Y'&/O*0?PK2D^!O
MA2;2]!L);>\GCT6]74;26:]EDE^TKG$KR,Q9V&3]XD5K?\)-=?W4_*C_ (2:
MZ_NI^5%@.:'[/'@JQNHKZSTJ<75KJ#ZM:Q_;YUBCN65@Q50V%#;VW #!SR#5
MCX>>$=5E\3:IXP\4Z1INF>(KRW33UCL)3.$MD9F&9"JDEBV2,=AZ5N_\)-=?
MW4_*C_A)KK^ZGY46 Q="^ G@OPUXJO=?T[39;>YNY&FDM!=2FS\UAAI1;[O+
M#D$_-MSS5&U_9P\$:;=6-Q:V%Z@TZ_;4[&T74IU@MK@A@3&@?"@[VX''/ID5
MU'_"377]U/RH_P"$FNO[J?E18#G['X-Z?J+^)[S7%8W_ (BGAENWLYWB94AQ
MY,8=2"0.2>QW'L:](4!5 '0<5R__  DUU_=3\J/^$FNO[J?E18#J:\UUC_DX
MOPM_V+&J?^E5C70_\)-=?W4_*O.]6\0W!_:!\,R;4W+X;U)>GK<V7^%%@/;:
M*Y;_ (2:Z_NI^5'_  DUU_=3\J+ =317+?\ "377]U/RH_X2:Z_NI^5%@.H(
MR/2L+3O!.E:?KDNM&)[O6'C,(OKI_,DCC)R43LBD@9"@9P,YP*J?\)-=?W4_
M*C_A)KK^ZGY46 B3X5^&X];?4TL2DCW8U![=)&$#70  G,8."^ .?4 ]1FEO
M/A9X;O\ 69-2GL2[RW*7DMN9&\B6X0 ),T?W2X 7G_9&<X&)/^$FNO[J?E1_
MPDUU_=3\J+ =37GGPG_Y#WQ,_P"QH;_T@LJVO^$FNO[J?E7 ?"WQ%<IKOQ((
M5/F\2LQX_P"G&S']*+ >T45RW_"377]U/RH_X2:Z_NI^5%@.IKD_%?PWTSQ9
M?)>33WUG=",0N]G=-&)(\YVLH.#SWQD=C3_^$FNO[J?E1_PDUU_=3\J+ ;.@
M:!I_A;1[72M*M8[+3[9=D4$8X4=3]22223R22:T*Y;_A)KK^ZGY4?\)-=?W4
M_*BP$_C/P%I'CZTM;76(YIH+:X2ZC6*9H\2(<JWRGG!YH\7^ ]*\=:1%IFKK
M/-:1R)*%CG:,EE(*DE<$X(!J#_A)KK^ZGY4?\)-=?W4_*BP&]<:9!=Z9)83A
MIK>2(PN'/+*1@Y/TINB:-:>'=&L=*L(O(L;*!+:"+).R-%"J,GG@ 5A_\)-=
M?W4_*C_A)KK^ZGY46 YSXA?\E5^'/_7Q<_\ HEJ],KQ'QWK]Q)\3/ $A5,I/
M<$<?],C7HO\ PDUU_=3\J+ :GB7PS8>+-+:PU!)&@+K(##*T3HRG*L&4@@@B
ML/P#\+M'^'PGELS/=W\[2>;?7DA>5E:5I-GH "YX &>IJQ_PDUU_=3\J/^$F
MNO[J?E18"5/ &DQ^-)/%2K/_ &R\'V4R^>VSRLYV[.F,\]*K-\+?#CZ\VK&Q
M)N&N!>-%YC>2UP!M$QCSMWX &?8>@J3_ (2:Z_NI^5'_  DUU_=3\J+ <Q<_
MLX^#;O7;G5IEUF6YN;C[5-&VMW?D2/G/S1>9L(X QC&!BKD/P8T>YU+Q5+J:
MRWMEKTD<DMG+<2.BL@ #KD_(W QMQC%;?_"377]U/RH_X2:Z_NI^5%@$'PQ\
M/2Z?J=G=V9U%=318[R6\<R23*HPH+'D8[8QCKUHM/ACX>M[#5+2:R.H+JD8B
MO9+YS-)<(!@*S-R0!T'X]:7_ (2:Z_NI^5'_  DUU_=3\J+ 6/#'@32/"4T\
M]C%*]U,B1/<W,K2RE%&$3<Q)P/\ ]>:Z&N6_X2:Z_NI^5'_"377]U/RHL!D5
MRWB7X@V>@:_IWA^"WGU77]01IH;"UV@K$N TLC,0$0$@9/))P :ZFO"-2G7P
M'^U3/KNO2BST/7] ATZPOYSM@CN8I79XF<\*SA@0#C.VJ [ZX^)EU::FVER>
M$]8DU1?**P0&!DD#[OF21I%7:NPYW%2...16?X:^-(\3W][;V_A36HH[#5%T
MB\N':V*V\Q*C)"S%BH+KDJ#U]C7;Z?KFGZM>3+931W9A4"2>$AD4_P!S<._?
M%>4_L\WUM-JWQ39+B)U'BFX<E7! 'EH,_3@_E0!WWB'XE:)X9\9^&_#%]<>7
MJFOF9;-.Q,:;B#Z9 ;'J0174G(!P,GTKYG^*/AK7/BIX0\1>,_#U]I0ET^Y7
M4-"N7W&5'L78J X;:!(RR#G@JX->Y?#7Q]I_Q,\!Z+XGT]U%OJ%JD[1YYA<C
MYT;T*G(/TH Y&']H&RFT/Q)K0\,ZX^D^';N>TU*XB6W<Q&'_ %KA!+N95'/R
M@G'0'I7I&CZS9:_I%EJEA<)<V%["EQ;SH?EDC8!E8?4$5\@6D>EZE\,/C3'<
M>.7\/>;KNJ8MXYXR)P>B>7C<XDQMPO)S@<UTGA33E\:^+_ASI'B2RNO#R7?@
M=GFT&VO)K=(I$EA" *&!5@HR!U]<XH ^I]PSC(SZ5GZ)J%YJ-O.]]ICZ5(EQ
M)$D<DR2&1 <+("A( 8<X/([U\OZ1X[M)/C'X FL-9,-K=Z_K-AJ%O<W3-<G$
M$WEI."0%!D1/+0C/3!)-0Z=?+<^'O"T4NL781OB9<V3O_:$@9K<^>/+8[LE>
M$ STXQB@#ZV!!&0<BJD^K6EMJ=KI\DP6\NDDDABP?G5-N\YQ@8WKU]:\S^!#
MQ6E[X]T>VN7FL=-UV2.VBDG:4PHT:-M!8DXW%N]7=?\ !NKW/Q(T"ZBUK4Q;
M+:WVZ9(E*0%F@*IG;@9P<9Z[: /2Z*@L;=[6TBADG>Y=!@S28W-[G%3T %%%
M% !7G?Q4_P"1I^%__8RM_P"FZ]KT2O._BI_R-/PO_P"QE;_TW7M 'H9Z'')]
M*\BNOVE-&TZ/Q/=7F@ZU#I/AK41IFJZDJ0/%;2$(=Y42[VC D7+*IQDG& <>
MNDX&3P*^8/AOX#M/BEJ_QKT._P!4FCT2[\6,;FSM=H-S&(8"07QG:V,''N*
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M6OZ?:SZ_J^HV_P 2-'U*];4=(LYV-XVUI!M: ?>@\LJRX&T8'.<T ?2X8$D
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MGJ:@NM,L[Z2*2YM(+B2(YC>6,,4/J">E6:* "H4LK>.YDN5@B6XD4*\H0!V
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M^+H=>OM,U'3+66T@2"*%XRDA4OD.AR<J/RKUK_A%&_Y^1_WQ_P#7H_X11O\
MGY'_ 'Q_]>E<#A?#?AVYT1[V:\UBZUFYNG#&6Y5$$:@8"JJ* !^'-9_@7X9Z
M+\/;OQ#<:3$T;:WJ#ZC<*QR%D8#(4=AG+8]6->E?\(HW_/R/^^/_ *]'_"*-
M_P _(_[X_P#KT7 \JB^&2:1KNKZIX?U:YT)]6D$U[!#'')%)-C'FA74[6( S
MC@XY%:_@KP1IO@32Y;/3U=VN)WNKFYF;=+<3.<O(Y[D_D!@"N^_X11O^?D?]
M\?\ UZ/^$4;_ )^1_P!\?_7HN!@T5O?\(HW_ #\C_OC_ .O1_P (HW_/R/\
MOC_Z]%P,&BM[_A%&_P"?D?\ ?'_UZ/\ A%&_Y^1_WQ_]>BX&#16]_P (HW_/
MR/\ OC_Z]'_"*-_S\C_OC_Z]%P,&BM[_ (11O^?D?]\?_7H_X11O^?D?]\?_
M %Z+@8-%;W_"*-_S\C_OC_Z]'_"*-_S\C_OC_P"O1<#!KSOXJ?\ (T_"_P#[
M&5O_ $W7M>Q?\(HW_/R/^^/_ *]><?%CPRT?BOX5#[0#O\3LOW>G_$MOCZ^U
M%P.IHK>_X11O^?D?]\?_ %Z/^$4;_GY'_?'_ ->BX&#16]_PBC?\_(_[X_\
MKT?\(HW_ #\C_OC_ .O1<#!HK>_X11O^?D?]\?\ UZ/^$4;_ )^1_P!\?_7H
MN!@T5O?\(HW_ #\C_OC_ .O1_P (HW_/R/\ OC_Z]%P,&BM[_A%&_P"?D?\
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MQ_\ 7H_X11O^?D?]\?\ UZ+@8-%;W_"*-_S\C_OC_P"O1_PBC?\ /R/^^/\
MZ]%P,&BM[_A%&_Y^1_WQ_P#7H_X11O\ GY'_ 'Q_]>BX&#16]_PBC?\ /R/^
M^/\ Z]'_  BC?\_(_P"^/_KT7 P:*WO^$4;_ )^1_P!\?_7H_P"$4;_GY'_?
M'_UZ+@>0>./^2C^!/^NUQ_Z*->@UR_CWPX8OB=\/XS.#YD]R,[.G[D^]>C?\
M(HW_ #\C_OC_ .O1<#!HK>_X11O^?D?]\?\ UZ/^$4;_ )^1_P!\?_7HN!@T
M5O?\(HW_ #\C_OC_ .O1_P (HW_/R/\ OC_Z]%P,&BM[_A%&_P"?D?\ ?'_U
MZ/\ A%&_Y^1_WQ_]>BX&#16]_P (HW_/R/\ OC_Z]'_"*-_S\C_OC_Z]%P,&
MBM[_ (11O^?D?]\?_7H_X11O^?D?]\?_ %Z+@=%5+6M9LO#NCWVJZE<)9Z?8
MP/<W%Q(<+'&BEF8^P )J[7E_QFN7UR32/",6CW7B"WOI1=:I86;0AWLXSG8W
MFR(NUY-BD;N5#C'-2!Z-I6J6NMZ9::C8SI<V5W"D\$\9RLD; ,K#V((-6J^3
MOA=XJUKP3\!?BEX&::]T+Q%\/[.];3&N#%)<)8^4\UFQ(+HQ"C82"1\N :V?
M!OB_QEI_B/P_$OB&;7+C7? 1UL6^J,BP)>HL>PJ5 V(2^&Y/KG- SZ78X!/I
M69X:\16?BO1;?5+#S_LLY8)]I@>!_E8J<HX##D'J.>M>!?!S7O&OC75?"-__
M &WJHTBX\+BYUPW")L_M-@H'E;T(V<R, GRX"=0><7X1_%;Q%XQL/A-X?UO5
M[Q1K]IJ]U=ZM&XBFNY;>Y=(X590-IV98[<9" =,T"/IW7-9M/#NC7NJ7TAAL
MK.%[B9PI8A%!)P!R3@=!R:Y1/C3X4DU'5K".[NYKS26"7\46GW#FV8KN ?"'
M'R\_2O,_A[XFUOQV)?!^NW#:B-.\47$1OW3#75C9LDJ;B."WFM C'^(!_>LG
MX?:?XGO_ (X_&Q?#^KZ=IR#5+#SH[NP>>20"W0LJ2"91&2N1DH^"<XXQ0,]P
M\/?%#PYXK\0/HNEWYNK];"#5-H@=5-M-_JW#%0ISCH#GUKJZ^;/B#<3Z%\5/
MB;<Z5,^GW5A\/EGM9+;Y3$\;3LFT#T*CCIVK!_X7CXGTB_\ #=]'?OJK/\)K
MCQ-/IQ(*W-_$D#*V!R"VYQ@>M 'UC17S78^-O$ECKGPG:PU^]UJQ\<:+=RZE
M(Y5UM98[,3I=1 @B,;SY>S[OS+QD<\[X.\=^*K7P#\)=5U?QCJEV?'NH6VGW
M]W+Y20V0"3N%APN5>9D2/<2>IQ@XH ^MJ*\J^%&NZVOC_P ?>%M1O)=6TS1K
MBW>POISND5)HM[0.W5BA[GG#"O5:!!1110 5YG\7?^1N^$O_ &-+?^FR_KTR
MO,_B[_R-WPE_[&EO_39?T >F5P-I\=O U]XVC\)Q:_#_ &Y*[Q0P/&Z)-(HR
MR1R%0CL,'*J2>#Z5WU>->.=%\/\ Q'\:>$;(3VEMI7@[6%UJ:9950O>(CI#;
MQ@?[4ID<_P"PJX;>2@!U+?'#P<M[K%K_ &E,TNCR^3J!6RG*VKX!P[!,+P0>
M3T-=9H.OZ;XHTJWU/2+Z#4M/N%WQ7-M('1Q[$5Y'\$I88_B!\:GF9%A7Q!&7
M9R-H'V.'.:Q/V08MEK\3KFP1E\+W/BZ[ET7:"(6@V1AS$.R&02=.,YH&?0]%
M?/?PY\8ZK\3K*+Q-+XR;PQ?Z?XFN;.]T:55DBDM8Y'B6U,19=KN-CB7!;T&#
M7'6OQ<\1I\8?AII=CXCN[[1O%EIKPN+Z?8JSM;QB2&2" EO*"$%03@ODY7@$
M@CZUKDE^*&@2+XB,4]S,_A^=+?4(TLY2\<C*KJ%7;E\JRG*Y'-?/MMXZ\5>'
M/AW\.=9OO%FI:C-XWUFPT*[FG,:1:?$6F9YH\)P[J@C))QDJ>,5;D>_\()\=
MY=(\1WL=]8:I8W*74DB2S%?L5O\ NV9@25_ASUXZT#/J-6W*#ZC-+7RO^T!\
M7==\%'Q!K&@:Y<W4NE:_I.GM'\L-G9K*T(DMV7=F>1Q*7+;<*&'S97%=5H/C
M&^^(-[XMO!XW_P"$:U'P[XG;3A:^7OA6VB,?[MX2R^89E8MYG8OQG;B@#WZB
MO-_CVNN1_#V\O/#6LS:/KMHR2V@0_+=.&&+=A@DB3[O R,Y%<]\.?BM>7/PJ
ML_%4>D:_XSU+4+N1;S2=*,#S:;-EM\!$TL0"Q$;.NX\''.:!'M-%?,UQXH\5
M>./VI'\,_P#"1Z[X0T%?!%MXA.E!;=9H+@WK1LDF X^Z@! 8]3AL50\.?$'Q
M)??%/X<Z7%XFO;[1O%-CK'VF^FVP_:GB"O#-!!EO)5<E0206YRO R ?5%9GB
M'Q'8>%]/%YJ,QBB:18D"(SO(['"HJJ"68GH ,UXA\)/&OB#Q'J-KX%U?4KIO
M%7AG4[H:]<EBAN+9,-;RC&05F$T/!Q]V7'W*Z?X_:2-2?P,6OKNTQXDLDQ;S
M&,',@YX[C'![<T >@>$/&&F^.-&74]*>=K8R20LMS;R02HZ,5=6C<!E(((Y%
M;=?*5_XR\86'B[XXW\7B?5;NV\"36LVFZ/"L7ES"2Q$K+-E,LNYB>"#QR374
M7OB'Q#I.L^!&T?Q3=ZIIOBG2KDW;R,LQCD6W\Y+N+(VHH(*E0-IW+P* /H6D
M9@JDG.!Z#-?,OA6Y\7:S'\(KBX\=:QN\4Z2XU%5$04E;3S0\8V?(^Y?O=\GV
MQZA^SUKVIZ_\.LZO?S:I>6.J:CIIO;C'FS)!>311L^ !NV(H) YQGO0!/#^T
M%X!FN[FW/B".!K6_.ESR7$$L445T,9A9V4*'^9>">X]:W_#'Q%T'QAKWB+1M
M*O&N-1\/S1V^HQ-"\?DO(F]!E@ V5P<KD8(KYF\'?"W4?C/H/QK\*#5;33-!
MO?B#=?;)?LS2W.U8+1F6,[PJDX #$''/![<YXGU#6/ ?BS]I+Q'H.N7FFW6@
MZGH4D4$17R[C_08%*RY!+*02, CK0,^X:*^:=1\>>+?''B7QG::1XCTWPYJ'
MAG4+6.)+R_>-/L[6T,Q>2W$1\T2&210=XQL&,$$G \1>./&=E)\3=67Q?J!7
MPQXGL+:SLT6-87AEAMF>-P%R5_>OCI^)H$?6M(Q"@D\ 5\S>)/B5XBUK0?B]
MKEEK5QHVL>"[\0V&EI_JVB2WBE#2I_RT\XNX&>@ QSG/LWB+Q'>-\.H;M8FL
MM5U.WBABB(W-#/,  ".^TL2?930!N6OBK3[SP_)K44DKZ>GF$R"%R2$=E9@N
M,D94D$#D8(R#47@OQMHWQ#\.VNN^'[S^T-)N@3!=+&R+( 2"5W 9&01GVIMQ
MI5OH7@:33;9!';6>GFWC4'.%2/:!^0KX@TSXU:K\*_V2OAE;Z?<26"W>BWLR
MW,3;&:5)6"*&]MQ<@<D(10!]_45\CZQXL\:?#W36L+'X@7/C"*[\,:IJ#ZTT
M*!HKB#+Q2(,LH&UA&P!P2N0 <BGO\4O&/@"WT?5CK5[XF?4? $NO2V-X%*"Z
MBBB=2@51@'><CDGZT#L?6M%?/?AWQGKVF^*?A+-:ZW=>(M-\9:>TFHK.P=$?
M[.)1<1@#]V,G;M''(]*TOV@_&/B/P=?VM[;0ZE<^%HK*9]1DT"=1?V!R-MUY
M)(\Z)>=R@\>AH$>Y45\X^)/B-K'A/QJOE:O=ZOHOC31XSX:+,41+X@87.,J'
M5U?G[H5J?XM\8>(?A[X\TZRUV\UBY\*F33[2'Q%ILRRB&X+@.E[!D$"8E0)!
MD#/04 ?1"2I*6".&*G:V#G!]#^=/KY$T+QI?_#_1O%#QZQ<2OJ/Q#ETB6XU+
M4&1;:%ECPV_:_EY(";MO&1C&*W?$VI^/?"\>D6K>.8FAO?%]C:0K83"[FAM)
MN&AEFDC7><@E3CH<'- 'T]17R!XQ\6>,O"?AKXI7]MXVU:9_!FK6IL$G,;>:
MD@C9XYCMRZ_,P XP#7H-[X_UW0?C;!IOB$ZE;:'?:HEMI.J:;*LUC(3%C['<
MQYW12%CN#8(/'(H ]^HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KS76/^3B_"W_8L:I_Z56->E5YKK'_)Q?A;_L6-4_\ 2JQH ]*HHHH
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M"S,<9A4Q)C"EBQ'XL23ZU6T3P!X>\-ZSJ&K:7I-M8ZEJ+!KNYA7#SD< L>_
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M9M*MF@L?^/9 F/)XQ\N.E:6EZ59Z)8Q65A;1VEK'G9%$NU1DY/'N23^-6Z*
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M@#5HK*_X22S]7_[YH_X22S]7_P"^: -6BLK_ (22S]7_ .^:/^$DL_5_^^:
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M .^: -6BLK_A)+/U?_OFC_A)+/U?_OF@#5HK*_X22S]7_P"^:/\ A)+/U?\
M[YH U:*RO^$DL_5_^^:/^$DL_5_^^: -6BLK_A)+/U?_ +YH_P"$DL_5_P#O
MF@#5HK*_X22S]7_[YH_X22S]7_[YH U:*RO^$DL_5_\ OFC_ (22S]7_ .^:
M -6BLK_A)+/U?_OFC_A)+/U?_OF@#5HK*_X22S]7_P"^:/\ A)+/U?\ [YH
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M6M<]#7RMJYU'X466LVGB;1T\9_##5M0DNX_$^F[7OM-:27)\]"#N5'Z2+]T
M9![ 'U517@.M_$'Q=X9NOC'K-OJNGW]OH%M#<6%I=V+E%'V82A<K,O')SQDD
MYR.E6M<^/FJ^&?$VH07MI8SZ7;>"H_$H6*-TF^T-*(S&6+D;._W01ZF@#V*7
MQ+I4&K-I;ZA;+J2V[7;6ID'F+"I :0KU"@L!GWJ?2M5L]<TZWO\ 3[F*\LKA
M=\4\+;D=?4'N*^?YY-?M/VAK/4+ZYTNZO9/ %_/$T-JRQJ_VJT)1AO)= <8.
M0<$U8\&_&CQ'XKT+P;I&E6>GVWB+5/#DVN3F"VS!'LE2)4CC,BX4LY).XD
M8.[*@'T'17A'B+XQ^+?"[:1;^(K.S\+7%YI\#"]EM7NK#[<9'66"25''E *(
MRI/4OR?EP>Q^//CO6?AU\.9]=T 6,EY'<VT06^C9XV2254.-K @X;(/(XZ4
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M3WP.KD^(_P 04TL:_!8Z7<^'[K1+C4$N7CV_99TC\R)0%G)F1QD'&T@C.<'
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M#45ROPR\6)XW\&V>KIJ=EJXF>4?:K")HHR!(P4%&9BK!0H8$_>S754 %%%%
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MZTV&_D6PGN/^>S0 [2_ YZ9&<9YKV+_A%%_Y^3_WQ_\ 7H_X11?^?D_]\?\
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M\%&VN?B[X;O]0U.[:^O? 5M.#-J,P%Q*0NX[-^UR<DD8//)YK#_9Y:Y\.0?
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M2Q(9'.6*HO"CIQ^9)R:Y7X:?&6'XF:M=06%M;_9;=[B&<K=!KBUDBEV!)X2
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MUUC_ ).+\+?]BQJG_I58UZ57FNL?\G%^%O\ L6-4_P#2JQH ]*HHHH ****
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M=V"#6U+]G&-YU@T?7WT'1X?",OA*UM[6V)N+:)EPLRSF3[Z\$97G'7O7I_\
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M47 \QTWX:Z%I/BA/$-O#<KJPLTL6F-Y,5DB3(3>A;:[ $@,P)Y//-=372_\
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M<VUI-.+6UDL;1+VYDN%M;>0@O%&')VJVU0>^% S@ 5ZO_P (M!_SVD_(4?\
M"+0?\]I/R%%P/"]+_9P\#Z/?Z)>VUIJ"W&B)<Q::QU6Y(M$G 61(P9,*FT8"
MC@9/%;&G_!WPWI9\.?9TOU'AYG;35;49V6$NK(V07^?*LP^;/!->N?\ "+0?
M\]I/R%'_  BT'_/:3\A1<#SCP5X T3X>Z?<66AV\MK:SSO<-')<R3!69BQ";
MV.Q<DG:N "3QR:H)\)O#9A\20SVUQ?6WB)B^IV][=RS1SML5,A68A/E15^7'
M"CTKU;_A%H/^>TGY"C_A%H/^>TGY"BX'D+_!GPS/I>H6-S#>7B7UFNG37%Q>
MRM<?95)(A67=N5.3G!!/&2<"NMTG2K?1=+M=/MO,-M;1K#&)I&D;:!@ LQ)/
M'J:['_A%H/\ GM)^0H_X1:#_ )[2?D*+@>(VW[/?@NRNXIK>UU"""#4/[4M[
M*+5+E+:VN<DEXHED"IDDD@#')]3FVWP/\*/HNNZ28+X6.N7[:GJ$:ZE< S7!
M"@MN#[E!V)\JD#Y1Q7L?_"+0?\]I/R%'_"+0?\]I/R%%P/+[GX9Z)>>*-&\0
MSK=RZMI%O):V<S7DN$CD"B0%-VUMVU<E@3P*RO#?P*\(>$=8O]0TFTO+,W;.
MYM%U"<VD+O\ ?>* OLC9LGE0#R<8S7LO_"+0?\]I/R%'_"+0?\]I/R%%P/'K
MGX(^$;WX?1>"I[">;P_"P>"*2\F:6!@VY6CE+;U(/((;CM2V_P %/"UO;:%%
MY%]*VC7?V^VGFU&>29KC;M\V5V<M*VWY?G)P  . *]@_X1:#_GM)^0H_X1:#
M_GM)^0HN!XE??L]^"=0T?4]-FL+OR=0U,ZS)*NH3K/'>'&9HY ^Z-N!]T@<=
M*L:Y\"O"'B'PWIFBWEI>&+39OM-K>QZA.E['*>LGVD/YI8Y.26.:]E_X1:#_
M )[2?D*/^$6@_P">TGY"BX'$:-X?LM T2'2K"-X;.%"B@R,S\Y)8NQ+,Q))+
M$DDDDG-<I8_!#PIIMOH<$%O?+%HM[+J%BK:C.WE3R,S.Q)?YLEW.&R/F/%>Q
M?\(M!_SVD_(4?\(M!_SVD_(47 \W\(^ ](\!0:JFC0SQC4KV34;D37,DQDN'
MQO8;V.W.!P,#CI7FWP9^#DND6>NGQ/8S)+-XFOM9MK1KPR6["28O%(4!QN (
MX/&0#C/-?2/_  BT'_/:3\A1_P (M!_SVD_(47 \ML_A=H-@/$H@2\0>(I#+
MJ.;V8^:Y0(67+?(=JA?DQP!6-JGP!\':M8>'K66VOX#H,(M;"YM-3N8+B.#
M'E&9'#LF !AB>@KVO_A%H/\ GM)^0H_X1:#_ )[2?D*+@>-^(O@7X.\3:OIF
MJ7.GW%K>Z? MI')IU[-:>9;CI#((G7S(_P#9;(Z^IJ/XZ^$M0\7_  DUOP]H
MEFMQ=W<*PPPB01* &'<].!7M'_"+0?\ /:3\A1_PBT'_ #VD_(47 \>N?@]X
M<\0Z)>6FM6=UJ!U"U2UG>]NY'F2-2&5%D#97# '(.20"22*JS_ #P;=6^L0S
MVNH7 UBVCM+]YM6NG>Y1,[=S&0DMR1NZXXSCBO:_^$6@_P">TGY"C_A%H/\
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MJ$Y2.6;/F$*7Q@[F^7&!G@4'X&^$_L M/(O_ "%U4:V%&I7&1>!@XESOS]X
M[?N\=*]E_P"$6@_Y[2?D*/\ A%H/^>TGY"BX'SM\/?A&_P#:OBNX\2V-P+>]
MUPZG;VCWA>WE"A/+9XP<9#)G!XZ9!Q76:M\%_".O+XC34M.DOHO$*HNHQ3W4
MK)+L^X5&[Y"O8I@@\UZ[_P (M!_SVD_(4?\ "+0?\]I/R%%P/(-'^#/AW0M&
MMM.LY-57[/.MS'>2ZK<2W0=5*KF5W+%0I(V'*X/2M'2OAKH6B7>G7-G#<0RV
M+SRIMNI LDDW^L>1=V)&/^T#CMCBO3O^$6@_Y[2?D*/^$6@_Y[2?D*+@<U17
M2_\ "+0?\]I/R%'_  BT'_/:3\A1<#FJ*Z7_ (1:#_GM)^0H_P"$6@_Y[2?D
M*+@<U172_P#"+0?\]I/R%'_"+0?\]I/R%%P.:HKI?^$6@_Y[2?D*/^$6@_Y[
M2?D*+@<U172_\(M!_P ]I/R%'_"+0?\ /:3\A1<#FJ*Z7_A%H/\ GM)^0H_X
M1:#_ )[2?D*+@<U172_\(M!_SVD_(4?\(M!_SVD_(47 YJO/=4_Y+YX;_P"Q
M=U+_ -*+*O9_^$6@_P">TGY"O.=6\-PC]H3PQ'YKX;PUJ;9X[7-E_C1<#H:*
MZ7_A%H/^>TGY"C_A%H/^>TGY"BX'-45TO_"+0?\ /:3\A1_PBT'_ #VD_(47
M YJBNE_X1:#_ )[2?D*/^$6@_P">TGY"BX'-5SE_X T?4_&>F>*KB.X?6M-A
ME@M91=2*D<<F-Z^6&VG.U>H/2O2/^$6@_P">TGY"C_A%H/\ GM)^0HN!S5<%
M\,/^0Y\1?^QD;_TBM*]B_P"$6@_Y[2?D*\^^%?AJ&37?B2#*XV>)F4=.?]!L
MS_6BX&Y172_\(M!_SVD_(4?\(M!_SVD_(47 YJN7\6_#ZP\73QW$UU?V5RB>
M49+*[DB#QE@2K*#M/('.,CL17IO_  BT'_/:3\A1_P (M!_SVD_(47 XG1O#
MVG^'M&ATG3[5+;3X4*)"N2,$DG)/)))))/)))-<9H?PIBTWPW-X5>>[M]"M[
MI[K3I],O)+.>%7D,AB+1LI(5F;'8J0"..?:?^$6@_P">TGY"C_A%H/\ GM)^
M0HN!YLWP[T&70KS29[-KJUO&#W+W$TDDTSC&':4MO+# P<\8XQ5>Z^&FD7MG
M=Q32ZC]HNHEA>^CU":*Z5%.55948,H!]",]\UZC_ ,(M!_SVD_(4?\(M!_SV
MD_(47 \XLO"T/AG3[PZ1%+<ZE.@5KJ_NGFED(!"[Y').!DG XY.!R:3X?^"[
M;P#X7M])MV\UP\EQ<3E0#-/(YDD<CW9CCT&!VKTC_A%H/^>TGY"C_A%H/^>T
MGY"BX'C/CC_DH_@3_KM<?^BC7H-<[X_\/11_$_X?1B5R))[D$G''[EJ]'_X1
M:#_GL_Y"BX'#^(O#MEXITJ33[]96MW97S!,\+JRD%65T(8$$ \&LGPC\.M+\
M(3R7<3W%]J,@=&O;R5I)-C.7V#)PHR>< 9ZG->G?\(M!_P ]I/R%'_"+0?\
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MWZ5JOB[PQH$>G:C#<:_#>RP/<PB,1&U*B5'4G(;YU_.O1LU\V?%D:#XN^/\
M\(K.:Y>VTZ]T[Q!D07#6CW *6QR'0J^&VDY!&X ]1D5YSX<^)49\/?#G2?%'
MBE+#P;=)K=@VHZA++-"UW#<1I:QSS"5#N$/GE?,<@D X+*K*#/MG<*JP:K:7
M-_<V45PDEW;*CS0J<M&'W;<^F=K?E7R+XFUC4?!UEIDL/B-/B/I&C:'YUS87
MUU)8ZBULUQ)LOK.3>3(X6,H2QW$*F&&]MW=?!*;07_:&^*<B%[75;Q-*O8+.
MXF<3&*2S#.QC)Z!N"<<'CC(% 'K7B?XFZ;X>\3V'AF".;5?$M[ ]W%I=H 9%
M@4A6FD).$3<0NX]2<"LA?C1$->O]#?PWK7]L68M"]HD*MO%QY^UD;=AE MI"
M3GTKSG2;^'X;?M?^-;SQ7*EE8^+='L%T#5;M@L"FWWK/:"1N$=F=9 F?F"YY
M(KW?2]=TG6;B[FL)X+OR0JRW<)#)_%\N\<$KSD9XW>] CA= ^/5CXCN7CM_#
MVMI#%J_]B3W#6ZE(+G>$(;#9V@D9;I7<^)/%%IX9@M6N-TD]W.MM:V\8R\\K
M9(51] 23V )/ KRK]F'4[+5K;XD/:74%V@\9ZD2T,@<#+*0>/6D^)LC_ /#4
M7P5BEDN%LS9ZZZ1J6\EKD00!"PZ;A&T^W//+8[T#/5-)UV\U#6]6L9]'NK&W
MLA#Y-]*R&*[+J2PCP<_(1@Y Y/%95A\2+._^*.J^!A:7,6H:?ID&JM.X'E21
M2R/&NWG.=T;?E7REXS^(?B/PK\0_VEFT?4;VYCL9_#2!7NY)/L%K*DGVN2++
M$QA0SL=N #3O$WBK1/"?Q9^)%_X!U:*82> ]-N8Y;&Z:[(47EP)6C&XG(C(8
MA2#EBW#,30!]LYKD?B;\2+3X7^'HM7O;*ZO;=[N"T*VH!*&5P@8Y(X!(S7S=
MJNN^&=*\*^(]>T/XDWFI>&=6?38YK71962TLYS,%&9I9)?)\U6 E48.%W'!.
M3C:IXGM!\(OB+ILNMVUS'9>/+06D*79EBM[>064BI$7.1%O:4KC /S$# - '
MU?H7CV#7/'7B/PNME<VUUHEO:7,DTP 29+@S!"F#G@V[@Y]JZG<*\!U;1K+X
MB?%OXM^'(-8:SO+OPQHL<4]C=F*>&02ZD0RE&##:60G'9AZU;^ 6LZI\1)[7
M5M6MKG3;GPQ9OX?NK8NZI-J"N!.Y4GY@JQQE&).?/?N*!'HU]\1+6P^)>E^#
M)+2X^V:C83W\-U@>5MB9%=>N<_O%[=ZZW-?/7QFUJZTKX]^&Y-):.37(O"&N
M/9VY(+/-FV,8V]\E3QWP:X[PKJMQK,7P4U#P]J-Q>ZKKZO:^*XEO79Y(3;N9
MWG3=\LD<P"AN"I.T8!Q0!];9%&<U\5+XB\1^"+:R65=7U";X9:]-9ZS-)<22
M-J5A<,&MF(SB1O+G5LG<08B.-PKZB\+Z5>^%OAW(T227&KR137[QRS-)F>0M
M)Y:EN0BDA%'95 [4 /\ &?Q*L_!7B3PKH]U9W,TOB&]-C!-$!Y<;A"_SDGT4
M]*[#(KX@LO%?A_Q&?@-KZZTM[XREUM_[86ZO#]H6[,,HEBEC)^0+)\J*0 J[
M0O!YU_#OBO6=7\ ^ _$ECJ%PWQ/D\3M9:W9M<MYFPW,BSPRP[L"-(L,JD84!
M2.N2#/LC(HKXZ?Q7XE\,3ZX+8QZ_J4MCJU[I'B71;QIFGP78Q7=N<XEB!V*>
M0-@48'%>C? 2[T#Q!XI3Q!X7\=KKMK>:4BWND6:R-%'(#D33;YG,<W53D!FY
MSG&: L>_YHW"OFOXQZY?:#\5C>N\.NZ*'TZ&:RM+UH=2TJ0S-MEB3.)(Y"0'
M Y(3OBJ'PX\5Z%XYUJ\7Q%XFU/3/B3I?B>]AFTR"Z,,[VPE=8(A#_P ^QM_*
M;(&"=S9R<T"/J/<*,U\1>&[YM'^#FN^.(?$&LWM[9>*=0TJ^O)-5NKI;331J
M+!LQB7G$8!W_ ']I^]TQT.L^)M/\&Z)=:QHGCX:QX&U/6K,ZC)9PRR6&EQ,A
M#!6$Q94=@A=0P SSC<00=CZ\W 5F:_JUQI%M#+;:;<:H[SQQ-%;%0R*S &0[
MB/E4')[X%?*5]9Z997?A.'3/B+?:SX>U/Q8HB-AJ$UO:PQR0OYEO$XF;>FX
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M]JBFT'3;BS:TET^UDM6;<8'@4H3ZE2,9KPW0OC/HWAFY\=&+PS;:3JS>,8=
MBCCGYU6^FCAV2.V/E^5LGKA8R>M2^//VF-0^'ECXT@U#PREQKOAO[#,;>"[Q
M#=6]U)Y:2([*#\K!E((Z@4 >W3Z)I]U)$\]C;3/#CRV>%24QTP2.,9/2K LX
M%N6N!#&)V4(90@WE1T&>N*\'U+]IN_\ ".L^+-#\5>%O[,UG2-,BUNUBL[@W
M27-B\WDM*Q5<KY;D;Q@\'(S6MK'Q\NM*\*^'?$T-GI.J^'-1U>+3KG5;#4#)
M!;PRL%2XSMY7>0K X()'O@'8]?O],M-5MS!>VL-Y >L4\8=3^!XI]O9P6ENL
M$$$<,"C BC0*H'I@<5A>%/$USXCNM<+6T45A97K6=M.CDF?8 )"00-N'W+WS
MM)]*Y'3/BSJ_B66#4- T"+5?#7]L2Z3<7:76V:%8V9)+C81@HKJ1C=NQSB@1
MZ3:Z?:V._P"S6\5OO.6\I NX^^.M97BGPG;^*$L)'D>UOM.N!=V5W%]^"4 J
M2/4,K,K#NK$'K7F-U^T1-8>'M)\7W.CPQ^"M0U-=-%V;DBXAWRF&*9TV[=C/
MM& V0&!QP:9!\>]><P7DOA>W@T6/Q*WAR\N#?9E1_/\ (21$"_,-Q&02.O&<
M4 >O_8[& NTT5JLTZ[97,:J9>.<^OTYHLM$TVP&;.QM;<,@3,$*KE.2!P.GS
M'CW/K7RIJNGR>/\ XH_'F/QCH=AXHTCPW#IKVMF]W)"]NBVLDX6%U"E=S,2Y
MR,YQ\P %>E:%\5=92U\%Z)X4\%VABU7PVVK6<#7PBB@2)[9&B^Z< +<+@]R/
MQH&>P0Z!IEO926<6GVL=I(2SP) HC8GJ2N,$TZ72=.6)_,M+81L0S;HUP2!@
M$\=< "O I/VH]<ATK4=7D\'0KIFF^*F\+W6+\&4R>9'&KH-N"-T@SDCCIFF^
M)_CP-5\-?%31?$WA&UO+WP=/9QZAIRW9>WN(+E%DB8.5!SC.5QU7KS0(]L\4
M>'KW4-'O$\/W]OX?UJ50L6I_8DN#']4. W'')J;P=X83PCH%OIPN'O)E9YI[
MJ10K3S2.7DD(' W.S' X&<#@5Y=XF^-GB'0;WQ98Z5X1M[N/PWI-CJ[-)?",
M2V\WV@%5 4X8?9FP.^><5/XN^/\ -H^K:GIVEZ-'>7.F>&HO$URMS<^5OAD=
ME$<> <L/+;). ,KZT >O/8V\ERMP\$33J,+*4!8#V/6H[;2;*RGEGM[.WMYI
MCF22*)59S[D#G\:YJY\<7EM\+IO%ATH_:8].;4!IYEP2 A<+N(X.*\MT']HS
MQ3KM[X)MH_!MFDGC#19-5TW=J7$;1QH[K-\G P_!7)XZ4 >^/:POOW1(0Y!;
M*CYB.F?6I"RJ54L 3T!/6O#+7]HS4]1^'F@>)+?PU% U_%?&Y%U> 1036SO&
M85*@L[.T;;<+T&3BJC:_;>-_B;\%/&-O8?9[C5]'O;@1L1O"/:B01LW?!- S
MV^#1-*%R]U#86?VAWWM.D*;BX^7)8#.>HJ9-)LHKQ[M+.W2[<8:=8E$C#W;&
M37B'@_XPV>D>%=#33/"\.DWFO>*-0TA+1)28$N$N)A++)(%_B,;-TZL *9IG
M[2NKZGI4=S%X0'F?\)1+X7<&\ 1IHW9&D0E>4W#@_7N*!'N-OI%C9SRS06=O
M#-+]^2.)59OJ0.:6PTFQTOS?L=G;VGFL7D\B)4WL>K' Y/N:\GT;XWZQ?:3K
MBWF@6MEK&C:]_8MZ#?9M(E,4<JSF0J"5*RJ,!<YXK&T7]IF^\1:)X>NM/\,I
M/=ZCX@N_#LT;77EI%- SKO!9<E6V9Y (STS0.Q[C+I5E/=I=2VD$ETGW)FC4
MNOT.,BC^R;+[<U[]D@^V,NQKCRE\PKZ%L9Q[5X]X<_:%N]7@CTV[T2&R\5OX
MAN?#JV0NB]N988Q*9!)MSL\ME/W<YXJU?_&;Q+X<_P"$>?Q#X131[:_UI]'N
MKA[O>D/S$0SIA>4DX S@@GD4"/68M,M((9(H[6&.*3.]$C 5O7([U%!H>GVM
M@;&&QMH;$@@VT<*K&<]?E QS61X+\4W'BP:O<&VBBT^VOY;.TN(Y"WVA8SM=
MR"!C$@=,<\H3T(KI: *,>BZ=#;PP)8VJ00?ZJ)85"Q_[HQQ^%(=(TTDH;.UR
MQWE?*7D^O2OG31/%^D_"_P")WQ^\2:A#NMM,DTLQ11]=TEN?D0=%+OMSZGDT
MS6?&-SX%^/>H>)_$FFVEDMMX0DN7&GRF0S8F3"L2H^8$X'4<T ?2#Z+I[^9N
ML;9O,.7S"OS'WXYKR[6/@OJESXGUB_7Q!I4VC:E(LDEIK&@QW<UJH0)L@E,B
MA4P,A61@"2><FHC\:_$5N^MQR>#I;H6=FEW;75N[QV\I9@K1N\R)M*9W$\C
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MZ.+5#XAN=(G\ZX#'3+R&*3<T9 ^<%0<'CAJV;_\ :..GZ%%XL.DQ2^"3K/\
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M 4444 %%%% !7F?Q=_Y&[X2_]C2W_ILOZ],KS/XN_P#(W?"7_L:6_P#39?T
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M?PQH'C:X\36VL16+7$<C!I0!)<*Q'E;I6)('W5VXZFOM-E#J589!X(/>O+]
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M\.^"=<\8WGB"&[M;#7[O04T^/3D"%?M@@CN'?.5\L9)'((ZUU?Q,UKQU\.?
MGCG5H_%EGJD=LEK=:2TME&;F%#\LRR[0J,K,,H0N0-V<XKT"T^#?A&S\.Z]H
M(TG[1HVNS2SZC97ES-<1SR2?ZQL2.VTL>3MQSS6?IO[/W@72?!5[X4M]'E_L
M6^V_:HY+^Y>:8+]U6F,GF;5[+NP,G &30!Y[XR\8>/CK'Q%@TSQ/!IT&A>'=
M-UNT TZ-V#R?;-\;%B<JWV9<G@CMCK5F+XG^)O'/B7QOHVF:D?#USX7T+3[^
M(FWC=;ZXN8I)2QW@GR5\M4^7!R6YX%>BW/P6\*7EQJT\UI?-+JME'IUZW]K7
M@\ZWCW;(S^]X WOTP?G;U.6W_P $O"&HW-G<S:;,+JUL?[,%S%?W$<LMIG/D
M3.L@:://.V0L!DXZF@#R#2/B=X^\?ZCI!MM>@\.6NJ>!3KXA@L$E>"Z62)20
MSYW*=YP".G;/-7O"GQ'\:+%\-]?UGQ-9R:?XET:>>\M)+)(H+:1+0SK*'!W
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M !1110 4444 %%%% !1110 4444 <M_PD]W_ '8_R/\ C1_PD]W_ '8_R/\
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MT^-5S?>+-:\-P^$M0DU;2+6"[NH5GBX27=LVG/)^0\46 ]H_X2>[_NQ_D?\
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M^-9%%%@-?_A)[O\ NQ_D?\:/^$GN_P"['^1_QK'I:+ :_P#PD]W_ '8_R/\
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M3XF> )"L>4GN"./^F1KT7_A)[O\ NQ_D?\:\G\<?\E'\"?\ 7:X_]%&O0:+
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M+DG>55Y"V>=T<1JU\>K6?0/BS\)/'=U%))X9\/W=_#J<T:%Q9BYMC%'.P'\
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M5;7X3:EX;N OBN>Y:#Q:@N"MR;7R)3=&["D'<LJIM9^58@*1NY^JZ0*%+$
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M4 >?>./^2C^!/^NUQ_Z*->@UY]XX_P"2C^!/^NUQ_P"BC7H- !1110 4444
M%%%% !1110 4444 ;O\ PBLG_/=?^^:/^$5D_P">Z_\ ?-='7(>(_BOX:\*^
M([70-1N[I=9NH'N8+.VT^YN9)(DQO9?*C;(&1GZBIN!<_P"$5D_Y[K_WS1_P
MBLG_ #W7_OFK'A#QIHGC[1(M7\/ZE!JNFRLR+/;MD!E.&4@\JP/!4@$=Q6W1
M<#G/^$5D_P">Z_\ ?-'_  BLG_/=?^^:Z(\"LJ;Q+:0:Y8:44N))[V&2>*:*
M!W@"IC.Z0#:I.X8!//:BX%+_ (163_GNO_?-'_"*R?\ /=?^^:Z.BBX'.?\
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M'11<#G/^$5D_Y[K_ -\T?\(K)_SW7_OFNCKG9?'VC0^.(/"33RC7)K5KU(3
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MNCHHN!SG_"*R?\]U_P"^:/\ A%9/^>Z_]\UT=%%P.<_X163_ )[K_P!\T?\
M"*R?\]U_[YKHZ*+@<Y_PBLG_ #W7_OFC_A%9/^>Z_P#?-='11<#G/^$5D_Y[
MK_WS1_PBLG_/=?\ OFNCHHN!SG_"*R?\]U_[YKSK5O#3C]H+PS%YRY;PWJ;9
MQZ7-E_C7M%>:ZQ_R<7X6_P"Q8U3_ -*K&BX'3_\ "*R?\]U_[YH_X163_GNO
M_?-='11<#G/^$5D_Y[K_ -\T?\(K)_SW7_OFNCHHN!SG_"*R?\]U_P"^:/\
MA%9/^>Z_]\UT=8>K>-=$T/7M'T2^U"&#5M7:1;&S)S)-L4LY '8 <D\<@=2*
M+@0?\(K)_P ]U_[YH_X163_GNO\ WS44GQ,\.1:ZVD-J'^EK<+9NPAD,*3L
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M$;D A2Z1E0<,._>O36F18C*S!4 W%FX 'J:+@<__ ,(K)_SW7_OFC_A%9/\
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MM/%^@:A/<K.L+FVN(K,7$<\&U!A0V48-D?,O?K[SI7P_T#1=2U2_M+ )=ZH
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M$$CL10,U-%6X31K!;LDW8@C$Q)R2^T;OUS7$_"?_ )#WQ,_[&AO_ $@LJ]"
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MQG!XZ5ZA<6L5U;26\R"2&12CHW0@]14.D:19Z#I=KIVGVZ6EC:QB*&",86-
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MO9&;^ZB$]JX[P)87OQ$T+Q;X;T?5O!OB:37/#DNE/XET+4Y;\VH$?EPQSG+
M#$CD+D,2"3GDT >SZ?\ '*74K.UFC\':U;&\AEN[4W@CCBEMXXDD:4N&(0'S
M%4*V"3G@ $C.C_::TG5%\.KH7AW7-?N?$&CRZSI\-I%$/,CC9%=&9G 5@7Y+
M8'& 22 6>(/A-XKU2V\#P)J6E7-EI&FO8:AIM[$[VLTIC14N54'EDV-M#9 W
MY'(S7EO@SPMK/PH^+?PI\''4M'U'6-,\*:I;$,[1+*AN;<K@9)#=_<*U '1:
MA\<&\7_$/X2Z[X:&LW&GZC%K4%YX=1A&[7-O$@\N5"0H='+<L<#ZXKO-(_:,
MTG59_!,?]D:E;)XIO;C3(II@@CM+N%9&>"9MV Q$3[<9W$<5SWAG]G;4O"'B
MOP/JUA?V3IH]UJ]]J*2(X,\U^!O\O^ZJD#&>M<GXO\(:=X5^%<_PRUG7;0>/
M=6U.XUGPPFGQM]H%W]I\Z&2/(.#&Y&YNFS>3A<T ?1OA?Q.OBB._DCM9;>*U
MNY+0/(01,4."R8ZKGO[&N/\ B[_R-WPE_P"QI;_TV7]=IX2\/Q^%O#>GZ6C"
M0VT05Y0H7S'ZNY Z%F)/XUQ?Q=_Y&[X2_P#8TM_Z;+^@1Z91110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN^$O_8TM_P"FR_H ],HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\UUC_DXOPM_V
M+&J?^E5C7I5>:ZQ_R<7X6_[%C5/_ $JL: /2J*** "BBB@ HHHH **** "O/
M/A/_ ,A[XF?]C0W_ *065>AUYY\)_P#D/?$S_L:&_P#2"RH ]#HHHH ****
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M/M]S_P _$O\ WV:+ =S17#?;[G_GXE_[[-'V^Y_Y^)?^^S18#N:*X;[?<_\
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M%<-]ON?^?B7_ +[-'V^Y_P"?B7_OLT6 [FBN&^WW/_/Q+_WV:/M]S_S\2_\
M?9HL!W-%<-]ON?\ GXE_[[-'V^Y_Y^)?^^S18#N:*X;[?<_\_$O_ 'V:/M]S
M_P _$O\ WV:+ =S17#?;[G_GXE_[[-'V^Y_Y^)?^^S18#N:*X;[?<_\ /Q+_
M -]FC[?<_P#/Q+_WV:+ =S17#?;[G_GXE_[[-'V^Y_Y^)?\ OLT6 [FBN&^W
MW/\ S\2_]]FC[?<_\_$O_?9HL!W-%<-]ON?^?B7_ +[-'V^Y_P"?B7_OLT6
M[FBN&^WW/_/Q+_WV:/M]S_S\2_\ ?9HL!W-%<-]ON?\ GXE_[[-'V^Y_Y^)?
M^^S18#N:*X;[?<_\_$O_ 'V:/M]S_P _$O\ WV:+ =S17#?;[G_GXE_[[-'V
M^Y_Y^)?^^S18#N:\UUC_ ).+\+?]BQJG_I58UH_;[G_GXE_[[-5W4/?QWS -
M>Q1M"ER>9$1BI90W4 E5)'0[1Z46 ]!HKAOM]S_S\2_]]FC[?<_\_$O_ 'V:
M+ =S17#?;[G_ )^)?^^S1]ON?^?B7_OLT6 [FBN&^WW/_/Q+_P!]FC[?<_\
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M?;[G_GXE_P"^S18#N:*X;[?<_P#/Q+_WV:/M]S_S\2_]]FBP$%%%%4 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
H %%%% !1110 5''!%"SM'&B-(=SE5 +'U/K110!)1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>dkdcu-20230331xs4a057.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a057.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "- 6T# 2(  A$! Q$!_\0
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M  E8W$=ZF+Z_N(G968("6=EQDL3GD]*_."8E;^;!(;S&(P<'.X]#7V'\)?\
M@HC>^&/#]OX?\>^'8O$UI9(L/VR JMP(P,#S(W&&('<<FMZ^!<80E2CS+JKZ
MLQHXM.<XU)<KZ.VQY)^T/^TE:_'NPT0_\(EI^@ZM:N[7EY:E7><XP &VA@G.
M<'/.*^U_ NK>%=$_86\.ZAXUM&U#P];6"RSVB@DRD295>/\ :QUXKRS]LOX0
M^ M<^"MC\5_".F0Z//+Y$S>1%Y0NHY2!AU'&\$]:Z'Q*A'_!-2 D#/\ 9L8_
M.<5S5)4:U"E&-U[VOD;TXUJ-:K*3O[MT:WP#^/7AG]J'4/$/@&[\ 6>D:%#9
M--;PL5<$9V\J%&T]\BO@^RA\/>"?C$]MKVGR:IX9T[6)8+FT,I0O$DC+MR,'
M@#IWKZ#_ .":G/QDU_H -)? _P"!5Y_\,_A39?&3]JO5O#FI.\>F/K%]/=>6
M<,\:2.Q3/;.,9]Z[*<88:O6A=\J29RU)2Q%*E*RYFVCW73/V^?#^E^(;#PWX
M.^'-O'X/$\=KO5@LFUF"[A&JX'7N2>]<G_P49^&WA[POKGA;Q%HVG0:;/K$<
MBW4=NNT2L!N#D#C('%=M\0_VIX/@K\5(OAKX*\!:!;:3IMS;61GNXSO)?;D@
M#TSUZU2_X*>3^;#X 9MJY$S^@Y3D"N.C%4\32<8N*EKO>YUUI<^&JJ4E)QTV
MM8ZCXCH/^';>FD<G[#:\_P#;<5!^P#_R;=\0_P#KYE_])Q4OQ"<R?\$W-/P!
M@6-L2.>!]H%0_L" _P##.?Q$3IBYFX_[=Q7._P#=*G^+]36W^UT_\/Z'YZW'
M_'S/_P!=7_\ 0C7I?[- Q\>O O\ V%(OYUYK<J1<2G& 9'(]_F->E_LT?\E[
M\"_]A.+^=?5U_P"!+T_0^9H:5X^OZG[4KT-/J+=@'\:522!_2OS0_2"2BBB@
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MX*:^!_;=_P!/]<W<^M>O_LV_'W3/@II/CJTU#3+W4&\1:=]DA>U*;8FP1ELD
M''/:OT&G_83^#%U<232^$W:21BS,+Z?D_P#?=,/[!7P3#;AX2D![?Z?<8_\
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MIXR_;+^'OB#X.>*/ -CX$DT[23&D.C6@P$ _YZ2<_*P;D<G->5_LI?M":5\
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MY?B;_GOI?_?J3_&E4>(QG,VEG_MG)_C6]3=@H =1110 4444 %%%% !1110
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M8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQFL=3^ 7B&P^*^BVGVX2VT=CXCT^)@OVH[0$G _OA^_I7HW[/'PYO] TB_\
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ME57+V\^QA&453=UU\NY]/?"B;PS<^"-)E\'K OAYX@UHMK]P(>PSTKM:\P^
M'@*W^''PYTG1(+J2]\M/.>>10NYW.XX4=!D],UZ?7CSMS.Q[$+\JN%%%%06?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>dkdcu-20230331xs4a058.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a058.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !S 2H# 2(  A$! Q$!_\0
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MS@<<<U#^WE'8QZ+\'TT[4)-4T]?#RBVOIAMDN8@L>R1@><L,''O7;_$SXH_
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M $%=0_[^K_\ $TO]@-_T%=0_[^K_ /$T :U%9']@-_T%=0_[^K_\31_8#?\
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MTU\)?!=E\+M,DC\/:>[V%W8:?:RM&'>& W29B5FYV_,>,]ZB-.#DH.6K\O\
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E?W4LC22W,Q &]V8DDXX]*]KHHKQZW\27J>S1_AQ"BBBLC4__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>dkdcu-20230331xs4a059.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dkdcu-20230331xs4a059.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !( 7,# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**0G%
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M*!W)%=;7YU_\%2?%^I_$;Q;\+?V??#EWMO/%>I1W.I1Q\E8A($AWC^YN+O\
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M![%W*J/]ZOSM_P""5WP<O/C!\2O&G[1?C>'[?J4NHSQ:5)."1]KD^:YG7/\
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MC.6.<FOV%_X)Z?LVK^SE^SYI5IJ-C]D\6ZX%U/6=X^='8?NH3Z>6A QV9GH
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M &&_5OX5?LU_#_X-_#&;P'X;\/P1:#=0-!J'G@/-J.Y"CO</@&1F!(/0 '
M'%9'P0_8]^$O[/4BW/@SP=96>J*)%&K76;F]"N>5$SY8+C"X&.!SG)R ?%?_
M  3V;P?X'_:9\<>%OB4MUJ'[1KW%SYNOWUTMU;3KM5Y([9N")"A)8E>54A2
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M@#Y!^-?_  3!^$?QJ^(&E^)KE;_PY%:VL-G/I6@B&WMKF.+B//R$J0N$RO\
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MW;^,O$$VOW"7.,6[R#F-,=1N+G)Y^8#MSZM110 4444 %%%% !1110 4444
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5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083758352576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-4/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DATA KNIGHTS ACQUISITION CORP.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001849380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">AMENDMENT NO. 6 <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755623120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 07, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 10,108<span></span>
</td>
<td class="nump">$ 30,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrepaidInsuranceCurrent', window );">Prepaid insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">10,108<span></span>
</td>
<td class="nump">30,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="nump">29,725,574<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,320,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">29,735,682<span></span>
</td>
<td class="nump">29,060,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,857,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,933,661<span></span>
</td>
<td class="nump">1,679,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Amount due to related parties</a></td>
<td class="nump">11,200<span></span>
</td>
<td class="nump">11,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">274,448<span></span>
</td>
<td class="nump">214,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Franchise tax payable</a></td>
<td class="nump">117,447<span></span>
</td>
<td class="nump">69,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">2,336,756<span></span>
</td>
<td class="nump">1,976,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantLiabilityNonCurrent', window );">Warrant liabilities</a></td>
<td class="nump">362,558<span></span>
</td>
<td class="nump">362,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,851,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DeferredOfferingCostsNonCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="nump">4,025,000<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesNoncurrent', window );">Working capital loan</a></td>
<td class="nump">239,081<span></span>
</td>
<td class="nump">207,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionLoansNonCurrent', window );">Extension loans</a></td>
<td class="nump">2,914,598<span></span>
</td>
<td class="nump">2,545,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">9,877,993<span></span>
</td>
<td class="nump">9,116,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,166,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">2,242,253<span></span>
</td>
<td class="nump">2,242,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(11,718,728)<span></span>
</td>
<td class="num">(11,632,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,609,810)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Deficit</a></td>
<td class="num">(9,475,991)<span></span>
</td>
<td class="num">(8,806,438)<span></span>
</td>
<td class="num">$ (6,413,955)<span></span>
</td>
<td class="num">(8,609,463)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Deficit</a></td>
<td class="nump">29,735,682<span></span>
</td>
<td class="nump">29,060,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,857,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember', window );">Class A Common Stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A Common Stock subject to possible redemption; 4,838,792 shares at redemption value of $10.74 and $10.53 per share as of March 31, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">29,333,680<span></span>
</td>
<td class="nump">28,750,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember', window );">Class A Common Stock not subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered, excluding offering costs (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DeferredOfferingCostsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DeferredOfferingCostsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionLoansNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of extension loans outstanding, non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionLoansNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PrepaidInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prepaid insurance current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PrepaidInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantLiabilityNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantLiabilityNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083758242288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 11, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Common share at redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">3,316,819<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember', window );">Class A Common Stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Common share at redemption value</a></td>
<td class="nump">$ 10.74<span></span>
</td>
<td class="nump">$ 10.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common Stock, subject to possible redemption</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">2,731,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember', window );">Class A Common Stock not subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, shares issued</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, shares issued</a></td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755544848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Formation and operating costs</a></td>
<td class="nump">$ 306,303<span></span>
</td>
<td class="nump">$ 560,185<span></span>
</td>
<td class="nump">$ 421,397<span></span>
</td>
<td class="nump">$ 5,103,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FranchiseTaxExpense', window );">Franchise tax expense</a></td>
<td class="nump">47,481<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">164,008<span></span>
</td>
<td class="nump">205,560<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operation costs</a></td>
<td class="num">(353,784)<span></span>
</td>
<td class="num">(610,185)<span></span>
</td>
<td class="num">(585,405)<span></span>
</td>
<td class="num">(5,309,291)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount', window );">Interest earned on securities held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RealizedAndUnrealizedGainLoss', window );">Dividends, realized and unrealized gain in Trust Account</a></td>
<td class="nump">327,399<span></span>
</td>
<td class="nump">43,053<span></span>
</td>
<td class="nump">19,097<span></span>
</td>
<td class="nump">1,371,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,762,640<span></span>
</td>
<td class="nump">6,325,281<span></span>
</td>
<td class="nump">4,489,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(625,059)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net income (loss) before provision for income taxes</a></td>
<td class="num">(26,385)<span></span>
</td>
<td class="nump">2,195,508<span></span>
</td>
<td class="nump">5,135,790<span></span>
</td>
<td class="nump">551,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(59,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(214,850)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(85,983)<span></span>
</td>
<td class="nump">2,195,508<span></span>
</td>
<td class="nump">$ 5,135,790<span></span>
</td>
<td class="nump">$ 336,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (54,958)<span></span>
</td>
<td class="nump">$ 1,687,692<span></span>
</td>
<td class="nump">$ 3,671,658<span></span>
</td>
<td class="nump">$ 240,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, Basic</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">8,264,526<span></span>
</td>
<td class="nump">8,667,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, Diluted</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">8,264,526<span></span>
</td>
<td class="nump">8,667,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember', window );">Class A and Class B non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (31,025)<span></span>
</td>
<td class="nump">$ 507,816<span></span>
</td>
<td class="nump">$ 1,464,132<span></span>
</td>
<td class="nump">$ 96,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, Basic</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">3,460,275<span></span>
</td>
<td class="nump">3,295,610<span></span>
</td>
<td class="nump">3,464,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, Diluted</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">3,460,275<span></span>
</td>
<td class="nump">3,295,610<span></span>
</td>
<td class="nump">3,464,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_FranchiseTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of franchise tax expense incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_FranchiseTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest earned on marketable securities held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RealizedAndUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RealizedAndUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083756550288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)<br></strong></div></th>
<th class="th">
<div>Class A Common Stock </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Class B Common Stock </div>
<div>Common Stock</div>
</th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Feb. 07, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Feb. 07, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase Decrease In Stockholders Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor', window );">Sale of non-redeemable private placement units to Sponsor</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,290,242<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,290,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares', window );">Sale of non-redeemable private placement units to Sponsor(in shares)</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockSubjectToPossibleRedemptionValue', window );">Re-measurement of Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,314,954)<span></span>
</td>
<td class="num">(13,745,600)<span></span>
</td>
<td class="num">(19,060,554)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,135,790<span></span>
</td>
<td class="nump">5,135,790<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,609,810)<span></span>
</td>
<td class="num">(8,609,463)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2021</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase Decrease In Stockholders Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,195,508<span></span>
</td>
<td class="nump">2,195,508<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2022</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,414,302)<span></span>
</td>
<td class="num">(6,413,955)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Mar. 31, 2022</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,609,810)<span></span>
</td>
<td class="num">(8,609,463)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase Decrease In Stockholders Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockSubjectToPossibleRedemptionValue', window );">Re-measurement of Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,359,593)<span></span>
</td>
<td class="num">(3,359,593)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336,658<span></span>
</td>
<td class="nump">336,658<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2022</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">2,242,253<span></span>
</td>
<td class="num">(11,632,745)<span></span>
</td>
<td class="num">(8,806,438)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2022</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase Decrease In Stockholders Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockSubjectToPossibleRedemptionValue', window );">Re-measurement of Class A Common Stock Subject to Possible Redemption</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(583,570)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(583,570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockSubjectToPossibleRedemptionShares', window );">Re-measurement of Class A Common Stock Subject to Possible Redemption (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(85,983)<span></span>
</td>
<td class="num">(85,983)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2023</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">$ 2,242,253<span></span>
</td>
<td class="num">$ (11,718,728)<span></span>
</td>
<td class="num">$ (9,475,991)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Mar. 31, 2023</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockSubjectToPossibleRedemptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of the shares of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockSubjectToPossibleRedemptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockSubjectToPossibleRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockSubjectToPossibleRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Sale of non-redeemable private placement units to Sponsor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents of Sale Of Non-Redeemable Private Placement Units To Sponsor in Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083754631024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flow from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (85,983)<span></span>
</td>
<td class="nump">$ 2,195,508<span></span>
</td>
<td class="nump">$ 5,135,790<span></span>
</td>
<td class="nump">$ 336,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_OfferingCostsAllocatedToWarrantLiability', window );">Offering costs allocated to warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,825,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RealizedAndUnrealizedGainLoss', window );">Dividends, realized and unrealized gain in Trust Account</a></td>
<td class="num">(327,399)<span></span>
</td>
<td class="num">(43,053)<span></span>
</td>
<td class="num">(19,097)<span></span>
</td>
<td class="num">(1,371,689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount', window );">Interest earned on securities held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,762,640)<span></span>
</td>
<td class="num">(6,325,281)<span></span>
</td>
<td class="num">(4,489,110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,739<span></span>
</td>
<td class="num">(83,061)<span></span>
</td>
<td class="nump">83,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">253,841<span></span>
</td>
<td class="nump">390,436<span></span>
</td>
<td class="nump">125,972<span></span>
</td>
<td class="nump">1,553,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_IncreaseDecreaseFranchiseTaxPayable', window );">Franchise tax payable</a></td>
<td class="nump">47,481<span></span>
</td>
<td class="num">(114,008)<span></span>
</td>
<td class="nump">164,008<span></span>
</td>
<td class="num">(94,042)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="nump">59,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">214,850<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(52,462)<span></span>
</td>
<td class="num">(294,018)<span></span>
</td>
<td class="num">(378,487)<span></span>
</td>
<td class="num">(940,463)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flow from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount', window );">Investment of cash in Trust Account</a></td>
<td class="num">(368,760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,300,000)<span></span>
</td>
<td class="num">(2,545,838)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(368,760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,300,000)<span></span>
</td>
<td class="num">(2,246,237)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flow from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NetProceedsFromInitialPublicOffering', window );">Proceeds from sale of Units, net of underwriting discount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromSaleOfPrivateUnits', window );">Proceeds from sale of Private units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,852,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(446,112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdvancesFromRelatedParties', window );">Advances from related parties</a></td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromWorkingCapitalLoan', window );">Proceeds from working capital loan</a></td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">207,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromExtensionLoan', window );">Proceeds from extension loans</a></td>
<td class="nump">368,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,545,838<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">400,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,131,638<span></span>
</td>
<td class="nump">2,764,419<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="num">(20,762)<span></span>
</td>
<td class="num">(294,018)<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="num">(422,281)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at the beginning of the period</a></td>
<td class="nump">30,870<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at the end of the period</a></td>
<td class="nump">10,108<span></span>
</td>
<td class="nump">$ 159,133<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="nump">30,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption', window );">Re-measurement of Class A common stock subject to possible redemption</a></td>
<td class="num">$ (583,570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,359,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest', window );">Redemption of Class A common stock held in Trust, including interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 91,909,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DeferredUnderwritingFeePayable', window );">Deferred underwriting fee payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InitialFairValueOfWarrantLiabilities', window );">Initial classification of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,176,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AdvancesFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with advances from related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AdvancesFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_IncreaseDecreaseFranchiseTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of franchise tax payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_IncreaseDecreaseFranchiseTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InitialFairValueOfWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The initial fair value classification of warrant liabilities disclosed in the supplemental non-cash cash flow activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InitialFairValueOfWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest earned on marketable securities held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NetProceedsFromInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public, net of underwriting discounts paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NetProceedsFromInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_OfferingCostsAllocatedToWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Offering costs allocated to warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_OfferingCostsAllocatedToWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromExtensionLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with proceeds from extension loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromExtensionLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromSaleOfPrivateUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of private units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromSaleOfPrivateUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromWorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with proceeds from working capital loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromWorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RealizedAndUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RealizedAndUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of redemption of Class A common stock held in Trust, including interest, classified as non-cash financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of remeasurement of Class A common stock subject to possible redemption, classified as non-cash financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083758263536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights Acquisition Corp. (the &#8220;Company&#8221;) is a blank check company incorporated in Delaware on February 8, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> or more businesses (the &#8220;Business Combination&#8221;). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023, the Company had not yet commenced any operations. All activity for the period February 8, 2021 (inception) through March 31, 2023, relates to the Company&#8217;s formation and the initial public offering (the &#8220;Initial Public Offering&#8221;), and, since the closing of the initial public offering, the Company has entered into a merger agreement (as described below), and continued a search for a Business Combination candidate. The Company has selected December 31 as its fiscal year end.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The registration statement for the Company&#8217;s Initial Public Offering was declared effective on May 6, 2021. On May 11, 2021, the Company consummated the Initial Public Offering of </span><span style="font-family:'Times New Roman','Times','serif';">11,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> units (&#8220;Units&#8221; and, with respect to the shares of Class&#160;A Common Stock included in the Units offered, the &#8220;Public Shares&#8221;), generating gross proceeds of </span><span style="font-family:'Times New Roman','Times','serif';">$115,000,000</span><span style="font-family:'Times New Roman','Times','serif';">, which is described in Note&#160;3.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> private placement units (the &#8220;Private Placement Units&#8221;) at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per unit in a private placement to the Sponsor, generating gross proceeds of </span><span style="font-family:'Times New Roman','Times','serif';">$5,852,750</span><span style="font-family:'Times New Roman','Times','serif';">, which is described in Note&#160;4.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Following the closing of the Initial Public Offering on May 11, 2021, an amount of </span><span style="font-family:'Times New Roman','Times','serif';">$117,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> (</span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (&#8220;Trust Account&#8221;) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company&#8217;s stockholders, as described below.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Transaction costs of the Initial Public Offering amounted to </span><span style="font-family:'Times New Roman','Times','serif';">$6,771,112</span><span style="font-family:'Times New Roman','Times','serif';">, of which </span><span style="font-family:'Times New Roman','Times','serif';">$2,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> was for underwriting fees paid at the time of the IPO, </span><span style="font-family:'Times New Roman','Times','serif';">$4,025,000</span><span style="font-family:'Times New Roman','Times','serif';"> was for deferred underwriting commissions, and </span><span style="font-family:'Times New Roman','Times','serif';">$446,112</span><span style="font-family:'Times New Roman','Times','serif';"> was for other offering costs. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Following the closing of the Initial Public Offering </span><span style="font-family:'Times New Roman','Times','serif';">$959,560</span><span style="font-family:'Times New Roman','Times','serif';"> of cash was held outside of the Trust Account available for working capital purposes. As of March 31, 2023, the Company has </span><span style="font-family:'Times New Roman','Times','serif';">$10,108</span><span style="font-family:'Times New Roman','Times','serif';"> of cash and a working capital deficit of $</span><span style="font-family:'Times New Roman','Times','serif';">2,326,648</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least </span><span style="font-family:'Times New Roman','Times','serif';">80%</span><span style="font-family:'Times New Roman','Times','serif';"> of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires </span><span style="font-family:'Times New Roman','Times','serif';">50%</span><span style="font-family:'Times New Roman','Times','serif';"> or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully affect a Business Combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 25, 2022, the Company, Data Knights Merger Sub, Inc., a Delaware corporation (&#8220;Merger Sub&#8221;), and Data Knights, LLC, the Company&#8217;s sponsor (the &#8220;Sponsor&#8221;), entered into a definitive Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with OneMedNet Corporation, Inc., a Delaware corporation (the &#8220;Target&#8221;, and together with the Company and Merger Sub, the &#8220;Parties&#8221;) and Paul Casey, as seller representative (&#8220;Casey&#8221;). Pursuant to the Merger Agreement, upon the closing (the &#8220;Closing&#8221;) of the Business Combination, the Parties will effect the merger of Merger Sub with and into the Target, with the Target continuing as the </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">surviving entity (the &#8220;Merger&#8221;), as a result of which all of the issued and outstanding capital stock of the Target shall be exchanged shares of the Class A Common Stock of the Company upon the terms set forth in the Merger Agreement.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On May 5, 2022, the Company extended the date by which the Company has to consummate a business combination from May 11, 2022 to August 11, 2022 (the &#8220;First Extension&#8221;). The First Extension was the first of </span><span style="font-family:'Times New Roman','Times','serif';">two</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">three-month</span><span style="font-family:'Times New Roman','Times','serif';"> extensions permitted under the Company&#8217;s governing documents.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On August 10, 2022, the Company extended the date by which the Company has to consummate a business combination from August 11, 2022 to November 11, 2022 (the &#8220;Second Extension&#8221;). The Second Extension was the second of </span><span style="font-family:'Times New Roman','Times','serif';">two</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">three-month</span><span style="font-family:'Times New Roman','Times','serif';"> extensions permitted under the Company&#8217;s governing documents.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On October 27, 2022, the Company filed a definitive proxy statement with the SEC in connection with the Company&#8217;s solicitation of proxies for the vote by the stockholders of the Company at a special meeting of the Company&#8217;s stockholders to be held on November 11, 2022 (the &#8220;Special Meeting&#8221;).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On November 11, 2022, at 10:00 a.m. ET, the Company held a virtual special meeting of its stockholders. At the special meeting, Company stockholders entitle to vote at the special meeting cast their votes and approved the Trust Amendment Proposal, pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO if the Company has not completed its initial business combination, from November 11, 2022 to August 11, 2023 (or such earlier date after November 11, 2022, as determined by the Data Knights Board). As a part of Special Meeting, the Company&#8217;s stockholders approved amendments to its second amended and restated certificate of incorporation (the &#8220;Extension Amendment&#8221;) and the investment management trust agreement (the &#8220;Trust Agreement&#8221;) between Continental Stock Transfer &amp; Trust Company, as trustee (&#8220;Continental&#8221;), and the Company governing the trust account (the &#8220;Trust Account&#8221;) established in connection with the Company&#8217;s initial public offering dated May 11, 2021 (the &#8220;Trust Amendment&#8221;), which together allow the Company to extend the deadline by which it must complete its initial business combination by up to </span><span style="font-family:'Times New Roman','Times','serif';">nine</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">one-month</span><span style="font-family:'Times New Roman','Times','serif';"> periods. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, shall cause </span><span style="font-family:'Times New Roman','Times','serif';">$0.045</span><span style="font-family:'Times New Roman','Times','serif';"> per outstanding share of the Company&#8217;s Class A Common Stock, or approximately </span><span style="font-family:'Times New Roman','Times','serif';">$122,920</span><span style="font-family:'Times New Roman','Times','serif';">, to be deposited in the Trust Account. As of March 31, 2023, the Company has executed </span><span style="font-family:'Times New Roman','Times','serif';">five</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">one-month</span><span style="font-family:'Times New Roman','Times','serif';"> extensions, out of the </span><span style="font-family:'Times New Roman','Times','serif';">nine</span><span style="font-family:'Times New Roman','Times','serif';">, resulting in deposits of approximately </span><span style="font-family:'Times New Roman','Times','serif';">$614,600</span><span style="font-family:'Times New Roman','Times','serif';"> into the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In connection with the proposed Business Combination with the Target, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Stock upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the proposed Business Combination with the Target is not consummated, in connection with an alternative proposed initial business combination, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least </span><span style="font-family:'Times New Roman','Times','serif';">$5,000,001</span><span style="font-family:'Times New Roman','Times','serif';"> either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of </span><span style="font-family:'Times New Roman','Times','serif';">8,768,456</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.42</span><span style="font-family:'Times New Roman','Times','serif';"> per share, for an aggregate of approximately </span><span style="font-family:'Times New Roman','Times','serif';">$91.4</span><span style="font-family:'Times New Roman','Times','serif';"> million. Following the payment of the redemptions, the Trust Account had a balance of approximately </span><span style="font-family:'Times New Roman','Times','serif';">$28.5</span><span style="font-family:'Times New Roman','Times','serif';"> million.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Based on the above, the Company will have until August 11, 2023 to consummate a Business Combination. If the Company is unable to complete a Business Combination on August 11, 2023 at the election of the Company subject to satisfaction of certain conditions, including the deposit of up </span><span style="font-family:'Times New Roman','Times','serif';">$2,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> since the underwriters&#8217; over-allotment option is exercised in full (</span><span style="font-family:'Times New Roman','Times','serif';">$0.10</span><span style="font-family:'Times New Roman','Times','serif';"> per unit), into the Trust Account, or as extended by the Company&#8217;s stockholders in accordance with the Company&#8217;s amended and restated certificate of incorporation) (the &#8220;Combination Period&#8221;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to </span><span style="font-family:'Times New Roman','Times','serif';">$100,000</span><span style="font-family:'Times New Roman','Times','serif';"> of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#8217;s </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit (</span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';">). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the shares of Class A Common Stock and the warrants that are included as components of the Private Placement Units. Such warrants will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) </span><span style="font-family:'Times New Roman','Times','serif';">$10.20</span><span style="font-family:'Times New Roman','Times','serif';"> per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than </span><span style="font-family:'Times New Roman','Times','serif';">$10.20</span><span style="font-family:'Times New Roman','Times','serif';"> per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Going Concern, Liquidity and Capital Resources</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and December 31, 2022, the Company had cash held outside of the Trust Account of </span><span style="font-family:'Times New Roman','Times','serif';">$10,108</span><span style="font-family:'Times New Roman','Times','serif';"> and $</span><span style="font-family:'Times New Roman','Times','serif';">30,870</span><span style="font-family:'Times New Roman','Times','serif';">, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial business combination. As of March 31, 2023 and December 31,2022, the Company had working capital deficit of </span><span style="font-family:'Times New Roman','Times','serif';">$2,326,648 </span><span style="font-family:'Times New Roman','Times','serif';">and </span><span style="font-family:'Times New Roman','Times','serif';">$1,945,267</span><span style="font-family:'Times New Roman','Times','serif';">, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company&#8217;s liquidity needs prior to the consummation of its IPO were satisfied through the proceeds of </span><span style="font-family:'Times New Roman','Times','serif';">$25,000</span><span style="font-family:'Times New Roman','Times','serif';"> from the sale of the Founder Shares and proceed from the promissory note from sponsor of </span><span style="font-family:'Times New Roman','Times','serif';">$78,925</span><span style="font-family:'Times New Roman','Times','serif';">, which was repaid upon closure of the IPO. Subsequent to the IPO, the Company&#8217;s liquidity will be satisfied through a portion of the net proceeds from IPO held outside of the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and December 31, 2022, we had investments of </span><span style="font-family:'Times New Roman','Times','serif';">$29,725,574</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$29,029,416</span><span style="font-family:'Times New Roman','Times','serif';"> held in the Trust Account, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes. For the three months ended March 31, 2023, we did not withdraw any of interest earned on the Trust Account. During the period ended December 31, 2022, we withdraw </span><span style="font-family:'Times New Roman','Times','serif';">$299,601</span><span style="font-family:'Times New Roman','Times','serif';"> interest earned on the Trust Account to pay Delaware Franchise Tax. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed. The Company will have until August 23, 2023 to consummate a Business Combination. If our initial business combination is not consummated by </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">August 23, 2023, less than one year after the date the financial statements are issued, then our existence will terminate, and we will distribute all amounts in the trust account. The Company intends to complete a business combination before the liquidation date and no adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after such date. There can be no assurance that the Company will be able to consummate an initial business combination by August 23, 2023 and/or have sufficient working capital and borrowing capacity to meet its needs. Based upon the above analysis, management determined that these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Accounts to repay such loaned amounts but no proceeds from our Trust Accounts would be used for such repayment. Up to </span><span style="font-family:'Times New Roman','Times','serif';">$1,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> of such loans may be convertible into units identical to the Placement Units, at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per unit at the option of the lender.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Risks and Uncertainties</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into law. The IR Act provides for, among other measures, a new 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom the shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased. For purposes of calculating the excise tax, however, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#8220;Treasury Department&#8221;) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Any redemption or other repurchase effected by us that occurs after December 31, 2022, in connection with a Business Combination or otherwise, may be subject to this excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the nature and amount of any PIPE financing or other equity issuances in connection with the Business Combination (or any other equity issuances within the same taxable year of the Business Combination) and (iii) the content of any regulations and other guidance issued by the Treasury Department and/or the Internal Revenue Service. In addition, because the excise tax would be payable by us and not by the redeeming holder, it could cause a reduction in the value of our stock. The foregoing could cause a reduction in the cash available on hand to complete a business Combination in the required time and redeem </span><span style="font-family:'Times New Roman','Times','serif';">100%</span><span style="font-family:'Times New Roman','Times','serif';"> of our public shares in accordance with our amended and restated certificate of incorporation) could be subject to the excise tax, in which case the amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights Acquisition Corp. (the &#8220;Company&#8221;) is a blank check company incorporated in Delaware on February 8, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the &#8220;Business Combination&#8221;). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, the Company had not yet commenced any operations. All activity for the period February 8, 2021 (inception) through December 31, 2022, relates to the Company&#8217;s formation and the initial public offering (the &#8220;Initial Public Offering&#8221;), and, since the closing of the initial public offering, the Company has entered into a merger agreement (as described below), and continued a search for a Business Combination candidate. The Company has selected December 31 as its fiscal year end.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The registration statement for the Company&#8217;s Initial Public Offering was declared effective on May 6, 2021. On May 11, 2021, the Company consummated the Initial Public Offering of 11,500,000 units (&#8220;Units&#8221; and, with respect to the shares of Class&#160;A Common Stock included in the Units offered, the &#8220;Public Shares&#8221;), generating gross proceeds of $115,000,000, which is described in Note&#160;3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 585,275 private placement units (the &#8220;Private Placement Units&#8221;) at a price of $10.00 per unit in a private placement to the Sponsor, generating gross proceeds of $5,852,750, which is described in Note&#160;4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering on May 11, 2021, an amount of $117,300,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (&#8220;Trust Account&#8221;) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company&#8217;s stockholders, as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Transaction costs of the Initial Public Offering amounted to $6,771,112, of which $2,300,000 was for underwriting fees paid at the time of the IPO, $4,025,000 was for deferred underwriting commissions, and $446,112 was for other offering costs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering $959,560 of cash was held outside of the Trust Account available for working capital purposes. As of December 31, 2022, the Company has $30,870 of cash and a working capital deficit of $1,945,267.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On April 25, 2022, the Company, Data Knights Merger Sub, Inc., a Delaware corporation (&#8220;Merger Sub&#8221;), and Data Knights, LLC, the Company&#8217;s sponsor (the &#8220;Sponsor&#8221;), entered into a definitive Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with OneMedNet Corporation, Inc., a Delaware corporation (the &#8220;Target&#8221;, and together with the Company and Merger Sub, the &#8220;Parties&#8221;) and Paul Casey, as seller representative (&#8220;Casey&#8221;). Pursuant to the Merger Agreement, upon the closing (the &#8220;Closing&#8221;) of the Business Combination, the Parties will effect the merger of Merger Sub with and into the Target, with the Target continuing as the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">surviving entity (the &#8220;Merger&#8221;), as a result of which all of the issued and outstanding capital stock of the Target shall be exchanged shares of the Class A Common Stock of the Company upon the terms set forth in the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On May 5, 2022, the Company extended the date by which the Company has to consummate a business combination from May 11, 2022 to August 11, 2022 (the &#8220;First Extension&#8221;). The First Extension was the first of two three-month extensions permitted under the Company&#8217;s governing documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On August 10, 2022, the Company extended the date by which the Company has to consummate a business combination from August 11, 2022 to November 11, 2022 (the &#8220;Second Extension&#8221;). The Second Extension was the second of two three-month extensions permitted under the Company&#8217;s governing documents. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On October 27, 2022, the Company filed a definitive proxy statement with the SEC in connection with the Company&#8217;s solicitation of proxies for the vote by the stockholders of the Company at a special meeting of the Company&#8217;s stockholders to be held on November 11, 2022 (the &#8220;Special Meeting&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On November 11, 2022, at 10:00 a.m. ET, the Company held a virtual special meeting of its stockholders. At the special meeting, Company stockholders entitle to vote at the special meeting cast their votes and approved the Trust Amendment Proposal, pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO if the Company has not completed its initial business combination, from November 11, 2022 to August 11, 2023 (or such earlier date after November 11, 2022, as determined by the Data Knights Board). As a part of Special Meeting, the Company&#8217;s stockholders approved amendments to its second amended and restated certificate of incorporation (the &#8220;Extension Amendment&#8221;) and the investment management trust agreement (the &#8220;Trust Agreement&#8221;) between Continental Stock Transfer &amp; Trust Company, as trustee (&#8220;Continental&#8221;), and the Company governing the trust account (the &#8220;Trust Account&#8221;) established in connection with the Company&#8217;s initial public offering dated May 11, 2021 (the &#8220;Trust Amendment&#8221;), which together allow the Company to extend the deadline by which it must complete its initial business combination by up to nine one-month periods. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, shall cause $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account. As of December 31, 2022, the Company has executed two one-month extensions, out of the nine, resulting in deposits of approximately $245,840 into the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the proposed Business Combination with the Target, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Stock upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the proposed Business Combination with the Target is not consummated, in connection with an alternative proposed initial business combination, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of 8,768,456 shares of Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of $10.42 per share, for an aggregate of approximately $91.4 million. Following the payment of the redemptions, the Trust Account had a balance of approximately $28.5 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Based on the above, the Company will have until August 11, 2023 to consummate a Business Combination. If the Company is unable to complete a Business Combination on August 11, 2023 at the election of the Company subject to satisfaction of certain conditions, including the deposit of up $2,300,000 since the underwriters&#8217; over-allotment option is exercised in full ($0.10 per unit), into the Trust Account, or as extended by the Company&#8217;s stockholders in accordance with the Company&#8217;s amended and restated certificate of incorporation) (the &#8220;Combination Period&#8221;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#8217;s </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the shares of Class A Common Stock and the warrants that are included as components of the Private Placement Units. Such warrants will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.20 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Going Concern, Liquidity and Capital Resources</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, the Company had cash held outside of the Trust Account of <span style="-sec-ix-hidden:Hidden_cZQeLnh3Zk29sDgjeEin2Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$30,780</span></span> and $453,151, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial business combination. As of December 31, 2022 and 2021, the Company had working capital surplus (deficit) of $(1,945,267) and $246,232, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s liquidity needs prior to the consummation of its IPO were satisfied through the proceeds of $25,000 from the sale of the Founder Shares and proceed from the promissory note from sponsor of $78,925, which was repaid upon closure of the IPO. Subsequent to the IPO, the Company&#8217;s liquidity will be satisfied through a portion of the net proceeds from IPO held outside of the Trust Account. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, we had investments of $29,029,416 and $117,320,973 held in the Trust Account, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes. During the period ended December 31, 2022, we withdraw $299,601 of interest earned on the Trust Account to pay Delaware Franchise Tax. During the period ended December 31, 2021, we did not withdraw any interest earned on the Trust Account. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed. The Company will have until August 23, 2023 to consummate a Business Combination. If our initial business combination is not consummated by </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">August 23, 2023, less than one year after the date the financial statements are issued, then our existence will terminate, and we will distribute all amounts in the trust account. The Company intends to complete a business combination before the liquidation date and no adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after such date. There can be no assurance that the Company will be able to consummate an initial business combination by August 23, 2023 and/or have sufficient working capital and borrowing capacity to meet its needs. Based upon the above analysis, management determined that these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Accounts to repay such loaned amounts but no proceeds from our Trust Accounts would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units identical to the Placement Units, at a price of $10.00 per unit at the option of the lender.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Risks and Uncertainties</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into law. The IR Act provides for, among other measures, a new 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom the shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased. For purposes of calculating the excise tax, however, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#8220;Treasury Department&#8221;) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Any redemption or other repurchase effected by us that occurs after December 31, 2022, in connection with a Business Combination or otherwise, may be subject to this excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the nature and amount of any PIPE financing or other equity issuances in connection with the Business Combination (or any other equity issuances within the same taxable year of the Business Combination) and (iii) the content of any regulations and other guidance issued by the Treasury Department and/or the Internal Revenue Service. In addition, because the excise tax would be payable by us and not by the redeeming holder, it could cause a reduction in the value of our stock. The foregoing could cause a reduction in the cash available on hand to complete a business Combination in the required time and redeem 100% of our public shares in accordance with our amended and restated certificate of incorporation) could be subject to the excise tax, in which case the amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760257264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Basis of presentation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Emerging growth company</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Use of estimates</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had </span><span style="font-family:'Times New Roman','Times','serif';">$10,108</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$30,870</span><span style="font-family:'Times New Roman','Times','serif';"> in cash and </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> cash equivalents as of March 31, 2023 and December 31, 2022, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Trust Account</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Upon the closing of the Initial Public Offering and the Private Placement, </span><span style="font-family:'Times New Roman','Times','serif';">$117,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> (</span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</span><span style="font-family:'Times New Roman','Times','serif';"> Accordingly, as of March 31, 2023, there were </span><span style="font-family:'Times New Roman','Times','serif';">3,316,819</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, excluding </span><span style="font-family:'Times New Roman','Times','serif';">2,731,544</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 31, 2023, there are </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and </span><span style="font-family:'Times New Roman','Times','serif';">4,838,792</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, which are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and 2022, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock &#8211; </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 583,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock - </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,333,680</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Net income (loss) per share</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net income (loss) between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for </span><span style="font-family:'Times New Roman','Times','serif';">12,085,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of common stock in the aggregate.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table reflects the calculation of basic and diluted net income (loss) per common share:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,687,692</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"><span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 4,838,792</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,500,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31,025)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 507,816</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"><span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 2,731,544</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,460,275</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At March 31, 2023 and 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Income Taxes </b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> unrecognized tax benefits and </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> amounts accrued for interest and penalties </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">as of March 31, 2023 and 2022, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Our effective tax rate was </span><span style="font-family:'Times New Roman','Times','serif';">(225.88%)</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">0%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of </span><span style="font-family:'Times New Roman','Times','serif';">21%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, due to transaction costs and the valuation allowance on the deferred tax assets.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within those fiscal years.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Basis of presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Emerging growth company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had $30,870 and $453,151 in cash and no cash equivalents as of December 31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Trust Account</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the Initial Public Offering and the Private Placement, $117,300,000 ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, there are 585,275 shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and 11,500,000 shares of Class A Common Stock outstanding, which are subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December 31, 2022 and 2021, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross Proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to public warrants and private warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,614,500)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issuance costs related to Class A Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,146,054)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Redemption of Class A Common Stock, including interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (91,909,483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,359,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,060,554</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Net income per share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net income per share is computed by dividing net income by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 12,085,275 shares of common stock in the aggregate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The following table reflects the calculation of basic and diluted net income per common share:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period of</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,671,658</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,667,969</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,264,526</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 96,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,464,132</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,295,610</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation Expense</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for stock-based compensation expense in accordance with ASC Topic 718, &#8220;Compensation &#8211; Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. The fair value of equity awards has been estimated using a market approach. Forfeitures are recognized as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Company determined that it was not probable that ARC would meet the performance condition as defined in the Introducing Advisor Agreement (See Note 5), and therefore, no stock-based compensation expense was recognized. At December 31, 2022, upon amendment of the Introducing Advisor Agreement, which amended ARC&#8217;s performance condition that was concurrently deemed to have been met, ARC was granted 1,378,517 shares of the Company&#8217;s Class B common stock at a fair value of $2.05 per share. The Company recorded the resulting $2,825,960<span style="white-space:pre-wrap;"> of stock based compensation expense on December 31, 2022, which is included in formation and operating costs in the consolidated statement of operations.  The fair value of the Class B common stock was determined by applying a discount to the actively traded Class A shares, which have an observable market price. The discount was calculated as the average discount of the Class B share price (derived) compared to the Class A share price (observable) for SPACs that have actively traded &#8220;Rights&#8221;.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760234272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InitialPublicOfferingAbstract', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InitialPublicOfferingDisclosureTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 3. INITIAL PUBLIC OFFERING</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to the Initial Public Offering, the Company sold </span><span style="font-family:'Times New Roman','Times','serif';">11,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> Units at a purchase price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Unit. Each Unit consists of </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> share of the Company&#8217;s Class A Common Stock, </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> par value, and </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> share of Class A Common Stock at an exercise price of </span><span style="font-family:'Times New Roman','Times','serif';">$11.50</span><span style="font-family:'Times New Roman','Times','serif';">&#160;per whole share (see Note&#160;9).</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 3. INITIAL PUBLIC OFFERING</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Pursuant to the Initial Public Offering, the Company sold 11,500,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one share of the Company&#8217;s Class A Common Stock, $0.0001 par value, and one redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $11.50&#160;per whole share (see Note&#160;9).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InitialPublicOfferingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on information about initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InitialPublicOfferingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083756714592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrivatePlacementAbstract', window );"><strong>PRIVATE PLACEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrivatePlacementTextBlock', window );">PRIVATE PLACEMENT</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 4. PRIVATE PLACEMENT</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> Private Placement Units at a price of $</span><span style="font-family:'Times New Roman','Times','serif';">10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Private Placement Unit for an aggregate purchase price of </span><span style="font-family:'Times New Roman','Times','serif';">$5,852,750</span><span style="font-family:'Times New Roman','Times','serif';">. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Private Placement Units are identical to the Units, except that (a) the Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of the Company&#8217;s initial business combination except to permitted transferees and (b) the Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) may be exercised by the holders on a cashless basis and (ii) will be entitled to registration rights.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 4. PRIVATE PLACEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of 585,275 Private Placement Units at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $5,852,750. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Private Placement Units are identical to the Units, except that (a) the Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of the Company&#8217;s initial business combination except to permitted transferees and (b) the Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) may be exercised by the holders on a cashless basis and (ii) will be entitled to registration rights.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PrivatePlacementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on information about private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PrivatePlacementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083756636112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 5. RELATED PARTY TRANSACTIONS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Introducing Advisor Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On June 26, 2021, the Company entered into an introducing advisor agreement (the &#8220;Introducing Advisor Agreement&#8221;) with ARC Group Limited, the Company&#8217;s financial advisor (&#8220;ARC&#8221;), pursuant to which ARC will make strategic introductions to the Company of potential target companies and/or their subsidiaries, affiliates, or representatives (each an &#8220;Advisor Target&#8221;) who may be interested in potential business combinations with the Company. In consideration for ARC&#8217;s services under the Introducing Advisor Agreement, we agreed to (i) pay to ARC (a) a retainer of </span><span style="font-family:'Times New Roman','Times','serif';">$50,000</span><span style="font-family:'Times New Roman','Times','serif';"> upon execution of the Introducing Advisor Agreement and (b) a success fee of </span><span style="font-family:'Times New Roman','Times','serif';">$100,000</span><span style="font-family:'Times New Roman','Times','serif';"> upon the closing our initial business combination, and (ii) cause to be issued to ARC equity interests in the post-combination company representing a five-percent (</span><span style="font-family:'Times New Roman','Times','serif';">5%</span><span style="font-family:'Times New Roman','Times','serif';">) ownership interest in the post-combination company, if at any time prior to June 25, 2022 (the &#8220;Termination Date&#8221;), or within six (</span><span style="-sec-ix-hidden:Hidden_-gBu7Ivd10mlotw_rZDvrw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6</span></span><span style="font-family:'Times New Roman','Times','serif';">) months after the consummation of an initial business combination or any financing with any Advisor Target or any affiliate of an Advisor Target (the &#8220;Equity Issuance&#8221;).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (</span><span style="font-family:'Times New Roman','Times','serif';">5%</span><span style="font-family:'Times New Roman','Times','serif';">) on any PIPE </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">that was brought by ARC in connection with the Company&#8217;s initial business combination upon the closing of the Company&#8217;s initial business combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued </span><span style="font-family:'Times New Roman','Times','serif';">1,378,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of the Company&#8217;s Class B Common Stock, up to </span><span style="font-family:'Times New Roman','Times','serif';">143,766</span><span style="font-family:'Times New Roman','Times','serif';"> shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Founder Shares</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On February 25, 2021, the Company issued an aggregate of </span><span style="font-family:'Times New Roman','Times','serif';">2,875,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B Common Stock (the &#8220;Founder Shares&#8221;) to the Sponsor for an aggregate purchase price of </span><span style="font-family:'Times New Roman','Times','serif';">$25,000</span><span style="font-family:'Times New Roman','Times','serif';">. On February 25, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';">15,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Executive Officer, </span><span style="font-family:'Times New Roman','Times','serif';">15,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Financial Officer and </span><span style="font-family:'Times New Roman','Times','serif';">5,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';">5,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to such independent director. The Founder Shares which the Sponsor and its permitted transferees will collectively own, on an as-converted basis, represent </span><span style="font-family:'Times New Roman','Times','serif';">20%</span><span style="font-family:'Times New Roman','Times','serif';"> of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. In connection with the Introducing Advisors Agreement, on December 31, 2022, ARC was granted </span><span style="font-family:'Times New Roman','Times','serif';">1,378,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B common stock, </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> par value per share, up to </span><span style="font-family:'Times New Roman','Times','serif';">143,766</span><span style="font-family:'Times New Roman','Times','serif';"> of which are subject to forfeiture by ARC if the Company&#8217;s public shareholders exercise redemption rights with respect to any of outstanding shares of Class A common stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;</span><span style="font-family:'Times New Roman','Times','serif';">six months</span><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company&#8217;s Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';">$12.00</span><span style="font-family:'Times New Roman','Times','serif';"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any </span><span style="font-family:'Times New Roman','Times','serif';">20</span><span style="font-family:'Times New Roman','Times','serif';"> trading&#160;days within any </span><span style="font-family:'Times New Roman','Times','serif';">30-</span><span style="font-family:'Times New Roman','Times','serif';">trading day period commencing at least </span><span style="font-family:'Times New Roman','Times','serif';">150 days</span><span style="font-family:'Times New Roman','Times','serif';"> after the Business Combination, the Founder Shares will be released from the lock-up.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Promissory Note&#160;&#8212; Related Party</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On February 8, 2021, the Sponsor committed to loan the Company an aggregate of up to </span><span style="font-family:'Times New Roman','Times','serif';">$300,000</span><span style="font-family:'Times New Roman','Times','serif';"> to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#8220;Note&#8221;). The Note was non-interest bearing and was payable on the earlier of July 31, 2021 or the completion of the Initial Public Offering. On June 1, 2021, the </span><span style="font-family:'Times New Roman','Times','serif';">$78,925</span><span style="font-family:'Times New Roman','Times','serif';"> outstanding under the promissory note was repaid in full. On March 31, 2023 and December 31, 2022, there is </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> amount outstanding under the promissory note.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Related Party Loans</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In order to finance transaction costs in connection with a Business Combination, the Company&#8217;s Sponsor, an affiliate of the Sponsor, or the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the &#8220;Working Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to </span><span style="font-family:'Times New Roman','Times','serif';">$1,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> of notes may be converted upon consummation of a Business Combination into units at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per unit. The Units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On March 31, 2023 and December 31, 2022, there is </span><span style="font-family:'Times New Roman','Times','serif';">$239,081</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$207,081</span><span style="font-family:'Times New Roman','Times','serif';"> outstanding under the Working Capital Loans, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company&#8217;s second amended and restated certificate of incorporation provides that, if the Company anticipates that it may not be able to consummate a Business Combination within </span><span style="font-family:'Times New Roman','Times','serif';">12 months</span><span style="font-family:'Times New Roman','Times','serif';"> from the closing of the Company&#8217;s initial public offering, the Company may, by resolution of the Company&#8217;s board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to </span><span style="font-family:'Times New Roman','Times','serif';">two</span><span style="font-family:'Times New Roman','Times','serif';"> times, each by an additional </span><span style="font-family:'Times New Roman','Times','serif';">three months</span><span style="font-family:'Times New Roman','Times','serif';"> (for a total of up to </span><span style="font-family:'Times New Roman','Times','serif';">18 months</span><span style="font-family:'Times New Roman','Times','serif';"> to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account as set out below. Pursuant to the terms of the </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Company&#8217;s second amended and restated certificate of incorporation and the trust agreement entered into between the Company and Continental Stock Transfer &amp; Trust Company, in order for the time available for the Company to consummate the initial Business Combination to be extended, the Sponsor or its affiliates or designees, upon </span><span style="font-family:'Times New Roman','Times','serif';">five</span><span style="font-family:'Times New Roman','Times','serif';"> business days advance notice prior to the applicable deadline, must deposit into the Trust Account </span><span style="font-family:'Times New Roman','Times','serif';">$1,150,000</span><span style="font-family:'Times New Roman','Times','serif';"> since the underwriters&#8217; over-allotment option is exercised in full (</span><span style="font-family:'Times New Roman','Times','serif';">$0.10</span><span style="font-family:'Times New Roman','Times','serif';"> per unit), on or prior to the date of the applicable deadline, for each of the available </span><span style="font-family:'Times New Roman','Times','serif';">three month</span><span style="font-family:'Times New Roman','Times','serif';"> extensions, providing a total possible Business Combination period of </span><span style="font-family:'Times New Roman','Times','serif';">18 months</span><span style="font-family:'Times New Roman','Times','serif';"> at a total payment value of </span><span style="font-family:'Times New Roman','Times','serif';">$2,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> since the underwriters&#8217; over-allotment option is exercised in full (</span><span style="font-family:'Times New Roman','Times','serif';">$0.10</span><span style="font-family:'Times New Roman','Times','serif';"> per unit) (the &#8220;Extension Loans&#8221;). Any such payments would be made in the form of non-interest-bearing loans. If the Company completes its initial Business Combination, the Company will, at the option of the Sponsor, repay the Extension Loans out of the proceeds of the Trust Account released to the Company or convert a portion or all of the total loan amount into units at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';">&#160;per unit, which units will be identical to the Private Placement Units. If the Company does not complete a Business Combination, the Company will repay such loans only from funds held outside of the Trust Account. Furthermore, the letter agreement among the Company and the Company&#8217;s officers, directors, and the Sponsor contains a provision pursuant to which the Sponsor will agree to waive its right to be repaid for such loans to the extent there is insufficient funds held outside of the Trust Account in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination. The public stockholders will not be afforded an opportunity to vote on the extension of time to consummate an initial Business Combination from </span><span style="font-family:'Times New Roman','Times','serif';">12 months</span><span style="font-family:'Times New Roman','Times','serif';"> to </span><span style="font-family:'Times New Roman','Times','serif';">18 months</span><span style="font-family:'Times New Roman','Times','serif';"> described above or redeem their shares in connection with such extensions. Pursuant to the foregoing, on May 5, 2022, the Company extended the date by which the Company had to consummate a business combination from May 11, 2022 to August 11, 2022. On August 10, 2022, the Company extended the date by which the Company had to consummate a business combination from August 11, 2022 to November 11, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As described in Note 1, on November 11, 2022, the Stockholders of the Company approved the Extension Amendment and the Trust Amendment to allow the Company to extend the deadline by which it must complete its initial business combination by up to nine </span><span style="font-family:'Times New Roman','Times','serif';">one-month</span><span style="font-family:'Times New Roman','Times','serif';"> periods from November 11, 2022. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, caused </span><span style="font-family:'Times New Roman','Times','serif';">$0.045</span><span style="font-family:'Times New Roman','Times','serif';"> per outstanding share of the Company&#8217;s Class A Common Stock, or approximately </span><span style="font-family:'Times New Roman','Times','serif';">$122,920</span><span style="font-family:'Times New Roman','Times','serif';">, deposited in the Trust Account in connection with the exercise of the monthly extension. In connection with each such extension, the Company will have until April 11, 2023 to consummate a Business Combination(see Note 11). On March 31, 2023 and December 31, 2022, there is </span><span style="font-family:'Times New Roman','Times','serif';">$2,914,598</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$2,545,838</span><span style="font-family:'Times New Roman','Times','serif';"> outstanding under the Extension Loan, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Administrative Services Arrangement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Commencing on the date of the prospectus and until completion of the Company&#8217;s Business Combination or liquidation, the Company may reimburse ARC Group Ltd., an affiliate of the Sponsor, up to an amount of </span><span style="font-family:'Times New Roman','Times','serif';">$10,000</span><span style="font-family:'Times New Roman','Times','serif';"> per month for office space, secretarial and administrative support. For the three months ended March 31, 2023 and 2022, we have incurred </span><span style="font-family:'Times New Roman','Times','serif';">$30,000</span><span style="font-family:'Times New Roman','Times','serif';"> in fees under this agreement, respectively.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 5. RELATED PARTY TRANSACTIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Introducing Advisor Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June 26, 2021, the Company entered into an introducing advisor agreement (the &#8220;Introducing Advisor Agreement&#8221;) with ARC Group Limited, the Company&#8217;s financial advisor (&#8220;ARC&#8221;), pursuant to which ARC will make strategic introductions to the Company of potential target companies and/or their subsidiaries, affiliates, or representatives (each an &#8220;Advisor Target&#8221;) who may be interested in potential business combinations with the Company. In consideration for ARC&#8217;s services under the Introducing Advisor Agreement, we agreed to (i) pay to ARC (a) a retainer of $50,000 upon execution of the Introducing Advisor Agreement and (b) a success fee of $100,000 upon the closing our initial business combination, and (ii) cause to be issued to ARC equity interests in the post-combination company representing a five-percent (5%) ownership interest in the post-combination company, if at any time prior to June 25, 2022 (the &#8220;Termination Date&#8221;), or within six (6) months after the consummation of an initial business combination or any financing with any Advisor Target or any affiliate of an Advisor Target (the &#8220;Equity Issuance&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (5%) on any PIPE that was brought by ARC in connection with the Company&#8217;s initial business combination upon the closing of the Company&#8217;s initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued 1,378,517 shares of the Company&#8217;s Class B Common Stock, up to 143,766 shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Founder Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 25, 2021, the Company issued an aggregate of 2,875,000 shares of Class B Common Stock (the &#8220;Founder Shares&#8221;) to the Sponsor for an aggregate purchase price of $25,000. On February 25, 2021, the Sponsor transferred 15,000 shares to the Company&#8217;s Chief Executive Officer, 15,000 shares to the Company&#8217;s Chief Financial Officer and 5,000 shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred 5,000 shares to such independent director. The Founder Shares which the Sponsor and its permitted transferees will collectively own, on an as-converted basis, represent 20% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. In connection with the Introducing Advisors Agreement, on December 31, 2022, ARC was granted 1,378,517 shares of Class B common stock, $0.0001 par value per share, up to 143,766 of which are subject to forfeiture by ARC if the Company&#8217;s public shareholders exercise redemption rights with respect to any of outstanding shares of Class A common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;six months after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company&#8217;s Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any <span style="-sec-ix-hidden:Hidden_bbHY3R68R0qhn-ZoycDM0g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> trading&#160;days within any <span style="-sec-ix-hidden:Hidden_oJtbLe8GvkWMoQVqcR68nA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span>-trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Promissory Note&#160;&#8212; Related Party</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 8, 2021, the Sponsor committed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#8220;Note&#8221;). The Note was non-interest bearing and was payable on the earlier of July 31, 2021 or the completion of the Initial Public Offering. On June 1, 2021, the $78,925 outstanding under the promissory note was repaid in full. On December 31, 2022 and 2021, there is no amount outstanding under the promissory note.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Related Party Loans</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to finance transaction costs in connection with a Business Combination, the Company&#8217;s Sponsor, an affiliate of the Sponsor, or the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the &#8220;Working Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into units at a price of $10.00 per unit. The Units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On December 31, 2022 and 2021, there is $207,081 and nil outstanding under the Working Capital Loans, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s second amended and restated certificate of incorporation provides that, if the Company anticipates that it may not be able to consummate a Business Combination within 12 months from the closing of the Company&#8217;s initial public offering, the Company may, by resolution of the Company&#8217;s board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to two times, each by an additional three months (for a total of up to 18 months to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account as set out below. Pursuant to the terms of the Company&#8217;s second amended and restated certificate of incorporation and the trust agreement entered into between the Company and Continental Stock Transfer &amp; Trust Company, in order for the time available for the Company to consummate the initial Business Combination to be extended, the Sponsor or its affiliates or designees, upon five business days advance notice prior to the applicable deadline, must deposit into the Trust Account $1,150,000 since the underwriters&#8217; over-allotment option is exercised in full ($0.10 per unit), on or prior to the date of the applicable deadline, for each of the available three month extensions, providing a total possible Business Combination period of 18 months at a total payment value of $2,300,000 since the underwriters&#8217; over-allotment option is exercised in full ($0.10 per unit) (the &#8220;Extension Loans&#8221;). Any such payments would be made in the form of non-interest-bearing loans. If the Company completes its initial Business Combination, the Company will, at the option of the Sponsor, repay the Extension Loans out of the proceeds of the Trust Account released to the Company or convert a portion or all of the total loan amount into units at a price of $10.00&#160;per unit, which units will be identical to the Private Placement Units. If the Company does not complete a Business Combination, the Company will repay such loans only from funds held outside of the Trust Account. Furthermore, the letter agreement among the Company and the Company&#8217;s officers, directors, and the Sponsor contains a provision pursuant to which the Sponsor will agree to waive its right to be repaid for such loans to the extent there is insufficient funds held outside of the Trust Account in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination. The public stockholders will not be afforded an opportunity to vote on the extension of time to consummate an initial Business Combination from 12 months to 18 months described above or redeem their shares in connection with such extensions. Pursuant to the foregoing, on May 5, 2022, the Company extended the date by which the Company had to consummate a business combination from May 11, 2022 to August 11, 2022. On August 10, 2022, the Company extended the date by which the Company had to consummate a business combination from August 11, 2022 to November 11, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As described in Note 1, on November 11, 2022, the Stockholders of the Company approved the Extension Amendment and the Trust Amendment to allow the Company to extend the deadline by which it must complete its initial business combination by up to nine one-month periods from November 11, 2022. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, caused $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, deposited in the Trust Account in connection with the exercise of the monthly extension. In connection with each such extension, the Company will have until April 11, 2023 to consummate a Business Combination (see Note 11). On December 31, 2022 and 2021, there is $2,545,838 and nil outstanding under the Extension Loan, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Administrative Services Arrangement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Commencing on the date of the prospectus and until completion of the Company&#8217;s Business Combination or liquidation, the Company may reimburse ARC Group Ltd., an affiliate of the Sponsor, up to an amount of $10,000 per month for office space, secretarial and administrative support. For the year ended December 31, 2022, we have incurred $120,000 in fees under this agreement. From February 8, 2021(inception) to December 31, 2021, the Company incurred $80,000 in fees under this agreement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755606864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 6. COMMITMENTS AND CONTINGENCIES</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Registration Rights</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to a registration rights agreement entered into on May 6, 2021, the holders of the Founder Shares, Private Placement Units (including the securities contained therein), the units (including the securities contained therein) that may be issued upon conversion of the Working Capital Loans, and any shares of Class A Common Stock issuable upon the exercise of the Placement Warrants and any shares of Class A Common Stock, warrants (and underlying Class A Common Stock) that may be issued upon conversion of the units issued as part of the working capital loans and Class A Common Stock issuable upon conversion of the founder shares are entitled to registration rights. The holders of a majority of these securities are entitled to make up to </span><span style="font-family:'Times New Roman','Times','serif';">three</span><span style="font-family:'Times New Roman','Times','serif';"> demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Underwriters Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company granted the underwriter a </span><span style="font-family:'Times New Roman','Times','serif';">45</span><span style="font-family:'Times New Roman','Times','serif';">-day option to purchase up to </span><span style="font-family:'Times New Roman','Times','serif';">1,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The aforementioned option was exercised on May 11, 2021.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The underwriter was paid a cash underwriting discount of two percent (</span><span style="font-family:'Times New Roman','Times','serif';">2.00%</span><span style="font-family:'Times New Roman','Times','serif';">) of the gross proceeds of the Initial Public Offering, or </span><span style="font-family:'Times New Roman','Times','serif';">$2,300,000</span><span style="font-family:'Times New Roman','Times','serif';">. In addition, the underwriter is entitled to a deferred fee of three and a half percent (</span><span style="font-family:'Times New Roman','Times','serif';">3.50%</span><span style="font-family:'Times New Roman','Times','serif';">) of the gross proceeds of the Initial Public Offering, or </span><span style="font-family:'Times New Roman','Times','serif';">$4,025,000</span><span style="font-family:'Times New Roman','Times','serif';">. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Right of First Refusal</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">For a period beginning on May 7, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">First Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (</span><span style="font-family:'Times New Roman','Times','serif';">5</span><span style="font-family:'Times New Roman','Times','serif';">%) on any PIPE that was brought by ARC in connection with an initial business combination upon the closing of an initial business combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Second Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued </span><span style="font-family:'Times New Roman','Times','serif';">1,378,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of the Company&#8217;s Class B Common Stock, up to </span><span style="font-family:'Times New Roman','Times','serif';">143,766</span><span style="font-family:'Times New Roman','Times','serif';"> shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 6. COMMITMENTS AND CONTINGENCIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Registration Rights</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to a registration rights agreement entered into on May 6, 2021, the holders of the Founder Shares, Private Placement Units (including the securities contained therein), the units (including the securities contained therein) that may be issued upon conversion of the Working Capital Loans, and any shares of Class A Common Stock issuable upon the exercise of the Placement Warrants and any shares of Class A Common Stock, warrants (and underlying Class A Common Stock) that may be issued upon conversion of the units issued as part of the working capital loans and Class A Common Stock issuable upon conversion of the founder shares are entitled to registration rights. The holders of a majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Underwriters Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company granted the underwriter a 45-day option to purchase up to 1,500,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The aforementioned option was exercised on May 11, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The underwriter was paid a cash underwriting discount of two percent (2.00%) of the gross proceeds of the Initial Public Offering, or $2,300,000. In addition, the underwriter is entitled to a deferred fee of three and a half percent (3.50%) of the gross proceeds of the Initial Public Offering, or $4,025,000. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Right of First Refusal</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a period beginning on May 7, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">First Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (5%) on any PIPE that was brought by ARC in connection with an initial business combination upon the closing of an initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Second Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued 1,378,517 shares of the Company&#8217;s Class B Common Stock, up to 143,766 shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760773824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantLiabilityAbstract', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantLiabilityTextBlock', window );">WARRANT LIABILITY</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 7. WARRANT LIABILITY</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable </span><span style="font-family:'Times New Roman','Times','serif';">30 days</span><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination and will expire </span><span style="font-family:'Times New Roman','Times','serif';">five years</span><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination or earlier upon redemption or liquidation.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company has agreed that as soon as practicable, but in no event later than </span><span style="-sec-ix-hidden:Hidden_pecVw-7_R0GR-O1MFLS0Dg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';"> business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants is not effective by the </span><span style="-sec-ix-hidden:Hidden_4KOodU4RC02gxRyhNxEksA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">60</span></span><span style="font-family:'Times New Roman','Times','serif';">th business day after the closing of the Company&#8217;s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company&#8217;s shares of Class A Common Stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Redemption of warrants when the price per Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';">$18.00</span><span style="font-family:'Times New Roman','Times','serif';">. Once the warrants become exercisable, the Company may redeem the Public Warrants:</span></p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.01</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per Public Warrant;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 days</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8217; prior written notice of redemption to each warrant holder; and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$18.00</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any </span><span style="-sec-ix-hidden:Hidden_wWOk2hbenkiF3eCjIIPW1A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="-sec-ix-hidden:Hidden_j3RPZoOibUKp_scxdjJSCw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Placement Warrants were identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until </span><span style="font-family:'Times New Roman','Times','serif';">30 days</span><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">In addition, if (x) the Company issues additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than </span><span style="font-family:'Times New Roman','Times','serif';">$9.20</span><span style="font-family:'Times New Roman','Times','serif';"> per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than </span><span style="font-family:'Times New Roman','Times','serif';">60%</span><span style="font-family:'Times New Roman','Times','serif';"> of the total equity proceeds, and interest thereon, available for the funding of the Company&#8217;s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s common stock during the </span><span style="-sec-ix-hidden:Hidden_9B-TMAVHjEWPMjdgpFxpbg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';"> trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below </span><span style="font-family:'Times New Roman','Times','serif';">$9.20</span><span style="font-family:'Times New Roman','Times','serif';"> per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to </span><span style="font-family:'Times New Roman','Times','serif';">115%</span><span style="font-family:'Times New Roman','Times','serif';"> of the higher of the Market Value and the Newly Issued Price, the </span><span style="font-family:'Times New Roman','Times','serif';">$18.00</span><span style="font-family:'Times New Roman','Times','serif';"> per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to </span><span style="font-family:'Times New Roman','Times','serif';">180%</span><span style="font-family:'Times New Roman','Times','serif';"> of the greater of the Market Value and the Newly Issued Price and the </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until </span><span style="-sec-ix-hidden:Hidden_-WzpzrAyj0OzmcEU8I-ydQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';"> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">At March 31, 2022 and December 31, 2022, the Company accounted for the aggregate </span><span style="font-family:'Times New Roman','Times','serif';">12,085,275</span><span style="font-family:'Times New Roman','Times','serif';"> warrants issued in connection with the Initial Public Offering (the </span><span style="font-family:'Times New Roman','Times','serif';">11,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> Public Warrants and the </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company&#8217;s statement of operations.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 7. WARRANT LIABILITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has agreed that as soon as practicable, but in no event later than <span style="-sec-ix-hidden:Hidden_l9q9OYpBaE-i-c9_ByMINg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class&#160;A Common Stock issuable upon exercise of the warrants is not effective by the <span style="-sec-ix-hidden:Hidden_O_rVnyonKkqQ7hhmRqfGSA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">60</span></span>th business day after the closing of the Company&#8217;s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company&#8217;s shares of Class A Common Stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Redemption of warrants when the price per Class A Common Stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the Public Warrants:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.01</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per Public Warrant;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 days</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8217; prior written notice of redemption to each warrant holder; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$18.00</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any </span><span style="-sec-ix-hidden:Hidden_g1uhXZ_IzE6YLS18Pibsaw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="-sec-ix-hidden:Hidden_ucp-6LYyYk2H8bhHlUU4tg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.The Placement Warrants were identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, if (x) the Company issues additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company&#8217;s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s common stock during the <span style="-sec-ix-hidden:Hidden_Tj-gOcDc5kC5FCMl3wJLvg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">At December 31, 2022 and 2021, the Company accounted for the aggregate 12,085,275 warrants issued in connection with the Initial Public Offering (the 11,500,000 Public Warrants and the 585,275 Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company&#8217;s statement of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantLiabilityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantLiabilityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760774080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER'S EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDER'S EQUITY</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 8. STOCKHOLDER&#8217;S EQUITY</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Preferred Shares </span><span style="font-family:'Times New Roman','Times','serif';">&#8212; The Company is authorized to issue </span><span style="font-family:'Times New Roman','Times','serif';">1,000,000</span><span style="font-family:'Times New Roman','Times','serif';"> preferred shares with a par value of </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> per share with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s Board of Directors. At March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> preferred shares issued or </span><span style="font-family:'Times New Roman','Times','serif';">outstanding</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Class A Common Stock </span><span style="font-family:'Times New Roman','Times','serif';">&#8212; The Company is authorized to issue </span><span style="font-family:'Times New Roman','Times','serif';">100,000,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock with a par value of </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> per share. Holders of the Company&#8217;s Class A Common Stock are entitled to </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> vote for each share. At March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of non-redeemable Class A Common Stock </span><span style="font-family:'Times New Roman','Times','serif';">issued</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">outstanding</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">in connection with the private placement (Note 4), excluding </span><span style="font-family:'Times New Roman','Times','serif';">2,731,544</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock subject to possible redemption as of March 31, 2023 and December 31, 2022, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Class B Common Stock &#8212; </span><span style="font-family:'Times New Roman','Times','serif';">The Company is authorized to issue up to </span><span style="font-family:'Times New Roman','Times','serif';">10,000,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B Common Stock with a par value of </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> per share. Holders of the Company&#8217;s Class B Common Stock are entitled to </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> vote for each share. On February 25, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';">15,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Executive Officer, </span><span style="font-family:'Times New Roman','Times','serif';">15,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Financial Officer and </span><span style="font-family:'Times New Roman','Times','serif';">5,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';">5,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to such independent director.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On December 31, 2022, ARC Group Limited, the Company&#8217;s Financial Advisor, was granted </span><span style="font-family:'Times New Roman','Times','serif';">1,379,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B common stock with a par value of $</span><span style="font-family:'Times New Roman','Times','serif';">0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> per share, up to </span><span style="font-family:'Times New Roman','Times','serif';">143,766</span><span style="font-family:'Times New Roman','Times','serif';"> of which are subject to forfeiture if the Company&#8217;s public stockholders exercise redemption rights with respect to any of the Company&#8217;s remaining outstanding shares of Class A common stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">At March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';">4,253,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B Common Stock issued and </span><span style="font-family:'Times New Roman','Times','serif';">outstanding</span><span style="font-family:'Times New Roman','Times','serif';">, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Holders of Class A Common Stock and Class B Common Stock will vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Business Combination on a </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';">-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A Common Stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B Common Stock shall convert into shares of Class A Common Stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B Common Stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A Common Stock issuable upon conversion of all shares of Class B Common Stock will equal, in the aggregate, on an as converted basis, </span><span style="font-family:'Times New Roman','Times','serif';">20%</span><span style="font-family:'Times New Roman','Times','serif';"> of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A Common Stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">issued, to any seller in a Business Combination, and any private placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 8. STOCKHOLDER&#8217;S EQUITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Preferred Shares </span><b style="font-weight:bold;">&#8212;</b> The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s Board of Directors. At December&#160;31,&#160;2022 and 2021, there were no preferred shares issued or <span style="-sec-ix-hidden:Hidden_byXh1qgX90qNILMCXVSaVw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Class A Common Stock </span><b style="font-weight:bold;">&#8212;</b> The Company is authorized to issue 100,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A Common Stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 12,085,275 shares of Class A Common Stock issued and outstanding, including 585,275 shares of non-redeemable Class A Common Stock issued in connection with the private placement (Note 4), and 11,500,000 shares of Class A Common Stock subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Class B Common Stock</span> <b style="font-weight:bold;">&#8212;</b> The Company is authorized to issue up to 10,000,000 shares of Class B Common Stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class B Common Stock are entitled to one vote for each share. On February 25, 2021, the Sponsor transferred 15,000 shares to the Company&#8217;s Chief Executive Officer, 15,000 shares to the Company&#8217;s Chief Financial Officer and 5,000 shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred 5,000 shares to such independent director. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, ARC Group Limited, the Company&#8217;s Financial Advisor, was granted <span style="-sec-ix-hidden:Hidden_OyBqbq_iQkytLYvGC9d64A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1,378,517</span></span> shares of Class B common stock with a par value of $0.0001 per share, up to 143,766 of which are subject to forfeiture if the Company&#8217;s public stockholders exercise redemption rights with respect to any of the Company&#8217;s remaining outstanding shares of Class A common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December 31, 2022 and 2021, there were 4,253,517 and 2,875,000 shares of Class B Common Stock <span style="-sec-ix-hidden:Hidden_STifUojKSEajZv3cqO8nRw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">issued</span></span> and <span style="-sec-ix-hidden:Hidden_Vj2cJtgcg0SBI0y6E-s6Sg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span>, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Holders of Class A Common Stock and Class B Common Stock will vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A Common Stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class&#160;B Common Stock shall convert into shares of Class A Common Stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B Common Stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A Common Stock issuable upon conversion of all shares of Class B Common Stock will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A Common Stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083764235456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 9. FAIR VALUE MEASUREMENTS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table presents information about the Company&#8217;s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,725,574</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,029,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Warrants are measured at fair value on a recurring basis. The Public Warrants were valued initially and at each reporting period that the warrants were not actively traded, using a Monte Carlo simulation. As of March 31, 2023 and December 31, 2022, the Public Warrants were valued using the instrument&#8217;s publicly listed trading price, which is considered to be a Level 1 measurement due to the use of an observable market quote in an active market. Private Placement Warrants were valued using a Monte Carlo valuation model using level 3 inputs at initial valuation and as of March 31, 2023 and December 31, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">At March 31, 2023 and December 31, 2022, assets held in the Trust Account were invested solely in BlackRock US Treasury mutual fund of $</span><span style="font-family:'Times New Roman','Times','serif';">29,725,574</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$29,029,416</span><span style="font-family:'Times New Roman','Times','serif';">, respectively. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments and are considered Level 1 assets.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statement of operations.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company utilized a Monte Carlo simulation to estimate the fair value of the Public warrants at each reporting period for its warrants that are not actively traded. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. On June 22, 2021, the Public Warrants surpassed the threshold waiting period to be publicly traded. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of March 31, 2023 and December 31, 2022, the Company classified the Public Warrants as Level 1.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s common stock that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at </span><span style="font-family:'Times New Roman','Times','serif';">zero</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Transfers</span><span style="font-family:'Times New Roman','Times','serif';"> to/</span><span style="font-family:'Times New Roman','Times','serif';">from</span><span style="font-family:'Times New Roman','Times','serif';"> Levels 1, 2 and 3 are </span><span style="font-family:'Times New Roman','Times','serif';">recognized</span><span style="font-family:'Times New Roman','Times','serif';"> at the end of the reporting period in which a change in </span><span style="font-family:'Times New Roman','Times','serif';">valuation</span><span style="font-family:'Times New Roman','Times','serif';"> technique or methodology occurs. For the three months ended March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> transfers between levels</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The change in the fair value of the derivative warrant liabilities for the three months ended March 31, 2023 and 2022 is as follows:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_ZO2hDNBMi0u8zP5YIF1kNA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_jQL209kLek2Gbb2s5yFT1A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (117,640)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,645,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,762,640)</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 134,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,955,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,089,028</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border:0pt;border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 9. FAIR VALUE MEASUREMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table presents information about the Company&#8217;s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments&#160; held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,029,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 117,320,973</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Warrants are measured at fair value on a recurring basis. The Public Warrants were valued initially and at each reporting period that the warrants were not actively traded, using a Monte Carlo simulation. As of December 31, 2022 and 2021, the Public Warrants were valued using the instrument&#8217;s publicly listed trading price, which is considered to be a Level 1 measurement due to the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">use of an observable market quote in an active market. Private Placement Warrants were valued using a Monte Carlo valuation model using level 3 inputs at initial valuation and as of December 31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December 31, 2022 and 2021, assets held in the Trust Account were comprised of $29,029,416 in money market mutual fund and $117,320,973 in U.S. Treasury Securities, respectively. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments and are considered Level 1 assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company utilized a Monte Carlo simulation to estimate the fair value of the Public warrants at each reporting period for its warrants that are not actively traded. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. On June 22, 2021, the Public Warrants surpassed the threshold waiting period to be publicly traded. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of December 31, 2022 and 2021, the Company classified the Public Warrants as Level 1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s common stock that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. During the year ended December 31, 2022 and for the period from February 8, 2021 (inception) through December&#160;31,&#160;2021 there were no transfers between levels.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.28</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The change in the fair value of the derivative warrant liabilities for the year ended December 31, 2022 and for the period from February 8, 2021(inception) to December 31, 2021 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of February 8, 2021(inception)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_4REQyUAf6022aVEF9i64Ww;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (234,110)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,255,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,489,110)</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083749960688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 10. SUBSEQUENT EVENTS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In accordance with ASC Topic 855, &#8220;Subsequent Events&#8221;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identified any subsequent events that would have required adjustment or disclosure in the financial statements other than as described below.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 17, 2023, the Company withdrew $</span><span style="font-family:'Times New Roman','Times','serif';">214,850</span><span style="font-family:'Times New Roman','Times','serif';"> interest earned on the Trust account to pay 2022&#8217;s income tax payment. The income tax was paid on April 18, 2023.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 19, 2023, the Company elected to exercise its sixth-month extension to the Termination Date, which extended its deadline to complete its initial business combination to May 11, 2023, by depositing </span><span style="font-family:'Times New Roman','Times','serif';">$0.045</span><span style="font-family:'Times New Roman','Times','serif';"> per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately </span><span style="font-family:'Times New Roman','Times','serif';">$122,920</span><span style="font-family:'Times New Roman','Times','serif';">, was deposited in the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 25, 2023, the Company withdrew $</span><span style="font-family:'Times New Roman','Times','serif';">73,846</span><span style="font-family:'Times New Roman','Times','serif';"> interest earned on the Trust account to pay 2022&#8217;s remaining balance and 2023 Q1 prepayment of Delaware Franchise tax. $</span><span style="font-family:'Times New Roman','Times','serif';">73,846</span><span style="font-family:'Times New Roman','Times','serif';"> was paid to the State of Delaware on May 2, 2023.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June 28, 2023, EF Hutton waived $3,025,000 of the $4,025,000 cash deferred underwriting commission, pursuant to a Satisfaction and Discharge Agreement (attached at Exhibit 10.22) that would otherwise be immediately due and payable upon the Closing, accepting in lieu thereof (i) a one-time cash payment of $500,000 at the time of the Closing; (ii) a $500,000 promissory note executed by the Company on June 30, 2023 (attached at Exhibit 10.21) in which it is obligated to make six monthly payments to EF Hutton in the cash amount of $83,333.33 from October 2023 through March 2024; and (iii) 277,778 ordinary shares of the Company (the &#8220;Ordinary Shares&#8221;) at $10.89 per share, for an aggregate value of $3,025,000.</p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 11. SUBSEQUENT EVENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with ASC Topic 855, &#8220;Subsequent Events&#8221;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identified any subsequent events that would have required adjustment or disclosure in the financial statements other than as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On January 5, 2023, the Company elected to exercise its third-month extension to the Termination Date, which extended its deadline to complete its initial business combination from January 11, 2023 to February 11, 2023, by depositing $0.045 per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $122,920, was deposited in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 8, 2023, the Company elected to exercise its fourth-month extension to the Termination Date, which extended its deadline to complete its initial business combination from February 11, 2023 to March 11, 2023, by depositing $0.045 per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $122,920, was deposited in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">On March 6, 2023, the Company elected to exercise its fifth-month extension to the Termination Date, which extended its deadline to complete its initial business combination from March 11, 2023 to April 11, 2023, by depositing $0.045 per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $122,920, was deposited in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083756719824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Basis of presentation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Basis of presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock', window );">Emerging growth company</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Emerging growth company</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Emerging growth company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Use of estimates</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had </span><span style="font-family:'Times New Roman','Times','serif';">$10,108</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$30,870</span><span style="font-family:'Times New Roman','Times','serif';"> in cash and </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> cash equivalents as of March 31, 2023 and December 31, 2022, respectively.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had $30,870 and $453,151 in cash and no cash equivalents as of December 31, 2022 and 2021.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock', window );">Trust Account</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Trust Account</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Upon the closing of the Initial Public Offering and the Private Placement, </span><span style="font-family:'Times New Roman','Times','serif';">$117,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> (</span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Trust Account</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the Initial Public Offering and the Private Placement, $117,300,000 ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Offering Costs Associated with the Initial Public Offering</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TemporaryEquityPolicyPolicyTextBlock', window );">Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</span><span style="font-family:'Times New Roman','Times','serif';"> Accordingly, as of March 31, 2023, there were </span><span style="font-family:'Times New Roman','Times','serif';">3,316,819</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, excluding </span><span style="font-family:'Times New Roman','Times','serif';">2,731,544</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 31, 2023, there are </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and </span><span style="font-family:'Times New Roman','Times','serif';">4,838,792</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, which are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and 2022, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock &#8211; </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 583,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock - </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,333,680</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, there are 585,275 shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and 11,500,000 shares of Class A Common Stock outstanding, which are subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December 31, 2022 and 2021, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross Proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to public warrants and private warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,614,500)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issuance costs related to Class A Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,146,054)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Redemption of Class A Common Stock, including interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (91,909,483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,359,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,060,554</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net income (loss) per share</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Net income (loss) per share</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net income (loss) between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for </span><span style="font-family:'Times New Roman','Times','serif';">12,085,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of common stock in the aggregate.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table reflects the calculation of basic and diluted net income (loss) per common share:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,687,692</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"><span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 4,838,792</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,500,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31,025)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 507,816</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"><span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 2,731,544</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,460,275</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Net income per share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net income per share is computed by dividing net income by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 12,085,275 shares of common stock in the aggregate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The following table reflects the calculation of basic and diluted net income per common share:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period of</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,671,658</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,667,969</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,264,526</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 96,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,464,132</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,295,610</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation Expense</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for stock-based compensation expense in accordance with ASC Topic 718, &#8220;Compensation &#8211; Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. The fair value of equity awards has been estimated using a market approach. Forfeitures are recognized as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Company determined that it was not probable that ARC would meet the performance condition as defined in the Introducing Advisor Agreement (See Note 5), and therefore, no stock-based compensation expense was recognized. At December 31, 2022, upon amendment of the Introducing Advisor Agreement, which amended ARC&#8217;s performance condition that was concurrently deemed to have been met, ARC was granted 1,378,517 shares of the Company&#8217;s Class B common stock at a fair value of $2.05 per share. The Company recorded the resulting $2,825,960<span style="white-space:pre-wrap;"> of stock based compensation expense on December 31, 2022, which is included in formation and operating costs in the consolidated statement of operations.  The fair value of the Class B common stock was determined by applying a discount to the actively traded Class A shares, which have an observable market price. The discount was calculated as the average discount of the Class B share price (derived) compared to the Class A share price (observable) for SPACs that have actively traded &#8220;Rights&#8221;.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risk</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At March 31, 2023 and 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Income Taxes </b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> unrecognized tax benefits and </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> amounts accrued for interest and penalties </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">as of March 31, 2023 and 2022, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Our effective tax rate was </span><span style="font-family:'Times New Roman','Times','serif';">(225.88%)</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">0%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of </span><span style="font-family:'Times New Roman','Times','serif';">21%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, due to transaction costs and the valuation allowance on the deferred tax assets.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within those fiscal years.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of accounting policy for assets held in trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy on derivative financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy on emerging growth company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TemporaryEquityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of accounting policy for temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TemporaryEquityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755584272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Class A Common Stock reflected on the balance sheet are reconciled</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock &#8211; </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 583,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock - </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,333,680</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross Proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to public warrants and private warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,614,500)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issuance costs related to Class A Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,146,054)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Redemption of Class A Common Stock, including interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (91,909,483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,359,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,060,554</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted net income (loss) per common share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,687,692</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"><span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 4,838,792</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,500,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31,025)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 507,816</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"><span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 2,731,544</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,460,275</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period of</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,671,658</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,667,969</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,264,526</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 96,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,464,132</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,295,610</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755609024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of assets and derivative warrant liabilities measured at fair value on recurring basis</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,725,574</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,029,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments&#160; held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,029,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 117,320,973</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of quantitative information regarding Level 3 fair value measurements inputs</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.28</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of change in fair value of derivative warrant liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_ZO2hDNBMi0u8zP5YIF1kNA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_jQL209kLek2Gbb2s5yFT1A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (117,640)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,645,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,762,640)</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 134,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,955,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,089,028</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border:0pt;border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of February 8, 2021(inception)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_4REQyUAf6022aVEF9i64Ww;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (234,110)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,255,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,489,110)</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083748881648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 11, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 10, 2022 </div>
<div>item</div>
</th>
<th class="th">
<div>May 05, 2022 </div>
<div>item</div>
</th>
<th class="th">
<div>Nov. 05, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 11, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 08, 2021 </div>
<div>item</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum', window );">Condition for future business combination number of businesses minimum | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount', window );">Payments for investment of cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 368,760<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 2,545,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.', window );">Deferred underwriting commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DeferredUnderwritingFeePayable', window );">Deferred Underwriting Fee Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CashHeldOutsideInTrustAccount', window );">Cash held outside the Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,108<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="nump">30,870<span></span>
</td>
<td class="nump">$ 453,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,326,648<span></span>
</td>
<td class="nump">246,232<span></span>
</td>
<td class="num">$ (1,945,267)<span></span>
</td>
<td class="nump">246,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount', window );">Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination', window );">Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination', window );">Number of three-month extensions for consummation of initial business combination | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination', window );">Extension period for consummating initial business combination</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination', window );">Maximum number of one-month extension periods for consummation of Initial Business Combination | item</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount', window );">Additional amount per unit required to be deposited in trust account | $ / shares</a></td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions', window );">Amount deposited into the Trust Account on execution of two one-month extensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 614,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 245,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfOneMonthExtensionsExecuted', window );">Number of one-month extensions executed | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination', window );">Extension period each time for the Company to consummate initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination', window );">Minimum net tangible asset upon consummation of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares', window );">Number of shares for which share holders exercised their right to redeem | shares</a></td>
<td class="nump">8,768,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Redemption price per share | $ / shares</a></td>
<td class="nump">$ 10.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Aggregate amount of shares redeemed</a></td>
<td class="nump">$ 91,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Trust account balance</a></td>
<td class="nump">28,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension', window );">Amount to be deposited in trust account in connection with the exercise of the first monthly extension</a></td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNetInterestToPayDissolutionExpenses', window );">Maximum net interest to pay dissolution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">2,825,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,725,574<span></span>
</td>
<td class="nump">117,320,973<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
<td class="nump">117,320,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount', window );">Interest withdrawn from Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">299,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet', window );">Convertible loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Units per price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Public share price considered | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,108<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="nump">$ 30,870<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfPublicSharesToBeRedeemed.', window );">Percentage of public shares redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount', window );">Additional amount per unit required to be deposited in trust account | $ / shares</a></td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units in Initial Public Offering, net of offering costs (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromSaleOfUnits', window );">Proceeds from issuance of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount', window );">Payments for investment of cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 959,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 959,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,771,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,771,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SaleOfStockUnderwritingFees', window );">Underwriting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.', window );">Deferred underwriting commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SaleOfStockOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of Private units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units in Initial Public Offering, net of offering costs (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets', window );">Condition For Future Business Combination Threshold Net Tangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional amount per unit sold in the company's initial public offering required to be deposited in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount deposited into the Trust Account on execution of two one-month extensions out of the nine.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be deposited in the trust account in connection with the exercise of the first monthly extension.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CashHeldOutsideInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash held outside the trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CashHeldOutsideInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which Common Stock exercised their right to redeem those shares for cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The extension period each time for the Company to consummate initial business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extension period for consummating initial business combination as permitted under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNetInterestToPayDissolutionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNetInterestToPayDissolutionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum net tangible assets upon consummation of the Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfOneMonthExtensionsExecuted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of one-month extensions executed by the Company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfOneMonthExtensionsExecuted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of one-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of three-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfPublicSharesToBeRedeemed.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of public shares redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfPublicSharesToBeRedeemed.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with interest withdrawn from Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromSaleOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents Proceeds from Sale of Units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromSaleOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SaleOfStockOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of other offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SaleOfStockOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SaleOfStockUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees incurred and paid for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SaleOfStockUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of transaction costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net increase or decrease in the carrying amount of the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083663594544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 05, 2021</div></th>
<th class="th"><div>May 11, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,151<span></span>
</td>
<td class="nump">$ 30,870<span></span>
</td>
<td class="nump">$ 453,151<span></span>
</td>
<td class="nump">$ 10,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount', window );">Payments for investment of cash in trust account</a></td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 368,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,300,000<span></span>
</td>
<td class="nump">$ 2,545,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantExercisable', window );">Warrant exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits accrued for interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(225.88%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38.96%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember', window );">Formation and operating costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,825,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | ARC | Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,316,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,316,819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember', window );">Class A Common Stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,838,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,838,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common Stock, subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,731,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">2,731,544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent to accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of  warrant exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083758259376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details) - Class A Common Stock Subject to Redemption - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable Class A Common Stock - Opening Balance</a></td>
<td class="nump">$ 28,750,110<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromIssuanceOfTemporaryEquity', window );">Gross Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TemporaryEquityProceedsAllocatedToWarrants', window );">Proceeds allocated to public warrants and private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,614,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TemporaryEquityIssuanceCosts', window );">Issuance costs related to Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,146,054)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest', window );">Redemption of Class A Common Stock, including interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,909,483)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Re-measurement of carrying value to redemption value</a></td>
<td class="nump">583,570<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,060,554<span></span>
</td>
<td class="nump">3,359,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable Class A Common Stock - Ending Balance</a></td>
<td class="nump">$ 29,333,680<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 28,750,110<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent to accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromIssuanceOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromIssuanceOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of redemption of Class A Common Stock subject to possible redemption, including interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TemporaryEquityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuance costs related to temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TemporaryEquityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TemporaryEquityProceedsAllocatedToWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross proceeds allocated from temporary equity to warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TemporaryEquityProceedsAllocatedToWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083754848960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) allocable to common stock not subject to redemption</a></td>
<td class="num">$ (85,983)<span></span>
</td>
<td class="nump">$ 2,195,508<span></span>
</td>
<td class="nump">$ 5,135,790<span></span>
</td>
<td class="nump">$ 336,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) allocable to common stock not subject to redemption</a></td>
<td class="num">$ (54,958)<span></span>
</td>
<td class="nump">$ 1,687,692<span></span>
</td>
<td class="nump">$ 3,671,658<span></span>
</td>
<td class="nump">$ 240,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, Basic</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">8,264,526<span></span>
</td>
<td class="nump">8,667,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, Diluted</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">8,264,526<span></span>
</td>
<td class="nump">8,667,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember', window );">Class A and Class B non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) allocable to common stock not subject to redemption</a></td>
<td class="num">$ (31,025)<span></span>
</td>
<td class="nump">$ 507,816<span></span>
</td>
<td class="nump">$ 1,464,132<span></span>
</td>
<td class="nump">$ 96,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, Basic</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">3,460,275<span></span>
</td>
<td class="nump">3,295,610<span></span>
</td>
<td class="nump">3,464,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, Diluted</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">3,460,275<span></span>
</td>
<td class="nump">3,295,610<span></span>
</td>
<td class="nump">3,464,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083753928592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>May 11, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfSharesIssuedPerUnit', window );">Number of shares in a unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares issuable per warrant</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO | Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfWarrantsIssuedPerUnit', window );">Number of warrants in a unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfSharesIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares in a unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfSharesIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfWarrantsIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants in a unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfWarrantsIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755918528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 11, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrivatePlacementLineItems', window );"><strong>PRIVATE PLACEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrivatePlacementLineItems', window );"><strong>PRIVATE PLACEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrants</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate purchase price</a></td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PrivatePlacementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PrivatePlacementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755023824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS - Founder Shares (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 23, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 25, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>D </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 2,825,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionLoansNonCurrent', window );">Amount outstanding under the extension loan | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,914,598<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,545,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Sponsor | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders', window );">Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays', window );">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays', window );">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences', window );">Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Chief Executive Officer | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Chief Financial Officer | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Two Independent Director | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Third Independent Director | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Second Amendment to the Introducing Advisor Agreement | ARC Group Ltd | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionLoansNonCurrent', window );">Amount outstanding under the extension loan | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,378,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionLoansNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of extension loans outstanding, non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionLoansNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents maximum number of shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected ownership percentage by the founders after completion of the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination during which the shares or warrant may not be transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_StockTransferredToOthersDuringPeriodShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares transferred to others during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_StockTransferredToOthersDuringPeriodShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The transfer assign or sell any shares or warrants after completion of initial business combination threshold trading days business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The transfer assign or sell any shares or warrants after completion of initial business combination threshold trading days business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_TwoIndependentDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_TwoIndependentDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ThirdIndependentDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ThirdIndependentDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083750420816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS - Additional information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 11, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 10, 2022 </div>
<div>item</div>
</th>
<th class="th">
<div>May 05, 2022 </div>
<div>item</div>
</th>
<th class="th"><div>Mar. 22, 2022</div></th>
<th class="th">
<div>Jun. 26, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 08, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination', window );">Period from the closing of the company's initial public offering to consummate business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Outstanding of promissory note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination', window );">Extension period for consummating initial business combination</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven', window );">Number of business days for advance notice of extension to be given | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination', window );">Number of three-month extensions for consummation of initial business combination | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregatePeriodToConsummateInitialBusinessCombination', window );">Aggregate period to consummate business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension', window );">Amount to be deposited in trust account in connection with the exercise of the first monthly extension</a></td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount', window );">Additional amount per unit required to be deposited in trust account | $ / shares</a></td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionLoansNonCurrent', window );">Amount outstanding under the extension loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,914,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,545,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WorkingCapitalLoansWarrantMember', window );">Working capital loans warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">207,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">Introducing Advisor Agreement | ARC Group Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RetainerFeeUponExecutionOfAgreement', window );">Retainer fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination', window );">Success fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfOwnershipAsConsiderationForService', window );">Percentage of ownership as consideration for service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget', window );">Threshold period for consideration payable after the closes on business combination or any financing with any Advisor Target or any affiliate of an Advisor Target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">First Amendment to the Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing', window );">Percentage of success fee on any PIPE that was brought by ARC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_PromissoryNoteWithRelatedPartyMember', window );">Promissory Note with Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote', window );">Maximum borrowing capacity of related party promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Outstanding balance of related party note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Outstanding of promissory note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth', window );">Expenses per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement | ARC Group Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth', window );">Expenses per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party transaction expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember', window );">Related Party Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumLoansConvertibleUptoConsummation', window );">Related party loans convertible up to consummation of a business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination', window );">Related party loans convertible up to consummation of a Business Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination', window );">Extension period for consummating initial business combination</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension', window );">Amount to be deposited in trust account in connection with the exercise of the first monthly extension</a></td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount', window );">Additional amount per unit required to be deposited in trust account | $ / shares</a></td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionLoansNonCurrent', window );">Amount outstanding under the extension loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,914,598<span></span>
</td>
<td class="nump">$ 2,545,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember', window );">Related Party Loans | Working capital loans warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember', window );">Related Party Loans | Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SecuritiesDepositHeldInTrustAccount', window );">Deposit held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_BusinessCombinationTotalPayments', window );">Business combination, total payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Second Amendment to the Introducing Advisor Agreement | Class B Common Stock | ARC Group Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionLoansNonCurrent', window );">Amount outstanding under the extension loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,378,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional amount per unit sold in the company's initial public offering required to be deposited in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AggregatePeriodToConsummateInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate period including extension period during which the company is required to consummate Initial Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AggregatePeriodToConsummateInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be deposited in the trust account in connection with the exercise of the first monthly extension.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_BusinessCombinationTotalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_BusinessCombinationTotalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionLoansNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of extension loans outstanding, non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionLoansNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extension period for consummating initial business combination as permitted under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum borrowing capacity of related party promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumLoansConvertibleUptoConsummation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of maximum loans convertible up to consummation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumLoansConvertibleUptoConsummation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents maximum number of shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of business days prior to the applicable deadline during which a notice of extension is to be given for deposit to be made in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of three-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfOwnershipAsConsiderationForService">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of ownership as consideration for service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfOwnershipAsConsiderationForService</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of success fee on any PIPE that was brought by ARC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from the closing of the Company's initial public offering during which the company is required to consummate Initial Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of maximum loans convertible up to consummation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The contractual monthly amount to be paid for support services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RetainerFeeUponExecutionOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of retainer fee upon execution of agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RetainerFeeUponExecutionOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SecuritiesDepositHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of securities or Deposits held in the trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SecuritiesDepositHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of success fee upon closing of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold period for consideration payable after the closes on business combination or any financing with any Advisor Target or any affiliate of an Advisor Target.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WorkingCapitalLoansWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WorkingCapitalLoansWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_PromissoryNoteWithRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_PromissoryNoteWithRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_AdministrativeSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_AdministrativeSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083754403136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 22, 2022</div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>item </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities', window );">Maximum number of demands for registration of securities | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnderwritingDiscountPercentage', window );">Underwriting discount (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnderwritingDiscountPaid', window );">Underwriting discount paid | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DeferredUnderwritingFeesPercentage', window );">Deferred underwriting fees (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.', window );">Deferred underwriting commissions | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,025,000<span></span>
</td>
<td class="nump">$ 4,025,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember', window );">ARC | Founder Shares | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">First Amendment to the Introducing Advisor Agreement with ARC Group Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing', window );">Percentage of success fee on any PIPE that was brought by ARC</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">First Amendment to the Introducing Advisor Agreement with ARC Group Limited [Member] | ARC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing', window );">Percentage of success fee on any PIPE that was brought by ARC</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">Second Amendment to the Introducing Advisor Agreement | ARC | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">Second Amendment to the Introducing Advisor Agreement | ARC | Founder Shares | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_OverAllotmentOptionPeriod', window );">Overallotment option period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">45 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DeferredUnderwritingFeesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of deferred underwriting commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DeferredUnderwritingFeesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum number of demands for registration of securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents maximum number of shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_OverAllotmentOptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of the over-allotment option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_OverAllotmentOptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of success fee on any PIPE that was brought by ARC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnderwritingDiscountPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting discount paid by the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnderwritingDiscountPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnderwritingDiscountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of per Unit offering price paid as discount to underwriter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnderwritingDiscountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083756740960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITY (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value per share</a></td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantsOrRightsIssued', window );">Warrants issued</a></td>
<td class="nump">12,085,275<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PlacementWarrantsMember', window );">Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantsOrRightsIssued', window );">Warrants issued</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Public Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination', window );">Maximum threshold period for registration statement to become effective after business combination</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination', window );">Maximum threshold period for registration statement to become effective after business combination</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value per share</a></td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed', window );">Percentage of gross proceeds on total equity proceed</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice', window );">Trading days determining volume weighted average price</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice', window );">Adjustment of exercise price of warrants based on market value (as a percent)</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantsOrRightsIssued', window );">Warrants issued</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value per share</a></td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice', window );">Adjustment of exercise price of warrants based on market value (as a percent)</a></td>
<td class="nump">180.00%<span></span>
</td>
<td class="nump">180.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage represents the class of warrant or right Adjustment of exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum threshold period for registration statement to become effective after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum threshold period for registration statement to become effective after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold number of specified trading period determining volume weighted average trading price , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross proceeds on total equity proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantsOrRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Value of issued derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantsOrRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083749714256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDER'S EQUITY - Preferred Shares (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083750146624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER'S EQUITY - Common Stock (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 23, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 25, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockNumberOfVotesPerShare', window );">Common stock, votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,316,819<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock, subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaNotSubjectToRedemptionMember', window );">Class A Common Stock Not Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock, subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockShareIssued', window );">Common shares, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockShareOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaNotSubjectToRedemptionMember', window );">Class A Common Stock Not Subject to Redemption | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockNumberOfVotesPerShare', window );">Common stock, votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Common stock, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare', window );">Shares issuable as percent of outstanding shares on Initial Business Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | Independent Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | ARC | Second Amendment to the Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | ARC | Founder Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | ARC | Founder Shares | Second Amendment to the Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of votes that each common share is entitled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockShareIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents of Common Stock Share Issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockShareIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents of Common Stock Share Outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding stock after stock conversion issuable pursuant to initial business combination transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents maximum number of shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_StockTransferredToOthersDuringPeriodShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares transferred to others during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_StockTransferredToOthersDuringPeriodShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=dkdcu_IndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=dkdcu_IndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760065440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Assets and derivative warrant liabilities measured at fair value on recurring basis (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="nump">$ 29,725,574<span></span>
</td>
<td class="nump">$ 29,029,416<span></span>
</td>
<td class="nump">$ 117,320,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="nump">29,725,574<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring basis | Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Warrant Liabilities</a></td>
<td class="nump">345,000<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring basis | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Warrant Liabilities</a></td>
<td class="nump">$ 17,558<span></span>
</td>
<td class="nump">$ 17,558<span></span>
</td>
<td class="nump">$ 251,668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083754691888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,725,574<span></span>
</td>
<td class="nump">$ 117,320,973<span></span>
</td>
<td class="nump">$ 29,029,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount', window );">Transfer of assets and liabilities between level 1 and level 2</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfer of assets into level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfer of assets out of level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3', window );">Transfer of liabilities into level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3', window );">Transfer of liabilities out of level 3</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,725,574<span></span>
</td>
<td class="nump">$ 29,029,416<span></span>
</td>
<td class="nump">$ 29,029,416<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of transfers of assets and liabilities measured on a recurring basis between level 1 and level 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083748871104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Quantitative information regarding Level 3 fair value measurements inputs (Details) - Private Warrants - Level 3 - Recurring basis<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>Y</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Y</div>
</th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Y</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements input</a></td>
<td class="nump">11.50<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1150<span></span>
</td>
<td class="nump">0.1150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements input</a></td>
<td class="nump">10.69<span></span>
</td>
<td class="nump">10.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1044<span></span>
</td>
<td class="nump">0.1010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements input</a></td>
<td class="nump">5.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Probability of Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements input</a></td>
<td class="nump">0.0265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0275<span></span>
</td>
<td class="nump">1.000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements input</a></td>
<td class="nump">0.032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.042<span></span>
</td>
<td class="nump">0.074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements input</a></td>
<td class="nump">0.0353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0391<span></span>
</td>
<td class="nump">0.0128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Dividend yield (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements input</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0000<span></span>
</td>
<td class="nump">0.0000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083756566400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Change in fair value of derivative warrant liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Change in fair value of derivative warrant liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Change in fair value of warrant liability<span></span>
</td>
<td class="text">Change in fair value of warrant liability<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Change in fair value of warrant liability<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Private Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Change in fair value of derivative warrant liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, beginning balance</a></td>
<td class="nump">$ 17,558<span></span>
</td>
<td class="nump">$ 251,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in valuation inputs or other assumption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,640)<span></span>
</td>
<td class="nump">$ 251,668<span></span>
</td>
<td class="num">(234,110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, ending balance</a></td>
<td class="nump">17,558<span></span>
</td>
<td class="nump">134,028<span></span>
</td>
<td class="nump">251,668<span></span>
</td>
<td class="nump">17,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Change in fair value of derivative warrant liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, beginning balance</a></td>
<td class="nump">345,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in valuation inputs or other assumption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,645,000)<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="num">(4,255,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, ending balance</a></td>
<td class="nump">345,000<span></span>
</td>
<td class="nump">1,955,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WarrantLiabilityMember', window );">Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Change in fair value of derivative warrant liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, beginning balance</a></td>
<td class="nump">362,558<span></span>
</td>
<td class="nump">4,851,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,851,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in valuation inputs or other assumption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,762,640)<span></span>
</td>
<td class="nump">4,851,668<span></span>
</td>
<td class="num">(4,489,110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, ending balance</a></td>
<td class="nump">$ 362,558<span></span>
</td>
<td class="nump">$ 2,089,028<span></span>
</td>
<td class="nump">$ 4,851,668<span></span>
</td>
<td class="nump">$ 362,558<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liability, fair value measurement with unobservable inputs, reconciliation recurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083750346720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 25, 2023</div></th>
<th class="th"><div>Apr. 19, 2023</div></th>
<th class="th"><div>Apr. 17, 2023</div></th>
<th class="th"><div>Mar. 06, 2023</div></th>
<th class="th"><div>Feb. 08, 2023</div></th>
<th class="th"><div>Jan. 05, 2023</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 28, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest earned</a></td>
<td class="nump">$ 73,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PaymentsOfFranchiseTax', window );">Payments of franchise tax</a></td>
<td class="nump">$ 73,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CashWaivedDeferredUnderwritingCommission', window );">Waived amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CashDeferredUnderwritingCommissions', window );">Cash deferred underwriting commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Third-month extension to the Termination Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountDepositedPerEachPublicShareOutstanding', window );">Amount deposited per each public share outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregateAmountDepositedInTrustAccount', window );">Aggregate amount deposited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Fourth-month extension to the Termination Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountDepositedPerEachPublicShareOutstanding', window );">Amount deposited per each public share outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregateAmountDepositedInTrustAccount', window );">Aggregate amount deposited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Fifth-month extension to the Termination Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountDepositedPerEachPublicShareOutstanding', window );">Amount deposited per each public share outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregateAmountDepositedInTrustAccount', window );">Aggregate amount deposited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Sixth one-month extension to the Termination Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountDepositedPerEachPublicShareOutstanding', window );">Amount deposited per each public share outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregateAmountDepositedInTrustAccount', window );">Aggregate amount deposited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RelatedPartyPayment', window );">Cash payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RelatedPartyPromissoryNoteExecuted', window );">Promissory note executed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth', window );">Executed per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,333.33<span></span>
</td>
<td class="nump">$ 83,333.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregateNumberOfSharesOwned', window );">Aggregate number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AggregateAmountDepositedInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount deposited in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AggregateAmountDepositedInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AggregateNumberOfSharesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders after the impact of the stock dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AggregateNumberOfSharesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AmountDepositedPerEachPublicShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount per each outstanding public share deposited in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AmountDepositedPerEachPublicShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CashDeferredUnderwritingCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CashDeferredUnderwritingCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CashWaivedDeferredUnderwritingCommission">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash waived deferred underwriting commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CashWaivedDeferredUnderwritingCommission</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PaymentsOfFranchiseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment of franchise tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PaymentsOfFranchiseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RelatedPartyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of related party payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RelatedPartyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RelatedPartyPromissoryNoteExecuted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of related party promissory note executed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RelatedPartyPromissoryNoteExecuted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of related party promissory note executed per month.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_ThirdMonthExtensionToTerminationDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_ThirdMonthExtensionToTerminationDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_FourthMonthExtensionToTerminationDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_FourthMonthExtensionToTerminationDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_FifthMonthExtensionToTerminationDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_FifthMonthExtensionToTerminationDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_SixthOneMonthExtensionToTerminationDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_SixthOneMonthExtensionToTerminationDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083750623136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 07, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 10,108<span></span>
</td>
<td class="nump">$ 30,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrepaidInsuranceCurrent', window );">Prepaid insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">10,108<span></span>
</td>
<td class="nump">30,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="nump">29,725,574<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,320,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">29,735,682<span></span>
</td>
<td class="nump">29,060,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,857,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,933,661<span></span>
</td>
<td class="nump">1,679,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Amount due to related parties</a></td>
<td class="nump">11,200<span></span>
</td>
<td class="nump">11,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">274,448<span></span>
</td>
<td class="nump">214,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Franchise tax payable</a></td>
<td class="nump">117,447<span></span>
</td>
<td class="nump">69,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">2,336,756<span></span>
</td>
<td class="nump">1,976,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantLiabilityNonCurrent', window );">Warrant liabilities</a></td>
<td class="nump">362,558<span></span>
</td>
<td class="nump">362,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,851,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DeferredOfferingCostsNonCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="nump">4,025,000<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesNoncurrent', window );">Working capital loan</a></td>
<td class="nump">239,081<span></span>
</td>
<td class="nump">207,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionLoansNonCurrent', window );">Extension loans</a></td>
<td class="nump">2,914,598<span></span>
</td>
<td class="nump">2,545,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">9,877,993<span></span>
</td>
<td class="nump">9,116,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,166,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">2,242,253<span></span>
</td>
<td class="nump">2,242,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(11,718,728)<span></span>
</td>
<td class="num">(11,632,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,609,810)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Deficit</a></td>
<td class="num">(9,475,991)<span></span>
</td>
<td class="num">(8,806,438)<span></span>
</td>
<td class="num">$ (6,413,955)<span></span>
</td>
<td class="num">(8,609,463)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Deficit</a></td>
<td class="nump">29,735,682<span></span>
</td>
<td class="nump">29,060,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,857,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember', window );">Class A Common Stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A Common Stock subject to possible redemption; 2,731,544 and 11,500,000 shares at redemption value of $10.53 and $10.20 per share as of December 31, 2022 and 2021, respectively</a></td>
<td class="nump">29,333,680<span></span>
</td>
<td class="nump">28,750,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember', window );">Class A Common Stock not subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered, excluding offering costs (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DeferredOfferingCostsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DeferredOfferingCostsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionLoansNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of extension loans outstanding, non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionLoansNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PrepaidInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prepaid insurance current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PrepaidInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantLiabilityNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantLiabilityNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755572256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEET (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 11, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Common share at redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">3,316,819<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember', window );">Class A Common Stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Common share at redemption value</a></td>
<td class="nump">$ 10.74<span></span>
</td>
<td class="nump">$ 10.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common Stock, subject to possible redemption</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">2,731,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember', window );">Class A Common Stock not subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, shares issued</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, shares issued</a></td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083756641840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Formation and operating costs</a></td>
<td class="nump">$ 306,303<span></span>
</td>
<td class="nump">$ 560,185<span></span>
</td>
<td class="nump">$ 421,397<span></span>
</td>
<td class="nump">$ 5,103,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FranchiseTaxExpense', window );">Franchise tax expense</a></td>
<td class="nump">47,481<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">164,008<span></span>
</td>
<td class="nump">205,560<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operation costs</a></td>
<td class="num">(353,784)<span></span>
</td>
<td class="num">(610,185)<span></span>
</td>
<td class="num">(585,405)<span></span>
</td>
<td class="num">(5,309,291)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount', window );">Interest earned on securities held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RealizedAndUnrealizedGainLoss', window );">Realized and unrealized gain</a></td>
<td class="nump">327,399<span></span>
</td>
<td class="nump">43,053<span></span>
</td>
<td class="nump">19,097<span></span>
</td>
<td class="nump">1,371,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,762,640<span></span>
</td>
<td class="nump">6,325,281<span></span>
</td>
<td class="nump">4,489,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(625,059)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net income (loss) before provision for income taxes</a></td>
<td class="num">(26,385)<span></span>
</td>
<td class="nump">2,195,508<span></span>
</td>
<td class="nump">5,135,790<span></span>
</td>
<td class="nump">551,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(59,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(214,850)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(85,983)<span></span>
</td>
<td class="nump">2,195,508<span></span>
</td>
<td class="nump">$ 5,135,790<span></span>
</td>
<td class="nump">$ 336,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (54,958)<span></span>
</td>
<td class="nump">$ 1,687,692<span></span>
</td>
<td class="nump">$ 3,671,658<span></span>
</td>
<td class="nump">$ 240,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, Basic</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">8,264,526<span></span>
</td>
<td class="nump">8,667,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, Diluted</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">8,264,526<span></span>
</td>
<td class="nump">8,667,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember', window );">Class A and Class B non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (31,025)<span></span>
</td>
<td class="nump">$ 507,816<span></span>
</td>
<td class="nump">$ 1,464,132<span></span>
</td>
<td class="nump">$ 96,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, Basic</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">3,460,275<span></span>
</td>
<td class="nump">3,295,610<span></span>
</td>
<td class="nump">3,464,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, Diluted</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">3,460,275<span></span>
</td>
<td class="nump">3,295,610<span></span>
</td>
<td class="nump">3,464,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_FranchiseTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of franchise tax expense incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_FranchiseTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest earned on marketable securities held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RealizedAndUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RealizedAndUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083754187120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)<br></strong></div></th>
<th class="th">
<div>Class A Common Stock </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Class B Common Stock </div>
<div>Common Stock</div>
</th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Feb. 07, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Feb. 07, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase Decrease In Stockholders Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class B Common Stock to Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">24,712<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class B Common Stock to Sponsor (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor', window );">Sale of non-redeemable private placement units to Sponsor</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,290,242<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,290,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares', window );">Sale of non-redeemable private placement units to Sponsor(in shares)</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockSubjectToPossibleRedemptionValue', window );">Re-measurement of Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,314,954)<span></span>
</td>
<td class="num">(13,745,600)<span></span>
</td>
<td class="num">(19,060,554)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,135,790<span></span>
</td>
<td class="nump">5,135,790<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,609,810)<span></span>
</td>
<td class="num">(8,609,463)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2021</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase Decrease In Stockholders Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,195,508<span></span>
</td>
<td class="nump">2,195,508<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2022</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,414,302)<span></span>
</td>
<td class="num">(6,413,955)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Mar. 31, 2022</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,609,810)<span></span>
</td>
<td class="num">(8,609,463)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase Decrease In Stockholders Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class B Common Stock to Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">2,825,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,825,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class B Common Stock to Sponsor (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockSubjectToPossibleRedemptionValue', window );">Re-measurement of Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,359,593)<span></span>
</td>
<td class="num">(3,359,593)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336,658<span></span>
</td>
<td class="nump">336,658<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2022</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">2,242,253<span></span>
</td>
<td class="num">(11,632,745)<span></span>
</td>
<td class="num">(8,806,438)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2022</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase Decrease In Stockholders Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockSubjectToPossibleRedemptionValue', window );">Re-measurement of Class A Common Stock Subject to Possible Redemption</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(583,570)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(583,570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockSubjectToPossibleRedemptionShares', window );">Re-measurement of Class A Common Stock Subject to Possible Redemption (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(85,983)<span></span>
</td>
<td class="num">(85,983)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2023</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">$ 2,242,253<span></span>
</td>
<td class="num">$ (11,718,728)<span></span>
</td>
<td class="num">$ (9,475,991)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Mar. 31, 2023</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockSubjectToPossibleRedemptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of the shares of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockSubjectToPossibleRedemptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockSubjectToPossibleRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockSubjectToPossibleRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Sale of non-redeemable private placement units to Sponsor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents of Sale Of Non-Redeemable Private Placement Units To Sponsor in Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755824720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 05, 2021</div></th>
<th class="th"><div>May 11, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flow from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (85,983)<span></span>
</td>
<td class="nump">$ 2,195,508<span></span>
</td>
<td class="nump">$ 5,135,790<span></span>
</td>
<td class="nump">$ 336,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_OfferingCostsAllocatedToWarrantLiability', window );">Offering costs allocated to warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,825,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RealizedAndUnrealizedGainLoss', window );">Dividends, realized and unrealized gain in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(327,399)<span></span>
</td>
<td class="num">(43,053)<span></span>
</td>
<td class="num">(19,097)<span></span>
</td>
<td class="num">(1,371,689)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount', window );">Interest earned on securities held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,762,640)<span></span>
</td>
<td class="num">(6,325,281)<span></span>
</td>
<td class="num">(4,489,110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,739<span></span>
</td>
<td class="num">(83,061)<span></span>
</td>
<td class="nump">83,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,841<span></span>
</td>
<td class="nump">390,436<span></span>
</td>
<td class="nump">125,972<span></span>
</td>
<td class="nump">1,553,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_IncreaseDecreaseFranchiseTaxPayable', window );">Franchise tax payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,481<span></span>
</td>
<td class="num">(114,008)<span></span>
</td>
<td class="nump">164,008<span></span>
</td>
<td class="num">(94,042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">214,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,462)<span></span>
</td>
<td class="num">(294,018)<span></span>
</td>
<td class="num">(378,487)<span></span>
</td>
<td class="num">(940,463)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flow from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount', window );">Investment of cash in Trust Account</a></td>
<td class="num">$ (117,300,000)<span></span>
</td>
<td class="num">$ (117,300,000)<span></span>
</td>
<td class="num">(368,760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,300,000)<span></span>
</td>
<td class="num">(2,545,838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount', window );">Interest withdrawn from Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">299,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(368,760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,300,000)<span></span>
</td>
<td class="num">(2,246,237)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flow from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NetProceedsFromInitialPublicOffering', window );">Proceeds from sale of Units, net of underwriting discount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromSaleOfPrivateUnits', window );">Proceeds from sale of Private units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,852,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(446,112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,925)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdvancesFromRelatedParties', window );">Advances from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromWorkingCapitalLoan', window );">Proceeds from working capital loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">207,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromExtensionLoan', window );">Proceeds from extension loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">368,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,545,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,131,638<span></span>
</td>
<td class="nump">2,764,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,762)<span></span>
</td>
<td class="num">(294,018)<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="num">(422,281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at the beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,870<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at the end of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,108<span></span>
</td>
<td class="nump">$ 159,133<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="nump">30,870<span></span>
</td>
<td class="nump">$ 453,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption', window );">Re-measurement of Class A common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (583,570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,359,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest', window );">Redemption of Class A common stock held in Trust, including interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 91,909,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DeferredUnderwritingFeePayable', window );">Deferred underwriting fee payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InitialFairValueOfWarrantLiabilities', window );">Initial classification of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,176,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AdvancesFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with advances from related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AdvancesFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_IncreaseDecreaseFranchiseTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of franchise tax payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_IncreaseDecreaseFranchiseTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InitialFairValueOfWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The initial fair value classification of warrant liabilities disclosed in the supplemental non-cash cash flow activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InitialFairValueOfWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest earned on marketable securities held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NetProceedsFromInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public, net of underwriting discounts paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NetProceedsFromInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_OfferingCostsAllocatedToWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Offering costs allocated to warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_OfferingCostsAllocatedToWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromExtensionLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with proceeds from extension loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromExtensionLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with interest withdrawn from Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromSaleOfPrivateUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of private units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromSaleOfPrivateUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromWorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with proceeds from working capital loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromWorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RealizedAndUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RealizedAndUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of redemption of Class A common stock held in Trust, including interest, classified as non-cash financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of remeasurement of Class A common stock subject to possible redemption, classified as non-cash financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083758323152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Data Knights Acquisition Corp. (the &#8220;Company&#8221;) is a blank check company incorporated in Delaware on February 8, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> or more businesses (the &#8220;Business Combination&#8221;). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023, the Company had not yet commenced any operations. All activity for the period February 8, 2021 (inception) through March 31, 2023, relates to the Company&#8217;s formation and the initial public offering (the &#8220;Initial Public Offering&#8221;), and, since the closing of the initial public offering, the Company has entered into a merger agreement (as described below), and continued a search for a Business Combination candidate. The Company has selected December 31 as its fiscal year end.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The registration statement for the Company&#8217;s Initial Public Offering was declared effective on May 6, 2021. On May 11, 2021, the Company consummated the Initial Public Offering of </span><span style="font-family:'Times New Roman','Times','serif';">11,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> units (&#8220;Units&#8221; and, with respect to the shares of Class&#160;A Common Stock included in the Units offered, the &#8220;Public Shares&#8221;), generating gross proceeds of </span><span style="font-family:'Times New Roman','Times','serif';">$115,000,000</span><span style="font-family:'Times New Roman','Times','serif';">, which is described in Note&#160;3.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> private placement units (the &#8220;Private Placement Units&#8221;) at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per unit in a private placement to the Sponsor, generating gross proceeds of </span><span style="font-family:'Times New Roman','Times','serif';">$5,852,750</span><span style="font-family:'Times New Roman','Times','serif';">, which is described in Note&#160;4.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Following the closing of the Initial Public Offering on May 11, 2021, an amount of </span><span style="font-family:'Times New Roman','Times','serif';">$117,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> (</span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (&#8220;Trust Account&#8221;) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company&#8217;s stockholders, as described below.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Transaction costs of the Initial Public Offering amounted to </span><span style="font-family:'Times New Roman','Times','serif';">$6,771,112</span><span style="font-family:'Times New Roman','Times','serif';">, of which </span><span style="font-family:'Times New Roman','Times','serif';">$2,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> was for underwriting fees paid at the time of the IPO, </span><span style="font-family:'Times New Roman','Times','serif';">$4,025,000</span><span style="font-family:'Times New Roman','Times','serif';"> was for deferred underwriting commissions, and </span><span style="font-family:'Times New Roman','Times','serif';">$446,112</span><span style="font-family:'Times New Roman','Times','serif';"> was for other offering costs. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Following the closing of the Initial Public Offering </span><span style="font-family:'Times New Roman','Times','serif';">$959,560</span><span style="font-family:'Times New Roman','Times','serif';"> of cash was held outside of the Trust Account available for working capital purposes. As of March 31, 2023, the Company has </span><span style="font-family:'Times New Roman','Times','serif';">$10,108</span><span style="font-family:'Times New Roman','Times','serif';"> of cash and a working capital deficit of $</span><span style="font-family:'Times New Roman','Times','serif';">2,326,648</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least </span><span style="font-family:'Times New Roman','Times','serif';">80%</span><span style="font-family:'Times New Roman','Times','serif';"> of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires </span><span style="font-family:'Times New Roman','Times','serif';">50%</span><span style="font-family:'Times New Roman','Times','serif';"> or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully affect a Business Combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 25, 2022, the Company, Data Knights Merger Sub, Inc., a Delaware corporation (&#8220;Merger Sub&#8221;), and Data Knights, LLC, the Company&#8217;s sponsor (the &#8220;Sponsor&#8221;), entered into a definitive Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with OneMedNet Corporation, Inc., a Delaware corporation (the &#8220;Target&#8221;, and together with the Company and Merger Sub, the &#8220;Parties&#8221;) and Paul Casey, as seller representative (&#8220;Casey&#8221;). Pursuant to the Merger Agreement, upon the closing (the &#8220;Closing&#8221;) of the Business Combination, the Parties will effect the merger of Merger Sub with and into the Target, with the Target continuing as the </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">surviving entity (the &#8220;Merger&#8221;), as a result of which all of the issued and outstanding capital stock of the Target shall be exchanged shares of the Class A Common Stock of the Company upon the terms set forth in the Merger Agreement.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On May 5, 2022, the Company extended the date by which the Company has to consummate a business combination from May 11, 2022 to August 11, 2022 (the &#8220;First Extension&#8221;). The First Extension was the first of </span><span style="font-family:'Times New Roman','Times','serif';">two</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">three-month</span><span style="font-family:'Times New Roman','Times','serif';"> extensions permitted under the Company&#8217;s governing documents.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On August 10, 2022, the Company extended the date by which the Company has to consummate a business combination from August 11, 2022 to November 11, 2022 (the &#8220;Second Extension&#8221;). The Second Extension was the second of </span><span style="font-family:'Times New Roman','Times','serif';">two</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">three-month</span><span style="font-family:'Times New Roman','Times','serif';"> extensions permitted under the Company&#8217;s governing documents.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On October 27, 2022, the Company filed a definitive proxy statement with the SEC in connection with the Company&#8217;s solicitation of proxies for the vote by the stockholders of the Company at a special meeting of the Company&#8217;s stockholders to be held on November 11, 2022 (the &#8220;Special Meeting&#8221;).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On November 11, 2022, at 10:00 a.m. ET, the Company held a virtual special meeting of its stockholders. At the special meeting, Company stockholders entitle to vote at the special meeting cast their votes and approved the Trust Amendment Proposal, pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO if the Company has not completed its initial business combination, from November 11, 2022 to August 11, 2023 (or such earlier date after November 11, 2022, as determined by the Data Knights Board). As a part of Special Meeting, the Company&#8217;s stockholders approved amendments to its second amended and restated certificate of incorporation (the &#8220;Extension Amendment&#8221;) and the investment management trust agreement (the &#8220;Trust Agreement&#8221;) between Continental Stock Transfer &amp; Trust Company, as trustee (&#8220;Continental&#8221;), and the Company governing the trust account (the &#8220;Trust Account&#8221;) established in connection with the Company&#8217;s initial public offering dated May 11, 2021 (the &#8220;Trust Amendment&#8221;), which together allow the Company to extend the deadline by which it must complete its initial business combination by up to </span><span style="font-family:'Times New Roman','Times','serif';">nine</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">one-month</span><span style="font-family:'Times New Roman','Times','serif';"> periods. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, shall cause </span><span style="font-family:'Times New Roman','Times','serif';">$0.045</span><span style="font-family:'Times New Roman','Times','serif';"> per outstanding share of the Company&#8217;s Class A Common Stock, or approximately </span><span style="font-family:'Times New Roman','Times','serif';">$122,920</span><span style="font-family:'Times New Roman','Times','serif';">, to be deposited in the Trust Account. As of March 31, 2023, the Company has executed </span><span style="font-family:'Times New Roman','Times','serif';">five</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">one-month</span><span style="font-family:'Times New Roman','Times','serif';"> extensions, out of the </span><span style="font-family:'Times New Roman','Times','serif';">nine</span><span style="font-family:'Times New Roman','Times','serif';">, resulting in deposits of approximately </span><span style="font-family:'Times New Roman','Times','serif';">$614,600</span><span style="font-family:'Times New Roman','Times','serif';"> into the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In connection with the proposed Business Combination with the Target, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Stock upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the proposed Business Combination with the Target is not consummated, in connection with an alternative proposed initial business combination, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least </span><span style="font-family:'Times New Roman','Times','serif';">$5,000,001</span><span style="font-family:'Times New Roman','Times','serif';"> either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of </span><span style="font-family:'Times New Roman','Times','serif';">8,768,456</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.42</span><span style="font-family:'Times New Roman','Times','serif';"> per share, for an aggregate of approximately </span><span style="font-family:'Times New Roman','Times','serif';">$91.4</span><span style="font-family:'Times New Roman','Times','serif';"> million. Following the payment of the redemptions, the Trust Account had a balance of approximately </span><span style="font-family:'Times New Roman','Times','serif';">$28.5</span><span style="font-family:'Times New Roman','Times','serif';"> million.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Based on the above, the Company will have until August 11, 2023 to consummate a Business Combination. If the Company is unable to complete a Business Combination on August 11, 2023 at the election of the Company subject to satisfaction of certain conditions, including the deposit of up </span><span style="font-family:'Times New Roman','Times','serif';">$2,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> since the underwriters&#8217; over-allotment option is exercised in full (</span><span style="font-family:'Times New Roman','Times','serif';">$0.10</span><span style="font-family:'Times New Roman','Times','serif';"> per unit), into the Trust Account, or as extended by the Company&#8217;s stockholders in accordance with the Company&#8217;s amended and restated certificate of incorporation) (the &#8220;Combination Period&#8221;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to </span><span style="font-family:'Times New Roman','Times','serif';">$100,000</span><span style="font-family:'Times New Roman','Times','serif';"> of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#8217;s </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit (</span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';">). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the shares of Class A Common Stock and the warrants that are included as components of the Private Placement Units. Such warrants will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) </span><span style="font-family:'Times New Roman','Times','serif';">$10.20</span><span style="font-family:'Times New Roman','Times','serif';"> per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than </span><span style="font-family:'Times New Roman','Times','serif';">$10.20</span><span style="font-family:'Times New Roman','Times','serif';"> per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Going Concern, Liquidity and Capital Resources</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and December 31, 2022, the Company had cash held outside of the Trust Account of </span><span style="font-family:'Times New Roman','Times','serif';">$10,108</span><span style="font-family:'Times New Roman','Times','serif';"> and $</span><span style="font-family:'Times New Roman','Times','serif';">30,870</span><span style="font-family:'Times New Roman','Times','serif';">, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial business combination. As of March 31, 2023 and December 31,2022, the Company had working capital deficit of </span><span style="font-family:'Times New Roman','Times','serif';">$2,326,648 </span><span style="font-family:'Times New Roman','Times','serif';">and </span><span style="font-family:'Times New Roman','Times','serif';">$1,945,267</span><span style="font-family:'Times New Roman','Times','serif';">, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company&#8217;s liquidity needs prior to the consummation of its IPO were satisfied through the proceeds of </span><span style="font-family:'Times New Roman','Times','serif';">$25,000</span><span style="font-family:'Times New Roman','Times','serif';"> from the sale of the Founder Shares and proceed from the promissory note from sponsor of </span><span style="font-family:'Times New Roman','Times','serif';">$78,925</span><span style="font-family:'Times New Roman','Times','serif';">, which was repaid upon closure of the IPO. Subsequent to the IPO, the Company&#8217;s liquidity will be satisfied through a portion of the net proceeds from IPO held outside of the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and December 31, 2022, we had investments of </span><span style="font-family:'Times New Roman','Times','serif';">$29,725,574</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$29,029,416</span><span style="font-family:'Times New Roman','Times','serif';"> held in the Trust Account, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes. For the three months ended March 31, 2023, we did not withdraw any of interest earned on the Trust Account. During the period ended December 31, 2022, we withdraw </span><span style="font-family:'Times New Roman','Times','serif';">$299,601</span><span style="font-family:'Times New Roman','Times','serif';"> interest earned on the Trust Account to pay Delaware Franchise Tax. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed. The Company will have until August 23, 2023 to consummate a Business Combination. If our initial business combination is not consummated by </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">August 23, 2023, less than one year after the date the financial statements are issued, then our existence will terminate, and we will distribute all amounts in the trust account. The Company intends to complete a business combination before the liquidation date and no adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after such date. There can be no assurance that the Company will be able to consummate an initial business combination by August 23, 2023 and/or have sufficient working capital and borrowing capacity to meet its needs. Based upon the above analysis, management determined that these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Accounts to repay such loaned amounts but no proceeds from our Trust Accounts would be used for such repayment. Up to </span><span style="font-family:'Times New Roman','Times','serif';">$1,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> of such loans may be convertible into units identical to the Placement Units, at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per unit at the option of the lender.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Risks and Uncertainties</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into law. The IR Act provides for, among other measures, a new 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom the shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased. For purposes of calculating the excise tax, however, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#8220;Treasury Department&#8221;) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Any redemption or other repurchase effected by us that occurs after December 31, 2022, in connection with a Business Combination or otherwise, may be subject to this excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the nature and amount of any PIPE financing or other equity issuances in connection with the Business Combination (or any other equity issuances within the same taxable year of the Business Combination) and (iii) the content of any regulations and other guidance issued by the Treasury Department and/or the Internal Revenue Service. In addition, because the excise tax would be payable by us and not by the redeeming holder, it could cause a reduction in the value of our stock. The foregoing could cause a reduction in the cash available on hand to complete a business Combination in the required time and redeem </span><span style="font-family:'Times New Roman','Times','serif';">100%</span><span style="font-family:'Times New Roman','Times','serif';"> of our public shares in accordance with our amended and restated certificate of incorporation) could be subject to the excise tax, in which case the amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights Acquisition Corp. (the &#8220;Company&#8221;) is a blank check company incorporated in Delaware on February 8, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the &#8220;Business Combination&#8221;). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, the Company had not yet commenced any operations. All activity for the period February 8, 2021 (inception) through December 31, 2022, relates to the Company&#8217;s formation and the initial public offering (the &#8220;Initial Public Offering&#8221;), and, since the closing of the initial public offering, the Company has entered into a merger agreement (as described below), and continued a search for a Business Combination candidate. The Company has selected December 31 as its fiscal year end.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The registration statement for the Company&#8217;s Initial Public Offering was declared effective on May 6, 2021. On May 11, 2021, the Company consummated the Initial Public Offering of 11,500,000 units (&#8220;Units&#8221; and, with respect to the shares of Class&#160;A Common Stock included in the Units offered, the &#8220;Public Shares&#8221;), generating gross proceeds of $115,000,000, which is described in Note&#160;3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 585,275 private placement units (the &#8220;Private Placement Units&#8221;) at a price of $10.00 per unit in a private placement to the Sponsor, generating gross proceeds of $5,852,750, which is described in Note&#160;4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering on May 11, 2021, an amount of $117,300,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (&#8220;Trust Account&#8221;) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company&#8217;s stockholders, as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Transaction costs of the Initial Public Offering amounted to $6,771,112, of which $2,300,000 was for underwriting fees paid at the time of the IPO, $4,025,000 was for deferred underwriting commissions, and $446,112 was for other offering costs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering $959,560 of cash was held outside of the Trust Account available for working capital purposes. As of December 31, 2022, the Company has $30,870 of cash and a working capital deficit of $1,945,267.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On April 25, 2022, the Company, Data Knights Merger Sub, Inc., a Delaware corporation (&#8220;Merger Sub&#8221;), and Data Knights, LLC, the Company&#8217;s sponsor (the &#8220;Sponsor&#8221;), entered into a definitive Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with OneMedNet Corporation, Inc., a Delaware corporation (the &#8220;Target&#8221;, and together with the Company and Merger Sub, the &#8220;Parties&#8221;) and Paul Casey, as seller representative (&#8220;Casey&#8221;). Pursuant to the Merger Agreement, upon the closing (the &#8220;Closing&#8221;) of the Business Combination, the Parties will effect the merger of Merger Sub with and into the Target, with the Target continuing as the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">surviving entity (the &#8220;Merger&#8221;), as a result of which all of the issued and outstanding capital stock of the Target shall be exchanged shares of the Class A Common Stock of the Company upon the terms set forth in the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On May 5, 2022, the Company extended the date by which the Company has to consummate a business combination from May 11, 2022 to August 11, 2022 (the &#8220;First Extension&#8221;). The First Extension was the first of two three-month extensions permitted under the Company&#8217;s governing documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On August 10, 2022, the Company extended the date by which the Company has to consummate a business combination from August 11, 2022 to November 11, 2022 (the &#8220;Second Extension&#8221;). The Second Extension was the second of two three-month extensions permitted under the Company&#8217;s governing documents. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On October 27, 2022, the Company filed a definitive proxy statement with the SEC in connection with the Company&#8217;s solicitation of proxies for the vote by the stockholders of the Company at a special meeting of the Company&#8217;s stockholders to be held on November 11, 2022 (the &#8220;Special Meeting&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On November 11, 2022, at 10:00 a.m. ET, the Company held a virtual special meeting of its stockholders. At the special meeting, Company stockholders entitle to vote at the special meeting cast their votes and approved the Trust Amendment Proposal, pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO if the Company has not completed its initial business combination, from November 11, 2022 to August 11, 2023 (or such earlier date after November 11, 2022, as determined by the Data Knights Board). As a part of Special Meeting, the Company&#8217;s stockholders approved amendments to its second amended and restated certificate of incorporation (the &#8220;Extension Amendment&#8221;) and the investment management trust agreement (the &#8220;Trust Agreement&#8221;) between Continental Stock Transfer &amp; Trust Company, as trustee (&#8220;Continental&#8221;), and the Company governing the trust account (the &#8220;Trust Account&#8221;) established in connection with the Company&#8217;s initial public offering dated May 11, 2021 (the &#8220;Trust Amendment&#8221;), which together allow the Company to extend the deadline by which it must complete its initial business combination by up to nine one-month periods. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, shall cause $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account. As of December 31, 2022, the Company has executed two one-month extensions, out of the nine, resulting in deposits of approximately $245,840 into the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the proposed Business Combination with the Target, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Stock upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the proposed Business Combination with the Target is not consummated, in connection with an alternative proposed initial business combination, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of 8,768,456 shares of Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of $10.42 per share, for an aggregate of approximately $91.4 million. Following the payment of the redemptions, the Trust Account had a balance of approximately $28.5 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Based on the above, the Company will have until August 11, 2023 to consummate a Business Combination. If the Company is unable to complete a Business Combination on August 11, 2023 at the election of the Company subject to satisfaction of certain conditions, including the deposit of up $2,300,000 since the underwriters&#8217; over-allotment option is exercised in full ($0.10 per unit), into the Trust Account, or as extended by the Company&#8217;s stockholders in accordance with the Company&#8217;s amended and restated certificate of incorporation) (the &#8220;Combination Period&#8221;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#8217;s </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the shares of Class A Common Stock and the warrants that are included as components of the Private Placement Units. Such warrants will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.20 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Going Concern, Liquidity and Capital Resources</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, the Company had cash held outside of the Trust Account of <span style="-sec-ix-hidden:Hidden_cZQeLnh3Zk29sDgjeEin2Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$30,780</span></span> and $453,151, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial business combination. As of December 31, 2022 and 2021, the Company had working capital surplus (deficit) of $(1,945,267) and $246,232, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s liquidity needs prior to the consummation of its IPO were satisfied through the proceeds of $25,000 from the sale of the Founder Shares and proceed from the promissory note from sponsor of $78,925, which was repaid upon closure of the IPO. Subsequent to the IPO, the Company&#8217;s liquidity will be satisfied through a portion of the net proceeds from IPO held outside of the Trust Account. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, we had investments of $29,029,416 and $117,320,973 held in the Trust Account, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes. During the period ended December 31, 2022, we withdraw $299,601 of interest earned on the Trust Account to pay Delaware Franchise Tax. During the period ended December 31, 2021, we did not withdraw any interest earned on the Trust Account. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed. The Company will have until August 23, 2023 to consummate a Business Combination. If our initial business combination is not consummated by </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">August 23, 2023, less than one year after the date the financial statements are issued, then our existence will terminate, and we will distribute all amounts in the trust account. The Company intends to complete a business combination before the liquidation date and no adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after such date. There can be no assurance that the Company will be able to consummate an initial business combination by August 23, 2023 and/or have sufficient working capital and borrowing capacity to meet its needs. Based upon the above analysis, management determined that these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Accounts to repay such loaned amounts but no proceeds from our Trust Accounts would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units identical to the Placement Units, at a price of $10.00 per unit at the option of the lender.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Risks and Uncertainties</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into law. The IR Act provides for, among other measures, a new 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom the shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased. For purposes of calculating the excise tax, however, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#8220;Treasury Department&#8221;) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Any redemption or other repurchase effected by us that occurs after December 31, 2022, in connection with a Business Combination or otherwise, may be subject to this excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the nature and amount of any PIPE financing or other equity issuances in connection with the Business Combination (or any other equity issuances within the same taxable year of the Business Combination) and (iii) the content of any regulations and other guidance issued by the Treasury Department and/or the Internal Revenue Service. In addition, because the excise tax would be payable by us and not by the redeeming holder, it could cause a reduction in the value of our stock. The foregoing could cause a reduction in the cash available on hand to complete a business Combination in the required time and redeem 100% of our public shares in accordance with our amended and restated certificate of incorporation) could be subject to the excise tax, in which case the amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083754662896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Basis of presentation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Emerging growth company</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Use of estimates</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had </span><span style="font-family:'Times New Roman','Times','serif';">$10,108</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$30,870</span><span style="font-family:'Times New Roman','Times','serif';"> in cash and </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> cash equivalents as of March 31, 2023 and December 31, 2022, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Trust Account</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Upon the closing of the Initial Public Offering and the Private Placement, </span><span style="font-family:'Times New Roman','Times','serif';">$117,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> (</span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</span><span style="font-family:'Times New Roman','Times','serif';"> Accordingly, as of March 31, 2023, there were </span><span style="font-family:'Times New Roman','Times','serif';">3,316,819</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, excluding </span><span style="font-family:'Times New Roman','Times','serif';">2,731,544</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 31, 2023, there are </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and </span><span style="font-family:'Times New Roman','Times','serif';">4,838,792</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, which are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and 2022, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock &#8211; </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 583,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock - </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,333,680</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Net income (loss) per share</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net income (loss) between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for </span><span style="font-family:'Times New Roman','Times','serif';">12,085,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of common stock in the aggregate.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table reflects the calculation of basic and diluted net income (loss) per common share:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,687,692</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"><span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 4,838,792</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,500,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31,025)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 507,816</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"><span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 2,731,544</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,460,275</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At March 31, 2023 and 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Income Taxes </b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> unrecognized tax benefits and </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> amounts accrued for interest and penalties </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">as of March 31, 2023 and 2022, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Our effective tax rate was </span><span style="font-family:'Times New Roman','Times','serif';">(225.88%)</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">0%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of </span><span style="font-family:'Times New Roman','Times','serif';">21%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, due to transaction costs and the valuation allowance on the deferred tax assets.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within those fiscal years.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Basis of presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Emerging growth company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had $30,870 and $453,151 in cash and no cash equivalents as of December 31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Trust Account</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the Initial Public Offering and the Private Placement, $117,300,000 ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, there are 585,275 shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and 11,500,000 shares of Class A Common Stock outstanding, which are subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December 31, 2022 and 2021, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross Proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to public warrants and private warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,614,500)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issuance costs related to Class A Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,146,054)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Redemption of Class A Common Stock, including interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (91,909,483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,359,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,060,554</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Net income per share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net income per share is computed by dividing net income by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 12,085,275 shares of common stock in the aggregate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The following table reflects the calculation of basic and diluted net income per common share:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period of</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,671,658</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,667,969</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,264,526</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 96,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,464,132</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,295,610</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation Expense</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for stock-based compensation expense in accordance with ASC Topic 718, &#8220;Compensation &#8211; Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. The fair value of equity awards has been estimated using a market approach. Forfeitures are recognized as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Company determined that it was not probable that ARC would meet the performance condition as defined in the Introducing Advisor Agreement (See Note 5), and therefore, no stock-based compensation expense was recognized. At December 31, 2022, upon amendment of the Introducing Advisor Agreement, which amended ARC&#8217;s performance condition that was concurrently deemed to have been met, ARC was granted 1,378,517 shares of the Company&#8217;s Class B common stock at a fair value of $2.05 per share. The Company recorded the resulting $2,825,960<span style="white-space:pre-wrap;"> of stock based compensation expense on December 31, 2022, which is included in formation and operating costs in the consolidated statement of operations.  The fair value of the Class B common stock was determined by applying a discount to the actively traded Class A shares, which have an observable market price. The discount was calculated as the average discount of the Class B share price (derived) compared to the Class A share price (observable) for SPACs that have actively traded &#8220;Rights&#8221;.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760196528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InitialPublicOfferingAbstract', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_InitialPublicOfferingDisclosureTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 3. INITIAL PUBLIC OFFERING</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to the Initial Public Offering, the Company sold </span><span style="font-family:'Times New Roman','Times','serif';">11,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> Units at a purchase price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Unit. Each Unit consists of </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> share of the Company&#8217;s Class A Common Stock, </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> par value, and </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> share of Class A Common Stock at an exercise price of </span><span style="font-family:'Times New Roman','Times','serif';">$11.50</span><span style="font-family:'Times New Roman','Times','serif';">&#160;per whole share (see Note&#160;9).</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 3. INITIAL PUBLIC OFFERING</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Pursuant to the Initial Public Offering, the Company sold 11,500,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one share of the Company&#8217;s Class A Common Stock, $0.0001 par value, and one redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $11.50&#160;per whole share (see Note&#160;9).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_InitialPublicOfferingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on information about initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_InitialPublicOfferingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083750343520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrivatePlacementAbstract', window );"><strong>PRIVATE PLACEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrivatePlacementTextBlock', window );">PRIVATE PLACEMENT</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 4. PRIVATE PLACEMENT</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> Private Placement Units at a price of $</span><span style="font-family:'Times New Roman','Times','serif';">10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Private Placement Unit for an aggregate purchase price of </span><span style="font-family:'Times New Roman','Times','serif';">$5,852,750</span><span style="font-family:'Times New Roman','Times','serif';">. </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Private Placement Units are identical to the Units, except that (a) the Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of the Company&#8217;s initial business combination except to permitted transferees and (b) the Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) may be exercised by the holders on a cashless basis and (ii) will be entitled to registration rights.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 4. PRIVATE PLACEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of 585,275 Private Placement Units at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $5,852,750. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Private Placement Units are identical to the Units, except that (a) the Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of the Company&#8217;s initial business combination except to permitted transferees and (b) the Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) may be exercised by the holders on a cashless basis and (ii) will be entitled to registration rights.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PrivatePlacementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on information about private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PrivatePlacementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083756779024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 5. RELATED PARTY TRANSACTIONS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Introducing Advisor Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On June 26, 2021, the Company entered into an introducing advisor agreement (the &#8220;Introducing Advisor Agreement&#8221;) with ARC Group Limited, the Company&#8217;s financial advisor (&#8220;ARC&#8221;), pursuant to which ARC will make strategic introductions to the Company of potential target companies and/or their subsidiaries, affiliates, or representatives (each an &#8220;Advisor Target&#8221;) who may be interested in potential business combinations with the Company. In consideration for ARC&#8217;s services under the Introducing Advisor Agreement, we agreed to (i) pay to ARC (a) a retainer of </span><span style="font-family:'Times New Roman','Times','serif';">$50,000</span><span style="font-family:'Times New Roman','Times','serif';"> upon execution of the Introducing Advisor Agreement and (b) a success fee of </span><span style="font-family:'Times New Roman','Times','serif';">$100,000</span><span style="font-family:'Times New Roman','Times','serif';"> upon the closing our initial business combination, and (ii) cause to be issued to ARC equity interests in the post-combination company representing a five-percent (</span><span style="font-family:'Times New Roman','Times','serif';">5%</span><span style="font-family:'Times New Roman','Times','serif';">) ownership interest in the post-combination company, if at any time prior to June 25, 2022 (the &#8220;Termination Date&#8221;), or within six (</span><span style="-sec-ix-hidden:Hidden_-gBu7Ivd10mlotw_rZDvrw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6</span></span><span style="font-family:'Times New Roman','Times','serif';">) months after the consummation of an initial business combination or any financing with any Advisor Target or any affiliate of an Advisor Target (the &#8220;Equity Issuance&#8221;).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (</span><span style="font-family:'Times New Roman','Times','serif';">5%</span><span style="font-family:'Times New Roman','Times','serif';">) on any PIPE </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">that was brought by ARC in connection with the Company&#8217;s initial business combination upon the closing of the Company&#8217;s initial business combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued </span><span style="font-family:'Times New Roman','Times','serif';">1,378,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of the Company&#8217;s Class B Common Stock, up to </span><span style="font-family:'Times New Roman','Times','serif';">143,766</span><span style="font-family:'Times New Roman','Times','serif';"> shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Founder Shares</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On February 25, 2021, the Company issued an aggregate of </span><span style="font-family:'Times New Roman','Times','serif';">2,875,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B Common Stock (the &#8220;Founder Shares&#8221;) to the Sponsor for an aggregate purchase price of </span><span style="font-family:'Times New Roman','Times','serif';">$25,000</span><span style="font-family:'Times New Roman','Times','serif';">. On February 25, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';">15,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Executive Officer, </span><span style="font-family:'Times New Roman','Times','serif';">15,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Financial Officer and </span><span style="font-family:'Times New Roman','Times','serif';">5,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';">5,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to such independent director. The Founder Shares which the Sponsor and its permitted transferees will collectively own, on an as-converted basis, represent </span><span style="font-family:'Times New Roman','Times','serif';">20%</span><span style="font-family:'Times New Roman','Times','serif';"> of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. In connection with the Introducing Advisors Agreement, on December 31, 2022, ARC was granted </span><span style="font-family:'Times New Roman','Times','serif';">1,378,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B common stock, </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> par value per share, up to </span><span style="font-family:'Times New Roman','Times','serif';">143,766</span><span style="font-family:'Times New Roman','Times','serif';"> of which are subject to forfeiture by ARC if the Company&#8217;s public shareholders exercise redemption rights with respect to any of outstanding shares of Class A common stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;</span><span style="font-family:'Times New Roman','Times','serif';">six months</span><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company&#8217;s Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';">$12.00</span><span style="font-family:'Times New Roman','Times','serif';"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any </span><span style="font-family:'Times New Roman','Times','serif';">20</span><span style="font-family:'Times New Roman','Times','serif';"> trading&#160;days within any </span><span style="font-family:'Times New Roman','Times','serif';">30-</span><span style="font-family:'Times New Roman','Times','serif';">trading day period commencing at least </span><span style="font-family:'Times New Roman','Times','serif';">150 days</span><span style="font-family:'Times New Roman','Times','serif';"> after the Business Combination, the Founder Shares will be released from the lock-up.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Promissory Note&#160;&#8212; Related Party</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On February 8, 2021, the Sponsor committed to loan the Company an aggregate of up to </span><span style="font-family:'Times New Roman','Times','serif';">$300,000</span><span style="font-family:'Times New Roman','Times','serif';"> to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#8220;Note&#8221;). The Note was non-interest bearing and was payable on the earlier of July 31, 2021 or the completion of the Initial Public Offering. On June 1, 2021, the </span><span style="font-family:'Times New Roman','Times','serif';">$78,925</span><span style="font-family:'Times New Roman','Times','serif';"> outstanding under the promissory note was repaid in full. On March 31, 2023 and December 31, 2022, there is </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> amount outstanding under the promissory note.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Related Party Loans</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In order to finance transaction costs in connection with a Business Combination, the Company&#8217;s Sponsor, an affiliate of the Sponsor, or the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the &#8220;Working Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to </span><span style="font-family:'Times New Roman','Times','serif';">$1,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> of notes may be converted upon consummation of a Business Combination into units at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per unit. The Units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On March 31, 2023 and December 31, 2022, there is </span><span style="font-family:'Times New Roman','Times','serif';">$239,081</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$207,081</span><span style="font-family:'Times New Roman','Times','serif';"> outstanding under the Working Capital Loans, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company&#8217;s second amended and restated certificate of incorporation provides that, if the Company anticipates that it may not be able to consummate a Business Combination within </span><span style="font-family:'Times New Roman','Times','serif';">12 months</span><span style="font-family:'Times New Roman','Times','serif';"> from the closing of the Company&#8217;s initial public offering, the Company may, by resolution of the Company&#8217;s board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to </span><span style="font-family:'Times New Roman','Times','serif';">two</span><span style="font-family:'Times New Roman','Times','serif';"> times, each by an additional </span><span style="font-family:'Times New Roman','Times','serif';">three months</span><span style="font-family:'Times New Roman','Times','serif';"> (for a total of up to </span><span style="font-family:'Times New Roman','Times','serif';">18 months</span><span style="font-family:'Times New Roman','Times','serif';"> to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account as set out below. Pursuant to the terms of the </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Company&#8217;s second amended and restated certificate of incorporation and the trust agreement entered into between the Company and Continental Stock Transfer &amp; Trust Company, in order for the time available for the Company to consummate the initial Business Combination to be extended, the Sponsor or its affiliates or designees, upon </span><span style="font-family:'Times New Roman','Times','serif';">five</span><span style="font-family:'Times New Roman','Times','serif';"> business days advance notice prior to the applicable deadline, must deposit into the Trust Account </span><span style="font-family:'Times New Roman','Times','serif';">$1,150,000</span><span style="font-family:'Times New Roman','Times','serif';"> since the underwriters&#8217; over-allotment option is exercised in full (</span><span style="font-family:'Times New Roman','Times','serif';">$0.10</span><span style="font-family:'Times New Roman','Times','serif';"> per unit), on or prior to the date of the applicable deadline, for each of the available </span><span style="font-family:'Times New Roman','Times','serif';">three month</span><span style="font-family:'Times New Roman','Times','serif';"> extensions, providing a total possible Business Combination period of </span><span style="font-family:'Times New Roman','Times','serif';">18 months</span><span style="font-family:'Times New Roman','Times','serif';"> at a total payment value of </span><span style="font-family:'Times New Roman','Times','serif';">$2,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> since the underwriters&#8217; over-allotment option is exercised in full (</span><span style="font-family:'Times New Roman','Times','serif';">$0.10</span><span style="font-family:'Times New Roman','Times','serif';"> per unit) (the &#8220;Extension Loans&#8221;). Any such payments would be made in the form of non-interest-bearing loans. If the Company completes its initial Business Combination, the Company will, at the option of the Sponsor, repay the Extension Loans out of the proceeds of the Trust Account released to the Company or convert a portion or all of the total loan amount into units at a price of </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';">&#160;per unit, which units will be identical to the Private Placement Units. If the Company does not complete a Business Combination, the Company will repay such loans only from funds held outside of the Trust Account. Furthermore, the letter agreement among the Company and the Company&#8217;s officers, directors, and the Sponsor contains a provision pursuant to which the Sponsor will agree to waive its right to be repaid for such loans to the extent there is insufficient funds held outside of the Trust Account in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination. The public stockholders will not be afforded an opportunity to vote on the extension of time to consummate an initial Business Combination from </span><span style="font-family:'Times New Roman','Times','serif';">12 months</span><span style="font-family:'Times New Roman','Times','serif';"> to </span><span style="font-family:'Times New Roman','Times','serif';">18 months</span><span style="font-family:'Times New Roman','Times','serif';"> described above or redeem their shares in connection with such extensions. Pursuant to the foregoing, on May 5, 2022, the Company extended the date by which the Company had to consummate a business combination from May 11, 2022 to August 11, 2022. On August 10, 2022, the Company extended the date by which the Company had to consummate a business combination from August 11, 2022 to November 11, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">As described in Note 1, on November 11, 2022, the Stockholders of the Company approved the Extension Amendment and the Trust Amendment to allow the Company to extend the deadline by which it must complete its initial business combination by up to nine </span><span style="font-family:'Times New Roman','Times','serif';">one-month</span><span style="font-family:'Times New Roman','Times','serif';"> periods from November 11, 2022. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, caused </span><span style="font-family:'Times New Roman','Times','serif';">$0.045</span><span style="font-family:'Times New Roman','Times','serif';"> per outstanding share of the Company&#8217;s Class A Common Stock, or approximately </span><span style="font-family:'Times New Roman','Times','serif';">$122,920</span><span style="font-family:'Times New Roman','Times','serif';">, deposited in the Trust Account in connection with the exercise of the monthly extension. In connection with each such extension, the Company will have until April 11, 2023 to consummate a Business Combination(see Note 11). On March 31, 2023 and December 31, 2022, there is </span><span style="font-family:'Times New Roman','Times','serif';">$2,914,598</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$2,545,838</span><span style="font-family:'Times New Roman','Times','serif';"> outstanding under the Extension Loan, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Administrative Services Arrangement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Commencing on the date of the prospectus and until completion of the Company&#8217;s Business Combination or liquidation, the Company may reimburse ARC Group Ltd., an affiliate of the Sponsor, up to an amount of </span><span style="font-family:'Times New Roman','Times','serif';">$10,000</span><span style="font-family:'Times New Roman','Times','serif';"> per month for office space, secretarial and administrative support. For the three months ended March 31, 2023 and 2022, we have incurred </span><span style="font-family:'Times New Roman','Times','serif';">$30,000</span><span style="font-family:'Times New Roman','Times','serif';"> in fees under this agreement, respectively.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 5. RELATED PARTY TRANSACTIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Introducing Advisor Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June 26, 2021, the Company entered into an introducing advisor agreement (the &#8220;Introducing Advisor Agreement&#8221;) with ARC Group Limited, the Company&#8217;s financial advisor (&#8220;ARC&#8221;), pursuant to which ARC will make strategic introductions to the Company of potential target companies and/or their subsidiaries, affiliates, or representatives (each an &#8220;Advisor Target&#8221;) who may be interested in potential business combinations with the Company. In consideration for ARC&#8217;s services under the Introducing Advisor Agreement, we agreed to (i) pay to ARC (a) a retainer of $50,000 upon execution of the Introducing Advisor Agreement and (b) a success fee of $100,000 upon the closing our initial business combination, and (ii) cause to be issued to ARC equity interests in the post-combination company representing a five-percent (5%) ownership interest in the post-combination company, if at any time prior to June 25, 2022 (the &#8220;Termination Date&#8221;), or within six (6) months after the consummation of an initial business combination or any financing with any Advisor Target or any affiliate of an Advisor Target (the &#8220;Equity Issuance&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (5%) on any PIPE that was brought by ARC in connection with the Company&#8217;s initial business combination upon the closing of the Company&#8217;s initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued 1,378,517 shares of the Company&#8217;s Class B Common Stock, up to 143,766 shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Founder Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 25, 2021, the Company issued an aggregate of 2,875,000 shares of Class B Common Stock (the &#8220;Founder Shares&#8221;) to the Sponsor for an aggregate purchase price of $25,000. On February 25, 2021, the Sponsor transferred 15,000 shares to the Company&#8217;s Chief Executive Officer, 15,000 shares to the Company&#8217;s Chief Financial Officer and 5,000 shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred 5,000 shares to such independent director. The Founder Shares which the Sponsor and its permitted transferees will collectively own, on an as-converted basis, represent 20% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. In connection with the Introducing Advisors Agreement, on December 31, 2022, ARC was granted 1,378,517 shares of Class B common stock, $0.0001 par value per share, up to 143,766 of which are subject to forfeiture by ARC if the Company&#8217;s public shareholders exercise redemption rights with respect to any of outstanding shares of Class A common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;six months after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company&#8217;s Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any <span style="-sec-ix-hidden:Hidden_bbHY3R68R0qhn-ZoycDM0g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> trading&#160;days within any <span style="-sec-ix-hidden:Hidden_oJtbLe8GvkWMoQVqcR68nA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span>-trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Promissory Note&#160;&#8212; Related Party</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 8, 2021, the Sponsor committed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#8220;Note&#8221;). The Note was non-interest bearing and was payable on the earlier of July 31, 2021 or the completion of the Initial Public Offering. On June 1, 2021, the $78,925 outstanding under the promissory note was repaid in full. On December 31, 2022 and 2021, there is no amount outstanding under the promissory note.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Related Party Loans</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to finance transaction costs in connection with a Business Combination, the Company&#8217;s Sponsor, an affiliate of the Sponsor, or the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the &#8220;Working Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into units at a price of $10.00 per unit. The Units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On December 31, 2022 and 2021, there is $207,081 and nil outstanding under the Working Capital Loans, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s second amended and restated certificate of incorporation provides that, if the Company anticipates that it may not be able to consummate a Business Combination within 12 months from the closing of the Company&#8217;s initial public offering, the Company may, by resolution of the Company&#8217;s board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to two times, each by an additional three months (for a total of up to 18 months to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account as set out below. Pursuant to the terms of the Company&#8217;s second amended and restated certificate of incorporation and the trust agreement entered into between the Company and Continental Stock Transfer &amp; Trust Company, in order for the time available for the Company to consummate the initial Business Combination to be extended, the Sponsor or its affiliates or designees, upon five business days advance notice prior to the applicable deadline, must deposit into the Trust Account $1,150,000 since the underwriters&#8217; over-allotment option is exercised in full ($0.10 per unit), on or prior to the date of the applicable deadline, for each of the available three month extensions, providing a total possible Business Combination period of 18 months at a total payment value of $2,300,000 since the underwriters&#8217; over-allotment option is exercised in full ($0.10 per unit) (the &#8220;Extension Loans&#8221;). Any such payments would be made in the form of non-interest-bearing loans. If the Company completes its initial Business Combination, the Company will, at the option of the Sponsor, repay the Extension Loans out of the proceeds of the Trust Account released to the Company or convert a portion or all of the total loan amount into units at a price of $10.00&#160;per unit, which units will be identical to the Private Placement Units. If the Company does not complete a Business Combination, the Company will repay such loans only from funds held outside of the Trust Account. Furthermore, the letter agreement among the Company and the Company&#8217;s officers, directors, and the Sponsor contains a provision pursuant to which the Sponsor will agree to waive its right to be repaid for such loans to the extent there is insufficient funds held outside of the Trust Account in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination. The public stockholders will not be afforded an opportunity to vote on the extension of time to consummate an initial Business Combination from 12 months to 18 months described above or redeem their shares in connection with such extensions. Pursuant to the foregoing, on May 5, 2022, the Company extended the date by which the Company had to consummate a business combination from May 11, 2022 to August 11, 2022. On August 10, 2022, the Company extended the date by which the Company had to consummate a business combination from August 11, 2022 to November 11, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As described in Note 1, on November 11, 2022, the Stockholders of the Company approved the Extension Amendment and the Trust Amendment to allow the Company to extend the deadline by which it must complete its initial business combination by up to nine one-month periods from November 11, 2022. In connection with each such extension, Data Knights, LLC, the Company&#8217;s sponsor, caused $0.045 per outstanding share of the Company&#8217;s Class A Common Stock, or approximately $122,920, deposited in the Trust Account in connection with the exercise of the monthly extension. In connection with each such extension, the Company will have until April 11, 2023 to consummate a Business Combination (see Note 11). On December 31, 2022 and 2021, there is $2,545,838 and nil outstanding under the Extension Loan, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Administrative Services Arrangement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Commencing on the date of the prospectus and until completion of the Company&#8217;s Business Combination or liquidation, the Company may reimburse ARC Group Ltd., an affiliate of the Sponsor, up to an amount of $10,000 per month for office space, secretarial and administrative support. For the year ended December 31, 2022, we have incurred $120,000 in fees under this agreement. From February 8, 2021(inception) to December 31, 2021, the Company incurred $80,000 in fees under this agreement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083761020880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 6. COMMITMENTS AND CONTINGENCIES</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Registration Rights</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to a registration rights agreement entered into on May 6, 2021, the holders of the Founder Shares, Private Placement Units (including the securities contained therein), the units (including the securities contained therein) that may be issued upon conversion of the Working Capital Loans, and any shares of Class A Common Stock issuable upon the exercise of the Placement Warrants and any shares of Class A Common Stock, warrants (and underlying Class A Common Stock) that may be issued upon conversion of the units issued as part of the working capital loans and Class A Common Stock issuable upon conversion of the founder shares are entitled to registration rights. The holders of a majority of these securities are entitled to make up to </span><span style="font-family:'Times New Roman','Times','serif';">three</span><span style="font-family:'Times New Roman','Times','serif';"> demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Underwriters Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company granted the underwriter a </span><span style="font-family:'Times New Roman','Times','serif';">45</span><span style="font-family:'Times New Roman','Times','serif';">-day option to purchase up to </span><span style="font-family:'Times New Roman','Times','serif';">1,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The aforementioned option was exercised on May 11, 2021.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The underwriter was paid a cash underwriting discount of two percent (</span><span style="font-family:'Times New Roman','Times','serif';">2.00%</span><span style="font-family:'Times New Roman','Times','serif';">) of the gross proceeds of the Initial Public Offering, or </span><span style="font-family:'Times New Roman','Times','serif';">$2,300,000</span><span style="font-family:'Times New Roman','Times','serif';">. In addition, the underwriter is entitled to a deferred fee of three and a half percent (</span><span style="font-family:'Times New Roman','Times','serif';">3.50%</span><span style="font-family:'Times New Roman','Times','serif';">) of the gross proceeds of the Initial Public Offering, or </span><span style="font-family:'Times New Roman','Times','serif';">$4,025,000</span><span style="font-family:'Times New Roman','Times','serif';">. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Right of First Refusal</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">For a period beginning on May 7, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">First Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (</span><span style="font-family:'Times New Roman','Times','serif';">5</span><span style="font-family:'Times New Roman','Times','serif';">%) on any PIPE that was brought by ARC in connection with an initial business combination upon the closing of an initial business combination.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Second Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued </span><span style="font-family:'Times New Roman','Times','serif';">1,378,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of the Company&#8217;s Class B Common Stock, up to </span><span style="font-family:'Times New Roman','Times','serif';">143,766</span><span style="font-family:'Times New Roman','Times','serif';"> shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 6. COMMITMENTS AND CONTINGENCIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Registration Rights</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to a registration rights agreement entered into on May 6, 2021, the holders of the Founder Shares, Private Placement Units (including the securities contained therein), the units (including the securities contained therein) that may be issued upon conversion of the Working Capital Loans, and any shares of Class A Common Stock issuable upon the exercise of the Placement Warrants and any shares of Class A Common Stock, warrants (and underlying Class A Common Stock) that may be issued upon conversion of the units issued as part of the working capital loans and Class A Common Stock issuable upon conversion of the founder shares are entitled to registration rights. The holders of a majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Underwriters Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company granted the underwriter a 45-day option to purchase up to 1,500,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The aforementioned option was exercised on May 11, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The underwriter was paid a cash underwriting discount of two percent (2.00%) of the gross proceeds of the Initial Public Offering, or $2,300,000. In addition, the underwriter is entitled to a deferred fee of three and a half percent (3.50%) of the gross proceeds of the Initial Public Offering, or $4,025,000. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Right of First Refusal</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a period beginning on May 7, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">First Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (5%) on any PIPE that was brought by ARC in connection with an initial business combination upon the closing of an initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Second Amendment to the Introducing Advisor Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued 1,378,517 shares of the Company&#8217;s Class B Common Stock, up to 143,766 shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083759224960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantLiabilityAbstract', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantLiabilityTextBlock', window );">WARRANT LIABILITY</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 7. WARRANT LIABILITY</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable </span><span style="font-family:'Times New Roman','Times','serif';">30 days</span><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination and will expire </span><span style="font-family:'Times New Roman','Times','serif';">five years</span><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination or earlier upon redemption or liquidation.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company has agreed that as soon as practicable, but in no event later than </span><span style="-sec-ix-hidden:Hidden_pecVw-7_R0GR-O1MFLS0Dg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';"> business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants is not effective by the </span><span style="-sec-ix-hidden:Hidden_4KOodU4RC02gxRyhNxEksA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">60</span></span><span style="font-family:'Times New Roman','Times','serif';">th business day after the closing of the Company&#8217;s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company&#8217;s shares of Class A Common Stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Redemption of warrants when the price per Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';">$18.00</span><span style="font-family:'Times New Roman','Times','serif';">. Once the warrants become exercisable, the Company may redeem the Public Warrants:</span></p><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.01</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per Public Warrant;</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 days</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8217; prior written notice of redemption to each warrant holder; and</span></td></tr></table><table style="border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$18.00</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any </span><span style="-sec-ix-hidden:Hidden_wWOk2hbenkiF3eCjIIPW1A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="-sec-ix-hidden:Hidden_j3RPZoOibUKp_scxdjJSCw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Placement Warrants were identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until </span><span style="font-family:'Times New Roman','Times','serif';">30 days</span><span style="font-family:'Times New Roman','Times','serif';"> after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">In addition, if (x) the Company issues additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than </span><span style="font-family:'Times New Roman','Times','serif';">$9.20</span><span style="font-family:'Times New Roman','Times','serif';"> per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than </span><span style="font-family:'Times New Roman','Times','serif';">60%</span><span style="font-family:'Times New Roman','Times','serif';"> of the total equity proceeds, and interest thereon, available for the funding of the Company&#8217;s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s common stock during the </span><span style="-sec-ix-hidden:Hidden_9B-TMAVHjEWPMjdgpFxpbg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';"> trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below </span><span style="font-family:'Times New Roman','Times','serif';">$9.20</span><span style="font-family:'Times New Roman','Times','serif';"> per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to </span><span style="font-family:'Times New Roman','Times','serif';">115%</span><span style="font-family:'Times New Roman','Times','serif';"> of the higher of the Market Value and the Newly Issued Price, the </span><span style="font-family:'Times New Roman','Times','serif';">$18.00</span><span style="font-family:'Times New Roman','Times','serif';"> per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to </span><span style="font-family:'Times New Roman','Times','serif';">180%</span><span style="font-family:'Times New Roman','Times','serif';"> of the greater of the Market Value and the Newly Issued Price and the </span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until </span><span style="-sec-ix-hidden:Hidden_-WzpzrAyj0OzmcEU8I-ydQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';"> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">At March 31, 2022 and December 31, 2022, the Company accounted for the aggregate </span><span style="font-family:'Times New Roman','Times','serif';">12,085,275</span><span style="font-family:'Times New Roman','Times','serif';"> warrants issued in connection with the Initial Public Offering (the </span><span style="font-family:'Times New Roman','Times','serif';">11,500,000</span><span style="font-family:'Times New Roman','Times','serif';"> Public Warrants and the </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company&#8217;s statement of operations.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 7. WARRANT LIABILITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has agreed that as soon as practicable, but in no event later than <span style="-sec-ix-hidden:Hidden_l9q9OYpBaE-i-c9_ByMINg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class&#160;A Common Stock issuable upon exercise of the warrants is not effective by the <span style="-sec-ix-hidden:Hidden_O_rVnyonKkqQ7hhmRqfGSA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">60</span></span>th business day after the closing of the Company&#8217;s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company&#8217;s shares of Class A Common Stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Redemption of warrants when the price per Class A Common Stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the Public Warrants:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.01</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per Public Warrant;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 days</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8217; prior written notice of redemption to each warrant holder; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$18.00</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any </span><span style="-sec-ix-hidden:Hidden_g1uhXZ_IzE6YLS18Pibsaw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="-sec-ix-hidden:Hidden_ucp-6LYyYk2H8bhHlUU4tg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.The Placement Warrants were identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, if (x) the Company issues additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company&#8217;s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s common stock during the <span style="-sec-ix-hidden:Hidden_Tj-gOcDc5kC5FCMl3wJLvg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">At December 31, 2022 and 2021, the Company accounted for the aggregate 12,085,275 warrants issued in connection with the Initial Public Offering (the 11,500,000 Public Warrants and the 585,275 Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company&#8217;s statement of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantLiabilityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantLiabilityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760934448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER'S EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDER'S EQUITY</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 8. STOCKHOLDER&#8217;S EQUITY</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Preferred Shares </span><span style="font-family:'Times New Roman','Times','serif';">&#8212; The Company is authorized to issue </span><span style="font-family:'Times New Roman','Times','serif';">1,000,000</span><span style="font-family:'Times New Roman','Times','serif';"> preferred shares with a par value of </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> per share with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s Board of Directors. At March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> preferred shares issued or </span><span style="font-family:'Times New Roman','Times','serif';">outstanding</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Class A Common Stock </span><span style="font-family:'Times New Roman','Times','serif';">&#8212; The Company is authorized to issue </span><span style="font-family:'Times New Roman','Times','serif';">100,000,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock with a par value of </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> per share. Holders of the Company&#8217;s Class A Common Stock are entitled to </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> vote for each share. At March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of non-redeemable Class A Common Stock </span><span style="font-family:'Times New Roman','Times','serif';">issued</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">outstanding</span><span style="font-family:'Times New Roman','Times','serif';"> </span><span style="font-family:'Times New Roman','Times','serif';">in connection with the private placement (Note 4), excluding </span><span style="font-family:'Times New Roman','Times','serif';">2,731,544</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock subject to possible redemption as of March 31, 2023 and December 31, 2022, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Class B Common Stock &#8212; </span><span style="font-family:'Times New Roman','Times','serif';">The Company is authorized to issue up to </span><span style="font-family:'Times New Roman','Times','serif';">10,000,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B Common Stock with a par value of </span><span style="font-family:'Times New Roman','Times','serif';">$0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> per share. Holders of the Company&#8217;s Class B Common Stock are entitled to </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';"> vote for each share. On February 25, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';">15,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Executive Officer, </span><span style="font-family:'Times New Roman','Times','serif';">15,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to the Company&#8217;s Chief Financial Officer and </span><span style="font-family:'Times New Roman','Times','serif';">5,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred </span><span style="font-family:'Times New Roman','Times','serif';">5,000</span><span style="font-family:'Times New Roman','Times','serif';"> shares to such independent director.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On December 31, 2022, ARC Group Limited, the Company&#8217;s Financial Advisor, was granted </span><span style="font-family:'Times New Roman','Times','serif';">1,379,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B common stock with a par value of $</span><span style="font-family:'Times New Roman','Times','serif';">0.0001</span><span style="font-family:'Times New Roman','Times','serif';"> per share, up to </span><span style="font-family:'Times New Roman','Times','serif';">143,766</span><span style="font-family:'Times New Roman','Times','serif';"> of which are subject to forfeiture if the Company&#8217;s public stockholders exercise redemption rights with respect to any of the Company&#8217;s remaining outstanding shares of Class A common stock.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">At March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';">4,253,517</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class B Common Stock issued and </span><span style="font-family:'Times New Roman','Times','serif';">outstanding</span><span style="font-family:'Times New Roman','Times','serif';">, respectively.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Holders of Class A Common Stock and Class B Common Stock will vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Business Combination on a </span><span style="font-family:'Times New Roman','Times','serif';">one</span><span style="font-family:'Times New Roman','Times','serif';">-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A Common Stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B Common Stock shall convert into shares of Class A Common Stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B Common Stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A Common Stock issuable upon conversion of all shares of Class B Common Stock will equal, in the aggregate, on an as converted basis, </span><span style="font-family:'Times New Roman','Times','serif';">20%</span><span style="font-family:'Times New Roman','Times','serif';"> of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A Common Stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">issued, to any seller in a Business Combination, and any private placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 8. STOCKHOLDER&#8217;S EQUITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Preferred Shares </span><b style="font-weight:bold;">&#8212;</b> The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s Board of Directors. At December&#160;31,&#160;2022 and 2021, there were no preferred shares issued or <span style="-sec-ix-hidden:Hidden_byXh1qgX90qNILMCXVSaVw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Class A Common Stock </span><b style="font-weight:bold;">&#8212;</b> The Company is authorized to issue 100,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A Common Stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 12,085,275 shares of Class A Common Stock issued and outstanding, including 585,275 shares of non-redeemable Class A Common Stock issued in connection with the private placement (Note 4), and 11,500,000 shares of Class A Common Stock subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Class B Common Stock</span> <b style="font-weight:bold;">&#8212;</b> The Company is authorized to issue up to 10,000,000 shares of Class B Common Stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class B Common Stock are entitled to one vote for each share. On February 25, 2021, the Sponsor transferred 15,000 shares to the Company&#8217;s Chief Executive Officer, 15,000 shares to the Company&#8217;s Chief Financial Officer and 5,000 shares to two of the Company&#8217;s independent directors. Following the determination of the Company&#8217;s third independent director, on March 23, 2021, the Sponsor transferred 5,000 shares to such independent director. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, ARC Group Limited, the Company&#8217;s Financial Advisor, was granted <span style="-sec-ix-hidden:Hidden_OyBqbq_iQkytLYvGC9d64A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1,378,517</span></span> shares of Class B common stock with a par value of $0.0001 per share, up to 143,766 of which are subject to forfeiture if the Company&#8217;s public stockholders exercise redemption rights with respect to any of the Company&#8217;s remaining outstanding shares of Class A common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December 31, 2022 and 2021, there were 4,253,517 and 2,875,000 shares of Class B Common Stock <span style="-sec-ix-hidden:Hidden_STifUojKSEajZv3cqO8nRw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">issued</span></span> and <span style="-sec-ix-hidden:Hidden_Vj2cJtgcg0SBI0y6E-s6Sg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span>, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Holders of Class A Common Stock and Class B Common Stock will vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A Common Stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class&#160;B Common Stock shall convert into shares of Class A Common Stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B Common Stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A Common Stock issuable upon conversion of all shares of Class B Common Stock will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A Common Stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083761020880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 9. FAIR VALUE MEASUREMENTS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table presents information about the Company&#8217;s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,725,574</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,029,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Warrants are measured at fair value on a recurring basis. The Public Warrants were valued initially and at each reporting period that the warrants were not actively traded, using a Monte Carlo simulation. As of March 31, 2023 and December 31, 2022, the Public Warrants were valued using the instrument&#8217;s publicly listed trading price, which is considered to be a Level 1 measurement due to the use of an observable market quote in an active market. Private Placement Warrants were valued using a Monte Carlo valuation model using level 3 inputs at initial valuation and as of March 31, 2023 and December 31, 2022.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">At March 31, 2023 and December 31, 2022, assets held in the Trust Account were invested solely in BlackRock US Treasury mutual fund of $</span><span style="font-family:'Times New Roman','Times','serif';">29,725,574</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$29,029,416</span><span style="font-family:'Times New Roman','Times','serif';">, respectively. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments and are considered Level 1 assets.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statement of operations.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company utilized a Monte Carlo simulation to estimate the fair value of the Public warrants at each reporting period for its warrants that are not actively traded. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. On June 22, 2021, the Public Warrants surpassed the threshold waiting period to be publicly traded. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of March 31, 2023 and December 31, 2022, the Company classified the Public Warrants as Level 1.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s common stock that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at </span><span style="font-family:'Times New Roman','Times','serif';">zero</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Transfers</span><span style="font-family:'Times New Roman','Times','serif';"> to/</span><span style="font-family:'Times New Roman','Times','serif';">from</span><span style="font-family:'Times New Roman','Times','serif';"> Levels 1, 2 and 3 are </span><span style="font-family:'Times New Roman','Times','serif';">recognized</span><span style="font-family:'Times New Roman','Times','serif';"> at the end of the reporting period in which a change in </span><span style="font-family:'Times New Roman','Times','serif';">valuation</span><span style="font-family:'Times New Roman','Times','serif';"> technique or methodology occurs. For the three months ended March 31, 2023 and December 31, 2022, there were </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> transfers between levels</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The change in the fair value of the derivative warrant liabilities for the three months ended March 31, 2023 and 2022 is as follows:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_ZO2hDNBMi0u8zP5YIF1kNA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_jQL209kLek2Gbb2s5yFT1A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (117,640)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,645,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,762,640)</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 134,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,955,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,089,028</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border:0pt;border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 9. FAIR VALUE MEASUREMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table presents information about the Company&#8217;s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments&#160; held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,029,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 117,320,973</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Warrants are measured at fair value on a recurring basis. The Public Warrants were valued initially and at each reporting period that the warrants were not actively traded, using a Monte Carlo simulation. As of December 31, 2022 and 2021, the Public Warrants were valued using the instrument&#8217;s publicly listed trading price, which is considered to be a Level 1 measurement due to the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">use of an observable market quote in an active market. Private Placement Warrants were valued using a Monte Carlo valuation model using level 3 inputs at initial valuation and as of December 31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December 31, 2022 and 2021, assets held in the Trust Account were comprised of $29,029,416 in money market mutual fund and $117,320,973 in U.S. Treasury Securities, respectively. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments and are considered Level 1 assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company utilized a Monte Carlo simulation to estimate the fair value of the Public warrants at each reporting period for its warrants that are not actively traded. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. On June 22, 2021, the Public Warrants surpassed the threshold waiting period to be publicly traded. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of December 31, 2022 and 2021, the Company classified the Public Warrants as Level 1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s common stock that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. During the year ended December 31, 2022 and for the period from February 8, 2021 (inception) through December&#160;31,&#160;2021 there were no transfers between levels.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.28</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The change in the fair value of the derivative warrant liabilities for the year ended December 31, 2022 and for the period from February 8, 2021(inception) to December 31, 2021 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of February 8, 2021(inception)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_4REQyUAf6022aVEF9i64Ww;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (234,110)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,255,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,489,110)</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083759194288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>INCOME TAX</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAX</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 10. INCOME TAX</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The income tax provision consists of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the period from</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(inception)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">214,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Deferred</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(715,345)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (118,531)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State and Local</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Deferred</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 715,345</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 118,531</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 214,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s net deferred tax assets are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period from</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Net Operating Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,893</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Sec. 195 Start-up Costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 833,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 88,493</p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 833,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 120,386</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Tax Liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Unrealized gain on Investment in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,855)</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 833,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_-9mRpELl-Ee-JT7U3Njw7g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (1,855)</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (833,875)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (118,531)</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Tax Assets, net of allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:12pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, the Company had zero and $162,132 of U.S. federal and state net operating loss carryovers available to offset future taxable income. The federal net operating losses can be carried forward indefinitely, subject to a limitation in utilization against 80% of annual taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of deferred tax assets and therefore established a full valuation allowance of $833,875 and $118,531 as of December&#160;31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period from</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Statutory federal income tax rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">State taxes, net of federal tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value of derivative liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (170.93)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25.89)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;">59.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs allocated to warrant issuance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 129.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 38.96</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s effective tax rates for the periods presented differ from the expected (statutory) rates due to the recording of full valuation allowances on deferred tax assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company&#8217;s tax returns since inception remain open to examination by the taxing authorities. There were no unrecognized tax benefits as of December 31, 2022 and 2021. No amounts were accrued for the payment of interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760027120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">NOTE 10. SUBSEQUENT EVENTS</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In accordance with ASC Topic 855, &#8220;Subsequent Events&#8221;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identified any subsequent events that would have required adjustment or disclosure in the financial statements other than as described below.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 17, 2023, the Company withdrew $</span><span style="font-family:'Times New Roman','Times','serif';">214,850</span><span style="font-family:'Times New Roman','Times','serif';"> interest earned on the Trust account to pay 2022&#8217;s income tax payment. The income tax was paid on April 18, 2023.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 19, 2023, the Company elected to exercise its sixth-month extension to the Termination Date, which extended its deadline to complete its initial business combination to May 11, 2023, by depositing </span><span style="font-family:'Times New Roman','Times','serif';">$0.045</span><span style="font-family:'Times New Roman','Times','serif';"> per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately </span><span style="font-family:'Times New Roman','Times','serif';">$122,920</span><span style="font-family:'Times New Roman','Times','serif';">, was deposited in the Trust Account.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On April 25, 2023, the Company withdrew $</span><span style="font-family:'Times New Roman','Times','serif';">73,846</span><span style="font-family:'Times New Roman','Times','serif';"> interest earned on the Trust account to pay 2022&#8217;s remaining balance and 2023 Q1 prepayment of Delaware Franchise tax. $</span><span style="font-family:'Times New Roman','Times','serif';">73,846</span><span style="font-family:'Times New Roman','Times','serif';"> was paid to the State of Delaware on May 2, 2023.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June 28, 2023, EF Hutton waived $3,025,000 of the $4,025,000 cash deferred underwriting commission, pursuant to a Satisfaction and Discharge Agreement (attached at Exhibit 10.22) that would otherwise be immediately due and payable upon the Closing, accepting in lieu thereof (i) a one-time cash payment of $500,000 at the time of the Closing; (ii) a $500,000 promissory note executed by the Company on June 30, 2023 (attached at Exhibit 10.21) in which it is obligated to make six monthly payments to EF Hutton in the cash amount of $83,333.33 from October 2023 through March 2024; and (iii) 277,778 ordinary shares of the Company (the &#8220;Ordinary Shares&#8221;) at $10.89 per share, for an aggregate value of $3,025,000.</p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 11. SUBSEQUENT EVENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with ASC Topic 855, &#8220;Subsequent Events&#8221;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identified any subsequent events that would have required adjustment or disclosure in the financial statements other than as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On January 5, 2023, the Company elected to exercise its third-month extension to the Termination Date, which extended its deadline to complete its initial business combination from January 11, 2023 to February 11, 2023, by depositing $0.045 per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $122,920, was deposited in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 8, 2023, the Company elected to exercise its fourth-month extension to the Termination Date, which extended its deadline to complete its initial business combination from February 11, 2023 to March 11, 2023, by depositing $0.045 per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $122,920, was deposited in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">On March 6, 2023, the Company elected to exercise its fifth-month extension to the Termination Date, which extended its deadline to complete its initial business combination from March 11, 2023 to April 11, 2023, by depositing $0.045 per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $122,920, was deposited in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755364976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Basis of presentation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Basis of presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Principles of Consolidation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock', window );">Emerging growth company</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Emerging growth company</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Emerging growth company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Use of estimates</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had </span><span style="font-family:'Times New Roman','Times','serif';">$10,108</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">$30,870</span><span style="font-family:'Times New Roman','Times','serif';"> in cash and </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> cash equivalents as of March 31, 2023 and December 31, 2022, respectively.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had $30,870 and $453,151 in cash and no cash equivalents as of December 31, 2022 and 2021.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock', window );">Trust Account</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Trust Account</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Upon the closing of the Initial Public Offering and the Private Placement, </span><span style="font-family:'Times New Roman','Times','serif';">$117,300,000</span><span style="font-family:'Times New Roman','Times','serif';"> (</span><span style="font-family:'Times New Roman','Times','serif';">$10.00</span><span style="font-family:'Times New Roman','Times','serif';"> per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Trust Account</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the Initial Public Offering and the Private Placement, $117,300,000 ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#8220;Trust Account&#8221;) located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Offering Costs Associated with the Initial Public Offering</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Offering Costs Associated with the Initial Public Offering</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TemporaryEquityPolicyPolicyTextBlock', window );">Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</span><span style="font-family:'Times New Roman','Times','serif';"> Accordingly, as of March 31, 2023, there were </span><span style="font-family:'Times New Roman','Times','serif';">3,316,819</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, excluding </span><span style="font-family:'Times New Roman','Times','serif';">2,731,544</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">On March 31, 2023, there are </span><span style="font-family:'Times New Roman','Times','serif';">585,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and </span><span style="font-family:'Times New Roman','Times','serif';">4,838,792</span><span style="font-family:'Times New Roman','Times','serif';"> shares of Class A Common Stock outstanding, which are subject to possible redemption.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">As of March 31, 2023 and 2022, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock &#8211; </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 583,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock - </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,333,680</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Class A Common Stock Subject to Possible Redemption</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 31, 2022, there are 585,275 shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and 11,500,000 shares of Class A Common Stock outstanding, which are subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December 31, 2022 and 2021, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross Proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to public warrants and private warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,614,500)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issuance costs related to Class A Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,146,054)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Redemption of Class A Common Stock, including interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (91,909,483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,359,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,060,554</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net income Per Share</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Net income (loss) per share</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net income (loss) between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for </span><span style="font-family:'Times New Roman','Times','serif';">12,085,275</span><span style="font-family:'Times New Roman','Times','serif';"> shares of common stock in the aggregate.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The following table reflects the calculation of basic and diluted net income (loss) per common share:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,687,692</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"><span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 4,838,792</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,500,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31,025)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 507,816</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"><span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 2,731,544</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,460,275</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Net income per share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net income per share is computed by dividing net income by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#8220;Placement Warrants&#8221;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 12,085,275 shares of common stock in the aggregate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The following table reflects the calculation of basic and diluted net income per common share:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period of</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,671,658</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,667,969</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,264,526</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 96,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,464,132</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,295,610</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation Expense</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for stock-based compensation expense in accordance with ASC Topic 718, &#8220;Compensation &#8211; Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. The fair value of equity awards has been estimated using a market approach. Forfeitures are recognized as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Company determined that it was not probable that ARC would meet the performance condition as defined in the Introducing Advisor Agreement (See Note 5), and therefore, no stock-based compensation expense was recognized. At December 31, 2022, upon amendment of the Introducing Advisor Agreement, which amended ARC&#8217;s performance condition that was concurrently deemed to have been met, ARC was granted 1,378,517 shares of the Company&#8217;s Class B common stock at a fair value of $2.05 per share. The Company recorded the resulting $2,825,960<span style="white-space:pre-wrap;"> of stock based compensation expense on December 31, 2022, which is included in formation and operating costs in the consolidated statement of operations.  The fair value of the Class B common stock was determined by applying a discount to the actively traded Class A shares, which have an observable market price. The discount was calculated as the average discount of the Class B share price (derived) compared to the Class A share price (observable) for SPACs that have actively traded &#8220;Rights&#8221;.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risk</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At March 31, 2023 and 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair value of financial instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Income Taxes </b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> unrecognized tax benefits and </span><span style="font-family:'Times New Roman','Times','serif';">no</span><span style="font-family:'Times New Roman','Times','serif';"> amounts accrued for interest and penalties </span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">as of March 31, 2023 and 2022, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Our effective tax rate was </span><span style="font-family:'Times New Roman','Times','serif';">(225.88%)</span><span style="font-family:'Times New Roman','Times','serif';"> and </span><span style="font-family:'Times New Roman','Times','serif';">0%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of </span><span style="font-family:'Times New Roman','Times','serif';">21%</span><span style="font-family:'Times New Roman','Times','serif';"> for the three months ended March 31, 2023 and 2022, due to transaction costs and the valuation allowance on the deferred tax assets.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the United States is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within those fiscal years.</span></p><p style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recently Issued Accounting Standards</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options&#8221; (Subtopic 470-20) and &#8220;Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity&#8221; (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of accounting policy for assets held in trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy on derivative financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy on emerging growth company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TemporaryEquityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of accounting policy for temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TemporaryEquityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083762470992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Class A Common Stock reflected on the condensed consolidated balance sheet are reconciled</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock &#8211; </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 583,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock - </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,333,680</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Opening Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross Proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to public warrants and private warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,614,500)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issuance costs related to Class A Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,146,054)</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Redemption of Class A Common Stock, including interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (91,909,483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,359,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,060,554</p></td></tr><tr><td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"><b style="font-weight:bold;">Contingently redeemable Class A Common Stock- </b>Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,750,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,300,000</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted net income per common share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,687,692</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"><span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 4,838,792</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,500,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31,025)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 507,816</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"><span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> 2,731,544</span></span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,460,275</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period of</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable Class A common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,671,658</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,667,969</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,264,526</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable Class A and Class B common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income allocable to common stock not subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 96,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,464,132</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of non-redeemable common shares </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,295,610</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per non-redeemable common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.44</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760193488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of company's assets and derivative warrant liabilities that are measured at fair value on a recurring basis</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,725,574</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,029,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments&#160; held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,029,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;Prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active&#160;Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable&#160;Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable&#160;Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investments held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 117,320,973</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Public Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of quantitative information regarding Level 3 fair value measurements inputs</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Private Warrants)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%<span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.28</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of change in the fair value of the warrant liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_ZO2hDNBMi0u8zP5YIF1kNA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_jQL209kLek2Gbb2s5yFT1A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (117,640)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,645,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,762,640)</p></td></tr><tr><td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 134,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,955,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,089,028</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border:0pt;border-collapse:collapse;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table><span></span>
</td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Private&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Public&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Warrant&#160;Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of February 8, 2021(inception)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,851,668</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_4REQyUAf6022aVEF9i64Ww;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in valuation inputs or other assumptions</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (234,110)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,255,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,489,110)</p></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value as of December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,558</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 345,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 362,558</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760280112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>INCOME TAX</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of income tax provision</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the period from</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(inception)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">214,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Deferred</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(715,345)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (118,531)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State and Local</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Deferred</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 715,345</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 118,531</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 214,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of significant components of the Company's deferred tax assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period from</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Net Operating Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,893</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Sec. 195 Start-up Costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 833,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 88,493</p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 833,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 120,386</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Tax Liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Unrealized gain on Investment in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,855)</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Deferred Tax Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 833,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_-9mRpELl-Ee-JT7U3Njw7g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (1,855)</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (833,875)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (118,531)</p></td></tr><tr><td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Tax Assets, net of allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the period from</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 8, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Through</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Statutory federal income tax rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">State taxes, net of federal tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value of derivative liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (170.93)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25.89)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;">59.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs allocated to warrant issuance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 129.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 38.96</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083749232448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 11, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 10, 2022 </div>
<div>item</div>
</th>
<th class="th">
<div>May 05, 2022 </div>
<div>item</div>
</th>
<th class="th">
<div>Nov. 05, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 11, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 08, 2021 </div>
<div>item</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum', window );">Condition for future business combination number of businesses minimum | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount', window );">Payments for investment of cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 368,760<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 2,545,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.', window );">Deferred underwriting commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DeferredUnderwritingFeePayable', window );">Deferred Underwriting Fee Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CashHeldOutsideInTrustAccount', window );">Cash held outside the Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,108<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="nump">30,870<span></span>
</td>
<td class="nump">$ 453,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,326,648<span></span>
</td>
<td class="nump">246,232<span></span>
</td>
<td class="num">$ (1,945,267)<span></span>
</td>
<td class="nump">246,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount', window );">Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination', window );">Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination', window );">Number of three-month extensions for consummation of initial business combination | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination', window );">Extension period for consummating initial business combination</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination', window );">Maximum number of one-month extension periods for consummation of Initial Business Combination | item</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount', window );">Additional amount per unit required to be deposited in trust account | $ / shares</a></td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions', window );">Amount deposited into the Trust Account on execution of two one-month extensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 614,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 245,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfOneMonthExtensionsExecuted', window );">Number of one-month extensions executed | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination', window );">Extension period each time for the Company to consummate initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination', window );">Minimum net tangible asset upon consummation of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares', window );">Number of shares for which share holders exercised their right to redeem | shares</a></td>
<td class="nump">8,768,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Redemption price per share | $ / shares</a></td>
<td class="nump">$ 10.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Aggregate amount of shares redeemed</a></td>
<td class="nump">$ 91,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Trust account balance</a></td>
<td class="nump">28,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension', window );">Amount to be deposited in trust account in connection with the exercise of the first monthly extension</a></td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNetInterestToPayDissolutionExpenses', window );">Maximum net interest to pay dissolution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">2,825,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,725,574<span></span>
</td>
<td class="nump">117,320,973<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
<td class="nump">117,320,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount', window );">Interest withdrawn from Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">299,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet', window );">Convertible loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Units per price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Public share price considered | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,108<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
<td class="nump">$ 30,870<span></span>
</td>
<td class="nump">453,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfPublicSharesToBeRedeemed.', window );">Percentage Of Public Shares To Be Redeemed.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount', window );">Additional amount per unit required to be deposited in trust account | $ / shares</a></td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Public share price considered | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units in Initial Public Offering, net of offering costs (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromSaleOfUnits', window );">Proceeds from issuance of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount', window );">Payments for investment of cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 959,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 959,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,771,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,771,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SaleOfStockUnderwritingFees', window );">Underwriting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.', window );">Deferred underwriting commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SaleOfStockOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of Private units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units in Initial Public Offering, net of offering costs (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets', window );">Condition For Future Business Combination Threshold Net Tangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional amount per unit sold in the company's initial public offering required to be deposited in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount deposited into the Trust Account on execution of two one-month extensions out of the nine.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be deposited in the trust account in connection with the exercise of the first monthly extension.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CashHeldOutsideInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash held outside the trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CashHeldOutsideInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which Common Stock exercised their right to redeem those shares for cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The extension period each time for the Company to consummate initial business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extension period for consummating initial business combination as permitted under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNetInterestToPayDissolutionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNetInterestToPayDissolutionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum net tangible assets upon consummation of the Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfOneMonthExtensionsExecuted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of one-month extensions executed by the Company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfOneMonthExtensionsExecuted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of one-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of three-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfPublicSharesToBeRedeemed.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of public shares redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfPublicSharesToBeRedeemed.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with interest withdrawn from Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromSaleOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents Proceeds from Sale of Units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromSaleOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SaleOfStockOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of other offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SaleOfStockOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SaleOfStockUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees incurred and paid for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SaleOfStockUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of transaction costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net increase or decrease in the carrying amount of the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083750359792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 05, 2021</div></th>
<th class="th"><div>May 11, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,108<span></span>
</td>
<td class="nump">$ 453,151<span></span>
</td>
<td class="nump">$ 30,870<span></span>
</td>
<td class="nump">$ 453,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount', window );">Payments for investment of cash in trust account</a></td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 368,760<span></span>
</td>
<td class="nump">117,300,000<span></span>
</td>
<td class="nump">$ 2,545,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantExercisable', window );">Warrant exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits accrued for interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember', window );">Formation and operating costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,825,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | ARC | Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember', window );">Class A Common Stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common Stock, subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | ARC | Second Amendment to the Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Founder Shares | ARC | Second Amendment to the Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent to accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of  warrant exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760633168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details) - Class A Common Stock Subject to Redemption - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AccountingPoliciesLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable Class A Common Stock - Opening Balance</a></td>
<td class="nump">$ 28,750,110<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ProceedsFromIssuanceOfTemporaryEquity', window );">Gross Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TemporaryEquityProceedsAllocatedToWarrants', window );">Proceeds allocated to public warrants and private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,614,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TemporaryEquityIssuanceCosts', window );">Issuance costs related to Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,146,054)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest', window );">Redemption of Class A Common Stock, including interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,909,483)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Re-measurement of carrying value to redemption value</a></td>
<td class="nump">583,570<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,060,554<span></span>
</td>
<td class="nump">3,359,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable Class A Common Stock - Ending Balance</a></td>
<td class="nump">$ 29,333,680<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="nump">$ 28,750,110<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent to accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ProceedsFromIssuanceOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ProceedsFromIssuanceOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of redemption of Class A Common Stock subject to possible redemption, including interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TemporaryEquityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuance costs related to temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TemporaryEquityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TemporaryEquityProceedsAllocatedToWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross proceeds allocated from temporary equity to warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TemporaryEquityProceedsAllocatedToWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083753935072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) allocable to common stock not subject to redemption</a></td>
<td class="num">$ (85,983)<span></span>
</td>
<td class="nump">$ 2,195,508<span></span>
</td>
<td class="nump">$ 5,135,790<span></span>
</td>
<td class="nump">$ 336,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) allocable to common stock not subject to redemption</a></td>
<td class="num">$ (54,958)<span></span>
</td>
<td class="nump">$ 1,687,692<span></span>
</td>
<td class="nump">$ 3,671,658<span></span>
</td>
<td class="nump">$ 240,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, Basic</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">8,264,526<span></span>
</td>
<td class="nump">8,667,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, Diluted</a></td>
<td class="nump">2,731,544<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">8,264,526<span></span>
</td>
<td class="nump">8,667,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember', window );">Class A and Class B non-redeemable common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) allocable to common stock not subject to redemption</a></td>
<td class="num">$ (31,025)<span></span>
</td>
<td class="nump">$ 507,816<span></span>
</td>
<td class="nump">$ 1,464,132<span></span>
</td>
<td class="nump">$ 96,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, Basic</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">3,460,275<span></span>
</td>
<td class="nump">3,295,610<span></span>
</td>
<td class="nump">3,464,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, Diluted</a></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="nump">3,460,275<span></span>
</td>
<td class="nump">3,295,610<span></span>
</td>
<td class="nump">3,464,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common stock</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083749876384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>May 11, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfSharesIssuedPerUnit', window );">Number of shares in a unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares issuable per warrant</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO | Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfWarrantsIssuedPerUnit', window );">Number of warrants in a unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfSharesIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares in a unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfSharesIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfWarrantsIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants in a unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfWarrantsIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083754637472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 11, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrivatePlacementLineItems', window );"><strong>PRIVATE PLACEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PrivatePlacementLineItems', window );"><strong>PRIVATE PLACEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrants</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate purchase price</a></td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
<td class="nump">$ 5,852,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PrivatePlacementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PrivatePlacementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755774112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS - Founder Shares (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 11, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 10, 2022 </div>
<div>item</div>
</th>
<th class="th">
<div>May 05, 2022 </div>
<div>item</div>
</th>
<th class="th">
<div>Jun. 26, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 23, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 25, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 2,825,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination', window );">Period from the closing of the company's initial public offering to consummate business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination', window );">Number of three-month extensions for consummation of initial business combination | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregatePeriodToConsummateInitialBusinessCombination', window );">Aggregate period to consummate business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven', window );">Number of business days for advance notice of extension to be given | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination', window );">Extension period for consummating initial business combination</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount', window );">Additional amount per unit required to be deposited in trust account | $ / shares</a></td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension', window );">Amount to be deposited in trust account in connection with the exercise of the first monthly extension</a></td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionLoansNonCurrent', window );">Amount outstanding under the extension loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,914,598<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,545,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount', window );">Additional amount per unit required to be deposited in trust account | $ / shares</a></td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">Introducing Advisor Agreement with ARC Group Ltd | ARC Group Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RetainerFeeUponExecutionOfAgreement', window );">Retainer fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination', window );">Success fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Sponsor | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from sale of founder shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders', window );">Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays', window );">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences', window );">Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Chief Executive Officer | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Chief Financial Officer | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Two Independent Director | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Third Independent Director | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Second Amendment to the Introducing Advisor Agreement | ARC Group Ltd | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ExtensionLoansNonCurrent', window );">Amount outstanding under the extension loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,378,517<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional amount per unit sold in the company's initial public offering required to be deposited in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AggregatePeriodToConsummateInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate period including extension period during which the company is required to consummate Initial Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AggregatePeriodToConsummateInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be deposited in the trust account in connection with the exercise of the first monthly extension.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionLoansNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of extension loans outstanding, non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionLoansNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extension period for consummating initial business combination as permitted under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents maximum number of shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of business days prior to the applicable deadline during which a notice of extension is to be given for deposit to be made in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of three-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected ownership percentage by the founders after completion of the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from the closing of the Company's initial public offering during which the company is required to consummate Initial Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination during which the shares or warrant may not be transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RetainerFeeUponExecutionOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of retainer fee upon execution of agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RetainerFeeUponExecutionOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_StockTransferredToOthersDuringPeriodShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares transferred to others during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_StockTransferredToOthersDuringPeriodShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of success fee upon closing of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The transfer assign or sell any shares or warrants after completion of initial business combination threshold trading days business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The transfer assign or sell any shares or warrants after completion of initial business combination threshold trading days business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_TwoIndependentDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_TwoIndependentDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ThirdIndependentDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ThirdIndependentDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083750001104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS - Additional information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 22, 2022</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Outstanding of promissory note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WorkingCapitalLoansWarrantMember', window );">Working capital loans warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">207,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">Introducing Advisor Agreement | ARC Group Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfOwnershipAsConsiderationForService', window );">Percentage of ownership as consideration for service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget', window );">Threshold period for consideration payable after the closes on business combination or any financing with any Advisor Target or any affiliate of an Advisor Target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">First Amendment to the Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing', window );">Percentage of success fee on any PIPE that was brought by ARC</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_PromissoryNoteWithRelatedPartyMember', window );">Promissory Note with Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote', window );">Maximum borrowing capacity of related party promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Outstanding balance of related party note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Outstanding of promissory note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth', window );">Expenses per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement | ARC Group Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth', window );">Expenses per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party transaction expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember', window );">Related Party Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumLoansConvertibleUptoConsummation', window );">Related party loans convertible up to consummation of a business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember', window );">Related Party Loans | Working capital loans warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember', window );">Related Party Loans | Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_SecuritiesDepositHeldInTrustAccount', window );">Deposit held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_BusinessCombinationTotalPayments', window );">Business combination, total payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember', window );">Founder Shares | Second Amendment to the Introducing Advisor Agreement | Class B Common Stock | ARC Group Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_BusinessCombinationTotalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_BusinessCombinationTotalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum borrowing capacity of related party promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumLoansConvertibleUptoConsummation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of maximum loans convertible up to consummation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumLoansConvertibleUptoConsummation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents maximum number of shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfOwnershipAsConsiderationForService">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of ownership as consideration for service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfOwnershipAsConsiderationForService</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of success fee on any PIPE that was brought by ARC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The contractual monthly amount to be paid for support services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_SecuritiesDepositHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of securities or Deposits held in the trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_SecuritiesDepositHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold period for consideration payable after the closes on business combination or any financing with any Advisor Target or any affiliate of an Advisor Target.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WorkingCapitalLoansWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WorkingCapitalLoansWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_PromissoryNoteWithRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_PromissoryNoteWithRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_AdministrativeSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_AdministrativeSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_RelatedPartyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755813488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 22, 2022</div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>item </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities', window );">Maximum number of demands for registration of securities | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnderwritingDiscountPercentage', window );">Underwriting discount (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnderwritingDiscountPaid', window );">Underwriting discount paid | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_DeferredUnderwritingFeesPercentage', window );">Deferred underwriting fees (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.', window );">Deferred underwriting fees | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,025,000<span></span>
</td>
<td class="nump">$ 4,025,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember', window );">ARC | Founder Shares | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">First Amendment to the Introducing Advisor Agreement with ARC Group Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing', window );">Percentage of success fee on any PIPE that was brought by ARC</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">First Amendment to the Introducing Advisor Agreement with ARC Group Limited [Member] | ARC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing', window );">Percentage of success fee on any PIPE that was brought by ARC</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">Second Amendment to the Introducing Advisor Agreement | ARC | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember', window );">Second Amendment to the Introducing Advisor Agreement | ARC | Founder Shares | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_OverAllotmentOptionPeriod', window );">Overallotment option period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">45 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_DeferredUnderwritingFeesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of deferred underwriting commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_DeferredUnderwritingFeesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum number of demands for registration of securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents maximum number of shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_OverAllotmentOptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of the over-allotment option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_OverAllotmentOptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of success fee on any PIPE that was brought by ARC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnderwritingDiscountPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting discount paid by the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnderwritingDiscountPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnderwritingDiscountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of per Unit offering price paid as discount to underwriter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnderwritingDiscountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083749121024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITY (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value per share</a></td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantsOrRightsIssued', window );">Warrants issued</a></td>
<td class="nump">12,085,275<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PlacementWarrantsMember', window );">Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantsOrRightsIssued', window );">Warrants issued</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Public Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination', window );">Maximum threshold period for registration statement to become effective after business combination</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination', window );">Maximum threshold period for registration statement to become effective after business combination</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value per share</a></td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed', window );">Percentage of gross proceeds on total equity proceed</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice', window );">Trading days determining volume weighted average price</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice', window );">Adjustment of exercise price of warrants based on market value (as a percent)</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_WarrantsOrRightsIssued', window );">Warrants issued</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value per share</a></td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>WARRANT LIABILITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice', window );">Adjustment of exercise price of warrants based on market value (as a percent)</a></td>
<td class="nump">180.00%<span></span>
</td>
<td class="nump">180.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage represents the class of warrant or right Adjustment of exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum threshold period for registration statement to become effective after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum threshold period for registration statement to become effective after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold number of specified trading period determining volume weighted average trading price , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross proceeds on total equity proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_WarrantsOrRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Value of issued derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_WarrantsOrRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083749781392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDER'S EQUITY - Preferred Stock Shares (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755640656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER'S EQUITY - Common Stock Shares (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 23, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 25, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockNumberOfVotesPerShare', window );">Common stock, votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">3,316,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common Stock, subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaNotSubjectToRedemptionMember', window );">Class A Common Stock Not Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common Stock, subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockShareIssued', window );">Common shares, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockShareOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,085,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_CommonStockNumberOfVotesPerShare', window );">Common stock, votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">4,253,517<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare', window );">Initial business combination shares issuable as percent of outstanding share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | Independent Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StockTransferredToOthersDuringPeriodShare', window );">Number of shares transferred</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | ARC | Second Amendment to the Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | ARC | Founder Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | ARC | Founder Shares | Second Amendment to the Introducing Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>STOCKHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights', window );">Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of votes that each common share is entitled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockShareIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents of Common Stock Share Issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockShareIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_CommonStockShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents of Common Stock Share Outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_CommonStockShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding stock after stock conversion issuable pursuant to initial business combination transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents maximum number of shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_StockTransferredToOthersDuringPeriodShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares transferred to others during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_StockTransferredToOthersDuringPeriodShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dkdcu_CommonClassaNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=dkdcu_IndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=dkdcu_IndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dkdcu_ArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dkdcu_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755256944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,725,574<span></span>
</td>
<td class="nump">$ 117,320,973<span></span>
</td>
<td class="nump">$ 29,029,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount', window );">Transfer of assets and liabilities between level 1 and level 2</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfer of assets into level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfer of assets out of level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3', window );">Transfer of liabilities into level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3', window );">Transfer of liabilities out of level 3</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,725,574<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,725,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market mutual fund | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,320,973<span></span>
</td>
<td class="nump">29,029,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,558<span></span>
</td>
<td class="nump">$ 251,668<span></span>
</td>
<td class="nump">$ 17,558<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of transfers of assets and liabilities measured on a recurring basis between level 1 and level 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083755258352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details) - Private Warrants - Level 3 - Recurring<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>Y</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Y</div>
</th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Y</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">11.50<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1150<span></span>
</td>
<td class="nump">0.1150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">10.69<span></span>
</td>
<td class="nump">10.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1044<span></span>
</td>
<td class="nump">0.1010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">5.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Probability of Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0275<span></span>
</td>
<td class="nump">1.000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.042<span></span>
</td>
<td class="nump">0.074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0391<span></span>
</td>
<td class="nump">0.0128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Dividend yield (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0000<span></span>
</td>
<td class="nump">0.0000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760581952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Change in fair value of warrant liability<span></span>
</td>
<td class="text">Change in fair value of warrant liability<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Change in fair value of warrant liability<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, beginning balance</a></td>
<td class="nump">$ 345,000<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in valuation inputs or other assumption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,645,000)<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="num">(4,255,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, ending balance</a></td>
<td class="nump">345,000<span></span>
</td>
<td class="nump">1,955,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember', window );">Private Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, beginning balance</a></td>
<td class="nump">17,558<span></span>
</td>
<td class="nump">251,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in valuation inputs or other assumption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,640)<span></span>
</td>
<td class="nump">251,668<span></span>
</td>
<td class="num">(234,110)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, ending balance</a></td>
<td class="nump">17,558<span></span>
</td>
<td class="nump">134,028<span></span>
</td>
<td class="nump">251,668<span></span>
</td>
<td class="nump">17,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WarrantLiabilityMember', window );">Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, beginning balance</a></td>
<td class="nump">362,558<span></span>
</td>
<td class="nump">4,851,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,851,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in valuation inputs or other assumption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,762,640)<span></span>
</td>
<td class="nump">4,851,668<span></span>
</td>
<td class="num">(4,489,110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue', window );">Fair value, ending balance</a></td>
<td class="nump">$ 362,558<span></span>
</td>
<td class="nump">$ 2,089,028<span></span>
</td>
<td class="nump">$ 4,851,668<span></span>
</td>
<td class="nump">$ 362,558<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liability, fair value measurement with unobservable inputs, reconciliation recurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_PrivateWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dkdcu_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083760680736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX - Income tax provision (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Federal.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (118,531)<span></span>
</td>
<td class="num">(715,345)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,531<span></span>
</td>
<td class="nump">715,345<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="num">$ (59,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (214,850)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083749652496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Net deferred tax assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net Operating Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_StartUpCosts', window );">Sec. 195 Start-up Costs</a></td>
<td class="nump">$ 833,875<span></span>
</td>
<td class="nump">88,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total Deferred Tax Assets</a></td>
<td class="nump">833,875<span></span>
</td>
<td class="nump">120,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred Tax Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_UnrealizedGainOnInvestmentInTrustAccount', window );">Unrealized gain on Investment in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,855)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total Deferred Tax Liabilities</a></td>
<td class="nump">833,875<span></span>
</td>
<td class="nump">1,855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: Valuation allowance</a></td>
<td class="num">$ (833,875)<span></span>
</td>
<td class="num">$ (118,531)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_StartUpCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Sec. 195 Start-up Costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_StartUpCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_UnrealizedGainOnInvestmentInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Unrealized gain on Investment in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_UnrealizedGainOnInvestmentInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083758252064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Federal income tax rate (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>INCOME TAX</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities', window );">Change in fair value of derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25.89%)<span></span>
</td>
<td class="num">(170.93%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance', window );">Transaction costs allocated to warrant issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.32%<span></span>
</td>
<td class="nump">129.71%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision</a></td>
<td class="num">(225.88%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38.96%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to change in fair value of derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs allocated to warrant issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083754803968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>INCOME TAX</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_U.s.FederalAndStateNetOperatingLoss', window );">U.S. federal and state net operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_LimitationOnAnnualTaxableIncome', window );">Limitation on annual taxable income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 833,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits accrued for interest and penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_LimitationOnAnnualTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents of Limitation On Annual Taxable Income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_LimitationOnAnnualTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_U.s.FederalAndStateNetOperatingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of U.S. federal and state net operating loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_U.s.FederalAndStateNetOperatingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140083663689680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Subsequent event - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 06, 2023</div></th>
<th class="th"><div>Feb. 08, 2023</div></th>
<th class="th"><div>Jan. 05, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Third-month extension to the Termination Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountDepositedPerEachPublicShareOutstanding', window );">Amount deposited per each public share outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregateAmountDepositedInTrustAccount', window );">Aggregate amount deposited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Fourth-month extension to the Termination Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountDepositedPerEachPublicShareOutstanding', window );">Amount deposited per each public share outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregateAmountDepositedInTrustAccount', window );">Aggregate amount deposited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Fifth-month extension to the Termination Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AmountDepositedPerEachPublicShareOutstanding', window );">Amount deposited per each public share outstanding</a></td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dkdcu_AggregateAmountDepositedInTrustAccount', window );">Aggregate amount deposited</a></td>
<td class="nump">$ 122,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AggregateAmountDepositedInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount deposited in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AggregateAmountDepositedInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dkdcu_AmountDepositedPerEachPublicShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount per each outstanding public share deposited in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dkdcu_AmountDepositedPerEachPublicShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dkdcu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_ThirdMonthExtensionToTerminationDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_ThirdMonthExtensionToTerminationDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_FourthMonthExtensionToTerminationDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_FourthMonthExtensionToTerminationDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=dkdcu_FifthMonthExtensionToTerminationDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=dkdcu_FifthMonthExtensionToTerminationDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>dkdcu-20230331xs4a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:dkdcu="http://www.dataknightsacquisitioncorp.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dkdcu-20230331.xsd" xlink:type="simple"/>
    <context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_FyUQPN4qe0OMnvM3JWkCvg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_OkbsNvrK3EiK9N0XIQ24yA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_3CzSjuwSC0Si51Ps-EQeBw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_pKJtyVvMnEGNV_bpgbIOwA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_qRsdIQljjU-ibnyalgU8ug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HKTnd3Yg0k23m_kWDWCW4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Yt0ReKG7x0axkO27tJcJkQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KOLd2DPW60K1uO5F86SP4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_86Daq9d6j0GAwbKckEBFNA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_ZMuTDpHFhkK3bBt9NctNIA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_xXVChhyI6k-ndPgI-1--gQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DzIyCou1hkeI-WohQI5SbA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_tGuxzL5MjkWBTR132SmvCw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_IHG1RFSPIE2Is1YIYVb5NQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_6-yCbHCVY0uGfDrYrKv0Iw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_6Bf7HXIAMk2oElQb9ogmow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_2_7_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_Xe0KcyySzEqyLKiwakwyLQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-07</instant>
        </period>
    </context>
    <context id="As_Of_2_7_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_n-8OnhgC0EeVoVPuKg1hVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-07</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g6Pq07wbNEa9FXfu1Ifs3Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_HJQOphMcxEKTWZeeZtSgpA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_Tv60Y58O_0WnZ3tyWWSaUA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_vEBEAARln0-juOH4J-Vj-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_o3_-97zDo0C3WX2zLxg1OQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_C3EiylpFM0KQmVJZCMEtQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_11_5_2021_iFKFTOhmqkmSj50YSfzJGg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2021-11-05</instant>
        </period>
    </context>
    <context id="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_fctU6QHKQEOu595qEl978g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-11</instant>
        </period>
    </context>
    <context id="As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2021-05-11</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_7bwDEPA2V0-iIfkW-TlPEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_goe_RVvoFUyh8ybQ7jTgQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_b2QDuXd4oUeF_buHUjKBrg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ZJf5YelKa0CSmVXNygkaMw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_AU1G1eFSN02wMgL4I9gmYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-07</instant>
        </period>
    </context>
    <context id="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_KwfTqwNCuk64IHdfIIUfOQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-07</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_THD-b4ZLeEmrlSnwTQZiEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ORH_Epj08k2OR4P3PXUF2A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_uEkHeFxWoUKCxd1wCPJN3g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_P6nhobuPVE6L9qTASsfgWA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_CHYctHL-NEC04rksJieDWA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Aq0HD_XsTkKPxGsqbD7Syg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_6_1_2021_To_6_1_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ylqtNA-bUEmL4qYAA8d_tw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_6IoH2prt10mKNC-IH_tP6A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_7UFsYW4z006S_tfRUh0Kjw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_z1cvmMf8N0SP-RnaUQjayA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_q8AQnXCt_EmVrk6I872x0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_OeMjnbZWu0aoMSIKBb6DzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_9p3Am8C7MEOlbQrXnk_2cg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_vJFpkC6zqk-9LH2SncbE-Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_XNE4PVnPmUe5dsW-sIzGIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_yldGfAut_UOwpJfZ6m96hA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ssFfLQvrEkeHJ26-YR0QHA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_A21K0pn7TUOZCpFwGWO4nQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_cESdCtZscUO59dYHHgaZpg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_P3mtcGxGrkKUFdj5qMeMsA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_m9dIOryBAU6cFXCIBqZNRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_4_25_2023_To_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_isjLRKvB20-ds3dYGWYkKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-25</startDate>
            <endDate>2023-04-25</endDate>
        </period>
    </context>
    <context id="Duration_4_17_2023_To_4_17_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_GxhdHNvlYEGHmFQK4ASs8Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-17</startDate>
            <endDate>2023-04-17</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_S4feA0vhSU--s22UyX83mw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_Su-w_xFE4ke175Cyk-kveg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_JWpjApV5kk6mkkkuH-ZYQg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_vKlhRJKu3EemIj0dy92Ntg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_x0VSehuBK02ZfQG1ov1NTw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_v4FiAYrj_UiV84PIq9aKlg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_ZP0J_NoaR0O08Cu16XJevg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_qrvljgLErEia_hKda3XtPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2023_95dncZH7m0qh7lCm80ElQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassAndClassBCommonStockNotSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassAndClassBCommonStockNotSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassAndClassBCommonStockNotSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassAndClassBCommonStockNotSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_NHlcD0Two0y88E2KkRoDFA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_OlTpv8vqnUW3HCd6Lr3SsQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_FUC4KYSqtUiLtDWVMSB8ZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_w7FiqmYDb0SNPeqJvA62Hg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_QX1AgoN1i0GRrr7rqmGn3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-y3TJWpkY0KEs_22qhgoTg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_DDMbCIawE0WRTKQo8ri2HQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dkdcu:MeasurementInputProbabilityOfCompletingBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_ybrEKTUYVEi2w4swS4gdww">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_SAyeztzxD0CqTCyFAOQf2A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_8dkF3R4YwUqerp4U-rpgZQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_g71uqyykEUaLUf1hlvHiRw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_JeEGJuHbaES_O44UyyPIfA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_bPi2WHn1CEmBrVfnbyV-yQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_8tE3iMpWckqAsmbEpESznQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dkdcu:MeasurementInputProbabilityOfCompletingBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_5w37XobWakKj_h4ipX-PCQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_h8eV0dNuHUC_ArrU2_om7Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_Qv7tGKJp8ESTjI2bmnNtTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_32dEYbIibku74IeSgOkApA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_MxCSmXH-QkW2v6_7S1_RpQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-7KCAAHgxkqAZ45nDl70BQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_AiXZHnfbmUaYN1Ptn1SXKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dkdcu:MeasurementInputProbabilityOfCompletingBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_t_sN0AW8l0ysvEDGgawN6g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_wJJYusvVpkCiZk86y5hcmg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_QhH0lFLktE2HTU1zggfIyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_zc8vCgsjJ02tRG0__b_sCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_gGMCV4IGL0WN2ukxJY-jVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_g_97mNUb4kStaMDUizkRmA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_hVTGu_0FbEy6zhs2-ZgI-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassCommonStockNotSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_ifs9AdjQcke5yZEerWtAKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassCommonStockNotSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_N0cKDx01fE-CPoTUE87ugg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:ClassCommonStockNotSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_wLPX3pqnoEGRhqgS36Atpg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-11</instant>
        </period>
    </context>
    <context id="As_Of_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_3SQJIMIvWUS9ELj-b17duQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-11</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_2_7_2021_xIunY2_KPEmoFeGygcAWFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2021-02-07</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_4TkL3ro1G0WNewZCXPJcSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_ePOJmFiwvU60MCXJN9p2Ug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_wiC7cqJRr0Cr05N-S5Q2Yw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_6aYBpgJYl06PCALWaa-w4w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_0kOvX431_0WNunHM_Al50g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_-SnL89jik0a1X0ZnHQTSug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_7tsBCIa7gk6SNfDSnFWCYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_o8R-ivw5E0eAlgI5XwvsAA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_aXuUNI1Ru0CZ99nEpdL7oA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2022-11-11</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_OperatingExpenseMember_Z4B4V5TZ9kOeJBQx4nhBbw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_y4Va1YH3m0eX130BeYRwng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:IntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6Bac23xTIkSPqevzW_S64Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_0L55K7OfcUakEf_TMfNGTg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6jC0xt_xPkW3XWSHKmx-Wg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_fqKCHCXgBkSvo0fCaH9NXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_0xI8gLPKx0-BmiEb0QOU0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_SGQAoQddE0emo9lL7Hd1eA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_THab5UCa2UyrRU_XTiFJiQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_3_23_2021_To_3_23_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_7vg13yQIHkePUv6ms7p3ng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">dkdcu:IndependentDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-23</startDate>
            <endDate>2021-03-23</endDate>
        </period>
    </context>
    <context id="Duration_3_23_2021_To_3_23_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ThirdIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6T3pPliyHUS0duvs0F4HAw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ThirdIndependentDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-23</startDate>
            <endDate>2021-03-23</endDate>
        </period>
    </context>
    <context id="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefFinancialOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9btB9vKZLEW4K63rfAMw5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-25</startDate>
            <endDate>2021-02-25</endDate>
        </period>
    </context>
    <context id="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefExecutiveOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_Mzinbo6790mIYa6MzPmccA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-25</startDate>
            <endDate>2021-02-25</endDate>
        </period>
    </context>
    <context id="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_1lq6y8qH_02AAAlWFjyicg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">dkdcu:IndependentDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-25</startDate>
            <endDate>2021-02-25</endDate>
        </period>
    </context>
    <context id="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefFinancialOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6znbrCXxFkGIcYmCY0iT1Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-25</startDate>
            <endDate>2021-02-25</endDate>
        </period>
    </context>
    <context id="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember__hwYxA9DEkqAKdAwnBpc_w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-25</startDate>
            <endDate>2021-02-25</endDate>
        </period>
    </context>
    <context id="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_TwoIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_4pqzZtHe2EG3qyNAxfbe9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:TwoIndependentDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-25</startDate>
            <endDate>2021-02-25</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_okqVlM4N3EWxKtzFTl4dfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_2ZVBDaVZVk2yU4cLdp7-rQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_qQvFEWW_20uSottBNfK9TA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_ekDZPE3EmEWL2qEJTcZkQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_3_31_2024_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_JnW2PcUwp0OM1e3d0ygcIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="Duration_10_1_2023_To_12_31_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_HiR7EAU8gUSivES6ft2axA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_6_28_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_9U3WXH3Tuk6B4AeZ9LZceA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-28</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_UkwcjyfyIkKPsh-ZJGYHfQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-11</startDate>
            <endDate>2021-05-11</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_3_22_2022_To_3_22_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_C-Ez8Wj92k-wMY601LQlhQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-22</startDate>
            <endDate>2022-03-22</endDate>
        </period>
    </context>
    <context id="Duration_3_22_2022_To_3_22_2022_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_6BKMWuaDzEmPd9vqRg5_Nw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-22</startDate>
            <endDate>2022-03-22</endDate>
        </period>
    </context>
    <context id="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:IntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-26</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-25</startDate>
            <endDate>2021-02-25</endDate>
        </period>
    </context>
    <context id="As_Of_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NTJiqMJD-EKRgG77t6L0wg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-25</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_C9XJ_5SJYkeABnyRWrMZ9w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_G6_zF5TSikiD8EVocXu3Mw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_5_2021_To_11_5_2021_xmuZ3mYtZE2S5AExqoqVLQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2021-11-05</startDate>
            <endDate>2021-11-05</endDate>
        </period>
    </context>
    <context id="Duration_5_11_2021_To_5_11_2021_NmXExQZglUSAztqWU0QU3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2021-05-11</startDate>
            <endDate>2021-05-11</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_9qk3u5ElcEGq6oIpa2IEYQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_z_RFqAY7JE2tlCBZNXCVwQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_5_11_2021_To_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_Zz-LC321iEOx0QXt64XTUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-11</startDate>
            <endDate>2021-05-11</endDate>
        </period>
    </context>
    <context id="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-11</startDate>
            <endDate>2021-05-11</endDate>
        </period>
    </context>
    <context id="Duration_5_11_2021_To_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_y47mRrlmNUqJZIDNSj342g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-11</startDate>
            <endDate>2021-05-11</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_M9ekq6WdLEucW-gPahd0mw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:ArcGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Cu5tn0_8kEi4cYONPPpMdw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_2_8_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_GfqTmPjOjEe_maJFOaIOog">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-08</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_TjM-esHGVEeoFX1cq_RpYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_6wnVrpWarEuBYWQ4-7W6Ig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_SeDSdYS9I0OQvO6F2ARe9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_gvo3MI-_1kGJuvLmpZZU2w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_ruu01iLDPE611oCSW8HUQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_QUoUswNMF02jFye3P74QXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_EF6C8NJFb0KSaqc-FbCmBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_0N5eYpz5zUyuKVAv4QYoVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_Nddpq_hUqUiHgJZLwEZXaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_hE2awbU3oU-sum3j2xFkxg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember__X7tf0I7ukiYWBqvSdHF_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2022-08-10</startDate>
            <endDate>2022-08-10</endDate>
        </period>
    </context>
    <context id="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2022-05-05</startDate>
            <endDate>2022-05-05</endDate>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_aJZ8MZKwr0C2EHSlNrQl3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_IhW2rhKKn0qo7A0xhD9s0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dkdcu:SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_zKlPVPHq4kWNIVjUBUSy9g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_Cfp-j1jKfkKwbJQkm0sqsA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_3RZpCGP7S0q5c4sXVDjShA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_2_8_2021_v79xWrSU2E2fOfIAgN6zrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-02-08</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_3sbSA6mVh0m3wtnOe9Ru3Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_OOd5AilGXE2sxPflL-HxVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_9L82rWITkUe_O0x-YM5jnw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_XXUqNLWvg0qpR2rSOgLQ_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dkdcu:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_BCoSdhDn8kSOYrKHJDYXHw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember__aKBWKKCl0y9GZbCCzx5Mg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_D81xSwKtWUK5pM73JnCYwA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-11</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_g-5Z8iiekEipUKjvBBe-og">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_QaJt1ia12ECl_HVZf-OHZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dkdcu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_6_28_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Qivj15x0skm53fAZP6Gj9w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-28</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_kF1v8eLYwUqIkingtOoNMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_bWhzWPZIyUW-IA3VsLVynA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_6_28_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_nn_yhuYka4eAFEk-2_Tg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-28</instant>
        </period>
    </context>
    <context id="Duration_4_19_2023_To_4_19_2023_srt_StatementScenarioAxis_dkdcu_SixthOneMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_ziSc7tDmME6Wx3vreHBoIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:SixthOneMonthExtensionToTerminationDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-19</startDate>
            <endDate>2023-04-19</endDate>
        </period>
    </context>
    <context id="Duration_3_6_2023_To_3_6_2023_srt_StatementScenarioAxis_dkdcu_FifthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NBJMLC3FJkeQ_zMEcQPEZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:FifthMonthExtensionToTerminationDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-06</startDate>
            <endDate>2023-03-06</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2023_To_2_8_2023_srt_StatementScenarioAxis_dkdcu_FourthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_2cSXaqbjC0G88fQ4Os87Uw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:FourthMonthExtensionToTerminationDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-08</startDate>
            <endDate>2023-02-08</endDate>
        </period>
    </context>
    <context id="Duration_1_5_2023_To_1_5_2023_srt_StatementScenarioAxis_dkdcu_ThirdMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_zROX-Jpz0Um4wcHHn0lc3g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">dkdcu:ThirdMonthExtensionToTerminationDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-05</startDate>
            <endDate>2023-01-05</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_S7Yu6E8CZU-ri3x6GhOt_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dkdcu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-11</startDate>
            <endDate>2022-11-11</endDate>
        </period>
    </context>
    <context id="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_wzq3pdLUSk-Hj-g34bsbKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dkdcu:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-11</startDate>
            <endDate>2022-11-11</endDate>
        </period>
    </context>
    <context id="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2022-11-11</startDate>
            <endDate>2022-11-11</endDate>
        </period>
    </context>
    <context id="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <unit id="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q">
        <measure>dkdcu:Vote</measure>
    </unit>
    <unit id="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">
        <measure>dkdcu:item</measure>
    </unit>
    <unit id="Unit_Standard_D_24WmzP3yxEKX8pNPNSJZgw">
        <measure>dkdcu:D</measure>
    </unit>
    <unit id="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A">
        <measure>dkdcu:Y</measure>
    </unit>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      id="Hidden_3qEwVNaUAEOXkCKclBiSpg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      id="Hidden_5vq8Teu4_UWE_AUrwtP8fg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="0"
      id="Hidden_MRX_ZdeGqE6bviB3Wa-65A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="0"
      id="Hidden_zgwXAYpqeUic9wcdWVt5uQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"
      decimals="0"
      id="Hidden_h8hx7Yav9kalxT66eXT2HQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4838792</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"
      decimals="0"
      id="Hidden_vDazgkJ0EEypzusvMTfWkw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3460275</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Hidden_WN0ZdMDEAUyc0sklXwd2jQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Hidden_DW21HBptw06l7swvsnr-FQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_hVTGu_0FbEy6zhs2-ZgI-g"
      decimals="INF"
      id="Hidden_0cQU6E49SkmrIed7ApF4pA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q"
      decimals="INF"
      id="Hidden_AfphFbe_SE-nxF-tg42oQg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Hidden_LaXFHryQ1EKRA0Kg9EIuMQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Hidden_27iDXPTmOUGuunAZFbooDQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="INF"
      id="Hidden_waxUz0m1IEW6QjHRetjPnQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Hidden_sFRSisEHb0uyrZ13hj0iXw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="INF"
      id="Hidden_N_bkTRU1XUaeJxlOVOwVeA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Hidden__awjW7FUnU6X-UDXcVZkog"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="INF"
      id="Hidden_Oqe_7WZuDk-uJW7b2n_V9Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"
      decimals="0"
      id="Hidden_f4QAOOmuLkO_Ioc9BVVxwg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4838792</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_wJJYusvVpkCiZk86y5hcmg"
      decimals="INF"
      id="Hidden__9-nOZ3Tf0ima9Px8fKAWQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA"
      decimals="INF"
      id="Hidden_YfcwETV8Rke8WGjFqtRR8A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="-3"
      id="Hidden_0d94tEnIEkOK4a0q11LgXQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="-3"
      id="Hidden_sR5KYKYr6UyM5gvaQmu5yg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="-3"
      id="Hidden_Irga6wd3h0KgMqeFTp1mnw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="-3"
      id="Hidden_QCO90ljSZkaitw7M44Mrkw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="-3"
      id="Hidden_Qx0YbLdM4ki2VJtXRBf4-g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="-3"
      id="Hidden_RvbG31uxZkuaQ4LC7BE17w"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="-3"
      id="Hidden_wom4GW2H80aU-QiWHaxL3w"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="-3"
      id="Hidden_3s5xo3tqrky61Ubyib2gZw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_g_97mNUb4kStaMDUizkRmA"
      decimals="INF"
      id="Hidden_2Htd6WhlbkygRfO0gyxADA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_ifs9AdjQcke5yZEerWtAKg"
      decimals="INF"
      id="Hidden_HcWfg_CLWUGwG6Xl75P2Hg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      id="Hidden_DKdOnAzLtUCI1ZhlkXnbag"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      id="Hidden__WJeqUvLsU6n6vU4zmYsLQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="0"
      id="Hidden_C8p4v91f6EqF3PeVT3q1HA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8667969</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="0"
      id="Hidden_9GKVwkMtTEuRw9kheUW9eQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8264526</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="2"
      id="Hidden_baAZDVWKLUSHycXy1IIhbg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="2"
      id="Hidden_iusRv-ELz0-MplJKcZYEww"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q"
      decimals="0"
      id="Hidden_HTQ80Zfj90KrdrZyrohsbg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3464052</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw"
      decimals="0"
      id="Hidden_8BGLyMLFEUyKaHad4t72gw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3295610</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <dkdcu:CommonStockShareOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_XXUqNLWvg0qpR2rSOgLQ_A"
      decimals="INF"
      id="Hidden_D6zPkpS9lkWf_IMzW356xQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:CommonStockShareOutstanding>
    <dkdcu:CommonStockShareOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA"
      decimals="INF"
      id="Hidden_WZjZE1J4WUmo3S6vFMdTQg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:CommonStockShareOutstanding>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_o8R-ivw5E0eAlgI5XwvsAA"
      decimals="0"
      id="Hidden_xvojYnxUHEmC31015lSKuw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_0kOvX431_0WNunHM_Al50g"
      decimals="0"
      id="Hidden_sr0HEoPf_kOjgN9eKDA_IA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="INF"
      id="Hidden_N6awHqBWSkOMkpgj69gueA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Hidden_Se6Y_IOxNUSaCbNTO65M1g"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw"
      decimals="0"
      id="Hidden_0J-Y_1iZYEWkURAB1nKYxA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g"
      decimals="0"
      id="Hidden_FA7L7c8AHkm0_hoZiQd32Q"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw"
      decimals="0"
      id="Hidden_olDCdqZL9UmfblrEUIpuTg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Hidden_RWf99jMgf0W1jlnexYZIAQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw"
      decimals="0"
      id="Hidden_Ko7IatCJIU6AMHUF46nbqQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g"
      decimals="0"
      id="Hidden_rWNMRiN0QUSHh15ufVHitQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw"
      decimals="0"
      id="Hidden_uAyRdQdgYk2tUF3OWZCuUw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Hidden_3klZK77hnEiuhfDEz3gTkg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
      contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw"
      decimals="0"
      id="Hidden_Ke0m9uvuCE2N4AzTXFQjpg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
      contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g"
      decimals="0"
      id="Hidden_0EZFGJGyk0qBGi0bHucDbQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
      contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw"
      decimals="0"
      id="Hidden_8LlqWkSsYUmTM-JHO1qetQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Hidden_NJo35Z17CkaxiBzkb-i2lg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw"
      decimals="0"
      id="Hidden_a3V9wCTvvUG6fgodk6FUsw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g"
      decimals="0"
      id="Hidden_PF55ytCECEG9GfY-ENWQBA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw"
      decimals="0"
      id="Hidden_KK9cdvbXLU2hAfuKYlSWXA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Hidden_zTCjO-FWJEeQF0ATLCLkzw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_N0cKDx01fE-CPoTUE87ugg"
      decimals="INF"
      id="Hidden_7-lMi5Vl10OtbuhSWUVJVg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q"
      decimals="INF"
      id="Hidden_B7jcxCdPlUCVznHRwDYv9A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tc_aAwsrkrhSUuTc2tCKH7Bcg_2_1">0001849380</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tc__-S_IkXC10inMqRaNub73Q_3_1">true</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Hidden_XCM27r7CoUKB2qNPHJZvKg">S-4/A</dei:DocumentType>
    <dei:EntityFilerCategory
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Hidden_zfxpuseI_0m-v2LU_40Fcw">Non-accelerated Filer</dei:EntityFilerCategory>
    <us-gaap:PreferredStockValue
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      id="Hidden_u4VC1Bk8lEqS28vAcCMv0g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      id="Hidden_fOlcofgYgUCSYhFsYAD0Jg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="2"
      id="Hidden_aMOH8UF2jkOmx4oY-W4V1w"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="2"
      id="Hidden_UG6XxWJds0CXaH4-vLv9Ng"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"
      decimals="2"
      id="Hidden_U8qb5VTrkUeQ6gm1nb5pcg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"
      decimals="2"
      id="Hidden_t491--BJ_U6REG8h_KXC-w"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="0"
      id="Hidden_3Oegvze3iUamAXcK8gfz6g"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"
      decimals="0"
      id="Hidden_TC2XcqvAn0uRRhHRnkeSow"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4838792</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <dkdcu:ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget
      contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q"
      id="Hidden_-gBu7Ivd10mlotw_rZDvrw">P6M</dkdcu:ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget>
    <dkdcu:Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ"
      id="Hidden_pecVw-7_R0GR-O1MFLS0Dg">P20D</dkdcu:Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination>
    <dkdcu:Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ"
      id="Hidden_4KOodU4RC02gxRyhNxEksA">P60D</dkdcu:Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw"
      id="Hidden_wWOk2hbenkiF3eCjIIPW1A">P20D</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw"
      id="Hidden_j3RPZoOibUKp_scxdjJSCw">P30D</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <dkdcu:NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ"
      id="Hidden_9B-TMAVHjEWPMjdgpFxpbg">P20D</dkdcu:NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw"
      id="Hidden_-WzpzrAyj0OzmcEU8I-ydQ">P30D</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Hidden_ZO2hDNBMi0u8zP5YIF1kNA">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      id="Hidden_jQL209kLek2Gbb2s5yFT1A">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:PreferredStockValue
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      id="Hidden_VDWoG3xUDkq-QnqfvPkfFQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      id="Hidden_W_tdiYbVOUGnMuYZaFehuw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Hidden_kKzVaGg-tkyGRoA-U4HSRg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"
      decimals="INF"
      id="Hidden_bcDIwsjDIU2tiRoMVJeRRg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Hidden_1KMWQDP80UmtJMI6pxRIgA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2242253</us-gaap:AdditionalPaidInCapital>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DzIyCou1hkeI-WohQI5SbA"
      decimals="0"
      id="Hidden_dGxMlHP5QkeRLf3Erq2Q8A"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2242253</us-gaap:StockholdersEquity>
    <dkdcu:CashHeldOutsideInTrustAccount
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Hidden_cZQeLnh3Zk29sDgjeEin2Q"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</dkdcu:CashHeldOutsideInTrustAccount>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="2"
      id="Hidden_cBacU7djtUCSXr11GkPXGw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="2"
      id="Hidden_3Es1orTY_USJ4itNDtiZDw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q"
      decimals="2"
      id="Hidden_lanKp2oqLU-qANj804gmEQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw"
      decimals="2"
      id="Hidden_5OAEfUoUY0K-bvq2FdDuFg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.44</us-gaap:EarningsPerShareDiluted>
    <dkdcu:TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA"
      id="Hidden_bbHY3R68R0qhn-ZoycDM0g">P20D</dkdcu:TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays>
    <dkdcu:TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA"
      id="Hidden_oJtbLe8GvkWMoQVqcR68nA">P30D</dkdcu:TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays>
    <dkdcu:Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      id="Hidden_l9q9OYpBaE-i-c9_ByMINg">P20D</dkdcu:Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination>
    <dkdcu:Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      id="Hidden_O_rVnyonKkqQ7hhmRqfGSA">P60D</dkdcu:Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg"
      id="Hidden_g1uhXZ_IzE6YLS18Pibsaw">P20D</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg"
      id="Hidden_ucp-6LYyYk2H8bhHlUU4tg">P30D</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <dkdcu:NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      id="Hidden_Tj-gOcDc5kC5FCMl3wJLvg">P20D</dkdcu:NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Hidden_byXh1qgX90qNILMCXVSaVw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw"
      decimals="INF"
      id="Hidden_OyBqbq_iQkytLYvGC9d64A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1379517</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Hidden_STifUojKSEajZv3cqO8nRw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"
      decimals="INF"
      id="Hidden_Vj2cJtgcg0SBI0y6E-s6Sg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Hidden_4REQyUAf6022aVEF9i64Ww">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Hidden_-9mRpELl-Ee-JT7U3Njw7g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1855</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <dei:AmendmentDescription
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_nxNU1V3DCku9BHHJINuSdQ">AMENDMENT NO. 6 </dei:AmendmentDescription>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_O-DsRzooSE2GB2YPzZwzlg">DATA KNIGHTS ACQUISITION CORP.</dei:EntityRegistrantName>
    <dei:EntitySmallBusiness
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tc_LrjCAvlHWUSu1YYxifZBJw_4_3">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tc_I3hwkJ9rM0WRSkz3k85sRw_6_3">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_JesIBITFnkSunBi9rfhiHw">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_eYp4eg20kEW93Cvcu0joAQ_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">10108</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_fe6Qec6DUkKSJNjQck5BaA_6_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_pflWTnVrdEmGjKURs3Vatw_7_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">10108</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_jzvL3PaCUES1x4Kw9o-hWw_7_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_jmTk0uGilkGtDHI21Vv5Hw_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29725574</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_X4ihOY-uNU-ipA_tBuS4RQ_9_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_jU0f0945-02NZ5PJ61mytA_10_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29735682</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_uxSSOjHxukasFAqFL59aVw_10_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29060286</us-gaap:Assets>
    <dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_364sXAXUMkqCAG-WuZOAJw_14_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1933661</dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent>
    <dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_wi7ndgIXyUyOUl7bb4Ng6A_14_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1679821</dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_SBl7yBkD2EiG_NivAQuRqw_15_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">11200</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_WML-d-UaKEK0Y569SEHdTQ_15_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">11500</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_1s0d2Q4NxU6vBJfp5K36eQ_16_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">274448</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_S-xNwBwwOEunpEDAvrDnXw_16_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">214850</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_6nWR4M7_a0eKl-V2rdC3Jw_17_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117447</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_M4l3fXfUjEyikJzrfQV84g_17_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">69966</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_E_nIuNNIc0S71-rBaKik5A_18_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2336756</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_iHcqT-CUz0u0M_LRkWeiNQ_18_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1976137</us-gaap:LiabilitiesCurrent>
    <dkdcu:WarrantLiabilityNonCurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_aJ7_U46cC0y34y-3vTQIyA_20_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">362558</dkdcu:WarrantLiabilityNonCurrent>
    <dkdcu:WarrantLiabilityNonCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_DD4kXQP5oUqRnlZADXNokw_20_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">362558</dkdcu:WarrantLiabilityNonCurrent>
    <dkdcu:DeferredOfferingCostsNonCurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_N5J0W_AgMkmKbqVmAT_wJA_21_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:DeferredOfferingCostsNonCurrent>
    <dkdcu:DeferredOfferingCostsNonCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_spT7e17PQ0iYiUrIEXA83g_21_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:DeferredOfferingCostsNonCurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_fwxG_phlG0-zowJymr-b2w_22_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">239081</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_QeYUx8nuh0KJPS9k1p6TKg_22_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">207081</us-gaap:DueToRelatedPartiesNoncurrent>
    <dkdcu:ExtensionLoansNonCurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_S7SGYSjLS0ut7-5VSEXF6A_23_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2914598</dkdcu:ExtensionLoansNonCurrent>
    <dkdcu:ExtensionLoansNonCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_czE3q62NgEuGwPX4X1Cx6Q_23_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2545838</dkdcu:ExtensionLoansNonCurrent>
    <us-gaap:Liabilities
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_Iu0T8dXkRUeqP0_N8UcCSg_24_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">9877993</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_RJ6hs_r2yEK7Y0LqvvUU9A_24_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">9116614</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w"
      decimals="INF"
      id="Narr_62RSk0fIZUChrAPBGoxlEQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="INF"
      id="Narr_lLJNC-Jw5UWKys-IP9vUHw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w"
      decimals="2"
      id="Narr_4sqodA-j-kyD8KVnfOql_A"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.74</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="2"
      id="Narr_8nOmFSy6LkanLcIaDnlePA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.53</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w"
      decimals="0"
      id="Tc_d_u4YKzNO02_GfvFOCkfPQ_27_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29333680</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="0"
      id="Tc_Me57LgP_gkKAGtvIYx6vKg_27_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">28750110</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Narr_yMy9cIFsCkW_IqM0PW00eA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_JtTuCEm_B0-DBuKscTPprA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Narr_IlL-QA136EOdqLSPvKwtBw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_RAC7vCX7wUmqzxJDgkcZsg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Narr_YdtJhDbB-EOnqmq_-HQURg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_KDMVFsSpS0mXF3hg213h8g"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA"
      decimals="INF"
      id="Narr_-cP9_7cpz0ynJ6niuWye5A"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_iM1J0yuOsESz-NJIrCvXQQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA"
      decimals="INF"
      id="Narr_5t4dUt6HOU2AxGp_k5LpoQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_PT1qJvxICUiQv2CdD5BUQw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_hVTGu_0FbEy6zhs2-ZgI-g"
      decimals="INF"
      id="Narr_nakMLoLc5k6bJvtV6wPtWw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q"
      decimals="INF"
      id="Narr_2pDRRScxUECo-1nqi1Brdw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w"
      decimals="INF"
      id="Narr_scKBAVP6q0ySjT7i0lnPLw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="INF"
      id="Narr_9IFi35-JfUeUK3dPSqZd2g"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA"
      decimals="0"
      id="Tc_meEFrlS_zECT-F3yvlmZXw_31_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="0"
      id="Tc_fn4vBE8COEq9-NptSEq5cQ_31_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="INF"
      id="Narr_SE5YcZ3TyEamPaOy0OU5Dw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_7DGbjZH4h0Ce0TiS7ugkbw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="INF"
      id="Narr_0dSNZaFkNkq_yIQV_P8-gg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_37ZGvz6X9UK7usLxbx4Mog"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="INF"
      id="Narr_p69fYo4uwk2gd80_0ih9wQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_TW4N6WMmF0-PC1DurO6ljw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="0"
      id="Tc_yNYiz0PUREuFGvM_VIV8Dw_32_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">425</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="0"
      id="Tc_xxAMnWfKnUmCFTlOQf_vWQ_32_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">425</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_xrt4_Zeu9UOrMpDi8QoWCQ_33_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2242253</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_QFQml17PYECM5vO0FYCS_w_33_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2242253</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_nAu0u7OWM06PwEbhv-j7Jw_34_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-11718728</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_OnnO60uynEa0DSx8i611sA_34_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-11632745</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_0llmDO0IXEmY3xGzwOvyWQ_35_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-9475991</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_xPj4hFILp06QWG9Bsayhkw_35_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8806438</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_-6iZ9z8Nw0-TzTP8E5avHQ_36_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29735682</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_G4JjXn4tT0iKLdNfTd9VgA_36_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29060286</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_i_g9I0whZ02BuGSbCKv0Yw_5_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">306303</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_fffWaDCeoEOoS-Lk1QAtfw_5_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">560185</us-gaap:OperatingCostsAndExpenses>
    <dkdcu:FranchiseTaxExpense
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_H7xFPMcyp0mGWUjYZMTNBg_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">47481</dkdcu:FranchiseTaxExpense>
    <dkdcu:FranchiseTaxExpense
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_YFVzhbXQA0SWVQdTiaVB-Q_6_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">50000</dkdcu:FranchiseTaxExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_Q2NkY_xQakyCA5CUAA3CzA_7_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-353784</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_LmQWM8nArE2SFdvqtkvU3A_7_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-610185</us-gaap:OperatingIncomeLoss>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_RtxhY1n7eU-13eRWG7q53Q_10_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">327399</dkdcu:RealizedAndUnrealizedGainLoss>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_Y4yFPKklK0OEEG8A-e9_pQ_10_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">43053</dkdcu:RealizedAndUnrealizedGainLoss>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_2z5Ryc4YEE6XiwNoVEqPUw_11_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-2762640</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_c8l-Dam0VEWICZsVfdeaaA_12_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-26385</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_bpazGDnkf0CpeTR2820_rw_12_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2195508</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_KWoRlTeMX0GLs9bVq3WA2g_13_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59598</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_BmgEdHb_8Uurpr2djOlnpg_14_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-85983</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_xhEsEmSA40uGiHpe8kksLA_14_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2195508</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="0"
      id="Tc_1xQ0GefAS0KdX7lJI72MRQ_16_3"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="0"
      id="Tc_tGgjM0D6Gkad8Qc07KmoSA_16_6"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="2"
      id="Tc_dbh28USOAkmgcx1TDH81OQ_17_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="2"
      id="Tc_iIRpX7-h4k6WQHwe5Cxu2Q_17_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"
      decimals="0"
      id="Tc_pIh9wyPIMEOOsLvbK1n1fw_19_3"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4838792</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"
      decimals="0"
      id="Tc_OWLMoCvzlUq1z2D8BT4p5w_19_6"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3460275</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"
      decimals="2"
      id="Tc_LoMbAnc1EkmTfvCjL8YaeA_20_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"
      decimals="2"
      id="Tc_0o1fOUeiX0K7m73EK5xNkQ_20_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ"
      decimals="INF"
      id="Tc__Hufem0fbUG3PVak7pLY4w_4_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ"
      decimals="0"
      id="Tc_q6zO0F2z0UCl1t_pbk2mtQ_4_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg"
      decimals="INF"
      id="Tc_OUp9gTvqvUi8RrJcWh2Tew_4_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg"
      decimals="0"
      id="Tc_XMKEYNJdBEC3Wy0lss4Eyw_4_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">425</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DzIyCou1hkeI-WohQI5SbA"
      decimals="0"
      id="Tc_1Qxj0O3JpEKE9D1ilryQIQ_4_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2242253</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_xXVChhyI6k-ndPgI-1--gQ"
      decimals="0"
      id="Tc_qzWE9SUOVUGk0eN7_c2Qrg_4_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-11632745</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_nSfUtdDeXkqOfRV583Co2w_4_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8806438</us-gaap:StockholdersEquity>
    <dkdcu:CommonStockSubjectToPossibleRedemptionShares
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q"
      decimals="INF"
      id="Tc_826RBxjKY0mEkXX-a2L-5A_5_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</dkdcu:CommonStockSubjectToPossibleRedemptionShares>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q"
      decimals="0"
      id="Tc_4yZdSg9440uxsyJR3dYgUw_5_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <dkdcu:CommonStockSubjectToPossibleRedemptionShares
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ"
      decimals="INF"
      id="Tc_kZmDeiSoyEuVumtbF6ETFw_5_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</dkdcu:CommonStockSubjectToPossibleRedemptionShares>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ"
      decimals="0"
      id="Tc_oMyGZB-d_0u7M-sP5as9oA_5_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_OOd5AilGXE2sxPflL-HxVw"
      decimals="0"
      id="Tc_5fR89A1NzU--iipqDJ7G3g_5_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">583570</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_3sbSA6mVh0m3wtnOe9Ru3Q"
      decimals="0"
      id="Tc_xCppH6lQmkmiODL98Ob_bA_5_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_XviSAHLeUkCa9-aorgyLHQ_5_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">583570</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q"
      decimals="INF"
      id="Tc_c_aIsQM1l0S4p60WgLIcbg_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ryAY8V2o6E-Lwqzc4da96Q"
      decimals="0"
      id="Tc_sfqmbH4Q0EqWPjR14Ty2PA_6_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ"
      decimals="INF"
      id="Tc_plk5jFuXcEidHNsozqefXg_6_7"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CbYThSHpXkWDuT-YpuJGOQ"
      decimals="0"
      id="Tc_5Hg6WgEZhEiieOUhM-rnZw_6_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_OOd5AilGXE2sxPflL-HxVw"
      decimals="0"
      id="Tc_gqRp6JPiCkeJwkAr2IGSIA_6_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_3sbSA6mVh0m3wtnOe9Ru3Q"
      decimals="0"
      id="Tc_P7bFqG6QV0CcYZPGd76h4A_6_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-85983</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_TQ_3vyhPGkOwmv3TPtYoXw_6_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-85983</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_goe_RVvoFUyh8ybQ7jTgQw"
      decimals="INF"
      id="Tc_ulIoRXylNU2EYi0ZIILlyA_7_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_goe_RVvoFUyh8ybQ7jTgQw"
      decimals="0"
      id="Tc_EUKuvkJA-EeHHtYr425pZQ_7_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_7bwDEPA2V0-iIfkW-TlPEg"
      decimals="INF"
      id="Tc_zvqvJqracEy-HdXOK3nLdg_7_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_7bwDEPA2V0-iIfkW-TlPEg"
      decimals="0"
      id="Tc_JYvsSzLYlU6nK8bYv5Z_TA_7_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">425</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_ZMuTDpHFhkK3bBt9NctNIA"
      decimals="0"
      id="Tc_zKCmGXJlWEutOllgM6ddiw_7_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2242253</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_86Daq9d6j0GAwbKckEBFNA"
      decimals="0"
      id="Tc_z9_I2jYZaEK6wSnEAxroyw_7_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-11718728</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_AN2PuMpvBEGVH39jO_vqTQ_7_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-9475991</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ"
      decimals="INF"
      id="Tc_fzVo9h8xG0un0KxaxlZybw_4_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ"
      decimals="0"
      id="Tc_iUkX8JSPkUW4cFu0ISP5Fw_4_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg"
      decimals="INF"
      id="Tc_yG9Kz8qPJ0SSXm9ZSJF6pA_4_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg"
      decimals="0"
      id="Tc_MxNflieEXEK89ggZIHX08Q_4_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">288</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_6Bf7HXIAMk2oElQb9ogmow"
      decimals="0"
      id="Tc_XXGAyFbF6Umcl83DTUXD6A_4_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_6-yCbHCVY0uGfDrYrKv0Iw"
      decimals="0"
      id="Tc_lVJUn-9Vtk6goL-9l-RTsA_4_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8609810</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_Ydf5t4ijP0Kqc0XqdazNbw_4_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8609463</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_cESdCtZscUO59dYHHgaZpg"
      decimals="0"
      id="Tc_XnQS1xUb-EGmpDDv2emyCg_5_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_cESdCtZscUO59dYHHgaZpg"
      decimals="0"
      id="Tc_2JgnZAcsHUOOFA0pN-ooEA_5_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_A21K0pn7TUOZCpFwGWO4nQ"
      decimals="0"
      id="Tc_WCm3Xu3QCE6Ec7-2-K0I9w_5_7"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_A21K0pn7TUOZCpFwGWO4nQ"
      decimals="0"
      id="Tc_Km4tZzr1DUSp5l4RmsXPcQ_5_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_m9dIOryBAU6cFXCIBqZNRQ"
      decimals="0"
      id="Tc_qsk6Ivd_tEWNcsnWzpWtmA_5_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_P3mtcGxGrkKUFdj5qMeMsA"
      decimals="0"
      id="Tc_XEy9IvSqw0m5vMf353ev0A_5_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2195508</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_5OHV7LoGYEe03fL4cAc_3A_5_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2195508</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ZJf5YelKa0CSmVXNygkaMw"
      decimals="INF"
      id="Tc_uqKjwucVrUqELeoSlax7cQ_6_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ZJf5YelKa0CSmVXNygkaMw"
      decimals="0"
      id="Tc_bC_WEfos0EqV2YqULIU5yA_6_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_b2QDuXd4oUeF_buHUjKBrg"
      decimals="INF"
      id="Tc_U0AJmsryyka-9TEie0as1w_6_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_b2QDuXd4oUeF_buHUjKBrg"
      decimals="0"
      id="Tc_npNdexUIWkub15-vMZBSDw_6_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">288</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_IHG1RFSPIE2Is1YIYVb5NQ"
      decimals="0"
      id="Tc_sWh7JsnoEU2vZbk9squKtA_6_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_tGuxzL5MjkWBTR132SmvCw"
      decimals="0"
      id="Tc_4wuy-cPI70SURv-2a0bimA_6_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-6414302</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw"
      decimals="0"
      id="Tc_uLnFCcX6pEWeDUoEJSDLng_6_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-6413955</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_Icd4WNlFlkid6BsMN24uLw_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-85983</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_roeJIkRjAkGdCvMuOwARNg_6_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2195508</us-gaap:ProfitLoss>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_TuH3Ln0vVkqCnYjzo15UUg_8_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">327399</dkdcu:RealizedAndUnrealizedGainLoss>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_oFFmmwx4AkawooO2xjQokg_8_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">43053</dkdcu:RealizedAndUnrealizedGainLoss>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_jjP4jYZLRUWAl6XPN0vA-w_9_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-2762640</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc__J092Zc1K0qkL1vOp_i64g_11_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-39739</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_6YBDwhpUT02B_I1D0cnPBw_12_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">253841</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_KfQCJZNFeEmDQ5r_1LbRpw_12_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">390436</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <dkdcu:IncreaseDecreaseFranchiseTaxPayable
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_prCMYYd_UUiIT6Cek5kE-A_13_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">47481</dkdcu:IncreaseDecreaseFranchiseTaxPayable>
    <dkdcu:IncreaseDecreaseFranchiseTaxPayable
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_3ZL8jQprS0OSq5Rj4idqRg_13_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-114008</dkdcu:IncreaseDecreaseFranchiseTaxPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_VS6b17GO_02rA4gkZs7Z9A_14_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59598</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_fKpqeAI6IEGYUYraSWukUg_15_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-52462</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_W08N_kL4VUKWBrTZfQoCsQ_15_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-294018</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_v2HG3lYcvUOxAL3pxBOf8A_18_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">368760</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_EMLKytGbCkGc0Py4Fr06ag_19_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-368760</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <dkdcu:AdvancesFromRelatedParties
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_KPof7OtRwUKQjIlCRhR4qA_22_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-300</dkdcu:AdvancesFromRelatedParties>
    <dkdcu:ProceedsFromWorkingCapitalLoan
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_RHAjvl7A20OB5hiszVrXUQ_23_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">32000</dkdcu:ProceedsFromWorkingCapitalLoan>
    <dkdcu:ProceedsFromExtensionLoan
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_hZgN_wus2kWCmJo4uhaTrA_24_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">368760</dkdcu:ProceedsFromExtensionLoan>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_Y9YJaLW_WkSDdPlZ5aA3cQ_25_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">400460</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_Jy3QDbx0xkemYQRvGkShLw_27_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-20762</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="0"
      id="Tc_pVFVvAJhN0-F62_O23DpYg_27_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-294018</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_Z8Yv2pzhS026ofI6jxknAw_28_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_fjbWwMiSukqfr6i4bCtcqw_28_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">453151</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Tc_7E1nCj4MVEuFb9BzzoKhCA_29_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">10108</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw"
      decimals="0"
      id="Tc_DIBFdwa3HUmLaFHzLcMuRQ_29_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">159133</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Tc_1kcDF7UKA02bo5lx2bPjxA_32_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-583570</dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption>
    <us-gaap:NatureOfOperations
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_1OzVSi66rUSynMQdMg13LQ">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Data Knights Acquisition Corp. (the &#x201c;Company&#x201d;) is a blank check company incorporated in Delaware on February 8, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; or more businesses (the &#x201c;Business Combination&#x201d;). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;As of March 31, 2023, the Company had not yet commenced any operations. All activity for the period February 8, 2021 (inception) through March 31, 2023, relates to the Company&#x2019;s formation and the initial public offering (the &#x201c;Initial Public Offering&#x201d;), and, since the closing of the initial public offering, the Company has entered into a merger agreement (as described below), and continued a search for a Business Combination candidate. The Company has selected December 31 as its fiscal year end.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on May 6, 2021. On May 11, 2021, the Company consummated the Initial Public Offering of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;11,500,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; units (&#x201c;Units&#x201d; and, with respect to the shares of Class&#160;A Common Stock included in the Units offered, the &#x201c;Public Shares&#x201d;), generating gross proceeds of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$115,000,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, which is described in Note&#160;3.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;585,275&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; private placement units (the &#x201c;Private Placement Units&#x201d;) at a price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per unit in a private placement to the Sponsor, generating gross proceeds of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$5,852,750&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, which is described in Note&#160;4.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Following the closing of the Initial Public Offering on May 11, 2021, an amount of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$117,300,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (&#x201c;Trust Account&#x201d;) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company&#x2019;s stockholders, as described below.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Transaction costs of the Initial Public Offering amounted to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$6,771,112&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, of which &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$2,300,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; was for underwriting fees paid at the time of the IPO, &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$4,025,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; was for deferred underwriting commissions, and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$446,112&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; was for other offering costs. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Following the closing of the Initial Public Offering &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$959,560&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of cash was held outside of the Trust Account available for working capital purposes. As of March 31, 2023, the Company has &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10,108&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of cash and a working capital deficit of $&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;2,326,648&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;80%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;50%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully affect a Business Combination.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On April 25, 2022, the Company, Data Knights Merger Sub, Inc., a Delaware corporation (&#x201c;Merger Sub&#x201d;), and Data Knights, LLC, the Company&#x2019;s sponsor (the &#x201c;Sponsor&#x201d;), entered into a definitive Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;) with OneMedNet Corporation, Inc., a Delaware corporation (the &#x201c;Target&#x201d;, and together with the Company and Merger Sub, the &#x201c;Parties&#x201d;) and Paul Casey, as seller representative (&#x201c;Casey&#x201d;). Pursuant to the Merger Agreement, upon the closing (the &#x201c;Closing&#x201d;) of the Business Combination, the Parties will effect the merger of Merger Sub with and into the Target, with the Target continuing as the &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;surviving entity (the &#x201c;Merger&#x201d;), as a result of which all of the issued and outstanding capital stock of the Target shall be exchanged shares of the Class A Common Stock of the Company upon the terms set forth in the Merger Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On May 5, 2022, the Company extended the date by which the Company has to consummate a business combination from May 11, 2022 to August 11, 2022 (the &#x201c;First Extension&#x201d;). The First Extension was the first of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;two&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;three-month&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; extensions permitted under the Company&#x2019;s governing documents.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On August 10, 2022, the Company extended the date by which the Company has to consummate a business combination from August 11, 2022 to November 11, 2022 (the &#x201c;Second Extension&#x201d;). The Second Extension was the second of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;two&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;three-month&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; extensions permitted under the Company&#x2019;s governing documents.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On October 27, 2022, the Company filed a definitive proxy statement with the SEC in connection with the Company&#x2019;s solicitation of proxies for the vote by the stockholders of the Company at a special meeting of the Company&#x2019;s stockholders to be held on November 11, 2022 (the &#x201c;Special Meeting&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On November 11, 2022, at 10:00 a.m. ET, the Company held a virtual special meeting of its stockholders. At the special meeting, Company stockholders entitle to vote at the special meeting cast their votes and approved the Trust Amendment Proposal, pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO if the Company has not completed its initial business combination, from November 11, 2022 to August 11, 2023 (or such earlier date after November 11, 2022, as determined by the Data Knights Board). As a part of Special Meeting, the Company&#x2019;s stockholders approved amendments to its second amended and restated certificate of incorporation (the &#x201c;Extension Amendment&#x201d;) and the investment management trust agreement (the &#x201c;Trust Agreement&#x201d;) between Continental Stock Transfer &amp;amp; Trust Company, as trustee (&#x201c;Continental&#x201d;), and the Company governing the trust account (the &#x201c;Trust Account&#x201d;) established in connection with the Company&#x2019;s initial public offering dated May 11, 2021 (the &#x201c;Trust Amendment&#x201d;), which together allow the Company to extend the deadline by which it must complete its initial business combination by up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;nine&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one-month&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; periods. In connection with each such extension, Data Knights, LLC, the Company&#x2019;s sponsor, shall cause &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.045&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per outstanding share of the Company&#x2019;s Class A Common Stock, or approximately &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$122,920&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, to be deposited in the Trust Account. As of March 31, 2023, the Company has executed &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;five&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one-month&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; extensions, out of the &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;nine&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, resulting in deposits of approximately &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$614,600&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; into the Trust Account.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;In connection with the proposed Business Combination with the Target, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Stock upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the proposed Business Combination with the Target is not consummated, in connection with an alternative proposed initial business combination, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$5,000,001&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;8,768,456&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.42&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share, for an aggregate of approximately &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$91.4&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; million. Following the payment of the redemptions, the Trust Account had a balance of approximately &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$28.5&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Based on the above, the Company will have until August 11, 2023 to consummate a Business Combination. If the Company is unable to complete a Business Combination on August 11, 2023 at the election of the Company subject to satisfaction of certain conditions, including the deposit of up &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$2,300,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; since the underwriters&#x2019; over-allotment option is exercised in full (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.10&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per unit), into the Trust Account, or as extended by the Company&#x2019;s stockholders in accordance with the Company&#x2019;s amended and restated certificate of incorporation) (the &#x201c;Combination Period&#x201d;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$100,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#x2019;s &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the shares of Class A Common Stock and the warrants that are included as components of the Private Placement Units. Such warrants will expire worthless if the Company fails to complete a Business Combination within the Combination Period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.20&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.20&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#x2019;s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company&#x2019;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Going Concern, Liquidity and Capital Resources&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;As of March 31, 2023 and December 31, 2022, the Company had cash held outside of the Trust Account of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10,108&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and $&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;30,870&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial business combination. As of March 31, 2023 and December 31,2022, the Company had working capital deficit of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$2,326,648 &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$1,945,267&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company&#x2019;s liquidity needs prior to the consummation of its IPO were satisfied through the proceeds of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$25,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; from the sale of the Founder Shares and proceed from the promissory note from sponsor of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$78,925&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, which was repaid upon closure of the IPO. Subsequent to the IPO, the Company&#x2019;s liquidity will be satisfied through a portion of the net proceeds from IPO held outside of the Trust Account.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;As of March 31, 2023 and December 31, 2022, we had investments of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$29,725,574&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$29,029,416&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; held in the Trust Account, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes. For the three months ended March 31, 2023, we did not withdraw any of interest earned on the Trust Account. During the period ended December 31, 2022, we withdraw &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$299,601&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; interest earned on the Trust Account to pay Delaware Franchise Tax. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed. The Company will have until August 23, 2023 to consummate a Business Combination. If our initial business combination is not consummated by &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;August 23, 2023, less than one year after the date the financial statements are issued, then our existence will terminate, and we will distribute all amounts in the trust account. The Company intends to complete a business combination before the liquidation date and no adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after such date. There can be no assurance that the Company will be able to consummate an initial business combination by August 23, 2023 and/or have sufficient working capital and borrowing capacity to meet its needs. Based upon the above analysis, management determined that these conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Accounts to repay such loaned amounts but no proceeds from our Trust Accounts would be used for such repayment. Up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$1,500,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of such loans may be convertible into units identical to the Placement Units, at a price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per unit at the option of the lender.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;IR Act&#x201d;) was signed into law. The IR Act provides for, among other measures, a new 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom the shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased. For purposes of calculating the excise tax, however, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#x201c;Treasury Department&#x201d;) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Any redemption or other repurchase effected by us that occurs after December 31, 2022, in connection with a Business Combination or otherwise, may be subject to this excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the nature and amount of any PIPE financing or other equity issuances in connection with the Business Combination (or any other equity issuances within the same taxable year of the Business Combination) and (iii) the content of any regulations and other guidance issued by the Treasury Department and/or the Internal Revenue Service. In addition, because the excise tax would be payable by us and not by the redeeming holder, it could cause a reduction in the value of our stock. The foregoing could cause a reduction in the cash available on hand to complete a business Combination in the required time and redeem &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;100%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of our public shares in accordance with our amended and restated certificate of incorporation) could be subject to the excise tax, in which case the amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.&lt;/span&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <dkdcu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
      contextRef="Duration_2_8_2021_To_2_8_2021_v79xWrSU2E2fOfIAgN6zrQ"
      decimals="INF"
      id="Narr_m_9SprT5mECuLy0YjwxRqQ"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">1</dkdcu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum>
    <dkdcu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ"
      decimals="INF"
      id="Narr_8lHByssoi0mEGyKP5OcowQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</dkdcu:UnitsIssuedDuringPeriodSharesNewIssues>
    <dkdcu:ProceedsFromSaleOfUnits
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ"
      decimals="0"
      id="Narr_uJtSc1X9zEKqB-eB_QMQuw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">115000000</dkdcu:ProceedsFromSaleOfUnits>
    <dkdcu:NumberOfWarrantsIssued
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg"
      decimals="INF"
      id="Narr_tABF-dmeVkiyaGtbubc-lg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</dkdcu:NumberOfWarrantsIssued>
    <dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_D81xSwKtWUK5pM73JnCYwA"
      decimals="2"
      id="Narr_u0zWzpBV9EGoKOLWMQLIoA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg"
      decimals="0"
      id="Narr_wmHQkh5y_0GQzufhuW3cCg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5852750</us-gaap:ProceedsFromIssuanceOfWarrants>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_5_11_2021_To_5_11_2021_NmXExQZglUSAztqWU0QU3w"
      decimals="0"
      id="Narr_Ror1kOiz10GuXDjEMke_WA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg"
      decimals="2"
      id="Narr_QpdQ9UBuGk-ab2g7OpHNPg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SharesIssuedPricePerShare>
    <dkdcu:TransactionCosts
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw"
      decimals="0"
      id="Narr_vf_hMcc25k2RI2d3LMPNTA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">6771112</dkdcu:TransactionCosts>
    <dkdcu:SaleOfStockUnderwritingFees
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw"
      decimals="0"
      id="Narr_KAHZ_ilQ_ESqZEpOWI6B-Q"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2300000</dkdcu:SaleOfStockUnderwritingFees>
    <dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw"
      decimals="0"
      id="Narr_H0G3qZ4PBEKKl5XPBt4AIw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.>
    <dkdcu:SaleOfStockOtherOfferingCosts
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw"
      decimals="0"
      id="Narr_Xa8e_7aE4kOgicRq9kkCgA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">446112</dkdcu:SaleOfStockOtherOfferingCosts>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_C9XJ_5SJYkeABnyRWrMZ9w"
      decimals="0"
      id="Narr_JaySfmnHmkO9FJH9elkSfg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">959560</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:Cash
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw"
      decimals="0"
      id="Narr_RaEG9UDGRUGWS3olkkUHSg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">10108</us-gaap:Cash>
    <dkdcu:WorkingCapitalDeficit
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_jf1hrEpciU-4FMfvMYO6JQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2326648</dkdcu:WorkingCapitalDeficit>
    <dkdcu:ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="2"
      id="Narr_guZxS1OltUavgW__zZSAbA"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.80</dkdcu:ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount>
    <dkdcu:ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="2"
      id="Narr_67SHys486EiCwM2r3dcLlQ"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.50</dkdcu:ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination>
    <dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA"
      decimals="INF"
      id="Narr_PRACNMXpjkGdmYKKlUrEnA"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">2</dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA"
      id="Narr_lTbclWfaWky18zKDYENEEg">P3M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA"
      decimals="INF"
      id="Narr_kTw6EvwyzUyWOXI8bOIjYg"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">2</dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA"
      id="Narr_8DgAK-nZ-EGY188kvf-N-A">P3M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      decimals="INF"
      id="Narr_gajh3oUhKUamVnWnHovbNQ"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">9</dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      id="Narr_i--tghQml0y1qPf3Y3lQQg">P1M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount
      contextRef="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_S7Yu6E8CZU-ri3x6GhOt_A"
      decimals="3"
      id="Narr_DnyaJGje7kCx0Yt86Mb6wA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.045</dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount>
    <dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      decimals="0"
      id="Narr_XiTkHm9srE6EsrtKJo1ANw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">122920</dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension>
    <dkdcu:NumberOfOneMonthExtensionsExecuted
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Narr_ydYeLziJtk-hHCd63x5Odw"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">5</dkdcu:NumberOfOneMonthExtensionsExecuted>
    <dkdcu:ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_vcUEw5FSekq9QsZZi604Gg">P1M</dkdcu:ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination>
    <dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="INF"
      id="Narr_wtw9Zzj88UWy34yzWDgT2Q"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">9</dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="INF"
      id="Narr_epi1RrA40E2xrVlLp0kUxg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">614600</dkdcu:AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions>
    <dkdcu:MinimumNetTangibleAssetUponConsummationOfBusinessCombination
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_BmilkgGuLE-rkc3iIK0S_Q"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5000001</dkdcu:MinimumNetTangibleAssetUponConsummationOfBusinessCombination>
    <dkdcu:CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      decimals="INF"
      id="Narr_L_mUhTJbf02m-fRf0F5z8A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8768456</dkdcu:CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g"
      decimals="2"
      id="Narr_zcmm8ZqFekK-6WDpfV7XMw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.42</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g"
      decimals="-5"
      id="Narr_PBU5lVXlk02H0o_g1qEUQA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">91400000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:AssetsHeldInTrust
      contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g"
      decimals="-5"
      id="Narr_Qc0a40hkyEuYN7gjeJg9qg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">28500000</us-gaap:AssetsHeldInTrust>
    <dkdcu:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_Cfp-j1jKfkKwbJQkm0sqsA"
      decimals="0"
      id="Narr_cFac52VTXE2Wj-m7Ld_EGQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2300000</dkdcu:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_Cfp-j1jKfkKwbJQkm0sqsA"
      decimals="2"
      id="Narr_bLF2mp6ankSpHevvmvUs6g"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.10</us-gaap:SharesIssuedPricePerShare>
    <dkdcu:MaximumNetInterestToPayDissolutionExpenses
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Narr_rPDunkUQPEmrUI_T5Kr_uA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">100000</dkdcu:MaximumNetInterestToPayDissolutionExpenses>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_GnqikDd1dEKIUi2-3BphUw"
      decimals="2"
      id="Narr_aW_BWTfQF0mtQBlsdr1PCw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharePrice
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="2"
      id="Narr_vg1VwnqTEEWqnRazLisXEw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.20</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="2"
      id="Narr_Y9saIerki0Wz7UfmGn2jDg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.20</us-gaap:SharePrice>
    <dkdcu:CashHeldOutsideInTrustAccount
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_BJ3DnDm8TkeSfCvmAEl7yw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">10108</dkdcu:CashHeldOutsideInTrustAccount>
    <dkdcu:CashHeldOutsideInTrustAccount
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_FnV-Y_OAtkmuvRST-K706g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</dkdcu:CashHeldOutsideInTrustAccount>
    <dkdcu:WorkingCapitalDeficit
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_Pn2EJ29ZL02meVIHbiNUAQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2326648</dkdcu:WorkingCapitalDeficit>
    <dkdcu:WorkingCapitalDeficit
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_piGUOOehSEOOWoMZkUHW6g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-1945267</dkdcu:WorkingCapitalDeficit>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_3CzSjuwSC0Si51Ps-EQeBw"
      decimals="0"
      id="Narr_rzT9mqj9hEyFe09066Uvhg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_q8AQnXCt_EmVrk6I872x0w"
      decimals="0"
      id="Narr_ElAsSvaE6k-kWqQCFaYHdg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">78925</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_IElnOJruS0S4v6zfo7Lt2Q"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29725574</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_KdcIJskPJUWKHnbe-BoNUA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Narr_jvTG3B1YhUiLbefBiZDQ8Q"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">299601</dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount>
    <us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Narr_tcMc55tqSUy6FD4DpET6Yw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1500000</us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="2"
      id="Narr_OTvEBXgTD0aaSwdtJHHIPQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <dkdcu:PercentageOfPublicSharesToBeRedeemed.
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="2"
      id="Narr_iI4QKgVYWEWqMjlrP45ODQ"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">1</dkdcu:PercentageOfPublicSharesToBeRedeemed.>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_2YicMT5uLEWIw6u8C06rdA">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Basis of presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Emerging growth company&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Use of estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10,108&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$30,870&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; in cash and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;no&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; cash equivalents as of March 31, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Trust Account&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Upon the closing of the Initial Public Offering and the Private Placement, &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$117,300,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#x201c;Trust Account&#x201d;) located in the United States with Continental Stock Transfer &amp;amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#x201c;Investment Company Act&#x201d;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Offering Costs Associated with the Initial Public Offering&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#x2019; equity upon the completion of the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Class A Common Stock Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#x2019; equity. The Company&#x2019;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events.&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; Accordingly, as of March 31, 2023, there were &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;3,316,819&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock outstanding, excluding &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;2,731,544&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock are subject to possible redemption.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On March 31, 2023, there are &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;585,275&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;4,838,792&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock outstanding, which are subject to possible redemption.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;As of March 31, 2023 and 2022, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Three&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Months Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock &#x2013; &lt;/b&gt;Opening Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 28,750,110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Plus:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;  &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Re-measurement of carrying value to redemption value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 583,570&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock - &lt;/b&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29,333,680&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Net income (loss) per share&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#x201c;Placement Warrants&#x201d;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net income (loss) between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;12,085,275&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of common stock in the aggregate.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The following table reflects the calculation of basic and diluted net income (loss) per common share:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Three Months Ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Redeemable Class A common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income (loss) allocable to common stock subject to possible redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (54,958)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,687,692&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"&gt;&lt;span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; 4,838,792&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,500,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income (loss) per redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.01)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-redeemable Class A and Class B common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income (loss) allocable to common stock not subject to redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (31,025)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 507,816&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of non-redeemable common shares &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"&gt;&lt;span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; 2,731,544&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,460,275&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income (loss) per non-redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.01)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Concentration of credit risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At March 31, 2023 and 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Fair value of financial instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Derivative Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Income Taxes &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company complies with the accounting and reporting requirements of ASC Topic 740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the United States is the Company&#x2019;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;no&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; unrecognized tax benefits and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;no&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; amounts accrued for interest and penalties &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;as of March 31, 2023 and 2022, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Our effective tax rate was &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;(225.88%)&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;0%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; for the three months ended March 31, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;21%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; for the three months ended March 31, 2023 and 2022, due to transaction costs and the valuation allowance on the deferred tax assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &#x201c;Debt &#x2014; Debt with Conversion and Other Options&#x201d; (Subtopic 470-20) and &#x201c;Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity&#x201d; (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within those fiscal years.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_U_v_ZoFRsU6v9G6EOvUWQA">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Basis of presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_9FHENoiLP0ibnVssHj1gsQ">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <dkdcu:EmergingGrowthCompanyPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_rDZb14pOmk27qNKRlKF_XQ">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Emerging growth company&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;</dkdcu:EmergingGrowthCompanyPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_bpBCB3tNF0GClCVtJ32WcQ">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Use of estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_OXRlmbl5r0ml1TgPRSzeHw">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10,108&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$30,870&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; in cash and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;no&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; cash equivalents as of March 31, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_zykdW-W9IkiRXgrwqmLG_w"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">10108</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_TbugI8XLg0Ocb0KHDmiTyA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_orxXGH17B0-lXHJEAtAQSA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_i4lla8oStEe4K8ThFOXI6g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:CashEquivalentsAtCarryingValue>
    <dkdcu:AssetsHeldInTrustAccountPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_D4L2l9BiD0udu4d7OcD2Ig">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Trust Account&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Upon the closing of the Initial Public Offering and the Private Placement, &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$117,300,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#x201c;Trust Account&#x201d;) located in the United States with Continental Stock Transfer &amp;amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#x201c;Investment Company Act&#x201d;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.&lt;/span&gt;&lt;/p&gt;</dkdcu:AssetsHeldInTrustAccountPolicyPolicyTextBlock>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_5_11_2021_To_5_11_2021_NmXExQZglUSAztqWU0QU3w"
      decimals="0"
      id="Narr_v7heVJWJYEGu_bcoM2MuBg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg"
      decimals="2"
      id="Narr_fb1Dl4_cvUeiHd7t1-fG3w"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_BmlEAvdVt0a9GFD3AApgdg">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Offering Costs Associated with the Initial Public Offering&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#x2019; equity upon the completion of the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <dkdcu:TemporaryEquityPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Group_yhrTbBWKOkWeeAS5_glvyA">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Class A Common Stock Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#x2019; equity. The Company&#x2019;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events.&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; Accordingly, as of March 31, 2023, there were &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;3,316,819&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock outstanding, excluding &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;2,731,544&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock are subject to possible redemption.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On March 31, 2023, there are &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;585,275&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;4,838,792&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock outstanding, which are subject to possible redemption.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;As of March 31, 2023 and 2022, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Three&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Months Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock &#x2013; &lt;/b&gt;Opening Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 28,750,110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Plus:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;  &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Re-measurement of carrying value to redemption value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 583,570&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock - &lt;/b&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29,333,680&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dkdcu:TemporaryEquityPolicyPolicyTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA"
      decimals="INF"
      id="Narr_cOTdt3PUa0WDE3rWjvoZtA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3316819</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w"
      decimals="INF"
      id="Narr_o7l_WPT6NEC9VpKZrTtWEA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_hVTGu_0FbEy6zhs2-ZgI-g"
      decimals="INF"
      id="Narr_mdrn_LXYdUiNWa_2mj26Ig"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w"
      decimals="INF"
      id="Narr_fZfPUHrGL0ynP8qvs-yiKQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4838792</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_ZqiR4o5I5EKTGPKwxSbcqA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Three&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Months Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock &#x2013; &lt;/b&gt;Opening Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 28,750,110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Plus:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;  &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Re-measurement of carrying value to redemption value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 583,570&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock - &lt;/b&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29,333,680&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ"
      decimals="0"
      id="Tc_x8noT7HZ8Ea8eJawCxiguQ_5_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">28750110</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ"
      decimals="0"
      id="Tc_3enq_4DgOEaXJn81x6Td1w_5_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="0"
      id="Tc_TB_nSYwuvkiGyG3PJ5jamg_7_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">583570</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="0"
      id="Tc_9QWE8CqyxEeR1SOkrfWpKw_7_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_FyUQPN4qe0OMnvM3JWkCvg"
      decimals="0"
      id="Tc_9sT6cpi0qE-E1p5DCnZ39Q_8_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29333680</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_OkbsNvrK3EiK9N0XIQ24yA"
      decimals="0"
      id="Tc_5msqLNiWGUCfYw3A2apaHQ_8_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_4iXzCCIpqUqQT1mLzDafFA">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Net income (loss) per share&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#x201c;Placement Warrants&#x201d;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net income (loss) between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;12,085,275&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of common stock in the aggregate.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The following table reflects the calculation of basic and diluted net income (loss) per common share:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Three Months Ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Redeemable Class A common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income (loss) allocable to common stock subject to possible redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (54,958)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,687,692&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"&gt;&lt;span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; 4,838,792&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,500,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income (loss) per redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.01)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-redeemable Class A and Class B common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income (loss) allocable to common stock not subject to redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (31,025)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 507,816&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of non-redeemable common shares &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"&gt;&lt;span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; 2,731,544&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,460,275&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income (loss) per non-redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.01)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <dkdcu:WarrantExercisable
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="INF"
      id="Narr_MVbGu3SNG0yaamCYA1A4Qw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:WarrantExercisable>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_0xOQiY3GskqY6yidCJuYjw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Three Months Ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Redeemable Class A common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income (loss) allocable to common stock subject to possible redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (54,958)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,687,692&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_3Oegvze3iUamAXcK8gfz6g;"&gt;&lt;span style="-sec-ix-hidden:Hidden_Oqe_7WZuDk-uJW7b2n_V9Q;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; 4,838,792&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,500,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income (loss) per redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.01)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-redeemable Class A and Class B common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income (loss) allocable to common stock not subject to redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (31,025)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 507,816&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of non-redeemable common shares &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_TC2XcqvAn0uRRhHRnkeSow;"&gt;&lt;span style="-sec-ix-hidden:Hidden_f4QAOOmuLkO_Ioc9BVVxwg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; 2,731,544&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,460,275&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income (loss) per non-redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.01)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="0"
      id="Tc_uSz1gBOQhUCZPBdUGGDuOA_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-54958</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="0"
      id="Tc_iyzxHTksMkWaeqzYPzTijw_6_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1687692</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="0"
      id="Tc_jt4E-ST-gkCSIXu_ndXVzg_8_6"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="INF"
      id="Tc_jt4E-ST-gkCSIXu_ndXVzg_8_6_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="2"
      id="Tc_CDGcuiBnnkymsuW5u8gYJA_9_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_CtECTfZ4J0-ejF09dxE73A"
      decimals="2"
      id="Tc_CDGcuiBnnkymsuW5u8gYJA_9_3_2"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="2"
      id="Tc_etoGQPBR9kWBZyuBtAsjBg_9_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_4dlRUw2VK0yaNZADJl7TGw"
      decimals="2"
      id="Tc_etoGQPBR9kWBZyuBtAsjBg_9_6_2"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"
      decimals="0"
      id="Tc_qUUWJeJQ3EyAiwS2nD90Pw_13_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-31025</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"
      decimals="0"
      id="Tc_I_nky-jpQEegLeFkJlmVqQ_13_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">507816</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"
      decimals="0"
      id="Tc_7wj1HLYCqEeOB5byl6qJaw_15_6"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3460275</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"
      decimals="0"
      id="Tc_7wj1HLYCqEeOB5byl6qJaw_15_6_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3460275</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"
      decimals="2"
      id="Tc_qnOsdnjebES_TrbZXM8-iw_16_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_OKjco9zT40GsrY-Qa--IOg"
      decimals="2"
      id="Tc_qnOsdnjebES_TrbZXM8-iw_16_3_2"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"
      decimals="2"
      id="Tc_xASg6hKpxUSSOGNOwz7xjg_16_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_R6RQUuHvUUmBQQgXnyeBSQ"
      decimals="2"
      id="Tc_xASg6hKpxUSSOGNOwz7xjg_16_6_2"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_r5Igr6sroEuilSyZANnCzQ">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Concentration of credit risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At March 31, 2023 and 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_YIzHszrorEyCVtVBkbDQ4w">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Fair value of financial instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <dkdcu:DerivativeFinancialInstrumentsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_hv2OFglg8EmqFQrEv_x8Yw">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Derivative Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.&lt;/span&gt;&lt;/p&gt;</dkdcu:DerivativeFinancialInstrumentsPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_Qez7QJkZ50SkuT0Fu8AIxw">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Income Taxes &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company complies with the accounting and reporting requirements of ASC Topic 740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the United States is the Company&#x2019;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;no&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; unrecognized tax benefits and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;no&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; amounts accrued for interest and penalties &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;as of March 31, 2023 and 2022, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Our effective tax rate was &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;(225.88%)&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;0%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; for the three months ended March 31, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;21%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; for the three months ended March 31, 2023 and 2022, due to transaction costs and the valuation allowance on the deferred tax assets.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw"
      decimals="0"
      id="Narr_I2d3r-ynM0Cl9r28SUIvzg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_LZpG7WrMjki4bz2V2pIWPg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="As_Of_3_31_2022_HJ_3MZeDg0aE3Ds-w-CCdw"
      decimals="0"
      id="Narr_XljdfjTZR0-h52uO4jLSbg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_ez8G0ImBv0ODksKCNw5LmQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="4"
      id="Narr_EC_xFfGhKUe3iib63Vi-9g"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">-2.2588</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="Duration_1_1_2022_To_3_31_2022_DIbB2OlACkWAW5iA5QCxCw"
      decimals="4"
      id="Narr_TwHLx9HitUGR9G7_Pzj4VQ"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2022_To_3_31_2023_95dncZH7m0qh7lCm80ElQQ"
      decimals="INF"
      id="Narr_lTKF1i5WbUK0_tzl39vSjA"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_j_ZSZ3QWRkCEeYtYvYfdkQ">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &#x201c;Debt &#x2014; Debt with Conversion and Other Options&#x201d; (Subtopic 470-20) and &#x201c;Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity&#x201d; (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within those fiscal years.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <dkdcu:InitialPublicOfferingDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_Gj_KkWriWUGW41GcjHXPwA">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 3. INITIAL PUBLIC OFFERING&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Pursuant to the Initial Public Offering, the Company sold &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;11,500,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; Units at a purchase price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per Unit. Each Unit consists of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; share of the Company&#x2019;s Class A Common Stock, &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.0001&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; par value, and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; redeemable warrant (&#x201c;Public Warrant&#x201d;). Each Public Warrant entitles the holder to purchase &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; share of Class A Common Stock at an exercise price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$11.50&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;&#160;per whole share (see Note&#160;9).&lt;/span&gt;&lt;/p&gt;</dkdcu:InitialPublicOfferingDisclosureTextBlock>
    <dkdcu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ"
      decimals="INF"
      id="Narr_GoAOXUaqi0GldBA65yTdgQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</dkdcu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_fctU6QHKQEOu595qEl978g"
      decimals="2"
      id="Narr_eB3jg7dLZUy1knOl0fcCPQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SharesIssuedPricePerShare>
    <dkdcu:NumberOfSharesIssuedPerUnit
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_y47mRrlmNUqJZIDNSj342g"
      decimals="INF"
      id="Narr_DiCrFsE9R0KGnBPidD1wGA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1</dkdcu:NumberOfSharesIssuedPerUnit>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g"
      decimals="INF"
      id="Narr_sZt_rwB1jU6Hd66CQV3JCw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:NumberOfWarrantsIssuedPerUnit
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_Zz-LC321iEOx0QXt64XTUw"
      decimals="INF"
      id="Narr_yYd-YRzu1U-aXpm90W_coQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1</dkdcu:NumberOfWarrantsIssuedPerUnit>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g"
      decimals="INF"
      id="Narr_1AlXl3yW7ECXplBChafC4Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="As_Of_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_3SQJIMIvWUS9ELj-b17duQ"
      decimals="2"
      id="Narr_3VnTsoXNuE2WwCBcp7vWaQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <dkdcu:PrivatePlacementTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_aZ6cs-hIkkSyq9gurkc1sg">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 4. PRIVATE PLACEMENT&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;585,275&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; Private Placement Units at a price of $&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per Private Placement Unit for an aggregate purchase price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$5,852,750&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Private Placement Units are identical to the Units, except that (a) the Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of the Company&#x2019;s initial business combination except to permitted transferees and (b) the Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) may be exercised by the holders on a cashless basis and (ii) will be entitled to registration rights.&lt;/span&gt;&lt;/p&gt;</dkdcu:PrivatePlacementTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_BCoSdhDn8kSOYrKHJDYXHw"
      decimals="INF"
      id="Narr_GiY_e7eIwU-hJL_yoGIWiQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="As_Of_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_BCoSdhDn8kSOYrKHJDYXHw"
      decimals="2"
      id="Narr_Pm5wubpzx0mUFmy8lHzFGA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_9p3Am8C7MEOlbQrXnk_2cg"
      decimals="0"
      id="Narr_P77Nsqz4q0aLfm8SL-ieLA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5852750</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_7rwS5Y0HLEaNnqCwbwvmPA">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 5. RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Introducing Advisor Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On June 26, 2021, the Company entered into an introducing advisor agreement (the &#x201c;Introducing Advisor Agreement&#x201d;) with ARC Group Limited, the Company&#x2019;s financial advisor (&#x201c;ARC&#x201d;), pursuant to which ARC will make strategic introductions to the Company of potential target companies and/or their subsidiaries, affiliates, or representatives (each an &#x201c;Advisor Target&#x201d;) who may be interested in potential business combinations with the Company. In consideration for ARC&#x2019;s services under the Introducing Advisor Agreement, we agreed to (i) pay to ARC (a) a retainer of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$50,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; upon execution of the Introducing Advisor Agreement and (b) a success fee of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$100,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; upon the closing our initial business combination, and (ii) cause to be issued to ARC equity interests in the post-combination company representing a five-percent (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;5%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;) ownership interest in the post-combination company, if at any time prior to June 25, 2022 (the &#x201c;Termination Date&#x201d;), or within six (&lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_-gBu7Ivd10mlotw_rZDvrw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;) months after the consummation of an initial business combination or any financing with any Advisor Target or any affiliate of an Advisor Target (the &#x201c;Equity Issuance&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;5%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;) on any PIPE &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;that was brought by ARC in connection with the Company&#x2019;s initial business combination upon the closing of the Company&#x2019;s initial business combination.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;1,378,517&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of the Company&#x2019;s Class B Common Stock, up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;143,766&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On February 25, 2021, the Company issued an aggregate of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;2,875,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class B Common Stock (the &#x201c;Founder Shares&#x201d;) to the Sponsor for an aggregate purchase price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$25,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;. On February 25, 2021, the Sponsor transferred &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;15,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares to the Company&#x2019;s Chief Executive Officer, &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;15,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares to the Company&#x2019;s Chief Financial Officer and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;5,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares to two of the Company&#x2019;s independent directors. Following the determination of the Company&#x2019;s third independent director, on March 23, 2021, the Sponsor transferred &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;5,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares to such independent director. The Founder Shares which the Sponsor and its permitted transferees will collectively own, on an as-converted basis, represent &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;20%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of the Company&#x2019;s issued and outstanding shares after the Initial Public Offering. In connection with the Introducing Advisors Agreement, on December 31, 2022, ARC was granted &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;1,378,517&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class B common stock, &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.0001&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; par value per share, up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;143,766&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of which are subject to forfeiture by ARC if the Company&#x2019;s public shareholders exercise redemption rights with respect to any of outstanding shares of Class A common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;six months&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company&#x2019;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company&#x2019;s Class A Common Stock equals or exceeds &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$12.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;20&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; trading&#160;days within any &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;30-&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;trading day period commencing at least &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;150 days&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; after the Business Combination, the Founder Shares will be released from the lock-up.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Promissory Note&#160;&#x2014; Related Party&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On February 8, 2021, the Sponsor committed to loan the Company an aggregate of up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$300,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#x201c;Note&#x201d;). The Note was non-interest bearing and was payable on the earlier of July 31, 2021 or the completion of the Initial Public Offering. On June 1, 2021, the &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$78,925&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; outstanding under the promissory note was repaid in full. On March 31, 2023 and December 31, 2022, there is &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;no&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; amount outstanding under the promissory note.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;In order to finance transaction costs in connection with a Business Combination, the Company&#x2019;s Sponsor, an affiliate of the Sponsor, or the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the &#x201c;Working Capital Loans&#x201d;). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$1,500,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of notes may be converted upon consummation of a Business Combination into units at a price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per unit. The Units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On March 31, 2023 and December 31, 2022, there is &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$239,081&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$207,081&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; outstanding under the Working Capital Loans, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company&#x2019;s second amended and restated certificate of incorporation provides that, if the Company anticipates that it may not be able to consummate a Business Combination within &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;12 months&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; from the closing of the Company&#x2019;s initial public offering, the Company may, by resolution of the Company&#x2019;s board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;two&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; times, each by an additional &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;three months&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; (for a total of up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;18 months&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account as set out below. Pursuant to the terms of the &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Company&#x2019;s second amended and restated certificate of incorporation and the trust agreement entered into between the Company and Continental Stock Transfer &amp;amp; Trust Company, in order for the time available for the Company to consummate the initial Business Combination to be extended, the Sponsor or its affiliates or designees, upon &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;five&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; business days advance notice prior to the applicable deadline, must deposit into the Trust Account &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$1,150,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; since the underwriters&#x2019; over-allotment option is exercised in full (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.10&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per unit), on or prior to the date of the applicable deadline, for each of the available &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;three month&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; extensions, providing a total possible Business Combination period of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;18 months&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; at a total payment value of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$2,300,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; since the underwriters&#x2019; over-allotment option is exercised in full (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.10&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per unit) (the &#x201c;Extension Loans&#x201d;). Any such payments would be made in the form of non-interest-bearing loans. If the Company completes its initial Business Combination, the Company will, at the option of the Sponsor, repay the Extension Loans out of the proceeds of the Trust Account released to the Company or convert a portion or all of the total loan amount into units at a price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;&#160;per unit, which units will be identical to the Private Placement Units. If the Company does not complete a Business Combination, the Company will repay such loans only from funds held outside of the Trust Account. Furthermore, the letter agreement among the Company and the Company&#x2019;s officers, directors, and the Sponsor contains a provision pursuant to which the Sponsor will agree to waive its right to be repaid for such loans to the extent there is insufficient funds held outside of the Trust Account in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination. The public stockholders will not be afforded an opportunity to vote on the extension of time to consummate an initial Business Combination from &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;12 months&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;18 months&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; described above or redeem their shares in connection with such extensions. Pursuant to the foregoing, on May 5, 2022, the Company extended the date by which the Company had to consummate a business combination from May 11, 2022 to August 11, 2022. On August 10, 2022, the Company extended the date by which the Company had to consummate a business combination from August 11, 2022 to November 11, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;As described in Note 1, on November 11, 2022, the Stockholders of the Company approved the Extension Amendment and the Trust Amendment to allow the Company to extend the deadline by which it must complete its initial business combination by up to nine &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one-month&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; periods from November 11, 2022. In connection with each such extension, Data Knights, LLC, the Company&#x2019;s sponsor, caused &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.045&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per outstanding share of the Company&#x2019;s Class A Common Stock, or approximately &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$122,920&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, deposited in the Trust Account in connection with the exercise of the monthly extension. In connection with each such extension, the Company will have until April 11, 2023 to consummate a Business Combination(see Note 11). On March 31, 2023 and December 31, 2022, there is &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$2,914,598&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$2,545,838&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; outstanding under the Extension Loan, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Administrative Services Arrangement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Commencing on the date of the prospectus and until completion of the Company&#x2019;s Business Combination or liquidation, the Company may reimburse ARC Group Ltd., an affiliate of the Sponsor, up to an amount of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per month for office space, secretarial and administrative support. For the three months ended March 31, 2023 and 2022, we have incurred &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$30,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; in fees under this agreement, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <dkdcu:RetainerFeeUponExecutionOfAgreement
      contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q"
      decimals="0"
      id="Narr_hHk_4BRMBE-3KDM6TJ_n4A"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">50000</dkdcu:RetainerFeeUponExecutionOfAgreement>
    <dkdcu:SuccessFeeUponClosingOfInitialBusinessCombination
      contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q"
      decimals="0"
      id="Narr_2pEKpDN_ykWPEDjBzTpAsg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">100000</dkdcu:SuccessFeeUponClosingOfInitialBusinessCombination>
    <dkdcu:PercentageOfOwnershipAsConsiderationForService
      contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q"
      decimals="2"
      id="Narr_eUNDVAl2jEmX_odjgwWdrw"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.05</dkdcu:PercentageOfOwnershipAsConsiderationForService>
    <dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing
      contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_6BKMWuaDzEmPd9vqRg5_Nw"
      decimals="2"
      id="Narr_B2U9d-5duUSXmZBAZSgfOQ"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.05</dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ"
      decimals="INF"
      id="Narr_DbPO6wJFG0miuXZLNaYvBg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1378517</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ"
      decimals="INF"
      id="Narr_sQvbQ2U9x0yHCiuxuZtCPQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">143766</dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw"
      decimals="INF"
      id="Narr_R_BRyHuFHEGSYLA18M9u6Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw"
      decimals="0"
      id="Narr_d3p9KIVWdUuoPJGGARqK0A"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember__hwYxA9DEkqAKdAwnBpc_w"
      decimals="INF"
      id="Narr_XIkFpV7x-UelbjdtCvwpPA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">15000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefFinancialOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6znbrCXxFkGIcYmCY0iT1Q"
      decimals="INF"
      id="Narr__AmFIwgXEkKZgZfKN_4Vvw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">15000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_TwoIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_4pqzZtHe2EG3qyNAxfbe9A"
      decimals="INF"
      id="Narr_kCwRjMLQ9E62mcX6GgXj0g"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">5000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_3_23_2021_To_3_23_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ThirdIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6T3pPliyHUS0duvs0F4HAw"
      decimals="INF"
      id="Narr_1-7VIRaVVU2guxZUeZDr_g"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">5000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw"
      decimals="2"
      id="Narr_Pi4mkjnwV0W1dUfRmTK1JQ"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.20</dkdcu:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders>
    <dkdcu:ExtensionLoansNonCurrent
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_IhW2rhKKn0qo7A0xhD9s0w"
      decimals="INF"
      id="Narr_J56PJgAycU2ZZLyBw_GWig"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1378517</dkdcu:ExtensionLoansNonCurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_IhW2rhKKn0qo7A0xhD9s0w"
      decimals="INF"
      id="Narr_ZRuG4HBsIUSvrW11U-G1lA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ"
      decimals="INF"
      id="Narr_kqUI5-G-C0OtlK9s-s8S-A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">143766</dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights>
    <dkdcu:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw"
      id="Narr_knboR-y4_E-ttCtdzsKr1A">P6M</dkdcu:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion>
    <dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw"
      decimals="2"
      id="Narr_V_vRXZ2cBEuUBs3QTnn4hQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">12.00</dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw"
      decimals="INF"
      id="Narr_QhgKmc059UCauYTl586NgQ"
      unitRef="Unit_Standard_D_24WmzP3yxEKX8pNPNSJZgw">20</dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays>
    <dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw"
      decimals="INF"
      id="Narr_rEFNRfk9kkKZb8BefjMqBg"
      unitRef="Unit_Standard_D_24WmzP3yxEKX8pNPNSJZgw">30</dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays>
    <dkdcu:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw"
      id="Narr_03TFcGNrPkCPAGNL42TULQ">P150D</dkdcu:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences>
    <dkdcu:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="As_Of_2_8_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_GfqTmPjOjEe_maJFOaIOog"
      decimals="0"
      id="Narr_9nraSoqBJ0aId_641UDOjA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">300000</dkdcu:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="Duration_6_1_2021_To_6_1_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ylqtNA-bUEmL4qYAA8d_tw"
      decimals="0"
      id="Narr_diY9jlFjwU2Gjzw_83_amQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">78925</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_XNE4PVnPmUe5dsW-sIzGIQ"
      decimals="0"
      id="Narr_evChlAHR1kyJA84fMctrxQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_yldGfAut_UOwpJfZ6m96hA"
      decimals="0"
      id="Narr_2hGoCyE_ZEmsi67nuslfnA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <dkdcu:RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_UkwcjyfyIkKPsh-ZJGYHfQ"
      decimals="0"
      id="Narr_H1OjJo3gZ0m9Drjgsy76Fg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1500000</dkdcu:RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_aJZ8MZKwr0C2EHSlNrQl3w"
      decimals="2"
      id="Narr_yG0x8Ampw0OkmndPu7XuSg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_t_sN0AW8l0ysvEDGgawN6g"
      decimals="INF"
      id="Narr_KUJtHdrUKkeLlw7Cs6PJ6Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">239081</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_QhH0lFLktE2HTU1zggfIyA"
      decimals="0"
      id="Narr_6ZHBtFS0X0qPyvnkoXudkQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">207081</us-gaap:CommonStockSharesOutstanding>
    <dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_f4GL3Qm4IUqhuU1vfIJnFg">P12M</dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination>
    <dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="INF"
      id="Narr_PbNPt_yapkSBHj3BAe6I9g"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">2</dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_rVGz1DSwEEq-KOUxag_OpQ">P3M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:AggregatePeriodToConsummateInitialBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_YQ0KGlguqkixneAHo31r-A">P18M</dkdcu:AggregatePeriodToConsummateInitialBusinessCombination>
    <dkdcu:NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="INF"
      id="Narr_yux4JMy-qUqno3WX7gqVwQ"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">5</dkdcu:NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven>
    <dkdcu:SecuritiesDepositHeldInTrustAccount
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_kF1v8eLYwUqIkingtOoNMA"
      decimals="0"
      id="Narr_HD5yUwVZiE-RSTKuU1Xt9w"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1150000</dkdcu:SecuritiesDepositHeldInTrustAccount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_P6nhobuPVE6L9qTASsfgWA"
      decimals="2"
      id="Narr_o8uhUDzuRk2Jrjr12gVrCw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.10</us-gaap:SaleOfStockPricePerShare>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_cGkdbrLM_k-ZycWOafyRbA">P3M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:AggregatePeriodToConsummateInitialBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_IyKpfzEit0ijDhGQNUl4xw">P18M</dkdcu:AggregatePeriodToConsummateInitialBusinessCombination>
    <dkdcu:BusinessCombinationTotalPayments
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_kF1v8eLYwUqIkingtOoNMA"
      decimals="0"
      id="Narr_xgT4brqN-kWVfXlKBQudbg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2300000</dkdcu:BusinessCombinationTotalPayments>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_P6nhobuPVE6L9qTASsfgWA"
      decimals="2"
      id="Narr_85ULlj3h8U-cBXAqdU2Kdw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_aJZ8MZKwr0C2EHSlNrQl3w"
      decimals="2"
      id="Narr_w6k4PhN0PkCmvn-4f7nMTQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SaleOfStockPricePerShare>
    <dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_CFK4nGkSJEe0kLnRaL6EjA">P12M</dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination>
    <dkdcu:AggregatePeriodToConsummateInitialBusinessCombination
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Narr_YHyZTQZ4_Ua-5Rsx11LQWw">P18M</dkdcu:AggregatePeriodToConsummateInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_wzq3pdLUSk-Hj-g34bsbKA"
      id="Narr_pQTfxQX_KUyciOArSX60_w">P1M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount
      contextRef="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_wzq3pdLUSk-Hj-g34bsbKA"
      decimals="3"
      id="Narr_IsNfwHB8kUy601g_626elA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.045</dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount>
    <dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension
      contextRef="Duration_11_11_2022_To_11_11_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_wzq3pdLUSk-Hj-g34bsbKA"
      decimals="0"
      id="Narr_cgsHplyH50i7HayJZF6IQg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">122920</dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension>
    <dkdcu:ExtensionLoansNonCurrent
      contextRef="As_Of_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_aJZ8MZKwr0C2EHSlNrQl3w"
      decimals="0"
      id="Narr_P5OjVCVLqEOCdCPZzXpnYw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2914598</dkdcu:ExtensionLoansNonCurrent>
    <dkdcu:ExtensionLoansNonCurrent
      contextRef="As_Of_3_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_zKlPVPHq4kWNIVjUBUSy9g"
      decimals="0"
      id="Narr_6VXdtLMUEUSm1ugwTTxW3w"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2545838</dkdcu:ExtensionLoansNonCurrent>
    <dkdcu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_2ZVBDaVZVk2yU4cLdp7-rQ"
      decimals="0"
      id="Narr_PsliPgJ9Lka-a-dGgrhRQQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">10000</dkdcu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_7UFsYW4z006S_tfRUh0Kjw"
      decimals="0"
      id="Narr__AicVxTEO0ijyz8ZJedorw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_6IoH2prt10mKNC-IH_tP6A"
      decimals="0"
      id="Narr_G09xTlH_2ki6W584tPQAWQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_HMPOOhticUawTcAaUlmg6Q">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 6. COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Pursuant to a registration rights agreement entered into on May 6, 2021, the holders of the Founder Shares, Private Placement Units (including the securities contained therein), the units (including the securities contained therein) that may be issued upon conversion of the Working Capital Loans, and any shares of Class A Common Stock issuable upon the exercise of the Placement Warrants and any shares of Class A Common Stock, warrants (and underlying Class A Common Stock) that may be issued upon conversion of the units issued as part of the working capital loans and Class A Common Stock issuable upon conversion of the founder shares are entitled to registration rights. The holders of a majority of these securities are entitled to make up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;three&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Underwriters Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company granted the underwriter a &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;45&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;-day option to purchase up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;1,500,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The aforementioned option was exercised on May 11, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The underwriter was paid a cash underwriting discount of two percent (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;2.00%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;) of the gross proceeds of the Initial Public Offering, or &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$2,300,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;. In addition, the underwriter is entitled to a deferred fee of three and a half percent (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;3.50%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;) of the gross proceeds of the Initial Public Offering, or &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$4,025,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Right of First Refusal&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;For a period beginning on May 7, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;First Amendment to the Introducing Advisor Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;5&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;%) on any PIPE that was brought by ARC in connection with an initial business combination upon the closing of an initial business combination.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;Second Amendment to the Introducing Advisor Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;1,378,517&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of the Company&#x2019;s Class B Common Stock, up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;143,766&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <dkdcu:MaximumNumberOfDemandsForRegistrationOfSecurities
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Narr_s-yOCNOCH0q9czdLoW7fIg"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">3</dkdcu:MaximumNumberOfDemandsForRegistrationOfSecurities>
    <dkdcu:OverAllotmentOptionPeriod
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_9qk3u5ElcEGq6oIpa2IEYQ"
      id="Narr_7l3PQh_ItUWjYJY_jNvg7w">P45D</dkdcu:OverAllotmentOptionPeriod>
    <dkdcu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_9qk3u5ElcEGq6oIpa2IEYQ"
      decimals="INF"
      id="Narr_6dAdKGn5yUu_j-WMhri_wA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1500000</dkdcu:UnitsIssuedDuringPeriodSharesNewIssues>
    <dkdcu:UnderwritingDiscountPercentage
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="4"
      id="Narr_4HDZkRXV3kO86IyYSD0xgw"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0200</dkdcu:UnderwritingDiscountPercentage>
    <dkdcu:UnderwritingDiscountPaid
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Narr_rLz8nRREqEyiYaFUw9Z9qg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2300000</dkdcu:UnderwritingDiscountPaid>
    <dkdcu:DeferredUnderwritingFeesPercentage
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="4"
      id="Narr_shP2kHG-hUu-OimqLWsXGw"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0350</dkdcu:DeferredUnderwritingFeesPercentage>
    <dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="0"
      id="Narr_VvbF9qaNwEihbB_Xfu7Zxw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.>
    <dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing
      contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_C-Ez8Wj92k-wMY601LQlhQ"
      decimals="2"
      id="Narr_HfayEQIsh0aHQ7jD-2BexQ"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.05</dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_uEkHeFxWoUKCxd1wCPJN3g"
      decimals="INF"
      id="Narr_w4pUxgqqNUWtvp4hn2Z0uw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1378517</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_M9ekq6WdLEucW-gPahd0mw"
      decimals="INF"
      id="Narr_EFB6fDxHo0SpTmiuKjoQzA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">143766</dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights>
    <dkdcu:WarrantLiabilityTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_glm-dHpVjk2Uh24z1yPlqg">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 7. WARRANT LIABILITY&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;30 days&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; after the completion of a Business Combination and will expire &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;five years&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; after the completion of a Business Combination or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company has agreed that as soon as practicable, but in no event later than &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_pecVw-7_R0GR-O1MFLS0Dg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants is not effective by the &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_4KOodU4RC02gxRyhNxEksA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;th business day after the closing of the Company&#x2019;s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company&#x2019;s shares of Class A Common Stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Redemption of warrants when the price per Class A Common Stock equals or exceeds &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$18.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;. Once the warrants become exercisable, the Company may redeem the Public Warrants:&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;in whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;at a price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$0.01&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; per Public Warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;upon not less than &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;30 days&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2019; prior written notice of redemption to each warrant holder; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$18.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_wWOk2hbenkiF3eCjIIPW1A;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; trading days within a &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_j3RPZoOibUKp_scxdjJSCw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#x201c;cashless basis,&#x201d; as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Placement Warrants were identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;30 days&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;In addition, if (x) the Company issues additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$9.20&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company&#x2019;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#x201c;Newly Issued Price&#x201d;), (y) the aggregate gross proceeds from such issuances represent more than &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;60%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of the total equity proceeds, and interest thereon, available for the funding of the Company&#x2019;s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#x2019;s common stock during the &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_9B-TMAVHjEWPMjdgpFxpbg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#x201c;Market Value&#x201d;) is below &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$9.20&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;115%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of the higher of the Market Value and the Newly Issued Price, the &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$18.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;180%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of the greater of the Market Value and the Newly Issued Price and the &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$10.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_-WzpzrAyj0OzmcEU8I-ydQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;At March 31, 2022 and December 31, 2022, the Company accounted for the aggregate &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;12,085,275&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; warrants issued in connection with the Initial Public Offering (the &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;11,500,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; Public Warrants and the &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;585,275&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company&#x2019;s statement of operations.&lt;/span&gt;&lt;/p&gt;</dkdcu:WarrantLiabilityTextBlock>
    <dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ"
      id="Narr_GaVrNZDX_kSILRGuEo7ETQ">P30D</dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_6wnVrpWarEuBYWQ4-7W6Ig"
      id="Narr_PVA_5Ze79U6z1Yq44x0N4g">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw"
      decimals="2"
      id="Narr_8wg35HZj6karahb0WX4gPw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">18.00</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <dkdcu:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw"
      decimals="2"
      id="Narr_m2h-J9gK5U-XGwzgEMu7Ew"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.01</dkdcu:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw"
      id="Narr_6KwLP-AtZUu_40hl3Vdg3w">P30D</dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw"
      decimals="2"
      id="Narr_9bBTvnJJ9kWCy11etKm31g"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">18.00</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_nMkmr3IxR0S4Ng7COIUVqw"
      id="Narr_GmDb5xUV6kOfChkAK48ymw">P30D</dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <us-gaap:SharePrice
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_THD-b4ZLeEmrlSnwTQZiEA"
      decimals="2"
      id="Narr_ikxpa1WbKUuSbkoEN3T98g"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">9.20</us-gaap:SharePrice>
    <dkdcu:PercentageOfGrossProceedsOnTotalEquityProceed
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ"
      decimals="2"
      id="Narr_tho6qIBp0UaZxrrUd4mw-A"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.60</dkdcu:PercentageOfGrossProceedsOnTotalEquityProceed>
    <us-gaap:SharePrice
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_6wnVrpWarEuBYWQ4-7W6Ig"
      decimals="2"
      id="Narr_q4S1euaBJk2UbCS2u-xoLw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">9.20</us-gaap:SharePrice>
    <dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ"
      decimals="2"
      id="Narr_xa1wNLDMzkWbiS2PE0_lEw"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">1.15</dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ"
      decimals="2"
      id="Narr_eH08CD25gEK0Ua8LjxMzoA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">18.00</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_g-5Z8iiekEipUKjvBBe-og"
      decimals="2"
      id="Narr_0MdGgQ_lS0WGZ8r9e7B6xg"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">1.80</dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="Duration_1_1_2023_To_3_31_2023_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_g-5Z8iiekEipUKjvBBe-og"
      decimals="2"
      id="Narr_WmbK6QOHREW9B0vQ3D4sdA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6Bac23xTIkSPqevzW_S64Q"
      decimals="INF"
      id="Narr_LproTjpq9U-REDlRUPO_PA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6jC0xt_xPkW3XWSHKmx-Wg"
      decimals="INF"
      id="Narr_iRRBC1ybzUOYQ7svywDC8Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_4ML8uWZTXUm4pUyBvWQiwQ"
      decimals="INF"
      id="Narr_diIvEq3-20mlMWv_eEGTGg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      decimals="INF"
      id="Narr_MOVzISFFMEm8Oo5O-HJejw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_0L55K7OfcUakEf_TMfNGTg"
      decimals="INF"
      id="Narr_Wax-0QQsJ0S4fJunqmh6AQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_fqKCHCXgBkSvo0fCaH9NXQ"
      decimals="INF"
      id="Narr__ghx70nlD0SEEQe6c4AINw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</dkdcu:WarrantsOrRightsIssued>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_MrlXHVPqFUmF4Z5KV3ChhQ">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 8. STOCKHOLDER&#x2019;S EQUITY&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;"&gt;Preferred Shares &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;&#x2014; The Company is authorized to issue &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;1,000,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; preferred shares with a par value of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.0001&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share with such designation, rights and preferences as may be determined from time to time by the Company&#x2019;s Board of Directors. At March 31, 2023 and December 31, 2022, there were &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;no&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; preferred shares issued or &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;outstanding&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;"&gt;Class A Common Stock &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;&#x2014; The Company is authorized to issue &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;100,000,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock with a par value of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.0001&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share. Holders of the Company&#x2019;s Class A Common Stock are entitled to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; vote for each share. At March 31, 2023 and December 31, 2022, there were &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;585,275&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of non-redeemable Class A Common Stock &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;issued&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;outstanding&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;in connection with the private placement (Note 4), excluding &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;2,731,544&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class A Common Stock subject to possible redemption as of March 31, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;"&gt;Class B Common Stock &#x2014; &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company is authorized to issue up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;10,000,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class B Common Stock with a par value of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.0001&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share. Holders of the Company&#x2019;s Class B Common Stock are entitled to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; vote for each share. On February 25, 2021, the Sponsor transferred &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;15,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares to the Company&#x2019;s Chief Executive Officer, &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;15,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares to the Company&#x2019;s Chief Financial Officer and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;5,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares to two of the Company&#x2019;s independent directors. Following the determination of the Company&#x2019;s third independent director, on March 23, 2021, the Sponsor transferred &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;5,000&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares to such independent director.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On December 31, 2022, ARC Group Limited, the Company&#x2019;s Financial Advisor, was granted &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;1,379,517&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class B common stock with a par value of $&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;0.0001&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share, up to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;143,766&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of which are subject to forfeiture if the Company&#x2019;s public stockholders exercise redemption rights with respect to any of the Company&#x2019;s remaining outstanding shares of Class A common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;At March 31, 2023 and December 31, 2022, there were &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;4,253,517&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; shares of Class B Common Stock issued and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;outstanding&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Holders of Class A Common Stock and Class B Common Stock will vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Business Combination on a &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;one&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A Common Stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B Common Stock shall convert into shares of Class A Common Stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B Common Stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A Common Stock issuable upon conversion of all shares of Class B Common Stock will equal, in the aggregate, on an as converted basis, &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;20%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A Common Stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 10pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;issued, to any seller in a Business Combination, and any private placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Narr_lymSmJJccUaQMjRUqg6D_w"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_VNcLEjHJAUaCZMpvLtPMBw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Narr_0zwXuWfsJk-WLdb4Mxs8Lw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_rujtr7-eDEq0guKGPaoEJw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA"
      decimals="INF"
      id="Narr_kGul5tmO2kajLU8WHKYYvQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_jCXnvA7QJkSqAjWV1YJDCQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA"
      decimals="INF"
      id="Narr_zR4KSQbS00-gfMcsraHsOA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_ZI7NYbJw_UKt5FWeLvsVVA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA"
      decimals="INF"
      id="Narr_-b4w_g-LhUupNJBFvInc3Q"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_gYtQY-AWokCTvPfFY1avgw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:CommonStockNumberOfVotesPerShare
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA"
      decimals="INF"
      id="Narr_z_vhAtkgDk2hROuvxEZ2gw"
      unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q">1</dkdcu:CommonStockNumberOfVotesPerShare>
    <dkdcu:CommonStockNumberOfVotesPerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_yIU_d30Ds0uQ4t592whBiw"
      unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q">1</dkdcu:CommonStockNumberOfVotesPerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_g_97mNUb4kStaMDUizkRmA"
      decimals="INF"
      id="Narr_F7CLokEFx0mc814jc5yqKQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_ifs9AdjQcke5yZEerWtAKg"
      decimals="INF"
      id="Narr_K-JHUitIqESKj2wNunysgw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_7dsyt3LugkGsz_fdywbH0w"
      decimals="INF"
      id="Narr_KetYLL_kO06m9-uBo1B9Xg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="INF"
      id="Narr_iI2s35hgV02FDS15mw-ZHw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="INF"
      id="Narr_fnb72YxZ1EqfvjmOPvizsA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_Ppl02wE0R0S2cScmDhKMlQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="INF"
      id="Narr_m_6fo_OOf0qgrEBUL41gbg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_f7uuNTqgakC6IP6bv3ujFA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:CommonStockNumberOfVotesPerShare
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="INF"
      id="Narr_kDkzxHTQ8UmmJcvQGe18GA"
      unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q">1</dkdcu:CommonStockNumberOfVotesPerShare>
    <dkdcu:CommonStockNumberOfVotesPerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_B4qjzgvGM0WgW7x3n4jqjg"
      unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q">1</dkdcu:CommonStockNumberOfVotesPerShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefExecutiveOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_Mzinbo6790mIYa6MzPmccA"
      decimals="INF"
      id="Narr_GsbVVKXzTUWeJ3viogOTZw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">15000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefFinancialOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9btB9vKZLEW4K63rfAMw5Q"
      decimals="INF"
      id="Narr_qR5eff72IES0-NOwk75iLQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">15000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_1lq6y8qH_02AAAlWFjyicg"
      decimals="INF"
      id="Narr_jHIWHC8EqEK1ZbyapAFd4A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">5000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_3_23_2021_To_3_23_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_7vg13yQIHkePUv6ms7p3ng"
      decimals="INF"
      id="Narr_lbzU2T1Rb0msrIw3ykhBYw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">5000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw"
      decimals="INF"
      id="Narr_k4XnqCxapUm0XkP2LUlKAQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1379517</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_wLPX3pqnoEGRhqgS36Atpg"
      decimals="INF"
      id="Narr_O_kGZPrXlkChie9aqq0Cvw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw"
      decimals="INF"
      id="Narr_P5OBOYf4wEqQvd8nnRx06Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">143766</dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="INF"
      id="Narr_wlejDTuRR020duFRPk6Zsg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_d2eueHj7iE6gG20J5Xnzmg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KOLd2DPW60K1uO5F86SP4A"
      decimals="INF"
      id="Narr_FFQxn5GibkqpTgLSS_-2Cw"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">1</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <dkdcu:Initialbusinesscombinationsharesissuableaspercentofoutstandingshare
      contextRef="As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_DP6cyL-SeUWj7pvuvs9JrA"
      decimals="2"
      id="Narr_LiPTQdN-sEmoQPEsK4m9BA"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.20</dkdcu:Initialbusinesscombinationsharesissuableaspercentofoutstandingshare>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_N82u0-JigEy2Mmr1RU2RvQ">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin:0pt 0pt 10pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 9. FAIR VALUE MEASUREMENTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The following table presents information about the Company&#x2019;s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:9pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;Prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Active&#160;Markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Observable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Asset:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Investments held in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 29,725,574&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Warrant Liabilities:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Public Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Private Placement Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;Prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Active&#160;Markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Observable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Asset:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Investments held in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 29,029,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Warrant Liabilities:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Public Warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Private Placement Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Warrants are measured at fair value on a recurring basis. The Public Warrants were valued initially and at each reporting period that the warrants were not actively traded, using a Monte Carlo simulation. As of March 31, 2023 and December 31, 2022, the Public Warrants were valued using the instrument&#x2019;s publicly listed trading price, which is considered to be a Level 1 measurement due to the use of an observable market quote in an active market. Private Placement Warrants were valued using a Monte Carlo valuation model using level 3 inputs at initial valuation and as of March 31, 2023 and December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;At March 31, 2023 and December 31, 2022, assets held in the Trust Account were invested solely in BlackRock US Treasury mutual fund of $&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;29,725,574&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$29,029,416&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, respectively. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments and are considered Level 1 assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#x2019;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The Company utilized a Monte Carlo simulation to estimate the fair value of the Public warrants at each reporting period for its warrants that are not actively traded. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. On June 22, 2021, the Public Warrants surpassed the threshold waiting period to be publicly traded. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of March 31, 2023 and December 31, 2022, the Company classified the Public Warrants as Level 1.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#x2019;s traded warrants and from historical volatility of select peer company&#x2019;s common stock that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;zero&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;Transfers&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; to/&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;from&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; Levels 1, 2 and 3 are &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;recognized&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; at the end of the reporting period in which a change in &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;valuation&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; technique or methodology occurs. For the three months ended March 31, 2023 and December 31, 2022, there were &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;no&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; transfers between levels&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Private Warrants)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Private Warrants)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Share price&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.69&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.44&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected term (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5.18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Probability of Acquisition&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2.65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4.2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.53&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.91&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dividend yield (per share)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;The change in the fair value of the derivative warrant liabilities for the three months ended March 31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Private Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Public Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Warrant Liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 362,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_ZO2hDNBMi0u8zP5YIF1kNA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Change in valuation inputs or other assumptions&lt;/span&gt;&lt;sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of March&#160;31,&#160;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 362,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Private&#160;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Public&#160;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Warrant&#160;Liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of December 31, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 251,668&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,600,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,851,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_jQL209kLek2Gbb2s5yFT1A;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Change in valuation inputs or other assumptions&lt;/span&gt;&lt;sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (117,640)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,645,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,762,640)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of March 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 134,028&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,955,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,089,028&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border:0pt;border-collapse:collapse;font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_3K3A-o2QEkC95aKbfl_Iyw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:9pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;Prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Active&#160;Markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Observable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Asset:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Investments held in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 29,725,574&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Warrant Liabilities:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Public Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Private Placement Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;Prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Active&#160;Markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Observable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Asset:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Investments held in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 29,029,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Warrant Liabilities:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Public Warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Private Placement Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_3_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_4TkL3ro1G0WNewZCXPJcSw"
      decimals="0"
      id="Tc_KeHiXirZFkCy9q4YBGiKAA_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29725574</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g6Pq07wbNEa9FXfu1Ifs3Q"
      decimals="0"
      id="Tc_OVPKtHJYkkevLi8_RjgdmQ_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">345000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_HJQOphMcxEKTWZeeZtSgpA"
      decimals="0"
      id="Tc_dmPW1IGvZkaIlVTvBMhnYw_10_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">17558</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_6aYBpgJYl06PCALWaa-w4w"
      decimals="0"
      id="Tc_XDiIopO91k-2ZmTeSoad3A_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_Tv60Y58O_0WnZ3tyWWSaUA"
      decimals="0"
      id="Tc_JdNMDlHkKE6zGwB6HcBpeg_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">345000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_vEBEAARln0-juOH4J-Vj-A"
      decimals="0"
      id="Tc_28wBwEQ0YUyqEzGBDdPrPQ_10_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">17558</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_3_31_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_ePOJmFiwvU60MCXJN9p2Ug"
      decimals="0"
      id="Narr_BY2JcUMGCE-RBfNsWWwPWw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29725574</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_0kOvX431_0WNunHM_Al50g"
      decimals="0"
      id="Narr_uzpfzLO6nkmgkNsRxkv5AA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_QX1AgoN1i0GRrr7rqmGn3w"
      decimals="2"
      id="Narr_porlIwgUP06nm7_faGzA2A"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      decimals="0"
      id="Narr_eSxiiTqij06FQEi0ZAHlDQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount>
    <dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Narr_NdNR_c781kipcgZYjZ03YA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_8CgPTPdHOUGRRzBsWTHJ_A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;March&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Private Warrants)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Private Warrants)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Share price&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.69&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.44&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected term (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5.18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Probability of Acquisition&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2.65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4.2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.53&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.91&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dividend yield (per share)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-y3TJWpkY0KEs_22qhgoTg"
      decimals="2"
      id="Tc_uwAW-ZDRR0GT3wH0-Mfm6A_3_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">11.50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_bPi2WHn1CEmBrVfnbyV-yQ"
      decimals="2"
      id="Tc_s8ZtEF3KWEuQKcCX_8VwbQ_3_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">11.50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_NHlcD0Two0y88E2KkRoDFA"
      decimals="2"
      id="Tc_Lz9Ow2Pik06fpNfjCsMoRA_4_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.69</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_ybrEKTUYVEi2w4swS4gdww"
      decimals="2"
      id="Tc_TeLSLN6uGEaNzPG71a-27w_4_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.44</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_w7FiqmYDb0SNPeqJvA62Hg"
      decimals="INF"
      id="Tc_v_JmWYX3EkyqzWZW6fEIaQ_5_3"
      unitRef="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A">5.18</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_g71uqyykEUaLUf1hlvHiRw"
      decimals="INF"
      id="Tc_bGUnv0GRCUyUQcWSWygwZA_5_6"
      unitRef="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A">5.12</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_DDMbCIawE0WRTKQo8ri2HQ"
      decimals="4"
      id="Tc_42xfd6X7mEWIKo63rJ37tg_6_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0265</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_8tE3iMpWckqAsmbEpESznQ"
      decimals="4"
      id="Tc_lIGn4KeP60azMPa6zufkmQ_6_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0275</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_FUC4KYSqtUiLtDWVMSB8ZA"
      decimals="3"
      id="Tc_iwLQFg70P0W0ZCtpjzl9-Q_7_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.032</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_8dkF3R4YwUqerp4U-rpgZQ"
      decimals="3"
      id="Tc_MLaQAwJ2YEK3VsBZdZW5xw_7_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.042</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_OlTpv8vqnUW3HCd6Lr3SsQ"
      decimals="4"
      id="Tc_aEZOxDMVQk6D_ZHDQydakA_8_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0353</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_SAyeztzxD0CqTCyFAOQf2A"
      decimals="4"
      id="Tc_6EPsw7DdyU2qotpBP02UiQ_8_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0391</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_QX1AgoN1i0GRrr7rqmGn3w"
      decimals="2"
      id="Tc_XopkTyFrPkC0x5MDpueQ9w_9_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_JeEGJuHbaES_O44UyyPIfA"
      decimals="2"
      id="Tc_8Z-ov8Ph3EW23g1SdTi_4g_9_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_zdULv7_43kem04eQX7oiDg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Private Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Public Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Warrant Liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 362,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_ZO2hDNBMi0u8zP5YIF1kNA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Change in valuation inputs or other assumptions&lt;/span&gt;&lt;sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of March&#160;31,&#160;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 362,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Private&#160;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Public&#160;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Warrant&#160;Liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of December 31, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 251,668&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,600,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,851,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_jQL209kLek2Gbb2s5yFT1A;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Change in valuation inputs or other assumptions&lt;/span&gt;&lt;sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (117,640)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,645,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,762,640)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of March 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 134,028&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,955,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,089,028&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border:0pt;border-collapse:collapse;font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_ruu01iLDPE611oCSW8HUQw"
      decimals="0"
      id="Tc_p-1QmXjSF02Nh58W3mlsqA_2_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">17558</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q"
      decimals="0"
      id="Tc_zH5qiDPjEkemrIOi-ojQnA_2_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">345000</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_gvo3MI-_1kGJuvLmpZZU2w"
      decimals="0"
      id="Tc__jKmYL1Ns0u2mSJ5kK2ySw_2_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">362558</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_SeDSdYS9I0OQvO6F2ARe9A"
      decimals="0"
      id="Tc_I00c7BPZAk-1VzkVyS6cbA_4_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">17558</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_6wnVrpWarEuBYWQ4-7W6Ig"
      decimals="0"
      id="Tc_1o4sdKnnNkq_zKwA1u8wHA_4_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">345000</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_TjM-esHGVEeoFX1cq_RpYg"
      decimals="0"
      id="Tc_jZwWnSZtwEeBPWEYfRjdOw_4_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">362558</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember__X7tf0I7ukiYWBqvSdHF_A"
      decimals="0"
      id="Tc_EVcU-H5HuEieiUEcvrYGlw_2_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">251668</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_hE2awbU3oU-sum3j2xFkxg"
      decimals="0"
      id="Tc_VVQSoDpbj0Ghn9OW8R3ukA_2_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4600000</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_Nddpq_hUqUiHgJZLwEZXaw"
      decimals="0"
      id="Tc_m88JGQBBKE6WEYWBi5ML6A_2_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4851668</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_x0VSehuBK02ZfQG1ov1NTw"
      decimals="0"
      id="Tc_JavFyKOh4kyj3mKICDANAA_3_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-117640</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_vKlhRJKu3EemIj0dy92Ntg"
      decimals="0"
      id="Tc_-vuHKvdMhEKihD0wLukt_w_3_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-2645000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_JWpjApV5kk6mkkkuH-ZYQg"
      decimals="0"
      id="Tc_qo2sFylQO0mIyakzyMefrg_3_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-2762640</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_0N5eYpz5zUyuKVAv4QYoVw"
      decimals="0"
      id="Tc_pXIphiM_LUWFbRLZ_HIjfg_4_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">134028</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_EF6C8NJFb0KSaqc-FbCmBg"
      decimals="0"
      id="Tc_wdl0_X_1zUus9igtleCBPQ_4_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1955000</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_3_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_QUoUswNMF02jFye3P74QXQ"
      decimals="0"
      id="Tc_L-AWW6EJ5kumkL5vpEXeMQ_4_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2089028</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g"
      id="Tb_9A3Ss4wVdUqMSRaizVhi3A">&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"&gt;NOTE 10. SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;In accordance with ASC Topic 855, &#x201c;Subsequent Events&#x201d;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identified any subsequent events that would have required adjustment or disclosure in the financial statements other than as described below.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On April 17, 2023, the Company withdrew $&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;214,850&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; interest earned on the Trust account to pay 2022&#x2019;s income tax payment. The income tax was paid on April 18, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On April 19, 2023, the Company elected to exercise its sixth-month extension to the Termination Date, which extended its deadline to complete its initial business combination to May 11, 2023, by depositing &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$0.045&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;$122,920&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;, was deposited in the Trust Account.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:&amp;quot;'Times New Roman','Times','serif'&amp;quot;;font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;On April 25, 2023, the Company withdrew $&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;73,846&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; interest earned on the Trust account to pay 2022&#x2019;s remaining balance and 2023 Q1 prepayment of Delaware Franchise tax. $&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt;73,846&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';"&gt; was paid to the State of Delaware on May 2, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On June 28, 2023, EF Hutton waived $3,025,000 of the $4,025,000 cash deferred underwriting commission, pursuant to a Satisfaction and Discharge Agreement (attached at Exhibit 10.22) that would otherwise be immediately due and payable upon the Closing, accepting in lieu thereof (i) a one-time cash payment of $500,000 at the time of the Closing; (ii) a $500,000 promissory note executed by the Company on June 30, 2023 (attached at Exhibit 10.21) in which it is obligated to make six monthly payments to EF Hutton in the cash amount of $83,333.33 from October 2023 through March 2024; and (iii) 277,778 ordinary shares of the Company (the &#x201c;Ordinary Shares&#x201d;) at $10.89 per share, for an aggregate value of $3,025,000.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:InvestmentIncomeInterest
      contextRef="Duration_4_17_2023_To_4_17_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_GxhdHNvlYEGHmFQK4ASs8Q"
      decimals="0"
      id="Narr_W2hoNMOWP0i4rzg_JVEcNA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">214850</us-gaap:InvestmentIncomeInterest>
    <dkdcu:AmountDepositedPerEachPublicShareOutstanding
      contextRef="Duration_4_19_2023_To_4_19_2023_srt_StatementScenarioAxis_dkdcu_SixthOneMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_ziSc7tDmME6Wx3vreHBoIw"
      decimals="3"
      id="Narr_AgsswMByr0CHyV1n4hpqgQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.045</dkdcu:AmountDepositedPerEachPublicShareOutstanding>
    <dkdcu:AggregateAmountDepositedInTrustAccount
      contextRef="Duration_4_19_2023_To_4_19_2023_srt_StatementScenarioAxis_dkdcu_SixthOneMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_ziSc7tDmME6Wx3vreHBoIw"
      decimals="0"
      id="Narr__bwetUT6pESjCQAk_9oaQg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">122920</dkdcu:AggregateAmountDepositedInTrustAccount>
    <us-gaap:InvestmentIncomeInterest
      contextRef="Duration_4_25_2023_To_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_isjLRKvB20-ds3dYGWYkKg"
      decimals="0"
      id="Narr_uQLn7T5xl0Sos6dZEN1Gdw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">73846</us-gaap:InvestmentIncomeInterest>
    <dkdcu:PaymentsOfFranchiseTax
      contextRef="As_Of_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NTJiqMJD-EKRgG77t6L0wg"
      decimals="0"
      id="Narr_awgA6ZwaA0-jBK1N9z6hUg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">73846</dkdcu:PaymentsOfFranchiseTax>
    <dkdcu:CashWaivedDeferredUnderwritingCommission
      contextRef="As_Of_6_28_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Qivj15x0skm53fAZP6Gj9w"
      decimals="0"
      id="Narr_l07fYU7PzE-OHu-M775lgw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">3025000</dkdcu:CashWaivedDeferredUnderwritingCommission>
    <dkdcu:CashDeferredUnderwritingCommissions
      contextRef="As_Of_6_28_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Qivj15x0skm53fAZP6Gj9w"
      decimals="0"
      id="Narr_7TwPSBzUn0Cl6anM23N74w"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:CashDeferredUnderwritingCommissions>
    <dkdcu:RelatedPartyPayment
      contextRef="As_Of_6_28_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_9U3WXH3Tuk6B4AeZ9LZceA"
      decimals="0"
      id="Narr_TZhifrol_Emdw15a5ubA1g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">500000</dkdcu:RelatedPartyPayment>
    <dkdcu:RelatedPartyPromissoryNoteExecuted
      contextRef="As_Of_6_28_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_9U3WXH3Tuk6B4AeZ9LZceA"
      decimals="0"
      id="Narr_0IJcacSG-kuvlzpHQMLLlQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">500000</dkdcu:RelatedPartyPromissoryNoteExecuted>
    <dkdcu:RelatedPartyPromissoryNoteExecutedPerMonth
      contextRef="Duration_10_1_2023_To_12_31_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_HiR7EAU8gUSivES6ft2axA"
      decimals="2"
      id="Narr_S6obIYsaq0-8-qW0BQt9qg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">83333.33</dkdcu:RelatedPartyPromissoryNoteExecutedPerMonth>
    <dkdcu:RelatedPartyPromissoryNoteExecutedPerMonth
      contextRef="Duration_1_1_2024_To_3_31_2024_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_JnW2PcUwp0OM1e3d0ygcIQ"
      decimals="2"
      id="Narr_94sjogzlfESNParGU-RC3g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">83333.33</dkdcu:RelatedPartyPromissoryNoteExecutedPerMonth>
    <dkdcu:AggregateNumberOfSharesOwned
      contextRef="As_Of_6_28_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_nn_yhuYka4eAFEk-2_Tg"
      decimals="INF"
      id="Narr_Ag-S5CSFo0GSlaYHMJ4zbA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">277778</dkdcu:AggregateNumberOfSharesOwned>
    <us-gaap:SharePrice
      contextRef="As_Of_6_28_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_nn_yhuYka4eAFEk-2_Tg"
      decimals="2"
      id="Narr_Fw2iecscSkesFyBqsOVAmA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.89</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_6_28_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_nn_yhuYka4eAFEk-2_Tg"
      decimals="0"
      id="Narr_iyZo0YNkoka9Bi7hLNjYbA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">3025000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_RblwZP-9DUmBX91KIsti1g_5_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_TinpKNxpWk6iLP1TSlKhjQ_5_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">453151</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_gTGSUCThr0GIjcCR3PNm-Q_6_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">21215</us-gaap:PrepaidExpenseCurrent>
    <dkdcu:PrepaidInsuranceCurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_dAnonmc6Pk-l1177LdmNjQ_7_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">61846</dkdcu:PrepaidInsuranceCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_Dgb0pOqxD0azO7Tnb4AcMQ_8_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_YGwAkJu5cEqiz15gPuEllA_8_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">536212</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_wLbf1d1ch0ysdt5QDctNxw_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_YEJd7vXA8EOukQbH_db1aA_9_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117320973</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_eR4N2KDywU2vo2I9gx-ixQ_10_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29060286</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_SaLcpEWsOUmtlddG2EYlpw_10_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117857185</us-gaap:Assets>
    <dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_1maUdy4iQkin4NeIK4S6Zw_13_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1679821</dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent>
    <dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_6DYygbATw02ya4_fzSm3mg_13_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">125972</dkdcu:AccruedLiabilitiesExcludingOfferingCostsCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_vTgoY0qjIEuwebG_E0FD7g_14_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">11500</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_PzV8-Y5dsEqK5mATgpnc6g_15_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">214850</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_uNghmCXt7U6jabH0eJmF2A_16_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">69966</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_0NGig1FRU0iXGP1c3bolZg_16_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">164008</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_dIjsFsPkqUSCh0sR-9qDpg_17_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1976137</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_xyq-UPyaAEiHK5HWZAkmtg_17_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">289980</us-gaap:LiabilitiesCurrent>
    <dkdcu:WarrantLiabilityNonCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_gTfgpfrXW0yGT_Z5RZt4xA_18_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">362558</dkdcu:WarrantLiabilityNonCurrent>
    <dkdcu:WarrantLiabilityNonCurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_s0CO9WMYy06ZMIAqR6xsDQ_18_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4851668</dkdcu:WarrantLiabilityNonCurrent>
    <dkdcu:DeferredOfferingCostsNonCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_WP0w9kh9aEyeg59VBrRpoA_19_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:DeferredOfferingCostsNonCurrent>
    <dkdcu:DeferredOfferingCostsNonCurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_K_g9yazeDkS9u_3Ls39LUA_19_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:DeferredOfferingCostsNonCurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_tzsqnMP1J0meUTeAdPpNeQ_20_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">207081</us-gaap:DueToRelatedPartiesNoncurrent>
    <dkdcu:ExtensionLoansNonCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_o-CaXKXN20idq_x_vzujmw_21_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2545838</dkdcu:ExtensionLoansNonCurrent>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_oXrt7B9Qs0G-L-L0RDtH4g_22_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">9116614</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_gFZuR0llCkKJLTrBnoCsow_22_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">9166648</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="INF"
      id="Narr_QYYqobg4zkWQJtd3XV9Xeg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg"
      decimals="INF"
      id="Narr_6KuFasZCyUO3DLsVOdobbA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="2"
      id="Narr_nLcWdmB5gEu5NMAI2NF0Bw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.53</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg"
      decimals="2"
      id="Narr_7uZ9iul740OMiN9Mn6ABRw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.20</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="0"
      id="Tc_UvGJfpJNmUyvoFE9oEcFBQ_24_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">28750110</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg"
      decimals="0"
      id="Tc_Rl5YKMk2PUun7cwXeFnNAQ_24_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="INF"
      id="Narr_oheOXmZ0p0u1r_JOSLECaQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_eEFIX1jSKU-h_Z9KBZqzCw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="INF"
      id="Narr_qq0X0guaKE2336klirWFkQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_MZFz9FbY0EmJ2jsqMQqTSA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="INF"
      id="Narr_JbnHqbpN-EmrBKA4nKihhA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_Qh3qqcozbUO5fHUQdjovdA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA"
      decimals="INF"
      id="Narr_5FNxDAzHT023E7BEuc0lpA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_uJ5G-27WbkiBG1Ht6tC7Qw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA"
      decimals="INF"
      id="Narr_pXdEQZEfIUmX1bNG_XEc_w"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr__e91UKg9UU-mbdGUu4uXlQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_N0cKDx01fE-CPoTUE87ugg"
      decimals="INF"
      id="Narr_I2ufn8-mOEivvhlH7sBw3A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q"
      decimals="INF"
      id="Narr_cCUyR3aweUuSHX25RF6xQg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="INF"
      id="Narr_pembWoKvTkaEQ5tDdouM_w"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2731544</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_ZFw6anSr_0uIQXGfBgOnBg"
      decimals="INF"
      id="Narr_R-burb9PiEm0cQHh8pQU0Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_0Ef8HsS1okKU1-bmVirJ3Q"
      decimals="0"
      id="Tc_3dSh_es03kSLXioMqsZV9Q_27_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember_N0cKDx01fE-CPoTUE87ugg"
      decimals="0"
      id="Tc_Ix2nIO7zq0OaGuiRFip8gA_27_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"
      decimals="INF"
      id="Narr_VglCnL2pR0Kykbqqs6EDxw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_nQWK5s3J40mPCspcJoSfyQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"
      decimals="INF"
      id="Narr_e8F49ISoxUm2nESFgVrq3Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_wKsG4cbEtkmazsxgpC3cAw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_fJvOPVKVlUmDx-I3IRl8Vg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"
      decimals="INF"
      id="Narr_dYD8Xe_pJk-NWNCIdLbyig"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="0"
      id="Tc_hl82ZCGImkqKS3SBs2BDXg_28_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">425</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"
      decimals="0"
      id="Tc_a2jQC42mtEaQhAhlOBioqQ_28_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">288</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc__QFh_K3wv0CRZN5e6jMnTA_30_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-11632745</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_s6DAPQFgxUOolQ2w_01Jeg_30_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8609810</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_GgWdoKdVcE6bweAVa7uyGQ_31_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8806438</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_MBHCFG1GJE-iw91iJLBnWQ_31_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8609463</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_r2Fqj5zNPEKpEXicF9QfUQ_32_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29060286</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_f1kMBAfK8U28r06O97MfsA_32_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117857185</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_7a0jMzEekEKs1V4V7jj3oA_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5103731</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_bJmNEKXLmE-HX103jsP-FQ_9_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">421397</us-gaap:OperatingCostsAndExpenses>
    <dkdcu:FranchiseTaxExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_-2KGvG69DUWHAeL-neVE9w_10_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">205560</dkdcu:FranchiseTaxExpense>
    <dkdcu:FranchiseTaxExpense
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_A9WEL222mkqc9wriY5gp7A_10_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">164008</dkdcu:FranchiseTaxExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_UuvVKwhMuUSLw2LxCMyMHw_11_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-5309291</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_z2QFA8C9DEmzJjsoi7GmBw_11_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-585405</us-gaap:OperatingIncomeLoss>
    <dkdcu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_IKYAxZm6VEy-sdWMQtylrg_14_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1876</dkdcu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_3OGTjmSjh0iWBpgwWz7hpQ_15_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1371689</dkdcu:RealizedAndUnrealizedGainLoss>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_AZ_DUXjLzESWxSmy9dny-g_15_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">19097</dkdcu:RealizedAndUnrealizedGainLoss>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_Wb3LNrwpWECk4clUmrzDKQ_16_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-4489110</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_qVT0ySmpC0eRpeh3A-zs0Q_16_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-6325281</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_rMDXvPeGnUqya2vLx_Hsmg_17_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-625059</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_a2EjBv4U9ESObXndSp1SNg_18_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">551508</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_eLsndga8xUmAjiNuUDojWA_18_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5135790</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_FmoCHqEHiku1jyrlebFgZA_19_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">214850</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_LkpzeFrA9Uuy72gap5vwDw_20_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">336658</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_yQAj7YB7i0u6xwS9Y9bgJg_20_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5135790</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="0"
      id="Tc_jj5teGH2YUaZrjAV6BBK5w_22_3"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8667969</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="0"
      id="Tc_jj5teGH2YUaZrjAV6BBK5w_22_3_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8667969</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="0"
      id="Tc_5jhAXktUhU-uNKS_k6KwUQ_22_6"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8264526</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="0"
      id="Tc_5jhAXktUhU-uNKS_k6KwUQ_22_6_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8264526</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="2"
      id="Tc_N76YRM4310qHClVHwYtZ0w_23_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="2"
      id="Tc_N76YRM4310qHClVHwYtZ0w_23_3_2"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="2"
      id="Tc_R-IZ3jhcKkqXbIOvia9a4A_23_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="2"
      id="Tc_R-IZ3jhcKkqXbIOvia9a4A_23_6_2"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q"
      decimals="0"
      id="Tc_NfYhucN-Q0Gqc9PRngNPtA_25_3"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3464052</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q"
      decimals="0"
      id="Tc_NfYhucN-Q0Gqc9PRngNPtA_25_3_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3464052</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw"
      decimals="0"
      id="Tc_8tGc-h5KI0a4F4XbQSDobA_25_6"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3295610</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw"
      decimals="0"
      id="Tc_8tGc-h5KI0a4F4XbQSDobA_25_6_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3295610</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q"
      decimals="2"
      id="Tc_6JU_UBc40Eus4qZMpbGGWg_26_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="2"
      id="Tc_6JU_UBc40Eus4qZMpbGGWg_26_3_2"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw"
      decimals="2"
      id="Tc_S6g0s3JgA0SbIruOEsDD9g_26_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="2"
      id="Tc_S6g0s3JgA0SbIruOEsDD9g_26_6_2"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ"
      decimals="INF"
      id="Tc_iEMTTAoujkKdYzAB7uGGkw_4_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ"
      decimals="0"
      id="Tc_HCt3US7J0k-ocmWyMYFfyQ_4_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg"
      decimals="INF"
      id="Tc_C2wqknDZnUmabdGIpenp-Q_4_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg"
      decimals="0"
      id="Tc_TZTAecaPXECXDXP_9q7avA_4_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">288</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_6-yCbHCVY0uGfDrYrKv0Iw"
      decimals="0"
      id="Tc_p6yaYkUTIkiF3J9exUqU6w_4_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8609810</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_E7Fe11iZVEyX14jFJ8iIhQ_4_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8609463</us-gaap:StockholdersEquity>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_9L82rWITkUe_O0x-YM5jnw"
      decimals="0"
      id="Tc_LGy24TTzsUeJIyGPUu-HqQ_5_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">3359593</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_t4-7XrbpjEqnMqvXlx6D_Q_5_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">3359593</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HKTnd3Yg0k23m_kWDWCW4g"
      decimals="INF"
      id="Tc_z7eU8OsEzUWSwUKtqIlB_A_6_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1378517</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HKTnd3Yg0k23m_kWDWCW4g"
      decimals="0"
      id="Tc__GRyhGQt30WfHzBjwE7kfg_6_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">137</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_qRsdIQljjU-ibnyalgU8ug"
      decimals="0"
      id="Tc_aM3RGlTOC0mHMNm8ThvEGw_6_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2825823</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_UDsiUqpwkEqGG2Ky3ArOpw_6_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2825960</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_9L82rWITkUe_O0x-YM5jnw"
      decimals="0"
      id="Tc_rgWOIUXb9kidm2HSNh9KmQ_7_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">336658</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_DFJfhTIxf0CGJv9qpndIrA_7_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">336658</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ"
      decimals="INF"
      id="Tc_OuGtR_tW6ESdip0kXPgSyg_8_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_RxSQX7-koEa8IbXU8ZvhYQ"
      decimals="0"
      id="Tc_bSUKSJ3pbUGl4j52bQtsMg_8_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg"
      decimals="INF"
      id="Tc_xu08xK7-BkW1daWlZqbZUQ_8_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_SVRH4OQgVUSlLi2FdswOKg"
      decimals="0"
      id="Tc_QRGRHL8GiEyVyunVfoUDYw_8_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">425</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_xXVChhyI6k-ndPgI-1--gQ"
      decimals="0"
      id="Tc_Eni_E4ooMUeuVNq5riIlnA_8_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-11632745</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc__H4b_7OmWUe_zB4x4BAhYA_8_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8806438</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_KwfTqwNCuk64IHdfIIUfOQ"
      decimals="INF"
      id="Tc_2a2nI-gLR0aqw_B0k1GQVw_4_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_KwfTqwNCuk64IHdfIIUfOQ"
      decimals="0"
      id="Tc_3qvRXL9zSkuIitzWUxt4jw_4_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_AU1G1eFSN02wMgL4I9gmYA"
      decimals="INF"
      id="Tc_RM4VnUr7NUGqVBdofGuN5Q_4_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_AU1G1eFSN02wMgL4I9gmYA"
      decimals="0"
      id="Tc_Dd_na0KteEGlEpIUFy6hZA_4_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_2_7_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_n-8OnhgC0EeVoVPuKg1hVw"
      decimals="0"
      id="Tc_Fbl6JxYQtEyGEddvK2sL1g_4_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_2_7_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_Xe0KcyySzEqyLKiwakwyLQ"
      decimals="0"
      id="Tc_tXCM97l03E2q2v2kMy7fUQ_4_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_2_7_2021_xIunY2_KPEmoFeGygcAWFQ"
      decimals="0"
      id="Tc_G4Z0FPSzTkKMU5cXz3PfUg_4_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Yt0ReKG7x0axkO27tJcJkQ"
      decimals="INF"
      id="Tc_lgruwMQnkk-9J1dWT_dMxw_5_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Yt0ReKG7x0axkO27tJcJkQ"
      decimals="0"
      id="Tc_BokN7KMBFkuFgL2XGjgSMg_5_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">288</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw"
      decimals="0"
      id="Tc_B96Q65Lupka4frvuczhfSA_5_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">24712</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg"
      decimals="0"
      id="Tc_GjCRfs-eNkaHa3tbRFFpwQ_5_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_yF5anY6KoUygBpTklfYedA_5_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_okqVlM4N3EWxKtzFTl4dfw"
      decimals="INF"
      id="Tc_afC7aJ5Py0epZb91uZsT5w_6_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares>
    <dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_okqVlM4N3EWxKtzFTl4dfw"
      decimals="0"
      id="Tc_SO9irq-JCUKAtEkHM_JVMQ_6_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor>
    <dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw"
      decimals="0"
      id="Tc_1Lq_k8pktU2TIjtqpSpqkg_6_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5290242</dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor>
    <dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg"
      decimals="0"
      id="Tc_kR2MfgfF5UOszX1e5rBWog_6_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor>
    <dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_qZTKhob_j02QAd8crLvrSg_6_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5290301</dkdcu:SaleOfNonRedeemablePrivatePlacementUnitsToSponsor>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw"
      decimals="0"
      id="Tc_qQSyEOYfskqbJpXhyYxfBA_7_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5314954</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg"
      decimals="0"
      id="Tc_ZPwVgxckHES7v7ewEP50dg_7_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">13745600</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <dkdcu:CommonStockSubjectToPossibleRedemptionValue
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_XEcsoItXZ0u6LurDmMr2iA_7_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">19060554</dkdcu:CommonStockSubjectToPossibleRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gJ0ofTAqQkeclGXOEFJiMw"
      decimals="0"
      id="Tc_Um-rNMYkHE67NGxX8PwqMg_8_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_R8n60sbBqkqEfJADhHDRzg"
      decimals="0"
      id="Tc_Js9ZlM5A5kanwEVGICGzTQ_8_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5135790</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_ZEYH7bijPkmxUnr77X2KGA_8_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5135790</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ"
      decimals="INF"
      id="Tc_mAdhZ-CUz06VojbkOv1YRw_9_2"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_PYYwYGnZ2UuBwimagaCTGQ"
      decimals="0"
      id="Tc_up4snfkxskeyIHz56U-g4w_9_5"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">59</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg"
      decimals="INF"
      id="Tc_FiOl0WhuOUOtIFj4K8fH4Q_9_7"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CMyVgqAWcEeuDHFeY3qaxg"
      decimals="0"
      id="Tc_GNmORRbOs06LaJpUKloI4A_9_10"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">288</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_6Bf7HXIAMk2oElQb9ogmow"
      decimals="0"
      id="Tc_S8Q-C9M3OEWr8nFUe-vRfA_9_13"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_6-yCbHCVY0uGfDrYrKv0Iw"
      decimals="0"
      id="Tc_I2VOn1CmRkmuo2tgVV87dA_9_16"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8609810</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_3cc1DTKvoEy55vr8w-4k4g_9_19"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-8609463</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_zjgHLyPgw0eOSb7A-12baQ_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">336658</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_zjgHLyPgw0eOSb7A-12baQ_6_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">336658</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_hV9NS9Ma1Eqs4jz_Ft9wLg_6_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5135790</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_hV9NS9Ma1Eqs4jz_Ft9wLg_6_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5135790</us-gaap:ProfitLoss>
    <dkdcu:OfferingCostsAllocatedToWarrantLiability
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_ZkRUOog4GkyLESGpgcs_kA_8_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">625059</dkdcu:OfferingCostsAllocatedToWarrantLiability>
    <dkdcu:OfferingCostsAllocatedToWarrantLiability
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_ZkRUOog4GkyLESGpgcs_kA_8_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">625059</dkdcu:OfferingCostsAllocatedToWarrantLiability>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_iW1PHTAkWkW9VgZkxHpOhQ_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2825960</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_iW1PHTAkWkW9VgZkxHpOhQ_9_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2825960</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_xsSaeFLFbkG8avTtcyzyaQ_9_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:ShareBasedCompensation>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_E_LFdyqZ20Gkx8F_xsRvBA_10_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1371689</dkdcu:RealizedAndUnrealizedGainLoss>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_E_LFdyqZ20Gkx8F_xsRvBA_10_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1371689</dkdcu:RealizedAndUnrealizedGainLoss>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_sVjN5C7O1k2Q3AmjgAFGdw_10_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">19097</dkdcu:RealizedAndUnrealizedGainLoss>
    <dkdcu:RealizedAndUnrealizedGainLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_sVjN5C7O1k2Q3AmjgAFGdw_10_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">19097</dkdcu:RealizedAndUnrealizedGainLoss>
    <dkdcu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_Qko-MgehTEumMM2cQkNS5A_11_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1876</dkdcu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount>
    <dkdcu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_Qko-MgehTEumMM2cQkNS5A_11_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1876</dkdcu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_WhUX6B1OqE6vtN4lGiQY4g_12_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-4489110</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_WhUX6B1OqE6vtN4lGiQY4g_12_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-4489110</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_EMISAq5iKUmeYtZTjeW_WQ_12_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-6325281</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_EMISAq5iKUmeYtZTjeW_WQ_12_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-6325281</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_R_XJX136Y0a6_vx0dQEwgg_14_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-83061</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_R_XJX136Y0a6_vx0dQEwgg_14_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-83061</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_aDeus0i4HEu1O9m_NZhfhw_14_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">83061</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_aDeus0i4HEu1O9m_NZhfhw_14_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">83061</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_6qU4Fc6gH0iDyZVcETQyUQ_15_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1553849</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_6qU4Fc6gH0iDyZVcETQyUQ_15_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1553849</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_oOWpjfmQ0kq1zCNH2ZmFSw_15_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">125972</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_oOWpjfmQ0kq1zCNH2ZmFSw_15_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">125972</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <dkdcu:IncreaseDecreaseFranchiseTaxPayable
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_FvrFo1ixPUaAyAXhMpxEFg_16_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-94042</dkdcu:IncreaseDecreaseFranchiseTaxPayable>
    <dkdcu:IncreaseDecreaseFranchiseTaxPayable
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_FvrFo1ixPUaAyAXhMpxEFg_16_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-94042</dkdcu:IncreaseDecreaseFranchiseTaxPayable>
    <dkdcu:IncreaseDecreaseFranchiseTaxPayable
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_VMB2wRY-yUWgPNAbrccIPg_16_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">164008</dkdcu:IncreaseDecreaseFranchiseTaxPayable>
    <dkdcu:IncreaseDecreaseFranchiseTaxPayable
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_VMB2wRY-yUWgPNAbrccIPg_16_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">164008</dkdcu:IncreaseDecreaseFranchiseTaxPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_7husQuxNrUO9aAFRL6HfZg_17_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">214850</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_7husQuxNrUO9aAFRL6HfZg_17_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">214850</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_wC1gewjkv0iZXiOdRocsYg_17_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_Uz4ftD4JqESRfZLsXafrVg_18_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-940463</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_Uz4ftD4JqESRfZLsXafrVg_18_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-940463</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_uCqYC6B3UE2m_pluVGnsrw_18_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-378487</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_uCqYC6B3UE2m_pluVGnsrw_18_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-378487</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_h42ifOCPxk61aBdBfw-m4w_20_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2545838</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_h42ifOCPxk61aBdBfw-m4w_20_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2545838</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_cROB-VOYcEa0y0MMZtet3Q_20_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_cROB-VOYcEa0y0MMZtet3Q_20_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_TjM7aAtTV0i3-zt3DNdSzQ_21_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">299601</dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount>
    <dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_TjM7aAtTV0i3-zt3DNdSzQ_21_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">299601</dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount>
    <dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_8IB8HLi4eUWgyPOrh1l6Og_21_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_0VbxG7-eSU2TtscRvFeLxA_22_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-2246237</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_0VbxG7-eSU2TtscRvFeLxA_22_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-2246237</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_YF7pB75HSECavwwyaf1FRg_22_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-117300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_YF7pB75HSECavwwyaf1FRg_22_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-117300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_9ohKa6mWB0W_39viFqKu5w_24_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_9ohKa6mWB0W_39viFqKu5w_24_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <dkdcu:NetProceedsFromInitialPublicOffering
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_mn9wUvM0oEeVdHL4riM7wA_25_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">112700000</dkdcu:NetProceedsFromInitialPublicOffering>
    <dkdcu:NetProceedsFromInitialPublicOffering
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_mn9wUvM0oEeVdHL4riM7wA_25_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">112700000</dkdcu:NetProceedsFromInitialPublicOffering>
    <dkdcu:ProceedsFromSaleOfPrivateUnits
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_vVUPnxqyH02tyYoaRqYu5A_26_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5852750</dkdcu:ProceedsFromSaleOfPrivateUnits>
    <dkdcu:ProceedsFromSaleOfPrivateUnits
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_vVUPnxqyH02tyYoaRqYu5A_26_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5852750</dkdcu:ProceedsFromSaleOfPrivateUnits>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_TyJb6LnOJU2QPf2jH-EThA_27_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">446112</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_TyJb6LnOJU2QPf2jH-EThA_27_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">446112</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_gDXSxvgg0k-NDZH_C9PeIg_28_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">78925</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_gDXSxvgg0k-NDZH_C9PeIg_28_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">78925</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_78BoQwImLEumlHXozRq_Bw_29_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">78925</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_78BoQwImLEumlHXozRq_Bw_29_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">78925</us-gaap:RepaymentsOfRelatedPartyDebt>
    <dkdcu:AdvancesFromRelatedParties
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_AOO-h08NBUuUwLxVsbHJfg_30_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">11500</dkdcu:AdvancesFromRelatedParties>
    <dkdcu:AdvancesFromRelatedParties
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_AOO-h08NBUuUwLxVsbHJfg_30_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">11500</dkdcu:AdvancesFromRelatedParties>
    <dkdcu:AdvancesFromRelatedParties
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_8KnhIxR_-EiCJto0bYLM2g_30_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:AdvancesFromRelatedParties>
    <dkdcu:ProceedsFromWorkingCapitalLoan
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_7vakT5DyqUKuxHvUYVaDTA_31_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">207081</dkdcu:ProceedsFromWorkingCapitalLoan>
    <dkdcu:ProceedsFromWorkingCapitalLoan
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_7vakT5DyqUKuxHvUYVaDTA_31_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">207081</dkdcu:ProceedsFromWorkingCapitalLoan>
    <dkdcu:ProceedsFromWorkingCapitalLoan
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_P2Awxn_fVkOO8lqRyQmsDw_31_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:ProceedsFromWorkingCapitalLoan>
    <dkdcu:ProceedsFromExtensionLoan
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_AOCMRQNcfU2IYiIG_Fu0Pw_32_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2545838</dkdcu:ProceedsFromExtensionLoan>
    <dkdcu:ProceedsFromExtensionLoan
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_y1RW-yE3Ok6CYSBLAjLYdw_32_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:ProceedsFromExtensionLoan>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_dIT0rpLVvU60VmtK3IpZTw_33_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2764419</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_dIT0rpLVvU60VmtK3IpZTw_33_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2764419</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_9E5WbvCq0E6PWRmqCmRiOQ_33_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">118131638</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_9E5WbvCq0E6PWRmqCmRiOQ_33_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">118131638</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_Qzto0ukTtEqcu901Kn2Ypg_34_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-422281</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_0mkDc3Yc6kq5P1RMFXui7w_34_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">453151</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_5oAXKrfNyUqh1g9NfQDh0Q_35_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">453151</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_5oAXKrfNyUqh1g9NfQDh0Q_35_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">453151</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_2_7_2021_xIunY2_KPEmoFeGygcAWFQ"
      decimals="0"
      id="Tc_mcTc7Q73-Ueopyj9h2nNdg_35_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_do3t2Fgmikyif-krl3AINg_36_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_do3t2Fgmikyif-krl3AINg_36_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_cg_2i8hhiUWiMBSd6vaMRg_36_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">453151</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_cg_2i8hhiUWiMBSd6vaMRg_36_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">453151</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_8oVCHZYctkCr0h6JpU_8HQ_38_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">3359593</dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption>
    <dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_8oVCHZYctkCr0h6JpU_8HQ_38_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">3359593</dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption>
    <dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_tp9YxPlCWUONEzoUOYkUWw_38_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:RemeasurementOfClassCommonStockSubjectToPossibleRedemption>
    <dkdcu:RedemptionOfClassCommonStockHeldInTrustIncludingInterest
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_c09xa1uUfkq2bOpFzZr3Hw_39_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">91909483</dkdcu:RedemptionOfClassCommonStockHeldInTrustIncludingInterest>
    <dkdcu:RedemptionOfClassCommonStockHeldInTrustIncludingInterest
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_c09xa1uUfkq2bOpFzZr3Hw_39_3_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">91909483</dkdcu:RedemptionOfClassCommonStockHeldInTrustIncludingInterest>
    <dkdcu:RedemptionOfClassCommonStockHeldInTrustIncludingInterest
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_mQeGvpeARUSdtETqdlRSHQ_39_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:RedemptionOfClassCommonStockHeldInTrustIncludingInterest>
    <dkdcu:DeferredUnderwritingFeePayable
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_xAs1Vd84WU6u73I_WZD_tw_40_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:DeferredUnderwritingFeePayable>
    <dkdcu:DeferredUnderwritingFeePayable
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_xAs1Vd84WU6u73I_WZD_tw_40_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:DeferredUnderwritingFeePayable>
    <dkdcu:InitialFairValueOfWarrantLiabilities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_CDPUhW1RTESc8weoTExWpQ_41_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">11176949</dkdcu:InitialFairValueOfWarrantLiabilities>
    <dkdcu:InitialFairValueOfWarrantLiabilities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_CDPUhW1RTESc8weoTExWpQ_41_6_2"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">11176949</dkdcu:InitialFairValueOfWarrantLiabilities>
    <us-gaap:NatureOfOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_HyzlKk_iaUWwtVzM6B2cqg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Data Knights Acquisition Corp. (the &#x201c;Company&#x201d;) is a blank check company incorporated in Delaware on February 8, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the &#x201c;Business Combination&#x201d;). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2022, the Company had not yet commenced any operations. All activity for the period February 8, 2021 (inception) through December 31, 2022, relates to the Company&#x2019;s formation and the initial public offering (the &#x201c;Initial Public Offering&#x201d;), and, since the closing of the initial public offering, the Company has entered into a merger agreement (as described below), and continued a search for a Business Combination candidate. The Company has selected December 31 as its fiscal year end.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on May 6, 2021. On May 11, 2021, the Company consummated the Initial Public Offering of 11,500,000 units (&#x201c;Units&#x201d; and, with respect to the shares of Class&#160;A Common Stock included in the Units offered, the &#x201c;Public Shares&#x201d;), generating gross proceeds of $115,000,000, which is described in Note&#160;3.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 585,275 private placement units (the &#x201c;Private Placement Units&#x201d;) at a price of $10.00 per unit in a private placement to the Sponsor, generating gross proceeds of $5,852,750, which is described in Note&#160;4.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Following the closing of the Initial Public Offering on May 11, 2021, an amount of $117,300,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (&#x201c;Trust Account&#x201d;) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company&#x2019;s stockholders, as described below.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Transaction costs of the Initial Public Offering amounted to $6,771,112, of which $2,300,000 was for underwriting fees paid at the time of the IPO, $4,025,000 was for deferred underwriting commissions, and $446,112 was for other offering costs. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Following the closing of the Initial Public Offering $959,560 of cash was held outside of the Trust Account available for working capital purposes. As of December 31, 2022, the Company has $30,870 of cash and a working capital deficit of $1,945,267.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;On April 25, 2022, the Company, Data Knights Merger Sub, Inc., a Delaware corporation (&#x201c;Merger Sub&#x201d;), and Data Knights, LLC, the Company&#x2019;s sponsor (the &#x201c;Sponsor&#x201d;), entered into a definitive Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;) with OneMedNet Corporation, Inc., a Delaware corporation (the &#x201c;Target&#x201d;, and together with the Company and Merger Sub, the &#x201c;Parties&#x201d;) and Paul Casey, as seller representative (&#x201c;Casey&#x201d;). Pursuant to the Merger Agreement, upon the closing (the &#x201c;Closing&#x201d;) of the Business Combination, the Parties will effect the merger of Merger Sub with and into the Target, with the Target continuing as the &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;surviving entity (the &#x201c;Merger&#x201d;), as a result of which all of the issued and outstanding capital stock of the Target shall be exchanged shares of the Class A Common Stock of the Company upon the terms set forth in the Merger Agreement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On May 5, 2022, the Company extended the date by which the Company has to consummate a business combination from May 11, 2022 to August 11, 2022 (the &#x201c;First Extension&#x201d;). The First Extension was the first of two three-month extensions permitted under the Company&#x2019;s governing documents.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On August 10, 2022, the Company extended the date by which the Company has to consummate a business combination from August 11, 2022 to November 11, 2022 (the &#x201c;Second Extension&#x201d;). The Second Extension was the second of two three-month extensions permitted under the Company&#x2019;s governing documents. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On October 27, 2022, the Company filed a definitive proxy statement with the SEC in connection with the Company&#x2019;s solicitation of proxies for the vote by the stockholders of the Company at a special meeting of the Company&#x2019;s stockholders to be held on November 11, 2022 (the &#x201c;Special Meeting&#x201d;).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On November 11, 2022, at 10:00 a.m. ET, the Company held a virtual special meeting of its stockholders. At the special meeting, Company stockholders entitle to vote at the special meeting cast their votes and approved the Trust Amendment Proposal, pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO if the Company has not completed its initial business combination, from November 11, 2022 to August 11, 2023 (or such earlier date after November 11, 2022, as determined by the Data Knights Board). As a part of Special Meeting, the Company&#x2019;s stockholders approved amendments to its second amended and restated certificate of incorporation (the &#x201c;Extension Amendment&#x201d;) and the investment management trust agreement (the &#x201c;Trust Agreement&#x201d;) between Continental Stock Transfer &amp;amp; Trust Company, as trustee (&#x201c;Continental&#x201d;), and the Company governing the trust account (the &#x201c;Trust Account&#x201d;) established in connection with the Company&#x2019;s initial public offering dated May 11, 2021 (the &#x201c;Trust Amendment&#x201d;), which together allow the Company to extend the deadline by which it must complete its initial business combination by up to nine one-month periods. In connection with each such extension, Data Knights, LLC, the Company&#x2019;s sponsor, shall cause $0.045 per outstanding share of the Company&#x2019;s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account. As of December 31, 2022, the Company has executed two one-month extensions, out of the nine, resulting in deposits of approximately $245,840 into the Trust Account.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In connection with the proposed Business Combination with the Target, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Stock upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the proposed Business Combination with the Target is not consummated, in connection with an alternative proposed initial business combination, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of 8,768,456 shares of Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of $10.42 per share, for an aggregate of approximately $91.4 million. Following the payment of the redemptions, the Trust Account had a balance of approximately $28.5 million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Based on the above, the Company will have until August 11, 2023 to consummate a Business Combination. If the Company is unable to complete a Business Combination on August 11, 2023 at the election of the Company subject to satisfaction of certain conditions, including the deposit of up $2,300,000 since the underwriters&#x2019; over-allotment option is exercised in full ($0.10 per unit), into the Trust Account, or as extended by the Company&#x2019;s stockholders in accordance with the Company&#x2019;s amended and restated certificate of incorporation) (the &#x201c;Combination Period&#x201d;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#x2019;s &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the shares of Class A Common Stock and the warrants that are included as components of the Private Placement Units. Such warrants will expire worthless if the Company fails to complete a Business Combination within the Combination Period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.20 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#x2019;s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company&#x2019;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Going Concern, Liquidity and Capital Resources&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2022 and 2021, the Company had cash held outside of the Trust Account of &lt;span style="-sec-ix-hidden:Hidden_cZQeLnh3Zk29sDgjeEin2Q;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$30,780&lt;/span&gt;&lt;/span&gt; and $453,151, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial business combination. As of December 31, 2022 and 2021, the Company had working capital surplus (deficit) of $(1,945,267) and $246,232, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s liquidity needs prior to the consummation of its IPO were satisfied through the proceeds of $25,000 from the sale of the Founder Shares and proceed from the promissory note from sponsor of $78,925, which was repaid upon closure of the IPO. Subsequent to the IPO, the Company&#x2019;s liquidity will be satisfied through a portion of the net proceeds from IPO held outside of the Trust Account. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2022 and 2021, we had investments of $29,029,416 and $117,320,973 held in the Trust Account, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes. During the period ended December 31, 2022, we withdraw $299,601 of interest earned on the Trust Account to pay Delaware Franchise Tax. During the period ended December 31, 2021, we did not withdraw any interest earned on the Trust Account. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed. The Company will have until August 23, 2023 to consummate a Business Combination. If our initial business combination is not consummated by &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;August 23, 2023, less than one year after the date the financial statements are issued, then our existence will terminate, and we will distribute all amounts in the trust account. The Company intends to complete a business combination before the liquidation date and no adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after such date. There can be no assurance that the Company will be able to consummate an initial business combination by August 23, 2023 and/or have sufficient working capital and borrowing capacity to meet its needs. Based upon the above analysis, management determined that these conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Accounts to repay such loaned amounts but no proceeds from our Trust Accounts would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units identical to the Placement Units, at a price of $10.00 per unit at the option of the lender.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;On August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;IR Act&#x201d;) was signed into law. The IR Act provides for, among other measures, a new 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom the shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased. For purposes of calculating the excise tax, however, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#x201c;Treasury Department&#x201d;) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Any redemption or other repurchase effected by us that occurs after December 31, 2022, in connection with a Business Combination or otherwise, may be subject to this excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the nature and amount of any PIPE financing or other equity issuances in connection with the Business Combination (or any other equity issuances within the same taxable year of the Business Combination) and (iii) the content of any regulations and other guidance issued by the Treasury Department and/or the Internal Revenue Service. In addition, because the excise tax would be payable by us and not by the redeeming holder, it could cause a reduction in the value of our stock. The foregoing could cause a reduction in the cash available on hand to complete a business Combination in the required time and redeem 100% of our public shares in accordance with our amended and restated certificate of incorporation) could be subject to the excise tax, in which case the amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <dkdcu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
      contextRef="Duration_2_8_2021_To_2_8_2021_v79xWrSU2E2fOfIAgN6zrQ"
      decimals="INF"
      id="Narr_oE_OWcuCPUaLmnL38KQSrw"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">1</dkdcu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum>
    <dkdcu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ"
      decimals="INF"
      id="Narr__8_nz8rGLECkdnr493XVSQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</dkdcu:UnitsIssuedDuringPeriodSharesNewIssues>
    <dkdcu:ProceedsFromSaleOfUnits
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ"
      decimals="0"
      id="Narr_tWdmwVA6V0SLwKgT5GthCw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">115000000</dkdcu:ProceedsFromSaleOfUnits>
    <dkdcu:NumberOfWarrantsIssued
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg"
      decimals="INF"
      id="Narr_UF2lpy25kUuEYpwbpwNIsg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</dkdcu:NumberOfWarrantsIssued>
    <dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_D81xSwKtWUK5pM73JnCYwA"
      decimals="2"
      id="Narr_HSiFOGQ2YEKHYHHusJnLdg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_2HT_yFzoU0inugkBVaLXkg"
      decimals="0"
      id="Narr_xU0RxFoTL0Sg3fyrGcbNxg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5852750</us-gaap:ProceedsFromIssuanceOfWarrants>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_5_11_2021_To_5_11_2021_NmXExQZglUSAztqWU0QU3w"
      decimals="0"
      id="Narr__tNjnF7S6kmxsywxa37bXQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg"
      decimals="2"
      id="Narr_wTwtt_v4j0eOv2yEWMOeRg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SharesIssuedPricePerShare>
    <dkdcu:TransactionCosts
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g"
      decimals="0"
      id="Narr_yTVi61axkECET7o1MYi38w"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">6771112</dkdcu:TransactionCosts>
    <dkdcu:SaleOfStockUnderwritingFees
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g"
      decimals="0"
      id="Narr_S7ecLtdJw0WRI0ZSt2Yg6w"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2300000</dkdcu:SaleOfStockUnderwritingFees>
    <dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g"
      decimals="0"
      id="Narr_rMDs8keZ3kuAtje9BsPE9A"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.>
    <dkdcu:SaleOfStockOtherOfferingCosts
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g"
      decimals="0"
      id="Narr_hTu786zymEWWzq77KN14Qg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">446112</dkdcu:SaleOfStockOtherOfferingCosts>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_G6_zF5TSikiD8EVocXu3Mw"
      decimals="0"
      id="Narr_7XoOkugdMku9XhN6_tm2Cg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">959560</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:Cash
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g"
      decimals="0"
      id="Narr_kngHyduLjECXIRlSQ7Oc-Q"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:Cash>
    <dkdcu:WorkingCapitalDeficit
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_1MOFRzVGBUC2C_VeocwLew"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-1945267</dkdcu:WorkingCapitalDeficit>
    <dkdcu:ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="2"
      id="Narr_xje7TZ--V06qAmC5CAOW9A"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.80</dkdcu:ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount>
    <dkdcu:ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="2"
      id="Narr_pUIG3lyVK0-6zXkxygmXpA"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.50</dkdcu:ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination>
    <dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA"
      decimals="INF"
      id="Narr_8cqxnvyhy020OvypatfoPQ"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">2</dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_5_5_2022_To_5_5_2022_S3qGBeL_mUWV80qRyGWUzA"
      id="Narr_-tQ8VUNdA0WHSEPFZpIdLg">P3M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA"
      decimals="INF"
      id="Narr_y35jDHIREUSwSobfVvrFCw"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">2</dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_8_10_2022_To_8_10_2022_aJSSNtV3S0u_e1knmXPnNA"
      id="Narr_qWzYbfxVnk2S7FCcPigDdg">P3M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      decimals="INF"
      id="Narr_49_sTkmA5UCOFs1bp6Xrug"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">9</dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      id="Narr_jzlacAGIqUWLS_palteGWg">P1M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      decimals="3"
      id="Narr_aKjpcztF_0CnxlJokrH4UQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.045</dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount>
    <dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      decimals="0"
      id="Narr_wlYUEWs8uE2Y9k3zaKqAfA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">122920</dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension>
    <dkdcu:NumberOfOneMonthExtensionsExecuted
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_4nDMqq5l_0yY-LxR8hboJA"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">2</dkdcu:NumberOfOneMonthExtensionsExecuted>
    <dkdcu:ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Narr_pK2GJrQeDkWELF-ioNkE_A">P1M</dkdcu:ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination>
    <dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="INF"
      id="Narr_W_ENoM0f6UOKk7eE_DQLsw"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">9</dkdcu:NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Narr_TRS5w4Q8s0SLjeap6FGOlA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">245840</dkdcu:AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions>
    <dkdcu:MinimumNetTangibleAssetUponConsummationOfBusinessCombination
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_sEfn5Pjs0UuvvrUMrbOByQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5000001</dkdcu:MinimumNetTangibleAssetUponConsummationOfBusinessCombination>
    <dkdcu:CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      decimals="INF"
      id="Narr_z0A1rqPCiEWoISvBjBIs0w"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8768456</dkdcu:CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g"
      decimals="2"
      id="Narr_-671-RQgrUKJQgI8RwaeXQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.42</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g"
      decimals="-5"
      id="Narr_KGusdaueakmSGYN4MQzsFg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">91400000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:AssetsHeldInTrust
      contextRef="As_Of_11_11_2022_hHR8AafK6kaFt359sgMQ5g"
      decimals="-5"
      id="Narr_McxjfwU8Fku0UXOQcTzCWA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">28500000</us-gaap:AssetsHeldInTrust>
    <dkdcu:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_3RZpCGP7S0q5c4sXVDjShA"
      decimals="0"
      id="Narr_pOETQbE67EqX8R3pkFKe0g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2300000</dkdcu:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_3RZpCGP7S0q5c4sXVDjShA"
      decimals="2"
      id="Narr_wFgekSbZO0uN0A_NX2dyUg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.10</us-gaap:SharesIssuedPricePerShare>
    <dkdcu:MaximumNetInterestToPayDissolutionExpenses
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Narr_XJ3m7FyRKkyW45xO3bBZww"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">100000</dkdcu:MaximumNetInterestToPayDissolutionExpenses>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_nkytggwfOUicjHUoROoi4g"
      decimals="2"
      id="Narr_N1zvwemyLkWMmiK69kjNUg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SharesIssuedPricePerShare>
    <dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="2"
      id="Narr_V2Pd_lOgN0CbHIatzyaEyw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.20</dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="2"
      id="Narr_bXGvsuTWqUq02h0XxGm4RA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.20</dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <dkdcu:CashHeldOutsideInTrustAccount
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Narr__apPkERyc0mwx9l8pn-k2g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">453151</dkdcu:CashHeldOutsideInTrustAccount>
    <dkdcu:WorkingCapitalDeficit
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_18xg_LQoCkK-ro_1hnq7TA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-1945267</dkdcu:WorkingCapitalDeficit>
    <dkdcu:WorkingCapitalDeficit
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Narr_c-6tMLhZTEy3GLiLLRc4hg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">246232</dkdcu:WorkingCapitalDeficit>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_pKJtyVvMnEGNV_bpgbIOwA"
      decimals="0"
      id="Narr_pYD1ff7bKUqbJoNt84sKYA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_OeMjnbZWu0aoMSIKBb6DzQ"
      decimals="0"
      id="Narr_WHuNGf0oMUq1hZbBBWuKxg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">78925</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_UpV77KJyIU-07f1u3Q4tmg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Narr_H0fzAwDYskybeeQXXT7nlw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117320973</us-gaap:AssetsHeldInTrustNoncurrent>
    <dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Narr_e9Hgb5P-JU6T6StJJxpxoQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">299601</dkdcu:ProceedsFromInterestWithdrawnFromTrustAccount>
    <us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Narr_OButbJAtxkC-77YeVUuNXw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1500000</us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="2"
      id="Narr_yNz8DbOEtE20y0jAeXCZDw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <dkdcu:PercentageOfPublicSharesToBeRedeemed.
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="2"
      id="Narr_Ao-1jPJ4ykulUHNpCdLaRg"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">1</dkdcu:PercentageOfPublicSharesToBeRedeemed.>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_Fmbr_UvpKEO8ROQAWUmADg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Basis of presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Emerging growth company&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Use of estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had $30,870 and $453,151 in cash and no cash equivalents as of December 31, 2022 and 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Trust Account&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Upon the closing of the Initial Public Offering and the Private Placement, $117,300,000 ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#x201c;Trust Account&#x201d;) located in the United States with Continental Stock Transfer &amp;amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#x201c;Investment Company Act&#x201d;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Offering Costs Associated with the Initial Public Offering&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#x2019; equity upon the completion of the Initial Public Offering.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Class A Common Stock Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#x2019; equity. The Company&#x2019;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On December 31, 2022, there are 585,275 shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and 11,500,000 shares of Class A Common Stock outstanding, which are subject to possible redemption.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;As of December 31, 2022 and 2021, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock- &lt;/b&gt;Opening Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Gross Proceeds&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 115,000,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;  &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Proceeds allocated to public warrants and private warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,614,500)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Issuance costs related to Class A Common Stock&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,146,054)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Redemption of Class A Common Stock, including interest&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (91,909,483)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Plus:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;  &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Re-measurement of carrying value to redemption value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,359,593&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,060,554&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock- &lt;/b&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 28,750,110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;background:#ffff00;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net income per share&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Net income per share is computed by dividing net income by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#x201c;Placement Warrants&#x201d;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 12,085,275 shares of common stock in the aggregate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;The following table reflects the calculation of basic and diluted net income per common share:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the period of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;February 8, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the year ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Through&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Redeemable Class A common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income allocable to common stock subject to possible redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 240,532&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,671,658&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,667,969&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,264,526&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income per redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.44&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-redeemable Class A and Class B common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income allocable to common stock not subject to redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 96,126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,464,132&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of non-redeemable common shares &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,464,052&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,295,610&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income per non-redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.44&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock-Based Compensation Expense&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company accounts for stock-based compensation expense in accordance with ASC Topic 718, &#x201c;Compensation &#x2013; Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. The fair value of equity awards has been estimated using a market approach. Forfeitures are recognized as incurred.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2021, the Company determined that it was not probable that ARC would meet the performance condition as defined in the Introducing Advisor Agreement (See Note 5), and therefore, no stock-based compensation expense was recognized. At December 31, 2022, upon amendment of the Introducing Advisor Agreement, which amended ARC&#x2019;s performance condition that was concurrently deemed to have been met, ARC was granted 1,378,517 shares of the Company&#x2019;s Class B common stock at a fair value of $2.05 per share. The Company recorded the resulting $2,825,960&lt;span style="white-space:pre-wrap;"&gt; of stock based compensation expense on December 31, 2022, which is included in formation and operating costs in the consolidated statement of operations.  The fair value of the Class B common stock was determined by applying a discount to the actively traded Class A shares, which have an observable market price. The discount was calculated as the average discount of the Class B share price (derived) compared to the Class A share price (observable) for SPACs that have actively traded &#x201c;Rights&#x201d;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Concentration of credit risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of financial instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Derivative Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income Taxes &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company complies with the accounting and reporting requirements of ASC Topic 740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the United States is the Company&#x2019;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &#x201c;Debt &#x2014; Debt with Conversion and Other Options&#x201d; (Subtopic 470-20) and &#x201c;Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity&#x201d; (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_DlWpaf7ZyE--w8e7B3E5wQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Basis of presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_ugwMMdIIlUilrCizxrHJqw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <dkdcu:EmergingGrowthCompanyPolicyPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_Xmp_r3Y7GE-wGJCJ3ysNVA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Emerging growth company&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</dkdcu:EmergingGrowthCompanyPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_IT7QZiP--EKb5n5lhah_sw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Use of estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_ROMBo4d-KEW-ljrwMWqSCQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had $30,870 and $453,151 in cash and no cash equivalents as of December 31, 2022 and 2021.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_aFhNK60vWUyM40TvYP4Jxg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">30870</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Narr_wAqj3Rl03k-F24G_VNmY8g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">453151</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="-3"
      id="Narr_GQfTdcJPhEmq8ND7gDkPqw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="-3"
      id="Narr_Ewp3Nd4fvESktwiAcSB8Pw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:CashEquivalentsAtCarryingValue>
    <dkdcu:AssetsHeldInTrustAccountPolicyPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_qNI8HejdsEuRoqgwRWStog">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Trust Account&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Upon the closing of the Initial Public Offering and the Private Placement, $117,300,000 ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#x201c;Trust Account&#x201d;) located in the United States with Continental Stock Transfer &amp;amp; Trust Company acting as trustee, and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act 1940, as amended (the &#x201c;Investment Company Act&#x201d;), which will be invested only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.&lt;/p&gt;</dkdcu:AssetsHeldInTrustAccountPolicyPolicyTextBlock>
    <dkdcu:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="Duration_11_5_2021_To_11_5_2021_xmuZ3mYtZE2S5AExqoqVLQ"
      decimals="0"
      id="Narr_7gw0SoXvB0e-lv8OGY3q8Q"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</dkdcu:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_11_5_2021_iFKFTOhmqkmSj50YSfzJGg"
      decimals="2"
      id="Narr_dvq_QmBwZEqo7JE0U0zV1Q"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_Xq1KrZHdeE248eAM7HFs2A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Offering Costs Associated with the Initial Public Offering&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as offering costs allocated to warrants in the consolidated statements of operations. Offering costs associated with the Public Shares were charged to stockholders&#x2019; equity upon the completion of the Initial Public Offering.&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <dkdcu:TemporaryEquityPolicyPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_fhm7Siq6Kk6yL0KKl0lkkA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Class A Common Stock Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, shares are classified as stockholders&#x2019; equity. The Company&#x2019;s Class A Common Stock features certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On December 31, 2022, there are 585,275 shares of Class A Common Stock related to the Private Placement Unit (Note 8) outstanding, which are not subject to redemption, and 11,500,000 shares of Class A Common Stock outstanding, which are subject to possible redemption.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;As of December 31, 2022 and 2021, the Class A Common Stock reflected on the balance sheet are reconciled in the following table:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock- &lt;/b&gt;Opening Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Gross Proceeds&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 115,000,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;  &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Proceeds allocated to public warrants and private warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,614,500)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Issuance costs related to Class A Common Stock&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,146,054)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Redemption of Class A Common Stock, including interest&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (91,909,483)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Plus:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;  &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Re-measurement of carrying value to redemption value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,359,593&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,060,554&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock- &lt;/b&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 28,750,110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dkdcu:TemporaryEquityPolicyPolicyTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_cPiNE1TrwEiEkVSRwpcLnQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassSubjectToRedemptionMember_plSfh-MYoU2sk5vMPfPRtQ"
      decimals="INF"
      id="Narr_frsXccNzG0yI5MyFhPNehQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_Wuho8W7ZJU-0VOstRdeQHw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock- &lt;/b&gt;Opening Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Gross Proceeds&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 115,000,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;  &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Proceeds allocated to public warrants and private warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,614,500)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Issuance costs related to Class A Common Stock&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,146,054)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Redemption of Class A Common Stock, including interest&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (91,909,483)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Plus:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;  &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Re-measurement of carrying value to redemption value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,359,593&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,060,554&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 5.75pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingently redeemable Class A Common Stock- &lt;/b&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 28,750,110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,300,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ"
      decimals="0"
      id="Tc_Owl-jrRR2U2S4GooWzVmIQ_2_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <dkdcu:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="0"
      id="Tc_ugrhOpYiB02wpnycWhpiIg_3_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">115000000</dkdcu:ProceedsFromIssuanceOfTemporaryEquity>
    <dkdcu:TemporaryEquityProceedsAllocatedToWarrants
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="0"
      id="Tc_KG7SY-lmbkiCx80KpdiE3g_5_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-10614500</dkdcu:TemporaryEquityProceedsAllocatedToWarrants>
    <dkdcu:TemporaryEquityIssuanceCosts
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="0"
      id="Tc_SVsoJGvMhEmy2UKs9zpMjw_6_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-6146054</dkdcu:TemporaryEquityIssuanceCosts>
    <dkdcu:RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="0"
      id="Tc_y5Ke43J370W8TysT17lJ3Q_7_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-91909483</dkdcu:RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="0"
      id="Tc_fwJP14Cx0EaSQA4NNJ4axA_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">3359593</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="0"
      id="Tc_M8wChOYki0-6ANI576v2gg_9_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">19060554</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ"
      decimals="0"
      id="Tc_agTOGxeanUGVHEin3jaHeg_10_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">28750110</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ"
      decimals="0"
      id="Tc_qZhYHy-w9UGTjxHb8kC3kQ_10_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117300000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_lP7EwBfRMkuryqN2zMOOGQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net income per share&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Net income per share is computed by dividing net income by the weighted average number of common stock shares outstanding for the period. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the &#x201c;Placement Warrants&#x201d;) since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend for the purposes of the numerator in the earnings per share calculation. Net income per common share is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common shares outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 12,085,275 shares of common stock in the aggregate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;The following table reflects the calculation of basic and diluted net income per common share:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the period of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;February 8, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the year ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Through&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Redeemable Class A common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income allocable to common stock subject to possible redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 240,532&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,671,658&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,667,969&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,264,526&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income per redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.44&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-redeemable Class A and Class B common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income allocable to common stock not subject to redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 96,126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,464,132&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of non-redeemable common shares &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,464,052&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,295,610&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income per non-redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.44&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <dkdcu:WarrantExercisable
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Narr_r5J3dAQkWU2hwkIohrUo8A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:WarrantExercisable>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_M0A8YHO8sESBPelt9J_G1g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the period of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;February 8, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the year ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Through&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Redeemable Class A common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income allocable to common stock subject to possible redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 240,532&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,671,658&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,667,969&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,264,526&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income per redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_cBacU7djtUCSXr11GkPXGw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_3Es1orTY_USJ4itNDtiZDw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.44&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-redeemable Class A and Class B common shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-top:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Numerator:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income allocable to common stock not subject to redemption&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 96,126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,464,132&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Denominator: weighted average number of non-redeemable common shares &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,464,052&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,295,610&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted net income per non-redeemable common share&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_lanKp2oqLU-qANj804gmEQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.48%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_5OAEfUoUY0K-bvq2FdDuFg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.44&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="0"
      id="Tc_LwQNralN4UGht9eTS0ZT5A_8_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">240532</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="0"
      id="Tc_gEWU1elYlUW7VAUU4ySyiA_8_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">3671658</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="0"
      id="Tc_xl2JldvbmE2eP3HmUc0PsA_9_3"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8667969</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="0"
      id="Tc_wYnX5Bf8OEKrycvCvzu1xg_9_6"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">8264526</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_0xaJdymLl0OY7FrkhSXKUQ"
      decimals="2"
      id="Tc_umm3y3TxGUe8oDpbTgLDSg_10_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_SZtu4r2CqUyztbzAc9az2Q"
      decimals="2"
      id="Tc_IgTUMVIjLEKXzfPykspgZw_10_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q"
      decimals="0"
      id="Tc_huW10Xjlx0OOyA8T62T6Ww_13_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">96126</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw"
      decimals="0"
      id="Tc_Es17RgWfdkyDNa4nklQINQ_13_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1464132</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q"
      decimals="0"
      id="Tc_CAs8Cp3Z-0eKMtB1XMrfAQ_14_3"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3464052</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw"
      decimals="0"
      id="Tc_GYzORes69EGUH69oeWmG4g_14_6"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">3295610</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_ribpcsC4FUiOZj2JMNQH8Q"
      decimals="2"
      id="Tc_-MDOx1K3WUOuvyr3xEec7w_15_3"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember_5mE2n5uz6kavZwsIEiBhdw"
      decimals="2"
      id="Tc_UKrDuNA7IkyEBz8_cUgsIQ_15_6"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_h4yJF8FDZk2g0vs7BZRZ5w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock-Based Compensation Expense&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company accounts for stock-based compensation expense in accordance with ASC Topic 718, &#x201c;Compensation &#x2013; Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. The fair value of equity awards has been estimated using a market approach. Forfeitures are recognized as incurred.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2021, the Company determined that it was not probable that ARC would meet the performance condition as defined in the Introducing Advisor Agreement (See Note 5), and therefore, no stock-based compensation expense was recognized. At December 31, 2022, upon amendment of the Introducing Advisor Agreement, which amended ARC&#x2019;s performance condition that was concurrently deemed to have been met, ARC was granted 1,378,517 shares of the Company&#x2019;s Class B common stock at a fair value of $2.05 per share. The Company recorded the resulting $2,825,960&lt;span style="white-space:pre-wrap;"&gt; of stock based compensation expense on December 31, 2022, which is included in formation and operating costs in the consolidated statement of operations.  The fair value of the Class B common stock was determined by applying a discount to the actively traded Class A shares, which have an observable market price. The discount was calculated as the average discount of the Class B share price (derived) compared to the Class A share price (observable) for SPACs that have actively traded &#x201c;Rights&#x201d;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_y4Va1YH3m0eX130BeYRwng"
      decimals="0"
      id="Narr_x7nJySX5ikyH2cXbVWfMyA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_uEkHeFxWoUKCxd1wCPJN3g"
      decimals="INF"
      id="Narr_OA-Ut2LqP0KzGuQB8jv0xg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1378517</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharePrice
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_wLPX3pqnoEGRhqgS36Atpg"
      decimals="2"
      id="Narr_sEZbhWytk0ehXX7IOEZ3TQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">2.05</us-gaap:SharePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_OperatingExpenseMember_Z4B4V5TZ9kOeJBQx4nhBbw"
      decimals="0"
      id="Narr_nKBUPrORhkacJoq_m6c3QQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2825960</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_ElqC65m54USTkS6HPLUfVQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Concentration of credit risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_87TI69vu30mklENRA-KHLw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of financial instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except warrant liabilities (See Note 9).&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <dkdcu:DerivativeFinancialInstrumentsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_SjwqaCNNq0WKmzJ7EfB0qQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Derivative Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.&lt;/p&gt;</dkdcu:DerivativeFinancialInstrumentsPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_UhFl38eawUCe6vgQVRybuQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income Taxes &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company complies with the accounting and reporting requirements of ASC Topic 740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the United States is the Company&#x2019;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Narr_OLnwJGjZAUCvnpcNgWqH3Q"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_GiDSppUEOUOn_J-4d59OLA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Narr_PqvEgFeJLk-bWOX6gCqTJA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_ZWNqevjSVUy5GpOy3i7GnA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_t7MJSQCImESFDyDol0GcSQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &#x201c;Debt &#x2014; Debt with Conversion and Other Options&#x201d; (Subtopic 470-20) and &#x201c;Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity&#x201d; (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for the Company for the fiscal year beginning after December 15, 2023, including interim periods within&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <dkdcu:InitialPublicOfferingDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_zAK-jRFJFE6Gjh9I53n7Mg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 3. INITIAL PUBLIC OFFERING&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Pursuant to the Initial Public Offering, the Company sold 11,500,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one share of the Company&#x2019;s Class A Common Stock, $0.0001 par value, and one redeemable warrant (&#x201c;Public Warrant&#x201d;). Each Public Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $11.50&#160;per whole share (see Note&#160;9).&lt;/p&gt;</dkdcu:InitialPublicOfferingDisclosureTextBlock>
    <dkdcu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_PybbK7jllkuNf3gGxzpqNQ"
      decimals="INF"
      id="Narr_TbTarYU-HECHA2cHsjn7Zw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</dkdcu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_5_11_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_fctU6QHKQEOu595qEl978g"
      decimals="2"
      id="Narr_PjjqBn-9rEma33YcvfOa1Q"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SharesIssuedPricePerShare>
    <dkdcu:NumberOfSharesIssuedPerUnit
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_y47mRrlmNUqJZIDNSj342g"
      decimals="INF"
      id="Narr_fEiTAohav0ag775u_hXWMQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1</dkdcu:NumberOfSharesIssuedPerUnit>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g"
      decimals="INF"
      id="Narr_oWRM9rxdbEupqt4TEM7oAg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:NumberOfWarrantsIssuedPerUnit
      contextRef="Duration_5_11_2021_To_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_Zz-LC321iEOx0QXt64XTUw"
      decimals="INF"
      id="Narr_sx0udbdfE0KgxZRYRmJPIg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1</dkdcu:NumberOfWarrantsIssuedPerUnit>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="As_Of_5_11_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_6U7HjjkPGk-50H6MVgA20g"
      decimals="INF"
      id="Narr_PE_SqZykFUWlHUxqnsxaJg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="As_Of_5_11_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_3SQJIMIvWUS9ELj-b17duQ"
      decimals="2"
      id="Narr__OpYJAPqF066jV5Yq9luxg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <dkdcu:PrivatePlacementTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_nOcF53VKfE-75HprFEZSIQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 4. PRIVATE PLACEMENT&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of 585,275 Private Placement Units at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $5,852,750. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Private Placement Units are identical to the Units, except that (a) the Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of the Company&#x2019;s initial business combination except to permitted transferees and (b) the Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) may be exercised by the holders on a cashless basis and (ii) will be entitled to registration rights.&lt;/p&gt;</dkdcu:PrivatePlacementTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember__aKBWKKCl0y9GZbCCzx5Mg"
      decimals="INF"
      id="Narr_sxh6lL1vKk67vr-0k4gHLA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="As_Of_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember__aKBWKKCl0y9GZbCCzx5Mg"
      decimals="2"
      id="Narr_H69MDnu600yQskM-C-s8aA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_vJFpkC6zqk-9LH2SncbE-Q"
      decimals="0"
      id="Narr_OeOYL6u_GkqS-Zb_3brTlQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">5852750</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_DLLd0hUY8kCh2q3KBhUSWA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 5. RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Introducing Advisor Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On June 26, 2021, the Company entered into an introducing advisor agreement (the &#x201c;Introducing Advisor Agreement&#x201d;) with ARC Group Limited, the Company&#x2019;s financial advisor (&#x201c;ARC&#x201d;), pursuant to which ARC will make strategic introductions to the Company of potential target companies and/or their subsidiaries, affiliates, or representatives (each an &#x201c;Advisor Target&#x201d;) who may be interested in potential business combinations with the Company. In consideration for ARC&#x2019;s services under the Introducing Advisor Agreement, we agreed to (i) pay to ARC (a) a retainer of $50,000 upon execution of the Introducing Advisor Agreement and (b) a success fee of $100,000 upon the closing our initial business combination, and (ii) cause to be issued to ARC equity interests in the post-combination company representing a five-percent (5%) ownership interest in the post-combination company, if at any time prior to June 25, 2022 (the &#x201c;Termination Date&#x201d;), or within six (6) months after the consummation of an initial business combination or any financing with any Advisor Target or any affiliate of an Advisor Target (the &#x201c;Equity Issuance&#x201d;).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (5%) on any PIPE that was brought by ARC in connection with the Company&#x2019;s initial business combination upon the closing of the Company&#x2019;s initial business combination.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued 1,378,517 shares of the Company&#x2019;s Class B Common Stock, up to 143,766 shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On February 25, 2021, the Company issued an aggregate of 2,875,000 shares of Class B Common Stock (the &#x201c;Founder Shares&#x201d;) to the Sponsor for an aggregate purchase price of $25,000. On February 25, 2021, the Sponsor transferred 15,000 shares to the Company&#x2019;s Chief Executive Officer, 15,000 shares to the Company&#x2019;s Chief Financial Officer and 5,000 shares to two of the Company&#x2019;s independent directors. Following the determination of the Company&#x2019;s third independent director, on March 23, 2021, the Sponsor transferred 5,000 shares to such independent director. The Founder Shares which the Sponsor and its permitted transferees will collectively own, on an as-converted basis, represent 20% of the Company&#x2019;s issued and outstanding shares after the Initial Public Offering. In connection with the Introducing Advisors Agreement, on December 31, 2022, ARC was granted 1,378,517 shares of Class B common stock, $0.0001 par value per share, up to 143,766 of which are subject to forfeiture by ARC if the Company&#x2019;s public shareholders exercise redemption rights with respect to any of outstanding shares of Class A common stock.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;six months after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company&#x2019;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company&#x2019;s Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any &lt;span style="-sec-ix-hidden:Hidden_bbHY3R68R0qhn-ZoycDM0g;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;20&lt;/span&gt;&lt;/span&gt; trading&#160;days within any &lt;span style="-sec-ix-hidden:Hidden_oJtbLe8GvkWMoQVqcR68nA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;30&lt;/span&gt;&lt;/span&gt;-trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Promissory Note&#160;&#x2014; Related Party&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On February 8, 2021, the Sponsor committed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#x201c;Note&#x201d;). The Note was non-interest bearing and was payable on the earlier of July 31, 2021 or the completion of the Initial Public Offering. On June 1, 2021, the $78,925 outstanding under the promissory note was repaid in full. On December 31, 2022 and 2021, there is no amount outstanding under the promissory note.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In order to finance transaction costs in connection with a Business Combination, the Company&#x2019;s Sponsor, an affiliate of the Sponsor, or the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the &#x201c;Working Capital Loans&#x201d;). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into units at a price of $10.00 per unit. The Units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On December 31, 2022 and 2021, there is $207,081 and nil outstanding under the Working Capital Loans, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s second amended and restated certificate of incorporation provides that, if the Company anticipates that it may not be able to consummate a Business Combination within 12 months from the closing of the Company&#x2019;s initial public offering, the Company may, by resolution of the Company&#x2019;s board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to two times, each by an additional three months (for a total of up to 18 months to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account as set out below. Pursuant to the terms of the Company&#x2019;s second amended and restated certificate of incorporation and the trust agreement entered into between the Company and Continental Stock Transfer &amp;amp; Trust Company, in order for the time available for the Company to consummate the initial Business Combination to be extended, the Sponsor or its affiliates or designees, upon five business days advance notice prior to the applicable deadline, must deposit into the Trust Account $1,150,000 since the underwriters&#x2019; over-allotment option is exercised in full ($0.10 per unit), on or prior to the date of the applicable deadline, for each of the available three month extensions, providing a total possible Business Combination period of 18 months at a total payment value of $2,300,000 since the underwriters&#x2019; over-allotment option is exercised in full ($0.10 per unit) (the &#x201c;Extension Loans&#x201d;). Any such payments would be made in the form of non-interest-bearing loans. If the Company completes its initial Business Combination, the Company will, at the option of the Sponsor, repay the Extension Loans out of the proceeds of the Trust Account released to the Company or convert a portion or all of the total loan amount into units at a price of $10.00&#160;per unit, which units will be identical to the Private Placement Units. If the Company does not complete a Business Combination, the Company will repay such loans only from funds held outside of the Trust Account. Furthermore, the letter agreement among the Company and the Company&#x2019;s officers, directors, and the Sponsor contains a provision pursuant to which the Sponsor will agree to waive its right to be repaid for such loans to the extent there is insufficient funds held outside of the Trust Account in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination. The public stockholders will not be afforded an opportunity to vote on the extension of time to consummate an initial Business Combination from 12 months to 18 months described above or redeem their shares in connection with such extensions. Pursuant to the foregoing, on May 5, 2022, the Company extended the date by which the Company had to consummate a business combination from May 11, 2022 to August 11, 2022. On August 10, 2022, the Company extended the date by which the Company had to consummate a business combination from August 11, 2022 to November 11, 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As described in Note 1, on November 11, 2022, the Stockholders of the Company approved the Extension Amendment and the Trust Amendment to allow the Company to extend the deadline by which it must complete its initial business combination by up to nine one-month periods from November 11, 2022. In connection with each such extension, Data Knights, LLC, the Company&#x2019;s sponsor, caused $0.045 per outstanding share of the Company&#x2019;s Class A Common Stock, or approximately $122,920, deposited in the Trust Account in connection with the exercise of the monthly extension. In connection with each such extension, the Company will have until April 11, 2023 to consummate a Business Combination (see Note 11). On December 31, 2022 and 2021, there is $2,545,838 and nil outstanding under the Extension Loan, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Administrative Services Arrangement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Commencing on the date of the prospectus and until completion of the Company&#x2019;s Business Combination or liquidation, the Company may reimburse ARC Group Ltd., an affiliate of the Sponsor, up to an amount of $10,000 per month for office space, secretarial and administrative support. For the year ended December 31, 2022, we have incurred $120,000 in fees under this agreement. From February 8, 2021(inception) to December 31, 2021, the Company incurred $80,000 in fees under this agreement.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <dkdcu:RetainerFeeUponExecutionOfAgreement
      contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q"
      decimals="0"
      id="Narr_mrbQNAAB5E6LOwLNPUWr0A"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">50000</dkdcu:RetainerFeeUponExecutionOfAgreement>
    <dkdcu:SuccessFeeUponClosingOfInitialBusinessCombination
      contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q"
      decimals="0"
      id="Narr_Qkl2ZtwZs0afuMY1dwvWBg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">100000</dkdcu:SuccessFeeUponClosingOfInitialBusinessCombination>
    <dkdcu:PercentageOfOwnershipAsConsiderationForService
      contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q"
      decimals="2"
      id="Narr_GYKnCLXfXUC64MpH7sslUQ"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.05</dkdcu:PercentageOfOwnershipAsConsiderationForService>
    <dkdcu:ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget
      contextRef="Duration_6_26_2021_To_6_26_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_TypeOfArrangementAxis_dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember_lmRMQMTT302vqvY1j9oO4Q"
      id="Narr_3PrGREL50U2DQuNSmViyfg">P6M</dkdcu:ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget>
    <dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing
      contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_6BKMWuaDzEmPd9vqRg5_Nw"
      decimals="2"
      id="Narr_J2y7c8dROU2qaFdaryr4mw"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.05</dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ"
      decimals="INF"
      id="Narr_nI7vSrnZ6Eq4A4LeU2TrUg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1378517</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ"
      decimals="INF"
      id="Narr_DHdPXfOb00i0um3MvnjBRQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">143766</dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw"
      decimals="INF"
      id="Narr_k8KGHo5KLECVjcD67BcJxg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw"
      decimals="0"
      id="Narr_KW8kAgr5cUS8vVlcyQWnOg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember__hwYxA9DEkqAKdAwnBpc_w"
      decimals="INF"
      id="Narr_avyBpwJ0n0OVxMMMihuZiA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">15000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefFinancialOfficerMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6znbrCXxFkGIcYmCY0iT1Q"
      decimals="INF"
      id="Narr_iPtXHT5osUq9d48NXyx1Iw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">15000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_TwoIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_4pqzZtHe2EG3qyNAxfbe9A"
      decimals="INF"
      id="Narr_AG6FacGPM0-TOe71GlkbZQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">5000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_3_23_2021_To_3_23_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ThirdIndependentDirectorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_6T3pPliyHUS0duvs0F4HAw"
      decimals="INF"
      id="Narr_sa6D2QB3e02ZFDkA2mwa7w"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">5000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders
      contextRef="Duration_2_25_2021_To_2_25_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_KpNgytd9dkaDCvLPol7UFw"
      decimals="2"
      id="Narr_f4X2BmaCTkOavtWXHjxBxQ"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.20</dkdcu:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ"
      decimals="INF"
      id="Narr_Qow3lGdI1U20mOTx1OTCeg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1378517</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_IhW2rhKKn0qo7A0xhD9s0w"
      decimals="INF"
      id="Narr_iRgyoihwK0CqBRk_ZIxqRA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_EHRRAPvqx0esvmhZls7bfQ"
      decimals="INF"
      id="Narr_oSFHTy6CMkOpybxBidvDRw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">143766</dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights>
    <dkdcu:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA"
      id="Narr_FNbZTqL060KCYNw4G-Jxew">P6M</dkdcu:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion>
    <dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA"
      decimals="2"
      id="Narr_NltVwj7ZO0WI1HGNmYTLiA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">12.00</dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <dkdcu:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9NvsQ0LNvUCtnZ_HZcX0PA"
      id="Narr_hLGbcdM-Jke7zEOLQt35yA">P150D</dkdcu:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences>
    <dkdcu:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="As_Of_2_8_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_GfqTmPjOjEe_maJFOaIOog"
      decimals="0"
      id="Narr_Puiefft-Q0avyLEKLOWH2A"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">300000</dkdcu:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="Duration_6_1_2021_To_6_1_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ylqtNA-bUEmL4qYAA8d_tw"
      decimals="0"
      id="Narr_GSEOj7vz7UWCPEdSdTBHsg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">78925</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="As_Of_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_ssFfLQvrEkeHJ26-YR0QHA"
      decimals="0"
      id="Narr_OAWZh2zsLk2TWpKPvYi99g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_PromissoryNoteWithRelatedPartyMember_yldGfAut_UOwpJfZ6m96hA"
      decimals="0"
      id="Narr_xPuHOe4lxEGvsZXwQ62h4A"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <dkdcu:MaximumLoansConvertibleUptoConsummation
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Cu5tn0_8kEi4cYONPPpMdw"
      decimals="0"
      id="Narr_yTHmrmXA2U685MqbQm6kug"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1500000</dkdcu:MaximumLoansConvertibleUptoConsummation>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Aq0HD_XsTkKPxGsqbD7Syg"
      decimals="2"
      id="Narr_hmEV-g36_EuNWa9e7hFvLw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_zc8vCgsjJ02tRG0__b_sCA"
      decimals="0"
      id="Narr_WCVtcwYkTketwgk7W_ue9g"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">207081</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WorkingCapitalLoansWarrantMember_gGMCV4IGL0WN2ukxJY-jVw"
      decimals="0"
      id="Narr_6XoEIRWYp02W7B85fJLdoQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:CommonStockSharesOutstanding>
    <dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Narr_Oedgnq_WnkWs9HHJjrhing">P12M</dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination>
    <dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="INF"
      id="Narr_v7xaDD6JcUyK0_HT-OI7Dg"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">2</dkdcu:NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Narr_PFDuO8PwMESAedg0WLwnjA">P3M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:AggregatePeriodToConsummateInitialBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Narr_FmC0atJ4V0Ogoc0vlhCgnA">P18M</dkdcu:AggregatePeriodToConsummateInitialBusinessCombination>
    <dkdcu:NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="INF"
      id="Narr_BL9uxVqsQUyucWxJmGWLIg"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">5</dkdcu:NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven>
    <dkdcu:SecuritiesDepositHeldInTrustAccount
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_bWhzWPZIyUW-IA3VsLVynA"
      decimals="0"
      id="Narr_MF9i2faL2kG0axJTj7Rqnw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1150000</dkdcu:SecuritiesDepositHeldInTrustAccount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_CHYctHL-NEC04rksJieDWA"
      decimals="2"
      id="Narr_CrU3d1QQwU2zxZWPDo8GYg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.10</us-gaap:SaleOfStockPricePerShare>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Narr_HnO2OS65iEexOwD5oFP7Ig">P3M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:AggregatePeriodToConsummateInitialBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Narr_neVKXw7i1kuYenpxwqp5WA">P18M</dkdcu:AggregatePeriodToConsummateInitialBusinessCombination>
    <dkdcu:BusinessCombinationTotalPayments
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_bWhzWPZIyUW-IA3VsLVynA"
      decimals="0"
      id="Narr__MKOierm8kusZgKq6-m8vQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2300000</dkdcu:BusinessCombinationTotalPayments>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_CHYctHL-NEC04rksJieDWA"
      decimals="2"
      id="Narr_sniTBJt1RkypzP4R_Brp8g"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_Aq0HD_XsTkKPxGsqbD7Syg"
      decimals="2"
      id="Narr_0eKCil74GESWdX59eoIjhQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</us-gaap:SaleOfStockPricePerShare>
    <dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Narr_ALldqhi0PkCjNEwqwoVbwA">P12M</dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination>
    <dkdcu:AggregatePeriodToConsummateInitialBusinessCombination
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Narr_Eqa-mlNy0U-4pk8FN8EvTw">P18M</dkdcu:AggregatePeriodToConsummateInitialBusinessCombination>
    <dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      id="Narr_UoPdwn7IbEu1eOxKYQKBqg">P1M</dkdcu:ExtensionPeriodForConsummatingInitialBusinessCombination>
    <dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      decimals="3"
      id="Narr_eJ-tIfGqIkiWYzqTt3ZHhg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.045</dkdcu:AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount>
    <dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension
      contextRef="Duration_11_11_2022_To_11_11_2022_kl41GU-f0U2uxLIgb1BzlQ"
      decimals="0"
      id="Narr_h29T-mLByk-oGxxPF4KCfw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">122920</dkdcu:AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension>
    <dkdcu:ExtensionLoansNonCurrent
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr__6Cu0fsLEkqS9HmTXhm9FA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2545838</dkdcu:ExtensionLoansNonCurrent>
    <dkdcu:ExtensionLoansNonCurrent
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Narr_hYQnUbQR3UeSAmKfEPl_oA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:ExtensionLoansNonCurrent>
    <dkdcu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_ekDZPE3EmEWL2qEJTcZkQw"
      decimals="0"
      id="Narr_pTNnnN4AWEqGH625jXKBeA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">10000</dkdcu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth>
    <dkdcu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_qQvFEWW_20uSottBNfK9TA"
      decimals="0"
      id="Narr_ngU72Ne5lEKvVHnhBVVSXA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">120000</dkdcu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionAxis_dkdcu_AdministrativeSupportAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember_z1cvmMf8N0SP-RnaUQjayA"
      decimals="0"
      id="Narr_e0t4M5UNPEqvS1usa_5EBA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">80000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_xn5_m0FBSkWYWtd2fN5XJQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 6. COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Pursuant to a registration rights agreement entered into on May 6, 2021, the holders of the Founder Shares, Private Placement Units (including the securities contained therein), the units (including the securities contained therein) that may be issued upon conversion of the Working Capital Loans, and any shares of Class A Common Stock issuable upon the exercise of the Placement Warrants and any shares of Class A Common Stock, warrants (and underlying Class A Common Stock) that may be issued upon conversion of the units issued as part of the working capital loans and Class A Common Stock issuable upon conversion of the founder shares are entitled to registration rights. The holders of a majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Underwriters Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company granted the underwriter a 45-day option to purchase up to 1,500,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The aforementioned option was exercised on May 11, 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The underwriter was paid a cash underwriting discount of two percent (2.00%) of the gross proceeds of the Initial Public Offering, or $2,300,000. In addition, the underwriter is entitled to a deferred fee of three and a half percent (3.50%) of the gross proceeds of the Initial Public Offering, or $4,025,000. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Right of First Refusal&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For a period beginning on May 7, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;First Amendment to the Introducing Advisor Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On March 22, 2022, the Company and ARC entered into the First Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed that the Company would pay to ARC an additional success fee equivalent to five percent (5%) on any PIPE that was brought by ARC in connection with an initial business combination upon the closing of an initial business combination.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Second Amendment to the Introducing Advisor Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;On December 31, 2022, the Company and ARC entered into the Second Amendment to the Introducing Advisor Agreement, pursuant to which both parties agreed to extend the Termination Date to December 31, 2024, and to change the performance condition for the Equity Issuance from the closing of an initial business combination to the execution of a business combination agreement. On December 31, 2022, following the execution of the Second Amendment to the Introducing Advisor Agreement, the performance condition for the Equity Issuance was deemed to have been met, and ARC was issued 1,378,517 shares of the Company&#x2019;s Class B Common Stock, up to 143,766 shares of which are subject to forfeiture if the public stockholders exercise redemption rights with respect to any of the remaining outstanding shares of Class A Common Stock.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <dkdcu:MaximumNumberOfDemandsForRegistrationOfSecurities
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_zi5bI1FyRkmU32Yjk6CwzQ"
      unitRef="Unit_Standard_item_ADV322CDOkO4knKmowW0Dw">3</dkdcu:MaximumNumberOfDemandsForRegistrationOfSecurities>
    <dkdcu:OverAllotmentOptionPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_z_RFqAY7JE2tlCBZNXCVwQ"
      id="Narr_ilURQURQXUuHxn7fx51aMA">P45D</dkdcu:OverAllotmentOptionPeriod>
    <dkdcu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_z_RFqAY7JE2tlCBZNXCVwQ"
      decimals="INF"
      id="Narr_tKvkDNOVBUqUNJn6lGtHIQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1500000</dkdcu:UnitsIssuedDuringPeriodSharesNewIssues>
    <dkdcu:UnderwritingDiscountPercentage
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="4"
      id="Narr_HYa4dDbjMEK7hhwP5Tg2Ag"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0200</dkdcu:UnderwritingDiscountPercentage>
    <dkdcu:UnderwritingDiscountPaid
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Narr_6wM63ogJ9UaqE6HFS9guRg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">2300000</dkdcu:UnderwritingDiscountPaid>
    <dkdcu:DeferredUnderwritingFeesPercentage
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="4"
      id="Narr_AOYmAI5tPEW5_VVmWkd4Iw"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0350</dkdcu:DeferredUnderwritingFeesPercentage>
    <dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_eOC5nP-epEaOJ7v0nhKthA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4025000</dkdcu:CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.>
    <dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing
      contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_C-Ez8Wj92k-wMY601LQlhQ"
      decimals="2"
      id="Narr_ugdPTYOjcUGlMrP2sVx3Fg"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.05</dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing>
    <dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing
      contextRef="Duration_3_22_2022_To_3_22_2022_us-gaap_TypeOfArrangementAxis_dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_6BKMWuaDzEmPd9vqRg5_Nw"
      decimals="2"
      id="Narr_gepflZ17K060awfYKq2OYg"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.05</dkdcu:PercentageOfSuccessFeeOnAnyPipeFinancing>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_uEkHeFxWoUKCxd1wCPJN3g"
      decimals="INF"
      id="Narr_w1ZCF3FtwEulPpTB98azOg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1378517</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw"
      decimals="INF"
      id="Narr_Dv0I9Pqum0WopSPhK9qXDQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">143766</dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights>
    <dkdcu:WarrantLiabilityTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_oyCgTeo_q0yvO0Iczq6I3w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 7. WARRANT LIABILITY&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has agreed that as soon as practicable, but in no event later than &lt;span style="-sec-ix-hidden:Hidden_l9q9OYpBaE-i-c9_ByMINg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;20&lt;/span&gt;&lt;/span&gt; business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class&#160;A Common Stock issuable upon exercise of the warrants is not effective by the &lt;span style="-sec-ix-hidden:Hidden_O_rVnyonKkqQ7hhmRqfGSA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;60&lt;/span&gt;&lt;/span&gt;th business day after the closing of the Company&#x2019;s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company&#x2019;s shares of Class A Common Stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Redemption of warrants when the price per Class A Common Stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the Public Warrants:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;in whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;at a price of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$0.01&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; per Public Warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;upon not less than &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;30 days&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2019; prior written notice of redemption to each warrant holder; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;$18.00&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_g1uhXZ_IzE6YLS18Pibsaw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; trading days within a &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_ucp-6LYyYk2H8bhHlUU4tg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#x201c;cashless basis,&#x201d; as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;warrants, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.The Placement Warrants were identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In addition, if (x) the Company issues additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company&#x2019;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#x201c;Newly Issued Price&#x201d;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company&#x2019;s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#x2019;s common stock during the &lt;span style="-sec-ix-hidden:Hidden_Tj-gOcDc5kC5FCMl3wJLvg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;20&lt;/span&gt;&lt;/span&gt; trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#x201c;Market Value&#x201d;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the Class A Common Stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;At December 31, 2022 and 2021, the Company accounted for the aggregate 12,085,275 warrants issued in connection with the Initial Public Offering (the 11,500,000 Public Warrants and the 585,275 Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company&#x2019;s statement of operations.&lt;/p&gt;</dkdcu:WarrantLiabilityTextBlock>
    <dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      id="Narr_RQMC260SIU6mWAUVDZb_zA">P30D</dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q"
      id="Narr_C5HW7rpxDUO-GRg852iZ4w">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg"
      decimals="2"
      id="Narr_ufgDjCpnv0CUIBSn9S_M5Q"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">18.00</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <dkdcu:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg"
      decimals="2"
      id="Narr_Xhg8xVu8AE-IqUfobJAqPA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.01</dkdcu:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg"
      id="Narr_V0ty8V4pLUm4vtDdh7rjbQ">P30D</dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg"
      decimals="2"
      id="Narr_LKQ6x4zj10mRWosgS3efTw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">18.00</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg"
      id="Narr_5Tt_ngskXky6x4dpewbOEw">P30D</dkdcu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <us-gaap:SharePrice
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ORH_Epj08k2OR4P3PXUF2A"
      decimals="2"
      id="Narr_jalzeqU90Eyx89peyP-59g"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">9.20</us-gaap:SharePrice>
    <dkdcu:PercentageOfGrossProceedsOnTotalEquityProceed
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      decimals="2"
      id="Narr_0-GUWt8-vUyFQjmfKMXrSA"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.60</dkdcu:PercentageOfGrossProceedsOnTotalEquityProceed>
    <us-gaap:SharePrice
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q"
      decimals="2"
      id="Narr_0b-KlvCTa02Nw2vOsKQKdg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">9.20</us-gaap:SharePrice>
    <dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      decimals="2"
      id="Narr_6GmjFY8rzkyG7euNDPdUUw"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">1.15</dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      decimals="INF"
      id="Narr_3e423EMiEUC_HmpwkmTHlA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">18.00</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_QaJt1ia12ECl_HVZf-OHZA"
      decimals="2"
      id="Narr_7Hin2Nzr7UWfVLa9ElUdmQ"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">1.80</dkdcu:ClassOfWarrantOrRightAdjustmentOfExercisePrice>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_QaJt1ia12ECl_HVZf-OHZA"
      decimals="2"
      id="Narr_z1KNqT9yEkSma7MIUvmMLQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">10.00</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_NbmAauLToEGJvq6HnVSZBg"
      id="Narr_7rbzSKLOfUGjg--44Z01aQ">P30D</dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_0xI8gLPKx0-BmiEb0QOU0g"
      decimals="INF"
      id="Narr_AsbJ04R3dUmWNPu0_KdPow"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember_6jC0xt_xPkW3XWSHKmx-Wg"
      decimals="INF"
      id="Narr_pcps90HwCESHFDbjeWS89Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_SGQAoQddE0emo9lL7Hd1eA"
      decimals="INF"
      id="Narr_ybxk6Pz-NEa2uWpV1irOOg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      decimals="INF"
      id="Narr_hU3yJ8PS-kGw_3nqHUEEig"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_THab5UCa2UyrRU_XTiFJiQ"
      decimals="INF"
      id="Narr_ZiWpukcpWEGWbvDPTeOcbg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</dkdcu:WarrantsOrRightsIssued>
    <dkdcu:WarrantsOrRightsIssued
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PlacementWarrantsMember_fqKCHCXgBkSvo0fCaH9NXQ"
      decimals="INF"
      id="Narr_wmtPBvitT0ypPiHeGU18KQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</dkdcu:WarrantsOrRightsIssued>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_mIldiqkdaEmwbKCa6-q1OA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 8. STOCKHOLDER&#x2019;S EQUITY&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Preferred Shares &lt;/span&gt;&lt;b style="font-weight:bold;"&gt;&#x2014;&lt;/b&gt; The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company&#x2019;s Board of Directors. At December&#160;31,&#160;2022 and 2021, there were no preferred shares issued or &lt;span style="-sec-ix-hidden:Hidden_byXh1qgX90qNILMCXVSaVw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;outstanding&lt;/span&gt;&lt;/span&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Class A Common Stock &lt;/span&gt;&lt;b style="font-weight:bold;"&gt;&#x2014;&lt;/b&gt; The Company is authorized to issue 100,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company&#x2019;s Class A Common Stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 12,085,275 shares of Class A Common Stock issued and outstanding, including 585,275 shares of non-redeemable Class A Common Stock issued in connection with the private placement (Note 4), and 11,500,000 shares of Class A Common Stock subject to possible redemption.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Class B Common Stock&lt;/span&gt; &lt;b style="font-weight:bold;"&gt;&#x2014;&lt;/b&gt; The Company is authorized to issue up to 10,000,000 shares of Class B Common Stock with a par value of $0.0001 per share. Holders of the Company&#x2019;s Class B Common Stock are entitled to one vote for each share. On February 25, 2021, the Sponsor transferred 15,000 shares to the Company&#x2019;s Chief Executive Officer, 15,000 shares to the Company&#x2019;s Chief Financial Officer and 5,000 shares to two of the Company&#x2019;s independent directors. Following the determination of the Company&#x2019;s third independent director, on March 23, 2021, the Sponsor transferred 5,000 shares to such independent director. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On December 31, 2022, ARC Group Limited, the Company&#x2019;s Financial Advisor, was granted &lt;span style="-sec-ix-hidden:Hidden_OyBqbq_iQkytLYvGC9d64A;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;1,378,517&lt;/span&gt;&lt;/span&gt; shares of Class B common stock with a par value of $0.0001 per share, up to 143,766 of which are subject to forfeiture if the Company&#x2019;s public stockholders exercise redemption rights with respect to any of the Company&#x2019;s remaining outstanding shares of Class A common stock.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At December 31, 2022 and 2021, there were 4,253,517 and 2,875,000 shares of Class B Common Stock &lt;span style="-sec-ix-hidden:Hidden_STifUojKSEajZv3cqO8nRw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;issued&lt;/span&gt;&lt;/span&gt; and &lt;span style="-sec-ix-hidden:Hidden_Vj2cJtgcg0SBI0y6E-s6Sg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;outstanding&lt;/span&gt;&lt;/span&gt;, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Holders of Class A Common Stock and Class B Common Stock will vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A Common Stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class&#160;B Common Stock shall convert into shares of Class A Common Stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B Common Stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A Common Stock issuable upon conversion of all shares of Class B Common Stock will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A Common Stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_KmljgCkYskWvTG2oKfEsyg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_g3LKGWp-b0GkDjXdxl28XA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="INF"
      id="Narr_F9PAgPp1vEaGhvf1_iolBQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA"
      decimals="INF"
      id="Narr_0uupdqVcnka8WRjpWmePKQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_Tz3pCCoj40-2Tr79l94EWw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_bhGeHFnOUEqd9uA-T4RTXA"
      decimals="INF"
      id="Narr_15-hJZM8zUe_SqrRzJYoiA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_mz0w46oPeUGHziUhhCdodg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:CommonStockNumberOfVotesPerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ"
      decimals="INF"
      id="Narr_tLQPl1hgREmIn3XLge_isQ"
      unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q">1</dkdcu:CommonStockNumberOfVotesPerShare>
    <dkdcu:CommonStockShareIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_XXUqNLWvg0qpR2rSOgLQ_A"
      decimals="INF"
      id="Narr_4KMHuHstl0Se5GwqhIOnKA"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:CommonStockShareIssued>
    <dkdcu:CommonStockShareIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA"
      decimals="INF"
      id="Narr_CrKAoQai9k-gMh9u4RQCXQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">12085275</dkdcu:CommonStockShareIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_XXUqNLWvg0qpR2rSOgLQ_A"
      decimals="INF"
      id="Narr_TklTzClYlU2B4r2oAAZIxQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_s1JcmrQvKkGU-l-Q0pzEEA"
      decimals="INF"
      id="Narr_NPUMAZN2FUeUAV-V9LCkOw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">585275</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_XmFzJlmc1EWv7dUG9AwMDQ"
      decimals="INF"
      id="Narr_3Ts8KQurpky1IrokmqkvsQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ"
      decimals="INF"
      id="Narr_QfQqu3IHOUC3S03AV1eP0Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">11500000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"
      decimals="INF"
      id="Narr_kaifN0wG9UehIvgGIZUugQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_KmsgC0a3F0-uXP4t2Bubpg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"
      decimals="INF"
      id="Narr_Wwe7FNNFdUqr4A4ZVgXccA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_xJ1KygLMYUKF0Vuao2aDFw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:CommonStockNumberOfVotesPerShare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_XsORvS1ZTkafBUZWNJZljA"
      unitRef="Unit_Standard_Vote_5UoUsHTIKkiyfH2v3edS0Q">1</dkdcu:CommonStockNumberOfVotesPerShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefExecutiveOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_Mzinbo6790mIYa6MzPmccA"
      decimals="INF"
      id="Narr_0sMBx09SjU6IUV3_TFeI-A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">15000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_srt_ChiefFinancialOfficerMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_9btB9vKZLEW4K63rfAMw5Q"
      decimals="INF"
      id="Narr_HY3GQOfQjUuLyTGDsgYI-A"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">15000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_2_25_2021_To_2_25_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_1lq6y8qH_02AAAlWFjyicg"
      decimals="INF"
      id="Narr_cmepE5IO0ES9jdkdCB2e1w"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">5000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <dkdcu:StockTransferredToOthersDuringPeriodShare
      contextRef="Duration_3_23_2021_To_3_23_2021_srt_TitleOfIndividualAxis_dkdcu_IndependentDirectorsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_7vg13yQIHkePUv6ms7p3ng"
      decimals="INF"
      id="Narr_wAo8OlIBJUyqcek_SSsB6Q"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">5000</dkdcu:StockTransferredToOthersDuringPeriodShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_wLPX3pqnoEGRhqgS36Atpg"
      decimals="INF"
      id="Narr_w30VTyt8qUCgiJkJmVXfPg"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_8EbN4GlIAUqz3yHoqQzPsw"
      decimals="INF"
      id="Narr_amTWJPWxyEKzCi6TIE1-Lg"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">143766</dkdcu:MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="INF"
      id="Narr_BWlx-K-fpU2ZNITTzwtArQ"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">4253517</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_QZJF87EHFEK188qNwbP_4Q"
      decimals="INF"
      id="Narr_uwaTb8pRLkCOkgSIt8Cznw"
      unitRef="Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg">2875000</us-gaap:CommonStockSharesIssued>
    <dkdcu:Initialbusinesscombinationsharesissuableaspercentofoutstandingshare
      contextRef="As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_CUp5TylSy0GfumEeEugnVA"
      decimals="2"
      id="Narr_HUNVNaXF3k6N7VQNzPayOA"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.20</dkdcu:Initialbusinesscombinationsharesissuableaspercentofoutstandingshare>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_X9w2RdnlvkGLhJbxenfTBA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 9. FAIR VALUE MEASUREMENTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The following table presents information about the Company&#x2019;s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;Prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Active&#160;Markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Observable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Asset:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Investments&#160; held in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 29,029,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Warrant Liabilities:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Public Warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Private Placement Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;Prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Active&#160;Markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Observable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Asset:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Investments held in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 117,320,973&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Warrant Liabilities:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Public Warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,600,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Private Placement Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 251,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Warrants are measured at fair value on a recurring basis. The Public Warrants were valued initially and at each reporting period that the warrants were not actively traded, using a Monte Carlo simulation. As of December 31, 2022 and 2021, the Public Warrants were valued using the instrument&#x2019;s publicly listed trading price, which is considered to be a Level 1 measurement due to the &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;use of an observable market quote in an active market. Private Placement Warrants were valued using a Monte Carlo valuation model using level 3 inputs at initial valuation and as of December 31, 2022 and 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At December 31, 2022 and 2021, assets held in the Trust Account were comprised of $29,029,416 in money market mutual fund and $117,320,973 in U.S. Treasury Securities, respectively. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments and are considered Level 1 assets.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statement of operations.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#x2019;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company utilized a Monte Carlo simulation to estimate the fair value of the Public warrants at each reporting period for its warrants that are not actively traded. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. On June 22, 2021, the Public Warrants surpassed the threshold waiting period to be publicly traded. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of December 31, 2022 and 2021, the Company classified the Public Warrants as Level 1.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#x2019;s traded warrants and from historical volatility of select peer company&#x2019;s common stock that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. During the year ended December 31, 2022 and for the period from February 8, 2021 (inception) through December&#160;31,&#160;2021 there were no transfers between levels.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Private Warrants)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Private Warrants)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Share price&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.44&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected term (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5.36&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Probability of Acquisition&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4.2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7.4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.91&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.28&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dividend yield (per share)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The change in the fair value of the derivative warrant liabilities for the year ended December 31, 2022 and for the period from February 8, 2021(inception) to December 31, 2021 is as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Private&#160;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Public&#160;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Warrant&#160;Liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of February 8, 2021(inception)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Change in valuation inputs or other assumptions&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 251,668&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,600,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,851,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of December 31, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 251,668&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,600,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,851,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_4REQyUAf6022aVEF9i64Ww;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Change in valuation inputs or other assumptions&lt;/span&gt;&lt;sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (234,110)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,255,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,489,110)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of December 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 362,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_iEqHdvARiUWMMj8pi17Naw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;Prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Active&#160;Markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Observable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Asset:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Investments&#160; held in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 29,029,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Warrant Liabilities:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Public Warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Private Placement Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;Prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Active&#160;Markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Observable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;Inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Asset:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Investments held in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 117,320,973&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Warrant Liabilities:&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Public Warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,600,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Private Placement Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 251,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_wiC7cqJRr0Cr05N-S5Q2Yw"
      decimals="0"
      id="Tc_6rpLeKAIsEe_vMtDEZIbcA_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_Tv60Y58O_0WnZ3tyWWSaUA"
      decimals="0"
      id="Tc_zrlVE5rymEev1Qu5dY8oAg_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">345000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_vEBEAARln0-juOH4J-Vj-A"
      decimals="0"
      id="Tc_359YL2u8Vkqhm44PuYrIUQ_10_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">17558</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_7tsBCIa7gk6SNfDSnFWCYg"
      decimals="0"
      id="Tc_qz8juPY2vkypugwqcH4rOw_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">117320973</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_o3_-97zDo0C3WX2zLxg1OQ"
      decimals="0"
      id="Tc_uA1zl37RpUerJmeaFTpRgQ_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4600000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_C3EiylpFM0KQmVJZCMEtQA"
      decimals="0"
      id="Tc_ER42PrHD60CSqBXKPtXRRg_10_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">251668</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_aXuUNI1Ru0CZ99nEpdL7oA"
      decimals="0"
      id="Narr_k-slNGlb70CKVNblUtrgSw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="As_Of_12_31_2022_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_-SnL89jik0a1X0ZnHQTSug"
      decimals="0"
      id="Narr_fzlPJZNZeEqb-saob5A19g"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">29029416</us-gaap:AssetsHeldInTrustNoncurrent>
    <dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount
      contextRef="Duration_2_8_2021_To_2_28_2021_uRyz8nIfgUWZcUbGZ5DZKw"
      decimals="0"
      id="Narr_Z05OBs6xvkmOn5t-HaJFPw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount>
    <dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount
      contextRef="Duration_3_1_2021_To_3_31_2021_gUusaqcJmkWPGzRQUeJV8g"
      decimals="0"
      id="Narr_gRq2w659xUaBzh1RFAalUg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount>
    <dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount
      contextRef="Duration_4_1_2021_To_12_31_2021_t2aXGk63HESQ8USp--Eegw"
      decimals="0"
      id="Narr_15-ZR14pr0yQVdK_5sBEVg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount>
    <dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Narr_pNqSxT7Ha0eP4SnbeyY7xQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_3xdCWzNjKkGTcWh0bpyLhQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Private Warrants)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Private Warrants)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Share price&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.44&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected term (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5.36&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Probability of Acquisition&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4.2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7.4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.91&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.28&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dividend yield (per share)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_bPi2WHn1CEmBrVfnbyV-yQ"
      decimals="4"
      id="Tc_rFwb_kI3AUCONxCusWin8A_3_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.1150</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-7KCAAHgxkqAZ45nDl70BQ"
      decimals="4"
      id="Tc_TOzHTgEHvUm0axqQhMm1Wg_3_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.1150</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_ybrEKTUYVEi2w4swS4gdww"
      decimals="4"
      id="Tc_3n4JO0yceEuqHmn70aHI8g_4_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.1044</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_5w37XobWakKj_h4ipX-PCQ"
      decimals="4"
      id="Tc_XC-GzgRSBEeNNPiCURqvHw_4_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.1010</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_g71uqyykEUaLUf1hlvHiRw"
      decimals="INF"
      id="Tc_Cu8em76UFU6Nlzhlr-naiw_5_3"
      unitRef="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A">5.12</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_32dEYbIibku74IeSgOkApA"
      decimals="INF"
      id="Tc_MVwKbBMhXkSTH7oJzGRGwA_5_6"
      unitRef="Unit_Standard_Y_xZeu1-qHO0yt0h0fxJQ04A">5.36</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_8tE3iMpWckqAsmbEpESznQ"
      decimals="4"
      id="Tc_Rl1cLw_tnUqFXzLrqD53wQ_6_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0275</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember_AiXZHnfbmUaYN1Ptn1SXKA"
      decimals="3"
      id="Tc_P_-GWAFgv02192iOYQ0PDQ_6_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">1.000</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_8dkF3R4YwUqerp4U-rpgZQ"
      decimals="3"
      id="Tc_5yzFoRLX_kKcgxa4vRo0cw_7_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.042</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_Qv7tGKJp8ESTjI2bmnNtTA"
      decimals="3"
      id="Tc_6mCz9yJ9pEKS_T3XL7K1kw_7_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.074</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_SAyeztzxD0CqTCyFAOQf2A"
      decimals="4"
      id="Tc_I8fhbu1ow0SIPIAs7yaCzw_8_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0391</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_h8eV0dNuHUC_ArrU2_om7Q"
      decimals="4"
      id="Tc_qABxfnz3qEG9rfOWyYtxtA_8_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0128</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_JeEGJuHbaES_O44UyyPIfA"
      decimals="4"
      id="Tc_QnRD0lXYbUGIBXFoco0XMg_9_3"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0000</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedDividendRateMember_MxCSmXH-QkW2v6_7S1_RpQ"
      decimals="4"
      id="Tc_EM_nf1ZGVESOzphMmRXsXA_9_6"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0000</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Group_43qTDkf5rE-4V60Yt3vBAw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Private&#160;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Public&#160;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Warrant&#160;Liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of February 8, 2021(inception)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Change in valuation inputs or other assumptions&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 251,668&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,600,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,851,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of December 31, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 251,668&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,600,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 4,851,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_4REQyUAf6022aVEF9i64Ww;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Change in valuation inputs or other assumptions&lt;/span&gt;&lt;sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (234,110)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,255,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,489,110)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Fair value as of December 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 17,558&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 345,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.84%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 362,558&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liability in the consolidated statement of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_qrvljgLErEia_hKda3XtPw"
      decimals="0"
      id="Tc_Y5hgmQv0L0-aMd3eBOEXKA_3_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">251668</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_ZP0J_NoaR0O08Cu16XJevg"
      decimals="0"
      id="Tc_zK_JLC5IEE2CSJkAVwX-wQ_3_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_2_8_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_v4FiAYrj_UiV84PIq9aKlg"
      decimals="0"
      id="Tc_uex-NeMRuUGMyxgtYO8Ukw_3_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4851668</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember__X7tf0I7ukiYWBqvSdHF_A"
      decimals="0"
      id="Tc__eIyFQwNbESbuFdByZGDPQ_4_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">251668</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_hE2awbU3oU-sum3j2xFkxg"
      decimals="0"
      id="Tc_JXo3bdf3r0CwrNNPp0ezKw_4_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4600000</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_Nddpq_hUqUiHgJZLwEZXaw"
      decimals="0"
      id="Tc_JYm4Ych8QU-Jsv8f7JV1fA_4_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">4851668</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_Su-w_xFE4ke175Cyk-kveg"
      decimals="0"
      id="Tc_NrVXkvjwwUWSU8YDcgCMOA_5_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-234110</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_Gh2CjqICCEKcfAtm_uPeaQ"
      decimals="0"
      id="Tc_4ddffYNfTEGm5J2pXbavPw_5_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-4255000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_S4feA0vhSU--s22UyX83mw"
      decimals="0"
      id="Tc_1KO289HitkG8kfO45ZCeTA_5_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-4489110</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_ruu01iLDPE611oCSW8HUQw"
      decimals="0"
      id="Tc_L7xQbDjSMk20U71KEGyzBQ_6_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">17558</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q"
      decimals="0"
      id="Tc_i3YcttQtE0qD_bVp81S3_Q_6_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">345000</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_WarrantLiabilityMember_gvo3MI-_1kGJuvLmpZZU2w"
      decimals="0"
      id="Tc_SRWH9u22CECKmX2n8DlWzw_6_9"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">362558</dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_9qVB0HwvVku_skTkgnP2Bw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 10. INCOME TAX&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The income tax provision consists of the following:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the period from&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;February 8, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Through&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Federal&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Current&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;214,850&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Deferred&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;(715,345)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (118,531)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;State and Local&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Current&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Deferred&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 715,345&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 118,531&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Income tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 214,850&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s net deferred tax assets are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the period from&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;February 8, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Through&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred Tax Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Net Operating Loss&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,893&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Sec. 195 Start-up Costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 833,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 88,493&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Deferred Tax Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 833,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 120,386&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred Tax Liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Unrealized gain on Investment in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,855)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Deferred Tax Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 833,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_-9mRpELl-Ee-JT7U3Njw7g;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; (1,855)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less: Valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (833,875)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (118,531)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred Tax Assets, net of allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:12pt 0pt 12pt 0pt;"&gt;As of December 31, 2022 and 2021, the Company had zero and $162,132 of U.S. federal and state net operating loss carryovers available to offset future taxable income. The federal net operating losses can be carried forward indefinitely, subject to a limitation in utilization against 80% of annual taxable income.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of deferred tax assets and therefore established a full valuation allowance of $833,875 and $118,531 as of December&#160;31, 2022 and 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;A reconciliation of the federal income tax rate to the Company&#x2019;s effective tax rate is as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the period from&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;February 8, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Through&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Statutory federal income tax rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;State taxes, net of federal tax benefit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in fair value of derivative liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (170.93)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (25.89)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;"&gt;59.18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Transaction costs allocated to warrant issuance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 129.71&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.32&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 38.96&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s effective tax rates for the periods presented differ from the expected (statutory) rates due to the recording of full valuation allowances on deferred tax assets.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company&#x2019;s tax returns since inception remain open to examination by the taxing authorities. There were no unrecognized tax benefits as of December 31, 2022 and 2021. No amounts were accrued for the payment of interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#x2019;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_g1X2tb3t30KJq-7pJuCNTA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the period from&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;February 8, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Through&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Federal&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Current&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;214,850&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Deferred&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;(715,345)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (118,531)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;State and Local&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Current&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Deferred&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 715,345&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 118,531&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:70.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Income tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 214,850&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_uG8jZmuNyEKffzX1PXYanA_8_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">214850</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_whJsxHl-hUuPHgDvotY_eA_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-715345</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_CFCq_ljBIUe2B1c9HyMnXw_9_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">-118531</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_T-kCnilt6E2Lt2zG3dJcWQ_13_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">715345</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="0"
      id="Tc_Tr4wBrc7mkyE1ZRXYDCu5Q_13_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">118531</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="0"
      id="Tc_z6gLIr_jt0G4lHcOvGq4Cg_14_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">214850</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_bRGJisxduUu53rijGnv34A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the period from&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;February 8, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Through&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred Tax Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Net Operating Loss&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,893&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Sec. 195 Start-up Costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 833,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 88,493&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Deferred Tax Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 833,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 120,386&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred Tax Liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Unrealized gain on Investment in Trust Account&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,855)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Deferred Tax Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 833,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_-9mRpELl-Ee-JT7U3Njw7g;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; (1,855)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less: Valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (833,875)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (118,531)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred Tax Assets, net of allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_TehFiJWTmUykGRks2Dn9Nw_7_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">31893</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <dkdcu:StartUpCosts
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_K2ij3Cu7mUiMRFhjKcaaMA_8_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">833875</dkdcu:StartUpCosts>
    <dkdcu:StartUpCosts
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_OQXMXOwmqkOGqeU0MJ5IJA_8_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">88493</dkdcu:StartUpCosts>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_FT6_5z5icEmgc_adzva2Jg_9_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">833875</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_XTwAaufuYUuVcmCPekKNQg_9_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">120386</us-gaap:DeferredTaxAssetsGross>
    <dkdcu:UnrealizedGainOnInvestmentInTrustAccount
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_2yGnS8B260OmrK6Vy-qiug_11_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">1855</dkdcu:UnrealizedGainOnInvestmentInTrustAccount>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_nUMcV31DVUeRJ1EwmbKIkQ_12_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">833875</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Tc_o1Pae4HZOkaCN7ZSHU7sLg_13_3"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">833875</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Tc_MN0Ose-VtEupDz55QQPdaQ_13_6"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">118531</us-gaap:DeferredTaxAssetsValuationAllowance>
    <dkdcu:U.s.FederalAndStateNetOperatingLoss
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_iLj_tRAFxUiJp1DOgzbIxg"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</dkdcu:U.s.FederalAndStateNetOperatingLoss>
    <dkdcu:U.s.FederalAndStateNetOperatingLoss
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Narr_uWnF4pq_ek2R0bBHeJk7Cw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">162132</dkdcu:U.s.FederalAndStateNetOperatingLoss>
    <dkdcu:LimitationOnAnnualTaxableIncome
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="2"
      id="Narr_sTHlCVH0Lkqa_IYT91j40w"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.80</dkdcu:LimitationOnAnnualTaxableIncome>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_BkFxwnZaqECztpOt6TLmWQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">833875</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g"
      decimals="0"
      id="Narr_ItBa2oGjxUe5CCywlhkDPQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">118531</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_4uXv6UBS1UebaK0dE_4xxA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the period from&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;February 8, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Through&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Statutory federal income tax rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;State taxes, net of federal tax benefit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in fair value of derivative liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (170.93)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (25.89)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;"&gt;59.18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.9pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Transaction costs allocated to warrant issuance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 129.71&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.32&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.03%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 38.96&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.13%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="4"
      id="Tc_-zGVQQ535UiYsjnjLbC07w_7_2"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="4"
      id="Tc_maRTpByffEGoWqMs5_D6hQ_7_4"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <dkdcu:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="4"
      id="Tc_lhEkvifUSkOxhpRPBC19BA_9_2"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">-1.7093</dkdcu:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities>
    <dkdcu:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="4"
      id="Tc_yUl-VGx6T026JqAsyIloJg_9_4"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">-0.2589</dkdcu:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities>
    <dkdcu:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="4"
      id="Tc_D0t5sKW3p06bDXu6FL5cGA_10_2"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.5918</dkdcu:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent>
    <dkdcu:EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="4"
      id="Tc_Rk17eR19rEiCQWbycxTnkA_11_4"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0257</dkdcu:EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="4"
      id="Tc_3SPhwU2teUiXb54VFUP4Gg_12_2"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">1.2971</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw"
      decimals="4"
      id="Tc_RNTbpJL3MkCxxBwQr42ENQ_12_4"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">0.0232</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      decimals="4"
      id="Tc_nY29vdizJ0qms1VMLHOMGg_13_2"
      unitRef="Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w">-0.3896</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_3ngPvdPM2E2PL6wMCG1flA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ"
      decimals="0"
      id="Narr_RO_dLhTdgUmPnPPmjBc2Qw"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw"
      id="Tb_CYc_H8dyEUSGp17szbPU8w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;NOTE 11. SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In accordance with ASC Topic 855, &#x201c;Subsequent Events&#x201d;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identified any subsequent events that would have required adjustment or disclosure in the financial statements other than as described below.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On January 5, 2023, the Company elected to exercise its third-month extension to the Termination Date, which extended its deadline to complete its initial business combination from January 11, 2023 to February 11, 2023, by depositing $0.045 per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $122,920, was deposited in the Trust Account.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On February 8, 2023, the Company elected to exercise its fourth-month extension to the Termination Date, which extended its deadline to complete its initial business combination from February 11, 2023 to March 11, 2023, by depositing $0.045 per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $122,920, was deposited in the Trust Account.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;On March 6, 2023, the Company elected to exercise its fifth-month extension to the Termination Date, which extended its deadline to complete its initial business combination from March 11, 2023 to April 11, 2023, by depositing $0.045 per share for each Public Share outstanding after giving effect to the redemptions disclosed above, or approximately $122,920, was deposited in the Trust Account.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <dkdcu:AmountDepositedPerEachPublicShareOutstanding
      contextRef="Duration_1_5_2023_To_1_5_2023_srt_StatementScenarioAxis_dkdcu_ThirdMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_zROX-Jpz0Um4wcHHn0lc3g"
      decimals="3"
      id="Narr_LHuPZ3QTUEmYuWnqsL94LA"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.045</dkdcu:AmountDepositedPerEachPublicShareOutstanding>
    <dkdcu:AggregateAmountDepositedInTrustAccount
      contextRef="Duration_1_5_2023_To_1_5_2023_srt_StatementScenarioAxis_dkdcu_ThirdMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_zROX-Jpz0Um4wcHHn0lc3g"
      decimals="0"
      id="Narr_Grr3_YeLBkiGx-LCm9IMRQ"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">122920</dkdcu:AggregateAmountDepositedInTrustAccount>
    <dkdcu:AmountDepositedPerEachPublicShareOutstanding
      contextRef="Duration_2_8_2023_To_2_8_2023_srt_StatementScenarioAxis_dkdcu_FourthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_2cSXaqbjC0G88fQ4Os87Uw"
      decimals="3"
      id="Narr_n4MrObnATUSbd3E7GRyUeQ"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.045</dkdcu:AmountDepositedPerEachPublicShareOutstanding>
    <dkdcu:AggregateAmountDepositedInTrustAccount
      contextRef="Duration_2_8_2023_To_2_8_2023_srt_StatementScenarioAxis_dkdcu_FourthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_2cSXaqbjC0G88fQ4Os87Uw"
      decimals="0"
      id="Narr_WvlcW5DBNUO95wwR1TQ9VA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">122920</dkdcu:AggregateAmountDepositedInTrustAccount>
    <dkdcu:AmountDepositedPerEachPublicShareOutstanding
      contextRef="Duration_3_6_2023_To_3_6_2023_srt_StatementScenarioAxis_dkdcu_FifthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NBJMLC3FJkeQ_zMEcQPEZA"
      decimals="3"
      id="Narr_QrV5i_BCG0WuZeSM9SpnSw"
      unitRef="Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ">0.045</dkdcu:AmountDepositedPerEachPublicShareOutstanding>
    <dkdcu:AggregateAmountDepositedInTrustAccount
      contextRef="Duration_3_6_2023_To_3_6_2023_srt_StatementScenarioAxis_dkdcu_FifthMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_NBJMLC3FJkeQ_zMEcQPEZA"
      decimals="0"
      id="Narr_mP7-VNWDqEW3akmei32NdA"
      unitRef="Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA">122920</dkdcu:AggregateAmountDepositedInTrustAccount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>113
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MM&8/T2[E?Q7/O[/V"UDU7ERD5?,;/;>VQ@S%NXH76>LL6I E^?YO]-(2<>2
MS1,.I'4@8QUHZT#'.IBM@SG6P6H=K+$.=NM@-]SOR6J8]B,>+:[+XAF5M;5
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M@/C^Y>Q^1[)U^?;QB4G)LG)S1<F2\B) ??_,F'S;*5YHUJ_()_\#4$L#!!0
M   ( '*3XU8,%3'EXP8  *LD   8    >&PO=V]R:W-H965T<R]S:&5E=#0N
M>&ULK5IK<Z,V%/TK&K?3V9W9Q$A"/-+$,XEAIYG9/";.=C\3+-MT>;@@.VE_
M?07&8"2AV W[80/VN4?<(Z%[#^;R-<M_%BM*&7A+XK2X&JT86U^,QT6XHDE0
MG&=KFO)O%EF>!(R?YLMQL<YI,*^"DGB,#,,:)T&4CB:7U6>/^>0RV[ X2NEC
M#HI-D@3Y/S<TSEZO1G"T_^ I6JY8^<%X<KD.EG1&V??U8\[/Q@W+/$IH6D19
M"G*ZN!I=PPL?.65 A?@SHJ_%P3$H4WG)LI_ER>W\:F245T1C&K*2(N!_MG1*
MX[ADXM?Q=TTZ:L8L P^/]^Q?J^1Y,B]!0:=9_".:L]75R!F!.5T$FY@]9:]_
MT#HA4O*%65Q4_X/7'99P<+@I6);4P?P*DBC=_0W>:B$. CB/.@#5 4@,,'L"
M<!V Q0"K)\"L \QC T@=4*4^WN5>"><%+)A<YMDKR$LT9RL/*O6K:*Y7E)8+
M9<9R_FW$X]AD^G#O^?<SWP/\:/;P[=:[?N8GLV?^Y\Z_?YZ!AZ_@X=%_NGZ^
MY0!P!K[///#IU\^78\:'+TG&83W4S6XHU#,4!G=9RE8%\-,YG2OB/7T\A.\1
M^.\0( W!F O7J(?VZMT@+>-=D)\##+\ 9""LN*#I\>%()8@^W*-A$PY5<AP?
MCC1BX&8IX8K/[.';W;C5W9_. =_*<GZ6+D&8%:Q0+9<=':GHR@UM.\&&A0TN
MY/900QE&+ ,ZI OS9)B)(';M+LQ7L$$#VQ@VN$[R9I.\J4\^#])P%144L. -
MT#>^D1=4E?2.QCJ\3-MTH)"SC"(&_R>D+*.@91J&(Z0LPY!!N(;JC$F3,=%F
M_"TK"K#(LV0_U7SB>Z>:2)=PA@FV'5/(6X&SH&*R%3CB$-,0<+X*APT7N3W3
M;37)6U4D[DG^@:UH#J(TS!(*/M73_?E"E;JE4['L RZ*=1#2JQ$O] 7-MW0T
M^>T7:!F_J_:3(<F\(<G\@<@ZLV$WLV%KE^)MRBAG98 &>4KYWI."@H:;/&(1
M+<"*QG,^5> YY^447(=AMDF9:J:T@YPZ4T.2>;9\HSNV):SU@4;LS(#3S("C
MG0$OVD9SFLZ++[Q[#.+H7SX+9178I,WIDG>M1TV#(R6+D8U=5]@J9)B)#2(4
M#T]&0=>0BH("A6UH.:YZEW ;55RM*M-5D"YIF?0BB'*P#>(-!=D"O 8Y+Q<,
MQ%'P$L75*E4)H24_=3VZ<A&P+<3+A2"8C+,P(DBL4+Z,,TW'A;"GJD"C;4@-
MK6CW67K6-@^:2JKG.56?0=F\FJU;R! QB+"*_:&&[8I]T/U#O=C<BNZK6,P+
M^F?P0KG[I&"=9]NH<H/\= _AK8UZI=:C=-)%%A;+]E2!0] E1&Q9/ 600$QL
MUQ#U4P )/"3L*H-:99!6F<?3!$"*1L,EKB,*H!WTY%4V))NOR@%!TR%]MW1K
M#*#>&4BK3"DAEH=WN(*B'5#@>M:0JM57KB&%$<&61?K64.L)H-X4>%&\8;ST
MI=)=QO<WWBPG2=FIL"S\J11$2W[R_C8DFU>S.0>2&>>F*0JK0AWXNZZLK?&
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M-W<DX#U.#N"_;REE/W;R[S[/GQ[/_@-02P,$%     @ <I/C5N>JHXS;"
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M,?KM7[]?3FK9O0*9)/NN;G9=D8&N*/I:%O5*H'F1\A1H'YO;8_P1P/P# &(
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M84GHQE(*8HDMN ,?!N07)"E][9#+?0"K">"*$%M_AXB478-RQ3;9!.R%TM,
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M>E1XA?'=6KYV05QVFJS1LA>IPJ+(3L,/,IK=B&A_T2"YU1QN"Q--%E+BE:F
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MGJZ'Y.$DOEEE* MDU;N'>"XRV)HPX0EMF7VZ_DVLZ)!!<[) \:G$;4YG]<#
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M"L_/+\++\TOO2N\<@&3O?'\[]].^ Q!UHG[CYV#P_;KYG]#%_R2!/*5-_Q)
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MG R<OW?XQG%EUL;@E,R5>G"3:3X*(A<0"LRL8V#T>L0)"N&(*(SO+6?0;>F
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M15_5V\0JSRF-2YQWD/Z25/%@/'D2C2YB>O'!>/28/O2GC=Y-HP#_"+<[^^V
M$S<;X#@;\( <?9)"$@+82HAC'_<R3Y0&Q3L[@9(P: P9,^I@5J #;B$+')$[
M:TM+UD/#@M8HRU,A\BXJ]KF#+^/Q.(#"OEG+H?&51\W*EX(=AXHPY$%DE96'
M>K>YXMB[+2@%N4G]?-M.A8VYDT<82 M'NO>2U(4W-J*X!HQ'IPCS;6>H:%>
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M::4P+$+X WQQ)A:TD/F^/ZA\\SY\X198L6(SP:0Q)=;* DJ ]!$RD\)!["^
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M 6!87+HD=9A3(1K%*MRK8YY'PJ/4Y^GUW=B#_*C?[^TE^WN#_;W+_3VYWPZ
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M3C27[R5AR,)3=.SKT^%_(G Z34'G([,6%,\0Z,#>.G^ 1WE0-]D<L;$6/^
M<?<]6:L+"?.)+]%7("+:>EON$G)()*732-@CK_[AW]Y;-[JHD.XK_A("G J&
M;,"9ZTZJVTUN&)#Y, \TL*K/;+N=6.RWP"B-:W=*[2%Q\[W-Z]T]4NT 2OS[
MTOJ0W</Z>\P,,?1.F&MXY4]15'7T$#_S''$CJ=-N/>UX8^L^MZ:GA\&04@H.
MD0P!=A3RFIMO^GLT.JWC; [O>W9/G]H:UJ5_._2];ENM>[MI1.M&7-NKW70?
M?(KZK6J?->F!1./+GJ_3NW[U:#3\OZK^[2KOIXCQ*K]GB3U+[%EBER6>.\HO
M3(W?<&+9/Z$UY+.,^+1[$A6(16CRNP5]-$Z'9Z?I^-EI^V:/TW0/#[P,CMM(
M)T\J1J/T=#A,A\"@S72-J70:EMOVY-&NNP]&&.K&Z0GTH1CVRIU?721GH]/'
M3X:#Y(K<60\#K:#SDW#L-)'^WK=38'+-2;B@[UIR.H$9PP[!+@KLQ!&P+<)%
MBI&,-VGW5'E!;33O/6E-8$I?50$=FX"3N?6.OKESH9@1K-#Q7D=H5T:\B0)5
M-<D-H6K:(N7^L@S>:%ZS,K-2_=T<BFW=ZC4W\=-$(]S]@?)@U]?1^F][]=_V
MZK_MU7_;ZR&QU'_;:_Z]O^WU=/AO70OWM\+]K7!_*]S?"O>WPOVM<'\KW-\*
M__NWPOM._/I+X?ZXKS_NZR^%^TOA_E*XOQ3^JDOA?26UOT3KJVI?57=7U7.W
M?6/&XO''J+\ZZZ_._OG5F?_QA>/63WMP-TZ_>$)PCI#RO_)1/ZU_5.6<?TOD
MN!GN?Y'EG3 S55K0HBFF#@?/3@_\>5'\X/22?RADHIW3"_YS+@7<3@/P?JJU
MBQ]H@?JG9M[\#U!+ P04    " !RD^-6K)*7J4D'  #C'0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970Q-"YX;6SM65MSTS@4_BN:L,O"C,G%26@7VLZTI2S,
M NU2V)U]5&PE%I4E(\E-RZ_?[\AVZK9.*"R\=:9-;%GG_IV+XIVEL6<N$\*S
MBUQIM]O+O"^>#08NR43.7=\40N/)W-B<>]S:Q< 55O T$.5J$ ^'3P<YE[JW
MMQ/63NS>CBF]DEJ<6.;*/.?V\D HL]SMC7K-PGNYR#PM#/9V"KX0I\)_+$XL
M[@8K+JG,A7;2:&;%?+>W/WIV.*']8</?4BQ=ZYJ1)3-CSNCF=;K;&Y)"0HG$
M$P>.KW-Q*)0B1E#C<\VSMQ))A.WKAOO+8#MLF7$G#HWZ1Z8^V^UM]U@JYKQ4
M_KU9OA*U/5/BEQCEPB=;5GMC2$Q*YTU>$^,^E[KZYA>U'UH$V\,U!'%-$-^5
M8%P3C(.AE6;!K!?<\[T=:Y;,TFYPHXO@FT -:Z2F*)YZBZ<2='[O],/QX9^O
MCM^\.'K_VRD[^NOCZP__[@P\.-/S05)S.:BXQ&NXC-E;HWWFV)%.1=I!?[B9
M?A1O8#" 22N[XL:N@W@CQ[?<]MEX%+%X&(^[%-I,_D(D*_)X@SKCE9O'@=_X
M?[JYXC+IYD(9_<P5/!&[/:2L$_9<]/8>/A@]'3[O,O$',;MF\&1E\&03]SL;
MO)G+N^,/1VR[SUK<'C[8CD=;SQN>[ 1I+ZP5*3O-..Q@84/\G'W(!#LT><'U
M)9..\=)GQLHOV.@-%EPIV"@:#H?TSXH5%U=Q64J?,<X*;MDY5]AKYNR781][
M1ZP0MMI6[7)EDJ%R.+G0G$I3Q"S5#HC4:<U8Z 0\N4/F7K*9P&XO++(9\N;6
MY,RC,)):X7MVR?R5[K6]CAT8;E-2XX6TJ('&NC[;]PQ A_@&Z4$FP"OR&91L
M !P10U*7/K2Y;6UP!YA;AD+O/)A(O6!]=JBX<VR?=,E1<T^]2<Z^R<&5>X.+
M:U$PH)/KG1S>9Z^,2H4-;+J<U,F:(B6TEUY5NADMV+GQ@J$),L'AOIKY][AS
MNCV-XJUIRSQM]!/X5J#=SI3H5JEV.+%O>UQJEABMZQ877$)6%E:><^A;**0K
M6JAGC]Z1_I/'$1,7B2H#<1QM0</I9/(U5[MR]@DBR!6%<4Z2EJ1P7E2=-5#>
MS1$04XC0B=5E Y>#[X9+6=#U:#UF#GX>9@Z^$S/'FKT4,UMB!&+Q-/AE% #"
M3@NC'79[R[6K\VTT;=M%&=^E4";%G!U=B*0DS[+C^5PFPD;?0OU2:JX3R55#
M'2)XBWYIUGE%HA%C5$P);>E5Q7EI% 8_@AL1-74LU+UUG'PF4;BZ^$5P:PVT
M>/PUU]W4/93=+JXA)AU8W7]_R/ZP!B![(W/I11IUJGOEN?WT7#K2<HF46$ 5
M3Q&,QEN_1]/15@<XDPI!;CTXV4UT1@WH)^-HZ^E3VK3,)"PC +82%;";"^E+
MK,IN-Q?E3,FD$I[5B!<7PB;274OONCD%]>KT)0&4EFL": 4=!RCF[5IUN\BT
MS?^^8CJ)XNEXC7/O4C]O%J16YG=W!M"OJ2Q*5?GNS4*0AE06.7.0@FJ9!!JJ
ME=AFPF.<*#R)0LP +E]5#5[Q@/AV6$+1%H4GEE9\+B7!&UU?\64_E,FOECU(
M1?TTD"D3J'!)7>-<6(]\H,S87/ZY#U$.LT8=\8,2A@ELQ<;9*IUA7JA[3P"^
M)W2!\Y*$]BU8\O03SBBA)5%AK)#O"B4][0MWJ3R7R,_447!PW.1:?@D"PD+"
M"^FY:I9"1$@C)<]07%_K<)/@G(8+*,[35-)&9.=F*R,:9LBW'GZ5^HQF'=13
M"VH!P91=5T,/]6I<U0MHPA0?MVH8/#>E]G1+HUS80,NO-9A!D9,J\8[I*8&0
M3+!"\1H#P0!E7,B?.5S:Y>RJ%%FZIOA4)> K,,!CX.!;(A^ @_&SBAK4>U1J
M19J0\.PJ5SC0_ G-V:]*PJ;$O]DY%U:$87;)J7F%,MV"25?=J4HYO(_"*VX$
MA)8>,V>J^),NN@P%A))JL[F!G(:;$NVD=I2K&Q6Y[BYI!@AQ%34AYPL8MT!D
M0^?B85:J T I7*5'//RU<9LK\^;2&\"\I?MU!:YUCK:S@^H!0BC*2K3[[#K\
M%:ITG?9U%+]U&;(I.6Y.J-V(9H^N)M,0XUJ9]5E9BPB9"V#,Q&JA@8E0"LZ3
M>FT2D4FT\]; _(2$H@T3 DOXK2HT]%UB>+#J,@#[EOEU^C;C"/X"*28J)<'?
M=2%+&<PL2*!4W)C0'O>OS<!T%*S&WE91NXX#VSZIA25PK($@@BK=A=M65A%
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M,/)&!T/G(3EN\&S-D_NZ?LYCX$T5 W?WE(ML',FPH)TZ8@R&(\_W_8U$O:!
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MJ;'"C"5"Q**4V\2H*<"FW*IZXK(4QY51N0A'36%XJ#2'4FK0=G9$% ZZXV&
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MZ^"@:=*?T,%]KB\U7O9QAKB@J7DP^6]L[D_N[2LVX^]QRDS7YJ?<J[Q7OO%
M<]WB"OR_\$E#9>^['*)F/\\?#TW/ .U5_3_O#&Y:0;SQ!:"_]KY4$"YL_.S&
MQH%@\]2TFEV][!W[!ZW^_?;F61#VFRMHG],,HD%O-.P(TSRU-0.G*_]:-=6X
MIQ3^,X.[R/ &K,\TKE'M@ ]8O7<>_0E02P,$%     @ <I/C5OPB-0$$'
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M]P1%W:?IOY:T+H/[_&O+?76/6G];E0UH*U$\B.2X&-3.92"6@X4XA23[YG]
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M'C+ XS!$;/4)!W1YUC ;V< MF<Z$&NCT3^=HBD=8W,^'3/8ZN16?A#CBA$:
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M?0YWZ_QS\NK2\H0,SILGZZSX7WDMCQV=*?-=EB>;LC"KP2:*]S_#[^4'<51
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MX]5H4]7-AB< &M5OB:KIQE1O)'7^#E> 6MD"5+DOX$XV^LM*(3&M289S4)<
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M8VQ?3FU+.V06?T6PDP?/1*>RX/Q9O\S"H6'I%0&#0&D(BA];F !C&@G7\:,
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ML+<W>K>;AF0+!F6;#<6V[Z:F?8+]_=.'%2O5<_>J%0-JNM4-.R+.TAP7VMW
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M>6.<?SI.23+W^J,4:%CVF0P%I,BX:I7TJFYEIV4'9_X+5WVP: 3".&,H@;6
M=CL#D9VJWE)-.,G+;FM)N.C=RF$DVG&@,D"\7Q/"=Q.90#?XWE]02P,$%
M  @ <I/C5NO)Z_[8"   V$X  !D   !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&ULU9QO;Z,Z&L6_BI4=K6:DV4F _&EGVTAIP;LCW9FIVMY[M2\). D[@'.-
MT[32?/BU"0EQ0IPR<ZYT]TU+$OMGX_/P8 Z&JS47WXH%8Y(\9VE>7'<64BX_
M=KM%M&!96'S@2Y:K7V9<9*%4'\6\6RP%"^.R4I9VW5YOV,W").^,K\KO[L3X
MBJ]DFN3L3I!BE66A>+EA*5]?=YS.]HO[9+Z0^HON^&H9SMD#D[\N[X3ZU-U1
MXB1C>9'PG @VN^Y,G(^TW],5RA*_)6Q=[&T3O2M3SK_I#Y_BZTY/]XBE+)(:
M$:I_3^R6I:DFJ7[\44$[NS9UQ?WM+9V6.Z]V9AH6[):GOR>Q7%QW+CHD9K-P
ME<I[OOXWJW9HH'D13XOR+UE797L=$JT*R;.JLNI!EN2;_^%S-1![%5SG1 6W
MJN >5K@\4<&K*G@'%;S!B0K]JD+_L()WHL*@JC XJ- _M=/#JL*P'/O-8)4C
M[8<R'%\)OB9"EU8TO5'*5=96 YSD.K(>I%"_)JJ>'-\'OTP> Y_<3>X?_T,>
M[R=?'B:WCY^^?GD@_R"4K_*8"?*P" 4KR%N?R3!)BW=77:F:UH!N5#7C;YIQ
M3S3CD<\\EXN"! H8-]0/[/4=YQR G@&X%D!7#=INY-SMR-VX5N+G4'P@KO>>
MN#W7(44Y1 W]NK53*)LJRJ"B_/K@D[=OWIVF^:_HD^>4-&]'\\D;TCW-#.Q,
MGT4[9MU#*Y&^GN@V$!O!AD;>+KJ]LB6O=70W]/IFP^HWLW2*_U@LPXA==U0.
M+YAX8IWQW__F#'O_;)(="?.1L  )HR"8H6Y_IV[?1A_?"1XQ%A=D)GA&BC!E
MA,_(K$I:52Q])V^:M+:2VVJ-A/E(6+"!#4J8GF0\C=U!K]>[ZC[MB]A0ZL(=
M7 [K<H8^@YT^ ZL^DTQ)(8F:SQ0RS.,DGY.--'+!"'N6U?PDY6%^2B9K VUE
M0L+\P?&873K]P>6%.;;!<;G#T6\@#?J#"^^B>?2'N]$?6D?_-@V+@MR06YYE
M:I0?)(^^-0VQE=)VB)$P'PD+D# *@AFZCG:ZCH#GM!%2723,1\(")(R"8(:Z
M%SMU+^Q'[>9H+?312I:A($]ANF)DN3VAZ41IFWK=6/%M!4?"_ ULM)\)/ZAS
MD7.0,%]7C)XM9@S_Y6[X+ZW#?W#%\YT\+'E><-$TTE92VY%&PGPD+$#"* AF
M:.OTZFO='C!U5C"0P%":#Z4%4!I%T4R1]PP-YT^[*K"C6TN.I/D5[<Q</H V
M2L\V:HKDUB*Y/Y1GU=9KYZWV%EIKA:3Y4%H I5$4S52^=F0<I"7C0#T9*,V'
MT@(HC:)HILBU,>/8G9DOJVRJCFZ5=ZM\FQ3%JM&VO;&36BN\H0T-*V-TG"9]
M:+,!E$91-%.\VK5Q[+;-3YU H8:-TV2--&B);#2 TBB*9FI9>T".W02Z8R)B
MN0SGI8:;HY"$>6R8<I6DX4Q6WMRG/)%)F)*[U31-(O)U-F-"%XQX6MX1?&+I
M"UFP-";3%Y)4A<M+U@5/59 T7IC:>]HZ-#:T2^/ZSST,#*B#!*51%,T,C-I$
M<JPNQOB>%5(DY=W=@JAIEA1A7BB9M=.0\%A'BTPR5@7%=%6H^FI:%O%LFN1A
M>5-8;2]3IC<;Y88Z3U":?V9LAB0K;Q4V!@'4:?JACIB*U\:28W>6'C:6DA*=
M*;63^5P?['PG_'NBIMW)/"=J$EZP-%59XF6;&=17ZU"H@K(H T.E""V^*O%^
M+VO4\; MM$T-C>'S-LE)K!)**(K:WGIWUM^R[V7KN((Z7!5M_WSEN(?79\@6
MJ;U%,U)J#\RQFV"/"]6RSN0Z.,HS1!R^J.F "H/&:*EF",?!\A/1\9WXC>I#
M33<HS:]HQMSSZ.H<ZJ:A:.;ZA]I.<ZU.SEZ<1.HLPJ*5GAG\]6+&OA=M8P9*
M\RO:?LQXAS$#;9&B:&;,U.Z<:W?G_F(QTQ@O4!,02O.AM !*HV>4]WJEO+8H
MJNU#UVX?_C]$$=2>A-)\*"V TN@9Y=WS451;D:[5!=N+HNJBI]:_\?RB)JSK
M11(MRA*J(T:\K1.Y4 7TK-DS?MK"%2EC>=0\J[7WM'6T0'W.,Z/H#)HDJ4(#
M:FK^4$?,V*@=3-?N8![=H+A=)&Q&@N=MLODZFZDKJ38W+.PMMM88NN@,2@N@
M-(JBF9%0VZ'N 'C#PH4:H%":#Z4%4!I%T4R1:Y_4M?ND1S<LME,'T7S7PHYK
M+?/PZ"K :?"YH8T&4!I%T4S]:CO3M3ME)](U5:?N/-+3MA](UU #$TKSH;0
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MH0NHWV><R^T'W<#N97;C_P%02P,$%     @ <I/C5OH#^EA-$0  V.   !D
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M$WVXQ4BN$JJ!O+^F5#R?J =4>ZDF_P%02P,$%     @ <I/C5A"-?KF9!@
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M8-RV9NP3:<L5&KE"_^S[?:GZ9V#W!KP%0](HE,:@-(ZBV<(;7R6(,&D8ZJQ
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MBF;18J&_V.%DGR],+PGG),DW=X#70#.!.+\AA+_O9!>H/K>,_@=02P,$%
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MY5!S+>?4MMKL/EG683%FL $'C1B-B!A#190EZ&M$U%PCVDVR'T\6)LPPDZ6
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M31CF+IV9]J2F,VW<#S3;GTL>TBK)HV>AT>"8:&M8%![C[-7ZM!=%9R;?QOE
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MH^T]H+GY^%8_ ZZ:CQ=A*849+U>1T!<4&UYRT9 (C_D1W$1E$FL%41L#T8I
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MCUOJLQJG"&"_/R5)_N.@>/W@^ ;,_%]02P,$%     @ <I/C5MUP4F[_"@
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M+24&(Q>3P#BL@JX6AJ*I"AR-86(WALT*O&V*1]9QH3VA1*/,0&UB4%H,2DM
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M<V6@#N:926 ;&Q@?EIKRRY6^STS-!XJ\4_-2[5EV#V '*4G24YV D,'<+-B
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MPS%K[>:;1>F#H8JM$5'?%E0@(O:6"50 )@UWD_2I#73 O+A&PX)-HZ*S48
M -2&71[#[Q5O)NO?R^[,*H!OO2R"V$!H7^&KG65Z$FRQ7I8E*M45>V@6?!TL
MXLY71+FZX=/3G77#[<=]"O-OY1I,4[4=DZ8C-5\D%VA5$K$372'SD2G9_MP5
M+'HL$Q-5%Y+*=FH*7ECA$@O$@3 [O(MFV0>E6BHPK-,BL76.ZD8R$H[\ 8I"
M;@$YSO1#8%&#DB,Z.8I,B3U%B=DN,Y,UBP&$/7<<_D053"G35'HK=;LU,QB0
M)D];)5ZR$XZ;!#L811^HM+$_85$B32AV4WD *_PKY]'R?D/<2%Z(E4G<J^,U
MKLG!5$,.JK:6V*9_#4!,:L'F'CE&W+,5*0S"DU8?,^1A/;)-*1=*08S<VE-;
MR$7-]8%B6#+R&0;AR,DII0(41I:MQ-;^62TG;L#NK?D[=)1IYSJH7G-' ->^
M&%O%YFV3V8HWD&[B"MX-ZSG@-LSFQ][3M.=HU>*7C&JK(I;.0RIQ%/VUQ EN
M2O!M*CC<OY.1P1/ 0[V18JA/VI1-A:B@+X/%E7_^.E5?X0C&U2CT=[B6FX.
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M3N2B'ONV1.XA0>ZI^4&WI3-?',1YT"NDC@5<8<H!(RF6[>4;BH32Y8?8)IS
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M:Z9X SJMRV/:1"@^#-$REXB\=^DFV"'2Y!/,9)O!IIF\A;&PH2 R$" '5G>
MJ"6!1#:"& ^#Q3#<(.36>'WWOFE@-D=(Z\8P_-3.T^YAK(?9&7!"[(H7=H79
MENV4T*LYO8NK!KFWPO4V_$@@'EX@>](/^]WS<-2]]+2G=<%(,VX^\D'RP>I<
M+[R <8>#P6/O(R/VFP(PB=D.4O'EX6@8]BZ&C\VSX>"V<2/"O>#X(^921R?-
M91E ;Y+9K4K.R&X0COJC\.*R]TU<JX=_C!'74TPY@>*#DYN(9D#*%MXS* 9D
MP9Z7GKUH))PH;T([<VG3;38A$\>%+*6)%)T/\[29W3!B- ;FG%)Q*6P;PZ*S
M)X-]#/:A>9?3L:6AL6U13U@-F%D4;'%B)<MHC^)W1ZL?4'MC D4DQ#B'X/1?
MCR]6+18R05^,R7!BW)IW'^==DE\1#9*!!-=/AV6<UVB9&CG]&T;+K1-9F68$
M]J0 ]=C.>NQ*@#:61-389=7D=^RY7B%M=@*3MN1ZB#ZE"727UF4AP^E8!!/(
M!(L[LA,2-DLJEZN%T02!<1!"!K2"N>601$RT-5 MSXC$NK9@*51R2M'O4@&:
M.P&[M2O4Y>B6M+E]PT\-0XSW,8>& 5?+<)X=3&JLTAJ,3G- <"O*-*%Z/2>,
M$/5??+=_W^>\73Y3VF'SKE_^L'W3L6#S#K'$^]$S@2JFZII@H953Y&"Z]7#/
M@AX8L6$4=KN1=]&/[V_32C^=.9_DJ:];"$3L!F%];^(%OF9?'H[ZX? B:AV\
MVWOQ;4L]K=ET&?;[_?!\M#VROU![[:/$(VBR/L<IF.83RFR0E=][#T$*[-&J
MY B5]@^N.]MZQ\2O*RI$PFT'EA4/;+.*\CF;Z,TZF-J1$,"N33%O\5BDL3GS
MQR$2E5:<XF@G-\DEXS"+33:2FT2ABVM<' =/9^;$YM&P%K?NYA""N91GTBL5
M:'?1NI%NJ._]TPSI<#[$\[$T)P F[;NY  /";%)[!TYMX"B7 2-XK0U;Z83)
M#;NBQ"?@.?BE3HGE$(<V#38=%$EVON4J/^73PH4LYSESU,H-$Z[&4-9R,K)%
M/&B2KB;C&\!4*=A]/CHT8\A-)V.\TOX,)1%DPP.S0>6B&9;XAV:,R$#?W9DH
M[$?*ZV ZN3X-1>V%<*9VM=YP%F)YR%C4/L?I=U4 .I).46"'8/C,GL9 @ V&
M^?N@XV_8)65'>%_MW; F^1C 1*)M]\IRA54GEM/-X,PJ#1Z!;M]]^LYOW_.$
M#VQ^E/:^_L;-W[ LW],&W-[\0?=A8VY#&*>L@*'=7AAM114-'AE%$[,95H24
M9M -]& AB#:8L"$,S%_%YI"-Q;*M5)O*^:/AR#?"#X(=!#<^;;O=ILH^1L='
MNX6?OL1MK\O9-U.6U'26^W---<8Y'@["RR'$?Q[L 8QP$9Y#3/=[F?Q69CF5
MHN'R]NQRSS(T3)(=IXXNMQ%+.#2 Y<T3]>JQR8 742?J^IR(.MWA[V;"QZ;I
MLVI"QWWT]YL?KS*_1W5V1OP^IV!71+VASZMA=!&.NN<_7&<V/,I^%M9)F<T[
M_7!P'I'!>ZK^[)GXR3H$T#V665E71$ X"I%@4"C]-7C?>G9 4,,59*3K6C8>
MN"(9[AG:'*68TWHZ9S5'.'1FV#RU4"4?^5"6)J30'!.)5!\C'_"H@>9^#[PH
ML$0$XG2M*!L,;U<%A9QQ;@0',S[K#6FG4G9R?UCK'1)3%>4#>G=TATF @D"_
MA'X(BQ;L$10,X%4%3"2 S'L#,[VZ5C-:KLV)@5<.@0RB<<F7FG$[P?L:I#4J
M5WS9D ML/->6Q6PO';%9,,R)J"FE5]HGX>/)J[NQ2>2#)H4V&B B_T&3?ZCC
M39[KK2MET771K@^ 6_(V5 KK5W=SE<.N8NA&@D'C21$,72A04E-7 :\K!*1Y
M49Y2O45&Z)KRIG)9MAY$'=^!8Z:LY.5)!\P"!45X%E;OC^L-&5A!2Y0#K0W#
MIG9V E7N#!5S:21U_P&*"MVL=,2,4(T2S#;739O2DQQ6("2((?P76PYT/"EV
MATZ*;[V74')_DPD6?AFA=0BSU /O6I<K5F8-EAP^ '$-I:-<9#V6EZ##FC^.
M8"FM@(3SH0SQTM-RUHH9"8[RC.8@I\0BPD*>TF/TYD8>+Z&"'&+$1N+1&]Y5
M2)E;N\\-"?"; XVXQOQMBX.%UZ=#J[FDC.^6Y$%/#7ZNE]]@7\ ,Y<QS2*&?
MT;CD:1E,3YLWSUZ]HQG5FKZ#,(UB \KBHC.R/]VYL5T8W2_1C9V2K0?S4Z;2
M)H!!F<$VVP!B(TL;UQPP%;GF8*K;<R5#TQ;J$@H)KMEI?A8/<K.$:<'1?UW!
M7A]E<J-&:P4^=G^X+7,QJ V?/Y.S;FQ072D<EHZBZ6U87E/4C>(!2]!:3-RD
MAPYQ>;829T,A3F51U&$E7-Y9'EC(.KC&D?QZ2C^";BEZXX /QD;Y[JM;Y.(&
M/"W@0K2@/@J#UPFLD &AM#7^,K8^K#5'9H(SZ3!=*E:F>88++!N]#U[$C=,P
MQ[E8I%Z8+26PR7E;CFF(8;9UR&^9LA.,(D7]KL9H4H%F)2&7)D.<+;46!=;=
MY:9E =M/6 Z>  R))M_C$T$Z+2A5U&DJ%14X4!&+IO0^G21P@A^"1(T'I'S<
M$?@Y75%R<8QT69HV&?JC$51I9H61<D)/7+LJODHZF=B@FZ]S=1>\4$B0;=8Q
MH2R6%$YD)J>JU&Z=YC D"<TK=HY@@0<V$TF5CJ>I^BK3]2GH3W9JBL@G>"2G
MS7D%I27D@UC8\B#,VX@'VB,5S,PU_NUGQ1XF\TJ6W#E7L]1,Z5;@1+FTA?@5
MUPF+^+4"J):HF%-:OGEQ"R9<6'!^!KL.-.^B)>AW:OH1W*%HE=5\XGUFN$A'
M;+8XW=OCICJ&IK:GQMF><6PMHX56EC2V**WD[:QR;"UL;$)<XP[2-1E_L1)<
MP\QW-=87,Y+$ZG>Y8E&PN:_-AH^+;5-,R(2+E,^V$#L65!H.X[!:T"$G-0$9
M-=NBS8LG&PQUJD4Y02?J#0TS&37\CST?KPJO$X4V!0(1K(0\[O6&G='HK]P:
M&/W5;<]&W2O7\7T#HUMF8Y/G-3'AMJ\H$'+/8/-:]_?18"%TW>QG"Z1,(O!^
MVWY:<-9B&CO!)QFS?EQS"K.UFN@Z"ZZJ&5H)H")BO/C^ZNZ-S7NVOO1E23BP
M+C[ZX@XE<)33Z-S#NI/2G631#UMG:D$)+N^&<,P-U_1;]WY\5TU*KF6ZB$Y[
M$4MX/X9N')KAT0&YK7>P@+*V,S>KS-0\;4\%./UT %-Y:[-K<FND@!(!SG3M
MXP@4NBM-:</LZ(?<:'7[IHG,#+I;Y(E,C9,WT,;4&[K$*MD;&CQNLI'0GW?-
MQ2^DLGR#(4$C ,)J&UZ//;#Q0+6. 8.;^ W'=/5I2UXJ)8-S6YVQC<]C7Q#8
MYM*410ZR\&N0L&6G[O-)-1J0LL@1 &C_&+UNW."Z.W]Q":H9KFH*N\\=)+0&
M3PKVY(-!+<@&0L[)XZ3Z@J0J8<,WDU%J.9^Q?/,C$SY+<?B7O)3FHP0U/35+
MDHD]-:/X+DUW";))E7].Y>R1-=$UA-$Q,'.-_1$3"1N(Q"FF8/+K0GN,7+DF
MJ::<_)E:.&SHRMD0GGBC:NQ=J9&!/7@Q:1LC!_;H;*O8[-2]LFO \VX=8;.Y
M/,]R+ :S =_4<XG4 T9PDCR>Z5ATOLR>];07X+5UI'3:OC%PZ-0_=.H?.O4/
MG?J'3OU#I_ZA4__0J7_HU#]TZA\Z]0^=^H=._4.G_I^S4]]TYU.G_F#8#[O#
M[A-;];?Z\FUJL_L?:\D_=.0?.O(/'?F'COQ#1_ZA(__0D7_HR"^W.BP.'?G_
MT8[\FZSM<TWE'[*SW>LP.+2V'UK;#ZWMWZ^U?7=H^*?I;O>70"MHNT%+^J9V
M[5.O<:2M*?N9JV?YN0"; J;/ ,TV.O&Q[;ZI(0Y(@_X"L<;C''%3-("E29K6
M385TAL1VV%U\C*CC;A2>=P=H9T^H*,FTCNBR4:BWLX5_[]CG87=P'D;#P8F/
M"G?8\*U2!K0YFU,<7W;#R^@R'(SZ)SOG?]IW OZM[P/4+4S]X64XO*R_A-"]
M#*/S*!P.![]3ZUS?U/;G$![Y1D#KQP&^Z:L _Q>? SA\!^#P'8##=P"^\3L
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M6>JA?EC0+0>U<Z#UA:) VXG;H+LWC7\ 4$L#!!0    ( '*3XU; W<P5C ,
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MF  1P#,,M&QC"(@Z"*!5!$VG/Y?4VZ((3AA39. >D?^4REMH7?.4LH?22VC
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M>?[V\K?+3_]]=>P@EEX>9T'$6R]BO$?$2?).EVYNDY_+7.8[YE_</7\TOD/
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M9D9;.JS6OLGATM,13C27[R5AR,)3=.SKT^%_(G Z34'G([,6%,\0Z,#>.G^
M1WE0-]D<L;$6/^  <?<]6:L+"?.)+]%7("+:>EON$G)()*732-@CK_[AW]Y;
M-[JHD.XK_A("G J&;,"9ZTZJVTUN&)#Y, \TL*K/;+N=6.RWP"B-:W=*[2%Q
M\[W-Z]T]4NT 2OS[TOJ0W</Z>\P,,?1.F&MXY4]15'7T$#_S''$CJ=-N/>UX
M8^L^MZ:GA\&04@H.D0P!=A3RFIMO^GLT.JWC; [O>W9/G]H:UJ5_._2];ENM
M>[MI1.M&7-NKW70??(KZK6J?->F!1./+GJ_3NW[U:#3\OZK^[2KOIXCQ*K]G
MB3U+[%EBER6>.\HO3(W?<&+9/Z$UY+.,^+1[$A6(16CRNP5]-$Z'9Z?I^-EI
M^V:/TW0/#[P,CMM()T\J1J/T=#A,A\"@S72-J70:EMOVY-&NNP]&&.K&Z0GT
MH1CVRIU?721GH]/'3X:#Y(K<60\#K:#SDW#L-)'^WK=38'+-2;B@[UIR.H$9
MPP[!+@KLQ!&P+<)%BI&,-VGW5'E!;33O/6E-8$I?50$=FX"3N?6.OKESH9@1
MK-#Q7D=H5T:\B0)5-<D-H6K:(N7^L@S>:%ZS,K-2_=T<BFW=ZC4W\=-$(]S]
M@?)@U]?1^F][]=_VZK_MU7_;ZR&QU'_;:_Z]O^WU=/AO70OWM\+]K7!_*]S?
M"O>WPOVM<'\KW-\*__NWPOM._/I+X?ZXKS_NZR^%^TOA_E*XOQ3^JDOA?26U
MOT3KJVI?57=7U7.W?6/&XO''J+\ZZZ_._OG5F?_QA>/63WMP-TZ_>$)PCI#R
MO_)1/ZU_5.6<?TODN!GN?Y'EG3 S55K0HBFF#@?/3@_\>5'\X/22?RADHIW3
M"_YS+@7<3@/P?JJUBQ]H@?JG9M[\#U!+ P04    " !RD^-6K)*7J4D'  #C
M'0  &0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6SM65MSTS@4_BN:L,O"
MC,G%26@7VLZTI2S, NU2V)U]5&PE%I4E(\E-RZ_?[\AVZK9.*"R\=:9-;%GG
M_IV+XIVEL6<N$\*SBUQIM]O+O"^>#08NR43.7=\40N/)W-B<>]S:Q< 55O T
M$.5J$ ^'3P<YE[JWMQ/63NS>CBF]DEJ<6.;*/.?V\D HL]SMC7K-PGNYR#PM
M#/9V"KX0I\)_+$XL[@8K+JG,A7;2:&;%?+>W/WIV.*']8</?4BQ=ZYJ1)3-C
MSNCF=;K;&Y)"0HG$$P>.KW-Q*)0B1E#C<\VSMQ))A.WKAOO+8#MLF7$G#HWZ
M1Z8^V^UM]U@JYKQ4_KU9OA*U/5/BEQCEPB=;5GMC2$Q*YTU>$^,^E[KZYA>U
M'UH$V\,U!'%-$-^58%P3C(.AE6;!K!?<\[T=:Y;,TFYPHXO@FT -:Z2F*)YZ
MBZ<2='[O],/QX9^OCM^\.'K_VRD[^NOCZP__[@P\.-/S05)S.:BXQ&NXC-E;
MHWWFV)%.1=I!?[B9?A1O8#" 22N[XL:N@W@CQ[?<]MEX%+%X&(^[%-I,_D(D
M*_)X@SKCE9O'@=_X?[JYXC+IYD(9_<P5/!&[/:2L$_9<]/8>/A@]'3[O,O$'
M,;MF\&1E\&03]SL;O)G+N^,/1VR[SUK<'C[8CD=;SQN>[ 1I+ZP5*3O-..Q@
M84/\G'W(!#LT><'U)9..\=)GQLHOV.@-%EPIV"@:#H?TSXH5%U=Q64J?,<X*
M;MDY5]AKYNR781][1ZP0MMI6[7)EDJ%R.+G0G$I3Q"S5#HC4:<U8Z 0\N4/F
M7K*9P&XO++(9\N;6Y,RC,)):X7MVR?R5[K6]CAT8;E-2XX6TJ('&NC[;]PQ
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M7HDTU').^MY[(VY$Q/J/B[^"\J_!8W:"_K1:H^?)C4A-3 XZ$Q%:G'W0 /C
M9Z@RD*(8^8@%1]Y!,/)&!T/G(3EN\&S-D_NZ?LYCX$T5 W?WE(ML',FPH)TZ
M8@R&(\_W_8U$O:! %>PB @A#9;81_+ZF'K'^@3<:'?[?_'\YZ%>Z_K)C/X"K
M%^,JEV\\"9:>?#\$MKUN&3(^_#?L[_\Z(?-SA ZFXI+2EEFR2[.;\BV$MFE.
MH,E!F3R*;BE+ D7!(9%H,5?:()DYI&XUJ?+?HD8D42;?.  !HSD4FA[+4IS(
MJ?R$A,EUI%@JXRRBK-H%+]XT<WNTY#KV[5HX2B:IT1GJO:Q YC01.(MDBAB
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M!XH^^ED6>V/4G'[99*R,43'].1-0K6H< .^G2IGB!A<H?QOG^']02P,$%
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M9)U9%OG=VM-99M,F%\C>;W0>])4:%4"0;*(R_I'<*IT7Z^ V+Z&7V:XN82,
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ML0)7.Q#'9UXXY,KIK1L1QBZB\Y,^SX\7/)WS Z#M9>IP*&OA2H&1F,AM2B0
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M+W#+E)<D8I8!D06USI5%GEHA-[D+&%RMB>)5Z/0CCTG=D7VX#)BY9)=;E](
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MW$'>DLLGO.5 B[E]!9L(K45F/V? 8Y!F <[?":'7 [-!^8[:_P]02P,$%
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M+$5ZNBTL9(YE@ 3%+W9.-FSA'D%F4OKLX-L?0&49@;5HOI(B7ZX.5#&^(%V
M+&*L46@"L*3X'B*0-'GQ/DUS*8'K>OX3<9U>._#M'8D9.:ZA$ -J1X=^#QR_
M[?7\0Z];CA.T?<\Y(S---1#*(W(CPG^%Z);6"X@^-7DJGZXH7P*&.EG3)*=E
M<4[P=*#X8P^L*J\/Y)7/Y/I(QIRRT0V)Z]>)ZY^<N(HM.8M92''WD% F..ZC
M,E],@DQ10OG#S\H<&.6N&<)4*=#J6'XW+_Q_GC;G:1V:<]SDBV*3OTOW UZ
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M_PK*WCI:2]HK,1BPW9-&2@+#F]I$37N6M+\1>VRCVN %.&FD_>//#";& WB
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M@%86T&H%U-F9 N.RP+A>8'JF@%X6T&L%QN,S!8RR@%$O<*Y*9EG ['L.D[+
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MQNEWJ4[&(_Y/_$))[R,=9 7=9MBQ.9V8M9A>[]KYS2,U0S>FXVFM 8/.0FC
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M1AAR8\37-(RS\+#O;S&%:6WC4!<$E&9!:3:41J T!TISC:8AP9Q,5%6M;_$
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MO=P1;%F\0#UC0K"DV%Q07\XJ\P;R\R?&Q.M.WL'F'P\,_P=02P,$%     @
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M%Y<E\K8[?U%\D_65"ZZP2\T>UT!#$-H YY><J_V+#E#^^#'Z#U!+ P04
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M-TR8!OK\EG/UNF/69%3+@N;_ %!+ P04    " !RD^-67.>Z6OT"  #L"P
M&0   'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6RM5FMOFS 4_2L6FZ96VD*
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MLV>/UR_(EEZ4)47U+WFNCQWT2+0IRFQ5%Q8M6,7I]O_PI7XCWA2PK",%S+J
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M5/.A6G B8LS3T=>D_RU]^K^)OOK&JXF;UM&?&/P]+^-HNT^5:(@2IW)5BCA
MCD MY5<[7$@KGD9'1HC0&050S8%J%*HQJ.9"->]$[S/LMJY<AQ1TEL%9#5%C
MJIEY8'6<>3!=QGQ.Z,ONXO;;?"[NYKK,1-#7V#DVH#,1H!J%:@RJN5#-@VH^
M5 M0FAI!S4P$"SD3P8+.1(!J#E2C4(U!-1>J>5#-AVH!2E.#HYF)8'6<B;"[
M-<I/3$?0NYWC!#H= :I1J,:@FFN]GXY@M"1CH97Z4"U :6H -),1+/UDA"/C
M*R;N4=)(WM>?,;Z"SE. :@Y4HU"-0347JGE0S8=J 4I3OT&OF<XP1*Z,'T)G
M'$ U!ZI1J,:@F@O5/*CF0[4 I:G!T4Q-&.JSMV>/K_1NYSB!3CF :A2J,:CF
MUMJI\16T4A^J!2A-#8!FQL%0/^/@W?CJVW-&?/'4FHM_TI(X<<ZCLM-2&GV5
MG6,#FOZ':A2J,:CF0C4/JOE0+4!I:@@U4PJ&R*_M'D*S^U#-@6H4JC&HYD(U
M#ZKY4"U :6IPO/D";WW^\OP!%C0/#]4<J$:A&H-J;JTI7YK7,KZ"YM>A6H#2
MU/[?Y-R'^F3C^_'5,LYG__4("YH^AVH.5*-0C4$U%ZIY4,V':@%*4X.H2;(/
M1\@1%C1_#M4<J$:A&H-J+E3SH)H/U0*4I@9'DS\?ZK^]^?P1%C25#M4<J$:A
M&JLU_9C(A=;I034?J@4H3>W_38I\J$^1O]_[A4=9.B.3E1A?51MHRQ4TU0I-
MW2[;!UMJ=QF,05/M4,V!:A2J,:CF0C4/JOE0+4!I:KPU&?GA)7(P!DVV0S4'
MJE&HQJ":"]4\J.9#M0"E*<%A-\EV6[]WP+O!V$(N43DQ$-.;76,$JCE0C4(U
M!M5<J.9!-1^J!;6F9$VMB[%M7+2OKK2;=+JM3Z?_U]]MJ/<[AP(TK0[5*%1C
M4,V%:AY4\Z%:4&L?_9Y$N\FKV_J\^I?P)5YM5B0]O" 4F\=_\ZBZ*9EG^9S'
MY4;$13PGZ^W&,6^WA"'\A>=17' B[N7Y:EVMRLKCQ;(L]!<4: (>JCE0C4(U
M!M5<J.9!-1^J!;6F7%"&UL5H="2*FM2ZK5][/-E^=]S;C9>V-_OR?IZ_E#PM
M9$@D6=BZEE>O=XX#:*X=JE&HQJ":"]4\J.9#M:#6[),#JWZQY+QTPC*\N5KQ
M?,&G/$GDXEO1VZ][<KBU?U:<^N?R&^0^3\Q>7Y1L#K^Y6H<+_B7,%W%:D(3/
M1='!IPM1>W6)V#THL[4DR6-6EMFJ^G')0Q%$\@#Q^WF6E;L'LH+G+/]>->_F
M/U!+ P04    " !RD^-6K/=4 _@*   Y?0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970V-"YX;6RUG6MOXD@6AO]*B5VM9J2>!MO<TIL@D;A\6?4E2C([VH^%
M*8*WC<M3+I*.U#]^?0NFP*G Z-TOW4!\GE.&U_:QW[I</@OY/5]SKLB/39+F
M5[VU4MFG?C^/UGS#\H\BXVGQEY60&Z:*M_*QGV>2LV45M$GZ]F P[F]8G/9F
ME]5GMW)V*;8JB5-^*TF^W6R8?+GFB7B^ZEF]UP_NXL>U*C_HSRXS]LCON?H]
MNY7%N_Z.LHPW/,UCD1+)5U>]N?4I'([*@&J+?\?\.=][3<I=60CQO7P3+J]Z
M@[)%/.&1*A&L^.^)W_ D*4E%._YLH+U=SC)P__4KW:MVOMB9!<OYC4C^B)=J
M?=6;]LB2K]@V47?B.>#-#E4-C$225_^2YV;;08]$VUR)31-<M& 3I_7_[$?S
M1>P%6,,W NPFP#XUP&D"G%,#ADW \#!@]$; J D8G9IAW 2,#P/&;P1,FH#)
MJ0'3)F!Z:I,NFH"+2@[U[U?]^"Y3;'8IQ3.1Y=8%K7Q1*:B*+G[S."W%?J]D
M\=>XB%.S._IY_D!=<CN_>_@/>;B;?[V?WSR$W[[>D]_(?+F,2TFRA,1I?6"5
M OW%Y8K%2?YKL<GO]R[YY>^_7O95T9@2V8^:Q+1.;+^1V"%?1*K6.:'IDB\[
MXGUSO&6]!PC> =@&0+_X&G??I?WZ75[;1N(7)C\2V_Y [(%M=S3HQAS^KVU:
MA(^K<*LCW#TA?&"]&4Y/:+Q3ASL=X=[IX5W[[IO#71[MPKL:'YP>WI4]-(=[
M?%%\==.N[)H0G-U!Y50\Y^R#JJ-MUS5KV,TJ+W:?\HQ%_*I77,UR+I]X;_:/
MOUGCP3^[)(:$N4@81<(\),Q'P@(D+ 3!-!$/=R(>FNBS;UN5*Y8NX_21B!7)
MI-C$>2[D"TF%XL6I7_*$*;XD&9/JI4O81OZYPD;"7"2,(F$>$N;7L%$%*ZO>
MI]ED>F&/+OM/^XI%I@Q!,$VQHYUB1T;%_E&4U:5:(Y;%JJA9$L'2G#PS*5FJ
MN@1JQ)TK4"3,1<(H$N8A83X2%B!A(0BFZ7B\T_$86#Z,D2)&PEPDC")A'A+F
M(V$!$A:"8)J()SL13XPGXQNQV13WBO=*1-\_D'S-BA1$M#5%EY2-Q'.EC(2Y
M2!A%PCPDS*]AX[V"87!0+!QO80\F@ZFE;Q:"6J4I;[I3WM2LO(3E.;DF^PKL
M4IN1<J[:D# 7":-(F(>$^4A8@(2%()@FWXN=?"^ 5_\+I(B1,!<)HTB8AX3Y
M2%B A(4@F"9B:] ^5Q[ K_]FY+EJAM)<*(TVM/WKZ- >.2-KHE](/6A:OR.M
M/9V,!H/#R_RI[0M1[=-5MN=>6$:5A:F28KF-RMO^^?(ISH4D\T?)^8:GBOPD
M\[L;XDNQS<AGU>417)OY9TL.27.A- JE>5":#Z4%4%J(HND*MUN%V\!RH(&A
MY(RDN5 :A=(\*,V'T@(H+431=#FWSIAE]"QFMUQ&Q:F9/?+25!#/*9?Y.LX(
MRTDDTCQ><EF;S*OB3%ZFCR/>*72H:];0+O9O?#\.#AZ4N]"<%$KSH#0?2@N@
MM!!%TP7<NF*6V19[6!?4M4B6).,R%LM*J+IT,_;"%@DG;*6X)&K-292(O"Q_
M4[+8Y@4P+]6^6<1I'5 06/I"5L7[M"IEGF.UKCYZK6D>F'SDZG5#MEK%2<Q4
M=0RQ]&"KSL,%ZL6]\Q6-R:;J6-%Y$8!:;U":!Z7Y4%H I84HFGX,M3Z=93;J
MO%CFBLR+&GU9U>E*5$>)L9CO5#74P(/27"B-0FD>E.9#:0&4%J)HNM!;(\]"
M.GD6U,J#TEPHC4)I'I3F0VD!E!:B:+J<6TO/,GMZ>O&>;Z.HK&16G)>535F8
MW(:WM#B5,T6>BX)^(<7V<:W(XJ5\#M.I^,D)=?>-N55G*QGJY4%I'I3F0VD!
ME!:B:+J26XO0,GN$MVUOMJ]E;[:JX+YK.K3=OM6AS0P]^P0-]0RA- JE>5":
M#Z4%4%J(HNFR;JU#"^D=6E#S$$ISH30*I7E0F@^E!5!:B*+IPRE:#]$V>XA?
MV(]XL]V0A9!%;-.UDT6Q>BGK#ZW_\6'_Y"Z]F[.=JW<HS872*)3F06D^E!9
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M]I6O+ Y<N#@HY?-8+*B7I#M@!J2$NP56LMY(#"/[2EDYJ7-H5?(AGL=ZQ?/
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M?$(#Q5O$89+])8>\K660Q2Z1<90'IR.(^.;XR5[R1)P$V,.& #L/L.L!@X8
M)P]P:@'4;0CHYP']>D"_(6"0!PP^VH.;![A9[H_)RC+M,<EF$Q$?B%"M4YHZ
MR.3*HM,$\XVZL^ZD2+_E:9R<!9?7<_)P^>/>)S?^Y=W]W+_Q__GWCIR3'["'
MD#@D8%R0!Q;N@-P 2W8"TAM+)N1ZL]VE'V<>2,;#Y$L:<BOXGDD@/YD03+4I
M*>=D#HN=$'SS-#%E.G#5O;G(!_GM.$B[89 W3/2(0[\2V[(=\B<Q2;)F A+R
MGX9UU<[R8%&P[!.6AN1U(>F&XG< :,*#CX?3>O]F>A\4-X-=W QV1NPW$/T7
M$ N>@!)R 3J=6N.5"UXD6[: J9':7 )B#\;LKS^H:_VM$PH3YF'"?$Q8@ 2K
M*.H4BCH9W>GV>.ND=3"EQ81YF# ?$Q8@P2K2]@MI^ZT/JP>9VZ:_RR3D[)&'
M7+Y^)5%IT80KA]9)?033H[&H=X_]C-+>8&+N3S7\4"NO=9!=Q<F[=$ZZM'J4
MUOH,WFU62>B@2.B@-:%WZG>@V?I:@[L^'Y@P#Q/F8\(")%A%3K>0T\6R/A=3
M6DR8APGS,6$!$JPB[;"0=OB[K&^H,36KYXYKWJ=OUN_7S*]UF%WE&6I=S:IW
M&C2THWKW&Q4Y';WS[K=-%WNP)!)$1,Y>@8GDBRZ#K9BN#PLFS,.$^9BP  E6
M$79<"#O&\L$QIK28, \3YF/" B1815IJE:MWZW<Y84ZN>-R@1T<U)VP?0%<=
M&SJUJYWZJ)T&^DX=5V^8]*1T0EN3?ROBQSSG)%Z1R\6O'4^X*IAI\]T*Z_IT
MH=(\5)J/2@NP:%61RY((M;'LDZ)61U!I'BK-1Z4%6+2JPF6)A+8NTS_EH8[N
M7<RRW?I:NGT(G<5$K8@T36)87W;G#=W3E^(&#RV+&+2]BO$0AVGJ5<JU^<6L
M+ERATCQ4FH]*"[!H55'+0@H=H'DF:ED%E>:ATGQ46H!%JRI<UE9HZ_K^4YYY
M)--^U6X<NVZ9J(445)K?,(>^77=,?;MAO\$VRP((;:^ S'GR?+X2 $0PJ2U7
MM@,Z/UB8- ^5YJ/2 BQ:5=BR"D-':-:)6HE!I7FH-!^5%F#1J@J7Y1C:6A+X
ME'6.M6]JSL"I>R=J\065YC=-8DSKYJEO2.V1WCWMLFIBOU,UX7N^A,V2O'((
ME^1L"^*X"T!;\&R'=?ZG-VH]!97FH]("+%I5Y+(Z8U,L)[512S.H- ^5YJ/2
M BQ:5>&3W2KMVU4^X:0Y^70I:]4\M+WSSC+B[D]Y=_A!:Y-CPLV3;6-J&^$-
M$T]\DY 05FF,U1NF:PQQW)EW/)'Q-MM)]AA+&4?9X1K8$H1JD'Z_BF/Y=J(V
MIQ7[(V?_ U!+ P04    " !RD^-6RW.5'A$%  !"'@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970W,2YX;6S565]OXC@0_RH6=SIU);:)0Q*@!T@M2>\JE5,%
MU^[#ZAY,,!!M$G.V ]UO?W82 @$3X.0^]*7$SLQO_C+#='H;0G^P)<8<O,=1
MPOJ-)>>K.\-@P1+'B-V2%4[$FSFA,>+B2!<&6U&,9AE3'!F6:;I&C,*D,>AE
M=R]TT",IC\($OU# TCA&].<#CLBFWX"-[<4X7"RYO# &O15:X GFKZL7*DY&
MB3(+8YRPD"2 XGF_<0_O?-B5#!G%6X@W;.\92%.FA/R0AZ=9OV%*C7"$ RXA
MD/A8XR&.(HDD]/BW &V4,B7C_O,6_3$S7A@S10P/2?0MG/%EO]%I@!F>HS3B
M8[+Y$Q<&.1(O(!'+_H)-06LV0) R3N*"66@0ATG^B=X+1^PQV-8)!JM@L"YE
M:!4,K0,&Z)Y@L L&^U()3L&0F6[DMF>.\Q!'@QXE&T EM4"3#YGW,V[AKS"1
MB3+A5+P-!1\?/-X_C<';_?.K#T;^_>1U[(_\O_Z>@*]@N$3) H,P 7R)P2,*
M*7A#48H!F6<WWQ"E*.'@.433, IYB!FX\3!'8<2^"/[7B0=N?OW2,[A04PHS
M@D*EAUPEZX1*+3 B"5\RX"<S/%/P>_7\$)X#\,\ 6#4 AG!PZ65KZ^4'JQ9Q
MA.@M:,$FL$RKI5!H>#F[I7)(/;N'@Y(=JMQQ.;M5XXQ6F7*M#*]U*N7*5&I6
MDF>$$4LIG@%1/\8X2"D-DP5X0"QD3?":D"G#=(VF$09/R2KEDH8D@>!&LN0T
MP1!%01IE!_!]3*((B%*R073VCRH'<QUMM8ZR/-^Q%0IPOR'JKQ2,&X/??H&N
M^;LJ?#K!/)U@OB:P2J#M,M!V';HRT#^;_RNV?XB6!VZ>"6-?FF#"$<>B67%9
MBIZ2@,2B*%$P)+$P8BF;V!IO[[_[[US>2&@_26-,,T1E2M1;LZN'<VG7>EL+
M-T4=C+86JA+DXZ"]6NAKT^5#]*PDCU,FCU,KZR6=1F&P[3),%:]:@&N_PCK!
M/)U@OB:P2A3<,@KN)ZC5KLY ZP3S=(+YFL J@6Z7@6Z?K]7K/-!3O B31 9T
MBB*4!%@5DQS.R>#D-+(>M&S'-,V>L=[W]C&9[9KF$9U7J]VUCCPOM.*C3NFC
MSH7E3SHJ3]Y0IC>3[8>('\44("9&KI5\I7):+?ZUB9R#N7M6?K5<10R\SF4Q
M\!6 MN4X)_W6+?W6O3BW<#([DUC=(RV4B75,!KN.POAC.K7Q9\563(?F;KXR
MZ_L8#=?BYTIM(ZN'N#8OM*)Y6M%\76C58.P-N_ 3M+-"25WAUHGF:47S=:%5
MPVWMPFWI;6H%7J6JM!VG<U![%&26 UWW@,ZK5^]J9YZ56G73;AZ'M5.@AKY6
M+^#JC&X=-R((VZY]6-L5A*HX^"I JV5#>*JZ[R9<>,&(>W%K*\#.II>"K&6;
MUE%Z'=.IS3\GMFK\;D*#]2/:X7\ 5>/I0SW&U:FA=4S3BN;K0JM&8S>IP<\P
MJD&MLYI6-$\KFJ\+K1KNW;P&-0]L!5[E%ZYK*:K/,9W=478WK3/;!6*KGMI-
M;?"CQ[9Z 5<GM6IP:[N6HK\=4RI#X:L@;;O3/=WA=K,;U#F\%6#.V20[IK/,
M3E?1XXX)3[C@K.3< <;>KBS&=)$M*1D(2)KP?*%3WI:+T/ML_7=P_P#OAODZ
M<P>3;U='B(KO(P,1G@M(\[8ME*+YPC(_<++*-G)3PCF)L\<E1C-,)8%X/R>$
M;P]20+DV'OP'4$L#!!0    ( '*3XU:[HH+=U (  /,)   9    >&PO=V]R
M:W-H965T<R]S:&5E=#<R+GAM;*U674_;,!3]*U8V34P:3?/9PMI(M &-!S8$
M8]NK26Z;",?.;+=E_WZVDV9E-8%*O#3^N.=<GV/7UY,-XP^B )#HL2)43)U"
MROK4=4560(7%@-5 U<R"\0I+U>5+5]0<<&Y %7']X3!V*UQ2)YF8L6N>3-A*
MDI+"-4=B5568_YD!89NIXSG;@9MR64@]X":3&B_A%N1=?<U5S^U8\K("*DI&
M$8?%U#GS3M.1CC<!/TK8B)TVTDKN&7O0G<M\Z@SU@H! )C4#5I\US($03:26
M\;OE=+J4&KC;WK)?&.U*RST6,&?D9YG+8NJ,'93# J^(O&&;+]#JB31?QH@P
MOVC3Q$:A@[*5D*QJP6H%54F;+WYL?=@!*!X[P&\!_O^ ^!E T *"UP+"%A :
M9QHIQH<42YQ,.-L@KJ,5FVX8,PU:R2^IWO9;R=5LJ7 RN?PZ_W9UCKZ?_4+'
MZ))FK (D\2.J.5N79F^/4I"X).*C"KB[3='1^X\35ZK4FL#-VC2S)HW_3)H
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MI"KAIEFH5QEP':#F%XS);4<GZ-YYR5]02P,$%     @ <I/C5BYC9!_X @
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MF4T735,;JIM6QG9 ?U/-:F_*7K]*URO94Z$^+?1TA.E#F=,[23.V-/UEUAC
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M!_G&(?8-J-SKD,@\#K%Y8%%<QT3F<8C-@S&U95'(/ [Y$C,4=VN8R#P.L7E
M[5[O<KC&C'K! *K>ZYC(0 ZU@5#U7L=$!G+Z6C#P\9V)#.3TD]C(!IV*5Z%6
M[UUD()?80+ LKK6FBPSD$AOH1X0IR7BQ*C>"->DW]ER5+8R*B1SD$CM("X0_
ML5#^S'H[1;=N<55,Y""7O&BF84[$6E1ISK)_VU7%1 YRB1VDIQ5[ID%<I!ZW
MOYD:?=P@];B=>H;=R?7EN7Q8LD*L0_D#M=R_2O/5HF+M1[< RK#L=A'4PTN>
M^W+?O)B6Z7KWKXC=/SHN_P%02P,$%     @ <I/C5G-\>"Q1 @  ^RP  !H
M  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\W:2VZC0!2%X:U8+""X[JN2
M5IQ13S*-L@'DE!^*;1#02K+[MIR!?5 />A)Q1JA 7/X)GQ#P^%(.S;AO3\-N
MWPV+S^/A-*RJW3AVO^IZ6._*L1GNVJZ<SD<V;7]LQO.RW]9=LWYOMJ66Y3+J
M_G9&]?1X.W/Q^M65_YG8;C;[=?G=KO\<RVG\Q^#ZH^W?AUTI8[5X;?IM&5=5
M_7FX[A[JRR;=G2=7B^>W5=4_OZ6JGCM(($CF#U((TOF##()L_B"'()\_*" H
MY@_*$)3G#[J'H/OY@QX@Z&'^H+1$&9<$21.L";1.R'4B\#HAV(E [(1D)P*S
M$Z*="-1.R'8B<#LAW(E [H1T)P*[$^*="/06U%L(]!;46PCTELG#-H'>@GH+
M@=Z">@N!WH)Z"X'>@GH+@=Z">@N!WH)Z"X'>@GH+@=Z*>BN!WHIZ*X'>BGHK
M@=XZ>5E"H+>BWDJ@MZ+>2J"WHMY*H+>BWDJ@MZ+>2J"WHMY*H+>AWD:@MZ'>
M1J"WH=Y&H+>AWD:@MTU>=A/H;:BW$>AMJ+<1Z&VHMQ'H;:BW$>AMJ+<1Z.VH
MMQ/H[:BW$^CMJ+<3Z.VHMQ/H[:BW$^CMDX^5!'H[ZNT$>COJ[01Z.^KM!'H[
MZNT$>@?J'01Z!^H=!'H'ZAT$>@?J'01Z!^H=!'H'ZAT$>L?D9Q,"O0/U#@*]
M _4. KT#]0X"O3/JG0GTSJAW)M [H]Z90.^,>F<"O3/JG0GTSJAW)M [H][Y
M)_4>QJ]#&:X]WVN\_D]2/9[/+=?+7Y;?.R?W^ 7G^K9B>/H+4$L#!!0    (
M '*3XU;.%<Q?#P(  .HK   3    6T-O;G1E;G1?5'EP97-=+GAM;,W:S6[B
M,!0%X%=!V5;$^#?3$;"9F6V'15_ 32XE(HDMVVWA[<<);:56'305(_5LB,#V
M/3>^TK=B>7OT%&>'OAOBJMBEY+\S%NL=]3:6SM.05[8N]#;EK^&>>5OO[3TQ
ML5@85KLAT9#F::Q1K)<_:6L?NC3[=<@_Q]8-JR)0%XO9C]/&,6M56.^[MK8I
MK[/'H7F7,G].*//):4_<M3Y>Y0T%^S!A7/E[P/.YWX\40MO0;&-#NK%]WL4.
M'8OIV%$LSY?XH$>WW;8U-:Y^Z/.1,OI MHD[HM1WY:GHU?GDE&^83I_\XORI
MS+G O',3G(]Y8H$^'_<RDO'TW.="%%)[_A5?$W/IB]^/QFDWU/QC=K[>)Q?V
MTSPBFQZ7W_';&;_6_V0? J0/"=*' NE#@_1A0/JH0/KX!M+'-4@??('2"(JH
M'(54CF(J1T&5HZC*45CE**YR%%@YBJP"15:!(JM D56@R"I09!4HL@H4606*
MK )%5H$BJT215:+(*E%DE2BR2A19)8JL$D56B2*K1)%5HLBJ4&15*+(J%%D5
MBJP*15:%(JM"D56AR*I09%4HLFH4636*K!I%5HTBJT:15:/(JE%DU2BR:A19
M-8JL!D56@R*K09'5H,AJ4&0U*+(:%%D-BJP&15:#(FN%(FN%(FN%(FN%(FN%
M(FN%(FOUE;+>.;?_S_'3L^QM.[SDL^DOONL_4$L! A0#%     @ <I/C5@=!
M36*!    L0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q0
M2P$"% ,4    " !RD^-65.=Y?.X    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !RD^-6F5R<(Q &  "<)P
M$P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( '*3XU8<[XK^^P(  '<)   8              " @0T(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !RD^-6BS53(L (  !200
M&               @($^"P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ <I/C5C\!.OC@!   +A\  !@              ("!-!0  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( '*3XU8,%3'EXP8
M *LD   8              " @4H9  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " !RD^-6#$B5WH0&  "&+   &               @(%C
M(   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ <I/C5N>J
MHXS;"   ]S$  !@              ("!'2<  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( '*3XU868TH\3AX  %>P   8
M  " @2XP  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !R
MD^-6-%W;RL :  "4B@  &               @(&R3@  >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ <I/C5D/E30G] @  0PD  !@
M         ("!J&D  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( '*3XU; W<P5C ,  (L+   9              " @=ML  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ <I/C5F</6#;I#P  )5D
M !D              ("!GG   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " !RD^-6Q#A*?#P(  !0)@  &0              @(&^@
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( '*3XU8VR68D
M1PT  '9&   9              " @3&)  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ <I/C5JR2EZE)!P  XQT  !D
M ("!KY8  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !R
MD^-6GI_]U@D,   G1P  &0              @($OG@  >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( '*3XU9>/(MT1P8  /L4   9
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M970R,"YX;6Q02P$"% ,4    " !RD^-6YIPR?;\'  "F2   &0
M    @('*Z@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M '*3XU9RFPLO, 0   @1   9              " @<#R  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ <I/C5F['5"X.!0  ]1H  !D
M             ("!)_<  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " !RD^-6KMXN(G<$   B)   &0              @(%L_   >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( '*3XU9<Y[I:_0(
M .P+   9              " @1H! 0!X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ <I/C5NO)Z_[8"   V$X  !D              ("!
M3@0! 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " !RD^-6
M^@/Z6$T1  #8X   &0              @(%=#0$ >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( '*3XU9XD5KHV04  %<E   9
M      " @>$> 0!X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ <I/C5A"-?KF9!@  ?RT  !D              ("!\20! 'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !RD^-6/>->@Y8"  !V"
M&0              @('!*P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    ( '*3XU:C3:\D PD  )!;   9              " @8XN 0!X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ <I/C5L$V$$AU
M P  HA   !D              ("!R#<! 'AL+W=O<FMS:&5E=',O<VAE970S
M,BYX;6Q02P$"% ,4    " !RD^-6YFM"'3H$  !Z&0  &0
M@(%T.P$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( '*3
MXU:DSVJ"&P4   XI   9              " @>4_ 0!X;"]W;W)K<VAE971S
M+W-H965T,S0N>&UL4$L! A0#%     @ <I/C5GD^!*'V!   51T  !D
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M 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " !RD^-6$81
M:-0&  !B)   &0              @(&>80$ >&PO=V]R:W-H965T<R]S:&5E
M=#,Y+GAM;%!+ 0(4 Q0    ( '*3XU;/L=2K( <   TS   9
M  " @:EH 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @
M<I/C5MUP4F[_"@  L%@  !D              ("! ' ! 'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6Q02P$"% ,4    " !RD^-6%F-*/$X>  !7L   &0
M            @($V>P$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4
M Q0    ( '*3XU8T7=O*P!H  )2*   9              " @;N9 0!X;"]W
M;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ <I/C5D/E30G] @
M0PD  !D              ("!LK0! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX
M;6Q02P$"% ,4    " !RD^-6P-W,%8P#  "+"P  &0              @('F
MMP$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( '*3XU9G
M#U@VZ0\  "59   9              " @:F[ 0!X;"]W;W)K<VAE971S+W-H
M965T-#8N>&UL4$L! A0#%     @ <I/C5L0X2GP\"   4"8  !D
M     ("!R<L! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '*3XU9>/(MT1P8  /L4   9              "
M@4+] 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ <I/C
M5LXRKF\)'   XY0  !D              ("!P ," 'AL+W=O<FMS:&5E=',O
M<VAE970U,RYX;6Q02P$"% ,4    " !RD^-6[F/',VT%  !3%0  &0
M        @($ ( ( >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0
M   ( '*3XU; X$-J^P4  ($@   9              " @:0E @!X;"]W;W)K
M<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ <I/C5G.?7@YR!   U0\
M !D              ("!UBL" 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q0
M2P$"% ,4    " !RD^-6,C-.Q$$2  "5VP  &0              @(%_, (
M>&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( '*3XU80RYN[
M, <  (1    9              " @?=" @!X;"]W;W)K<VAE971S+W-H965T
M-3@N>&UL4$L! A0#%     @ <I/C5G*;"R\P!   "!$  !D
M ("!7DH" 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " !R
MD^-6>691ZPX%  #2&@  &0              @('%3@( >&PO=V]R:W-H965T
M<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( '*3XU:NWBXB=P0  "(D   9
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M970V-2YX;6Q02P$"% ,4    " !RD^-6$(U^N9D&  !_+0  &0
M    @($7>P( >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    (
M '*3XU;DZO6BF@(  &0(   9              " @>>! @!X;"]W;W)K<VAE
M971S+W-H965T-C<N>&UL4$L! A0#%     @ <I/C5F9Z$LYP"   <%(  !D
M             ("!N(0" 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"
M% ,4    " !RD^-6E_O)S<8%  #D+@  &0              @(%?C0( >&PO
M=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( '*3XU9) ..^%04
M "LI   9              " @5R3 @!X;"]W;W)K<VAE971S+W-H965T-S N
M>&UL4$L! A0#%     @ <I/C5LMSE1X1!0  0AX  !D              ("!
MJ)@" 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " !RD^-6
MNZ*"W=0"  #S"0  &0              @('PG0( >&PO=V]R:W-H965T<R]S
M:&5E=#<R+GAM;%!+ 0(4 Q0    ( '*3XU8N8V0?^ (  *$)   9
M      " @?N@ @!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%
M  @ <I/C5L/W2K&M P  N1$  !D              ("!*J0" 'AL+W=O<FMS
M:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " !RD^-6T#&C) ,#  "7"P
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M+G)E;'-02P$"% ,4    " !RD^-6\)= 0WL%  !5,@  #P
M@ $ULP( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ <I/C5G-\>"Q1 @
M^RP  !H              ( !W;@" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ <I/C5LX5S%\/ @  ZBL  !,              ( !
M9KL" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %0 5  #%P  IKT"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>242</ContextCount>
  <ElementCount>262</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>59</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>110101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>110201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>110301 - Disclosure - INITIAL PUBLIC OFFERING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOffering</Role>
      <ShortName>INITIAL PUBLIC OFFERING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>110401 - Disclosure - PRIVATE PLACEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacement</Role>
      <ShortName>PRIVATE PLACEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>110501 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>110601 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>110701 - Disclosure - WARRANT LIABILITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiability</Role>
      <ShortName>WARRANT LIABILITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>110801 - Disclosure - STOCKHOLDER'S EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquity</Role>
      <ShortName>STOCKHOLDER'S EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>110901 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>111001 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>120202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>130203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>130903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>140101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>140201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>140202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>140203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>140301 - Disclosure - INITIAL PUBLIC OFFERING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails</Role>
      <ShortName>INITIAL PUBLIC OFFERING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOffering</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>140401 - Disclosure - PRIVATE PLACEMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails</Role>
      <ShortName>PRIVATE PLACEMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacement</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>140501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS - Founder Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>140502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>140601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>140701 - Disclosure - WARRANT LIABILITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails</Role>
      <ShortName>WARRANT LIABILITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiability</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>140801 - Disclosure - STOCKHOLDER'S EQUITY - Preferred Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredSharesDetails</Role>
      <ShortName>STOCKHOLDER'S EQUITY - Preferred Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>140802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails</Role>
      <ShortName>STOCKHOLDER'S EQUITY - Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>140901 - Disclosure - FAIR VALUE MEASUREMENTS - Assets and derivative warrant liabilities measured at fair value on recurring basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Assets and derivative warrant liabilities measured at fair value on recurring basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>140902 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>140903 - Disclosure - FAIR VALUE MEASUREMENTS - Quantitative information regarding Level 3 fair value measurements inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Quantitative information regarding Level 3 fair value measurements inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>140904 - Disclosure - FAIR VALUE MEASUREMENTS - Change in fair value of derivative warrant liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Change in fair value of derivative warrant liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>141001 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEvents</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>200100 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>200105 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEET (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>200200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>200300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>200400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>210101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationss</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>210201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciess</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>210301 - Disclosure - INITIAL PUBLIC OFFERING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferings</Role>
      <ShortName>INITIAL PUBLIC OFFERING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>210401 - Disclosure - PRIVATE PLACEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacements</Role>
      <ShortName>PRIVATE PLACEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>210501 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionss</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>210601 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciess</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>210701 - Disclosure - WARRANT LIABILITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilitys</Role>
      <ShortName>WARRANT LIABILITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>210801 - Disclosure - STOCKHOLDER'S EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquitys</Role>
      <ShortName>STOCKHOLDER'S EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>210901 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementss</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>211001 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>211101 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventss</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>220202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>230203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTabless</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>230903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTabless</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>231003 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxes</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240301 - Disclosure - INITIAL PUBLIC OFFERING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss</Role>
      <ShortName>INITIAL PUBLIC OFFERING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOffering</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240401 - Disclosure - PRIVATE PLACEMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss</Role>
      <ShortName>PRIVATE PLACEMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacement</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss</Role>
      <ShortName>RELATED PARTY TRANSACTIONS - Founder Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss</Role>
      <ShortName>RELATED PARTY TRANSACTIONS - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240701 - Disclosure - WARRANT LIABILITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss</Role>
      <ShortName>WARRANT LIABILITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiability</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240801 - Disclosure - STOCKHOLDER'S EQUITY - Preferred Stock Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredStockSharesDetails</Role>
      <ShortName>STOCKHOLDER'S EQUITY - Preferred Stock Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails</Role>
      <ShortName>STOCKHOLDER'S EQUITY - Common Stock Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240901 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240902 - Disclosure - FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240903 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>241001 - Disclosure - INCOME TAX - Income tax provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails</Role>
      <ShortName>INCOME TAX - Income tax provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>241002 - Disclosure - INCOME TAXES - Net deferred tax assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails</Role>
      <ShortName>INCOME TAXES - Net deferred tax assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>241003 - Disclosure - INCOME TAXES - Federal income tax rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails</Role>
      <ShortName>INCOME TAXES - Federal income tax rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>241004 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="dkdcu-20230331xs4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>241101 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEvents</ParentRole>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. dkdcu-20230331xs4a.htm 255, 276</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesNoncurrent in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. dkdcu-20230331xs4a.htm 255, 276</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. dkdcu-20230331xs4a.htm 267, 288</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. dkdcu-20230331xs4a.htm 268, 289</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 92 fact(s) appearing in ix:hidden were eligible for transformation: dkdcu:CashHeldOutsideInTrustAccount, dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays, dkdcu:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays, dkdcu:CommonStockShareOutstanding, dkdcu:Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination, dkdcu:Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination, dkdcu:NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice, dkdcu:ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget, dkdcu:TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays, dkdcu:TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays, us-gaap:AdditionalPaidInCapital, us-gaap:AssetsHeldInTrustNoncurrent, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:DeferredTaxAssetsLiabilitiesNet, us-gaap:EarningsPerShareDiluted, us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3, us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3, us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3, us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3, us-gaap:PreferredStockSharesOutstanding, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross, us-gaap:StockholdersEquity, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding, us-gaap:WeightedAverageNumberOfSharesOutstandingBasic -  dkdcu-20230331xs4a.htm 9</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 4 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies -  dkdcu-20230331xs4a.htm 9</Log>
    <Log type="Warning">[dq-0712-Presentation-Base-Set-Order] Role '141001 - Disclosure - SUBSEQUENT EVENTS (Details)', a level 4, Detail role, appears before '200100 - Statement - CONSOLIDATED BALANCE SHEETS', a level 1, Statement role. dkdcu-20230331.xsd 30, 174</Log>
  </Logs>
  <InputFiles>
    <File doctype="S-4/A" original="dkdcu-20230331xs4a.htm">dkdcu-20230331xs4a.htm</File>
    <File>dkdcu-20230331.xsd</File>
    <File>dkdcu-20230331_cal.xml</File>
    <File>dkdcu-20230331_def.xml</File>
    <File>dkdcu-20230331_lab.xml</File>
    <File>dkdcu-20230331_pre.xml</File>
    <File>dkdcu-20230331xex10d15.htm</File>
    <File>dkdcu-20230331xex10d16.htm</File>
    <File>dkdcu-20230331xex10d17.htm</File>
    <File>dkdcu-20230331xex10d20.htm</File>
    <File>dkdcu-20230331xex10d21.htm</File>
    <File>dkdcu-20230331xex10d22.htm</File>
    <File>dkdcu-20230331xex23d1.htm</File>
    <File>dkdcu-20230331xex23d3.htm</File>
    <File>dkdcu-20230331xex23d4.htm</File>
    <File>dkdcu-20230331xex3d4.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dkdcu-20230331xs4a014.jpg</File>
    <File>dkdcu-20230331xs4a020.jpg</File>
    <File>dkdcu-20230331xs4a021.jpg</File>
    <File>dkdcu-20230331xs4a026.jpg</File>
    <File>dkdcu-20230331xs4a028.jpg</File>
    <File>dkdcu-20230331xs4a032.jpg</File>
    <File>dkdcu-20230331xs4a034.jpg</File>
    <File>dkdcu-20230331xs4a036.jpg</File>
    <File>dkdcu-20230331xs4a037.jpg</File>
    <File>dkdcu-20230331xs4a038.jpg</File>
    <File>dkdcu-20230331xs4a057.jpg</File>
    <File>dkdcu-20230331xs4a058.jpg</File>
    <File>dkdcu-20230331xs4a059.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="713">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="9">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>119
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dkdcu-20230331xs4a.htm": {
   "axisCustom": 0,
   "axisStandard": 15,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 713,
    "http://xbrl.sec.gov/dei/2022": 9
   },
   "contextCount": 242,
   "dts": {
    "calculationLink": {
     "local": [
      "dkdcu-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dkdcu-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dkdcu-20230331xs4a.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dkdcu-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dkdcu-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dkdcu-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 405,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 86,
    "http://www.dataknightsacquisitioncorp.com/20230331": 17,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 107
   },
   "keyCustom": 127,
   "keyStandard": 135,
   "memberCustom": 30,
   "memberStandard": 26,
   "nsprefix": "dkdcu",
   "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100090 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dkdcu:PrivatePlacementTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110401 - Disclosure - PRIVATE PLACEMENT",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacement",
     "shortName": "PRIVATE PLACEMENT",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110501 - Disclosure - RELATED PARTY TRANSACTIONS",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactions",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110601 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dkdcu:WarrantLiabilityTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110701 - Disclosure - WARRANT LIABILITY",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiability",
     "shortName": "WARRANT LIABILITY",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110801 - Disclosure - STOCKHOLDER'S EQUITY",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquity",
     "shortName": "STOCKHOLDER'S EQUITY",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110901 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurements",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111001 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "120202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "17",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "18",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "19",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_2_8_2021_To_2_8_2021_v79xWrSU2E2fOfIAgN6zrQ",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "dkdcu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum",
      "reportCount": 1,
      "unitRef": "Unit_Standard_item_ADV322CDOkO4knKmowW0Dw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)",
     "menuCat": "Details",
     "order": "20",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
     "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "menuCat": "Details",
     "order": "21",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)",
     "menuCat": "Details",
     "order": "22",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)",
     "menuCat": "Details",
     "order": "23",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140301 - Disclosure - INITIAL PUBLIC OFFERING (Details)",
     "menuCat": "Details",
     "order": "24",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
     "shortName": "INITIAL PUBLIC OFFERING (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140401 - Disclosure - PRIVATE PLACEMENT (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails",
     "shortName": "PRIVATE PLACEMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
     "shortName": "RELATED PARTY TRANSACTIONS - Founder Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_SponsorMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_yxo6X-TUDki23ihqXTNUvw",
      "decimals": "INF",
      "lang": null,
      "name": "dkdcu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_D_24WmzP3yxEKX8pNPNSJZgw",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dkdcu:PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "RELATED PARTY TRANSACTIONS - Additional information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_us-gaap_RelatedPartyTransactionAxis_dkdcu_RelatedPartyLoansMember_UkwcjyfyIkKPsh-ZJGYHfQ",
      "decimals": "0",
      "lang": null,
      "name": "dkdcu:RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "dkdcu:MaximumNumberOfDemandsForRegistrationOfSecurities",
      "reportCount": 1,
      "unitRef": "Unit_Standard_item_ADV322CDOkO4knKmowW0Dw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140701 - Disclosure - WARRANT LIABILITY (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
     "shortName": "WARRANT LIABILITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140801 - Disclosure - STOCKHOLDER'S EQUITY - Preferred Shares (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredSharesDetails",
     "shortName": "STOCKHOLDER'S EQUITY - Preferred Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_huwzmSg6DEaVrC_UVjuDSA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
     "shortName": "STOCKHOLDER'S EQUITY - Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaNotSubjectToRedemptionMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_g_97mNUb4kStaMDUizkRmA",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140901 - Disclosure - FAIR VALUE MEASUREMENTS - Assets and derivative warrant liabilities measured at fair value on recurring basis (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Assets and derivative warrant liabilities measured at fair value on recurring basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140902 - Disclosure - FAIR VALUE MEASUREMENTS (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-y3TJWpkY0KEs_22qhgoTg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140903 - Disclosure - FAIR VALUE MEASUREMENTS - Quantitative information regarding Level 3 fair value measurements inputs (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Quantitative information regarding Level 3 fair value measurements inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_ruu01iLDPE611oCSW8HUQw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140904 - Disclosure - FAIR VALUE MEASUREMENTS - Change in fair value of derivative warrant liabilities (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Change in fair value of derivative warrant liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141001 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_4_25_2023_To_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_isjLRKvB20-ds3dYGWYkKg",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "200100 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Uncategorized",
     "order": "37",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "200105 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)",
     "menuCat": "Cover",
     "order": "38",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEET (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "200200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "39",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_KwfTqwNCuk64IHdfIIUfOQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "200300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT",
     "menuCat": "Statements",
     "order": "40",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_2_8_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Yt0ReKG7x0axkO27tJcJkQ",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "200400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "41",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
     "menuCat": "Notes",
     "order": "42",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationss",
     "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "43",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciess",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dkdcu:InitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210301 - Disclosure - INITIAL PUBLIC OFFERING",
     "menuCat": "Notes",
     "order": "44",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferings",
     "shortName": "INITIAL PUBLIC OFFERING",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dkdcu:PrivatePlacementTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210401 - Disclosure - PRIVATE PLACEMENT",
     "menuCat": "Notes",
     "order": "45",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacements",
     "shortName": "PRIVATE PLACEMENT",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210501 - Disclosure - RELATED PARTY TRANSACTIONS",
     "menuCat": "Notes",
     "order": "46",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionss",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210601 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "47",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciess",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dkdcu:WarrantLiabilityTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210701 - Disclosure - WARRANT LIABILITY",
     "menuCat": "Notes",
     "order": "48",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilitys",
     "shortName": "WARRANT LIABILITY",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801 - Disclosure - STOCKHOLDER'S EQUITY",
     "menuCat": "Notes",
     "order": "49",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquitys",
     "shortName": "STOCKHOLDER'S EQUITY",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_2_7_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_KwfTqwNCuk64IHdfIIUfOQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210901 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "50",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementss",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211001 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "51",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211101 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "52",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventss",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "53",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "54",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTabless",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "55",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTabless",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231003 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "56",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_2_8_2021_To_2_8_2021_v79xWrSU2E2fOfIAgN6zrQ",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "dkdcu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum",
      "reportCount": 1,
      "unitRef": "Unit_Standard_item_ADV322CDOkO4knKmowW0Dw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
     "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_RelatedPartyTransactionAxis_dkdcu_FounderSharesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dkdcu_ArcGroupLimitedMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_us-gaap_TypeOfArrangementAxis_dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember_wLPX3pqnoEGRhqgS36Atpg",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_dkdcu_CommonClassaSubjectToRedemptionMember_01Thp353ck6jHzuEdXTCOQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock reflected on the condensed consolidated balance sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_5_11_2021_sfI_N2JD3EerrNOAqfGAdg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240301 - Disclosure - INITIAL PUBLIC OFFERING (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
     "shortName": "INITIAL PUBLIC OFFERING (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "dkdcu:ClassOfWarrantOrRightPriceOfWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240401 - Disclosure - PRIVATE PLACEMENT (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss",
     "shortName": "PRIVATE PLACEMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
     "shortName": "RELATED PARTY TRANSACTIONS - Founder Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RepaymentsOfRelatedPartyDebt",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RepaymentsOfRelatedPartyDebt",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
     "shortName": "RELATED PARTY TRANSACTIONS - Additional information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "dkdcu:MaximumNumberOfDemandsForRegistrationOfSecurities",
      "reportCount": 1,
      "unitRef": "Unit_Standard_item_ADV322CDOkO4knKmowW0Dw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240701 - Disclosure - WARRANT LIABILITY (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss",
     "shortName": "WARRANT LIABILITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240801 - Disclosure - STOCKHOLDER'S EQUITY - Preferred Stock Shares (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredStockSharesDetails",
     "shortName": "STOCKHOLDER'S EQUITY - Preferred Stock Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_wrGoBVcm0k-UyN4-MtECrQ",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_uAJECRwqzk-o2AqAFxz8Kg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240802 - Disclosure - STOCKHOLDER'S EQUITY - Common Stock Shares (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
     "shortName": "STOCKHOLDER'S EQUITY - Common Stock Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_YgmzklYK7U-4WsSoKjXQzA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240901 - Disclosure - FAIR VALUE MEASUREMENTS (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
     "shortName": "FAIR VALUE MEASUREMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_7tsBCIa7gk6SNfDSnFWCYg",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations",
     "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_3_31_2023_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PrivateWarrantMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_-y3TJWpkY0KEs_22qhgoTg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240902 - Disclosure - FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_ClassOfWarrantOrRightAxis_dkdcu_PublicWarrantsMember_34ov0FjmRkWCakeT67If7Q",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "dkdcu:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240903 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241001 - Disclosure - INCOME TAX - Income tax provision (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails",
     "shortName": "INCOME TAX - Income tax provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_BpbiE3R2HkOO9r7prunRHw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241002 - Disclosure - INCOME TAXES - Net deferred tax assets (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails",
     "shortName": "INCOME TAXES - Net deferred tax assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2021_RpL_iEMX90ubwd-ikfoP2g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241003 - Disclosure - INCOME TAXES - Federal income tax rate (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails",
     "shortName": "INCOME TAXES - Federal income tax rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_2_8_2021_To_12_31_2021_zREMlBCQdk-eu0sdU57lgw",
      "decimals": "4",
      "lang": null,
      "name": "dkdcu:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_eF_EWa6FpUWvO5DJf6F9_w",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "dkdcu:U.s.FederalAndStateNetOperatingLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004 - Disclosure - INCOME TAXES (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "As_Of_12_31_2022_ZVTHC3EKgUqe73ddhlwEFQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "dkdcu:U.s.FederalAndStateNetOperatingLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_T_2HmpG1sUOf12fNNip6TA",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_5_2023_To_1_5_2023_srt_StatementScenarioAxis_dkdcu_ThirdMonthExtensionToTerminationDateMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_zROX-Jpz0Um4wcHHn0lc3g",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "dkdcu:AmountDepositedPerEachPublicShareOutstanding",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_8GjlRG-drEC7G1UDrQBolQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241101 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dkdcu-20230331xs4a.htm",
      "contextRef": "Duration_1_1_2023_To_3_31_2023_zwMLUHNBJUKdIa7mxYYt6g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dkdcu:InitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110301 - Disclosure - INITIAL PUBLIC OFFERING",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOffering",
     "shortName": "INITIAL PUBLIC OFFERING",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 59,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document and Entity Information"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dkdcu_AccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent to accounting policies.",
        "label": "Accounting Policies [Line Items]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "AccountingPoliciesLineItems",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "dkdcu_AccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to accounting policies.",
        "label": "Accounting Policies [Table]"
       }
      }
     },
     "localname": "AccountingPoliciesTable",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "dkdcu_AccruedLiabilitiesExcludingOfferingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered, excluding offering costs (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities Excluding Offering Costs, Current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesExcludingOfferingCostsCurrent",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional amount per unit sold in the company's initial public offering required to be deposited in trust account.",
        "label": "Additional Amount Per Unit Required To Be Deposited In Trust Account",
        "terseLabel": "Additional amount per unit required to be deposited in trust account"
       }
      }
     },
     "localname": "AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "dkdcu_AdministrativeSupportAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for administrative support agreement.",
        "label": "Administrative Support Agreement [Member]",
        "terseLabel": "Administrative Support Agreement"
       }
      }
     },
     "localname": "AdministrativeSupportAgreementMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_AdvancesFromRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with advances from related parties.",
        "label": "Advances from Related Parties",
        "terseLabel": "Advances from related parties"
       }
      }
     },
     "localname": "AdvancesFromRelatedParties",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_AggregateAmountDepositedInTrustAccount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount deposited in trust account.",
        "label": "Aggregate Amount Deposited in Trust Account",
        "terseLabel": "Aggregate amount deposited"
       }
      }
     },
     "localname": "AggregateAmountDepositedInTrustAccount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_AggregateNumberOfSharesOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares owned by the founders after the impact of the stock dividend.",
        "label": "Aggregate Number Of Shares Owned",
        "terseLabel": "Aggregate number of shares"
       }
      }
     },
     "localname": "AggregateNumberOfSharesOwned",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_AggregatePeriodToConsummateInitialBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate period including extension period during which the company is required to consummate Initial Business Combination.",
        "label": "Aggregate Period To Consummate Initial Business Combination",
        "terseLabel": "Aggregate period to consummate business combination"
       }
      }
     },
     "localname": "AggregatePeriodToConsummateInitialBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount deposited into the Trust Account on execution of two one-month extensions out of the nine.",
        "label": "Amount Deposited Into the Trust Account on Execution of Two One-Month Extensions",
        "terseLabel": "Amount deposited into the Trust Account on execution of two one-month extensions"
       }
      }
     },
     "localname": "AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_AmountDepositedPerEachPublicShareOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount per each outstanding public share deposited in trust account.",
        "label": "Amount Deposited Per Each Public Share Outstanding",
        "terseLabel": "Amount deposited per each public share outstanding"
       }
      }
     },
     "localname": "AmountDepositedPerEachPublicShareOutstanding",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "dkdcu_AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount to be deposited in the trust account in connection with the exercise of the first monthly extension.",
        "label": "Amount to be Deposited in Trust Account in Connection With The Exercise of First Monthly Extension",
        "terseLabel": "Amount to be deposited in trust account in connection with the exercise of the first monthly extension"
       }
      }
     },
     "localname": "AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ArcGroupLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to ARC Group Limited, the Company's financial advisor (\"ARC\").",
        "label": "ARC Group Limited [Member]",
        "terseLabel": "ARC"
       }
      }
     },
     "localname": "ArcGroupLimitedMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_AssetsHeldInTrustAccountPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of accounting policy for assets held in trust.",
        "label": "Assets Held In Trust Account, Policy [Policy Text Block]",
        "terseLabel": "Trust Account"
       }
      }
     },
     "localname": "AssetsHeldInTrustAccountPolicyPolicyTextBlock",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dkdcu_BusinessCombinationTotalPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payment in business combination.",
        "label": "Business Combination, Total Payments",
        "terseLabel": "Business combination, total payments"
       }
      }
     },
     "localname": "BusinessCombinationTotalPayments",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer).",
        "label": "Deferred Underwriting Commissions Noncurrent",
        "terseLabel": "Deferred underwriting fees",
        "verboseLabel": "Deferred underwriting commissions"
       }
      }
     },
     "localname": "CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_CashDeferredUnderwritingCommissions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer).",
        "label": "Cash Deferred Underwriting Commissions",
        "terseLabel": "Cash deferred underwriting commission"
       }
      }
     },
     "localname": "CashDeferredUnderwritingCommissions",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_CashHeldOutsideInTrustAccount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash held outside the trust account.",
        "label": "Cash Held Outside In The Trust Account",
        "terseLabel": "Cash held outside the Trust Account"
       }
      }
     },
     "localname": "CashHeldOutsideInTrustAccount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_CashWaivedDeferredUnderwritingCommission": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash waived deferred underwriting commissions.",
        "label": "Cash Waived Deferred Underwriting Commission",
        "terseLabel": "Waived amount"
       }
      }
     },
     "localname": "CashWaivedDeferredUnderwritingCommission",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ClassAndClassBCommonStockNotSubjectToRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock A and B representing ownership interest in a corporation that is not subject to redemption.",
        "label": "Class A and Class B Common Stock Not Subject to Redemption [Member]",
        "terseLabel": "Class A and Class B non-redeemable common stock"
       }
      }
     },
     "localname": "ClassAndClassBCommonStockNotSubjectToRedemptionMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_ClassCommonStockNotSubjectToPossibleRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Class A common stock not subject to possible redemption.",
        "label": "Class A Common Stock Not Subject To Possible Redemption [Member]",
        "terseLabel": "Class A Common Stock not subject to possible redemption"
       }
      }
     },
     "localname": "ClassCommonStockNotSubjectToPossibleRedemptionMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_ClassOfWarrantOrRightAdjustmentOfExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage represents the class of warrant or right Adjustment of exercise price.",
        "label": "Class Of Warrant Or Right Adjustment Of Exercise Price",
        "terseLabel": "Adjustment of exercise price of warrants based on market value (as a percent)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAdjustmentOfExercisePrice",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants",
        "terseLabel": "Minimum threshold written notice period for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_ClassOfWarrantOrRightPriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Price of Warrants or Rights",
        "terseLabel": "Price of warrant",
        "verboseLabel": "Price of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.",
        "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger",
        "terseLabel": "Stock price trigger for redemption of public warrants (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.",
        "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.",
        "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days",
        "terseLabel": "Threshold trading days for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption price per share or per unit of warrants or rights outstanding.",
        "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights",
        "terseLabel": "Redemption price per public warrant (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "dkdcu_CommonClassSubjectToRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation that is subject to redemption",
        "label": "Class A common stock subject to redemption [Member]",
        "terseLabel": "Class A Common Stock subject to possible redemption"
       }
      }
     },
     "localname": "CommonClassSubjectToRedemptionMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_CommonClassaNotSubjectToRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation that is not subject to redemption.",
        "label": "Common Class a Not Subject To Redemption [Member]",
        "terseLabel": "Class A Common Stock Not Subject to Redemption"
       }
      }
     },
     "localname": "CommonClassaNotSubjectToRedemptionMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_CommonClassaSubjectToRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation that is subject to redemption.",
        "label": "Class A Common Stock Subject to Redemption [Member]",
        "terseLabel": "Class A Common Stock Subject to Redemption"
       }
      }
     },
     "localname": "CommonClassaSubjectToRedemptionMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares for which Common Stock exercised their right to redeem those shares for cash.",
        "label": "Common Stock Holders Exercised Their Right to Redeem Shares for Cash , Number of Shares",
        "terseLabel": "Number of shares for which share holders exercised their right to redeem"
       }
      }
     },
     "localname": "CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_CommonStockNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of votes that each common share is entitled.",
        "label": "Common Stock, Number of Votes Per Share",
        "terseLabel": "Common stock, votes per share"
       }
      }
     },
     "localname": "CommonStockNumberOfVotesPerShare",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dkdcu_CommonStockShareIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents of Common Stock Share Issued.",
        "label": "Common Stock Share Issued",
        "terseLabel": "Common shares, shares issued"
       }
      }
     },
     "localname": "CommonStockShareIssued",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_CommonStockShareOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents of Common Stock Share Outstanding.",
        "label": "Common Stock Share Outstanding",
        "terseLabel": "Common shares, shares outstanding"
       }
      }
     },
     "localname": "CommonStockShareOutstanding",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_CommonStockSubjectToPossibleRedemptionShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of the shares of common stock subject to possible redemption.",
        "label": "Common Stock Subject To Possible Redemption, Shares",
        "terseLabel": "Re-measurement of Class A Common Stock Subject to Possible Redemption (in shares)"
       }
      }
     },
     "localname": "CommonStockSubjectToPossibleRedemptionShares",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_CommonStockSubjectToPossibleRedemptionValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of common stock subject to possible redemption.",
        "label": "Common Stock Subject To Possible Redemption, Value",
        "negatedLabel": "Re-measurement of Class A Common Stock Subject to Possible Redemption"
       }
      }
     },
     "localname": "CommonStockSubjectToPossibleRedemptionValue",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.",
        "label": "Condition For Future Business Combination Number Of Businesses Minimum",
        "terseLabel": "Condition for future business combination number of businesses minimum"
       }
      }
     },
     "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "integerItemType"
    },
    "dkdcu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.",
        "label": "Condition for future business combination threshold Net Tangible Assets",
        "terseLabel": "Condition For Future Business Combination Threshold Net Tangible Assets"
       }
      }
     },
     "localname": "ConditionForFutureBusinessCombinationThresholdNetTangibleAssets",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_DeferredOfferingCostsNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.",
        "label": "Deferred Offering Costs Non current",
        "verboseLabel": "Deferred underwriter fee payable"
       }
      }
     },
     "localname": "DeferredOfferingCostsNonCurrent",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_DeferredUnderwritingFeePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.",
        "label": "Deferred Underwriting Fee Payable",
        "terseLabel": "Deferred underwriting fee payable"
       }
      }
     },
     "localname": "DeferredUnderwritingFeePayable",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_DeferredUnderwritingFeesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of deferred underwriting commissions.",
        "label": "Deferred Underwriting Fees Percentage",
        "terseLabel": "Deferred underwriting fees (as a percent)"
       }
      }
     },
     "localname": "DeferredUnderwritingFeesPercentage",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_DerivativeFinancialInstrumentsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy on derivative financial instruments.",
        "label": "Derivative Financial Instruments Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsPolicyPolicyTextBlock",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dkdcu_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to change in fair value of derivative liabilities.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Fair Value of Derivative Liabilities",
        "terseLabel": "Change in fair value of derivative liabilities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs allocated to warrant issuance.",
        "label": "Effective Income Tax Rate Reconciliation, Transaction Costs Allocated to Warrant Issuance",
        "terseLabel": "Transaction costs allocated to warrant issuance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs.",
        "label": "Effective Income Tax Rate Reconciliation, Transaction Costs, Percent",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransactionCostsPercent",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_EmergingGrowthCompanyPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy on emerging growth company.",
        "label": "Emerging Growth Company Policy [Policy Text Block]",
        "terseLabel": "Emerging growth company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyPolicyTextBlock",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dkdcu_ExtensionLoansNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of extension loans outstanding, non-current.",
        "label": "Extension Loans, Non-current",
        "terseLabel": "Extension loans",
        "verboseLabel": "Amount outstanding under the extension loan"
       }
      }
     },
     "localname": "ExtensionLoansNonCurrent",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The extension period each time for the Company to consummate initial business combination.",
        "label": "Extension Period Each Time for the Company to Consummate Initial Business Combination",
        "terseLabel": "Extension period each time for the Company to consummate initial business combination"
       }
      }
     },
     "localname": "ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_ExtensionPeriodForConsummatingInitialBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension period for consummating initial business combination as permitted under the Company's governing documents.",
        "label": "Extension Period For Consummating Initial Business Combination",
        "terseLabel": "Extension period for consummating initial business combination"
       }
      }
     },
     "localname": "ExtensionPeriodForConsummatingInitialBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of transfers of assets and liabilities measured on a recurring basis between level 1 and level 2.",
        "label": "Fair Value, Assets and Liabilities, Transfers Between Level 1 to Level 2, Amount",
        "terseLabel": "Transfer of assets and liabilities between level 1 and level 2"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liability, fair value measurement with unobservable inputs, reconciliation recurring basis.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Value",
        "periodEndLabel": "Fair value, ending balance",
        "periodStartLabel": "Fair value, beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValue",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_FifthMonthExtensionToTerminationDateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to fifth month extension to termination date.",
        "label": "Fifth Month Extension to Termination Date [Member]",
        "verboseLabel": "Fifth-month extension to the Termination Date"
       }
      }
     },
     "localname": "FifthMonthExtensionToTerminationDateMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to first amendment to the introducing advisor agreement with ARC Group Limited, the company's financial advisor (\"ARC\").",
        "label": "First Amendment to the Introducing Advisor Agreement with ARC Group Limited [Member]",
        "terseLabel": "First Amendment to the Introducing Advisor Agreement"
       }
      }
     },
     "localname": "FirstAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_FounderSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for founder shares.",
        "label": "Founder Shares [Member]",
        "terseLabel": "Founder Shares"
       }
      }
     },
     "localname": "FounderSharesMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_FourthMonthExtensionToTerminationDateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to fourth month extension to termination date.",
        "label": "Fourth Month Extension to Termination Date [Member]",
        "terseLabel": "Fourth-month extension to the Termination Date"
       }
      }
     },
     "localname": "FourthMonthExtensionToTerminationDateMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_FranchiseTaxExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of franchise tax expense incurred during the period.",
        "label": "Franchise Tax Expense",
        "terseLabel": "Franchise tax expense"
       }
      }
     },
     "localname": "FranchiseTaxExpense",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_IncreaseDecreaseFranchiseTaxPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of franchise tax payable.",
        "label": "Increase Decrease In Franchise Tax Payable",
        "terseLabel": "Franchise tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseFranchiseTaxPayable",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_IndependentDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to independent directors.",
        "label": "Independent Directors [Member]",
        "terseLabel": "Independent Directors"
       }
      }
     },
     "localname": "IndependentDirectorsMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_InitialFairValueOfWarrantLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The initial fair value classification of warrant liabilities disclosed in the supplemental non-cash cash flow activities.",
        "label": "Initial Fair Value Of Warrant Liabilities",
        "terseLabel": "Initial classification of warrant liability"
       }
      }
     },
     "localname": "InitialFairValueOfWarrantLiabilities",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_InitialPublicOfferingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "INITIAL PUBLIC OFFERING"
       }
      }
     },
     "localname": "InitialPublicOfferingAbstract",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "xbrltype": "stringItemType"
    },
    "dkdcu_InitialPublicOfferingDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure on information about initial public offering.",
        "label": "Initial Public Offering Disclosure [Text Block]",
        "terseLabel": "INITIAL PUBLIC OFFERING"
       }
      }
     },
     "localname": "InitialPublicOfferingDisclosureTextBlock",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOffering",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dkdcu_Initialbusinesscombinationsharesissuableaspercentofoutstandingshare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of outstanding stock after stock conversion issuable pursuant to initial business combination transaction.",
        "label": "Initial Business Combination Shares Issuable as percent of Outstanding Share",
        "terseLabel": "Shares issuable as percent of outstanding shares on Initial Business Combination",
        "verboseLabel": "Initial business combination shares issuable as percent of outstanding share"
       }
      }
     },
     "localname": "Initialbusinesscombinationsharesissuableaspercentofoutstandingshare",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest earned on marketable securities held in Trust Account.",
        "label": "Interest Earned On Marketable Securities Held In Trust Account",
        "negatedLabel": "Interest earned on securities held in Trust Account",
        "terseLabel": "Interest earned on securities held in Trust Account"
       }
      }
     },
     "localname": "InterestEarnedOnMarketableSecuritiesHeldInTrustAccount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_IntroducingAdvisorAgreementWithArcGroupLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to introducing advisor agreement with ARC Group Limited, the Company's financial advisor (\"ARC\").",
        "label": "Introducing Advisor Agreement with ARC Group Limited [Member]",
        "terseLabel": "Introducing Advisor Agreement",
        "verboseLabel": "Introducing Advisor Agreement with ARC Group Ltd"
       }
      }
     },
     "localname": "IntroducingAdvisorAgreementWithArcGroupLimitedMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_LimitationOnAnnualTaxableIncome": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents of Limitation On Annual Taxable Income.",
        "label": "Limitation on Annual Taxable Income",
        "terseLabel": "Limitation on annual taxable income"
       }
      }
     },
     "localname": "LimitationOnAnnualTaxableIncome",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of maximum borrowing capacity of related party promissory note.",
        "label": "Maximum Borrowing Capacity of Related Party Promissory Note",
        "terseLabel": "Maximum borrowing capacity of related party promissory note"
       }
      }
     },
     "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_MaximumLoansConvertibleUptoConsummation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of maximum loans convertible up to consummation.",
        "label": "Maximum Loans Convertible Up to Consummation",
        "terseLabel": "Related party loans convertible up to consummation of a business combination"
       }
      }
     },
     "localname": "MaximumLoansConvertibleUptoConsummation",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_MaximumNetInterestToPayDissolutionExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Maximum Net Interest To Pay Dissolution Expenses",
        "terseLabel": "Maximum net interest to pay dissolution expenses"
       }
      }
     },
     "localname": "MaximumNetInterestToPayDissolutionExpenses",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_MaximumNumberOfDemandsForRegistrationOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum number of demands for registration of securities.",
        "label": "Maximum Number Of Demands For Registration Of Securities",
        "terseLabel": "Maximum number of demands for registration of securities"
       }
      }
     },
     "localname": "MaximumNumberOfDemandsForRegistrationOfSecurities",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss"
     ],
     "xbrltype": "integerItemType"
    },
    "dkdcu_MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents maximum number of shares subject to forfeiture.",
        "label": "Maximum Number of Shares Subject to Forfeiture if Public Stockholders Exercise Redemption Rights",
        "terseLabel": "Maximum number of shares subject to forfeiture if public stockholders exercise redemption rights"
       }
      }
     },
     "localname": "MaximumNumberOfSharesSubjectToForfeitureIfPublicStockholdersExerciseRedemptionRights",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum threshold period for registration statement to become effective after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "MaximumThresHoldPeriodForFilingRegistrationStatementAfterBusinessCombination",
        "terseLabel": "Maximum threshold period for registration statement to become effective after business combination"
       }
      }
     },
     "localname": "Maximumthresholdperiodforfilingregistrationstatementafterbusinesscombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum threshold period for registration statement to become effective after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "MaximumThresholdPeriodForRegistrationStatementToBecomeEffectiveAfterBusinessCombination",
        "terseLabel": "Maximum threshold period for registration statement to become effective after business combination"
       }
      }
     },
     "localname": "Maximumthresholdperiodforregistrationstatementtobecomeeffectiveafterbusinesscombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using probability of acquisition.",
        "label": "Probability of Acquisition [Member]",
        "terseLabel": "Probability of Acquisition"
       }
      }
     },
     "localname": "MeasurementInputProbabilityOfCompletingBusinessCombinationMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_MinimumNetTangibleAssetUponConsummationOfBusinessCombination": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum net tangible assets upon consummation of the Business Combination.",
        "label": "Minimum net tangible asset upon consummation of business combination",
        "terseLabel": "Minimum net tangible asset upon consummation of business combination"
       }
      }
     },
     "localname": "MinimumNetTangibleAssetUponConsummationOfBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_NetProceedsFromInitialPublicOffering": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public, net of underwriting discounts paid.",
        "label": "Net Proceeds From Initial Public Offering",
        "terseLabel": "Proceeds from sale of Units, net of underwriting discount paid"
       }
      }
     },
     "localname": "NetProceedsFromInitialPublicOffering",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of business days prior to the applicable deadline during which a notice of extension is to be given for deposit to be made in trust account.",
        "label": "Number Of Business Days For Advance Notice Of Extension To Be Given",
        "terseLabel": "Number of business days for advance notice of extension to be given"
       }
      }
     },
     "localname": "NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "integerItemType"
    },
    "dkdcu_NumberOfOneMonthExtensionsExecuted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of one-month extensions executed by the Company.",
        "label": "Number of One Month Extensions Executed",
        "terseLabel": "Number of one-month extensions executed"
       }
      }
     },
     "localname": "NumberOfOneMonthExtensionsExecuted",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "integerItemType"
    },
    "dkdcu_NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of one-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.",
        "label": "Number Of One-Month Extensions Permitted For Consummating Initial Business Combination",
        "terseLabel": "Maximum number of one-month extension periods for consummation of Initial Business Combination"
       }
      }
     },
     "localname": "NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "integerItemType"
    },
    "dkdcu_NumberOfSharesIssuedPerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of shares in a unit.",
        "label": "Number of Shares Issued Per Unit",
        "terseLabel": "Number of shares in a unit"
       }
      }
     },
     "localname": "NumberOfSharesIssuedPerUnit",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The threshold number of specified trading period determining volume weighted average trading price , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Number Of Specified Trading Days Determining Volume Weighted Average Trading Price",
        "terseLabel": "Trading days determining volume weighted average price"
       }
      }
     },
     "localname": "NumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of three-month extensions permitted for consummating Initial Business Combination under the Company's governing documents.",
        "label": "Number Of Three-Month Extensions Permitted For Consummating Initial Business Combination",
        "terseLabel": "Number of three-month extensions for consummation of initial business combination"
       }
      }
     },
     "localname": "NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "integerItemType"
    },
    "dkdcu_NumberOfWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of warrants issued.",
        "label": "Number Of Warrants Issued",
        "terseLabel": "Number of warrants issued"
       }
      }
     },
     "localname": "NumberOfWarrantsIssued",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_NumberOfWarrantsIssuedPerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of warrants in a unit.",
        "label": "Number of Warrants Issued Per Unit",
        "terseLabel": "Number of warrants in a unit"
       }
      }
     },
     "localname": "NumberOfWarrantsIssuedPerUnit",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_OfferingCostsAllocatedToWarrantLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Offering costs allocated to warrant liability.",
        "label": "Offering Costs Allocated To Warrant Liability",
        "terseLabel": "Offering costs allocated to warrant liabilities"
       }
      }
     },
     "localname": "OfferingCostsAllocatedToWarrantLiability",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_OverAllotmentOptionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of the over-allotment option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Over Allotment Option Period",
        "terseLabel": "Overallotment option period"
       }
      }
     },
     "localname": "OverAllotmentOptionPeriod",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_PaymentsForInvestmentOfCashInTrustAccount": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash outflow for investment of cash in trust account.",
        "label": "Payments For Investment Of Cash In Trust Account",
        "negatedLabel": "Investment of cash in Trust Account",
        "terseLabel": "Payments for investment of cash in trust account"
       }
      }
     },
     "localname": "PaymentsForInvestmentOfCashInTrustAccount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_PaymentsOfFranchiseTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment of franchise tax.",
        "label": "Payments of franchise tax",
        "terseLabel": "Payments of franchise tax"
       }
      }
     },
     "localname": "PaymentsOfFranchiseTax",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_PercentageOfGrossProceedsOnTotalEquityProceed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of gross proceeds on total equity proceeds.",
        "label": "Percentage of Gross Proceeds on Total Equity Proceed",
        "terseLabel": "Percentage of gross proceeds on total equity proceed"
       }
      }
     },
     "localname": "PercentageOfGrossProceedsOnTotalEquityProceed",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected ownership percentage by the founders after completion of the proposed public offering.",
        "label": "Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders",
        "terseLabel": "Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders"
       }
      }
     },
     "localname": "PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_PercentageOfOwnershipAsConsiderationForService": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of ownership as consideration for service.",
        "label": "Percentage of Ownership as Consideration for Service",
        "terseLabel": "Percentage of ownership as consideration for service"
       }
      }
     },
     "localname": "PercentageOfOwnershipAsConsiderationForService",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_PercentageOfPublicSharesToBeRedeemed.": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of public shares redeemed.",
        "label": "Percentage Of Public Shares To Be Redeemed.",
        "terseLabel": "Percentage of public shares redeemed"
       }
      }
     },
     "localname": "PercentageOfPublicSharesToBeRedeemed.",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_PercentageOfSuccessFeeOnAnyPipeFinancing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of success fee on any PIPE that was brought by ARC.",
        "label": "Percentage of Success Fee on Any PIPE Financing",
        "terseLabel": "Percentage of success fee on any PIPE that was brought by ARC"
       }
      }
     },
     "localname": "PercentageOfSuccessFeeOnAnyPipeFinancing",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from the closing of the Company's initial public offering during which the company is required to consummate Initial Business Combination.",
        "label": "Period from the closing of the Company initial public offering to consummate Business Combination",
        "terseLabel": "Period from the closing of the company's initial public offering to consummate business combination"
       }
      }
     },
     "localname": "PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_PlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to placement warrant.",
        "label": "Placement Warrants [Member]",
        "terseLabel": "Placement Warrants"
       }
      }
     },
     "localname": "PlacementWarrantsMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_PrepaidInsuranceCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prepaid insurance current.",
        "label": "Prepaid Insurance Current",
        "terseLabel": "Prepaid insurance"
       }
      }
     },
     "localname": "PrepaidInsuranceCurrent",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_PrivatePlacementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "PRIVATE PLACEMENT"
       }
      }
     },
     "localname": "PrivatePlacementAbstract",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "xbrltype": "stringItemType"
    },
    "dkdcu_PrivatePlacementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Private Placement [Line Items]",
        "terseLabel": "PRIVATE PLACEMENT"
       }
      }
     },
     "localname": "PrivatePlacementLineItems",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "dkdcu_PrivatePlacementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a private placement.",
        "label": "Private Placement [Table]"
       }
      }
     },
     "localname": "PrivatePlacementTable",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "dkdcu_PrivatePlacementTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure on information about private placement.",
        "label": "Private Placement [Text Block]",
        "verboseLabel": "PRIVATE PLACEMENT"
       }
      }
     },
     "localname": "PrivatePlacementTextBlock",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacement",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dkdcu_PrivatePlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.",
        "label": "Private Placement Warrants [Member]",
        "terseLabel": "Private Placement Warrants"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_PrivateWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to private warrant.",
        "label": "Private Warrants",
        "terseLabel": "Private Warrants"
       }
      }
     },
     "localname": "PrivateWarrantMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_ProceedsFromExtensionLoan": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with proceeds from extension loans.",
        "label": "Proceeds from Extension Loan",
        "terseLabel": "Proceeds from extension loans"
       }
      }
     },
     "localname": "ProceedsFromExtensionLoan",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ProceedsFromInterestWithdrawnFromTrustAccount": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with interest withdrawn from Trust Account.",
        "label": "Proceeds from Interest Withdrawn from Trust Account",
        "terseLabel": "Interest withdrawn from Trust Account"
       }
      }
     },
     "localname": "ProceedsFromInterestWithdrawnFromTrustAccount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ProceedsFromIssuanceOfTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of temporary equity.",
        "label": "Proceeds From Issuance Of Temporary Equity",
        "terseLabel": "Gross Proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfTemporaryEquity",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ProceedsFromSaleOfPrivateUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sale of private units.",
        "label": "Proceeds From Sale Of Private Units",
        "terseLabel": "Proceeds from sale of Private units"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPrivateUnits",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ProceedsFromSaleOfUnits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents Proceeds from Sale of Units.",
        "label": "Proceeds From Sale Of Units",
        "terseLabel": "Proceeds from issuance of units"
       }
      }
     },
     "localname": "ProceedsFromSaleOfUnits",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ProceedsFromWorkingCapitalLoan": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with proceeds from working capital loan.",
        "label": "Proceeds from Working Capital Loan",
        "terseLabel": "Proceeds from working capital loan"
       }
      }
     },
     "localname": "ProceedsFromWorkingCapitalLoan",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_PromissoryNoteWithRelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for promissory note with related party.",
        "label": "Promissory Note with Related Party [Member]",
        "terseLabel": "Promissory Note with Related Party"
       }
      }
     },
     "localname": "PromissoryNoteWithRelatedPartyMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.",
        "label": "Public Warrants [Member]",
        "terseLabel": "Public Warrants"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_RealizedAndUnrealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Realized and Unrealized Gain Loss",
        "negatedLabel": "Dividends, realized and unrealized gain in Trust Account",
        "terseLabel": "Dividends, realized and unrealized gain in Trust Account",
        "verboseLabel": "Realized and unrealized gain"
       }
      }
     },
     "localname": "RealizedAndUnrealizedGainLoss",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_RedemptionOfClassCommonStockHeldInTrustIncludingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of redemption of Class A common stock held in Trust, including interest, classified as non-cash financing activity.",
        "label": "Redemption of Class A Common Stock Held in Trust, Including Interest",
        "terseLabel": "Redemption of Class A common stock held in Trust, including interest"
       }
      }
     },
     "localname": "RedemptionOfClassCommonStockHeldInTrustIncludingInterest",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of redemption of Class A Common Stock subject to possible redemption, including interest.",
        "label": "Redemption of Class A Common Stock Subject to Possible Redemption, Including Interest",
        "terseLabel": "Redemption of Class A Common Stock, including interest"
       }
      }
     },
     "localname": "RedemptionOfClassCommonStockSubjectToPossibleRedemptionIncludingInterest",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.",
        "label": "Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 10.00 [Member]",
        "terseLabel": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00"
       }
      }
     },
     "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.",
        "label": "Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 18.00 [Member]",
        "terseLabel": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00"
       }
      }
     },
     "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of maximum loans convertible up to consummation.",
        "label": "Related Party Loans Convertible Up To Consummation Of Business Combination",
        "terseLabel": "Related party loans convertible up to consummation of a Business Combination"
       }
      }
     },
     "localname": "RelatedPartyLoansConvertibleUpToConsummationOfBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_RelatedPartyLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for related party loans.",
        "label": "Related Party Loans [Member]",
        "terseLabel": "Related Party Loans"
       }
      }
     },
     "localname": "RelatedPartyLoansMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_RelatedPartyPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of related party payment.",
        "label": "Related Party Payment",
        "terseLabel": "Cash payment"
       }
      }
     },
     "localname": "RelatedPartyPayment",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_RelatedPartyPromissoryNoteExecuted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of related party promissory note executed.",
        "label": "Related Party Promissory Note Executed",
        "terseLabel": "Promissory note executed"
       }
      }
     },
     "localname": "RelatedPartyPromissoryNoteExecuted",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_RelatedPartyPromissoryNoteExecutedPerMonth": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of related party promissory note executed per month.",
        "label": "Related Party Promissory Note Executed Per Month",
        "terseLabel": "Executed per month"
       }
      }
     },
     "localname": "RelatedPartyPromissoryNoteExecutedPerMonth",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The contractual monthly amount to be paid for support services.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party Per Month",
        "terseLabel": "Expenses per month"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_RemeasurementOfClassCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of remeasurement of Class A common stock subject to possible redemption, classified as non-cash financing activity.",
        "label": "Remeasurement of Class A Common Stock Subject to Possible Redemption",
        "terseLabel": "Re-measurement of Class A common stock subject to possible redemption"
       }
      }
     },
     "localname": "RemeasurementOfClassCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after completion of a business combination during which the shares or warrant may not be transferred.",
        "label": "Restrictions On Transfer Period Of Time After Business Combination Completion",
        "terseLabel": "Restrictions on transfer period of time after business combination completion"
       }
      }
     },
     "localname": "RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_RetainerFeeUponExecutionOfAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of retainer fee upon execution of agreement.",
        "label": "Retainer Fee Upon Execution Of Agreement",
        "terseLabel": "Retainer fee"
       }
      }
     },
     "localname": "RetainerFeeUponExecutionOfAgreement",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsor": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Sale of non-redeemable private placement units to Sponsor.",
        "label": "Sale Of Non-Redeemable Private Placement Units To Sponsor",
        "terseLabel": "Sale of non-redeemable private placement units to Sponsor"
       }
      }
     },
     "localname": "SaleOfNonRedeemablePrivatePlacementUnitsToSponsor",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents of Sale Of Non-Redeemable Private Placement Units To Sponsor in Shares.",
        "label": "Sale Of Non-Redeemable Private Placement Units To Sponsor In Shares",
        "terseLabel": "Sale of non-redeemable private placement units to Sponsor(in shares)"
       }
      }
     },
     "localname": "SaleOfNonRedeemablePrivatePlacementUnitsToSponsorInShares",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_SaleOfStockOtherOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of other offering costs incurred.",
        "label": "Sale of Stock, Other Offering Costs",
        "terseLabel": "Other offering costs"
       }
      }
     },
     "localname": "SaleOfStockOtherOfferingCosts",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_SaleOfStockUnderwritingFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of offering fees incurred and paid for underwriters.",
        "label": "Sale of Stock, Underwriting fees",
        "terseLabel": "Underwriting fees"
       }
      }
     },
     "localname": "SaleOfStockUnderwritingFees",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to second amendment to the introducing advisor agreement with ARC Group Limited, the Company's financial advisor (\"ARC\").",
        "label": "Second Amendment to the Introducing Advisor Agreement with ARC Group Limited [Member]",
        "terseLabel": "Second Amendment to the Introducing Advisor Agreement"
       }
      }
     },
     "localname": "SecondAmendmentToIntroducingAdvisorAgreementWithArcGroupLimitedMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_SecuritiesDepositHeldInTrustAccount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of securities or Deposits held in the trust account.",
        "label": "Securities Deposit Held In Trust Account",
        "terseLabel": "Deposit held in trust account"
       }
      }
     },
     "localname": "SecuritiesDepositHeldInTrustAccount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_SixthOneMonthExtensionToTerminationDateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to six one month extension to termination date.",
        "label": "Sixth One Month Extension To Termination Date [Member]",
        "terseLabel": "Sixth one-month extension to the Termination Date"
       }
      }
     },
     "localname": "SixthOneMonthExtensionToTerminationDateMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for sponsor.",
        "label": "Sponsor [member]",
        "terseLabel": "Sponsor"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_StartUpCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Sec. 195 Start-up Costs.",
        "label": "Start-up Costs",
        "terseLabel": "Sec. 195 Start-up Costs"
       }
      }
     },
     "localname": "StartUpCosts",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_StockTransferredToOthersDuringPeriodShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares transferred to others during the period.",
        "label": "Stock Transferred to Others During Period Share",
        "terseLabel": "Number of shares transferred"
       }
      }
     },
     "localname": "StockTransferredToOthersDuringPeriodShare",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_SuccessFeeUponClosingOfInitialBusinessCombination": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of success fee upon closing of business combination.",
        "label": "Success Fee Upon Closing Of Initial Business Combination",
        "terseLabel": "Success fee"
       }
      }
     },
     "localname": "SuccessFeeUponClosingOfInitialBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_TemporaryEquityIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuance costs related to temporary equity.",
        "label": "Temporary Equity Issuance Costs",
        "terseLabel": "Issuance costs related to Class A Common Stock"
       }
      }
     },
     "localname": "TemporaryEquityIssuanceCosts",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_TemporaryEquityPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of accounting policy for temporary equity.",
        "label": "Temporary Equity, Policy [Policy Text Block]",
        "terseLabel": "Class A Common Stock Subject to Possible Redemption"
       }
      }
     },
     "localname": "TemporaryEquityPolicyPolicyTextBlock",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dkdcu_TemporaryEquityProceedsAllocatedToWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gross proceeds allocated from temporary equity to warrant.",
        "label": "Temporary Equity Proceeds Allocated To Warrants",
        "terseLabel": "Proceeds allocated to public warrants and private warrants"
       }
      }
     },
     "localname": "TemporaryEquityProceedsAllocatedToWarrants",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_ThirdIndependentDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to third independent director member.",
        "label": "Third Independent Director [Member]",
        "terseLabel": "Third Independent Director"
       }
      }
     },
     "localname": "ThirdIndependentDirectorMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_ThirdMonthExtensionToTerminationDateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to third month extension to termination date.",
        "label": "Third Month Extension to Termination Date [Member]",
        "terseLabel": "Third-month extension to the Termination Date"
       }
      }
     },
     "localname": "ThirdMonthExtensionToTerminationDateMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account.",
        "label": "ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount",
        "terseLabel": "Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account"
       }
      }
     },
     "localname": "ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination",
        "label": "ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination",
        "terseLabel": "Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination"
       }
      }
     },
     "localname": "ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.",
        "label": "Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences",
        "terseLabel": "Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences"
       }
      }
     },
     "localname": "ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold period for consideration payable after the closes on business combination or any financing with any Advisor Target or any affiliate of an Advisor Target.",
        "label": "Threshold Period for Consideration Payable After the Closes on Business Combination or Any Financing with Any Advisor Target or Any Affiliate of an Advisor Target",
        "terseLabel": "Threshold period for consideration payable after the closes on business combination or any financing with any Advisor Target or any affiliate of an Advisor Target"
       }
      }
     },
     "localname": "ThresholdPeriodForConsiderationPayableAfterClosesOnBusinessCombinationOrAnyFinancingWithAnyAdvisorTargetOrAnyAffiliateOfAdvisorTarget",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_TransactionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of transaction costs incurred.",
        "label": "Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "TransactionCosts",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The transfer assign or sell any shares or warrants after completion of initial business combination threshold trading days business combination.",
        "label": "Transfer Assign Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Trading Days",
        "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferAssignAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.",
        "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger",
        "terseLabel": "Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.",
        "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dkdcu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.",
        "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days",
        "terseLabel": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dkdcu_TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The transfer assign or sell any shares or warrants after completion of initial business combination threshold trading days business combination.",
        "label": "Transfer Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "dkdcu_TwoIndependentDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to two independent director member.",
        "label": "Two Independent Director [Member]",
        "terseLabel": "Two Independent Director"
       }
      }
     },
     "localname": "TwoIndependentDirectorMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_U.s.FederalAndStateNetOperatingLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of U.S. federal and state net operating loss.",
        "label": "U.S. Federal and State Net Operating Loss",
        "verboseLabel": "U.S. federal and state net operating loss"
       }
      }
     },
     "localname": "U.s.FederalAndStateNetOperatingLoss",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_UnderwritingDiscountPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of underwriting discount paid by the company.",
        "label": "Underwriting Discount Paid",
        "terseLabel": "Underwriting discount paid"
       }
      }
     },
     "localname": "UnderwritingDiscountPaid",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_UnderwritingDiscountPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of per Unit offering price paid as discount to underwriter.",
        "label": "Underwriting Discount Percentage",
        "terseLabel": "Underwriting discount (as a percent)"
       }
      }
     },
     "localname": "UnderwritingDiscountPercentage",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss"
     ],
     "xbrltype": "percentItemType"
    },
    "dkdcu_UnitsIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new units issued during the period.",
        "label": "Units Issued During Period, Shares, New Issues",
        "terseLabel": "Sale of units in Initial Public Offering, net of offering costs (in shares)",
        "verboseLabel": "Number of units issued"
       }
      }
     },
     "localname": "UnitsIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_UnrealizedGainOnInvestmentInTrustAccount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Unrealized gain on Investment in Trust Account.",
        "label": "Unrealized gain on Investment in Trust Account",
        "negatedLabel": "Unrealized gain on Investment in Trust Account"
       }
      }
     },
     "localname": "UnrealizedGainOnInvestmentInTrustAccount",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_WarrantExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of  warrant exercisable.",
        "label": "Warrant Exercisable",
        "terseLabel": "Warrant exercisable"
       }
      }
     },
     "localname": "WarrantExercisable",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_WarrantLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "WARRANT LIABILITY"
       }
      }
     },
     "localname": "WarrantLiabilityAbstract",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "xbrltype": "stringItemType"
    },
    "dkdcu_WarrantLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to warrant liability.",
        "label": "Warrant Liability",
        "terseLabel": "Warrant Liability"
       }
      }
     },
     "localname": "WarrantLiabilityMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dkdcu_WarrantLiabilityNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of warrant liability.",
        "label": "Warrant Liability, Non Current",
        "terseLabel": "Warrant liabilities"
       }
      }
     },
     "localname": "WarrantLiabilityNonCurrent",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_WarrantLiabilityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of warrant liability.",
        "label": "Warrant Liability [Text Block]",
        "terseLabel": "WARRANT LIABILITY"
       }
      }
     },
     "localname": "WarrantLiabilityTextBlock",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiability",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilitys"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dkdcu_WarrantsOrRightsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Value of issued derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants Or Rights Issued",
        "terseLabel": "Warrants issued"
       }
      }
     },
     "localname": "WarrantsOrRightsIssued",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "dkdcu_WorkingCapitalDeficit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of working capital deficit.",
        "label": "Working Capital Deficit",
        "terseLabel": "Working capital deficit"
       }
      }
     },
     "localname": "WorkingCapitalDeficit",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dkdcu_WorkingCapitalLoansWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for working capital loans warrant.",
        "label": "Working Capital Loans Warrant [Member]",
        "terseLabel": "Working capital loans warrant"
       }
      }
     },
     "localname": "WorkingCapitalLoansWarrantMember",
     "nsuri": "http://www.dataknightsacquisitioncorp.com/20230331",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r363",
      "r413",
      "r426",
      "r427",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ARC Group Ltd",
        "terseLabel": "ARC Group Ltd"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefFinancialOfficerMember": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Financial Officer [Member]",
        "terseLabel": "Chief Financial Officer"
       }
      }
     },
     "localname": "ChiefFinancialOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r227",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r138",
      "r227",
      "r386",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r138",
      "r227",
      "r386",
      "r387",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r402",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": {
     "auth_ref": [
      "r12",
      "r62",
      "r367"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrual for Taxes Other than Income Taxes, Current",
        "terseLabel": "Franchise tax payable"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r1",
      "r85",
      "r92"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r5",
      "r382"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r396",
      "r397",
      "r398",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r84",
      "r91",
      "r106",
      "r122",
      "r160",
      "r162",
      "r164",
      "r168",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r268",
      "r272",
      "r289",
      "r382",
      "r410",
      "r411",
      "r430"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r102",
      "r111",
      "r122",
      "r168",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r268",
      "r272",
      "r289",
      "r382",
      "r410",
      "r411",
      "r430"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrust": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.",
        "label": "Assets Held-in-trust",
        "terseLabel": "Trust account balance"
       }
      }
     },
     "localname": "AssetsHeldInTrust",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "auth_ref": [
      "r390"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Marketable securities held in Trust Account",
        "terseLabel": "Investments held in Trust Account"
       }
      }
     },
     "localname": "AssetsHeldInTrustNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [TEXT BLOCK]",
        "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r360",
      "r361",
      "r382",
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r30",
      "r104",
      "r365"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash held outside the Trust Account",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r25",
      "r30",
      "r32"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash at the end of the period",
        "periodStartLabel": "Cash at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r25",
      "r76"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "verboseLabel": "Supplemental disclosure of non-cash financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r107",
      "r108",
      "r109",
      "r122",
      "r141",
      "r142",
      "r144",
      "r146",
      "r149",
      "r150",
      "r168",
      "r187",
      "r190",
      "r191",
      "r192",
      "r196",
      "r197",
      "r202",
      "r203",
      "r206",
      "r210",
      "r217",
      "r289",
      "r364",
      "r385",
      "r391",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "STOCKHOLDER'S EQUITY"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r59",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "WARRANT LIABILITY"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Number of shares issuable per warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Number of warrants to purchase shares issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r59",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r15",
      "r87",
      "r95"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies.",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r40",
      "r182",
      "r183",
      "r362",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingencies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Class A common stock [Member]",
        "terseLabel": "Class A Common Stock"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Class B common stock [Member]",
        "terseLabel": "Class B Common Stock"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r396",
      "r397",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Ordinary shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock par value per share",
        "verboseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, shares authorized",
        "verboseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, shares issued",
        "verboseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r4",
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common Stock, shares outstanding",
        "verboseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r4",
      "r382"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r90",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of credit risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r67",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r394",
      "r417",
      "r419"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r43",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Units per price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r77",
      "r78",
      "r198",
      "r297",
      "r374",
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net increase or decrease in the carrying amount of the debt instrument for the period.",
        "label": "Debt Instrument, Increase (Decrease), Net",
        "terseLabel": "Convertible loans"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseDecreaseForPeriodNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Offering Costs Associated with the Initial Public Offering"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r394",
      "r418",
      "r419"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "netLabel": "Total Deferred Tax Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "verboseLabel": "Total Deferred Tax Liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r65",
      "r416"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "verboseLabel": "Net Operating Loss"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: Valuation allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred Tax Liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input",
        "terseLabel": "Fair value measurements input",
        "verboseLabel": "Derivative liability, measurement input"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r10",
      "r189",
      "r190",
      "r191",
      "r195",
      "r196",
      "r197",
      "r302",
      "r395"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Related Parties, Current",
        "terseLabel": "Amount due to related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r14",
      "r189",
      "r190",
      "r191",
      "r195",
      "r196",
      "r197",
      "r302",
      "r395"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.",
        "label": "Due to Related Parties, Noncurrent",
        "terseLabel": "Working capital loan"
       }
      }
     },
     "localname": "DueToRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r118",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r139",
      "r141",
      "r144",
      "r145",
      "r146",
      "r147",
      "r277",
      "r278",
      "r351",
      "r353",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (loss) per common stock",
        "verboseLabel": "Basic net income per common stock"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r118",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r141",
      "r144",
      "r145",
      "r146",
      "r147",
      "r277",
      "r278",
      "r351",
      "r353",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (loss) per common stock",
        "verboseLabel": "Diluted net income per common stock"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net income Per Share",
        "verboseLabel": "Net income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r245"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "netLabel": "Income tax provision",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r123",
      "r245",
      "r261"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory tax rate",
        "verboseLabel": "Statutory federal income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r414",
      "r420"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "verboseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r50",
      "r100",
      "r115",
      "r116",
      "r117",
      "r125",
      "r126",
      "r127",
      "r129",
      "r135",
      "r137",
      "r148",
      "r169",
      "r219",
      "r236",
      "r237",
      "r238",
      "r257",
      "r258",
      "r276",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r298",
      "r355",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r28",
      "r44"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "negatedLabel": "Change in fair value of warrant liabilities",
        "terseLabel": "Change in fair value of warrant liability"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r279",
      "r280",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of quantitative information regarding Level 3 fair value measurements inputs"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTabless"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r69",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Company's assets that are measured at fair value on a recurring basis",
        "terseLabel": "Schedule of assets and derivative warrant liabilities measured at fair value on recurring basis",
        "verboseLabel": "Schedule of company's assets and derivative warrant liabilities that are measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTabless"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r200",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r280",
      "r311",
      "r312",
      "r313",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r279",
      "r280",
      "r282",
      "r283",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurements",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r200",
      "r220",
      "r225",
      "r280",
      "r311",
      "r377",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r200",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r280",
      "r313",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Change in fair value of derivative warrant liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r72",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r72",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of change in fair value of derivative warrant liabilities",
        "verboseLabel": "Schedule of change in the fair value of the warrant liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsTabless"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3",
        "terseLabel": "Transfer of liabilities into level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3",
        "verboseLabel": "Transfer of liabilities out of level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Transfer of assets into level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "terseLabel": "Transfer of assets out of level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in valuation inputs or other assumption"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r200",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r311",
      "r312",
      "r313",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r286",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring basis",
        "verboseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r74",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).",
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal."
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r166",
      "r167",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r201",
      "r215",
      "r274",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r373",
      "r403",
      "r404",
      "r405",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r17",
      "r83",
      "r88",
      "r98",
      "r160",
      "r161",
      "r163",
      "r165",
      "r352",
      "r372"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Net income (loss) before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r180",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAX"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r123",
      "r246",
      "r249",
      "r255",
      "r259",
      "r262",
      "r264",
      "r265",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "INCOME TAX"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r124",
      "r136",
      "r137",
      "r159",
      "r244",
      "r260",
      "r263",
      "r354"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "negatedTotalLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r242",
      "r243",
      "r249",
      "r250",
      "r254",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expense"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase Decrease In Stockholders Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r19",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest earned"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r11",
      "r122",
      "r168",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r269",
      "r272",
      "r273",
      "r289",
      "r371",
      "r410",
      "r430",
      "r431"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r9",
      "r86",
      "r94",
      "r382",
      "r393",
      "r406",
      "r425"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders' Deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDER'S EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r103",
      "r122",
      "r168",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r269",
      "r272",
      "r273",
      "r289",
      "r382",
      "r410",
      "r430",
      "r431"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r41",
      "r42",
      "r184",
      "r185",
      "r186",
      "r407",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset.",
        "label": "Measurement Input, Exercise Price [Member]",
        "terseLabel": "Exercise price",
        "verboseLabel": "Exercise Price"
       }
      }
     },
     "localname": "MeasurementInputExercisePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Dividend yield (per share)"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Expected term (years)",
        "verboseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Risk-free rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Share price",
        "verboseLabel": "Share Price"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market mutual fund"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r151",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:",
        "verboseLabel": "Cash flow from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flow from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r25",
      "r26",
      "r29"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:",
        "verboseLabel": "Cash flow from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r18",
      "r29",
      "r89",
      "r97",
      "r101",
      "r112",
      "r113",
      "r117",
      "r122",
      "r128",
      "r130",
      "r131",
      "r132",
      "r133",
      "r136",
      "r137",
      "r143",
      "r160",
      "r161",
      "r163",
      "r165",
      "r168",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r278",
      "r289",
      "r372",
      "r410"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss) allocable to common stock not subject to redemption"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Non-operating expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r80",
      "r96",
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties.",
        "label": "Notes Payable, Related Parties",
        "terseLabel": "Outstanding balance of related party note"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Formation and operating costs",
        "terseLabel": "Formation and operating costs"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "verboseLabel": "Formation and operating costs"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r160",
      "r161",
      "r163",
      "r165",
      "r372"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operation costs"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-Allotment Option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Payment of offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r3",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred shares, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, shares authorized",
        "verboseLabel": "Preferred shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r3",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, shares issued",
        "verboseLabel": "Preferred shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred shares, shares outstanding",
        "verboseLabel": "Preferred shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityPreferredStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r3",
      "r382"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r110",
      "r178",
      "r179",
      "r366"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expense"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of Class B common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from sale of Private units",
        "verboseLabel": "Aggregate purchase price"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from Related Party Debt",
        "verboseLabel": "Proceeds from promissory note"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r101",
      "r112",
      "r113",
      "r119",
      "r122",
      "r128",
      "r136",
      "r137",
      "r160",
      "r161",
      "r163",
      "r165",
      "r168",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r267",
      "r270",
      "r271",
      "r278",
      "r289",
      "r352",
      "r372",
      "r380",
      "r381",
      "r389",
      "r410"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r226",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r99",
      "r301",
      "r302",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "verboseLabel": "Related party transaction expenses"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r226",
      "r301",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r299",
      "r300",
      "r302",
      "r303",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "verboseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactions",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedLabel": "Repayment of promissory note",
        "terseLabel": "Outstanding of promissory note - related party"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r6",
      "r57",
      "r93",
      "r358",
      "r359",
      "r382"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r100",
      "r125",
      "r126",
      "r127",
      "r129",
      "r135",
      "r137",
      "r169",
      "r236",
      "r237",
      "r238",
      "r257",
      "r258",
      "r276",
      "r355",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of income tax provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of significant components of the Company's deferred tax assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Reconciliation of Net Loss per Common Share",
        "terseLabel": "Schedule of basic and diluted net income (loss) per common share",
        "verboseLabel": "Schedule of basic and diluted net income per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTabless"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r81",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r46",
      "r48",
      "r49",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r107",
      "r108",
      "r109",
      "r149",
      "r202",
      "r203",
      "r204",
      "r206",
      "r210",
      "r215",
      "r217",
      "r376",
      "r385",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r228",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Fair value per share",
        "verboseLabel": "Public share price considered"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance at the end (in shares)",
        "periodStartLabel": "Balance at the beginning (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Price per unit"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.",
        "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares",
        "terseLabel": "Warrant Liabilities",
        "verboseLabel": "Warrant liabilities"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsAssetsAndDerivativeWarrantLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r107",
      "r108",
      "r109",
      "r122",
      "r141",
      "r142",
      "r144",
      "r146",
      "r149",
      "r150",
      "r168",
      "r187",
      "r190",
      "r191",
      "r192",
      "r196",
      "r197",
      "r202",
      "r203",
      "r206",
      "r210",
      "r217",
      "r289",
      "r364",
      "r385",
      "r391",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r16",
      "r50",
      "r100",
      "r115",
      "r116",
      "r117",
      "r125",
      "r126",
      "r127",
      "r129",
      "r135",
      "r137",
      "r148",
      "r169",
      "r219",
      "r236",
      "r237",
      "r238",
      "r257",
      "r258",
      "r276",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r298",
      "r355",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement",
        "terseLabel": "Statement"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED BALANCE SHEETS"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r148",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r50",
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of Class B Common Stock to Sponsor (in shares)",
        "verboseLabel": "Number of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r50",
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Class B Common Stock to Sponsor",
        "verboseLabel": "Proceeds from sale of founder shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r39",
      "r382",
      "r393",
      "r406",
      "r425"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at the end",
        "periodStartLabel": "Balance at the beginning",
        "totalLabel": "Total Stockholders' Deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDER'S EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r60",
      "r121",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r219",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "STOCKHOLDER'S EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquity",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquitys"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Common stock, conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r296",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Events.",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r296",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r296",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r296",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r305",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "verboseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEvents",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSubsequentEventss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosurePrivatePlacementDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
        "verboseLabel": "INITIAL PUBLIC OFFERING"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "verboseLabel": "Re-measurement of carrying value to redemption value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.",
        "label": "Temporary Equity, Aggregate Amount of Redemption Requirement",
        "terseLabel": "Aggregate amount of shares redeemed"
       }
      }
     },
     "localname": "TemporaryEquityAggregateAmountOfRedemptionRequirement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r187",
      "r190",
      "r191",
      "r192",
      "r196",
      "r197"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Contingently redeemable Class A Common Stock - Ending Balance",
        "periodStartLabel": "Contingently redeemable Class A Common Stock - Opening Balance",
        "terseLabel": "Class A Common Stock subject to possible redemption; 4,838,792 shares at redemption value of $10.74 and $10.53 per share as of March 31, 2023 and December 31, 2022, respectively",
        "verboseLabel": "Class A Common Stock subject to possible redemption; 2,731,544 and 11,500,000 shares at redemption value of $10.53 and $10.20 per share as of December 31, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedOnCondensedConsolidatedBalanceSheetDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "auth_ref": [
      "r0",
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Redemption Price Per Share",
        "terseLabel": "Common share at redemption value",
        "verboseLabel": "Redemption price per share"
       }
      }
     },
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "terseLabel": "Common Stock, subject to possible redemption",
        "verboseLabel": "Common stock, subject to possible redemption"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r0",
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Schedule of Class A Common Stock reflected on the balance sheet are reconciled",
        "verboseLabel": "Schedule of Class A Common Stock reflected on the condensed consolidated balance sheet are reconciled"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTabless"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r166",
      "r167",
      "r201",
      "r215",
      "r274",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r403",
      "r404",
      "r405",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureCommitmentsAndContingenciesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureStockholderSEquityCommonStockSharesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r369",
      "r377",
      "r379",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasury Securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r241",
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits accrued for interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetailss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r152",
      "r153",
      "r155",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciess"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r253"
     ],
     "calculation": {
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureIncomeTaxIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Redeemable warrants",
        "verboseLabel": "Warrant"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Public Warrants expiration term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureWarrantLiabilityDetailss"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r140",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average shares outstanding, Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r139",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average shares outstanding, Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetails",
      "http://www.dataknightsacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomePerCommonShareDetailss",
      "http://www.dataknightsacquisitioncorp.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.dataknightsacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r383": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r384": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r433": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r434": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r435": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r436": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r437": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r438": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r439": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>120
<FILENAME>0001104659-23-077706-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-077706-xbrl.zip
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MG0?CZ?D.* P<<-\?(\%;2E:BY!-G+R!BGVQB2ALC@XA9GQ70[\,A_9[&@]_
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MKZE T2M68#UO4+0'E79&\[N !),EI5Z/>!2S? ]QEM>:"(&>F8%CHG9K39>
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M/D5"_WR)8Q/FDJ[(+_\'4$L#!!0    ( '*3XU8F4H@N @X  #KE   6
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M*5/=B$I"Q#\59"@R?-&K?*4=_+^ZF% HO0_<YR ,TIU!I(5+MW2''M7Q^8@
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M/B_6_!3%SPG"+^YSB)@.1_X<1UX0!LP_4<9&[0%L^'/5&][<!YM[:@M9A/?
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MC59W2!JX*QC?IJU'SB_GD;<"!&QH8^1"VI$/YL5 B=+1=T-Z5<W7"*5#-R7
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M6CSSY)G<[(DW\P&[#'"U>Z6)+;# %,>"6<Z&:D8$3.KC?D3Y#49OLR':QDE
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MX!(O8H^5LL2$( %KE7&1@@^'TV^S'YC MW2U6((FA[H>7[9[?-U.3QTS';P
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M-8)PU^T05K?#NA:7'Z71X9T;8&8_>B!\37[.O<E)@IA/>8B8.R1X.6^(&-
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M4-OUS,^ D&<;"D?#,6#+"'!21ER$2LOUY2_!DAJ@)>.!F)\K.*R")C""6<X
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M.? :4MZ(B7V&"[66P2N+)N&.A&"@U:,+%PU !"E%KTIC>RZ&07COZE]HIS@
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M-PD\ 3$UUVC3>&R#V)K; 9\9AG2CBA!5A5!V[57:M%2WR!#B#0'$$N>(RN2
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M$(V7]S'9+OP3E_*0P(.0%:K#89#VKDL2,)D[JL,%77; :\\.$*2/ZID"NKR
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M*T,(/&[\-/-1!TU^6FX=>1F]B)KC!-%'(,0AVV,*T2X >NLQ/P638[)0XV(
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MX7;ALFW Z78/(=&FD<WB*AS7WWLWF,Z3(_T%A?XX6N L20EN%+,<0!YG26=
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M2;E(586$BULB]]8*]4Y*CYXV0^R?5=+V**4G#\LYT0O"R5Z0110=J&.L^.B
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MC9G0=W"]SSYTI=*] .IS$/X&<&KMW=CR6,#FVFXQ,)6U1 U(E>IE0%38##T
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M\NLRFS(!]"6)?Q[0IJ&&]&C5OYC'G64OL?",Q652'KX]_!H4+T:"0YRF1;'
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MMS;*9^C6I!=Z=&NEA&9TLW*\22289^_NC8UMH]@BSX1(+LH+>":1#84%-%^
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M*;W$-82ZV**-6S3O<J&R-J+GN30:Z,KR[(,G"@4%GG<3A&QV=X;_,*5\_S@
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MQG"N]M8V.8[?E?L#''<DS4YI]K@]BK9TY<@9Y:0!@1NWZ<)J-?=T'@VP8?,
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M#(7N->'PT:\I+7!]MQ)!ZV3+A!"PSMO-?_(^N+G:_1CUW*>&V*_P(_MELQ&
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M)'?!R$O>@I&+)?[/TVBR7/2F#[WI;#0WEF/< &P 6)+>9H^L(N:+VKIK,5T
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MUO_89.M+6QDHSMF228^40H_/C;-#/L\N\6KNG=!R_7 ;H(J3KZ;#:F'=I M
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MJXR4.4C&=X<6I$UM#XXNK:N0Q1H>X8"AP.%=)^8&_YC+V'7O;TSGN* .?T?
MI.#14(F&ZT&&HNKQ;/J$-B\HH&AT_W=XBJLG^)*S4";$[F\O'&?<9.J[O+&^
MRA? V_VE^/0=!8;K^G$NM21HD$D&:GM]^2 &N?OW\"AY.1G^'J,'/%J<W^,3
M%8\DJ^)"8@_31V3V <<@475R$Z*.;W@&2E!#+Q_\+:FR%I_;AJ6S!K5=$>05
M!CD J52NB4(,9?>]1UKBYKM=_B_B\T7) .!X F?ZX)66)(=$_6S"/864?;0
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MVA1-=K@*<+\^W4F<H&AI>J_.BYND=GU^2S+))0X@,:V\%&LRH(Z\DBZ/C$P
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M7724 I9IZ9E]P%"AKCJY"0'4TC>FQ#Y_=!KIS/3ZRQMWA01<,T,-J)+TK_2
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M$RCM$*BB=1%U?W!)"L5TRRC70:A\@_;<:_-C1U[.ROQX5.!L8G.B\8*<2QH
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M2A@"1[^B*&Z3DM,=5GTSX!D'U.U]5Y=U+)P@)5;/>Q4,1Z@[F)YLD2J-C$(
M]Y^S7<X,"DF$C<$:]KOI60B[\MA$3E=[:2S]._3%>4?E%*H[F)X4DBJ-C$(
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M_LWU12=WAA4$4$"RJ+R:/5M$1=$H*C_P;.F2$R0*M**_4[Z(20:T_N5<<@+
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M3<+MD!?&2F>MGDX:_^!2+0G!M4 M9L_\J/RH*R8 "16[D:'W8Q-+HOR:QCY
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M*PI^*5]:@'D]'6@+7)H ;J<S\FF?R@5_[MB-*[ETR=.E(('+BT%_<-,Y/M5
MJ#+$BF=VFT9KLJ&#7R4F/LUE8?;00;7B  %O<.%%%2DC-MU&V(U#'$M39@\P
MZI6YA24,6'U=%*J^O_K!GX2JYIL3F2XV4H[EE.NYM*6.^N4'JK[@"7TQB?\>
MKGW73@]*C=?7 +UB]X,D;'LR@S]1E'HV>+5,JKR8KUA:M#*"Y4M1J8_0D4EG
MD!#@LBI[]'EPQ&A&IF<3S]HG/M""I B,<S)-5TM2IC!:^G?(($EG\+O?[69X
M$BW,RG%)XZ5/?G!15!8MP&;KN=]&:V*#$*;Z^C&5)\%$8.C)]Z+UB.0YBM>'
M6'8;)XJ0_> ')!,+J0-!Q#;VL,Q,EY?8<A^A(UO/("'UQ6RH%-QC3<)FFI&M
M[F ZTDJJ+&35LVG1ADV]EBV8C <4A=O'POW4>:*U+I^,? "/S0T[B0XU76,3
M%S1' 8D(FZ/$B2 .Q3UZ\T,'"X%CS5)_.!V))5D:&8T %@]/\.7 1'X>SM0;
M?<?.:I+W;OG-/_W2RMG4=%0M2=6*4#)N 3RWIYOG!&E%Y">]FX[LJ(DZ4S_
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MOKVU\ =DV.].Z ?&:X!B6.06 _\,46<@<!21H>;CV46:8)1//O0B(,CR/=O
MD.Q84+XT5DD9^4/0K#U)*3__$@C\><S"XSB#?QY+P^FZZM;40ZF\2.IYKP4
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MW#"D8@2CR7-%6"G4;3T-E6BX'F0HJCXF-_-HJ+PQ/)764\FI;@7P*C\RXIY
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MD4(&?+@[@',2F>^AX &AYS??2[>R28FE_;%S*1TX^A4E<3WH7P/:[*U-A+K
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M;<N-ZU;V5U1YF:><L7SK=M745,FVW$<ULN58<G?RE&)+D,6)#.J0E/LH7Q^
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MC>R#/4:8+,FV)>[PG-9PM='62D/!+E#RONS=(ZAUILC_<*F7[63)@!)0A_&
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M6ZE@&+$L%P<S&44BA0?^[V_[.\/=PZ-M?%"/:VG-PECP KZEG!VVEZ]K76A
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M$.'JRGK="I"70(N?KII>7ZR(#9.\,.8J"'>PIO%-'1==W9DIE^D[9YOE.TV
MLU5>DT8"]*'T44$8^WA"7Z@GSM1.*9TKUYL^TEHR)E ]"LG(3GYI%^I5ILHM
MSU!Z)W18NO>7-IGE8\^QOX"5IS.C2JFS".6K ]9QJ-GRV<.ISE/E7M&?T0Z(
MW+2<*:_>Y1<$C-MY\NXX,IV@&ZPZ4<W%2(EWZZH]AOMT6TJ=AZ+-T\!4NX<_
M<DSEA5\T7 I^P8.W#8 XBZUSUBO,A)U"$_9@M+ILOFV,#*H&^LHU-B&/A3:!
M$'J!EI,RAX!C4-D.&NN:VB00=Q";![,.=.9<T,C)NQ4T;,1X<!.&-=%W7>!(
MKT3*=<@-!F'S#%LX$"T?ZXP:.L)-%#F=PZ8E%B6LX'PO$8J9H/IM/)! 9S=1
MVH;QU-H4!&U6XE]8K"%$?%R"M@HL>&&?$9_#&7J(01I/2DHG!M95>9I<[XE9
MP:X>?P6"=.L]%F&7)7^\_(IMFG((&(E >E:-%%BO%EA7$,5]6A/(0M45EW)G
MOP["\N2 ;<HGE%C%\$.4GNY ;_E(\%NM%J*.AM@T4-@"&TOJ8J[D9G*I9BUC
MS@$!SKP<8/QX5>%>I1+1R@Y#H]N,"RIJ'RQ"94TV)0R_:R2F&=)X8<K 2,!O
M<=](-1T=BT7D<"X(/NRG56G>;3CJTM=D7F%K_ K\&-',Q5K)(#7DA7@P*J8^
M102-_HJN<5D2U$@IPZ(I&=FO-_'7. ?SGQK1U*NJ->]?_ZH(JTHCN6J(BHWV
M'1!MY_F=Z!9JQ956<$Q0%S$RR?:K&"1P'&"0DFLD  >&&$OB/BZB27:P/0$B
MI->EZ#6.;JI[I'CTNA LI2O:2A&=U*@JD$BW8I7J0%3J5=1!IU#1..Q8IT1[
M?AW?T1*+*9AFB;8SM(]E2822Y\)5^[F5F:9/_10Z;NIA&_!'2)5[#?8;,78%
MU>F@X<CT4U4LQ=)9&RPL_1)LV*;IURLVJ^PD+CNS6C5O<RS&AK-6:#4-C1.>
MZN*VGZI4'W)+!=LF#D.AQ1HF@$92GPT5\[E!L2/"U)XO[5 L);G00-.3/PS_
M]LO&C?;ZN%$?-^H/5_UFN?C8DD-8E(65@ROFI"#I*E">=N1ASOS",Q:"Z%=K
M0H%![9K*1E;<.!^1SC>9<+ED,?IN_SN!G]"E%X:0-FNAAI*C,XR,;7-HJW;(
MH736MG4W@,X9]287K*P*/,,\$4XZZ4FBRA[&N=8P^+PZI%6.Z,*[_0UDK]:G
M(NE73 T$C+JT\LUZ?;1KWZU_GL1UJ\Q\DD58$-G+:C+ (Y.<2P2YG7GU)9=/
MM%Q*,<"V98J[%%NWP4D3-ZO[Z>C  N_PV%=)11YY(PG(.Y'S;BSP?63OMAIY
MHS1>V2\80D<=E8B<;AV2 9N=#OS0X3IR&$\F\%Z_,SIWQB.!_EM,WAB7JTI=
MZ;^N8SM\AS!9 Q0KP S@R@6KS7;KK@APC((,/N>-B&\%+C1^&D_5EOD^K26-
MGELMJ4'R;V!0XRR[Z6FO:V%WUQ^.?-W)QVHNJ.U<#5Y8F=IP5R:#ADE4Z+P5
MD7  ^YCK[("%<?43G(G0T#9YU>5-!%YZ'4R;SBM)9.D7SC.5S^X<B%]GJ7T^
MO18DL<I\:7+7]KN[M+#U7E<\[G='Y^YX'/CI%3ZTKJ7'C$@Z,,I6AVW7724E
MNMT>TBK5@9AQW"D8KI+D[#6:#B85P8=2M]9:88@B1B==W# ;1$J.._NF 0#Y
M<9583'&C101UIJ2B(K6Q0:DCWZ*LR^AJ[4(7BC4[%5.V\8PD'6#+T@%[O6 (
M_=+->(/4T<)[DAWHRT''BDPM"]KI689 R*9%8A%HLCX8 7.Z)[A=R5K1D]NK
M0MT;;OTAD->>ZHOKN1S[UC[6*>8UIK;,<J2%55%I;_:J4VK]?(/EDNU65$Q
M1*$@ZLY.\/,,=/)E8/0OY_]%9ZPK E ;W.3%]6'_;?EDT@#HF.VR3GVP-5@^
M5854D0S]8@[AMYU9\=W];R&!9IH.N,WW!F9SGI;:5T&5&'X7DY*]CGEZ\Z0O
MR/<UGNEGO6>Z]TRO\0E;T,W_@Z81&V7 NG:PN%5>$C-N^%!:*K7V5RY#Q!%I
M CJ(!4+YLF!<JQU4F)N[@O51I8'I.N&L[5+1%@AZ-G6]9:TK):+6;[1C&-[_
ML8<WXO_/ETGDIU8ZO6_)/U(F.8A>4$1_8+='XT8WIB3A.(L1)'-Y<?;V[/3B
M[)J=7+Z[NGQW?'U^>7&T/?YA\_( JTG[7ZNPEN=KWHD9^CQ7XL#^XH\4-5##
MV9%+H%D*.Z?!T'E59DU^3E=\MLCH.X'GD)2_5S'.K *\-W0<WNJ!^6<"I47,
MRB%O51]$#[V/D+;5-OL76#F%6+"/U2KU^,[/^]G#_R99XO3!KU]'%)L_?A'O
MJJ=9+U[ ?LM(C/S%5M%J]5I'6!-]^@&&<<[>G+T[>_V1'9^<G%U=L[.W5[]?
M?GQ[=G'-+B_8]9LS=GWV[NU[=GQQ"HS_XO0<V?Y[=OGA^O?SB[-3>OO\8IV,
MCE]W&-=OSM^SD2K9Z?%'=OD;^]>'B[. [0QM%N::?'DO51].JE[Q*F8G7(G%
M7XP?_PI2]2^[>'\58?J(A['^KKKGO:NN=]6M5?&1-3D[XYZ0P9U>'5NFC!PY
MXY7#N0_.LJ)5DTVSHM'F<\</T.WH\.&<4E\]O;]+#;<\TW7EHD:IKRNO>L0E
MP=4PJ$.E(2L\,ELC2J50/_B#UD"(T?9Z-GCVPFVO"RP\VHVY @OUG\ +9*CA
M52^>/WWZT%+VO1",UO>UB+/Y QYT\I=W>=+;/]LZ^_&VS!=]]IH8._V<]'/2
MSTD_)_V<]'/2STD_)_V<]'/2STD_)_V<]'/2STD_)_V<]'/RP^=D+</.7@SK
MVP<R\,*29AF]*S89*('?C==V-!B]$,F*V%@S_#?#XY34C$<P.LS\V6 4-7VY
M859_@^$ 7FZ,-AB]^')C9V\P_/O&_7'85<%7/&Q\>40T^L$S&*VFPX,T2T5C
MWJT?&?W.&P^XO*[&Y'DJL5Z(>B21\OT?&BG_LV'QVTQ&]T7%M_%P,_@Q*Y/X
MU7\!4$L#!!0    ( '*3XU9K<N(RTR8  !8X 0 :    9&MD8W4M,C R,S S
M,S%X97@Q,&0Q-BYH=&WM??E3VTC:\+_2'_O.+E0)8W,D'$FJ2&!W>+\D4('L
MU/ST55MJVQUD2:,#Q_O7?\_1W6KY@$P26./15FW&Z.A+SWV^^C_;V^?)2":A
MBL2O-Q_>BR@-J[%*2A'F2I9P=:++D;A)LTPFXH/*<QW'XFVNHZ$2XJC3V^]T
M.T<OMK??O(*AWIEWTN18O-S9V]GM[NZ)7O>X=WC<.Q)7'\3FYYMW6_3PV>6[
MF]^OSGG2J\]OWU^\$QO;.SN_[;W;V3F[.>,;,'I/W.0R*72ITT3&.SOG'S?$
MQJ@LL^.=G<EDTIGL==)\N'/S:6=4CN/]G3A-"]6)RFCCS2N\ O\J&;UY-5:E
M%.%(YH4J7V]\OOGG]B$\4>HR5F]>[=C_\K/]-)J^>17I.U&4TUB]WAC+?*B3
M[3+-CO>Z67D";^[ [9EGOFY/=%2.CGO=[B\GF8PBG0RW8S4HCP\ZAX?UI5P/
M1^Y:REL[SE4L2WVG<&QOU#!6,C_NI^7H9':"16]F]KU!FI3; SG6\?3X'S=Z
MK KQ44W$IW0LDW\$? 7^6ZA<#_YQ0D\7^C\*AH;ME>IKN2UC/83!<:TGO/]C
MN"?H_YWN ?_$.?N-.2>*=M=/XPANGG\=Z;XN__ZWWHON2:_;Z;UXM=.'P\M^
MUE+O71D^:V>YTP6L)-;E]'BDHT@E\,#?_W:XV]T[>;6##_*J\.AIYZ\W\,LA
MB,A^K.PH_32/5+X=IG$LLT(=VQ_^LE[ Y",^!?QD(=P!A#KA3W=TU#GZ!==6
MYO#_R*U.Y:4.96Q.'0#-/'\ 7[K>HP6A8[/!GWV&.*8>#T61AZ\WHMLHK+81
MA[M[>[VOZFNO&\%G[/8Z7[+A!IP2X-&_<IF-=+AAUQ'I(HOE]%@GL4[4=C].
MPUM[& <'G?TCF(,PPL,0 .XR'1_SIUL UHAUN#9S@+N=W3V#@AEB;K0RYSB'
M-G1!)P!LY?%^;P&TPO\/:067B?J@HH^J?-7/W[Q+\RS-)9Z"N*YTJ<3N03<0
M+_8.#\1E'.$CUR,93<6EO(6ER4B<PQ3B*I<ZURK ^Q\^BH.#O?U]\?GZ]"=B
MVSV$ 39QH^)CT=L^[':WCWJ'VR][AT=/-O>KRDY"ST4J-">(N)KFQW_KTO].
M9N\BF!Y7\(ER_#5WF\8\+M)8(S5#?I,F:JRB1)6=,!V_VJD\,-Q!G-XA>F'Y
MPV,@Z'=0M4=8QFD&HH#H[0<"*$3W\2CZ;J?W8Q3]D?C,KEO4:8GT'4F6.$NK
MH3C-47X"DOGR %$1QNVK7'PBD>D3X"K0J&&N5!*(=Y?XP&%W?^]G(LK/9HF/
M]%EWC]RJSD#&H;,[?CIZ\5\["&]=7ZJBU(-I<V67B>BKD8P'(AT(QQ>$SQ0V
MRY$2N,#=[LF[= RB^93^ZIUL!>)"R+'(0&PL0!(O4S&6MTI,TTJ  )\.!@"*
M,*X:9W$Z)4$?'OF2:KA7Y:)4<MP1-R-=B%@!6.<"I.5"#-(<E "<%"Z-"Q@I
M$B#61,2H"QQOBF][@Y+6@"^8Y75@)Z%91A@J^/+>:#!"52+YC6#G<3H1_:DH
MX'R 0=-4N2JKG/^":;,I3EAZ:\1-JJ!Q:8)J"BP1SK>L2L7K.Z_7=XH8N'BE
MCT4P5P'UD$GC*7WO9Q0R5_B]!B#VII/B6#P)V_V4@@".BSVK2JT*QW17Y".Q
M@L":P>N-[H8(51P; =/]760R-'\_)/OC69#@.@+1;QM?5,=).@%)V\BR>R\>
M5Q-P$GE]Q<K@"XC7QIM>9Y$HOD(+_!W(#E&$OC+0#:0&2!Y"MM4W$/S_?87_
M7LL8UC1)\ULD.02D]&2D<Q72HPB+196I'"&$7QU/"Q4/ I'F O$$]'4DGE4X
M$O!8@>\4#40:RZF(%%(Y">1ID*=C4<+.D9;A?Y$(*Q%6.<D27](^$,$B RQE
M@ 0L0*+,^.IV (@MLTS!@B.<SNC>XBVM5R>AX2!P%Q:G8/] 9XEHY@K8@D("
MC4^6(UG2^N"TQFFD!QK>F%NAD$S#"T1.4/M"H-+F+.:HZ;QTW*+N:F#&[G-
MW5QE /TDJR!HDA !?"A60QG'4Z'@%8W?$2 3L=9B]I<JUT6D&67A&GR4L,G-
M1BAZH$@$ (ZCUISOJ>#VYTCH?WDPWGL&8-P0K(#H*K@W)FH,< NDUBC4!Z^
MLS162G._[*!Q;,["NL#>M?&F'+W:@4'NM\P& BVQJ+LWU(GK4N:E.(-U68V"
M>(*5ITN=5 IX8@E+G146C5RI$]H4(!Q(^@"2Z%RP@B0\LD@(;[G$:J/7_C-
M+R?@%57_"\AIB%529'G:)Y5"YE.4Q'0:H83RHBLB.2U ;91%E3OQ!M"@AO]
M1,! 0 (T? -EGJDWCRP*5:".C8)8F@Q3?+:H-$ +@12*8!)XU["*I<43I6;E
M(W$Q<!.Q-#>_XD H3?(D3I_F#18&"K-6=ZI@UNAA8S%*JS@225K6>#LPTFD.
MVTZ38-%X*/<Y+*8[WIALD@<I=*0SH8!QAFB@%WH\5I&&YX$9(Z*#-D_3P-PZ
M5"URKS9R'ZPZ<I]YV.$!(XF!R$%JJ=!RJ:@*Z4*..ADJ*B G$@(7Q)80QP:
MN^11)O8V2A-@QP#\2:+RCD!R,JARPKE%4R!2H:09&)T0X![02"?V+U #$UYO
M.JFM>;G#/]8.\?D['54R#D186_>"1\67AZR/JVL7_:&56;]D A_ZA%R3QBGY
MIV?^WCWB4-^X:G8=\;^CW+F>97@[S-,JB69L:UZ(0/.&V>(N^ES]+<_@X9Z'
MB%ZT@KGB!RO,AD%D<JBV^\!-;K?E +C&L8PGP%8-H3L\[.SN_W)B7.9\K3L3
MWK">01/S4.3<O43]-]YD(&4 J4%&&H XW3#.I/E0)OH_3 S$, 4.DR#%0UHU
M5$E(Q(9)"/J=0-(@"26P>B]S=V)K:::3>:-,0%Q^B*P;-&3%DA*0S4$,RC(^
MJQ/XF$@0^ZJ<*)48]T'T^'9R.J/]SLL5]%AU.[O>JI["[HTGK9)".IOC6Y6H
M@2X+L?GY6IQAZ$E> /3$P,L8(";X.9&OA A)6X]F*3>?Z>"H-5O\B&3S8M5%
MKW,GXZ?)G'I$ DY? L05,D9MQ6I&]]H=_J=W<!  :I#Y(4,!*TFJ<6UDZ",!
MN]-JLM#H3!;K6ELI<#FDHUE'U4#G!6H?"2PZ+W!5UJU5+[TC3N%=H+E(*5DF
M-#M 6DO#A"0\+G:)&?6O]%>"T-U[>5)XEO!6[UEMY'NYZLCW^ZQS!]4.9^PF
MJP-]!$"+3$Y):VG@8P!K3\-;$ +8OXLH=B=SG58(\B'*#G?L\>E;O@**T3"7
MXP)=4V&N^[6KR((]H4/H,R92:N#F"%&&U")X*UJHL[56]6>%(8?/ $-JOZZ/
M& CF]/4:D-JGD!CX 4Q BK=Y>@O4GKV]G]2=2BKK=DW'8TWF 8$2.;[1 Z8R
MQ2@E?AR0\06(@[^(*D/6]#^['SXXSW% */6R W=1)%.D&3&# BE;9L;<'RDV
ML]6>Z'"&E<QX5CO(:\RZ"G* 95)']:9RWH+8#&4Q@K]"!>@=;0&SHP7@#"_$
M&(Y]5)A8&7=*H!HG#>X+- =]R+"/*HM(*7'3,)--9!)J4$CH37*'E[*LBAE%
M@YDD_H,N[98?KC2V'ZTZMG_. /P026(7:;#,8DX@>5T[ MZF,B?#_QE9Z)!C
M9?#:G3'_9<"Y*LFQ<,THMUS]4<$KR+QF@=OA*2&,01>>B >'2\[J[W-B1II-
MXW#[='UYY5QMF^QKT(6+3LG3D+2[ : F<E0[&0C"L^L F34I5+P5--P4P,\3
M1N;[Y7*S-C@!.(UPA&)$K]LE29T77XR YA0HM3.5-"_0^/@:3JI1A"!7?3PE
M*P+%HN"8<!XZJNVHN9-*:)UW:&Q >BH=K6)!?E#!72*\< (%!MR$0.'21&W3
MQ3#6@\&6,TW AY*: @5?PECUR$3UXJF5V9FH#T1O9^]%20$Z_(1/KYTFD  H
MBCU:0^$MH@/ZA/=)Z10*=^CF$(QSJ(:UTML:@\I8J;)V,J5AB$)4?0H '!2E
MT$<KC ]H&M%@S'/PX[.*2E\!1A4='PU@Q$+Y(7]X.JP^\;J!U42.]-, P  <
MT<=51[+6J/#C;)/\>6_DY[]Y$A1'<WV+AZ--I!$;L1J !&Q1ZICYF^_)LT=H
M%, YA"X6 "5 K#'6P];Z:!:!K9K=6 [%KFS@JI7Q6<,'SB1!B$N%PR@M1KD&
M;TLBYV- -QZ+YU]5'M)' GB)-7_%A.1C/&MDH0;NQQ79U[PW8'R0X]F5GC#D
M&WIDI\2SA5M'QGO)49BUG)U$,Z&]L]\B,-X^HZK+"LBO)*X%R$%Y3.;#XSA)
MZGP@ ,3PQ>!=]OFUG'RU.7FON^JL?*G@#F)D$B%J.Y4T1$HLA\H+Q)QE?#>@
M:ZJRMHY>(7\U'(>X#Z(?Z<3:X\G%XA 5R_V1U%/X)@P6D"]_S-QLA@P8_SF0
MVBI'5)F/Y'3K J4[KH )2K'?[=W2R(^+2@UW"D'I@J_A)ZEMTT-+L]0:V.A[
MC/Z$<VM%B,1<^F[#9S3G'O-<2#\[[7)WWSMGWM 5P#NGS.ZV#L%GZQ"<0:.]
MSLO67?)C?.UY)1HD5%2 &5"25""\WLF0+5$ CG<D9-VKDI4C##W9W-L2$Z5N
M"_*8R*+F;,LYHILH2V,=ME'XJP[8SR(,?Q%@YTJ/^Z@#D;[AHBB=<#0@V<N+
M2$#](E%HTT!K3;\J@ \5Q3917Q3.OJ*Y%HVH1M?96ZSK@&IH3;0XHM/)K)H(
M$T]RC8FY=DC,(DCSTF:]99A" T^1G33C'$=:JUT!2FN8?A.M./(\QC*>(KCA
MQ@29PITV3&'%R=/*IU><&K]\;?LX%@M2+HS)5?+3QNH:8!0X&0W95>&1KQ#T
M2#\8NAEA+3G*&94\)E=D7C$!T &\7!5>0AV:1S'L2L9%Z@TZ:[7S!NV("[95
MH6.G=%:WLD:<IJ77#\/..2P\<F]%E#H[$[7 GIL1DVCR%Z'5QV8^<OBV,53W
M3G[[Z,S4L,U,HH%7P"P5&XOHV5D&T!'_-/IQ5N4@:JO"Y6XOR@,)[!>BLS/3
MD?T3A["?"=US:8+F7.NC-F:R;)2CV7K1&+ *<QF!QGP;)/G>:=IGM0MU83/Q
M&?"FB<Q-V(CW@O5R2_%')7/*EJ>S- R2/HY=6IZBV5FR%=UZ$JPMD!:"0&+'
M8;<B)9V:15C#A".9K2/]&1'0E4^@>:6;*6?$JG4)CX5P]V,J3J/(E& 35VRD
MQNS_'4V2H0QOX?Q!)!PRP:MCYH/Y\$00L'*X@OB+CY'5'64UQ*1[XDWMW]9!
MXWQL_NLSSH&&Z;L1O>^)L0&^QA+J-Y5  %QMO"!GB((U'-9C!&*43HI4H4M)
MYH SZ PAK1#'&5>),I'_S7 %%^7K;*'\)YPK4JBT<99.*1Q0)L(]N7;-[(:E
M7XY6)\=IA7XMBC0P/KZFLW3)+.2_(7MGH5G3]8?S,\R!D1!Y8&76!/51S0[S
M >?H,&X/L^$5!RO/!2/%*AG"-ZM]=8%E3SBB_Z6PO E:E]'\BR%4K:3_.&',
MR4"C>1D#1BX2^$3C5NQ_#EQKY3/#;HQ05-="6@QI5K(#0;(J;,#5,LJ%8F;!
M&6.YC!20" S *@(DL5FN58F&"UT/[GFR(Y3PB/[6=S>)K"*/D G[N102Z@3)
M4HXH@PD?=8D#?HGX7#K8$I.1HI'A;@:D+T(6D7!D%[X6 ?F*TXR]4L 5ZBS3
MG')%RMF K$WV01EF">1\BV<W0\[XMDB<Q[)155E@]$8!O!$]939(!:,M2FEC
MV$)S^N%<F+9->QL(\NC!]TO'"EWVOYELT5B/F8/C6[!NH,F40FM6#Z>I*+\V
M$,L^<6"]:T7C]&>VGP%.F@B1,CU>;7+_H_1G.5%YH&;FLR-4FW)KQ0D5XK;,
M 6F0&!BD)6*#/N""].D\Q5@7(#-$1#CVC R6)R3A5"CS8KF(' "_8 E3U@';
M"/Y%F5=4[ 3^,IA*I(F#:,(T4AR:"D0L*1&E3Q"QQE4LZ?4[+F*(*Z@7R.92
M#$)%-[Q6\ Y,B?FUS\1QO;_?>J[_*Y[KO=9SO2Z>Z_T52,;\MNS:E[NT3#TO
M%Q#+-]&.WNT3YX+"B$HT*-14S\3>(LV#J6XY3I,LIL!X\3<1;V^$-$."7254
MGRTPM'W3B7"H-[/8!NHH!ZWV*U"\D1!725;U8UV,4(-WT?6H"?."3D!$"LDO
M=4+QDR0+F1\85PG/#:?&M451FJ4\:0A"($#)/+(B5G&KX]BZPGR3PZ .CSKA
MN":2M4KC+0MC71]/6AHQS%P-:LEN]@%W?1,+IG-*(99)L'*[O6\MS OG!H"0
MP,BXGAZ9LMU[)\;(:NO8%<;/J")ZU7O.+F5VN&6G55"^!T9(8M8$B*D4R$H7
M*4XL<%')]+G1F0 B;43J @P/-XK ?B"""I1E0UG@<:'I97N43@)/A:@AK53A
M*-%_5(N_Q*V:4O!:10=?'[5_?=%[195E&)?JJG^6N,PT-VDKJ/8T=)L^BN=L
M;+*OSKS9J I32R;-\]TLMFIXK7=+1WBRPK6/6R'\FX7P_JH+X3*9SB YPBVI
M@B9[P*MN-*,X<OH6:Y  SHF*@QJ5"+*!8F<R-I)TP1AE<, *^&2RG,^1,O:!
M^Y=6IZ' Q#".'F@.\3&&B;2@R0E0S<RYG;K$!BHR=%5^T[S>CU>B%.@%K*55
MBM<$'\-5Q\=:SEDFKRV(;$/Q!KDHOXOY'&@%ZZ/# :!\:%$$"ZJ@6QXK/6G"
M&0[_)GR8@*Q?K+BQO[4^KWQQC%G/)WFU%B>^U\['$09^8@E\T!=<=L]BDV9M
M9Y7B3L:5BY^K2"RD H1S!EX7;W+OR+JH"VYPTAP'FGRU#CMD*0!!TYGAV7EH
MG(2IL_^BC;S*,>Z$BZG%9 _&="\R/#FS,$J72]=DC= @B(;$[>8MW*9>(9JC
MXM2T-R!7,5=:+*JX-/R-S=&)J==-W X-_O?EJ;7T8+7IP7.HU]&(?$"CS3)Z
M0$*?R_*<"1]X* 1A)I8!0YD\K""Q;BF6F; #EO@"/Z) %E;,Y(Q=E>-;C>@Q
M]$J1US=P=3Y9[];(54V\K:S@3F[JERW+F;X";*7U<?CN2*N!./\*5(1JDEP.
M0+K%0HR4TMF'<W:#A=[&T$.DQUE:6,_5,I=>G0@J062?XO9\:9O#';*,4GQU
M8K-!,UERVG?.)G.\A$8:)W?3>W5@2U^AS%%8_Q7,@[PAL?%D.HD 5')<9YY6
MPQ&&VJ&";$M%8DDX?!:-D.'H@3@Y&S"FFQ^MKSSB"$>"98Q*5@H$)R+C\I&2
MQ'+25F-Y7@3P691C(?) 69SSX;08R#E?T@L1#D.,4JJGS+7Z:]S$AD#)T*G"
M.H\(4:PD;R6D,)8PEB4#WD.,%#[5,,JX=>7["L=(R1A([;P!#$A!;?A<W$?
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M"(STP1C,Q'3SHHQMLN8=8+O96 \T1I6ZIVV89<W&8'%>EA6>DHHY%M4\(&-
MDH0T>8$9-K?XK0>FN AO:*"!OMN;;J AO.%<$A.=)%AD 3XK@ ^Y*HIB9A71
M6">ZX(7RP%BP0VINQR'1B[#0+8@NE#O^=#ION$R!)@#V3HN__VWOZ 2P3I&T
M:XNA^!^_;DW?K% ]VT"#3L0=YT_#*-S_3 $X[E\/J'3'716, ]?@0FOF_.'
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MKA5HV0AB;U6<3E9ILTC=FFR>8QTL<V BBZT<9%:H8_O#7P=Z5PT+0*J( 9$
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M] [B3J>]NVTH I?.+WFC"&_8ZEB'8:0>:[?/$O51A:>J$+5]CU11P,'+QS+
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M9Z N<1[)A-T?,%ZFOY"> 88?#/OW;MNH@31U2[SH*XP/P,6H(?5!Q1(#L*E
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MZ7MDU>=56."@6/\#^5\%CKJ3'CW#E)%U>9H2JF&^_?ZZLX[F[-A?#0<IK,?
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MJD:V+SE>\AK,P-.YS%RK4*1E@;XUD:<EFLCLG.!$3.=S2XT3KGH;4X-9M\*
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MC\P"+TLX"ZCDD(,Y#$&KR5L5LA-3LI&=CIS-P)<(/+'LK6^TBI^;.<[8WX_
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MJ!W*OCW3L;=2ZWHDIGISQZ89J=A];W3U7J]1/FOZ6WO;"RX\0?USZ?7[Q^&
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M_UFZB6QX]OPTN!J^'P4?W@7G'ZY'5_3);\/+R^'Y]=5?;Z2\.#I\^376A=^
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MBJ;6S?879(I@OO@@YY-)702"!-78-82_)!A&NS@\.0R#XQ]_/ K^"Z1,!2.
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M/[N!DA%_)[LO5M@7L]PW!.:4P[J_$1\KNF$XF8#PI/UY)F0Q1%A1KPDZ<JE
M(A/6CFRKFH+&9.24 =-.H4A+O$P]H=\X!C.Y2;^QWX"/-31VJ4EA8)E'^H+9
M=//96T/OKL8U",K06'$RTI2T!=?QG_CL-'CSZ8O77'FEQ:3YZ:D<=F>3!#:M
MS_DR58B99^*USEQ0L3RDQ]J=EZ!BDRXX_8^N""?SNZCIZHOQ,J^+B!#WH:#P
M6YYQO&ED6%8[:R@ZH594$M(P33)<Z,#V;;*<=T&7#5>X==<+S"7)./1/%[3"
M,P\[@MW\'#'A"U&WXDRWSEV 5;E)&H_QRU!A<11=)UET+RP>:7#QS!(B;B@A
MM$D6Q7=)F6,8B!R8H(.1'DK,BM.ZR)!P00C<,5:GJ1/I0$;DJ!37^UB06V!#
M)1D>,-ZRF)\K]D-'/ E[<.7F3A+T+Z\$2M/ZJO_U),?XU$=IE^9/0L6.#>64
M*L6I4K;G9<U>;3RGAKJ+.CT'=;4"S94]0U'Y*:!>?87I.H0=G[#1A!U,,C+*
MR>AP\4@(@HI!F*!VJ^GQC#\(,='UI#U'8B.WARE?N/+TSM J40(PZOB8$TPJ
M-2S9I.J2TL:00ZFO01,.N1\_U#!/G7@0CK.9TK7\?L1N\^C=E'#/6+K+4QQ,
M%-Q"[T!X4TH6+%*1E)^\QI',H<QK' *-3?P(9+^EZD:NORKZ3#,XH;RNI**?
MZ;0RZ'6FX B5F)$,\R!&M1"@&BV2^@K"(2E-0K83]*(U<H@:6V=B?R]LXUZ8
M[L"]<)[[ENVE0J_5ERJ16=ZCSB%VF+0YL9(]$6.QB/BYCTSDQW'GSY'!@= '
MY$.*M0^)\(59;'Q(\&\0.>(>:0EY0;E,HZ0@%#&!FI/*4:OPZZ4''>4CB6L^
MN^*YQV^DBZ1YVIY(1BEL&<L_09>1D^J_/W+;/7(W.W#DK@T2JH#CADK(EQXW
M<?(RER:Y:M>B[WE-COC&KJ8=S:!IQ=G-: +R!PSH-W[C#NX?.<^=%ELHBME"
M8[*U18E>7)R&D.Q*1%P0'HBN?@T;X_>E>%0/A@.BT4"]C/RA3I<JAU'HX.W
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M:XERB@$TTOPZY;?+>+"6,'>E.&[P_DK"IO8.;>!2[V##FFT0\O@%BWH5NS]
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M(U>0O40H=*)1"BXG&7%!CQ<2TUOQE$8;NGZT3$\F7EH$LY(JGEKO-! ;1=%
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M0V'3QBDLF>D ?R,501A'SFS0+LTR[!9;2RW/TL77FC71QNX&LK/T5'E]9O6
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MBST%UZR4"K)7AYE >QX>0@)?.D ^>IA0,42(6S 574P2S$3>M2S!Z>F@1[3
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M_B/?F/8]I<D=#['@W>VM@M9ET*Z3%$!=UUW[M02+$W;L5)<KW]BLS>+GG8M
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MK#@?YK15+K#B^3J!S!'F6'!R2,X_O4$T49NJ"J,B^BO$!RSE'1/3U,%2>*_
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M=<[;FETAF<Z[A<WD-%%WN@!')5S"PKN"=%U4F$5;R9U=<W :?''DT[T W(8
MG,]W1@!RZ;]$R.5&=^O62/BM<?);:;HYE?<1'CQ,V;5)NDG&M; HO4P*];P\
M^OY@/.@@8C %_BZM(7_JO$ZG%_HLMDXFKQ85^UCY-F/E/^QCY8\]5KZ:K.2[
MG^!VBZE6&V47N8RXZ*:EA#S^6(<)PS:2+K3%3Q@.ZQLE'(%"M<CA?B5I8TJ[
M^D4R^85CE5&5(4R=P<*8#/#_CV;F;HLJUTD5EIQ@2>MU Z*3*)U(0%>L2:[/
M:A.)YZ 1%:')"].4^,3RRIRE/17,7AR][)"* QWLZ6+3%G?X))I'$ZID5WGP
M0PHG'2!]@DNO?\;9DB>8[XN9<1Z?OU 'WE">4[CT)[8(JY_\ZZAE.@T M*DA
M[@']EKAQ'95^K,#<$_'@X'APP$E1!W?$A-=U;QBJZ>YKSEX<3KY3U',GPG3?
MZ4P*MQ_/"%^-_WH^:!OFVDD1NZE[$S01B-1<N&)-_AC^K'-.FU/9T\EV!S09
MA<&0PTFGL+]#UFR46)?7N*55FT&K@4VXG=9%QFS<.KN;F9;0@SHWA8]MNZ5E
MW:B,.K!7,;>A8O[YYPZHF!]H6S?DP\.RO(/H/BI,%%R.Q2J>3):LQN>5&WX8
M9H$YZ$X3'<!IG=69*EI\F2:0+ON<>!!TE3L=L2_*OIB^&\?OT6;WAV$;AZ$H
M=N P@+TU%*\#%D@S3J%-ST.<*SX1MNB ;@LWI"6U)XRXQH$P45(7D?D#R>N=
MHQ=U5!OM=KWL=_<6=G=9[L#NOF W_<>*G76:FFA=0J2VZ;Z*$,EH=Y84U:]R
ME7=6JK(5JE:WL+*N5/^@)7WXY7[';V/'5]4.['C-572!EMT6-[JC^#M8EL@Y
M 1(BJWD;ZMUK3:)63_<5S[:]0^MZ!W;H991]DB1#JE^QW@8-SJ#Y,=S_7*FY
MZ4^M7 K)T"C4I<J<" J]COR\&A]H*%:TL=M41>0!#H'%H(,8H@2N-A(&<32+
M;M#;0G34:?)GC>5R-; K*6'8AKC%A*(1V9[B0.XCJGWM40+O]_Y6L%<MG. W
MV/LGBS$"G1@L_37H1701'!=O4*G);09]OD&B'>+0(#IUV)ASS2<TF]<5T[L3
M42+\(U/5?5Y\*I&JJ(C1JH4O\VG%_[I7\$JJ-2,^&CD&1.P45=&82D<<3+!H
M)S'Y(*V1]L=="QVC]<&ATA+%"(JIE"ZH&4L:"\,@=4P5G8:I4ZM=CB:5[C*,
MKCV&+;>7V#(=)B6@ \:#$UMZO"TN.;BI_!,&4XW4)*<X:6QN!\?U#1)8(<<'
M,CXI#"##/ZZ+_ _$S<"G5+$'G9[C?#8ND?TI)2<"30$)(=@\F#!/<5OR%3#:
MQXG!C]%G-F='Z\HZUWWUUO1TK$%B0R](P (C@T[B9[,HT1PD" Y$IV*4$IK/
M>!7GMXL2Z9E"WI3$U$28)*&!*2AFX)!G:@+'D-.18W3/22&#: IZ!NQ-"N7I
M=_-F*4"P<YR>D%4R"]#JE&GV&H <#1U (7Z#)S'423I8&LQLFY#J464(%N-I
M<2N[X*+;G6T.@D-3H_?_A2:K.L7OC1Y4]F[<Q";^*UB<KF9T*UA;H63:KB"+
MJIH8"HR/G%894[\1'U5@G?8HCK&:&RY'JN:WJ/9Q$3+8LD]@3E/[!'Q;Y0)Y
M)YQ[:L>O"Y<1S;*A,A2GKVX0<[Z=L@RPKBHK[?OF()N($$=_,('93BIT1,?F
M,V+P=):.L"@3N,'R&;]?( [R Z?&I+O>4JJ1#A$[J%$R&CU5)A9VKHQD(5RC
MNH%^W15!M,J%T#;46%VKL?$JVBJ./6<*ZK$:,*J1@0C$Q<<,V_Q9J"=PX9&/
MJ)+]XCCK=#3ZY].+2R-E#T8?P=H[_O[I]S_\.'C#Q6\VG!I^&<6LHA0=\LLF
MY1=^YLPDQ5W \FJ<#!X0#6.2CPPQ\(\^,;#,@FG.]O;:WFSH_QS!X<EG!,.+
M0?=+6+[([RC8TGDA_7)V,31LPT*Q)%,CX+Y$,>K0NU51$$>8],HY)HU=KRDS
M_%/(55F$)1!)2$C)X;),&&:IN"W=39T_&:4+B=.1:PW7G8D68HY9N>RAC>,N
M"T5,@)]K8N1+F"TQSS0:S-*"9[E4F$,I:RD>0@PPHE;+KCN'E["6<I=\]$A"
M4;53$C).Q(IQ0N+HUF_#<GBQ)B&'-^RQ#]O$/KS:8Q_VV(?O?G+4H9+LV#31
M ECXE>*:<8Q93F656FGA0OYC80*@XI  TE%8,H8STL[O$G7/<2O,J3;16IXA
M1$#G$G.:&4)/4(*H:,(D0KOXGB04B5*^E8A+6;AL,1IVE\0U7=:<74J TIL;
MQ%ACV8A^'=F6]>M5E-=D<[38U#:O(^F%/N*>A"CB&>M*:KKB,SIKAO+68[+%
MBCI5+4Y&0P'/R3^P ,4XJ2C=GSC4B D?&V(>8?EE7CBIE:%=(,./SK6WD0YV
M4M$MX836FXLUQTK/'2IP0_WU%%1-ILZ_-RJ+OB67_I0*JC=OG5#N&["7DA(F
M&#2DPB;B8V:2N8IW;U_M'3I;<.C<W^^"0Z=Q_$5'YP/S'@[_U^*0E>HOI()J
M7#A-[+W"+U=+(@VUCDU&'^F5G8=[!3EL!S=L0$IU=R&_;F\"UV/M<QSHR"^Z
M8 LU%W 2#7'A$.B"E0S#_35:!,]>(J_K\:O0T3=)R!D?3A\1+W87[2;?7FK:
M#@Y"S%U>8VSMGM )KC'9G8!3S:U!44)G%.&::Y90^A<61FJM!"YG8.4R[C<U
M+]TAN/5VV_WJ=?0Y7A'O]K+^(>_"ZM_4>FM:8XO2QI @)^0;QD+"<!=E<4JQ
M!#IWCDGF7U9NB9D+Z9^M+;.>8TU.-9]G(H/'/UV &@RL+@7;H]T?C@,4TX,;
M.H=S>E$98-V"% 3ZC:@>0A2MS,7LOE33TGM4PX1SXA0][/L:-+!T%),,KN^:
MW+N\U3T&$)J>!PQ =ZBY:_R)GX+F1&Y5JAM*N0!HEV;Z'%9&L;7,_J_)J79+
M7F9B&*6SZU1YUGJ3B[6RFC7KQ=1;LS69H*CC9^Y4>+41_"-JZHGD_F03@?Z=
M!*G049U8?\4JQ[$C1W0.#@]3/&E)AQ-<B#GFT4+(.$+F3<U3O;:(A0X=:B71
M+$-Q %A/GG5W"_^_0'/F=8$5V Q"UYF(-U)[@#L7T;M,<6DA*-&D)'GA@) X
M PF+IBDIA6M47M\JLOE:SFOW*MPV5+C/GW= A3LU(F]378T"# C"Z9,GO+];
MA>OQ%K!EZRWZV#GZ%LK)5Y\M@X(NU%*E%D/7<E)B2GB5L+G)/U@J ^SC1HY2
MUM(3 7"X[<.S($6SCESF'JA(&#3 L)15RB6\INL _1*GBJZYPKG-GCQ*=X4L
M[-"8O,Z*D:;F3S@!!T!H+W30S##5>95GL*^HZI&F)32Y=A0>+UWC/CP,AM[=
M[F#//;!Z=])XEPX1MF)&9I[ZYU;GH%B=GMPRDUM0J5)6./RY#QU8_9A6'.NC
M\29>G[0=6JR*6N*G+/8Y=*;1HZ)K!+QX]*Q)!65TG+GKIQ&SZ.5@@Y /VN22
M^H]DE/E#U7HROB$X@/B)<_^=3%-2>"@% $MRB3Z>:JP(Z8Y) ?L,-Q2T*3>%
MJ1.T(%N,6F%"K%E2IHI85K9?MWGSBV%G:'%>'#8N@:4B^.3#/T?GP_/KJ_V5
MO(TK.=J!&_DMEA\#*S8OUL.ACVS-W?(632>L[,27+'*O<$,DTF"*0+27\-)R
MNO#D/V92982XL!G!<F.P0FT*_=*/$Q:#('G<"QQ$QI5X.K_GAET1ZE]-.]/3
M'SIZNC]:6SA:XQTX6N\05'5*^^4M,@]=?=H8AL8;%UDBX#:6]KHR.)S<^VB?
MYK[54.^/^U#O/M3[W4_&'RC)L6XRG\3CY +0N;#"I](H7(]IX'-RF5.!3Z%F
M06]HAR307#5.11F!8:.#%!V$J&D;$E1.$JA:\L1S%.L49$RR[-3>\[%8"9C,
MS*!L]D0)[9>&,C7DT%33%C<2@SWTN.=]:AB@<MLZ416O$K>I),>254.D. @\
MM>:&^<LG6#_(^P>',5&:1"_#6K*>>0KUVBK\;V9=E>[<E[D$7OP9Z* ;<A>1
MB55,Q$=3F0LA@N-'\PU!#0WS[<CVVHNR0R:9W"V&=AVL;M*)FD%IHE808&AJ
MG G.6C<.0S,:UN"</EA1^;#Q<QU":S:CH_O.HTOVQ* =+^,)<:(KK3=S=<10
M=R%T GN@!J$7FKS%&G @L()VQ4:V;3^I[IGE)>Z=7&_W[+7%;6B+DQW0%B_I
M\.%>6+\4^L>L2E)+6&8PIHZTX4U.H2_B8*)"IKS'X,XB6#AN=6>_N5$VVZD+
M*EMH&3-Z)0LKJW3+:&DBPH$MI3;E6>,2( */%X+N[3RRZ._A:PM'3=D$-&6Z
MN 43:+COI4[I#GE,(?0BBND$R=3_4"!;W5"ARAJ$.MP,,B&[L2_V^3 9@FJS
M2;'O!!-]A[=-I<E92,>_>O*< BYW49+2ZNAK0@?9=,]D =W[H'M1.]=+7P':
M:6FO?Q?TC].KX.PFEH2/WRMSV+.+IA20(Y'F)5SA)M6#W NS;0BS> >$V4<N
M]WW!9>XV!N909* NE8:T42.LEU4.BT:'QHEY593('<U!GTA-^>+^@O#V,.F4
M0XXEV_(;7MF-=I1AB0]^O\&WL<'5#FSP=X8]T\F9V!A_AHHZ8_J57'2VU)<V
M$\\HK)\S3UB#?>#2O0 N<9H<[7\0Q+8(<?,B)\B%Y,7Z[T7H5L<=7=T6>7US
M&XQ.?QY>LNZ->73-*TKBF/IIRK"A7W#R8ZBKHR(.YN!X )>"I F>1MH$INYP
M;51M,KL]"1UN*3QOPRQ#E,>E7.[Z>CD^>O)?U,W_KJ.B(JK;CD?^6T,G,(@U
M,QI"KBO$9K3>'"&-4@)/E;=*58S0RV=N2$N(L;FXLDD6U51Q-O(%G7J*H>*H
MO,4:8O?N=U--#L>+Y#*LT#"YNR?"O=L<T"L9<L3UR^W6<-[@$B;9J_@5D9A1
M4I!TA'9 AV+VG!6S@V39_I'H_,IM1!!KY6A)(%M0A\14;L7J71S<)1$7'\YO
M,D(H9^J^-"SA($KN$"ITP)9W&5Q<HL@I[T' #T(=628,?!PMM#]$_[K2'+^2
MD0<;2P0\&_DX/'FV9+VRQ8V\) (KE/5?<M)"MTO$%(&(H=))8'4A XQG,V<2
M,>O)G75 N/NS>8E)S>54\C.Y<&&FF*;8]&\6T>W:?(5[5CO>M;\&MW$-3G?@
M&GS/M.4/"VL8UR>I5DJ\)*4&O3&&U3*P_5GG@G\^D%.,P%_8DHBR&>@SN]RV
M)=X(NE:Y8=^MI#YCM<8;=O!$=97/2 #9%^M++*'#*#04UN3V:DHDU,>,1B2%
MF65 \-<:XSEP6%^(!Q65#8N+1&&$]]' <4H:FXUDX1=/99]E1VHX&JL2.^6^
MX%/6LO;*?/30AV4FB[-_)?)BR4)T;2HS!\T%<9*CS;SHM)?U9R;38-$,^6?3
MX%<J+1)21_"(_P[VAVR D8R!;>_SWZ]&P7 &)WX29?)15,;1G\'/:3XV+6FG
M@__=E4(4M7ZD1=PZ(O,\5?* A42?RT7L"OIE7$.N8T *MID-/M%54)SH03>\
ME?Q1RIEF+C14^EYKK_H*C*4QB$Z!@1<X^JR5W(#X_JQ4G72+$LZG]/+.*@'D
M*]>!^1<@3K</'%H=.#U^M('39T?[P.EC"IS^NZE;-SN@;CGLH9[I?V7LN\VB
M!D,;Z\+0H^=B&"LP4P8F$PXKSL \[C7Y+6RMVQW86J=)RA3\9Z)8KK65WA$S
M,@4^./BR$.(WW#:_145!V+E"H5;F$NEWQ2/(2VN2C. R1Z(<O%30/9.3NL84
M2_A J[M=[C'JRD#'=900-$GV5;N%A%QQDT@[GIU*2Z3VV' 2>0)8^P>U S,!
MG>0JG@#HKBE0)U^8^9 Q%VS6^U8#IU1KWJRH,OP_T[Z?>/;'G&=OT=]%,S'-
M+N(7IHLZ+L^,)0UHO"V-T*%4*3=]S$NM[]*<]ZZ!K=2;W@&!<A&5)1ZO=PRB
M$#\V(7MD&SW,:R"9<8SD%>^QB\SA\]LR;3CYAG[)*1R"H,0NVFR.T!16C40&
MH5BC<)2DT7*ECF:LBDNM@OS!I+M&HD]$]%OX'L&32*;>C(M*Z%;(+4X^-A5E
MPMFIK9/C9S_^8$VG6.U/S39.S1\[<&HN86,44F.8:,=,4))XMS!F<)H0YFR]
MJ.K5RLN9'/!KW,Q]\5.,FZ)/C-Q,DS1BX .9ZE2!IL1$9^ZQL+3" ,="TYJ%
M*V*K^A[B0'!"5Q:[Y>_A!Q6Q&F2E)"SM85+;/2"?=N" G.0%1B9 KHYT=N,#
MS@%C;VU!*-S6]UGIZV_ZB/0<"2XBXF1$OT/^2J$'<EV>_9JI$Q9R:IUT\(O@
M$PXPD="G7("228GPONAY?0FGBWCBB%+04?]<*; _+]LX+^D.G!>V$:Y@ZVSJ
M'.BY*RS.;?6MH6TN^I Z AM[+-"W4)>BEZ]*[*-E*B@36)RH</-J";0]T][I
MSK+0A9ONVU6;5JX)DVH\Z+AB.JX65 ?_R#4;U_ZBV>[!F>W P3FQ5O.%H;]9
M.T/2;K,9&^RFL7,.X>&Y&FGK6S[KNRB\0Q@ZE@M6JF(P_;)?.!< A>9RN"&<
MC>R1^XB/PT_4=[-!V)E0-5YE_ BN$^$00V!(U-23#/GR(*::K:84,P+JU0U2
MMLR3C'E+6A 'TCY!A:SUY4:RQO7/^'WWNPQV7]OWP9_;7K=MSML\8[X76<32
M=Z2X,U"V7"G6-,6@V)T)QYD=<<5^'6?)]$?H#9O _HQ]38""JZ&;A$HX:0S%
M,G!H?^=_,]&5[8#H<I+1?GT0])8 ]HTH,)S@VV2<"%F(^XH.0'W85R? -_]:
M$-X.WHS]-MW&-LUW8)MJKO4KI[3B RLHN56^;;WALGFC2@G3X^XZXP.-Y9LW
M281ZN5?85:C?QX='*D5*CZ9\;8YKYG&AOXDP/$V;FQ^.%=<8D'B!5AX$FM<H
M05F8SR/D(JR24K-%MOV(;G:JPT/#Q&MTQJ4)21ND^LHI,ZL0WLC2A\UF=:;)
M7TD#)Y8:"=L@,G,>S3%R,XMNHG]A7FEN57DD)*MGE,!:Y%$\B9 DF2Y$E2HV
M:"EL$,5)_D:C)P?B(4(X*$W=3"E:EWNB/8]04X^5IO<3 KP[+:<<:.,Z\[<7
M-ML0-O,=$#9G5'_DV\N8\"L)&479X"1.=*8U-:VE#WU5NJ+'@*PSL'PK:@K+
M<XEY[&>Y++IL$2LGI9(%%_[: =34XZ6;>':\1TT])M340^DF$A%?;K) 3QH<
M$15+\-(M.:/34JN>S%$7)MV26PX;K OM9Q;B.[A$F^'_#FK]KOA_*\.7A$HC
M-96#KI@1ZW >0X>\A-6HM/%9 GQ*:CV74&&7HAVA&[5UYA9%Z;PNF+@TG[:F
M8./QA7:Y-&); KM[D^<OUD+^W $MY-S@]T^3TF,7"49W#RD%KO>Q)F"Q'CMT
M8I-GOI=I!+NA#8#N[GA\%?C8&:?6GZ#6KF+#MNIJZDR/;!F1G1. .(A(6*L3
M+&(T5I1#%WW1Z_>G91NGI=B!TW+E7#1#N6@>!AJ2/(B#SP8-V'#PHNW(7$ J
M7AX)XNL3;D(LTNFGU+G,&6[?3_C7IGZ!Y1VB>[=CE!U(W%#<X"LS^4P?)RJ9
MFRYW] ?M8R[XH!EH).VVD6Y;.B15^&^\E#D.;1-VB7^$,P#WYW$;Y['<@?-X
MG@=74<J:T46AGIQR/&,AX8HWP:6JZB+K^7HS=M$0M+4[G9'*:I'#QDFH=,Z>
MQQN,_-4Y.]683+[U=IV]BX_5AGVMIF@WD[)@^"0J^8^N!G2DB:ZLYI?]& ]S
M.;)F.G5?C^>Q[.VQPPA'QXOAP+D.Y; JG\'DI.3J<MH]T"6V'3J!6^4!@=T:
MVUP1TL!+0IT R"_J>0E3:W ?&S4E_('H+ /6D_LGRE1=Q-6N<A!X]#(&CQ-S
MP9)%L2*JH#VHFE/20:$S06T\905^+[2V(;2J'1!:O\ 9L[P7ZR8UD K@&(+D
MU3M^\:)1O6=BJH.4%AE\*V_4) [:,FSO7DXK!7-W\@D#UYELTNX&; 17N"!)
M*?FSIH(AH0\_=GSA+/8BJR:X%D#3WM7#;)GE(FQ%T+)]'FC7B52W8SN\D589
MQ]O(J]R?K8-Z!\Z6V4LZJ7N=X_7!Y[^<8K%%W*D'QR\&()-3E<51@60=I:-?
M-FA.VSL3RU'QZ>*ZU9S%D_.QH,^QH+S/O8J;_#+!3)J+PY-#)I;!NNMP,";R
M/L11R,%1G]6DQ@NJ,YT]]#B8A82%W4ZQ/--DPC/]TN8MHTE=TA7+&R[L&JXC
M?U_H8,GY>+E1H8/+T<]G5]>CRS?!]>7P_.K=Z#(8_CPZOP[.SJ^N+S^>7)]]
M.+]Z$[P?P8>G>WGV6(LA7 JQX<.<#(9Z0CS0<^,+9M&!*4#$Y"'TPZ2="J\O
M?<Q%M%0V631M>KB^DXK4!4,B@OJMA.>U5!/SWO,O(^^M)6S49'<=(,$DZ\@D
MU'S1B$&C+S(D4B+Q%L>%25-4VA/(Q<E*>:[G32WEY,"OC-/U#AH?08&G( B5
M$)#:&8YF6.V^K2K9E[H&C..WI!>:%,LV*L]PFS2YL#R&$_M"O[T&GD] @JO;
M6P9&_*34W GBX(OF4H#3\C)Y90Z%!TZGN<$^@7?37D@RAI+:[%6^&?$KF#1&
M8[K%F.[VI(:/MV#%M9RO8(@5T((S!V?[,(G(2<A)4:B[G%T#'G87,ZFQ!(M^
M+15>,\I368_%O&D^<=!P5SAN5W\(QN-*,5'RGF)EZWFE*0L[JI*Y3MPSI^=+
M)L=U[/*0I?SE)-)UX4#+0_9?%@-RXAV/B2871+1O30ZNBJ;S5)&-A44YKPLX
M&69^#Z2'I]<GEI-9"P3K6B%1JL6G=[2=]-<LQP( Z@#O"GU!K M/9FS*3#I=
M!MAH0G5PVC11XX7;CX9#9FFFN@<QSZ=[Q,DV$2?/]HB3/>+DNY_ZU1"C#_#!
MO-<JEO9/.S*^69%R38$*KX O--E&YON47L)=*0G_L GLW="\6I#Z4B>@.:;T
MLX.;0:!I/P7")C29#6;/[NMI>?DE35DOKD#')\ WHD7A(14^:++IPKR "35Y
MHL9Y_DF#3%#Y;D;Y6BY[Z0FL/W;23;=Y2%W/,\QX8SG-,XCE?QECB%P&-YG.
MMC.3TXU#:B2ON&O0E3(H)/FD#IM9=VNNL(M?KW37\I@K.&?L\0P+Y7R-ZQAN
M6G/A&0M%?P#"/]>4_HU[L!6&D"U)'_*4VDDLG.F%59 RKA91X?RH9QV2["Y/
M04OON,%M2K.)GN2(S^"6F*-2MU,TV'\C4X#UKH$><TJ&%EVIR[[GO+%:KIK(
M8S-+XD::I(?*[:%2W12-.IV3)96P*4"GP991O&)]NQ+ST3C8WJ#I;GGY(^'%
MD6)_@@EVV7"<ZA"))24I*-I.6PS&.:.)Y3$>!D/J%=PRZ,Q?'62@\MX+W)AI
M=,^\T;I3'=WI8#Q$,6KD'VS=&'1M7=R&?:JF+*M4/)\ZK\#&X)\@;'"+F\GH
MP"$XN>JZ]J$OR65&W9J26#4YJY(J19\MKEBL"ZWG@9&BCK7+M<ZIS 5M5<Y6
M%*+M)/NCSOB%M!\DFHA=E(ZSF$7?++%%SKAPNH/8(YDI^R[T$H89@BC9E.4M
MQUI!8J,XF 1I7LH=Z6S*<<Y,&!XF$?<N%SYF%W$G\XUAMM%UJ8VPPZYXJ9/M
M&W3]R]?7S W94^/H:B+=D1$++0JYM5CJ8>=C/)9"^5UWJ__:T!U[ R=O[M8!
M"HQ\DOAP61=_R:XWF2I3 &)&T!MQA+"\*)F==-%QOYFM"LIEIAJ[?^\D>:QU
MFM[SOMBP5JY;'+U+.VS[1//"2F?^2([3)"J=U)25E_R@=8_[A>Y\*'CAU[SK
M0H+3!>%4=Z.2:(WB;*&8[#K]VZ8CT_T:]IVEJ'#.'O[0A,SD>(G;8XP5WLIV
MU3\FFC#76(\"@)XE6(J*B5^P68N3(2?1 ?\:[8LGCG*&4R$A>S@\$PRKWT2H
MC'IJ,.LQS';AZ)V#UW^)2.@Z_[TQ.'>[_M_ST=GU+Z/+ /X3G%U=?1R>GXR"
MX?EI<#5\/PH^O*,OKD8G'R_/KL]&5\'EZ.)R=#4ZOQZ=!F]_AV_/KH*3T>7U
MV;NSD^'U*#C_<-G\R=GY]8?@MU_.3G[!;ZZ\[X:7H^#DP_D_L86W\,)?AO\<
M!6]'H_/_]W\W?#']\OS#-?\ZT+$]>/KC^>FHU:GAR36.#O=W& SA[U]'\-AI
M&$#_AQ<7[Z%1[,_5-;;M_.[]\+>KPV9COPY_EU=#F^_HI>^@'9S",+CZ\!Z:
MU1%&_ Y?<75U]O,Y_/O@;  31 T.W\+P3FC2#X8#6(1@!(V=7)_!P'@XET,,
M27*G?L5 Y;OV;&\\VH.W]*X/%V?GV#@\=O+AX_G5Z'T RX;M_ (#@"8/SMY!
M-_[[X^C*+ &NW:\7P_/?0:&#00RQ/[_"0\.K#^<P?;_#>T]&%]<TD]*8_  F
MY)?AM3\L6%"<1'S'F5VWJ^'9*?<?NP"S]?'\_>CJBJ85/QN]/_OY3%X \T\?
M7WR\Q)U\C9]=?H3O$-P"S^I_#QMM'^*+?X.# #-[?GIV_C-U%08S^OD#_!5V
MK3>\Z^+]Z/1GZ"@,'?;P^8@"Q@&V U/Q%J8@>'=V.H*G+W_&V3G!>:5Q?* C
M]_X#3OLE/'0.IP[?.KR$7?(S+RV]SDZT??M>R7BL]=,NK2ZZ@;YQXKHYI#(M
M%91L7K22^.3B41#"I1'I<E-Z'"+69IN >CW.[Y2I?$-VC/P&T;CWMUROO,=-
MX$1[HQX:ZP%!?4WQ*JDCJ.]6U\=4.FZ)MJXB=8K,[;X/'&PS</!\'SC8!PZ^
M^XET\)[SZIHB!FMZ@*F;,WW8M2J-GAL&G&+U,Y/][KO!!Z$4V$K:[Z)"9+JH
M""/NEOL[I9*[Z99QHGL>*OG49VT4QX441E&<C$HLZH[?MJ]O-G^_QZ?;Z!C#
M=*PD%P8P<GQIE\:4>VN<-^(UH?FZ^__;^]:GMI%MWW]%E5MU"E<I3$+>R3Y3
MFQ!FACT)Y (YJ:E;]X-LMT$36?+6 ^+]UY_UZI<D&SM <$A_F2&VW.K'ZO5>
MZS?HZ\[3[]^7^(V>B8L>Y\]J$$?^?CE.[\5;YD_9<>VXWE\*WAM\,C>"C\::
M#7U(J&<U/WG7GR.6'6&H:7^=)\*L?'',7Y&A FG4K1C>NK#$J2U0)NLV:/J*
M8UZ%GDZYV"#P\#[]#<\1;A0!',Y*5>L(!4P#3L5V3FRCVX&2.9 PT()9M_.7
M3$?%_EZ0$19WZ$C@91%M[0S0"3GFI-ZYDQ$'W"]+,6V6S/AJ\1M=H&;Q"-L]
MS))+AF/W&]&;! =0;NI,XA:X2CCD,?K!TYK=AA*'HTDXI"PYNY5[H/"T8^C;
M\"CE#[<NON^U'+0*=,:Z/@ [U_3G2<CT6_Y;]IS:=$#O'84]Q76FN@7/%V7%
M?)(AE<BI,2LN<0.2NDY&Y^B@YX1$:B!XUB3H>E+XL8$HI'!GFK-KQ:_9UU<6
MI^)ZVW]QKBK#K9F3Q8A!<<;E3<)#3*(U;Y\!*7/.+3'WVY 3*['=Z#(V)40G
M-G6X;@?P8BDE?4V&N<_Q^ISFK7."%\VHN5(ZX\)FT;@QN/@;MD/:-6!GSDF8
M03Z6Q5F93$WVSV^[)Z<F^8@"I3UR9@4?8:PCHL3<SL[@OB!Y7 D] 4<HPLCN
M=">"X[-SBQW!>4B<SZJ4^;P5>^4SQOW1N)CX*\F+^N4S?#DNDTO, *VC/=!<
MBG&::'PXXK]OVR6_2\X&&5SG?'"38XFSX![K+HY;"$R*.-$LB[@/,ZAY*,:
M!LM!)XJY!IN0AA>8(<"TS'FXUIMI 4 E4+$L_<LYGM:V<[K;6/*)G<,4@D@Q
M2-PN7" 1*5RF?5S>V]S#[OG43,*<L7[.W:BT:K_?*YQP]8Q%(HG'L $QC,ZB
M5E&Y/N5C_1)3I84!+;E>L<F;L!)AP:4@7.11W9"R8J=J58J.2]I?Q8I[U<T
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MZXT^1%GGM9T!ZVHI-_G0+:C$$\S%?I&X5O0>.53$FE>\PK9YM+!54=V*#N.
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MIKK ] PQD6@4%3/#7J >&64L"PJW^#9N\?D&W.+# J]C.<8&@2"JW](E&S&
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MTV@<C8[L#5#?%",CPT2G.@JEWV@XO36Q-DO3N-5HS.?S^GR['IEI8S1HS-+
MWVGX492HNI=Z:X<'= 6_E?0.#P*52N'.I$E4^GKM?/1V8P\C4IWZZO"@4;S:
ML>/(6QP>>/I2).G"5Z_7 FFF.MQ(H[BUW8S3?3S9P.UK8ZXVYMI+9ZW-9O/%
M?BP]3X?3#5]-TM:K^M[>\I+1TUEY+;*BM8SR9:HO%=&^8^;*#!@8%\,F49AN
M3&2@_47K^Y$.5")Z:BX&42##[VOV"EX39?3D^WT>G>C?%0B!IIVCE0M&-PNR
MESK18^WK=-&::<]3(0;\[;N]K>;V_D&#!D(/\2VZ<'TE36L<I;/]ZVJY3=Z'
M$2-55^F&]/44Q$G#%;D$_=_<LF]HQO'*C);&)F[QQ[GB!1I'OH>QSM4,.L#C
MS?K6YD%C;$5^<)9=.)TR#\3S47O4%C_WNN^.1T/1[OSCO#OLCKK]GNCT!V?U
M)R+$V:!_VAT.^X,/HM<?.277-[V#?8PG$,S'ZS6Z0NXMQ[XJ!H\CXRFSX4:^
M+^-$M8HW57EV061FN2##=7$'(JTZ,TVTZLHW'3,U^.^5;J1,JEWIYUJ",^?#
M][;KVSLOJ@Z8$RZ<\6L[^+556#O\ZZMFL]9L-E?<._7N)<WF;GWWU:.2YJ<L
M5&*[61.4B6Z(U*!5:K"-%#'L3^;PGO'UP?WTURQ)]61A+^D0$Z>M[=WXSI!Y
MIZ+?]@?BE_;)N2,&3L?I_N(<U<211,;].20/243;_2W3-O2+3F3B>DU(<80<
M,)=&"1=7(B/I;DVLSY11.A0P,1]@(ITI03K9:NYWH@ P9,&?-O=?U@2-'"]$
M;*) )U!&&HE8+NC%>2N.LS0E>EA8S(QYHXEXHT)W!B$O1#>\5$E*4">IB9.3
MSAW3'B,>*;.<E6[%1H>NCJ4ODBP@RA/D,C'+0L_PPU&6R- #G$*,,8E8+_SJ
M91U4-W>;^]V0Z;@R4?0XT)6Z)-R%]YZ:R,Q/:2*=B#!*$<)FX$J,D56%IA +
MUH7$/P&E\?.;6_57+T2L#"B%X"@+4TV\N;,;= 6(NAG8+%@9K<@C@RBSXWGZ
M'DU/HD#Q0KJNR2!?R4/!%ZF=8^UZ16^G,LT,;)LL017J$S(1$V@EFB<ML:Y?
MBK_N;=>VMQ$(MX$;A9+@&'/WW30:0YI-Z[LU\'&I@I4K1\J]=N4G&6;2+(H+
M^\SWNJY.LE.=Y*T:F\H#.S5^X%0:W,XOU9^6'Y[)!9LT>P:,$=HIERB0GB*C
M8:.(?>DJ6@M:KQD;.#\#K=@'/)6 0[(N>!,-8FIT37DU&("88VD1V_D]W'B2
M^2*(0K6PEJ/$>:BI%ABFH)'0Q78 =;BRL+HV["FV[(KY3(.GL7(C4J67*5HE
M*89D0)Y<U,00L\.Q(R-\-861@F--%V[87V3=*H1"Q3A+=*@2$)2+)[:.H]+U
M6,(:>TH60SI/N8@H'"H%0A\):^,3*8=M768I^.<4[2_L0_!;Y:O\J3@S228Q
M.186M#($H/7Q2R@1/EG+%T'H(%">QM*!!*T'.4:A8R9)$T<NXHA!2,U#6+GV
MUL%A'2*)E:LG&H; 82BIQ*'6G[XD/VS=?TD\G<!'%BT=^C"BC;$?N1=5^@0%
M5X@O02"O_&TK_$?$*L$Q$VJ%D0FDOP*7\TMKA^OR9:E2^W*GC77M6N5)M73[
M/$>$U?4L+2 +W32#_\5%G,D'W)T^YC,5VAQBXTTB@V5*8W.[9F(U>@0C#<6K
MH$@C,/#Q8L66]W'MV8H>V(K&7VY%6-. PX(4EY$/>Z D:Z$.XA0O+#";JY3'
M,4*I"WKU-3"BEZ- I"(SE:'^W0:M\CFC?*TFMBT%"(+PPH%,IXGR)S0,[V#%
M8_RV^8^X&LOPPF1QZBXH7261CUCD+I9$$PV5 ELACP%OS>D&)4,Y <PA5U"3
M"<V#RP6O)+.,XPA(*,CAE12I@;DH1<R["GC0U$J9(KQW<3="4 UO3AQ-)MK5
M<!_0T3P1*S,;)RDBM6:/,ZF]FY#N@/12"!.94N-AHFQ,MT^ZLT)5&).G\&L,
MTPW)TN!#'"5 T$F>5DH:)6,<$/#['NM9K#[\?2JA;D23M,)J("_(,*8JA!<C
M8"0$*IBG"7$$/L>X-=',HPN<JJ&]I$(@90+@L"@;\,EE*R'I,X!O P-=S4=&
M32'Z=-^J]GYRE.#BID K)O\@YOM_9[H4[MG$/F,MC J@?]*.3E#Q)=1K-OB(
MJ19X3_8CJ0C2D4<3[C:M7[@9=1H)!B9/# <>5=#>2DH=*]+*72AM%1P&A)Y#
M#"L* =PF!)\B,Z/"U&Z)\PNSMD"S,)@LC*7V8(V^S.'>I],^"(XYM5<+S8*\
MG!I%%?N,RUAO5<X"A5QJ*6C)?3%!B5^5YV910E#A/^7/WXLW=3AOS?J;A#7$
MW!VHCK$#P#,!B]AV#%<U4[ _)&NM<EH&"$\I+(28PLK"N^"Q+<67F)C:#4L$
M+L>H<:_U!\KB72[; C2INHI52"T/6G(W2N!:6 J:SJ.ES;5$]*,P5#8ZLA)4
M""]!X:R*U5++$I\ZHOG8G.%?,V]JAX;E4(I#KI^Q6R+0)%'(.I,I(@7JOX0J
M_<T?]L4$ZUNK5FC:*XPR-X(GYHS+HHR\B40RZA:IN#A&@<J!#.\Y_)&5XU8*
MYNFR-6?Z0(9,K[0X498B>H72MV 7Y .=!57OB<80C8VOA-ZE0X5>U4$2Q?D4
M*Y[WM8J%>'B=7]/GWKW4^2!;2]S]QWL4O(]^>\S^GIER.T*Z%U.#J.G1ED1D
M6M\U^6>_(N'JC7QC@LH/KB;RS\W;%%'=&;$[C?F5ZN;C]<W%6$Y1H\"G+S88
M/[2D/T?.+#8K]NI;.R_V\VT4>ZUY8[OR>1/T?[H)^C5]\:M%Z#\:D,>(ZI2%
MRHP+/.FBB$&YD+<;"!IPI.26K^U\2H:?18,!<199WMZJ/$Y(,G^:-BB *0."
M!&6LAW<$2=XQ?7)I;)DT)K;JH-*9%$8(_2,ZS+=:YA+F2C!>4;E)T* &8 *1
MO%J.EFH$VU/>H*#'D7,LF+>C+%$[,KD-GW"["4422A J$BPF"YFL,A-J4C">
M,@ R'GBL )D\.=O*H@HOT]5F:@6P(?G.Y"6A:> VAL4,*//BI!C,NQV0F):?
M;DP!TTQH;<&HB;(0+XWLSA *L3(W<_.;/M#*?XC,Q6U(^.XUR/4.O >5)[[-
M\QHX[S)R@;NN 6FNO&P55BF> .,3>O4TJKO4TF@P."FO5)O"7%(QR";%G?'F
M&GA97-/A&,D+,5R@)J7Z@QH$P'P>%_54;K+L;I0!_?C@-;5XER&+)@_L4,5@
MY?FHGMXL6!_JBFLXV(CUN'P/#IZLE541];*Q+"&)<%U#J$7AO$7)0(@,-0-0
M:P!X"\UXVEW65ZH4@4U@*4/R^4(L#7&Y.KPJ25+T5SGLY,V+'%0B(%QB%MNW
M+UL80<$T]?1M(]2E?7@N([A"BJBY,-4)[<SEEXJX& C;6-$(:E-V62@L,Z$M
M]A$VC/HM@\?2SD[IA-RDG618:RX86)B\F2#!_Z3*4)5GG@_B%5JH?8'Q?]SJ
M.0[9)I O-0N(^HA*HJHG0+DK2WPK6\)NLG)Y&,*$=-Z*R@+;4"@HW72L)Q;X
MG2L*IK1Z%;V2>7J5_;S5O@$%=8Q&+5SLH'.Q0GHI]NY68V^N,&J2P3)X0.&R
M-O C(Z2JV.J'B86>I6+LDIJB\H26E]OVUR,X<!,*3T5[^PF=Z9OB;1!YT%:-
MSOB%4\X0TEHK!V4M+<"Y7C55 AW1?V(KVO;]0J B^E')G>HX\VV56%L>CBBC
MD=VY*;I 4!0=<Y(Z+&);H6MJ!2OH>U+,4>VVY&E WW#:);1*HL+0;)\.3O;$
M]-N+Q 2!-#/EQG+1RUQM12$_&5<GJC1R(!C)*3&_PQOE9&]<]ERWNER9U!GE
M9C;6JO"&M/">L&Q_<T "0=M@X"0H_9(%8LYV_^W!&^B?FC5Y.[R O!-D-'I;
M/I7/DR>*%6K+!YGDXUO"SSA3.#IV1*=_>M;N?1#MSL^]_OL3Y^B=,Q2CX_9(
MT-W1H-T;MCM\6K+_5KP_[G:.<:,[Y$.( J]M<=8>C.P[T#IU!IUN^Z3Z8$VT
M>T=BU&>"SC]'3F\DVB<G_??.D7B#B<_.3KJ=]IL31YRTW]?$L3-P</E]N_L+
M..F.AF) )S>) .;L=APF=^RT!]W>._&^.SH6 V=XYG1X"(ER-G!^.C]Z=TH3
M#9Q3Y^A#R;@CCOLG1\Y ] =,>GC>Z3ATJG)(5]K#8?==;RA.VQ_$D3/L#APB
M>3YTON(AT0?WTBX?:;+8CHYK5L#<1YIC%B+XE7ULZIXOS\S,M86X:7Z@G7&
MZQ+68SQ-U.05@6:4\A1:"=#1SHWR^,#)M=ESY&DG+U"0DQ]"NH/- MI'2'AQ
M9(JC.[?S7&R>E4R1Z_)NV96MM"1"/FHM#O<)X40Z>$-H+]^%P04/LE(^!2+%
M*MJ]J\?G[Y_:CV:5HS[/P=K'8<28].=3UKL$-W2LR;?'B[@"RCOE]CP":98'
MY1AB6=?:3@#OO!1S):L]5TT;"0CH#.\M*+$'#*FR^[KJO7$@F_2G[XJ7]H"
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M+*YUK2?V6]"']&^YDCQHB<Z&Q#F-;7.X3Z"S<^$QARE4+>XU3 ?V+'P$#5U
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M,WY9KFJE&'HJ*-3N2%?=X<BV5D U%;F3C0?/S,8VAF3\.="6R26N1I%30-W
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MOO,\XXQ\ZY5G,_FZC_C[0P[_!U!+ P04    " !RD^-6&\S?B;N]#0 PVI
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M^!=/$%B<)&] 77R7NOB9J4LJ1I.?X>T2NA"K?3I3-!*MW.QBU%VJLR[=&T\
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M@#5/V\9U0+U6-+/:;,I3:(7I%JNI,<Y'UBT[,-!G+A\>Z7WP=D^\[AZ4V+%
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M.DNP)MLIXQ.VV)+[>N.>/?N;ZLTH (;<M;-DJ+2VS@@G TN$#6_5V>:'K.T
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MCVH5AW-]9ZI-5[6_SZ_\! /"*&&8_H4^<[C^)W1N08Q6';#R5(/6ZD;HPFU
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M<+?+!Y5B\HN*R:U7*";/YI(E@X1$)Z+,.@KX,\/L!VIY2R4'\7]%=Q27H_T
MXYGA-;0].Z%N+)UHDA0G3<?=DD0J+5;XBTL@ICM04_40$5T#^\*7XRFQ@A]N
M9^I3-U]#':"6L[[X3I<;R.O(5%C&WHG[0Q6*JU=6J$ZZ%LX\I43H.CO+:H30
M4\Z1V+#XO$G<9(G<6/:VJ&%J).OK J:Y762QZ=($_0]8*Y1P]MGV^NGB:E,[
MU;GI"E.LG5BV;*29YT_?U<VDHNEV;?GYT0+L(';5[QIVS/%L$^+OS$;F>DG?
M[ :PT4;F6_AW8R,QUN08(G8&MN*=9$E>R5;6;.#!J-AC4S8.L[4SL@?_M;]S
M5]0'>I3-HB98[,S/%4)E-7*C)6BZ(RA^YG-OF)"^7KQ2V>?8V2F;,^8TD,KM
M>FUA7TAV;X\CSGZN5JA:SI3+UF BZ&/!>!^7'T_6^ZO-KTCVR9-E@J@[&8*3
ME5?F;+:?_1(;7K8R6F[K^D210R-GG=0I7:8(RP.FJJ0O7571Z)6=F$PW_G9E
M7U4 <(!Z1Z0]4,: )XOTK0W8K&NKCMRS3=3-ONER,2*90/8.E(-0@TY7M P4
M^9RBF"$;.T$X,VK:?R]!VMRLN;?YC3M51;Y[VQF310<S;FK5[ [K<X>2TX%>
MZV+[U#'0&-5"Q:,6*K/!!D/1X70J^4GO,;DWK'4RG7J.&XH;<+'$GJB="!L&
M:1/4:0U'([@I,2+>G,P98G<86>9RY?&9MP%185+UBL_O\$IW0N<&ZKF7/+RL
M((V,7JF!$XJ#YC_LB9*:J;)+X@1DJ4E5*W*9#JQ;*@5)333CYL9H'2'!(/:U
MS<LR-MUP%!LM<=606JDB))R42YO6P\A>V>B[XJ9_#]$J]-X(<! 6%8U3HDCC
M=.EJ;E*]%*4T$D4V\ <**H%A\ "TT8:2B.*&LK(KM>Q%O7SZM6YC'7?5M,EM
M_&@4$\6FV=@*$^BX@]E:?:Y"*(W>E<G&KG'78&GM\GR+?;$CV"3[C(#=&=P[
M@0?8]9OO15.L=H+8?=!N-M^PP]KAVWK]Z @G!I#EV+\"?S6*DOY_8QIK!$-A
MO=(Y,+D3!I8.G$@^ 9;%= 8 ET">'/?>D5!OUHDU/U 8Z[BZ4BUV8[;#RIQ9
M)O:C'-"H+BNHAR#-BSE%'G_(7-Q*=6AI49'N.]SW7-D/G9V=JK[!U<;Q$?S_
M?P-JJSNM$J"F>L#,69RE>_)BTW=91U8@MVAN:PF;;]S6-K>G;49+7EJ8K)0I
MJOE*U"'<2[?HCDD_V8KQR)AY3L31877TL]&J5G3'#O1=&+BJD#W1=Y9*-#NB
M=&>?&@,S*E M^M@BD1DZ_H1PDOK;X@E-HB#4/7'-/M_J-617(UQ0QB(6RNL[
M@;ISFCNGNBKCI4@0Q1!)<?)XBMX#YH0:/9>GJ"8N@=](F+U0@T\,F-:*D*F*
M"N<V7<Z$F/RFR\@;?1H56"2=/SX*'#A=T$TDF E0"D94.I0JE*9@*=4P&0\[
MB-FE[&H4'V>/NQR$04$MX6QI"<A_N3]^5"VO-;\+L(LT5F)%M@O$Q.?)IM+D
M4I;IOR0$B_,5#AI@D$"YXPM7#9VEF-V5G'O6!+N$87.^O4W\/F-.G&-NL'0>
M\WSK"N[+06__@$\YX4^<#T8JNY!*"/5[/+:;T]VB2(D24=)7%5//.6VEEZLH
M5F$7LIN9[2XXHB7W:VD!"]^-O6(R/40H4_80B1]YIK6[#D%:9I3,3VR7D#17
M=4/)6NTYP5/-=N#8XYZZ>[(#616)<$;(L CC^&*?"[J=JE'_1DI3@@#,8\S$
M]].<7*B1KJ4D/_2>,.3#8]2X03(4NHT)Y?K\YUS1BQ[RO,7'<('40L5YH\($
MU!5D[+&Q D& U(WEA;DGKE?>H;J4\6/R-N:<>%[G=Y-[ECW!M]T3O&R_O60<
M4J:XM8WVVR_;F_F171!O5#G",YF%5N&ZN.YM6]^R\?D&&Y^7[>N+LYFR??T>
MWM"+;FQ7&M._CMM8OC%\T3O"%[;7^Z+&D2LL]>47MI(,79"++1MYEYDX929.
MT3-Q9"/O?O\((.>(W_:.>>_VL#\XNCWF@_JMS?O-7M.V&]7CP4]B5O&%V-'+
M-/9^6F_<SL<OU*KXY.+\IGM^<ZT[U^ZO+>T8H+NU;^:TQ [;E49]1S?X1%E4
MWF5,G]__K=_G?#A\=E$N ;2M2CWE:GTK'B59L*9P7SM7OW=O.N>G9^>GWZYO
MKO[$YMNWC5J]7CU:C?2)$1D,R=28# >=H8!/A:(M'*U!W8@")$^QMK+BLA#Q
M"P 9U]^^PE7^>=.]^GK]N=N]N3ULU>OM^FI (0=C.!JCX=8&A^W>?7W=N]\U
M0O'IJOO/;\"7O_SY[;I[2E!QVSAJM=JMU2 B'H_A@ 09U_M'(X[VFD; #5[?
MG%V<7P.U[YQ?_]&]NNY\O/AV<_.Y>WEU<7EQW?ER?7O86!%$].C$3.3XC"9@
M, /34^PX+:E57QLQD>S@XI, E'__>7W3N>E^!7( _[J^[)[<?+N^/3XZ7(_9
M@#(AP>3??S(]P[MXBOTC-_7]IC<GG6]($.!RSR^ 871_ZUR!X/K;IXNK/^"O
M+Q<7O\._X*97@YMX=(;#,ST^DQ.\E3/$P+3KI.=P;1EVYTA/]PO@?O?TT]EY
MY_SDK/,%>,L%D(DKU%$N/N%_?S\_^^WSBJ1'CL[T\,2[: +2@I HT?_2)!N
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M:8\&AVXWK$:C46DT1 FZBW[H8<0]K4@I+R*>'AX=?E#)S[#G>JMEM5IMD "
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M>.#U(Q$_16TD?*'IR#[#?W_G/+<I,(/%#9P E.#']XY++6%[V'\\ 8T&Q]J
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M*)%T.?(..K>OS5;)%01K+\&DYS*X>0D*Z[AB220Y4XI+'Q>HHN@4_3..2EC
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M&1U3"].(:$H\NO2=>_SL4@M$^C4E WF1K^4@UK7[(YP#'YIK> #XXK$PY6A
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MDX:"%5H*X%%K1=>C -RB.D_N&M1'MNNP34W]Z!UT.F2RGV;2GW0(2TG-3C"
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MT1D'YLY%OFC_B!XP6C/J43<@.[M22="^?I^R8T'50"'67<:  .0?4!_N")[
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M%MV*0GJ5.^*KR#*1+,XCL0J <8DGR_!;K,+A7YR=N[23%4+P.9G^_HD+++K
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M0]7M1M67KX58T#3;XX,EV(P.J]<3JU>? <_G&#P[\4_/G)Z\W'D!ZX+4]\T
M6 ^<;E63MRI%YC*+;D4AO<K3\55DF4@6Y^Q8!<"X=!E-%L;;L:&7ZQ)@MCP!
M9K^S?^*PVX4M-S1L>0B6I6/?#L&W.D<%D:![L.CN$JL *$<,CML[;N^23K8D
MZ:2NK&]N'HGVJ7C]-/."-(%CY5&:>&G?NTNS;[":%XA15(C8BU.1;(9S=7OR
M3+K'^YPTNPG7YG)'MCMW9#G*]1;BM M>/@M2&WQUB+K-B+H9N2..^3J<7B?F
M>^8?.;W7Y8*L>"[((MP,J^!8>83GX3HM1/S35UI$AMXYG%3<R(WU*&YU;L>1
MWWUU[!\?+XPAK\+Q7YQ'N^R.%4+QL\Z)R^YP\;Z-C?>=^(>'77__Q+%PA^0;
MFN%Q[)^=GG)YC$-QA^*;R<?W_:.3KG_:=4CN<C<V-'?CM'/0=*K\5(A>+!>U
MMR>CVZ*WH0_O=<^4;\4+12%][ZTHA/=?"<(K)P_^Z1LO[?>C0&:Y)Y+0"Z-,
M!D6J_BH&TKL:I4F>9MY W$HO20LO2@(<-Q_"$V,O+8N]M+\W2H-OLO#D]Y%,
M<MAT7O;^@'6\(O4R&0U[999SS4YO7-M#Q[NNO2+T1IF\C=(RC\?PRS]+F:,S
MJ!B(@C9SD0Y'^%JX>ZGVAP?#90%E@T'MH8'(<0,!+%X.<:R>)[Q>F0,BY3E\
M.NQ%B2@PN04>>B][62FRL=?M^M[!_L&A3P"($OQY D>AYP8RDW=1,? "4>8$
M 4_<W&3R!A=/^]Z/75]E6'@[F82CY'!FS)GY<;_3W?=&,O-&92^. B_'1K^[
M^.8>'$&.TCS"@T8)?&*=0=T1G",K\\(300!$5WBPE_/R!C]1VSWP<2D%E;P$
M0!!8X+-/Z:T<]N#%U9-XL&D'.#S!#H-GG:.CEA,<'K<?H>V]$P#M>+]3BV,\
M72&S88[OBXK<NX!UX ._=G<![&SJ)4?%_'<+/RI'^&@>??>0,>&G(@80RKTA
MT,\ CQ2E8>Y[@('\:!VV@ H6.M-O8H6!E!HU$F-$;3H/0&G_B*$$E)$7 &H$
M'H$*OV^[VHM8P)[/\7-8W+LJ@)9H,V(TRM+O-! 27OAC%^[NU<&^WX(TM.XU
MH<BY0I$ZYA+2XD/RN\R"**?-2 &PG#A/9RD<Z9&,D=BT_HUJ>!ZD<2Q&N7RM
M_Z$ZH;_>QY?,=)>3S"C2T0S1?;8L <:P,.W:*_\W;DB_:E:/]/_=F=9P?S7W
M^Q69]@"0&/#*B_K>!R^7<>P-QTP.1"^$^^P*KQ, 8'@_!9IA"22#"$CVHY3(
MBOY72Y]X+<\=OE3P/U\]?$%A_T4& '[4 J07Y<"$LC@BL2"2BM4K5MFX^8[W
MH>^-TQ*DH4CR/OP*_LAL=+(Q2/0+)6ZL5_H@)8H9R.5[91*C#"$QI5XC84.]
M0D2 Q_TL'=(6A(?,>8S,^#9%D3=(@:OR5GQZXBX";,\D_H[W26JJ^8'2:":.
M^%MZ)V]1')HU4.D"AD^HC8),RF^P;BB'HT*EYMI@Z$F2[?;/O3A-;@ 6UB*A
MC*-;!L^0<WU%$@!YLM L02&K9*MZ">[V%RUB+RH1>_^M()%/#M28@FC>Y15<
M8/@_K1@9R8,&?QB!T,X\I2W5+M@<7&FL#;C;%S7E$E#X(H !-+6G$4YT[UZ&
M.NPHS6S8P.=@"H6Y-Y Q"66$0DTH=Z9PK9_"Z/;GO\%_-'R"&,@";;%!@ZP.
MD8ZTNV'_KXNCWJG#.PZ.+'."J;A[QN>@7=-__X>]^<HX1-:;9J_U0!+K5,J0
M.R#F>2/W>ID4W_:(8E^+^$Z,<W7*L[/.@9ES^=H,-4$X>,>=L[._>M4_$1H3
MH!R*[WL6P&J!:?Z5_HC01'^&JA7<[>M,(DG<2ER[MJKA; ?=SLF2+J5AT!U6
M5_ WX0TRV?_W'_YR_?FBH5KQ(OAO$%794,2UB37J(^#%Q J(:<)]4QL%I7>)
MGZW[G8:5=:BV@<O)XDW2W5AFW: 0+*:* N\R2P$71.QTM+75T2[++"]%0@+3
M=M4\3H"3C:LX2V7I1].U"8-"J!RBYD-6\"WY*L+:AKPPE?Q(BHZ9.[1J;7]
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M.^@*;8LB!I4EQMVAKF':RK'UCW4SC> UV42*%H DN5,.@1:@%H)-3B&+!LW
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M@>X$^FQ&=07WJB9[AD)+YXBL&I7\VRR$UB@H$H.%',W5OGA['";6%U#YA-)
MD;U4+%#G#>!7JZD*O/_\916D">43&+ I;F^9G%;^ :?S$,NPIZ.7IK48L,\@
MDWJ.J;F51$?XAV@"4GLR-,0M:Q7[7&,)C&Q3 =U0[8WUINK1-ZAVW*3DCDIG
M^ E\[6[YT"["T$TAA<O_75^W[#\D]<EG8P+=2*".);.10F5;^? H%?11X+C%
MJVF"I554V3>.IYH7ZSD=J Y--Y&I 5MJ^I;1(8['F$N!J*=6U9<W"LG$8O7G
M:L[SQ;VY>_^;6?D"&-@^6]O7+4H K2C4J NBOPIB:&@.76AM?7GX(F8 _&X*
M)FC.\Y/7 QOB5F183^RQLT1Y27#\%_V1RZ#$''A))> #D=Q('C(T(V03B 05
MEPGYT?2LH8^E4HTQ(U8KPF6"I6HLZ%1 9E:H96JJ4)4*I28\!S(L<2LF_J2&
M;]T7AFHD*_=D',E;F3?"D#.M!"MEFS.I9-@" >6BRECKG]C3O&!&:Y$^L\"F
MAASQT7C1R8%2F(T^&;Y*@!VI^-4<]U%+\C)CJ*RSM,;(6BZ1YZ/3&ZQ7.]U@
M\W2#CV*\*%G,W.T>4?S!8UZ&\I7C=)A)IB?UX/P^H$Z4O>RKJ=17)W_75OZ2
M#?4/E52BKI\8$"$ 2 "<>,<>>ZJ W MYP,4$#C3+LQ?1^$>B#" !H#H5J,&)
M:OPAETOJ$9%<Y3/-7;C0[9C)IE,LS!GV)S#T$<@])7PKP4"E,7@'F;P%:<!W
MP-"M70((MRB0G'QRFRJGYQ)!KWN;Z$EY+PY?)^@V3]!1!,IXZ\*4(U"ZH<B0
M7;TBH;&%6+R&"CIGEF#M8@;8X>98K[$(4M+G0?=M5V8,R[B(1C$:$:-(JM9*
M]]<]F)]50HRJB%OJ$^@[+C"4WP5Z^Z;710"'KY^@*H\0NO&5F7^ISRRJ ;13
M7E_5<TZL1S79Q*7-AE2#%YUQ*=H35Q$*S=S&^HSK^DFJ0=>US=<?JJ#9\2[9
MRZH+8%EM\%7Q>15;IF-9JH02C:U@,..@]=NQB7X6LOT4X'#32GV9R%J)XT;&
MHI,FFRA-4L9/5;W,;@X>'DXS%A 'U'>(8BK2_'0)LL!C[T^>^O$]KI^>;&(#
M>!&HC5)HI=I:3^8-WH\P)LNIJ:'6W6+8>T(F-P)+%?\NRDS&WF_X@O/P-J*1
M,;]F*;:)_/O?+[2R?8=LN,\L#7[][*."%I;$\,"<)0L\#\IV6!06//]0I@6E
M9CSN]8Q>>92;)A9VOP=$^H=C^N8,9SETY9FN/'/UAK-LMF;PTPKI!%5KK!$Z
MXK=H7)^MIF GUZ#,,0;/@\<P=Z:D[JZ],LNYDVFGI? BD]&0GJAI/2A)3']A
MB>V7]M+^WB@-OH&=;T;1F*QPS*0>)E%_[-5T@RVZ"VY@E6/_B"B.!";?BQN!
M9G$U-($ZSOH>?-W#48@1#8=+\QS_?RB&XD8VQLJUW1=YH*M+PXAHKD.B=@=;
M0H8P$MCY605(^>M^%):@'62<M:O"OJ@O5^6'6'RHNMOJ*.JLVMFJS90UI @_
MO5.#!BREW'B&N'U9RQMK[NKG5_0J3_?S*WHUJ'('=%4\B:";=+68,9S4SIX@
MV-EF^'',/<T Y5.@PT!3!$XX3,=( .C ) K23@>M.F,S$QG+T2!-N,=\7P1Y
M!-OEOS"J:CJC?$"=-)$T(\($BBB1>ERKN*'T0,R41@&I$U2H=S:KZI.VZA-'
M*RU:TVL5Y_0@*.)O<'0N,;+QZT$4AC)1&+!_6&_3M68&Q9$S*)Q!X?J];+CG
M&7/%!C(> 7_.[[",9>S]6<J<I*H+4JYMD%*W+L%,*'.?.#.D+!KYCMRC%A^F
M?H.6B)X_/*G<;6V5 E8?$>ID%Q2OG[T8]O!D-#%6Y#SXLXR8GP%OS$:=O_6R
MGW[^/0%5Z-<3WWN?8=V6J42^%-DWW_LHL.OOEU2$]# ]XWOX&SCS?\$]A^G0
M]WXY[W:]H_>?Z)GSHDA>>[^(#(S1<\S[!0V)OKC62I;W*>V\]O:[W;VC(P]T
M!N_L\- [ DE*C[W;0XWK-9@WL,)_A'"";WP $93?.D$Z7-Y,C/UJ)(8.>9/&
MJ*[1JS)^E/Y&F42OGV5#-5&HD)^$_?[\^MC2]JC0[9[@R;/LX0!6Z/7 4O+^
M+E"?ORH!5]E!<+#??98M_"<\'PQ2W_OT#Z_;/3T^?):W[IP='^]Z1]VCO8.#
MDY,E#XY1[WS'I&H1Z7_$A ,#0('ETJH]O^8Z-<VW88EX[(4RQE;V8W]&]VW*
ME\-A/SC4#'EYY9^H#Y/H8P[#SO$N(Y&>)\%_A:#1SY$,MW0(U-B5;KI4R;5:
M20%)Q!I<R)40ID')#?#[E$9LZA&NWEV055R;G5%S141FXH;=@EM'*6?VB_Y*
MTX5P^Q< ZO<1F.P?,5GE0[5C:AQM G'3H+F XOE6R#ZI'%OI)%S;CAB22_G-
MGD*G<UT:T^I, H]NB(SII9C@*['0!-![J"826$M183[CO<J?(5_2CFKE/QJ,
M<U6AA6E*,=Q5EB;\R>ZTR4W7.)>R3PW%L=)R9E;ME&H6JWHEE 5GJ%?S4[2B
MYLWLO?Y @JECF&GQ: 8?#,<VW'C:W_]ZT!R0MKM6&.JUZZ'UT:OH%\:!J:*&
M!-K:Q O2'*S*AN*A$".=KZ45R^>3[FA/ ^M+</ B^RDU>JAA+&(X>J-F4.CA
M& O9U\G,;4UQ4W79*O@,ZN85*O#P7RJ@O(S%OX3O'>X;5V4YFOSU4><8?DY=
M8Y1+A_P!VMIHFG)@Q?WP<S& )<O1/1MB6+V/TS1[SLN#-?C-_TA1KZ_]B1-*
M]X_VNL<G,_2C1?+7F;?WH!YC:&I<79Y?>%^J<9?W@G45CZ*MGD4T 4%7@C7^
M\S^"BG")B[!BMFC<F^IIK4G5%M?R"QDOK3=6"Y:OQKX>N@W=]"H!2_N!:0TV
MOYLW'/  \W/=P@'':Q4.J#P"1YU7?]4 9>>_^F1ZQ&"_\VHB8J ^NR=BL*GQ
M@7L#+A-P42YA[:0<?2<O4>AIO%#?$[RG?LN@G_HU!?XFOE3PZIYBQ,;#RR:X
MT:UK?RSA-]ZH9_[5N,D'AD&$%X7__L,_]\\.3X*P>_S/H[/3DW\>'?=._GEV
MVA?_[,.'1[W34WE\%/S P.5?7/W^\>/YEW]\?G_]V[O++Y___W]<79]?O_OX
M[M,U_'5U^>[B^O>K?[XZ.5(_>@'A-,OQK7;O?7[OP?X].H!G3O!3=03C'U_@
M 5370K),I^__&EW7>3FD=* !;#Y6W@\R^JAJY &S5MBN3"6/YU./ZSJ-9KL"
M*OU0\P"CX2C-"I$4JEE!K;R^,0Z&7HRY*)ELOK\YX.6<![S0MM#>)#L#O^Q'
M"5B>:)&:WTXFK]1&GM$</=X 6:0TYT\;K2-RZ[<VYMP1$R-!=W7#,]U/.6G$
M'/1,6]-#H;W#<NO:IDJG.>O,#/=>I*M%V[$]"?B5J,.@]/(.#D^FA486Z>9Z
M *K_S@TW*.WI#DU[#,^ 84US!;&^A 8V@J&&;7!50"@'TI#>3K1+O4RM88@3
M/@$]YD89L\HI F=G9XWM37RCQ]33JH2QN3+M,0ND2J5J&_7H1; GDDHTF;TY
MI+%M"W=Z6#9&(*H7,);A<AB2*C-8-C%S!][]68*&!M>-'!!]FI?8C$M0+DO=
MN:=']\T8O+=LO^8<K'AF<.OEV&]M6Q%V0>[%V (E&$BX:L6P$$5@EVDF5%]>
MX;T%V7I'Z*J^(/P!0I6]K 16SO;Z&<V=Z/K-!K[4OY<:\W(5^I & ?J* G0/
M'!_17P)/KZ"E'X%UX!F<$IO)-+L12?0OH9U1E TELFJ6<E";G54,J*P0&STA
M/]%/2<).XE%1,Z%1.QC+)"IR']=#:LA-]IO!;]Q:D8E0\:%/(@_%G_8 9AK/
MD6L.^/:_WE[\[FL69GUXKC_#U:W/OYJ'514B$$8\7@'L5I,<K\K>RZ%RM0=&
MY#O@=O%X#],-0QRF"[(L$NRCM"^7D',H:6[9^2B+8A5^.R#</?#U7#9440HY
MG<5XJH>\PFML,AX-JT&P=295H"]2J( $JBF8^:>G$;?.2=[!3[7DG'459H!E
M3PO'7=\:G,KMT7!UI@7.WH0S5N#S^9OJ-WF9W4:WFM^J!\6#8,R%:$"\W)XI
MDUC[:W#;O,K@?6$/XUP!!*^ <5$QO)?#=6LR-5[#"#8CJ2TQ7"WV+HY!H44E
M"+FEGG&BV:I7R&"0I'%Z0XRN6DJU?L+\?.;TK6LQ=C"1C,$&XV;LWT=P)(FQ
M%%)UN1A^S[0[ZZ=I ;155Y#Y?1JMS*Z4?AN/]3?M1P(8WD:!*B:S-'RE[W O
MLN@6:7:0YB-4+"GV]P'-PB2T#XXPI%'":5#FTDPP!+4_]N[2+*8>TL+;^?+U
M[:ZJ,S??2 09GAN^?;=+>^3T\>R;1#.F'*%A0:.%XRB!C14FJQQ4N#)0; *'
M?--/Z#@)X$P!+RE4-<1[+:TF0Z.6?=!0N/,'A38MO=H[KZ]LZ]F60)J]WD>1
MP&WA_HT:^#;* ;ZY#O^= V*,\XCPY[TQA\Q$7GKF"\W$ID<^ X8IK1C_LC?W
M O'65I;QE([<V-WZT_6Y,<)F\Y8GG><!?.9)GOWK9G.^IGU+LJCJGS[2C<#9
M<<,-F:E/DQDAH0T,GBTQMZG9!&Z%,$N.:<TK7NX=T/V2HJ:F%AUKM6BF0>-/
M,Q%VYE%AZI4AMAY#WC"I-!; S$H_0FY!)B*@B-)0YE:9FLI6_9T];A@I0.>_
M:6@U-1A8"A3#"FS7SE1 D-TPG_8T']#J*GBU_?J.J2N M:48C"44];K6:ZQM
M/A347*PG1B+ +T#ANU1F5P:,615DD8=UOAU>C8!Y8R"Y73.U%*NGH8\E&^PW
M78H2Q OLGL^&?B'[;%<RCB<.]D*>HLN&,Z2)H'Y#09[E^_ MQ)RN_5MJ1$/Y
MYWAL25HD]V*MS(':U<Q+;5?FYPU56E]59W9@XX5"1U; X<5C?2?/%^M[M=\Y
MF!+JH]"-^9<+]+E WPH$^IYU9->DX3-=,%^H:(IB=TM):)E/NISG)K3#K%M[
M9S\J-RS^V]+9+4=0U:@<2XBT [+RZQC%F\Q;;JA&^;IU+42EX(J;&\PTQ$9N
MPDO*88^[R=6SH*M7*HE5_<R[%7$)+_VS%#0,]*$*7^-**@GD[0B50'U]EWJ_
M 2=%I?,C"$\$U^^=JX[W%DNH #X[/Q[L[_O[_'^[WA!$)7S84S]GZX6:ZG&L
MK%]%+R?%^BYU 23E"Y1.=IGA<]=PE0!]O(&O:?:-1*<@CX9W/O_BZ "2,F09
M/FNM'AC_&#ZE:!4EE?]+9BEL3ATNF#P<Q8I8%<&5/P >]D"M)%UDKKVII</6
MI3$$H7YB.4ZK(GZZ]R+%,Y"SA4-9UHMJ%ZT7'HDQ\5S5R*_"\BO;9IV2*#SA
MG]4^)&JTE3$%8 @3?\\@GTLWLF:,W8>D+Z2;7D\#*\7Q>W_HWHCA'V5>L&G6
M+U3\0^-(3R@W&_"A?D3>=UUOKBW\)V%3C6F)B45Q]#GULN0FT&:CY$M-D+50
M#TWK"^"1XC:=X$[^#"0#S;IB:?-TIS!Q55L=KR.CX;.\-SW"9_5DGFU%41P;
MH/&5HV3 R5]4^EVW4:_*%+%;TV0M1[@S1T &36U&9^9L=+P+U5-%8>#$HIFT
MB<8D!!"O'E4O1@EG4O#S9AY,RX&XXX/M+C;3..Q(NV[Y@O,Q@#AP GP>#&2(
M<T^F&9^KBG,7Z:U,A,5#+G&D\ MC6S5+9M*&YS:UL,FQ1[VA".(XT)#<+L :
M,*N":F"L#D>R#U=:T*-JM*T=*/-:L;LJ"R44UVU^#*H'!G(J^CABR'EAF>D@
M#,9W4LSQ*>ZD5!54/)NL(6OK+CF*B(HLCI@/UGP6F8K[X!QGT2*U+>$Z*801
M1OC36N?FZB"-"I8T"7$\"J\?95;XW$H \#5P?7P;?.2S?,)[AGL@/Q%&E72
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M!+WK>>TAP[W62=_Y>Y0+[]VP!XQERT7G&BD[7:?LO)RR@_K+>Y/R.$6#,=D
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M@Q6^,>R[+Y-<]P5P%V=?W.$*7UR2<J-KU=0N2+-1FN&X N[PB0D1]]^GFP3
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MJIOE<:38%/%)W*WJJ/B";6NOIY ?D.IM&F/;UZ0<2K#, ;>C_%O.74&'*0Y
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M'C:"W1%&PVFO6'>Y4KK+A:5T(!#7GO%-4>$?S0WW:CJH*(L!Z,;_DA,ZH<+
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M!5 '^?1P\T_?(@:LT.4F0ULI7< >,7(H -*9E![683_5@AI+D6&%0)2&EL)
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M"=Q2*B:1@*F \%+W2Q:KOAJH:.6(2Z7_I)ITP<\@5+1TWJGN^Y<VY(OS_?W
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M@YAY;_[ BW#'N! K93>\L5["D\[7Z)GM<=_L]RMCR'58_L%Y-&5LU CBH]:
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M1\:EN(YXPRR<G2V>;.TAN_'N9RM^E"S@JY'[W0 N!^\R3VPA/YL+,IK!DMS
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MT)'D.L1!E1EP4H$56RY/2YINH#K>&[ #<MT2)LOG#*M>WIV96 P\!!,[[@M
MR3\<H1X%0IV_#<!2\-<](MPD @T6KL*5#GL+^O84[<4;>!MTYE HGXFX5*H]
MP_'FC#_Y0^ZTC NQ(/&04>+%9O[:^+ %FMA$"'!Y-&&%#05$"=!1X'?]*4@[
M;>+)[SN<SPUW#ALJR*5U&#;Y(0F!I,PB8MM6Y]7D]:OV:_FG J_F&>J,H_64
M)H]^,RGY8CF"BN \0/$7S)#YMBO.49F@:-6 >2,0&QGPAB=.3[;[R&[T"DG?
MC8 S!ZCYLSAS)("YSY99JR "-XI#>1HI?,5QV!Z#Y^33*>R%N(1X/"?(G:MA
MHR$EMB/*+BDOQ^&726I^OO]NSY@O.*"XX6OD3)LXRH.V0EI/Z5D AETGY8%:
MTDCSUE,F92#.6UB+F@M)LQ>>)62^U"04B4O+?>GQ2ACS KX0P][X9^M1 #P6
MG@7-=GP8Y0O1SR/DLBO$\FV #+Y$_B _AQ_*C<NM0UYS[4),9<C/.?/50]_-
M!%M@Z4;BS:,H$;_.[3U:E-+X%Y)WRD%GT#((+P]^ ED(I:00O%J&9=$-9KPJ
M43EV5B\$5V? >-90V[V)1\T<V)L2,*7+5?ZM6'".$CK:^GN G=@Q8%QS(>7E
M3T/!L?UE)JF%QAI>F7HE,IAG,D2"3K/--=(>#L:U!;.&YP0&&@FS6N@'$XX^
M)XWR10#6!%Q?GZ1@RR#ARAF,6.R!>/ *5AX-%:F*"E*%W5L/&<5-D16PT!-[
M"B1U;KQR%<.'3P2K$TQ1'+?:SJE0*?3HR'OQLZ6'G+I3<0/F^RY4!X);3OT.
M]!#XDOJSL-B/GZ],<=<'W5:L3))VA=LF?7U0OR@6D(C_B/V*@+7?<M!L0;,0
MFB*'1WO9;EE#8R+V65SN+3S\P9_>C5"7D"QR G)*J9)"GMU(=<3C0MZA:!&O
MRHV0+XG'E?3O3,XZ:X29YJMW0>()QFD+,6BX<JT"X."AOX6AM>MXPE,6JAG'
MZX(?TYAQ#\TC$$5,, ;/10[-O]N<@VAX.;2LEF7,Y8G!HM79X%FE'MW<H0GA
M'L!CXMD9?R?H/-8R)SO+M\!^7KFWN>-')W*P)X J834/0E1S?(2B1B*<(.R
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M5SXZ03*)E9/-C0MSEE1-CHJFP5T[UMN; )-W IB#X+?PS?9;PC9ANUQTR.Y
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M'*A9=CI@+=Z#+HZZE@TNX0<0*?!4WGE:U"8^FIL&M)]0U2%IC45:50IO%IA
M/H\2<HC1V8IIQ&ZT]!18BX?/\+)MM2P+TO"-"!9,A$&$4:PJ74YK4B% )Y&C
M'G!FN-CTN]"%MD @HSB:RL%T8[V]"9E9Z2\%_"#BKJXK[#PGP1H]]P:K]4JO
ME150Y?TZ86G<&_U MRZ_XS)"EQO L]T#131!-+&NL46IHO&,;2VVW#_?U*)
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M77DP0@,RF?V-D\UR<'] $4(ZLR"OM=S- G%+F"0=Z'8\.9 ^*)M[:>8G>+5
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M\T.>'_+\K/?\6"VKLKHS\ON0WX?\/K!G@JJZY/0AIT\%3A]0=^3KGPT_\,_
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M<=0?]<W.L*\_*A=,IL&_VUZ",FK% 9;SF.4<837R<3578R.UM-YU'?TQ@9A
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M86N@T9*"1?--!#><J)&^6D]W6]<J?HEL+:4$^7B""CRVB/BY?I$_60CU*&J
MZ]MR^]_FD<N2."@B%]\I0C43!AJHXITB#.-0/UAN7ON+A]@[&T.;- _^8?/@
M'ZU7=%I6^S@.XN%KEC\_CM4U'&;"'-R<<U.?DR#:(MHZ.MKJ'L=)K"SZ$7[2
M@_8$SKYXN&'3V]A*D_9@.YMITFH?+3T//NWS(A+V7D738>N%[T;#^=G0NU$^
MU1&]))B.G7!),)%@>O&OW[ C6;=MDG Z-DB3<$($O^,VGT]XN IBDE$UI-_1
MRA9L.MQ\,6*Q,/%!W*INI$O2J/RX.U:G>RR": 7(Z[%ZM#@E$:-AV2'14GN*
MK-$>:$(^='5+/79CBT ZX"8]E3.\^MUGB2.6Y[RN5&ZMVY(X9+[X49BE+1P>
M.R=-.,\I(8^93BY*J>1Q8O3@6;[K5^KQ6&P,GB$\PYG5ZN!/+J*(0YY7E2SB
MT+NP0A3[EZ9KLWMKD,7\C/NQ39[2-A']$/T\7LX>S3;M>1;QLYNL#Q>LETD(
MRK"Q!P';5/37Q,G40/=G+9=-8#[F]1W.:7IPT7, !:U0YC%$$8-6K^N+!<;G
M9_*M]9NR)*52(<4B.?7+AA?\[\2]95ZA\*>).NUSJ;#'5ZNZUDRK3W>'=J]O
M6J,^(?/DD%EN -4'F3"Q9P2]4NMMV.Q)E%S8MCB7.#)";G,A1B:>[&T,Y:3,
M\X([YMO<> 6!=..EA4('HI?&R[8%,\I*9@$<K6+9,#VR23;0 ^1,MV>.H6$>
MP?%$X?@,5LP#X#@RQ\,^62Y:W'P.^8*Y3CH#$@5*@+V2F?*XD05S7'KBP81.
MK;7*=F=@#GI#PC'A^*BMH[9EF>/>DR78D8JKKY\O+HV/GZ^,RR"J7C8U!-[U
M3[$ZD>3#AY*V:8U'9G<PKDY(U3K+D$#?Q$S"!X)^+.19N]\Y$8OLX?D/UT',
M/,-661",T@PI3>I4TPP?T+I\4ZIRV^Q;?=/JM(F,B(Q.,-NP,C+JC(4IVFT?
M0^'<\\CJSV&P$&N]1R?J^[\3=S$75S?%<\8-25PDE9WLU'\-!^:H2T8J(?YD
MC-11U[3&0[)1-]JH9)ON5ZFNZ8"+W6M$7U:$C:WF:4UWJCK[==0V1P-KWZ2V
M=C?K(9F)'FM$CQOMW)KN5&7TV!WV3*LS.GE#6.L#O[H,Z=!5^41?X\#^-A,_
MX&$$!-D>OD7S6%C*K][QJ6N[<;7=-0['E,I5I'T:$4 [)91U B9$_]![\,A9
MFO);N<DR)U$F2)1Q"./ZA"B#C/)"2:**&.=D<7--\^?D+75:-V7WUDV^U@H>
M1!8GGBQ\:.%:1TGZD!K,!;O'$93_9//%6X/9=ICPK%:&=/.Z%[Q56,Q?'Z)N
MFSVK9W;;70)>XX%7K]I)$XIYAR>3K+N#I'C'IUS868X1\EON)]7+A%KI5:6;
MT'QU<O_+/F;3J]T?F)U10PLK"?$'0'S=K:KVJ&L.1MT3-8XN Q\7!W;1(@SF
M;A0%X;WA!W&#+:+]!RMJF MX>+EW- F"8[,_Z)OBF4XD*Y;(X]#D<5SYLV9O
M;!7)H]&6XU/+/+T3#-H]KVY=HQ2]^O"4!M=\MLUVIV\.K+TGS389.T1/5/PI
MZ6ELCBPAU+O]D\]Y327XKX%_8USS<+ZWE)O:D%%CPC3/O<CZQAAKM!D$]F8L
MLKYQS>HWH]'6;,V<PG56ND\FQ>[PPK+>(2*S;UG5^H-/[/0)]4<8&%U%?7,L
MPEVD(/.9PXSW<Q[><-^^-WY.(M?G463\&H@?7]AQ8[7D4U"23\H@7"+M7M<<
M]1N8<4JX;9AMMXS;GMGN]<A0RY4V8 V#ZXM/>12;1L@]%HMW%BR,[T_)5CM(
M@(3R&![1R*?.89)1SS+;T 3SN?KPG' J4/UP4E>JVJ4=3YVI:C"VS.'PR84F
M=132C\T-VE=.4)-)9-<D0LI>>%P";A-2&=I=LV^-S?ZH5VUJ$ EM(KT])O<V
M@O0ZIM7KFMU^)3WDC\1(?[C\?_;V>76VVI\YUG0<[*D>X=>ZLJ0:;1[15YTP
M4TN('%_B<%W2J>HH[7=PR7\.=1.)K^*VXHDNSCHFN..-6^8EW'AIM<0!MTVC
M9W9D>-V(9L* B R6Q+,@%,_G8)M=#-&9P_%0?^Y&4:(^"Y(XBL4+<6.#148P
M-7YCH3TSNN*Z':O3Q2^]XS:?3WBHW^TT)US=L C?:0:ANZ,^0?%DH5BKN'(!
MBHVV5Q\FP:3@N3AKKY%@O4T2S!0BK&/U\E^HG0BKE>[>_(Q+RBC6#*?3T%QB
MPO#)Y <7,'Q2-MYE,)\'OAR$4BH9NR@6RT6CB9*M9_;[EMD>#!1FC%WN6U<I
MVA!B/"'MNU:&8*]/AN#I0K%6AF !BJ=N"%Z(J\9NX#-/R#@7LHP-FRW<F'F-
M-L-6(KG-UVGWN^1C-M0Z;;,WZ)O]<843LD_GY GL1V71";!WK($Y[(Y.U+"[
ML.UDGL@*&D?FXC3'5GHF4J]M#O]AA5Q]D_7%35YUNV9WW#-[H^[K$\F9)6HX
MI!2L.36TS=%P:'8Z[=<G8@T^MHPE*DEFY2J9U6E\,FM=ZN)JFG97CP36>N[:
ME@2\37GVK]IM<]P9FL-.;^^T56\93O17#_I[7'UJC>GO5=LR!X.QV>UTGZP!
M-$G<YZI6,;+X[.*_(<14;AZ43':O$6?9)))>5G3(I<9RW;:EJG(YLS\2=L:@
MXA[VZ[:NR1*[UG Y#!6M&-EUVY;*J*@[[)E69U12<_HFAG'/M0%UY?MF<VC[
ME-\X^'^[4SXP/'>=Q<[U.XW:NJ>S)<>]U?^*?_2OY76E M9KC;66HF:SJW>^
MGRGBM*P?BSJ;U1J/LK?40'?Y7A!A /X<NWJYMQR>.W=CV^,L!'8P>YN[^#Y(
MM BU3B\C4)TX,5S>H7_DGS0S#\[LP O"<\UF<DN82<+N(,>YX6>3D+-O9VPJ
M;GS.O#MV'ZE5CH52JMG;><JINO PL-E&^@JVHCZGM8\C6J+];HYK,F,6\NE/
M+WZXOKHL907P6@B.<,Z\MWG.JMX2.C^P3\@IO!2?"@!DO;_9%GHH;M_*ONQH
M&>)^K_U4;OWCS,KVL#70:$G!HL4<@AM.U$A?K:>[K6O%DW"=GU[\V9]V>N/Q
MN/^GXUB=/WM\8/W)^GSZI]6UI_U1=SATAH,7<G/E+W[W6>((&>^H=P\@0#:)
MWM\_7?S^[N/U^W<H>C=]T_C\Y<KX</7EMPOC\NK3N_>?OKY_)U[]]O/'3^+%
MAX^?+CY=?KSXU?CX";]T_?'J4RK.*URTLHC;HU7"R:T9>C#XW#'$SLPCP_5M
M+W'$GQ/N!7>0S>MYQHS="H5ZQHV(S;DQY\Q7^;?R-XZZ EC(Z>^Y%_&[&0\Y
MI%'%,S>"SOK?[\7J6,SGXKG>B+^C!;?C)&H=2E_8=(@?_3@,G,0&>!_N=*[%
MKD\#3YP%;'FB*00V4[PO&)=A!W"A2+QG!_,)'H0X#N;;+L8KU&YCKO0[%C/C
M/SZL$HZ#1S"M#\Y5_I+!4N%[\)8XL3@(00O/7<[U\9[Z>X7KP>E?^?PW[GSB
ML<&<OY(('C0.C!O!%PP^G8JSAF?&RZ>]I2^S6[?^?_:^M;EM(VGW^_LKIISL
MEEP'8G@G9>]NE2S+&VULR<=2*F<_I4!R*"$! 087R7I__>F>&=QXIP02 Z"W
M*EZ*%P#=_71/WZ:'O9+:].,] #Q'G#M()X:!HIW/'(_!6L*W.7NR@@=VCG&&
MS?_^0ZO??-]J(4W?^#TV1. E;D__WP9D_OVOT W>;Y6]_-HK$+"\DNT,.PF?
M'=DX,FW!&/^!H_Q6-=>K[_J+ ,G^=!4PMOT@!9P5-S882,-,/?[(],&@P%>M
MZ5HTB?M&XV%%-L 4NNP;S ]GP&^Q;T^8.0/0,I%H <:(3_%'<(WL<S2V^NA5
M T5L/U H[IQ[@K5^K,8!^%RP(L #//B,.VCX5VS(@&]*%7L&/T)]+=JD(3^(
M=FH8:S&6M62I1]ELA_!!_1 >"'Y@N9-<@;06-?\QG=#TGI59B2C#ZX\X"%2L
MGLK, D-LB_M!]'S**O/)=JP=>MEYS6(C/ ;!F@E_!!6;XQ<]=R:SZ ]N:"/G
M@*NF;+-VG3]"1W!5&.9W@FJ1SH@C*NGF0C1EFW.?OXM>O,\AGH@]\Z1R(/QI
MP31\B%/;?';#X-W4^LXGZ=@S"LJD4F9K)>IKR.@W/Z4_>-43+^3&A$SA63=D
MQX9+*:V__W#6'YR]7TR[+>2]7FYB%AYYQ_ +U0$7Z!G<]QE51)R_A Y$\#HT
M)CF-I539_A![E84GN.D%M]3ZDN!K)^]9NBEHS5ZX%*9NO?'&T>5W6#HC1RM:
MJY3^8! 6N,;+0C/2'=*=''1GT;^/H+JSTK ]]65G?_,@2H-7S5-Q7NG7-$E7
MBM45GZN( 7!B!3; ":LM[69L7:V\GPAW+5KCU4_TQ73,>X%9U</BLX^6/PY]
M/XIVSAW3?L;("%3U4ZQE%^!N67%$](W[H:VT>VTT]H^?K.-S7/"V)92PRGR.
M;:I1.)==M)=K$G&R,@#N/#CR&P+U%886+#F\ZWISUQ.F>?3,Q*@FCJFC[58X
M,M[BWJ"$7_!<.X^=W\.2@U]MK+?0R^4S45Z1K6&J %2.F'Q=2E0F&<1J:=EV
MZ >>*-^P>0CL]H$$U[&?A8@F+OP%JR)S8 7U?=,#.E$.-J9SGQY,F4&^B&Y]
MB1;N.09\\B3C&-5P3R\!=2J5\R3R DGN /,K:[,R[G@<BJE=KB.^-#%QX096
MPC(B\R=%)$X^A1[J@O&RF#4M+=/V738SQ3'$F"L)?3X-\2LH/B RB' ]#8,0
MM&45IV7F:A6K5?II06PR V^"]F32_E&5;\/U\$$GUA2TD_FP@%M3D((3 %)$
MU@=OE;# G+DANFH*1'!W5'<@;!)RM!(F>P24\> 9[S&%IW$]7SY9PM!4'DXD
M#>""HB8ER@[2$_1X5.*8+1MB[@?63"!F9/H21!GF/YJ6+=PT,^85 DR^!K/S
M.M$"&TT0F1^._D M IK'#Z9S+^YF)E,(TK\9<;@HMJ$F3X97$0L(O@V7 VG@
M]P'[[-SWP]E<B@:_EY ;PC-Z]G,$GE5TI)GHRQQJ\" -[NNR@OB0$^Z//6LD
MZS&K4SY2U@O0Q$R]Q1^%;PXVQQ(Q>);(&0\>W(EKN_?8KPN/]VA-X/J89?2!
MG\@SF>]%JZ>P(4!CVY&,4]A5%:M8_"N-T!;P!&X*>TR82K@]B(*KN$-9SQW0
M+(IHYARHFGL6(E$5U$1Z#"SV$C<$(CQ4433D\SEP;_)B(:;(:U!KT);6H"&U
M!E%K$+4&K<* 9CT>'\5B-(_Z&>X2,UQ<Q\>-P\[!Q-LR4=7N18FJ=.R4_2N*
M;&[#D2%_=>6,&P:L?!^!]4^X$$11%!)Z$L7$FSB37!(YH6*]MS)=EGV2SY\O
MC,B7Q&4\=K'\.2Q%L-*>X(>[W/-6_B![0R%?>>0K>H:BU\@2H4H<R(F'^FJ;
M0H;JP7>^Z6)4F+Z[;!))8M23P+WG(M05'Z2(%H^0$@/;]?9?32\Z$R^^JR#'
M!%__ KR+9P.=0I_;-O<2EU8&:SM)4EPD??T&^QIZ?H@NCJJM+?+ 8.%<155C
M&]087)&=^7DA?Y A:(,')3FEN !L!5<L<FP>L-5,/%@B5N"MY+WL-8/G3[(@
MB]("AP:\J#!J54/O+O0>K4=\@TN?<D^4+*B"+WQ+C(;P"9\>K/%#VI=<,[92
MC123>\FRN7'9;0>Q'O\NXP$9H*LQF%'(9H.G)]7\G*4G<Z9B.@')6(:R2V_)
MDU_*A["OW%OY2>Y4[4%1VM@TDJLF5@8OI;;D,4R>8ZKUD8//F]PW2KH"7#P^
MYJ@Z(BS-&K(H'KD'LN_!PT8#ZH1BD.C"<T1;_WP^#CU+(5> ,OFU&I'*_\)0
M&F[\HSK]0OR7B?RX%YC8FY8X^P7E+A;- O]N^2(.R2PV%\#P #,<\W!D6^/,
MGD@1=(RX[&^9"KN-%W+GL/@$H8,J)V0P 5REC(RR&48*%YE;CB4F)+;@!PY[
MX+;(!\(?,Z$C8]-_2)@-;UN>B&T\O(ZX;(2V1$(R#X'1VX0+;R6"P)T'DF#G
M,A!C)RH%\.2RD;)@$JP3\,/A)A96G-PT(6\7LQ4;HZQTZ(@VRQ3OJI2(B.JB
MH#?#E"S?,3!43;JK6RM7X7>5!#&1PVV%32DIQ<Z,%!*>/X(X9/?4\YZ/ 1=P
M,+FE\EGLP7W"<%FD?:Q%"N72\)U[8\OGZHF$WXO/&34H6[&QE$^N#"@^:-D[
M.<^#-,*V+ZF+Z1/^?2ZR&1&WA*B^BZ00V,H?VV>- 8.'L04*4;#P\9CSB9]D
M\#)J84AHJCP2J!>JF ,PEPE0(8 H'3&W0Y_]V&KTXCO$U_QZ]?5291UCO4QG
M0_"Q'5_:A(5'[C;:\?4$.L#4B[F=H"GCR*)D2P >GX%VX5^3Z,P'D0][0BN.
MJQA W)+E&;C?CZW$8,O5/7L;7_4J^^S$>LM^[*D)V,GMQ2IY8J4_!.W #.EW
MN,2S*E@C*V[&@8L+C2AY!P^>&]X_J$HXO-5%#EE*!Y3'864;&87(EGG4'J28
M#@^FX--@5U,E-K@L+$:XC@<6K)?/S$8XK32$8(,P=QE88VLN"C+F?IATM@%3
M^!:R11#\W:5O9EP#V37H\*1I,)TY15C!5QYYE#X3N9/X2>%>P/]XZ57V9@L"
M$_;%30-1'S-<( $J2EBD^&3#XZ:'<E17I$JDPY4]M*<A+[;[\].ZJE .98WE
MOOS$CL *:]H@)T?>U<;64:GY"1/3=F63GT MI!KT6ARUW'X>X>@+F/A9.&.I
M><[?(M044BH'J$:A>O1L\0,Y<90LO++V>UDC\,?<,<&US#J L+ZF5&$7;QE7
MY<@7RKTM*<=^/FI1*EYMS.\+T"RF?2?1E:4'BG1%QE^1PMRM41B>6BR6?:.V
M,>BTC%ZWNTZ/,NX&*-^/K69C.,0JJ_R%(6*+Q&E0'MTJ+RSM7*]VI\O8C+(<
M/F969S0]TKF3J9>1W'2G7$M8^\T9#S"T2TK",J)GYD@$D> .1%+U&^QG]PG\
M =E9@1EM$VOBPB*"P#WAAJ$@/.'L2W<]QD3DMZ-?CIMM5+BN&AU41\.1LBZ*
M>:O+R3QX0M]H0Y^4B%<8%EQDAE2M)Z+^K?0EA?J8?^CG+PA#%9I5C*RRF<!A
M'QFI\GG6_YJ)?YUIXHU*]U&I>OQ7:'G<*VPK+XW^H-$?1ZKOGU%]G^K[5-_?
M,/IC8/:[K>FT]_NH,^K^WNVTNK^?#4>]W]O]P6 T';<&(_-LTY"/UV=DURP;
MRPT!^\%QS420S0,_/IQ_/K^^N%PQ-N0U-V<Y7^_VY\O+NT.T/>PLBNSSG-^R
MFT_LR_FWBY_CW4";'^]@J-G24_(:KI\(=]@-?7#@_&1VZ!ZQN"0!=#Q:55!/
MQ]*,O4^O &88N-D50+R3-?E)Q!H9?'@G:\X#+WHP=<.6BL%WFU_8:_0W#C9-
M&9_4]3&K.K7=I\AIB?X^Q7C[G5P_GX!/6Y>F5+XA_JHY M,9!GR!T+3-?^6L
MRG(0?)0S&/;UR_>7@J )8O4N<?V(7%^;!6LV6AN/WR1)'$D29(6.;H5*LM)5
MA.6;3-#&8U=)$F2"*B@%,D': !]-$ GB"((0%=G";<TRDZ.J=J683>:>I$!2
MH$574^#3HJN)(,@"Z2 %4@=-!$'J0%(@*2@R&]TA"4('0=#JH(<@FHU.GP21
MGR#V/,9V:X/"\:C&IHZEGI&CG'*\<6U\-0/ZB_1'_?R+_V8H&;LVDO?/-^TW
M+S5QAY7KR\@B :4%M*501S):3\G&;KKU9([^=0 A'ISRUW06?O5<2?PG;/_=
M\1#:'>L*!- Z4$*J=DA5JZ2P#Q.4D8#)+AV'DFUY&M*[\NO=MLQ#(3)><= ]
M!?,:&:&]&+ GO=J'_(<DGH2M7_J Y'U ZU:#>.@\&?*I6=Z!D$WTDB;OKLG1
M<,)2A+PE<%*UC[CV-]TEDGG=#-QQ('WHE FIM79V_. IE./)G%(M=3)QE&HA
M85.JI2SRI@!MN[^NYMI2GJ4\L*X;O:3&>:MQC81?T8"LN@*OFW6C) OI]$%T
MFI(L52"]"B9.!P=.:\V/SPRHWG*N@^R/L5WF->+'@RQD&Y\ZS8)@4,,83AUZ
M19F8\J"Z;O22%N>LQ362?46#-G7\6O7D73?;1GD84NE#J#2E8:I >A4LG [>
MV]^VGO6EL6$X^=GR ]=#@M_FM^"O8X@X7AT/_W8"@M!B-H=01"AZ=1A98A E
MISU3OJ@\*W#=Z"5%/[ZBTUJ16XQ*L"DM;(YE:8DG*S-<96(+61@]+(Q,E-4&
M.2]+IHW,\9_WGALZDW<_C,><3Z>'QL@>_6NWMY=WMSFN-T>EM3A3JM"/)_&N
M('F7X^NKQ8\M9^02CTAMTD=($1ZV'^I*/"*=(9W9SS6O,XLRV>*Z* ?9!V(!
MF4@RD:0RA!)"";'@Z$GSNG.!S,6..?)J $6[=M)^<LU3FT^#=X-&.ZJ26 X0
M$[P[E6]EV'$1>EB68*;O\\!_5ZT6CD-ENBM)WY;,=:UHKC2&-6IK/V8:N58T
M$X!+2%QAFXX*SM%6BK*Z:F;=Z"5+5 ^2JXI?$G%M15PW>O7:N$Y:?,CT8AE)
M+DLW[4O2BZ;_P$QGPL;X@O\56H^F+0_8H=I+7EVVQVRB_O&@O;#'VS+@8?-W
MZGZL _\UY7]POU:W1PC-J?.DC/!<W7:J#SR;A,X:HU-O<+;/C$&[7X)&S6T[
MR(H/TPH5\RJ>G)>1+K([M; [G:;1&;8(H =M9RI.VG"/$UA:.IWN6Y)Q5=>7
M*VI(K*X&+P8Q1K,[H+Y"S?L*]4-V5<L7U&!8'YHKC>&Z&21J,*P.O;4%\#&G
MFB\YANW&V8)KV&ONDN(^:ANA_NG"8F.W_VA/!)F5:ID5_4BN*GY)Q+45<=WH
MI6[!.I!,W8*E)+X\Q0XM\HAU(5FK3D/]V% W\).]*Z:)43\V$/(K2V^)"M_8
MNM(RFLWF+ITKU!6IET;OD/G\4$:ZR%(5#>4B+)5^7*@1\ D(! 1B 75ODD6H
M;V=G=*$'>?S0L-&2-]&EW_.%&[W/QV.04. SCX^Y]6B.;$ZU)VKU/'JKYYXM
MZ)V<MGE74HJU;5JA9LYJT%M; %>,9)H62?26FUZR1.3LD1!+0G+=1%PW>JG#
MLQJFF'HX-4P$?O7XW+0FC'^?<\>'F^'T1S=XX!X;9\Z:H7))?DV=ZI I^>6Z
MGS.U]:CU(MBT[VB,=OMP RC7L2'P3 <N@CI:3<1L/QZ5-&AS\RBQB;2+M.NP
M1T76@TM%M[EJ!8G]+$DE\4#&EHQM38PMQ0($F))SB<!$;#I"SR]QJ@36J9CE
M;&UO<%4QH]UDV!<6".[<P+0/4@LHHU3W2OQ+9$/D7'?W(TKQ%\20?2U>KTF=
M)SN$L@3OA?Q[.>"=TUE4E90P87N-!UL*:'>:X*SN?9)5K<39)FR3%:N?I$ME
MQ5K&H)O3N5@D9%V$_#[OX[!J)=JZT5O;EF=-M7?QR%2CV\SO**PRBKG"'='7
MKG.:37>^H][G_'J?*TDR#;0E\-.P/!IH2\BO#[WUG@5&_<#UU')B 1FZ6ADZ
M CX!@8! +*!YN&01:!YN^?M9%P=>4'6*QMX>?>RM?C17&L-UFXA&0W&K0V]M
M 5PQDFO=<TKT5H!>LD2'"F-V[SQ"^EKM]X12_02I'\EU$W'=Z*UMEV@%S3&U
M@FJ8*[PP_0<Q$!?>_9,'>$H6\_DX]*S @EL_<'O"+(?=>:$?,'6D%I51J%>4
M>D4)_-1(HG>OZ)X[/LZ,P4Y;BPG>!&\-BN';=R-FN))^]KG'3\73O_D7.Y&X
M?UN>OM 4T6-PZ[BG%Q:.SI3^=IZ<EY$N,FM%0UE#LW;(9"F)FUJZ" C$ FKR
MK.,"0*V<&J9GOWKN')[[6:1H^5^A-9_!5PWF\)RRL&44[@LFE-*,].4AI?I/
M9A[D,8&DO9[@L@]@WG=,&FG!\BQ3X@DI20V51"0Q=QI451@_=E\G-C!+_N94
M7$ \'G6ZDLM(]-;3Z.TUH(_<X\JO_-KB0#^6$$R()WODC8DMFEF4 E86E5"N
M*!0JW!,LS\-REH;$4F4MO[[?;:: #C;8WC2L*P\+\N+K<_#@(<^B)L7;WK.L
M*P^U:G@FY2L/</14OE*QL+;MV+O"1OSUQ$4A8N3:$VIE(YX<GR=5-\[%(*IJ
MUGJQOCK*W"_-7AF_C ZGEK5UHVJ*M4/O:" \$9MR;8@O$Z=H=2SMZKBV/;\V
M^*M*3_]&O-S=W)U_9N>WMY=WM_GY5960_\O;_CN@%!,WQ-DV19L6C=BUURX!
MC5B8HW5N&;UA.\?P91W+*F>+7]A?J!&*-.+57AL5-&)ACHJ(6=].GS21-%%;
M3=28@]L4L=TXVU45U]5E>LWFCMJIY=Z(P@H-Q(!:,(",;.V-[![>3J=E#%M#
M\G8(7'MT3VP"%'9-=#K=MP2I([<1$)=>LB&$&%4Y"[57L&]TA]U\RR*U@5>%
MMYULQ,SGJ_,/5Y^O[JXN;PUV=_GEZ\VW\V__99?_]]>KN_^R\^N/[/;NYN*7
MGV\^?[S\=BN:" ;OHX]//EY^NKJXNLMS?=2W@>SXNUC0&*TP595DR(NWJ1"3
MZJ<X&]L>"! [[#$A)I'6$"#V;*BJ X_*LNV#+ 2Q@(PD&4DM>50CI2&8$$R(
M!70D -F+P_.(CA+0,+VN#F_UV=Q\%L>\XI$"YGCLA7S"^/<Y=WR>TXBG,HIY
MGTQX)>G;DMC6IK38,KK-+N%T:W182>*VY)$U NE9AT!*(%WA.FK4!]XRFMC6
MK5=+M_['FQY/@JL8<*$]$616ZF56LDM?U^ATAH11_<2H'\EU$W'=Z)49PWJ1
M7$UC+#-Z991DA1MFSV>8T&.3D#./VV; )VQN>L$SE3ORZW"M),G[][#6B@UU
M S\=>K^A#U6;I;S5)F@3M',L6%>*"]0.6D\M)Q:0H2O0T-$27A=)Z\<% @*Q
M@+HR:V7[J;%2PS3LE3-V9YP%YG<>-U=2L8CZ*(_>1ZD?S97&<-VJ];KU6+8'
MU&%)$*UZ#XV6XW1I\2!ZR1*5J ^(UDHMA:@?R743<=WHI9;,:IAB:LC4,!/X
MR3.=\8/EBV1@OJG BN1\J1N3NC$)_-3)4?YNS-: L$W8+D>EFMHQ:04C%I"A
MJ[RAHS6\-J+6CPL$!&(!]6/6R_A30Z:&:=C;!]<+6,"]&9OP44!5(NK%I%[,
M:F.X;F7ZP_=B+L[BVW;@XWJ&R-^<B@N(QR.X$]S+5<)'?]'HZ3<K4RLA%3X9
M\S_:$T%FHU9F8VDH]&XFI*X8I3;,VHJX;O12&V95C#$U8FJ8 ?S(I]SS^(1Y
M_)$[85[GVE0DSTM-F)HW8>YIR7I]@C=U:)2DS5(_-A#R*TNO3N5I:L(D+2<6
MD*&KO*$C[[4VHM:/"P0$8@$U8=;+^%,3IH8IV O7$<^-)XW//7=F^;[K/3/'
M#>B4\1U3KZXWX=ZI_.1=:_Z=^:YM3=@/3?&_:M*_+0];'$_VLVQG1J_?RVDQ
M7T-SX)D._,(##:PF%N(@CA1A.6E+/"$E(279[/EJNUC /4[$"O&6.DIU[BC]
M17LBR/!HA5C=#<^"EXKTM]KO:0FN)ACT8PG!A'BR1P*7V**912EJ>5$IWHKB
MH<*=N'=N8-IL''HH'&9;IN")11VY>7;D*KV 0+'N_L7Z=MVB>+3O5!*CU<XK
M;UPGW5AM#TDQMO?ZED,QVD:G0]/:2"^.UB.AJ5I@YGA@-%^0.:X+[$GSB05D
M_"II_!9\@K[1.2.?H)I(T(]%A!)B 746:VHNBEDXJ/%8PXSSM>N<KL@WOZ-6
M#AH#2V-@JXWANHT).](86*UH)@"7D+@:C?:C=EVBM]STDB6J!\E5Q2^)N+8B
MKAN]-$>V#B33C%D-\XP7IF-.3';I<._^F7T(?<OAOL\^N\"W\W%.ITY5)+=,
M$V<K-7&V2QVJ-(TNUR;46K&!D%]9>G4:Q44#9TG+B05DZ"IOZ,AYK8ND]>,"
M 8%80%VAM;+]U/6I83;V?#SV0CYA%@[QXGY@,(_;9@#OS$TO>*;2$C5_'KWY
M<S_;-.S2V;#4DT+MG16EM[8 +M+$PCU.NLTF35FE*:LE%1J9C>(]LVXN!T57
M%:'4IU5;$=>-7NJVK(8IIGY*#3-X'^$ZCV9@/?)XVW9.:;N*I&JIB5+S)DK]
MV% W\%-!NI@>R_T6\4Z_0]@F;)>CP$Q=E+2"$0O(T%7>T-$:7AM1Z\<% @*Q
M@-HHZV7\J8]2RRSLE'L>GS 0"/>>/"N "[ IYVQN/ILCFU/9B#HI:8QFM3%<
MM[K]X?LL]ZQR&LV\#@&KI!QK"]+">RD1F-IU4VYI+RQ:<(7W5W[0G@@R);4R
M)8<\A9X$66V2ZR;BNM%+/9;5,<?49ZEAAN_R>\ =WW(=9KNF0X4+ZK"D#DL"
M/S5G5*G#LFV<M6C,%:&[&M5GS#P*1-.9Y[KK[P[9R,]EI(OL4M%0+JQ/;O=5
M=P.+Y&].Q07$XU53_0DV>G*!@$ LH/9*6DBH5;-"K9J_N=Z?V)PY-N=68-HY
MIG/+*%7JSJ3NS'I@N&X5?]VZ,]N=,X(H0;3B?3@T#Y/H+3>]9(EHK20AEH3D
MNHFX;O126V<U3#&U=&J8";QP'4'*R.9L[KDSR_==[YDY;L!]*IWDU^ Y<KT)
M]T[EE]^UYM^9[]K6A/W0%/^K)DOV;P MD$W[F<26T<MKM/L>; @\TX&+>*#-
MU43,AI85TJ"=&DF)3:1=I%T'JO/KNSQAHZM8DZC157<7]7C'&M5%M&37*FO7
M#KG?GUR#<D)&/RX1F(A-1VBV)4Z5P#H5.S&A1JBI2C/NG8LMN([KG(Y##Z41
M'V)EY96#+Z-X]TJX;U%W]3G$O77W5*+4NZ8,VW>O>F>8UU[UBAK)W6-G31&A
MIPIU]&78?BHT,'K=-JD0J5 1?KNF_-HAU3XTAB](M==*QC2]MZH2)WM7*WNW
MU/G2[ [(8R"<'+540T@AGNR8-R>V5->HY+7XJ&1Y1:%2X7YUF2S//4&N<:>,
M^.N)BZDM(]>>%-"UKK<'?U@&O;B'77-+^H]1YGYI_H&9[1B]5O,?/XU*V6"G
M$7JV=Z:1;KV@N[W,NG5F# =GI%JD6H6IEE8\VYYLWZA-)ZV><=;%\<X[*519
M.M^+ 0?QA'A")K9N)G8?YV5@=+M=<EX(.R_ 3EP0J %Z:&FBN=1D1K1?@K0?
M3OTJ^%2E07XC'"YNOGRYNOMR>7UWR\ZO/[*+F^N[J^M_7UY?7%W>YK?6Z ((
MFFM-<ZT)PS2J\]!SK?6CF0!<0N)J-*:4.KV)WG+32Y:H'B17%;\DXMJ*N&[T
MTDSL.I!,$[,US$;>\=G<]4SOF?&_0F0&57+R:SBN),G[MQ#7B@UU S\=*KVA
MP;=6;"#D5Y9>[8Z0+BX76G5B2<N)!63HZFGH"/@$! ("L: J[:ID$8Z<W*T(
M%ZK2:GIAF[[/SIGI3)A\_8&-W=G,11ZYXS^9'X[^X.. !2Z;N[XOSDWT^(3/
MYH'E.E3)HEY3ZC6M-H;K5H0\?*_IGD._SXQ.ITLH)93J=&(VW.-$(E.[J<"U
MGI*[PV%['[4G@FQ)K6S)(0>IDB"K37+=1%PW>JGQLSKFF-H[2TD\%4"HRY.Z
M/ G\U )"79Z$?$)^;2O<U.593RTG%I"AJY6A(^ 3$ @(Q +J\CRD1?B)FBFK
MU4QYBQV3#ZX]X9XOLN:#]VK//#N9\*DUMH*W.>V>+Z.8J6626B;K@>&Z%>%I
M/&=UZ*TM@"M&,HWG)'K+32]9HGJ07%7\DHAK*^*ZT4M=FKGG]LK(S#*T2;XP
MM_?5XU/N>7S";N&*<+/STS95#ZA%DEHD"?S4/T$MDH1\0KYV#2.'VNA3=".D
M_CN\"Y7S*IY<EI$NLEI%0YG:W&H&? (" 8%80/V.9!&H$;.TC9@KDK4MJNI0
MWR7U758;PW4KJU/?977HK2V 2SGJB 9::C30,J?<9B4UC\Q*/4BN*GY)Q+45
M<=WHI2;*.I!,W9T:)@PO4D?>4(V$NCJIJY/ 3UTBU-5)R"?D:U<$W_/X*.KG
M+)U>[Y#S_%1&NLA>%0UE_>U5AX!=44'#/4Y:NYP61^+5CP4[+$E7U%I97>5]
M@5=)K9-%MD[JA^JJUG.H?;(^-%<:PW4S2-0^61UZ:PM@C=HG=]EC08V3&C5.
MTDG@9%#JWH]35?R2B&LKXKK12XV3=2"9&B=+27QY2AQ:9!#K0C(U41+XJ36#
MFB@)^?6AM[SE;AJ-65;MIM&89+6J8[7TXT*-@$] (" 0"ZA_DRP"]7<6W]_Y
MTIWNMNG[[)R-<]_Q7D:I4F\G]7;6 \-UJQ8>OK?S4!DD@FD%B2M)!R<-P-1/
M(W?(8/Y;>R+(K%3+K"RJY9)=:3?.,I9E T?DKT[%)<0#5D!IZPH)K4BNFXCK
M1B_U?=:!9.K[/#CQ+\@C%HV*&M5:J#N4ND/K#7XJIA78';I[]DC'&*\NN"$]
M*;CTKK&:4$^JAE:"F**+*2'3J;'I+$,>F8!#[6X$!&(!-<"21: &V%(TP'Z@
M!EAJ@*4&V!IAN&YE4VJ +9LD:PO34J*4&F"I ;84FD=FI4QFI:XHI8:WVHJX
M;O12VVIUS#$UIVJ8XCN'7P26ZY@VFYO6!+[*QN;<"DR;:AS4>%J>QM,]CV1K
M&=U^GQ!.K1\EZ2[=$]Y&NYO'J8.$[LK2JU,U>D]PGQF=SBXG'U,KIU[*?;Q#
MENJBQ&2TRF*T>@-CT.\1NBLJ;;C'B5R7Z,SVRBY.=&9[A35XT<D<&MT.'=RN
M>U^C?M"N:H&&>AOK0W.E,5PW@T0'MU>'WMH"N,AZN(CM=@GKJ,M1HR['3]H3
M06:D6F9$/Y*KBE\2<6U%7#=ZJ?^QZ$P@]3^6H_]1/R#7J(Q#W8\T=K/>X"=[
M5^#83:W80,BO++TEJF=CUK+5,@:ML[U3E]0J6;A*[Y#@_+F,=)&I*AK*-&VL
M9L G(! 0B 74E:FG12@V%UL1B5-;9FWK1M2661^:*XWANADD:LNL#KVU!7#1
M;9DMH]EL4FNF3EJX0^;R0GLBR)14RY3H1W)5\4LBKJV(ZT8OM696+1U81EE2
M:R;5/*@UDUHS"?S4]4&MF81\0K[^1>W%<WK;QEEKE]EPU*6IEW;OD.O\7$:Z
MR&H5#65JSJL9\ D(! 1B 75IDD6@_DWJWZQ/<8GZ-^M#<Z4Q7#>#1/V;U:&W
MM@ ^:B_DUC3H!H[(7YV*2X@'S(5%U!5Z5-TF#I!UJY9UTXKDJN*71%Q;$=>-
M7FHIK0/)U&Q:2N*I=$/-IM1L2N"GYA5J-B7D$_(UJ<WOVVS::AF])G6;ED^]
M=^@V_:6,=)'9*AK*U%)4,^ 3$ @(Q +J-B6+0-VF.R9QRT@IU9VHVY2Z32M&
M;VW;6:C;M!KTUA; A4Z.6DR#=HQF>^\L**4\B\UO?M">"#(KU3(K^I%<5?R2
MB&LKXKK12VV>=2"9VCP/[2VJ:Y[:?!J\&S3:D0-I.4!?\.Y4OI7AT/EX',Y"
MVPSXA$WXU!I; 95+\NOP'+G>A'NG\LOO6O/OS'=M:\)^:(K_59,E^W> %LBF
M'4[5Z'2,SEEWEV,U7J87ZZ@//-.!BWB@N]4$RH9^$U*<G1I(]5:<W<_;)L4A
MQ3EFM5Y?O5D8Z2]5B+I32^>1[I"]I1/KR>B1T2,OFW"R=BE9 92BV4;H*CF;
M](;7VC9;'5BG%Z<TM%]'7>?6=N%6%2K:=>J^,.E^YP:FS?P'D,2#:X.H?'%R
MV^ ]XW^%P EVHE+Q.7E#NLA:_/7$Q="Z$1!^N$S\%@N@/H>86>-@X;#<VI:D
MUY2#VPWL/T:9>Z09*%.29^TAZ-4H+R>G1+;V"/K7TA<Z&K%J6Z)?4PZ^5OG.
MC.Y@0+I'NJ>K[NG+P/VJ!AO5L-LS!H.S';7PJ.W>>@.$&% 7!I U)6NZJS5M
M=XW.H$L^#4$K'Q^Y?69T.MV:.LE'JTP03U96'4K$%K(]^=N>KG'6;^9E>E1U
MHBZ0JO >@8V@N;NY.__,/E^=?[CZ?'5W=7EKL+O++U]OOIU_^R^[_+^_7MW]
MEYU??V2W=S<7O_Q\\_GCY;?;J-KQ\?+3U<7578YKG;ZM4,>K?6RK!W9 "2=N
M.+)YX09+(PZ^=M."1ES-,;II&;UA^Z#ZN9:+E5LA\FMPU AK&K'OM;LG-.)J
MGOF),V/0Z9,*DPJ7@'VO;/72B*DY:G"OV7Q)L::VOC#%!\03LM5DJXNPU9V6
M,6P-R=LB"):]:E1RX&FSQX7XM/.>%LU91;;L,)-'MU@VHSO,S;#MN&.FRD 4
M=:J? A.(._QS[_A@%7T,@?%^@O/5$FWM;H4UX=-/$^LQ^A?^B7XMKRL+B]W&
M6=0L>"H,0/3.]]/(K#7_EJU%-AMGP^0M^2/UGNM;@>6"*>&V&5B/')\[=>.Q
MS4T/=?_A?>KBAY]LT>XF=DS)N-=<Y-#_I)\TL3RG8]=VO7>1.4Z1\" 5NRVL
MS#T_'7G<_//4G,*-WYGVD_GL*RK/FHVXE>5=;-$[^##(;!:_0E;H(ZU#B&A!
MYSJIQ<5D#QZ?_O/-#W<W%RMU$%_#*N'-3#MC6=5;;_YUA[:2N5-V 9\" /Q8
M%\PM^I!EWQ)?=FPC$?Q>^ZED_<MZ4%J#1C]"2PR6:&D3X$:)LOC5>KW;2JN0
MA#7YYYO?>_W6N,EY^_=.?S+XO=OI3'\W!T/\LST9=7J=P9"WWDCF'F]9;;UB
M65WYE'__*W2#]UN?57YMWUDZHU?P)>M>_7I]_NO'J[O+C^SKMQOVZ>;;EW-V
M<7/]\?+Z%MZ[N/GRX>KZ$ILWSN\NOUQ>W[&;3^SFZ^6W\[NKF^O;V"LK,PN
M:';W\R7\]^WRDGVYN;[[^99= @L^LB_GWRY^9IV6P=K-=J<2U)Y8#@L>W- W
MG8EO,/Y]S$&[Q59D!F^Q.??47Q,S,-]NIOGXKH?P6^/55)HX6$EM<^[S=]&+
M]%W17U8K*MJHL33A[].KGQD&;G;U$^]DE[O$YX\6.W@GNY0%7O1@ZH8M2>;:
M:&4&A-I<7:7;;O0W#$'^Z57A]T"3P;M[^+KY#/G?Q+8,^\\:[0V'0+V2^YH<
MM70@[C>:+\1M1@"MYHNO0Q+(0P-  ,,!"2"OU'"C3\PL&,UGAQ% L]'5Y+S
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MN(I6RITV8VO(-_TKXG77R[TKYZ]EV!'&N=1/BF1=#[XY7$.^O:X7H-L[?"]
MQ?529)!^"DP@1YO4EGB:Z#>*_V/7MLVYS]]%+])W[<.M'B0#9N9W^*X3)"*1
M.2<S#-SH#8$T^4XF+Y5.5,GOX#N1CC7_AN0$7O1@ZH8M2>:+@=<[:_0VSG^<
M6(\K;NG";::V^Q0Q,OK[%"_];N1Q\\_3)V#=^[GK6X'E@GYQVPRL1[YP305L
M<>/HJ^8(K$ 8\ 7:?X*?Q?^^TI?I;NP\J2+-@\;9QNZ3*M)<1SD/M^S=JB+-
M591SQL4:-H9%$KA,%;IK/2!)N"!3UYN]$Z_@U_RD:9S"1V])VB3M'*3=;'0V
M;LS76-K;RZ.O],Y>EPG8K$6O=L:'B[[XWW]H]9OOE__-(7S:YMR4BIA*26:;
M.U(J8HXOF8TIB/64[I23V&O-R86T5+IES/%TWSV(/??]< 8/E%LZFT19$5%N
M\Q *$666MH-[ D=*\\7L**:D<G"EU8 '&54^BE_S&E6^<?@7/KGF05G,LFX2
M/HI_]!H)?S0#4YJT7QQ\WR=)OU32FB_+7RS'FH4SDF]5Y6M^SU&^!_>ZCB??
M>N=I=-,CZ?,4N!_DM7IV\K/E!ZZ'].77?-7=L =4HSZ X[M.!!0"RDXK<XF!
M\HU/^&P>Y#FVD6!",-G1QZL-3/;<SJB<OG)L9_Q-\ 3/+P62S'O._ >0G,_<
M,/ #T\'+L5-VX<YF+K+6'?^9GYG1:3MC_DW#RE^M5O?KPCD+7:/3;1O]?O^0
MH*AXJ^MN:!J^I!&X9&C:4CY1QW3EZ>@0V-: ;5B]O8H$-@);#<"F?//:@>UE
M3KJ&'OD'T[?&#%QO-K&PFW#"G*4#'.;<DX[ZH7SS"CKB^UF3U5\H=M_9">AV
M)Y]Y>LMIGLH9A+W\ZI*#HW#?AJ"T.D](4"(H$92*<H*K#25*2U_8IN_+)K1S
MX3&+-]@'-D[YQ,P/1W_P<< "EWFI2@AEL8^9Q=;=.,7VI\[9'GW3UKK#IVT,
M.BVCU^T2@/3,#NH.H$[':+8ZQF!8\U(:(>C%"&H:K<[0Z X&]<XB4])XEZ2Q
M!IYS.2!2IQSSH7WB2MF..N679?&AV:I3\8&R>INPT,KI8*<:8F']2(P*P2,7
M4U&6-"YE;??.VK*4VRG]T _,<9U3]#/Y3$S:'%/3,:5K*5U+Z=I#]*T/.T-C
M<-8F %&RC>P/P:>T\*%$;0T2M44YR^7 !F5H*1-#&5K*T%)6CNP&845CK%0V
MG:O9046:/$9Z[GUJ<KZ\KO29NXVSR,M41QNI=[Z?IF;H9T]#:IP-D[?4>4CR
MO2TC^\<V-ST$Z</"@/[<-2H[H:7=3?1)Z52OM<BA_\D<+A"'<WC E.N]BZQ"
MB@1UJ$%;J,<]/Y5G%YA3N/$[TWXRG_WH1.AFHQUIW;O8L'3P89#9+'Z%K-!'
M6H<04<K&"3N7".0?)GOP^/2?;WZXN[E8.4D&7X,Y\V:FG9DFH]YZ\Z\[$8>Y
M4W;ABG.^_%@7S"WZD&7?$E^V31Y2GPM^K_W44T=@K/EXXP;JUJ#1C] 2@R6R
MR0+<*%$6OUJO=UMI72?JO_\5NL'[K0*77]M9,Y7L1Z\ 5W87RZ_7Y[]^O+J[
M_,B^?KMAGVZ^?3EG%S?7'R^O;^&]BYLO'ZZNX<7MW?G=Y9?+ZSMV\XG=?+W\
M=GYW=7-]&V]^*3,+@&AV]_,E^^_E^3=V":1_9!\O+RZ_?+C\QCHM@[6;[78E
M"#VQ'!8\N*%O.A/?8/S[F(,"R+P-9FN2+,[$#,RWFVD^_NI<R=,,Q56ZS4:O
M7=*C@5X1APU+<AS2\0:_(84O\%7W.ABX73ND#1N#&AXD2-I%VG4,I)TU:G@:
M*RE7(<I5$J[GB+02'QJYEF@(W=5OVXW!68'4K3X?=-F[KX@6K0-9I]$MR<'I
M)1=$&OB%.@HU [Y:/CJ5=53DSUN-7J>J%*ZOT#5[Y:"Y'+JT^PE"NV2N7G=<
MT&8GNZ#S=L>NC>S[YYOVFQ<'3 <^"G&O<P:.=-QE164)_OEPXT).PBR1,%N-
M_L;%I/!S4;YZKJ3\$]9P=QP]MWNX54&P;HMMM#JU???XX, -(%MEMX3-/86Y
MN[)*S6PWAH=%;B&:^5KGME(G$E7&KSRD$2R+]_ERRU(-%T9O#!S):R40',NZ
MUL3]/9_\$?K!3+8JEMKW?:VT-76&-> !^="E]:$OW-G(<OB$O&?RGC7UG,A[
M)@R0]ZP?",A[WL%[]OUP!@]$KC.YSN0Z5\MUWE.WR74FUYE<Y]I[3>0Z$PC(
M==YA>?UB.=8LG,D*K^GLFJ$B%YI<:%TM';G0^>@XN=*U=Z6+7T$/[EN_5KEN
M'/Z%3ZYYD-O)RP2 XSK6KT7 1S,PI6W]Q<'W=ZW@$Q(JYTR;WW&A)1^:?&CR
MH2OF0^^EVN0ZD^M<^'IYMF+*^MJY@CKJW,G/EA^X'I+\-E>?:AU/]!AYJQN.
ME =.0"(@Y>+ EQA(WU(G+Y./3SX^^?A[^_AUTO[=PH#:+"(O"Q5*<-QJ/%$>
MO +Q'-_X(W="[N?G:%3[J%0Y77+]R6D;1Z(?AP,_YG(FR6#CD9[%D+G[\2,M
MH]7K$*8)TXM#4G6C<A.DVXVS@YV_5 ]8;SSDLB*P;FT[S+-*P%Z,4JL+X<V1
M:?7H7HQ&JT?ABDF8NBGMBXU3>OBE;D0=WVM4T7)9$9QOH4R;4/?"]0,\:<N3
M(6\)^UX6X)H1L/Q6ZG"<@\4)Q:7%=%A_561<,!/VL6F]5HZ1L%890-*'XO5!
M1M6E48?<8VA2B*6(N]X*T5IU8'$U5**X&G%QP-:E0GQ\#AR[/EQ ^%T/2Y4)
MSDMCEO)R7'4L71],F>M3N/ZWY_H^FWONU JH(I)/H6^M5= G*5E8P%\RIFVP
ML]AFVNDWWQY2:VIB;DGM#IQ7*!G/"LQ#D Z^JAE 3SQIDLHH&=>.D?JHKJ=(
MC0=5HW"OQ@,]5;J(3$G)6'0<CW]M:X->W@:U/RPE3#;/AIESSPS@^FSL^H'/
M3&?"^/<Y=WSNOZO(E) #%X K;1AWZH;8CP-EWD!/4#IL(P$A*:<B?"V1E*W
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MA@B9>WL0>^[[X0P>*+<R$HFR(J(\^,[9EX@R2]O!/8$C91MC=A14N3NTTFK
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MW =<SE"V 9NZ'E!O.2OE!1*%/U=]4B1%:15M)%=-=!,O]0"VCWL^PY-* 18
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MX'41PRM>(S\HH=X^<&F\,;HR/5"D3DM$Z9W-+M^KV+R'QBQG_W9FO52W'51
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M-$89X:!O)7>;PK<;9QF5/VDV^D,:IT%-'E2S+]X]T.RTG7:?#$,)"V'[RWE
MIW/40LYY+?0D9Y(SR;EX.9_1:3O4=[#YN)TC'II;D51/J>J$U0@"ZXX<_0_6
M&1K]_L XZY^1S,E:D+4H&CFT_[A\Y4E"#B&'D$/((>00<JAUHBZM$X5G9<H(
M&7UKJ%LMRV)_A7:VI8:H*/P$FT50-!O-#HF2%)P4O"2EN4J@XJC57$(%H8)0
M0:@@5%0%%=0GHG]2XN5](MFC=3,)"BK<E;WDJQ47" OE:/GH&-U^UVCV\IL*
M7'>9D_X3%@HOBVG%!2J1$A8("X0%P@)A@9HA:MH,D4T]4 5,W[JH5B374,J%
M-S)TJ(V!U)6DK%5122N2J718!Y))RG4@F:1<!Y)+7M;_*<"@\?"/N>.#Y=XG
M,H8(G'N+P7>KO:U/I+4[,W5CW<3RY[;Y##!U^/O]GLFV''[ZP./&F%U@AQ^*
MOY[D[T:N/=D9AQ/K,?H7_HDNKAIT1#ZEVSB+U$MU[*AWOI\J,]ML_BV;@FDV
MSH;)6ZK-1[[G^A;N#GGG<=L,K$>.9*5N/+:YZ:'*/[Q/7?P0_4M97+:[J:R0
MY':OM\BA_TD_:9+/.QV[MNN]^Z$I_O<^18(29%L8I7M^.O*X^>>I.84;OS/M
M)_/95U2>-1OMO[T?N=X$/FE&#]7!AT%FL_@5LF*%M-:+HM<8+HE"O;=%%(?@
M_X(5Z"3<_H?)'CP^_>>;'^YN+E9"'5^#2GDST\[ 7;WUYE]WHO''G;(+^!2D
MZ\= -]-@7XVV11ZN8H[)K,D_W_S>' Z:/7[6^7UR=M;_O3ON\]_/SB;-WP>M
M,SX93WOMWKCU1MY5_N+;U>TOG\XO[FZ^W?[>Z[4ZG;[ZN !C.\K<,FTQWOP+
MGY.I!_W'3Z/<%P25CFT-EY&0?D1KA=RM  @<PZ>WV-#U ,_+/9_Y#VYH3]C8
M!.2$MOW,QJ[C6_ 1"QXXF[JV[3YAQYAG^7^RJ3D.7,\W6.#><_C<8T]6\,!,
MVT;,X ]<\:[E3!%1*'U, -OAA$_@!7S#\MG<<[\_P_.9 9\!+3_!W_Z<CX,0
MKCOB\$..5WIF$SZ&YV!/#_).@<L>W0#N@)?W R_$W7)@'3SY-GP\XD"&+_;0
MF7.XZJ.X$-X/H&C:/ES1'WO6:*=G:?SC)^LP2^/>>+IEWRX_G]]=?F1W-^SF
M^O++Y<?KRSLQCWGP_I;=?+W\=GYW=7-]R\ZO/[*KZX^_WMY]^V_.Z-O+^4CC
M;051OW'V8()TP%Y9/@#J&='CSKD'B &HV:[OP[-A>6!F/C.'@S?+S/&#!2]0
M8E.XLER7I1P!IF$0>KQQ("=L-YV+B.+?@1"+.V. F0\&Q9J"(^X$S./CT/.0
MOI64.OQ>&$F$\ .;@M;Y;.JYL]2W0?FL1S"I\ L?M(JC:G&Q4;3!/H%:\._F
M;&YS [16:N\SF&:?<0>U;_&<]Z;XMR7NC<>^&^P)"9!%&_5<(!6A2-\MT&4.
MMN''=F/(@),VW-/ O\ZBO\1U?NPW^LG''A>J!#39SPUV+BZW=-I\?%MS/ YG
M(2P4\*QK;]]I)7=L%"9FE+#<J@NV$B03"NL#P@B]C,05&0JC$T"O[<[1S!B
M:^]/CD(U&%@F+JMFW 9>*67 2W'OT1ISO\&NILBEB<L<-V#@,#V)SSVX(-S;
M%Q91? -NB$\'.H5P&8>@6S..YOII\T.K!TW##1:!&$9HDGW.A6L0:UH1O/_
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MR[ "N& ^9Y@&'B\ZUK$;+!:1R(>)'SNYB_!J,DX6)HVFH:<*?,*[!9<T4%E
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M+L(\-&R7>$AJ#R&%^1#-5PY3)#6CU$E;DQ?[C1U.(R\<T[AU.1]>'9L>B"'
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M);+<$VGE&Q0ZB>.425)&/E7YW!LH9)FOZ5.>6$7R7B ;+]E BM6N] 363?\
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M)R?=J[=XVBIT$9X02F[K*V5@B&D5:$P[DIQ1NV5A55T6L&&XU)K],!H [60
M )1,]=I9NJ;W@^0/WEI#H%M0Q&JWUQ!G]_D@>S1/$6\@8 ^4L8$G71<X'\-;
MK2Q^>^P/(E*.P8M%K!6 '>$.78FF7!6!^.' !F4;6BYP$VIOAS+326L>^28
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MWUI2Z1*8=!(A,=NL+6I*5,!:([@,'US;(TI2KOO)#$M42.@>IN= ;UQRL%.
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MBC#%,E(%L\M0;6 SX7YS,VCC3<VYR=??K3@/C9L%W0Y='Q@'A7/A"_!(H$:
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M5;$$/QIT)1K^CF:& L;?4#>^;9PWH:#QSRD;.31BE04S.N \K(0(]JLA=A1
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M$V/N'1P8&^9=.LD 0><IDN<3B(Q2B!D?_8^R-[&AH2$=V[M*7=DZ\6G)YX0
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MZ /^<!2?'1_&)R]?JFK #[*$2>I.5GKID+!0IOHJ/GAU$+^"KUY2TRC%'NT
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MNN8D[_,IRV8T?;VT$RZG@\L4]IUA3A32OEYU0<!/9&HUPV,U&<R#^OPZ6V=
M]@R!$!8T6,Q!E3KQV>!Y5TW0W"R(HTOFX)8DK10=VB=9+;#O]&XICX<6JU"
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M(E8LJV.*)ZC+Q*\]NN<EG()P"K9TW:B&+?12I67$RBBC3UH-G$L3,5/G*[5
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MMLJ6G]4PC/B*00R#&!K6;40#Y?36.@7V+JR5:F=*BBP(51 J\0^(2/S?V%)
M6DX%A@4$&E$NR^1*W:3K7I"[7 /^ZB#4@(<:\,[B!*WWI+0>WH%2&GZ)E1'4
M-Z-APY= I3.,>&.C9'+1&-?O&# ^FRNU6[](06-,W%J02HP#1L/B4I-J!$9A
MN*>#Q++$SDM5)7]55)>8R1A5934%>\YJC$LS8N9&3U9@FL8VP2'U#3("S@@!
M;*:*]8&#S;JF'Y-JI:!F((=:9I?<@MF9-I-\UGR'7]TA^0SBN47QE$27D4KJ
M1J@PR#)BY"LEH\HUKBG@+,PKBI\&^TO@Y_$\*Z3N3?ZH6=#%4[YQ*VV([V+$
MNGN1$-P9?*FNZKRQV*IZ,NH86EIR#F4-V:;XZA5LW]=5DJH"3.)D40E%59C(
M\'M<@E@@!GT]O4M5=UX+V+[4GE+IN<Y/6?DH+N'F^T_>87*;5$MK"@%3>3T.
M7)Q59Z>XYSNA-Q*]$E;@SDL%L,WHRX3W4=..F\)D[]!TS:R%R:US9APV1GJ=
MC]T:0!897>#;6,6I.$WD:BK3U6L8VY6\,\34'[72&J\+J34A/1R"<9Y2F,>I
MOF& OGF;5O"_5W5>%&3/RXKP>)39H'[J)PB%[T-G"%5EV/+",#$VTFR&/ $D
M G92T@49I YMN21BW52-YU7?#M9!)RP77;)F&I5P;12 B+L.ZPHN<2WQP*4
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ME.!QV ?3]T4*0O^)9?X%E==N7^[>S^M9U>A**\>&E?EN3PPE]>4;5"?N@SG
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M$I3WRZ<S\#D2:;'"D!;HII+O^J3MPB /G'>=8E?-6]JOQK8I$U54&H#.=R<
MKR\(4\&\1!^^&T[RK_SVD),4>P9T:2<J*\S8-U5QS<3<.F5*$1@WRWB);FX+
MEI]J,J )U]DTR>E7XWG)"4I.Q\FWY%KPY/QWP(&[N&Q0\'5+RO<41XU^JLH]
M]..VZ;I9(U.[)J'7(?)"A<*JK][%)*.PC?+EQ(%#7[O!U$_>3,3L-#6A7 $R
MS<0=%_YWJP/\XF\7[W[Z\-'7!=[LDZS4J#F)0 3Q7@N*.XNMK2WQJM:_<TQU
MS"'KF7--RC4G?R2(<H6-U$JF=#CJR\8_&/U:PQ@A-[>[O 8QW5KH&.-Z9J!E
MI88HI@28_J/*%-NRNU#ZK(:51H.2XQ+DF*/]MJFJQ"C183SM.MA<G7KHY)^K
MV;G2XDS"JN@T$K'],R[)P_^+>1*.;FWO5+]-NE44@YDG/!>4VRE)FMEK;=1M
MIA);*MU$AF]"4 3($;0HN;3!2D2IY Q^L%U4$=I3^@S:":MULH4=%W,'\))#
M!99= _%5">LQ\?H&U ]%/K^_B3Y@4X'$]'YQ#(:W):504]0/< F\(7CS+5#"
M[$<*I03_*R?(O:!&,+:8SX5<'/3[6-T;BPGF@NEL4J49E7B(NK:?0+JR=\82
M/LAYV;3UW%P!YHOZ7&.'!JTDFUZ=CU$55$K&;725$S('/Y'L!GCJI%KX#GGL
MC$;9%_@INA8THDD_&N\"P?M18>X4D>QCR.GK[IE+S[0$X'#)K6U]ZKG7%]??
M]89!]TF\&^4-I-($AL&\%O^!%6:7&=C#O(C, ^./7WONXE!,%A2I4:07(%$B
MBTIF4#;_*=;R>VTM$UQ=796X%L7-EE0ICGJ$=GM_U,:T-W1$POH  Z[8UJ'C
MH)SLA4)82NHZ1P9Y<> '7G"=)VPLYW5K41U&LR)IP::=FO>F\UKI#_7E2RP^
MA6$LU!^ZRI-TI*V3]52E+-1]V#55OLJS%MDEQ0FVQ=,\:=M9\_K%B\5BL:TA
M[(^:EE9O'VZ3%RE<(I_X#GE!Z=M(5[Z56*]!BXU%374%OYDCC!7'5VBM]7TH
MEYWT+[J?CV'?$41$UT9A7 ONG1(!&=A^_2@MO=&?DNGL.PEP"*@"@HIX;T\1
M/)0EQAS)9XE)3^HCBL:U!MN!/X:M']KZ72A%O4U4<6L5??=4NB=G:0'.O27?
M^*RI==]THC/XJ_6701O*^*(IGK+JDNJ=DZC(KN \LEZE"(^WA%&*%S%-E+2J
MX),*_L%S[8"R@' 3@(_=,3'P/-T*D!1UEJ0W8J]9$]N!D,4OV77U20<MR%G:
M8I7?F@$&)2#LB"2\P2S@A.K',#05\@C#[## C$J2VD&P6^8R VU/O\7XY.>L
M'N6"'I)6+)$W%/60").^N6\3>] 9HUT#-;V']K.M )G>RSR4!#5\"6L8(N4#
M2X>XX<Q$Y?M%M I!3AZRG("$=%OJ5-2BR49UUF*=&]Q$BYK-==$\/E==!V3)
MWF3%E5I^P?ZN(--NT40AZ)$2O2U)/&F[N:?RZ6N2S[&=K1VX<G^;5.Q[E\T"
M)D47[__,L:\+?8&+RVK>1OU,PO_>D6O91L=@;L1KKGS_74\AH2G8\4#37)1H
M6T]5*:NK?3 38%WL6!_^CP2,KR+Z.[IS%REXPA6<L;_5U7P6_>,?;_P0JE(4
MSJS%6'<-9^W9^<G)\^CEX<N]HZ/34RG>PPQS@7^U'(G_4] ;)_!"]#'V=[]
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M)4M4'%5J6O>JS@WPZ(5_>#'8FLL&W=7@9LPE@,/SL4'*.N6JNT3R\I:ZA:X
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MXW#?\6BT;88E.D^*2=2 OG4(4]21#.M+BXY[WFNZ[7[7%LILM5!F[U1XA,*
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M1>RDE'NQZ#@]=.AK_S[U0=%U4=79W#P@;8%R8D#!J^=^+D(<O^A5C"-X(]Y
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M"L%(PDC$8\.T"T4FL/H&'KS<SV.?SGIZ/6JP#I<5'OB:I-1NB7T:?/I$Q,I
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M@&4Z_N5/ZNG9,!%_92+46;;J+(@>BBLGHH]DMF8>8YL,>2B&1WY9G LK,%=
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M7_M5>.._,@)Q/A]JYV*]O!,4I"$LV$ 9, &@XRTP<'J/'W\,Q7LQ_@""&D6
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M&C<_S^#;4NM-)J@402M[SDS$-VAZJ#KL!'4OJ,+1U MO0!*!8D9I.?HK\_F
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M$K-)GEI^6$>0DG@ &O*<U?GRXA7I'CQ1O"H$=AA:YG)-6-;#(0E\!J/E/5K
MV0R3!E.,?8R+!AE;W>S+8TTQ[=8LOI+'K,.(6M.468RR7Z2Q1W#B\L:7BD4:
M/U</1@V(J_@:1G>!&(-U\Q=8-F" H@&&BCTGC'QCF9JYJY@'(]!#%\HRQ 2I
M3V @ @7>'7R*-:$WG@)K"BXH<&.&=<0 ;' UT(GSOLG309T<D:59Z;A23& $
M/^,*OV7+$^&M'T<A/H8\0'J0/@*5\ V-JK#2L]CD4,0D7]Z@J$$IM/W&8ZHO
MX\=0MF]L7 R+D2<GPB=/5K[-O,Q6*3N**244/6!.8"EY##J@ D<JRDM(PZP6
M8!ED;S$>HJJLC>^6S!%7F[\)QE+\A!EO)B&M=T=)3K[X"/^"GX(!14HA$+<B
MT#IS"2N Q=W);2KM_2\*:&3;D3\GHIM^9"*EC)15X[S8<>+'>->P?=8^YSKE
MQ"AB-^7;BFL<SYL06VK1M"^J+9JBN<+J2ON>*ZP55NE%&]P;C<2<I->,[A\K
M9E#PUKI'2@2M_(V+Q>9R0-GEKU'JDM-F>[)_?J'DU#SV T?:NK+DG#]K5^8@
M%TBNKNQQ7 :KWA*\U8U*,AM5V\E85ZL(FI<QTA48?AX*/Y7WG^S=D%[33F2J
MK3 3R^9A$9X;F(D2@Z1U9"CM(.Q#,WRH?TM2^Q<MM7641@I*$J?:\M)*>2SD
M56I3;%+1I"$$\;=@!>6\7<@Y+'F#EKU^NDK:/D; 7CU2P-8[\=BVB4>;>-Q)
MXO%Q)H'48,W=FP2YN"W$IY\N:T'Y!9%*_] GYIT,624!<C$(,-TYCD9909$L
MN#][,\_D6>CD0*J3?FA.ZY8OY?J,F4C+Z<U<1)L>?>5I\>6O!>HTG,M4>O24
M13570PTO;J4"X&BK\D3'(@ PQ_=+P;'D=87$%J;7_/\HN7\7Q2J3D(A;"FN8
M;D[N,^W]X"Z66R\Y+!>AC@<'N@W=N&0T%>,L$,NPN899LV\JM%MKB)*<')4I
MZ\<1I$+8[-\GD-<>N.-/V26H.$+>1%Z46!"UR3)V<BMYB>O-%VB8&,S%OG[.
M[?L&37>MBDV9US$$C11"56)F,:I&,35QB]<KJ/F.B'5>*C4N%2U<[N4__RLB
M?[;TZ6_1Z.O9[_/\8_FP#U%XAAV$0'AJX8B??>:KEAPER7^D+?:W.C'Z-AG%
MT=U:>NF__LJB],V#)\5?VY8O]SB0R/A#7E5=OKR/QZ%::WF8I!_)D[SA?ZJ3
MI;-\^XOS:Y:F\E86YTCS0_9\Y2CH4H3$O!-D5)ZHCFOH53G)5(A4YHQG>!%M
MKI.RJ'?IZL804YI<#]5PKHW+X80@S KS3?5KV7G"Q,MB*Q\*Y<M;[5RD1!68
MM.QW\L5XS?ZS"+&RFYX/1+JB*86IC_;HAR@5SDOZF>>HBX72,!T^@:&+MQ%I
M1?@J:D7R%!CH"XU4[F0V-@-)$**;:!9Y?-]J=)5G2@%;Y%AYM2#V;^EG"BH<
M6]4K!9[B>+\F%6$KSY^24UELOY0W^S*:?&%<$8-86*@E$]UD6\H*![I7C>GZ
MA \)$1D4;13DKB%(+A487A!R/EM B3_VO9BOV#\0*3P4EN<[@ /5K2]GW#N/
M+J)_WW&;(/VQ!00>][G^+PHHC,5$4(6DOIS#*:39S$\X5U3JSX!W_":J !HM
M(U"#4ZQR,73#2R]-/=2)>+!OOTW]H0];;C;:[5=F*9)NAH*9>7\V$V.?.[R-
M)<O.O7OR"+.YK#"3$0K7B'Z"GQ+X(L,_QP(V^-)_!<O$KG:$)MJDK("A_7>;
MW Y#E;_X1J<P?OH;> 8]1'\7+& D1P0V0(C"0.M)6<:EFO5%\C0Z3=DP;RDA
M6J]PX;J+GY\4B[UGWE>A&]+IMGKPA_QT55B7XODY-P\Z;J?3:70Z7-O_$1P:
M3$C2:E2J6P:IF^WS-T1FV"[LMXWMGOL#AYP!-'<6^)CV^!+_0TK!C^JKG^FK
M6O!X5)C3&%Q0TQ%ZCKLHC;!R0S9;5)C<0?Q^P[91!9S#&@?-%\X7T!:K&T4=
MA,QXEW*?*>-^&W._\\%+QMY?5"%"%^#0I.7;SWSU-\RO]3,?%\7LB)Z7J!N8
M$\^/U95_/FN!:4N2(ZI^"\FJ(NU>8":CV::H[.A8P;JYCUR^L)';-<H^J8QK
M<HGL^DO0?/%)C(!CD!* \4??*E_KYKD4)E@7^OW_41RR-@+((KCH]2_>//JG
M%>#YOV81K:%,5'$OB5NP[8VZR(=4#-CST^@. P\@0+&_IQ*[^6VNA%5"FBL
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M0:!;P0(G *F:0/XJ;^F**IMR_[# X-XU+KPI'Q7$'G5EE>TX98WOG]GX1H5
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M?!8XP9@EW[-RVL?\]GGUHI'RS=8;.H#V&_E?_]24D*5TJ@F($N-[85@92:2
MD]'.G=4&8A[GCO!5SZJ.&OAYCHCEX86B%*"[KKJ!(V)+*UKJK8)@QXXJ=!\V
MS(0K^2+/[*L?)XNS$7W5K-)<:DFB2"%R94Y!>KU<B^XD64+.W6"QXE5J3\KV
MD+H"*X\+]%]/_3$8E+)'8[/SQFQ/\ A-STOJP;-E3@N3)2-.LKPQ7^]E::0^
MX%03?5)(2#5SW2B_@Y_(3!CGFM)8K4N^KR65O=:;)97,MH1\2+?7:'=?&-0K
MJ6(S 60\'R<\30#.BFCJOVFDQ6M.WF'GZ@?S9H9AH[_J#2E=(W:2V#1V6IDX
MHR^N#PPCYUDV5Y:0?9D=U&Z<#P[C(+:WY]:@T3\0]-F#?NI!]TYNTXWVH>Z9
M%'3177R2%MF.[$;[[DR1JM'NKR7,!\I<,\L$UY7N.V3T'W8I-Y],[T$5N9<6
M!:U1EHFFIRZLK#-=5[)L+>EZOB6Z/B2O=K/Y];?*X8_B9C<35-*"5UF'^3>Z
ML3-V5&':<].@8//W&^U2YNJ,/UJ?4M+YW2J_+:,9I:+0?0S3VF-G\9_;8AT6
MR'7#U5,$R]M__?") P061L\)HYZ%T1I::L\PVJ,YNJ'&TP4AK_\V&@DQF2@2
MT@7IYX18->TV4('OH_ F^OFG[8FF11K5"$+/XK(H/59WM*R22$ZG>#NAVVCU
M+4:VBY'>D6&DU>CTMJ>;C@8C!Q(&VD!W?(9SFP3>5['S>$3-C[C&,:BGL_6@
M<=&U!US;8-C3#[C3:+8.(?)5/R%=!R6U@=S&LH=Q=&/MN>>P^>O,^NUFH]FV
M,'@.L[[.,&B=-SH=:[F?D.7^,XZ5 AI8N^Z(#??S1N_\& ]8]K]H=UJ3=O-Y
MJA .P(Q?02(F2*N]38+4S=C?'!0G9?I?88'^)/#B[<5LZD")>FB#.E#B,=9_
M;SMFGX7!05O_X 2VMV$G6.O_4*S_#_#WGZ^.T32TMK^T_;N-WC9R<:=[P#6W
M]EOMQD7S&.UX:[DO$=KG/[_GZ[;68CMUP[W3;+2V%]FIP^9K (.:V*Z/*[C9
M2O;&&NZ'8KCK6^36M#M>V[W=:;2W8=J=[@'7W79O @:M[;[#[A4;+FQW(S<Z
M/5K43ZK_+7<QO8VXCPX.13K#%D*RB8B?E-L-R9XBL:"FM"/5AB>D?F=K]S*J
M:DQ$388JVA*I@60\Q01;F%3.=C*Z6S<.H,=^U_;8MSWV=]=CGW'X9Y9@L^['
M]DW->QOA9&_9X"AOCC\6J><'Y=ZOLJWMO4OM ;EQ(3#NQ$_5R%P/I0OWRIID
M,;7WXD<93Y)-C'27OT3W2-5-Q/-V1H90H1:2V'/0D%NR>]:CFY\^6\L?A?U'
M]_RA#GS\B/-&^V*/72D66U&H3H:;MN%8W5WP,';[?+V-^O,=]#;*X=5L],XM
MO9^/WOOL)/3LK-SO',!NCP9:EI6?E][]_?9"L]Q\U.BRW/S<W-P^!'Q;;CY(
M=%EN?EYZ]QJM0W C+3<?)+HL-S^W;FY:2[MNNST:=%ENMMQLN?E8T&6YV5K:
MEIN/ %W+CN!\OP-0[!'8)&T-CJ#;Z%HU9[G@Q(_ <L'>CZ#9Z+3M$6SI"!YY
MG436ANVQ_7Q_@2@/CKF@TCWNPG^E"HNWUVI^!3F>J=7\XTBR]H""410@</[Q
M7?N[=: Q(#=XS\AXRAP"V2S>97*\"T>-K8$$73@+$@+)86-$-X6V(-D=2/J-
M0?^@42);T+I$B%5?_/LP_N''![]E4;8+E/4:@\.61:K-I859G6'6;QRV+,M[
MZDF<(90LC"R,'@>C#V__OR_8E6L=!/V&8DV,+8BLRBL1QF@39(&T32"M 9[S
M?<]%?;)_#]#Q0AOXV088. Q^P&!H=VG;259<"3V["TB?5\Q@+#2+P"BO"OQ6
M1*^_^S&=_OT'>/P:8NI:Q+A^/]CB $P+S@,&9_^8P<GIFP,$YV/'BB_<J*_1
M/,1^_LS'M.AZ)QLRK &#-1+9>VC*MNUTVJ-*!&MT_OLD1G57QGURPD.RVB2-
MB>EY+"A]S/1H75R\>8>_#D7J?!;QK3\2W&OD73B)/>";;)1F.)O@431[P!VQ
M/'2*/-2OVQ!FRT8'@AS+1@M7L&M$C#78Z'(^#V SU+GN<S1)[]8;=V.9P#+!
MJOL4-2+&&DSPJ_""=.I< ?:=+V(T#:,@NMF"6V+9X&39@"\)UH@8UJ0Z$.18
M-K)L9-G(LI$URJQ1]J237WT!M49@J!E]3BB=L/I>FH6(A8B%R)/N%1X)1#:[
MUU>SC+.><-%M]+NTCK=H=<QC/Q'.OVB.QTL_=& M@1^%R:NME<X<XHFO=] /
M-:O9?F7%]X]=XF[G.I7L6)J?8$*N-*[JW&TUNXU.?VOUHQ9:>X360PVTGQE=
MW8[;'/0:S8%%UW&@:W5#YV=&5V?@]OJ#1G\;PU0MNO:.KH?:GCTSN@!<[7;C
M?#MCNBVX]BZZ5G?(?&9PM2[<3J_3:%O19=&U?72=N[T>2%-K=1T%N&JF%\_[
MC?/MS+\]6F1MVF?S"+=\Q.&F33OH'>&6[2F?PI8?ZDM8WRUOV 3P63,E&]Y8
MNS;'!=/^6V]HOC?_'_BOW[Z\=][^].[+SY>.O.OHW:Q34+WF)=SC2"<]QEH\
MJ2U77V:KC35ZUKYHM-O;:W[Q[%LMG.R+XLUP"\ZUTAVUQB>X2YT+B\]3Q>>2
MZU>UP6>[T=Y>A-NB\Z#0N;0$MS;H['0:70O/$X7GTHL6M8'G6:MEE;O%9VWQ
MV6TW^CT+S].$9_VU^]GY1?^B<=XY=80^^E;,48+6AAD?3C><.A4L%BP6[&V6
MNMYFP1>O[+091W^*42K&SB=Q*T*^W()-)YV5/S-NOPQMLKH&)4WUDP6[O5%3
MO_T><>W4J4)XYS=WZK=EB^*#W=]R%._XAE#]MFQ1?+#[6W:D.Z^XKM^6+8H/
M=G_+9?&.+Z74;\L6Q0>[/XMBB^+#WY^U*$X!Q?9^URD$4^W-'WO*)[5E>[^K
MAAFU*R\0X=B+G?\1\(__UVG9-/JAW-S:2J>X.A=PM=S61:?1/=3K5Q:2&W>8
MJS,JVVZSW6WTMM>CPJ+R %!9]XM6+;?7&C1ZV^NS:5%9>U36OP3['$SAWJ'>
ML+*8W+A569TQ>=$%.;D=-\=BTF)R.S9EN]48'.I5*HO)H]3=;8"21>164S>G
M3H73"@S:^S46"Q8+]J[5@=ZU*F>&MA.&/]I$[Z&T>Z[3=*"6V^VU@62V'.@8
MD%6SX4 =M]5J-OK;B_18<.T] U,;<+7==KO7:&XO9&/!M?=@3&W U3WO-UK;
MB[U8:.T]]EP;:+7<3O.BT;8#-BRX=J 4>]U&WT[Z/ IHU4PE#AIM:VL](?-P
M4EL^XBB3O4Y@3_FDMGS@ET9^2+UA(':_S#471JM1OQE&\5C$9Z,H"+QY(EZK
M?S'?VH-73;E=VLS[!M\-4Q&JA7 VP<O22'U 6IP_*60<C(.3W\%/)!\WFR]P
M.VFL%B9?V.)MKIE&Z3;:_55 &?NW%<^/X)F3(+I35%/_?880?#V,A??U[ [H
M]&8>)7[J1V"HB,!+_5M1>B8OAE^LONH-DRC(4E':Z _P,_W/)XK \Y7A_/KL
MN9YL^NB#D")IT#L,JF^XP4%CL%+-'/(&+2O5C)56:O?Z4'UC5NH>"*PL*QTZ
M*_6/5FA+YV=U>OF0-VA9J6:LM#*R4!^J;\Q*YT<K*RPK659Z1E;J-<Y;Q[I!
MRTJ6E9Y7*QT(K"PK'38K]1H7UOZI[9Z/!&G+$_*# TE4'/E!6([X_]E[\^:V
MC:QO]/_W4Z"R3-EU(9B[)#N3*MER\N29>+F69S)3M^X?3:!)(@8!!HLDSJ=_
MSSG=#32XB10W$.Q,C2R16'KYG7WIBFQ$SVF?"#NN^488BJC(1AB*.-!&I%&1
M:+(ZEW;/2SZ_SC"T!5D2I['>F]; BN0-F9 BT=></%JP%+YG?=^@_PZ:,+OR
MR, ['HB#!G_-?(\'?LCI[,!5M_S4CU_]_.15G[-^X+O6NV@,:^OS9&='$B)?
M7[:\:<Q"N"DN$GLJL,3Z6<?E<X]G5L2- @3BW[]K?;<.U*Z=XP--2WMV8=%Y
MO,&Z?(C"873[UA:K\5OH.@8CN\=(YZ0Q<@<;.PC8-VY LC^0])SN28/DEJ7,
MBX;VCB27 =E^0-8Z;59T&SWZ8U ?#<RJ#+-+I]4\:9B]"Z+, Y$72T4<H61@
M= 1N==K*]<?W__YZ^VX]"/V.?(U[!D5/HFCM@-P)(Z=S^X%[.+M]@N?,D;(Z
MH';"X$'HL-" 81=@$)[S$P8#]N: E4BR\DCHV5VGU84GS-V%'L@+Y95&1['R
M'2_P=G_W<SKZZ14\?@TV]9G'.'X_X :<!ISPY>4I@W/]6,]A@RQS<]MGMU$9
M:9EOM2I1B9MS<$CNH#OI;MIE=1:?B':LM3EZFQHL=*W0>NR@^RF5ME9L2AN=
M/=8%"MY-3TL#]OE2U JMQR[ WJW6%F]X>)3=[5X[[6L#]CV _;)Z;' [L'>7
M'1QY&F!OV\U&<U?=B@W8YPMG*K0>NP![IWKTNS[8+QM=YWHW7=\-U&L.=5%@
M6;$I;=)P]_)Z9Z<%&[#7'.S=JFWQADI,I^-<&4_,[J$NXZ/568\U',D?7]T8
M)!RFP^]5M5RZU5LB@Z)U8U-FB0R*#(JV6:+9,..9'FOX5#_>J@0.=^>&.,5=
MW4W'VPI83D_UK#UXH*[7:^_2G5MK<.VWP_NN FF5 5?/OFZUG7;#@&O-0%>E
MP?547].#1UW;[9;3,)QK70=DQ<&UNM/GH8]QZO6<WNX<A 9:1P_,5 9:+?OR
MLN=T=W-*F '7\?E6E32N3N?**//K!RKJ$WBHY4X]MS-A#:=\AKO\5&^Q&D[9
M['(=IES5^IVCE.M4S[&^NL0U"U)_$G#K)F3!-/%WW-FL'B&6+:MR:CGE91N_
MM)#GK%;A/.&_N$ZGEE->#O\EI3UGM0IG"?\EE3NUG/+R@["7%/N<U2J<)_P7
MYWS7<LK+X;^D_.>L5L' O^937N[;6%(2=%:K8.!?\RFOX/YGM/$&_JM9X9+"
MH'VOPE-=I PZ*K *2RN#SFH5#!965F:<U2H8+)P/%DPA3J4+<=ZCUC")_81;
M_V)!QJU7UM<H98'UA=_S,.,T_^8;_*<I_H&_K#MXHW7C_9DEU#_9I :L%2VL
MY?Q6AP;/:LIG@.+]U@A5;TOW7G-4O2G7'\5[+D:JWI;NO;BI>E,^ Q3OMWJ@
M>ENZ]RJJZDW9H/ADY[<Z;'964S8H/MGYK8Y^G=64:XSBU7$M$\0ZMWTW)6CG
M,.4:%B>973Z'738E:)4N09OM[=8R$6-38;;=N5![!OF*%A3PCFNG]6@@;*K$
MMCOMR4#X)/?SO"J]CE;6M0Z$KPV$3;[^EB<S'1G"'0-A ^$M3UPZ,H2;!L(&
MPEN>HW14"#<;A@WO^@"DPVWHH@@1**R;;.AQ=V\U.(_M+3Y&K=+.S5>SP=4J
M.MFY6F$V^/0V>"T6;8J%*ETL-!O9,3WDUPWCU'=^QS[R!]YQZ5SM3J&O[T[5
MN'RG$N<#$1+;!HGK!E7J.[]C'R8$[[C:I:.NOCM5X]3M2IP\1$AL&"0:)![[
MH"*2SCMT_-9WI^J.Q&.?:D0\T5@L:\<;CAM<V.P<HP-N2[7=D'LO(5F'W6^4
M,62V[E 5 ^ML7==LW6ENW9J&IZGA.*D:CHY)F# U'"=<P]';3* 8")L:CJI!
MN&L@;&HX3KN&HV<R+TWV\&G7<%SN,IIQ5OMYAA"N9@U'UW!A ^'3KN'8:23O
MK/:SHB4<SXZRF/SODZC@V-#_8C;XU!+\NYM%M,T&G]H&]]:+IM:Y@N-5ROH!
MW_\PUQP8C4;=TX]BC\<7;A0$;)+PU^J7-SL8XX5 [.MF$2:Z@'VFH=,@+@(V
MC;+T]<!_Y)XB[D8#=I]&I>98#I7)RZ[PNU?Z%UN->!:.B&G"Y%(=\&H.AW_[
M_KIW>?UF%NDS8/5W,E[Q)S[HM9_"F%WQR0-'"H21QF,6P-MN,V[= B2&/'2Y
M\[?OF[T&C,]? .\=#$2^=>E /#40BS_"VT*6^E&86-' ^A3R#]S[R%.+A1Y<
ME[A9DM"7#WXZ*KZFXX0NWR06C(P-^1@T0BOE;$RWW;*46?\(\;V)O- *^) %
M%O. -*(XL=P(WAZ'L!L+K_:6#;(\QA&[Y_#D\ANM-+(\SL=6.F)IZ>+$8DG"
MQWV\(QUQ:X!<33P6[@$F]Z!=#I\P:Q*E,#.?!<'4 F!.K20#'I@D@RRPW, /
M$:B6/V9#G A._0L'Y/X1Q8$<DQN-87^G!=G/\2+#!,Z'"=RED?MM% 6PFM;O
M_E^9[X&(. H7<*RO0 !1'Y97$( ?$DE\X/$0!G<SC+DDZDA068G"WD7C,=Q#
MT['\),F H("ZQN)FH.W$ARF*!P<^'C%F1>+Y'UGBL;]L(*TQ^S.*K7\Z=P[,
M&Y_#']T1"X?<MF"7W1%=7GKKVXC%GM7G@<_O84V0GO&:G$9QK-%@ "/PX6K^
M""]&LDR*18=/0WB'"^,)U/+CP&.>9$&*O&4$KX('I#%#D%CW49"-.5$VP@8G
MA%P,?DR3%-8,S&">I%6B[H8A[B,1]R\@HD(7<?A;., /"?X(G7<H!&)"PCLA
M#ZP;@I"?')'X%] 6"Y(H)U\@D@%S4Y36,0\8$C$0V+P&,,CG#?@*HNB; PN
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M2?+";V+A__&=EA#83W!V$D]":"@+;@&1H)&7C2>2!82>VO82'2&CFZ?3!&@
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MHVRZ#>/[H=EPVBUT*8H/159CBF=(J5EYU+!;-B$7#U29">(Y+QW+^HJ!97D
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MJ."LN<W^\DAE37M3'6''7["7XK&B0;X\[$4+SCVPF)H:\UR;I !,D4&8\W^
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M9+*)HT.$G"GIJ[#LS$\8E6Z5L[DICUDOW;*IRH@+]@F7:WH-<(:(6L=+9E3
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M5L[,D4"B:9))BGH'J!VB!2D.AF19E-=,4&6+8_TQ\L&D+UC)B$J&E#>-CD1
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MDS7(4E!QU0L$Y2IE=G/E1#P&OJVDEK*M8G*+>_2/$"U,L58(J;<1BSW:&O:
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MAW=PYDU5/ 9V;FYQ;%7B@K$%RM6:?[-663$)&,(JIHAO;D9*G,F7CH# X=L
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MAH)73,_%Z0UP>F.>CB)/L!W@Z(,H@$^3US13,L-R"B5J0NH,V"3AK]4O;W:
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M#2.1\Q$_L-BK$A&;4,-1W4+"E@(TD1@89T'J3T2LL>>TNH^S;DRATY(B"]L
MTD(VOOH0@59+4"SY,LD32ID=4H=6;]-" .236669K1,(.'@L<$DR!A S9I'
M"B3PIP_$C%XLX4W&I#?0T((,=]RZ9_%4K>6B91')$[2 XD]E@\2RY9@>12&W
M\WL,_4]B'U3#?[$ KD!_5B'-RS:*X,A]GCYP'EH_-'L=5 A(*< 7_=!J7*H/
M=ID2LVA!!;D^$1(N[*;/61\^DN;3M )A804%F4Q;PH/(F4'N3OYZ&.I_"1N!
M8-6%)* +9!B.U'V$D8C1L3[P06M!5%#/A,DC%YK21KF$N$SH4$WA7:7'HI@
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M'O9&\OL9SA_V3?0$4HMIXZMLZ^[N]U=??[^SU?Q![81=17X>BM)>,2P2"M0
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MU7,:5U7MCW-TM.ZW:<&AH+KWYC4'P&K[RNY=7L%$JMJ=YNA8K0UGW7OKF /
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M/QYF'S;,/C3IRPI*)K39G<BL>S_95X?77]EP-E77%;#+E#;.LJY5W:9<0/?
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M\S=(IVQ#\_R80U8,AOFYGL-+^'=#^AU6I?*+FI:;^UKR@,]E[O2$S^ W@H]
MHIC2T[N)S[L<OG;6,K]\(3;O;(0XV ?:; G9FNZ=6CB,4&/]C\80R/6(RY^
M)<O:V5Q&3HR!PB5," (QJ-A4Q+-PQ=Y52M9Q[79S^N>-^D T(43' K^OZO2+
MAHQ<1&V:E#AK%ZHTTT0#XL^'(XWQW$D8DL=EYJTO6-O;_'E=#NZ[KER4AKH
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MRU(+,TD-_ U)PP+-ZG);$K@66-9/'S ZVJIZYP=,%28='V\\ZN+S!=X-@DU
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M#$V520 '&S'L) 72,UUU4J-R#]*1,"@NS>&<QHV@5U%1%T;2V=N(.@1GM\V
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M0P0,PTO&: 1ISNR'?!4!5QT@R#/]B2H6.O1(!R+3+">?/)PK.9)S;O]>_R3
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M2N.:M [(99KHPN IP-Z!DAT]&(CH0\G' UN^B:9VEL:M O$&+<F&'6AGHT:
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MU$9E44D((@?>$:=Y+6(;1B,!&NU1VX,$,?N<Q.)<Q;9*5*2\16.RE2!5E$%
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M3<ITY: +6/FP*H@P^??&BO!ZXTQOW)J9_F#QZ 0OHY6:>;CU)MI!HIYV3\%
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MMJS><@)]3I=+MZN9X1V\ ?,H33^W-.0:5+BB60[D;<6O!--2I>?ZS=X[:DZ
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M[$$3W!S":79Q0':DO.'+1.ZA;D%HBNK.NF75V;&DI:*UL^X8 FJ#4^BUE[#
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M$NXFM(:Z-;EZZ7N7"Z$0#8>W%JXZZ03BRS3%?HZ7RPYSD,DZ7]U8.%4C-#G
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M]9#H6N1\Z:(OX?7GTYM2-? V@[TRRQNIU>A>Z)!MT"9S'KIX@%.WLO0N\XL
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M $INV3)[9MAGN7S"6=90D-$@"!>2=S/>V*QMG9VG\7;=+J-\8WY$(CN1G )
M:(N9PB%$5I63]GC\,<(2QH+UG5N"AZ5O.S!+<!-!<>X4AR.9J_ZR_XT_OQ6(
M-&+N^"]\3'/!ZSWWRXK(I..=:E(L8&C1GB2I2&X/H1&W-S>*D0J! ).]^F;@
MV[%1O2VF:"-=PL*KKG<8=RRN%RE%11/7U+ZDJ-^!QX#".U*M%":1VS[GR]PY
M?7G7'!'.75I"ECY#JZ9YZDX5OJ(RI]9>BG).]_BWYMFY;B]%I'2%NO34571N
MIU/LI,NER[D F@3-$CWW*4:=+ ;\>H=V1IDAAY0)[7$@#(NA%>92T:F$34_>
MN2_!B%^0G#*D$,VE$MV4=D3Z6V3I/"^0S,URS@=7VU VSZGW(4.@1&-X?/C7
M3NUHRF ;;$STG@><\PG58BE4RM5&R8_D,Q2E)*%IVANI7-K-9(>#4S &_H%.
MB@Q):E_,-71#U)(]:TKNC)UC040"+ZT"G42"?$U>)"IW=8,-0VZYCDY#6I17
M<*!^"S7+?_*$D6D9C/!4GU@]K&MT#OVF_/U&\0>XWS=^P%AT-8A>!CRX.2U>
MK+=V".-7/X6@S-0O[?LU?7FUY#HQ+UJISI"M\PKI%&6T[[J*BZ.^"M=7\\1P
MN-$0EUV*1FYK3VR=? %YRGTK!J5I1[P6Z*;D$2V70Y.Z%<[A^(M1$8O6  ?5
M+^'CU$VIS",%!^@%;\<HX-':M]KA-/"VRYDU <__1+%\:%C+QC3%33X3V)2'
M<M!_@ ?Y-K1DO<RG3078T/<^"7ISJ/=3H"I.0@4N*$=H'OV_R8T%Q(9V5+6]
MYQ3<%ROKJ1*QA2#?\+:9D1$_94/SY AO.$_.-/<4YSV+HG5NPS5@9L7I>D[0
M",1TBJ_[)$SK?*8O!TU,OXC$W*+D!;+N<%3F<_%W_W(\>O0P&4NV[1IWL@?J
M7;UR:<Z).W1BT=0^TAJ!/T1:\Y,7=="<=MR>B]M*6R^];G[^.+G!/"!Z>!W1
MH\1R5YZ)0M%1-GE'#T?'W>]13%2FPZ)<H\R.+VJ"@3E+-(M9,<QJF2S(0#GZ
M4!3P-<[:B<X:UY39%,0G+_*F0J#2VI/:[A%X#3)$2%Q=*2RF2;!QUKXES2.7
M43\WVAX^.8Z?)$Y[D9D.!BUM0&#0UH@2S7E*T>C1P^Z\I61X+%.L^N(S-ZQ2
M*:7;?4?)/W*I<@.2F8H;F.41?A*^#%AM<(E&-=?\0+$U\TD.3]Q9"[2F<FAN
M9$3!49)_.UH\7(RGI?*>D\9TEJ3JI^\:,A>=8'/ /DJ+WFA?7+Y,<?F+G!^A
M2G'MV;>.(]4#.] YON^[U+3TD_74D.!A9!/D+R%'D_T]6=3UNOK;P0&Z4F?3
M%%VI!PPU.S@":/GP8%J<DW^97JMS_!5F[\%GSEX\+T53,UH,540)+D?DW!R<
MXK9+=X!3^.#PWL'1_0,^(8;N0XI6^FJ( VN<#[%)#Z.C8(CC\HM,Y[5.X<DU
M3N%BLL8>S_.&6.V CL@A_,YAZ;*<MF<Z/H;3#% T.M\V>KQMS=R7F[2MDBN^
MB,=! [0  OZVR*;DEVG\<GCO2=QK<+LK^@_W%?U]1;\S.5\]7NE66\"*/P:/
MH+&'2(IKLU9,XCQE$B'-I"/L76LOF*7G(J],B_-:\A7157'/-%D"C\DPRMYC
MRW+VI-BU8GY)@ (J#4_;64_A< -\B)\@ZD3A3[V'S6CI%\].DPG8C+TG[ATY
M!1Y7/8T:<9#$-86RH!%H9DU;*@(Z^OF/KSTZ&CF#-%LQNR.%4Y6SMC:>'E%+
M+#,M\9925.#B"L *-.,R',T#V!#H)_3KIM3(O<FC#R3%YZ>(V9<1F"&WP'^*
M1#[U[S)"_;-.US D!Z;:H:?I"/_R!:WNZS9^^CCFX>H:(EZ54$(.0R_M&T5T
M^D#!VT204Y!4<5&0XY.\F[]DO&N%7"NC312-V\9NB_7&46!\03[6M$E;ZIH3
MU$^Y8685$-/V%GH>,;P*O.OPCN/WV;%2/[-Q7R-JCC3.#0ODI25O+)+9CN?C
M+8.S=P[#*:4:VG:<8O.8[L2C]8NWP1PYW;ODA9IBD30KN14Y#'-:(]VMP-H<
MPBIAM <=,0G\3[JMFVG'G%&SSL"',D_7O(CCN:ZR96%0]U8@5B]*$.P9+5OT
MPD,(%A<E,9<;*0>D>0.V.#)]_#-2]<1H/5MLO =P$CT:E"3>&+*(;-E F]U:
M4 :)A9'CY@R"@0$&GF>6\^$JZ>"QAA8]CQU$2LW<VPC$KXW5>NH;=24MK.D@
MHV+@Y+VOMXA*8\E0*. O"\#3=VZ2W!RG+%9]^ ?%N2"%F53ITDR<SP7=U6B_
MF6?.LB[('K1^SY:S"B2;2$>64ENKNA4+AD6LT8:1L9:;PNBU70'WXQY$7+3)
MZ[#+\MJ7[/!\CIJR$?)*MP.-!;8CG,_(:7C^4I^,TOX5FDFWG VX74(HXHP7
MB(LI@5Y+N@?P2ZLL:<U/6E]^+=U:<L/\2#)(;B_4["+]/[@62FO,',%H]Z9;
M#H6/0G[;5#IUK8S/.;.W61SE H&;]D%XVE.> QI!.1V*9O69RZ<T-4]XDQ)4
M4?QC7J\?&3E$G  2YJ1V?"N<'AON<><\8PT98?N1E5I]3,*YS&(*J^,SOVQR
M<1^8+-()62?8Z884?S$+DV "RVA3$]K;=<J[V"U(9S_#,LF\ N<E^T9O+N/=
M=VQHQV0JM7R@T.JB6%H*/,Y",GLXI^_I\$?@HGW#E0  1.LD[GF5]2DGTYQF
M+#$)6JEU:.(-:3O=VK4X0'XX'SBT]MAKF]-"<)Q2["#4=9"16TG';\7;/!_2
M!H3G.I"<!MHIEI56=!HE+[@<&A'[-3D( \U)EH8=.2EF4FX6IG39.G]'D<!M
MF$T^ I)$>)2J&2N^MM*ZF"_-<II6SDBN#2W2=>!6B+;:P;9MV8,R)YI@%9#K
M]_+#6_ESO,K)AH*<;?>!ZV&5JROE6VV,^70'2\!  3H Z=;:W"CD< 7912ZA
M [LZTIY.+V,S",2;4V98G]1&>"&?\E<Y=^P="]3\2G>E4BBL)(-[N<8V>Q6Y
MV]W],+N:7 Z^B::9/EF4[_Y^-+JA-I?^X3!HN\?*+9J0P%N:0&WE;04F!UH%
MBAM=%E'16!MA@/SQ6X@V\\)O<G*FJ^NTO4I0NU!G0T,Z#M+@:-"_K0ZM7G)/
MQWU9C!M&IM,12:;2<P=#O=S8([\-T2VW&64S9ONJ)<8=>+=2\P/]03A3TGY(
M@8#\VX[^G3^$-M"]DZU-X+-&_/6$6K)K&>]V6:0W$??4W 'AX<H^C_[GLB(Q
MZJ&UJYX"@_G**C4OPG(8='PC7HG(34B")V6V/8Y4.7KQJ0'W]/4+C_$.68UQ
M5JPK"YXEUJ*-8B&T3S68>0>&28-OKD@8GUPP/>Q4 RO9-P9PZZ%MS1%(D4TY
MZ17Q!'BTFUL5<VGKI:_()"8+CNXV+ -1E.-LJHP,GFU:]TTM&(?O=[K^;HW
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MX4EG8PXG[<_NID="BB6$(PQ1:)%+*9E76@=@=IP&9166.3L<'08F9HV4&K.
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MQ;*JVF,H+U_Q]Q0KK9!M-?B.SLS >Z=MH*M,#-*X=%K0V0-N2QP='6K]2<H
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MVLUM)OC\:, 7$V;+3A)[ H&M^I8QWU#EL45&'./S:#9(-'YYS)WI77!KDY<
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M5VZ(24&4XK2I9YUN.  6QN\!H!T5NB1Y$:R4>WG@R4D-=<)XA&UYC6 UUC;
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M1#("M@4W.J:11(BNMPN3.3&2 TY$./5X5 %JT/.,;0@=SBL\Z'W 0I"VEN>
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MLNG\G\DG6@C@+8/THZQ""Y_((<H5@A0NF#ZTM=+^9&_WR%UY)^W=R3MI[PC
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MU@6#5VY,>46A@D'":!TU#M>"V29 R'SU,P4GH:[\N$+&X.T&8A,68K,BN@)
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M.1)3UK+SEZ#PE+%WYN>*E6G6Q]\R3O&54<?IO-]0-ZHT>^6]R01%]&^JW\_
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M#:57?]!R@,.&D!/N ^IJ19EQ3"=,R:''Z; 8_P'V!J)$-%AACW'$TCE 2(1
M8N5@MB+X$-!ETN< JXF"259CS8$O+EV=OV6\\2@BC.U!Z^)(&ZLZDEM+<!"4
MK/1!RT%.:)P5B,O9^_A#(39@A@D\&ALN?WG'#K/W\T.8WE+=ZB--[C0)C).D
M9?&R'_U4H>V4TKX:9JCU7@?R&#+A7U[87]QKQI/7#_D]WL'92/7'4]#M?_[#
MR>'1R:M)S/@)?/>[W^2)*2_HMOF8)I<1HC0F5L((0Z*0HE%%J41F@Y[F]]),
MS'-X$.X&1BSX5I-X*M(*2M$XKC6QX25%IW<LH69,@V:T;(XJ&^^&7PS038<F
MOCA&K@?HEJ^Y/33A3L'0.S+>*C)^BZ0TRD!#WN&:\ R]% PX9$HV3/R$0Y0"
MD=93!7+#VE.&6!G_C00"TRPHNDJB7(@CG3,6,_8;979,?Z49PL1SGFI*( 6Q
MI\P,:Y4#:T3!NXZ 5T? 9QJQ?A*QU422B GG*N[OY& 7AF5,S)@E?061$' =
M)W!5-!G!TB4['W4B@=)"=*AYC+,6V3#$0-S-1#]6F\=;9E6:\7D:JGAU&;UG
M$[EQC,SK(7RX^%T(TC'2U>\(NQ]CH0#GPUD./8$^DQ"[K?]R44-S<@HR.'1!
MD^Y8!R5(4-LK-%!_GI898LQQ-BEK]8AC;]X4<ZY,I9URQM-$9IIPSJIPZ\9T
M+9C._G&78+S)'%45-HS)I#+Q8Y/4$%C)ZECU@07\5&LN"-(&N"W&!$78XK;W
M9:9OR%C!'VI^H#?L_ZEY=UJ>.=&OVM#Y7'\ WWJ&49F/?H\+NZC.1?M^:*/
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M]F5Z]8)225]T, U_]P7VLXE3?YZ?VH%NW) Z=.)2AUSJT#J!;MA)0V^O& X
M!,LW;#W@!RL&S_B<>*>C+(JEE<X1(TK8TI!N'&E74IMRCJV^,N\4I*"@<J&(
MIL28OR<D64$9QYY3;.\T_J:EJ];*(>O]??\JS8@,KE*&$[8'U FD5HL[WL1J
MFA<%<&?[*W:J8P"<-+$@3G/6>:2*E^4_U^=%7%9\[6/TL:5G>U'V6M0BYQH1
M"A!<J]:<;F*.H.^@TDZ-T,1AG\BN6=B5]30,&"Z[XC):PD!#!R=VR+M.;GH5
MY4+1"PE4(_&'LSK.6&",U-A-QPN;*G5UUI:MG>J7A'AR;-7X%5(U^A@4&I]2
MJ<2I%WFQ8UMPNB&$'LJJIH*?7;P]0Y6.TLB0,GAMF+(KD9%ITV,F:LI(PW)C
MH6L:YM7LHQPIH(* ..,Y54,*]@?]#G3DC))T\%6Q;>_"9%>5)#&KF)MJ'K11
M$'+=DCXB<7$2<2&(8$9E\H%/N)IBE[2][]()#3L;JF*0<EM&<\BM&O%5IXCQ
M049Q9:*0;"=]VOCBAH.2G27B*8%*$?C4S$!)5;ON&M:P7OMZ/NR5:[Q.#/4R
MZR ,. S5Z1+VB,:_)]21E) "XSX.;Z![V&F$"7"]?TLI/7=_\2DA;))OK8C^
M3G-JM9?D:+1)&]399]1<ZEXQ+*$5BG92&E=EIE''D$3%VB4FF9Z4\Q<2JH94
M$7/&O54JI%O+:@JT\NKL9$L.;YD='F%#1^X'VCQK/M2<ZS8#L(*MV?I)4HK%
MGN0:179B&GULH<M(?"R+L%P-^\T8Z#TMWPCD08#W]&>QJ;H&&BDS;A6A?PFF
MN*X K^9D*CAU$1K_43%MQOJ\E"?JG130WT2^PEJ[7?@79@'C;4?@*FL$G,"*
M*/(=108K423<I#5'>*5:_-B[P8PK,[TP*\4,U]FJB)[ 2R<?:6"'_A2/K;.3
M9U%;M5&UD(=JXW%FEN8949Z3AX=[:V*"#W8ZM-FQ@(7)M_9[0(QC?P7*6-4S
MKX%Z4"PK;QD2T^TZ%X [DU6;^MB!2?-J%LZ3\).L #;I>+>;E-[]VKIFY+I2
MDC*EY$D*N WSC;]LVU N-Z.HZ'=+<KX6A6E>!^HB$%B-@45*!<N0!..(M-A)
M_<[BDQ56>F'O,;J\O6<"AUL7.[(9V+!7Z^:!GV5CDV[W7$1BDGJ7:1K2NQ (
MA%@3MI-.+JF#ELR-P2/FYLX]EB7UE9!KT7&OZ[!6:CGI\T5>@O&)?"#Z<85&
M-_3_G5(3:D4]97.,(@>JJFAF#(&9%&;LI9>W2,TQ[HAY,=E:M+,6GUU&B'5)
MIU'SX;6[1PMD7/SR:X<)=7YT=X7SNP!!D5QBAVVAEDE+Q$)CQL(%\?HG:4G)
M7VQ<L5+(EMT\ GJMFZSK9D3YRVIW[I!M<!-M[1UN-&WY:TY;G\@-\#7M81W,
ML]=I[[GWL>W]AEX1T]N"&@M;+(J* YBQ3K"D11P]\ X]/@%3G9M^3U;3[8LT
MT/TFYW6 8@V%X-EP%E^X[(;]@@,$KG^-^)F9#6TNK_[X\0M?$^O]*&)/P31$
MQUN]4=6\.;3=];@[^?6>Q/5XBX4_9W[N]\ TGW<K[G =ZF,C3G^998RV3ZR>
M.OQ-M6(BVI4.Z]2U36$M68*=/\C[FILT'QT!WN$K4J7UZ.<(V4&9\M%^-2B6
MAI%O_DR,#MWQ(6=LE)+Z)W^+<(W=CO<YB^&!%%5:ZN7."KON;:<G2\D0;S];
M#=]DP;*A5?NWKZK(TG=1@=-UE^P>1!P\B4OVM>U=!/"8]SZ->UF:_D!S]V!W
MA^I!FSL 7RD@8>IHSKD>5\#MQ:O<E&903ZVPKS'".UA]=+DSKIZ';H1,9GK?
M(F.P]Q+TH5+%W#G) YC)13D<1@664F(W(.ECBV]"/$#I/T4OY3QE?FRL/ZH<
M*'__>'KA54FJN??L"]8J8HCD-TR4!J/L]+_IE:\+)IZ=QB/8?6Z=!0(+;E%)
MC9F*"%UCSVAS\]!'D);3__><NH/8*[LPC8QDZKA#IM=PP;UM^3*/!:5*BANN
M?:[8SKBZG7J88&L.7 56%5)24KUYD_2QDE>*O:Y91<7M)IH96[VS6A.0ELT$
M(C@<=-A?WW_XC*E=;SY=M"0KQ:2E4]+7R!\3RH]N(I5;Q7TF@ *L_-I,-@==
M H>F;E_D5OGCP>ZNAL69Q;/6.AA^LNN"X2X8/K$Y#5(6CFNFN%TW+\*]"C7O
M)-'N55W7K7>SO;W4?F+KO9][ VL0U<+NC1;&YAMZ%KV<VG*G9FZ:J^-T-$JC
MI+#3?B<B7%4<@O-I6Y[5.AYUGP\H/J/AK+[K-$A3X_;:_;#/$VF73E0:?E;-
MW5%=_%N9**]SH#-LK@<IJQUEST27"#HY+2H<6)@W[*#2B'0H%6XQV>/N;N?5
MCORO-9-/H'"27=:1#C)M[ JO=T;G4&"'.$2B)@=16LDD^'<\U=B&WI]P0\SN
MKF<U.=27LR_OYPYS]&M.Z68?C*C@!(IK-="T)V8:S#4T.)_?VKS^F].,H>%F
M-3R_5:_S9;8Z=YQJ<[U.?TN5]SN8(0-MJE8W@\5@+E?[K,)?E[O=LN DB8_
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M]@WH:\1ST!KZ6B?*=5RBG$N4>VS4F!O!INQR1/R-#:KZ^!"EG>=FA^E__&!
M+2FIDV^*)<\Y]?@I#?J> 7,P(0YC(>62@AMFD0R163YXXCI10GP'6[MROW64
M!L"T!/Q$&F$.$0&NSGW(Y42AW_PVA9-+.&8'!MVD9CXVH9Z*RY&TF?U=0KSI
M=%YY^P?4R 2)C8/_FFJ-LQ*Q":7]B. ]LV6._8I!;(/.Q8 3W)R*PBHD*PV"
M.HV[1IC.CA!72HB5I@43F>G0H=BLX'=X@K2IZZ@,YZ3.Z? @ZM<"78N<4LP*
M1W*.Y)CD+*%,2*M(>Y1D&F01R42BI)#2M&)M)PJSLW%([*<<=3GJFF1HXGC&
MQ#R=!D?RUFYQRH59#()->J"&N-8/$#@9+(! =@4LFWKV(?NS,N+6B !W'?VM
M6+-C+F9<5>_>G'K=#BAQ9Q0>''NG04$=92G='!&TQ=MGHSA;T&"ZX8(G#1=,
M SQL.TM$FY67VBG%.5FD+F(3\HC21E/+BCD3>2U ^4C@V##5JQJFWJ_UPGV=
MWVODUU[$3=Q]_FAN[(6J3BS7F1]QB3"V($;OF4HLRR(8!Y@#098J)=V)2]:H
M<P;D#U4[,$)*1HW"9Q&_LN\36HN5B4?)U!%Z8BFG&0@W\3D:7IG7!D1+C!5-
MSKTRO%1%U=:F56%U6@\*S5O0>M@_,D7?"B9[FY?<+PKG=($-X<4?^E/T'DOI
M'Z>J:@]-E3U+6:@<PT>X7;1GKC X8_<N-?B#2)MY267GB:#%]DNQL.LI(&ND
M'3B27"5)$JB?Q 5U>WC*PF;\:DZ^EK@=-7$,-+9A5B5<]\:@,1 B'IKA8*,#
MPT5>[*C,41E1V5?"ZV507J8.5/ZDV0P7)2$1B7XHH4[IEJ,T>"TG(6F:8[!R
M$.:@!B"3XVI*;%'GJ,Y1'5$=MCT#64GYL*29":55DG LD$_LT[:?^?_9>]?F
MMHUE;?3[_A5S'*]5=AV*X4V49">IDF4Y\4IL^;6<G3?G2VH(#$4L@P"#BV3F
MUY_NGAE@P(M$2: (@+-K+X<B@;GU,WV?'GTRC\^9NLN7ZH1Z 7?D3?-2(:1;
MXSQU?Q"]2:[)+-XBX8YU4Z6/249=LL"/[*5%VR [=H-]!J$< N8 QQZL$H\8
M]AJ3&J#*]%N@6Z!G0%^![1S[=.FL1'0.=KK,(2^@;AYQ16T@0E--[1!\5'HW
ML<)S'BN4>R#K1MU#H/!K[AN]:RH$6>N5VJ57"HN\<\]':]ST#."IZ -]D7?A
MC+(6_)(!:KB#F:2.+$N% %BN&Q+Z[M6D$Z8^7C,0355<?98FJEX*=RD?#(^8
MT9%R>L#(!X*??/HN.^@&7XIO7IQ5U8 ^L_L(,X] %6X3O>=5&EKV.708$@\M
MJH1!/L*-;K*%$,MB&XNDQ)^Z\$5>I*E6>E6)\IQ=8;:X!XR%Z",?UKG@BSE9
M*Q,B#%FK7I-I6SICB_(MVJ64BJZ9F[!?+3?ANS1P=8JCK*[KJ8/WZ4S=A^,+
M;8C2=OMT>E89MYJ5);N5)70]"-8FY/+V7AC 2>=?#&]:4K$/8CPY PGP_DR)
M.'X-<HCK8]!I7"@O(8MF2$E"A6U-13WC,G2I97:MA+P&V+BSIF_C%_?@!(-J
M,28C?A%QO&!6WT"BY(DJQB3UD74,:7MYD2JS$>5S7HY5W>MRZV%13]_.0[?4
M2,]=\0*68D6PL0]*C5R+ECJKE=_;H[2QL7(!RHM55, D$B,P10)YYC4[*64L
M'29)PP)K\QF>QC9@X_KA7-_5$QMWU8$&."+-SKC 1PV]I1[6!?6H)9VIJBFF
MSJAQ?TYWORO*L3^HW$R@PY\8R,&H#N[L3!Q10&J)ZC1OK"- #BZC5K2.=[IF
M]8HLGVXYP81&IG,#UFHE]RH14]'J+W>*ST?6>CE\N<M:+]N>W1\J3)0B:,["
M@(B,./DH;X+4IR$U?N45*KU.]Z1@;&DUNR#5VDQZ$[*CA'1&* JY:\129:DE
M4J?U#=EIQF]BD?4,ZGM(]P1ED:UL*SWO=MN=HP]2&-,I>/-L.M4MH?)__8X^
MR'3[R95J'Y;HV<,2]K#$)H<E2N [*Q6$1_$;N:GE-D7OGKPP"[F.ON567:5&
MKA/NN0P13<<04#U664?X/M/WS>:\I,W>CXU#?/W.OW(^@J_H-YQ)B#J--!"7
M.FDAA]&>1W0XRA-VTC5 531P)(4#6?FO>"H0Y/F5/.9G\IF=GH?#.L!AH"^#
M6SZ5]CEWGN2WL#W9*;EU>TK=X;YB/K^*.7NGLG1.97U&K,"51GHFY:_\0VXG
MR]87UI2JGP4J<5Q=2:<R*]1A/O-: YV"1*Y(=<==P:]>R,$ D8MQG#ADI*Q'
M7OQ5V91@.V)>2/%"27E-'NZ;-$:Y/Q)XU$=>WRJ+=$7AM_GWGY2W$81IK \
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MQDF_F3.?MO65W'QT9V2BZFZ,A2MD?=;L#HY )&@"MJ"9*T$70\J+)%.Z!^1
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M! ]-3+D7))Q.;GCQRK&G0>+Y#)H9X;5@L&#3,!+,][X*?PYO :*",,$/"9W
M&$EXX.J':;1B2BO6@-UXO@]OPDP B?_ ;Z,YN^%S;$0.%;X:ITD:$8WH*( D
M6?MI-LYM4>BSR"/.RDX=)\3% D)] C;IZ"#D)3!<;PR/ $6,9\[CQ)OB<8PL
M7/WDN^@B$!^$^U$D9 @=O0;:\H!?"01/]I7KQ4Y*MS3+@S@!]^>PP9 V'I!N
M[ 4 $SRN QM/'>=1H$Q]N0O#O%@?O#>BLT+P5/%M @=V##L"Q!*@F?;32(B
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M>N!7<N J'KN<?_"?BS>7&%YKLU-X7U&14G:1R<[06YM(!MM2J;Z8S$%_1AB
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MHMH- ?.C%!1&&#1U #WP.(:_L(O(B[^2REWL!E?3& 8(2Y+F(0P_Q+TJ5SL
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M?BB?*/I/'>EW+3J@._EY!>5^)E1B5P<^GP-17V$=I067?Q+I<63%FFA6]RO
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M1.QL&@+  ^0H3@0SDZP"L"JNPL2C2UUB[QM(+NF>"G _)C'N+61WT 4" I0
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MDLD2TW7ONX*569>C3" 7C]5DKFXML[V:L!J/H%;43,AA,!$ZC'3=W *NZ49
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M=F,Y4V7,!" RE7X'/=$G<-=:W6#!4)4T@[4@<G_Q-3%Y6]%1SWT^ O\7=0[
M:&8M;@O4$9C'PM_X P.X&H,)S:/JKAB \BI(UT;J,7B+$S[FNEK?K2\J@@]
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MA02^++K4^O"#"=JG^F^/EH%@0C7L.999N%)95K0X^2T5-ZQ3 YL;K@"\N\@
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MD.8\OP[YD'D[@HP3*BFX5!I$H_!&75L1KXQK$@/3$D?$9]O\-6?"XD_YK+B
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MWZ%!"J T O<1[':RSCK!8;*2)/)N+$86%$G.T,#A!X KA38O=D4?S;+RDS'
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M"ZB>6+>I.3?)L']*]L%AZYKHE#;=D7R2]B4$0**#NU5;GEM"'2R'I;"R5OB
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M#FO&F)/%Q_ -QK.,V5(BG6IVXC!Y#5SK\BTF$]'?(*2('8+,4^W_1FN6,C0
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M#7(($97 4A5HZQ(,VVH:65RY%5$KQ1/>XLC#>>W0K&D\K,L\HZ6&1.EP>HE
MO-:-$,)./K"@A%=O$OJ'\(@Y45LK!88']):'\L&J>M(Z_93<5K7V62_+&59.
MXZFVK&$J"&G+/X$"5]-3C A$7O;(E'1.P%[\<&I&X@=)D]E)!WP09 SP=L-M
M&+$L0A>4;L=YMI2Z;/W@8.5E>KYTNJ!%:*]'&R1[/.P/5?A.73*Q;SP]/+-A
M("O*.?89FHI4$!9+CJ::,.2M_Z^W*![>)V^9%'N> ^-38RN6\6D4^,!T=P:D
MYJBYS;L. *))?'UW%6_J]QQ1J39'1^4Q1Z#-C+>9,YK-VZ0/&LMW?SV-<^?'
M+&U+$#C@0:J.3GU%WAH_LC<*<R,AO $U.]D5B%@POP0[AR@N<(C47*+C1GLR
M:IQO!)2@FX3T>H,P%&%17=':9$0=,]0>V5-&)RX#RAE)38>"K^?B1A>ML[:C
M[WOP,-KJG(,!D(X'1M49R^1A<@)DWYDQ1<=+I'(?\&(4*:/].N7U,<4+:XM-
M$F?F/.52(SGT,-Z9:>'Y5!;MX:WFZO!22YQ$O*\/6LG1J7[I5^:>LK[_ %^_
M[SSI&[BY'-L7&NM1D8Q?*<*KI40ZH&+@RT[U#+%<";39M<7LY(NL)I.Z)Z,I
MJ2SS7[.6LN)UOL@1G;!4,:PA,/5UU5UJ0V<C:>*:]KNNVL1\:ELO6D(5'JEJ
MF8K#I0B<G81B=_@*<J*/=SG174[TGG.B>'LV*=_Z.<*5+ 4XM,"%E&0!H8,6
M=0^109%%3L:R,LVE*\:4G5+/.,9;<&/O@:T'Y>9I\K3-="=?@?1 48\61>DT
M)FE+=M:)DE>^"RJ4B!"<VU#+_VQ46">%/FET3V.O-+1H:+)&_>,04N;-9(8Y
M%\4)J%>U^1(V>LHNR6EN5:LL^(UQHHMY-U>6(HR<K4G+M%7FD+O#WI.5LR\Q
M9 8]U!23N8\WA6=@W@PC]M>YOJX@=R(MH&!ID1WK 12'Z_#0D^V5<P]%K)XH
MR"94O@+C >5'Q^0#$>Q6<1/R@B-N4*"\3?&9'FB,H?:BB3=H$,K%PNOCS/X(
MTYSN%9RG%]+*AM*A((A!XG@$G+;0_F7(5K#]QSQ,?S7%T*UR&G0S5%4=QU.Q
M04&,H&;,2[]7%/$>>2%*PTO24WRN&#.!+?;D"6/Q#A[=&PK'OC"6( /!I3 3
M!:/(0=PF_ ;)]GFU9<>/80&.G^Y-> J1B*5>D^-'WBCVI,%;<U$A6P'WC84V
MF#F=0TW9!6.3T>RK$*O,8DMYY/<H6@W+_&5^!T(/KB<\+@L2"E],$E-WSG2O
M#H?#E0D090)$IE"YZK,U?%(9U8-CPU@$#L-V"08_+]/\U>Y($VQ2@#20XJ9(
MM&JIMBMF_ 8K7HZ#=HPQ\G._<4X09/$(]8B!_9C92/D).ITCI6B*]1Z5U_'Q
M4_Q)(8TKS :#<0664= 0#3NK ZMN2U$0(B@UIP)@'_N[:JZ=;(MLHQG.]/17
M>?X)^9R9I5XXY"^K63</&N/Y/&^##-3J8IA"(,ZL85Y.LAK?U037*MPVY,ID
M-DU<)F_,4*W5UTLZJ.OXJRJA.LL @L.P#'71DMWC6;IX,6.RDPG<,2:4E27K
M(&HC8-.47-W6 TPH*!Y7XQ!B")07PY/Z9.50\0]E+/>5NEGID2BK0++F?U 6
MWE\OLSQG%V *G'*#3?3808[ I/3_LCW/QA\S^PK]%KY&UIFVP:/\EU0/EQ=!
MU1E.;&RGO*=2==&R2PQAH(WH_7 ?><W@L36;1,YMT38?,%X55=>@/:6?L52D
M$8$@@Q [:@IS(\U!U5#+"084DHP2,! ;#N#-)0$3P68K&D4X'?.\O8YE9J-Z
MJZX/3S%[5\E=W 9W>I16F8G7N5/T+>6R *LOK/N;!\)>4"YM9CJPW:\R='7F
M0$8>"B5&",:$DJ8X6O"%%VZR-["'=B+U;R=2_:#(0/@C),'9)% !.)W)3N)V
M$J<E#E24BXEY<2V)BQ%\AQO,Z'C5B,-I2)OO$/RI-L&=N;UA;,QB+7C(H&![
M03+\86Q\S;['-^(,^6<'_R4_>$$\#A*;JDK%\87KD:.T3QS-/3.<^ .C51,[
M5KD,1UCEXIFT%GUX]OK4#&.*J 5 -K9,Y]DP"R(1M=*[Q#X++)V!$WS_I&!#
MG7;";AY^@R$I#^'"$!7I#M(46*+N=QW1?2QA.2K@%=;2W$-S[O=D<S$4W;<9
M)J_ACB\=%"?I\1XS?P]@GUIK*6^S6\BUD1H?])P1E''OU>L?^UFWZTG$2CE@
M-H1K_<32/P>=N:ESCX OKJH:4;/"R(Y-?J@XR$>6;-HTB^JKUG5>O=8+,(%J
MF\'24MC^.8,_VW0%*#2(HL_,$WZ_V^@*A;"_E4O2?Y\O&FFO>U:D:Y9W]+/H
M-UP+(&O<<UK80\@3@A5 <0X?KT*G*5]889,Z-ZY<[CXG?U/,\*/CO2<MNC,G
M .%\*:F ZD@M3@")7;&UQ"/BG[?&LPS"%9U#.KK#UE; (#/)S9&?-"GS>!&N
MKZ)*V;G[:X]H9W %@@9J.@E/U:\,MV<JOD5Q?KX\  ".L.]]!6BB)SLTT0Y-
M=,]HHIB>"T/:WG=L 8UX!C[QVD ["45@N,X((DRB4HEHW0^K2J4:0ZT9M^:>
M'#\=I 384A+=X[1=??4,DY2YON0$T,+[/[YWO'6#Q CHOF$/+G>94:,^13XA
MEX^NSC:7A[D$R%F3)&,U-L]N'")E@_L+:OWR9EP7(T=DX6*M (H]K[/%11I
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M25#C86I%7N3'\IC!&1?E^/@8*KYTH5@04DN3[XX.S9^/P7M)+K-9ERM3WN:
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M[RQ9Y_7,3R3"MZ[%=\?'GKN0^A3/X#8@>@C;2S;CK@%8SR@WQGOJL0LJP/E
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M8[!BH#I*Z_?#Y2Z5RZWJ.C\;_87,!-*L/E(2^NI8@N^S2MAH%^N%A_R(#%"
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M<4 :)^,"3_B:N<I.2)7/N/JVSQ \#WD8"E4$T,.-D7S2+&F6"T]>.@T<K>;
M;VXNIIIL(QB_=S,+VT7]90<O0%F1-C]/K>'\P-"WC.OV%X=4!\H>ZB@(9MYL
MC13"^J2^U;"'D5->=H+']00S0>RJ3#J\U:/UC8@>(L>)"AF@J8IZD>,N90$W
MAU\-E;!C./#HP;H ](*I6EC-F$7.VF@P.%BMF<U%(W OC;FH-,E1L@A0$-9
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MR_R)2!=2XPA(G -:*R8*XP5.IEDSW>]F9/Z/IGL^GCT7=D#'16&.VS6'2PK
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MH:1 [#A!8 @?%S;L'TSL.O$9"[J(>^;P!RS8<\UQ)DP&WN"XR%8\P0CM220
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M$O6RXGB!&W-L[ZSK#3[E_=E4'*XHBLN0S,)ZT.3*8E F <.QR:N-VMHE O+
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MCQ''S$S]]2]=!] *.05Z0:-!--_ TT$*IJ59N,-T8S8I;;$9]8HI+MLEJP/
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MN*=-K$E:N/4%Q,R^XJ5*^BR]!RDTM[<W Y1+D<E5)RZ\S4KX,^G0/'%W$<<
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MZF2P$7<P+_2G9C+;>F%]]D:]KO?N@%FN(>Z DX'2*3G!":O,+=K4@!J7-&^
MEN%05/^ZJ$[+<.+M&5B(J-QICJ-9'M/?08'IE]=MXY"O?]*="XXR($)R]@/"
M"Q7R2=FVUFODVF5*;8FRGF4G@CA)"L_-6FF2@8M"]KH@\PE)HLD@ITW'!YCK
M<02V^9&8WQ\@^5Q.[/VN526[]52W^G\RN=]ENS=")"]O0O*Q,[^WH*OD0 =
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M-O $M1GJV!>K8W\=X^^#H>:LB=&'4..P5'WK4@E F=0P5UC/%GR?9G*C2JQ
MBUH[AUNPQG_\89+Q2"81>P9F0N:\,.;\J@;PY7#Q!RL,K^+BVJ23K]XWBX";
M%SI)8Q2KC[L+S,585Z CB7CJJV9<$_T!KDH39[()*$MXI!;"!O5K#2VBT"(*
M+:*+4%-(GLL^O'E<VQ<>VX1G ]!M8>0;PR%<$"]7^JD\4)(*%V51[W>HHR32
MD43FC"K*-V2!D/4OAO6O-C3^%GX_Z@*)W]<S#YV%T:-;O66R^Y"0I6477_H
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M:?(J%8H7TKB++CSLI''OZQC#[+ JU >C@=(K2&WU/BFP<1':^;@]5X*F(XE
M'2-$F1!E0I1Y(\I\B=3L;Y&6^E5C=U^J?T]X=W9(F%^-,*\PD/PJVW4F:%.
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M<?D#_@U1)V7:XBR"B=SW')_75U!5URXS9%,Q$47KT!Y#;(6)\'4OE(%Y0WV
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M*" 1PG3>Z= ?V:0M\DV!AM&<R#J(,PNW__F)"/1?YPI<?2AYOJ]E-7DS/I-
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M)@M^SV/U=BL24L!K/ WP6%&R[ZV@VH U6Y.<H")+L3>#<K$ -976I  @3AI
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MZ(\[R$%MU]Q=RR;8TI. 3]* MB+ZLL=)#N\Z7S7M"5)MW#1DJ.RA;'HBG0Q
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M0PS<;U:P>_$J)DJ$H"\:QE]$Y+S%@[ &6(G=-I:]6"%R'L7U:%U94]=$VS#
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ML&[2"(!;4.>[<-L9TCPF?=VE:HBT-H$N],A-%QUJ'ST@N_*)(::>+C;&!=W
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M#P?L-<(!#^CO!Y^+E(6).'.XSE2V'*3F1%V+FD(B0W;)CS=)2ZNZO"Y>))V
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ML3KW^EJX^D_2T$;AH*C)+DIZA6U^Z/\ Z0B K@A5([7;;:8W>Q2DS,5CQT/
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M<0JJ]ZQ(EUS&(Q<O&;GTI7UQ)C[X4B<(?L,$3_M8!4H2N];\('3US@E_^SS
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MTV4B>%M*.G/I//%_B@415 $'RT4;)@77NVTGW?A06]7#\_[]^$&N9ENF,)Q
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M/FV NP)*.@:K$/\0=]S2*3X9M D/H&1X"OH(*1,JI=!$QBV4I($%BC2)_!!
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MIJ#KJPIR :@?L,M&1$J')F9G0QN<L(F#>ZV1W&^0:P@G55C:AHGC\G<9_\\
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M0VAAAR(]8K_XW[\ROSU99*_+AFUK%32A:V#?@+-BP$V<@#PN:X<V$2$[!7#
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MSWU&RJ\BU^XJKOZ[<BTVP3]/L&5<CE(;UD#2%JPS'W,6U]L87RW8]$K)2-5
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M]ZUE9KDP^ %5SLM,W:9ZSE?'B41NU%H5&H\=C2D(HW*ALY9%C14RH;5-4W$
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M;$$DLO0W+VUQ0R>I5V?"N++%+0N<%QS*#F_RCM]L%'%R5EP#JIU.=9YNNP-
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M;K_-ZCM("13/)P)&)'VX<" Z(&#5/<8!*T2"SSS@V9!- [-/5Z%0AI"#^WO
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M!7'[*^ /R!W^B7P8A-U("!LF5.W0CHA>?^6$MBUA;+7]CJ-"I\*4@.RA@Z7
MV7/0^@/=I#J:\R)GO&;NO,$UB7VF/EX"XOU0OT7I@@BMP5(>L!X"Z=[@W7;
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MB2Q,*)Q)3<8$D25_XXDC7GO?,R<"\LD11YERCX&$W,Z83BXSG*N/$.#'U"D
MF80\EA&%C BE1RH]D00Q)0,ADR(R8UDB"6I,__H3QYMXUS,GF^@8K"I*.+O&
M/793%4;XK*.X/LI1/D$:59BL2E6@DUI)S=#E M?C/"@YR#-\X]2H51.W3!;/
M9]<M:^JGZ5Y=04-/R#93+*QKP_[3@%^W,O1@-+.J3<BXU!D6JZ>>.FPU4YS@
M:J];I$9/M%YJ=]"=E).A?E=_ZA7=U!"O-4?3+*%W\GH6F@UGF*$Z(2TBK5$*
M3JZ&JEJ6I%G%[*"A)Q)9'U"+=*&^]/GYDYL2BX^#]FK)HJ%;_)VIX/M2V=[0
M,D2^6>1M(J=%"IV=K6,=N(&H6O#VB] )#+XY<!7QO:*$]BX2<%R.=[NPO3K&
M?[RWE4^:>$B]VB5WSQ/;FQ]%15'FSM:.W7Y.HEJ]?X5^M0_A]*9+NU>:>#=4
M'#NF[KG'I9P_NSSFWL!?#:-$__U0J7;R@:1C1-P (B!'$#$B;@$1^ ,3(^(&
M$!&+IAM!1"R:;@41L6BZ*"+>WX#R)8R\:<A^?;CW^=',+X#F4R7UUU'#;VP9
M.E+HR^ &\6^R)?F ORH@/[S_S#MHX-73G2B_.FP13!&);:_@<8S^&/VQ,+PK
M89@Y9H80FZ?__1PZOV);\(_R0=B?.99Y,2T$M$#\K@#<EW97:&1Y$*Q-/Y#6
M8;YP,OSJ_:!@>SUNKZ'+)1CC)[;W3)WOL7ME&;&/ZJ\!1."D7@$0K[3VO W(
MQ*QQ/8IXGZ7X(YGE<T'S>UKU!E5H'O7",MS@#@U*(+U[$_(+>?^[;_*-N.R7
MZ[?OX>C>!&IC^KVM37Y;+VUW]80)U8WH3&.;\_YLSH-]__N;F(C'^@:C#JY)
MO;>>\*\5-]U5Z2:%T6._G*>XFL(O0)J2Y:GN<\7?;LB(6(LU9/0/M_#4I:BC
M*T&LFQ=M&]4$>D1%6X\+CO8EH3O6_5$[F2WP\]Q3EJA5'%<E4%H^]<<_%)[(
MI,]UIXHY..;@'\_!A-"UZH+*-9ZRN#?VY:2J3<PV^=M5@G^7@_NJ8=6:*VN@
M,6J]3?1[>FTZZPC!Q8(4324(FGB%A;^'*WMD9[1133,5%5FP@.& V"^X6;_@
MS*'>+9O[OR!\@HH(Y"6V%M->3'O?6?%%TIH+A744DCRCZ)1^J<?G^U,;+U5F
M4KY+M9OS)+H7RJ!6X@F2.-?Y]Z>YV%O5IQI18;'86K^\M7[%%(&;@,M+MO^U
MX7)%]1QSQ\U0P;7A\@VXXSX,B*B3<*CQ*EN%][(!(;-P3W.):6M)G2#2Z;H\
M;T)/.8T,"(9XH9GP]W*4_T8M*U"-ZNW)+_M=3GZOE.L0"L&0LU$UJ5L2=U=-
M_[@F2-XOZ5YO+7-?1P A*[\L_@K*&+=:BU4!%S>M=-\8IUBI@>K5O!;J_SZ)
MQ;%LN &0Q++A.C&6MV3#L.2S6M6C)6ZA;@A::7N<KK-0-D#3B*:8!/25WA .
M/R7 4C&68-MR8@KTH,=)WT:-2J*^ ;%+&;N4L4MYY^D4H;PL0_ZN& %W-TU#
M>E%Z^O7QA) ):8JO'=FE.P7);:Y\(8LL*S*;P.'_4\1KSF4L*6))$4N*NPH^
M_9ZD&')5.;U\8C-<R],ZX[(@CPD150*%=A9!I!,4B2>R:>HGQ*%>-:_#(-7V
M6L*W<$*_WN?<5IV'S(XZM>E@Q^TWY)2^1@7_OA#J#]S.&X7*??BEGV-GG1&4
MH)MJDK7"VN?)I4E6LLHJJ:Z"ZL:13<7@"3)SSJ:*A44L+&)A<0O"XG-,K3/"
MHB?6)8L;."U^[NJR7"*YH6[Y2%A$9E6&3B>(S+G\H!\1PGJ+#NH5-E>I5_H5
MKH>QS0+6Z[?RM7*K7N"Z46.G'L9U^$I_&!=4^%2W%4F3,[+FGM,B;VZSKU\Y
MQ;!K73J-N>%&""3FAJ/='\/@VX0@MDDP=37L5*Z"[Y )\UWS];_K'?*X!D),
MOS']_MBB"*PDV1[875:\G :*#<KX>O5G1I;N(M <YHA'/+9GYW$KU <=@J\U
MF4! &$K>=%Y+D"+F(B^O4VI'4XU4$U1JJ1XS\E&O.>J/?X@$D\XF,N1K%ZUC
M9HZ9^7:9^4XBP9?B9J8P7"MCMN_CY%I,"9--;TZAEJU4$# FZ40V?2[?\7LY
MP,=VR!QE+V*R!S#7Q()V&= JL40[=HMCM^*VW(K[SBTL>*!O=D/^:H?L];*D
M6O85<X@O9A7.\\&X)'!XL9!64#=:9'<0"1K_Q )-WYV.8V;]>F8]N7C]4_S\
MBB&9<ZA;Q154JFO4!C5V#N[<.;BA_-[;8?#[4L:1+Q$R9U]<O::+VYO'3')(
MRPZWJ-%SMJ]8AL0HJ(<[RDDC4HD,'5=+C)G\)S#Y:?V4NVFU]4$U7D1%)J:J
M\SF:_+M3]IF,TVOGE%Z+O>_F0LX=*G11+YIVH,U;[A38_:EHO$O#>TUE.L\_
MN6F>F8GC,@ZJ\R+)"@2#-#R336293[S%]]W)/N;]^^/].SD7N CSX\V2JA#%
M+H^K3Z4V(5%C4Q\IB/G1H0"32N!XYB=6F'PK>_RPH-1!+EV<+/[)Z;$_58#>
M&% N=!_GOBRM/4Y_I>9>9>84G;:VX'OY*>YTD]E%P8)"-1WF36333(*@TI][
MC2\6';?!)=<&RG<6'7=FJ+U+=JS6BR3?7HLLIY9K='DP8K6Y&\@.5/$[ ]VQ
MS%LEZ[YEIL9 M&T1FEIZ?&WA#HY\XS8#MY !&O',5NZLFZ;Q6J>!B6)-[*<!
MOB[UA1'=';FI%2L08:E,ADS0]&N>8,R",0M^"Q:\;-KF+[&@@^=;V4%CN,:9
M4:/"+KK,RBET$ NBME:)#$TD&.9'AF..C($"F  (1!FB'AJQO@TIU\8F ,1)
M)O'Y\S<^?[XGVV/+H@?)Z:]*OT$;][/:-"MR:Z#0V<><W;5,:( $%253"9RD
M$_AG)G[^0)J/>?V'\OIEC9Q?Y_6:H&37X@84M%[6$ZBZ0V7K?,#KS/MX_7O&
M.$Q;@X]CDFBIZ'A)-T4C]K!NUL.*\]KOPR!YY0[*JW5KW8VS,!IMHHK/ =\'
MK-RVFJ #5Q:DON+I!)[YQ,NOWYV48WZ-[Z%\F6;E5BXP'"2BD$Z-RTU\]R+T
M7U;![ [2V>Y#28>>Q(Y/ZXA-7W4AS&1>?*H]-4E<E1?"2EANO-G<%Z!K@[1S
M@D[1B0SUB2<6,>O?#"_$K/^Y^O[6E/O[DC/U3TK*O!Z7GVSU9[;T>PWU6^Z_
M"+Z_3^>^^[ !SB1*G5/\3[:;SF4[#EY*UI-UO%MPRRE%@*N BC^;( @FP1"I
M[]HD(98!L0SX:=F2Y[*5BB.OB^MZ7JM5ZWT[9YAYQ_21$& "(<! (9 Z9_U_
M/%'R#J(?;Y%"WIS/U:B?)\0ZEH=#X/S D""TL3@/_1N<JGZ^&W1%L?=WW+,@
MINB8HK^?6Y_71<?!6 PI*&BA]%Q3TC#'&\^ Y*(*C9;I0*CH +.!#.86TNE_
MO]>N<::B#1S!8ZM<ONLO-EK2)-D%6UQM,C7E#?\F,DK09"Y >C-8:&L2+)!=
MJ8X0Q"^%<-W!C[UPU>C$<;O4!IB/@2U8>F\R33:&)D\Z&KULM"?MKGO@+%6:
MQ5^PE/IP>M,6[36W\""Y]()]MCS703N'"#@VGYJB;0N=X7!ACI741AMTJJY,
M/3UFGX""(J=IBDC0J5,'*K 4/AW6Q&5A/2KZC&CT; 'W*IVGTB2GM(R<\L6P
M9FI>471&^37?H@IUY[$EF^,QNRUE>#;3!0LAB(GN'JEC2U'W &9.L'^_CH>"
MNE1E$%CR$28RI9G>+25EF\NG2P1?L#LY4^_<%M63OX^'Y[>U;54";6 'F#F+
M#:,N#>1YCE8XCVXVV K9+.(Y'V(#?Z!/F] &5/\5X/YRPO\B<*>]45;U]'0*
M;S749K9A,&RN&X*;/$/W%K!#VL=$!U%Z 4C!AC HE3!$E0%"$+P2D#,<"^Y>
M70)]_0U".W'>Q7?-N_CTS.TOEM2_$L<Y$AUY*!/6$!5AY6W6=6UU[+GHTD;?
M;(LOG/7RRU)U8E6;<WZ]-(M<UN2D8JXCD$%!8#*32--X@B#BHL"Q4(B%PM7L
MB:\6"EV='M8:&MGF/2,M^4^@:#390"A$#7"I%VSK. #\3T "4_@WL)VHVRVT
MM":JI+IQ]#>.E7WG6%E,T3%%?R^*_A[1WZ.,[;:]O>,=AE027Q2$>?L0^]<"
MAKM]!"H7&C,M.[#'Y$<4RWLU<F).0>MI/L(MW"-LH=KJU;F\V'DKF>="L;^W
M,WJ^# Z *U:>B%FOQB>GPBA;RXT6F[S_QS_X [3NSMW .8DIB788.OV"LX+/
MIJ PXLQZ[M2T(:_)9R&V6.!/N.*)-8ZD*$;357M0U-ZDG(N<E'PNW;QK]XU1
M<9,MCH<X-Z^2,V?1Z"SZ/11N1][ "Q[!2^'WW9MNE'22#I 0 'W3EAU@O =Z
M%<?Q7H!<=6R4%V.KF>3F=J[&IHR:.IVR-THWE]UZ9THM%I*Y&?,M>E+F._+,
M7,IPZW#;X!WTH@8S![%I\_DT"(L#4#<;@/JV]9$.L(>8)*FNDB'J_BH'_PB/
MA8%9HE9\05LD.\9BLFQKDV+G;*KI[ZXW_(@F@M""/*O_O1^&B+[:NZ$04=)E
MG;68:V*NN1S7# 175H?CQQ9?,AK><"06P=3S;Y!KOFU8\\A'/)<M]%5^XMO!
M]>V(O? Z&P73Q],2*!>-%L\MY*S')ONI;O^)_7TC.7S%KWM6=+'Y_[/WI4VJ
M*LG?[Y]/89S_3,1,A)YA7\Z=N1&HN"MNN+TA$! 1!&41]=,_!6J?[M;3;7>[
M@,V+V[</76)55N8OE\K*7.>9;:D+(2A+9EE/@HS%N_;>S;)+WJ"@;Q>M;$^:
M0WJ&WS2P3-UE<_87W(S/4M"KX,4,0O;'NI8MPB67<'-D*[J^:52Y]BR_;C&0
MV=:(G93Y^0 >-XK"@)4$_R;>251Y]2RZ"0H-\U65YOG,?"P7>0_S!D Z_X9W
MWG"D/>*SSS"#Q\\(T[#<I[/,YCYI].A,LP%)U?P:@B=L)M>TNCQ+D9[ZA4C-
MT<:\X6^6$6]B4IDYQVJKU=0HD4[61V_C:E^5IA [H4I.![;T*@]GQO.>9E?0
M2S+[&S25<ORFC8J^PGN=T@#!VP5BW5)__(U3>!HA\4^[\>F4LI8,;^?11VA_
M8I-LO !SZ5O555<7V1;NYF7+JP?(G20;7Y[6[<S8L\=T4V/GD-0J3:E%BX=:
M9R4;/TNT?Y9T?*<\S'L?."8'K0]XT!K9O,SKJ-J/I&0]^_;0[3F1<87*G:F@
M.!"J=VH#S:HOG5&/;@E(V-<(IY-:.PD6)%@055?FPEA07B-FF2.W2X@3BY[6
M+F@+2F4"+"#>P8*'3%?9A2*SKT*13\&=* <ELWL6:HTJ!8ID2P6V"E/4LN&/
MFP)VAY!:3S5R9@U9M*'J1A\OEP[!YM?OAGGN&90\4##'+_#NQNALH.+$F[,*
MZZEF[PYA7;/5K^(.6L&@>3/G+*2*U9EL6N<')2,2V;D/KYX54E.H D:7.]::
MGR,FVRFH/7N)WB;!)JH<>A;=_*I3Q*0QZ^IS<>NLU44.E9CP,F#$(Y%1I_L;
M4;%)9<4U>]6>P<_SZTP9+;<-JJ<&9?81'$WC\'$CTN@$7^X) 6^05![FJ8$B
M+"IZIM%OY,IR;;S1PLOS%'FZ<T'JC/-EO;KMB44UX^J;8MMB,CQ6ZK35>YPO
M[\*@+X^7=TSQ_BK&4K[L.[-\F4=<K6W5>Q6E?9]5/(O@OEY*<K7X,=)1DEN$
M$0AA?4GO7=@MG1H4,LH5RW-]6>V@G:R#9/,#54#"+I88<NH,*!'N1+B_IW!?
MW0*[L'"+R*R5PY"YRXJM*3,UN*QF+5N!<(>]L9/.F#_^9L"G@Z6+1FHA:C+X
MV*&;5!*,3X+QL0G&G^%GP-5ZOY5O4A _=ROU,K%8M\LJ<P\_ WA]" [^0Z^4
MQ7YOQDL$[O$%+O6@K2)>JT=)\N9>V $.F"G[>A>) _#A$O"/V>HENGU=P)?\
M*UX]'-J**VJF(K.B;0)*.<\D;U]H!ACX8*E O9^P](5682I447\%Y=JC!JX0
ML[K9900T;+T(PVD"1=(D=NS-_SN1YD2:XR#-J2N+\Z6[,7Q-G!TBSS1;!77-
M<Y;10GP!@BN*&H@S<-RI- '1:>I$^;Y_?P/__;U*7;M>5DF]KL@UM8M.,YS[
M=[R+:GN<]X0K9C;5<Q3870EX"W2+:E^VJG)/8HFQKS ]D?0VQ58P-30 70HB
MTMB)!IG_3@ E 90$4#X'*'$SZSZ&*/5L*5<HPL4*F]%\&M8JM:S9#Q'ER8S#
MB.,2^O^^1->M>-IMSYJ8A<DEM[+C[H>Q1Z2XFSN+ N"0+2_H%A,)6#F?=_YQ
MC=Z%$:7*=V]PRICR21!^C;TV4EC.\&VCR587[$"3"G1KP@/L#;N>(G0:(J T
M0A%)V],$5A)827JFGHTK$UBO9YE)E>(1RH8(CB;K$X<)<&5?19_"R31,G4J<
M.S+J_A.6[+_"%LX\Q]4FFZ^[=A>?F02,0\5^82K"U,<,Q:F2$B7)FH-)!CT0
M4J;E!M9BT ')3&G@]:H=9O/8;I"T[(+A@*-":0J/,2>:*9J2!H8XAR0NY^?3
MYD1W*_XC:ZN__PM^'#XG&8IH!^ SW;_\"5N"+SE #_3/JX#$?A_WJT*P9R?'
MNR46,D%^Q].\PY__[_GT?WNY&<DR+/O7 >J>K6NZVWDD1#U5R8QM1=0SX@1\
M]2_1\,6-LU\G1?U$L /&_GJ"RX 2*?PG1?TS]?O7@!Y'Q)R+Z\PSDKWP;G:?
M.CP*X?'PS'+"[+%?MF*(0?)[\.X7;PWW)8!T!/Y)7&E;7IW>H\^P6DQ-[0!'
M_Z_+Y4Y9".\GZW0#B H$*>AY',C*$T^*Y_#E2ZJ>(I<8(JN@**@\'J.RH$@P
M+6"$(@GT&"4%&H9AG"1%BL3)'[MOO3(S'^@((^?IO#S395+51KE8ZG923*[%
MESOE;IEKI')<N_D;67;K['29+EMG&]T.5^":;)L)1G:0_<KVM* (A,8A 7KQ
M].F3SS\("$50!/TT]/JD>8\:.3 KKE8&1&'SN\[8;_95>2)'BBND?J_K>GA\
M<D&7L)P/>X=($QB31$&!E+& 86,*\/%X+$P(E,0 DTNT\FJW"7&,4!-Q(HAC
M10&?@"AAC".D $UD&A5A&E(DZL4G@!6R,%A[W ;(J5>'_75ITYD9JMP28 %_
M/;*JE&K5'#3L\EK&[(S5:='>0(R '(\<^OIVB4]57B_6F#J1S[4:,G@G>CQR
M/%&Z:K70SK$9ALUW9WIGG:-] 1.0UR.+R&QJB)(P9><^ILZ&$V7:Z#!@Y-$[
MI_69.1N,!EFV:'C-.3/-$?J6$?#C=]:[]%+C[6X3RLW6NEI&>*?+JF#DT3N5
M<0W*5RU*UJN\/?7SS5JON6$$XL0\%_Q\UJK)8WVI=HK%D33LL8M@Y-$[N77)
MT!NM*<=OUIWV7"R-*Q*G"N3Q.PE]LUR:XTJ-K8[$:H[T3273]<'(HW?J_+C2
ME?C>5,^,9M8"&]7P]<H7J..1&=;OF,:XCO";AEVM;9LLTZ1: OT**X+<;W&(
MY8IX@>6UGNM@L\V@/3%],/)HGK0G$<1VV_4A$>US"Z;2AI6%"D8>?7N_X[NS
MQC3;@N96$\_GFWYY.%(%^#54@:%Y?+BD)[TBH>?0;A5N66;>1,%0^'AHJ<QS
M[39);/@E;RIZ2W#:-=$78/1X:+G:9K2>8:!LA[-%%D?:[6Z=$6#L>&C7@WN\
MM'$'D%(QJ[/A/"-B<S48BKX>"C?R?'-HKM:05B(E?M-7Y+H*WHJ?F.NZ!6BI
MC$@6J6R(Z:KE5?H2&$H<#VV,.(7/;N0B6_4EMI(W%(["@(B2QT-KOL2/*""
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M0EB6)*B*$I0VLQ:*#?YEJF";G>!:_2-4D'Q'&KY+,XQC,OSCH=MBO-CPRU8
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MGJ/(X/F?@B#Q]0[O#MQ)7.0A?+_X<7[4")'$19*XR)WC(C#Y$PV_@IM,P&>
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MU=8D?+ (*1OGT,:]??#/!JIO2I>##7C'$'-T4/;20,HX C=YCISM14W0V/J
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M=;[O!X#PJ+4C0TOQ0)$_6HE3Q9"#RR9=VW/<-/AMGZP)?G,56W'<.'N.=T?
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M_BZ7;_+3/MSNLAV)\A6KRZ[[BY: P3&WRRY/CGW_3I@DTC1V5OG7%^;9?]S
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MJM;4 DHRJ%8.Y(R'_[P74O/LY',NM63!_,_(D, 1"JD$WK5D>,T360'S1-A
MC71C1FV-(5T??&-X#/Q$D.A>\$3@C7\GL0#1SET6?M";3Q!1\9,^1_7-\21J
M%JB1T+73K0Y,"!U_N7\L3L5PJ6!OX0F5N]GGSD"CHLN@?,"$[0X2C>N*;[)G
M&OP9EVYB[/0MF"&SNS2J(/D%0?>\8GO++ &%/?(UH!3.A 1Y;!*6/?:#/J-0
M266J ^B2131CQ5[N"SOZ,XN2T'""&RH+4?1.N1J]HV 5ABD>IF 1C4!F?'!O
M@:Y5RL)'*EQ.>JB4>Q%=^20"A!F;9*Q:-B,DWYSU:&C[U/><'XH$RN8H-Z8+
M9A* *K,@2FKR1LBZ4J3!_DXP(DN$SPUL;&<VPPL,G^][%Z6%9_)U:T+G8_4=
MZ:)4;*T6C].XD9064GG]F+\<[^'LF7XBX;%V_P^N/O7;SL!2%97>IS;EKHT1
MXI"DM6IY3U2;C1J>=[^Y&0PN<P^:-G7JH]2XLGZ<+^H'Y<$A1Q,LS:I:%B5-
M.EFZ$:SN<!O72.D#O]IQ-2';IP)*?\R;E:M2<:KH9OHT=7O3OD8O4T84(X.
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M]G7^IEM7)+%WWBXUR_?SJG(UI@N%O8W/8'.W]0-&^\QRGKO;'3 %ME53!I0
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M^1T3O/+?"5[?"5[OD."5?%&"5^H#$KP& %N$35*H'3ZT#2@IZ+J:F=V#?2H
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MO'T<-3=3:SZ^7_'&-^))^BU;*WZ^/[8>;A[@XH=!N6?_+KP3EOAH^-_'>TF
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M,MXE/@O\""[N.5'H^L:N8@?.Z\# ^]8%4X*Y<Y%$)P.J))U<B.? ?0Z,Y8_
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M>$[F\.R 2_MJ5Y@QO;=%PWQ['7F]3[_J3LI:*D_D5;=(LLOQ]4UK,W".WXG
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MZ[XB.8: $\"TV4\?-B1Y-@0G \G?G-P2[Y^IR<#FV<X5=]&QB.#J=VQT2O=
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M]T70R*AD!K\/O0(%1O;C>MZTQRCPC#"!]R@0R%QIV^"".)GP.0MWZQ>A1^!
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M4&M'64!&D!.>L^#1>>9@6QD2.ES>!8M%9S"##MF.<-3PN [!8E47JCPD92Z
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M&V\[M-)/&SUN.S.FE7(K3)J.DB5.3YM&ADT.J_7"YD%4R&*H-%WEY<UV;<8
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MW!-$ADJDJ=1_OKR)2/H^DSHE341Y&?)\'3QSK.HKEU;NWU$HJ/X,#4E0HBM
MG7_FNHFZOOY!3<#EI;3W3*=*'[W8O508FKIJ6]+>1"\30AS,Q?OW4U7I;2&^
M:"&>LPMN"_%5.X*XIVZRZ2)6XB:;+F4AJ,QM(2YA(8C[Q&U+7,1*W&33;2%N
M"^%?".J>(&\K\7$K\=H(U'-GZA\!QG<)^8Z7U?[IRF%B]]L_D>_#)_ST37+@
M[XN<JXKX*R=Y09UY+ALP_'OT:;K4M4]__M[^V5V9+G/A8_?QD_Z)JUCXB]-D
MKS)UOH=>.X]U]WVUW;5W%;HJ5KAPY?<->@A=$3M<O$K\G,XY6"G>.N?<-D)
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M/C6.O0S5@)?AE.S"OHD7B2V8B7 ^L>7M.6]WR+.Y"A?4=ZUG!NVK>,R1/J4
M!H$N?H7<VSTM($)?*PK[-U%X+E%XIKT-"&2.X:'<TO]&3(>VIQF!(@MQ8@QM
M0)^AZAQ<("4<.A]8+_! BJ8O^,S>G0_1DD9335Y "6* @Z4UU45=U2> M4>
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M[M%<[\7#G&6K<_FH7YY)=>GRM#@\JQV*;;/ZZ5]KP81K/[)N-(O<G1EN-#]
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MET7\B)F7;"]^Q.R6RR*N,%ZR,5Q9GAN8 5PQ@IS2FCHPO.U*#DPMTBS/"\P
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MUW#H.['X=#IX:?S50'6CDA5KL6 >Z]N ML=]."^Y40R-4]OJY$XQF/0 ]EN
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M81MIG(]Z"V8AV&[;0'^0K.'"!=M!!LA8S<6J-DP!"MQ<*A8='DE.P:@8^N2
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MM1Z/K^4=]S+L3DZM!U"A1C1\^Q+KG$X$ZBWD#1&B3HSZ^"+W <CPCN7WE6%
MV_V^;5$X<RKH7AQZPGJ8X1+DTLB!/XMYC'58/:-G^@[W@2^$-&"EH.FKGD_<
M4R&,P",25<TH^ FIS/L3,-3.U-&8]VV1_S5"GT2S)DJIJFF.3XV?P N#@:Y"
MWUG@6*1C<,#KOA.&!#U,,8#!CP!=AHG[*\4H-29'C 8P+!UC!3$!J#?L"^P\
M9;8<1@@RLP;O-- ?K$[:C#L#&CB[>&.8Z9'PF$H\?:0C,CQ&.4UHN46><'EJ
M&$Z$1H?4MV!VJB&DNZ%O,C3-@7@]#NL0&#$_%T*9PU-3/1L\+2H\0EL4;WYB
MR ;.ZH47SQ,V&%"@"WY6R@<Q*N,U V"9R'6I;^-+%1,H9EM_<;KA:D0&A\_8
M0R!N^NTQ\R3&+H6BB]7 5[:"+_?+WE?NLY0OS#+@KUP0*  ]!SSS4$><KHNP
M!Q1%@S.BQT!<JI"]9%CX5D)K G&W$XR%/NIFV(H;6"+UO[M1@9(E?+RAY%G-
M25CK"-.V;L82=PFJS=T[2!$J?#-S^1#J<B):[UFH*A#=BEWUXJO>$AWH&(A]
M,9&3*0+0>+\-\48:M1NH(ZI2.U%(A>,*0(6<=B,370E_*:0&S;1!1$Z09-&+
M(7P'VM:$=&@H$IE8Z:=1-_Q(H('1<0'4J4E&"U@HX%$@4PG>+GX+&&_4))L2
M'(O=E1/CC:R87J(F-#HP?3>0>0-,KX;?SZ=,HUMX)>G2Z+@^PDMS7U10'X@I
MVQK-Z6%@1#D0=P:<\0SB%"<?MNFD#9+VB\WC%BS21TZ'ZB33)(+QU'8H#U4Q
M9G7)I"4/./ 7HQTP9H)VP0+P;8I]+A76)+(-SZ>;]S[:)*H>L36,?A_I!AWC
M,B#V?D"%$?68TVU"\G#B!6>=7S3X X:8AB! %0#S*]'5M*^3]=OT,OJ4O06)
M#5D#(2 -2"67BG$(-@RV1#8%$<NQ(U$2Q,J2**6Z+#[)PI.O6[ 15RRQ1U\(
M5099.A"NC,C%4 & R-YGD2]0JW02<X3/YT.-[L3'0M2O,-K8MGUG3>'&B)=Z
MO#?B'0/68<UXA N1A[#:ASG[E*]GHH18XP2B)P '9BV!FC,8:YG4VB7.H8@:
M1/4)^%;@BFF'QB5]M>43W)\8I0O6Q.]NH=".IB^8*&=TVZT9^SA<M@4):8AD
M/>C&HZ&'*0(OJ$'+?&1#.L4J>C^3;?"A])Q5L.DIY]1N?&$B=6EJ:()@+UCL
M9$.AUSD*RUE X3U0^3KG:7CA!HZCAC%10J?$5%0'=J+J<3N@#)> 99II:?A?
M$Y$0P.154Q+/L())9=&ON<@TW07^NI;O422:EIF(*LIPYT9[!*.>%AX1JQAY
M? >8;:2+/ZHF1BN+Q, FFTT9PR37&F1SKD0B,)OM"Z'/(;X\#W^7F#01$RJ,
M33A$W0F)$=C/UWE>$U6D*.W/:*@!;B^$Y2QW6?C0 G2;YS4$^9)B."3%<LZ0
MB[*./B2B#DQC IX7N @F[@G5K0H.^")Q$X9Q+D0YD::ZW>7PWX".1F/@][[K
M_3][;]K<-I(EBGZ?7X%PNR;L"(B-C9L]U1&R+-?XOBK+UU+=COFD2 ))$5T@
MP,8B6?/KWSDG$PLWD9) $B"S(]I%D5@R\^P[L(!=YI:=DUA:")"_-4W=Z(ED
M)(JK+DZ;*\/"L:P5&.K#H8B@8LQW)4:,6"!B%V'5YS _YI$*#0:.H9NV*?[H
MP6/[?9.<] MXM'0S("^\+,@\$7H.HO#N#-._M< 7$P-]H2G@Z_/5)!/.4R(I
MV K-9!QAK#*,-"D2I-S.=R'L/8''@*\H+TG8+/HO\!V@31DRI\O/)7L90"]H
MO\CO7I';5R:#=753IH/IFF//YYE9NM'MB30SE$!YR/0!]R1>LH.$XA6(NI<<
M8\MPW.'8&MWVACU^ZXP==CNTNN:M.68V<SS'XC97.<8U9M[V3B?'F(7,\P%1
M+\EA$[J/VJ<,]'WL$/-[!-^?NZGV[N+RT_G[_2<7;RT3=F'*%\P?.(XQKQ6S
MF9#1*#Q%]H_+@2.CR^>M8^N#KJW]>?U9PU,#ELQD!05^(M$A<T\*&?\;5FR$
MN3).$&&4_"%S5/(0)'P5Q7<LE%/02;]).+F[IT7!":GZHLX#J]Z"@-,H6V'$
MILAGBVH><5\$RP>+,BS?*+PV\3VH'.)&%RMJ2*< :R B&5'94M58GO^Z$!OC
MF%-"S:) M4&0Y-:2N(74)\Q$Q<-9NEROQ5GZUG2PQ69IJ"%<Q&AE!.D=@#)<
M6A@:*!L65Q:IY5@P]^C"F,>3H%_("!/)F_?D*\5C$M4RTJO1_64^N_DX2MU
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M]TVF2*-K<4W=[%HU5?LI]#[DOM^>!L)N.23/&)IZO__ZZ4.'4-B?C-!%"25
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M@.(,]+TIX#9V8A/@)<QF@)N@TB"F$RK$G O),X4E3@#4L1:@:'F8(.>2;6D
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M=!F)8(^#W@/2G=0>8L53%,[_6Z".4!/@5<65J)[>"XL#N'$NE#U\.F)Y %@
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M>>H%R -*>5YQ*K28,6>B7@K+JJAS:7C'RZ9;7MD*:^5>BMN+EBO8OE52@^B
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MIAJ@-)S!VVXNOW2A(3U#$.5Z"-Q5JBS2 EJY59V04YYR@BJ[P$XX-7BF7&7
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M(!4]\H43@16 S$IP;CM=M43X\L!Q72#HW,GRH=)IE:^,)*^HLN)5RYK'!)X
M/!EA*^$$H"50#) >8@>^4KY,'HAVCS< ,N*C!--Y@D/AS_GVBR<4JY',3UPV
MBY+TK'BZN&F*D*K2YXA/V+T?Q6);L9_\=3:.X61CV "=E#BTA/#%%^M?Q3;+
M?<T1 W[]9^<:GAYSEF2 %8\^#SS-S6*@+7@>)\I&3HV7$B' T^XPYU\LR?/O
M?6 ]GKQQ#=&5V%.PG3#2QEF:Q95'S-@C0G*!B^Q)_$GV.,\)US.S'",?6!6C
M:/L(3MA= ?5\?P)YB-U&01 ]D.*P2 051OAA)S+LA6H;*9'Y/5)]=F$;;);P
M#_F'ZEM[\"HYQ7+*?IXA4L*IRX4(_Q3+TBC_@M1@\<V<#ZOJU!+7X#="F1^(
M895IG*^K,C7SS;:.N=ZP,U1#.8O'B@MG!QD8;)@*$ T A&EVNFIB<!,@87<,
MQ9N:  A%$HV!1&>H9FC7"(AGAC$W:4L'BV(V;M3D)G7FX*-Y=CUU5[#,%L\N
M$A'O6@YCDR"O?T*5 OWK0&^:M4V??EI@'7ROJT#_(JG0CES9R]PM0ZXQ/Q31
M@]H8_O%D8TDB;E0VUD)PM-L9#&OCS@IR30MK]SK&H,Z,AN%AL@OKR>0X%D7]
M1Q'#\%%0\22E8$8;-.[=TVS+"-3H=+OU$>C.E>1E^/U2]TCFEH+1&=;-9_<+
MQM/27.=CKDIU/5H%R*@U;[49:NZ.6*X"=A.UW=<RYB9SX3+[2NFNS5)Z[#H*
ME90V>BBKOW8N>%"6=^KI]YA4ET8I"R@A+DPPP=N-[D)XUO_/WKLV-8XE:Z/?
M]Z]0S)[]'HAPN2WY7C5[(EP4U<V>:N %>GHF3IQPR/(R:%I('DF&8O_ZLS)S
MW73Q!1FP36EBNANPK'7+E?=\DG(]DSN7G[[(Q70Q!9+2ZO[<Z3:Z@PYFS?VY
MTV^T^K9*6J4,<*X#\R^M2E'/Y(1#PF("^9%)2JFD?N@%BRDEWU*RJ9LRFD T
MLZ(YBUV1S+LD&5[EP,-T^]W&<-"'YQ:AL4;(]>7KIL1'&AN#RY3!:F834EYE
M(K)?'_T@L":9[<+,9)AHR/>?[\4BIHV@%$G7\J?__:>Q-W0Z7K_?&?=<VQMW
M6C,VGLR&SMCI#^QN=]CV^JTIIYV?W-?*CS?N^ZJXP["Y+ Q%_[[&G?G=C7%3
M=I<T?Q:6E(GT.PV[Y61J0#)YTX]BVI:?) M)Z"Q^@ SX\K('E1M,:?*<BO[<
M:MHMRK)]3I$$T&*GV5%5$N64VS32 8S\!B_@7P*V>B<3,T7XK@V;\1H)#DM#
M5TY'RPYQ%%\_] ;Y-(;_R*1G*'T7DE.C^*.,-1KK$FDA#DJ#6\YY,/O#G?&A
M/[K!H_N4R/320=/IR##F1Q6OA)VPNLW!X+\L_2/L1V$S(>_5V+*,LDG?RF:V
MBK^M24$1YY)&\X^.W>R]TK'D[D/;N-2N=1>SV7__Z3]O+DY*$R_@9RZ'XWLW
MR"1?B#]QF8#)Q)PL3R@K.%$2ROWK!G29W=6R[=H1DW"4?"JYS5"$VA )^IA1
M+GF#S>5<G]]7Q3/@)<!R-,< >3;L8%U:_BE'/L7O=:/5[>%#7)ZIYY!AB:'<
M-'6].Y(\G'&@-@5'$4:IK*!Y9CT65G+DF)TO-L-'1C04,LH:<7FF'H6Z!WCT
M_IY-?2X,@R=K,9<B$%\$*(0T)9&!+Q4(K@W8C7:GUW & SU62%(5Q*@H5Y$O
MD=.4HJ2YMPGM\@IOE]'>Z31[=;+B?B0K]CJ'<1 OM^9!L_O#K=D^F OWHN=\
M((FX+WG._1^.MH?-]H'4(+SH.:]$^'B/:QXV^_WWMF9N(VD.O<O5%9<$YEM1
M\:NTM-8:/)I]7=LS(T)KU=JW4R9W5U6P3J-\TT3R@*4IMYI@FC"%#ZVFW35"
M2Z^67TXJYL&FER_=MA<L.""-=-D6<2L^Y%^*M?WZ(]/2;O&@7H^6VB]&2_T5
MUVU7M+2<+K9>,*F\[Y(F.B]'$RM@ M\E38!Z_"YIHKLA36RN3;\+R5'0L-_E
MX?>V*OP2.OEAY,]FE/G<GK3P\3_]]?3?"__!#0"&Z83BN=>0GI!@T+1E_2QB
MT2^KSN\Z2^_MT46%!E]<M[AC8$'N,RJGB/^_G*+^(U) >7[J#T@!_1^2!P@M
MNZ8 J4S_@!2 .O4/0 %YU?EPJA4RV0SP^8M01E&W?C]$L)]N[5WHR_8KZ<OO
MG"VNRZ!X<PJG_+074W;?__'MM@7B*Q[?ZO2'=W%\Z_(=#OKXWG_?DG5I#/M[
M?&_H7CT A7!_5H_ WT[USF\_EH_4J7VD;^0C/8#F14ZC;;>H,^WK.4IW'(3<
M$U)9Z4S]X4AEB4>U)I6U7M<?CU16>I]^;%)9[9Y]9Z12^V@K^V@/DQ+VTU&[
MXTO_ WE8#R3 X#1ZSK QZ QJ!VR%E-X?ZW1_&/_LCWFZ/XK[]AV>;NW=+4FE
MW?\#[@S*HOOO$M/+V(76,V"<#K?-<3E@4]WN./4W:G=<NGT_<MOC<GJJU/6X
M_%7[WOWX)9H4EZV\;EF\9<OB<G*J6Q<?>.OB_J#I' AFP[L'>AH<"&#(>S^(
M?K-S(+!$[_PDG&;G0+"2#N,@GAFM6"L;]B/%*%OB6C OWRCDL9IY[TF'QM=K
MUTD\\V#+FU\4.&4=V]KY6E^@7:?@#8>1D?AJ_3KIVN\ZK_#EFCV(6[S/60O=
MYHLD[= =W?7)O54GQ_V5Y*_7RO'51?+K7\0=WCH^2+LY>(F8XZM+PY=L&768
M8NV+="7^\X6:^=5R;3_[&KUL?[?]D(%;7]9]OIE_?\D&;[5$>^O[]I)]Q/9
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M^8.S[1W8$<&[MDVNR7''[CG#;C6*MYOKD+%ID*TNP@] ]0=/Q?O#R5W;.96
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M%A\)/$'H]OR[Q:G;GUI2.]WCS;CD*G)VX8?O+^E<+R:)/_7=V,>2O5;'KNQ
M7X?*:@Y5^TI>PE<B+A.(Y3>]2=4<*7LG!I;>BFXY='?/[O2=BA6MG;5(KJ\
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M^[M@[UO7H^^,Y@?G4>K/^.R W:K>#K(&O3,$X+2JUV!=;P=S:+/!PTL4IO\
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M/TV>MU!A?1!#%)+=GG^W..WX4TL*RU?<B<$JB;_!3EQRB9U==05"WA\C?B2
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M(OI:$]'.B.CTWPN^$NLL!#O/?V#69>"&ATA$/]=$M#,BNF*WONJJ>@7.@.3
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M7IRXWR?M?"ZA'<U#N1+(N5L02#7&3Y(%YX1P*M$B35*7.BUQ"0RLAS0?P[!
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M 5"=2!;\7WJSC6- _HH\E O6[\=<B:?CAALZ TL(!.F4CV;!.2>@,.=.CM/
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M\2=0/1[X%9U"L_?O/G7Y-H%95>Q0Q[F^8?QM9GWA]CHG5Y8?$R%21 JWCQ=
MC49IE$2KE-A(;MGH,6P@=CAI)H08PT2% J9E2J0@G2P:XL>JV!T;_3P*304T
ML06&GHO[@3L $/R^U,$XAX**M&GYPOF(TTB/(Q$"_[6(_63J>])#I[4H/A34
M>FAC06:68H/BJ5@HCBP6BNS75_W82=V5WU8CJT6)I\%E++(GQ'($>+E:$DQ?
MY7-JOS0V=<5@F Z90DY[M&1;HKBX*YZ+F?;>0L*+0/*N@B" :C_LN4ZU?F44
M8K1;*V^ I3@?!$>ES@JNGH A2<U%\050P6'FF/;K'-,ZQW2'6&RT!QD=(-,A
MDM]2RDM(46:(3(P2EDIYX-R.CS0J*\:RI -8WM-E8U$&@2X0E(&O3-BJ[8Q$
M,CQ^_S/5N2@-:-QQ6D[=2&1C#<;9C0:3.<-/ECA%K<@N460J*!4"58 *+V1.
M0U%I1FD^"CT_"*#J0=*D-@A\2ED@X)R&S"_"<%QIF,)$T] U5\(KD_DUTOXZ
MML951XW%]%N@R9B1;Q--5'?*.T!N0N@7,UIGIF:,$+G?#6B/1;L/H4]F =2V
MW"SEBGJ>6[*X5NRTHCUHJ,+!QU)U-:IDA"$[P:@9.!/S)3=&T%TV7S'*X9ZQ
M?8B])-$-%"WJY(&&^=Z,6<Z"A)$6)N)B1EY4KD56SK4'AJ[9;$,M7.0YO=Y1
M4N>(+>@5J"WG$4WP.!N;32<M&C9S TN1*Z./=RS4+HU&D4P$1YB:VU/F^W"Q
MOVC"5ZKP!1=,[;4HEG[69J.67EQ=D@5ZRU4;J\U+HX;1GRM!OT1VL84F7N1F
MP(5GJD(U<RJY#PP0ACQ&I:2WT-\US6][,0P-<AVQ)92!D<^Z<U/]9G3 JE1S
M<$UCN\Y[7]@U1GX/]*")%_/40S0FA%8*X6?^S;P5? ^7CY_-XAY*V<QV-8$P
M5F]9R* F6KR?ODDY'.*(Q11E?U79+B>?"RI>%."-0 K/3!ICU.2@P54IBTP\
M2B<R93.PBS#;DZ4?HMD,'D&8!A9C0UT-"@DQ*+&)G"U1REP,Z ^B'1[7%:%)
MP9%9WRZ>0&H$10IL0RFUX.2.D9/D\C7!0\AIS2 -@(3E/"N.[F4&!^;CT8#B
M[!)P;:76$5<1 IFGNR5.WFF66,BQZ>M.8QIA]*94 !=Y/X*@:2 DX01PI]$<
MN0'$D:!!$&P>?@)Q*<$F,/X!3E0CVUTDF10K4^\R#1#UQ5[/)\&7"!B_E%K+
M#7-@MPWID4")!C6OLA4OT'3>DXC/0CU%!H:'VB?(7CTO,^EBW' )K!LEY%&>
M"!W&DMTCC#(!?;4B <3H*XWY@W""D@D<^0_'$H-M*I*;L<N2&G+M._%]5ED!
MJ[1!VC\#PD$('[B!U 22L=/K.H/:^-C8^&COQO@P#T_I<;J!H0ZAZ-KI#&S?
MFZ5<R8:&>J=0VSS1N:-1K"$]L\N2-M :7=)/)$2D AN9B$Y7B 0Q+07>RJB9
M#4/MB4WY4E2I7DP'S5L3Y2,]UY0R-'4P-<RLXQ$4P,4+SGS!\=U @P'E(.!%
M0HZPNXX[\N]XQX2)(+ZB-A[W]-Q-INZ_Y>H@SE0&8/<,=LP'G!Z;6HD83_AU
MJ&2BH8&25'?=D9?F*];@+WRK?I(-URF15<CV2<#UXN2/)P5@JU]%FZ60K1>R
M(TO,;A44MK:'A2W&CLN]TT291)=_B+( <1<289GH#^0F\[]# KITBV,G#XFU
M8[2A@QK'[W,AFB*R,EWK5^F)&DTY?2<RX5=>*0T6EY$.G?,H/,&*4RC?X8..
M.\-.O_T*67SO53!T=B,8^+E]R!S<7LN$3B;G:XDA^BHLN"3+[&48L KN^.7R
M0\DZ'5.3N<7"EE2O \T804X(9.L8X6XY)Q0U%9PMD*.:%7W4Y2KB<@\YR8(E
M7CC%H-" *I71U-EDQN)8@OF]>5:WUC 4R+EDVH^NCR81H=YG9YJ*9IB<7<(C
MG(/ZJF\8;*O*A1/0IH*D3,YM9%6*MV33XQJK#XX+F 8_&BP>C-4[#:%7;!IK
M8O,(<:: =(PX,^* $2@0)(!PV0WVGQB[9%;4MH'*-":Q:',E+"^CK;H+9K\+
M3Q[AX*(\'F^9:.@N"Z; ;S$7S5A$!B#$BZ0$*WOIL24$J<S*EW/"NZCQT1JJ
MB X\F,DB@0@M_MV#FQ<$RF-Q'TV-F#(NZ %QXUE X7F\AX;2I[2:PNV54WLX
MSFP6E:'"(@W\-M@;.0;\KK[+5X6E9K& -*(V+,J=)74 44"%QR@++X"S\&7F
M7UC8)P^P]HP UC=?]GG(LIX"I135:V.4]1,7^@TB:]WY\53HN\9%D2N!1S2*
M._QVB8V"*%7INQC)^#MJ7[+<EW.# %T-DFK0C1E[?D+?(:\1)P5P02'*\H1(
M_@Z:$T%$NL%/G#-!4L:%CNB'6NK(W+)&GE#N(:G!3_.6@B2[AJ(!IFB//&8"
MPFO"0C;SP4%N>#!CJ;CS[UI*D50G)=R2)MYMG"T;I,?UJ2FUCY0!3U?S2:"'
M*7N0Q8+(UXWA()GA-L+LB,!=8'&Z>TQ"0O 1]$.\NA;:%>T8A<@:]P<]^Q4*
M,]ZK"MK=43U"YM!V "_4.N#RYCRZ4#90I*.#H&,!5K=EVZT&/S+XQ\!N 7\A
MP!(0WH'VJ-NMLJ>-6LB BP%K!#E+]]B%"?!^0!4J'27_O<^9[S6 ^4.<@,_R
MSZTF_ZH-#).^_XF\O$O6M'*L2Z6^$; &><_QF^3ICA:I2N\R(I_:I%^2@WJ8
MR5>#.OFJ3K[:?2-,PQB/35CA:">.A:YFI,@>0%5$M&K))T#C,MC$9GP&VFBL
M^U:6<\9,1.@4E]-IRC23AL!'G;LBP(U(R(CMJI"0)="V::''<B6E^6IB.A9%
ME1K:0)GY<0+ZVFR!R&!S.+1Y2DH]JJ=\#/ )431*?$TX3$W ,$MF_Y0X'F0^
MM?6SB%6;D+;<VN7:9$)U\M3W:HL(*\3E"B46FSL^Y-*DDJR=164)&H!#%:IT
MYK521J:%K#HH,^">=3G7>##5H,8N$:.$G^,MP2E3KJ?TH9#CQ'2@K-1!C!MN
M?".KY*CBG<PW@/S+51*CH8Q9]H,I]24M7%:OYUFQ%",V9#J0-/&J'G-DM0%@
M%N<&_M1W8^$DX+/$OV,&QY,1Q1=&O^CSB!9[#6E4$=)H20'<;L4HG/Y.9J!V
MAURU4HZ#)]-DP23I(#8F"L^X<%O OR$%AGPG@";G9UEM1@(60#&%ZW,2A=!^
M9LHFG&"H?IM?$J:QR;&GPX3?.BQO$3Y@F:CU$*'O661=86Q4U-R94\(:$W)#
MB0:9B(9D"),'A1BG7T4N4E-D&Y.2:]!-M/G/L#>W\C<I]A)*VKJ_]U,A%DDZ
MZ0*@HTQF:6GJ34E2(/B,1L>%EN=:!5N$XN<R30K6]_E8N<DR8E:RZ09Q0*QQ
ME*G1"!X5(!"BYRX2614DU2WY!<JLU$F6G/BF BE7#$,!@$COJYQE;)Z,>8H2
M;3=SE#.)N4-?)U_\R?*%W0+Y-BCK$&>$-J"$090MAX5B)ZB=R#RGO64IP2"$
M#!UDSU[/UB,WCIAUT[K(YQ9/\=X(1W<"7C_^'& .%KON&4(H<XDS%SC;NS&S
M)?I,(&L2>D9E^P*X'CKLK2R ;8:4J,L+H1<M '9,NMFI(R4T8B#@"-DO$_+B
MX1Y80>1B4(&V W&8 ?+/W&'"Y10R4$@_:Y_8N'=L1EKU 623Q@Q&(;@6YHL8
M/$4_0M<7OB<.,%FM/)>F@HA1!+LI.;E:A]A0AYCF= @P53-2*7,?UA9A0WDI
M5;,#H]X1T4ZU"7\>K5@-7$G(\1:1GX3?3PH)8\!+X@9P[B0A"06]28A:\\T-
M72<OVCH*,-O,\!E0%B6'X4LRUS?/P9"IZU"<*/HMB\#5)+\AR;,<R5_[<%0F
M4>LVPUF,2DP74=QYG=F4K=T"\TA$'U$X"[\-]N[,"(:I#\*&TIXEVQ/5@])&
MA*QL\4I#ZY B3GBI\D)N*FE7OXE6M$G^N!K/,'G+ G_9.%SO^O3D*R6C\8'4
M.%_]T.5*'Z0-#SIUTO#F@;G>;@)SD)#Y5>9ZF@1CZ9.LPW5;A>MNLGDZB6))
M9Y<7#;Q\,Q\+,K!E-0;U8X)B:6@TFX:EVN_AY[? 68B/F1]PX8%<!0/TNE!(
M@X[ELJ)I9.B2MXBYW757EM^B4J.!5C121C:S%M-H"\#;F'$;W3*<A,IR0S>O
M6HF>/@&1SN>!^%65AZG.7C!=W=AKH\W:?!? 3H+&C!J/N5P14EI\MA1L'5J.
MM1XN!VBAT%M10D4(4 C3%*%Y9\X'U!AR(])3 A#^HU)YBA+!#<,%5J43_ ^?
M_5=XN=WZ\#>T_##G:\8U/_[0$W-5#J2>]X238XBI@6HN%%/ QW/4Y&:W'X^4
M6J_AH@QEJSC5?R^XV2 Q\_.S_;^%V8K'2RIDU)%CR==<MKZ5^BW*43W83+)"
MD5&E@5+D/NO=*<F6RB5!4OX,'H@[B:#1):F*NI]XGK"K7W?31S.'VC;(0HJ-
M9L7'8B=6WWK-L_11JZ7#09ODL6:Y!*WU<DLL'0YZ)QS+^C"%YBNV^_&.&!+E
MT)O@+-G+R=4H\!&^6.F? ;*51Y%4)5Y8Z*J A'T)VV[P,S,1$3QI5UA]8+?=
M#W8'EF1WI_"39M2%<@=TH=D#Z[?F=?.D:0$V>?^3W>ZVK".9.#ML]>" KR_^
M<5P*UD[GMOZH7W#W+A<3_HF!LKRT:-($,SOZSA? 8F'JQ11R@TW.HW$DR\K\
MS/*2\JH2Y>[,[31A5WH0<Z5ZTLU+1NB8GJ"P<$JX^\H\S_;%5 UD4%@ERE6%
MH\()E@&[+;EL@A7DNQ*LWP"B7[.W10HX<[CO)3(J/T?-^(S9'DL3'NEM$:;Q
M@NFYDA=.G2&6$8-A=.]3)C;6\>0?R$E]@4XOD[V!&RCT ?Q]RG3Q#<S7V"FL
M(!/?;$B9'*B,7UB<'W,.!8XP3S72,3#X<&_@+1@WL.[])& NN,R:UFB-(V:5
MOQ3\;ZI*E I$B;+%SU; $)->MZ3 /$]Y,F57W3B3;+#;)"VA1X:4@RJBDZM]
M26;B0DB9I?#&PTRX&M8)5W7"U>X3KJ#'$W\/8MI!]$+FDJ_S[4JP@1()BVP&
M=5WDP$O$$ D?S"4*)!-;)+*O,Q]*5^3T&BI]72H#P#U4E:4$/)G$D3NEEE_0
M34(J&9"UR@2>5A@RS+<7I?438E;ELE6A&+I*=Z1]T@Y!/DUE!C?($O7S#K=R
M.#\^["9\&]2UK)8MMORWT ==-_M9(=^V]*N_2TQ5.*< 6E4C'Z:RVP:J>D4C
MD[R+0@)DVQ?Q@_<!BD068J!\$$6\^: M2&@_A*,)!+IF7E=  ZLL$ZJ!X<Z,
M(!N)E)4YD\*L(0?Z6Q@]<@%S6VQZ IL&=2T,&S66PKH(TT;YL\!MO^ D]<2E
M%])'!-WA%;A6F0STD1^(@D!J80>%TT]4]0551E.T5.[\B4"Z5/4>,/2_%RJF
MM71#]*&1[O?E>,6S;BSJUU5-(3E7M.6?:=TJ\9MNL4R/RIGPDO"':<PZP% Q
MM>P&36!)63FWD\@(R?L#A&(KP4<U7"T!N7"3"@-,?EA0LUX*E;K@V]6)DH#.
M JFGHJOB4FLIS2Q<BCMMX A'"8 YS$6U6](0157(C<TPLX0AHA0R43#K)G?6
M#'"=2Z#"4CE(00#)[FLIU>\5:CMA9"JD+QY: ]=:8@>"1?OS:'1IW3/.)J9<
MA[O%:R@E1(A Q&$"[!< 7US^D_0F ':L.1DNF4D]5ZW<KI28LJX__ .((O.7
MO^6:4UI'.DXE<(H _\IS4Z;P=(CR4@-K2^X)-Y$2F9A+3Q&VX)0S+G?ZKT62
M*IO!M-$6(3["1RASBQETGW6*9H3S,]?YHJT3WC536IXLZ&J4>'$B_"X$5(E'
MQ;TL?C DIY]OM*8Y19FSFK!1,20^%8%L"G;+U-!L_@[J?4]SEK?$C3EAF;$;
MX-7C>A@K15_"JZB\&>C#F_(WNM S9,D"I6DJ&GK/"/9Y^5H-OVEF3:^Q"(W]
MJ/92.UR+3G!#8:45\->25Q<@S>BZ2EQMJD^ + 6B!6,MG-7[WVF72(^[11U5
M=K/#.DYD+:AQ3X4+ WR&-/6259):(IY?Y6=;MN\EADI."5+/9J/1_=$D :$9
MS4ZH/]L)"9KQH._8K5X=AMXT#-W?31A:'!\:WZ+!GCA!E>ZSWKQB>Y-<US<S
MZ[(\LX&H'72_(<JD;G/#P, /#4Q^@Q/EGD>M@JQ ;)8J3 S, =&VPI%6R2B=
M91[[#[2#]!U(R16O(;>^:I. +W)C"K4"J(//[52XRZI?%+=1)Q+; (.7!G:,
M"'%;ERJ"D\=QS#HIQ.G>0#5^*L*>JC,"Z#2ZEZW(UI'0, 5:.!;F/RT8:B$>
M?-5E 7%-</]_Y=I3KV$Y+<<F-RQA=&C'9-4B]<&)LLR UT/MSKC=L7N]0<V)
M-N5$@QU5JN=L:JJ[6M)_I*'RM4HNM,#_76*G8Z.1+*"+KR-)@A7(ZZR8@8'7
M@((QC$+SY2B[7P&"H5'B?RKXD:0/23B. &7TEEC)4Z[(3:\:*O^6P..7U3WE
M<?E))\FRD3+_C3%\3!/C\S7G1% 9 :#N\"?^M9C>BO(H"<'#Z06:S&$D0(#Y
MAJ1P8>;\Q$\1I!>_O@RQ<!K=PSP]S+>)8D[QX:J-G8,W-UHDJ-,:OCK.G^81
M"UT#HZ-\Q"Q/&@K_&J(*)9=HF"7CGMT;]NLTO8VYTG!'^A&=W2?"A.+_%>>7
MJV?&:[&% U7=01IO!3ZY%)(FRWDYQ)?,<@J3*F;SP)61JY:F;*'TL+RUARGM
M32Y$&RW3PI==Z3 BW'I5@R.^)B93:/00!=,D:Q:)@\PBWW-&1!7@4@[DNT$)
M]YQ^0L*3K>XW)?"<X,\ZS;Q1+#SE+!G&MQ"JFI0M:H^2[;#6NG&_,TC_O6+I
M(@Z3<9=;6TYM;6W,3>Q6EIU *D[.L_N*3 5/#T]7G%^=Z/MRB;[(DR 7!AVE
M@6B#B\6'TF.4_33#%?C1R$,I3U;%+FD-$[G>_ JRI-+68LN\,EJ3A>(%E?8F
MI@TZ%6#%%]>P^NG\FEAA-6M&T[:O7",C<'3!JX3;3_KY5CN7M)\-DHZYP8OY
MSDM<<V4]>DC5ENE,L+BL*IMD(J0XV>8NW ]VRZC11HXO6K,4>OMI0.)L:FQ"
M8"+%3%W7H+,<B@H&"+!1ABOQ#@&/V53.J=!5] /1S60*LCNG;F2*94#4\CFL
MTISQC D>F0X83!.CJ!!D'U:QP5H0#E#56B6)"-^5SL1(IVVH'& /2U#+7_,F
MI&H))<2_5W<-GKR'CAO'N4."2K.DU$:BNY7'@RQ)%Y?HH?IN7JHH#[Z^[.KD
M$M4(&C6ANNB40#J5LK6NX\BAHG*!M*^SQ.HLL5UGB<&%1QZ5M7B(8<#*A.2Z
M699F"E(!$5X*50,22%1=:H7R"RQ'=Y*5TH3XCI G4O:;C\W=)X,[)7< -D.:
M W2M$KS*$$EUR+A:'DNQ4+8DV%"4M) 803D=4W42(*(6&% 4Z1)0Q<&5%,\7
M0!<H^:< FF*$;,RR!M< WT4D;$R3H&SIF#U$?PA%4>"%9<D8IL "2C>4I36B
MP$[6G@G)+[5ET&D1$WB&$6. @J "[H=CY?!32!N>:#[N:K 3U6DKDRG(I60:
MR/CJ/5_SO9^4S37P57VX'+VFXHJ)#S>;>+L,IC930#>9;'T#R7BY3PO<LU@K
M>*=:3*$_EMI,/R&- -*%2-?*-G:3V:Z"W<$[[IDKZZI4LFQO ,%"L8B3:,IR
M#AC[E!LDT1-#)XS\^3.!25\&;IB,AW8=<MK<'6/OTAVCSA(M&_F;)8[3PO-<
M$HE2(&VJE2B:.0!#P-1;@:5-@(WZF'[8L!*NZR?@)%;X-4S 2&HNIE[V3;$I
M XH\,[<<;3J7RL,XMEN#7JNS*T+D!^N\[5'JI:\[,'+64C/ZQI*M%U!-J9\&
M](R$V*,RI8+K^HQ_C/X4*.L54WE:-0/LR2 <QIE '&1VBN]3?R+MM$X0-5.]
M/7OV;>GI5VABXVZKU]Y9G(E30/MM*:" M;\+Y^I!R_:\=[4,.FLW*$1V6T\N
MXP?9' 4OIX=HT+WU'8$CK&@03B6-^E+:N$.D!T_ J:!;:L/GJ+."&DTO0CT>
MPX#D^;L'_QB,J=G^+7XL5OKG+F&_2\W\2?C=9)^5LHIR?E@!&)WDSO6_\W<>
M]5K'W.!X4@G@5#LH,@A .8+L:1.B2?,@HU6'V6%EQIA&7Y(E&83I^* A)P -
M2J[4]>-D:1("_%$%WN9P1KY75"N!*C,A.GY>!!15"-$]$6:/2)>/9L:")*?-
M[UQ#9+**62^;*I9]:*BI[ 2A97QXZY)-94822Z9)P05IN$#40#>H,@*JUA&X
M/QM:Q=VF(J' +PN5W9#(NN)YTV=:7J0E@30R%Q; 'E0F,?M.U&*4=:G2UYIM
M5W,L_)YS-:/+?,4YEB"5%!]"%)&L:0XG>*_X2,")'4EVND&2]*<2R)&2,?F=
M#M@M(*0C6GM#M1W'^+C177QIYG-Y4 $;LF^4IY%OI9Z: #E^LC1L+RM&\C$+
MD*54S*:[@Q>[EL.X2[M6'W\R@.X*R17 :T3/L%@U"%O"OQJB9$IT#@,/4^2)
M='@RR"6&P)Q+-_<VTT!, &%338OH,@8.UV)/,0$UL_&TRKDQU;6L;.TEOJ=/
M[*DA\M5R*>T%2ONDX4 V( OPS>HQ5..LU81\2 <C2RXS._FL,\@U+ENW03EC
MIG-C *K#6D<SJ'(&76D\[-E#VZD]+!M[6#H[37@QD?&1:O51*D-]%P9%IR18
M[V+!/3AGXI@)D!F5Q@'UUO\_>V_:W$:2G8W^%<2]XS>(B)+,?9EV.((MJ6WY
MG>E62)IQW$^, E @JP568:H 4IQ??_.L>3(K"P!)M2#:B+![1!*H)9>39WG.
M\_B\H'A I OBV;R]9P-V_RMV)XZ+]4RO$5L)QRE4U^%&;Z2, ^+S52U?HV)Q
M#_Y8Y[S#:Z$6-;>9$B+V%O(23$L)(@I39S 0?2M)+/BW3EG"%G+UJ;R]+2;X
M$5K0@]OB=E0TAN,5NU>%V#*3U%@#<X49>Q+DP]Y&$&' K][6")5PBV,*':?.
M_(R1'/KD7X;]U7);-E/V;.KH#V>!]$DCTW-"B>5/R]&E]C!<G9T<G)R?[6S.
MQC;G9)LVQVB$^#E48_,IU0=DOB)U-HK=)G)$^P#.M[:8L&8# ML@_4=[;O9
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ML]/34_D*=J9X)BY#>IVQS^'N='"4G?;>Z0-6!QOL8XEO=AQ^"VYFVL^!T*N
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M?*&[H04'X#XT'JJ:E/06EN>[&P8CIBT6@997XV\$/^MWW:MU).D-@8$D55@
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M0Y&<W$COT[E-,FT/O,O&]\A2W-8"7V&_@-J&MDH8:?9E.<4R+[ASDX(8 ^
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MZ^0^:V^X6T]/!!XG 274;9 O)Z5I+^B9>TX*<7T!4ECA@EK];<6!4?$&[H@
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M02- 6GN+CN*]^YL"3VI\/"ZI 7*6N'"R'O(IWCPW^7Q>5,+/0%>NQGIPD ^
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M"*_L>I#='\&W3-757Z4IF%H.'>"(,F8-0Y_G7K)NAWO)(.Y$V*HAG6^( *F
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MI#,):B9$IDGN%)[>L\AXHH_C ^"T1)RW^\\M,JGNU1'+#=!UH4A#XJ0A!M2
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M+%Q$,,]1,CA+OOY],9MB^344N+BK9\YOA)-'H7!2_K&!AG,FH4>! N/D5H$
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M\5%<_QR[H9P9'&5<,SV$90ZC//.GX,YH;F@T8[V\RYZ:E[-(.81*GF2%4 L
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M7EH=TE>%13]O:MF*K1Y=!C,R>_27?G-&#FU90?7A0<#V0JQ5CZUS//8ZZH2
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MZ]]>?WH-I'1XX3=UTRS=*M-E#L16\,F#B[.SL)\'H)HS[G#&[^;5HG1[#R_
MZ8\1=%LW#Z(=2>99QR8:81ZA1'*9EL9:C>LGK9WH5NI3F 65QL5E'G&+-(4>
M6QO,.RPO/"%8(%Z8BF)[+;HXS$C,ACE35RTS2R2?)=H>Q%DA38.ZD5X&3+@I
M*0>DR(K9''ED2FU.2& ,V[9,GEDI(4T\)0F+4A//-2*F#;IN9R:?F*4&YYX
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MN(]$]YX%?_K%A7I8+?:$2N''U1>4O](W.I8WLJJ=EO#_#>8S7 $+"'J5W#4
M[X<@!'B@EM0.K3.9>5<20^N[HLJ%UB'*S">76$_Q+W!&8]IN=GWM]33BBA8H
MK LJ8"8:/N7YW'>"^QF_VF@]":M,*L-+:E12\W4KRCU./HO\SP/OXUX=')V<
M7'Q'K]-Y<=^9NMZ_K,UVQC&:#T5*(O@.$N[=L (*_C*=T:=[(PCX4$*W,,,
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MX,$/>%\"2[C71"B!?Q3K !O?$R1^/Q8+Y_MR&ZL\Q!#; 6K4^A3]QQY22$S
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M ;^JK$@U+9%)7=#^\@N!MQ_-:V;[!1L_=M^] >4E$VO%[4DFS C=XQ_+'S9
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M>6DW_J=X4Y$4H$RF#'^Z3D'GM]="+W=:R7K&BA&[)<TH[=)/2B7EDT2U2D$
M8\)19?S>PIW)"Z]66&7)]0=E'>372C4;&YN7L;+DKW,PC6=1OJF]_(4/F^<I
M"\'?S)&+#1:9TY^8^\J8<*6![^6T-B^B#B[(,F(& ^&VDH'FB'[4,&P;@TQ+
M[2XD0I%BWBB0,KR*:$!*5/7[G5V4LG-W<A;>RSJ>YJK.G!0":G!J >!:"NP
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MU#'K<#"Y7^<M.Y JWVN<?/;1"6(CJ7$)TI%_@<:)+2VA5X6/Q=\U2 T96JD
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M 8[CAXDJ^KQKU-'-"&YM?#G^,CS.KN&&11&[V-_<V=[=>#X#=&OCB8&+,/W
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MI7F$#YC8Y*L^ VL(L\J?.)G0A8-MD$")!).U-Z*B=XY2ZBP#)=7+M'J2L;7
MR%U5T&&35%L?E\;T'E:-L+( ]"4*CU&BL.)I5"JR^RS^Z28[2E,)KO(E?K'V
M/+E%M%IRR^L$O9Z2K')<!%@?>I"JKE58%(0F)'21-*-3S93A E''MUISC6SO
M1(,VUEM'V93 1J5-984Y!-4@,W32$BHYA!E@"O$Q#176%(B3PQ>36-VFZ:;C
M,VE2%%E53Y,;' .[ /:RI[2<::M@(Y+V,<2<7V>QJ:>]6QL>U6TATWE=VRVS
M3(!'TAJ+!;77&8]1C[!89PRP1P-5*, E4;X-4#T,N$\*UZ-SNG1-I:VI#LJF
M*EZW+QH#5V\(G2/^AH#&?;M]/I-O<Y(0E&A*B^NF(;T@K"@(\=TO#]+WI\EE
M#>H@!W6DSF+)M\8 =N?(W!B."E*ZE -P!.V(Q7)9W"V>,H)W0LZUFX5U*78U
MCEYF5I29Y)XRHZ3"6/KWE!-NAB8$4FL6@CGJ$*'UQY(AXW/8L)6G\M_/I"0Y
MV'^[:7;!T8AH,/32_1#IGMQ)ND_R8" 8?^E*1"W'6,3ACQTJS=ZR#&0/S4M,
M-^-_L>E4/;WD]E7"Z11KQKF$KUA\V9HRBE%B\X*L4C#0L4 L(QH\(MF!M8$O
MKNNA:>/:Q5I*T2P:DU="HJIHUK 1]5=EVSFGQ0FF+SL[8+UB>S,*Y-![[%I&
M1?"#/-(YP7+*AW:'["5^18F_O)O$@^8[C[)+C+<%@Q(481F<)V7%9N'O"JAN
M\FV4MI N&")2K6IKC7AL( 3]&# Z-QF,HU+CB'@<3AG>KE3A;;Y2'I^=C1YY
MU2.OG@AY]4,KN*L[*;A/:9;.ZEEPA 7T.F7"-WI;O77J)ZJ_IW 0_L/0LCF%
M3Q,XOJ55M.\E9EA;H$(%=JY4Z#RZ56AI5\&NZV"/C<GV:MP%;VL\OAUI=NAO
M?/$Y'^- *ZBGRT2>S+ V7)V'RJKFR(751"-!TG0<XCFX'V##?<*Z+OC2[V_/
MW@;O=?$X57_CU=-'HU8]G^G=HE',9:_*I%%@I-6.<BN9'-JD5!:TN&E%!:BR
M2K W_")FH6Z0-$D+'U6N:Z+AA2J!?1;IW>_IR>XF>G_=,99AP7)U>HPMWW/2
MM[Z_MV0,=A*411);W:LD3W@V/+(JS01DN[#'%3,T!405D:MNUXJ.FW^AT^O&
MV?.AGCLFUTO2:I+T]6Y>%/>A^<B5GT9U+24PX2@!2H)D63"&EL:)PHIW):(1
MPJ:ZX<#G^/U.VQQB%,;\LND&3PAXS82JT$!;-AK(@HSD$Q CN? O^NZM*Z.!
MMEX"&NBS"_&Q;#>-!#K.='&HE<31_'6(3B!>\:>,B,K59R!58:/2L85BO@]B
M:4ED2T H=X$NN3BE]1Z6] RPI#;V_4^-?3>Y+-F98B6HO.4)=C=WMXG!;3ST
M4C2\!_XNU8SZBL?"9 $A<&VRBJTM:YA G/+-S[JMB4ND3Z1,C*=SL8.51B89
MQDLO63;.I\0Q$LX@OP(3*F;36QE$)!7?-5HS-'+!/"]Y;NL:5*RND:FQPL>M
M6]23!-./TFDM/;-\JTGC75-UP2T?&1_1[%17,&.;&J=4@#&31,IPC$^*RT2E
M$IC0?CVT&HDQ5KQ)%Q]*+)1*#;@2_X:JOO$W#H<)==L8"TB.RQ*ZWAL@4B4O
MFD9B(];1&X;?!9_5X' X4K!^'SS2DG(7P4_<_+*WLH$E_;8S<&-?F)K.(%WT
M.,[&+GIFY$[%5"BH>DHWM=HH@:#Z>!D$O0N48DKZK*/9**FA7BJ_"P+HQ.:&
M[5 ;.N?9I58L<>5&'FIG&XZH)>!I-DX6W5I\&:2E*FM152YU!L_O84#?"0:D
M#QP;+"DU!4H?O6IFV6)O[[W.Q6Z&.S]_^'!\-#P-X/_/C^&?@_/A DW?XMW6
MM0ZV,1G2B8D]9AH2[PDU>>;ID-HR-57WSG$TC\9@L"B&\%O5;M7G\+39S9_1
M.RS!/=PRWD'X9._'U^K;G_324[Y9:_@GUX*O]F V3^;9\.AT>#XX_<>CGDU&
MM5'[W@0;]PI61_I-MDYD\[BQR\)\-A0"1M9[PSIUMQ(0MZ-B5S.*!2G!HSS#
M2QY3C(8R'R[T?%H[X9?VD$:4?X$_6XW-!%"OKG&.7C;:1']/''U*R"@;*7_K
M_.71@?-(YY\@+R(;.E+SLV+%#"&U7+0?>;/O>1? >*IG(W@R=435S5AUU4+,
MK1N)Q<U3L<W8Z^9BN34'UC6QO.K X+UH&7NUM+)::NJE7S]_?A^<G0].WA^?
M_'H_?41,IHJ[Q=%.:U8"*39ZPB'.89/@K[I(RSAE65_7#2HM?@A^K,Z@1FS'
M9R!V$5QC"K9;<4)];7MCG=FS.MT[0R6)W4'@^QWXRDZE8P^93H6E%PTUA$74
MZ'Q!-T1OR;YIJ ZCCD'R54\C:F ,*P.;FB&"$T?G2>,Y76[==C*D%3JWJPS\
MVU4DJD,#!M/LSA_MK>M/XJHG\;IQ$$^'OQZ?G9\.L&P^.#W^];?SLV#PZ^EP
M^&EX<NYC)Z1C"===DE)W:[RWM;0Z"=A3IK:PJ"_B&ML[*M+-)F?D:P4Y;O8@
MQQ[D^)) CJ]5-[55TY?3X1FH(59.8"L$?PY.3P<GY_\(CD_.?H=_'2WR9;22
M<E,M=J;EUFHQ2_DLZ3<5C.L2= SY-7CI6R:Q-M!Q@BZL8'L1K$ /L8<5K HK
MV'ZAL *]E3\(L&!1#_F7@S0P/-<]UN#'P!IHP_([( W4LWN<08\S>!Z<P3DH
M"Q!L%L04VQ)6T5=<8?2GB1NO3^X]$P#!X]&N#C_ L/?#P ;XA!Y:\(+E[<[0
M@N\-*&CJDI8JZ8$&+Q1H #8+5D!X<C9<=$$<AA]AGF]^GS>,C!.PZ7''DXH=
MBR81"-=#(/]I0"7VG"ABP>I@5E/MCKCS=LM\Z85@12&X&X%(CS9Y1K2)':IN
M9K M1T'!380YXCZ($TU?]D/@3;:?!V^R_6QXDVW[VN]/YF/#33PV=RNY:P6B
MG,/:S!FUVZPI%(KWI%V#'HXI;9G%K78E*X!15J5H7 V*DL[ @L<NJ]2?UC+5
MA[I*$G?' :,H BH/+*4YN*<&I2P#6#PNJ>,=XX\^P(KZ+O7>LA[-O25P58[R
M8BY:8B$=)V86J$%NIHDC(P5LT=V]K#>4T:S5?,"A&*7>[I0E'<,AP1ZQ0I2+
MD1CK@TM1-XL8)^^'N6EVTGA$",X=)*0'X'Q' ,[=-/0"/,>#\#>D5!Q_]_;9
M43CN<+X'%*<QX97Q.&-+51D$9@_2>=VGM9D)%V-J^#XX^FUP>CX\O:=)94%U
MU'>/KD"W8MM/C^VRHJ426N=3L4 86/"$F1CT+:M^ &<8^[8EK2,]RXM$SC/<
M46N;<)A_4;+_?N&I?DH!VWC%\M44K^&G+Q\__P,!7P;Z=;:*2XUV5LZ$2G9+
M(D?++.3^P/@5]39%QA#NO3U.['1,-,94F<VZW-D8(]3-A158^I4"RK9Z0%D/
M*'O&?J6BUL@Z(H9BN\?U,S %;Z\EZT9GZ?;'RHTS9F7#B&J"N;G_05X]<4BM
M:R(AZRFRDWR*U ^7I2Q_(C'\*N]MJE7OO*8#='<#R@T*4<ZFMG,VWOTZ ZU/
M-G1F!/,W]N+[O5MY[QY[\SI3:V5[%^W2J[\EM\&G*(,[E79<:/J>:R-Q8=+U
M__RWS;V-=^>G@Y.S3\?GYX./P?O/1[];-MSP&[>$AUDVN-RT(6<<55_DB!Q4
MC+%ADRHW"$;?45:<WVZCHAK\]B0I%!YJE.=?FS&E_CBLZAY^\YR&)8:Z"A4N
M-*W-,W1$T7/(3(\21+)A>+).RRN)(H[1@*?0I4I-TTULFFP'-1&UP@>8#>XS
M14A!DNH,#ETQ3LM$(PM+P;F V$F5(UYZ($^]J*PH*DU).1V>'?]Z0GAZ4 YG
M+@[W);!_FNS? F)B+=8**5PDF*%538D7>IRJ^:/">)HD"<(Z.Z+=2#N8$.JS
M:<U]6_>&(WH!755 6S?[\/33,4MH\/D#I1$'QR?8VA5NN*,5PQ+WUW89W%0(
MUTNSZWRJ4V0M^!4(RT]Y82Y+L!8H7OR;:H6H0K&G"2>BOK0<J?SY7!"SZ"WX
MKU'N#!K*<D_C;YS>QS0:I=.N&+GV4&B(;I7,S@?D!N>!YA-3;'&QM;-WL+_?
ME\>L6AZS\SSE,=;V27Q#-E!7PYSD%0J/OO+AB%174J;AMA@WM3(5=W\!>>.V
MO+/H%HXO8KG98A2\N>)\UT 93_' 4RW$ /'V<*JHY38?)TY8,K*'H#N"H%>C
MOX$;:1S5I?$/K7G1)[^H5">"A =P'TU3G5/S(4,U? E7I1T \9CSZ_J=5-XS
MPR;N]&3NMB/QV%L%5'8:S]NXYP55&TZ3]?UQDAR.1X<7>Z.MC8N=S:W)Q<'V
MWO9%,AEO[&QL1!L;VSL=3=:/+W:W=K9VOP,3[\.[K/_KM5FWKV8LQAS^_<OP
MY&S8:K9^L'DNMP@\XV+[<&=WO^^LOJ)6/WBNSNK6EEF-TQTX!ZKDD>W_Z1CL
M4@".?#4:P3=R0IQ4W </ULR?SP-%R>5]?47??2OZ<-WK"EM^W+A]D/UUG]9M
M\JY?\OL5)B'9DJRU<- WBU=55D(C/2;JLFW@?QOGX5G:-7HL'%U%1^Z"L730
M/(E2:1C_OW66!-L;8;"UL;7UP"[*G^L*NP-0@K_1+#E8(QQCC)$H[@EH-QTH
MD^2KN/6$<\-RR82:22+ 8*@Z_):AWYNDB @.I&5V4?P@4=\/<<(\#MRGQO:K
M4HNFM4:@.?@<'SM[CA0OC4P].1Q?Z4ZLV_<0EO *A"$IZ2QS$2FHZ6!M>]W^
MX@R6\PK1@FG*X#[U)+;+Q;2>8F^@6+W:<HN=ZF^T!34. ^8QDMO"Z7U$)JQ>
M6E4Q"B^G/\C;0;7'"=\B+"ZFLOM=L+B2PNSW57Z37'.;RM#:*UP==3\UX8A6
M99T*.<%U"V=8MIVEVD(Q8991#/*4SR<FTL=D*5^G^93G#Q-8:+F+Q^+6X8::
M@2+4%K9K8/L+ 6^D/@$6XEM*^T+NA*Z(-]Z$K3RP-P:6ETF!X ACJ$E+\GJM
MOZ+6;Y8'>K5^DC(V>9GR7P ]'%.&"K?= 0Y:2DKU4LFD,RH^GRL#\4ZA 4B!
MB>ZC.D511 >>^K5A?]:_<F[=YN!K51-3;]?4Q1P/H<!YX$SH43EC80 RS X$
M-LT$+)W![1/-YTE$9^_.BB"D:CH=R5NN#=R6;0V=,+Z#3E!G;ID>:'C;1$Z
MLRAM4ADS/HW2CA0RJL("4GW<Z5VRH.K5?E%ZRG.]\8J/=;.RL].8LQJQ6."2
M5%W$<./;NZ=KP>7R:%N$$SO>TN!K""VRAM -QC0:%W-@K16+(8*"U'<'L<TF
M/$AR8[Q2R-QV#YGK(7//")D3G>5U).2FJS/B2"%J$D6R$FIJ&_A2*.4 3$L"
MY[2><AVW$_ONBGP_/:V414B.LWJ. 9A2T6;@?:V"\ZN-%[?T0Q6?@ 4 8I*4
MJN:W@S@A9]V.QDX1.A^DI[!6M^EQ7$=![?:8JCK2#*N"1<Y'"25%D'Y!*I_0
MW."?T480#AM5XX*>W@ >?Y.@PE[;4E4NS&W=N*K<X;4'H@RH=C8468FD\-#Q
M#H*&L]V&AS"YCN,[W]L"B]?ITJIX%A0G;-2*P>KHJU5(+/1LFYO8NS8KVD!-
M8H,5 EK-T,8=[2"=K'HA5I"VX5OL6#^F&M]^;C6^W:OQQU/C5NIW927>M%H>
M4XTG?C7N,(_WBOP[*/+)HRAR5N(MCL %?'@=6* F796A[EQP9#5EE9(*"HVK
M;O9W.T!=([;/T)(5Z65O1=F[?*SXJ*P_!0^5/-H=19 B![;TD[ DP%Y>)5-4
MW]EX6BOH41#%?^4UA\4(XY*7U3S/A%B/\S/KI/;16(%[&;_+"M+7?\'F89"J
M ZP8N,X)$*T2J:OV/[GADB1-Q=#+V(HR=O58^LWZP)5LA@:2DO#-TTPBM&B8
M8L Z(ZF+XNNTS"WTZ#VY20H*(3>'Q\2W54/>J$XCL@8QSU/.YU^GL,1B;6QO
MV JQ6\&^@^/0R]N*11>/)F^NSXQ. 3$\<.D2?6( NJNR6%P^J.TN=8>:6[ F
M,8T+GWH/THIE2,'V)B7<-]LN_0BKEFZ#S5W.R#MXW(,MO@GSB8W:VMO9W3[8
M[%%;JZ*VMIX'M:7,KDFP(GZ+&*-=$)>X)^.T&-<SKL#'!'TY+M+1\U#6&Q <
M$U%9#D;4/'4.$7CEU@-S)LXV(II_I7 "FYG@AI?BAY/G%Y5I:9S,RBPO>OO*
MO)!4O$GB/>-2,5Y )M,8,YI&R$=.G0K(&;VV<&#$C^9\O&V+VYOP?),,F\,2
M)8K;QCS('*6YSE-CC&D/9D3\(E;E J\%EE2K\)-.WAI0%ES- O[!DB*;"/\Z
M$1HP?'C![8X8;^2T6"!/EA_,XQ@G%"=B&OB?*5KVY 2/NV\W=_2B/M7;X:6[
M3_[2 ]U'Y"G?^?2+>VB=$@7<^_NQ' (G++,E<E@2XQU'9!:>?BLJ!FJ72CFD
M@(,?5( 23K#>3I\@,E3-29O(B;I)I]-)/;7".X\'C9)7?"BB&DRG:92"I7R)
MN+_*PF4P.0V[GARM->CCA?IOS2&U07#.%)$8)9U>TQEA! ,.[08G3ZTK00IT
MU]S@3VF_0'T5U'V%V*_+G+ _1.+(S2@B*P[R'(2SYI3Z)79M5%<O9%T56Y%3
M.ZO"I(@ZA07\J\[&DKD0(M^Q2ZBIN=K^6:=<EDB':.)C[G[JN6YNO-UWJW#9
M5)(82%!B!(]G[,7N-P&S>"SO=>+99--G<$%^A[F9^0OZ#O?52]VE5Y'I%:-V
MF)PX8T.&*P?&G\]D>AO\/A=#9[&&4SJ:BV9YXPV4=PC^0'X3#+@]FEZ9&/L]
MIJ-:J+-M%>+_OJ]$+#K8_I D)1RKX;<Y?#XI+\!-/=P\[/W/5?W/9VJ5AMM&
MZE!MG!:ZLV=3U6C;_NM9?+@)MM4'QU/M"5'Z4FN1E$J ,M$1TA6B1>N\4D67
MU@#S*#69$\;%TNNH:(6XK608;X-!&5#IJR<[?^_RD(;@26F(#(\=]83[[M35
MFWSR9@ZG-ZGTH)Q< 7J22J#U!PB'7<,_IR%=S*#^(F$Y1"(3OGRB["O1,K>B
MP^9WN!QY78S19\2'%[KS3X80@4BZN"MPL;"<&4_411.OFTW%F\_<>>CK5Z5J
MAN;9\!S=6=Y*N1(5E[/<Q7 S@T<L/V1@*E:I_*"9PJU2X0YZ\&[J9_5RB\:-
MMH>N;M78K#'"-A.X4VU,=F[SHK>0N?H@-*1"HNSX.[7=N%U3W"L4!+1&2MFF
M.)DDM-P^R2&I45PU)545P;FXM=DFZ$QC["H1KA'B%4DN(Y8YW=/P^,OGH,8+
MNSGGR%]]HQYEW;3JO+U2+.].C^7ML;Q+L;Q"+C".-D?)1K1]L;6]&UWL[!P>
M7!QNC'8N#@\/D_W13I*,(R^YP/'?+_:V]P\V#UX<M<#QW__EB 7^'!S_,3P]
M(U*!T^''X<!#*G"X^2>U@\TG%-HI!QS:.4<RDHN=@YWM@YYC8,6S>?A<' .\
M@Z05: \#V<2 =E&[#J=XU1)_DV0MU!V*=^.7(J=KOBY=#G1EN)XA^US1"--S
MY$XL5QU[<'JA2H?5E NOX,*(/:^4AGF8BD=N&_F."R  FQ!T'S/B$18*YQ8,
MV')4(0PK=S1.DKBT;W^-'[@F6OV\4K$([+8:C0578I?-:FQ*R\B@,.Q8>M#-
MB_0:PQ0@GV/%\C;6IGHZ(RLTR>M2E:BI$5F63HH*!,N.P10N:L4<R;B^7./[
MBB3/UG6N>I1DR22E%$M[R/,:%FOLHARL]SUP$=8?6'S^A4=G-VEIUJ#S=D55
M:$5231FEDT=M"Y1=>X[I6= >HQK1:;.<<'.Z384K19C%_3E8B]:-L=L:IWHA
M9_K@7[=!,A7[&-8.3&=);ID1P%F:(<<=$3-Z?<6V*9X265I*M8FZ1<78,E#7
M8#UT.I+ ?&77:L!NW7NG?,9Q<ZNX+7!S5EAKCRU\5&.:MD1U]GLR5?SM+\6@
M0E G-LKH_69\&& 9^J+-;&*5$#=2KO1LC4&^2::@"M<VM]:%&, ""(TE=&OT
MD)/%L-@.L#;6%^#5F@',N(S)$LFYI("A /-DUQUA#O5'8%=@Z.@LPB/!?=(1
MR2KZIC*M6!=B[Y%,@7PO=HBIPKE37/U+]#;XD!>JU3A^)85%U]\Q+R/S2=1@
M[@N=3'34FCJIX*^NHVE-QK#S7.$L0*#9O)*$ I)/IJKQDL:^*IC8^&N6WTR3
M^))X5RT*R]5N0/48'&[IMDN'(YQ,)QIP9I<LDU[+NNC<&NQMOKA.1IP;[D#E
M6O"/,UN0>[=&%N?PR1MJ2D,^O<TGA%-EL>#NW1C3YN!]E593JM80446QH42A
MI"6^IBP"G-+ WX@>]@DN?DJ'O\GEIYL/5395F\RBK_SRL9.+;#^G 5?M>.9Z
M&& G\R*><M\ZD)"$)(U[3?([BE0*(2)5>8(-[A9$@5B8.3<;W4KO<E\D!_LD
MY257.$1C8A72ZIZ?!*.]2N>Z"8<#ZK5B6"T A2@*%)2KR.[_9LA2.J7E+D -
M]1Y:-'Z3^KH5>U)]W59;Z5%4LJKC,S!&&<L+M 4PK7?KO@#^)^>..!SWF>KT
M^!H8V5,>]U3F>^^+\#1!>'PB*?"FN?(V&-Y9=:RH+$3#I*"#K_,QD:X2(U!)
M2] 8%EO.!(-T.!.\P4XRC?@L/_00*:TA!WI25S6W('(.# X$-I@NQ+J2)I&W
M=C"48H.*+-:M0J/SY4B_1^S9]4BEVH:2QMA+D&R_AT_23>6!_$95F2-+AA.T
M%)XAV/++!14WK@R;9*Q_FE:$^L[^F=Q-%-$TMYV("HF)D:V$9:M@%U%*._QW
MLLJ_4XLR2K+''&&UO0?O[9>#F,3UN('I)2/ =]?IEIAW.EV*7A<O)70IFRXF
M35PFR^5Q!-<+ S!>8M71,\FH S@M3!OTXHRL,4F&TEBPR(_1#>Q<NS7<RC?X
M:A<X]\T<BW88"(\):0C<'-^E%9HK2S(CSAGE^YJ4N//!94=1 4#%%V>RM>0K
M]['B:B56&(@3#-$BX,YF@M=0R[W\-?<WVNS30,>#3XI$+$J/\+I0#1#0V$K9
MJ2%/:A0PLLQS*1)49,Z.VE$NKGT!FE)!9!9*JY7T^)K\A=FP^4E"1.:(#%TW
MUYQ3@86'=:[ECS,R_[5=]TBFE1JQ\D0,T*1BG%L#-_M]#\1S'H:[G87&$7C0
M^G=XOJ&VOM25C?S$,$$\A_#$:!9=*D%AT-6U@E*%'O7>AN^6#IY'GY$D(V<A
MYG )HI(*3\_X[DU?<ZPF6U;LV:GP4:=8M 9(/G59YN.4$J0F@RC)Y)+B,9X@
MAUA:+%RA&QU:KKL:HX"_7E, 0C7ZY,=*R8&%F6LB3>^ 0%+9<1#=&CN*QLD$
M TU@(3OTTH=[.WO[FSN[%UOQYM[%SG:\>3':'>]>C/?CO5&RN;=[L+WERP#]
M_6)_=W=[?^?%)8#^]?(_GX[/CH8?/PY.AI]_;R5^-C<V3ZC4H[S8.MS>/?P.
M&^9/\[S"S,[FQL+4CG<&[HB?-B$D&ZLS/P,V*=(Q8R^(K)BX/]#ZE=H*AF[#
M95EGV)F8;A+=:<+H;[RO"@8]DQ.@ 8NH:V)M1% ].Q7P7L([\([#GW5-$8*[
MTTS:( J/*AADDVA,O9!M'"_Z[T4.8PIF290Y28SDS0R4Y7HHJAB4>S'C6P+F
M*#^P0I2 8"BLJ1@3L7O?2K23"2=*<CJPPX#@7XMD7E>LGS.)59/',\XO,^K4
M3NR !-M%3S,ECES0RPQ'?J5HD=T>+=*C19Z<^>T==^D.#.NRVZ+:/J=X]C%F
M[YS42^PH)80QIGLV?I2,JS>$JN1(9%47F<X48(\N:I_F[^7>*GX4/\70;8"
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M#X#W0O8"  '/49/^*'"27GI>("3@J:7ID> EO2R]+(# 4XO1O9$EO>"\4##
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M$7N^15.,D['@-QL4C\V_XI-_KK&3,OZK]6>>0YE/TQA>)[L>\+:_"\S&RT#
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MFNFZ.XW58+ /5WIZU/XY%?1%%%[GJ+6 2ZAJ=0::H@R;5V%HW8.AOF!*CA+
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M 3:#/6/21'RYE1Q.@OAS5^GD)F;7^MM@(%2^I8:K1X8G:N&*^=O.^<-YJ]F
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M79.(CQ+!$*J*<#[!U->BA2. SWN'((7M1FT1RI <MJ3COL/Z54I$FL9-"J;
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M ?>?;#[LH>9I-1:-Q20\2:9HNGVJ4==Q=V.T?T+#FZ"C0RK\8Y/..L<A5+#
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M;(K\?_;>O+EM),L7_?]]"D3U[0XI+J02J<66W3W1LBU7:<J6="U5UTS<F'"
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MQ$]>$*0JTXNK%T]O;(AH6_2+KL!GWF\6V:##W!K[ITOAV_8M__G97(<EM1!
M B8BQ60CE8I24+*@<_X1/4[93.-B>#J>9!(W16N1Q/>["'T7H7].$?KJL9Q[
M_K'3 HDON;"A3U?@E84;EL+$+).5ED8=94<4JXWWV%3]--EV=G=WM_K[>SO]
MP_8E3>-Z_HXF&2:.SX$N.G[O_%H 6T,L;K *KL-,?&)OP*X:H=H!FH5NL<W
MV.U;AT\7BZ-?,Z!M%U)HO)'4NZHT>_[;1QN_@4KZT23*-B[/A5>DWF"$?N]1
M 8?JG1JD'BQ1&",4ENN\ 074.8/E0!#V<Z^($$Q0P=_O0)V-X/ =I3J!Y5VZ
M[?RG&@Y3>.M_%^U;+-V%[VX ]QJWT<!]$58<:]UE0S\X8]5-T+W+K([QIL&
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MBX%'*S.ZI8/+)+FI ]&PKX$C/=@]7%LK"'"0FC[")8RRUI8M:X;ZBL,;#-X
MI<>*D61IBEI]I'I5K =7)2X4"3@[Z'X3&\]*GJ+;+G#G-$QPV>3$#"BCWF%
M"A$7DM3$[WD]JUTKAO7[/-O54JDC)U%*"W[O36O:EEJ9/=]G$--N]$^Z;<^3
MK9,%%%=;IH>L#&<%&<A'O5R>=1__E7&.3P6SF9B$O3(SLY:4C7L?DG!&W:^/
M N/3/N<?5[;F_N^BKO=DA2:9N!7T2\I=85Z(Y$]PBG(DW/*KL>(2]AHT0_E:
M<Z6>DTSQW@/>=H[*K6801?U,&C?PY*22'7@-%"$UX;(K,G/IPI)5D4490<1:
M?:GK;FP:@<WOVB<"*NEFS47=94)BJ3+K]@[2<8T31N6#??C:&O4^[*+>7=3[
M.46]Y9PW8%$[1Q1&NFN0Z7_M[^RX0.LMY'3?0%//BW1^S\&4?G:E%XZHH:G"
MBD>I9:, %[86C .WDKW+MY:2JDRFK^&2:FL7 V7%A(HIT:;P1TJ,7--2+V.5
MQ[QC4WJ,TP@J;2CY^SG=*VHXR"78&LOTR-)O<7P&E8WRHP/L>&+B4'()E?"B
M&F7]>JVJC8_L"E_SV#;2S)SD$.J(%D4-+4?GM>O58(FE?S=65+N0($@1B!,"
M,+,_46+[A(*H'I%&@;$'2HW>0K B;GJ+7\"CQW9K2 .22)690PK$"@R1P*U@
MN35U(S=_\-.1;-!=Q\$,;XIJN/:&<\"A#HB$\]%$32HB]GNC,!:&CD+Q[Y"B
M+2%JCIE)_PZ,8)F?+:^[^N:'/$Q,P:2>-[">XPFWP9F89L9J'")ZJ0YXX SB
M8(A;8V;N1=1JBMW^0+%CO &K3,?<$)AADS 24#"4O8&SQ.V'U:0!V2B%25KB
M$5I=0F_ S,@2'##ZJJX8W-?TI#,ZIRZ6AZG#T C*$ 4T+QHN$G J.EZFQZB!
M^)N++4CGTKAE"+R^7&9]>PFX;%HC$2&;?D;8.(@[]%&453%X&2OT/%,$!.1
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MMYZG"1F610O]--59SEECX"78U@'5H1)AU?E(D5SZL_88MP+K\]&;:E ?2L0
MUBGMH4UW'CF2 Y7?8%> :K&/SD&\Y&@Q/>-&D29E&5_S+$>3)$.9G@PGKHL9
M*_35SKU3S4E';XG#<@X?IU9=:LZ$R\D3-Y(9]I6Z@WD3SR?QE^G0O-5SK;;'
M+0U0'>QT :HN0'5K@,ISPN ?/WF]7E\:%9D,_>SSX8N]P_[.3_RR)?*+G=G*
M,4R!C[SIJS#&EDM;@PA.>N5AUJ&;5WCVT#'?<:MZO>V^V1W^SZTSJ(ZXX:XE
M-*8J-UQWIW(N1W:G4E-^A<(%X2M),!69AD2H5K^89#@[DY[SXK(2BQ N&&M?
MIQX(/+1,G!LH>#M6C7F^J.P&OC![193/KB'-SHCUX/)$WB13K_0?]EXB Q"6
MAB?#YQ.EN3?Q&J_($_T%<QKZIL*/=H@=VMQHEN'GJ1Z8O+#'.XS)(A9%5DG(
MXN_XHM>80HP^/_D.V)AFMWO;AP>:W6JQTYM\<VAK'4T=Y='2XWTE)^O19[EZ
M<O&1@Z:):?D-F_;WGP?"L/+14ZU#?WMG_Z_K,\V__:5WL/-Z]M_O,?5>?_OP
MY<I)8*Y&<H?5DE-?79R?\W2YAP=U@Z4N6TUE:*Z0I@OA1VSPPU&M5Z,P #DG
M6O3.[FLC:5IVI-9\_M5S]7RH8_'!"O3WMYV:I4Y=S%6$)M3MS&5"P9W&O&I:
MOO/^W&TZ0II+G<_>]HN-X68YS':2T9]%R)8/M2;"\MJ.CI8[G_WM@PVO[714
M^@X[XEGF?,Y3Y8TKS+^5Y&.EF%DAWHZ8.DYT;U*2;@1W[6O04=@RY]/;[AVV
MG+ZPXHF"(-R/JZ.?Y7*HPXU!VSE4$5 9N([SO]<P)QTUK<"":[N\>Z.S;M^6
M-;D='2UW/H?;O78344U%XA2CCHJ6K1OU6TY%[\\ZFEFZ/KW?>A$FZ:,=[2QW
M/OW62RT+I[0CGHYX'D0\[\.HXSTKL.-[>ZTWY#4)G5.1J$&_[2BIHZ0'4M*%
M!J_HJ*C3H^]/11J%JJ.=+@3[0.)QWJA885WC>>1U?L2E^Z-[A\^%"]EAURZP
ML7QQUG\VA/1.P\9V5+1TU;K]\;&2BDR7[PN-%M<1U)(CWSB62#DG_WH>--5%
M[KO(_>.IZ.2\HYZEZ]F[&\&S(1_G V-3=EQH%73T7-C01S#44L3QPVIZ1!KJ
MR&GYY/1\K+9S1-KJ:&@%-+3S; @H(_3><XW#]0'C:QU%+9^B#IX'17U2'36M
M 37M/Q=J,A"MG077:=Z/H*0+1*H&UO11J;S+15J%FWNW[82D&[Z)UM21T&H<
MV_]UTGI"@O%D70G1"B*V+]M-.N_^YHTGK\^<$^F)$1IFU.G8RQ=H+UNO'&EZ
MNO3""(@J*PC?O2.E%9!2V[-KW_WR]D-'.,N=SV[;BQF/AT,!:,6;.O)9MCK4
M=O+!5E2^TGW7CK]A$ZRP4X8Z1G1_2KH.TR0>,XQ_%U9;D;^QO]-ZE?I8]^QT
MNGJCE<NWWE[+B>F;-/ ZNNKHITOP?Q@)3;JTM140S\OMEL<[CG43U8YRENT.
M:G_4U1"/T_&?55+11GC=<DIZKP*58FLUY1=IB)WH.TS0E9#3BW;3T4F,#6+0
MU=@57:\DQ-%^5?K$ZA2,8BWM++)5((BT/5(V2T;.:0+#4QW&6D=2#R4I+"L:
M.V^\B'HF7XR4RCMRZFIF'T5-Y_!O$G04M'15J?44]$'E0$*(<DV-9L9AGG<M
MKSKW]4,H*?&_;OT^<;K>5RNBHD_*Q][+6=O)*,LK/8J.AL,P\*[#CIY6P97:
M#@O1]6[H6-'C: <!(+(07=M=+YE5,*&Z-_OG'+O[PG^#\/H__@[_Z)?ZD?+2
M5X,D'\DC=*_S77R43&%GYZ]/-]*Y/<W[>Y/<V2G_'U[Y9NM (.)IW/3O_V,/
M?^#Y7Z_2I(B#+3^)DO25[B%MS4N.39^6_DIM#5+E?=WRAO#J5UYTXTTS?5Q>
M;O?W=&_J5Z8/-:Z$L[_]\N5?G?)/7(^9Q1Q[W[:L)9.-WL*.V*_X+OU52D.2
M[Q)NGOLJ51&UK\1G5YY*^P(D]:K?VS[X3MM2$A"M_VZY"7_WG%&JAO_XZ2^7
M9V]KAX4?@G_K3N#T3;4Y^$__<8G4A_825AG"IF?F)'G_8>WO/+JLKFK3<A%Y
M&Z+@YN) $)$WR=0K_8<]95Q&(0Q\OL_CTF> =LPK\D1_P?M%WU1VU3K/<LWL
ML9G+P)^DH;KP>)FS'-ZE]E1_.<-.!TT3&R11@*2@TO'??QYH)OIDC>6_N]BX
MWS3_]I?>P<[KV7^_Q]1%Q*R8!.;R]3NLUH627KWVXBS6?K[#X4$.N]1ENT43
ML2Z$'^^LE[3G2*WY_*OGZOE01XO-BHMBT!D3RYW/\VA-<*JB+(F=CT44A5T!
M5=?IZ[[DD\1;"+6C<K(].G]]YR1[S"S.!E]8X^VJI[K$F,?0T?NCMQWA+'<^
MN]A@QV\[X0R'6_E(;5V,5#1T+I)A?N.E7395AT#X %(J\@$ZX"T0^8Z.5D!'
MK6=)18X1PRZM<R75G+W6ZT+G7II/-T*5;7;4TWF('C"+D_-CYR2^5EG>V6.K
MR ONM[SIP'F2Y5NFGW>1^B,/[G+>)%[:99DO/\N\_84*YVGR;=IYB+JBSL?0
M4#&(0M_*#>[PXU;A,CIX+H1TD2?^UU$2!:KKI;ML,CIL>Q3-*$4=Y706VB/(
MQ[3S[NBH4ZL?149=/^]5DY3IYWW2\KXG)5EU+;U7J6BWWH]MZ&BFFVY'3DL/
M];<_/EO2TR<U256&&.!8-M,14Z>#/X::+$^ <S29I,DUMA_T$!FCDWN=J_)1
MI-4UL^RHZ<FH"2L.02.G=-OWJI-[2\\M:7F7@D\J4.-)AV/0,:('D@_V^&8@
MC"Z8VY'2HT@IHM8[78/F%?5O:GG\#>A'@4J$O9N\<-Q9:5W\]K[T8SN0',JX
M[8AHN?-Y%G5KG]2?19@B(TK&L.K31F=21UG+G<^+9U $8 AKL9^R(ZWEDU;;
ME>^+X[<804G2KG-JES_Y /*1@O^]G<.CKD?/:HHD#S>^M)Z*HJB+Y':1W*<@
M)1@"5BJ]A\WH8FPK\$?NM5[;UB0$!R++'/$N=9344=+]*6F2Q%F"^'X3U+ [
M?*T.7^M1Y&39_!T@_>JI:A:0OFT$5:37X37*NK=)"ARJHZ+5N+[;3467R<1Y
M6V1Y,NYR)%<1OFUY(A*2#RI(4=B13T<^]R>?LE>A\R[QBS$WXNC(:,DRK-]Z
M:^U?":9EET9:1T7K8:7I+D]KLH)/,XQ%?46H55&O7[8JFM.;"!<K]/G)U<XC
M_^^GXX]')Z?OCC\Y9^^=\Z-?CIV3T\OCT\N3L].C#Q_^V_EP_/[2>?/AZ/2W
MU\[%R2^G1Y>_?SKF"]^???AP]L?%_[=&<V['SMQWE$&832)O^BI.8FGB=.<A
M1V&LMH2I/@$UX=SQQ[ORD-:U6^M;X^[:K77MUIJ7RW/"X!\_?>X%P?[NX>'@
M<]#K[7W>V]O?^SS8&0P^'^[X+WJ#_L%N[X7ZB=_ZA,0<QG#>\E>[!W49=7+J
M_'%R>7I\<>'\\>OQI^.S]ZZC/'_$B8K.2*4J3YR1ESF^5V :;#X*LU*+<;PX
MH,@\KIQX#>'Z@7(R.#UP.?X>J C6 #.,X#%P73Y23H ==X=AFN7.30KZM8H=
M;Y!<J^TGY+6/%L:MZI#7WS[8O[,&O'>PO;]0 [;HO/I\V*-T&"4W>N'TYZV;
MU)N\8L9U TMU*\\POWN#+(F*7+U&]O&]6/I\6K NO*^0DG_OK,,?O.B6_$F7
M',X@7O"/GW9_NG7Y]W>V7RRTH;KUO]_ZBQ7^-/QF*5.VS9A[6K2&TO;N0&F[
MVWN[RYYL.-^$(PT@4+Z$8&IJ:/U7U/Y?@;:J4OQKYF=^,C7T0ZT)1+F%4!<N
M',=/__&*+JG[<7X,"GJL>%CW^3TI+UX.!UQT2.YQ#.ZS4#\4R:\]TUS47_>=
MEWO.;S%^!0:/_V<1LO"F:/:VU7;W1]O5CI&M&R-[Z&1;1;;MI](WTU>/);05
M]BN?G<_/V<_.&R]-I\X1RLE*>7U'6L]F.OLVY>6K[^A]ZHW5G(/4O_T@[:W5
M7+KC\X,<G^5FK80Y&"?.H\[(4@?\=A2JH7/\3?D%H22<#8>A;T/>=^>A-=-I
ME?K\;+7EE3DXVF#VKX&O=*8<]=F[3E=$C.O.7=?BH+:!57<NV\YE>P^7K>M\
M^/#6==!/"UNNHJD3QI1YXGL3SX?EP&24? %+IMP7HJ8?E!1:P3D[/^]SXV#M
MI]+GZ.=]'Z:!5_S;.0[&P$??P/]_3+Z.<J^MS+']5/8D-OH=G$$'VP?KY#&=
M]?[>2FM[V[VU<OIV9^F'/DLK< 4_Y+RLP %LFL!U#N#G<"#:H%<_6S5Z+?Q*
MZ^I$6(T#6.IC+HI!Y^[MW+V=NW<]%ZI]1ZUS]^:94S)7USF)_2Y!=\UY8.>X
M?6Z\J/U4^AP=MUV&X5J05N>M;:NWMCM /]X!6GFV[OKZ:+LDW6=U(MJ@0C];
MC7DMG$'K:OFO+DF7&^S=[J.==D[:SDG;.6D[)VWGI)WOI#V+U4<5G*J\V@6@
M<\ZN,^_KG+//C0>UGTJ?HW/VW"LBYZV7J6E'5NO _'XPQ^R#?$[K,X?N]/Q8
MIZ?SRG9>V1_C1+1!=WZVJO):>'_6U=1?G5=V3AOO+I&V\]%V/MIU7*CV';4?
MU4=;&E)W 4QH9,0=6D(;^&7GU^WXUMJ3[0_EZ/WAVP_^WPNXS,N+5,$B72GL
M'B6E'*;)U/]\EYY0Z]IM[XXC+.>%/[:GM][C'0I=G[VNS][M??9V=_L[_L[^
M[N<]=3#XO+>_?_#9&_0./^_V^KM[^_W#_=[^X4_\5K[C^-L(R"\_^KS_HM_;
MZ<MO3\X0:;OO=\AMVZU!>Y>!.T<K[E:ZR,)X?_;I(S:+_=?9Y<GI+\[1+Y^.
MCS\>GUZ:1)"G[W78>[F0F5YB'\/Z<%SJ2ZC[%!Y-TC!R^ONNT]_I]YT-:GV(
M'*F_\_K^VV3$F6P3/:CW>M-U!E-JD^B-D_B*+*S%K4=<QW/> <'?>" S_3*I
M!@>H'CX^JXU3;7R-*3S?:12<>SF=&0,N$/6EE/Z169[X7T=PCTI-3TFYU[D9
M)9ER8@]IQYM,@'LX"9NRF=$UD/W+C95^EAOX$IS;8V?@7)0CK,X&Y^*B5ALI
M'YE6!%;W4ZR9_<:LMH#;H'Q.Z G_QAZ>*AUG#K7SQ'6-D]P![JK2FQ#6+5##
M$#MWHD$?PD!&7A0Y(P],?!PDF/P3'K8S5EX, @S6.//3<(#/39RL@#WBYXO[
MH*[-.1MPNJHOV7S*KI_WX $+61:U0SVZ0 [E N&,BRCW8I446<1M46_"?.16
M$21=9V%)\MPC0Z<?R3:*IEO)#2Y,5@RR, B]=*JIN\2IW'@PI=@(%#9]+':A
M;Z(+O3HW0=>TYA.%XQ!99Q1ZK,3!#)DLGX@MS7C^:QRB-+$>^<8Y@88&AK1Q
MO>D\+/EQJ=R33R_);]B@,(9CFH^\W/'!BO;@E"[LYHNG%3@IG*? &:;)V,GA
M].%)I__"W9X/XP^\V%<.'@FB568 R%)4,GPD=ZOSC]F=@ 6<T#&Y&87 ?;!9
M\4"IV!E[@7*\:R^,2.>$,9,$:6*7KC,ITJSP8 W@,GX.CGKBI7FH9"KP2X@Z
M*S$Z-1P"'Z2+QCS"<LW@?/%:X'K*>AOQY);+I$>"?8+#N !FJGVL69%>A]?X
M!<P8#]/CZ(+'55NYU^O.=&O=HC4US=M$!S@GW9%B["*@&^-B/."M4:!%P3IF
MRB_2D/:TIC7 VS(XJ,,DA=U))F1;*)9G#2_#1>R]>)V1FH'JQ2/T=D<V1FAL
M P4NO=<:+(D(& *'::9(&?.G8HX"RI(T&X43:UF2E"D[N>%>W=<)3!-T('P[
M6<)PHF&MD%6 8FH_UCXP#NC&"=VOSWL8,P>;U:D&"H<+=J-*4]821+<08G\$
MI]8K4"=M7*]U)V]8 '(O.,17@L)7=6W"5B"0 .S-0!:$'+WD+W5&Z<[?/)0Z
MBE.&D.>4/=I#LD JNR=/+^5P;23KJ+N=GOWA.I>XV&!X'IOE!CX+2I5*+4)5
M>.#55:+70;X<%WGA17##M8I!*,CYTVN2$<?V+ W6U:P>I .M80)4[T3J"L[R
MU!F@5XJN'$S=BAG3N#L;F8*MH#NU>OX%!IA'TTUW\5[(.WBDJ)C#[*(HN<E>
M+7N3Z(>:-T,[2<.8?)Z#".9<>9KE<VRX77OU>N35>]04[NBKZFT;EPK_QQ[.
M=TQWJ1R^?P%_EO=O.\=S9)_+O-H^N*)GB,%&3 8(MV298-3,(S.W1D<;AOHS
MXCO$.40V!HE?\)G BU"E#(>A#_(Z<]0U'+;8)UF%EWJEGEF'WA][4QBIER4Q
MJ&KXYY^%RG(YLS$:G&S!L]D%QR <\JB2& /5PTUZWM%DDB;7<&[?)G ,69^V
MC,V!@J.P:5NTI"9FL 79,%1@E(LXA-.<D[0=*T4<4G,%A=I$7=SJLT]W>#Q4
M6+L;6&9@!\1T<,ZW/0/&!-_=JF^4&PASV\37#KWK)-7/\_02T)8%R<1F=<T2
M(D^]..-Q,V-38SBF>2G_9RQXYCI58ML85 =#>@CN&.QMCG+*VE[84)5E:-N*
M<,$U*L;C"E]^V+ TBQ?7!NYFX!03WI);'$<P"?^>*PIF/2KH0$ID-MG4-L?]
ML<F68P#_O0()DN46V;C6$4'EJEP!9X/7$NRV.5X54>OFKUK.9WH3KX09@7X+
M<R([\"8IH@ 911'1D?,<C(NPD&+SA*6@"]>4-C$N0NJ  0MO!,4Z2:TM3P91
M>&6NL295E7K$#Q=,QQJ;H9T!:B[(T5B3+$=-LAQL/?3N/9B$R,)E?=70I KF
M\UW8N*]Q<A.I -V)H&&K<,*$F +W WF$2VCLTZ97;COO<4.*%#:DR2/I/L+C
M/,,.:XY(YH3HQ^/%;EP2O@BE0\DRM4, 1CY.@A"9)VX&,//X2MF/>5O1N";>
ME"SQ!?M>M94K>A&O%-DNO%JX6'[DI2QP^/S@60J^%%EN/ZUY,);!_R#3@Y[2
MV^[M:_MMS@Y;*X@T!>8\"D]/5E%3.Z\CSV/AN(<SY +FVWBL@A!(%0[(!*DP
M8 ,1]5%?+5U#?Q;*7W]%RM\E,JTA.RUF#%S@1-]\-2$-"G6F@2)=25OK2!IH
MBN?Y? $TWX&R4"/4ZA_RB="B:=<)X.T^7(-OA[V43RZI)YF*(G3D8.#%97Z,
M4]L(8S\JB$AQU!/+)(N\&U#OHE#!]1/BJ_B&3)]WE,LF5 '$S?X=<7IP=F+I
M%;&OI?'CP0H2^_+2^MLHX@BTDE)PP$"5LM1>6&LVY&94[4U6?P)%3B-ZO#4,
M,M ]5$7(,DR!.>'0+.O=_%@1_R19K\S'*Y2S]&S@ZM]XK\F'@R(FSY,T5M.:
MRB\.)=XS' AI1QF&W;43LJ;$@?YCCTM\DRG(4-?1FH^L:GU\1-^Y]Q7G4;<\
MR(='A&$3"3N:)+0)WX-"HC2QB'IZ1X(I!\6D$NH?:UOQN#V&EZ#>!G-4MJYO
MZ2DF3";>81@!L.-K5!'1BJ#A@00,)<[;I%"0!@+S \(<XW5HM)7J5%;FV6YW
M&3U=1L\/D='3:2[WTUQV5Z2Y?*I8A^P0^H/MPXH&\Q#UPUB>_%@Q.S/2AMD/
M!+P;=)(A$B+P3 5_S7JN5^</W3UX%&'U][?WUX&T0*>KTA96YDDD >TO"2/P
M!HH4H] PR--YKJV&B)%V:U?\0K<^8I'!+PY-4/Z0K(B$0C'*-L)-O'8(EIZH
M14!3UV&"-Y*<_^#=E K&&85LO,D$+M=AY7G# H4JA(>+AJ[5J8Q4&^-60@(N
M\E&2AO_6.@VN(QJV8M0.PTC4!]!507T3W8<34.!;F$2(P:.$[=\) =6*B@FR
MET9!P[!=)3X(2EM+^@ :MY/$,QJ3Y7>R+>:ZYCC7B:,U.'A[GH:R->P L!;1
MBF6"/I=I;]99>N7%LBZP5.^,K[D>\$SG[@'IAAOA=<,>-WN\X ?;3$=_GH>7
MR9A9_T;-AM?N5H?MO#DLW2I_+ MJN'T%#&A08T 7<UE"-1L CSQFAEPE2> Z
M</!"_@Y6ZJO*^20CY(.6&M89:$@+F*.]+\X*^(ZBMYX##&8$VC7H$(\H_]$Z
MY'<[T@\[O!_N>'CGGU:]3^2K3R*=J(">=7A+JE =P"/+%M:FR6#0(F-8 %LG
M#=R56\EOSQPVIX@#.R7,Y*SP-X_+CI'ACW.E3I# E"E[\B:>[P<IW>+E@UMW
M^-=%__#O>OPU#1$-N!8!T*'0):UE--/H+K;J,B/FF,K(55XY+";G+"A0>Q5Y
MCB%%>7Q@DQD[Z^:15>>N?0AE[*W*75NF/AD+Y[)9F[7=.(OR/W1XI/(0=K@"
M926H#OMD)>FT*\413G(\>3!H#)TG0W+ XG?'Q"HQ2(DK_9I\E8U96PTJ7$."
M)WJD*,'S-:E6_J:=,:.CWC,QO_GY0\[O-'A[,"G&^$([3Z=Z#..$,C.G=BP?
MEW%8I+7X(TDCG9.,$JII<5\O34Z3ZABH0$C%7=J+1\ &KTT*J%OFZ3>O>1FR
M2H%E*5E>7G/R4)9IWD.)_*(]!<+7TJ3K"H6/ APM&9,[.#N*^ET=,WP(,]Q?
M$3/\&&8^*%=<)Z'98:?J/(VKI8S\E5$MS4],&N*\HAO22>F<'L4^G%1,OM$:
M.2<?^4DFSC7,KX@SBER1RAW4\K :0D>&J=_J@6'.,L#4^M#D83!CX=>9=+'9
M ;G.S4@Q@R>OQ]W>R"4693)'V^AQ/>WN(Y8/H8_;(OEZ\)<?>>$X0V4:7A[P
M]K'QXR?C<1%+AH,5QRHI J@,U0>=BFN^OP+5)>9T/_-=@'3'N>0F*X5T;[Z8
M]"%)Q]E$*C..27@).\@X95)%BK-S0/QMC;TP(H_:8"JN-M+5T2/$>8T*_05A
MY&Q,@#81K6"2*J1C7(&\2,TK]8*H8%/[$ZS".5U4(ADW[)*F60<!7):1VRW%
MG^D<2+25?V-Q*P<&2Q;T@N#3>83DSQ*?(*]&8Y4.'-^'I[WLE_2P^;U\Z71N
MYB> G\PZ^#&!<TFC>5UK/SI3I;NT8?P>A[GSRX'KO >]3#EOB@PX"A#*N9=^
M=9<VBH\>L IXDA?(0%SGS5&OY^R]/UW>(' IX #\!F<I2,9+>^VEBEXY_WMO
MS^GO[#HO=W>=/>#*JSD4Q\B>7CD#[%GWSP (]"O3I^<77[?]9:U)?51<"\=I
MD,L\H:<JPDC(QR("*9LYG\)(39V_>>/):^?"]])!DB;%U<CY\.%\:4/J[?0H
MGX_""\@LCD @G/[A.A<%^I4/ET4X6(SD92,X*3F*PG=O@7AW=GI+>_D1>@DH
MTH^M%:?.9>%_%>RX)1U9-1DE8-HX&_V=_J9S\/)PJW_X\L6*CNT6GUM0<:;;
M.2W%/V,BWC'3KCF[:Y#O,Q<4I+\G,RO32_I=@D^7X+."!)\[ZXZF]&.9<FD.
M+,"2WGZP^W+?.8L"YV+D ><]\[Z2WK:T][.DZ^\O3](=P_?.>>J%:0AZZ<<P
M!@4Y >5]?W]W;V^9(@^D70T)<*G"SCE-MD'@O=QYN>GT^R^W]@\/7ZY6X$U@
M-;9]7(U_POC HH]5_N/IJ9_",2IAY]MOEV<V]@X/=YS?G(L\52IW0045#72O
MOR(-%"9/.NC!D@_D.S48A,KY+0JSU_@A]9Q_J31>(D.NGT]22 ]?]+8.]PZ7
MQ)[FG<^ %F?[*RS./U.DTLB[P?/Y&G])O>UK6JG*3ZN! V")[C5GX8FLURZT
M,I]GN"!QK!DS3%!(NK#4DV1OG'!:$D8 RPS+2GI=+<Q 52R4O.4Z843X"AS:
MP(P.T5*Y?%/%L+D^9UK@.]*"?P4J)1?OI!A$H>],$OA7EU^+GUJ*)=EY;4;3
MA!8G85*,K,*]5%J2JC%B*F$5,68BT2 XB,$E(5GB1$D)]*/@=<D8!H)A:IH.
M(G_EY*B]:U)KR$E('KU F5)TV+B8RZ]ASSBK.H"!9I3B9L*Y$G[G6GYEQV(I
MSV71]MQ_,UP3[4'_MY0GZ46\2G(L8<3A8Y(>%O.BHSKATLAZ/0XNI)?5D)@2
ML,Q"3#8C) Z3>V <[K!^49)AE23\":9(%N(PR6'.^0OXBX]A-AJ_K& )U**+
M9&_=DD$EY$0Q.QE:-*V592<F;0W3-N#TXL#UV#H^\R ^$\QDJ=\A6UF',&<#
MI)F=$4RG-LXIH;N\UV!W:EIK*H&#H_T%/PHB HL2_5X&M^)\0XQ0*00O@X/!
MR1(6]@Q>8A7;9:Z#AG:9>8,1M]3#LLOZH%Q3I4_G8CP+$7*G4<XD.)79(D#W
M7+\'E+VA@[5VDJDG:&EN4QU?I6)SDP:7%'SB>!7F8&J8Z6F4+!SY>))+N2=P
M"OTH"2SSW29V=IU@,O  #CHR_N[,/>C,J85GKESL0<@0212B9>045*ZDYXC0
MX$#%:AC2!E,V$<<[66"XNCIH1/61\4QVF/HV(3T/91&P64)V(5F5,VH!O"/1
M86<L"@ 2E<'H1%TIH2"]@5.)S8 P&1KLU*E.J1;=\ 9$0Y:@(B 99CJ*[&6-
M:4V@ZC<JG6:9,,$JHOID7I!Y656BWO"XNVS2IZ+F84.=4TUOD8IR*JY.,0\@
MI1T+O#':"5B=3QEO.B6'RH!GZT=F%5SDHY)_+,K<7(3-"F\6W42/TE 250%%
M L^KU%>=*N!7"K2TLFD]E[*)T.6M,2E*0I,S *\4MHT9^82P*/5]=<UK#GH
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M%T"!.]+&%'H^-%@4X2F;3FH6VM%M^#,6>DUIL^D6.),H)-A6@N<GDW\\L,K
M4\2> A%:HBJSAY!J)73T#KD$%OW*%:E*++07_.SK?G/FN0-=F62]S[5U,&):
MB$:- M;X="TX9R-9J;.3*+H+$S0:8'*SI%0]4VEF-DEA,2)UA3'$H# -=QIQ
M-TOIC#V;5&,(M1$I'/EVI0,#U>]IU.SEUZ4^CV,5U:ND&QA7U8-#/HYL7N*%
M@4]&JBP]D.AV-^% -,"0K!CN%8/:.6;8X"U@=M51>#EN@O 3 HG?#!14<^VX
M91SQUNKKYIB+;B>%\'92OBK!C#BI(/F3Q^=*3"H#)5SIX2"N(R\K;V1P&^WK
MK]JP]!:K>)5O9Q<I84978F+H:36KXW*,R@H[T,-*G&;:OK1T7U40^+5Y;"!7
MJB$;H0-3,<QMEX*99DH/*FVGAF4ER;CL"*<<#(VXQ>D:-EP*3:;>.X7>H /;
MYV!_7*7>9.0 K3\YD[AK<]^%#2*M'N[<5Y5+FK?_!QM'?I?F[77&,^.!7HL&
M[HVC-#W;'SKFEGE;]SIO:^=MO6O7]KU@Y]#K!][G%WN'@\][_=W!YT$_V/O\
M8F<(_[<[W.GO?8?.[$_0<>[DU/GCY/+T^.+"H29_9^^YZUQ%(%,;5FUDS6JJ
M=K/+89B"4F)R^M OR;R?E6)]>HC2\>1$WB13K_0?]BR1WN0$X4;XO(&:4Q!I
M(ZJ8_H()F[ZID/\.G3Z;^&>92Y[J@<D+>[QP>:"_QT1I!"\3Y@%'0AZQ#T^P
M&*>\23-1BZZL)V/ >0AR1G-+_7GK!L3E*^82-[!"MQY0\[LW *,&=N<UGM7O
MQ3SO(A]P>O='S__[SWEPI]7>[1;[Z18;#AU>\(^?^C_=NO![+[J5?Z*5_SE/
MD>,\ 7=95^5TAL!V;R>PY<]TD51\=W1YY/QV>O++KY<7SM';__/[R<7)Y<G9
MJ?/V[-/Y-DK(<J(_SGX^BCNO^^2>CANN]4S;0ZTM)\XWTU>/HB]1D<4B[DV^
M.>2W=K2=V8Z-Z<CM&<QE?WMW;\G3.?7&ZM6]!KG7VS[8O_W8R.^H0'9G:IUF
MU9VI[SV=2ZRFZ0Y5=ZA:>ZC:HZ,_3]+[<1T"9Z?''X_?G1Y?D@?@[-,1>@,Z
M/\ :LI3.#_#,F$[+B;/S W3D]DSFPC;+^BC[G9.@.W _P('KG 3KLF5TJ'ZF
M3):U&=@*<BI7-LJG'5/+\A'OG,IZCC ^>>+\*Z'R>I.J56:U=DF-75+C<G'M
M:RF*M[E;EI:5N*XV>I<MV:61/3I;<K];[.4M]EZWVEV&Y/=T-J]70.3MV<?S
MH]/_=BY B_GMU[,/[XX_773QD ?PX;9/;C'?6P[#L4VA1_2!?I[^M1^71R$8
MWAMOX#EGL7).#%J<<B[3 LR!@&I@/WJI/W+Z!Z[3W^GW.A;6L; VS:X]%-IR
M@JR'<>]"4UWH=GUG]3@2^_F^-+ &40^*ECIO4B_ ;L)G,.K!M-OEI]GE%83H
M6(E1JHU;N#*M?0T%2VL69@VTI,[0ZPR]>8;>13(9=8;>,V!_G:'7;C;4<H+L
M#+V.Q#I#K]OE-9 >;.AU=EYGYW5V7F?GK7Z)UO!4/2]MK2/^]5VB-23^UBS,
M>NG'"UU)_ZF&PQ34YO\N6NTA6E-"Z$Y(IW2U6.[\L,[U3S6/>C)T_E.EZ=3Y
MN.W\&GIYU<?>>^$ZO</#%]Q88$S-ZUO-33M_>VNY6N=O7W."?%X67$=B/ZB_
MO2H.NTWNW.TM$WAK*!HZ7:43)&M%D)VNTI%8B^>R7FK30J?#N5=$SELO4]/.
M<;"&A-D)XV? *9\;A3XOZ=P182N)<.ELLB4"_7($#\R<WY+,R[P&F=ZAZJUL
ME$\[I@Y5KT/5ZU#UOA^JWJ-9VS.%EML[W'ZQ$"RW@^!Z8G2Y[0[Q;(G+O;>W
M_:);\*=:\/L82+=REG4W(^Z7>[3=7[K-]/W3C^AO$%L>R'4GC&%)QN,D?KAO
ML?4T\4CNWO;IW<I-UWJ"K:+4UA/FO?V*3%OKZUKL2.T)2.V.22P56E@#)QTE
M*]6<<=U>/^5>MRUG:>4[V:DRG2K3#DIM/6$N697YN=O?9ZD_/$6R<[?9:\')
M.P5B'?ETIT \3P7B^5'JLW..=,387F)<!=M<']5L81CE./T*2W/T=5K\>X79
M5P\*WJV)(FB&$839)/*FK^(DECR).X\)P1.V)#J+(WEP@E@YN9V[+V27FM6E
M9G6I64W+Y3EA\(^?/JN70V_7W_,^]]3AX//>_L#__-+;4Y^#G?V]G=W@A7^X
MN_<3OW4%":+SV7L=CJ5*RX_ <@&Y\5^_GKPYN72.C-3X_C-?V607-K5;$S'T
M3-/W6M$9]D%I<JV<F!@R];%A<M"]MO0V.T]^)PJ;^VLJ"S/GYW57O=\F8SB]
M4^<B3_RO(_A.I545_(=?RX<+ VMUE5^D(78&;\SJZBAY#5SDW3+>U8/4D6M'
MKFU8QHY<.W)MT3)VY-J1:XN6L2/7CEQ;M(P=N7;DVJ)E_$[DNHU^^VZE'T^P
MW4(^!Y)M>'8[UKI;RHYL6[C6W5(^+=D^2V"J+D/KKAE:73[6H@G;*5GWA^+H
M4K&Z5*QYJ5@O#U]X>\-@Y_/@\,7+SWN#H?_YL'?8^^SM]Q5\OW?X\F5?4K'X
MCN-O(R"__,WG_?W#?J_WO=*T:+OOQQ7L0]*4F<L#=]ZL&']P49#]XOSL].+L
MDW/Q^_GYV:=+Y^B73\?''X]/+[]'5E@8 _, I>+E0O9[.0HS9^ZX7$&$\3*D
MU:-)&D9.?]]U^CO]OK.1X[W(F_H[K^^_82:_5#:,'M1[O>DZ@ZGCQ?#2<1)?
M.>^\W'-^B_'.S'4^?'CK.I[S#BC]QDN5$X7C$ <8A1XS382DH42&C0</[&*2
MQ%F2S@S+'HESY/]9A'SNX RGD^W*L'SX1G+C'C&0\R+U1UZF9H>"RW,6JX\J
M.%4YO5_>=M?%R4?JX3LGN2*U46T[ERH=9TZ1P2L'1>[$2>X$:@B:0(!8040M
M9M.=;.1%D3/RKI6#@QDK+P8YD &I^6DX@%OR!'\8\ZW*^:C2*Y5:#]@ HM2/
M'Z@HN=G<7LT1^N/7XT_'1Q>N0SF!8]R*6"5%%DV=D4K539B/7)J"V<\:+<G4
M+HJ!ZYS$_GQ2HE/AW(R2*)IN)3<X\ZP89&$0>ND43VCE+<[&XM1OO?^8W7UO
M&BC'K/GM[>\BTL77/?A,/XILRX7YI":IRF!K25S.G*X2-?^1;[Q0473[ZW!7
M%XJ-QI..(F,^S_D.Y]MU2/;18::SZ>6.#[:Q!P>T/)4XF?,(7@C4*#3RN,'4
MS_W,J"9%FA4>O!H&=3,*_9%UGIR;$)C,&#\[> YI>#)\Y<@\7?[)^H9.<A@7
M6 :!@&?P2U:DU^$U?@%C0)I\BEDUD@*BK3E +T5$"&T\)1I"F?B8Z<.N!TSS
M3)6O@,"0M<+],_P 7]-[\3K#FT"T<B+EZQ7S3,^,$S4-8IC)T'5$!CO Y#)G
MU]WK[;O]%_O6S,K#;,\&A *L0U; BMUZ*:TU+-VM%YI-0(Z;9J-P@E^EF/T>
M.#!&'/PDN8';@*ZN$Y@%"#J<"%E4CH>: AX;4&OTM$"12E*1< Y<- YC/KBT
M%A4Y.5!(=&!NJ#1EJ8B/AC,GA/EPYD3SKI'@:UR6%9,$S(T,3IPKW%KXJD+J
MQ&',3L$UQ);*4UUG&"4QP;JJ;\HOJ+P)'Q.H",Y+BA]KJU[E$"M2+$[/_G"=
M2UR6]V>?CET&7(Q!W*O4HA;E#)-4725Z4O+EN,@++X(;K@6ND>A=3S C%N>1
M\L3TY&K>J.* %B0!TG,B=04G:NH,T*- 5PZF9D'=*A>M;@Q?RV]$6AV"TI+<
M9*]6LY25XZ']6F%,;JI!A'S0?ICE)GHY>[OVJ_3(K_*H&=S16]#;-D8M_\<>
MSG<LY*F<AW\!9Y/W;Y<40*(3^,A$^>;4,&=Q*R20 6O6!)C1J:63J)A9!XE?
M,%G",46E(AR&/L@#.+#70.ZQCQ1)5WJEII%9U ;/_EE8L>838V\* _.R)/8&
M$?[Y9Z&R7 Y1#,/%$Y1K#7W3,&\O)[$P5HKXA!RGNO"U='D^-W23QT^%2=^D
M80Y'B0XLCO;VQ\#[O<DD3<0@FF5C*-KD,;S"L*2;^.:A=XVBDG_B9\#)I^4.
MDHG-*68?2@((#):,AYYI(R8BNQ\FTFA[X;.K'--U-@;5P>!Z)+B^L!,Y<FAK
M,V#Y59:AT2(D@\M4C,<5MO:P86D.B5X+^(A;&CC%A'=EX18X&V'L1P5SOXHA
M996<.$=Z?3_2K#+0VC;\>VX#&'FH1<).HZH,#P@VD8GK&X&5Y[+E)*0R*M&5
M^_W(RS(\79K/J_' 4@C/DRS?>ALE&<ZBG,&;Q$MY03;4)APBX/Q9;I&L:QTL
M'$BY],X&;R+H^W,,<1GX_.W*F1%L.J3Y)),D@W4A^^$F*:) *[MXAAST1:.J
MQ?2CI9<+UY0V%"Y$ZH#1 V\$33Q)+5I+!E%X9:ZQ)F5O-/QBV0C$#1=,S1JG
M(6 0C>H;\CQ6R<H9D#SVP@@+JA],Q\,T&8OB9PZ&"@S7A3W[&B<WD0JN@ F0
MUC]AXD^!78+PP=6#.R?3>>=^10I-NZ5P?T52^!+I9ZB(M524=HL@1*PBK8;:
MMQ8G<&X",#W\/*)3 NLJG\"6_^:K"0E1.C<W8::JM&F;U<VB Z5/IJ((C3AD
M42Y3^K#*28'&DXFEL$;>S28>YP >XSI1J."^"9$R#C;+TW  :@']#8R"#A%R
M53-(4 8*Y'A\YBOBL'(=*YXP^""Q+RUUY8TBCD (E4<4!JZ4I:' &6>UEXZI
M+>PV6=H%BD(O]'@9 EDA'DH=DB*(!^;:!HKYJ<)NB9-=F8]7R-?HJ< MO]'6
ML7V)YSK/DS16TYKBA1Q6.V5"' :)P0Q#2]J[49/6(+/L<8G3(P4^!:)EHADH
M,]7:^(AP<^\KSJ-)_V,JLRF.C6!QE\/W( "4)AO10^Y%.N/: )E80GVAM2&/
MV65\/HIFF*JRU3M+)!C_M1H.:<Y#V#-UC=(==4<:&0@,_*#/*C%WF!90XAB_
M#U'K-5*+/0>TPMO.>[PT!]Y%*PO_=5$[Q==I;;:J0NI7\/GG86M_R+!(>2]%
M$,')1PT9IE\J8TB*J+=,TA"=,:BE\[3(Q5&D>""S61\%ZRE:H?>!YH'MPN-*
MK1[V%-7X?)&ZQPRFDTP/D$R[*Y),GRI*&;L8_F"U+&R04D:'XRM%@<M(]27/
M!>CH"DAWB"0!QT+!7T P%2NOZ@I:B5N!2*=AWUM'-B# JW2#34+$0X8F@;C'
MV.4F',L#T\7V9,XZ+/4F5<YX_8Y%6K&X#4!N8P21*"5D=0:$PR9>.XQ"7^0:
M// Z3/!&XM ?O!O\ZHS\A\#+X$+*M  R,BZ+C1">@@P41),6?!FS,6VT(4$6
M^2A)PW]K'H7+ ;:7#K,.PT@X/.@3J+;P=1SL@V]AM"$Z+A.7!3F8:"RP.'Q
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MZC1CV6#D@1T7_ #+L/7[I,%[\\GV:GR2G'=S%:AQF'B<HZ./6(F$5L89!BC
M2.&: :G)R)RW]-Q?YL62FM9Z+\#_P4JLBC$\#S*:9YN4 1#<&0X8V*$0^K88
M?)&PSH7DR^QO]_:=#3#1A^3/A\UW3F+R"^+/; 18UQXX&^<%B O?.8IC>+3/
MG&'3M2XZV'8V3N$-P%- *^+GN)4''6[WG(T_/")M=!!$7CA&:F212$UW-N=%
MNC7)9=X8A6,NF4-D*A@;.2,;R"2C3+R43*"YD4]X0#BTTPJ-68&W3G4XKN-\
M3ZM4LU_X!@DA<\M\1C;OD)(S>#&9NZBN*#]GNT[,+C2<)Y/4"S-V\);6&"Q1
M9M(NK!TG)4N_'8-E%.V#(5R':5YP:-I.";:,]MG!8:MLA<YS'!X2F!].4$V2
MS#$?B1K-@#2\)I=5)9I=*H E7V??%F=JXIMC=97 @63WM/'B4PQ2^_%GG?7)
MHL27+D[WQ*2]OZH,DC+#W 3E+INC-K9R;YD .D>JH80+,<Z10GQ6!.15BG/N
M*#3NP1@Y6/V*DD9F]9C7E$_1F S?0)QX9'QTJ5$PBCREJ&3@K=EK<J7ZFW8.
MM,[%K&2#S4TIWW9^IY'; TG1K@KMK.NJ90[F'7-^JZH-'ZR#[I5534UE$PJ9
MII5]S:(I0,MOE-RH:W0BD,B:/RJ3\X.,(50R !X5,;:RG&HH_B/4&8=%9/F5
MZ]S!1\\=\AA3L* 76@;1L8$'L(&#%;&!CV'FJRCBZL3..GM*Z^RX(9U.GV%=
ML$,NY[GB%@_D4>S#D<34&>UBYZQO/\G$ND;W3IQ1HADYU8-:/GM#KI=A[;=&
MW(T5,/%"DYS*'(1?9[+P9P?D.C<CQ;PN997G+F_DNL4RP[4CQJ>P\8Y8$(0^
M;HMDBL%?I&)FJ&/"RP/>/@Y,H&Y:Q%AQ47/J&8H *D,IJFN,S/=7(,%C+NTP
MWV%FIU2JD;YLW--\,>D%DK2\B51FU-,PECP)@@#(5:385P%R;FOLA:2U#Z:2
M<$'>[+):1&$<#2[9F !I8B.K2:J0C'$!\B(U;]3KH8)-K3A+]B+J(MKRDRP[
M3BZB20<!7)91 D:*/],QD.Q(_HW%JIP7-#'U>N#3>804Q97,$%Z,!E6&3N^R
M1((QPS=T'??FYJMU20FY#ZI.O\L!Z7) EI0#8@N#W8.%BNK)4'.92J77]TI7
MK(T&!K 8M&1IP_@]#G/GEP.74IJ5\Z;(@#<!SSSWTJ_NTD;QT0-2@R=Y@0S$
M==X<]7K.WOO3Y0T"EP)DP6]POH-DO+377JKHE?._]_:<_LZN\W)WU]D#_K><
MM]</Q3%*ZE?.P$O3Z3\#(-"O3)^>7WS=]I>U)O51,3X$AT>6>4)/582IH1^+
M".1UYGP*(S5U_N:-)Z^="]]+0<PDQ=7(^?#A?&E#ZNWTD 5S?ADRBR/0C4[_
M<)V+ FC7.5P6X2 J@)>-X*3DJ!2^>PO$N[/36]K+C]!M1$($3+-@ZEP6_E=$
M[5C>D56340+JG+/1W^EO.@<O#[?ZAR]?K.C8;O&Y!65_NIW34OPS)N(=,^VN
M[NR68K;,GEB1D"4\HTZN=G*UDZN=7.WD:B=7GX=<-2@_RSS"<X#OEO3V@]V7
M^\Y9%&!,'XCTS/M*(FYI[V>FT-]?'E,XAN^=\]0+TQ!$^,=39W]_=V]OF6P!
M.$*)OKA\AN"<)MO %%[NO-QT^OV76_N'AR]7RQ0FL!K;/J[&/V%\8Q7$*O_Q
M9/FG</RWO_3W]EZ#M#K??KL\OU7O\'#'^<VYR%,%7*@4U7O]E8KJ@R6?R7=J
M, B5\UL49J_Q0^HY_U)IO$1F/".S#U_TM@[W#O=>.QL'^SMP7 _[<%Q[JU*]
MY;@&M%#;7V&A_IF&XR2.O!L\KJ_QE]3;OJ95J_S4QFC+;A=MZ:(M*XBV//-
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M\ZG&&N/RX0<OJ,&PJ2VH!=GZM[_T#G9>?[]_D28>,8,+ 70]1PB2VBP84MP
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MT]6>5%?+!1C-:6M.7*\0W7;JW8H?AF9?N(;QW C:^3M684FK=G0S^Q\33'<
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M,8X$NTB<$O&BE8C56.=+X3DK<G1SZ0D+1))PY[I\ZWSF1S?'VCBL][CI9PN
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M*TN:[E4$%Q?)3CAT GK:>6"B'.SP1#,NBLN<M6J/5?@KZL\#T ]1@J3 YP;
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M:8I;@5X.]-O!WH2H:%R&B)@@VIG/)?O#D M E"$?$%02K5!EOZ(T+=MDAY8
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M<_V>^G]7HQ#LT[@U8V!9#LO2:''E"#7#@',(:LMZBK:\34)J*2 M=GIER5I
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M4Q_C_$I?P434=]1O@K8=F5T4UQI55-'>>PK4W2K4LN=T90LJ6J&\ZKTI#A^
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MH\"8CH]G*K1+3YH),=!,BL5/E'['*W':VWS:VZ\GT]X*DH>!R:AI+,/NA:9
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M6NR^+E_+\CZ:KHA <SDJ?V0P<#"H<IESW3;>9NS<,1,H+,B-"EC3=_!L2UH
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M>\,4'UV)'5F@N_Y,OJ@"Y^R;HT\I'EEV?W.@<QI+;_:Q]^RM@FFC-:J705+
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M\;;^\WO->4X[=K.E#5?^W\P6W585U(Q>LE;5$H-3U> _17R4 ;LT4%%%E-7
M7>'/JQ!3&+ N^AY])W3B 5T?VQ%O%)19\0(%CV=54CU4%67+^\K&VB#A5+MP
M6C:(L9$KM3PBL32_Y<C+HJOV)#V&$@"HBNZ*H>1F%\DW' )&JW15;W.DCQ8P
M#L&(9S#""MRR&8L0G%A%&XE,MVL*J^D>B+(AA9 R8D0Q-6QPZ=N9W-2J6&0E
M=4&E"0,OD-0BI%U-GV3-D'7"S;3'8^J>\%3QRA7C4UNWX5-=G3N-^)G-EY>Q
M +]B1@!KDIUXD @T.I7"]V:!S64728$M>T.IL#;]("II_K?(Q:UF8".BG 5W
M Y9@*L2+P"!\$4164]7!M$H#MCU,/KET\DT90@1#\P'Q"^U$XQJ&3./9-94/
M*,3HQI;(\H-A8$"I;L=+K%7S.DUXAV#PZ"H3LOZ-JT>!PYG=G&<AV\B6(T9\
M^0UHG> -3],(T^UM?PPHB!-FOABL$.=9XVFH=5.3&4[^1,I2BJ(J6B)A1X/(
MSU)[N" S[&-:J7;$"9R5>B9B7&CAY39C#P>USE+V+E4H*$"U.E/PYYX&M"(R
MO['4'RT\?/H*9% Y,7H:T%6DSD6U7KC?!%"3[S_8'*QMHR*0:34\#5?9PE2=
M?C(:;U=*W2*F@+(N4TDHIYPF0O(13J2NLQ@M>+#6/)N6P%5"F2+?1KQ*=>^#
M$O' +*9.QR2Y*LZ3E3E)[3?>>1$@+PC%3O4PV9"]&RC!O5X0 _OLI<DO9&J#
M,!CA_X'X!Q$Z*2G&D)'3W]A I6HXLF^O+5A'\5;@): *%VVURVY9&/BZ93==
MP4QVQ_L2#L!LQ[=\39/S-!C3);1,;&N(!@:OF[_#TU)MA%?^*L%)CQ/X]D],
MCY.*?X;!8R.5/F"*$43=)T[97H!2T7L$C4)4A-?B$;U9F5!< CFY-H .J7D"
MA[J4LG #V(NMG@95[H0B)(0[43*-D'RFL"RE;A/'XOZ1EDN?E6K]:3W+O&2/
MW4[1CR2[=W8R546M-^GQ906_U+ZB OC#ZCW)4ENY7PNCG.N"TU#OVWH3S(E(
MMHJ0;':)S '6,[7^D0%SQTD1YW.?G_;.TEY>1D$CYXWAMB"[+48!6A 90M 6
M(_('7:?)"'O5C4;)E7J7.OT#.-<Y%D0>1IZV.!CG(4KJEU1NG^)R,EQ.ALO)
M6$ L\09F#WI#T3<^_"EM9ZD;%<8AC)->$"E+ %G](+LPC<]8_S6.+%1/.'H2
MZO"=BCQID 5@J<F5W=P/XZZ4E[RLL<@54E"VYU90L,,2^3-&(>FZ!QA"2J[A
MH-BJL*0]JRH5 [HA>!AA[$QA5=HE<?T9GMQJZ+!LVV 3+?%($H87%?=J)<J8
MQ!75A#XDG"+C<L',GSZ%>&N.ANG^TT-!MC==/,1!(^,2)@8UGN\WMANCW @4
M?&H).:4RRIX/])Z7%]#RVK'5*PO]YI5^6-KH*^E"NG1<P^NB_"_7B,\_AZZ!
M$#07V\!PZ-&JQZL8#\'.91EM.%J6I%G2KV8O37?"S(J>B4&3:ECI*+,<-1RK
MPQUVYN8.JG^V:IMF_?V6V0'EMWO?6MV6-PP'U'\HBH$:0^HI.@JNLD:@C6HV
M!YSL7+@QJ$P5$RVR;-"8H*I9EM736IM.)-<@BF<5L93ZPWEG"3>,9.*MS,0@
M5D^K>3&NB&\QQ66[.459Q5NTAD[1:?NH:L;6)6ZDH\?UG25+HPP#49Z(U8^:
MW(;X M@<=&0(CHCDFL4%N3?6[MRPZ.SPN*GU$O.):RN9<-J6"5R#!0TQ9>L]
M4R"A[!G==<.F8>+DY]PGBS6.6>\FR"50^*)!@8_CJ+ D!?+232B10/].MDO)
M(O-+#;Q>+>L6, JE&5F 47PP\+(29$UMCG*+;.@,(*<X&"&$R!@I1O-(V 7N
M>ZHJI.P4A;[IN-BPMY1:8;DLR'U?V>T2H[#2+BY QZ/R+KIJ >_?T+M."A6,
MI&36) ZE7/"*6QRS-*L/+>F>-=TD,\XP> _YOLCQB@.C$W/=UWV327N)*8^H
M3!PZ#:2TV'SQ!55S296F6-D*A-J"2JAM_P8N:Q%+J=04<\#EIQ9$>X8Y4/$K
M4!N)5U%N%/HOS64S=2KXN<I)6F^"F8'78)U6,\&SNH9_B8R2 EE,:9W%LS*E
M$AHNAZDRX>]PS'ZR,J<2?U2-SA/==58#1=BRMR:;VE-YQ-5%PE*GOE>4S5;>
MJVL]_?^?O2]A;AO)TOPKB)Z="3("5EGR4>7R[$3(MJI:.U6V1U)U[\;$1 =(
M@A3:(,#&H:-__;XK3R1)R98HDD;$3)=%$D B\^7+=WSO>[(%.3,@M<)HARV!
M*:P:+=FQ]@?O3CYR$]8(__GLQ +X&K?4OD!I.M8C6.>)V+7 ,-"2+:^+O$PF
M]J_@7OK8NTY'U/-//!<3!1.(Q<_19=,L?O[AA^OKZZRJ#V;E%6C.),LQ_;E2
M.96KQR^"M,0_4 )X;SMFZ1'6JZR[J:R1I[+@M XI!5S95,%"C\TZ_Y9<!TW<
MK';,V_#Z.BLJZ[T0D UFC,>ITU9^V4I'[[H#%O,B*>P:$;#U#J*S!/>:]'=
M*SVSL*)LCM:VH@S,1B"JY(HJWI<N@".9#"#[:@4LI2J=" %,"T.)3B&HF)I6
M3)'5 (T-SM(M50*XU;09I6,2>O8=@# 2+8&I4U\:Q!7:1H\,]Q?9%AR6,D7
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MQ\DB3V$?Y!EL@$D(W[OI"L->9C8K,YV$N9-AN6M2*\JF%,<& ]-$(9FQ39+
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ML!.W,!:B2<,$*1KF@E LG6!\3(QJK_"V3.%=;E?;WT\628 2W:7]$Q^4<.1
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MCX+:D9@@@GAL^:U!XUHF4ARQD<$^%QZNL7M"T!EOBI7H V-E3N!08C>4#=V
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MS,L:R9;*&M0)OCSM-[9T;K!71VHQHF!WD;(JTEN-[IVF:3UT3!?PETK=AX?
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M"#B'7[#!9YU=-@@T6+40FLX@0!%GI1-!'[[=@BCJ=H=^=UL/^^6O'#5 ^>4
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MT:FJU12EXWQ$OQ(#PF"+!+&C; N/7=0$6Z)4&;!.U&() V.7@]HR,BU2'[<
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MV@5=+47F.XT/ S4\/--/21G]J^31$Y8"Y\LA!:C*1 <9=)V)FW[ R,2H@#2
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M'?NI;B ;XR9Q0BV23-QSK#SC*LEDQ\T([!E$@?:(9FD.[\F2NJ9AXI+2-H7
MP5 "W37UU5'W2]UX&RK[15(,!Z?2H0#/F2 L)'%W2YVT'28>IQT7-8)H7]^:
MY3&04^ !_F<#U8B)\SSLI-!SAJ@B=N_5YF8PVYANH''P_XKR6W (454('9'0
M=;@5O$/15QF9L]RTIMJZ1#F9J59ABP^06R1BC,LA]$)5TSJ#[FJH>SE)01:Z
M;_-H7>^,0J0OBVJ))>,P$FC)Z [$R"IS]V,N*AZXOB'9.)'Z'V  ^506F"9L
MO .$?;*Y,TC-;=\7^O!1TI\^!;-ZVS6K/Q0U' Y)&%IL+;K#IT_QIQ/\IF/
M8I:!:+PBRP:4^Y;KZI$>'65,8Y+\+3O/EWEOW>PUCE$Y,_+<:NS"=+MV-"2P
MU/+@W;:< ?]4U\/%5J2S#MJ*4_]HQK(PM#JE,AFADITLV!$FA*4;; &@C+FO
M$_@(BABMAO!?F'>B62&-)*7<88#<S"JJ;M)/4_#1+?UT;--.HDC'>>,P6NQ/
M;=UQFI[;W0T=& RE3[1=%T):(U.&&ECQZE=K>^N..*[8(!3]GV/=A$T&CT9$
ME(UUTL4BEZ3WZ_"H0;;H/ZGA%C65@7_2QBMJ (*@V'?,8<"T3-/'"%'<64$4
M5Q#%>V?2;>OP3O>%@CP;*SJB?(DH1:+*)K>$<1_\RR>.R#!;B*77%W-1UUZ7
MB 0>3A"K,<3*?GO:]MN.:[]A3$IT'-AG%1,BYVEUUO5H(W*F$["R3I(, R$G
MIN5]\)_@[*ECED< 3H-CILYCCU;T\1]W2(\">X""LK.:Q%H=:YD +*TMF-R(
MNR%FVBK,E=O&P,^*)\#9S\N )\$5.GWN']I_M"[&0T(8*,0'!4$!\8QJP%B"
MJ&3._FR39[ JEKX/SM"]JM4^&+)%_S9@!$DIS$5V1)E$$PLEVSLX>C.LT?Q-
M-LYFG$0QG'VK9:0I=CI/(3Q:@5+'L.\-0W]U]$TX*\?:9HI*BU%3?2E'&(JU
MJC?;=H3OELDSXU1#1J&H:NLOB*J9,LTY-2S.<2P4YDZ@CSH9I=]!W4E4&KXY
M 7YS_EJ\/F<X0U%WD#9Z^7'Z$#.8OY6&MM/G]#B7RE[EQ763A4FP-8YSQP?O
M-HS(#M7Q&BTBB<CO0<^M U<TIU3YB-HO&UA]&!<WK(9^UUAPQ/N*&RAN+\[2
M,V#_8U<0AT>6I-Y^F"2UMZ,281Q^J!-TE^;8@QRGAT(]?.8@/0AFWZD*#BQC
M!7/A[::P 77WM&P!KSD7.C%X^/A"_?7R&5J(,Z7R,0JWO?>OZW,RRY!5FH()
M8-(J,=T*RG8N4!1AA=X$CT8PZSZ_C+&M8RC#X:S66G3]J%7_+38!K .UZ-:\
MHL#S(U;,9'-=M@*#IK2J+VCJ L(Q32<I):"2!(AP,$WJLR)>J]:ICZQ5F,))
MT':V M4M6_^TQ6I7-]>!F;M;PJ4#6=C':B8[X9TK9W*P<,6<HKZ4]H3-TBGR
MM</#$/9Q-L_\!?#CA?)_R!D2RTW'::WX+"KX,S=$UP^&Z)O5&@[+>I8%BIB[
M@V+CV8<^#&Y\,.V^=\ZIE/-6V&DUM_0#IJINY-J6;+F1"[+';(.9K<!S2Y%1
MDB[V4S>"WV=%+FRG9Y)5#*T5->.M3)C;]OVD:TCO#=>V]\!6A7;;()L>;E??
M&LI[%)6_*PG0J6SYTY5L6G,!"@V:<?-Y0=V/J()$_;]3)5%/M8A5TC58VUGW
M#;C2\L^. <$@J&210D L"OWKLHH(_4@FR /9M$=>#)8Q0%R=KAM\ ?2B)K?>
M)U@)US+@R!'LRI>M\X9(?>^ 2 V7>': 1B(3S%6';Q,>1=[+@6*(>]BU9]:U
MU>93:U 4-ACHNC8)[410+V:G=_PD7S7L;<"*<( NOE5**V*FGF#H&^>!3/N7
M4.L]"S"Q0G74?S;YV';!K3UQNH&8_ARF;3C6XS4E*X8%2Z![=U:"!C&L/A4O
MB![I73 .Y<&S\/"%6()/T8Z^B6)&=*JFHW90C6N<HM$E%8E4IXR0(] *=A6]
M,D/_+""$I03*,TW\[9A/MEK$ T,'(LEX\HP42YR=[FT4-Q02<O06 TD8G-*S
M$8PZZP]Q1=;II)N:5G3E)83KVS9J]&=6;*6_?B3]M?,P^DL78X'A^Y'OD59?
M&'6_VF55]C5=4DVH<&8^B>+S5'(0)BE0M1Q9CV?LO3%=,>_HBP%9WRLZ[=I/
MQ,P"9!@KB/W58;[0,Z%.]+!F94H !IT0N R2[S,"/8*I_'V<@,#B-VH3.0S^
MLK<9J'.7(:SNF-TE!(70S#'E3J/3R0#+[P/-? 7?R\P=9!]&Q-4 &_!??-XB
MH9+2F8X/XY?T(DGEG#^T?"7/TWFFFX70BT]H'&5OJ1ETSR0%"_CG.@XPQZM2
M[DG1G)YYYD4+A3 /:J9BGPZ<N#9\ ,7;* 6J)-<E'29MLUEED"#ZK7^""Y;1
M^= I!^?Y2!DS="WERJ5(.EY+KM)SXE=*YD=2,KL/%:<5])HZGSXE X=3334Z
MA9,Z=#'ZHXGD.0AVL$]>HY@]+0IULR)U$4/62%5;);'DZHH2]7,MBD3@QT4&
MX,QHBDZ=&N$5XIBFV5_W77%200X0]%4"(&K(':N)%J<).A+&"\-_]I%9>\BH
M?#T7Z665O$TO05]7*$+"A@SYHR>67O^2@UZM'@6R,V#(0[D*5$K-D.X7$'#N
MHTIJ@R8X36N^5C"U%<X[*SKK1YJVXM-&!6R=O9,/.GM(7=K4P9)PL^@\K>D?
M(QAQ=P5&7($1EP*,",512AJKVYP@$!A#$VRXZ&R/:U63&5RG4Y3L*(KM) ^E
M?X2("!XRBLBN8$-TS"4S[C5><RI<%Q80'73UC>J8^GM/V$F-@!#UN3>^H?T
MC['_"L,[D[2L6C&G;N6NENZ#040CY#E#TE5G:X)W[ZNO]8M<DV/ZA%WI&&*F
M7Y<X^0]/2@G<J3+.>*^]+Q+-TG[7>E?JRU$E92('M&^[7E/$B^))8<M[T09$
MWZ]QJA2FPB56HP.73">& 7EU6L 8QAF6E*I-'=Q.]639#>8(XPDH-XB5K%V!
M.\<_NN'*<#P0F3[3\NY7AUA%)0H97L5@\L00V_;2#9=CY8?]2'[8WL/X87^H
M(QF7T4646<Y7:.J^N4*<I:159L-JC+O/LP(6#+'H(J2IT,#BJE$_YWAYQ9$,
MXDC"$(HO\W^U0*/:>#7"LCA/Y#NZ7!_B84[ !+Q&IE*P4^L.0F(81B.5\L:1
M9"OA*D,&](W.8%SP9A!LP#5!E"HZ3<^16\(MONHBJME-&W*:]=2DJ-E^NU/T
MWRDFOM,4I.7Z7V459>@5K5SDL0[)=J5X7W_HN#\(ND"*5H<>)\2B;&,4?B@T
MXQ/ PSY0[J6WN]$=8F))EVYL[AG_<QD/U5-3^3L/!9&USQ@:^$YNSX+'+@:$
M;6D?EKR5E3KOS9GWH%F[;;Z=C-Z#$B"'W9(+E/8 >;D@'Y:# IBG&0Q(3C0=
MLOQL3?W%2ZH^NISS+(VR-+0R-O=43RM8Y?(X?,Y]9 (8&,C(G5:+E/,3*-P,
M9$'3659<)HET.Y@)>H&>/E+&PR2M W5%\Y#<7^:ATES-N,&!5)Y)[M9B>*=Z
MF[:QH_.%R7<U< TRY64*V9ELDUX!]#<9U3I!T-YW#^]U9\&!33X]YV>;Q@N0
M<SQ7M@JN&\VW-QJS]GV=BO-;%IV$G[01(S1-A9/)&RC(@_4B7A.;]XG9G?*"
M:00P_D'L*VU@\RB9$$@3\B:<U#4#B3$732$@'C/-2'G XS(=\0\I/H;FZ.4L
M:6VH4!JUXC3&F%X,MFTXG[%"CK=)K]PB&223N.!?FS%@9.!RG4_GPNLODQ$+
M'9XY ZAUDR/QCQM/<9M67"%1%%4NF@)\";'GK:24%\9L*E8MJ+H]Z)O4 PQ;
M,3I0V4,,U$K'$3/:$(RCYR@Y1GR7G&S$7$XN ]O":4?DX-#GS,\3K)Y*3"Y#
M 3@3M^S.(PIZEM)A;B(G%V:H81I40PJ01&XX-MAWALHZK:'2B;1ZR$@*8!ZB
MIB>,>Y7RBX.%"B*&\1M5%[/1OY2D!?+S(CO'.LUA&,8# #UZ!KX1M!F+#&8?
MCX"#VL=ML'H>S>#>4UD&%S)7-H0(O>2^%3,/]B+RE6'A;<[3LY5"ML8@1WVT
M44F!?9%#NYD*5I&/KD%8 _/@*D[Z(SE-#P3JOVV\RK PFH=9F8-16<A"N1YF
MQ<F++  :\4-4;@=%0F#0!4 DV)[ME+MIX@!FF,NK;.]GL85K<6TMD".=AX#Q
MB]#PSM$V)CQ.FM?!PO3EI!;++5O%;59^^8<*@6K!ZY.<CRX>&JV[4O=8V*#<
MLA@\RG3?.QRVAN.-8AVO@K4#!VZP5+E73D7_<H]Y^H/UJZZ#D0%0AE6FW'/P
M%F32D)P( P%MA+>TRH?WF.X_6)>=;:_V8X3J[:V@>BNHWL-!]5BWS977H@QT
M='PBQ+ILAGD$>EJY97@Z8G9#Q+!INRHO)T/K9H)L"8R*I7=!GX0E-%K,$M+!
M4_)1).3997,A:TD\, (5J&-U7?\DO(%5Y;FE9E"([[%OZXT D,MM5RUB3ME6
MT.U95D_)GEH>*_X-9.F@]OM^%B3$\\T[<1NW\.YT93<P8FO&&Y_''POU=%NQ
MUKVMC>UE4'40;7T@&)0'E7I@"IK[?5P_FM)77UQ:/'%.,?(PUK,O;+LX.E,2
M:+<)O&PG4M<NSBC8"L8((U.DUX\FEF ..'5-FXQ;"ESH98<)B<"1_J5BGLP3
M*A;J9AUW1,^OOU&.A3H:7H0!^I=N/DS'(<W$>IKC143$!D7X>47\64U9FM*5
MA2+J;63,4/*.^W,17M0AU=I9Y;-^+!G[0!78O^<($%/'K^^(MM"!;XO2Z;T,
MC$'J0(1.2V7\82(-O/RPLVW).#BD.PX9CHNKGDO)I%^H^WH+PBVP61U=4CUD
M/VH67(75I?RQ+N4#E>.X?(>%:5"I;^&7A;01J-UH'M-MZ$.+>=P+!ZQF-7_-
M+ZWN($.H(&L>0GRF<4EG1:DV%#YU:?'0FV9NVDBW2%5CPQ?A--:N#5!KK:KP
M@?;SS_F,A@&22]?"$P123S*?&4';.#SYFD,0VN*EU6T!>V"D#A;265\0I9HG
M8H&P$M'.^G&EM29C"V4!.C&QPFT6/(=WMM!CXC\-)+6@BLOITM"B5>UR8W3'
M,)#*]_GH;02=@R UM'[BKI@%_K.@YCFM47JG$;5/ &YR;CJ1J 5'2.>>PTS;
M=XQZ"6EO[=![L_ZM@)<#<MBADG.U=J8-+X5;S(77(#A#KX7(:_I=RS3OW\;V
M.6C]T.S9$$ZR4R=8V3Q7;NDBWSH=R>H[O\*(UGG[&AVI=1'CAB>7V,/80>*F
MKVJL!LW]E[W-S5"IHHT6?:[7+&OO2:]1YF7DG6/IW6K=VZ,TFV[?2O+]_'ZL
MH@=R5'Z!Q8!>P3%$=#_B13DLBC(F3DR-QM.>RH]^YIYTVZ_==MG<5=JV:LD4
M[H;S[6-EA";(46Y8D$_.DFSB^H<IVK=8ZN:I?";3H%.R;''R)_EI=(JPN;5H
MO6,DBNUMES+K\!XT8,8.4VDMC9TTS^XZBG""M5/X3BKVBPA*(8H+JTB?M4\S
M@E6LTRBSZO*E1$+'Y4#_X##&F,O OE:F"6ID)3^MFZLI]T%[CW">AA)X;-UF
M_BF;'S0,:Z3B-_C6Q4#]1V7Q#<P8ZEP6G?+B. 4'^%>H8J*UC*SOJ1GF4/*4
M01O=ZY?!](NJEM^!-2](- ,=.4(V5?VLH5>F#$U2' 84F_UE2[.'XCZ =:%T
MO6GJV MZS7I)?.RR^<XIU[9$M[D"6U?6$8$A]2^9IS/M2'KPQ:8S+9M%ZB\M
M_H2T<M8+^[)A][8NL3F-.J(?8#U-4P'_5 4=TBJL$KQ">[=)- ;!#Y8;CFCA
M&?N(9+O4!V4R4RXYF*9XR84W88Y7 ^*'BV>,_+G:?IAJJ@46X0*ZWFOQZ"+6
M00B[]7AT?2OG_J(GIM33F#,&]#>]Z9RD<+RJ-&>.<G<7/+W17+X'TT3>(B]!
M8 8E560%XF+<(&D[X8L <64Z'"Z\D!N/$7CX? 4\7 $/[PEXN++!E\\&;U5A
MN>EGB-I:\C:Z@E))H7N(SE4+2*AJ)A-E<V+?34+2:&+R&AX:2P..WW3$S32*
M4+^_*)H,:0&Q\U B#P,^ ?HY&JVXUO27E0OYM(]O"];RR38=K\!X)GZ)928,
M,Y[YZ#,6OQU7)T2SR-ZO9GO:*=+:+@I6/B(4B4=781^#<F^78B$MJ21<4A$>
MXK/%[2<?[*,6ZQ:&0N"4\I)LW&X3Q[;ECTV!JUF1DZTOB#S'ZS_J($6\>VO)
M%&.KIG5E0VV\!8"[*QS(4Q="NW/C6 N?8G_\'F37)8$FKJ"!262P3NVZ] .Y
M@]W5B7W:)W9OR.KKU1@,R'1U J6474]_R-'7Z3"=$+R"VFQ%UQ!:0,.%EN<I
M:= BQ^>@B5@FLZ9&I4]X28YLC(O37*T;R'K-\32*\F^K<_^TS_US]]P?B"QL
M!UO1\V&4K-/GM+XH@K7M=?O,5L.'MAH4M )'KB^2#(*A6^K9TR(G8H.TN-4^
M<<M)%'D_>=7[QYZ!U?<@P+.C7X]/OGP^^'+\\4/PZ?/'PZ,WOW\^.KE3XM%E
M+>1X H?H@:A%WZ+O7+T.CG. ]+F-;_\X2W) %W6+ER!@GY8.F,@+(+-PQ@.=
M_$R2U^O=]?&_];T8(3HV0]]=49_Y,TX&9T<64P\#IYWXN$VFE94YLLR$6-B"
M_2&O>D\ICH-67O "AL,9UPZZ,7)JN'H8V?VHM)!S@(S[Z(%N])<K%61](6H9
M7N[CP<*L^#^;* - )QI[]"U U"F7J$N0HRE4DVF 70QF98KA<S5$^BF^3X>H
M7(QD?69X1*-^O"'1BEG@B5H36MU<@(4+LVP.-?'&(8Z+:=)J/M[WQ&]),H.D
M@?FVK ?9PD:[C"ZM,JNMC9VK(5^[GFT,L!<\";ZS!Z-H9O"]7-TF8-?=9_+5
M4*>]^VI.M)/+4X@J#84W\6@9 1U)4H_L?+2AWNSR#M6C4?JZ<IUEP=BVUV+2
ME'E:G;49<:-@##3*$S5 0#NDISFM^N%9FDR"H^_J'.(&?80,#.5I#L^B5 FS
MO(NVA32\%"1H7(LAA@W^;.)3F3HFW(NHQ(+]-VJSQW7A8<D.X9R89) :9$F@
MA3A1AYG[KWLCVG#P' )NO4-#I]C 8^VZ!0O7H3N2+P:\[AY!9C6W_]IB_4PK
M"P=G/-("[CA[D3O/]YX!8(8/6YIKXLYBTB-8M=18A3Y^)%OC@<@W#XM9FE1#
M1D6W8U&_\K8S=*'4(T7JLU@^M])VJ-K .!&1)PP(ZNWE:=*6@$/UP8,=Z=JM
MT:7N)4M.HTR,!B!ZFW%IPI#PB2I3]4.""-G[0Q+L9JKT4C/78O"I:ZYFD(8#
M7#A]IJY<7<EZX:,%'X63+\H9;"XI! 2, OR.OI_FS)-AI4X[Z]4_*AD(#DY9
M=E#1F4.FQ#QNW5IA)K76@^-"^!MN(9P;9[.XZ\#E($>[#Y^&^$67<GNH/NF"
ME:S]FI54_I&D\@.1=!R('"%PY(D6)(.2>C'7"P^S%E1HE<HM5_>B?F;[!M:W
M7(%6S9-H@E6PQ(X'IH$BB@(MV@Q7GR454I*+!S+T'M>1P:=/E1GO^ED6<3O?
M^%9;G":OTVS(N3,058?+ZCPI+0G1,T0T+8E5&44/<5]=WR5TK-"A%XL=;0W9
MC$50$OE*H/U( NV!"LT^%.R[VE'K ]W^R@##^FS+'G(9+M+6\5O=@*>;('1+
M&BCFA=>#7A[:M137,%CZ[N#C9+]]L0*AKT#H#]ZHWKF>)@#*H1VYL(X3H&D;
MN&</UO&1R1.?IQ28$3X.4,'@8)UKCKZT3UQ(^ZHQ(A+SL6'IF#!;(?=\HKK[
M"UVWU2,6* Q;&?.%6Y=S6>0EF6(>2VR>W>5_,';]5G.O(&0_1C!.K4Z7^A%X
M./K/7(=F&8L\RTI= W:HUOJ*NH!N%=<S&E,!NYUZ5);I.?O\4.M/_6;(.#&/
MIB!#F4RARW!:0X04Y502KTO_\O-U'(^X>=T!3^8%'8:7CW]M6:VFN2V[W]Q_
M$$0*X9?4.=(966JSYSTKK)AH54Q+(:=@*K*'"B_I;+N-@"XX@!M5%D]($"LG
MG>Q2S6/ &Z6/\95MV+#S<N1(H<:]>1UAM!.LZ+))3)$7S4ABP>"'4QTMML(J
MZ'NXW.Y7[',SXL?%$LW YBFVAS"%8X>3DM=6^KLP/G4PE%"+M0C1 @)_:#(]
MUX\V]7I O*0]6_H:"TMG3)7*70'9$+I:RJQLH>07"KH9KV^!6)+?^NI)5=S&
MTNG#.S_N8T?N8%3XF9F3+UIG5;UD"/I5NB'BBVH:0G(JP=4O,#1W3 Q'MXHS
M.PT)S]/DHCTNTD]3LREVPT5?AH(ZOK;YX(:.P6T? 2?9I7=;&JVZJT+C+D9_
MJN&L/,P?R<-\('HWO BVL'D'/>L/=33H.K@)M.4T19LZZ00ZN!P*&EL*M5/9
MTF[0W([.J#=P)=0H T7Z[5+*H#*8C)A,?ZKO5W'*9A:G;W_/D6H17W&3P/M
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M:?SRY#L8*EP_HK$]N3HW'%&U$B[A-2/.;KZ-<O?3:1(#CUV&N3J(BZ1Y<R7
MKDN$/!!R89=NZ%G$H6 '5?'<B[(R!2ADTF%U2A+;X1N8 >2LI/:D<ZZYV 0.
MLKIJ8SG K0/0L_E7W60D3X521.K.[8(@8S1BJX(S;IY3RQMMKP?6S'%(W,.%
MAL[^#'%EE)3$\G7E0RN9";N !4!<ZX3VL1BK+709\#HFW"%34"9%5>-V0)3?
M7O %]I6C<1@W5X]K-\$F:7:'K-@[&WO[2\"*_;0UZ0/QW'C[O@RZS:,DDJM2
M<4(^6:A?3 ^5I%_G;8>#')(]BM*03_:JV#E-O7=##93RSDH) ] D:!J4'!K4
M]:)@G#.\2ALHE=T"Q^IJ(JU9"ZRB'Y+]G8)RJV[0!QNC GCJ?=JB>N;2RDD"
MS:8Q5PG_Z>XAY@E<!I_%"Z0LPC+]9'491VJM&65KI2$\AT0>*N2R8S>DZA>0
MZU)A#Q!!@=#B9%Y3P3KR W0F.G18L?"58DAS A>156;?TIA;:E76U.O?:KC+
M<1XK#ZO$]#6$BR%H<B!H9]F6<WM;>A>O2[&+&]R9)2&93(J924SQ G22S382
MR'VXM;%D<,EI*44.5%4QIMXZ>@59TUYJJ@8!#]#5L1+DE>4S^BXF(AZ$@^!<
MTRE8GK#W(*.IK%1M&M%U+@?GV >X<4)17IF(I$YY85U[<JXO-;K @="CK=AP
M-QBUF1G;XYPN (U/CHQ=%]]S_D8)F@^%:6(LX;=:O 8*\U]M!!I#-0(469N"
M#YDEUV07>I?>+4AVF_GJAH;51G"@F1R 2$BH##SQ 8*/R7@=SMJ^PFU45^Z1
MG71B$LHB"]3^1BCAH5R]E#UD8W>F64!@U=#THEZ-:&*FE1Z36(1W$=&X@@&T
M,LQNS3![(+XN7Y.)+PMA4#4QE^%.L/&&D?!TZG =UP8Y$3O+BV)%@SAY..(.
M@DA:'_;HT#:[2B]RR^9",*2'7<Y#PYQ@5:A=JZN&F&6=Q*77,#3DAMU)>O"@
MCAZP$\AODQA*:,G(-(ED8F*Q["RPIA#>)2PWX8((9'_.VG(YM5)FLX46MG<U
M6@,].3JT<]TK\?;8Q=L#D46\2TX3] 2GQ;FZ#B:@:YS/8_]M$YM F WXEO_&
MB$Z?#<"$5N07<N#J')EM$KS5'.CC0)9%\Z\<&D\<=U04WYX1AQ99 >2KDN>7
MYNH%C<#?"=6^[MH^*))_<T-&ZIK]#)8ZR+P)N&GP=N')!F(9Z!E=(PT3A-"
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M3WTTBJ#P7B-7.Q3U8/<HRT1IMSCK?KSNH[#G M2Y;  42C,-C!=R"]%LU('
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M^2G&%P&,"-$^DLGJ':/S<T9"*).TPLZ\TGZ1?HM5/^:G*Z308Q<A>P]%VM.
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M>91Y#:0ET#XKE7E7*G._I3*ASL7 -8J^Q# ;X-B!-0ZDR6/)"#^\@(ZOR7A
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M6%_'Z1TK9@M>@'(P[:/"J8=>+2_5"(OQZ95B^O/'J=W2S#"#/*$,0ZL0DSX
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MVXP5;@R1-6\[Z*.RH-U#TIM7MN?UC49=^;F,E^?>\!^+##GMDW'5IUEU253
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M\5'_:%\D(3]QDB3ZV[LOQT>'.P=S9>2__G.:%F\7[BK_;,[MH(.?)RYKN_O
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M9RFX00X:<RK&$.<';*\8!?=#&A[#?8#_I8)-&&62XMF:9L@DB:0EJ='G>(.
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M2$)^OFY%:7R1^43N"]&AN2^4X$=I]_6;ZF*CH,HPLOB"M"+3R 7=+FAXEEU
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M\<6A@ILC6AM;&UC;#7<]46-N,0?Z"&P#N<D*CNBLN!$#XL'E]BI@J^@$[M"
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MUH/BINAO%'>CYVU$9V.WM]/KG<%'5W\_OSA]^M#IH_+IEG*0SNG]6QOP8<V
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M?F?'ICM1WII1/[&<.@UV@IUJ"=YS8S'-2X)X7,[#0JU9-GFO<RB90ZRMVDN
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M4.K")?W8I$=RIZ-2QB0##=)?#BB5 ZV"?/I^1O$'N;)<,;=!_'0>O(KSJ_;
M2BF07\YEOC5@#\2MX)X;N5^J!,;&-*>T*VU.G-._4H+O&?JQ$C@*4!TSSI9(
M@@]HPER^.?*8=?E]C%J)2*5^#RSMVEW93%V_'99S>'+I##M")3^.RH4' SVA
M4 Q.D50-#TA6RBQHA$$#[@#21[ES%$6)[@A,%#L?Y*-[4_=E MR8Z$DUM-Q)
MQF1D,W%0"AWLQP",'5+]<U,$5P>XI89;](U+W9WA5ZU/]$65[IT-EG[Y>DD_
MH?=EG?_F)A"O]1K&R;U9B$!1\?Q7%''8[DABH$1V7-U@^6&"F1WJWA0ZJI+F
M1D;A2.OJ#$SR:S[%J4=2"^IEZ<H!N-M@L;Y* [7HH:M #WU2P-#>$P*&FD3D
M%C%T-;FMNVUN:YO;VH*$?K\^4JR7/E("TWNF-B\6S=-D8&5+YK<2$A?Z@8"#
MCZ?QM;*]Q[9K[J"%.;!H0-:R41^:"AO(C+XS);9Q+JO(C-UDS7ZZGC?I4Y9>
M9VK<Z!WEKX2NV,/AEU=+?!&C,P9ATVM S;6K,15HGWW3V0!Q=C]E!,2/E)>9
M]!QN= F41&TYL73+S&U$-KB4Y\C;)(K8-&Y(#A*!?O% ?(O[B8N'DLW!0_&Z
M_%_:IM,F3(JUDB$;RSSN0.4WH?$-F%<-RH7&,.725&P3U6@;;)BTP"78361S
M70_TL-2Q-*@>4#!,-==I&3:Q=;+M8&X,_)[ZJALQL5X:IK&[:Z#W4AOYK1>J
M^55H:+YMO?.69)%]+>/#:V[Z8V#(').K3=W7"R]0RLCV79/$#CJ5JB'X0:PR
MKM:61BJN'!JC^_D@B_I,]$P'6,>. &$H;1!H+J%1^.KYI:-)C3Y"DUI$"V$Z
M0('D4I*V:[UZ\;VVW!0CJB!3#,5@$-G6#9=MW94W'I\E!D3G)<V9S+SEK)M6
M#5PHO*K5Y:L67C[;?Z B^-*<\-"U_K4I-6T7VN5)[VZM2.^#BK+@-Y5]U47P
MAXJG31T%&8R/.A 1JBX>^2W^EFU9'VW$*U]6N8 1Y6V[@$?6FIU;?[$/Z)(A
MPD5>,#PLX2B#\M6'CVXP1$1Y<'Y; 16P)@=B;\SGG-_#TV/K*B:\EQCT$ R
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M*:*^C(.,K3+0*LM+*LO51K$7:8'\T'85@R,I;D3?*&Z$C:+Y(FT*JX:HRY*
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MZ_RW>06QZ%;UZQ/DZ$J(:ZE@GS5'^#LS(_]VOF8]!&D\R_1!;Z2)-]6*RO%
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M >"BC2(EO'BWRY)(X"QY\N3RRU_ZWAUR_#$Y$,.3#='?6 7:8A;/A&D*A#V
M#DM&__4.>8W-VO(2";*%FSIHGI@XC4BX478UTEQP?%Q4+>;JO%=LX8\KOGQ%
M:>ONRM[=VUYZ3B2"5Z@.9:9"#-IFF^7T5?"=;LX:?+Q1NS_/:_)%R5W3-=EX
M2VH64U95&*5LRI+7ZA=GUN[['*DU8E0GP-'1;;ST5WRS6QJK+'3TM1]+@0H&
M"E?\$W\0W:!&H#>WQ6<]4&VKW,H$EP^AQN)"NUTU?;U.9"HN+1:6<I$5:[H
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M!X,L_:FRG3 G0%2D0ZEXLU <01]KW6K:U?[U2J'8+9+#6K,I:>4XR]1E.I3
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M>J4R9KYAH>&@O42?KR[2X"HD*$NL0;PW\E,!%D&(*#NM%@A.J3\C$7+[H4Z
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MK<&=7CPFT0&JZSRF#G,-$2<W^':W"T5?A74.Y:;5\[@G$[B)0M?QU2W"D'M
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M7F]L7"2GU1N/I3=6%M_1ZN+$DJ4Q*.>W\.:9&5:'!"WJ&6C10!57V#<":^1
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MQI;3.-FM=^[;ENW6=DWZ.4=+<LQ.EGQZ2>K]^@$@J1?+EJWX3;+9N[5K8U,
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MNH\GC6]+@,<&P*?"(Z#"N^T#L-[9>0_O?P;@?P\\_#L;B8CODY"2W2UH> C
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M#^+P" TRAC.".:%3[Q?2&X6(_$ME15G?S-E/P"@H?)?>K?5UIG G0+%M4/J
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M3FK8Y'=0RPRHV1_VECS['/4S!L'4(D*^XMMUX-.MZ$Q].H\CU?5$T?4"T13
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M%][O_G,&76K;J"L3HO]KI^@KS.G2!CUR4XA]A?P\M?9V0GS!M>J</H9Q!/S
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M97R@[S%QV<(@4FO@79-V'?,+;?S?)++!S@@K#+?WS L0O;<O1#\&5/N1P0<
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M[/GHY9>U%2ON4"ORJOOFM^L5O)D;[!?/!']P"=C)@! ]:1D-HKH&A8RGP2V
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MP/+!'2N\HT"6H7-T4800 ;<_=W%2J?!N$6:?XRG55EL<KW >ON.M=I:K8ZN
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M+9=ZG/KB:;T87%X=3$5+"T)?14IO; QJ(0X[[".4I"S)#,3/_/B9%]R<]EX
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M&5R8]\XW[Z+N,TG6#VU85QBH&TFV$9YZI$8.?GWT0D@UQ'K[KK9_;&^U^SO
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MTW';(I,.PMZY"%M+XQ"<X6#1![XC@I+GZ0TB_U_F+JA,R?*>5O^]  9T6LA
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M7Y!7Z5:S..W^D<BP(1=)?H,T>. Z+B)]9*'MLZE9,96]E PUWVYST'R/>T6
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MKDFVD>3>_I/K-&B[]OF?'YHVI'O$T$(T-+\ MDW]M9ZC)MZ] %#T'ME? %'
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MC@Z9DCY<P<9EQ6_*F%R%NFJ@T#]&T\I2W=621/B_N#]0& =&B D["6&W?0R
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MZD4C?:K7CYRV3MK:"'R$K& B/[8G3?43+0CCSC-U)KSIWN#V@;N#98Z,!EX
MH[6-2\^$P,"*\*_ 3I^)R2C66+FY^I,<''H&M=OM</0_M"U6RD@9C*3,^F%0
MW<8Q944+UDI]"Q>TY,8ZC%09%U.+5# ^#20S;%S59;9[MW;)<?UPCA<LFCP
M66O43%>N7'>^G?7:'[[)41_2\M.:_T=^CSH(ONAZ28TMG#^(FTSFI<!G7GM7
M]GA-_/*!]Y.;>2D$4OWU14-%N%?);Y%6:C,>MYV'R:]:E[B&8B]2Y.C,K9,#
MUY:Z.;!B>:_PXAS]5Y5['C[*R0ZV93+[2R^G%/UH#MJ<>HQ+ F]HG3M?%"7H
M^GL-]+Y'W/4@ H\#I5J3_96*'"I'.>5%*R>:R'7.) S<^/YKG^YS>N)A_2^"
MJL!]\0BV*(X&[>;S34B-$-NBO!E[ 6#"CJ0YFY=84R'J0:H?'R.*2^N^$!?]
M_L;S_,88AG340.5Z2*W 0YY#X=8X;2OTZ6-Z3VO)@\($#I>/9S)\QZZT=O5J
MAQ==(PRAE 0TD:^+\B*R)FX\UFEE@N7V&V@S9Q\U$6Y7TIQSW48$7[B#;<H'
M*I^2W%YO,PG"ZOT\OO"S:XHQ)45BM@7+(2+UYR6MJEUA?(D^!*];2Z@YI%I:
MNC]SD2^YY+=)<6D-@5[[%'Q6%VVY:*TNR]DRYGV+O>/0/FHX0,=%Y_(VSMC#
MZ"F B@Z_Q8+8!!%=X+.]:GS2G*7+U)+$0/XEPH]!9SHR1=$GT5B: %&0'.%-
MY<:D17#C+^BGLEJPG-\D<*;*O+ALIW_+$)!UVHN YBE$<%&N+?;D'D(4A+>E
MN.294KBD-^J5EHL5?QY.S)88[0C]90$P'+EPZXVA;:00RK[Z6BB@_)L=)6.7
MI)VD% *(6R4!WY'L4XB5J3R[8/+P8G+JD:.6^ X#!+KT>73?3F (LJ-RLMN
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ML+_0,4P\WQ"&A"+*=&TS)TCNV2E>5OX?4$L#!!0    ( '*3XU;#X".P%LP
M +S8   9    9&MD8W4M,C R,S S,S%X<S1A,#(P+FIP9Z3Z"3A4__L_CA^-
M*&+(O@Z1):0LE76T(&2M[$M%V9)D7X>$R!:A**,0$;(OV?>UL2O[V-?,6 >S
M_,ZHU^O]_GS_G_]U_9;A7->9.<_[?CX>C_N^G\LYA_23- TP:*IIJ $4QP"
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MHK*JL:FYI;6MO:.S?V!P:'CDYZ]1],SLW/S"XM+R"G9S:WMG=P^W?T#F10%
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MTH9O8CA2L/QV$!]B9^E;C"X9!QGJ4AN>!A0YZ1^1N^6VTX7[7U&L@';Y9 G
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M[P$QVQ88U$]U.GM8V_%FY;>H'T,)@^O" \JEZ]7EQS(^S12L>! ,(R9@UTA
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M^7I%.^UV/K-7L2&G=S%;G#_R\\34<&Y'@96YN=FX;-/^[BQCN4L$L)TB&7;
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MYU<.1KZ1&\ 7<0%WH.')%'_C',,+.Z5X=71@)_,HQXXA9@=V"NZ#YTE'\+Y
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M;4U4S")32900TU/7W^6*3B>:)!.HX"7PQGOPV9D_9@:(INM^PM8Q)<9@U0R
M)46C>ZFYE+C6M"I[:??Q;V4& 77,0%/V=/JK.YW?&KB-;.0- \*R358.[I;.
M!]VVE:)ZF5T_-A;1JVBTF/ 09: S[(24$RN;:XP0^=K!$&GTT0L,'FJ@.KU+
MS<72WP+Z?*.V)\?;]G?[1=R B@^?7.;G//GL$T]<BI-QTC/F/L'XZ]CR7S(_
M)27"59/MC22.Q>^%^*]*)>J(1;^JM^2TT+J-[ C)+QAQ:A<\W31^6Z?>KV_F
M[0.<]T<OR68/([A#*/L+@^ZL?%47HR2C6EJ3@J"GBK>9N'T*%1'RAR=K&7"F
M>TWI:HZJ2&UHM>K[0/\<;6NT;:B[F84R;1=[*H]B,. \W:;I5^^7/E- /X'S
M;"$R%1:;298(I=+2HM]N>LON2(;V;Q!9NLYUV1]?C*W7<&QV^+DBJJB-"6M,
MA5<\W],K-7MWQDI"4*T56&]Q\]%](;/.=HU3M43A\:4W/\T483Y<D#DDO5>;
M$2:UX*O92M*()V?O<_M[<7*>3<+F+J/O,+/&V,0\S\\KNWOQA2G>55OY%*?D
MEFI4_:73\-R8@K"-S]]+!M[TB/"5A 50K%#9BRO3X&YK#',9E'Z[,'[)RXC_
MJM)3^=L+D 9E#IQKLQ6C )9EONVELX"928:QTZP?W?C,1TQ;U Z*;=64+23Q
M]\.J_LS7!6^9$FD'X*8'CDVI=/V*O$E:6=<DXCREM%"4J3NW-7#^:!34L=QG
MXD/)4RL+Y&0/8<4(,M>E>]H+U4SD'\QWRO]]>G,4]TGL%B,+1>NE9$2$[(19
M2Q6X.9P>J58]G[!+:S5AFG[?1L'[8&30)ZG!F68EN7<HX]O=:LD%UJB(4.5I
M]\P193IP9RC_W'+*7E_KZ:MB#_D8A.EY:BC&YV!6BX!4_F7G:=[@)-"JLJ(R
M4RVFB0THM;;_B(N#L^AZ?IVTW'==[OZE][TPJG0W.@3MK] T*K6<J"?NH7F"
MT3K22/(AQJB1TZ/:W4[FI>%:X5./.<C*<;&@K=I/BJJSNFQ>F53?W;/&3,Q>
MA80*M?5$CI3AV;$A/5,-[>[:EK:I-_G]-Y'5#:X6S_P4>R4D)0N.%PF.=,UW
M-\\^W<ZC@S4</ G^1"?TXWAT$R5[U7,H"+I="G\-G+->?%<?<DOI^KG^>T.3
M)=6I(0D^L6Y9<ZCO.!H:A2$!6I7%M;X<<Q61BH7O&>BE+7J0]074/R?>S0XP
MVIS>3XO_D+>^;#S%6\MKB5?'3(2F9+Q\:/=$?X*GGHMB(5"126?$G4?!>*0D
MUS_ R5>GLF_4^U94A3H_548_WL09VE1'M^0H,>Y9E'OSTZ2NN/7X2+\E"^XB
MNH!N.8GQZN<6YO+7WI["7YY<4+.7K#WA=6U#I[0T15OW7._"&7H:HLQOZLZ#
ML)>RSDQXIN'3)$ O]6YA'2._1'RQTLF\F)>U# /GW4A V,51A^+))J7&]/)W
M%:)C/?ZRMIB8QEZ[<I_'\GY6]ZL5,B.?L0]>@E/["=LZ/[1WM@D2?[CUR>+7
MS\D2<^C[ZKON_O#('>W3J\V>G/0?,DRI2NXZU=JW6?GT@-*A6@+.A]67T>:B
M;,_.%3P9$6MX38TU&N*5P*FCD9SC32XYRX4H13_JI9L\,7FW2, I147;_H5#
M2I>RMXB^LDC* _VGBDRMRMS#\3.7DM!<N@R3#4]D^C>[80NN([*+PT5>640&
ML_4 *Z;)DF1M7'F$TKC4[S;ETMV';4';*>O^[N\D@AU.,H8\5+IV8/@ SX=9
M62HW-?J9M.8IM=^OCJS>_V%O3E=';=[ABYZ06C"<$"];^NW?3A71_VW@TX#3
M_?(73A%G3Z3WT@\:0+I+?[O[(O>BO*"M/_RN.D_MN6^,[N%#?O]]6&!/ B)"
MR0\&)%J]%R:5OCP%,F!N1DHSA <;FL][Q)\3/LW<9Y#HM6$BB*D)?.2S(0%1
MPMPNYO'@<DF5Z_Y&'DM%NS!5AIDS\V5\]1B#_Q>*H:<*>A=\C(1E>$4CA%U=
MGUS[<@62G6=%ZQ"WRJEHQ!0H))CKM/Q:A1,'R>,3J!$[E7Q5A9[RMM=!W^1S
M)1$*%XW7RYI-,N.N*C0G>+YHT0^^E8'>5J$Y?EY5R&4[7: 4@$E0Y['7IW])
MHT]"3U*_>ER,DEU/56C#G]D;1U 4,.,\28" !7*XIJ#-6IGMSXUPY*5H=<U+
MV>N:-7#.+_XYH\L=50L/7PT(9=/:T "4;LO&N\3S_?GF9RP^SQ)^BUV;U2LO
M#NM.O',S1B$\33621N=#+J<DA[V4I@";?<5VCZ.JE,['WK#;X[PB% 1[-7EK
M&6MJ6&>5,R5.!E=9T,>^_^V&C:K^7A3@>H4Y.'5H= 5^:N/Q-D'IQ1/G)^\+
MXIHR;2V\:,%T#NW7B]@D#*.Z5+@7(:7<'BRC9GY7*EY,MB'>SH<J+1G]+C4K
MQAFNYAJ;CD^H&:P(\)WPYK;1HT9B[)\J#(^\Q(MZHRL94*4?8Y$2O7.\C@R1
MR0"] HV>_<4-E9E GJ#A^ ('*9$?=A3T2E=V"M*5>;B]=+I&G/P6O)<<C]Z9
M$#4Y>F=BBC6)>&ZY8S'(W(HW8<S/%(XUU-YF:=[Y"%0_"(ITRS%M61[8'GOU
M@L/F6KW166?6=.4/=(3A\MV[;VU./57Z$C1QC[$^@\?'B,<Q:V)*=%/Q^@)%
M0WW64E74 G*&0V9L++-".Z5?;5\;<,?-9@JQ309%#[ZPK@%$QS:TRJ,'^WJN
M7#@3>(I&17HT208R&@BD[69<V<ZDOM+"OZI"=:7GBC5SX+R+NB9@H))Q[F0/
MO\RI9$!_(&;XN]4+0/+5[4A\6,2,+H]8*0[<5PCX('?IA*2FUM]#_!@&?6-*
MKH.;!3^CQ?*DS>C0NFMUCZ?V^4>3"'Y_[_*V=2HG'%RZ2EPAZ&;4F_WB_TB=
MR:\J=T5FYDJ+_U6T$^Q6?-,4O8PM9J)TONR[L^28LU_=AQ.M7)Z/']5\547<
MBR_=.!#[,"28MJ-LSM[0GDE3.>=J=0TGMONT$&O@\,D^H_Q&ZK+3>43HC:@4
M2A^,F'0SG&Y;# '!/:*E57@5]61W?5HZ#?U-W:KQVP&!]\EUN"/73TS/%\)X
MW^:!40'^,4[!'K/85*639RL-*S57^OI-KL,0V#HPK &G+[IQ^ZKCWR?'Z8P,
M!Y*Q)V!GO@D'[QLB_R^VOCHLRN8-=Q$$14)*.I1ND9(&E982J:5#B26DFR6D
MN[ND<R66[@X16&*E9>EFZ>: 7_W.N<X?"_N^U\03]PS/##//K9O7EU\#SM99
MWX_)\0O1#<%]CWFJ(/:;(Y8C%63*NWT+F#YU&INE*Z[W%VY*(]@+\82WZV-K
MN01V -$23SD+07AT!U&M+,_9<$1N@)D0E1G].H_--3_OK*,A#G0WS OL%BR7
MYV6E],2)N;-SS4'DX" PD?3OR*D.;+<]C9JF&!GUQ\L!\\O7\.FLHRL+<#53
M[DP#_;BT3W0/GTE&(!'U8(1O2V+%F:LQGU_VVY6NJMY\W:88M'Z[@I!ECA:"
M]9W?0Z+7-$VA&JU)TC;6G7MAOS/S\'K'K/(;?HE\$S:L6<I") +*G9!;^G+]
MEX+K#=@+ 1 ;NNCLAJ9+WJ&BK;2[">IQ"[DY<"XRQ!#67AF K2ZD.>FX8G<F
M?*%<A:EDLZ6-42U]IPV5X)B,OMQI2:OW!=ON"%!W5I*^K$/BRQ@'T>$<Z E"
MK&/NB?@H+ZB9:M65 ;:;,&WXLLW2IZ\D@B\N]UM#N *_<3^60<1#%BFTX&/"
MD-YF$=P]XPNX^Z_I@=Y-Z?:?HB1GEE3@4>+,CD:6)5%<K"NN_;5KMX*#\A'X
MDF;FTO!$)JGJDI&*)-'/ST3LN:O3!\P8Y)H4XQ^_&AQOB5.U?WI95Q,A$9DL
M4;25N6]U.NW0+25@@JAM']+$2D,P7&AXSZS#IWO*2N1!5G1VG2X_3N?-+[T]
M1P0U6OL'$(4S&PF3P2R=F%EQ"5_$@C*!@/W@*V?W+#/;3E-[FD9IML%:)RGW
M%,OI\JKRWA)9CM+]P-JP($"O7AW$I&%?--!A &:.Y.:D#8D[DY9Y%:P0IMVQ
M_5/(31DC'KCEEA^,EN!TBIR6+&B+*-SZL7S@EN*4N@3!VYR<[MZOBT"K5JGD
MY"RB;7;SAP<XZ*IO $&:GS( &'<3)C"TL\%2_A5[KD4L[CS@M06Z*R'5"Z2Y
MJ]:Q9C)M%;')(]O8ZWDHW"6UIW9:VI]GZ)-<L4S6^[IA.@WC:Y^"\L43S9.D
MJYS>_0O5@M%MSNI%4_8F.V AXM6K'$(4A+*'+!S*:K[#\<[\"TI\7'9OXG3A
M@J[%:8U@%:5:XG)8+_IKG6A8\^ -7AF;',PSA'W;A[3F0 .6$]LQS94ZY/[:
M>:?]]383WH\S<LT)5946&*3\V4Y6L)X WU)AN300:5T7J%95/XZ=WLM @+F,
MD@D\895G1>&>G<G]M$(.E-QEB3D3D]):2]WF2J8GL>L4R,*EA[>\V"1#3\WO
M!A4VKXS;E@P>H#8RUI?P>_$A26+V5.3K)J<?1XL.5PGYH-+RKF_]SL31E:NK
MJ'7RB]1Q)X/98&_D48KV4_4^3[9M?^$M; -$ZN653O6ZVQ;2-S&[A)Y(DEBZ
MC=P"GO'B(;BQ<WL00PB[U#%,S$MXJ8Z+F#@^>7)I%I8 1V=( .<C%Z>?4O7/
MG) )PT/'63B8-GA;.^8%DJ)YE(WZM'*F4]ZMVR&]^_FMMD::2BX%#]3Y=4Y$
MI'FW:S/(8<>L,ED9, &:R+@/@IXLJ+^'"+9[9C>0KN_P:BF+?):G$R,\Y//,
M:M[7OEF!K!G$L)A\0^E=D_.P0HA8C^YP<AC#,H0^1R<G)H.!QQ_WU<,2I$8T
MI:P.ZQ@$J2T<6IZ,<B#"Z;^'3W+Y]ZTSH4:!G\ZOMV(?78:ZVMJRLGTV)7T2
M&S[1K^F2OR:>V<4I6G:2&N@"$\AY[^OZ&_/$?8A5@<SNUQ#AFY%P7[YU"]\S
M7/&(T;);0%7V@68 +66OF[@K5>*2KDT7P?J84A$T5^7'!N-@^&^WR85 T1<+
M%OI/OWW7#J@?,U6GJ32.7@>-)K:GT$!E\#OP\&M6E 6I@9]J_:M%T)=V1J??
M6M%L<;[_["W(U-NZN/%!34C^%P<_SZO28J&B(2W\$( GX<CO47$JM?NCS&OW
M1YG7[H(C/]$7-;> <K6]"^3/^_Q;-VJ_]<EN <M&?]Y2BA]^?TTUT>^R=>T5
M> O0#[T*=\S)*I?O!6\Y2"SLW#V:M2U[J!9JM2.&WK!69VAI$1G@50"X*#2^
MG3D,F7Z;DO2DT2Y+E;'OYXU&Z.-N?,_/+M0MD1EC(E&)R<7ATMGS?WAZLE($
M?__C 76%];IHRUDN1JX>US-[;]=?+E>LJ&UCTCC^^#*;$3 ^HHC'JY S/SV_
M=S7T\)\92@FO-6)ZF@8.A%IW^'QWYR)R7N."3IS:0C,0WB*1C(<[\F&V:@Y=
M&2*B<]8D(FWB=(:S</ MX%%&9-ZZ>JT@=+EB7C?_S#C8#G":A<-*B)+A#@>5
M>(@!-I@-&?1VJ7G#TEE0]V].AG@?E2]V_\#TEQ$V;" #+-M+;,$:&<^4REBX
M3&N5DQ82+^LW4B#4G9YZYAR)>(500"-!;PT3:OR6! GAN7(G:\_<QWA><H<L
MU#* O?B68A::"!.E)-IJ%(X9:MZ?V._37>Q7U1MXP^P^?(KMDME9=0L@^I1T
M"K%$+ER%_+D7USP@:EZ?ICTCR[P> JP7P]YXC&#PU%"A-CLD"<H!-Y1DRFU
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M=TUUILK!>!*@G_1H-4A+[Z!C$BVZ_T=T87_!%^&\/:@GK18<^D1^+JK7+<B
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MUJVAN-CZFWBY!],*KD\[=ML-97 98+RMVY1"6O5U+0VNJZD6[Y1^9)T67@E
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M)3_(P;[NN2I$R??9F4R_:V(AGL1FMW9%_!$33]W]%ZG[KI4?8 +Y6N\KYH#
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MDB-* >[+,[W98<"(O=*ZT[;%YE32U@K6*!8J=L"O<+->SE_VR)B9SE&2O@^
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MU Z3M4O!/2+XVX=!7=(I<1SABV_R)%UR-BP]F7J;/<;%K&TP"6X!-%N53+>
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M0?[8$72L\"GT>V0TP0.A8;Q5+V=Q32<]&]U9L;O_#R;9]&TRGN"[VJ%JE5>
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M:=)K\3UN=W/Z'Y[_=8UK>P0].%>V+[&DNW$4"B[Z!]3L"*S2_H(J*C1A 0\
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M['T^51KB![N@=5VWZ@ME?X:A3Z) 3,-R"!)#$7L+SE0AW9EC (8=8F.&NVS
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M/: )X.HPV93SWGX)& 0(KM7I?;M!1Y9SX5^=53RR> 5 A6VCES(GA^Q.^J\
MT31Y!@UMXN?D)0/6@)?A[UF/Z$_ZUA<=,X6N )F2$1<[:NO%**;.+,^0UBO
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M-]DA=/A3"+A2#Q6Y*X=NQ$1:@^V>;IB Z%QM0V8WZ0K (*Q\6HT]N49RMK?
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M_F>P20"ZKOT'L%+C2?W(_:_B-M".^+]50*^?@^;PR8@<#G*Z-M3IC+\E:YR
M@150#U)O_["G3K'^O(0]*!KJ@+V0]%A(U7%R*9)!OPYVOVG^[;8^^?/^?Q+'
M'XG97SD(#BE@;NZM4V2+.9QG4+_W/\/U]1<>+X,Y>O[-Z;5O(8D :/DJIU]_
MPR\\M9-],=U.^H-=_])[C-]F9XA9&EY6",]]>%JY>N6A'3\#GER-?W-Z7_W%
MIR!MI?LX+LLQZGPZ=N+Y4\;6FBO+7GF>?'?>JFC*TTK9DNRM#++L7K5*7Y8N
M<T ^E)@,S"C5/]WVK'72\P5_5BQ:OH)[2Q676;^CJZB#M/N");>,+]2%!#HP
M!/8U?UIZRY85V/( R:\'J6W@7?W"7LMWL2W[4Z!)K!) #E=/B?Q4D9 -O-WS
MH.J#7S%"#11AR)5KZEU\(=#5@!=( D4U%C!G?!%) )VCK';TWXL_*[@,0;8%
M,+V5:_ZT;"J06-2UA&E*3!_[4V^0\B5PHQJ<%LNR,KHO6-15RQ +-6P5 ] ^
MM8OS0+HF,"P&FB3*\@7HFF 'O:M 6C&PKPG8$LV5?*%9AN(:A\- 1P Y75I'
M0&HF9QQW_!GHJF;HU%,BTBHN7P)TD9/ 0F"CTZSW+JM(D,1N4+"8EX@$^@@
MF8N!F@-]'&$.F\'&OE29L6]*H ^;J%R\HQ/C=J ;^]:P'6/,2>Z:G@3,Q4#C
M?'-4]"X"0\L)9#U/4J[T+OY34U8<!_DKCWW!<F!(:BR:T9STB_]4;S=0F<:"
M)-&8>>Q/O00+P9'!!@JKE4QZ[,Q GSH[O8E_UW^J":QPU0M%H-]^!I?U50 ]
M'E3-(!)3>_%G $.0 </SK2+!C.Y1I2+!#&C7;9"*F?_?! !02P,$%     @
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M:LMY)J6V@=T#@^ID'HV5%[$3MR Z-4@C$WME]N2%0"BHZPGPS!"8CWLYYAI
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MSI6<2N;H7@V>TM/P17R_/Q]&N)"NTB]/]0T@+2Q).IS2/S]^U?S7:Z)UGM!
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M$@?Z)!B>_FYD5/CY[Q$Z'\-($)9WM*_Z"O"P.F YX-)VW6:A=U&L!MM\H;F
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MVM<WGJK]PY?V^_]_CT[YITN?*59;C5)T*7JY\$IFZJGEY&\TE-5^;(2KB43
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MQXF =L[B?;\X73SU81YWCX2A F)JY_2/1 \6U:$(^G.KGA9."BU^%48=6CN
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M(&NS8#7NVH+3"W\^^?"CK'S_70H34?,K)T$"R>JH/X6?P:U6%^=]R!XF*6K
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MND1 QD?81IG:UXB]O-6[1,#8J#\,M0DZ6+OIAO\YD.OC<;Q20;L>8;*_C @
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M2]NV+A(!+08N^$%<D8=&@\\J5/P*Q4XIWW9I5:LLH1MD5"A,JY!:%:DLOM0
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M]/YNJZOYY46A_BMUHC\S/[U,[C7B<7&GV?\?BN']/RO<-2T6X'R#>;!9^@(
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M7+CNN(-I@H+EVT_)\A_H7'XK"^"?( F=3]FR-5)DWIF7]R$M5--843!R57)
M.0AD6/V]YNJ+N@\/0F+%]1\CQT9B].U2;L[-&(^&B[\QGCV]LGF47Y&U+ U'
M$SWU]E[2M1AXZ7'0^^-N[S<!![;N1[*%>"I"8V'?,<\Z@6<J=#YM &M;=M=_
M2VOWI)EE6_FJ^$;"QAFKOPB/5*;3AW>A=<!V9Z]?:+)3JG\EGB\!1RW*1#4*
M8W;ZN^O#JAKE^:8-&?Q;?WBW]J$;U\+:M.E!HZ8ZUMNG'_>,/94^+Y;EYN)Z
MEADO^(;1$Y8/,3MI>Y^M[R\/-G[,2A5;CMX'087-UI5%<!X^R\6!68S.?O5\
MZ*8J1,2*46*S]UL#<H3%B>U#9)4MS0+?3FJ@)]SJSLR:I9B>$B57T6X$W@]-
MQY)D[6C6-!ZOC-87$G=<'Y,2[_^UO6PD\=W4%J/\[ AZ.*:<&'I4@ L$QE4N
M<+6\/;R-?>+;[^K-G]ZL'5S;)R*NI[09/-RLZ!P "E.^M1X#G]7Q1.MD*4]A
MR\D_-=!= B;+^'5Q^K"O$,'QQM<U\7PQ,7TS6NZMNR_D5CRWK91]0\:)9S$T
MKCJD8<Z%UM/Y+6XOK9S'W'^<]B&/VC ##3AU(W9N!#<BMXVK,67$6M#\@^P+
M"C*M4R3'H@>*H0,EW80E4PI\U-2$V8VB&TS9*18GRI1;3D<._7KCU1H,9F,M
M5;+O8.\.@Z\?IQX96:(6LA-0&IR:N4U2J4^?@H_W]YN#O[;9S.F;XV#8K/9F
MQBHL*&RWDF-F ;"I]UVX-ADZQB Z)]=-B1<*6#Y*&7Z][=C&#@W)L3'#272
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M>8@L= 2$?VBQ_W#SD\9+^OGB&>A$"G=005W08I3K KO%S'F:DOU :_<]UK(
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M#06W*WT4/#%W2]_<"@.T-P%.09F0USC5EFN-O PZFB]]B@5(!Y+Z60&:\!M
M>TOC4K4!;P'1L\ +HCP7(Z_I\U\JT\].71%OV77Z'.P:4L3NW:QV/]%0GMC\
MZ9<M2SX.BL-3X! RD1?(I99K%B*)Z*8[I/55 -(/KZ_?),Y&/+?.E2V[>S^U
M,M'5.PW>/90"<Z8CFL?+8$E3NVPI.U:LIW^0%7NP7%FEWM/DTF0ZT C&FSLN
MQU&MH^9"R:H;WSM8<7_B$EQ[+PF6VF;>UZ\UP%@]&!&/SZ2XU0PYCSODB*.=
M!=>T@N)21SPLM_H"3NZ"RZ+. EA@C"K\%X\6NN#0XCWE3SD?C)!$/_[_NTM*
MSN/=FZI,+W,C9=*[O>N^=\BU%0>OF$(SJ#K=HVCR5WA-@^48 97_#[+5O8HP
M]77M\;T%4SD:;NS=7E]>.7L\Z745)$H15"T\J$4)L<:_8Q6A 5CF1-X!_&?[
M_JL[ "7!@FQ&+PMQ[1F#Y=NE+,1RLET&$^.S4YKQ;ZSKZ;J#16[3,U)_D&?G
M^^#OKC9$]KW*@\'9AF-L8+*XT'+*,N=7?J9JI J#C4GQQ2C*],N>.4Y(8US1
M(\ K=XNR&A"THLA.%LM_9%_##N]&1-:/AT-*P2FMF:\8N84V'GO:\D!_I!5D
M>V!MT8\^E4S3\#\)?-L0*#Q334;>$G"Z>*]LRZ7*U5^TETLV"\VYUGE;#"QJ
M[B#K\;UW, !2T&R'HSK3 4NT7@+H2BH;IG935F4^_+"K\,I+45RA==V@BP@&
MDF[>('2_>5FGE CI\X^5#3IQH:<ZO1X,Y:+IA2J=SD:O)RB]BS?>T I^7I47
M?0?D;A3&FIX>#:FG>'LZ9>?'@B.OT9677>S]LH\HMRN2DSM  '#.U-*PRM2X
M^T6=[UWI%^U,Z;I%(S)OXYJ"OH*!2Y]%=PP3C2;]]] >)ZMY,/KLI?$BKP[-
M::4 FM&H!,.IH4F\S6E<3X:Z$<XG1Q_-Y<YAZ.SO-7B]6Y$[K+R?KC3 MJ,E
MYC1_+;IEB0Z;&7X>@I#W3UF5D^EXU7249=%U_K'1?.D<V/$=K.<J.0S1*7#<
M/O*6V>5UWUO#A6RF]32.W\3UGSW\#8("SR\2ESSNS6W0[W-H=G 0[5H;1SL(
M&">]CEQ I,Z[H//!5=]G3ZUBEF]@UVWOX8R,LR^F+0[3U9^YL'O]["B_@1R+
MU+)Y"W3Y_VCYSJ@FOV_-($J1)KT7 :D"*E6ZHB!=>B=*+P(B'0*A"$AH"@(*
M2.BA1TJH :2KB$!HTB&A0R"1%DF \3=EW9DU<]?,_<_,A_WE76>==Y^S]GGV
ML\LY?W)ZOLK_]>OL_5;O7#$334?Q>774\L/QQMEEW3G'VBQ1G.'\)MJOQ(_Z
MT5![G3O_04?Q?RQFUBL3E3"XD<>5M$^O#CN_!G2XY(&O=RE;J"C&%_B):][$
M#4U.#6QKTOP+WN2J8IIS\[N9JDK!XHE;GGO%[[H.:7-SURKBA\]_\$S<MN&:
MI76F3A/[+[1-5(].3H%"MY0\9D1*V\5"[94GU"L%S#'4-B!9/[=V]'' -,>N
M/AJMWWKC3"Z.Y/7DF-MSDF,C[<%.'9UER7IDLKFY8WC,[A%,DO)J6ASD47IQ
M;ODG@RL0L<+_420T[D=N7=%[^,7<U$&'*3N8JM"ED8?,T1W#/R?:X\A4H,]<
MF0JT-$G?P][F3HX%+QKD O[R+'GC\-J(JCG/,;D9*\;Y1Q3Z/U99HD20VAI\
M)'/"&P6"=^]G@IFQ?PP8OEXJ-.7,(7#^6!]V\0-FBV3O4L5;PM#;9^<Y/Q2F
MJ['K-_L8:@%>H;"3/%QV>O!95(8,TK@JC6U&IUDV8)\DLVNCP/4WGH5R?&\)
M\)SFHQ\;-;F]%#0OOA6,N0YF=H2OCE[UZ&)JM(L4TFN<6'5,]J,"3C?!L^5:
M A3OAER)5LTT_&O**F&1?&7HZHX##B_-?::=$-JOW8^N2JL7=YH9C-V64[GK
M\]S5S_5%R15)CVQY4G0M2P]->L>@^)K+4\KO!7+DJ_Q8_9+0M ?KGNK"B7LA
M]X*9TCMRSR#W49K7\V-EWVT[>A,?@D2,D]7)VB<PSFQE9,3'^;NG&1;K8-OU
M;C=@BC&&3A!(3XB6RDD.]#ORKO:DG\GTXWM&63\0SFS4R3&9AA^_2-G-./EL
M:E<RK2[0=7!UUWKSG,GX_.K,#PWR(&#*&$FEWIA^*YSNYWM.$JR]:_8F=[K)
M9W17$3Z^8X>/8TIJ]5I9[M(C^_ L)?BU<VB4/$&K9XD"2!^:9]>(NZB'&> -
MO2OT!,'(ER_]>\H2?4RRBDOWD;U9YWD-;>SQ2#(\M^$D* 0-9YK;GK8Z2XU)
MHVHBQDE349Z_L[L$-'15KU9KQ&>C:?*\O==#?'1&GF6$S?Y)7MOH4#@OBN)H
M8%57&EM6?;8D2IC)($ ?GQ> C&L,*_71GZ3GPGYN3P];_68R6WY5369[J%PY
M6&/;V>S0SK4X:9EO>W0?GA3NT(UEQKO1J?3<U74)/,@QP\NW_>X3#;5(7(:7
M7_""E,:[N$+#EY^,8RVIA/AECSVY.^[N&W>&:O1(8F5-"/,1[#%I( :8-57+
M/-.S#*<(1;QB9Z26<)[0[=!1L%Z*^;K'./ Z<.I'M6YI8;.LJG&='<&][_0L
MJS]6R:<H[&/2T=69V(NA7+5!!&42,B@*-CH#MWW">?9'@(1(Q1,'<X <2#M/
M'*S7C-.BU&I:1E#E]5WW]\*!PA$S*$<:7"<T#JGA6FH]6&]G^ZA>,%U391*Q
M)V9#,B-UKZ3"7?5&P[AC7AIY3IK84W+\?P,L!C/C<@3 M+[)@^_5PD'D5&A@
MS:*(CJ=T'Y-F3LJ9Y=M_%:O\/]:N/>AQ%3 /#Q190BG-9U1#@O"NB/=U(=>4
M!G3*5#I3'O^VA@L?%]*\-V6.T>TX+'M)(>!O?N G4-_L6?[..8G,:2^4WS;C
MXK>D&)?GHG,JF5NP$H#^#_PM20?-P'@QPW>O'3>3*.V.BN+V_.W3/26H8KB;
M1NL1>1_K("=&M)P/U@_V,8*JS#P*<I0[KX+-!(6!5'!PK9Q!KA\OG+.W0-F?
M%0T:^5I/JI3!7\#)EP#&&:SC?4+LW&VFXPFY6RY4:HI,823))75^D/Q8%Y<'
MVYE1#$S+V9LI6D_FQ\5>!#1\9_CUCMJW$5_\75@9U?S(SO(?K@@+.G&AS2<:
MSZ$4#12=TR2=B)=11QE>:L;PQ0II#:=J.O&4)4X\/"E0/W[=>NE/,K3\6B1C
M9+6M=84B^YV> LJ/ L -K\ V72$KRVO&+U_1Z4SC:1S=^*VK%_Z8[EZP'_38
M_$ 9>N.%^L9)/UDXX*PZIO>>J%I5DP3/2U1E\$X*38VYABIVB8*1TMC@$4[>
MJ.).D['['/;I**0,!K:WZ(R!&3.&^@_&82*8;B$F?;I,U\#DF 3*!4M(F<0%
MUKR8")\"OYTLLEK,;=R/Z+_GF\+\35X>= D@JH!".O"O6Y;H\3YM*))/";_$
M!K6ZV2M*/J_P.*PCD=G7("WKF^7[BI'>B/S_&A%:/KK&\AJ=ZWK]B1S@3$)&
ME2\Z=Q-I^%=W1SI$V'&M[Y"1Q07GIH7S'L4K#_*2>Q4'A G;(+[2,ZMXAZCQ
M7'BRN[=?8L'U29+63XTF:8Q"=LEYX6@J9OL1]'J4(.B1 6%H,+5T&_7J3/MU
M!QE?JHABE':T&OD@E O)O<*J,:\\>4=_[ &?RUNH84GNX2XT1?T^OH>10-.C
MR#C_[33()_S!5>N+WU5KG\_0'4!R$CD.& T9AGE\U@U57EK<B(B[!)"_,MYU
MP#5_^:)1!@@%\9.1##$F&Z3'^+*-XI17@9T\>78F>U_V;VLP.J:N7 )>+['A
MA*GYDHKGK!LN <,6*9P,4^TSCNPT*9!(@/;SJVOYD^]--*G-CU4"@MSP-WO4
MNVU;PRV#F_;;0?'4=$/&M0#'-SZ/*2M8#K]4H.\_VLT/J10C2^N8((?\(6+@
M7R07@9;)0^H4;5Q6J37:%CFOVQVW",?'\$)H3&[2&^?MW.E4&Q.H*F>IR,I^
M>L$%6]1D;A3B90$W?J CU&X =[&O[UT@]+'3I"/.$5H%DL*YI_A>+%=XV :7
M2*:)9MQR O-8@)/ 5Y&B>-MOM<@'I0^"OT3MK] U#$9JT3(Z*K+OK>,55VOB
MN_A!#S\=X:(<%"V!\II[Y#>,-+CVC%*-P]^WW2* /J(Z\Q%QZ^[UT&@P P,_
M+FG[XTD+$%?>_06<N$JO>JL,/Z.P>\&ZAB>DGV2B@,-^-!ZV%3S4EFLBD;@G
MI3Y:)^_Q?,\N1L9(2O!+@!1I7!S8E]OM:E?K>@F(89@=C0HZ+=CT<5T]2+35
MYRAN'&_ZU>-<_\A+<O,2\$:CB1Z!!YIF]EP"J'R6SK35+3:07Y(C7 ]:)J?R
M@+/<UOBRM9!N9I /&/T,YC]1*,+M5V0QZ+T,NKEBR/XEUR \*K[<;KNYX@[3
MXI7-W5V;0Y.B@^4"8"*)*:S2;)HTBE/ZJ\-?FSCJ?FTK6>7;.;T_F@>N^#8\
M<G-WM"R\U#O6F.5K?L/A=&EZUG:<O6RE1,.KS([[KJ*BP>H0@[,Q>B]=-HAW
MT%%IV!7ZCV4O^1_+\RB-Z@7=^8^F[OZWHBU@.F'M@IF.EK!>2%H*NL[NC,5T
MVI-#*MW]>*3N:G]S&X[@:NX4(_,HA@#$_H,"62=5.. _E2@=EUO_D);*T.S0
MHH]#J*^S/7'@6'VR!O%Y[TW7+LC[E9(B6K0B?V43558!\TDNZ*L5H1RY!"#@
M*?*&>FK,JS.)(G=V'85RAK,?*7GX_"9OCO#//3Y(@#(<=<<O,7X>.VI]K3#]
ME<QY:KZ#><>[-XIA<)GI$N!ES!^:BSEM/KOA(#&>?C,\>PAFNZWA7:W!TI+0
MY)U*X:!GJ*SRPRN[7=^G-8,)MI]_ANZTZ7ORW*S%:N?G*7?K>&?:[E!W$V7L
M!9^3FIEUFG[77X ASN:?O;!_1Y@I,,9KH*$#X)PO79S&#-LR7Z80XPC\3OTE
M(#7L$A!-LE@](,MJG>BB)F1$_+XW<_KT]L3]XZ59^:UAHLG..VG*7C@K;2"?
MWC34Z@3<%[\</+/N3Q3ECP=.!D.)8O D1<?0OR14N24)0?DG5N=N2ZS()<"5
MK5H?YXUV[Q.5#:49P-;\2M-^A^91(A]WW9'X=5Z%>+R+JQYX?0F882WUFX-:
MN/40S-#(P$N *4)AH%,XTZ&I98/:<B>3F&@=->FWJO_AZ.#-!7<7;F#VC^&:
MOUQSBHXI3R"_[0D_'6'B(;XL=W$K-ZNYC"8E26K-$K/,*]EWK#&GCK%KS%@B
MKE(FU6'S;XR/ODBK44] &@_42TV1S CLJS,0)"-:O-R$=OI7PKQP2HZF?XH[
M0C[.PK)^/:H2_G/+*U%#7\,\@A_[?$5_D?:?UB:0#'MF'2&,M%N6GMXT3V_S
MY& @HKMOE-.&<-C+Y=OB+)"Q])OUW9/3'0WE9/TQZ2 9\KGM]OGDCJ2:;)J&
MOD2G5E\-99S?+&4_>:^R58KJS2I[8?W5<]U^']EX:F:7BLT6UKBH&?J)J;[?
MX#67&36%]J'?ZJ6+6%1)6"]8[[<,4]1$% =JGRX[\=I!BKP!EBB2S/ZQZ1+0
M-!1SO%'OU$H8PDLEEP9KT!]]5/HQA+5Z'<'Z!5@$O\_CWN@=)8$BR;O-A"..
MNZ O--9K?U1S72#6VA.QBF5>IQF_0D5U)D$.%9%3$=:<4CVG;U.<%RPZV4^
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M-9V'']>JTA1Z12E\TM7R=Z:V<_$[*7WQ+%+<KY!',5V8_^HEP!,K.6"@FLY
M*"=['B+ 8=YZ%>LV-&DU7B"&-\R))]T/J%I^\LWUBNLB2S?E&+TAZ!* 9UZ9
MZ8>GMS//$4K,)T"*,''F^>V3MW\R2^.RI&1\O1)[TR&V!V_DZ/17?3LKM$I
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M@X8C,6CCOF6(NC@^/5D.:_=X^OAQV^)YGEKG)2#'DR6R17H_Z@-\["1Y8<*
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M#6$&SNVQ1 J@;)MP$+S(Z;YC5A](BJ!?#!(=+_T\GJ%]:/]-;:#O(-O]V.W
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MMRIZPVGX2U2%GX51LF.]:ZG-]N<:A>;Q^4<E9$Y/"Z/,R="B/4 V=4'IH$L
MD\Y*'OO*KZW0L#='G@S\68$%U\_SD(PKQ)C@=L\IQ+U7I^TEB/Z4I>[[ E$<
M<'-&,1B K)#*J1'"8O'H>DEQ3+1ZEL";*PQEZA" 9JM<T[^=OAN+W];MOF(R
M"O/-Y/Z,C)2^^@SX_/.:[LNJL=: UT*96(-Z<SL7QO,O2H4T+#-*O+)&%8MI
MRN;'Y&C@/'"HX"X.VG\)H)=)#/*N5HF(D(V01TK%9UG\^7HPZ#6*-<//6$^I
M\Q(LYWO:\[.5TRHI3U)FV. )3UBI[Y_E6Q627 DF-:$83'>BO/#GPR.6"7=$
M:W[+=3L!?\(,A,!\XH8?J4O$9-;:R,VPS3EOV_)$]"SRX7H2U>,Z(Q^S)P9N
MZ_DXTAQTG#.XY96NLJN-[UZP$C!U!-D3$,ZQ2<Y[F=TK!"?V=G!%80_Z\=?1
MMNU?336\B!I\!+N!$)3'Q';[:**3IW3@=IY* C6W7=%/R0%55YP96A>GV$NT
MBY3 F$TT=3S_&_(-!*QES*I96Z;W J/Y[N(225*L;>.6 _*U2K?>W]7?N#)@
MMT9K]$IVJ;Y2AW95/$"R!;;<LF!0.;[NT^D;-">*!0;A(_K"4[MR5@WUEHUS
M]'+U4VUZK'W6:4Y9ZP\C'_LO \ >S3CV'F.JK>F3%O7;>-_* (D^IUM2 EI"
MH/TA)9.T\D[GE<0^PX#>2T C-\'OZ<3%<)W\^W>(-B'_5TH;76 <^UXW!AY_
MP8,;2CWB5;=1=75^-0PN'15[+M7FW)L6C>&56#VV>5BFZ%)76W>FWIG(__R6
M6-=9Y% 3(>YDU)L7:%F/(LE(5[,EL'BUT+RL$'2Z]SWZG/3LJ,X/XX>-K+;;
MYJ/HQDE#_8-<:W]D_"'Z;\1\&J--[W0,\B>J$QK["N[.(+C3R=)9?WEGT'R8
MP9:S-SNIN[QD4(6B.@X@4'+0DV7Z*+Z153"=EE]$H2--F]R3C<4F)EVRI"*S
MGHE*&B_D4E[X*8/[0RFA[4M (I_()-)BY5S#?"HPJ4E_.T?&5=8U<\<;TSVG
MA>Y..39.YAHFZ%BW-:% W"\REQZ3_7%[M5!YO&(U7< X WH<AL/+TYD]=E"Q
MN=$(=A\205/QT)[E_M%9/=WS0_.S;W4)38-L:KWF*.JK[;^C;&R_*SR!?N&O
M"Y^1IAXO,PV2F+5[U+*X2^!X:HX1V:S?YY,]+\<BN7'=O7R2"4-$4S4O_5"%
MFKQ@]CEJ$O6V;93,>:%.?)<PP:PW3M]SV;&%F7H*OXXSNKO4Y0N<O02@#0^^
MF*UZRJW,I2?*Q[=-3(=1GAE(BNS31P+JH 8XT0$&'I [C@%">K#Z-?"3HOX#
M\@&>HH([A:DCHUH%4["IS]\4?S1M[%X"HG.5S;,63Z1"A4X^X3??J"N'9FH"
M:98</6_H?:8BHSFY]9,6/FCDG4@(P1_:$CPQ#$FC]#%5A%HSLWM?F2SOSO53
MBHH*1$J.@]16_-X Z2X!'E"6G3-PHM!4D\:-=DG'L"+0^Z_"&#4OOT1^2I)Q
MR2S)V6Y1O#C3+MO,.9ORYS4J?B/O8!S>5%=2GJ\KAY@*?I6WAU+&!IQ\&3NZ
M!"2H\^$?I\;_+ JINY\PJI\$#O]-G@#\<EJ*H\0Z%8A.RONPV^*PFPE(W>=>
M,\Y&'9> [/JTU>ZRT 'XWB:F4V55(QK^(G!KOK^ JS-C_6@^D>.=33OY1&%=
M3A_T.B@23X[V16"6F;?P'@;MYMD*N2#CMK57RIGYSKD#X[VVNNIGRPY'$XB4
M+ F%SI\M7_@1D]TLQY(1=#(]9YGS=S-4=G%4";]2TCM3^.[7Z:_*#.0=T(:J
M#'#E)(#DJT.S'T^MZ185'(:E<WZ[>L0WM05L&.TS]/[237W0M.AM3.0KD1KH
MCY5->=N_LH'4XT\$LI*X<=4#[=*)A5_;$QJK5?QTV5]]"<B J?7 .)XOP*AL
M)$L1RPX/&4OG(6KIJXI8FTJ2+DK5$ 3B#/%JE\ EB7[<5']I\H1C1 MW"3CI
M]6,DG,STGFW&^Y)40J*HFSQ=Z/EYTY3Y:\,Z<V+4;]F#:#MQP?&KNJJ2(2_J
M6UL5!8;# PYC9U>@MGT$,%$M%#6#!L:"=&3BT]+]G%:E3Q<_ECDI?WT5'G$=
M;-6K'CQG-PMLF#B0F35I@BX$%["?PT A-230S!$54C8HLD1S&(!X2(;@77=.
M2VCN8B&9C"'%:T$6T[[0IQ"Z>YC 2X!7Z[U*@0(AX.HFXND$D@%/L[J,Y4:K
M11C@T-Y<"AWUAJ.Y+)HJ^4'H"D_^QF5(T+Q&L@)[<T(?\1588="3@_5MPM?M
MN:3;<IFV8@A>:&ZK$FHJI'XB-.1DACVW/"-HE'+'ECZN^KM@_13L:FEI_A5M
MI1%[? @V22$)$^G=.P=\+7.\J-?SZ$USHN#C?=VA84<K?UP>&MYO*-H3=7T:
M=-^G9#N*MS5--^B!"&A=J\<D]\B/C"2$9TO"8P;;IZ9SATN7;-[X^-K$+/FC
MWE<^0^<UM!OK;W=!PT7,MX;,IKK(07Y-A,75@*IY6UW8*$LJW4#ID!1S7*SD
M^#%W>5-3F.:"-@7=/W>+A$#*,UW\VTO"R?;U"O<<O$Q'F!K)VVB8J 8B*4%O
M$8W4Z?N$4?DUIYM&K+EE]9O3)F9>*LQ%PN)J.WII=P#V/"G^IE;WWTP#4KA2
M'A9B#BOMRMQUBP;D4C8\>WQ;WT( ;6LR3E$?2[X_C%3/TB)>X?]S$' ) !OR
M_[K!\,<G@/#=T^O:)4"<;"^JJ8-Y1AYZ'L- .FF]!'27I^]1@3=KA\[/"^D
M;R@ Y-N:2?ZC__V G']FP_K_,QL ^#MG!D*KUS<_5P%^IG4)4*L#4__SCTO
MJ'?<)<#'$.#H\38EL%"[9.GO@ ?_#- XP,J<7-4XG,/@WXY=PS Q*:/^Z"E?
M+[H$4)'^^8I[/R;W5X/.T?-SN2]((?*4E4A/ [W>QDO *G]BTPQ_RC\:!EQT
M82XN<C6!OV_0FGY@YNLV,]?X?/,24###?WJ$ C]["%Y'_%V"'%E1O?_VD5+)
M-_NXY;^K_.<?0A=V"^#E"<VQ_SR<\F(N%]"Y5OAB6KM[982Y'_LBR$=ACC2O
M\9&Q-0GH')X"0?S;RC,O& DZI.8VC9/)L6M;6)2P^6,:KI1KCH SIZQBLP7\
M@3GX\TV!J(O-M"7/DG_;I3LR5&^#815? ($UEX ]*HW-?U23]T(-O'A?I?)9
ME# O$GW[_RK9K]L#,[/&:[($SKO'[-/0^KYM.)?X?52#E7;_N!_7_/"KYIEE
MVJLF,KJ>F]8Q8U8_P0UZ28B#I!"9?FS=]U*^5HJN]/?N\H<R>^=_U:7J'I))
MXN/^@(U(AK=HPRKIECH\P!0UX4W=%$&HZ?SQHYT4L:K3ZIN(#P\U<SQG"X9X
M+%X3FVA=SF88[/(3>Y4#H?1[4J0@RGZ[6V".SLE!V0CJ,)=OY\L9OY2P"U:%
M:G65/D0>+^#<L(3AB>6=FDWI>E_N!R3);4.=WEQU6!COU/Y'[X  SN_ZMQ]\
MC$I )IY4XGVA,)!\)V[O,6P:$2U5TT0,6A1.>;)5TM(9WK4\__TN)**NLX/W
M8F;.5NSW*&-]_8PZY:*6STGR._([J=I<6NM'(R%1#..JS_&RZ$58BJIN,0.=
M9[BJW[6R]PU_,KX/$=(HR>?:@$G*OD4KP@1=-*_I=_!>)PUUQ3>F Z+Z4]K/
MO(U DZWVLNS.LOEES\.A $]ERC3K7_<^JR= $#P"^18'0> /YGDIC%6P=1;&
M=P])%628M,D9?ZZ[:@"XV*HME&OY%Z'A\*09[P"/.Y8TE$"C41I-BPZ/7'ZU
M[A6FY!Z?*YZX31S;O3E0]:D%$K[C>#X<" LN1 I1PJ9;H3&-#&P7J&4FD!;'
MHC?-K7R_>8$ H*D@0!9R,*AB='<O9RW(*>K65DHW T%?&U=6B!AO&G:07N;X
MC16T?G_^,"87]9O9_\)"BK7W%>WO:>B_]R3,FIN=YXV@?RZNNFC3*)7X5K7*
MW]K]@'5U5;JI2U&"6O-\\3SXOIM]+J#IP=?R+DK;R(<'/\D&!+@L=#?3[LLM
MB),#>&9^=",T!FB6&7;.').+"7- AATF;=2PZ_/G)QU).KCF*_7D\+(PQWBB
M0>BF^7D>R+URI(IMIDE_L@5"_,K84:DVP<-? =<NN%+V1"+9;0:]E_9KU5VI
M4FC_Y/KB$._A4\=1UBQDYO=YIU3]S"U*D2[!#D(9WGOUI!,W[SB--*0H@X46
M/RG.T[<+M$BRXZ4?"UBN?;%[H4%(QX=@V).;^.E#$_@9M@KX$ _'5*\/KGZD
M%LA@X+&(?*B[^,VNNZ1EPVKJ5J1CXL1?9A\E[*'!TA06)'5EO<[G^:?"$-<>
M6AA%;>CP4!<?(=*5]^#-L5VDR.RRD_[+?@J_!X[41$!I]B6 .LC\0V56D'?T
M>CAS![07.72"Q"<FDOSPPSJXD#=!2B^.>"7&-]L\&88W&SX5$E<@*"6.478)
MZB[KI9.EWC1>O<;87\1$0V3#](MGG8U9OCYNFO@1SJ^N:E35URMC 92YA+Q5
M=NQ-C?AN%VSPSG?K_6,_VJ\OT,*NP8V*[Y=(UP_468;P6KKCE.FJ9ACKXTAI
M'_G]-53&K":MF7A3/*_*H?74EY]Y68LU>QWUJJI9^Z.P8.G]?.="-<\U"5KG
MD,_PMU%47AIL4;(<H, EA3BC<;[SJ<#7S=I\>EU4HG[V$3/DZ$O G-5@@0A^
M!E*,"HJTTF\97_[VN7$B,#-0Q!]Z7,."D?>6R8>)B4O6DMJO]'[K$(D\$G)4
M&D(H.B4LT*O0<A'2T3I#&LDA&C1(]NH>SXK0*,G"W1J'!S"_ C:SZ,%[I='A
M1]6VW8,,;Y@N1E_N=#'C)4.[",L?ZH*X]6\ILN&>N7 TGZ^.^A[=OJ:=N6';
M 38 FV>G$:%>L:5G:QA(ELD3?E27W_F[* %@Z(S>%$41!DC0NQ5=090[*5Y"
MST\J8RGQ\-*W^T^]$Q"BVK[Y[3Q3 MO#62EW9& LX[YQ+6/F1Y8BCX#N#JVE
MO\E44R8G33\ST@3R=FSD?#? W:\4!PP M,=$[9_>!/BCH!!;Q2LBT7=YG@IP
MWM\H.]!D(>.?G8A+T]&KKK)%C+Q_![NM.>"H2FXN'S9'0\VK]%);0]F#QO]*
M1?0)1Z6$4I*K5CY^NJR<W$7E:2Z>GS]JPI\@.=BBSM.,2VM!<V)O,B^,E#]*
MJ[^Y_ZJWLQG8ZKV&!?<NW<7+8"71'T"*:&$<R=1SO/2W6OM7&Z. IBS5,<JN
M4'WT9B+(>;7:P7?>!$)C%_W$+H-Q+(W3.EA@>FHT^2A/['E&I!%*.-]-U%.3
M7JUQNLM^\H+,(]SO;^0-"'7$ND_NW82$[7-^B&]]NY:Q\O*!6G7L>:&J;( ?
MONK0<-)M7,Z/5J3@W;:H'<2X<6AH=#WK*L5/,?)]_4L \_:<18-Q1*6=[=_
M,EC7!:"(:BC!SWQ$5P168/MFOWF?%%50LP\/E6O4@D)6L?^)L_>.:NK;&D6#
M2!$0!.DM"DB1)DB3%E#I(DUZ4Y$2$) >(!! >A60+@2E2XE(Z! ZB$AOTB'T
MGE!":.'R.]]WSGWWO7O?&._]L4=&]IYKEC77FF7OM>8251Z6;+EE#M4=RYN\
M$&/,1+<37GG8C=@7W7,G(Y:<QT=H#WDE1!F8@R?57F#^S--#EAN1O]3S^+Y?
M\A-O6%JCI>#@?&M+\,D=QQ/&TM2:Z@P?^)_Q56Q!7$VRO7_);%M!5GI'Y-X#
M766%YNVE.-)UE6%/:SJ(AVKER'&-MIP[/D;C6?UGZ=GT>&+6G>/("_Z<QR/6
M:*CY$7&NJD2'=_G*+>^+#@7I2P?B[;X$>O!$3:6.U%<G=OU#]@1^BN6_8V=&
MS;;EK78_FD+V[GUX%]Q!=&K<WJ#SD1L;5QLL,7-N7@(5%HWD=2*WG\^?L5\E
MD]]%N..%E[)$B2_>8P>BODW#[#90KSR$RTQI(_B2O@4IM.AC U/RZK7F7DZ,
MJ'3K@Y_F^'T <V%S$A56O"NWO),L?DGS"(JGOCE"?)$WQ_0\Q9[LTJ![)I%+
M)2JD<>EYZ<G,[P,69>V:^CK@E$=Q9(NUX?(:X*(&2)R\TAU'*I,_W'2+(K#&
M>#$EH,L<I/;%S^;X@67]ZI!=P@Z=)C&\_2N6+$YB@=I<;GY^1EFDVS/:]$9:
MZP"IT^%Y9R!P[!@6B>)/Z#1;B_CF.!C(.1!@]81D*('[35C-\D'%%:#3",54
M@^V)XL9_7W#]LBE6F.#FQN;\^?TVDTXZO#L8KH:76[;!-_0\KX]0]TS0SS'1
M$OK]7)G&8!ONN+-W 2YL>]#5Y!>&G,3>A_V\I9;^0?8M2A+#\*42XK,DX?="
MFG8W2_> \=WKCE4Y=YHG9Q,+;0EX8S>(%592G>L*$)85\_5)L^KYZ^2U]1RW
M^/!@H.X&\$[YL0+I@MZ8?#-+@=!-8W&$BH+'%];I:JQ4MO];5^']W2*D3K.L
M.D5"R8;@,@=WFU2@S ^\3N$VX\B@+:ZT,)7K#[''<+/*&^@+3&'!DAB621ES
MG6T?,5>4%]35//>@<DL\O)/'YUK!SW)BE(:6XW S/3K_*VIC$#(D\YH&)6@D
M-5N/^ 1Z-T@M#(\[-M^5Z_0C60U-C?P);J"3[2ZJ>G3O3;/3]E\ ;:PNU_^?
M/4G_VPN\_;)0V@Q0:B^D+S%O%O1L<;F^U.G$,3NNI-;W[P^Y!6\2,YYH@(8)
M/YG"]JIU@J)/.RC>B@4?0Y%88&GS<DP3 W")[T;%8_EB)1(HIA4FRDO,P;@-
M<2LPX JP/1D,-<97%D!?8_I/PIO$EBQUNF,\4=;3;Y1)FIRG.I->L_L;JW)^
M*P+Y+_F!5%U5H4F3=@' (D>]+4:IDSLR22R?Q&56'G%54(?F*&RO)$QUH%&-
MF'7]B*6T3H?XK!)5$-K\PPX+;^R1]J6XX#9S(5WNO17:+R.=>I[VOX\M@9X/
M/\])^4YV@V(9K2DE]+C7]@T;> 79R D7!YQ!%%C18 (-%E> %=_NRI'#_.YU
M\Z0TM^CS2*EZ^3V&Q0IU6E&T7!B&<(#=]:1AVT2QPQA-356'>FW8<I.X8''2
M[':%UM/6G<&J^Z&*/""-^\!S29^1T#S5L21HGW% @+0LUQ?P>8EE*O0-NB6J
M(<^1U1PJ_G,,F39'U]00+M]Y/+,Z^?E"$JL3WV(?9V>(M0M62 O:Y[V<F/JS
M\-I.GFH7*.(TVK,KAE9EO[B/Y>, ^=-< 1A,K"3P<V@8*][[_%G,$C5R9+[[
MC8&OD*)^<K=YSL=RIY<,7,U?<NNMS@AR>V#J=_6V#*X&FPK<!A]-JL)Q$TOV
M-1G$W1ONS+06U]XT$@,5QWN5.H[*//:UDX,<AAQ(4Y"5*V-J-4$4BK2;&$C(
MGIR'/5'2TAS!I,>">'>D25KKW'77%FMUVS!Q&>^1V]\P9[UZ_K[U<L?/^/;#
M1[AX]\ 5OY.#TW3]D#47:PH%.9P>WE?ZHR*[LF^Q &%R@@.Q]R7VCL4*3:MQ
M T(S1/!5^!17U-.' 'KJUE=;Y,0*3ID%:D8NKB6#3Y[TU@C3ZYE^^C]73S-\
MX[[,3P;2=/ZHBJM$/B-7NP'W8((3%[K5T>K]?8;S5U\>\([5)<F,?_FD2T/;
MEDI)(NCT'+VP4P_L=(TT"A0=;=+P79I[*:."+'=F;<G@U.A1H.']^?HR3F(&
M&)'S$%.-:OYP;])%?V601SF'2Q8+SP*%!3S4M2\03<W[45&'WN8O+G%H>5;P
M]N&#O@ :"NSDSK#3LK-TJW=YF9:CO""/.[>07--!^N)AMYLII_AETIO)P/NS
M^"(5K%'>4KWH5Q,O\O=*7*M*K>PY,HB\FZ^I/Y.GC6(*V"T=H.*$C(?(Y2KY
MVD7C-CE8B.+=^J%=R5N2S&L-_L%"I>%L\>HR?+SU^S<)?7Y2,<NN=R%I5G76
M=ZVVZ?8H?5W$;KB%L>=T,.R%2!(SX_*G<E)$[QH=I$G]G$TQ M?DK ^X!?:8
ML;.NQW&(KB0H8X4T?VZ*=3+<=_LB_N5X?20?#SY_M&5%A%)!8==**C;$S'N=
MJ1/=F$U23)Q70C1:-ZV?I7=P^EZ 7RA= 8ZW"F(1/,L"EK#$P'EGTZHU:XK
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MH.XJW7"!J.#C5G2]WCESEQT-SJ<31#_5,RTF^P.8[;"Y9/\]*^%[RXJU,$M
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M[^.G*F/F#&5?:_)!T^PT8ZX /8ER6OF\R<6<-DVCD2&O%'.+NWRY=; @G''
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M592#K[?OS/;\8R9=[H>^\+Q14/SMEPK91_TA8I[SPKILZ:6NU"PLC3[VK;9
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M+,G#\FAA?-/?$*NELM*8_2'P-_NEZ9##F7-AH@U)P6<!5V>*4/6A-TH<)(X
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M/[YU0UBE4(2)BBB.(_5)L,,8)0A<NWP2U=,,!(?"^IY?=!D2.BKW;T2#?NR
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M'B,ZU(D'=BG>F[@0Q)+.M#&-%F;N)6\D][%\$6 ^9*H):)A\4'KQ"*L3+Y'
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MC;6CG8_N9&Z\F/J#L( H04D4HT2M$KN3D+,FY*9&&I:U@CT&,2:S8PQB(-'
M($L?ONB43?\0Q6!$L;?M;&;F/.^N8Q6!-V&1YX 7A+ B N^P^:1388HZ7J#Y
M_<;]]N':F['<A\-MWIS2$1?OTK)ISG)+Q[4^C#H2W?]3ZI4:@[17@NT.V6A;
MC?Y9)I&EF/!TH.>]/:]YENT-)!EY=$+_.6#AVJ/A-IO-A>IS0*"<$MS1TZO0
MS*NJO^KKFR:WTZ>53T3IAPF_Q+^6*?#!LI:OY2QV7)N%!3G3/O$JE)R;^U/
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M\'9)_%$$B7\>YJE4AT+/J(]@;]5$J4U85D,>Q)%VM;9;^A67D8!3 =B11M;
M+D'+^L):M!%K_=+JI1RT"GII]E2M)-OJLCST#S"(3?9@86"&1DX_2-Z7(/O
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MUXIQ0ETG[>5Y&R_72AJ\7SWE,HI415A9$K3'0H'@,>>03![>ZUG=YX!IO7/
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M"NS7/S-:FG.6[1*HUQQ[@%VS=CIRXB7]=B0\.]\CDQU5"DXV'5E=6I;//WA
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MKW@/*C%80-,U]$AH<:FYSVENGJM2\Z[CA_RX:XH H-*+8,0_F%"[B!T\,^+
MWT3KLY,_ON92&:C80?_=SM5_VFE]\ \]BBQO,2%>IC";OYE7_U+W?N9?/Q>.
MI0^=41?]:_;"_\H>_A^KOXA;?QOIU?S-Z/K7_JI9!$AO-UN//R T!E"GQ=G!
M2Q\9\M#T!WW\HVC?]P1W+V,RC2(;YV.'S#VJCA/HPXU-10H+Z@+<EZ5+ ":E
M.FYI-V[4-$/):> F7>;>#[_)3VLAH!(L6;<ID=O"$347W"49Y6,I.*3L0\_'
MV[UU\]$<[.%/[^59.<%S($:09;M/LJDIH..;%9L*QC")SSCOIA2R2>.4,0:
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M:N@(2.^A!P'I"35 @.'WKG?*FF_^F/GFV_?N?^XY]Z[G.?N<O?>S[L7DQ0*
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MKXX/ *H3=D+L)^PK*^,,G)(7;?2%OK#H^>W2*(Z;EI_*DB(ZL5EK@7?1-83
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M;,D*L#'Q>I*D\B1PD/(;M\EUBZIH\J0@L70IN=Y=1Z?/*I![:_CP0"X9QN]
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MK3Q7E@BX>W[W<I/66E\ )I![2H82UYS+E[P&57HV%G^+3UM$^ON':M R!]X
MFLD0-MHX*W DB-KXSL'-G6J?]IAK3N&%P_D+D'Y:(?#=U2;H&J]$C9-LOGM0
MJF#!P?3K+^7(C=$] 9YO'G"^?ZD'?=$3)Y:RN\WG+P)MG@O:,&)F7"U2N$=]
MS:)SB0R=B7Z>^>O<;BTNAA/N[3U_DT2FO6D)Y6]N,_(:5#R.OFY8,S]^= %X
MA#U8@^\J/6]686P(!A.69P]3AUKS3SQBU0>FDC5%(P-N,.K[H@K_'8%,^@XV
MZVQWG&@C D=9Y#&LS#$TR_S?^OP&>K<TV*)==9V@EX=3,4SV:!T!"2=+^91=
MBO#>?* ,JC_KC?2;G,5XXVWYPY),)K)<@#M>]RU4D19Q(^DFC<SBE%W_T$[D
M85#UC<>1SW]FN*J7)IS7_#Q&8P\:!ZB(TB=Q[<JF_<H"NDTU6AYI7T'K*P)B
MIJ8F%$\V!L<8.-N\ V]75:.33PVY\]/M1 W 35^3B25L#XU_,]YIBJ)@>_W:
MH$)2C\9Q7G^C_#@""!=LR4DY==&G=#J<$ZB/W=!NT*Q+  9$ >AZ]+:/[]4S
MAO]8.Q<C)!<>NEN"GAXQZQ#45V[V=E(F*$N*#'\L[ ?\"'&YP< (:;H ?"X_
M!N]= *16-[ZN1+4H='V"O*A/LZRO2^GYJG:*D;BW_*5[&A"7+S+G,8D3D4]X
M7O="W11N2'NO])WE*I7*KSPJ-C$F.>3&KTMQ_YB:S>#I?[ETH;#T^GV*?!F7
M'X9!D?_K]?#_E)>>@0W/>]&IR\,6-A% MA"Y)UT_MJ'/BJT?/^VKKJ%YKY#Z
MTA'?($$,UB$ZA$,T,.A1E,0XJVI*@.-;:JGHCU ]B?!4]:[HM-8A*RX9CP\S
MTFHWV-5:NM<R?,T$%LUE^&3W(,30\@*K;F_/1Q_G^J7_Q#<74%'-H\S'I1G4
MSD773LHRWPKJ;Z9]DJI<?)%;-CB?Q->$3'P#NP"4U2BX$AFUX-P7@%;1%+N#
M(!>7EVINQ<&C)Z<&UH*+JE?\GP^J/)ATYDS5#6GKAKI-F*T]N3T;WJSD.@BX
MCWISPS$?AR6S7DMZ(F0;.ZX?#EP()S_=DS:<L2(E;:),MUW9=%XRR_WIVBX$
MI&J0YA]5-48R*$P8C;UIQ%1??8/@I]VK0@?O1;_^:SK72$C0-:0ONE,7O(6=
M%C:O.7W);ZO3*13=N9'YE8GQF4*<SG=_A:;1=RA#@I,72TL ^R0WK.K.SY=D
M5/(3E8-/X@G8E-D",FME;O;L!+SKI"(=230R("R.P=#I#V^BZ;4$,Q[#GSBF
M6[4R_-'L_:BAGV>W,<]&-G#(1^3=&9'>\\ZS$!MU;_.PNEGSGI&7.;**&-7&
MJ<U?5/+B3W<A[MZW6^;7,YYQ44A^?O):^;%Y$_.0RT$:GTVKZ2YH(-=J\C,N
MJ29-J"A2+T@+WK@Q' /:$[*0GL,%9A* W%WA_D:J$?[4]W]^6#=[]7+ !2/<
M?>N'XM>E_0[G.7^'@(>M6C+T8*"RDT1_QMO4?T)-FRZS*_R3J"V)YKH<9Q7>
M41G%>OM?PV\36&J&)$LCC>\K)09WV&]DTN:.PB7@^#H,=$J& DDY,WT<3X5Q
MTN3Z*_#.1/DRLAOG=-65^Q< 51+-*]*T4G)"&ZP M*Y0ZETQQ5Y9S^@R/?%P
ML5G)IK ,TYHA.NHIP+3.+5YNPYZ1Y<#F#9CNL9:+V:7X^]Z-KCB"L'UR@FNV
M1MI;Z,,0&$6/7OL7[VF?)RN=CL>L!A_<;S IW*CS_,L\8S7]_)U@!DM/T,T$
MA. 3FM2]\VI(D?BL*@KYNYVT%GB"#/Z!K)[%"<ZW\,;9_A&Z#_[\N,]V3>7>
M3P+Z$_3'O:)BR+J<MM-U[NIA ,3IW?()X$=BG,Z.$GCQ@;])P128*YFQ:E;=
M#6SO_>Y)I_*Z*C="%LDTO;9G/B.4D9<_$U7B9!OGYH(S#@5$?RS5O&(("K@
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M'JM*K>.+K]\GA64!+Z9N (D'ALQ3'04\1S[7&X9AJ'R+C#>48I/V3=CJP.+
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MUNR3E_0_@PB$[RMIQ&1S]-LF%GIJ1B6J#R=^!.K+3V,-<WR5NBY%2+*G:<%
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M]H7)VZR<3-0.7YJU=ZO_V:NWL[]-YVS5>>_\P];W!]]#QT+5AW(+/E4E7;?
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MHFM+OXG*5Z%'^GM>/NT%C,CF@;HQ-?):BA([=; @%IZ1$'NN^J7!(69K[":
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MW'N\K?[AG9?B>;,L(!7\4JNKFG=H7+!1H3;NH"NS>#*-(5.[O:<K[)A==81
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M5A[8+M'V1[39A!__FCBQ?5?^("M$&B?8!<:U(=O22EX\9'_'0:YJ!:*/SS1
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MSH.?+8Q64JR>GLYV8U$N*,L0?I+ .<R9+#FT:0K)E#=ZC4D=7D#_69^KZ"1
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M,VS_>P98@>(L.Z7N3+W)F'9UP4")W&30T6><B\R?.6S3M%FD;J>BO*O\0X\
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M/'6N9*)4&W2L5UC-$#XR\4W5CV=4:!31L,#>RV,M\NO7#X1;LLO%=.-\2?.
MWT#HIX_ERH1ODF=N;P*317#%J'J5.2_!<C:U-!FL3[9.,\^AK+9/CZ"XREBB
M'7XUXO!>R+UF>8U+)!)YI];DE0B/G$"^-YC#TCVU)R&X4!A<X_^%3B0= FD7
M<^760^6*#4E?B89=E0N:8,[PE=E7B< HW66X278N$27<T=$+T@[1C57E6W9K
M((2G5DXQ)XW N%2XH]9+@))'QCVG7M.76\:=RZM;A9JR2^JZLDQI<PR::&%1
M4P+W(O83UTFEVHF#<%!"8X$U'522-B=?O9T:6T* A%!_0OL?=-1/:C%S.W\>
M%B&./'Q%<BS+)_L]]MU7&*96]O%A$G\EN"7CVQC#0)<QM<XVC[XIC+S88O+
M['NO:HIJNEL-E7'/LXY_\"F%!04FS59=$9KB^B=]:+7!9[4 Q:D#I?!8:>:2
M(>O*JCPM58J @[[<_5*EI$E]2Q$7I$R<+FJ@XC3TY#OYSHZV=#R&PWHN3[C-
MP8ZAR<I2Q+CUXHM)^%[S*RUX72M/KXW1!FOLRNRKX#;;3X!891$=M14)FL[5
MO&8_L*%50V *V[SNXA^]E^\'RMM?%[2W7_+=?^\^HKQ6)R2[=KQ2C)6IY<T=
M_P#0(W D;)UL=O+D[GSX?.?;J89P@7JMY06=OJFJ)!N,Y4GXF"+JP]:T1'+
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M>S8P9 [S@-BCH2ST\-!4M/S+WG4<1'X9AR=9HI:G2,%&=H+5]T<IV2!UL^6
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MY>UC,TS6AYF7Y:&P=>@B!8)'VZ(*TQBV\7764/E"W?\XLGTM+<=+C,"0R@=
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M:VA(/#/M>6TS2[5[V@UYJ^M7#NTG'93PZ3"UKCR*K?X1D3<V$7+\4)D62XQ
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M7OBL&H3:ZX*8)Y"8F]#$G96IJZ9B3WGS&9PX[GV]AYDM,&IU;"$,OC#:C,C
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MGZZ"L!HJE,L44<)3,C"6C8]B)R[ "@@O-ST->V3/*GY O@YB,.<I*A9-, 9
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MH?P?R4TG\Y19DE9P%W-I#\V)R-KMR]TQ'*DRM?VTIW:^3O!7B!7/OX S^ _
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M</3+@MP@:47L*_'D0\'4ZQ=+'H]!WV]6D-6=FZ ;TDZ SUI3A9)@F.?H^=M
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M(27E/YP5_A_.2O*B@>8A!>I,H.3@\%[A1CI;Q^JH%M6@/88&6I*26[-<]]M
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M5(M:+MQW.;@>UU\TN69P*WEOB$K!_I#*3!EQ71L@],&O_Z@UW+L(7?1K?ZE
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M@6*W0\'X3?2& <;P5SZFH.O>U0!--,F*X-\2)#%PE6$=\N(^I#2JO2M7#7W
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MH! <XL!H%TZO3(WE8:^NS:VM61K(P-^A*(-?/=8MC.Z3AO$@T7H"N?03AV9
MT%DNQ%HLQGZ?'TU$YEU_?%7C)D8-Z1=\Q(MY#&[9,X1^@.*"(9J3'R/<761J
MT0<UPJ0*>]R\9C->'&1>5KLVKFJ:$.]>L>GJL$$#=9JG8DQ,2'#4#R@Y86UP
MDV]UC*EA2Y"O:DA.NE;77D1)<0L]4K+ 7HA_V[LB<%J]N%[Y3!ZU#WY2 76
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MKKUH\1M]KH79@RU,CTKT;55>?XEML'\-XFW+N6@(MU(+7!G=(!N>?B"!1M-
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M9>$%_?(IH5K@M0?H'YV/HKY"/FR8KMILO?WAZ:D3WWG&W71'GK5?NO313^(
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M>_(GWHD)BF.L?D.:<]8RU02Q#Q!E(,:=?@FG?5MCM]Y0[EF[*3AHU_M\'"Y
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M0/OI[<U04PH-N' +WB!22@,>391!PZ&C3:?HSQ;2 %+[0?@@^\K<EXFL3&D
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MA%@*)8+"%LP;A"6=+F';+-N419U]KE.%"R#3"Y1S'WAT(LX<X#JEP63!C2]
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M.M6SL^W'/2A2T0ME'1K'];0M9]TG;<HF$>:>*AKLB];/XJ.2'\3L9.NGRM*
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MC@ZYE\&-O0,ZYBH@K4@O64S"*<;#,2$ -ZXXH)ZGRB_Z1M<=E2U>U_MR$?=
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M!14I'EY3[;4PV%%F0 HBH*O]Q4@/!BPAYI/L*;VDN_7GGJH'6>_L_52UTZ;
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M<Z9%YCR RAP@,2NPSK=%W->*8?.V^CY\;R%(@48,(KC K<*W%1C&&RC@D+E
M,<KF_V5MJ+E<,E;@0LSBU=AN-ZGYM%)!>P<N3"=3^-"AA/X_3AX#FC/5HN-6
M5=0FS7(JXQ2=ZHKO(;]?V/948E?1C>V::H#X9Y^)C\.R>VVF/X0V-3L$9(K&
M$Y7I&@WRHC3/9P6(:(*ZOG/>S,S'2_[+[\,]BK_\N7%-Y'4^%D5UB6+)Y;MF
M[,<W:J4ZZO9HOG'JNE-PZ[K@@*?LX^;O<16?"T;H*-+>><Z)&?DCNNH/_*JD
MDC]_2%NWJXBVL+BS<CGE9\0B.BT+$SDB[T0?"AK3ZM 7+1A@?>Q56K2OC/UI
MQ I1D,S&&%:\FX:'&*:-=,!=ES\2OJ&/O>H-]66N]TV$2B4QO(>5Z$,G7C)/
MSEC-SA,(D=5ZQT_,]%O!W9+>2[LFX$)0_78>*W;A3VM:12>-#O&;K/+>=8?"
MUEY<.WZG)PM=V$B>]A4C$\3-Q3?24Y/-RB3CRX<F5&*CMLPGP:=!D6D%HX[#
MOJM.!P;.%&$,SF_30%F<-;< ^PAC1;LX<'?,S C5,E@EVT U1>'>Q0?'A(-&
MZ3Q4FM_]MX2'OD5O@H@!_7SE(R2=(;S=;+4%03GR^#/U[+C7%_=)V'PNA'&D
M0O%LGM=<@!B.;7)N>'8>>=6JJ??"<]3/^25DT?3UI;E+1T0N7@]DQ4W2KY)U
M]"]D[/?8VC!K43?,4&B%Q7GTTT,LBWJ.:.ZY\S)^8VJK:P\0T'PNC4PB!T"Z
M\OL)#.0N(3=%;.?<+P9'3E7G-.OKEES.6;=@Q>/GSH&L#3"2D8$W=J*[- A0
M+ _I_1B[_90+W(\W*XAFZAL>2#D2Z]X1$/NT:^'9^,7<0S9WTXJ-S'M3*@CR
MLP%V_)&35277BN& T([XT@PM*>26B+SH?-QEI:&R#X?B5%%Y,E9#57)2R?(^
M13XK.4M=.OT:L]%4'UI  WJY'\9<48%\6!5%G3$ORF826A$4Y9OXKS;0]Q/-
M2ES!SPQK5>.X )V_FO>"S_WSA&U0YPH*;+/SAL0L3KC'4Q,O:N=X]0_7;(>/
M'??1IHFTB*L-$A.1=:JJQNB+*<\#7/!Q7[SV;#_TU*[8__OPJ\>^.80*?9M(
M>MGQQX$72SQ;AMUB\VH)DISN*BZ ?P8N9CFVT\(XQI"G*?SJ*(T/YMC2#A68
MN:3$ICDDSL[@7M0_CJF]6DA8.0*Z7>4"[:VD]8[7<N<7$;1E=?:*F^!1]!/V
MC;)E4@W>9H[\$V9"/V227+?AHR'I))ADOE8P4TO]@PM$HRRAZ>&L_&!2Y8=(
M;)7(R)+IDBGE,F&LO8=SW3&(ELLQ_H68?4\X3="G=W&! ZLDMK\$V2N5]>@H
M2&9;#3P!2=:K^A>WNM8]'RB0)E"RUHP^87M6<A]R@?&K[_\V]V1F$"$'JPR-
MGH]D>Z$GT)6!MAQF%!<09+5'41+(-JNW:L2MT)V14Z=D&,MK[1^^'^&(#+43
MW+T#??N1>]<".DPG/PSR+%T_NNS33PPS@$_"^NL\9"F^_C"A.7VT4V9@+\6V
M6XVO81M&S4DOYH]?N@'OX&Y/@H>"USV"U2Q=B:@ -E@_A\UERFF611D>^T6C
M-S>GKB_;#0_.R)Q_YI<3&J=<\1BW9/EC*KYGXTD-?"FRKA^,(JJST$74A42F
M\6V[R)AJQ.&"6T6_GO\QX4]L&CT*H*8Q]6H*#8;R5)/47#K^\M40APB#,MT'
MIA-1S[O5W6;I>8WS VT!.N]Z3/#MG]=8F&479^.+PZ8ZB+/I)X)E6K\G19^U
M U1>1?]N$^!D]C_<./30'53F0&Z<J>EW\7<&X?^Y=LQSYV.ODZ*OB@B:3+A0
MN9HG)O,!970^0E51< EFS%]PRPT*;#J9L_[!AKF$RY?=RO"T>1>ONU&'1Q;R
M=(XG$\/<ODQ=,?9V5*3'D=NW#_VTFW7<][ZS$(-V+M$*$)(]%RJ^N\WWTA*#
MN4?;66%?WFBTNZVO^H$A<:N3.Y[LE@7N>O42C]/GJ0F6G:Q3E5'5J2CZ_7PW
MJX_/CQW=U7]F>\L>?17"A\GVE!^ST0S\%;HL39.C/DS_>HYV*?IZJEBM\.KS
MJH'&H8L+GY1[7_7E2=$YB(0)K[(%0R*ZSTFHV7!'!75Q7H&:;%O1NVHQD#]]
M*]K==>%*P=B *+4YG2=C%;7VF&Z593\3G/MH5:_"#Y2<*1,[G7E*0/2F$6SF
MD[[(>/0:21)[N(:&CF?Q4517]R2A1?23VF5>-LS1YAFA.@0$;?W38I3,5-/I
M,3791EU]_R*3 \4?NN\,(XM%*0H[MB$+E,6[%4K32Z]*+.82< _S<Y7'RQ8)
MXR%E81Z+AUD:V;5OS#I'3#UD6N>"#HO?JI1I_GZCIJQK/JL[)YZR>D$@.\H_
M7\N;W^U'0?:B4J/$[6P)V3\<<WF&LPL#FCNKY25JDK14R('.V@>J6?X'KU%[
MCJJAD]0&.AQ^92$'+L89SBL$8$]7<FXD'-O/LF#TM8X,]">P.&U<(#0-/=]V
M!OPZQP76?Q(:2!3X!2Z0"1'Y??4EPZ]L5!X70* &0_^X&0,+ H^>C7UW+%L^
M!-5*^L?XM9'P@&-#@78Z2HG9H5.33LEHVWJLE\4C&H%?4$18::$_Q/YKZ[+&
MCI0KH3!WU1'[._['K8QQK[ =+5@H(B0:SK(G"%N;C$,6&]49NQ=(PW;4O7U+
MS=&P)9U(=@@Z/:$KT)W=B::P=P9WQC^1?_*4OF%8OCX2?@^L4_"@<P'=.7@\
MW1;R,7%EW9MG[LR8"-*X!>2'>$$%FD,S>XE _Q,E2W,0I9\YHLTYR/'["9VA
M.<9"">NIC$X*AK&+P@5JU5N.+:Y_05/0ST:S<J3EGSQ!45<3^A^V2ZQHU6,8
MNU>@CP<^58TM75&N!QGBQS=/US!"X+B[/0OVUA 111JZSE'O>&$,^;-NY<E(
MH7]X\+VZJ'+6-<A2*]+LV[Y(U!(8A5\RX )E"AOX-]019FH;)\S'Q/5'E@3#
MN/VM81Q5BQ5=B=GTE_8]8:,8AH3OR :%]*4LG]D,!:I$?QA+C)5(]X>S*;GY
MK+KJY3%35LP:%UC]@7K9EX&]#77!C7"J!*GE7SEG]I"HG#?S7Q C><$9\.Y.
MJJJ7,2@!*XI:1)^E(SG& Z*;,Q/=VO>A.HF[-R>OYY03E@A#^JK0G6V (AW.
MI='+E.JZ4>P8K4*8/KW\4ACK1QM8\Z9#U[;I6>4"D<&OHS!.%'OCHNZ)[N_L
MU]\,PS.O#\8/HG[DYF!S:,UCN0U7<$I?1V$1%VY_+%M+J9M<M^Y3$MA[;<66
M=\E=57%"O&>X,LC>GG&YI#_VW5P)JX<84&13/_*AJ2B394GW\7 5278:Q?#9
M22=M[*&!8,B!1*7E+L\@EOLO_*,3C@K=6 .#W' _/0\%VU3!LK(_@NHD#"X?
M.:G<I8]J&Q$BZK)LJ*1&A"A=@Y+*4MAX8GC@BG%$[LMSLC>+[C7*&8V%U1((
MY]R,M*4;W0^V\Q5T>; 6"8Q@:=,A_])W20Q?-B[ $$9;K,5$RIRO**:HSXM1
M?"CJJ[')@<ES1(AK;JE0=P;O0!5B^:G$_*QV3! Y(7H=O9,E?,0JJ_>FE,^9
M^MRGVK4*/XO1LKC.8<D**K(Y0<)-)C*,LY<>/7+YF>)'4'R8Y^Z]'3NE="ZX
MSQ-^*I^K["**37,!U^_'1446;_D64P<B2VM_78Q6(;HY,(/4:@[;7LXQO,K:
MR)@C^5IWJ@])?*8O4@S#J".6NJF/_%169@T&)+)GVGX!XVF6.>6=Q&9[XZ!Z
M;##U M6%=1!-?6P/WO#\N78/C&&6S^+=4@;&, ^/8(758[JN?C2$G;(M_'JW
M(-VC^>K/^=.NCFS>TM+*C'!C;WE>>O)+K%DG6()%Y)F^Z=_6W_KBXL;.((G>
MEU_"+G;91^G->4_](U^?_Q2Q9 TNP#;UR/\MM:K>3'XKVP4EL7!&W:Z[Q[S2
M"">R)-Y8'?X5VWQO;@OB+/#]5;%+M]/'"UT.BB>I57_NX/C=ZK>>*C22;@.N
MO(I6V9)T4YU?@C?YFO>/]AH+G3K45RX 8VF&YF*OTX,H6RAJ5B_+>Z^5R5SX
ML^"MR-1M9@.S$SD<&U(5.F%OPE3BC$W[5XKM?$?>0\TLLU.JNOQHY,#KA6UC
ML6ET]%H,J6N<_F*L"K_'+=7NYH9)JG!SQ(EO'6%'S+WO^>D ,+<(LPEZ.[OJ
M;6#$S/3D]VI-OJ$'S7K[HF\\KVX58;Q[:E&?,>#&UF3Y_I IJ<"A$0'4]3+#
MY?M?M7G';=.6"?=P^RIHR#JD@%M9H7-59=>8*R3?>7CQ7VHD*UWDS;6)$1?2
M\O@T^RZ\F=2.I:4E/=,:U.3#J[&LZ7ZO?H$EB/M84W?/^7?H88F4H)LN=>',
MMP)U"=<=]9C&,1B!P'S*N8R#U-6%G'=N<(Q6Y.J>=['Y(G4:4<&F8>U6:4R-
M)IBP6K4]!2_J[CUDP=NOWW0S3BI2N>A=PJ,1?B?Z\_SII9FTB95@M7P!Q0[R
M_AL5?CI7I_*DY>!\_+=SAEC)'X>#9<QS\^>('FA6>P+Q2'O>C/S^[L(#U#Z6
MDH\E^9'D!L7%5E<98.27[VHF2O$/$P?I.HIJU/:ZNF'JS,XXPYU'_KSV.7SO
MV!L(2J.8QW-C6*>]WKK**]90NX/C/O2[I?2VO"O[(_Z>RT*Z5Z)CQ2@7$+E"
MMSC95>+.I^KB)%B_T_,\,!,Z>]M5VM6=U(M<[2+@(D1./ G^B4M$XS*>![W@
M$[<Z5Y14^4K26\+4VNWMR,]8+I!]&O*%T2_'K$W#5[>*B#X)1GU#W$Y57D_H
M8_8P(B5HZ>7NNY$B;WR63=8GR^S]73J=@TZUNG[!LC[Z]T]U-7%:5\LC.4QQ
M/*88POM'X&(1^FC0$L3MII#4BI/'XI<[N,!B%EJ4"X@Y@BO;2%0$IWN-U.,,
M!5Y0E*[<?<%<?.2X\UZ7M^D]T:,<40U$1'K186S]9\UAU#S#T&#R3T'M/GE'
MWQ=E1;0_*V&7"+I:)/A[E!9-E&,L"X4I]^Q"=PJ,%1TPLM ;-,6*IB%&4\>_
MU(+5$-7O8K6_:':SZ;8>$^_J1E%?,N^.==8,D*'>1Z'%]9"%'1>IR1SC/:01
MS8V1",227BK]("-K0CN9W1:<5?HJ&K[QGE4];J@*MN #.$M]]U8(.'H6%(I#
M^YA?6;.?FL]R4+33'%-(;Q#<EQ,W,,)@I04+_6KGRNO.M+.L^S"'D/6ZHH3M
M SC$MRK!,:($V)+C0>]S0@\Z:$*S."C3%1BPZ$G$XE.PH:Y\))H++*DX@-6D
M;U6'QG!PL.6E%V<#"OD.EIN=T=#2MEWE,"Q8%LOZ.ZVG]G7ZY33Q@:(::R]S
M<T*%J0.<,VP$^PMC?(7PDB@+K3B7"U2@BP/MN8""'0EZ5 82:2Q+SJPH#1<[
M Z$YYR7BN#8R%K&D6L;VMZ-V.4[](Z3+\('*]&?0P!&F-R)O(T$8F@H[\DM-
MW)HGC96^D?5KD0=LR8>T=)\$Q[;FLB&D&1/_(;BJ/R0PI*Y#S '[#(N\01H^
M%$QJA;<;0DS14H/A E?#@^6"IIKP#*E,:$1=]9%CT.AMZBS$6SWOA/49Q]P8
MD2>1!2K39L%]M"O,?2(]*V7_(KIR#.#3: %HLBKH&@XH!FH!)P$2*6 =28,2
MF$4_SKY",!9'K;QD?(_,P8+,TU@Q-A[K07,4J Z@V,?!FW0?WM!^-U^:6NIZ
M[]<?U:(-?3_X<W @KM\0H&,PM*,$K#G-6%_.I[#N_= 562O]'''JKQ^MH%T3
MN!=1^ +QVA468;?"/G]ZU)+T"2'*Z:Q$1E8;9 9^0<A-]WVHW]/CY^3CL8M7
M)U5GW[A3?'7?K]ZBPI^W9;"IE4_'3YRPBJUI;+@OALNFH5_ >'"[;R-$B5J!
M4A:I%%1DZ?,]KU/63<LZ"^YW8V*:<"%1_->(I6O-\\)9L[A]=-2[RX&@<6<I
M^_S-K7#A6U82)>DKMPS@5SXWQ3HN;B#/9T1XK;_5^T4B<[C ;#<]8<SW$DZ4
MWD6)N^Q*$L$=&)B-VUN$%W.7-VZ\-_!)*%UB2G,5.6=/MB$CP]Z?9A->NV6$
MMB;/=4PM%W@$[&58E=VM@8]CQ'#?2%)8^[P7IBBZ%#6>LYIXH>W(VYSH-W7Q
M->&A64PX7>L25;UNX*K&96IO.%FOY&G4>RJKSMY9/C-^U??52\OF#BR!'12=
M-9F6VC[E-"@^+KA$BEO#[7K?58"]0ODSMM[(/ZU3[:<H7/BE/RBF\TEB)N8[
M*H7E3I?-QGIWS1TN#36U?A__96Q>[,1S[^L>8R^U9R^WG4A59VD]R_;H9J3U
MU6K90=^E^MEY[QXU!9I45'SFAA=ZJ"'[EJ;"ZV"<9MQ="/ %$%''FXROBG(D
MG1_MO*=?>(TO0M?I+KJ)^)@+1-A]+\1**T=J"H>@N[O/EYU8[PN86S_QK6:'
M9Y"#[0\(@9 "QM1O8[6Q?1_L!QUB?FI*IC__6,XKIO6L+W#?-:;5GB6]QML%
MSA-ME@/C+S'E;;EP="AFV0;%G,2W3'"VFJXAXT8DYSV<S-Y)+FT3V%,7>31V
M91IM:KK.WUF]2#:MDU,@GTCU<7W=%A#J$Z#^PB\45$T)B5R]9>#>(;40W7'D
M<I-!TNF:@53_?PL@)R&O_G^]28BWHO:TM/D0#](6PD9[/UJZVY5T.4X:1XMG
M7) Q=0JWE3MO+KZEJ\,A-Q9WX+;\EJY,(FU;L7NV_5FR0A*95I-P33>MC9;;
M!/*S]#Z\KZ1)/?(X7J[>(ME^%%'=?@X0:*Z!$[HF^4.,K3K]]FB&:!/47"R>
M7WFL[]WD_2[WL5%^]YKPJI'5>3.KL'@W.Y,MD<>W+$O-:Y'9UNU-CKPT<4?E
M[K%2#US3=U<Q;0NL]+;).]X-3)HCBNDX6S2 O='M4?I,T_W7#>I*@,QA70W#
MXTR29IBE5PGK+<YA-[XRD/#6\!A+LX(>R1^1TCD#1\X5W!JP?MR2O6@VXF45
M/UD]1FG^!$K-DG;ZC>P,M+C4=2VR(?BFW?D\D5PAL^MQ0A2S1PKI.GOTO1R^
MJ1D?[+0&L;OLN$ ,X;3]Z\4)6!T*C#R?*TO3^V3E1A*9QUX?P^QJ"\5X9)G*
MXUVNZS794>,5^<R&S9LE5F"?RC6K,.$9,@D-UL?[/WU &HPLNNQU&=E#$*.5
MS2W2A.9Q@I'UNL28@%>!GD.7] S<5/>::W.!E(>JP%AIJ.QH3N_8]P*I!DL7
MI4(%+F#FS@<7T!F[K9@V>VF]_V=-=>$J8V3A@TZ2>Z)A#)C4-8$A3ITV%K^8
MMN.)<^ J08.>3ZU;;.[O>ZCN44@NO;K;QF):TEBQ)9^E("<<?.?AH5V#6[K3
M"H\4<(&I:E/.-KC.^:.NG_O[V8W9_:X@2C]F++5.&$GI3O-[(I5F&_%$0*JX
M_:92%3QQJ6%JP>6E9F/@V)HG;5^OIPO5L#AW.LT_-U<I]4TM**2WO=L)ZXP<
M;BX(55[+OP-Y\AC.AGC$9-^>Y1M0)&Z\F6/JZ;R^WK4@!P45PK-(*A>HZ^4(
M4#,2,^TJDD;.?[3P\_[#GJ? MV>'Z.[DB<J/B$H?&Q024>*)JFE]<G%7]"\)
MB=:.@4]+9VL5K%*<O@NF%+&@Z'"@"0J"#C &ZLBAXGKRS*6S"ZJD"H?^)P8Y
M9K6KKCNXP,,RD\4W UQ@Q!>L0[URXIR2'%D?P@Z:-]N8)\^X,]HY!S[J<>Z_
M7"]>$5UU3&"QP/LKB33/F%CP]N8@VQ!D]YU539?29\JVVH<CM367MQT=["O&
MBD^=J8%,K&>@>JDD^1O%K"_:,B5.XET!EB/&/E]:/^@&[M4KD"XK^M5M98SK
MQ 9%CGEBU=Y T50!K96X++-QNHFT!)]!K+;TM<WI(.PXSC0;CHDV2,6]8\,B
M$/=M^E:V;E,ML8YFF3%/#QJ*@"T?('G<W1?B *L=84BB.95IBW"FRT-PW!@*
MG%L1TFW@R-N-<!]P)VG<FL@%_"O/3G+V0P$T)Y0S'WSE[\ST#2O%;$/0U%L9
M/]+3^#NC-=!U+O-U&4\7-AWHN%4,>]E1V''Y/WAIZM_S$B3C6_!^$##=EW]0
MPZ0DL*+ZT(MJ@0+3Z"\<%;!E$K8ZC_-&6)()Z^9@%,<,R-KZ_/RG54)S>Z'!
M(MG1]*$'\765S!A'$FS)^BL#PDSX+W,>?\]R]#D[8!I!AO@1Q#!ZRB(*ZAH#
M=27M^TH:406C<"X/$JK,=*WCG_1SY!!N<O'P7\B(3=9RY0(+J/:K)O!?F'^<
MSPU+0LOO+:/#.$\2XBF8]<M@S(H+$D**53%&7MWO3(<E:?9#7X0OP9L.N>,#
MS\$^9X+()\*$Z&[$> @7\#1=15B12>OJS]F\C0<1QY\;X\Z%6JT$W ?'+W:!
MLQ#F'1I^!_MG@D(/ZYBR8B# &4T83Z@O0B]*&* G):;P,N"X8]DF)-6(5"^/
M(5DQO;_S()%-Z*5]C5P@<M74TXK#MNBF.7;CQ#.]S (U61=Q+2H2*X1_)2:Y
M_TQ,&?^&F%!UI!+1VI&8/O1>/PB? T^3FR-8F.P9?Z%;!_LPUTZ+%C;B3'N)
MTYI+D4V(:$0)*@+KG)<;CN7)'*';;=TA$\?)?)^R9_QCH$1LM\-3%A>0N.4J
M.=>7.[I 4OA,<L+_Y *4]MH$J>D.=_QV[,'7EZL_&"P^&NM^55[C,'7[@L ^
M7YBZVT;QVE-J@Z$ZW;C0M?B'>UJZ][XV0J32$@:&'[USU[W)4 3W'2:K?X6V
M^VPGRY;<OOW'KZYB@===I6\*E1U4%=Q4/Q/<V=FE!4@C^D$*<_[@9,R%^":D
MZOR39UN:;9MU\AL^3CM>19RZ;70H&I['((V1[DOBQ/N<B[LX>UC^O7-68L0A
M]X))@];,I]^^95+=%S$_!D[K\M<.Z*$@MQ15?4*_][HSI8(U6[M@SW. I'W\
MA<^G=K^L'V[]?8UZ)-$A.]FX6S_;.M1"8_-.QX9_UD?]0LSM+W23Z?LT"Y:U
MO;$4E[*NO[WQJCS]D^SX4%625WQIA]";SZ#] $?VJXUR/G*CGPM0V1F171;K
MQL?/W)NZW::#^Y7S+F;/#1O6@;!=&:_PQH#&5X>IO5V_7MW3^>>4NNT7/$,5
ML0XIK9_Y;W]O.?Q?;ZKQ9@KBP.?L0Y]XHL-?^TGSX@NPTTS[R_2D1GVM@FD.
MG-1U1Z''XUKHB>\/KY29;1FN3SK:7X'I3Z:<S\XPH/8](,=<Q5LP>=Q05'HP
M\A#%UN:>T*H@H#S\P:8#;>FQ#A]9D+V$Z>0"<07K>+MG+2<'9NP#CF0G5PT3
MC6CG"==I50T(47V-W)G^G-SP(R45B\YF1S)D(P.;>J[(F=TPFFUW6T7\8#:L
M<Q3IYVVL*E/60K4N5';U4OP'%Q+/VEKL[A[;VUN$(CWEC#- #2W%"BP7T$,O
M&31!QA6].P:?'.E?_]0OW@]&ZALK/=^1UFW7^.3HL/;!,;2.M]1[%GQ:_U:%
M^B,N('I\Y-'&U9R(UYW9)]:MKKX,__B"]MZY_:.QA>.*W:\N9AIIU-K?,L 2
MQ_\%+SN/M:?@^R/@H7S'S6WJ<>)73?:4TF/?1P8I#CN=-Z'L/#+6)7&Z$;>_
MN]K4)Y-E2:1Z3#TJL8#$^]=K:_Z2K_R*RZ<.&S'S.#VA$C2G-5P'467FA$QV
M6D36JYF4[YK/'5U]&$C-JKTE1[R^K++:+M/X/Q4(.5(]D\G.E=W'VW9].A2:
MUC3:.)4)\S^ELV_]7=#!.4;P$.0 OJ% W]2V4(I[OX_O!Y;X'>+*2&L3.W:R
M!K\60JT:,:&V.H46D6PMYTMP6VN('ZIULJ[008N/77?VV;O#+S=8G0G;<M%7
M(O_J4\5<+47G[>6-2N)]VM+SY]_V1S6&U_+SF@PFY%S7\3;^6O0*Y;IK5'LJ
ML=N:X1[KL8?PS+E/4PR>,"^4R2.?K$7O,JG(<^&<DD*O,TA-) $<G-Q5UG/P
M;SGX$3;JS>I:/A1E'H2><+J@S9.V\QH-#6E"CQG$RLY*+D":YVC.@'R+1]35
M_'9[Z1<__AJFD-*,MEM?@NU4F:H(U^?]8T$$U?/9(#G$OF6T^:9-[86G 59Z
M]KG/IGVA^%J"+<)31([K+6D?X.<"WRVQ7Z?,\:MQ7"!49L,=/76Z&S$;Q@5^
M*1%O&"![2>E8E,>-NRF<*[C;;*'POH69C9?#OO@13&MG5#87R/@]S%F";JJQ
M$%J3.(?G$_ XQ"J6-+RQ:MA4HU3=-YKX[>D;L,^88U)SB%0<N'\D\CTQ@0N<
M=1ECM#/9:'0'GQ.]GF,<A^24(Y8*HIMID:P8&3S[+CB!MGP&EO=M1BVEH!_@
MV.D>G$M;8$O6GAPY5=D<D!=?(=!9@Q_%L^XM@K/O.;:4U7D8+W2+^:%X<S5R
MB="M#T%BT@,\W9D!TVI +.Q:13_;Q O0 ?;D3QRDD!+15E T,"%Z(@+[.@TW
M7[#_ZP5,M3LCM1')V ,YD=J-XA6<%(</B?YN#2&&35$C3C'TY3P7X$>,7P$W
M9MQK"H5&%UDQZM!5+0-*V<5UB*4#=>!]6.PD:;$G]%0%Z5&8X:[_#F/TIWHH
M_>':1 J79MY]N -5Q5*$EF2BOMX6J*.Y"-L.F6:5P%XC]+*.0J\/DFK5VV"J
M#?@%]QZY G$K=$_DQ-1^F@7G#).P&?[O]9&PUC":Z54N4%TZ>GD;*47_ C2L
M#4%5_V8Z7:W)F5:G(3X+OTHW/D&"_:ZNH)=4!G":/_KDJ/D<8UE,4Y4,AT(F
M,'9?1]3"6E@HZ*+8?(XR(]R+) $MY4(Y%P@"7_C;-K%0T+RGQM@3'-_RYYPS
MY22JQ=*.*O92*CUU,E!EVFBO]?UH85 $7RH\C3[%TH(ZGT9R 6]B\#?W?X$,
MSK^%# $(,K";D&$&P0'$%7*6(:E-,(;X *=*+= ?SD TM#/D-[,Y;&1W((;]
M=9(+&#W9<)9@&">\-7S\N[@2\+?BROU1'RX@7OC\=\R_Q 8#G6%+1R!@>8!(
M0H@T@M475\$_4?]445G176Z/@RVI0VC;=]T1)@VVA$EQ8#UR%:;,576;QND_
M5%WU)DG1"3_YY+S09P/_45]QWYNV85,'+AWY 6[B##,W'+%8CJ<26NGQRAP)
MQ"7W#F,)M@K.?S]!D%V DY]%[,9)('-N?SI;1]'Q5),9:Y':&<%X3#0Y!A]"
MGF5\7>O\OJCO3@4O=*ZXY]L_?Z0<[5ZCMBKFO%8>=K/.F5=\$"[S<0*U0-*D
M!VCFDD88L.,L47:ROC%U8.WQ]]<?J):E$8FY@T@L]I3?_GUI_<9Z!\0\OUU,
M=^DGG?&<>"#KJEAYNT$PYT4V,S- V2!_E!1NM_B(J,[RIP?EU8^&8"(E.9*E
MR<@TD&X>/CMLSZ>GUJ @>T_'HUDYHW25,"^0Z6ZH0M>B%,#KJ>PL5.6'P-%'
M9@K##;Z#9CR&KTO?3@@*%'B$!,UF,0BS^5^2;/(*4TM95>QO7 #N\6%YR&:M
MC\Z3-;MT>]WP:$=CI]D-?[,RDX+TG0X[!-?1HC,;CC4Y]NCIW0-#KGTJBA$A
M#N)^!ML/D'19!LJ-!/[ K>UGGZ]=I(<8/L, I2F<V4M%K6VQ&AJ/O1N6>XFY
M[&C]_10,'U;Z07W#AH.=VN>*E-O'Z4>L*2H';GUYI;MKNW2^N9W=\% (B[3+
MWK/=?84+A#'PQH0A\9*8=6,U<Z._"A#\A\#Q_U2U5^ ,(O[ZH8+34>G)>S!C
M37.%-+^_]MO:>AYYR!>C;2PW</^DY)MWLP5V0GI>^NL7ZD59*XEUA$E7V)6R
M^.]7#;JM!IP,W;4%$@AG4=(YQI<^5EF42UYV-G>Z_OB7$?\OM[KTZ!N;OY80
M7#YG146<=6L=:@O$S[MC*'_B]@Z[9<!HX2/AY/="AVF7!TPZA["?^);W[HII
MUS-!OGG+!:0-E=SDQ>@ZN4;9K>V44+NV_27>YM<FMMU4)LBY\UMW)'_L#QXL
ME?U\A!TJZKT\Z&V7&V]R2*-O&KW5O;\Y6A/YL[W6OS\BA\(^'U0J>?7L8KV6
MS<&51P(M5\3NPZ(:0]68AX;HGHOD5Z+";ARE'H^Q%YW7*0/-%:0')W&WA_")
M"6=_G5UP1%,U6>?2B3 $'9("9CK0!]N9DFCD>(66L/:0.E4;='A_K^0296:U
MY\"#;T/9"HK"K2?K8C->UYRO-EVKAARRH#=]?!O3LDR94UEPYOFE,C]ZE4@?
MLN-%>QQ'R14ORN(/H+1=LI%\@>'/^,2F''W,7Q,T6<JTG4[!"5%[2W-^V654
MO0D,M_AQ>^T^=OW"L5;ONX#$!*DT(H\";U.OWSB#$^YAG29KERS[!2BE'=B?
M([ 4,5P_(>?^G!J/+W"#"6!Y:*(F#YKK*W,C>F\;?J9$53\/(GL].&UBS^NW
MUR<Z57FQ)LE]H0>GII[RBO0IJ2=W_2?B*^W[QCH9V5"C16D.\] W>IW]WO3H
MS:1^LO]7WNB[+6-%O&)7X[#+3#'7RA*80.&JFD-3UTQ_P=#&<97/LO O9H?>
MF0N&H+[W5#\M^$5$V1%2&HP^OF"27F0D3)5;[Q2ULW/?>S$E*+4Y(6)]9%>U
MWFO7#2QUX"LFSWY8X]QYP:R;\7I]^VEA9-,83=$]TT1UZL4T<*W57SAGT"@O
MY7*_$F??17D3I,2BLA-[3L;!--8KX>SG-S7ZB^OYB/I3!,*7$2BH:TRX(EQ@
M4H%P"RHNCRP[K[O<T'_&IMY/@G;S@=?1@]23BM<R#)_.@<5<H%Z:(XXU"#.M
M+H^?O9 4Y+F0$[,@?=-[ONS'[N@5Z\03&O&Z/N>OYJ^#,AWF\ $"RX#(-O.R
MS!W8*-]0Y5,[&ONTX?;E=)7QY,MM8\+\BH8%M[>/AOU!*2G=_QR2LK(,5*L4
M2%O58DXQ^B8=G!L#XV5\;07=L.O#;+6![HUS6? (I_9VI0J/HA4,2\D0Q@4R
M2_%LCGAD(P>FP#GUT873'\VHMHIF#7 .?$1LIBY:-M17'2-_IRXF4PM<^[-T
M?PS5>Z-2EM)/&)9F.9I3]3B&FHAUU$9?0=_\H.;S[O9CE8$;15;>Q!@/V:NA
MHC&M=XMJ;SB?.C)MOR1(>,,%FL/;V3Z8B4N'B%E<0%X*L=I&>AHJ@2%_[4C?
M24]<FB/-0KXC$)+MGL:'1V;Q[+%SA%$!]2!\E=KC"LU9$@\7&.N"7$H0(I&P
MGW"5+@=-DH9G3K/B<)$0@;">7 :9$-28N]S'0R&2"*JWR6=!<7%-C*&ZR7$&
MIR%TXCQPGU3H[NLB[N,"CR5?;N9XH"BHN2PVB_XF#X<@X#JB'@*&EW=)U)F-
MS%?Q*]FHT>;!C$:J!<<("N"K'6 BX2Q!DPXAZ+Y\+K#QB]32EX-: WG!SP;A
M*^"&#4+^&S@RLT'X_.]Y#?D/7BO_B]=<<J17,]G]YWP)H\GK^\_#?Q(W1;?@
M,J<R8<+QV$G"+;HR=$&]]HTYQ%/<2W(SZXDX]#RIMS"($"G=37W+:C?9S*&,
MLK+K:66LZ/X$MK?F<DCH&-HLL(]C'&K*J9!A5%0XH5N)A\"69E&.: \^ZVXS
M]5 PYX'-_<PM],Y1%.4<TV: (P)=]F\YH:#_:4X(PIM_DQ1"_VM2:#+50%4W
MS1]./\<N/[4-/L01@WIGP9CSCKN"4558A4U^0ZSWDQRHS1Q3[\U/YC@V=Q=8
M0;CH7P*!Z"58:GI"(XRQNW!S"\R^HXZ,W_Q&6D^IWIX!9Z ;11E[ZSDUA'\"
M-J%T:YESDZG;?C,;"6(V5?O-2IK,[TI:EL<JQ&_K,&&P)56 LYUC2JE(8$Z@
M:7\4:E%(K&@IV*+Z<N&7?ZZJI>Z&NDIQ!'!&J2#1^G=U<)N<BH%JEG:FS&9B
M:*OV.N$E[C]*9P:)P\1P.H8+'(C <R9P;60,*\X=#-O,[S1[:3'?(1HW-'(W
M[]<C5C<9]P?8\GID]:=[_;%0]T'.W\_J9O\K7CN9LV?1Y&AO$DEU<+.6QON/
M3-#W2Z+W(UG6?]\>PQYY K94B4+6F;'T)#@TF__8NS@+;LS!O\^VXXZ#+:3?
M1;5 K#.TU!UH.GC1?P*VV%V#E!2W\7:MSP$E\!^ V7\!-C=8,/$I%<^*^0A;
M;02?XB;(2.:",@N^;*@<C0A#]J2M0#?L+/[%]F!4+1?X2*<NAI5*OWQ.?IU'
M*:*H[M=:O_1!.S;\#A\#*8P.E'^ZW#Z?B_'PHGK..=13?F;M?MG\(',W.@Q/
M=I"'"[X=_##7-U54:IA?:6C#3L<JD+-H575]CJ+T@P7T\Q:NBNYM%JC*Q]E>
M<]K] K4ZA'+2[:L:EWMQ(H%OV^N7C@>7?#R_7V7@<KHO?Y$F56NN/7>V# '#
M[E>/G"-JF+\^K5B01XJ?KXXYDW"]WZA_BT[[-M))CO;7E[74X@8,Q6+VA?H9
MR7C/PKGER:8_QPNWZ!1X':*'!"^R[[@8]7]8*EN=P6XA@X)@W1"U]WEV8'*]
M;F\4=;$V99=E2$Z;[Z4Q&Z+""]*)RRY*Q$IV%$OO72!ZM*:46( )<.8MVV7A
MY!+<F/-@$)^X)V,451M%0?\\G&Y*"VN.V\\,6^<"(66L8D(U%[AAB7;HQ0G:
M(=^U@0%NRHF^LP56@H.6;J(+/^]+C]\HC>AR]2>YCRS/52K>Z$FWY0+MF*\A
MQ(*94$F2;RC\$?TE#6U,MR0S-$.]7:V'S 4?F]P,V.<"",YW7S>^"Y.>OX$G
MYT;%)IK,?=20.%S1_"6HT*WS[NL)^4AC[3Q+XU6=14E<1[]6.%'2E:A[ M6W
M)A-FDK*6TK)C22-=A:<WSXAI^5.]OHH@,9,AV[OR1ZJYR[;GH=L&GC^SE[65
M(IHW!ITO((^(!%:MN=-]L@,3&LIP$M$A,3X8T*TZ*LS9A++=(6.RW!QKD6?D
M5FE"(%A2//CK</I=HY$.5=<:7P5^;HC_0Z3WD,8"/"C[[=DTT/7@=!LO![=N
MDY8^F%>'*<;T=H(!E:$^U*RQ@PF-]K)]9265G8MSSDN>*\P>H</JL?=,.VLD
MSE^4852-[OB:AW6G%X>Z'D+FEHX?C7+2.44YFBX?04Q$5ZHJM^WY6HFD:KIU
M>M7,?;O\;W]LR]/,!5P1NP)'ZKB J*:P36WJB4L^5QJZ')#^SUM.:H3+E[;1
MJQIP6C31.KS \'3PG Q0%:U3&NIF[% K/YB424M;0<1M0+HP"B=)QUMT>;0-
ML7N>-^\0_"1U0UM:47 9+VY'[ZLC">BKNEP?7:%=W'GRL;NNP%'&DFD9KVG%
M@UVB>>_22ER&:65C= \O4KQ< 9P#BU_[PU#2G:A/_TQMM[%'[[7(_IH]DS1P
MFC#P*6'MQT[1Y[Q.-(D.W->TJ5C-%I:Y(8D2Q++(-0KN[45IU#VZK+[#Y+MV
MFS=)N%IT#+,5*TI[_YXZV.__\MVPA>%3\FJ*P9I5.0]O1+^H]4FEFH'1J7M.
M]"#JHFG'QX22T]M=!YB=&9<Y-WOSS;4F8#4Y8&7_@$6Q0:<C9L%R8)&883;_
M."DSS6_?'O$220DRK!22#0BR$OUTP; <ZD(7%RA6&YZP;O+9^33RY+BW:6E(
MC=>(.&L?QY"J5$'NKK!7ZO: OIA7:S4&XU?#;U?4YE04*#WI.]$<15^OE917
MINN0Y9!V,1=ZCP]IG8]'=<PMM?D.;!,2H1,$/U1R.NC(T=4^EPH,S\>:8S.2
MC<]/?(="B_788_Z<4-,Q6-BP2B5U/4*!2HCN,^U9L? K4]-7.UCZ9;YV^'XD
MN>TTF7 _F/00)S$C#^OR^VK2MRH;48FWKBQ>WK_K*".Z,2/CF:8W_:VYFKIO
MU2S8&-ITU'%.H;B4,&!"$FV80CB)BM7GW997ZBKY_/JY4=>JSH&N?H=TXPR@
M_3KZ;%. VEW$-HZX'4N9^J;+J=+CU,(5F9#\YI,15V23_..!M4+V195/!3D=
MCFOFH2U6,_/N98SX5]$0S#ZY"Y-ER0;1>,B]Q9G3K5%! 3+O;IT.;[D6Q,H/
MI^.9QUP1DL=#I9B7UJV*NU>JCO*JYPZ5*/@/[AW[Z#[4>I:5F(96#85K;:]B
M0/B RUG6Q*CWCHQC\T;!>QGZ=#7J^KFPNC3"@)^>185R1AV'G %_XE2W8 #O
M!EW B&!2/5OH<F7?L.C\"\R%9*N*B!^3VL\2AF!G5[,$Q1YH9S=I\T1WKGDB
M"_%JB,_2W@6[5EE<H"U!O*0G]\*%2[BR3%>.P@=W@_.=\(%+^V-M5)P5]X8E
M%%SU_R%@4$% D.CU+M=#-*NNG&O;+:$H]@W>T+J<O@VYIQUF963A/I+[RN66
MK !:LO^E[(^%6UUJGH?3.LULYY_I%XO!5!V<]KRS'XDTE.DNT?9UKY'\-F81
M'G8P.Y%'YK&W"/P9%PC_Z<0%##6XP,BI!/K5%,3R&(*] H="U%5Z$!=HM6;F
M<$P#UDX8@%]SZ>"S7RG^=UW7.@8&SCPVVB.8V/3'6_YKA]S&L:HTP9'&@"3[
M>HSB02FO(T:%);Z$-Y]N:3MT1C>0E=OY^QPS<I^A16V$$2Z73H2&ORD$N\U"
MPC75C'T@5%WB I7@TP D^9;5$$S;+8V3G?;T2\$*^4PLL$M>Y^T(]?$,N,P%
MO+@ *&P,J=(6ZT5.I=;RV\@"D)_B5?[4T=4V93%_<08W<C[.T(R9[]D4R5+4
MQ4,?\2 X4N\81_6QJB15$Z6D=IT#]H@T4*JS=_3E8B'42AC@ NO&H0F\E"()
M#=9Q%ZO2@"KP2[N";L[V43=-<:+C[=6Y&RG1<.9VUI/\/+ YO)D9":D)+9"V
M_EM-=/7C61 "D#FVR\)]K%!+#H/CQUJFD!HA'BPCG5XLMW<CJ7?'3)NXJKHS
M5IA=W3A^L+DIES/#!>Q6ORPA[H_0:'F0\:3>&F_2^VI#+I#D'_F.M/(:9XX'
M6^IRORX9V9:JTZGE7*#0@Q5WY>U& BO0 <*:$QS;#;Y->9 A;JB(K=#:F(+D
M0=<A<U*?.8?&\:U?A>0!]AS[YYU[?I <@/TE!]CN+??:@A<_<0'Z2C<7&$:.
MNZ\@1"%8S8*\^,#(AH7^#B[ ,5YFX&ZO"JJ\(KU/^'R."^P$6X0N0 N .F:F
M,6)J0@T(T"V </@OT;![/:&7E*X/:8# .C "G88X10;)/:NG1JTSG@RF::##
M8-XAL%J%%X>@$96$)<UIVTD2+VE< H0>,11#9N4MIWTT@:'\/N-O2=V?_[.D
M[G\A$JY08COB5>%T55B%4+)C.Q7).1E 6OT!'J(%KR4\ )=X_BH=3W/V@I^-
MD*QCK(3G%-BZ0#"A=<4-,K10],LY! 2I!7\5C%TF$78;IDTC2W"WWQ7CYD58
M 7B,#MTJA;T(.N(2+JX>]BEO=F,;J.O0Y3I2CWZ$=PL!:[]AC_U5-):J;?]+
M(+@SW1^2_I- 0&\*!)O? L%N<E.GM.2&; J$Q7\2"#V_!<*4N)6E$NEA^T#X
M-]V^*M;?]4#UWI6VD.8Z)$/\!A? ]LUF[('F6("&3B8\H2#7-6?B>Z-5"#/U
M2\N/Z3F;>^M&F%\=^1YL[I>'_=XOCYYRY($$@M/_(!!PCQRVG!5QS=SHO(].
M@#F$3-61&.*;M6/!OPN$3;' &?L?\KI*$O^4Q_UO;)??\VDRF5_<CT#N6GL9
M@OI.$MY,"4-Q;Y"042FX(46&Y(8,R'S*U HG+9THX/!S@1R%L?+G[%X8A2W=
MM9G\/(-SNTO:@QBWP6S,E9+_;+9;5X^%+:GB-\]>DY)9T*.;N,BN@'6S32.@
M>8F8E1V3]S1,^OUP%T*M5C#W_P_6WCP>JC;\'Y]2:9]*6BA3*9*B0F2;RA,B
MIJBF*-..5"I$&DX;2B2$4IJ$)#%M4L1DKZS9II"Q[\R,;;8SQ_<^0QD]/<_G
M^?Q^GS^>YS6G%S7W.?=]O=_OZWI?UZ$U[?X_J1Q[_:URO/^LH?G*:&I#UN!F
MH_WTTEHQEWRXD17?6BRM&^9%&DGK/ER)S/B5UG5>2L4(7R62+>=GI);5[]/0
M6B&E6+W\ZTS5>0S\QIO"YT1:. M7C;-B[_%B>78P,Y_PE;+9-]_W?_J0?S>!
M0^ZZ6=/P(H%%IK?2\VF!":HW^=V\P3Y]"V$0LH0;GVVCQH*\/^CA_/UOA3PC
MU9P(2U\V9[G3OD^2=UZ=UG*=<+:]*IW##:P34&3=CK>:OJSH4==)'A>5FCSN
M1=9KI0GK^5=)R\G:W,Z+;.5&QRR!(X8R)_V>_?%!SR4!N\K"I[GNECQ9D(VM
MG=>0WC9;1<VW_<&NNN ^>#&U_8F/[N)HQD!"-:&H&WY.ONI15UPEGY5,.EZF
MJ\J*SZ[\<B;<:^!.Z"N*X5&C#/QVXE-X/<LV9^' _5.D/&3E"V\=YV5XK-OI
MFHSC4WJZ"@JX75-R+MI[[3VGI%]PKVACG!7 *Y)KG241H3W1TV][EA(:;!__
MG6!_8?S^:O.8%;Z;0UST-LN%G)P^U<J,9*CW=N,I8KV/EPMM\A F4]7CT;>:
MMG&Z+V,_3[U[A3\Q=Z+%*^Z:.G_\QU(W;4:6]DF;A;=G\0\FDU;TE8?D*=:F
MGEAY@D,[ &?8.SA_:X&E6:U9T,PWQOT!,]H&4S8\\%DVS3A3Q<-<.[SMX\><
M-=)FR?%SMIT49\SB;C,+^^G^C_=LE%>XL^7!61O51H*L@[;M]9[N[IZ"LTOK
M'>8C\U1H0QA\-X_8M)<VYU6!W+(G<LY/:F3-*]NZ:_@I^W5N))AKR*\X3BWG
M3\^.?79U$\]<FUA,8;UT&<( .N/X)07O4[NV(@F:G>?HXESZU^85#MLEK_-.
M'_*-O19K<L+27KFJ"OY,S>+ZSHW98[''1$@X++DL%.TYK"2$RA T]IBFFC7;
MV&7-?/1"VM[GBT,K7L9L)5N/.V>MW*'&LU2OAJ(583,.M=-WO>=%)%QTIAV_
MN,]F_VN9(!_--2'%CSSIQRA<;@ BF/ND]],0)M^-AMJ9/1Z3>  &.5^C!7_1
M^BI$=N:[0YALM'EHTTT0+8<PESQ4^<]IK<QZ$.SYWLK5%V2/6D11MAX\\9$Z
MDVND_+GA\,+O/J%NBAH]2P[3K.K]!M@S)3L3*0H)5ISJ'GWB>H!SMO1!77II
M0]ER04)_K.C_U(2+<CO[!M,:"D_/.-ZK-6"=[7]LZ6[;@QBXPP=6"&<-8>[F
M,)$)FMP*: X(JNX")"6Y[WD-G56IHY;W?/>N^**:4@&!%B<XL$A#TF1-QLD4
M^8/<8AN C84<(;C7[,3B>M)U#3U"MJIT2Z23TP*_B* O>VW9&BV7CJ<67\V2
M4X#X30X_ZO?GR1)U,C-C[-6;$A_<)]W+"C_4EC5Q=^X4G?-&[] @$.3YUWK2
M.\^0/OP-?!,>*H;?.K:2MIMRL*7IMFQ5V(<YA.E\#6G#\CF.G/VJ7$J3!VW:
M$&9>[&,UG];-DVY+F"CSW@EG]:M>7=09)H_<H[^AFK"AJ[H.KOB! N*;J<@[
M5B/R%P"BN32UWH< @Z"PQS#@982>Y4,8Y_(DZ4_";$H/I9GTI+C.TZ?(R)G\
M.1X2$:_DOF='CR=TT'JE4D P3( [[G62/KI1T"90VYX[Z9/Y2R3"^YE7\&P!
MA+11U^D2 =7"MX/ V>,K0%W-03[3.M!)06X\AL"+ ""+]!@PK+7PM7CPZ/,
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MT&;KEW!P5VF]JVE"%XU:XD26:\!TT4?Z(!V@^*>;4Y )GFKA0QC:[H&IOTB
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M%*%8&CJPS^C&S)^HM_ES D[,3E8R Y)HP3%=H!R Z"D[D+EZ\YM4+B1VUH$
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M'@!$.MI$/NV!G\7LRT96^\_ZPG\)#*H1L>'C\T>]UJ3J_> 6+UNMR)W-+7)
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M>"/@]5AVSD1<NU#NV29/2=Y E718<<.&I<1)>X+I_N)])W\*F8W7\ !+,KI
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M$+7^9/F6V8WU9K@>.S"J";1&P\^?^]>U0":Q;>-V33\",_8C,)&SMG2+[N5
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M&XUKJ*J&Q@0=KGAI'J]SU+K$'\J$Z[QK@E=^7#.LPV]R:BP9L(W/-D&WQ-=
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MNA[K=>>;8*&=\1BHPY6=JU ^/G-W^>!,W7 G1X66.?@79$NO%,&-L((SC7Y
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ME<6Q[_(I6T]_Z#=+?]$&/ )0[&*XT<(W;D?K0;S04IXAQ^U10[DW=?<XOT7
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M,V1:PW5^S6O-PI"#>HU#>+;CHL%2HS[&8?ZV8]@=;.G$C^9*C)95FZ>"4FT
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M<>O9C.J/4-Z<K5[N0$75WYKTCFX6#[(,"\1(%RNX9PFIWZW[]"CH4&Q.'^&
M:2S9OX;*79Y7WL^9@T2*".,=\E<[K6\W#\M>GWR7-/S\5NN\YKU[<#B8ZY!
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MO4D E9>"?SU.!L;N47 6,_:MGC*&XT=2B &FRQ 3.5M2,K:0.,M'DB1=)QS
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MN,^L3GN/JUX$]C$L^*AY]A D]+.S8 *. OYJF%R;*Q]&)7F1<KTR>GN>8M.
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MX0;P/>$4/I"IK"R=)!;D*4+Z)F+OZ54P5VC=6DN/$J\)(%X?O55T_/54GLA
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M?]_W?#@?SCF;>W+MM?4W]\[NS.PU]_7OZQ7 '0T5=14 'CX @'?S US/ Y0
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M&]E'TG9?:"=1A3GYJZ7D\B 6RXPI:3GQN[A=W2+9/X!F%=AO$"F(>'"0/D4
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M,5#<VVI+"46H\""N/6^ZNW:/+&2$25HAX=2N5R34DNH:<.-EJZ",0YNMK?-
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M7K5U%_4XOY11ZL_>X0TRKWU]))='$,'*)/!%,*8'EQE^VM=)=<>!(9 5\SH
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M5,?WU[V/&LM$!^QFSDIXC9WZE1#(,3@1?!,W:<4L+^JX6!IAW%[--AL@;0?
M-,_G<U$UI58/WU!GL;2_(X_^DB\@U7-6<K,B$-I3>>$9^+)>:*_+O.E"V,MF
MDK=6SUA=TJQ112&R!=7?WL'*$IK/?;&#T6S:4CH79YD;M!OF!=(=HWF$]#LD
ML JL<K8#<I?Y&@"5N'J\B-60HWA;HD33R10X=@T0K.)W7Z"S^[0#&@I4F!]V
M02:M6I05F@9-PTJW?+;L.^5RAIYH?A#O >NP%VN(;BS.!]:"#\8V=;7E^D_:
M-G!VR4^1LWH0@CY$4T0$2$C,(;>N3KR5W4Z1G(CQC+Y_G].5"B&P??7XV!PE
MTBX2G,%6/<7U<:?U7JHVAX.N%?S%6R5\&4#*!"HDC645%C.I^_G0LFE,<I>1
MTR^5Z!-AAH.QVK/CZNC'%]3Z%>5B+BF71N?FPDMO&8^?[=:=7P-BCUI3\Y9
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M&D :G41$:]G.+Y_FO6-U2GX?[<2>3*N8>T*?(P-EQ--F]XU)'^O5A_N.\/Z
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M"%.WTK)0^Z+4.W*/=!V?.]:L1!BC^^'U5KYCO!GY,)5^F1^E2XA,L!U-HG_
ME",[\C%_KS22S?F"Q:Z4*=O1JU_B@42;#+2J1#B*S$GU%7=#7@GGCR;%ED=/
M52S9PKSX-GCN_U1>,<^?3^]&AN]:L9=G+AG<X59@>7D^JF[)3,J W8!I?-UX
MT:G*&18KG?DSESR].YX91)"8$H79Y6)GCG_!]VGD&X51BQ3G4X2@/=>">1+!
MM],"F["AE*]1QQ8B-K6 A:$7 V3<[<E*FE E)WEB14J])$!V&-B,@_(S_5LR
MB4QW(FXG5?G ,&,6-34 5W92'H#C?S'C^][#02^WN&UI+9+_.^1_0/7I/S4R
M]YQN!Q']G\AQNM/_6U1J=C'ROU,E[@3^&Y.FP0<@B H,XQ6]8_WM$$K.*5+S
M44T,;R+Q6[HB(+U.JD2.8G,[&TJ]C9B'.H-9CYXBD;^K$SG=%4@.PM9]+8K0
M=M=/&IJJ!V/X1Q,U@E,84]U[RT+?#(VH:PB=#BJ9&++7Q'+KJK+R"\G;_%P@
M(W69 R*KJP](]J>^)++KDE34K9#7. )6SLIHQ8\V<79V)\I%_EU_Y!;SFBD(
MKW L.,#DSL$F)!Q5^;X'([@0=P, W6IT>>#E:V_]SO6+);;-B^JA#E[%C 34
MO@[!W>7:=.\;@/6_4#9#!;MY:_._E)KE:YJN]( -^HP_D[]B']7KCUNA=EUQ
M9#P979;VMM:T>>+Y#??T,^]0<-TS3WJ:7-\E?Z=B+;+M<;\J,T!&<I2%X)5?
MT0.1V1#A0"525C.GD[QO$6'6\ET*/!VSD]"?N?R LWPI1X*PQ"Y8M!Z#W8L%
M2QO&\>_?O>0M==W9?/QLO2F0MF(1J2Y=P'D2(2?MZ0H*,7'*)$UB/O6_'F<(
M<VJG'ID-+YKW:U]IS<B]#>]S>;^;&94_HF&"'OQ)(13YUCU:H3+V"].F2_>L
M)6Y1?V>Q"%O2US+9W,_[9J'4TAS:^O&8>:W9=U#\Y\JQB:^5(A46I=@D]<&3
MZ#P89!4:!-\W+3UTH%%N.:#.?EZS;<B_:PE/%$_BO $@(*^PY*>ZNH>.5^HN
M34^$P?).T>;CF+F'V( L3_K9K.'C#032[]RI4?FB<JU1$#)H>/;E^Q^8J_/\
MK (*';!Z./D'!^%=Y*&%O>N6]7+?0/T9'';E);W3[^!ZJ8)X(D_Y'!8VE,?$
M_:"W_)>-Q+NXU-GIK4%4A,7]PBY#5A]MU^SD^UTOE?,\85W>S7.D!R(C=H]K
MON4JB?']7CWO\L*=9CD5S=2<Z8@<B>F[Q!E)>GP1P=Q='(PH.R'^Y6 6(FXX
MIPP0&/P$X<3> $XK Z=6:O<1%0T?/L =/]TGO^0=NP:>UANG  =97Z53DZFA
MZW#C>^KNQSA00KK<W<1W")Y^Q5E#OFO:G>CL]70ISW15$XM()77!MCO-U=T9
M-:'!TER#<-*?XWL$RDFPW]QGCAF)L%6,RU+&UV;;W<:R2I&ADX>L4RRX0\EK
M8!^DXIGT-R_@1:+.8B0/]-V?K2.YU:CPM;/+6%EAINY:#CF;P *KV;TSA_/T
MKB44.JX37 .G3GPZLFP1^5M,5C:_.5I_$@XL2O?9;MA=<RP7I@:FW_^UWJ+.
M%A@A1$YU,0&)6STW]OK@:D$N4GMY)LM $]UE87) Q=CJ[3<-^.$>Y?,N1N6>
M^??[:$G7DKJ!5C5GWAEPNJ*JH;VNZKBZ2Y3M8\[OJC)%C-&BFLK@B#H..37]
M#;!J>NA^^#)I3[N)D78#<K2TUA;(H&#CY.";EV/)R?G)M'9Q#WT#>#4L+;@D
M\_Q*</]8HWB:P35QA"GEP3W+=8EN%XC@"HTI=%=IR'.+EVZH0'M79=RG3K8&
M2U>R&73J7UG7T(!4@C.A58;4%IA2]-F#T"URW1!&Q^>N&>%[UFBNN-=C"QJ4
MB%+.WWKP'W'1WR\G>TR9L7Q+*,HKX$0S/!_\?(YEA/UP-_<QEYO]W6\_>A>B
M8.8]"_!P 7]FL.?03Q)FIL9&=<7&Y \H*<8[^F7"\U2]/)0V8MP:<.P&!GLW
M-3LAY@3TUWS"_QDVH_."  &%EST+>L\+/87#'S5"[_PP$+XJJ;EU2Y-74'=P
M01><!;3X%T%]Z$?X)N-2&61K^/F\,ZST;S1?E!<3[R++0RR;[C[JB^/QEU43
M;9C-(V!W*E@E-2;U[B=TXWR(=\]7D6A\3_2 <$YO+EB$)BE9LZ:,/5E>+2L:
MJO=K\,TG+9T'NP5T\U:'0ZQZF/QHA"O.[G2]\P;PD'E;R82E^Q)A!!I=2Y^3
M /\A>^,XI5!_Z+0-X?-].X9QO '8$3-DY4W;O@%*/:NO0Z9Q1+)X4SOT'5ZF
MZA,NSU-Y5O<D5TRX_<HGF*.LB^C""^-BTSK,_C1$[@]+N_XY;AWLV!4\*O\2
M+O7;7' [>2Z$3OLL9=; .>U8]NR@-86E(R-B_O$U&ZSUZ2A-.SHO8J+._>%<
M:=5<<TSP6S9M3\)T:#KER/,:R.<D4;'DED1$IHFGHRH&#748IUYF^&R7X5MU
MD7R%@_[X'>+^/GT=:*<>\C#AB&SH!8$G92)^_70&4G/ZX=84@KQ>VN)9T8%"
M!P0_!_)P,QG^V93!%EYV1+;!GS PD[5><5I:CLYLG[_W##E>QN?HMBWPL.:#
M6-J].-SW0*I*FEF];GD,A/IK2A]Q2UV4_"!@Y,%4S\!J]20G,/>%;U7XVK#4
MCE':7F;%K\R'&ORK_"K2YLGU' U[FA%7G2QJ)XD]SV/US85)^_IYQ7>@(X\2
M\AM^Y1,;"<Z9)T@/U[]S&,G5)LS3[1[_5MB&P N5'HW?YQ82$Y/9?N6(]]&Q
MI<A92%+;TC&/=H8[RU;JPU)\A4B[(O=E;::!)QOEW2X1K3!S%6VHRT2*)I,M
M;7885_$;C6 ?Y8_-@A8EUP.M+YI\#!BT3<R[YQB0;YKM5@+QCLMIRM_LVW01
MDY->\4Q<"0";1TPA6XE)E;^^_Z5^JGYW%Y9!1??[@8)/SY&^)%=-@9=[0 RJ
MQ+_?&7J1\<75UA=DX;7$1-][\L 5N^34RO&VATQ)S$&BRSW]/E:JP',+ C#"
M5FUU]X%:]E?[,=F;>@C& 39KNA_G,VWY+C-.QBF^'B,L2^OAS=K/=UM[2J$>
MU(**GUJ85>KN>&TF-RR6HQF4ALNNF7Z4.J)9R#<\)#46-1I<>"5FTC,=F6"]
MQ955P8FG\QH,$7O80]Q26H*Z\N(-((A\-&578AI^'X/576I"\!RIC=7XF+R:
M(VA.[QW92!P0%;PLEEIQT:V5^S0(6W  =:+]*Y+C)76F<574-8F,SQ$U0L(?
M&0G:EB<06/VENJ %%(%=(^4+XZWV==V:,=W\+TIE,:)K2G3B@VH;ODX'DQW>
MIZ$'9,1R&)OZ@]>)(QVDW<.DW\-T YX#O&CO65H@J496OT1@*'?0DWVS+3<
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MOZFA5S';G,/?BXAA+Z?;.!-*/58_FV7(<5:R9IB\IO:J&*LC$;$.F[9V@P@
MKNP^IT+,RS15*"JRD@]P?7]R\XQV_#Z:8&M*UX?8N?VJU*U.S86XZJ!*AJFK
M2(54]R9'(G7Q&;AF(V;<!I=R<314? 351 V^"6AEN*]>ASMIS'UPFV[#^^S#
M_SC7DKFHG)(N*]OC-7.M_"Q$[RNI>CZQ*@OQ[VD@#C1;Z1T>:-*!DERLOLP$
M,$$^R^P*>D##EE_2DHQ<<,FK^/ED?>J]2QF+__2SP[O!O(Y/;X<'I"IJ]:R_
M/GW$X2*IJSM-:*;MKD7ND9^.&ZOM5R@_%_N(_.!U75(OG$1:?L.XCG7R;)</
MT<+U;2RYHO2,+@:7?:JM&[P<R"D#C9<%J"%,B:W'U.=YO4(#>+NV>I=J?RAY
M1S[MQ]$_C=_^!M/5+\X-*-O==GQ2J?YCO='R4S _FJS=^,_4Z*Z4J3-/U?BK
M<X.')\HJZG% C :RRU*M8^:PT2\AHN88+'WR+(Z^2G!8C3EEUV(?M09$P2.G
M>T!1%]M) 96[U]/=37Y!%2%#[=5UTSAD68;T1]I^]',A Y;4?RY#" +M;<!5
MH D/MXVQZN%#Q&<R%KS2CT^K@OR-LM$9>4I/!G?/&XZR0J1*#!Y>WC6ZGEGZ
M;62N/>FT]"EJAE'&?)CCQF_E']R@WD/XIQS'#J&@X2))]$X;P%\UMC.N/UPY
MPIYG<I7PA "X=UTI,%OGP%NI 8OG,X$RQ.T8+V=;JGDP/8HBZGV*WS^;:3]?
M/Y&HH[L0,>&3%5:M_S;$_&<Q<8ZWD5/T\%/^&FC6NNJ&-N-]!C+'HNI:KO6+
M G?F"@@+N;-_$("R&32D\C=H;*??UM U#)L8>]G_C5__(?U[^S*!;A+?-J^T
MLA";4==,(>Y^FA#OPO5,B=X[D6,Y_$Z=,JS@+RP=HM;59/I(A#")C!BD]K)#
MK?AKA,U"9HJ:]H^%=<8\<#IJ)\9SW%R6]P]GU1+(";2Y=>!RQ(9//_HMDW.;
M+#1ES\WDU@4NG,475YO?7A:2"7<+_BEJ='(;,A*TD^5D^230O$RI2LVKV$R)
M\0N.N;GL@^?]6.Y-+[W\XJ; YZ@"W=F2EJZ91G--B.#%3R1R_,  J+9%U& 5
M?:7B83$!1NLIHB+AJ.G>Q<0BURKCH5+9&"0PVI94X46K,\6J(-THG@0]D9MR
M%%JLKV_#KLP67&FZY*NE@#K<CBN;8 G5=5;H\YWP<=?J=M2BB'9+U?ZS<K[K
M==E%>V+G%F\.6W'<=\6(G9U*AR#DOA_Z(/F:BH6,)YY^"O+F7;SD:J.YB@U3
M/@@PX,?H!;^<$[FUF'XS70YO;( 'D'^)UC["?R#/8OM5DN!BC=@))!?+=T>R
M3WGW:EJX2ZCOS\L97I>C3/8PI<"L)YJF/A7C8OIHS3QDP2/0;P>Q=OZ+GW%(
MX%@E\XQ+ZJ,4VV1AC\&#[Z(XZY>5ONVKD[OE2Y!JH^!FK(:!>.O:Z#T@XO":
MD; ,RXQVJ;<-\8&4:%V \<>;?J1:/=0-34UHC6=RLH.AJ@<D*</;!R[2>+OS
M=6Q/J>/#7=L'/))):OW7^DD8"YX'OD*'@S)KH1I([C4J%3<>;\&$-*Y^_=&/
M7F]#QZ4L5:7UUKE'I$UJ'=:6W$P7%W:-LH.NLUII<-\/0R-T9KY2#SC7BS2Z
MJSEE68RY7'_3MVJ!K2]B4TYK_;-ZX+@85R3#X5%!,']A:^-T'7^VL8EW6P(A
MX,'YP(=\;M0NJKS+JRSG1N;M]S<WA@7\.82;]ELNYW^8&O+;H']DN>>V9UQ?
M-L1JD%Z0^RUSV#M\YHJ_9&M'D[J$0S7VP27BRM/J2@7X@0P-F"343?_B<12R
MDZI=/[G85'TLDBC8CG=0P-@?KS=!8:G?OSD%24RG9UJMP0=YHV1796*@]R$Y
M]8,-;JJ*TRJ**:;F#+YP.G1MXR2P9+FZO'CEO?K.A/6-YL'34J/*/_G2OY2.
M"EBNQPN9$1FK^4>G?,%35N_JR0HZ-1]+SC\"S59*QC@UM=SAY-^58WR5:XI+
M#V%WRUF;@?MXO1/D9KX0D<TI6TG3P6F6_M N<L07(XD7_J'F)-^UPC70 ?V7
MF;JJDR 3DS$?SO@*NT5!\O>7(DM_]$R=0IZF,M$X+;[-MLLK'A:N[J";I?JE
M.I[Q<?#I1B;+,^776B+C=S\6+W(0QU3['GM&7W_WL<7YD$H?D0M]"ZP26I[+
MX)[U!+MC=;IJND+(1*B[52:;KH-I/R>AM 9H5\N\;J,*S66*WT*F?Z3@^Y$'
MCD+%;7IVL_M0EWUR9+YEQ_.:4W99!_Q;9@V(AUJY$.O?@)VF .^T"L<[$12\
MU_)@[=GNM9"OQ9%\Y8"/9_,ATS%V0D*>.7B+^LH]P#"KGXGJCR4UEG^C5JY/
MLBPQQ8L_CF6V).S"J\ETR9M.,=+ZL?RCYATY$=OS=G06<U+&P=EE:L<YJ##>
M1F2\!2OD?26<]>-JQQ 3A&1X.B@U=B@(#G#DRQY_[];SQ1\ZU\033(B9T.Z<
M@11-LI]Z7ND2)F]IJS#'5VWFO@^=Z@(12LF$(#13$$-HOG01!C)+OV/6UB[M
MVN<Z-_T\[NLV]._GM:KW4_;7G@>JV&5/1)WSX^S1_A!:89TK3&Y_^$9VDH:%
M,3Q1T%W28(S&P-S$,?C&/-BQ@^P)E&XD!'0/2)75[6S,T>K(7D2*1OJ:#;$X
MOS8([7E<5 NC58$J(F\=A>,J^3V;.M)!RS_4_)B7O>O9VZAK0.=%? Z5/D*I
MC=G_.5O=5U''ZR(':"L[E$X( _ZUEBP$Q$_^FS[[^#_V6A*E$]*>A8\*49SX
MVUDMP@ O<IVEV$=L'P4T9!QG/GJ8?$S/&^"D+CWBH)7<9[ [(6:;X^ZB)%;G
M-G[["\CQHM2T_B<)=^L<4W0=S/7<\8A_AO5'JW71!W*;CWCE N;SD8' 4K90
MXK+#@^<_YK8G4X&&[LQKK<3?KV,W ]W38#$N2D/IIH2-?9<$ZQ!F5)VDZV6"
M^.\I4Q=_UP,S/*PP+"QD_\\]X,]CN'V T0;>@87<!BN6[!Y@:?\?*;#<8C=S
M=,BJS?^DP 4HO0?W *JY_VNM'\7N=+US1^ @@%X<N^NI_'?$4BLKI&WZ3(*+
M?U647$?)GR5ZE&0N%T @I/YF2-W*#*W<TUI(E/U83(2@A%IZW@TUCV"L1--I
M6W)JU&6'^[5HB@_Z\U?"Y.@2^[9:_:S=]'3"?5ROEW?[$%7(O2IA&S^AS[^P
M_!68!MW8H;?- 3'+9SJ]27I_N/>2(N0 PFL/I243H0W:LQ^'EP53F*SVC\WA
MH;(,#JN Z;DUC19&1X#:APV^G>5Y77)ZM.48UF#H<RYBC#"T2U(F)-NB*RMK
M-7@\%37.@V/@)GNNU1.2<TK[F--1":\V6#UH^.G9RJ;=%X\/F?6-J9)#M/$-
M M]QN@,P]3?JM3GC9;[O:E)AHY=#&8Q%*B&U 0NR*@D3W#=$]/PK9Q:P:_NL
MI!]?K[SD'"T,#]KABC-W+P.-)F690)2=N4#?OLVF^*V1NXR3K'Y8O.1\/TVX
M[BA$>%W-U#@'< _HVC=3KJXRWS>:6K4T4_/P>#FFQOP^NU@>RWWM$R7.C9O"
M,5?15>:Z'<"/JLOO*$BTP\K'_L@)MV25'8-5,\E=-^Q;]-TP_\,7S$?H*BJ>
MO_&V*X+6Z$E9-B7@/7JN$_)X!Y!X[D#V@)^LT452D/0)#%ZMM2@_(+1%WL;P
MY4PL0LX*%FW!E;TM+&G;DH*?WF#!;(];_D!D ,.T?AC9A((C(V$5C7$UOD[(
MJ=5EY;XQ7I;XA *=[S!IU&52IQH"& .=$NG8Q[>+[V/ND\(9]O\T[M7] /,]
MGQCCNE% -/[NLL$WU51-:?Y+$D_O5J)*X':;7?6^=_Y<<YX7EIA<WUN&$VX-
M\1XYYS;IU/I;62AHJ,)LL1'C4)N+P^(BOGY69VEQFWV,%=L@9E+KF&^<MJE>
M"&J?UXMO^ =] Q#*7IZ[!SB.!84,!$O.#<;P*/:WDX,$^^T?]NH*:VQNI)QX
M7M8F$0?/^]N%W@.>G(D%4Z4B/+OP&T,_I/%GQVL&_A[1)9_C,JZH;@KI:+E*
M<VBQ(;B\>(.F2(JQ^ G1[1%N;8R<6]/G"6QJQJ-9BM^1J3?D@]MH^)V'UW\R
MG88VTNKNBU&-=+P7/7JCH"P(]#=J#'R%04/0'OV+D8USND'5_Z#&'#E+-+PC
MS;757EQ]$J7BZDQ6LL7<;"PS/9+V;HGA72U>99DTG#>8&EB&B'ZIAWO6MX>5
MX$K;='G<!&J)L9M2C)!M\<?*X8OPA]]Q-TR)<%JW UM+VEK:/N:E]N^$"0W#
MROE#[$,BVZ$#A/R1HNP&TYTJ0= A-W#%V*O.QX;1XH9F[TG\KR8V\/K7,";Y
M@BVS)6+'$ BI$NF>'K[M TW_CP#&V<-KZ"$8<89^+RL\V?FWIPI'#O"LPSLZ
M2,A9;? [7^#F$NSF@D<%ME8G7*Y!"'9&*!YJ_L)FYH[%9)DULLF*L98H;5!X
MU\?5+CIO3?2U)+U! 57P3\-\<HQ(L6]WR/.%NI(*,[7G7UDV#R&EG$<J_@>R
M]'>+WL$XJ*$HGA $0VO K;!FEJ[I,H^;Q55I&G-"&_]$K7O,C;R#_U#?"I7R
M+%:$=^4NKDHMQ/9U[I/8SIP%!K>),E8>8/ZBY=C$W8.G NH'0VC+ T0%Q@<Q
M.Q1_Z!7 :Z31F,I1EPKH*1(,6BU\'\0]]/FQ5P_C^1E\X!ZPB!P;*B#!:B"
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M8TW$J*RFQJOX:23-3\<?G40$C;"*Z>9/^NY<FNFQK5##Z*@*(NO4>-WI9]5
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M6$ZDK)_P8:$GA5GI<CR.8X^,XYG>%D4_P2-><@/G_P2A%6=!.,@/<*S3"3Z
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M;1-POX'G&H 7US["SB9Q;0?98\R)/KN0S@E4F%>*9#EN45J/'[^[*(+S^_P
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M@X3)L4MX1W)7BZW4KW U>2&J:WY +['SW'/QY:HC@%]*1[W8!#/:]I$>Q8^
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M^LL)QR5EJAX:/7C6K+J _R(MSMB2^TK#+>NB+/O-3SA:V?M#+^N8Y%N  ;J
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M&(..@8.!@4-.@$= _K_<[KL!)-BHQ6CF:"BL %02%#02E/M^ -.#G!@H?VN
M?VDHJ \R8F)AX^#B/71H( :@HJ"AH:*C_2'UPZ\!#[\#T$DP2%F>RF.2O;3
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MOZ39_U3LW_1: >"CH3PX#XT$( OXS1_-,W5YXO J#$H4<0%R+HC4:*UN:<G
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MJ@'QZOQ+)B1PNR7$F6_7O'-X?8.0S(ST]X <Z:I;N,H_\,;.0V916<P(GWL
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M$09-,R[=(?+_C:WB7@A\BAA3N,W<@N^L1\2O0%%XY*E3^6+Y1)?741YU6JU
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M]&Q_#]%5$_XZ"6=?LE "^%"=$(&E3M2WG/+!FT0'[F;KU%NA*[,S@JK*9CD
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M#$(6"NJ;FY)7>$M!)L\Y)&/C,1]/'Z9Y4QX ];7'T*IU4]DQ#/:HT>G)S)Z
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M2H&$#.%U(%H&'O6$ETVS2'6[<M./-L]0L<,B &(;G$%:]ME0SN#OEYN123]
M#AJ-5(V^A1%E:5QZ%%^'6^/?R:VC$7] ]9O&U!^2C9ZSW<2383%!:.E1RK##
M)IJ3]?RL$_O[,<U2>W12@?2T!R*;<5GDL([)8IL2,XVK">X5J?)]<&.R(OH+
M',)E)F]<->G@*BYX=N\9':BNKXL:G* 0L;$WT'@%/X!U' <]-NBM=I^V7&5M
M92)!RL"5R[_[J[=%JLHS=H!M+\KYEE[N%).,%H@!\8<EKH11]C,X!X+P06&&
M7]7KYKV-A^RN8+/*(_2-MSO*S)@ODY*EE6B#!IP)[<7L'!E6A]@7$P*<K,,_
MF1A5\;$;^V^A$M%OQ?.,.,L0@++[J0PI*@?R[!K#P+=+X:>GLV":RE-KU4^"
M)1+FP+KA2XJJ J0DG+_)&P8Y>S.7KMD&,PF?U]I>8^.[F'*X\L2)CU(VVQTD
MG#F28YB*"!0&:0VLA(=G?2D!UMI35OG8GJ$5N ]^WJR)ZN%)5&4HO6*B;N<K
M!>;17?4:-!:%Y[W7L*^L'V-B$@P;8LQK[^IEP@=:YZ[XLZC,FD<'$;PYI+P>
M=\JWCMN-L;("!%JTH4,;;$ .X.R$M_#XKQ "=06MAJ#>QSYY&S7S+YM,@$FM
M]0[7KX2J@\N#!04E,P"74D0)@83SA;.+> >C]NY]CM9"AL,U4^RE'13&L:1R
MTC<D)D79WPT/O9>N$JGLWF>JB&J'XRO+875AMON]@06T,]6]2P<'D:VO@MR-
MJN=8;M@'P7CR?O9E\#$2K/_!WGN&-=FT:Z-!$*1+[Z 404.1WHL@74! Z4UI
M H8B+?0FO0D("-*17D+OO1?I)=))@B ]H0:(L'G7>M[UK?7X[!_?C_WM8Q_'
M_C$_<A_)S#7GG'->UV1FKIM;(2^#CYU<$OK-5WB:[P1RSU"FDNUZN8WE_>P+
MAZ"S\)^!S"&A-X# 23S=?V7G,/-$Z5XK9=\^.1-HO/X*<9@"CE\_"1B:079>
M#^C= &;<]P'>=!MD,VO3'>;S'1+H4?EI&<[=QV7;23> 'C8(L<2,6FL=%@0.
M)%MH-M1*7WU#(#<@-[1K_I(B4(5.)AFQAG=-M_:+F1L=6@(.5ZA7G!?>G!.Z
M2$.DI0A2OL,:4,O(%<*:7_8UG!(:?2CS;<;P@E_^?&N$-]TK0>%N6CB!_YML
MS:([$%.,\N3>X5A)EJK:<K?-L0(=.-&NX4+EN]C=D-S+IQ#NV0Y*<-0X2]0E
M)77"CK=GK(U/J\/VHY<\609Z-''/I?9-@X+HAL1VM9K1HJ5V,GR3IRPDT2M
M[2H_F<6#:\FN>:/Z;VK1G(L\2VS>Q18Q.4\E_=^[ ;;#^U=$Y6:<G+[-'OJJ
M4V8]-.5X3OV0.*DM(I@M4*#4P'>0/2FJ+IOBQ(_-'#76?QYIVUPSN5]^P'O2
M^Y;2SG[WX4H;[X5HZ#">I(?++)19AAE< ^W-XE8YB?C9ECUPWV'>V:\";_&!
M>K$UFZ<BJ#J+M-X);=[E79=-Y<]NOSB>QBC!&5'W6V*>T018^T7'/=F 1/D2
M%K+W#KM11G*:TK!U'-7K;K48XRIQ/_CN4HK-+YE+9R_)CKHL9M1!/-S4[$JM
M/EVE7I(+D>X@^27]\7.MS,2[CL5J"0G+%M#47^:X&$72[D,*L/W9P;2?C8_G
M],E2I(( H5CT[S0KCDC+XVK.D&.+$ZI9#/?4J4T+2-\8:18/XU'E\1]D,Z3]
MF;)Q0*22 %BZ_\2YB#UE@L'?@D1R()L<HU7DZSN+8;*&_-B6T.C\R-"G*OP[
M;SBR?SC:DA%R<';\^]![?/):'!S2-\]"X'0(X?'E<(*[^##G6,<26?12U'UX
M/NTW]R$G=N'"P+,R:A<65U9R/:L#'K]2:FA!=B.+IQ0TV!U7 Q8Q^ZN&6XZK
M@KM&:^12P IS7T6T3^FV!*5W5G)N^Y(IYR);]+N4E3RYTL$,ZHG)EWBFZZT7
M[EQ.-J;^:WUZ\J:?3(WS>*=QF? 5ZJM\4%"FYN-..O0-P&#N^L'N-<UT_2@$
M?S!_F_HR_BS&V]X4GSW1,/EC)&OV2ND2JJJ$8T**X$0+OZ/8J5ZX&8F1(,DB
M CF2NR5L?3HX-DP6T^X#;[$?3+P_LNW->F >W<$+Q?W$H-:)_%WX%22Z:+G"
M7C7Z80N8$?A\!TLF+/#1]#4_VE-QLHT3MP".7U^A;% M*M*H_:-&^BC/T0OG
M79-N#%-^H8,C%%X4[FY.:F?4D.WO]& NFB.JF\S+VAW/&1\*K*\A?<$(30.[
MPB!1>\(!(8TT]"_L:,*$EG9!SZ.+QZ$I5+%WCH\_"*;W(;5ZXAG1M!C9>:7X
MNS\'(EW*NWT*"F9]%AF&,7TIHK*\^@ R:)(<4VJPS".-<K!ZKZ@1)(JCL6U6
M2L'3FBA$Z]G9+T1KNE!HJB/;"&OLLBB3:_JO_6L9\*.#W_MOYIABO+^^.WH!
MVB!3=A.YWL^(P4[!SCH=, 0S]",4D*?EBY3:H];P[5,O^=4!N0:?$AL<'[@<
M_[Y)\D0W*?WH>C;5=G3AL[-V93@-AKT*&_Q%),N-+]%'A$W*)PIP3NP$/P]M
MDY8>,;>7>:4'M7LCW3,P0:G/2UG.W<62$:XINTB5"T+LLQZ_%KFORCW.*S-D
MHQ(9\8*2/Z;1!A!'6N&[ZT?8T8@ !L$63@/NRD8JE;![.Y:\+W6T4$E4LGJO
MPC 6\1.K>U'D5++UBB5<H@N=[01OIUX\[@UPZ!#8F>3YX<.DN>1(K1285.-\
M)W8$:TA\?1)/ :4\"/6_BRH*(5RKD^ Y:20S,QJTY_#RZ#IH5;E;F\S(9S0_
M(R. UC>:XJ[7D/A]F->68L :3&LPL?D</YE>RMI0CCTDYK5Y)#UNA1<\&]?!
MVSIP-G_J\%$B?,7:8,VR!Q7<VB3&+5:)"X6%1]<1#C;55P5O#II G=S]=+4:
MFN]+=WXE4"2/]$[^_</N#H(C8L,=<,J'-C)C2E*KFN6I7#Q;O)R#Y(I4I]%V
M-:T\Q/Z$94':7("BZ2<E!;^JGG5<I+4\PEST6><WDC-R?ND-G6@'ZZ4A%?KQ
MD;T]$HH#22+)<#^"D1T@CY/*[-RC^B\C=%3-2^R\I-_+[UTH4S6#D-#^2]E8
M]\99#'\N>K6WK\3.1?IT(58Q=M8#U<O%7\6!D-%I B _2&X&2IC'==(8]W00
MSUDA?UX50BREVSYH415G<<7$9;,E$I1P+9P-2?=[>^17&OXR MH;)?<L+2E%
M3:NM%M$R;R0%WO4]A& >H^8S8?$1'115TVSS%>[[#E?V@[JBD;1R^V1@)N.$
MVM&>A(1&YN1=%FH,31EX#;:GYVW)3M]??@:=[!7Z$J?ZT#V YX>'I$LZH-$+
ME=JS:%T(D<GU>92U^$I5^F?[=Z*:00H_Z$),LIA4G%@%*?&MTVG3KUBSH_?[
M'AM@2SZ.4B=4,A)AQS/M<C0)%@".^+-C!%"<?0_ATO;$#PSM1?U9K@<;JQ-_
M8J4H?9(4K!);;.K::JZ<4$#.-Y+V'U<NVY4Y%63>D98=.Y[Z\H*#1&G2-5!L
M# !RR*:6$H4=DMT +%961G^7DHL3M^E-J\A+ANJ),0EX2>-YFQ+"&\/:E(N[
M;2U]K1PB-E,6]6+*]?$IJ!(2XG$>X] /W0 ^.AAKQ:8N7AHHN:6Y\5LRS;QH
MIL#W/,IT.333MT6F#K9<3!L;S2"J9^.R2^R@EY_U1U[3NS]D#Q:&L3&^D<.#
M<G++2?HYP/<: RA\B2WSUD9_AY1&IV349Q\<:+-QF(G?&Z9CZ8VYBOK5]A!%
MHQY V._'&6&-HFN=Y07M%U '/[:R3AY,K"ZF.^I:2A3PV#ARF/ 57+\!,/G5
MPMR,4L-RZ\WQ>\[T/?G7E(8%(J0*4OBAQ('.<FSL'J4=%&A=! M10(]HN4@V
MP\JVT4&)NTPZKW;,/-1596=HH<N=I(W%&[#GZX725,^DZ4W/_GCJ'O?85Q%4
M8#XPOS..]9F]^JG+YS<G$P7NEYW]?"2_]&N-5\V^).)/+\)W1Q_=X_ %J;+D
M)35[7\:<0I[,R=P'1W[KF .]UU-O-^Z?]UZ>?_23TMBXATR+,WCO?C7VK,Y.
MYSV,NBNL,\*?Z(K;4\(V\E1<F!!D6&A^8OW5]DME44:N>2K=4#_ .S6B XBV
M[4DR+2PH]GILA5+V%!B88&I5O2X7!ZPW.A47+?J^1)[NM2R[F*IV*H4Z\KV&
M6?$/C#8;XQ %8PFO7W/.K![VKXJ&016R39"URPN5Q0WI]6TVAA53!A?!)A(9
M[_'LZ+ K74W#(X4< A@Q:LCY_#SS7O*=%'F> (VW1(6SH&1J1;R?[S,_BMK:
M TY!/@.7RJ$83M%(8=75"=4P,A?V&J6%YP,?7A%%#3>B6V%+HX9%#8D'6R,V
MS*\\$IW<7Q.9OHI/<U;^+E;<(8JVU;F=$P&4[XRD6Y9WC&)C4B:5CNY!78F(
MJM<)$%(.ZX<4@Q"T;I\',VTUBMQX>U!K5DB]!*$7+ZF2*&KQZI,^CB=NH(0/
M)/[Z7F-]71:/X6'*P?>UI8KDNB2AJI#@KB<9ZZ=,U6,.QA@]Y&KN-[OTN$QO
M=Q5A+OK-N??Y FT)D%50_B<\A2R,?FHOR!.6'>O/6-]PZS4<I43=&+1F"!2I
M.K9G0U\ZDYJ02V2D1W>9XTDI(QO[C)CK04[,982+J\\"BKJ?FM?4G>.Z'S5:
M4)GLR;2_PYZ"7$N !;5J9ASC2AUUM<-4]ZGG\3F\]&0[[A2/PU:\HZJ1-P!X
M83:*5!?*\YZ'=UU#P/KCL"NA\B9Y4 W6=B])&S0#K'S+Y @I(/P0;XV0:ZL^
MY.6<.^$1[WU"78^%5\\PQN!QR2VJZ7?>RM&^%!689^VUDP_G]+7;X\ZZ_.I9
M*?SWR3YM,'T#<3X*E+9ILQWH$$5QQ/=?M(E;PQFDV5[0XZ27#GN]2[R;;$48
MK,XW'*<E?@ZQUE$+5B(1I_I)GQI8SV...)%YV#;%<] FR1RU&) IE-!\_"+W
M^&>62Z#2.^Q/:*\KN=T; !5>B) 8#^A$VM6@.EMGEG=>D%4!1''ALZXLE?I6
M)'4(L$5L&CH8?^ITQU=]QI>I=%FDE:3>TL6U8'647ED\G6H5.<1&$)N\<;]L
M!D]8--J?R=P \_(6G'@I61#5[)F>SK9^N@>*+'%AR,*2,W!DA(04Q^:KRWJL
M<?\-@-(-0KLC8JD9WGOF26;GD:A2P38AL.]%&T=Y]T+N_%&@^.''  IWITB[
M0K,%=-ZBPTFV32>L[.OS*#\IB]CJH'!:4$[J6I-5C%YX"$87?@.@!W^%XR8X
M53Q[YP;2(316-1MF><_.-F1@Y0@J")3"^J0B'%V&X9EO<X!/8*'CS$GZ80$T
M=J*?3.Q;?I9O7R?<@1Q:7-SCK6%^VAL8(%,$4_XH?$B$/H93YY=LCSI9EJ\5
MS&64.<<9ZCW]\H Q)$&.=HU42A4!H47'#^AIP(&*\;TMLQXJX1K:9Q$B;$UO
M&7Z^I0U4QHXC%E5"><;Y:GW#:,5KS.70=X0$<%0FLM<I,.Q'FG#G?%C@B0F6
M=-EM1OIT7YZ'8G11)%=Z,_/S:T9SH:=?>7I4#''4OEA(,):4^)."M4R0JZV(
MT5A+36-)/W-]T?GRVF]?\_E+CVAR1](!1?F^*K.^YLB07J/")%]6U*/*R<5X
M@;L6J>)]L'S$1T(VLNZ>T])&,YG9"G]>!QFZ62E3NWR[%&_K]@V!Y?X[P^QQ
MWVFMJ^Y=/.MBVH'VQG_47R5 Q\.-SYN4D<NU]:O)-D6_G\]@G04K:Y9U[QYW
M5CQ%F_=1F]-CGL'98-]F3WQ6;A<"YOLOPU9C^C#E8!S1;3GF:!A#R:$;%R_G
M[,.YYVGO#A_&L(ZD76CB,4D#;:HPS'Q09<* @OY\@:$>(%<!N9?+5DP5@K,2
M[T[C_TIC!)&>D]WH #M=]Z^HWP#4N,LFRR;<M2[XLAAN -6>.C> Z>@G@),G
M?YUN((LD4*$36_>&QN]ZK_7Q$:#7>LY%C2J_!N0[>'^J^BJOSI1HQ';G><)W
MQE1KPI2A <$9JCV\AZK8G$R"\VV)([OPNX>Q'6M^ZV!JX4_=#NZ\%611TW?\
M;>_EU$J2%%7UQ/CV!PHZ^3_>24\="$6.@(-\@>\2RY\NV$LP=)[E8KM^X8T.
MQ=FH7/F&^7:<7A: *M.[[D*%Q\#30$*R1+M\!0U?N9\H]FGO4:A-C#J.9K:J
M8#L]K!TTAS,1OD8G<4LX0F"P B,#>Y<597_'1 56)5AR/N$QD-%S>\((<7A-
M:(_H]>='6KGPW*[5I.U.^?;Q;0@W%'A[N:V5)8.4!BMA$[B!TN/CFY)+*HZL
MDGEIU,\YF]A8F^+#6(X8T=$W $NV@&VJ H^SE.H%(P6G^T!*KNH<Z4!:JC[?
MIS> 3UM]YE=T_]K-J.#";O\/Z)G18Z@GQSUF3Y#748OY:"?-.;(&>_A==X?
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M!Y'\&V<&+DNVA[7;<:YFKJCIC5UO4'@(A5;'G 64G4VW<>;L(GMA^_O(AQ'
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M=6I.9D>_O_+9=6=132W%4U,&_#$0B-C!.SXME44FF0:XRSZ1A3UJN=[Q?V5
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M_:]F++CL67!]><K!3OI3PD!Q=P:0\9OV]$T/NY^/8V,W;1^4 &(L<6R*C3
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MVOLD@@W%))<(N/5<8>&B21;%//L<S0@0!Q=7%?O@(E$I0=]^3WSY59S8AEY
M6(=0/,7:ZM(26M<H2I)8^_]B[RVCXOR2?>'&">YN00)!@[LEP4. !-<0M.D
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M&74*C-F=FVT=6WD& 7JO+3) -S:KI]Q^LC1$JD!?XPC9SLN_?2E*<:CG=@?
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MEJQ\.G<?NR]#:+-1*S+WO#)H;,Y*OB4^80*W=C&0UR8Z^V)I.)GX@C-(E>X
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M>T_!M))O92N*!3'6$\-BI,Y^A7_0NBRIL4#U3&!HFP-/[(V)<? "$7C$_2-
MUZ$-QB/:0X'O76JJ9/4.V^2(H> $X,9ZAI8V6975SK-]613985N%\6NP7"W_
MQSQ0-"VDMJ+5.;3%)->(A.LQ)W4L=@ZA91MB,ZZHZ^WQX/M$TZV]LV7+CPLJ
M@8G/Y3W@XMN&$A1MYC![7GJE%TUJ+>*-Z,D25OIEJ!)!5$3RZT0*/OD>,$)J
M'X/Q:U*1;' :.X1+K4*5UE[YRS#M0,7B6L+G)\O<N7*=OYR5T,CWEVL=JD'E
M/H^FHFFTFWE&VB C]3<?)SU#^"@\KN0)K\T+N+O"SHNIV?\U>C4JQZ[78ER8
M:TN,TJOFV*$AC$76R0S.R%ZX1V\,83\AM^&[J8KOYI\K#O8+@M1+-W QW@NT
M!%*38T&J'MC>2L 9\G-!J55%!J9[X2;/5QD>JQ'R?,P2H*7"JO#4V%N#Q1'_
MNKP9"Y0RP6@H]+4G'^G+A$DJ0.<:8!LSO?=QY;"XZ'$7ISS5EA#>)4WD8T)5
M= N[I2>3KNJ*\QI-S8]NMSY5,,44)H>Y_\C)(#1^6[&;=AH6>M)43_]RFWLO
ME]K3\I>T3,&EWF#MKA\W_/0. #D,E_ K[YAO5JPGS]NFU"W>9DOD) _GIYWS
MVV3*I;N<J_4;%X7R5L.]]>JGOZ]N$BE6&WPODZX?;KY@S7*W=RYB)88 W,_N
M $0G#U:FK;P/JV,D^(6A9L_/#G&(X[]7HJ %CSYN5NKU)]AUGTN:W^&B<W?"
MC8!,.Z(I$5.3$*W0%SC3YE;%W3+-@_M?P$7C7/FHX_8=R>^];!LU)Q@N[\/V
M*?0=P@.X5 ,CO].H2\9LT;ZC8]DRLJ-W+(>:9E+V0;#_F9]VGP/1<=P9VBT9
MWF5/CXSL>*LYET+ATL5D.4@L5CGKD6WZP4!N)W=8+0%AA:O.JDK#[EDZO*Y9
M'.N%!IZJI6W[UD<#J:K;>N\*5)Q^C0= 8G"LNN>[MS2]"=@TQXRM_,'Q32<C
M[_0B=OVXIGU<KA15X$>TNYF"3R>$]$]CGNV]^O2E)1%(S:SQQ&<HJCH"$)TH
MX 0!>#2'=<MBV4&_E)68(/V&8'< G<8KMM.>_M2F,*JCA7-3#8;3SS"SX#3I
MT4 WRC >;E=Z/VEF>W:U&?RJS#,R5\Z<ATP":,&-8F+%];B>?F1CQ:#L=[-N
M;<SZ^_M,$[TQ+IS&4ETHT4VK+T\'K;L#7LJ-F"_=3J519)H+'=M>EHTXPFC-
M\#4<WU6_F%@P%L#^1!X?^FSS\86*M*(@!(U?AL)O3 !I8SSE>'@MN>J/+Y(5
MP^ CZ.;VN$TW(I^+*5F3V;S1_F+TZ74/W>4[?VP?6H(0BWREU5VJNOD',9#"
M5J=]BB,2%5>69';VHI)*P=X.*C,C>%_+EWDDJ%?$:X_FQ5RJ.[\:GJCN@^-2
M?K=4VG1S*^S>>&F(2S;ZM3?0VP(>.J8KL3@7?MA*(XS1)D@*Y/P0-B+ >UWW
MV8II7UI#:IQE_B3N 9 &3=%U7P97D,Z:G/_1D\(H8F0UZ^6,/6DG P-\J;;8
M#FJ:9&]18L=-<[!)WC.J!*@^["3OV6:L\P]SY'6PF"X_K,->G6#LE7'(J8X[
M$9*5%"BK94$)K@\08VE7<%TB1\8NL<U93CV"'U3E5]?&7M)&_4@:2A,5 PA(
MVCLMTJ);!P@;=3:C[9X;SF_KCI69&-TD>C>\:(T_OFHX_3U_":O+0;?8\,S]
MBLV$U3)<VC)]!BAU?M1F["-QVRYILDM76(LA!UK*A!\E4J\G2F [C;XP<9BT
MLYNUD[AIF/D.X$HZC?>*O7OY0=$'"WC-+PJ6G@FBB>TES:/\AXVH^=58\4K/
M3'3(4#[G(!U?P$?*YK=3G QZ#S?%HIWW;V!>20>@EW\!$1)$MMP!6#RZS:YH
M?E_6IYYN)_]MJ!P@_7A<(EDJN(N\$^J#BO0LVN6WFUTBGGHXG?>-4L6YV@>F
M.1^\)>TR"AKGR"%XW(X'9JMRP^U9'>:KVR'Q;'3&8%J0+3L^9JQP:_;+!A4:
M] "M',DKRCE)Q,SEP@-< 008^GD!XF(RI$B9N3Y29"DCP0\EV(.+E!MS5"6Q
M/HVW3GU>,[3^@5DH]2T-][;A9>DA,CDL15+.)*3!T1NB8=]3R=5\_P!Q&7*P
MHAEV8TBV7(T_(?_B3<;$)I-+1N"/K2S)&66_!T@&7.FG,U+";YBFT=_N^[1>
MW.JCB&9L? 7L;INTD:'T[&2C^SRH6#19L&.@F')D;R'FZ1DA6.-+C>-N+#$I
M"YZ+K+D#/)"B9X^:@O"LSA,BE;5T,'.848TYNM?/F5S9"]U.-#'=RU;W)8VS
M^D!7R@<%U9^,C82"9;2#\PF==*3$5S)QNT5I/EZ*I#H6J96\=*BB612Y.,JJ
M7"KW!3E' KKNXU+*WY5N#1JD=P K(_]N>;;&'\M:/Z\V@\6/SOT]6#-T\?PQ
MK[ER2DV1_CV&"EFUEE/&P&.U!P_PCAZC(P9>>86<5QY% F R-$@EO8F^_ ID
MX<G@M5$95<A>\_,7*=MTJKH<%GS'-25 6IY12X=@@#TRJ<N0,0HZ6)\I@O_\
MIRI[XW&H3PF6HMFS0Z./FEC27WQDX0<QI7:7R2D)0$?_<OO;\4R6B\J&F+)-
M?V^T6&\=$ZY5LP\GRFRA_4_K&B*5TU##,[!_;"3X-Q><45561@+6*_S(P*H#
MP*?XF)-\>\F/+:J5KYZPH+-+.4& 8)>N-+X/W)7<)R82^"*SGJ:>;P/?5[%D
MU#(ZJ[#.+I*AC"%M?ENKY>4'*$.2_1>UXA=SHO8.+3[;1M3NIQ:!8_4VIM>,
M<.L"Z,]F^$9(U^PBZW3K0.U9PPMT 7]O )[-9 L-!UIL!U)^942C-T7B9B[T
MY.*TC&J6RWOV@V=XU+FB=^"\-$?S_>_S&S.Z:ST-@KQE @O+F'&W,FS&]AZG
M+&A8/_0L% #.<]FXUUS^93$OUY[6IMP!WBK:6&[,R*PX'MKO9\ :JX1:C,[K
M0>$DK^V9TNA[#L304:4OA!TB 14EP 9H6_291WSY6>UC%6:_:$)-4'0'DA1^
M!W@-CV:@:(:GI,J&52Q_#WL)1HE\-,A:O#]]<OI["M>$.H*S<"9<C6*8AWO<
M*2[M>S&A:MI1Z[81K/UQ!XD::)'U-O">[F;?S6P/QUP#B$L1-)W6 -VG!X6*
MGR_O2N^U L#%E ;IM)J-]9UMH@YD(MY=4Q+"7ZTRB"/[@?2'=CL3G"(05O;M
MH-Z$%_?GY*,04SF7C<:EUV-,:[F509& XX%K6AB^7O_$XJ[2<S-<VP/6"9YW
MYDG[#[][X[[0WZ=UGG]*\,&FT)6R@U!*O'A72;=ITO[+-'6^>^8<VV<"S83Q
M9&EIKOQ[F^0Z_-!., V;A;7 -S.=*!JZZED3 0H3 ("QAQ2!;RFM8[ ?3NW$
MR0TG(_X/I:+M<]2=611&XA<2RK)0AOJ?$W)T;N==AYAV[^W&%\'.?3 >0YVT
M&]8XYHVY@]K+A,A&$'R^1\2K9N?]K[-!GYH''^95)+OW" ?[5G+P3BO3_HM0
M$G]3VN:EXUE9?0=@IUQUO*(0UKCAK,XA5/U+=F/YPQ7?!SZZMX]H3+[-+:&\
M@X9K+%,%CGZ_ WA(P1IM<_ PX8\"+@_/NB8K8@M;U<YB,E+14&Y$4?J\)A?!
MI#WGS>,S6Y/V5M//N&YR\X<IS)K[JUFJ=XVF-5%,/?^J_4[5LRJIO_'FL?ZM
M(8^>(&PL])8!T?IUN!PXL:A.LJ?BK!.4^, X>#Q>[+?,95^ *<W"'RAT11!0
MJ%PN<R@;3G%[ $[][V8^+UM6U5EZEY3.OF3CK\E!\H"4FT\5"0BU(" M.2H]
M/\QQOO(]>^O)BC1<1N29W*<C</]P;')AX;:N%UNTKB[%!-2P/S/A>8NVY3KB
M0$4VQB@O0&KL[RJ]_NZ;  Y0&D4VS$3 1/9U7>S9J+%CJ%:RF#ACA152:?4L
M>,7RH^T9\;Q48=3PL"0JY*O^<8 ^PH3^3UWB [U79 EW:)IF>(72#1P'7TW5
M^52;:F<;NX]8&OFPP"_!P;U>Y6<4<R2@TH0EA?55-AT ZDI2T[?=?OJRAKP
M?NY6RCS@V9PN')BRBS_IZ9+_Z)#?*:8B*Q^:I A7O(\(U:+L9=4:&D)7GZI&
M?E[*>?-X3"N6_W[WP^0+:Z7. VL.N,:(+/5\URPW?T&2GW-)J K]O6:&KFW@
M^;IW@)!L"P1IU_FL;O.EP1W >H="(JWC9SVN_?Q'RA=U#M$J^/6A#S! '?>[
M>N+8S!W@,$UVE;7VU/]J,T",,3P+ ]$8=TTK7>?5EYFW4^%F+V&@M*ENPZJE
M6GEVK/+!PP# "=$!B_4;KO#YVQ!2J3L5CZ9UA-T!)EMU"L&9#T,G]4E$ZOBK
MPPY%GE$%C+U+NATX7T:J<-^8W5[DWY*HR>K= =IMT8:O7\.3(/[PZM,.4J2%
MSF1N<*^A*C"M,*6,+);9E8 EC>2#@Y@SCHA@X$"Y(]8U"D(IM!#IQSKG>N0C
MO!IQ+76N6RVA;*@0S3U0\<U*JG E.UVZ6:_N#M"M8K-S!S@?880G&EQVW!S+
M,4IN=]041;@IF]<A9#KR-6Q$0QRN^8O5B@Q4&T5E'&0G??KC;T\2OJT39P1F
MK'LU=FO@7<N/"R'M6UU@^"P&(B*[0#NH0D$\]?0;SZE#=]H!M!  @:?X6LU_
MHCUAV_*JOQ=5-W+H_Y06]/V6]PXPL A/O>V[W^NGK&[<[P!_EM#4'@$RJT^"
M=.#@I':#<S]=MW74\O6?YA":YM5T_/D)<7_FE(-OR,7U[]S^@Q-@YG]H_X?V
M?Y>V2GA6=AUVS7/OA/25W $*=86A_V&(GJ,55=!L*&4/B=5956B]L"R?BXO%
M+1G*KJNNWC5KBE_5'<!GXMZ%9<LNNP,L"Z&4*5CY_YT1T]3]=XCKM[(?W '6
MI1&"MWVA]QL3+N?N7X1IO5K5"^<A-4%^5/%/[]U3&KX#O!3Q7Y5CJ/@_9_O?
M(:93^KM[&<JXTWD#&8YKZ7@*:-)"TM&]F9.:)OS?U<Q_:XB%VM/U1CP,"QJ^
M'O@9;$%AG[M1->0$IZ]TFN''[V\?WE0XU+5I>Z;0R(8QMTSQ;% _$ZJI&6'"
M"NKDQ#O#6BHG-)]R6Y34Y^9VK#CXJ6A@'L^O=8"ET5<UEW:M,5MW&.(>!S/"
MI76JW$FE,.2V"F5>%H*)K7_D?:#-J[).@BD@F+9ZRWEMA_#OH95E^'D'Z"V]
M VA-U#'N[\N<J8E3/";CUXO4[VV3I\:C>N^)11?@BZ'@R2HCB/!";FG [1=O
MXQ@*BW\NV UZ.EH\5+:/SV.5IS'+/!<?7D?%6J1>^SPN(XSLATB,A;F"+"?J
MKG8SE70F#K=2)@U8#"K(B(74-H.T:@BZ7>;=?G><!<>%W7*!TPW@MQ^3QK[(
ME]+>J&FT9BW-K'NF_?Q)GM.XG"&")J(? HA=B:Y 6R.,O78SAY\*)>5LIV:Q
M3_(Y6"4>C )?+<$P=8:*/Y)$JURH#(PZ_^@"7!+$Q^<DOI?>A>RW/P8WC^DB
M&$/<GN6+1N6UU,<I7TE_+,'X3DI\-?M,W/H'Q=O.)YW1]QXI=-=XVM7L0TK#
MV3F?C7TI2,(OM=1,3I6*YU&FKC464IZ1UY<A0%J7C\:65+7Z4?V;@TENU;Q5
M/QMK'#*70=; P(5IQ[5EO/Y'?0B*Q*I$D?1?@0,[_"WUS\I^1U5E!?K;4]L-
M"(,?QD8FAN6JI(.)#RB4(Q.F\*).Z3RJ!!!SH745DFM;7?-J]A)0+D<60TQ^
MHJZ;7J5L4U];M)_[]9*2\QCMC2U!WH]>[;J014XDTRN_<8HE%)9Z53!1D/ 5
MO("I^SI>_I>"IP<$9"^K :\/"^+F*:JOG=U(Y/HX!;.Q?1?(YRQG*N?;S1U-
M9#VPK=UA=4@V5GHMY4AHQ\<_<\WG?/G\#@!43VP%WGY1-)W/Y[!%^V'[)]RE
MQ_<GY+\$7O+NH++5%74$.97K=SF'X9,EE7Z5^<1>U6@X)XWO4U&6J;2JD%(+
MA-G32]V',KK3K"UQO9<.<^U3ABK./B=,!]I^B7R+ $N&3D8=+5.TBFMYA$>H
M0SO_KLAE9;:_8X[1,R=SH,?;#3+?3ZJ47 *(P3%JUBV60L,Y&1F[=FJ$2"[&
M?F'TI4EC4#Z"0S_?-7T?GR.Z3[^)5O)F7*DDA_!M:F^S-DTMT+'8B+>@8=]]
M]HO\)C>G'!#G% <7)=LK6W7FW>F(Q-(=0*,I\FAHU0,BQ=-$[RM_P+5UL3ZW
M+VL+DGYZN:76W);427G<.PZMZ:LZ*WNJ%7ID@M)'(-\E;-'502.E!&O#[6I6
M3+8IF@=':</7H>N;N.^Z& 9?L2FO"?"2U2:^A,D!WAP,!?AB*8"5PMOYD8W=
M^P5&R,C1L>XYRC0?/#ZK>N\RPD9J>JL@%:W^CZCA0TG3'>P;77M^4LA# Z0;
M?-/70XY"P%3)Q9[(Z-?/-<M$G6<QY=AB[X('U@H!7L+DQP=EB/->!NPV9,27
MW?CMYI"E8)>"?G,W(&X7Z4W;9V)+Q82X@\67^D\6L%=H]J4$$;0Z86LO2^!;
M1B)S<\2_$D"S:3$9F("WP&@^LG"3]C<K1/(;+[$'!@$G.X4W]6_<G IQ!P@*
MU]/C:AY@I;&@/_9M<TI!DSG=:!Z#J(/T$'&]TE@]H:.3&A@_#(V_SYV-\$$W
ML\2ML/F9]^42 K-4^'[PC801]@Y+[MMTFQ&M?Q49=EI1U]!*7'CS#=57.HB"
M_KT*8PS VV2TXPO4[BQ->VX6L:-G-^9H.XG"79K/K>,5C^4U7O6YU0R&;]H#
M&^LV(P<Y_S#I=?6UOAJH#DS(@^2U=V[$GG:AL>(1:?@05&J$WP&(7JO17%-(
MF(R%'=2IQ<CSFDIW6&6R'#-K4CA;*U%CT2JSB'=U LYVQF:%;T1[QI5$BGPQ
M/KP:^)H_QJ1YT(^3+ZTB71:'%*\ UT)D2.KG?)3<"J6\"C/K%S-H?,L3A)ML
MCYD'#!67!ZE8''W.JK)\_$O!4<9(A=*%79K,AB(I62)8?:.%W=O'&V8%H$2Z
MF!8=.0 J_Z!X#F%U<17Z5+L N$+8,=R/OBU=(4D'/EMF;L^0QY2(;1FTPY:$
M2LI2J_SY#< Q?6/%1:?B5A39[H]O,DPG86A'8<K/0.O15)?P_.N3B,2G02_R
M SD&UNG;,,& 2Y(:MRKR7[?TB=BGTJI0R-9#"](!2B=VM%,F/^$!GT>(+TTP
M>J,^*'LX:TUS!_R@M 'D:>XPBQ@C2T&\_- WNO[D6#4['0LPEP6N,FJ&]_?>
M 2*:1VM<;\Q4IJ0DS5W.,*O?U5PT6A'Q)P=(!BS,>ZZ%0 "^!-A,1,[X/."E
M6@0EI)UL^D3-Z+-0^B^W$1'/_:W(404CM4^PXZ?))#X(\H&= N+I+51I/MA6
MA!M7=IA6\F2>&0G2ST1U[8;FU=MORB3RM><=+CPQ1>QHAYI8==H:'G@>Q)V3
MI2-,;)I9RO0ON49E,)'YD"5)>$HJS)%H 8@Z_+HZUO;=R94!2^)C42)(9L&;
M(45L*G37P3X-_A7_"/XZ1G(IQY*"8WP^DW2%AD9M7HO0GRR:I8"Q$9:!]<LG
M>Q@ ;R'H3$A;[[B:)ZH&WEL@LP#^P(<5?GJY,:^&V!KFYB=6YO&=Z\1FO-=T
M"+^(\MLI!A;M::L9WE,-?.CG]90E;:7LL4_-I34QQ67U>C\55<39IV4P=N98
MD<L]+JI3"JO[7B U4:?,E$EF#3K/ ](1#FER;?<<0NV\5ALU9#ZLM@(9UMV<
M9+L-&S9Y1;6'+O(JG/UK*EXMN2 %-R#A)15@2!KHFAUQRX^P1T[[2'\Q6+35
MO=R[5%@G7:5G#M4-5?$9$PS%*PQZMZ%\X"+',*P =L]&!/<Z@\<4IJSL!;Q]
M#7V?+JK7M[2*[*/X<Y$Z]A;9Q:R@!"E30:S +K![#X"K(U3",>:4UE?D\&5K
M0E[:O.+4ET38C*XG\2:.E<P;:/ Z&DNE42' %U_!N0.O53]+%&Z?59F6F5+Y
MR%,)6LYLF\^DW"6O:,W9]304_69O3N<_AW+[9Y\_(<\=_CORG&F(J7>I_Z /
M?/DFJCGU]N/O^Y"_U #IVH]%N$;QO.016=.I"=;ZB$9?T(A=*R;]Y,/ZB729
M:BNN+CP[7 H#83?5ZQ7MQ1CE:N_X6IG"LVXC6&NRP(=5DFWA>3BVIB+*EDP=
MROY^)7"[&!?-UX%/0\V%\_"Z-FM:K6(;OO/ G&V_V?0;ACU4CFZKB-ZSJW^R
MW?J;LPR6W>5UD@0XXEJ'K4=E,X'Y9>I;H3AW9\!S^<;Q69_+Y)NY+MDHPUW^
M5@1]8Z2#>DLS&JLZ<<C;:.)1,I3 PT,Y1J._J?RH'%9. V5R#ADESSNQ<DSR
M\H=R/K@!_><%I0;0_G#7,<+NQ!V]LS..+;O/Z[C?KJSK0+WMLK8RS-4S==E4
MOS2-=MTO?7A _KG?@[]_"UFD=>4&DZ!F$J*3",HQ3-B[X*\_D&XMD>(52%3L
M2@XK9JE0,V[LP;=00F %UHTHR8<:V?.N*".Z!)+!Z=_M?\G_TCG'<X>X"0%T
M>#0,OTY8&/ =OJE5%,.7"A2\F($>R89_M:/1Z&T3-6N9+)RYYF)(=K%WV@!L
MSK[2#N/P)G^%ZSX"\/K6'%+1/L[V#,4$IMD#-+81WXY^96C2Y0\B'ZDKD6XM
M91"W>#,TY$6DI&7&CG2$"3>DPR55Q]T&'86&>11I=XL]YE7WN%],>A(=:,JQ
MJ<9J+%:!;M+KY^F]5U(_6'Y-*(A<ZJ:U68C^Y*8PL(YW2G>2@VOZ+RL[\=)L
M]_,\K1+>1F :+ 20>26"9!41(LDP-O<I85K0RH?0(S8\/?18N7/,:ADNL(P_
M YA0>X+'C6\OO>PC@_H$M<Y[><V>YD0 RS?AK6R C\%9Q=,U>01!"$/4FIK8
MUO&C!NKZ]K!]_,\/'5J>(>J;Z#2QOLUX5SR%#JZJ187G>BX/1UB^QVW,.166
M?*+#>H(F?!36ZQCEQS GPP:6N=TYVR0UK[S)HE6J^^Q3ISDTR9B*7NO:[^ -
M1SFIN /$2HD7FM9G'H8+M4A"F&B]HWY,RF=E/WXWVSI';-0YI<:L@(,_PO(5
M!ZM$>-V,S(\6;*0W?9).!K_-?%16OO.8![([7_;2XH74AR;T(S*^!@7U*R7C
M!875;(*?BM]31"]/8RJV3;'B)V,ZKWYW\I88,_@ZS<.P SUZL#\E61@KI^.T
MXZUE7O[#+N50.G./\DG14N)C-,[S]<@+O;64(O\"Y#$D[64F"W2;\NNVFA?S
M*I%P7Y_8?I,*%C3I+&[FE _O?OO6E7@(,L(=H9EQE(K[R)R>_!2\?22(=ZF)
M-9/F4&M>KCAFX8D!>]Q#Q4J M:''U6^O=,:^SV+S!5@=92_B2%"K@?[LP<>$
MYS8,.21</XH!E7J09?RZ."H[0[\201/@Y6SV-\.=--<^VO#D]B.;^"'O,DPS
MNY,.I +EK9_&7[*N%>X V4E_+@PB?#)S2_FKG0T^FIL'RMLR;NS0;"0U?>&S
M"95_59[N4U. *H+114TW:UT-5Y-', 26;WM!1O-+_=\95H3L[_>N[9/,5RDW
M<@:4#0X"2*<303\Z5LG,+BYD_Y*M_N]\\U8\0^OA8R]F#US5MIK:ZF==76WW
MA4% '0=R*O.$FD(3?93X(44Y:<_2<9^'XQ7"]#B7,Y7[#D) !_9&V\W1"YL[
M@/&1 Y:WC"=[T3LGT]]X:WEW@+'!?T_W[C@^\O]3NC>$IQV M)O<'-KDRC3E
M*E,K*ZO+XCJ/^+$@LCWQ^8FJ),#I1RS_:Z3-BDV8U$.GU9^N@VX<B@&U_19T
MJ?;,>2]<F.E_#F402%I$,X!^ROY#<<"S43DFX&R8TC4;37_HG%*Z4JBOK$:6
M0:** _F"0^H&.VZ](LJZ@Z/A7JO2ZJ(HI)G^(*[< %(,3$WX5-3PR<I$XV+4
MFV;O#O"/%187UDYGB/2T7[V=FQ66Y#+V31O3:CG.#V/TR,#T>6/QW;H/A2XR
MR1CI402Z%1R_UG!R\4K+BF0S>DB6^S9:-==JR +_&T!\] E_L&GR/]%7<%1W
M"@)<Z4CD6[I_R-9 $?HHGDKW"20 -Y9 11R+O?T]EZ0JTOZ+;;OD3*L12'IG
M)ZW<"0(.??,FV0*=?3 :5<"3[C+)-/V?<,C*:V;\1VOPUS>ZT[^-JZJL?N?K
M^V^MWP%^)^P?QT4QT.BW&L"+/=</$9)\"]MW )+YM=U]A<YMY0&(YXD9^HE^
MW:!0]CZ^^0EU(;!HDK5M&?W[J'$H*R6.RE5DE_)*-*EI_S\9X) P7_ M[4R]
M+/&2R3,W)@1&WL\=B@Z[>*.A0*FO2_IB^+4;"Y(X?34WF3XL& MSHME0K]Y:
MVW[YU"O%6Q5=-6E(@\ ZVEQP[+VJ$WU[_DJ\OY*$%RO2M@-P+9MG)W*^70Q*
M]6B OFM6:)U+^YA(56')^>(- S8M)6W@+T)6ZYRVFTRIQVYY8!N-4'NCEZD]
MX0A@6DQH#MQ4GG3-Q\]NI:8!\YE-SI;47-,?1&&$1_)=7V?_N4+G*$9OE3>N
MS/ FTBA&WK6_/G8(UFE\$ ICM;8BH".AY?[IQMG?)$:>OY8- /H3M8K>A)1Z
M[A9Y5JM:-"0-L_9UQ=M@!0P5H55*"W!-_&/#!M_< ;KX\';.;SE:IBV:VI-Z
M$XP@Q0^L.QU99-0>C4LUJ'^7-W9V=I9C ?68HDY="Y<8[[P%56CH?VN,G%17
MTXQ7$0\2@# / # P?L %U"S7CTUC_ME<G1Z&T/ VP;@JWJMX%ME1S@9UWY1;
M_VAL6$DLX8R7[]OLP1/#DWM'X[J,4_>XGHNKHK9 ).U=VG-=[!4C7 ,<:I;'
ML1Z>3L<9U_EIIWS_>%4R/,R['9.AF#@44@L6J?)+XW;I*C(RW2%1P6\5*-8+
MYW.%/D&SB260H_(/\[_?G/"0%B^G7:\D8\SK=HL+&D.'MEXEVKZSB"?:=HA6
MCB92'GT B,=&GVOXAW.U>LV^FJZ!"0:]'*\[^USNBJ18(I0^_Q:C2$9Q&-BG
M(>62!JNZ ]B,X=A10&-J,U5X'$^M9M<;C>;X"\>='JWK#FB:/",28Y^//%O^
M)T(]+KD&P/LJ2L'!K[+4583QG7<FSW8V<6M)_Q=S;QD5Y[(MBC:0(,'=)4@@
MP3VX!0LA6'!-"![<&I<$=PB0 ,$=&H);8\$A!*=QZ,:; -UH![WDW+W/V7NM
M==9]8]QWQGM_>E1_75_5M)K2535G%"C8@/Y!2'UYK(6+7ZA/D4:P-%4X[2 T
M_56<4X/!:9F[_Y'U+KEL4(Z4UV/I0O>D$+.9O^'1#W_^-7J9;QG;D<(.J@>%
M;1 ;M<Q5:=GA(RX'FMI@S"7F)VLNKF.2,ZK2E+;GT@\AGGY-K1WI1O7&N(M^
M41ARK+B=;^X- 'P2!K>WQ!ZU*__=@DH%!D%%8G*Y\ZEY/3E^@K*'^X1QKB;L
M,/"$[+I8+=!:8D0P!:,')W[S"-]6GT:]5S1C>LJ.:-318@JN+3,/3;S/SR'I
M"+! )Y3+6M/_[_FS)HF_-D(8L4)5.R[4U.PH,O1<MDG )SY:5<+;DO5MEHU,
M&B=O#P-^RC<&'B3=F3WKQ.E>V#1K E- ]MZ(P0:3M_XKA9]=MP"_!)U_0^!?
M#4Q,R+9R=X;U%]BR0M_L;+):U=+<@ 4JY0&2I2X_&(CEWB1L#!T()0SU^*(P
MEKXO7EP1)%T6\"3GX\A#*.7U1\5G6,TOD!DGAW_#?G[H%\S#.Z<YI6\!$A[^
MWN>U,T^FS=;WY!$!:H&WPW3W']X%!UM2$B,V"-$><>_8:K"B[4)<9?I40/F>
M>OB-XM?L]1L_(< ^;]=VL9)K]M]9>V!@^J4$2E\IYV7:#U,SQI^+40?O+&\F
M/PZ\L^8RU<+I7ZJC+V1H'R '%?@S3X*EH-P2/0M69V56-B4F#3.%-4OON5X:
M?HJM31Q6JUGHBG>8_3N_(@K1HX(XGI.*A8S3&G\^I+=LX4C744]A^5X1YJ8Z
M2 5P#0:@M\)W@O[;(=RG]17^+\P7^?@MX+\3F^W2JHB_$U\I10^9?WE!^8HY
MYA8@P_Z/*W-B<,Z\OQ&7,2U3PG][X=^1,"'PC?[_*=9_"'+U:_YU+)]9$+2(
ML9XQ_,WQV"@4I%[7](_[FY/_=_@6.MUCN$D=W@DB>"=D/-L<H* WT_@#0J18
M;B[US;A&[!>&K]=RLL2;=L&_ SU-%9'3<P1W6Q82N,XV[ILNG.H)>7=N2?6I
M2K!MTTRP/A&'>BO'!U$GWS'#P[,1[WI_9MC,9(ZUN3'; \!5^>ER3O<'-I;M
M$L%]WXB_1Z69-YSQB YUU\62)6B7O,CW_%_[0W*N.!'#0U57JHRV+,Y1GP.W
MS4]H!?<.%;M6_P]\<^O@0SP UMINFYIK3UJ_.IJ;?RZBDAGR,"F$>CT<P/?S
M/S+W_W<T=,VF1YQ&A'DX.'*^B/AYIK?V0;XO7I6K-V6(+8HUNS!C\O_ =X,5
M9@2H.CK7V%')<./K+2"M407Z)F<>(4J\G\6P!O'\&WE,R7G>T#R5W?6MS'Z"
MRK^>5KZ8_W?>!P9:Q'5ZF! M/N-+I?C^?O)0<NLE>8ZN(2E@U=C?@1*/^O<K
MK*/ \YX8QM[#".2OC5\I2['[NY<IAW]T1$P(>'L#&1J02JEL88MC9"^&86IV
M1H^)/X;KX4EA,\Q$K1V&STJ3M"5?'QPT!.C.K%]Z[IKNT:J\G2O/Y:"63!1P
M'?4-^GNNUPC? K#LLMG DU7.>3;I+UHH]3:IJE@!L5F>=-F<X+]1!GTCT#W5
MT\N -^K[WLZX"D3<1QQO!&1/82TZB"J(SHSDBPO0Z/[!YTHAQS/:F,8D9@\,
M0J([!AAT=>E ,D[_SFI8W%EI';N+!M"5 +RZO!RT/[H7GF;1Z6$EB]O4."ZV
M72WTU9]O?+2X O]$>X^P7)[[8'N:\7NR0?"W/"8 X(QZC)W][\V2-[0:W6Z%
MJBWMB+T%W)',UB3J7?LK.3+](/<I'>'W4]:,G;V_4X.=)O'52 6E"7^?0I0T
MU)F@J5R.K:]6\=THK=('K#?KP9A0R&PK'.',8+:X$ @)PH\]'L"69I@!"#PU
M^8) CDT6$EHA"9H]<-5\^N)6\K:6>APWYP?:4[Z[M,UYZ?Y0_8D&XG/HN078
MFM/FV_J2VDHS92S I_I:V4#S4U71%<K"&_9(E5='U#C#%YZ5020K#H&TJ!X8
M(5:<OD'RZH!(TE#^4N9\YJ6(H@3/54H;\4^%K5*J$8 XG2;6!'5^AR%2/ZJ!
MD!C5V;] )RUM?M\AFW::6Z86?%FVHMQ$W+M^S?@=UX/MD<J/M=X4^'TO&6R/
M3) [K#KA\-!?JVJYZGVU%"@[ZR(F4S=:S>!3Q<!$L/6;ELN2(H!O1'3@PUT&
MTNF3:Q[H5NO,88]PU1<;XC0?\L#C?7JRMU;Q6,)1KLAJQ?H./YSZZ]?"BK8I
M/]&[%ZP%G!?K"0J(6UA=^,T\FG"AG8MJFJT0*XI9W[%PB\8)]F8+%CO+U%CD
M0TE,B<1]N.Q9M6OHNGK;K(W!,QU[(N;*VB>A@RU/M9=;4Q*"? &P>IF$%3KD
M_9]I9XV^D[_$D^U(1WF^,"O?'Q$H+ZBY!+?&GFSH%^E'!(XFX"U$],D;TNOW
M05B/L.^QVOQ*F&Q_KPH1&B/=+=Y3F^8^I16Q3ABK^R1^@(6'\1B.#S!J; \]
M'CUB4WWVTM(M0L+ $VLU(Z.#%7%3+TF[-H:_9!?X<)JK2(8<HC&M8'_<>IUT
MR":?7#&H-(LFQR5V8'\+B )[5]@3 :_L;H1GF&B">AUI^B= PB1]W"79,ZQ1
M;AJ#_D,$*_K55+"0N4M!H;?Z@S?\D]7U[2SKN8W(DNC7YCA=K<7Q!"UB(E/7
MZ3_$WBP6*ED-I#]\"\CBD(0H!,'B%/HS$OH<''5,.Q'[-R'%<IX%#44G:7MD
MCLY;N.VEPZR8)J&,+M_V6>Z%HIUT*'+[5R/2-(BN-%#5;I)J,*D@=3]S0EOQ
M*3L]_4/G!\O\J87X5#>8B^$)>?B#@]K2);GRD,]7IK> I#8H[W4<]RV@>.3B
M=^FT?Z]F+<N0RA(Y\:658ZA:H.TZ3U+"JFKG0JC5"2Q,;V$BD@.8W!B=_(:6
MFC(-D+L@-LM24@0R]D7$R3CP!B>%:P:.P.AX@G87&%9#<@GM$9!(;K!.OA$\
M+4K2Z_R!H?86"UE,J!Q>2:*;.,WD*! K[DKO@G! AFQ7< \B[I7.'H)_)0(*
M1.8OQ7PF&B):$NE CZV2T,\"4NK-2#.A,KMFFU8$(=8UTX$T)G#11$/[2<4M
MDP'7=_G:.]VI-^[)V))$+W'1\2X94H2/V$,\<XCL9AGO^;_HX( (@RQ-HF]^
MW$R>:]HQ=:K\=&*+I +*#B,&(G3QO.G[ZO3J":GW%M)#I8F!'6/&TS+01Q!)
M.8;,JMU1'ZX)23>??!@C4^/@ GW>^R>A'88_7\I*U^1FZ8^MUGI]":A">:WW
MM39%"U];7YG#,VP;.Z:-C'6CG(U?'R703BL'7[M\%[<@(#Q+0)4$0.VN#,MW
MI%E;$K0GA:]IQBO/M[#WR5<(!:CV0WJ']UCJVDH91="DS0$)1?[$2-(7R).;
MAQ$OX[?8QT_9)ZO2X"S4QVE/-R3DX,U)+GY3]3*1-%[MZQK$P#?83OG3'AR.
MUBV"W[2HG217N?)D@(&;1PZ;&L0&]D2VYO22NKFH3,.I*X4"8.&RG9>XXRT@
M]=XQK9IZ#*ML($KMG.\7%>.C256I[!;8X4]>2G^C&4]'><<'AS?$"?B51W.Q
M(_=^G*^57_4X<\<F\V=MA>2HFYCT.>"J"461J0UY6P"NU*UY(V. E3LY\Y!<
M7)G&(%NJSHG FU7.H//+]:D,U&&O-$=F;ZMY_UU8!:>I3RBVU;^0V@P#BT]#
M\)V2!VC5+O>AGS$ *JSE-4^K1F!8\0UW=NW*"2D92#%]>%JA9A[N9I\FKK,J
MW/L(ZDQ.8;5B[$[."$S)\LL*L81G)1@9_0K2GJT&\=PPKJ#<^VB*]A.B)&6"
M'I4S:J8%+'(_*_,*^Q1IR/8+1S;W5S!#3"SC/?C%2G(@GOTJXO,>B2DPI<<W
M9'IS^C!["X=&0C'M\8L77H_CPKV9\+J^]$6- @+\,K:%S.GG'#KXD5CA>>%P
M;N5GX0M^[R45B2?=.>(2;P%$UR/'^V8:"(R^A<H.GC;$:A2(=_]*/N.%_HA7
M1E;Z@G41UN=ZDR[3J*A/3=\_$&!O[%<R1EV@.P21!7(.2^I6 *WA/=\R%#?;
M=D57K2R95<O(O0:^PTLP["1>WL@][<*:$JM2Z,\A%;H%8"Z#4HS,X*T1\V:_
M*NMWP/-IR]2ZA8M+Z' ^,:F*K39>1F#Z@+< T*_/C%\#S:$,ZLBI6=.<MF6L
M9+=AB/]]CZ:ULE \_].J"]4:_H"42&TZC?D^5BE\MG;9OO4ZIZ>D(YZ\[0N)
MS^S:_>M!__MO.MVIQIZ."6%?6*]XMC3%Z][7G>;#XU-2\B%_Y+"ICM4GOMF?
M@% SGVQH5SH[[Y-=1(5BM:?9+@FW@7\0U1!+:E>AR;;YF%A&;TDSH"KT[F(
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MX<^]4G_M#J1K3-][M:DKU7Q\!C\?#ZC+V:8:$:(E\3Z>\;9I"9/+JV.SZEL
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MP%5[[PGCMNG76\C.\Z/(84U4(B&E2>!6?1*=IZ1FP_72CS#OK[@_8)>#)QS
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MC79^#+)5#&WF(=2 #(Q6V:*[=UD=L2ADBMX!9LIVRDD^-I"=HKG2?,&!+WM
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M\JDER;4?!<*W6Q?VBQ,_28BT/IS[28Q__/=,Q)*WSE@HQ2D2OQJ1;U\X4"$
M[.M6L]V/S\67U"Q+QM.@C)3@8XT>V375W*7%E13+,;#2G6VR^?J+Z>177T.2
MRLJ$NUV79-0;W'8>D\3H^XR*M&/L'=20O$;>TQ*J="IDQ</#VJ!:V($2%C=*
M!N#50W]K]NV;90Q(NP$1^K9)*@8,U:NM2>N]$M=OK99U^('O'!#O4Q5,QSO0
M0;[C8FR\W7/CUYU%:N>*_]AX=?=*;?F7<*K#MZ3Q80O02R#OT%YS3D96W,"K
M#K34 [MVRUC 3R!?"Q=)V+:2=6X#@^I^:+H*.:;PDQ3)\=<!]?C]-C.A$*Q@
M\)E@FRIYZO,,[GAR'DMOMY3'#,KTW)J\@+>'H[)2GM_P!G@%'8C[D8(()PO8
MG/HTF%.$263NU/0K:)?YS8I\TH+Y>T\QUCH-U'+6;C F#T+Y7+_A#A 4M*U]
M!U!)OEAE&95V3-A<W^BO,$!W30NHH&B8L9SPLVFFYO_Y?NP-;*.>5%F<G#[Q
MF=A%=UQ6OD<D;*Q[T!)2^L[\5B-DGO:E:<WP=7R1EK.'Q:VVTEAJJ I,Y7[U
M\^O>I@#==N]W[ZPI3C<Z*)VV9]+0;S  [O_KL/__)_F+\RHL8?D.X"XS< >(
MIOTGV%R/N0R(- "6(1Q?3JWJSJS7D$YU57,^8XLD?I6TIX(%\-)Y@__\C_YS
MQ]=5MTI(JW^ MF._-,B7@:%J$Q5@08Z:B/,M6^\O#6XQJO24RL$9SBZG++R-
MUUU-J9R8[4BF"[_EV!.9=:6_0V\NRU]U94IK/$&4]HK3_F2N29-+93/1IR+^
MJIS6S2V.XS7Q5@K_EM"[_:C_DA:>^W>H+(*MDN*/AH._)T=+P7_N]]@R1/P>
M$7WB$>!J_X)C@/T![EK2UK5VHZ$$-K;%LM!TSY-:I6^ ^'X46::)MQ)C")6C
M.T S[89?7^P_P);1.P 4]S:6[=,=H)MT7S*IVN@9ES&+"H70\J8#64^4.-H<
M5B8'WM2ZSLA%I% %;C>$ZYF:H7+MIZ,]XDQN0N-%X?037_E>$K0%&0AK\^V!
M7]P=@.(T-N*6L3&AU^_1X)M;C2?5>/@W:(ZA%:UNGU^P?A*39:>6!RCB,[3<
M[UR(C);!O@,<6#C>B)C<<\SQGD\5?^:8R_AZPJZ)G,>U\FZJG?33EI;Q,[)?
M%3A[C&HS/&9L4*PNPFN7>'_Q>"5U'[9*FN,_V@JN7I@A8Q$3_P!GB3.61,X_
M+RT.?._DYXP;**3_$O5)*JS8F:V2DO8OA.%,LG"M1#V=6ELYL:XZ]GVQY?0I
M*:#RS4^S@BW11YXC:A;%)DNV!HEY"V:+^HMEBBN7^=KUS(&.*$H<]6@5QDM:
M;\6S?LOS[VPY';9_]%'TN/EY!V"\%?3[.RBTE<F%^-R$'V8&.T\I4"U'!/_:
M==,J[&;O\QVCBNM3WUIWLI9%:Z.,B]@__& ;^28?F(KIJLLG+4+/*"IZ)*[U
M5N2?Q/!/8'_^7V\9I_3B]YIEM%7AX6168+1D8"!T\\,I*6:&BOY+3,3#-<N5
M,L.!$\.>$_H(14T#?N?7ZW$(K;?"?_3+_-W>QQ'K2%8X#0\Q<+U/FH("-.M!
M0^G].MZ:6M_R=-U2NV$'8'*S4TD3]UO!S:4CZON_[QCD[(J;)' WEU&*">%7
MR;/W@;ZX/I-S$"%<0UG-M"VM3RRHCU&*SK;4[!/9RXL)7?IK= 9*D@WR\Q-G
MP#47!+U24T2?A.T$@W#2_WC4E!-+X??*HT#T!M?OM[*LVK7Z;S[.1%IOA?X*
M]9Q(E(I_%\/_E;;%*9"@F?Z/&*G_[ZBJ$)]ID7=>K<$/,5^DV82M%+1*.=BU
M=S7MG2Z_NE7=#KFW/L;3[;]RAB)1]F7^.\UR_R)(M:H1D>^RIF7I1I.+F7)3
MXL"D26_5TAO[R"7>V:<J@A,K]R](V)@"64U &AJ_=(N<2]45-#U?R(8*-3+A
M-GLEX@SE-UE*)S+/]7&Q8X-5UNN3ME6F>)+56Z>A%E:0]&#FCV+T'N7KB])]
MD2A[[?]$Q$=:;)"""TTSG"HX=@O.P;=^FV[7_ZL\_7''8V=\)R/:;OQ+/-#]
M :B*:_\5,7D_.>O_@!L-JV1(!0U<F_,%A?S(/:\\6.U @/F;CG#CUW7KJ]RY
M1&_P57X_,PEV7M-&-TG7;N@)!HUT9J<#=H9ZWU Y35-,_K6D.X';_;HK:-7?
M&YNJ&YLB]HXX9.VG"2@E,#"^*V)JM KTW$K7P<ZKW^7*.UR%5'E3)?1:/@F6
M?FW&O9'I_U$Z3^NM%-IOM+^"/7"=)+'4<"=0,41-^UHW1'^M&H?1[4VXOL=V
MMBZ&\AGX#H"&F-* WP%"<V9^S;Y[HL+$WTO7W<W.IQ0=^IZ,0,$_>WW$]SY-
MSP1\+O-4.7JP?IM"\<OTG[QN5C_MB1;RX1W N%SFEU:%W%^3V(<8[KWR"P!)
MN)7M.6A/K@(.]WXH/\*:_LPAT9DIW B7C"5>B99.H=-S==YG<BBE?R:"%QUW
M+[T=O[^,F'A$8L%O$0&V$-;J1L/F2*46U7BL+SK*Z&CIVUDO.+'\?F^'O^RM
MDKM&L]\!7BF&Z+L>LF]QJ,EK/I-L]C3O0Z%6Y^=7>AFQ@S2$+LI@[3JM&&,E
M%J1*6-'%'H]P5+Z6R]*VJJ3.^LTI,=%P@><J34#N<_((8^YKA3<KT(DPYWWZ
MG@_\HO;]L6!5)WB@R@3X++="\4IH-,&NWH/DI-+9S+'I=4RAI-GLO9+^%9F>
M%R%('[QZL$KNLOYPOLVP77*DK03JR!,/= ^L3Q)Z.@K^'%UM_$"_KC8V>,_+
M%?9DR!T@IB9-**G;- +R#O])PM=TF4%V"V>MMMJC6JIB2D;/[!=XZC"^7E[I
M]U,@LS*@/XAXND7-B;BN!*3D:7-J,#!N:/.X3.1!,@.#4]TS@@!&1(AXQ%;9
M]N2OG3*WGV?6>(7V<*4#K675HN;O!I(0)HV4L0'-].TZ*8Z#YW',.N86;N\^
MRPTPSF;(TC(" XTGW#3"FF)"2X&++R?/2OW(Y%S.KS->SB]C XH,1A1UZGB9
M1>G5#Y<5K(#]/1?B>+5PW^,7J2J,=3,U'Z85OO+_2.+8C,PA5E\/NW#H'!5Q
MYIB;@N"NEY<6&B,*MC5A*_F")V.%Q@;/3Q*_Q,/#KPXWBM;I/Z*0$>^T@?C4
MJ-N_1G(\?4JR1A8P';##SX;6(TVMDB&A/^-+8K/@&%Y6B_UU4_@4JW:**Z:+
M=N 1)8ZO]I#HH%AGN1G4I-'6;]WP& ^D/,.%%+K)SNN^27"AXG\1_M'C(6Y>
M(X:E[D\Y-*=+KQB.W40%N6 4V0,,IGQBC\$:=M!B6L[U.-:@M-!4S?#\+:="
MJ4U]<K*78^"APV'TX6D_IX>U([U^'5;7< M]QTY_P)C OC3[)$B_A)JRKXWQ
M=L!>XWEEP[@0+?V*[I<>G%A+]KCPG@91TZ\P,2J]&?B+!,7OBD,[:_Q-Z2%8
MV9@)/\*7< =&P5'FA'@RF6QH][G'(X2'"AR_]Y@T\O#%T?&K2;JI8S!Z_:3#
MI_6#@XJGT:;D@]T\'*-\(\XRZ&X\N,#C7AKBZ)97^2-%O;E&!C9>((I2[&@3
M2!B#_ML![J$<1?I.1D^RCHIB-S"OK;C4>:8#:PVIIB0F=.9<E6:3HY&R&F>#
M5LN(.Q"V<B5A:^M]3))A[%I[<I J0?;>VQK=@CB-'&>(DNZ=HE<$ '+[!.A^
MM-C3W7&5F/Y='\A^;OB39VO8!\RB>\W+K;*B8_)L?MO5B:(6OC?K@P8=Z]*@
M7E9@RB2'W2PCQ=,GLIT^<-M':8UV^ $<R-N#J.:*$:Q=+D ]C3A'-_VS95U(
MX+*-'E^>HP1*#:@(U1\ 0#%^N.7/6Q-+867"G$DT<4:I9LOHF=1ED2G:)\HY
MI$R^@^GLLIMZ$HNR)QQ]K8]4C3+J,D]0FHQ[K,S_H\WI+98SO\"NR59<F6HM
M$<,56T>A)LJ_M.N:X!B]9?<;F(*UW_;IW@&FW X!7I2\FBJB:,5")]O=&NB[
M[<2U6='BS$?5XCL7F1R6#=55\7SG1<]Y/QIBU/%1JHO[*WK-37_Y2H1RTAY>
MH%N/J"VPQ:?)@F9PZT@_?NW(#:6T","HJMYFNLSN?#@-ZT[76=8_DZ"EWIG:
M.RX$AGA'+M.9S.>MZ%;D&]M'?@V%=_P0X>?&Q"F4LMW-B?A1]IK$)"A&@7O\
MC3 FI$-J!VUC?P)RW8Z!^.[S0=7[6HH1RMQ28+L+N@-\[W&DPUG\&E]:V3!V
MH8J74IXF/RYX3(W402Q"&FJQO#D.&954W50+I.5.CGRM/(?LF?&'HPC%/[1%
M]G(!0,NY-A0KI;! ??CC*6Y.I!*DE<$8;YDN+,4 &,/-)(L_DA%&*L/+\)(V
M?4X%QN*'LV_"."UTC+E_6+0K4L>7OQF<6!4QBAWLF/B33\+A434F6CP1Z;:U
M]$\ -8 ( WL<Y=<W_#3D.WNS.P"NO8=0F7 %6&%-;+.>^77[PNT,;4+4'8 &
M"ZU<JI2TVV-=IQ:A5@QT6..)V&ZTDC3XM 8>K#UA%E$\>(KE/%1<FY7X'C6N
M.:MD%S684Q90KRTQCA7J.]1&.[$%HTX.AZ9Z'[J[9O9M'1G.6[ (-C@7:59I
MQ1I99K:DGZ8ZM'Y#A/:;L(^#K+T]WZTWRQ!X7DFZ'VC##V3E'<_- J^34+J#
MUS*NJU*O=#\7<5*BT;VE %QZ=%W5)4(KR%0M*X 1:HQ0EKCRI>;Y3CNXR:#]
MEDQ2Y@?GV0+"]H,HRZ)!TY L;$&_L%5,H<A%U>)R2<W)/??/-OA%J@+=D?,T
MS-UB  O-$X$0J:_;>[B1[>X3S63+,4[JW_#3:U5/UVD#I%GA26"<!>H?36R5
M(3Q\X!66()&O'KAE(B_UG<;#IF-;;&5>PY5":WDH3*RD9:8M:J:$<-'4_'",
MGQV)2#-=R]5_1I6>:!^Z;A<>;]AS^75(K\-DCA88]\>+$,\18*@//RT1(JJS
M>&G1-E6Q,'?S[.%\.324@'!V#6#F'VI_F)4RC+;0*@.AOJG=/D2#IW=*.A_9
MTT6#TZ'SIY?FEE-"AS6:6$'[Y[YD?@O:D'+I3FH$K&Q2,O-]7BEK%IGNT@/Z
M.K3 .=26Z\[ KB:>3C\T8,PMU#;MT,!*\'I_?^298JT$LW.Q*WE$$%;46T+E
M0;$*\,XW_!@0*9QD6 5V$]P>7F%@BCX/;->9.DZ!OK-W)-D6+F:/.^EZ2/:J
MXU+II9YI\4[;HRFD"JP (M<V+KWL@Q%]7B8YN<L@T4\AP UJW;9!F]<C)Q/Z
M5<K00.__UNO3TV4VM/5EB=YS$G'IQ+S!XDN#OC3XHSUR,*COR<)B[72(T+L9
M1O.G]:+H9L2LH5R0P$Z9)RUZ!1I^Q;9>&A&.$)5WK:E0Y;*7<9X!3_SHOMG1
MM'P$DEV=OM\6)3_K%?>7UF?M3BT/++%9>00?^>+ED,M5\,[6E$?!,%A2B2$A
MV!H+#^L;DV5%!0AU5KUVC?7#Q)1"_,KMUO):?=9HG3M^DK?',0'383\:NGN%
MXH/L%\$H&G9.+P":]X;OIR;JQ)]^[?IWAE[F7M:)J:3('>#]4?X=()]$9T=G
MNZD0F3R&>P?XV5SLMZN0"/ B)M*2Q?AC %T]/LH<AGH^:(A2!I%OF@%'3]V#
M\,O%^O.]HZFMT#:;O[)$0A3SUTS9E> J<,:>NIZ*+'85ERWP /4+.[OCW1.1
M[++K,7P-:U@IU". A<,>:F_:DS!H:=<RXD2UQ4@%46+^2$9"A1N=T.MC64.(
MAZGDQ2N0[C(EB**G4FM+S3XZO^C=_4AQ9.^9O\:ND>-_C?^;%_[4]?8+RLH?
MO-$+O9WP(@UQ"Q=<3(MVE\%&C*F_DDXL(0^R*VV4+\:1C<,?;L2?J_4.EG>S
MQ#AX+P95T>1]6\[/+X;I+^88U$8WTZ(%.U6</ALP"WV=*O+$4UF+:>&@E"%P
M .^;*$VTL0^1)E;B[01%,#@VR+6]9DG!L5FONC\5XA+^);-M)@NZ"X5=]!OC
M]S0%Q75GJ^48+7#]BD%7X=YTHXREY<6B::@PSZ,C^'0?LFQFH2*ED[MH*"9!
M+MPE5TIA&"N%3K;O)&E<E@R-1G]4ENEC.:&0F<4UIY[YS<]U&"3[^U+7&(P^
M>3/CAIWQ_H@@2I[IA'0>@=MX,>+EI,!)5L0IBD45X0;PO/A_:A6+Q07G TGP
M?#K#]B/N2; 207G;1.@S7O[LB!4ARRK1[%;!=I/A6"N%;]@"RR^HD]2!D#&D
M>DO,.G'6B68DOO54NOH1^_7)J,!"FW^1/>=:99"\(Z'\XP_V8;S\*DRW3 F(
M<?29#8.57*NLFL)0.MNONHX'MG&;*0"[I)<X>N43LK1/$:$O&BMA,KT:F"_R
MD?)E^R&V#Q[>;/YP\?0VQM(N#4$_[Q?:\^6/[98A<.7(PNN'-G *M6-KV$O6
MFT?-+RFB,8K:H>+[>L^5V9./BIV5"%\Q@]NRG7QJAMUX'YDG8-G$1(BN6:8"
M+E_UF3R BT0>(E^MIR7:+EID=G+E1OSL<0 ?;A&JL/>I2&B(CFD*3!8@MB%I
M8Q$4Q^%G%3CMYP5I9OF&F/$C+3T-%@WZ^D0Q9$&O.LZ(S_+I #@H ;(T(CG#
MI-'2,HO !*4,'E=;*0SP9E-P('V\DN[K@5LZ%"8WXH,:?Y3Q]TG^CV WZFO
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MZ14/#:H%&^K SMM][+V%$XH-\D@IW#:\3XDJA;MTXEZ@QJ:?SH$E(-L]L23
M[:[O74WU/R75(/;B>V/&(I_XT&RL'N4JNW\,I;%:C$T,]FKM[VXVQ;:>J\_$
MFSS(GIM]*MU[?FEA"UP>W0*87[Z+97U++F5]2P #U,/.P?AAW[ZW3+MM>]9:
MU$>%F7,&2%9EO@A"<?:4O!K'^M'^6-()BNL"\0BKR7"^ _3X4L/5TSSR(D>D
M-[/9=%4;UCT94AX_9 #58Q7P*O)SC"/EH8YDP+2>6P'816B+,5Y@$<*"*R_$
M1RYGD8$_V=I2+8N?BG@HL0_7:Z/] 8C>*7O5FE2<BK3)YY<U;H]>S&D* 9Z6
MB 3)H\)O6&AU[)D5,$;(>6OI+D5!-H2:^UAS4LNLNB$>8,",1>^W #@-&9,<
MQPI *L/G8LH$5R.OP,G1/)R+7>=)33%9&*TMTKI;8<V*UY^KZ1D+Y+;!K@OU
M84CO7$1USP)+ M3QD&/_&$^AV'JXY$%.Q,)AWD]"X=<0=5G*^K?K8&^\?%A@
M%T7_^7CK1&Z#L15*4>DPR^(W<2S*2MG="-75P!7\Z8(DPU9R;O.D\3?-:H)1
M!@!G1C$'?W\KM%0$Y?JEI!YFLV.)G^WN0F_PCX_&U@9[?<RU[B:HROZ<8<OR
MC\Z\-O(0KR JA^\_K2M&'#*V1""EIEHF*<-BS.(R!C]PQ/"K<X"_R?VF2O./
M%^;_U&36=K)TQ"WV4K0=V^]G58G?KDXTP$OG;R4A@B7E\4[&$L&R$F6%O?YQ
MO4&*[>BS\#9V!+;V# @%&FG_8=TH!30/"1U^HP#NZB=ZKCKNP-T/R-00U91N
M+J$("7Y7LF)]X>%>->;R[FGJK!)5U^8+$E.?LF[X-_RX<NV?OJ,4ARWAE(@@
MQ.3KAD<I,@XB0YIK+ADAC+]Z=>*YM&GGU]=?,V]%]O #^V#/'-Z4IL3.(\%I
MS?;S]8MD%64;,)H [N:;[U?F7$6>G\SH1Z?8*)_G"]0,8 ) #@"4S*?UIOA(
M*>_R.X#=2'[75<ROST,NH:ZC_1:CLQ:#W8^5#Q30A 1U&M0H.AT&1=X_Z.E)
MC[]6/)X3ZD'^^0:9?T>%U._;S':U6\6B[8O,-3E&MC"6<16&_PI#)A0LU5\)
M9SN<,)+]7^U==U23:Y,/Y8KT(B"$*DVZ@"#20:1$!+&!E!"EMQ 0D*A413H$
M%((7I1-!6D1*P- [*(0B$8*4)( B@@D(Y$* 9?><>^^W7O=\NW_L]^V>W3_F
MGSGSG/<WSSOOO#/OS#O/PEJ;A@*'+G#;<;$93,%U[6OG"6\Z@<279-2K>EJZ
MTT&OTB\(F@M?,1Y\GB;/6-J!$^@A1\7KVM4+(C7MFD[?Q0/B>-[5ZEY@$.5=
M4GJ^/>Q75YYCE^55N(S? D;4V=VQ^RR==/2:HE1:-,-8U0B#RVFJ/0BOKT!>
M@20TQ/6NF+\:4_6O%W&:HB.ON5;+F!."!^?1X1]J[>S01.@I2,ZLM?D$S'"X
M@YSFZ9F@IL-Q50_$4BA)K@>$9Q$'Z->);3$$PR>5<.GNXSO@K]J$[A&?FMX!
M?]D<T E,Q+H"&U.<M/C$6O[KV7HY#$6DXS4(->OC*68HQ!Q65C[VBUEW<CUB
M,+@W$+[L4ACD)S!1A]R0?"S,7UP<(KDIP)51XO!9%UR=6SJ-0J56NLK?3+GE
M9JS&?Y_MR-U#?_%W?\1C//LM.9)W+#QLWL#B'!X&L:EKF0*"S^^Z*(1QJV3N
MQ$W'S#;7;H52[1-"6N[!F&AO9F</ %<P<4NDKF[!<OY98XP->JF48K@?>%:'
MU(*#4+9R2;FJ8.WK=6D[@\Z"<9=[3?JE&R6C3423WE*BNEK8VRO4QZK 7D\Q
MOX8&G\;I/5C<^E4426 7Y2!3"[B0S5;DU!<U'B0<P/?.UKT[Q06$%;42O(8T
M*Q[D=//7H^3%CS;J.*W5^D'O?'9])>*0*_G:>!T<BO;*70-W8>6S6K\GQ6;9
MZ>@H,N@4<$61H"7W6DN)^:P=P!+[[<[U55[C(T*(IU-,N^_X)9QS/D7Y&9RC
MA,LTCG_?_58CN[E9]6CSG9?<4=FLZP-]QB;25#0$*CBP&3(!G''<DU*K_*1S
M[:0,]V"3E5&LN%A\=Y[\Q-*XB@>,IZ@GBA6A$%@..&)\6_B5>KZ)L<39\/L3
M^I>+:'X]D<P9A2V4M5QHJ8N)0=:KZ&E"<BSHA =S:HR%^%3Y7/T[8,NG9+HM
M@?LI/H-V,<K[Z>FZW@!;^N0!X*81,6=GW(9B&(^: A-,2GM'P 5I\\ZG+X[+
M"[%]74 " AG.\L\<:[_''0\-@'[5G"R,(S('L[Q[-,+!+)LH:SRO&LAB8HQ3
M$/':*]57DDLW]:D@WKV8*O%Q/?EDU@$ CPZM/,5)DS:EQ/^ZEU':YPF^SJZ@
M?.[4C/&-Q[SWY>?O,&*\>>RCPQVI'K.)NZ9P)8L()Z>ZD5!.\9W[%=92PM5
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M6?U")1*+)[A2""*KQY(SA+.K[_P6::L!V_^\_)R-J!SE!>%==D15MT'+EP\
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MXX@EF 3^*G=D:.CY3&TT(!02$@)Y3M!_E$JD&RI%1; HI#6N&H6"<RX\T*@
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ME*.41<Z$"9  7PY/+ZAX/$,X'VC27]B).T-9G<-!3FYT!&O<!MZMA*#Z>2Q
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M&)2N,[&\HI3;LH(0KD(8T)!H@;"0HI"&J+/'-QM"*QH==^8?%W<6X=X5'3X
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MU",</40>A'\55_3BY3U:,48=4[Z[WM[VH-HD/AE:M^,M#LQ:CPME]_(PG-Q
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M=IE*OD2N\[EEJ+^D(][_?A/>^LQ(.C) S8TA*JKA_(KA5H+L!'6D>'0VOY,
MIW5W6.PJ0B,!?.2'<\W'"78IX02=#2HK')JF5@V=,QZP/WP\F=R!40$9;(%>
MKL#1/#8!QM-Y7 2M\LZCBX*A@KQ/G@SJSP37L>BOI/A69#GQ'A^[-+W/X;4Z
MD=R%0 4'$33XNA[XY</[)J;-:8?@J);^&&F):J8W<^KHV^Q6) !*481APV;X
M3*CG$]ZR=UZ'"E]J] K:T:N+Y>E0;()?4C?,=WH3MW5?]\G$Y6+;/6SUN6I>
M7D/AF:B/ECH=]NS)2&$[_*&AI-,&^^K*JB[P)@_, P5Q,GO?VSSK*<[ )4R/
M@*\\/J]&2/9CZY8E1V,WU31,S)Z56J@AJ%\1Y*-F=>X'G&#I^_,NXK5P2%WL
M8GB;D7/U.K_(."84:]G\C+TH[/T5GY,!IU.EOCS:!ESI#MWR^P9%PSA)1G#6
MYL*@WK'@O377_=1$6JW8_#-=@OAHVUULDW'ZW-R\WD3]@,G#^O:&)@I,BB+U
M6\$:[6%6NP=,"2J+"S\\!9]X>"34SV P>/ME,) XS:_8A),*>U9]ES_*:51X
MV_*(9><K)G;-$Q:>/@?I@7,&"([:)0?<1//1'%K>URB2RG+YX=()4YFC ^#,
M0<P$"!H9M<AMA^./*MLHV#4;W5[.4MO1*'FL_/W7O-CQC@T&*[Z\/;4'P>]"
M)A=[-"6FDI^G['Q@ZJ46\XD5[;QFBA,ZG9H4,\AAG1\;'$(UQU_C&N@45VM%
M2I6F.R'9%(#12("ZW-+7$A^";94-"= E%U ^]-=S-?ND4X8PE>/J;"UL6D8X
MU*E*36?LF:&>1!NGY+.Y6ZSBP:"^!H(@-DIG%.0$8L47L.S(;>"^I?=0\!I_
M]?JZ]?MVK]7$@7CZ>:G(Y!*"R0#!Z<-\3RVVD1#Y?9O7SQ;WL=A8:25RJO40
MNN*0?Z.YM'UG#[+J:]HMR?@7_AF.KPV$4^MT"#"$5@YX%ON,HO>7$5[/C0((
M+T6H$L+1?_XV%<0Z1E0+T,,A8PD0>_X6^4#]^ERE>Q,/[]/D.&B^9 9F>%R=
MB-U?I"<8XS+ZI&.]^ $XX:,,X?3LH#I4H&-IO<E/SGFQ6W9B>7BV\0#/MBG0
M2PC;9IX2-I!P8;KGBO#$6[4M#R'&6YAA'5/C>%V;YBH[KOTW@27UQ/;+^:)O
M]@/?'1+;'VS=&9'?C03R-@ 9\%Y=DM)WI@[,I5<_U<->,8.Y^K#MK)]<W3<@
MDCZ*D,BF!6JXMO4%0V2LDL7V0(FUQ8P^;V_/[).K2U* E7V(<1"J234#MJT
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MEKV%]7"_]M#J2.A2&9SSWE?=]]Z^Z!]6K@EJN9?D)11M7FZY28GZVIB_E#,
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MH3S.N%+_7B;F O<#'TLF><K9]W92QY'\:X*);B\NS]H&A2N-=>2ICC>;RP'
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MZ]!-MEFK&*VC<@6?_$PM/O.L=IJ(>TQ>:.DN(\DFWJ\IGF-T%IJ*YYS+(?M
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M.KY;O+]#)4=HZ:59PF>>ATG/%TL88A[SGZN[]@!N'*>77NE4]:?Z%P/"=LY
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M=2TR,#(S,#,S,2YX<V102P$"% ,4    " !RD^-6)E*(+@(.   ZY0  %@
M            @ $A&P  9&MD8W4M,C R,S S,S%?8V%L+GAM;%!+ 0(4 Q0
M   ( '*3XU:'5 SP>F4  *\2!P 6              "  5<I  !D:V1C=2TR
M,#(S,#,S,5]D968N>&UL4$L! A0#%     @ <I/C5N%'A7SF>   ?CH' !8
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M9#$W+FAT;5!+ 0(4 Q0    ( '*3XU;SK:M-4J(  .%6!  :
M  "  :<+ @!D:V1C=2TR,#(S,#,S,7AE>#$P9#(P+FAT;5!+ 0(4 Q0    (
M '*3XU;#]X1T3@\  ,-.   :              "  3&N @!D:V1C=2TR,#(S
M,#,S,7AE>#$P9#(Q+FAT;5!+ 0(4 Q0    ( '*3XU8+-/)C[1,  ":D   :
M              "  ;>] @!D:V1C=2TR,#(S,#,S,7AE>#$P9#(R+FAT;5!+
M 0(4 Q0    ( '*3XU:<*RTB$ 0  * ,   9              "  =S1 @!D
M:V1C=2TR,#(S,#,S,7AE>#(S9#$N:'1M4$L! A0#%     @ <I/C5N03A&P3
M P  R0<  !D              ( !(]8" &1K9&-U+3(P,C,P,S,Q>&5X,C-D
M,RYH=&U02P$"% ,4    " !RD^-6<^".Y9<$   O#@  &0
M@ %MV0( 9&MD8W4M,C R,S S,S%X97@R,V0T+FAT;5!+ 0(4 Q0    ( '*3
MXU8437-4N@8  !)%   8              "  3O> @!D:V1C=2TR,#(S,#,S
M,7AE>#-D-"YH=&U02P$"% ,4    " !RD^-6&\S?B;N]#0 PVI  %@
M        @ $KY0( 9&MD8W4M,C R,S S,S%X<S1A+FAT;5!+ 0(4 Q0    (
M '*3XU:&?7)VXGL  +5\   9              "  1JC$ !D:V1C=2TR,#(S
M,#,S,7AS-&$P,30N:G!G4$L! A0#%     @ <I/C5L/@([ 6S   O-@  !D
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M<S1A,#,R+FIP9U!+ 0(4 Q0    ( '*3XU:'6G-*)ZD  .W5   9
M      "  6MD%0!D:V1C=2TR,#(S,#,S,7AS-&$P,S0N:G!G4$L! A0#%
M  @ <I/C5B8T$FR"C0  O+,  !D              ( !R0T6 &1K9&-U+3(P
M,C,P,S,Q>',T83 S-BYJ<&=02P$"% ,4    " !RD^-6GO'C,HSJ  #=[P
M&0              @ &"FQ8 9&MD8W4M,C R,S S,S%X<S1A,#,W+FIP9U!+
M 0(4 Q0    ( '*3XU9ZQTVJ?IL! /': 0 9              "  46&%P!D
M:V1C=2TR,#(S,#,S,7AS-&$P,S@N:G!G4$L! A0#%     @ <I/C5L2UP"K]
M*@  7"T  !D              ( !^B$9 &1K9&-U+3(P,C,P,S,Q>',T83 U
M-RYJ<&=02P$"% ,4    " !RD^-60@  RZ8C  ##)0  &0
M@ $N31D 9&MD8W4M,C R,S S,S%X<S1A,#4X+FIP9U!+ 0(4 Q0    ( '*3
MXU9D_&%JP"(  /$C   9              "  0MQ&0!D:V1C=2TR,#(S,#,S
B,7AS-&$P-3DN:G!G4$L%!@     = !T ^@<   *4&0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
